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New antimicrobials – before and after
entering clinical development
P532 Antimicrobial activity of telavancin against Enterococcus
faecalis, E. faecium and E. avium: results from a European
surveillance programme (2007)
T. Fritsche, H. Sader, R. Jones (North Liberty, US)
Objectives: To evaluate the potency of telavancin (TLV) against
enterococcal isolates (Enterococcus faecalis [EF], E. faecium [EFM] and
E. avium [EAV]) collected as part of a European surveillance protocol
for 2007. TLV is an investigational, intravenous, semi-synthetic, rapidly
bactericidal lipoglycopeptide that is broadly active against both aerobic
and anaerobic Gram-positive bacteria. The agent has been evaluated in
two Phase 3 complicated skin and skin structure infection clinical trials.
Methods: Non-duplicate clinical isolates (919 total; see Table) of EF
(579), EFM (318) and EAV (12) were submitted from 26 medical
centres in Europe participating in TLV surveillance. Identiﬁcations were
conﬁrmed by the central monitor and all isolates were susceptibility
tested using CLSI broth microdilution methods.
Results: Among the comparators, TLV was the most potent agent tested
against Enterococcus spp. (EF and EFM; MIC50 values, 0.25 and 0.06
mg/L, respectively; see Table) compared with vancomycin (VAN; 1 and
1 mg/L), daptomycin (1 and 2 mg/L), levoﬂoxacin (1 and >4 mg/L),
and linezolid (1 and 1 mg/L). TLV was 4-fold more active (MIC50)
than VAN against EF and 16-fold more active against EFM (only 15.4%
of EFM had TLV MIC values of >1 mg/L compared with 29.6% having
VAN MIC values >4 mg/L). Overall, 9.7% of tested enterococci were
VAN-resistant, including 1.0% of EF and 25.8% of EFM; TLV remained
16-fold more potent (MIC50) than VAN against these resistant EFM
strains. Among the comparators, only daptomycin and linezolid were
uniformly active against all enterococci (>99% susceptible), followed
by teicoplanin (92.4%) and VAN (88.9%). All but one strain of EAV
were inhibited by 0.06 mg/L of TLV.
Table. Antimicrobial activity of telavancin against year 2007 enterococcal isolates
Organism (N) MIC (mg/L) Cumulative % inhibited at MIC (mg/L)
50% 90% 0.06 0.12 0.25 0.5 1
EF (579) 0.25 0.5 1 22 84 99 99
VAN-susceptible (573) 0.25 0.5 1 23 84 100 −
VAN-resistant (6) >2 >2 0 0 0 0 0
EFM (318) 0.06 2 66 79 80 80 85
VAN-susceptible (224) 0.06 0.12 82 99 100 − −
VAN-resistant (82) 2 >2 18 21 21 22 40
EAV (12) 0.06 0.06 92 92 92 92 100
EAV, Enterococcus avium; EF, E. faecalis; EFM, E. faecium; VAN, vancomycin.
Conclusions: Based on MIC50 potencies, TLV was the most active agent
tested against European (2007) Enterococcus spp. isolates, and inhibited
94.0% of strains at 1 mg/L, whereas only 88.9% were inhibited by  4
mg/L of VAN (current breakpoint). Continued monitoring for resistance
emergence in enterococci and other Gram-positive pathogens will be
critical in assessing the long-term efﬁcacy of this promising agent.
P533 Activity of telavancin tested against viridans group and
beta-haemolytic streptococci, and multidrug-resistant
Streptococcus pneumoniae
T. Fritsche, G. Moet, H. Sader, R. Jones (North Liberty, US)
Objectives: To evaluate the activity of telavancin (TLV) tested against
viridans group streptococci (VGS, ﬁve species), beta-haemolytic strepto-
cocci (BHS) and Streptococcus pneumoniae (SPN), including multidrug-
resistant strains. TLV is a novel, rapidly bactericidal lipoglycopeptide
active against Gram-positive pathogens, including resistant subsets, and
has been evaluated in complicated skin and skin structure infection
clinical trials.
Methods: The activity of TLV was compared with those of other
antimicrobial classes using reference broth microdilution (CLSI, M7-
A7; Mueller-Hinton broth supplemented with 2−5% lysed horse blood)
methods tested against 1005 streptococci (100 each of ﬁve VGS species;
100 each of Lanceﬁeld Groups B, C and G BHS; and 205 SPN,
including multidrug-resistant patterns [>3 classes]) recovered from
global surveillance programmes.
Results: Among tested VGS, 99.8% had TLV MICs of 0.06 mg/L.
All MIC50 and MIC90 values for S. anginosus, S. constellatus, S. mitis
and S. oralis were 0.03 mg/L; S. intermedius showed an elevated MIC90
(0.06 mg/L) and the highest TLV MIC (0.25 mg/L). Serogroups B, C and
G BHS had the same modal TLV MIC (0.03 mg/L), but MIC90 results
varied from 0.03 mg/L for Group C BHS to 0.06 mg/L for Groups B
and G BHS. All BHS were inhibited by 0.12 mg/L. Against SPN,
TLV had a pronounced modal MIC at 0.015 mg/L (also MIC50 and
MIC90) and 99.5% of results were either 0.008 or 0.015 mg/L (highest
MIC). No difference in the TLV MIC90 (0.015 mg/L) was observed,
but the MIC50 was slightly lower (0.008 mg/L) for two resistance
phenotypes (penicillin-nonsusceptible [30 strains] and erythromycin-
resistant [10 strains]). TLV MIC results did not correlate with
mechanisms of resistance found for b-lactams, macrolides, tetracyclines,
ﬂuoroquinolones and trimethoprim/sulfamethoxazole. Overall, >99% of
TLV MIC results occurred within three dilution steps (0.015−0.06 mg/L)
for the tested streptococci.
Conclusions: TLV was found to be highly potent against prevalent
VGS, BHS and SPN. All isolates were inhibited by 0.06 mg/L TLV,
with two exceptions (0.2%): one group G BHS at 0.12 mg/L and one
S. intermedius at 0.25 mg/L. These results demonstrate that TLV may be
an excellent therapeutic candidate for serious infections caused by these
pathogenic organisms.
P534 Antimicrobial activity of telavancin and comparator
agents tested against recently isolated (2007) European
Staphylococcus aureus and coagulase-negative staphylococci
T. Fritsche, D. Biedenbach, H. Sader, R. Jones (North Liberty, US)
Objectives: Telavancin (TLV) is an investigational, novel, rapidly
bactericidal lipoglycopeptide that is broadly active against Gram-positive
pathogens, and has completed complicated skin and skin structure
infection clinical trials. Given concerns over the rapid emergence of
resistance among staphylococci, including community-acquired strains,
we compared the potency of TLV versus other antimicrobials against
contemporary oxacillin-susceptible (OX-S) and OX-resistant (OX-
R) Staphylococcus aureus (SA) and coagulase-negative staphylococci
(CoNS) collected as part of a European antimicrobial resistance
surveillance programme.
Methods: Consecutive, non-duplicate patient isolates (n = 2834) were
submitted from 26 medical centres in Europe (10 countries), Turkey and
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Israel during 2007 (2202 SA [OX-R, 29.3%], 632 CoNS [OX-R, 76.1%])
and susceptibility tested using CLSI (M7-A7) broth microdilution
methods.
Results: Compared with OX-S SA, TLV MIC90 values varied by
one dilution in OX-R SA (0.12 versus 0.25 mg/L, respectively; see
Table), but was unchanged for OX-R CoNS (0.25 mg/L); all isolates
were inhibited by 0.5 mg/L. TLV was 2-, 4- and 8-fold more potent
(MIC90) than daptomycin, vancomycin and linezolid, respectively, when
testing SA, and 2-, 8- and 4-fold more potent, respectively, when testing
CoNS. Among CoNS, TLV was most active against S. lugdunensis
(MIC50, 0.06 mg/L) and least active against S. warneri (MIC50, 0.25
mg/L; 10 isolates each); MIC50 values for other species (S. capitis [20
isolates], S. epidermidis [316 isolates], S. haemolyticus [34 isolates], and
S. hominis [59 isolates]) were all 0.12 mg/L. High levels of R to other
agents were observed among OX-R SA and CoNS with respective R
rates (%) as follows: erythromycin (69.8/68.0), clindamycin (30.0/29.7),
gentamicin (19.7/37.9), levoﬂoxacin (90.7/65.7), tetracycline (11.6/18.3)
and trimethoprim/sulfamethoxazole (1.9/45.3).
Organism (N) MIC (mg L)
TLV VAN LEV LZD
50% 90% 50% 90% 50% 90% 50% 90%
OX-S SA (1556) 0.12 0.12 1 1 0.5 0.5 1 2
OX-R SA (646) 0.12 0.25 1 1 >4 >4 1 2
OX-S CoNS (151) 0.12 0.25 1 2 0.5 0.5 0.5 1
OX-R CoNS (481) 0.12 0.25 2 2 4 >4 1 1
LEV, levoﬂoxacin; LZD, linezolid; TLV, telavancin; VAN, vancomycin.
Conclusions: TLV displayed higher potency than the other agents tested
against SA and CoNS (MIC50 and MIC90 values for both, 0.12 and
0.25 mg/L), and inhibited all isolates at 0.5 mg/L. TLV exhibited
similar potency for OX-S and -R strains. The continued and rapid
emergence of resistant staphylococci, including community-associated
OX-R SA, necessitates the timely introduction of new therapeutic agents
and longitudinal surveillance to assist in control efforts.
P535 Activity of telavancin against isolates from recently
completed Phase 3 studies of complicated skin and skin
structure infections
K.M. Krause, S.L. Barriere, M.M. Kitt, B.M. Benton (South San
Francisco, US)
Objective: Telavancin (TLV) is a novel, bactericidal lipoglycopeptide
with a broad and potent Gram-positive spectrum of activity that includes
meticillin-resistant Staphylococcus aureus (MRSA). TLV possesses a
unique, multifunctional mechanism of action that includes inhibition of
cell wall biosynthesis and disruption of bacterial membrane function. The
efﬁcacy and safety of TLV have been studied in patients with complicated
skin and skin structure infections (cSSSIs) in two methodologically-
identical, worldwide, Phase 3 studies (ATLAS 1 and ATLAS 2). Here, we
report the susceptibility testing results for TLV and comparators against
the Gram-positive isolates collected in these studies.
Methods: A total of 1506 baseline Gram-positive isolates were obtained
from 1867 cSSSI patients enrolled in the ATLAS studies throughout
North America, Europe, South Africa, South America and Asia during
2005 and 2006. All isolates were identiﬁed and susceptibility tests
were performed at a central laboratory. MIC values were determined
by the CLSI broth microdilution method, using frozen reference MIC
panels.
Results: MIC50, MIC90 and ranges for TLV against staphylococci,
streptococci and enterococci are shown in the table. Based on MIC90
comparisons, TLV was 2−4-fold more potent than vancomycin, and up
to 2-fold more potent than teicoplanin against staphylococci. Teicoplanin
was more active against enterococci (MIC90 = 0.25 microg/mL)
than TLV or vancomycin (MIC90 = 1 microg/mL and 2 microg/mL,
respectively), but less active against coagulase-negative staphylococci
(MIC50 = 2 microg/mL). Daptomycin MIC values were similar to
TLV against staphylococci and S. pyogenes, but were elevated for
S. agalactiae (MIC90 = 0.25 microg/mL), other Streptococcus spp.
(MIC90 = 1 microg/mL) and vancomycin-resistant enterococci (MIC90
= 2 microg/mL for E. faecalis and MIC50 = 2 microg/mL for
E. faecium/E. avium, respectively). Linezolid MIC90 values were
consistently 1−4 microg/mL.
Organism No. of TLV MIC (mg/mL)
isolates MIC range MIC50 MIC90
Staphylococcus aureus 1214 0.12−1 0.5 0.5
MSSA 464 0.12−1 0.5 0.5
MRSA 750 0.12−1 0.5 0.5
CoNS 6 0.25−0.5 0.5 NA
Streptococci 201 0.015−0.12 0.06 0.06
S. pyogenes 61 0.015−0.12 0.03 0.06
S. agalactiae 46 0.06−0.12 0.06 0.06
Others* 94 0.015−0.12 0.06 0.06
Enterococci 85 0.06−1 0.5 1
E. faecalis 78 0.25−1 0.5 1
E. faecium and E. avium 7 0.06−0.25 0.12 NA
CoNS, coagulase-negative staphylococci; MRSA: meticillin-resistant
S. aureus; MSSA, meticillin-susceptible S. aureus.
*Includes S. acidominimus, S. anginosus, S. bovis, S. canis, S. constel-
latus, S. dysgalactiae, S. dysgalactiae ssp. equisimilis, S. intermedius,
S. mitis, S. oralis, S. pneumoniae and viridans group streptococci.
Conclusions: TLV was active against Gram-positive pathogens common
in cSSSIs. Based upon MIC90, TLV was among the most active agents
tested. These data highlight the potential therapeutic use of TLV in the
treatment of cSSSIs due to Gram-positive pathogens.
P536 Activity of telavancin against complicated skin and skin
structure infection isolates according to specimen source
B.M. Benton, S.L. Barriere, M.M. Kitt, K.M. Krause (South San
Francisco, US)
Objective: Telavancin (TLV) is a novel, bactericidal lipoglycopeptide
with a broad and potent Gram-positive spectrum of activity. TLV’s
unique, multifunctional mechanism of action includes inhibition of
bacterial cell wall biosynthesis and disruption of bacterial membrane
function. The efﬁcacy and safety of TLV were studied in patients
with complicated skin and skin structure infections (cSSSIs) in two
identical, worldwide, Phase 3 studies (ATLAS 1 and ATLAS 2). Here, we
report the susceptibility testing results by infection type (major abscess,
deep/extensive cellulitis, wound, burn or ulcer) for TLV against the
Gram-positive isolates collected in these studies.
Methods: A total of 1506 baseline Gram-positive isolates were obtained
from among the 1867 cSSSI patients enrolled in the ATLAS studies
throughout North America, Europe, South Africa, South America and
Asia during 2005−06. All isolates were identiﬁed and susceptibility tests
were performed at a central laboratory. MIC values were determined
by the CLSI broth microdilution method, using frozen reference MIC
panels.
Results: See Table.
Conclusions: TLV was active against Gram-positive pathogens common
in cSSSIs, irrespective of the infection site. These data highlight the
potential therapeutic use of TLV in the treatment of Gram-positive
cSSSIs at a variety of infection sites.
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Organism No. of TLV MIC (mg/mL)
isolates MIC range MIC50 MIC90
Staphylococci (1220)
Major abscess 638 0.25−1 0.5 0.5
Deep/extensive cellulitis 303 0.12−1 0.25 0.5
Wound infection 191 0.12−1 0.5 0.5
Infected burn 16 0.25−0.5 0.25 0.5
Infected ulcer 72 0.12−1 0.5 0.5
Streptococci (201)
Major abscess 91 0.015−0.12 0.06 0.06
Deep/extensive cellulitis 68 0.015−0.06 0.03 0.06
Wound infection 22 0.015−0.12 0.015 0.03
Infected burn 5 0.015−0.06 0.03 NA
Infected ulcer 15 0.015−0.12 0.06 0.12
Enterococci (85)
Major abscess 19 0.25−1 0.5 1
Deep/extensive cellulitis 30 0.25−1 0.5 1
Wound infection 14 0.25−1 0.5 1
Infected burn 2 0.5 NA NA
Infected ulcer 20 0.06−1 0.5 1
P537 Cell wall and membrane effects of oritavancin on
Staphylococcus aureus and Enterococcus faecalis
A. Belley, B. Harris, T. Beveridge, T. Parr Jr., G. Moeck (St-Laurent,
Elora, CA)
Objective: The lipoglycopeptide oritavancin (ORI) exerts rapid bac-
tericidal activity in vitro against meticillin-resistant Staphylococcus
aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE),
distinguishing it from glycopeptides like vancomycin (VAN). In this
study, we compared the ultrastructural effects of ORI and VAN on MRSA
and of ORI on VRE by transmission electron microscopy (TEM).
Methods: Exponentially-growing S. aureus ATCC 43300 (MRSA, 109
CFU) was exposed to 1 mg/L ORI or 16 mg/L VAN (16 X their
respective broth microdilution minimal inhibitory concentrations) for 10
min whereas the VRE clinical isolate E. faecalis A5241515 was exposed
to ORI at 1 mg/L (16 X its broth microdilution minimal inhibitory
concentration) for 10 min. Bacteria were ﬁxed in 2.5% glutaraldehyde,
embedded and thin sectioned for TEM. TEM was performed using a
Philips CM10 under standard operating conditions at 100 kV.
Results: Compared to VAN treatment, fewer cells were present in ORI-
exposed MRSA samples, an indication that some cell lysis had occurred.
The presence of cell ghosts (remnants of ﬁxed lysed cells) indicated that
lysis occurred mainly at the cell wall peripheral to the septum. Both
ORI and VAN induced membrane inclusions; however, the effects of
ORI were noticeably more pronounced. ORI had a distinct effect on
the septum as evidenced by deformations and loss of the ‘mid-line’, a
region of dense staining due to the activity of autolysins that cleave cell
wall polymers during daughter cell separation. Interestingly, ORI did
not affect the mid-line of the VRE isolate. VRE exposed to ORI had
small, thin ﬁbers protruding from division scars, the visible junction
between existing and nascent cell wall in enterococci. These ﬁbers
probably resulted from cell wall breakdown as examination of VRE cell
ghosts showed that rupture occurred at these sites. ORI-exposed VRE
also exhibited membrane inclusions and septal distortions.
Conclusion: TEM data strongly suggest that ORI affected the
coordination of cell division in S. aureus. ORI apparently induced
breakdown of the cell wall at division scars in VRE. These effects on
MRSA and VRE suggest that ORI may act largely during growth and
division of these important pathogens.
P538 Anti-enterococcal and anti-sreptococcal activity proﬁle of
oritavancin in Europe
D. Draghi, G. Moeck, F. Arhin, C. Pillar, D. Sahm (Herndon, US;
St. Laurent, CA)
Objective: Oritavancin (ORI) is a bactericidal lipoglycopeptide under
clinical development for the treatment of infections caused by a
variety of Gram-positive organisms (Org). Vancomycin (VAN)-resistant
enterococci (VRE), in particular E. faecium (EM) with the vanA
genotype isolated from non-hospitalised persons, are prevalent in Europe
(EU). This surveillance initiative established a current in vitro activity
proﬁle of ORI against enterococci (EN) and streptococci (STR),
including those resistant (R) to currently available agents.
Methods: Recent (2005) clinical isolates of E. faecalis (EF; n = 151),
EM (n = 150), S. pneumoniae (SP; n = 100) and b-hemolytic streptococci
([BS]; 41 S. pyogenes [SPY], 26 S. agalactiae [SAG], 11 Group C, G
and F streptococci) collected from 35 hospital sites across 14 countries
in EU, were centrally tested by broth microdilution (CLSI; M7-A7). ORI
assays included 0.002% polysorbate-80 throughout. ORI activity for EN
was analysed according to VAN susceptibility (S) and for STR according
to macrolide or penicillin (PEN) S status. Additionally, multi-drug
resistance [MDR; concurrent resistance to  2 of the agents listed: PEN,
cefuroxime, erythromycin (ERY), and trimethoprim-sulfamethoxazole]
among SP was examined.
Results: See table.
Org Category N ORI mg/L
MIC range MIC90
EF All 151 0.0005−1 0.25
VAN S 132 0.0005−0.5 0.06
VAN NS 19 0.03−1 1
EM All 150 0.008−0.5 0.12
VAN S 117 0.008−0.25 0.03
VAN NS 33 0.008−0.5 0.5
SPY All 41 0.015−0.5 0.25
ERY S 34 0.015−0.5 0.25
ERY NS 7 0.03−0.12 NA
BS All 11 0.001−0.12 0.12
ERY S 7 0.001−0.12 NA
ERY NS 4 0.03−0.12 NA
SP All 100 0.0005−0.015 0.008
PEN S 67 0.0005−0.015 0.008
PEN I 18 0.001−0.008 0.008
PEN R 15 0.002−0.015 0.008
MDR 26 0.002−0.015 0.008
Non-MDR 74 0.0005−0.015 0.008
SAG All 26 0.03−0.25 0.25
ERY S 20 0.03−0.25 0.25
ERY NS 6 0.06−0.25 NA
NA = not applicable for <10 isolates; NS = non-susceptible (intermediate
and R).
Conclusions: ORI showed potent activity against all EN; however, the
ORI MIC90 was higher for VAN NS versus VAN S enterococci. Based
on MIC90, ORI was active against all STR, regardless of resistance
phenotype. Based on these ﬁndings, ORI offers promise for the treatment
of infections caused by EN or STR, including those R to currently used
agents.
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P539 In vitro activity proﬁle of oritavancin against resistant
staphylococcal populations from a recent surveillance
initiative in Europe
D. Sahm, G. Moeck, C. Pillar, F. Arhin, D. Draghi (Herndon, US;
St. Laurent, CA)
Objectives: Oritavancin (ORI), currently in clinical development for use
in the treatment of infections caused by Gram-positive bacteria, is a
potent bactericidal lipoglycopeptide. ORI has previously shown potent
activity against staphylococci (STA), including resistant (R) strains. This
surveillance (SUR) initiative was undertaken to proﬁle the in vitro
activity of ORI against drug-R and multi-drug resistant (MDR) STA
in Europe (EU).
Methods: Recent (2005–2006) clinical isolates of S. aureus (SA;
n = 557) and coagulase-negative staphylococci (CoNS; n = 78) from
hospital sites in EU (48 sites; 15 countries), were centrally tested by broth
microdilution (CLSI; M7-A7) against ORI and relevant comparators.
ORI assays included 0.002% polysorbate-80 throughout. ORI activity
was analysed for STA according to oxacillin (OX) susceptible (S)
status and MDR phenotypes. MDR was deﬁned as concurrent R to
3 of the following agents: ciproﬂoxacin (CIP), clindamycin (CLI),
erythromycin (ERY), gentamicin (GEN), Ox, quinupristin-dalfopristin,
trimethoprim-sulfamethoxazole (SXT), vancomycin, daptomycin (non-
susceptible [NS]), and linezolid (NS).
Results: 58.9% of SA and 61.5% of CoNS had an MDR phenotype.
The most prevalent MDR phenotypes among SA included 16.7% CIP-R,
ERY-R, and OX-R; and 16% CIP-R, ERY-R, OX-R, and CLI-R. Among
CNS, 24.4% were 6-drug R which included CIP, CLI, ERY, GEN, OX,
and SXT.
Organism Phenotype N ORI mg/L
MIC range MIC90
SA All 557 0.008−4 0.25
Ox S 152 0.008−0.25 0.12
Ox R 405 0.015−4 0.25
MDR 328 0.008−4 0.25
Non-MDR 229 0.015−0.25 0.25
CoNS All 78 0.008−1 0.25
Ox S 22 0.008−1 0.25
Ox R 56 0.015−1 0.25
MDR 48 0.015−1 0.25
Non-MDR 30 0.008−1 0.25
Conclusions: SUR studies are essential for reviewing current trends
in in vitro susceptibility patterns among antimicrobial agents used to
treat serious infections. ORI had potent and consistent activity against a
diverse EU collection of staphylococci which included OX-R and MDR
phenotypes.
P540 Comparison of oritavancin versus vancomycin as treatment
for clindamycin-induced C. difﬁcile ribotype 027 infection in
a human gut model
S. Baines, R. O’Connor, K. Saxton, J. Freeman, M. Wilcox (Leeds, UK)
Objectives: C. difﬁcile infection (CDI) is a nosocomial disease of
increasing importance. First line treatment is limited currently to
metronidazole or vancomycin (VAN). Recent reports have questioned the
efﬁcacy of current therapies for CDI, particularly against an apparently
hypervirulent C. difﬁcile (CD) strain, PCR ribotype 027 (NAP1/BI).
Oritavancin (ORI) is a lipoglycopeptide with activity against Gram-
positive bacteria, including drug-resistant pathogens. We evaluated the
efﬁcacy of ORI and VAN in treatment of clindamycin-induced CDI in
separate experiments in an in vitro human gut model.
Methods: CD PCR ribotype 027 was used in both experiments.
Clindamycin instillation was used to achieve human gut concentrations
and to induce CD spore germination, proliferation and high-level
cytotoxin production. ORI and VAN were instilled at levels equivalent
to expected human faecal concentrations. Gut ﬂora and CD (vegetative
cells and spores) were recovered and enumerated using selective media
and viable counting. CD toxin was detected by cytotoxin assay.
Results: Clindamycin exposure elicited CD proliferation and high-level
(5RU) cytotoxin production in both experiments on day 35. ORI and
VAN levels peaked at 52 and 1144 mg/L in vessel 3, respectively.
VAN instillation reduced vegetative CD counts within 1 day but did
not affect CD spore counts. On day 2 of ORI instillation both CD total
and spore counts declined by approx 2 logs cfu/mL; on day 3 counts were
below the limits of detection and remained so during the rest of ORI
instillation. Centrifugation and washing of culture samples, in addition
to exposure to activated charcoal (20−40g/L) did not enhance recovery
of C. difﬁcile. Cytotoxin titres declined to the limits of detection in both
experiments but did so 5 days sooner in the VAN experiment. Further
CD proliferation and high-level cytotoxin production occurred 12 days
after the end of VAN instillation, whereas CD in the ORI experiment
was only sporadically isolated at the limits of detection.
Conclusion: Both ORI and VAN were effective in treating clindamycin-
induced CDI in a human gut model, but only ORI appeared active
against spore forms of CD. Recurrence of toxin production was observed
following VAN instillation but not ORI. These results suggest that
ORI should be as effective as VAN in treating CDI, and may prevent
recrudescence of CD spores.
P541 Dalbavancin (DECIDE) tested against indicated Gram-
positive species in European medical centres: results from
France
R. Leclercq, C. Soussy, Y. Rio, M. Roussel-Delvallez, J. Etienne,
D. Biedenbach, R. Jones (Caen, Creteil, Metz, Lille, Lyon, FR; North
Liberty, US)
Objective: To assess the dalbavancin (DAL) spectrum and potency when
tested against recent clinical isolates from ﬁve medical centres in France
from October to December, 2007 (374 strains).
Methods: Standardised and reference-quality susceptibility (S) methods
of agar diffusion were applied by each investigator. Etest (ET; AB
BIODISK, Solna, Sweden) and CLSI (M2-A9) disk diffusion (DD)
tests were performed with concurrent quality control (CLSI M100-S17,
2007) and repeated testing of strains showing unusual resistance (R)
patterns in linezolid (LZD)-R, vancomycin (VAN) or DAL-non-S. A
total of 374 strains were tested against DAL and VAN by ET; and
LZD, cefoxitin (meticillin susceptibility surrogate), levoﬂoxacin (LEV),
gentamicin (GEN), tetracycline (TC), erythromycin (ERY), clindamycin
(CC; plus D-test, penicillin (PEN) and ceftriaxone (CRO) by DD. All ﬁve
French sites had acceptable quality control results. DAL-S was deﬁned
at 0.25 mg/L for staphylococci and streptococci.
Results: DAL exhibited 16-fold greater activity than VAN against the
251 S. aureus (MIC50/90, 0.094/0.125 mg/L), 50 coagulase-negative
staphylococci (CoNS; MIC50/90, 0.064/0.125 mg/L) and 73 beta-
haemolytic streptococci (BHS; MIC50/90, 0.016/0.032 mg/L). The
most common beta-streptococci group was S. pyogenes (approx. 60%
of strains). MRSA rates were uniform from 20 to 29% (average at 25%)
among sites and S rates across all staphylococci were LZD (100%),
LEV (55−74%), ERY (59−73%), CC (80−86% with additional 9−18%
inducible R), TC (93−94%) and GEN (63−98%). D-test positive rates in
BHS and CoNS were 0 and 47% of ERY-R/CC-S isolates, respectively.
LEV-R BHS (one each of gr. A and G) were detected in Paris. The most
elevated DAL MIC results were 0.25 mg/L (two strains, SA and CoNS)
from Paris and Lyon.
Conclusions: DAL, a novel glycolipopeptide (t1/2 at 6−8 days; once
weekly dosing) showed high activity (MIC90 range, 0.032−0.125
mg/L) against tested staphylococci and BST from France. The
documented DAL activity (16-fold greater than VAN) exhibited wide
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spectrum of coverage of contemporary Gram-positive pathogens endemic
to the ﬁve centres including strains R to other antimicrobial classes.
Table: Comparative activity of DAL in France (5 sites)
Method/Antimicrobial % S activity by pathogen (no.)
S. aureus (251) CoNS (50) BHS (73)
Etest
Dalbavancin 100 100 100
Vancomycin 100 100 100
Disk diffusion
Linezolid 100 100 99
Erythromycin 73 59 73
Clindamycina 86 (9) 80 (18) 73 (0)
Levoﬂoxacin 74 55 94
Oxacillinb 75 49 NT
a. Includes % R results with D-test inducible CC-R in parentheses.
b. MRSA rate was 25% tested by cefoxitin disks (21 mm); and all
BHS were CRO- and PEN-S.
P542 Comparative activity of dalbavancin tested against indicated
Gram-positive species in Europe: results from two Spanish
medical centres (DECIDE Program)
R. Canton, A. Pascual, D. Biedenbach, R. Jones (Madrid, Seville,
ES; North Liberty, US)
Objective: To assess the activity of dalbavancin (DAL) tested against
recent clinical Gram-positive isolates from two medical centres in
Spain over the time interval of October to December, 2007. DAL has
documented activity comparable to glycopeptides (vancomycin [VAN]
and teicoplanin), a prolonged elimination half-life and clinical success
in trials for complicated skin and skin structure infections. Potency of
DAL was determined separately in ﬁve European nations to monitor
potential geographic variations against indicated species.
Methods: Standardised and reference quality susceptibility (S) methods
of agar diffusion were applied by each investigator. Etest (ET; AB
BIODISK, Solna, Sweden) and CLSI (M2-A9) disk diffusion (DD) tests
were performed with concurrent quality control (CLSI M100-S17, 2007)
and repeated testing of strains showing unusual resistance (R) patterns
of linezolid (LZD)-R, and VAN or DAL-non-S. A total of 150 strains
were tested against DAL and VAN by ET, and LZD, cefoxitin (for
meticillin testing), levoﬂoxacin (LEV), gentamicin (GEN), tetracycline
(TC), erythromycin (ERY), clindamycin (CC; plus D-test), penicillin
(PEN) and ceftriaxone (CRO) by DD. All sites had acceptable control
results using three QC strains. DAL-S was deﬁned as 0.25 mg/L.
Results: DAL exhibited high potency against the 100 S. au-
reus (MIC50/90, 0.047/0.094 mg/L), coagulase-negative staphylococci
(CoNS; MIC50/90, 0.047/0.125 mg/L) and beta-haemolytic streptococci
(BHS; MIC50/90, 0.016/0.016 mg/L). This activity (MIC50 compar-
ison) was 16-, 32- and 64-fold greater than VAN, respectively. MRSA
rates varied from 6 to 24 (15% overall) between sites and S. aureus
S rates were LZD (100%), LEV (82%), ERY (75%), CC (96% with
additional 9% inducible R). D-test positive rates in CoNS were 5%;
overall CC-R was at 35%. Meticillin R did not adversely inﬂuence
DAL activity. All BHS (63% S. pyogenes) were PEN- and CRO-S.
GEN (75−95% S) and TC (85−96% S) were modestly active versus
the S. aureus and CoNS strains.
Conclusions: DAL, a novel long-acting glycolipopeptide (once weekly
dosing) demonstrated high activity (MIC90 ranges, 0.016−0.125 mg/L)
against tested staphylococci and BHS from Spanish hospitals. The
highest recorded MIC was 0.25 mg/L, conﬁrmed in a CoNS from
Madrid. The exhibited DAL potency (16-fold greater than VAN)
appears to cover contemporary Gram-positive pathogens endemic in this
area of Europe.
Comparative activity of DAL in Spain
Antimicrobia1 % S activity by pathogen (no.)
S. aureus (100)a CoNS (20) BHS (30)b
Dalbavancin 100 100 100
Vancomycin 100 100 100
Linezolid 100 100 100
Erythromycin 75 50 87
Clindamycinc 87 65 90
Levoﬂoxacin 82 50 90
Ceftriaxone NT NT 100
a. MRSA rate was 15%.
b. Includes gr. A (19), gr. B (3), gr. C (2), gr. F (2) and gr. G (4), and
all BHS were PEN-S (zone, 29mm).
c. Includes results from D-test (inducible CC-R).
P543 Daptomycin susceptibility testing of linezolid-resistant
Staphylococcus cohnii isolates
V. Papaioannou, S. Tsiplakou, A. Stylianakis, D. Paraskevopoulou,
F. Zoumpouloglou, D. Lykou, A. Koutsoukou (Athens, GR)
Objectives: Daptomycin is a cyclic lipopeptide with potent activity
and broad spectrum against Gram-positive bacteria approved for
the treatment of complicated skin and skin structure infections and
bacteraemia, including right sided endocarditis. The aim of this study
was to evaluate the susceptibility of daptomycin against 26 clinical
isolates of multi-drug resistant Staphylococcus cohnii, all being resistant
to linezolid, recovered from blood cultures.
Methods: 26 non-duplicate isolates of Staphylococcus cohnii were tested
for susceptibility to daptomycin with the method of E-test (AB Biodisk,
Solna, Sweden) according to the manufacturer’s recommendations. Those
isolates were isolated from blood cultures of patients hospitalised in
KAT hospital during a period of approximately three years (July 2005
to November 2007). Susceptibility testing was performed using the
VITEK2 System (Biomerieux, France). MICs for linezolid were also
determined with the use of E-test. Interpretation of MICs was according
to CLSI guidelines.
Results: All isolates were found resistant to oxacillin, ciproﬂoxacin,
clindamycin, erythromycin, quinupristin/dalfopristin and susceptible to
gentamicin, teicoplanin, tetracyclin, trimethoprim/sulfamethoxazole, and
vancomycin. Susceptibility to fucidic acid and rifampicin varied from
intermediate to resistant. Most isolates were intermediately resistant to
moxiﬂoxacin except for two that were resistant. All isolates were resistant
to linezolid (MIC 8 mg/L) and susceptible to daptomycin with MICs
ranging between 0.5 mg/L (8 isolates, 30.8%), to 0.75 mg/L (11 isolates,
42.3%) and up to 1.0 mg/L (7 isolates, 26.9%).
Conclusion: Daptomycin showed excellent in vitro activity against
multi-drug resistant isolates of Staphylococcus cohnii. It seems to be
a promising solution to such isolates of Gram-positive bacteria while
other therapeutic options such as linezolid, teicoplanin and quinupristin/
dalfopristin are being eliminated by increasing resistance.
P544 In vitro time-kill studies of oritavancin against drug-resistant
isolates of Staphylococcus aureus
G.A. McKay, S. Beaulieu, F.F. Arhin, T.R. Parr Jr., G. Moeck (Ville
Saint Laurent, CA)
Background: Oritavancin (ORI), a semi-synthetic lipoglycopeptide,
exerts bactericidal activity against Gram-positive bacteria including
vancomycin (VAN)-resistant S. aureus and enterococci. To characterise
ORI activity in vitro we performed time-kill (TK) experiments against
S. aureus of clinical importance, including recent antibiotic-resistant
isolates.
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Methods: 6 strains of S. aureus (1 meticillin-resistant [MRSA],
1 community-acquired [CA] MRSA, 1 linezolid-resistant MRSA,
1 heterogeneous VAN-intermediate [hVISA], and 2 VAN-resistant
[VRSA]) were tested in TK assays based on CLSI guidelines. ORI assays
included 0.002% polysorbate-80 throughout. ORI and comparators VAN,
teicoplanin (TEI), linezolid (LIN) and daptomycin (DAP) were tested at
static concentrations approximating their free peak (fCmax) and free
trough in plasma when administered at standard doses. Cell counts were
determined by serial dilution plating.
Results: ORI showed concentration-dependent killing of all strains
tested: at its fCmax (predicted from a 200 mg dose in humans), ORI
displayed bactericidal activity ( 3 log kill relative to starting inoculum)
against the MRSA, CA MRSA and linezolid-resistant MRSA within 2 h.
Against VRSA, ORI demonstrated 3 log kill relative to starting inoculum
within 3 h for VRS2 and 6 h for VRS1. At fCmax, ORI was bactericidal
against hVISA at 24 h; at fCmax predicted from an 800 mg dose, ORI
achieved 3 log kill by 6 h for this strain.
Conclusions: ORI displayed concentration-dependent killing of MRSA,
VRSA, hVISA in vitro. ORI was more rapidly bactericidal against all
bacteria tested than were VAN, TEI, LIN or DAP at physiologically-
relevant concentrations. These data support the conclusion that ORI
displays concentration-dependent bactericidal activity on recent, drug-
resistant isolates of S. aureus.
P545 Clinical efﬁcacy of iclaprim in complicated skin and skin
structure infection: preliminary results from the ASSIST-2
clinical trial
M. Dryden, O. O’Hare, E. Sidarous, P. Hadvary, K. Islam (Winchester,
Bournemouth, UK; Reinach, CH)
Objective: To compare the clinical efﬁcacy of iclaprim (ICL) with that of
linezolid (LZD) at the test-of-cure (TOC) visit in the ASSIST-2 (Arpida’s
Skin and Skin Structure Infection Study-2), randomised, multicentre,
double-blind, Phase III clinical trial.
Methods: Patients with complicated skin and skin structure infection
(cSSSI) were randomised to one of two treatment arms: intravenous ICL
0.8 mg/kg q 12 hours or intravenous linezolid (LZD) 600 mg q 12 hours
and received 10−14 days treatment. Clinical cure rate at the TOC visit
in the intent-to-treat (ITT) and the per protocol (PP) populations was
the primary efﬁcacy endpoint for this study. The non-inferiority margin
assigned was <12.5% for the 95% conﬁdence interval (CI) for treatment
difference.
Results: The ITT population comprised 494 patients (ICL: 251; LZD:
243), with 404 of these patients eligible for the per-protocol (PP)
population (ICL: 205; LZD: 195). The distribution of cSSSIs at baseline
was: wound infection (45%), major abscess (30%), cellulitis (28%),
infected ulcers (8%), and infected burns (7%), with little variation
between the treatment groups. The most commonly isolated baseline
pathogen was Staphylococcus aureus (309 isolates), accounting for 63%
of all Gram-positive pathogens (ICL: 59%; LZD: 66%). Meticillin-
resistant S. aureus (MRSA) represented 50% of all S. aureus strains
(ICL: 50%; LZD: 50%). Clinical cure rates were comparable between
treatment groups in the ITT population (ICL: 81.3%, 95% CI =
75.9%-85.9%; LZD: 81.9%, 95% CI = 76.5%-86.5%). In the PP
population there was a small numerical difference between the two
groups (ICL: 90.0%; LZD: 96.9%).However, the number of patients
receiving prohibited antibiotics and being therefore excluded from
the PP population was much higher in the linezolid group. In a
clinically evaluable population including the patients taking prohibited
antibacterial agents during the trial, the clinical cure rates were
comparable (ICL: 84.7%, 95% CI = 79.3%-89.2%; LZD: 86.6%, 95%
CI = 81.4%-90.9%). The 95% CI for treatment difference was −8.83%
to 4.95% in the population.
Conclusions: ICL shows high efﬁcacy in patients with cSSSI as
evidenced by the high cure rates. ICL achieved the pre-specﬁﬁed primary
endpoint of non-inferior clinical cure rate when compared with LZD. ICL
could be a useful addition to the antibacterial armamentarium for cSSSI.
P546 Dose linearity and gender-independent pharmacokinetics
of intravenous iclaprim assessed in two randomised,
double-blind and controlled cross-over studies
U. Ullmann, R. Brandt, P. Hadvary, K. Islam (Reinach, CH)
Objectives: Iclaprim, a new antibiotic from the class of the diaminopy-
rimidines, had linear pharmacokinetics (PK) in the ﬁrst-in-man dose
escalation studies. In order to conﬁrm the initial PK proﬁle of iclaprim,
two more PK studies were conducted.
Methods: In two randomised, double-blind, and placebo-controlled
cross-over studies the PK proﬁle in response to iclaprim dosing was
investigated. In Study A, 24 healthy subjects (12 males [m], 12 females
[f]) received a single intravenous (IV) infusion (150 mL in 30 minutes)
of 1.6 mg/kg, 3.2 mg/kg or placebo applying a three-way cross-over
design. In Study B, 24 healthy subjects (12 m, 12 f) received a single
IV infusion (150 mL in 30 min) of 0.4 mg/kg, 0.8 mg/kg or 1.6 mg/kg
(150 mL in 60 min) or matching placebo applying a four-way cross-
over design. Blood samples for PK assessment were taken at pre-deﬁned
time points from pre-dose until + 24 hours post-administration (p.a.).
Treatments were separated by wash-out phases.
Results: The mean age of the subjects in Study A was 31.1 yrs (range
19−45) and in Study B, it was 33.5 yrs (range 20−45). PK data obtained
from these two studies are shown in the following table; SD values are
shown in parentheses. PK parameters such as the elimination half-life,
clearance and volume of distribution were comparable within the study
groups (m vs. f) and also across the studies.
Dose AUC(0−inf) (ng·h/mL) Cmax (ng/mL)
Overall Male Female Overall Male Female
Study A
1.6mg/kg 4550
(1189)
4475
(977)
4619
(1395)
1519
(337)
1545
(232)
1495
(420)
3.2mg/kg 9265
(2899)
9572
(2830)
8984
(3057)
2900
(553)
2921
(478)
2881
(635)
Study B
0.4mg/kg 1030
(281)
1003
(262)
1063
(313)
382
(79)
376
(91)
388
(66)
0.8mg/kg 2082
(709)
2175
(712)
2004
(729)
831
(245)
866
(294)
801
(204)
1.6mg/kg 4017
(1524)
4005
(1308)
4029
(1773)
1139
(290)
1109
(329)
1169
(256)
Conclusion: IV iclaprim PK after single doses (0.4 up to 3.2 mg/kg)
exhibits dose linearity. The PK proﬁle of iclaprim is independent of
gender.
P547 Assessment of safety and tolerability proﬁles after iclaprim
administration in complicated skin and skin structure
infection from the ASSIST-2 clinical trial (Arpida’s Skin and
Skin Structure Infection Study-2)
P. Hadvary, M. Dryden, M. O’Hare, E. Sidarous, W. Danker, A. Leighton,
K. Islam (Reinach, CH; Winchester, Bournemouth, UK; Durham, US)
Objective: To compare the safety and tolerability of iclaprim (ICL)
with that of linezolid (LZD) in the ASSIST-2, randomised, multicentre,
double-blind, Phase III clinical trial.
Methods: Patients with cSSSI were randomised to one of two treatment
arms: intravenous ICL 0.8 mg/kg q 12 hours or 600 mg intravenous
LZD q 12 hours and received 10−14 days treatment. The use of
systemic or topical antibiotics, steroids or Type IA/III anti-arrhythmic
drugs was prohibited during the study. Concomitant aztreonam and/or
metronidazole were allowed.
New antimicrobials – before and after entering clinical development S127
Results: Safety and tolerability data were obtained from 494 patients in
the ITT population (ICL: 250; LZD: 244). Treatment-emergent adverse
events (AEs) were reported in 56% of patients (ICL 54%; LZD 59%). In
general, ICL was better tolerated than LZD, with fewer patients reporting
AEs in all categories (drug-related, severe, serious, and those that led to
discontinuation of the patient from the study). The AEs were generally
mild to moderate in intensity in both treatment arms. A listing of AEs
that were possibly or probably related to study drug (>5%) is shown in
the table.
Table: AEs possibly or probably related to study drug in >2% of patients
System organ class ICL, n (%) LZD, n (%)
Blood and lymphatic system disorders 0 7 (2.87%)
Gastrointestinal disorders 24 (9.60%) 38 (15.6%)
General disorders and administration site
conditions
12 (4.80%) 10 (4.10%)
Infections and infestations 4 (l.60%) 7 (2.87%)
Investigations 31 (12.4%) 27 (11.1%)
Metabolism and nutrition disorders 3 (1.20%) 5 (2.05%)
Nervous system disorders 16 (6.40%) 26 (10.7%)
Psychiatric disorders 6 (2.40%) 1 (0.41%)
Respiratory and thoracic disorders 1 (0.40%) 8 (3.28%)
Skin and subcutaneous tissue disorders 13 (5.20%) 12 (4.92%)
Conclusions: ICL exhibits a good safety proﬁle and was well tolerated
in patients suffering from cSSSI. AEs of generally mild to moderate
intensity were observed. These results indicate that iclaprim has an
excellent safety and tolerability proﬁle in patients with cSSSI.
P548 Analysis of the effect of iclaprim on the QT interval in the
ASSIST-2 clinical trial
P. Hadvary, M. Dryden, M. O’Hare, W. Danker, K. Islam (Reinach,
CH; Winchester, Bournemouth, UK; Durham, US)
Objective: To assess the effect of ICL on QT prolongation in the
ASSIST-2 (Arpida’s Skin and Skin Structure Infection Study-2), a
randomised, multicentre, double-blind Phase III clinical trial.
Methods: Patients with cSSSI were randomised to one of two treatment
arms: intravenous ICL 0.8 mg/kg q 12 hours or intravenous linezolid
(LZD) 600 mg q 12 hours and received 10−14 days treatment. ECG
monitoring was carried out as part of the safety evaluation of these
patients and was performed at the following time points: Screening
(within 1 day of study entry), Day 1 pre- (Baseline; BL) and post-dose,
and Day 4 (post-dose).
Results: The ITT safety population comprised 494 patients (ICL: 250;
LZD: 244). QT prolongation data corrected according to Bazett’s formula
(QTcB) are summarised in the Table.
Table: Mean value and mean change from BL in QTcB measurements
ICL LZD
Mean value
(ms)
Mean change
from BL (ms)
Mean value
(ms)
Mean change
from BL (ms)
BL (Day 1 pre-dose) n = 249 n = 243
mean (SD) 424.9 (24.7) − 425.1 (23.8) −
Day 1 post-dose n = 243 n = 240
mean (SD) 432.7 (27.1) 7.8 (13.7) 426.7 (23.8) 1.9 (11.9)
Day 4 post-dose n = 240 n = 235
mean (SD) 428.9 (26.5) 4.2 (18.0) 425.5 (24.8) 0.7 (17.4)
The mean QTcB change from BL on Day 1 (post-dose) was 7.8±13.7 ms
and 1.9±11.9 ms in the ICL and LZD treatment groups, respectively. On
Day 4 (post-dose), the mean change from BL was smaller; 4.2±18.0 ms
(ICL) and 0.7± 17.4 ms (LZD). Three patients in the ICL treatment arm
were reported to have median QTcB intervals of >500 ms after dosing
on Day 1 and Day 4, compared with no patients in the LZD group. One
patient and 0 patients in the ICL and LZD groups respectively had an
increase of >60 ms from BL in QTcB interval on Day 1 post-dose, and
no patients exhibited this increase on Day 4 post-dose. The percentage
of cardiac adverse events possibly or probably related to study drug was
higher in the LZD group (ICL: 0.68%, LZD: 1.4%), and no cardiac
events were attributable to QTc prolongation.
Conclusions: Intravenous ICL tended to induce a small, transient
prolongation of the mean QTc interval by approximately 4−6 ms post-
dose. No cardiovascular adverse events related to QTc elevation were
reported.
P549 Lack of effect of the novel antibiotic iclaprim on the
anticoagulant activity and the pharmacokinetics of warfarin
in healthy subjects
P. Zeman, D. Trenk, M. Cap, S. Leggewie, E. Stengele, P. Hadvary,
K. Islam (Reinach, CH; Bad Krozingen, DE)
Objectives: The aim of this study was to investigate the potential
drug-drug interaction between the novel antibiotic iclaprim and the
anticoagulant drug warfarin in healthy subjects.
Methods: This was an open-label, randomised, two-period cross-over
study in twelve healthy male subjects. Administration of either a single
oral dose of warfarin 25 mg alone (W) or a single oral dose of
warfarin 25 mg on day three of an eight-day steady-state intravenous
(IV) iclaprim treatment regimen (W+I) was performed. The treatment
periods were separated by a washout period of at least 12 days. Plasma
pharmacokinetics (PK) of R, S-warfarin and the anticoagulant activity
of warfarin (INR – International Normalised Ratio) as well as PK of
iclaprim were determined. Safety parameters of the warfarin and the
iclaprim plus warfarin treatment regimens were assessed in addition.
Results: Total anticoagulant effect of warfarin was determined by
calculation of the area under the effect vs. time curve; treatment ratio
of W/W+I (AUEC: 1.059 [1.004, 1.116] 90% conﬁdence interval) and
the maximum INR observed (1.077 [1.020, 1.137]) were close to unity.
Therefore, the anticoagulant activity of warfarin was not affected by
concomitant treatment with iclaprim. Ratios for the area under the
plasma concentration time curve (AUC0-inﬁnity) of the more potent S-
enantiomer of warfarin (1.009 [0.949, 1.074]) and the maximum plasma
concentration (Cmax: 1.005 [0.947, 1.066]) were within the conventional
bioequivalence ranges. Similar ﬁndings were obtained with regard to PK
parameters of R-Warfarin which conﬁrms lack of interaction between
iclaprim and warfarin. Administration of warfarin during the course of
iclaprim treatment had no effect on plasma PK of iclaprim determined
after the ﬁrst infusion as well as during steady-state of the antibiotic.
Administrations of iclaprim and warfarin were well-tolerated by the study
subjects.
Conclusions: Results from this study demonstrated that repeated
intravenous infusions of iclaprim had no effect on the anticoagulant
activity and plasma pharmacokinetics of orally administered warfarin.
Thus, IV infusions of iclaprim may be administered to patients on
warfarin treatment without the necessity for dose adjustments of the
anticoagulant drug.
P550 Preliminary results of the microbiological efﬁcacy of iclaprim
in complicated skin and skin structure infection from the
ASSIST-2 clinical trial
M. Jones, M. O’Hare, C. Burley, W. Danker, K. Islam, P. Hadvary
(Reinach, CH; Bournemouth, UK; Durham, US)
Objective: To compare the clinical efﬁcacy and microbiological cure
rate of iclaprim (ICL) with that of linezolid (LZD) at the test-of-cure
(TOC) visit in the ASSIST-2 (Arpida’s Skin and Skin Structure Infection
Study-2), randomised, multicentre, double-blind Phase III clinical trial.
Methods: Patients with cSSSI were randomised to one of two treatment
arms: intravenous ICL 0.8 mg/kg q 12 hours or intravenous linezolid
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(LZD) 600 mg q 12 hours and received 10−14 days treatment. By-patient,
by-pathogen, and overall bacteriological response rates were secondary
endpoints in this study.
Results: Of the 494 patients in the intent-to-treat (ITT) population,
376 patients had a Gram-positive pathogen isolated at baseline and
were included in the modiﬁed-intent-to-treat (MITT) population (ICL:
192; LZD: 184). Gram-positive pathogens accounted for 72.3% of the
total number of pathogens isolated at baseline, while Staphylococcus
aureus (309 isolates) was the most commonly isolated pathogen at
baseline from the Gram-positive group, accounting for 62.6% of all
Gram-positive pathogens (ICL: 59.4%; LZD: 65.8%). Meticillin-resistant
S. aureus (MRSA) made up almost half of all S. aureus strains (ICL:
49.7%; LZD: 50.0%). Clinical cure rates in both treatment arms in the
MITT population were comparably high (ICL: 81.3%, LZD: 81.5%).
The by-patient and by-pathogen bacteriological response for S. aureus
(eradication/presumed eradication vs persistence) at the TOC visit are
shown in the table below for the MITT population.
Bacteriological response ICL LZD
n % n %
By patient n = 192 n = 184
Eradication 148 77 144 78
By pathogen
S. aureus (total) n = 149 n = 160
Eradication 115 77 126 79
Persistence 21 14 12 8
MRSA n= 74 n = 80
Eradication 55 74 60 75
Persistence 10 14 8 10
Conclusions: ICL shows good clinical and microbiological efﬁcacy
against S. aureus, including MRSA, the major causative pathogen
in cSSSI. These rates were comparable to those observed for LZD.
ICL could constitute a useful antibacterial for the treatment of cSSSI
including infections caused by MRSA.
P551 Pre-clinical studies of a new quinolone (UB-8902) against
Acinetobacter baumannii resistant to ciproﬂoxacin
R. Lo´pez-Rojas, J. Sa´nchez-Ce´spedes, F. Docobo-Pe´rez, J. Vila,
J. Pacho´n (Seville, Barcelona, ES)
Objectives: To evaluate the in vitro and in vivo activity of a new
derivative of ciproﬂoxacin (UB-8902) against Acinetobacter baumannii.
Methods: We used two A. baumannii strains (Ab58 and Ab661). The
antibiotics of the study were ciproﬂoxacin, moxiﬂoxacin, and the new
generated quinolone UB-8902. Animals used were immunocompetent
C57BL/6 female mice.
In vitro tests: MIC (microdilution method) and bactericidal activity
(time-kill curves) were performed following CLSI recomendations.
In vivo assays: we studied the toxicity parameters of the UB-8902 [lethal
dose 0 (LD0), lethal dose 50 (LD50), and lethal dose 100 (LD100)]
inoculating groups of 6 animals with rising concentrations in base 2
of UB-8902, from 0.5 mg/kg/ip to reach a 100% of mortality (Reed
and Muench method). To ascertain the bacterial minimum lethal dose
(MLD) and the bacterial lethal dose 50 (BLD50) of the strains Ab58 and
Ab661, groups of 10 animals were inoculated (using a murine model of
peritoneal sepsis) with a potentially lethal concentration (8 log cfu/mL),
and decreasing in base 10 until reaching the minimum which caused a
100% of mortality. To study the effective dose 50 (ED50) of UB-8902,
we used a model of peritoneal sepsis with groups of 10 animals with an
inoculum similar to the MLD of the strains, and treated with a dose of
UB-8902 from 0.5 mg/kg, increasing in base 2, to LD0 or until a 50%
of survival was reached.
Results: MICs (mg/L): Ab58, CIP = 0.25, MOX=0.016, UB-8902=0.03;
Ab661, CIP=8, MOX=1, UB-8902=0.5. In time-kill curves for Ab58,
bactericidal activity was observed from 4 h with 4xCMI of UB-8902,
from 8 h with 4xCMI of CIP, and there was no bactericidal activity
with MOX. For Ab661, bactericidal activity was observed from 4 h
with 4xCMI of UB-8902, from 4 h with 4xCMI and from 8 h with
2xCMI of CIP, and from 8 h with 2xCMI and 4xCMI of MOX. The
toxicity parameters of UB-8902 (mg/kg) were: LD0=512, LD50=608.5,
LD100=2048. The MLD was 7.5 log cfu/mL for both strains, being
BLD50 of Ab58 6.11 log cfu/mL and 7 log cfu/mL for Ab661. The
ED50 of UB-8902 for Ab58 was 16 mg/kg, and for Ab661 was 128
mg/kg.
Conclusions: The new quinolone UB-8902 presents bactericidal activity
against A. baumannii resistant to ciproﬂoxacin and is effective in
reducing the mortality in a model of murine peritoneal sepsis, with a
dose lower than the toxic one, which warrants the future assessment of
its efﬁcacy in other in vivo experiments, such as a discriminative murine
model of pneumonia.
P552 Intracellular penetration and activity of the new ﬂuoro-
quinolone UB-8902 in human polymorphonuclear leukocytes
S. Ballesta, I. Garcı´a, J. Sa´nchez-Ce´spedez, J. Vila, A. Pascual
(Seville, Barcelona, ES)
Background: UB-8902, a 7-(4-methyl)-piperazine ciproﬂoxacin deriva-
tive, is a new ﬂuorquinolone that shows higher in vitro activity than
ciproﬂoxacin. The uptake of UB-8902 by human polymorphonuclear
leukocytes (PMN) and its intracellular activity against isogenic strains
of Staphylococcus aureus with sequential mutations in gyrA and/or parC
genes were also evaluated.
Methods: Uptake of UB-8902 by PMNs was determined by a
ﬂuorometric assay. The effect of cell viability, environmental conditions,
metabolic inhibitors, potential competitive substrates and PMN-stimuli
on intracellular uptake was also studied. The intracellular activity was
determined by incubation of PMN containing intracellular bacteria in the
presence of UB-8902. Wild-type and mutant S. aureus with mutation in
gyrA and/or parC were used for the killing assays.
Results: UB-8902 uptake by PMN was rapid and saturable at
extracellular concentrations higher than 10 mg/L. At extracellular
concentrations of 2 mg/L, the cellular to extracellular concentration
(C/E) ratio was 6.5 ±0.8. The efﬂux of UB-8902 from PMN was
also a rapid process. The intracellular penetration of UB-8902 was
slightly increased when dead cells were used (7.6±1.3 versus control
6.5±0.8) and unaffected at 4ºC (C/E ratio 6.3±1.5). The uptake
of UB-8902 by PMN was signiﬁcatly affected by the extracellular
pH (intracellular penetration decreased at basic pH and increased at
acid pH). Sodium cyanide, an inhibitor of mitochondrial oxidative
metabolism, signiﬁcantly impaired intracellular penetration of UB-8902
(C/E ratio: 3.3±1.4). The ingestion of opsonised zymosan signiﬁcantly
increased the levels of PMN-associated UB-8902 (C/E ratio: 9.9±
1.3). Neither cell stimulation by phorbol myristate acetate (PMA) nor
ingestion of opsonised Staphylococcus aureus, modiﬁed the uptake (C/E
ratio:7.1±0.8 and 7.0±1.0 respectively). At extracellular concentrations
evaluated, 0.125, 1 y 5 mg/L, UB-8902 signiﬁcantly decreased the
intracellular survival of wild-type S. aureus. For the mutant strains,
UB-8902 only showed signiﬁcant intracellular activity at extracellular
concentration higher than 1 mg/L.
Conclusions: UB-8902 penetrates into PMN, reaching high intracellular
concentrations and it remains active intracellularly against S. aureus.
P553 Deﬁnition of wildtype MIC distributions for targeted species
for determination of optimal dosing for zaboﬂoxacin, a novel
ﬂuoronaphthyridone
R. Jones, P. Ambrose, M. Wikler (North Liberty, Albany, San Diego, US)
Objectives: Zaboﬂoxacin (formerly DW-224a) is a new quinolone-
like agent with potent activity against pathogens responsible for
New antimicrobials – before and after entering clinical development S129
respiratory tract and uncomplicated skin and skin structure infections
(S. pneumoniae [SPN], H. inﬂuenzae [HI], M. catarrhalis [MCAT] and
S. aureus [SA]). Zaboﬂoxacin was evaluated by CLSI MIC methods
for subsequent PK/PD target attainment (TA) analysis to optimise doses
used in various clinical trials.
Methods: Recent (2006) wildtype clinical isolates from worldwide
locations (Europe, Asia, North and South America) were susceptibility
(S) tested by CLSI methods: SPN (225; 200 wildtype, 25 levoﬂoxacin-
resistant [LEVO-R]); SA (200 wildtype, 200 MRSA and LEVO-R; 25
CA-MRSA); HI (55 wildtype); MCAT (10 wildtype) and CoNS (40
wildtype with 20 LEVO-R). Zaboﬂoxacin was compared to LEVO,
gemiﬂoxacin [GEMI] and moxiﬂoxacin [MOXI]. PK/PD studies of TA
were calculated by Monte Carlo simulation from this MIC distribution
for doses 50–800 mg daily (protein binding at 77%).
Results:Wildtype SPN and SA (MIC90, 0.03 mg/L); and HI and MCAT
(MIC90, 0.015 mg/L were very zaboﬂoxacin-S. In contrast, LEVO-
R SPN (MIC90, 1 mg/L) and MRSA (MIC90, >8 mg/L) had higher
zaboﬂoxacin MIC values. CA-MRSA were zaboﬂoxacin-S (also LEVO-
S). Beta-lactamases and PBP-mediated resistances did not adversely
inﬂuence zaboﬂoxacin potency. Zaboﬂoxacin (MIC50, 0.015 mg/L) was
two- and eight-fold more potent than GEMI and MOXI versus wildtype
penicillin-R SPN. 90% TA was achieved against SPN, HI, and MCAT
wildtype pathogens (MIC, 0.06 mg/L; 300 mg/day) and many LEVO-
R SPN.
Target pathogen (no.)a Zaboﬂoxacin MIC (mg/L) MIC 90% (mg/L)
50% 90% Range GEMI LEVO MOXI
SPN, WT (200) 0.015 0.03 0.0004−0.06 0.03 1 0.25
SPN, PCN-R (101) 0.015 0.03 0.008−0.06 0.03 1 0.25
SPN, LEVO-R (25) 0.12 1 0.06−8 1 >8 8
HI, WT (55) 0.008 0.015 0.004−0.03 0.008 0.015 0.03
MCAT, WT (10) 0.015 0.015 0.008−0.015 0.015 0.03 0.06
MSSA, LEVO-S (200) 0.03 0.03 0.008−0.12 0.03 0.25 0.06
MSCoNS, LEVO-S (20) 0.03 0.03 0.008−0.03 0.03 0.25 0.12
a. PCN = penicillin, WT = wildtype.
Conclusions: Zaboﬂoxacin was two- to 16- and two- to >64-fold more
active than MOXI or LEVO, respectively; equal to GEMI versus RTI
pathogens and wildtype MSSA. Optimal dosing appears to be achievable
due to high zaboﬂoxacin potency versus these 755 contemporary clinical
strains. Clinical trial designs and PK/PD-based dosing regimens will be
optimised for this promising, new orally administered agent.
P554 Tigecycline in intensive care unit infections
E. Paramythiotou, F. Kontopidou, E. Papadomichelakis, A. Antoniadou,
G. Poulakou, A. Armaganidis, H. Giamarellou (Athens, GR)
Objectives: Tigecycline is a novel broad-spectrum glycylcycline
antibiotic, which possesses activity against a broad range of Gram-
positive, Gram-negative, atypical, anaerobic and antibiotic-resistant
bacteria. It has been approved for complicated infections of skin and/or
subcutaneous tissues and complicated intra-abdominal infections. For
compassionate use it has been given for the treatment of infections
caused by multi-resistant organisms. The aim of this study was to assess
the efﬁcacy of tigecycline in ICU infections caused by strains resistant
to other antibiotics.
Methods: This is a prospective study conducted in the 18-bed medical–
surgical ICU of “ATTIKON” university general hospital. Patients with
severe ICU infections treated with tigecycline were included. Tigecycline
was used either in cases of infections caused by pan-drug resistant Gram-
negative microorganisms, including colistin, or as empirical treatment in
patients with life-threatening infections which did not respond in other
treatment or were colonised by PDR pathogens. Data recorded included
demographic characteristics; site of infection, other antibiotics used
concomitantly, treatment results after ﬁfteen days follow up, outcome
and adverse drug reactions.
Results: Between 12/ 2006 and 11/ 2007 seventeen patients were treated
with tigecycline. Among them nine patients were treated for ventilator
associated pneumonia (VAP), ﬁve for complicated skin or intra-
abdominal infection and three for septic shock of unknown origin. Ten
patients were treated empirically. Three patients received tigecycline as
monotherapy and fourteen received other antimicrobials simultaneously.
Seven cases of VAP were due to Acinetobacter baumannii alone and two
cases were mixed respiratory infections (Acinetobacter b plus Klebsiella
pn) and all of them were cured. Among the rest, one patient was cured
and a temporal improvement was noted in 4/7 patients. Most of pathogens
were susceptible only to colistin and tigecycline and four patients were
infected with colistin-resistant strains. Dose was 50 mg × 2 or 100 mg
× 2 IV without adverse effects.
Conclusions: Though the number of patients is small, our results are
encouraging about tigecycline use for the treatment of ICU serious
infections especially in ventilator-associated pneumonia. Given the
problem of MDR pathogens in ICUs, tigecyclin could be an effective
treatment choice. However more experience is urgently required.
P555 Anti-inﬂammatory effect of lycopene on chronic bacterial
prostatitis rat model
Y.H. Cho (Seoul, KR)
Purpose: Chronic bacterial prostatitis (CBP) is the most common
urological disease in adult males, with antibiotic therapy being the gold
standard for its treatment. However, long-term therapy results in many
side effects as well as bacterial resistance. For these reasons, there is
a need for a new treatment modality to replace traditional antibiotic
therapy. Lycopene, an extract of tomatoes, has antioxidant effects against
various bacteria and synergistic effects with antibiotics. We evaluate the
synergistic effects of lycopene on the treatment of CBP in an animal
model.
Materials and Methods: Forty ﬁve rats demonstrating CBP were
randomly divided into 4 groups; the control, lycopene, ciproﬂoxacin and
lycopene with ciproﬂoxacin groups. All drug treatments were conducted
over a period of 2 weeks. After treatment, the results were analysed, with
the microbiological cultures and histological ﬁndings of the prostate and
urine samples compared with the control group and between each group.
Results: The uses of ciproﬂoxacin, and lycopene with ciproﬂoxacin
showed statistically signiﬁcant decreases in bacterial growth and
improvements in prostatic inﬂammation compared with the control group
(p< 0.05). The lycopene with ciproﬂoxacin group showed a statistically
signiﬁcant decrease in bacterial growth and improvements in prostatic
inﬂammation compared with the ciproﬂoxacin group (p< 0.05).
Conclusions: These results suggest that lycopene may be an effective
material in the treatment of CBP. Especially, the combination treatment of
lycopene and ciproﬂoxacin has synergistic effects. Therefore, it is suggest
that the combination of lycopene and ciproﬂoxacin may be effective in
the treatment of CBP, and with a higher success rate.
P556 Efﬁcacy of doripenem against Pseudomonas aeruginosa
in nosocomial pneumonia, including ventilator-associated
pneumonia
J. Chastre, J. Jiang, K. Kaniga, I. Friedland (Paris, FR; Mountain
View, US)
Objectives: Doripenem (DOR, a new carbapenem for which an MAA
has been submitted in the EU) has potent activity against bacterial
pathogens commonly responsible for nosocomial pneumonia, including
ventilator-associated pneumonia. In two open-label, multicentre clinical
trials of patients with nosocomial pneumonia, the efﬁcacy of DOR
against P. aeruginosa was compared with piperacillin/tazobactam (PTZ)
in non-ventilator-associated pneumonia and early-onset (<5 days)
ventilator-associated pneumonia patients (Study 1), and to imipenem
(IMI) in early-onset and late-onset (5 days) ventilator-associated
pneumonia patients (Study 2).
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Methods: Adults in Study 1 were randomised to treatment for 7−14
days with 1-h infusion of IV DOR 500 mg q8h or 30-min infusion of
IV PTZ 4.5 g q6h. After 72 h of IV study drug, patients were allowed
to be switched to oral levoﬂoxacin 750 mg QD. Adults in Study 2 were
randomised to treatment with 7−14 days of IV DOR 500 mg q8h as
a 4-h infusion or IV IMI 500 mg q6h for 30 min or 1000 mg q8h
for 60 min. No oral switch was allowed. Clinical cure rates at the end
of treatment were measured in the microbiologically evaluable patients
(those who completed the study and had at least one bacterial lower
respiratory tract pathogen identiﬁed at baseline that was susceptible to
the study drug received).
Results: Overall clinical cure rates in microbiologically evaluable
patients were 82.1% (69/84) with DOR versus 78.3% (65/83) with
PTZ, and 69% (80/116) with DOR versus 64.5% (71/110) with IMI.
The pooled clinical cure rates from both studies in microbiologically
evaluable patients with P. aeruginosa was 81.6% (31/38) with DOR
versus 54.8% (17/31) in the pooled comparators. The 95% CI of the
26.7% difference (2.4; 51.1) did not cross 0. The comparison within
each trial was 83.3% [15/18] DOR versus 70.6% [12/17] PTZ (Study 1)
and 80.0% [16/20] DOR versus 42.9% [6/14] IMI (Study 2).
Conclusions: DOR is a potent new carbapenem that, in a post hoc
analysis of pooled data, showed signiﬁcantly higher cure rates than its
comparators against P. aeruginosa in nosocomial pneumonia, including
ventilator-associated pneumonia.
P557 XF-73, a novel anti-staphylococcal antimicrobial with very
rapid bactericidal activity
K. Miller, N. Ooi, J.K. Hobbs, W. Rhys-Williams, W.G. Love, I. Hayter,
M. Katila, I. Chopra (Leeds, Brighton, UK)
Objectives: XF-73 is the lead compound in an entirely new class of anti-
microbial agents, developed to address the growing and unmet need for
prophylaxis and treatment of drug resistant bacteria. It has previously
been shown to be highly potent against a range of S. aureus strains
including meticillin-sensitive Staphylococcus aureus (MSSA), healthcare
associated meticillin resistant S. aureus (HA-MRSA) and community
associated meticillin resistant S. aureus (CA-MRSA) strains. XF-73
exerts rapid bactericidal activity and the aim of this study was to further
characterise this effect.
Methods: Time-kill studies for XF-73 were conducted on S. aureus
SH1000 at 4x MIC and samples were taken and prepared for scanning
electron microscopy. Membrane integrity in the presence of XF-73 was
determined using the BacLight assay, which evaluates the ability of
propidium iodide to penetrate into the cell following 10 minutes of drug
exposure. A luciferin/luciferase assay was performed to quantify XF-73-
induced leakage of intracellular ATP.
Results: SH1000 cell numbers decreased by 4.5 logs following 5
minutes exposure to 4x MIC of XF-73, and by 7 logs following 30
minutes exposure. Scanning electron micrographs following 5 and 30
minutes exposure to XF-73 showed no morphological damage of SH1000
cultures, compared with untreated cells. Nevertheless, treatment for 10
minutes with XF-73 caused complete perturbation of membrane integrity
as evidenced by a 100% loss of membrane integrity in the BacLite assay
compared to 0% in the absence of XF-73. ATP leakage was not observed
following exposure to XF-73.
Conclusion: The rapid bactericidal activity of XF-73 is not associated
with signiﬁcant cellular lysis. This is consistent with the absence of
morphological damage to S. aureus cultures exposed to XF-73 and the
lack of leakage of intracellular material (ATP) after a period where
cell viability is reduced by 7 logs. Membrane integrity was however
perturbed, suggesting that although the cell remained physically intact,
the membrane was severely damaged. Investigations are ongoing to
elucidate further the mechanism of action of this highly potent and
rapidly bactericidal anti-bacterial agent.
P558 XF-73: a novel antimicrobial – Investigation of the change
in MIC against multiple MRSA strains during a 55-passage
study
W. Rhys-Williams, W. Love, I. Hayter, D. Farrell, R. Janes, M. Robbins
(Brighton, London, UK)
Objectives: XF-73, the lead compound in a new class of anti-microbial
agents, has previously been shown to be potent (MIC50 1 mg/L) against
a range of Staphylococcus aureus strains including meticillin-sensitive
S. aureus (MSSA), healthcare-associated meticillin-resistant S. aureus
(HA-MRSA) and community-associated meticillin-resistant S. aureus
(CA-MRSA). XF-73 is bactericidal (MBC50 1 mg/L) and the aim of
this study was to investigate the propensity of XF-73 to cause mutational
resistance in common MRSA clones including USA300, responsible
for the majority of CA-MRSA infections in the USA. An antibiotic
comparator (fusidic acid) was also studied.
Methods: MICs were determined for XF-73 and fusidic acid using a
macrodilution broth method. Five “Network on Antimicrobial Resistance
in Staphylococcus aureus” (NARSA) strains were tested: NRS382,
NRS384 (USA 300), NRS271, NRS123, NRS387. All 5 strains were
passaged 55X at 0.5X MIC (determined from the previous passage) to
investigate whether there was an increase in the MIC, suggestive of the
development of mutational resistance.
Results: The initial MICs of XF-73 and fusidic acid were found to be
0.25−0.5 mg/L and 0.12−0.25 mg/L respectively against the 5 MRSA
strains tested. For all 5 strains, a rapid increase in the MIC of fusidic
acid was observed after only 2−5 repeat passages, with the MIC reaching
256 mg/L after 33−42 passages. In comparison, the MIC of XF-73 did
not increase signiﬁcantly (<8-fold increase), even after 55 passages.
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Passage 0 0.5 0.25 0.25 0.25 0.25 0.12 0.25 0.12 0.12 0.12
Passage 55 1 0.5 1 0.5 0.5 256 256 256 256 256
Conclusion: Mutational resistance to fusidic acid in S. aureus is an
important resistance mechanism. In the UK and Australia, susceptibility
to fusidic acid is deﬁned as an MIC of 0.25 mg/L or 0.5 mg/L
respectively and resistance is deﬁned as an MIC of 2 mg/L or more. All
5 MRSA strains rapidly developed resistance to fusidic acid after only a
few repeat passage exposures. In comparison, with XF-73 there was no
signiﬁcant increase in MIC against all ﬁve selected MRSA strains, even
after 55 repeat passages. This suggests that the likelihood for mutational
resistance development against XF-73 is remote and hence demonstrates
potential for a long clinical lifetime.
P559 XF-73: a novel antimicrobial with broad-ranging
Gram-positive antibacterial activity
W. Love, W. Rhys-Williams, I. Hayter, D. Farrell, J. Curry, M. Robbins
(Brighton, London, UK)
Objectives: XF-73, the lead compound in a new class of anti-microbial
agents, has previously been shown to be potent (MIC50 1 mg/L) against
a range of Staphylococcus aureus strains including meticillin-sensitive
S. aureus (MSSA), healthcare-associated meticillin resistant S. aureus
(HA-MRSA) and community-associated meticillin resistant S. aureus
(CA-MRSA). XF-73 is bactericidal (MBC50 1 mg/L) and the aim of
this study was to investigate its anti-bacterial activity against a range of
aerobic and anaerobic Gram-positive bacteria.
Methods:MICs for XF-73 were determined against a panel of 65 Gram-
positive bacterial strains (56 aerobic and 9 anaerobic) using the CLSI
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broth microdilution methodology. XF-73 was used in a log2 dilution
series from 0.03 to 64 mg/L. Where possible, both antibiotic resistant
and susceptible strains were included.
Results: XF-73 was found to have antibacterial activity (MIC range
0.25−4 mg/L) against all 65 strains tested. The results are provided in
the table.
Species (No. of isolates) Characteristic/Phenotype/Genotype XF-73 MIC
Range
(mg/L)
Staphylococcus aureus (15) MSSA, MRSA, VISA 0.5−1
Coagulase-negative
Staphylococcus spp. (5)
MSSE, MRSE, S. haemolyticus,
S. saprophyticus
0.25−1
Enterococcus spp. (9) Vancomycin susceptible, VanA,
VanB, VanC
0.5−2
Beta-haemolytic Streptococcus
spp. (9)
Macrolide susceptible and resistant
clinical isolates
0.25−2
Alpha-haemolytic Streptococcus
spp. (15)
Penicillin and/or macrolide
resistant, multi-resistant clinical
isolates
0.5−4
Corynebacterium jeikeium (2) Clinical isolates Both 0.25
Listeria monocytogenes (1) Clinical isolate 0.5
Gram-positive anaerobic species
(9)
Clostridium, Peptostreptococcus
and Propionibacterium spp.
0.5−4
Conclusion: XF-73 demonstrated potent activity against all of the
aerobic and anaerobic Gram-positive bacteria tested. These initial results
suggest that XF-73 has potential for use as a novel antibacterial agent
against a wide range of clinically relevant Gram-positive pathogens.
Studies are ongoing to investigate the use of XF-73 in a range of different
bacterial disease indications.
P560 In vitro and in vivo activity of SB006, a novel branched
antimicrobial peptide selectively active against Gram-negative
bacteria.
S. Fabiole Nicoletto, I. Baster, G. Pirri, A. Giuliani (Colleretto
Giacosa, IT; Cracow, PL)
Objectives: The aim of this study was to investigate the in vitro and
in vivo activity of SB006 against selected MDR Gram-negative clinical
isolates.
Methods: MICs and MBCs were determined in MHB by the broth
microdilution methodology, according to CLSI procedure. MIC was
deﬁned as the lowest drug concentration causing complete suppression
of visible bacterial or fungal growth. MBC was deﬁned as the antibiotic
concentration that induced at least a 3 log reduction of the initial bacterial
inoculum.
The in vivo activity of SB006 has been evaluated using a neutropenic
mouse model of infection. Mice were infected intraperitonally using a
0.2-ml volume of a high dose inoculum (3xLD50) of Pseudomonas
aeruginosa (clinical isolate). Several single dosages of SB006 were
administered at 1 hour post-challenge. The total dose required for
survival of 50% of mice at 72 h (ED50) was determined.
Results: The in vitro activity of SB006 and reference compounds
against an expanded panel of clinical bacteria recently collected has been
determined; all tested strains show resistance to several currently used
antibacterial agents. SB006 was active against Gram-negative bacteria;
the MICs of SB006 against Acinetobacter spp. (2 strains), Enterobacter
spp. (4 strains), Escherichia coli (12 strains), Klebsiella pneumoniae
(6 strains), Pseudomonas aeruginosa (16 strains), Salmonella enteritidis
(1 strain), and Stenotrophomonas maltophilia (1 strain) were between
4 and 32 mg/L, while colistin showed MICs ranging between 0.25 and
8 mg/L. The MIC and MBC values of SB006 ranged between 8 and
32 mg/L, while those of colistin ranged between 0.25 and 4 mg/L. The
MBC/MIC ratio was always 1 for SB006 and colistin. Moreover, in vivo
studies showed that SB006 was active in an experimental mouse model
of infection against a clinical isolate of P. aeruginosa.
Conclusion: SB006 showed good activity against different Gram-
negative bacteria isolates with a potency and spectrum of antimicrobial
activity comparable to those of colistin and showed to be bactericidal.
As colistin, SB006 seems to selectively perturb the bacterial membrane:
this mechanism of action is expected to circumvent the problem of
resistance. These features make the antimicrobial branched peptide
SB006 a promising template for the development of new antibacterial
drugs.
P561 SASP: rapid bactericidal activity against USA strains of
meticillin-resistant Staphylococcus aureus
A. Barnard, K. Pitts, D. Brown, A. Wilkinson, H. Fairhead (Cambridge,
UK)
Objectives: SASP is a unique antibacterial protein that acts by binding to
bacterial DNA and halting replication and gene expression, resulting in
rapid cell death. SASPjectTM is a novel platform technology by which a
SASP gene is delivered to selected bacteria via dedicated bacteriophage
vectors. Previous studies using S. aureus-speciﬁc SASPjectTM vector,
PTSA1.2/A, showed SASP is rapidly bactericidal (assessing kill at 3
h) against 163 geographically diverse clinical MRSA isolates spanning
SCCmec types 1-V (105 cfu/ml). In this study, efﬁcacy of SASP against
MRSA strains isolated in the USA is determined by time kill assay over
24 h at higher cell densities (107 cfu/ml). Speed of kill of SASP against
an MRSA USA300 isolate is also assessed.
Methods: Ten different MRSA isolates of different USA types were
tested for susceptibility to SASP by time kill assay. Bacterial cells
were grown overnight in Luria-Bertani broth supplemented with calcium
chloride (10 mM), diluted to 2 x 107 cfu/ml and mixed with an equal
volume (500ml) of PTSA1.2/A (6 x 107 pfu/ml). Cultures were incubated
at 35ºC, samples were removed at 0, 1, 2, 4, 6 and 24 hours and viable
cells were enumerated following overnight incubation on blood agar.
Speed of kill was assessed by the same method against a clinical MRSA
USA300 isolate diluted to 5 x 105 or 5 x 107 cfu/ml with viable counts
performed at 0, 2, 5, 10, 15, 20, 30, 45 and 60 mins. For all controls,
PTSA1.2/A was replaced with buffer.
Results: SASP was rapidly bactericidal against all 10 clinical isolates
tested, with 5 isolates showing a >3-log drop in viability within 1 h and
remaining isolates showing a >3-log drop in viability within 2 h.
In the speed of kill assay, SASP caused a >99.9% drop in viability within
5 mins against the 105 culture and a >99.9% drop in viability within 10
mins against the 107 culture.
Conclusions:
• SASPject vector, PTSA1.2/A can effectively deliver a SASP gene to
all tested MRSA strains.
• SASP shows rapid bactericidal activity against tested MRSA strains
covering different USA types.
P562 The efﬁcacy of SASP targeted to meticillin-resistant
Staphylococcus aureus in mixed staphylococcal cultures
K. Pitts, A. Barnard, D. Brown, A. Wilkinson, H. Fairhead (Cambridge,
UK)
Objectives: SASPjectTM is a novel platform technology which allows
bacterial species to be targeted with the SASP anti-bacterial protein by
means of a species-speciﬁc delivery vector, without affecting the body’s
normal microbial ﬂora. This study utilised a Staphylococcus aureus-
speciﬁc SASPjectTM delivery vector, PTSA1.2/A, developed for intra-
nasal elimination of MRSA. SASP has previously demonstrated rapid
bactericidal activity against a wide range of clinical MRSA and meticillin
susceptible S. aureus (MSSA) isolates. In this study the effect of co-
cultures of MRSA, MSSA, S. epidermidis and S. haemolyticus on the
efﬁcacy of SASP is assessed.
Methods: S. epidermidis was grown overnight in Luria-Bertani broth
and mixed (107 cfu/ml ﬁnal concentration) with a clinical MRSA strain
at ﬁnal concentrations of 104, 105, or 106 cfu/ml. PTSA1.2/A (6 x
108 pfu/ml) was then added. Mixed cultures containing MRSA and a
clinical MSSA or S. haemolyticus strain were similarly prepared and
again supplemented with PTSA1.2/A. Appropriate mono-cultures and
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PTSA1.2/A controls were also assayed. Cell viability was measured over
time by performing cell counts at 0, 1, 2, 4 and 6 hours.
Results: The presence of S. epidermidis did not affect the rate of kill
of MRSA by PTSA1.2/A, with no detectable survivors by 2 h for any
of the 3 MRSA cell concentrations tested±S. epidermidis. Furthermore,
S. epidermidis grew at the same rate in the presence or absence of
PTSA1.2/A. A similar trend was seen with S. haemolyticus. PTSA1.2/A
killed both MRSA and MSSA cells when co-cultured (no detectable
survivors by 4 hours) and the rate of kill of MRSA (>3 log drop in
viability in 2 h) was comparable in the presence or absence of MSSA.
Conclusions:
• SASP delivered by PTSA1.2/A is rapidly bactericidal against MRSA.
• Rate of kill, in the combinations tested, is unaffected by the presence
of other staphylococcal species commonly found in the human nose.
• The presence of PTSA1.2/A does not affect the growth rate of other
staphylococcal species, indicating that the SASPjectTM system can be
used to target selected bacteria whilst leaving the normal ﬂora intact.
P563 Evaluation of the type I signal peptidase of Staphylococcus
epidermidis as novel antibacterial target
K. Bockstael, N. Geukens, J. Anne´, P. Herdewijn, A. Van Aerschot
(Leuven, BE)
Objectives: In a time of emerging bacterial resistance there is need
for novel antibacterial targets. One of the bacteria of concern is
Staphylococcus epidermidis, an opportunistic pathogen associated with
foreign body infections and nosocomial sepsis.
We aim to develop antimicrobial drugs against a new target, the type
I signal peptidase (SPase I). SPases I have a role in protein secretion
as they remove the signal peptides from secretory proteins during or
after translocation across the membrane and have been shown to be
essential for the viability of the cell. S. epidermidis has three type I
signal peptidases, Sip1, Sip2 and Sip3.
We therefore aim to evaluate the SPase I of S. epidermidis as a novel
antibacterial target and to design, synthesize and evaluate the inhibitory
activity of potential SPase I inhibitors.
Methods: For all DNA manipulations standard techniques were
used. SDS-PAGE was used to analyse the overproduction of the
enzymes in Escherichia coli after IPTG induction. Puriﬁcation of His
tagged enzymes was performed under native conditions using afﬁnity
chromatography on a Ni2+-NTA agarose column. SPase expression in
planktonic and sessile grown S. epidermidis was analysed by RT-PCR
experiments.
Substrate analogues were rationally designed (by modelling using the
structure for the E. coli signal peptidase) and synthesised by solid
phase peptide synthesis using classical coupling reagents for peptide
bond formation and Fmoc protected amino acids. The synthesised
compounds were puriﬁed by Reversed Phase-High Performance Liquid
Chromatography and analysed by High Resolution Mass Spectrometry.
Inhibitory activity against SPase I was evaluated by an in vitro inhibitor
assay based on intramolecular ﬂuorescent resonance energy transfer
(FRET) using an internally quenched ﬂuorescent peptide substrate based
on a S. epidermidis preprotein.
Results: The SPase I genes of S. epidermidis were cloned, expressed
and puriﬁed in E. coli and biochemically analysed. The enzymes were
used to develop and optimise a FRET based in vitro assay, allowing
evaluation of potential SPase I inhibitors such as rationally designed
peptide substrate analogues.
Conclusion: Due to their unique properties, SPases I seem to be an
attractive target for the development of new antimicrobial drugs. A
FRET based in vitro assay was developed and used for the evaluation of
potential SPase I inhibitors.
P564 Disruption of Pseudomonas aeruginosa quorum sensing
using high-afﬁnity antibodies derived from immunised sheep
S.S. Palliyil, I.D. Broadbent, K.A. Charlton, A.J. Porter (Aberdeen, UK)
Objectives: Pseudomonas aeruginosa is an opportunistic human
pathogen which, like many other Gram-negative pathogens, employs
quorum sensing – regulated virulence factors to establish an infection in
its host. The bacterium is notorious for antibiotic resistance and causes
life-threatening infections in immunocompromised and cystic ﬁbrosis
patients, and also accounts for 11% of nosocomial infections worldwide.
Quorum sensing in Ps. aeruginosa populations is controlled by low
molecular weight (hapten) signalling molecules known as homoserine
lactones (HSLs). Previous work in our lab has demonstrated that sheep
are capable of producing high afﬁnity, high speciﬁcity anti-hapten
antibodies, so we sought to develop anti-HSL antibodies derived from
immunised sheep and explore their potential as novel antibacterial agents.
Methods: Derivatives of Ps. aeruginosa HSL molecules were syn-
thesised, conjugated to suitable carrier proteins, and used to elicit an
immune response in sheep. Post immunisation, sheep polyclonal sera
were analysed using immunoassays to determine the level of speciﬁc
immune response. Bioassays were also employed to demonstrate the
abilities of the sera to block Ps. aeruginosa quorum sensing.
Results: The ability of immunised sheep polyclonal serum to bind
speciﬁcally to quorum sensing molecules has been demonstrated by a
series of in vitro immunoassays and bioassays. Immunisation with a
mixture of three HSL subgroups resulted in high antibody titre polyclonal
serum which showed nanomolar afﬁnities to the free form of HSLs when
applied in a competition format.
Conclusions: Antibodies are an attractive method for controlling
bacterial virulence and bioﬁlm formation in Gram-negative bacteria, and
at the same time these ‘antipathogenic’ drugs are less likely to develop
resistance in bacteria compared to conventional antibiotics.
The results from preliminary experiments are highly encouraging and
demonstrate the possibility of isolating nanomolar afﬁnity anti-HSL
antibodies from immunised sheep. Phage display antibody libraries are
currently being constructed from sheep peripheral blood lymphocytes,
and will be screened in due course for anti-HSL monoclonal antibodies.
P565 Interaction of PZ-601 (SMP-601) and other b-lactams with
chromosome- and plasmid-encoded class C b-lactamases
J.D. Docquier, L. Xerri (Siena, IT; Malvern, US)
Objectives: The overproduction of chromosome-encoded class C b-
lactamases in derepressed mutants of Enterobacteriaceae and Pseu-
domonas aeruginosa is a known mechanism able to compromise the
efﬁcacy of penicillins and cephalosporins for the treatment of infections
caused by these organisms. More recently, the emergence of plasmid-
encoded class C b-lactamases, currently spreading in Enterobacteriaceae,
is of increasing concern. We carried out a comparative study on the
interaction of PZ-601 (a novel carbapenem with a spectrum including
multidrug resistant Gram-positive pathogens) with several class C
enzymes.
Methods: The stability of PZ-601, imipenem and cephalosporins to hy-
drolysis by P99 AmpC, CMY-2 and FOX-7 b-lactamases was investigated
spectrophotometrically, using either direct hydrolysis measurements or
the reporter substrate method. Antimicrobial susceptibilities of clinical
isolates and transconjugants (or transformants) thereof were measured
using the microdilution broth method as recommended by the CLSI.
Results: In enzyme assays, PZ-601 behaved as a poor substrate of
these enzymes and, similarly to imipenem (IPM), showed degradation
rates slower than those observed with tested oxyimino-cephalosporins
cefotaxime (CTX) and ceftazidime (CAZ), and piperacillin (PIP),
as reﬂected by the higher catalytic efﬁciencies measured with the
latter compounds. These data were conﬁrmed by the changes in the
antimicrobial susceptibility proﬁles when a CMY-2-encoding plasmid
was transferred into an E. coli laboratory strain (J53). This transformed
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strain gained resistance to CAZ, CTX and PIP, while it showed only a
reduced susceptibility to PZ-601.
Strain b-lactamase MICs (mg/L)
PZ-601 IPM CAZ CTX PIP
E. coli J53 None 0.25 0.12 0.12 0.06 1
E. coli J53 (p26Sm02) CMY-2 2 0.12 64 16 >512
E. coli 26Sm02 CMY-2 4 0.25 64 32 >512
Enterobacter cloacae RM-SI AmpC 8 0.5 64 64 32
Klebsiella pneumoniae Kpn7 FOX-7 8 0.25 256 32 >512
The parental clinical isolates all exhibit the lower MIC values with IPM
and PZ-601, while a high level of resistance was observed with the other
agents. It is likely that for PZ-601, permeability defects in these isolates
may act synergistically with a slow b-lactamase degradation, explaining
in part the different susceptibility to the latter, as compared to IPM.
Conclusion: PZ-601 was conﬁrmed to have a better stability to class C
b-lactamases than tested oxyimino-cephalosporins and penicillins, even
though it appeared to be slightly less stable to these enzymes than
imipenem.
P566 Stability of PZ-601 (SMP-601) to different clinically relevant
extended-spectrum b-lactamases
J.D. Docquier, L. Xerri (Siena, IT; Malvern, US)
Objectives: PZ-601 is a new carbapenem showing activity against
meticillin-resistant Staphylococcus aureus and vancomycin-resistant
enterococci. PZ-601 has been shown to exhibit good activity versus
Gram-negative pathogens producing extended-spectrum b-lactamases
(ESBLs) (Paterson et al.; Lolans et al., ICAAC 2007). The stability
of PZ-601 to various clinically-relevant enzymes is investigated and
compared to that of other b-lactams.
Methods: The stability of PZ-601 to the hydrolytic action of represen-
tative TEM-, SHV-, CTX-M- and GES-types ESBLs was investigated
spectrophotometrically, using either direct hydrolysis measurements
or the reporter substrate method. In the latter case, inactivation
parameters were computed from enzyme inactivation time courses in
the presence of various carbapenem concentrations. Susceptibilities to
PZ-601, imipenem (IPM), ceftazidime (CAZ), cefepime (FEP) and
piperacillin (PIP) were measured (microdilution broth method, CLSI) for
recombinant strains carrying the cloned b-lactamase gene and clinical
isolates with known b-lactamase content.
Results: In enzyme assays, PZ-601 behaved as a transient inactivator
of all tested b-lactamases. It showed an excellent stability to these
enzymes, as reﬂected by extremely low deacylation rates. Interestingly,
PZ-601 was more stable than IPM to GES-1, behaving as a poor
substrate of this enzyme. MIC values of PZ-601 were not affected by
b-lactamase production in laboratory strains of E. coli expressing the
cloned b-lactamase gene, in comparison with the control strain carrying
the empty cloning vector.
Strain ESBL MICs (mg/L)
PZ-601 IPM CAZ FEP PIP
E. coli DH5a(pBC-SK) None 0.25 0.12 0.12 0.06 1
E. coli DH5a(pLBII-TEM-72) TEM-72 0.25 0.12 64 4 512
E. coli DH5a(pLBII-SHV-12) SHV-12 0.25 0.25 256 8 256
E. coli DH5a(pLBII-CTX-M-1) CTX-M-1 0.25 0.25 1 4 64
E. coli DH5a(pBC-GES-1) GES-1 0.25 0.5 2 0.12 64
The determination of the antimicrobial susceptibility proﬁles of the
clinical isolates producing the same ESBLs revealed an in vitro efﬁcacy
of PZ-601 similar to that of IPM, while higher MIC values were
expectedly recorded for third- and fourth-generation cephalosporins and
penicillins.
Conclusion: Due to its stability to most types of clinically-relevant
ESBLs, PZ-601 is active on both ESBL-producing laboratory strains
and their parental clinical isolates. PZ-601 might represent a valuable
alternative drug for empiric therapy when broad-spectrum antimicrobial
activity, including both multidrug-resistant Gram-positives and Gram-
negatives, is required.
P567 New thioureides of 2-(4-methyl-phenoxymethyl) benzoic acid
with antimicrobial activity
C. Limban, G.M. Nitulescu, C.D. Badiceanu, O. Dracea, I. Raut,
C. Larion, A.M. Israil, M.C. Chiﬁriuc (Bucharest, RO)
Objectives: The present application is a continuation of our re-
search concerning the synthesis and characterisation of 2-(4-methyl-
phenoxymethyl)-benzoic acid thioureides with antimicrobial activities.
The aim of this study was to evaluate the in vitro antimicrobial activity
of some newly synthesised chemical compounds using qualitative and
quantitative methods.
Methods: The new thioureides were obtained in three stages: ﬁrst,
the 2-(4-methyl-phenoxymethyl)benzoic acid by reacting sodium p-
methyl-phenoxide with phtalide, then the synthesis of the 2-(4-methyl-
phenoxymethyl)benzoic acid chloride, and ﬁnally the corresponding
isothiocyanate is treated with primary aromatic amines to obtain the
new compounds.
The qualitative screening of the susceptibility spectra of different
microbial strains to these compounds was performed by three adaptated
diffusion methods: paper ﬁlter disk impregnation with the tested
substances solutions, the disposal of tested solutions in agar wells
and the spotting of tested solutions on solid medium seeded with
microbial inoculums. The quantitative assay of the antimicrobial
activity was performed by broth microdilution method in 96-well
microplates in order to establish the minimal inhibitory concentration
(MIC).The antimicrobial activity was tested against Gram-positive
strains (Staphylococcus (S.) aureus, Bacillus (B.) subtilis), Gram-
negative (Escherichia (E.) coli, Pseudomonas (P.) aeruginosa, Klebsiella
(K.) pneumoniae) and fungal strains (Candida (C.) albicans, Aspergillus
(A.) niger). All tests were performed comparatively with reference
strains: K. pneumoniae IC 13420, E. coli IC 13529, S. aureus IC 13204,
P. aeruginosa IC 13202, B. subtilis IC 12488, C. albicans IC 249,
A. niger IC 13534.
Results: Chemical structures of the synthesised compounds have been
elucidated by theirs 1H-NMR, 13C-NMR, IR spectra and elemental
analysis.
Our results showed that the tested compounds exhibited speciﬁc
antimicrobial activity, the highest activity being noticed against
suspended fungal cells (MIC ranging from 62.5 to 15.6), followed by
P. aeruginosa (MICs from 250 to 31.5). Antimicrobial activity against
Gram-positive bacteria were noticed for most compounds exhibiting very
low MICs (MICs from 1000 to 62.5).
Conclusion: The 2-(4-methyl-phenoxymethyl)-benzoic acid thioureides
exhibited speciﬁc antimicrobial activity and may be regarded as potential
antimicrobial agents.
P568 A synthetic derivative of the host immune defence
peptide, bactenecin, activity against clinical isolates of
meticillin-susceptible and meticillin-resistant Staphylococcus
aureus, a potential new therapeutic agent
E. Williams, S. Desgranges, M. Devocelle, H. Humphreys, D. Hughes
(Dublin, IE)
Vancomycin is one of the few antibiotics still effective in the treatment
of meticillin-resistant Staphylococcus aureus (MRSA) and treatment
failures are increasingly reported with this antibiotic. Therefore, the
development of alternative antibiotics with novel modes of action
is critical. Cationic antimicrobial peptides with structures resembling
naturally occurring host defence peptides are promising candidates.
Some of the beneﬁts of host defence peptides as antimicrobial agents
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include, reduced capacity to develop resistance, multiple and novel
modes of action and reduced toxicity.
Objectives: In this study, the potential of an 8 amino-acid linear peptide
derived from bactenecin, an immune peptide found in bovine neutrophils,
as a therapeutic agent for the treatment of MRSA, was investigated.
Methods: The minimum inhibitory concentrations (MIC) of D and L-
stereoisomers of the bactenecin derived peptide, for thirteen MRSA
and twelve meticillin-susceptible S. aureus (MSSA) isolates from
bloodstream infections were determined. The effect of pH, salt
concentration and cations, calcium and magnesium, on the in-vitro
activity of the peptide was also investigated. The capacity for
development of in-vitro resistance to the bactenecin derived peptide was
also studied by sequential exposure of two MRSA isolates to the L-
peptide, and comparison of the MIC of surviving colonies to the parental
colonies.
Results: All isolates were susceptible to the bactenecin-derived peptide
with MIC 50mg/ml for the L-peptide and MIC 5mg/ml for the D-
peptide. Optimal bactericidal activity was reached over the pH range 7.0
to 9.0 and potassium phosphate concentration of 1−10 mM. The MIC
was not affected by calcium and magnesium. Sequential exposure of two
clinical isolates, seven times to a sub-inhibitory concentration of the L-
peptide, did not change the MIC, suggesting that further exposure would
be required to generate resistance.
Conclusions: Our study concludes that this bactenecin-derived peptide
may have potential for development as an alternative anti-staphylococcal
agent, as it is effective against invasive isolates of MSSA and MRSA, is
active under physiological conditions and does not easily select resistant
mutants.
P569 In vitro activity of a cecropin A-melittin antimicrobial
peptide hybrid vs. multidrug-resistant strains of Acinetobacter
baumannii prevalent in the UK
D. Wareham, P. Khanna, W. Kamysz (London, UK; Gdansk, PL)
Objectives: Acinetobacter baumannii has emerged as an important noso-
comial pathogen causing burn wound infections, ventilator associated
pneumonia, bacteraemia and sepsis in the critically ill. The organism
exhibits formidable multi-drug resistance with the commonest isolates
in the UK (OXA-23 clone 1) exhibiting resistance to all b-lactams
(including carbapenems), b-lactam / inhibitor combinations, quinolones,
and aminoglycosides. In view of the lack of agents in development for
the treatment of MDR Acinetobacters we set out to determine the in-
vitro activity of a hybrid of two antimicrobial peptides, cecropin A and
melittin (CAMEL) versus a collection of recent clinical isolates and
determine the killing kinetics versus the OXA-23 (1) strain.
Methods: A 15 residue peptide based on residues 1−7 of cecropin A
and residues 2−9 of melittin was synthesised using fmoc chemistryand
puriﬁed by solid phase extraction. Sixty-six consecutive clinical isolates,
identiﬁed as A. baumannii by API 20NE and conﬁrmed by speciﬁc
PCR for the OXA-51 gene were obtained. Inhibitory and bactericidal
concentrations of CAMEL peptide were determined by microtitre
dilution using according to standard BSAC methodology. Time-kill
assays using Camel peptide at 1 X and 2 X the MIC were performed on
a representative isolate of OXA-23 clone 1.
Results: The MIC50 of Camel peptide was 8 mg/L and the MIC90 16
mg/L with a range of 4−32 mg/L. The MBC50 and MBC90 were 16 and
32 mg/L respectively (range 8−64 mg/L). In time kill assays Camel was
rapidly bactericidal within 2 hrs. At 2×MIC >3-fold log reductions in
CFU/ml were sustained over 24 hrs.
Conclusions: CAMEL peptide exhibited promising activity versus
prevalent strains of multidrug resistant A. baumannii and was rapidly
bactericidal versus the OXA-23 clone 1 of A. baumannii. Further
studies to determine in vivo stability, bioavailability and toxicity towards
eukaryotic cells are needed to enable further development of this novel
compound.
P570 Resistance studies on the siderophore
monobactam/b-lactamase inhibitor combination BAL30376
B. Hofer (Basel, CH)
Objective: Multi-resistant clinical isolates of Gram-negative bacteria
were examined for their propensity to develop resistance to BAL30376,
novel combination between the monobactam antibiotic BAL0019764 and
the speciﬁc b-lactamase inhibitors BAL0029880 and clavulanic acid.
Methods: Isolates of Pseudomonas aeruginosa, Acinetobacter sp.,
Stenotrophomonas maltophilia, Enterobacter cloacae, and Klebsiella
pneumoniae were examined for their propensity to spontaneously acquire
resistance to BAL30376 and selected comparators, either in single-
step selection or by repeated passaging in cultures with increasing
concentrations of BAL30376.
Results: Population analysis indicated single-step resistance frequencies
of 10−8 to 10−10 for BAL30376 against the strains Enterobacteriaceae
and Acinetobacter. The frequency of appearance of spontaneous
resistance to cefepime or meropenem in susceptible strains was between
10−6 and 10−9. Subpopulations with elevated BAL30376 MICs (up
to 8 mg/L) were identiﬁed in all P. aeruginosa strains examined,
with incidence between 10−7 and 10−9. Subpopulations resistant to
cefepime or meropenem were also detected at an incidence between
10−5 and 10−7. Repeated passaging in cultures containing BAL30376
yielded strains with >4-fold elevated MIC after 10−20 passages. Strains
with >4-fold elevated MIC towards cefepime or meropenem appeared
within 4 passages under the same conditions. Many of the resistant
isolates obtained in these studies had increased levels of expression of
b-lactamase.
Conclusion: Low frequencies of spontaneous resistance to BAL30376
were observed. Despite its complexity, the triple combination is relatively
refractory to development of resistance.
P571 Bactericidal effect of the siderophore
monobactam/b-lactamase inhibitor combination BAL30376
C. Geier (Basel, CH)
Objective: BAL30376 is a novel combination between the monobac-
tam antibiotic BAL0019764 and the speciﬁc b-lactamase inhibitors
BAL0029880 and clavulanic acid. We have assessed the in vitro time-kill
kinetics of this combination using a selection of multi-resistant Gram-
negative bacteria.
Methods: MICs were determined by standard broth micro-dilution
methods. A preliminary MBC was determined by plating out the clear
wells from the MIC determination and counting colonies 24 and 48h
after plating. Time-kill studies were done in standard growth medium
with an inoculum of approximately 106 cfu/ml. Serial dilutions were
taken a 0, 3, 6, 24 and 28 h after inoculation.
Results: MBC was 1−4×MIC for the action of BAL30376 against
most strains of Enterobacteriaceae and Acinetobacter sp. that were
investigated. MBC could be up to 16×MIC for the action of BAL30376
against some strains of Pseudomonas aeruginosa. Against the same
strains, the MBCs of cefepime and meropenem were 1−4×MIC
for susceptible strains of Enterobacteriaceae and 4−>32×MIC for
susceptible strains of Acinetobacter and P. aeruginosa. Time-kill analysis
demonstrated that BAL30376 decreased the cfu count by 3 orders of
magnitude within 24 h at 4 and 8×MIC against Enterobacteriaceae,
Acinetobacter and P. aeruginosa. The kill kinetics were dependent on
inoculum density and were faster with an inoculum of 5×104 cfu/ml
and slower with an inoculum of 107 cfu/ml.
Conclusion: BAL30376 has marked bactericidal activity against a
range of multi-resistant Gram-negative bacteria, including carbapenem-
resistant strains.
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P572 In vivo effectiveness and dose response of BAL30376 in
murine peritonitis sepsis model caused by Pseudomonas
aeruginosa or by extended-spectrum b-lactamase producing
Escherichia coli
S. Navon-Venezia, M. Page, A. Schmitt-Hoffmann, Y. Carmeli (Tel
Aviv, IL; Basel, CH)
Pseudomonas aeruginosa (PA) and extended spectrum beta lactamase
(ESBL) E. coli are common nosocomial pathogens often affecting
immunocompromised patients that are difﬁcult to treat. Against these
pathogens we aimed to study in a lethal mice peritonitis sepsis model
of infection the in vivo efﬁcacy of a new monobactam beta lactamase
inhibitor combination, BAL30376 speciﬁcally designed to overcome
most resistance mechanisms in non-fermenters and Enterobacteriaceae,
including metallo betalactamases and ESBLs.
Methods: PA and ESBL E. coli with MIC< 0.0625 mg/L for BAL30376
were used as infecting bacteria in the in vivo model. Neutropenia
was induced in ICR mice (23−25 g) and peritonitis was induced by
intraperitoneal inoculation of either PA or ESBL E. coli. Efﬁcacy was
studied at various bacterial inocula: 5×102 –1×104 cfu /mouse (1−50
LD50) for PA, and 4−8×106 cfu /mouse (4−8 LD50) for ESBL E. coli.
Mice (n = 12) were treated with BAL30376 three times a day given ip
for three days. Dose effect was studied at a range of doses between 6.25
to 100 mg/Kg. Survival was monitored for seven days post infection and
compared with control groups (A saline placebo group and a meropenem
treated group) using log rank test.
Results: In two sets of experiments PA peritonitis (at 6x LD50) resulted
in 70–100% mortality in placebo group. BAL30376 had 100% protection
at doses  25 mg/Kg (p< 0.01) similarly to the meropenem treated
group. Lower doses of BAL30376 were moderately protective. ESBL
E. coli peritonitis was studied in two experiments (4−8x LD50) and
resulted in 100% mortality in placebo group. BAL30376 had 100%
protection at doses  12.5 mg/Kg (p< 0.01). With both pathogen studied
at various inocula and dosages of BAL30376 dose effect were conﬁrmed.
Conclusions: BAL30376 was highly effective in treating lethal
peritonitis and sepsis caused by PA or ESBL E. coli in murine model.
P573 Comparative efﬁcacy of EDP-420, azithromycin,
telithromycin, clindamycin, trimethoprim/sulfamethoxazole,
linezolid and levoﬂoxacin against murine skin abscess
induced by meticillin-resistant Staphylococcus aureus
USA300 PVL+ mecA strain
X. Luo, R. Wu, M. Wang, L.J. Jiang, D. Wachtel, A. Polemeropoulos,
L.T. Phan, G. Wang, Y.S. Or (Watertown, US)
Objectives: USA 300, a pulsed-ﬁeld type of meticillin-resistant
Staphylococcus aureus (MRSA) isolates, has demonstrated in outbreak
and non-outbreak community-acquired (CA-MRSA) as well as hospital-
associated S. aureus skin and soft-tissue infections (SSTI) which
is becoming one of the biggest infectious mysteries of the decade.
Investigators are not sure where it came from, where it lives, how it
spreads and how to treat empirically. USA 300 had an antimicrobial
susceptibility proﬁle demonstrating resistance only to b-lactams and
erythromycin while retaining susceptibility to clindamycin, levoﬂoxacin,
trimethoprim–sulfamethoxazole, and vancomycin. Guidelines for the
empirical treatment of CA-MRSA on SSTI are ambiguous. EDP-420,
a new bicyclolide (bridged bicyclic macrolide) with unique structural
features, was sensitive against USA300 in vitro. It is necessary to
compare its in vivo efﬁcacy with major antibiotics in murine skin
abscess model induced by USA300 and to determine its skin and abscess
concentration (a tissue PK).
Methods: Skin abscess was induced in mice by subcutaneous inoculation
of 107 CFU of USA300. Mice developed abscess within 1 day. Abscess
bacterial counts increased progressively. Bacterial counts can reach 109
CFU/g skin abscess tissue if leave untreated. Treatment was initiated
immediately, 24 h and 48 h after inoculation. Bacterial burden in abscess
and lesion sizes were compared by the end of the experiments. Single
dose pharmacokinetics of EDP-420 in plasma, normal skin and abscess
tissue were compared in abscess infected mice.
Results: EDP-420 was as effective as linezolid and clindamycin in the
MRSA (S. aureus USA300) model of murine abscess with a PD50s of
5.3, 7.3 and 10.7 mg/kg respectively. Levoﬂoxacin and telithromycin
were less active than EDP-420 with a PD50s of 20.1 and 25.9
mg/kg respectively. Azithromycin and trimethoprim/sulfamethoxazole
performed poorly with a PD50s of >100 mg/kg. EDP-420 exhibited an
8 fold abscess/plasma AUC ratio. Abscess in untreated animals appeared
24 h after inoculation, and persisted for up to 2 weeks.
Conclusion: EDP-420 demonstrated better efﬁcacy in the CA-
MRSA murine abscess model in comparison with currently marketed
oxazolidinone, lincosamide, ﬂuoroquinolone, ketolide, macrolide as well
as dihydrofolate reductase inhibitor/sulfonamide class antibiotics. The
results indicate that EDP-420 is potentially a potent antibiotic for
treatment of CA-MRSA in SSTI.
P574 Comparative effects of faropenem-medoxomil and
amoxicillin-clavulanate on the normal oral and intestinal
micro ﬂora and the selection of penem-resistance
M. Koch, W. Heizmann, J. Nagelschmitz, A. Dalhoff (Kiel, DE)
Objectives: Community-acquired enterobacteriaceae have acquired
ESBL- or AmpC-producing genes thus requiring more active b-lactams
such as faropenem. However suppression of the normal ﬂora in the oral
cavity and gastro-intestinal tract may select for colonisation with resistant
bacteria. Therefore we evaluated the effects of orally administered
faropenem-medoxomil (FAR) or amoxicillin-clavulanate (A/C) on the
normal human ﬂora and on colonisation of the oral cavity and colon.
Emergence of penem-resistance was monitored.
Methods: Healthy male volunteers were dosed orally for 8 days with
300mg FAR or 875/125mg A/C, bid. Oropharyngeal swabs and faeces
were collected prior to the 1st dose, and then on 1, 7, and 14 days after
dosing. Species representing the oral/faecal ﬂora were sought including
Streptococcus spp., Lactobacilli, Enterobacteriaceae, Peptostreptococci,
enterococci, Bacteroides spp., and Clostridium spp.. Clostridium difﬁcile
toxin A + B was analysed by EIA. Colonisation with Candida albicans/
krusei was monitored. Emergence of penem-resistance was screened by
using media containing 2, 4, 8mg FAR and 4, 16mg meropenem.
Results: No signiﬁcant changes in the oropharyngeal ﬂora were seen
either in the FAR or the A/C groups. Transient increases in faecal
enterococci were seen in both groups, and in E. coli in only the A/C
group. Counts of B. fragilis spp. tended to decrease in both groups.
C. difﬁcile was not isolated nor toxin detected from any subject. No
colonisation with Candida spp. was found. Transiently, P. aeruginosa
was isolated only on day 1, but not 7 + 14d after exposure to FAR (n = 2)
or A/C (n = 1). No penem-resistant Enterobacteriaceae were isolated, but
in each of 3 volunteers penem-resistant E. faecalis were isolated but
which disappeared on day 14.
Conclusion: 8 day exposure to FAR resulted in no changes in the
oropharyngeal and minimal changes in the faecal ﬂora. C. difﬁcile was
not selected and overgrowth with Candida spp. was not detected. Penem-
resistance did not emerge. Thus, FAR does not seem to cause major
changes in the resident oro-pharyngeal or faecal ﬂora or lead to the
emergence of penem-resistance.
P575 Tifacogin, a recombinant tissue factor pathway inhibitor elim-
inates serum-resistant Escherichia coli from blood cultures
S. Schirm, X. Liu, L. Jennings, P. Jedrzejewski, Y. Dai, S. Hardy
(Emeryville, US)
Objectives: Tifacogin – tissue factor pathway inhibitor (rTFPI), has
demonstrated therapeutic effectiveness in acute inﬂammatory disease
after lethal challenge with Escherichia coli in several animal models of
severe sepsis. Tifacogin is being evaluated in a phase 3 clinical trial in
patients with severe community acquired pneumonia. The mechanism of
action of tifacogin after acute bacterial infection is not well understood.
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Our current study investigates the effects of tifacogin after acute infection
in vitro. The objectives were to show whether fragmented tifacogin had
antibacterial activity against E. coli which could be mapped to the C-
terminus and to investigate the effect of heparin on the antibacterial
activity of fragmented tifacogin.
Methods: 10% donor derived blood or serum were used to culture
3 strains of serum resistant E. coli for 4 hours at 37ºC with varied
concentrations of fragmented tifacogin prepared using plasma proteases
or synthetic C-terminal peptides. Bacterial survival was assessed by
plating serial dilutions of the reaction mixes onto tryptase soy agar plates.
Colony numbers were determined after overnight incubation at 37ºC.
Direct interaction between TFPI peptides and E. coli was investigated
by ﬂuorescent microscopy using ﬁxed bacteria and ﬂuorescently labeled
peptides. Heparin was included in some cultures or binding experiments.
Results: C-terminal tifacogin fragments and synthetic peptides exhibited
antibacterial activity in a complement-dependent fashion. While intact
tifacogin slightly enhanced E. coli growth, tifacogin digested with plasma
proteases dramatically reduced growth. The activity was mapped to
a highly positively charged region previously identiﬁed within intact
TFPI as a heparin binding site. Synthetic peptides including the positive
region were highly active (MIC90 10−30nM). Antibacterial action
involved the classical complement pathway including terminal complex
formation since factors C1q, C2, C3, C4, C5, C6 and C9 were required.
Direct interaction with the bacterial cell surface of E. coli was seen.
Complement mediated killing and cell surface binding were reversed by
low amounts of heparin.
Conclusions: Our results show a novel activity of the C-terminus of
tifacogin in complement resistant E. coli infection that is released by
fragmentation of tifacogin. As tifacogin is rapidly degraded in vivo,
our ﬁndings suggest that tifacogin may have a therapeutic role in
management of disease caused by acute infection.
P576 Highlights on the mode of action of ST-246, an
anti-orthopoxviral compound
S. Duraffour, S. Vigne, K. Vermeire, J.M. Crance, D. Garin, R. Jordan,
D.E. Hruby, G. Yang, G. Andrei, R. Snoeck (Leuven, BE; Grenoble,
FR; Corvallis, US)
Objectives: ST-246 is a highly potent and orally bioavailable anti-
orthopoxviral molecule that targets the F13L protein of vaccinia virus
(VACV). We investigated part of its mechanism of action by using small
interfering RNAs, i.e., siF13Ls, designed to speciﬁcally knockdown the
F13L gene and by characterising ST-246 resistant strains of VACV and
camelpox virus (CMLV).
Methods: The VACV strains Copenhagen, Western Reserve (WR)
expressing GFP as a C-terminal fusion protein with F13L or an F13L
deleted virus expressing GFP from the F13L locus, and the Iran CMLV
strain were used. Cultures of human embryonic lung ﬁbroblasts (HEL)
were transfected with the siF13L of interest, and infected 24h later
at a MOI of 0.01. The effects of siRNA were determined by real-
time RT-PCR, viral titrations and ﬂow cytometry. For the selection of
resistant viruses, VACV and CMLV were propagated in HEL cells under
increasing concentrations of ST-246 for approximately 17 passages.
Strains exhibiting at least 100-fold increase of their wild type 50%
inhibitory concentration (IC50) were deﬁned as resistant.
Results: Real-time RT-PCR and viral titrations data indicated that
siF13Ls (100 nM) knocked down the VACV and CMLV F13L gene
transcripts by more than 85% and reduced their replication by 90%. At
lower siF13L concentrations, VACV and CMLV replication was inhibited
in a different way, which is in agreement with our previously published
data on the anti-VACV and -CMLV activity of ST-246. Flow cytometry
analysis showed a reduction of VACV-WR replication expressing a F13L-
GFP, but not of a F13L deleted VACV-WR, by siF13Ls and ST-246 and
validated a common target, i.e., F13L. Furthermore, the IC50 values
of two ST-246 resistant CMLV mutants were >20mg/ml compared to
0.005mg/ml for the wild type. In the case of VACV, a 120-fold increase
of the IC50 value indicated a ST-246 resistant phenotype. Sequencing
of the F13L genes, for both resistant and wild type VACV and CMLV
strains, is currently ongoing.
Conclusion: We have shown the inhibitory potency of siF13L inducing
a speciﬁc silencing of the F13L gene which resulted in the inhibition of
VACV and CMLV yields. We demonstrated the mode of action of ST-246
at the protein level and not on mRNA. A single target for ST-246 has
been validated in VACV and CMLV. We also isolated ST-246 resistant
clones of both viruses and the determination of mutations induced by
ST-246 in the F13L gene is currently investigated.
P577 REP3123, a novel inhibitor of methionyl tRNA synthetase
from C. difﬁcile
I. Critchley, T. Jarvis, J. Guiles, X. Sun, R. Evans, D. Davies, L. Green,
U. Ochsner, C. Young, D. Citron, S. Bell, D. Drolet, S. Gill, N. Janjic
(Louisville, Bainbridge Island, Culver City, US)
Objectives: C. difﬁcile-associated disease (CDAD) is caused by
overgrowth of toxin-producing strains of C. difﬁcile (CD) following
disruption of normal gut ﬂora. Currently, there are few therapeutic
options and clinical problems are associated with disease recurrence
and the persistence of spores in the environment. In this report, we
describe biochemical, crystallographic, microbiological and in vivo
efﬁcacy properties of REP3123, a novel diaryldiamine inhibitor of CD
methionyl tRNA synthetase (MetRS).
Methods: REP3123 was synthesised and puriﬁed as a single active
enantiomer. CD MetRS was expressed in E. coli and puriﬁed to
homogeneity. The enzyme was crystallised by sitting drop vapor
diffusion and structures were solved by molecular replacement.
Microbiological testing was done according to CLSI guidelines. Toxins
A and B were detected by semi-quantitative immunoassays, Western blot
and cytotoxicity assays. In vivo efﬁcacy of REP3123 was evaluated in
the hamster model of CDAD.
Results: The tight binding of REP3123 to MetRS (Ki=20 pM) is
competitive with methionine but cooperative with ATP. Inhibitor binding
is accompanied with a conformational change in the enzyme in which
the inhibitor occupies the methionine binding pocket and a newly
created hydrophobic pocket. REP3123 is highly active against CD,
including the NAP1/027 outbreak strain (MIC range, 0.25−1.0 mg/L). In
contrast, REP3123 is inactive against Gram-negative bacteria and many
anaerobic bacteria that constitute normal gut ﬂora such as Actinomyces,
Bacteroides, Biﬁdobacterium and Lactobacillus species. As a protein
synthesis inhibitor, REP3123 inhibits the production of CD toxins A
and B under a variety of culture conditions. REP3123 is also highly
effective in inhibiting spore formation. In vivo, REP3123 exhibits low
oral bioavailability and superior efﬁcacy to vancomycin in the hamster
model of CDAD.
Conclusion: REP3123 is a novel mechanism-of-action antibacterial
agent that exhibits potent and selective inhibition of CD with limited
potential for disruption of normal gut ﬂora. REP3123 effectively inhibits
toxin production and sporulation, exhibits low oral bioavailability and
protects against CDAD in vivo. With these unique features, REP3123
represents a promising new development candidate for the treatment of
CDAD.
P578 Antimicrobial activity of ceftobiprole tested against leading
European bacterial pathogens: results from an international
surveillance programme (2005–2006)
T. Fritsche, H. Sader, M. Janechek, R. Jones (North Liberty, US)
Objectives: To evaluate potency of ceftobiprole (BPR) against the most
serious and commonly occurring Gram-positive and -negative pathogens
isolated in Europe. BPR, an investigational parenteral cephalosporin,
is currently under regulatory review following completion of Phase III
clinical trials. This agent is uniquely active against oxacillin-resistant
(OXA-R) S. aureus (MRSA), as well as other Gram-positive and
-negative pathogens, making it an attractive candidate for broad-spectrum
therapy.
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Methods: Consecutive, non-duplicate isolates (17,206) from blood-
stream, skin and skin structure and respiratory tract infections were
collected from medical centres in Europe (23), Turkey (2) and Israel
(1) participating in the BPR Surveillance Program during 2005–2006.
Identiﬁcations were conﬁrmed by the central monitoring laboratory and
all isolates were susceptibility (S) tested using CLSI methods against
BPR and comparator agents.
Results: Results are in the Table. Among SA (27% OXA-R) and CoNS
(75% OXA-R) isolates tested, BPR inhibited 100% at 4 and 8
mg/L, respectively. While BPR MIC90 values for OXA-R strains were
elevated over those of OXA-S strains (8-fold), MIC90 values for other
cephalosporins correspondingly increased 32-fold. BPR was 4-fold
more potent when testing beta-haemolytic streptococci (BHS) and SPN
compared with CRO or FEP; all BHS were inhibited at 0.25 mg/L
and >99% of SPN by 0.5 mg/L. BPR was similar in potency to CAZ
and FEP (MIC50 values, 1 mg/L) against tested Enterobacteriaceae;
coverage against EC was nearly identical for the three agents (94−95%
inhibited at 4 mg/L). FEP provided enhanced coverage against KSP
(90% at 8 mg/L vs. 78−84% for BPR and CAZ), although BPR and
FEP had lower MIC values than CAZ against ESP. Cephalosporins were
largely inactive against ESBL-producing EC and KSP. BPR was equal
in potency to CAZ (MIC50, 2 mg/L) against PSA and two-fold more
potent than FEP, although % inhibited for these agents at 2/4/8 mg/L
were similar. None of these agents inhibited >49% of ASP at 8 mg/L.
Species (no. tested) MIC90 (% at 2/4/8mg/L)
BPR CROa or CAZb FEP
S. aureus (SA; 4,028) 1 (>99/100/−) >32 (39/72/75)a >16 (66/76/81)
Coagulase-negative staphylococcus (CoNS; 1,840) 2 (93/>99/100) >32 (22/33/47)a >16 (41/62/77)
S. pneumoniae (SPN; 1,528) 0.25 (100/−/−) 1 (>99/>99/100)a 1 (>99/>99/>99)
E. coli (EC; 2,779) 0.12 (93/94/94) 1 (93/94/95)b 0.25 (94/95/96)
Klebsiella spp. (KSP; 883) >8 (77/78/78) >16 (80/81/84)b 16 (84/87/90)
Enterobacter spp. (ESP; 571) >8 (81/84/87) >16 (66/68/70)b 4 (88/92/96)
P. aeruginosa (PSA; 984) >8 (54/65/79) >16 (56/69/76)b 16 (49/66/80)
Acinetobacter spp. (ASP; 320) >8 (41/41/42) >16 (15/32/39)b >16 (26/37/49)
Conclusions: BPR displays prominent activity against European
staphylococci, including OXA-R strains. The compound also displayed
activity against Enterobacteriaceae, similar to that of extended-spectrum
cephalosporins, as well as against some non-fermentative bacilli. Given
the breadth of its spectrum, BPR may be useful in those European
institutions/ regions where MRSA and PSA are both prevalent.
P579 Antimycobacterial activity of two Berberis species used as
traditional medicine in Iran
F. Khadem, H. Zare Maivan, H. Movassagh, M. Salimi, M. Shariﬁ,
T. Sohrabi, B. Yazdanpanah, M. Rostami Baroei, M. Abolhassani
(Tehran, IR)
Objectives: Tuberculosis (TB) is the leading cause of mortality
worldwide, infecting about 9 million people and killing approximately
2 million people annually. In recent years, emerging multiple drug
resistance (MDR) has become a major threat, thus there is an urgent need
to search natural products for developing new, effective and affordable
anti-TB drugs. Berberidaceae, especially berberis species are well known
medicinal plants and are used in traditional medicine, foods and dies
in Iran. Chemical composition of Berberidaceae species show that their
anti-inﬂammatory and anti-tuberculosis activity is mainly due to alkaloid
constituents. This study was conducted to compare antimycobacterial
activity of extracted alkaloids from root bark and fruit of Berberis
vulgaris and B. integgerima from the natural ﬂora of Khorasan ecological
region.
Methods: Root bark and fruit from two species were collected, shade
air dried, lyophilised and powdered. Chloroform extracts containing
alkaloid fractions were obtained. Fresh solutions of each extract were
dissolved in 2% DMSO. The Chloroform extracts were incorporated
into the Lowenstein-Johnson medium after solidiﬁcation with ﬁnal
concentrations of 500, 250, 125, 62.5 and 31mg/ml. Bacterial suspension
test was adjusted to 3×105 CFU per ml Mycobacterium bovis BCG
(Strain 1173 P2, Institut Pasteur, Paris, France) and incubated in 37
degrees of Celsius for 21 days. The minimum inhibitory concentration
(MIC) amounts were evaluated after 21, 28 and 35 days of incubation.
Mycobacterium bovis BCG was cultured in presence and absence of
reference drug (Kanamycin) as controls. All tests were carried out ﬁve
times.
Results: All four root bark and fruit chloroform extracts showed
signiﬁcant (P< 0.05) MIC concentrations (31–500mg/ml), therefore
31mg/ml was considered to be the best MIC for all four extracts.
Conclusion: Medicinal plants are an important resource to ﬁnd original
active drugs or new therapeutic agents especially against TB. The results
indicate that root bark and fruit of Berberis vulgaris and B. integgerima
can be used as antimycobacterial agents because of their considerable
MIC values. Our investigations show that these remarkable results
are due to alkaloids such as berberine, palmatine, oxyacantine and
jatrorrhizine. Further investigations are required to assess the activities
of these compounds against MDR M. tuberculosis.
P580 Antistaphylococcal activity of semi-puriﬁed fractions from
Eleutherine americana
S. Voravuthikunchai, B.O.T. Ifesan, W. Mahabusarakam, C. Hamtasin
(Hatyai, Songkla, TH)
Introduction:Meticillin-resistant Staphylococcus aureus (MRSA) infec-
tions are a global health concern due to the severity of the illnesses they
may cause, ranging from mild to very severe infections. The numbers
of S. aureus strains that exhibit antimicrobial resistance properties have
increased and there is a potential risk of transmitting antibiotic resistance
genes to the human microbiota through foods. Interest in plants with
antibacterial properties has revived as a consequence of current problems
associated with the use of antibiotics. Preliminary research from our
laboratory revealed that the crude extract from Eleutherine americana
produced good antibacterial effect on S. aureus from foods. The aim of
the present study was to examine the activity of semi-puriﬁed fractions
from this plant extract against meticillin-resistant strains isolated from
foods and enterotoxin-producing reference strains.
Methods: Twenty-two MRSA strains isolated from food together with
two enterotoxin-producing strains (ATCC 23235 and ATCC 27664)
were used in this study. The Minimum inhibitory concentration
(MIC) was determined by the broth dilution method and Minimum
bactericidal concentration (MBC) was performed with the extracts
that gave signiﬁcant MIC values using a sterile loop streaking
on fresh MHA (CLSI standard methods). Time-kill assay in the
presence of these fractions were carried out. The crude hexane extract
was chromatographed on column chromatography and fractions were
obtained on the basis of their TLC characteristics.
Results: Fraction Ea 6.3 had MIC90 of 0.25 mg/ml while Ea 9.0 gave
MIC50 of 0.125 mg/ml with MBC values ranging from 0.25  1.00
mg/ml for the two fractions on all the strains tested. Kill-curve in the
presence of Ea 6.3 at 4MIC resulted in total killing of the cells at 20 h
for reference strains and 24h for MRSA while fraction Ea 9.0 reduced
the inoculum size by 7 log cycle.
Conclusion: Both fractions were very effective against all food isolated
MRSA as well as enterotoxin-producing strains. These semi-puriﬁed
fractions are being investigated in our laboratory to provide alternate
treatment against MRSA.
Acknowledgements: Supported by Graduate School Prince of Songkla
University and Thailand Research
Fund (BRG 4880021, ﬁscal year 2005–2008).
P581 Approach to identify novel antimicrobials against
staphylococci
I. Abaev, O. Korobova, E. Pecherskikh, P. Kopylov, N. Kiseleva,
D. Donovan (Obolensk, RU; Beltsville, US)
Objectives: Bacteriophage endolysins degrade the host cell wall
peptidoglycan with near-specie speciﬁcity, and thus are of interest as
S138 18th ECCMID, Posters
antimicrobials against Staphylococcus aureus. Previous S. aureus phage
endolysin studies have been based on organisms from Western Europe
and North America. Our study extends this to phages from Russia. We
have developed a screening system to identify novel phage endolysin
proteins of S. aureus.
Methods and Results: Lytic bacteriophages have been selected from
clinical and environmental samples, or by induction of prophages from a
population of temperate bacteriophages from MRSA and MSSA strains.
High titer phage lysates of lytic bacteriophage have been tested by nine
PCRs to screen for S. aureus phages carrying endolysin genes from either
ﬁve homologous groups (>90%) or four stand alone endolysin genes.
This strategy should rule out known endolysin genes and thus identify
putative novel genes that are not homologous to previously reported
genes. Crude phage lysates harboring candidate novel endolysins are
tested for their ability to kill live pathogenic staphylococci in both
zymogram analysis and turbidity assays. In the zymogram analysis,
selected phage lysates demonstrate two bands (53 kDa and 27 kDa)
that are not present in control lysates. Eight phage-associated lysates
from candidate novel endolysin harboring phages have demonstrated the
ability to kill exponentially growing MRSA and MSSA. Positive isolates
are subjected to shotgun cloning of phage DNA and some cloned inserts
have been sequenced. Currently, the subcloned phage DNA fragments
have no similarity to data deposited in public databases.
Conclusions: The proposed approach is showing promise for identifying
novel endolysin genes. Our next focus will be to perform MALDI-TOF
analysis on puriﬁed phage proteins known to harbor lytic activity in
zymogram analysis.
Acknowledgements. This research is supported by ARS-ISTC #499/3571
Project Grant.
P582 Photodynamic therapy against resistant bacteria from cystic
ﬁbrosis patients
O. Torun, S. Ak, B. Sener (Ankara, TR)
Objectives: Photodynamic therapy (PDT) combines a photosensitizer
dye with visible light to generate reactive oxygen radicals toxic to cells.
High rate of antibiotic resistance in cystic ﬁbrosis (CF) isolates highlights
the need for new treatment strategies. This study is aimed to evaluate the
in-vitro effect of PDT alone and in the presence of antibiotics on MRSA,
Pseudomonas aeruginosa (PA), Stenotrophomonas maltophilia (SM) and
Burkholderia cepacia complex (BCc) isolated from CF patients.
Methods: Four MRSA, 4 PA, 8 SM and 2 BCc isolates were initially
tested for susceptibility by microdilution method. PDT was applied by
using toluidine blue at a light dose of 54 J/cm2 with a light emitting diode
on microtiter plates and killing was determined by viable cell counts.
PDT was also applied on antibiotic containing MIC trays and effect on
MIC values were tested. MBC values were determined by direct plate
count for MIC and MIC+PDT trays.
Results: All PA, Sm and Bcc strains were resistant to ceftazidim (CAZ),
meropenem (MEM), ciproﬂoxacin (CIP) and amikacin (AK), except for
two PA strains susceptible to AK and CIP. All MRSA strains were also
resistant to AK and CIP. Overall PDT alone exhibited 4 log killing in
8, 2 log in 4, 1 log in 5 and no effect in one strain. PDT application
in presence of antibiotics lowered the MIC values in all bacteria except
for two PA strains, at least for 4 folds for all the antibiotics tested
to susceptible levels. PDT application in the presence of antibiotics
decreased viable cell counts at least 3 logs for all the MRSA, SM, BCc
strains. PDT+CAZ and PDT+MEM achieved no bactericidal activity in
3 PA strains while AK and CIP exhibited bactericidal activity in the
presence of PDT for all PA strains.
Conclusions: Although PDT alone was not able to achieve bactericidal
activity for all the tested strains, a signiﬁcant bactericidal effect was
detected when PDT was applied in the presence of antibiotics for all
bacteria except for PA. Resistance to antibiotics in CF isolates may be
overcome by the synergistic activity of PDT which should further be
improved for in-vivo application.
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P583 Enhanced activity of daptomycin and vancomycin combined
with imipenem or oxacillin against community-acquired
MRSA isolates
R. Jones, P. Rhomberg, R. Fritsche, H. Sader (North Liberty, US)
Objectives: To study glycopeptides and lipopeptides in combination with
potent antistaphylococcal b-lactams against community-acquired MRSA
(CA-MRSA). CA-MRSA has emerged as a serious clinical therapeutic
problem because of limited orally administered treatment options,
recognised virulence (Panton-Valentine leukocidin) and ubiquitous
presentations in outpatient practice in the USA and worldwide. Serious
invasive cases needing hospitalisation require prompt selection of
bactericidal, parenteral agents. We report drug combinations with
enhanced killing activity.
Methods: Following CLSI susceptibility (S) test screening of >100 CA-
MRSA, vancomycin (MIC50, 1 mg/L), daptomycin (MIC50, 0.25 mg/L)
and imipenem (IPM; MIC50, 0.5 mg/L) each had potential treatment
utility as well as oxacillin (OXA; MIC50, 16 mg/L) in combination. Ten
strains with USA300 PFGE patterns (three USA300–0114) or variations
were selected for checkerboard synergy/interaction tests. Interpretations
used FICA calculations. The control b-lactam was OXA and internal
organism control was S. aureus ATCC 29213 (MSSA).
Results: All drugs tested alone were consistent with expected results for
a MRSA except IPM where contemporary USA300 CA-MRSA MIC
values ranged from only 0.03 to 2 mg/L (S levels by CLSI and US-FDA
breakpoints). Combinations of IPM with daptomycin and vancomycin
clearly indicated enhanced inhibition (and killing; data not shown) for
9−10 of 10 strains (synergy [SYN] or partial SYN [PSYN]). Similarly,
OXA with daptomycin or vancomycin demonstrated SYN or PSYN
at concentrations easily achievable in vivo. The control MSSA strain
interaction results varied from indifference (daptomycin or vancomycin)
to PSYN (daptomycin/OXA).
Combinationa Interaction category (occurrences):
Synergy Partial synergy Additive Indifferent Antagonism
DAP/OXA 6 4 0 0 0
DAP/IPM 4 6 0 0 0
VAN/OXA 1 9 0 0 0
VAN/IPM 9 0 0 1 0
aDAP = daptomycin, OXA = oxacillin, IPM = imipenem and VAN = vancomycin.
Conclusions: Carbapenem (IPM) MIC results for CA-MRSA strains
endemic in USA remain low (0.03−2 mg/L; MIC50, 0.5 mg/L)
and combinations with either daptomycin or vancomycin demonstrate
enhanced inhibition (SYN or PSYN) and bactericidal activity. No
antagonism was observed and these combinations should be considered
for severe cases of CA-MRSA infections and studies should be expanded
to endemic hospital-acquired MRSA.
P584 Activity of oritavancin against Staphylococcus aureus isolates
that show heterogeneous resistance to vancomycin
F.F. Arhin, I. Sarmiento, T.R. Parr Jr., G. Moeck (Ville Saint Laurent, CA)
Objectives: Oritavancin is a semi-synthetic glycopeptide that is currently
under investigation for use in therapy for severe Gram-positive infections.
Its spectrum includes Staphylococcus aureus isolates with different
vancomycin susceptibility proﬁles. S. aureus isolates heteroresistant to
vancomycin (hVISA) are increasingly being reported and have been
linked to clinical failure of vancomycin. This study determined the
activity of oritavancin against hVISA.
Methods: Clinical isolates that ﬁt the hVISA proﬁle (n = 11) were
obtained from the Network on Antimicrobial Resistance in Staphylococ-
cus aureus (NARSA) repository and hVISA designations were veriﬁed
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using (i) teicoplanin screening agar as recommended by the European
Antimicrobial Resistance Surveillance System, (ii) the conventional
vancomycin and teicoplanin Etest, and (iii) a modiﬁed vancomycin and
teicoplanin Etest using a higher inoculum and brain heart infusion
(BHI) agar plates. MICs were determined by broth microdilution
against oritavancin, vancomycin, and teicoplanin according to CLSI
guidelines. When testing oritavancin, the procedure was modiﬁed to
include polysorbate-80 (0.002% throughout test). Plates were read after
24 and 48 h incubation. Reference or quality control strains of different
vancomycin susceptibilities (sensitive, intermediate and resistant) were
included in all tests as controls.
Results: The hVISA phenotype was conﬁrmed for all isolates.
Oritavancin showed potent activity against the hVISAs with an MIC
range of 0.25−1 mg/L and an MIC90 of 1 mg/L when the plates are
read after 24 h incubation. Oritavancin and comparator MICs read after
48 h of incubation were identical or within one doubling dilution of
those read after 24 h of incubation. From the MIC90 values, oritavancin
was 2- to 4-fold more potent than vancomycin or teicoplanin.
Agent MIC range (mg/L) MIC90 (mg/L)
Oritavancin (read after 24 h) 0.25−1 1
Oritavancin (read after 48 h) 0.25−2 2
Vancomycin (read after 24 h) 2−4 4
Vancomycin (read after 48 h) 2−8 8
Teicoplanin (read after 24 h) 2−8 8
Telcoplanin (read after 48 h) 2−16 16
Conclusions: Oritavancin was 4- to 8-fold more potent than the
comparator drugs vancomycin and teicoplanin against hVISA strains
in broth microdilution assays. This ﬁnding supports further development
for oritavancin against challenging infections.
P585 Detection of oxacillin resistance in staphylococci: comparison
of MicroScan and cefoxitin disc diffusion test
P. Lanzafame, M. Zoppelletto (Trento, IT)
Objectives: Recently Clinical and Laboratory Standards Institute (CLSI)
has recommended the use of the cefoxitin disc diffusion (DD) test for
detecting meticillin resistance in Staphylococci. The ability of MicroScan
panels PBC 21 (Dade Behring, West Sacramento, California, USA) to
detect oxacillin resistance in 786 clinical isolates of Staphylococci was
evaluated by comparing results with cefoxitin DD test.
Methods: 425 S. aureus and 361 coagulase-negative Staphlylococci
(CNS) isolates from all body sites were tested. Microdilution suscep-
tibility testing by MicroScan panel PBC 21 was performed according to
manufacturer’s instructions. From an 18−24-h blood agar plate, isolated
colonies were emulsiﬁed in 0.85% sterile saline to yield a turbidity of
0.5 McFarland. The suspension was vortexed, and 0.5 ml was added to
25 ml of sterile distilled water containing 0.02% Tween 80. Panels were
inoculated by using the MicroScan inoculator set and incubated for 24
h in MicroScan WA 96.
Cefoxitin DD testing was performed according to CLSI M100-S17
guidelines. The inoculum was prepared directly from 18-h agar plates,
and MHA plates (Kima, Italy) were incubated at 35ºC for 24 h.
Controls included S. aureus ATCC 29213 and ATCC 25923. PBP2a
agglutination was performed, as a gold standard, when results of
the phenotypic methods were not in agreement. PBP2a agglutination
(Oxoid, Cambridge, UK) was performed according to manufacturer’s
instructions.
Results: 112 (26.3%) strains of S. aureus and 231 (64.0%) of CNS
isolates were resistant by MicroScan, whereas 114 (26.8%) strains
of S. aureus and 231 (64.0%) of CNS isolates, respectively, were
resistant by cefoxitin DD test. The two strains giving discrepant results
between MicroScan and the cefoxitin DD test were examined by PBP2a
agglutination and they were conﬁrmed as resistent. The inhibition zone
diameters of the discrepant S. aureus strains were 22 mm, closed to
break-point of resistance.
Conclusion: When coagulase-negative Staphlylococci (CNS) were
tested, MicroScan showed an excellent performance to detect oxacillin-
resistant Staphylococci, in comparison with the cefoxitin DD test (100%
sensitivity). Considering S. aureus strains, the sensitivity of Microscan
was 98.2%, compared to the cefoxitin DD test.
P586 Tigecycline activity against Staphylococcus aureus exhibiting
multidrug-resistant phenotypes in Europe
D. Sahm, D. Draghi, C. Pillar, C. Thornsberry, M. Dowzicky
(Herndon, Collegeville, US)
Objective: Staphylococcus aureus (SA) can cause complicated skin and
skin structure infections and complicated intra-abdominal infections.
Recently in 2006, tigecycline (TIG) was approved in Europe (EU) to
treat these infections. SA worldwide are becoming resistant to the most
commonly prescribed antimicrobial treatments. TIG is used in healthcare
settings where resistance (R), including multidrug resistance (MDR) has
become prevalent. Recent outbreaks of this organism have shown clearly
that resistance can develop to several different agents. Careful monitoring
of new agents such as TIG has become imperative.
Methods: In total, 686 SA isolates were obtained from 28 hospitals in ten
countries across EU during 2006 to 2007. Isolates were tested centrally
by broth microdilution (CLSI M7-A7). TIG activity was analysed by
oxacillin (OX) and MDR status deﬁned as resistance to 3 agents which
included OX, minocycline, erythromycin (ERY), clindamycin (CLI),
gentamicin, and levoﬂoxacin (LEV). EUCAST breakpoints were used
to interpret TIG MIC results and CLSI (M100-S17) breakpoints were
used to interpret all other agents, where applicable.
Results: The susceptibility rate overall for SA tested against TIG was
99.4%, with MICs ranging from 0.03 to 1 mg/L. Regardless of OX
or MDR status, the TIG modal MIC and MIC90 (mg/L), remained
consistent at 0.12 and 0.25, respectively. TIG maintained the lowest
MIC90 of all comparators tested. The most common MDR phenotype
was 3-drug R with concurrent R to ERY, LEV, and OX (18.1% of all
isolates surveyed) followed by 4-drug R with concurrent R to CLI, ERY,
LEV, and OX (17.3% of all isolates surveyed). Among MDR populations,
TIG maintained >99% susceptibility rate.
Conclusion: TIG has exhibited exceptional in vitro activity against SA
including MDR populations. The potential for R to emerge and spread
is increasing among SA according to recent CDC reports, therefore
continuous monitoring provided by this surveillance initiative is essential
to guide clinicians for new therapeutic options.
P587 Analysis of tigecycline activity against Staphylococcus aureus
based on patient location and clinical specimen source in
Europe
N. Brown, D. Draghi, C. Thornsberry, C. Pillar, D. Sahm, M. Dowzicky
(Herndon, Collegeville, US)
Objective: Proﬁling novel agents such as tigecycline TIG for changing
resistance trends is important to determine differences among speciﬁc
patient populations and sites of infection. TIG, a glycylcycline, was
approved in 2006 in Europe (EU) for treatment of complicated skin
and skin structure infections and complicated intra-abdominal infections.
Staphylococcus aureus (SA) has the propensity to develop resistance,
which can vary with patient locations (PL) and type of infection (as
reﬂected by varied specimen source [SS]). Therefore, analysis of anti-SA
TIG activity was stratiﬁed according to PL and SS using data collected
during 2006 to 2007.
Methods: SA isolates were collected from locations broadly dispersed
across EU (including ten countries) and tested centrally using broth
microdilution according to current CLSI standards. TIG activity was
analysed by PL (outpatient [OP], intensive-care unit [ICU], and inpatient
non-ICU [IP]) and SS (blood [BL], respiratory [RP], skin and skin
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structure [SST], and urine [UR]). EUCAST breakpoints were used to
interpret all TIG MIC results.
Results: See Table.
Org Category TIG
Total n MIC range MIC90 % Susceptible
SA OP 109 0.06−1 0.5 99.1
IP 391 0.03−1 0.25 99.2
ICU 174 0.03−0.5 0.25 100
BL 162 0.06−0.5 0.5 100
RP 242 0.03−0.5 0.25 100
SST 262 0.03−1 0.25 98.5
UR 16 0.06−0.5 0.5 100
MIC in mg/L.
Conclusion: Based on susceptibility rates and MIC90s, TIG consistently
maintained a high level of activity, regardless of PL or SS. Due to the
propensity for SA to develop resistance, continued monitoring of the
activity of novel agents against this species is imperative.
P588 Bactericidal activity of iclaprim against meticillin-sensitive
and -resistant Staphylococcus aureus
L. Weiss, M. Bihr, K. Islam, S. Lociuro, S. Hawser (Reinach, CH)
Objectives: Iclaprim is a novel diaminopyrimidine antibiotic that ex-
hibits potent bactericidal activity against major Gram-positive pathogens,
notably including MSSA and MRSA. Iclaprim exerts its antibacterial
activity by speciﬁcally and selectively inhibiting microbial dihydrofolate
reductase (DHFR). Intravenous iclaprim recently completed two phase III
trials of complicated skin and skin structure infections. This study aimed
to determine the bactericidal activity of iclaprim against 16 S. aureus,
including MSSA and MRSA. Several of these isolates were resistant to
the related diaminopyrimidine trimethoprim (TMP).
Methods: MICs were performed against a selection of 16 isolates
representative of the MIC range, including MSSA and MRSA, using
the CLSI microbroth dilution method. MBCs and time-kill studies were
performed under CLSI guidelines.
Results: The MIC range for iclaprim for the 16 isolates of S. aureus
was 0.015 to 2 ug/ml. The MBC range for all isolates was 0.015−2
ug/ml with MBC / MIC ranging from 1−2. For trimethoprim the MIC
range was 0.25–128 ug/ml and the MBC range 0.25−>128 ug/ml. Nine
isolates were run in time kill kinetic studies. Iclaprim demonstrated
a rapid bactericidal kill with the majority of isolates exhibiting a
 99.9% reduction in colony forming units following 4.2−7.5 hours
exposure to iclaprim. Vancomycin MICs for all isolates ranged from
1−2 ug/ml and MBCs from 1 to >8 ug/ml. The MBC / MIC range was
1−>8. Vancomycin was characteristically slowly bactericidal in time-kill
studies.
Conclusions: Iclaprim exhibited rapid bactericidal activity against both
MSSA and MRSA, including isolates that were resistant to TMP.
P589 In vitro activity of retapamulin against Staphylococcus
aureus isolates resistant to fusidic acid and mupirocin
N. Woodford, M. Afzal-Shah, M. Warner, D. Livermore (London, UK)
Objectives: Retapamulin is a novel pleuromutilin antibiotic licensed
in the USA in 2007 for the topical treatment of impetigo caused by
S. aureus and Streptococcus pyogenes; It is also licensed in Europe for
treatment of impetigo and secondarily infected open wounds caused by
the same organisms. We determined its activity in vitro against current
S. aureus isolates from the UK, including many resistant to fusidic acid
and/or highly resistant to mupirocin.
Methods: Six-hundred and sixty four isolates of S. aureus were
recovered from storage. These had been submitted for reference
investigation from laboratories throughout the United Kingdom. MICs
were determined on Mueller-Hinton agar in accordance with CLSI
guidelines. Susceptibility was categorised using CLSI criteria, where
available; otherwise BSAC criteria were used (for mupirocin and fusidic
acid).
Results: Susceptibilities of the 664 isolates are summarised below:
Antibiotic MICs (mg/L)
Range MIC50 MIC90
Retapamulin 0.008−2 0.06 0.125
Mupirocin 0.06−>1024 0.5 1024
Fusidic acid 0.015−>256 2 32
Oxacillin 0.06−>128 128 128
Erythromycin 0.125−>128 128 128
Clindamycin 0.03−>128 0.125 128
Gentamicin 0.015−64 0.5 64
The S. aureus included 488 (74%) MRSA (oxacillin MICs >2 mg/L),
336 isolates (51%) resistant to fusidic acid (MICs >1 mg/L), and 254
(38%) with high-level mupirocin resistance (MICs >256 mg/L); 103
(16%) isolates were resistant to both to fusidic acid and to high levels of
mupirocin. Retapamulin inhibited 663 (99.9%) isolates at 0.25 mg/L; a
single MRSA isolate, also with high level mupirocin resistance required
a retapamulin MIC of 2 mg/L.
Conclusions: As a reﬂection of its unique mode of action, retapamulin
has demonstrated excellent activity in vitro vs. S. aureus, irrespective of
their level of resistance to other antibacterials.
P590 Susceptibility of Staphylococcus aureus among skin
and wound specimen sources in the United States:
laboratory-based surveillance study 2005–2007
G. Tillotson, D. Draghi, D. Sahm, T. del Fabro, K. Tomfohrde,
I. Critchley (Louisville, Herndon, US)
Objectives: As meticillin-resistant Staphylococcus aureus (SA) infec-
tions increase, current data are needed to assess the susceptibility (S)
of SA in the US. In this study rates of antimicrobial S for SA were
reported from US laboratories from 2005 to 2007 with regional trends
of resistance (R) identiﬁed.
Methods: The Surveillance Network (TSN®) comprises 296 laboratories
from the 9 census regions of the US. TSN laboratories reported S
data for antimicrobials by isolate with specimen source description,
region, year of isolation, and patient location (PL including outpatient
[OP]; inpatient [IN]; intensive-care unit [ICU]). Commonly prescribed
agents were studied, these included ciproﬂoxacin (CIP), levoﬂoxacin
(LEV), clindamycin (CLI), daptomycin (DAP), erythromycin (ERY),
gentamicin (GEN), oxacillin (OX), linezolid (LIN), and trimethoprim-
sulfamethoxazole (SXT). S data from skin and wound specimen sources
were studied during 2005 to 2007. Speciﬁc phenotypes were further
investigated for associated R and multidrug R (MDR) patterns. Data
was interpreted using current CLSI standard criteria.
Results: There were >380,000 isolates of SA tested and reported for
the period 2005 to 2007. OX R was observed for 57.0% of SA in 2007
with little change from 2005. There was little difference in rates of OX
R between OP and IN cohorts. Among all PL in 2007, R rates (%)
were 18.6 for CLI; 64.8 ERY; 37 CIP; 39.5 LEV. Generally as expected,
isolates from the ICU tended to be slightly more resistant among the
agents studied. Regional variation in R rates was noted with the highest
rates in the central regions and lowest in New England and Mid Atlantic
regions among the agents studied. There was high activity observed for
SXT and GEN. LIN R was extremely rare and DAP R was not observed.
MDR rates (%) varied among patient location: 28.5 OP; 39.3 IN; and
51.5 ICU.
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Conclusions: SA has become OX-resistant in both the community and
hospital setting; however, little change was observed in the past 3 years.
MDR strains are now common in all settings and empiric therapy should
be guided by local susceptibility patterns due to the regional variation.
Currently, SXT, GEN, DAP, and LIN exhibited S rates >95%; however,
continued monitoring is warranted due to the propensity of this organism
to become resistant.
P591 In vitro effect of fusidic acid on staphylococcus strains with
macrolide-lincosamid-streptogramin B resistance
E. Sesli Cetin, H. Gunes, A. Aynali, S. Kaya, B. Cicioglu Aridogan,
M. Demirci (Isparta, TR)
Objectives: Antimicrobial resistance of staphylococcal isolates contin-
ues to be a problem for clinicians worldwide. A major problem in the
treatment of S. aureus infections is the ability of this pathogen to be
resistant to a number of antibiotics. Relationship between meticillin
resistance and resistance to other antibiotics has been reported in
previous investigations. Fusidic acid displays its antibacterial activity
via inhibiting protein synthesis without binding to bacterial ribosomes.
This unique mechanism of action prevents cross-resistance between
fusidic acid and other antibiotics. This study was carried out in order to
determine the in-vitro effect of fusidic acid on stapyhlococcal isolates
with macrolid-lincosamide-streptogramine B resistance.
Methods: The study included 532 staphylococcus isolates consisting
of 59 MRSA, 101 MSSA, 200 MRCNS and 172 MSCNS. Testing for
MLSB and was accomplished by the ‘D-zone’ test in accordance with the
recommendations of the CLSI. Fusidic acid resistance was investigated
by agar disk diffusion method according to the criteria of ‘Comite´ de
L’antibiogramme de la Socie´te´ Franc¸aise de Microbiologie’.
Results: Of 532 staphylococcal isolates, 62.4% were susceptible and
37.6% were resistant to MLSB antibiotics. 62.5% of the resistant isolates
exhibited a constitutive resistance phenotype, whereas 37.5% were
inducibly resistant. All of 101 MSSA isolates were susceptible to fusidic
acid. Susceptibility rate to fusidic acid was higher among strains without
MLSB resistance (82.8%) and strains with iMLSB (82.7%) resistance
than that observed among isolates with cMLSB (58.4%) resistance. We
have also determined that susceptibility to fusidic acid was signiﬁcantly
lower among MRCNS isolates with cMLSB resistance phenotype.
Conclusion: The relatively low susceptibility to fusidic acid detected
in our study among strains with MLSB resistance accompanying to
meticillin resistance, may be explained with the reports suggesting
that multidrug-resistant phenotype can develop as a consequence of
continuous exposure of an organism to an antibiotic to which the
organism is chromosomally highly resistant. These results indicated that,
although fusidic acid can stil be considered as an alternative agent for
the treatment of infections caused by meticillin resistant staphylococcal
strains, it should be kept in mind that susceptibility rates may be lower
than expected if the isolate is also resistant to MLSB antibiotics.
P592 In vitro activity of tigecycline against MRSA,
vancomycin-resistant enterococci, and extended-spectrum
b-lactamase-producing Escherichia coli and Klebsiella
pneumoniae clinical isolates collected in the Czech Republic
H. Zemlickova, P. Urbaskova (Prague, CZ)
Objectives: To describe the antimicrobial susceptibility to tigecycline in
the Czech Republic among isolates of meticillin-resistant Staphylococcus
aureus (MRSA), extended spectrum b-lactamases (ESBL) producing
Escherichia coli (n = 90) and Klebsiella pneumoniae (n = 100) and
vancomycin-resistant enterococci (VRE) (n = 111).
Methods: The isolates were collected in 36 microbiological laboratories
partipating in the European Antimicrobial Resistance Surveillance
System (EARSS) in the Czech Republic in 2000–2007. The isolates
of MRSA (n = 105) and ESBL-producing K. pneumoniae (n = 100) were
collected from blood. The isolates of ESBL-producing E. coli originated
from blood (n = 19), urine (11), and wound infections (5). VRE isolates
were collected from blood (25), sputum (9), wound (39), urine (34),
and stool (5) specimens. A single isolate per patient was accepted. In
vitro MICs were determined according to the CLSI (formerly NCCLS)
guidelines. The criteria of the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) were used to interpret MIC results.
Results: All VRE, MRSA, and ESBL-producing E. coli strains were
susceptible to tigecycline using EUCAST breakpoints, i.e.  0. 25 mg/l,
 0.5 mg/l and  1 mg/l, respectively. As many as 93% of ESBL-
producing K. pneumoniae strains were inhibited by 1mg/l of tigecycline
and ﬁve such strains were inhibited by 2 mg/l. Two K. pneumoniae
strains were resistant to tigecycline with MICs of 4 mg/l.
Conclusion: In the Czech Republic, tigecycline has a good activity
against MRSA, VRE, and ESBL-producing isolates of E. coli. Strains
intermediately resistant (5%) and resistant (2%) to tigecycline were
found among ESBL-producing K. pneumoniae isolates.
P593 Comparison of daptomycin Etest MICs on Mueller-Hinton,
Iso-Sensitest and brain-heart infusion agars with and
without calcium supplementation to broth micro-dilution
MICs against 20 Staphylococcus aureus isolates
L.M. Koeth, J.M. DiFranco (Westlake, US)
Objectives: The effect of calcium concentration on Etest daptomycin
minimum inhibitory concentrations (MICs) using three different types
of agar was studied.
Methods: The Etest manufacturer (AB Biodisk) recommends BBL
Mueller–Hinton agar (MHA) for daptomycin testing, which historically
has calcium levels at 25−30 mg/L. MHA (Mast), Iso-Sensitest agar (ISA,
Oxoid) and Brain–Heart Infusion agar (BHIA, Difco) with free calcium
concentrations of 8.5−52.9 mg/L were used in this study. Twenty clinical
isolates of Staphylococcus aureus with daptomycin MICs of 0.25−2
mg/L were selected: these were retested in triplicate using CLSI broth
microdilution (BMD; calcium concentration of 52.5 mg/L) and tested
once with two lots of Etest on each of the study agars. The quality-control
strain, S. aureus ATCC 29213, was included with each day’s testing. The
calcium concentration of each agar and broth was determined using ion
selective electrode methodology.
Results: As expected, daptomycin MICs decreased with increasing
amounts of calcium (Table). Etest MICs using MHA (calcium 28 mg/L)
averaged 1.32-, 1.75- and 1.16-fold higher, whereas unsupplemented ISA
averaged 3.3-, 2.9- and 2.3-fold higher than those for strains with BMD
MICs of 0.5, 1 and 2 mg/L, respectively. The best correlation of Etest
and BMD MICs was with MHA (calcium 42.8 mg/L) and ISA (calcium
52.9 mg/L). Etest MICs on BHIA were signiﬁcantly higher than BMD
MICs, and even with a BHIA calcium concentration of 52.6 mg/L, were
approximately one doubling dilution higher than BMD gold standard.
There was little lot-to-lot variation noted between Etest MICs.
Media [Ca2+] mg/L Mean daptomycin Etest MIC
(mg/L) for strains with BMD
MICs of:
0.5mg/L
(n = 8)
1mg/L
(n = 14)
2mg/L
(n = 14)
MHAa 28 0.66 1.75 2.32
MHA 42.8 0.53 1.37 2.06
MHA 51.9 0.31 1.36 1.83
ISA (unsupplemented) 8.5 1.63 2.93 4.67
ISA 30.5 0.85 1.74 2.58
ISA 41.9 0.72 1.42 2.32
ISA 52.9 0.53 1.24 1.98
BHIA (unsupplemented) 21.9 2.17 3.73 5.60
BHIA 30.8 1.93 3.21 4.98
BHIA 42.5 1.38 2.83 4.02
BHIA 52.6 1.07 2.23 3.55
aCalcium concentration equivalent to BBL unsupplemented MHA.
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Conclusion: This study supports the Etest manufacturer’s recommenda-
tion that MHA is the best choice for susceptibility testing of daptomycin
by Etest. However, there was a large percentage (85.7%) of strains with
BMD MICs of 1 mg/L that had Etest MICs of 1.5 or 2 mg/L on MHA
(calcium 28 mg/L). The daptomycin susceptible breakpoint is 1 mg/L
and there is currently no intermediate or resistant breakpoint. Because of
the methodology shift in MIC at the daptomycin breakpoint using Etests
on MHA containing 28 mg/L Ca2+, it is suggested that Etest MICs of
1.5 or 2 mg/L are to be considered indeterminate and retested by BMD.
ISA or BHIA media are not recommended for use with the daptomycin
Etest strip because falsely resistant interpretation could result.
P594 Conﬁrmation of high-level mupirocin resistance in S. aureus
isolates using the mupA EvigeneTM kit
R.L. Skov, L. Hansen (Copenhagen, DK)
Objectives: Mupirocin is the only anti Staphylococcus aureus topical
antibiotic licensed for eradication treatment of nasal carriage of
S. aureus. Mupirocin resistance occurs both as “high level” or “low
level.” Since application of mupirocin ointment into the external nares
results in concentrations >20,000 mg/L, only high-level resistance (MIC
of >256 mg/L) is signiﬁcant in this setting. High-level resistance is
caused by the expression of the mupA (or ileS-2) gene that encodes an
additional isoleucyl tRNA-synthetase that is not bound by mupirocin.
In this study we investigated the mupA EvigeneTM kit for conﬁrmation
of mupA high-level resistance in isolates screened positive using a 5mg
mupirocin disc.
Material and Methods: A total 39 out of 4692 clinical S. aureus isolates
(1223 were MRSA) with an inhibition zone <20 mm against a 5mg
mupirocin disc were investigated. The 39 isolates were tested by mupA
EvigeneTM hybridisation assay with capture and detection probes for
the mupA gene producing a red colour, assay time of 3.5 hours. Wells
were read both visually and using an ELISA reader at 490nm, using
an OD of 0.50 as cut off. The isolates were further MIC tested by E-
test (using the manufacturer’s instructions) and a 200 mg mupirocin disc
using conﬂuent inoculum on Mueller Hinton agar. S. aureus ATCC 29213
(mupA negative) and AIS2006–079 (mupA positive) were included in
all runs.
Results: Six isolates, all MRSA, were found positive for mupA by the
mupA EvigeneTM both visually and using Elisa reader (OD 2.0−2.7
for positive compared to <0.16 for mupA negative isolates). All 6
mupA positive isolates had MIC >1024 mg/L and inhibition zones
<13mm using a 200mu;g disc, whereas mupA negative isolates had
MICs between 0.064 and 8 mg/L and inhibition zones between 20 and
37mm by disk diffusion.
Conclusion: In summary, the mupA EvigeneTM identify isolates with
high-level resistance to mupirocin fast (3.5 hours) from isolates with low
resistance. This investigation supports the use of mupA EvigeneTM in
clinical settings for the conﬁrmation of high-level resistance in mupirocin
resistant S. aureus.
P595 Evaluation of the Vitek AST-GP66TM panel and Vitek
TwoTM for susceptibility testing of selected antibiotics with
coagulase negative staphylococci
M. John, J. Daniel, D. Diagre, S. Milburn, B. Wilson, Z. Hussain
(London, CA)
Objective: To compare the AST-GP66TM panel and Vitek TwoTM with
agar dilution for determination of susceptibility of antibiotics commonly
used to treat coagulase negative staphylococci (CoNS) infections
(clindamycin, erythromycin, linezolid, oxacillin and vancomycin).
Method: Susceptibility was performed on 693 CoNS isolates, compris-
ing 14 species. Panels were set up and tested as per the manufacturer’s
instructions. Agar dilution was performed using CSLI methods. The Mec
A status of isolates was determined using PCR. Agar dilutions covered
all the MIC values obtained from the Vitek panels. Differences of 
2 dilutions were noted. In addition, MIC’s were converted to qualitative
categories (sensitive or resistant) according to CSLI guidelines. Category
errors were then assessed as very major (resistant by VitekTM, sensitive
by agar dilution), major (sensitive by VitekTM, resistant by agar dilution)
or minor (change from sensitive to intermediate).
Results: In total 3,485 MIC values were generated by each method.
3,443 MIC values were evaluated, out of which 126 had  2 dilution
differences (3.6%). The remaining pairs differed by  1 dilution.
Altogether there were 6 very major errors, 22 major errors and 13 minor
category errors. For clindamycin there were no very major errors, 7
major and 10 minor category errors. For erythromycin there were 5 very
major, 11 major and 2 minor errors. For linezolid there was 1 major error
(no very major or minor) and for vancomycin 1 minor (no very major
or major). For oxacillin there was 1 very major and 3 major (no minor)
category errors (only calculated for S. epidermidis and S. scheiﬂeri). For
other species the MIC did not necessarily correlate with the presence of
the MecA gene. The cefoxitin screen (6mg) did not correlate well with
the presence of the Mec A gene.
Conclusion: Vitek TwoTM and Vitek AST-GP66TM panels were
reliable for determination of susceptibility of CoNS to clindamycin,
erythromycin, linezolid, oxacillin and vancomycin. Our results also
conﬁrm that CLSI guidelines (presence/absence of MecA)should be
followed for interpretation of MIC’s between  0.5 and 4.0 for oxacillin.
The cefoxitin screen was not useful in identifying MecA positive isolates.
P596 Validation of agar dilution for susceptibility testing of
coagulase-negative staphylococci to tigecycline
M. John, J. Daniel, D. Diagre, B. Wilson, S. Milburn, Z. Hussain
(London, CA)
Objectives: To compare in vitro susceptibilities of a large series of
speciated coagulase negative staphylococci (CoNS) to tigecycline using
the E-testTM and agar dilution. A secondary objective was to determine
whether tigecycline agar dilution plates were stable over a two week
period.
Methods: Susceptibility was performed on 693 CoNS isolates,
comprising 14 species. E-test has been validated as a method for
determining susceptibility to tigecycline and was performed according
to the manufacturer’s instructions and read in a blinded fashion by two
examiners. Agar dilution was performed using methodology described
by the CLSI. In addition, a proportion of isolates were re-tested by
agar dilution for a period of two weeks to ascertain the stability
of tigecycline plates. MIC’s were converted to qualitative categories
(sensitive or resistant) according to CSLI guidelines. Category errors
were then assessed as very major (resistant by E-testTM, sensitive by
agar dilution) or major (sensitive by E-testTM, resistant by agar dilution).
Results: Tigecycline is bacteriostatic against CoNS, which made the
determination of MIC’s by E-testTM at times difﬁcult to read. Overall,
MIC’s determined by agar dilution were one dilution higher than those
determined by the E-testTM. When converted to qualitative categories
(sensitive or resistant) this did not result in category changes in most
cases when interpreting susceptibility. Overall there were 3 very major
category errors (resistant by E-testTM, sensitive by agar dilution) and 30
major errors (sensitive by E-testTM, resistant by agar dilution). Almost all
category errors occurred with S. haemolyticus (34%) and S. epidermidis
(11%). MIC’s by agar dilution did not change when the testing was
repeated over a two week period.
Conclusion: Apart from for S. haemolyticus, agar dilution appears to be
a valid method for determining susceptibility of CoNS to tygecycline.
In addition, once agar dilution plates have been prepared the tigecycline
remains stable for at least 2 weeks at 2−8ºC.
P597 Oritavancin sterilises in vitro bioﬁlms of Staphylococcus
epidermidis and vancomycin-susceptible and -resistant
enterococci
A. Belley, E. Neesham-Grenon, T. Parr Jr., G. Moeck (St-Laurent, CA)
Objectives: Oritavancin (ORI) is a semi-synthetic lipoglycopeptide
that is currently in clinical development for serious Gram-positive
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infections. We sought to determine whether ORI can eradicate bioﬁlms
of Staphylococcus epidermidis and vancomycin-susceptible and -resistant
enterococci, which are prominent in infections of indwelling devices and
infective endocarditis, respectively.
Methods: The following strains were used for in vitro bioﬁlm studies:
vancomycin (VAN)-susceptible Enterococcus faecalis ATCC 29212
(VSE), VAN-resistant E. faecalis ATCC 51299 (VanB VRE), E. faecium
ATCC 51559 (VanA VRE), S. epidermidis ATCC 12228 and the slime-
producing strain S. epidermidis ATCC 35984. Bioﬁlms were established
in MBECTM Physiology & Genetics Assay plates (Innovotech; Ed-
monton, Canada). Minimal bioﬁlm eradication concentrations (MBEC)
values for single antimicrobial agents (ORI, VAN, linezolid [LIN]) and
for agents in combination (ORI with moxiﬂoxacin [MOX] or rifabutin
[RFB]) were determined in three independent experiments.
Results: Bioﬁlms of VSE, VanB VRE and VanA VRE were sterilised
by ORI at MBECs of 2 to 4 mg/L following 24 h of drug challenge.
In contrast, the VSE and VRE bioﬁlms were tolerant to VAN and
LIN, exhibiting MBEC values >128 mg/L for both agents. Bioﬁlms of
S. epidermidis ATCC 12228 were sterilised by ORI at an MBEC of 2 to
4 mg/L but also exhibited tolerance to VAN and LIN with MBECs >128
mg/L. Sterilisation of S. epidermidis ATCC 35984 bioﬁlms required
combinations of ORI (MBEC of 4 mg/L) and MOX (MBEC of 4 mg/L),
or ORI (MBEC of 4 mg/L) and RFB (MBEC of 0.125 mg/L).
Conclusion: Oritavancin shows promise as monotherapy or in combina-
tion against medically important bioﬁlms derived from VSE, VRE and
S. epidermidis strains.
P598 Prevalence of antimicrobial resistance of enterococcus
species isolated from blood patients with haematological
malignancies in Russia
A. Mironova, A. Brilliantova, E. Trushina, I. Phrolova, L. Speranskaya
(Moscow, RU)
Objective: The aim of this study was to determine the prevalence of
enterococcal species isolated from blood cultures and their antibiotic
susceptibility in Hematological Centre throughout a 5-year period
(January 2003 – November 2007).
Methods: Enterococci were identiﬁed by basic tests and by PCR
ampliﬁcation of ddl genes. Minimal Inhibitory Concentrations (MICs)
were determined by broth microdilution method (CLSI). Resistance
genes were detected by PCR.
Results: A total of 80 enterococcus species were collected from January
2003 to November 2007. Most were Enterococcus faecium (65), the rest
were E. faecalis (14) and E. durans (1). The number of E. faecium
cases per year increased from 63% (10/16) in 2003 to 86% (18/21) in
2007. E. faecium strains (vs. E. faecalis) were more resistant to the
following antibiotics: levoﬂoxacin (98 vs. 33%), erythromycin (94 vs.
64%), highly-level resistant to streptomycin (89 vs. 43%) and gentamicin
(97 vs. 50%); except chloramphenicol (11 vs. 43%) and tetracycline (26
vs. 64%). Five (7.7%) E. faecium isolates were resistant to vancomycin
(MIC ranged from 128 to 1024 mg/L) and teicoplanin (MIC from 16
to 32 mg/L) and carried vanA genes. E. faecium showed an increase
in vancomycin resistance from 7% (1/15) in 2005 to 10% (1/10) in
2006 and 17% (3/18) in 2007 and a trend to decrease chloramphenicol
resistance from 20% in 2003 to 0% in 2006 and 2007. After long
treatment with linezolid, VREF strain reisolated from blood displayed
low level linezolid-resistance with a MIC = 4 mg/L.
Conclusion: E. faecium was the predominant enterococcal specie
isolated from blood cultures. The rate of vancomycin-resistant E. faecium
bloodstream infections has increased since 2005 to 2007. E. faecium
was found to be increasingly chloramphenicol sensitive. The occurrence
of low level linezolid resistant is a threatening problem for Russian
hematological patients.
P599 In vitro activity of tigecycline against enterococci
A. Lesenne, J. Aires, N. Bourgeois-Nicolaos, B. Couzon,
F. Doucet-Populaire (Paris, Le Chesnay, FR)
Objectives: This study was undertaken to determine in vitro activity of
tigecycline, the ﬁrst representative of glycylcyclines, against 65 entero-
cocci French isolates and to correlate this activity with their resistance
gene content. Moreover, the activity of tigecycline was compared to
that of other tetracyclines (tetracycline, minocycline, and doxycycline)
and 4 main antibiotics used in the treatment of enterococci infections
(amoxicillin, vancomycin, linezolide, quinupristine-dalfoppristine (QP)).
Methods: MICs were determined using the CLSI agar dilution method.
We studied 55 clinical isolates of enterococcus of human origin and 10
isolates of animal origin (30 Enterococcus faecalis and 35 Enterococcus
faecium) among which 11 strains resistant to glycopeptides (VRE)
harbouring the vanA or vanB gene. The presence of the 2 main genes
encoding tetracycline resistance in Enterococci: tet (M) (ribosomal
protection) and tet (L) (efﬂux) was detected by PCR on all the strains.
Results: Among the 65 isolates studied, 22, all E. faecium, were resistant
to amoxicillin (MIC range 0.125−64 mg/L). Only 49% of the strains were
susceptible to QP. All the strains were susceptible to linezolide (MIC
range 1−2 mg /L). Among tetracyclines antibiotics, tetracycline was the
least active molecule with 41% (n = 27) of susceptible strains (MIC90:
64 mg/L); 46% (n = 30) strains were susceptible to doxycycline (MIC90:
= 16 mg/L) and 54% (n = 36) to minocycline (CMI90: 64 mg/L). All
the 43 tetracycline resistant strains ((MIC> 8 mg /L) possessed at
least one of the 2 genes: tet (L) or tet (M). All the studied strains,
whatever their phenotype and genotype of tetracyclines resistance, were
highly susceptible to tigecycline with MIC90 equal to 0.125 mg/L (MIC
range 0.03−0.125 mg/L). No difference of susceptibility was observed
according to the species and to the phenotype of resistance.
Conclusion: Tigecycline presents a good in vitro activity against
E. faecalis and E. faecium including VRE. This activity is not modiﬁed in
the presence of genes tet (M) and tet (L) the most frequent in Enterococci
encoding tetracyclines resistance.
P600 Impact of the new CLSI non-meningitis penicillin
breakpoints on the reporting of antimicrobial susceptibility
in pneumococcal infections
L-H. Su, C-H. Chiu, T-L. Wu, A-J. Kuo, C-F. Sun (Taoyuan, TW)
Objectives: The present breakpoints for deﬁning the susceptibility
of meningeal pneumococcal isolates to cefepime, cefotaxime, and
ceftriaxone are different from those for nonmeningeal pneumococcal
isolates due to the attainability of these agents in the cerebral spinal
ﬂuids. However, although the penicillin breakpoints were deﬁned based
upon measured penicillin concentrations in the cerebral spinal ﬂuids
after intravenous infusions and upon meningitis treatment failures, the
breakpoints have been applied to nonmeningeal pneumococcal isolates
since the deﬁnitions were developed in the late 1970s. In 2008, a new
set of breakpoints will be published by the CLSI to be used for deﬁning
the penicillin susceptibility of nonmeningeal pneumococcal isolates. The
present report aimed to assess the impact of the new breakpoints on the
reporting of pneumococcal susceptibilities.
Methods: The MICs of penicillin to pneumococcal isolates were
examined by the standard broth microdilution method as recommended
by the CLSI. The results between 2000 and June 2007 were collected and
analysed against both of the old (susceptible,  0.06 mg/L; intermediate,
0.12−1 mg/L; resistant,  2 mg/L) and new (susceptible,  2 mg/L;
intermediate, 4 mg/L; resistant,  8 mg/L) deﬁnitions.
Results: Results from a total of 3156 pneumococcal isolates, including
1.1% of meningeal isolates, were available for analysis. With the old
deﬁnition, the rate of penicillin nonsusceptibility increased from 88.6%
in 2000 to 92.9% in 2007 (average, 91.2%). With the new deﬁnition,
the rate of penicillin nonsusceptibility decreased from 34.5% in 2000 to
2.5% in 2007 (average, 20.4%). Notably, the proportion of isolates with
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the MICs of 1−2 mg/L increased signiﬁcantly from 41.4% in 2000 to
70.7% in 2007.
Conclusions: Application of the new breakpoints will result in a
signiﬁcantly lower rate of penicillin nonsusceptibility in nonmeningeal
pneumococcal isolates. Clinicians may feel more conﬁdent in using
penicillin for the treatment of pneumococcal infections, and thus the
use of other advanced drug classes may be exempted. However, as
the population of pneumococcal isolates with borderline penicillin
susceptibility (MIC, 1−2 mg/L) is increasing, the regimen of penicillin
treatment must be closely monitored to achieve a satisﬁed therapeutic
outcome.
P601 A longitudinal perspective on Streptococcus pneumoniae,
Haemophilus inﬂuenzae, and Moraxella catarrhalis resistance
trends in Europe: from GLOBAL surveillance studies
D. Sahm, N. Brown, C. Pillar, D. Draghi, M. Obot-Tucker,
C. Thornsberry (Herndon, US)
Objective: Streptococcus pneumoniae (SP), Haemophilus inﬂuenzae
(HI), and Moraxella catarrhalis (MC) are three of the most common
pathogens associated with community-acquired pneumonia (CAP).
Changes in the prevalence of resistance (R) and multi-drug R (MDR)
among these pathogens can become problematic for clinicians treating
infections. R rates can vary according to regional distributions. The
GLOBAL Surveillance (SUR) initiative is a longitudinal study that
benchmarks antimicrobial R among respiratory pathogens (RPs).
Methods: SP, HI, and MC isolates taken from patient specimens were
collected from 6 countries in Europe (EU): Belgium (Bel), France (Fr),
Germany (Gr), Italy (It), Spain (Sp), and the United Kingdom (UK). The
years (Y) of collection were 03−04 (04), 05−06 (06) and 07 (respectively)
for SP (N: 3213; 1542; 755); HI (N: 3183; 1578; 860) and MC (N:
722; 379; 163). All isolates were centrally tested by broth microdilution
and interpreted according to CLSI standards (M7-A7 M100-S17). Data
were analysed according to b-lactamase (BL) status [positive (+) and
(−)] for HI and MC; for SP analysis included penicillin (PEN) and
MDR phenotypes [R to  2 drugs: PEN, cefuroxime, trimeth-sulfa,
azithromycin (AZI), and tetracycline].
Results: Overall for SP, PEN-R (%) was 12.7 in 04, 12.8, in 06 and 11.8
in 07. The PEN-R rates (%) varied in 04, 05, and 07, respectively: Bel
(7.4; no data; 6.8), Fr (32.9; 23.7; 19.4), Gr (3.5; 5.7; 1.3), It (6.8; 7.7;
21.2), Sp (25.4; 20.8; 7.9), and UK (2.2; 2.8; 3.9). The prevalence (%)
of MDR-SP ranged from 3.4 (UK) to 44.2 (Bel) in 04, 4.3 (UK) to 33.2
(Fr) in 06, and 12.4 (UK) to 48.2 (It) in 07. >98% of MDR-SP were
susceptible (S) to levoﬂoxacin (LFX). For HI, BL + rates (%) varied by
country from 8 (Bel) to 32.3 (Fr) in 04, 7.3 (Gr) to 23.4 (Fr) in 06,
and 3 (It) to 18.9 (UK) in 07. Based on MIC90, LFX and ceftriaxone
were the most active agents tested against HI, regardless of BL status
with MIC90s of 0.015−0.03 mg/L all Y. For MC, overall BL + rates (%)
increase by Y slightly: 96.4 (04), 96.6 (06), and 98.2 (07). Regardless
of phenotype, LFX and AZI were the most potent agents against MC,
based on MIC90s (0.06 mg/L).
Conclusion: LFX showed potent activity against the RPs studied. LFX
was active among PEN-R and MDR-SP and BL +/− HI and MC. %S
among SP, HI, and MC remained high all Y for LFX. Continued SUR
is warranted to monitor any changes that may occur among agents used
to treat CAP pathogens.
P602 Antimicrobial resistance in Streptococcus pneumoniae and
Haemophilus inﬂuenzae isolated from respiratory tract
infections between 2001 and 2007
B. Altun, D. Gur (Ankara, TR)
Objectives: Local data on antimicrobial resistance is necessary in
the empirical therapy of respiratory tract infections. The rate of
antimicrobial resistance in respiratory isolates of Haemophilus inﬂuenzae
and Streptococcus pneumoniae from children were determined and were
compared by year.
Methods: Antimicrobial resistance in respiratory isolates of H. in-
ﬂuenzae(n = 565) and S. pneumoniae (n = 736) were investigated.
Susceptibility to penicillin and cefotaxime were determined by E-test
(AB Biodisk, Solna, Sweden) in S. pneumoniae. In vitro activity of
the remaining antimicrobials were evaluated by disk diffusion method
according to CLSI criteria. for H. inﬂuenzae, strains b-lactamase
production was detected using chromogenic nitroceﬁn disk method (BD,
Sparks, USA).
Results: Resistance rates are given in the Table. b-lactamase production
was detected in 3.4% of H. inﬂuenzae. Penicilin (intermediate and high-
level) and trimethoprim-sulfamethoxazole (TMP/SMX) resistance rates
were 34.7% and 44.4% in 2001 and were 55.2% and 60.9% respectively
in 2007 for S. pneumoniae.
Table: Overall rates of resistance to antimicrobial agents in respiratory
H. inﬂuenzae and S. pneumoniae isolates (2001–2007)
H. inﬂuenzae S. pneumoniae
n I (%) R (%) n I (%) R (%)
Ampicillin 565 − 5.5 ND ND ND
Penicillin ND ND ND 736 38.1 4.2
Ampicillin/sulbactam 565 − 0.7 ND ND ND
Cefaclor 518 2.9 2.5 ND ND ND
Cefotaxime 565 0.2 − 736 − −
Meropenem 535 − − ND ND ND
Clarithromycin 557 0.9 2.5 ND ND ND
Erythromycin ND ND ND 736 1.1 21.6
TMP/SMX 565 0.4 18.5 736 7.7 45.6
Oﬂoxacin 509 − − 736 1.2 0.2
Levoﬂoxacin ND ND ND 460 0.7 −
Tetracycline 514 0.2 0.9 702 2.6 24.5
Chloramphenicol ND ND ND 736 10.7
ND: not determined.
Conclusions: Highest rate of resistance has been observed for
trimethoprim-sulfamethoxazole in both microorganisms. b-lactamase
production in H. inﬂuenzae has not increased over the years. Penicillin
resistance has increased in S. pneumoniae. Resistance to levoﬂoxacin
is very low at present. Monitoring of the resistance rates may help
the clinicians in the empirical therapy of respiratory infections due to
S. pneumoniae and H. inﬂuenzae
P603 Bactericidal activity of moxiﬂoxacin and levoﬂoxacin
against Streptococcus pneumoniae with dual gyrA and parC
mutations
R. Davidson, E. Campbell (Halifax, CA)
Objectives: Streptococcus pneumoniae (Sp) is the most common
bacterial cause of respiratory tract infections (RTIs). RTIs are virtually
always treated empirically without the beneﬁt of susceptibility tests.
Although ﬂuoroquinolone-resistant Sp isolates are uncommon, these
have been associated with clinical failure. Thus, we sought to determine
the efﬁcacy of moxiﬂoxacin (MXF) and levoﬂoxacin (LFX) against
isolates with double-step parC/gyrA mutations.
Methods: Eight strains of Sp collected via an active surveillance
programme were characterised for gyrA and parC QRDR mutations by
PCR and DNA sequencing. MICs of MFX and LFX were evaluated using
a microbroth dilution method and their bactericidal activity determined
using Mueller–Hinton broth supplemented with 5% lysed horse blood in
a pharmacodynamic model. Sp were inoculated at a density of 1 x 106
CFU/ml, incubated at 35ºC, and examined for viable growth at 0, 1, 2,
4, 6, 12, and 24 h after exposure to MXF or LFX. Drug concentrations
approximated epithelial lining ﬂuid (ELF) levels or Cmax of MXF (400
mg) and LFX (500 mg). Protein binding was accounted for and drug
elimination over a 24-h dosing interval simulated.
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Results: All eight strains in the study had documented gyrA and
parC mutations consistent with ﬂuoroquinolone resistance. MICs ranged
between 1 and 4 mg/L for MXF and between 8 and 32 mg/L for
LFX. At ELF concentrations, MXF was bactericidal against all eight
isolates and LFX was bacteriostatic against four strains and had
characteristics comparable with the growth control in four strains. At
Cmax concentrations, MXF was bactericidal against ﬁve strains and
bacteriostatic against three strains, LFX had characteristics comparable
with controls for all eight strains.
Conclusions: Only MXF consistently achieved bactericidal activity
against high level (parC/gyrA) ﬂuoroquinolone-resistant S. pneumoniae
at either ELF or Cmax concentrations. When treating patients
without the beneﬁt of susceptibility testing, MXF has the greatest
likelihood of achieving bacterial eradication, even when challenged with
ﬂuoroquinolone resistant S. pneumoniae.
P604 In vitro activity of tigecycline against contemporary clinical
isolates of Streptococcus pneumoniae
J. Blondeau, S. Borsos (Saskatoon, CA)
Objectives: Streptococcus pneumoniae (SP) remains amongst the most
prevalent causes of community-acquired respiratory tract infections.
Both penicillin and multidrug resistant strains may compromise drug
use and ongoing interest in newer antimicrobial agents necessitates
ongoing testing of clinical strains. We determined the in vitro activity
of tigecycline against blood and respiratory SP isolates.
Methods: Minimum inhibitory concentration (MIC) testing was based
on current Clinical and Laboratory Standards Institute procedure by
microbroth dilution using 105 cfu/ml tested against doubling drug
dilutions in appropriate media. Following incubation, the lowest drug
concentration preventing growth was the MIC. For mutant prevention
concentration (MPC) testing, 109 CFUs were applied to solidiﬁed
Todd-Hewitt broth containing doubling drug dilution and following
incubation, the lowest concentration preventing growth was the MPC.
Results: A total of 174 isolates (47 blood, 127 respiratory) were tested.
MIC values were not different for blood versus respiratory isolates.
The MIC50/90/100 (mg/L) values were 0.031/0.063/0.063. The MIC
range values were 0.008−0.063 mg/L. Against penicillin intermediate
and resistant strains, tigecycline MIC values ranged from 0.008−0.063
mg/L. MPC values ranged from 0.063−0.5 mg/L.
Conclusions: Tigecycline was highly active in vitro against contem-
porary blood and respiratory SP isolates. No isolate had an MIC
above 0.063 mg/L and MIC results were not different against penicillin
susceptible or resistant strains. MPC values were 0.063−0.5 mg/L. This
data suggests tigecycline to be highly active against SP isolates and also
demonstrates a low propensity to select for resistance.
P605 The impact of blood in media on the determination of
mutant prevention concentration testing of tigecycline
against clinical isolates of Streptococcus pneumoniae
C. Hesje, S. Borsos, J. Blondeau (Saskatoon, CA)
Objectives: Tigecycline (Tig) is the ﬁrst of a new class of compound –
glycylcyclines – with potent in vitro activity against penicillin-
susceptible and multi-drug resistant strains of Streptococcus pneumoniae
(SP). The mutant prevention concentration (MPC) deﬁnes the drug
concentration threshold blocking the growth of resistant bacterial sub-
populations present in high density bacterial inocula. We measured
the minimum inhibitory concentration (MIC) and MPC values for Tig
against SP isolates and compared MPC results on solidiﬁed Todd-Hewitt
broth (STHB) to those on STHB + 5% sheep red blood cells (SRBC)
and to those on tryptic soy agar (TSA) + 5% SRBC.
Methods: For MIC testing, the recommended CLSI procedure was
followed: 105 cfu/ml tested against doubling drug dilutions in THB
with incubation at 35−37 degree C in 5% CO2 for 18−24 hours. For
MPC testing, 109 CFUs were added to drug containing agar plates:
1) TSA-5% SHRB, 2) STHB (1.5% agar) and 3) STHB + 5% SRBC
incubated as described for 24−48 hours and screened for growth. The
lowest concentration preventing growth was the MIC or MPC depending
on method.
Results: For SP isolates (including ATCC 49416) MIC50, MIC90
and MIC range values (ug/ml) were 0.016, 0.031 and <0.008−0.31
respectively. MPC50, MPC90 and MPC range values (ug/ml) on STHB
were 0.063 (75%), 0.5 and 0.063−0.5 as compared to 8, >8 and 4−>8
on STHB + 5% SRBC and 8, 16, 1−16 on TSA + 5% SRBC. MPC
values for SP ATCC 49416 were 0.125 ug/ml on STHB versus 8 ug/ml
on STHB + 5% SRBC.
Conclusions: Tig was highly active in vitro against SP with MICs
0.031 ug/ml. MPC values ranged from 0.063−0.5 ug/ml on STHB
and were substantially higher when test media contained blood (>90%
4 ug/ml; >37% 8 ug/ml). This data suggests that SP testing of Tig on
blood containing media yields falsely elevated values. STHB appears to
be a more suitable media for SP MPC testing against Tig. Tig appears
to have a low propensity to select for resistance.
P606 Regional trends in telithromycin and azithromycin resistance
among Streptococcus pneumoniae isolates
V. Allizond, G. Banche, J. Roana, N. Li Vigni, N. Mandras, D. Scalas,
V. Tullio, N. Carlone, D. Savoia, A. Barbui, A. Cufﬁni (Turin, Biella, IT)
Objectives: This study compared the in vitro activity of telithromycin,
the ﬁrst ketolide developed for clinical use, with that of azithromycin,
one of the most commonly used macrolide for treatment of respiratory
tract infections, against 198 Streptococcus pneumoniae isolates at
some North West Italy’s hospitals between 2005–2007. Erythromycin-
resistance phenotypes were determined to correlate the different bacterial
resistant pattern to antimicrobial susceptibility.
Methods: The determination of minimal inhibition concentration (MIC)
was carried out using the microdilution broth method according to
Clinical and Laboratory Standards Institute (CLSI) with an inoculum
of 105 cfu/ml and antimicrobial concentrations ranged from 0.03 to 64
mg/L. Minimal bactericidal concentration (MBC) was determined by
plating 0.1 ml from the wells showing no visible growth on agar plates
and incubating for 18 h. The erythromycin-resistance phenotype was de-
termined by the triple-disk test described by Giovanetti et al. Commercial
disks of erythromycin, clindamycin and josamycin were used.
Table. In vitro antimicrobial activity of telithromycin and azithromycin against
erythromycin-susceptible and erythromycin-resistant S. pneumoniae isolates
Isolatesa Drug Number of strains having MIC (mg/L) equal to:
64 32 16 8 4 2 1 0.5 0.25 0.12 0.06 0.03
Erythromycin-susceptible (n = 137)
TEL 20 12 105
AZM 31 51 31 12 12
Erythromycin-resistant (n = 61)
cMLSB (n = 26) TEL 2 4 6 12 2
AZM 22 2 2
M (n = 26) TEL 14 10 2
AZM 6 18 2
iMLSB (n = 9) TEL 4 1 4
AZM 9
a198 S. pneumoniae isolates. cMLSB = constitutive resistance; M = M resistance;
iMLSB = inducible resistance.
AZM = azithromycin; TEL = telithromycin.
Results: 69.2% of the S. pneumoniae isolates were erythromycin-
susceptible (Ery-S). Among the 30.8% erythromycin-resistant (Ery-
R) pneumococci, 42.6% expressed the constitutive MLSB phenotype,
42.6% the M phenotype and 14.8% the inducible MLSB phenotype.
Azithromycin showed a high activity against S. pneumoniae Ery-S
strains, with MIC values ranging from  0.03 to 0.5 mg/L. The
Ery-R isolates were all resistant to azithromycin (MICs  8 mg/L).
On the contrary, both Ery-S and Ery-R streptococci isolates were
homogeneously susceptible to telithromycin, with MIC values  1 mg/L,
according to CLSI. Telithromycin and azithromycin MBC values were
S146 18th ECCMID, Posters
generally higher than the corresponding MICs, reﬂecting the same trend
observed for MIC values for all the strains.
Conclusion: The uniform activity of telithromycin against S. pneu-
moniae, including Ery-R isolates, suggests that this ketolide may
offer a valuable alternative for treatment of streptococcal infections.
Furthermore, in addition to several other reports, even the ﬁndings from
this regional study, emphasize that an active surveillance of phenotype
distribution and antibacterial resistance in pneumococci is essential to
guide the effective use of empirical treatment option for streptococcal
infections.
P607 Antimicrobial susceptibility of Lactobacillus strains used in
probiotic products
G. Blandino, I. Milazzo, D. Nicolosi, S. Puglisi, D. Fazio (Catania, IT)
Objectives: Antimicrobial susceptibility testing of Lactobacillus spp.
used in probiotics products is advisable for checking biosafety. In fact
probiotics should not carry acquired resistance potentially transferable
to endogenous bacteria; moreover, intrinsic resistance could prevent
treatment of a infection due to Lactobacillus spp. However there is still
a lack of agreement on the guidelines of the susceptibility testing of
Lactobacillus spp. and of the interpretative breakpoints. The aim of
this study was to test the susceptibility of Lactobacillus sp.using the
guidelines of the new 2006 CLSI M45-A document for infrequently
isolated or fastidious bacteria.
Methods: We tested the susceptibility to ampicillin, meropenem,
vancomycin, gentamycin, erythromycin, clindamycin (recommended by
CLSI, 2006) and, also, 2 cephaloporins and 2 ﬂuoroquinolones of 19
Lactobacillus isolates from 5 fermented foods, 5 food supplements and
4 vaginal products available in Italy. The strains were isolated using
different media under standardised cultivation conditions. The species
designation was determined by standardised methods including API kits
and PCR. MICs were obtained by broth microdilution according to 2006
CLSI document.
Results: The MIC results were evaluated using CLSI breakpoints to
predict clinical success and microbiological breakpoints suggested by
FEEDAP Committee (EFSA J., 2006) to distinguish probiotic strains
with acquired resistance. All the Lactobacillus isolates were b-lactamase
negative and susceptible to ampicillin and imipenem by both breakpoints.
The isolates of L. plantarum, L. salivarius and L. paracasei conﬁrmed
intrinsic-resistance to vancomycin; the other isolates tested had MIC 
4 mg/L (susceptibility breakpoint). Gentamycin had poor activity against
Lactobacillus isolates. Atypical resistance to erythromycin occurred
in 1 L. salivarius isolate. A wide range of MICs was observed for
cephalosporins and ﬂuoroquinolones.
Conclusion: The results showed that Lactobacillus isolates used in
probiotics do not show particular risk of acquired and potentially
transferable resistance. However, for Lactobacillus isolates involved in
serious infections, the marginal susceptibility or resistance to some
relevant drugs should be taken into account.
P608 Effects of tylosin and chlortetracycline on the proliferation
of antibiotic-resistant bacteria in a simulated river water
ecosystem
J. Mun˜oz-Aguayo, K. Lang, R. Singer (Saint Paul, US)
Objective: The objective of this study was to examine the effects of
varied concentrations of chlortetracycline (CTC) and tylosin tartrate salt
(TYL) on the selection of resistance in aerobic bacterial populations in
a simulated river water ecosystem.
Methods: Six replicates of a 10-day experiment using river water
in continuous ﬂow chemostats were conducted. In each replicate, 1
chemostat served as the control to which no antibiotic was added. In
the ﬁrst two replicates, TYL was added at concentrations of 100 ng/L
and 10mg/L. In replicate 3, TYL was added at concentrations of 10 mg/L
and 50,000mg/L, and in replicates 4 through 6, TYL was added at
concentrations of 10mg/L, 1000mg/L and 50,000mg/L. The amount of
TYL present in the chemostats from samples taken on days 0, 3, 7 and
10 was quantiﬁed with a commercially available competitive enzyme-
linked immunosorbent assay. The viable bacterial count was determined
by plate count from days 0 through 10 using 1/10-strength LB agars with
and without 16mg/ml of TYL and Columbia CNA agars with and without
16mg/ml of TYL. The presence of the erm (B) gene in the bacteria within
the chemostats was assessed on days 0 through 10 by extracting DNA
from a chemostat sample followed by PCR using previously published
primers. Results of the TYL replicates were compared to the CTC
replicates that were conducted previously.
Results: There was no signiﬁcant difference among treatment groups
in the total bacterial load within the chemostats when assessed on LB
agar plates (8−9 log10 CFU/ml). Although the chemostats with higher
levels of TYL had lower bacterial loads on Columbia CNA agar and
Columbia CNA agar with 16mg/ml of TYL, there was no difference
among chemostats in the proportion of the total bacterial load that grew
on CNA agar with 16mg/ml of TYL. No differences among chemostats
were observed when bacteria were grown on LB agar with 16 mg/ml of
TYL. The gene erm (B) was detected on many days of the replicates,
mainly in the high TYL concentration chemostats.
Conclusions: Low concentrations of TYL in this in vitro experiment did
not select for increased levels of resistant bacteria. This is identical to
the observation in the CTC experiment. Whereas high doses of CTC did
select for tetracycline-resistant bacterial populations, high doses of TYL
did not appear to have this effect. These results question the biological
signiﬁcance of low tylosin concentrations observed in the environment.
P609 Establishment of reference substances for the microbiological
assay of antibiotics and MIC values determination
S. Tyski, W. Grzybowska (Warsaw, PL)
Objectives: In vitro bacterial susceptibility to antibiotics is tested
in number of laboratories. However, quality of antimicrobial agents
substances applied in Minimal Inhibitory Concentrations assays,
especially – their biological activity, is often unknown. Since 2000 year,
we have participated in several collaborative trials organised by European
Directorate for the Quality of Medicines to assign potency values
for candidate European Pharmacopoeia Chemical Reference Substances
(CRS) and WHO International Standard used for the microbiological
assays of antibiotics. These standards are also the best substances for
MIC values determination.
Methods: The following antimicrobial agents were tested: erythromycin,
nystatin, colistin, amphotericin B, spiramycin, bacitracin, and rifamycin.
The assay was performed as described in Ph. Eur., using diffusion
or turbidimetric methods and standard bacterial strains from ATCC
recommended by Ph. Eur. for particular agent. Statistical analysis of
results was performed with the usage of CombiStas programme.
Results: Erythromycin: 7 labs participated, obtained by us weighted
combined estimate was 948 IU/mg (trial established potency = 960
IU/mg. Nystatin: three CRS batches were analysed, obtained by
us results (6041, 5446, 5963 IU/mg), respectively corresponded to
trials established potency (6030, 5600, 5710 IU/mg). Colistin: 6 labs
participated, obtained by us weighted combined estimate was 584143
IU/vial (trial established potency = 580935 IU/vial. Amphotericin B:
three CRS batches were analysed, obtained results (993, 987, 990
IU/mg), respectively corresponded to trials established potency (990,
960, 944 IU/mg). Spiramycin: 7 labs participated, obtained by us
weighted combined estimate was 4540 IU/mg (trial established potency
= 4530 IU/mg). Bacitracin: 7 labs participated, obtained by us weighted
combined estimate was 63.1 IU/mg (trial established potency = 62.9
IU/mg). Rifamycin: diffusion method – 6 lab. participated, obtained by
us weighted combined estimate was 857 IU/mg (trial established potency
= 856 IU/mg; turbidimetric method – 4 labs participated, obtained by us
weighted combined estimate was 849 IU/mg (trial established potency =
856 IU/mg).
Conclusions: Participation in collaborative trials showed, that results
obtained in our lab – member of OMCL Network, are very good quality
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and allowed to establish antimicrobial potency of several reference
substances suitable for the MIC values determination.
P610 Tigecycline – in vitro susceptibility of anaerobic bacteria
R. Mutters, H. Bykow, C. Nonnenmacher (Marburg, DE)
Objectives: To determine the in vitro susceptibility of anaerobic
and selected mircoaerophilic bacterial species for tigecycline a new
glycylcycline anibiotic. Additionally it should be examined if the test
results are biased by the medium or the incubation time used.
Methods: Minimal inhibitory concentration (MIC) testing was per-
formed for tigecycline with the epsilon test (Etest®, AB Biodisk,
Sweden) as recommended by the manufacturer. Tigecycline stripes with a
concentration gradient from 0.016mg/ml to 256mg/ml were used. As test
media Columbia blood agar at pH 6.8, Columbia blood agar at pH 7.3,
Brucella agar and Schaedler agar were used. 297 isolates, representing
89 species were checked. Cultivation was conducted at 37ºC for 48 hrs
and 72 hrs, respectively under anaerobic conditions or in the case of
microaerophilic bacteria under mircroaerophilic conditions.
Results: All tested species exhibited low MIC values and could be
identiﬁed as susceptible. But denpendency from the chosen media and
growth conditions could be demonstrated. Comparable results were
observed with Schaedler agar and Columbia blood agar at pH 7.3.
Lowering the pH value of the Columbia blood agar to 6.8 led to
different MIC values, Brucella agar again exhibited different MIC values
compared with the other media. A reduction of the incubation time from
72hrs to 48hrs resulted in poor growth for several of the fastidioud
species and in minor MIC values.
Conclusion: It could be shwon that the results of tigecycline
susceptibility testing of anaerobic bacteria are dependent from the solid
growth medium, the pH value and the incubation time. Because of
the stability and comparibility of the results with Schaedler agar and
Columbia blood agar at pH 7.3 it can be recommended to test tigecycline
susceptibility on solid agar media at 37ºC with an incubation time of
72hrs, preferably on Schaedler agar. Because of the low MIC values
determined for all isolates tigecycline appears to be a promising new
agent for the treatment of infections caused by anaerobic bacteria.
P611 Activity of 5 antibiotics including tigecycline and meropenem
against anaerobic bacteria: a French multicentre study
L. Dubreuil, L. Calvet, C. Soussy, C. Lascols, C. Muller-Serieys,
H. Marchandin, H. Jean-Pierre (Lille, Cre´teil, Paris, Montpellier, FR)
Objectives: The study was deigned to evaluate the activity of
tigecycline (TGC), meropenem (MPM), piperacillin–tazobactam (PTZ),
metronidazole (MTZ) and clindamycin (CM) against 155 anaerobic
bacteria during a survey carried out in 2007 in 4 French university
hospitals.
Methods: MIC were determined using E test strips on Brucella blood
agar (inoculum McFarland 1).
Results: See the table.
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B. fragilis 62 0.19 0.5 98.3 0.25 0.75 98.3 0.38 2 98.3 0.125 0.25 100 0.75 >256 75.8
Other Bacteroides 35 0.19 0.5 100 0.19 0.5 100 0.75 8 97.1 0.25 0.5 100 2 >256 51.4
B. fragilis group 97 0.19 0.5 99 0.19 0.75 99 0.5 2 98 0.19 0.5 100 0.75 >256 61.8
Prevotella spp. 23 0.09 0.19 100 0.19 0.25 100 1 3 100 0.25 0.5 100 0.75 64 69.6
Clostridia 81 0.047 0.25 100 0.5 2 97.5 1 8 98.8 0.19 0.5 98.8 1 16 82.7
GPAC 54 0.047 0.09 100 0.03 1.5 100 0.04 0.5 100 0.125 8 88.9 0.125 2 96.2
All anaerobes 155 0.047 0.5 99.3 0.06 2 98.1 0.125 8 98.1 0.125 0.5 96.1 0.125 >256 62.6
N: Number of tested isolates; TIG, tigecycline; MERO, meropenem; PipTaz, piperacillin + Tazobactam; METRO,
metronidazole; CLIN, Clindamycin; %S: Percentage of susceptible strains; GPAC: Gram-positive anaerobic cocci.
Conclusions: TGC was the most potent agent against all Gram-positive
anaerobes (MIC 0.5 mg/L). At least 97% of all anaerobic bacteria
were inhibited by TGC, MPM, and PTZ. The clindamycin resistance
rate remained high (>40%).
P612 Comparative activity of meropenem, imipenem and
piperacillin / tazobactam against 1118 bacteria involved in
hospital infections: a French multicentre study
M.L. Joly-Guillou, J.D. Cavallo, M. Chomarat, L. Dubreuil, J. Maugein,
C. Muller-Serieys, M. Roussel-Delvallez, C. Soufﬂet (Angers, Saint
Mande, Lyon, Lille, Bordeaux, Paris, FR)
Objective: This study was designed to evaluate the activity of
meropenem (MPM), against 1118 non repetitive strains isolated from
bacteraemia (55%), pneumonia (29%), peritonitis (12%) and wounds
infections (3%), during a survey carried out in 15 French community
and university hospitals, in 2006. Susceptibility tests and Minimum
Inhibitory Concentrations (MICs) of meropenem (MPM), imipenem
(IPM) and piperacillin plus tazobactam (PTZ) were determined by
Etest® method (ET) in each centre. Disc diffusion test for MPM and
MICs by the agar dilution method (AD) for MPM, IPM and PTZ were
determined in speciﬁc centres for E. coli (EC), others enterobacteriaceae
(EB), Pseudomonas aeruginosa (PA), aerobic Gram-negative bacilli
(AE), Acinetobacter (AB), meticillin susceptible Staphylococcus aureus
(MSSA) and coagulase-negative staphylococci (MSCNS) Streptococcus
pneumoniae (SP) and anaerobes (AN).
Results: MICs obtained by AD are listed in the table.
n MPM IPM PTZ
%S MIC50 MIC90 %S MIC50 MIC90 %S MIC50 MIC90
EC 149 100 <0.016 <0.016 100 0.05 0.08 90 1.5 8
EB 149 99 0.019 0.05 99 0.11 0.87 85 1.64 14.8
PA 126 95 0.37 3.1 83 1.22 9.1 90 4.5 16
AB 79 98 0.46 1.35 97 0.33 0.96 42 1.41 123
AE 36 83 1 227 83 0.95 227 90 2.5 884
MSSA 145 100 0.09 0.12 100 0.032 0.046 100 0.96 1.84
MSCNS 137 100 0.06 1.1 100 0.013 0.09 100 0.43 0.85
SP 136 100 0.016 0.22 100 <0.016 0.1 100 0.14 3.3
AN 138 100 <0.015 0.5 99 0.048 0.5 92 0.5 16
MIC: Minimum inhibitory concentration; %S: percentage of susceptibility;
n: number of tested isolates.
Conclusions: Compared to IPM, MPM displays lower MICs against EB,
EC and PA. Except for AE, MICs90 of carbapenems are <4mg/l. Against
AB, carbapenems display similar MICs; Compared to carbapenems, PTZ
is less active against EB and AB but not PA. Some discrepancies were
noted between MICs realised by ET in each centre and MICs realised
by AD in speciﬁc centre. Especially for aerobics, MICs by ET were
frequently higher than MICs by AD.
P613 In vitro activity of ceftobiprole against select Gram-positive
and Gram-negative pathogens isolated from Europe in
2006–2007
M. Torres, D. Draghi, N. Brown, C. Thornsberry, D. Sahm, C. Pillar
(Herndon, US)
Objective: Ceftobiprole (BPR) is a pyrrolidinone-3-ylidene-methyl
cephalosporin with activity against a broad spectrum of clinically
relevant pathogens, including meticillin-resistant S. aureus (MRSA).
BPR is intended for use in hospitals against infections where resistant
Gram-positive (GP) and Gram-negative (GN) bacteria, particularly
MRSA, are suspected. As such, BPR is currently being developed to
treat hospital-acquired pneumonia (HAP) and complicated skin and skin
structure infections (cSSSI). The current surveillance initiative assessed
the in vitro activity of BPR and comparator agents against GP and GN
European (EU) clinical isolates from the past year.
Methods: During 2006 and 2007, GP (S. aureus [SA], coagulase-
negative staphylococci [CoNS], and S. pneumoniae [SP]) and GN
(Enterobacteriaceae [EN] and P. aeruginosa [PA]) clinical isolates were
collected from 28 laboratories in 11 EU countries. All isolates were
centrally tested by broth microdilution at Euroﬁns Medinet, Inc. (CLSI;
M7−A7).
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Results: Against the tested SA, the MICs of BPR were similar to those of
vancomycin and linezolid by MIC90 of 1 mg/L and 2 mg/L, respectively.
BPR MICs against MRSA were  2 mg/L with the exception of 1.3%
of MRSA isolates which had BPR MICs of 4 mg/L. Against EN and
PA, BPR was similar to cefepime (FEP) by both MIC50/MIC90 (FEP:
0.06/4 mg/L for EN and 4/16 mg/L for PA).
Organism Phenotype Total n BPR MIC (mg/L)
Range Mode MIC50 MIC90
SA All 1,010 0.12−4 1 0.5 2
MSSA 272 0.12−2 0.25 0.25 0.5
MRSA 738 0.12−4 1 1 2
CoNS All 378 0.12−4 1 0.5 2
MS CoNS 114 0.12−1 0.12 0.12 0.25
MR CoNS 264 0.12−4 1 1 2
SP All 432 0.002−0.5 0.008 0.008 0.25
PEN S 335 0.002−0.06 0.008 0.008 0.015
PEN NS 97 0.004−0.5 0.25 0.25 0.5
EN All 1,912 0.015−>32 0.03 0.03 16
CAZ S 1,656 0.015−>32 0.03 0.03 0.12
CAZ NS 256 0.03−>32 >32 32 >32
PA All 533 0.06−>32 2 4 16
CAZ S 421 0.06−>32 2 2 8
CAZ NS 112 2−>32 >32 16 >32
PEN: penicillin; CAZ: ceftazidime; S: susceptible; NS: non-susceptible.
Conclusion: BPR had potent in vitro activity against the tested GP
pathogens, regardless of resistance to meticillin or PEN. BPR was
comparable to FEP against both CAZ S and CAZ NS of EN and PA,
though MICs of both FEP and BPR were elevated against the CAZ
NS isolates. These results show the potential of BPR for the treatment
of HAP and cSSSIs. As BPR is intended for use in hospitals where
resistance is common, continued surveillance of BPR activity against
target pathogens is warranted.
P614 In vitro activity of a mixture of mustard oils (isothiocyanates)
against antimicrobial and multidrug-resistant bacteria
A. Conrad, D. Bauer, T. Nobis, H. Richter, I. Engels, D. Jonas,
U. Frank (Freiburg, DE)
Objectives: A herbal native preparation containing Tropaeoli majoris
herba (nasturtium = N) and Armoraciae rusticanae radix (horseradish
= H; Angocin® Anti-Infekt N, Repha GmbH, Germany) may be used
for treatment of upper respiratory (URTI) and urinary tract infections
(UTI). The preparation’s antimicrobial efﬁcacy is based on mustard oils
(isothiocyanates = ITC), which are cleaved from glucosinolates after oral
intake: benzyl-ITC from N, and allyl and phenylethyl-ITC from H. The
objective was to assess the antimicrobial activity of a mixture of ITC
against antimicrobial and multi-drug resistant bacteria.
Methods: Agar-dilution susceptibility testing was performed. ITC were
mixed according to the proportion within the preparation by adding
50% (v/v) benzyl-ITC, 37.9% allyl-ITC, and 12.1% phenylethyl-ITC
(all Fluka, Germany). The oil-mixture was dissolved in tryptic soy
broth containing 8% Tween 80. Serial dilutions were performed and
the mixture was added to Mueller Hinton agar just before casting in
order to obtain concentrations ranging from 1% to 0.001%. Bacterial
species were tested by use of a multi-point-inoculator (48 isolates
in duplicates). Different bacterial species originated from a German
surveillance project on antimicrobial resistance and included ESBL-
producing Escherichia coli (n = 49), ciproﬂoxacin resistant E. coli (53),
ESBL-producing Klebsiella pneumoniae (49), imipenem, ceftazidime
and multi-drug resistant Pseudomonas aeruginosa (50), penicillin and
macrolide resistant and intermediate resistant Streptococcus pneumoniae
(43), meticillin resistant Staphylococcus aureus (48), vancomycin
resistant Enterococcus faecium (50). After incubation for 24h at 37ºC,
minimum inhibitory concentrations (MIC) were assessed, followed by
subculturing to determine minimum bactericidal concentrations (MBC).
Results: MIC90 (% v/v) / MBC90 (% v/v): ESBL-producing E. coli
0.015/0.125, ciproﬂoxacin resistant E. coli 0.03/0.25, ESBL-producing
K. pneumoniae 0.125/0.125, imipenem, ceftazidime and multi-drug
resistant P. aeruginosa 0.03/0.06, penicillin and macrolide resistant
and intermediate resistant S. pneumoniae 0.015/0.03, meticillin resistant
S. aureus 0.004/0.5, vancomycin resistant E. faecium 0.015/>1.
Conclusion: The mixture of ITC displays broad activitiy against various
antimicrobial and multi-drug resistant bacteria.
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P615 Increasing number of ESBL-producing Escherichia coli
during the last three years in Stockholm – A challenge for
the clinical laboratory
A. Iversen, M. Andersson, M. Vondracek, C.G. Giske (Stockholm, SE)
Objectives: This study aimed at describing the epidemiologic situation
of ESBL-producing Escherichia coli (ESBL-EC) in the Stockholm area
during 2005 to 2007. The PhenePlate System (PhP) was validated as
a screening method used for epidemiological typing of all ESBL-EC
isolates and genotypic characterisation of the phylogenetic subgroups of
the CTX-M b-lactamase was performed in parallel.
Methods: Clinical isolates of ESBL-EC for the years 2005 (n = 217),
2006 (n = 315) and 2007 (until September, n = 290) were epidemiological
typed with the PhP biochemical typing system for E. coli. The global
congruence between PhP-typing and pulsed-ﬁeld gel electrophoretic
(PFGE) patterns on XbaI digested DNA was examined for a subset of the
isolates (n = 56) by the Comparing Partitions computer software. Unique
PhP and PFGE-types were deﬁned as isolates with similarity indices
above 0.96 and 0.85 (Dice coefﬁcient), respectively. Index of diversity
was determined by Simpson index, while the Wallace coefﬁcient was
used to evaluate global agreement between the two typing methods.
Results: A steady increase in the prevalence of ESBL-EC for the years
2005–2007 was observed, while the total number of susceptibility tested
isolates between the years was comparable. A tendency towards increased
multi-resistance was noted. Using the PhP System 28 major clusters (5
isolates of the same PhP-type) were found and two of these clusters have
so far been conﬁrmed with PFGE. In the subset of isolates subjected to
parallel evaluation of PhP and PFGE greater discriminatory power was
observed for PFGE, although not statistically signiﬁcant. The Wallace
coefﬁcient showed that two strains belonging to the same cluster by
PFGE had about 83% chance of having the same PhP-type, while
conversely strains belonging to the same PhP-type had 74% chance of
having the same PFGE-type.
Conclusion: Efﬁcient epidemiological typing of ESBL isolates within a
reasonable time-span is of great importance to clinical laboratories. For
this purpose PhP, which is a less labour intensive method than PFGE was
validated for epidemiological typing of ESBL-EC isolates. PhP-typing
was found to be less discriminatory than PFGE, but can probably be used
to exclude similarity by PFGE at the 85% cut-off level. Conversely, PhP-
clusters should always be conﬁrmed with PFGE. Genotyping revealed
that CTX-M-15 and -14 are the most prevalent ESBL-variants in the
Stockholm area.
P616 ESBL-producing Enterobacteriaceae in a County of Sweden
during 2002–2007
A˚. O¨stholm Balkhed, M. Ta¨rnberg, A.V. Johansson, M. Nilsson,
H-J. Monstein, L.E. Nilsson (Linko¨ping, SE)
Objectives: To investigate the occurence of ESBL-producing Enterobac-
teriaceae in the County of O¨stergo¨tland, Sweden.
Methods: From January 2002 until August 2007 ESBL-producing
strains were collected in the county of O¨stergo¨tland with 420 000
inhabitants. The ESBL phenotype was conﬁrmed by Etest with
ceftazidime, cefotaxime and cefepime, with and without clavulanic acid.
PCR ampliﬁcation was performed to screen for presence of CTX-M
genes. CTX-M positive isolates were subjected to DNA sequencing.
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Results: A total of 217 clinical isolates, 191 Escherichia coli, 24
Klebsiella pneumoniae, 1 Shigella sonnei and 1 Citrobacter koseri, with
an ESBL phenotype was found. The isolates mainly came from the
urinary tract but also from blood and other sources. Patients identiﬁed
with ESBL-postive isolates were 6 in 2002 and increased to 39 in 2006.
From January until the end of August 2007 32 patients were found.
Onehundred ninety-three bacterial isolates were further investigated. The
PCR revealed that among E. coli 66% belonged to CTX-M group 1, 32%
consisted of CTX-M group 9 and more rare was CTX-M group 2. In
K. pneumoniae 47% belonged to CTX-M group 1 and the other half was
conferred to other enzymes. In S. sonnei CTX-M group 1 was found and
in C. koseri CTX-M group 9 was detected. In 4 patients we found both
ESBL-producing E. coli and K. pneumoniae. Eight patients had repeat
isolates with ESBL-producing E. coli in urine specimens for more than
6 months.
Conclusions: Prevalence of ESBL in clinical specimens is still rare, less
than 1%, in our region but the number of patients with ESBL positive
isolates increases. CTX-M group 1 is the dominating enzyme group in
both E. coli and K. pneumoniae.
P617 First clonal outbreak of a multi-resistant CTX-M-15
producing Klebsiella pneumoniae in Denmark
D.S. Hansen, D.S. Christiansen, E.M. Nielsen, F. Hansen, L. Nielsen,
B. Bruun (Hillerød, Copenhagen, DK)
Objectives: Increasing frequency of extended spectrum bete-lactamases
(ESBL) producing organisms have been reported worldwide, causing
major problems in treatment of serious infections, limiting antibiotic
therapy to broad-spectrum antibiotics such as carbapenems.
Until the mid-nineties TEM and SHV and their derivates were the
predominant b-lactamases, but recently a new group, the CTX-M
b-lactamases, have emerged and now seem to be the most widespread
ESBLs in many countries. Since the ﬁrst case reports in E. coli from
Japan in 1986, the CTX-M enzymes have disseminated worldwide,
especially among Enterobacteriaceae.
The rate of antibiotic resistance in the Nordic countries has generally
been low; however, recently outbreaks of ESBL-producing organisms
have been described from both Norway and Sweden. We here describe
the ﬁrst clonal outbreak of a multi-resistant CTX-M-15 producing
Klebsiella pneumoniae in Denmark.
Methods: Antibiotic susceptibility testing was done by disc diffusion
(Oxoid disc, Isosensitest agar, SRGA breakpoints). ESBL-production
was screened for using a cefpodoxime disc; phenotypic conﬁrmation
was by the Combi-disc method using Rosco tablets (ceftazidime and
cefotaxime +/− clavulanic acid). Identiﬁcation of ESBL type was done
by PCR and sequencing, typing by PFGE using XbaI.
Results: In April 2007 we became aware of two patients with a multi-
resistant ESBL-producing K. pneumoniae in a medical ward. The isolates
were resistant to gentamicin, ciproﬂoxacin, cephalosporins, trimetho-
prim/sulfamethoxazole and piperacillin/tazobactam, but susceptible to
meropenem and colistin. Soon thereafter we found more isolates, and
a systematic screening of patients on the four involved wards, as well
as a retrospective search in archives and freezers, identiﬁed a total of
36 patients colonised/infected with the strain. Six isolates dating back
before the index cases were found, the earliest from January 2006. All
isolates had the same or minor variation of the PFGE pattern.
Conclusions: This is the ﬁrst report of clonal outbreak of a multi-
resistant CTX-M-15 producing K. pneumoniae in Denmark. The length
of time this strain has been able to survive and spread in the hospital
environment fully underscores the potential of this and similar CTX-M
producing strains to disseminate worldwide.
P618 Predominantly clonal transmission of CTX-M-1 harbouring
K. pneumoniae in two wards
M. Kaase, A. Anders, S. Friedrich, G. Schieren, T. Fo¨rster, F. Szabados,
T. Sakinc, B. Kleine, S.G. Gatermann (Bochum, DE)
Objectives: Resistance against third generation cephalosporins in
K. pneumoniae is an increasing problem and is mainly due to extended
spectrum b-lactamases (ESBL). A worldwide increase of CTX-M-type
b-lactamases has been described in recent years but epidemiologic data
from Germany are scarce.
Methods: From January 2006 to April 2007 we collected 38 non-copy
isolates of K. pneumoniae with an ESBL phenotype from ward A (N
= 29) and B (N = 9), located in different hospitals and representing
different patient populations. Typing was performed by PFGE after
enzymatic DNA macrorestriction with XbaI. PCR for TEM, SHV and
CTX-M was conducted in all isolates. In single representative isolates
genes coding for CTX-M were sequenced. MICs of b-lactam-antibiotics
were determined by Etest or microdilution, susceptibility testing for other
antibiotic classes was done by agardiffusion.
Results: 15 and 3 isolates from ward A belonged to clone 1 and
2, respectively. 5 isolates from ward B (clone 3) had identical PFGE
patterns. All isolates had an SHV b-lactamase as expected. TEM was
found in 21 isolates, a CTX-M b-lactamase was found in 36 isolates.
In 34 isolates, including all clone 1, clone 2 and clone 3 isolates, a
CTX-M-1 group b-lactamase was found. A CTX-M-9 group b-lactamase
was found in two isolates.
MIC50 was >256 mg/l for piperacillin, 8 mg/l for piperacillin/tazo-
bactam, 6 mg/l for temocillin, >256 mg/l for cefotaxim and 128 mg/l for
ceftazidim. Resistance rates against other antibiotic classes were 94.7%
for ciproﬂoxacin, 78.9% for tobramycin, 34.2% for gentamicin, 26.3%
for doxycyclin and 52.6% for sulfamethoxazol-trimethoprim.
Conclusion: Clonal transmission was the most important factor
responsible for spread of CTX-M-1 group harbouring K. pneumoniae
in both wards. Predominant clones were different in both locations
highlighting the signiﬁcance of local epidemiological studies. Temocillin
and piperacillin/tazobactam retained good activity in vitro agains ESBL
K. pneumoniae isolates in our area.
P619 Epidemiology and molecular screening of ESBL-producing
Enterobacteriaceae in a Dutch hospital
E.J. van Hannen, C. van Oostveen, L. Kool, B.J.M. Vlaminckx
(Nieuwegein, Utrecht, NL)
Objectives: Over the last ﬁve years, resistance against third-generation
cephalosporins has increased exponentially in the Netherlands. Until
2002, ESBL-producing micro-organisms were virtually absent in our
hospital. Nowadays approximately 6−7% of clinical Escherichia coli,
Enterobacter cloacae and Klebsiella pneumoniae isolates carry plasmids
encoding the ESBL phenotype.
In analogy to our MRSA policy, we actively search for ESBL positive
micro-organisms to contain their further spread. To enable rapid
screening, we developed a real time PCR test to detect the CTX-M
gene in Enterobacteriaceae with an increased MIC to third-generation
cephalosporins. Theoretically, the beneﬁt of this molecular screening
would be a two days shortening in the time needed to detect an ESBL.
Methods: We performed a retrospective analysis of the epidemiology of
ESBL-producing E. coli, E. cloacae and K. pneumoniae strains in our
hospital. Subsequently, all ESBL-producing strains were screened for the
presence of TEM, SHV and CTX-M genes by a classic multiplex PCR.
A real-time PCR, detecting all 5 CTX-M groups, was then developed
and used to enable rapid, weekly screening for ESBLs on our intensive
care unit (ICU).
Results: In 2002, less than 1% of our clinical E. coli isolates was ESBL
positive. This number rose steadily to 6% in 2007. For E. cloacae and
K. pneumoniae, these numbers were 1.3% in 2002 and 7% in 2007 and
1% in 2002 and 5.8% in 2002, respectively.
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Molecular analyses showed that approximately 60% of the ESBL-
producing strains in our hospital carried the CTX-M gene, with the
relative contribution of CTX-M increasing over time. We therefore
developed a real-time PCR to detect the presence of this gene. This
PCR was then used in an ongoing weekly screening for ESBL-producing
Enterobacteriaceae in our ICU.
Conclusion: The occurrence of ESBL-producing enterobacteriaceae in
our hospital has increased from approximately 1% in 2002 to 7% in
2007. Sixty percent of these bacteria carried the CTX-M gene. Molecular
screening for this gene in clinical isolates from the ICU speeds up the
detection of more than 60% of ESBL-producing enterobacteriaceae in
our hospital with two days. Parameters to evaluate the additional value
of this newly developed strategy are the reduction of secundary cases
and the time needed to control an ESBL outbreak.
P620 Extended-spectrum b-lactamases in the Czech Republic
J. Hrabak, J. Empel, T. Bergerova, P. Urbaskova, M. Gniadkowski
(Plzen, CZ; Warsaw, PL; Prague, CZ)
Objectives: Extended-spectrum b-lactamases (ESBLs) are one of the
most important mechanisms of resistance to newer generation b-lactams
in Gram-negative bacteria. In the Czech Republic, there has not
been done yet any molecular epidemiology study on ESBL-producing
organisms. The objective of this analysis is to characterise ESBLs and
ESBL producers in one of the biggest Czech hospitals, the University
Hospital in Plzen.
Methods: In 2006, a 1-month survey of ESBL-producing bacteria was
performed. Twenty-four non-repetitive isolates of Klebsiella pneumoniae
(n = 10), Escherichia coli (n = 9), Providencia stuartii (n = 3), Enter-
obacter cloacae (n = 1) and Proteus mirabilis (n = 1) were collected.
The isolates were typed by RAPD and used in conjugative transfer
experiments for ESBL-mediated resistance. ESBLs were characterised
by isoelectric focusing, bioassay, and PCR and sequencing of bla genes.
Results: At least seven different ESBL variants were identiﬁed in the
isolates. SHV enzymes dominated in K. pneumoniae (SHV-5, SHV-12
and probably SHV-2), whereas CTX-M b-lactamases, mostly CTX-M-
15, were predominant among E. coli. The CTX-M-15-encoding gene
was preceded by the ISEcp1 element at a distance of 48 bp. TEM-type
ESBLs were produced by the remaining strains; TEM-92 by all P. stuartii
isolates, and TEM-132 – by E. cloacae. Genes coding for SHV-5, SHV-
12, CTX-M-15 and TEM-132 were located on conjugative plasmids. A
signiﬁcant number of isolates (K. pneumoniae SHV-5, E. coli CTX-M-
15 and P. stuartii TEM-92) appeared owing to clonal dissemination of
producer strains.
Conclusions: This work showed a high diversity of ESBL variants in
the Czech hospital, which included both globally-disseminated and more
locale-speciﬁc enzymes.
This work was partially supported by a research project MSM
0021620819.
P621 Monitoring, epidemiology and molecular analysis of
extended-spectrum b-lactamase producing Klebsiella
pneumoniae strains isolated at a large hospital in Budapest
during a four-month period
T. Tirczka, A´. To´th, I. Damjanova, E. Szila´gyi, J. Korom, F. Bukovszki
(Budapest, HU)
Objectives: Comprehensive multilevel investigation of outbreaks caused
by extended-spectrum b-lactamase producing Klebsiella pneumoniae
(ESBL-KP) in a large tertiary hospital in Budapest during period of
four months.
Methods: During the study period ESBL-KP strains were recovered from
18 different hospital wards. Altogether 270 samples were examined, of
these 48 environmental and 163 patient and staff samples, respectively.
Antimicrobial susceptibility testing was performed by disk diffusion
method according to the recommendations of the CLSI. On the basis
of preliminary phage typing results ESBL-KP isolates were tested by
PFGE. Molecular typing was performed by SHV, CTX-M and TEM
PCRs, plasmid proﬁle analysis, transfer of resistance determinants and
sequencing of resistance genes.
Results: 132 ESBL-producing clinical isolates of Gram-negative
pathogens (GNPs) were collected from October 2006 to January 2007
from 82 patients and hospital staff as follow: Klebsiella pneumoniae
(n = 86), Escherichia coli (EC) (n = 35) and other species (n = 11). One
of 48 enviromental samples was positive for ESBL-KP.
70% of samples recovered from the Neonatal Intensive Care Unit
(NICU), 50% of samples from the Neurosurgery and the Chronic Internal
Medicine Ward (CIMW), respectively, and 30% of samples from the
Intensive Care Unit (ICU) proved ESBL-producers.
The molecular characterisation of ESBL-KP strains isolated from the
NICU showed that all of them belonged to the same pulsotype (X clone)
and harboured blaSHV-5 gene on plasmid of app. 90 kb.
PFGE analysis of ESBL-KP strains isolated from 9 adult wards revealed
parallel existence of three different genetic clones: the Hungarian
Epidemic Clone (HEC, pulsotype N), the Epidemic clone III (EC III,
pulsotype S) and the clone L. All of them harboured blaCTX-M-15 on
large plasmids ranged from 50 to 90 kb.
Conclusion: Three parallel outbreaks caused by ESBL-KP were detected
in the NICU, the ICU and the Neurosurgery from October to December
of 2006. Additionally high colonisation rate (32%) with ESBL-KP was
found in the CIMW.
P622 Outbreak of CTX-M extended-spectrum b-lactamase-
producing Klebsiella pneumoniae in a large general hospital
Trust in the UK
L. Xu, S. Shabir, K. Hardy, K. Nye, P. Hawkey, J. Stone (Birmingham,
Cheltenham, UK)
Objectives: The aim of this study was to investigate the molecular
epidemiology of an outbreak of ESBL-producing K. pneumoniae in a
large general hospital Trust in the UK.
Methods: Isolation of ESBL-producing Enterobacteriaceae mainly from
catheter urines increased from approximately 5 to 40 isolates per month
at a large general NHS Trust Hospital. All isolates recovered over a
three month period were screened for susceptibility to cefpodoxime by
the BSAC disc diffusion method and ESBL production conﬁrmed using
cefpodoxime, cefpirome and ceftazidime with and without clavulanate.
Eighty-one of these outbreak isolates were subjected to multiplex PCR
to detect all blaCTX-M genes. Clonal relationship was studied by PFGE.
Results: The eighty-one ESBL-producing isolates included 62 K. pneu-
moniae and 19 E. coli; 60 isolates (74.1%) from the hospital and
21 isolates (25.9%) from the community. More than 95% of these
clinical isolates were recovered from urinary specimens. Multiplex
PCR screening identiﬁed a blaCTX-M gene in 55/62 K. pneumoniae
isolates (88.7%) and all of them harboured a blaCTX-M group 1.
Characterisation of the regions surrounding the blaCTX-M showed that
all isolates carried ISEcp1 upstream from the blaCTX-M and 35 had
a IS26 element inserted into ISEcp1. PFGE analysis conﬁrmed that
all 55 blaCTX-M positive K. pneumoniae isolates belonged to a single
epidemic clone (>87% similarity), designated strain GK.
Conclusion: This is the ﬁrst well documented report of a large outbreak
of CTX-M-producing K. pneumoniae in a major hospital Trust in the
UK. We demonstrated that the dissemination of CTX-M-producing
strains of K. pneumoniae both in the hospital and the community is
due mainly to the diffusion of a single epidemic clone. The outbreak
highlights the epidemic potential of CTX-M-producing K. pneumoniae
and the importance of strengthening infection control measures. Further
genotyping of CTX-M producing isolates by DHPLC and sequencing
will be undertaken and extensive investigations to determine the source
of the outbreak are continuing.
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P623 Trends in extendeds-spectrum b-lactamase Klebsiella
pneumoniae in a tertiary Spanish hospital (1993–2006)
C. Ardanuy, M. Dominguez, L. Calatayud, F. Tubau, J. Ayats, C. Pen˜a,
M. Pujol, R. Martı´n, J. Lin˜ares (L’Hospitalet de Llobregat, ES)
Objective: The objective of this study was to characterise the ESBL-
K. pneumoniae strains isolated in a tertiary hospital during a 14-year
period (1993–2006).
Methods: Screening of ESBL was performed by double disk synergy
test. All available K. pneumoniae strains were typed by PFGE (XbaI).
The ESBL characterisation was performed by isoelectric focusing of
betalactamases and by PCR of ESBL family. All ESBLs genes of strains
causing nosocomial outbreaks were sequenced.
Results: During the study period, K. pneumoniae was isolated from
clinical samples of 4925 patients admitted to our hospital. Three hundred
and seventy three (7.6%) K. pneumoniae carried an ESBL, and the
majority of them (197/373, 53%) were isolated from ICU patients.
Isolates from 290 patients were available for further studies. Sixty-seven
different PFGE patterns were found among the 290 isolates studied. Two
major outbreaks were observed throughout the study period. The ﬁrst of
them, involving 150 patients, occurred between 1993–1995 and was due
to the spread of strains of Kp1 clone. The majority (85%) of Kp1 isolates
produced one ESBL and 15% two ESBLs. By sequencing 34% of ESBL-
Kp1 were identiﬁed as SHV-2 (pI 7.6), 51% as SHV-5 (pI 8.2) and 15%
as SHV-2 plus SHV-5 (pIs 7.6 and 8.2 respectively). The second outbreak
was due to Kp29 clone and accounted for 53 patients. This epidemic
Kp29 strain produced an SHV-2 betalactamase (pI 7.6). The majority
(66%) of Kp29 isolates were detected between September 1999 and
November 2000. Another eight clusters of ESBL-K. pneumoniae (SHV-
family) involving 2 to 7 patients each were detected throughout the study
period. During 1999–2006 period, 8 unrelated K. pneumoniae producing
CTX-M-9 family were detected. Only 2 unrelated strains harbouring a
TEM-family ESBLs were detected in 1995 and 2003, respectively.
Conclusion: Although the global prevalence of ESBL-K. pneumoniae
infections in our institution was 7.6%, the annual frequency ranged from
3% to 18%. Two major outbreaks were associated with the dissemination
of epidemic strains producing SHV-2 and/or SHV-5 ESBLs. Isolation of
strains producing CTX-M-9 or TEM families of ESBLs is infrequent
among K. pneumoniae.
P624 Extended- and broad-spectrum b-lactamase-producing
Klebsiella pneumoniae isolates in 17 clinical health
institutions in Portugal participating in the ARSIP Program
N. Mendonc¸a, E. Ferreira, D. Louro, M. Canic¸a for the Antibiotic
Resistance Surveillance Programme in Portugal
Objectives: We report phenotypic and genotypic analysis of clinical
isolates of K. pneumoniae of both community and nosocomial origin
recovered in various hospitals and public health institutions of Portugal.
Methods: A total of 212 K. pneumoniae strains isolated over six
consecutive months of 1999 in 14 hospitals and 3 other public health
institutions were tested for susceptibility to 23 antibiotics by using
CLSI guidelines. New enzymes and respective transconjugants were
also tested for susceptibility. PCR and sequencing were used to screen
and identify blaTEM, blaSHV, blaOXA, ampC and blaCTX-M genes.
Biochemical characterisation was performed by isoelectric focusing.
Genetic relatedness of 131 isolates was studied by PFGE analysis.
Results: Mostly strains were from women, patients >60 years-old
and urinary tract infections; 86% were resistant to ampicillin, 29%
to trimetoprim-sulphametoxazole, 16% to aminoglycosides and 2%
to ﬂuoroquinolones; 16% were multidrugresistant and 15% expressed
an ESBL phenotype, although only 13% (27/212) of these were
conﬁrmed by genotyping. Indeed, molecular methods identiﬁed 11
strains possessing blaESBL-SHV genes (blaSHV-2A, blaSHV-5, blaSHV-
12 and blaSHV-55), 9 with blaESBL-TEM (blaTEM-3, blaTEM-10 and
blaTEM-24) and 7 with blaGES-1, encoding ESBL enzymes; 9 with
blaLEN, 8 with blaOKP, and 160 with blaSHV-1 and blaSHV-type
encoding non-ESBL enzymes; and 4 strains hyperexpressing blaSHV-1
genes, that expressed an ESBL phenotype. Only IEF method identiﬁed
the expression of the blaSHV-type gene in 4 strains. Overall, we detected
26 new enzymes: SHV-60 to SHV-62, SHV-73 to SHV-83, LEN-18
to LEN-21, LEN-23, OKP-A-12 and OKP-B-15 to OKP-B-20. Twenty
additional strains isolated during a second period, between March and
November 2006, in three of the 14 participating hospitals, contained
ESBL-encoding genes whereas none of the strains isolated in the same
hospitals in 1999 carried such genes: blaSHV-5, blaSHV12, blaTEM-
10, blaTEM-52, blaCTX-M-15, blaCTX-M-32 and blaCTX-M-61. The
PFGE analysis showed that strains were diverse, and 25 clusters were
deﬁned, the largest including 14 strains of different biological origins, 6
of which expressed GES-1 enzymes. No dominant epidemic clone was
detected.
Conclusion: We described the expansion of b-lactamases produced by
K. pneumoniae in 3 large regions in Portugal, providing evidence that
the genotypes of K. pneumoniae strains in community and hospital
environments is changing.
P625 Spread of CTX-M extended-spectrum b-lactamases among
Escherichia coli and Klebsiella pneumoniae isolates in Italian
long-term care facilities: results of the ﬁrst nationwide
prevalence study
L. Pagani, R. Migliavacca, M. Spalla, D. Saviane, L. Regattin,
V. Botti, C. De Luca, A. Raglio, A. Goglio, S. Brusaferro (Pavia,
Udine, Bergamo, IT)
Objectives: In the present century CTX-M Extended-Spectrum Beta-
Lactamases (ESBLs) have become predominant mainly in E. coli, and
the producers are increasingly isolated from community patients. Over
60 different CTX-M-type enzymes have been identiﬁed from around the
world. Reports of Italian isolates with CTX-M ESBLs only began to
appear in 2003. The objective of this study was to evaluate the diffusion
of CTX-M type b-lactamases among E. coli and K. pneumoniae clinical
isolates recovered from Long-Term Care Facilities (LTCFs) residents
across Italy.
Methods: All catheterised inpatients at the 37 facilities involved in
the study were surveyed in the same day between Sept. 2006 and
Jan. 2007. Susceptibility testing of urinary isolates was performed
with VITEK2 System (Bio-Me´rieux). All isolates identiﬁed as ESBL
producers according to CLSI criteria were tested at ﬁrst for blaCTX-M
alleles by PCR with universal primers. ESBL-CTX-M producers detected
by phenotypic and genotypic methods were then investigated by using
speciﬁc primers for various blaCTX-M groups. The clonal relationships
between epidemiologically relevant E. coli and K. pneumoniae strains
were evaluated by PFGE.
Results: A total of 496 Enterobacteriaceae isolates were recovered. The
overall ESBL producers rate was 39.7%. All isolates were characterised
by co-resistances but all retained susceptibility to carbapenems.
The prevalence rates of E. coli, the most frequent uropathogen, and of
K. pneumoniae were 40.5% and 8.5% respectively. Seventy-two E. coli
(35.8%) and ten K. pneumoniae (23.8%) produced ESBLs, with 75%
and 60% respectively producing CTX-M enzymes. CTX-M-1-group
ESBLs were the most prevalent in E. coli (49/54 strains) but CTX-M-
9-group variants were also identiﬁed (5/54 strains). K. pneumoniae
isolates produced CTX-M-1 group enzymes exclusively. The ﬁve E. coli
CTX-M-9-type producers were from 4 LTCFs: two located in Southern
Italy and the others in Northern Italy. E. coli CTX-M-9-type producers
were clustered in three clonal lineages, one of which responsible for an
epidemic in a LTCF in Catania.
Conclusions: Our data conﬁrm that LTCFs are reservoirs of MDR
pathogens and that CTX-M-type ESBLs are widespread also in these
settings. The overall CTX-M producers rate in LTCFs is higher than
that reported in the second Italian nationwide survey (2003) for isolates
from acute-care hospitals. Our results document the dissemination of
CTX-M-9-type genes also in Italian area.
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P626 Molecular types of extended-spectrum b-lactamases in
Escherichia coli strains isolated from community-acquired
urinary tract infections in Turkey
H. Arslan, O. Kurt Azap, S. Serin Senger, F. Timurkaynak (Ankara, TR)
Background: Extended-spectrum b-lactamase (ESBL)-producing Es-
cherichia coli have been increasingly recognised in the community. The
aim of this study was to determine the prevalence of CTX-M, SHV, and
TEM types of ESBLs for community-onset ESBL-producing E. coli in
urinary tract infections (UTIs).
Methods: ESBL-producing E. coli strains isolated from adults with
community-onset UTIs during two distinct periods in 2004 and 2006
were collected from four centres in different cities of Turkey. The
presence of ESBL was established on the basis of CLSI criteria and
conﬁrmatory tests. Polymerase chain reaction and DNA sequencing were
used to characterise the blaTEM, blaCTX-M and blaSHV genes.
Results: We analysed 54 E. coli isolates (18 isolates from 2004 and
36 from 2006–2007). The prevalence of CTX-M, SHV, and TEM
were 94.4% (51), 9.3% (5), and 42.6% (23) respectively. Sequence
analysis of the blaCTX-M containing isolates revealed that these isolates
contained two different blaCTX-M, 2 (3.9%) with blaCTX-M-3, and
49 (96.1%) with blaCTX-M-15. We found 3 different ESBL blaSHV
types: blaSHV-12, blaSHV-5, and blaSHV-2. There were 2 blaTEM-116
carrying isolates.
The two isolates carrying TEM-116 had also CTX-M-15, and they
belonged to the 2006–2007 period. There were no other signiﬁcant
differences in the two periods regarding the ESBL types. In the table
the distribution of the CTX-M, SHV, and TEM ESBL types is shown.
Table: The distribution of ESBL types among the isolates
ESBL types Number of isolates
TEM SHV CTX-M 2004 2006−07 Total
− − CTX-M-15 16 31 47
− − CTX-M-3 0 2 2
TEM-116 − CTX-M-15 0 2 2
− SHV-5 − 1 0 1
− SHV-2 − 1 0 1
− SHV-12 − 0 1 1
2 3 51 18 36 54
Conclusions: ESBL-producing E. coli in non-hospitalised patients seem
to be emerging with various types and prevalence in different countries.
Our study revealed dissemination of CTX-M type ESBL in E. coli strains
isolated from community-acquired UTIs in Turkey. CTX-M-15 was the
most common enzyme.
In this study in only two of the isolates we found ESBL-type TEM, and
they were isolated in 2006. This may indicate that a novel ESBL type
(TEM-116) has emerged. A close follow up whether this novel ESBL
type disseminates would be appropriate. The coexistence of CTX-M-
15 with ESBL-type TEM genes has been observed in two isolates,
compatible with similar ﬁndings in recent studies.
P627 Rapid emergence and dissemination of blaCTX-M among
Enterobacteriaceae in USA medical centres: report from the
MYSTIC Program (2007)
M. Castanheira, R. Mendes, P. Rhomberg, L. Deshpande, R. Jones
(North Liberty, US)
Objective: To characterise extended-spectrum b-lactamase (ESBL) and
plasmid-mediated AmpC (pAmpC)-encoding genes among Enterobac-
teriaceae (ENT) isolates collected from USA medical centres, and to
identify plasmid-mediated ﬂuoroquinolone resistance (pFQ-R) encoding
genes among ESBL-producing isolates.
Methods: 1,392 ENT isolates were collected from 15 USA medical
centres through the MYSTIC Program during 2007 and tested by the
CLSI broth microdilution method. ESBL-positive (clavulanate inhibited)
strains were tested for the presence of PER, GES, VEB, CTX-M and
OXA enzymes with a multiplex PCR approach. ESBL screen positive
but not conﬁrmed were screened for pAmpC genes. Isolates were also
tested for qnr-type, qepA and aac(6′)-Ib-cr. Primers annealing on genetic
structures ﬂanking the resistance encoding genes were used to obtain
complete DNA sequences. Amplicons were sequenced in both strands
and results analysed.
Results: Among 70 (5.0% of the total) ENT isolates with an ESBL
phenotype, blaCTX-M was detected in 28 (40.0%; 24 E. coli, 2
K. pneumoniae, 1 P. vulgaris and 1 K. oxytoca). CTX-M-15 (18 strains,
64.3%) and CTX-M-14 (9, 32.1%) were most prevalent; CTX-M-3 was
observed in one strain (3.6%). These isolates were collected in 12 centres
(80.0% of the participating sites). OXA-encoding genes with ESBL
spectrums were identiﬁed in 10 isolates, one co-producing CTX-M. Five
isolates harbored blaCMY-2 (4 E. coli and 1 K. pneumoniae), while 4
isolates carried blaFOX-5 (3 K. pneumoniae and 1 K. oxytoca). Nine
ESBL-positive (12.9%) isolates carried qnr genes (2 qnrA, 6 qnrB and
1 qnrS). The qnr genes were found in one isolate carrying each of
the b-lactamases: blaFOX-5, blaCMY-2, blaCTX-M-15, blaOXA-2 and
blaOXA-10. Only one (3.6%) CTX-M-producing strain carried aac(6′)-
Ib-cr. This isolate harbored blaOXA-10 and blaCTX-M-14. Meropenem
was active against all blaCTX-M and ESBL-producing strains.
Conclusions: For over a decade CTX-M-producing isolates have been
reported as the highly prevalent ESBL resistance mechanism in Europe
and Asia. In contrast, these enzymes were considered unusual in the
USA. In this 2007 collection of ENT from USA medical centres,
at least 2 distinct CTX-M-type enzymes have disseminated among
different species and institutions. In addition, the prevalence of pFQ-R
encoding genes among b-lactamase-producing isolates was higher than
that observed in ENT not carrying these resistance determinants.
P628 Occurrence of blaCTX-M genes in quinolone resistance
Enterobacteriaceae isolates from Brazil
L.A.R. Minarini, N.A.C. Trevisani, A.L.C. Darini (Ribeira˜o Preto, BR)
Objectives: To determine the prevalence of plasmid-encoded extended-
spectrum b-lactamases (ESBL) among a collection of quinolone
resistance Enterobacteriaceae isolates recovered in a community setting
from Brazil.
Methods: Two hundred ﬁfty seven non-repetitive nalidixic-acid resistant
enterobacterial isolates were collected in a private laboratory from
January 2000 to May 2005. The production of ESBL was detected
according to Clinical and Laboratory Standards Institute (CLSI) criteria.
Beta-lactamase-encoding genes were detected by PCR using universal
primers for the TEM, SHV, and CTX-M families. The ESBL isolates
were tested for qnrA, qnrB, qnrS and aac(6′)-Ib-cr genes by PCR
technique. Conjugation experiments were performed to determine
whether the ESBL genes carrying plasmids were self-transferable.
Hybridisation experiments were performed with a Southern transfer
from recombinant and original plasmids harboring blaCTX-M. Genetic
structures surrounding the blaCTX-M genes were analysed by PCR and
the genetic relatedness of the isolates determined by pulsed-ﬁeld gel
electrophoresis.
Results: Twenty four (9.3%) ESBL-producing Enterobacteriaceae strains
were isolated during the study period, 9 were Escherichia coli, 6
K. pneumoniae, 5 Enterobacter cloacae, 2 Providencia stuartii, 1 Mor-
ganella morganii and 1 Citrobacter freundii. PCR and DNA sequencing
detected isolates harboring blaCTX-M-2 (n = 13), blaCTX-M-9 (n = 3),
blaCTX-M-8 (n = 2), and blaSHV-5 (n = 6). The ESBL-positive isolates
were also positive for the blaTEM-1 gene, except one M. morganii
isolate. Plasmids harboring blaCTX-M were not transferable and ranged
from 40 to 180 kb in size. One K. pneumoniae isolate co-harbored
blaCTX-M-2 and qnrB2 gene and an E. cloacae isolate that was qnrA
positive harbored blaSHV-5. However, ESBL and qnr genes were found
in different plasmids. No aac(6′)-Ib-cr gene was found in ESBL isolates
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studied. ISEcp1 was identiﬁed upstream of the blaCTX-M-9 and ISCR1
was found in isolates harboring blaCTX-M-2.
Conclusion: The results presented in this study provided additional
data about the molecular epidemiology of plasmid-encoded ESBL
determinants among enterobacterial isolates recovered in a Brazilian
community setting. A large diversity of genotypes was circulating
in the community, with a predominance of blaCTX-M-encoding non-
conjugative plasmids. A low prevalence of Qnr determinants was found
in ESBL-producing isolates recovered from Brazilian community.
P629 Phylogenetic groups of non-clonally related Klebsiella
pneumoniae clinical isolates with and without
extended-spectrum b-lactamases
A. Valverde, T.M. Coque, F. Baquero, R. Canto´n (Madrid, ES)
Objectives: Phylogenetic groups of Klebsiella pneumoniae isolates have
been associated with the presence of speciﬁc chromosomal b-lactamases
and the environmental compartment origin. In this study the population
structure and phylogenetic groups of different K. pneumoniae isolates
with and without extended spectrum b-lactamases (ESBL) recovered
from hospitalised and non-hospitalised patients were characterised.
Methods: A total of 102 non-clonally related K. pneumoniae strains
recovered from 26 outpatients and 76 hospitalised patients were analysed.
Isolates distribution was as follows: 66 ESBL-producing isolates (1989–
2004) (10 blood, 28 urine, and 28 other samples) and 36 non-
ESBL-producing isolates (2005–2007) (14 blood, and 22 urine). Clonal
typing was established by XbaI-PFGE. Phylogenetic groups (KpI,
KpII, and KpIII) were determined by PCR ampliﬁcation of the gyrA
gene and further analysis of the RFLP pattern obtained with HaeIII
and TaqI (Brisse et al. CMI 2004; 10:942−5). Ampliﬁcation of the
chromosomal blaSHV, blaOKP and blaLEN genes was also performed.
ESBL characterisation was established by PCR and further sequencing.
Results: Distribution of isolates between different phylogenetic groups
was as follows: KpI (81/102), KpII (3/102) and KpIII (18/102). This
distribution was not substantially affected when considered different
sources and resistance patterns. Most of the susceptible isolates
obtained from blood cultures belonged to KpI group (13/14) as well
as those obtained from urine samples (18/22). The corresponding
values for ESBL producers were as follows: (6/10) and (24/28),
respectively. Nevertheless, a clear association was observed with
CTX-M-10 producing isolates and KpIII-group (p< 0.001, Chi squared
test), irrespective of clinical source and patients’ origin. KpIII non-
ESBL-producing isolates were recovered from outpatients. Most of the
KpIII-isolates (15/18) were also positive for blaLEN.
Conclusions: KpI is the most prevalent phylogenetic group in
K. pneumoniae isolates from clinical origin in both ESBL and non-ESBL
producers. However, KpIII phylogenetic group, previously associated
with environmental sources, was consistently linked with blaCTX-M-
10 and chromosomal blaLEN gene. This association might reinforce the
potential environmental origin of these ESBL-producing isolates.
P630 Prevalence of faecal carriage of ESBL-producing Enterobac-
teriaceae in patients with severe abdominal infections
M. Ta¨rnberg, A˚. O¨stholm Balkhed, H. Hanberger, A.V. Johansson,
H.J. Monstein, M. Nilsson, L. Pa˚hlman, L.E. Nilsson (Linko¨ping,
Uppsala, SE)
Objectives: A Swedish multi-centre study was carried out to determine
the aerobic enteric faecal ﬂora in patients with severe abdominal
infections during hospitalisation, with a special emphasis on carriage of
Enterobacteriaceae producing extended spectrum b-lactamases (ESBL).
Method: Rectal swabs were obtained at admission to hospital, during
antibiotic treatment and at least 48h after end of antibiotic treatment.
Samples were also obtained during operation and at clinical indications.
Cultures were performed on chromogenic agar with antibiotic discs.
Antibiotic susceptibility testing was performed using the disk diffusion
method according to the Swedish Reference Group for Antibiotics.
ESBL-phenotype was conﬁrmed by Etest with cefotaxime, ceftazidime
and cefepime, with and without clavulanic acid. The isolates were
subjected to PCR for screening of CTX-M genes, using universal
CTX-M primers, followed by DNA-sequencing.
Results: Of 129 analysed patients, 14 had isolates of Enterobacteriaceae
with an ESBL-phenotype. Twelve patients were colonised by only one
species with ESBL-phenotype, one patient had two (Escherichia coli
and Klebsiella oxytoca), and one was colonised by three different species
(E. coli, Klebsiella pneumoniae and Proteus vulgaris). Many patients had
repeat isolates and several subpopulations were detected during the study
period. E. coli (n = 8) was the most frequently found species, followed
by K. oxytoca (n = 4), Citrobacter spp. (n = 2), K. pneumoniae (n = 2)
and P. vulgaris (n = 1).
Four of eight patients with E. coli had ﬁndings of CTX-M genes,
belonging to CTX-M group 1 or 9. Multi drug resistance was seen among
two of these CTX-M producing isolates. One of two K. pneumoniae had
a CTX-M enzyme belonging to group 1.
K. oxytoca and Citrobacter spp. were found to harbour the chromoso-
mally encoded b-lactamases K1 and Sed1, respectively. In P. vulgaris no
CTX-M or K1 enzyme was detected.
Conclusions: The prevalence of faecal carriage of isolates with ESBL-
phenotype among patients with severe abdominal infections was 10.9%.
At admission to hospital 5.4% and 0.8% of the patients had ESBL-
producing E. coli and K. pneumoniae, respectively, in their faecal ﬂora.
These data may have implications for antibiotic treatment in abdominal
infections.
P631 Presence of extended-spectrum b-lactamase-producing
Enterobacteriaceae in the faecal ﬂora of patients from
general practice
C. Meex, P. Melin, J.D. Docquier, T. Kabasele, P. Huynen, P.M. Tulkens,
D. Giet, P. De Mol (Lie`ge, Brussels, BE)
Objectives: The aim of this study was to determine the extended-
spectrum b-lactamase-producing Enterobacteriaceae (ESBL-E) carriage
in community patients’ faecal ﬂora and to characterise the detected
ESBLs.
Methods: This study was performed at the University Hospital of
Lie`ge (Belgium). From March 2007 to June 2007, a total of 284
faecal specimens were collected from 284 patients who consulted their
general practitioner. Each sample was homogenised in 1 ml of sterile
saline and aliquots were inoculated on three different selective culture
media: ChromID ESBL agar (bioMe´rieux) and MacConkey agar +
ceftazidime (2 mg/L) and Drigalski agar + cefotaxime (1.5 mg/L).
All the Enterobacteriaceae growing on these media were identiﬁed and
tested for susceptibility by the VITEK2 (bioMerieux). The detection of
ESBL production was performed by combined double disks (ceftazidime,
cefotaxime and cefepime disks alone and a disk containing clavulanic
acid). Characterisation of these ESBLs was performed by PCR assays
targetting blaTEM, blaSHV, blaCTX-M, the most frequent ESBL genes,
followed by amplicon sequencing.
Results: Overall, 53 Enterobacteriaceae were recovered on the selective
media from 284 samples (18.7%). Among these, 25 were identiﬁed as
ESBL producers: 20 Escherichia coli, 3 Proteus mirabilis, 1 Serratia
fonticola and 1 Enterobacter aerogenes. These 25 ESBLE originated
from 20 patients (7.04%). Among the ESBL-E. coli, the following
ESBLs were found: TEM 19 (n = 1), TEM 52 (n = 4), CTX-M 1 (n = 5)
and CTX-M 15/28 (n = 2); 2 amplicons of TEM genes were not correctly
sequenced. The ESBL from the E. aerogenes was TEM 52 and those
from the 3 P. mirabilis were TEM 24. For 6 isolates, 5 E. coli and 1
S. fonticola, PCR did not demonstrate any ESBL gene of type TEM,
SHV or CTX-M.
Conclusions: (1) Out of all screened community patients, 7% were found
to be colonised in their faecal ﬂora with ESBL-E strains. (2) E. coli
accounted for the majority of ESBL-E isolates, while P. mirabilis and
E. aerogenes were in a minor proportion. No ESBL-Klebsiella sp.
was recovered. (3) Various ESBL genes were identiﬁed. (4) TEM-
and CTX-M-derived enzymes were the most frequently encountered
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ESBLs. No SHV-derived enzyme was found. (5) The study shows that
antimicrobial resistance among Enterobacteriaceae in the community
becomes a reality which should probably be taken into account in
treatment recommendations.
P632 High prevalence and diversity of extended-spectrum
b-lactamases in faecal Escherichia coli isolates of healthy
humans
L. Vinue´, S. Martı´nez, J.P. del Pozo, Y. Sa´enz, C. Torres, M. Zarazaga
(Logron˜o, ES)
Objectives: To study the prevalence and genetic characterisation of
extended-spectrum beta lactamases (ESBLs) in faecal Escherichia coli
isolates of healthy humans and to analyse the surrounding regions of
ESBL genes and its possible inclusion in integrons.
Methods: 105 faecal samples recovered from healthy humans were
seeded on Levine agar plates supplemented with cefotaxime (2 mg/L)
and were incubated at 37ºC for 24 h. One colony per sample with
E. coli morphology were identiﬁed and screened for ESBL production
by double-disk test. All ESBL-positive E. coli isolates were included
in this study. Susceptibility testing to 17 antimicrobials was performed
by disk-diffusion test and genes encoding CTX-M, SHV and TEM
type b-lactamases were analysed by speciﬁc PCRs and sequencing. The
genetic environment of blaCTX-M genes as well as the presence of
integrons and their gene cassette compositions were characterised by
PCR and sequencing. The phylogenetic group of ESBL-positive isolates
was determined by PCR.
Results: ESBL-producing E. coli isolates were detected in 7 of 105
analysed samples (6.6%). The ESBL genes found were the following
ones (number of isolates): blaCTX-M-14a (1), blaCTX-M-14b (1),
blaCTX-M-1 (2), blaCTX-M-32 (1), blaCTX-M-8 (1), and blaTEM-52
(1). The genetic environment of blaCTX-M genes were as follows: i)
ISEcp1 and IS903 surrounding blaCTX-M-14a gene; ii) IS26/ISEcp1
and orf477 surrounding blaCTX-M-1 gene; iii) ISEcp1 and orf477
surrounding blaCTX-M-32 gene; iv) blaCTX-M-14b included into the
integron In60 with dfrA16 plus aadA2 gene cassette arrangement in their
variable region; v) the surrounding region of blaCTX-M-8 gene could
not be identiﬁed. The blaCTX-M-32-positive isolate harboured a class 1
integron which included a variable region of 2000 bp. The phylogenetic
groups A, B1 and B2/D were detected in 2, 1 and 4 of our ESBL-positive
isolates, respectively.
Conclusions: A high prevalence and diversity of ESBLs are detected
in faecal samples of healthy humans, mainly of the CTX-M class. The
gene blaCTX-M-14 has been found in structures related with insertion
sequences or integrons.
P633 Characteristics of clinical extended-spectrum b-lactamase-
producing isolates from companion animals in Finland
S.D. Nyberg, K. Thomson, A. Myllyniemi, K. Pelkola, J. Jalava,
M. Rantala (Turku, Helsinki, FI)
Objective: Characterisation of ESBL-producing isolates of animal origin
in Finland.
Methods: During a 4-year period 2004–2007, clinical isolates from
animals yielded 16 Escherichia coli, seven Enterobacter sp., two
Acinetobacter sp., one Aeromonas sp. and one Klebsiella pneumoniae
non-susceptible to cefuroxime or cefotaxime. Bacterial identiﬁcation was
done with conventional biochemical methods and susceptibility testing
with microdilution or disk diffusion method. Detection of TEM, SHV,
CTX-M, and OXA genes, was performed by PCR and pyrosequencing.
Pulsed Field Gel Electrophoresis (PFGE) was used for studying the
clonal relationship of the isolates.
Results: Isolates were derived from twelve dogs, nine horses and ﬁve
cats. For one isolate the animal species was not mentioned. Seventeen
isolates were from urine, seven from wound discharge, two from vaginal
discharge and one from faeces. Nine isolates carried an ESBL-gene. A
CTX-M-1 gene was present in ﬁve isolates (4 E. coli, 1 Aeromonas
spp.), while one isolate carried a CTX-M-9 gene (E. coli). Two isolates
had an SHV-type gene (1 K. pneumoniae, 1 Enterobacter sp.), and one
Acinetobacter sp an OXA-51 gene. The PFGE-proﬁle was identical
for two ESBL E. coli isolates from two different animals, although
no regional or temporal relationship was apparent. ESBL genes were
not detected in 18 isolates, but non-susceptibilty to 3rd generation
cephalosporins suggests the presence of other mechanisms. Some of
these isolates were resistant to cefoxitin which may indicate presence of
AmpC.
Conclusion: Since isolates resistant to 3rd generation cephalosporins
have emerged in companion animals, clinical laboratories should
routinely screen bacterial isolates for resistance to these agents. Broad
spectrum cephalosporins should be used judiciously in veterinary
medicine.
P634 Prevailing occurrence of SHV-12-producing E. coli isolates
in retail raw meat samples in southern Spain
P. Egea, L. Lo´pez-Cerero, J. Rodrı´guez-Ban˜o, M.D. Navarro, Y. Doi,
A. O’Keefe, D.L. Paterson, A. Pascual (Seville, ES; Pittsburgh, US)
Introduction: Potential transfer of antimicrobial resistance from enteric
zoonotic bacteria of food animals to humans is a cause of concern.
Monitoring resistance is essential especially for important human
therapeutic antibiotics as narrow spectrum cephalosporins. Currently,
sick and healthy food animals are increasingly recognised as reservoir
of extended spectrum b-lactamases-(ESBLs)-producing E. coli. Previous
reports have focused on faecal samples from farm animals and abattoirs,
but few data are available from commercial food supply.
Objective: a study was conducted to examine ESBL-producing E. coli
(ESBLEC) in raw meat samples from Seville and to characterise their
antibiotic resistance.
Material and Methods: A total of 94 prepackaged raw meat
samples, including chicken, turkey, beef and pork, were purchased
from retail stores (large chain, wholesale and deli grocery) in Seville
from September through December 2006. After an overnight incubation
in broth medium, homogenised were subcultured on McConkey agar
supplemented with 1 mg/l cefotaxime or 1 mg/l ceftazidime. Lactose-
positive colonies were identiﬁed by standard biochemical tests. Screening
of ESBL production was done using the double disk diffusion method.
ESBL characterisation was carried out by PCR assays with group-
speciﬁc primers and sequencing. Strain relationship was studied by REP-
PCR.
Results: Twenty ﬁve samples (27%) yielded 51 unrelated ESBLEC
strains. ESBLEC was detected in chicken (13/15, 87%), turkey (7/12,
58%) and beef (1/12, 8%) and pork (4/55) (Chi2, p< 0.001). Twelve
(37%) samples from the deli grocery were positives, 9 (26%) from the
large chain and 4 (14%) from the wholesale store (Chi2, p = 0.127).
Forty three (84%) strains produced SHV-12 and they came mainly from
poultry (93%).
Conclusions: In our study a very high ESBLEC contamination was
exhibited in raw poultry for human consumption. In contrast with
previous studies, where CTX-M both M-1 and M-9 groups were the
main enzymes associated with animals and food samples, the ESBL
type predominantly detected in our area was SHV-12.
P635 Multidrug-resistant Salmonella enterica serovar Virchow
encoding blaCTX-M3 located on an IncN plasmid isolated
from Turkish food of avian origin
M.D. Avsaroglu, E. Junker, A. Schroeter, R. Helmuth, M. Akcelik,
F. Bozoglu, B. Guerra (Ankara, TR; Berlin, DE)
Objectives: Characterisation of plasmid mediated extended spectrum
cephalosporins resistance by a blaCTX-M3 in S. Virchow isolated from
Turkish Food of avian origin.
Methods: 76 chicken meat samples were collected from different
markets in Ankara, Turkey (2005–2006). All isolates were tested for
their susceptibility to 17 antimicrobial agents, and ampicillin resistant
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isolates were tested for an extra panel of 11 b-lactams. One S. Virchow
PT26 (DMC19) isolate showed a resistance phenotype typical for ESBLs.
The presence of blaCTX-M3 was detected by PCR/sequencing. The
complete resistance repertoire (resistance genes, class 1 integron and
mutations in the quinolone resistance determining regions) of this
strain was characterised by molecular methods. The strain was typed
by XbaI-PFGE and plasmid proﬁle analysis. Location of ESBLs was
determined by hybridisation assay. The plasmid was analysed by RFLP.
The incompatibility group of the plasmid was investigated according
to replicon typing by PCR. Conjugative properties were examined by
bacterial matings.
Results: The S. Virchow isolate had a multi-drug resistance
pattern of [AMP–EFT–CTX-CRO-CPD-ATM]–STR–SUL–TMP–SXT-
NAL. Together with blaCTX-M3, the strain also carried blaTEM-1-
strA/B-sul2-dfrA14 genes. A gyrATyr-87 mutation was responsible for
the NAL resistance. No qnrA, B or S genes were detected. The strain did
not possess any class 1 integron. The strain showed a common PFGE
pattern like other S. Virchow isolates. It had only one plasmid of about
45 kb, named pBD2006. The blaCTX-M3 gene was located on this
plasmid. After several intents the pBD2006 could not be transferred by
conjugation. The plasmid belongs to the IncN incompatibility group.
Conclusions: blaCTX-M3 genes located in very big plasmids (300 kb)
are wide spread among humans isolates in Mediterranean Regions. In the
present study, the gene, located on a smaller plasmid, could be associated
to food products of avian origin.
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P636 Molecular identiﬁcation and clonal dissemination of
Haemophilus haemolyticus in acute pharyngotonsillitis
N. Yamanaka, M. Hotomi, D. Billal, J. Shimada, K. Yamauchi,
K. Fujihara (Wakayama, JP)
Objectives: Bacterial infection plays an important role in the course
and pathogenesis of acute pharyngotonsillitis. Although nontypeable
Haemophilus inﬂuenzae (H. inﬂuenzae) is a human respiratory pathogen,
Haemophilus haemolyticus (H. haemolyticus), the closest relative of
H. inﬂuenzae, is considered to be a pharyngeal commensal. This study
was designed to identify H. haemolyticus separate from H. inﬂuenzae by
polymerase chain reaction (PCR). Clonal diversity of this pathogen was
also evaluated by pulsed ﬁeld gel electrophoresis (PFGE) in this study.
Materials and Methods: Clinical isolates from acute pharyngo-
tonsillitis were studied to distinguish H. inﬂuenzae (38 strains)
from H. haemolyticus (28 strains). H. inﬂuenzae and non-haemolytic
H. haemolyticus were originally deﬁned by typical colony morphology
on chocolate agar, X and V growth factor dependency, and no reaction
in the porphyrin test. Hemolysis was assessed as zones of beta-
hemolysis surrounding individual colonies grown on horse blood agar to
differentiate hemolytic H. haemolyticus. PCR primers were designed to
amplify 16S rDNA, 7F3 epitope of outer membrane protein P6 and IgA
protease gene (iga) to distinguish H. haemolyticus from H. inﬂuenzae.
Clonal diversity of H. hemolyticus was also evaluated by PFGE.
Results: H. haemolyticus was distinguished from H. inﬂuenzae by three
independent PCR sets. All strains of H. inﬂuenzae expressed the 7F3
epitope but lacked the 7F3 epitope in H. haemolyticus. The iga gene
was also identiﬁed in only H. inﬂuenzae. PCR for 16S rDNA also could
distinguish H. inﬂuenzae from H. haemolyticus. There was no clone
identiﬁed in H. hemolyticus while nontypeable H. inﬂuenzae showed
three clones.
Conclusion: H. haemolyticus is considered to be a pharyngeal
commensal. It is important to distinguish the microorganism from
causative pathogens. However, the standard methods can not reliably
distinguish H. haemolyticus from H. inﬂuenzae. The recognition that
some strains of apparent H. inﬂuenzae are H. haemolyticus is essential
to understand association of true H. inﬂuenzae with respiratory tract
infections.
P637 CagA variants in Iranian Helicobacter pylori isolates recov-
ered from patients with different gastroduodenal diseases
M. Douraghi, Z. Karimi, M. Bababeik, M. Esmaeili, M.A. Mohagheghi,
M. Eshagh Hosseini, M. Mohammadi (Tehran, IR)
Objectives: The biological activity of CagA protein is related to the
variable region of CagA containing variable numbers of EPIYA motifs.
Binding of phosphorylated CagA to SHP-2 occurs with varying afﬁnity.
CagA is subdivided to the East Asian and Western subtypes based on
its binding to SHP-2. The East Asian-type CagA binds to SHP-2 more
strongly than the Western-type CagA. Due to the high prevalence of
cagA-positive Helicobacter pylori (Hp) strains in East-Asian countries
as demonstrated in our country, assessment of the presence or absence of
cagA alone is not very informative. Consequently, CagA variants typing
in term of the subtype and number of EPIYA motifs may be important in
determination of the binding afﬁnity of CagA to SHP-2 and the clinical
relevance of cagA. The aim of this study was to characterise the CagA
variants of Iranian Hp strains.
Methods: Genomic DNA was isolated from 142 Hp strain isolated from
infected patients, followed by PCR ampliﬁcation of the variable region
of the cagA gene using cag2 and cag4 primers. Puriﬁed PCR products
were sequenced. The sequence of each resulting subtype was deposited
in the GenBank.
Results: One hundred and twenty four (87.3%) of examined isolates
were cagA positive. Six CagA variants differing in length of PCR
products were identiﬁed. Two to six EPIYA motifs were detected among
the sequenced strains. The most prevalent (59.7%) PCR amplicon
was 550bp designated as A-B-C type. All of the sequenced CagA
variable region were identiﬁed as the "Western" type. Although there
was no statistical association between any of the CagA subtypes and
gastroduodenal disease, a speciﬁc CagA subtype yielded longer PCR
product (750 bp), designated as A-B-B-B-C-C and was found exclusively
in GC patients.
Conclusion: Evaluation of the variations in the cagA variable region
seems as an effective method of screening for highly virulent cagA-
positive strains. The primary ﬁnding of our study showed that Iranian
stains have a lower binding afﬁnity to SHP-2 than other East Asian
strains. It is not unlikely that circulating of A-B-C type as the most
prevalent type in Iranian dyspeptic patients and lower binding afﬁnity
of our strains to SHP-2 result in lower frequency of gastric cancer and
peptic ulcer diseases in our population compared to other East Asian
countries.
P638 cagA/vacA genotyping of Helicobacter pylori strains isolated
from Cuban and Venezuelan patients
V. Guariglia, D. Ortiz, M. Cavazza, M. Correnti, M. Avila, B. Gutiererz,
M. Perrone, F. Megraud (Caracas, VE; Habana, CU; Bordeaux, FR)
Among the different genetic determinants involved in H. pylori virulence
we ﬁnd the citotoxin associated gene (cagA) and the vacuolating
citotoxin gene (vacA). Different studies have shown the importance of
the presence of these genes in the strain affecting a patient and the
development of a gastric disease.
Objective: The aim of the study was to determine the presence of
different H. pylori cagA/vacA genotypes among patients with gastritis
in Cuba and Venezuela.
Methods: Biopsies were taken from 61 patients from Venezuela and
from 71 patients from Cuba. Biopsies were cultured on selective media.
DNA from the biopsies was obtained using a proteinase K protocol. A
region of 349 pb of the cagA gene was ampliﬁed by PCR using the
primers F1/B1, VA1-F/VA1-R set of primers to amplify the 259 bp (s1)
or the 286 bp (s2) regions of the conserved portion of the vacA gene
and VAG-R/VAG-F set of primers to amplify the 567bp (m1) or the
642bp (m2) regions of the conserved portion of the vacA gene. All the
ampliﬁed regions were resolved on a 1% agarose gel electrophoresis at
80 volts for approximately 2 hours.
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Results: The 349pb region of the cagA gene was ampliﬁed in 34 of the
61 Venezuelan patients (56%) and in 20 of the 71 Cuban patients (28%).
We found a signiﬁcant difference (p = 0.0015) between the presence of
the cagA gene in both countries. When we analysed the prevalence of
cagA related to the allelic variants we found a signiﬁcant difference
between both countries: in Venezuela we observed a signiﬁcant higher
percentage of the genotype cagA positive/m1s1, in comparison with
Cuba (p = 0.0025). The percentage of cagA negative/m1s1 strains in
Cuba was signiﬁcantly higher than in Venezuela (p = 0.04). Out of the
71 patients from Cuba we found that in 8 of them there was co infection
with a least two different strains since we detected both m1 and m2
alleles on them.
Conclusion: We found signiﬁcant differences between the genotypes of
the strains from both countries. Since the cagA and vacA genes are some
of the virulence factors of H. pylori related to its pathogenesis and the
severity of the gastric disease, these results are of great importance to
the regional health systems of each country for the control, tracking and
prevention of gastric cancer.
Grants: FONACIT G-2005000371 / LOCTI-IBA-02–2007 and IBA-03–
2007. Inalum-Alumnware
P639 Qualitative and quantitative composition of gut microbiota
from cystic ﬁbrosis patients
J.M. Sa´nchez-Calvo, M. Garcia-Castillo, A. Lamas, M. Rodriguez-Ban˜os,
F. Baquero, L. Sua´rez, R. Canto´n, R. del Campo (Madrid, ES)
Objective: To analysed the gut microbiota of cystic ﬁbrosis (CF) patients
by classical culture-based methods and also by non-culture molecular
approaches.
Methods: Faecal samples from 18 CF-patients and also from 20 healthy
volunteers (HV) were seeded in selective agar plates including: M-
Enterococcus, manitol-salt, MacConkey, MRS, and ESBL. An additional
blood-Columbia agar plate was including in order to estimate the aerobic
bacterial concentration in faeces, and also the organims not recovered on
selective plates. Five different colonies per morphology was subculture
in the corresponding plates, and their clonal relationship was assessed
by PFGE. Antimicrobial susceptibility was tested in the different PFGE
pattern clones by agar dilution method. Total DNA was obtained
from the faeces (QuiAmp minikit, Quiagen) and quantitative-PCR
experiments were conducted in order to know the bacterial density for
the Bacteroides–Prevotella–Porphyromonas, Fusobacterium, and Lactic
Acid Bacteria (LAB) groups. PCR-DGGE was performed with universal
primers sets (V2-V3 region of 16S) and also with the described bacterial
groups.
Results: Considering the blood-Columbia agar plate, lower bacterial
charge was found in the CF faecal samples than in the HV. Curiously,
Gram-negative bacteria were not detected in CF samples, neither in
the selective mediums (MacConkey and ESBL) nor in the blood-
Columbia agar. Enterococcal and staphylococcal clones were detected
only in 10 and 9 CF patients, respectively, whereas for HV these genera
were represented in all subjects. Several LAB genera as Lactococcus,
Lactobacillus, and Pediococcus were detected in almost 50% of the
CF samples. Multirresistance to four or more antibiotic families
were corroborated in all CF isolates. Quantitative-PCR results showed
statistical differences among the density proportions of the bacterial
groups in the CF-patients versus the HV: Bacteroides–Prevotella–
Porphyromonas (6:1), Fusobacterium (1.8:1), and LAB (2:1) groups.
DGGE-experiments showed particular bands associated only to CF-
patients.
Conclusion: Qualitative and Quantitative signiﬁcant differences were
detected in the CF gut microbiota when comparing with that of HV,
being relevant the higher amounts of anaerobes in the CF faces and the
absence of Gram-negative cultivable organism. These differences can be
related with antimicrobial selective pressure and particular gut mucosal
conditions in CF patients.
P640 Serotype distributions and molecular characteristics of
Vibrio parahaemolyticus isolates in Malaysia
F. Shamsuddin, V. Nadarajah, N. Ahmad, R. Md Yasin, M. Nishibuchi,
M. Ishibashi, K.H. Ong (Kuala Lumpur, MY; Kyoto, JP)
Objectives: To determine the serotype distributions of Vibrio para-
haemolyticus isolates in Malaysian clinical isolates and to identify the
genotypic characteristics of the strains.
Methods: A collection of fourteen V. parahaemolyticus clinical isolates
from various hospitals and National Public Health Laboratory in
Malaysia from year 1997 to 2000 and 2005 to 2007 were serotyped
using commercial O and K antisera. The isolates were subjected to PCR
analysis to detect species-speciﬁc toxR gene of V. parahaemolyticus, tdh
and trh toxin genes, presence of orf8 gene and conﬁrmation of pandemic
strain by group-speciﬁc PCR (GS-PCR).
Results: From the fourteen clinical isolates, eight were serotyped
as O3:K6 making it the dominant serotype (57.14%), followed by
O4:K68 representing three isolates (21.43%) and one strain each
representing serotype O1:KUT, O3:K5 and O4:K8 respectively. All of
these isolates were positive for the toxR gene and were conﬁrmed as
V. parahaemolyticus. All the isolates were also positive for the tdh toxin
gene except for one strain of serotype O1:KUT. None of the isolates were
positive for the trh gene. Only those of serotype O3:K6 and O4:K68
possessed all genotypic characteristics of the pandemic strain, being
positive for the tdh gene and negative for trh gene, positive for the
orf8 structural gene and were also GS-PCR positive. However, the three
other serotypes were negative for orf8 gene and were GS-PCR negative.
Conclusion: This study showed that pandemic serotypes are present
in Malaysia and are represented by serotype O3:K6 and O4:K68. In
this limited number of isolates, O3:K6 and O4:K68 were shown to be
the dominant serotypes. These particular strains possessed all structural
genes of the pandemic strain which were further conﬁrmed by GS-PCR
method.
P641 Faecal prevalence and strain diversity of Listeria
monocytogenes in healthy cattle, sheep and swine herds in
northern Spain
J. Esteban, B. Oporto, G. Aduriz, R. Juste, A. Hurtado (Derio, ES)
Objectives: Although the incidence of human listeriosis is low
compared to salmonellosis or campylobacteriosis (0.88 cases per 100,000
inhabitants per annum in the last 5 years in the Basque Country),
Listeria monocytogenes is among the most important foodborne bacterial
pathogens due to the high mortality rate (20−30%) and severity of the
disease. L. monocytogenes is a ubiquitous organism that inhabits the
intestinal tract of various livestock species that act as major reservoirs
and source of human infection via faecal contamination of food products.
The aim of this study was to determine the prevalence and strain diversity
of L. monocytogenes in healthy ruminants and swine farms.
Methods: Faecal samples from 30 animals per farm were collected from
343 farms (120 ovine, 124 beef cattle, 82 dairy cattle and 17 porcine)
and screened in pools by an automated enzyme-linked ﬂuorescent
immunoassay (VIDAS® LMO2, bioMe´rieux). Positive samples were
subcultured onto the selective and differential agar ALOA and
biochemically conﬁrmed. Within-herd prevalence of L. monocytogenes
was investigated by individually analysing 50 animals from a selection of
pool-positive herds. Isolates were characterised by serotyping and ApaI
PFGE analysis.
Results: L. monocytogenes was isolated from 46.3% of dairy cattle,
30.6% beef cattle and 14.2% ovine farms, but not from swine. Within-
herd prevalences established by individual testing of 197 sheep (4 herds)
and 221 cattle (5 herds was 1.5% (0.0−4.1%) and 21.3% (5.1−72.3%),
respectively. Serotyping of 114 isolates (20 ovine and 94 bovine)
identiﬁed complex 4b the most prevalent (81.7%), followed by 1/2a
(14.0%), 1/2b (2.1%) and 4c and 4e (1.1% each). Distribution of
serotypes varied slightly among the different host species. PFGE analysis
performed on 67 isolates indicated that the L. monocytogenes population
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in Basque farms is genetically highly diverse and identiﬁed the presence
of different strains within each farm.
Conclusion: Prevalence values observed in ruminants indicate that good
management practices and control strategies at the production level are
crucial to reduce L. monocytogenes contamination in the live animal at
the primary production level before entry to the slaughterhouse to reduce
risk of human infection.
P642 Phylogenetic grouping of Escherichia coli isolates from
patients’ stool samples with diarrhoea
M. Trkov, D. Dovecar, M. Paragi, M. Grabnar, J. Ambrozˇic Avgusˇtin
(Ljubljana, SI)
Objectives: Escherichia coli is a normal inhabitant of the gut ﬂora but is
also frequently isolated in cases of infections. The population structure
of extraintestinal strains has been studied during the last decade through
the assignment of E. coli isolates to one of the four main phylogenetics
groups (A, B1, B2 and D). Since less data are available for E. coli causing
intestinal infections, the aim of our study was to assess the implication
of the genetic background of selected intestinal E. coli isolates.
Methods: 66 E. coli isolates from patients’ stool samples with diarrhoea
of unknown origin, were assigned to one of the phylogenetic groups
using the method described by Clermont et al..Virulence genes vtx1,
vtx2, eae, ipaH, eltA, and estA were detected by PCR using the “DEC
Primer Mix” produced by Statens Serum Institut, Denmark. EHEC-hlyA
was determined on enterohemolysin agar plates, Oxoid, England and by
PCR using primer pair hlyen1/hlyen2 (5′-GGT GCA GCA GAA AAA
GTT GTA G-3′/5′-TCT CGC CTG ATA GTG TTT GGT A-3′). The O
antigens were determined by using antisera produced by the Institute of
Immunology, Croatia and Siﬁn, Germany.
Results: 10, 17, 25 and 14 isolates were placed into the phylogenetic
groups A, B1, B2 and D, respectively. Serological groups found within
group A isolates were O5, O6, O15, O75 and O86. Only one of the
two O157 isolates within this group carried an eae gene. In none of
the other nine isolates vtx1, vtx2, eae, ipaH, eltA, or estA genes were
detected. To our surprise all of the 12 determined O26 isolates were
placed into group B1. All 12 isolates carried an eae gene, nine were
EHEC-hlyA positive and two carried additional the vtx1 or vtx2 gene.
The most prevalent O serological groups found within B2 phylogenetic
group were O1, O2, O4, O6, O18 and O142. One of the isolates was
O157 with a detected eae gene. 14 isolates were placed into group D.
In all of the six determined O157 isolates the eae gene was detected.
Additionally the O157 isolates carried either the EHEC-hlyA and/or the
vtx2 gene. The eae and EHEC-hlyA genes were also found in the two
O145 isolates from phylogenetic group D.
Conclusions: The majority of the O26 and O157 isolates associated
either with eae, vtx1, vtx2, or EHEC-hlyA genes were placed into the
B1 or D phylogenetic group. Thus, phylogenetic grouping could be
partially used in screening projects for a rapid assessment of potentially
pathogenic E. coli strains (EPEC and VTEC associated) in Slovenia.
P643 Ciproﬂoxacin resistance, virulence determinants and
phylogenetic background of uropathogenic Escherichia coli
isolates from general practice patients in Slovenia
J. Ambrozˇie` Avgusˇtin, A. Palandacic, M. Trkov, M. Grabnar (Ljubljana,
SI)
Objectives: Urinary tract infections are mainly caused by uropathogenic
strains of Escherichia coli. Knowledge on virulence traits and
phylogenetic background of extraintestinal (ExPEC) E. coli has increased
tremendously over the last years. Results of several studies revealed,
that human ExPEC strains mostly belong to phylogenetic group B2
followed by group D, and that quinolone-resistant ExPEC strains have
less virulence factors (VFs) than quinolone susceptible strains. The aim
of our study was to gain insight into the genetic difference between
ciproﬂoxacin susceptible and resistant strains recovered from urinary
tract infections of a random population of patients subjected to empirical
antimicrobial treatment in general pratices in the Ljubljana region.
Methods: E. coli isolates recovered from patients with symptoms of
urinary tract infections were collected and identiﬁed at the Institute
of Public Health of the Republic of Slovenia. A random sample of
44 ciproﬂoxacin resistant and 53 ciproﬂoxacin susceptible isolates,
as determined by the disk diffusion method according to the CLSI
standards, were included in the study. All isolates were placed into
phylogenetic group A, B1, B2 or D as described by Clermont et al..
The isolates were screened by PCR for 23 virulence genes, including
adhesins, serum resistance genes, toxins, invasins, and genes involved in
iron aquisition.
Results: Alltogether, 16.5%, 5.1%, 45.4% and 33% of the isolates were
placed into phylogenetic group A, B1, B2 and D, respectively. Among
the ciproﬂoxacin susceptible isolates the most prevalent group was B2
(56.6%), followed by group D (30.3%), whereas the resistant isolates
were almost equally distributed within groups D, B2 and A (36.2%,
32% and 27.3%). Virulence genes were found in both resistance groups.
However, there was an obvious difference in the distribution of kpsMTII,
usp and iroN genes, being detected in 71.7%, 30%, 67.9%, and in 43.1%,
13.6% 38.6% of the ciproﬂoxacin susceptible and resistant isolates,
respectively. The prevalence of virulence genes varied signiﬁcantly
between isolates from different phylogentic groups and also within each
group if the isolates were divided into subgroups according to the
ciproﬂoxacin resistance proﬁle.
Conclusions: Since non-B2 ciproﬂoxacin resistant E. coli isolates with
less VFs, are frequently isolated from general practice patients, they have
to be considered as important uropathogens.
P644 M serotyping of group A beta haemolytic streptococci
isolated from throat infection by emm-gene sequence analysis
from Turkey
G. Akca, N. Sultan, D. Engin, M. Yalinay Cirak, R. Olguntu¨rk (Ankara,
TR)
Objective: Following group A beta haemolytic streptoccoci related throat
infections, invasive diseases may occur due to several virulence factors
such as M protein. The purpose of this study is to determine emm types
of Turkish people suffering throat infections and investigate the relation
between M-types, sex, age and type of diseases.
Methods: 114 S. pyogenes strains were isolated from throat cultures
and identiﬁed with conventional microbiological methods (culture,
serotyping, API Strep®). emm speciﬁc PCR products of these strains
were obtained using emmP1, emmP2 primers recommended by Centers
of Disease Control. emm types of the strains were sequenced by DNA
cycle-sequencing analyse. Local and global alignments were performed
by Clustal W v1.7 software and Blast server. Phylogenetic dendrogram
was drawn. The correlation between “emm” types and sex of the patients
have been evaluated by Chi-square test statistically. The distribution of
age and “emm” types of the patients were analysed by Mann-Whitney
U test.
Results: Of the 114 strains (85%), 97 strains’ emm types were identiﬁed
as 1, 3, 4, 6, 9, 11, 12, 14, 18, 22, 24, 29, 33, 43, 48, 75, 77, 78, 89,
90, 102, 112, 118. The other 17 types could not have been identiﬁed
and accepted as nontypeable. The most frequently seen types were
emm 12, 3, 1, 75, 29 respectively which were isolated from school age
children under 10-years-old. The patients’ age distribution was found
variable but mostly accordant to emm types which were identiﬁed from
invasive streptococcal infections. It was found that there’s no statistically
signiﬁcant difference between the emm types and the sex of the patients.
Besides, 15 of emm/M types which were determined in this study,
including the most frequently seen types (emm 1, 3 and 12) were
found that they were also in the contents of M types of 26 VV vaccine
(suggested to be effective as 76.9%) developed for Group A streptococci
(GAS)
Conclusion: This preliminary study is the ﬁrst emm-gene sequence
analysis presented from Turkey which determines the M types of GAS
strains in our country. If the research can be generalised to all different
regions we will get more exactly and comprehensive results about the
M types of Turkish people.
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P645 Molecular epidemiology and pathogenesis of pneumococcal
cerebral abscesses in Scotland
D.J. Inverarity, J. Hinds, M. Diggle, G. Edwards, T.J. Mitchell
(Glasgow, London, UK)
Objectives:
• To document the molecular epidemiology of pneumococcal cerebral
abscesses in Scotland.
• To perform microarray DNA comparative genomic hybridisation
(CGH) using isolates from the commonest multi locus sequence
type (MLST) and serotype to document regions of diversity in their
genomes.
• To assess in vitro expression of virulence-associated genes from these
isolates.
Methods:
• The Scottish Meningococcal and Pneumococcal Reference Laboratory
database of invasive pneumococcal cases was searched for cases of
cerebral abscess where pneumococci had been grown from pus.
• DNA was extracted from overnight cultures at 37ºC using a phenol
chloroform extraction method. RNA was extracted from cultures in
brain heart infusion broth at 37ºC grown to an optical density at 600nm
of 0.6 using an RNeasy Mini kit (Qiagen). Fluorochrome CyTM3 or
CyTM5 dCTP (GE Healthcare) was incorporated into DNA or cDNA
as part of a randomly primed polymerisation reaction. Competitive
hybridisation against reference DNA or cDNA extracted from TIGR4
(a fully sequenced serotype 4 isolate) was performed on prehybridised
glass slide microarrays constructed by robotic spotting of PCR
amplicons. Slides were scanned (ScanArray®, Packard Biosciences)
and data analysed using Bluefuse (BlueGnome) and Genespring GX
7.3.1 (Agilent Technologies) software.
Results:
• Of 8 identiﬁed cases, 5 were male and 5 died from their disease
within 30 days of culture (overall case fatality 62%). The serotypes
seen (n = 8) were serotype 3 (37%), 4 (24%), 10A (13%), 12F (13%)
and 19F (13%). MLST data was available for 6 isolates – ST180
(50%), ST162 (16.7%), ST218 (16.7%), ST246 (16.7%).
• DNA CGH of two serotype 3 ST180 isolates suggested that gene
deletions were present in several previously recognised regions of
diversity.
• RNA expression microarray analysis identiﬁed several up-regulated,
virulence associated genes. The functions of relatively few of these
genes were known but included an iron ATP transporter – ATP binding
protein (SP0242), hyaluronidase (SP0314) and a serine protease
(SP2239).
Conclusions:
• Most cases of pneumococcal cerebral abscess in Scotland are not
preventable using existing formulations of pneumococcal conjugate
vaccine.
• A microarray approach to identify which genes are present and
expressed by pneumococci causing this condition can identify
virulence associated genes and their products which could be targeted
by alternative prevention strategies or novel vaccines.
P646 A case of cutaneous listeriosis in a man
I. Zdovc, K. Zelenik, M. Pate, J. Avbersek, M. Lusicky, B. Krt,
M. Ocepek (Ljubljana, Maribor, SI)
Objectives: In humans, listeriosis caused by Listeria monocytogenes
usually occurs in certain high-risk groups (neonates, pregnant women,
immunocompromised adults) but rarely in persons without predisposing
factors. Sepsis, meningitis and meningoencephalitis are common features
of listeriosis in humans; rare cutaneous form of the disease is linked
mainly to occupational hazards (veterinarians, laboratory workers).
A case of L. monocytogenes skin infection in a man is presented. A
54-year-old male veterinary practitioner developed pustular changes on
the skin of arms and hands after assisting the delivery of stillborn calf.
During the parturition one of his gloves tore and he continued with
exposed hands. He suspected the bacterial infection to be the cause
for stillbirth therefore he took a sample of placenta and sent it to
the laboratory for bacteriological examination. Later, pustular changes
developed on his skin; the swabs were taken for bacteriology and
L. monocytogenes was isolated. The patient was treated successfully with
amoxicillin and clavulanic acid.
Methods: Cultivation, identiﬁcation, serotyping and genotyping of the
strains from pustulae and placenta were performed. As a genotyping
method, pulsed-ﬁeld gel electrophoresis (PFGE) was used and performed
following the CDC standardised PulseNet protocol for L. monocytogenes
using restriction endonucleases AscI and ApaI. The genotyping results
were analysed using BioNumerics software (Applied Maths).
Results: Pure cultures of small haemolytic colonies suspicious of
Listeria spp. were grown after 24h incubation on sheep blood agar
from all specimens. The colonies were identiﬁed as L. monocytogenes
with biochemical kit API Listeria (BioMerieux). Serotyping resulted
in serotype 4b in all isolates. The cleavage of the DNA with both
AscI and ApaI exhibited identical PFGE restriction patterns of all
strains suggesting the zoonotic transmission of the infection with
L. monocytogenes.
Conclusion: To the best of our knowledge, this is the ﬁrst case of
cutaneous listeriosis where the evidence for zoonotic transmission of
L. monocytogenes was supported by genotyping methods.
P647 Phylogenetic analysis of genus salmonella based on
polyphasic and numerical taxonomy
M. Tajbakhsh, K. Motavaze, B. Noori nayer, M. Chiani, M. Zali
(Tehran, IR)
Objective: The genus Salmonella is a member of the family
Enterobacteriaceae. There are over 2500 serotypes of this genus based
on antigenic differences associated with gasteroenteritidis and enteric
fever (typhoid) in human. The division of Salmonella into seven major
groups has been conﬁrmed by sequence analysis of house keeping, 16S
rRNA and invasion genes.
In this study two method of phylogenetic relationship were used.
Sequencing method of 16S rRNA and gyrB used to polyphasic taxonomy
and RAPD-PCR were used to numerical taxonomy.
Method: Fourty and thirty six strain which isolated from clinical samples
were used to sequence and RAPD-PCR analysis respectively. After
serotyping their DNA were extracted by phenol chloroform method and
PCR ampliﬁcation and RAPD-PCR were done by universal, sequencing
and random primers.
At last PCR products run on agarose gel 1.2% and staining with Ethidium
Bromide.
Sequencing results analysed by Clustal X, DNA Star, BioEdit, MEGA4
and RAPD-PCR results was analysed by NTSYS 2 softwares.
Result: The similarity with 16S rRNA gene sequence99.7%, 23S rRNA
98.4–100%, gyrB 97.2−99.8% and amino acid sequence of gyrB 99.8–
100% were obtained.
According to the results, 16S rRNA sequences showed poor separation
at or below species level. 23S rRNA gene sequence data was better
than 16S rRNA to analyse differentiation at the species, subspecies
level. The gyrBgene (topisomerase type II) is useful to analyse closely
related species at subspecies and serovar level. It was observed that gyrB
separation is better than 23S rRNA sequences.
The results of RAPD-PCR were defferent. Based on the primer similarity
patterns were different, but the average of them observed between
70−89%.
Conclusion: RAPD-PCR results showed that this method is useful to
analyse similarity between several serotypes of Salmonella. It is not
suitable to Identify unknown isolates according to the genetic pattern of
RAPD-PCR.
In contrast of sequencing method this technique is cheap and easy, but
it’s resolution and sharpness less than sequencing method.
So sequencing method is the best for characterisation and identiﬁcation
of Salmonella’s strains for epidemiology and phylogenetic study. A large
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number of groups within Bacteria can deﬁne and distinguished from each
other by this method.
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P648 The carriage population of Staphylococcus aureus from Mali
is composed of a combination of pandemic clones and the
divergent genotype ST 152
R. Ruimy, A. Maiga, L. Arman-lefevre, I. Maiga, A. Diallo,
A. Koumare, S. Koumare, K. Wattara, A. Andremont, E.J. Feil (Paris,
FR; Bamako, ML; Bath, UK)
Objectives: To characterise a sample of Staphylococcus aureus isolates
from asymptomatic carriage in Mali, Africa, and to compare the results
to the known diversity of the carriage population in order to evaluate the
role of microepidemic and pandemic clonal spread in shaping S. aureus
population structure.
Methods: Nasal swab was performed in 448 patients admitted for
emergency surgery to a single hospital point G in Bamako. S. aureus
isolates were characterised by multilocus sequence typing and the results
compared against the entire MLST data set and a previous study of
carriage isolates from the UK. We used a combination of eBURST and
phylogenetic approaches to analyse the data.
Results: Prevalence of nasal S. aureus carriage was 19.6% (n = 88).
Carriers differed from non carriers for gender (51% vs 35%) and for
mean age (41 vs 51.6) (p< 0.05) but not for chronic health status and
previous hospitalisation. Only one isolate was meticillin resistant. Of the
87 meticillin susceptible isolate, 97% were resistant to penicillin, 6% to
erythromycin and 74% to tetracycline. The 88 isolates characterised by
MLST were found to correspond to 20 STs. Eighteen of these STs were
present in the MLST database and two STs were new. No new alleles
were detected. Seven of the 20 STs (ST5, ST8, ST15, ST30, ST88,
ST152, ST291) were found in at least 4 strains, 4 of the STs (ST1,
ST101, ST120, ST852) were found in 2 or 3 strains, and 9 of the STs
corresponded to only a single isolate. We note the presence of many
of the commonly recorded S. aureus clonal complexes in the Malian
carriage population (CC15 (28%), CC8 (8%), CC5 (7%), CC30 (4.5%),
CC88 (4.5%), CC45 (3%), CC121 (2%)) but also a high frequency
(~24%) of the previously rare genotype ST 152.
Conclusion: Our results conﬁrm the pandemic spread of many S. aureus
clonal complexes, an observation which challenges purely neutral
hypotheses regarding their origin and maintenance. In contrast, the high
prevalence of ST 152 demonstrates that microepidemic transmission may
also be important, and that much of the diversity of S. aureus population
remains to be uncovered.
P649 Frequency, molecular typing and association with clinical
disease of Staphylococcus aureus Panton-Valentine leucocidin
positive isolates in a tertiary hospital
E. Vagiakou, G. Ganteris, S. Vourli, M. Orfanidou, A. Vatopoulos,
H. Malamou-Lada (Athens, GR)
Objectives: To evaluate the frequency, the molecular typing and the
association with clinical disease of S. aureus carrying Panton-Valentine
leucocidin (PVL) from hospitalised and outpatients during 22 months
(1/2006−11/2007)
Methods: During the study period 405 S. aureus strains were isolated
from soft tissue abscesses, purulent skin infections and nasal swabs
obtained from hospitalised and outpatients. S. aureus strains were
identiﬁed by conventional methods and automated system VITEK2
(bioMerieux). The antibiotic susceptibility testing was performed by disk
diffusion agar method and the determination of MICs by VITEK2. PVL
genes (lukF-PV, lukS-PV) and SCCmec types were determined by PCR,
while the genotypes of the isolates were investigated by pulsed ﬁeld gel
electrophoresis (PFGE)
Results: A total of 405 S. aureus strains were isolated from different
patients (312 from hospitalised and 93 from outpatients). MRSA strains
were 228 out of 405 (56.3%). Especially 61.5% (192/312) MRSA strains
were recovered from different wards of the hospital and 39.8% (37/93)
from outpatients. PVL+ strains represented 9.6% (39/405) of the isolated
S. aureus strains (38 community acquired (CA) and only one hospital
acquired) while PVL+ strains represented 16.7% (38/228) of the isolated
MRSA. All of the CA MRSA strains were PVL+ (37/37, 100%) and
one MRSA PVL+ strain was isolated from nosocomial infection (1/192,
0.5%). One MSSA PVL+ was isolated from an outpatient. The origin of
PVL+ strains was: abscesses (25), nasal carriage (7), furunculosis (3),
cerebrospinal ﬂuid (CSF) (1), cellulites (1), pyomyocitis (1), peritoneal
catheter (1). All of the MRSA and MSSA PVL+ strains were SCCmec
type IV by PCR, while 13 PVL+ strains were also investigated by PFGE
and showed only one clone ST80. All the MRSA PVL+ isolates were
resistant to oxacillin (OXA), kanamycin (KA), tetracycline (TE) and
intermediate susceptible to fucidic acid (FA).
Conclusions:
1. In our hospital the prevalence of S. aureus PVL+ strains was
approximately 10%, while the prevalence of the MRSA PVL+ strains
was approximately 17%
2. All CA MRSA and one CA MSSA strain were PVL+ SCCmec type
IV and 13 of them were genotyped as ST80
3. One MRSA PVL+ strain was isolated from CSF of a hospitalised
patient with clinical signs of meningitis
4. The MRSA PVL+ strains had the same unique resistance pattern to
antibiotics (resistance to KA, OXA, TE and intermediate resistance
to FA)
P650 PVL(+) MRSA causing infections in hospitalised patients
A. Wong-Beringer, M. Lee, J. Yamaki, K. Shriner (Los Angeles,
Pasadena, US)
Objectives: Concerns for Panton-Valentine leukocidin (PVL) producing
community-associated (CA) MRSA strains overtaking healthcare-
associated (HA) infections and the potential for severe infections in
association with PVL expression level have led us to determine 1)
molecular epidemiology, 2) disease spectrum, and 3) correlation of
disease severity with PVL gene expression level in hospitalised patients
infected with PVL(+) MRSA strains.
Methods: 186 MRSA isolates obtained from patients during 7/05−6/07
were saved for molecular characterisation while medical charts of
patients were reviewed for relevant demographic, laboratory, and clinical
data. We screened all isolates for the presence of lukS-F gene by
PVL Evigene® test (AdvanDx, Woburn, MA: a qualitative nucleic
acid hybridisation assay for research use only). Using published
protocols, PCR typing for SCCmec types (I-IV), USA300;ST8 and PVL
transcripts by reverse transcriptase-PCR using SYBR green with primer
speciﬁc for lukF gene were performed on a subset of strains. MRSA
NRS384 (PVL(+) USA300;ST8, SCCmec IVa) and NRS22 (PVL(−),
USA600;ST45, SCCmec II) strains served as positive and negative
controls respectively.
Results: PVL(+) strains caused 45% (83/186) of MRSA infections in
hospitalised adults; 54% were HA per clinical criteria. 96% of PVL(+)
strains (52/54) belong to USA300 and 85% (46/54) carried SCCmec
type IV cassette. CA-infections were 92% cellulitis +/− abscess plus
1 necrotising fasciitis. HA-infections were more likely to be invasive
(pneumonia, bacteraemia) than CA (53% vs 5%, p< 0.05), with 60%
from nursing home residents. Patients with HA compared to CA
infections were older (mean age: 68 vs 48y, p< 0.0001) with higher
APACHE II score (12.3 vs 3.4, p< 0.0001). Of the PVL(+) isolates
tested (n = 61), pvl transcript levels ranged from 0 to 8.9 fold higher
than control strain. When grouped based on level of pvl gene expression,
strains with 2-fold higher mRNA levels vs 0−2 fold relative to control
strain were more frequently CA (57% vs 43%) and less likely to cause
invasive infections (43% vs 55%) such as pneumonia (7% vs 32%).
Conclusion: Over half of the USA300, SCCmec IV, PVL(+) strains
caused healthcare rather than community-associated MRSA infections
in adults, with the predominant place of acquisition in the nursing home.
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PVL expression levels vary widely among clinical isolates; high PVL
expression levels do not predict invasive disease.
P651 Gastro-intestinal carriage of MRSA in patients with
community-acquired diarrhoea
N.K. Cope, J. Smullen, K.G. Kerr, A.M. Snelling (Harrogate, Bradford,
UK)
Objectives: There is increasing concern about cases of infection with
meticillin resistant Staphylococcus aureus (MRSA) in the community,
but comparatively little work has been done on reservoirs for MRSA
outside the hospital. Since S. aureus has the potential to colonise the gut
and may be enterotoxigenic, we sought to determine the prevalence of
MRSA in diarrhoeal samples originating from the community.
Methods: During a year-long survey, faecal samples from non-
hospitalised patients submitted for standard investigation of diarrhoeal
symptoms were also screened for S. aureus by the diagnostic laboratory.
Samples were cultured on mannitol salt agar at 37ºC in aerobic
conditions for 48 hours. S. aureus isolates were identiﬁed by latex
agglutination and DNAse activity, and MRSA were conﬁrmed by
resistance to cefoxitin.
Results: Of 2624 faecal samples investigated, 405 (15.4%) tested
positive for the presence of S. aureus. Of these, 384 (14.6% of all
samples) yielded meticillin sensitive S. aureus (MSSA) and just 21
(0.8%) yielded MRSA. The latter originated from patients aged 3
months to 95 years and 15 (71%) of these had no previous history of
colonisation or infection with MRSA. However, the majority, (16/21 or
76%) of the MRSA isolates came from patients aged over 75 years. The
overall carriage rate of MRSA in stool samples from non-hospitalised
individuals aged over 75 years, with diarrhoea was 11% (16 of 144
specimens). This compares to an MRSA gastrointestinal prevalence of
7.6% amongst elderly patients with nosocomial diarrhoea in our hospital
over the same time period.
Conclusion:MRSA colonisation is a risk factor for subsequent infection.
This study has demonstrated that the gastrointestinal tract can be a
signiﬁcant reservoir of MRSA in the over 75s living in the community,
and it is possible that strains are being disseminated via diarrhoeal
episodes. This has consequences for control of MRSA in the community,
where emphasis is often placed on controlling just nasal and skin
colonisation. Further studies of faecal MRSA are warranted, including
their enterotoxin status and risk factors for gastrointestinal colonisation.
P652 Prevalence of and risk factors for colonisation with
meticillin-resistant Staphylococcus aureus at the time of
hospital admission
A. Antoniadou, F. Pliarchopoulou, D. Plachouras, E. Karaiskos,
S. Atmatzidou, K. Protopapas, S. Tsikrika, K. Kouvelas, E. Moschona,
S. Athanasia, A. Zaﬁraki, E. Papadomichelakis, H. Giamarellou
(Athens, GR)
Objective: To determine the prevalence of MRSA colonisation
among patients presenting for hospital admission, its correlation with
community-acquired MRSA (CA-MRSA) prevalence and to identify risk
factors for MRSA colonisation
Methods: In a tertiary teaching hospital, surveillance cultures from the
nares, axilla and inguinal areas were performed at the time of admission
for all patients except those admitted in the oncology and hematology
unit. Demographic information and possible risk factors for colonisation
were also recorded.
Results: Swab samples were collected from 937 patients presenting
for admission in a year. Patients lived in urban areas in 87%, had
a mean age of 57years (median 63) and a female to male ratio of
1.1:1. Staphylococcus aureus was isolated from 142 (15.1%) patients
and MRSA from 30 (3.2%) of the patients (20% of colonising isolates).
Detection of colonisation was 88.7% in the nares, 40.8% in the
axilla and 51.4% in the inguinal area. In 3 (2.7.%) and 7 (4.9%)
colonisation was only evident in the axilla and inguinal area respectively.
All colonising MRSA isolates exhibited in their sensitivity tests the
pattern expected for CA-MRSA with the majority of them sensitive
to cotrimoxazole, clindamycin, minocycline, rifampin and quinolones.
Interestingly tetracycline and fucidic acid were inactive in the majority
of strains. In the multivariate analysis comparing MRSA-colonised to
MSSA-colonised patients, independent predictors of MRSA colonisation
were: age <50 (p = 0.017), the presence of an indwelling urinary catheter
(p = 0.036), the absence of hospitalisation the preceding year (p = 0.02)
and the presence of skin disease (p = 0.009).
Conclusion: Colonisation with MRSA of patients admitted to the
hospital is low and probably reﬂects the prevalence of colonisation with
CA-MRSA in the community. Risk factors for MRSA acquisition do
not correlate with previous contact with healthcare facilities but with
younger age, skin diseases (affecting skin integrity) and debilitating
conditions (as expressed by the presence of an indwelling urinary
catheter). Larger sample of data may be required to further explore risk
factors associated with MRSA colonisation in the community.
P653 Identiﬁcation of the transmission vectors of Staphylococcus
aureus circulating in a neonatal intensive care unit
T. Conceicao, M. Aires de Sousa, R. Barroso, E. Paulino, L. Sancho,
M. Brito, J. Garrote, H. Carreiro, M. Machado, H. de Lencastre
(Oeiras, Lisbon, PT; New York, US)
Objectives: The neonatal intensive care unit (NICU) of Hospital
Fernando Fonseca, Lisbon, Portugal assists an average of 450
newborns/year and employs 100 healthcare workers (HCW).
Previous reports revealed that in 2002, 22% of the infections at the NICU
were due to staphylococci. Identiﬁcation of the reservoirs and routes of
transmission of these microorganisms is a matter of major concern.
Methods: Between July 2005 and June 2007, 10 infection episodes
occurred at the NICU. Staphylococcus aureus isolates were recovered
during each episode from the infected babies, from nasal swabs of
parents and HCW that had contact with the babies, and from the
environment. The isolates were characterised by PFGE, spa typing and
multilocus sequence typing. Virulence determinants were detected by
multiplex PCR.
Results: All but one of the 10 infection episodes (chronologically
designated I to X) included a single infected baby. None of the
30 S. aureus strains recovered was resistant to meticillin. Molecular
characterisation distributed the 30 MSSA isolates into eight PFGE
patterns (A to H). The majority of the isolates (n = 20, 67%) belonged
to two major clones: A (spa type t1228 and ST5, n = 11) and B (t012
and ST30, n = 9). Although none of the isolates was PVL positive, all
except PFGE pattern B strains were positive for LukE-LukD and gama-
hemolisin variant determinants.
In two episodes, isolates belonging to the same PFGE type, but a
different subtype, were recovered from both a baby and a HCW (A1,
A2 in episode II and B4, B5 in episode X, respectively). No identical
isolates from babies and parents and/or environment were found in the
same episode. Nevertheless, a HCW isolate from episode II showed the
same PFGE subtype (B1) of the babies’ isolates in episodes I and VII and
a similar type with isolates from babies in episodes VI (B3) and X (B4).
However, no direct contact was reported between the four infected babies
and this HCW. In addition, in episode VIII the baby was infected with
the same strain (PFGE A3) recovered from a HCW and the environment
in two anterior episodes (III, VI).
Conclusions: Our data suggests that a S. aureus transmission route could
be traced between a HCW and the babies in two infection episodes
(II and X). Highly related isolates belonging to two major clones
were periodically recovered during epidemiologically unrelated infection
episodes, which might indicate that these strains are endemic at the
NICU.
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P654 The search and destroy strategy does prevent spread and
long-term carriage of MRSA; results from household
screening following a ST22 (E-MRSA 15) outbreak
S. Bo¨cher, M. Knudsen, C. Reese, H. Høgsted, P. Schouenborg,
R.L. Skov (Copenhagen, Vejle, DK)
Objectives: From November 1, 2002 to December 31, 2005 440 persons
were infected/colonised with MRSA ST22 during a hospital outbreak in
Vejle County, Denmark.
This study was made to deﬁne the carriage rate, treatment outcome and
spread of MRSA in households of previous ST22 infected/colonised
patients and hospital staff.
Methods: The household visits were carried out from December 2006
to March 2007 and included samplings from all household members
and pets as well as from the environment. Household members were
sampled from nose, tonsils, urine and skin lesions; pets were sampled
from nose, anus and skin lesions; and the environment from telephone,
favourite chair, toilet ﬂush handle, TV remote control and skirting board
by the bed. Swabs (Regular ﬂocked swabs, Copan, Italy) from human
and animal samples were incubated in TSB (SSI diagnostics, Denmark).
PCR positive broths were sub-cultured on blood agar (SSI) for ﬁnal ID
and susceptibility testing.
Urine samples were cultured on Chromogenic MRSA agar (Oxoid,
UK). Environmental sampling was performed with Biotrace Dipslides
(Biotrace, UK). Isolates suspected to be MRSA were conﬁrmed and
typed using mecA, SCCmec and spa PCR.
Following household visits, MRSA positive households received cleaning
instructions, MRSA eradication treatment and follow up according to
local MRSA-guidelines.
Results: Samples were obtained from 102 out of 251 households; 88
(45%) patients, 15 (27%) hospital staff, plus 45 relatives of patients, 22
relatives of hospital staff and 31 pets. 20 MRSA positive persons were
identiﬁed; 16 patients (15 ST22, 1 ST5) and 4 patient relatives (2 ST22,
2 ST5). All households of hospital staff were negative. The 31 pets from
23 households were also negative. MRSA was found in tonsils (80%),
nose (74%), and in urine (16%); from catheterised patients only. MRSA
was found in the environment of 4 presently positive, long-term MRSA
ST22 carriers. 88% of the positive patients had previously received
MRSA treatment. After re-treatment 4 patients were still positive: 2 with
catheter, 1 with ﬁstulas and 1 with alcohol abuse. The mean follow-up
time was 11 months.
Conclusion: Follow-up on 103 previously MRSA ST22 positive
patients/hospital staff showed that 20% of patients were positive;
following re-treatment 95% were MRSA negative. The environment was
a possible reservoir for re-colonisation in households of long-term and
present carriers. No pets were found positive for MRSA.
P655 Meticillin-resistant Staphylococcus aureus in young dogs and
their owners
M. Corrente, M. D’Abramo, F. Latronico, G. Greco, M. Marinaro,
V. Martella, C. Buonavoglia (Valenzano, Rome, IT)
Objectives: An outbreak of neonatal mortality in dogs by a Meticillin-
resistant Staphylococcus aureus (MRSA) is reported and the possible
role of the owners as reservoirs of the infection is evaluated.
Case presentation and results: A female boxer at the ﬁrst pregnancy
gave birth to 12 pups without post-partum complications. As the
dam developed agalactia, the pups were fed with artiﬁcial milk. The
entire litter died within 10 days with signs of severe septicaemia.
The bitch was living with a male boxer and both the dogs tested
negative by seroagglutination for Brucella canis. One pup was sent to
the laboratory for necropsy. Multifocal haemorrhagic lesions in various
organs were observed. Tissue samples from the organs were subjected
to investigations for viral and bacterial pathogens. By PCR, the samples
tested negative to Canine Herpesvirus and Canine Parvovirus type 1. By
bacteriological analysis, a strain of S. aureus was isolated in purity from
heart, liver, spleen and kidney of the pup. The strain was found to be
Meticillin resistant by a PCR assay speciﬁc for the mecA gene.
In order to investigate the source of the infection by MRSA,
bacteriological analysis was extended to the dogs and persons living
in the household. Swabs from several parts of the body were taken from
the parents of the pups, from the 2 owners (a man and his wife), and
from a relative, a woman who occasionally looked after the animals. The
man and this woman worked as medical attendants of the same hospital.
From all the samples MRSA was isolated, for a total of 17 strains.
The strains exhibited the same pattern of antimicrobial susceptibility,
being resistant to more than 3 classes of non-b-lactams. All the strains
possessed the staphylococcal chromosome cassette mec (SCCmec) II and
lacked the Panton valentine leucocidin (PVL) genes. In addition, they
displayed the same pulsotype, thus suggesting a clonal origin.
Conclusion: From dogs and humans living in the same household a
single MRSA clone was isolated displaying typical pattern of HA-MRSA
(multidrug resistant, SCCmec II type and PVL negative). Since two of
the persons were medical attendants in a hospital, and the dogs had
no contact with other animals or persons, we hypothesise that a MRSA
clone spread from the hospital and got adapted to the household, causing
a fatal infection in the pups.
P656 Prevalence of meticillin-sensitive and resistant S. aureus
nasal colonisation in healthcare workers in a tertiary hospital
V. Spyropoulos, H. Moraitou, M. Makarona, F. Havouti, N. Tsagarakis,
D. Kalikantzaros, N. Lolis, S. Kanavaki (Athens, GR)
Objectives: The aim of this study was to establish the rates of nasal
carriage in medical and nursing personnel of a tertiary care Hospital
for both meticillin-sensitive (MSSA) and resistant (MRSA) S. aureus,
in order to perform infection control measures, if necessary. The MRSA
strains isolated were further tested by PCR for the presence of mecA
and pvl genes.
Methods: A total of 220 nasal swabs were taken from 111 healthcare
workers participating in the study, of which 43 were medical (21
ICU clinicians and 22 medical microbiology doctors) and 68 non-
medical staff (34 nursing and 34 laboratory personnel). All swabs were
cultured onto Columbia Blood agar (Oxoid, UK) and ChromID MRSA
agar (Biomerieux, France). All unique-patient S. aureus isolates were
identiﬁed by VITEK2 automated system and were further tested for
antibiotic susceptibility by both VITEK2 system as well as Kirby-Bauer
disk diffusion method. All S. aureus isolates were further tested for the
presence of mecA and pvl genes by PCR (Genotype Staphylococcus,
Hain Germany).
Results: In total, the prevalence of S. aureus nasal carriage was 18.0%.
MSSA carriage was 12.6% and MRSA 5.4%.
MSSA prevalence was 11.6% (5/43) among medical personnel and, in
particular, 9.1% (2/22) for laboratory doctors and 13.6% (3/21) for ICU
clinicians. MSSA prevalence among non-medical staff, was 13.2% (9/68)
and in particular, 17.6% (6/34) for laboratory personnel and 8.8% (3/34)
for ICU nursing personnel.
MRSA prevalence was 4.7% (2/43) among medical personnel, and
in particular, 4.5% (1/22) for laboratory doctors and 4.7% (1/21) for
ICU clinicians. MRSA prevalence among non-medical staff was 5.9%
(4/68), 0% for laboratory personnel and 11.8% (11/34) for ICU nursing
personnel.
All MRSA strains were found positive for mecA gene, by PCR, while
only one strain was found to be pvl positive (5%, 1/20).
Conclusion: The prevalence of MSSA as well as MRSA nasal carriage
is within the expected rates, as commonly mentioned in the literature.
The highest MSSA rates were found among non-medical laboratory
staff, while, the highest MRSA rates were found among ICU nursing
personnel. Among medical personnel, the prevalence rates were similar,
for both MSSA and MRSA. This study is a part of an ongoing
epidemiological surveillance conduced in our Hospital, in order to
eliminate MRSA carriage.
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P657 Meticillin-resistant Staphylococcus aureus nasal carriage in
an army recruits population: prevalence and genotyping
U. Demirpek, T. Haznedaroglu, M. Ozyurt, B. Bozdogan (Ankara,
Istanbul, Aydin, TR)
Objective: Although MRSA strains are strictly related to hospital
setting community-acquired meticillin-resistant Staphylococcus aureus
(CA-MRSA) is emerging worldwide. MRSA carriage is important for
dissemination of CA-MRSA infections. The aim of this study was to
determine the prevalence of MRSA nasal carriage among army recruits
who are from different geographic areas of the country.
Methods: A total of 4843 army recruits were examined by nasal
cultures. Staphylococcus aureus strains were characterised and identiﬁed
by conventional methods. Antimicrobial susceptibilities were tested by
disk diffusion method and all MRSA strains were typed by SCCmec
and PFGE. Potential risk factors for colonisation have been noted down
using a questionnaire; such as admissions to hospital, antibiotics usage,
hometown, educational level, annual salary, job.
Results: Staphylococcus aureus strains were isolated from 552 (12%) of
4843 participants. Seven out of 552 S. aureus were resistant to meticillin.
Overall community-associated MRSA carriage rate was 1.3%. Presence
of mecA gene was conﬁrmed in all 7 strains by mecA PCR. SCCmec
typing and PFGE typing showed that 5 isolates were type III and A
pulse-type, and the remaining 2 strains were type II and B and C pulse-
types. The cases are found out to be admitted to hospital and/or used
antibiotics.
Conclusion: MRSA is emerging in community level. Army is one of
the risk group for MRSA dissemination and infection. The carriage level
was 1.3% similar to carriage rates in previous studies from Turkey. The
major A clone obtained from 5 of 7 soldiers were related to a hospital
clone in a military hospital in the same area. Large scale studies should
be done to evaluate presence a CA-MRSA clone other than hospital
clones.
P658 Genotypic characterisation of Staphylococcus lugdunensis
F. Laich, N. Batista, M. Lara-Pe´rez, E. Pe´rez-Roth, B. Rivero-Pe´rez,
S. Me´ndez-A´lvarez (S/C de Tenerife, ES)
Background: Staphylococcus lugdunensis is a coagulase-negative
staphylococcal species. Until the 90s, association of these bacteria to
human pathogenic processes was considered a rare clinical event but
during last years infections by this agent have considerably increased
and now it has to be considered as a possible cause of breast
abscesses, peritonitis, infected joint prostheses, osteomyelitis, discitis,
septic arthritis and pacemaker infections.
Objectives: The main goal of this study was to perform the genotypic
characterisation of S. lugdunensis clinical isolates recovered by the
Microbiology Service of the Hospital Universitario Ntra. Sra. de
Candelaria (Tenerife, Spain) during an eight year surveillance period
(1999–2007).
Methodology: Seventy-ﬁve isolates recovered from 70 patients were
ﬁrstly identiﬁed by classic microbiology biochemical and phenotypic
methods. Identiﬁcation was then conﬁrmed by sequencing 16S rDNA
and rpoB genes encoding the beta-subunit of RNA polimerase. After
identiﬁcation, each isolate was analysed by the following methods:
(i) Multiplex PCR (MPCR) detection of the genes mecA and ileS-2,
encoding meticillin and high-level mupirocin resistance, respectively;
(ii) PCR ampliﬁcation of the ribosomal internal spacer transcript
(ITS-PCR), and (iii) Pulsed-Field Gel Electrophoresis macrorestriction
patterns (RFLP-PFGE).
Results:MPCR ampliﬁcation of the genes mecA and ileS-2 was negative
for all the 75 isolates. ITS-PCR patterns permitted to distinguish 18
different genotypes, being types D and E the two major ones constituting
the 25.3 and 18.6% of the isolates, respectively. The RFLP-PFGE
analysis showed higher discriminative power than ITS-PCR and allowed
to distinguish 34 genotypes. PFGE type 11 was the one including the
higher number of isolates (8, 10.6%).
Conclusions. This study permits to conclude the existence of a high
genotypic diversity within the species S. lugdunensis. We may conclude
that the heterogeneity observed is greater than previously reported.
P659 Non-invasive coagulase negative staphylococci: population
variability and meticillin resistance
N.A. Faria, D.C. Oliveira, H. Lencastre, H. Westh (Oeiras, PT; New
York, US; Copenhagen, DK)
Objectives: Staphylococcal chromosomal cassette mec (SCCmec) is a
large heterologous mobile genetic element carrying the mecA gene.
This gene is the central element of meticillin resistance (MR) in
staphylococci and has largely been studied in Staphylococcus aureus.
The origins, reservoirs and dissemination routes of SCCmec elements are
not well understood, although their elucidation might improve infection
control measures targeting reduction of b-lactam resistance. For that
purpose, it is necessary to characterise SCCmec elements circulating in
staphylococci other than S. aureus, both in the hospital and community
settings.
Methods: Five-hundred and twenty eight non-invasive coagulase neg-
ative staphylococci (CNS) were collected among 67 Danish volunteers
from three different patient groups: (i) children  2 years; (ii) patients
from a Dermatology department; and (iii) patients previously identiﬁed
as community-onset MR S. aureus (CO-MRSA) carriers. Susceptibility
tests for a panel of eight antibiotics were performed using disc diffusion.
Internal transcribed spacer PCR (ITS-PCR) was performed in order to
conﬁrm VITEK2 identiﬁcation and to clarify unspeciated isolates.
Results: MR-CNS was found associated to patients from the derma-
tology department and to children  2 years (50% resistant isolates
in these groups versus 4% MR-CNS isolates in CO-MRSA carriers).
Fifteen different species were identiﬁed among the 528 CNS, out of
which 15 (3%) could not be identiﬁed by VITEK2. ITS-PCR was useful
for the speciation of more exotic CNS isolates.
Conclusion: Resistance patterns showed that reservoirs of MR-CNS
were associated with patients with hospital contact rather than CO-
MRSA patients. In addition, the reservoirs of SCCmec elements among
CNS isolates were more diverse than expected, since MR was observed
in 11 of the staphylococci species recovered: S. epidermidis (40%),
S. haemolyticus (74%), S. hominis (42%), S. saprophyticus (44%),
S. simulans (20%), S. xylosus (25%), S. warneri (4%), S. capitis (45%),
S. cohnii (50%), S. caprae (14%), and S. kloosii (20%). The ongoing
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characterisation of the SCCmec elements in this collection will help
to elucidate the genetic relationships and dissemination routes of these
mobile genetic elements between S. aureus and CNS isolates and among
CNS isolates.
P660 MRSA carriage in healthcare personnel in contact with farm
animals
M.W.H. Wulf, E. Tiemersma, J. Kluytmans, A.C.A.P. Leenders,
J. Berkhout, A. Voss (Veldhoven, De Bilt, Breda, Den Bosch, Venlo,
Nijmegen, NL)
Objective: In the Netherlands, veterinarians in contact with pigs and
pig farmers were found to have a higher risk of meticillin resistant
S. aureus (MRSA) carriage than the general population. Isolates of
closely related spa-types, corresponding to MLST type ST398 were
found in pig farmers, pig veterinarians and pigs. The objective of this
study was to investigate if contact with pigs and veal calves or other
livestock is a risk factor for MRSA carriage in Dutch healthcare workers
(HCW).
Design: Healthcare workers in four general hospitals and one university
hospital were asked to ﬁll in questionnaires about contact with animals
and take MRSA cultures of their throat and nares. Cultures of all HCW
in contact with livestock were processed and for each HCW in contact
with pigs or veal calves, screening cultures from a minimum of two
HCW with no contact with livestock were processed.
Results: 77 of 1721 HCW (4.4.%) reported direct or indirect contact
with pigs and/or veal calves, 145 reported contact with other livestock
animals. Two MRSA-positive HCWs were found; one in contact with
veal calves and one in the control group. The MRSA carriage rate in
the group in contact with pigs and veal calves was 1.7% (95% CI,
0.07%-8.0%) and in the control group (category 3) 0.15% (95% CI,
0.01−1.0%). No carriers were found among HCW in contact with other
livestock (95% CI 0−3.2%).
Conclusions: An estimated 3% (CI 2.6−4.1%) of hospital staff working
in Dutch hospitals with a rural adherence region belong to a high risk
group for MRSA carriage according to the Dutch guidelines. While
MRSA carriage in HCW in contact with livestock is higher (10-times)
than in other HCW the difference is not statistically signiﬁcant.
Networks for surveillance of antimicrobial
resistance
P661 Five years of Belgian MIST (meropenem information on
bacterial susceptibility testing) surveillance: 2001–2005
D. Govaerts, G. Coppens, D. Fameree, B. Masschelin, F. Meunier,
C. Sion, P. Turner, G. Vandenhoven (Montigny-le-tilleul, Genk,
Charleroi, Turnhout, La Louvie`re, Huy, BE; Macclesﬁeld, UK;
Brussels, BE)
Objectives: The activity of meropenem and 6 comparators was studied
in the MIST trial, on a total of 2.553 isolates (706 Gram-positives and
1.847 Gram-negatives) from 6 general non teaching hospitals in Belgium,
collected from 2001 to 2005.
Materials and Methods: Centres collected consecutively up to 50 and
75 unduplicated, aerobic Gram+ and Gram− isolates respectively from
patients admitted in ICU, haematology and general wards. CLSI methods
and E-tests were used for susceptibility testing. ESBL and AmpC
production were conﬁrmed by at least a 3log2 reduction in ceftazidime
MIC in the presence of clavulanate and a ceftazidime MIC> 8mg/l not
lowered by the presence of clavulanate respectively.
Results: S. aureus (n = 237) was the most frequently isolated Gram+
bacteria with 98–100% susceptibility for the carbapenems. Among
the Enterobacteriaceae (n = 1371), meropenem was the most active
antibiotic (99.9%), followed by imipenem (98.5%), cefepime (98.3%)
and amikacin (93.1%). Lower susceptibility rates were observed for
piperacillin–tazobactam (83.1%), ceftazidime (80.2%) and ciproﬂoxacin
(75.8%). More than 50% of E. aerogenes isolates (n = 232) were resistant
to ceftazidime, piperacillin–tazobactam and ciproﬂoxacin, while the
carbapenems and cefepime were extremely active (>95% susceptibility).
Susceptibility rates among all Enterobacteriaceae remained stable for
all antibiotics tested between 2001 and 2005. The prevalence of ESBL-
producing isolates varied from 1.7 to 3.9% for all Enterobacteriaceae,
from 0 to 4.3% for E. coli (n = 322), 0 to 9.5% for K. pneumoniae
(n = 160) and 0 to 4.9% for E. aerogenes. The prevalence of AmpC
producers among E. aerogenes isolates varied from 0 to 42%.
Susceptibilities of ESBL and AmpC producers to carbapenems varied
between 98–100%.
Against P. aeruginosa isolates (n = 273), the rank order of susceptibilities
during the study period was: meropenem (88.3%), ceftazidime (87.9%),
piperacillin–tazobactam (86.1%), amikacin (85.7%), imipenem (84.2%),
cefepime (77.9%) and ciproﬂoxacin (76.9%). Susceptibility rates for
P. aeruginosa remained stable for all antibiotics tested, excepted
cefepime, which declined between 2001 and 2005.
Conclusions: During the study period, the carbapenems and cefepime
were the most active agents against the Enterobacteriaceae, including
ESBL and/or AmpC producers. Meropenem and ceftazidime were the
most active agents against P. aeruginosa.During 5 years of Belgian MIST
surveillance, susceptibility rates for meropenem remained stable.
P662 Bacterial resistance surveillance in China: a report from
Mohnarin, 2004–2005
Y-H. Xiao, J. Wang, Y. Li (Beijing, CN)
Objective: To establish the nationwide antimicrobial resistant investiga-
tion network and get bacterial resistance information in China.
Methods: The clinical bacterial isolates were collected from 17 network
hospitals around China, antibacterial minimal inhibitory concentration
(MIC) were determined by standard agar dilution method recommended
by CLSI.
Results: A total of 4075 isolates were collected from 17 hospitals in
15 cities. The results of MICs showed the followings: The detection
rates of oxacillin-resistant Staphylococcus aureus and Staphylococcus
epidermidis were 62.9% and 82.89% respectively. Penicillin non-
sensitive Streptococcus pneumoniae were 40.7%, which included 10.5%
penicillin-resistant strains and 30.2% penicillin-intermediate strains
40.7%. 5 strains of Enterococci were vancomycin-intermediate, but
all the strains were sensitive to teicoplanin. All Staphylococci were
susceptible to glycopeptides. Macrolide-resistance was a predominant
phenomenon for Gram-positive cocci. Enterobacteriaceae were obviously
resistant to the third generation cephalosporin except for ceftazidime,
and the resistance rates were 20%-70%. Carbapenems still remained
highly activity against all the target bacteria. In addition, latamoxef,
piperacillin / tazobactam, cefoperazone / sulbactam and cefepime were
all active against Enterobacteriaceae and the resistant rates of which
was bellow 10%. 10.6% of Pseudomonas aeruginosa and 10.4% of
Acinetobacter baumannii were resistant to imipenem, and most of
them were multidrug resistant. Combinations of b-lactam/b-lactamase
inhibitor and ﬂuoroquinolones also had potent antibacterial activity
against non-fermenters. Amikacin was active against Enterobacteriaceae
and P. aeruginosa.
Conclusion: meticillin-resistant Staphylococci, penicillin non-sensitive
S. pneumoniae, macrolides-resistant Gram-positive cocci, cephalosporin-
resistant Enterobacteriaceae, multidrug resistant nonfermenters and
ﬂuoroquinolone-resistant E. coli were the predominant problems. No
glycopeptides-resistant Staphylococcus was found and glycopeptides-
resistant Enterococci remained seldom.
P663 Resistance surveillance of bacterial pathogens from North
American patients hospitalised with pneumonia: a 10-year
report from the SENTRY Program (1997–2006)
T. Fritsche, G. Moet, H. Sader, R. Jones (North Liberty, US)
Objectives: The emergence of resistance (R) among pneumonia
pathogens has resulted in increasing reliance upon ﬂuoroquinolones and
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advanced-generation b-lactams, including carbapenems. We summarize
the prevalence and susceptibility (S) proﬁles of bacterial pneumonia
pathogens collected during ten years of the SENTRY Antimicrobial
Surveillance Program (1997–2006).
Methods: Participating North American medical centres (24/year)
referred 50 consecutive, non-duplicate pathogens (19,406 isolates) from
lower respiratory tract sites determined to be the probable cause of
pneumonia in hospitalised patients (community and nosocomial in
origin). Isolate identiﬁcations were conﬁrmed and susceptibility testing
was performed using CLSI reference methods at a central laboratory
(JMI Laboratories, North Liberty, IA).
Species (no. tested) Antimicrobial %R
agent 1997 2002 2006
SA (5774) OXA 39.4 45.9 61.4
PSA (3764) CAZ 19.0 12.6 17.4
IMP 8.0 7.3 13.6
CIP 15.3 23.8 23.0
KSP (1541) CRO 1.2 (9.3) 6.9 (21.7) 5.3 (12.6)
IMP 0.0 0.4 3.2
CIP 3.2 5.8 9.5
SPN (1282) PEN 9.2 16.4 11.8
ERY 14.5 23.7 29.4
EBS (1222) CRO 13.2 7.8 17.9
CIP 3.4 3.9 7.7
EC (798) CRO 1.6 (7.0) 1.0 (7.2) 7.7 (7.7)
CIP 1.6 9.3 30.8
ASP (540) CAZ 29.5 39.0 58.8
IMP 3.3 5.1 14.7
CIP 34.4 54.2 73.5
*Numbers in parentheses are ESBL-phenotype rates (% 2mg/ml).
Results: Selected pathogens with unique or emerging R characteristics
are in the Table. The 10 ranked pathogens comprised 90.4% of all isolates
and included: S. aureus (SA; 28.1%) > P. aeruginosa (PSA; 19.4%) >
Klebsiella spp. (KSP; 7.9%) > H. inﬂuenzae (7.7%) > S. pneumoniae
(SPN; 6.6%) > Enterobacter spp. (6.3%) > E. coli (EC; 4.1%) >
Serratia spp. (3.8%) > S. maltophilia (3.6%) > Acinetobacter spp. (ASP;
2.8%). Among Gram-positive species, R emergence was notable for
SA (oxacillin [OXA] -R currently 61.4%; ERY-non-susceptibility [NS],
69.2%) and SPN (ERY-R, 29.4%; PEN-R, 11.8%). Among enterics,
CIP-R (30.8% for EC in 2006) and ESBL-phenotype rates (KSP and
EC; ranges 6.7−23.9% and 3.8−11.7%, respectively) have increased
considerably. An increase in IMP-R in KSP primarily results from
a continued east coast epidemic of clonal strains expressing serine
carbapenemase (primarily KPC-2) enzymes. While CAZ- and IMP-R
among PSA has increased, R to CAZ and ﬂuoroquinolones have become
predominant among ASP; only polymyxins remain largely S (>97%).
Conclusions: Although temporary resistance declines were detected
among some North American pneumonia pathogens, all showed
increasing resistance to most class agents during the monitored
period. Continued longitudinal comparisons of emerging pathogens and
changing susceptibility proﬁles are critical elements in guiding empiric
therapies and epidemiologic interventions.
P664 Escalating resistance among non-fermentative Gram-negative
bacilli: Report from the North American SENTRY
Antimicrobial Surveillance Program (1997–2006)
H. Sader, T. Fritsche, M. Stilwell, R. Jones (North Liberty, US)
Objective: Systemic infections due to non-fermentative Gram-negative
bacilli (NFB) are often difﬁcult to treat because of rising resistance
rates and limited therapeutic options. We evaluated the occurrence and
antimicrobial susceptibility proﬁles of NFB pathogens collected over
10 years of the SENTRY Antimicrobial Surveillance Program in North
America.
Methods: Consecutive clinically signiﬁcant and non-duplicate NFB
strains (12,435 total) were submitted from medical centres in the USA
(25) and Canada (5; 1997–2002 only) and susceptibility tested by
broth microdilution using CLSI methods and interpretive criteria at a
central laboratory (JMI Labs, North Liberty, Iowa). Speciﬁcally, changes
in susceptibility rates were analysed over time. Carbapenem-resistant
P. aeruginosa (PSA) and Acinetobacter spp. (ASP) were screened for
metallo-b-lactamase (MBL) enzyme production by a disk approximation
method or by Etest (AB BIODISK, Solna, Sweden).
Organism (no. tested) MIC50 (mg/ml)/% susceptiblea
Amikacin Cefta-
zidime
Imipenem Levo-
ﬂoxacin
TMP/SMX
Acinetobacter spp. (1,779) 4/84 8/59 0.25/91 0.5/62 0.5/74
Aeromonas spp. (102) 4/97 1/95 0.5/97 0.5/99 0.5/87
A. xylosoxidans (118) >32/14 4/86 2/92 2/57 0.5/90
B. cepacia (88) >32/10 4/74 4/51 2/60 0.5/88
P. aeruginosa (8,420) 4/96 2/83 1/87 0.5/74 >2/46
P. ﬂuorescens/putida (155) 4/96 4/90 1/87 0.5/85 2/52
S. maltophilia (1,309) >32/13 8/54 >8/1 1/83 0.5/99
aBased on CLSI breakpoints for Acinetobacter spp., P. aeruginosa and
S. maltophilia.
TMP/SMX = trimethoprim/sulfamethoxazole.
Results: The most commonly recovered non-fermentative Gram-negative
bacilli were PSA (68%), ASP (14%) and S. maltophilia (SM; 11%).
Polymyxin B (tested 2001–2006) was very active against PSA and
ASP (99% susceptible), but displayed more limited activity against
other NFB. Tigecycline (2002–2006) exhibited good activity (MIC50
/ % at 2 mg/L) against ASP (0.5/92) and SM (0.5/93), but limited
potency against PSA. The activities of other antimicrobials are in the
Table. Susceptibility patterns of PSA and SM remained very stable
during the decade. In contrast, ASP susceptibility rates decreased for
most agents, including (1997/2006 % susceptible): imipenem (94/78),
amikacin (92/80), gentamicin (77/61) and ciproﬂoxacin (73/53). Many
imipenem-non-susceptible ASP strains (77%) were from three medical
centres in the New York City area, the remaining were from 13 centres
and collected mainly in 2006 (61%). Imipenem-resistant PSA strains
were widely distributed geographically. No MBL-producing strain was
identiﬁed among ASP and PSA isolates.
Conclusions: Therapeutic options to treat NFB infections are becoming
increasingly limited secondary to progressively rising resistance rates.
Continued NFB surveillance remains necessary to optimise empiric
antimicrobial therapy, especially for the less frequently isolated and
difﬁcult to test species.
P665 Trends in prevalence and antimicrobial susceptibilities
among skin and skin structure infection pathogens in North
America: Report from the SENTRY Program (1997–2005)
G. Moet, R. Jones, H. Sader, T. Fritsche (North Liberty, US)
Objectives: Rising resistance (R) rates being observed globally in skin
and skin structure infection (SSSI) pathogens are challenging accepted
approaches to empiric management. We present a nine year summary
of the prevalence and susceptibility (S) trends of bacterial pathogens
producing SSSI collected from USA and Canadian medical centres
participating in the SENTRY Antimicrobial Surveillance Program.
Methods: Participating North American (NA) medical centres were
directed to send 50 consecutive, non-duplicate SSSI pathogens/year.
USA (21) and Canadian (5) medical centres submitted isolates for the
years 1997–2002; USA sites only participated during 2004–2005. Isolate
identiﬁcations were conﬁrmed and susceptibility testing was performed
using CLSI reference methods at a central laboratory (JMI Laboratories,
North Liberty, IA).
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Results: The top 7 ranked pathogens comprised 85.2% of the total (8,520
isolates; see Table) with S. aureus (SA) being predominant, ranging
from 40.4−53.1% between years. Other ranking pathogens included
P. aeruginosa (PSA), Enterococcus spp. (ENT), and E. coli (EC) which
were second to fourth each year except in 2004, when ENT and PSA
reversed rank. Prevalence of beta-haemolytic streptococci (BHS) varied
from ﬁfth in 1998, ninth in 2000, then ﬁfth again in 2004/2005. The all-
years NA MRSA rate was 35.9% (9% in Canada) and ranged from 31.3
to 56.2% among USA census zones. Highest ENT vancomycin R (VAN-
R; 16.5%) was found in 2005 and highest erythromycin R rate (25.8%)
in BHS was found in 2004. Trending increases in ﬂuoroquinolone (FQ)
R rates among EC and Klebsiella spp. (KSP) reached 24.4 and 12.8%,
respectively. ESBL phenotype rates for EC (12.8%) peaked in 2004 and
for KSP (20.5%) in 2005. In contrast to these changes, ceftazidime-,
imipenem- and levoﬂoxacin-R rates for PSA (higher in earlier years)
have trended downwards.
Organism (no.) R pattern % R All years % R (range)
SA (3,862) MRSA 35.9 24.0−49.4
PSA (908) Imipenem (IMP)-R 6.1 1.1−9.8
Ceftazidime (CAZ)-R 10.0 7.8−13.1
Levoﬂoxacin (LEV)-R 18.9 15.7−22.5
ENT (748) Vancomycin (VAN)-R 12.4 7.6−16.5
EC (610) CAZ-R 2.8 0.0−7.0
LEV-R 9.3 2.4−24.4
EBS (409) CAZ-R 17.8 7.6−25.5
BHS (379) Erythromycin (ERY)-R 19.8 8.8−25.8
KSP (344) CAZ-R 5.2 0.0−17.9
LEV-R 3.2 1.4−12.8
Conclusions: SSSI pathogen prevalence has changed minimally since
1997 (exception, BHS). MRSA rate differences are notable between
countries and between USA census zones. R rates for ENT (VAN-
R), and EC and KSP (FQ and ESBLs) are increasingly of concern
whereas R among key agents targeting PSA have improved from earlier
SENTRY surveillance periods. Continued surveillance monitoring of
these trends, both locally and globally, provides useful information
for empiric management of SSSI and in assessing needed changes to
antimicrobial therapy guidelines.
P666 Meropenem, b-lactam with the highest activity against
Gram-negative isolates from the intensive care unit – Part
of the MYSTIC (Meropenem Yearly Susceptibility Test
Information Collection) Programme, 1997–2007
J.A. Patzer, D. Dzierzanowska, A. Pawinska, P.J. Turner (Warsaw,
PL; Macclesﬁeld, UK)
Objectives: MYSTIC (Meropenem Yearly Susceptibility Test Infor-
mation Collection) is a longitudinal surveillance study comparing the
in vitro activity of meropenem (MEM) and other antibiotics against
bacterial strains from clinical units that use MEM for treatment. The
aim of this analysis was to assess the in vitro activity of MEM and eight
other antibiotics against Gram-negative isolates from a paediatric ICU.
Methods: 1300 Gram-negative isolates were obtained from various
clinical specimens of children hospitalised in the ICU in 1997–
2007. The isolates were identiﬁed using conventional methods. The
Minimum Inhibitory Concentrations (MICs) of MEM, imipenem (IPM),
piperacillin+tazobactam (TAZ), cefotaxime (CTX), ceftazidime (CAZ),
cefepime (CPE), gentamicin (GM) and ciproﬂoxacin (CIP) were
determined using the NCCLS agar dilution method.
Results: The collection of Gram-negative isolates included Escherichia
coli (n = 187), Enterobacter cloacae (n = 233), Klebsiella oxytoca
(n = 118), Klebsiella pneumoniae (n = 211), Serratia marcescens (n = 50),
Acinetobacter baumannii (n = 137), Pseudomonas aeruginosa (n = 253)
and other species (n = 111). MEM, IPM and CIP were the most
active against 94.2%, 92.2% and 95.2% of isolates, respectively. The
MIC90 (mg/L) of MEM was nearly identical in 1997 and 2007. It
was equal to 0.06 for Enterobacteriaceae, 1.0 for A. baumanii and
8.0 for P. aeruginosa. The MIC90 of IPM was equal to 0.25 for
Enterobacteriaceae, 1.0 for A. baumannii and 16 for P. aeruginosa.
During 1997–2007, among Enterobacteriaceae were only found two
E. cloacae and one E. amnigenus resistant to carbapenems. Among
carbapenem resistant P. aeruginosa isolates one strain producing metallo-
b-lactamase VIM4 was found. The overall order of susceptibility of
tested isolates to other b-lactams was CPE (85.8%) > TAZ (75.2%) >
CAZ (72%) > CTX (53.6%). Susceptibility to GM characterised 66.9%
of isolates. The incidence of extended spectrum b-lactamase producers
among Enterobacteriaceae decreased from 39.7% in 1997 to 20.7% in
2007.
Conclusions: MEM, IMP and CIP were the most active antibiotics
(>90% susceptibility) against Gram-negative isolates, with no observed
reduction in activity over 11 years. A greater proportion of P. aeruginosa
isolates were susceptible to MEM than to IPM. Carbapenems, such as
MEM, can be used as an option in the ﬁrst line therapy of nosocomial
infections in the ICU.
P667 Acinetobacter spp. infections: the Latin American scenario
in the SENTRY Antimicrobial Surveillance Program
(1997–2006)
A. Gales, D. Xavier, S. Andrade, R. Jones, H. Sader (Sao Paulo,
BR; North Liberty, US)
Objectives: To evaluated the frequency of occurrence, the antimicrobial
susceptibility proﬁle and the temporal evolution of antimicrobial
resistance among Acinetobacter spp. isolated in Latin America.
Acinetobacter spp. is an important nosocomial pathogen in Latin
America and exhibits high rates of acquired resistance to many
antimicrobial agents.
Methods: Consecutive non-duplicate bacterial pathogens were collected
in the last decade (1997–2006) from hospitalised patients in 10 Latin
American medical centres (7 countries). The antimicrobial susceptibility
proﬁle to >20 antimicrobial agents was evaluated by CLSI broth
microdilution methods and interpreted by CLSI M100-S17 (2007) or
US-FDA package insert criteria for Enterobacteriaceae (tigecycline).
Results: A total of 1,807 isolates were collected during the 10-
year period. The highest number of isolates were collected from
Brazil (53%) > Argentina (19%) > Chile (14%) and Mexico (6%).
Most isolates were collected from bloodstream (57.7%) followed by
respiratory tract (31.9%) infections. The activities of selected drugs
are shown in the table. Polymyxin B, tigecycline and imipenem
demonstrated the highest in vitro activity against Acinetobacter spp.
A signiﬁcant increase (p< 0.05) in the resistance rates for imipenem
(6.7−24.4%), meropenem (6.7−24.3%), cefepime (38.3−54.8%), cef-
tazidime (56−72.1%), amikacin (55.4−68.2%) was observed when
comparing 1997 and 2006 results.
Antimicrobials MIC (mg/L) % Susceptible % Resistant
MIC50 MIC90
Amikacin >32 >32 34.9 59.5
Cefepime 16 >16 35.1 49.7
Ceftazidime >16 >16 27.9 63.7
Ciproﬂoxacin >2 >4 30.5 69.0
Imipenem 1 >8 83.5 15.3
Meropenem 2 >8 81.0 15.3
Polymyxin B 0.5 1 98.1 1.9
Tigecyclinea 0.5 2 98.1 0.0
a. Not tested in all years.
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Conclusions: Polymyxin B remains the most active drug against Acine-
tobacter spp. in the Latin American countries evaluated by the SENTRY
Program and tigecycline was also active. An important reduction in the
susceptibility rates to some broad-spectrum antimicrobials, including the
carbapenems, was observed, limiting therapeutic options available.
P668 Drug resistance amongst European isolates of Escherichia
coli isolated from the MYSTIC Programme 2007
P. Turner (Macclesﬁeld, UK)
Objectives: In a time where resistance amongst the Enterobacteriaceae
tends to be dominated by Klebsiella and Enterobacter species it
is useful to also examine the susceptibility patterns expressed by
Escherichia coli – still the commonest Gram-negative organism involved
in nosocomial infections.
Methods: During 2007 a total of 496 clinically signiﬁcant, non-copy
isolates of E. coli were obtained from European centres involved in the
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection)
Programme. These were examined using CLSI methodology and
associated interpretive criteria in order to ascertain their susceptibility
to a range of compounds. Extended-spectrum b-lactamase (ESBL)
producers were conﬁrmed by synergy with clavulanic acid and AmpC
production by lack of synergy with this compound.
Results: See the table.
% Susceptible*
E. coli n MEM IPM CAZ CPM P+T CIP GM
All 496 99.8 100 84.9 90.6 88.7 76.4 84.6
ESBL 29 100 100 0 0 65.5 31 30
AmpC 13 100 100 0 61.5 53.9 61.5 100
R to CAZ/CIP 25 96 100 0 30 56 0 28.6
R to CAZ/CIP/GM 10 90 100 0 42.9 50 0 0
*CLSI criteria.
MEM: meropenem; IPM: imipenem; CAZ: ceftazidime; CPM: cefepime;
P+T: piperacillin+tazobactam; CIP: ciproﬂoxacin; GM: gentamicin.
Conclusions: Whilst still at a low level ESBL (0.6%) and AmpC (0.3%)
positive strains were isolated, and these were frequently also resistant
to other classes of antibiotics (ﬂuoroquinolones, aminoglycosides and
b-lactam/b-lactamase combinations) as well as the cephalosporins. The
carbapenems remain a useful therapy option against this type of isolate.
P669 Antimicrobial drug resistance in human non-typhoidal
Salmonella isolates in Europe 2000−04: a report from the
Enter-net international surveillance network
J. Threlfall, I. Fisher on behalf of the Enter-net participants
Objectives: To investigate the occurrence of resistance to antimicrobials
in salmonella strains from humans in ten European countries over the
ﬁve year period 2000–2004
Methods: The antimicrobial susceptibility test results of salmonella
isolates received from ten countries – Austria, Denmark, England and
Wales, Germany, Ireland, Italy, Luxembourg, The Netherlands, Scotland
and Spain – that supplied data for all years between 2000 and 2004
were extracted from the Enter-net Salmonella database. Interpretation of
sensitivity results had previously been harmonised throughout the Enter-
net network. Descriptive and statistical analyses were undertaken using
Microsoft Excel and Epi Info version six. Relative proportions were
compared using the Chi-squared test for trend.
Results: Results of antimicrobial susceptibility testing for 134,310
isolates of non-typhoidal salmonellas from cases of human infection
in ten European countries from 2000−04 has demonstrated an overall
increase in the occurrence of resistance, from 57% to 66% over
the period of study. In contrast multiple resistance (to four or more
antimicrobial drugs) has declined from 18% to 15%. The most signiﬁcant
increase in resistance has been to nalidixic acid (14% to 20%),
particularly in Salmonella enterica serovar Enteritidis (10% to 26%),
the most common serovar over the period of study. For England
and Wales this increase has for the most part been attributed to
infections linked to contaminated eggs originating outwith the United
Kingdom. For S. Typhimurium, the second most prevalent serovar,
there has been an overall decline in the occurrence of resistance to
ampicillin, chloramphenicol and tetracyclines, attributed to a decline in
the occurrence of multiresistant S. Typhimurium DT 104. For S. Virchow,
a serotype with a predeliction for invasive disease, there has been a
substantive increase in resistance to most antimicrobials, attributed to
the spread of drug-resistant strains associated with poultry.
Conclusion: Results indicate that the overall interpretation of suscep-
tibility data from different countries ishould take into account both
indigenous strains and also strains originating as a result of foreign
travel and the importation of contaminated foods. Because of the
widespread importation of foods, it is important that controls to reduce
the emergence and spread of drug-resistant strains of Salmonella are
internationally implemented.
P670 Evolution of antimicrobial susceptibility patterns of aerobic
and facultative Gram-negative bacilli causing intra-abdominal
infections: results from the SMART studies, 2003–2007
M. Guembe, E. Cercenado, M. Marin, R. Insa, E. Bouza (Madrid, ES)
Objective: SMART (Study for Monitoring Antimicrobial Resistance
Trends) is an ongoing global antimicrobial surveillance programme
focused on clinical isolates from intra-abdominal infections (IAI).
The objective of this subanalysis was to assess the evolution of
the antimicrobial susceptibility patterns among aerobic and facultative
Gram-negative bacilli recovered over a period of 5 years at our
participating institution.
Methods: We tested the in vitro activity of 10 antimicrobials, commonly
used to treat IAI, against consecutive unique isolates from IAI using
microdilution techniques according to the CLSI guidelines for MIC
testing. All isolates were screened phenotypically for extended-spectrum
b-lactamase (ESBL) production. Isolates recovered within 48 hours of
hospitalisation were considered community-acquired (CA).
Results: Over the study period a total of 572 aerobic and facultative
Gram-negative bacilli were recovered from 510 patients, of which
258 (45%) were CA. Enterobacteriaceae composed 91% of the total
isolates. E. coli was the most common isolated species (52%). The
susceptibility rates of Enterobacteriaceae over the study period ranged
from 76.8−85.2% to the ﬂuoroquinolones, 86.6−96.1% to cefotaxime,
91.1–100% to cefepime, 89−96.1% to piperacillin–tazobactam, 95.5–
100% to amikacin, 98.2–100% to imipenem, and 98.2–100% to
ertapenem. ESBLs were detected in 6.3% of E. coli, 5.4% of Klebsiella
spp., and 2.7% of Enterobacter spp. ESBL producers generally had
a more antibiotic-resistant proﬁle than non-ESBL producers and 16%
of them were CA. Susceptibility rates to ﬂuoroquinolones, cefepime,
piperacilin-tazobactam, amikacin, imipenem, and ertapenem were,
respectively, for P. aeruginosa: 71.8%, 76.9%, 82%, 82%, 58.9%, and
28.2%; for A. baumannii: 66.6%, 66.6%, 66.6%, 66.6%, 100%, and
33.3%; and for S. maltophilia: 42.9%, 0%, 0%, 14.3%, 0%, and 0%.
Conclusions: Over the 5-year-study period we have not observed
signiﬁcant increases in resistance of aerobic and facultative Gram-
negative bacilli causing IAI to commonly used b-lactam antimicrobial
drugs. A minority of ESBL-producing Enterobacteriaceae were CA. The
carbapenems, including group I agents like ertapenem, were the most
reliably active drugs in vitro against isolates producing IAI.
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P671 Sentinel Surveillance of Antibiotic Resistance in Switzerland
(SEARCH)
A. Kronenberg, K. Mu¨hlemann, M. Schlegel, J. Evison on behalf of the
Sentinel Surveillance of Antibiotic Resistance in Switzerland (SEARCH)
Objectives: Comprehensive, representative and valid surveillance of
antibiotic resistance on local, national and international levels is key
to resistance control. We established a national surveillance programme
in Switzerland within the frame of the National Research Program of
Antibiotic Resistance (NRP49).
Methods: Routine resistance data are collected electronically on a
weekly base from 22 clinical microbiology laboratories into a central
data base. Data are validated, mapped to a common nomenclature
and subjected to algorithms identifying double samples, deﬁning
microorganisms as contaminants versus pathogens and nosocomial
versus community-acquired.
Results: In 2006 SEARCH received resistance data on 100,988 clinical
isolates and 396 different bacterial species. The system represents
approximately 80% of acute care hospital days and >30% of Swiss
practitioners in the outpatient setting. Geographical distribution is even.
12.2% of samples derive from children <15 years of age and 4.6% from
<2 years olds.
Isolates from sterile anatomical sites contribute 24% of all data. The
relative distribution of hospital isolates was 24.6% from outpatient
departments, 17.2% from surgery, 16.6% from internal medicine, 8.1%
from intensive care units, 5.5% from paediatrics, 4.4% from obstetrics
and gynaecology and 23.6% mixed or others. Among practitioners
providing isolates the specialities were 30.4% general practitioners,
20.2% gynaecologists, 14.9% internal medicine, 7.6% paediatricians and
26.9% others.
In 2006, 2305 Swiss hospitalised patients experienced colonisation
or infection by at least on of four prominent multi-resistant germs
(MDR) (Meticillin-resistant S. aureus, extended-spectrum b-lactamase
producers, multi-resistant P. aeruginosa and Acinetobacter spp.) and
15.2% of these had invasive infection. Attributable mortality was
at least 80 deaths per year. Prevalence of MDR showed signiﬁcant
geographical differences with higher rates in South-West Switzerland
(6.6%) compared to the Northeast (3.8%, p< 0.001).
Conclusion: The Swiss national system for antibiotic resistance
surveillance provides a valuable tool for large scale, detailed and timely
monitoring of antibiotic resistance in human medicine.
P672 Antimicrobial susceptibility patterns of inducible
Enterobacteriaceae isolated from intra-abdominal infections
worldwide: results from SMART 2006
F. Baquero, F. Rossi, P. Hsueh, D. Paterson, G. Bochicchio,
G. Gallagher, K. Lantz, J. Baez-Villasenor, J. Chow (Madrid, ES;
Sao Paulo, BR; Taipei, TW; Pittsburgh, Baltimore, West Point, US)
Objective: SMART (Study for Monitoring Antimicrobial Resistance
Trends) is an ongoing global antimicrobial surveillance programme
focused on clinical isolates from intra-abdominal infections (IAI).
We assessed antimicrobial susceptibility patterns among inducible
Enterobacteriaceae worldwide in 2006.
Methods: 82 worldwide sites (distributed as: Asia/Paciﬁc – 24; Europe –
34; Latin America – 11; Middle East/Africa – 5; North America – 8)
tested the in vitro activity of 12 antimicrobial agents commonly used
to treat IAI against consecutive unique inducible Enterobacteriaceae
isolated from IAI. Microdilution techniques followed Clinical Laboratory
Standard Institute (CLSI) guidelines. All Enterobacter, Serratia,
Citrobacter, Providencia spp., Morganella morganii, Hafnia alvei, &
Proteus vulgaris were considered for the purposes of this study to possess
an inducible ampC b-lactamase gene.
Results: Inducible Enterobacteriaceae were recovered from 19%
(1175/6134) pts, representing 18% (1204/6633) of total isolates. 38%
(461) of isolates were recovered <48 hrs and 60% (721) were recovered
48 hrs of hospitalisation; whereas, for 2% (22) the time recovered was
unknown. Enterobacter spp. (48%), Citrobacter spp. (24%),M. morganii
(11%), and Serratia spp. (7%) were the most common inducible
Enterobacteriaceae. % susceptibility rates are reported below.
Conclusion: Enterobacter species were the most common isolates.
Ampicillin-sulbactam and cefoxitin were the least active agents against
inducible Enterobacteriaceae; whereas, imipenem, ertapenem, and
amikacin were the most active agents in vitro.
Entero-
bacter
spp.
Citrobacter
freundii
Morganella
morganii
Serratia
spp.
N = 583 N= 210 N= 127 N= 86
Ertapenem 93 98 99 99
Imipenem 98 98 98 99
Cefepime 85 91 97 94
Ceftriaxone 60 64 80 87
Cefoxitin 8 13 78 38
Ceftazidime 61 66 77 91
Cefotaxime 61 62 91 86
Ampicillin–sulbactam 21 43 4 13
Piperacillin–tazobactam 75 80 95 91
Amikacin 94 92 98 99
Ciproﬂoxacin 84 80 86 87
Levoﬂoxacin 88 85 89 94
P673 CARE-ICU – Controlling Antibiotic REsistance in Intensive
Care Units – First report from a web-based programme for
improved infection control in European ICUs
H. Hanberger, D. Arman, H. Gill, S. Kalenic, P. Naaber, E. Scicluna,
C. Suetens on behalf of CareICU – IPSE
Background: CARE-ICU is a web-based programme for IC surveillance
in the ICU setting developed within the EU Commission sponsored
project IPSE. The aim of the programme is to improve surveillance
and control of antibiotic resistance (ABR), AB consumption (ABC) and
hygienic precautions in the ICU setting of EU member states.
Methods: A programme for yearly registration of ABC, resistance
and clinical practices with automatic feedback through a website
http://www4.smittskyddsinstitutet.se/careicu was developed. Participants
are national ICU networks and individual ICUs. The national contact
points of IPSE were asked to identify ICUs who would be willing
to take part in the large pilot study. ABR was deﬁned as the sum of
intermediate susceptible and resistant strains. Antibiotics (AB) to which
>90% of isolates of a species were susceptible were deﬁned as treatment
alternatives (TA90) which is a novel index of susceptibility to measure
the magnitude of MDR among Gram-negative bacteria. For each ICU
the clinical practices and infection control measures were analysed in
relation to the needs based on local resistance patterns and ABC.
Results: 34 ICUs in 8 countries participated in the collection of
ICU data for 2005. ABC varied widely from 348–4992 DDD1000
(deﬁned daily dosages per 1000 occupied bed days), median 1417
DDD1000. Frequencies of ABR varied greatly between species, ICUs
and countries: The median (range) of MRSA, ESBL phenotype of E. coli,
ESBL phenotype of K. pneumoniae were in percentages: 11.6 (0–100),
3.9 (0−80) and 14.3 (0−77.8) respectively. TA90 for P. aeruginosa
to aminoglycoside, ceftazidime, ciproﬂoxacin and carbapenem varied
between 0 (9 ICUs), 1 (8 ICUs), 2 (3 ICUs), 3 (6 ICUs) and 4 (4
ICUs). Failure to screen for alert microorganisms in relevant patients at
admission was a general problem as well as lack of rooms for isolation
precautions and cohort care for patients colonised or infected with Alert
organism. Understafﬁng was common but facilities for hand disinfection
was in general available by each bed.
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Conclusions: CARE-ICU has become a focal point for promoting more
appropriate use of AB and improved infection control. By correlating
ABC and resistance, as well as hygienic precautions, best practice in
AB policy and hygiene interventions was deﬁned for each unit. The
single most needed improvement in almost all settings was increased
hygiene compliance of healthcare workers.
P674 Antimicrobial susceptibility of the bacteria causing
community-acquired respiratory tract infections in Poland,
2005–2006 (continuation of the Alexander Project)
M. Kadlubowski, A. Skoczynska, A. Klarowicz, W. Hryniewicz (Warsaw,
PL)
Objectives: The aim of the study was to evaluate susceptibility patterns
of major agents of acute pharyngitis/tonsilitis and lower respiratory tract
infections in Poland, 2005–2006.
Methods: The study was performed on 811 isolates of the four species:
Streptococcus pneumoniae, Haemophilus inﬂuenzae, Streptococcus
pyogenes and Moraxella catarrhalis. The strains were isolated in 42
healthcare centres, from ambulatory or hospitalised patients. In the
second case, the study included only the isolates, which were recovered
during the ﬁrst 48 hours after the patients’ admission. Isolates were
checked for their susceptibility to drugs commonly used in the treatment
of respiratory tract infections, according to the CLSI guidelines. ATCC
strains were used for the quality control purposes.
Results: Among pneumococci, more than 20% were non-susceptible
to penicillin (PNSP), almost 70% of which were fully resistant.
Nearly 90% of PNSP were also resistant to at least two other
drug groups, e.g. macrolides and co-trimoxazole. Almost 10% of
pneumococci were non-susceptible to the 3rd-generation cephalosporins.
Beside penicillin, the lowest in vitro activity against S. pneumoniae
had co-trimoxazole and tetracycline. Among H. inﬂuenzae, 8.1%
were ampicillin-resistant b-lactamase producers. All of them were
in vitro susceptible to amoxicillin/clavulanic acid and 3rd-generation
cephalosporins. Co-trimoxazole and clarithromycin were the least active
in vitro drugs against this species. More than 91% of M. catarrhalis
isolates were penicillin-resistant b-lactamase producers, although all of
them were susceptible to various other antimicrobials. All of the group
A streptococci were susceptible to penicillin, however an increase in
resistance to tetracycline and macrolides was observed.
Conclusion: Although the frequency of PNSP (~20%) seems to be stable
in Poland, the number of isolates resistant to at least three groups of
antimicrobials is being increased. Enzymatic resistance of H. inﬂuenzae
to b-lactams is stable as well (~10%) of isolates, but resistance to
macrolides is growing. Further increase in resistance of S. pyogenes
to all groups of macrolides is being observed. M. catarrhalis remains
susceptible to many antibiotics.
P675 Comparison of antimicrobial susceptibilities of bacteria
isolated in Canada, the United States, and Mexico – Results
from the T.E.S.T. Program 2004–2007
R. Badal, S. Bouchillon, B. Johnson, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: The Tigecycline Evaluation Surveillance Trial (T.E.S.T.) is
a longitudinal surveillance study that monitors the in vitro activity of
tigecycline (TIG) and several comparator antimicrobics in dozens of
countries. This analysis of T.E.S.T. data compares the susceptibility of
commonly-isolated pathogens collected in Canada, The United States of
America, and Mexico.
Methods: 49,886 isolates were collected and identiﬁed to the species
level at 231 participating sites (215 in the USA, 8 in Canada, and
8 in Mexico) and conﬁrmed by the central laboratory. MICs were
determined by each site using supplied broth microdilution panels and
interpreted according to CLSI guidelines. % susceptible of each species
or phenotype to each of the study drugs was determined for isolates
from each of the 3 countries.
Results: Organism/antimicrobic combinations which showed more than
25% variation in % susceptible between countries are listed below:
Organism Canada USA Mexico
Acinetobacter n = 123 n = 3113 n = 95
Ak 91 83 56
Cpe 79 50 54
Caz 81 50 28
Lvx 81 52 35
PT 86 60 40
S. pneumoniae n = 31 n = 1070 n = 70
Mer 94 79 66
H. inﬂuenzae n = 132 n = 2749 n = 67
Amp 83 73 57
E. coli n = 220 n = 6370 n = 238
Aug 76 76 37
Amp 47 43 8
Cpe 96 98 62
Cax 95 95 48
Lvx 77 75 29
Min 85 87 62
ESBL+ n = 16 n = 595 n = 126
Mer 100 73 99
PT 94 52 79
Ak = Amikacin; Cpe = cefepime; Caz = ceftazidime; Lvx = levoﬂoxacin;
PT = piperacillin/tazobactam; Mer = meropenem; Amp = ampicillin;
Aug = amox/clav; Cax = ceftriaxone; Min = minocycline.
Conclusions: There are several pathogens for which antibiograms differ
dramatically between Canada, the USA, and Mexico. Although the US
sample size is vastly larger than the other two countries, there were
enough strains to lend credence to the data from Canada and Mexico.
Many drugs showed no signiﬁcant difference in %S among the three
countries, but when there were large variations, Mexico usually had
the lowest susceptibility rates, and Canada the highest. Interestingly, the
positions of Mexico and the USA were reversed for ESBL producers vs.
Mer and PT.
P676 A global perspective of antimicrobial in vitro activity from
the T.E.S.T. Program: annual analysis from 2004–2006
S. Bouchillon, B. Johnson, M. Hackel, J. Johnson, D. Hoban, R. Badal,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Tigecycline, the ﬁrst member of the glycylcyclines, was
marketed in mid 2005 and has demonstrated success against multiply-
resistant species and phenotypes. Due to its chemical structure, resistance
to tigecycline is reportedly difﬁcult to produce even in the laboratory.
The T.E.S.T. Program is an ongoing global surveillance with the ﬁrst
post-marketing prospective report of tigecycline and comparator in vitro
activity for the years 2004 through 2006.
Methods: More than 60,000 clinical isolates were collected from 335
investigative sites in 47 countries worldwide. MICs were determined by
broth microdilution according to CLSI guidelines using identical panels.
Results: Results are given by year for all pathogens and antimicrobials.
Summary data for tigecycline and key species are presented in the table.
Conclusions: Tigecycline demonstrated no signiﬁcant shift in MIC
values over three years from its pre-marketing baseline values.
Tigecycline activity was retained even against strains resistant to
other antimicrobials, including ESBL-producers, Acinetobacter spp.,
meticillin-resistant S. aureus, vancomycin-resistant enterococci, and
S. pneumoniae.
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2004 2005 2006
Organism n (04/05/06) M
IC
50
M
IC
90
M
IC
50
M
IC
90
M
IC
50
M
IC
90
E. co./K. pn./K. ox.1 5029/5298/5943 0.25 1 0.25 1 0.25 1
ESBL producers 370/447/569 0.5 2 0.5 2 0.5 2
Enterobacter spp. 2347/2315/2660 0.5 1 0.5 2 0.5 2
Serratia spp. 986/1000/1103 1 2 1 2 1 2
Acinetobacter spp. 1482/1342/1418 0.25 1 0.25 1 0.25 1
P. aeruginosa 2043/2098/2456 8 >16 8 >16 8 >16
S. aureus 2426/2604/2523 0.12 0.25 0.12 0.25 0.12 0.25
MRSA 1139/1234/1017 0.12 0.25 0.12 0.25 0.12 0.25
Enterococcus spp. 1483/1606/1830 0.06 0.12 0.06 0.12 0.06 0.12
VRE 208/247/286 0.06 0.12 0.06 0.12 0.06 0.12
S. pneumoniae 1329/1371/1418 0.06 0.5 0.03 0.25 0.03 0.12
1E. coli, K. pneumoniae, K. oxytoca.
P677 Prevalence of Helicobacter pylori resistance to antimicrobial
agents at two different locations in Belgium: a 10-year
surveillance
Y. Glupczynski, H. Nizet, C. Berhin, C. Baude (Yvoir, BE)
Objectives: Monitoring of primary antibiotic resistance in H. pylori at
a local level is of utmost importance since antimicrobial resistance is an
important indicator of treatment failures. We aimed to compare the rates
of primary antimicrobial resistance of H. pylori (Hp) at two locations in
Belgium and to investigate possible links with disease severity, gender,
age and ethnicity of patients (pts.).
Methods: Between 01/98 and 10/07, Hp culture of gastric biopsies from
untreated pts. endoscoped at UCL St-Luc, Brussels (Br) and at UCL
Mont-Godinne, Yvoir (Yv), south Belgium was carried out centrally at
one laboratory. Susceptibility testing (disc diffusion and/or Etest) to the
following agents was performed: metronidazole (Mtz), clarithromycin
(Cla), amoxicillin (Amx), levoﬂoxacin (Lvx) and tetracycline (Tet).
Results: Data were available for 1614 Hp isolates (977 in Brussels;
637 in Yvoir). The prevalence of Hp infection was 25% in B (36%
non-caucasians) and 21% in Y (9% non Caucasians). Global primary
resistance rates were 31.7% to Mtz; 18.4% to Cla and 16.8% to Lvx;
7.4% of the strains displayed double Mtz/Cla resistance and 2.9%
displayed triple resistance (Mtz/Cla/Lvx). Resistance rate to Amox and
Tet was T1%. The rate of Mtz resistance was higher in B than in Y
(40% vs. 25%; P< 0.05) while it was identical for Cla (16.6% vs.
21.2%, NS) and for Lvx (15.5 vs. 19.0%; NS). Primary resistance to
Mtz was signiﬁcantly higher in non-Belgian born patients (41.1% vs.
27.8% in Belgian-born; P< 0.01) and in females (38.2% vs. 26.1% in
males; P< 0.05). There was no difference in resistance between ulcer
and non-ulcer dyspepsia-associated Hp isolates.
Conclusion: High Mtz, Cla and Lvx resistance rates were observed at
two different locations in Belgium and no signiﬁcant trends occurred
over time, except for Lvx resistance which increases from 10% in 2002
to over 25% in 2007. Country of birth and female gender were the
only risk factors identiﬁed for Mtz resistance. Our results emphasize the
importance of local data for optimisation of anti-Hp treatment strategies.
P678 Potency and spectrum of tigecycline tested against bacterial
pathogens producing skin and skin structure infections in
European medical centres, including community-acquired
meticillin-resistant S. aureus
H. Sader, R. Jones, G. Moet, T. Fritsche (North Liberty, US)
Objective: To evaluate the activity and potency of tigecycline when
tested against a large collection of bacterial pathogens causing skin and
skin structure infections (SSSI). Tigecycline is the sentinel representative
of the glycylcycline class and was recently approved by the European
Medicines Agency for the treatment of complicated SSSI and intra-
abdominal infections.
Methods: Consecutive, non-duplicate bacterial isolates (4,567 strains)
were collected from 2000 to 2007 from patients with documented SSSI
in >30 medical centres (14 countries) participating in the Tigecycline
Surveillance Program in Europe. All isolates were tested using CLSI
broth microdilution methods against tigecycline and key comparator
agents commonly used for therapy of SSSI. Tigecycline-susceptible
(S) breakpoints (US-FDA/EUCAST) were deﬁned as 2/1 mg/L
for Enterobacteriaceae (ENT); 0.5/0.5 mg/L for staphylococci, and
0.25/0.25 mg/L for streptococci and enterococci. S. aureus infections
diagnosed within the ﬁrst 48 hours of hospitalisation were considered to
be of community origin.
Results: SSSI pathogen rank order (top 8), potency (MIC90) and S
rates for tigecycline are shown in the Table. S. aureus (22.7% MRSA)
was isolated from 45.7% of SSSI cases and tigecycline inhibited
99.8% of strains, including all community-acquired (CA)-MRSA, at
the S breakpoint. CA-MRSA showed low S to erythromycin (37.5%),
clindamycin (63.5%) and levoﬂoxacin (17.5%). Tigecycline was also
very active against enterococci (93.2% S), including vancomycin-non-S
strains (100.0% S), BHS (99.6% S) and CoNS (97.9% S). Linezolid
was also active against Gram-positive organisms, but generally 8-
fold less potent than tigecycline. Tigecycline (98.4–100.0% S) and
imipenem (98.4–100.0% S) were the most active compounds tested
against E. coli, Klebsiella spp. and Enterobacter spp., while high rates
of R to levoﬂoxacin (5.5−16.4%) and gentamicin (7.1−12.7%) were
observed among these pathogens.
MIC90/%S
a
Organism (no. of isolates/% of total) TIG LEV CLI T/S LZD
S. aureus (2,089/45.7) 0.25/99.8 >4/76.4 >2/88.5 0.5/97.6 2/100.0
Meticillin-resistant S. aureus (MRSA; 474/10.4) 0.25/99.6 >4/11.0 >2/59.1 2/91.7 2/100.0
Community-acquired (CA)-MRSA (137/6.6) 0.25/100.0 >4/17.5 >2/63.5 1/94.9 2/100.0
E. coli (426/9.3) 0.25/99.5 >4/80.3 −/− >2/70.1 −/−
P. aeruginosa (PSA; 399/8.7) >4/− >4/71.4 −/− >2/6.3 −/−
Enterococci (293/6.4) 0.25/93.2 >4/59.0 −/− −/− 2/100.0
Beta-haemolytic streptococci (BHS; 256/5.6) 0.12/100.0 1/100.0 0.25/92.6 0.5/99.6 1/100.0
Coagulase-neg. staphylococci (CoNS; 234/5.1) 0.5/97.9 >4/49.6 >2/74.4 >2/69.3 1/100.0
Enterobacter spp. (ESP; 182/4.0) 1/98.4 1/92.3 −/− >2/89.6 −/−
Klebsiella spp. (KSP; 142/3.1) 1/100.0 4/88.0 −/− >2/81.0 −/−
a. According to US-FDA breakpoints. TIG = tigecycline; LEV = levoﬂoxacin; CLI = clindamycin; T/S =
trimethoprim/sulfamethoxazole and LZD = linezolid.
Conclusions: Tigecycline was highly active against the top 8-ranked
pathogens producing SSSI, except for P. aeruginosa, and showed
the broadest spectrum of activity among the antimicrobials tested.
Tigecycline, linezolid and vancomycin were the most active compounds
tested against Gram-positive species while tigecycline, amikacin and
imipenem were the most active against Gram-negatives. Tigecycline
represents a welcome choice for use in treating common Gram-positive
and negative pathogens producing serious SSSI.
P679 Trends in bacteraemia: England 2002–2006
N. Potz, M. Lillie, J. Davies, C. Jackson, A. Pearson (London, UK)
Objectives: This paper presents the nine species of bacteria (and
Candida) responsible for the majority of bloodstream infections (BSI)
in England during 2006, and the changes in trends of these species over
the last ﬁve years.
Methods: Voluntary reports of bacteraemia are collected using electronic
reporting from laboratories in England and Wales to a national database.
Information indicating how many blood cultures were taken and how
many tested positive were provided through the mandatory MRSA
surveillance undertaken in England. Bloodstream infections are deﬁned
as clinically-signiﬁcant positive blood cultures.
Results: The total number of blood cultures taken has increased by over
17% between 2002 and 2006, while the number of cultures that prove
positive has increased by 14%. The numbers of bloodstream infections
reported has increased, however, this may in part be due to an increase
in voluntary reporting. The top ﬁve organisms responsible for BSI have
changed in relative frequency over the last ﬁve years, with E. coli
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overtaking S. aureus rather dramatically as the most common cause of
bacteraemia.
2002 2003 2004 2005 2006
Total blood cultures 1500832 1611714 1546630 1695371 1752914
Total positive blood cultures 249311 264766 261899 278281 285152
All episodes of bloodstream infections 76231 92770 96101 102785 109696
No. (%) No. (%) No. (%) No. (%) No. (%)
Escherichia coli 12709 (16.7) 15052 (16.2) 15741 (16.4) 16961 (16.5) 18043 (16.4)
Coagulase negative staphylococci 6604 (8.7) 8609 (9.3) 10091 (10.5) 11708 (11.4) 14184 (12.9)
Staphylococcus aureus 12895 (16.9) 14603 (15.7) 14173 (14.7) 14065 (13.7) 13616 (12.4)
Enterococcus spp. 442l (5.8) 5611 (6.0) 5887 (6.1) 6477 (6.3) 7070 (6.4)
Klebsiella spp. 3515 (4.6) 4169 (4.5) 4639 (4.8) 4853 (4.7) 5162 (4.7)
Streptococcus pneumoniae 4163 (5.5) 5135 (5.5) 4526 (4.7) 4971 (4.8) 4539 (4.1)
Pseudomonas spp. 2382 (3.1) 2969 (3.2) 2897 (3.0) 3069 (3.0) 3454 (3.1)
Enterobacter spp. 1874 (2.5) 2256 (2.4) 2284 (2.4) 2314 (2.3) 2410 (2.2)
Proteus spp. 1662 (2.2) 1882 (2.0) 1818 (1.9) 1805 (1.8) 1839 (1.7)
Candida spp. 1042 (1.4) 1272 (1.4) 1376 (1.4) 1573 (1.5) 1687 (1.5)
Conclusions: The increase in blood culture reports is thought to be due
to an increased number of rapid investigations of pyrexia of unknown
origin (PUO) in patients presenting in the Accident & Emergency
Department. Whilst the numbers of E. coli bacteraemia reports have
increased, their proportion of all BSIs has remained stable. It is therefore
unclear how many of the increased number of reports represent a true
increase in case numbers and how many represent an increase in case
reporting. The apparent increase in the proportions of coagulase-negative
staphylococci requires further investigation. It is interesting to observe
that no apparent increase in the proportion of candidaemia BSI was seen
as has been reported in other countries where there are an increasing
proportion of elderly and immunocompromised patients.
P680 In vitro activity of tigecycline tested against pneumonia
pathogens from patients hospitalised in European medical
centres, including multidrug-resistant Acinetobacter spp.
H. Sader, R. Jones, M. Janechek, T. Fritsche (North Liberty, US)
Objectives: Emergence of resistance (R) among pneumonia-producing
pathogens has been a variable that confounds empiric management. We
evaluated the activity of tigecycline against leading bacterial pathogens
recovered from patients hospitalised with pneumonia. Tigecycline was
approved by the European Medicines Agency and US-FDA for the
treatment of complicated skin and skin structure infections and intra-
abdominal infections and is currently under investigation for treatment
of hospital acquired pneumonia.
Methods: Consecutive, non-duplicate, lower respiratory tract isolates
(3,864) were submitted from 34 medical centres located in Europe (13
countries) and Israel in the 2000–2007 period. Susceptibility (S) tests
were performed using CLSI methods (including ESBL conﬁrmatory
tests) and interpreted by US-FDA and EUCAST criteria.
Results: Ranking of the top-10 occurring pneumonia pathogens and
key resistance (R) characteristics were (see Table): S. aureus (28.3%
oxacillin-R [MRSA]) > P. aeruginosa (19.6 imipenem [IMI]-R) > E. coli
(8.5% ESBL) > Klebsiella spp. (28.9% ESBL) > Enterobacter spp.
(25.6% ceftazidime [CAZ]-R) > Acinetobacter spp. > S. pneumoniae
(23.1% penicillin-R) > Serratia spp. > S. maltophilia > H. inﬂuenzae
(12.8% b-lactamase positive). Acinetobacter spp. exhibited high R rates
to IMI (43.1%), CAZ (77.0%), ciproﬂoxacin (CIP; 82.8%) and amikacin
(AMK; 65.1%); while 34.9% of strains were R to all 4 drugs (MDR).
R to these antimicrobials did not adversely affect tigecycline activity,
which inhibited >95% of strains non-S to CAZ, CIP or AMK, 93.3% of
strains non-S to IMI and 91.8% of MDR strains at 2 mg/L. Tigecycline
was also very active against S. maltophilia (MIC90, 2 mg/L; 99.2%
inhibited at 2 mg/L), MRSA (MIC90, 0.25 mg/L; 99.5% S) and
Enterobacteriaceae with an ESBL-phenotype, but showed limited activity
against PSA.
Conclusions: Tigecycline is a potent agent targeting pneumonia
pathogens displaying highly resistant phenotypes including S. aureus,
Enterobacteriaceae, S. pneumoniae, H. inﬂuenzae, and some non-
fermentative Gram-negative bacilli. Only tigecycline and the polymyxins
showed reasonable in vitro activity against Acinetobacter spp. Empiric
use of tigecycline may be prudent for patients less likely to have
P. aeruginosa as a causative pathogen or for directed therapy of indicated
species.
Organism (no. tested/% of total) Tigecycline MIC (mg/L) % S
50% 90% Range (US-FDA/
EUCAST)
S. aureus (1,067/27.6) 0.12 0.5 0.12−1 99.8/99.8
P. aeruginosa (786/20.3) >4 >4 0.12−>4 −/−
E. coli (366/9.5) 0.12 0.25 0.12−1 100.0/100.0
Klebsiella spp. (353/9.1) 0.25 1 0.12−4 98.6/92.4
Enterobacter spp. (223/5.8) 0.5 1 0.06−4 99.1/96.0
Acinetobacter spp. (209/5.4) 1 2 0.12−4 97.1/77.5a
S. pneumoniae (121/3.1) 0.12 0.12 0 12 −/−
Serratia spp. (121/3.1) 1 2 0.12−4 99.2/92.6
S. maltophilia (114/3.0) 1 2 0.12−4 99.2/77.2a
H. inﬂuenzae (109/2.8) 0.5 1 0.12−1 −/−
a. Enterobacteriaceae breakpoints were used for comparison purposes only.
P681 In vitro activity of tigecycline against inpatient and
outpatient isolates from a European population
M. Hackel, S. Bouchillon, B. Johnson, R. Badal, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Tigecycline, a member of a new class of antimicrobials
(glycylcyclines), has been shown to have potent broad spectrum activity
against most commonly encountered species responsible for community
and hospital acquired infections. The T.E.S.T. Program surveyed the in
vitro activity of tigecycline and comparator compounds against in-patient
and out-patient pathogens from Europe for the period from 2004 to 2007.
Methods: A total of 16,451 clinical isolates from 93 testing sites in
22 European countries were tested. Minimum Inhibitory Concentration
(MICs) were determined by each site using common broth microdilution
panels and interpreted according to EUCAST guidelines.
Results: See the tables.
Enterobacteriaceae Acinetobacter spp.
In-patients
(n = 5,546)
Out-patients
(n = 1,097)
In-patients
(n = 926)
Out-patients
(n = 148)
%S MIC90 %S MIC90 %S MIC90 %S MIC90
Tigecycline 91.7 1 95 1 na 1 na 1
Amikacin 95.9 4 96.5 4 72.7 >64 73.3 >64
Cefepime 82.3 8 85.8 4 59.8 32 60.3 >32
Ceftazidime 0 >32 0 32 57.4 >32 60.3 >32
Imipenem 98.9 1 98.8 1 82.5 16 78.4 8
Levoﬂoxacin 82.2 8 83.4 8 55.2 >8 62.6 >8
Minocycline 82.9 8 86.7 8 92.4 4 98.5 1
Pip-Tazo 83.8 64 88.2 32 64 >128 70.2 >128
na = Breakpoints not available.
S. aureus Enterococcus spp.
In-patients
(n = 1,415)
Out-patients
(n = 374)
In-patients
(n = 1,042)
Out-patients
(n = 119)
%S MIC90 %S MIC90 %S MIC90 %S MIC90
Tigecycline 100 0.25 100 0.25 100 0.12 100 0.12
Levoﬂoxacin 72.6 16 83.9 8 54.1 >32 69.3 >32
Linezolid 100 4 100 4 100 2 100 2
Minocycline 99 0.5 99 0.5 53.2 >8 41.6 >8
Vancomycin 100 1 100 1 93.9 2 95 2
Conclusion: Tigecycline’s in vitro activity was comparable to or
greater than most commonly prescribed broad spectrum antimicrobials
without any demonstrable change in activity between in-patient and
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out-patient bacterial study strains. Tigecycline’s inhibitory activity
against Enterobacteriaceae, and Acinetobacter spp. was comparable to
imipenem. Against Gram-positive organisms, tigecycline’s activity was
comparable to linezolid and vancomycin.
P682 Comparative analysis of tigecycline in South America from
2004–2007
M. Hackel, R. Badal, S. Bouchillon, B. Johnson, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Tigecycline, the ﬁrst member of the glycylcyclines, was
ﬁrst marketed in 2005 and has demonstrated success against multiple-
resistant species and phenotypes. The T.E.S.T. Program is an ongoing
global surveillance with the ﬁrst post-marketing prospective report of
tigecycline and comparator in vitro activity for the years 2004 through
2007.
Methods: 4,230 clinical isolates were collected from 16 investigative
sites in 5 countries in South America. MICs were determined by broth
microdilution according to CLSI guidelines using identical panels.
Results: Results are given by year for pathogens and antimicrobials.
Summary data for tigecycline and key species are listed in the table.
2004 2005 2006 2007
Organism N(04/05/06/07) M
IC
50
M
IC
90
M
IC
50
M
IC
90
M
IC
50
M
IC
90
M
IC
50
M
IC
90
Enterobacteriaceae 234/585/512/260 0.5 1 0.5 1 0.5 1 0.5 1
ESBL producersa 25/103/73/26 0.5 2 0.5 2 0.5 1 0.5 1
Acinetobacter spp. 53/111/59/50 0.5 1 0.5 1 0.5 1 0.5 1
P. aeruginosa 55/130/144/62 8 >16 8 16 8 >16 8 >16
S. aureus 64/215/116/97 0.06 0.12 0.12 0.25 0.12 0.25 0.12 0.25
MRSA 28/94/62/51 0.12 0.25 0.12 0.25 0.12 0.25 0.12 0.25
Enterococcus spp. 37/93/88/42 0.06 0.12 0.12 0.25 0.06 0.12 0.06 0.12
S. pneumoniae 41/96/57/52 0.25 0.5 0.12 0.5 0.015 0.06 0.015 0.06
H. inﬂuenzae 29/107/20/23 0.5 0.5 0.25 0.5 0.12 0.25 0.12 0.25
Conclusions: Other than a 1-doubling dilution increase in the MIC90 of
S. aureus, tigecycline demonstrated no increase in MIC50/90 values over
four years from its pre-marketing baseline values. Tigecycline’s activity
was retained even against strains resistant to other antimicrobials, includ-
ing ESBL-producers, Acinetobacter spp., meticillin-resistant S. aureus,
vancomycin-resistant enterococci, and penicillin-resistant S. pneumoniae.
P683 Tigecycline activity in Europe: a comparative analysis by
country 2007
M. Hackel, R. Badal, S. Bouchillon, J. Johnson, D. Hoban, B. Johnson,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Development of bacterial resistance continues to cause
concern world wide, but the availability of newer agents offers clinicians
options for therapy. Tigecycline has a very broad spectrum of activity,
including strains resistant to other drugs. As part of the global
Tigecycline Evaluation Surveillance Trial (TEST), strains collected in 22
European countries in 2007 were evaluated for susceptibility to several
commonly used antimicrobials.
Methods: 14,254 strains were collected and identiﬁed at 93 sites in 22
countries. MICs were determined at each site using EUCAST guidelines
on microdilution panels.
Results: The table summarizes tigecycline results.
Conclusions: Bacteria isolated from than 22 different European
countries had generally similar antibiograms, with no isolates from
any site showing signiﬁcantly different sensitivity patterns. The greatest
variability was seen in Acinetobacter, with TIG MIC50 values ranging
from 0.06 to 1mg/mL. TIG’s consistant broad spectrum of activity may
make it an excellent therapeutic option against European pathogens.
Country Enterobacteriaceae Acinetobacter spp. S. aureus Enterococcus spp.
TIG n TIG n TIG n TIG n
MIC50 MIC90 MIC50 MIC90 MIC50 MIC90 MIC50 MIC90
Austria 0.5 2 153 0.12 1 6 0.12 0.25 50 0.06 0.12 18
Belgium 0.5 2 645 0.25 1 118 0.12 0.25 208 0.12 0.25 131
Czech Republic 0.5 1 76 0.12 0.5 13 0.12 0.12 19 0.12 0.12 16
Denmark 0.5 1 283 0.12 0.25 49 0.12 0.12 76 0.06 0.06 57
Finland 0.25 0.5 75 0.25 1 9 0.12 0.12 31 0.12 0.25 17
France 0.5 1 1412 0.25 1 279 0.12 0.25 454 0.12 0.25 279
Germany 0.5 1 1174 0.12 0.5 214 0.12 0.25 345 0.12 0.25 219
Greece 0.5 1 372 0.5 2 70 0.12 0.25 127 0.06 0.12 77
Hungary 0.5 1 150 1 2 44 0.12 0.12 50 0.06 0.25 30
Ireland 0.5 2 222 0.12 0.5 45 0.12 0.12 74 0.06 0.25 42
Italy 0.5 1 1643 0.5 1 287 0.12 0.25 489 0.12 0.25 309
Latvia 0.5 1 145 0.5 1 29 0.12 0.25 49 0.06 0.12 30
Lithuania 0.25 1 66 0.25 1 15 0.12 0.12 35 0.12 0.25 15
Norway 0.5 0.5 71 0.06 0.25 15 0.12 0.12 24 0.06 0.12 15
Poland 0.5 1 75 0.25 0.5 14 0.12 0.12 24 0.12 0.12 15
Portugal 0.25 1 73 0.5 0.25 15 0.12 0.12 25 0.06 0.12 15
Slovenia 0.5 2 73 0.25 1 15 0.12 0.12 25 0.12 0.12 15
Spain 0.25 1 809 0.5 1 140 0.12 0.25 271 0.12 0.25 159
Sweden 0.25 0.5 209 0.12 0.12 44 0.12 0.12 57 0.06 0.12 45
Switzerland 0.5 0.5 157 0.12 0.25 20 0.12 0.12 51 0.12 0.12 33
The Netherlands 0.25 0.5 149 0.12 0.5 30 0.12 0.12 49 0.12 0.12 30
United Kingdom 0.25 1 361 0.12 1 72 0.12 0.25 120 0.12 0.12 98
P684 In vitro activity of tigecycline and 13 comparators against
pathogens from a global population of intensive care patients
in 2007
M. Hackel, D. Hoban, S. Bouchillon, B. Johnson, R. Badal, J. Johnson,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Tigecycline is a novel antimicrobial from a new class
of compounds, the glycylcyclines, which has been shown to have
potent broad spectrum activity against most commonly encountered
species responsible for community and hospital acquired infections. The
Tigecycline Evaluation Surveillance Trial (TEST), a global longitudinal
surveillance study, surveyed the in vitro activity of tigecycline and 13
comparator compounds against pathogens from ICU patients from a
global population during 2007.
Methods: A total of 14,113 clinical isolates from 386 testing sites in
49 countries were evaluated. Minimum Inhibitory Concentration (MICs)
were determined by each site using common broth microdilution panels
and interpreted according to CLSI and FDA guidelines.
Results: See the tables.
Drug Enterobacteriaceae
(n = 7,576)
Acinetobacter spp.
(n = 1,646)
MIC50 MIC90 MIC50 MIC90
Tigecycline 0.5 2 0.5 1
Amikacin 2 4 8 >64
Cefepime 0.5 8 16 >32
Imipenem 0.5 1 1 >16
Levoﬂoxacin 0.06 8 4 >8
Minocycline 2 16 0.5 8
PipTazo 2 128 64 >128
Drug S. aureus (n = 1,722) Enterococcus spp. (n = 1,252)
MIC50 MIC90 MIC50 MIC90
Tigecycline 0.12 0.25 0.06 0.12
Levoﬂoxacin 0.25 32 16 >32
Linezolid 2 2 2 2
Minocycline 0.25 0.5 4 >8
Vancomycin 1 1 1 >32
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Conclusion: Tigecycline’s in vitro activity was comparable to or greater
than most commonly prescribed broad spectrum antimicrobials for all
ICU bacterial study strains encountered. Tigecycline’s inhibitory activity
against Enterobacteriaceae, and Acinetobacter spp. was comparable to
imipenem. Against Gram-positive organisms, tigecycline’s MIC90 values
of 0.25mg/mL suggest that tigecycline may be an effective and reliable
therapeutic option against these pathogens in an Intensive Care setting.
P685 Tigecycline activity tested against bacterial isolates causing
bloodstream infections in European medical centres
H. Sader, G. Moet, T. Fritsche, R. Jones (North Liberty, US)
Objective: To assess the activity of tigecycline against bloodstream
infection (BSI) isolates from European hospitals. Tigecycline is a novel
glycylcycline antimicrobial approved by the European Medicines Agency
for the treatment of complicated skin and skin structure infections and
intra-abdominal infections.
Methods: Bacterial isolates (non-duplicates) were consecutively col-
lected in the 2000–2007 period from documented BSI in patients
hospitalised in 34 medical centres located in Europe (13 countries)
and Israel. Frequency of occurrence of pathogens was determined
and their antibiograms assessed using reference broth microdilution
methods according to CLSI M7-A7 (2006). Tigecycline-susceptible
(S) breakpoints (US-FDA/EUCAST) were deﬁned as 2/1 mg/L
for Enterobacteriaceae (ENT); 0.5/0.5 mg/L for staphylococci, and
0.25/0.25 mg/L for streptococci and enterococci.
Results: A total of 25,401 strains were tested. Tigecycline was
highly active against the 10 most frequent pathogens (Table), except
for P. aeruginosa (PSA). Among the 5 most common pathogens
(18,802 strains; 74% of the total), tigecycline was active against
>99% at the established S breakpoints. The main resistance phenotypes
detected were meticillin-resistant (R) S. aureus (MRSA; 28.3%) and
CoNS (77.6%), ciproﬂoxacin-R E. coli (20.3%), extended-spectrum
b-lactamase (ESBL)-screen-positive Klebsiella spp. (22.8%) and E. coli
(7.9%), imipenem-R PSA (IRPSA; 21.7%) and Acinetobacter spp.
(ASP; 30.5%), and vancomycin-R enterococci (VRE; 5.0%). Tigecycline
activity against MRSA (MIC90, 0.25 mg/L; 99.8% S) was similar to
that against meticillin-S S. aureus (MIC90, 0.25mg/L; 99.9% S), and
98.0% of VRE were S to tigecycline. ESBL-producing E. coli and KSP
exhibited high rates of R to levoﬂoxacin (62.4 and 31.8%, respectively)
and gentamicin (31.7 and 45.1%), but were S to tigecycline (100.0
and 98.9%, by US-FDA breakpoints). 95.3% of ceftazidime-R ESP and
96.1% of imipenem-R ASP were inhibited at  2 mg/L of tigecycline.
Cumulative % inhibited at tigecycline MIC (mg/L) of: % S
Organism (no. tested/% of total) 0.12 0.25 0.5 1 2 4 (US-FDA/
EUCAST)
E. coli (5,793/22.8) 66.5 95.7 99.6 99.9 >99.9 100.0 >99.9/99.9
S. aureus (5,642/22.6) 68.7 95.3 99.9 100.0 − − 99.9/99.9
Coagulase-neg. staphylococci (CoNS;
3,396/13.4)
57.0 88.8 98.9 100.0 − − 98.8/98.9
Enterococcus spp. (2,265/8.9) 75.3 97.0 99.9 100.0 − − 97.0/97.0
Klebsiella spp. (KSP; 1,706/7.6) 8.5 58.7 87.3 96.2 99.4 >99.9 99.4/96.2
P. aeruginosa (PSA; 1,481/5.8) 0.1 0.3 1.1 2.4 11.1 45.9 −/−
Entertobacter spp. (ESP; 977/3.8) 2.3 44.8 81.9 92.2 97.9 100.0 97.9/92.2
S. pneumoniae (551/2.2) 99.5 100.0 − − − − 100.0/100.0
Beta-haemolytic streptococci (535/2.1) 98.5 100.0 − − − − 100.0/100.0
Acinetobacter spp. (ASP; 509/2.0) 18.7 39.3 55.8 83.5 97.6 100.0 97.6/83.5a
aENT breakpoints were applied for comparison purposes.
Conclusions: Tigecycline exhibited a wide-spectrum of activity and
potency versus contemporary BSI isolates collected in Europe, including
multidrug-resistant organisms.
P686 Extended-spectrum b-lactamase production in Europe
M. Hackel, R. Badal, S. Bouchillon, J. Johnson, D. Hoban, B. Johnson,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Infection by extended-spectrum beta lactamase (ESBL)-
producing bacterial pathogens is increasing worldwide, with the
prevalence of ESBLs in Europe varying greatly from country to country.
Patients with infections caused by an ESBL-producing organism are
at increased risk of treatment failure. The Tigecycline Evaluation
Surveillance Trial (TEST), a global longitudinal surveillance study,
determined the ESBL status and antibiotic susceptibilities to tigecycline
and comparator compounds for 6,782 Escherichia coli, Klebsiella
oxytoca, and Klebsiella pneumoniae, from 22 European countries from
2004 to 2007.
Methods: 6,782 Enterobacteriaceae (2,871 E. coli, 815 K. oxytoca,
1,938 K. pneumoniae) from 22 European countries were analysed
in this survey. The isolates were identiﬁed to the species level at
the participating sites and conﬁrmed by the central laboratory. MICs
were determined by each site using supplied broth microdilution
panels and interpreted according to EUCAST guidelines. ESBL testing
was performed by Laboratories International for Microbiology Studies
(LIMS), a subsidiary of International Health Management Associates,
Inc. (IHMA, Schaumburg, IL, USA) following CLSI guidelines.
Results: See the table.
2004 2005 2006 2007
n
(% ESBL)
TIG
MIC90
n
(% ESBL)
TIG
MIC90
n
(% ESBL)
TIG
MIC90
n (% ESBL) TIG
MIC90
E. coli 558 (3.9) 0.12 525 (9.7) 0.12 994 (8.7) 0.12 794 (9.8) 0.25
ESBL 22 0.25 51 0.25 86 0.25 78 0.25
K. oxytoca 148 (5.4) 0.25 142 (2.8) 0.25 272 (2.9) 0.25 253 (2.8) 0.5
ESBL 8 0.5 4 0.5 8 0.25 7 0.5
K. pneumoniae 393 (13.0) 0.5 305 (14.4) 0.5 724 (9.7) 0.5 516 (15.5) 0.5
ESBL 51 0.5 44 0.5 70 0.5 80 0.5
Total 1099 (7.4) 0.25 972 (10.2) 0.25 3148 (5.2) 0.25 1563 (10.6) 0.25
ESBL 81 0.5 99 0.5 164 0.25 165 0.5
Conclusions: Rates of ESBL production in Europe have increased
gradually during the period of 2004 to 2007, with a decrease in the year
2006. The incidence of ESBLs varies greatly from country to country,
ranging from 2.6% in Denmark to 24.2% in Greece in 2007 (data not
shown). Tigecycline retained excellent in vitro activity over time, with
MIC90 values of 0.5mg/mL for all four years, suggesting tigecycline
may be an effective option against these difﬁcult to treat pathogens.
P687 The in vitro activity of tigecycline against 2,423 clinical
isolates. Comparison of the EUCAST and the FDA approved
breakpoints
J. Papaparaskevas, A. Tsakris, L. Tzouvelekis, A. Priftis, N.J. Legakis
and the Hellenic Tigecycline Study Group
Objectives: The multicentre comparison of the in vitro activities of
tigecycline and comparator agents against Gram-negative and Gram-
positive clinical isolates.
Materials and Methods: During 2006–2007, a total of 2,423 non-
duplicate clinical isolates were collected from 17 General Hospi-
tals in Greece. MICs to tigecycline, penicillin, ampicillin, amoxi-
cillin+clavulanic acid, piperacillin+tazobactam, cefotaxime, ceftazidime,
cefepime, imipenem, amikacin, minocycline, levoﬂoxacin, vancomycin,
and linezolid were determined using a microdilution method.
Results: Species distribution included Escherichia coli (464, 18.8%),
Klebsiella pneumoniae (350, 14.2%) Enterobacter spp. (247, 10.0%),
Acinetobacter spp. (235, 9.5%), Moraxella catarrhalis (39, 1.6%),
Enterococcus spp. (513, 20.8%), Staphylococcus aureus (505, 20.1%)
and Streptococcus pneumoniae (70, 2.8%). Isolates were collected from
skin and soft tissue, blood, urine, respiratory tract, intra-abdominal, iv
catheter, biological ﬂuids, and genital specimens (20.6, 18.8, 18.6, 15.2,
10.8, 3.7, 3.3, and 1.9%, respectively). Tigecycline MIC50, MIC90, as
well as susceptibility rates according to FDA and EUCAST approved
genus/species speciﬁc breakpoints, are shown in Table.
No signiﬁcant differences were recorded between meticillin-resistant and
susceptible S. aureus, vancomycin-resistant and susceptible Enterococcus
spp., penicillin-resistant and susceptible S. pneumoniae, or imipenem-
resistant and susceptible Acinetobacter spp.
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Genus N MIC (mg/L) FDA breakpoints** EUCAST breakpoints**
50% 90% S (%) I (%) R (%) S (%) I (%) R (%)
E. coli 464 0.12 0.5 99 0.5 0.5 99 0 1
K. pneumoniae 350 0.5 1 99 0.5 0.5 91 8 1
Enterobacter spp. 247 0.5 2 93 5 2 88 6 6
ImpNS* Enterobacteriaceae 110 0.5 1 99 0 1 94 5 1
Acinetobacter spp. 234 1 1 No breakpoints available No breakpoints available
M. catarrhalis 40 0.03 0.12 No breakpoints available No breakpoints available
Enterococcus spp. 513 0.12 0.12 100 0 0 99 1 0
S. aureus 505 0.12 0.25 100 0 0 99.5 0 0.5
S. pneumoniae 70 0.5 1 No breakpoints available No breakpoints available
*ImpNS: Imipenem Non-Susceptible; **S: susceptible, I: intermediate, R: resistant.
Conclusions: Tigecycline exhibited potent in vitro activity against the
majority of the clinical isolates in this study. Species with the highest
MICs recorded were S. pneumoniae among Gram-positive cocci and
Enterobacter and Acinetobacter spp. among Gram-negative bacteria.
Interpretation of the results, using the different breakpoints established
by the two organisations, may inﬂuence substantially the resistance rates
reported for K. pneumoniae and Enterobacter spp.
P688 Analysis of resistance and vancomycin “reverse creep” in
Latin American Staphylococcus aureus: ten-year report of the
SENTRY Antimicrobial Surveillance Program (1997–2006)
R. Picao, H. Sader, R. Jones, S. Andrade, A. Gales (Sao Paulo, BR;
North Liberty, US)
Objectives: To evaluate the antimicrobial susceptibility (S) rates of
S. aureus, including meticillin-resistant (MRSA) strains, collected in
Latin American medical centres as part of the SENTRY Antimicrobial
Surveillance Program. The Brazilian MRSA clone is highly prevalent in
the region and usually shows high rates of antimicrobial resistance.
Methods: A total of 8,705 S. aureus referred from seven Latin American
countries during a 10-year period (1997–2006) were S tested to 13
antimicrobials by CLSI broth microdilution methods. The frequencies
of S. aureus with vancomycin MIC values 1 mg/L collected by 7 of
10 medical centres that participated in the programme since 1999 were
analysed by comparing two time periods, 1999–2001 and 2002–2006.
Results: Overall, 37.3% of strains were MRSA. Brazil contributed with
the majority of S. aureus (3517/40.4%) and MRSA (1443/41.1%) strains.
S rates are shown in the table. MRSA rates increased from 33.8%
in 1997 to 40.2% in 2006 (p = 0.007). S rates for many non-b-lactam
agents increased among MRSA as follows (1997/2006): clindamycin
(13.2/16.3%), erythromycin (3.9/8.6%), gentamicin (7.8/27.3%), tetracy-
cline (29.9/79.5%), co-trimoxazole (30.9/67.0%). Chloramphenicol and
rifampin S rates increased from 25.5% and 48.5% in 1997 to 65.6% and
60.7% in 2005, respectively. All increases in S rates among MRSA were
statistically signiﬁcant (p< 0.05), except for clindamycin. Interestingly,
the percentage of S. aureus/MRSA with vancomycin MIC 1 mg/L
decreased from 93.9/96.6% in 1999–2001 to 86.7/92.3% in 2002–2006
(p = 0.00001).
Antimicrobial agent MRSA (n = 3253) MSSA (n = 5452)
MIC (mg/L) % S MIC (mg/L) % S
50% 90% 50% 90%
Ciproﬂoxacin >4 >4 8.3 0.25 0.5 96.2
Clindamycin >8 >8 12.4 0.12 0.25 98.0
Gentamicin >8 >8 15.6 2 2 95.9
Erythromycin >8 >8 6.9 0.25 8 82.1
Linezolid 2 2 100.0 2 2 100.0
Teicoplanin 2 2 100.0 2 2 100.0
Co-trimoxazole >2 >2 65.1 0.5 0.5 98.8
Vancomycin 1 1 100.0 1 1 100.0
Conclusions: The increase in the MRSA rates coupled with increased
S rates to non-b-lactam agents and decrease in the frequencies of
strains with vancomycin MIC 1 mg/L (“reverse creep”) may indicate
the emergence and dissemination of new MRSA clones, distinct from
the Brazilian clone, in the Latin American countries surveyed by the
SENTRY Program.
P689 Frequency and antimicrobial susceptibility proﬁle of
vancomycin-resistant enterococci from Latin America:
a report from the SENTRY Antimicrobial Surveillance
Program (1997–2006)
A. Gales, H. Sader, K. Santiago, A. Pgnatari, R. Jones (Sao Paulo,
BR; North Liberty, US)
Objective: To evaluate the prevalence and susceptibility proﬁle
of vancomycin-resistant enterococci (VRE) in Latin America. VRE
emerged nearly twenty years ago in the United States (USA) and rapidly
disseminated in many USA hospitals; however, its prevalence seems to
remain relatively low in Latin America.
Methods: As part of the SENTRY Antimicrobial Surveillance Program,
a total of 2026 enterococci isolated between January 1997 and December
2006 from Latin American hospitals were studied. The susceptibility
proﬁle to nine antimicrobial agents was determined by CLSI broth
microdilution methods and results interpreted according to CLSI
document M100-S17 (2007).
Results: E. faecalis (78.2%) and E. faecium (12.7%) were the most
frequently isolated species. Blood (41.4%) and skin/soft tissue (11.0%)
represented the most frequent body sites of infection. A total of 112
(5.5%) strains were identiﬁed as VRE, with 46% of them being isolated
in Brazil. The VRE frequency increased from 0.0% (1997 and 1998)
to 10.3% (2006), with an important increase after 2002. Although the
numbers of E. faecalis and E. faecium exhibiting the VRE phenotype
were similar, the percentage of vancomycin-resistant E. faecium (VR-
EFM; 19.7%) was proportionally higher than vancomycin-resistant
E. faecalis (VR-EF; 3.3%). A signiﬁcant increase in VR-EFM isolates
was detected in Brazil between 2005 and 2006. VRE was most frequently
isolated from urine (18.5%). The antimicrobial susceptibility proﬁle of
VRE isolates is summarised in the table. Linezolid and tigecycline were
the most active compounds tested against VRE. In contrast, the majority
of VRE were resistant to teicoplanin (vanA pattern).
Antimicrobial agent VR-EF (53) VR-EFM (51)
MIC50 MIC90 %S MIC50 MIC90 %S
Ampicillin 4 16 86.8 >16 >16 2.0
Teicoplanin >16 >16 3.8 >16 >16 5.9
Gentamicin-HL >1000 >1000 18.9 500 >1000 76.5
Streptomycin-HL 1000 >2000 83.0 >2000 >2000 15.7
Quinupristin/dalfopristin >2 >8 1.9 1 >2 68.6
Linezolid 1 2 100.0 1 2 100.0
Conclusions: An important increase in the frequency of VRE has
been observed in Latin America and appears to be associated with
the dissemination of endemic clones expressing the vanA. Linezolid
and tigecycline were the only antimicrobials with broad activity
against Enterococcus spp. independent of the species identiﬁcation or
glycopeptide phenotype.
P690 Prevalence of vancomycin-resistant Enterococcus spp. and
associated resistance patterns among isolates collected over a
decade of SENTRY Program surveillance in North America
M. Castanheira, D. Biedenbach, H. Sader, T. Fritsche, R. Jones (North
Liberty, US)
Objective: To investigate the susceptibility pattern of E. faecalis and
E. faecium in the USA and Canada medical centres over 10 years;
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secondarily, to analyse trends in vancomycin-resistant Enterococcus spp.
(VRE) in North America during the same period.
Methods: Isolates from bloodstream infection (BSI; 7,284) and other
sources (2,763; mainly urine and wound) recovered as part of a 10-year
surveillance programme (1997–2006) were analysed for susceptibility
proﬁles. Isolates were collected from medical centres in the USA
(52) and in Canada (8) and were tested at a central laboratory (JMI
Laboratories, North Liberty, IA) using CLSI broth microdilution methods
and interpretation criteria.
Results: Overall, the VRE rate was higher in BSI (19.1%) compared
to other sources (14.5%). In the USA, VR E. faecalis rates were
stable over ten years (3.3%) with signiﬁcant year-to-year variation but
without trending. In contrast, VR E. faecium steadily increased from
50 to 70%. The percentage of vanA phenotype increased in both
species over the years, becoming the predominant resistance phenotype
in more than 85% of VRE isolates. The table shows the yearly
progression of VRE BSI isolates in the USA and van phenotypes. In
Canada, VRE was documented in <1% of BSI isolates and included
E. faecium only. Higher resistance rates to other agents were noted
among VRE compared to susceptible strains. These included ampicillin-
resistant E. faecalis at 13%, ciproﬂoxacin-resistance at 95% for both
species and high-level gentamicin and streptomycin resistance rates
were 20−40% higher among VRE compared to vancomycin-susceptible
strains. Linezolid-resistance was 1.3% and 2.5% among VR E. faecium
and E. faecalis, respectively, compared to <0.5% among vancomycin-
susceptible isolates.
Conclusions: At the beginning of this study (1997), VRE were
considered to be primarily a USA problem. As expected, VRE has
disseminated within other countries, becoming a worldwide concern.
The spread of VRE in North America warrants continued susceptibility
proﬁling of large numbers of isolates from multiple medical centres to
track changes. The 20% E. faecium VR increase in the USA (nearly
all caused by the presence of vanA) and an associated increase in co-
resistance has been alarming. Other countries should take note of the
USA VRE experience and initiate infection control measures to limit
this important pathogen from becoming widely endemic.
Year
Organism 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
E. faecalis
n 371 378 408 348 361 487 431 466 415 436
%Ra 4.9 2.9 0.7 4.0 1.4 2.9 4.6 2.6 4.3 5.0
%vanA 55.6 45.5 66.7 42.9 40.0 57.1 35.0 50.0 50.0 86.4
E. faecium
n 130 144 136 133 155 167 190 231 224 281
%Ra 50.0 50.0 61.0 57.1 60.0 70.7 70.5 68.0 70.5 69.4
%vanA 75.4 88.9 80.7 84.2 88.2 86.4 88.1 94.9 95.6 99.0
aRepresents vancomycin non-susceptible rates (8mg/ml, CLSI M100-S17).
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P691 Effect of ﬂuoride content of the oral bioﬁlm on the surface
structure of titanium
E. Urba´n, A. Sta´jer, K. Turzo´, E. Mihalik, Z. Rakonczay, E. Nagy,
M. Radnai (Szeged, HU)
Background: High ﬂuoride concentration and the low pH in prophylactic
mouthwash and gels used to prevent caries may modify the surface
structure of the transgingival region of implants made of titanium (Ti).
Fluoride, like a reductive agent may have an opposite effect and attack
the oxide layer. The aim of the present work was to study whether
the changes on the surface structure of Ti caused by high ﬂuoride
concentration and acidic pH alter the adherence and colonisation of
bacteria.
Methods: Polished commercially pure titanium CP grade 4 discs
(Camlog) were used. Each sample was treated for 1 hour with one of
the solutions: mouthwash containing 0.025% ﬂuoride, a gel containing
1.25% ﬂuoride and a solution of 1.0% NaF (pH 4.5). The surface
structures were analysed by atomic force microscopy (AFM) and X-ray
photoelectron spectroscopy (XPS). The colonisation of Porphyromonas
gingivalis strains was studied by scanning electron microscope (SEM)
after 5 days of anaerobic incubation and the quantity of the bacterial
protein was determined by commercially available kit (Pierce).
Results: The roughness of the treated sample surfaces (Ra), as revealed
by the AFM measurements, was increased signiﬁcantly (2 times for the
gel and 10 times for the 1% NaF solution) as compared to the control
surface. No changes were detected in case of the mouthwash. The high
ﬂuoride concentration and acidic pH in the case of the gel and the 1%
NaF solution resulted in a strong corrosion and a modiﬁcation of the
composition of the titanium surface. The XPS spectra revealed formation
of ﬂuoride containing complexes (NaF and Na2TiF6) bound strongly to
the surface. A correlation was revealed between the roughness of the
surface and the thickness and the maturity of the P. gingivalis bacterial
colonies developed on the titanium surface. The number of the bacteria
was signiﬁcantly increased due to the changes in the surface caused by
NaF treatment.
Conclusions: High ﬂuoride concentration and acidic pH increase the
roughness of the titanium surface. Bacterial bioﬁlm colonisation on
this rough surface was proved to be more mature. The present study
indicates that high ﬂuoride concentration and acidic pH may affect the
development of transgingival epithel junction on the Ti surface.
This work was supported by the GVOP-3.2.1.-2004−04–0408/3.0 project
funded by the EC and the Hungarian Ministry of Economy, and the ETT
project (434/2006) supported by the Hungarian Ministry of Health.
P692 Are silver-coated Foley catheters resistant to encrustation by
crystalline bacterial bioﬁlms?
S.D. Morgan, D.J. Stickler (Cardiff, UK)
Objectives: To examine (1) the vulnerability of silver-coated silicone
and silver/hydrogel-coated latex catheters to colonisation by crystalline
Proteus mirabilis bioﬁlm; (2) to determine the extent to which silver
ions elute into urine from these catheters.
Methods: Laboratory models of the bladder were ﬁtted with size 14
Ru¨sch silver-coated silicone catheters or Bard IC silver/hydrogel-coated
latex catheters. Ru¨sch all-silicone catheters were used as non-coated
controls. Models were supplied with artiﬁcial urine at 1 ml/min and
inoculated with 10 ml of a 4 h urine culture (2 x 108 cfu/ml) of
P. mirabilis NSM6, a test strain that had been isolated from the blocked
catheter of a patient. Models were operated until the catheters blocked.
Scanning electron microscopy was used to visualize the bioﬁlms that had
developed on the catheters. The silver content of urine ﬂowing from the
catheters over three day periods from models that had not been inoculated
was assayed by atomic absorption spectroscopy.
Results: The mean times the models took to block calculated from
data obtained from ﬁve replicated experiments were 54.3±15.8h for
the silver/hydrogel-coated catheters, 73.5±23.0h for the silver/silicone
devices and 65.0 ±11.3h for the controls. Analysis of variance revealed
no signiﬁcant differences between these mean values (P = 0.257).
Scanning electron microscopy conﬁrmed that catheter blockage was due
to crystalline bioﬁlm formation. The eye-hole and lumenal surfaces of
all three types of catheter were shown to be colonised by extensive
co-aggregates of cells and crystals. Analysis of urine failed to detect
silver in the urine draining from the catheters (limit of detection 0.05
mg/L). At blockage the mean viable cell populations in the urine from
the models were 1.8 x 107 cfu/ml for the control, 3.4 x 107 cfu/ml for
the silver/silicone catheter and 2.9 x 107 cfu/ml for the silver/hydrogel
catheter. One-way analysis of variance revealed no signiﬁcant difference
in these mean values (P = 0.148).
Conclusions: The silver-coated silicone and the silver/hydrogel-coated
latex catheters are equally vulnerable to encrustation and blockage
by crystalline bacterial bioﬁlm. The concentrations of silver eluting
into urine from these catheters are less than 0.05 mg/L and are not
antibacterial.
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P693 Staphylococcus aureus bioﬁlm eradication: a new approach
by phodynamic therapy
F. Giuliani, M. Becherelli, L. Fantetti, G. Roncucci (Siena, IT)
Introduction: Bioﬁlms have remarkable medical importance for several
infections. Today bacterial bioﬁlm properties are not fully understood and
strategies for their treatment remain undeveloped. Standard antimicrobial
treatments often fail in bioﬁlm eradication and chronic infections
can arise. The development of alternative therapies against bioﬁlm
infections represents one of the major public health concern. Recently,
photodynamic therapy (PDT), is receiving considerable interest for
its potential as antimicrobial therapy. The principle of PDT is rather
simple: a photosensitizer is taken up into cells and activated by light
of appropriate wavelength causing cell death through the production of
active oxygen species (ROS).
Objectives: The aim of this study was to investigate the efﬁcacy of
cationic Zn(II)phthalocyanines (PC) of novel synthesis as photosensitiz-
ers for selective in-vitro eradication of S. aureus bioﬁlm.
Methods: S. aureus ATCC 6538 bioﬁlm was carried out in a 96-wells
ﬂat bottom sterile polystyrene microplates. After 24h incubation at 37ºC,
appropriately diluted Zn(II)PC solutions (0.05−50 microM) were added
to each well. After 5 min incubation in the dark Zn(II)PC-treated bioﬁlms
were irradiated with red light (30 J/cm2). Bioﬁlms residual vitality
after photoinactivation was determined by XTT assay. Cell survival
was expressed in terms of the percentage inhibition of XTT formazan
production (measured at 450 nm) by treated bioﬁlms compared with
values obtained for untreated bioﬁlms.
Results: The antibacterial kiling effects on the S. aureus bioﬁlms,
after photodynamic treatment with cationic Zn(II)PC, were linear in a
concentration-dependent manner. The 50% cell killing was obtained at a
very low concentration 0.05 microM with the most effective compound
and at least 95% killing was caused by all the Zn(II)PC tested at higher
concentration (50 microM).
Conclusion: Our results have shown that cationic Zn(II)PC photosensi-
tizers in conjunction with red light (600–700 nm) of moderate intensity
display a potent in vitro activity against sessile S. aureus cells. The
photodynamic inactivation by Zn(II) PCs resulted more effective or rapid
than vancomincin, one of the most common antibacterial agents used for
the Sthaphylococcus spp. treatment, indicating their potential usefulness
for the eradication of S. aureus bioﬁlm-associated infection.
P694 The possible role of the LPXTG protein SesC in
Staphylococcus epidermidis bioﬁlm formation
M. Shahrooei, V. Hira, B. Stijlemans, R. Merckx, P. Hermans, J. Van
Eldere (Leuven, Brussels, BE; Rotterdam, Nijmegen, NL)
Objective: Several well-studied proteins with deﬁned roles in Staphy-
lococcus epidermidis bioﬁlm formation (Aap, Bhp, SdrF and SdrG) are
LPXTG motif containing proteins. We investigated the involvement of
another LPXTG protein (SesC -Accession: NP_765787-Bowden et al.
Microbiology. 2005; 151:1453) in bioﬁlm formation.
Methods: Different clinical isolates of staphylococci were tested for
the presence of sesC by PCR. Our previously described in vitro and
in vivo rat models were used to investigate the time course of gene
expression in planktonic and sessile bacteria during bioﬁlm formation
and persistence. A recombinant protein of SesC was produced and used
to raise polyclonal antisera in rabbits. Immobilised recombinant SesC
was used for polyclonal antibody puriﬁcation from rabbit serum. ELISA
and Western blot were performed to demonstrate the presence of SesC in
the cell-wall fraction. Puriﬁed anti-SesC IgG’s and FITC-labelled goat-
anti-rabbit antibodies were used in immunoﬂuorescence assays to study
in vitro protein expression and the effect on bioﬁlm formation. The
sesC gene was cloned in pCN68 (AEM. 2004, 70:6076) and expressed
in sesC negative strains of S. aureus RN4220 and a clinical isolate of
S. haemolyticus. Bioﬁlm formation ability of transformed strains was
compared to that of wild strains.
Results: The sesC gene was present in all S. epidermidis strains. The
expression of sesC was signiﬁcantly upregulated during the early and late
in vivo infection. A small statistically not signiﬁcant difference in gene
expression between sessile and planktonic bacteria was observed in vitro.
Fluorescence microscopy data conﬁrmed the gene expression study data.
Furthermore, we demonstrated that polyclonal antibodies against SesC
reduced in vitro S. epidermidis bioﬁlm formation. Expression of sesC
in non S. epidermidis strains didn’t lead to any signiﬁcant difference in
bioﬁlm formation ability of the transformed strains.
Conclusion: The presence of sesC in all tested S. epidermidis strains
but not in all other staphylococcal species indicates the importance of
sesC for S. epidermidis.
The observed upregulation in sessile bacteria and the ability of polyclonal
anti-SesC antibodies to inhibit bioﬁlm formation in S. epidermidis
suggest a role for SesC in the S. epidermidis bioﬁlm formation. The
precise role in bioﬁlm formation of this protein remains to be solved.
P695 Detection of staphylococcal ability for bioﬁlm formation in
otitis media in children. An evaluation of three different
detection methods
A. Niedzielski, J. Paluch-Oles, M. Koziol-Montewka, A. Magrys,
G. Niedzielska, M. Kotowski (Lublin, PL)
Objectives: Chronic otitis media (OM) is a common paediatric infectious
disease. The infection has long been considered to be a sterile
inﬂammatory process. The previous application of highly sensitive
techniques of molecular biology suggests that metabolically active
bacteria exist in culture-negative paediatric middle-ear effusions. To
explain these observations it has been previously proposed that chronic
OM may result from a mucosal bioﬁlm infection. Bacterial bioﬁlms are
difﬁcult to detect in routine diagnostics and are inherently tolerant to
host defences and antibiotic therapies. In addition, bioﬁlms facilitate the
spread of antibiotic resistance by promoting horizontal gene transfer. The
purpose of this study was to analyse a phenotypic and genotypic ability
of isolated staphylococcal strains for bioﬁlm formation during the course
of otitis media in children by using three different detection methods.
Methods: A total of 96 effusions from the mid-ear, obtained from 48
patients aging between 2 and 6 with chronic otitis media, were tested
bacteriologically by conventional methods. The identiﬁcation to species
level was performed by using API tests (Bio Merieux). Among 36 culture
positive specimens, 16 strains of Staphylococcus spp. were screened for
bioﬁlm formation by tissue culture plate (TCP), Congo red agar (CRA)
method and presence of ica A, B, C, D operons.
Results: Of 16 Staphylococcus spp., Api Staph revealed 8 strains
of S. epidermidis, two S. sciuri, one S. capitis, one S. caprae, one
S. warneri. The remaining three strains were identiﬁed as S. aureus.
Regarding coagulase negative Staphylococci (CNS) isolates, 6 (37.5%)
revealed the phenotypic ability to produce bioﬁlm, conﬁrmed by TCP
and CRA methods. Three of these isolates (18.7%) were also icaA and
icaD positive and slime forming. Two S. aureus strains, detected as icaA
or icaB positive by PCR analysis displayed a bioﬁlm-negative phenotype
in TCP and CRA methods.
Conclusion: Among the Staphylococcus genus, the species that is most
commonly involved in bioﬁlm formation is S. epidermidis. Bioﬁlm
formation is encoded by the ica operon and coexpression of icaA and
icaD is required for full slime synthesis. TCP method correlates with
the results of ica detection and is more speciﬁc than CRA.
P696 Staphylococcus epidermidis bioﬁlm modulates cytokine
production
A. Spiliopoulou, F. Kolonitsiou, I. Spiliopoulou, M. Krevata,
G. Dimitracopoulos, E. Anastassiou (Patras, GR)
Objectives: To compare the immune response of Staphylococcus
epidermidis bacterial cells existing either in planctonic or in bioﬁlm
phase.
Methods: A reference slime producing S. epidermidis strain
(ATCC35983) was used in the present study. Slime production was
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conﬁrmed by Christensen’s method. Planctonic phase bacteria were
obtained after a 6h incubation in proper medium. Bioﬁlm phase bacteria
were obtained by incubation in 24-well tissue culture plates for 48h and
subsequent rinse; bioﬁlm phase cells remained attached to the bottom
of the wells. Peripheral blood mononuclear cells from multiple healthy
donors were isolated and co-cultured in 24-well ﬂat bottom tissue culture
plates either with live S. epidermidis planctonic cells at a ratio of 25:1
or with bioﬁlm phase cells. Cytokines were measured in triplicate, using
the Luminex® xMAPTM technology, in cell-free supernatants collected
at 2, 4, 6, 12, 24 and 48 hours. The 8-plex assay kit was used for
the simultaneous quantitative determination of the following cytokines:
TNFa, IL-1b, IL-6, IL-8, IL-10, IL-12p40, IL-13 and GM-CSF, whereas,
the 3-plex high-sensitivity assay kit was used for IL-12p70, IL-2, and
INF-g.
Results: Kinetics of cytokine production revealed that TNFa and IL-
10 accumulation was higher at 12h, whereas IL-12, IL-2, INF-g, and
GM-CSF peaked at 48h. IL-1b, IL-6 and IL-8 levels exhibited a
plateau pattern between 6 and 48h. IL-13 was not detectable in most
experiments. Bioﬁlm phase bacteria elicited production of lower levels
of all cytokines tested as compared to planctonic phase bacteria. This
phenomenon was more prominent for IL-12p40, as bioﬁlm phase bacteria
led to 35-fold lower IL-12p40 production. Although cytokines’ levels
showed interdonor variability, the overall pattern was reproducible in all
experiments. Differences were statistically signiﬁcant (p< 0.05). Mean
peak value±standard deviation of each cytokine in pg/mL from a typical
representative experiment is shown in Table 1.
TNFa IL-1b IL-6 IL-8 IL-10 IL-
12p40
IL-
12p70
IL-2 INF-g GM-
CSF
Planctonic
phase
5200
±270
8500
±460
9460
±350
8900
±550
212
±30
120
±18
1.79
±0.3
3.04
±0.26
5.7
±1.5
130
±14
Bioﬁlm
phase
210
±25
749
±60
420
±35
2800
±340
80
±15
3.5
±0.4
0.11
±0.02
0.13
±0.03
2.04
±0.35
60
±8
Conclusion: S. epidermidis cells embedded in bioﬁlm induce low-
level production of proinﬂammatory and adaptive immunity cytokines,
especially IL-12p40, which is a key cytokine in development of TH1
responses leading to suppression of immune system, and may explain
observed silent, persistent, infections.
P697 The coupled effects of physicochemical and ﬂow conditions on
Staphylococcus epidermidis adhesion and ica genes expression
A. Foka, M. Katsikogianni, V. Chini, Y. Missirlis, E.D. Anastassiou,
I. Spiliopoulou (Patras, GR)
Objectives: Meticillin resistant Staphylococcus epidermidis (MRSE)
is the predominant species associated with medical device infections
impeding their long-term use. The critical step to development of
infections is bacterial adhesion to biomaterials mediated by non speciﬁc
interactions, as well as bacterial slime production encoded by the ica
operon. The coupled effects of speciﬁc chemical terminal surface groups
and ﬂow conditions on the initial adhesion of S. epidermidis were
investigated in correlation to the expression of two genes of the ica
operon.
Methods: Reference control strains (ATCC35984, slime-positive and
ATCC12228, slime-negative), and two clinical strains isolated from
different hospitalised patients, (one ica-positive/slime-positive and one
ica-positive/slime-negative) were investigated. Bacteria were grown in
BHI medium and then suspended in physiological saline at a concen-
tration of ~3×109 cells/mL. Hydroxyl (OH)-terminated (hydrophilic)
and methyl (CH3)-terminated (hydrophobic) glass surfaces were used as
substrates in a parallel ﬂow chamber. Bacterial adhesion was examined
under two ﬂow rates: 2mL/min and 20mL/min for four hours. Total
RNA from both bacterial supernatant (s) and adherent (a) bacteria
after detachment with trypsin, was isolated by the Trizol method.
Reverse transcription followed by quantitative Real-Time PCR (qRT-
PCR) allowed the detection of expression levels of icaA and icaD. Table
1 summarizes the results.
Table 1: Quantiﬁcation of icaA and icaD expression by qRT-PCR
Bacterial Slime qRT-PCR
strain icaA (copies/mL) icaD (copies/mL)
(OH), ml/min (CH3), ml/min (OH), ml/min (CH3), ml/min
2 20 2 20 2 20 2 20
s a s a s a s a s a s a s a s a
ATCC 35984 + 0 0 8 0 0 0 13 5 80 52 583 56 104 114 1864 8
ATCC 12228 − 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2264 − 1 0 0 2 5 0 0 4 11319 108 36 2 161 2 121 3
4388 + 3 0 3 1 8 5 0 3 3 31 6 11 39 297 56 5
Conclusions: Surface chemistry and ﬂow conditions inﬂuence the
expression level of both ica genes. Hydrophobic biomaterial surfaces
and faster ﬂow rate seem to play a crucial role to initial adherence
increasing ica gene expression.
P698 In vitro activity of caspofungin and anidulafungin against
Candida albicans and C. glabrata bioﬁlms
A. Valentı´n, E. Canto´n, J. Pema´n, M. Bosch, M. Gobernado,
J.P. Martı´nez (Valencia, ES)
Objectives: Candidiasis is frequently associated with bioﬁlm formation
on indwelling medical devices such as central venous catheters, urinary
catheters, heart valves and joint prostheses. Candida spp. bioﬁlms are
less susceptible to antifungal agents than planktonic (free-living) cells.
The aim of this study was to test the ability of C. albicans and C. glabrata
to form bioﬁlms and to determine the activity of caspofungin and
anidulafungin against free-living cells and bioﬁlms of both species.
Methods: 16 C. albicans and 23 C. glabrata strains from blood cultures
were studied. MICs of planktonic cells were determined following
the CLSI M27-A2 document. MIC2 corresponded to the lowest drug
concentration that showed a reduction of growth  50% compared
with the growth control. Bioﬁlms were formed following the method
described by Ramage. et al. (1). Antifungal agents at concentrations
ranging from 16−0.03 mg/L were added to polystyrene microplates
containing Candida bioﬁlms of 24 and 48h of maturation. Antifungal
activity against bioﬁlms was assessed by the XTT reduction assay. Sessile
MICs (SMICs) 50 and 80 corresponded to the lowest drug dilution
that supported an OD  50% and  20%, respectively compared with
control.
Results: 10 C. albicans and 3 C. glabrata developed bioﬁlm (62.5
and 13.04%, respectively). Geometric mean SMIC50s and SMIC80s of
caspofungin against C. albicans bioﬁlms of 24/48h of maturation were
0.683/1.878 and 16/16 mg/L, respectively; and against C. glabrata
0.038/0.12 and 0.095/0.12 mg/L, respectively. For anidulafungin, these
values were: 0.521/4.52 and 16/16 mg/L against C. albicans and
0.095/0.63 and 0.12/1 mg/L against C. glabrata.
Conclusions: C. albicans produced more bioﬁlm than C. glabrata.
Caspofungin and anidulafungin showed activity against C. albicans
bioﬁlms of 24h of maturation, but not against those of 48h. Both
echinocandins displayed excellent activity against C. glabrata bioﬁlms
of 24 and 48h of maturation.
Reference(s)
[1] Ramage G, et al. Standardized method for in vitro antifungal
susceptibility testing of Candida albicans Bioﬁms. Antimicrob
Agents Chemother 2001; 45:2475–2479.
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P699 Implication of Candida bioﬁlm maturation on the
susceptibility to amphotericin B, caspofungin and
posaconazole, alone or in combination
S. Tobudic, C. Kratzer, W. Graninger, A. Lassnigg, A. Vorderwinkler,
H. Fischer, E. Presterl (Vienna, AT)
Objectives: Candida bioﬁlm-associated infections are a particular
challenge in modern implant surgery because of their resistance to
conventional therapy. In this work was determined the activity of
amphotericin B, caspofungin and posaconazole alone or in combination
on bioﬁlms of various Candida species at distinct levels of maturation.
Material and Methods: Bioﬁlms of 44 isolates from blood, central
venous catheter, urine, skin swabs and medical devices swabs of cardiac
surgery patients (C. albicans n= 25; C. glabrata n = 8, C. parapsilosis
n = 5, C. tropicalis n = 2, C. krusei=1, C. famata n = 1, C. norwegiensis
n = 1, C. guilliermondi n = 1) were grown for either 24, 48 or 72 hours
in 96-well microtiter plates. The bioﬁlms were treated for 48 hours with
amphotericin B (AMB), caspofungin (CAS) and posaconazole (POS)
alone in increasing concentrations according to the respective MIC (1–
128×MIC) and with combination therapy: AMB 0.5 mg/l/CAS 0.5 mg/l
or 1 mg/l, and AMB 0.5 mg/l/POS 0.5 mg/l or 1 mg/l. The optical density
(OD) was determined using XTT-reduction assay at a wavelength of 450
nm. The OD of the untreated bioﬁlm of the respective isolate was set as
1. To test for viable Candida spp. in the bioﬁlms, the unﬁxed bioﬁlms
were scraped off and seeded to Sabouraud agar.
Results: Treatment with CAS reduced signiﬁcantly the OD of 24- and
72 hours C. albicans bioﬁlms at concentrations of 1×MIC (p< 0.05),
while no signiﬁcant reduction of the OD of 48 hours old non-albicans
Candida bioﬁlm was detected up to a concentration of 128×MIC.
AMB reduced the OD of 24- and 72 hours bioﬁlm signiﬁcantly at
concentration of 1×MIC – 4×MIC (p< 0.05). Signiﬁcant OD reduction
of 48 hours old bioﬁlm achieved AMB at concentrations of 8×MIC
(C. albicans) and 32×MIC (non-albicans). POS was equally effective
at all stages of Candida bioﬁlms and reduced the OD at a concentration
of 1×MIC-2×MIC (p< 0.05). Combinations of antifungals led to
signiﬁcant reduction of the OD of the bioﬁlm in the each stage of
development (p< 0.01).
Conclusion: Candida bioﬁlms show different degrees of susceptibility
to therapy with a single antifungal agent depending of the phase
of development. Particularly 48 hours old bioﬁlms exhibit less
susceptibility. Combination therapy attained high OD reduction and may
be an option for the treatment of bioﬁlm-associated infections.
P700 Comparison of bioﬁlms formed by clinical oral isolates of
non-Candida albicans Candida species
S. Silva, M. Henriques, R. Oliveira, D. Williams, J. Azeredo (Braga,
PT; Cardiff, UK)
Objectives: Oral candidiasis is a signiﬁcant problem in patients
undergoing treatment for cancer or organ transplantation. Furthermore
it is one of the most common and persistent conditions encountered in
individuals with human immunodeﬁciency virus infection and acquired
immunodeﬁciency syndrome. Many Non-Candida albicans Candida
(NCAC) species, such as Candida glabrata, Candida parapsilosis and
Candida tropicalis have recently emerged as signiﬁcant pathogens of
clinical importance. Bioﬁlms have clinical signiﬁcance as they exhibit
high resistance to host defences and antimicrobial agents, therefore
representing a persistent source of infectious organisms. Thus, the aim
of this study was to compare bioﬁlms formed by different oral isolates
of NCAC species.
Methods: A total of 6 strains were isolated from oral tract, including
C. parapsilosis (n = 2), C. glabrata (n = 2) and C. tropicalis (n = 2).
References strains of each species (C. glabrata ATCC 2001, C. tropicalis
ATCC 750 and C. parapsilosis ATCC 22019) were also assayed. Bioﬁlms
were analysed after 48 hours through total biomass quantiﬁcation by
crystal violet staining. The ultrastructure of the NCAC species bioﬁlms
was observed by Scanning Electron Microscopy. Matrix material was
extracted from bioﬁlms and their protein and total carbohydrate contents
were determined by the Lowry and Dubois methods, respectively.
Results: The results showed that all NCAC species were able to form
bioﬁlms, although there were differences among species and strains.
However, C. glabrata strains are less capable to form bioﬁlm compared
with the other species. Candida parapsilosis and C. tropicalis strains
revealed a multilayer bioﬁlm structure that consists of a dense network of
yeast, hyphae and pseudohyphae. On the other hand, C. glabrata strains
revealed a dense and compact multilayer bioﬁlm structure intimately
packed with yeasts without of either pseudohyphae or hyphae. Matrix
isolated from C. parapsilosis bioﬁlms consisted of higher amounts of
carbohydrates but small amounts of proteins. In contrast, matrix from
C. tropicalis strains consists mainly of proteins, with smaller amounts
of carbohydrates. Matrix from C. glabrata strains consisted of lower
amounts of proteins and carbohydrates.
Conclusions: As a general conclusion, it was possible to infer that
clinical oral isolates of NCAC species present different behaviours in
terms of bioﬁlm formation, structure and chemical composition.
P701 In vitro anti-bioﬁlm activity of micafungin in a lock strategy
E. Cateau, M-H. Rodier, J-M. Berjeaud, C. Imbert (Poitiers, FR)
Objectives: Catheter-related candidiasis are associated with the forma-
tion of a fungal bioﬁlm which alters the susceptibility to antifungal
agents. Catheter lock therapy could represent a conservative strategy
of the catheter in candidaemia involving the static instillation, usually
during 12h, of a concentrated solution of antimicrobial agent (100 to
1000 MIC) into the catheter lumen. This study deals with the in vitro
anti-bioﬁlm potential of micafungin, used as a lock solution, to manage
C. albicans bioﬁlms.
Methods: Bioﬁlms of two C. albicans strains (ATCC 66396 and ATCC
3153), 12 hours or 5 days old, were formed on 0.5 cm sections of 100%
silicone catheters. Micafungin 5mg/mL (corresponding approximately to
170 MIC) was then added to the bioﬁlms and catheters were incubated
for 12h at 37ºC. Micafungin was then removed by washing. The
metabolic activity of yeasts within the bioﬁlm was assessed with XTT
method, 24h, 48h or 72h after the end of the locks. Controls without
antifungal were realised and used as references to calculate the inhibition
percentages induced by micafungin locks.
Results: For a young C. albicans bioﬁlm (12h), the growth inhibition
induced by a 12h micafungin 5mg/mL lock therapy and observed
after a 24h culture without antifungal was at least 67% whatever the
studied strain. 48h after the end of the lock, micafungin demonstrated
a signiﬁcant inhibitory activity on the development of 12h old bioﬁlms,
reaching at least 54%. 72h after the end of the lock, the inhibition
observed was at least 40%.
The efﬁciency of micafungin lock on the development of a mature
C. albicans bioﬁlm (5 days old) was also signiﬁcant: the inhibition
observed 24h or 48h after the end of the lock was at least 54% suggesting
a persistent efﬁciency.
Conclusion: These results showed that the micafungin lock treatment
was efﬁcient in vitro, on the studied strains, whatever the bioﬁlm
maturation stage. This study suggests that this echinocandin could have
a real anti-bioﬁlm potential and could become an interesting actor in the
lock approach.
P702 CgCDR1, CgCDR2, and CgERG11 gene expression in
Candida glabrata bioﬁlms formed by bloodstream isolates
J.H. Shin, S. Kim, M. Shin, S. Suh, D. Ryang, S.J. Kee, S.I. Jung,
S.J. Jang, H.S. Lee (Gwangju, KR)
Objectives: A number of molecular mechanisms have been implicated
in non-bioﬁlm antifungal resistance in C. glabrata, but the relevance
of these mechanisms to C. glabrata bioﬁlm cells has rarely been
examined. We determined whether the expression of azole-resistance
genes is altered during the developmental phases of bioﬁlm formation
by C. glabrata
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Methods: Four bloodstream isolates of C. glabrata from cases of
central venous catheter-related fungaemia showing high in vitro bioﬁlm
formation were studied. A microtiter-plate-based colorimetric assay
was used to test the ﬂuconazole susceptibility of Candida bioﬁlms
at 80% inhibition using the 2,3-bis[2-methyloxy-4-nitro-5-sulfophenyl]-
2H-tetrazolium-5-carboxanilide (XTT) reduction assay. The expression
of CgCDR1, CgCDR2, and CgERG11 genes during the early (6 h),
intermediate (15 h), and mature (48 h) phases of bioﬁlm development,
and corresponding planktonic cells, were examined using real-time PCR
methods.
Results: The ﬂuconazole minimum inhibitory concentrations (MIC) of
C. glabrata bioﬁlms formed at 6, 15, and 48 h were all >1,024 ug/ml.
The bioﬁlms at 15 h exhibited an approximately 3.3-fold upregulation
of CgCDR1 compared with the corresponding planktonic cells, which
was higher than the values for bioﬁlms at 6 (1.5 fold) and 48 (0.8 fold)
hours (P< 0.05). The CgCDR2 transcript levels for bioﬁlms were also
highest at 15 h (3.1-fold upregulation), but were minimal at 6 and 48 h
(0.5 and 0.8 fold) (P< 0.05). By contrast, the CgERG11 transcript levels
did not differ among the 6-, 15-, and 48-h bioﬁlms.
Conclusion: Our study demonstrated a temporal increase in the
expression of the CDR1 and CDR2 genes in C. glabrata bioﬁlms formed
by bloodstream isolates during the early bioﬁlm development stage.
P703 New focus – old disease: the paranasal sinuses as possible
focus for bacterial lung infections in cystic ﬁbrosis patients
H.K. Johansen, J. Fisker, T. Pressler, S.K. Hansen, S. Molin, N. Høiby,
C. von Buchwald (Copenhagen, Lyngby, DK)
CF patients often have nasal polyposis and sinusitis because of impaired
mucociliary clearance and mechanical obstruction of the sinus ostia
by thickened mucus. CF patients who have had a lung transplant are
colonised in their new lungs with the same clones as those that were
cultured from their old lungs. It has therefore been suggested that the
sinuses may serve as a bacterial reservoir after transplantation.
We have genotyped ﬁrst and subsequent P. aeruginosa lung isolates from
CF children by using the ArrayTube chip and PFGE. Among ﬁrst isolates
we found a large genetic diversity. We also found that after successful
antibiotic eradication of P. aeruginosa new colonising isolates had the
same genotype as the initial colonising strain. The large genetic diversity
in CF children is distinct from most chronically infected patients in our
CF clinic where the diversity of strains is more restricted.
Nineteen CF patients (7 males, 12 females, median age: 19 years (range
6−46)) have been treated with Functional Endoscopic Sinus Surgery
using CT image guidance to evaluate whether their sinuses serve as a
bacterial reservoir for their lung colonisation or infections. Seven patients
were chronically infected with P. aeruginosa, 2 with Burkholderia, 1 with
Achromobacter and 5 were intermittently colonised with P. aeruginosa.
We found full or partial agreement between lung and sinus bacteriology
in 18/19 (95%) of the patients. Seven patients chronically infected with
P. aeruginosa have an identical genotype in their lungs for more than
15 years and this genotype was identical to the P. aeruginosa obtained
from the paranasal sinuses. Four of ﬁve intermittently colonised children
had growth of the same genotype of P. aeruginosa in their sinuses and
sputum samples collected up to 2 years prior to the surgery.
In Gram stained smears from the sinuses we found that the bacteria
were organised in bioﬁlm structures similar to those seen in the lungs.
In sinus smears we only detected few inﬂammatory cells compared to
the lung smears. We think that the colonisation is immunological silent
in intermittent colonised patients and cause only an insigniﬁcant anti-
P. aeruginosa antibody response (Th1 response). When the bacteria grow
in the lungs a shift towards a Th2 response is seen with high antibody
production. In future, we will sample simultaneous sinus and lung
cultures in intermittently colonised patients to determine the primary
focus for the airway infection.
P704 Adhesion to and bioﬁlm formation on IB3−1 bronchial cells by
Stenotrophomonas maltophilia: implications in cystic ﬁbrosis
G. Di Bonaventura, A. Pompilio, C. Picciani, M. Nicoletti,
R. Zappacosta, R. Piccolomini (Chieti, IT)
Objectives: The increasing isolation of S. maltophilia from the sputa
of cystic ﬁbrosis (CF) patients has become a cause for concern in the
CF community, as the organism is resistant to many of the antibiotics
prescribed in the management of CF. However, the role of S. maltophilia
in the physiopathology of CF pulmonary disease has not yet been
clariﬁed. The aim of the present study is to characterise the interaction
between S. maltophilia and CF bronchial epithelium.
Methods: Twelve S. maltophilia strains from the sputum of CF patients
were tested for adhesion to bronchial epithelial cells isolated from a
CF patient (IB3−1; ATCC CRL-2777). IB3−1 monolayers were exposed
for 2 h (37ºC, 5% CO2) to S. maltophilia 108 CFU/ml (MOI: 1.000),
then adherence was measured by direct agar plating. The most adhesive
strains (TC9 and TC10) were chosen for further characterisation. To
determine the contribution of ﬂagella to the ability to adhere to
IB3−1 cells, ﬂiI (codifying for the ﬂagellum-associated ATPase) mutants
of TC9 and TC10 strains were generated. Furthermore, swimming
and twitching motility tests were performed. The signiﬁcance of the
difference (P< 0.05) was calculated by ANOVA-test and Neumann-Keuls
test.
Results: All isolates tested adhered to IB3−1 cells, although striking
differences were observed (mean±SD: 2.1×106±1.7×106 cfu/chamber).
In particular, TC9 and TC10 strains (causing monomicrobial and
persistent infections) showed an adhesion (5.6×106 vs 5.0×106
respectively; P> 0.05) signiﬁcantly higher than other strains tested. TC9
and TC10 strains signiﬁcantly (P< 0.01) increased adhesion from 2 to 6
h incubation (TC9: 5.6×106 vs 9.3×106; TC10: 5.0×106 vs 1.1×107;
2h vs 6h, respectively). Microscopy showed that after 6h-incubation
S. maltophilia forms structures consistent with bioﬁlms. Adhesion levels
did not correlate with ﬂagellar motility. On the contrary, adherence of
ﬂagellar mutants ﬂiI- TC9 and TC10 was signiﬁcantly (P< 0.001) lower
than wild-type strains (TC9: 2.5×106 vs 5.6×106, ﬂiI- vs wt; TC10:
1.7×106 vs 5.0×106, ﬂiI- vs wt).
Conclusion: Our results suggest, for the ﬁrst time, that the ability to
adhere to CF-derived bronchial epithelium is common in S. maltophilia
isolates. Flagella function as adhesins in direct binding to IB3−1 cells.
The ability showed by S. maltophilia to rapidly organise itself as a bioﬁlm
could have clinical relevance contributing to antibiotic resistance and
bacterial persistence in CF patients.
P705 Mechanisms of environmental persistence of multidrug-
resistant Acinetobacter baumannii isolates responsible for
outbreaks in three Italian hospitals
P. Landini, G. Fugazza, M. Spalla, R. Migliavacca, E. Giacobone,
A. Navarra, M. Labonia, L. Pagani (Milan, Pavia, San Giovanni
Rotondo, IT)
Objectives: Acinetobacter baumannii (Ab), an environmental Gram-
negative bacterium, is considered one of the most dangerous emerging
pathogens. The increasing number of outbreaks by clonally related
multidrug resistant (MDR) Ab underlines the importance of clonal
spread in nosocomial infections. We investigated the mechanisms of
persistence in the hospital environment of Ab isolates responsible for
outbreaks in three Italian hospitals.
Methods: 52 clinical isolates, collected from 2 acute care hospital and 1
long-term and rehabilitation facility between 2002–2006, were identiﬁed
and tested for susceptibility with standard procedures. Genotyping was
performed by PFGE analysis. Bioﬁlm formation was determined by
crystal violet assay. To assess contribution of cellulose production to
bioﬁlm formation, cultures were grown in the presence of different
concentrations of cellulase.
Results: Genotyping by PFGE showed that most of MDR Ab isolates,
susceptible to carbapenems, able to cause recurrent outbreaks in the
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studied settings belonged to the same DNA group (clone A), while
the others, resistant to carbapenems too, belonged to clone B, which
shows close relationship to European clone II. Both clone A and clone
B isolates are proﬁcient in bioﬁlm formation, which was favoured by
growth in nutrient-deﬁcient medium in comparison to rich medium,
and by lower growth temperature. Bioﬁlm formation was inhibited by
treatment with the lytic enzyme cellulase in both clones, suggesting
that cellulose may act as an important adhesion factor in Ab. However,
bioﬁlms formed by clone A were less susceptible to cellulase treatment;
in addition, clone A, but not clone B, displays a dark red phenotype on
Congo Red-supplemented medium. These observations strongly suggest
production of additional cell surface-associated structures involved in
bioﬁlm formation in clone A. Finally, clone A showed much stronger
resistance to desiccation than clone B.
Conclusions: Our results show that bioﬁlm formation in Ab is favoured
in conditions more typical of the external environment rather than of
the human host, conﬁrming that bioﬁlm might be involved in the Ab
persistence in the environment. We show that cellulose is an important
adhesion factor for Ab; however, the clone A identiﬁed in our study
seems to possess additional bioﬁlm determinants involved in resistance
to environmental stresses such as desiccation, and thus potentially
important in environmental persistence.
P706 Aeromonas hydrophila polar ﬂagellum produces two
redundant sodium-driven stator motor proteins
M. Wilhelms, A. Lacasta, J. Tomas, S. Merino (Barcelona, ES)
Aeromonas hydrophila is a ubiquitous water-borne bacterium that has
been associated with a wide variety of human diseases, which include
gastrointestinal and extraintestinal infections. Mesophilic aeromonads
constitutively expressed a single polar unsheathed ﬂagellum and 50%-
60% strains can also produce multiple lateral ﬂagella in hifhly
viscous environments. Both ﬂagella types are important virulence and
colonisation factors.
Aeromonas polar ﬂagella genes are distributed in ﬁve non-contiguous
chromosomal regions and two of them contain genes whose encoded
proteins are homologous to polar ﬂagella stator-motor proteins. Polar
ﬂagella region 3 contains pomAB genes, and region 4 contains motX.
Only motX mutation abolishes polar ﬂagella motility. These results
suggested that lateral ﬂagella stator-motor LafT-U can supply PomA-
B function or the presence of a second polar stator-motor involved in
polar ﬂagella motility.
The objective of this work is to completely characterise the polar ﬂagella
stator motor of Aeromonas hydrophila strain AH-3 and correlate polar
ﬂagella motility with bioﬁlms formation.
Deﬁned A. hydrophila AH-3 mutant in lafTU and a double mutant
in both lafTU and pomAB, showed that both mutants are able to
swim in liquid media. Then, transposon-insertion mutagenesis using the
A. hydrophila pomAB mutant as recipient strain, allow us to identiﬁed
a new chromosome polar ﬂagella region (region 6) containing two
polar stator-motor genes named pomC and pomD. A. hydrophila PomC
and PomD are highly homologous to sodium-conducting polar ﬂagella
stator-motors. Distribution of pomAB and pomCD is identical in all the
mesophilic Aeromonas strains tested, either if the strains were able to
produce lateral ﬂagella or not. Furthermore, analysis of A. hydrophila
pomCD mutants and double mutants in both pomAB and pomCD showed
that only double mutants abolish polar ﬂagella motility.
Swimming motility assays in presence of different amiloride and sodium
chloride amounts with A. hydrophila AH-3 and polar ﬂagella stator-
motor mutants demonstrate that PomA-B and PomC-D polar ﬂagella
stator-motor are sodium dependents. Bioﬁlm assays showed that polar
ﬂagella motility is involved in bioﬁlm formation.
In conclusion we demonstrated that PomA-B and PomC-D are redundant
set of sodium-driven stator motor proteins, as none of them by separate is
essential for polar ﬂagella motility neither in aqueous nor high-viscosity
environments.
P707 The AcrAB-TolC efﬂux system contributes to bioﬁlm
formation in Salmonella enterica serovar Typhimurium
M. Webber, C. Burrows (Birmingham, UK)
Objectives: To determine the role of the AcrAB-TolC efﬂux system of
S. Typhimurium in bioﬁlm formation.
Methods: Strains used were S. Typhimurium 14028 and isogenic
derivatives lacking acrAB or tolC. Bioﬁlms were grown in deﬁned
minimal media in microtitre trays or transwell trays and quantiﬁed by
staining with 1% crystal violet and measurement of absorbance using
a FLUOstar optima plate reader. RNA was prepared using the SV
total RNA kit (Promega, U.K). Gene expression was determined using
comparative RT-PCR and denaturing HPLC.
Results: Mutants lacking either acrAB or tolC were compromised
in their ability to form bioﬁlms compared to 14028. L829 (14028,
tolC::aph) produced 3 fold less bioﬁlm compared to 14028, L830 (14028,
acrAB::aph) was further compromised in its ability to form bioﬁlm and
produced 10 fold less bioﬁlm than 14028. Co-incubation of mutants
lacking acrAB or tolC and 14028 separated by a membrane which acts
as a barrier to cells but not solutes in transwell assays showed no rescue
of bioﬁlm formation. This suggested that the bioﬁlm defect of L829
and L830 can not be alleviated by a molecule(s) secreted by wild-type
strains. RT-PCR of acrB and tolC demonstrated that both genes were
over-expressed (2-fold) by cells in a bioﬁlm relative to cells grown in
planktonic culture.
Conclusions: A functional AcrAB-TolC efﬂux system is required for
normal bioﬁlm formation in S. Typhimurium and expression of this
system is increased during growth as a bioﬁlm. It was not possible to
rescue bioﬁlm formation in the transwell experiments suggesting that
AcrAB-TolC does not export a structural molecule required for creation
of a bioﬁlm. The data presented here demonstrate that AcrAB-TolC is
required for bioﬁlm formation as well as intrinsic resistance to many
antimicrobials and pathogenicity as has previously been described.
P708 Differences in bioﬁlm development and antibiotic
susceptibility among human clinical Ureaplasma sp.
M. Garcı´a-Castillo, M. Ga´lvez, M.I. Morosini, F. Baquero, R. del
Campo, M.A. Meseguer (Madrid, ES)
Objectives: The aim of this work was to investigate the ability of
clinical isolates of Ureaplasma sp. to be bioﬁlm formers, comparing
the antibiotic susceptibility between sessile cells (minimum bioﬁlm
inhibitory concentration, MBIC) and their planktonic counterpart
(conventional MIC).
Methods: A total of 11 Ureaplasma sp. isolates were obtained from
clinical samples that included urine, semen, and urethral exudates from
urethritis or chronic prostatitis, and also from urine of two healthy
volunteers. All isolates were recovered during 2007 at the Service of
Microbiology of the University Hospital Ramo´n y Cajal, in Madrid,
Spain and corresponded to unrelated patients. Mycoplasma identiﬁcation
was carried out by growth in 10C broth medium and growth of typical
brown colonies on A7 medium by urease production in the presence
of manganese chloride. Antibiotic susceptibility was determined by
broth microdilution method. Bioﬁlm susceptibility assay was performed
in 96-well microtiter plates, using the 10-C UREA-medium pH 6.
Bacterial bioﬁlms was investigated by immersing the pegs of a modiﬁed
polystyrene microtiter lid into this bioﬁlm growth plate until the media
turned from orange to fuchsia. Comparison between MBIC50-MIC50
and MBIC90-MIC90 values was carried out only in strains able to form
bioﬁlm.
Results: Positive bioﬁlm formation was observed in 9 isolates (81.2%);
being the two bioﬁlm non-formers isolates obtained from urethral
exudates. Taking into account the antibiotic susceptible-resistant concept,
most Ureaplasma isolates were susceptible to all antibiotics used when
the traditional MIC test were applied. However, the resistant isolates
increased considerably when the antibiotic susceptibility test was carried
out in bioﬁlm formation. In general, MBIC were one or two dilution
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higher than MIC, although there were some exceptions in which the
MBIC was lower. These contradictory results were observed in four
strains for telythromycin, levoﬂoxacin, and tetracycline, observing a
higher susceptibility for these antibiotics in the bioﬁlm formation than
in the planktonic one. Nevertheless, comparing the MIC50−90 with the
MBIC50−90 in all bioﬁlm-formers strains, MBIC values were higher for
all antibiotics.
Conclusion: Ureaplasma sp. isolates from clinical human samples
are able to growth in bioﬁlm formation showing reduced antibiotic
susceptibility compared with the planktonic one; although for some
antibiotics MBICs are lower than MICs.
P709 Association between bioﬁlm formation and antibiotic
resistance by Salmonella enteritidis
I. Cirkovic, M. Svabic Vlahovic (Belgrade, RS)
Non-typhoidal salmonellosis in humans is usually a self-limiting
disease conﬁned to the gastrointestinal tract, but when infection
spreads beyond the intestine, or when immunocompromised persons are
affected, effective antimicrobial treatment is essential. Besides, numerous
studies have shown that Salmonella spp. are capable of adhering and
forming bioﬁlm on diifferent surfaces and under different environmental
conditions. The aim of this study was to analysed the association between
antibiotic resistance and bioﬁlm formation between tested strains of
Salmonella Enteritidis.
A total of 30 strains of Salmonella Enteritidis were isolated from patients
with acute diarrhoea at the Institute of Infectious and Tropical Diseases
in Belgrade during 2002. The strains were identiﬁed and serotyped
by conventional methods. Antimicrobial susceptibility testing for 11
antibiotics was performed according to the CLSI recommendations.
The quantiﬁcation of bioﬁlm formation was performed by modiﬁed
microtiter-plate test. Differences in the quantities of produced bioﬁlm
were examined by Friedman test, followed by the Wilcoxon signed ranks
test. Statistical analysis of relationship between antibiotic resistance and
bioﬁlm formation was examined by Spearman coefﬁcient of correlation.
Fully susceptibility to all antibiotics was established in 10 (33.3%)
isolates, and 20 (66.7%) strains were intermediary susceptible or
resistance to one or more antibiotics All isolates were sensitive to
cefotaxime, gentamicin and ciproﬂoxacin. 13 (43.3%) isolates were
resistant or intermediary susceptible to tetracycline, 8 (26.7%) isolates
were resistant to nalidixic acid, ampicillin, and amoxicillin-clavulanic
acid, while 3 (10%) were resistant to trimethoprim-sulfamethoxazole,
chloramphenicol and kanamycin, and 2 (6.7%) was intermediary
susceptible to cefuroxime. Among 27 (90%) bioﬁlm producing isolates,
21 (77.8%) were weak, 2 (7.4%) was moderate, and 4 (14.8%) were
strong bioﬁlm producers. Antibiotic resistance was more frequently
seen in bioﬁlm-positive than in bioﬁlm-negative isolates (p< 0.05).
Statistical analysis showed correlation between resistance to antibiotics
and the quantity of bioﬁlm by biﬁlm producing strains of Salmonella
Epidermidis.
Bioﬁlm-positive isolates of Salmonella Enteritidis were more resistant
to antibiotics than bioﬁlm-negative isolates. Obtain results found an
association between bioﬁlm production and antibiotic resistance.
P710 Impact of antibiotics on bioﬁlm and some other properties
of Klebsiella pneumoniae in vitro
A. Hostacka, I. Ciznar (Bratislava, SK)
Objectives: K. pneumoniae is a pathogen responsible for different
human infections and it is also involved in outbreaks of nosocomial
infections. Antibiotic resistance of these bacteria have become a serious
clinical problem. The effects of subinhibitory concentrations (sub-MICs)
of ciproﬂoxacin, enoxacin, norﬂoxacin, gentamicin and netilmicin on
bioﬁlm formation, hydrophobicity, lipase and response to oxidative stress
in two clinical K. pneumoniae strains (39, 61/P) were evaluated.
Methods: Microtiter plate assay for bioﬁlm formation, adherence to
xylene for hydrophobicity, spectrophotometric method with Tween 20
for lipase activity and effect of H2O2 for response to oxidative stress
were applied.
Results: Bioﬁlm production by the strain 39 treated with quinolones
and aminoglycosides and by the strain 61/P with aminoglycosides was
markedly decreased. The most effective concentrations (1/2 of the MICs)
suppressed bioﬁlm formation to 28.7−56.9% of the control levels.
Quinolones to the lesser extent altered bioﬁlm in strain 61/P. Though
antibiotics in the most cases enhanced bacterial adherence to xylene,
the strains remained in the hydrophilic state. Decreased lipase activity
to the different range in the strains treated with all concentrations of
quinolones (with the exception of norﬂoxacin and enoxacin in strain 39)
and netilmicin and with some concentrations of gentamicin was found.
Antibiotic treated bacteria in most of the cases showed higher sensitivity
to oxidative stress (with the exception of norﬂoxacin), but in case of
netilmicin in strain 39 no changes were observed.
Conclusion: K. pneumoniae treated with antibiotics manifested sup-
pressed bioﬁlm production and also altered adherence to xylene, lipase
and response to oxidative stress in dependence on strain, type and
concentration of antibiotic.
This work was supported by Ministry of Health of the Slovak Republic
under the project Analysis of bioﬁlm production in nosocomial strains as
a basis to prevent infections in healthcare institutions 2005/24-SMU-02.
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P711 Rapid decrease of intrathecal cortisol levels correlates with
severity of bacterial meningitis
O. Beran, O. Dzupova, M. Holub (Prague, CZ)
Objectives: Bacterial meningitis (BM) still represents an infectious
disease with a signiﬁcant morbidity and mortality. We have previ-
ously demonstrated that the elevated cortisol concentrations in the
cerebrospinal ﬂuid (CSF) are associated with the severity of BM and
can also serve as useful diagnostic marker for differentiation from viral
meningitis [Crit Care 2007]. Therefore, the present study was aimed
at description of the kinetics of CSF cortisol levels during BM and
assessment of its relationship to severity and distinct bacterial aetiology
of the disease.
Methods: A total of 55 patients with BM were enrolled in the study.
The BM severity was evaluated using APACHE II (Acute Physiology
and Chronic Health Evaluation), SOFA (Sequential Organ Failure
Assessment) and GCS (Glasgow Coma Score) scoring systems. Paired
samples of CSF and serum were obtained on admission and 3−5 days
later. Concentrations of cortisol were determined by radioimmunometric
assay. Statistical analysis was performed using SPSS softwareTM.
Results: Bacterial aetiology was conﬁrmed in 42 BM patients (76%):
Neisseria meningitidis in 17 cases (40%), Streptococcus pneumoniae
in 14 cases (33%) and 11 cases were due to other bacteria. Increased
CSF cortisol correlated with serum cortisol on admission as well as
follow-up (r = 0.60, p< 0.001; r = 0.78, and p< 0.001, respectively).
In addition, CSF cortisol levels on admission were associated with
APACHE II (r = 0.77, p< 0.001), SOFA (r = 0.68, p< 0.001) and
GCS (r = −0.60, p< 0.001). Also, CSF cortisol demonstrated a decrease
between the initial and follow-up lumbar puncture (p< 0.001). Moreover,
this decrease correlated with APACHE II (r = 0.53, p< 0.001), SOFA (r =
0.51, p< 0.001), and GCS (r = −0.46, p< 0.001). Although CSF cortisol
concentrations were higher in pneumococcal meningitis compared to
meningococcal meningitis, this difference was insigniﬁcant (p = 0.12).
Conclusion: Our results demonstrate that the initially elevated CSF
cortisol levels rapidly decrease after administration of BM therapy (i.e.
antibiotics and dexamethasone). Moreover, this reduction was more
pronounced in patients with severe course of BM. The tendency of
the association between the high CSF cortisol levels and pneumococcal
aetiology of BM observed in our study should be further evaluated on a
larger cohort of patients.
Acknowledgment: The study was supported by the grant IGA
NR/9316−3.
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P712 Spontaneous Gram-negative bacillary meningitis in adult
patients
V. Pomar, N. Benito, R. Pericas, J. Lo´pez-Contreras, M. Gurguı´,
P. Domingo (Barcelona, ES)
Objectives: The aim of this study was to describe the incidence, pre-
disposing factors, aetiology, clinical features, complications, treatment
and outcome of adult patients with spontaneous Gram-negative bacilli
(GNB) meningitis (GNBM) during the last 25 years in a tertiary hospital.
Methods: We prospectively collected all cases of spontaneous bacterial
meningitis occurring in adult patients at the Hospital de la Santa Creu i
Sant Pau (Barcelona) between 1982 and 2006. Cases due to Haemophilus
inﬂuenzae were excluded.
Results: Six hundred sixty-four patients with bacterial meningitis were
registered. Forty of them were caused by GNB (6%). Twenty-three
occurred in the ﬁrst 12 years (56%) and 17 in the last 12 years (42%)
(p= 0.27) with an overall incidence of 2 cases/100.000 patient-year.
There were 23 (58%) men and the mean age was 63 years (SD 16
years). Underlying conditions were present in 29 patients (73%). An
extrameningeal focus was found in 30 cases (75%): urinary infection in
13 patients (43%), and otitis/sinusitis and abdominal focus in 4 patients
(13%), respectively. Nine episodes (22%) were nosocomial acquired.
The classic triad of meningitis (altered mental status, fever and neck
stiffness) was found in 13 patients (32%). Escherichia coli was the most
common cause (15 patients [38%]), followed by Pseudomonas spp. in
10 patients (24%). However, Pseudomonas spp. was the leading cause
in nosocomial cases.
During the clinical course, neurologic complications occurred in 20
patients (50%) and systemic complications in 27 patients (68%). The
overall mortality rate was 53% (21 patients). We found no signiﬁcant
difference (p = 0.678) in mortality rates between two periods. To have
underlying diseases, urinary infectious (versus other infectious focus) or
developing acute renal failure were independent factors associated with a
higher mortality (OR 9.8 [CI95% 1.2−77.6]; OR 8.7 [CI95% 1.2−64.3];
OR 11.7 [1.4−99.8], respectively).
Conclusions: Currently Gram-negative bacilli are an unusual cause of
GNBM, accounting for 6% of all spontaneous meningitis in adults. No
differences in the incidence were found over the 25-year period of study.
Most of the patients have underlying diseases and this is a risk factor of
higher mortality. The mortality rate is high (more than ﬁfty percent of
cases) and seems not to have decreased in the last years.
P713 Clinical features and prognosis factors of community-
acquired acute bacterial meningitis in Spain
E. Sulleiro, D. Rodriguez, B. Almirante, R. Amaya-Villar, P. Ferna´ndez-
Viladrich, C. Rodrigo, D. Fontanals, P. Catalan, M.A. Meseguer,
J. Colomina, G. Prats (Barcelona, Seville, Madrid, Alzira, ES)
Objective: We conducted a multicentre study to determine clinical
features and prognostic factors of community-acquired acute bacterial
meningitis (ca-ABM) in nine hospitals of the Spanish Network for
Investigation in Infectious Pathology (REIPI)
Methods: From Nov 2003 to Sept 2006 all patients >29 days diagnosed
of ca-ABM were prospectively evaluated. The diagnosis was based on
clinical condition, chemical and microbiological results in cerebrospinal
ﬂuid (CSF) and/or blood. Outcomes were classiﬁed as favourable or
unfavourable (death or cure with disabilities). Predictors were identiﬁed
through logistic-regression analysis.
Results: Four hundred and ﬁfty ﬁve patients were included, 56% were
men, the median age was 42 years (range: <1−91), Streptococcus
pneumoniae (Sp) 43% were the most common aetiology agent followed
to Neisseria meningitidis (Nm) 30%, Listeria monocytogenes (Lm)
13% and others 14%. Nm was the most common pathogen among
patients  18 years (45.9%) and Sp in >18 years (80.7%). Predisposing
conditions were oto-mastoiditis or sinusitis in 20% of the cases, previous
immunosuppression (16.7%), diabetes (12.4%), CSF leak (8.5%) and
alcoholism or cirrhosis (8.5%). The triad of fever, neck stiffness and
altered mental status was present in 43.7% of the episodes. Rash was
present in 20% of the cases, 12% had focal neurological deﬁcits and
9% seizures. Penicillin susceptibility was tested in 146 Sp strains; of
which 21.2% showed intermediate resistance (IR) and 4.8% resistance
(R); of 119 Nm strains 6.7% presented IR to cefotaxim. Ampicillin
susceptibility was tested in 39 Lm strains and all were sensible. Outcome
was unfavourable in 26% of the cases with an overall mortality of
14%. In the multivariate model the unfavourable outcome risk factors
appeared: age 65 years, respiratory failure, neurological deﬁcits and
seizures during treatment.
Conclusions: The most common pathogens causing ca-ABM in our
area are Sp, Nm and Lm. Unfavourable outcome is high, so particular
attention should be done to people with identiﬁed risk factors.
P714 Community-acquired acute bacterial meningitis in older
people in Spain
E. Sulleiro, D. Rodriguez, R. Amaya-Villar, E. Garcia-Cabrera,
P. Ferna´ndez-Viladrich, S. Molinos, A. Coloma, D. Fontanals,
P. Catala´n, M.A. Meseguer, J. Colomina, B. Almirante (Barcelona,
Seville, Madrid, Alzira, ES)
Objective: Older age is considered to be an important risk factor
for unfavourable outcome in community-acquired Acute Bacterial
Meningitis (ca-ABM). The aim of this study is to describe clinical
characteristics and outcome of ca-ABM in patients over 65 years
compared to younger ones
Methods: A prospective multicentre study of ca-ABM was carried
out in 9 Spanish hospitals included in the REIPI programme (Spanish
Network for the Research in Infectious Diseases) between 1/11/2003
and 30/07/2006. Patients were diagnosed on the basis of a compatible
clinical, biological and microbiological data. An adverse clinical
outcome was deﬁned as death or cure with disabilities.
Results: 415 patients were diagnosed with ca-ABM, 293 <65 years-old
(median age: 29.8, range: 0−64) and 122 65 years years-old (median
age: 74.4, range: 65−91). Among patients over 65 years Streptococcus
pneumoniae (Sp) was the most frequent aetiology (44.3%), followed
by Listeria monocytogenes (Lm) (20.5%). Lm was signiﬁcantly more
frequent in this group compared to younger patients (20.5% vs 7.5%,
p< 0.05) among which Neisseria meningitidis (Nm) was the most
common aetiology (12.3% vs 32.1%, p< 0.05). Diabetes (28% vs 6%,
p< 0.05) and a distant foci of infection (12.7% vs 3.9%, p< 0.05)
were more frequent in elderly who more often presented the classic
triad of fever, neck stiffness and altered mental status (50% vs 39%,
p = 0.021), a GSC (Glasgow Score Come) <14 (79.3% vs 50.2%,
p< 0.05), focal neurological deﬁcits (21.2% vs 11%, p = 0.007) and
respiratory failure (23.7% vs 11%, p< 0.05). Elderly cohort was treated
with third-generation cephalosporin associated to ampicillin in 41% of
the cases compared to only 18% of the cases in patients under 65 years
(p< 0.05). Among patients over 65 years hemodynamic failure (25.4%
vs 12%, p< 0.05), a GSC decrease on evolution (26.3% vs 13.8%,
p< 0.05) and an adverse clinical outcome (45% vs 20%, p< 0.05) were
signiﬁcantly more frequent. Mortality rate was higher among adults over
65 years (29% vs 8%, p< 0.05).
Conclusions: ca-ABM in patients over 65 years is predominantly due to
Sp followed by Lm which is signiﬁcantly more frequent in this group.
Ca-ABM in the elderly cohort signiﬁcantly present with more severe
clinical features and adverse evolution being overall mortality in this
group signiﬁcantly higher.
P715 Secondary cases of meningococcal disease can be prevented
by the immediate identiﬁcation and eradication of the disease-
causing strain of Neisseria meningitidis in close contacts
B.E. Kristiansen (Skien, NO)
Objective: To prevent secondary cases of meningococcal disease by
the identiﬁcation and eradication of the disease-causing strain in close
contacts of the primary case.
S182 18th ECCMID, Posters
Methods: Following the bacteriological veriﬁcation of invasive meningo-
coccal disease, the local physician is informed and “close contacts”
(household members, kissing contacts, classmates, and playmates,
children in the same kindergarten and others who have slept in the
same room as the patients during the last 2 weeks before admission)
are identiﬁed. On the same day or the following day, throat specimens
are collected, plated and incubated at 37ºC in 10% CO2. Upon growth
the next day of oxidase-positive Gram-negative diplococci, colonies are
picked and DNA extracted. A PCR amplicon restriction endonuclease
analysis (PCR AREA) with primers from the folP-gene is performed.
When the PCR AREA band pattern is identical with that of the disease-
causing strain, contacts are given rifampicin.
Results: During the period 1988–2007 there have been 66 primary
cases with meningococcal disease in the County of Telemark (165.000
inhabitants). No secondary case has been seen. The mean incidence
of invasive meningococcal disease in all Norway during the ﬁrst 10-
years period (1988–1997) was 3.63/100,000 inhabitants/year (CI: 0, 52)
and fell to 1.39 (CI: 0, 48) during the last period (1998–2007). The
corresponding ﬁgures for the County of Telemark were 3.41 (CI: 1, 35)
and 0.84 (CI: 0, 50), and in the 3 neighbouring counties the ﬁgures
were 2.89 (CI: 2, 89) and 1.74 (CI: 0, 62). The disease-causing strain
was found in 70 (3.1%) out of a total of 2252 contacts. The prevalence
of the disease-causing strain was higher (14.8%) in household members
and kissing contacts than in all other groups combined (1.7%). The odds
ratio for carrying the disease-causing strain in household-members and
kissing contacts was 8.74.
Conclusion: Secondary cases of meningococcal disease may be
prevented by the rapid identiﬁcation of the disease-causing strain in close
contacts followed by subsequent eradication with rifampicin. Household-
members and kissing contacts have the highest risk of carrying the
disease-causing strain.
P716 Short-course therapy for adult meningococcal sepsis and/or
meningitis: 23-year experience
C. Cabellos, R. Verdaguer, M. Cisnal, R. Pallares, X. Ariza, F. Gudiol,
P.F. Viladrich (L’Hospitalet, ES)
Objective: Short course therapy for meningococcal disease have
been previously shown as effective as longer therapies. In order to
reinforce our results in adults we present our accumulated experience
in 138 patients (pts) treated with a short course therapy for systemic
meningococcal disease.
Patients and Methods: All pts admitted to our hospital with systemic
meningococcal disease (positive blood or CSF culture or meningitis with
petechial purpura) from January 1984 have been scheduled to a short
4 days antibiotic therapy and have been compared with the historical
7 days treated pts. Data were prospectively recorded in a 128 variables
protocol.
Results: 138 adult pts (37 M/101 F) mean age 45.5±20 (18−87) were
evaluated. Mean duration of therapy was 4.9±2 days, median 4 days. 17
pts presented shock on admission, 38 pts were treated with penicillin, 90
with ceftriaxone, 5 with cefotaxime and 4 with other drugs. Mortality
was 13/138 (9%) due to early sepsis in 5 pts, neurological complications
in 1 and late causes in 7. Mild neurological sequelae were present in
15 pts (12%). No relapses were observed after one month follow-up.
When compared with pts treated previously with a 7 days or longer
therapy course, 129 pts, (36 M/93 F) mean age 43.8±19 (18−80), mean
duration of therapy 7.22 days, there were no differences in positive blood
cultures, shock on admission (25 pts) mortality 12/129 (9%), due to early
sepsis in 9 pts and neurological complications in 3, relapse (no cases) or
sequelae 12 (10%) (NS). Antibiotic therapy in this long course therapy
group consisted in penicilIin 119 pts, ampicillin 4 pts and chloramfenicol
6 pts.
Among short course therapy pts, in the subgroup of 16 pts presenting
as sepsis without meningitis (1M/15 F) mean age 47.38±22 (18−82)
with shock on admission in 3 pts treated for 4.6±2 days there were a
mortality of 1/16 (6%), no relapses and sequelae were present in 1 patient
without differences with the previously long-therapy treated pts. In the
subgroup of 10 pts presenting as severe sepsis (hypotension or shock +
thrombopenia + coagulation disorder with or without meningitis) with
mean age 49.6 (21−73), shock in 7/10 and disseminated intravascular
coagulation in 8/10 mortality was 3/10 (30%) all of them in the ﬁrst day
of therapy.
Conclusion: Short course (4 days) antibiotic therapy in adult meningo-
coccal disease either meningitis or sepsis (including severe sepsis) is a
safe therapy without relapses.
P717 Epidemiology of bacterial meningitis during a 5-year period
in an infectious diseases unit in northern Italy
A.M. Azzini, C. Grigolo, A. Tedesco, E. Concia (Verona, IT)
Objective: To evaluate the frequency of isolation of S. pneumoniae
(SP), N. meningitidis (NM), H. inﬂuenzae (HI), L. monocytogenes (LM)
and other bacteria during meningitis, also deﬁning their patterns of
antibiotic susceptibilities, in order to optimise both prevention strategies
and antibiotic therapy of this severe infection.
Methods: During a 5 years period (January 2002–June 2007) we
prospectively evaluated patients affected by meningitis, in particular
we collected their demographic data, the presence of co-morbidities
and meningeal infection’s predisposing factors. Liquor biochemical
characteristic together with microbiological results were reported; the
susceptibility test were performed by Kirby Bauer method.
Results: During the study period we collected 31 bacterial meningitis
(BM), increasing from 2002 (4 cases) to 2006 (10 cases), with this trend
conﬁrmed during the ﬁrst half of 2007 (6 cases). During the ﬁrst three
years period we found only SP as causal agent, but from 2005 NM has
appeared and become predominant in relationship with other bacteria.
During the study period we had only two LM (in 2002 and 2006) and one
HI (2006). SP has never found to be penicillin resistant but in 25% of
cases it showed an intermediate susceptibility to this antibiotic. 80% of
NM was resistant-intermediate to penicillin. The only isolated HI didn’t
produce b-lactamases.
Conclusions: In our Institution BM is becoming more frequent than
in the past, and this disagree with national data which show a trend
in reduction from 2006. In particular we noted an increasing NM’s
frequency of isolation, with a predominance in last 3 years if compared
with SP, which remained quite constant. This data are too limited to
be interpreted as an outbreak but they call our attention to preventive
interventions such as vaccination for this severe infection.
In contrast with European Antimicrobial Resistance Surveillance System
data, the frequency of isolation of penicillin-resistant SP is low,
but we frequently found penicillin resistant-intermediate NM. These
antibiotic patterns support our empirical antibiotic approach to BM with
ceftriaxone (2 gr bid i.v.) in association with levoﬂoxacin (500 mg bid
i.v.) which shows in vitro activity against LM as well. The effectiveness
of this antibiotic treatment is proved by the mortality for BM as well,
that was 0% during the study period.
P718 Laboratory-conﬁrmed meningococcal disease in children
over a 10-year period in Athens, Greece
E. Lebessi, M. Papadimitriou, G. Tzanakaki, M. Tsolia,
A. Doudoulakakis, F. Lykou, V. Papaevangelou, K. Kallergi,
J. Kremastinou (Athens, GR)
Objectives: Meningococcal disease (MD) may be presented clinically
as septicaemia, meningitis, or both. Our study aimed to review the
epidemiological data of MD, and to assess the phenotypes of Neisseria
meningitidis in the paediatric population admitted to "P.&A. Kyriakou
Children’s Hospital" over a 10-year period.
Methods: The study population included patients with: (i) suspected
invasive infection, meningitis and/or septicaemia and (ii) blood
and/or CSF samples positive for N. meningitidis. All cases were
laboratory-conﬁrmed by culture and/or PCR. Culture, identiﬁcation and
serogrouping was carried out by standard methods. Susceptibilities
to antimicrobials were determined by Etest. All isolates were sent
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for serotyping and serosubtyping to the Hellenic National Meningitis
Reference Laboratory. In addition, CSF and/or blood samples were also
subjected to PCR for the detection of meningococcal DNA.
Results: During the study period, 235 cases of MD were recorded in
patients (135 boys, 100 girls) aged from 15 days to 14 years (mean
5.1y±3.7SD). The clinical diagnoses were: meningitis associated with
septicaemia (41.3%), septicaemia (40.0%), and meningitis (18.7%). In
150 cases (64%) the diagnosis was conﬁrmed by PCR. The annual
distribution of cases was: 15, 13, 39, 44, 53, 30, 15, 9, 10, 7 for the
years 1998–2007, respectively. Most of cases (66%) occurred during the
winter and early spring. Serogroup B accounted for 44.26% (104/235);
serogroup A for 12.77% (30/235); serogroup C for 7.23% (17/235);
serogroup W135 for 6.81% (16/235); serogroup Y for 0.85% (2/235);
while non-serogroupable remained 28.09% (66/235). Serotype and
subtype was determined in 72% of the isolates. A high differentation was
observed among the phenotypes belonging to serogroup B. Phenotype
B.4:P1.14 was most predominant (23.6%). All isolates were found to be
susceptible to cefotaxime, and 82% to penicillin. Fully resistant strains
were not found.
Conclusions: The epidemiological pattern of MD studied cases is similar
to that found elsewhere in Europe. In contrast, the phenotype B.4:P1.14
(ST-269) is rarely found among the meningococcal strains isolated in
other European countries. PCR is a valuable tool for the rapid diagnosis
of meningococcal disease, as antibiotic prior sampling may reduce the
diagnostic efﬁcacy of the culture.
P719 Acute bacterial meningitis in an Athens childrens hospital
over an 8-year period (2000–2007)
K. Papavasileiou, H. Papavasileiou, G. Tzanakaki, S. Chatzipanagiotou,
H. Panagiotaki, J. Kremastinou, A. Voyatzi (Athens, GR)
Objective: this study describes the epidemiological and clinical features
of bacterial meningitis in children for an 8-year period (2000–2007) in
a paediatric hospital.
Materials and Methods: A total of 1630 hospitalised children with
suspected clinical symptoms and signs of meningitis, aged between 16
days to 14 years, underwent a lumbar puncture. CSF and blood samples
were investigated by laboratory methods such as white cell count in
the CSF as well as cultures. In addition, all samples (blood and CSF)
presenting >50 cells of polymorphonuclear type, were investigated by
a multiplex polymerase chain reaction (PCR) for N. menigitidis (N.m),
H. inﬂuenzae type b (H.inf) and S. pneumoniae (S.pn.) at the National
Meningitis Reference Laboratory. All isolated strains were identiﬁed
by using classical methods. Susceptibility test was performed by E-
test according to CLSI guidelines. Serogroups were determined by slide
agglutination test.
Results: Seventeen percent (17%, 272/1630) were found positive for
meningitis; 219 (80.5%) had lymphonuclear predominance and 53
(19.5%) polymorphonuclear. Proven bacterial meningitis was diagnosed
in 53 children with median age of 3−5 years. Males (157/272,
58%) outnumbered females. The most prevalent microorganism causing
bacterial meningitis was N.m (n = 43, 81%) followed by Enterococcus
faecalis (n = 3, 5.6%), S.pn (n = 2, 3.8%), S. agalactiae (n = 2, 3.8%),
Enterobacteriaceae (n = 2, 3.8%) and S. pyogenes (n = 1, 2%). A
high percentage (40%) of patients developed bacteraemia. Of the 43
meningococcal cases, 6 (14%) CSF samples were CSF culture and PCR
positive while 37/43 (86%) cases were only PCR positive. Of those
23 (62%) were blood positive, 10 (27%) CSF and the remaining 4
(11%) were PCR positive for blood and CSF. The most predominant
serogroup was B (53.5%), followed by A (14%), W135 (11.6%),
C (2.3%) while 18.6% remained non-groupable (NG). The phenotype
4:P1.14 predominated among the serogroup B strains. The majority of
S.pn strains belonged to serotype 18C. All strains were susceptible to
antibiotics. Most cases occurred during winter (November-March).
Conclusions: After the use of vaccines (H. inf type b, N.m and S.pn)
the frequency of bacterial meningitis has been decreased. N.m serogroup
B:4:P1.14 was the prevalent cause of bacterial meningitis. No cases
of H.inf meningitis was recorded. The use of molecular techniques
contributed signiﬁcantly towards more accurate and rapid recognition
of bacterial meningitis infections.
P720 Epidemiology, clinical presentation and prognostic factors
for death of bacterial brain abscess: a twelve-year review
M. Gutierrez-Cuadra, M.A. Ballesteros, A. Vallejo, C. Farin˜as-A´lvarez,
E. Min˜ambres, D. Sua´rez, J.D. Garcı´a-Palomo, A. Va´zquez-Barquero,
M.C. Farinas (Santander, ES)
Objective: Despite the advent of modern neurosurgical techniques, new
antibiotics, and powerful imaging technologies, brain abscess remains a
potentially fatal central nervous system infection. The aim of this study
was to determine the epidemiological trends, prognostic factors, and
outcomes of bacterial brain abscess.
Methods: Over a period of 12 years (1992–2005), 71 patients were
retrospectively identiﬁed as having brain abscesses in a tertiary referral
hospital in northern of Spain. Quantitative data are expressed as Mean
(SD) and qualitative data are expressed in number and/or percentage
(%).
Results: The mean age of the 71 patients was 45.2 years (10.6). There
was a male predominance (73% of cases). Fever (28 patients, 30%), focal
neurological symptoms (27 patients, 30%) and headache (19 patients,
26.8%) were the main clinical manifestations. The frontal lobe was
the commonest anatomical site (28 patients, 41.2%). Bacteria were
isolated from 33.8% of patients and monomicrobial infections occurred
in 18 (37.5%) patients. No microorganisms were isolated in 23 (47.9%)
patients. Staphylococci accounted for 33.5% of isolates and were the
prevalent pathogens associated with haematogenous spread. Head and
neck infections, neurosurgical procedures and immunosuppression were
the main predisposing factors. Twenty seven (40%) patients underwent
surgical procedures and 39 (57.4%) patients need anticonvulsive therapy.
Fifteen (21%) patients died, most of them (12 patients, 29.3%) received
only medical treatment. The most important univariate predictors of
mortality were the presence of immunosuppression (P= 0.003), multiple
organ failure in the ICU (P = 0.001), medical treatment alone (P = 0.05),
multiple abscesses (P = 0.05), older age (p= 0.02), and the APACHE
II score in the ICU. Logistic regression analysis showed that multiple
organ failure (odds ratio [OR], 30.7; 95% conﬁdence interval [CI] 1.8
to 514.1), multiple abscesses (OR 3.7; 95% CI 1.0 to 14.2), and delay
to start antibiotic treatment after the diagnosis (OR 1.5 per day; 95% CI
1.1 to 2.1) were associated with a high mortality.
Conclusion: Despite the availability of new antibiotics and the
development of better neurosurgical techniques, mortality of brain
abscess is still high. Multiple organ dysfunction, abscess number, and
delay to start antibiotic treatment after the diagnosis were associated
with higher mortality.
P721 Is vancomicin necessary in empirical treatment of
community-acquired meningitis?
R. Gu¨erri, G. Vallecillo, F. Sa´nchez, E. Lerma, E. Sole´, J. Villar,
J.L. Lo´pez-Colome´s, R. Perello, A. Dı´ez-Pe´rez (Barcelona, ES)
Introduction: Community Adquired meningitis is an important disease
in our emergency departments. Empirical treatment is necessary in order
to improve prognosis. National guidelines (SEIMC) include vancomicin
combined with cefotaxime as ﬁrst election therapy.
Objective: To study susceptibility to different antibiotics in community
adquired meningitis reviewing initial empirical treatment, and determine
whether the introduction of vancomycin in the empirical treatment
provides some beneﬁt
Methods: a descriptive retrospective study reviewing medical reports
and microbiological cultures in patients admitted in the Emergency room
of the Hospital Universitario del Mar, Barcelona (455 beds, and an area
of inﬂuency of 500000 habitants) during 1 year (june 2006 to june 2007).
Results: 19 patients were admitted with community-adquired meningitis.
10 men and 9 women. Mean age 52 (range 23−78).
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The most common causative organisms were S. pneumoniae 9 (47.3%),
N. meningitidis 7 (36.8%) and L. monocytogenes 3 (15.9%).
Among S. pneumoniae, only 1 strains was resistant to Penicillin
(Minimum inhibitory concentration (MIC) >0.1mg/ml) but continued
sensibility to cephalosporin and vancomicin. The rest of isolated strains
had MIC< 0.5mg/ml to cephalosporin group. Of N. meningitidis in
1 case was resistant to penicilin (MICs >1mg/ml) and showed fully
sensibility to cephalosporines and vancomicine. No resistance to tested
antibiotics was observed in L. monocytogenes.
In the Emergency Department cefotaxime and vancomicin as empirical
treatment was initiated in 11 patients (57%). Four patients died (all
of them with combined treatment), from whom 3 had pneumococcical
meningitis and 1 with meningococcical menigitis.
Conclusion: S. pneumoniae is the most frequent pathogen in community
adquired bacterial meningitis in our population. All isolated S. pneumo-
niae, N. meningitidis, L. monocytogenes strains remained susceptible
to currently used antibiotics in empirical treatment. Therefore, adding
vancomicin as empirical treatment in community adquired meningitis
does not improve any beneﬁt, and theoretically only adds potential side
effects and increased costs. However, monitoring the resistance rates in
our community is necessary in order to adapt clinical guidelines.
P722 Scrub typhus central nervous system complications
D-M. Kim (Gwang-Joo, KR)
Background: Orientia tsutsugamushi spreads throughout the body via
the bloodstream and lymphatics, and induces vasculitis leading to
symptoms of systemic organ invasion.
Among these, meningoencephalitis is a life-threatening manifestation.
Methods: We conducted a prospective study of potential scrub typhus
patients who were admitted to Chosun University Hospital between
September 2004 and December 2006 to investigate the clinical and
laboratory features of patients with scrub typhus meningoencephalitis
and the therapeutic outcomes, and to determine the factors associated
meningoencephalitis
Results:Multivariate analysis demonstrated that the presence or absence
of pneumonia was signiﬁcantly associated with the occurrence of
scrub typhus meningoencephalitis (OR, 8.9; P< 0.001; CI, 2.9−27.2).
Although appropriate antimicrobials such as doxycycline agents were
administered at an early stage, meningoencephalitis still occurred.
Conclusions: Physicians should be aware of the possibility that
meningoencephalitis could be developed during the course of appropriate
drug therapy such as doxycycline. Close observation and intensive care
are essential for patients with factors associated meningoencephalitis,
particularly those with pneumonia. Increasing the dosage of doxycycline
or administering antimicrobial agents such as rifampin with good
penetration to the central nervous system, should be considered in such
cases.
P723 Neurological complications of Mediterranean spotted fever
L. Ammari, A. Berriche, B. Kilani, H. Tiouiri, A. Ghoubantini,
F. Kanoun, C. Fendri, T. Ben chaabane (Tunis, TN)
Background: Mediterranean spotted fever (MSF), a systemic Rickettsia
conorii, is endemic in the Mediterranean region. It thought to be a benign
disaese, but in 5−10% of cases, it is responsable for severe systemic
manifestations. Neurological involvement has been reported in 28% of
cases.
Objective: The aim of this study is to describe demographic character-
istics, clinical presentation and outcome of neurological complications
of MSF.
Methods: we conducted a retrospective study of patients who developped
MSF with neurological involvement between January 1992 and June
2007 and admitted in the department of infectious diseases of Rabta
Hospital in Tunis. The diagnosis of MSF was based on clinical criteria
and/ or positive rickettsial serology.
Results: 16 patients with neurological manifestations of MSF were
included, 15 male and 1 female. The mean age is 42.7 years. 9
patients are living in rural area and 10 owned dogs. Typical clinical
signs are: fever (100%), headache (43.5%) and maculopapular rash
(75%), inoculation eschar (62.5%). Neurological involvement includes:
7 meningitis (44%), 5 encephalitis (31%), 3 meningoencephalitis (19%)
and 1 case of facial nerve palsy (6%).
Biochemical laboratory tests revealed: normal white blood cell count in
8 cases (50%), thrombocytopenia in 7 cases (44%), hepatic cytolysis
in 10 cases (62.5%). A high level of lactate dehydrogenase is noted
in 10 patients (62.5%). Lumbar puncture was performed in 14 cases.
Analysis of cerebrospinal ﬂuid revealed pleocytosis with normal glucose
and protein levels in 12 cases (86%). Rickettsial serology was performed
for 15 patients. Antibody titers against Rickettsia conorii detected by
indirect immunoﬂuorescence are positive in only 5 patients. Cerebral
CT scan is normal in 3 cases. All patients received antibiotherapy:
ﬂuoroquinolone (11 cases), doxycycline (5 cases) for a mean duration
of 13 days. Mechanical ventilation was initiated for 1 patient. Clinical
outcome is favourable for all patients.
Conclusion: Rickettsial infection should be considered as a cause
of neurological involvement in endemic areas. Early diagnosis and
appropriate treatment are mandatory to prevent fatal issue of this
potential complication of Mediterranean spotted fever.
Molecular studies with fungal pathogens
P724 Use of a new PCR to identify Candida species isolated
directly from a positive blood culture
E. Rosello´, N. Loaiza, V. Rodriguez, G. Codina, A. Andreu, A.M. Planes
(Barcelona, ES)
Objective: Evaluation of a multiplex real-time PCR to identify Candida
species from positive blood cultures.
Materials and Methods: A PCR technique to identify Candida was
evaluated using: a) the fungus-speciﬁc universal primer pair, ITS3 and
ITS4, to amplify a rDNA region (a portion of the 5.8S region, the
ITSII region and a portion of the 28S region); b) ﬁve species-speciﬁc
TaqMan probes to identify the most frequent species isolated in clinical
samples (C. albicans, C. parapsilosis, C. glabrata, C. tropicalis and
C. krusei); and c) a generic Candida TaqMan probe. The PCR was used
on the supernatant of positive blood cultures shown to contain yeasts
by Gram staining. DNA extraction was made using the EZ1 automatic
system (Blood DNA protocol, Quiagen). For the PCR reaction, 5ml
from the extraction were transferred to a tube containing C. albicans,
C. parapsilosis and C. glabrata species-speciﬁc TaqMan probes; if
negative, the procedure was repeated with C. tropicalis and C. krusei
species-speciﬁc TaqMan probes. Finally, if there was no ampliﬁcation,
the reaction was repeated with the generic Candida TaqMan probe.
Results: 73 blood cultures from 63 patients (32 males/31 females; 51
adults/12 children) were used. Patients were admitted to ICU (43%),
surgery (28.5%), haematology and oncology (8%) and internal medicine
wards (20.6%). Positive blood cultures were subcultured on blood agar,
Sabouraud agar and CHROMagar Candida. Subcultures resulted in:
61 pure cultures, 12 mixed (yeast and bacteria) and 1 mixed to two
Candida species. The species identiﬁed from different cultures were:
29 C. albicans, 19 C. parapsilosis, 18 C. glabrata, 6 C. tropicalis,
1 C. lipolytica and 1 C. guilliermondii. The ﬁrst PCR (C. albicans,
C. parapsilosis and C. glabrata species-speciﬁc TaqMan probes)
correctly identiﬁed all C. albicans and C. parapsilosis, and 16 out of 18
C. glabrata. The second PCR identiﬁed all 6 C. tropicalis. The universal
Candida PCR detected the remaining two species (C. lipolytica and
C. guilliermondii). This PCR detected and identiﬁed, directly from blood
culture, 94.6% of yeast causing fungaemia.
Conclusion: The proven real-time PCR permits the detection and
identiﬁcation of species causing candidaemia in less than three hours,
while the conventional systems take at least 48 hours.
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P725 Identiﬁcation of Candida species by restriction enzyme
analysis
R. Yis, M. Yu¨cesoy (Izmir, TR)
Background: Identiﬁcation of Candida species isolated from clinical
specimens gives information about the antifungal susceptibility as well
as sheds light to the choice of empirical treatment.
Objectives: This study was planned to apply restriction enzyme analysis
(REA) for more rapid and reliable identiﬁcation of Candida albicans and
non Candida albicans species which had been previously identiﬁed by
conventional methods and to compare the results.
Methods: In this study 146 Candida strains (40 C. albicans, 27
C. parapsilosis, 26 C. tropicalis, 25 C. glabrata, 11 C. kefyr, 10
C. krusei, and seven C. guilliermondii) isolated from various clinical
specimens and C. albicans ATCC 14053, C. parapsilosis ATCC 90018
and C. krusei ATCC 6258 were included. The strains were identiﬁed
according to germ tube test, morphology at cornmeal tween 80 agar and
CHROMagar Candida and API 20C AUX system.
PCR was performed by using primers which targeted ITS1, 5.8S rDNA
and ITS2 regions. PCR products were digested with MwoI enzyme for
all species and with BslI for C. parapsilosis and C. tropicalis strains.
Sequence analysis of four C. albicans and two C. guilliermondii isolates
which resulted in different restriction patterns was performed.
Results: Calculated lengths of REA products obtained by MwoI enzyme
are presented in the table. Restriction of C. parapsilosis and C. tropicalis
isolates with BslI resulted in three bands of 413, 94 and 63 bp and three
bands of 326, 187 and 63 bp, respectively. Three C. albicans isolates
which produced a different restriction pattern had point mutations
(guanine instead of adenine); one isolate had insertion/deletion type
mutation and these mutations were the reason of a different pattern. In
addition, sequence analysis of two C. guilliermondii isolates showing
various fragments with different lengths were 66.6% similar with
GenBank C. guilliermondii var. guilliermondii and 91.2% similar with
C. guilliermondii var membranaefaciens (nucleotide seqeunce). Because
of this high nucleotide sequence similarity, these isolates were accepted
as C. guilliermondii var membranaefaciens.
Lengths of REA products, bp (no. of isolates)
C. albicans C. parapsilosis C. tropicalis C. glabrata C. kefyr C. krusei C. guillier-
mondii
141,84,261 336,146,88 325,154,97 414,174,171,86,80 370,430 289,134,83,54 355,302
(36) (27) (26) (25) (11) (10) (5)
184,141,165,95 390,300
(4) (2)
Conclusion: As a result, we can conclude that restriction enzyme
analysis with MwoI and BslI enzymes can be used for the identiﬁcation
of Candida species which need rapid identiﬁcation or which are
problematic with conventional methods that are still accepted as gold
standard although some variations can be observed with this method.
P726 Nucleotide differences in internal transcribed spacer regions
of rDNA and 5-ﬂucytosine resistance among clinical Candida
dubliniensis isolates in Kuwait
S. Ahmad, E. Mokaddas, Z. Khan (Safat, KW)
Objective: Clinical Candida dubliniensis isolates are classiﬁed into four
genotypes based on nucleotide sequences of internal transcribed spacer
(ITS)1 and ITS2 regions of rDNA. Some of the isolates from the Middle
Eastern region are resistant to 5-ﬂucytosine. This study was carried out
to determine nucleotide differences in ITS region (including ITS1−5.8S
rRNA-ITS2) of rDNA that deﬁne 5-ﬂucytosine resistance among clinical
C. dubliniensis isolates in Kuwait.
Methods: A total of 76 C. dubliniensis isolates recovered from various
clinical specimens in Kuwait were assigned to one of four genotypes
based on ampliﬁcation of rDNA with genotype-speciﬁc primers. The
susceptibility of the isolates to commonly used antifungal agents
including 5-ﬂucytosine was performed by Etest. DNA sequencing was
performed to correlate speciﬁc nucleotides in ITS region of rDNA with
the four genotypes and to deﬁne signature residues associated with
resistance of C. dubliniensis isolates to 5-ﬂucytosine.
Results: Majority (49 of 76, 64%) of C. dubliniensis isolates belonged
to genotype 1, DNA sequences of ITS region of rDNA from 12
randomly selected isolates were identical and matched completely with
the prototype strain CD36. A total of 21 isolates (21 of 76, 28%) yielded
an amplicon with genotype 4 speciﬁc primers only and their ITS region
sequences matched completely with the prototype strain of genotype
4. Only 1 isolate belonged to genotype 3. None of the C. dubliniensis
strains belonged to genotype 2. Five isolates yielded amplicons with
more than one genotype-speciﬁc primer pair and DNA sequences of
the ITS region from these isolates identiﬁed them as hybrid strains. A
total of 21 C. dubliniensis isolates were resistant to 5-ﬂucytosine, all 21
belonged to genotype 4 and were characterised by the presence of a T
residue at nucleotide position 82 in the ITS region.
Conclusions: Only three of four genotypes based on ITS region
sequences were detected among clinical C. dubliniensis isolates in
Kuwait with most (64%) of the isolates belonging to genotype 1. All
C. dubliniensis isolates resistant to 5-ﬂucytosine belonged to genotype 4
and were deﬁned by a signature nucleotide in the ITS region of rDNA.
The C. dubliniensis hybrid strains closely related to genotype 4 but not
containing this signature nucleotide were not resistant to 5-ﬂucytosine.
P727 Genotypic relatedness of Candida spp. in neonatal intensive
care unit
K. Eimra, K. Truusalu, H. Ja¨rv, M. Ilmoja, H. Padari, I. Lutsar (Tartu,
EE)
Objectives:We aimed to characterise the genetic relatedness of Candida
species isolated from samples taken on clinical grounds in two NICUs
in Estonia using pulsed ﬁeld gel electroforesis (PFGE).
Methods: Candida spp. were isolated from August 2005 to May 2006
in unit A and from June 1999 to November 2005 in unit B and
stored in sterile water or cryopreserved. The species were identiﬁed
with CHROMagar Candida, Corn Meal Agar with Tween 80 and API
Candida. The relatedness of the isolates was analysed by optimisation
of previously described PFGE method as follows: BssHII digested DNA
was electrophoresed with a voltage of 4V/cm, temperature 14 degrees
C, linear ramped pulse times 5 to 50 seconds and run time of 20 hours.
Results: A total of 83 isolates (12 from blood, 57 from trachea and 14
from other sites) from 52 neonates were analysed. Of 16 invasive isolates
C. parapsilosis (n = 8) and C. albicans (n = 6) were most commonly
seen. C. guilliermondii (30%), C. parapsilosis (30%) and C. albicans
(29%) were predominant isolates in colonised patients. In unit A all
6 C. albicans isolates were genotypically different whereas in unit B
only 2 clones among 18 isolates were identiﬁed. Of 25 isolates of
C. guilliermondii and C. parapsilosis each only 2 and 3 different clones,
respectively, were seen. However, Candida strains isolated in 2000−01
differed from those obtained in 2005−06 by one or two bands suggesting
that microevlolutionary changes within a strain had occurred.
Conclusion: Although C. guillliermondii was a frequent coloniser in
the NICU patients, yet it was rarely associated with the invasive disease.
The presence of a limited number of different clones of C. guilliermondii
and C. parapsilosis indicates permanent source in the NICU and suggests
for transmission by direct or indirect contact and cross-colonisation by
healthcare workers.
P728 Establishing a rep-PCR DNA ﬁngerprinting library for
moulds
K. Reece, E. Atkins, T. Ross, S. Abedi, C. Smith, W. Dutch, M. Wise,
J. Embry, S. Frye, M. Healy (Athens, US)
Objectives: Discrimination among moulds is often difﬁcult. The
advances in many areas in microbiology are limited when looking
at moulds. Morpholological characterisation and staining techniques
are still very common. Sequencing and real-time PCR can be used
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but additional technologies are needed for investigation of moulds.
Previous studies have shown the promise for the use if rep-PCR DNA
ﬁngerprinting as a molecular method to characterise some moulds.
This study reports the compilation of an expanded Mould database as
an additional tool that can be applied to mould characterisation and
subspecies discrimination.
Methods: A total of 250 previously characterised moulds (including
strains from 30 Genus/species) obtained from environmental and clinical
sites and ATCC reference strains were cultured. The isolates were
extracted and then ampliﬁed using the Mold Kit for DNA ﬁngerprinting.
The ampliﬁed product was separated using a microﬂuidic based
detection. The resulting data was analysed using dendrogram analysis
and a Mould library was created using the DiversiLab Software. An
additional 50 mould isolates were processed and compared to the library
for validation.
Results: The resulting ﬁngerprints from the ﬁrst 250 characterised
isolates grouped into multiple clusters. No different Genus/species
showed the same ﬁngerprint pattern. Some species had more than one
ﬁngerprint pattern, or cluster, indicating discrimination to the subspecies
and/or strain level. Many of the 50 isolates used for validation showed
matches to the library. Some isolates formed new clusters but no false
positive groupings are seen.
Conclusions: These data suggest that a characterised library may prove
useful to provide additional information or conﬁrmation when using
DNA ﬁngerprinting for moulds. The DiversiLab System shows promise
as a tool to aid in surveillance and identiﬁcation of hospital acquired
infections and epidemiological studies.
P729 Evaluation of differential expression of calnexin gene during
transition from mycelial to the yeast infective of the fungus
Paracoccidioides brasiliensis and localisation of native protein
L.S. Feitosa, W.L.. Batista, P. Xander, Z.P. Camargo (Sa˜o Paulo, BR)
Introduction: Paracoccidioides brasiliensis is a dimorphic fungus
responsible for paracoccidioidomycosis (PCM); man is infected by
inhalation of conidia. The cellular differentiation of P. brasiliensis from
mycelium (M) to yeast (Y) in the lungs is essential factor to establish
the infection. Calnexin is a chaperone that recognises speciﬁcally
monoglucosylated glycoproteins in the endoplasmic reticulum, being
an essential component of the folding process of nascent secreted
glycoproteins. Objective: Evaluation of differential expression of the
PbCNX transcripts and analysis of cellular localisation of protein native.
Methods: RNA isolated from P. brasiliensis after heat shock and
at different phases. The cDNA encoding PbCnx was cloned and
overexpressed as recombinant protein in Escherichia coli and used to
immunise rabbits in order to obtain anti-PbCnx serum.
Results: Expression of the PbCNX transcripts was investigated in total
RNA isolated from P. brasiliensis after heat shock and at different phases
of the mycelium to yeast (M-Y) transition or yeast and mycelium phases
(Y and M), by real time RT-PCR. Our results suggest that there was an
increased in PbCNX expression at 10 h after temperature change (25
to 36ºC), but normal levels was observed at the last point analysed (M-
Y). Additionally, there was a 3.5-fold increase in transcription after heat
shock at 42ºC for 60 min. Antibodies used in the reactions recognise
speciﬁcally a single 70 kDa in the cell wall (alkaline-mercaptoethanol
extract) component, compatible with the predicted size of the protein.
Conclusion: The evaluation of differential expression during transition
from mycelial to the yeast infective of calnexin suggest that is a heat
shock protein and is the ﬁrst time that PbCnx has been observed on
the cell surface, however, its function is speculative. Financial support:
FAPESP and CNPq.
P730 Molecular karyotype of Sporothrix schenckii: analysis of
chromosomal polymorphism among different isolates
L.S. Feitosa, A.A. Sasaki, Z.P. Camargo (Sa˜o Paulo, BR)
Introduction: Classical genetic analysis of S. schenckii, aetiological
agent of sporotrichosis, has been impaired by the absence of known
teleomorphic stage. Experiments employing in vitro mutagenesis led to
the selection of few mutants with stable phenotypes, since the number
of revertants were high. The genetic composition of the fungus is
poorly known and information about the genome size and chromosome
organisation is scarce.
Objective: This study aims to provide a better characterisation of S.
schenckii chromosomal polymorphisms among human clinical isolates
(lymphocutaneous forms), and ambient sources.
Methods: Approximately 2X107 yeast cells were imbibed in low melting
agarose. Spheroplasts were obtained by digestion of the cell walls with
zymolmyase and disrupted in a solution containing EDTA, sarcozyl and
proteinase K. Electrophoretic separation was performed under pulsed-
ﬁeld gel electrophoresis (PFGE) conditions.
Results: Differences in electrophoretic mobility of bands suggest the
existence of chromosomal polymorphism and make it difﬁcult to
correlate the banding pattern among isolates. The analysis of our results
shows 5 to 6 chromosomal bands and genome size about 28 Mb.
Differences among the number of chromosomes and electrophoretic
mobility of chromosomal bands were observed. New and distinct proﬁles
emerged when comparing our data with previously described ones. The
results also indicated that isolates from different geographical areas
present quite similar banding patterns.
Conclusion: The results were consistent with a haploid number of
4−6 chromosomes. The haploid genome was estimated to be in the
range of 28 Mb. The plasticity fungus genome could have implications
for maintenance of genome functionality and for the control of gene
expression.
Financial support: FAPESP and CNPq.
P731 Characterisation and expression of the gene encoding a gli-
coprotein of 70 kda (gp70) from Paracoccidioides brasiliensis
J.T. Maricato, L.S. Feitosa, R. Puccia, G.H. Goldman, J.D. Lopes
(Sa˜o Paulo, Ribeira˜o Preto, BR)
Introduction and Objectives: Paracoccidioides brasiliensis is a
thermodimorphic fungus that causes Paracocciodioidomycosis (PCM),
human systemic granulomatous disease prevalent in Latin America. Most
of the genes encoding and proteic sequences of relevant fungal antigens
remain uncharacterised. P. brasiliensis produces some important antigens
like gp43 which has been fully characterised, and a 70 kDa glycoprotein
(gp70) recognised by 96% PCM patients’sera. It has been shown that this
puriﬁed antigen modulates murine peritoneal macrophages functions and
that passive immunisation of mice with speciﬁc anti-gp70 mAbs before
fungal infection, signiﬁcantly inhibited lung granuloma formation. The
purpose of this work was molecular cloning and characterisation of the
gene that encodes gp70 from P. brasiliensis followed by heterologous
expression of the recombinant antigen to better understand the role of
the gp70 in PCM.
Methods and Results: Using degenerated oligonucleotides correspond-
ing to peptides obtained by microsequencing from gp70, recognised
and isolated with speciﬁc mAB (C5F11), a 384-bp DNA fragment
was ampliﬁed from the P. brasiliensis genomic DNA (pbgp70). This
fragment showed 97% of similarity with one of the Expressed Sequence
Tags (ESTs) in P. brasiliensis EST databank. Specifc oligonucleotides
were synthesised attempting to obtain the sequence and amplifying
the genomic and cDNA sequences corresponding to this EST. Using
these speciﬁc oligonucleotides, 2.0 kb products were obtained by PCR
of the genomic DNA and cDNA. These fragments were cloned and
sequenced by primer walking. In preliminary sequence analysis it was
found the open reading frame in a 1.6 kb fragment. Deduced amino
acid sequence showed prevalence of hydrophilic regions which probably
contains B-cell epitopes, one putative T-cell mouse epitope and high
Jameson-Wolf Antigenic Index. BLAST analysis showed homology with
putative proteins from the fungus Coccidioides immitis, Aspergillus
fumigatus, Ajellomyces capsulatus, which are phylogenetically close to
P. brasiliensis. Other oligonucleotides are being synthesised to achieve
the heterologous expression of the cDNA sequence and subsequent
obtention of the recombinant protein for further biological assays.
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Conclusion: The 2.0 kb genomic DNA and cDNA cloned sequences
presents some predicted characteristics of the P. brasiliensis native gp70
and may represent the gene of the gp70 antigen. Financial Support:
CAPES
P732 Identiﬁcation of Paracoccidioides brasiliensis highly virulent
isolate ligands peptides by phage display with fungicidal
activity in vitro
E.S. Kioshima, F. Aliperti, L.L. Villa, J.D. Lopes (Sa˜o Paulo, BR)
Introduction: Paracoccidioidomycosis is a human systemic granuloma-
tous disease, prevalent in South America, caused by a thermodimorphic
fungus, Paracoccidioides brasiliensis. This fungus presents complex
antigenic structure and some of these components have been related
with its pathogenicity, of which little is known. Objective: To isolate
molecules expressed in the surface of highly virulent but not in
non-virulent isolated yeast cells of P. brasiliensis by phage display
techonology, thus identiﬁng possible virulence factors.
Methods: A phage display library containing the insert CX7C was
screened to search high-virulent isolate of yeast cells of P. brasiliensis
ligands by Biopanning and Rapid Analysis of Selective Interactive
Ligands method. After three rounds of selection, the DNA corresponding
to peptide inserts of randomly chosen phage clones were sequenced.
Peptide sequences were then analysed according to their enrichment and
by Clustal W sequence alignment. Selected motifs were used to search
nonredundant protein databanks (National Center for Biotechnology
Information [NCBI] BLAST.
Result: The B10.A mice were inoculated with yeasts of different isolates
of P. brasiliensis. Animals that received non-virulent isolates Pb18 and
Pb265 groups behaved as the control group which received only PBS,
but the group that was infected with highly virulent isolate Pb18 died
90 days after injection. We identiﬁed three peptides (CGSYGFNAC,
CGLRLESTC and CGLRLESTC) that bound to the surface of the high-
virulent but did not or did less in non-virulent isolate of P. brasiliensis in
all experimental conditions tested (P< 0.01). Other experiment showed
that phage-cells binding was dose-dependent. By EIA assay with
synthetic peptides, a signiﬁcant binding of these peptides to gp43
(the majority molecule) was not observed. These peptides exhibited
fungicidal activity in vitro against P. brasiliensis by inhibition of colony
forming units.
Conclusion: The peptides CGSYGFNAC, CGLRLESTC and CGLR-
LESTC may represent ligands of molecules that can be involved in the
virulence and pathogenicity of this fungus. Financial support: FAPESP.
P733 Genotyping of Trichosporon asahii strains isolated from
urinary tract infections in a Turkish university hospital
Z.C. Karahan, E. Koyuncu, I. Dolapci, O. Arikan Akan, A. Tekeli
(Ankara, TR)
Objectives: Trichosporon infections are associated with a wide
spectrum of clinical manifestations ranging from superﬁcial cutaneous
involvement to severe systemic disease depending on the immune status
of the patient. Trichosporon asahii appears to be the most important
species in the genus. Invasive infections with T. asahii has been described
most frequently in immunocompromised hosts, although some case
reports of T. asahii infections in immuncompetent patients exist. In this
study, we evaluated the genotypic relatedness of T. asahii strains isolated
from non-immunocompromised patients’ urinary tract infections.
Methods: A total of 25 T. asahii urinary strains were studied. The
isolates were obtained from17 immuncompetent patients (11 male, 6
female, median age 44) hospitalised at different wards (neurosurgery,
urology, nephrology, orthopaedics, reanimation) of Ankara University
Ibn-i Sina Hospital between July 2004-April 2005. None of the patients
were neutropenic during the period when T. asahii was isolated. T. asahii
identiﬁcation was made by using the API 20C AUX (BioMe´rieux Vitek,
USA) and conﬁrmed by PCR by using genus and species speciﬁc
primers. Genotyping of T. asahii strains were made by RAPD and REP-
PCR methods by using M13 and ERIC2 primers, respectively.
Results: All of the isolates gave amplicons by Trichosporon speciﬁc
primers. When species speciﬁc PCR was performed, 23 of the isolates
obtained from 15 patients gave amplicons. These 23 isolates were
subjected to genotyping. RAPD analysis by M13 primer resulted in
clustering of the isolates into 5 groups; four of the groups were composed
of single isolate, and the ﬁfth group contained 19 isolates. The results of
REP-PCR analysis showed good corelations with the data obtained by
RAPD method, although this method produced three different groups.
Two of the groups contained single isolates which corresponded to the
two groups of RAPD analysis. The third group consisted of 21 isolates
containing the two isolates which were distributed to different groups by
RAPD analysis.
Conclusion: Here we report 15 immuncompetent patients with urinary
tract infections due to Trichosporon asahii. In this ﬁrst study of invasive
trichosporonosis from Turkey, 19 of the 23 isolates were found to be
genotypically related, suggesting that a single genotype was prevalent in
the hospital environment. The genotypically unrelated four isolates were
probably of endogenous origin.
P734 Clinical performance of FXGTM :RESP (Asp +) assay for
aspergillus on respiratory specimens
C. Lass-Florl, J. Bille, D.S. Perlin, S. Park, K. Lagrou, E. Harrison,
W. Meersseman, X. Cui, M. Hughes, D.W. Denning, J. Maertens
(Innsbruck, AT; Lausanne, CH; Newark, US; Leuven, BE; Manchester,
UK)
Objectives: Early diagnosis of invasive aspergillosis (IA) is essential
to survival. Classical microbiological methods are slow and insensitive.
Real-Time PCR offers the prospect of both faster and more sensitive
microbiological conﬁrmation of IA. FXG :RESP (Asp +) is a new test
kit that detects both Aspergillus spp. and Pneumocystis jirovecii, utilising
molecular beacons. This ready to use PCR assay consists of an extraction
kit plus PCR assay and is CE marked. In this report we focus on the
clinical performance for Aspergillus spp.
Methods: The FXG :RESP (Asp +) real-time PCR kit was tested on 198
respiratory specimens from a wide variety of patient groups, collected
from 4 European hospitals. Analysis was carried out using an AB7500
thermocycler. Samples of BAL were mostly stored at −20 to −80ºC
prior to DNA extraction using the MycXtraTM fungal DNA extraction
kit. Some sputum samples were also processed. The FXG :RESP (Asp +)
results were compared with culture for Aspergillus spp. The whole assay
time including extraction is <4 hours from BAL and <5 hours from
sputum. The limit of detection was ~1 genome for A. fumigatus (as
assessed by puriﬁed Af293 DNA), and this was used as the clinical
cut-off. An internal ampliﬁcation control reaction within the kit detects
inhibitors that might affect the PCR reaction, although positive results
in the presence of inhibition may be reported.
Results: Overall, for all 198 respiratory samples the sensitivity was 74%
and speciﬁcity 93% with positive and negative predictive values 76%
and 92% respectively. On 75 freshly collected sputum and other lower
respiratory tract samples the sensitivity and speciﬁcity were 79% and
88% respectively. The FXG :RESP (Asp +) assay also detects Penicillium
spp. as the target sequence in this fungus is identical. 3 samples were
culture positive for Penicillium spp., and positive for FXG :RESP (Asp
+) and recorded as ‘false positives’. The FXG :RESP (Asp +) does not
detect Zygomycetes or Candida spp., and this was conﬁrmed in the
clinical study.
Conclusions: Overall the speed of detection and sensitivity of the
FXG :RESP (Asp +) assay will bring considerable clinical beneﬁts.
Additional prospective and supportive clinical trials are ongoing.
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P735 Identiﬁcation of the pre-mRNA splicing protein U2AF35 in
the opportunistic fungus Pneumocystis carinii
C. Thomas, B. Sanyal, P. Vohra (Rochester, US)
The opportunistic fungus Pneumocystis carinii (PC) is an intractable
organism responsible for severe pneumonia in patients with AIDS or
other immunosuppressive conditions. PC is phylogenetically similar to
the non-pathogenic yeasts S. cerevisiae and S. pombe. The regulation
of gene function is a complex process critical to the survival of
eukaryotes, and thus presents potential targets for novel therapy. Pre-
mRNA processing with removal of intervening sequences (introns) is an
important step in gene regulation. The assembly of multiple proteins
on small nuclear RNA occurs in the spliceosome. Although many
components of this molecular machinery is conserved in eukaryotes,
there are many signiﬁcant differences between S. cerevisiae, S. pombe
and mammals. The process of gene regulation in PC is unknown. We
have previously reported that PC genes contain multiple small introns,
yet lack features found in S. cerevisiae and S. pombe (Infection and
Immunity, Nov. 1999, p. 6157–6160). Here we report the identiﬁcation
and cloning of the PCU2AF35 gene, encoding a critical splicosomal
protein required for processing the 3′ end of the intron. PCU2AF35 is a
621-bp ORF encoding a predicted 206 amino acid protein. The predicted
molecular weight is 24.1 kDa, similar to S. pombe U2AF35. PCU2AF35
contains a conserved RNA recognition motif (RRM) postulated to bind
RNA sequences. PCU2AF35 is most homologous to S. pombe U2AF35
(72% identity). We have expressed this gene as a recombinant protein
to determine its function in PC intron removal. Our investigations
may provide new insights into the pathogenesis of PC and potential
new therapeutics for treating PC pneumonia through identiﬁcation of
mechanisms involved in PC life cycle regulation.
Supported by NIH grant 2R01 AI-48409 to CFT.
P736 Rapid identiﬁcation and differentiation of Trichophyton
species, based on sequence polymorphisms of the ribosomal
internal transcribed spacer regions, using rolling circle
ampliﬁcation
F. Kong, Z. Tong, X. Chen, T. Sorrell, B. Wang, Q. Wu, D. Ellis,
S. Chen (Sydney, Adelaide, AU; Beijing, CN)
Objectives: To develop a novel padlock probe and rolling circle
ampliﬁcation (RCA)-based method, for identiﬁcation of single nucleotide
polymorphisms (SNPs) to differentiate between major members of the
genus Trichophyton.
Methods: The ITS region (ITS1, 5.8S and ITS2) of 42 dermatophytes
belonging to seven species (Trichophyton rubrum, T. mentagrophytes,
T. soudanense, T. tonsurans, Epidermophyton ﬂoccosum, Microsporum
canis and M. gypseum) were sequenced. Polymorphisms were identiﬁed
after multiple sequence alignment and comparison with relevant archived
GenBank sequences. Either species-speciﬁc or group-speciﬁc padlock
probes were designed to detect the species above.
Results: DNA sequencing demonstrated demonstrated intra-species
genetic variation for T. tonsurans, T. mentagrophytes and T. soudanense,
but not for T. rubrum. Signature sets of SNPs between T. rubrum and
T. soudanense (4 bp difference), and T. violaceum and T. soudanense
(3 bp difference) were identiﬁed. The RCA assay correctly identiﬁed
ﬁve Trichophyton species. Although use of two “group-speciﬁc” probes
targeting both the ITS1 and ITS2 regions were required to identify T.
soudanense, the other species were identiﬁed by single ITS1-, or ITS2-
targeted species-speciﬁc probes. There was good agreement between ITS
sequencing and RCA assay.
Conclusion: Despite limited ITS sequence-based variation between
Trichophyton spp., the RCA-based SNP detection assay showed potential
as a simple, speciﬁc and reproducible method for rapid (2 hours)
identiﬁcation of Trichophyton spp.
P737 Genotypes of human Blastocystis hominis isolates and its
pathophysiological varaibility in exeperimentally infected rats
E.M. Hussein, A.M. Hussein, M.M. Eida, M.M. Atwa (Ismailia, Cairo,
EG)
Background: A deﬁnite correlation between the distinct genetic
variability present in Blastocystis hominis parasite and its pathogenecity
has not yet been conﬁrmed.
Objectives and Methods: The ﬁrst objective of this study was
identify the genotypes of B. hominis clinical isolates obtained from 28
gastrointestinal symptomatic patients and 16 asymptomatic individuals
by PCR using sequenced-tagged site (STS) primers. The second objective
was evaluation the pathophysiological variability between different
B. hominis genotypes induced in experimentally infected rats by identify
the histopathological changes, the mortality rate and the intestinal cell
permeability in Ussing chamber. Infected rats with asymptomatic and
symptomatic human isolates were used.
Results: Only 4 B. hominis genotypes were identiﬁed among all the
human clinical isolates. Subtypes 1, 2, 3 and 4 were detected among
18.2%, 9.1%, 54.5% and 18.2% of the human isolates. In symptomatic
isolates subtypes 1, 3 and 4 were detected in 28.6%, 57.1% and
14.3% respectively. In asymptomatic isolates subtypes 2, 3 and 4 were
identiﬁed in 25%, 50%, and 25% respectively. Subtype 3 was the
commonest among humans. Different degrees of pathological changes
were found among infected rats by symptomatic subtypes as compared
with asymptomatic subtypes. The moderate and severe degrees of
pathological changes were found only in symptomatic subtypes infected
rats while mild degree was found only in asymptomatic subtypes infected
rats. No extra intestinal lesions were found. Only subtype1 induced
mortality rate with 25% among infected rats. On evaluation of the
intestinal cell permeability, a prominent increasing in short circuit current
(A¨Isc) was found in symptomatic subtypes 1 compared to symptomatic
subtypes 3 and 4 infected rats. Meanwhile, minimal effects were found
in asymptomatic and control groups.
Conclusions: Subtype 1 is relevant to the pathogenecity of B. hominis
while, subtype 2 is irrelevant. The presence of subtypes 3 and 4 among
symptomatic and asymptomatic isolates suggested that the variability
on Blastocystis pathogenecity among these subtypes may be related to
the presence of sub-strains (pathogenic or non-pathogenic) which needs
further studies.
Amoeba
P738 Real-time PCR as a semi-quantitative alternative for
microscopic detection of Dientamoeba fragilis
T.J. van Middelkoop, B.A. Poell, L. Mulder, J.J. Verweij (Enschede,
Leiden, NL)
Objectives: Since the discovery of Dientamoeba fragilis, the pathogenic-
ity of this organism has remained controversial. Microscopic detection
did not imply a quantiﬁcation of this frequently found faecal parasite.
A new real-time PCR based on the 5.8S ribosomal RNA gene was
developed for the detection of D. fragilis in faecal samples. We examined
if this could provide a semi-quantitative alternative for microscopic
detection.
Methods: Microscopic examination was carried out on IHK stained
faecal samples collected after SAF ﬁxation with the Triple Faeces Test
(TFT). A selection of 200 positive and 200 negative samples was made.
Real-time PCR was performed on the corresponding fresh stool samples.
The PCR also included an internal control (PhHV) to detect inhibition
of the ampliﬁcation by faecal constituents in the sample.
Results: In the ﬁrst half year of 2007, 2052 faecal samples were
examined of which 394 were positive for D. fragilis (19.2%). In the
selection of 400 samples no inhibition of ampliﬁcation was found. In
200 microscopically negative stool samples D. fragilis was ampliﬁed
in 12 cases. In these 12 samples, the presence of D. fragilis could be
conﬁrmed microscopically after re-analyses of the permanent staining
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preparations in 9 cases, corresponding to a speciﬁcity of 98.5%. In a
selected group of 200 faecal samples from patients in which one or two
preserved samples showed D. fragilis trophozoites, D. fragilis-speciﬁc
ampliﬁcation was detected in 184 DNA samples wich corresponds to a
sensitivity of 92%. The mean Cp value of the positive samples was 30.7
with a range from 20.1 to 37.8.
Conclusions: The real-time PCR for the detection of D. fragilis achieved
98.5% speciﬁcity and 92% sensitivity. The use of this assay in a
diagnostic laboratory offers the possibility of introducing DNA detection
as a feasible technique for the routine diagnosis of intestinal D. fragilis
infections and provides a reliable semi-quantitative measure for further
pathogenicity studies.
P739 Molecular assays to diagnose Entamoeba histolytica and
E. dispar infections in a non-endemic area (Parma, Italy)
A. Calderaro, C. Gorrini, S. Peruzzi, G. Piccolo, G. Dettori, C. Chezzi
(Parma, IT)
Objectives: The detection of Entamoeba histolytica (Eh), causative agent
of amoebiasis, is an important goal of the clinical parasitology laboratory.
The identiﬁcation of E. dispar (Ed) as a morphologically identical but
non-pathogenic species has highlighted the need for non-microscopic
detection methods able to differentiate the 2 species. Moreover, a
reassessment of the worldwide prevalence of amoebic infection based
on discriminatory methods has been strongly recommended by WHO.
The area in which our laboratory is located has seen in recent years
an increase of people travelling through and a signiﬁcant ﬂow of
immigration from tropical countries which has led to a parallel increase
in imported infections.
Thus, the aim of this study was to promptly diagnose and discriminate
Eh and Ed infections and to assess their occurrence among patients with
suspected intestinal parasitosis presenting to the University Hospital of
Parma.
Methods: The specimens analysed in this study were selected from the
whole of the clinical samples sent to our laboratory with the suspicion
of intestinal parasitosis during 2003–2007 and subjected to standard
procedures (microscopic examination) for the detection of intestinal
parasites. In particular, 730 samples (715 faeces, 7 liver abscess samples,
8 intestinal biopsies) belonging to 407 patients were analysed. The
samples were subjected to culture for intestinal protozoa and molecular
assays (conventional or Real-Time PCR) able to distinguish Eh from Ed
DNA.
Results: Eight patients (1.96%) proved to be infected by Eh (3
with extraintestinal and 5 with intestinal amoebiasis; 5 with imported
amoebiasis and 3 with the disease acquired in Italy) and 36 by Ed
(8.84%). In particular, in 4 of the 8 patients with Eh infection, only
molecular methods were able to detect the presence of the parasite.
Conclusion: Our results underline that traditional methods underestimate
the prevalence of amoebic infection and highlight the important
diagnostic role that PCR can play. Species differentiation by PCR
becomes an important tool for clinicians as it permits them to focus on
Eh infections and to avoid treatment when non-pathogenic Ed is present.
The relatively high prevalence of Ed infections observed in this study
versus the more rare Eh infections, is indicative of the existence in
the community of a faecal-oral route of agents with an exclusively
inter-human circulation and calls for the activation of adequate control
measures.
P740 Amoebic keratitis in Iran (1997–2007)
M. Rezaeian, S. Farnia, M. Niyyati, F. Rahimi (Tehran, IR)
Objective: Amoebic keratitis introduced as a painful corneal infection
which sometimes lead to poor vision and blindness. The main goal of
this study was to report amoebic keratitis during ten years from 1376–
1386 in patients who was suspected to amoebic keratitis and referred
to parasitology laboratory, School of Public Health, Tehran Medical
University, Iran. Other aim was to assess the major risk factor for
developing this sight-threatening disease. Comparison of lens culture
and corneal scrapes culture also performed.
Methods: During 1376–1386, 142 patients referred to department of
parasitology, School of Public Health, Tehran Medical University. Details
of each patient such as age, sex, history of contact lens wear, type of
contact lens, clinical symptoms were record in questioners. Keratitis was
diagnosed on the basis of culture of lenses and/or corneal scrapes on
non-nutrient agar overlaid with Escherichia coli and direct microscopy
of lenses and/or corneal scrapes.
Results: Among 142 patient who referred to department of parasitology,
School of public health, Tehran Medical University, Iran, 49 patients
(34.5%) had Amoebic keratitis. 73.46% of these patients were from
Tehran but there were a few cases from other cities. The commonest age
was between 15−25 (75.5%) and more female (37:12) were identiﬁed
then male. It is worth to mention that 44 patients (89.79%) were contact
lens wearers which among them 41 patients (93.18%) wore soft contact
lens and only three patients suffer from amebic keratitis because of
wearing hard contact lens. Other ﬁnding of this study demonstrated that
the most common sign of the patients was severe pain combined with
photophobia.
Conclusion: This study indicate that Acanthamoeba keratitis continue
to rise in Iran. This is due to increase frequency of lens wearers as
well as consideration of ophthalmologist to Acanthamoeba as an agent
of keratitis and improvement of laboratory methods. Another ﬁnding of
this research was the conﬁrmation of soft contact lens as a major risk
factor. It is recommended to educate contact lens wearers for regular
disinfection. Besides, culture of corneal scrapes was negative in most of
cases, so lens culture were performed which had a much better result.
P741 Diagnosis of dientamoebiasis: efﬁcacy of culture and
comparison of three culture media
O¨. Kurt, I. O¨stan, N. Girginkardesler, U¨.Z. Ok, A. O¨zbilgin (Manisa, TR)
Objectives: The diagnosis of dientamoebiasis depends on the demon-
stration of Dientamoeba fragilis, a common but rarely identiﬁed
intestinal protozoon. Its nuclear structure can only be seen with
permanent stains, such as trichrome or iron hematoxylin; therefore,
examination of permanent stained smears of fresh or ﬁxed stool samples
by an experienced microscopist is obligatory for the diagnosis of
dientamoebiasis. Culture is known to be a more sensitive method but
it is out of scope of many laboratories in routine diagnosis. However, it
may identify the overlooked cases with microscopy and is reported to
be less laborious than trichrome staining. Our aim was both to assess
the efﬁcacy of culture and compare the efﬁcacies of three culture media,
Robinson’s, Dobell’s and Talis’s diphasic egg medium (TDEM) in the
diagnosis of dientamoebiasis.
Methods: Among the 93 dientamoebiasis patients diagnosed in the
Parasitology Laboratory of Celal Bayar University Hospital, stool
samples of 80 and 75 patients were inoculated in Robinson’s and Dobell’s
media, respectively, while 65 were inoculated in TDEM; stool samples of
61 patients were inoculated in all three media. In addition, stool samples
of 160 Dientamoeba-negative individuals diagnosed with the microscopic
examination of trichrome stained smears were inoculated in all three
media. All culture tubes were checked by the microscopic examination
of a drop of sediment at 48, 72 and 96 hours after inoculation. The
sensitivity and speciﬁcity values of Dobell’s medium and TDEM were
assessed compared to Robinson’s medium.
Results: Diagnostic efﬁcacies of each medium were found to be 90%,
76% and 86% for Robinson’s, Dobell’s and TDEM, respectively. Among
the 160 microscopically-negative samples, the growth of D. fragilis
was detected in 17 (11%), 5 (3%) and 6 (4%) in Robinson’s, Dobell’s
and TDEM, respectively. All positive samples in Dobell’s medium and
TDEM were also found to be positive in Robinson’s medium.
Conclusion: Our results suggest that microscopy may overlook
signiﬁcant number of dientamoebiasis cases, which are detectable with
culture, and Robinson’s medium may be used effectively even in routine
diagnosis of dientamoebiasis, instead of trichrome staining. Culture is by
far less expensive than molecular methods and may be preferred where
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novel diagnostic methods, such as PCR, are not available due to their
higher costs, especially in developing countries.
P742 Detection of amebiasis among men who have sex with men,
with or without human immunodeﬁciency virus infection
C.C. Hung, N.Y. Ko, P.Y. Wu, C.H. Wu, W.C. Liu, H.Y. Sun, S.C. Chang
(Taipei, Tainan, TW)
Objectives: Men who have sex with men (MSM), regardless of HIV
status, are at increased risk for amebiasis because of oral-anal sexual
contact in Taiwan. In this study, we aimed to evaluate the association of
seroconversion for Entamoeba histolytica infection with newly acquired
intestinal infection with E. histolytica among MSM.
Methods: Between 1 January, 2007 and 30 November, 2007, 143 MSM
(128 HIV-infected) who were free of gastrointestinal symptoms provided
both blood and stool specimens for serological tests and speciﬁc amebic
antigen tests for E. histolytica infection, respectively. Anti-E. histolytica
antibodies were determined using indirect hemagglutination (IHA) assay
(Cellognostics, Boehhringer Diagnostics GmbH, Marburg, Germany),
while stool amebic antigen was determined using commercial test kits
(ENTAMOEBA TEST, TechLab, Branchburg, NJ) followed by poly-
merase chain reactions (PCR) using speciﬁc primers for E. histolytica.
Results: In this survey, the prevalence of intestinal E. histolytca infection
was 9.1% (13/143) and the seroprevalence of E. histolytica infection
(IHA titers 32) was 17.5% (25/143) among the subjects. MSM
who were seropositive were at statistically signiﬁcantly higher risk for
intestinal E. histolytica infection with an odds ratio of 25.56 (95%
conﬁdence interval, 6.316, 103.4) (p< 0.0001).
Conclusion: We found that MSM who were IHA-seropositive for E.
histolytcia was more likely to present with intestinal E. histolytica
infection than those who were seronegative. In clinical settings where
amebiasis is suspected and stool samples may not be readily available,
serologies for E. histolytica is a cost-effective screening alternative to
identify E. histolytica infection among MSM.
P743 Indigenous amebiasis in hypoendemic area: myth or reality?
M. Ivanova, M. Nedzvedz, S. Poljakova, E. Saridze, S. Fedorovich,
E. Glod (Minsk, BY)
Amebiasis is one of the three most common causes of death from
parasitic disease. Belarus is considered a non-endemic country since
indigenous transmission of the Entamoeba histolytica parasite may be
virtually non-existent. However, invasive intestinal and extra-intestinal
infections have also been found among Belarusian population.
Objectives and Methods: The medical records of in-patients, who had
been diagnosed as cases of amebiasis, at some hospitals in Minsk in
1994–2006, were retrospectively reviewed. This grope consist of 24
patients, 13 females and 11 males, average patient age was 56.4 years
(range 22−81 years). To avoid overdiagnosis in each case, amebiasis
was conﬁrmed by the identiﬁcation of hematophagous trophozoites of
Entamoeba histolytica by microscopic examination of stool, pus and
tissue intravital and postmortem. Unfortunately, this is the only test
available in Belarus now. According to outcomes of disease there were
16 dead patients and 8 recovered ones.
Results: The epidemic investigation shows that only 2 patients have
visited endemic amebic countries. All fatal cases were misdiagnosed,
before the deaths following clinical diagnoses were made: liver abscess,
acute gangrenous cholecystitis (2), tumour of brain, Crohn’s disease
(2), intestinal tuberculosis, pulmonary tuberculosis, cancer of colon
(4), mesenteric thrombosis, acute anaemia, sepsis (2). Pathologic
investigations reveal various amebic intestinal damages: terminal
enteritis (1), ascendant colitis (1), sigmoiditis (4), total colitis (3);
extraintestinal damages: liver (7), gall bladder (3), pancreas (1), lungs
(2), brain (3). All of patients were burdened of premorbid conditions
(diabetes mellitus, cancer, chronic diseases of lungs, GIT, heart).
In the group of survived patients, there were 6 cases of liver amebic
abscess, 1 case of complicated amebic sigmoiditis and 1 case of amebic
colitis with ulcerative colitis.
Conclusions: Amebiasis can be indigenous in the former hypoendemic
countries and can has very severe fatal forms. It is necessary to improve
clinical diagnostic and parasitological methods, to perform an antigen
detection using ELISA to provide a more reliable comment on the
epidemiological pattern and clinical impact of the disease.
P744 Prevalence of Entamoebae infection in Sudan
A. Saeed, H. Abd, G. Sandstrom, B. Evengard (Stockholm, SE)
Objective: The frequency of E. histolytica and E. dispar was studied and
sociodemographic conditions associated with E. histolytica and E. dispar
infection. A descriptive study was carry out in urban area of Khartoum
the capital city of Sudan.
Methods: Stools samples were examined by microscopy and positive to
Entamoeba were analysed by PCR to differentiate between E. histolytica
and E. dispar.
Results: E. histolytica was detected in 106/196 (54.1%) and E. dispar
in 100/196 (51%). The age groups most infected were >30 years old
followed by <9 years old. E. histolytica was signiﬁcantly associated
with diarrhoea 103/196 (52.6%) and with the presence of Red blood
cells in the stools 101/196 (51.5%).
Conclusion: E. histolytica and E. dispar infections are common in
Khartoum, therefore we need to apply a technique help in differentiation
between them in the routine diagnosis of the samples.
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P745 Comparison of three methods of real-time PCR with blood
smears and antigen detection in plasmodial infection
N. Bourgeois, A. Boutet, D. Basset, P.J. Bousquet, M.J. Carles,
S. Charachon, L. Lachaud (Nimes, Montpellier, FR)
Objectives: In malaria, rapid and accurate diagnosis of Plasmodium spp.
is needed for adequate and efﬁcient treatment. Three different rapid PCR
methods were compared to the routine diagnosis method.
Methods: A transversal study was conduced in our laboratories
located at Montpellier and Nıˆmes University Hospital. Routine method
associated microscopy examination of Giemsa-stained blood smears
and antigen detection by Now® Malaria kit. For control samples,
antigens were not routinely searched when positive diagnosis was already
obtained. DNA was extracted from the previous blood samples. The
three methods of real-time PCR were optimised, and the SYBR Green
was used for ﬂuorescence detection in a LightCyclerTm instrument. The
PCR1 ampliﬁed a speciﬁc sequence on the P. falciparum Cox1 gene.
The PCR2 ampliﬁed a species-speciﬁc region of the multicopy 18S
rRNA present in the four plasmodium sp that infect humans. Species
differentiation was obtained by melting curve analysis. The PCR3
ampliﬁed a mitochondrial DNA sequence that allowed the differentiation
of P. falciparum from the three others species.
PCR methods were compared between each other and with the routine
method. Kappa and McNemar tests were performed.
Results: On the 245 blood samples (195 diagnosis and 50 controls)
collected between 2005 and 2007, 118 samples were positive for at least
one of the ﬁve methods (72 [36.9%] at diagnosis, and 46 [92%] at
control).
Compared to the routine method, there was no false negative, neither
in PCR1 nor in PCR3 for P. falciparum diagnosis. It is noteworthy
that microscopy alone was negative in ﬁve samples, three of them also
negative in PCR2. In all P. ovale, vivax and malariae infections, PCR1
was negative, as expected, whereas PCR2 and PCR3 were positive and
concordant (simple Kappa coefﬁcient = 1). Globally, for ﬁrst biological
diagnosis, PCR3 alone (n = 103) and the association of PCR1 and 2
(n = 195) were fully concordant with routine method. As regards control
samples, the three PCR methods remained more often positive than blood
smears (92% vs 34%) and this for a longer period after treatment.
Conclusion: Those three rapid PCR methods showed excellent results,
used solely or in association. Nevertheless, PCR did not detect additional
cases of malaria potentially undiagnosed by routine testing.
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P746 Epidemiology of imported malaria to Catalonia (Spain):
2001–2006
M. Quesada, N. Cardenosa, J.P. Millet, L. Acosta, M. Oviedo,
J.A. Cayla`, R. Garcı´a, E. Rodrı´guez, L. Sa´nchez, A´. Domı´nguez
(Barcelona, Murcia, Madrid, ES)
Objective: To describe the epidemiology of malaria imported to
Catalonia in six years (2001–2006).
Methods: In this retrospective study, we investigated malaria using data
provided by database reports of illness of obligatory declaration from
2001 to 2006. Epidemiological data were analysed by age, sex, country
of origin, country and date of trip, reason of travel, chemoprophylaxis,
type of malaria, specie of plasmodium, treatment, length of hospital stay
and outcome.
Results: During the study period, 1000 cases were notiﬁed in Catalonia,
94% (944) laboratory conﬁrmed. Missing information or indeterminate
results affected all variables. Almost all malaria cases (99.8%, 936) were
imported: 87.6% (784) from Africa, 8.7% (78) from Central and South
America, 3.6% (32) from Asia and 0.1% (1) from Oceania, by 24%
(192) Spanish citizens and 76% (623) immigrants. Forty-nine percent
of cases (441) were imported from Western Africa. In 80% (674) of
patients P. falciparum aetiology, 14% (120) P. vivax, 4% (32) P. ovale
and 2% (15) P. malariae were conﬁrmed. Among the subjects, 60%
(600) were men. The youngest patient was 5 months and the oldest 92
years old, 52% of patients (522) were in the age group 21 to 40 years
old. Most common reasons for travel were individual travel 43% (254),
tourism 37% (219) and professional or missionary travel 17% (102). In
25% (210) cases some kind of chemoprophylaxis was documented, but
only 29% (60) speciﬁed which drugs were taken and only 10% (21) of
cases did it correctly. Chemoprophylaxis consisted in meﬂoquine in 57%
(85) of cases, chloroquine phosphate in 12% (18) and doxicicline in 7%
(10). Fifty-nine percent (533) of patients required hospitalisation and
16% (75) of them stayed at the hospital more than 7 days. Four cases of
malaria death were reported, all of them due to P. falciparum infection.
These patients were Spanish adults that travelled to African countries
and did not take chemoprophylaxis. Two hundred three children living
in Catalonia and travelling to their parents’ endemic country of origin
became infected by Plasmodium spp., 55% (111) of them did not take
antimalarial drugs.
Conclusions: During the period 2001–2006 in Catalonia P. falciparum
was the main aetiology. Western Africa is the region and the continent
from which most cases are imported. Immigrants contribute with most
of cases. Children and Spanish adults deserve special attention because
they often do not take preventive measures.
P747 Pyrosequencing for Plasmodium falciparum resistance in
returning travellers, refugees and immigrants to Alberta,
Canada
S. Shokoples, S. Yanow (Edmonton, CA)
Objectives: Travelers to malaria endemic areas, refugees and immigrants
infected with malaria can provide information on the resistance patterns
of circulating parasite strains. In 2007 we received 13 blood samples
from 8 patients with Plasmodium falciparum malaria. These samples
were tested for malaria and speciated by real-time PCR. Samples that
were positive for P. falciparum were genotyped at the pfdhfr locus by
pyrosequencing. In this study, we have examined three single nucleotide
polymorphisms (N51I, C59R, and S108N/T) associated with resistance
to the antimalarial sulfadoxine-pyrimethamine (SP).
Methods: DNA was extracted from 40 microlitres of whole blood using
the PSS Bio Instruments 12GC or the Qiagen QIAamp Blood Mini Kit.
Real-time PCR was carried out as described (Rougemont et al., 2004)
with some modiﬁcations. Primers used for pyrosequencing were modiﬁed
from those designed by Zhou et al. (2006).
Results: All of the malaria strains tested showed at least one mutation
in the pfdhfr locus; the majority of the strains showed mutations in
all three codons. One traveler to Papua New Guinea had been infected
with parasites carrying two mutations in the pfdhfr locus: 59R, and
108N, consistent with high levels of resistance to SP in this area.
Sibling refugees from Sierra Leone harbored parasites with the triple
mutations 51I, 59R, and 108N. Both developed symptomatic malaria
upon arrival in Canada. These genotypes correlate with high SP failure
rates documented for Sierra Leone (Checci et al., 2005).
Conclusion: Molecular surveillance of P. falciparum in returning trav-
elers, refugees and immigrants can contribute valuable genotyping data
to global sentinel networks on the prevalence of drug resistant strains
in those regions. Future work will include developing pyrosequencing
protocols for other mutations associated with drug resistance, including
pfATPase6 and pfcytb.
P748 Chloroquine susceptibility phenotype and virulence of
Plasmodium falciparum
G. Saliba, W. Kamouh, A. Fontanet, J. Lebras (Paris, FR)
Objective: In order to study the relation between Plasmodium falci-
parum’s virulence and phenotype, Chloroquine® resistant or susceptible,
we postulated, based on the Fitness concept, that the susceptible
phenotype would be more virulent in-vivo than the resistant one and
thus more predictive of severe malarial episodes.
Methods: A case-control study on severe malaria imported into
metropolitan France over the period of January 1st 1996 and September
30th 2006. Cases and controls were deﬁned as subjects manifesting
severe and non severe malarial episodes respectively.
The world health organisation classiﬁcation, 2000, was used to assess
the severity of malarial episodes. The criterion of >4% of peripheral
parasitism in non-immune patients was excluded among the above
criteria. All patients fulﬁlling this condition, solely, were regarded as
manifesting non severe malaria. Using a bilateral 80% statistically
powered test to detect a minimum odds ratio (OR) of 2.0, the number of
subjects required was estimated to be 91 severe and 364 non severe cases.
Independent risk factors of severe malaria, and subsequently virulence
assessment of Plasmodium falciparum’s phenotypes, were determined
using multiple logistic regression models.
Results: Our study population consisted of 81 severe and 840 non severe
cases. The threshold of 80% statistical power required for an appropriate
analysis was respected by recruiting 921 subjects thus increasing the
case-control ratio to ~1/10. Regarding severe falciparum malaria, the
Chloroquine® susceptible phenotype turned to be a protective factor
compared to the Chloroquine® resistant phenotype. After controlling
for age, level of parasitism, continent of infection and native zone, the
resistant phenotype was signiﬁcantly associated with an increased risk
of severe malaria with an OR of 1.85 (95% CI: 1.09−3.1). This result
was controlled and consistently conﬁrmed in several logistic regression
models including and excluding missing data.
Conclusion: Virulence and Fitness do not seem to correlate. The adap-
tive advantage of the Chloroquine® susceptible phenotype, according to
the Fitness concept, does not result in more enhanced in-vivo virulence.
This is the ﬁrst study to address this subject without any restrictions of
age or of aetiology of severe malaria.
P749 High proportion of microscopically conﬁrmed highlands
malaria in Eldoret, Kenya (2450 metres)
L. Gabrhelova, Z. Nagyova, A. Kolenova, K. Moses, E. Kalavsky,
N. Jalili, A. Kalavska, V. Krcmery (Trnava, Bratislava, SK)
Introduction: Malaria is a serious public health problem with social and
economic consequences in sub-Saharan Africa in altitude under 1500–
2000m. Despite of altitude higher than 2000 m, cases of non-imported
malaria were observed sporadically in 1990 as “highlands malaria”. The
reason why malaria is ascending to higher altitudes is global warming,
agricultural and hydrological changes in combination with other causes.
Methods: We investigated the proportion of conﬁrmed malaria cases
among suspected non-imported malaria cases in a community health
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centre in Eldoret, Kenya. Within 12 months (6/2005−5/2006) 16484
patients in OPD were seen.
Results: In 4985 patients (30%) malaria was clinically suspected and
microscopic investigation of blood smear with direct microscopy and
Giemsa staining of peripheral blood was performed. Of 4985 suspected
cases, 1939 (39%) were positive. All patients received ACT (artemisine
combination therapy) – CoArtem (Artesunate/Lumefantrine), no death
on malaria was observed and loss of follow up was common. Also no
single case of cerebral malaria was noticed. Cure rates were up to 99%
when practically all patients responded to initially therapy.
Conclusion: “Highlands malaria” is a daily reality and up to 2000 (12%)
cases a year among more than 16000 patients visits is seen even in
altitude about 2500 m.
P750 Usefulness of polymerase chain reaction in the diagnosis of
asymptomatic Plasmodium infection
A. Rodrı´guez-Guardado, F. Pe´rez, J. Orda´s, J. Ferna´ndez, A. Perez,
J.A. Carto´n (Oviedo, ES)
Background: In malaria-endemic countries with stable transmission of
malaria, semi-immunity is usually acquired after childhood. Infected
adults have either uncomplicated malaria or asymptomatic parasitaemia.
This fact is frequent in immigrant population
Methods: During the period of one year we screened 117 immigrants
to investigate the presence of asymptomatic malaria. In all patients
we realised microscopic examination of thin and thick blood smears,
determination of plasmodium antigen (BINAX NOW®) and nested-PCR.
Results: During the period of the study we diagnosed 5 cases of
asymptomatic malaria in ﬁve patients (4 women, one man). The
other techniques were negatives. The countries of precedence were:
Equatorial Guinea (two cases), Senegal, Brazil and Ivory Coast (one
case respectively). The mean of stay in Spain was 852 days (limits 123–
1825). No patients come back to native countries in this time. In three
cases the nested-PCR was positive to Plasmodium falciparum and in two
cases Plasmodium malariae. No patients showed symptoms or analytic
disturbance. All patients were treated with quinine and doxycicline.
No patients dead. After the treatment the PCR became negative in all
patients.
Conclusions: Asymptomatic Plasmodium spp. parasitaemia in immi-
grants proceedings of malaria-endemic country is frequent. PCR appears
to be a useful method for detecting asymptomatic malaria or low
parasitaemias in immigrant patients. This fact is very important in
detection and management of imported malaria.
P751 Can non-speciﬁc biochemical tests improve the diagnosis and
contribute to prognosis in imported malaria?
J. Poluga, G. Stevanovic, M. Pelemis, J. Nikolic, M. Pavlovic
(Belgrade, RS)
Objectives: The objective of this study was to evaluate role of
nonspeciﬁc biochemical tests in malaria diagnosis, according to their
sensitivity, speciﬁcity and positive predictive values. In addition,
comparison with parasitaemia, occurence of complications, recovery
duration and organ failiure was examined to determine possible
prognostic value of routine biochemical parameters.
Methods: A retrospective study included 64 patients, diagnosed and
treated for malaria in Institute for Infectious and tropical diseases KCS,
from January 1999. to December 2006. and healthy control group
(n = 11).
Results: Thrombocytopenia, leukopenia, hyperglycaemia, hypocholes-
terolaemia and elevation of transaminases, lactate dehydrogenase (LDH)
and creatinine were associated with malaria. Although thrombocytopenia
had highest sensitivity (84%), hyperglycaemia, leukopenia and hyper-
bilirubinaemia were the most speciﬁc (100%) and with the strongest
positive predicitive values (100%). Malaria complications were asso-
ciated with anaemia, leukopenia, thrombocytopenia, hypoproteinaemia,
hyponatraemia and elevation of LDH and creatinine. Hypocholestero-
laemia, anaemia and ﬁbrinogen elevation had a signiﬁcant effect on
recovery duration. Hepatosplenomegaly in malaria was associated with
thrombocytopenia and LDH elevation, as jaundice was associated with
anaemia.
Conclusion: Nonspeciﬁc laboratory test are useful for prompt and
accessible orientation and avoidance of misdiagnosis in febrille travellers
returning from endemic regions. Furthermore they proved as valuable
auxiliary diagnostic and prognostic tools in combination with the
microscopic detection of parasites.
P752 Estimating parasitaemia of Plasmodium falciparum:
UKNEQAS experience
M. Manser, C. Olufsen, P. Chiodini (London, UK)
Objectives: Approximately 10 percent of the malaria cases from the
United Kingdom are seen at the Hospital for Tropical Diseases. The
remainder of cases are widely distributed throughout the UK, thus any
haematologist can be called upon to diagnose malaria in their laboratory.
UKNEQAS Blood Parasitology Scheme was established in 1986, part
of its remit was to assess the accuracy of the estimation of malaria
parasitaemia the UK. Participants in this EQA scheme are required
to identify blood parasites present in either thick or thin ﬁlms and
to estimate the percentage parasitaemia of Plasmodium falciparum if
appropriate.
Methods: Eight distributions each containing one Geimsa stained thin
blood ﬁlm and/or a Field’s stained thick ﬁlm are dispatched annually to
300 laboratories in both UK and overseas to examine for blood parasites.
Participants are expected to estimate the percentage parasitaemia, in
the blood ﬁlms containing trophozoites of Plasmodium falciparum, by
expressing the number of infected cells as a percentage of the red blood
cells.
Results: Results of participants’ performance for the diagnosing and
estimation of the percentage parasitaemia of Plasmodium falciparum
were analysed over a ﬁfteen year period. It was noted that between 16 and
58 percent of participants failed to estimate the percentage parasitaemia,
between 7 and 28 percent overestimate it, between 2 and 10 percent
underestimate and between 1 and 7 percent misidentiﬁed the malaria
species present. It was also noted that the higher the parasitaemia, the
more likely it was to be overestimated.
Conclusion: Although the analyses of results achieved by participants
for other blood parasites has shown an overall improvement, estimation
of the percentage parasitaemia of Plasmodium falciparum remains
unchanged. One reason for this is the failure of many participants
to specify the percentage parasitaemia. Of those that overestimate the
parasitaemia, it is assumed to be due to counting the number of
trophozoites per 100 red blood cells and not the number of parasitised
red blood cells.
P753 Polymorphism of merozoite surface protein-3a gene of
Plasmodium vivax in isolates in Iran
A. Raeisi, A. Shahbazi, M. Nateghpour, H. Mirhendi, M. Asmar,
M. Ranjbar, L. Faraji, F. Kamali (Tehran, Tabriz, IR)
Introduction: The world wide distribution of P. vivax has expanded
signiﬁcantly and the number of cases reported has been on the rise.
Approximately 88% of malaria cases in Iran are caused by Plasmodium
vivax, and in order to management of the disease, understanding the
population genetic structure of the parasite is necessary for designing
and applying drugs and vaccines. Among many potential candidates,
merozoite surface protein-3a gene (PvMSP-3a) is promising target to
develop an effective vaccine.
Objectives: This study was designed and carried out to determine the
variation of this gene, as a genetic marker, in Plasmodium vivax isolates
in malarious areas of Iran.
Method: Diversity in PvMSP-3a gene was assessed in 85 Plasmodium
vivax isolated from four southern and east-southern provinces of the
country by PCR/RFLP method. Ampliﬁcation was performed with two
primer pair sets in a nested PCR format and the products were digested
by the Enzyme HhaI in RFLP method.
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Results: Based on the size of the PCR products, we observed 3 biotypes
A (about 1900bp), B (about 1400bp) and C (about 1100bp) of PvMSP-
3a gene. Biotype A was predominant. According to RFLP patterns,
10 allelic groups of the gene were observed, that, 7, 2 and 1 groups
correspond to the biotype A, B and C, respectively. Mixed genotype and
multiple infections were not seen.
Conclusion: We found that RFLP method with HhaI enzyme is a useful
method for determining the polymorphism of biotype A of PvMSP-3a
gene.
P754 Risk factors and epidemiology of malaria in endemic zones
of Venezuela
H. Rodulfo, M. De Donato, B. Gonza´lez, C. Go´mez, M. Herrera,
L. Gonza´lez, J. Moreno, C. Contreras, L. Villegas (Cumana, Caru´pano,
Tumeremo, Caracas, VE)
Malaria is the infectious disease with the highest prevalence in the
world. In Venezuela, malaria is produced by Plasmodium falciparum,
P. vivax and rarely P. malariae. Here, we carry out a metanalysis
with all the available data from six different studies from our research
group in different areas of Venezuela, as well as all the available
information from published and unpublished sources, in order to
characterise the risk factors and the epidemiological trends of the
malaria disease. The diagnosis of malaria is commonly performed by
the microscopic examination through a network of diagnostic centres.
OptiMAL, Parasight and ICT have also been used in the ﬁeld and for
comparison reasons with sensibility and speciﬁcity values above 85 and
95%, respectively. PCR has also been used for population based and
comparison studies, showing a great diagnostic power. In the endemic
areas, all these techniques have detected asymptomatic infections caused
mainly by P. vivax, and PCR have detected a higher proportion of
mixed infection, which are most likely playing an important role in the
permanence of disease. Malaria incidence in Sucre state was very high
between the years 2000–2002, but after 2003 has declined progressively
to be close to eradication in most areas. The main transmission factor
here is the geographic condition with large swamp areas and the poverty
of the communities. In Bolivar, the incidence have always been high,
but since 2004, it has become an epidemic grown out of proportions,
producing over 90% of the cases for Venezuela, and irradiating to other
states. Here, as well as in Amazonas, the main transmission factor is the
large selvatic area, the poorly developed health infrastructure and the
migration pattern shown by the natives and illegal miners. The vector
commonly reported here is A. darlingi, but recently, new species have
been pointed out as vectors. Even though Venezuela has been an endemic
area for a long time, our results have shown that a large proportion of
people do not know how to prevent the disease. The analyses of age
group, sex, occupation and cultural habits as risk factors have shown
different patterns depending on the studied areas. The use of impregnated
mosquito nets, shown to be a very successful prevention measure in many
countries, is not widely used in the endemic areas. The ofﬁcial control
measures are usually limited to insecticide spaying and early diagnosis.
P755 Malaria in Tunisia: epidemiology, clinical aspects and
management
B. Kilani, L. Ammari, H. Tiouiri Benaı¨ssa, R. Abdelmalek,
A. Goubontini, F. Kanoun, E. Chaker, T. Ben Chaabane (Tunis, TN)
Objectives: To study the epidemiological, clinical, laboratory features
and management of malaria in Tunisia where the disease has been
eradicated since 1980. All the cases were imported, mainly from African
countries.
Methods: Medical records were reviewed for patients with microscop-
ically conﬁrmed malaria diagnosed at our department during a twenty
years period (from august 1986 to december 2006).
Results: 110 patients were included in the study. 90.9% of them were
male, and median age was 30 years (range, 14−57). 52.7% of patients
were caucasian.34.5% of them had history of malaria and were from
Central Africa. Only 26% of cases had taken chemoprophylaxis with
poor compliance, mainly in tunisian travellers. Of a total of 110 cases,
87 were caused by P. falciparum, 14 by P. vivax, 3 by P. ovale, 2 by
P. malariae, 2 patients had dual infection and in 2 cases plasmodia
were unspeciﬁed. 97% of cases were acquired in subsaharian Africa. All
immigrants living in Tunisia have acquired infection in their countries
of origin and develop symptoms after a journey. Tunisian people were
infected outside the country while travelling for many reasons. 94% of
patients gave history of fever; 29% however were afebrile at the time
of their presentation. Other commonly but unspeciﬁc symptoms were
headache, chills, myalgia and gastro-intestinal troubles. 38% of cases
had jaundice.
Thrombocytopenia (<150,000/mm3) was the most prominent laboratory
feature occurring in 41% of cases. Hemoglobin levels below 12 g/dl
were observed in 22%. Leucopenia (<4000/mm3) was noted in 22%.
Leukocytosis in 7%. ALT (>22U/l) was elevated in 40% of cases.
Diagnosis of malaria was made in asymptomatic African students in
7 cases. 2 patients (Tunisian) had severe falciparum malaria requiring
treatment at the ICU.
For P. falciparum cases, meﬂoquine was the drug of choice, whereas
chloroquine associated to primaquine was used for other species. All the
patients recoverd well.
Conclusion: Malaria remains a major public health problem in many
subsaharian countries. Due to the increased number of international
travellers for many reasons, we should be altert to the reintroduction
of the prevent disease in our country.
P756 Malaria: between two ports
I. Neves, R. Correia Abreu, M. Guimara˜es, E. Gonzalez (Matosinhos,
PT)
Introduction: For our hospital geographic localisation, between port of
sea and airport, ill travelling people are referring to us.
Objectives: To evaluate clinical epidemiology aspects and evolution of
the malaria cases.
Methods: Retrospective revision of the interned malaria cases in the last
6 years (January 2001 to April 2007).
Results: In this period 18 malaria cases had been interned (15 men: 3
women), 6 had occurred in 2006; average ages 43±14 (16−62) years.
All with recent stay in Africa (Angola, Mozambique, Cameroon, Coast
Ivory and Libyan), without previous prophylaxis; 10 live there, 4 had
travelled and 4 were sailors embarked that had arrived in port there. In
72% the responsible parasite was P. falciparum, 11% P. vivax and in
17% was not possible identiﬁcation. The most common manifestations
had been gastrointestinal symptoms, fever and chills. They had presented
thrombocytopenia (100%) and anaemia (78%). The complications had
been acute renal insufﬁciency, cerebral malaria and ARDS. That had
occurred in no resident endemic area people, with high parasitaemia
(10, 20 and 35%) and in a pregnant woman. Patients with complications
had necessity of intensive care. They had been treated with quinine and
doxycycline, plus primaquine in the others species. The bed average was
8±5 (4−29) days. Mortality was 5.5% (1 case), with favourable evolution
in the others.
Conclusions: In Portugal, malaria is an imported disease, most origin
in Africans countries of Portuguese ofﬁcial language, and in our case
22% in embarked sailors. As related in literature, the severe cases had
happened in not residents, high parasitaemia and predispose conditions.
Prophylaxis measures must be taken, especially in travellers and sailors
who arrived to endemics areas.
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immunotherapy
P757 Differential expression of Toll-like receptors in chronic
hyperplastic candidosis
A. Ali, S. Natah, Y. Konttinen (Vantaa, FI; Alberta, CA; Helsinki, FI)
Introduction: The ﬁrst step in the host defence against oral candidosis is
recognising Candida albicans through a set of germ-encoded pathogen
recognition receptors e.g. Toll-like receptors (TLRs). In man, ten types
of such receptors have been identiﬁed so far out of which only TLR2,
TLR4 and TLR6 have been linked to mediating Candidal ligands e.g.
zymosan and mannan.
Materials and Methods: Biopsies from patients with chronic
hyperplastic candidosis (n = 5), leukoplakia (n = 5) and healthy mucosa
(n = 5) were immunohistochemically stained with the full panel of TLRs
(TLR1−9) antibodies to visualize and compare the staining pattern of
the epithelial layer in the three categories of tissues.
Results: On analysis, the epithelium of all tissues was divided into three
layers: basal, middle and su-perﬁcial. Two of the ﬁve chronic hyperplastic
candidosis sections showed high numbers of hyphae compared to yeasts,
which paralleled a decrease in the expression of TLR2 and an increase in
the stai-ning intensity of TLR4. Leukoplakia and healthy tissue sections
demonstrated stronger immunostaining of TLRs except TLR9 for the
ﬁrst and the basal layers for the latter.
Discussion: This study supports the concept of negative regulation of
TLRs which, for long time, are either ligand-bound (e.g. in chronic
hyperplastic candidosis), or not stimulated (in healthy tissue). It also
augments the opinion which says that Candida albicans, through its
hyphae rather than conidia, may exploit TLRs i.e. TLR2, to evade the
immune system of the host. Leukoplakia seems to be more alert to lessen
the chances of worsening the already-diseased tissue.
P758 Polymorphisms in the mannose-binding lectin and in the
MBL-associated serine protease genes in intensive care unit
patients with systemic inﬂammatory response syndrome
A. Smithson, R. Perello, G. Garcia-Segarra, G. Espinosa, D. Tassies,
C. Freire, P. Castro, B. Suarez, F. Lozano, J. Nicolas (Barcelona, ES)
Background: Polymorphisms in the mannose-binding lectin (MBL2)
and in the MBL-associated serine protease (MASP2) genes have been
associated with an increased risk of infections. The aim of the study is
to asses the possible association between polymorphisms in these genes
and the frequency of infections and death among intensive care unit
(ICU) patients with systemic inﬂammatory response syndrome (SIRS).
Methods: Blood samples from 243 consecutive UCI patients with SIRS
(mean age 62.75±15.69 years; 63% men) admitted in our hospital from
January 2003 to January 2004 were prospectively collected. For further
comparison samples from 104 blood donors were also included in the
study. At entry, 94 patients exhibited septic shock, 29 severe sepsis, 49
had sepsis and 71 had a noninfectious SIRS. Mean APACHE II, SAPS
II and SOFA score at ICU entry were 17.4 + 6.3, 36.5 + 11.8, 8.7 + 3.1,
respectively. In-hospital rate mortality was 30%. Six single nucleotide
polymorphism’s (−550 G/C, −221 C/G, +4 C/T, codon 52 CGT/TGT,
codon 54 GGC/GAC and codon 57 GGA/GAA) in the promoter and
the exon 1 of the MBL2 gene and the Asp 105 Gly single nucleotide
polymorphism’s in the MASP2 gene were genotyped using a sequence-
based typing technique.
Results: No signiﬁcant differences were observed in the frequencies for
low expression MBL2 genotypes and for the wild type MASP2 genotype
between patients with SIRS (13.02% and 94.4%, respectively) and the
healthy controls (15.3% and 97.1%, respectively) (P= 0.86 and P= 0.6,
respectively; Chi square test). Although patients with an infectious cause
of SIRS had a higher incidence for low expression MBL2 genotypes
(15.7%) compared to those with a non infectious SIRS (6.5%), these
differences were not statistically signiﬁcant (P= 0.064; Chi2 test). No
differences were found regarding the frequency for low MBL2 among
patients with septic shock or with severe sepsis or among non-survivor
ICU patients. The presence of polymorphism’s in the MASP2 gene was
not associated with a higher rate of infections or mortality.
Conclusions: Although patients with MBL2 genetic polymorphisms
causing low MBL2 levels have a tendency to present a higher incidence
of an infectious cause of SIRS, the presence of MBL2 or MASP2 genetic
polymorphism’s do not seem to have a signiﬁcant impact neither in
mortality nor in the severity of infections in ICU patients with SIRS.
P759 Toxin production by meticillin-resistant Staphylococcus
aureus strains is related to differences in cytokine levels by
peripheral blood mononuclear cells
F. Kolonitsiou, A. Spiliopoulou, V. Chini, M. Krevata, E.D. Anastassiou,
I. Spiliopoulou (Patras, GR)
Objectives: To investigate the immune system response in terms of
secreted cytokines, to the existence of staphylococcal virulence factors
among meticillin-resistant Staphylococcus aureus (MRSA) isolates.
Methods: Twenty-two, 18 clinical and four reference MRSA strains were
characterised on the basis of toxin gene proﬁle by PCRs (PVL, tst,
enterotoxins of the egc operon, eta, etb). Clones were deﬁned by agr
typing and MLST, while tst expression was calculated by quantitative
reverse-transcription PCR (RT-PCR). Peripheral blood mononuclear cells
from healthy donors were isolated by standard procedures and were co-
cultured in 24-well ﬂat bottom tissue culture plates with live MRSA cells
at a ratio of 25:1. Cytokine measurements, using the Luminex® xMAPTM
technology, were performed in cell-free supernatants collected at 6 and
12 hours. The 8-plex assay kit was used for simultaneous quantitative
determination of the following cytokines: TNFa, IL-1b, IL-6, IL-8, IL-
10, IL-12p40, IL-13 and GM-CSF.
Results: MRSA elicited production of detectable amounts of all eight
cytokines. A negative correlation was detected between PVL genes
carriage and production of GM-CSF at six hours, and TNFa, IL-6, IL-
10, IL-13 and GM-CSF at 12h. The presence of tst gene was correlated
with release of greater amounts of TNFa, IL-6, IL-8, IL-10, IL-13 and
GM-CSF at 6 and 12h. The presence of tst gene correlated with lower
levels of IL-12p40 at 12h. Expression level of tst and presence of the
remaining superantigens were not related to cytokines’ levels. Analysis
of agr types and cytokine proﬁle showed that MRSA of agr1 (including
tst-positives) induced production of greater amounts of TNFa, IL-6, IL-
8, IL-10, IL-13, GM-CSF and IL-12p40 at 12h than agr2 (including
egc-positives) and agr3 (including PVL and egc-positives) MRSA. All
differences were statistically signiﬁcant (p< 0.05).
Conclusions: Our data reinforce the knowledge that toxic shock
syndrome toxin-1 has strong proinﬂammatory and immunoregulatory
properties, perhaps in association with other factors, as it directs immune
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system to TH2 response by promoting the release of IL-10 and IL-13
and down-regulating the production of IL-12p40. PVL has a diminished
potential towards triggering immune responses, as strains possessing
PVL genes elicited production of lower amounts of pro-inﬂammatory
cytokines and cytokines of adaptive immune response.
P760 Inﬂuence of combined contraceptive vaginal ring on vaginal
microﬂora and immunity
V. Orlova, Y. Naberezhnev, O. Lebedeva (Belgorod, RU)
Objectives: to establish inﬂuence of vaginal ring on microbiocenosis of
low female reproductive tract.
Methods: 31 female women age of 20−25 years old were examined
before and after 3-month usage of contraceptive vaginal ring (NuvaRing).
Vaginal ring is combined low-dosed hormonal contraceptive which
releases 120mg of etonogestrel and 20 mg of ethinyloestradiol daily.
The samples of vaginal discharge were inoculated into a culture
medium (Columbia base agar, blood agar, Man Rogosa Sharpe medium,
semisynthetic growth medium, McConkey agar, Gardnerella vaginalis
agar and Sabouraud agar) and cultured for anaerobic and aerobic
bacteria. Secretory immunoglobulin, IFN-gamma, IL-4, lysozyme in
cervico-vaginal mucus were detected by ELISA. Data were analysed
using Statistica 6.0 (StatSoft, USA).
Results: After vaginal ring usage considerable changes of vaginal micro-
biocenosis structure were observed. Amount of Lactobacillus increased
from 104 to 106 colony forming units (CFU) and Biﬁdobacterium
from 18.2±1.2 to 44.4±6.1 CFU (p 0.05). Percentage of women,
having three-component microbial association (Peptostreptococcus,
Staphylococcus and Streptococcus) decreased from 66.7±8.8% to
46.7±9.1%. Nevertheless, number of Candida albicans increased from
102 to 104 which gave rise to symptomatic yeast infection.
Elimination of cocci during NuvaRing usage could be consequence of el-
evation of secretory immunoglobulin (from 47±12.5ng/ml to 94.5±22.1
ng/ml) and IL-beta (from 95.7±29.1 pg/ml to 130.2±29.1pg/ml)
(p 0.05). High rate of Candida detection, apparently, could be result of
high local level of estrogen among women using contraceptive vaginal
ring.
Conclusion: Thus, our studies showed increasing concentration of
lactobacilli and biﬁdobacterii, and cocci elimination, wich is favourable
for antiinfectious resistance of female reproductive tract. Meanwhile,
high risk of yeast infection appearance doesn’t make possible to
recommend this type of contraception for women with recurrent
candidiasis, diabetus mellitus, AIDS and etc.
P761 Immunmodulatory potencies of linezolid in a LPS model of
human whole blood
C. Lambers, M. Will, C. Wagner, M. Zeitlinger (Vienna, AT)
Objectives: Gram-negative sepsis resulting in septic shock is one
of leading causes of death in critically ill patients. One important
determinant of mortality is the release of endotoxin, which is a structural
component of LPS. It is generally accepted, that the ﬁrst mediators
in the cascade of LPS-induced events are cytokines, like TNF-alpha
and IL-1beta. Because treatment options are limited, a wide range
of therapeutic strategies are still under investigation, but convincing
reduction of mortality is still lacking. New approaches are focused on
immunmodulatory effects of antimicrobials. Several studies investigating
Linezolid in different models of Gram-negative sepsis showed signiﬁcant
reduction of pro-inﬂammatory cytokines but used un-physiologically
high doses of LPS. The aim of our study was to characterise the
immunmodulatory effects in a model of human whole blood with
concentrations of LPS and Linezolid reﬂecting physiological conditions.
Methods: Whole blood from 10 healthy volunteers was incubated with
50 pg/mL LPS W/o 13mg/mL Linezolid for 2 and 4 h. RT-PCR was
performed from messengerRNA (mRNA) of IL-1b, IL-6 or TNFa,
18sRNA was used as control. Protein levels of the supernatant were
measured using ELISA for IL-6 and TNFa.
Results: Incubation of human whole blood with LPS signiﬁcantly
increased mRNA levels of cytokines compared with baseline. The
addition of Linezolid signiﬁcantly reduced mRNA levels of IL-1b
(−49%; p< 0.01), IL-6 (−49%; p< 0.01) and TNF-a (−61%; p< 0.02)
after 2 hours. In addition, after 4 hours reduction on mRNA levels of IL-
1b (−49%; p< 0.01), IL-6 (−25%; p< 0.03) and TNF-a (−32%; p< 0.04)
were observed. Although LPS stimulation increased levels of IL-6 and
TNFa between 100 and 1000-fold, in contrast to mRNA no reduction
by addition of Linezolid was observed on protein level.
Conclusion: The previously assumed immunmodulatory effects of
Linezolid were conﬁrmed in our in vitro sepsis model on gene expression
level. However, differences to previous ﬁndings which have shown
signiﬁcant reduction on protein levels were observed. This discrepancy
might be mainly ascribed to methodological differences, since compared
to previous work more physiologic conditions were employed in the
present setting.
P762 Inﬂuence of linezolid on phagocytosis and killing of
Gram-negative bacteria by polymorphonuclear neutrophils
T. Gru¨ger, N. Schnitzler, S. Nidermajer, K. Brandenburg, J. Zu¨ndorf
(Bonn, DE)
Objectives: In a recent phase III clinical trial on linezolid it
became obvious that in the linezolid treatment arm more patients
acquired Gram-negative catheter related blood stream infections. It
was postulated, that linezolid may trigger the acquisition of Gram-
negative infections associated with higher mortality rates despite
adequate anti-Gram-negative therapy. Therefore, we analysed the impact
of linezolid on phagocytosis and killing of Gram-negative bacteria
by polymorphonuclear neutrophils (PMN). Phagocytosis and killing
of pathogenic microorganisms by PMN are of high relevance for the
prognosis of patients suffering from bacterial infections.
Methods: Whole-blood samples were taken from healthy volunteers
and incubated with linezolid in clinical relevant concentrations (5,
20 and 50 mg/L) and compared to a drug-free control. CD11b-
expression of PMN was evaluated using ﬂuorescence-labelled mAB.
To measure phagocytosis, ﬂuorescence-labelled Gram-negative bacteria
(Escherichia coli, Burkholderia cepacia, Pseudomonas aeruginosa) and
Gram-positive control (Staphylococcus aureus) were added to the blood.
Bacteria : PMN ratio was adjusted to 5:1. Phagocytosis was stopped after
5, 15, 30, and 60 min, respectively. Samples were subsequently analysed
by ﬂow-cytometry.
To evaluate the inﬂuence of linezolid on killing of bacteria whole blood
was incubated with 0 (control), 5, 20 and 50 mg/L linezolid, respectively.
Killing of bacteria in whole blood was determined after three hours of
incubation by plate counting.
Results: Linezolid impaired CD11b-expression of PMN in a
concentration-dependent manner up to about 15 percent. Additionally,
linezolid also impaired phagocytosis of E. coli (5 to 29%) and to a
lower extend of B. cepacia ( 15%) and P. aeruginosa ( 10%) in
a concentration-dependent manner. In contrast killing of tested Gram-
negative and Gram-positive bacteria were not affected by linezolid
compared to the control.
Conclusion: Our data reveal a negative, concentration-depended
inﬂuence of linezolid on the CD11b-expression of PMN and on
phagocytosis of E. coli and to a lower extent of B. cepacia and
P. aeruginosa but not of S. aureus. Despite no observable inﬂuence of
linezolid on the killing of S. aureus, E. coli, B. cepacia, and P. aeruginosa
an impaired phagocytosis of Gram-negative bacteria might be critical,
especially, in patients with otherwise impaired immune system even if
patients receive additional adequate anti-Gram-negative therapy.
P763 Granzyme K levels and NK cell lytic activity in experimental
mice challenged with LPS and/or IL-2+IL-12
M. Rucevic, L.D. Fast (Zagreb, HR; Providence, US)
Objectives: Widespread activation of the innate immune system by
infecting pathogens results in uncontrolled systemic release of an array
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of inﬂammatory mediators that generate clinical sepsis. Recently, we
found that the levels of Granzyme K (GrK), a potent lymphocyte serine
protease, correlate with the stage of sepsis but, the reason for increased
GrK levels during inﬂammatory responses/sepsis is unclear. Since natural
killer (NK) cells, which are know to be critically involved in the course
of sepsis may also be responsible for the production of increased GrK
levels, the aim of the present study was to investigate the changes in
GrK levels along with the NK cells lytic activity in experimental animal
models.
Methods: Recipients C57BL/6 mice were injected with bacterial
lipopolysaccharide (LPS, 25mg) in the ﬁrst experimental model. In
the second model, inﬂammatory response was induced in recipients by
combined injection of cytokines, interleukin (IL)-2 and IL-12 (3×105 U
rhuIL-2 + 1mg rmuIL-12) which were also shown to be synergistic
inducers of granzymes message. Our previously developed GrK-ELISA
system was used to measure the plasma levels of GrK in LPS and/or
IL-2+IL-12 injected recipients. Subsequently, the NK cells lytic activity
was examined by testing the ability of single cell suspension prepared
from recipient spleen cells to lyse the NK sensitive target, 51Cr-labeled
YAC cells.
Results: Increase in GrK levels in mice plasma follow the increase
in NK cell lytic activity in LPS challenged mice while in IL-2+IL-12
challenged mice no signiﬁcant increase in NK cell lytic activity was
observed. Furthermore, the changes in GrK levels in mice plasma of
both experimental models were found to correlate with the changes in
GrK levels of septic patients.
Conclusions: GrK could constitute at least one of the mechanisms by
which NK cells contribute to systemic inﬂammation/sepsis. In addition,
the results conﬁrmed the role of GrK in sepsis pathology and further
indicate that it may be a potential diagnostic marker and/or novel
therapeutic target for further treatments of this life-threatening disease.
P764 Chronic infection with hepatitis B virus is not associated
with early senescence of CD8+ T lymphocytes
P. Carotenuto, A. Artsen, A.D. Osterhaus, O. Pontesilli (Rotterdam, NL)
Objective: To assess whether CD8+ T lymphocyte phenotype in patients
with chronic hepatitis B virus (HBV) infection is compatible with
accelerated senescence, as observed in infection with other persistent
viruses, namely cytomegalovirus (CMV).
Methods: T lymphocyte subpopulations have been quantiﬁed in
separated peripheral blood mononuclear cells from 24 chronic hepatitis B
(CHB) patients (age 18−56 years), 28 healthy age-matched blood donors
and 16 convalescent patients with acute hepatitis B (AHB). Expression
of CD45RA and co-stimulatory molecules CD27 and CD28, determined
by 4-colour direct immunoﬂuorescence and ﬂow cytometry, was used
to establish the maturation phases of CD8+ T lymphocytes according
to the sequential loss of CD45RA, CD28 and CD27 (combined with
re-expression of CD45RA during quiescence) according to the model
proposed by Appay and Rowland-Jones (Semin. Immunol.2004;16:205–
212). Percentages of lymphocytes in each subset were compared by
Student’s t test and the differences scored as signiﬁcant by p< 0.01.
Results: Comparable percentages of CD45RA+ CD8+ T lymphocytes
were found in healthy controls (60±15% of CD8+ T cells) and
CHB patients (65±14%), but AHB patients showed signiﬁcantly lower
percentages (46±19%). Truly naive (CD45RA+ CD27+ CD28+) CD8+
T lymphocytes were signiﬁcantly more represented in CHB patients
(23±16%) than in both healthy controls (11±11%) and AHB patients
(11±7%). The AHB patients showed a relative expansion of the recently
activated antigen-experienced (CD45RA- CD28- CD27+, intermediate
phenotype) CD8+ T cells whereas the supposedly quiescent analogous
subset (CD45RA+ CD28- CD27+) was signiﬁcantly smaller in the
CHB patients (20±12%) compared with healthy controls (36±21%).
No signiﬁcant difference was found in the late (CD28−CD27−) antigen
experienced subsets.
Conclusion: The data suggest that chronic infection with HBV is
not associated with accumulation of terminally differentiated CD8+
T lymphocytes and a corresponding early senescent phenotype, but
otherwise by a larger input or accumulation of naive lymphocytes in
peripheral blood.
P765 Generation of inﬂuenza recombinant haemagglutinin-speciﬁc
lymphocytes from cordblood-derived dendritic cells:
immunotherapy model from an unprimed source
A. Safdar, W. Decker, E. Shpall (Houston, US)
Background: Cordblood-derived (CB) is an important source of mostly
unprimed stem cells. We sought to generate CB-derived dendritic cells
(DC) immunotherapy against inﬂuenzavirus.
Methods: Recombinant hemagglutinin (rHA) was expressed in insect
(SF9) cells by recombinant baculovirus. The HA gene of inﬂuenza A
New Caledonia/20/99 (H1N1) inﬂuenza virus was independently cloned
into the plasmid baculovirus expression vector pPSC12. Generation of
Immature DCs. Umbilical cord blood units discarded from the MDACC
CB bank were used after IRB approval. DC Loading and Maturation.
After six days of culture in GM-CSF and IL-4, immature dendritic cells
were loaded with rHA protein. Immature dendritic cells were suspended
at a concentration of 4×107 cells/ml, mixed with rHA and incubated
for 10 minutes on ice in an electroporation cuvette. T-cell Priming and
Re-Stimulation. Upon maturation of loaded DCs, they were incubated
at a ratio of 1:10 with autologous non-adherent PBMCs (typically 50%
CD3+), plus IL-12. ELISpot Assay. Typically, 104 to 105 lymphocytes
from each culture were mixed at a ratio of 10:1 with thawed dendritic
cells, plated in triplicate on anti-IFN-gamma coated ELISpot plates (BD
Biosciences) and cultured overnight (12−18 hours). ELISpots for with
putative HA peptide epitopes were performed similarly using 1×105–
2×105 lymphocytes incubated overnight in 3.75mg/ml peptide.
Results: rHA-speciﬁc lymphocytes demonstrate identiﬁable HLA-
restriction. As demonstrated by Figure, HA-primed lymphocytes (HLA
DRbeta1*1503) from a different CB demonstrated a nine-fold increase
in statistically large spots when restimulated with the DR15–262
epitope (p< 0.00002). These data suggest that 1 in 1,900 of the HA-
speciﬁc T-cells were DR15–262 restricted in a highly-speciﬁc fashion.
Total ELISpot numbers (p< 0.0002) and total IFN-gamma release
(p< 0.00004) between lymphocytes restimulated with DR15–262 and the
control peptide were statistically distinct as well. Incubation of peptide
DR15–262 in conjunction with HA-primed/DR15- lymphocytes or in
conjunction with adenoviral hexon-primed (irrelevant) lymphocytes did
not demonstrate signiﬁcant numbers of IFN-g spots.
Conclusions: The results demonstrate that, despite the generally naive of
CB lymphocytes, inﬂuenza HA-speciﬁc responses can be generated ex
vivo and could be potentially be used to enhance immune reconstitution
following allogeneic stem cell transplantation.
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P766 Staphylococcal activation of plasmacytoid dendritic cells
requires preformed IgG
M. Parcina, C. Wendt, K. Heeg, I. Bekeredjian-Ding (Heidelberg, DE)
Objectives: Induction of type I interferon (IFN-I) production has
previously been detected in response to infection with intracellular
bacteria and upon stimulation of human PBMC with extracellularly
located Staphylococcus aureus or Escherichia coli. In spite of these
observations the molecular mechanism triggering IFN-I by extracellular
bacteria has so far not been elucidated. The aim of the study was to
provide information on the mechanism involved in IFN-I induction by
staphylococci.
Methods: Human plasmacytoid dendritic cells (PDC) were enriched
from PBMC with BDCA4 microbeads. PDC were resuspended in culture
medium w/o human serum and stimulated with staphylococci. IFNa
secretion was quantiﬁed by ELISA. Anti-staphylococcal immunoglobulin
was detected by Western Blot.
Results: Here we demonstrate that staphylococcal activation of human
plasmacytoid dendritic cells occurs in a species-speciﬁc manner. Inter-
estingly, all donors tested responded to S. aureus while only few donors
responded to S. epidermidis and other coagulase-negative staphylococci.
PDC activation was subsequently found to depend on the donor serum.
We further show that IFNa levels depend on the concentration of
preformed antigen-speciﬁc IgG. Moreover, S. epidermidis-responsive and
non-responsive donors can be distinguished by the presence or absence
of anti-S. epidermidis Ig.
Conclusion: PDC recognition of extracellular bacteria requires a prior
humoral immune response with antigen-speciﬁc IgG formation. Since
IFN-I primes immune cells for a more efﬁcient response to pathogens
our data suggest that the human immune response to S. aureus is
more efﬁciently unleashed than that to other staphylococci. Furthermore,
patients at risk for developing sepsis may beneﬁt from vaccination
against common bacterial pathogens.
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P767 Mapping of the binding domains of the Newcastle disease
virus phosphoprotein in P−L and P−(NP-RNA) complexes
F. Jahanshiri, K. Yusoff, J. Abdulah, R. Abdul rahim (Kuala Lumpur, MY)
Newcastle disease virus (NDV) is an avian pathogen which affects
the poultry industry worldwide. Outbreaks of the disease known as
Newcastle disease (ND) often result in mass culling of the infected
chickens. NDV has also oncolytic activities against human malignancies
which lead to tumour apoptosis and cell death. Besides that NDV can
serve as a viral vector to express and deliver foreign genes which is
useful in vaccination and gene therapy. To identify the mechanisms
involved in NDV pathogenesis as well as its anti cancer properties,
the understanding of the mechanisms involved in the transcription and
replication of the virus is of fundamental importance. One way to
characterise such mechanisms is to identify the involvement of the
viral proteins and their interacting partners. It has been shown in other
paramyxovirues that the phosphoprotein (P) plays a central role in the
transcription and the replication of the viral genome. Together with
the large (L) protein, it forms and stabilizes the active RNA-dependent
RNA polymerase complex. It also mediates the interaction between the
L protein subunit of this complex with the viral nucelocapsid (NP-
RNA) template comprising a nucleocapsid tightly bound RNA genome.
Employing a yeast-two hybrid system the presence of P-L interaction
in NDV was investigated. However, due to the low expression level of
L protein yeast, no interaction was observed. Therefore, an in vitro co-
translation approach was carried out to identify P-L interaction. The
result showed that NDV P protein is also involved in the stabilisation of
L protein. To identify the presence of NDV P−(NP-RNA) interaction and
the involved domain(s), co-immunoprecipitation was performed. Puriﬁed
NP:-RNA template along with in vitro translated P or its derivatives were
separately co-immunoprecipitated using anti-His antibody. The results
revealed that the immediate N-terminal of P protein is involved in its
interaction with NP-RNA template.
In conclusion, the current study has delineated the key interacting
partners of NDV P. This knowledge will be useful for structural and
functional exploration of this protein.
P768 Host cellular responses in Nipah virus infection
L.Y. Chang, S.S. Hassan, S. AbuBakar (Selangor, Ipoh, Kuala Lumpur,
MY)
Objectives: Nipah virus (NiV) is a zoonotic infectious virus that causes
severe to fatal central nervous system infection in human during an
outbreak in Malaysia in 1998. During the outbreak, NiV also causes
disease in pigs. Unlike the infection in human, infected pigs normally
present with respiratory distress syndrome and the disease is less severe
in comparison to human infection. The present study was undertaken to
investigate and understand the possible molecular mechanisms that may
contribute to the difference in pathogenicity of NiV infection in the two
hosts, human and pigs.
Methods: We examined NiV infection and replication in selected cell
culture systems representing the two hosts, human and pigs. The state of
dysfunction of the NiV-infected cells was then examined using proteomic
approaches.
Results: Infection of four different cell types representing the two
host organisms using NiV shows that the virus establishes productive
infection in all the cell types examined. There are no differences in the
capacity to support NiV replication between fully susceptible porcine
stable kidney cells (PS) and human lung ﬁbroblasts cells (MRC-5),
respectively. However, there are differences between these cells, and
human neuronal cells (SK-N-MC) and monocytes (THP-1), in the ability
to support NiV replication and virus release. The SK-N-MC cells are
less able to support NiV infection when compared to the PS cells.
Subsequent examination of the changes in cellular host response as a
result of NiV infection in both human and pig cells identiﬁed a total of
15 differentially expressed proteins. Most of these proteins are involved
in virus replication or RNA synthesis, and proteins associated with the
cellular functions of the mitochondria or the induction of apoptosis. The
potential importance of these differentially expressed proteins includes
the regulation of NiV replication in the two hosts as well as the
manifestation of cellular cytopathic responses to the infection.
Conclusion: The proteomic analysis of NiV-infected cells of human
and pigs identiﬁed differences in the key cellular pathways and events
occurring during NiV infection in the two hosts, respectively, that
could contribute to the differences in manifestation and severity of NiV
infection.
P769 Crimean-Congo haemorrhagic fever virus infects peripheral
blood mononuclear cells and does not disrupt tight junctions
in MDCK-1 cells
A-M. Connolly-Andersen, K-E. Magnusson, A. Mirazimi (Solna,
Linko¨ping, SE)
Objectives: Crimean Congo Haemorrhagic Fever is characterised by
severe bleeding with mortality rates averaging 30%. There is no veriﬁed
treatment or prophylaxis making this a grave disease to contract.
The molecular mechanisms underlying pathogenesis are completely
unknown, however a few theories have been postulated for other viral
haemorrhagic fevers. It could be a direct effect of viral infection on
cells that can cause haemorrhage (through disturbing tight junctions) or
it could be a host mediated effect. If infection disrupts tight junctions,
that could be the cause of blood vessel leakage explaining the observed
haemorrhages.
In this study we have analysed the effect of viral infection on tight
junctions in different model cell lines. We have also studied the ability of
Crimean Congo Haemorrhagic Fever Virus (CCHFV) to infect different
human cells.
Methods: In order to study viral effect on tight junctions, different
polarised cells were grown on Transwell semi-permeable ﬁlters and
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transepithelial electrical resistance measured. Visualisation of the tight
junction proteins occludin and ZO-1 was performed by indirect
immunoﬂuorescence microscopy, to study localisation of these proteins
upon infection.
Infectivity of cells was veriﬁed by western blotting, PCR and indirect
immunoﬂuorescence.
Results: Tight junction integrity was analysed by both TER and IF, and
there was no measurable disruption indicating viral infection does not
disturb tight junction integrity.
Viral protein and RNA could be found in different cells.
Conclusion: There was no measurable effect on tight junction integrity
in highly polarised cells.
P770 Replication of Vaccinia virus on PBMC is restricted by
mediators of innate immunity
C. Castilletti, L. Bordi, C. Agrati, E. Lalle, F. Carletti, E. Cimini,
M.R. Capobianchi (Rome, IT)
Objectives: No detailed studies have been conducted on interactions
of poxviruses with the immune system, relevant to clarify pathogenic
mechanisms of poxviruses infection, and to improve poxvirus vaccine
vectors and immunomodulatory strategies. The aim of our study was to
better understand the cellular targets of Vaccinia Virus (VV) infection
and their consequences of infection for cells involved in the generation
of antiviral immune responses.
Methods: The ability of VV to productively infect normal PBMC and
different cell subpopulations (CD14+, CD4+/CD8+ and CD4−/CD8−)
was determined by back titration of infectivity and quantitative detection
of viral genome in kinetic studies. In the same experiments the extent
of induction of IFN alpha and/or gamma, was measured at both mRNA
and protein level.
Neutralising antisera against IFN alpha and gamma were used to
establish if the low replication rate of VV in PBMC is due to the
activation of the IFN system.
Results: VV replication efﬁciency in PBMC is generally low, and
is restricted to few PBMC subpopulation (namely: CD14+ and
CD4−/CD8−), while resting T cells do not support VV replication.
Neutralising antibodies to IFN alpha and gamma strongly increase the
replication of VV in CD14+ and CD4−/CD8− cells, indicating that these
cytokines are induced by VV, and are at least partially responsible for
restricted replication in PBCM subpopulations.
Conclusions: Our ﬁndings indicate that mediators of innate immunity,
such as IFN system, are important factors in the control of orthopoxvirus
replication in white blood cells, and may be exploited as therapeutic
strategy to counteract severe infections, that can occur as result of
zoonotic exposure in humans.
P771 Avian inﬂuenza H5N1 virus is able to disregulate interferon
response activation in human PBMC
E. Lalle, L. Bordi, R. Chiappini, A. Sacchi, M.R. Capobianchi,
C. Castilletti (Rome, IT)
Objectives: The extraordinary spread of highly pathogenic avian
inﬂuenza A (HPAI) H5N1 viruses has resulted in devastating outbreaks
in domestic poultry and sporadic human infections with a high fatality
rate. Unlike most other inﬂuenza infections, H5N1 infection causes a
systemic disease. The underlying mechanisms for this effect are still
unclear. Impaired Interferon (IFN) response may be involved in enhanced
pathogenicity of HPAI H5N1 infection. We investigate the ability of both
H5N1 and H3N2 viruses to trigger the activation of the IFN system in
human PBMC in vitro.
Methods: Human, freshly collected, PBMC from healthy donors were
exposed to either HPAI H5N1 or H3N2 to assess the extent of induction
of IFN alpha and gamma at both mRNA and protein level. Moreover,
we used quantitative Real-time RT-PCR to compare the mRNA levels of
IFNAR-1 and of downstream cascade of IFN response genes, such as
PKR, MxA, OAS.
Results: The HPAI H5N1 virus was more effective than H3N2 in
inducing IFN alpha and gamma, at level of both intracellular mRNA
and released protein. On the contrary, mRNA for IFN stimulated genes
(ISGs) were less effectively induced in PBMC infected with H5N1 virus
as compared to H3N2. Moreover, IFNAR-1 mRNA levels were reduced
in PBMC exposed to H5N1 as compared to H3N2 and to unstimulated
PBMC.
Conclusion: Our data suggest that the H5N1 virus, although being
able to induce IFN alpha and gamma to a greater extent than the
less pathogenic H3N2 subtype, is able to attenuate the response to
IFN alpha by reducing the extent of IFNAR-1 expression, so that the
downstream IFN activated cascade is less efﬁcient as compared to H3N2.
As IFN system represents one of the ﬁrst lines of defence against virus
infections, the impairment of this critical host innate immune response
may contribute to the high virulence of HPAI H5N1 virus in humans.
P772 Comprehensive analysis of genomic sequences of oncogenic
viruses in colorectal cancer
V. Militello, L. Barzon, M. Trevisan, C. Militello, G. Palu` (Padua, IT)
Objectives: The aim of this study is to investigate whether there is
an association between oncogenic viruses and colorectal preneoplastic
lesions and carcinomas.
Methods: This study was conducted in tissue samples from 113
patients diagnosed with colorectal polyp or cancer, including 72
archival colorectal cancers and matched adjacent mucosa and biopsies
of colorectal cancers, polyps, and adjacent mucosa, which were
longitudinally collected from 41 consecutive patients. Biopsies from
10 subjects, who underwent colonoscopy without detection of benign
or malignant lesions, were used as controls. The presence of the
herpesviruses (EBV, HCMV) and the polyomaviruses (JCV, BKV, SV40)
was investigated by quantitative real-time PCR. Detection and typing of
HPV was performed by PCR and sequencing.
Results: EBV-DNA was detected in 30% of cancers and polyps (without
signiﬁcant differences between benign and malignant lesions) and in
14% adjacent mucosa (lesion vs adjacent mucosa, P< 0.05); HCMV-
DNA was detected in 4% of cancers and in 2% of adjacent mucosa
(P=NS). In control biopsies, EBV and HCMV DNA was detected in 50%
and 10% of cases, respectively. Both EBV and HCMV were detected
in tissue samples at very low viral genome equivalents/cell, consistent
with lymphocyte/macrophage inﬁltration. HPV-16 was detected in 4% of
cancers (all rectal carcinomas), but not in adjacent mucosa nor in control
samples. No polyomavirus DNA was detected in any sample.
Conclusions: This study seems to exclude a role of EBV, HCMV, and
polyomaviruses in the pathogenesis of colorectal cancer, whereas high
risk HPV-16 could be involved in some cases of rectal carcinoma.
These results are at variance with some reports in the literature, which
demonstrated a high prevalence of JCV and HCMV sequences in
colorectal cancer and suggested these viruses could have a role in
tumorigenesis.
P773 Human cytomegalovirus infects adrenocortical cells and
stimulates adrenal steroidogenesis
M. Trevisan, G. Masi, U. Matkovic, G. Palu`, L. Barzon (Padua, IT)
Objectives: Based on our observation that human cytomegalovirus
(HCMV) genome and expression of both early and late genes are
frequently detected in functioning adrenocortical tumours, aim of this
study was to investigate whether HCMV infects and replicates in
adrenocortical cells in vitro and the effects of viral infection on
steroidogenesis and adrenocortical cell growth.
Methods: human adrenocortical carcinoma (ACC) cell lines NCI-H295
and SW-13 and primary ACC cell cultures were infected with clinical
isolates of HCMV and with the HCMV strain AD169 and analysed by
immunoﬂuorescence assay. At different time points, steroid hormones
were measured in culture medium, while cells were harvested for RNA
extraction and evaluation of gene expression by microarray analysis.
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Infected cells were tested with BrdU assay and stained with propidium
iodide and annexin-V antibody for the evaluation of apoptosis, cell
proliferation, and cell cycle.
Results: all the HCMV strains employed resulted in productive
replication in ACC cells, as demonstrated by expression of both early
(pp72) and late (pp65) viral antigens. Analysis of the kinetics of viral
replication in ACC cells showed efﬁcient production of infectious viral
particles. HCMV infection of NCI-H295R cells signiﬁcantly increased
the production of cortisol and 17b-estradiol, an effect which was probably
due to viral replication/viral gene expression rather than interaction
of virus particles with the host cell, as demonstrated by experiments
with UV-inactivated virus. This effect on steroid hormone production
was accompanied by a marked induction of the storoidogenic enzymes
CYP11B1 and CYP19. Moreover, HCMV infection showed a cytopathic
effect on adrenocortical cells outlined by induction of apoptosis, cell
vacuolisation, inhibition of cell proliferation, and increase of cellular
S phase. Finally, evaluation of global human gene expression proﬁle
by microarray analysis showed that HCMV infection induced genes
involved in growth control and stress response. Bayesian analysis
unveiled two key genes, P2Y11 and P2X4, induced by HCMV infection
and involved in adrenal steroidogenesis.
Conclusion: these results demonstrate for the ﬁrst time that HCMV
infects and replicates in human adrenocortical cells. HCMV infection
of adrenocortical cells stimulates cortisol and estrogen production and
changes cellular gene expression proﬁle toward a condition of stress
response.
P774 Evaluation of the AcroMetrix® OptiChallenge Inhibition
Panel in different QIAGEN® sample preparation protocols
automated on the QIAcube
C. Kupfer, Y. Lee, G. Schulte, M. Sprenger-Haussels (Hilden, DE)
Objectives: The Clinical and Laboratory Standards Institute recom-
mends that all clinical assay performances should be evaluated in
the presence of potentially interfering substances to validate assays,
to quantify interference effects, and to conﬁrm interference in patient
samples (CLSI EP-7-A2). This is particularly important for homebrew
assays, where no data is available from the manufacturer on the
performance of the assay in the presence of such substances. Clinical
laboratories are responsible for verifying in all assays that the levels of
interfering substances in their patient population are within an acceptable
range.
Methods: The AcroMetrix OptiChallenge Inhibition Panel is a 7-
member panel that mimics patient plasma containing potentially
interfering substances that frequently occur due to clinical conditions
such as hemolysis, icterus, or lipaemia.
We have evaluated the interference effect of the inhibition panel
members on the performance of different silica-based sample preparation
protocols on the QIAcube and their manual reference methods. Common
bloodborne viruses, such as HCV and HBV, and different internal
controls were spiked into each panel member in equal quantities.
Results: All tested automated sample-preparation protocols tested
performed well and removed a good amount of the interfering
substances when speciﬁc amounts of each analyte spiked were quantiﬁed
in the presence of potentially interfering substances and compared
with no-interference control. Results of the automated protocols were
comparable to the manual reference methods. Different extraction
and ampliﬁcation chemistries show different susceptibilities to single
interfering substances.
Conclusion: The automated QIAGEN extraction protocols, tested for
isolation of viral RNA and DNA, have been proven to serve as reliable
and robust methods. The inhibition panel was only minimally diluted,
so the extraction systems were tested at the highest possible level of
interference. The tested protocols were able to remove the majority of
potentially interfering substances.
The OptiChallenge Inhibition Panel provides an effective tool to monitor
the performance of nucleic acid extraction and ampliﬁcation methods and
simpliﬁes the required validation processes by providing plasma samples
that mimic interfering patient samples. This panel could be useful in QC
release testing of DNA and RNA extraction and ampliﬁcation systems.
P775 Importance of molecular detection for diagnosis and
monitoring mumps-virus infection
E. Royuela, A. Castellanos, M.E. Guisasola, J.C. Sanz, M. Mosquera,
C. Sanchez-Herrero, F. De Ory Mancho´n, J.E. Echevarrı´a for the
CIBERESP Investigators Group
Objectives: Mumps-virus (MVs) is a paramyxovirus that causes
fever, headache and swelling of the salivary glands. Complications
such as meningitis, encephalitis and orchitis are relatively frequent,
however permanent sequelae are rare. Routine vaccination included in
immunisation schedule has resulted in a dramatic drop in the number of
reported mumps cases, although, outbreaks in vaccinated population have
recently occurred, including large outbreaks worldwide. World Health
Organization (WHO) recommendations for diagnosis of mumps infection
includes isolation of MVs from clinical specimens or seroconversion
(or signiﬁcant rise in serum mumps IgG titre) or positive serological
test for mumps-speciﬁc IgM antibodies. These recommendations do not
include molecular detection using RT-PCR. Our goal was to evaluate the
importance of RT-PCR detection methods for MVs detection in clinical
samples.
Methods: For that reason, we developed an study including serological
and RT-PCR detection methods, in which 593 complete cases were
analysed (complete cases include serum and saliva and/or urine samples).
Results: From these analysed samples, 296 (49.9%) were positive, being
30.7% IgM and RT-PCR positive, 29.7% IgM positive but RT-PCR
negative and a surprising 39.5% IgM negative but RT-PCR positive.
This 39.5% positive to RT-PCR showed 97.43% IgG positive, indicating
a secondary vaccine failure since reinfection was discarded after analysis
of patients vaccination antecedents.
Conclusions: Data presented in this study demonstrate the importance
of molecular detection methods for diagnosis of MVs infection and for
the evaluation of vaccine failure previously reported, since using only
serological methods the MVs infection incidence is understimated.
P776 Serological and molecular diagnosis of measles using oral
ﬂuid samples
V. Hutse, K. Van Hecke, R. De Bruyn, O. Samu, T. Lernout,
J.J. Muyembe, B. Brochier (Brussels, BE; Kinshasa, CD)
Objectives: Measles Virus (MV) is responsible for a very contagious
disease characterised by high fever, coryza, cough, conjunctivitis
followed by the appearance of a maculopapular rash. Despite the
development of a combined vaccine (Measles-Mumps-Rubella), measles
remains a major cause of mortality in developing countries and a cause of
continuous outbreaks in more industrialised countries. Currently measles
is diagnosed by traditional serological and molecular assays on serum
and nasopharyngeal secretions.
The introduction of oral ﬂuid as an alternative medium to serum would
open many perspectives. In advantage to venepuncture, the collection
of oral ﬂuid is less invasive, less painful, less expensive (i.e. no trained
personal required) and safer (prevention of needle stick injuries). Since
measles appears mostly in children a non invasive sample collection like
oral ﬂuid would be an enormous asset to determine measles RNA and
antibodies as quick as possible in case of/or to avoid epidemic measles
outbreaks.
Methods: In this study seventy-three measles positive and ﬁfty
measles negative tripled samples (serum, oral ﬂuid and nasopharyngeal
secretions) were analysed. Samples were collected in the Democratic
Republic of Congo (Kinshasa) by the National Measles Laboratory.
In addition 22/50 negative samples came from volunteers of the
Scientiﬁc Institute of Public Health, Belgium (IPH). Oral ﬂuid samples
were collected using an Oracol collection device (Malvern Medical
Developments) and were controlled for quality and quantity by an IgG
quantiﬁcation assay.
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The detection of measles antibodies was performed by commercialised
ELISAs. An in-house nested RT-PCR has been developed for the
detection of measles RNA.
Results: The anti-measles IgM ELISA (MicroImmune) on oral ﬂuid
has been validated against the IgM ELISA (Dade Behring) on serum
(=golden standard) and resulted in a sensitivity and speciﬁcity of
respectively 93.1% and 100%. The validation of a molecular nested
RT-PCR on oral ﬂuid was performed against the standard assay on
nasopharyngeal secretions and gave a sensitivity and speciﬁcity of 100%.
Conclusion: The obtained results conﬁrm that both serological and
molecular oral ﬂuid assays are suitable for routine use.
The use of oral ﬂuid samples may also promote the participation rate
of patients, GP’s and paediatricians in the Belgium measles surveillance
system and other epidemiological studies in the framework of WHO
elimination programme.
P777 Should PCR replace the indirect ﬂuorescence antigen test for
detection of Varicella zoster on skin swabs?
D. Ursi, K. Bergs, H. Goossens, M. Ieven (Edegem, BE)
Background: An indirect ﬂuorescence antigen (IFA) test is classically
performed for routine diagnosis of varicella zoster (VZV) infection on
skin swabs. In this study the results of the IFA tests were compared to
the results of PCR on skin swabs collected between January 2003 and
June 2007.
Methods: Skin swabs were collected and immediately transported to the
lab in virus transport medium (VTM). DNA extraction was performed
on 200ml VTM with a Qiagen blood kit (Qia). From august 2006 on,
DNA extraction was performed with a NucliSens easyMAG extractor
(EM) (bioMe´rieux). Elution volumes were 50ml for Qia and 55ml for
EM.
PCR was performed according to the assay of Griffais et al. (NAR,
1991). From Sept 2005 on, this assay was replaced by a real-time PCR
assay described by Sto¨cher et al (J.Clin. Virol. 2003).
The IFA test was performed by spotting the swab on a multispot plate.
After addition of a MAb against VZV followed by incubation with
a FITC labeled conjugate (Argene), the spots were analysed with a
ﬂuorescence microscope. The test was interpreted as positive, negative
or not interpretable if the number of skin cells in the sample was too
low.
Results: Between January 2003 and June 2007 a total of 380 swabs were
analysed with IFA. A total of 283 swabs were scored as not interpretable
(74.5%). Sixty one swabs were scored as negative (16%) and 36 as
positive (9.5%). In total, 352/380 swabs were also analysed by PCR.
In the IFA non-interpretable group, 273/283 were analysed by PCR. Of
these, 75 were positive (27.5%) and 198 were negative (72.5%). Thirty
four of the 36 IFA positive swabs were analysed by PCR. All were
conﬁrmed by PCR. In the IFA negative group, 45/61 were analysed by
PCR. Three swabs were PCR positive and 42 were negative.
Conclusions: In this study, the performance of PCR was clearly superior
to the IFA test that is routinely used for diagnosis of VZV infection on
skin swabs. Especially, the number of uninterpretable results with IFA
is unacceptably high. In this category, more than a quarter of the swabs
produced a positive result by PCR, increasing the number of positive
results as compared by IFA alone by more than 200%. Moreover, some
additional positives were found in the IFA negative swabs. In Belgium,
the IFA test is reimbursed by the national health ensurance system, while
PCR on skin swabs is not. Therefore, switching the reimbursement to
the most performing test should be considered.
P778 Evaluation of a new VIDAS® test for the detection of
Epstein-Barr virus VCA IgG&IgM and EBNA IgG
antibodies in human serum samples
L. Allard, A. Foussadier, P. Desmottes (Marcy l’Etoile, FR)
Objective: The aim of the study was to evaluate the performance of
the 3 new automated VIDAS Epstein-Barr virus (EBV) reagents for the
determination of the patient EBV serological characterised. The EBV
reagents currently under development on VIDAS instrument are aimed
to detect immunoglobulins against Viral Capside Antigen (VCA) and
Epstein-Barr nuclear antigen (EBNA):VIDAS VCA IgG, VIDAS VCA
IgM and VIDAS EBNA IgG
A comparison of the VIDAS EBV® tests was performed with EBV
automated tests on the LIAISON® system (DiaSorin, Italy) using
characterised sera samples.
Methods: VIDAS EBV VCA IgG and EBNA IgG reagents use speciﬁc
EBV peptides coated on the solid phase to capture viral antigen
immunoglobulins. The peptide-EBV IgG antibody complexes are later
revealed using an anti-human IgG conjugated to Alkalin Phosphatase.
VIDAS EBV VCA IgM is based on immunocapture of serum EBV IgM.
Twenty four sera from EBV primary infection, 20 sera from EBV past
infection and 31 negative sera samples with a clinical status determined
with the Immunoﬂuorescence Gold Standard method (IF) were tested
with the 3 VIDAS EBV markers to determine the performance. A
concordance analysis between VIDAS and LIAISON was performed on
an average of 75 samples on the 3 reagents. Discrepant results were
analysed using IF.
Results: On deﬁned IF characterised samples, the speciﬁcity of VIDAS
VCA IgM, VCA IgG and EBNA IgG were 96.1%, 96.4% and 100%
respectively and the sensitivity of VIDAS VCA IgM, VCA IgG and
EBNA IgG were 100%, 95.6% and 100% respectively. For comparison,
the speciﬁcity of LIAISON VCA IgM, VCA IgG and EBNA IgG were
98.0%, 96.4% and 97.6% respectively and the sensitivity of LIAISON
VCA IgM, VCA IgG and EBNA IgG were 100%, 91.1% and 100%
respectively.
Therefore, on this preliminary study VIDAS EBV overall performance
leads to a more accurate clinical diagnosis of EBV primary infection
than LIAISON EBV.
On random samples the concordance between VIDAS and Liaison VCA
IgG, VCA IgM and EBNA IgG is 97.3%, 97.3% and 98.6%, respectively.
Conclusion: The new VIDAS EBV reagents presented good perfor-
mance in accordance with the patients’ serological status established with
the IF. Evaluation on routine samples has also shown that VIDAS EBV
reagents performed better than another automated test. VIDAS EBV
reagents will be a good alternative to currently used manual method for
MNI determination enabling single testing as well as series.
P779 Performance evaluation of VIDIA® CMV IgG assay, a new
automated immunoassay for the detection and quantiﬁcation
of CMV IgG in human serum and plasma
F. Limonne, J. Dupret-Carruel, P. Desmottes (Marcy l’Etoile, FR)
Objective: The VIDIA system is a new automated, primary tube
immunoassay instrument designed to reinforce traceability and simplify
the daily workload for routine testing.
We evaluated the performance of VIDIA CMV IgG (bioMe´rieux) in
terms of measuring range, precision, sensitivity, speciﬁcity. A correlation
study with VIDAS CMV IgG was also performed.
Material and Methods: The VIDIA CMV IgG assay principle
combines a two-step “ELISA indirect” immunoassay method with a
ﬁnal chemiluminescence detection. In the ﬁrst step CMV IgG antibodies
present in the sample bind with puriﬁed CMV Ag coated on the magnetic
particles and with the anti-human IgG monoclonal conjugated with
alkalin phosphatase (PAL) for the revelation phase.
The results of the tests are expressed in AU/ml (Arbitrary Unit). The
positive cut-off was deﬁned at 3 AU/ml, a grey zone is deﬁned between
2 and 3 AU/ml and samples below 2 AU/ml are considered as negative.
The study was performed by testing 60 positive and 43 negative samples.
The serological status of the samples was established according to
the results obtained with 3 CE-marked immunoassays: VIDAS CMV
IgG (bioMe´rieux, France), CMV-IgG-ELA Test PKS medac (medac
Diagnostika Germany), Enzygnost Anti CMV/IgG (Dade-Berhing,
Germany).
Correlation with VIDAS CMV IgG was performed on 291 samples.
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The study was done in the bioMe´rieux R&D laboratory during the
development phase of the VIDIA CMV IgG reagent.
Results: With a measuring range up to 400 AU/ml, the precision
obtained for samples at 10 AU/ml up to 250 AU/ml was between 4%
and 12%, respectively.
Sensitivity and speciﬁcity were 100% on 103 samples tested.
Correlation coefﬁcient between VIDIA CMV IgG and VIDAS CMV IgG
was found at 0.89 and the concordance between the results of the 2 tests
was 100%.
Conclusion: The very good concordance found between VIDIA CMV
IgG and the status of the samples deﬁned 3 CE-Marked tests, leads
to a 100% sensitivity and speciﬁcity for the new VIDIA test under
development. VIDIA CMV IgG is also well correlated with VIDAS
CMV IgG and presents a good precision throughout the whole measuring
range.
These ﬁrst results show that VIDIA CMV IgG could adequately
discriminate between IgG positive and negative samples, even if these
results will have to be conﬁrmed on the ﬁnal commercialised product.
P780 Rapid and efﬁcient detection of viral gastroenteritis by an
automated multiplex real-time PCR approach
T. Schuurman, L. Gard, H.G.M. Niesters (Groningen, NL)
Objectives: Traditionally, viral gastroenteritis is diagnosed by antigen
detection, electron microscopy, and increasingly PCR. However, this
necessitates the use of separate assays for the different viruses. Multiplex
real-time PCR (MPCR) provides an efﬁcient alternative for diagnosis
of viral gastroenteritis, especially when limited specimen is available In
addition, it may be complemented by a similar approach for bacteria and
parasites. In this study we compared our traditional detection methods
to a 3-tube multiplex real-time PCR.
Methods: Stool specimens (n = 212) were obtained between July and
December 2007 for routine diagnostics of gastrointestinal viruses at
UMCG. Routine procedures consisted of antigen detection (astrovirus
[hAsV], rotavirus [hRoV]), or singleplex real-time PCR (adenovirus
[hAdV], enterovirus [hEV], norovirus genogroup I + II [hNoV],
parechovirus [hPEV]). Nucleic acids were isolated by NucliSENS
easyMAG speciﬁc A protocol (bioMe´rieux) using the phocin distemper
virus (PDV) as internal control. Multiplex real-time PCRs included
hAsV, hNoV, hRoV, PDV (Mplex 1), hEV, hPEV, PDV (Mplex 2), and
hAdV, bocavirus (hBoV) (Mplex 3). Detection of hBoV was included to
study its possible role in gastroenteritis.
Results: Fully concordant results were obtained by MPCR in 96.3%
of tests requested. Positive specimens not detected by MPCR were
exclusively specimens with low levels of viral RNA (Ct> 39), except for
1 clearly antigen positive hRoV. MPCR detected more hRoV (4/153),
hPEV (8/185), and hAsV (1/135) in specimens negative by routine
procedures. In addition, MPCR detected 3 positive hRoV infections in
specimens with insufﬁcient volume for antigen testing. Another 30/212
specimens tested positive for hAdV, and 7/212 for hBoV, although in
the latter case, Ct values were always >35. Unresolved results due to
inhibition were obtained for 3, 4, 6, and 3 specimens by routine PCR,
Mplex1, Mplex2, and Mplex3 respectively.
Conclusion: MPCR provides a feasible alternative to separate routine
diagnostics tests for detection of viral gastroenteritis. MPCR increased
the sensitivity for hRoV and hPEV, although the sensitivity for hEV was
slightly reduced. However, the clinical relevance of the infections missed
by MPCR seems limited based on the high Ct values. Finally, the role of
hBoV in the aetiology of viral gastroenteritis seems questionable based
on the amount of hBoV DNA detected.
P781 Comparative evaluation of the NucliSENS easyMAG
automated system for the extraction of viral DNA from
whole blood samples: application to the monitoring of
cytomegalovirus and Epstein-Barr virus loads
S. Pillet, T. Bourlet, B. Pozzetto (Saint Etienne, FR)
Objectives: Due to the high amount of genetic material in whole blood
samples, the new extraction methods must be carefully evaluated by
comparison to the reference techniques such as those using columns to
recover correctly the nucleic acids used in ampliﬁcation techniques. The
aim of this study was to evaluate the ability of the NucliSENS easyMAG
automated system (bioMe´rieux) using magnetic silica to extract viral
nucleic acids from human whole blood for the determination of the viral
load in patients suspected of cytomegalovirus (CMV) or Epstein-Barr
virus (EBV) infection.
Methods: Two hundred microlitres of whole blood were extracted either
by the manual Qiagen method (QIAamp DNA blood extraction kit) or
by the “Speciﬁc B” protocol on the NucliSENS easyMAG instrument.
CMV or EBV DNA was quantiﬁed by using the respective R-gene
ampliﬁcation kits (Argene). Ninety six samples (including 75 found
initially positive in our laboratory) and 80 (59 positive) were selected
for CMV and EBV analysis, respectively.
Results: A total agreement between the two extraction techniques was of
88.5% for CMV and 81.3% for EBV. The sensitivity of the NucliSENS
easyMAG extraction method was 89.3% and 100% for CMV and
EBV respectively; for comparison Qiagen extraction method exhibited a
sensitivity of 82.6% and 83.1% for CMV and EBV respectively. As EBV
tests, CMV tests were performed from same samples to compare the
two extraction methods: the sensitivity difference with the conventional
method used in our lab could be attributed to samples storage. For
samples found positive after extraction by both methods, the correlation
coefﬁcient (r test) between the viral loads was 0.855 for CMV and
0.942 for EBV; the mean between the difference in viral loads was
−0.00859 log copies/mL for CMV (not statistically signiﬁcant) and 0.22
log copies/mL for EBV to the beneﬁt of the automated extraction method
(p< 0.001).
Conclusion: The excellent concordance between the results obtained
after using both extraction methods validates the capacity of the “Speciﬁc
B” protocol to extract viral DNA from whole blood with the NucliSENS
easyMAG system in two models measuring viral load. A trend was
noted for a better sensitivity of NucliSENS easyMAG regarding the low
values. The additional advantages of this automated extraction technique
include: reduction of technical time (2/3) and of cross-contamination
avoiding centrifugation, and improvement of standardisation, traceability
and quality control assessment.
P782 Evaluation of a new immunochromatography test for the
detection of Norovirus
D. Kato, Y. Nakayama, H. Tajiri, T. Tanaka, Y. Hirayama, K. Kamata,
S. Sekine (Tokyo, Nagano, Osaka, JP)
Objectives: Norovirus is one of the most common pathogens causing
gastroenteritis and belongs to the family Caliciviridae, which is a
non-enveloped, positive-sense, single-stranded RNA virus. RT-PCR and
ELISA are widely used detection methods, which have drawbacks such
as long turnaround times, relatively high cost, need for specialised
equipment and trained technicians. The newly developed Quick Ex-
Norovirus "SEIKEN" assay is based on immunochromatography (IC)
method, which is easier to perform, rapid, cost efﬁcient and offers true
clinical value.
Materials and Methods: A total of 163 faecal specimens obtained from
adults, children and infants in Japan, who showed acute gastroenteritis
symptoms during period May 2006 to March 2007, were collected and
stored in a public laboratory and two hospitals in Japan.
The reactivity of this test was evaluated against Virus-like particles
(VLPs), containing 6 genotypes of genogroup 1 (G1) and 13 genotypes
of genogroup 2 (GII).
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The test was performed according to the instruction manual. In summary,
0.1 g of faecal specimen (or 100mL of VLPs) was added to the specimen
preparation tube, containing 0.9 mL of specimen buffer, then mixed
with a tube mixer for 30 sec. and centrifuged at 2000xg for 5 min.
An aliquot of 300mL of supernatant was transferred to a sample tube
and after capping this tube with a specimen ﬁlter, ﬁltrate is collected
into a reaction tube. The IC test strip was inserted into this tube and
interpretation was done after 15 min. incubation time at room temp. All
clinical specimens were also tested by RT-PCR, as described by Yan et
al. (2003). A primer set of G1-SKF and G1-SKR was chosen for G1
and a set of G2-GKF and G2-SKR for GII identiﬁcation.
Results: Fifty three (53) of 163 samples (32.5%) were positive by the
IC test. Sensitivity, speciﬁcity and overall agreement were 73.6%, 98.9%
and 87.7% respectively, when compared with RT-PCR. Nineteen (19)
specimens were negative by the IC test, but positive by RT-PCR. These
discrepancies might be due to low viral load in these specimens. The IC
test showed positive against all VLPs, including GI types 1, 2, 3, 4 & 6
and GII types 1 to 8, 12 to 15 and 17.
Conclusion: The sensitivity and speciﬁcity of the IC test for clinical
specimens were comparable with current Norovirus detection methods,
hence the Quick Ex-Norovirus "SEIKEN" assay might be a valuable
attribute in the clinical setting.
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P783 Neoplasia in patients with HIV infection: effect of HAART
C. Asencio, J.L. Puerto, J.L. Andrey, A.A. Garcia-Egido, M.A. Escobar,
S.P. Romero, J.A. Bernal, J. Gonzalez-Outon, F. Gomez (El Puerto
Santa Maria, ES)
Surveillance data indicate that, the incidence and type of HIV related
neoplasias has changed after the introduction of HAART.
Objective: To determine the incidence and types of cancers in the pre-
HAART and post-HAART eras, and the differences between women and
men.
Methods: Retrospective record review of HIV infected patients with
cancer from January 1991 to December 2003 at a teaching hospital.
Results: A total of 268 HIV patients with cancer were identiﬁed, 206
men (age: 38±11 years, CD4: 123±39/mL) and 62 women (age: 44±16
years, CD4: 68±27/mL), of them 90 were detected in the pre-HAART
(33.6%) and 178 in the post-HAART era (66.4%, p=n/s). AIDS deﬁning
cancers (Total: 215, 72.4%; of them 108, 77.7% in men vs. 31, 22.3%
in women) were more frequent pre-HAART (Total: 76, 54.7%; of them
60, 43% in men vs. 16, 11.5% in women) than post-HAART (Total: 63,
45.3%; of them 48, 34.5% in men vs. 15, 10.8% in women). Non AIDS
deﬁning cancers (Total: 53, 27.6%; of them 34, 64% in men vs. 19, 36%
in women) were less frequent pre-HAART (Total: 14, 26.4%; of them 9,
17% in men vs. 5, 5.3% in women) than post-HAART (Total: 39, 73.6%;
of them 25, 47.2% in men vs. 14, 26.4% in women). Total cancer related
mortality was higher pre-HAART (61% vs 52%, p< 0.05) and in women
(60% vs 55%, p=n/s) than post-HAART (Total: 53, 27.6%; of them 36,
18.8% in men vs. 17, 8.9% in women). AIDS deﬁning cancer related
mortality was higher pre-HAART (65.8% vs 36.5%, p< 0.01) in both
sexes (p< 0.01), while non AIDS deﬁning cancer related mortality was
higher post-HAART (76.9% vs 35.7%, p< 0.01) in both sexes (p< 0.01).
Conclusions: The incidence of non AIDS deﬁning cancer increased,
although the total incidence of HIV related neoplasia has not changed
after HAART. Total cancer related mortality is higher pre-HAART and
in women. Both sexes have a higher mortality by AIDS deﬁning cancer
pre-HAART and, by non AIDS deﬁning cancer post-HAART.
P784 Inﬂuence of anti-retroviral treatment on gastric secretion,
Helicobacter pylori colonisation of gastric mucosa and fungal
colonisation of upper gastrointestinal tract in HIV-infected
patients
P. Skwara, A. Ciesla, I. Sobczyk-Krupiarz, M. Bociaga,
A. Kalinowska-Nowak, T. Mach (Cracow, PL)
Objectives: HIV infection is considered to have negative inﬂuence on
gastric acid juice secretion and results in higher prevalence of fungal
colonisation of upper gastrointestinal (GI) tract, whereas Helicobacter
pylori (Hp) prevalence in stomach seems to be lower in HIV-infected
patients (pts). The aim of the study was to estimate inﬂuence of
antiretroviral treatment (HAART) on gastric secretion, Hp colonisation
of stomach and fungal colonisation of upper GI tract.
Methods: 94 HIV-infected pts were studied, half of them had CD4
lymphocyte count <200/uL. 9 of 21 pts receiving HAART belonged
to this group. Biopsy samples were taken during endoscopy from corpus
and antrum of stomach to conﬁrm presence of Hp by histological
analysis and rapid urease test. Quantitative mycologic cultures from oral
and oesophageal swabs were analysed in 70 pts. Gastric secretion was
evaluated in 37 pts using Kay method on the basis of BAO, MAO and
PAO. The results were compared to HIV viral load (VL) detected by
PCR.
Results: VL decrease correlated with increased BAO (correlation
coefﬁcient r=-0.165), MAO (r=-0.287) and PAO (r=-0.289) and
decreased BAO/MAO ratio (r=0.22). Prevalence of Hp in pts on HAART
in comparison to the rest of pts, was lower in both corpus of stomach
(28%vs48%) and antrum (38%vs62%) /p> 0.05/. Hp was present in
corpus and antrum (respectively) in 29%/47% of pts with VL< 500
copies/mL and 44%/49% of pts with higher VL /p> 0.05/. Fungal
colonisation rate in pts on HAART (vs the rest of pts) was lower in
both oral cavity (64%vs87%) and oesophagus (64%vs84%) /p> 0.05/.
Lower prevalence of fungal colonisation in pts with VL< 500 copies/mL
(vs the rest of pts) was found in oral cavity (67%vs90%) /p> 0.05/ and
oesophagus (58%vs87%) /p< 0.05/.
Conclusions: Inhibited HIV replication due to antiretroviral therapy
results in increase in gastric secretion, as well as decrease in fungal
colonisation of the upper GI tract and Hp colonisation of stomach.
P785 Liver toxicity and plasma drug levels of lopinavir in HIV/HCV
co-infected patients according to the degree of liver ﬁbrosis
J. Moya, J.L. Casado, A. Moreno, L. Aranzabal, C. Gutierrez,
M. Perez-Elias, S. Moreno (Madrid, ES)
Objectives: HCV co-infection is a well known risk factor for developing
hepatotoxicity in HIV-infected patients receiving HAART. However, few
data exist about liver toxicity with r/lopinavir and the inﬂuence of plasma
drugs levels, especially in patients with different stages of HCV disease.
Methods: Prospective cohort study of 51 HIV/HCV co-infected patients
who underwent a liver biopsy and who received lopinavir as the third
drug regimen. Liver ﬁbrosis was staged using a scoring system of 0 (no
ﬁbrosis) to 4 (cirrhosis). Hepatotoxicity was deﬁned as an increase in
AST/ALT levels over ﬁve times the upper limit of normal, or a 3.5-
fold increase if baseline levels were abnormal, with or without clinical
symptoms of liver toxicity. Plasma through levels of lopinavir were
determinated by HPLC in all the cases.
Results: Mean age was 41 yrs, 73% were male, and 73% were former
IDUs. Of note, 58% of patients had a prior diagnosis of AIDS. Mean
estimated time of HCV infection was 17.6 yrs, mean HCV viral load
was 1.298235 UI/ml, and the predominant HCV genotypes were 1 and 3.
Median plasma drug levels of lopinavir were 7315 ng/ml (638–11206),
with differences according to the stage of ﬁbrosis (8114, 6614, 6008,
and 4412 ng/ml for ﬁbrosis stage 1 to 4, respectively). Notably, in three
cirrhotic patients with an advanced stage of disease (MELD scale >11),
median plasma through levels were 881 ng/ml. During an accumulated
time of 461 months on r/lopinavir therapy, there were 5 cases of
hepatotoxicity. In these patients, plasma trhough levels of lopinavir were
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similar to those observed in patients not developing toxicity (6502 vs
7368 ng/ml).
Conclusions: The risk of liver toxicity was very low in HIV/HCV co-
infected patients receiving r/lopinavir. In these patients, plasma drug
levels of lopinavir showed high interpatient variability and were not
associated with toxicity.
P786 Dream changes after efavirenz treatment
M. Velasco, J. Pareja, J. Losa, A. Espinosa, J. Valverde,
A. Delgado-Iribarren (Madrid, ES)
Objective: Although sleep disturbance is a frequent side effect of
efavirenz, there is no studies about abnormalities in the quality of
dreams.
Method: This is a pilot study. HIV patients without neuropsychiatric
diseases underwent a polisomnography (PSG) study before and after
efavirenz treatment. Efavirenz plasma levels were assessed before the
second (PSG). Patients were awoke at ﬁrst REM sleep period during the
night and at REM sleep period occurring after 5:00 am and invited to
tell the dream. Dream changes were evaluated by recall rate, number
of thematic units and emotional content classiﬁed into four categories:
violent/highly anxious, moderately anxious, pleasant and neutral. Dream
length was assessed by the number of words included in the description.
Chi square, Student T test and Z signs test were used to compared results.
Results: Eighteen PSG were performed in ten patients. Second PSG
was performed after 10.4 (SD 5.4) days of efavirenz treatment with
all patients having therapeutic efavirenz plasma leves (>1mg/ml).
Dreams were recalled in 84% before efavirenz and 43% after efavirenz
(p = 0.024). There were no differences in the mean number of words per
dream before and after efavirenz treatment (61.96 versus 47.5, p = 0.115)
neither in the number of thematic units (16 versus 6, p = 0.442). There
were less anxious and violent dreams after efavirenz (3 versus 1). The
proportion of dreams with no neutral emotional content (either pleasant
or unpleasant) was 37.5% before efavirenz and 66.7% after efavirenz
treatment (p = 0.046).
Conclusions: Efavirenz treatment increases the proportion of no neutral
dreams in this group of patients. There were no longer dreams and no
more dreams with negative emotional content after efavirenz treatment.
Dream recall was lower after efavirenz treatment. Further studies in this
area are needed.
P787 Improved long-term survival among AIDS patients with
progressive multifocal leukoencephalopathy receiving potent
antiretroviral therapies
J. Garcia-Garcia, J.L. Casado, I. Corral, A. Moreno, F. Dronda,
M.J. Perez-Elias, J. Peris, S. Moreno (Madrid, ES)
Objective: To determine the outcome of progressive multifocal
leukoencephalopathy (PML) in patients with AIDS.
Methods: A retrospective cohort of 52 subjects with AIDS who were
diagnosed of PML (clinical and neuroradiological ﬁndings of active
PML, no other aetiology, and/or PCR detection of JCV DNA in CSF,
and/or histopathological ﬁndings in biopsy) from 1996 to 2007.
Results: At diagnosis, the median CD4+ cell count and plasma HIV
RNA level were 93/mL (range, 7–410/mL) and 4.8 log copies/mL
(2−5.7), respectively. A probable immune reconstitution inﬂammatory
syndrome (IRIS), deﬁned as new onset (<180 days) of symptoms shortly
after initiation of HAART, was described in 10 cases (19%). As expected,
patients with IRIS had higher CD4+ count (181 vs 117/mL) and a lower
HIV RNA level (2.95 vs 4.6 log copies/mL, p = 0.002) at the time of
diagnosis. JCV DNA was detected in 52% of cases, and, of note, the
CD4+ count was higher in patients presenting with a negative value (156
vs 113/mL). Moreover, JCV in CSF was mostly detected in patients
without IRIS (57 vs 33%). During a median follow-up of 745 days, a
total of 14 patients died (27%), most of them during the ﬁrst 3 months
after diagnosis (13 out of 14 cases, 93%). The probability of survival was
90% and 70% at 24 weeks for patients with or without IRIS, respectively
(p = 0.15, log-rank test). There was no association between initial CD4+
count and mortality (28% vs 25% for patients below or above a CD4+
count of 100/mL). At the end of follow-up, HIV viral load was <50
copies/ml in 64% of cases, and CD4+ cell count was 357/mL, without
differences according to initial response.
Conclusions: The prognosis of PML in patients with AIDS receiving
potent antiretroviral therapies has improved signiﬁcantly, and, for patients
surviving three months after the diagnosis, the outcome is similar to that
observed in the HIV population. IRIS diagnosis was not associated with
a worse outcome.
P788 Safety and efﬁcacy of a ﬁxed-dose combination of zidovudine,
lamivudine, and nevirapine in antiretroviral-naive and
−experienced HIV-1 infected patients
S. Sungkanuparph, S. Kiertiburanakul, B. Piyavong, W. Manosuthi,
K. Malathum (Bangkok, Nonthaburi, TH)
Objectives: To evaluate the safety and efﬁcacy of a ﬁxed-dose combina-
tion (FDC) of zidovudine, lamivudine, and nevirapine (AZT/3TC/NVP)
which has recently been available in developing countries and is planned
to replace the extensive use of the FDC of stavudine, lamivudine, and
nevirapine (d4T/3TC/NVP).
Methods: A cohort study was conducted in HIV-1 infected patients who
were initiated FDC of AZT/3TC/NVP as an initial antiretroviral therapy
(ART) or as switching ART from other stable regimens at a medical-
school hospital in 2006. Patients were followed up for 12 months and
were categorised into initial ART and switching ART groups.
Results: A total of 241 patients were included; 62% were male and
mean (SD) age was 40.4 (8.7) years. Mean (SD) body weight and
hemoglobin were 60.2 (11.3) kg and 13.4 (1.8) g/dl, respectively. Of
241 patients, 51 were in initial ART group and 190 were in switching
ART group. In initial ART group, median (IQR) baseline CD4 cell
count and plasma HIV-1 RNA were 159 (70–210) cells/mm3 and 5.4
(4.6−5.9) log copies/ml, respectively. In switching ART group, median
(IQR) baseline CD4 cell count was 386 (276–519) cells/mm3 and all
had plasma HIV-1 RNA <50 copies/ml. Of 190 patients, 184 (97%)
switched from NNRTI-based regimens and 116 (61%) were FDC of
d4T/3TC/NVP. Median (IQR) duration of ART prior to switching was
34 (22−51) months. By intend-to-treat analysis, 78% in initial ART
group and 91% in switching ART group had plasma HIV-1 RNA <50
copies/ml at 12 months of FDC of AZT/3TC/NVP. At 6 and 12 months,
median CD4 cell count signiﬁcantly increased from baseline to 303
(p =0.030) and 352 (p< 0.001) cells/mm3 in initial ART group; 415
(p = 0.026) and 436 (p = 0.018) cells/mm3 in switching ART group.
During 12-month follow-up period, 14% and 6% of patients in initial
ART group and switching ART group, respectively, had discontinued
FDC of AZT/3TC/NVP due to adverse events. These adverse events
(initial ART, switching ART) included anaemia (4%, 3%), rashes (6%,
0.5%), nausea/vomiting (4%, 1%), hepatitis (2%, 0%), myalgia (0%,
0.5%), and non-improved lipodystrophy (0%, 0.5%).
Conclusions: A FDC of AZT/3TC/NVP has good safety and efﬁcacy
for using as initial ART in antiretroviral-naive patients and for switching
ART in patients with stable ART and complete viral suppression. The
virological and immunological outcomes are favourable. In resource-
limited settings, a FDC of AZT/3TC/NVP is an alternative for replacing
a FDC of d4T/3TC/NVP.
P789 Tolerance and quality of life improvements: Kaletra® soft-gel
capsules vs Kaletra® tablets: the KaleVie study
N. Terrail, S. Guessant, H. Akkari, L. Michel, B. Laribii, L. Guillin,
A. Becker, S. Hansel-esteller (Montpellier, Paris, Perpignan, FR)
Background: Kaletra® tablets were introduced in september 2006 in
France to replace soft gel capsules (SGC) with no need for refrigeration
or dosing with food, and a new excipients formulation. The aim of this
study was to evaluate in real life the tolerance, the change of comfort
of drug intake, and quality of life between the end of the last month on
SGC (M0) and the ﬁrst month on tablets (M1).
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Methods: From september 2006 to february 2007, an open investigation,
multicentre prospective study was conducted on HIV patients (pts)
switching from Kaletra® SGC to tablets to compare the course of comfort
of drug intake, quality of life, conﬁdentiality, with or without food intake,
preservation of drug, tolerance, and impact of new tablet formulation on
everydaylife between M0 and M1.
Results: 81 pts were included (59 males, 22 females); mean age:
44 (29−77 years). Seropositivity detections dated back to 11 years
(1 month – 21 years). Mean duration of antiretroviral treatment was
9 years: 2 years on Kaletra® (1 month – 6 years).
Comfort of drug intake evaluated on a 0 to 10 graduated scale went
up from 7.9 to 8.6 (p< 0.05), and 73% at M1 compared to 64% at M0
did not have quality of life affected with HIV infection and treatment.
Removing food restrictions was very important for 50% of pts; no
need for refrigerate upgraded conﬁdentiality for 65% of pts and was
considered as very important for 94%. Food intake with SGC or tablets
increased gastro-intestinal tolerance in 75% pts. Diarrhoeas and gas were
less frequent and severe when switching to tablets (p< 0.05) and were
not more associated with a regimen including AZT (p> 0.05) or a ﬁrst
month of Kaletra© treatment (p> 0.05). There was less dislike with the
yellow tablets than orange SGC (p< 0.05). Observance did not increase
(p> 0.05) but no patient encountered any conﬁdentiality problem leading
to miss an intake and 23% had the feeling tablets were more efﬁcient;
18% declared they would change their travel habits at M1.
Conclusion: Following switch from SGC to tablets, subjects reported an
increased quality of life and conﬁdentiality, and a better tolerance. Food
intake lowered gastro-intestinal adverse events with either SGC or tablet
formulation.
P790 Efﬁcacy and safety of ﬁlgrastim in HIV/AIDS patients with
bacterial infections
T. Tsertsvadze, L. Sharvadze, N. Gochitashvili, M. Karchava (Tbilisi,
GE)
Background: To assess the effect of ﬁlgrastim (G-CSF) in HIV/AIDS
patients with bacterial infections with or without neutropenia since it
is supposed that ﬁlgrastim, together with increase of neutrophil count,
can also enhance their functional activity and thus improve outcome of
bacterial disease.
Methods: 48 HIV/AIDS patients with severe bacterial infection/sepsis
aged 19−60 (study group) were enrolled in the randomised controlled,
open-label, prospective follow-up study. Among them 29 patients were
neutropenic with absolute neutrophil count (ANC) <1.0×109/l, and 19
were non-neutropenic. Patients in the study group were treated with
standard therapy (antimicrobial drugs and symptomatic treatment) and
ﬁlgrastim 5mg/kg daily for 5−7 days. In control group were included 17
HIV patients with severe bacterial infection or sepsis with (9 patients) or
without (8 patients) neutropenia on standard therapy without ﬁlgrastim.
Functional activity of neutrophils was measured by nitroblue tetrazolium
reduction (NBT)-test.
Results: As neutropenic so non-neutropenic ﬁlgrastim-treated patients
required fewer hospital days for infections and fewer days of intravenous
antibacterials compared to control group; death and relapse rate was
less frequent in patients with ﬁlgrastim. Severe neutropenia was less
frequent in neutropenic patients with ﬁlgrastim compared to control
patients. NBT-test showed improved neutrophil’s functional activity in
ﬁlgrastim-treated patients. Filgrastim was not associated with increase
in HIV plasma RNA level or any new or unexpected adverse events.
Conclusions: Filgrastim was safe and effective for severe bacterial
infection/sepsis in HIV/AIDS patients with or without neutropenia.
Filgrastim was well tolerated by patients and signiﬁcantly improved the
patient’s quality of live. It may reduce the duration of infections, hospital
days for infections, days of intravenous antibacterial agents and risk of
relapse. Filgrastim treatment was also associated in improved neutrophil
functional activity.
Further studies are required to optimise treatment regimen.
P791 Pharmacokinetics of lopinavir combined with rifabutin in
a clinical setting
S. Carbonara, A. Matteelli, M. Regazzi, P. Villani, E. Ciracı`, A. Carvalho,
I. El-Hamad, M. Cusato, C. Tinelli, L. Monno (Bari, Brescia, Pavia, IT)
Background: The use of ritonavir-boosted lopinavir (LPV/r) plus
adjusted dose rifabutin (aRFB) is currently allowed in HIV-infected
subjects with mycobacterial disease (MD). This study investigated the
pharmacokinetic (PK) parameters of LPV/r when associated with aRFB
in a clinical setting, from which no such data have been published thus
far.
Methods: This prospective, multicentre study enrolled consecutive HIV-
infected subjects with MD for whom clinicians chose a combination
regimen including LPV/r (standard dose)+aRFB (150mg 3x/week), as-
sociated with any anti-mycobacterial (AMB) drugs and no antiretroviral
(ARV) drugs other than nucleos(t)ide reverse transcriptase inhibitors.
Treatment adherence was supervised. A 12-hour PK assessment of
plasma LPV levels was performed on 1 occasion after >14 days of
LPV/r+aRFB administration and, when feasible, after >14 days of RFB
withdrawal. LPV plasma levels were centrally assayed by a validated
HPLC-UV method (lower quantiﬁcation limit 50ng/mL). PK parameters
were calculated by standard non-compartmental methods (KINETICA,
version 4, InnaPhase). Intra-subject changes in PK parameters were
evaluated by calculating geometric mean ratios (GMR) and 95%CI
(SAS).
Results: LPV PK parameters were obtained in 25 subjects during aRFB
co-administration: median age 40 years (range 27−54), weight 61Kg
(42−77), males 72%, Caucasian 64%, black 20%, other races 16%, HVC
or HBV co-infection 32%, liver impairment 24%. MD was tubercular
in 64%, non tubercular (24%) and undeﬁned (12%). Mean±SD LPV
Ctrough and Cmax were 11.3±5.1 and 18.7±6.9mg/mL, respectively.
AUC0−12h was 166.2±63.4mg.h/mL and CL/F 0.05±0.02L/h/kg. LPV
PK assessments in absence of RFB were also available for 6/25 patients.
The GMR (95%CI) of LPV CL/F/Kg, Ctrough, Cmax and AUC0−12h
when associated with aRFB versus alone were 1.17 (0.66−2.07), 0.84
(0.40−1.77), 0.80 (0.47−1.37) and 0.88 (0.44−1.76), respectively.
Conclusions: Mean LPV Ctrough and AUC0−12 during aRFB co-
administration in our clinical population were well above the minimum
recommended target levels (even those recommended for antiretroviral
experienced patients). LPV showed a non-signiﬁcant intra-patient mean
increase in CL/F (17%) when associated with aRFB versus alone;
however, this ﬁnding evidenced a high inter-subject variability, probably
determined by the different patient characteristics which emphasizes
the usefulness of therapeutic drug monitoring during AMB-ARV
combination treatments.
Nosocomial outbreaks
P792 Cross-transmission of a multidrug-resistant Acinetobacter
baumannii clone produced endemic nosocomial bacteraemia
and one outbreak in a Mexican Hospital
M.D. Alcantar-Curiel, R. Morﬁn-Otero, M.D. Jarillo,
E. Rodriguez-Noriega, J.R. Araiza, B.E. Real, C. Gayosso, J.I. Santos,
C.M. Alpuche-Aranda (Mexico City, Guadalajara, MX)
Background: Multidrug-resistant Acinetobacter baumannii (Aba) has
emerged as an important cause of endemic nosocomial infections and
epidemic outbreaks.
Objectives: To describe the antimicrobial susceptibility proﬁle associ-
ated to genotyping of Aba causing nosocomial infections and outbreaks
in one Mexican Hospital.
Methods: This is a descriptive molecular epidemiology study performed
in a 1,000-bed tertiary care University Hospital in Guadalajara, Jalisco,
Mexico. From December 2002 to August 2007, one hundred Aba isolates
from nosocomial infections were detected from several wards in Hospital
Civil de Guadalajara. Clinical data were collected from medical records.
Antibiotic susceptibility testing was performed by disc diffusion method
Nosocomial outbreaks S205
according to CLSI guidelines. Clonal analysis was determined by ApaI –
Pulsed Field Gel Electrophoresis (PFGE).
Results: Sites of isolation included: Skin and soft tissue (46%),
bloodstream (42%), sterile ﬂuids (8%), and respiratory tract (4%).
All Aba isolates were resistant to all quinolones, aminoglycosides,
and b-lactam antibiotics, with 50% resistance to carbapenems. Genetic
ﬁngerprinting by PFGE of these isolates showed extensive heterogeneity
between isolates, although one major cluster involving 37 patients
belonged to a single clonal type. This Aba clone was an endemic in
2005 and 2006, and produced an outbreak in 2007. This clone was
detected in the majority of the hospital wards.
Conclusions: Proper control of this multidrug-resistant Aba will require
a multidisciplinary approach, including identiﬁcation of resistance
mechanisms, optimising antibiotic use based on local epidemiology and
vigorous implementation of infection control procedures.
P793 Spread of multidrug-resistant Acinetobacter baumannii in
intubated patients
E. Alp, M. Yerer, S. Kocago¨z, G. Metan, D. Esel, Y. Gurol, M. Doganay
(Kayseri, Istanbul, TR)
Objectives: Acinetobacter baumannii constitutes one of the most
common cause of ventilator associated pneumonia in intensive care
units. The colonised patients are important source for environmental
contamination and patient-to-patient spread of microorganism. The major
mode of transmission from patient-to-patient and environment-to-patient
is contaminated hands of healthcare workers. The aim of this study was
to determine the risk factors for the colonisation of respiratory tract and
infection with A. baumannii in medical ICU (MICU) and examine the
genetic relatedness of the strains to show the spread of isolates.
Methods: This study was conducted prospectively between December
1, 2004 and January 31, 2006 in MICU. Patients (>16 years) admitted
to the MICU and mechanical ventilated and/or intubated were enrolled
in the study. Endotracheal aspirate of these patients were screened for
A. baumannii at the beginning of intubation (in the ﬁrst 48 hours), at
the end of ﬁrst week and at the time of withdrawal of endotracheal tube.
Patients intubated shorter than 48 hours were not included into the study
and data of A. baumannii colonised or infected patients at ICU admission
were not evaluated for the risk factors. Strains isolated from colonised
and infected patients were evaluated for genetic relatedness. Genotyping
analysis was performed by pulsed-ﬁeld gel electrophoresis (PFGE)
Results: Ninety-eight patients were evaluated for A. baumannii
colonisation during or at the end of their entubation and 44 (45%) of
these patients were colonised with A. baumannii. The mean time for
A. baumannii acquisition was 7.46±3.74 days (range 2 to 16 days).
The length of entubation (OR:1.032, p: 0.014) and diabetes mellitus
(OR:4.140, p:0.008) were found to be the major risk factors for the
colonisation of respiratory tract with A. baumannii. During the study
period, A. baumannii infection developed in 35 (80%) of 44 colonised
patients. The important risk factors for infection were A. baumannii
colonisation (OR:3.962, p:0.006) and tracheostomy (OR:4.857, p:0.001).
Genotyping analysis was performed for 59 isolates. Overall, three clones
(clone A, B, C) were determined from patients, whereas 88% belonged
to clone A (52 isolates), 7% clone B (four isolates) and 5% clone C
(three isolates).
Conclusion: This study showed the spread of A. baumannii in intubated
patients in a ICU with inadequate infrastructure.
P794 Risk factors for nosocomial Acinetobacter bacteraemia: a
case-control study of intensive care unit patients
O. Tunger, G. Keles, C.B. Cetin, H. Gazi, S. Coban, I. Aras,
M. Sakarya (Manisa, TR)
Objectives: This study was performed to identify risk factors and
to determine the attributable mortality and outcome of Acinetobacter
bacteraemia in intensive care unit.
Methods: A retrospective case-control (1:1) study was conducted in
a tertiary, academic hospital, with 300 beds. From January 2001
to December 2006, 54 cases and 54 controls were included. Cases
were all the true nosocomial bacteraemias by Acinetobacter spp. A
control was deﬁned as the consecutive patient with negative blood
cultures, matched by sex, age (±10 years), primary and secondary
diagnosis, APACHE II score (±2 points), operative procedures, and
date of admission. Characteristics and mortality rates of patients with
Acinetobacter bacteraemia and their controls were compared. The results
were analysed using SPSS (version 11.0) for Windows.
Results: The mean age was 51.05±22.30 years (median = 56) for the
cases, and 47.90±20.58 years (median = 44) for the controls. There
was a trend for a longer median duration of hospitalisation among
case patients, compared with control patients (33.31±30.67 versus
11.55±10.50 days; p = 0.06). Patients with Acinetobacter bacteraemia
had signiﬁcantly more hemodynamic instability (hypoxia, shock) and
longer length of ventilator requirement than controls. Case-patients were
more likely than controls to have had central venous catheter, peripheral
arterial catheter, mechanical ventilation and total parenteral nutrition
(p< 0.05). Thirty-three (61.1%) of the case patients died, compared with
14 (25.9%) of the control patients (p = 0.001). Attributable mortality is
determined by subtracting the crude mortality rate of the controls from
the crude mortality rate of the cases. The attributable mortality was
35.2%.
Conclusion: In critically ill patients Acinetobacter bacteraemia is
associated with a signiﬁcantly increased mortality rate.
P795 Role of tigecycline in the control of outbreak of
carbapenem-resistant Acinetobacter baumannii infections in
an intensive care unit, Kuwait
V. Rotimi, W. Jamal, M.I. Salama, K. El-Din, N. Dehrab (Safat,
Jabriya, KW)
Objective: To report 3 different episodes of nosocomial outbreaks of
multi-resistant Acinetobacter baumannii (MRAB) infections in an ICU
setting, successfully controlled with tigecycline.
Methods: The outbreaks of Acinetobacter infections occurred in
February and April, 2006 and April 2007. Patients’ ages, nationality,
underlying co-morbidities, prior antibiotics used, site of infection, major
reason for hospital admission, whether or not ventilated and length of
ICU stay, were recorded. Samples of endotracheal tube (ET) secretions,
sputum, blood, urine, CSF and wound were collected and cultured on
appropriate bacteriological media. The isolates were identiﬁed using
automated VITEK2 ID system and the API 20NE system. Susceptibility
testing was done by the Etest method. Molecular typing of the isolates
was determined by PFGE. Patient and environmental screening strategies
previously agreed to by the Outbreak Management Committee were
carried out. Patients were nursed in isolation rooms or single side rooms.
Results: A total 21 patients, aged 19–75 years, were involved. Time
of admission to time of acquiring infection ranged from 3–31 days.
All isolates were resistant to 15–17 antibiotics, including carbapenems
(MRAB-C) but susceptibile to tigecycline with MIC90 of 2mg/ml.
Overall mortality rate was 14.3%. The ﬁrst outbreak involved 6 cases
with pnuemonia, meningitis and UTI. Time to clearance of the MRAB-C
after therapy with amikacin and ciproﬂoxacin was 8.3 days and was
associated with a mortality rate of 50%; tigecycline was unavailable
for use at this time. The second outbreak involved 10 patients (6
bacteraemias, 3 pneumonia and 1 UTI). All patients received tigecycline
in adequate doses. Time to clearance was 2.8 days and all survived. Five
patients (3 bacteraemias, 1 pneumonia and 1 abscess), were involved
in the third outbreak. They were also treated with tigecycline. Time
to clearance was 3.1 days and all survived. Environmental screening
revealed gross contamination of many surfaces and equipment within
the unit. Genotypic characteristics demonstrated 2 distinct clonal strains.
Other measures included closure of the ICU to new admissions during
the second outbreak to allow for adequate cleaning and disinfection of
the unit.
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Conclusion: Two clones of MRAB-C were responsible for the outbreaks
and successful control included the use of tigecycline and aggressive
infection control strategies.
P796 An outbreak of multidrug-resistant Acinetobacter baumannii
colonisation and infection in a neonatal intensive care unit
of a major paediatric university hospital in Athens, Greece
E. Petridou, J. Papavasiliou, H. Kirikou, A. Charisiadou, P. Fratzaki,
S. Photopoulos, K. Xerakia, A. Pangalis (Athens, GR)
Objective: The aim of this study was to investigate and report the
epidemiologic, bacteriologic and clinical features of an outbreak caused
by A. baumannii in a Neonatal Intensive Care Unit (NICU)
Materials and Methods: During a 10 month period, from October
2006 to July 2007, 180 infants were hospitalised in a 20 bed NICU.
Surveillance cultures of nasopharyngeal and anal swab specimens
were performed regularly to every neonate admitted to the NICU,
and every 2 weeks until their discharge. Twenty two infants were
colonised by A. baumannii. The isolated strains of A. baumannii were
identiﬁed and tested for antibiotic susceptibility by VITEK2 automated
system (Biomerieux, France). The results of sensitivity tests were
evaluated according to CLSI recommendations. The isolates proved to
be resistant to aminoglycosides, cephalosporins, penems, co-trimoxazole
and ciproﬂoxacin and sensitive only to colimycin, doxycycline and
tetracycline. Five of those neonates developed bacteraemia and one
of them died from sepsis. Environmental surveillance did not reveal
the A. baumannii source. Epidemiological investigation revealed that
acinetobacter entered the NICU in October with a colonised neonate
coming from a maternity Hospital in a distant area where the
microorganism was abundant. The infection control committee of the
hospital reinforced the usual preventive measures as cohorting of the
the colonised/infected neonates and especially the proper hand hygiene
protocol among healthcare workers in order to control the outbreak.
A. baumannii disappeared from NICU after the discharge of the last
colonised neonate.
Conclusions: Outbreaks of multi resistant bacteria is a major problem
in NICU because of the prematurity of neonates, the consumption of
antibiotics, the use of invasive devises and the prolonged hospitalisation.
Surveillance cultures, followed by a good medical practice and standard
hygienic precautions should be stressed out.
P797 Burkholderia spp. contamination detected in ultrasound gels
M. Eyigor, G. Evcil Celik, B. Gultekin, N. Aydin (Aydin, TR)
Objectives: Contamination of pressure transducers, propofol, water used
to dilute alcohol including skin antiseptics, mouthwash, antiseptics, etc
has resulted in outbreaks of nosocomial infections. Similarly, there are
also reports stating that contaminated ultrasound gels cause hospital
infections. In this study, Burkholderia spp. contamination determined
in ultrasound gels used in our hospital were investigated.
Methods: During surveillance studies performed for infection control
in our hospital, an increase in wound infection rates were determined
and environmental cultures were performed to determine the source of
infection. In ultrasound gels, Burkholderia spp. was grown. Therefore, all
gels in the hospital were collected to investigate for contamination. Gels
were packed in boxes containing 12 plastic bottles, and inoculations into
blood agar and EMB agar for culture were performed. Bacteria grown
in cultures were deﬁned by conventional methods and BBL Crystal
Identiﬁcation System (Becton Dickinson and Company). In order to
investigate relationship with clonality, pulse-ﬁeld gel electrophoresis was
performed in identiﬁed origin.
Results: Two different brands of gels were found to be used in our
hospital. A total of 669 unopened bottles of gels from two brands were
sampled for cultures. When no growth was observed in any of total 364
bottles for one of the brands, these gels were distributed back to the
hospital. As for the other brand, a total of 305 bottles were investigated
and in 222 (72.8%) of them, similar colony growth was detected. One
strain was taken per packet therefore total of 21 strains of Burkholderia
spp., were deﬁned. Pulse gel electrophoresis was performed for all 21
strains and was found that all originated from the same clone.
Conclusions: It should be considered that ultrasound gels may be
contaminated during production and/or packaging and may be a source
of nosocomial infections.
P798 Pseudo-outbreak of Serratia marcescens in a tertiary care
hospital
D. Dundar, M. Meric, H. Vahaboglu, A. Willke (Kocaeli, TR)
Objectives: To investigate an outbreak due to Serratia marcescens
isolated from different samples (mostly cathether tips) of the patients.
Methods: Between September and November 2007, an apparent increase
in positive culture results for S. marcescens was observed in the
Clinical Microbiology Laboratory of Kocaeli University Hospital. A
pseudo-outbreak was suspected and an outbreak investigation including
retrospective and prospective studies using chart review, environmental
sampling and random arbitrary polymorphic DNA-polymerase chain
reaction (RAPD-PCR) of randomly selected isolates were performed by
Infection Control Commitee.
Results: During the epidemic period, 67 strains of S. marcescens were
isolated from the various specimens of both hospitalised and outpatients.
Average isolation number was 4 strains/month of the bacteria in the
previous months. Nine of 67 strains were belong to true infection.
Thirty-ﬁve of them were isolated from cathether tips and 11 from
deep tissue biopsy specimens. S. marcescens was also isolated from the
saline solution in culturing area of the laboratory and recognised that he
technician has been using the same stock saline solution for processing
the specimens without changing needle. RAPD patterns of the isolates
were identical with the pattern of saline strain. The contaminated saline
solution was discarded, the technician was educated and no additional
cases of suscepted contamination has been observed.
Conclusion: This pseudo-outbreak emphasise the importance of the
periodic observation of specimen processing procedures and education
of laboratory workers in the microbiology laboratory.
P799 A nosocomial outbreak of CTX-M producing Serratia
marcescens in a Bulgarian neonatal hospital unit
R. Vatcheva-Dobrevska, I. Ivanov, E. Georgieva, T. Kantardjiev
(Soﬁa, BG)
Objectives: The nosocomial spread of ESBL-producing S. marcescens
remains a signiﬁcant world-wide problem although in Bulgaria it have
been rarely reported. The study investigates the epidemiology of a
nosocomial outbreak of ESBL-producing S. marcescens in a neonatal
intensive care unit.
Methods: A total of six infants were clinically studied. Three of
them have experienced various clinical symptoms, one died with
meningitis and two were clinically healthy. Six isolates S. marcescens
were cultured from CSF (1), throat aspirate (3), nasal swabs (2).
Identiﬁcation, antimicrobial susceptibility and tests for ESBL production
were performed by VITEK2(BioMerieux, France) and conventional
methods. PCR detection of CTX-M, SHV and TEM ESBL encoding
genes was performed. Molecular typing was carried out by using ERIC-
PCR and REP-PCR. The six isolates were compared with another set of
35 isolates originating from different hospitals from all over the country.
The fragment analysis was carried out in a novel capillary electrophoresis
instrument HDA-12 (eGene inc., USA) that generates results within eight
minutes.
Results: The antibiotic susceptibility testing revealed two types. Five
isolates were multidrug resistant, susceptible only to ﬂuoroquinolones
and carbapenems and one isolate was generally susceptible. Only
CTX-M gene was found among the ﬁve MDR strains. The molecular
typing grouped the isolates in two clusters – one containing the ﬁve
identical MDR isolates and a second one including the unrelated
susceptible strain. The two methods applied generated concordant results.
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The general comparison with the other nosocomial isolates from the
country revealed a total of ﬁve genotypes.
Conclusions: This study is the ﬁrst to present molecular diversity
of nosocomial S. marcescens isolates from Bulgaria. The applied
PCR typing systems ERIC-PCR and REP-PCR proved efﬁcient for
discrimination of closely related as well as unrelated nosocomial isolates.
P800 Nosocomial outbreaks caused by Serratia marcescens
L. Lazarevska (Skopje, MK)
Background: Over the course of 2005, we registered and investigated
two nosocomial outbreaks caused by Serratia marcescens. The ﬁrst one
occurred in the neonatal intensive care unit (NICU), at the Clinic of
gynaecology and obstetrics, and the second one in the paediatric intensive
care unit (ICU) of the Clinic for Children’s Diseases – Medical Faculty –
Skopje, R. Macedonia.
Methods: The initial and ﬁnal Information were elaborated by the
Department of Epidemiology and the Department of Microbiology at
the PHO Institute for health protection-Skopje. During the outbreaks,
throat, nose, and eye swabs, as well as blood samples were taken from
every patient hospitalised in the ICUs. Materials from working surfaces
and medical staff were taken for bacteriological investigation.
Results: Case A: In January 2005, 10 premature infants in NICU were
infected (n = 5) or colonised (n = 5) by Serratia marcescens. Four of them
developed septicaemia, which was fatal for one of the babies. One baby
had conjunctivitis, and ﬁve babies had no clinical symptoms.
Case B: In July, 2005, seventeen newborn babies were registered in
outbreaks caused by Serratia marcescens in ICU. Five babies suffered
from septicaemia, in ten cases bacteria were isolated from the trachea,
in one case from the nose and there was one case with eye-isolated
bacteria.
Apart from Serratia marcescens, we registered ﬁve cases with Klebsiella
aerogenes (n = 5) and Pseudomonas aeruginosa (n = 5).
Only six babies manifested clinical symptoms and all babies were treated
with antibiotic regimen.
Conclusions: Throughout both nosocomial outbreaks, the units were
partially closed, the infected newborn babies were isolated and a general
cleaning was carried out, as well as disinfecting of all units. The supply
of antibacterial soap was replenished and the babies were not breast-fed,
but put on formula feeding.
A focal source for all micro-organisms was not identiﬁed, but we believe
that bacteria transmitted via contaminated hands play an important role
in the outbreaks. Cohorting, isolation of colonised and infected newborn
babies, and rigorous environmental hygiene were crucial measures in
preventing further hospital infections.
P801 Measles outbreak and serological testing of healthcare
workers in a Spanish hospital
V. Pascual, S. Gonzalez, E. Calbo, M. Riera, M. Rodriguez-Carballeira,
J. Garau (Terrassa, ES)
Background: In 1981 the combined measles-mumps-rubella vaccine
was introduced in Catalonia. In 2006 the Public Health Department
reported that the prevalence of IgG measles antibodies was ~99% in
children and adult population. Recently, a measles community outbreak
occurred in our area. A patient was diagnosed of measles on his 7th day
of hospital stay. CDC recommendations state that healthcare workers
(HCW) with direct patient contact and without documented immunity
should be vaccinated as soon as possible and relieved from direct patient
contact, from the 5th to 21st day after exposure. This measure is costly
and represents a considerable burden for the hospital. The objective of
the study was to determine the prevalence of measles antibodies among
HCW and to evaluate a questionnaire as a screening tool.
Material and Methods: This was an observational study in an acute
care hospital in Terrassa, Spain. All HCWs born between 1966 and
1980 were included. A questionnaire regarding previous exposure or
immunisation with the triple vaccine was used. ELISA immunoassay
was used to measure measles IgG antibody titres. HCW with exposure
to the index case were relieved from direct patient contact until ﬁnal
serological results were obtained.
Results: 44 HCW were exposed. Only one seronegative HCW was
relieved from patient contact for 15 days. 586 (91.7%) out of 639 HCW
were tested. 6 (1%) refused serological testing, 78.4% were women.
Median age was 33 years. 74% were physicians and nurses. 22.5%
referred a previous measles episode, 29% previous vaccination, 4.2%
referred both, and 55% did not refer any previous disease or vaccination.
The seroprevalence was 90%, 81%, 80%, and 86%, respectively. In the
whole cohort the prevalence of IgG antibodies was 86%. The sensibility
of the questionnaire was 85.6% and the speciﬁcity was 14%.
Conclusions: Seroprevalence of measles antibodies in HCWs was high
but lower than expected. Data obtained through personal interview did
not provide accurate information as to be used as a surrogate for
immunity. In case of a nosocomial outbreak, the determination of the
immune status in exposed HCW is useful in order to avoid unnecessary
interventions. All HCWs must be tested and, if necessary, vaccinated
before their incorporation into the hospital.
P802 Uncommon nosocomial transmission of TBC in an outpatient
clinic in 2005: possible route of pathogen
T. Eckmanns, H. Epple, H. Karcher, P. Buchholz, P. John, T. Schneider
(Berlin, DE)
Objectives: We report an uncommon nosocomial transmission of
Mycobacterium tuberculosis in an outpatient ear, nose and throat (ENT)
clinic. The ﬁrst patient suffered from an acute otitis media. The
second patient complained about sudden deafness. The index patient
was diagnosed with tuberculosis otitis media 3 months after the initial
diagnosis. The second patient was diagnosed with tuberculosis otitis
media 5 months after the initial diagnosis and 3 months after the index
patient.
We investigated the contact situation regarding the two patients and the
probable route of transmission.
Methods: The case histories were checked for possible contact between
the two patients. The similarity of the pathogens was investigated by
molecular methods. The hygienic situation of the outpatient clinic was
audited and the hygienic plausibility of the transmission of the pathogens
was investigated by laboratory experiments. Potential other contacts in
the clinic were traced back and investigated using a t-cell based assay
(Elispot) for IFN-gamma.
Results: Both patients met once in the ENT clinic. Both had an invasive
ear examination on this day. Microbial investigation revealed the same
clonal pattern.
The audit revealed incomplete compliance with hygienic necessities,
especially concerning hand disinfection and environmental disinfection
between different consultations (e.g. contact to ear microscope). In
addition, staff reported that the rinse water of the ear suction device was
not changed between consultations. An experiment proved a possible
contamination of the suction device by contaminated rinse water. A
second experiment showed that the ﬂyback of rinse water in the upside
down hanging suction device was able to contaminate the apex of the
device.
None of the 10 contacts, who were treated in the ENT clinic on the same
day revealed a positive result in the Elispot.
Conclusion: Investigations demonstrated probable transmission in the
outpatient clinic. Different routes of transmission are possible. A
lecture in hand disinfection was given and a new hygienic management
was established which included systematic disinfection of patient
environment between consultations. In addition structural changes like a
hanger for the suction device were established. Hygienic management is
a challenge in ENT clinics, as patient turnover is high, infectious disease
are common and many medical devices are used.
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P803 Audit of pulmonary tuberculosis management in a hospital
with high tuberculosis prevalence: a tool for quality
improvement in tuberculosis control
M. Hites, C. Melot, S. Van Den Wijngaert, A. Dediste, S. De Wit,
M. Gerard (Brussels, BE)
Objectives: To avoid nosocomial TB transmission, infection-control
measures, using administrative controls, engineering controls and
personal respiratory protection are recommended by the CDC. An audit
on the implementation of these administrative controls was performed at
Centre Hospitalier Universitaire Saint Pierre (CHUSP), a public hospital
in Brussels, Belgium, with high incidence of TB admissions. In countries
with low TB incidence like Belgium, many doctors lack experience in
recognition of RTB.
Methods: A retrospective observational study on all patients admitted to
CHUSP, with suspicion of active respiratory TB (RTB) or with positive
cultures for M. tuberculosis from a respiratory specimen, between
January 1, 2002 and December 31, 2006. The use of airborne precautions
(AP) was evaluated for each hospitalisation episode (HE). A decision tree
for predicting active RTB based on 4 criteria (upper lung inﬁltrate at the
chest X-Ray, fever, weight loss and CD4 count), elaborated by El-Solh
and al. (Am J Respir Crit Care Med 1997; 155: 1711–16), was tested.
Median TB management intervals (25th and 75th inter-quartiles) were
calculated. Intervals exceeding 24 hours were considered to be a delay.
Figure: % of HE with delays in diagnosis and treatment in active RTB
(n = 374).
Results: The incidence of active RTB from 2002 to 2006 was 4.25/1000
admissions. The cohort consisted of 971 HE. The ratio of active RTB
to number of AP HE was 374/962. Among the 374 HE with active
RTB, there were 92 AP failures (51 delays in TB suspicion, and 41
AP stopped prematurely). Theoretical delays in TB suspicion (10/364:
2.75%) generated with the decision tree were signiﬁcantly inferior to the
observed delays (46/364: 12.64%, p: 0.008). The median TB suspicion,
treatment and overall management interval was: 0 (0−6) days, 3 (1−6)
days and 4 days (1−7 days), respectively [ﬁgure: % of patients with
delays in diagnosis and treatment in conﬁrmed RTB (n = 374)].
Conclusions: APs are not correctly implemented in 25% of patients
diagnosed with active RTB at CHUSP. Although overall TB management
intervals seem reasonable, they are under-estimated, as some patients
with active RTB are referred to CHUSP by other institutions. Results
will be presented by distinguishing HE referred from other institutions
to those HE entirely managed by CHUSP medical fellows. The
retrospective utilisation of a decision tree has increased sensibility of
RTB detection from 84% to 97%. Prospective evaluation of the tree is
required to test speciﬁcity.
P804 The inﬂuence of patient heterogeneities on healthcare-
associated infection, epidemic behaviour and control
J.V. Robotham, D.R. Jenkins, G.F. Medley (London, Leicester,
Coventry, UK)
Objectives: Mathematical models have shown patient movement
patterns to be important to healthcare-associated infection (HCAI)
epidemic behaviour. Increased understanding of patient and hospital
heterogeneities inﬂuencing these patterns would be of potential beneﬁt
for infection control. The objectives of this work are to: i) characterise
the patient population and describe their movements within a healthcare
network; ii) determine the consequences of these movements for HCAI
epidemic behaviour and control.
Methods: We analysed seven years of admission data from a UK
NHS Trust enabling us to fully characterise the demographics and
network of movements between the three hospitals comprising the Trust.
Consequences of these patterns for infection transmission and control
were explored using mathematical models of infection spread, using both
analytical and simulation-based methods.
Results: Despite most patients only visiting hospital a few times (40%
being seen only once), for the ﬁnal three years of data, readmitted
patients constituted nearly 80% of admissions (numbers were lower in the
ﬁrst four years, attributable in part to left censoring), with approximately
80% of these being within one year.
Readmissions varied between demographic groups; most notably young
women (21–30 yrs) and the elderly appeared to be ’core groups’
(the latter being a greater threat for HCAI). Analytical results showed
effective isolation of these patients on admission (or clearing carriage at
discharge) approximately halved their transmission potential.
Simulation results showed hospitals with the greatest number of
admissions and whose patients were most likely to be readmitted had
higher prevalences. Movement patterns were found to be critical to
control success. For example: in a setting where each patient has, on
average, 1.5 infectious admissions, admission screening has little beneﬁt;
whereas for an average of 2 infectious admissions, a strategy allocating
60% of its resources to screening the admission population is optimal.
Conclusions: Readmissions constitute a substantial proportion of the
admission population and their consideration is likely to be crucial to the
design of effective and cost-effective control strategies. Heterogeneities
in movement patterns between hospitals imply optimal control strategies
may vary between institutions. Future work will focus on investigation
of tailored control strategies that identify and target patients at high risk
of readmission.
P805 Scabies outbreak in an acute care setting involving 1,075
individuals
M. Buehlmann, H. Beltraminelli, C. Strub, X. Jordan, P. Itin, A. Widmer
(Basel, CH)
Objectives: Sarcoptes scabiei is an ectoparasite that causes either
sporadical or in institutional outbreaks. We report a large outbreak in
an University Hospital and a Rehabilitation Facility, that was controlled
only after several months by strict infection control measures (IC).
Methods: Setting: University Hospital: primary and tertiary care centre
with 750 beds, 39 intensive care unit (ICU) beds and 27,000 admissions
per year. Rehabilitation Facility: primary and tertiary care centre with
92 beds (8 ICU beds) for patients with complex disabilities, spinal cord
and brain injuries.
Epidemiological investigation: Scabies case deﬁnition: 1) positive skin
scrape or 2) dermatoscopy or 3) typical burrows without history of
prior scabicide treatment. Attack rate: The attack rate was deﬁned as
the number of symptomatic healthcare workers (HCW) in relation to
all HCW exposed to scabies, and was evaluated by a standardised
questionnaire.
Interventions: Individuals with scabies: treatment, contact precautions
until 24 hours after initiation of treatment. HCW in contact with index
case: preemptive treatment, including all household members (HM).
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Patients in contact with the index case or infected HCW: dermatological
examination, later preemptive treatment for all patients.
Results: In June 2007, a HIV patient was diagnosed with Norwegian
scabies (crusted scabies) after a 6 week hospitalisation in the ICU of an
University Hospital and consecutive transfer to a Rehabilitation Facility.
University Hospital: 4 HCW and 3 HM and no patients were diagnosed
with scabies within 9 weeks from June to August 2007. The attack rate
was 18% in HCW overall, 27% for HCW with direct contact to the
index case and 10% for HM. The outbreak was ﬁnished in August after
initiation of strict IC.
Rehabilitation Facility: No diagnosis of scabies was made at the
beginning of the outbreak. Two HCW, 2 HM and 2 patients were
diagnosed with scabies from July to September 2007 due to difﬁcult
implementation of IC. The attack rate of HCW was 3.9%, and 12.9%
for HCW with direct contact to the index case. The outbreak stopped
after simultaneous preemptive treatment of all HCW and patients in the
Rehabilitation Facility.
Overall, 1075 individuals underwent preemptive treatment.
Conclusions: Case ﬁnding during scabies outbreaks is impaired by
uncertain diagnostic tests in the early stage of disease. Therefore, in
a hospital setting, early broad preemptive treatment and strict IC are
essential for control.
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P806 Prevalence of nosocomial infections in Lithuania
R. Valinteliene, V. Jurkuvenas (Vilnius, LT)
Objectives: The main objective of the surveys was to determine
prevalence of nosocomial infections and risk factors in Lithuania.
Methods: Nation-wide point prevalence surveys of nosocomial infection
(NI) were undertaken in 2003, 2005 and 2007 in 39, 35 and 30 acute
hospitals correspondingly. Data were collected during bedside interviews
by the medical doctors recording current status of patient. CDC criteria
were used for NI diagnosis.
Results: There were app 8000 patients evaluated each year. The
prevalence of nosocomial infections revealed was in 2003 – 4.3%,
2005 – 3.4%, 2007 – 3.5%. Prevalence of hospital acquired infections
varied widely between departments wit top level in intensive care (app.
20%). It was clear tendency of increasing NI prevalence in nursing
departments, where NI prevalence in 2007 (6.3%) exceeded surgical
(4.6%) and trauma (5.5%) departments. The most prevalent NI were
those of respiratory tract, accounting (accounting up to 30.1–44.3% of all
NI) and surgical site infections (14.7–22.6%). Prevalence of risk factors
was signiﬁcantly higher in university hospitals compared to regional and
local in all three surweys, but there was no difference in nosocomial
infection prevalence rates.
Conclusion: Prevalence studies give the realistic view on NI problem,
allows to follow national NI tendencies and gives valuable data needed
for NI control.
P807 Increasing numbers of Rhodococcus infections at a large
university hospital NHS Trust, Nottingham – An investigation
S. Capewell, J. Palfreyman (Nottingham, UK)
Objectives: Towards the end of October 2003 an unusual organism
was grown from a number of paediatric blood culture bottles from
one of the children on the Oncology Ward at the Nottingham City
Hospital Campus. Routine Laboratory identiﬁcation Tests as to the
identiﬁcation and signiﬁcance of this Gram-positive organism were
inconclusive. The Reference laboratory subsequently identiﬁed the
organism as Rhodococcus sp. (not Rh. equi). The isolation of this type of
organism increased over the following months and it was decided that an
epidemiological investigation was required to ﬁnd the source of infection
and to prevent further outbreaks in a ward of vulnerable children.
Methods: A number of epidemiological methods were engaged to assess
the outbreak. These included a study as to where the patient came from, a
case assessment including time from line to infection, line usage, age and
sex, as well as what type of underlying disease. A review as undertaken
to see if this increase in infections caused by Rhodococcus sp. was
occurring elsewhere in the hospital or the United Kingdom. Finally
screening and environmental swabs were taken as well as a generally
survey of the ward.
Results: There were no conclusions or similarities to be drawn from the
case reviews or screening swabs. This increase in Rhodococcus infections
had not been noticed in any other areas of the hospital or elsewhere
within the region or country. On investigation of the Ward it was found
that the HEPA ﬁlters had never been changed. These were removed and
swabbed. Rhodococcus sp. was grown from 3 areas of the ﬁlters. Since
their removal no more cases have been seen at Nottingham University
Hospitals.
Conclusions: This was a nosocomial infection. The HEPA ﬁlters were
the source of the Rhodococcus sp. infections seen in the Oncology ward
at Nottingham University Hospital.
P808 Clinical and autopsy diagnosis of infectious diseases at an
Italian teaching hospital
M. Bonadio, G. Andreotti, G. Pieroni, M. Castagna (Pisa, IT)
Objectives: To evaluate the frequency of autopsy diagnosis of infectious
diseases and to compare clinical and autopsy ﬁndings of infectious
diseases at an Italian teaching hospital
Methods: A comparison of clinical and autopsy ﬁndings of cases studied
between january 2001 and march 2007 at the Department of Pathology of
Pisa hospital was made. A total number of 512 autopsies were performed
in adult patients; 318 patients males and 194 females; mean age 65.0
yrs ±15.4 SD. 160 patients died in medical wards, 115 in intensive care
units, 88 in surgical wards and 149 in emergency department. Particularly
201 cases with clinical diagnosis and/or autopsy diagnosis of infectious
conditions were evaluated.
Results: 15 (7.5%) out of 201 autopsies showed no evident ﬁndings of
infectious conditions while in the clinical diagnosis an infectious disease
was included. 186 (36.3%) autopsies (114 males, 72 females) out of
512, revealed ﬁndings of infectious conditions involving 1 or more site
of infection. Mean age of patients with autopsy ﬁndings of infectious
disease was 63.3 yrs ±14.5 SD. In 72 (38.7%) out of 186 cases with
autopsy ﬁndings of infections, no infectious diseases were diagnosed pre
mortem. Underdiagnosis was most common in lung infections.
In 31 cases a clinical diagnosis of sepsis or septic shock was made. In
23 of these one or more sites of infection were evidentiated at autopsy.
Infectious ﬁndings at autopsy included: pneumonia (n = 120), abdominal
S210 18th ECCMID, Posters
infections (n = 27), meningitis or encephalitis (n = 8), pulmonar and/or
extrapulmonary tubercolosis infections (n = 11), endocarditis (n = 15),
invasive fungal infections (n = 12), AIDS/HIV (n = 3), HCV severe
chronic hepatitis or cirrosis (n = 14), viral systemic infections caused
by Herpesviridae (n = 8), urinary tract infections such as kidney abscess
and acute pyelonephritis (n = 8).
Conclusions: These data underline the relative high frequency of
infectious diseases at autopsy. The number of cases with clinically missed
infectious conditions at autopsy was particularly high in lung infection
and endocarditis. This fact conﬁrms the difﬁculty in reaching a correct
and timely diagnosis for this kind of infections in critical ill patients.
P809 Estimating disease burden of healthcare-associated infections
in Finnish acute care hospitals
M. Kanerva, J. Ollgren, O. Lyytika¨inen (Helsinki, FI)
Objectives: Few population-based estimates of disease burden for
healthcare-associated infections (HAI) exist. We estimated the morbidity
and mortality related to HAIs based on the data from the national preva-
lence survey performed in 2005. We also evaluated the completeness of
the National Hospital Discharge Registry (HILMO) as a source of HAIs.
Methods: Data from the national prevalence survey constituted the basis
for the register linkage. The survey included all inpatients (n = 3234) in
acute care wards for adults in 30 hospitals. The Center for Disease
Control and Prevention (CDC) deﬁnitions for HAIs were used and
McCabe classiﬁcation for comorbidity. In total, 753 HAIs were recorded
in 703 patients (prevalence of HAI patients, 8.5%). Using the date of
the prevalence survey and the patient’s national identity code, data on
hospitalisations including International Classiﬁcation of Diseases (ICD)-
10 codes for discharge diagnoses were obtained from HILMO, and the
dates and causes of death from the National Population Information
System. The incidence of HAI was calculated by Rhame and Sudderth
formula using the prevalence (%), mean length of hospitalisations
and mean number of days before HAI onset. Using the incidence of
HAI and the 28-day case fatality of HAI patients in the prevalence
survey, the annual estimates were extrapolated from the total number of
hospitalisations in adult specialties in all Finnish acute care hospitals in
2005 (n = 304,456).
Results: In Finland (population, 5.2 million), we estimated that annually
a total of 48,267 hospitalisations in adult acute care wards ended up to at
least one HAI (9282 HAIs per million population) and 1514 patients with
HAI died within 28 days (291 deaths per million population); 62% of the
HAI patients who died did not have an ultimately fatal underlying disease
(181 deaths per million population). In 33% of the hospitalisations with
HAI, ICD-10 codes in HILMO indicated an infection. The proportions
of HAIs coded in HILMO varied according to the severity of HAI: from
53% of surgical site/organ space infections, and 45% of pneumonias to
6% in urinary tract infections.
Conclusions: Our disease burden estimates can be used in healthcare
planning and resource allocation. Notably, they did not cover paediatrics.
The sensitivity of discharge diagnoses to recognise HAIs was low, but
should not be overlooked as an additional case ﬁnding method, especially
for severe HAIs.
P810 National 14-year survey of nosocomial meningitis in children
and comparison of two periods, 1993–1998 to 1999–2006
B. Rudinsky, A. Ondrusova, P. Kisac, P. Beno, J. Miklosko,
P. Fedor-Freybergh, F. Bauer, M. Huttova, M. Sramka (Nove Zamky,
Bratislava, SK)
Introduction: In 1993–1998 and in 1999–2006 we have performed
2 surveys of paediatric bacterial meningitis in all 8 neurosurgery/
paediatrics and infectious diseases departments in Slovakia.
Patients and Methods: In a prospective multicentric observational
study, a prospective protocol was used to assess every case of meningitis
appearing in clinically hospital stay in 0–18 years old patients in all 8
paediatric neonatal or neurosurgery departments in Slovakia. At least one
positive CSF culture was involvement criteria. Mortality on infection,
and/or CNS sequel and treatment (surgery, antibiotics) were analysed.
Results: 171 cases were enrolled. Comparing the two periods in our
study of nosocomial meningitis 1994–1998 (A) to 1999–2004 (B) in
aetiology, Gram-negative aetiology was more frequent in the second
period (B) 40% vs. 2 5.3%, p<0.05). Vice versa fungi were more
frequently obtained in the ﬁrst period (8.7% vs. 2.0%, p<0.05). All
S. aureus were oxacillin (OXA) resistant
Concerning Gram-negative bacteria Acinetobacter baumannii (14 vs.
6.1%) and Pseudomonas aeruginosa showed emergence (8 vs. 5.2%).
Six (6) of 18 (30%) Enterobacteriaceae were cefepim resistant. Three
Ps. aeruginosa isolates of 9 were resistant to meropenem.
Analysing mortality, there was no signiﬁcant change in mortality among
two periods of time (14.0% and 14.1%, NS), however there was a
signiﬁcant decrease of neurologic complications (e.g. hydrocephalus,
palsy, epilepsy), in the 1999–2004 (29.9%) in comparison to 1993–1998,
(42.9%, p<0.01). In contrast to that, cerebral abscess as a complication
of meningitis appeared more frequently in 1994–2004 (14.3% vs. 3%,
p<0.02).
Conclusion: There were no major changes in aetiology of nosocomial
meningitis in children comparing 1993–1998 and 1999–2006, despite
there was a trend towards in the increase of Ps. aeruginosa and
Acinetobacter baumannii (9–12%), but the trend was only marginally
signiﬁcant for Gram-negative bacteria (35.5% vs 2 5.3%). Alarming
was the level of resistance to teicoplanin in coagulase negative
staphylococci – more than 10%. Mortality remains unchanged (12%
in 1999–2006 in comparison to 15% in 1993–1998), but the number
of neurologic sequellae decreased, probably because the proportion of
inappropriate treated cases decreased from 20% to 10.3%. Nosocomial
postoperative meningitis is still not a rare disease with 10–15% mortality
and should be effectively prevented, and if occurs, radically treated with
ATB.
P811 Risk factors and prognosis of external ventricular
drainage-related infection
E. Garcı´a-Cabrera, E. Jimenez-Mejı´as, J. Serra-Vich, J. Garcı´a de Chuz,
M. Portillo, V. Pintado, J. Colomina, G. Prats, J. Pacho´n-Diaz on behalf
of the Spanish Network for the Research in Infectious Disease (REIPI)
Objective: To study the risk factors associated to external ventricular
drainage (EVD) related infection.
Methods: Cohort study carried out since May 2004 to December 2006 in
six tertiary hospital of Spanish Network for the Research in Infectious
Diseases (REIPI). Inclusion criteria: Adult patients (14 years) with
EVD, during more than 24 h. Exclusion criteria: previous infection of
central nervous system (CNS) at catheter’s insertion day or death in
the ﬁrst 24 hours. All patients were followed until catheter withdrawal,
infection, or exitus. Cases with EVD-related infection (EVDRI) deﬁned
by: a) clinical features (fever, meningeal signs, low Glasgow coma scale
[< 14 or lower than previous status]); b) CSF ﬁndings (pleocytosis
100/UL, hipoglycorrachia < 40mg/dL or CSF/blood glucose ratio
<40%, and increased protein level > 100mg/dL); and c) microbiological
criteria (positive CSF Gram-stain, positive culture of CSF and/or
catheter’s tip). Patients without EVDRI were compared with cases. The
end-points were the EVDRI and exitus, and the independent variables
were: sex, age, diagnosis at admission, underlying diseases, prophylaxis,
concomitant infections, previous antibiotic treatment, and those related
to catheter use, including the need of catheter exchange. To control
the interaction/confusion between variables a model of binary logistic
regression adjusted by Wald test was used; signiﬁcant differences were
deﬁned as p< 0.05.
Results: 323 patients were included, the median of catheterisation time
was 10 days (2–88) days. The infection rate was 11.4% (37 patients).
Thirty-four (91.8%) were monomicrobial; aetiological agents: Gram-
positive cocci 17 (32.5%), Gram-negative rods 20 (50%), others 3
(7.5%). Independent risk factors associated to EVDRI were: age (OR
0.958, CI 95% 0.93–0.98); underlying disease (OR 2.80, CI 95% 1.11–
7.07); Apache II (OR 1.12, CI 95% 1.04–1.22); catheter exchange (OR
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9.58, CI 95% 3.14–29.20), prophylaxis at ﬁrst catheter (OR 0.20, CI
95% 0.07–0.66). The mortality rate was 24.3% in EVDRI group and
21% non-infected patients (p = NS).
Conclusions: EVDRI is affected by the need of catheter exchange,
the initial severity of patients, and comorbidity. Prophylaxis before
the insertion reduced the EVDRI. EVDRI is not associated to higher
mortality.
P812 Clinical signiﬁcance of nosocomial spontaneous bacterial
peritonitis in liver cirrhosis patients and impact of the 3rd
generation cephalosporin resistance of Gram-negative bacilli
on the outcome
H.S. Cheong, Y.M. Wi, E.S. Kim, C.I. Kang, D.R. Chung, K.R. Peck,
N.Y. Lee, J-H. Song (Seoul, KR)
Background: There have been few reports of the aetiologies and
treatment outcome for nosocomial spontaneous bacterial peritonitis
(SBP) in liver cirrhosis (LC) patients.
Objectives and Methods: We performed a retrospective cohort study
to compare the microbiological and clinical characteristics and outcome
between nosocomial and community-acquired SBP in LC patients. All
cases of SBP, in which culture was proven at Samsung Medical Center
from Jan. 2000 to Jun. 2007 were included. Medical records and
laboratory data were reviewed. Nosocomial SBP was deﬁned as SBP
diagnosed after 72 hours of hospitalisation.
Results: A total of 236 patients with SBP were enrolled (mean age,
56.6±10.7 years; male/female, 166/70). Nosocomial and community-
acquired SBP were 126 and 110 cases, respectively. Among 239
microorganisms isolated, Escherichia coli accounted for 43.2%, Kleb-
siella spp. 14%, Streptococcus spp. 9.7%, Enterococcus spp. 8.1% and
Staphylococcus aureus 5.1%. The overall mortality rate of nosocomial
SBP was higher than that of community-acquired SBP (58.7% vs.
37.3%, p = 0.001). Nosocomial isolates of Gram-negative bacilli (GNB)
were signiﬁcantly more resistant to 3rd generation cephalosporin (42.1%
vs. 10.0%, p< 0.001) and quinolone (30.9% vs. 50.0%, p = 0.003)
than community isolates. Multivariate analysis revealed that nosocomial
infection, concomitant hepatocellular carcinoma, presentation with
shock, elevated creatinine and resistance to 3rd generation cephalosporin
of GNB were signiﬁcant risk factors for the 30-day mortality in SBP.
Conclusions: Nosocomial SBP has a poorer outcome than community-
acquired SBP. The resistance to the 3rd generation cephalosporin of
GNB, which is more frequent in nosocomial SBP than in community-
acquired SBP, adversely affects the outcome of SBP in LC patients.
P813 Signiﬁcance of positive urine cultures during the immediate
post-trasnplant period in renal transplant recipients. A
retrospective study
M. Koukoulaki, I. Baraboutis, E. Platsouka, V. Papastamopoulos,
V. Hadjiconstantinou, O. Paniara, A. Skoutelis, S. Drakopoulos
(Athens, GR)
Purpose: Urinary tract infections (UTI) are the commonest bacterial
infections in renal transplant recipients. The study of UTIs in the
immediate post-transplant period is of particular importance (higher
degree of immunosuppression, presence of foreign bodies, exposure to
nosocomial pathogens). Purpose of this retrospective study was to audit
UTIs during the ﬁrst post-transplant month and identify potential risk
factors.
Patients and Methods: Renal transplant recipients with complete
urine culture (UC) and urinalysis data for the ﬁrst post-transplant
month (period of September 2002-September 2007) were included
in the study. All recipients, besides the induction therapy and triple
immunosuppressive regimen, were treated with prophylactic antibiotics,
namely intravenous cephotaxime for 10 days and then per os
ciproﬂoxacin for six weeks.
Results: 116 renal transplant recipients (mean age 50.6±9.7 years,
male gender in 74.1%) were studied. During the follow-up period
of one month, 50 positive UCs were identiﬁed, derived from 38
(32.7%) recipients. A total of 27 recipients had only one positive UC.
Urinalysis identiﬁed pyuria in 18 out of 38 recipients. Most frequent
pathogens were Gram(+) bacteria (22/50.44%) (Enterococcus faecalis
commonest), followed by Gram(−) bacteria (17/50.36%) (Pseudomonas
aeruginosa commonest) and fungi (11/50, 22%) (3 Candida albicans,
8 Candida non-albicans). Mean time of identiﬁcation of positive UC
was 14±4.7 days post transplantation. Preliminary statistical analysis
revealed signiﬁcant association of probability of a positive UC with
female gender (Pearson c2, p = 0.043) and cold ischaemia time (non-
parametric test Mann Whitney U, p = 0.005). When the analysis included
only the positive UCs accompanied with signiﬁcant pyuria (deﬁned
as 8–10 white cells/hpf), the above-mentioned associations were not
reproduced.
Conclusions: Positive UCs were observed in 32.7% of renal transplant
recipients, with Enterococcus faecalis and Pseudomonas aeruginosa
being the commonest pathogens. It should be emphasised that all patients
with positive UCs received speciﬁc antimicrobial therapy, irrespective
of symptoms or puyria, due to concerns for defective inﬂammatory
response. The issue of when to treat an isolated positive UC by a potential
pathogen in the immediate post-transplant period has not been resolved.
The probability of a positive UC in the ﬁrst post-transplant month was
related to female gender and cold ischaemia time.
P814 First results of ventilator-associated pneumonia results in
ﬁve Dutch hospitals
T.I.I. van der Kooi, B.H.B. van Benthem, J.C. Wille, J. Mannie¨n
(Bilthoven, Utrecht, NL)
Objectives: Since 2005 Dutch hospitals can participate in the PREZIES
surveillance of ventilator-associated pneumonia (VAP), in which the
incidence of VAP as well of that of several risk factors are registered.
These data are analysed to assess the most important risk factors in order
to feedback case mix-adjusted data to the hospitals.
Methods: Data are collected and infections diagnosed based on the
PREZIES-protocol, which is based on the CDC-deﬁnitions. Surveillance
ended when a VAP was diagnosed or after a maximum of 28 ventilation
days per period. Data were analysed with Cox regression.
Results: Five hospitals collected data on 457 ventilation periods (3098
ventilation days) with 411 patients. The average VAP incidence was
6.3% per ventilation period (9.4/1000 ventilation days). In univariate
analysis neurosurgery compared to general surgery (HR 4.1), position in
bed (supine compared to semirecumbent, HR 0.3) and SDD (HR 0.18)
were signiﬁcantly associated with the risk of VAP. Infection frequencies
differed signiﬁcantly per hospital. Therefore in multivariate analysis
these data were adjusted for hospital and also for non signiﬁcant risk
factors with a p-value < 0.2 (age group).
In multivariate analysis the VAP risk was signiﬁcantly higher for patients
with a mean daily sedation score of four or higher (HR 6.4, 95%CI 2.6–
15.7) and for patients on oropharyngeal prophylaxis (HR 16.7, CI 2.3–
118). The risk for patients who were treated with multiple dose inhalers
was lower, compared to those patients not treated with inspiratory
medication (HR 0.36, 0.15–0.91). The interpretation of the results is
hampered by the frequent presence of collinearity.
Most frequent organisms were Klebsiella pneumoniae (24%), Pseu-
domonas aeruginosa (13%), Haemophilus inﬂuenzae (11%) and
Staphylococcus aureus (11%). In 9 of 29 cases two micro-organisms
were cultured.
Conclusion: Oropharyngeal prophylaxis, the use of multiple dose
inhalers and the average daily sedation score were signiﬁcantly associated
with the VAP incidence.
P815 Frequency and predictors of ventilator-associated pneumonia
recurrence: a meta-analysis
I. Siempos, Z. Athanassa, M. Falagas (Athens, GR)
Objective: Large clinical series focusing on the risk factors associated
with recurrence after the onset of an initial episode of ventilator-
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associated pneumonia (VAP) produced inconsistent results. A meta-
analysis would be helpful to shed light on the issue. To estimate the
frequency of VAP recurrence and to identify risk factors associated with
it.
Methods: PubMed, Scopus, Current Contents and references of retrieved
articles were searched, without language restrictions. Pooled odds ratios
(OR) and 95% conﬁdence intervals (CI) were calculated by using both
the Mantel–Haenszel ﬁxed-effect and the DerSimonian-Laird random
effects models.
Results: The overall frequency of VAP recurrence in 1,166 patients of
the nine eligible reports was 23.7%. Among the twenty evaluated risk
factors, only inappropriate empirical treatment (OR=1.99; 95%CI 1.06 –
3.72), acute lung injury/acute respiratory distress syndrome (OR=1.76;
95%CI 1.12–2.75) and shock (OR=1.55; 95%CI 1.01–2.41) at the day of
diagnosis of the ﬁrst VAP episode were found to be associated with VAP
recurrence. There was also evidence, albeit inconsistent, that severity of
illness at ICU admission was associated with VAP recurrence.
Conclusion: Recurrence involves almost one in four cases of VAP
and is associated with inappropriate empirical treatment, acute lung
injury/acute respiratory distress syndrome and shock, but not with ﬁrst-
episode causative pathogens. Recognition of these predictors may permit
the timely implementation of measures to prevent recurrence of VAP.
P816 Closed tracheal suction systems for prevention of
ventilator-associated pneumonia
I. Siempos, K. Vardakas, M. Falagas (Athens, GR)
Objective: By meta-analysis of randomised controlled trials (RCTs), we
assessed the evidence that closed tracheal suction systems (TSS) prevent
ventilator-associated pneumonia (VAP).
Methods: We searched PubMed and Cochrane databases to identify
RCTs that compared closed with open TSS for the management of
mechanically ventilated (MV) patients.
Results: Nine RCTs were included in the meta-analysis. There was
no difference on VAP incidence between patients managed with closed
and open TSS [odds ratio (OR) = 0.96, 95% conﬁdence intervals (CI)
0.72−1.28]. There was no heterogeneity among the eligible trials (I2=
0, 95%CI 0−0.65). The compared groups did not differ on mortality
(OR= 1.04, 95%CI 0.78−1.39) and on intensive care unit (ICU) length
of stay (one RCT: 12.3 ± 1.1 vs 11.5 ± 1.4 days, and the other RCT:
15.6 ± 13.4 vs 19.9 ± 16.7 days). Suctioning with closed systems was
associated with longer MV duration (weighted mean differences: 0.65
days, 95%CI, 0.28−1.03) and higher colonisation of the respiratory tract
(OR= 2.88, 95%CI 1.50−5.52) than open TSS.
Discussion: The available evidence suggests that closed as opposed to
open TSS usage did not provide any beneﬁt on VAP incidence, mortality,
or ICU stay of MV patients.
P817 Opinions of intensivists and nurses towards use of selective
decontamination of the digestive tract and selective
oropharyngeal decontamination
I.P. Jongerden, A.M.G.A. de Smet, J.A.J.W. Kluytmans, M.J.M. Bonten
(Utrecht, Breda, NL)
In the past decades, use of Selective Decontamination of the Digestive
tract (SDD) and Selective Oropharyngeal Decontamination (SOD) has
been object of discussion. From May 2004 to July 2006, a large group-
randomised, controlled cross-over multi-centre study (13 hospitals) was
performed in the Netherlands, in which the effects of SDD and SOD
as compared to standard care, were determined on patient survival and
antibiotic resistance. As part of this trial, assumptions by intensivists
and nurses on effect of SDD and SOD, as compared to standard care,
were studied, and the inﬂuence of these assumptions on compliance to
the study protocol was determined.
Questionnaires were developed, based upon semi-structured interviews,
to inventarise experiences of intensivists and nurses with SDD and SOD,
and to inventarise assumed effect. Furthermore physicians were asked
to appraise current and expected (after application of SDD) mortality
rate in the included patient group. In the last week of each six month
study phase, during 24 hours, all nurses and physicians received the
questionnaire, which could be ﬁlled in anonymously.
Divided over three studyperiods, 1024 questionnaires were returned by
nurses and 253 by physicians. Expectations on effect of SDD increased as
the study proceeded, both in nurses and physicians. Physicians expected
less reduction in mortality when using SDD, as compared to SOD and
standard care(signiﬁcant difference). The assumed relative reduction in
mortality as appraised by physicians raised as the study proceeded.
Application of SDD was considered time consuming and annoying for
patients, but increasingly effective.
P818 Risk factor analysis of deep sternal wound infections after
cardiac surgery
K. Graf, D. Sohr, A. Haverich, A. Kola, P. Gastmeier, I.F. Chaberny
(Hannover, Berlin, DE)
Objective: Deep sternal wound infections (DSWI) represent a severe
problem in cardiac surgery. We observed an increasing incidence of
DSWI in our university hospital in the period from January 2006 to
September 2007. Therefore a case control study was performed to
identify signiﬁcant risk factors.
Methods: All cases of DSWI were recorded using CDC deﬁnitions over
a 21 months period. All patients directly operated following a case patient
were considered as control patients as long as they did not develop
a surgical site infection. The following risk factors were recorded for
each case and control patient: diabetes mellitus, BMI >25, COLD, renal
insufﬁciency, nicotine abuse, immune suppression, preoperative exposure
time, ASA-score, risk class stratiﬁcation; date and duration of operation,
time at extra corporal circulation, antibiotic prophylaxis, preoperative,
intraoperative and postoperative serum blood glucose level, duration of
mechanical ventilation, length of stay on ICU and in hospital. Univariate
and multivariate analyses were performed.
Results: During the study period a total of 120 adult patients (72=male,
48= female) who underwent coronary artery bypass grafting (n= 91)
or other cardiac surgery (n = 39) developed DSWI. On average the
DSWI symptoms revealed 25 days after operation. Isolates cultured
most often showed S. epidermidis (25%), followed by MRSA (19%),
enterococci (14%), S. aureus (12%), coagulase-negative staphylococci
(10%) and others (20%). The multivariable logistic regression model
identiﬁed age greater than the median age of 68 years (OR 2.19; CI95
1.20–4.06), diabetes mellitus (OR 5.36; CI95 1.35−5.36), nicotine abuse
or immune suppression (OR 5.46; CI95 1.91–17.58) and intraoperative
blood glucose > 8mg/dl (OR 2.27; CI95 1.17−4.42) as signiﬁcant risk
factors for DSWI. Preoperative antibiotic prophylaxis (OR 0.31; CI95
0.13−0.70) and extubation on the day of operation (OR 0.25; CI95
0.11−0.55) had a protective effect.
Conclusions: Our data mainly conﬁrm the results of previous risk factor
analysis. These ﬁndings should assist clinicians in identifying patients
who are at increased risk of DSWI, as well as in developing strategies
to minimise modiﬁable risks.
P819 Impact of skin and skin structure infections on hospital
length of stay, mortality and costs: a matched cohort analysis
K.S. Akhras, S. Lin, A. Quintana, H.T. Hatoum (Raritan, Chicago, US)
Introduction: Skin and skin structure infections (SSSIs) are among
the most common nosocomial infections. Given the high prevalence of
SSSI infections, the potential economic impact from a health system
perspective is considerable. Little is published in the literature on the
impact of SSSI infections using real-world data.
Objective: To estimate excess hospital length of stay (LOS), mortality
and costs attributable to SSSI.
Methods: Retrospective matched cohort study using Thomson Med-
STAT data from the United States from 2001 to 2005. Patients 18 years
of age, hospitalised 2 days with a secondary diagnosis of SSSI were
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identiﬁed using ICD-9 codes and were matched with a control cohort
of non-SSSI hospitalised patients using principal diagnosis, age, gender,
and admission time frame as criteria. Up to 4 matched controls were
randomly selected for each eligible SSSI case. Outcomes variables were
LOS, total hospitalisation charges, and mortality. Fixed effect models
and conditional logistic regression were used to analyse outcomes.
Results: Among the 1,472,965 hospitalisations, 23,681 cases were
identiﬁed with secondary diagnosis of SSSI and matched with 90,235
patients (control). Cellulitis/abscess was most common (66.6%) followed
by surgical site infections (21.6%), osteomyelitis (8.3%) and diabetic
foot infections (2.8%). Microbiologically evaluable patients accounted
for 11.7% of cases. Mean and median unadjusted LOS and charges
for SSSI cases were 11.4 and 8 days and $51,311 and $27,942
compared with 6.3 and 4 days and $29,883 and $16,919 for controls.
Regression models on LOS and total charges to adjustment for potential
confounding variables, including frequency and number of therapeutic
and diagnostic procedures performed, showed that SSSI cases incurred
an additional 3.81 hospital days and $14,671. Similarly, adjusted odds-
ratio of mortality between cases and control was 1.31 (95%CI 1.21–
1.42) indicating an increased mortality risk in hospitalised patients with
SSSIs as secondary diagnoses.
Conclusion: SSSI is associated with signiﬁcantly higher LOS, total
charges and mortality. Given the high number of SSSI that occur
annually, the burden on the health system is considerable. More effective
means to prevent or to treat SSSI will most likely be cost-saving.
P820 Outcomes and costs associated with monomicrobial and
polymicrobial pathogens in patients with skin and skin
structure infections
K.S. Akhras, S. Lin, A. Quintana, H.T. Hatoum (Raritan, Chicago, US)
Introduction: Although skin and skin structure infections (SSSIs)
are caused predominantly by Gram-positive pathogens, polymicrobial
infections and multidrug-resistant (MDR) pathogens are becoming a
growing concern. Little is published about outcomes associated with
monomicrobial versus polymicrobial SSSI.
Objective: To compare length of hospital stay (LOS) and hospital
charges associated with monomicrobial and polymicrobial infections in
patients with SSSI.
Methods: This retrospective analysis used Thomson MedSTAT data
from the United States from 2001 to 2005. Patients 18 years of
age hospitalised 2 days with a primary or secondary diagnosis of
SSSI were identiﬁed using ICD-9 codes. Microbiology data were used
to classify patients into microbiologically evaluable (ME) and non-
microbiologically evaluable (non-ME). ME patients with infections were
further classiﬁed into Gram-positive, Gram-negative, monomicrobial,
and polymicrobial infections. Outcomes variables were LOS, total days
of IV antibiotics and total hospitalisation charges.
Results: Of the 1,472,965 hospitalisations, 44,743 cases were identiﬁed
as SSSI of which 5403 (12.1%) were ME. The overall unadjusted mean
and median LOS and total charges for SSSI cases were 9.4 and 6 days
and $40,150 and $ 20,911. Overall mean days of IV antibiotics therapy
was 8 days. The table reports results by pathogen type for ME SSSI
cases.
Unadjusted LOS and total hospitalisation charges by pathogen type
Monomicrobial* Polymicrobial*
Gram-positive Gram-negative All polymicrobial
N = 2889 N = 907 N = 1607
LOS, mean (median) 9.3 (6) 9.9 (7) 14.9 (8)
Antibiotics therapy days, mean 8.2 8.3 11.0
Total charges, mean (median)* $37,684
($19,053)
$42,001
($20,771)
$68,538
($26,789)
*Not all patients had charge data available.
Conclusion: In this large database, SSSI type infections caused by
polymicrobial pathogens were associated with longer LOS, longer
treatment duration with IV antibiotics, and higher total charges compared
with monomicrobial infections.
P821 The epidemiology of hospitalised cases of skin and soft tissue
infection in Europe
S. Pulgar, M. Mehra, A. Quintana, A. Kempel (Raritan, US;
Freiburg, DE)
Objectives: Data on complicated skin and soft tissue (SSTI) infections
are scarce and a comprehensive assessment of all segments of
SSTIs is not available. Therefore, the purpose of this study was to
provide a thorough overview and in-depth insight to the burden of
SSTI (distinguishing between community- and nosocomially-acquired
infections) in European countries based on a detailed analysis of available
statistical data, surveys and publications.
Methods: A multi-step approach using country-speciﬁc hospital
discharge and surveillance data and data derived from a literature
review were chosen to analyse the burden of SSTI in France, Germany,
Italy, Spain and the UK. Relevant publications were identiﬁed through
MEDLINE search of the medical literature (2000–2007) using the terms
abscess, cellulitis, wound infection, ulcer wounds, skin and soft tissue
infections. Annual hospitalisations for infections (cellulitis, abscesses,
cysts) and underlying diseases susceptible to SSTI (burns, diabetic
complications, decubitus ulcers, trauma) were extracted from annual
country-speciﬁc hospital discharge surveys. Incidence rates for surgical
site infections were obtained from the 2005 Hospital in Europe Link for
Infection Control through Surveillance (HELICS).
Results: The analysis resulted in an estimated number of 1.3 million
hospitalised SSTIs in 2004 in the EU-5. Of these, more than 25% were
nosocomially acquired skin infections, while the majority of SSTIs were
community-acquired or acquired in long-term care facilities. The largest
proportion of all hospitalised SSTIs were cellulitis amounting to 52.7%
of all SSTI, followed by surgical site infections with 15.8%, diabetic
skin infections amounting to 15.3%, decubitus ulcer infections to 12%,
traumatic wound infections (burns, fractures, other open wounds) to
4.2%.
Conclusion: These ﬁndings highlight the burden of SSTIs and associated
underlying conditions in Europe. The summarised overview on all
segments of SSTIs provides a better understanding of the large number
of SSTIs and their origin.
P822 Post-operative bacterial meningitis: a 2-year study in a
neurosurgery department
E. Samaras, M. Varvarou, E. Vartzioti, K. Bakopoulos, G. Bethimoutis,
I. Stergiou, V. Varsos (Athens, GR)
Introduction: Post-operative bacterial meningitis is deﬁned by a positive
CSF culture in patients with clinical and laboratory ﬁndings indicative of
meningitis and is associated with a wide variety of conditions requiring
neurosurgical management.
Material and Methods: 745 patients who were operated on due to
craniocerebral injury (CCI) or non-traumatic pathology (Non CCI) in
the Neurosurgery Department of “Red Cross” Hospital, Athens, in the
period 2005–2006. Meningitis, was diagnosed in 18 patients (14 male, 4
female), mean age 49.06 years. The records of patients were Statistical
analysed by the statistical package SPSS 13 for Windows.
Results: Post-operative bacterial meningitis was observed in 2.4% (18)
of the patients. The incidence rates meningitis among patients with CCI
and those without CCI were 4.31% and 2.07%, respectively. Among
patients with CCI, mortality reached 20%, while death was the ﬁnal
outcome of post-operative meningitis in 30.77% of the patients with
non-traumatic pathology.
The mean age of patients who recovered fully was 46 years and that of
patients who eventually died was 56 years..Age forms an independent
prognostic factor for the outcome of postoperative meningitis (p<0.05).
In decreasing order of frequency, the isolated pathogens were as
follows: Acinetobacter baumannii, Staphylococcus spp., Enterococcus
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spp., Enterobacter spp., Pseudomonas aeruginosa, Alcaligenes faecalis,
Corynebacterium. Eleven patients developed meningitis during their stay
in ICU. Of these, 5 eventually died (45.45%). Mortality among patients
stay in the Neurosurgery department was zero. Patients stay in ICU as
a result to bad clinical-physical status they presented the worst outcome
to post operative meningitis (p<0.05).
Conclusions: (1) Age was shown to be a statistically signiﬁcant
determinant of survival among those who developed post-operative
meningitis (p<0.05). (2) The ﬁnal outcome is worse in patients
staying longer in ICU (p<0.05), compared to patients managed in the
neurosurgery department. (3) The post-operative day that a CSF culture
becames positive was not related to the ﬁnal outcome of the CNS
infection. (4) The incidence of resistant microbes mainly Gram(−) is
increased.
P823 Treatment of joint prosthesis infection according to current
recommendations improves outcome
B.Y. Betsch, S. Eggli, K.A. Siebenrock, M.G. Ta¨uber, K. Mu¨hlemann
(Berne, CH)
Objective: Evaluation of recently recommended treatment modalities for
prosthetic joint infection (PJI).
Methods: A retrospective cohort analysis of 68 patients with PJI of hip
or knee treated between 1995 and 2004 was conducted at the University
Hospital Bern (Bern, Switzerland).
Results: A two-stage exchange was the most frequently (75%) surgical
strategy, followed by retention/debridement (17.6%), one-stage exchange
(5.9%), and resection arthroplasty or suppressive antimicrobial treatment
(1.5%). The chosen strategy was in 88% in agreement with the
recommendations. Adherence was only 17% for retention/debridement
and 0% for one-stage-exchange. Most (84%) of PJI were treated with
an adequate or partially adequate antimicrobial regimen. Recurrence
free survival was observed in 51.5% of PJI episodes after 24 months
follow-up. The risk of failure was signiﬁcantly higher in PJI with a
surgical strategy other than recommended (Hazard ratio (HR) 2.34, 95%
conﬁdence interval (CI) 1.10−4.70, p = 0.01), and in PJI with antibiotic
treatment not corresponding with recommendations (HR 3.45, CI 1.50–
7.60, p = 0.002). Other risk factors associated with lack of healing were
a high infection score at the time of diagnosis (HR 1.29, CI 1.10−1.40,
p<0.001) and presence of a sinus tract (HR 2.35, CI 1.10−5.0, p = 0.02).
Conclusions: Our study demonstrates the value of current treatment rec-
ommendations. Inappropriate choice of conservative surgical strategies
(such as debridement and retention) and inadequate antibiotic treatment
are associated with failure.
P824 Tolerability of prolonged linezolid-rifampicin combination
in bone joint infection: a retrospective study
L. Legout, X. Lemaire, S. N’guyen, H. Dezeque, C. Loez, M. Caillaud,
E. Beltrand, H. Migaud, L. Dubreuil, Y. Yazdanpanah, E. Senneville
(Tourcoing, Lille, FR)
Background: High clinical success rate has been reported in patients
(pts) treated with prolonged linezolid therapy (PLT) for bone joint
infection (BJI) but bone marrow toxicity, especially anaemia, occurred
in up to 25% of pts. Recently, a 35% decrease in the serum linezolid
concentration was observed after the administration of 600mg of
rifampin due to a hypothetic increase in intestinal secretion of linezolid.
Objective: To assess whether linezolid-rifampicin combination (LRC)
therapy reduces bone marrow toxicity compared with linezolid
monotherapy or other linezolid combinations in patients with BJI.
Methods: Medical charts for pts with BJI treated with linezolid for
at least 4 weeks were reviewed. Frequency of bone marrow toxicity
events was assessed in pts treated with LRC and in those treated with
linezolid monotherapy or other linezolid combinations. Anaemia was
deﬁned as haemoglobin value < 9.0g/dl, leukopenia as a total leucocyte
count <4×109/L, and thrombocytopenia as a platelet count <100×109/L.
Results: 94 pts of mean age 53.5 ±17 years (range 18–94) treated
for BJI (devices infection = 37%, chronic osteomyelitis=33%) between
1999 and 2006 were eligible for the study. Comorbidities included
diabetes mellitus (27.6%), alcoholism (9.6%) and chronic renal failure
(6.4%). 43 pts (44.8%) were treated with LRC, 25 (26.6%) with linezolid
monotherapy and, 28 (29.7%) with other linezolid combinations. Surgery
was required in 75 pts (79.78%). Culture of intraoperative samples
and bone biopsy (122 microorganisms) were positive in 91pts (96.8%)
[(meticillin resistant Staphylococcus aureus: 38 (31%), coagulase
negative staphylococci: 46 (37.7%), others Gram-positive bacteria:
21 (17.2%), Gram-negative bacilli: 12 (9.8%), anaerobes: 5 (4%)].
Polymicrobial infections were seen in 21 pts (22.34%). Demographic
characteristics were comparable between pts treated with either LRC
or other linezolid regimens. Anaemia was recorded in 5 of the 43
LRC pts (11.6%) and, in 22 of the 51 pts (43%) treated with other
linezolid regimens (p= 0.001). The mean delay from onset of anaemia
and initiation of linezolid therapy was 13.4 ±8.7 weeks in LRC pts
and 9.5 ±4.3 weeks in the other pts (p = 0.001). 21/27 (77.8%) had to
stop linezolid therapy and 15 of them had to be transfused. No other
haematological adverse events were recorded.
Conclusion: PLT for BJI resulted in less anaemia episodes when it was
combined with rifampin than when it was used in either monotherapy
or other combinations.
P825 Risk factors and surgical site infection in a tertiary care
hospital in Greece
A. Masgala, G. Nikolopoulos, Z. Touloumis, V. Schizas, C. Dervenis,
T. Kakavoulis (Athens, GR)
Objectives: To estimate the risk factors for surgical site infection (SSI)
in the surgical wards of a tertiary care hospital in Greece.
Materials and Methods: In two surgical wards of 33 beds each,
a total of 41 patients with surgical infections were recorded during
the period 1/7/07 to 30/11/07. We applied logistic regression models
to examine the effect of the following risk factors on the type of
infection: underlying diseases (cardiac failure, diabetes mellitus, renal
failure, respiratory failure, neoplastic disease, connective tisue disease,
malnutrition, obesity, liver insufﬁciency), smoking, alcohol consumption,
medications (chemotherapy agents, corticosteroids, others), American
Society of Anesthesiologists (ASA) score, type of anaesthesia, type of
surgery, duration of surgical procedure, postoperative time in Intensive
Care Unit (ICU) and time on ventilator.
Results: Among 41 patients with surgical infections, 26 were males
(63.41%) and 15 were females (36.59%) while the mean age was 62.02
years. Totally, 22 had SSI (53.66%), 3 had pneumonia (7.32%), 3 had
bacteraemia (7.32%), 2 had intraabdominal abcesses (4.88%), 3 had
pneumonia plus intraabdominal abcesses (7.32%), 1 had bacteraemia
plus SSI (2.44%), 2 had central catheter infection plus SSI (4.88%),
1 had SSI plus intraabdominal abcess (2.44%), 1 had pneumonia plus
bacteraemia plus SSI (2.44%), 1 had pneumonia plus SSI plus central
catheter infection (2.44%), 1 had bacteraemia plus SSI plus central
catheter infection (2.44%), and 1 had pneumonia plus bacteraemia plus
SSI plus central catheter infection (2.44%).
Using logistic regression analysis, we found that only postoperative time
in ICU or time on ventilator can increase almost 10 fold the risk of
acquiring any surgical infection other than SSI (Odds ratio:10.8, 95%
Conﬁdence Interval:2.01–58.10).
Conclusion: More than half of the patients in this study experienced a
surgical site infection. Postoperative time on ICU and time on ventilator
affected signiﬁcantly the type of infection.
P826 Arthroscopic knee surgery: postoperative wound infections,
antibiotic prophylaxis and preoperative hair removal. Data
from AMBU-KISS
E. Meyer, E. Ingenhoven, R. Babikir, M. Dettenkofer (Freiburg,
Neuss, DE)
Objectives: In 2002, a database was set up within the context
of the project AMBU-KISS (surveillance of surgical site infections
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in ambulatory surgery) to document post-operative wound infections
occurring in ambulatory surgical centres located in hospitals and medical
practices. Reference data are compiled on internal quality assurance and
contribute to the control of surgical site infections (SSI).
Methods: A SSI is diagnosed according to CDC criteria either during
post-operative surveillance by the surgeon himself or by another
doctor or family doctor. The reference data are made available to the
participants in anonymous form every six months. Furthermore, AMBU-
KISS participants were interviewed about perioperative prophylaxis and
preoperative hair removal.
Results From 10/2002 to 6/2007, we received results from 101 centres
performing arthroscopic knee surgery. A total of 71 infections occurred
after 73,165 surgical interventions. The mean incidence was 0.08, i.e. 8
infections occurred after 10,000 operations. 40 centres completed the
questionnaire. 36/40 participants removed the hair of their patients,
mostly with razors (32/36) and immediately prior to surgery (31/36).
24/40 centres did not give perioperative prophylaxis, whereas 16/40
administered antibiotics for selected patients. 13/16 preferred 1st or 2nd
generation cephalosporins as single shot (12/16) prophylaxis and applied
them before incision (14/16). However, 4 centres administered antibiotics
for 3−6 days post surgery or the evening before surgery (2/16).
Conclusions: The AMBU-KISS protocol is suitable for assessing and
deﬁning the magnitude of surgical site infections in ambulatory surgery,
in which setting they were shown to be very low. However, there is still
room for improvement with respect to the implementation of infection
control guidelines. Guidelines do not recommend routine hair removal. If
shaving is necessary for technical reasons, clippers instead of razors are
recommended. More frequent use of broad spectrum prophylaxis than
applying a single shot is not only useless but costly and may give rise
to bacterial resistance. Generally, there is no evidence to support the use
of antibiotic prophylaxis in arthroscopic knee surgery. Therefore, it is
imperative that antibiotic prophylaxis be restricted to high-risk patients
all the more in an ambulatory setting with very low infection rates.
P827 First case series of post-operative ocular infection due to
Streptococcus dysgalactiae ssp. equisimilis in humans
S. Preziuso, J. Kaliamurthy, P.A. Thomas, V. Cuteri (Matelica, IT;
Tiruchirapalli, IN)
Clinical infection due to Streptococcus dysgalactiae ssp. equisimilis
(S. equisimilis), including primary bacteraemia, pneumonia, endocarditis,
arthritis, and streptococcal toxic shock syndrome are increasing;
however, there has hitherto been only one report of ocular infection.
In the present report, infection due to S. equisimilis is described in three
immunocompetent patients after ocular surgery and in one theatre nurse.
The three patients had a history of uncomplicated small incision cataract
surgery with posterior chamber intraocular lens implantation. They
developed pain and reduced vision in the operated eye 48 hours after
surgery. On examination the affected eyes revealed dense peripheral
corneal inﬁltrates with exudates in the anterior chamber. Gram-stained
smears of vitreous ﬂuid samples revealed numerous Gram-positive cocci
in pairs and short chains, culture of these samples grew beta-haemolytic
streptococci provisionally identiﬁed as Streptococcus dysgalactiae ssp.
equisimilis by biochemical methods. The identiﬁcation was conﬁrmed
by PCR for a 16S rRNA sequence speciﬁc to the species S. dysgalactiae
and for a sequence of the streptokinase precursor gene speciﬁc to human
isolates of the subspecies equisimilis.
Intravitreal cefazolin and amikacin along with topical oﬂoxacin and
tobramycin for a few days resulted in resolution of infection in the
patients.
The organism was also isolated from a throat swab sample collected
from a 35-year-old healthy nurse who had assisted at the three surgeries.
The nurse did not give a history of systemic infection and had no signs
of upper respiratory tract infection or other diseases.
This is the ﬁrst case series of postoperative ocular infection due to
S. equisimilis. The infection may have been transmitted during surgery
or the healthy carrier (theatre nurse) may also have transmitted the
infection. Epidemiology of this organism is probably undervaluated
and antibiotic treatment without bacterial identiﬁcation is often done.
Bacterial culture and identiﬁcation by PCR followed by antimicrobial
sensitivity testing are recommended in order to better investigate the
spread and pathogenic potential of S. equisimilis and to evaluate the risk
of nosocomial infections due to asymptomatic carriers.
P828 The effect of 3rd generation cephalosporin use restriction
on antimicrobial resistance and clinical outcomes among
intensive care unit patients
Y.B. Seo, H.J. Cheong, W.S. Choi, J. Lee, J.Y. Song, W.J. Kim (Seoul, KR)
Objectives: The primary goal of this study was to evaluate the
effect of 3rd-generation cephalosporin restriction policy on the changes
of the antimicrobial usage among patients admitted to ICU. The
secondary goal was to investigate the changes of meticillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci
(VRE) colonisation rate. The third aim was to analyse the differences
of the isolation rate of MRSA, VRE, 3rd-generation cephalosporin
resistant Acinetobacter baumannii, extended spectrum b-lactamase
(ESBL) producing Escherichia coli and Klebsiella pneumoniae from
clinical specimens between pre- and post-restriction period. The fourth
aim was to estimate the impact on clinical outcomes of patients,
including hospital day, infection-related mortality and medical expenses.
Methods: This study was conducted between February 2006 and January
2007: a cross-sectional study with intervention measures. All patients
admitted to the intensive care unit were eligible for investigation. Third-
generation cephalosporin use restriction program was implemented at
March 20, 2006. We compared the differences of antibiotic usage,
bacterial resistance and clinical outcomes of patients between 1 month
before restriction and after 8 months.
Results: Seventy-four percent reduction in cephalosporin use was
observed after 3rd-generation cephalosporin restriction. This was
accompanied with increments of piperacillin-tazobactam (781.3%) and
4th-generation cephalosporin (417.1%) use. There was no signiﬁcant
difference in colonisation rate of MRSA and VRE. The isolation rates
of MRSA, VRE, 3rd-generation cephalosporin resistant A. baumannii,
ESBL-producing E. coli and K. pneumoniae from clinical specimens
of sputum and urine did not show signiﬁcant differenc, while those
from blood and CSF were positively correlated with the usage of 3rd-
generation cephalosporin. In clinical outcomes, the infection-related
mortality and the length of hospotal stay were not different. However,
medical expense was decreased signiﬁcantly.
Conclusion: Despite the signiﬁcant decrease of 3rd-generation
cephalosporin consumption after restriction policy, the bacterial re-
sistance patterns remained unchanged. In clinical outcomes, medical
expense was decreased signiﬁcantly. Restriction of 3rd-generation
cephalosporin was demonstrated to be efﬁcient in the view of decreased
invasive infections and economics among patients of ICU.
P829 Beneﬁt of a single preoperative dose of antibiotics in a
Sub-Saharan district hospital: minimal input, massive impact
F. Saxer, A. Widmer, J. Fehr, I. Sooka, P. Kibatala, H. Urassa,
H. Mshinda, R. Frei, T. Smith, C. Hatz (Basel, CH; Ifakara, TZ)
Objective: To evaluate the impact of a single shot preoperative
antimicrobial prophylaxis in reducing the rate of surgical site infections
(SSI) in an African hospital with very limited resources we implemented
standardised guidelines with one dose of Amoxicillin/Clavulanic Acid
within 2 hours prior incision.
Methods: In this rural district hospital in southern Tanzania an average
of 150 surgical interventions is performed in two operating theatres every
month. Ventilation is achieved by a defective air condition and open
windows. Household soap is used for scrubbing.
Instruments are reprocessed by either heat (150ºC for 1 h) or steam
(134ºC for 5min, temperature sensitive devices at 121 ºC for 20min);
a chemo-indicator is in use with every sterilisation process.
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In a four month period in 2004, patients admitted for clean or clean-
contaminated interventions had been included as pre-intervention group.
The perioperative management differed depending on the surgeon.
Patients admitted in the same setting in 2005 were enrolled as
intervention group. They received one dose of 2.2g Augmentin® as
intravenous infusion within 2 hours before incision. The substance
was targeted at the bacteriologic pattern detected in SSIs of the pre-
intervention group.
Patients were assessed daily and 30 days postoperative; in case of SSIs
they received free diagnostic workup and treatment. Infections were
identiﬁed according to the CDC classiﬁcation; samples were analysed
by Gram stain and agar (CHROMagar Orientation and CHROMagar
S. aureus) in the local laboratory and the University Hospital Basel using
standard methods. Data were reviewed by a senior infectious diseases
specialist with full chart review.
Results: In the pre-intervention group 527 patients qualiﬁed for routine
antimicrobial prophylaxis that was administered in 88% after incision
and did not cover the expected pathogens to a large extent. One hundred
and fourteen patients (21.6%) developed an SSI with 60% of detected
pathogens being resistant to the administered antibiotics.
After implementation of the guidelines, the incidence of surgical site
infections signiﬁcantly decreased from 21.6% to 4% (11/276).
Conclusions: The implementation of a single shot antimicrobial
prophylaxis dramatically decreased the rate of surgical site infections
in a hospital with very limited resources. Such guidelines – though
developed for industrialised countries – are even more effective in non-
industrialised countries.
P830 Peritoneal dialysis-associated peritonitis: clinical features
and predictors of outcome
D.P. Kofteridis, A. Valachis, K. Perakis, G. Papazoglou, K. Stylianou,
E. Daphnis, G. Samonis (Heraklion Crete, GR)
Objectives: To identify epidemiological, clinical and microbiological
factors affecting the outcome of patients with peritoneal dialysis (PD)-
associated peritonitis
Materials and Methods: All of patients with PD-associated peritonitis,
admitted to the University Hospital of Heraklion, Crete, Greece from
1990 to 2007 were identiﬁed and their charts were retrospectively
studied.
Results: A total of 247 episodes of PD-associated peritonitis occurring
in 82 patients have been evaluated. The median age of patients was 68
years (range 10–92); 51 (62%) were males. Seventy-four (90%) had an
underlying condition such as cardiovascular disease 48 (59%), diabetes
mellitus 26 (32%), heart failure 17 (21%), autoimmune disease 6 (7%)
and cancer 2 (2%). There were 104 episodes (42%) of Gram-positive,
46 (19%) of Gram-negative, 13 (5%) of polymicrobial and 11 (4%) of
fungal peritonitis, while in 73 episodes (30%) cultures were negative.
Regarding outcome, patients were divided into 2 groups: those with
curable and those with complicated episodes. Complicated episodes were
characterised by death due to peritonitis, relapse or repeated episode,
removal of catheter and need for temporary or permanent haemodialysis.
There were 183 (74%) curable, while 64 episodes (26%) were considered
complicated and included 11 (4.5%) deaths, 22 (9%) relapses, 13
(5%) repeated episodes and 18 (7%) catheter removals. Multivariate
analysis revealed that presence of purulent exit-site infection (P<0.001),
peritoneal dialysis efﬂuent cell count >100/ml for more than 5 days
(P<0.001), prior antibiotic use during the last 3 months (P<0.05) and
low serum total protein level on admission (P<0.05) were independent
predictors of complicated episodes.
Conclusions: Exit-site infection, number of days with the peritoneal
dialysis efﬂuent cells count >100/ml, prior antibiotic use and serum
total protein level are potential predictors of outcome in PD-associated
peritonitis and may distinguish high-risk patients. Further study is needed
to determine whether an aggressive management of these high-risk
patients could improve outcome.
P831 Infections in patients with head injury: a 6-year retrospective
study
I. Kourbeti, J. Papadakis, D. Karabetsos, C. Neophytou, M. Filippou,
A. Ioannou, M. Anastasaki, A. Vakis (Heraklion, GR)
Objectives: Infections in patients with traumatic brain injury (TBI) are
associated with prolonged hospitalisation and adverse outcomes. The
acknowledgement of the pre-disposing risk factors may help decrease
the morbidity and mortality
We conducted a retrospective cohort study to determine the incidence,
bacteriology and risk factors for development of infection after head
injury
Methods: The records of patients >18 years old, admitted with head
injury in Crete Univ Med Ctr between 1999 and 2005 were abstracted.
Data were analysed with SPSS
Results: 877 events were analysed with a total of 338 surgeries. Burr
hole was the most common procedure (28%). Males predominated
(75.6%) and the median age was 40. Surgical site infections
(SSI) developed in 11.2% of the patients that underwent surgery.
Wound infection was the most common (53%). Meningitis/ventriculitis
comprised 43% of the SSI. Coagulase negative staphylococci (CNS)
predominated as pathogens
Ventilator Associated Pneumonia (VAP) in 7.4% of the entries and
they were the most common infections other than SSI. Gram(−) bacilli
predominated in VAP with Acinetobacter spp. being the most common
Risk factors for SSI surgery through sinus (p<0.001), CSF leak(p = 0.01),
ICU stay (p<0.001), use of a dural substitute (p = 0.01), drain
placement and duration of drains, ICP placement (p = 0.01) and
concomitant infections (p<0.001). Development of meningitis was
associated with surgery through sinus (p<0.001), ICU stay (p<0.0001),
CSF leak (p<0.05), use of ventricular drains (p<0.01) and concomitant
infections (p<0.001). SSI and meningitis were associated with prolonged
hospitalisation but only meningitis with an increased mortality (p<0.05).
In multivariate analysis surgery through sinus, ICU stay were associated
with development of SSI and meningitis but only SSI with CSF leak
Conclusions: Infections are common in patients with head injury.
Superﬁcial and deep SSI are associated with prolonged hospitalisation
and increased mortality. Some of the risk factors may be minimised by
careful surgical technique and aseptic management of foreign devices.
The type and sensitivities of the pathogens must be determined institution
by institution for effective empirical treatment
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P832 Human Rhinovirus: a role in adult LRTI?
H. Donaldson, J. Troughton, P. Coyle, S. Feeney, D. McAuley,
R. McMullan (Belfast, UK)
Objectives: Human Rhinovirus (HRV) is a picornavirus often respon-
sible for the “common cold”. It has been associated with exacerbations
of asthma and chronic obstructive pulmonary disease in adults and
with bronchiolitis and pneumonia in children. However, there is limited
information on HRV-associated lower respiratory tract infection (LRTI)
in adults without chronic lung disease, partly due to few laboratories
offering routine HRV detection in adults. The aims of this study were,
ﬁrstly, to describe the epidemiology of LRTI associated with HRV in
hospitalised patients, particularly, clinical outcomes in terms of chest
consolidation, duration of hospital admission and mortality. Secondly, to
compare these measures among patients with coexisting bacterial LRTI
(HRV+bacterial), to those with HRV infection only.
Methods: Data were collected on 27 adult patients with respiratory
secretions which tested positive for HRV who had been admitted to
two University hospitals in Northern Ireland, between 2003 and 2006
with a primary diagnosis of LRTI. HRV was detected from respiratory
secretions by a reverse-transcriptase polymerase chain reaction (RT-
PCR). A bacterial isolate was deﬁned as a positive result from at least
one of the following: sputum culture; blood culture; atypical pulmonary
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pathogen serology, legionella or streptococcal urinary antigen. Duration
of hospital admission was expressed as geometric mean and interquartile
range (IQ).
Results: Results are summarised in the table. There was no detectable
signiﬁcant difference between the patients groups in terms of age
(p = 0.81), sex distribution (p = 0.25), presence of chest consolidation
(p = 0.71), duration of hospital admission (p = 0.46), and mortality
(p = 0.38).
Number
of patients
(M, F)
Mean
age
(years)
Consolidation
present
Duration of
admission (days)
Hospital
mortality
Total cohort 27 (12, 15) 51.5 7 (25.9%) 13.2 (8.0, 16.0) 5 (19%)
HRV+bacterial 10 (7, 3) 52.8 3 (30.0%) 15.5 (8.8, 45.3) 1 (10%)
HRV only 17 (8, 9) 50.7 4 (23.5%) 12.0 (6.9, 16.0) 4 (24%)
Conclusions: Patients with a LRTI who isolated HRV only, had
similar clinical outcomes in terms of duration of hospital stay, chest
consolidation and mortality compared with patients with a bacterial
LRTI who co-isolated HRV. Although the dataset is small, these ﬁndings
suggest that HRV may have a role in the aetiology of LRTI in hospitalised
adults.
P833 Inhaled corticosteroids increase the risk of pneumonia? A
further step in a population-based study
J. Almirall, I. Bolibar, M. Serra-Prat, J. Roig, I. Hospital, E. Carandell,
M. Agustı´, P. Ayuso, X. Balanzo´, A. Torres on behalf of PACAP Group
Aim of the study: To identify if the inhaled treatment general and
inhaled corticoids in particular are risk factor for community-acquired
pneumonia (CAP).
Patients and Methods: This was a population-based case-control study
with a target population of 859,033 inhabitants >14 years of age. All
patients with conﬁrmed radiographic CAP presented over 1-year were
prospectively registered (n = 3336). Each case of conﬁrmed CAP was
frequency matched to a control subject (n = 3326). Then we selected
all chronic bronchitis or asthma diagnosis (CAP patients= 473 and
controls=235) in order to compare the inhaler treatments. Then we
adjusted for illness severity considering the use of oxygen therapy.
Results: Multivariable analysis including health habits, household and
work circumstances, clinical conditions and comorbidities, and oral
treatments, conﬁrmed IT as independent risk factor of CAP. Among
chronic bronchitis or asthma patients, IT remained a signiﬁcant risk
factor of CAP with a dose-related relationship, particularly when steroids
or plastic pear-spacers were used (see table).
Variable Cases
(n = 473)
Controls
(n = 235)
OR 95%CI P value OR
(adjusted
per O2)
95%CI
Age: mean (SD) 59.6 (20.0) 60.9 (20.7) 0.99 0.99−1.00 0.99 − −
Sex (% women) 189 (40.0%) 103 (43.8%) 0.85 0.62−1.17 0.324 − −
Inhalers 183 (38.7%) 69 (29.4%) 1.52 1.08−2.12 0.015 1.43 1.00−2.03
Inhaled steroids 13 (4.3%) 1 (0.6%) 7.44 0.96–57.39 0.05 1.70 1.09−2.68
Inhaled beta-agonists 88 (23.3%) 43 (20.6%) 1.17 0.78−1.768 0.451 1.08 0.70−1.64
Inhaled anticholinergic drugs 84 (22.5%) 21 (11.2%) 2.29 1.368−3.83 0.002 2.17 1.26−3.75
Puffs/day
1−6 77 (16.5%) 38 (16.5%) 1.16 0.75−1.79 0.002 1.11 0.71−1.74
6–10 41 (8.8%) 17 (7.4%) 1.38 0.76−2.51 1.32 0.72−2.42
>10 58 (12.4%) 9 (3.9%) 3.68 1.78−7.64 3.31 1.52−7.23
Inhalers
Without spacer device 129 (28.8%) 55 (24.3%) 1.39 0.96−2.02 0.013 1.27 0.87−1.87
With spacer device 54 (12.1%) 14 (6.2) 2.28 1.23−4.25 2.02 1.06−3.88
Conclusion: IT is a signiﬁcant and independent risk factor of CAP in
the general population and among patients with chronic bronchitis or
asthma, particularly when medication contained steroids or plastic pear-
spacers were used.
P834 Use of ACE inhibitors and risk of community-acquired
pneumonia
P. Rafailidis, D. Matthaiou, I. Varbobitis, M. Falagas (Athens, GR)
Objectives: The administration of angiotensin-converting enzyme (ACE)
inhibitors has been suggested as an alternative strategy for lowering the
risk of community-acquired pneumonia (CAP) in the elderly, especially
in patients with neurological and cerebrovascular comorbidity.
Methods: We critically examined the relevant data from studies
regarding the impact of ACE inhibitors in lowering the risk of CAP
and/or mortality due to CAP in the elderly. We searched in PubMed,
Cochrane database and references of initially retrieved articles, and in
http://clinicaltrials.gov for ongoing trials.
Results: We identiﬁed 285 evaluable studies. Eleven studies met the
inclusion criteria and were evaluated further, of which 6 were prospective
studies, 2 randomised controlled trials, and 3 retrospective studies. All
studies including patients of Asian origin demonstrated a statistical
signiﬁcance in favour of ACE inhibitors. This was not the case, though,
for studies including patients of non-Asian origin.
Conclusion: The available data suggest that ACE inhibitors may
contribute to the reduction of the risk of CAP. Nevertheless, the clinical
data are scarce and mainly comprise of studies including patients of
Asian origin. Since there seem to be differences regarding the genetic
polymorphism of ACE among patients of different origin, future studies
may need to incorporate relevant genetics data that may help clarify the
role, if any, of ACE inhibitors in prevention of CAP.
P835 Diabetes, glycaemic control and risk of hospitalisation with
pneumonia: a population-based case-control study
J.B. Kornum, R.W. Thomsen, A. Riis, H. Lervang, H.C. Schønheyder,
H.T. Sørensen (Aalborg, Aarhus, DK)
Objective: To examine whether diabetes is a risk factor for hospitalisa-
tion with pneumonia and to assess the impact of HbA1c level on such
risk.
Methods: In this population-based case-control study we identiﬁed
patients with a ﬁrst-time pneumonia-related hospitalisation between
1997 and 2005, using healthcare databases in Northern Denmark. For
each case, ten sex- and age-matched population controls were selected
from Denmark’s Civil Registration System. We used conditional logistic
regression to compute odds ratios (ORs) as a measure of relative
risk (RR) for pneumonia-related hospitalisation among persons with
and without diabetes, controlling for comorbidity, alcoholism-related
conditions, pre-admission use of antibiotics and immunosuppressants,
marital status, presence of small children in the household, and degree
of urbanisation.
Results: The study included 34,239 patients with a pneumonia-related
hospitalisation and 342,390 population controls. The adjusted RR for
pneumonia-related hospitalisation among persons with diabetes was 1.26
(95% conﬁdence interval (CI) 1.21−1.31) compared with nondiabetic
individuals. The adjusted RR was 4.43 (95%CI 3.40−5.77) for patients
with Type 1 diabetes and 1.23 (95%CI 1.19−1.28) for patients with
Type 2 diabetes. Diabetes duration 10 years increased the risk
of a pneumonia-related hospitalisation (adjusted RR 1.37; 95%CI
1.28−1.47). Compared with persons without diabetes, the adjusted RR
was 1.22 (95%CI 1.14−1.30) for diabetic persons whose HbA1c level
was <7%, and 1.60 (95%CI 1.44−1.76) for diabetic persons whose
HbA1c level was 9.
Conclusions: Type 1 diabetes, and to some extent Type 2 diabetes,
are risk factors for a pneumonia-related hospitalisation. Poor long-term
glycemic control among patients with diabetes clearly increases the risk
of hospitalisation with pneumonia.
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P836 Speciﬁc clinical determinants of community-acquired
Legionnaires’ disease associated with the Paris or Lorraine
endemic strains
A. Duclos, C. Ginevra, S. Jarraud, C. Campese, D. Che, J. Etienne,
P. Vanhems (Lyon, Saint Maurice, FR)
Objectives: Legionnaires’ disease (LD) is primarily caused by Le-
gionella pneumophila sporadic or endemic strains. The Paris and the
Lorraine strains are the main endemic strains in France. The objective
was to explore the clinical determinants of infection associated with
these two strains in patients with community acquired LD.
Methods: A double nested case-control study based on data from the
French national surveillance network of incident LD between 1998 and
2005 was performed. All notiﬁed patients with a community acquired
LD based on X-chest ray of pneumonia and deﬁnite biological diagnosis,
were included. Cases were patients infected with Paris or Lorraine
strains, whereas controls were those infected with sporadic strains.
Epidemiological and clinical factors associated with Paris or Lorraine
strains were assessed by adjusted odd-ratios, according to multivariate
logistic regression models.
Results: Study population included 883 persons for whom infection
occurred with sporadic (n = 364), Paris (n = 37) or Lorraine (n = 32)
strains. Compared to patients infected with sporadic strains, female
gender (adjusted odd-ratios [OR], 2.47, 95% conﬁdence interval [CI],
1.44 to 4.25), ageing (OR for one year increase in age, 1.03, 95%CI,
1.01 to 1.05), treatment with steroids (OR, 3.47, 95%CI, 1.84 to 6.52)
and history of hemopathy or cancer (OR, 1.90, 95%CI, 1.00 to 3.59)
were more frequent among those infected with Paris strains. Compared
to patients infected with sporadic strains, smoking (OR, 2.09, 95%CI,
1.11 to 3.96), diabetes (OR, 2.35, 95%CI, 1.12 to 4.91) and the 2004–
2005 period of LD notiﬁcation (OR, 8.30, 95%CI, 1.12 to 60.60) were
independently associated among those infected with Lorraine strains.
Conclusion: Several patient characteristics were associated with
endemic strains of Legionella pneumophila. These determinants were
different for patients infected with Paris or Lorraine strains. These results
observed in France should be extended to other areas to corroborate the
potential link between the host susceptibility and a peculiar Legionella
pneumophila strain background.
P837 Molecular epidemiology of Legionella pneumophila in
Comunidad Valencia (Spain)
M. Coscolla, F. Gonzalez-Candelas (Valencia, ES)
Objectives: The main objective is to investigate the epidemiology of
Legionella strains in a Spanish region that includes an area where
legionellosis has become almost endemic, with continuous bouts of
sporadic cases and several outbreaks affecting tens even hundreds of
people, by using molecular and phylogenetic methods. Given that the
culture efﬁciency of this bacterium from respiratory samples is very
low, a minor objective was to obtain sequences derived from infected
sputum without culturing it.
Methods:We have ampliﬁed and sequenced six protein coding loci and 3
intergenic regions for which we developed primers anchored in ﬂanking
conserved genes. Sequences of these nine markers were obtained in a
dataset including about 100 clinical and more than 150 environmental
samples, some related and others not to the clinical isolates, collected
along several years. Environmental samples were sequenced from pure
cultures while a semi-nested PCR approach was used to directly amplify
and sequence DNA from sputum samples. When available, cultured
clinical samples were also analysed. The obtained nucleotide sequences
were used to infer evolutionary, population genetics and epidemiological
relationships among them.
Results and Conclusions: Comparisons among sequences derived from
isolates from the same patient (cultured isolate and DNA from sputum)
were 100% identical, so ampliﬁcation and sequencing from respiratory
samples without culturing is feasible and more efﬁcient.
Occasionally, clinical isolates from the same outbreak were very similar
but not completely identical which, given the evolutionary rates in
this bacterium, might be explained having different origins despite a
common epidemiological pattern. For those cases with clinical and
presumed environmental source isolates, we consistently observed lack
of congruence between samples from both origins, probably because
the origin of the infection was not actually identiﬁed. Therefore, the
molecular analysis could complement the epidemiological investigation
in order to correctly identify the environmental sources of infections.
Although we have detected a large genetic diversity in both clinical
and environmental samples from the Comunidad Valenciana, our results
indicate the existence of a predominant clone among clinical isolates
which is the main responsible for recurrent outbreaks in a restricted area
where legionellosis has become almost endemic.
P838 Penicillins vs. trimethoprim-based regimens for acute
bacterial exacerbations of chronic bronchitis: a meta-analysis
of randomised controlled trials
I. Korbila, K. Manta, I. Siempos, G. Dimopoulos, M. Falagas
(Athens, GR)
Objectives: Semi-synthetic penicillins (SSP) (amoxicillin, ampicillin,
pivampicillin) and trimethoprim-based regimens [TMP, co-trimoxazole
(TMP/SMX), TMP/sulfadiazine) have been used for the treatment
of patients with acute bacterial exacerbations of chronic bronchitis
(ABECB).
Methods: We searched MEDLINE, Current Contents, and the Cochrane
Central Register of Controlled Trials to identify and extract data from
relevant RCTs for a meta-analysis comparing the effectiveness and
toxicity of penicillins with trimethoprim-based regimens.
Results: Out of 134 RCTs identiﬁed in the search, 5 RCTs, involving 287
patients, were included in the analysis. There was no difference between
patients with ABECB treated with SSP compared to those treated with
TMP, alone or in combination with a sulfonamide, regarding treatment
success [intention to treat (ITT) patients: 262, odds ratio (OR)=1.68, 95%
conﬁdence intervals (CI) 0.91−3.09, clinically evaluable (CE) patients:
246, OR=1.59, 95%CI 0.79−3.20] or drug-related adverse events in
general (186 patients, OR=0.37, 95%CI 0.11−1.24), diarrhoea, skin
rashes, or withdrawals due to adverse events (179 patients, OR=0.27,
95%CI 0.07−1.03).
Conclusions: Based on limited evidence leading to wide conﬁdence
intervals of the estimated treatment effects, SSP and trimethoprim-based
regimens seem to be equivalent in terms of effectiveness and toxicity for
ABECB.
P839 Treatment of patients hospitalised with community-acquired
pneumonia using moxiﬂoxacin versus levoﬂoxacin and
ceftriaxone: comparing costs from the hospital and social
insurance perspectives
A. Lloyd, A. Holman, T. Evers (London, UK; Wuppertal, DE)
Objective: To estimate the costs to German hospitals and statutory health
insurers of managing patients hospitalised with CAP and treated with
moxiﬂoxacin (MXF) or a combination of levoﬂoxacin plus ceftriaxone.
Methods: To ascertain costs from a hospital perspective, drug costs
were taken from the Rote Liste; costs for hospitalisation were taken
from a recent publication that reported bottom-up costing for the
components of CAP management in 22 German hospitals; and costs for
investigations and procedures were obtained using the German hospital
fee scale, used for private patients. To estimate costs from a social
insurance perspective, diagnosis-related group (DRG) codes including
hospitalisation, medication, diagnostic and therapeutic procedures were
used. Data on individual patient resource use were taken from
a prospective, randomised, double-blind study of adults with CAP
requiring hospitalisation and parenteral antibiotic therapy. Patients
received sequential treatment with IV/oral antibiotics (either MXF
[N=368], or comparator [N=365]) and for 7–14 days.
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Results: As the percentage of patients reporting clinical response (MXF,
80%; comparator, 84%) met criteria for clinical equivalence, cost-
minimisation analysis was appropriate. From a hospital perspective,
mean per-patient costs were €2,190 (95%CI: €1,954, €2,463) for the
MXF group, and €2,619 (95%CI: €2,422, €2,832) for the comparator
group, with a between-treatment difference of −€430 (95%CI: −€740,
−€138). From an insurer perspective mean per patient costs were €2,683
(95%CI: €2,576, €2,798) for the MXF group, and €2,669 (95%CI:
€2,581, €2,768) for the comparator group, with a between-treatment
difference of −€14 (95%CI: −€127, €152). Net income to the hospital,
deﬁned as the difference between the insurer payment and hospital cost,
was €493 per patient for the MXF group (95%CI: €304, €664) and €50
(95%CI: −€110, €201) for the comparator group.
Conclusions: From a hospital perspective, treatment with MXF was
signiﬁcantly less costly than treatment with the comparator, with no
clinically signiﬁcant difference in outcomes. There was no signiﬁcant
difference in cost from an insurer perspective. This analysis found that
compared with comparator, MXF reduced drug cost, had no signiﬁcant
effect on other costs and therefore reduced the per-patient cost of
managing CAP.
P840 Excess death attributable to inﬂuenza in the Czech Republic
in 1986–2006
J. Kyncl, B. Prochazka, M. Havlickova (Prague, CZ)
Objectives: Annual inﬂuenza epidemics differ in duration and magni-
tude. Inﬂuenza infection is underestimated, being easily mistaken for
one of acute respiratory infections (ARI) since showing similar clinical
symptoms. The aims of this study are to ﬁnd correlation between
mortality and inﬂuenza morbidity and to model mortality in different
weeks of the year outside the inﬂuenza epidemic.
Methods: Data on daily deaths from all causes and deaths from diseases
of the circulatory system in Czech Republic were available for 1986–
2006 (altogether 2 317 522 and 1 267 718 deaths reported, respectively).
Data on the incidence of inﬂuenza and other ARI were taken from the
surveillance programme. The weeks in which ARI morbidity exceeded
the epidemic threshold and at the same time, circulation of inﬂuenza
virus among the population was reported by the National Inﬂuenza
Centre, were considered as inﬂuenza epidemic weeks. Analysis was
based on the assumption that outside the epidemic periods, deaths are
distributed according to the Poisson distribution with a linear trend
depending on time and with periodic behaviour during the year. The
morbidity rate is only expected to increase in the epidemic compared to
non-epidemic period.
Results: When comparing the weekly morbidity from acute respiratory
illnesses and weekly mortality for all causes of death, the peaks of
these two parameters almost overlap. In the epidemic period (152 weeks)
28.3% of ﬁndings were above the unilateral 95% tolerance limit of the
model, compared to the non-epidemic period (926 weeks) with only
4.0% of ﬁndings above this limit. The mean estimated excess of annual
deaths from all causes was 1922 (18.66 per 100 000). The median of
deviations of the estimated number of deaths from the actual number of
deaths is negligible at 11.9 for the non-epidemic period, being equal to
129.8 for the epidemic period, p<0.001. Similar results were found for
deaths from diseases of the circulatory system accounting for 54.7% of
all deaths in the study period.
Conclusions: The presented results conﬁrm clearly and unambiguously
excess in death rates during the inﬂuenza epidemic periods, depending
on the duration and magnitude of the epidemic. The mean annual excess
rate for Czech Republic is 1.7% population, the major part of this rate
being attributable to inﬂuenza. Vaccination against inﬂuenza proved both
effective and cost-effective and therefore is to be recommended as the
most important preventive measure.
P841 Whooping cough in Catalonia, Spain
M. Romero, M. Quesada, N. Cardenosa, G. Carmona, M. Oviedo,
G. Codina, A´. Domı´nguez (Barcelona, ES)
Objective: to estimate the incidence of pertussis among general
population, and to identify individuals with pertussis among the contacts
of children with conﬁrmed pertussis.
Methods: From April 2003 to April 2004, 465 pertussis-suspect-cases
were reported from voluntary healthcare centres all over Catalonia.
Pertussis infection was conﬁrmed by means of culture and/or polymerase
chain reaction assay of the nasopharyngeal specimens. We recorded a
detailed cough history at presentation, as well as we asked parents for
details of their child’s immunisations and veriﬁed any information they
gave from the parent held record or medical notes. A descriptive analysis
was carried out of the demographic characteristics, clinical history,
complications, treatment, diagnostic methods, epidemiologic information
and vaccination.
Results: During the study period, there were a total of 71 laboratory
conﬁrmed cases of B. pertussis infection. There were 30 males and 41
females. Most (n = 31; 43.7%) of the patients were less than 1 year of
age. Seven percent (5) of patients were between 1−6 years, 22.5% (16)
were between 7 and 14 years and 26.8% (n = 39) were older than 14
years of age. Forty one cases (60%) presented paroxysmal cough, 22
(32%) post-tussive vomiting, 18 (26%) inspiratory whoop and 17 (25%)
apnoea. The vaccination status was not known for 24 (33.8%) patients.
Of the total vaccine status documented cases, 31 (66%) patients were
vaccinated. Fifty patients (70.4%) were considered the index or co-index
cases, 47 of them (94%) were children under 15 years old. Pertussis was
conﬁrmed in 18.3% (13/71) of the contacts of 50 index cases. Among
these contacts identiﬁed as a pertussis case, 61.5% (8/13) were older
than 14 years of age. These contacts were father (6 cases), mother (6),
brother (2), sister (2), grandmother (2), others (3).
Conclusion: In this sample of cases of whooping cough arising in the
highly vaccinated population of Catalonia, the overwhelming majority of
cases were infants less than 1 year of age and older adults. Healthcare
professional should be in alert to identify new cases of pertussis. The
early recognition of pertussis index cases by healthcare professionals, the
treatment of the cases and prophylaxis of the contacts is fundamental to
control an outbreak in the community.
P842 Pertussis surveillance in one geographic area of Catalonia,
2003–2007
M.R. Sala Farre´, C. Arias Varela, A. Recasens Recasens, G. Codina
(Terrassa, Barcelona, ES)
Objectives: In Catalonia pertussis suspected cases should be reported
to the Epidemiological Surveillance Unit. In 2003 a pilot surveillance
program was undertaken, suspected clinical cases should be laboratory
conﬁrmed. Means to conﬁrm cases were offered to public health services,
mainly urgency wards. This report summarises the epidemiological
factors associated with pertussis conﬁrmed cases in one geographic area
of Catalonia (Valle`s Occidental) with 836077 inhabitants. Incidence rates
and trends are described.
Methods: Clinical symptoms to suspect pertussis included cough for two
weeks, and at least one of the following symptoms: dyspnea, paroxysm
coughing, inspiratory whoop or post-tussive vomiting. Conﬁrmation
of cases requires PCR testing of nasopharyngeal ﬂuid or Bordetella
pertussis (BP) culture or to be epidemiologically linked to a laboratory
conﬁrmed case. Samples are analysed on a central laboratory of Hospital
of Vall Hebron in Barcelona. Epidemiological data and vaccination status
had been collected individually from all cases. Correct vaccination status
was evaluated according to the Catalonia vaccine schedule and the age
of each case.
Results: During the 2003–2007 period 127 conﬁrmed cases were
reported. Higher incidence was in 2003 and 2007 (until November)
with 6.4 cases/100000 inhabitants and 5.6 cases/100000 inhabitants,
respectively. Cases were more frequent on children under one year (35%)
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and among 10–14 years (19%) but 30–39 years old cases were 14%. Most
cases have received the doses of BP vaccine recommended according the
age (47%). Two cases died (1.6% lethality rate), both had one month of
live. PCR were more sensitive when it was done at the ﬁrst days of
disease.
Conclusion: The predominance of paediatric cases can be a real
incidence of cases, it may be to an increased awareness of pertussis by
paediatric physicians or typical symptoms of BP infection in children;
or it may be a combination of all these factors. The role of cases
on vaccinated patients should be taken into account to evaluate the
vaccination strategies.
P843 New insights in determining the aetiology of severe
community-acquired pneumonia and its implications
N. Poblet-Mas, M. De la Torre, J.M. Sirvent, L.J. Garcia-Gil
(Girona, ES)
Objectives: Severe community-acquired pneumonia (SCAP) can be
caused by different bacteria which show similar clinical presentations.
Legionella pneumophila (LP) can be difﬁcult to diagnose and its
prevalence might be underestimated. The main goals of this work were:
1. To evaluate the aetiology of SCAP, the prevalence of the aetiologic
agents and its relationship with the clinical manifestations and the
risk factors.
2. To assess the use of a new PCR method speciﬁc for LP as an analysis
of routine.
Methods: A total of 256 specimens (BAL, blood and urine) from 96
patients (66 with SCAP and 30 controls) admitted in the Intensive Care
Unit (ICU) were analysed, from December 2004 to November 2007.
Etiological agents were assessed simultaneously by culturing, by urinary
antigen test (UAT) and by PCR for LP. Kendall’s Tau-b correlation,
Mann-Whitney and Kruskall-Wallis tests, and Fisher’s Chi-square were
performed, using as dependent variables SCAP patients or LP-positives
by PCR. Thirty-one independent variables were analysed, twenty-three
describing symptoms, seven for risk factors and one for the causative
agent. The level of signiﬁcance was set at P<0.05.
Results: The most prevalent pathogen was LP (45.5%), followed by
Streptococcus pneumoniae (25.8%) and others (8.2%). In 20.5% of the
patients no aetiologic agents were detected. Polymicrobial infections
were found in 24.2% of the patients with SCAP. LP-positives obtained
by PCR were signiﬁcantly (P<0.001) higher than those obtained by UAT.
Smoking (P<0.05) and respiratory diseases (P<0.01) were identiﬁed
as risk factors. On the other hand, fever, cough, fatigue, dyspnea,
sputum, tachypnea, pulmonary shunt and inﬁltrate, amongst others, were
symptoms of SCAP (P<0.005). Signiﬁcant differences between SCAP
and control patients (P<0.05) in the ICU length of stay were only
observed when the infection was polymicrobial. Although a signiﬁcant
correlation (P = 0.001) was found between SCAP and LP positives by
PCR, no correlation was observed (P>0.05) between SCAP and LP
positives by UAT.
Conclusions:
1. The signiﬁcant symptoms and risk factors found in this study should
be taken into account when diagnosing and selecting the initial
antibiotic therapy.
2. Polymicrobial infections present a worse prognosis and more
agressive clinical evolution.
3. Urinary antigen test is not sensitive enough to determine SCAP
positives, while PCR is a better and more powerful tool.
P844 CAPNETZ: Data on clinical efﬁcacy of antibiotic therapy
and mortality of CAP in Germany
T. Welte, O. Burkhardt, R. Marre, N. Suttorp for the CAPNETZ Study
Group
Objectives: Because of the medical and economic impact of community-
acquired pneumonia (CAP), the Federal Ministry for Education and
Research (BMBF) has, since 2001, been ﬁnancing a network on
CAP (CAPNETZ). CAPNETZ was founded to gain new insights into
pathogenesis, particularly on pathogen-host interactions, to improve
actual care in this area in Germany.
Methods: CAPNETZ integrates components of health research as well
as clinical and basic research (horizontal network) on one hand and
supports cooperation among general practitioners, community hospitals
and universities (vertical network). The network partners report each
suspected case of pneumonia to the local clinical centre of CAPNETZ.
In case of CAP conﬁrmation all clinical and microbiological data are
documented.
Results: By the end of 2006, a total of 5,965 patients had been
included in CAPNETZ of whom 1807 were out-patients and 4,158
were in-patients. The mean mortality was 8.2%. A further 5.8% of
the patients died within the subsequent 5 months of observation after
the cure of CAP. In spite of optimal conditions, an evaluable sputum
sample could only be obtained from about half the patients. Usually
a throat swab or nasal rinse was obtained for virus or mycoplasma
diagnosis and urine was provided for antigen diagnosis (legionella and
pneumococci). Even in most cases with sputum no causal pathogen could
be found. S. pneumoniae was the most important pathogen, followed
by H. inﬂuenzae and M. pneumoniae. With a prevalence of ca. 3%,
legionella were rare. Nevertheless, they were linked to marked excessive
mortality, emphasising the importance of performing a urine antigen test
if there is a clinical suspicion of legionella. With a prevalence of about
3%, infections with Enterobacteriaceae were rare and primarily occurred
in the risk group of very old and comorbid patients and patients from
nursing homes. The mortality of these patients was 8-fold higher than
in patients from a domestic environment. For the older patients (> 65
years), survival was highly dependent on the adequate primary antibiotic
therapy. For this group (CRB-65 > 2), moxiﬂoxacin was superior to
b-lactam antibiotics. For patients with less severe disease (CRB-65 0
and 1), antibiotics like ampicillin were as effective as broad spectrum
antibiotics.
Conclusion: The CAPNETZ data conﬁrm the importance of pneumo-
cocci in CAP. The more severe cases beneﬁt notably from an antibiotic
therapy with moxiﬂoxacin.
P845 The performance of CURB-65 in community-acquired
pneumonia deteriorates with increasing age
M.J. Parsonage, D. Nathwani, P. Davey, G. Barlow (Hull, Dundee, UK)
Background: CURB-65 has been validated as a predictor of mortality
in community-acquired pneumonia (CAP) (Lim et al. Thorax 2003)
and is recommended by the British Thoracic Society (BTS) and
Infectious Diseases Society of America (IDSA) CAP guidelines to guide
management decisions. There has been concern about the performance
of CURB-65, however, in older adults (Myint et al, Age and Ageing
2006).
Objectives: To assess and compare the performance of CURB-65 in
different age groups.
Method: Retrospective analyses of data prospectively collected for
a CAP quality improvement study were performed (Barlow et al.
Thorax 2007). Patients were stratiﬁed into four age-based cohorts: 16–
64years (Group 1), 65–74years (Group 2), 75–84years (Group 3), and
>85years (Group 4). For each age cohort, 30-day mortality was stratiﬁed
by CURB-65 score. Sensitivity, speciﬁcity, positive predictive value,
negative predictive value, and area under the receiver operator curve
(AUROC) were then calculated. Statistical analyses were performed by
SPSS (version 12) with a p-value of <0.05 taken to indicate statistical
signiﬁcance.
Results: 428 patients were included in the study (Group 1 = 132,
Group 2 = 92, Group 3 = 128, Group 4 = 76); 53% female. Across
the groups, there were signiﬁcant differences in social circumstances,
oximetry <92%, urea >7mmol/l, new confusion, chronic illness, ITU
admission and mortality. In patients with non-severe CAP (deﬁned as
CURB-65 = 0 to 2), 30-day mortality was 3% in Group 1 compared
to 6%, 13%, and 27% in Groups 2 to 4, respectively. At the current
cut-off of >3, sensitivity and speciﬁcity were 0.33 and 0.98 in Group
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1, respectively, 0.77 and 0.62 in Group 2, 0.79 and 0.5 in Group 3, and
0.65 and 0.48 in Group 4. In Group 1, sensitivity and speciﬁcity were
highest at a cut-off of >2 (1.0 and 0.83, respectively). AUROC was 0.93
(95%CI 0.88 to 0.99, p<0.001) in Group 1 versus 0.74 (0.58 to 0.90,
p = 0.005) in Group 2, 0.74 (0.64 to 0.83, p<0.001) in Group 3, and 0.59
(0.46 to 0.73, p = 0.2) in Group 4.
Conclusion: Misclassiﬁcation as non-severe CAP (CURB-65 = 0 to 2)
of patients who subsequently died increased across the age cohorts. The
performance characteristics of CURB-65 deteriorated with increasing
age. Clinicians should interpret CURB-65 scores in elderly patients with
caution, especially in those >75years. In those <65years, a score >2 may
be a better indicator of severe CAP.
P846 The time to ﬁrst antibiotic dose does not predict early
clinical failure in severe community-acquired pneumonia
A.H.W. Bruns, J..J. Oosterheert, E. Hak, I.M. Hoepelman (Utrecht, NL)
Objectives: The time to ﬁrst antibiotic dose (TFAD) has been raised
as an important performance indicator in patients (pts) suspected
of community-acquired pneumonia (CAP). However, the advice to
minimise TFAD to 4 hours (4 h) is only based on retrospective database
studies. Moreover, adopting TFAD as performance indicator may lead
to prioritisation of pneumonia pts to others and unnecessary treatment
for pts who ultimately receive a differential diagnosis, contributing to
an increase in antibiotic (AB) use, resistance and costs. Therefore, we
studied the effect of minimising TFAD on early clinical failure in a
prospective setting.
Methods: Pts admitted because of severe CAP without previous AB
treatment to our university hospital, were prospectively followed. On
admission, pts’ medical data and TFAD were recorded. Appropriate AB
therapy was deﬁned as all identiﬁed pathogens being susceptible for the
initiated antibiotics. Early clinical failure was deﬁned as a respiratory
rate >25/min, peripheral oxygen saturation <90%, partial pressure of
arterial oxygen <60mmHg, haemodynamic instability or altered mental
status on day 3 of hospitalisation. Multivariable assessment of factors
predictive for early clinical failure was performed.
Results: 166 pts (mean PSI 108.8±24.1; age 67.2±14.5 year) were
included. Overall, median TFAD was 3 h12min. In 100 pts (60.2%)
TFAD was <4 h (median 2 h23min) and in 66 pts (39.8%) >4 h (median
5 h17min). No other signiﬁcant differences were observed between both
groups. In 82 pts (49.4%) aetiology could be established. Of these, 68
pts (84.1%) received appropriate AB therapy. 24 pts (26.4%) with TFAD
<4 h had early clinical failure, as compared to 22 pts (35.5%) with TFAD
>4 h (Odds Ratio (OR) 0.7; 95%CI 0.3−1.3; p= 0.22). In addition, after
correction for pneumonia severity and appropriateness of AB therapy,
no favorable effect of TFAD <4 h was found (p = 0.30). Furthermore, no
time-effect relation could be identiﬁed in TFAD and early clinical failure
(corr. 0.14; p>0.05). In multivariate analysis not TFAD but an arterial pH
<7.35 on admission (OR 5.7; 95%CI 1.3–25.3), confusion on admission
(OR 3.4; 95%CI 1.5−7.6) and Staphylococcus aureus infection (OR
7.2; 95%CI 1.3–39.6) were independently associated with early clinical
failure (P<0.03).
Conclusions: Clinical parameters on admission other than TFAD predict
early clinical failure in severe CAP. Therefore, implementation of TFAD
as performance indicator may not be desirable.
P847 Evaluation of a new immunochromatographic assay for the
detection of Legionella antigen in non-concentrated and
concentrated urine samples
S. Blanco, A. Lacoma, C. Prat, L. Haba, L. Fuenzalida, I. Latorre,
J. Dominguez (Badalona, ES)
Objectives: The aim of the present study was to evaluate the sensitivity
and speciﬁcity of a new ICT: Uni-GoldTM Legionella Urinary Antigen
(Trinity Biotech, Ireland) against the Binax Now Legionella test in non
concentrated (NCU) and concentrated (CU) urine samples.
Methods: The samples tested were grouped into 3 categories;
Group 1: 80 NCU and CU samples from patients with pneumonia caused
by L. pneumophila. Legionnaire’s disease was diagnosed by isolating
L. pneumophila from respiratory specimens and/or by serology and/or
by urinary antigen detection (Bartels EIA).
Group 2: 38 NCU and 26 CU samples from patients with pneumonia
of other aetiologies and also 22 NCU and 19 CU samples from patients
with bacteraemia from a non-respiratory focus.
Group 3: 50 NCU and 20 CU samples from patients with urinary tract
infections, with no signs of pneumonia.
Results: The Uni-GoldTM LUA test detected Legionella Urinary
Antigen in 51/80 NCU samples from Group 1 patients (63.75%
sensitivity). Binax Now test detected Legionella in 54/80 NCU samples
from group 1 patients (67.50% sensitivity). Both tests were all negative
for urine samples from Group 2 and 3 patients (100% of speciﬁcity).
The overall concordance of the tests for NCU was 89.42% (k 0.961, SE:
0.023). (p: 0.083).
After concentration of the urine samples, Uni-GoldTM detected 76/80
(95% sensitivity) and Binax Now 78/80 (97.5% sensitivity) of the Group
1 samples. The speciﬁcity was 95.4% for Uni-GoldTM LUA and 100%
for Binax Now. The overall concordance of the tests for CU was 96.5%
(k 0.931, SE: 0.031). (p: 0.655).
Conclusions: UniGold test is a technique simple to perform, and the
results are obtained in 15 minutes. Unigold when is compared to Binax
Now doesn’t show statistically signiﬁcant differences. The concentration
of antigen present in urine by ultraﬁltration increased the sensitivity.
P848 Long-term course of clarithromycin for the treatment of
stage II COPD patients with frequent exacerbations
K. Zykov, A. Averianov, E. Shmelev, A. Tsoi, A. Rvatcheva,
O. Brodskaya, A. Chuchalin (Moscow, RU)
It was shown that standard courses of antibiotic treatment of exacerbation
of chronic obstructive pulmonary disease (COPD) with macrolides or
b-lactams have clinical beneﬁts and may also reduce the frequency
of further exacerbations. But the data about the long-term courses of
macrolide treatment are still controversial.
The aim of the study was evaluate the safety and efﬁcacy of long-
term course of clarithromycin in comparison with standard course of
amoxicillin/clavulanate potassium for the treatment of stage II COPD
patients with frequent exacerbations.
Methods: 51 patients (32 male and 19 female) with exacerbation of
stage II COPD were enrolled in randomised parallel-group multicentre
trial to compare the efﬁcacy of course of clarithromycin (CLA)(Fromilid,
KRKA, Slovenia)with standard course of amoxicillin/clavulanate potas-
sium (AMC) tablets (Amoksiklav, Lek d.d., Slovenia). All patients
(mean age 57.3±1.1 years, smoking history 34.1±1.6 pack/years, FEV1
50.2±1.8 of predicted) had frequent exacerbations (3 or more per year)of
COPD. Chlamydophila pneumoniae IgG antibodies in diagnostic titers
were found in 70.5% patients. After randomisation 25 patients of AMC
group received 625mg of AMC three times a day during 10 days. 26
patients of CLA group were treated with 500mg of CLA twice daily
during 10 days then 250mg once daily during 50 days. The follow-up
period was 12 months. The study was conducted according to the GCP
rules, Helsinki Declaration and Russian laws.
Results: No one patient has dropped out of the study. In CLA group
there were 6 mild and 2 moderate, in AMC group – 2 mild and 5
moderate adverse events that did not need to stop the treatment. Dyspnea
(MRC scale), sputum volume and purulence signiﬁcantly reduced in both
groups after 12 months. FEV1 changes in both groups were unreliable.
The number of exacerbations in CLA group reduced from 4.3±0.2
to 1.4±0.2, and in AMC group – from 4.5±0.3 to 2.4±0.3 per year.
Exacerbation-free interval was longer in CLA group 258.4±17.0 days
than in AMC group 192.8±24.8 (p<0.03).
Conclusion: long-term courses of clarithromycin for the COPD
treatment are safe with few mild adverse events. Changes of dyspnea,
spirometry parameters, sputum volume and purulence in CLA-treated
and AMC-treated patients were equivalent. Long-term clarithromycin
treatment of stage II COPD patients with frequent exacerbations was
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associated with longer exacerbation-free interval compared to standard
AMC treatment.
P849 Empirical ﬁrst-line antibiotic-therapy in adult patients with
acute upper respiratory tract infections in eastern part of
Poland
L. Panasiuk, W. Lukas, J. Skorupka (Lublin, Zabrze, PL)
Objectives: The main objective of the study was the evaluation of
the frequency and the veriﬁcation of appropriateness of the use of
antibiotics in empirical ﬁrst-line therapy in adult patients with acute
upper respiratory tract infections. In addition, the aim of the study was
to discover whether there are any differences in the amount of antibiotics
prescribed according to the place of residence (urban, rural), gender and
age.
Methods: The analysis covered medical records of 4,047 patients
from 47 health centres in the Lublin Region (eastern part of Poland)
concerning the period of one year – 1 September 2005 – 31 August
2006. From among all the diagnoses, only newly diagnosed cases of
acute upper respiratory tract infections were selected in patients who
had no medical history of chronic respiratory diseases. Age, gender,
and place of residence of patients were recorded, as well as the fact of
prescribing or not prescribing an antibiotic by a physician during the
ﬁrst visit, and the type of antibiotic used.
Results: The documentation contained the records concerning 1,386
visits, the reason for which was qualiﬁed by physicians as acute infection
of the upper respiratory tract. Acute pharyngitis and tonsillitis, acute
respiratory tract infections of multiple and unspeciﬁed sites, a common
cold, and acute bronchitis were the most frequent diagnoses made. While
analysing all the cases it was noted that antibiotics were applied in
empirical ﬁrst-line therapy in 1,103 cases, which constituted 79.58% of
the total number of morbid cases. The antibiotics most frequently used
were: amoxicillin (26.77%), amoxicillin with clavulanic acid (13.1%),
macrolides (12.5%), and doxycycline (10.5%). No statistically signiﬁcant
differences in the use of antibiotics were observed according to patients’
age, gender, and place of residence.
Conclusions: The analysis showed that in the great majority of cases
the use of antibiotics was inappropriate. If this situation persists, in
the near future it will lead to an increase in the phenomenon of
antibioticoresistance in Poland. In order to prevent this situation, it is
necessary to carry out an extensive educational action concerning the
hazardous effect of excessive use of antibiotics, both among physicians
and the whole society.
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P850 Investigative use only test card using the VITEK2 system
as compared to broth microdilution
R. Buckner, D. Fuller, T. Davis, K. Newcomer, S. Mirrett, L. Reller,
E. Smith-Moland (Indianapolis, Durham, Omaha, US)
Objective: The purpose of this study was to demonstrate the
effectiveness of antimicrobial susceptibility tests for Cefalexin (CN),
Cefditoren (CDN), Cefsulodin (CFS), and Ceftobiprole (BPR) on the
VITEK® 2 platform.
Methods: This multicentre trial tested Gram-negative isolates using an
investigative use only (IUO) card (GN14) containing CN, CDN, CFS, and
BRP. Challenge isolates (100), reproducibility isolates (best 10 strains),
and quality control isolates (20 replicates of Pseudomonas aeruginosa
ATCC 27853 and Escherichia coli ATCC 25922) were tested at each site
by automatic and manual dilution using the GN14 IUO card. Clinical
isolates were tested by automatic dilution at all sites. Broth microdilution
(BMD) reference testing was performed on all reproducibility, challenge,
quality control and clinical isolates using the same standard inoculums
prepared for the GN14 test cards. Reproducibility tests were performed
in triplicate daily for three days. Essential agreement (EA) (within ± one
log dilution) and categorical agreement (CA) (S/I/R) was determined for
each microorganism/antimicrobial combination.
Results: Essential agreement for all 431 clinical isolates was > 93.0%,
while categorical agreement was > 90.3% (Table 1). Reproducibility for
the automatic diluted isolates was 100.0%, 98.9%, 97.8% and 98.9%
for CN, CDN, CFS and BRP, respectively. For the manual dilution,
reproducibility was 98.9%, 98.9%, 92.2% and 98.9% for CN, CDN,
CFS and BRP, respectively. The EA, for 100 challenge experiments using
automatic and manual dilution methods, was >96.0% for all antibiotics.
Table 1: Percent EA and CA for GN14 Card vs. BMD
Type of isolates CN CDN CFS BRP
Clinical (N = 431) EA 93.0 97.7 96.8 97.2
CA 96.3 90.3 95.8 95.4
Challenge Automatic Dilution (N= 100) EA 100.0 99.0 97.0 100.0
CA 99.0 93.0 95.0 93.0
Clinical & Challenge Auto Dilution (N= 531) EA 94.4 97.9 96.8 97.7
CA 96.8 90.8 95.7 94.9
Challenge Manual Dilution (N= 100) EA 99.0 99.0 96.0 100.0
CA 99.0 91.0 94.0 93.0
Conclusions: This evaluation provides convincing evidence that the
performance of antimicrobial susceptibility tests for CN, CDN, CFS and
BRP on the VITEK® 2 platform is comparable to conventional testing
in a clinical laboratory.
P851 Comparison of the VITEK®2 AST-N054 test card with
MASTDISCS® manual disc testing for the detection of
extended spectrum b-lactamase production in Escherichia
coli with CTX-M phenotypes
H. Donaldson, M. McCalmont, D.M. Livermore, P. Rooney, G. Ong,
E. McHenry, R. Campbell, R. McMullan (Belfast, London, UK)
Objectives: A new antibiotic susceptibility card, AST N-054, was
introduced for testing aerobic Gram-negative bacilli on VITEK®2
(bioMerieux) systems in 2007 and has been widely adopted for routine
use in the UK. We compared its performance to an established manual
method for detecting extended-spectrum b-lactamase (ESBL)-production
in Escherichia coli. E. coli with CTX-M enzymes are now prevalent
throughout the UK, partly owing to the spread of epidemic clones with
CTX-M-15 enzyme.
Methods: ESBL-producing faecal isolates of E. coli (n = 337) recovered
from patients in nursing homes were evaluated. Based on greater
resistance to cefotaxime than ceftazidime in agar dilution, all were
inferred to have CTX-M type enzymes. Seventy-three belonged to
strain A, the most prevalent epidemic lineage, which typically produces
a low level of CTX-M-15 enzyme; 64 were non-strain A and their
CTX-M enzymes remain to be fully identiﬁed. Each isolate was tested
using the AST N-054 card on the VITEK®2 and with MASTDISCS®
ID ESBL detection disc diffusion (DD) tests (Mast Diagnostics). All
VITEK®2 advanced expert system (AES) summary interpretations that
included ‘ESBL’ were categorised as successful. The susceptibility result
recommended by the AES software was also recorded.
Results: Overall, the AST N-054 card detected ESBL production in 93
of the 137 isolates tested (test sensitivity 67.9% [95%CI, 59.7–75.1]).
Strain A accounted for the majority of the 44 detection failures, with
35/73 strain A isolates incorrectly reported vs 9/64 non-strain A isolates
(p<0.0001). By comparison, manual detection based on UK national
recommendations with screening using cefotaxime and ceftazidime discs
followed by conﬁrmation using the MASTDISCS® method correctly
detected ESBL in 135 of the 137 isolates (test sensitivity 98.5% [95%CI,
94.5–99.9]). Of the 44 isolates found to be negative for ESBL production
by VITEK®2, the AES reported 29 as susceptible to cefotaxime, and all
as susceptible to ceftazidime and aztreonam.
Conclusion: These data suggest that the AST N-054 card for the
VITEK®2 system may be less reliable than combination discs for
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detection of CTX-M b-lactamase-producing E. coli circulating in the
UK; particularly for the strain A isolates, which tend to be less resistant
to cefotaxime and ceftazidime than most others. In consequence many
ESBL producers may be inappropriately reported as susceptible to
substrate cephalosporins.
P852 Analysis of the Dade Behring MicroScan Walkaway system
for the identiﬁcation and antimicrobial susceptibility testing
of cystic ﬁbrosis Pseudomonas aeruginosa
C.J. Megson, R. Townsend (Shefﬁeld, UK)
Objectives: Cystic Fibrosis patients are often colonised with atypical,
hypermutatable strains of Pseudomonas aeruginosa (CF-PSA). The
ability of CF-PSA to mutate frequently promotes diversiﬁcation within
the CF lung resulting in multiple colonial morphotypes and conferring
adaptive mutations such as loss of certain phenotypic characteristics and
resistance to antimicrobials. Consequently it is unsurprising that CF-
PSA are notoriously difﬁcult both to identify and to assess for their
antimicrobial susceptibility.
This evaluation assessed the ability of the Dade-Behring Walkaway
system to correctly identify and accurately assess antimicrobial
susceptibility of CF-PSA isolates by comparison with BSAC disc
diffusion methodology.
Methods: 58 CF-PSA isolates of mixed morphotype inocula were used.
These were tested using the Miscroscan NC-32 panel. Discrepancies
in identiﬁcation were further investigated using API 20NE. Five
antimicrobial agents were compared with results interpreted using BSAC
breakpoint guidelines.
Results: 66% of isolates identiﬁed correctly with a high probability
(>85% likelihood). 15% identiﬁed correctly at low probability, the
remainder (19%) either gave an incorrect identiﬁcation with a low
probability or failed to give an identiﬁcation.
A total of 290 antimicrobial agent/isolate combinations were tested of
which 240 (83%) were in complete agreement. The overall false resistant
(major) error rate was 17% (50/290). No false susceptible (very major)
errors were observed.
Conclusion: CF-PSA showed atypical reactions for several identiﬁcation
tests; notably only 69% of all isolates were positive for citrate
utilisation, and 66% were positive for tobramycin resistance. Five of the
identiﬁcation tests within the panel are tests for antimicrobial resistance.
Given that the levels of resistance in CF-PSA are unusually high, it
seems inappropriate for susceptibility to be used as a means to achieve
identiﬁcation of these organisms.
In our hands for our CF-PSA isolates the system demonstrated apparently
high false resistant rates.
It was noted however that many of the isolates that were resistant to
meropenem demonstrated inducible resistance to other b-lactams. It may
be that the Walkaway was able to detect resistant mutants that could
not be discerned using BSAC guided disc diffusion and this area may
warrant further investigation.
P853 Comparison of three automated systems (BD Phoenix,
MicroScan WalkAway and VITEK2) for detecting imipenem
resistance in Acinetobacter baumannii
C. Kulah, E. Aktas, F. Comert, N. Ozlu, I. Akyar, H. Ankarali
(Zonguldak, Istanbul, TR)
Objectives: Carbapenems are considered the gold standard treatment
for multidrug resistant Acinetobacter baumannii infections, however,
resistance to this agent has been reported increasingly. Reliable
susceptibility testing results remains a critical issue for the clinical
outcome for these patients. Automated systems are currently used in
many clinical laboratories. This study was organised to evaluate the
accuracies of three automated susceptibility testing methods for testing
Acinetobacter baumannii against imipenem.
Methods: One hundred twelve selected isolates of Acinetobacter
baumannii collected between January 2003 and December 2006 were
tested to conﬁrm imipenem susceptibility results. Bacterial isolates
were identiﬁed according to conventional bacteriological techniques and
conﬁrmed by API 20 NE (bioMerieux, France). Strains were tested
against imipenem by broth dilution, disk difusion, Etest (AB Biodisk,
Sweden), BD Phoenix (Becton Dickinson), MicroScan WalkAway (Dade
Behring) and VITEK2 (bioMe´rieux) automated systems. Data were
analysed by comparing the results from each test method to those
produced by the reference broth microdilution (BMD) test performed
using in-house prepared panels.
Results: MicroScan performed true identiﬁcation of all A. baumannii
strains while VITEK2 unidentiﬁed one strain, and Phoenix unidentiﬁed
two strains and misidentiﬁed two strains. The BMD testing showed that
25 strains were susceptible to imipenem while 87 were resistant All
other test systems in the study produced errors when A. baumannii was
tested against imipenem. Etest showed the best performance with only
two minor error (1.8%). VITEK2 produced eight minor errors(7.2%).
BD Phoenix produced three major errors(2.8%). Disk diffusion produced
two very major errors (1.8%) and three major errors (2.7%). MicroScan
showed the worst performance in susceptibility testing with 28 very
major errors (25%) and 50 minor errors (44.6%).
Conclusions: Testing difﬁculties for imipenem do exist in susceptibility
testing systems. Reporting errors can have serious implications for the
clinical outcome for patients. We suggest clinical laboratories using
automated systems for routine use should consider using a second,
independent antimicrobial susceptibility testing method to validate
imipenem susceptibility.
P854 Evaluation of the BD Phoenix™ Automated Microbiology
System to detect inducible-macrolide-lincosamide-
streptogramin B resistance in Staphylococcus species
C. Gosnell, C. Yu, D. Turner, J. Reuben (Sparks, US)
Objectives: Macrolide-resistant (Mac-R) staphylococci may have
constitutive or inducible resistance to clindamycin. Currently, constitutive
resistance to clindamycin can be easily detected by a number of manual
and automatic antimicrobial susceptibility testing methods. On the other
hand, inducible resistance to clindamycin can only be detected by
the D-test as described by CLSI. The D-test requires placing a 2-ug
clindamycin disk and 15-ug erythromycin disk approximately 15mm
apart per standard disk diffusion testing methods. Mac-R staphylococci
showing the “D-zone” would be reported as clindamycin-resistant. In
this study, we will describe a new integrated test to be offered in the
BD Phoenix Automated Microbiology System (BD Diagnostic Systems,
Sparks MD) for the automatic detection of inducible clindamycin
resistance in staphylococci.
Methods: A total of 408 strains of staphylococci, including 293
Staphylococcus aureus and 115 coagulase negative staphylococci were
characterised by Standard Broth Microdilution (SBM). All Mac-R
staphylococci strains were tested using the D-test. Each Mac-R
staphylococci strain was then tested in the Phoenix system using panels
with the integrated iMLSb test reagent and algorithm. Workﬂow and
results obtained from the Phoenix method were compared to the CLSI
method for accuracy.
Results: Out of the 408 strains tested, 194 strains were determined by
SBM as Mac-R and clindamycin susceptible staphylococci. Of these
strains, 136 were determined to be inducible-clindamycin resistant by
the D-test. The following table compares the Phoenix vs. D-test results.
The overall sensitivity and speciﬁcity using the Phoenix iMLSb test was
99.3% and 96.6%, respectively.
D-Test
positive negative
Phoenix iMLSb positive 135 2
negative 1 56
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Conclusions: The integrated iMLSb test in the Phoenix System provides
accurate detection of inducible-clindamycin resistance in staphylococci.
This method also eliminates the necessity of performing the D-test and
the associated subjective interpretation of test results.
P855 Identiﬁcation and susceptibility testing of Enterococcus
casseliﬂavus and Enterococcus gallinarum by Phoenix 100
system (Becton Dickinson)
K.-S. Chatzigeorgiou, A. Tarpatzi, N. Siafakas, M. Pantelaki,
N. Charalampaki, L. Zerva (Chaidari, Athens, GR)
Objectives: Although E. casseliﬂavus/ﬂavescens and E. gallinarum
are of low pathogenic potential, they may be implicated in invasive
infections. The aim of the present study was to assess their
correct recognition by Phoenix and to investigate their antimicrobial
susceptibility proﬁle using the same system.
Methods: A total of 82 consecutive non-E. faecalis and non-E. faecium
enterococcal isolates were collected during two hospital surveillance
studies for VRE faecal carriage; all were identiﬁed as E. casseliﬂavus/
gallinarum by Phoenix (without species discrimination). Speciation was
conﬁrmed by a multiplex PCR assay (speciﬁc for ddl-E. faecium, ddl-
E. faecalis, vanA, vanB, vanC1/2, vanD, vanE and vanG genes). Pigment
production was also recorded. Susceptibilities towards 8 antimicrobials
(penicillin, ampicillin, erythromycin, gentamicin, streptomycin, line-
zolid, teicoplanin and vancomycin) were determined by Phoenix and
E-tests (AB, Biodisk) against linezolid and teicoplanin were performed
for selected isolates.
Results: According to PCR all 82 isolates harboured the vanC ligase
gene and by pigment production 66 were identiﬁed as E. gallinarum and
16 as E. casseliﬂavus/ﬂavescens. All but one isolates tested susceptible
to both penicillin and ampicillin. Eleven strains (13.4%) were found
to be intermediately resistant and 5 (6.1%) resistant to erythromycin.
Five isolates (6.1%) exhibited resistance against streptomycin. For 3
E. gallinarum isolates Phoenix produced a teicoplanin MIC >16mg/ml,
not conﬁrmed by the E-test and PCR (3 major errors, 3.6%). Vancomycin
MICs by Phoenix ranged from 4 to >16mg/ml. Regarding linezolid,
Phoenix characterised 6 strains as resistant (all susceptible by E-test; at
least 6 major errors) and 21 strains as intermediately resistant (only 4
intermediately resistant by E-test; at least 17 minor errors). On repeat
testing Phoenix classiﬁed again 8 susceptible isolates as intermediately
resistant and 1 intermediately resistant strain as susceptible (at least 9
minor errors).
Conclusion: E. gallinarum and E. casseliﬂavus/ﬂavescens are accurately
identiﬁed as a group by Phoenix and are rather multi-susceptible species
with the former being more frequently recovered from faecal samples
of hospitalised patients. Rare major errors with teicoplanin and major
and minor errors with linezolid, which may call into question correct
speciation, stress the need for conﬁrmation with supplementary testing.
P856 Evaluation of the Oxoid M.I.C.Evaluator susceptibility test
strip in comparison to Etest assay and BSAC agar dilution
S. Mushtaq, M. Warner, D.M. Livermore (London, UK)
Objectives: The Oxoid M.I.C.Evaluator™ strip comprises an antibiotic
gradient immobilised on a plastic support strip. We compared its
performance with AB Biodisk’s Etest® product and with the BSAC agar
dilution method, which was taken as a reference.
Methods and Materials: All tests, whether by M.I.C.Evaluator
strip, Etest strip, or agar dilution were done on IsoSensitest agar,
supplemented as recommended for agar dilution by the British Society
for Antimicrobial Chemotherapy. The inocula used for both strip types
corresponded to a 0.5 McFarland. A total of 8775 individual organism/
antibiotic combinations were tested by each method; the total number of
isolates was 837, chosen to represent most clinically relevant fastidious
and non-fastidious species.
Results: Essential agreement of MIC values, ± 1 doubling dilution to
the agar dilution reference method, with off-scale results excluded, was
88.2% for the M.I.C.Evaluator strip against 86.0% for the Etest strip.
When one of more value was off-scale, (e.g. strip >32mg/L and agar
dilution 128mg/L) agreement was 72.4% for the M.I.C.Evaluator strip
against 69.9% for the Etest strip; this included instances, (e.g. cefotaxime
and oxacillin vs. MRSA) where MICs are notoriously ﬁckle. For both
strip types, agreement was best for non-fastidious genera including
staphylococci, enterococci, Enterobacteriaceae and non-fermenters and
weaker for beta-haemolytic streptococci and H. inﬂuenzae. In many
instances where there was disagreement with the reference method, the
results of the M.I.C.Evaluator and Etest strips agreed with each other,
whether for individual isolates, or for particular antibiotics against the
generality of a species: for example, both tended to estimate lower
imipenem MICs than agar dilution for P. mirabilis.
Conclusion: The M.I.C.Evaluator™ strip has essentially equivalent
performance to the Etest® strip, with both giving good agreement to
agar dilution results determined by the BSAC method.
P857 Performance evaluation of M.I.C.Evaluator™ strip (Oxoid)
and comparison with the BSAC reference method
R.W. Smyth, S. Bengtsson, J. Cloke, G. Kahlmeter (Va¨xjo¨, SE;
Basingstoke, UK)
Objectives: To evaluate the performance of a new product, the
M.I.C.Evaluator™ strip for the determination of minimum inhibitory
concentrations (MIC) of antibiotics for a selection of reference strains,
recent isolates and stored strains displaying a variety of resistance
mechanisms.
Methods: The M.I.C.Evaluator™ strip was tested in parallel
with the BSAC agar dilution reference method. Enterobacteriaceae,
Pseudomonas, Acinetobacter, staphylococci, streptococci, enterococci,
Haemophilus and Neisseria together with appropriate reference strains
were tested. Antibiotics were as shown in the results table. Iso-Sensitest
Agar with or without supplements was the basic medium. Inocula were
standardised to 0.5 MacFarland, strips were placed on 90mm dishes and
incubated at a temperature of 35–37ºC for 18–20 h or, for some strains,
up to 24 h. The reference method was carried out according to BSAC
guidelines. Results were read and recorded by different workers working
independently.
Results: For each organism group/antibiotic combination the middle
ﬁgure shows the essential agreement (EA) i.e. ± one dilution step,
between results obtained with M.I.C.Evaluator™ strip and the reference
method. The ﬁgure to the left shows the percentage yielding results two
or more dilution steps lower than the reference method and the ﬁgure
to the right shows the percentage of results two or more dilution steps
greater than the reference method. All ATCC reference strains gave MIC
results within the published range.
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n = 202 66 34 53 153 163 55 102
Amoxy/clav 0–100−0 2–98−0
Amoxycillin 0–84−16 4–96−0 1–97−2
Ampicillin 0–95−5 0–96−4 1–99−0 9–89−2 0–85−15
Cefotaxime low 0–87−13 0–81−19 1–63−36 0–84−16
Cefotaxime high 0–77−23 0–79−21 0–61−39 0–91−9
Ciproﬂoxacin 0–70−30 0–97−3 0–97−3 0–92−8 0–100−0 0–76−24
Erythromycin 0–100−0 0–93−7 4–93−3
Gentamicin low 0–93−7 0–64−36 0–100−0 0–95−5
Gentamicin high 0–95−5 0–73−27 0–91−9 1–92−7
Imipenem 0–97−3 0–100−0 0–100−0 13–87−0 5–91−4 0–100−0
Linezolid 0–99−1 20–80−0 3–97−0
Levoﬂoxacin 0–96−3 0–100−0 0–86−14 1–98−1
Oxacillin 1–85−14 5–87−8
Penicillin low 3–46−51 1–73−26 0–95−5
Penicillin high 3–58−39 1–74−25 0–95−5
Tetracycline 6–94−0 1–92−7 12–88−0 13–87−0
Vancomycin 3–96−1
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Conclusion: M.I.C.Evaluator™ strip compared to BSAC refer-
ence method showed >80% EA for ampicillin, amoxicillin, amox-
icillin/clavulanic acid, erythromycin, imipenem, levoﬂoxacin and
vancomycin. In almost all instances of poor agreement the
M.I.C.Evaluator™ gave a result greater than that of the reference method.
P858 Comparison of Oxoid M.I.C.Evaluator™ device with
broth micro-dilution and Etest® device from AB Biodisk
for antimicrobial susceptibility testing of staphylococci,
streptococci and enterococci
R. Rennie, L. Turnbull, C. Brosnikoff (Edmonton, CA)
Objective: The current study was designed to evaluate a new product
utilising an agar based gradient endpoint system (MICE™) produced by
Oxoid (Thermo Fisher Scientiﬁc) as an alternative to broth microdilution
for accurate MIC test results of staphylococci, streptococci and
enterococci that can be utilised effectively in critical care.
Methods: A total of 154 strains of MSSA, MRSA and CNS, 158
strains of S. pneumoniae, beta-haemolytic streptococci and viridans
group streptococci, and 106 strains of enterococci were tested. A total of
13 antimicrobial agents that were evaluable for each genus and species
were tested. The strains were inoculated into BMD trays (CLSI M7-A7)
and onto Mueller Hinton agar. The MIC strips were added to the plates
according to each manufacturer’s instructions and were incubated for 20–
24 hr at 35ºC. Inhibition was read where the elliptical zone intersected
with the strips. ATCC S. aureus 29213, S. pneumoniae 49619, and
E. faecalis 29212 were the quality control strains.
Results: Quality control strains were within CLSI published ranges. For
the clinical strains, 5300 agent-organism MIC results were available
for analysis. Over 99% of results were within 2 doubling dilutions
comparing BMD to either Oxoid’s MICE™ or AB Biodisk’s Etest®
device. Compared to BMD there were 5 Very Major errors (0.09%),
and 8 Major errors (0.15%) observed with both devices. Four of the 8
major errors occurred with penicillin and staphylococci
Conclusions:MICE™ device results for clinical strains of staphylococci,
streptococci and enterococci were comparable to the gold-standard CLSI
BMD observations and to Etest® device results for 13 evaluable antimi-
crobial agents. Additional antimicrobials are undergoing evaluation. The
gradient endpoint MIC device provides accurate susceptibility test results
for these Gram-positive clinical species.
P859 Comparison of Oxoid M.I.C.Evaluator™ device with broth
micro-dilution and Etest® device from AB Biodisk for
antimicrobial susceptibility testing of Enterobacteriaceae
R. Rennie, L. Turnbull, C. Brosnikoff (Edmonton, CA)
Objective: The current study was designed to evaluate a new product
utilising an agar based gradient endpoint system (MICE™) produced
by Oxoid (Thermo Fisher Scientiﬁc) as an alternative to manual and
automated broth microdilution systems for accurate MIC test results of
Enterobacteriaceae that can be utilised effectively in critical care.
Methods: 250 recent clinical strains of Enterobacteriaceae, including
16 genera and over 30 species were tested. Initially, seven evaluable
antimicrobials were tested: ciproﬂoxacin, amoxicillin, amoxicillin-
clavulanate, ampicillin, levoﬂoxacin; and cefotaxime and gentamicin
(low and high concentrations). The strains were inoculated into BMD
trays (CLSI M7-A7) and onto Mueller Hinton agar. The MIC strips
were added to the plates according to each manufacturer’s instructions
and were incubated for 20–24 hr at 35ºC. Inhibition was read where
the elliptical zone intersected with the strips. ATCC E. coli 25922
P. aeruginosa 27853, S. aureus 29213 and E. faecalis 29212 were the
quality control strains.
Results: Quality control stains were within CLSI published ranges. For
the clinical strains, 2250 agent-organism MIC results were available
for analysis. Over 98% of results were within 2 doubling dilutions
comparing BMD to either Oxoid’s MICE™ or AB Biodisk’s Etest®
device. Compared to BMD there were 8 Very Major errors (0.4%),
1 Major error (0.04%) and 7 minor errors (0.3%) observed with both
devices. Six of the 8 VM errors occurred with amoxicillin and ampicillin
with Proteus species.
Conclusions: MICE™ device results for clinical strains of Enterobacte-
riaceae were comparable to the gold-standard CLSI BMD observations
and to Etest® device results for seven evaluable antimicrobial agents.
Additional antimicrobials are undergoing evaluation. The gradient
endpoint MIC device provides accurate susceptibility test results for
Enterobacteriaceae.
P860 Validation of M.I.C. Evaluator strips following ISO guidelines
M.H. Nabuurs-Franssen, M.T.H. Bohne, J.W. Mouton (Nijmegen, NL)
Objectives: Oxoid has developed a new system for determining the MIC.
These M.I.C.Evaluator strips (M.I.C.E.) provide a gradient of antibiotic
stabilised on a polymer strip covering 15 doubling dilutions.
The aim of the study was to evaluate these M.I.C.E. vs the MIC reference
method (ISO 20776−1) according to ISO guidelines (ISO 20776−2).
Methods: Following the ISO protocol, during daily clinical laboratory
work 300 consecutive Gram-negative strains (fresh isolates) were
collected. Identiﬁcation was performed following standard procedures.
From each strain, the MICs were determined following ISO guide-
lines (ISO 20776−1) and instructions of the M.I.C.E. manufacturer,
respectively. For the M.I.C.E. an inoculum of 0.5 McFarland was
streaked on a Mueller-Hinton agar plate. The M.I.C.E. were put on
the plate and incubated for 16–20 h. The MIC values were read
following instruction by two independent lab technicians. The fol-
lowing M.I.C.E. were evaluated: gentamicin 256−0.016mg/L (Ge256),
gentamicin 1024−0.064mg/L (GE1024), amoxicillin 256−0.016mg/L
(AM), cefotaxime 32−0.002mg/L (Cef32), cefotaxime 256−0.016mg/L
(Cef256), levoﬂoxacin 32−0.002mg/L (LE), imipenem 32−0.002mg/L
(IM), ciproﬂoxacin 32−0.002mg/L (CI). For the interpretation of the
MIC and M.I.C.E. the EUCAST breakpoints were used. Discrepancy
analysis was performed following the ISO guideline.
Results: The isolates collected belonged to the following species
Citrobacter spp. (n = 35), Enterobacter spp. (n = 35), Escherichia coli
(n = 30), Hafnia alvei (n = 3), Klebsiella spp. (n = 34), Morganella
morganii (n = 30), Pantoea agglomerans (n = 3), Proteus spp. (n = 37),
Providencia rettgeri (n = 3), Serratia marcescens (n = 3). 63% of the
strains were susceptible for the different antimicrobial agents. The
category agreement after discrepancy analysis was: Ge256 99%, GE1024
99%, AM 96%, Cef32 99%, Cef256 99%, LE 98%, IM 99% and CI 98%.
Very Major Discrepancy was found only for CI 1%, Cef32 0.7% and
Cef256 0.3%; and none for the other antimicrobial agents. There was no
Major Discrepancy was for any antimicrobial agents.
Conclusion: The new M.I.C.E. to determine MICs demonstrated an
excellent performance for the interpretive category determinations of
SIR of the antimicrobial agents tested. M.I.C.E. provide a welcome new
methode to determine susceptibility during routine practice.
P861 Effect of lower inoculum on MIC broth microdilution: a
comparison with the ISO reference method
M.H. Nabuurs-Franssen, M.T.H. Bohne, J.W. Mouton (Nijmegen, NL)
Objectives: Rapid, accurate and reproducible determination of the MIC
value is important for adequate patient care, for local and international
resistance surveillance. For epidemiological studies of susceptibility and
for comparison of new and existing antimicrobial agents. The ISO
reference method (ISO 20776−1) prescribes an inoculum of 2–8×105.
The rationale behind the lower limit is not fully clear. In addition, some
MIC devices do use lower inocula. For instance, the (former) guideline
of the BSAC stated 10^5 /ml. The aim of this study was to evaluate the
effect of a lower inoculum size on the MIC determination using the ISO
protocol (ISO 20776−2).
Method: During daily clinical laboratory work 300 consecutive Gram-
negative strains (fresh isolates) were collected. Identiﬁcation was
performed following standard procedures. From each strain, the MICs
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were determined with both the 2–8×105 inoculum (ISO 20776−1)
and with a 5–10×104 inoculum. MIC values were read independently
by two lab technicians. For the interpretation of the MICs the
EUCAST breakpoints were used. The following antimicrobial agents
were tested: amoxicillin (AM), cefotaxime (Cef), ciproﬂoxacin (CI),
amoxicillin/clavulanic acid (AC). The MIC values of the lower inoculum
size was compared to the reference method following ISO guideline (ISO
20776−2).
Results: The isolates collected belonged to the following species
Citrobacter spp. (n = 35), Enterobacter spp. (n = 35), Escherichia coli
(n = 30), Hafnia alvei (n = 3), Klebsiella spp. (n = 34), Morganella
morganii (n = 30), Pantoea agglomerans (n = 3), Proteus spp. (n = 37),
Providencia rettgeri (n = 3), Serratia marcescens (n = 3). Forty-ﬁve per-
cent of the strains were susceptible for the different antimicrobial agents.
Following ISO guidelines the essential agreement after discrepancy
analysis was: AM 99%, Cef 98%, CI 98%, AC 98% and the category
agreement was: AM 96%, Cef 99%, CI 97.%, AC 92%, respectively.
The Very Major Discrepancy was found only for Cef 0.3%. Discrepancy
analyses with the M.I.C.E. found the same MIC as the 5–10×104
inoculum. A Major discrepancy was only found for Cef 0.3%. Minor
discrepancies were found for AM 4%, Cef 0.6%, CI 3.3%, AC 8.3%.
Conclusion: In this study, a lower inoculum size (5–10^4) did not
inﬂuence the outcome of the MIC determination; there was a very
good category agreement and essential agreement between the different
inoculum sises for the antimicrobial agents tested compared to the
reference method.
P862 Detection of VISA/hVISA in routine clinical isolates:
Microscan® modiﬁed procedure vs. Etest®
M. Ballardini, M. Meledandri, A. Ferrari, S. Falco, M. Balice,
M. Gallo, C. Fontana, P. Bernaschi, M. Carletti, A. Silvestri,
N. Corradetti, G.P. Testore (Rome, IT)
Objectives: Detection of VISA/hVISA strains should be pursued in
routine clinical microbiology, to prevent possible therapeutic failure.
Although PAP-AUC is known as reference method, many laboratories
use more manageable techniques, primarily Etest® (AB-Biodisk). In
this work we evaluate the performance of MicroScan® (Dade-Behring)
automated method (also with a modiﬁed procedure) vs. Etest.
Methods: MRSA clinical isolates, mostly from SSI, BSI and ulcers of
hospitalised patients in Italy (8 centres in Rome) in 2007, not classiﬁed
by respective centres as VISA/hVISA (vancomycin MIC 2mg/ml at
Vitek® or Phoenix® ASTs for all strains), were retested as follows:
culturing on VA agar screen (vancomycin 6mg/ml – Biolife - 0.5 and 2
McF, 48 h); vancomycin’s MIC measure for screened colonies by means
of Etest ‘standard’ (MHA 0.5 McF, 48 h), Etest ‘macro method’ (BHI
2 McF, 48 h) and Microscan panels (standard 0.5 and modiﬁed 2 McF
inocula, 48 h).
Results: After screening, 106 collected strains produced 53 suspected
‘not-VSSA’ (none detected by respective Vitek/Phoenix ASTs). With
CLSI 2006 breakpoints, Microscan showed high sensitivity (100%;
Wilson CI 75–99), low speciﬁcity (55%; CI 38–71), high npv (100%;
CI 87–99) and low ppv (47%; CI 29–65) vs. Etest (standard inoculum
0.5 McF, both with Etest and Microscan). Using Walsh’s (2001)
classiﬁcation, we obtained similar results: sens.100% (CI 60–99),
spec.27% (CI 15–42), npv100% (CI 89–99), and ppv19% (CI 10–
35): in this case, 2 McF inoculum was used both for ‘macromethod’
and Microscan. Correlation (Spearman) was also observed between
Microscan and Etest MICs/results: R=0.650 (p<0.001) and R=0.512
(p<0.001), respectively for 0.5 and 2 McF.
Conclusion:Microscan seemed to be an alternative to Etest for detection
of presumptive VISA/hVISA, even when instrument is forced to work
likewise an Etest macromethod. High sensitivity, with advantage of
automation, allows practical ﬁrst level identiﬁcation of strains. On the
other hand, overall data show that use of a glycopeptide agar (VA
or TP) for screening is essential for recovery of suspected strains,
especially in hospital settings as those analysed, with probable signiﬁcant
unrecognised rate of VISA/hVISA.
P863 Mecillinam susceptibility in Escherichia coli with and
without ESBL: a comparison of disk diffusion and Etest on
Mueller-Hinton agar and Iso-Sensitest agar
E. Matuschek, C.G. Giske, G. Kahlmeter (Va¨xjo¨, Solna, SE)
Objective: Mecillinam is a 6-amidinopenicillin highly active against
Gram-negative bacteria such as Escherichia coli and Klebsiella
pneumoniae and has been used successfully in Scandinavia for the
treatment of uncomplicated urinary tract infections. Mecillinam is semi-
stable to many b-lactamases but MIC values for b-lactamase producing
strains are elevated to varying degrees. Currently used MIC breakpoints
for mecillinam and E. coli in Europe are 8/8 (BSAC), 2/8 (CA-SFM),
2/8 (NWGA) and 1/8 (SRGA). This study compared susceptibility results
with Etest and disk diffusion on Mueller-Hinton agar (MHA) and Iso-
Sensitest Agar (ISA) in E. coli strains with and without b-lactamases,
including a variety of ESBLs.
Methods: Mecillinam Etest (AB Biodisk, Solna, Sweden) and disks
(10mg, Oxoid, Basingstoke, UK) were used on ISA (Oxoid) and MHA
(Oxoid). All testing was performed with Kirby-Bauer inoculum, except
for disk diffusion on ISA which was done with a semi-conﬂuent
inoculum (as described in the methods by BSAC and SRGA). A
total of 280 E. coli isolates from urine samples were investigated.
Of these, 161 were consecutive strains from Kronoberg County and
119 were ESBL-producers from Karolinska University Hospital. ESBL
production was detected by clavulanate synergy disks (Oxoid), followed
by PCR targeting CTX-M, TEM and SHV b-lactamases, and subsequent
sequencing.
Results: There was excellent correlation between susceptibility testing
performed on ISA and MHA, with r>0.99 for MIC v MIC both for the
consecutive E. coli and the ESBLs. The zone diameters were generally
smaller on MHA, but again correlation was strong (r=0.93 for the
consecutive E. coli and r=0.97 for the ESBLs). The distribution of
mecillinam MIC from our consecutive E. coli was closely similar to
that presented on the EUCAST website with a peak at 0.125mg/L. The
ESBL-producing E. coli, mostly CTX-M-15 and -14, had higher MIC
values with a peak at 0.5−2mg/L. EUCAST has suggested a preliminary
MIC breakpoint of S 8, R>8mg/L. Our results indicate a tentative
disk diffusion breakpoint for a mecillinam 10 mg disk of S 15mm, R
14mm, both for MHA and ISA.
Conclusion: There was good agreement between MIC and disk diffusion
for mecillinam and E. coli on both ISA and MHA. We suggest that disk
diffusion can be used to predict mecillinam susceptibility for E. coli
strains both with and without ESBL enzymes.
P864 Comparison of Etest and combined disk for detection of
metallo-b-lactamase-producing isolates
E. Campana, R. Pica˜o, A. Nicoletti, R. Girardello, S. Andrade,
A.C. Gales (Sa˜o Paulo, BR)
Objective: The aim of this study was to comparatively evaluate the
ability of E-test MBL strip (AB BIODISK, Solna, Sweden) and com-
bined disk (CD) assay for detection of MBL-producing Pseudomonas
aeruginosa (PSA), Acinetobacter spp. (ACB) and enterobacterial clinical
isolates.
Methods: A total of 46 genetically unrelated clinical isolates were tested,
including 28 P. aeruginosa (10 SPM-1, 14 IMP-type, 3 VIM-type and
1 GIM-1), 1 P. putida (IMP-1), 10 Acinetobacter spp. (9 IMP-1, 1
SIM-1), and 7 enterobacterial strains [Enterobacter cloacae (1 IMP-1 and
3 VIM-1), Klebsiella pneumoniae (2 IMP-1) and Serratia marcescens
(1 IMP-1)]. Nineteen imipenem (IMI)-resistant isolates but non-MBL
producers were included as negative controls. The isolates were classiﬁed
as MBL producers by E-test according to the manufacturer’s instructions.
The CD assay was performed adding 2, 4, 6, 8 and 10 ul of EDTA (100
mM) to IMI disks. The isolates were categorised as MBL producers
considering an increase of 5mm in inhibition zone of IMI/EDTA disks,
compared to the IMI disk alone.
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Results: The sensitivity (S) and speciﬁcity (E) of E-test and CD assay
are shown in the table below. Results of S and E (100% and 33.3%,
respectively) for E-test were the same regardless of the MBL type
produced. The best E results obtained by Etest and CD were observed
for the Enterobacteriaceae group (80% and 100%, respectively). Two
positive controls (Acinetobacter spp.) and four negative controls (2
P. aeruginosa and 2 enterobacterial strains) were categorised as non
determinable (ND) by E-test. The best S and E results for CD assay
were achieved after dropping 6 ul of the EDTA.
E-test® CD
Species S % E % S % E %
General 100 33.3 76 95
Acinetobacter spp. 100 0 40 50
P. aeruginosa 100 25 93 83
Enterobacteriaceae 100 80 100 100
S: sensitivity; E: speciﬁcity.
Conclusions: Our results indicated that, although the E-test was able
to correctly identify almost all MBL-producing isolates, false positive
MBL results may occur when using this methology. On the other hand,
false negative results may arise when CD test is used to screen for
MBL-producing isolates. In summary, these two methods are suitable for
preliminary MBL screening for some selected species, but should not be
used as the unique indicator of such resistance determinants production.
P865 Comparison of Neo-Sensitabs™ with paper discs in the
routine disc diffusion antimicrobial susceptibility testing
J.H. Kauppila, V.M. Koskela, M. Koskela (Oulu, FI)
Objectives: The aim of this study was to compare the use of
Neo-Sensitabs™ (Rosco, Taastrup, Denmark) with paper discs for
antimicrobial susceptibility testing by disc diffusion method according
to the recommendations of CLSI.
Methods: We analysed antimicrobial susceptibility of 476 clinical
bacterial isolates and 7 ATCC control strains by parallel disc diffusion
susceptibility testing with paper discs (Oxoid Ltd, UK) and Neo-
Sensitabs™ (table 1). Clinical strains were tested once, but testing was
repeated when interpretative disagreement was found. ATCC control
strains were tested weekly 10 times.
Results: Zone correlation with the Pearson test value for diameters
produced by the discs of two manufacturers was high. Overall
agreements (test results within 4mm range) were also very high. When
the comparison was based on CLSI breakpoint categorisation, agreement
ranged between 78.5% and 100% (table 1).
Very major, major and minor error rates were 0.2% (8 strains), 0.15% (6
strains) and 2.7% (106 strains) of all analyses, respectively. Three out of
8 very major errors occurred when there was no intermediate category.
The rest 5 were detected when testing amoxicillin + clavulanic acid
(AMC) or cefuroxime (1 case) activity against ESBL-strains. 59% of
all errors occurred when testing activity of betalactams (mostly AMC)
against ESBL-strains, and that is very understandable considering the
character of this kind of betalactamase enzymes.
All MRSAs were found by both oxacillin discs and only 1 was missed
by Oxoid cefoxitin disc, but the oxacillin inhibitory zones of the
Neo-Sensitabs™ were more difﬁcult to read at MRSA-strains. Oxoid
vancomycin discs failed to detect 4 VRE-strains.
Other observations in routine use: Occasional blank paper discs were
found (totally resistant at ﬁrst and fully susceptible at re-testing). No
Neo-Sensitabs™ found to be blank. Paper discs were dropped from the
plate at about 1−2% of the analyses. The Neo-Sensitabs™ were not
dropped. The Neo-Sensitabs™ were broke down at about 1−2% of the
analyses, and it sometimes hampered the measurement of the zone sise.
The dispenser of the Neo-Sesitabs™ has 7 locus, which makes the edge
effect more prominent in some cases.
Conclusion: The zone diameters produced by Neo-Sensitabs™ and
paper discs correlate well and showed good interpretative agreement.
Therefore, the Neo-sensitabs™ are potential alternative to the paper discs
for antimicrobial susceptibility testing by disc diffusion method.
Table 1: Correlations and agreements of the test results for clinical strains
Agreement No. of tests performed
Pearson
correlation
coefﬁcient
Overall based on
CLSI breakpoint
categorisation
STC EC PAE AGNR
Ampicillin 10 ug 0.992 96.6 100.0 29
Aztreonam 30 ug 0.980 97.9 93.6 10 37
Cefoxitin 30 ug 0.969 88.9 98.6 144
Ceftazidime 30 ug 0.954 98.1 94.8 44 169
Ceftriaxone 30 ug 0.981 97.1 95.9 170
Cefuroxime 30 ug 0.968 96.9 96.3 161
Ciproﬂoxacin 5 ug 0.982 98.6 98.8 130 47 170
Clindamycin 2 ug 0.977 93.5 97.8 139
Co-amoxiclav 30 ug 0.934 89.0 78.51 172
Co-trimetoxazole 30 ug 0.976 93.4 96.5 150 167
Imipenem 10 ug 0.975 97.2 100.0 92 48 146
Linezolid 30 ug 0.841 98.0 100.0 150 96
Meropenem 10 ug 0.902 98.0 100.0 25 127
Nitrofurantoin 300 ug 0.956 97.0 90.9 8 37
Oxacillin 1 ug 0.982 95.2 93.9 147
Piperacillin+tazobactam 110 ug 0.954 98.1 97.6 49 161
Rifampicin 5 ug 0.957 97.2 100.0 145
Tobramycin 10 ug 0.962 98.8 98.8 135 49 162
Trimethoprim 5 ug 0.976 98.8 99.7 150 173
Vancomycin 30 ug 0.886 100.0 97.12 147 98
STC = Staphylococcus spp., including 34 MRSA strains. EC = Enterococcus sp., including 21 VRE strains.
PAE = Pseudomonas aeruginosa. AGNR = Aerobe Gram-negative rod, including 41 ESBL strains.
1. 95% of disagreements were strains producing ESBL-, AmpC or K1-b-lactamases.
2. 7/8 of disagreements were VRE-strains. In 4 cases Oxoid discs failed to detect VRE. So the rates of true test
results considering the resistance mechanism are 99.0% for Rosco tablets and 95.0% for Oxoid discs.
P866 Comparison of two methods (Etest and MicroScan) for
detecting vancomycin susceptibility in Staphylococcus aureus
E. Cercenado, O. Cuevas, A. Vindel, M. Goyanes, M. Marin, E. Bouza
(Madrid, ES)
Objective: The efﬁcacy of vancomycin in the treatment of infections
due to Staphylococcus aureus and speciﬁcally to MRSA has come under
debate. There is also a concern for the decreasing in vitro susceptibility
of isolates to vancomycin, the difﬁculty in laboratory detection, and the
potential therapeutic implications of resistance. Moreover, vancomycin
efﬁcacy is lower against MRSA infections with agr group II isolates.
In this study we compared two methods for detecting vancomycin
susceptibility among clinical isolates of S. aureus and determine the
agr groups of the MRSA isolates.
Methods: A total of 463 S. aureus isolates (135 MRSA) obtained from
a national multicentre survey in Spain in a prevalence study performed
in 2006 were evaluated. Vancomycin susceptibility was determined
using the microdilution method MicroScan (Dade-Behring) and the Etest
method (AB Biodisk). The same inoculum was used for both methods.
Detection of heterorresistance (GISA/hGISA) was determined by the
Etest macrodilution method. A multiplex PCR was used to determine
the agr types of the MRSA isolates.
Results: The origins of the isolates were skin/wound (67%), respiratory
(13%), blood (8%), urine (6%), and others (6%). A total of 449 S. aureus
isolates (97%) had vancomycin MICs of less or =1mg/L, and 14
(3%) had MICs of 2mg/L with MicroScan. By Etest, 2 isolates had
vancomycin MICs of 0.75mg/L; 58 of 1mg/L; 242 of 1.5mg/L; and 161
of 2mg/L. None of the isolates was GISA/hGISA. Among the MRSA,
129 isolates (95.5%) had vancomycin MICs of less or =1mg/L, and 6
(4.5%) had MICs of 2mg/L with MicroScan. By Etest, 1 isolate had
a vancomycin MIC of 0.75mg/L; 3 of 1mg/L; 67 of 1.5mg/L; and 58
(43%) of 2mg/L. Among the MRSA isolates that had a MicroScan result
of less or = 1mg/L, 3% of isolates had both MicroScan and Etest of less
or =1mg/L, 51% had an Etest of 1.5mg/L, and 46% of 2mg/L. Of the
6 remaining isolates with MicroScan MIC of 2mg/L, 2 isolates had an
Etest result of 1.5mg/L, and 4 isolates of 2mg/L. The agr groups of the
MRSA isolates with vancomycin MICs of less or =1mg/L by MicroScan
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were: 17% group I, 80% group II, and 3% group III. All isolates with
vancomycin MICs of 2mg/L by MicroScan were agr group II.
Conclusions: The results of this study show variability in methods
for the determination of the in vitro susceptibility of S. aureus and
MRSA isolates to vancomycin and a high proportion of MRSA isolates
belonging to the agr group II.
P867 Re-evaluation by microdilution of Etest method to determine
tigecycline susceptibility in Acinetobacter
M. Casal, F. Rodrı´guez, J. Blanco, E. Gardun˜o, R. Ortiz de Lejarazu,
A. Tenorio, R. Bartolome´, N. Larrosa, B. Johnson, N. Garcı´a-Escribano
(Co´rdoba, Badajoz, Valladolid, Barcelona, ES; Schaumburg, US;
Madrid, ES)
Objectives: There has been different communications related to not
reliability of E-test method with different microorganisms. The aim of
this study is to reevaluate by microdilution the presumably resistance to
tigecycline (TGC) of 95 Spanish Acinetobacter isolates.
Methods: All isolates were derived from different sources. We have
collected Acinetobacter isolates with a MIC >2mg/ml, obtained by
E-test, from four Spanish hospitals during 6 months. Organism
collection, transport and retest of TGC susceptibility was carried out
by Laboratories International for Microbiology Studies, a division
of International Health Management Associates, Inc. (Illinois. United
States). Minimum inhibitory concentrations (MICs) were determined
by the CLSI (2007) recommended broth microdilution testing method.
TGC was supplied by Wyeth Pharma and all other antimicrobials
were supplied by Microscan (Dade Behring, Sacramento, CA). CLSI
breakpoints were used for all the antimicrobials. For TGC we used the
breakpoints recommended by FDA and EUCAST for Enterobacteriaceae.
Results: Despite of the results obtained by E-test in which all the isolates
were resistant to TGC, by microdilution all the isolates were susceptible.
TGC was the most potent agent with a MIC50 of 0.5 mg/ml and a MIC90
of 1mg/ml. One isolate out of 95 had a MIC of 4 mg/ml for TGC.
Therefore according to EUCAST and FDA TGC breakpoints, resistance
to TGC was 1.1% and 0% respectively. Percentages of resistance to other
antimicrobials are shown in the next table.
Antibiotic No. Resistant isolates Resistance (%)
Piperacillin-tazobactam 87/95 91.6
Ceftazidime 88/95 92.6
Cefepime 89/95 93.7
Meropenem 86/95 90.5
Levoﬂoxacin 85/95 89.5
Amikacin 69/95 72.6
Minocycline 4/95 4.2
Tigecycline
EUCAST 1/95 1.1
FDA 0/95 0
Conclusions: TGC was the most active antimicrobial against Acineto-
bacter. It is important to take into account that E-test underestimates
in vitro activity of TGC vs. Acinetobacter. This could have important
implications for patients with an Acinetobacter infection.
P868 Vancomycin-resistant enterococci: validation of susceptibility
testing and in vitro activity of novel antibiotics
M. Rathe, L. Kristensen, H. Schumacher (Herning, DK)
Objectives: Acquired vancomycin resistance among Danish clinical
isolates is rare making detection of low level resistance challenging.
We evaluated the current breakpoints, given by EUCAST, ability to
discriminate vancomycin resistant enterococci (VRE) from vancomycin
susceptible strains. Furthermore we evaluated the antimicrobial activity
of daptomycin, linezolid and tigecycline towards both VRE and
vancomycin susceptible strains.
Methods: A total of 125 unique isolates were tested. The isolates
were classiﬁed by PCR as either vanA, vanB or susceptible. They
were divided upon 82 Enterococcus faecium (33 vanA, 25 vanB and
24 susceptible) and 43 Enterococcus faecalis (1 vanA, 20 vanB and
22 susceptible). On each day of testing appropriate QC strains were
tested. All determinations were within published QC ranges. MICs
were determined with Etest (AB Biodisk) on Mu¨llerHinton (MH) agar
according to the instructions of the manufacturer. Disk diffusion test
were performed using vancomycin (5mg.), tigecycline (15mg.) and
linezolid (10mg.) disks from Oxoid on Iso-sensitest agar, according to
the recommendations of the Swedish Reference Group for Antibiotics.
Results: All strains were susceptible to tigecycline (MIC50 and MIC90
were 0.125mg/L) and linezolid (MIC50 and MIC90 were 2mg/L). For
daptomycin MIC50 and MIC90 were 2 and 4mg/L respectively. Disk
diffusion results were in concordance with Etest results. Vancomycin
MIC determination by Etest produced 4 very major errors (resistant
strains misinterpreted as susceptible) when compared to the vancomycin
genotype. Disk diffusion produced 17 very major errors for E. faecalis
and 15 for E. faecium. A tentative breakpoint of 15mm. for E. faecalis
produced only three very major errors while a tentative breakpoint of
16mm. for E. faecium produced only four very major errors. Off note we
found that 96% of strains with the vanB gene and 20% of the susceptible
strains had a diffuse inhibition zone edge.
Conclusion: Our study suggests that disk diffusion using the current
breakpoints is inadequate when testing for vancomycin resistance,
producing an unacceptably high number of very major errors. Modifying
breakpoints would lessen the number of such errors considerably but not
eliminate them. Inspecting the inhibition zone for a diffuse edge may
contribute to identifying resistant strains.
P869 Evaluation of phenotypic methods for detection of extended-
spectrum b-lactamases in a clinical microbiology laboratory
Y. Cosgun, M. Yucel, E. Yildiz, A.E. Karakoc (Ankara, TR)
Objective: Extended spectrum b-lactamases (ESBLs) are an increasing
cause of resistance in nosocomial isolates of Enterobacteriaceae.
The laboratory detection of ESBLs can be complex and sometimes
misleading. The aim of this study is to evaluate the results of CLSI
ESBL disk diffusion screening criteria in 243 Escherichia coli and 140
Klebsiella spp. nosocomial isolates, together with the results of CLSI
disc diffusion clavulanic acid inhibition effect (CAIE), VITEK2 CAIE
and double disk synergy (DDS) methods.
Method: A total of 383 Gram-negative bacilli (243 E. coli, 120
Klebsiella pneumoniae and 20 Klebsiella oxytoca) which were isolated
between April 2005-December 2006 and deﬁned as nosocomial
pathogens according to CDC criteriae were included in this study. All
the strains were evaluated with respect to CLSI screening criteria using
the discs; cefpodoxime (POD), ceftazidime (CAZ), cefotaxime (CTX),
ceftriaxone (CRO) and aztreonam (ATM). Isolates that were considered
to be potential ESBL producers according to the CLSI screening criteriae
were then examined with CLSI disc diffusion CAIE using CAZ and CTX
in the presence and absence of CA. All the strains were also analysed
by VITEK2 system (AST-GN13 panel, BioMerieux, France) according
to MIC breakpoint values of CTX, CTX/CA, CAZ, CAZ/CA, cefepime
(FEB), FEB/CA. DDS was tested evaluating the synergistic effect of
amoxicilline clavulanic acid (AMC) with CAZ, CTX, CRO, POD and
ATM.
Results: According to CLSI screening criteria 148 isolates (91 E. coli,
51 K. pneumoniae, 6 K. oxytoca) were determined as potential ESBL
producers. Of these 148 isolates; 139 were DDS positive, 140 were
VITEK2 CAIE positive. Considering the CLSI ESBL conﬁrmation
criteria, 134 isolates showed CAIE using CAZ, CAZ/CA and 133 isolates
showed CAIE using CTX, CTX/CA. The sensitivities of the ﬁve discs
used for ESBL disk diffusion screening were as CRO > CTX = ATM >
POD > CAZ in decreasing order.
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Conclusion: Although phenotypic methods for determination of ESBL
production have been widely used in routine microbiology laboratories,
they have certain limitations. While the results in this study favour the
use of either automated antimicrobial susceptibility system or DDS for
this purpose, CLSI phenotypic conﬁrmation with these methods increase
the reliability.
P870 A practical aid for detection of extended-spectrum
b-lactamases in Enterobacteriaceae
N. al Naiemi, Y.J. Debets-Ossenkopp, C. Vandenbroucke-Grauls,
P.H.M. Savelkoul (Amsterdam, NL)
Objectives: The detection of Extended-Spectrum Beta-Lactamases
(ESBLs) is of special importance, because this resistance genes present
serious implications for therapy. Currently, genotypic characterisation of
ESBL genes is considered the gold standard for ESBL identiﬁcation.
However, the detection of ESBL genes with PCR and sequencing is
complex and does not provide information about their expression. In this
study, we evaluated the performance of the combination of the molecular
hyplex® ESBL ID (h-ES-ID) test and the ESBL screening agar (ESA)
in the identiﬁcation of ESBL-producing Enterobacteriaceae isolates.
Methods: The h-ES-ID is a multiplex-PCR-ELISA for the direct
detection of b-lactamase-producing bacteria. In the presence of relevant
DNA, speciﬁc ampliﬁcation products of the blaTEM, bla SHV, bla
CTX-M (except CTX-M-8) and bla OXA-1 group are synthesised and
subsequently visualised with the h-ES-ID hybridisation modules. The
ESA is a MacConkey agar with third generation cephalosporins, AmpC
b-lactamase inhibitor and vancomycin. We examined a total of 149
clinical Enterobacteriaceae isolates, 61 of them had been previously
characterised as ESBL-producers with PCR and sequencing. The other
88 isolates were ESBL negative.
Results: The sensitivity, speciﬁcity and duration of test of h-ES-ID and
ESA were 98% (60/61), 57% (50/88), 3 hours, 100% (61/61), 93%
(82/88) and 18 hours respectively. With the combination of h-ES-ID and
ESA, all the ESBL-positive and ESBL-negative isolates were detected
correctly. CTX-M ESBL producers were detected within 3 hours with
h-ES-ID. The low speciﬁcity of h-ES-ID was mainly due to TEM-1
producers among Escherichia coli isolates. These isolates were correctly
identiﬁed with the ESA.
Conclusion: The combination of h-ES-ID and ESA is a quick,
effective, and easy to use method for ESBL detection, especially of
CTX-M ESBLs, which are the most prevalent ESBLs worldwide. This
combination of tests provides useful early therapeutic guidance by the
rapid identiﬁcation of ESBL-positive isolates.
P871 Extended-spectrum b-lactamases screening agar with AmpC
inhibition
N. al Naiemi, J.L. Murk, P.H.M. Savelkoul, C.M. Vandenbroucke-Grauls,
Y.J. Debets-Ossenkopp (Amsterdam, NL)
Objectives: The serious increase in the prevalence of Extended-
Spectrum Beta-Lactamases (ESBLs) worldwide creates a need for
effective screening methods to detect these resistance genes. The
currently used screening agars have low speciﬁcity, mainly due to growth
of isolates of species with inducible AmpC b-lactamases. In this study
we evaluated an ESBL Screening Agar (ESA) which inhibits growth
of AmpC-producing isolates and Enterococci, and compared it with
the commercially available BLSE agar (AES Laboratory, France) for
selective isolation and presumptive identiﬁcation of ESBL-producing
Enterobacteriaceae.
Methods: The ESA consists of two MacConkey Agars containing either
ceftazidime 1.0mg/l or cefotaxime 1.0mg/l + cloxacilline 400mg/l +
vancomycine 64mg/l. The BLSE agar is a commercial double-plate
agar (MacConkey + ceftazidime 2mg/l and Drigalski + cefotaxime
1.5mg/l). The agars were evaluated with 208 Enterobacteriaceae isolates,
70 of them had been previously genotypically characterised as ESBL-
producers. The other 138 isolates were ESBL negative. The ESA was
further evaluated with 100 clinical specimens. All clinical specimens
were futher characterised for ESBL production with ESBL combined
disc test and ESBL Etest.
Results: The sensitivity and speciﬁcity of the ESA and the BLSE agar
tested with the 208 Enterobacteriaceae isolates were 100% (70/70) and
84.7% (117/138), and 100% (70/70) and 57.2% (79/138) respectively.
Isolates of species with inducible AmpC were most commonly the false
positives on BLSE agar. The ESA detected all 5 ESBL-positive clinical
specimens correctly, 4 specimens were false positive. The sensitivity and
speciﬁcity of the ESA in the clinical specimens in this study were 100%
and 95.7% respectively.
Conclusion: The speciﬁcity of ESA for screening of ESBL-producing
strains was signiﬁcantly better than the speciﬁcity of BLSE agar; the
better performance of the ESA was mainly due to less false positive
results due to Amp-C-producing strains. The ESA performed well also
when inoculated directly with clinical specimens. We conclude that
ESA is a sensitive and convenient method to directly screen for ESBL-
producing organisms in clinical specimens.
P872 Detection of ESBLs in various Enterobacter cloacae isolates
in the Polish External Assurance National Quality Control
Scheme POLMICRO 2007
E. Stefaniuk, J. Fiett, J. Empel, M. Gniadkowski, E. Zurek,
W. Hryniewicz, B. Chmylak (Warsaw, PL)
Objectives: The aim of this study was to evaluate quality of performance
of microbiology diagnostic laboratories in Poland. POLMICRO is the
National External Quality Assurance Scheme Programme in Poland.
It addresses several important questions in bacterial identiﬁcation and
susceptibility testing. In one of 2007 editions Enterobacter cloacae was
selected for distribution as a resistant alert pathogen.
Methods: Nine isolates of E. cloacae were prepared as a part of
POLMICRO 2007/III. Each of 476 laboratories participating in the
programme received a set of three phenotypically different isolates.
The aim of every laboratory was to identify the strains to the species
level, provide susceptibility testing results and to detect and interpret the
AmpC- and/or ESBL-mediated resistance. The results were delivered
via Internet. The study set of E. cloacae strains included: a) strains PM-
107, PM-108 and PM-109 with AmpC derepression, b) strains PM-110,
PM-111 and PM-112 with inducible AmpC and ESBL, and c) PM-115,
PM-116, PM-117 with AmpC derepression and ESBL.
Results: Results were received from 467 (99.36%) laboratories and
434 laboratories obtained acceptable results. Because of the educational
character of the control some kinds of errors were permitted. Four-
hundred and sixty-four laboratories correctly identiﬁed isolates to the
species level. Most of laboratories correctly determined susceptibility
to given antibiotics and provided correct clinical interpretation. The
minority of laboratories had difﬁculties with the proper interpretation
of resistance mechanism. Some of these, 9.66% have misinterpreted
the AmpC derepressed mutants as ESBL producers. Some others,
3.65% have not detected ESBLs in wild-type strains whereas 13.09%
laboratories have not identiﬁed ESBLs in the context of the AmpC
derepression.
Conclusions: The great majority of participating laboratories (93%)
were able to properly detect b-lactamase mediated resistance mechanisms
in E. cloacae. The results achieved by most laboratories in POLMICRO
2007/III indicated their competence in the area covered by the control.
P873 Rapid Etest MIC testing using CHROMagar and Mueller-
Hinton agar for Gram-positive and Gram-negative aerobes
A. Engelhardt, A. Yusof, P. Ho, C. Johansson, K. Sjo¨stro¨m (Solna, SE)
Objectives: Same day MIC results of key antibiotics against important
Gram+ and Gram− pathogens can be clinically valuable. Rapid results
can be used to verify, correct, adjust or de-escalate empiric therapy,
as necessary. Appropriate and adequate therapy implemented early can
impact clinical outcome and save signiﬁcant costs. We compared a
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prototype CHROMagar (CMA) to Mueller Hinton agar (MHA) for MIC
testing with Etest to evaluate the possibility of obtaining same day results
for 12 antibiotics of choice for 14 clinically important species of aerobes.
Methods: 108 challenge strains, including MRSA, GISA/hGISA, VRE,
ESBL, AmpC, MBL, OXA phenotypes used comprised: staphylococci
(18), enterococci (11), Escherichia coli (17), Klebsiella pneumoniae (6),
Enterobacter cloacae (5), Citrobacter freundii (5), Serratia marcescens
(5), Pseudomonas aeruginosa (16), Acinetobacter baumannii (10),
Stenotrophomonas maltophilia (10) and Burkholderia cepacia (5) and 9
ATCC reference strains. Etest strips (Gram+: oxacillin, vancomycin, line-
zolid, daptomycin, tigecycline, gentamicin, tetracycline, ciproﬂoxacin, ri-
fampicin, clindamycin, erythromycin, trim/sulfa), (Gram-: ciproﬂoxacin,
amikacin, tobramycin, gentamicin, aztreonam, piperacillin/tazobactam,
cefepime, cefotaxime, imipenem, tigecycline, colistin, trim/sulfa) were
tested on CMA and MHA according the manufacturer’s instructions and
read at 4, 6, and 24 h.
Results: Good MIC agreement between CMA and MHA (80–100%
+/− 1 dilution) was seen at 24 h for 153/168 (91%) of drug/species
combinations (>8000 data points). Enterobacteriaceae could be read at
6 h and results agreed (+/-1 dilution) with 24 h values for > 90% of
cases for both media. 50% of Gram+ strains could be read at 6 h while
Gram-negative non fermenters (GNF) and certain resistant phenotypes
could only be read after overnight incubation. Colour changes on CMA
were useful species markers.
Conclusion: Rapid same day Etest MIC results for key antibiotics could
be reliably obtained for Enterobacteriaceae, and some staphylococci and
enterococci with CMA and MHA. GNF and certain resistant phenotypes
required overnight incubation. CMA should be further evaluated for
specimen MIC testing to generate same day results for urgent clinical
cases.
P874 Evaluation of a new Etest strip for detection of plasmidic
AmpC
A. Engelhardt, A. Yusof, P. Ho, C. Johansson, K. Sjo¨stro¨m (Solna, SE)
Objectives: Simple and reliable methods for detection of plasmid
mediated AmpC phenotypes are needed in clinical laboratories. In a
previous study (ICAAC abstract D-0451, 2006), Etest prototype strips
for detection of AmpC based on cefotetan (CN) ± cloxacillin (CLO)
was found to be useful. However, cefotetan powder is no longer
readily available. Cefoxitin (FX) resistance used as a screen for AmpC,
comprise an alternative to CN for the design of a FX based test.
This new FX±CLO prototype strip was compared to CN±CLO using
genotypically characterised strains.
Methods: FX 512−8 ug/mL ±CLO double-sided Etest strip was
tested with 48 clinical strains comprising: Escherichia coli (24),
Klebsiella pneumoniae (7), Proteus mirabilis (1), Serratia marcescens
(4), Klebsiella oxytoca (1), Enterobacter aerogenes (7), Enterobacter
cloacae (2), Morganella morganii (2). AmpC genotypes (PCR based)
included CMY-1, CMY-2, DHA-1, ACC, FOX and MIR. Standard Etest
MIC procedure for Gram-negative aerobes was used and reduction of the
cephamycin MIC by 3 dilutions by CLO or the presence of a “phantom
zone” or deformation of inhibition ellipses after 16–20 h incubation was
interpreted AmpC positive.
Results: See table.
Etest AmpC Results
CN±CLO FX±CLO
Phenotype Strains (N) + − + −
Plasmidic AmpC 29 29 0 26 3
Chromosomal AmpC 15 13 2 10 5
Negative controls 4 0 4 0 4
Detection of Plasmidic AmpC (%)
Sensitivity 100 90
Speciﬁcity 100 91
Conclusion: Etest FX±CLO showed acceptable sensitivity (90%) and
speciﬁcity (91%) for detection of various genotype plasmidic AmpC
enzymes and may comprise an alternative diagnostic tool for routine use
in clinical laboratories.
P875 Detection of plasmid mediated AmpC b-lactamase in clinical
isolates by three different methods
S. Ak, B. Sener, G. Hascelik (Ankara, TR)
Objectives: AmpC mediated b-lactam resistance in Escherichia coli and
Klebsiella spp. is an emerging problem all over the world. High level
AmpC production is typically associated with in vitro resistance to all
b-lactams except for carbapenems and cefepime. AmpC detection is
important to ensure effective therapeutic intervention and optimal clinical
outcome. Nevertheless, detection of AmpC mediated b-lactam resistance
is a challenge for laboratories. There is no recommended CLSI guidelines
for detection of this resistance mechanism. The aim of our study is to
address this issue by tetsting different methods.
Methods: A total of 210 blood isolates of E. coli and Klebsiella
spp. resistant to cefoxitin, amoxycillin-clavulanic acid, aztreonam, and
any of cephalosporins were taken to the study. All isolates were
identiﬁed by Phoenix automatised system. Susceptibility testing against
imipenem, ceftazidime, cefotaxime, aztreonam, cefepim, cefotetan,
cefpodoxime, cefoxitin, amikacin, tobramycin, amoxicillin-clavulanic
acid and ciproﬂoxacin were done by disc diffusion. For the phenotypic
detection of plasmid mediated AmpC b-lactamase inhibitor based
method with boronic acid and modiﬁed-three dimensional test were used.
The isolates found as AmpC b-lactamase positive based on phenotypic
results, were conﬁrmed by multiplex PCR for the presence of six
different classes of AmpC b-lactamase coding genes.
Results: Boronic acid inhibition test revealed 46 positive isolates. When
the inhibition test performed by boronic acid was coupled with clavulanic
acid to rule out ESBL presence, the number of positive isolates decreased
to 20. Modiﬁed-three dimensional test yielded 26 positive results. With
multiplex PCR 4 isolates were conﬁrmed as plasmid mediated AmpC
b-lactamase producers. All of these four isolates had inducible type
AmpC b-lactamase and none of them had ESBL.
Conclusion: Although boronic acid inhibition test can be useful for
phenotypic detection of AmpC type b-lactamase, clavulanic acid must
be added to the inhibition test in order to prevent the false positive results
on account of presence of ESBL. For the conﬁrmation of presence of
AmpC b-lactamase, molecular methods, although expensive and labour
intensive, should be used in clinical laboratories.
P876 Phenotypic AmpC detection – which inhibitor is best?
R. Hope, M. Warner, R. Hill, D.M. Livermore (London, UK)
Objectives: Synergy testing for conformation of AmpC activity is not so
well established as for ESBLs, and the inference of AmpC phenotypes
often relies on indirect indicators, e.g. resistance to cefotaxime and
cefoxitin but not cefepime. Oxacillins and boronic acid derivatives, do
however, inhibit AmpC enzymes and we compared their utility in synergy
based detection tests for these enzymes.
Methods: The potential inhibitors, cloxacillin 100mg/L, benzo(b)thio-
phene-2-boronic acid 100mg/L and phenylboronic acid 200mg/L were
tested in combination with cefotaxime, ceftazidime, cefpirome and
cefoxitin by the BSAC agar dilution method against 71 oxyimino-
cephalosporin or carbapenem-resistant isolates with a variety of known
resistance mechanisms.
Results: In general, cefotaxime was the best indicator substrate
for AmpC hyperproduction in Enterobacteriaceae, irrespective of the
inhibitor. Thus, with either boronic acid derivative 8 fold synergy
was seen with cefotaxime for >90% of AmpC hyperproducing
Enterobacteriaceae, with fewer than 5% false positive results for strains
with ESBLs or other resistance mechanisms. Cloxacillin gave 4-fold
synergy for 90% of AmpC producing Enterobacteriaceae too but this
low potentiation threshold was associated with poor speciﬁcity, with 30%
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false positives among the isolates with other modes of cephalosporin
resistance. Moreover cloxacillin failed to potentiate cephalosporin
MICs for AmpC-hyperproducing P. aeruginosa isolates; whereas 16-
fold, synergy typically was seen for the boronic acid, ceftazidime
combinations. Some failures (mostly with Enterobacter) occurred when
ESBLs were present together with AmpC enzymes.
Conclusion: Benzo(b)thiophene-2-boronic acid/cefotaxime combina-
tions provided the most effective AmpC synergy test for Enterobac-
teriaceae, with cefotaxime MICs potentiated 8 fold for >90% of the
AmpC producers and with good speciﬁcity. Boronic acid/ceftazidime
combinations were more suitable for P. aeruginosa.
P877 Evaluation of Sensititre® Yeastone® for direct antifungal
susceptibility testing from blood cultures
A. Camporese, S. Grosso, G. Bruschetta, R. De Rosa, M. Avolio
(Pordenone, IT)
Objectives: The aim of this study was to evaluate Sensititre YeastOne
(TREK Diagnostic Systems, Cleveland, USA), already used in our
routine diagnostics for performing in-vitro antifungal susceptibility
testing, starting directly from the bottle of blood culture positive for
yeasts, with the explicit aim of intervening to reduce the TAT for
antifungal susceptibility testing.
Organisms (no. tested) MIC (ug/ml)
and Range MIC50 MIC90
antifungal agents Reference
procedure
Direct
procedure
Reference
procedure
Direct
procedure
Reference
procedure
Direct
procedure
Candida albicans (20)
amphotericin 0.008−0.06 0.008−0.06 0.03 0.03 0.06 0.06
ﬂuconazole 0.125−0.25 0.125−0.25 0.125 0.125 0.25 0.25
itraconazole 0.016−0.03 0.016−0.03 0.016 0.016 0.03 0.03
ketoconazole 0.008−0.016 0.008−0.016 0.008 0.008 0.016 0.016
5-ﬂuorocytosine 0.03−0.06 0.03−0.06 0.03 0.03 0.06 0.06
voriconazole 0.008−0.016 0.008−0.016 0.008 0.008 0.016 0.016
Candida glabrata (10)
amphotericin 0.03−0.25 0.03−0.25 0.06 0.06 0.125 0.125
ﬂuconazole 16–32 16–32 16 16 16 16
itraconazole 0.5−4 0.5−4 1 1 2 2
ketoconazole 0.016−2 0.016−2 1 1 2 2
5-ﬂuorocytosine 0.03−2 0.03−2 0.06 0.06 0.5 0.5
voriconazole 0.25−2 0.25−2 0.5 0.5 1 1
Candida tropicalis (4)
amphotericin 0.25−1 0.25−1 0.25 0.25 0.5 0.5
ﬂuconazole 2−8 2−8 4 4 8 8
itraconazole 0.25−2 0.25−2 0.5 0.5 1 1
ketoconazole 0.125−1 0.125−1 0.5 0.5 1 1
5-ﬂuorocytosine 0.25−4 0.25−4 0.5 0.5 2 2
voriconazole 0.008−1 0.008−1 0.06 0.06 0.5 0.5
Candida parapsilosis (4)
amphotericin 0.125−1 0.125−1 0.25 0.25 0.5 0.5
ﬂuconazole 2−8 2−8 4 4 8 8
itraconazole 0.125−1 0.125−1 0.25 0.25 0.5 0.5
ketoconazole 0.125−1 0.125−1 0.25 0.25 0.5 0.5
5-ﬂuorocytosine 0.125−1 0.125−1 0.25 0.25 1 1
voriconazole 0.016−0.5 0.016−0.5 0.06 0.06 0.25 0.25
Candida krusei (2)
amphotericin 0.25−1 0.25−1 0.25 0.25 0.5 0.5
ﬂuconazole 128–256 128–256 256 128 256 128
itraconazole 0.5−2 0.5−2 1 1 2 2
ketoconazole 0.5−2 0.5−2 1 1 2 2
5-ﬂuorocytosine 0.125–16 0.125–16 0.5 0.5 4 4
voriconazole 0.125−2 0.125−2 0.25 0.25 1 1
Methods: In our laboratory, blood culture bottles are normally incubated
using the system BacT/ALERT 3D (bioMerieux, Marcy l’Etoile, France).
Sensititre YeastOne was used by direct inoculation from positive blood
culture bottles in 40 cases of candidaemia. All the results obtained
directly from a positive bottle were compared with those obtained using
standard laboratory procedures, after sub-culturing from a positive bottle
onto solid media. The strain of Candida parapsilosis ATCC 22019 was
used for quality control. The direct susceptibility test was performed
as follows: the positive blood culture bottle was shaken and used to
prepare a Gram stain to conﬁrm the presence of yeast monomicrobism.
Five to six ml of the sample were aspirated with a vacutainer test tube
(Sarstedt, Nu¨mbrecht, Germany) and centrifuged at 3200 revs for 15
minutes; the microbial pellet was gradually suspended in a small aliquot
of physiological solution then diluted with physiological solution in
order to obtain turbidity of 0.5 McFarland. This ﬁnal suspension was
used to perform the susceptibility test according to the manufacturer’s
instructions. Incubation at 35ºC was continued for 24 hours.
Results: The table summarises the in vitro susceptibilities (MIC’s range,
MIC 50 and MIC 90) of the 40 isolates of Candida spp., compared
with the results obtained in accordance with the standard procedures.
Considered as a whole, out of a total of 40 strains tested, no very major
errors or major errors were revealed and only ﬁve minor errors (98%
agreement rate out of a total of 240 drug/bug combinations tested).
Conclusion: The results obtained from direct inoculation of Sensititre
YeastOne demonstrated excellent performance and compared very well
with tests performed using standard procedures. In addition, results were
easy to interpret and available on average 3 days earlier than conventional
results, allowing a potentially very signiﬁcant reduction in the TAT
and providing tangible information, about the current management of
antifungal therapy or, if necessary, its modiﬁcation.
P878 Detection and reporting betalactam resistance phenotypes
in Escherichia coli and Klebsiella pneumoniae: a multicentre
proﬁciency study in Spanish laboratories
M.C. Conejo, C. Mata, F. Navarro, A´. Pascual and the GEMARA
collaborative group
Objective: To evaluate the ability of Spanish microbiology laboratories
in detecting and reporting betalactam resistance phenotypes in well-
characterised clinical isolates of Escherichia coli and Klebsiella
pneumoniae expressing extended-spectrum b-lactamases (ESBL) or
AmpC b-lactamases.
Methods: Twelve well-characterised strains were sent to 57 laboratories:
6 clinical isolates expressing the most prevalent ESBL in our country
(2 CTX-M-10, 1 CTX-M-9, 1 CTX-M-14, 1 TEM-4 and 1 SHV-
12), 3 isolates producing AmpC-type enzymes [ACBL; 2 plasmid-
mediated (FOX-5 and CMY-2) and one E. coli hyperproducing
chromosomal ACBL], and 3 ATCC reference strains (1 with SHV-8).
Laboratories were requested to use routine methods for identiﬁcation
and antimicrobial susceptibility testing (AST), considering the strains
as blood isolates. Reference results were established by two independent
laboratories by using API strips for identiﬁcation and CLSI microdilution
and disc diffusion methods and interpretative criteria for AST.
Results: Automated systems were used by 61% of laboratories for
bacterial identiﬁcation and AST. The remaining laboratories used semi-
automated or manual systems. Ninety one percent of laboratories
correctly recognised all seven ESBL producers and consequently
low rates of errors were observed when testing cephalosporins and
aztreonam. The highest rates of errors with all the ESBL producers were
observed when testing the penicillin/b-lactamase inhibitor combinations,
but in more than 60% of cases these errors were not related to
the MIC value but to the microbiologist interpretation (minor errors).
No discrepancies were observed for carbapenems in ESBL producers.
Correct recognition of all three ACBL producers was assessed by
47% laboratories. ACBL producers were erroneously reported as ESBL
producers in 11 cases and as penicillinase hyperproducers associated or
not to permeability reduction in 10 cases. Interpretative criteria applied
to ACBL phenotype were not uniform, but a tendency of considering
carbapenems as the only therapeutic option was observed.
Conclusions: Most laboratories in Spain detected the ESBL phenotype,
but detection of the ACBL phenotype by routine methods needs to be
improved.
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P879 Assessment of capacity of Russian microbiological
laboratories to detect ESBL production in Gram-negative
bacteria by phenotypic methods
O. Kretchikova, N. Ivanchik, R. Kozlov (Smolensk, RU)
Backgound: Patients with infections caused by ESBL-producing
organisms are at an increased risk of treatment failure with b-lactam
antibiotics. Thus ability of microbiological laboratory to detect ESBLs
is very important. No adequate information of ability of Russian
microbiological laboratories to detect ESBL is available so far.
Objectives: To assess capability of microbiological laboratories in
different regions of Russia to detect ESBL production in Gram-negative
bacteria with phenotypic methods.
Methods: This study was a part of nationwide external quality control
program. Forty three microbiological laboratories from 22 regions
of Russia participated in the study. Two "blinded" strains (ESBL-
producing strains of Enterobacter cloacae and Providencia rettgeri)
were distributed for identiﬁcation, susceptibility testing to cefotaxime
(CTX), ceftazidime (CAZ), cefepime (CFP) and interpreting resistance
phenotypes (including ESBL) with any test routinely used in the
laboratory. E.cloaceae was producing TEM-29 (ESBL). P. rettgeri was
producing TEM-1 and STX-M-3 (ESBL). MICs of both strains for
different antimicrobials are presented in the Table. Sises of zones of
inhibition for CTX, CAZ and CFP formally were in “susceptible” range
for both strains according to CLSI breakpoints.
Results: In 3 of 43 laboratories automatic susceptibility testing systems
(ATB Expression and VITEK) were used, in remaining 40 laboratories
susceptibility testing has been performed by disk diffusion method. In
all laboratories identiﬁcation was done correctly. ESBL production in
E.cloaceae was detected only in 4 (9.3%) laboratories and the strain was
considered as resistant to CTX, CAZ and CFP. None of these laboratories
used automatic susceptibility testing systems (ASTS). In all laboratories
using ASTS E.cloaceae strain has been reported as susceptible to CTX,
CAZ and CFP. ESBL production in P. rettgeri was detected in 7 (16.3%)
laboratories, 3 of which used ASTS and the strain was considered as
resistant to CTX, CAZ and CFP.
Table: MICs of tested strains for antimicrobials (mg/L)
Strain CTX CTX/CL CAZ CAZ/CL CFP CFX AMX AMX/CL
E. cloacae 0.25 0.25 8 0.25 1 64 256 64
P. rettgeri 8 0.125 0.5 0.25 8 2 256 256
CTX = cefotaxime, CAZ = ceftazidime, CFP = cefepime, CFX = cefoxitine, CL =
clavulanic acid, AMX = amoxicillin.
Conclusion: Capacity of routine clinical microbiological laboratories
in Russia to detect ESBL production in Gram-negative bacteria is
inadequate and needs to be improved.
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P880 Validation of the extended-spectrum b-lactamase phenotype
with molecular methods
T. Bruderer, L. Poirel, H. Adler, P. Nordmann, R. Frei (Basel, CH;
Le Kremlin-Bicetre, FR)
Objectives: In order to validate extended-spectrum b-lactamase (ESBL)
screening and conﬁrmation assays, we determined the presence of 6
different ESBL-encoding genes in a representative collection of Swiss
isolates showing an ESBL phenotype. In the subset of isolates in which
no ESBL genes were detected, the presence of SHV-1 hyperproducing
penicillinase, group D oxacillinases, and plasmid-mediated AmpC
b-lactamases was additionally assessed.
Methods: The clinical Enterobacteriaceae isolates expressing an ESBL
phenotype were consecutively collected at the University Hospital
Basel (n = 39) or obtained from several Swiss laboratories (n = 33). As
phenotypic conﬁrmatory test, three different ESBL Etest strips (AB
Biodisk, Sweden) were used: ceftazidime, cefotaxime, and cefepime,
each plus/minus clavulanic acid. Repetitive patient isolates and K1
hyperproducing Klebsiella oxytoca were excluded. To determine the
molecular types, PCR amplifying SHV, TEM, CTX-M, VEB, PER, GES,
OXA-1, OXA-10 genes as well as genes of the SHV-1 promoter region
and of 6 different phylogenetic groups of AmpC was performed and
amplicons were sequenced.
Results: Among 162 isolates showing an ESBL phenotype, molecular
analysis demonstrated that 103 (63.6%) expressed a CTX-M type,
23 (14.2%) a SHV ESBL-type, 17 (10.5%) a TEM ESBL type, one
GES-1, and one PER-1 ESBL. Among the 21 (13.0%) isolates in
which no ESBL-genes could be detected, 12 Klebsiella pneumoniae
and 6 Escherichia coli harboured the typical C to A mutation in the
second position of the SHV-1 −10 promoter region associated with
hyperproduction of SHV-1. These 18 isolates showed a characteristic
susceptibility and ESBL screening/conﬁrmation pattern that differed
signiﬁcantly from all molecularly conﬁrmed ESBL isolates except
for GES-1. The remaining two E. coli and one Citrobacter koseri/
amalonaticus contained an OXA-1 gene explaining the false positive
cefepime/cefepime + clavulanic acid Etest.
Conclusions: Almost all phenotypic ESBL isolates in which no ESBL
genes could be detected were SHV-1 hyperproducers known leading
to false positive results in phenotypic ESBL tests. The relatively high
number of false positive results might be explained by the low incidence
of ESBLs in Switzerland. Because of their unique characteristics
determined in this study, SHV-1 hyperproducers can be excluded.
P881 Detection of ESBL production by the Hyplex® ESBL ID
multiplex PCR-ELISA system
O. Paniara, E. Kraniotaki, E. Belesiotou, E. Perivolioti, M. Nepka,
K. Fountoulis, E. Platsouka (Athens, GR)
Objectives: Extended-spectrum b-lactamases (ESBL), the enzymes that
are able to hydrolyse diverse b-lactam antibiotics, are widely distributed
among Enterobacteriaceae. This study was performed in order to
compare a novel multiplex-PCR-ELISA-System with the conventional
microbiological methods for the detection of ESBL-producing blood
isolates of Klebsiella pneumoniae, in a Greek tertiary hospital.
Methods: Sixty-two different K. pneumoniae isolates from blood
cultures of inpatients (77% ICU, 18% medical wards, 5% surgical wards)
were collected over a two year period. Two Escherichia coli blood
isolates one positive and the other negative for ESBL production, were
used as positive and negative controls respectively. They were identiﬁed
by standard methods and MICs were determined by the VITEK2
automated system, according to CLSI guidelines. ESBL production was
screened by Etest ESBL. The Hyplex® ESBL ID method involves
ampliﬁcation of blaTEM, blaSHV, blaCTX-M and blaOXA bacterial
DNA by multiplex PCR and hybridisation of the PCR products to speciﬁc
oligonucleotide probes: a Consensus probe (TEM, SHV, CTX-M and
OXA speciﬁc) and a CTX-M speciﬁc probe. Nine of the above positive
blood cultures were tested directly with the Hyplex® ESBL ID test.
Results: Sixty-one out of sixty-two K. pneumoniae blood isolates were
found to produce an ESBL activity by the Etest. The same isolates gave a
positive result with the Consensus probes demonstrating the presence of
ESBL phenotype-associated genes (sensitivity 100%, speciﬁcity 100%).
Only three of the sixty-one isolates gave an additional positive result
with the CTX-speciﬁc probes proving ESBL production. The nine
blood cultures that were tested directly gave identical results with their
respective isolates.
Conclusion: The hyplex®ESBL ID test can be reliably applied for the
detection of ESBL genes carriage by Gram-negative species directly in
positive blood cultures or in blood isolates. This diagnostic utility may
be very useful for the timely detection of ESBL genes and has to be
evaluated.
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P882 ChromID ESBL agar for the detection of extended-spectrum
b-lactamase producing Enterobacteriaceae
J. Montgomery, J. Wang, J. Nakos, V. Gurtler (Melbourne, AU)
Objectives: Extended spectrum b-lactamases (ESBL) are major nosoco-
mial pathogens, and more recently have emerged in community patients.
This study evaluated chromID ESBL (chromID) chromogenic agar for
the rapid detection of ESBL in Enterobacteria as part of the routine
identiﬁcation and susceptibility testing of isolates, and was compared
with molecular detection.
Method: Using a multipoint inoculator (in-house agar dilution method)
244 pure cultures of Enterobacteria was stamped onto chromID agar,
as part of the daily identiﬁcation procedure. In addition Jarlier’s double
disk synergy tests were also performed. PCR for CTX-M, SHV and
TEM genes was performed on all isolates. AmpC PCR was also done.
Results: Of 244 isolates, 97 were ESBL positive by PCR. These
were Citrobacter freundii (6), Enterobacter aerogenes (5), Enterobacter
cloacae (30), Escherichia coli (30), Klebsiella oxytoca (10), Klebsiella
pneumoniae (13), Proteus penneri (1) and Proteus vulgaris (2). Enzymes
detected included TEM (45), SHV (42) and CTX-M (65). Multiple genes
were detected in 51 (53%) of isolates. Five PCR positive isolates that
failed to grow on chromID, were K. pneumoniae (CTX-M, TEM and
SHV), K. oxytoca (CTX-M), E. aerogenes (SHV) and two E. coli one
with SHV and the other TEM. There were 36 that grew on chromID but
were not conﬁrmed by PCR. Of these false positives 27 (75%) were chro-
mosomal or plasmid-mediated AmpC producers. Of 30 Enterobacteria
that grew on chromID but produced no pigment, 13 were ESBL produc-
ers and included C. freundii (3), E. coli (6), K. oxytoca (1), E. cloacae (2)
and P. vulgaris (1). The sensitivity and speciﬁcity of chromID was 95%
and 80%.In comparison Jarlier’s disk synergy testing were positive in 64
isolates of which 58 were ESBL producers. This method did not detect
39 of the ESBL producers. Sensitivity was 60% and speciﬁcity of 96%.
Conclusions: ChromID agar is a very sensitive medium for the
detection of ESBL-producing Enterobacteria. Some isolates that grow
on the medium but have no pigmentation are ESBL producers. AmpC
producing Enterobacteria are a signiﬁcant source of false positive growth.
P883 Comparison of phenotypic tests for detection of
plasmid-mediated AmpC b-lactamases
J. Montgomery, J. Nakos, V. Gurtler (Melbourne, AU)
Objectives: Detection of plasmid-mediated AmpC b-lactamases is
important for optimal outcome in patients with serious infections.
Laboratory detection of these enzymes is difﬁcult. This study compared
six phenotypic methods of detection of plasmid-mediated AmpC
b-lactamases with PCR.
Methods: Organisms selected included 106 Escherichia coli, 17
Klebsiella spp., three Proteus mirabilis and two Salmonella spp.
Etest MICs wre performed on all isolates. Multiplex PCR comprised
MOX, CMY, DHA, ACC, EBC and FOX genes. Phenotypic tests;
cefoxitin resistance (CR): disk testing with benzeneboronic acid (BB),
benzothiopene-2-boronic acid (BT) and 3-aminophenyl boronic acid
(AB) each combined with a third generation cephalosporin with and
without the boronic acid derivative, (a zone diameter difference of ﬁve
millimetres or more indicated enzyme presence): tris-EDTA (TE) and
cefoxitin with a ﬂattening of the zone indicating inhibition; Cica-beta-
C-test (CC) using the chromogenic cephalosporin HMRZ-86, combined
with a boronic acid inhibitor. Disk diffusion tests used standard CLSI
methods. Etest MIC were performed according to the manufacturers
instructions and interpreted according to CLSI criteria.
Results: Of a total of 128 isolates studied 29 were PCR positive. Twenty-
one of 106 Escherichia coli; ﬁve of 15 Klebsiella pneumoniae, one of
two Klebsiella oxytoca and two Salmonella spp. were PCR positive.
Enzymes detected were DHA (13) and CIT (16). Three Proteus mirabilis
were PCR negative. Six PCR positive and 57 PCR negative isolates had
cefoxitin Etest MIC results equal to or less than 16mg/L. The table
summaries the results when compared with AmpC detection by PCR.
Phenotypic
method
Sensitivity
%
Speciﬁcity
%
Positive
Predictive Value
Negative
Predictive Value
CR 76 58 34 89
BB 76 80 52 92
BT 72 61 35 88
AB 69 88 63 91
TE 45 92 62 85
CC 31 91 53 82
Conclusions: No one phenotypic method tested reliably detected all
plasmid-mediated AmpC enzymes. A combination of CR and CC may
be useful but requires further study. Screening methods still require PCR
conﬁrmation.
P884 Development and validation of a novel media (CHROMagar
ECC CTX-M) for isolation of CTX-M producing Enterobac-
teriacae whilst inhibiting ampC producing organisms
L.P. Randall, A. Brook, M. Kirchner, C. Teale, N. Coldham,
M. Woodward, E. Liebana, F. Clifton-Hadley (New Haw, UK; Parma, IT)
Objectives: To develop and validate a novel media based on
CHROMagar ECC to isolate bacteria containing the blaCTX-M gene
whilst inhibiting ampC strains and to evaluate different phenotypic tests
for identifying blaCTX-M strains as being ESBL producers.
Methods: A panel of strains was assembled to assess different agars for
ability to isolate bacteria containing the blaCTX-M gene whilst inhibiting
ampC strains. The panel comprised 123 isolates (mainly E. coli) and
was characterised genotypically (tested for blaCTX-M blaOXA, blaSHV,
blaTEM and ampC genes) and phenotypically (cefepime, cefotaxime,
cefpodoxime and ceftazidime MAST ESbL ID disks, the Cica-Beta test
and MICs). The ﬁnal evaluation panel comprised ~ 54% and ~ 32% of
strains positive for blaCTX-M and ampC genes respectively. A range of
agents was evaluated as additives to CHROMagar ECC and the most
optimal combination selected to produce CHROMagar ECC CTX-M.
The CHROMagar ECC CTX-M was assessed against other agars with
and without enrichment for the isolation of blaCTX-M positive organism
from bovine faeces spiked with 101 to 104 cfu/g of blaCTX-M strains
with and without the presence of ampC strains.
Table 1: Recovery of CTX-M positive colonies from bovine faecal
samples spiked with ~101 to 104 cfu/g CTX-M positive strains with
and without ~104 cfu/g ampC positive strains
Agar % of colonies that were CTX-M positive
for spike levels;
With/without presence of ampC strains
Spike level 101 102 103 104
CA-ECC 0/0 17/0 0/0 20/17
CA-ECC + 2mg/ml CTX 0/80 0/17 50/100 50/100
CA-ECC + 8mg/ml CTX 17/100 0/100 17/100 50/100
bioMe´rieux ESBL 0/67 0/50 33/83 83/100
CA-EEC-CTX-M 67/83 67/100 67/100 67/100
CA-ECC, CHROMagar ECC; CA-EEC-CTX-M, CHROMagar ECC
CTX-M, CTX, cefotaxime. If no colonies were recovered from faeces
directly cultured onto agars, then enrichment was used (faeces overnight
in buffered peptone water at 37º).
Results: CHROMagar ECC CTX-M showed a 98.5% sensitivity and
83.6% speciﬁcity for growth of the blaCTX-M positive strains in the
panel and this was superior to CHROMagar ECC with addition of
different concentrations of either cefotaxime or ceftazidime and to
bioMe´rieux ESBL-Bx agar. CHROMagar ECC CTX-M was also overall
superior to other agars for the isolation of blaCTX-M strains from bovine
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faeces, and was capable at detecting ~ 10 cfu blaCTX-M strains per gram
of faeces, even in the presence of ampC strains (Table 1). The sensitivity
and speciﬁcity of MAST ESbL ID disks for conﬁrming the blaCTX-M
strains as ESBL strains ranged from 93.9% to 100% for the each set
of disks but the sensitivity and speciﬁcity could be increased to 98.5%
and 100% respectively by taking results from two sets of disks. The
Cica-Beta test showed a 77.3% and 90.9% sensitivity and speciﬁcity for
conﬁrming the blaCTX-M strains as ESBL strains.
Conclusion: The results show that CHROMagar ECC CTX-M is a highly
sensitive, selective and speciﬁc agar for isolating medically important
blaCTX-M strains, particularly in the presence of ampC strains. The
MAST ESbL ID disks proved to be highly sensitive and speciﬁc at
conﬁrming blaCTX-M strains as ESBL’s, particularly if results were taken
from two sets of disks.
P885 Evaluation of a chromogenic medium (chromID™
ESBL, BioMe´rieux) for the screening of ESBL-producing
Escherichia coli
T. Halaby, W. Goessens, T. Krooshof, A. Hofkamp, M.G.R. Hendrix
(Enschede, NL)
Introduction: Detection of Extended-Spectrum-Beta-Lactamase (ESBL)
producing E. coli isolates relies on decreased susceptibility for at
least one of the indicator antibiotics as recommend by the CLSI.
The results are subsequently conﬁrmed in an ESBL conﬁrmation test.
This two-step procedure is necessary to increase the speciﬁcity as
decreased susceptibility may rely on mechanisms other than ESBL.
Since ESBLs are increasing worldwide companies have developed
selective chromogenic media in which the most important ESBL-
producing organisms are identiﬁed by a difference in colony colours.
Growth followed by colourisation is only possible if organisms possess
b-lactamases capable of hydrolyzing the indicator antibiotics present in
the agar.
Objectives: to evaluate the performance of a chromogenic medium
(chromID tm ESBL, BioMe´rieux) compared to the CLSI ESBL-
screening procedure.
Methods: 1968 E. coli strains prospectively sampled between 1/9/2006
and 1/9/2007 isolated from community and hospitalised patients were
included. Susceptibility testing is performed by agar dilution and ESBL
detection is performed using ceftazidime, ceftriaxone and aztreonam as
indicator antibiotics. E. coli strains with MICs > 1mg/l for either agent
are subjected for conﬁrmation. Conﬁrmation for ESBL is performed by
combined double disks (DD) of Becton Dickinson (Sparks, MD, USA),
consisiting of cefotaxime (30 micg) or ceftazidime (30 micg) alone and
combined with clavulanic acid (10 micg). All isolates growing on the
chromID tm ESBL with pink to burgundy colours were also subjected
to the same conﬁrmation procedure.
Results: 1799 isolates were ESBL negative according to the CLSI
guidelines and did not grow on ChromID tm ESBL plates. 169 isolates
were tested positive of which 81 also grew on ChromID tm ESBL plates.
75 out of the 81 were conﬁrmed ESBL-positive by DD. 64 isolates out of
88 not growing on ChromID tm ESBL but positive in the CLSI screening
were negative in the DD conﬁrmation. One isolate missed by ChromID
tm was tested positive in the DD conﬁrmation. 23 remaining isolates
were not tested.
ChromID ESBL pos ChromID ESBL neg
CLSI pos 81 88 169
CLSI neg 0 1799 1799
1968
Conclusion: Application of the CLSI guidelines resulted in twice as
much isolates suspected for ESBL as by ChromID tm ESBL-agar plates.
However, the majority of the extra positives are false positive probably
due to the presence of other resistance mechanisms. Screening for ESBL
with ChromID tm ESBL-agar plates has a higher speciﬁcity than the
method advocated by CLSI.
P886 Evaluation of a chromogenic agar plate as screening
medium for the detection of extended-spectrum
b-lactamase-producing Enterobacteriaceae
M. Boudewijns, M. Zuliani, M. Vandermarliere, J. Colaert (Kortrijk, BE)
Objectives: To evaluate the performance of a selective chromogenic
agar medium (ChromID ESBL, bioMe´rieux) as primary medium
for the detection of extended-spectrum b-lactamase (ESBL)-producing
Enterobacteriaceae directly from clinical specimens.
Methods: Clinical specimens (urine samples, lower respiratory tract
samples, perineal swabs and wound swabs) were prospectively collected
from a hospitalised patient population. Specimens were inoculated on the
ESBL medium and the in house media (MacConkey agar medium and
blood agar medium). Isolates were identiﬁed to the species level by use
of VITEK2 ID cards (bioMe´rieux). Isolates were screened for ESBL
production by MIC analysis and the ESBL test with VITEK2 AST-
N045 cards (bioMe´rieux). ESBL production was conﬁrmed by use of
the combined-disk method (ceftazidime and cefepime with and without
clavulanic acid, Rosco) and the E-test method (cefotaxime, ceftazidime
and cefepime with and without clavulanic acid, AB Biodisk).
Results: A total of 558 specimens were obtained from 374 patients.
The ESBL medium yielded growth of 111 isolates from 101 specimens
(18%). These 101 isolates consisted of 57 Enterobacteriaceae isolates
(51%). The non-Enterobacteriaceae isolates belonged mainly to the
species Pseudomonas aeruginosa. Of the 57 Enterobacteriaceae isolates,
30 isolates were conﬁrmed as being ESBL producers (speciﬁcity
27%). The non-ESBL-producing Enterobacteriaceae isolates consisted
mainly of the genus Enterobacter. A total of 31 ESBL-producing
Enterobacteriaceae were isolated in this study. All but one of these
isolates were recovered from the ESBL medium (sensitivity 97%).
Conclusion: The chromogenic ESBL medium is a sensitive medium
for the detection of ESBL-producing Enterobacteriaceae. Regarding
the speciﬁcity, the growth of non-fermenting Gram-negative rods is a
frequent ﬁnding. However, use of the cytochrome oxidase test enables
rapid identiﬁcation of most of these bacteria. A more important issue is
the growth of Enterobacteriaceae with other resistance mechanisms then
ESBL production. This makes the use of conﬁrmatory testing obligatory
for species known to harbour these non-ESBL resistance mechanisms.
P887 Comparative performance of three phenotypic conﬁrmatory
Etest strips for the detection of extended-spectrum
b-lactamases-producing Enterobacteriaceae in Belgian
hospitals
Y. Glupczynski, C. Behrin, C. Bauraing, P. Bogaerts (Yvoir, BE)
Objectives: Criteria for ESBL detection have only been established for
a limited number of Enterobacteriaceae species (E. coli, Klebsiella spp.,
Proteus mirabilis) by the Clinical Laboratory Standards Institute (CLSI).
ESBL production in other species is clinically signiﬁcant, but remains
under reported owing to the lack of consensus guidelines. We evaluated
the performance of 3 phenotypic conﬁrmatory Etest strips to detect
ESBL producers among a large collection of Enterobacteriaceae clinical
isolates collected in Belgian hospitals.
Methods: 332 ESBL-producing Enterobacteriaceae clinical isolates (149
E. aerogenes, 131 E. coli, 31 K. pneumoniae 11 E. cloacae) obtained in
2006 from 86 centres were investigated. ESBL production was assessed
by multiplex PCR analysis (TEM, SHV, CTX-M) and DNA sequencing.
Three Etest strips containing cefotaxime (TX), ceftazidime (TZ), and
cefepime (PM) alone and in combination with clavulanate (CL) were
evaluated. Etest results were considered positive according to the CLSI
criteria established for E. coli, Klebsiella spp. and P. mirabilis (i.e., a
> 3 two-fold concentration decrease in MIC tested in combination with
clavulanate versus its MIC when tested alone) or when a deformation
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of the inhibition ellipse was observed. Indeterminate Etest results were
considered negative.
Results: Isolates were found to possess blaTEM (n = 300; 153 with
TEM-24 type) blaSHV (n = 31) with SHV-4, -5, and -12 as the most
common types) and CTX-M (n = 35; CTX-M-15, M-1, M-9, M-14,
M-2 as the most frequent). Ability of Etest strips in detecting ESBL
phenotypes in all species isolates was as follows: PM/PM-CL (95.8%),
TZ/TZ-CL (54.8%), and TX/TX-CL (53.3%). Against Enterobacter
aerogenes and other AmpC-positive species (n = 365), accurate ESBL
detection was consistently achieved only by PM/PM-CL (89.7%; 93.2%
in E. aerogenes) while Etest results were mostly indeterminate due
to off scale values for TX and TZ-based Etests. Against non-AmpC
producing species (n = 367), sensitivity of ESBL detection was: TZ/TZ-
CL (92.8%), TX/TX-CL (92.2%) combination of both TZ and TX ESBL
Etests (96.4%).
Conclusion: Etest PM/PML appears as the best single phenotypic
conﬁrmatory Etest performance for ESBL detection in this collection
of Enterobacteriaceae containing a large proportion of AmpC producing
isolates. Combination of TZ-TZ-CL and TX-TX-CL Etest strips is well
suited for the detection of ESBLs in E. coli and in Klebsiella spp.
P888 Rapid detection of extended-spectrum b-lactamase production
S.P. Gregory, S. O’Hara, J. Duffy (Salisbury, Loughborough, UK)
Objectives: The aim of this study was to create a method for the
rapid detection of extended spectrum b-lactamases (ESBLs) from Gram-
negative culture isolates using AK rapid technology. Adenylate kinase
(AK) is novel and sensitive microbial cell marker which can be used
to rapidly detect the growth of microorganisms without the need for
conventional culture. The rapid AK method results would be compared
to a phenotypical ESBL-conﬁrmatory assay which takes 18–24 hours.
Methods: A panel of culture isolates comprising ESBL positive and
negative strains were screened by inoculating two MIC-Strip ESBL test
strips obtained from Merlin Diagnostics (Bornheim, Germany) according
to the manufacturers instructions. The ﬁrst strip was incubated overnight
at 35–37ºC and the result read visually. The phenotypical conﬁrmation
test is a 3 two-fold decrease in MIC of the suspected organism to
cefpodoxime in the presence of a ﬁxed concentration of clavulanic acid,
versus its MIC when tested alone. The second strip was incubated at
37ºC for 5 hours after which 0.05 mL was removed from each well,
diluted 1:4 in Mueller-Hinton II broth and 0.1 mL of this diluted sample
was then added to a microtitre plate.
The samples were then processed on a microplate luminometer with
automated injection of the following reagents:
0.05 mL mixed bacterial lysis agent/puriﬁed ADP – for a 5 minute
incubation time the adenylate kinase in the sample converts ADP to
ATP.
0.05 mL Luciferase/Luciferin Reagent – followed by a 1 second read.
The results of each sample were then assessed according to an in-
house devised algorithm and classiﬁed as ‘Growth’ or ‘No Growth’ and
interpreted in the same way as the MIC-Strip ESBL test.
Results: There was 100% agreement between the rapid AK method and
the MIC-Strip ESBL for all the organisms tested. All the ESBL positive
and negative strains were correctly identiﬁed by both methods.
Conclusion: This new rapid method correctly predicted a posi-
tive/negative result for phenotypical ESBL conﬁrmation within 5 hours.
P889 Comparison of VITEK2 generated extended spectrum
b-lactamase phenotypes to double-disc test results in
Enterobacteriaceae
L. Naumiuk, B. Rybak, G. Brzezinski, E. Naumiuk, A. Samet
(Gdansk, PL)
Objectives: The aim of the study was to compare results of extended
spectrum b-lactamase (ESBL) detection suggested by ESBL phenotypes
generated by VITEK2 (bioMerieux) advanced expert system (AES) to
the results of double disk tests (DDT).
Methods: We retrospectively studied AES generated phenotypes
suggesting ESBL presence in Enterobacteriaceae and results of DDT
routinly performed to conﬁrm the presence ESBL enzyme. Modiﬁed
DDT was done with cefepime, cefotaxime and amoxicillin+clavulanic
acid disks. AES phenotypes which included ESBL alone and/or ESBL
together with other b-lactams phenotypes were taken into analysis.
Analysis was performed by our laboratory information system – Promic
(Antrez).
Results: From May to November 2007 we performed 928 Enterobacte-
riaceae susceptibility tests using VITEK2 cards GN021 or GN041. In
140 isolates – among others 46 Enterobacter cloacae, 29 Escherichia
coli, 16 Klebsiella pneumoniae, 13 Citrobacter freundii – AES suggested
detection of ESBL phenotype although DDT conﬁrmed its presence in
only 66 isolates. The highest agreement between the AES and DDT
was in E. coli (100%) and Klebsiella spp. (99%). The least correlation
was noted in E. cloacae (46 phenotypes/6 conﬁrmed), Morganella
morganii (10/1) and Serratia marcescens (10/2). In 64 isolates when
AES suggested ESBL phenotype as a sole b-lactams phenotype DDT
conﬁrmed ESBL production in 48 of them. In this case agreement
between the AES and DDT with regard to species was the same.
Conclusion: VITEK2 AES proposed phenotypes which suggest ESBL
presence do not need conﬁrmation in E. coli and Klebsiella spp.
The same phenotypes in chromosonal cephalosporinase producers
like Enterobacter, Citrobacter, Serratia and Morganella always need
conﬁrmation by another method for example modiﬁed DDT.
P890 Performance of VITEK2 ESBL conﬁrmation test in a set of
well characterised clinical isolates of E. coli, K. pneumonia,
K. oxytoca and Enterobacter species. An alternative for
double disc testing
Y.J. Debets-Ossenkopp, N. al Naiemi, S. Lee, J.L. Murk, J.A. Mulder,
C.M.J.E. Vandenbroucke-Grauls (Amsterdam, NL)
Objectives: Severe infections caused by ESBL-producing micro-
organisms are becoming more common all over the world. Rapid
and accurate ESBL detection has to be pursued by routine clinical
laboratories in order to offer assistance in guided antibiotic therapy.
Phenotypic ESBL conﬁrmation tests must be performed on isolates that,
based on initial antimicrobial testing, are suspected to produce ESBL.
We evaluated the performance of the VITEK2 ESBL conﬁrmatory test
on two sets of clinical isolates.
Methods: Strains; First set: 31 E. coli (ECO), 3 Klebsiella pneumoniae
(KPN), 1 Klebsiella oxytoca (KOX), 19 Enterobacter spp., ESBL
positive (+) and 7 Enterobacter spp. ESBL negative (−) conﬁrmed
by molecular methods. Second set: 50 Enterobacter spp. ESBL(−) or
(+), phenotypic conﬁrmation with Double Disk Synergy Test (DDST),
Double Disk Combination Test (DDCT) and ESBL E-test. Conﬁrmatory
tests: VITEK2 ESBL card (in conjunction with VITEK2 GNS N048),
DDST, DDCT and E-test cefepime.
Table 1.
Strains Sequencing DDST/DDCT/E-test VITEK2 ESBL test
ESBL+ ESBL− ESBL+ ESBL− ESBL+ ESBL−
First set
E. coli (31) 31 28 3 28 3
K. pneumoniae (3) 3 3 3
K. oxytoca (1) 1 1 1
Enterobacter (26) 19 18 1 17 2
7 7 1 6
Second set
Enterobacter (50) ND 27 27
ND 10* 10*
ND 13* 13*
* MICs cefotaxime and ceftazidime >1mg/L.
Results: see Table 1. Three out of 31 ECO were misidentiﬁed (2/3
SHV-12, 1/3 CTXM-2) with VITEK2 ESBL test as well as with DDST,
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DDCT and E-test. All Enterobacter isolates ESBL (+) strains, that were
conﬁrmed by PCR and sequencing and/or by phenotypic conﬁrmation,
were correctly identiﬁed with the VITEK2. One sequenced Enterobacter
spp. ESBL (−) was false positive with the VITEK2. In 13 out of 40
ESBL (−) strains (phenotypic conﬁrmation), VITEK2 was positive.
Conclusion: For the ECO, KPN the VITEK2 ESBL test performed
as well as the DDST, DDCT and E-test. For Enterobacter isolates
performance of the VITEK2 ESBL test needs further evaluation.
P891 Effect of Oxgall on the imipenem-disc Hodge test in screening
metallo-b-lactamase-producing Gram-negative bacilli
K. Lee, C.K. Kim, D. Yong, J.H. Yum, Y. Chong (Seoul, KR)
Objectives: Increasing prevalence of carbapenemase-producing Gram-
negative bacilli (GNB) has been a concern, but only a few phenotypic
screening tests have been reported. We have been using the imipenem
(IPM)-disk Hodge (cloverleaf) test to screen metallo-b-lactamase
(MBL)-producing GNB. As the original Hodge test using Mueller-
Hinton agar (MHA) was low in reproducibility, we now use MacConkey
agar with much improved results. We investigated responsible ingredient
that improve the results with MacConkey agar.
Methods:Materials used were MHA, MacConkey agar, 10-ug imipenem
disk, Oxgall, starch and lactose. Bacterial strains used were those with
known b-lactamases and clinical isolates. The surfaces of test media were
inoculated using E. coli ATCC 25922 as was the CLSI disk diffusion
test. After drying the surface, test organism was heavily streaked from
the centre to the periphery of the plate and an IPM disk was placed at
the centre. After overnight incubation, decrease of inhibition zone along
the streaked line was measured and decrease of 3mm was arbitrarily
interpreted as positive.
Results: Preliminary comparison using VIM-2-producing Pseudomonas
aeruginosa (PAE, n = 4) and Acinetobacter spp. (ACI, n = 3) showed
that 3 of 7 isolates were Hodge test positive by using MHA, but all
were positive by MacConkey agar. Addition of 1% lactose or starch to
MHA did not change the results. With 3 IMP-1-producing and 4 VIM-2-
producing isolates, addition of 0.2% Oxgall did not improve the results,
but addition of 2% changed the mean inhibition zone from 4.2mm to
8.7mm. OXA type carbapenemase-producing ACI gave positive results,
although the reduction of inhibition zone was less than those with
MBL-producing isolates. MHA-containing 2% Oxgall showed positive
results with 26 of 28 OXA-type carbapenemase-producing ACI. On
MacConkey agar, ESBL- or plasmid-mediated AmpC-producing isolates
did not show positive Hodge test. blaTEM-107-cloned E. coli showed
that the b-lactamase activity was much higher when grown in the Oxgall
2mg/ml-containing ZYP-5052 medium, suggesting bile may enhance
release of b-lactamase into the surrounding medium.
Conclusion: Bile is the ingredient, which improve performance of
imipenem-disk Hodge test in the detection of MBL-producing isolates.
P892 Comparison of performance of MacConkey agar and
Mueller-Hinton agar in imipenem-Hodge test
S.G. Hong, S.K. Hong, H. Lee, S.H. Jeong, W. Song, K. Lee, Y. Chong
(Gyeonggi-do, Busan, Seoul, KR)
Objectives: Imipenem-Hodge test for screening of carbapenemases is
usually performed with Mueller-Hinton agar (MHA). However, some
metallo-b-lactamases (MBL) producing strains show negative results.
The aim of this study was to compare the performance of MacConkey
agar (MCA) and MHA in imipenem-Hodge test.
Methods: The strains comprised 21 MBL-producers (14 IMP-producing
Pseudomonas aeruginosa, 3 VIM-producing P. aeruginosa, 1 IMP-
producing Acinetobacter baumannii, 1 VIM-producing A. baumannii,
1 SIM-producing A. baumannii and 1 VIM-producing Alcaligenes
faecalis) that were not clearly positive from imipenem-Hodge test with
MHA. Twenty nine isolates of non-carbapenemase-producing Enterobac-
teriaceae (AmpC b-lactamase producers, and/or ESBL producers) were
also tested. The surfaces of MHA and MCA plates were inoculated with
a lawn of indicator strain, Escherichia coli ATCC 25922, according to
CLSI disk diffusion method. After drying the agar surface, a test strain
was heavily streaked from the centre of the plate to the periphery and a
10mg imipenem disk (Becton Dickinson) was placed at the centre. After
overnight incubation at 35ºC, presence of deﬁnite growth of indicator
organism in the inhibition zone along the test strain was interpreted as
positive. The two results from MHA and MCA plate were compared.
Results: With MHA, 9 of 21 MBL-producers showed negative results
and 7 were weak positive, while deﬁnite positive results were obtained
from only 5 strains. However, with MCA, 18 of 21 MBL-producers
showed positive results and 3 were weak positive. All of the other
non-carbapenemase producers were negative with MHA. However, with
MCA, one AmpC-producing E. coli showed clearly positive indentation.
Conclusions: Imipenem-Hodge test with MCA were more sensitive and
easier to read the results. The use of MCA should be helpful to clinical
laboratories for the detection of MBL-producing bacteria.
P893 Prevalence and detection of metallo-b-lactamase-producing
Pseudomonas aeruginosa strains from clinical isolates in Iran.
H. Rezaei Yazdi, G. Behzadian Nejad, S. Najar Peerayeh,
M. Mosatafaei (Tehran, IR)
Introduction: Pseudomonas aeruginosa is an opportunistic human
pathogen and a cause of nosocomial infection, especially in immuno-
compromised patients. Carbapenems mainly imipenem and meropenem
are potent agents for the treatment of infections caused by multidrug-
resistant P. aeruginosa. Resistance to carbapenems in Pseudomonas
aeruginosa is often due to loss of the OprD porin. The up-regulation
of Mex AB-OprM efﬂux pump system compromises the activity of
antibiotics including meropenem. The production of MBL is another
mechanism for resistance to b-lactams including carbapenems.
Materials and Methods: The 126 isolates used in this study were
selected from variety clinical specimens collected during 2006 at two
university hospitals in Tehran, Iran. The isolates were identiﬁed by
standard laboratory methods as Pseudomonas aeruginosa.The MICs for
antimicrobial agents were determined according to the guidelines of the
National Committee for Clinical Laboratory Standards. P. aeruginosa
strains that showed resistance or reduced susceptibility to imipenem
and/or ceftazidime were selected for further evaluation of MBL
production by Etest MBL strips.A reduction of imipenem or ceftazidime
MICs by 3 two fold dilution in the presence of EDTA was considered
as positive.PCR analysis for detection of VIM-type MBL and IMP-type
MBL was carried out with speciﬁc primers. Positive controls (MBL-
producing strains)were used for PCR and Etest MBL strips.
Results: Of the 126 nonduplicate isolates tested, seventy strains
that showed resistance or reduced susceptibility to imipenem and/or
cetfazidime, were selected. Seventy isolates that showed resistance or
reduced susceptibility to imipenem and/or ceftazidime were screened
for presence of MBLs by Etest MBL strips. Etest MBL strips showed a
positive results for eight P. aeruginosa strains. Finally, the 8 strains that
were positive by Etest MBL strips gave a positive result with PCR.These
eight strains carried a bla VIM-type gene, and bla IMP-type gene not
detected.
Conclusion: The results from this research demonstrated that approxi-
mately, MBL-positive strains had multidrug-resistant(MDR). These data
demonstrate that VIM-type gene are the most prevalent MBLs among
clinical specimens of P. aeruginosa in Iran. Reports of acquired MBLs
are increasing world wide among both non fermenters and enterobacteria.
Therefore, suitable therapeutic methods should be used to prevent the
spread of these resistances.
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P894 Evaluation of the Cica-Beta Test for routine detection
of AmpC cephalosporinase hyperproduction and
extended-spectrum b-lactamase production
L. Blairon, S. Van den Wijngaert, M. Reynders, O. Vandenberg,
F. Crokaert, A. Dediste (Brussels, BE)
Objectives: Distinction between ESBL and AmpC cephalosporinase
hyperproduction (AHP) among resistant strains of Enterobacteriaceae
is not easy in routine with automated identiﬁcation systems, because of
the low performances of the expertise in recognising such phenotypes.
Cica-Beta Test (CBT) a new chromogenic method is available for rapid
detection of AHP, ESBL, and metallo-b-lactamases (MBL). In the present
study, we evaluated the performances of CBT in the detection of AHP
and ESBL.
Material and Methods: All isolates were tested on VITEK2. ESBL
detection was performed using chromID ESBL Agar and CBT-CVA, in
comparison to combined double disks, according to CLSI guidelines.
AHP was assessed by CBT-C compared to detection of synergy
between 3rd-generation cephalosporins (3GC) and either boronic acid
or cloxacillin. We also tested CBT-I as a screening method able to
detect either AmpC, ESBL, penicillinases or MBL. CBT-MBL was not
tested because of the low incidence of MBL-producing bacteria in our
institution. Inclusion criteria for Enterobacteriaceae were deﬁned by (a)
a positive ESBL-screening or expertise on VITEK2; (b) a resistance up
to 2nd-generation cephalosporins in non-natural AmpC-producers or a
resistance up to 3GC in constitutive AmpC-producers.
Result: Among 40 consecutive stains, 23 were ESBL+, 26 were AHP+.
Sensitivity of CBT-CVA and CBT-C was 83% and 54% respectively,
and speciﬁcity was 65% and 29%. The CBT-I detected a resistance
mechanism in 72%. A discordance between a negative CBT-I and a
positive CBT-CVA or CBT-C was encountered in 12 cases. ChromID
ESBL was positive for all ESBLs, but the speciﬁcity was very low (41%).
Conclusions: The goal aimed by CBT as a screening test for rapid
detection is not reached because of the importance to pick colonies at
boundary of inhibition zone of a 3GC; however, these step requires 18–
24 h of reincubation after primoculture. The CBT is difﬁcult to read
with few contrast between a positive result and a negative one. The CBT
lacks robustness and isolates must be picked in 5 minutes after removing
from the incubator, when the b-lactamase production is maximal. Finally,
the test is very expensive, and shows poor performances. We observed
discordances between the screening test and the speciﬁc CBTs. For those
reasons, CBT is not useful in routine. In comparison, a chromogenic
medium such as ChromID ESBL Agar remains a cost-effective screening
test for ESBL with a maximal negative predictive value.
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P895 First detection of transferable metallo-b-lactamases in the
Netherlands
N. al Naiemi, M.C. Rijnsburger, P.H.M. Savelkoul, M. Llamas,
M. Sparrius, C.M. Vandenbroucke-Grauls, Y.J. Debets-Ossenkopp
(Amsterdam, NL)
Objectives:Metallo-b-lactamases (MBLs) are of special importance due
to their role in microbial resistance to b-lactam antimicrobial agents,
especially carbapenems. The prevalence of Pseudomonas aeruginosa
strains that produce MBLs is increasing worldwide. Currently, nothing
is known on the prevalence of these strains in The Netherlands. We
determined the prevalence and the type(s) of MBLs produced by strains
of Pseudomonas species isolated at the VU University Medical Center,
in Amsterdam, The Netherlands.
Methods: During the ﬁrst 7 months of 2007, the susceptibility proﬁles
of 650 isolates from 329 patients were analysed. Isolates with decreased
susceptibility to imipenem- and/or meropenem were tested for the
production of MBL with MBL E-test. Site of infection/colonisation, and
location of the patient in the hospital at the moment of strain isolation
were recorded. DNA ﬁngerprinting of the strains was performed with
ampliﬁed fragment length polymorphism analysis (AFLP) to determine
clonal relations. Transfer of resistance was investigated with conjugation
experiments. The presence of VIM MBL genes was determined by PCR
with generic primers. Further molecular characterisation of resistance
genes conﬁrmed the resistance pattern.
Results: Of 329 patients, 12 (3.6%) carried a MBL-positive Pseu-
domonas strain. Six strains were associated with clinical infection. The
urinary tract was the most common site of infection. Epidemiological
and molecular analysis showed no indications for a clonal outbreak in
our hospital. Results of the conjugation experiment showed that these
resistance genes were transferable. VIM PCR conﬁrmed the production
of VIM MBL in Pseudomonas isolates of two patients.
Conclusion: To the best of our knowledge, this is the ﬁrst report
that describes infections caused by MBL-producing Pseudomonas
spp. strains in The Netherlands. Although the prevalence of metallo-
b-lactamases is yet low, these results signal the need for development of
accurate diagnostic tests by clinical laboratories to detect the presence
of these resistance genes, so that speciﬁc isolation precautions can be
taken to control their dissemination.
P896 Pseudomonas aeruginosa producing VIM-2 metallo-
b-lactamase in Cantabria, Spain.
M.C. Rodriguez, B. Ruiz, C. Rodriguez, L. Martı´nez-Martı´nez
(Santander, ES)
Background: Carbapenem resistance rates of P. aeruginosa (Pae) in
Spain and in other countries are similar, but strains producing metallo-
b-lactamases (MBL) are quite uncommon in Spain. We report Pae
producing VIM-2 in Cantabria, Spain.
Methods: All Pae isolates intermediate/resistant (I/R) to imipenem
(IMP) and/or meropenem (MPM) (1 per patient) in Jan2004-Dec2006
were tested for MBL production. Susceptibility studies were done by
Microscan, ETest strips and microdilution (following CLSI instructions;
8-fold decrease in the MIC of IMP or MPM combined with 0.4mM
EDTA plus 0.04mM 1,10-phenantroline, compared with the MIC of the
carbapenem alone indicated MBL production). MBL encoding genes
were detected by a multiplex PCR (Mendes R., et al, 2007); PCR and
sequencing were used for identiﬁcation of blaVIM-2 and characterisation
of type 1 integrons. Clonal relation of isolates was tested by Rep-PCR.
Hydrolysis of IMP was detected by spectrophotometry.
Results: The blaVIM-2 gene was detected by PCR in 10 isolates for
which the MICs of IMP and MPM ranged 32–128 and 16–32mg/ml
respectively. In all cases the strains were I/R to ceftazidime, cefepime,
gentamicin, tobramicin and ciproﬂoxacin. 9/12 strains were amikacin-R.
All isolates, except 1, were aztreonam susceptible. All isolates had
a single Rep-PCR pattern. Hidrolysis of IMP in MBL(+) isolates
ranged 0.1622 to 0.2159 nmol/min/mg protein and was abolished in
the presence of 5 mM EDTA. An integron with 5′CS-aac(6)-blaVIM-2-
putative transposase-enconding gene-3′CS was observed.
Conclusions: We have documented in Northern Spain clonally-related
multiresistant P. aeruginosa strains producing type-1 integrons encoding
blaVIM-2 and aminoglycoside-modifying enzymes.
P897 First report of a Morganella morganii clinical isolate
producing VIM-2 carbapenemase
G.J. Da Silva, O. Cardoso, S. Domingues, G. Bento, G. Ribeiro
(Coimbra, PT)
IMP and VIM metallo-b-lactamases (MBL) are the most frequent
carbapenemases, hydrolysing all b-lactams except aztreonam. They are
often encoded by gene cassettes inserted into class 1 integrons. They
are mostly disseminated among Gram-negative non-fermenters and have
been rarely found in Enterobacteria. In 2004, a Morganella morganii
isolate was collected at the University Hospitals of Coimbra, Portugal,
from a patient’s urine with an unusual susceptibility proﬁle for this
species. The aim of this work was to investigate the mechanism
responsible for the reduced susceptibility to imipenem observed in this
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isolate. Susceptibility tests were conﬁrmed by the disc diffusion tests.
MICs were determined by Etest. A synergy test with imipenem and
EDTA was performed for detection of a MBL phenotype. Conjugation
experiments were done by the ﬁlter mating method. Plasmid isolation
was performed by using Plasmid Midi kit (Qiagen). A multiplex PCR
was used for detection of VIM and IMP genes. Class 1 integrons were
detected with speciﬁc primers 5′CS and 3′CS.
The isolate was resistant to amoxicillin, cefoxitin, cefuroxime, nor-
ﬂoxacin, ciproﬂoxacin and susceptible to aztreonam and amikacin. It
showed decreased susceptibility to cefotaxime, meropenem, imipenem
(MIC= 3mg/L) and ceftazidime (MIC= 6mg/L). The double-disk
synergy test with imipenem- and EDTA-containing disks suggested the
presence of a MBL. A multiplex PCR with IMP and VIM speciﬁc
primers with positive controls for VIM-2 and IMP-5 (1,2), and further
sequence analysis of the unique amplicon ca 800 bp, conﬁrmed the
presence of a VIM-2. Combinations of 5′CS, 3′CS and VIM primers
were used to study the surrounding genetic context. A class 1 integron
was ampliﬁed, integrating a unique cassette of aadB allele, unexpectedly
not the blaVIM. The amplicon obtained with 5′CS and VIM reverse
primers carried the aacA7 cassette, followed by the VIM-2 cassette. It
was not possible to amplify a segment with 3′CS primer, suggesting that
this integron has an unusual structure. A plasmid >10 Kb was found
and blaVIM was ampliﬁed, but all the conjugation experiments were
unsuccessfully using E. coli K102 as recipient.
To our knowledge, this is the ﬁrst identiﬁcation of VIM-2 inM. morganii
worldwide. Apparently, spread of this MBL through enterobacterial
population is low and it remained in this hospital a sporadic case, but
the low carbapenem MICs found can mask the real situation.
P898 First occurrence of carbapenem-resistant Pseudomonas
aeruginosa isolates producing VIM-2 metallo-b-lactamase in
a Tunisian university hospital
W. Mansour, O. Bouallegue, D. Bettaieb, S. Dahmen, L. Poirel,
P. Nordmann, N. Boujaafar (Sousse, TN; Paris, FR)
Objective: To characterise the b-lactamase-associated mechanisms of
resistance of carbapenem-resistant Pseudomonas aeruginosa isolates
recovered at the University Hospital Sahloul in Tunisia during a two-
years period.
Methods: Seventy-ﬁve non-repetitive carbapenem-resistant P. aerug-
inosa isolates were recovered from November 2003 to May 2006.
Metallo-b-lactamase (MBL) genes were searched by phenotypic and
genotypic analyses, in particular genes for IMP-1, VIM-1 and VIM-2.
Genotyping was done by ERIC-PCR. Ampliﬁcation of class 1 integrons
was performed by PCR with speciﬁc primers.
Results: All P. aeruginosa isolates were resistant to most b-lactams
tested including imipenem. Five P. aeruginosa isolates possessed the
blaVIM-2 gene. They had been isolated from blood culture and urine
of patients hospitalised in the intensive care units or urology ward.
Genotyping revealed that the VIM-2-positive P. aeruginosa isolates
belonged to a single clone. The blaVIM-2 gene was likely located
on the chromosome of those strains, and found to be inserted in
a class 1 integron. The other carbapenem-resistant P. aeruginosa
isolates (corresponding to three distinct clones) did not produce any
carbapenemase.
Conclusion: This is the ﬁrst report of dissemination of VIM-2 in
P. aeruginosa in Africa. The occurrence of MBL determinants among
P. aeruginosa isolates in Tunisia is worrying and further underlines the
wide spread of VIM-2 worldwide.
P899 Genetic characterisation of the new blaVIM-18 and
comparative antimicrobial susceptibility proﬁle of VIM-18
with highest homologous VIM-variant, VIM-2: report from
the SENTRY Antimicrobial Surveillance Program
M. Castanheira, R. Mendes, J. Bell, H. Sader, R. Jones (North Liberty,
US; Adelaide, AU)
Objective: To characterise the genetic context of a new blaVIM-variant
from India; and to compare the antimicrobial susceptibility (S) proﬁles
of E. coli carrying recombinant plasmids harbouring blaVIM-18 and
blaVIM-2. We recently found that VIM-producing P. aeruginosa were
highly prevalent in Indian medical centres (55% of the carbapenem
[CARB]-resistant [R] isolates) and VIM-2 was the most common VIM-
variant (38.6%).
Methods: As part of the SENTRY Program, CARB-R isolates were
screened for metallo-b-lactamases (MBL). Positive isolates were then
ampliﬁed and sequenced with MBL internal primers and primers
targeting conserved structures of class 1 integrons. blaVIM-2 and
the new blaVIM were ampliﬁed, cloned into PCRScript plasmid
and transformed in E. coli XL1 Blue. Colonies were selected with
chloramphenicol (30mg/L) and ceftazidime (4mg/L). The presence and
orientation of blaVIM was conﬁrmed by PCR and sequencing. S testing
was performed by E-test (ABBIODISK, Solna, Sweden). The region
ﬂanking the MBL integron was ampliﬁed using a degenerate primer
approach. Plasmid contents analysis was also carried out.
Results: P. aeruginosa isolate 243–31C was recovered from a sputum
specimen in Kolkatta, India (2006). PCR and sequencing showed the
presence of new blaVIM variant, named blaVIM-18 (Lahey Clinic).
The deduced VIM-18 protein comprised 262 amino acids showing 74.3
to 99.2% identity to other VIM enzymes. VIM-18 was identical to
VIM-2, except for the deletion of four amino acids. The MBL active
sites were all present. The E. coli carrying blaVIM-18 showed lower
MIC values for ampicillin, cefoxitin, cephalothin and ertapenem (3-,
6-, 4- and 4-fold, respectively) when compared to those obtained
from the E. coli carrying blaVIM-2, while similar MIC values were
noted for imipenem, meropenem, piperacillin, cefotaxime, ceftazidime
and cefepime. blaVIM-18 was the only R gene cassette in a class 1
integron that was ﬂanked upstream by a resolvase gene (tnpR) from
Tn5051-like. Further analysis showed that this isolate carried no plasmid.
Conclusions: VIM-18 displayed reduced activity to some b-lactams,
while retaining similar activity against anti-pseudomonal agents when
compared to VIM-2. Thus, the 12-bp deletion in VIM-18 seems to have
little effect in the activity against target CARB and anti-pseudomonal
cephems. VIM-18 was found in one P. aeruginosa isolate among
numerous VIM-2-producing strains, and it appears to be an evolutionary
derivative.
P900 High carbapenem resistance among Pseudomonas aeruginosa
from India: a national epidemic of multiple metallo-
b-lactamase clones (VIM-2, -5, -6, -11 and new VIM-18)
M. Castanheira, J. Bell, R. Jones, D. Mathai, J. Turnidge (North
Liberty, US; Adelaide, AU; Vellore, IN)
Objectives: We assessed the prevalence of MBL-encoding genes among
carbapenem-resistant P. aeruginosa isolates recovered in India during
2006. In addition, class 1 integrons harbouring MBL genes were
ampliﬁed and compared and MBL-positive isolates were molecular typed
to evaluate clonal dissemination.
Methods: A total of 282 P. aeruginosa were consecutively collected
in 10 Indian medical centres and tested by CLSI broth microdilution
methods. Isolates resistant to imipenem or meropenem (MIC, >8mg/L)
were screened for MBL-encoding genes by Real-time PCR. Positive
samples were tested with primers targeting the class 1 integron conserved
structures anchoring in the MBL genes. Amplicons generated were
sequenced on both strands and MBL isolates ribotyped for possible
clonality.
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Results: Among the 282 isolates, 96 (34%) showed carbapenem
resistance and MBL genes were detected in 53 strains (19% of total; 55%
of carbapenem-resistant). MBL-producing P. aeruginosa were detected
in 9 of 10 hospitals. Five blaVIM genes were found, including a new
variant named blaVIM-18. This new MBL gene showed a 12 bp deletion
(position 428) when compared to blaVIM-2 and was carried as a single
gene cassette in a class 1 integron. VIM-2 producing isolates were most
common (38 strains) and were detected in 8 medical centres. VIM-6
was identiﬁed in 12 isolates from 4 sites. VIM-5, VIM-11 and VIM-18
were found only once. Two medical centres had 3 distinct MBL types and
other 2 had 2 MBL types. Wide genetic diversity was noted among MBL-
carrying P. aeruginosa with 21 and 10 ribotypes seen among VIM-2- and
-6-producers, respectively. Seven clones were found in 1 participant
hospital and 6 clones were noted within institutions. blaVIM-6-carrying
integrons of 3.5 and 5 Kb (5 and 7 isolates, respectively) were detected
and 2 sites had both blaVIM-6 integron types.
Table.
MBL clonality
Site CARB-Ra/
MBL (%)
MBL types
(No. of isolates)
Intra Inter No. of
clones
Kolkatta 30/22 VIM-2 (3), -5 (1), -18 (1) 0 2 2
Indore 42/42 VIM-2 (3), -6 (5) 1 2 3
New Delhi 34/18 VIM-2 (8) 1 3 4
Trivandrum 11/11 VIM-6 (2) 1 0 1
Hyderabad 51/17 VIM-2 (3), -6 (2) 1 3 4
Chennaib 46/0 None − − −
Kochi 30/20 VIM-2 (5) 0 2 2
Manipal 30/20 VIM-2 (10) 2 3 5
Mumbai 30/22 VIM-2 (3), -6 (2), -11 (1) 0 3 3
Rajkot 25/25 VIM-2 (4) 0 1 1
a. CARB-R: carbapenem-resistant; b. Clones of non-MBL CARB-R
P. aeruginosa were documented and VIM-2 by Toleman et al. (2007)
from a 2003 isolate.
Conclusions: MBL-producing isolates have recently been reported in
India, but limited data exists on the prevalence and characterisation
of MBL-encoding genes. In this study we show that MBL-producing
P. aeruginosa are epidemic in India with a great diversity of MBL-
types (5 VIM types, including new VIM-18). In addition, different MBL-
carrying integrons were observed, suggesting widespread dissemination
of MBL-carrying mobile elements. Carbapenem resistance rates among
P. aeruginosa were elevated and were principally caused by MBL
production (57%).
P901 blaVIM-2-carrying integron among Enterobacteriaceae
isolates in Mexico: report from the SENTRY Antimicrobial
Surveillance Program
L. Deshpande, R. Jones, R. Morﬁn-Otero, E. Rodriguez, H. Sader
(North Liberty, US; Guadalajara, MX)
Objectives: To characterise metallo-b-lactamase (MBL)-producing
Enterobacteriaceae (ENT) strains isolated in a Mexican hospital and to
evaluate the genetic context of the MBL-encoding genes. Carbapenems
are generally very active against ENT but resistance has been emerging
and has increased rapidly in some geographic areas due to the
dissemination of MBL-carrying integrons.
Methods: ENT collected as part of the SENTRY Antimicrobial
Surveillance Program were susceptibility (S) tested against >25
antimicrobials by CLSI broth microdilution methods. Isolates with
imipenem and/or meropenem MIC at 2mg/L were screened for MBL
production by the disk approximation test; positive isolates were further
characterised by PCR and gene sequencing. Primers targeting the class 1
integron conserved structures anchoring MBL genes were used to reveal
integron structure. Amplicons generated were sequenced on both strands
and MBL-producing isolates were evaluated for possible clonality by
PFGE.
Results: Three isolates, all from one hospital in Mexico, exhibited
positive MBL-screening test results. Two E. cloacae (2005 and 2007)
and one K. oxytoca (2006) yielded a PCR product with blaVIM primers.
The MBL gene was embedded in a 2.8-Kb class 1 integron in all strains.
Sequencing revealed that blaVIM-2 was located in the ﬁrst position of
the integron followed by 2 gene cassettes: an open reading frame (orf)
and an aminoglycoside acetyl transferase gene (aacA7). The 400-bp orf
showed low homology with other DNA sequences; however the deduced
amino acid sequence showed active domains of a chorismate mutase
enzyme from Pseudomonas ﬂuorescens. The degree of carbapenem
resistance varied signiﬁcantly among these VIM-2-producing isolates.
The E. cloacae isolates were epidemiologically unrelated and one strain
was S to both imipenem and meropenem (ertapenem also S; 0.12 or
0.25mg/L) based on current CLSI breakpoints of 4mg/L (see Table).
MIC (mg/L)a:
Organism IMI MER ERT CPM AMK TET CIP TIG
K. oxytoca
(13268A)
>8 >8 >8 4 4 4 1 0.25
E. cloacae
(3876A)
4b 1b 0.25b 2 4 2 0.03 0.5
E. cloacae
(1068D)
8 1b 0.12b 2 8 >8 0.5 0.5
a. IMI = imipenem, MER = meropenem, CPM = cefepime, AMK =
amikacin, CIP = ciproﬂoxacin, TIG = tigecycline.
b. Indicates susceptible level carbapenem MIC results.
Conclusions: The ﬁnding of distinct ENT strains over a period of 3
years harbouring the same blaVIM-2-carrying integron indicates that this
mobile genetic structure has become locally endemic. MBL-producing
ENT may not be detected by clinical microbiology laboratories due
to S-level carbapenem and other b-lactam MIC results, requiring new
detection strategies or revised S breakpoints.
P902 Molecular typing indicates an important role of two
international clonal complexes in the dissemination of
VIM-producing Pseudomonas aeruginosa clinical isolates in
Hungary
B. Libisch, B. Balogh, J. Paszti, G. Szabo, M. Gacs, M. Fuzi
(Budapest, HU)
Objectives: VIM metallo-b-lactamase-producing serotype O11 or O12
Pseudomonas aeruginosa isolates infecting or colonising 19 patients
from seven hospitals were reported from Hungary between 2003 and
2005. In this work we identiﬁed VIM-producing Pseudomonas spp.
strains from Hungarian towns and hospitals where these resistance
determinants had not been detected before. Our aim was to characterise
these isolates by molecular and phenotypic tools and to investigate their
epidemiological relationship.
Methods: We screened the isolates by EDTA-inhibition based pheno-
typic tests. blaVIM genes and class 1 integrons were detected by PCR
and were sequenced. PFGE was performed by the method described by
Poh et al. with modiﬁcations and MLST was carried out according to
the protocol published by Curran et al.
Results: The newly identiﬁed P. aeruginosa MBL producing isolates
could be assigned to serotypes O1, O11 and O12. All isolates proved
multidrug-resistant; however, it is notable that all P. aeruginosa isolates
remained susceptible to aztreonam by the current CLSI breakpoints.
VIM-producing Pseudomonas spp. clinical isolates from two novel
locations and hospitals in Hungary were identiﬁed, with the detection
of three new blaVIM carrying integron types and the presence of the
blaVIM-2 allele in Hungary. By applying various typing techniques
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including multilocus sequence typing we revealed an important role
of two international clonal complexes in the dissemination of blaVIM
positive P. aeruginosa in hospitals in Hungary. We characterised a
P. aeruginosa nosocomial clone with a singleton sequence type (ST313),
too, that could have acquired blaVIM-2 and blaVIM-4 gene cassettes
from a yet unidentiﬁed local gene pool in Hungary.
Conclusions: This is the ﬁrst report of the occurrence of P. aeruginosa
isolates from Hungary belonging to an international clonal complex
initially described as BG11. In this study we have demonstrated a high
diversity of MBL carrying integrons in Hungary and also propose that
a combination of different factors, such as clonal spread and local
acquisition of MBL genes may both contribute to the appearance of
VIM positive Pseudomonas spp. strains in our country. This work was
supported by the DRESP2 FP6 project.
P903 Dissemination of VIM-1- and VIM-4-producing Acinetobacter
baumannii clones in an intensive care unit
A. Poulou, N. Spanakis, F. Markou, A. Ikonomidis, S. Pournaras,
M. Diomidous, D. Vrizas, A. Tsakris, P. Rozi (Serres, Athens,
Larissa, GR)
Objectives: Acinetobacter baumannii complex are opportunistic
pathogen with increasing relevance in hospital infections, especially
among patients hospitalised in intensive care units (ICUs). The
organism often exhibits multidrug resistance and recently outbreaks of
carbapenem-resistant isolates have been reported worldwide. Acineto-
bacters develop resistance to carbapenems through various mechanisms
including production of metallo-b-lactamases (MBLs). In Europe,
carbapenem resistance has been only sporadically attributed to the
production of MBLs. We describe the dissemination of two different
VIM-type MBLs among clonal carbapenem-resistant A. baumannii
isolates in a Greek ICU.
Methods: During a two year period (April 2005-March 2007) 24 MBL-
producing carbapenem-resistant A. baumannii isolates were collected
consecutively from clinical specimens of separate patients hospitalised
in a medical-surgical Greek ICU. The isolates were tested by MICs,
phenotypic MBL testing and PFGE. PCR and sequencing assays were
used for identiﬁcation of carbapenemase genes and mapping of integrons.
The location of the MBL genes was investigated by PCR, curing and
hybridisation experiments.
Results: The MBL-producers had multidrug-resistant phenotypes and
clustered in two distinct clones. All 19 isolates of the predominant clone
contained blaVIM-1 along with blaOXA-58 and the intrinsic blaOXA-
66 carbapenemase gene. The remaining 5 isolates belonged to a distinct
clone and contained blaVIM-4 along with the intrinsic blaOXA-69
carbapenemase gene. In all cases blaVIM alleles were integrated in class
1 integron variable structures. A. baumannii isolates belonging to the
two VIM-producing clones were also detected in the environment of
the ICU. PCR, curing and hybridisation experiments indicated that the
blaVIM alleles were chromosomally-located.
Conclusions: This study illustrates the spread of blaVIM-1 and
blaVIM-4 MBL genes among different clones of multidrug-resistant A.
buamannii in a well deﬁned clinical setting.
P904 Prevalence of the blaIMP-1 gene in epidemiologically
unrelated Pseudomonas aeruginosa isolates in Korea
J.S. Jin, J.W. Kim, C.H. Choi, J. Kim, Y.C. Lee, S.Y. Seol, D.T. Cho,
J.C. Lee (Daegu, KR)
Objectives: Resistance to carbapenems is reported increasingly in Pseu-
domonas aeruginosa worldwide. This study investigated the resistance
mechanisms against carbapenems and the molecular epidemiology of
carbapenem-resistant Pseudomonas aeruginosa isolates from a Korean
hospital.
Methods: A total of 79 carbapenem-resistant P. aeruginosa isolates were
obtained from a tertiary hospital, located in Daegu, Korea. Antimicrobial
susceptibility was determined by agar dilution methods. Resistance to
carbapenems was characterised by a carbapenemase activity test and
PCR ampliﬁcation. The oprD gene was screended by PCR and the
expression of OprD protein in the outer membrane was determined by
SDS-PAGE. PFGE was performed to determine the clonal relatedness
of P. aeruginosa isolates.
Results: The resistance rates of metallo-b-lactamase (MBL) producers
against b-lactams, aminoglycosides and ﬂuoroquinolones were signiﬁ-
cantly higher than those of MBL non-producers. Of the 79 carbapenem-
resistant P. aeruginosa isolates, two MBL genes were detected in 50
(63.3%) isolates: blaIMP-1 in 40 isolates and blaVIM-2 in 10 isolates.
Both the blaIMP-1 and blaVIM-2 genes were inserted in the gene
cassettes of class 1 integrons, which were located on the plasmids. The
oprD gene was not ampliﬁed in the 43 isolates: 23 of the 50 MBL
producers and 20 of the 29 MBL non-producers. The remaining 36 oprD-
positive isolates showed the reduced expression of OprD in the outer
membranes. PFGE suggests that carbapenem-resistant P. aeruginosa
isolates originated from the diverse clones.
Conclusion: We report the ﬁrst outbreak of IMP-1-producing P. aerug-
inosa in Korea. A high prevalence of plasmid-borne MBL genes
in epidemiologically unrelated P. aeruginosa isolates suggests the
possibility of the intra- and interspecies dissemination of the MBL genes.
P905 Nosocomial outbreak caused by multidrug-resistant
Pseudomonas aeruginosa producing IMP-13 metallo-
b-lactamase in France
G. Cuzon, T. Naas, D. Tande´, R. Baron, C. Berthou, B. Lejeune,
G. Rossolini, P. Nordmann (Kremlin-Bicetre, Brest, FR; Siena, IT)
Objectives: Acquired metallo-b-lactamases (MBLs) are emerging
resistance determinants in Pseudomonas aeruginosa and other Gram-
negative pathogens. Six different MBL-types: IMP, VIM, SPM, SIM,
GIM and AIM, have been identiﬁed. IMP13 has only been described in
Italy so far. Here, we describe the molecular characterisation of IMP13-
producing P. aeruginosa strains from Brest, located West of France.
Methods: Carbapenem-resistant P. aeruginosa strains recovered were
analysed for their DNA content (genomic or plasmid), by isoelectric
focusing (IEF), imipenem hydrolysis, conjugation assays and pulsed-ﬁeld
gel electrophoresis of SpeI digested genomic DNA. PCR were performed
for MBL-genes (IMP, VIM, SPM, SIM and GIM), blaKPC, blaTEM
and blaSHV genes, the chromosomal class C b-lactamase blaAMPC and
blaOXA-50 genes.
Results: An outbreak of P. aeruginosa showing a multidrug-resistant
(MDR) phenotype (being susceptible only to colistin, amikacin, and
fosfomycin) was observed, from February to May 2006 in the
hematology ward of the hospital of Brest, France. The outbreak involved
4 patients with a total of 7 isolates, mostly from blood samples
specimens. Analysis of isolates involved in the outbreak revealed MBL
activity, and PFGE revealed clonal relatedness. A blaIMP-13 gene
cassette inserted into a class 1 integron which also contained an aacA4
aminoglycoside resistance cassette encoding an AAC(6)-Ib enzyme was
identiﬁed in all strains. The blaIMP-13-containing integron and its
genetic environment was different from the epidemic IMP-13-producing
P. aeruginosa isolate from Italy. The blaIMP-13 gene was chromosome-
encoded. Epidemiological investigation revealed no recent trip to Italy
of any of the patients and the only common point between these patients
was their hospitalisation room. However, no overlap in hospital stay, nor
the presence in the environment, since all the environmental samples
were negative for MBL-P. aeruginosa, could explain cross transmission.
Conclusion: Unlike VIM-producing P. aeruginosa for which large
nosocomial outbreaks have been reported in France, Greece and Italy
this is the ﬁrst report of a nosocomial outbreak caused by P. aeruginosa
producing an IMP-type enzyme in France and the second description of
an outbreak related to IMP-13-producing P. aeruginosa isolates.
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P906 Metallo-b-lactamases type IMP associated with loss
expression of OprD porins in nosocomial isolates of
carbapenem-resistant Pseudomonas aeruginosa
C. Gayosso-Vazquez, D. Alcantar-Curiel, R. Morﬁn-Otero, E. Rodriguez-
Noriega, Z. Mussaret, L. Cardiel, V. Firo, N. Justiniani, J.I. Santos,
C. Alpuche-Aranda (Mexico City, Guadalajara, Merida, MX)
Background: Carbapenem resistance (CBPR) in Pseudomonas aerugi-
nosa (Psa) is associated with metallo-b-lactamases (MBLs) production
or AmpC activity combined with loss of the porin OprD. In addition
overexpression of efﬂux pumps could confer CBPR. In this study we
investigated molecular mechanisms of CBPR in Psa causing bloodstream
infections in Mexican hospitals.
Methods: We analysed eight Psa strains characterised in our laboratory.
Antimicrobial susceptibility testing was performed by disk diffusion and
dilution methods following CLSI standards. MBLs activity was detected
by EDTA (0.5M)-disk synergy test with MEM (10mg) or IPM (10mg)
and by E-test-MBL. The MBL genes were characterised by PCR using
speciﬁc primers for IMP, GIM, SPM and VIM, and sequencing analysis.
Production of OprD porin was performed by SDS-PAGE from outer
membrane proteins. PFGE and endonuclease restriction analysis was
used to characterise clonal dissemination.
Results: The eight Psa strains were isolated from three different hospitals
in Mexico: Hospital Civil de Guadalajara (3), Hospital OHoran, (4)
and Hospital General de Mexico (1). All strains were 100% resistant
to AMK, CAZ, CIP, FEP, GEN, IMP, MEM and the MIC to IMP was
>256mg/mL in 6/8 strains. MBLs activity was conﬁrmed in all strains,
however by PCR and sequencing analysis only four strains were IMP
type and negative to the other types. Three of these IMP-expressing
strains failed to produce OprD porin. The PFGE proﬁle demonstrated
clonal variability.
Conclusions: Although isolates analysed are few, this is the ﬁrst study
that conﬁrmed multiresistance, including CBPR in Psa strains causing
serious nosocomial infections selected in different geographic areas in
Mexico.
P907 Molecular epidemiology of Pseudomonas aeruginosa
producing IMP-9 type metallo-b-lactamase isolated in
Guangzhou, China
C. Zhuo (Guangzhou, CN)
Objectives: To investigate the resistance mechanisms and the genetic
relationship of imipenem-resistant Pseudomonas aeruginosa isolates
recovered in some hospitals in Guangzhou.
Methods: Imipenem-resistant P. aeruginosa clinical isolates were
collected in various wards of four hospitals from Mar 2005 to Mar 2007.
The isolates were analysed by PFGE for genotype, Etest MBL, PCR and
sequencing for carbapenemase-encoding genes.
Results: During the study period, 134 clinical isolates of imipenem-
resistant (MIC 8 to >128mg/L) P. aeruginosa were isolated, and
were classiﬁed by PFGE typing into 40 clusters, based on UPGMA
(unweighted pair group method with arithmetic averages) clustering
method. Each hospital had its own major epidemic strains, cluster A
strains was most common in Hospital A(43/66, 65.15%), and strains
belonging to cluster B, C, D were isolated from Hospital B (22.6%),
Hospital C(33.3%) and Hospital D (31.6%), respectively. Although there
was no epidemic circulating in all 4 hospitals, cluster Q appeared both
in Hospital B and D and cluster A also appeared both Hospital B
and Hospital C. There was one isolate belong to independent with the
same genotype found in various samples from hospital A environment
survey, though six patients of lower-airway colonisation with clone A
Pseudomonas aeruginosa had been admitted to the same ICU of hospital
A for many times. Analysis of antimicrobial resistance of the epidemic
strains from four hospitals, revealed that 44 of 45 cluster A isolates of
Pseudomonas aeruginosa produced IMP-9 metallo-b-lactamase, with pI
of 7.8. The bla gene located in class 1 integron, and none of cluster B,
cluster C and cluster D isolates produced IMP-9 metalloenzyme.
Conclusion: The various degree of outbreak of Imipenem-resistant
Pseudomonas aeruginosa had occurred in four hospitals individually
in two years survey. Wide dissemination of IMP-9 metalloenzyme
contributes partially to the imipenem resistance of P. aeruginosa isolates
of cluster A. It was important to manger the patients colonised with
epidemic strain only to prevent clonal transmission.
P908 Biochemical characterisation of the subclass B2
metallo-b-lactamase SfhI
F. Fonseca, A. Correia, J. Spencer (Aveiro, PT; Bristol, UK)
Objectives: Metallo-b-lactamases are characterised by their ability
to hydrolyse almost all b-lactam antibiotics and are not inhibited
by commonly used inhibitors (e.g. clavulanate, tazobactam). The
b-lactamase SfhI was detected in strain Serratia fonticola UTAD54, an
environmental isolate obtained from untreated drinking waters in the
Northeast of Portugal. The aim of the present study was to purify this
class B carbapenemase and determine its biochemical properties.
Methods: The blaSfhI gene was cloned into expression vector
pET-26b(+) after PCR ampliﬁcation using speciﬁc primers and the
accuracy of the DNA construction veriﬁed by sequencing. The
recombinant plasmid was transformed into Escherichia coli BL21(DE3).
Metallo-b-lactamase SfhI was puriﬁed from induced cultures of
E. coli BL21(DE3)(pSfhI) grown in M9Y medium supplemented with
kanamycin at 25ºC. Puriﬁcation of SfhI was achieved by means of
two chromatographic steps, anion-exchange at pH 8.5 followed by size
exclusion at pH 7.0. Molecular mass and metal content of SfhI were
determined by mass spectrometry. Initial hydrolysis rates for a range of
b-lactam antibiotics were measured in 50 mM Hepes buffer pH 7.0 at
25ºC.
Results: High level production of recombinant SfhI was achieved.
Approximately 80mg puriﬁed protein per liter of culture were obtained.
By SDS-PAGE, protein was estimated to be >95% pure. On SDS-
PAGE gels the puriﬁed SfhI migrates as a single band of approximately
26 kDa. Molecular mass of SfhI was determined as 26136 Da
by mass spectrometry, in agreement with values predicted from the
deduced amino acid sequence. The puriﬁed protein was shown to
bind one equivalent of zinc, consistent with the assignment, on
the basis of amino acid sequence, of SfhI to the B2 metallo-
b-lactamase subgroup. Preliminary kinetic data suggest that SfhI
hydrolyses penicillins, cephalosporins and carbapenems, exhibiting high
afﬁnity for carbapenems and low afﬁnity for penicillins and third
generation cephalosporins. Hydrolysis of cefoxitin and moxalactam was
also detected.
Conclusion: The overexpression of blaSfhI allowed us to obtain a large
amount of SfhI enzyme, enabling effective protein puriﬁcation. Although
the SfhI sequence is the most divergent (c.50% identity) of the known
B2 metallo-b-lactamases, kinetic studies showed a substrate range that
generally resembles those of other subgroup members, but includes
cefoxitin and moxalactam, known inhibitors of these related enzymes.
P909 Hydrolysis parameters for doripenem, meropenem and
imipenem tested with b-lactamases of molecular classes A to D
A.M. Queenan, W. Shang, K. Bush, B. Flamm (Raritan, US)
Objectives: Doripenem (DOR) is a carbapenem with activity against
Gram-negative pathogens including activity against P. aeruginosa. One
of the mechanisms of resistance observed for carbapenems such as
imipenem (IPM) and meropenem (MEM) is hydrolysis by b-lactamases
with carbapenemase activity. The purpose of these experiments was
to determine the interactions of doripenem and comparators with
b-lactamases of molecular classes A to D.
Methods: b-lactamases were puriﬁed by gel ﬁltration and ion exchange
chromatography. Protein concentrations were measured by BioRad
Protein Assay. Purity of b-lactamases was assessed by PAGE gels.
Initial hydrolysis rates were measured spectrophotometrically, and kinetic
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parameters were determined using a Hanes plot. MIC values were
determined using CLSI broth microdilution methodology.
Results: Most Class A b-lactamases, including the ESBLs TEM-
26 and CTX-M-15, demonstrated very low levels of hydrolysis for
DOR, IPM and MEM. However, a subset of Class A enzymes, the
serine carbapenemases KPC-2 and SME-3, showed hydrolysis of all
carbapenems tested. For KPC-2, DOR (kcat value 0.55 s-1) and MEM
(kcat 3.6 s-1) were hydrolysed 9–60-fold slower than IPM (kcat 31 s-1).
For SME-3, DOR (kcat 2.4 s-1) and MEM (kcat 3.2 s-1) hydrolysis was
approximately 100-fold slower than IPM hydrolysis (kcat 320 s-1). The
Class B metallo-enzymes such as VIM-2 also hydrolysed DOR more
slowly than IPM (kcat 2.4 s-1 and 20 s-1). The Class C P99 and Class
D OXA-10 had negligible hydrolysis of all carbapenems (kcat <0.02
s-1).
Conclusions: Doripenem was stable to hydrolysis by ESBLs and
AmpC-type b-lactamases. Hydrolysis of all three carbapenems was
observed with the serine carbapenemases and metallo-b-lactamases. For
the carbapenemases, DOR hydrolysis was 5–100-fold slower than IPM
hydrolysis.
P910 Porins and ertapenem resistance in Klebsiella spp. from the
UK
M. Doumith, M. Ellington, D. Livermore, N. Woodford (London, UK)
Objectives: Although still rare, carbapenem resistance is increasingly
detected in Enterobacteriaceae, with ertapenem often the most affected
analogue. We investigated mechanism(s) of ertapenem resistance in
clinical isolates of Klebsiella spp. referred to the UK’s national reference
laboratory.
Methods: MICs were determined by agar dilution or Etest. Isolates
were typed by PFGE of XbaI-digested genomic DNA. Nine isolates
highly resistant to ertapenem (MICs 8mg/ml) were investigated further.
b-lactamase genes were identiﬁed by PCR. Phe-Arg-beta-naphthylamide
(PABN) was used to test the contribution of efﬂux pumps. Porins
were proﬁled by SDS-PAGE. Transcription of ompK35 and ompK36
porin genes and the acrB efﬂux pump gene was analysed by real-
time reverse transcriptase PCR. Porin genes and their promoter regions
were sequenced. Complementation analysis used a plasmid encoding
OmpK36.
Results: The PFGE proﬁles of 30 ertapenem-resistant clinical isolates
from 26 laboratories were heterogeneous. Imipenem and meropenem
MICs ranged from 0.5 to 16 and from 2 to16mg/ml, respectively.
All 9 strains studied in detail produced ESBLs: CTX-M group1
(n = 3), CTX-M group1 and 9 (n = 3) and SHV (n = 3) were identiﬁed.
Ertapenem MICs were reduced by 2-fold in the presence of PABN,
contraindicating efﬂux as a contributor to resistance. Isolates lacked
OmpK35 and OmpK36, but there were no signiﬁcant variations in
the levels of expression of ompK35, ompK36 and acrB genes as
compared with carbapenem-susceptible isolates. Sequencing ompK36
revealed various point mutations or insertion sequences (IS) within the
Open Reading Frames (ORFs), predicted to result in early termination
of translation. Sequencing of ompK35 identiﬁed a wild-type sequence
for 2 isolates and an ORF disrupted by point mutation or IS10 for
2 others whereas, for 5 isolates, IS1 was identiﬁed in the promoter
region or at the end of the ompK35 ORF resulting in a 10 amino acid
deletion. Carbapenem MICs for all strains were reduced markedly when
complemented with a plasmid carrying an intact ompK36 gene.
Conclusions: Ertapenem-resistant Klebsiella spp. from the UK represent
diverse strains. Their major mechanism of ertapenem resistance is ESBL
production in combination with porin loss, most importantly OmpK36
in conjunction with an ESBL.
P911 Characterisation of carbapenem-nonsusceptible Escherichia
coli isolates from a university hospital in Taiwan
Y-F. Liu, J-J. Yan, W-C. Ko, S-H. Tsai, J-J. Wu (Tainan, TW)
Objectives: To investigate characteristics of carbapenem-nonsusceptible
Escherichia coli isolates collected between 1999 and 2005 at a Taiwanese
university hospital.
Methods: A total of 9 nonduplicate carbapenem-nonsusceptible E. coli
isolates were examined. Genetic relatedness was analysed by PFGE.
b-lactamases were characterised by PCR and isoelectric focusing. Outer
membrane proteins and transcripts were investigated by SDS-PAGE and
Northern blotting. Cloning experiments were performed to investigate
the role of membrane permeability in carbapenem nonsusceptibility.
Results: The 9 carbapenem-nonsusceptible isolates were found to
produce the CMY-2 AmpC enzyme (N = 8), the CTX-M-14-type
extended-spectrum b-lactamase (N = 1), the SHV-12 extended-spectrum
b-lactamase (N = 1), and the IMP-8-type metallo-b-lactamase (N = 1)
alone or in combination. All carbapenem-nonsusceptibe isolates revealed
a decrease in the transcription and protein expression of ompC, and
susceptibility to carbapenems was restored in one isolate by introducing
the cloned ompC gene. PFGE revealed genetic diversity among the 9
isolates. All patients with the carbapenem-nonsusceptible isolates had
been treated with carbapenems (6 patients) and/or extended-spectrum
cephalosporins (5 patients) before isolation.
Conclusions: Our study suggests that the decreased susceptibility to
carbapenems in E. coli in the hospital might arise by the stepwise
accumulations of multiple drug-resistance determinants in different
clones.
P912 Carbapenem (cﬁA) resistance gene in Bacteroides fragilis
group strains in Belgium
I. Wybo, O. Soetens, K. Van Doorslaer, D. Pie´rard, S. Lauwers
(Brussels, BE)
Objectives: In a recent Belgian survey [1] 3% of the B. fragilis group
strains were not susceptible to meropenem. In our university hospital a
decrease in susceptibility to meropenem was observed from 97% in 2005
to 92% and 93% in 2006 and the ﬁrst 8 months of 2007 respectively.
In isolates belonging to other species of the B. fragilis group isolates
susceptibility to meropenem was 97% in 2006 and 100% in the other
years. The purpose of this study was to determine the prevalence of the
cﬁA carbapenem resistance gene in B. fragilis group isolates collected
for a Belgian survey for resistance in anaerobes and to look for the
presence of the cﬁA gene in meropenem non-susceptible strains of this
group isolated in our hospital.
Methods: From October 2003 to February 2005 238 B. fragilis group
strains (135 B. fragilis and 103 other species) were collected in 9
Belgian hospitals. Also included in this study were 15 meropenem non-
susceptible strains isolated in our hospital. Meropenem susceptibility
was determined by Etest®. The following breakpoints were used for
susceptible and resistant strains: 4 and 16mg/L. The strains were
screened for cﬁA gene by PCR with speciﬁc primers.
Results: Of 135 B. fragilis collected for the survey three showed reduced
susceptibility (MIC=8) and three were resistant (1 with MIC=16 and 2
with MIC=32). All these isolates and three of four isolates with a MIC
of 4 were cﬁA gene positive. All B. fragilis isolates with a MIC less than
4, one Bacteroides fragilis isolate with a MIC of 4 and the 103 isolates
from other species were cﬁA gene negative.
Fifteen meropenem non-susceptible strains (MIC>4; 12 B. fragilis, 1
B. thetaiotaomicron, 1 B. ovatus and 1 B. vulgatis) were detected in
our hospital since 2005. Eleven B. fragilis isolates were cﬁA gene
positive. The cﬁA gene was not detected in the remaining B. fragilis
strain (MIC=8) and in the other species.
Conclusion: The prevalence of the cﬁA resistance gene in Belgian
survey isolates (2003–2005) was 6.7% (9/135) in Bacteroides fragilis
isolates. All except one of meropenem non-susceptible B. fragilis strains
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isolated in our hospital since 2005 were cﬁA gene positive. The cﬁA
gene was not detected in other species of the B. fragilis group.
Reference(s)
[1] Wybo. I. et al. Third Belgian multicentre survey of antibiotic
susceptibility of anaerobic bacteria. Journal of Antimicrobial
Chemotherapy 2007; 59: 132−9.
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P913 Characterisation of the virulence markers of Shiga
toxin-producing Escherichia coli isolated from beef samples
M. Weiner (Pulawy, PL)
Shiga toxin-producing Escherichia coli (STEC) strains are an important
cause of bloody diarrhoea, haemorrhagic colitis and haemolytic uremic
syndrome. Transmission of STEC occurs through consumption of
undercooked meat. STEC often belong to O157:H7 however, several
other serogroups have been identiﬁed. The pathogenicity of STEC is
mediated by Shiga toxin (Stx) and the intimin. Recent studies described
additional factors: 67-kDa IrgA, Efa1, LPF or Saa.
Objectives: To characterise the virulence markers of STEC isolated from
beef.
Methods: The STEC were isolated from beef samples (n = 342) by
the use of DNA hybridisation with DIG probes and then tested
using the multiplex PCR (rfbO157, stx1, stx2, ﬂiCH7, eaeA, ehlyA,
O26wzx, rfbO111, rfbO113 and 16SrRNA) and PCR assays (O45wzx2,
O55wzx2, O121wzx1, stx2c, stx2d, stx2e, stx2f, katP, iha, toxB, efa1,
saa, lpfAO157/OI-141, lpfAO157/OI-154, lpfAO113, eae alpha and
gamma).
Results: Sixteen stx-positive E. coli strains were detected, eight were
O157:H7. The stx1 marker was observed in all E. coli O157:H7 and
in four non-O157:H7 isolates. The stx2 gene was detected in all E. coli
O157:H7 and in seven of non-O157:H7. The identiﬁcation of Stx variants
resulted in presence of the stx2d gene in 13 STEC and among them 3
strains had the stx2c marker. Among eight of the O157-negative STEC,
three belonged the O26 group. These isolates also carried the stx1
(one strain) or stx2 genes (two isolates). None belonged to the O45,
O55, O111, O113 or O121 groups. All harboured the enterohaemolysin
(ehlyA) gene whereas the intimin marker (eaeA) was observed in all
E. coli O157:H7 (alpha) and O26 isolates (gamma). The factors such
as katP, toxB and efa1 were detected in all O157:H7 as well as in
one O26 isolate. Fifteen STEC were the iha-positive and ﬁve the saa-
positive. None of the isolates possessing the saa marker was O157 or
O26. The presence of the lpfAO157/OI-141 and lpfAO157/OI-154 genes
was noted among 8 O157:H7 and in one O26 STEC. The lpfAO157/OI-
141 gene was present in 4 other STEC including E. coli O26. None
of E. coli O157:H7 had the lpfAO113 marker that was observed in
the all remaining STEC. In one isolate belonging to the E. coli O26
group, for the ﬁrst time a simultaneous presence of the lpfAO157/OI-
141, lpfAO157/OI-154 and lpfAO113 was noted.
Conclusion: The obtained results can provide a better knowledge of the
genetic diversity of STEC strains as well as should lead to great progress
in molecular epidemiology.
P914 Virulence potential of extraintestinal pathogenic Escherichia
coli strains isolated from skin, wound and soft tissue infections
M. Starcic Erjavec, Z. Petkovsek, K. Elersic, M. Gubina,
D. Zgur-Bertok (Ljubljana, SI)
Objectives: The bacteria Escherichia coli (E. coli) is an important
facultative anaerobe of the intestinal normal ﬂora, but pathogenic strains
can cause an impressive variety of different types of intestinal and
extraintestinal diseases. Strains causing infections differ from commensal
E. coli due to possession of virulence factors. The best characterised
pathogenic E. coli strains are those from infections of gastrointestinal
tract, urinary tract, meningitis and sepsis. Some reports of E. coli strains
involved in skin, wound and soft tissue infections can be found, however
to our knowledge no survey of the virulence potential of these strains
has yet been performed. Therefore, in the presented work, a collection of
122 extraintestinal pathogenic E. coli strains isolated from skin, wound
and soft tissue infections were studied.
Methods: Isolates were obtained from the Institute of Microbiology and
Immunology, Medical Faculty in Ljubljana, Slovenia. The phylogenetic
group of each strain was determined and the strains were screened
by PCR with primers speciﬁc for the following virulence (related)
genes cnf1(cytotoxic necrotising factor 1), hlyA (haemolysin), subA
(subtilase cytotoxin), papGII (class II PapG adhesin), papGIII (class
III PapG adhesin), sfaDE (S ﬁmbriae), afa/draBC (Afa/Dr adhesins),
iucD (aerobactin), kpsMT (synthesis of group II capsule), ompT (outer
membrane protease) and usp (uropathogenic-speciﬁc protein). Dot-blot
hybridisation experiments were performed to validate the PCR assays.
Results: Our results showed that 66% of the studied E. coli isolates
from skin, wound and soft tissue infections belonged to group B2, 12%
to the group A, 12% to the group D and 10% to the B1 group. The
cnf1 gene nucleotide sequences were detected in 34% of strains, hlyA
in 31%, papGII in 16%, papGIII in 23%, sfaDE in 37%, afa/draBC in
1%, iucD in 50%, kpsMT in 65%, ompT in 20% and usp in 48% of the
tested isolates. No strain harboured subA sequence.
Conclusion: Our results showed that the virulence potential of E. coli
strains from skin, wound and soft tissue infections is comparable to the
virulence potential of pathogenic E. coli strains from other extraintestinal
infections (Table 1).
Table 1. Comparison of results from different studies on extraintestinal pathogenic E. coli isolates
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75 urosepsis isolates (USA) 16 41 71 7 25 9 nt** 63 nt nt 1
170 pyelonephritis isolates (USA) nt 39 60 9 nt 17 63 86 82 nt 2
74 cystitis isolates (USA) 34 36 5 31 36 4 nt 62 nt nt 3
377 urinary tract infection isolates (Japan) 50 51 nt nt 46 8 39 nt nt 85 4,5
88 vaginal isolates (Japan) 19 22 nt nt 20 6 35 nt nt nt 6
100 cystistis isolates (Israel) 34 44 31 17 37 14 nt 69 53 nt 7
110 urinary tract infection isolates (Slovenia) 23 25 34 13 24 2 42 nt nt 44 8
122 skin, wound and soft tissue infections (Slovenia) 34 31 16 23 37 1 50 65 20 48 9
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P915 Cloning and expression of HpaA protein of Helicobacter pylori
S. Najar Peerayeh, J. Atooﬁ, M. Farshchian, A. Azimian, M. Razeghi,
R. Samimi (Tehran, IR)
Introduction: Helicobacter pylori is associated with the chronic
gastritis, peptic ulcer, gastric adenocarcinoma, and gastric mucosa-
associated lymphoid tissue (MALT) lymphoma. The antibiotic therapies
do not protect from potential re-infection, and have a risk for
development of drug resistance. Therefore, the prophylactic vaccine
mediated protection against H. pylori is an attractive clinical interest.
H. pylori adhesin A (HpaA) is a conserved surface lipoprotein and plays
important roles in pathogenesis of infection. In this study an hpaA gene
cloned in pET expression vector and the recombinant protein (rHpaA)
was over expressed in E. coli.
Methods: Genomic DNA of the standard H. pylori strain 26695
was isolated as the template and hpaA gene was ampliﬁed by PCR.
Prokaryote expression vector pET28a inserted with hpaA gene (pET28a-
hpaA) was constructed. The recombinant plasmid was used to transform
competent E. coli DH5alpha, and positive clones were selected. Then
the recombinant plasmid was used to transform E. coli BL21DE3 for
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expression of recombinant protein HpaA. The expression of recombinant
protein induced by isopropythio-beta-D-galctoside (IPTG) at different
concentration was examined by SDS-PAGE. Western blot assay were
used to determine immunoreactivity of rHpaA by a rabbit polyclonal
antibodies against whole cell of H. pylori.
Results: In comparison with the reported corresponding sequences, the
nucleotide sequence homology of hpaA gene was 98.8%. HpaA fusion
protein was able to react with the rabbit polyclonal antibody against
whole cell of H. pylori.
Conclusion: A prokaryotic expression system with high efﬁciency of
H. pylori hpaA gene was successfully established and HpaA fusion
protein showed satisfactory immunoreactivity. These results indicate
that production of speciﬁc recombinant protein is an alternative and
potentially more expeditious strategy for development of H. pylori
vaccine.
P916 Characterisation of a Streptococcus agalactiae serotype Ia
lineage with enhanced invasiveness
E.R. Martins, J. Melo-Cristino, M. Ramirez (Lisbon, PT)
Objectives:We have recently identiﬁed a lineage of group B streptococci
(GBS) expressing serotype Ia as having enhanced potential to cause
early-onset invasive disease in neonates (EOD). Characterisation by
multilocus sequence typing (MLST) revealed that this lineage was
characterised by two sequence types: ST23 and ST24. Data in the
literature suggests that ST23 is not particularly virulent so we decided to
further characterise this PFGE lineage regarding antibiotic susceptibility
and the presence of the genes encoding the alpha and alpha-like family
of surface protein, with the aim of clarifying the apparent heterogeneity
within the lineage.
Methods: Susceptibility to penicillin, chloramphenicol, cefotaxime,
tetracycline, vancomycin, erythromycin and clindamycin was tested
by disk diffusion according to the CLSI guidelines and interpretative
criteria. Macrolide-resistant isolates were further classiﬁed as having the
cMLSB, iMLSB, or M phenotype by a double-disk diffusion test. A
multiplex PCR reaction was set up to detect the presence of the erm(B),
erm(A) and mef genes. Surface protein gene proﬁling was also obtained
by a multiplex PCR assay targeting the bca, alp2, alp3, alp4, eps and rib
genes.
Results: All isolates were fully susceptible to penicillin, chlorampheni-
col, cefotaxime, and vancomycin and resistant to tetracycline. Resistance
to erythromycin was found in 3 isolates occurring simultaneously with
clindamycin in two isolates. Of the 3 erythromycin-resistant isolates, 2
had the cMLSB and 1 the M phenotype. The isolate presenting the M
phenotype carried the mef gene, whereas the erm(A) gene [erm(TR)
variant] was found in the 2 cMLSB isolates. All isolates carried a single
macrolide-resistance determinant. All isolates tested presented only the
bca or eps genes, encoding the alpha-C and epsilon surface proteins,
respectively. The bca gene was found associated exclusively with isolates
representing ST24 and the eps gene only with isolates presenting ST23.
Conclusions: In spite of the mostly homogeneous susceptibility proﬁle
of the GBS lineage with enhanced potential to cause EOD, the
complement of surface proteins further conﬁrms the distinction in two
sub-populations already suggested by the MLST analysis. The unusually
high proportion of isolates representing ST24 and carrying the bca
gene in our collection and not frequently found elsewhere, may have
been decisive for the identiﬁcation of the enhanced invasiveness of this
lineage.
P917 Characterisation of cloning and in vitro expression of enolase
from Streptococcus suis 2
X.Z. Pan, W. Sun, C.J. Wang, F. Zheng, J.Q. Tang (Nanjing, CN)
Objectives: To clone enolase (eno) gene and investigate some
characteristic of its product Enolase (Eno) in Streptococcus suis serotype
2 (S. suis 2, SS2).
Methods: Using the Qiaexpress expression plasmids, the enolase
gene was inducibly over expressed in E. coli to produce Enolase
with a hexahistidyl N-terminus to permit its puriﬁcation. Western-blot
experiment and Enzyme-linked immunosorbent assay were used to detect
its antigenicity. Whole cells ELISA was developed to give conﬁrmation
about Enolase localisation. Moreover, an adherence assay with Hep 2
cells was performed to determine the implication of the Enolase in the
S. suis 2 adhesion. Action on lymphocytes designed to explore the role
of Enolase in immunoreaction related to streptococcal infection.
Results: A highly homologous eno gene was unveiled by the genome-
wide mining. The target DNA fragment of about 1.3 kb was successfully
ampliﬁed using the genomic template of 05ZYH33 and protein
expression analysis showed that a 75 kD protein can be observed in
12% SDS-PAGE, indicating that the recombinant 6His-fused Eno protein
can be produced in E. coli under the induction of IPTG. Western-blot
experiment demonstrated clearly it shares strong speciﬁc antigenicity.
ELISA result suggested that Eno can occur on the surface of 05ZYH33
strain. Adherence assay showed a signiﬁcant reduction in the adhesion
of S. suis 2 in the 6His-fused Eno pre-incubated cells compared to the
non-incubated cells. Evaluation of antibody titers in ELISA indicated
that serum samples from pigs with SS2 infection have higher levels
of antibodies that react with the recombinant Enolase than with whole
bacteria sonication lysis and MRP. Apotosis of lymphocytes showed that
streptococcal Enolase is a novel cross-reactive antigen that may play an
important role in the initiation of the autoimmune diseases related to
streptococcal infection.
Conclusion: The results exhibited the properties of Eno protein and
provided an efﬁcient Eno-based method for monitoring SS2 infection.
Together, our data supported that Eno can function as a novel antigen,
and may play pivotal roles in the severe infection of S. suis 2.
P918 Usefulness of denaturing high-pressure liquid
chromatography to assess in situ gut microbiota in neonates
M.F. De La Cochetiere, G. Caillaux, F. Le Vacon, J. Caillon, J.C. Roze´,
G. Potel, C. Gras-Le Guen (Nantes, FR)
Objectives: Microbiota colonisation of the neonatal gastrointestinal
tract develops within a few hours after birth and major changes occur
during the ﬁrst postnatal weeks. Current knowledge of the gut microbial
ecology is based on faeces studies, mainly by classical culture-dependent
techniques. Nowadays, a new technique of ﬁngerprinting, the DHPLC
can be used. So far, however, no data is available for kinetics of
implantation, growth and development of endoluminal microbiota in
infants. Thus we did a prospective analysis of the in situ gut microbiota
during neonatal surgery by classical cultures techniques, TTGE and
DHPLC.
Methods: Newborns under 28 days of life requiring digestive surgery
were included after parental information. During surgery, intestinal
swabs were sampled. Then, the intestinal microbiota was analysed by
conventional culture-based techniques and by two culture independent
methods based upon bacteria DNA extraction and separation of ampliﬁed
16S rRNA gene fragments using Denaturing High Pressure Liquid
Chromatography (DHPLC) and Temporale Temperature-Gradient Gel
Electrophoresis (TTGE).
Results: 11 newborns (gestational age 33±2 weeks) were included. Two
were born via caesarean section. Among the 6 newborns operated before
48 hours of life, 4 had a negative culture, no TTGE bands, three of which
had a positive DHPLC analysis. The most frequent bacteria were Gram-
negative bacilli (Enterobacter and E. coli), Gram-positive cocci (negative
coagulase Staphylococcus-NCoS). Three were found with Pseudomonas
(P. aeruginosa) and one with Clostridium (C. butyricum).
The three techniques used have shown coherent results. None
uncultivable bacteria have been found.
Conclusion: Our work shows that DHPLC, based on DNA static
analysis, is a powerful technology. DHPLC is a reproductible method that
allows rapid characterisation of the bacterial establishment in neonates.
DNA amplicons are easy to elute for sequencing. Moreover, it offers
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full automation. The neonatal supra-mesocolic tractus is colonised very
early in life mostly with Enterobacteria and NCoS.
These results could be helpful to design speciﬁc antibioprophylaxis
guidelines in neonates and to monitor microbiota changes induced by
various neonatal diets and treatments.
This work has been supported by Atlangene and Transgenomic
P919 Molecular evaluation of Brazilian vaginal lactobacilli micro-
biota and the role of hydrogen peroxide-producing isolates
R.C.R. Martinez, S.A. Franceschini, M.C. Patta, S.M. Quintana,
A.C. Nunes, J.L. Moreira, K.C. Anukam, G. Reid, E.C.P. De Martinis
(Ribeira˜o Preto, Belo Horizonte, BR; London, CA)
Objectives: To study vaginal lactobacilli populations by culture-
dependent [polymerase chain reaction and ampliﬁed ribosomal DNA
restriction analysis (PCR-ARDRA)] and culture-independent [PCR and
denaturing gradient gel electrophoresis (PCR-DGGE)] methods, and to
evaluate the ability of isolates to produce H2O2.
Methods: This study, approved by local Ethics, comprised three groups
of women recruited in the city of Ribeira˜o Preto, Sa˜o Paulo State,
Brazil: 64 healthy, 68 diagnosed with vulvovaginal candidiasis (VVC)
and 64 with bacterial vaginosis (BV). Samples from lateral vaginal wall
were obtained with swabs, transferred to tubes containing physiological
saline and decimally diluted. Dilutions were surface plated on de Man
Rogosa Sharpe (MRS) agar and incubated for 48 h at 37ºC (aerobiosis
and anaerobiosis). Isolates characterised as Gram-positive rods, catalase
and oxidase negative were identiﬁed by PCR-ARDRA and evaluated
semi-quantitatively for H2O2 production (Merckoquant Peroxide Test;
Germany). Swabs obtained from patients were also evaluated by PCR-
DGGE for detection of lactobacilli.
Results: Lactobacilli were isolated from 87.5% of controls, 88.2%
of subjects with VVC and 32.8% of women with BV using PCR-
ARDRA, compared to 98.4%, 94.1% and 57.8% assessed by PCR-
DGGE, respectively. By PCR-ARDRA, L. crispatus was the most
prevalent isolate in control group (37.0%), followed by L. johnsonii
(16.4%). In VVC patients’ group, L. crispatus was also the most common
isolate (35.9%) followed by L. jensenii (21.8%), whereas in the group of
BV, L. gasseri (36.4%) and L. crispatus (18.2%) were more frequently
found. According to PCR-DGGE, L. iners was the most prevalent species
in all groups. Only L. crispatus was detected accordingly by both
methods in the three groups (Kappa coefﬁcient = 0.531). From healthy
and VVC groups, 1.4% and 2.6% respectively of the lactobacilli isolates
did not produce H2O2, whereas in the BV group, this rate raised to
31.8%. In both healthy and VVC groups, L. crispatus and L. johnsonii
produced, comparatively, the highest average amounts of H2O2.
Conclusions: The evaluation o vaginal microbiota was dependent on the
methodology employed and the results also suggest the absence of H2O2-
producing lactobacilli in the vaginal microbiota may be a contributing
factor for the development of BV, whereas the presence of these isolates
may not be protective against VVC.
Financial support: FAPESP # 04/14580−0 and # 06/06595−2; CAPES #
6159/06−2
P920 The occurrence of intestinal spirochaetosis in comparison
with infections due to other enteropathogenic agents in a
selected group of patients
A. Calderaro, S. Peruzzi, C. Gorrini, G. Piccolo, G. Dettori, C. Chezzi
(Parma, IT)
Objectives: Intestinal Spirochaetosis (IS) is a human large bowel
infection due to Brachyspira aalborgi and B. pilosicoli associated with
abdominal complaints (diarrhoea, pain, weight loss).
The prevalence of IS in the general population in comparison with other
gastrointestinal infections was poorly investigated till now.
In our laboratory, we studied the occurrence of IS in a selected population
with gastrointestinal complaints and/or potential risk factors for IS
(immigration/travels from/through developing countries, HIV infection,
male homosexuality) and compared the results with the occurrence of
gastrointestinal infections due to viruses, bacteria other than spirochaetes
and parasites.
Methods: In the period 2002–2007, clinical samples belonging
to 269 patients with gastrointestinal disorders were subjected to
microbiological and virological investigations in our laboratory to search
for enteropathogenic agents: from 258 patients we received faecal
samples, from 9 patients both faecal samples and colonic biopsies, and
from 2 only colonic biopsies.
The research of intestinal spirochaetes was performed by a 16S rDNA
Restriction Fragment Length Polymorphism-Polymerase Chain Reaction
(RFLP-PCR) assay and PCR-positive samples were inoculated in a
selective blood agar medium with spectinomycin and rifampin.
Enteropathogenic agents other than spirochaetes were searched according
to standard procedures by conventional (microscopy and culture) and
molecular methods.
Results: In 5 years 19 cases of IS (7%) were diagnosed by RFLP-PCR:
11 by B. aalborgi, 6 by B. pilosicoli and 2 mixed infections by both
species. Ten of these patients were also infected by enteropathogenic
agents other than spirochaetes.
The other patients were infected by intestinal parasites only (17.1%),
gastroenteric viruses only (3.7%) or bacteria other than spirochaetes
only (5.9%) whilst in a relevant group of individuals (66.1%) no
enteropathogenic agents were detected.
Conclusions: Even if it refers to a selected population presenting
gastrointestinal symptoms and risk factors for faecal-oral infections, the
prevalence of IS reported in this study (7%) is of interest: in fact, our
data suggest that IS may be more frequent than suspected in comparison
with other gastrointestinal infections.
Therefore, we are conﬁdent that physicians should take IS into account
when subjects with chronic abdominal discomfort present to their
attention.
P921 Whole genome pyrosequencing of the epidemic multidrug-
resistant Acinetobacter baumannii European clone II
M. Iacono, L. Villa, D. Fortini, R. Bordoni, F. Imperi, R. Bonnal,
T. Sicheritz-Ponten, G. De Bellis, P. Visca, A. Cassone, A. Carattoli
(Segrate, MIlan, Rome, IT; Lyngby, DK)
Objectives: the whole genomic DNA sequence was determined for an
epidemic Acinetobacter baumannii strain (ACICU), belonging to the
European clone II and carrying the plasmid-mediated blaOXA58 gene,
implicated in carbapenem resistance. We compared the ACICU genome
with that of A. baumannii ATCC 17978 and of Acinetobacter baylyi
ADP-1, with the aim of identifying novel traits related to virulence,
drug resistance and pathogenesis.
Methods: the genome was sequenced by high-density pyrosequencing
and characterised for both genes coding and non coding. The genome
was also analysed for lateral gene transfer.
Results: A. baumannii ACICU strain contains a single circular
cromosome of 3,904,116 bp and two plasmids (ACICUp1 and ACICUp2)
of 28,279 and 64,366 bp, respectively; the chromosome contains 3,758
genes. (3,670 CDSs, 64 tRNA genes 8 rRNA operons).
Genome comparison showed 86.4% of syntheny versus the reference
A. baumannii ATCC 17978 strain and 14.81% versus A. baylyi ADP-1.
36 putative alien islands (pAs) are detected in the ACICU genome: 24 of
them were previously described in the ATCC 17978 genome, 4 identiﬁed
by the lateral gene transfer analysis in both ATCC and ACICU and 8
completely new, being absent in the ATCC 17978 genome
21 putative TonB-dependent outer membrane receptors were found in
the ACICU genome, likely involved in iron uptake. ACICU has a
conspicuous number of transporters belonging to different superfamilies,
the number of which for unit length of genome (76.2) is much higher
than that of ATCC 17978 (57.2) and ADP-1 (62.5), and similar to values
reported for some pseudomonads.
Moreover, an antibiotic resistant island, AbaR2, was identiﬁed but it
is shorter than the AbaR1 previously described in the multiresistant
A. baumannii AYE strain.
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Conclusion: the pathogenicity of A. baumannii is poorly understood and
this organism is commonly regarded as a low-virulence bacterium, in
spite of the severity of infections it causes. pAs in ACICU genome are
partly divergent from those described in ATCC 17978, by acquisition
of several interesting genes encoding membrane transporters, drug
resistance and virulence trait for invasion and adherence. Four clusters
of acquired genes were identiﬁed associated to putative phages. Since
phage-related pathogenicity islands have been identiﬁed in the genome
of important pathogens, the presence of unknown sequences poses the
question of whether they could be involved in pathogenicity.
P922 Draft genome sequencing of two Enterococcus faecium
strains by pyrosequencing technology reveals niche-speciﬁc
gene acquisition
W. van Schaik, M.J.M. Bonten, R.J.L. Willems (Utrecht, NL)
Objectives: Enterococcus faecium has recently become an important
cause of nosocomial infections. The rapid rise in E. faecium infections
can be explained by the acquisition of antibiotic resistance mechanisms
combined with the evolution of a hospital-associated E. faecium clade,
termed Clonal Complex 17 (CC17). To reveal the genetic diversity in
E. faecium strains from different environmental niches, we sequenced
the genomes of two E. faecium strains from different clonal complexes
(CC22 and CC17, respectively) using pyrosequencing technology.
Methods: The strains studied were E1071 (CC22, a vancomycin-
resistant isolate that was picked up during routine hospital surveillance)
and E1162 (CC17, a vancomycin-sensitive bloodstream isolate). The
genomes of these two E. faecium strains were sequenced by Keygene
(Wageningen, The Netherlands) using the GS FLX sequencer (454 Life
Sciences, Branford CT, USA), with 20-fold coverage of the genome. Se-
quences were assembled using Newbler Assembler (454 Life Sciences).
The draft genomes were annotated using the TIGR Annotation Engine
and the encoded proteins were compared using PROMPT (Protein
Mapping and Comparison Tool; http://webclu.bio.wzw.tum.de/prompt).
Results: The total number of sequence that could be assembled into
contigs was 2.7 Mb for both strains, suggesting all but complete coverage
of the genome. Automated and manually curated annotation of the draft
genome sequences resulted in the prediction of 2716 and 2697 proteins
for E1071 and E1162, respectively. More than 2200 proteins were more
than 95% identical on the amino acid level between the two strains.
Approximately 10% of the proteins were unique to each strain.
Using PROMPT the predicted proteins from the genomes of these two
strains and the publicly available E. faecium DO strain (CC17) were
compared. This revealed that the CC17 strains had genomic islands with
functions in sugar uptake and metabolism that were absent in E1071. Two
(partial) prophages were also speciﬁc for the CC17 strains. The presence
of the TcrB copper resistance system and a speciﬁc point mutation in
the vanX gene in strain E1071 strongly suggest that this strain originates
from pigs.
Conclusion: Rapid draft genome sequencing has revealed the acquisition
of several niche-speciﬁc genes in E. faecium and identiﬁed several
genes and genetic elements that may be unique for CC17. The genome
sequences contribute to ongoing functional studies into E. faecium in
our laboratory.
P923 Identiﬁcation of a novel genomic island speciﬁc for
Enterococcus faecium CC17 by using the deltarho-Web model
E. Heikens, H.L. Leavis, W. van Schaik, M.J.M. Bonten, R.J.L. Willems
(Utrecht, NL)
Objectives: Most hospital outbreak and invasive Enterococcus faecium
belong to a single clonal lineage, complex 17 (CC17). We hypothesise
that acquisition of genes, involved in antibiotic resistance, metabolic
pathways, and virulence, contributes to the ecological success of CC17.
So far, antibiotic resistance genes and the enterococcal surface protein
gene, esp, which is contained on a putative pathogenicity island and plays
an important role in bioﬁlm formation, are documented CC17-speciﬁc
determinants. To identify more genes, which contribute to the success
of CC17, we used the deltarho-Web model (http://deltarho.amc.uva.nl).
This model analyses the dinucleotide composition of a complete
genome, which allows the identiﬁcation of horizontally transferred genes,
recognised by their anomalous dinucleotide frequency (DF).
Methods: A complete genome sequence was designed from the only
sequenced strain, E. faecium DO, a CC17 isolate. Because this strain is
sequenced partially and the order of the contigs is not known, we created
a so-called complete genome sequence by randomly concatenating all
contigs larger than 2022 bp, which was submitted to the model. PCR
and dot blot hybridisation (DBH) were performed to determine presence
and absence of genes located in regions with anomalous DF in 41 CC17
isolates and 95 non-CC17 isolates. Expression of CC17 speciﬁc genes
at mRNA level was determined by RT-PCR.
Results: The model identiﬁed 5 regions with anomalous DF. PCR and
DBH showed that 1 of these regions is CC17 speciﬁc and consist of a
genomic island (GI) of 8 genes. Forty of the 41 CC17 isolates (97.56%)
harbour this GI and only 5 of the 95 non-CC17 isolates (5.26%). The GI
genes putatively encode 2 sugar transporters, 2 glycosyl hydrolases, an
extracellular sugar binding protein, 2 proteins with unknown function,
and a transcriptional regulator. At both sides of the GI inverted and
direct repeats were found and one end is ﬂanked by an integrase gene,
indicating horizontal transfer. RT-PCR showed expression of all 8 genes.
Conclusion: By using the deltarho-Web model, a GI speciﬁc for
CC17 was found. This illustrates that detection of anomalous DF
using this model is a good approach for identifying acquired genes
in E. faecium. We hypothesise that ST-17, the presumed founder of
CC17, acquired this GI, tentatively encoding a novel metabolic pathway,
as an adaptive mechanism providing CC17 a selective advantage in
hospitalised patients.
P924 Presence of pRI1; a small cryptic mobilisable plasmid isolated
from Enterococcus faecium of human and animal origin
L. Garcia Migura, H. Hasman, L.B. Jensen (Copenhagen, DK)
Objectives: This study focused on the molecular characterisation of
a small cryptic mobilizable plasmid (6038 bp) sequenced from an
E. faecium 9631160−1 of poultry origin. Presence of the pRI1 replication
initiation gene (rep) was analysed in a panel of E. faecium isolates from
human and animal origin in different European countries.
Methods: A plasmid replicon was cloned in vector pVA891. The insert
was sequenced and primers were designed to complete the entire DNA
molecule. 159 isolates were screened by PCR for the presence of the
pRI1 rep. Of those, 40 were vancomycin resistant E. faecium (VREF) of
broiler origin from the UK, 92 were of animal origin (broiler=41, pig=51)
from Denmark (DK) and 27 were VREF isolated from hospitalised
patients, 7 from Germany (DE) and 20 belonging to the CC17 and
collected across Europe. Transfer of the pRI1 was assessed by selecting
transconjugants in media with vancomycin or streptogramin.
Results: Sequence analysis of pRI1 revealed 8 open reading frames.
Based on sequence similarity at DNA and protein level, pRI1 contained
a rep highly identical to the repA from the pEFNP1 plasmid from
E. faecium N15. A mob gene was also identiﬁed whose putative
function could be the mobilisation of the plasmid. pRI1 harboured a
cluster of 4 coding sequences (CDS). CDS1 translated into a truncated
EfaeDRAFT_2604. CDS2, CDS3 and CDS4 coded for 3 hypothetical
proteins, EfaeDRAFT_2603, EfaeDRAFT_2602 and EfaeDRAFT_2601
respectively. The 4 CDS exhibited 100% homology to those described in
contig658 (from nt 8940 to 10196) of E. faecium DO. In addition, an IS
with 100% homology to ISEfa4 described in a vanD-type VREF 10/96A
was also identiﬁed. Of 159 isolates tested for presence of pRI1 rep, 60
produced an amplicon. Of those, 27/40 were from UK, 22/41 and 2/51 of
broiler and pig origin from DK, 5/7 from DE and 4/20 belonged to the
CC17. Conjugation experiments veriﬁed transfer of the pRI1 together
with conjugative plasmids harbouring resistances to vancomycin and
streptogramin.
Conclusions: The genetic composition of pRI1 illustrates the plasticity
of the enterococcal plasmids and the “mosaic” arrangements of the
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different genes assembled into one mobile genetic element (MGE). The
presence of pRI1 in enterococcal isolates geographically separated and
from different origin demonstrates the ability of enterococci to acquire
and transfer MGE, emphasising the need for further studies to reveal the
meaning and role that they play in nature.
Current methods for typing MRSA and
MSSA
P925 Comparison of the DiversiLab System and pulsed-ﬁeld gel
electrophoresis for typing meticillin-resistant Staphylococcus
aureus isolates
F. Tenover, E. Gay, S. Frye, S. Eells, M. Healy, J. McGowan, Jr.
(Atlanta, Athens, US)
Objectives: Typing of meticillin-resistant Staphylococcus aureus
(MRSA) isolates is difﬁcult for clinical microbiology laboratories to
perform. Pulsed-ﬁeld gel electrophoresis (PFGE) is time consuming and
often difﬁcult to interpret for inexperienced users. Thus, we examined the
ability of the Bacterial Barcodes DiversiLab system (DL) to distinguish
among USA PFGE types and to correctly differentiate outbreak-related
MRSA from sporadic isolates collected from several U.S. hospitals.
Methods: 105 isolates of MRSA of PFGE types USA100–1100 (plus the
Brazilian clone) from the ICARE and CDC strain collections were typed
using the DL system. DL strain relatedness was deﬁned as a minimum of
>95% similarity with up to 1 band difference. USA types were deﬁned
using >80% similarity. In addition, 4 unique sets consisting of 6 MRSA
isolates each (where 5 isolates were indistinguishable by DL and 1 was
an unrelated DL type), each from separate outbreaks in 3 U.S. hospitals,
were typed by PFGE. Tenover criteria were used for PFGE outbreak
analysis.
Results: DL separated the 105 MRSA isolates of known USA types
into 13 clusters and 6 singletons. DL grouped USA100, 200, 600,
and 1100 isolates into unique clusters. Multi-locus Sequence Type 8
isolates (USA300, 500 and Brazilian clone) often clustered together at
>95% similarity in the DL dendrogram, although USA300 and 500 DL
patterns showed a consistent 1 band difference. USA400 and 700 isolates
also clustered together but had distinguishable DL patterns. Among
the hospital outbreak clusters, PFGE and DL both identiﬁed the same
“unrelated” organism in all 4 sets; however, PFGE showed more pattern
diversity than did DL.
Conclusion: DL is less discriminatory than PFGE, although it tends
to cluster isolates of the same USA type together. DL can be used to
identify USA types only by direct comparison of DL patterns with a
known USA type strain. Although the DL patterns of the outbreak strains
were indistinguishable, the PFGE patterns of 3 of 4 sets reﬂected greater
pattern diversity. Thus, DL is useful for screening for potential outbreaks
of MRSA, but additional typing may be necessary to conﬁrm strain
relatedness and speciﬁc USA types.
P926 Comparison of an automated repetitive sequence-based
PCR typing technique to pulsed-ﬁeld gelelectrophoresis and
multi-locus sequence typing for characterisation of epidemic
meticillin-resistant Staphylococcus aureus strains
W.B. van Leeuwen (Rotterdam, NL)
Objective: the DiversiLab™ system, which employs repetitive sequence-
based PCR (rep-PCR) to genetically characterise microorganisms
(prokaryotes and eukaryotes), was evealuated as a molecular typing tool
for meticillin-resistant Staphylococcus aureus (MRSA) strains.
Methods: we have analysed a representative selection of the HAR-
MONY collection, composed of MRSA strains (n = 33) from 11
European countries. DiversiLab results were compared to those assessed
by pulsed-ﬁeld gelelectrophoresis (PFGE) and clonal designations based
on multilocus sequence typing (MLST).
Results: the level of discrimination was determined by application of
Simpson’s index of diversity, resulting in indices of 90.5%, 87.7% and
86.0% for PFGE, MLST and rep-PCR respectively. A high level of
concordance in classiﬁcation of the MRSA strains was obtained using
each method. MLST and rep-PCR distinguished 15 and 17 genetically
related groups, as PFGE differentiated the collection into 28 pulsetypes.
Conclusion: compared to both other typing techniques, the performance
of the DiversiLab is good with respect to labour intensity and rapidity.
This system may be useful for long-term epidemiological studies, but
lack the discrimination needed for outbreak analysis.
P927 Epidemiological typing of meticillin-resistant Staphylococcus
aureus strains by FT-IR
R. Guiomar, O. Preisner, Z. Videira, J.A. Lopes, J.C. Menezes,
J. Machado (Lisbon, Oporto, PT)
Meticillin-resistant Staphylococcus aureus (MRSA) is widely known as
the most signiﬁcant nosocomial pathogen due to the burden of disease
it causes, as well as to the evolution and global spread of multidrug-
resistant clones.
Objective: The goal of the present study is to evaluate the Fourier
transform infrared (FTIR) spectroscopy as a rapid, accurate and cost-
effective method to characterise and discriminate between MRSA strains
responsible for nosocomial infections.
Methods:MRSA strains were studied by Pulse Field Gel Electrophorese
(PFGE – enzyme SmaI) and rep-PCR, two molecular methodologies
that provide the genomic ﬁngerprint with high discriminatory power.
Although time consuming and labour intensive PFGE is accepted as the
gold standard for molecular typing. MRSA strains were also studied by
FTIR assess the overall molecular composition of microbial cells in a
non destructive manner, giving the “whole organism ﬁngerprinting”. The
collected spectral data were analysed using a wide range of chemometrics
techniques to discriminate closely related strains.
Results: MRSA were separated in distinct clones by PFGE, rep-PCR
and FTIR. Analysis of SmaI macrorestriction proﬁles of the MRSA
clinical isolates revealed ﬁve major clusters. The rep-PCR allowed
grouping strains within various degrees of genotypic relatedness leading
to the identiﬁcation of bacterial clones. All the strains were evaluated
by FTIR spectroscopy as well. Different pre-processing methods were
analysed in order to reduce spectral variability. Unsupervised and
supervised classiﬁcation methods were employed to cluster the different
MRSA clones based on similarity of their FTIR spectra. Our results
demonstrated concordance with PFGE and rep-PCR methods.
Conclusion: FTIR spectroscopy is a promising tool for epidemiological
typing of MRSA, providing quantitative information about the total
biochemical composition of the intact cell reﬂected in the infrared
spectra. FTIR is a simple, non-destructive, without use of any reagent
and rapid to perform thus has the potential for an alternative method for
MRSA epidemiological typing. In case of nosocomial outbreak FTIR
enables a fast identiﬁcation of MRSA clones responsible for hospital
infection and a rapid implementation of controlling measures leading
to a decreasing of new cases of nosocomial infection due to the same
bacterial clone, saving suffering and money.
P928 Spa typing is an excellent method for surveillance of MRSA
S. Melin, S. Lofgren, A. Matussek (Jonkoping, SE)
Objectives: Pulsed-ﬁeld gel electrophoresis (PFGE) is considered gold
standard for typing of Staphylococcus aureus, but the method is afﬂicted
with problems. Simple objective molecular methods, like spa typing, can
therefore considerably simplify epidemiological studies of S. aureus. In
this study we compare spa typing to PFGE, related to epidemiological
data in a low endemic setting, and show that spa typing is an excellent
method for surveillance of transient outbreaks of meticillin-resistant
S. aureus (MRSA).
Methods: All of the MRSA (n = 304) isolated in the county of Jonkoping
from January 2003 through July 2006 were analysed by spa typing and
PFGE. In addition, Panton-Valentine leukocidin (PVL) toxin presence
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was investigated using a PCR based method. Epidemiological data was
collected and 12 outbreaks were identiﬁed, including 68 isolates.
Results: We identiﬁed 24 different spa types and 28 different PFGE
patterns in 20 PFGE types. Isolates within three of 12 outbreaks
exhibited several related but distinguishable PFGE patterns. In seven of
the outbreaks all of the isolates were of a single PFGE type (SE97−3).
All of the isolates within an outbreak were of the same spa type. Three
outbreaks contained isolates of spa type t015 of which all belonged to
PFGE type SE97−3 and two outbreaks consisted of isolates of spa type
t008.
Isolates carrying the PVL toxin gene, occurring in outbreaks, were all
community-associated (Table 1).
Table 1: Description of the MRSA outbreaks in the county of Jo¨nko¨ping, 2003–
2006
Outbreak Number and association in outbreaks spa
type
PFGE pattern PVL
1 2, neighbours t202 SE03-9 +
2 3, family t015 SE97-3f −
3 8, associated to retirement home t630 SE97-3, -3t, -3v −
4 11, associated to retirement home t008 SE00–11a, -11d −
5 12, associated to retirement home t050 SE97-3af, -3, -3d −
6 3, hospital t015 SE97-3 −
7 2, family t008 SE00-7d +
8 15, associated to retirement home t669 SE97-3af −
9 3, associated to retirement home t223 SE04-4a −
10 3, hospital t993 SE97-3f −
11 3, family t015 SE97-3a −
12 3, family t1096 SE01-3 +
Conclusion: All isolates within an epidemiological well characterised
outbreak were of the same spa type, revealing better concordance to
epidemiological data than PFGE as three outbreaks included isolates of
PFGE patterns with minor differences, splitting well deﬁned outbreaks
into more than one. Furthermore spa typing is superior to PFGE in
routine microbiological laboratories due to its objectivity, short turn-
over time, ease of use, and possibility of interlaboratory comparability.
spa typing must therefore be considered a very useful method for
epidemiological investigations of MRSA in low prevalence areas.
P929 Molecular characterisation of Staphylococcus aureus dialysis
associated bacteraemia isolates. Developing microarray
analysis towards future rapid typing applications
M. Stone, J. Wain, A. Ivens, T. Feltwell, A. Kearns, M. Jones,
K.B. Bamford (London, Cambridge, UK)
Objectives: Staphylococcus aureus is an important pathogen in
healthcare associated infection. Within the haemodialysis setting it is
responsible for high levels of morbidity and mortality and associated
with access related bacteraemia. A particular problem with in any
healthcare setting is deﬁning preventable transmission and recurrence of
clinical infection. To aid this deﬁnition we need timely locally applicable
typing systems that are technically and ﬁnancially suitable for everyday
use. Our objective was to use well characterised isolates from the
dialysis associated bacteraemia setting as a platform towards developing
a clinically relevant rapid typing system which would eventually be of
use within a routine diagnostic laboratory.
Methods: Thirty-nine consecutive clinically relevant renal S. aureus
bacteraemia isolates collected between July 2002 and March 2003
were characterised by antibiogram, phage typing, pulsed-ﬁeld gel
electrophoresis (PFGE) and multi-locus sequence typing (MLST).
Meticillin resistance was detected in 46% of isolates and deﬁned by
phenotypic and molecular methods. A deﬁned representative subset
of isolates were characterised using a staphylococcal microarray. The
combined approach was analysed using Bionumeric software.
Results: Phage typing followed by PFGE revealed eight patterns,
clustering into 2 major types, EMRSA-15 and EMRSA-16. MLST
showed that the MRSA isolates belong to ST22 and ST36. Isolates
that were identical by MLST had either identical or similar PFGE
fragment patterns. Microarray analysis allowed the deﬁnition of ‘core’
and ‘accessory’ genomes and the identiﬁcation of potential ampliﬁcation
targets for use in a relevant and rapid typing scheme. Accessory
genes were deﬁned by approximately 23% of 4016 staphylococcal
features on the array and is supported by current literature in this area.
Bionumeric software is displays the level of congruence between PFGE
and microarray analysis.
Conclusion: EMRSA-15 and 16 were identiﬁed as major groups within
which to deﬁne future subtyping targets. Suitable gene targets for
discrimination are identiﬁed and can be deﬁned and developed in this
way. This is a realistic approach towards developing novel technology
based typing systems that could be used in future diagnostic settings.
P930 Investigation of epidemiological links between patients
harbouring identical, non-predominant MRSA genotypes as
deﬁned by double-locus sequence typing
L. Senn, G. Zanetti, F. Bally, C. Chuard, A. Cometta, M.C. Eisenring,
G. Kuhn, D.S. Blanc (Lausanne, Sion, Fribourg, Yverdon, CH)
Background: Molecular epidemiology postulates that 2 isolates belong
to the same chain of transmission if they are similar according to a highly
discriminatory molecular typing method. This has been demonstrated in
outbreaks, but was never studied in endemic situations. Epidemiological
links cannot be established between isolates of meticillin-resistant
Staphylococcus aureus (MRSA) that belong to endemic predominant
genotypes. In contrast, small clusters of identical genotypes, some of
which are subtypes of predominant genotypes, could be studied for
epidemiological tracking.
Objective: To investigate epidemiological links between patients
harbouring MRSA genotypes that belong to non-predominant typing
clusters at a regional level.
Methods: We recently showed that double-locus sequence typing
(DLST), a new typing strategy for MRSA that uses the repeat sequences
of clfB and spa genes, was reproducible and discriminant enough to make
this method a candidate of choice for epidemiological analyses. Our
laboratory centralises the majority of the MRSA isolates from Western
Switzerland. All nonrepetitive isolates received between 2005 and 2006
were typed by DLST.
Results: 1658 MRSA isolates were typed. 1118 (67%) belonged to 4
predominant genotypes, 216 (13%) to 54 small clusters of 2–12 patients,
and 324 (20%) were unique. Strong epidemiological links (simultaneous
hospitalisation in the same ward/hospital/long term care facility, or
member of the same family) were found in 22/54 (41%) small clusters
of non-predominant genotypes, totalising 60/216 patients (28%). In
addition, weaker epidemiological links (hospitalisation during the same
year in the same ward/hospital/long term care facility, or same place
of residence) were found in 41/216 patients (19%). In the remaining
115/216 (53%) patients harbouring identical non-predominant genotypes,
no epidemiological link could be detected.
Discussion: In our setting of patients harbouring non-predominant
MRSA genotypes, epidemiological data could not explain the chain of
transmission behind all isolates of the same genotype. One hypothesis
is that our surveillance system was not able to detect the missing links.
Another hypothesis is that some genotypes are stable over time, so that,
as for predominant genotypes, epidemiological links can no longer be
found.
Conclusions: Epidemiological tracking of MRSA isolates at a regional
level cannot be inferred from molecular typing alone.
P931 Double locus sequence typing: a high through-put molecular
typing method for meticillin-resistant Staphylococcus aureus
G. Kuhn, G. Zanetti, P. Francioli, D.S. Blanc (Lausanne, CH)
Background: Molecular typing is required for the surveillance of
meticillin resistant Staphylococcus aureus. We recently showed that
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DLST, a new typing strategy for MRSA was reproducible, as
discriminant as PFGE and gave unambiguous results (JCM 2007, 45:54–
62). Rapidity, accessibility, ease of use, cost and amenability to construct
an electronic database, are other important criteria of convenience for
longitudinal comparison of large numbers of isolates (CMI 13, suppl. 3;
2007).
Objective: To evaluate DLST according to convenience criteria for the
surveillance of MRSA at a regional level.
Material and Methods: DLST is based on single strand sequencing
of partial repeat sequences of genes clfB and spa. All procedures and
reactions were adapted to function in 96 well format. Our laboratory
centralised the majority of the MRSA isolates from Western Switzerland.
All isolates received between 2005 and June 2007 were typed by DLST.
Results: The laboratory isolated and received 1668 isolates during the
study period. Typing of one plate (96 isolates) was performed in a weeks
time (including bench work, sequence analysis, and incorporation into
a Bionumerics database); all isolates were processed within 18 weeks.
Reinjection was necessary for 15.2% of clfB and 5.7% of spa sequencing
reactions, and the DNA of 1.3% of all isolates had to be extracted again.
The cost of consumables was calculated to be Euro 9.-/isolates, (versus
Euro 2.40 with PFGE), and the stafﬁng cost Euro 13.−/isolates (versus
26.− with PFGE).
Discussion: Cost efﬁciency was achieved by performing DLST in 96
well plates. In a weeks time, 96 isolates could be typed, whereas only
48 isolates could be typed by PFGE using a rapid protocol (JCM
1992; 30:577–80). DLST was cheaper than PFGE, and accessible to all
laboratories with sequencing facilities. The low percentage of isolates
from which DNA had to be extracted a second time indicated a robust
protocol. Using an improved polymerase for PCR, the percentage of clfB
sequence reinjection was considerably reduced. The major advantage of
DLST is that genotypes can be unambiguously assigned, which allows
to incorporate results in an electronics database.
Conclusions: The use of DLST proved to be a convenient method for
longitudinal surveillance of MRSA genotypes at a regional level.
P932 Species identiﬁcation and simultaneous detection of
rifampicin resistance in staphylococci using rpoB sequencing
B. Hellmark, B. So¨derquist, M. Unemo (O¨rebro, SE)
Objectives: In recent years, coagulase-negative staphylococci (CoNS)
have been recognised as causative agents of various infections, especially
in immunocompromised patients and related to implanted foreign body
materials. A major problem is to distinguish clinically signiﬁcant CoNS
strains from those representing contamination. Therefore rapid, highly
sensitive and speciﬁc methods are needed for species identiﬁcation and
further typing. Foreign body infections caused by CoNS are difﬁcult
to treat since CoNS have the ability to produce bioﬁlm. b-lactams
and glycopeptides lack activity against bioﬁlm producing and stationary
phase bacteria. In contrast, rifampicin has the ability to penetrate bioﬁlm.
However, resistance to rifampicin may rapidly emerge and, accordingly,
monotherapy should be avoided.
The aim was to develop and evaluate a rapid and objective method,
based on rpoB sequencing, for species identiﬁcation and simultaneous
detection of rifampicin resistance in staphylococci.
Methods: Fifty-one isolates, representing 17 different Staphylococcus
species, were included for species identiﬁcation, and isolates (n = 30)
from eight patients, obtained pre- and post-treatment with rifampicin,
were included for detection of rifampicin resistance.
A real-time PCR followed by sequencing was developed for a 1052
bp segment of the rpoB gene. The sequences were analysed using
BioEdit software v. 7.0.5.3 and submitted to GenBank for species
identiﬁcation. In case of discrepancies between the initial phenotypic
species identiﬁcation (using ID32Staph) and rpoB sequencing, 16S
rRNA gene sequencing was used.
Results: Forty-nine (96%) of the 51 isolates were possible to species
identify using rpoB sequencing and the two remaining isolates were
not staphylococci according to the discrepancy analysis. Comparing the
results of rpoB sequencing with the phenotypic identiﬁcation revealed
that eight (16%) of the 49 isolates differed regarding identiﬁed species.
Each isolate resistant to rifampicin from the eight patients displayed
identical rpoB sequence as its corresponding rifampicin susceptible
isolate except for one (in six patients) or two (n = 3) nonsynonymous
single nucleotide polymorphisms (SNPs), or an insertion of one codon,
which has not previously been described (n = 3).
Conclusion: Sequencing of the rpoB gene is a rapid, objective and
accurate method for species identiﬁcation and simultaneous detection
of rifampicin resistance in staphylococci.
P933 Application of the (GTG)5-PCR ﬁngerprinting for rapid
identiﬁcation of staphylococcal species occurring in humans
D. Novakova, P. Svec (Brno, CZ)
Objectives: Staphylococci are natural inhabitants of skin, glands and
mucous membranes of mammals and birds and play very important role
in human infections as well. Development and evaluation of effective and
reliable identiﬁcation tools is needed for routine and rapid identiﬁcation
of increasing number of Staphylococcus spp. occurring in human clinical
material.
Method: A group of 68 type and reference staphylococcal strains
representing 22 taxa of human associated staphylococci was analysed
by rep-PCR ﬁngerprinting with the (GTG)5 primer. The clinical isolates
as well as strains isolated from healthy hosts and environmental samples
were tested.
Results: All tested strains were typeable by the (GTG)5-PCR producing
DNA fragments ranging from 200 bp to 4500 bp. Majority of the tested
species revealed species-speciﬁc ﬁngerprints, moreover Staphylococcus
capitis ssp. capitis, S. capitis ssp. ureolyticus and Staphylococcus
cohnii ssp. cohnii and S. cohnii ssp. urealyticum were differentiated
at the subspecies level. In contrast, Staphylococcus hominis subspecies
were not clearly distinguished. Staphylococcus sciuri ssp. sciuri,
Staphylococcus intermedius and Staphylococcus cohnii ssp. urealyticum
strains revealed two different ﬁngerprint clusters each. The highest
intraspecies similarity showed Staphylococcus warneri (88.95%) and
Staphylococcus auricularis (87%) strains in this study.
Conclusion: The obtained results imply that rep-PCR ﬁngerprinting with
the (GTG)5 primer is suitable method for reliable and rapid identiﬁcation
of the majority of staphylococcal species occurring in humans.
The study was partly supported by the project MSM0021622416.
P934 Evaluation of MLST for Staphylococcus aureus typing using
labelled-primers chemistry
V. Chini, E.D. Anastassiou, I. Spiliopoulou (Patras, GR)
Objective: Staphylococcal typing is important for studying nosocomial
and community outbreaks, deﬁning the relationship between isolates.
Multilocus Sequence Typing (MLST) relates staphylococci on the basis
of the nucleotide sequences of ~450 bp internal fragments of seven
conserved housekeeping genes (arcC, aroE, glpF, gmk, pta, tpi, yqiL).
For each gene fragment, the different sequences are assigned as distinct
alleles at each of the seven housekeeping loci (the allelic proﬁle or
sequence type, ST). A major advantage of MLST is the ability to
compare results obtained by different studies via Internet, in freely
accessible databases. The purpose of the present study was the evaluation
of MLST using the labeled-primers chemistry.
Methods: Five representative MRSA were selected according to their
phenotypic characteristics, SCCmec and agr types, PFGE, and the
presence of toxin genes. These strains were also previously characterised
by MLST using the BigDye Terminator chemistry (BigDye Terminator
v3.1 cycle sequencing Kit, Appliedbiosystems) and the ABI 3730 XL
Capillary Sequencing (Appliedbiosystems) device. Bacterial cultures
in Brain Heart Infusion broth (BHI), after overnight incubation at
37ºC, were used for DNA extraction applying the phenol:chloroform
method. The seven housekeeping genes were ﬁrst ampliﬁed by PCR.
PCR products were then puriﬁed and sequenced bi-directionally by
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using labeled-primers chemistry (Cy5.5 for the forward and Cy5.0 for
reverse primers) and the OpenGene DNA Sequencing System (Visible
Genetics, Inc. Toronto, Ontario, Canada). PCR conditions were optimised
in experiments applying gradient of primer concentrations.
Results: Optimised ﬁnal concentration of primers was achieved at
0.1microM for the downstream and 0.15microM for the upstream in
each reaction tube. Results from both MLST techniques concerning the
allelic proﬁles, the Sequence Types (ST) and the Clonal Complexes (CC)
agreed and no variations were detected.
Conclusion: The adaptation of MLST using the labeled-primers chem-
istry and vertical electrophoresis, which is for the ﬁrst time reported,
gave reproducible results, allowing its application in laboratories that do
not possess a capillary sequencing device.
P935 Molecular characterisation of meticillin-resistant
Staphylococcus aureus nasal isolates from patients with
uncomplicated skin infections
R. Shawar, N. Scangarella, G. Li, M. Twynholm, M. Dalessandro,
J. Breton, J. West, L. Miller, P. O’Hara, H. Madsen, D. Payne, R. Goering
(Collegeville, US; Greenford, UK; Research Triangle Park, Omaha, US)
Objectives: In order to better understand the clonal composition and
epidemiology of meticillin-resistant Staphylococcus aureus (MRSA)
from nasal carriage, we molecularly characterised all nasal MRSA
isolates recovered in 2004–2005 from patients with uncomplicated skin
infections enrolled in Phase III clinical trials of retapamulin, a new
topical antibiotic agent.
Methods: Nasal swab samples were obtained from patients with
uncomplicated skin infections enrolled in ﬁve global phase III
clinical trials. All nasal MRSA isolates were examined by pulsed-
ﬁeld gel electrophoresis (PFGE), multilocus sequence typing (MLST),
Staphylococcal cassette chromosome (SCCmec) typing, and were tested
for the presence of Panton-Valentine leukocidin (PVL) genes. Nasal
MRSA isolates were recovered from patients in 7 different countries
(Costa Rica, France, Germany, India, Peru, South Africa, and the United
States) but the vast majority were recovered from patients in the United
States.
Results: A total of 105 MRSA isolates were recovered from nasal
cultures at baseline and/or at follow up visits from 62 patients. Of the 54
baseline MRSA isolates, 23 (42.6%) were determined to be PFGE type
USA300, PVL-positive and contained type IV SCCmec and of those
20 were also MLST type 8. Except for one isolate recovered from a
patient in Costa Rica, the vast majority (19/20;95%) were recovered
from patients in the United States. The remaining 31 MRSA isolates
were distributed among 4 other recognised MLST/PFGE genotypes or
were not matched to any PFGE types currently in the CDC database. Of
the 30 patients who had a nasal MRSA isolate recovered from more than
one follow up visit, 19 (63%) had the same PFGE type at each visit.
Conclusions: This study demonstrates that PVL-positive, USA300
MRSA was carried in the anterior nares of patients with uncomplicated
skin infections and was found to be the predominant type collected from
the baseline nasal samples of patients in the United States. The majority
of patients who had MRSA isolated from their anterior nares at two or
more visits maintained carriage of the same PFGE type. Both of these
ﬁndings have signiﬁcant implications for epidemiologic investigations
and for planning future interventional studies.
P936 Determining evolutionary lineages of Staphylococcus aureus
using variable number tandem repeats
K. Hardy, B. Short, J. Thomas, M. Enright, P. Hawkey (Birmingham,
Warwick, London, UK)
Objectives: The aim of the study was to determine the ability of variable
number tandem repeat typing to deﬁne evolutionary lineages using a well
characterised global collection of MSSA and MRSA isolates.
Methods: Ninety two isolates of S. aureus from diverse origins were
included in the study. The isolates consisted of 41 MRSA (SCCmec
types I to IV) and 51 MSSA isolates, as well as examples of isolates
from the ﬁve major global clonal complexes. All isolates were typed
using three sequence based typing methods, MLST, spa and sas typing
and using 7 previously described variable number tandem repeats termed
staphylococcal interspersed repeat units (SIRU). The numbers of repeats
at each locus were determined and a 7 digit proﬁle generated. All of
the epidemiological typing data was analysed using Bionumerics and
SIRU data analysed using Euclidian coefﬁcient. Simpson’s index of
diversity was used to calculate the index of discrimination of all the
typing techniques.
Results: All isolates were typeable by all four typing methods, and
gave 100% reproducibility. SIRU typing provided the greatest level of
discrimination (D=0.997 CI 0.995, 1.000), signiﬁcantly greater (P<0.05)
than that provided by the most discriminatory sequence based method,
spa typing (D=0.9847, CI 0.975 to 0.994). Both spa and sas typing
gave a higher index of discrimination than MLST (0.965 versus 0.939
respectively).
Cluster analysis of the SIRU proﬁles demonstrated concordance with
the MLST data, whilst providing a greater degree of diversity. Isolates
that are diverse by MLST (greater than two loci different) were not
clustered together by SIRU. SIRU typing arranged the isolates into ﬁve
main groups, clustering together isolates from CC30, CC22, CC1, and
CC5 into distinct complexes, while the majority of isolates from CC8
were clustered together. Singleton strains, those unrelated to the major
clonal complexes, were diversely spread.
Conclusion: This study uses isolates that have been previously used to
deﬁne the evolution of MRSA and clustering analysis demonstrates that
SIRU has excellent concordance with previously used sequence based
typing methods. SIRU provides a greater degree of discrimination than
MLST allowing a more detailed insight into the evolution of individual
clonal complexes, whilst still retaining the overall population structure
exhibited in the clonal complexes deﬁned by MLST.
P937 Variable number tandem repeat assay for typing
meticillin-resistant Staphylococcus aureus
B. Rivero-Pe´rez, E. Pe´rez-Roth, J. Alcoba-Flo´rez, F. Laich,
A. Espinoza-Jime´nez, S. Me´ndez-A´lvarez (Santa Cruz de Tenerife, ES)
In the work with pathogen microorganisms, the knowledge of their DNA
ﬁngerprints is necessary for the delineation of outbreaks of infections
disease and for the global tracking of them. For these reasons, on the
last decades an intense search of methods to improve this way has taken
place. Variable Number Tandem Repeat Assay (MLVA) was described
for the ﬁrst time in 1995 as a new typing method for Haemophilus
inﬂuenzae. Later, in 2003 Sabat et al. introduced it for the study of
Staphylococcus aureus. However, the usefulness of this technique is still
an opened question.
Objectives: The aim of our study has been to determine the utility of
MLVA for typing S. aureus isolates and to compare the results obtained
with those generated by means of the Pulsed-Field Gel Electrophoresis
(PFGE).
Methods: A multiplex PCR assay, optimised by us, containing primers to
simultaneously amplify clfA, clfB, sdrCDE, spa and sspa loci, and PFGE
macrorrestriction patterns analysis were applied to a group of meticillin-
resistant S. aureus (MRSA), collected since 2002 to 2006. The results
obtained by both approaches were compared by means of the power of
discrimination of each of them.
Results: All MRSA isolates were typeable by MLVA, being grouped in
23 types, according to the criteria established by Sabat et al. (2003),
whereas the PFGE assay distinguished 17 types according to the criteria
established by Tennover et al. (1995). As a general rule, within each
pulsed-ﬁeld type, a majority MLVA pattern and others that had one band
change with this were noticed.
Conclusion: MLVA is a reliable technique, with a high power to
discriminate MRSA isolates. This capacity can be used to perform a local
characterisation of MRSA collections. MLVA patterns seem to belong
with PFGE types, whenever we consider subtypes (one band different of
the majority pattern) inside MLVA types.
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P938 Multicentre evaluation of the Toxo IgG assay on the Family
of Access® immunoassay systems from Beckman Coulter
P. Flori, D. Uettwiller-Geiger, O. Flecheux, R. Tran Manh Sung,
C. Darte, F. Bouniort, M. Olson (Saint-Priest-En-Jarez, FR; Port
Jefferson, US; Marnes-la-Coquette, Marseille, FR; Nyon, CH;
Chaska, US)
Background: Toxoplasma gondii is a protozoan capable of infecting
many species of mammals and birds. Human infection is common
worldwide, although prevalence varies with subject age and geographic
location. Infections in adults and children past the neonatal stage is
usually unapparent. Primary infection acquired just before and during
pregnancy may lead to fetal death or serious congenital abnormalities.
Serological conﬁrmation of antibodies to Toxoplasma is indicative of
exposure to the parasite and is the principal means of diagnosis and
follow-up.
The Access® Toxo IgG assay is based on paramagnetic particle, solid
phase technology and chemiluminescent signal detection. The Access
Toxo IgG assay has been restandardised to the WHO 3rd international
standard TOXM.
Objectives and Methodology: Access Toxo IgG assay reproducibility
was evaluated at three centres. Reproducibility was determined with nine
samples with varying degrees of reactivity and two controls, analysing
ﬁve replicates of each sample for seven days. Concordance (percent
agreement) with the Abbott AxSYM assay was evaluated at two sites.
Two hundred and seventy nine de-identiﬁed residual samples from
pregnant subjects were tested as well as four hundred and seventy one
non-selected samples from male and female subjects who had Toxo IgG
testing ordered. The platform utilised at all centres was the Access 2
Immunoassay System. Similar performance has been demonstrated on
the UniCel® DxI 800 Access Immunoassay System.
Results: At the cut-off (10.5 IU/mL) within site total CV% ranged from
8% to 10%. The overall agreement of the Access Toxo IgG assay to
the AxSYM Toxo IgG assay was 97.3% (95%CI, 95.9% to 98.4%).
The relative sensitivity was 98.0% (95.9% to 99.2%) and the relative
speciﬁcity was 99.5% (98.1% to 99.9%).
Conclusion: The Access Toxo IgG assay provides excellent concordance
to the comparison method to aid in the diagnosis of Toxoplasma gondii
infection and the determination of protective levels of antibodies in
pregnant women and the general population with the advantage of a
rapid, automated random-access immunoassay system.
P939 Analytical performances of the new Access®Toxo IgG assay
F. Bouniort, O. Flecheux, A. Clement, C. Stoia, F. Margotteau,
D. Duhamel, J. Poropane, R. Falcou, C. Walton (Nyon, CH;
Marnes-la-Coquette, FR; Chaska, US)
Objectives: In order to be aligned with international standardisation
recommendations, Beckman Coulter has restandardised the Access®
Toxo IgG assay to the WHO 3rd International Standard (TOXM). The
purpose of this study was to evaluate the analytical sensitivity including
limit of blank (LoB), limit of detection (LoD), limit of quantiﬁcation
(LoQ), as well as linearity, precision and analytical speciﬁcity of the
new Access Toxo IgG assay.
Methods: The analytical sensitivity was determined according to the
CLSI EP17-A procedure. LoB and LoD were deﬁned with four negative
and low level samples tested 60 times. LoQ, determined with samples
with known expected Toxoplasma IgG concentration, was determined
over ﬁve days with one run/day and ﬁve replicates per run. Linearity was
studied with Toxoplasma IgG high positive samples diluted from 1:1.5 to
1:32. The precision studies used negative, low, medium and high positive
samples and included intra- and interassay determinations or studies as
well as inter-lot studies. Analytical speciﬁcity was determined by testing
310 samples obtained from patients with speciﬁc disease conditions.
Results: The Access Toxo IgG assay displays a LoB, LoD and LoQ
of 0.10 IU/mL, 0.40 IU/mL and 3.2 IU/mL, respectively. The linear
regression slope for linearity study was 1.07 with a total mean recovery
percentage of 99.9%. The precision studies demonstrated a CV below
6%, 11% and 11% for intra-assay, inter-assay and inter-lot, respectively.
Among the 310 samples tested for the analytical speciﬁcity, 303 were
found negative with the new Access Toxo IgG assay.
Conclusion: The new Access Toxo IgG assay provides excellent
performance, with the advantages of a rapid, automated random access
immunoassay system.
P940 Comparative studies of the new Access® Toxo IgG assay
F. Bouniort, O. Flecheux, A. Clement, C. Stoia, F. Margotteau,
D. Duhamel, J. Poropane, R. Falcou, C. Walton (Nyon, CH;
Marnes-la-Coquette, FR; Chaska, US)
Objectives: A new quantitative Access Toxo IgG assay, restandardised
by Beckman Coulter to the WHO 3rd International Standard (TOXM),
was studied in order to determine concordance between the new assay
and the AxSYM** Toxo IgG assay. Relative speciﬁcity and sensitivity
were calculated within the tested populations as compared to a reference
method.
Methods: The concordance studies were performed with samples from
non-selected blood donors (n = 700), non-selected hospitalised patients
(n = 3824) and non-selected pregnant women (n = 358). The comparative
device used for these studies was the Abbott AxSYM Toxo IgG assay
and a percentage of agreement between the methods was calculated.
Speciﬁcity and sensitivity were calculated based on a ﬁnal interpretation
of the results (deﬁned as a reference method) obtained with the current
Access Toxo IgG, the AxSYM Toxo IgG and the bioMe´rieux VIDAS
Toxo IgG assays.
Results:
• Blood donors: The agreement between the new Access Toxo IgG and
the AxSYM Toxo IgG assays was 97.57% (683/700). According to
the reference methods, the new Access Toxo IgG assay displayed
speciﬁcity and sensitivity of 99.53% and 99.37%, respectively.
• Non selected hospitalised patients: The agreement between the new
Toxo IgG and the AxSYM Toxo IgG assays was 97.64% (1781/1824).
According to the reference methods, the new Access Toxo IgG assay
displayed a relative speciﬁcity and sensitivity of 98.89% and 99.70%,
respectively.
• Pregnant women: The agreement between the new Toxo IgG and the
AxSYM Toxo IgG assays was 98.92% (552/558). According to a
reference method, the new Access Toxo IgG assay displayed speciﬁcity
and sensitivity of 100% and 100%, respectively.
Conclusion: The new Access Toxo IgG assay provides good agreement
in comparison with the AxSYM Toxo IgG assay. The new Access Toxo
IgG assay displays excellent relative speciﬁcity and sensitivity results
compared to reference Toxo IgG methods. The new Access Toxo IgG
assay can be used either with the Access® Immunoassay System or with
the high-throughput UniCel® DxI 800 Access Immunoassay System.
P941 Evaluation of the new ARCHITECT CMV IgM, IgG and
IgG avidity assays
K. Lagrou, M. Bodeus, M. Van Ranst, P. Goubau (Leuven, Brussels, BE)
Objectives: A panel of new CMV assays for the ARCHITECT
instrument has been developed including a CMV avidity assay based
on a new technology. The purpose of this study was to compare the
performance of the fully automated CMV IgM, IgG and IgG avidity
tests on ARCHITECT with other available assays.
Methods: 503 consecutive fresh patient sera (routine sera) received at the
University Hospital laboratory for CMV IgM and IgG testing on AxSYM
(Abbott), 100 preselected AxSYM IgM positive sera and 96 sera from
33 pregnant women with a recent CMV primo infection (seroconversion
sera) were tested for CMV IgM and IgG on the ARHCITECT (Abbott),
VIDAS (BioMerieux) and Dade Behring assays. The seroconversion sera
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were also tested with the IgG avidity tests developed on ARCHITECT
and VIDAS. The speciﬁcity of the avidity tests was assessed on 100
preselected AxSYM IgM negative, IgG positive sera.
Results: The relative agreement for the CMV IgM determination on
the routine sera between ARCHITECT and VIDAS, Dade Behring and
AxSYM was respectively 97%, 94% and 93% for the CMV IgM tests
and 99%, 98% and 98% for the CMV IgG tests. CMV IgM reactivity
on ARCHITECT but not with the other assays, occurred only in 1 of
the 503 routine sera (0.2%). In 3.0% of routine sera CMV IgM was
positive only on AxSYM. CMV IgG avidity was high in 50% of routine
sera with ARCHITECT CMV IgM reactivity. All preselected AxSYM
IgM positive sera with a low VIDAS IgG avidity were reactive on all
IgM assays tested. The speciﬁcity of the CMV IgG avidity test was 98%
for ARCHITECT and 76% for VIDAS. No high CMV IgG avidity test
results were found within the ﬁrst 3 months after seroconversion with
both assays. High avidity was attained earlier on ARCHITECT than on
VIDAS. In several patients no gradual increase in avidity was observed
after seroconversion. This phenomenon was more frequent with the
ARCHITECT avidity test compared to the VIDAS assay. The increase
in the avidity values after seroconversion needs further validation.
Conclusion: The correlation between the newly developed CMV IgM
and IgG tests on ARCHITECT with the VIDAS and Dade Behring
assays was excellent (94%) and was highest between ARCHITECT and
VIDAS. The CMV IgG avidity test reliably excluded recent infections
and showed an excellent speciﬁcity (98%).
P942 Earliest possible diagnosis of seroconversion for toxoplasmosis
in pregnancy
V. Meroni, F. Genco, P. Lanzarini, M. Stronati, L. Ciardelli, F. Garofoli,
L. Bollani (Pavia, IT)
The early and deﬁnitive detection of a recently acquired infection is
critical for the clinical management of the mother and her foetus.
IgG antibodies are often absent in early phases of infections and IgM
antibodies may be non speciﬁc and disappear at the end of pregnancy.
Therapy usually given as early as possible could affect antibody
production. To distinguish early infection from non-speciﬁc antibody
response we evaluated two routine tests for IgG and for IGM two
new conﬁrmation immunoblots and mmunological tests in 39 pregnant
women with suspected seroconversion.39 pregnant women negative for
anti-Toxoplasma IgG (LIAISON Toxo IgG II DIASORIN Italy, VIDAS
toxo IgG II Biomerieux France)and positive for IgM with at least
one of the two tests routinely used(LIAISON TOXO IgM DIASORIN
Toxo IgM ISAGA BIOMERIEUX)were followed weekly to detect the
production of anti-Toxoplasma IgG. Spiramicyn was given at the ﬁrst
positive IgM test. All samples were also tested with LDBIO TOXOII
IgG and LDBIO TOXOII IgM the latter being not commercially available
(LDBIO DIAGNOSTICS France). In 12 out of 39 women lymphocyte
stimulation was performed using Toxoplasma antigen (DIASORIN)and
CD25 and Stimulation Index were evaluated.10 women resulted IgM
ISAGA and type II WB negative in all these cases no seroconversion was
recorded even after therapy interruption. IgM ISAGA and LDBIO TOXO
II IgM was positive in 29 women. For 13 patients the seroconversion was
proved with the appearance of speciﬁc anti-Toxoplasma IgG during the
follow-up. In 4 they were already present in the ﬁrst sample by LDBIO
TOXOII IgG in 9 IgG antibodies were detected on subsequent samples
earlier with LDBIO TOXOII IgG and with LIAISON Toxo IgG assay.9
were also positive in lymphocyte stimulation.13 women were LDBIO
TOXOII IgM negative and no IgG was detected with all the tests on later
samples even after the treatment was discontinued. In 5 cases lymphocyte
stimulation conﬁrmed these results.
Conclusions: In 36 patients an early and correct diagnosis was reached
with LDBIO TOXO II IgM. LDBIO TOXO II IgG and LIAISON Toxo
IgG II were positive earlier and conﬁrmed the seroconversion several
weeks before the other IgG test. In all negative cases it was possible to
stop safely the therapy and to reassure the women. No infected woman
was missed, all positive women were given the appropriate therapy and
prenatal diagnosis was offered. We had three false positive results at IgM
(one also with lymphocyte stimulation).
P943 Performance of ﬁve commercial immunoblots for serological
conﬁrmation of syphilis
C. Roure sobas, M. Brun, P. Miailhes, H. Salord, Y. Gille, S. Tigaud
(Lyon, FR)
Objectives: The incidence of syphilis has increased yearly since 2000.
Syphilis is famous for its polymorphic presentation and diagnosis is
usually established by serology. Nontreponemal test and a speciﬁc
treponemal test are classically used. Immunoblots (IB) (IgG and IgM)
have recently been proposed as conﬁrmatory tests, but without clear
indications. Except for Inno-Lia (Innogenetics), performance data are
rare. The multiparametric approach is based on antibody responses
to 3 immunodominant Treponema pallidum recombinant polypeptides
(TpN47, TpN17, TpN15) and one synthetic peptide (TmpA) blotted onto
strips.
Methods: The present study compared 5 commercial IB IgG tests
(InnoLia, Innogenetics; Euroline, Euroimmun; EcoLine, Virotech;
Recomblot, Mikrogen; and Virastripe, Servibio) and 3 IgM IBs (InnoLia,
Euroline, and Recomblot) in routine. All sera were tested by the
rapid reagin plasma test (RPR), the T. pallidum hemagglutination assay
(TPHA), the immunoglobulin IgG-ﬂuorescent T. pallidum absorption
assay (IgG-FTA-ABS), the immunoglobulin IgM-ﬂuorescent T. pallidum
assay (IgM-FTA), and an enzyme immunoassay (IgM-EIA). We tested
44 well-deﬁned sera at different stages of syphilis (clinical and serology
ﬁndings), 20 sera with an indeterminate serological status for syphilis
and 7 samples from subjects with potentially interfering diseases. For 5
patients, we also compared serology results at diagnosis and at 3 to 6
months’ follow-up, to investigate antibody kinetics.
Results: All IgG IB assays provided comparable results and conﬁrmed
the 44 syphilis. No sera from patients with autoimmune disease or
lyme borreliosis were positive. TpN47 and TmpA was the most frequent
antigen in all stages of syphilis and band intensity varied with TPHA
titer. Anti-TmpA antibody levels tended to fall after treatment, and
TNp47 indicated serological scarring.
Whenever ELISA-IgM and FTA-IgM were concordant, the IB IgM test
conﬁrmed diagnosis, and identiﬁed 4 out of 6 discordant cases (ELISA
IgM negative, FTA IgM positive). The recomblot IgM and the InnoLia
IgM achieved the highest sensitivities.
Conclusion: The main interest of IB tests lies conﬁrming or ruling out
a diagnosis of syphilis in case of discordant screening ﬁndings. Further
studies are needed to assess application to latent and neonatal syphilis.
P944 Use of the recombinant k39 immunochromatographic
strip-test for serological diagnosis of visceral leishmaniasis:
experience from Apulia, southern Italy
R. Monno, R. Bruno, E. Di Molfetta, P. Bottalico, C. Rizzo, D. De
Vito, L. Fumarola (Bari, IT)
Objective: Visceral leishmaniasis (VL) is endemic in our area, Apulia,
Southern Italy. The aim of this study was to evaluate a commercially
available membrane-based immunoassay (MBI) using a recombinant
protein rk39 as antigen in comparison to the immunoﬂuorescent antibody
assay (IFA) for the detection of speciﬁc anti-Leishmania antibodies.
Methods: A total of 264 individuals including 19 patients with VL (3
of whom HIV-positive), 67 with suspected VL and 40 healthy controls
were tested. VL diagnosis was made by microscopic demonstration of
Leishmania amastigotes in Giemsa stained smears from bone marrow
aspirates and/or on the presence of speciﬁc antibodies. In a HIV-positive
patient diagnosis was performed by the PCR on peripheral blood. IFA
and MBI were performed in all 264 sera according to manufacturer’s
instructions.
Results: The MBI was positive in all the 19 patients with VL
(diagnosed by the presence of antibodies by IFA and/or the presence
of amastigotes in bone marrow aspirate) and negative in sera from the
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remaining individuals. The sensitivity and speciﬁcity of MBI was 100%,
respectively. The IFA failed to detect anti-Leishmania antibodies in the
ﬁrst serum sample of a HIV-positive patient but antibodies were detected
in a second serum sample obtained 7 days later. On this patient the
MBI was positive on the ﬁrst serum sample tested. The MBI works
well also on HIV–Leishmania co-infected patients in whom low yield
of serological studies may be a most characteristic ﬁnding. Follow
up performed on 7 patients with VL showed that both antibodies to
Leishmania detected by IFA and MBI remain at detectable levels up to
12–24 months. A dilution trial performed on sera of 2 patients showed
that a positive reaction by MBI was detectable at serum dilution up to
20,480, indicating that a strong immuno-response is mounted against the
rk39 antigen.
Conclusions: The MBI is a reliable test for diagnosis of leishmaniasis
and is not only a good alternative in a setting where a reliable enzyme
immunoassay or IFA tests are not available, but also in well equipped
laboratories because positive results can be obtained in 10 minutes. The
cost of MBI in our experience was approximately 8.43 euro per test,
compared with approximately 12 euro for IFA. MBI appears highly
sensitive, speciﬁc, rapid and cost-effective for the serological diagnosis
of VL in our location where VL has a low endemicity.
P945 Virus-speciﬁc antibody activity of different subclasses of
immunoglobulins G in Cytomegalovirus infections
E. Matveeva, A. Burkov, A. Obriadina (Nizhny Novgorod, RU)
Objectives: Patients with primary, reactivated or convalescent phase
of Cytomegalovirus (CMV) infections were examined for antiviral
antibodies of the IgG subclasses. The purpose of this study was to
investigate the diagnostic value of anti- CMV IgG subclasses for
diagnosis of acute CMV infection.
Methods: A total of 52 serum samples from patients with different
phases of CMV infection were tested for anti-CMV IgG, IgM and
IgG avidity by commercially available enzyme immunoassay (RPC
“Diagnostic systems”, Russia). Anti CMV IgG speciﬁc to envelope
glycoprotein (gB) were studied to conﬁrm recent infections. The
reactivity pattern of IgG subclasses to individual CMV proteins (pp150,
pp52, pp38, pp28) were analysed with subclass speciﬁc monoclonal
antibodies from Zymed Laboratories Inc., USA.
Results: The distribution of CMV-reactive IgG subclasses among groups
with different CMV infection phases was analysed. CMV-speciﬁc IgG1
was predominant in all groups. In primary infection frequency of anti-
CMV IgG3 is signiﬁcant higher (75%) than in latent phase (13%,
P = 0.001) and reactivated CMV infection (23%, P = 0.032). Frequency
of anti-CMV IgG4 is signiﬁcant higher (62%) for reactivated CMV
infection than for convalescent phase (10%, P = 0.001). No difference
was observed in total IgG subclass value in all analysed groups.
No signiﬁcant difference was found for IgG2 and IgG4 reactivity to
individual CMV proteins between studied groups. In primary infection
anti-pp28 IgG1 was detected rarer (25%) than in reactivated CMV
infection (85%, P = 0.018). Among patients with acute CMV infection
(recent or reactivated) frequency of anti-pp150 IgG3 positive sera is
signiﬁcant higher (38%) than in group of latent infection (0%, P = 0.001,
P = 0.003).
Conclusions: Frequencies of anti-CMV IgG4 and anti-pp150 IgG3 are
different for acute and latent CMV infection and anti-CMV IgG3 and
anti-pp28 IgG1 – for primary and reactivated CMV infection. The
measurement of IgG subclasses reactive with individual CMV proteins
may be a sensitive indicator of CMV infection phases.
P946 Signiﬁcance of laboratory ﬁndings for the diagnosis of
neurosyphilis
N. Chepurchenko, M. Gladisheva, A. Burkov, A. Obriadina (Nizhny
Novgorod, RU)
Objectives: The usage of recombinant T. pallidum antigens in ELISA
and passive hemagglutination assay (TPHA) has the potential for
improvement lab diagnostics of neurosyphilis. The aim of this study was
to evaluate the diagnostic relevance of cerebrospinal ﬂuid (CSF)-tests,
to analyse antibody reactivity pattern in CSF from neurosyphilis patients
by ELISA and TPHA and new criterion of the intrathecal production of
speciﬁc IgG deﬁnition.
Methods: Four full-length recombinant proteins (TmpA, 47, 17, 15
kDa) were expressed in E. coli and then used individually to develop
ELISA and TPHA tests. The FTA-ABS, TPI, ELISA, TPHA, VDRL,
CFT (complement ﬁxation test) tests were performed on CSF samples
from 22 patients with a diagnosis of active neurosyphilis, from 4 patients
treated for neurosyphilis and from 17 patients without syphilitic CNS
involvement. TPHA-IgG titres have been determined in paired serum
and CSF samples from 13 neurosyphilis patients and 1 patient without
syphilitic CNS involvement.
Results: When CSF was used as diagnostic ﬂuid sensitivities of
FTA-ABS, ELISA, TPHA (82.3%, 86.4%, 86.4% accordingly) were
higher in comparison with TPI, VDRL, CFT tests (62.5%, 58.8%,
60% accordingly). However, VDRL and CFT demonstrate 100%
speciﬁcity in contrast with treponemal tests (speciﬁcity 75–84.6%).
The best result matched with clinical diagnosis of neurosyphilis was
demonstrated by next three combinations: FTA-ABS+ELISA+TPHA,
FTA-ABS+ELISA+VDRL or FTA-ABS+TPHA+VDRL – 88.4%.
Antibodies speciﬁc to 17 kDa (88.9–90.9%) and TmpA (72.2–86.4%)
were prevalent in CFS samples. There is no correlation in titers of
antibodies speciﬁc to individual T. pallidum recombinant antigens in
paired serum and CFS samples from patients with neurosyphilis. In
the same time strong correlation was observed when paired CFS/serum
samples from patient without syphilitic CNS were tested.
Conclusions: Different antibody reactivity pattern in paired CFS/serum
samples may indicate intrathecal production of antitreponemal antibod-
ies.
P947 Sensitivity and mutant recognition of the DiaSorin liaison
HBsAg assay
S. Nick, H. Scheiblauer, E. Spranzi, S. Wacker (Langen, DE; Saluggia,
IT; Dietzenbach, DE)
Objectives: Determination of HBsAg is still indispensable for the
diagnosis of HBV infection despite additional anti-HBc screening and
NAT. Yet, high sensitivity and mutant recognition are the prerequisites
for HBsAg detection. The European regulations require an overall
sensitivity equivalent to an established device, early detection to be state
of the art and recognition of virus variants. The Liaison HBsAg assay
was challenged for analytical sensitivity, seroconversion sensitivity and
frequently occurring HBV mutants.
Methods: Diagnostic and analytical sensitivity of the Liaison HBsAg
assay were assessed using 37 commercial seroconversion panels,
internationally recognised HBsAg standards (PEI HBsAg ad and ay,
2nd WHO HBsAg standard and HBsAg mutant samples (4 recombinant
constructs S143L (ayw), C76Y/R169H, S53L/ I126N/ S210N, C76Y/
T143M/ F219S and 4 naturally occurring mutants G129H, M133T,
G145R, T143L).
Results: Seroconversion data revealed that the Liaison HBsAg assay
showed an overall clinical sensitivity in the range of European CE-
marked HBsAg tests. Among the 20 HBsAg tests assessed by PEI
it ranked at position 9. Analytical sensitivities of the Liaison HBsAg
were 0.023 PEI U/ml relating to the PEI HBsAg ad standard and 0.038
PEI U/ml for the HBsAg ay standard. Based on the 2nd WHO HBsAg
standard analytical sensitivity was 0.049 IU/ml. In addition, the Liaison
HBsAg test detected all natural mutants as well as all recombinant
constructs investigated.
Conclusions: Sensitivity of Liaison HBsAg assay meets the current
state of the art in the sense of the European regulations. Analytical
sensitivity of the Liaison HBsAg complies with the revised European
requirement for 0.130 IU/ml relating to the 2nd WHO HBsAg standard.
Seroconversion sensitivity is in a good range with other CE-marked
assays. The assay shows no deﬁciencies in the detection of frequently
occurring HBsAg mutants.
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P948 Bacteriological and serological aspects of Chlamydophila
pneumoniae pharyngotonsillitis in adults
R. Timpanaro, B. Bisignano, A. Stivala, A. Garozzo, A. Castro,
G. Tempera (Catania, IT)
Objective: Acute pharyngotonsillitis is one of the most common
infections encountered by family physicians. Most patients with
acute pharyngotonsillitis have symptoms that can be attributed to
infection with a respiratory virus, such as adenovirus, inﬂuenza virus,
parainﬂuenza virus, rhinovirus, and respiratory syncytial virus. However,
in approximately 30% to 40% of cases, acute pharyngotonsillitis is
of bacterial aetiology. Group A beta-hemolytic streptococci (GABHS)
are responsible for most bacterial cases of acute pharyngotonsillitis,
although other pathogens, such as Neisseria gonorrhoeae, Arcanobac-
terium haemolyticum, Mycoplasma pneumoniae, and Chlamydophila
pneumoniae, may be the causative agents in sporadic cases.
To assess whether C. pneumoniae plays a role in pharyngotonsillitis,
the prevalence of C. pneumoniae detection in adult patients with upper
respiratory illnesses was investigated.
Methods: Clinical samples from 98 adult patients were sent to our
laboratory from family physicians between January 2006 and March
2007. All clinical and serum samples were collected from patients who
were diagnosed with pharyngotonsillitis based on clinical symptoms.
During the same period, we enrolled 75 healthy subjects without any
history of respiratory tract infections in the 3 months before enrolment.
The nasopharyngeal swabs were evaluated for isolation of C. pneumoniae
in cell culture, all specimens were passaged three-times. The presence
of chlamydial inclusions was examined by Immunoﬂuorescent (IFA)
staining and Giemsa staining.
A commercial microimmunoﬂuorescence (MIF) test was used to measure
C. pneumoniae-speciﬁc IgG, IgM, and IgA antibodies (Labsystems,
Helsinki, Finland distributed by Dasit, Italy).
Results: C. pneumoniae was detected by isolation in ten patients
(10.2 per cent) but in none of the control. Immunoﬂuorescent (IFA)
staining and Giemsa staining of 98 pairs of matched swabs detected
C. pneumoniae in three by both methods, in four by Giemsa staining
alone, and in three by IFA alone.
Twenty-four (24.5 per cent) of 98 patients had a positive result for
C. pneumoniae IgG antibodies and nine (9.2 per cent) for C. pneumoniae
IgA antibodies. No patient had a C. pneumoniae IgM antibodies.
Conclusion: Our results suggest that the therapeutical choice of acute
pharyngotonsillitis in adults should take into account the possibility of
C. pneumoniae infections.
P949 Laboratory evaluation of UniCel DxI 800 analyser (Beckman
Coulter) for HBV and HCV serological markers
M. Miedouge, F. Abravanel, C. Lalanne, J. Izopet (Toulouse, FR)
Objectives: The UniCel DxI 800 analyser (Beckman Coulter) is
a multiparametric immunoassay system with random access that
uses magnetic particules separation and indirect chemiluminescent
technology.
In this study, intra-assay and inter-assay precision, and a comparison
with the Vitros ECi (Ortho Clinical diagnosis) were evaluated for the
following virological markers: antibody to hepatitis C virus (anti-HCV)
and four hepatitis B virus (HBV) markers i.e. HBsAg, anti-HBc, anti-
HBc IgM and anti-HBs.
Methods: Intra-assay precision was determinated by measuring within
one run 20 replicates of the manufacturer positive controls. For inter-
assay precision, the same controls were tested daily during the evaluation
period in 26 to 36 runs depending on the markers.
Comparison of the two analysers was assessed by testing patients sera
previously analysed in our laboratory with the Vitros ECi and stored at
−23±5ºC. Negative and positive samples were compared: respectively
104 and 108 for HBsAg, 120 and 133 for anti-HBs, 225 and 36 for
anti-HBc, 103 and 21 for anti-HBc IgM and 109 and 26 for anti-HCV
For the quantitative anti-HBs assay, correlation with the Vitros was
determined with the Spearman regression test. Moreover linearity,
accuracy and detection limit were evaluated using serial dilutions (from
500 mUI/ml to 10 mUI/ml) of the WHO internationnal standard for
anti-HBs (W1042).
Results: Coefﬁcient of variation for intra-assay and inter-assay tests were
respectively 0.8% and 4.4% for HBsAg, 2.1% and 5.1% for anti-HBs,
2.4% and 6.2% for anti-HBc, 5% and 8.7% for anti-HBc IgM and 3.7%
and 7.4% for anti-HCV.
The concordance rates between the two methods were high: 100% for the
ﬁve markers except for negative HBsAg sera where one discordant result
was observed (99% concordance). Anti-Hbs results appeared statistically
correlated either with Vitros results or with the WHO standard (p<0.01
with Spearman test). All the ﬁve replicates of the 10 mUI/ml sample
were detected. The throughput of the analyser was estimated at about
200 tests per hour.
Conclusion: The results of this evaluation conﬁrmed that the ﬁve
assays meet the criteria of the Common Technical Speciﬁcations of the
European Union’s Directive on In Vitro Diagnostic Medical Devices in
terms of speciﬁcty and sensitivity. Together with a high throughput, the
DXI provides a useful tool for serological diagnosis of HCV anc HBV
infection in routine practice.
Host microbial interactions
P950 Tifacogin and a synthetic TFPI peptide fragment suppress
cytokine production due to Streptococcus pneumoniae and
Staphylococcus aureus in whole blood cultures
Y. Dai, S. Schirm, X. Liu, S. Hardy (Emeryville, US)
Objective: Tifacogin, rTFPI, has demonstrated efﬁcacy in acute
inﬂammation after Escherichia coli infection in several animal models
of severe sepsis. Tifacogin is currently being evaluated in a phase 3
clinical trial in severe community acquired pneumonia patients. Our goal
was to investigate tifacogin activity in bacterially-induced inﬂammatory
disease in an ex vivo model using disease relevant bacteria. The objective
of this study was to investigate if cytokine production was reduced
by tifacogin and TFPI-derived peptides in an ex vivo model of blood
cultures inoculated with S. pneumoniae or S. aureus.
Methods: Tifacogin and synthetic C-terminal peptides derived from
TFPI were prepared and their effect on inﬂammatory cytokine production
in 10% human blood cultures containing Gram+ pathogens including
S. pneumoniae and S. aureus were measured with and without
vancomycin. For cytokine analysis, whole blood assay reactions were
incubated for 18–20 hours and cell-free supernatants were harvested.
Aliquots were used in a custom pro-inﬂammatory human cytokine panel.
Bacterial titers were measured by serial dilution of cultures, plating on
appropriate agar and incubation overnight at 37ºC.
Results: Addition of tifacogin to vancomycin reduced inﬂammatory
cytokines IL-1B (7 pg/mL compared to 36 pg/mL for vancomycin
alone), IL-6 (1100 pg/ml compared to 3450 pg/mL), TNF-a (37 pg/ml
compared to 250 pg/mL), and IL-8 (3000 pg/mL compared to 25000
pg/mL) respectively compared to vancomycin alone. Similar changes
were noted with other anticoagulants suggesting the effect was tied to
clotting inhibition. In combination with vancomycin, a TFPI peptide but
not its scrambled control also signiﬁcantly reduced IL-6, IL-8 and TNF-a
levels compared to vancomycin alone. The effects of tifacogin and TFPI
peptide reinforced each other to lower cytokines to near baseline levels,
suggesting different underlying mechanisms. Similar ﬁndings were noted
when erythromycin was substituted for vancomycin.
Conclusions: Our results show that tifacogin and an rTFPI peptide
demonstrate anti-inﬂammatory effects by reducing cytokine levels
in blood inoculated with S. pneumoniae or S. aureus. These data
suggest that tifacogin has antiinﬂammatory activity in addition to
previously demonstrated anticoagulant activity. Tifacogin and rTFPI
peptide fragment may have adjunctive antiinﬂammatory activity in
combination with antibiotics.
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P951 IL-17 is associated with severity of invasive meningococcal
disease
O. Beran, O. Dzupova, D. Lawrence, M. Holub (Prague, CZ; Albany, US)
Objectives: The aim of the present study was to determine the
cytokine proﬁle of plasma and cerebrospinal ﬂuid (CSF) during invasive
meningococcal disease (IMD) with use of a multiplex system. The
relationship between cytokine concentrations and IMD severity was also
assessed.
Methods: A total of 12 patients with IMD were evaluated. Paired
plasma and CSF samples were obtained at the time of diagnostic (day
1) and follow-up (day 3−5) lumbar puncture (LP). Plasma and CSF
concentrations of 11 biomarkers (TNF-a, IL-1b, IL-6, IL-8, IL-10, IL-12,
IL-17, MCP-1, MIP-1b, IL-1Ra, leptin) were analysed using a Luminex®
analysis. Disease severity was evaluated using Acute Physiology and
Chronic Health Evaluation (APACHE) II score, Sequential Organ Failure
Assesment (SOFA) score and Glasgow Coma Scale (GCS) score.
Results: Plasma concentrations of IL-6, IL-10, IL-17 and IL-1Ra were
associated with APACHE II on day 1. With regard to the severity of
organ dysfunction on day 1, plasma IL-6, IL-8 and IL-10 concentrations
showed the best correlation with SOFA. Unlike plasma cytokines, CSF
concentrations were not associated with the disease severity.
Conclusion: Multiple cytokine analysis revealed cytokine patterns
associated with inﬂammatory response during IMD. Moreover, the study
is ﬁrst to demonstrate that the increased IL-17 plasma concentration
is associated with IMD severity. Since IL-17 is mainly produced by a
CD4+ T cell subset (Th17 cells), our results suggest an important role of
these cells in the IMD pathophysiology. Acknowledgement. The study
is supported by a grant IGA NR/9316−3.
P952 Waddlia chondrophila multiplies within human macrophages
in a vacuole associated to the endoplasmic reticulum
G. Goy, A. Croxatto, G. Greub (Lausanne, CH)
Objectives: Waddlia chondrophila is an obligate intracellular bacteria
which belongs to the Chlamydiales order. It was isolated twice from
aborted bovine foetuses, ﬁrst in 1990 in the United States and then in
2002 in Germany. A serological study supported the abortigenic role of
Waddlia in bovine species and inoculation of a pregnant cow with this
intracellular bacteria was associated with foetal death within 2 weeks.
Recently, we observed a strong association between the presence of anti-
Waddlia antibodies and human miscarriage. To further investigate the
pathogenic potential of W. chondrophila in humans, we studied the entry
and the multiplication of this obligate intracellular bacteria in human
macrophages.
Methods: Monocyte-derived macrophages were incubated with living
or heat-inactivated bacteria for 15 min at 37ºC after a centrifugation
step. Cells were then washed and further incubated for different
periods at 37ºC. Entry was assessed by confocal microscopy and
bacterial growth was quantiﬁed using immunoﬂuorescence with mice
anti-Waddlia antibodies and real-time PCR. Intracellular trafﬁc of W.
chondrophila in human macrophages was assessed by studying the co-
localisation of the bacteria with various cell markers.
Results: Confocal microscopy conﬁrmed that W. chondrophila is able
to enter into human monocyte-derived macrophages. W. chondrophila
organisms were shown to multiply readily within macrophages. The
proportion of infected macrophages increased from 13% at day 0 to 96%
at day 4, and the mean number of bacteria per macrophage (assessed
by immunoﬂuorescence) increased of more than 2 log in 4 days. This
growth was conﬁrmed by real-time PCR with a 3 log increase in 4
days and was associated with a decrease in the number of macrophages.
As expected, the heat-inactivated bacteria, which also entered into the
macrophages, did not increase over time and exhibited no cytopathic
effect. Using immunoﬂuorescence and confocal microscopy, we showed
that W. chondrophila escape the endocytic pathway and co-localise with
markers of the endoplasmic reticulum.
Conclusion: This study shows that W. chondrophila enters and multiplies
logarithmically within human macrophages suggesting its possible
human pathogenicity.
P953 Streptococcus pneumoniae, Neisseria meningitidis and
Haemophilus inﬂuenzae elicit distinct patterns of
inﬂammatory parameters in cerebrospinal ﬂuid of patients
with bacterial meningitis
D. Grandgirard, R. Ga¨umann, G. Pluschke, S. Leib (Berne, Basel, CH)
Objectives: Morbidity and mortality of meningitis caused by S. pneu-
moniae, N. meningitidis, and H. inﬂuenzae, the three major causes of
bacterial meningitis, differ dramatically with S. pneumoniae causing the
highest incidence of neurological disabilities and death. Pathogenetic
mechanisms underlying these differences may involve inﬂammatory
reactions of the brain in response to the different invading pathogens.
Inﬂammatory mediators in cerebrospinal ﬂuid (CSF) from patients
suffering from bacterial meningitis caused by the three different bacterial
species were assessed with the aim to identify inﬂammatory mechanisms
that contribute to the pathogen related differences in outcome.
Methods: A deﬁned panel of inﬂammatory parameters were assessed
in CSF from patients with conﬁrmed meningitis due to S. pneumoniae
(n = 32), N. meningitidis (n = 38), or H. inﬂuenzae (n = 3). Concentrations
of cytokines, chemokines and matrix-metalloproteinase-9 (MMP-9) were
assessed by a microsphere-based multiplex assay. In addition, the
concentration of MMP-9 was determined by gelatine gel zymography.
The activity of nitric oxide synthase was determined by measuring
nitrate/nitrite levels.
Results: IL-2 (Kruskall-Wallis p<0.03), IFN-gamma (p<0.03), and
MCP-1 (p<0.01) were found to be differentially up-regulated during
bacterial meningitis caused by the three pathogens, with S. pneumoniae
triggering the highest, and H. inﬂuenzae the lowest CSF concentrations of
these cytokines. CSF levels of MMP-9 also differed among the pathogens
(one way analysis of variance p<0.001) with levels in pneumococcal
meningitis being signiﬁcantly higher than in meningitis caused by
H. inﬂuenzae (Bonferroni’s p<0.05). Nitric oxide synthase activity in
CSF did not differ for the three causative pathogen.
Conclusion: From the inﬂammatory parameters assessed, concentrations
of IL-2, IFN-gamma, MCP-1, and MMP-9 were signiﬁcantly higher in
CSF samples from patients with meningitis caused by S. pneumoniae
compared to H. inﬂuenzae and N. meningitidis. The higher case fatality
rates and incidence of neurological sequelae caused by pneumococcal
meningitis compared to meningococcal or H. inﬂuenzae meningitis may
be associated with an increase in these inﬂammatory parameters.
P954 The host response in pneumococcal meningitis: differential
transcriptome analysis in cerebral cortex and hippocampus
M. Wittwer, J. Rohrbach, S.L. Leib (Berne, CH)
Background: For bacterial meningitis (BM) treatment options are
insufﬁcient as evidenced by a high mortality of up to 30% and the
occurrence of neurological sequelae in up to 50% of the surviving
patients. Knowledge on the diseases processes is prerequisite for
improvements in therapy. By setting the global gene expression proﬁle
in the context of biological meta-data resources we aimed to unravel
the pathological processes which determine the outcome of bacterial
meningitis.
Methods: An infant rat model of experimental pneumococcal meningitis
(PM) was used. Brain regions prone to injury e.g. the cortex and the
hippocampus were dissected form animals in acute and late phase of the
disease e.g. at 24 and 72 h after infection. Gene expression proﬁles were
assessed with Affymetrix GeneChip® Rat 230 2.0 arrays. Signiﬁcance
of transcriptomic changes were calculated with a moderated Bayesian
t-statistics using the limma package. GO statistics was performed by the
GOstats software packages provided by the Bioconductor project.
Results: From 31,000 transcripts of the rat genome represented on the
chip, approximately 17,000 were detected in both control and infected
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animals. 3600 genes were found to be signiﬁcantly (FDR Benjamini-
Hochberg p 0.05) regulated at 24 h.p.i and approx. 1100 genes at
72 h.p.i.
Gene Ontology statistics revealed that genes which were regulated at both
time points after infection were mainly involved in immunological and
inﬂammatory processes. This observation applies for both the cortex and
the hippocampus. In the cortex the dominant process was angiogenesis
at 24 h, while it was neurotransmitter signalling at 72 h after infection.
Genes found to be regulated in the hippocampus at 24 h.p.i were mainly
involved in apoptosis shifting to neurogenesis at 72 h.p.i.
Conclusion: By integrating differential gene expression data in the
context of biological research databases this study expands the current
knowledge of pathways of injury and regeneration in BM. This
approach identiﬁed angiogenesis, neurotransmitter signalling, apoptosis
and neurogenesis as targets for the development of new therapeutic
strategies.
P955 Apoptosis of T lymphocytes in the culture of peripheral blood
mononuclear cells from patients with late Lyme arthritis
S. Grygorczuk, J. Osada, J. Zajkowska, M. Kondrusik,
T. Chmielewski, R. Swierzbinska, S. Pancewicz, M. Dabrowska,
S. Tylewska-Wierzbanowska (Bialystok, Warsaw, PL)
Objectives: Apoptosis of activated T lymphocytes is essential in
physiologic regulation of inﬂammatory and immune response. Lympho-
cyte susceptibility to apoptosis may be increased in immune deﬁcits
and decreased in autoimmune disorders. The pathogenesis of chronic
articular symptoms in Lyme borreliosis (Lyme arthritis – LA) is
unclear and has been hypothesised to involve aberrant immune response,
including possible autoimmunity. We studied apoptosis of peripheral
T lymphocytes obtained from patients with late LA and cultured in
presence of Borrelia burgdorferi sensu lato (B. burgdorferi) antigens.
We checked for abnormalities in apoptosis rate, especially for decreased
susceptibility to apoptosis which might be a hallmark of uncontrolled
inﬂammatory/immune response or autoimmunity.
Methods: Peripheral blood mononuclear cells (PBMC) from 23 subjects:
14 patients with LA persistent or recurrent for > 6 months (LA
group) and 9 persons with no clinical suspicion or after exclusion of
Lyme borreliosis (control group – C) were incubated for 48 hours
with no stimulation or with addition of non-viable B. burgdorferi
spirochetes: Borrelia afzelii VS 46110 (B.a.), B. garinii 20047 (B.g.)
or B. burgdorferi sensu stricte B-31 (B.ss.) as antigenic stimulation.
Fraction of T lymphocytes (CD3+ cells) undergoing apoptosis was
measured by ﬂow cytometry with annexin-V binding assay.
Figure. Fraction of apoptotic T cells (median) in the 48-hour
culture either unstimulated (−) or stimulated with antigens of three
B. burgdorferi genospecies. Empty bars – healthy controls, ﬁlled bars –
Lyme arthritis patients: *p< 0.05, **p< 0.01.
Results: There was a signiﬁcantly higher fraction of annexine-V positive
(apoptotic) T cells in LA (median values – 18–25%) than in C group
(10–12%), both with and without antigenic stimulation (Fig). The T
cell apoptosis tended to be increased in presence of B. burgdorferi,
but the effect was weak and statistically signiﬁcant only in the study
population analysed as a whole (LA + C), with rate of apoptosis rising
under antigenic stimulation by a median of 10–17% of the baseline (i.e
of the value found in unstimulated culture).
Conclusions: No proof of decreased apoptosis of T lymphocytes in late
LA was found. Peripheral CD3+ cells from LA patients appear to be
more prone to apoptosis in culture, independently of the exposition to
B. burgdorferi. The role of this phenomenon in the pathogenesis of LA
is not clear and may require further study. Some pro-apoptotic effect
of B. burgdorferi s.l. on human CD3+ cells was observed, which may
reﬂect spirochete’s natural defence mechanism against host’s immune
system.
P956 Nramp1 limits the intracellular growth of Salmonella
typhimurium by impairing bacterial iron uptake and
strengthening macrophage effector functions
M. Nairz, G. Fritsche, I. Theurl, M. Theurl, S. Mair, R. Bellmann-Weiler,
H.C. Barton, G. Weiss (Innsbruck, AT; Southampton, UK)
Objectives: Natural-resistance associated macrophage protein 1
(Nramp1) is a phagolysosomal transmembrane protein which acts
as a transporter for protons and divalent ions including iron.
Nramp1 functionality is associated with an increased resistance against
various intracellular pathogens including leishmania, mycobacteria and
salmonellae.
Methods: We investigated the regulation of iron homeostasis and
immune function in RAW264.7 macrophages stably transfected with
functional or non-functional Nramp1 in response to infection with
Salmonella typhimurium, the causative agent of murine typhoid fever.
Results: Macrophages bearing functional Nramp1 displayed a reduced
expression of transferrin receptor 1, resulting in the decreased
acquisition of transferrin-bound iron. In contrast, the expression
of the transmembrane iron-exporter, ferroportin 1, and in parallel
cellular iron release was signiﬁcantly higher in Salmonella-infected
Nramp1-functional macrophages as compared to phagocytes lacking
Nramp1. Conceivably, Nramp1 functionality caused a reduction in the
cytoplasmatic iron pool within macrophages. Additionally, Nramp1-
expressing macrophages were capable of limiting the intracellular
persistence of S. typhimurium signiﬁcantly better as compared to cells
non-functional for this protein. This antimicrobial effect of Nramp1
was characterised by the reduced iron access by engulfed Salmonella
and the increased formation of nitric oxide, tumour necrosis factor and
interleukin-6 by infected phagocytes.
Conclusions: Our data suggest that the protective effects of Nramp1
may be partly attributable to its capacity to reduce the iron availability
within phagocytes, an effect which limits microbial iron access while
concomitantly strengthening macrophage immune effector functions.
P957 Interferon-gamma limits the availability of iron for
intramacrophage Salmonella typhimurium
M. Nairz, G. Fritsche, S. Mair, M. Theurl, I. Theurl, A. Schroll,
P. Brunner, K. Hantke, G. Weiss (Innsbruck, AT; Tubingen, DE)
Objectives: In stimulating effector functions of mononuclear phago-
cytes, interferon-gamma (IFN-g) is of pivotal importance in host defence
against intramacrophage pathogens including salmonellae. As the activity
of IFN-g is modulated by iron and since a sufﬁcient availability of
iron is essential for the growth and proliferation of pathogens, we
investigated the regulatory effects of IFN-g on iron homeostasis and
immune function in murine macrophages infected with Salmonella
enterica serovar Typhimurium (S. typhimurium).
Methods: We investigated the effects of IFN-g on iron homeostasis and
immune function in RAW264.7 macrophages in response to infection
with Salmonella typhimurium.
Results: In S. typhimurium-infected phagocytes, IFN-g caused a
signiﬁcant reduction of iron uptake via transferrin receptor 1. In parallel,
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we observed an enhanced efﬂux of iron from Salmonella-infected
macrophages upon activation with IFN-g, which could be traced back
to an enhanced expression of the iron exporter ferroportin 1. Moreover,
the expression of haem oxygenase 1 and of the siderophore-capturing
antimicrobial peptide lipocalin 2 was markedly elevated following
bacterial invasion, with IFN-g exerting a super-inducing effect. This
observed regulatory impact of IFN-g reduced the intracellular iron pools
within infected phagocytes, thus restricting the acquisition of iron by
engulfed S. typhimurium while concomitantly promoting NO and TNF-
a production.
Conclusion: Our data suggest that the modulation of crucial pathways
of macrophage iron metabolism in response to IFN-g concordantly aims
at withdrawing iron from intracellular Salmonella and at strengthening
macrophage immune response functions. We therefore propose that these
regulations reported herein reﬂect novel antibacterial effects of IFN-g
being consistent with the principles of nutritional immunity.
P958 Inﬂammatory cell inﬁltration and inﬂammatory cytokines:
indicators of Streptococcus agalactiae infection in
experimental mouse mastitis
G. Trigo, A. Franc¸a, M. Dinis, R. Gil da Costa, E. Bonifa´cio Andrade,
P. Ferreira, D. Tavares (Porto, PT)
Streptococcus agalactiae is a major contagious pathogen causing mastitis
highly adapted to survive in bovine mammary gland.
Objectives: This study focuses on the use of a mouse model of
Streptococcus agalactiae-induced mastitis as a practical approach for
regarding the pathogenesis of the bacteria.
Methods: BALB/c mice in 10–15 th day of lactation were intramammary
(i.ma) challenge on both L4 (on the left) and R4 (on the right) abdominal
mammary glands with 108 cells of S. agalactiae isolated from bovine
mastitis (infected animals) or with PBS (control animals). Throughout
the study the colonisation was evaluated by bacterial counts (CFU)
in the mammary gland, kidneys, spleen and liver. Mammary tissue
alterations were evaluated by haematoxylin-eosin staining of mammary
sections. Cytokine production in the mammary gland during infection
was evaluated by ELISA.
Results: S. agalactiae i.ma infection showed that the bacteria replicates
in the mammary gland and peaked 24 h later. At the same time, a
massive inﬁltration of polymorphonuclear cells (PMNs) and an increase
in IL-1b, IL-6 and TNF-a (inﬂammatory cytokines) levels were detected
in the mammary gland. After this, a gradual decrease on bacteria load
was observed which was accompanied by a decrease in the number of
PMNs and an increase of macrophages and lymphocytes, indicating an
evolution into a chronic process in the mammary tissue. A decrease in
the levels of TNF-a, IL-1beta and IL-6 were observed in the mammary
gland 72 h after infection, which was accompanied by an increase in
the levels of IL-12 and IL-10. Dissemination of the bacteria from the
mammary glands to the kidneys, spleen and liver was observed 6 hours
after infection, with a peak of the CFU after 12 hours for the kidneys
and spleen and after 24 hours for the liver. The bacterial load in these
organs was signiﬁcantly lower than the one observed in the mammary
gland, throughout the study.
Conclusion: The mouse model of infectious mastitis proposed here is
suitable and less costly than cows for the study of pathogenesis of
S. agalactiae and it can be used as a tool for evaluating potencial vaccines
against mastitis induced by S. agalactiae.
This work was supported by the Fundac¸a˜o da Cieˆncia e Tecnologia (FCT)
grant POCTI/CVT/57144/2004 and FEDER
P959 Crucial role of IFN-gamma receptor in murine Legionella
longbeachae infection
I. Gobin, K. Selenic, Z. Trobonjaca, M. Doric, M. Susa (Rijeka, HR)
Objectives: Legionella longbeachae serogroup 1, a facultative intracel-
lular pathogen is a causative agent of life-threatening pneumonia. Human
infection is particulary common in Australia, but sporadic infections have
been documented in other countries. Previous studies have shown that
activation of U937 macrophages with interferon-gamma (IFN-g) restricts
the growth of L. longbeachae. In this study we decided to explore the
role of IFN-g receptor in L. longbeachae mice infection. We explored
the kinetics of bacterial multiplication and patohistological changes in
IFN-gR −/− knock out and C57Bl/6 mice.
Methods: Pathogen-free 6- to 10-weeks-old IFN-gR −/− and C57Bl/6
(control) mice were infected by intratracheal inoculation with L. long-
beachae serogroup 1 (clinical isolate D4968) using a dose of 103 CFU.
We determined the mortality rate and bacterial clearence from the lungs
of infected mice at different time points post infection. We also followed
the patohistological changes in these organs during 72 hours of infection.
Results: Our results showed a dramatic difference in the mortality
rate between IFN-gR −/− and control C57Bl/6 mice. After intratracheal
infection with 103 CFU of L. longbeachae all IFN-gR −/− mice died
within 5 days, while control mice survived the infection. Mice infected
with 103 CFU of L. longbeachae were not able to overcome infection
for more than 5 days. In contrast, control mice could reduce the bacterial
burden in the lungs below the assay detection level 14 days p.i. They,
however, showed focal peribronchiolar inﬂammatory cell inﬁltration with
basement membrane injury, three to seven days after infection. On the
other hand, IFN-gR −/− mice developed severe bronchopneumonia with
destruction of the alveolar wall and inﬁltration of the interstitial tissue
within neutrophils and lymphocytes three days after infection.
Conclusion: Our results shows that IFN-g receptor plays a crucial role
in the host defence against L. longbeachae serogroup 1 infection. The
ﬁndings suggest that retardation of the host immune response caused by
deﬁciency of IFN-gR, might allow bacteria to grow and cause fulminant
pneumonia.
P960 The degree of invasiveness of Campylobacter jejuni inﬂuences
cytokines induction in the human monocytic cell line THP-1
A. Al-Muraikhy, K. Tabbara, G. Botta (Dhahran, SA; Manama, BH)
Background: Campylobacter jejuni can cause enteritis that is associated
with an acute inﬂammatory response. C. jejuni can penetrate the
intestinal epithelial barrier and interact with leucocytes, inducing
proinﬂammatory cytokines. The severity of clinical symptoms is related
to strain differences. We studied the in vitro invasiveness of eight human
isolates of C. jejuni, which possess three, two, or none of the virulence
genes cdtB, ciaB and iam, with the human monocytic cell line THP-1
and determined the levels of cytokines (IL-1, IL-6, IL-8, IL10, IL 12
and TNF) induced.
Methods: The invasion assay was carried out in 24 wells plate with a
multiplicity of infection of 200:1 for 90 minutes followed by treatment
with Gentamicin for 120 minutes. Cells were lysed with 0.01% triton and
plated to determine the intracellular organisms /cell. Semi quantitative
RT-Multiplex PCR was used to assess the kinetics of cytokine mRNA
expression in similarly infected cells and ELISA for cytokine levels.
Results: Invasiveness directly correlated with possession of virulence
genes, with the most invasive isolates possessing all three genes, followed
by those possessing cdtB and ciaB, followed by those with cdtB and
iam, while the least invasive were those lacking all three genes. As for
cytokine mRNA expression, TNF was most signiﬁcantly correlated with
invasiveness, with IL-1 and IL-8 closely following, while expression of
IL-6, IL-10 and IL-12 was essentially similar for all isolates. Cytokine
protein expression on the other hand showed a signiﬁcant difference
between one of the most invasive and least invasive of the isolates with
respect to TNF and IL-8 and lower differences with respect to IL-1.
Conclusion: C. jejuni infection of monocytoid cells triggers expression
of proinﬂammatory cytokines, most signiﬁcant of which is TNF. This
appears to correlate with the virulence of the isolate and might be
responsible for the severity of pathology and symptoms.
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P961 The Toll-like receptor 2 agonist Pam3CSK4 induces
microglia-mediated neuronal cell death in vitro
S. Ebert, M. Zeretzke, T. Hoffmann, L. Rollwagen, S. Bunkowski,
H. Schmidt, M. Goos, R. Nau (Go¨ttingen, DE)
Objectives: Microglial cells, the major constituents of innate immunity
within the brain, express Toll-like receptors (TLR) recognising
exogenous and endogenous ligands. Upon treatment with agonists of
TLR 2, TLR 4, and TLR 9, primary mouse microglial cells change
their morphology and release nitric oxide and inﬂammatory cytokines.
Activated microglia can injure neurons. We investigated the inﬂuence of
TLR 2-activation on neuronal viability in vitro.
Methods: Primary mouse cortical neurons and co-cultures of primary
mouse cortical neurons and primary mouse microglial cells (ratio 2:1)
were treated with the TLR 2-agonist Pam3CSK4 (Tripalmytoyl-cysteinyl-
seryl-(lysyl)3-lysine; 10mg/ml) in combination with interferon-gamma
(100 U/ml) for 72 hours. Control cultures were exposed to interferon-
gamma alone for 72 hours. Cells were ﬁxated in 4% formaldehyde and
stained with the neuronal marker Map-2, the microglial marker isolectin
B4, and haemalum. Viability of neuronal cells was assessed by a blinded
observer and by measurement of the Map-2-stained area using the image
processing and analysis program WCIF ImageJ. Student’s t-test was
perfomed to analyse differences between groups.
Results: Treatment with Pam3CSK4 did not affect the viability of
neurons in the absence of microglial cells (Map-2 stained area: 102% in
Pam3CSK4-treated cultures versus 100% in control cultures, p = 0.904).
In co-cultures of neurons and microglial cells, however, treatment with
Pam3CSK4 led to visible neuronal damage reﬂected by a signiﬁcant
reduction of the Map-2 stained area of approximately 20% (p<0.05).
Conclusion: The TLR 2-agonist Pam3CSK4 induces microglia-mediated
neuronal damage in vitro. During bacterial meningitis, TLR 2 is
stimulated by bacterial products, e.g. bacterial lipoprotein. The activation
of microglial cells by agonists of TLR 2 might contribute to the neuronal
damage in patients with bacterial meningitis leading to an impaired
clinical outcome.
P962 Role of invariant NKT lymphocytes in the hepatic
granulomatous response to Leishmania donovani infection
A.S. Drogoul, F. Robert-Gangneux, M. Lisbonne, B. Turlin, C. Guiguen,
A. Herbelin, M. Samson, J.P. Gangneux (Rennes, Paris, FR)
Objectives: Visceral leishmaniasis (VL) is a life-threatening infection
due to protozoan parasites from the Leishmania genus. L. donovani in
India and East Africa, and L. infantum in the mediterranean basin as well
as in Brazil are the responsible species for VL. During VL, the hepatic
granulomatous response is correlated to the parasitic clearance. However,
cellular organisation of mature granulomas is still not totally understood,
but seems to involve NKT cells. This particular cell population, at the
interface of innate and acquired immunity harbours surface molecules
from both NK and T (TCRab) cells. Among NKT cells, invariant NKT
lymphocytes (iNKT) are hepatic parenchymatous cells that harbours a
semi-invariant TCR, Valpha14-Jalpha18, associated to restricted beta
chains. Here, we analyse their role in the granulomatous response during
liver infection with L. donovani in a murine model deleted in iNKT cells.
Methods: C57BL/6 Ja18−/− mice and congenic wild-type mice were
infected with L. donovani promastigotes. At days 15, 30 and 60, groups
of 4 mice were sacriﬁced in order to analyse:
– the hepatic parasitic load on May Grunwald-Giemsa stained smears,
– the hepatic granulomatous response on hemalun-eosin-safran stained
histological sections,
– the hepatic damage that was evaluated by dosing alanine
aminotransferase (ALT), aspartate aminotransferase (AST), lactico-
dehydrogenase and alcaline phosphatase levels in the serum.
Results: Compared to wild-type mice that rapidly control the infection,
iNKT−/− mice presented with signiﬁcantly higher hepatic parasitic
loads until 10-fold more, at D15 and D30. In parallel, the histologic
examination of liver sections displayed a delay in the granuloma
maturation. iNKT−/− mice presented at D30 with few large granulomas
(13.3% with > 25 cells) versus 33.6% in wild-types, and granuloma
maturation was reached in 20% of them versus 50%, respectively. At
D60, 40% of the granulomas were matures in iNKT−/− mice and
the parasitic loads declined until similar results to wild-types. Hepatic
enzyme dosages showed a similar hepatocyte damage in both groups
without statistically signiﬁcant difference.
Conclusion: Finally, our data underline the role of iNKT lymphocytes in
the early and efﬁcient organisation of hepatic granuloma that warrants a
clearance of parasites. In C57/Bl6 mice that exhibit a resistant phenotype
to Leishmania infection, the settlement of the adaptative response allows
a deﬁnitive cure of the infection.
P963 Iron overload favours the elimination of Leishmania infantum
from mouse tissues by enhancing the production of reactive
oxygen species
S. Costa, S. Pereira, C. Teixeira, A. Toma´s, R. Appelberg, S. Gomes
(Porto, PT)
Objectives: We have previously determined that iron overload decreases
the growth of Leishmania infantum in the liver and spleen of a
susceptible mouse strain. The purpose of this work was to investigate if
the inhibitory effect of iron overload on the growth of this protozoan
is dependent on the production of reactive oxygen species by the
macrophagic NADPH oxidase.
Methods: To achieve this goal, we used mice genetically deﬁcient in the
p47phox subunit of NADPH oxidase (p47phox knock-out). Control and
knock-out mice were treated with iron-dextran (10mg) or saline solution
and 10 days later were infected with L. infantum. Mice were sacriﬁced
two weeks after infection and the parasite load was determined in the
liver and spleen.
Results: In both organs, iron overload decreased L. infantum growth in
control mice but not in knock-out mice, indicating that the mechanism
through which iron exerts its inhibitory effect on the growth of the
parasite is dependent on the production of reactive oxygen species by
the host cell.
Conclusion: Iron overload inhibits L. infantum growth in mice through
the production of reactive oxygen species by NADPH oxidase, a potent
antimicrobial mechanism to which Leishmania is susceptible.
P964 Heat-shock response in Brucella abortus
N. Amir Mozaffari, R. Rajabnia (Tehran, IR)
Objectives: Heat shock proteins are highly conserved molecules and
serve a variety of functions in bacterial cells including protein folding
and transport. They mainly serve to protect cells from various forms of
stresses including heat shocks. In reference to the potent antigenicity
of hsp and its activation of macrophages, the differences in virulence of
Brucella cells may be originated from differences in patterns of response
to heat shocks induced by the high degrees of fever that is usually
manifested in brucellosis.
Methods: Five B. abortus strains, isolated from human and cows,
were subjected to 39, 40, and 42 Celsius degrees heat treatments.
The bacterial whole cell proteins were extracted and resolved by SDS-
PAGE electrophoresis. Western blottings were used to detect antibody
production against the extracted bacterial proteins especially hsp60 in
both control and patient sera.
Results: SDS-PAGE gels revealed protein bands mainly in the range
of 10–100 KDa. The amounts of a 60 KDa protein band (hsp60) was
signiﬁcantly enhanced following heat shocks in relation to the unheated
bacterial cells. The heat shock response points to a signiﬁcant higher
production of a 60 KDa protein (hsp60). The sera from brucellosis
patients reacted with several of these cell derived protein bands in
western blots, none of which were reactive with sera from healthy
individuals. The western blot protein bands showed striking differences.
Conclusion: The results of this study point to the immunogenic
properties of Brucella heat shock proteins, especially the overwhelming
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response towards hsp60. Therefore, hsp60 can be an appropriate
antigenic candidate for engineering subunit vaccine against Brucella,
as well as for ELISA test development.
P965 Deletion of a glycosyltransferase in Enterococcus faecalis
leads to abolishment of glycolipid synthesis and increased
susceptibility to opsonophagocytic killing
I. Toma, I. Sava, C. Theilacker, M. Heizmann, M. Halima, J. Huebner
(Freiburg, DE)
Objective: Enterococci are generally considered a commensal of the
human gastrointestinal tract but may also cause bacteraemia, urinary
tract infections, abdominal infections and endocarditis. We have shown
previously that lipoteichoic acid (LTA) is the target of opsonic
antibodies against Enterococcus faecalis. Glycolipids are important in
the maintenance of membrane elasticity and constitute the lipid moiety
necessary for anchoring LTA in the cell membrane.
Methods: A non-polar deletion mutant was created in gene EF2890
of E. faecalis 12030 by targeted mutagenesis. Bacterial glycolipids
were analysed by a modiﬁed Blight-Dyer extraction and detected by
thin-layer chromatography. Cell lysates were characterised by western
blot using rabbit antibodies raised against whole bacterial cells and
puriﬁed LTA. An opsonophagocytic assay (OPA) was used to test the
susceptibility of the wild-type strain and delta-EF2890 against rabbit
antisera. The hydrophobicity was analysed by comparing distribution in
hydrophilic and hydrophobic solvents. LTA was quantiﬁed by ELISA
using antibodies raised against enterococcal LTA.
Results: Homology search revealed that EF 2890 shares high similarity
with alMGS, a glycosyltransferase from Acheloplasma laidlawii,
involved in the synthesis of monoglycosyldiacylglycerol (MGlcDAG).
MGlcDAG is a major constituent of bacterial cell membranes. Wild type
and delta-EF2890 displayed equivalent growth kinetics and stationary
phase survival. Glycolipid analysis by TLC revealed that inactivation of
EF2890 leads to a complete abolishment of glycolipid synthesis. The
loss of glycolipids resulted in a retarded motility of LTA in SDS-PAGE.
The content of LTA in the cell wall of the mutant strain was signiﬁcantly
higher than in the WT. Compared to the WT, EF2890 mutant was more
susceptible to opsonophagocytic killing mediated by polyclonal rabbit
antiserum raised E. faecalis 12030.
Conclusions: Deletion of the glycosyltransferase EF2890 resulted in
complete abolishment of glycolipid synthesis. The absence of glycolipids
leads to an increased retention of LTA on the cell wall and increased
suscebtibility to antibody-mediated opsonic killing. Since we have
shown previously that opsonophagocytic killing of E. faecalis 12030
is exclusively mediated by LTA-speciﬁc antibodies, our results suggest
that an increased epitope denisity may facilitate the deposition of opsonic
antibodies.
P966 Acinetobacter baumannii outer membrane protein A targets
voltage-dependent anion channel and induces early-onset
apoptosis and delayed-onset necrosis in dendritic cells
J.S. Jin, J.S. Lee, J.W. Kim, C.H. Choi, H.Y. Chung, J.C. Lee (Daegu,
Busan, KR)
Objectives: Acinetobacter baumannii outer membrane protein A
(AbOmpA) is an important pathogen-associated molecular patterns that
has been associated with host cell death. We investigated the dendriric
cell (DC) death in response to AbOmpA and its implication of immune
responses against A. baumannii.
Methods: Murine bone marrow-derived DCs were treated with recombi-
nant AbOmpA. Subcellular localisation of AbOmpA was determined by
confocal microscopy and immunoprecipitation. Molecular mechanisms
of DC death were analysed by ﬂow cytometry and Western blot assay.
Wild-type A. baumannii and isogenic AbOmp (−) mutant strains were
intraperitoneally infected in the mice.
Results: AbOmpA induces DC death, which started as apoptosis
and later transformed to necrosis. AbOmpA targets mitochondria and
interactes with voltage-dependent anion channel (VDAC). Apoptotic
cell death is preceded by the transient elevation of mitochondrial
transmembrane potential and an increase of intracellular reactive
oxygen intermediates (ROIs). These events are followed by a loss
of mitochondrial transmembrane potential, mitochondrial swelling,
activation of caspases, and externalisation of phosphatidylserine. Both
apoptosis and necrosis of AbOmpA-treated DCs are signiﬁcantly
inhibited by N-acetyl cysteine, suggesting that ROIs are responsible for
the induction of apoptosis and necrosis. AbOmpA induces maturation
of DCs, but ROIs produced by DCs impairs the cytokine production
of T cells interacted with DCs and induces T cell killing. Wild-type
A. baumannii impars maturation of DCs and results in high mortality in
mouse model, whereas AbOmpA knock-out mutant induces maturation
of DCs and no animals died.
Conclusion: Our study indicate that VDAC-targeting AbOmpA induces
DC death and the subsequent dysfunction of T cells for the adaptive
immunity. Thus, we propose mmune dysfunction mechanisms of
A. baumannii-infected hosts regarding the mitochondrial targeting of
bacterial proteins.
P967 Tolerability of N-chlorotaurine, a new endogenous antiseptic,
in the bronchopulmonary system
A. Pinna, R. Geiger, B. Treml, L. Barnickel, C. Walther, S. Scholl-Bu¨rgi,
W. Gottardi, R. Arnitz, C. Sergi, A. Lo¨ckinger, M. Nagl (Innsbruck, AT)
Objective: N-chlorotaurine, an important representative of the long-
lived oxidants produced by human leukocytes, can be applied in human
medicine as an endogenous antiseptic. This study was designed to
evaluate the tolerability of inhalative N-chlorotaurine (NCT) in the pig
model.
Methods: Anesthetised pigs inhaled test solutions of 1% NCT (n = 7),
5% NCT (n = 6), or 1% NCT plus 1% ammonium chloride (n = 6),
and 0.9% saline solution as a control (n = 7), respectively. Applications
were performed every hour within four hours, i.e. 4 inhalations in total,
with 5ml each. Lung function, blood oxygenation, and circulation were
monitored. Pharmacokinetics were investigated by oxidation capacity in
bronchial ﬂuid and by determination of taurine and chloride in serum.
One hour after the last dosing the animals were euthanised, and lung
samples for histology were removed.
Results: Arterial pressure of oxygen (PaO2) decreased signiﬁcantly over
the observation period of 4 hours in all animals. Compared to saline, only
1% NCT + 1% NH4Cl led to signiﬁcantly lower PaO2 values at the 4
hours measurement (62mmHg± 9.6 vs. 76mmHg± 9.2, p = 0.014). The
corresponding increase in alveolo-arterial difference of oxygen partial
pressure (AaDO2) was signiﬁcantly higher only in the 1% NCT + 1%
NH4Cl than in the control group (P < 0.01), too. Pulmonary artery
pressure increased about 9.7mmHg by 5% NCT, about 7.8mmHg by
1% NCT + 1% NH4Cl (P < 0.05 versus control), about 4.3mmHg by
1% NCT (P > 0.05 versus control), and about 6.7mmHg by saline.
Histological investigations revealed inﬂammatory reactions, districts
with atelectasia, districts with emphysema, and districts with fragmen-
tation of ﬁbers in both the test groups and in the saline group with no
statistical difference.
There was no systemic resorption of NCT detectable. Local inactivation
of NCT below detectable levels took place within 30 min. The
concentration of NCT tolerated by A549 lung epithelial cells in vitro
was 0.25−0.5 mM, which was similar to that known from other body
cells and 25-fold higher than that of chloramine T.
Conclusion: The endogenous antiseptic NCT was well tolerated at
a concentration of 1% upon inhalation in the pig model. Addition
of ammonium chloride in high concentration provokes statistically
signiﬁcant impact on blood oxygenation, which would require adjustment
of dose. These results are in accordance with previous clinical studies
in man and animals.
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P968 A new approach in the diagnosis of intestinal parasites
J.J. Verweij, R.J. ten Hove, T. Schuurman, M. Kooistra, M. van
Esbroeck, T. Vervoort, J. van den Ende, L. van Lieshout (Leiden,
Groningen, NL; Antwerp, BE)
Background: Twelve years ago molecular diagnostics for the differ-
entiation of E. histolytica and E. dispar were implemented in Leiden
and proved to be highly sensitive and speciﬁc. At that time, using PCR
only as an additional technique to differentiate cysts and/or trophozoits
that were seen by microscopy, it was never anticipated to use PCR
as a ﬁrst line diagnostic. During the following years the isolation of
parasitic DNA from faecal samples and PCR techniques, were improved
and simpliﬁed. Moreover the introduction of real-time PCR made it
possible to multiplex different targets into one reaction. These new
technical possibilities made it feasible to introduce PCR also for the
detection of other intestinal parasites. The ﬁrst multiplex real-time PCR
for the simultaneous detection of the three most important diarrhoea
causing protozoa and an internal control proved to be a sensitive and
speciﬁc method for the detection of E. histolytica, G. lamblia and
Cryptosporidium (HGC-PCR). Two studies were performed to deﬁne
a diagnostic strategy for the implementation of molecular methods in
the routine diagnosis of intestinal parasitic infections in general practice
patients and in returning travellers and immigrants.
Methods: DNA (n = 350) from faecal samples originating from
patients attending their GP with gastrointestinal complaints was tested
retrospectively with HGC-PCR. In a second study, PCR analysis was
performed on a weekly basis on faecal samples (n = 3591) from returning
travellers using HGC-PCR and a Strongyloides PCR. In both studies
PCR results were compared with microscopy and anamnestic data.
Results: In both studies, detection rates of the parasitic infections
included in the PCR were increased signiﬁcantly as compared with
microscopy. In the GP patients no other pathogenic parasites were
detected using microscopy and in the returning travellers additional
parasites were found with microscopy in 55 cases only, especially in
those travelling to high risk areas.
Conclusions: Multiplex real-time PCR offers a highly sensitive and
speciﬁc diagnostic alternative for labour intensive microscopy in clinical
laboratory practice. Additional diagnostic methods for the detection of
parasitic infections that are not included as PCR target can be limited to
a selected group of patients.
P969 Optimisation of a ﬂow cytometry protocol for detection of
Encephalitozoon intestinalis
J. Barbosa, A. Gonc¸alves Rodrigues, C. Pina-Vaz (Porto, PT)
Microsporidia are spore-forming protozoa considered emerging
pathogens in immunocompromised patients. Encephalitozoon intestinalis
is one of the most important microsporidian human pathogen. The
infectious form is a small spore, usually resistant to common water
treatment. Its detection is very important but is difﬁcult, time-
consuming and requires specialised technicians; phase contrast and/or
semiquantitative immunoﬂuorescence-microscopy are the most common
used techniques.
Objective: Our main objective was to develop and optimise a speciﬁc
Flow Cytometric (FC) protocol for detection of E. intestinalis and
to establish its detection limit; additionally, FC viability studies were
undertaken, in order to evaluate the infectious risk.
Material and Methods: A known concentration of E. intestinalis
spores (Waterborne Inc, USA) were stained with different concentrations
of a Alexa Fluor 488 mouse monoclonal antibody (Microspor-FA,
A700A488; Waterborne), at varied times (45 min, 1 h30m and 12
hours), at different temperatures (37ºC and 25ºC) and then analysed
in a FACSCalibur cytometer (Becton Dickinson, Canada) at FL1
(525 nm – green ﬂuorescence). Several dilutions (2×105 to 1×104
spores/ml) were afterwards stained with the optimised antibody
concentration and analysed by FC for assessment of the detection limit.
Cross-reactions were investigated using both prokaryotic (Escherichia
coli, Staphylococcus aureus) and eukaryotic microorganisms (Candida
albicans blastoconidia and Cryptosporidium parvum and Giardia lamblia
(oo)cysts). Suspensions with dead spores were stained with 5mg/ml of
propidium iodide (PI, Sigma) (a marker of death with cell membrane
lesion) following the staining with the speciﬁc ﬂuorescent monoclonal
antibody and analysed at FL3 (670 nm-red).
Results: The optimal speciﬁc-antibody concentration was 10mg/ml,
incubated overnight at 25ºC, in the dark; it provided a clearly separated
histogram from autoﬂuorescence. A threshold limit of 5×104 spores/ml
was established bellow that value, ﬂuorescence was insufﬁcient to
allow discrimination. No cross-reactions occurred with bacteria, fungi
or parasites. When using the two ﬂuorescent probes simultaneously
(speciﬁc-antibody and PI) dead spores showed double ﬂuorescence (FL1
and FL3). A new detection method using a FC protocol is now available
for the detection of E. intestinalis, allowing the simultaneous assessment
of viability of the infective forms.
P970 Chagas’ disease: evaluation of a rapid
immunochromatographic assay for the detection of
anti-Trypanosoma cruzi antibodies
S. Gabrielli, A. Faraone, S. Bonelli, A. Mantella, M. Strohmeyer,
S. Filardo, F. Bartalesi, V. Bejarano, G. Cancrini, A. Bartoloni (Rome,
Florence, IT; Camiri, BO)
Objectives: Chagas disease, caused by Trypanosoma cruzi, affects 7.6
million of people in Latin America. A survey was carried out to assess
its prevalence in two rural Bolivian communities (Bartolo, Chuquisaca
Dep., and Casas Viejas, Santa Cruz Dep., Bolivia), and to evaluate
the performance of Chagas Quick Test, a new immunochromatographic
assay (ICT) to detect anti-T. cruzi antibodies.
Methods: 226 subjects were enrolled (121 males, 105 females); the
infection was evaluated using a conventional T. cruzi IgG ELISA test,
the above mentioned ICT, and the microscopic analysis of Giemsa
stained thick smears. Individuals showing discordant ICT-ELISA results
underwent molecular analyses. DNA was extracted from blood dried
on ﬁlter paper using Chelex-100® method. T. cruzi nuclear DNA was
ampliﬁed using primers TCZ1 and TCZ2 for the ﬁrst reaction and TCZ3
and TCZ4 for the nested ampliﬁcation. Amplicons were sequenced and
subjected to GenBank to give the most likely identiﬁcation.
Results: ELISA was positive in 142 people (62.8%); infection rate
increased according to age from 15.3% in 1−9 years old individuals, to
100% in over sixties, independently by sex. No parasitemic individuals
were found by hemoscopic analysis. A total of 159 subjects (70.3%)
proved positive to ICT; all subjects positive to ELISA had a positive
result (relative sensitivity 100%), with an intensely coloured test line.
Moreover, 17 individuals negative to ELISA proved positive to ICT,
with a very faint test line. The agreement between ELISA and ICT was
92.4% (209/226) (kappa 0.83). Molecular assays conﬁrmed the infection
in 4 serologically discordant subjects.
Conclusions: seroprevalence of T. cruzi infection in the study population
is very high, and increases rapidly with the age, showing that parasite
active transmission occurs universally. Negative results obtained by
microscopy ﬁt in with the low sensitivity of this diagnostic tool
conditioned by the low parasitaemia in chronic infected people. Chagas
Quick Test showed an almost perfect accordance with the conventional
ELISA. PCR conﬁrmed to be an useful complement to serological
methods; it contributed to increase ELISA sensitivity and partially
corroborated ICT results, supporting the advice that very faint test lines
have to be considered as likely positive. Further investigations are needed
to deﬁne the infectious status of subjects with discordant serology and
negative PCR assay.
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P971 Serological screening of Chagas’ disease in pregnant
immigrant women proceeding from endemic areas in Spain
P. Alonso, A. Rodrı´guez-Guardado, M. Rodrı´guez, A. Escudero,
E. Vega, P. Leiva, J. Carto´n (Oviedo, ES)
Objectives: Maternal-fetal transmission of Trypanosoma cruzi generally
occurs in 2–12% of pregnant infected mothers. The arrival of pregnant
women proceeding from endemic areas to non-endemic countries due to
immigration phenomenon make possible the apparition of this diseases
in this group of patients. The possibility of congenital infection in
pregnant immigrant women in non-endemic areas has been studied only
occasionally.
Methods: We determined anti-T. cruzi antibodies in all the pregnant
immigrant women proceeding from endemic areas attending in obstetric
service of Hospital Central de Asturias, a universitary hospital in the
Northern of Spain, from 07/03/07 to 23/10/07. The ID-Chagas antibody
test (Particle Gel Immuno Assay – PaGIA, DiaMed-ID –) was used as
screening assay: red coloured polymer particles are sensitised with three
different peptides representing antigenic sequences of T. cruzi.
Results: During the period of the study we screened 103 pregnant
women (mean age 29 years, limits 17–43). The countries of origin were:
Ecuador (32.0%), Colombia (17.5%), Brazil (15.5%), Paraguay (9.7%),
Dominican Republic and in a minor percentage Venezuela (5.8%),
Argentina (2.9%), Bolivia (2.9%), Cuba (1.9%) and Mexico (0.97%).
Sixty patients lived in urban areas and 24 in rural areas. In 20 patients the
characteristics of the living place was unknown. Only ﬁve patients lived
in houses where the reproduction of triatomine bugs is possible. Two
patients had family history of Chagas’ disease. None patients presented
positive antibodies anti-Trypanosoma cruzi.
Conclusions: Although the pregnant women arrival of endemic areas,
no case of Chagas’ disease was detected, probably due to the absence
of epidemiological risk factors. Undoubtedly further studies of large
samples are necessary to evaluate maternal transmission risk in
immigrant population in Spain.
P972 Paediatric Chagas’ disease in a non-endemic area
T. Juncosa, V. Fumado´, M. Sanllorente, A. Aguilar, R. Pino
(Barcelona, ES)
Objectives: During last years, increasing migration from Central and
South America, the endemic area of Chagas Disease, has introduced
among our paediatric population some patients infected by T. cruzi,
infected either in their origin country or in ours, via vertical transmission
from their infected mothers. The objective of this study is to describe
the cases of children with Chagas Disease attended at our Imported
Pathology Unit during the last four years (2003–2007).
Methods: All patients coming from endemic areas and newborns from
Chagas Disease seropositive pregnant women, were studied by two
ELISA tests (Bioelisa Chagas BiokitR with recombinant antigens and
in-house ELISA with complete antigens). Patients with available sample
(59) were also screened by nested PCR (TCZ3/Z4). Conﬁrmed cases
received Benznidazol treatment (0.7mg/Kg/day during 60 days).
Results: Screening was performed to 155 patients, aged one day to
13 years old (110 immigrants and 45 born in Spain). Ten of them were
seroreactive in both ELISA tests (6.45%) and we had enough blood from
ﬁve of them for PCR tests, which were positive for all samples. Vertical
transmission was demonstrated in two children born in our country, one
from a Bolivian mother and the other from an Argentina’s one. The eight
immigrated children were born in Bolivia. Follow up is in course in eight
out of the ten seroreactive patients (two of them didn’t continue attending
our hospital) in order to establish the effectiveness of treatment. Negative
PCR and decreasing speciﬁc antibodies have been demonstrated in all
studied patients.
Discussion: Our results demonstrate a seroprevalence for T. cruzi
infection of 7.2% (8/110) among the paediatric immigrated population
coming from Latin America, and an incidence of congenital infection of
4.4% (2/45). Both percentages are high enough to encourage serologic
screening for Chagas Disease to all children coming from Latin America,
mainly from Bolivia. Post treatment serologic control must continue until
antibodies level become negative. We have demonstrated titles decrease,
but negativisation has not been assumed in any case.
P973 Chagas’ disease among Latin American immigrants in
Madrid. A serological survey
N. Portocarrero, M. Baquero, M. Gutierrez (Madrid, ES)
Introduction: Chagas’ disease, caused by infection with Trypanosoma
cruzi is a signiﬁcant health problem in Latin American, where an
estimated sixteen to eighteen million people are infected. Outside
of endemic regions, Chagas’ disease may be transmitted through the
transfusion of infected blood components, congenital infection and organ
transplantation.
Objective: To determine the sero-prevalence of antibodies to T. cruzi in
a community sample of Latin American immigrants to Madrid, Spain.
Methods: Eligible subjects were born in South America, Central
America or in Mexico. Participants were attending a variety of medical
clinics at the hospital Carlos III, Madrid, Spain. Serum samples
were collected from January 2005 to November 2007. Antibodies to
Trypanosoma cruzi were identiﬁed using a commercial screening EIA
method (Biokit, Spain). Specimens that were repeatedly reactive by EIA
were analysed by an indirect immunoﬂuorescent assay, (Biocientı´ﬁca
S.A, Argentina)
Results: A total of 588 serum samples were studied. The geographic
distribution of the patients was: 274 Ecuador (46.6%), 88 Colombia
(15%), 82 Bolivia (14%), 31 Peru (5.3%), 28 Brazil (4.7%), 18
Dominican Republic (3%), 11 Venezuela (1.7%), 8 Argentina (1.4%), 8
Mexico (1.4%), 6 Chile (1%) and 34 other countries of Latin American
(5.9%).
Thirty patients out of 588 (5.1%) were considered reactive for antibodies
to T. cruzi by EIA. Indirect immnunoﬂuorescent assay was performed in
26/30 reactive samples by EIA, being 20 positive.
Twenty ﬁve reactive samples corresponding to 82 patients (30.5%),
coming from Bolivia, 3/274 (1.1%) from Ecuador, and 2/5 (40%) from
Guatemala.
Conclusions: High rates of T. cruzi seropositive patients among Latin
American immigrants underscore the importance of screening in this
population to prevent transmission by blood transfusion or organ
transplantation as well as congenital infection.
The Chagas antibodies EIA showed improved sensitivity over the Chagas
indirect immnunoﬂuorescent assay (IFA).
P974 Chagas’ disease in Latin American immigrants in Valencia,
Spain
P. Segarra, M. Garcı´a-Rodrı´guez, I. Jime´nez, R. Sanz, X. Garcı´a-Fabra,
V. Abril, T. Fraile, C. Parada, E. Ortega (Valencia, ES)
Introduction: Chagas Disease is caused by Trypanosoma cruzi.
Approximately 70% to 80% of infected individuals remain in the
indeterminate form throughout their lives, whereas as many as 20%
to 30% develop into a cardiac form (arrhythmia, heart failure, . . . )
or a digestive form (megaesophagus, megacolon). The only treatment
available nowadays in Spain is Benznidazole.
Objectives: To analyse epidemiological and clinical features of adults
patients with Chagas Disease.
Methods: Since January 2005 until November 2007, we tested sera from
Latin American adults coming to a Tropical Disease consultation, or
travelers with an epidemiological risk for Trypanosoma cruzi infection.
Immunological diagnosis was made using commercially available
serological tests: Recombinant ELISA (BioElisa Chagas, Biokit S.A®,
or Dade Behring®), and IFI (MarDxDiagnostic®).
Case deﬁnition: Any patient with epidemiological risk factors and two
or more different serological tests positive. Clinical and epidemiological
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review, physical examination, HIV serology, chest radiography, electro-
cardiography (ECG), echocardiography, and radiographic contrast study
of esophagus and colon were performed.
Results: Thirty six cases of Chagas disease have been identiﬁed, all
of them Latin American immigrants. Mean age 40.17 years (23–65).
Gender: 75% women, 25% men. Polymerase chain reaction was available
in 20, and positive only in 2. Most of the cases (86%) were from Bolivia.
Twenty nine (80%) were indeterminate forms, 4 patients (11%) had
a chronic cardiac form, 2 patients (5%) a mixed form, and 1 (2%) a
chronic digestive form. A forty four years old woman died because of
dilated cardiomyopathy and complex ventricular arrhythmias. The other
abnormal ECG ﬁndings were sinusal bradycardia, right bundle-branch
block, complete A-V block, left anterior fascicular block. All patients
were HIV seronegative. Treatment with Benznidazol was started in 8
patients.
Conclusion: Chagas Disease is an emergent disease in Europe because
migratory movements. Most of our patients are asymptomatic women
from Bolivia, however, about 20% of the patients have chronic forms
that can progress to heart failure, and can require intensive and
multidisciplinary care.
P975 Prevalence of oral trichomoniasis in patients with
periodontitis and gingivitis using PCR and Direct Smear
A. Athari, L. Soghandi, A. Haghighi, B. Kazemi (Tehran, IR)
Objective: Trichomonas tenax, a commensal ﬂagellated protozoan,
inhabits in human oral cavity. This parasite is cosmopolitan and
frequently found in patients with poor oral hygiene and advanced
periodontal disease. There is only one published study that rebound the
prevalence of this parasite in Iran. This PCR based study compared the
prevalence of oral trichomoniasis in patients with oral diseases and a
healthy control group.
Methods: From May 2006 to April 2007, the subgingival dental plaques
of 160 patients with gingivitis or periodontitis and 160 controls who
attended to Dental School of Shahid Beheshti Medical University, Iran
were taken and examined by wet mount smear, and Giemsa staining.
Likewise, a PCR protocol was developed for speciﬁc detection of T. tenax
using a pair of primers designed for its 18S rRNA gene.
Results: Thirty three (20.6%) of patients were PCR positive while 28
(15.5%) were diagnosed using wet preparation and Giemsa staining. In
the other hand, 2 (1.9%) of control group were identiﬁed positive by PCR
procedure. The prevalence of oral trichomoniasis in our study (20.6%)
was compatible with many other published reports which mostly has
ranged from 12%-32%.
Conclusion: The study revealed dependence between the frequency of
occurrence of T. tenax and the state of periodontitis. The present PCR
procedure could provide a simple and rapid detection method of T. tenax
in dental plaque.
P976 Real-time PCR in diagnostics of Trichomonas vaginalis
infection
M. Sviben, G. Vojnovic, I. Kolcic (Zagreb, HR)
Objective: Trichomonas vaginalis is the most common parasitic cause
of sexually transmitted infection in the world. Methods used for
the laboratory diagnosis of T. vaginalis infection include microscopic
examination of wet mount preparations, culture and more recently
polymerase chain reactions (PCR). The objective of this study was
to determine the prevalence of T. vaginalis infection in men tested at
the Parasitology department of the Croatian National Institute of Public
Heatlh between July and October 2007. A comparison of real-time PCR
with culture and wet-mount microscopy in the diagnosis of trichomonosis
was also performed.
Methods: Urine samples from 151 men were tested for T. vaginalis using
culture and real-time PCR. One part of urine sediment was inoculated in
Diamond’s medium and examined for motile organisms after 24, 48 and
72 hours. From other part of sediment DNA was isolated using a spin
column kit (High Pure PCR Template Preparation Kit; Roche Diagnostics
GmbH). Real-time PCR was applied for detection of T. vaginalis DNA
using a TaqMan Universal PCR Master Mix kit (Applied Biosystems).
To rule out the presence of PCR inhibitors in the individual patient
specimens, an internal control kit (TaqMan Exogenous Internal Positive
Control Reagents; Applied Biosystems) was used. The ampliﬁcation and
detection were performed using 7500 Real Time PCR System machine
(Applied Biosystems).
Results: Out of the 151 urine samples tested, 2 were positive by culture
and 2 more (4 altogether) by PCR. The prevalence of T. vaginalis
infection in male study population according to PCR was 3%. Real-
time PCR also exhibited greater sensitivity than culture did (100 vs.
50%).
Conclusions: Despite all the efforts invested in development of better
diagnostic tests for trichomonosis, PCR is not commonly used. The main
reason is that T. vaginalis infection is not perceived as a signiﬁcant public
health problem. However, this perception should be changed based on
recent studies suggesting a role of T. vaginalis in adverse pregnancy
outcome and HIV transmission. A real-time PCR has immediate
and important implications for diagnostic testing in the microbiology
laboratory. The enhanced sensitivity, ease of performance and speed of
this technology make it an appealing alternative to conventional methods
which have been used for many years.
P977 Prevalence of hydatid cyst in a slaughter-house in Iran: a
ten-year survey
H. Tavakoli, N. Jonaidi Jafari, M. Izadi, M. Parsa (Tehran, IR)
Objectives: Parasitic diseases are a major group in zoonosis, in which
hydatidosis has a special situation prevalence of hydatid cyst in a
region’s animals in dangerous that could lead to prevalence of the
disease in man. This will also increase inurn, disadvantages such as
removing, contaminated organs of animals (e. g. liver and lung), decrease
products like milk, weigh, wool, quality of meat plus economic expenses.
Evaluation and determining of health and economic importance of each
disease would be the ﬁrst step in any prevention and control programs.
Methods: In this retrospective survey, slaughtered animals (cow, sheep)
were studied in respect to hydatid cyst infection according to kind of
animal, year, and season in a ten-year period (1996–2005) in Semnan’s
slaughter-house.
Results: The ﬁndings of this study showed that 13–25% liver and
15.97% lung were conﬁscated (the total no. of slaughtered animals was
359716 include 39698 cow and 320018 sheep). Based on the results
37.43% of livers and 51.18% lungs were infected by hydatid cyst.
The mean of liver and lung infection in cow was 4.84% and 4.41%
respectively. This rate was 5.05% and 6.84% in sheep. On the basis of
season the most infection rates in both animals were observed in turn
in autumn and winter. The estimated economic damage due to omission
of infected organs, only by hydatidosis in this period was 1667720000
Rails.
Conclusion: The results of the study, from the epidemiological aspect,
could be a conﬁdent starting point, in preventive and controlling
programs of this important parasitic disease. Due to zoonosis the
presented proposals would decrease the human hydatidosis.
P978 Bursts of trichinellosis in a Romanian industrial area
R. Neghina, A.M. Neghina, I. Marincu, L.D. Giurgiu, L.M. Leahu,
R. Moldovan, I. Iacobiciu (Timisoara, RO)
Objectives: To overview and analyse epidemiologically all the trichinel-
losis cases diagnosed during an endemic decade in an industrial area
from Hunedoara County, situated in the central-western part of Romania.
Methods: We retrospectively extracted data from the medical records
of 353 patients hospitalised during the period 1996–2005 at “Dr.
Al. Simionescu” Hospital from Hunedoara, Department of Infectious
Diseases. There have been analysed the following particularities
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regarding the study group: age, gender, inhabitance area, year and season
of hospitalisation and profession.
Results: Most of the patients (27.47%, n = 37) were in the age group
of 10–19 years old; 198 patients (56.09%) were women; 233 patients
(66.01%) lived in the urban areas among whom 195 patients were
inhabitants of Hunedoara town; 1997 was the year with the largest
number of the cases (32.58%, n = 315); 55.24% of the patients were
hospitalised during the winter; 42.66% were unemployed people.
Conclusion: Hunedoara town and the surroundings belong to a heavy
industrial area in decline where a lot of people are poor and unemployed.
There is also a large gipsy community living in unsanitary conditions,
eating uninspected pork products. This facts can explain the frequent
bursts of trichinellosis that occur in this area especially within the group
mentioned above. Most of the cases were diagnosed in winter when,
according to regional food habits, a lot of pigs are slaughtered.
P979 Subtyping Blastocystis hominis: is subtype 2 responsible for
asymptomatic infections?
F. Dogruman Al, H. Dagci, H. Yoshikawa, O¨. Kurt, M. Demirel
(Ankara, Izmir, TR; Nara, JP; Manisa, TR)
Objectives: Blastocystis hominis is probably the most common
eukaryotic organism in the intestinal tract of humans, with increasing
reports indicating its presence in patients with gastrointestinal and
dermatological manifestations. However, little is currently known about
its pathogenesis in human infections. Isolated both from humans and
various animals, this interesting protozoon has numerous known subtypes
and the relation between these subtypes and its pathogenesis is yet under
research. The aims of this study were to identify B. hominis isolates
in both adult and paediatric patients with and without symptoms in
two hospitals in Manisa City, Turkey, and subtype them to identify any
correlation between the reported symptoms and subtypes.
Methods: Stool samples of the individuals were examined with routine
O&P examination and the presence of B. hominis was conﬁrmed with
the examination of trichrome stained smears. All positive samples were
inoculated in Robinson’s medium and a total of 92 samples were included
in the study. The individuals were grouped according to having any
related symptoms or not. DNA was extracted from each sample using the
QIAamp DNA Stool Mini Kit (QIAGEN, Hilden, Germany)according to
the recommendations of the manufacturer, followed by genotyping with
PCR using seven different primers. Chi-square testing was applied for
the statistical analyses.
Results: Microscopic examination of the stool samples of symptomatic
cases revealed that only 11 (18.6%) were B. hominis-positive. Subtype
3 was by far the most common (n = 31; 55.4%) Blastocystis subtype
and Subtype 2 was found more common in asymptomatic cases with
a statistical signiﬁcance (p<0.05). No other signiﬁcant relation was
detected with other subtypes in the study.
Conclusion: Concordant with the results of the previous studies, Subtype
3 isolates were found to be most common in Manisa, as well. Further
studies conducted with cases from different regions are needed to
conﬁrm the present relation with Subtype 2 and asymptomatic infections.
P980 Prevalence of Giardia intestinalis lamblia among children
with allergies from Saint-Petersburg, Russia
M. Suvorova, E. Tarasova, E. Kazennova, N. Rodionova, R. Al-Shehadat
(Saint-Petersburg, RU)
Odjectives: The percentage of allergic children in Russian megalopolis
is increasing each year. It’s considered that about 70% of children in
Saint-Petersburg have various kinds of allergies.. From the previous
studies we see that there are certain association between the Giardia
intestinalis detection in stool specimens and clinical manifestations of
allergies. In Saint-Petersburg 43–45% of children with allergy symptoms
from atopic dermatitis to bronchial asthma were infected with Giardia
intestinalis. However the possibility that allergies might be associated
with other parasites (Ascaris lumbricosis, Eterobius vermicularis,
Trichinella spiralis, Diroﬁlaria immitis) was not investigated. Therefore
the goal of this study is to ﬁnd connections between allergy symptoms,
Giardia intestinalis and helminthes.
Materials and Methods: 40 children under 12 years old with allergy
were involved in this study. 20 of them were positive for Giardia
intestinalis and 20 were negative. For Giardia intestinalis detection we
used traditional microscopy and PCR.
Feaces from all children were examined by PCR and microscopy for
helminthes identiﬁcation.
DNA from faeces were extracted with “DNA-express” kit (Lytech,
Russia). PCR was performed with speciﬁc primers, and detected by gel-
electrophoresis in 1.5% agarose.
Result: In all 40 cases microscopy analysis was negative for helminthes
and for Giardia intestinalis. Patients with G. intestinalis group have been
tested positive by PCR at least twice.
In G. intestinalis positive group (20 children) 6 patients were detected
with T. spiralis (30%), 5 with A. lumbricosis (25%), three cases with
D. immitis (15%) and 2 cases with E. vermicularis (10%).
In G. intestinalis negative group (20 children) one was detected with
T. spiralis (5%), 3 – D. immitis (15%). A. lumbricosis and E. vermicularis
were not detected.
Conclusion:
1. Children infected with Giardia intestinalis are more predisposed to
helminthes contamination.
2. Prevalence of Trichinella spiralis, Ascaris lumbricosis, Diroﬁlaria
immitis, Eterobius vermicularis among allergic children was high.
3. The only helmint that was found in same percentage from both groups
of children was Diroﬁlaria immitis. The only helminthes that is not
transmitted through the intestinal tract.
P981 Preliminary analysis of the molecular phylogenetics of
Toxocara canis (Nematoda: Ascaridoidea) using nuclear
ribosomal second internal transcribed spacer sequences
A. Rodriguez-Morales, R. Barbella-Aponte, M. Arria (Caracas, VE;
Valencia, ES)
Objectives: Toxocariasis is a zoonotic disease caused by Toxocara canis
and T. cati. Human is their paratenic host. Although many clinico-
epidemiological aspects have been studied in almost 60 years after the
discovery of human disease, many biological and molecular aspects are
still lack of knowledge and research. After a careful review of literature
we did not found any study describing the phylogenetics of Toxocara
using any molecular marker.
Methods: For these reasons, nuclear internal transcribed spacer 2 (ITS2)
rDNA sequences were used for the ﬁrst molecular phylogenetic analysis
and tree of ﬁve Toxocara species. ITS2 rDNA sequences were already
available from GenBank (accession numbers AB110034, AB110033,
EU189085, AM231609 and AB027152), corresponding to T. canis,
T. cati, T. vitulorum, T. malaysiensis and T. tanuki. Phylogenetic analysis
was made after aligned these sequences using GeneDoc 2.7 (Figure),
using the method of Maximum Parsimony and the bootstrap test for
phylogeny with MEGA 4.
Results: As expected, T. canis and T. cati ITS2 alleles are monophyletic,
as well T. malaysiensis with T. vitulorum (Figure). As expected also,
we observed a high nucleotide diversity (p = 0.705825; Tajima test =
0.461359) between the studied species.
Conclusions: The nuclear ITS rDNA sequence has been extensively
used to deﬁne genetic markers for different species of nematodes and
the aims of this study were to use the ITS2 to investigate the levels of
genetic variation within Toxocara and generate a ﬁrst phylogenetic tree
(Figure). If there are normal levels of gene ﬂow between populations
(or species), these populations are likely to be similar in their overall
genetic characteristics, and genes for important characteristics are likely
to spread easily. ITS2 of other Toxocara species should be included in
further analysis (eg. T. genettae, T. lyncis, T. vincenti, among others), to
S264 18th ECCMID, Posters
better deﬁne the evolutionary relationships and phylogeny of the genus
Toxocara.
Figure. Multiple sequences alignment (upper) and evolutionary rela-
tionships of T. canis and other spp. (lower). The consistency index is
(0.0777457), the retention index is (0.509554), and the composite index
is 0.449561 (0.396156) for all sites and parsimony-informative sites (in
parentheses). The percentage of replicate trees in which the associated
taxa clustered together in the bootstrap test (500 replicates) are shown
next to the branches.
P982 Is multiple-stool-specimen ova and parasite examination
necessary?
F. Gru¨nbaum, C. Mun˜oz, R. Morato´, E. Gime´nez, R. Soler, T. Llobet,
P. Coll (Barcelona, Reus, ES)
Objectives: We performed a retrospective analysis of 12,862 ova and
parasite (OP) examinations of stool specimens from 8109 patients visited
at Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, between 2004
and 2006 to evaluate the utility of such tests in multiple, independently-
collected stool specimens.
Methods: Multiple-specimens from a single patient were considered
related to the same clinical episode if collected within 14 days. A series
was thus deﬁned as specimens of the same clinical evaluation. A positive
result was deﬁned as the presence of pathogenic OP in stool specimen.
Presence of Trichomonas hominis, Chilomastix mesnili, Endolimax nana
and Entamoeba coli were also considered positive. A second or third
specimen was considered positive for a parasite only if the previous
specimens were negative. As a positive result for another parasite in the
same series was considered a further positive result, a single series could
have more than one positive result. Standard parasitological techniques
were used.
Results: Of the 12,862 specimens submitted, 10,086 corresponded to
single-specimen series, 1942 to 2-specimen series and 734 to 3 or more
specimen series. To evaluate the utility of multiple-specimen examination
we focused on series of at least 3 specimens. The ﬁrst specimen
collected was diagnostic in 49.15% (29 of 59) evaluated cases. The
examination of 2 specimens increased sensitivity to 79.66% (47 of 59).
The third specimen collected provided additional information in 12 cases
(20.34%). Information provided by the ﬁrst specimen, in comparison
with the second, was not statistically signiﬁcant (p = 0.074), although a
tendency was observed. Differences between information provided by the
ﬁrst and third specimen were statistically signiﬁcant (0.006). Differences
between second and third specimens were not statistically signiﬁcant
(p = 0.352).
Conclusions: These data suggest that 2 specimens per series should be
studied in order to achieve sensitivity closest to 80%. As the difference
in information provided by the second and third specimens is not
signiﬁcant, a third specimen is not needed.
P983 Anti-giardial activity of carvacrol, thymol and eugenol
M. Machado, C. Cavaleiro, L. Salgueiro, J. Poiares-da-Silva,
J.B. Custo´dio, M.C. Sousa (Coimbra, PT)
The protozoan parasite Giardia lamblia is recognised as one of the
most important non-viral infectious agents causing diarrhoeal illness in
humans around the world. Current therapy against G. lamblia infection
(giardiasis) is unsatisfactory due to high incidence of undesirable
side effects and a signiﬁcant failure in clearing parasites from the
gastrointestinal tract. Consequently, new compounds are being screened
for antigiardial activity, namely essential oils and their pure compounds,
which revealed on previous studies important antibacterial, antifungal
and antiparasitic activity. In the present work, we studied the effects
of pure phenolic-compounds such us carvacrol, eugenol and thymol
on G. lamblia growth and adherence. Culture trophozoites of WB
strain (ATCC 30957) were incubated in growth medium with different
concentrations of phenolic compounds for 48 h at 37 ºC under anaerobic
conditions. The concentrations that inhibit the growth at 50% (IC50)
were determined by total cell counting. To study the effects on Giardia
adherence, an inoculum of 5×104 trophozoites was exposed to pure
phenolic-compounds at IC50 concentrations during 7 h at 37ºC in Keister
medium without serum. The number of unattached and attached cells
was determined microscopically using a haemocytometer (Neubaeur
cell counter chamber) and the results were expressed as percentage of
attached trophozoites in relation to the total number of Giardia cells
reached from each assay. The experiments were performed in duplicate
and in three independent assays (n = 3), and the analysis of variance
(ANOVA) was used. The growth of G. lamblia was signiﬁcantly inhibited
by thymol, carvacrol and eugenol. The most active compound was thymol
(IC50 = 47mg/ml), followed by carvacrol (IC50 = 50mg/ml) and eugenol
(IC50 = 131mg/ml). The tested phenolic compounds inhibit G. lamblia
trophozoites adherence (p<0.001) from the ﬁrst hour of incubation.
The total cell number (attached and unattached cells) after 7 hours of
incubation was unaffected by eugenol, but was decreased by carvacrol
(30%, p>0.05) and thymol (50%, p<0.01). These results suggest that
carvacrol, thymol and eugenol have antigiardial activity inhibiting the
cells growth and attachment, inducing cell death. Therefore, these
compounds seem to have potential for use as therapeutic agents against
giardiasis.
This work was supported FCT POCTI (FEDER).
P984 Effects of phenolic-rich essential oils on the morphology and
adherence of Giardia lamblia trophozoites
M. Machado, L. Salgueiro, J. Poiares-da-Silva, C. Cavaleiro,
M.C. Sousa (Coimbra, PT)
Attachment of Giardia lamblia trophozoites to enterocytes is essential
for colonisation of the small intestine and is considered a prerequisite for
parasite-induced enterocyte dysfunction and clinical disease. G. lamblia
trophozoites can also attach to in vitro cultured cells as well as to glass,
plastic and to a variety of artiﬁcial substrates. Considering that inhibition
of its attachment may have therapeutic potential, it was of interest to
study the ability of essential oils to inhibit the G. lamblia adherence.
In previously studies we have showed that phenolic rich essential oils
inhibit the growth of G. lamblia in vitro. In the present work, we
evaluated the effects of essential oils on morphology and adherence of
G. lamblia trophozoites. Essential oils were obtained by hydrodistillation
from fresh plant material and analysed by GC and GC-MS. Constituents
were identiﬁed from their retention indices on two different phases GC
columns (polydimethylsiloxane and polyethyleneglycol) and from their
mass spectra, which were compared with reference data. An inoculum of
5×104 trophozoites (WB strain, ATCC 30957) was exposed to essential
oils at concentrations that inhibit the growth at 50% (IC50) during
7 h at 37 ºC. The morphological alterations were studied by optical
and transmission electronic microscopy. The number of unattached and
attached cells was determined microscopically using a haemocytometer
and the results were expressed as percentage of attached trophozoites in
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relation to the total number of Giardia cells reached from each assay.
The experiments were performed in duplicate and in three independent
assays (n = 3), and statistically, the analysis of variance (ANOVA) was
used.
The essentials oils from Thymus zygis ssp. sylvestris, Thymbra capitata,
Origanum virens, Lippia graveolens and Syzygium aromaticum inhibit
G. lamblia trophozoites adherence (p<0.001) since the ﬁrst hour of
incubation. The main morphological alterations promoted by essential
oils were deformations in typical trophozoite appearance, such as
modiﬁcations on the cell shape, alterations in plasma membrane,
presence of precipitates in the cytoplasm and intracellular clearing. The
results suggest that these phenolic-rich essentials oils have anti-giardial
activity modifying the attachment ability and promoting cell death by
a lyses process, having potential for use as therapeutic agents against
giardiasis.
This work was supported FCT POCTI (FEDER).
P985 High Prevalence of Giardia in dogs from Portugal: genetic
characterisation of isolates by sequencing analysis of
beta-giardin gene locus
J. Machado, M. Machado, P. Ramalho, J. Poiares-da-Silva, M.C. Sousa
(Coimbra, Braga, PT)
Human giardiasis is considered a zoonotic infection, although the role
of animals in the transmission to humans is still unclear. Molecular
characterisation of cysts of human and animal origin represents an
objective means to validate or reject this hypothesis.
Some animal derived isolates appear to be similar or identical to human
derived genotypes while others represent unique genotypes that seem
to be host-speciﬁc. When considering the zoonotic potential of each
genotype, the Assemblage A and B are believed to represent a major risk
for human health since both appear to be infective to a wide range of wild
and domestic host species. In the present study, isolates of Giardia were
genetically characterised by using PCR-based procedures to determine
the occurrence of potentially zoonotic genotypes of G. lamblia.
Faecal samples (n = 37) were obtained from dogs in kennel situations
in north of Portugal. The parasitological study was performed by
microscopy observation (direct examination and after concentration
by Copropack S.A.F, Biomedics, S.L.) and G. lamblia coproantigen
detection was performed by immunocromatograﬁc method (Sick Gia-
rdia/simple Giardia, Operon). The b-giardin gene locus was ampliﬁed
by nested-PCR and PCR products were sequenced with dRodamina
Terminator Cycle Sequencing kit. The reading was performed using an
ABI PRISM 310 automatic DNA Sequencer and the obtained sequences
were aligned with those available in Genbank using Clustal X program.
Sequence accuracy was conﬁrmed by two-directional sequencing.
A total of fourteen faecal samples were positive to Giardia cysts (51.8%),
one for Isospora sp. (3.7%), four to Ancylostoma sp. (14.8%), two to
Toxocara canis (7.5%) and one to Capillaria spp. (3.7%). The Giardia
antigen detection test was positive for 13 dog faeces samples (48%).
Of 16 Giardia cysts and/or antigen positive faeces, 12 samples were
successfully ampliﬁed at the beta-giardin locus gene. The sequencing
analysis showed that the assemblage A was detected in eight samples.
This is the ﬁrst genetic characterisation of Giardia isolates in dogs
from Portugal. The results conﬁrmed the high prevalence of Giardia in
dogs and showed that the zoonotic Assemblage A was common in this
domestic animal. The results demonstrate that a signiﬁcant proportion
of dogs in north of Portugal harbour zoonotic Giardia and should thus
be considered a potential reservoir for infection in humans.
This work was supported FCT POCTI (FEDER).
P986 Albendazole versus praziquantel in the treatment of
neurocysticercosis: a meta-analysis of comparative trials
D. Matthaiou, G. Panos, E. Adamidi, M. Falagas (Athens, GR)
Objective: We investigated the role of albendazole and praziquantel
in the treatment of patients with parenchymal neurocysticercosis by
performing a meta-analysis of comparative trials of their effectiveness
and safety.
Methods: We performed a search in the PubMed database, Cochrane
Database of Controlled Trials, and in references of relevant articles. Six
studies were included in the meta-analysis.
Results: Albendazole was associated with better control of seizures
in comparison with praziquantel in the pooled data analysis using
a random effects regression model of the incidence of seizure
control [patients without seizures/(patients X years at risk)] [156
patients in 4 studies, point effect estimate =4.94, 95% conﬁdence
interval 2.45−9.98]. In addition, albendazole was associated with
better effectiveness regarding the total disappearance of cysts in
comparison with praziquantel (335 patients in 6 studies, random effects
model, OR=2.30, 95%CI 1.06−5.00). There was no difference between
albendazole and praziquantel regarding adverse events and development
of intracranial hypertension due to the administered therapy.
Conclusion: A critical review of the available data from comparative
trials suggest that albendazole is more effective than praziquantel
regarding clinically important outcomes in patients with neurocys-
ticercosis. Nevertheless, given the relative scarcity of trials, more
comparative interventional studies, especially randomised controlled
trials, are required to draw a safe conclusion about the best regimen
for the treatment of patients with parenchymal neurocysticercosis.
P987 Assessment of parasitic and microbial infections in vegetables
using different washing methods
A. Khosravi, E. Asadollahy, A. Armani (Ilam, IR)
Objectives: Vegetables are very important part of the dairy food.
Contamination can occur in vegetables particularly if there is a poor
sanitation condition such as what in present in some part of Ilam province
in Iran. Both microbial and parasitic infection can be found on vegetables
if the washing method is not accurate.
Methods: 180 vegetable samples were randomly selected from retailer
in different areas of the Ilam city. Vegetables were rinsed with tap water
thoroughly keeping the water for examination while the sample treated
with detergent and hypochlorite separately and the water kept again
for examination purposes. Formalin-ether concentration was applied
comparing to sedimentation and direct microscopy
Results: The parasitic infections were observed in more than 40% of
samples while the microbial infection in more than 70%. The parasitic
infections were reduced after treating with detergent but this was not
statistically signiﬁcant. No signiﬁcant decrease was observed for the
microbial infection after washing with soap while it was signiﬁcant after
treating with hypochlorite. Giardia lamblia (43%), Ascaris lumbricoides
(5.6%), Taenia (8%), Entamoeba coli (7.8%), other Amoeba (7%) and
Trichucephalus (5%) were the most prevalent infection in samples.
P988 Outbreak of cyclosporiasis in Istanbul, Turkey, during an
extremely dry and warm summer
M. Ozdamar, S. Turkoglu, E. Hakko (Kocaeli, TR)
Objectives: Cyclospora cayetanensis is an important agent of traveler
diarrhoea in developed countries and was responsible for numerous
foodborne outbreaks worldwide. We describe a Cyclospora outbreak in
a region between Istanbul and Kocaeli during a very warm and waterless
summer.
Methods: 286 patients with diarrhoea were admitted to Anadolu
Medical Center outpatient clinics during July-August 2007. Stools
are investigated routinely for coccidian parasites in the microbiology
laboratory of the Anadolu Medical Center, especially in the summer
months. Modiﬁed acid-fast stain and careful microscopic examination
(including UV light analysis) are performed after Para Pak (Meridian
Diagnostics) concentration. C. cayetanensis speciﬁc polymerase chain
reaction (PCR) based on nucleotide sequences for ITS-1 region was
performed in microscopy positive stools.
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Results: C. cayetanensis oocysts were found to be positive in the stool
of 16 patients. C. cayetanensis (7 female, 9 male, median age is 41.94
plus/minus 10.0). C. cayetanensis DNA were found to be positive by
PCR in only 12. The diarrhoea was persistant in most of these patients.
No cases were detected in June and September.
Conclusion: Cyclospora prevalence was signiﬁcantly higher compared
with 2006 season (data not shown). The food histories showed that
some patients had eaten a green salad. There were additional cases that
we could not have the possibility to further analyse. All the patients
were successfuly treated with trimetoprim-sulfametoxazol (TMP/SMX
160/800mg bid). C. cayetanensis infection is more prevalent in Turkey
during summer as reported previously. The laboratories should always
consider performing modiﬁed acid-fast staining (very efﬁcient for this
purpose) to diagnose this parasite in acute or sub-acute diarrhoea cases.
A single-step PCR is not as sensitive as the conventional method but
serve to further analyse the genome of the parasite. An extremely dry
summer came after an extremely warm winter in 2006–2007 season.
This deserves further speculation to correlate with outbreaks.
P989 Fusarium oxysporum and free-living amoebae
E. Cateau, C. Goncalves, J.M. Berjeaud, C. Imbert, M.H. Rodier
(Poitiers, FR)
Objectives: Fusarium oxysporum is responsible for infections in
immunocompromised patients. Some authors have identiﬁed hospital
water distribution systems as reservoirs of Fusarium species. In
these systems, amoebae of Acanthamoeba and Hartmannella genus
are also often recovered and it is known that these protozoa can
inﬂuence the growth of other microorganisms as bacteria or yeasts.
We have investigated the potential interactions between A. castellanii
or H. vermiformis and F. oxysporum (isolated from a cornea).
Methods: A. castellanii ATCC 30234 or H. vermiformis ATCC
50256 trophozoites (5.105/ml) were incubated with 5.104/ml conidia of
F. oxysporum (MOI = 0.1). The coculture was incubated in PBS at 27ºC
during 24, 48 or 72 h. Controls were realised by incubating fungus in
PBS alone. After incubation and amoebae lysis, dilutions of this lysate
were plated on Sabouraud agar to determine CFU.
Trophozoites (5.105/ml) of each amoebae strain were incubated during
24, 48 or 72 h in PBS at 27ºC. Amoebae were pelleted and F. oxysporum
conidia (5.104/ml) were cultivated in the resultant supernatant. After 24
or 48 h of incubation, each suspension was plated on Sabouraud agar and
CFU were numbered. The germinative potential of F. oxysporum conidia
was microscopically determined at 4, 8, and 24 h.
Results: In cocultivation experiment, the presence of each free living
amoeba led to an increase of F. oxysporum growth whatever the duration
of incubation.
The contact (24 or 48 h) of F. oxysporum with the amoebae supernatants
promoted an increase of the number of fungal CFU, compared to Fusar-
ium growth in PBS alone. The conidia germination, microscopically
veriﬁed, occurred only with the supernatant of H. vermiformis after 24 h
of incubation. No germination was observed after incubation in PBS or
in A. castellanii supernatants.
Conclusion: The results of this preliminary study indicate that the
presence of free living amoebae in the same environment could lead to an
increase of the F. oxysporum development. Moreover, the A. castellanii
and H. vermiformis trophozoites used here can release substances able
to favour the growth of this fungus. So, in hospital water taps, a special
attention should be paid to the presence of free living amoebae, which
can not only promote bacterial growth, but also development of fungal
pathogens.
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P990 Contribution of RSV and hMPV to patients with inﬂuenza-
like infections during 2006–2007 season in northern Greece
G. Gioula, A. Melidou, M. Exindari, D. Chatzidimitriou,
V. Kyriazopoulou-Dalaina (Thessaloniki, GR)
Background: Every year, during inﬂuenza season, many different
viruses (such as RSV and the newly discovered hMPV) co-circulate,
infecting individuals in the community.
Objectives: The aim of this study was to determine the contribution of
RSV and hMPV to inﬂuenza-like illness (ILI) cases during 2006–2007
inﬂuenza season in N.Greece.
Materials and Methods: One hundred and twenty-nine pharyngeal
swabs (129) from patients presented as ILI infections during the last
inﬂuenza season (2006–2007) were examined at the National Inﬂuenza
Centre by conventional and molecular techniques for inﬂuenza viruses,
RSV and hMPV.
Results: Of the 129 patients examined, 52 (40.3%) were laboratory
conﬁrmed inﬂuenza (AH3) infections, 7 (5.4%) were laboratory
conﬁrmed RSV infections and 8 (6.2%) were laboratory conﬁrmed
hMPV infections. Five of the seven RSV cases appeared in children
younger than 3 years old. Co-infections (RSV and A(H3) inﬂuenza
viruses) were detected in two cases, concerning adults. From the 8 hMPV
cases, ﬁve were children <9 years old and three were young adults
(<25 years old). Co-infections (hMPV and A(H3) inﬂuenza viruses)
were detected in two cases, concerning both children and adults. 2006–
2007 inﬂuenza season started in January 2007 and lasted till the end
of March, peaking in February. RSV was detected in the beginning and
the end of this season, while hMPV was circulating during the whole
period.
Conclusions: As RSV and hMPV infections mimic inﬂuenza, it is
common to be clinically confused, especially in children. Including
RSV and hMPV in the laboratory diagnosis of ILI cases distinguish
the contribution of these viruses in such infections.
P991 Multiplex MLPA assay for simultaneous detection of 6 viral
agents causing central nervous system infections
P.F.G. Wolffs, C.A. Bruggeman, C. Vink, G. Simons, A.J. van den Brule
(Maastricht, Eindhoven, NL)
Objectives: Molecular DNA-based diagnostics are increasingly being
used for detection of infectious agents in cerebrospinal ﬂuids. However,
the increasing list of targets and the small sample volume are challenges
that demand an improved molecular diagnostic approach. Therefore,
in this study we have developed a multiplex ligation-dependent
probe ampliﬁcation (MLPA) assay for the simultaneous detection of
Cytomegalovirus, Epstein Barr virus, Herpes Simplex virus I and II,
Varicella Zoster virus, enteroviruses and an internal control.
Methods: An MLPA reaction consists of three steps: ﬁrst an annealing
step where the 2 probes hybridise to their target region, secondly a
ligation step to link the two probes, and lastly a PCR to amplify the
ligated probes followed by detection by gel electrophoresis. The main
advantage of using MLPA is that only one primer set is used for the ﬁnal
ampliﬁcation reaction, in contrast to for example multiplex PCRs. This
offers the opportunity to detect up to 45 targets simultaneously without
affecting the reaction negatively. The MLPA reaction is preceded by a
reverse transcriptase PCR to ensure the detection of both RNA and DNA
viruses. In this study the MLPA assay was tested on 50 cerebrospinal
ﬂuids of patients with suspected central nervous system infection. The
MLPA was performed in two centres and compared with singleplex real-
time PCR analysis performed in routine diagnostic laboratories. Real-
time PCR analysis were considered to be the “gold standard”.
Results: MLPA results showed 100% accordance (intra-laboratory
variation) and a repeatability of 92% (inter-laboratory variation). Overall
the MLPA test had a inter-laboratory sensitivity of 87% (number of
correct positives by MLPA/ total number of positives by real-time PCR)
Molecular diagnosis of viruses S267
and a inter-laboratory speciﬁcity of 94% (number of correct negatives
by MLPA/ total number of negatives by real-time PCR). When analysed
per target individually, the inter-laboratory sensitivities were between 90
and 100% except for CMV, where no positive samples were tested, and
EBV, where no positive sample could be identiﬁed. The inter-laboratories
speciﬁcities per target varied between 98% and 100%.
Conclusions: In conclusion, although further optimisation is needed
to improve the EBV detection and CMV positive samples should be
tested, this MLPA assay is a new promising tool in the ﬁeld of rapid
simultaneous detection of infectious agents causing central nervous
system infections.
P992 Performance of the APTIMA HPV assay as compared to
Hybrid Capture-II on cytologically and histologically deﬁned
specimens
J. Dockter, S. Joo, A. Schroeder, B. Eaton, D. Getman, C. Giachetti
(San Diego, US)
Objectives: The APTIMA HPV Assay detects HPV E6/E7 mRNA
from 14 high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56,
58, 59, 66, 68) in liquid Pap specimens. It utilises Gen-Probe’s
target capture, Transcription-Mediated Ampliﬁcation, and Hybridisation
Protection Assay technologies, incorporates an internal control, and
can be run on both the semi-automated Direct Tube Sampling (DTS)
instruments and the fully automated TIGRIS DTS System (TIGRIS).
In this study, the performance of the APTIMA assay was evaluated in
residual Cytyc PreservCyt liquid-based cytology samples from US and
France referral populations, including samples determined to contain
atypical squamous cells (ASC), and samples classiﬁed as CIN 1−3.
Methods: PreservCyt samples (n = 367) were diluted 1/4 in APTIMA
specimen transport media and tested on TIGRIS. Samples were also
tested using the Digene Hybrid Capture 2 (HC2) assay following its
standard assay procedure.
Results: The APTIMA assay detected 259 of the 367 samples tested
(70.6%) and the HC2 assay detected 260 (70.8%). The reactivity rate for
the APTIMA assay in ASC samples was 69.1%. For these same samples
the HC2 assay reactivity rate was 81.8%. For samples determined to be
CIN-1, -2, or -3 (n = 375), APTIMA assay reactivity rates were 76.8%,
95.5%, and 96%, respectively, while HC2 assay reactivity rates were
76.8%, 93.2%, and 92%, respectively. For samples determined to be
CIN 2 or -3 (n = 319), the APTIMA assay achieved 95.8% reactivity,
while HC2 assay reactivity was 92.4%. Inter-assay concordance was
87.5% overall, 80% for the ASC samples, and 95% for the CIN-2 or -3
samples.
Conclusion: The APTIMA HPV assay exhibited lower reactivity than
the HC2 assay in samples with ASC cytology, and higher reactivity than
the HC2 assay in disease-positive (CIN-2 or -3) samples. Concordance
between the APTIMA and HC2 assays was 95% in histologically disease-
positive specimens.
P993 Analysis of VZV and HSV in different matrices by the use
of afﬁgene kits
N. Finnstrom, K. Bergsten, H. Strom, A. Sauerbrei, P. Wutzler
(Maurens-Scopont, FR; Bromma, SE; Jena, DE)
To date there is no consensus on how to best diagnosing for varicella
zoster virus (VZV) and herpes simplex virus (HSV), which sample
matrix to use or which technology. Real-time PCR may offer excellent
performance for this type of diagnosing. However such a method not only
needs to be sensitive and speciﬁc but must be ﬂexible and validated to
handle different matrices, and ﬁt together with a diversity of methods
for sample extraction.
Objectives: The aim of this study was to analyse a wide range of
matrices for VZV and HSV 1 and 2 using the afﬁgene® VZV tracer
and the afﬁgene® HSV 1/2 tracer kits (Cepheid AB, Bromma, Sweden),
respectively. The results from the commercial PCR assays were compared
to in-house PCR assays.
Methods: DNA from 178 samples diagnosed for VZV and 352 samples
diagnosed for HSV from 22 or 8 different matrices, respectively, were
prepared using Qiagen blood mini kit (Qiagen, Hilden, Germany).
Subsequently, the presence of VZV and HSV-1 and 2 was analysed
using afﬁgene® VZV tracer and afﬁgene® HSV 1/2 tracer, respectively,
on the Mx3000P instrument (Stratagene, La Jolla, USA). Fifty-two
samples were also prepared using afﬁgene® DNA extraction (Cepheid
AB, Bromma, Sweden) according to the manufacturer’s instructions and
analysed using afﬁgene® HSV 1/2 tracer. Prior to this study the samples
had been analysed using Qiagen blood mini kit and an qualitative in-
house PCR. Positive and negative agreement were calculated.
Results: Generally more positive samples were detected using afﬁgene®
assays in combination with the Qiagen blood mini kit preparation system
compared to the in-house assays. In e.g. CSF six (of 40 samples) were
detected positive for VZV using afﬁgene® VZV tracer while only one
using the in-house method. For HSV-1 detection the corresponding
numbers in CSF were 5 compared to 3 of 40 for afﬁgene® HSV 1/2
tracer and in-house assay, respectively. For HSV-2, 6 compared to none
of 40 were detected with respective assay.
The positive agreement, for analysing VZV in all matrices was 85%
and the negative agreement was 92%. For HSV-1 the corresponding
ﬁgures were 97% and 89%, respectively, and for HSV-2 100% and 90%,
respectively.
Conclusions: Afﬁgene® VZV tracer and afﬁgene® HSV 1/2 tracer are
sensitive assays for detection of varicella zoster and herpes simplex
viruses. A wide variety of sample matrices can be analysed using
either Qiagen blood mini kit or afﬁgene® DNA extraction as sample
preparation method.
P994 Speciﬁc detection of hepatitis C virus in clinical samples
using a novel simpliﬁcation strategy
N. Boulter, S.P. Siah, C.J. Vockler, N.A. Coulston, K. Warton,
P. Rajasekariah, J.R. Melki, D.S. Millar (Sydney, AU)
Objective:We have shown previously that DNA simpliﬁcation is a novel
procedure that is able to speciﬁcally detect all high-risk strains of the
Human Papilloma Virus in a single reaction. We wished to determine if
it was possible to use a modiﬁed simpliﬁcation strategy to detect RNA
encoding viruses and used Hepatitis C virus (HCV) as a model organism.
Background: HCV is a major cause of chronic hepatitis, cirrhosis and
liver cancer on a global scale. One of the most sensitive methods for
the detection of HCV is reverse transcription PCR (RT-PCR), which in
addition to improved sensitivity compared to serological methods, can
also be used to monitor disease activity in response to anti-viral drugs.
We aimed to produce a simpliﬁcation-based RT-PCR assay for HCV
RNA that was as sensitive and speciﬁc as current viral-load monitoring
assays.
Methods: Treatment of DNA with sodium bisulﬁte results in the
conversion of cytosine residues to uracil, which are subsequently
ampliﬁed as thymine. Although such methods have been applied to
the detection of DNA viruses such as HPV, the treatment of RNA
with sodium bisulﬁte results in total degradation of the RNA and thus
was of no clinical utility. We have developed a novel method for the
simpliﬁcation of RNA using sodium bisulﬁte, which eliminates RNA
degradation and shows similar sensitivity and speciﬁcity to conventional
approaches.
Results: Baseline sensitivity tests were conducted using serial dilutions
of HCV (Acrometrix cat# 96–0203) diluted in normal human serum
and puriﬁed using the Qiagen QiAmp UltraSens viral kit. Positive
signals were generated from as little as 15 IU/mL of virus, indicating
negligible RNA degradation. In addition, a number of commercially
available panels were obtained including; BBI Diagnostics Genotype
Panel (PHW202), Worldwide HCV panel (WWHV301), HCV RNA
genotype performance panel (PHW202) and HCV RNA linearity panel
(PHW804), all of which produced results indicating that the HGS
simpliﬁcation strategy performed as well as conventional RT-PCR.
Furthermore, sequencing of amplicons derived from different genotypes
demonstrated that the method could be used for genotyping individual
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HCV strains. Finally the method was assessed on a blinded panel of
clinical samples the results of which shall be discussed in more detail.
Conclusion: RNA simpliﬁcation is a novel approach for the reliable
detection and genotyping of RNA containing pathogens such as HCV or
HIV.
P995 Development of immuno-polymerase chain reaction as a
highly sensitive method for viral detection
Y.J. Chan, J. Huang, A.Y-M. Chen, D.M-T. Ho (Taipei, TW)
Objectives: To develop a more sensitive and rapid method for viral
antigen detection, the study combined an immune response (antigen-
antibody) and a polymerase chain reaction (PCR) to form a new method,
immuno-PCR (IPCR). The goal is to enhance the detecting limit of the
conventional enzyme-linked immunosorbent assay (ELISA).
Methods: A monoclonal antibody, mAbH3 or mAbN, which recognises
the inﬂuenza A (H3N2) or a SARS-coronavirus recombinant antigen
(GST-N), was covalently linked to a cytomegalovirus DNA fragment
(394 bp) respectively to form a protein-DNA complex, mAbH3-DNA
or mAbN-DNA. The complex was puriﬁed and used for the reporting
second antibody. To compare the detection limits of the conventional
ELISA and IPCR, ﬁrst antibodies against inﬂuenza A or SARS-
coronavirus antigens were ﬁxed onto micro-well plates with serial diluted
standard antigens (HA titer more than 1:160 or GST-N) as the targets.
Conventional secondary antibodies and the antibody-DNA conjugates
were used for reporting the antigen levels.
Results: By using a quantitative real-time PCR the calculated copy
numbers of the mAbH3-DNA IPCR correlated with the levels of the
target antigens with the detecting limit down to 1:1000 dilutions, while
the detecting limit of the conventional ELISA was 1:10 under the same
experimental conditions.
A similar experiment using the SARS-coronavirus antibody-DNA
conjugates revealed that the detecting limit for GST-N was 2 ng/ml,
while the detecting limit of the conventional ELISA was 30 ng/ml.
Conclusions: IPCR is more sensitive than conventional ELISA for viral
antigen detection. It is promising to adopt IPCR to detect small amount
of viral products.
P996 Evaluation of real-time PCR assay for early detection of
Cytomegalovirus infection in solid-organ transplant recipients
M. Pape, K. Mandraveli, D. Papadopoulou, E.I. Kazakos,
S. Alexiou-Daniel (Thessaloniki, GR)
Objective: The aim of this study was to evaluate the advantages of
Real-time PCR for early detection of CMV infection in solid-organ
transplant recipients by comparison to four serology methods such as
ELISA, Capture-ELISA, IFA, Western-blot.
Methods: The study included 90 solid-organ transplant recipients with
clinical manifestations of recent CMV infection. Whole blood specimens
and sera were collected from all patients. The whole blood specimens
were processed with Real-time PCR (artus CMV LC PCR, QIAGEN)
to detect CMV viral load, while the same assay was employed to
detect EBV (LC EBV Quantiﬁcation, Roche) and HSV/VZV (artus
LC, QIAGEN) in 67 and 38 samples, respectively. All sera were
tested for anti-Cytomegalovirus IgG/IgM antibodies by ELISA (AXSYM
Abbott). IgM positive results were conﬁrmed by Capture-ELISA (CE-
Bouty), indirect immunoﬂuorescene (IFA, Focus) and Western-blot (Wb-
Immunogenetics) assays.
Results: CMV viral load was detected in 20 patients, while 7 of these
patients had evidence of EBV co-infection(PCR+). EBV viral load was
detected in 14 specimens, but no HSV or VZV DNA was detected.
ELISA revealed an anti-CMV IgG positive rate of 90% in both PCR
positive and negative patients. IgM antibodies were present in 15/20
(75%) CMV PCR positive patients and in 14/70 (20%) CMV PCR
negative patients. The positive rates of the rest serology assays for the
PCR(+) and ELISA IgM(+) patients were Capture Elisa (+) 84%, IFA (+)
73%, Western-blot (+) 88%, while the respective rates for the PCR(−)
and ELISA IgM(+) patients were Capture Elisa (+) 50%, IFA (+) 35%,
Western-blot (+) 43%. High viral load (>103 copies/ml) was detected in
10/15 patients with ELISA IgM positive results. Low viral load (<103
copies/ml) was detected in 5/20 patients with ELISA IgM negative results
Conclusion: The referring doctors are requested to provide more clinical
informations. Double samples should be tested by all serology assays in
order to access a safe diagnosis and eliminate the possibility of false
negative and positive results. Evaluation of viral load by Real-time PCR
seems to be more sensitive and speciﬁc for the early detection of CMV
infection than the serology assays.
HIV
P997 Relationship between gastric secretion, bacterial and fungal
colonisation and histological changes in gastric mucosa in
HIV-infected patients
P. Skwara, I. Sobczyk-Krupiarz, A. Ciesla, J. Loster, T. Mach
(Cracow, PL)
Objectives: Abnormal secretion of acid gastric juice in the course of
HIV infection may result in bacterial and fungal overgrowth in stomach.
The aim of the study was to estimate gastric secretion in HIV-infected
patients (pts) in relation to severity of immunodeﬁciency and route of
HIV transmission as well as inﬂuence of changes in gastric secretion
on bacterial and fungal colonisation of stomach and gastric mucosa
histology.
Methods: 71 HIV-infected pts were studied, 35 with CD4 lymphocyte
count <200/uL (group 1) and 36 with CD4 >200/uL (group 2). Biopsy
samples were taken during endoscopy from corpus and antrum of
stomach for histological analysis and gastric juice samples were taken for
quantitative bacteriological and mycological analysis. Gastric secretion
was evaluated in 37 pts belonging to group 1 (19pts) and group 2 (18pts)
on the basis of BAO, MAO and PAO analysis. In this group, route if
transmission in 21 pts was intravenous (drug addicts), whereas sexual in
the rest of patients.
Results: However no statistically signiﬁcant difference in BAO between
the two groups was noted, statistically signiﬁcant decrease in gastric
secretion /p<0.05/ was found in group 1 in comparison to group 2 (MAO
11.8vs18.3; PAO 14.8vs22.7mmol HCl/h). Such relationship appeared to
be much more evident in pts infected via sexual route (MAO 7.4vs20;
PAO 9.3vs25). Gastric juice culture in pts with MAO<10mmol HCl/h
in comparison to the rest of pts, revealed more frequent signiﬁcant
growth of both fungi (58%vs32%) and bacteria (33%vs8%). Pts with
fungal colonisation >104 CFU/mL had lower BAO (1.8vs3.3), MAO
(11.2vs17.5) and PAO (14.5vs21.5) in comparison to the rest of pts.
Similarly, pts with bacterial colonisation >104CFU/mL had lower BAO
(1.3vs3.0), MAO (8.8vs16.1) and PAO (11.2vs20.1). No statistically
signiﬁcant correlation was found between bacterial colonisation and
histological changes in gastric mucosa except for higher prevalence
of chronic active gastritis in corpus of stomach /p<0.05/. Fungal
colonisation correlated with higher prevalence of chronic non-active
gastritis in corpus of stomach /p<0.01/.
Conclusions: Signiﬁcant decrease in gastric secretion was found in
severely immunocompromised HIV-infected pts, provided they were not
intravenously infected drug addicts, followed by more frequent bacterial
colonisation which correlated with chronic active gastritis and fungal
colonisation which correlated with chronic non-active gastritis in corpus
of stomach.
P998 Differences in health resources use and associated cost
between HIV immigrants and Spaniards
M. Velasco, V. Castilla, L. Moreno, R. Hervas, J. Losa (Madrid, ES)
Objective: The speciﬁc impact of immigration on health services
utilisation and related cost have been hardly analysed. To compare
resource utilisation patterns among HIV-infected immigrants and
Spaniards and to estimate the direct healthcare costs of HIV/AIDS care
in both groups of patients we designed this study.
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Methods: All adult patients with HIV infection attended during the years
2003 – 2005 in a secondary teaching hospital. Immigrant was considered
a patient non-born in Spain. We evaluated episodes of health resource
consume: hospitalisation, any kind of out-patient visit, emergency room
visit without hospitalisation, any kind of hospital-day care, out-patient
surgery, and HAART dispensation. For the cost calculation, we used a
unitary cost for DRG per admission, ofﬁcially assigned standard costs
for cost of individual out-patient and ER visits and real cost of Pharmacy.
We compared all variables between immigrant and Spaniards.
Results: During the period of study 372 patients were attended, 12%
immigrants. They generated 9662 episodes of health resources consume,
11.4% from immigrants. Number of hospital admissions per patient was
higher in immigrants 1.3 (4.4) than Spaniards 0.9 (2.7), p = 0.03. There
were no differences in case-mix 2.2 (1.4) and 2.1 (1) and unitary cost per
admission (1511 and 1539€), number 9.2 (8.8) vs 9.8 (11.8) p = 0.85 and
cost (46.9 (18.6) vs 45.3 (18.9) € p = 0.1) of out-patients visits per patient
and ER visits (1.6 (1.7) vs 2.7 (4) p = 0.26 and ER cost per patient (94.1
vs 157.8 € p = 0.33) between immigrants and Spaniards respectively. The
cost of HAART per patient was slightly higher in Spaniards 7351.8€ than
immigrants 7153.9€, p = 0.01. The proportional distribution of health
resources use was different: hospitalisation was more used in immigrants
and ER visits in Spaniards. The global distribution of cost was similar
between both groups, and 75% were attributed to HAART. Total cost
per patient did not differ between both groups.
Conclusions: There were no major differences in the use of health
resource and associated cost between immigrants and Spaniards, except
for a higher use of hospitalisation in immigrant population. HAART
dispensation is the main health resource used and principal reason for
expense in both groups.
P999 HIV-associated pulmonary hypertension: to screen or not to
screen?
S. Cicalini, P. Chinello, F. Lisena, N. Petrosillo and the Latium
Registry for HIV-associated Pulmonary Hypertension
Objectives: Pulmonary hypertension (PH) is a well-known cardio-
vascular disease with a poor prognosis that occurs in HIV-infected
patients with a frequency of 0.5% compared with the 0.02% in the
general population. On April 2004 in the Latium Italian Region,
with an estimate of 5000 HIV-infected subjects, a Registry of PH in
HIV-infected subjects was instituted. HIV-infected patients diagnosed
as having PH after undergoing a diagnostic algorithm for clinical
suspicion of PH, were enrolled in the Registry. The availability of new
therapeutic options for PH allowing a better prognosis led us to submit
to an echocardiographic screening HIV-infected asymptomatic subjects
followed-up at our outpatients clinic. Aim of this study was to estimate
the frequency of PH in HIV infected patients without cardiopulmonary
symptoms.
Methods: 510 consecutive HIV-infected outpatients with no symptoms
or signs of cardiopulmonary disease underwent echocardiography to
evaluate pulmonary systolic arterial pressure. Clinical characteristics
of HIV-PH asymptomatic patients were then compared with those of
symptomatic patients with HIV-PH enrolled in the Registry.
Results: Between April 2004 and November 2007, 23 out of 510 patients
(4.5%) were found to have an elevated PSAP. Four out 23 (4/510, 0.8%)
were classiﬁed as having HIV-PH according to Venice classiﬁcation.
Secondary causes of PH were identiﬁed in 16 patients. Three patients
are still undergoing diagnostic procedure for classiﬁcation of PH. Data
on asymptomatic and symptomatic HIV-PH patients are shown in table 1.
Conclusions: HIV-PH could be more frequent than expected, and
probably latent for many years. Since PH could complicate the course
of HIV infection regardless the degree of immunosuppression, and
represents a signiﬁcant cause of morbility and mortality, a systematic
cardiopulmonary evaluation and follow up should be incorporated in the
clinical management of HIV infected patients. An early diagnosis and a
proper follow-up could ameliorate the prognosis of PH.
Table 1
Symptomatic
patients (N = 15)
Asymptomatic
patients (N = 4)
p
Gender
Males 9 4 0.2
Females 6 0
Agea (years) 42±9 38±4 0.2
CD4+T-lymphocytesa (cells/mmc) 282±187 179±106 0.2
HIV-RNAa (copies/ml) 115,584±185,984 1202±825 0.03
PSAPba (mmHg) 67±19 49±13 0.06
HAARTc
Yes 6 3 0.3
No 9 1
Mortality
Yes 4 0 0.3
No 11 4
aMean±SD; bPSAP: pulmonary systolic pressure; cHAART: highly active anti-
retroviral therapy.
P1000 Relationships between urinary IL-18, MMP-9 and BMP-7
concentration and renal lesion in HIV-1 infected patients
M.M. Dabrowska, A. Wiercinska-Drapalo, E. Siwak, R. Kranc,
R. Flisiak (Bialystok, PL)
Objectives: HIV infection of glomerular endothelial and mesangial
cells can cause progressive renal lesion. IL-18 and MMP-9 which are
overexpressed during an HIV-1 infection can stimulate proinﬂammatory
response in the kidney, which can be counterbalanced by increased
production of BMP-7.
Methods: A cross-sectional study was performed in 76 HIV (+) patients
(57 male, 19 female, aged from 20 to 59 years, 58 on HAART) and
17 HIV (−) volunteers. Plasma HIV-1 RNA was evaluated using the
Amplicor system. Urinary IL-18, MMP-9 and BMP-7 concentration
was measured by ELISA (Ray Bio and R&D Systems respectively).
Creatine clearance was calculated by using of Cockroft-Gault formula.
In statistical analyses U Mann-Whitney and Spearman correlation tests
were used.
Results: We observed the increase in urinary MMP-9 and the decrease
in urinary IL-18 in HIV (+) patients in comparison to control group
(6.09±1.39 v. 4.5±0.94 ng/ml, p<0.05 and 15.28±2.54 v. 42.66±11.02
pg/ml, p<0.05). There were no signiﬁcant differences in urinary BMP-7
regarding to HIV (−) group (2.61±0.54 v. 3.16±0.68 pg/ml, p = 0.09).
No signiﬁcant correlation was found beetwen CDC classiﬁcation and
urinary IL-18, MMP-9 and BMP-7 concentration. The mean urinary
MMP-9 concentration observed in patients undergoing HAART was
signiﬁcantly lower than in patients without ARV treatment (4.97±0.98 v.
10.18±4.76 ng/ml, p<0.05). HIV-1 RNA was positively correlated with
urinary MMP-9 concentration in HIV (+) (r=0.29, p<0.05). Moreover
urinary MMP-9 concentration was positively correlated with urinary
BMP-7 concentration (r=0.34, p = 0.005) and negatively correlated with
creatine clearance (r=-0.32, p<0.05) in studied population.
Conclusion: Increased urinary MMP-9 concentration is associated with
plasma HIV viral load and could be a new biomarker of subclinical renal
lesion. MMP-9 augment together with BMP-7 increase may be explained
by compensatory protection mechanism against renal damage.
P1001 Heart rate variability in AIDS-patients co-infected with
T. cruzi
D. Correia, R.J. Molina, L.A. Resende, S.F.N. Oliveira, F.F. Neves,
V. Silva (Uberaba, BR)
Background: Chagas disease caused by the protozoan Trypanosoma
cruzi and transmitted by the triatomid bugs is highly prevalent in
almost all Latin and Central American countries affecting between 11–
13 million peolple. HIV infection is also high widespread in such
countries. Cardiac autonomic impairment has been well characterised
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in chronic chagasic cardiomyophaty as well as in HIV/AIDS related
heart involvement.
Objectives: Evaluate the cardiac autonomic function by using the
computarised analysis of heart rate variability in patients with the co-
infection HIV/Chagas disease.
Methods: With the ethical approval, we studied 57 patients, gender-
and age-matched, 19 (T. cruzi-HIV group), 19 (HIV group) and 19
(control group). A continuous ECG recording in DII lead was performed
in supine rest, cold face and passive tilt tests and R-R intervals were
acquired. The overall variability of R-R series was assessed in the time
and frequency domains using autoregressive power spectral analyses.
Results: The groups were similar regarding to gender and age. The
electrocardiographic’s analysis of mean values of R-R intervals did not
differ in the three studied groups (p= 0.814). In baseline, the HIV group
showed a statistically signiﬁcant increase of the low frequency area,
compared with the co-infected group (p = 0.01), a decrease of normalised
low frequency area, compared with co-infection group (p = 0.03), an
increase of the high frequency area compared with co-infected (p = 0.03).
The variance was signiﬁcantly higher in the co-infected group compaired
with the HIV-group (p = 0.03).
Conclusion: In baseline conditions, a shift of cardiac sympathovagal
balance, suggestive of an impairment of sympathetic modulation, was
detected in patients with the T. cruzi/HIV co-infection.
Table 1: R−R intervals, Variance and Spectral Components in Control, HIV and
T. cruzi/HIV groups in baseline
Indices Control Group
(n = 19)
HIV
(n = 19)
T. cruzi/HIV
(n = 19)
P value
Mean RRi (ms) 856.72
(734–952.5)
854.05
(777.5–934.5)
824.52
(726.5–923.5)
NS
Variance (ms2) 439.77
(489.3–889.45)
3346.36
(3622–717)*
4591.5
(249.5–1245.5)#
0.03
LF (Hz) 124.57
(0.09−0.11)
0.09
(0.08−0.11)
0.08
(0.06−0.1)
NS
LF power (ms2) 152.13
(93.06–270.5)
826.26
(189.7–1104)*
980.7
(11.47–269.05)#
0.01
LF (n.u.) 27.76
(43.91–69.3)
42.05
(32.1–51.26)*
37.33
(15.93–58.07)*
0.03
HF (Hz) 58.08
(0.27−0.33)
0.29
(0.22−0.36)
0.31
(0.26−0.35)
NS
HF power (ms2) 73.77
(62.34–154.9)
823.17
(106.1–824.05)*
1713.97
(22.97–386.4)#
0.03
HF (n.u.) 17.02
(21.3–37.95)
34.45
(20.76–49.52)
36.11
(20.89–48.73)
NS
LF/HF ratio 2.37
(1.14−3.24)
1.72
(0.73−2.37)
2.95
(0.24−3.45)
NS
A one-way ANOVA was used for statistical comparisons. RRi: R−R intervals;
LF: Low frequency area; HF: High frequency area; LF n.u.: Low frequency area
in normalised units; HF n.u.: High frequency area in normalised units.
*p< 0.05 in comparison to Control Group; #p< 0.05 in comparison to HIV group.
P1002 Bloodstream infections among human HIV-infected adult
patients: epidemiology and risk factors for mortality
M. Ortega, M. Almela, A. Soriano, F. Marco, J. Martı´nez, J. Mallolas,
J. Gatell, A. Mun˜oz, J. Mensa (Barcelona, ES)
Background: Bloodstream infections are a frequent complication found
in HIV-infected patients and are usually associated with a poor prognosis.
Objectives: This study was undertaken to describe the epidemiology
and sensitivity pattern of pathogens causing community-acquired (CA)
and nosocomial (N) bloodstream infection (BSI) in adult HIV-infected
patients along the ﬁfteen last years, to establish risk factors for mortality
and hence to give guidance in the choice of empirical antimicrobials.
Methods: The type of study was a retrospective analysis of BSI episodes
prospectively collected through a blood culture surveillance program
from January 1991 to December 2006. We used non-conditional logistic
regression methods with death as dependent variable.
Results: 1,077 (6%) episodes of BSI occurred in HIV-infected patients
out of 16,946 total episodes in the period of study. CA and N BSI
were 634 (59%) and 443 (41%), respectively. S. pneumoniae and
S. aureus were the most frequent pathogens (n = 279, 44%) in CA BSI.
Coagulase negative staphylococci and S. aureus were the most frequent
microorganisms isolated in N cases (n = 369, 38%). Cotrimoxazole
resistance was common in CA and N BSI caused by Gram-negative
bacilli (50% and 61%, respectively). However, resistance rates to
ceftriaxone were low (3%). Crude mortality accounted for 140 cases
(13%). The independent risk factors associated with mortality were:
liver cirrhosis (OR: 2.90, 95%CI: 1.55–5.41, p= 0.001), corticosteroids
treatment (OR: 3.51, 95%CI: 1.87–6.56, p< 0.001), neutropenia (OR:
2.21, 95%CI: 1.15–4.23, p= 0.02), inappropriate empirical therapy (OR:
2.44, 95%CI: 1.29–4.65, p= 0.006) and isolate of C. albicans (OR: 7.58,
95%CI: 1.61–35.65, p= 0.010).
Conclusions: BSI in adult HIV-infected patients was often caused by
Gram-positive pathogens in both CA and N settings. An inappropriate
empirical therapy and the presence of other immunosuppressive factors
were independent risk factors for mortality. Ceftriaxone could be used
as the initial empiric therapy for HIV-infected patients with suspected
CA BSI.
P1003 Clinical performance of FXG:RESP (Asp +) assay for
Pneumocystis jirovecii on respiratory specimens
P. Hauser, K. Lagrou, X. Cui, C. Lass-Florl, D.S. Perlin, S. Park,
J. Maertens, M. Hughes, P. Bowyer, D.W. Denning, J. Bille (Lausanne,
CH; Leuven, BE; Manchester, UK; Innsbruck, AT; Newark, US)
Objectives: Pneumocystis pneumonia continues to be a common
infection in HIV patients and also occurs in other immunocompromised
patients. Early diagnosis is known to improve outcome, and speciﬁcally,
exclusion of the diagnosis, reduces the need for toxic empirical high
dose cotrimoxazole therapy. Real-Time PCR offers the prospect of
faster and highly sensitive detection of P. jirovecii. FXG:RESP (Asp +)
[Myconostica, UK] is a test kit that detects both P. jirovecii and
Aspergillus spp., utilising molecular beacons. In this report we focus
on the clinical performance for P. jirovecii.
Methods: The FXG:RESP (Asp +) real-time PCR kit utilises the large
subunit mtRNA gene as a target to detect P. jirovecii and the assay is
highly sensitive, being able to detect 6 target copies. The assay appears
to be speciﬁc for Pneumocystis spp., with the possible exception of
Fusarium solani. It was tested blindly on 196 BAL samples, collected
from 4 European hospitals. All results were compared to microscopy,
usually Calcoﬂuor or Gomori methanamine silver stains, performed
shortly after the sample was collected, and in non-AIDS patients
whether patient was treated for PCP. Most HIV/AIDS samples had been
previously extracted and stored frozen as DNA; the remainder were
extracted with the MycXtra™ fungal DNA extraction kit, having been
stored frozen unprocessed.
Results: The kit contains an internal ampliﬁcation control to detect
potential inhibition of the PCR reaction and 6 (3%) of the clinical
samples showed evidence of inhibition. These results were excluded
from analysis, although 5 were positive by both microscopy and the
FXG:RESP (Asp +) assay, and would be reported clinically. 42 samples
were from HIV/AIDS patients and 148 from other patients, mostly
with leukaemia. With respect to Pneumocystis detection, the FXG:RESP
(Asp +) assay had good performance with a sensitivity of 97.4%,
speciﬁcity of 92.9%, positive and negative predictive values of 90.4%
and 98.1%. 8 samples had negative microscopy but very high FXG assay
signals, suggesting that the microscopy was falsely negative, as reported
in prior literature. These were reported as false positives
Conclusions: The clinical performance of the FXG:RESP (Asp +) assay
for the diagnosis of Pneumocystis pneumonia is superb. Overall the speed
of detection and sensitivity of the FXG:RESP (Asp +) assay should bring
substantial clinical beneﬁts. Prospective and supportive clinical trials are
ongoing.
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P1004 Effectiveness of vaccination against HBV infection in
HIV-infected persons
A. Kalinowska-Nowak, T. Mach, M. Bociaga-Jasik, A. Garlicki,
P. Skwara (Cracow, PL)
Objectives: The aim of the study was assessment of the efﬁcacy of
the standard vaccination against HBV among HIV infected patients and
vaccination with additional doses in patients who did not develop the
protective level of antibody after the initial vaccination. Inﬂuence of the
stage of HIV infection was analysed.
Methods: 54 HIV infected individuals, 20 women (37%) and 34 men
(63%), mean age 32 years were analysed. 32 patients (59.6%) were
treated with antiretroviral drugs. Stage of HIV infection was assessed
on the basis of data derived from medical records and immunological
status at the moment of introduction of vaccination (CD4 cells count,
viral load). Efﬁcacy of vaccination was compared with control group
(56 healthy volunteers). In both groups hepatitis B virus infection was
excluded by serologic tests. HBvaxPro vaccine produced by Merck Sharp
& Dohme Company, dose registered for adults was injected at month
0−1-6. Patients with anti-HBs < 10 IU/l have received booster doses of
vaccine month intervals, no more then three.
Results: Protective level of antibodies was found in 52 (92.9%) persons
from control group and 32 (63%) HIV infected individuals. Anti-HBs
> 100 IU/l was twice more common in control group (80%) than in
investigated group (46.3%) (p<0.001). Protective level of anti-HBs had
14.3% patients with CD4 below 200 cells/ml, none of them had anti-HBs
> 100 IU/l. Patients with higher CD4 cell count had better response for
vaccination (p = 0.015). Differences between patients with high and low
viral load were not statistically signiﬁcant (p = 0.015) but patients with
viral load below 10 000 copies/ml had slightly better response then those
with higher viral load. Efﬁcacy of vaccination was also associated with
the level of distraction of immunological system before introduction
of HAART (patients with CD4 < 200 cells/ml or HIV-RNA > 50 000
copies/ml had worst immunological response for vaccination). After the
ﬁst additional dose of vaccine anti-HBs > 10 IU/l had 79.7% patients,
87.1% after the second dose and 90.7% after the third dose. Anti-HBs
> 100 IU/l had subsequently 57.4%, 66.7%, 79.6% patients.
Conclusions: Effectiveness of the routine vaccination schedule was
lower among HIV individuals in comparison with healthy volunteers.
Inﬂuence of the progression of HIV infection on the response for
vaccination was detected. Additional vaccine’s doses have improved
efﬁcacy of immunisation which was comparable with general population.
P1005 Factors associated with presence of isolated anti-HBc
antibody in HIV-infected persons in Taiwan
C-C. Hung, W-C. Ko, J-J. Tsai, C-E. Liu, W-W. Wong, S-C. Su,
M-W. Ho, S-H. Cheng, C-H. Yang, Y-H. Lin, W-J. Miao (Taipei, Tainan,
Kaohsiung, Chung-Hwa, Hsin-Chu, Taichung, Tao-Yuan, Hwa-Lien, TW)
Objectives: To determine factors associated with presence of isolated
anti-HBc antibody (positive anti-HBc antibody with negative HBsAg
and anti-HBs antibody) in HIV-infected persons in Taiwan where the
prevalence of chronic hepatitis B virus (HBV) infection is 15–20% in
the general population aged 25 years or greater and vertical transmission
is the major transmission route for HBV.
Methods: Clinical characteristics of 403 HIV-infected persons aged
15 years or greater who had an isolated anti-HBc antibody pattern
were compared with those of 943 HIV-infected persons who developed
protective HBV immunity after HBV exposure (negative HBsAg;
positive anti-HBs and anti-HBc antibody). HBV DNA was measured
in 68 persons with isolated anti-HBc antibody who had available serum
specimens. Among these 68 persons in whom 45 persons had available
anti-HBs titers, the relationship between HBV DNA load and anti-HBs
titer levels were analysed.
Results: In univariate analysis, factors associated with presence of
isolated anti-HBc antibody included older age (41 vs. 37 years, p<0.001),
sexual transmission route (66.6 vs. 60.1%, p = 0.033), lower median CD4
counts (203 vs. 295 cells/mgL, p<0.001), and high plasma HIV RNA
load (4.65 vs. 4.44 log10 copies/mL, p = 0.008); HCV seropositivity
and intravenous drug use were not independent associated factors. In
multivariate analysis, independent associated factors were age (odds
ratio, 1.022, 95%CI 1.011−1.034) and a CD4 count less than 100
cells/mgL (odds ratio, 1.605, 95%CI 1.236–2.083). Among the 68
persons with isolated anti-HBc antibody and HBV DNA measurement,
14.7% had detectable HBV DNA. Of the 45 persons with isolated anti-
HBc antibody who had determinations of both anti-HBs antibody titers
and HBV DNA load, 38 (84.4%) had titers between 1 and 10 mIU/mL.
Only 13.2% of these 38 persons had detectable HBV DNA while 28.6%
of the 7 persons with anti-HBs titer less than 1 mIU/mL had detectable
HBV DNA load (p = 0.296).
Conclusion: We concluded that, different from what have been reported
by investigators in the Western countries that chronic HCV infection is
associated with isolated anti-HBc antibody pattern, age and CD4 counts
lower than 100 cells/£gL were associated with presence of isolated anti-
HBc antibody in HIV-infected persons in Taiwan, and compromised
immunity with subsequently waning of anti-HBs titers might play a role.
P1006 Characteristics of patients with a short delay between the
ﬁrst HIV-positive screening test and the diagnosis of AIDS
at Lyon University Hospitals, France from 1985 to 2007
D. Baratin, D. Peyramond, C. Trepo, J.L. Touraine, C. Chidiac,
P. Vanhems (Lyon, FR)
Objectives: A diagnosis of AIDS shortly after a detection of HIV
antibodies suggests a long lasting course of disease without treatment.
To explore a late access to care, we studied the factors associated with
a short delay (Sh.D) between the ﬁrst HIV positive screening test and
AIDS.
Methods: Prospective anonymous cohort study of 2253 patients with
AIDS followed since 1985 to 2007 with conﬁrmed dates of the ﬁrst
HIV positive screening and AIDS (European AIDS deﬁnition) at Lyon
University Hospitals. Population was stratiﬁed into 2 groups according
to a delay > or 3 months (M) between the ﬁrst detection of HIV-1
antibodies and AIDS. Two periods before and after introducing HAART
(1996) were analysed. Multiple logistic regression was used to identify
the factors associated with a delay 3 months (Sh. D) based on their
odd-ratio (OR) and 95% conﬁdence interval (95%CI).
Results: A total of 736 individuals (32.7%) were in the Sh.D. group.
The multivariate analysis identiﬁed factors associated with a Sh.D:
age (per 1 year increase) OR 0.95, [95%CI 0.94−0.97], male gender
(OR 2.04, [95%CI 1.32−3.20]), heterosexual intercourse (OR 2.03 [CI
95%: 1.42−2.91]), injecting drug use (OR 0.30 [95%CI 0.15−0.58])
and other exposure of HIV infection (OR 2.31 [95%CI 1.49−3.56])
compared to homosexual intercourse, CD4 <100/mm3 at AIDS (OR
1.69 [95%CI 1.24−2.29]), Pneumocystis jirovecii pneumonia as initial
AIDS event (OR 1.84 [CI 95% 1.15−2.92]), oesophageal candidiasis
(OR 0.37 [95%CI 0.21−0.64], lymphoma (OR 0.32 [95%CI 0.16−0.64]
compared to Kaposi’s sarcoma diagnosis, AIDS diagnosis after 1996 (OR
3.96 [95%CI 2.88.-5.44]) and two simultaneous opportunistic infections
at AIDS (OR 1.55; 95%CI 1.08−2.21) compared to one.
Conclusion: Gender, route of infection, age at ﬁrst positive screening,
recent years of AIDS diagnosis and an advanced immunosuppression
were independently associated with a Sh.D between HIV-1 infection
detection and AIDS. These results provide opportunities to plane
interventions to populations who are most likely to access lately to care
after HIV infection. The reasons of a late access to care need to be
explored urgently for individual and public health beneﬁts
P1007 Seasonal variation of Pneumocystis jirovecii infection:
analysis of underlying climatic factors
A. Sing, S. Schmoldt, M. Wildner (Oberschleissheim, Munich, DE)
Objectives: Pneumocystis jirovecii pneumonia (PCP) represents a seri-
ous opportunistic infection in immunocompromised patients. However,
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the modes of transmission are still not completely elucidated. Seasonal
changes of PCP incidence might be associated with climate changes.
Therefore, we explored the relationship between PCP incidence and
climatic factors.
Methods: Between April 1992 and December 2006, 576 microscopically
conﬁrmed cases of PCP were diagnosed at the Max von Pettenkofer-
Institute serving the major hospitals in Munich, Germany, for laboratory
diagnosis of P. jirovecii. The monthly incidence of PCP – both for
the pre- and post-HAART area, respectively – were correlated with
the three most important monthly weather data for Munich obtained
from the German Weather Service., i.e. mean temperature (ºC), height
of precipitation as a measurement for rainfall activity (mm) and
wind strength (Bft). Statistical methods used were bivariate graphical
exploration and multiple linear regression modelling of the inﬂuence
of weather parameters on the monthly incidence rates as dependent
variable with adjustment for mean annual incidence and logarithmic
transformation to achieve normal distribution.
Results: While there was a clear seasonal pattern in PCP incidence
with two peaks in May and August, no signiﬁcant correlation was
found between PCP incidence and rainfall activity or wind strength. In
contrast, PCP incidence was positively correlated with the mean monthly
temperature. This correlation seems to be more pronounced in the post-
HAART area than in the pre-HAART period.
Conclusion: To our knowledge, this is the ﬁrst study using multiple
linear regression statistics on monthly climatic data. In contrast to
previous and more descriptive studies from Spain and the UK showing
season-related PCP incidence patterns with maxima in the winter
months – as it is known from other infectious respiratory diseases,
we found an opposite incidence pattern with PCP incidence maxima
in late spring and summer. Moreover, PCP incidence was positively
correlated with the mean temperature. Possible explanations for this
seasonal variety of PCP incidence will be discussed.
P1008 Anti-R7V antibodies prevalence in HIV-infected patients
followed in the ambulatory care centre of a university
hospital, Cotonou, Benin
E. Laﬁa, M. Houeze, M. Zannou, A. Bigot, F. Guedou, S. Anagonou,
I. Zohoun (Cotonou, BJ)
Background and Objectives: A cellular epitope (R7V) is acquired
by HIV when the virus is released by budding. All known variants
present this epitope at their external membrane. Induced anti-R7V
antibodies were described in vitro to neutralise cell infection. Research
also indicated an association between the slow or non progressor status
of HIV infected patients and presence of anti-R7V Ab.
Objectives were to determine the prevalence of anti-R7V Ab in HIV
patients followed in the Ambulatory Care Centre at the University
Hospital of Cotonou, Benin, and to assess the relationship of the Ab
with the clinical status of patients.
Methods: A cross-sectional study was carried out from May to
November 2007. 131 consenting patients were enrolled (average age
was 36 and sex ratio=0.5). Blood specimens were drawn at the inclusion
visit; serum sample was collected, coded and stored at −20ºC until
anonymous testing. Samples were tested for anti-R7V by ELISA (Ivagen,
Bernis, France). The statistical Pearson chi2 test was used to compare
the presence of anti-R7V Ab and the variables, clinical status of the
patients and treatment.
Results: For 114 patients among the 131, date of HIV diagnosis ranged
from February 1999 to August 2007. Mode of contamination was
unknown for all patients.
Anti-R7V Ab were found in 90.4% of patients HIV-diagnosed in 2006,
in comparison of whose diagnosed in 2004 (43.4%), p<0.01. The
prevalence of Ab was also highly signiﬁcant (p<0.01) in the group of
60 asymptomatic patients (83.3%) versus the group of 71 symptomatic
patients (59.1%). Less anti-R7V positive results were observed for
patients under ARV treatment (53.2%) than for naive patients (85.5%),
p<0.001. No difference was shown between immunocompromised
patients (CD4 200 cells/mm3) and patients with no decline of CD4
(500 cells/mm3).
Conclusion: Prevalence study of the anti-R7V Ab in 131 HIV-infected
patients showed: i) ARV treatment decreased the level of the Ab, as
previously described; ii) it seems that there is no relationship with the
immunocompromised status and decrease in the presence of Ab; iii) anti-
R7V Ab are highly more frequent in HIV patients always asymptomatic,
for whom the detection of this humoral marker could be recommended.
A follow-up of the patients who tested positive for anti-R7V Ab will
enable to determine whether the presence of Ab is predictive of a slower
progression, or non progression toward AIDS.
P1009 Molecular epidemiology of HIV-1 in newly diagnosed
patients in southern Spain
M.J. McConnell, F. Docobo-Perez, R. Mata, F. Fernandez-Cuenca,
P. Viciana, L.F. Lopez-Cortes, M. Trastoy, J. Pachon, P. Perez-Romero
(Seville, ES)
Objective: To characterise the subtype diversity and determine the
prevalence of resistance mutations in the reverse transcriptase (RT) and
protease (PR) regions of pol in treatment-naive individuals at a tertiary
medical centre in western Andalucia from 2004 to 2006.
Methods: We included 72 HIV-infected, treatment-naive patients
receiving care in our Hospital. Patients were categorised as either recently
infected or chronically infected. Patient age, sex, risk factor, coinfection
status (hepatitis B and C), viral load, and CD4+ T cell counts were
determined at the time of diagnosis. Plasma HIV RNA was quantiﬁed
using the Amplicor HIV-1 Monitor Test 1.5. Viral sequences were
ampliﬁed and the data were used to determine the subtype diversity,
prevalence of resistance mutations in the RT and PR genes and for
phylogenetic analysis.
Results: The subtype B virus was present in 88.9% of the individuals,
9.7% were infected with the circulating recombinant form CRF-02AG,
and 1.4% with the subtype recombinant B/G. Of 17 newly infected
patients 88.2% were infected with sybtype B, 5.9% were infected with
CRF02-AG, and 5.9% with B/G. Of 55 chronically infected patients
89.1% were infected with subtype B and 10.9% were infected with
CRF-02AG. Interestingly, 6 of the 20 individuals (30%) identifying
heterosexual contact as their primary risk factor were infected with
CRF02-AG, whereas only 1 of 43 individuals (2.3%) identifying
homosexual contact as their primary risk factor were infected with
CRF02-AG (p<0.01 chi-squared). One resistance-associated mutations
(RAM) in either the RT or PR genes was present in 86.1% and 83.3%
had RAM to one class of antiretroviral drug, whereas 2.9% contained
RAM to two classes of antiretroviral drugs. No isolates had mutations
associated with resistance to all three drug classes. No primary resistance
mutations within the PR gene were observed. However, 86.1% contained
at least one secondary mutation within the PR gene associated with PI
resistance. M36I (41.7%) and L63P (48.6%), were the most common.
Mutations in the RT region were less prevalent than in the PR region.
Only two isolates had mutations in RT associated with resistance to
NRTIs or NNRTIs. K103N mutation was present in 2.8%, while Y188C
was present in 1.4%.
Conclusion: These results elucidate the subtype diversity present in this
region and suggest that the transmission of highly resistant virus variants
is not occurring at a high frequency in this population.
P1010 Prevalence of CCR5, CCR2 and SDF1 genotypes in general
population and HIV seropositive individuals in Georgia
M. Karchava, N. Gochitashvili, N. Dvali, N. Badridze, T. Tsertsvadze
(Tbilisi, GE)
Objectives: Host genetic factors might be one of the factors determining
the rate and severity of HIV epidemic in particular country, and also is an
important host factor for pathogenesis and natural history of HIV disease.
Unlike CCR5 delta32 mutation, mutation CCR2–64I and SDF1−3A do
not provide protection against HIV infection, but still play a role in the
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HIV disease progression. The prevalence of HIV in Georgia remains
very low (0.01% in general population, about 1% in IDUs). Taking into
consideration high prevalence of HCV and HBV infections in general
population (6% and 4% respectively) and even higher in high risk groups
(in IDUs 68 and 59% respectively) in our country low prevalence of HIV
is unexpected. Moreover, there is high rate of IDU and STDs in Georgia;
and neighboring countries where high migration of Georgian population
takes place already have wide scale HIV epidemic. The objectives of
this study was to study the host genetic factors in the general population
and HIV infected individuals in order to study the correlations between
CCR5delta 32, CCR-64I and SDF1−3A genotypes and resistance to HIV
infection and/or disease progression in our country.
Material and Methods: A cross-sectional study design was utilised
to examine CCR5, CCR2 and SDF1 genetic variants. 139 persons
representing a non pregnant general adult population and 120 HIV
infected individuals were enrolled in the study. Mutations were
detected by the polymerase chain reaction/restriction fragment length
polymorphism method.
Results: Of 139 individuals from general population 2.8% were caring
mutations in both CCR5 genes. However, overall allele frequency
(6.37) was similar to the frequency among European population. No
homozygous mutation was found among HIV infected group and the
allele frequency was equal to 2.5. Allele frequency of CCR2 and
SDF1 allele was 14.9 and 10.75 and 36.7 and 32 among two groups
respectively.
Conclusions: The frequency of CCR2 and CCR5 mutations is
comparable to the frequency among European population; however, the
rate of homozygous mutated CCR5 delta gene is among the highest.
Moreover, to our knowledge, the frequency of SDF1−3A allele frequency
in Georgians is among the highest ever reported (the highest rate reported
to date is 29.75 among Cretan Greeks). According to the results of our
study the frequency of those gene mutations partially might be a reason
for lower HIV prevalence in the county.
P1011 Seroprevalence of HIV in Russia (1987–2006)
A. Khryanin, V. Reshetnikov (Novosibirsk, RU)
Objective: Currently the spread of HIV infection is acquiring an
epidemic pattern in Russia. Thus, HIV incidence rates increased 24-fold
in 2001, and the cumulative number of HIV cases reported in the country
increased ten-fold compared to 1997–1998.The aim of the present study
was to analyse the epidemiology of HIV infection in Western (WS) and
Eastern (ES) Siberia over the period from 1987 through 2006.
Methods: Siberia consists of 14 administrative regions with total
population of 32 115 697 citizens, which is about one fourth of total
Russian population. The data from district STD clinics were obtained
and registered in the departments of social statistics of the regional
committees of statistics.
Results: HIV incidence rate in Siberia accounts for 17.0% of all HIV
infected persons in Russian Federation. Additionally, the HIV incidence
rate is higher than average in Russia by 13.1 percent. Trends in the
incidence of HIV infection are shown in the Table (number of reported
cases in Russia).
In 2002, HIV incidence rates in Irkutsk and Novosibirsk were 102.1
and 8.9 (per 100 000 inhabitants), respectively. More than 50% of all
HIV cases were reported from intravenous drug users aged 19–29 years
in 2004 (in comparison 80% in 2000). Males comprise 70% of newly
diagnosed HIV cases. Sexual transmission was reported in 4.7% in 1999
and 54.3% in 2004. The sexual/intravenous routes ratio was 1/1.7 in 2004
(in comparison 1/21 in 1999).
1987–1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Russia 7.02 10.95 26.41 79.88 173.00 226.00 264.99 303.27 331.55 385.30
Siberia 226 493 5.46 12.88 24.39 31.29 35.69 39.97 44.41 49.53
Novosibirsk (WS) 16 29 48 167 361 600 768 918 1.08 1.45
Irkutsk (ES) 22 47 3.29 7.99 11.56 14.06 15.65 17.38 19.43 21.50
Conclusion: At present HIV epidemic unevenly spreads in the Siberian
region. There reservoirs of infection are already formed in some
administrative territories such as Irkutsk (ES). As for Novosibirsk (WS),
the process of formation is under way. Local intervention programmes
are urgently needed to prevent the forthcoming HIV epidemic in Siberia.
P1012 Trend of prevalence of human immunodeﬁency virus type
1(HIV-1) non-B aubtypes in Galicia, northwestern Spain
J. Rodriguez-Calvin˜o, S. Cortizo-Vidal, L. Rodriguez-Otero,
D. Gutierrez, P. Romero-Jung, A. Prieto, E. Varela, A. Aguilera-Guirao,
B. Regueiro (Santiago de Compostela, ES)
Objectives: HIV-1 non-B subtypes plays an important role in the
HIV epidemic and its prevalence has increased throughout the years.
Understanding the cause of this increase is important for public health
strategies. The aim of this study was to observe the trend of prevalence
of HIV-1 non B genotypes in Galicia (North West of Spain) between
2003 and 2007.
Methods: In a prospective study in Santiago de Compostela, from a
total of 322 newly diagnosticated HIV patients, we deﬁned subtypes
by partial sequencing of the polimerase gene by means of automated
sequencing (CEQ 2000 system, Beckman Coulter Inc) and phylogenetic
analysis using the geno2pheno program (Max Planck Institut Informatic,
http://www.geno2pheno.org).
Results: The subtype B was the most frequently isolated. The non-B
subtypes proportion found between our patients were the following: non
recombinant subtypes A, C, D, F and G (45.83%) and recombinant
subtypes AE, AG, BF and BG (54.17%). Subtypes AG and D were
the most prevalent and there were no diferences in relatives frequences
of recombinant and non recombinant subtypes over the years. In newly
diagnosticated HIV patients, the prevalence of non-B subtype viruses
was: 3.17% in 2003, 2.59% in 2004, 1.49% in 2005, 12.72% in 2006
and 11.66% in 2007.
Conclusion: The present data suggest that a signiﬁcant trend to higher
prevalence in patients infected with non-B subtypes was observed and it
became more intense for the two last years; however, HIV subtype B is
still the most commonly found. On the other hand, comparing between
the non-B subtypes we conclude that there are a similar proportion of
recombinant and non recombinant non-B sybtypes.
P1013 Structural analysis of the RNA region preceding Gag start
codon in HIV-1 type A variants circulating in Russia
I. Lapovok, E. Kazennova, M. Bobkova (Moscow, RU)
Objectives: There are three stem-loops in 5′-untranslated region of
HIV-1 RNA playing important roles in viral replication: apical loop
of DIS hairpin required for dimerisation of genomic RNA, SD hairpin
essential for the generation of subgenomic mRNA and ø hairpin being
the major determinant for speciﬁc packaging of virus-like particles.
These hairpins are located in the region of approximately 100 nt length
preceding Gag start codon.
The purpose of the study was to compare the structure of this region
in different genetic HIV-1 subtype A variants characteristic for Russia
among them the strains carrying the pol gene mutations A62V, V77I,
A62V/V77I and no mutations (wild type).
Methods: We have studied 12 samples of PMBC from HIV-infected
individuals belonging to four pol gene groups. Prior analysis of genes
gag and env found HIV-1 subtype A in these patients. Sequences of the
region preceding Gag start codon (650 bp) in nested PCR products were
generated.
Results: We have found that the apical loop of DIS hairpin from almost
all samples of HIV-1 subtype A in Russia had the same palindrome
AG[GUGCAC]A typical for 84% samples of subtype A circulating in
the world. The only one sample with A62V mutation characteristic for
Russia had the palindrome structure GG[GUGCAC]A. One sample of
wild type virus had the palindrome structure AG[GUGCAC]G. There
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were no special features in the structure of SD and ø hairpins in Russian
samples.
Conclusion: The substitution of A to G in one of three purine residues
ﬂanking the palindrome may play the essential role in the forming of
structure “kissing-loop” of double genomic RNA of HIV-1. Our data also
demonstrate that the structure of SD and ø hairpins is very conservative
in HIV-1 subtype A. The structural peculiarities of the apical loop of
DIS hairpins can be used in genotyping of virus subtype A.
P1014 Inﬂuence of p38 MAPK isoforms (alpha, beta, gamma
and delta) in apoptosis induced by HIV-1 in CD4+ T
lymphocyte-based cell lines
D. Gutierrez-Sanmartin, E. Varela-Ledo, A. Aguilera-Guirao,
S. Romero-Yuste, P. Romero-Jung, A. Gomez-Tato, B.J. Regueiro
(Santiago de Compostela, Pontevedra, ES)
Background: The CD4+ T cell reduction characteristic of HIV-1
infection is thought to result, in addition from infected T cell death,
mainly from uninfected bystander T cell apoptosis. Nevertheless, the
immunologic and virologic mechanisms leading to T cell death during
HIV-1 infection are not yet fully understood.
Objective: In the present study we analyse the individual implication of
the p38 mitogen-activated protein kinase (MAPK) isoforms (alpha, beta,
gamma and delta) in apoptosis induced by HIV-1, taking into account
that HIV-1 replication is known to be blocked by p38 inhibitors.
Methods: We used the SupT1 cell line where death induced by HIV-1
mainly happened by uninfected bystander cell apoptosis. A variety
of SupT1-based cell lines were constructed constitutively expressing,
under the control of cytomegalovirus promoter (PCMV), each dominant-
negative p38 isoform and each wild-type p38 isoform as control. An
EGFP marker gene, under the control of the HIV-1 promoter, was
inserted in all of them. These cell lines were infected with HIV-1 and
analysed by ﬂow citometry.
Results: We found that survival in SupT1-based cell lines infected by
HIV-1 was increased by dominant-negative p38alpha, p38gamma and
p38delta isoforms, but not by the dominant-negative p38beta isoform.
HIV-1 replication was delayed most by the dominant-negative p38delta
isoform and to a lesser extent by dominant-negative p38alpha and
p38gamma isoforms. Moreover, these three dominant-negative isoforms
reduced apoptosis induced by HIV-1 in both infected and bystander cells.
Conclusions: These results suggest that, in SupT1 cell line, p38alpha,
p38gamma and p38delta, but not p38beta, are implicated in HIV-1
replication and apoptosis induced by HIV-1 in infected and bystander
cells.
P1015 HIV-1 induces apoptosis in primary osteoblasts and HOBIT
cells through TNF-a activation
M.C. Re, E. De Crignis, C. Ponti, L. Cimatti, M. Borderi, M. Tschon,
D. Gibellini (Bologna, Trieste, Italy, IT)
Background: Several HIV-1 infected patients show bone loss and
osteopenia/osteoporosis during the course of disease. The mechanisms
underlying this degenerative process are largely unsettled and the
relantionship between HIV-1 and osteoblasts/osteoclasts cross-talk
regulation has not been yet investigated. The aim of our study is focused
on analysis of biological effects of HIV-1 on osteoblasts and osteoblast-
like HOBIT cells to determine the mechanisms involved in the bone loss
in the course of HIV-1 infection.
Methods: Human hipbone osteoblasts of patients were obtained from
commercial sources or isolated from HIV-1 negative patients enrolled
after giving their informed consent. HIV-1 DNA was determined by PCR
whereas RT-PCR was employed to determine viral RNA, cell membrane
markers and TNF-a mRNA. Flow cytometry procedures were used for
apoptosis and membrane markers analysis. TNF-a supernatant analysis
was performed by commercial kit.
Results: Primary osteoblasts and HOBIT osteoblast-like cell line were
challenged by speciﬁc HIV-1 X4 and R5 strains and proviral HIV-1
PCR analysis showed that these cells are not susceptible to infection.
On the other hand, HIV-1, heat-inactivated HIV-1 and HIV-1 gp120
treatment induced a signiﬁcant apoptotic process activation at 72–96
hours (p<0.01) that is tackled by soluble CD4 treatment suggesting an
interaction between gp120 and cell membrane proteins. Hence, CD4 and
co-receptors membrane protein and mRNA expression was assayed by
ﬂow cytometry and real time RT-PCR, respectively, in osteoblasts and
HOBIT. Although the CD4 and CXR4 mRNA was costantly detectable
in both the cell models, CD4 and CXR4 proteins are expressed at very
low density in a low percentage of cells (4−6% and 4% respectively)
whereas CCR5 is signiﬁcantly more expressed. Finally, we analysed
the mRNA and protein synthesis of TNF-a a pro-apoptotic factor in
osteoblasts biology. HIV-1, heat-inactivated HIV-1 and HIV-1 gp120
treatment induced both the TNF-a mRNA and supernatant protein
increase at 24–96 hours. Moreover, anti-TNF-a pretratment tackles the
apoptosis induction suggesting a direct role of TNF-a in the HIV-1
related activation of apoptotic process.
Conclusions: These results indicate that HIV-1 triggers apoptosis in
osteoblasts and HOBIT cells without infection but through the gp120
interaction with cell membrane suggesting a novel mechanism in the
HIV-1 related impairment of the bone mass structure homeostasis
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P1016 Caspofungin as ﬁrst-line therapy of invasive aspergillosis in
haematological patients: impact of baseline characteristics
on response rate at end of treatment and survival
J. Maertens, R. Herbrecht, H. Akan, L. Baila, C. Doyen, A. Gallamini,
A. Giagounidis, O. Marchetti, R. Martino, L. Meert, M. Paesmans,
L. Ameye, M. Shivaprakash, A. Ullmann, C. Viscoli for the Infectious
Diseases Group of the EORTC
Caspofungin (C) (70mg day 1 and 50mg daily thereafter) was evaluated
as ﬁrst-line therapy of probable/proven IA (ﬁrst trial ever to strictly
adhere to EORTC-MSG criteria) in 61 haematological pts receiving
either standard chemotherapy or autologous HSCT (EORTC trial 65041).
Conﬁrmation of diagnosis and assessment of efﬁcacy were performed by
a Data Review Committee (DRC). The primary efﬁcacy endpoint was the
proportion of patients with complete and partial response at the end of
C treatment (EOT), deﬁned with standard response assessment criteria.
Survival at day 84 was among the secondary endpoints.
In the Modiﬁed Intention to Treat analysis (including all patients with
proven/probable IA receiving > 1 day of C treatment), 38 of 61 pts
(62%) had acute leukaemia (mostly myeloid leukaemia) and 51 (85%)
were neutropenic (<500 cells/mm3) at study entry. Forty-six patients
(75%) had uncontrolled cancer. Median age was 64 years (range 19–
86). Fifty percent of patients had a Karnofsky score < 50. Median and
mean duration of C treatment were 15 and 27 days, respectively (3–84).
At EOT, 20 of 61 (33%) pts had a favourable outcome (95%CI 21%–
46%), while 9 (15%) and 31 (51%) had stable and worsening disease,
respectively. Survival at day 84 was 54% (33 of 61).
The response rate at EOT was not inﬂuenced by age, gender, type
of underlying haematological disease, status of the underlying disease,
certainty of diagnosis of IA, site of infection or presence of baseline
neutropenia; however, the median Karnofsky performance score at start
of C therapy was higher (p = 0.04) in patients with a favourable outcome
(median 70) compared to patients with an unfavourable outcome (median
50). Similarly, patients with stable disease had a higher performance
score (p = 0.02) compared to those without disease stabilisation.
Survival at day 84 was signiﬁcantly inﬂuenced by the status of the
haematological disease at start of C therapy (uncontrolled cancer 40%-
controlled cancer 93%; p<0.001) and by the Karnofsky score at baseline
(15% survival for score <50, 57% for a score 50–60 and 69% for score
>60; p = 0.009).
In conclusion, we identiﬁed Karnofsky performance score and status of
the underlying haematological disease as signiﬁcant baseline variables
for response at EOT and/or survival at day 84. In future clinical studies
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in IA, consideration should be given towards stratiﬁcation of patients
according to these baseline ﬁndings.
P1017 Caspofungin use in daily clinical practice for treatment of
invasive aspergillosis: results of a prospective observational
registry
J. Maertens, G. Egerer, W. Shin, D. Reichert, M. Stek, S. Chandwani,
M. Shivaprakash, C. Viscoli for the CAN-DO(IA) study team
Objective: To prospectively assess real world experience with Caspo-
fungin (C) administered as monotherapy or in combination therapy for
initial or salvage treatment of proven or probable invasive aspergillosis
(IA).
Methods: A prospective observational registry was developed to collect
data from patients treated with C for a single episode of IA. Information
was collected from Apr-06 to Sep-07. Clinical efﬁcacy was determined
by the local investigator as favorable (complete or partial) or unfavorable
(stable disease or failure) at the end of C therapy (EOCT).
Results: One hundred and three consecutive patients with proven or
probable IA (per EORTC/MSG criteria) were identiﬁed from 23 sites
in 11 countries. Outcomes were assessed in 101/103 patients since 2
patients were not discharged from the hospital at study termination.
The most frequent underlying conditions included malignancy (77%),
allogeneic hematopoietic stem cell transplantation (HSCT, 20%), solid
organ transplantation (SOT, 9%), autologous HSCT (8%), & HIV/AIDS
(3%). Neutropenia at start of C was recorded in 57% cases. Eighty three
patients (82%) were treated for probable IA. The majority (85%) of
patients had pulmonary IA. In culture-proven cases, A. fumigatus was
the most frequently isolated species followed by A. ﬂavus. The majority
of patients received C monotherapy (83%), primarily as salvage therapy
(86%). Most salvage treatment (74.2%) occurred in patients refractory
to prior antifungals. A favorable response at end of C treatment was seen
in 56% (57/101) of patients with similar favorable outcomes for C used
as combination therapy (56%; 9/16) or as monotherapy (57%; 48/85).
Favorable response rates in signiﬁcant subgroups were: malignancy 52%
(41/79); allogeneic HSCT: 57% (12/21); neutropenia: 53% (35/66).
Serious adverse events were reported in 4 cases (4%); only 2 patients
(2%) discontinued treatment due to a drug related AE (respiratory failure
& skin reaction). An overall survival rate of 73%(75/103) was observed
at the EOCT.
Conclusions: In daily clinical practice, an overall favorable response rate
of 56% was observed in patients with proven or probable IA treated with
C monotherapy or combination therapy. Also, a favorable response rate
of >50% was seen in high-risk patient sub groups, including those with
malignancy, allogeneic HSCT, and neutropenia. These real-life ﬁndings
are consistent with the ﬁndings observed in randomised clinical trials.
P1018 The use of caspofungin in neutropenic patients with
haematological malignancies and concomitant candidaemia
L. Pagano, L. Fianchi, R. Fanci, A. Candoni, M. Caira, A. Nosari,
S. Storti, M. Sanguinetti, M. Morselli, C.G. Valentini, M.E. Mitra,
M. Ofﬁdani, P. Viale (Rome, Florence, Udine, Milan, Campobasso,
Modena, Palermo, Ancona, IT)
Objective: To evaluate the efﬁcacy of caspofungin in neutropenic
patients (pts) with hematological malignancies (HM) and candidaemia
Design: The study was conducted in 8 Hematology divisions;
neutropenic HM pts with clinical evidence of infection and positive blood
culture for Candida were enrolled.
Patients and Results: Between January 2005 and November 2007, 22
episodes of candidaemia were registered. All the 22 enrolled patients
[M/F 16/6; median age 49 yo (range 19–71)] (11 AML, 4 ALL; 5
NHL, 2 MM) had received chemotherapy. Nine of them (41%) developed
candidaemia during a HSCT procedure (6 allogeneic and 3 autologous).
Before the infection onset and at start of caspofungin, all pts were
neutropenic (ANC<0.5×109/l) for a median average of 5 days (range
2–41). Other risk factors were: CVC (77%), steroids administration
(41%), mucositis (73%), diabetes (13%), Candida colonisation (36%).
Nine pts (41%) received systemic antifungal prophylaxis (5 ﬂuconazole,
2 itraconazole, 2 voriconazole) for an average of 13 days (4–60).
The most frequent symptoms were: fever (100%), dyspnoea (27%),
jaundice (13%), diarrhoea (13%), shock (13%). Candidaemia diagnosis
was made after a median time of 3 days (range 1–12) from the
onset of fever; Candida species isolated were: albicans 9 pts (41%),
parapsilosis 4 (18%), krusei 3 (14%), tropicalis 2 (9%), dubliniensis 1
(4.5%), guilliermondii 1 (4.5%), famata 1 (4.5%), lusitaniae 1 (4.5%).
Caspofungin at standard dosage was administered as front-line treatment
in 16 pts (73%); in the other 6 pts, previous antifungal therapy (3
L-AmB, 1 itraconazole, 1 ﬂuconazole, 1 voriconazole) was switched
to caspofungin after no more than 48 hours on treatment at candidaemia
diagnosis. The median duration of caspofungin therapy was 13 days
(range 6–26). No side effects (WHO >2) were registered. Antifungal
treatment was efﬁcacious with remission of fever and other symptoms
and negative blood cultures in 15 pts (68%). At 30 days following
candidaemia onset, 9 pts had died (41%), but the candidaemia was
responsible for the mortality in only 4 pts (overall attributable mortality
18%).
Conclusions: Our data, reporting the largest series of neutropenic HM
pts and concomitant candidaemia treated with caspofungin. This study
conﬁrms the efﬁcacy and safety of this approach in a subset of very
compromised pts similar to that reported in literature in non neutropenic
pts.
P1019 Efﬁcacy and safety of caspofungin monotherapy in cancer
patients with candidaemia
N.V. Sipsas, R.E. Lewis, I.I. Raad, D.P. Kontoyiannis (Houston, US)
Objective: There is a paucity of data regarding the efﬁcacy and safety
of caspofungin (CAS) in cancer patients with candidaemia.
Methods: We retrospectively reviewed the medical records of all
adult cancer patients with candidaemia (EORTC criteria) treated
with CAS monotherapy for at least 3 consecutive days at MD
Anderson Cancer Center (March 2001-February 2007). CAS was given
intravenously at 50mg /day after a 70mg loading dose. Demographic
characteristics, clinical and microbiological data, outcomes, minimal
inhibitory concentrations (MIC) of Candida isolates (CLSI method),
were recorded.
Results: We identiﬁed 65 such patients (20 or 31% had hematological
malignancies). The clinical response and mycological response after 7
days of CAS was 80% (51 patients) and 78% respectively. The overall
mortality was 5% for day 7, 12% for day 14, and 20% for day 30.
The 30-day Candida-attributable mortality was 11%. Bivariate analysis
showed that factors signiﬁcantly associated with crude 30 day mortality
were an APACHE II score >20, ICU admission, a positive culture of the
tip of the removed central venous catheter, especially when CFU/ml was
> 15, persistent fungaemia after initiation of treatment, and the presence
of intercurrent bacterial infection. The 30 day attributable mortality
in the 12 patients (18%) with ﬂuconazole-resistant or susceptible-dose
dependent Candida bloodstream isolates (MIC 8mg/ml) was 25% vs.
8% in the 53 patients with ﬂuconazole-susceptible Candida (p <0.05).
CAS was well tolerated.
Conclusion: Although selection of candidemic cancer patients who
received CAS monotherapy might account for the observed favorable
outcomes, in our experience CAS had comparable efﬁcacy and safety to
the ones described in candidemic patients without malignancy.
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P1020 Prospective, multicentre study of caspofungin for treatment
of documented fungal infections in paediatric patients
T. Zaoutis, H. Jafri, L. Huang, F. Locatelli, A. Barzilai, W. Ebell,
W. Steinbach, J. Bradley, J. Lieberman, C. Hsiao, N. Seibel, H. Laws,
M. Petrecz, A. Taylor, J. Chow, N. Kartsonis, A. Ngai (Philadelphia,
Dallas, US; Taipei, Kaohsiung, TW; Pavia, IT; Tel Hashomer, IL;
Durham, San Diego, Long Beach, Washington, West Point, US; Berlin,
Dusseldorf, DE)
Objective: A prospective open-label study was performed to obtain data
on the efﬁcacy & safety of caspofungin (CAS) in paediatric patients
(ped pts) with invasive candidiasis (IC), oesophageal candidiasis (EC),
or invasive aspergillosis (IA).
Methods: Ped pts ages 3 mos-17 yrs with proven IC, proven EC, or
proven/probable IA (EORTC/MSG criteria) received CAS at 50mg/m2
daily (70mg/m2 on Day 1) as either primary or salvage monotreatment
(max 70mg/day). Favourable responses required complete resolution
of clinical ﬁndings & microbiological (or radiographic/endoscopic)
eradication (complete response) or signiﬁcant improvement in these
parameters (partial response). The primary efﬁcacy assessment was at
end of CAS treatment (EOT) and included pts with a conﬁrmed diagnosis
and receipt of atleast 1 dose of CAS.
Results: Of the 49 pts (33 at 6 mos-11 yrs & 16 at 12–17 yrs) enrolled,
48 had conﬁrmed disease: 37 IC, 1 EC, & 10 IA. Most IC pts (35/37)
had candidaemia & received CAS as primary treatment (31/37). Most
pts with IA had pulmonary involvement (8/10, including 2 with >1 site
of infection). All pts with IA were refractory & received CAS as salvage
treatment. CAS was dosed for 2–87 days (median 10 & 38 days for IC
& IA, respectively). Success at EOT was 30/37 (81%) in IC, 1/1 in
EC, & 5/10 (50%) in IA. IC outcomes were generally similar across
Candida spp. No pt developed a serious drug-related adverse event or
discontinued CAS due to toxicity. All-cause mortality during treatment
or the 4-week posttreatment follow up period was 10%.
Conclusions: In this study, CAS was effective & generally well tolerated
in peds pts with IA or IC. Outcomes in peds pts are consistent with those
reported in adults.
P1021 Efﬁcacy of caspofungin compared to itraconazole as sec-
ondary antifungal prophylaxis: a multinational case registry
J. Vehreschild, M. Sieniawski, S. Reuter, D. Reichert, J. Maertens,
A. Bo¨hme, G. Silling, R. Martino, G. Maschmeyer, A. Ullmann,
O. Cornely (Cologne, Ulm, Oldenburg, DE; Leuven, BE; Frankfurt,
Mu¨nster, DE; Barcelona, ES; Potsdam, Mainz, DE)
Background: Patients surviving an invasive fungal infection (IFI) in
need of further cytoreductive chemotherapy are at high risk for recurrent
fungal infection. In the absence of randomised controlled trials on this
issue, applied prophylactic regimens are diverse and rely primarily on
the personal experience of the attending physician.
Methods: A multinational case registry of patients in need of
secondary antifungal prophylaxis has been conducted from October
2001 onwards. Patients with leukaemia or high-grade lymphoma and
a history of probable or proven IFI according to EORTC/MSG criteria
were analysed if undergoing an additional episode of neutropenia and
receiving prophylaxis with either itraconazole or caspofungin. Data
collected comprise demographics, underlying disease, ﬁrst episode of
IFI, antifungal prophylaxis, incidence and outcome of breakthrough IFI,
and survival.
Results: A total of 75 patients were evaluated, 47 receiving itraconazole
and 28 receiving caspofungin. Age, gender, underlying malignancy, type
and treatment of 1st IFI, and isolation measures were evenly distributed
between both groups. Treatment of underlying disease more often was
stem cell transplantation in the caspofungin group (21.3% vs 50%, P=
0.01). There were more patients with liver (0% and 25%, P = 0.001) or
spleen (0% and 14%, P = 0.017) involvement of 1st IFI, with uncontrolled
1st IFI (0% and 10.7%, P = 0.049), or uncontrolled malignancy (8.5%
and 32.1%, P = 0.012) in the caspofungin group. No signiﬁcant difference
for the occurrence of probable or proven breakthrough IFI (17.0% and
28.6%, P = 0.186) was observed. Treatment outcomes for recurrent IFI
and underlying disease were similar between both groups. Mortality
attributable to IFI (4.3% and 3.6%) and overall mortality (10.6% and
25%) were not different between both groups.
Conclusion: Both, itraconazole and caspofungin performed equally
efﬁcacious as secondary prophylaxis of IFI in high-risk patients. While
there was a trend towards higher risk of recurrent IFI and death in
the caspofungin group, these patients were at signiﬁcantly higher risk
probably inﬂuencing the choice of drug: They had a higher rate of
uncontrolled fungal and underlying diseases and underwent stem cell
transplantation more frequently. In spite of antifungal prophylaxis, risk
of breakthrough IFI was high. Prospective controlled trials are warranted
to deﬁne the best strategy of secondary antifungal prophylaxis.
P1022 Efﬁcacy and safety of micafungin for treatment of serious
Candida infections in patients with or without malignant
disease
O.A. Cornely, F.M. Marty, P.G. Pappas, A.J. Ullmann (Cologne, DE;
Boston, Birmingham, US; Mainz, DE)
Objectives: To evaluate the efﬁcacy of micafungin for the treatment
of invasive candidiasis/candidaemia in patients classiﬁed as having
malignancy versus no malignancy at baseline.
Methods: Data (modiﬁed intent-to-treat population) were analysed from
two phase III, multicentre, randomised trials conducted in patients
with conﬁrmed Candida infection at baseline. One trial, in adults
and children, compared micafungin (adults: 100mg/day; children:
2mg/kg/day) with liposomal amphotericin B (L-AmB; 3mg/kg/day); the
other, in adults only, compared micafungin (100mg/day and 150mg/day)
with caspofungin (50mg/day; 70mg loading dose). In both trials, the
primary efﬁcacy endpoint was treatment success at end of therapy,
deﬁned as both a positive clinical and positive mycological response.
Treatment success at end of therapy, n/Nº (%)
MICA
n= 244
L-AmB
n= 245
MICA100
n = 191
MICA150
n = 199
CAS
n= 188
No Malignancy 118/157
(75.2)
107/149
(71.8)
95/123
(77.2)
109/143
(76.2)
99/136
(72.8)
Malignancy 62/87
(71.3)
69/96
(71.9)
51/68
(75.0)
33/56
(58.9)
37/52
(71.2)
– without neutropenia 41/53
(77.4)
48/62
(77.4)
34/48
(70.8)
24/39
(61.5)
31/43
(72.1)
– with neutropenia 21/34
(61.8)
21/34
(61.8)
17/20
(85.0)
9/17
(52.9)
6/9
(66.7)
MICA: micafungin 100mg/day in adults and 2mg/kg/day in children; MICA 100:
micafungin 100mg/day; MICA 150: micafungin 150mg/day; L-AmB: liposomal
amphotericin B 3mg/kg/day; CAS: caspofungin 50mg/day with 70mg loading
dose.
Results: In the micafungin/L-AmB trial, there were 183 patients with
malignancy (37% were neutropaenic) and 306 with no malignancy.
In the micafungin/caspofungin trial, there were 176 patients with
malignancy (26% were neutropaenic) and 402 with no malignancy.
Key efﬁcacy ﬁndings are shown in the table. In general, rates for
treatment success with micafungin were similar in patients with and
without malignancy and were similar to rates observed with L-AmB
and caspofungin, although in one group (patients with malignancy,
micafungin 150mg/day, caspofungin comparator trial) treatment success
was lower than in other groups (P = 0.15). Most patients with malignancy
and neutropenia were successfully treated by all three drugs, although
with the exception of patients receiving micafungin 100mg in the
caspofungin comparator trial, rates were lower (non-signiﬁcantly) than
in non-neutropaenic patients with malignancy. For all three drugs,
the incidence of discontinuations due to treatment-related adverse
events (AEs) was similar for patients with malignancy (7.7%) versus
no malignancy (8.0%). In the L-AmB comparator trial, a smaller
proportion of the total population discontinued therapy due to treatment-
related AEs with micafungin (4.9%) versus L-AmB (7.9%). In the
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caspofungin comparator trial, comparative values were 2.5%, 3.0%,
and 3.6% for micafungin 100mg, micafungin 150mg, and caspofungin
50mg, respectively.
Conclusion:Micafungin was effective and well tolerated in patients with
or without malignancy. Micafungin is shown to be a valuable therapeutic
option for the treatment of invasive candidiasis and candidaemia across
a broad range of patients.
P1023 Pooled analysis of safety for micafungin
O.A. Cornely, P.G. Pappas, J.A. Young, P. Maddison, A.J. Ullmann
(Cologne, DE; Birmingham, Minneapolis, US; Leiderdorp, NL;
Mainz, DE)
Objectives: Micafungin (MICA) efﬁcacy has been demonstrated in
different patient populations [1−4]. To better understand the safety proﬁle
of MICA, a pooled analysis of clinical trial safety data was undertaken.
Methods: We analysed safety data collected from 15 clinical trials
conducted worldwide. Adverse events (AEs) were coded using MedDRA
5.0. All patients (N=2653) received 1 dose of intravenous MICA at a
median daily dosage of 100mg (range: 8.9–896mg) for adults (aged
16–92 yrs) and 1.5mg/kg (range: 0.4−4.7mg/kg) for children (aged 0
wks-15 yrs), over a mean duration of 15 and 17 days, respectively.
Results: Mean subject age was 41.5 yrs (SD ± 18.7 yrs) including
226 (8.5%) children (<16 yrs) and 336 (12.7%) elderly patients (65
yrs). Common underlying conditions were HIV (37.2%), haematopoietic
stem cell or other transplantation (23.7%), and solid tumour or
severe organ disorder (11.0%). Frequently reported MICA-related AEs
(2%) included phlebitis (2.8%), nausea (2.6%), vomiting (2.5%),
hypokalaemia (2.2%), pyrexia (2.2%), and increases in alkaline
phosphatase (2.6%), aspartate aminotransferase (2.5%) and alanine
aminotransferase (2.0%). In comparative studies, the MICA safety proﬁle
was superior to liposomal amphotericin B, and similar to ﬂuconazole and
caspofungin (table).
Adverse event Candidaemia/Invasive
Candidiasis
Candidaemia/Invasive
Candidiasis
Oesophageal
candidiasis‡ Prophylaxis†
MICA
100mg
(n=316)
AmB
3mg/kg
(n=321)
MICA
100mg
(n=200)
MICA
150mg
(n=202)
CASPO
50mg#
(n=193)
MICA
150mg
(n=260)
FLU
200mg
(n=258)
MICA
50mg
(n=425)
FLU
400mg
(n=457)
Hypokalaemia 21
(6.6%)×
38
(11.8%)
4
(2.0%)
5
(2.5%)
3
(1.6%)
1
(0.4%)
1
(0.4%)
8
(1.9%)
8
(1.8%)
Pyrexia 23
(7.3%)×
39
(12.1%)
2
(1.0%)
0 1
(0.5%)
5
(1.9%)
1
(0.4%)
4
(0.9%)
5
(1.1%)
Rigours 2
(0.6%)×
19
(5.9%)
1
(0.5%)
2
(1.0%)
1
(0.5%)
6
(2.3%)
0 1
(0.2%)
5
(1.1%)
Creatinine
increased
6
(1.9%)×
17
(5.3%)
0 1
(0.5%)
1
(0.5%)
0 0 1
(0.2%)
3
(0.7%)
Infusion-related
event
52
(16.5%)×
87
(27.1%)
5
(2.5%)
0 5
(2.6%)
9
(3.5%)
8
(3.1%)
2
(0.5%)
4
(0.9%)
Treatment-related: assessed by investigator as having at least a possible relationship to study drug.
AmB: liposomal amphotericin B; CASPO: caspofungin; FLU: ﬂuconazole; MICA: micafungin.
†Haematopoietic stem cell transplantation (HSCT) was the main inclusion criterion.
‡Most oesophageal candidiasis (OEC) patients were HIV positive with AIDS.×P< 0.05, Fisher’s exact test.
#After a 70mg loading dose.
Conclusions: This large database with more than 2650 patients
demonstrates that MICA has a favourable clinical safety proﬁle.
Reference(s)
[1] Kuse ER, et al. Lancet 2007;369(9572):1519–27.
[2] de Wet NT, et al. Aliment Pharmacol Ther 2005;21(7):899–907.
[3] Pappas PG, et al. Clin Infect Dis 2007;45(7):883–93.
[4] van Burik JA et al. Clin Infect Dis 2004;39:1407–16.
P1024 Multivariate logistic regression modelling of variables
associated with treatment outcomes from two large,
prospective micafungin registrational trials
D.L. Horn, O.A. Cornely, M.I. Morris, A.J. Ullmann, C. Wu,
L.L. Kovanda, D.N. Buell (Philadelphia, US; Cologne, DE; Miami,
US; Mainz, DE; Deerﬁeld, US)
Objectives: Two recent, large, prospective micafungin trials in patients
(pts) with candidaemia and invasive candidiasis reported: (1) micafungin
100 and 150mg were non-inferior to caspofungin (CID 2007;45:883;
study 03−0–192), (2) micafungin was as effective as liposomal
amphotericin B, with fewer adverse events (Lancet 2007;369:1519; study
FG-463–21−08). Further analyses were undertaken to identify variables
associated with overall treatment outcomes in adults.
Methods: Separate models were created for 03−0–192 (578 pts) and FG-
463–21−08 (492 pts). Potential explanatory variables were age, gender,
region, infection type, neutropenia status, baseline steroids, APACHE
II score, catheter status, Candida spp., and baseline condition. Overall
treatment success at the end of IV therapy (Rx) was deﬁned as clinical
and mycological success. Point estimates and 95% conﬁdence intervals
(CI) for the comparative odds for each variable were calculated.
Results: In 03−0–192, catheter removal, region, baseline APACHE II
score, infection type, age group, and steroids had signiﬁcant effects
on treatment outcome (p = 0.0023, 0.0001, 0.001, 0.031, 0.041, 0.003,
respectively). Odds ratio (OR) analyses demonstrated signiﬁcantly less
likelihoods to achieve treatment success for: (1) Pts without catheter
removal (OR= 0.49, 95%CI = 0.31, 0.78), (2) Pts treated in India vs
those in North America (OR= 0.14, 95%CI = 0.06, 0.29), (3) Pts with
a baseline APACHE II score of >20 to 30 or >30 vs 20 (OR= 0.42
and 0.28, 95%CI = 0.24, 0.72 and 0.10, 0.77), (4) Pts with disseminated
infection (OR= 0.36, 95%CI = 0.14, 0.91), (5) Pts 70 yrs vs <50
(OR= 0.46, 95%CI = 0.25, 0.84), (6) Pts receiving steroids (OR= 0.50,
95%CI = 0.31, 0.79).
In FG-463–21−08, baseline APACHE II score and neutropenia status
during Rx had signiﬁcant effects on treatment success (p = 0.0001,
0.003). OR analyses demonstrated signiﬁcantly less likelihoods to
achieve success with: (1) A baseline APACHE II score of >20 to
30 or above 30 vs 20 (OR= 0.51 and 0.09, 95%CI = 0.30, 0.87 and
0.03, 0.27), (2) Neutropenia (OR= 0.32, 95%CI = 0.15, 0.68).
Conclusion: In both micafungin trials, pts with high APACHE II scores
were less likely to have treatment success. Additionally, pts in 03−0–
192 were less likely to achieve success if they did not have removal of
catheters, were receiving Rx in India, had disseminated infection, were
70 yrs, or were receiving steroids. Neutropenic pts in FG-463–21−08
were less likely to achieve treatment success.
P1025 Economic analysis of micafungin versus liposomal
amphotericin B for treatment of candidaemia and invasive
candidiasis in the UK
G. Park, M. Sidhu, A. van Engen, O. Schoeman (Cambridge, Staines,
UK; Hoofddorp, NL)
Objectives: To investigate the economic impact of introducing
micafungin (MICA) (Mycamine®) for the treatment of systemic candida
infections (SCIs) (including invasive candidiasis and candidaemia),
a health economic analysis was performed comparing MICA with
liposomal amphotericin B (L-AMB) (AmBisome®).
Methods: The model was based on observations and time-points from a
phase III, randomised, double-blind, clinical trial which compared MICA
with L-AMB[1]. The model (originally developed for Germany) entails
a period of 14–20 weeks starting from initiation of treatment and was
analysed from a UK hospital perspective. Hospitalisation and primary
medication costs were included in the current analysis. Unit costs of
these resources were taken from appropriate UK costing sources. As
the price for MICA was not available at the time of analysis, the price
per recommended daily dose (RDD) of MICA (100mg) was assumed
to be equal to the price per RDD of caspofungin (50mg). The model
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endpoint was deﬁned as the percentage of patients that achieved complete
or partial clinical and mycological response after initial treatment, and
were alive after the 12-week follow-up period. The model was analysed
using two methods: a cohort simulation and a probabilistic simulation
(i.e., Second-Order Monte Carlo [MC] simulation).
Results: The health economic analysis shows that with MICA 52.9% of
patients were successfully treated and survived 12 weeks after treatment
ends compared to 49.1% for L-AMB (see Table 1). In addition, MICA
was, on average, less expensive than L-AMB costing £ 26,838 and £
29,549 per patient, respectively
Table 1: Summary of results
Treatment strategy
Outcome MICA L-AMB
Average cost per patient
Medication £5,812 £6,580
Hospitalisation £21,026 £22,969
Total £26,838 £29,549
Effectiveness* 52.9% 49.1%
C/E £50,755 £60,197
Incremental C/E ratio L-AMB is dominated by MICA
*% of patients that are succesfully treated and alive after 12 weeks.
Because the costs are lower and the effectiveness is higher for MICA
(cost-effectiveness [C/E] ratio = £ 50,755) in comparison with L-AMB
(C/E ratio = £ 60,197), MICA dominates L-AMB from a cost-
effectiveness point-of-view. The results of the MC simulation and
the sensitivity analyses showed that MICA remained the most cost-
effective option throughout the analyses, although considerable variance
in treatment-associated costs was observed for both treatment options.
Conclusions: The lower costs and higher effectiveness reported for
MICA versus L-AMB in this analysis indicate MICA is the more cost-
effective therapy in the treatment of SCIs when compared to L-AMB.
Reference(s)
[1] Kuse ER, Chetchotisakd P, da Cunha CA, et al. Micafungin
versus liposomal amphotericin B for candidaemia and invasive
candidosis: a phase III randomised double-blind trial. Lancet
2007;369(9572):1519–27
P1026 An evaluation of hospital length of stay in intensive care
patients with invasive candidiasis treated with anidulafungin
versus ﬂuconazole
D. Kett, A. Reboli, C. Rotstein, A. Shorr, S. Gasper, H. Schlamm
(Miami, Camden, Washington, New York, US; Hamilton, CA)
Objectives: Invasive Candida infections in critically ill patients are
associated with high attributable mortality and signiﬁcant healthcare
costs. The most signiﬁcant cost results from an increased hospital length
of stay (LOS) (Rentz et al). Although a number of antifungal drugs
are available to treat these infections, few studies have compared the
mean LOS associated with these agents. The objective of this study was
to compare intensive care unit (ICU) and total hospital LOS in ICU
patients receiving anidulafungin (ANID) versus ﬂuconazole (FLU) for
treatment of invasive candidiasis.
Methods: Data from patients conﬁrmed to be in the ICU on day of entry
into a phase 3, randomised double-blind study comparing intravenous
(IV) ANID (200mg Day 1, then 100mg daily) and IV FLU (800mg
Day 1, then 400mg daily) for treatment of invasive candidiasis (Reboli
et al) were retrospectively analysed. ICU and total hospital LOS were
determined for all eligible ICU patients and for those who survived to 2
weeks after end of treatment (EOT).
Results: Sixty-three of the 245 patients in the primary analysis
population of the study were conﬁrmed to be in the ICU at study entry
(ANID, n = 35; FLU, n = 38). In this group, the mean ICU LOS was 23.4
± 24.1 days for ANID versus 29.3 ± 26.2 days for FLU (difference, −5.9
days; 95%CI, −18.7 to 6.8), and the mean total hospital LOS was 32.6 ±
23.7 days for ANID versus 39.3 ± 29.9 days for FLU (difference, −6.6
days; 95%CI, −20.1 to 6.9). Fifty-four of the 63 ICU patients survived
to 2 weeks after EOT (ANID, n = 32; FLU, n = 32). In this group, the
mean ICU LOS was 24.8 ± 24.7 days for ANID but increased to 34.9 ±
27.0 days for FLU (difference, −10.1 days; 95%CI, −24.3 to 4.2), and
the mean total hospital LOS was 34.9 ± 23.4 days for ANID compared
with 47.3 ± 28.8 days for FLU (difference, −12.4 days; 95%CI, −26.7
to 1.9).
Conclusion: In ICU patients with invasive candidiasis, ANID treatment
was associated with shorter ICU and total hospital LOS compared with
FLU treatment, and these differences were more pronounced in patients
who survived for 2 weeks after EOT. These numerical differences in
LOS will likely have ﬁnancial implications given the expense associated
with prolonged hospitalisation and ICU usage.
References
Reboli AC, et al. N Engl J Med. 2007;356:2472–82.
Rentz AM, et al. Clin Infect Dis. 1998;27:781−8.
P1027 Cost-effectiveness of posaconazole versus standard azole
treatment (ﬂuconazole or itraconazole) in the prevention
of invasive fungal infections among high-risk neutropenic
patients in Spain
S. Grau, R. de la Ca´mara, M. Sanz, E. Carreras, I. Jarque,
M.A. Casado, F.J. Sabater, G. Papadopoulos (Barcelona, Madrid,
Valencia, ES; Kenilworth, US)
Background: Posaconazole (POS) has demonstrated to be superior to
standard azole therapy (SAT; ﬂuconazole or itraconazole) in preventing
both invasive fungal infections (IFIs) and reducing overall mortality
among high-risk neutropenic patients (Cornely 2007).
Objectives: To evaluate the cost-effectiveness of POS compared with
SAT for the prevention of IFIs among patients with acute myelogenous
leukaemia (AML) or myelodysplastic syndromes (MDS) who are at high-
risk of developing an IFI due to chemotherapy-induced neutropenia.
Methods: A decision-analytic model was used to predict the likelihood
of IFI and death, using published data from the Cornely trial. Patients
in the model were assumed to have received prophylaxis with POS
or SAT (ﬂuconazole, 81%; itraconazole, 19%). Clinical results were
extrapolated to lifetime horizon by extending the model with 1-month
Markov cycles including speciﬁc mortality risk for underlying diseases.
Model outcomes include IFIs avoided, life-years saved, total costs,
incremental cost per IFI avoided, and incremental cost-effectiveness ratio
(ICER; incremental cost per life year saved) of POS versus SAT over
a lifetime. The analysis was done from the perspective of the Spanish
HealthCare System. Data on life expectancy were obtained from Spanish
Statistics Institute. Information on medical procedures was obtained from
the Cornely study and an expert committee. Costs for IFI treatment and
drug/administration costs were taken from published literature (€2007
values). A deterministic and probabilistic sensitivity analyses (PAS) were
performed.
Results: POS is associated with fewer IFIs (0.05 versus 0.11 p = 0.003),
increased life years (2.52 versus 2.43), and (excluding costs of the
underlying condition) signiﬁcantly lower costs (€5,911 versus €7,475)
per patient relative to SAT over a lifetime horizon. Results from the
PSA indicate that there is an 87% probability that POS is a cost-saving
strategy versus SAT and that the probability that the ICER ratio for POS
versus SAT is below an estimated €30,000 per life year saved threshold
is 98%.
Conclusion: Posaconazole has been shown to be more effective than
standard azole therapy in preventing IFIs and reducing overall mortality
in high-risk neutropenic patients. An incremental cost-effectiveness
analysis done from the perspective of the Spanish HealthCare System,
has indicated the dominance (lower costs and greater efﬁcacy) of
posaconazole versus ﬂuconazole or itraconazole.
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P1028 Cost-effectiveness of posaconazole vs. ﬂuconazole in the
prevention of invasive fungal infections among patients with
graft-versus-host disease in Spain
S. Grau, R. de la Camara, E. Carreras, M.A. Sanz, I. Jarque,
M.A. Casado, F.J. Sabater, G. Papadopoulos (Barcelona, Madrid,
Valencia, ES; Kenilworth, US)
Background: Ullman et al. (NEJM 2007) had shown in a recent
clinical trial that posaconazole (POS) is similar to ﬂuconazole (FLU)
in the prevention of invasive fungal infections (IFIs) among allogeneic
hematopoietic stem-cell transplant (HSCT) patients with graft-versus-
host disease (GVHD).
Objectives: To assess the cost-effectiveness of POS versus FLU in
preventing IFI in patients with GVHD from the Spanish National Health
System perspective.
Methods: A decision-analytic model was developed to assess the
average per patient treatment costs, IFIs avoided, life-years gained, and
incremental cost per life-year gained of each prophylactic treatment
(€ 2007). The trial results were extrapolated to a lifetime horizon by
extending the model with one-month Markov cycles including speciﬁc
mortality risk for GVHD. Patients are assumed to receive POS or FLU;
probability of IFI, IFI-related death and death from other causes were
obtained from the published clinical trial. Long-term mortality and
prophylaxis drug and IFI treatment costs were estimated from secondary
sources. One-way and probabilistic sensitivity analyses were conducted.
Results: preliminary results shows that POS is associated with fewer
IFIs (0.05 vs. 0.09), increased life years (8.01 vs. 7.78), and higher IFI-
related costs (prophylaxis and IFI treatment) (€11.585 vs. €6.959) per
patient relative to FLU over a lifetime horizon. Costs for treatment of
IFIs comprised 82% of the total cost for FLU and 29% for POS. The
incremental cost-effectiveness of POS versus FLU is estimated to be
€20.246 per life-year saved. Results are most sensitive to changes in the
cost of preventing an IFI and the efﬁcacy of prophylaxis. A second-order
probabilistic Monte Carlo sensitivity analysis was conducted to assess
the effects of parameter uncertainty on the study ﬁndings, particularly as
relates to treatment efﬁcacy and the costs of preventing an IFI. Results
indicate that there is a 70% probability that POS is cost-effective at a
€30.000 per life year saved threshold, threshold commonly used in Spain
for assessing the cost-effectiveness of new technologies.
Conclusion: Based on this analysis, we conclude that posaconazole is a
cost-effective strategy in Spain for the prevention of IFIs among patients
with GVHD.
P1029 Posaconazole versus standard azole therapy in the pro-
phylaxis against invasive fungal infections among high-risk
neutropenic patients in Canada: a cost-effectiveness analysis
A.A. Tahami Monfared, A.K. O’Sullivan, G. Papadopoulos (Kirkland,
CA; Medford, Kenilworth, US)
Objective: Posaconazole has been demonstrated to be signiﬁcantly
superior to standard azole therapy (i.e., ﬂuconazole or itraconazole) in
preventing invasive fungal infections (IFIs) (P<0.001) and in reducing
overall mortality (P = 0.048) among patients with haematological
malignancy with prolonged neutropenia (Cornely et al. NEJM, 2007).
The objective of this study was to assess the cost-effectiveness of
posaconazole in this patient population from the perspective of the
Canadian healthcare system.
Methods: A decision-analytical model based on trial results was
developed. Patients in the model were assumed to receive prophylaxis
with posaconazole or standard azole therapy (ﬂuconazole, 81%;
itraconazole, 19%). The probabilities of experiencing an IFI, IFI-
related death, and death from other causes over 100 days of follow-
up were estimated from the trial data. To extrapolate results beyond
the trial period, the model was extended to a lifetime horizon using
1-month Markov cycles in which mortality rate is speciﬁc to the
underlying disease as estimated from Statistics Canada and Surveillance,
Epidemiology, and End Results (SEER) program data. Long-term
mortality, drug costs, and IFI treatment costs were estimated using
published literature. The model was used to estimate costs, IFIs avoided,
life-years gained, and the incremental cost-effectiveness ratio (ICER)
of posaconazole versus standard azole therapy (using 2007 Canadian
dollars).
Results: Posaconazole is associated with fewer IFIs (0.05 vs. 0.11)
(P = 0.003), increased life-years (0.744 vs. 0.728), and (excluding costs
of the underlying condition) slightly lower costs ($7,147 vs. $7,332)
per patient relative to standard azole therapy over a lifetime horizon.
A second-order probabilistic Monte Carlo sensitivity analysis was
conducted to assess the effects of parameter uncertainty on the study
ﬁndings, particularly as they relate to treatment efﬁcacy and the costs of
an IFI. Results indicate that there is a 53% probability that posaconazole
is cost saving versus standard azole therapy and a 70% probability that
the ICER for posaconazole is at or below the $50,000 per life-year saved
threshold.
Conclusion: In addition to the proven efﬁcacy, posaconazole appeared
to be cost saving relative to standard azole therapy (i.e., ﬂuconazole
or itraconazole) in the prevention of IFIs among high-risk neutropenic
patients.
P1030 Economic evaluation of posaconazole compared with
other systemic fungal therapies in patients with refractory
invasive aspergillosis in Canada
A.A. Tahami Monfared, S. Rajagopalan, R. Danna, G. Papadopoulos
(Kirkland, CA; Williamsville, Morristown, Kenilworth, US)
Objective: To evaluate all-cause mortality and cost of treatment in
patients with refractory invasive aspergillosis (rIA) treated with either
posaconazole or other systemic anti-fungal (SAF) therapies.
Methods: All-cause mortality and cost of salvage therapy of posacona-
zole oral suspension (800mg/day) and other SAF treatments were
assessed using an open-label, multicentre, externally controlled study in
patients with invasive aspergillosis who were refractory to or intolerant
of conventional antifungal therapy. Data from external control cases were
collected retrospectively to provide a comparative reference group. All
patients had failed to improve or progress with prior antifungal therapy.
Prior antifungal therapies for the majority of patients were liposomal
amphotericin B, amphotericin B, or itraconazole. Cases of aspergillosis
deemed evaluable by a blinded data review committee included 107
posaconazole recipients and 86 control subjects (modiﬁed intent-to-treat
population). The populations were similar and balanced with regard
to pre-speciﬁed demographic and disease variables. All-cause mortality
were analysed using the survival technique. Cost analysis was censored
at day 372. Economic evaluation were conducted using survival data
and costs of pharmacotherapy (estimates are based on 2007 Canadian
dollars).
Results: Signiﬁcantly more patients who were treated with posaconazole
responded to therapy compared with similar patients treated with other
salvage therapies. Patients with rIA treated with posaconazole appeared
to confer a highly signiﬁcant survival beneﬁt over the control cases. The
cumulative rates of survival at 30 days and at the end of therapy were
74% and 38%, respectively; for control subjects, those survival rates
were 49% and 22%, respectively. The Kaplan-Meier survival curve was
signiﬁcantly different (P = 0.0003). In addition, posaconazole appears to
be a "dominant" (i.e., cost saving) option for the treatment of refractory
aspergillosis when compared to the active comparator receiving standard
antifungal salvage therapies ($14,839 vs. $38,158). Sensitivity analyses
demonstrated that the cost savings observed were maintained over a
range of alternative values for costs and outcomes.
Conclusions: Treatment with posaconazole as compared with other
systemic anti-fungal therapies provided a signiﬁcant survival beneﬁt in
patients with rIA at lower cost of drug therapy.
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P1031 Pharmaco-economic analyis of posaconazole versus
standard azole prophylaxis in high-risk neutropenic
AML/MDS patients in Germany
M. Thalheimer, O.A. Cornely, T. Hoppe-Tichy, U. Schuler, H. Knoth,
M. Kiehl, A.J. Ullmann, A. O’Sullivan, H. Ostermann (Heidelberg,
Cologne, Dresden, Frankfurt/Oder, Mainz, DE; Medford, US;
Munich, DE)
Objectives: The objective of our analysis was to estimate the cost-
effectiveness of antifungal prophylaxis with posaconazole vs. standard
azole therapy (i.e., ﬂuconazole or itraconazole) in patients with
acute myelogenous leukaemia (AML) or myelodysplastic syndrome
(MDS) and at high risk of developing an IFI due to chemotherapy-
induced neutropenia. Posaconazole signiﬁcantly prevents invasive fungal
infections (IFIs) and reduces overall mortality vs. standard azole therapy
in these patients (Cornely et al. NEJM, 2007).
Methods: A decision-analytic model was developed based on the results
of the large multicentre trial, extrapolated to a lifetime horizon and
analysed from a German perspective.
The probabilities of experiencing an IFI, IFI-related death, and death
from other causes over 100 days of follow-up were estimated from
the trial data. Long-term mortality data is based on the database of a
large German university clinical centre, drug costs were estimated using
published sources. IFI treatment costs were derived from a multicentre
retrospective chart review. Due to a lack of published data on the
impact of an IFI on quality of life of AML/MDS patients, a panel
of 20 hematology-oncology experts estimated this impact based on
the SF-6D questionnaire. The utilities derived from the analysis of the
questionnaires served to estimate the quality-adjusted life years (QALY).
The pharmacoeconomic model presented was used to estimate incre-
mental cost per patient, incremental cost-effectiveness ratio (ICER) per
life-years saved and incremental costs per quality-adjusted life years
(QALY).
Results: Posaconazole is associated with fewer IFIs (0.05 vs. 0.11;
p = 0.003) and slightly higher overall treatment costs (1,041 €) per patient
relative to standard azole therapy over a lifetime horizon. The ICER
per live-years saved was 10,235 €. Posaconazole prophylaxis resulted in
0.1 QALYs gained in comparison to prophylaxis with standard azoles.
Results from a probabilistic sensitivity analysis indicate that there is an
81% probability that the cost per QALY gained with posaconazole is
below 20,000 €, a commonly accepted threshold for cost-effectiveness.
Conclusion: Based on the clinical data and on the assumptions, our
analysis demonstrated that posaconazole is likely to be cost-effective
relative to standard azole therapy (i.e., ﬂuconazole or itraconazole) in
the prevention of IFIs among high-risk neutropenic patients.
P1032 Retrospective, multicentre, pharmaco-epidemiological study
of the administration of liposomal amphotericin B in
patients admitted to intensive care units
F. Alvarez-Lerma, F. Mariscal, E. Quintana, G. Rialp, J. Dı´az,
M. Pe´rez, B. Alvarez, I. Ausı´n and the Study Group for Liposomal
Amphotericin B in ICU
Objective: To analyse the indications and posology of liposomal
amphotericin B (L-AMB) in patients admitted to intensive care units
(ICUs).
Methods: Retrospective, multicentre and observational study of patients
admitted to ICUs and treated with L-AMB for any reason in 2006.
Invasive fungal infections (IFIs) were classiﬁed as proven, probable or
possible. Treatment indications were classiﬁed as ﬁrst line or as rescue
treatment.
Results: 179 patients were included and 30 ICUs participated. Mean
APACHE II score was 20.9 (SD:7.9), mean length of ICU stay was 28.6
(SD: 24.0) days and intra-ICU mortality rate was 43.4%. Most common
pathologies were medical pathology (45.3%) and surgery (34.1%) and
68.2% of the patients had severe sepsis or septic shock. Invasive fungal
infections were proven, probable and possible in 43.6%, 15.6%, and
25.1% of cases, respectively and not classiﬁed in the remaining 15.7%.
Aetiology: Candida albicans (38.0%), Candida non-albicans (15.1%),
Aspergillus spp. (7.3%), two or more Candida spp. (12.3%). Mean
duration of treatment was 15 days at a mean dose of 3.7mg/kg/day.
In 47.5% of the cases L-AMB was used as rescue treatment after
ﬂuconazole (40 cases) or caspofungin (30 cases) and as ﬁrst line in the
other 52.5% of the cases. Clinical response in evaluable patients (n = 354)
was classiﬁed as satisfactory in 53.9% (n = 33) of the cases (72.6% in
proven infection) and microbiological eradication in evaluable patients
(n = 308) was achieved in 67.6% (n = 33) of the cases. Adverse events
were detected on 51 patients but were classiﬁed as serious in only 4
(2.2%) patients. Severe renal failure requiring a change in the antifungal
treatment was detected in only one case. There was no change in the
mean creatinine value at the end of treatment in the patients treated with
L-AMB, despite the fact that 109 (60.9%) were receiving nephrotoxic
drugs concomitantly.
Conclusions: L-AMB was used predominantly in critically ill patients
(haemodynamically unstable), both as ﬁrst line and as rescue treatment
above all for proven infections. In this group of patients satisfactory
clinical response was very high. L-AMB was well tolerated, with
little alteration of renal function even in patients taking concomitant
nephrotoxic drugs.
P1033 Inﬂuence of liposomal amphotericin B on the renal function
of intensive care patients with elevated serum creatinine
levels. A multicentre, retrospective, observational case
collection study
F. Alvarez-Lerma, F. Mariscal, M. Nieto, M. Pe´rez, C. Pinilla, T. Puente,
I. Ausı´n and the Study Group for Liposomal Amphotericin B in ICU
Objective: To study the inﬂuence of liposomal amphotericin B (L-AMB)
on the renal function of intensive care patients with elevated serum
creatinine levels (SCL) at the start of L-AMB treatment.
Methods: This is a sub-analysis of a pharmacoepidemiological
retrospective study of patients admitted to Spanish intensive care units
(ICUs) during 2006 and treated for at least one day with L-AMB. For
this sub-analysis, only patients with SCL >1.5mg/dl at the start of
treatment (baseline) were included. Primary endpoint was SCL at the
end of L-AMB treatment. Secondary endpoints were: discontinuation
of treatment due to nephrotoxicity, and differences among groups
(SCL 1.5mg/dl at the end of treatment vs SCL >1.5mg/dl at the
end of treatment) by dose and duration of L-AMB treatment, along
with differences in the percentage of nephrotoxic concomitant drugs
administered.
Results: Of the 179 patients admitted to the pharmacoepidemiological
study, 49 (27.4%) presented with SCL >1.5mg/dl (median: 2.3
and range: 1.53−7.0) at baseline. Of these 49 patients 83.7% were
haemodynamically unstable, APACHE II score was 23.3 (SD: 8.8), mean
length of ICU stay was 28.6 (SD: 24.0) days and intra-ICU mortality rate
was 63.3%. Median dose of L-AMB was 3.6mg/kg/day (range 1−6) and
median duration of treatment was 12 days (range 1–33). Concomitant
nephrotoxic drugs were taken by 59.2% (n = 39) of patients. At the end
of L-AMB treatment, 40.8% (n = 30) of patients presented with SCL
1.5mg/dl, and the remaining 29 patients maintained SCL >1.5mg/dl.
Of this latter group, only seven patients presented with higher SCL than
at baseline, none of them 1.5 x basal line value. No patient discontinued
treatment due to nephrotoxicity. Comparing both groups of patients,
no differences among dose of L-AMB and duration of treatment were
seen. In addition, no differences were observed between groups in the
percentages of patients taking nephrotoxic concomitant drugs.
Conclusion: Although this is a small case collection study, L-AMB
was safely used in haemodynamically unstable patients with deteriorated
renal function. No differences concerning dose and duration of L-AMB
treatment, and concomitant nephrotoxic drugs were seen between both
groups. L-AMB is a treatment option for high risk patients with
deteriorated renal function.
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P1034 Effectiveness and safety of AmBisome® (liposomal
amphotericin B) in combination with voriconazole in
patients with invasive fungal infections. A multicentre
retrospective study (RAVES study)
E. Askari, P. Garcı´a, I. Jarque, S. Nicola´s, C. Blanco, M. Caballero,
J. Ca´ceres, E. Garcı´a, V. Go´mez, M. Canales (Madrid, Valencia,
Lorca, Palma de Mallorca, Las Palmas, Pamplona, ES)
Objectives: To study the efﬁcacy and safety of the combination of
AmBisome® and voriconazole in patients with invasive fungal infections
(IFIs).
Methods: Retrospective, multicentre, data collection of patients treated
with a combination of AmBisome® and voriconazole in Spanish
hospitals. Data were included from patients treated for at least six
days from October 2003 to November 2006. Infections were classiﬁed
as proven, probable and possible according to the EORTC criteria.
The primary endpoint was one month survival after drug study
discontinuation.
Results: Thirteen patients were included in the study, eight were
oncohematologic (ﬁve neutropenic) and ﬁve were intensive care
patients. Four hematologic patients presented with a proven IFI
(Aspergillus ﬂavus, Fusarium spp., Scedosporium spp., and Candida
spp.+unidentiﬁed mould), two with a probable IFI (Fusarium oxysporum,
and Scesdosporium spp.) and two with a possible IFI (in one case
cerebral toxoplasmosis was diagnosed in the necropsy study). Four
intensive care patients presented with a proven infection (Candidaemia)
and one patient showed a probable IFI (Aspergillus ﬂavus and Aspergillus
fumigatus). Doses of AmBisome® ranged from 2 to 5.5mg/kg/day with
a minimum treatment duration of six days and a maximum of 50 days.
Two patients died within one month after study drug discontinuation:
one patient after 48 hours and one after 30 days. Neither death was
related to the fungal infection (one case cerebral toxoplasmosis and
in the other one peritonitis). After discontinuation of study drug, a
complete response was observed in nine patients, a partial response
in three patients, and the patient with cerebral toxoplasmosis remained
stable. Six patients experienced alterations in hepatic function, and in one
of them voriconazole treatment was discontinued due to hepatotoxicity.
No clinically relevant increases in serum creatinine levels (i.e. serum
creatinine twice baseline level) were observed.
Conclusion: Although this is a small collection of cases, the efﬁcacy
results suggest no clinical antagonism of AmBisome® plus voriconazole
in combination. Safety results suggest that this combination can be
administered to high risk patients.
P1035 Safety of liposomal amphotericin as a once-weekly
antifungal prophylactic regimen in very low birth-weight
premature infants
A.C. Arrieta, K. Shea, V. Dhar, J. Cleary, S. Kukreja, N. Ashouri,
J. Singh (Orange, US)
Objectives: Candida infections are a common cause of morbidity and
mortality among very low birth weight (VLBW) infants. Several studies
have shown that prophylaxis may decrease the incidence of candidiasis
and improve survival. At a rate of 2.6/1000 patient days, a large number
of infants will be exposed to drug to prevent one infection. The safety of
a prophylactic drug then needs to be exhaustively evaluated. We studied
the safety of liposomal amphotaricin B (L-AmB) given once weekly at a
5mg/kg dose as a prophylactic regimen to prevent Candida colonisation
and invasive infection in VLBW < 6 weeks of age.
Methods: Premature newborns < 32 weeks gestation; <1500 g birth
weight; < 7 days of life were eligible. Subjects were randomised to
receive L-AmB 5mg/kg once a week or placebo (dextrose in water).
L-AmB trough level was obtained on day 7. Surveillance cultures were
obtained at baseline, 72 hours later and then weekly from rectum, axillae
and respiratory tract. Study drug was continued until no risk factors
(antibiotics, central vascular access, hyperalimentation, endotracheal
intubation) were present or 6 weeks of life which ever was earlier. Blood
cultures were obtained as clinically indicated. Electrolytes, renal and liver
function, as well as mortality and incidence of necrotising enterocolitis
(NEC) and intraventricular haemorrhage (IVH) were monitored for
safety.
Results: Twenty subjects were enrolled in to each study arm,
demographic features and risk factors were evenly distributed. Steroids
were used in 40% and 15% of L-AmB and placebo arms repectively.
While on study, 5% on L-Amb and 15% on placebo arm developed
colonisation; one subject on placebo developed invasive disease. One
patient in each group died due to complications of prematurity. There
was no signiﬁcant difference in the incidence of IVH (grade III-IV),
NEC or in the need for platelets, packed red blood cells and potasium
supplementation. Renal and liver function changes were similar in both
groups and of no clinical or statistical signiﬁcance.
Conclusions: The safety of once weekly 5mg/kg L-AmB in VLBW
infants is supported by our trial and was comparable to placebo. Data
from our pilot study suggests that a larger multi-centre trial is warranted
P1036 Comparison of antifungal therapy in intensive care unit
and oncological patients
B. Luethi, J. Sasse, U. von Both, C. Ruef (Zurich, CH)
Objectives. New antifungal agents have enlarged treatment options for
invasive fungal infections. However, these drugs are more expensive than
older agents such as ﬂuconazole (FLU) or amphotericin B (AmB). The
purpose of this study is to describe antifungal therapy (AFT) in ICU and
oncological patients at a European tertiary care hospital.
Methods: Prospective observational, non-interventional study on 3 ICUs
and 1 oncology ward (ONC) to assess AFT, reasons for treatment
changes and clinical outcome in 50 consecutive patients (48% female,
median age 53.5, range 23–74 yrs; 36 ICU, 14 ONC). Standard criteria
for the diagnosis of invasive fungal infections (IFI) were used.
Results: Mean length of hospitalisation was 59 days, the mean length
of ICU stay 25 days. Overall mortality was 30%, without statistical
difference between ICU and ONC patients. The following risk factors
for IFI were highly prevalent: neutropenia (58%), use of broad-spectrum
antibiotics (94%), total parenteral nutrition (18%), intraabdominal
surgery (24%). We evaluated a total of 58 AFT cycles (1582 treatment
days), including 103 courses (data for initial courses in table). Mean
duration of treatment was 8.4 days (amB) 15.4 (CAS), and 14.7 (VOR).
Modiﬁcation of initial AFT was necessary in 50% of cycles. Rates of
premature change (PC) of AFT for individual agents were: AmB (73.3%
overall, 53.3% due to adverse events (AE)/20% due to treatment failure),
FLU (31.3, 12.5/18.8), VOR (70, 50/20), CAS (28.6, 0/28.6). The rate
of PC due to AE was signiﬁcantly higher with AmB and VOR than with
FLU and CAS.
ONC
[38 cycles;
(% of cycles)]
ICU
[20 cycles;
(% of cycles)]
Indication for AFT
Increased colonisation index 1 (2.6) 5 (25)
Fever and neutropeniaa 20 (52.6) 3 (5)
Possible IFIa 12 (31.6) 1 (5)
Probable/proven IFIa 2 (5.3) 8 (40)
Physician’s decision 3 (7.9) 3 (15)
Agent used
AmBa 15 (39.5) 0
FLUa 5 (13.2) 14 (70)
Itraconazole (ITR) 2 0
Voriconazole (VOR) 7 (18.4) 3 (15)
Caspofungin (CAS) 7 (18.4) 3 (15)
Other 2 0
aSigniﬁcant difference between ONC and ICU patients.
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Conclusion: AFT in oncology is still predominantly based on AmB,
which has been replaced in ICU patients by newer agents (VOR, CAS).
In oncology patients indication for AFT is rarely based on probable or
proven IFI, while this diagnosis is more often established in ICU pts.
Premature discontinuation of AFT is frequent with AmB and VOR and
is usually caused by AE.
P1037 Antifungal use in intensive care units
M. E`izˇman and the ESAC Study Group
Objectives: To provide benchmarking data on antifungal use in all
intensive care units in Slovenian general hospitals and teaching hospital
to analyse total use and general use pattern.
Methods: Antimicrobial use data for 21 ICU from all Slovenian general
hospitals and one University hospital were obtained from January to
December 2006 as part of the national antimicrobial consumption
surveillance. Use data of systemic antifungals at the level of the
active substance were collected in accordance with the Anatomic
Therapeutic Chemical (ATC) classiﬁcation and Deﬁned Daily Dose
(DDD) measurement unit (WHO version 2006) and expressed as DDD
per 100 bed-days.
Results: During the year 2006 11 333 (2.95% of total number)
patients were hospitalised in ICUs. The average length of stay was
3.99 days. Mean systemic antifungal use was 22.82 (range 0.87–
67.52) DDD/100 bed-days; in medical ICUs (n = 3) 15.31 (range 2.86–
46.56), in surgical (n = 3) 30.87 (0.87–67.52) in interdisciplinary (n = 3)
14.10 (7.72–23.0) and in University medical ICU (n = 3) 15.50 and in
surgical ICU 42.21 DDD/100 bed-days respectively. Fluconazol was the
most frequently prescribed antifungal (mean 21.0 DDD/100 bed-days)
followed by caspofungin (0.62), amfotericin B (0.60), voriconazol (0.51)
and itraconazol (0.05).
Conclusion: Antifungal use was heterogeneous in Slovenian ICUs with
the mean lying at 22.82 DDD/100 bed-days. Benchmarking data might
provide a tool for assessing strategies that aim to optimise antifungal
prescribing in ICUs.
P1038 Disinfecting power of multi-purpose soft contact lens
disinfecting solutions on fungi colonising the conjunctiva
and environmental air isolates
C. Ma, M.V. Boost, P. Cho (Kowloon, HK)
Objectives: There has been increasing concern about fungal corneal
infections since the outbreak of Fusarium infections in 2005 in soft
contact lens wearers, which led to withdrawal of one multi-purpose
disinfecting solution (MPS). Although FDA guidelines require MPS
to reduce numbers of a type strain of Fusarium solani by one log
dilution, their effectiveness on other strains is not routinely tested. Poor
compliance with lens care routines and rubbing of the eyes can introduce
fungi into the eye. This study investigated effectiveness of soft contact
lens MPS against commensal and environmental fungal isolates.
Methods: The lower conjunctival surface and eyelashes of 30 subjects
aged 20–24 were swabbed with a saline-moistened swab and cultured
on potato dextrose agar with chloramphenicol (PDAc). Environmental
fungi were obtained from ten cultures of PDAc exposed for 30 minutes
in urban areas near to ﬂower beds and lawns. Plates were incubated at
25ºC for 7 days and fungal isolates sub-cultured, identiﬁed, and used as
challenge strains against three soft lens MPS solutions using the stand-
alone test required by FDA Guidelines. F. solani (ATCC 36031) was
used as a control.
Results: Sixteen subjects were colonised with fungal organisms yielding
a total of 23 isolates. Air sampling yielded a further 14 isolates.
Isolates were mainly Penicillium (38%) and Aspergillus (30%) species,
the latter being an ocular pathogen. Both MPS "A" and "B", which
contain polyhexamethylene biguanide (PHMB), failed to achieve a one
log reduction for any of the isolates though the reduction of F. solani
was 1.3 log. MPS "C" which contains POLYQUAD was able to achieve
a 1.0 or greater log reduction for all isolates.
Conclusions: MPS containing PHMB failed to successfully reduce
viable fungal numbers by one log, although able to meet FDA Guidelines
for the test strain of F. solani. Failure to inhibit such strains may increase
the risk of ocular infection in contact lens wearers, as infections may
be caused by other fungal pathogens, particularly Aspergillus spp. and
poor compliance with lens care routines may lead to contamination with
fungi. In the light of recent increase in microbial keratitis of fungal
aetiology, changes to FDA guidelines to expand numbers of strains and
species may be appropriate.
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P1039 A daptomycin assay by high-performance liquid
chromatography
C.M. Tobin, A.M. Lovering, A.P. MacGowan, J.M. Darville (Bristol, UK)
Objectives: Daptomycin (DAPT) is a new lipopeptide antibiotic with a
unique mode of action. Its spectrum of activity includes most clinically
relevant Gram-positive pathogens. With this drug there are few published
pharmacokinetic data and these have been limited to healthy volunteers.
With all new agents, it is important to be able to measure the serum
concentrations, for an understanding of the drug’s pharmacokinetics and
for the management of patients with multiple organ failure. Our aim was
to develop a high performance liquid chromatography (HPLC) method
for therapeutic drug monitoring (TDM).
Methods: The column was a C-18, 5-micron (100 x 4.6mm) with
a guard column of the same material. The mobile phase was 0.2 M
phosphate buffer, pH 5.5 and acetonitrile (70:30) and the ﬂow rate, 1.5
mL/min. The samples were prepared by mixing with equal volumes of
acetonitrile, left for 5 min and centrifuged (13,000g) for 5 min. Ten
micro-litres of the supernatant was injected. DAPT was detected by UV
absorbance (223 nm). The reproducibility, linearity, accuracy, precision,
and the lowest limit of quantiﬁcation (LLOQ) were investigated.
Results: The retention time (RT) was 6 min. The assay was reproducible:
The % CV was 2.8 for a spiked serum containing 2.5mg/L DAPT (n = 3).
For a serum 5mg/L DAPT sample, the intra-day assay precision %CV
was < 4 (n = 32). The inter-day %CV was < 8. The assay was linear
from 0.5 to 100mg/L (R^2 = 0.9993). Serum recovery was > 93% when
aqueous and serum samples 2.5, 20.0 and 100.0mg/L were compared.
The accuracy was excellent: the observed and the target concentrations
(20, 40 & 80mg/L) were closely correlated, with all the % errors <2.5.
The LLOQ was 0.5mg/L (n = 4, %CV was 5.2).
Conclusion: The HPLC method was reproducible, linear and accurate.
It was straightforward and rapid with a RT of 6 min for DAPT and a
total assay time of 10 min. It will be suitable for both a busy TDM
laboratory and for the rapid processing of large batches of samples for
research purposes.
P1040 Cidal activity of oral third generation cephalosporins
against Streptococcus pneumoniae in relation to cefotaxime
intrinsic activity
F. Caﬁni, L. Aguilar, L. Alou, M.J. Gime´nez, D. Sevillano, M. Torrico,
N. Gonza´lez, J.J. Granizo, J.E. Martı´n-Herrero, J. Prieto (Madrid, ES)
Objective: To explore killing kinetics within 12 h of oral versus
parenteral third generation cephalosporins against ten S. pneumoniae
strains exhibiting cefotaxime MICs from 0.03 to 2mg/l.
Methods: Killing curves were performed following CLSI recommen-
dations with double dilution concentrations ranging from 0.015mg/l to
4mg/l (concentrations achievable in serum after standard doses) and a
ﬁnal inoculum of 1−2 106 cfu/ml. Colony counts were performed at 0,
2, 4, 6, 8, 10, 12 and 24 h. The killing kinetic proﬁle of each antibiotic
was deﬁned as the ﬁgure resulting when concentrations needed to obtain
90%, 99% or 99.9% reductions in initial inocula within 12 h (dosing
interval for oral cephalosporins) are plotted against strains distributed
by increasing cefotaxime MICs.
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Results: The Figure shows the concentrations needed to obtain 90%
reduction in initial inocula within 12 h for the 10 study strains
(white columns: cefotaxime; gray columns: cefditoren; diagonal stripes:
cefpodoxime; black squares: cefdinir; black columns: ceﬁxime).
Conclusion: The similarity of the killing kinetic proﬁles of cefditoren
and cefotaxime may be important when choosing an oral third generation
cephalosporin as initial or sequential therapy in areas with high penicillin
resistance prevalence
P1041 Critical evaluations of generic piperacillin/tazobactam
compared to the branded product: a worldwide sampling
of 26 intravenous formulations
G. Moet, H. Sader, T. Fritsche, R. Jones (North Liberty, US)
Objective: To evaluate generic piperacillin/tazobactam (P/T) intra-
venous product activity by diffusion and MIC assays compared to
branded product (Zosyn® or Tazocin®; Wyeth). P/T is a widely
used penicillin/b-lactamase inhibitor combination (8:1 ratio). Recently,
generic formulations have been introduced into various global markets
said to possess bioequivalence and the original brand was reformulated
using proprietary methods to enhance quality.
Methods: We studied “non-branded” generic lots for antimicrobial
potency against 4 assay organisms (triplicate testing; P/T MICs,
1−4mg/L), and directly compared to current branded agent. Generic
P/T products (26 samples from 23 lots) were from Greece (3 lots), India
(5), Philippines (10), Portugal (1), Taiwan (2), China (2), Jordan (1)
and Spain (2). CLSI susceptibility testing applied reconstituted product
sample vial contents to prepare panels having 20 dilution steps between
0.5−8mg/L. Each strain was tested and the lowest reproducible MIC
value was used for calculating lot potency compared to control (Zosyn®
lot B75011).
Results: All tests were performed on the same day from fresh stock
solutions. 4 manufacturers (Astral, Meditrina, YSS and Zurentus) had 2
or more lots. The branded formulation consistently produced the lowest
MIC results (range, 1.0−3.5mg/L) and generic products had MIC results
that were consistently elevated, indicating reduced activity varying from
−3 to −35% (ave. −16%; only Orchid Piptamate was equal). Largest
differences were observed with Zopercin (151018; −21%), Tazidron
(07077; −27%) and Vigocid (8001C; −35%), and the tazobactam effect
also appeared diminished. A second sampling of 3 lots (PIPTAZ AUPM-
601 and AUPI-601; Vigocid 8002C) exhibited consistently decreased
activity that varied from −3 to −20%, demonstrating reproducibility of
the MIC-based assay.
Conclusions: In vitro activities of various formulations of intravenous
P/T products can vary signiﬁcantly as assessed by this incremental MIC
assay system when applying product vial content to reference dilution
testing. Per-label activity was noted for the branded formulation and
all but one generic lot (among 26 sampled from 15 manufacturers)
had decreased potencies. Hospital formularies should be cautious when
applying generic products without well-documented equivalence by
chemical parameters, biologic tests related to in vivo bioavailability or
clinical outcomes and direct in vitro potency assays.
Product (no. lots) Assay organism MIC (mg/L) % variation
E. coli (2) P. aeruginosa S. aureus
Zosyn control (1) 1.75−3.5 2.0 1.25 NA
STADA (2) 2.5−5.0 2.5−3.5 1.25−1.5 −15 to −23
Tazorex (1) 2.5−5.0 2.5 1.25 −23
Tazotum (2) 2.5−5.0 3.0 1.25−1.5 −11 to −16
Tazidron (2) 1.25−5.0 2.5 1.25 −13 to −27
Piptamate (1) 1.75−3.5 2.0 1.25 0
P1042 In vitro activity of tigecycline against Stenotrophomonas
maltophilia tested by time-kill studies
B. Aracil, Y. Gil, J.L. Go´mez-Garce´s (Mo´stoles, ES)
Introduction: The pharmacodynamic activity of tigecycline for
Stenotrophomonas maltophilia are not deﬁned.
Methods: Antimicrobial susceptibility testing of 80 clinical isolates from
1996 to 2006 was performed by agar dilution. Tigecycline concentrations
were serially increased in time-kill studies with representative strains
of different susceptibility, MIC of 0.5mg/liter, and MIC of 8mg/liter.
The in vitro susceptibility of the strains was tested by time-kill studies
in duplicate. From an initial inocule gives of 0.5 105 ufc/ml serially
counting were done at 0, 2, 4, 6, 24, and 48 h.
Results: Eighty isolates were tested and were found to have the following
antimicrobial susceptibility proﬁles: tigecycline, MIC50 of 2mg/liter and
MIC90 of 4mg/liter; ciproﬂoxacin, MIC50 of 1mg/liter and MIC90
of 8mg/liter; colistin, MIC50 of 16mg/liter and MIC90 of 32mg/liter;
gentamycin, MIC50 of 16mg/liter and MIC90 of 32mg/liter; ceftazidime
MIC50 of 32mg/liter and MIC90 of 32mg/liter; piperacillin-tazobactam
MIC50 of 128mg/liter and MIC90 of 128mg/liter, and imipenem,
MIC50 of 32mg/liter and MIC90 of 32mg/liter. According to FDA
breakpoints 81.2% of the isolates were susceptible to tigecycline, 12% of
the isolates were considered intermediate and 3 isolates were resistant.
A reduction of 0, 0, 1, 2.2, 3, and 3 log10 was produced at 0, 2, 4, 6,
24, and 48 h., respectively.
Conclusion: Concentration escalation studies with tigecycline revealed
a maximal killing effect near the MIC with no additional extent or rate
of killing at concentrations 2× to 4× the MIC for tigecycline with
independence of the categorisation were susceptible or resistant.
P1043 In vitro activity of tigecycline against Acinetobacter
baumannii tested by time-kill studies
B. Aracil, Y. Gil, J.L. Go´mez-Garce´s (Mo´stoles, ES)
Introduction: Tygecicline is a new expanded broad spectrum antibiotic
against Acinetobacter baumannii, its pharmacodynamic activity is not
well deﬁned yet.
Methods: Antimicrobial susceptibility testing of 85 clinical isolates from
1996 to 2006 was performed by agar dilution. Tigecycline concentrations
were serially increased in time-kill studies with representative strains of
different susceptibility: MICs of 0.5mg/l, 1mg/l., 2mg/l, and 4mg/l.
The in vitro susceptibility of the strains was tested by time-kill studies
in duplicate. From an initial inocule gives of 0.5 105 ufc/ml serially
counting were done at 0, 2, 4, 6, 24, and 48 h.
Results: Eighty-ﬁve isolates were tested and were found to have
the following antimicrobial susceptibility proﬁles: tigecycline, MIC50
of 0.25mg/liter and MIC90 of 2mg/liter; ciproﬂoxacin, MIC50 of
0.25mg/liter and MIC90 of 8mg/liter; colistin, MIC50 of 1mg/liter
and MIC90 of 2mg/liter; gentamycin, MIC50 of 1mg/liter and
MIC90 of 32mg/liter; ceftazidime MIC50 of 8mg/liter and MIC90 of
32mg/liter; piperacillin-tazobactam MIC50 of 32mg/liter and MIC90
of 128mg/liter, and imipenem, MIC50 of 1mg/liter and MIC90 of
32mg/liter. According to FDA breakpoints 96.5% of the isolates were
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susceptible to tigecycline. A reduction of 0, 0, 0, 1.2, 3.5, and 3.5 log10
was produced at 0, 2, 4, 6, 24, and 48 h., respectively.
Conclusion: Concentration escalation studies with tigecycline revealed
a maximal killing effect near the MIC, with no additional extent or rate
of killing at concentrations 2× to 4× the MIC for tigecycline for the
susceptible and intermediate strains.
P1044 Bactericidal activity of simulated serum concentrations of
daptomycin vs. vancomycin against vancomycin-susceptible
and resistant Enterococcus faecium: a pharmacodynamic
model
L. Alou, L. Aguilar, D. Sevillano, M.J. Gime´nez, M. Torrico,
N. Gonza´lez, M.J. Este´vez, J. Prieto (Madrid, ES)
Objective: To assess the inﬂuence of protein binding (36.9% for
vancomycin – VAN – and 91.7% for daptomycin – DAP –) and the
decreased susceptibility to VAN in E. faecium on the serum bactericidal
activity of VAN and DAP over the dosing interval.
Methods: Serum concentrations after iv 6mg/kg od DAP vs. 1000mg
bid VAN were simulated in an in vitro computerised one-compartment
dynamic model using Mueller Hinton broth supplemented with 4g/dl
human albumin and 100mg/l calcium. Initial inocula: 7.0 log10
cfu/ml. Antibiotic concentrations and colony counts were determined
(in triplicate) over 24 h. Pharmacokinetic parameters were determined
and AUCall was calculated by the linear-log trapezoidal rule. E. faecium
strains (S) were chosen based on VAN MIC/MBC (mg/l): S1(1/32); S2
(2/64) and S3 (128/>128), with DAP MIC/MBC values of 2/16, 2/8 and
4/16mg/l, respectively.
Results: Cmax (mg/l), t1/2 (h) and AUCs (mg/l x h) were: 44.5 ± 2.6,
6.0 ± 0.5, and 286.5 ± 13.1 for VAN and 85.7 ± 5.8, 8.1 ± 0.2, and
852.7 ± 15.8 for DAP, respectively. Initial inocula ranged from 7.0 to
7.3 log10 cfu/ml. Mean ± SD colony counts (log10 cfu/ml) are shown
in the table.
4 h 6 h 12 h 24 h
VAN S1 7.0±0.1 6.8±0.2 6.3±0.3 5.6±0.2
S2 6.5±0.1 6.5±0.1 6.4±0.4 7.3±0.3
S3 7.7±0.0 8.2±0.2 8.9±0.2 8.9±0.2
DAP S1 4.7±0.6 4.0±0.6 2.6±0.4 3.8±0.7
S2 5.1±0.1 4.9±0.1 4.5±0.1 4.0±0.6
S3 4.7±0.0 4.0±0.2 3.1±0.5 3.6±0.3
Conclusions: DAP exhibited bactericidal activity (>=3 log10 reduction)
at 24 h regardless VAN susceptibility, MBC values or presence of
albumin physiological concentrations. VAN was not bactericidal (<1.5
log10 reduction) even against VAN-susceptible strains.
P1045 In vivo ﬂuoroquinolone concentrations and in vitro selection
of resistance in Streptococcus pneumoniae
E. De Vecchi, L. Nicola, S. Zanini, L. Drago (Milan, IT)
Objective: To compare the ability to select for resistance in
S. pneumoniae of levoﬂoxacin (LVX), ciproﬂoxacin (CIP), pruliﬂoxacin
(PRU) and moxiﬂoxacin (MXF), which are commonly prescribed for
treatment of community acquired infections in Italy.
Methods: Fluoroquinolones susceptible S. pneumoniae (n = 30) isolated
from lower respiratory tract infections were used. Frequency of
spontaneous single-step mutation allowing for bacterial growth in
presence of plasma and epithelial lining ﬂuid (ELF) peak and trough
concentrations were calculated. Multistep selection of resistance was
evaluated by performing 10 serial subcultures on antibiotic-containing
agar plates, in which a linear gradient ranging from the peak to
the trough concentrations of each drug was obtained, followed by 10
subcultures on antibiotic-free agar. LVX was tested at concentrations
obtained with 500mg and 750mg dose. MICs were determined after 1,
5, 10 passages on antibiotic-gradient plates and after 10 subcultures on
antibiotic free agar. Resistant strains selected after multistep selection
were characterised for DNA mutations by sequencing gyrA, gyrB, parC
and parE genes.
Results: LVX and MXF showed the lowest frequencies of mutations
(median <11−11) at plasma peak and at all ELF concentrations, while
medians ranging from 10^-8 to 10^-6 were observed for CIP and PRU. In
multi-step selection of resistance, CIP and PRU selected for the highest
number of resistant strains (19 and 31, respectively. LVX selected for 2
resistant strains at plasma concentrations. No selection of resistance was
observed for LVX ELF concentrations and for plasma and ELF MXF
concentrations. Mutations in parC, parE and gyrA genes were found in
CIP and PRU resistant strains, while only parC mutations were found
for LVX.
Conclusions: LVX and MXF, which are known to possess the highest
activity against S. pneumoniae among the tested ﬂuoroquinolones, are
also characterised by a lower capacity than CIP and PRU to in vitro
select for resistance when tested at concentrations occurring in vivo.
P1046 In vitro selection of resistance by in vivo concentrations
of ﬂuoroquinolones in Pseudomonas aeruginosa and
Staphylococcus aureus
L. Drago, L. Nicola, S. Zanini, E. De Vecchi (Milan, IT)
Objective: To compare the ability to select for resistance in
Staphylococcus aureus and Pseudomonas aeruginosa of levoﬂoxacin
(LVX), ciproﬂoxacin (CIP), and pruliﬂoxacin (PRU).
Method: Twenty strains of S. aureus and of P. aeruginosa susceptible
to ﬂuoroquinolones, isolated from lower respiratory tract, mainly of
nosocomial origin, were considered. Frequency of spontaneous single-
step mutation allowing for bacterial growth in presence of plasma
and epithelial lining ﬂuid (ELF) peak and trough concentrations were
calculated. Multistep selection of resistance was evaluated by performing
10 serial subcultures on agar plates containing a linear gradient ranging
from the peak to the trough concentration of each drug, followed by
10 subcultures on antibiotic-free agar. LVX was tested by considering
concentrations obtained after 500mg and 750mg administration. MICs
were determined after 1,5,10 passages on antibiotic-gradient plates and
after 10 subcultures on antibiotic free agar.
Resistant strains selected were characterised for DNA mutations by
sequencing gyrA, gyrB, grlA, parC and parE genes.
Results: Frequencies of mutations in P. aeruginosa were similar at
plasma and ELF peak concentrations for LVX (median: 8×10−10 and
<10−11 at plasma, 4×10−11 and <10−11 at ELF, LVX 500mg and LVX
750mg, respectively) and CIP (median: <10−11 and 8.67×10−10, at
plasma and ELF, respectively) but higher for PRU (median: 1.25×10−8
and 1.01×10−7 at plasma and ELF, respectively). In S. aureus higher
frequencies of mutations were obtained both with CIP (median:
1.11×10−7) and PRU (median: 2.76×10−10) than with LVX (< 10−11)
at plasma peak concentration.
P. aeruginosa was more prone than S. aureus in becoming resistant to
ﬂuoroquinolones after multi step selection (58 resistant strains vs 47,
P. aeruginosa vs S. aureus). The lowest number of resistant strains was
selected by LVX 750mg both in P. aeruginosa (n = 33) and S. aureus
(n = 3).
Mutations in gyrA, parC, grlA and gyrB were mostly associated with
resistance.
Conclusions: Fluoroquinolones are characterised by a different ability
to select for resistance, depending on bacterial species and in vivo
drug concentrations. Generally, ELF concentrations selected for less
resistant strains than plasma concentrations. Globally, LVX selected for
less resistance than comparators both in P. aeruginosa and S. aureus.
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P1047 Effects of b-lactams on mixed cultures of common
respiratory isolates as an approach to treatment effects on
nasopharyngeal carriage
D. Sevillano, L. Aguilar, L. Alou, M.J. Gime´nez, N. Gonza´lez,
M. Torrico, F. Caﬁni, P. Coronel, J. Prieto (Madrid, ES)
Objectives: To explore b-lactam effects on the evolution over time of a
bacterial load containing common pharyngeal isolates.
Methods: A computerised two-compartment pharmacodynamic model
simulating free serum concentrations obtained with amoxicillin (AMX)
875mg tid, amoxicillin/clavulanic acid (AMC) 875/125mg tid and
cefditoren (CDN) 400mg bid regimens over 24 h was used. Strains and
MICs (mg/l) of AMX, AMC and CDN were: S. pyogenes (0.03, 0.03
and 0.015), penicillin-resistant S. pneumoniae (PRP; 2, 2 and 0.25),
a b-lactamase positive H. inﬂuenzae (BL+; >16, 2 and 0.06) and a
b-lactamase positive AMC-resistant H. inﬂuenzae (BLPACR, >16, 8 and
0.06). A mixture of identical 1:1:1:1 volumes of bacterial suspensions of
each strain were prepared yielding an inoculum approx. 4×106 cfu/ml.
Antibiotic concentrations were measured both in bacteria-free antibiotic
simulations (SBF) and in antibiotic simulations with the mixed inocula
(SMI) and T>MIC calculated.
Results: T>MIC (% dosing interval) and mean % initial inocula
reduction (%IIR; cfu/ml) are shown in the Table.
CDN 400mg bid AMX 875mg tid AMC 875/125mg tid
T>MIC % IIR T>MIC % IIR T>MIC % IIR
SBF SMI SBF SMI SBF SMI
S. pyogenes 84.3 79.0 E 99.9 24.9 92.8 99.9 99.9 E
PRP 24.0 25.6 94.1 43.2 17.7 41.8 40.8 32.8 78.4
BL+ 57.4 58.0 E 0.0 0.0 +66.6 40.8 32.8 +20.1
BLPACR 57.4 58.0 E 0.0 0.0 +2.5 4.5 4.6 +215.1
E = eradicated (cfu/ml below limit of detection). Positive values mean regrowth.
b-lactamase production decreased AMX concentrations and T>MIC
against PRP or S. pyogenes, and eradication was precluded. The presence
of clavulanic acid countered this effect, and S. pyogenes was eradicated
(but not BL+ and PRP). CDN resistance to TEM b-lactamase avoided
this effect, and eradicated S. pyogenes, BL+ and BLPACR, and reduced
in 94.1% S. pneumoniae counts.
Conclusions: Co-pathogenicity seems to be gradual since calvulanic acid
countered this effect for strains very susceptible to AMX as S. pyogenes
but not for strains with AMXMICs values in the limit of susceptibility as
PRP. There is a potential therapeutic advantage for b-lactamase resistant
cephalosporins with high intrinsic activity against streptococci.
P1048 Plasma protein binding of anidulafungin is similar to other
major Echinocandins
P. Inskeep, J. Lin (Groton, US)
Introduction: Anidulafungin is one of three echinocandins approved in
the USA for intravenous treatment of systemic fungal infections. Early
reports, using ultracentrifugation methods relying on total radioactivity,
indicated that protein binding of anidulafungin in human plasma (84%)
was substantially lower than independently determined values of protein
binding for caspofungin (97%) or micafungin (99%). Similar differences
were observed for rat and dog plasma. Subsequent to the initial protein
binding study with anidulafungin, a non-enzymatic intramolecular
rearrangement of anidulafungin when incubated in plasma was observed.
This product retains the radiolabel and thus would not be distinguishable
from anidulafungin when total radioactivity is measured in the protein-
free fraction from ultracentrifugation.
Objectives: To accurately determine protein binding at 37ºC of unlabeled
anidulafungin in rat, dog, monkey, and human plasma using dialysis and
an LC/MS/MS method that is speciﬁc for parent.
Results: Using dialysis and the speciﬁc LC/MS/MS assay, greater than
99% of plasma anidulafungin was observed to bind to protein across the
initial concentration range of 1.0 to 10 ug/mL for all 4 species (and 100
ug/mL in monkey plasma). Thus, all three major echinocandins appear
to be extensively bound to plasma proteins. In addition, the amount of
parent anidulafungin decreased during the incubation period suggesting
that non-binding degradation products of anidulafungin were formed.
Conclusions: Plasma protein binding of anidulafungin is similar to other
major echinocandins. These studies underscore the importance of using
speciﬁc analytical methods, rather than total radioactivity, in assessing
the protein binding of macromolecules having the potential for non-
enzymatic rearrangements.
P1049 Lack of anidulafungin interactions with CYP enzymes and
transporters in in vivo and in vitro systems
P. Inskeep, R. Walsky, B. Feng, S. Campbell (Groton, US)
Introduction: Anidulafungin (ANID) is one of three echinocandins
approved in the USA for intravenous treatment of systemic fungal infec-
tions. Patients with severe fungal infections treated with echinocandins
are usually hospitalised and on multiple drug regimens. The lack of drug-
drug interactions (DDI) of and by ANID with other agents minimises
the need for dose adjustments during polytherapy.
Objectives: Use in vivo and in vitro systems to assess the DDI potential
of ANID.
Methods: Pooled human liver microsomes and puriﬁed CYP2C8 were
used to investigate CYP interactions. In vivo studies in rats and monkeys
were used to assess the potential for CYP induction. Transporter-
transfected HEK cells were used to investigate the potential for ANID
to interact with hepatic transporter systems.
Results: In pooled human liver microsomes, ANID did not in-
hibit CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6 or CYP3A
(IC50>17.5 uM), and a slight inhibition (12.0 uM) of CYP2C8
(amodiaquine N-deethylase activity) was observed. However, using
puriﬁed recombinant human CYP2C8, no inhibition (IC50>17.5 uM)
was observed (rosiglitazone N-demethylase activity). In a 4-week study
in cynomolgus monkey dosed at 0, 2, 5, or 30mg ANID/kg/day,
no changes in total hepatic cytochrome P450 content were observed.
In a 4-week study in Fischer 344 rats dosed at similar targeted
doses, no increases occurred in hepatic enzymatic activity assessed
by total P450 content, 7-ethoxyresoruﬁn O-deethylase, benzphetamine
N-demethylase (36% decrease in high dose male rats), and erythromycin
N-demethylase activities. These studies demonstrate a low potential
for ANID to induce hepatic enzyme activities. The potential for
anidulafungin DDI via interaction with 3 major hepatic transporter
systems was also investigated. ANID was not a substrate for organic
anion transporting polypeptides hOATP-B, hOATP-C, and hOATP-8
across the concentration range of 0.01 to 100 uM. ANID did not
inhibit uptake of probe substrates for hOATP-B or hOATP-C across
the concentration range, and only showed slight inhibition of hOATP-8
(approx. 20%) at a concentration of 10 uM.
Conclusion: Given that circulating plasma concentrations of anidula-
fungin in humans at steady state following the 100mg loading dose
and 50mg/day treatment are in the range of 1 to 3 uM, these results
indicate a very low probability of DDI through CYP or OATP transporter
interactions by anidulafungin.
P1050 The antibacterial activity of PZ-601 (SMP-601) against
MRSA studied in an in vitro pharmacokinetic model
A. Noel, K. Bowker, A. MacGowan (Bristol, UK)
Objectives: PZ-601 (PZ) is a new injectable carbapenem with in vitro
activity against MRSA 2mg/L. We studied the antibacterial activity of
PZ at simulated human serum concentrations against 5 strains of MRSA,
PZ MIC range 0.09−2mg/L, in an in vitro pharmacokinetic (pK) model.
Methods: A single compartment open dilutional in vitro pK model
was used. 5 strains of MRSA were tested: representative strains
of UKEMRSA 15 (PZ MIC 0.38mg/L), UKEMRSA 16 (PZ MIC
0.19mg/L), the Michigan strain VISA (PZ 0.75mg/L) and two MRSA
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with MIC values on the low (PZ MIC 0.09mg/L) and high (PZ MIC
2mg/L) ends of the MIC distribution. PZ concentrations simulated were
Cmax of 35mg/L, t 12 1.5 h with dosing 12hly for 48 h. The inoculum
was 106 CFU/ml. Emergence of resistance was assessed by population
analysis proﬁles.
Results: The antibacterial effect was – PZ reduced MRSA count by
2.3−4.3 logs at 24 h and >4 logs at 48 h. Strain kill kinetics were similar
across the range of MICs tested. No resistance was detected.
Conclusion: PZ-601 at simulated human serum concentrations had a
marked antibacterial effect against MRSA strains MIC 2mg/L
Strain
33922 36895/
EMRSA16
27706/
EMRSA15
19898
VISA
33820
PZ MIC (mg/L) 0.09 0.19 0.38 0.75 2.0
log change in viable count at
6 h −2.1 −3.7 −2.9 −3.1 −2.4
12 h −2.5 −3.7 −2.5 −3.5 −2.3
24 h −2.4 −3.7 −2.3 −4.3 −2.3
36 h −4.2 −4.4 −4.5 −4.3 −4.2
48 h −4.2 −4.4 −4.5 −4.3 −4.2
P1051 The antibacterial activity of telavancin and vancomycin
against UK EMRSA 15 and 16 strains studied in an in
vitro pharmacokinetic model
A. Noel, K. Bowker, S. Tomaselli, A. MacGowan (Bristol, UK)
Objective: Telavancin (tela) is an injectable new semi synthetic
lipoglycopeptide antibiotic with broad activity against Gram-positive
pathogens including MRSA. It has a double mechanism of action
on the cell membrane and wall resulting in bactericidal activity. We
used an in vitro pharmacokinetic (pK) model to simulate serum free
drug concentrations of tela and vancomycin (vanco), and studied their
antibacterial effect against representative strains of UK EMRSA 15 and
16.
Methods: A single chamber dilutional in vitro pK model was used
to simulate serum free drug concentrations. Tela Cmax 10mg/L, t 12
8 hr, 2 doses over 48 h; vanco Cmax 14mg/L, Cmin 3.5mg/L, 4 doses
over 48 h. Two strains of UK EMRSA 15 and 16 were used (both tela
MIC 0.19mg/L). Experiments were performed in triplicate at an initial
inoculum of 10^6 CFU/ml. Antibacterial effect was measured by log
change in viable count at 6 h (d6), 12 h (d12), 24 h (d24) and 48 h
(d48). The maximum kill was recorded (dmax) and the area-under-the-
bacterial-kill curve between 0–24 h (AUBKC24) and 0–48 h (AUBKC48)
calculated.
Results: The killing kinetics of both strains were similar, therefore
the antibacterial effect measures were pooled for tela and vanco, and
compared.
Conclusion: Tela produced signiﬁcantly greater early killing of EMRSA
15 and 16 than vancomycin (d6, d12). The maximum kill was also greater
(dmax) as was the antibacterial effect in the ﬁrst 24 h (AUBKC24).
tela vanco p
d6 −3.8±0.2 −2.7±0.8 0.008
d12 −4.0±0.3 −3.3±0.3 0.034
d24 −1.9±0.4 −2.4±0.2 0.134
d48 −1.7±0.5 −1.7±1.0 0.960
dmax −4.0±0.1 −3.2±0.1 0.005
AUBKC24 21.5±6.9 33.8±3.2 0.05
AUBKC48 62.5±17.7 85.5±10.5 0.12
P1052 Inoculum effect of b-lactams and killing curves
determination in AmpC-producing (DHA-1) Klebsiella
pneumoniae isolates
H. Cerna, T. Bergerova, P. Urbaskova, J. Hrabak (Plzen, Prague, CZ)
Objectives: An inoculum size is a critical point in treatment of
infections caused by extended-spectrum b-lactamase- and AmpC-
producing bacteria. A treatment failure was described in many cases
of infections due to these bacteria. An inoculum effect determined by
standard dilution method is not an appropriate model of the infection
process in organism. The aim of this study is to compare the inoculum
effect determination on b-lactams by a standard microdilution method
and the description of dynamic of bacterial population of AmpC-
producing Klebsiella pneumoniae after addition these antibiotics.
Methods: Four DHA-1 producing Klebsiella pneumoniae strains (two
inducible and two with high level of expression) were used in this study.
MIC and inoculum effect was determined by a classical microdilution
broth method (CLSI). Dynamic of bacterial population – bacterial count
was measured by direct plating samples after addition antibiotic in brain-
heart infusion.
Results: Using standard inoculum (105 CFU per ml), the strains
producing inducible AmpC were determined as non-resistant to
cefotaxime (CTX) (MIC = 1mg/l), ceftazidime (CAZ) (MIC = 4mg/ml)
and cefepime (FEP) (MIC = 2mg/l) according to EUCAST criteria.
When the inoculum was 106 CFU/ml, the strains were resistant to all
tested b-lactams (e.g. MIC of CTX was 256mg/ml, MICs of CAZ and
FEP were 1024mg/ml). The strain with a high-level expressed AmpC
was not resistant only to cefepime (MIC = 2mg/l). MIC of CTX was
64mg/l and of CAZ 128mg/l. Killing curves showed different times
required for an inactivation of antibiotics. For the strains producing
inducible AmpC, decreasing count of bacteria were observed in CTX
for 6 hrs in a concentration of 1mg/l, at least for 7 hrs in a concentration
of 2mg/l, in CAZ for 3 hrs in a concentration of 1mg/ml, for 6 hrs in a
concentration of 8mg/l and in FEP for 3 hrs in a concentration of 1mg/l
and at least for 7 hrs in a concentration of 8mg/l.
Conclusions: This work showed that the time required for hydrolyzing
antibiotics by b-lactamases under the MIC is shorter than the time
recommended for MIC reading by standard method. Therefore the
data obtained using microdilution method do not exactly described the
situation in the organism and the inoculum effect could be misinterpreted
due to lack of antibiotic in a well of microtiter plate.
This work was supported by a research project MSM 0021620819.
P1053 In vitro enrichment of resistant Staphylococcus aureus
at daptomycin subtherapeutic concentrations within the
mutant selection window: effect of treatment duration
S. Vostrov, I. Lubenko, S. Zinner, A. Firsov (Moscow, RU;
Cambridge, US)
Objective: To study time-dependent enrichment of resistant sub-
populations and concomitant loss in susceptibility of S. aureus, ten-day
treatments with daptomycin (DAP) were simulated in vitro.
Methods: S. aureus ATCC 43300 (MICDAP 0.2mg/L) was exposed
to once-daily dosing of DAP at subtherapeutic ratios of area under the
curve (AUC) to the MIC of 32 and 64 h, which have been reported
recently to result in maximal selection of resistant mutants. Susceptibility
(culture MIC) and bacterial growth on agar plates containing 2× and
4×MIC were tested daily. To provide an integral presentation of the
time course of mutants grown on DAP-containing plates, areas under
the bacterial mutant kinetic curves (AUBMCs) were calculated from the
start of treatment to the 3rd (AUBMC3), 5th (AUBMC5) and 10th day
(AUBMC10) of treatment.
Results: With both dosing regimens, DAP-resistant S. aureus were
enriched on the third day. Further enrichment occurred gradually, without
abrupt increases in mutant numbers. By the end of each treatment,
numbers of mutants resistant to 2× and 4×MIC of DAP were comparable
to those of susceptible organisms, but they were not completely replaced
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by DAP-resistant mutants. Similar patterns were inherent in the time
course of susceptibility of DAP-exposed cultures, with 16- and 8-fold
increases in the MIC by the end of treatment at AUC/MIC of 32
and 64 h, respectively. This gradual enrichment of resistant mutants
and concomitant loss in susceptibility were conﬁrmed by the AUBMC
analysis. At AUC/MIC of 32 h, production of mutants resistant to
4×MIC was reﬂected by a 2.9 times greater AUBMC10 than AUBMC5
and by a 2.2 times greater AUBMC5 than AUBMC3. At AUC/MIC of
64 h, AUBMC10 was 3 times greater than AUBMC5 and AUBMC5 was
2.1 times greater than AUBMC3.
Conclusions: The time-resistance relationships established in this study:
(1) allow prediction of subsequent enrichment of DAP-resistant mutants
and concomitant loss in susceptibility after long-term treatments based
on data obtained in shorter treatments, and (2) show that relatively
minimal early expressions of resistance seen in short treatments are
precursors of more resistance that occurs with longer DAP treatments.
P1054 Daptomycin pharmacodynamics against Staphylococcus
aureus hemB mutants expressing the small colony variant
phenotype
D. Begic, C. von Eiff, B. Tsuji (Buffalo, US; Mu¨nster, DE)
Objectives: S. aureus small colony variants (SCVs) are slow-growing
morphological variants of S. aureus that have been associated with
poor clinical response to prolonged antimicrobial therapy. Recently, we
determined that vancomycin bactericidal activity is attenuated against
genetically deﬁned S. aureus mutants displaying the SCV phenotype.
Limited data exist on the killing activity of daptomycin (DAP) against
SCVs. In this study, the bactericidal activity & pharmacodynamics
(PD) of DAP were evaluated against site-directed hemB mutants
(hemB::ermB) displaying the SCV phenotype.
Methods: The wild-type meticillin-resistant S. aureus strain COL &
the meticillin-susceptible strain Newman, as well as their corresponding
hemB mutants with SCV phenotype, Ia48 & III33, were used for these
studies. MICs were performed in quadruplicate as per CLSI. Log phase
time kill experiments were performed in duplicate for each strain at
106 CFU/ml at increasing DAP concentrations (0, 0.5, 1, 2, 4, 8, 16,
32, 64 times the MIC) over 24 h. PD analysis was performed using an
integrated area approach for reduction in area under the CFU versus
time curve from 0 to 24 h, Log10(AUCdrug/AUCgrowth control) versus
DAP concentration:MIC which was ﬁt to a Hill-type pharmacodynamic
model.
Results: MICs for DAP against COL, Newman, Ia48, and III33 were
1.0, 1.0, 2.0 & 2.0mg/L, respectively. DAP exhibited concentration
dependent, bactericidal activity against both S. aureus phenotypes.
Against the wild type strains COL and Newman exposure to DAP at
concentrations 4.0 x MIC achieved 99.9% kill by 6 h. Values >4.0
log10 CFU/ml reductions occurred at 4 h exposed to8.0 x MIC of DAP.
Against both mutants, 99.9% kill was achieved for DAP 16 x MIC in
8 h. Maximal bacterial reductions for normal phenotype/hemB mutant
COL/Ia448 & Newman/III33 at 24 h at maximal exposure were −5.4/−5.0
−5.5/5.0 log10 CFU/ml. Maximum likelihood parameter estimates for
reduction in area for Emax for COL/Ia48 & Newman/III33 were 5.8/4.6
& 5.6/4.5. PD model ﬁts describing the concentration-effect relationship
for DAP vs. all strains were excellent (r2 0.97).
Conclusion: S. aureus SCVs represent a major therapeutic challenge.
DAP achieved rapid and sustained bactericidal activity against both
S. aureus hemB mutants tested displaying the SCV phenotype. This
study may have implications for the optimal therapy of persistent and
difﬁcult-to-treat infections due to S. aureus SCVs.
P1055 In vitro adsorption and release of antibiotics from
cancellous bone
T. Sahinides, K. Kanellakopoulou, N. Galanakis, Z. Chrisouli,
H. Giamarellou (Athens, GR)
Objectives: Drug delivery systems have become of signiﬁcant impor-
tance in the contemporary management of chronic bone infections.
Several antibiotics have been studied for their release patterns from
cancellous bone. We report the adsorption and elution proﬁle of human
cancellous bone impregnated with moxiﬂoxacin (MXF), teicoplanin
(TEIC) and fucidic acid (FUC).
Methods: ~1 g of processed cancellous bone was compressed into a
wire-mesh cylinder made of stainless steel and impregnated with 5ml
of antibiotic solution (100mg/ml, active product ingredient) for 1 hour
at room temperature. Five replicates for each antibiotic were incubated
separately at 37 oC in 5ml of Mueller Hinton broth and transferred daily
into a new elution tube for 42 days. The amount of antibiotic eluted
in broth was assessed by a microbiological assay (agar diffusion using
Bacillus subtilis ATCC 6633 for MXF and TEIC and Corynebacterium
404 CIP 5216 for FUC).
Results: High concentrations of MXF and FUC were measured on the
ﬁrst 5 days (>100mg/ml) with a rapid decline until day 10 (mean value
~50mg/ml), showing a steady state curve thereafter. On day 20 the MXF
concentration remained signiﬁcant (~25mg/ml), whereas the amount of
FUC decreased to ~13mg/ml. On day 30 MXF concentration maintained
a value of ~10mg/ml as opposed to FUC concentration (~2.9 mg/ml). By
day 40 the MXF level was reduced to ~2mg/ml. On the contrary, very
low levels of TEIC were measured after the ﬁrst 4 days (<10mg/ml).
Conclusion: After an initial burst of release in the ﬁrst 5 days, MXF
attained high concentration in the elution ﬂuid for up to 4 weeks. FUC
had a similar release pattern reaching the lowest values in less time.
TEIC was found to have an inferior elution proﬁle against the other two
antibiotics. Cancellous bone can be used as a carrier of antibiotics for
local delivery. The implications of these ﬁndings need to be examined
in the clinical setting.
Antibiotic elution proﬁle.
P1056 Hypoxia induces antibiotic resistance in Pseudomonas
aeruginosa
B. Schaible, K. Schaffer, D. Keating (Dublin, IE)
Objectives: Cystic Fibrosis (CF) is an autosomal recessive disorder with
a frequency in Ireland of 1/1461 live births. Pulmonary Pseudomonas
aeruginosa infection contributes signiﬁcantly to morbidity and mortality
in CF. Within the CF lung bioﬁlm P. aeruginosa is exposed to hypoxic
conditions and is often found to be multiresistant to various antibiotics.
In this study we investigated the inﬂuence of hypoxia on antibiotic
resistance in P. aeruginosa.
Methods: P. aeruginosa was incubated in cation adjusted Mueller-Hinton
broth for 6 h under either ambient normoxic (21% oxygen) or hypoxic
conditions (1% oxygen). IC50 values for chloramphenicol, ciproﬂoxacin
hydrochloride, novobiocin, tetracycline and tobramycin were determined
after incubation of P. aeruginosa in increasing antibiotic concentrations
in either normoxia or hypoxia. IC50 values were calculated as changes in
optical density measurements (OD610). To identify potential molecular
mechanisms underlying resistance development, expression levels of
the 4 major multidrug efﬂux pumps of P. aeruginosa (mexAB-
OprM, mexCD-OprJ, mexEF-OprN) were investigated. After incubation
in hypoxia bacterial mRNA was isolated using phenol chloroform
extraction and reverse transcribed. Expression levels were measured by
real time PCR with primers amplifying segments from mexA, mexC,
mexE cDNA.
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Results: Incubation in hypoxia for 6 h signiﬁcantiy increases IC50
values for ciproﬂoxacin HCl (p = 0.038) and tobramycin (p = 0.006). IC50
values for chloramphenicol (p = 0.076) and novobiocin (p = 0.083) were
increased without reaching signiﬁcance. Hypoxia did not affect IC50
values for tetracycline. Preliminary analysis of mRNA expression levels
for mexA, mexC and mexE showed no difference between normoxic and
hypoxic conditions.
Conclusion: Short term incubation in hypoxia increases antibiotic
resistance in P. aeruginosa. We speculate that hypoxia within the CF
lung could be an important stimulus for the development of antibiotic
resistance.
P1057 Evaluation of vancomycin and daptomycin against MRSA
and hVISA in an in vitro PKPD model with simulated
endocardial vegetations
M. Rybak, S. Leonard (Detroit, US)
Objectives: Historically vancomycin (VAN) has been the primary
treatment for infections caused by meticillin-resistant Staphylococcus
aureus (MRSA). However, continued selective pressure has led to
non-susceptible strains including hVISA. Infections with hVISA are
associated with prolonged bacteraemia and VAN failure and are often
high bacterial load infections. Our own study of hVISA at the Detroit
Medical Center (DMC) from 2003–2006 demonstrated a prevalence of
8.3%. The objective of this study is to evaluate VAN and daptomycin
(DAP) against VAN susceptible MRSA and hVISA in a PK/PD simulated
endocardial vegetations (SEV) model.
Methods: Five clinical isolates were used, MRSA 494, MRSA 67,
hVISA(s) 1720, 2295 and 1629. All isolates were obtained from the
DMC. The hVISA strains were conﬁrmed by population analysis proﬁle
ratio with Mu3 as the control strain. Simulated doses of VAN 1 g
Q12 h (Cmin 5–10mg/L) and 2 g Q12 h (Cmin 15–20mg/L), and DAP
6mg/kg Q24 h (Cmax 95.7mg/L), 10mg/kg Q24 h (Cmax 129.7mg/L),
and 12mg/kg Q24 h (Cmax 164.8mg/L) were used in the PK/PD SEV
model over 72 h in duplicate. Changes in bacterial CFU/g at 72 h
were compared by ANOVA with Tukey’s post-hoc test. P 0.05 was
considered signiﬁcant.
Results: VAN MIC was 0.5mg/L for MRSA 494, MRSA 67, and hVISA
1720; 1mg/L for 2295; and 2mg/L for 1629. DAP MIC values were
0.125 for MRSA 67 and hVISA 1720 and 0.25mg/L for MRSA 494,
hVISA 1629, and hVISA 2295. Against both MRSA strains DAP 10 and
12mg/kg killed to detection limits (> 7 log10 CFU) by 24 h and 6mg/kg
by 48 and 56 hours (average T99.9 for 6mg/kg – 6.2 h; 10mg/kg – 2.7 h;
12mg/kg – 2.4 h) whereas VAN achieved a maximum kill of 2−3 log10
CFU/g by 72 h (P<0.01). Against hVISA strains, VAN only reduced
the bacterial load by 1−1.5 log10 CFU/g over 72 h regardless of dose
exposure, whereas DAP achieved rapid bactericidal kill (average T99.9
for 6mg/kg – 10 h; 10mg/kg – 5.6 h; 12mg/kg – 4.8 h) to detection
limits of 2 log10 CFU/g (P< 0.01).
Conclusion: Overall, DAP achieved rapid and effective kill against both
MRSA and hVISA. VAN however, displayed slow and minimum kill
against MRSA at high inoculum and displayed minimal to no activity
versus hVISA regardless of high dose exposure. Further evaluation of
high-dose DAP is warranted.
P1058 Intracellular activity of antibiotics against a stable small
colony variant of Staphylococcus aureus isolated from a CF
patient in model Calu-3 human airway epithelial cells
H.A. Nguyen, O. Denis, A. Vergison, P.M. Tulkens, M.J. Struelens,
F. Van Bambeke (Brussels, BE)
Objectives: Persistence of S. aureus infections in CF may be related to
the presence of small colony variant (SCV) variants and of intracellular
bacteria. Using a stable thymidine-auxotrophic mecA negative SCV
of S. aureus isolated from a CF patient, we showed that most
antibiotics (AB) act only poorly on intracellular forms in a model
of human THP-1 macrophages (ICAAC 2007, abstr. A1437). We
have now compared the activity of commonly used (gentamicin,
rifampicin, vancomycin, moxiﬂoxacin) and newly developed AB
(linezolid, tigecycline, oritavancin) against this SCV isolate using Calu-3
cells as a model of airway epithelium.
Methods: MICs were determined in MH broth after 48 h incubation.
Intracellular activities (IA) were measured as the change in post-
phagocytosis inoculum [delta log CFU] after 24 h or 96 h in Calu-3 cells
(normal bronchial epithelial cells) incubated with ABs at extracellular
concentrations (Ce) corresponding to their respective peak (Cmax), free
peak (fCmax), trough (Cmin) and free trough (fCmin) in plasma when
administered at standard doses.
Results: Over 24 h, the intracellular inoculum remained constant (−0.14
± 0.01 log CFU with 10mg/L lysostaphin to prevent extracellular
growth). All AB showed a concentration-dependent effect, with a
signiﬁcant inoculum decrease at Cmax for TGC, LNZ and RIF, fCmax
for MXF, Cmin for ORI low dose, and fCmin for GEN, VAN and ORI
high dose. At 96 h, the activity of all drugs (except LNZ and TGC)
markedly progressed at Cmax, approaching or reaching a bactericidal
effect, while regrowth was observed at Cmin for all drugs but VAN,
MXF and RIF.
AB MIC (mg/L) delta log CFU measured at 24 h for Ce (mg/L) corresponding to
Cmax fCmax Cmin fCmin
Ce IA Ce IA Ce IA Ce IA
TGC 0.125 1 −0.54±0.05 0.2 0.17±0.04 0.13 0.18±0.12 0.026 0.55±0.14
LNZ 2 16 −0.98±0.07 8 −0.19±0.04 4 −0.16±0.08 2 0.21±0.09
RIF 0.0005 18 −0.59±0.08 2.7 −0.28±0.08 1.2 −0.23±0.11 0.18 −0.14±0.09
MXF 0.125 4 −1.74±0.18 2 −1.34±0.05 0.4 −0.20±0.08 0.2 0.17±0.02
GEN 0.125 18 −1.72±0.10 18 −1.72±0.10 1.5 −0.62±0.11 1.5 −0.62±0.11
VAN 0.5 50 −1.59±0.01 22.5 −1.28±0.04 10 −0.93±0.12 4.5 −0.89±0.09
ORI 200mg 0.015a 32 −1.91±0.02 4 −1.27±0.05 2 −0.85±0.05 0.5 −0.22±0.02
ORI 800mg 0.015a 128 −2.53±0.53 16 −1.61±0.05 16 −1.81±0.05 2 −0.85±0.05
a In the presence of 0–0.002% P80.
Conclusion: Prolonged incubation with high concentrations of bacteri-
cidal drugs is needed to durably act on intracellular SCVs, suggesting
the importance of AB selection and PK/PD optimisation to avoid failure
in eradicating these bacteria in CF patients.
P1059 Activity of antibiotic combinations towards intracellular
small colony variants of Staphylococcus aureus in a model
of THP-1 macrophages
H.A. Nguyen, O. Denis, A. Vergison, P.M. Tulkens, M.J. Struelens,
F. Van Bambeke (Brussels, BE)
Objectives: In a model of human THP-1 macrophages intracellular
infection, small colony variants (SCV)s of S. aureus have been shown to
be poorly susceptible to most antibiotics (ICAAC 2007, A1437), except
ORI, MXF or RIF (−2 log CFU in 24 or 72 h). In the present study, we
have examined whether combining these drugs could further enhance
intracellular efﬁcacy in comparison with conventional associations (RIF-
OXA, RIF-VAN, RIF-FA) as comparators.
Methods: We used a stable thymidine-auxotrophic mecA negative
SCV of S. aureus isolated from a cystic ﬁbrosis (CF) patient. MICs
were determined in MH broth after 48 h incubation. Intracellular
activities were measured as the change in post-phagocytosis inoculum
[delta log CFU] after 24 h or 72 h of incubation with antibiotics at
extracellular concentrations corresponding to their respective serum peak
concentration (Cmax) when administered at standard doses.
Results: Combination of RIF with OXA, VAN, FA, or MXF was
indifferent (same activity as RIF alone at 24 h, slight reduction at 72 h).
In contrast, combination of ORI with RIF or MXF resulted in synergistic
effects both at 24 h and 72 h (higher activity than observed for the most
active drug given alone), with RIF-ORI reaching the limit of detection
at 72 h.
Conclusion: The data suggest that combining oritavancin with other
bactericidal antibiotics may prove useful for eradicating intracellular
SCVs, and plead for the further evaluation of such combinations in in
vivo pertinent models of recurrent staphylococcal infections that imply
SCVs.
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Antibiotic(s) MIC
(mg/L)
Cmax
(mg/L)
Delta log CFU from initial
inoculum at
24 h 72 h
Oxacillin [OXA] 0.125 64 −0.06±0.04 −1.31±0.06
Vancomycin [VAN] 0.5 50 −0.11±0.04 −1.35±0.08
Fusidic acid [FA] 0.03 30 −0.33±0.07 −0.87±0.04
Rifampicin [RIF] 0.0005 18 −1.40±0.18 −3.39±0.18
Moxiﬂoxacin [MXF] 0.125 4 −1.20±0.05 −2.53±0.04
Oritavancin [ORI] 0.015a 25 −2.53±0.10 −2.98±0.11
RIF−OXA −1.28±0.05 −2.81±0.01
RIF−VAN −1.42±0.04 −2.75±0.01
RIF−FA −1.06±0.01 −2.44±0.11
RIF−MXF −1.22±0.06 −2.95±0.07
RIF−ORI −3.19±0.10 >5b
MXF−ORI −3.26±0.13 −4.18±0.16
aDetermined in the presence of 0.002% P80.
bBelow the limit of detection (−5 log).
P1060 Identiﬁcation of a Staphylococcus aureus strain with
increased intracellular growth and reduced intracellular
susceptibility to gentamicin
A. Olivier, F. Van Bambeke, M.P. Mingeot-Leclercq, P.M. Tulkens
(Brussels, BE)
Objectives: The persistence and recurrence of many S. aureus infections
(such as endocarditis) has been ascribed to its intracellular character. Our
aim was to examine the intracellular development of S. aureus strains
differing by their hemolysin (hl) production as well as their intracellular
response to antibiotics, using both phagocytic (THP-1) and endothelial
cells (HUVEC).
Methods: Intracellular growth was measured by the change in CFU
(Delta log /mg prot.) recorded 24 h after infection. Controls were
maintained with gentamicin (1 x MIC) to prevent the development of
extracellular bacteria. Confocal microscopy was performed with bacteria
tagged with ﬂuorescein isothiocyanate, and vital staining of lysosomes
using LysoTracker® Red DND 99.
Strain Characteristics Gentamicin
MICa
(mg/mL)
Intracellular
growth in
THP-1
Gentamicin concentr. (in
× MIC) allowing to reach
a static effect
Intracell. Extracell.
8325-4 Laboratory strain cured of all
prophages.
0.2 0.2±0.1 2.3×MIC 1.5×MIC
DU5942 Mutant derived from
8325-4. Disrupted for
gamma-hemolysin (hlg)
0.3 1.9±0.1* 5.0×MIC 1.3×MIC
DU5942-M1 Mutant derived from
8325-4. Disrupted for hlg
and complemented with
pCU1-hlg+
0.3 1.8±0.1* 5.0×MIC 1.3×MIC
DU5938 Mutant derived from 8325-4.
Disrupted for alpha- (hla),
beta- (hlb), and gamma- (hlg)
hemolysins
0.2 0.3±0.1 − −
n = 3. *p< 0.001 (ANOVA)
aMicrodilution in Mueller-Hinton broth pH 7.4.
Results: S. aureus DU5942 showed a more important intracellular
growth than the other strains (also observed in HUVEC). This was not
due to hlg disruption, since it was also observed for the complemented
strain DU5942-M1 but not for the multidisruptant strain DU5938. Dose-
effects studies with gentamicin showed a similar response for all tested
strains extracellularly. In contrast, DU5942 and its M1 mutant were
less sensitive to gentamicin than 8325−4 intracellularly, exposure to
higher extracellular concentrations being required to prevent intracellular
growth. No difference was seen between strains for other antibiotics
(oxacillin, vancomycin or telavancin). Confocal microscopy showed
that, after 24 h of infection, all strains were conﬁned in lysosomes in
THP-1 macrophages. In endothelial cells, most bacteria colocalised with
lysosomes but a small number appeared free in the cytoplasm.
Conclusion: We identiﬁed a strain with high capacity of intracellular
growth in both professional phagocytes and endothelial cells. This effect
seems to be related to a lower intracellular susceptibility of the strain to
gentamicin but not to its hl status.
P1061 Quantitative determination and pharmacokinetics of
oritavancin in rabbit serum and tibia
O. Be´langer, O. Rozborskaya, E. Dietrich, M. Malouin, V. Ostiguy,
I. Fadhil, K. Laquerre, D. Lehoux, A. Rafai Far, T.R. Parr Jr.
(St-Laurent, CA)
Objectives: Oritavancin is a novel lipoglycopeptide characterised by
its activity against Gram-positive organisms, including vancomycin-
resistant staphylococci and enterococci, and its long half-life. It is
under preclinical evaluation for the treatment of osteomyelitis, an
acute or chronic bone infection predominantly caused by staphylococci
and requiring prolonged parenteral antibiotic administration. Given the
importance of the rabbit model of chronic osteomyelitis in predicting
clinical efﬁcacy, we report here pharmacokinetic parameters in rabbit
serum and tibia.
Methods: Rabbits were administered a single intravenous (IV) dose
of oritavancin at 20mg/kg. They were sacriﬁced at 7 time points
ranging from 5 minutes to 7 days (n = 3/time point), a blood sample
was collected and the tibiae were harvested and ground to a powder.
Oritavancin was extracted from serum by the precipitation of serum
proteins with acidiﬁed acetonitrile. Given the difﬁculties in extracting
the oritavancin from bone, an indirect method of analysis was sought
whereby the concentration of oritavancin was determined through the
detection of a product of acidic degradation, 4-(4-chlorophyl)benzyl-
4-epi-vancosamine (CBV). A 50mg fraction of the tibia powder was
acidiﬁed with 0.5ml of 1N HCl and incubated for 5 minutes at 70
degrees Celsius. After centrifugation, the supernatant was transferred
and the pellet treated two times under the same conditions. CBV in
the pooled supernatants was concentrated by solid phase extraction.
The quantitative determinations of oritavancin and CBV relied on liquid
chromatography/mass spectrometry (LC/MS).
Results: The dose-response curves of oritavancin in serum and in tibia
were linear with a limit of quantitation (LOQ) of 0.0125mg/L and
0.2mg/kg, respectively. The serum concentration was 200mg/L at 5
minutes with a half-life of 2.4 hours, falling below 5mg/L after 24
hours with a terminal half-life of 40 hours. The maximal concentration
of the drug in tibia was 15mg/kg of bone, reached at 5 minutes and
maintained for at least the ﬁrst 24 hours, and a half-life of 12 days. The
calculated area under the curve (AUC) in serum and tibia was 1001 hour
x mg/L and 1992 hour x mg/kg, respectively.
Conclusion: Oritavancin rapidly penetrates in osseous tissues and is
maintained there at high concentration. It is slowly eliminated, such that
its levels are maintained for days, suggesting a potential for the treatment
of bone infection.
P1062 In vivo selection of carbapenem-resistant Pseudomonas
aeruginosa following sub-optimal dosing
V.H. Tam, K.R. Ledesma, A.N. Schilling, K.T. Chang, T.P. Lim,
R. Ghose, R.E. Lewis (Houston, US; Singapore, SG)
Objective: We have previously demonstrated P. aeruginosa (PA)
resistance emergence due to sub-optimal carbapenem exposures in an
in-vitro infection model (Antimicrob Agent Chemother 05), but the in-
vivo relevance of the observations is not well established. We examined
the impact of a sub-optimal carbapenem exposure on PA resistance
emergence in a neutropenic murine pneumonia model.
Methods: Female Swiss-Webster mice (22–26g) were rendered neu-
tropenic by 2 doses of cyclophosphamide on day-4 and -1; transient
nephrotoxicity was induced by uranyl nitrate on day-2. Anesthesised
animals were infected with approximately 10^6 CFU of PA [a mixture
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of wild-type (WT) ATCC 27853 and its isogenic porin deleted (OprD−)
mutant (MIC of 1mg/l and 4mg/l, respectively) in a 1000:1 ratio] intra-
tracheally under laryngoscopic guidance. Serum TNF-alpha and IL-6
were measured by ELISA 16 hours after infection. Pharmacokinetics of
meropenem in infected animals was determined by a single dose study.
Ten animals were treated with either IP meropenem 400mg/kg every
8 hours or placebo. Treatment was given 2 hours after infection for 4
days. Quantitative assessment of bacterial burden [total and those with
reduced susceptibility (3×MIC)] in animal lung tissues was performed
at baseline, upon death or at the end of experiment.
Results: Both serum TNF-alpha and IL-6 were found to be signiﬁcantly
elevated in infected animals, compared to controls (p<0.01). The
meropenem dose used (400mg/kg) resulted in a Cmax of 354.1mg/l and
terminal t1/2 of 18.9 minutes. The corresponding T>MIC for the WT
and OprD-mutant were 33% and 26%, respectively. Meropenem therapy
offered a signiﬁcant survival beneﬁt at day 4 (100% vs 0%, p< 0.01),
but complete replacement of bacterial population by the OprD-mutant
in lung tissue was observed in 30% of the animals.
Conclusion: Our in-vivo results validated previous in-vitro observations
that sub-optimal meropenem exposures might facilitate selective
ampliﬁcation of resistant sub-population(s) in a heterogeneous PA
population. Optimal dosing regimen design should aim at preventing
resistance emergence during treatment, in addition to clinical beneﬁts.
P1063 Itraconazole-ciproﬂoxacin interaction on the
pharmacokinetics of the intestinal compartment:
preliminary results in rats
A. Benini, C. Caveiari, P. Franceschetti, E. Bertazzoni (Verona, IT)
Among their pharmacokinetic characteristics ﬂuoroquinolones (FQs) ex-
hibit transintestinal and biliary elimination; moreover, they may interfere
with hepatic metabolism. Interactions of FQs with enzymeinhibitors or
inducers could be possible during therapy. The inhibitory effects on the
hepatic metabolism of Itraconanzole (Itz) should be considered in the
kinetics of FQs.
Objectives: To study the effect of Itz on intestinal kinetics of
Ciproﬂoxacin (Cpx) following different administration schedule.
Methods: Wistar rats (weight 174.0+12.5 g, mean+SD) divided in
three groups were treated as follows: group 1: Cpx, 15mg/kg/day,
orally administered by gavage for three days; group 2: Cpx two hours
after oral administration of Itz (10mg/kg/day) for three days; group
3: Cpx for 3 days and Itz (10mg/kg/day) on the 2nd and 3rd day of
Cpx administration. Samples of blood, intestinal and hepatic tissues
and faeces were collected after three days of treatment, two hours
after the last Cpx administration. Cpx concentrations were determined
by microbiological assay (agar-well diffusion method, K. pneumoniae,
Isosensistest agar).
Results: reported in the table as mean+SD
After three days of Itz administration the levels of Cpx increased
signiﬁcantly in liver and faeces (not signiﬁcantly) while decreased in
serum (1/4 positive samples) and intestinal tissues. The administration
of Itz for 2 days in rats in treatment with Cpx induced a signiﬁcant
increase of Cpx serum levels, a reduction of intestinal levels and a
marked decrease in faeces in comparison to Cpx alone.
Drugs Serum (mg/L) Intestinal
tissue
(mg/kg)
Liver
(mg/kg)
Faeces
(mg/kg)
Cpx 0.05±0.01 (5/5) 10.4±12.2 0.0±0.0 231.6±279.9
Cpx + Itz 3 days 0.06 (1/5) 4.2±2.7 1.0±0.3** 367.3±264.9
Cpx + Itz 2nd-3rd d 0.2±0.2* (5/5) 7.2±2.4 0.0±0.0 111.8±29.7
*p< 0.05, **p< 0.01 Students t test versus Cpx alone
Conclusions: These preliminary results suggest a possible involvement
of Itz on the intestinal secretory mechanisms of Cpx and changes in
the enterohepatic circulation. The inhibitory effects of Itz on the Cpx
intestinal pharmacokinetics seems different according to timing of Itz
administration.
MIUR PRIN 2003-Prot. N. 2003051858_003
P1064 Different effect of pre-treatment with phenobarbital
on transintestinal elimination of moxiﬂoxacin and
ciproﬂoxacin: preliminary data
E. Bertazzoni Minelli, A. Benini, C. Caveiari (Verona, IT)
The ﬂuoroquinolones (FQ) are widely used in clinical practice, and
exhibit pharmacokinetic properties such as good oral bioavailability,
transintestinal elimination through the gut, and biliary excretion. FQs
can interfere with hepatic metabolism and drug interaction with
enzyme inducers may occur. Few data are available about intestinal
concentrations of FQs and their pharmacokinetics interactions in the
gastrointestinal compartement.
Objectives. To study the effect of phenobarbital (Phe, enzyme inducer)
on intestinal, hepatic and faecal concentrations of Moxiﬂoxacin (Mxf)
and Ciproﬂoxacin (Cpx).
Methods. 30 Wistar rats (180.2+/-7.8 g weight, mean+SD) were divided
in 6 groups and treated as follows: group1: Phe (80mg/kg/day, i.p.)
and Mfx (10mg/kg/day, po) 2 hours later; group 2: Phe (80mg/kg/day,
i.p.) and Mfx (50mg/kg/day, po) 2 hours later; group 3: Phe
(80mg/kg/day, i.p.) and Cpx (15mg/kg/day, po) 2 hours later; group4:
Mfx (10mg/kg/day, po); group 5: Mfx (50mg/kg/day, po); group 6:
Cpx (15mg/kg/day, po). Samples of blood, intestinal and liver tissues,
and faeces were collected after three days, 2 hours after the last
FQs administration. Cpx and Mxf concentrations were determined with
microbiological method (agar diffusion, K. pneumoniae, Isosensitest
agar).
Results. Mfx was not detected when administered at 10mg/kg/day;
pre-treatment with Phe induced no modiﬁcations. Higher doses
of Mxf (50mg/kg/day) produced good intestinal concentrations
(10.3+/-5.5mg/kg) that increased to 16.3+/-4.3mg/kg in rats pretrated
with Phe. Faecal concentrations of Mfx are similar in the two treated
groups (280.0+/-32.1mg/Kg). Mfx was not detected in serum and hepatic
tissue. Cpx: Intestinal concentrations of Cpx were 10.4+/-12.2mg/kg,
when administered alone, and 24.8+/-23.7mg/kg in rats pretreated with
Phe; parallel respective serum levels showed a slight decrease(0.04 and
0.02mg/L, respectively). Cpx was detected only in liver of rats pretreated
with Phe. Faecal concentrations of Cpx were 231.6+/-279.9mg/kg when
administered alone and 87.0+/-44.0mg/kg in rats pretreated with Phe.
Conclusions. The enzyme inducer Phe produced an increase of the
concentrations of Mfx and Cpx in the intestinal tissue. Mfx and Cpx
showed different behaviour in the intestinal compartment. Phe can
modify the pharmacokinetics of Cpx and, in minor extent, that of Mxf.
MIUR PRIN 2003-Prot. N. 2003051858_003
P1065 In vivo efﬁcacy of moxiﬂoxacin monotherapy against clinical
isolates of B. fragilis with intermediate susceptibility
M. Glenschek-Sieberth, K. Merfort, S. Obertegger, I. Knezˇevic,
R. Endermann (Wuppertal, DE)
Objectives: Moxiﬂoxacin (MXF) is the only marketed ﬂuoroquinolone
with FDA approval for the monotherapy of complicated intra-abdominal
infections. The obligate anaerobic bacterium, Bacteroides fragilis, is
implicated in intra-abdominal infections. In this study, the antibacterial
efﬁcacy of MXF against clinical isolates of B. fragilis with intermediate
susceptibility (4mg/L) was evaluated using a murine granuloma
pouch model. Breakpoints (susceptible 2mg/L, intermediate=4mg/L,
resistant 8mg/L) for B. fragilis were deﬁned by CLSI.
Methods: Twenty clinical isolates of B. fragilis (MIC=4mg/L) and
B. fragilis ATCC 25285 (MIC=0.5mg/L) were used. Pouches for the
murine granuloma pouch model were created by injecting 5 mL of
air and 0.5 mL of 0.1% croton oil in olive oil under the skin of
the back. After removing the air (day 3), a bacterial suspension was
injected into the pouch (day 5). Infected mice were treated with MXF
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100mg/kg IV, b.i.d. for 2 days. This dose simulates the AUC of the
human 400mg once-daily MXF IV dosage. To compare the efﬁcacy of
MXF with piperacillin/tazobactam (PIP/TAZ), three of the strains (the
ATCC 25285 strain and two intermediate isolates) were studied in the
pouch model. Mice were treated with PIP/TAZ 400mg/kg IV, b.i.d., a
dose that simulates the human PK/PD driver time above MIC of 3.375
g q.i.d. PIP/TAZ IV therapy.
Efﬁcacy was assessed by the reduction in colony forming units (CFUs)
in pouch exudates 48 hours post-infection compared with the infection
control.
Results:MXF, 100mg/kg b.i.d., achieved a CFU reduction of >99.9% in
15/20 intermediate susceptible strains, >99% in 3/20 strains and >90%
in 1/20 strains. A CFU reduction of <90% only occurred in 1/20 strains.
The comparison of MFX and PIP/TAZ demonstrated similar efﬁcacy
against the ATTC strain and the two clinical isolates despite
the differences in the breakpoint category (intermediate [MXF] vs
susceptible [PIP/TAZ]).
Conclusions: In a murine granuloma pouch model, MXF achieved a
CFU reduction of >2 logs against 90% of clinical B. fragilis isolates with
intermediate susceptibility (4mg/L). Furthermore, MXF was as effective
as PIP/TAZ against two strains that were intermediate for MXF but
susceptible to PIP/TAZ.
Sepsis
P1066 Red blood cell deformability in diabetic patients suffering
from severe sepsis
C.A. Gogos, T. Moutzouri, D. Dimitropoulou, H. Bassaris,
G. Athanassiou (Patras, GR)
Objectives: Diabetes mellitus and sepsis are accompanied by haemorhe-
ological abnormalities, which cause a secondary hyperviscosity syn-
drome involved in the pathogenesis of microvascular complications. The
diabetic patients are more vulnerable to infections and sepsis is a major
cause of morbidity and mortality in diabetes. The aim of the present
study was to investigate the impairment of RBC deformability on a series
of patients with sepsis, diabetes mellitus and diabetic patients suffering
from severe sepsis.
Methods: Forty patients with severe sepsis, no history of diabetes
mellitus and normal baseline glucose values, 12 patients suffering from
diabetes and no infection and 24 diabetic patients with severe sepsis
were enrolled in the study. All septic patients were admitted in the
Department of Medicine of Patras University Medical School during
a period of 6 months, while diabetic non-septic patients were enrolled
from the outpatient clinics of the Endocrinology Unit. RBC deformability
was measured using a ﬁltration method based on the initial ﬂow rate
conditions of blood samples suspension by using a Nuclepore membrane
based Haemorheometer. Values are expressed as the Index of Rigidity
(IR)and high IR values indicate low RBC deformability
Results: We observed no differences in severity, organ dysfunction
and ﬁnal outcome between diabetic and non-diabetic septic patients.
Mean SAPS II score was 23.5% vs 26.8% in non-diabetic and
diabetic septic patients accordingly. The mortality in the group of non-
diabetic septic patients was 22.5% and in the group of septic diabetics
34.3%, while septic shock occurred in 15.0% and 20.8% accordingly.
Patients with sepsis and patients with diabetes mellitus had signiﬁcantly
(p< 0.01)higher IR than healthy controls (13.9±2.86 and 12.26±2.28 vs
8.46±1.21, accordingly. Most signiﬁcantly, diabetes mellitus and severe
sepsis had an additive effect on RBC deformability, as IR in those
patients was signiﬁcantly higher than patients with diabetes and sepsis
alone (17.72±6.31).
Conclusion: It seems that both diabetes mellitus and severe sepsis
compromise the RBC deformability and increase the RBC rigidity index.
Interestingly, when they co-exist, they seem to have additive effects. This
supports the hypothesis that the presence of diabetes mellitus further
affects the already compromised deformability of the red blood cells
and this may contribute to the microcirculatory functional impairments
in septic diabetic patients.
P1067 Alterations of innate and adaptive immune responses of
patients with septic syndrome due to ventilator-associated
pneumonia
A. Pelekanou, A. Kotsaki, I. Vaki, V. Karagianni, H. Kranidioti,
E. Spyridaki, E.J. Giamarellos-Bourboulis (Haidari, GR)
Objectives: Sepsis is the clinical expression of deregulated immune
response. This study aims at investigating the expression of immune sys-
tem components in septic patients with ventilator-associated pneumonia
(VAP), the leading cause of morbidity and mortality among nosocomial
infections in intensive care units.
Methods: Peripheral venous blood was sampled from 52 patients
with sepsis, severe sepsis or septic shock (according to ACCP/SCCM
1992 criteria) within 24 hours of diagnosis. Twenty six suffered from
VAP; 26 from other infections, namely pyelonephritis, bacteraemia and
intraabdominal infection, all well-matched for severity, age and sex and
they were used as controls. After lysis of red blood cells with ammonium
chloride, white blood cells (WBCs) were stained by FITC-conjugated
monoclonal antibodies for CD3, CD19, CD14, Annexin-V, and PE-
conjugated antibodies for CD4, CD8, CD(16+56) and HLA-DR. Flow
cytometry was used to determine subpopulations of mononuclear cells,
apoptosis and HLA-DR expression.
Results: In patients with VAP, median expression of CD3/CD4,
CD3/CD8, CD3/CD(16+56), CD(16+56) and CD19 was found in
35.01%, 21.29%, 4.02%, 8.91% and 8.89% of WBCs respectively.
Moreover, expression of Annexin-V (marker of apoptosis) on monocytes,
T-helper and T-cytotoxic lymphocytes was 15.39%, 4.90% and 2.98%
respectively. CD(16+56) expression was positively correlated to both
CD3/CD8 and CD14/HLA-DR (p 0.026 and 0.019 respectively). Median
CD14/HLA-DR in patients with VAP was 56.88% and in controls
73.17% (p 0.046). Respective expression of CD3/CD(16+56) was 4.02%
and 6.62% (p 0.025) and of CD(16+56) 8.92% and 18.07% (p 0.011).
Conclusions: In patients with VAP increased immunoparalysis is found
as evidenced by lower CD14/HLA-DR expression. This is accompanied
by decrease of T-LGL and NK cells and may explain increased mortality
observed among patients with VAP. It may also constitute a future
therapeutic target.
P1068 Triggering receptor expressed on myeloid cells (TREM-1)
gene expression in critically ill patients
A. Kotsaki, I. Vaki, I. Dimopoulou, H. Kranidioti, S. Orfanos,
A. Pelekanou, E. Giamarellos-Bourboulis, A. Armaganidis (Haidari,
Athens, GR)
Objectives: Triggering receptor expressed on myeloid cells (TREM-1)
is a recently discovered receptor on monocytes and neutrophils.
When stimulated, TREM-1 ampliﬁes the toll-like receptor(TLR)-
initiated response to invading pathogens allowing the secretion of pro-
inﬂammatory chemokines and cytokines. Our aim was to estimate
TREM-1 mRNA levels in critically ill patients.
Methods: Ten ml of heparinised venus blood were collected upon
admission from 14 critically ill patients, ﬁve with systemic inﬂammatory
response syndrome (SIRS) and nine with severe sepsis/septic shock
(ACCP/SCCM criteria). Peripheral blood mononuclear cells were
isolated. RNA was extracted after trizol and chloroform treatment and
cDNA was synthesised. Expression of mTREM-1 was estimated by
real time PCR against the expression of reference gene of beta-2-
microglobulin. RNA isolated from PBMCs of healthy donor was applied,
as control.
Results: Quantiﬁcation of mRNA transcription levels using PFAFL
equation showed that the levels of mRNA were higher in patients with
SIRS (range 2.9×103–1.5×107, median 1×106 copies) compared to
patients with severe sepsis (range 13.3–3×106, median 1×103 copies).
Conclusions: Although former results using ﬂow cytometry analysis has
showed that TREM-1 receptor is up regulated in sepsis, pronounced
TREM-1 gene expression was found in SIRS compared to severe
sepsis/septic shock. These results render the hypothesis that when
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TREM-1 receptors reach a critical amount to ampliﬁe the inﬂammatory
response, internal signals stop further mTREM transcription.
P1069 Detection of superantigenic toxin Vbeta T-cell signatures
during menstrual and non-menstrual staphylococcal toxic
shock syndrome but not during S. aureus septic shock
T. Ferry, T. Perpoint, D. Thomas, A. Lepape, O. Dauwalder, G. Monneret,
C. Badiou, C. Chidiac, F. Vandenesch, J. Etienne (Lyon, FR)
Objectives: To detect in vivo production of superantigenic toxins early
after onset of staphylococcal toxic shock syndrome (TSS) and septic
shock by identifying superantigenic toxin discriminant Vbeta signature
(DVbS) in patient’s peripheral blood mononuclear cells (PBMC).
Methods: Patients with S. aureus TSS or septic shock were prospectively
enrolled in Lyon, France, during one year. The Vbeta repertoire of each
patient was determined by ﬂow cytometry at the onset of shock after
puriﬁcation (by Ficoll density gradient sedimentation) of PBMC labeled
with anti-CD3 and 24 anti-Vbeta antibodies. The toxin gene content of
all S. aureus isolates was determined by multiplex PCR. We determined
which Vbeta subset was signiﬁcantly expanded in the presence of each
superantigenic toxin gene (i.e. the DVbS of a given superantigenic toxin)
in vitro with PBMC from healthy donors incubated nine days with culture
supernatant of each isolates.
Results: 14 patients were included, 5 with TSS (including 3 menstrual)
and 9 septic shock. Patient with septic shock, in comparison with patients
who had TSS, were older (61 vs 30 years), were lymphopenic (0.8 vs
2.5 G/L), had more frequently a medical history of immunosuppression
(44% vs 0%) and had a higher mortality rate (56% vs 0%). In vitro,
the DVbS were as follows: TSST-1: Vbeta 2; SEA: Vbeta 9, 22; SEB:
Vbeta 3, 14, 17; SED: Vbeta 1, 8; egc: Vbeta 5.3, 7.1, 9, 23; and SElK:
Vbeta 5.1. The DVbS of TSST-1 and SEB were detected in patients with
menstrual and non-menstrual TSS (Figure, panel A and B, respectively),
whereas no Vbeta signature was detected during septic shock (despite
isolates produced superantigenic toxins in vitro).
Conclusion: Early analysis of the Vbeta T cell repertoire in patients
with staphylococcal TSS: (i) is useful for detecting the superantigenic
toxin DVbS; (ii) may help to conﬁrm the diagnosis of TSS and
hasten the administration of anti-toxin therapy. During septic shock,
this approach failed to demonstrate superantigenic toxin involvement.
However, a medical history of immunosuppression and lymphopenia due
to apoptosis in this patient population may limit the expansion of targeted
T cells.
P1070 Evaluation of serum TNF-alpha, IL-10, leptin, CRP levels as
prognostic markers in patients with sepsis and septic shock
S. Cesur, A. Sengul, Y. Kurtoglu, S. Arslan Ozel, Y. Kalpakci,
A. Bilgeturk, S. Kinikli, H. Erdem, Z. Biyikli, C. Eyigun, C. Bulut,
T. Aslan (Ankara, Istanbul, TR)
Aim: The aim of this study was to determine the diagnostic value of
serum TNF-alpha, IL-10, leptin, CRP levels in differentiating sepsis
from septic shock and the prognostic value of these evels in predicting
mortality or outcome in patients with sepsis and septic shock.
Material and Methods: Forty-sixth patients with sepsis (32 of sepsis
and 14 of septic shock) and 50 healthy subjects were inluded in the
study. Serum TNF-alpha, IL-10, leptin, CRP levels were compared
between patients with sepsis and septic shock and healthy subjects
and the prognostic value of these markers in predicting mortality were
determined. For this aim, before treatment(1st day) and during the 3rd
and 5th days of treatment serum TNF-alpha, IL-10, leptin, CRP levels
were compared between patients with sepsis and septic shock and with
those of healthy controls. For statistical evaluation, Mann-Whitney and
Fisher’s Exact tests were used.
Results: Serum CRP levels were signiﬁcantly lower in patients with
septic shock than sepsis before treatment. On the 3rd day of treatment,
there was no difference in any parameter other than CRP levels. While
serum CRP levels were found to be low in patients with sepsis on 3rd
day, they were increased in patients with septic shock. On the 5th day
of treatment, no difference was found in any parameter between patients
with sepsis and septic shock.
In the patient group (both sepsis and septic shock), in the comparison
between patients who survive and those who die, no difference was
found in the parameters before treatment except for IL-10 levels, serum
IL-10 levels being higher in the patients who died. On the 3rd day
of treatment, serum TNF-alpha and CRP levels were different between
surviving and dying patients. Serum TNF-alpha and CRP levels were
higher in dying patients than those in surviving patients. On the 5th day
of treatment, merely serum TNF-alpha levels were different between
dying and surviving patients, values being higher in dying patients.
Conclusion: When the diagnostic value and prognostic values of these
markers were evaluated, CRP levels were useful in discriminating
between sepsis and septic shock before treatment and on the 3rd day of
treatment, whilst IL-10 and TNF-alpha levels were useful in predicting
mortality in patients with sepsis before treatment and on the 5th day of
treatment respectively.
This project was supported by Scientiﬁc and Technical Research Council
of the Turkish Republic with project number of SBAG-2841(104S358).
P1071 Risk factors for meticillin-resistance among patients with
Staphylococcus aureus sepsis
M. Lupse, M. Flonta, A. Almas, M. Suciu, V. Zanc (Cluj-Napoca, RO)
Community-acquired infections caused by meticillin-resistant Staphylo-
coccus aureus (MRSA) seem to be increasing. Characteristics permitting
recognition of patients with such strains would aid infection control
efforts and choice of empiric therapy pending culture and susceptibility.
The aim of the study was to develop an objective mechanism to
estimate the probability of meticillin resistance in a given patient with
Staphylococcus aureus sepsis.
Material and Method: Retrospective review of medical records for
all adults patients having at admittance in ICU Teaching Hospital
of Infectious Diseases (Ian 2006-sept 2007) the diagnosis criteria for
sepsis, according to ACCP/SCCM expert panel recommendation, and
staphylococcal aetiology. Risk factors for the presence of meticillin
resistance in Staphylococcus aureus isolates recovered from patients with
staphylococcal sepsis were assessed.
Results: From 285 adult patients non-HIV with sepsis (27% nosocomial
sepsis), we selected 50 cases (17.54%) with conﬁrmed Staphylococcus
aureus aetiology. Median age was 51.6 years, 26 males (52%). The
MRSA rate was 30%. Of 7 characteristics included in the logistic
regression (age, hospital onset, number of SIRS criteria, skin ulcers,
respiratory involvement, shock, positive blood cultures), the only
independent feature for MRSA was hospital onset (p = 0.04)
Conclusions: Through multivariate modeling techniques we conﬁrm
that nosocomiality is the most important determinant for MRSA and
that patients with MRSA bacteraemia were not signiﬁcantly older or
more severe than those with meticillin-sensitive Staphylococcus aureus
bacteraemia.
P1072 Recognising patients with sepsis in the emergency
department before and after protocol implementation
M. Tromp, D. van den Berg, L. Peters, M. Hulscher, T. van Achterberg,
B.J. Kullberg, P. Pickkers (Nijmegen, NL)
Objectives: The aim of the present study is to evaluate the effects
of implementation of the Surviving Sepsis Campaign guideline in all
septic patients in the Emergency Department (ED). Patients 16 years
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with sepsis in the ED at a 953 beds University Medical Centre in The
Netherlands were included in the study.
Methods: Data were collected and analysed by means of a prospective
cohort study from July 2006 to August 2007. The inclusion criteria
were: (suspicion of) an infection AND presence of 2 SIRS criteria
extended with an altered consciousness, cold chills, SBP< 90mmHg,
MAP< 65mmHg, hyperglycaemia in the absence of diabetes mellitus.
A multidisciplinary team developed the new sepsis guideline for nurses
and doctors in the ED, which was introduced at the ED in November
2006.
The six major actions (6 items bundle) which were included in the sepsis
guideline are: measure lactate 6 hrs, take 2 blood cultures before start
antibiotics, start antibiotics 3 hrs, perform a chest X-ray, take urine for
sediment and culture and hospitalise or discharge the patient 3 hrs.
Results: 765 patients (451 men, 314 woman) with sepsis in the ED
were included in the study. 159 patients before protocol implementation
(period I), 447 patients after introduction of the protocol (period II) and
159 patients were included after presentation of the ﬁrst results (period
III). Compliance with the six major actions described in the methods (1
point earned per item) improved signiﬁcantly (p< 0.0001) as illustrated
in the ﬁgure. Hospital length of stay was median [25–75%range] 6 [2–
12], 7 [3–12], 6 [3–11] days in period I, II and III, respectively. The
hospital mortality rate was 6.3, 6.0 and 5.0% in period I, II and III,
respectively (p=NS).
Conclusion: Implementation of a sepsis guideline resulted in a
signiﬁcant improvement of the compliance to the guideline. This
improvement tended to be associated with a decrease in hospital
mortality.
The management, diagnosis and treatment for patients with sepsis in the
ED can be improved by implementation of a sepsis guideline.
P1073 Early pattern of IL-6, TNF-alpha, IL-12 and IFN-gamma
levels in septic patients
S. Mera, C. Cismaru, V. Zanc, D. Tatulescu, M. Flonta, D. Carstina
(Cluj-Napoca, RO)
Objectives: Overcoming severe infections requires effective response
involving both the innate and adaptive immunity. Priming and
modulation of the immune response are driven by bacterial products
and several endogenous mediators, such as cytokines. We analysed
several proinﬂammatory cytokines in the early sepsis and studied their
correlation with aetiology and severity.
Methods: In 24 septic patients we analysed serum levels of IL-6, TNF-a,
IL-12 and IFN-g at day 1, 2, 3 and 7 upon admission. Patients (19
males/5 females) had the median age of 65.5. The primary infection had
urinary (11), respiratory (11), dental (1) and cutaneous (1) origin. 14
healthy volunteers served as controls.
Results: At admission, median PCT was 10 ng/ml (0.5–10) and median
SOFA score was 6 (range 1–11). 5 patients (17%) died during the
ﬁrst week. IL-12 and IFN-g were undetectable both in controls and
septic patients at all time-points. Septic patients had median TNF-a
concentration of 6 pg/ml at admission and decreasing at the following
time-points, while in controls TNF-a was undetectable. In septic patients,
IL-6 had a median level of 78 pg/ml at day 1 and decreased at 38 pg/ml,
9.15 pg/ml, 2.97 pg/ml at day 2, 3 and 7 respectively. Patients with
severe sepsis (n = 38) had the highest IL-6 levels, reaching a median
of 102.2 pg/ml, patients with sepsis had a median value of 61.2 pg/ml
while IL-6 in controls was 1.78 pg/ml. TNF-a showed similar levels
and kinetics between urinary and respiratory sepsis, yet in respiratory
sepsis IL-6 increased more prominently. Gram-positive sepsis led to
higher amounts of circulating TNF-a and IL-6, reaching 23.6 pg/ml and
130 pg/ml respectively while in Gram-negative sepsis, median levels of
TNF-a and IL-6 were 6.6 pg/ml and 60 pg/ml respectively. Two non-
survivors had very high IL-6 at day 1 (over 1000 pg/ml) that did not
follow the descendent trend of IL-6 levels at next time-points.
Conclusions: During early sepsis, a rapid inﬂammatory response is
mounted and driven by the innate immunity, yet excessive response may
prove detrimental. Since we did not detect circulating levels of IL-12
and IFN-g, it appears that sepsis does not to elicit an adaptive immune
response in its early phases. The low levels of TNF-a are maybe due
to the short half-life of the molecule. IL-6 release might be inﬂuenced
by the primary site of infection and aetiology, and it could serve as a
potential routine, reliable parameter in monitoring septic patients.
P1074 Statins for infection and sepsis – A systematic review of the
clinical evidence
M. Falagas, G. Makris, D. Matthaiou, P. Rafailidis (Athens, GR)
Objective: Statins are currently used for hyperlipidaemia control and
considered useful in protecting from cardiovascular events. In addition,
there is increasing use of evidence for the potential use of statins in
treating infections.
Methods: We performed a systematic review of the literature that com-
pared the outcome between statin and non-statin users among patients
suffering from sepsis or other infections (bacteraemia, pneumonia, ICU
infection, viral infection and other bacterial infection). The relevant
studies were identiﬁed from searches of the PubMed and the Cochrane
Library Databases.
Results: Twenty studies were identiﬁed out of which 9 examined
the use of statins in patients with sepsis, bacteraemia, or multi-organ
dysfunction syndrome, 4 community acquired pneumonia (CAP), 1 ICU
infections, 2 other bacterial infections, and 4 viral infections. In total,
11 studies had data regarding mortality as the main outcome: 8 showed
decreased mortality in statins users (3 of them reported on patients
with bacteraemia), 2 showed no difference in mortality and 1 reported
an increased mortality in patients who received statins. Seven studies
examined the risk of sepsis as the main outcome; 6 of these studies
showed a decreased risk of sepsis in patients receiving statins, while one
study found no difference.
Conclusion: The majority of the studies suggest that statins may have
a positive role in the treatment of patients with sepsis and infection.
However, the reviewed studies have several methodological limitations.
Conclusions regarding this important clinical question should wait for
the results of ongoing relevant randomised controlled trials.
P1075 Anti-platelet activating factor effects of antibiotics: a new
insight into therapy of sepsis?
A. Tsoupras, M. Chini, N. Tsogas, A. Lioni, G. Tsekes, C. Demopoulos,
M. Lazanas (Athens, GR)
Objectives: There are data supporting the role of inﬂammatory
mediators, such as anti-platelet activating factor (PAF), in sepsis. These
molecules can act in synergy with infectious agents to initiate and
propagate the disease process. In animal models, beneﬁcial effects have
been observed as a result of treatment with various antagonists of PAF;
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however the precise role of PAF as mediator of the diffuse inﬂammatory
state characteristic of sepsis remains to be determined.
Methods: In order to examine the possible interactions between PAF
and antibiotic treatment, we studied the effect of different compounds
against PAF biological activity. We assessed the in vitro inhibitory
effect of various compounds against PAF-induced aggregation on washed
rabbit platelets by evaluating the IC50 of each drug. We also studied
the in vitro effect of these drugs against rabbit plasma PAF-AH (the
main degradating enzyme of PAF) and PAF-CPT (the main de novo
biosynthetic enzyme of PAF) of washed rabbit leukocytes.
Results: Clarithromycin, azithromycin, linezolid, amikacin, netilmicin
and piperacillin/tazobactam exhibited IC50: 0.06, 0.1, 0.29, 0.73, 0.74
and 4.92mg/mL respectively. Concentrations equivalent to their IC50
values against PAF activity, inhibited in vitro the PAF-CPT activity of
washed rabbit leukocytes. Furthermore, clarithromycin and azithromycin
in concentrations of a log10 higher than their IC50 values against PAF,
increased in vitro the rabbit plasma PAF-AH (table 1).
Drug mg/mL % Inhibition
of PAF-CPT
% Increase
of PAF-AH
Clarithromycin 0.04 59.09
0.21 34.73
Azithromycin 0.16 34.85
1.56 40.12
Piperacillin/tazobactam 2.81 62.94
Amikacin 0.31 60.26
Netilmicin 0.5 47.68
Linezolid 0.25 51.22
Conclusion: Many antibiotics exhibit high inhibitory effect against
PAF-induced washed rabbit platelet aggregation and its main de
novo biosynthetic enzyme PAF-CPT while only clarithromycin and
azithromycin seem to activate plasma PAF-AH. The promising in vitro
results need to be further studied and conﬁrmed by in vivo tests, in order
to optimise the efﬁcacy of antibiotic treatment in sepsis.
P1076 The natriuretic peptide (BNP) as a marker of sepsis
C. Petrocheilou, A. Karaferi, M. Pouyiouka, V. Karabasi, C. Achilleos,
A. Nitsa, M. Toutouza (Athens, GR)
Objective: The discovery of a reliable marker for sepsis is of great
signiﬁcance for the on time management and survival of septic patients.
The aim of the study is the evaluation of the reliability of the Natriuretic
peptide (BNP) as a marker of sepsis in comparison to C Reactive protein.
Methods: We studied 58 patients of the ICU in a year period. They
were separated into 2 groups. Group A with 8 non septic patients and
Group B with 50 patients suffering from great sepsis and septic shock.
Blood samples were taken from all patients at their admittance and
at days 2, 3, 4, 6, 8 and 10. The levels of BNP were analysed with
microsomatic immunoenzyme method (AXSYM – ABBOT) (Normal
value <100 pg/ml) and the levels of CRP with nefelometry (Normal
value <5mg/ l).
Patients with heart failure were excluded from the study.
Results: The mean value of BNP in Group A was 24.2 pg/ml, while
the mean value of BNP in Group B was 971.2 pg/ml. The difference is
statistically important.
The mean value of CRP in Group A was 103.3mg/l, while in Group B
it was 107.062mg/l. The difference has no statistical importance.
Conclusion: The evaluation of the results seem to drive to the conclusion
that the levels of BNP are reliably increased in patients with great sepsis
and septic shock and may be a valuable diagnostic tool.
P1077 Diagnostic value of the soluble triggering receptor expressed
on myeloid cells-1 in critically ill patients with suspected
sepsis
L.F. Li, X.D. Guan (Guangzhou, CN)
Objective: To evaluate the diagnostic and prognosis value of plasma
levels of the soluble triggering receptor expressed on myeloid cells-1
(sTREM-1) in critically ill patients admitted with clinical suspicion of
sepsis.
Methods: All consecutive adult patients, who were newly hospitalised
in the surgical intensive care unit (SICU) from January to October 2006,
were prospectively enrolled in this study if they had clinical suspected
infection and fulﬁlled at least 2 criteria of the systemic inﬂammatory
response syndrome (SIRS). Patients were not enrolled if they were older
than 80-year-old, were immunocompromised, died or were discharged
within 12 hours after admission. Within 12 hours after enrollment, the
levels of plasma sTREM-1 and CRP, TNF-Alfa, IL-6, procalcitonin
(PCT) were measured, and the microbiological cultures were performed.
Base on the results of cultures and the decision of intensivists, all patients
were classiﬁed into different groups as SIRS (no infection), sepsis, severe
sepsis, or septic shock. The levels of plasma sTREM-1 and CRP, TNF-
Alfa, IL-6, and PCT in different groups were compared.
Results: There was a signiﬁcant difference of median plasma sTREM-1
levels at admission between different groups (68.8 pg/ml in SIRS
group, 69.7 pg/ml in sepsis group, 106.2 pg/ml in severe sepsis group,
373.5 pg/ml in septic shock group, P< 0.001). The capacity of Plasma
sTREM-1 to differentiate the presence of sepsis or septic shock was
assessed with a receiver-operating-characteristic curve (ROC) analysis.
The area under the ROC when Plasma sTREM-1 was used to differentiate
the presence of sepsis was 0.82 (95%CI, 0.70−0.94, P< 0.001). The area
under the ROC when Plasma sTREM-1 was used to differentiate the
presence of septic shock was 0.96 (95%CI, 0.90−1.0, P< 0.001). Only
sTREM-1 was found to be an independent predictor of the prognosis with
sepsis. The area under the ROC was 0.87(95%CI, 0.77−0.97, P< 0.001),
when Plasma sTREM-1 was used to prognoses the presence of death in
sepsis patients.
Conclusion: There were higher plasma sTREM-1 levels in critically ill
patients with sepsis syndromes. TREM-1 was an effective indicator of
diagnosis of sepsis and septic shock, and also an effective prognosis risk
predictor of sepsis in critically ill patients.
P1078 Comparison of procalcitonin with interleukin 8, leucocyte
count and rate of immature to total neutrophils for the
early diagnosis of severe bacterial pneumonia and sepsis in
pre-term infants
G. Dementyeva, M. Kushnaryova, E. Chursina (Moscow, RU)
Objective: To evaluate procalcitonin (PCT) as a test for early diagnosis
of bacterial pneumonia and sepsis in preterm infants and to compare the
results of PCT with those of interleukin 8 (IL-8), leucocyte count, rate
of immature to total neutrophils (I/T).
Subjects and Methods: Serum PCT (BRAMS PCT-Q™) was
prospectively measured along with IL-8 (ELISA), leucocyte count in 82
preterm infants, 26–36 wk of gestation. Preterm infants were classiﬁed
to two groups according to their infections status: (1) 48 preterm infants
with severe bacterial pneumonia and sepsis (positive blood cultures),
(2) 34 noninfected preterm infants wiht respiratory distress syndrome
(RDS). PCT, IL-8, leucocyte count, I/T were analysed for sensitivity,
speciﬁcity and positive and negative predictive values.
Results: At a cut off value of 2ng/ml, the sensitivity of PCT was 92% and
speciﬁcity was 97%. The positive and negative predictive values of PCT
in the diagnosis equalled 97.7% and 89.1%, respectively. Sensitivities
for IL-8 (70ng/ml), leucocyte count (15·109/l) and I/T (0.2) was
50%, 66%, 35% and speciﬁcities – 94%, 71%, 88%, respectively.
Conclusion: PCT was the most speciﬁcity and sensitive diagnostic
parameter in the diagnosis of severe bacterial pneumonia and sepsis.
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A PCT concentration 2ng/ml might be useful in differentiating severe
bacterial pneumonia and sepsis in preterm infants.
P1079 Comparison of neutrophil volume distribution width
with C-reactive protein and procalcitonin for diagnosis of
culture-proven sepsis
J.S. Lin, H-C. Tai, S-F. Kuo, S-L. Young (Changhua, TW)
Objectives: Rapid diagnosis of bloodstream infection is problematic
due to time-consuming blood culture. Current biomarkers in diagnosis
of sepsis either lack of sensitivity and speciﬁcity or are expensive.
Neutrophil volume distribution width (NDW) which is generated on the
hematology analyser when measuring complete blood count has been
demonstrated by Chaves et al (2005) as a potential predictor of sepsis in
a fast and cost-effective manner. However, its clinical usefulness remains
un-established. In this study, NDW values were compared with plasma
concentrations of C-reactive protein (CRP) and procalcitonin (PCT) for
diagnosis of culture-proven sepsis.
Methods: Within 12 hours of blood culture submission, NDW and
concentrations of CRP and PCT of peripheral blood samples were
retrospectively reviewed or analysed. After exclusion of contaminated
samples in blood culture, only laboratory data obtained from patient
samples of positive bacterial blood culture were recruited for comparison
with those of negative culture. Among them, NDW, CRP and PCT
were measured using VCS technology of LH750 hematology analyser
(Beckman Coulter), immunoturbidometry (COBAS INTEGRA 800,
Roche Diagnostics) and enzyme-linked ﬂuorescent assay (VIDAS
BRAHMS PCT, bioMerieux), respectively. Positive blood culture was
used as the gold standard for diagnosis of sepsis. Receiver operating
characteristic (ROC) curve was constructed and area under ROC curves
(AUC) was determined for evaluation of diagnostic power.
Results: Laboratory data of 194 unrelated patients (age of range, 0–
101 years), were collected. Of them, 60 and 134 had positive and
negative bacterial culture, respectively. To predict bacteraemia, NDW had
a similar AUC (0.78 [0.70−0.85], p< 0.001) as PCT (0.80, [0.73−0.87],
p< 0.001) but CRP had a lower AUC (0.64 [0.56−0.72], p = 0.002). The
optimal sensitivity and speciﬁcity at an appropriate cutoff value were
0.72 and 0.73 at 24.5 for NDW, 0.75 and 0.70 at 0.6 ng/mL for PCT,
and 0.59 and 0.56 at 63.3mg/L for CRP, respectively.
Conclusion: Our preliminary study had demonstrated that NDW had
a superior diagnostic accuracy in bacteraemia than CRP as PCT in
prediction of bacteraemia. This ﬁnding might imply a potential role of
NDW for laboratory prediction of culture-proven sepsis in a fast and
cost-effective manner.
P1080 Procalcitonin as a diagnostic and prognostic marker in
chronically-critically ill patients
H. Tsangaris, D. Kavatha, M. Gourgoulis, D. Plachouras,
E. Paramythiotou, E. Karampekiou, A. Armaganidis, H. Giamarellou
(Haidari, GR)
Objective: To investigate Procalcitonin (PCT) levels as prognostic
markers of infection and to correlate maximum as well as every other day
changes of PCT levels to mortality of chronically critically ill patients.
Methods: This is study including all patients hospitalised for more
than 10 days in ICU. Blood samples for PCT, WBC, and CRP were
drawn every other day. Patients were classiﬁed to one of the following
groups according to ACCPM 1994 criteria 0: no infection, 1: localised
infection and sepsis, 2: severe sepsis and septic shock and SOFA score
was recorded. PCT concentrations were measured by an automated
immunoﬂuorescent assay (PCT KRYPTOR) PCT values were categorised
as alert and non alert values using x-bar test. Maximum PCT (PCT max)
levels and number of days with PCT higher than the alert value were
compared between survivors and non-survivors. All PCT levels were
correlated with CRP, WBC and SOFA score with the Spearman test and
compared among the various groups of severity of infection by one-way
ANOVA. Categorical variables were compared using the chi-square test
and continuous variables with non-parametric Mann–Whitney U test.
Results: PCT plasma concentrations were measured in a total of 169
samples collected from 11 patients (8 male and 3 female) followed
up for a mean of 34.5 days (range 14 to 67) until discharge or death.
The alert value in this population was calculated as 0.88 ng/ml. Mean
PCT (±SD) concentration of patients categorised as having no infection,
sepsis and severe sepsis–septic shock were 0.47 (±0.40), 1.86 (±3.86)
and 4.82 (±7.58) respectively (p< 0.0001). There was a deﬁnite but
weak correlation between PCT concentrations, CRP (Spearman’s rho
0.21, p< 0.007) and SOFA score (Spearman’s rho 0.3, p< 0.0001) but not
with WBC. PCT max was 4.33 in survivors and 12.98 in non-survivors
(p NS). Mean total days with PCT higher than alert value were 2.44 and
5.66 respectively (p NS)
Conclusions:Mean PCT plasma concentrations correlated to the severity
of the infection. There was a weak correlation among PCT, CRP and
SOFA score and a trend to higher mean PCT values and to more mean
total days above the alert value in non-survivors than survivors.
P1081 Evaluation of F-18-ﬂuorodeoxyglucose positron emission
combined with computer tomography (FDG-PET-CT-scan)
in critically ill patients suspected of Infection
K.S. Simons, P. Pickkers, C.P. Bleeker-Rovers, J.G. van der Hoeven,
W.J.G. Oyen (Nijmegen, NL)
Objectives: During their stay at the intensive care unit (ICU), many
critically ill patients are suspected of a focal infectious process. Timely
identiﬁcation and localisation of infection is critical in appropriate
treatment of these patients. FDG-PET has shown to be valuable in the
evaluation of fever of unknown origin and suspected focal infectious
diseases in non-ICU patients, but no studies have been performed in
critically ill patients. In this study, the value of FDG-PET-CT-scanning
in diagnosing focal infection was studied in ICU patients.
Methods: Between October 2005 and June 2007 all FDG-PET-CT scans
ordered in ICU patients for evaluation of persisting fever or suspected
focal infection were retrospectively analysed. The ﬁnal diagnosis was
used for comparison with FDG-PET-CT results. A diagnosis was never
based on the FDG-PET-CT results alone.
Results: 29 FDG-PET-CT scans were performed in 28 ICU patients
(including 4 children, median age 58 years). In ﬁfteen patients FDG-
PET was performed because of persisting fever (median duration of
fever 17 days) and in 15 patients because of suspected focal infection.
Seventeen patients were eventually diagnosed with an infection, one
patient with malignant lymphoma, and in 12 cases no diagnosis was
reached. The PET-CT scan was performed after a mean ICU-stay of
22 ±2.8 days. No complications occurred during the transportation and
scanning procedure. Sixteen FDG-PET-CT scans were classiﬁed true
positive and were considered to be contributory to the ﬁnal diagnosis.
Three PET-CT scans were considered false positive, in one case leading
to additional diagnostic procedures. Additionally, ten true negative and
no false negative scans were found. Thus, 84% of the abnormal FDG-
PET scans were clinically helpful and FDG-PET contributed to the
ultimate diagnosis in 55% of all patients. FDG-PET was considered
helpful in 94% of all patients with a ﬁnal diagnosis.
Conclusion: FDG-PET-CT scanning is of additional value in the
evaluation of persisting fever and suspected focal infection in critically
ill patients. A normal FDG-PET-CT scan also ruled out a focal infection
with a very high negative predictive value.
P1082 Is venous access port inner surface colonisation related
with port obstruction?
M. Alonso, A. Martinez, A. Serrera, A. Ramos, J.I. Bilbao, M. Portillo,
J. Leiva, J.L. del Pozo (Pamplona, ES)
Objectives: Venous acces ports (VAP) are used in patients receiving
long parenteral therapy. However, use of these devices is associated
with infectious and mechanical complications. One of the most
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common causes of mechanical failure is catheter lumen occlusion. This
complication may lead to the removal of the port. Although precipitation
of drugs and blood clots can obstruct the device, we propose here that
colonisation of the port inner surface may be related to port obstruction.
The aim of this study was to analyse if port colonisation and obstruction
were associated in a signiﬁcative way.
Methods: We performed a 27 months prospective study on all the
removed VAPs of our hospital. We analysed reasons for removal and
we cultured all the removed ports (catheter tip and septum culture
after a vortexing-sonication procedure). We compared colonisation ratios
on the group of patients whose VAPs were removed because of the
obstruction (group 1) and the group of patients whose VAPs were
removed because of end of use or because of a mechanical complication
other than obstruction (group 2). Patients with port-related infections
were excluded. The cut-off to consider the ports to be colonised was
>1000 cfu/ml for both cultures (catheter and septum). Differences were
statistically analysed using the chi-square test.
Results: From August 2005 to October 2007, 240 VAPs were removed
from 240 patients. Ports were removed due to end of use in 187
(77.9%) cases, 34 (14.2%) ports were removed because of infectious
complications and 19 (7.9%) because of mechanical complications.
Seven of the ports were removed due to obstruction (group 1) and
197 because end of use (group 2). Colonisation rates were 3/7 (42.9%)
and 16/197 (8.1%) in groups 1 and 2 respectively. Differences were
statistically signiﬁcative with a p value of <0.019. Coagulase-negative
staphylococci were the most frequent isolated microorganisms, followed
by Candida species.
Conclusions: Data from this study suggest that port colonisation may
play a role in the genesis of port obstruction. Antibiotic lock therapy
might be useful in this scenario to try to avoid removal because of
obstruction. However, more prospective studies are warranted to address
this important issue.
Clinical epidemiology of bloodstream
infections and occupational blood exposure
P1083 Incidence of central venous catheter-related infection in a
community hospital
M. Delgado, J. Yebenes, L. Ballester, G. Sauca, E. Vidal, R. Icart,
J. Capdevila (Mataro, ES)
Introduction: Catheter-related infections (CRI) are a main cause
of nosocomial bloodstream infections and are related to important
morbidity and mortality. In the Spanish Nosocomial Infection Study
(EPINE) the prevalence of catheter-related bloodstream infection (CRBI)
is between 2.5 and 3.4 episodes per 1000 hospitalised patients.
Objective: To asses the incidence of central venous catheter related
bloodstream infections (CRBI) in a community hospital.
Methods: Prospective daily follow-up of all central venous catheters
(CVC) inserted in the Hospital de Mataro during a period of 9
months. Main patient’s demographic data and catheters characteristics
were recorded. All catheters were inserted using full sterile barrier
methods. Hubs were closed with disinfectable needleless mechanical
valve connectors. Catheters removed by suspicion of infection were
semiquantitatively cultured using the roll plate method. Two blood
cultures were also performed. According to clinical and microbiological
criteria, catheters were classiﬁed as: not infection-related, entry-site
infection, colonised catheter, and CRBI.
Results: During 9 months 597 catheters were placed in 480 patients, 282
males (58%). Total catheterisation days were 4886. Mean catheterisation
days were 8.19 (1–58). Catheters were inserted in the emergency room
in 35 cases (5.8%), 151 in surgical theater (25.2%), 45 in others units
(7.23%) and 365 in ICU (61%) where a trained and specialised nurse
team exists. The subclavian access were used in 194 catheters (32.49%),
jugular in 124 (20.7%), brachial in 245 (41%) and femoral in 30 (5.02%).
Catheters were removed by end of treatment in 419 cases (70.18%),
dysfunction in 42 cases (7.03%), and by fever or suspicion of infection
in 40 patients (6.7%). Seven episodes of CRBI were registered, all of
them caused by S. epidermidis, which results in an incidence rate of
1.43 episodes/catheterisation days. No CRBI was observed during this
period in the ICU, resulting in an incidence rate of 0 in ICU and 2.25
episodes/1000 catheterisation days in conventional hospitalisation units.
Conclusion: The incidence of CRBI in our institution is in the
accepted normal range. We observe relevant differences in CRBI’s rates
between conventional hospitalisation units and ICU where a trained and
specialised nurse team exists. This suggests the importance of catheter
manipulation in the genesis and prevention of CRBI.
P1084 Use of disinfectable needleless mechanical valve connectors
and catheter-related bloodstream infection rates in a
polyvalent intensive care unit
M. Delgado, J. Yebenes, T. Zaro, M. Perez, E. Lavado, M. Cegarra,
A. Dalmau, J. Almirall (Mataro, ES)
Introduction: Disinfectable needleless mechanical valve connectors
(DNMVC) have been introduced to avoid needlestick injuries in
healthcare workers but they are accompanied by concerns about the
possibility of an increase in the risk of catheter-related bloodstream
infections (CRBI) associated with their incorrect use. Use of bundles
can facilitate the adherence to the handling recommendations.
Objective: To observe the rates of CRBI after the development of
a handling bundle in a polyvalent intensive care unit (ICU) where a
DNMVC (Smartsite) are used to close the intravenous catheter hubs.
Method:We used a 5 recommendations bundle (nurse implication in the
epidemiological surveillance, selection of the safest place of insertion,
understand insertion as a surgical procedure, maintain the endoluminal
sterility during infusion and avoid unnecessary insertions, manipulations
or removals). Every three months data were reported to the nurse shift
that was responsible of surveillance and diffusion of the results to the
rest of the nurse shifts.
Results: From January to September 2007, a total of 510 catheters were
inserted in 229 critically ill patients during more than 24 hours, 273
of they were central venous catheters and 237 arterial lines. The mean
length of insertion was 6.3±6.0 days, and it supposes 3227 days of risk.
We don’t observe any CRBI and 2 primary bacteraemia (0 and 0.62
episodes per 1000 days of risk respectively).
Conclusions: Rates of CRBI and primary bacteraemia were minimal
during the 9 months that the observational study was performed (0
and 0.62 episodes per 1000 days of risk). Inclusion of nurses as active
part of the epidemiological surveillance can help the implementation of
simple recommendations. We can not associate the use of disinfectable
needleless mechanical valve connectors with increased rates of catheter-
related bloodstream infections.
P1085 Catheter-related bloodstream infection in patients on
total parenteral nutrition: 10-year surveillance data in a
university teaching hospital in Dublin, Ireland
C.J. Collins, M.H. Fraher, J. Bourke, D. Phelan, M. Lynch (Dublin, IE)
Objectives: Total parenteral nutrition (TPN) is a well-recognised risk
factor for catheter-related bloodstream infection (CR-BSI). However,
there is limited data in the literature speciﬁcally addressing CR-BSI in
patients on TPN. Surveillance of CR-BSIs in patients on TPN has been
ongoing in the Mater Misericordiae University Hospital (MMUH), a
525-tertiary referral hospital in Dublin for over 10 years. In 1997, a TPN
surveillance Clinical Nurse Manager (CNM) was appointed. Protocols
re insertion of central venous catheters (CVCs) speciﬁcally addressing
location of insertion and skin preparation were introduced in 2002.
Quarterly TPN committee meetings along with frequent educational
sessions were introduced. Our aim was to demonstrate the epidemiology
of the organisms causing CR-BSIs in this subset of patients and the
impact of the above measures both on the incidence of CR-BSIs and the
duration that the CVC remains in situ before infection occurs.
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Methods: Data on all patients prescribed TPN has been collected
prospectively. Individual cases were reviewed at quarterly meetings over
this time period and cases were assigned to appropriate categories
as per CDC deﬁnitions on CR-BSIs. All CVCs were non-antibiotic
impregnated. The data was analysed only for non-tunnelled CVCs.
Results: 194 CR-BSIs in 1,197 patients (total of 12,296 catheter days) on
TPN were recorded in the 10-year time period. Staphylococci accounted
for over 80% of infections each year with few Candida spp. or Gram-
negative infections (ﬁg 1). A reduction in the overall incidence of CR-
BSI (33.6 to 5.1/1,000 catheter days) and an increase in the duration that
the catheter is in situ before infection occurs (mean 4.8 to 8.2 days) was
noted.
Conclusions: The high proportion of CR-BSIs in patients on TPN due
to staphylococci has important implications for treatment. Glycopeptide
therapy alone may be sufﬁcient empirical therapy in this subset of
patients unless severely septic. Appointment of the surveillance CNM
allied with auditing, feedback, education and insertion protocols led to
positive effects on the incidence of CVC infection and catheter duration
before infection.
Epidemiology of Organisms (rates/1,000 catheter days)
P1086 Association of platelet parameters and Gram-negative
bacteraemias: a case control study
M. Dalamaga, M. Pantelaki, K. Karmaniolas, K. Daskalopoulou
(Athens, GR)
Background and Objective: Bacteraemia and sepsis, as uncontrolled
generalised inﬂammatory responses, involve thrombopoiesis and haemo-
static mechanisms. Mean platelet volume (MPV), platelet distribution
width (PDW), their correlations with platelet count and inﬂammation
markers and their clinical signiﬁcance have not been studied in
bacteraemias in depth. The aim of this study was 1) to determine whether
newly diagnosed patients with Gram(−) bacteraemia, in comparison to
their controls, would be characterised by ineffective thrombopoiesis, as
reﬂected by MPV and PDW and 2) to explore their correlation with
inﬂammatory markers and their signiﬁcance in the course of bacteraemia.
Material and Methods: We have evaluated 22 incident cases of
Gram-negative bacteraemia (13 men and 9 women, 23–82 years) and
an equal number of hospital controls with minor non-infectious and
non-neoplastic conditions, individually matched for age (±5 years)
and gender and month of diagnosis. To assess thrombopoiesis and
inﬂammation, we have determined platelet count, MPV, PDW and
leucocyte count using Sysmex SE-9000 blood analyser. CRP levels
were determined using immunonephelometry (Dade-Behring, Germany).
Statistical analysis of data was performed with SAS® version 9 software.
Results: Signiﬁcantly low mean values of MPV and PDW, together with
signiﬁcantly high mean values of platelet count, leucocyte count and
CRP were shown in patients with Gram(−) bacteraemia in comparison
to their controls (p< 0.001). There was not any statistical signiﬁcant
difference in platelet count, MPV, PDW and CRP levels (p> 0.05) in
patients with Gram(−) bacteraemia based upon the number of leucocytes
(those with leucopenia n = 3 and those with leucocytosis n = 37). There
was a signiﬁcant inverse relationship between MPV (and PDW) and
platelet count in patients with bacteraemia (r=-0.78; p< 0.001) as well
as a signiﬁcant inverse relationship between MPV and CRP (r=-0.52;
p = 0.01). Adjusting for age, gender and CRP levels, MPV (or PDW) is
a signiﬁcant predictor of bacteraemia. Patients with Gram(−) bacteraemia
who responded favorably to antibiotic therapy presented normal platelet
parameters after ten days of treatment.
Conclusion: Platelet parameters have been shown to provide an
accessible and clinical useful index for estimating the impairment of
thrombopoiesis and the degree of inﬂammation in patients with Gram-
negative bacteraemia as well as for predicting favorable response to
antibiotics.
P1087 Incidence and risk factors of recurrent bacteraemia due to
Escherichia coli
J. Villar, A. Rodriguez Aranda, F. Sanz, J.R. Otero, F. Chaves
(Madrid, ES)
Objectives: E. coli recurrent bacteraemia (RB), deﬁned as relapse or
reinfection, is a relevant but not well known clinical process. The aim
of this study was to determine the frequency of RB and risk factors for
relapse (isolates with the same pulsed-ﬁeld gel electrophoresis pattern
[PFGE]) or reinfection (different PFGE) after a ﬁrst episode of E. coli
bacteraemia.
Methods: This is a retrospective study conducted in a tertiary Hospital.
RB was deﬁned as a new episode of bacteraemia after at least 1 month
since a prior episode sucessfully treated. Patients with RB during 2001–
2005 were included. The control group included 41 patients with a single
episode of bacteraemia and a year of follow-up. A systematic review of
clinical data was performed. Blood isolates were analysed by PFGE
and the phylogenetic background studied. We compared demographic,
clinical and microbiological variables between relapse or reinfection and
control group.
Results: 945 patients had E. coli bacteraemia, 32 (3.4%) had RB.
We studied blood isolates from 28 patients (4 excluded) with 58
clinical episodes. According to PFGE analysis, 13 patients (46.4%)
suffered relapse and 15 (53.6%) reinfection. Relapse occurred earlier
than reinfection (median, 56 versus 67 days, p = 0.02), and it was caused
by strains more resistant to antibiotics. In the comparison with no
RB, multivariate analysis showed that patients with relapse were more
likely to be younger than 60 years (OR:17.5; p = 0.05), admitted in
the nefrology unit (OR:246.9; p = 0.012), to have received antibiotics
previously (OR:15.6; p = 0.045) and to be infected with ciproﬂoxacin
resistant strains (OR: 97.0; p = 0.008). On the other hand, patients with
reinfection were associated with prior hospital admissions (OR: 21.6;
p = 0.027), being admitted in haematology/oncology units (OR: 19.8;
p = 0.037), having a central intravascular catheters (OR:60.9; p = 0.008),
and having a biliary/gastrointestinal source of infection (OR: 20.9;
p = 0.039). The distribution of phylogenetic groups in relapses was: group
B1 38.5%, D 30.8%, B2 23.1%, and A 7.7% and in reinfections was:
group B1 33.3%, B2 25.9%, D 18.5%, and A 22.2%.
Conclusions: We have determined the frequency of recurrent Es-
cherichia coli bacteraemia in our hospital and delineated some risk
factors for relapse and reinfection. Appropriate management for the
prevention of further recurrences may need more research on treatment
strategies and virulence factors of E. coli strains
P1088 Invasive Staphylococcus aureus Infections Cohort
(INSTINCT)
H. Wisplinghoff, A. Kaasch, K. Achilles, A. Langhorst,
G. Peyerl-Hoffmann, A. Wo¨hrmann, G. Fa¨tkenheuer, B. Salzberger,
W. Kern, H. Seifert (Cologne, Freiburg, Regensburg, DE)
Introduction: Nosocomial bloodstream infections (BSIs) are important
causes of morbidity and S. aureus is one of the most important
nosocomial pathogens.
Methods: INSTINCT was established to prospectively monitor clinical
features of S. aureus BSI (SAB) in Germany using a web-based
database. Data are collected by infectious diseases physicians aided by
specially trained medical personnel to monitor risk factors, predisposing
conditions, portal of entry, clinical course, diagnostic and therapeutic
procedures as well as outcome up to one year after SAB.
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Results: Between January 2005 and September 2007, 468 cases of
SAB were detected in the 3 participating university hospitals. Patients
had a mean age of 61 years and 33% were female. Length of stay
averaged 33 days. Underlying conditions most often included cardio-
vascular (35%), or renal (27%) disorders and diabetes mellitus (27%).
SAB were classiﬁed as nosocomial in 54% of patients another 26% were
healthcare-associated. Primary SAB was seen in 61% of cases, of which
28% were catheter-related. Secondary SAB most often originated from
skin and soft tissue infections (7%) or surgical wound infections (5%).
18% of S. aureus isolates were meticillin-resistant. Severe Sepsis and
septic shock at onset of SAB were seen in 4.5% and 2.5% of patients,
respectively, secondary complications were reported in 14% of patients,
most commonly endocarditis, osteomyelitis or spondylodiscitis. The
mean duration of S. aureus bacteraemia was 3.5 days. Patients received
a mean of 16±13 days of appropriate anti-staphylococcal therapy.
Adherence to ID consult recommendations such as TEE (recommended
in 50%, followed in 34%) and follow-up blood-cultures (61%; 48%)
varied signiﬁcantly between centres. The crude 7-day-mortality was 15%,
in-hospital mortality was 23%.
Conclusion: INSTINCT currently represents one of the most detailed
prospective SAB studies. Data from the ﬁrst years underscore the
importance of SAB and conﬁrm the feasibility of this very detailed
monitoring design.
P1089 Primary bloodstream infections and catheter-related
bloodstream infections in critically ill patients: impact on
length of stay and mortality
M. Michalia, M. Kompoti, A. Paridou, G. Kallitsi, A. Koutsikou,
P. Clouva-Molyvda (Athens, GR)
Objective: Previous studies have suggested that catheter-related
bloodstream infections (CRBSIs) are associated with lower attributable
mortality than other types of BSI. The aim of our study was to compare
the impact of primary BSIs (PBSIs) and CRBSIs on length of stay (LOS)
and mortality in intensive care unit (ICU) patients.
Patients and Methods: All patients admitted in our 8-bed multidisci-
plinary ICU were included in the study. Data recorded were: gender,
age, admission category (medical, emergent surgical, elective surgical,
trauma), Acute Physiology and Health II Evaluation (APACHE II) score
at admission in the ICU. All patients were prospectively followed and
the occurrence of the ﬁrst BSI episode in the ICU was recorded. Length
of stay (LOS) in the ICU, total number of BSI episodes in the ICU
and ICU outcome were recorded. Primary BSI (PBSI) and catheter-
related BSI (CRBSI) episodes deﬁned according to standard criteria were
analysed. Attributable mortality for PBSI and CRBSI was estimated and
further investigated with logistic regression models adjusted for potential
confounders. Statistical signiﬁcance level was set at p< 0.05.
Results: Three hundred eighty-four consecutive patients (273 males and
111 females) were included in the study. Age (mean±SD) was 52.9±19.4
years, APACHE II score 18.2±6.4, LOS [median (interquartile range):
16 (9–32) days. In 76 patients (19.8%) the ﬁrst BSI episode was PBSI
and in 41 (10.7%) CRBSI. Overall mortality was 16.4%. Mortality
in patients without BSI was 12.0%, in patients with PBSI 27.6%
(attributable mortality 15.6%, p = 0.001) and in patients with CRBSI
19.5% (attributable mortality 7.5%, p = 0.189). LOS was signiﬁcantly
shorter in patients without BSI compared with either PBSI or CRBSI
group (14.6±11.0 days vs. 39.0±26.4 days in the PBSI group and
39.8±20.2 days in the CRBSI group, p< 0.001). In a logistic regression
model adjusted for age, gender, APACHE II score, admission category
and total number of BSI episodes in the ICU, PBSI was signiﬁcantly
associated with increased probability of death in the ICU compared with
patients without BSI (odds ratio=3.4, 95% conﬁdence interval 1.2–10.7,
p = 0.033) while CRBSI had no signiﬁcant effect on mortality.
Conclusions: In our patient sample, PBSI increased 3.4-fold the
probability of death in the ICU compared with patients without BSI.
The estimated attributable mortality for PBSI was 15.6%. CRBSI did
not signiﬁcantly inﬂuence mortality.
P1090 The association between mucosal colonisation with
opportunistic pathogens and bloodstream infections in the
two neonatal intensive care units in Estonia
U¨. Parm, E. Sepp, T. Metsavaht, M. Ilmoja, K. Pruunsild, L. Maipuu,
S. Ko˜ljalg, E. Makoid, I. Lutsar (Tartu, EE)
Objective We aimed to study mucosal colonisation of neonates with
potentially pathogenic microorganisms in order to ﬁnd out whether and
how this is associated with blood stream infections (BSI).
Methods All newborns admitted to both Estonian NICUs within ﬁrst
72 h of life and needing empiric antibacterial therapy (ampicillin or
penicillin in combination with gentamicin) for early onset neonatal
sepsis were prospectively enrolled. The nasopharyngeal and rectal swabs
were collected on admission and thereafter twice weekly until D60 or
discharge. Samples were plated on blood, McConkey and Saboraud
agar. Blood cultures were drawn when clinically indicated. The ﬁnal
identiﬁcation of species was conducted with BACTEC 9240, VITEK2
and API 20E systems. MRSA was identiﬁed by PCR for nuc and
mecA genes. The genetic relatedness between mucosal and bacteraemic
strains of MRSA and K. pneumoniae was analysed by pulsed ﬁeled gel
electrophoresis (PFGE).
Results A total of 200 pt (100 with BW <1500g; median NICU stay 6.8
days) were enrolled from Aug 2006 until July 2007. The most common
colonising Gram-negative microorganisms were K. pneumoniae (23%),
E. coli (15%), E.cloaceae (15%), K. oxytoca (14%) & A. baumannii
(13%) with the median documented duration of colonisation of 8 days
for Klebsiella spp. and 5 days for the remaining organisms. Of 54
BSI infections 45 were nosocomial origin (58% caused by G-positive,
40% by G-negative and 2% by Candida spp.). The risk of BSI was
greater during colonisation by G-negative than by G-positive bacteria
(15/21 vs 13/31, respectively [OR 3.5; 95%CI 1.1–11.3]). The rate of
infection per 100 days of colonisation was the highest for MRSA (4.6)
followed by 1.4; 1.2; 0.9; 0.7; & 0.7 for A. baumannii, E. cloacae,
E. coli, K. pneumoniae & Serratia spp., respectively. The lowest rate
of 0.2 was observed for K. oxytoca. During the study in each unit one
outbreak of nosocomial infections caused by K.pneumonia and MRSA,
respectively, was seen. Increased rate of mucosal colonisation preceded
both outbreaks. A molecular typing of mucosal and BSI isolates of
K. pneumoniae and MRSA revealed a similar PFGE pattern.
Conclusion In NICU mucosal colonisation by MRSA and to lesser
extent by A. baumannii and E.cloaceae carries a signiﬁcant risk for
BSI. Isolation of newborns colonised by microbes with the highest risk
of subsequent BSI, should be implemented to avoid cross-colonisation
by healthcare workers and thus prevent BSI.
P1091 Bloodstream infections among newborns in intensive care
unit in a country network in Bogota, Colombia, 2001–2007
I.F. Corrales, J.A. Cortes, A.L. Leal, G. Buitrago, J.S. Castillo,
C.A. Alvarez (Bogota, CO)
Background: Bloodstream infections are common among patients in the
neonatal intensive care unit (NICU). Here we show the frequency of the
microroganisms found in the blood of patients in the NICU belonging
to a national network in Colombia.
Methods: A country network with 27 public and private tertiary hospitals
from 3 cities was stablished. Laboratory information was transferred
monthly to a central data base and compiled by the use of Whonet
software (WHO, ver 5.4). Bloodstream infections were selected from
those patients in the NICU.
Results: Between 2001 and 2007 (june), a yearly average of 689
bloodstream infections were detected among patients in the NICU.
60% to 70% of the isolates were Gram-positive, while near 30%
were Gram-negative bacilli. In the ﬁgure, the annual percentage of the
microorganisms more commonly isolated is shown. Of interest, 84% of
the coagulase negative Staphylococci (CNS) were resistant to oxacillin
and between 6.9% and 10.8% of E. coli isolates had a phenotype that
suggested the presence of extended spectrum b-lactamases (ESBL). Such
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phenotype was more frequently found in K. pneumoniae (41.1% to
51.1%). Candida albicans was the most frequently found yeast.
Discusion: Although oxacillin-resistant CNS predominated among
bloodstream isolates, a high prevalence of Gram-negative bacilli was
found, with a frequent expresion of ESBL. Fungal infections are not
uncommon. Higher effords in infection control and antibiotic use should
be made in order to diminished the number of resistant infections in
high risk neonates.
P1092 Maternal and neonatal bloodstream infections: data from
the Finnish Hospital Infection Program, 1999–2006
E. Sarvikivi, O. Lyytika¨inen on behalf of the Hospital Infection
Surveillance Team, Finnish Hospital Infection Program (SIRO),
National Public Health Institute (KTL), Helsinki, Finland
Objectives: Maternal microbial ﬂora may be a source for both maternal
and newborn peripartum infection. The aim of this study was to evaluate
the epidemiologic features and distribution of the causative pathogens of
healthcare-associated bloodstream infections (BSIs) in women who were
admitted for obstetric care and in neonates in Finnish hospitals during
1999–2006.
Methods: A prospective laboratory-based surveillance was performed in
9 Finnish acute care hospitals that participated in the Finnish Hospital
Infection Program, including three tertiary care centres. Women in labour
and infants with ages not more than 28 days were included. Infection-
control nurses in each hospital regularly reviewed the laboratory
database for positive blood culture results. Clinical information and
microbiological data were recorded on a standardised case-record form.
CDC deﬁnitions for nosocomial BSIs were utilised, both primary and
secondary BSIs were included. We focused on ‘early-onset’ neonatal
BSIs, referring to an infection with a positive blood-culture during the
ﬁrst 6 days of life.
Results: The study included 175 445 deliveries, of which 30 178
(17%) caesarean sections, and 177 987 live births. We identiﬁed 118
maternal peripartum BSIs (rate, 0.7 BSIs/1000 deliveries; range by year,
0.3−1.5/1000 deliveries), of which 67 (57%) occurred after a caesarean
section, and 766 neonatal BSIs (rate, 4.4 BSIs/1000 live births), 288
(38%) of which were early-onset BSIs (rate, 1.6 BSIs/1000 live births;
range by year, 1.1−2.4/1000 live births). The main causative pathogen
of both maternal and neonatal early-onset BSIs was Streptococcus
agalactiae (GBS) (Table). Of the infants with early-onset BSIs, 116
(40%) received intensive care and 16 (6%) died within a week after the
positive blood culture; 7 (44%) of those had GBS disease. One of the
mothers received intensive care, none of them died.
Conclusions: Maternal peripartum BSIs were rare and no fatal cases
were detected. Neonatal early-onset infections were more common and
led often to need of intensive care and even to death. Peripartum
infections due to GBS, which was the most common pathogen, may be
reduced by national prevention guidelines. Such guidelines were released
in 2006 in Finland; future surveillance will show the impact of these
guidelines.
Table: Distribution of causative pathogens in maternal and neonatal healthcare-
associated bloodstream infections (BSIs) in Finland during 1999–2006
Maternal BSIs (N = 118) Early-onset neonatal BSIs (N = 288)
Streptococcus agalactiae 21% Streptococcus agalactiae 33%
Staphylococcus aureus 14% Coagulase-negative staphylococci 31%
Coagulase-negative staphylococci 11% Staphylococcus aureus 11%
Streptococcus pyogenes 10% Escherichia coli 6%
Viridans streptococci 9% Enterococci 3%
Eschericia coli 7%
Enterococci 7%
Others 22% Others 16%
Polymicrobial 3% Polymicrobial 5%
P1093 Pseudomonas aeruginosa bloodstream infections: a 6-year
retrospective review in a university hospital
C. Meuris, C. Laurent, B. Delaere, Y. Glupczynski (Lie`ge, Yvoir, BE)
Objectives: P. aeruginosa bacteraemia (PAB) is a serious infection
associated with a high mortality. Severity of underlying diseases, origins
of infection, antimicrobial resistance and inadequacy of antimicrobial
therapy have all been associated with an excess mortality rate. The
objective of this study was to evaluate the epidemiology and the risk
factors of PAB on the mortality rates among patients admitted to a 380-
bed university hospital.
Methods: Retrospective cohort study of all patients admitted between
01/00 and 12/06 with a clinically signiﬁcant PAB (at least one positive
blood culture, excluding polymicrobic episodes of PAB). All medical
charts were reviewed by means of a computer-based system. Variables
studied were: demographic data, comorbidities (solid or haematological
cancers, chronic lung, cardiac or liver diseases, solid organ transplant),
immunosuppressive therapy, hospital events (nosocomial acquisition,
admission to ICU, major surgical procedures), appropriateness of
empirical antimicrobial therapy, mortality at day 7 and 30.
Results: 81 cases, 51 males (63%). Mean age: 64 yrs. Mean incidence
of PAB: 3.9 per 100 bacteraemia episodes; 69% of PAB nosocomially-
acquired. Underlying illnesses: 32% haematological cancers; 68% non
haematological group (solid cancers 16%, COPD 11%, pulmonary grafts
7%, immunosuppressive therapy 16%), invasive diagnostic procedures
60%. Sources of PAB: respiratory 35%, primary 26%, urinary 15%.
Number patients with appropriate empiric therapy 64% (100% with
appropriate adjusted therapy). Crude mortality rate associated with
PAB 31%; Attributable mortality at day 30 was 21% (18% at day
7); no signiﬁcant difference in attributable mortality between patients
with haematological illnesses (19%) and those with other comorbidities
(22%); No differences in mortality rate according to the adequacy or
inappropriateness of empirical antimicrobial therapy (20% vs 24%) but
2 out of 3 haematological patients with inadequate initial treatment died
from their PAB.
Conclusions: the incidence of PAB has remained stable over 6 years.
Two third of the episodes were of nosocomial origin. Haematological
diseases, solid cancers and invasive procedures were the most common
underlying diseases. Attributable mortality rate at day 30 was 21%
and was not inﬂuenced by the type of underlying illnesses nor by the
appropriateness of initial empiric therapy except in neutropenic patients
with haematological cancers.
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P1094 Analysis of risk factors for central venous catheter insertion
site and catheter tip colonisation and for CVC-associated
bloodstream infection in a randomised clinical trial
D. Luft, M. Dettenkofer, C. Wilson, A. Gratwohl, C. Schmoor, D. Heim,
H. Bertz, A.F. Widmer (Freiburg, DE; Basel, CH)
Objective: To identify risk factors for skin colonisation prior to central
venous catheter (CVC) placement and within 10 days after CVC
insertion, for CVC-tip colonisation and for CVC-associated bloodstream
infection (BSI).
Methods: As part of a randomised clinical trial, patients in the
haematology units of the university hospitals Freiburg, Germany, and
Basel, Switzerland and one cardiothoracic surgery unit (Basel) were
enrolled after informed consent. Quantitative skin cultures were obtained
from the insertion site prior to CVC placement and at regular intervals
after CVC insertion. Cultures from the CVC tip on removal were
undertaken (roll plate technique). In addition, data were collected on
infection signs, therapy, nosocomial infections (according to CDC-
criteria). The statistical analysis was performed using linear and logistic
regression models.
Results: Four hundred patients (219 haematology, 181 surgery) with
inserted CVC were enrolled in the trial (2002–05). Age >65 y and
male gender were independent risk factors for skin colonisation prior
to CVC placement in all patients and within the subgroup of surgical
patients. Independent risk factors for skin colonisation within 10 days
after CVC placement in all patients were: (i) colonisation prior to CVC
placement (baseline colonisation), (ii) surgical patient, and (iii) male
gender. Baseline colonisation of the skin at the insertion site was a
strong predictor of CVC tip colonisation (15 CFU). The underlying
disease – haematological malignancy – was the strongest risk factor for
CVC-related BSI.
Conclusions: The level of skin colonisation prior to catheter insertion
predicts catheter colonisation and possibly subsequent infection. Elderly
and male patients are at particular risk for colonisation of the skin and
may be a target population for special precautions with meticulous care
of the insertion site before and during catheterisation.
P1095 Needleless positive-pressure mechanical valve connectors:
are they safe?
V. Cossey, M.J. Thelissen, G.A. Goossens, M. Stas, A. Schuermans
(Leuven, BE)
Objectives: To determine whether the introduction of a needleless
positive-pressure mechanical valve connector in adult and paediatric
hematology-oncology units inﬂuenced the rate of catheter-related
bloodstream infections (BSI) and the type of causative micro-organisms.
Methods: A mechanical valve (MV) connector system (CLC2000®, ICU
Medical) was introduced in November 2005 and replaced miscellanous
conventional open systems (COS) with a standard Luer-Lock removable
cap. The main objective of this change was to reduce the use of heparin
ﬂushes in long-term tunnelled catheters (Hickman®, CR Bard).
The retrospective analysis included all patients with new Hickman
catheters, inserted during two different study periods. The catheter-
related BSI rate was observed during 6 months for each system and
reported as number of BSI per 1000 catheterdays. The results with
COS (January through June 2005) were compared with a similar period
with MV-use (September 2006 through February 2007). Microbiological
characteristics of bacteraemias occurring during each period were also
compared. The hospital policy for care of Hickman catheters did not
change over both study periods.
Results: During the COS-period, 39 Hickman catheters were inserted
in 15 children and 24 adults with a total dwell time of 1544 and 1899
catheter days respectively. During the MV-period 60 Hickman catheters
were placed in 13 children and 47 adults with a total dwell time of 1181
and 3223 catheterdays respectively.
Both in the paediatric and adult population, the rate of catheter-related
BSI during the MV period was signiﬁcantly higher than during the COS-
period: resp. 11 vs 1.29 infections per 1000 catheterdays (p =.009) and
12.4 vs 6.32 infections per 1000 catheterdays (p = 0.019).
During the MV-period, the percentage of polymicrobial BSIs increased
from 0 to 84.6% in children and from 8.3% to 21% in adult patients.
Conclusion: A signiﬁcant increase in the rate of BSI was found
among hematology and oncology patients with newly inserted Hickman
catheters concomitantly with a change from a conventional open system
to a mechanical valve connector, despite additional educational sessions
regarding proper use of the device. The risk and type of BSI are
clearly associated with the catheter cap design which promotes microbial
contamination. The observed effects are more pronounced in children.
P1096 Late port-a-cath infection with Enterobacter amnigenus – An
example of Gram-negative port-a-cath infection
W. Lepe`re, M. Recher, M. Rothen (Bruderholz, Biel, CH)
Objectives: To demonstrate the microbiology of infections of totally
implantable venous access devices with emphasis on the importance of
Gram-negative bacteria.
Methods: Case report and search of infectious disease charts
Results: We report a case of sepsis with Enterobacter amnigenus as
a consequence of a totally implantable venous access device infection
caused by contaminated saline solution. The indication for implantation
of the port-a-cath system had been antibiotic treatment of diabetes-
associated osteomyelitis of the foot which had been completed two years
before onset of the actual disease. Explantation of the port-a-cath system
together with adequate antibiotic treatment rapidly resolved the infection.
Enterobacter amnigenus is a facultative Gram-negative pathogen
associated with soil and water and displays a high percentage of natural
antibiotic resistance. Enterobacter amnigenus infections have been
associated with tap water, cardioplegia ice, thermometers, milk formulas
and saline, albumine or heparine infusions. Port-a-cath infections with
E. amnigenus have not been reported so far.
In a search of the charts of infectious disease consultations during the
previous 5 years, 10 port-a-cath infections were identiﬁed, of which
Gram-negative bacteria accounted for 60%. Gram-negative rods involved
were Enterobacter cloacae (4), Klebsiella pneumoniae (2), Pseudomonas
aeruginosa (1), Enterobacter amnigenus (1) and Alcaligenes spp. (1). 3
infections were polymicrobial. Only in 4 cases (40%), typical Gram-
positive skin bacteria were identiﬁed in pure culture (Staphylococcus
aureus (3), coagulase-negative streptococci (1)). Treatment of Gram-
negative infections always required explantation of the intravascular
device.
Conclusion: In conclusion it is crucial to re-evaluate the need
for implantable venous access devices once the system is not
used for therapy anymore. Furthermore, this case underlines that
beside commonly isolated skin bacteria such as streptococcus and
staphylococcus species, implantable intravascular catheter infections may
also be caused by bioﬁlm-producing Gram-negative bacteria, which
should be considered in the empiric choice of antibiotics.
P1097 Under-reporting of occupational blood and infectious ﬂuid
exposure in a teaching hospital
M. Pirs, M. Poljak, K. Seme, M. Maticic (Ljubljana, SI)
Background and Objectives: Occupational blood and infectious
ﬂuid exposure (OBE) poses a risk to healthcare workers (HCW).
Implementation of safety precautions is crucial in preventing the
transmission of hepatitis B virus (HBV), hepatitis C virus (HCV),
and human immunodeﬁciency virus (HIV) in healthcare settings. Other
key factors are HBV immunisation and appropriate post-exposure
management.
The objective of the present study was to determine the proportion of
HCW experiencing OBE, post-exposure managing and the proportion of
vaccinated HCW in the largest tertiary and teaching hospital in Slovenia.
The knowledge of HCW’s hepatitis B surface antibody (anti-HBs) status
was also assessed.
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Methods: 251 HCW from surgical and non-surgical wards and
laboratories completed a conﬁdential questionnaire. All categories of
HCW were assessed (doctors, nurses, laboratory workers and support
personnel).
Results: 124 HCW (49.4%) experienced at least one OBE and only 63
of them (50.8%) reported the incident. HBV, HCV and HIV serology was
performed in 44 cases for HCW (69.8%) and in 47 cases for the index
patient (74.6%). Our personal observations as well as several studies
showed that the most common reasons for non-reporting the OBE are
the belief that the patient involved was not infected with HIV or HCV
and that the wound was adequately disinfected. Signiﬁcant amount of
time and paperwork involved in reporting the incident are also a factor.
Another important reason is the fear of being judged as well as the
anxiety they would suffer while waiting for the test results. The data was
further analysed according to category of HCW as shown in table 1.
Table 1. The analysis of the results of conﬁdential questionnaire among HCW according to job category.
all HCW physicians registered
nurses
nurses support
personnel
laboratory
workers
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
No. 251 51 38 88 8 66
HBV vaccination 229 (91.2) 49 (96.1) 37 (97.4) 82 (92.3) 3 (37.5) 58 (89.2)
anti-HBs titer following
vaccination
106 (46.3) 22 (44.9) 23 (62.2) 22 (26.8) 3 (100.0) 36 (60.0)
Latest anti-HBs titer 227 49 36 80 6 56
0 IU/mL (non-responder) 15 (6.6) 2 (4.1) 1 (2.8) 5 (6.3) 0 (0.0) 7 (12.5)
>10 IU/mL 73 (31.9) 23 (46.9) 16 (44.4) 7 (8.8) 0 (0.0) 27 (48.2)
unknown 83 (36.2) 18 (36.7) 14 (38.9) 42 (52.5) 1 (16.7) 8 (14.3)
never determined 56 (24.5) 6 (12.2) 5 (13.9) 26 (32.5) 5 (83.3) 14 (25.0)
OBE 124 (49.4) 34 (66.7) 28 (73.7) 44 (50.0) 2 (25.0) 16 (24.2)
Reporting of OBE 63 (50.8) 15 (44.1) 17 (60.7) 22 (50.0) 1 (50.0) 8 (50.0)
HBV, HCV and HIV screening
of HCW
44 (69.8) 11 (73.3) 12 (70.6) 13 (59.1) 1 (100.0) 7 (87.5)
HBV, HCV and HIV screening
of index patient
47 (74.6) 13 (86.7) 15 (88.2) 12 (54.5) 1 (100.0) 6 (75.0)
Anti-HBs titer following
reported OBE:
54 (85.7) 12 (80.0) 15 (88.2) 19 (86.4) 1 (100.0) 7 (87.5)
0 IU/mL (non-responder) 5 (7.9) 1 (7.1) 2 (12.5) 0 (0.0) 0 (0.0) 2 (25.0)
>10 IU/mL 28 (44.4) 9 (64.3) 8 (50.0) 8 (38.1) 0 (0.0) 3 (37.5)
unknown 27 (42.9) 4 (28.6) 6 (37.5) 13 (61.9) 1 (100.0) 3 (37.5)
HCW – healthcare workers. OBE – occupationa1 blood and infectious ﬂuid exposure; HBV hepatitis B virus.
HCV – hepatitis C virus. HIV – human immunodeﬁciency virus; anti-HBS serum level of hepatitis B surface
antibody.
While the majority of HCW received HBV immunisation (91.2%), the
serum concentration of anti-HBs following immunisation was assessed
in 106 (46.3%) HCW only. 15 (6.6%) HCW were non-responders and
73 (31.9%) reported adequate serum levels. Surprisingly, over one third
of HCW (36.2%) did not know their serum levels of anti-HBs, while for
56 (24.5%) their response to immunisation was never conﬁrmed.
Conclusion: The rate of OBE in this pilot study and inadequate post-
exposure measures are disturbing. Our data has shown that better
educational programs are needed to increase awareness about the risk
and prevention of OBE among the HCW. HCW should be encouraged
to undergo testing to determine adequate response to HBV vaccination
and most importantly to improve the compliance with the recommended
measures following OBE.
P1098 Healthcare workers’ exposure to blood-borne pathogens in
Lebanon
U. Musharraﬁeh, A. Bizri, N. Nassar, A. Rahi, A. Shoukair,
R. Doudakian, G. Hamadeh (Beirut, LB)
Objectives: Study the pattern of occupational exposure to blood and
body ﬂuids (BBFs) at a tertiary care hospital in Lebanon for 17 years.
This is the ﬁrst study to provide baseline data aiming to introduce the
suitable interventions.
Methods: This study retrospectively reports a 17 year experience (1985–
2001) of on-going surveillance of HCW exposure to BBFs at a 420
bed academic tertiary care hospital. Exposures were deﬁned as any eye,
mouth, or other mucous membrane, non-intact skin, or parenteral contact
with blood, or other potentially infectious body ﬂuid. The endpoints were
the annual number, nature, and cause of accidents, as well as the HCW’s
status, injury tool, site, and source.
Results: 1590 BBF exposure-related accidents were reported to the
Infection Control Ofﬁce. The trend showed a decrease in these exposures
over the years with an average±SE of 96±8.6 incidents per year (ﬁgure).
In the last 6 years, the average rate of BBF exposures was 0.57 per 100
admissions per year (average of needle stick injuries alone was 0.46
per 100 admissions). Needle sticks accounted for 75% of the injuries,
sharp objects for 10%, splash and spill for 3%, and in 12% it was not
clearly speciﬁed. The highest occurrence of these exposures was on the
ward (35%) followed by the operating room (17%) and intensive care
units (15%). The reason for the incident, when stated, was attributed to
a procedural intervention (29%), improper disposal of sharps (18%), to
recapping (11%), and to other causes (5%). The patient or source of
incident was known in 64% of cases. For studying rates of exposure
among the different occupational categories, the year 2001 was taken
as an example. 13% of house ofﬁcers, 9% of medical students, 8%
of attending physicians, 5% of nurses, 4% of housekeeping, 4% of
technicians, and 2% of auxiliary services employees had a BBF exposure
during that year.
Figure 1. Incidence of blood and body ﬂuids exposure over the years by
type.
Conclusion: The current study showed that exposure of HCWs to BBPs
remains a problem. This can be projected to other hospitals in the country
and raises the need to implement infection control standards as part of
a complete system where the culture of safety becomes an integral part
of the organisation. Prospective studies are needed on a yearly basis to
identify high risk groups and develop focused interventions.
P1099 Underreporting of accidental blood exposure in Belgian
hospitals
E. Leens, C. Suetens on behalf of the Belgium National Steering
Group of Accidental Blood Exposure
Objectives: In order to estimate the percentage of accidental blood
exposures (ABE) not reported to the occupational health department
in Belgian hospitals, a national underreporting study was carried out.
Methods: In May 2006, the Scientiﬁc Institute of Public Health invited
55 hospitals participating to the national surveillance of ABE (EPINet)
to the study. Twenty percent of the healthcare workers (HCW) ﬁlled
out a questionnaire anonymously during the annual consultation of
occupational health (OH). They were asked how many percutaneous
injuries (PI) or blood or body ﬂuid exposures (BFE) occurred during the
last month and the last year, and if so for how many ABE a registration
formular (EPINet or OH insurance) was ﬁlled out.
Results: Till 28 February 2007, a total of 3311 questionnaires from 25
hospitals was received. For the recall period of 1 month 103 PI occurred
in 78 HCW, of which 52 PI were registered by 38 HCW (underreporting
of 49.5%, Table 1). BFE were more frequent in 1 month, but were much
less registered: 165 HCW mentioned 452 BFE in the study, but only 3
cases (by 3 HCW) were declared to the surveillance or OH insurance
system (99.3%). For the recall period of 1 year the percentage of non-
reported injuries was 45.2% of the PI and 96.4% of the BFE.
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Table 1: Percentage not reported ABE in Belgian hospitals, 2006
% not reported (95%CI)
last month last year
PI 49.5% (39.5–59.5%) 45.2% (40.8–49.6%)
BFE 99.3% (98.1–99.9%) 96.4% (95.1–97.4%)
Conclusion: Results show that half of the PI was not declared by
the HCW. The underreporting rate in Belgian hospitals is similar to
average rates found in literature. The high underreporting rate for BFE
was possibly related to a misinterpretation of the deﬁnition. Based on
the results of this study and the PI rates of the national surveillance,
the annual number of PI in Belgian hospitals could be estimated at
approximately 10800 PI.
P1100 Seroprevalence of blood-borne infections among blood
donors in Venezuela, 2001–2002
J. Benitez, A. Rodriguez-Morales, M. Arria (Maracay, Trujillo,
Caracas, VE)
Objectives: From the data collected at the Ministry of Health from whole
nation public and private blood banks (BB) ﬁnd out the proportion of
blood units discarded for being seropositive HBV, HCV, HIV, syphilis and
Trypanosoma cruzi, and the seroprevalence of these infections among
their donors.
Methods: ELISA serological testing was done with 715,393 donors seen
at 535 blood banks between 2001 and 2002. Samples that were repeat
reactive (RR) with the ELISA underwent supplementary Western blot
(WB) testing.
Results: Of the 715,393 blood banks donors, 9,294 of them (1.3%) were
positive for syphilis (VDRL), 6,107 (0.85%) for HBV (anti-HBc), 4,825
(0.67%) for T. cruzi, 3,859 (0.54%) for HCV and 1,870 (0.26%) for
HIV. In the Figure a summary of the seroprevalence of these infections,
among public and private blood banks, per year, is presented.
Conclusions: Although syphilis or Treponema pallidum infection was
the most important blood-borne disease found in this study, the
seroprevalence found is lower than others reported in other countries
in the region (e.g. Goiaˆnia, Brazil, 1989, 4.1%). For HBV and HCV,
the seroprevalence estimates were also similar than those found in other
countries in the region (such as Rı´o de Janeiro, Brazil, where in 2005
the anti-HBc was 2.05% and 0.79% in 2004 for HCV), indicating high
rates of infection by HBV and HCV and a persistent risk of HBV and
HCV transmission by transfusion. For Chagas disease is also lower than
others reported in other countries in the region (e.g. Goiaˆnia, Brazil,
1989, 3.3%). Finally for HIV the found seroprevalence is similar to that
reported in Mexico (Irapuato, Mexico, 2003, 0.24%). But as seen herein,
those seroprevalences are regional, and our report is nationwide. Further
epidemiological research is expected. [Figure. Seroprevalence of Blood-
borne Infections among Blood Donors in Public and Private settings in
Venezuela, 2001–2002]
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P1101 Skin care and use of colouring- and perfume-free products
for hand hygiene: important foci for hand hygiene promotion
A. Conrad, I. Poser, S. Wenzler-Ro¨ttele, A. Pﬁster-Wartha,
M. Dettenkofer (Freiburg, DE)
Objective: Hand disinfection with an alcoholic hand rub is the
most effective measure for preventing nosocomial infections. However,
frequent use of hand hygiene products may cause skin irritation, which,
in turn, results in poor hand hygiene compliance. Additionally, many
products contain colouring and perfumes which hold a certain risk of
sensitisation, although they do not contribute to efﬁcacy. The objective
was to improve hand hygiene by promotion of skin care and introduction
of colouring and perfume-free products for hand hygiene.
Methods: A campaign to improve hand hygiene at the University
Medical Center Freiburg, Germany, was initiated along with the
introduction on 11 intensive care units and hematology wards of a
colouring and perfume-free product line (disinfectant and soap). The
intervention was accompanied by 15 min training sessions on hand
hygiene indications, technique and skin care. Before and after a 6-week
intervention phase, opinion on hand hygiene and acceptance of products
were evaluated using structured questionnaires.
Results: Of a total of over 1200 questionnaires distributed 54% (of
660) were completed before and 41% (of 611) after the intervention
(by nurses and by physicians). Hand hygiene was judged to be of high
relevance to patient safety by 76% of the respondents before and by 85%
after the intervention. Before the intervention, 36% had no preference
for any hand disinfectant, and used various products according to
availability. However, after the intervention 41% preferred the colouring
and perfume-free alternatives. This ﬁgure was dependent on gender since
almost 50% of women preferred the test products compared to less
than 30% of the men. The colouring and perfume-free products were
generally tolerated as well as conventional preparations. Only 3% of the
respondents complained about malodour of the test preparations. The
most frequent complaint associated with hand hygiene preparations in
general was dryness of the skin (over 70%). Healthcare workers’ use of
skin care rose from 52% to 64%.
Conclusions: Skin care and use of colouring and perfume-free products
are important foci of hand hygiene promotion. Taking into account
that staff tends to prefer products they know, this project successfully
introduced a colouring and perfume free-product line which was well
tolerated. Since colouring and perfume are dispensable, in future, only
colouring and perfume-free hand hygiene products should be used in
daily routine.
P1102 Effectiveness of hand-cleansing agents for removing
meticillin-resistant Staphylococcus aureus from
contaminated skin
Z. Muszynski (Poznan, PL)
Objectives: The effectiveness of hand-cleansing agents in removing
a hospital strain of meticillin-resistant Staphylococcus aureus from
artiﬁcially contaminated hands of ten volunteers was studied.
Methods: The products used were plain liquid soap, ethyl alcohol
70% (by weight), 10% povidone-iodine liquid soap (PVP-I), and 4%
chlorhexidine gluconate detergent in water. The experiments were
performed using a Latin square statistical design, with two 5 x
4 randomised blocks. The removal rates of S. aureus cells from
contaminated ﬁngertips were estimated by analysis of variance, the
response variable being the logl0, reduction factor (RF), ie, logl0 of
the initial counts minus logl0 of the ﬁnal counts. In the ﬁrst and second
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blocks, the ﬁngertips of the volunteers were contaminated in mean with
3.95 logl0 colony-forming units (CFU) light-contamination hand and
7.24 logl0 CFU heavy-contamination hand, respectively.
Results: In the ﬁrst block, there were signiﬁcant diferences between
treatments (P< 0.05). The 10% PVP-I (RF, 3.96) and 70% ethyl alcohol
(RF, 3.95) had signiﬁcantly higher removal rates than plain liquid soap
(RF, 2.44) and 4% chlorhexidine (RF, 2.98). In the second block, 10%
PVP-I (RF, 4.55) and 70% ethyl alcohol (RF, 3.80) also were signiﬁcantly
more effective than plain liquid soap (RF, 1.95) and 4% chlorhexidine
(RF, 2.24; P< 0.05). Plain liquid soap was signiﬁcantly more effective
than 4% chlorhexidine detergent.
Conclusions: The results suggest that 10% PVP-I and 70% ethyl alcohol
may be the most effective hand-cleansing agents for removing meticillin-
resistant S. aureus strain from either lightly or heavily contaminated
hands.
P1103 Hand hygiene after toilet visits
D. van der Vegt, A. Voss (Nijmegen, NL)
Introduction: Compliance with hand hygiene in the healthcare setting,
is generally low (on average 40%), despite the fact that good hand
hygiene still is one of the most important measures to prevent nosocomial
infections. Since the main indications for hand hygiene differ between
healthcare and non-healthcare settings no comparison has been done.
Objective: Aim of the present study was to investigate the degree of
compliance with hand hygiene after toilet visits in and outside the
healthcare setting.
Methods: We observed different group of healthcare providers
(hospital/laboratory personnel and participants of ECCMID 2007),
and users of public lavatories along motorways with regard to their
compliance with hand washing after toilet visits
Results: Compliance with hand hygiene after toilet visits was, 46%, 84%
and 75%, respectively. Obviously, healthcare workers show a different
compliance with hand hygiene in and outside the healthcare setting.
Conclusion: While the comparison of these different groups most
certainly is “ﬂawed” and “biased” it is interesting to see, that
hand hygiene compliance after toilet visits is the lowest in the
healthcare setting, while another group of healthcare-workers (ECCMID
participants) had the highest compliance. Possibly, the feeling of a
“miasmic” environment (presumed “dirty” public toilets) triggers hand
hygiene compliance, whereas the “clean” hospital environment may jam
the trigger to do so.
P1104 Engaging more than 300 healthcare facilities from Europe
to participate in the testing of the WHO multimodal hand
hygiene improvement strategy
G. Dziekan, J. Storr, B. Allegranzi, A. Leotsakos, C. Engineer, H. Sax,
D. Pittet (Geneva, CH)
Healthcare-associated infections (HAI) affect hundreds of millions of
people worldwide and are a major global patient safety issue. During
healthcare delivery, in most cases pathogens are transmitted by healthcare
workers’ hands.
Prevention of HAI is the target of the First Global Patient Safety
Challenge, “Clean Care is Safer Care”, launched in October 2005 by
the WHO World Alliance for Patient Safety. WHO “Guidelines on Hand
Hygiene in Health Care (Advanced Draft)” have been produced together
with a multimodal implementation strategy to improve hand hygiene at
the bedside. The strategy is currently being tested at selected hospitals
within each of the six WHO regions worldwide to validate the guideline-
recommendations.
Objective: To acquire feedback on the feasibility of implementing
a multimodal HH improvement strategy in non-selected healthcare
facilities across the socioeconomic and cultural range, including highly
developed and least developed countries.
Methods: The WHO programme has set up a web-based community
platform to allow every HCF in the world to register and participate as
a Complementary Test Site. Registered facilities have access to a suite
of 40 implementation, training and evaluation tools, including a detailed
"Guide to Implementation".
Results: Within the ﬁrst ten months more than 300 healthcare
facilities (hospitals, ambulatory clinics, long-term care facilities) from
European countries have registered either as individual healthcare
settings or represented by national/sub-national coordinators. Several
networks of hospitals have formed as part of national or sub-national
campaigns following a pledge by the Ministry of Health to address
the growing burden of HAI. In Italy 143 hospitals are engaging in
the HH improvement strategy, in Switzerland 116 hospitals, in Spain
and Catalun˜a 22 hospitals are participating. National coordinators
have adapted and translated the provided material to implement the
multimodal HH improvement strategy to ensure engagement and
sustainable effect.
Conclusion: Political awareness and leadership can mass-mobilise
healthcare facilities to engage in quality improvement strategies offered
at a global level. Coordination at national or sub-national levels is needed
to provide a consolidated approach to ensure sustainability.
P1105 Foul places to trigger clean behaviour
B. Wiesman, M. van Schie, A. Voss (Delft, Nijmegen, NL)
Introduction: Compliance with hand hygiene is a continuous problem
within healthcare settings. Multimodal interventions are recommended
to improve healthcare workers compliance, including those focussing the
attention on hand hygiene by visual reminders, such as “speaking walls”
(posters).
Objective and Method: We were looking for new and innovative ways
of placing reminders for hand hygiene within the hospital setting. Aim
of the study was to evaluate the effect of “promotional toilet paper” on
hand-rub use in hospital wards. The hand-rub use was measured using
dispensers equipped with sensors that allowed wireless transfer of data
to a central computer. A software was developed to translate the different
dispenser motions into hand-rub use data (NewCompliance®)
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Results: Placement of promotional toilet paper signiﬁcantly increased
the hand rub use of healthcare workers. The effect decreased after some
time and could be repeated after introduction of a new design.
Conclusion: This study shows that a simple, low cost intervention,
namely the placement of toilet paper containing motivational messages,
may have a signiﬁcant impact on the use of hand disinfectants and may
therefore become a part of the multimodal interventions to increase hand
hygiene compliance. Furthermore, automated data collection of hand rub
use can be a useful instrument to evaluate the effect of interventions
to increase hand hygiene compliance. As with many interventions, the
effect loses its impact over time, but can be boosted by a change
of motifs. Obviously, in the case of motivational toilet paper, clean
behaviour can be triggered in foul places.
P1106 Wristwatches as potential sources of hospital-acquired
infection
A.R. Jeans, J. Moore, C. Nicol, C. Bates, R.C. Read (Shefﬁeld, UK)
Objectives: To measure the rate of bacterial hand and wrist contamina-
tion, particularly by Staphylococcus aureus, amongst healthcare workers
(HCWs) who wear wristwatches.
Methods: Two consecutive cohort studies of wristwatch wearers and
non-wristwatch wearers were conducted amongst samples of HCWs. In
the ﬁrst study (n = 300), wrists were sampled by skin swabs and hands
by direct plate inoculation. In the second study (n = 355) this was done
after the HCW was asked to remove their watch immediately prior to
sampling.
Results: S. aureus was found on the hands of 25% of the wristwatch
wearers and 22.9% of the non-wristwatch wearers in the ﬁrst study.
Watch wearers had higher counts of bacteria on their wrist (p< 0.001),
but not on the hands.
In the second study, removal of the watch prior to sampling resulted in
increased counts of bacteria on both hands as well as the watch wrist
compared with non-watch wearers (p< 0.001).
Conclusion: Wristwatch wearers have an excess of bacterial contami-
nation of the wrists. They do not have an excess of hand contamination
unless the watch is manipulated.
P1107 Improving patient area disinfection cleaning in 34 acute
care hospitals
P. Carling on behalf of the Healthcare Environmental Hygiene Study
Group
Objectives: It has become increasingly recognised that microbial
contamination of the patient’s immediate environment plays a signiﬁcant
role in the transmission of many healthcare associated pathogens.
Despite the recent recommendation that hospitals experiencing increased
transmission of MDROs “Monitor (i.e., supervise and inspect) cleaning
performance to ensure consistent cleaning and disinfection of surfaces in
close proximity to the patient and likely to be touched by the patient and
healthcare professionals” (CDC –2006; Category 1B), there currently
exists no practical means of evaluating and improving the effectiveness
of these activities.
Methods: An invisible ﬂuorescent targeting method was used to
conﬁdentially evaluate the cleaning of 14 standardised high-touch
objects. Rooms were marked following terminal cleaning and re-
evaluated after one to two patients had occupied the room and it had
been again terminally cleaned.
Results: 1511 rooms and 19,361 objects were evaluated in 34 hospitals
ranging in size from 25 to 721 beds. The mean proportion of
objects cleaned was 48.5% (95%CI 42.9 to 47.5) prior to educational
interventions. While sinks and toilet seats were relatively well cleaned
(79.5%), consistently low rates of cleaning were documented for objects
at high risk for microbial contamination including bedpan cleaners,
toilet area handholds, bathroom and room doorknobs and bathroom
light switches (23.3%). Following educational programs and process
improvement feedback the cleaning of 448 rooms and 5386 objects
were evaluated in the same manner. Overall thoroughness of cleaning
improved to 77% (95%CI 78.5% to 89.2%) or 62% from baseline. All
hospitals realised signiﬁcant improvement over pre-intervention results
(P 0.0001).
Conclusion: The use of an objective targeting method in 34 acute
care hospitals disclosed substantial opportunities for improving room
cleaning/disinfecting activities. Following educational interventions and
ongoing performance feedback to the environmental services staff, highly
signiﬁcant enhancement of near-patient environmental cleaning was
objectively documented in all hospitals.
P1108 Bactericidal effect of disinfectants on Chryseobacterium
meningosepticum
M. Ceyhan, E. Kilic, I. Yildirim, M. Ozalp, A.B. Cengiz, A. Bagdat,
C. Barin (Ankara, TR)
Three outbreaks caused by Chryseobacterium meningosepticum on
5 different wards of a tertiary care paediatric hospital (Hacettepe
University, Ankara) with 7 different positive environmental samples
were observed between July 2006 through January 2007.Antibiogram
typing and ERIC-PCR revealed that all isolates were epidemiologically
related. C. meningosepticum was isolated from several dry environmental
samples(electric button, computer keyboard, phone, door knob, AMBU
bag) in addition to an infant formula. Disinfection and cleaning of the
environmental surfaces were started in twice daily manner. However, we
could not ﬁnd any precise route of disinfection and type of chemical to
use in the literature. This study was planned to evaluate the efﬁcacy of
hospital disinfectants against C. meningosepticum.
Polyhexanide (Hexanios G+R, France), didecyl dimethylammonium
chloride (Surfanios, France), 4% chlorhexidine digluconate (Dermanios
scrub chlorhexidine, France), 6.66 g benzalkonium chloride plus 3.33g
alkyldimethylammonium chloride (Cleanisept spray, Germany) and
solution containing 42 g ethanol, 0.05g didecyl dimethylammonium
chloride (Descosept AF, Germany) were tested for bactericidial activity
against C. meningosepticum isolated from the door-knob according to
the principles of EN 1040 standarts. Surviving colonies were enumerated
and expressed as colony forming units per milliliter. The reduction rate
was calculated as the expression of the disinfectant efﬁcacy according
to the following formula log10 reduction = log10 control count −
log10 disinfection count. Log10 reductions of >5 were taken as an
indication of satisfactory bactericidal activity. Susceptibility testing was
performed using the quantitative suspension test.
The test results are presented as log10 reduction of the bacteria after
5 and 60 minutes of contact. All studied disinfectants were uniformly
bactericidal (effective in producing a >5-log reductions) in 5 and 60
minutes at their in-use concentrations. The efﬁcacy of Hexanios G+R
and Surfanios were tested three different concentrations including in-use
concentrations, other disinfectants were studied for in-use concentrations
only.
The efﬁcacy of surface disinfection and cleaning in reducing microbial
loads and their dissemination is one of the critical points to control
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outbreakprevent prevention of nosocomial infections. All of the studied
disinfectants can be used in cleaning of the environmental surfaces
during nosocomial C. meningosepticum outbreaks.
P1109 A new experimental model designed to evaluate the antifun-
gal effect of UVC radiation against medical airborne fungi
L. Malic, I. Ailincai, M. Mares (Iasi, Bucharest, RO)
Objectives: The aim of this paper is to propose a new and reproducible
experimental model designed for evaluation of fungicidal effect of UVC
radiations with a wavelength of 254 nm against medical airborne fungi,
and its validation.
Methods: We achieved a testing module with a continuous monitoring
and setting of work parameters (temperature, humidity, exposure time)
and a complex device for generating UVC radiations and measurement
of dose which offer the possibility to perform experiments in biological
and radiological safety conditions. In order to validate this device,
we performed some experiments with six strains of airborne fungi
(Aspergillus niger, A. ﬂavus, A. fumigatus, A. ochraceus, A. terreus and
Neosartorya ﬁscheri). For testing we used fungal spores suspensions
in saline solution with 0.05% Tween 80, having a ﬁnal concentration
of 106 CFU/ml. From each suspension, 0.1ml have been plated onto
Potatoes Dextrose Agar and after drying, the Petri dishes were exposed
to UV radiations in a dark ﬁeld for various periods of time (ﬁnal doses:
9.3, 27.9, 55.82 and 111.66 mWs/cm2). After exposure, the plates were
rapidly covered with black paper and transferred to incubation in order to
prevent DNA photoreactivation. Each test was done in triplicate. After
72–96 hours of incubation, the intensity of fungicidal effect has been
calculated using the Ir (decimal logarithmic reduction index).
Results: The Ir values have a linear increment for all tested strains
while the UV doses increase. The arithmetic means of Ir were: 3.16 –
A. niger, 3.58 – A. ﬂavus, 3.89 – A. fumigatus, 3.96 – A. ochraceus,
4.29 – N. ﬁscheri, 4.41 – A. terreus. The difference of susceptibility
for these six species to UVC radiation is not statistical signiﬁcant
(p 0.05), but the increase of p values when A. terreus is compared
with the remaining strains emphasise some minor differences. Also,
no signiﬁcant differences were observed between the three series of
experiments (p> 0.05) demonstrating the validation of our model as a
reproducible one.
Conclusion: We proposed and veriﬁed a new experimental model for
studying the fungicidal effect of UVC radiations. The tests performed
using six strains of spore-forming fungi have proved that our model is
a safe, easy to perform and reproducible one. This model may be used
for dose evaluation in order to determining the appropriate CFU number
reduction for medical airborne fungi in hospitals, pharmaceutical, food
and feed industries.
P1110 Point-of-use ﬁlters to prevent fungal contamination of
hospital water
A. Onken, P. Gaustad, T.G. Abrahamsen, A. Warris (Rud, Oslo, NO;
Nijmegen, NL)
Objectives: To investigate whether the installation of point-of-use ﬁlters
could retain the fungal contamination of the hospital water at the
Rikshospitalet, Univ. of Oslo, Norway. Previously, we showed that the
hospital water of the paediatric oncology department was contaminated
by fungal organisms. Furthermore, hospital water has been suggested
as a route for transmission of invasive ﬁlamentous fungal infection and
preventive measures are needed to protect immunocompromised patients.
Methods: In April 2005 water samples were taken from 10 showers (hot
water) and 10 sink taps (cold water) at the paediatric oncology ward,
including four BMT units. The samples were collected in sterile glass
bottles on three different days in an 8-day period. Then, point-of-use
ﬁlters (Pall-Corporation®) were installed on the taps and showerheads.
Sixty samples were taken from showers and sink taps before installation
point-of-use ﬁlters, 20 samples were taken with the ﬁlters in place. The
collected samples were ﬁltered through sterile ﬁlters, pore size 0.45 mm.
The ﬁlters were deposited on Sabouraud glucose agar, incubated for 7
days and examined for fungal species and identiﬁed by macroscopic and
microscopic characteristics. Aspergillus isolates were identiﬁed to the
species level.
Results: Filamentous fungi were recovered from 97% (58 of 60 samples)
of the water samples before installation of the point-of-use ﬁlters.
Aspergillus fumigatus was isolated in 21 of 60 samples (35%).
On average, 2.9 colony forming units (cfu)/ 500ml of ﬁlamentous fungi
were recovered, Aspergillus sp. 0.7 cfu/ 500ml, A. fumigatus 0.6 cfu/
500ml.
After the installation of local ﬁlters no moulds were recovered (20
samples), but the ﬁlters were rapidly occluded within 1 or 2 days.
Electron microscopy showed that the surface of the occluded ﬁlters was
completely covered with large amounts of particulate colloidal material.
Conclusions: The installation of point-of-use ﬁlters retained the fungal
contamination of the hospital water completely. Due to a high level of
organic material in the water, the ﬁlters were blocked after being in
use for only 1 or 2 days. Pre-ﬁltration at the inlet of the water into
the paediatric oncology department should be carried out to get rid of
the organic materials. At present, it is not clear, if this is feasible. Our
ﬁndings indicate that point-of-use ﬁlters might be useful unless the water
contains much organic material blocking the ﬁlters.
P1111 Healthcare professional preferences in educational strategies
against antimicrobial resistance in a developing country
J.S. Castillo, R. Sa´nchez, G. Buitrago, A.L. Leal, J.A. Corte´s,
C.A. A´lvarez on behalf of GREBO
Background: Infection control strategies are based on behaviour
understanding and education. Educational strategies tend to fail due
to inability to use adequate methodologies or didactic approaches to
healthcare workers. Here we try to ﬁnd out the educational preferences
for healthcare workers in Bogota´, Colombia.
Methods: We perform a cross sectional survey in a 50 hospitals network
with 11626 hospital healthcare workers. Estimated sample size was
collected with a multi-stage sampling strategy. Interviews were done
using a format deﬁned by an expert panel. Preferences were scored in
a likert scale. An electronic capture application (Teleform™) was used,
all descriptive analysis were carried out in Stata 9.0 (licensed version).
Results: 598 healthcare givers were included. All work shifts were
represented. Sample had 33.1% physicians, 41.6% nurses and 25.3%
other healthcare givers. 65.7% reported only graduate instruction.
Inadequate self reported knowledge was 33.8%, no differences between
medical and non medical professionals were not found. Educational
activities were a need for therapeutic and preventive areas. How to
give information to patients was a second motivation for physicians.
Workshops were the most preferred educational activity (Figure 1). The
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main argument to choice an strategy were in decreased order the capacity
to improve knowledge, availability, no special technology requirements,
ﬁnantial support, time and effort demanding activities (Figure 2).
Figure 1. Preferences in educational methodology
Figure 2. Key features for activity selection
Conclusions: No differences were found in preferences for medical and
nonmedical target. Self reported preferences are of great relevance to
design an educational intervention to contain antimicrobial resistance.
Participatory interventions as workshops are the favorite ones.
P1112 Inﬂuence of a hygiene promotion programme in infection
control on an intensive care unit
J.F. Murcia-Paya´, E. Garcı´a-Va´zquez, A. Melgarejo-Moreno,
J. Martı´nez-Herna´ndez, F.J. Gil-Sa´nchez, M. Canteras,
J. Go´mez-Go´mez, J. Allegue (Cartagena, Murcia, ES)
Objectives: The inconsistent application of hygiene measures by
healthcare workers accounts largely for the epidemic dissemination of
nosocomial infections (NI); our aim is to know the prevalence of NI on
an Intensive Care Unit (ICU) and to assess the inﬂuence of a hygiene
promotion programme in the rate of NI.
Patients and Methods: The efﬁcacy of a hygiene promotion programme
to prevent NI was assessed in our ICU during 1-year period; initially, a
prospective and observational study of NI cases on the ICU during a 6
month period (PI) was done; epidemiological and clinical variables as
well as information about risk factors related to NI were assessed. These
data were compared to those corresponding to a second prospective
and observational study period (PII) during which a health-workers
hygiene promotion programme was established. Education of hospital
staff was an essential component of the programme aimed to predispose
healthcare workers to adopt hand hygiene behaviour (poster campaign
and educational meetings and handouts), reinforce and enable the
behaviour (provision of an alcohol hand rub beside each patient’s
bedside). Antibiotic policies and ICU staff were the same during the
two periods.
Results: 395 patients were assess during PI and 411 in PII; there were
not statistically signiﬁcant differences on epidemiological or clinical
variables during the two periods; there was no difference in risk factors
related to NI (underlying conditions, severity at admission, rate of urgent
surgeries, invasive techniques, ICU length of stay, mechanical ventilation,
etc.). The rate of infection in PI was 26% and 16% in PII (p< 0.05).
Hand-washing rate was signiﬁcantly higher in PII than in PI (previous
to patient care: 45% and 35% respectively and post patient care: 63%
and 51%, respectively)
Conclusion: Patient’s features during PI and PII were similar; there was
a signiﬁcant increase in ICU staff hand-hygiene compliance during the
educational phase; the incidence rates of NI during the pre-programme
period (PI) were signiﬁcantly higher than during the programme period.
P1113 Peripheral venous cannulation in surgical patients: could
we improve?
A. George, S. McKain, K. Shute, K. Swarnkar (Newport, UK)
Aims: More than 90% of all patients admitted to hospital will
have a peripheral cannula inserted. Complications associated with this
procedure include extravasation, thrombosis and infection. We aimed to
investigate both the compliance of peripheral venous cannulae insertion
with national guidelines as well as assess the indications, maintenance
and complications associated with its use.
Methods: 40 randomly selected surgical patients with a peripheral
venous cannula in situ were monitored daily for 8 days or until removal
of the cannula. A non-interventional study was undertaken by gathering
information on all aspects of care including site, size, use and indications,
level of documentation, status of dressings, infection/ thrombosis risk
using the VIPS (Visual Infusion Phlebitis Score) as well as cannula
changes.
Results: Analysis demonstrated poor compliance with choice of non-
dominant hand, cannula size, continuing indications for use. 96% of
cannulae had no documentation regarding its insertion, removal or
changes. 40% of the inserted cannulae were never used. Compliance
of cannulae care and maintenance was poor with most of the cannula
dressings becoming contaminated with blood, pus or ﬂuid or the cannulae
being inappropriately secured with non-sterile adhesive tape and bandage
dressings – inappropriate and contaminated dressings showing a strong
association with infection. A high rate of infected cannulae (17%) and a
non-compliance with best practice for cannulae removal was seen even
when the VIPS score was 2 or more (indicating active thrombophlebitis)
with a signiﬁcant group being left in and used even in the presence of
active infection. Most cannulae were left in-situ for 48 or more hours
after its use had stopped with a signiﬁcant minority being left in for
more than 120 hours.
Discussion: This study shows that though deﬁnite protocols exist for
the use, maintenance and removal of peripheral cannulae, they tend
to be eclipsed and sidelined. The insertion of these small peripheral
intravenous devices poses the potential of becoming a major source
of infection if their use and maintaince is not monitored. An overall
improvement in the awareness of peripheral intravenous cannulae care,
use and documentation is essential to ensure best practice in surgical
patients.
P1114 Simple procedures to reduce Staphylococcus epidermidis
adhesion to indwelling medical devices
C. Sousa, P. Teixeira, R. Oliveira (Braga, PT)
Objectives: The aim of this work was to develop expedite procedures to
reduce Staphylococcus epidermidis adhesion to materials normally used
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in indwelling medical devices such as catheters and prosthesis using only
a pre-contact of the material surface with two conditioning substances:
heparin and gentian violet. Heparin is a proteoglycan with strong
anticoagulant activity, normally used to minimise thrombus formation,
and gentian violet is a triphenylmethane dye that is normally used as a
biological stain and as antiseptic agent.
Methods: Three clinical S. epidermidis strains were studied: 9142-M10,
9142 and IE186. Acrylic and silicone were used as substratum. Coupons
(2 cm× 2 cm) were immersed in heparin or in 1% gentian violet solution,
left to soak for 2 hours and left to dry overnight at 21 ºC. For the adhesion
assays, the coupons were placed in 6 well tissue-culture plates with 4 mL
of a cell suspension (1×109 cells/ml), for 2 hours, at 37ºC and 120 rpm.
Each coupon was then stained with 4,6-diamino-2-phenylindole (DAPI)
solution and adhered cells were visualised under an epiﬂuorescence
microscope and enumerated with appropriated software. The coupons
with adhered cells were also observed by scanning electronic microscopy
(SEM).
Results: The results of the adhesion assays point to a signiﬁcant decrease
in bacterial adhesion to silicone and acrylic after pre-contact with both
conditioning substances. The only exception was observed for strain
IE186, which adhered at a similar extent to acrylic pre-contacted with
gentian violet and non-pre-contacted acrylic.
Conclusion: The results obtained in this work have a potential clinical
signiﬁcance showing that both heparin and gentian violet are effective in
reducing bacterial adhesion. Pre-treatment of biomedical materials with
these substances may constitute a successful and expedite procedure
to reduce the incidence of nosocomial infections, especially during the
insertion of indwelling medical devices.
P1115 Transmission of inﬂuenza virus within a French university
hospital during three inﬂuenza seasons, from October 2004
to April 2007
P. Vanhems, C. Regis, F. Najioullah, B. Barret, C. Gorain,
S. Pires-Cronenberger, L. Pollisard, V. Escuret, F. Morﬁn, B. Comte,
D. Floret, B. Lina (Lyon, FR)
Objectives: A prospective study was conducted during 3 inﬂuenza
seasons at Edouard Herriot Hospital (Lyon, France) from October 2004
to April 2007 to describe nosocomial cases of inﬂuenza and to document
the role of healthcare workers (HCW) in the transmission of this virus.
This hospital counts for 1,000 beds.
Method: In 2004/05 (study #1) 15 wards participated to the study, 36
wards in 2005/06 (study #2) and 39 in 2006/07(study #3). HCW and
hospitalised patients with Inﬂuenza Like Illness (ILI) syndrome were
included. A nasal swab was taken for virological diagnosis. Medical
history and vaccination status were collected for each case. Nosocomial
cases were deﬁned as occurring after at least 72 hours of hospitalisation
for the patients or exposure to an infected colleague or a patient for
HCW. Descriptive statistics were used for data reporting.
Results: A total of 872 ILI cases were identiﬁed, 71 in 2004/2005,
365 in 2005/2006 and 436 in 2006/2007. Children (Ch) were included
only in studies #2 and #3. The sample counted for 168 adult patients
(AP), 151 HCW and 553 Ch. There were 39 AP, 27 HCW and 90
Ch with laboratory conﬁrmed inﬂuenza; 21 nosocomial inﬂuenza cases
were observed; 13 for the AP, 5 for the HCW and 3 for the Ch. In
study #1, 9 transmissions were observed from patient to patient (n = 3),
from patient to HCW (n = 3) and from HCW to HCW (n = 3); in study #2
one transmission was observed from patient to HCW and in study #3,
11 transmissions were observed from patient to patient (n = 3), from
patient to HCW (n = 3) and from HCW to HCW (n = 3). 2 patients with
severe underlying disease and with conﬁrmed hospital acquired inﬂuenza
died. Among ILI cases 77/168 AP, 14/553 Ch and 47/151 HCW were
vaccinated against inﬂuenza. 21 (15%) cases of conﬁrmed inﬂuenza
occurred in 138 vaccinated individuals (16 patients and 5 HCW). In
study #1, circulating inﬂuenza A strain differed from the vaccine strain.
Communautary inﬂuenza epidemic was moderate during study #2 and
#3. In study #2 Inﬂuenza B was more prevalent and might be more easily
transmitted than inﬂuenza A.
Conclusion: Nosocomial inﬂuenza occurred at each season which
highlights the need of using appropriate preventive measures for control.
Most transmissions were from non-vaccinated individuals, underlining
the importance of vaccinating HCW to limit transmission.
P1116 How does vaccination of healthcare workers affect the num-
ber of inﬂuenza virus infections in nursing home patients?
C. van den Dool, E. Hak, J.C.M. Heijne, M.J.M. Bonten, J. Wallinga
(Utrecht, NL)
Objectives: In epidemiological studies an increase in inﬂuenza vaccine
uptake by institutional health care workers (HCWs) was associated
with decreased inﬂuenza illness and mortality rates during the inﬂuenza
season among nursing home patients. Since these studies were restricted
to a small number of nursing homes in few inﬂuenza seasons
with different vaccine-strain matching and vaccine coverage, the
generalizability of these ﬁndings remains uncertain. We, therefore,
developed a simulation model to determine the effects of increased
inﬂuenza vaccine uptake by HCWs on inﬂuenza attack rates among
nursing home patients in different scenario’s and for different vaccine
coverage levels.
Methods: We use a stochastic individual-based model with discrete
time intervals to simulate inﬂuenza virus transmission in a 30-bed long-
term care department. We track patients and staff and their stage in the
inﬂuenza virus infection cycle: Susceptible, Exposed (infected but not
yet infectious), Infectious and Recovered/immune. An individual’s risk
of being infected depends on the number of contacts it has, and the
likelihood that the contacted persons are infectious.
Individual vaccination is assumed either to induce perfect immunity
against infection or to have no impact at all. Most parameters in the
model are based on earlier observations (e.g. latent and infectious
periods, contact structures). The impact of uncertainty in some
parameters (such as vaccine efﬁcacy and transmission probability) was
evaluated using a Latin Hypercube Sampling uncertainty analysis.
Results: Increasing vaccination of HCWs decreases the number of
inﬂuenza virus infections in patients linearly; for every 25% of HCWs
vaccinated, the patient attack rate decreases with 4%. No herd immunity
is observed. The maximal relative risk reduction for patients (when
HCW vaccination rate increases from 0% to 100%) is 67%. Increasing
vaccination of HCWs decreases both the number of introductions
of inﬂuenza virus into the patient population, and the total number
of infections following an introduction. Variation in attack rate per
department is high.
Conclusion: Increasing vaccination of HCWs can prevent a large
fraction of inﬂuenza virus infections among nursing home patients and
reduce the number of institutional outbreaks. The absolute risk reduction
for patients is equal for every 10% increase in vaccine coverage among
HCWs, independent of the initial coverage.
P1117 Enterobacteriaceae producing extended-spectrum
b-lactamase: duration of carriage and implication for
surveillance
C. Bellini, I. Nahimana, L. Senn, A. Wenger, P. Francioli, G. Zanetti
(Lausanne, CH)
Background: In 2004–2005, ESBL-producing enterobacteriaceae
(ESBL-E) were found in 1.2/1,000 patients in our hospital. ESBL-E
were of CTX-M type in 79% of the cases (Lartigue MF et al, AAC
2007), and represented 0.7% of all enterobacteriaceae. In 2006, the
rate of colonisation/infection by ESBL-E raised to 2.2/1,000 patients,
representing 1.7% of all enterobacteriaceae. No outbreak was detected.
This increase prompted more stringent infection control measures in
addition to contact precautions, which included routine screening of
ESBL-E carriage in all readmitted patients with a history of previous
infection/colonisation by ESBL-E.
Objective: To describe the duration of ESBL-E carriage.
Setting: 850-bed general university Hospital.
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Method: Duration of carriage was described in patients for whom
follow-up screenings were available. These included i) readmitted
patients with a history of ESBL-E, who were identiﬁed by an automated
alert and underwent rectal swab and culture of any previously positive
site; and ii) patients who had non-systematic serial screenings because
of prolonged hospital stay.
Results: From April 2006 to November 2007, ESBL-E was detected
in 91 new patients. Detection occurred <48 h after admission in 46/91
(51%); ESBL-E were Escherichia coli in 69 cases (76%) and Klebsiella
pneumoniae in 15 (16%). 47/91 new patients had 1 to 9 (median 2)
follow-up screenings in the context of either a prolonged hospital stay
or a new admission. In addition, 9 patients with history of ESBL-E
before the study period had 1 to 8 (median 2) follow-up screenings in
the context of a new admission. In the total population of 56 patients
with follow-up screenings, 38 (68%) had persisting colonisation after a
median period of 56 days (range 1 to 608). The other 18 (32%) were
eventually negative after a median period of 126 days (range 8 to 358).
Conclusion: prolonged carriage of ESBL-E is frequent, which warrants
routine follow-up screening of all patients with a history of infection or
colonisation by ESBL-E at the time of new hospital admission.
P1118 Biological monitoring of sterilisation procedures in dental
ofﬁces in Venezuela
T. Bello, A. Lodato, C. Arango, C. Marrero, J.H. de Waard,
L.A. Guevara (Caracas, VE)
Objective: To evaluate the incidence of sterilisation failures in a
convenience sample of dental ofﬁces in Venezuela.
Methods: 284 strips with spores of Geobacillus stearothermophilus and
Bacillus atrophaeus and an evaluation form were distributed to dentists
interested in participating in this study. The dentists mailed the processed
strips and the evaluation form to the laboratory for culture.
Results: Tests were submitted from 108 dental ofﬁces. The sterilisation
methods were convection dry heat (93%) and steam under pressure (7%).
A total of 32.4% sterilisation failures were detected. Convection dry heat
failed with 32% (32 out 100) and steam sterilisation with 37.5% (3 out
of 8)
Conclusion: A high percentage of failures occurred in the sterilisation
of instruments reprocessed for the use in patient treatment. Steam
under pressure failed more often than convection dry heat sterilisation.
These results show the need for ofﬁcial guidelines to be developed by
Venezuelan health authorities and to make it compulsory for dentists
to biologically verify sterilisation processes. When corrective action is
taken, routine use of spore strips for quality control could increases
patient safety.
P1119 From “chicken run” to quality care and best practice
in management of patients with infections caused by
extended-spectrum b-lactamase-associated bacteria
A. Guleri, R. Palmer, B. Lunt, K. Lunt (Blackpool, UK)
Objectives: Recent ITV show and press news successfully drew the
attention of public and doctors towards the overlooked rising problem in
community with ESBL-producing strain of E. coli, associated mortality,
association with consumption of foreign poultry and limited national
surveillance. This media coverage did miss the complete picture. High
quality patient care and best medical practice has been a top priority at
Blackpool Victoria Hospital that witnessed rapid rise in ESBL associated
infections especially community patients with UTI. This surveillance
study over 2 12 years provides data on rising rate of ESBL infections in
hospital and community, associated variations, susceptibility, and guides
our strategy of optimal management of community and hospitalised
patients.
Methods:
• Laboratory data on ESBL testing (since February 2005);
• Research: Comparing single plate double disk synergy technique with
four combination disc technique plates for ESBL testing.
• Direct ESBL screening/conﬁrmatory test on positive blood cultures.
• Standard comments on reports: multidrug resistance mechanism,
infection control protocol and discussion with microbiologist in
planning management.
• Risk stratiﬁcation approach for severe sepsis in admission and
emergency units.
• Enhanced liaison with GPs for patient speciﬁc discussion;
• Raising awareness.
Results: Rising rate of ESBL positive bacteria, especially E. coli
seen in the last 2 12 years (refer graph). 619 isolates were conﬁrmed
ESBL positive. 34.5% (community specimens). Overall 70.1% (urines)
and 10.5% (blood cultures). E. coli (62%), followed by Klebsiella
sp. and Enterobacter sp. (approx 20% each). Overall susceptibility of
E. coli: Ciproﬂoxacin, Gentamicin and Tazocin (16 – 50%). Urinary
E. coli: nitrofurantoin (79%), trimethoprim (18%), ciproﬂoxacin (14%),
gentamicin (71%), tazocin (46%). Susceptibility to imipenem 100%.
Conclusions: There has been a rapid emergence of CTXM-E. coli in
England causing UTIs in community population. Blackpool is witnessing
a similar phenomenon. Our comprehensive approach to the problem
has included raising awareness in GPs, hospital consultants and junior
doctors (especially from admission units), encouraging patient speciﬁc
management discussion, regular local surveillance and feedback, and risk
stratiﬁcation approach for sepstic patients in admissions. Single daily
dosing IV ertapenem is currently offered from assessment units and in
near future to be administered at patients home.
P1120 Epidemiological typing of multi-resistant Klebsiella
pneumoniae strains by FT-IR
R. Guiomar, O. Preisner, Z. Videira, J.A. Lopes, J.C. Menezes,
J. Machado (Lisbon, Oporto, PT)
Klebsiella pneumoniae is an important nosocomial pathogen that has the
potential to cause severe morbidity and mortality, not only in intensive
care units and amongst paediatric patients, but also in medical and
surgical wards.
Objectives: Evaluate the usefulness of a novel application of FT-IR
spectroscopy in identiﬁcation of multiresistant Klebsiella pneumoniae
(MRKP) clones responsible for nosocomial infection outbreak in
Portuguese hospital.
Methods: Seventeen multiresistant Klebsiella pneumoniae strains
isolated from eleven patients from December 2006 to May 2007
during an outbreak in a Portuguese hospital were studied to identify
MRKP clones by antibiotic susceptibility test using the disk diffusion
method on Muller–Hinton agar (Kirby–Bauer methodology). For the
antimicrobial agents tested inhibition zone diameters were measured and
used only with the objective to identify and to compare the different
clones. Simultaneously to the antibiotic susceptibility testing, strains
were evaluated as well by Fourier transformed infrared spectroscopy
(FT-IR – Bruker Optik GmbH). Several pre-processing methods have
been investigated and the best treatment was selected based on its
contribution for the chemometrics model robustness.
Results: As determined by disc-diffusion antibiotic susceptibility testing,
MRKP isolates were distributed into to seven different antibiotypes
groups. Two major clones responsible for the nosocomial infection
were identiﬁed. Eight strains belonged to the same resistance pattern,
designated by clone A. Another four strains belonged to another group
that shows a different resistance pattern, designated by clone C. The other
ﬁve strains have shown different resistance patterns while compared with
each other as well as while compared with the previous clones. The
FT-IR analysis of the same strains showed results concordant with the
disc-diffusion antibiotic susceptibility testing and identiﬁed clone A and
C as the predominant clones.
Conclusion: FT-IR is cheaper, easier and faster to perform and
allow the access to the overall information of the bacterial cell. Our
results demonstrate that application of FT-IR spectroscopy together with
chemometrics methods has considerable potential to effectively fulﬁl
the current requirements for rapid and correct differentiation of closely
related strains implicated in nosocomial outbreaks.
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P1121 Presence of ESBL-producing Enterobacteriaceae in the
stools of outpatients with intra-abdominal infections
requiring surgery
S. Algarate, C. Seral, M.E. Llaneza, M. Pardos, R. Chaco´n,
J.C. Salinas, F.J. Castillo (Zaragoza, ES)
Objective: Bowel ﬂora may provide a substantial reservoir of resistant
microorganisms and precedes intra-abdominal infections. Their suscepti-
bility patterns may provide useful information for empiric treatment. We
determinate the ﬂora that colonises the bowel, the incidence of ESBL-
producing and/or carbapenem-resistant Enterobacteriaceae (Eb) and the
colonisation by non-fermenters Gram-negative bacilli (NF-BGN) in the
stools of outpatients with intra-abdominal infections requiring surgery
in 71 selected patients from 2005 to 2007.
Methods: Rectal swabs were collected at baseline and inoculated on
MacConkey agar plates (MC), MC supplemented with cefotaxime (CTX)
1mg/L, MC with ceftazidime (CAZ) 1mg/l and in modiﬁed CCDA
containing cefoperazone 32mg/L. Bacterial colonies were identiﬁed
from each plate using routine laboratory techniques. Eb growing in
antibiotic supplemented media were identiﬁed and screened for ESBL
production by the double-disk synergy test. Conﬁrmation was performed
by E-test with CTX/CTX-clavulanic acid (CA), CAZ/CAZ-CA and
cefepime (FEP)/FEP-CA.
Results: Rectal swabs were obtained at baseline in 71 selected patients.
In 69 of 71 patients (table) growed Eb and abscence of G− faecal ﬂora
in two patients. Nine (12.7%) patients harboured an ESBL-producing
Eb (4 E. coli CTXR-CAZS-FEPS, 2 E. coli CTXR-CAZR-FEPS, 2
E. coli CTXR-CAZS-FEPR and 1 C. freundii CTXR-CAZS-FEPS) and
9 patients were colonised by NF-BGN (12.7%).
Table: Species of Enterobacteriaceae identiﬁed and susceptibility to some b-lactams
Resistance (%) Ertapenem
n/m AMC CTX CAZ FEP MIC90 range
E. coli 77/65 11.68% 14.28% 3.89% 3.89% 0.016 <0.002−0.094
K. pneumoniae 5/5 40% 0% 0% 0% 0.016 0.006−0.016
K. oxytoca 5/5 20% 0% 0% 0% 0.012 0.004−0.012
C. freundii 5/5 80% 40% 20% 0% 0.064 0.006−0.064
P. mirabilis 3/3 0% 0% 0% 0% 0.012 0.006−0.012
E. cloacae 5/4 100% 20% 20% 0% 0.19 0.008−0.19
H. alvei 2/2 100% 0% 0% 0% 0.32 0.016−0.32
n: number of isolates; m: number of patients; AMC: amoxicillin/CA.
P1122 Risk factors of hospital-acquired infections in a
neurology-neurosurgery intensive care unit, in a tertiary
care hospital, in Turkey
C. Bulut, M.A. Yetkin, C. Ataman Hatipoglu, G.R. Yilmaz, F. Erdinc,
E. Yildiz, E. Karakoc, A.P. Demiro¨z (Ankara, TR)
Objectives: Intensive care unit (ICU)-acquired infections are associated
with high mortality, excessive length of ICU and hospital stay, and high
hospital costs. The risk factors for nosocomial infections may differ
according to the type of ICU. The aim of this study was to evaluate
the risk factors for ICU-acquired infections in the patients treated in
neurology-neurosurgery ICU.
Method: The study was conducted in Ankara Training and Research
Hospital, from May 2006 to May 2007. The patients treated for more
than 48 hours in 14-bed neurology-neurosurgery ICU were enrolled into
the study. The patients were followed until death or three days after
discharge by prospective daily surveillance. Nosocomial infections were
identiﬁed according to CDC criterias. Risk factors for ICU-acquired
infections were analysed with a logistic regression model.
Results: Two hundred and ﬁftyfour ICU-acquired infections occurred
in 160 (36.1%) of 443 patients during 5224 patient-days. The overall
rate of ICU-acquired infection was 57.3/100 patients and 48.2/1000
patient-days. The most common site-speciﬁc infections were urinary
tract infections (38.5%), pneumonia (31.7%), and bloodstream infections
(22.9%). Urinary catheter-associated urinary tract infection rate was
23.7/1000 urinary catheter-days; central line-associated bloodstream
infection rate was 37.9/1000 central line-days and ventilator-associated
pneumonia rate was 31.6/1000 ventilator-days. The utilisation ratios of
urinary catheter, central line catheter and ventilator were 0.90, 0.39 and
0.34, respectively.
In univariate analysis, age >60 years, being a neurology patient,
presence of nasogastric tube, central venous catheter and arterial
catheter, mechanical ventilation were determined as signiﬁcant risk
factors for ICU-acquired infections (p< 0.05). Multi-variate logistic
regression analysis revealed, being a neurology patient (p< 0.01),
presence of nasogastric tube (p< 0.01), presence of central venous
catheter (p< 0.01), mechanical ventilation (p< 0.1) and parenteral
nutrition (p> 0.05) as independent risk factors.
Conclusion: In this study, ICU-acquired infection rates were found
higher when compared with NNIS results. In interpretation of device-
associated infection rates, those high rates made us to take immediate
precautions both for decreasing device utilisation and emphasising the
importance of device application and care practices.
P1123 Screening cultures for multidrug-rresistant acinetobacter
and MRSA in hospitalised patients
M. Garcia, A. Nogue´s, J. Aramburu, P. Gassiot, F. Barcenilla,
A. Manonelles, A. Jover (Lleida, ES)
Objectives: The aim of this study was to describe the microbiological
performance of screening cultures (SC) for multiresistant Acinetobacter
spp. (ACI) and meticillin resistant Staphylococcus aureus (MRSA)
isolated from hospitalised patients.
Methods: Axillary (A), Faringeal (F), Nasal (N), and Rectal (R) swabs
for carriers control of ACI and MRSA received from hospitalised adult
patiens were studied during a year (October 2006 to September 2007).
In the same period, prospective SC were performed in all Intensive Cure
Unit (ICU) patients in the ﬁrst 24 h of their admission.
Samples were processed by conventional methods, and also in an
ACI selective medium (Leeds medium, Bio-Me´dics, Spain) and in
MRSA-ID screening medium (bioMe´rieux). Identiﬁcation and antibiotic
susceptibility was performed by Wider System ® (Soria Melguizo, S.A.,
Spain).
Results: We processed 2544 samples (704 A, 963 F, 782 N, and 663 R).
480 of this were from ICU patients. These cultures represent the 11%
of all bacteriological cultures received from hospitalised patients in the
same period in our laboratory.
113 new patients were colonised or infected by ACI, and 65 of them were
detected by SC. Rectal swab was the most useful (51% of 65 patients)
followed by faringeal swab (38%). 74% of patients with ACI were from
ICU and all but 2 were nosocomial.
In the same year we had 85 new pacients with MRSA, 29% of them were
detected in SC. Nasal swab detected 60% of all isolates and faringeal
swab 34%. We detected 2 patiens with MRSA at the time of their ICU
admittance.
Conclusions: We point out the high work load that screening controls
cultures represents for the microbiological laboratory.
The best sample for ACI detection was R, and N was for MRSA. In this
setting we found Leeds medium very useful in rectal screening of ACI
carriers.
SC were useful in detecting patiens colonised by multirresistant
microorganisms in ICU patiens at the time of their admittance
P1124 Information overload or under load! How national
knowledge weeks can help busy professionals
S. Wiseman, F. Hansraj, P. Kostkova, G. Jawaheer, M. Catchpole,
A. Roy, J. Freed (London, UK)
The National electronic Library of Infection (NeLI) www.neli.org.uk
is a single-entry portal to evidence based medical knowledge around
infection and covers a broad range of infectious diseases.
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The National Resource for Infection Control (NRIC) www.nric.org.uk
was launched in May 2005 in response to National Audit Ofﬁce
(2000/04) recommendations for a national infection control manual. The
project, funded by the Department of Health (UK), is endorsed by NeLI
and provides a single access point to the best available evidence and
resources on infection prevention and control.
The overall aim of both NeLI and NRIC is to provide relevant evidence
based policy, guidance and quality information, published within the last
5 years (where possible) in a timely manner. The key added value of both
sites is the quality appraisal of posted documents, which is conducted
in collaboration with major professional societies and expert committees
in the UK.
Promotion of the websites is ongoing through conference attendance and
publications, but it is often obvious when talking to infectious disease
and infection prevention specialists that they struggle to keep up-to-date
with guidance, research and policy in this important area. Therefore,
in January 2006 we started producing a monthly eNewsletter, which
is currently subscribed to by more than 1800 professionals, and this
provides information on the latest news, upcoming conferences and new
resources added to the websites in the last month.
In an effort to help with either information ‘overload’ (too much
information) or ‘under load’ (not knowing what you need to know)
it was agreed that National Knowledge Weeks (NKW’s) were the way
forward. The aim was to identify the best resources, policy and expert
comments regarding the prevention and/or control, treatment and care of
speciﬁc diseases, infections and infection control practice for healthcare
professionals.
This presentation outlines the three specialist areas promoted through
the websites in 2007; Tuberculosis, Seasonal Inﬂuenza, and Infection
Control along with the subsequent analysis of page views received, the
popularity of the page, the geographical location of the incoming trafﬁc
and the means of accessing the page through use of the web server logs.
The discussion will include an evaluation on whether NKW’s add value
to the sites and achieve their aim and represent the way forward for
2008.
P1125 Implementation of the "Do Bugs Need Drugs?" programme
in British Columbia, Canada
E.M. Blondel-Hill, K. Dreher, D. Patrick, M. Carson on behalf of
the “Do Bugs Need Drugs?” Working Group
Objective: To implement a province-wide program for wise use of
antibiotics in British Columbia (BC), Canada (population 4.3 million).
Methods: Educational resources for healthcare providers, the public and
children were adopted directly or adapted from the Do Bugs Need Drugs?
(DBND) program, which originated in 1998 in the adjacent province
of Alberta. DBND key messages promote: 1) handwashing prevents
infections, 2) bacteria and viruses are different, and 3) use antibiotics
wisely.
In 2004, based on the success of DBND in Alberta, the British Columbia
Ministry of Health provided $1.4 million to implement the program
in BC. A program coordinator and assistant were hired. A steering
committee with representatives from all health regions was organised
as was a DBND working group. An extensive training program was
developed with nursing students to teach Grade 2 (7−8 year olds) and
daycare children. A 20 page parent guide was distributed to all public
health units. A mail out of print materials and an antimicrobial reference
guide was distributed to all physicians, dentists and pharmacists in
the province. A provincial media campaign included advertisements on
television, in movie theatres, parent magazine, and public transportation
stations, buses and trains. Collaborations were established to follow
prescribing rates and resistance patterns over time. An initiative with
a food/pharmacy chain has been established for pharmacy personnel to
deliver the program in communities throughout the province.
Results: Since 2004, educational materials have been distributed to
8665 physicians, 1078 trainees, 3795 pharmacists and 2865 dentists.
Continuing education sessions have been provided to 863 physicians,
175 pharmacists, 210 infection control practitioners, 400 nurses and 520
nursing students. The Grade 2 program has targeted 12,950 children
(>40% of Grade 2 children in Vancouver) and the daycare program has
targeted 3384 children, 441 care providers and 39 childhood education
students. The televison advertisement has reached 75–85% of the target
audience (females aged 25–54) an average of 6–12 times over a 4 week
period.
Conclusions: Recognising that health promotion campaigns have a
signiﬁcant delay between education and outcomes (in this case, reduced
rates of antibiotic resistance), the BC government has committed an
additional $2 million over the next three years.
P1126 Improving outbreak management by understanding barriers
faced by professionals in hospitals and public health
A. Timen, M. Hulscher, D. Vos, J. van Steenbergen, R. Grol, J. van
der Meer (Bilthoven, Nijmegen, NL)
Objectives: The effectiveness of outbreak control depends substantially
on the adherence to guidelines. Adherence to guidelines is often not
optimal and this has been related, among others, to knowledge, attitudes
and behaviour of professionals. Little is known about the factors that
inﬂuence adherence to authoritative guidance in emergency situations.
This study aimed at identifying the most important constraints and
facilitators related to professionals in order to improve the quality of
outbreak management.
Methods: To qualitatively study and understand barriers to appropriate
outbreak control, 26 in-depth interviews with hospital microbiologists
and infection control professional and public health physicians and
nurseswere carried out in the Netherlands. The conceptual framework
of Cabana (JAMA, 1999) was used to discuss recommendations on
case ﬁnding, infection control, diagnosis, treatment and prophylaxis
taking into account recent crisis situations (SARS, outbreaks of
C. difﬁcile ribotype 027, rubella outbreak). After classifying the barriers,
questionnaires were developed for each group of professionals including:
38 items for public health physicians, 40 items for microbiologists, 26
items for infection control professionals and 40 items for public health
nurses. The questionnaires were subsequently administered to hygienists
in hospitals (N= 95), physicians and nurses in public health services
(N=33) and a representative sample of microbiologists (N=30). A ﬁve
point, asymmetric Likert scale was used to assess appropriateness of
each item.
Results: The response amounts 96% for the public health physicians,
84% for the public health nurses, 63% for the hygienists. The study
is still ongoing among microbiologists. Preliminary results show that
adherence increases when outbreak control measures are evidence based,
do not disturb the daily routine in the hospital/department and take
into account the safety of the personnel. Effective communication
between microbiologists and clinical specialists increases the adherence
to infection control measures and therapy recommendations.
Conclusions: The quality (evidence based development, applicability)
and timeliness of scientiﬁc guidance during emergency situations are
among the most important predictors for the reported adherence by
professionals. Further qualitative and quantitative analysis of the data
will provide a comprehensive basis for tailored interventions to improve
adherence.
P1127 Compliance with contact precautions in acute care teaching
hospital
M. Alkaabi (Alain, AE)
Introduction: The essential factors for limiting the spread of Meticillin
resistant Staphylococcus aureus (MRSA) are the surveillance cultures of
MRSA infection or colonisation in high risk group of patients admitted
to the hospital in addition to the use of contact precautions. On the
other hand, poor adherence to contact precautions and poor hand hygiene
practices among healthcare workers (HCWs) are among the main reasons
for the nosocomial spread of MRSA and failure of the infection control
programs.
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Methods: Between May 2nd and Jun 5, 2005 we conducted an
observational study to monitor the overall compliance with the contact
precautions with regard to MRSA among doctors, nurses, medical
students and other HCWs during routine adult patient care. These
precautions included: hand washing; usage of gloves, gowns and mask,
and cleaning equipments after usage. This observational study was
conducted in the setting of acute healthcare teaching hospital. The
observation was performed in 10 hospital inpatient units which had
patients who were colonised or infected with MRSA.
Results: We observed more than 455 opportunity of compliance to the
ICPs. 130 opportunities were observed among males and 325 among
females. These observations were as follows: among doctors were
94; nurses were 199, among medical students were 50 and among
other HCWs were 114 observations. The overall compliance rate of
all HCWs to the ICPs was 67%. Compliance observed among males
was signiﬁcantly less than among females, 73% vs 80% (P= 0.05). The
overall compliance rate to hand washing was 77% (ﬁg. 1).
There was no signiﬁcant difference in hand washing compliance rate
between doctors and nurses 82% vs 83% respectively (p= 0.9). However,
the observed nurses were statistically more compliant to put on gowns
(p = 0.02), gloves (p = 0.02) and masks (p = 0.01) than doctors. The rate of
cleaning equipments when removed from the patient room by any HCW
was only 25%. Eighty ﬁve percent of the observed HCWs preferred to
use alcohol-based dispensers than the soap and water.
Conclusion: Unlike other investigators, we found that nurses washed
their hands not more often than did doctors but both groups washed
there hands more often than medical students and other healthcare
workers. This is because nurses and doctors had the most opportunities
(82% & 83%) to wash their hands.
P1128 Analytical study of infection control measures in Russian
ICUs: lessons from real life
R. Kozlov, D. Galkin, A. Fokin, V. Mischenko (Smolensk, RU)
Introduction and Purpose: Epidemiological assumptions show that
2−2.5 millions of patients acquire healthcare associated infections (HAI)
in Russia annually. To uncover reasons for the high prevalence we aimed
to assess common practices of infection control (IC) in Russian ICUs.
Methods: The study was conducted in 38 multidisciplinary (MD) ICUs
from April to August 2007. Project coordinators worked in each of
23 cities and distributed speciﬁc questionnaires among ICUs medical
doctors. The data were than collected and analysed in reference centre of
the institute of Antimicrobial Chemotherapy of Smolensk State medical
Academy.
Results: Out of 400 ICU physicians’ questionnaires 84.5% were from
MD and 15.0% from specialised hospitals (SH). No information was
provided in 0.5%. Absence of single patient rooms for isolation was
noted in 57.5%; presence of one single room was indicated in 12.8%,
2 – in 20.3%, 3 and over – in 9.1% of respondents’ answers. Duration of
stay in MD hospitals varied from 1.9 to 18.0, in SH – from 1.9 to 36.0
(average 4.5 days). Availability of liquid soap and/or alcohol hand rub
doser in wards was registered in 74.8% of respondents’ answers. Use of
individual alcohol hand rub solutions after contact with patient reported
62.8% of respondents. Presence of HAI guidelines on antimicrobial
chemotherapy was registered by 51.8% respondents only. Compliance
with guidelines averaged 82.3%. No guidelines for insertion and catheter
care reported 10.8% respondents. Routine MRSA carriage screening
on admission to MDH was registered in 17.8% of respondents and in
26.7% for SH; routine use of mupirocin for MRSA decolonisation was
registered in 3.6% of respondents in MDH and in SH – in 38.3%.
Discussion: Ofﬁcial statistics indicates prevalence of 30,000 of HAI in
Russia annually. This was one of the very ﬁrst studies to assess real
situation with IC that found comparatively low compliance with existing
measures in ICUs in combination with virtual absence of quintessential
barrier measures, use of alcohol hand rub solutions and adherence to
guidelines.
P1129 European survey and consensus on infection control
standards and performance indicators
B. Cookson, D. Mackenzie, A. Coutinho, A. Gilsdorf, I. Russell,
J. Fabry (London, UK; Copenhagen, DK; Lyon, FR)
Objectives: To assess the situation in European Member States (MS)
regarding the progammes, structures and processes in place for HCAI
and AMR stewardship and whether there was a consensus amongst
infection control professionals and leading healthcare workers for
proposed standards and performance indicators (SPIs).
Methods: A questionnaire survey was performed in all MS to explore
the current situation. A steering group (Andreas Voss, Peet Tull, and
Carl Suetens) helped inform the project group as to the design of
national and local SPIs, which were then to be explored in detail, as
well as practicality and level of detail. We used the results of several EU
consensus meetings and DG SANCO documents on HCAI/AMR that
had been explored with MS’s departments of health. Data were analysed
within Excel(TM) spreadsheets.
Results: 29 (88%) of the 33 MS replied. Analyses showed that 72%
had a national HCAI, and 62% an AMR, programme. National laws
were in place (55% HCAI/32% AMR). Reductions in HCAI/AMR were
targets for approximately two-thirds of programmes, but much variation
in responsibilities (9 explored) and topics covered (9 explored) e.g.
only 12 MS produced an annual report and 14 covered aspects of
occupational health. The same was true for PIs (7 explored), e.g. only 5
considered hand hygiene. Training was considered in only 43% for HCAI
and 71% for AMR. HCAI surveillance (78%: 59% compulsory, 41%
recommended) and AMR (95%: 55%, 45%). The results clearly indicated
a wide variation and the need for a consensus. National and local SPIs
were developed: ﬁve groups with 51 SPIs. 82% (28/34) MS responded:
an average of 83% agreed with these, 12% agreed with alteration, 2%
were neutral and 3% disagreed. There were 138 statements of underlying
principles relating to these SPIs (82% agreed; 6% with alterations, 5%
neutral, 3% disagreed. 89% thought the tools were practical, 57% thought
the level of detail was about right but 39% thought it was too much.
Conclusions: We have described a wide variation in SPIs in Europe and
proposed SPIs that had a high level of agreement with relevant healthcare
workers. Further discussions will need to take place within the project
and with MS to explore issues of practicality.
P1130 Optimising the ﬂow of ID-AST information between microbi-
ology laboratory and intensive care unit with the new feature
of EpiCenter version 5.5 connected to the BD Phoenix system
E. Ronco, C. Lawrence, P. Louis, C. Boudry, B. Clair, A-L. Roux,
M. Rottman, J-L. Gaillard, D. Annane, J-L. Herrmann (Garches, FR)
Objectives: Rapid ID and AST can have a signiﬁcant impact on
the management of infections especially with the spread of multidrug
resistant bacteria to the community. Recently released systems that
perform automated ID and AST, beneﬁting from advanced expert
systems, can impact the workﬂow of the microbiology laboratory for
a typical hospital. The connection to the hospital information network
enhances the transmission of microbiological results from the lab to
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the primary care physician, thus potentially affecting the management
of the patient. Whether this direct link improves patient’s care is still
questioned. In this pilot study, we compared the transmission by courier
of paper printout results from the laboratory to the ICU to that using the
new feature of EpiCenter version 5.5 ID-AST system (BD Diagnostic
Systems, USA).
Methods: During a period of 15 days, we measured times to effective
transmission, from Gram stain, culture, ID-AST to ﬁnal validation
(internal turn-around time [TAT]), from ﬁnal validation to ICU, and from
ICU to the prescriber (external TAT). EpiCenter version 5.5 connected
to the Phoenix ID-AST system was not connected to the laboratory
informatic software during this study.
Results: Internal mean and median TAT from preliminary results
to validation was 1 h47mn and 30mn respectively [0–19 h15mn] and
internal mean and median TAT from ID and AST results to validation
was 2 h42mn and 2 h respectively [30mn-6 h30]. Internal TAT by
EpiCenter was 0mn, as the system together with the Phoenix ID-AST
automate allowed electronic networked transmission after validation.
By courier, median and mean TAT for preliminary results and/or ID-AST
results only were 25 h10mn and 55 h55mn respectively. By comparison,
median and mean TAT with the use of EpiCenter were 21 h36mn and
25 h11mn respectively.
When considering the time between specimens’ arrival in the laboratory
and the ﬁnal results’ transmission to the ICU and to the prescriber,
external mean and median TAT from validation to ICU by courier
was 3days-21 h-31mn and 3days-8 h-47mn respectively. By comparison,
median and mean external TAT with the use of EpiCenter were
1day-19 h-55mn and 1day-8 h-18mn; which correspond to a 55% time
reduction.
Conclusion: We observed a 55% internal and external mean TAT
reduction. This encouraging result will allow us to set up a protocol
investigating beneﬁts in clinical outcome provided by real-time ID-AST
results transmission.
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P1131 Pneumonia in patients with cancer
C. Gonzalez, T. Johnson, S. Evans, K. Rolston (Houston, US)
Objectives: The epidemiology of infections in cancer patients undergoes
periodic changes which impact empiric therapy. Pneumonia is the most
common site of infection in such patients. Our primary objective was
to describe the current microbiology of pneumonia in cancer patients
presenting to our emergency centre (EC).
Methods: Retrospective review of medical records over a 5 month period
in 2006.
Results: A total of 7,784 EC visits of which 272 (3.5%) were due
to episodes of pneumonia, occurred. Of these, 98 (36%) had positive
cultures from respiratory specimens and/or blood. Fifty-seven (58%)
had an underlying hematologic malignancy (HM) whereas 41 (42%)
had an underlying solid organ cancer (SOC). Respiratory specimen
cultures were positive in 65 patients (66%), blood cultures only in 21
patients, and both blood and respiratory cultures in 12 (12%). Sixty-
one patients (62%) had monomicrobial infections, whereas 37 had
polymicrobial infections. The proportion of polymicrobial infections was
higher in patients with SOC (49%) than in patients with HM (30%). The
organisms isolated most often from respiratory specimens of patients
with SOC were Pseudomonas spp., Stenotrophomonas maltophilia,
various Streptococcus spp. and Staphylococcus aureus. A similar pattern
was seen in patients with HM. Blood culture isolates were often different
from respiratory specimen isolates when both sites were culture positive.
Candida spp. but no moulds were isolated from patients with SOC,
whereas moulds (mainly Aspergillus spp.) were isolated from patients
with HM. Two mycobacterial infections and one case of PCP were also
documented.
Summary and Conclusions: Pneumonia accounts for approximately
3.5% of EC visits at our Comprehensive Cancer Center. Thirty-six
percent of these episodes are microbiologically documented. Organisms
that cause community acquired pneumonia in other patient populations
(Streptococcus pneumoniae, Haemophilus inﬂuenzae, Legionella spp.,
Mycoplasma pneumoniae) are seldom seen in cancer patients. Conse-
quently, empiric therapy for cancer patients presenting with pneumonia
may vary considerably from options mentioned in various guidelines.
Ideally, empiric therapy should be based on local microbiologic and
susceptibility data.
P1132 Detection of Helicobacter pylori DNA in liver tissue samples
from patients with hepatocellular carcinoma
N. Rizk, S. Zaki, H. Maghraby, M. Rashed, N. Ragab (Alexandria, EG)
Introduction: Helicobacter pylori (H. pylori) is one of the most common
bacteria worldwide found in more than 50% of human population. The
presence of H. pylori is the main cause of several gastro-duodenal
diseases, including peptic ulcer and gastric cancer. It has been designated
as class I carcinogen by the World Health Organisation. Chronic H. pylori
is related to a variety of extra gastric diseases, including liver diseases.
Objectives: the aim of the present study is to evaluate the presence
of H. pylori in human hepatocellular carcinoma (HCC) to determine if
H. pylori may contribute to the development of this disease.
Materials and Methods: Liver specimens from 33 patients with
HCC diagnosed by histopathology were studied. Tumour tissue samples
were examined by polymerase chain reaction (PCR) for the presence
of genomic 16S rRNA of Helicobacter genus using speciﬁc primers.
Besides, other genes (26kDa cell surface protein, cagA, vacA) speciﬁc
for H. pylori were also screened by PCR. The specimens were examined
for H. pylori by immunohistochemical procedure using anti-H. pylori
antibody.
Results: Genomic sequence of H. pylori was found in 11 of 33
(33.3%) tumour tissues. On the other side, H. pylori was proved to
be immunohistochemically positive in 7 tumour tissues (21.2%).
Conclusion: The presence of H. pylori in HCC tissue by means of
molecular methods and immunohistochemistry supports the concept of
the close association between H. pylori and HCC development. But, their
eventual role in hepatocarcinogenesis, although it is plausible, remains
to be proven.
P1133 SeptiFast PCR combined with blood cultures for the
microbiological documentation of fever in neutropenic
cancer patients
K. Jaton-Ogay, F. Lamoth, G. Prodhom, L. Senn, O. Marchetti,
T. Calandra, J. Bille (Lausanne, CH)
Background: Blood cultures (BC) identify the aetiology in only 1/3 of
febrile neutropenic episodes. New diagnostic tools are thus needed for
guiding investigations and antimicrobial therapy. LightCycler SeptiFast
(Roche) is a real-time PCR for the detection of bacterial (9 G+ and 10
G− species) and fungal DNA (6 species) in blood.
Objective: To assess the utility of SF combined with BC for the
microbiological documentation of fever in neutropenic cancer patients.
Material and Methods: Blood samples for BC (4 aerobic + anaerobic
sets, Bactec 9140) and SF (4 EDTA tubes) were drawn simultaneously
in adult febrile neutropenic cancer patients undergoing myeloablative
chemotherapy for haematological malignancies. Microbiological docu-
mentation by SF and BC were analysed.
Results: 186 samplings (SF/BC 1:1) were analysed in 119 febrile
episodes. 18/186 (9.6%) SF analyses were invalid (contamination of
negative control), 12 (6.4%) were inhibited. 88 pathogens were detected
in 59/119 (50%) febrile episodes by BC and/or SF (see table).
Using BC as reference, sensitivity of SF was 50%, speciﬁcity 64%, PPV
29%, NPV 81% and efﬁciency 60%. BC were positive in 20/74 (27%)
and SF in 14/74 (19%) samplings drawn in the absence of antibiotic
therapy. For samplings drawn during antibacterial therapy, BC were
positive in only 12/112 (11%), whereas SF detected pathogens in 38/112
(34%, p< 0.001).
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Conclusions: Septifast combined with blood cultures is a promising
tool for the microbiological documentation in febrile neutropenic cancer
patients.
BC and SF
(n = 14)
BC only
(n = 25)
SF only
(n = 49)
Gram-positives 3 18 11
Staphylococci 2 5 7
Streptococci − 6 −
Enterococci 1 1 4
Other (not in SF panel) − 6 −
Gram-negatives 11 7 29
Enterobacteria 7 5 8
Non-fermentative bacteria 4 − 21
Other (not in SF panel) − 2 −
Fungi 0 0 9
Candida sp. 7
Aspergillus sp. 2
P1134 Quantitative CMV PCR in stem cell transplant patients:
DNA manual extraction versus automatic extraction
L. Carden˜oso, J. Navarro, J. Azcona, N. Arenal, E. Lomas, P. Sanchez,
R. Camara (Madrid, ES)
Introduction: The success of preemptive treatment of CMV infection
in stem cell transplant (SCT) recipients before disease progress depends
on efﬁcient early diagnostic tests. The aim of this study was to compare
a commercial quantitative CMV-PCR assay with DNA automatic
extraction (TNAI-PCR) versus manual extraction (CA-PCR) in the
diagnosis of CMV infection in our allogeneic STC recipients, comparing
the results obtained by PCR with those obtained by antigenaemia (pp65).
Methods: All patients were prospectively monitored post-SCT with
antigenaemia (pp65) CINApool® (Argene) and Cobas Amplicor CMV
Monitor Test® (Roche) (DNA manual extraction, CA-PCR). A total
of 211 blood samples obtained between January 2005 and May 2006
corresponding to 45 CMV infection episodes from 24 SCT patients,
were tested retrospectively using COBAS Ampliprep TNAI kit® (Roche)
(DNA automatic extraction system, TNAI-PCR).
An episode is deﬁned since the ﬁrst positive sample by any method
until the ﬁrst negative sample by both techniques. A positive sample
was deﬁned by antigenaemia 2 cel/4×105 cel and/or PCR 600
copies/mL. Repeated positive samples were considered the same episode.
Independent episodes in one individual were considered if there were at
least 15 days of negative serial detections. Samples and episodes were
analysed independently. Concordance between methods was determined
by Kappa and Spearman coefﬁcients. P-values lower than 0.05 were
considered statistically signiﬁcant.
Results: Good correlation was found between CA-PCR and TNAI-
PCR (Spearman coefﬁcient=0.8, p< 0.001). Assuming qualitative
interpretation of PCR, good concordance was also found between CA-
PCR and TNAI-PCR (Kappa index=0.6, p< 0.001).
Episodes analysis: As a whole, TNAI-PCR detected 39 out off 45
episodes (86.7%) and by CA-PCR 32 out off 45 episodes (71.1%)
(p = 0.07).
Twenty out off 45 episodes (44.4%) were detected by both techniques
at the same time. Five episodes (11.1%) were detected only by
antigenaemia, 8 episodes (17.8%) by TNAI-PCR only and 1 episode
(2.2%) by CA-PCR.
In 24.4% episodes, TNAI-PCR was earlier than CA-PCR (median = 34
days). Thus in 42.2% (24.4%+17.8%) episodes TNAI-PCR improved
CMV detection versus CA-PCR.
Conclusion: Automatic extraction improves sensibility detecting positive
samples and lowers CMV infection diagnosis delay time in SCT patients.
But in this moment, pp65 antigen detection cannot be replaced by all
biological molecular methods.
P1135 Atypical mycobacterial infection in an allogeneic
haematopoietic stem cell transplant patient with
bronchiolitis obliterans
O¨. Kumbasar, O¨. Akan, G. Tarhan, S. Uysal, A. Azap, H. Akan
(Ankara, TR)
Objectives: A 29 years old female with a previous diagnosis of chronic
myelogenous leukaemia who had an allogeneic stem cell transplant
(ASCT)in 2004 was admitted to the hospital with dyspnea and increased
sputum production. After ASCT she had received cyclosporin A for
GVHD and at the 9th month of transplantation had a diagnosis of
bronchiolitis obliterans (BO). Steroids were started and continued. The
course was complicated with lower respiratory system infections that
were succesfully treated. 1.5 year after the diagnosis of BO, she was
admitted for cough and progressive dyspnea. Chest X-ray revealed a
heterogenous inﬁltration with a cavity in the left lung. Clinical and
radiological ﬁndings were compatible with pulmonary tuberculosis (TB).
Sputum, brochoalveolar lavage TB cultures with Bactec system and ARB
were negative. Anti-TB therapy was initiated. There was no improvement
and she returned back to the hospital 5 months later reporting that
she did not use the drugs because of nausea and vomiting. There was
progression on the pulmonary X-ray. Sputum was positive for ARB. She
was transferred to the ICU two weeks later because of severe hypercapnia
and respiratory failure. She was intubated and ventilated.
Methods and Results: The growth obtained in Bactec system was
identiﬁed by PCR-RFLP as Mycobacterium abscessus. She received
imipenem-cilastatin, amikacin and clarythromycin. In one month she
improved clinically and pulmonary X-ray ﬁndings resolved. One month
later, she was again admitted to the ICU because of hypercapnia
and acidosis. She was intubated and mechanically ventilated. She
had a diagnosis of ventilator associated pneumonia. She died one
month after the second ICU admission. Mycobacterium abscessus
is a very rare pathogen, a rapid grower, and causes disseminated
infections in patients with cystic ﬁbrosis, bronchiectasis, ﬁbrosis due
to previous mycobacterial diseases, immunosuppressed subjects and in
lung transplant recipients. The agent has a tropism for the respiratory
tree, produces tuberculoid granulomas with caseous lesions, and resistant
to standard anti-TB drugs and is generally susceptible only to parenteral
antibiotics and oral macrolides.
Conclusion: ASCT is a complex immunosuppressive state that may
predispose to infections caused by any rare pathogen. We think this is the
ﬁrst case with M. abscessus infection after ASCT and the structural lung
disease (bronchiolitis obliterans) caused predisposition to this infection.
P1136 Bloodstream infections after solid-organ transplantation
S. Serin Senger, E. Kursun, O. Kurt Azap, F. Timurkaynak, H. Arslan
(Ankara, TR)
Objectives: Analyzing the characteristics of bloodstream infections
occurring in solid organ transplantation (SOT) recipients.
Methods: All bacteraemia among SOT recipients in our institution
during the period from January 2002 to December 2007 were included
in the study. We performed a retrospective chart review to determine the
patient data such as age, gender, the duration from transplantation to a
diagnosis of BSI, whether the BSI was hospital- or community-acquired.
The primary BSI was deﬁned as the bacterium isolated from blood
culture, which is not related to an infection at another site. Otherwise it
was deﬁned as secondary BSI.
Results: A total number of 58 BSI episodes in 42 patients were
diagnosed. Of these patients 11 (26.2%) were female. The ages of the
patients were in the range 18 to 68 years, with a mean value of 42.1.
There were 30 liver, 11 kidney, and one liver-kidney recipients. Of the
episodes 17 (in 13 liver and 3 kidney recipients) were diagnosed within
the ﬁrst month after the transplantation, 22 (in 10 liver and 2 kidney
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recipients) during the 1−6 months period, and 19 (in 7 liver, 6 kidney,
and one liver-kidney recipients) after the sixth month. Of the episodes
10 were primary. The most common focus of BSI was abdominal among
liver recipients with 35 (97.2%) episodes, whereas it was urinary among
kidney recipients with 6 (54.5%) episodes. Escherichia coli was the
most frequent agent in both groups of recipients. Two episodes were
polybacterial. The list of causative agents was shown in the Table.
Table: Frequencies of causative agents of BSI among SOT recipients
Causative agents Liver
recipients
Renal
recipients
Liver
& renal
recipients
Escherichia coli 21 5 −
Nonfermentative Gram-negative Bacilli 7 2 1
Enterococcus spp. 5 − −
Staphylococcus aureus 4 − −
Klebsiella pneumoniae 2 2 −
Streptococcus anginosus 1 − −
Salmonella group D − 1 −
Enterobacter spp. 2 2 −
Proteus spp. 1 − −
Klebsiella pneumoniae & Enterococcus spp. 1 − −
Klebsiella pneumoniae & Morganella morganii 1 − −
Total (n = 58) 45 12 1
Conclusion: The number of BSI episodes was highest in the period of
1 to 6 months after the SOT. Secondary BSIs were considerably more
frequent than the primary BSIs. The leading foci of secondary BSIs were
consistent with the region of transplantation; that is abdominal for liver,
whereas urinary for kidney SOT.
P1137 Infections in patients with myelodysplastic syndromes
D.P. Kofteridis, A. Stavroulaki, A. Valachis, C. Kalpadaki,
M. Tzanakakis, H.A. Papadaki, G. Samonis (Heraklion Crete, GR)
Objectives: To describe clinical characteristics and outcome of
infections in patients with myelodysplastic syndromes (MDS).
Patients and Methods: Infections occurring in patients with MDS, cared
for at the University Hospital of Heraklion, Crete, Greece from 2004 to
2007 were retrospectively reviewed.
Results: Fifty four episodes of infection occurring in 32 patients
have been studied. The median age of patients was 77 years (range
66–95); 24 (75%) were males. At the time of infection, 9 patients
(28%) had been classiﬁed as RAEB-I, 7 (22%) as RA, 7 (22%)
as RAEB-II, 4 (12.5%) as RCMD, while 3 (9%) and 2 (6%) as
RARS and 5q(−) syndrome, respectively. The median length of hospital
stay was 9.6 days (range 2–50), while the median white blood cell
count on admission was 1700 cells/ml (range 100–5500/m). The most
common was respiratory tract infection [27 episodes; (50%)], followed
by urinary tract infection [7; (13%)]. Nine episodes were complicated
by bacteraemia. The responsible microorganisms were identiﬁed in
19 (35%) of the episodes. The most frequently identiﬁed causative
organisms were Staphylococcus epidermidis, isolated from 4 specimens
(21%), Enterococcus faecalis from 4 (21%) and meticillin-resistant
Staphylococcus aureus from 3 (16%). Regarding outcome, patients were
classiﬁed into 2 groups: those with curable and those with complicated
episodes. An episode was deﬁned as complicated if responsible for
the patient’s death or prolonged hospitalisation (14 days). There were
25 complicated episodes (46%) including 4 deaths (7%). The rest 29
episodes (54%) were curable. Univariate analysis showed a trend of
patients with RAEB-I for complicated course as compared to patients
with other MDS subtypes (P = 0.051), while patients with grade IV
neutropenia (neutrophils <500/ml) developed infections signiﬁcantly
more frequently (P< 0.05). Multivariate logistic regression analysis
revealed that grade IV neutropenia is associated with complicated course
(OR: 8.306 95%CI: 1.286–51.235, P = 0.026).
Conclusions: Severe infections represent a serious threat for patients
with MDS, especially those with grade IV neutropenia. Neutropenia and
probably the MDS subtype may predict the relative risk.
P1138 Current trend in the epidemiology of bloodstream infections
in patients with haematological malignancies and solid
neoplasms in Iasi, Romania
C. Panzaru, M. Dan, I. Miron (Iasi, RO)
Objectives: to characterise the epidemiological and microbiological
spectrum of systemic infections in hematological and oncological
patients.
Methods: a prospective study of bloodstream infections was conducted
between May 2004-June 2006 in two hospitals from Iasi.
Results: We investigated a total of 92 suspected episodes of systemic
infections that occurred among 79 selected patients, involving 40 males
and 39 females (mean age = 26 years old). There were 45 (48.91%)
febrile episodes with positive blood cultures and 47 (51.09%) with
negative blood culture. The most common microorganisms were Gram-
positive cocci 15 (33.33%), followed by stable cell-wall deﬁcient forms
9 (20.00%), Gram-negative bacili 9 (20.00%), Gram-positive bacili 5
(11.11%), fungi 5 (11.11%), and anaerobes 2 (4.44%). From the total
23 strains of cell-wall deﬁcient forms (51.11%), 14 returned to their
typical morphology (6 Gram-positive cocci, 5 Gram-positive bacilli, 3
Gram-negative bacilli) and 9 were L-stable.
Conclusions: (1) The isolation rate, 48.91%, was in accordance with
literature reports; similar percentages of Gram-positive and Gram-
negative isolates were found (the shift from predominating Gram-
negative to a Gram-positive aetiology was noted). (2) We found a high
proportion of cell wall deﬁcient forms, rarely reported before. (3) Studies
reporting local microbiological ﬁndings are necessary because they
support an initial empiric antibiotic regimens for prophylaxies or therapy
more accurately than from other areas. The right treatment protocols
remain to be established.
P1139 Strongyloides stercoralis hyperinfection in an
immunosuppressed patient with a nephrotic syndrome
T. Baptista-Fernandes, D. Alfaiate, P. Branco, L. Relvas, A. Dias,
T. Marques (Carnaxide, PT)
Objectives: Strongyloidiasis is highly prevalent in tropical and
subtropical regions, with endemic foci in some temperate areas. Its real
prevalence is probably underestimated.
We intend to alert to nephrotic syndrome as an unusual presentation of
chronic infection, to the risk of potentially fatal hyperinfection syndrome
in the immunocompromised population and, therefore, the need for a
high suspicion and accurate laboratory diagnosis.
Methods: We report the case of a 31-year old Cape Verdean woman
living in Portugal, admitted with profuse diarrhoea, abdominal pain and
dehydration. She had been diagnosed with nephrotic syndrome (minimal
change disease) of unknown aetiology four months before and was
receiving prednisone and mycophenolate mofetil.
Bacteriological and parasitological investigation included examination of
faeces, sputum, urine, blood and cerebrospinal ﬂuid.
Results: A diagnosis of Klebsiella pneumoniae sepsis was made and
Strongyloides stercoralis larvae were found in faeces and sputum. Hy-
perinfection was considered and mycophenolate mofetil was suspended,
steroids tapered and albendazole was started. Eosinophilia on peripheral
blood only became evident after suspension of the immunosuppressors
(reaching 5.0×109/L). Human Immunodeﬁciency Virus and Human
T-limphotropic Virus serologies were negative.
She was treated for a month, with dramatic clinical improvement,
regression of the eosinophilia, absence of larvae on stool or sputum and
resolution of the nephrotic syndrome (proteinuria was 13 g/day prior to
therapy to 1.3 g/day on discharge).
Conclusions: Chronic strongyloidiasis is a rare and reversible cause of
nephrotic syndrome.
Infections in the immunocompromised host S315
Immunosuppressive therapy has a high risk of causing fatal hyperin-
fection or dissemination of S. stercoralis and, therefore, screening is
advised, in patients with a sugestive epidemiological history, prior to its
initiation. Combination of parasitological examination (including faecal
concentration and culture) with serology is probably the best approach.
The diagnosis of S. stercoralis hyperinfection should be considered in
immunosuppressed patients from endemic areas presenting with acute
respiratory or gastrointestinal symptoms and Gram-negative sepsis, even
in the absence of eosinophilia. In these cases other body ﬂuids should
also be examined and attention should be payed, on routine examination,
to the incidental ﬁnding of larvae.
P1140 Molecular evidence of a nosocomial Pneumocystis jirovecii
transmission among 16 patients after kidney transplantation
S. Schmoldt, R. Schuhegger, I. Huber, H. So¨llner, M. Lindermayer,
J. Heesemann, L. Bader, A. Sing (Munich, Oberschleißheim, DE)
Objectives: In recent years, nosocomial clusters of Pneumocystis
jirovecii (formerly P. carinii) pneumonia (PCP) among immunocompro-
mised individuals were reported. Mostly, the source of infections was
suspected within the clinical settings when transplant recipients and PCP
patients shared hospital facilities.
Methods: We report a cluster of 16 renal transplant recipients positive
for P. jirovecii. None of them received anti-Pneumocystis prophylaxis
prior to P. jirovecii detection. Epidemiological studies revealed that 15
of them were kidney transplanted at a German university hospital and
attended the same inpatient and outpatient clinic from January through
September, 2006. Multilocus sequence typing (MLST) was performed
on the following genes: ITS1, beta-tub, 26S and mt26S.
Results: P. jirovecii DNA was available from 14 patients and
showed identical MLST types among these renal transplant recipients.
Surprisingly, one patient who was treated at a different nephrological
centre and negated personal contacts to patients from the renal
transplantation cluster harboured the same P. jirovecii MLST type. Three
HIV patients and one bone-marrow transplanted hematologic malignancy
patient – treated at two different medical centres – were used as controls
and revealed different MLST types. Interestingly, in three of the four
previously described regions new alleles were detected and one new
polymorphism was observed in the mt26S region.
Conclusion: The epidemiological data and the genotyping results
strongly suggest a nosocomial patient-to-patient transmission of
P. jirovecii as the predominant transmission route.
P1141 Critical care-related infections in heart transplant recipients
P. Mun˜oz, A. Ferna´ndez-Cruz, J. Palomo, J. Ya´n˜ez, J. Guinea,
M. Valerio, J. Hortal, E. Bouza (Madrid, ES)
Objective: Reports on infections of heart transplant (HT) recipients
during early postoperative ICU stay (ICU-E) or requiring later ICU
readmission (ICU-L) are very scarce. Our aim is to describe these
infections in HT before and after use of daclizumab.
Methods: We reviewed ICU infections in our HT cohort (1989 to 2007)
and compared ICU-E and ICU-L infections before and after daclizumab
(1989–2002 vs 2003–2007).
Results: There were 48 ICU infections in 36/387 patients (9.3%): 25
(52%) ICU-E and 23 (48%) ICU-L.
ICU-E infections: Low respiratory tract infections (11; 44%), catheter-
related bloodstream infections (BSI) (6; 24%), primary bacteraemia
(2; 8%), mediastinitis (4;16%), gastrointestinal (GI) infections (1; 4%)
and other (1;4%). Microorganisms were Gram(−) (12/48%), Gram(+)
(9/36%), Aspergillus (2/8%), Candida, and C. difﬁcile (1;4% each). All
mediastinitis, 53.8% of the BSI, 45.8% of the pneumonias, and only
17% of the septic shocks occurred in the ICU-E stay. Mortality was
35% (7/25).
Median time to ICU readmission was 87 days (IQR:51–1037) and 52%
of the infections were nosocomial. ICU-L infections were pneumonia
(13/23; 56.5%; only 2 ventilator-associated pneumonia), disseminated
infections (4; 17%), GI CMV infections (2; 8.6%), and others (4; 17%).
All CMV infections (5/22%) and 4/6 aspergillosis occurred as ICU-L
readmissions. Gram(−) (9; 39%) and Gram(+) bacteria (3; 13%) were
also detected. Attributable mortality was much higher (13; 56%).
When pre- and post-daclizumab periods were compared, we detected
a disappearance of all opportunistic infections (CMV, Aspergillus,
Pneumocystis) requiring ICU admission in the post daclizumab period.
From 2002, mortality per episode decreased (19/35 vs 1/13), as did the
need for ICU readmission due to infection (1.6 vs 0.4 episodes/year).
Conclusion: 9% of HT recipients will have an infection during their ICU
stay (52% in the ﬁrst post-HT ICU admission). Opportunistic infections,
septic shock, and BSI are extremely rare today, thus reducing the need for
ICU readmission. Mortality of HT patients who are readmitted because
of infection is high (56%).
P1142 Isolation of Asaia sp. in two bacteraemia cases in patients
with idiopathic dilated cardiomyopathy awaiting heart
transplants
S. Juretschko, T. Beavers-May, L. Helsel, A. Steigerwalt, S. Stovall
(Little Rock, Atlanta, US)
Objectives: The genus Asaia consists of 3 species, A. bogorensis, A.
krungthepensis, and A. siamensis, all described as acetic acid bacteria
and originally isolated from tropical ﬂowers in SE Asia. A. bogorensis
is the only species that has been associated with human disease, in
a case of bacteraemia and another of peritonitis. A fourth species
designation, "A. lannaensis", is unpublished; however, a corresponding
sequence has been deposited in GenBank. Here we describe the ﬁrst two
cases of nosocomial infections with Asaia sp., closely afﬁliated to "A.
lannaensis".
Case study: Two patients, 15 months and 5 years old, with idiopathic
dilated cardiomyopothy awaiting cardiac transplantations in one unit
at Arkansas Children’s Hospital developed bacteraemia. Both patients
within one week developed similar symptoms, such as high grade fever,
hypotension, leukopenia, and thrombocytopenia. Multiple blood cultures
drawn from PICC lines, central venous lines and a peripheral culture
(from one patient) were positive for Gram-negative rods. Isolates from
both patients were non-motile, non-hemolytic, strictly aerobic, catalase
positive and showed negative reactions for oxidase, indole, urea and
esculin hydrolysis. The pink pigmented colonies grew on blood and
chocolate agar, but not on MacConkey and Mueller-Hinton. Growth was
seen at 25 and 35ºC, but not at 42ºC. The BD Phoenix identiﬁed the
organisms as Pseudomonas luteola and Acinetobacter baumannii with
conﬁdence values of 99 and 90%, respectively. The Remel rapID NH
kit resulted the pathogen as Gardnerella vaginalis with a probability
of >99.9% in each case. Non-matching biochemical results excluded
these organisms for true identiﬁcation. The organisms were submitted to
the CDC for 16S rDNA sequence analysis and extensive biochemical
tests revealing that both strains are 100% identical to each other.
Further phylogenetic analyses showed the two unknown organisms to
be 100% identical with A. lannaensis and a 99.6% similarity with A.
bogorensis. Both patients received 14 days of meropenem and had their
lines removed. Subsequent both patients recovered and received heart
transplants.
Conclusion: This is the ﬁrst report of human infection with the
bacterium "A. lannaensis". The physical location of both patients, the
temporal association of infections as well as the isolation of two
identical pathogens suggests a nosocomial infection. An epidemiological
investigation did not identify a source of this organism.
P1143 Aspergillus galactomannan antigen in liver transplant
recipients: a high false-positive rate in serum samples
obtained during the ﬁrst week post-transplantation
J. Fortun, P. Martin-Davila, M. Alvarez, A. Sanchez-Sousa, L. Gajate,
R. Barcena, J. Nun˜o, S. Moreno (Madrid, ES)
Background: Aspergillus galactomannan antigen (GM) is a useful tool
as early marker of patients at risk to develop invasive aspergillosis (IA),
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but it could have false-positive (FP) results. The causes of FP reported are
varied like some foods, altered intestinal barrier, other types of fungi and
semi-synthetic b-lactam treatments, especially piperacillin-tazobactam.
Methods: From jul-03 to Apr-07, a prospective study, testing
periodically GM in serum samples of liver transplant recipients (LTR),
was performed in our Institution. Platelia Aspergillus EIA-sandwich
microplate assay was used following the manufacturer recommendations.
Samples with an index >0.5 were considered positive. GM test was
performed weekly during the 1st month after transplantation. Uni- and
multivariate analysis were performed to evaluate the relation of false
positive GM with clinical circumstances or therapeutic procedures after
transplantation. In vitro studies including diferent b-lactams were tested
for the presence of Asp-GM by use of Platelia Aspergillus test.
Results: During this period, 3 pts (3.4%) had a diagnosis of IA and
GM were positive in 2 of them. After excluding patients with IA, a total
of 414 serum samples from 85 LTR were analysed. Mean number of
samples per pt was 4.8 (median:4.0). The number of FP of GM was
40 (9.6%), corresponding to 28 pts. FP GM in samples obtained during
the 1st week post-transplantation was 36% (27 of 75), in comparison
to 3.8% (13 of 339) in samples obtained after the 1st week (p< 0.001).
Multivariate analysis showed that prophylaxis with ampicillin was the
only independent factor related with a FP GM. In vitro studies showed
a positive GM results (>0.5) in 4/6 ampicillin vials, in 3/6 piperacillin-
tazobactam vials, in 0/6 cefotaxime vials and in 0/6 controls.
Conclusions: The frequency of FP GM in LTR in our centre was
signiﬁcantly high during the 1st week post-transplant. The present study
suggests that ampicillin administered as prophylaxis to our patients
during the ﬁrst 2 days could be the cause of FP GM. Due to the
timing of IA in these patients, it seems advisable and safety to delay
GM monitorisation in these patients
P1144 Prospective study of infectious complications in a cohort
of 54 consecutive allogeneic haematopoietic stem cell
transplant recipients
A. Martı´n-Pen˜a, M. Aguilar-Guisado, I. Espigado, R. Parody,
J.M. Cisneros (Seville, ES)
Objectives: To determine the incidence, aetiology and mortality during
the ﬁrst 2 years after transplantation in allogeneic stem cell transplant
recipients (allo-HSCT).
Methods: Prospective, observational study of a consecutive allo-HSCT
adult recipients cohort, between July-03 and May-06. Descriptive
analyses of infection and mortality.
Results: 54 consecutive allo-HSCT recipients were included, median age
40.5 years (16–58), 52% males. Median follow-up was 180 days (9–720).
Eighty-two infections occurred in 41 patients. Incidence of infection was
1.4 episodes/patient during the ﬁrst year and 2 episodes/patient during
the ﬁrst 2 years after transplantation. In the pre-engraftment period (PEP)
the incidence of infection was 0.5 episodes/patient, in the mid recovery
period (MRP) was 0.6 and in the late recovery period (LRP) 0.8. In
the PEP there were 29 infections (35.4%), and the most frequent were
catheter-related (34.5%), pneumonia (17.2%) and bacteraemia (17.2%).
In the MRP there were 27 episodes (32.9%), the most frequent were
CMV infection (42.3%), and primary bacteraemia (22.2%). In the LRP
there were 26 episodes (31.7%), being the most frequent CMV infection
(23.1%) and mucocutaneous infection (23.1%). Etiological diagnosis was
established in 65/82 episodes (79.3%). Bacterial aetiology predominated
(55.4%), followed by viral (40%) and fungal (4.6%). In the PEP Gram-
positive bacteria were the most frequent aetiology (42.8%), followed by
Gram-negative (33.3%). There were 2 invasive aspergillosis (9.5%). In
the MRP Gram-negative bacteria predominated, together with viruses,
all of them CMV (42.3%). In the LRP the most frequent aetiology
were viruses (66.6%) mainly CMV (33.3%) followed by VHS (22.2.%).
Thirteen patients died during the follow-up (24%) The mortality rate by
periods was: 5.5% (PEP), 11.8% (MRP) and 8.9% (LRP). Death was
infection-related in six cases (46%).
Conclusions: The incidence of infection after allo-HSCT is high and
reaches 2 episodes per patient up to 2 years after transplantation. The
most frequent infections in the pre-engraftment period are catheter-
related and pneumonia, whereas in mid and late recovery periods is CMV
infection. The most frequent aetiology are bacteria, but viruses increase
in frequency along the recovery periods and are the most frequent in
the late recovery period. Mortality is high, and predominantly related to
infection.
P1145 Comparison of quantitative PCR after automatic DNA
extraction and pp65 antigen detection for diagnosis of CMV
infection in stem cell transplant recipients
J. Navarro, L. Carden˜oso, J. Azcona, N. Arenal, E. Lomas, P. Sanchez,
R. Camara (Madrid, ES)
Objectives: Cytomegalovirus (CMV) infection has been recognised
as one of the major causes of morbidity in stem cell and solid
organ transplant recipients. Efﬁcacy of treatment is closely related to
accurate early diagnostic laboratory tests. Quantitation of CMV DNA
by conventional polymerase chain reaction (PCR) and pp65 antigen
detection in peripheral blood specimens are performed in our department.
The aim of this study is the comparison and correlation between the two
methods in the diagnosis of CMV infection in our stem cell transplant
recipients.
Methods: We retrospectively reviewed peripheral blood samples from
stem cell transplant recipients obtained between January 1st 2005 and
September 10th 2007. Quantitative PCR was performed using COBAS
Ampliprep TNAI kit® (Roche) after DNA automatic extraction, and pp65
antigen was detected by CINApool Anti HCMH ppUL83® (Argene)
kit. A positive sample was deﬁned by a pp65 antigenaemia 2 cel/
4×105 cel and/or PCR 600 copies/mL. Episodes were deﬁned as
serial positive samples until continued negativity for at least 15 days.
Samples analysis and episodes analysis were performed independently.
Qualitative variables are expressed as proportions. Concordance between
both methods was determined by testing Kappa index and Spearman
coefﬁcient. P-values lower than 0.05 were considered statistically
signiﬁcant.
Results: We studied 439 samples, identifying 84 episodes from 53
different patients. Samples analysis: 10.3% of pp65 determinations were
non-evaluable and 1.1% of PCR were invalidated. 212 (48.3%) positive
samples were detected (18.4% were detected only by pp65, 33.5% only
by PCR and 48.1% by both methods). Correlation between pp65 and
PCR was medium (Spearman coefﬁcient=0.37, p< 0.001). Assuming
qualitative interpretation of pp65 and PCR, medium concordance was
also found (Kappa index=0.42, p< 0.001). Episodes analysis: 19.0%
were detected only by pp65, 16.7% only by PCR and 64.3% by both
methods. 36.9% episodes were detected at the same time by PCR and
pp65. 8.3% were early detected by pp65 and 19.0% by PCR, and in both
cases with a median of 7 days.
Conclusions: Medium correlation has been found between pp65 antigen
detection and conventional PCR. An important proportion of samples
and episodes have been detected only by one test, so both methods are
complementary, and PCR cannot replace antigenaemia.
P1146 Evaluation of the cytomegalovirus reactivation after solid
organ transplant
P. Perez-Romero, F. Flor-Parra, J. Mier-Mota, A. Martin-Pen˜a,
E. Garcia-Prado, M.C. Roque-Cuellar, M. Sanchez, M.A. Gomez-Bravo,
E. Cordero, J. Cisneros (Seville, ES)
Objectives: The goal of this work was to determine in solid transplant
recipient patients whether or not the valganciclovir preemptive therapy
can protect from CMV late disease allowing the early activation of the
speciﬁc immune response against CMV in T cells.
Methods: We studied solid transplant recipients with high risk for
CMV infection. Patients with negative serotype for CMV receiving a
CMV-positive transplant were followed. From week two post-transplant,
CMV viral load (VL) was determined periodically in blood, using real
time PCR with CMV especiﬁc ﬂuorescent-primers compared to known
Infections in the immunocompromised host S317
standards. The results of the PCR were used to guide the administration
of preemptive treatment with valganciclovir. The same samples were
used to quantify CMV VL by the antigenaemia test. We also measured
the T cells especiﬁc immune response against CMV by ﬂow citometry,
detecting especiﬁc cell surface markers (CD69 and CD3) and citokines
production (IL-4 and IFN-gamma).
Results: We followed a total of 113 transplants (kidney: 55, liver:43 and
heart:15). Two of the liver transplant patients had the features for the
study. In the ﬁrst patient, VL was detected by real time PCR 20 out of the
22 weeks (non-consecutives) analysed (VL from 3 to 97975 copies/ml),
begining two weeks after the transplant. However, the antigenaemia test
was positive on week 5 post-transplant and only two more consecutive
weeks. Guided by the real time PCR results valganciclovir preemptive
therapy was administered in two cycles from week 3 to 9 and from week
11 to 15 respectively. The CMV especiﬁc immune response was positive
at week 22 after the transplant, which could contribute to the cleareance
of a CMV rebound between weeks 22 and 25 without the administration
of valganciclovir.
In the second patient, the PCR was positive 10 out of the 13 (non-
consecutives) weeks analysed (VL from 4 to 28907 copies/ml) begining
four weeks after the transplant. Again, the antigenaemia test was positive
only on week 5 post-transplant. Valganciclovir preemptive therapy was
administered from week 4 to 11 and no especiﬁc immune response has
been detected yet.
Conclusion: Real time PCR provides a rapid, accurate and more
sensitive method for early detection of CMV VL, allowing better
monitoring of solid transplant recipient patients and early administration
of valganciclovir preemptive therapy. Furthermore, in one of the patients
the we detected early activation of the especiﬁc immune response against
CMV.
P1147 Phenotypic and genotypic characterisation of Neisseria
gonorrhoeae isolated from HIV positive and negative
patients in Italy: emergence of ST 661 clone
S. Starnino, N. Bilek, P. Stefanelli on behalf of Neisseria gonorrhoeae
Italian Study Group
Objectives: Reliable data concerning the incidence of Neisseria
gonorrhoeae infections in Italy is lacking, as is information about
the phenotypic and genotypic characteristics of circulating strains.
Gonococcal isolates (n= 401) collected from patients with or without
concurrent HIV infection, were characterised by serovar determination
and antimicrobial susceptibility testing. Selected isolates were studied
by opa typing, porB sequence analysis and Neisseria gonorrhoeae Multi
Antigen Sequence Typing (NG-MAST).
Methods: The methods used for phenotypic and genotypic characteri-
sation of the strains were already described in the literature.
Results: The isolates were assigned to three different serovars (IA,
IB, IA/IB), with IB the most frequently encountered. Ciproﬂoxacin,
penicillin and tetracycline resistance phenotypes were detected as well
as resistance to two or more drugs. Two main opa types were identiﬁed
accounting for 79.7% among the analysed strains.
Despite the presence of different STs (as identiﬁed by NG-MAST),
some never detected in other countries, genetic characterisation of
the circulating strains showed the persistence of ST661 in a speciﬁc
geographic area. This large cluster might indicate that re-assortment and
DNA recombination are not extremely frequent among strains circulating
in that geographical area or alternatively, isolates of this genotype have a
ﬁtness advantage over other strains circulating enabling it to persist in the
population. The association of this cluster to a drug resistant phenotype
could have negatively inﬂuenced the infection of individuals, a particular
concern in the case of HIV positive patients. The chain of transmission
was well established for isolates identiﬁed as ST661, as evidence of the
power of NG-MAST in the genetic study of gonococci. These results
support previous reports on the rates of individuals co-infected with
HIV and the circulation of resistant gonococci.
Conclusion: In conclusion, no correlation was found between speciﬁc
gonococcal phenotypic or genotypic traits with co-infection with HIV-1.
Moreover, a large cluster of resistant isolates was detected in Italy despite
a low incidence of gonorrhoea. The combination of microbiological and
epidemiological data enables the identiﬁcation of clinically signiﬁcant
strains circulating that would otherwise not be disclosed, such as the
ST661 cluster.
P1148 Predictive factors for typhlitis in paediatric oncology
patients with neutropenia and abdominal focus
N.R. Rivas, A. Vin˜a, G. Yerino, S. Ceccoli, L. Praino, E.L. Lo´pez
(Buenos Aires, AR)
Several risk factors related to typhlitis in neutropenic patients have been
reported. However, few data are available in Latinamerican children.
To identify independent risk factors for typhlitis we performed a
retrospective cohort study in a Tertiary Care Center between 01/2003–
11/2007.
Methods: Inclusion criteria: POP with neutropenia and abdominal focus
(AF). Case deﬁnition: Typhlitis: AF and bowel wall thinckess ±4mm
by CT scan and/or ultrasonography. Control group: Patients that didn’t
fullﬁlled case deﬁnition. We excluded patients without AF.
Outcome: Typhlitis. Predictive factors: age, underlying disease, Cytosine
arabinoside (ARAC) therapy, fever, diarrhoea, vomiting, abdominal pain
and tenderness, sepsis and platelets. Hospitalisation days, microbiologic
data and parenteral nutrition were also analysed. Statistical analysis: To
compare categorical and continuous data between groups we used Chi-
square and Mann-Whithney tests, respectively (error 0.05). The multiple
regression analysis included all factors with p< 0.05 in the univariate
model.
Results: From 82 AF episodes in 63 patients; 24 (29%) were typhlitis.
Age: 126 mo (median) r5–211, male 41/82 (50%). Acute Myeloid
Leukaemia (AML) typhlitis 10/24 (42%) controls: 9/58 (15.5%) p 0.01
OR 3.8 (CI95% 1.1–13). Cases differed from controls in the presence of
fever 24/24 (100%) vs 49/58 (84%) p 0.04; diarrhoea 24/24 (100%) vs
44/58 (75.8%) p 0.008; abdominal pain 22/24 (91.7%) vs 38/58 (65.5%)
p 0.01; abdominal tenderness 17/24 (70.8%) vs 10/58 (17.2%) p 0.001;
sepsis 14/24 (58.3%) vs 18/58 (31%) p 0.02; platelets 18,000/ul (median)
r3,000–370,000/ul vs 48,000/ul r6,000–244,000/ul p< 0.01 and ARAC
17/24 (70.8%) vs 24/54 (44.4%). No statistical difference in vomiting
and epigastric pain. In the multivariate analysis, factors that remained
signiﬁcantly associated with typhlitis were abdominal tenderness p 0.02
OR 3.1 (CI95% 1.1−8.6) and abdominal pain p 0.02 OR 12.8 (CI95%
1.5–109). Microbiologic agents in typhlitis 9/24 (37.5%) vs 9/58 (15.5%)
p 0.03. Klebsiella sp. and E. coli were most prevalent. Duration of
hospitalisation in typhlitis:16.3 d (median) r2–60 vs 10 (3–60) p 0.001.
Parental Nutrition in typhlitis 17/24 (70.8%) vs control 3/58 (5.1%)
p< 0.001. Mortality: 3/82 (3.6%), tiphlitis 2/82.
Conclusions: In POP with neutropenia, images to conﬁrm typhlitis
should be done when abdominal pain and tenderness are present.
Typhlitis was more frequent in patients with AML, ARAC and severe
trombopenia.
P1149 Incidence and risk factors of infection in a single cohort
of 110 adults with systemic lupus erythematosus
S.J. Jeong, H.K. Choi, H.S. Lee, B.S. Chin, S.H. Choi, S.H. Han,
M.S. Kim, C.O. Kim, J.Y. Choi, Y.G. Song, K.W. Choe, M.W. Kang,
J.M. Kim (Seoul, KR)
Objectives: Systemic lupus erythematosus (SLE) is a chronic,
usually life-long, potentially fatal autoimmune disease characterised
by unpredictable exacerbations and remissions with variable clinical
manifestations. Although there is a high probability for clinical
involvement of other various organs in patients with SLE, infectious
diseases have emerged as one of the leading causes of morbidity and
mortality, accounting for 14–45% for SLE-related deaths.
A number of factors have been reported to increase risk of infection
in SLE patients. While previously studies have focused on describing
risk factors, data regarding predictors of infection at the time of SLE
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diagnosis or immediately before the infectious event is deﬁcient. The
aims of this study are to describe infectious complications and analyse
their risk factors at the time of SLE diagnosis using a single cohort of
110 adults with SLE.
Methods: A retrospective review of 110 patients who met the American
Rheumatism Association criteria for SLE from June 1991 to January
2000 was performed. The records were analysed to determine the risk
factors for infection by comparing patients who had suffered at least
one infectious episode (n = 32; 38%) with patients that had none(n = 38;
60%).
Results: The incidence of infection in 110 patients with SLE was
4.4/100 patient-year. Pneumonia constituted 33 percent (14 cases) of
all infectious complications and the most frequently yielded pathogen
was Streptococcus pneumoniae(20%, n = 3). According to univariate
analysis, signiﬁcant risk factors for infection were: high SLEDAI score,
total accumulated dose of corticosteroids, follow-up duration, initial
C3/C4/anti-dsDNA antibody/WBC count, frequent ﬂares. Multivariate
analyses retained SLEDAI score (13, p = 0.01), C3 (<90mg/dl,
p = 0.01), positive anti-dsDNA antibodies(p< 0.01) at the time of
SLE diagnosis as independent predictors for infection and frequent
ﬂares(p = 0.04), follow-up duration (8 years, p = 0.023) as independent
risk factors for infection.
Conclusion: In lupus patients, infections are most often caused by
community acquired bacteria. SLEDAI score, C3 level, anti-dsDNA
antibodies are independent predictive factors and disease ﬂare rate,
follow-up duration are independent risk factors of infection. On the basis
of our ﬁndings, it seems mandatory to closely observe SLE patients with
factors mentioned above.
P1150 Trends in bacterial isolates from blood cultures and their
resistance in relation to the antibiotic consumption at the
haemato-oncological department in the period 2000–2006
B. Weinbergerova, Z. Racil, I. Kocmanova, M. Lengerova,
J. Lochmanova, P. Volfova, K. Hrncirova, J. Mayer (Brno, CZ)
Objectives: The indiscriminate use of antibiotic (ATB) has contributed
to increase the antimicrobial resistance, which has signiﬁcant inﬂuence
on mortality rate in immunocompromised pts. Continuous monitoring of
pathogens, resistance and consumption of ATB is of cardinal importance
for empirical ATB use in hematooncological pts.
Methods: The aim of the study was the retrospective analysis of trends
in bacterial strains and their resistance isolated from blood cultures (BC)
in large hematooncological dpt. in Czech Republic in relation to the ATB
consumption in 2000–2006.
Results: During the entire period the average total No. of BC per year
obtained at our dpt. was 4170. The percentage ratio of positive BC from
total No. of obtained BC remained around 15% all the time. Gram-
positive (G+) strains predominate (70%), but 67% of them were caused
by coagulase-negative staphylococci, that are in majority of samples
assigned as contaminant. The Gram-negative (G−) strains caused in
average 30% of bacteraemias per year during the whole period. 70–
80% of all G− isolates consisted of the following strains: Pseudomonas
sp., Klebsiella sp., Escherichia sp. and strains of G− non-fermentative
bacteria. The development of ATB resistance among isolates of G−
strains was following: the resistance of Pseudomonas sp. to carbapenems
was the biggest issue in 2001 (53%), it resulted in marked decrease
of their usage and enhanced usage of the third generation (III. g.)
cephalosporins. This led to lower incidence of Pseudomonas sp. isolates
from BC (2001 – 20% vs. 2003 – 13%) and to its greater sensitivity to
carbapenems (2001 – 47% vs. 2003 – 73%). On the other hand No. of
ESBL Klebsiella sp. isolates rose in 2004. Since 2000 the consumption of
amikacin has been signiﬁcantly increasing which resulted in much higher
resistance of Klebsiella sp. to aminoglycosides (2000 – 16% vs. 2005 –
51%). More frequent usage of vancomycin and III. g. cephalosporins
between 2000 and 2004 was in 2004 reﬂected in an extreme increase
of vancomycin-resistant enterococci (VRE) isolated from BC (40%).
An appropriate regimen and marked decrease in usage of the above
mentioned group of ATB led to the elimination of VRE in the following
years.
Conclusion: Continuous monitoring of isolates from BC and their
resistance in relation to the usage of ATB facilitates the choice of
appropriate drug for the empirical treatment of febrile neutropenia and
thus results in lower morbidity/mortality of pts. and costs of ATB therapy.
2000 2001 2002 2003 2004 2005 2006
Total No. of BC 4115 3950 3795 4786 4491 4330 3730
Positive BC (%) 18 15 14 14 13 10 14
Strains distribution
All G+ isolates (%) 72 72 68 63 66 74 65
Staphylococcus coagulase-negative from all G+ (%) 70 71 68 67 68 65 60
All G− isolates (%) 24 25 30 34 32 24 34
Pseudomonas sp. from all G− (%) 19 20 25 13 18 14 16
Klebsiella sp. from all G− (%) 20 26 19 19 23 24 16
Escherichia sp. from all G− (%) 19 24 27 26 20 30 33
G− non-fermentative b. from all G− (%) 10 7 8 10 3 11 14
Resistance
of Pseudomonas sp. to carbapenems (%) 33 53 39 27 23 20 47
of Klebsiella sp. to amikacin (%) 16 30 35 36 50 51 12
of Enterococcus sp. to vancomycin (%) 0 4 0 8 40 3 0
P1151 The values of leukocyte count, C-reactive protein, and
erythrocyte sedimentation rate for diagnosis of osteomyelitis
in patients with diabetic foot ulcers
N. Yapar, B. Akinci, B. Ay, S. Yener, S. Yesil (Izmir, TR)
Objectives: Diabetic foot infections are serious problems in diabetic
patients and osteomyelitis is not a rare complication of these infections.
In this study, we aimed to investigate the diagnostic values of WBC
count, C-reactive protein (CRP) level and erythrocyte sedimentation rate
(ESR) for diagnosis of osteomyelitis.
Methods: Patients admitted to our hospital with diabetic foot ulcers in
three years period, from January 2004 to December 2006, were included
in the study. Demographical data, duration and classiﬁcation of foot
ulcer, WBC counts, ESRs, and CRP levels were recorded. Reference
values of tests were 0−5mg/dL for CRP and 0–20mm/h for ESR.
Osteomyelitis was diagnosed according to the radiological ﬁndings (X-
ray and MRI). Sensitivities, speciﬁcities, positive and negative predictive
values (PPV and NPV) of laboratory tests were calculated.
Results: In the study period 142 patients were admitted to the hospital
with complaints of diabetic foot infection. Of these patients, 100 (70.4%)
were male, 42 (29.6%) were female and mean age of patients was
62.28±11.34 (35–88). Duration of ulcers were shorter than one week
in 19 (13.4%), 1−4 weeks in 38 (26.8%) and longer than four weeks
in 84 (59.2%) of patients. Osteomyelitis was diagnosed in 52 (36.6%)
patients and 35 (67.3%) patients with ostemyelitis had ulcer for more
than four weeks. For diagnosis of osteomyelitis, sensitivity, speciﬁcity,
PPV and NPV of WBC, CRP, and ESR levels were summarised in the
table.
Table. Sensitivity, speciﬁcity, PPV and NPV percentages of laboratory
tests
Test Sensitivity
(%)
Speciﬁcity
(%)
PPV
(%)
NPV
(%)
Leucocytosis 57.6 54.4 42.2 69
ESR (higher than 20mm/h) 94.2 8.8 37.4 72.7
ESR (higher than 75mm/h) 40.3 75.5 48.8 68.6
CRP (higher than 5mg/dL) 90.3 15.5 38.2 73.6
CRP (higher than 100mg/dL) 55.7 78.8 60.4 75.5
Conclusions: ESR and CRP levels had very low speciﬁcities (8.8% for
ESR and 15.5% for CRP) but their sensitivities were comparatively high
(94.2% for ESR and 90.3% for CRP). When different levels of ESR
(higher than 75mm/h) and CRP (higher than 100mg/dL) were taken in
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to consideration we realised an elevation in their values. We concluded
that none of these tests has high sensitivity and speciﬁcity alone. But for
evaluation of a patient with diabetic foot ulcer, especially with longer
duration, they should be considered together.
P1152 Treatment failure of cefepime therapy for febrile
neutropenic patients with bacteraemia caused by cefepime
susceptible ESBL-producing organisms
Y.E. Ha, Y.M. Wi, C.Y. Kang, H.S. Cheong, D.R. Chung, J.H. Song,
K.R. Peck (Seoul, KR)
Objective: A retrospective analysis was carried out to evaluate treatment
outcome of cefepime therapy for bacteraemia caused by apparently
susceptible ESBL-producing E. coli and K. pneumoniae(ESBL-EK) in
neutropenic patients.
Method: From January 2005 to December 2006, we selected the febrile
neutropenic patients with bacteraemia due to ESBL-EK who were treated
with cefepime. Antibiotic susceptibility testing was performed on using
the modiﬁed broth microdilution method. For each isolates, MICs were
determined for inoculum sizes of 105 and 107 cfu/ml. To characterise
ESBLs, the TEM-, SHV-, and CTX-M-related genes from clinical
isolates were ampliﬁed by PCR.
Result: Fifty-eight patients with ESBL E. coli and thirty-one patients
with ESBL K. pneumoniae bacteraemia were identiﬁed during the study
period. Of these patients, there were ﬁfteen febrile neutropenic patients
using cefepime. As a result, six eligible patients were included.
Table 1. Clinical outcomes of 6 febrile neutropenic patients with ESBL-producing K. pneumoniae and E. coli
bacteraemia treated empirically with cefepime to which the causative organisms were susceptible in vitro
Age/
Sex
Underlying
disease
Site of
infection
Organisms Responsible
ESBL
Initial
antibiotic
Cefepime MIC
(mg/ml)
Treatment outcome
regimen 106
cfu/ml
107
cfu/ml
52/F Multiple
myeloma
Urinary
tract
E. coli TEM FEP 8 >256 Cure: complete response to
initial antimicrobial therapy
70/F Lymphoma Unknown K. pneumoniae TEM FEP,
VAN
8 >256 Failure: persistent fever and
bacteraemia after 3 days;
changed to imipenem, but
infected by MRSA on 9th
day and died on 30th day of
treatment.
40/M Aplastic
anaemia
Biliary
tract
E. coli TEM FEP 8 >256 Failure: persistent fever and
bacteraemia after 3 days;
changed to meropenem
without biliary intervention
and died on 20th day of
treatment.
41/M Aplastic
anaemia
Lung K. pneumoniae TEM FEP 2 128 Failure: persistent fever and
bacteraemia after 3 days;
changed to imipenem and
transferred to a hospice
hospital on 15th day.
45/F Lymphoma Perianal
abscess
E. coli TEM FEP,
VAN,
MTZ
2 128 Failure: persistent fever
after 3 days; changed to
imipenem and vancomycin,
but died on 20th day of
treatment.
70/M Lymphoma Unknown K. pneumoniae CTX-M FEP 2 128 Failure: persistent fever and
bacteraemia after 3 days;
changed to imipenem, but
infected by Candida on 5th
day and died on 24th day of
treatment.
Abbreviations: FEP: cefepime; VAN: vancomycin; MTZ: metronidazole; GI: gastrointestinal.
Conclusions: The outcome of cefepime therapy for bacteraemia due to
ESBL-EK was poor, even in apparently susceptible organisms. Thus,
cefepime might not provide an optimal therapeutic option in ESBL-EK
infections, even in apparently susceptible isolates.
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P1153 Association of Ureaplasma urealyticum infection with
varicocele-related infertility
S. Najar Peerayeh, H. Zeighami, R. Salman Yazdi, M. Razeghi
(Tehran, IR)
Introduction: Varicocele is a physical abnormality present in 15% of
healthy men and 40% of men being treated in infertility clinics. The
association between reduced male fertility and varicocele likely is related
to semen abnormalities, decreased testicular volume and decline in
Leydig’s cell function. On the other hand, the presence of U. urealyticum
in semen is also related to a decrease in sperm density, motility
and morphology. Thus in this study, the prevalence of U. urealyticum
colonisation in infertile patients with and without varicocele compared
with healthy men and their negatives effects on semen parameters were
determined.
Methods: Semen samples were obtained from infertile patients with
or without varicocele and healthy control and were subjected to the
routine semen analysis and PCR. DNA was extracted by Cadieux
method, and analysed by PCR protocol with species-speciﬁc primers
for U. urealyticum (urease gene).
Results: U. urealyticum was detected by PCR in 23 of 146
(15.75%) semen specimens from infertile patients and in 3 of 100
(3%) healthy men (P< 0.001). Infertile patients with varicocele had
higher U. urealyticum colonisation [17/81(20.98%)] than those without
varicocele [6/65(9.23%), P = 0.086] or healthy controls [3/100 (3%),
P< 0.001].The percentage of sperm cells with motility, volume of
semen ﬂuid, concentration of sperm cells, and sperm cell with normal
morphology were signiﬁcantly decreased in infertile men (P< 0.001). In
the group of varicocele patients with PCR positive for U. urealyticum
the volume, count and morphology of semen samples were lower than
in the varicocele patients with PCR negative results, but the differences
were not signiﬁcant (P> 0.05).
Conclusion: The results indicate that U. urealyticum colonisation may
be additional negative factor inﬂuencing varicocele status and worsening
the reproductive potential.
P1154 The prevalence ofMycoplasma genitalium in the Netherlands
L. Smeets, D. Maljers, J. Merks, C. Bakker, J. Middelburg, S. Bruisten
(Delft, Amsterdam, NL)
Introduction: Mycoplasma genitalium (Mg) has been recognised as the
third-most important cause of urethritis, after Chlamydia trachomatis
(Ct) and N. gonorrhoeae (Ng), and may also play a role in cervicitis and
pelvic-inﬂammatory disease (PID). The goal of this study is to determine
the prevalence of Mg in different populations in the Netherlands.
Methods: Study populations: (A) 163 men with non-speciﬁc complaints
of urethritis (NSU) that visited the anonymous sexual transmitted
infection (STI) clinic of the Health Service Amsterdam, hereafter:
“high-risk population”. (B) patients that visited their general practitioner
(GP) in the Delft/Westland area, hereafter: “low-risk population”. This
population was divided in subgroups based upon information provided
by their GP. (1) men with urethritis, (2) women with pelvic inﬂammatory
disease (PID)/cervicitis, (3) men and women asking for STD-screening.
Diagnostic STI-samples (urethral swabs, urine and vaginal swabs) were
anonymised for this study.
Methods: Mg was detected by real-time PCR based on conserved
regions of the MgPa adhesin gene as described (Jensen et al. JCM 2004
42 683–92). Positive controls were kindly provided by JS Jensen. Ct was
tested by PCR, Ng was tested by PCR and/or by culture.
Results: The results are shown in the table.
Table: the prevalence of M. genitalium compared to C. trachomatis and
N. gonorrhoeae in the different patient groups.
M. genitalium C. trachomatis N. gonorrhoeae
(A) High-risk population
% urethritis NSU (163) 18 (11%) 50 (30%) 1 (0.6%)
(B) Low-risk population
% urethritis (240) 20 (8.3%) 46 (19%) 8 (3.3%)
& PID/cervicitis (304) 5 (1.6%) 10 (3.3%) 1 (0.3%)
% “STD screening” (315) 10 (3.2%) 26 (8.3%) 5 (1.6%)
& “STD screening” (297) 8 (2.7%) 14 (4.7%) 1 (0.3%)
Of the high-risk population, 18 urine samples (11%) were found positive
for Mg. Of these 18, one was HIV+, one patient was also acutely
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infected with HBV. Five (27%) were positive for Ct, this was similar
as in the total group (30%) One Ct was an LGV-type and another
was also positive for Ng. Of the low-risk population, 20 (8.3%) men
with urethritis were positive by Mg PCR. A lower prevalence was
found among asymptomatic men (10; 3.2%), women diagnosed with
PID or cervicitis (5; 1.6%) and asyptomatic women (8, 2.7%). No double
infections were found in these groups. Mg was not detected in the control
samples.
Discussion: Our data conﬁrm the previously described correlation
between the presence of Mg and urethritis. The co-infections in group
A underline the high-risk category these men belong to. Women with
symptoms have a similarly low prevalence as women without symptoms.
In each of our subgroups, the prevalence of Mg was lower than of Ct,
but higher than of Ng. Routine testing for Mg is useful for urethritis in
males, but less so for women in an outpatient setting.
P1155 Evaluation of four nucleic acid ampliﬁcation tests for
Chlamydia trachomatis in urine specimens
L. Dean, K. Perry, E. Arnold, A. Charlett, S. Alexander, C. Ison,
G. Underhill, A. Lloyd, C. Walker, H. Mallinson, S. Scragg, C. Carder,
G. Ridgeway (London, Portsmouth, Liverpool, UK)
Chlamydia trachomatis is the most common sexually transmitted
infection in the United Kingdom and nucleic acid ampliﬁcation testing
(NAAT) is the method of choice for diagnosis. Our aim was to assess
the diagnostic sensitivity and speciﬁcity of four commercially available
NAATs: Roche COBAS AMPLICOR, BD ProbeTec ET, Gen-Probe
Aptima 2 Combo and Artus C. trachomatis Plus real-time PCR. The
tests were evaluated against the same specimen panel with the same
reference standard using a statistically valid number of specimens to
provide a conﬁdent measure of sensitivity and speciﬁcity.
The evaluation panel consisted of 2374 male and female urine specimens.
Of these 1519 were negative and 595 were positive. Samples were
assessed following the UK testing algorithm for C. trachomatis that
demands retesting of all initially positive samples and deﬁnes a positive
sample as one that is reproducibly positive by the test in use.
An imperfect standard was constructed using three of the four assays
under evaluation (COBAS AMPLICOR, ProbeTec ET and Aptima
2 Combo). To help assess any resulting bias ﬁve different methods
(denoted as options 1−5) were used to construct the standard, showing
how much the sensitivity and speciﬁcity could vary. Sensitivity and
speciﬁcity were assessed against the status deﬁned by each of the options.
The data below represents results from one of the ﬁve options used to
deﬁne specimen status. Differences in sensitivity and speciﬁcity between
each of the options were not statistically signiﬁcant.
Overall, the most sensitive assay was the APTIMA 2 Combo (99.4%),
followed by the COBAS AMPLICOR (96.85%), the ProbeTec ET
(95.81%) and the Artus real-time PCR (94.9%). When data was analysed
by sex, all assays were found to have a higher sensitivity with male urine
specimens than with female urine specimens.
The ProbeTec ET assay had the greatest speciﬁcity (99.81%) followed
by the COBAS AMPLICOR (98.17%), the APTIMA 2 Combo (98.15%)
and the Artus real-time PCR (97.9%).
The assays evaluated achieved good sensitivity and speciﬁcity. However,
we have demonstrated that there are statistically signiﬁcant differences
in the sensitivity of these assays. It is of note that the most sensitive
test (APTIMA 2 Combo) was the least speciﬁc (99.37%) while the least
sensitive (ProbeTec ET) was the most speciﬁc. This ﬁnding demonstrates
the interrelationship between sensitivity and speciﬁcity inherent in all
these test platforms.
P1156 Identiﬁcation and characterisation of new immunoreactive
proteins of Chlamydia trachomatis
V. Forsbach-Birk, K.-I. Pfrepper, U. Simnacher, E. Soutschek, A. Essig
(Ulm, Neuried, DE)
Objective: The serological detection of chronic urogenital infections
caused by Chlamydia trachomatis is complicated by the lack of known
immunoreactive antigens that do not share crossreacting epitopes with
other Chlamydia species pathogenic to humans. For that reason we aimed
to identify and characterise new so far unidentiﬁed immunoreactive
antigens of Chlamydia trachomatis.
Methods: Puriﬁed elementary bodies were analysed by 2D-PAGE
followed by Western blotting with sera from patients with proven pelvic
inﬂammatory disease caused by Chlamydia trachomatis. Unknown
antigens being identiﬁed by that method were cloned in Escherichia
coli and characterised with panels of sera from patients with chronic
urogenital infections with Chlamydia trachomatis as well as from healthy
blood donors with positive MIF tritres for Chlamydia trachomatis or
Chlamydophila pneumoniae.
Results: Besides known immunoreactive antigens like MOMP, OMP2,
and HSP60 a number of new immunoreactive antigens of Chlamydia
trachomatis were identiﬁed by 2D-PAGE and Western blotting with the
deﬁned sera. The newly identiﬁed antigens were produced recombinantly
and proved to be immunoreactive. Their reactivity to the deﬁned serum
panels was compared to known immunoreactive antigens. The data
revealed a high sensitivity of the newly identiﬁed antigens. They showed
lower crossreactivitiy to Chlamydophila pneumoniae and a much better
discrimination between patients with chronic urogenital infections caused
by Chlamydia trachomatis and seropositive but healthy blood donors.
Conclusion: The newly identiﬁed antigens need to be further
characterised but might be of importance in order to improve current
serological approches for the diagnostics of Chlamydia trachomatis
infections.
P1157 A new real-time quantitative PCR to detect Coxiella
burnetii DNA
G. Greub, J. Rolain, J. Bille, D. Raoult, K. Jaton (Lausanne, CH;
Marseille, FR)
Objectives: Q fever is a worldwide zoonosis due to Coxiella burnetii.
The clinical presentation may be acute (pneumonia and/or hepatitis)
or chronic (most commonly endocarditis). Diagnosis mainly relies on
serology. However, PCR was also shown to be useful for the diagnosis
of both acute and chronic Q fever.
Methods: A quantitative PCR to be used on ABI Prism 7900 Sequence
System (Applied Biosystem) was developed. DNA was extracted with
Magna-PureR (Roche) and the PCR was performed using 5ml DNA
and 15ml PCR mixture. Primers and probe were selected from highly
conserved sequence of the ompA gene. Development of the quantitative
PCR was done using DNA extracted from a valvular sample. The
quantitative PCR was then blindly evaluated with 183 DNA samples
(31 biopsies, 110 sera/EDTA blood and 42 urines) provided from the
“Unite´ des Rickettsies” (Marseille). Among them, 41 samples taken
from patients with a positive Coxiella serology were positive with the
Marseille home-made nested LC-PCR.
Results: Using eubacterial 16S rRNA PCR and the new quantitative
PCR, the positive control was still positive when diluted 1/1,000
and 1/100,000, respectively. With the quantitative PCR, no signal
was detected in presence of bacterial DNA of other bacterial species
potentially present in various non-sterile clinical samples. When tested
blindly on 183 samples, the speciﬁcity of the quantitative PCR was 100%
(142/142) and the sensitivity was 71% (29/41). The sensitivity was 88%
(7/8) on biopsies samples, 69% (20/29) on sera/EDTA blood, and only
50% on urines (2/4).
Conclusion: This quantitative PCR is a speciﬁc method that exhibits
an analytical sensitivity about one hundred fold higher than eubacterial
PCR. When tested blindly, the quantitative PCR exhibited a speciﬁcity of
100%, a good sensitivity on valvular samples taken from patients with Q
fever endocarditis or vascular infection, and a fair sensitivity on serum
samples from patients with chronic Q fever.
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P1158 Antimicrobial resistance of Mycoplasma hominis and Ure-
aplasma urealyticum among women with vaginal discharge
E. Draghijeva, P. Egbase (Kuwait, KW)
Objectives: The aim of study was to isolate Mycoplasma hominis
(Mh) and Ureaplasma urealyticum (Uu) and determine the antimicrobial
resistance in cervicovaginal samples of women who had complaints of
vaginal discharge using Mycoplasma IST2 (Biomerieux).
Methods: There were 151 patients with vaginal discharge included in
the study: 59 pregnant and 92 non-pregnant. Vaginal samples were taken
from endocervical region after ecocervical mucus had been swabbed
clean. Mycoplasma IST2 used for investigation of Mh and Uu provided
information about the presence or absence of Mh and Uu and also
their antimicrobial susceptibility to doxycycline, josamycin, oﬂoxacin,
erythromycin, tetracycline, ciproﬂoxacin, azithromycin, clarythromycin
and pristinamycin.
Results: Uu has been isolated in 9 (15.2%) pregnant women, while Mh
has been isolated in 1 (1.7%) of them. Uu and Mh have been both isolated
in 49 (83.1%) of these patients. While of 92 non-pregnantwomen,
respectively 10%, 6% and 84% have been isolated.
The Uu and Mh has been shown the lowest sensitivity to ciproﬂoxacin
with 6 (22.2%) of isolates being resistant. The mixt Mh/Uu isolates have
shown high sensitivity on Erythromycin and Clarythromycin with 83%
and 81.5% respectively being sensaitive.
Conclusions: A higher prevalence of Uu/Mh is noted in the vaginal
swabs as well as higher resistance in the quinolones. Low level resistance
to microlides and pristinamycin must be taken into account in the
empirical teatment strategy.
Antibiotic susceptibility studies in
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P1159 Increased antimicrobial susceptibility proﬁles among
polymyxin-B-resistant Acinetobacter baumannii clinical
isolates
R. Mendes, T. Fritsche, H. Sader, R. Jones (North Liberty, US)
Objective: Infections caused by multidrug-resistant (MDR) A. bau-
mannii have become a major treatment challenge, requiring the re-
introduction of polymyxins into clinical practice. Given this situation,
the emergence of polymyxin B (PB) resistance (R) is expected. Recently,
increased antimicrobial susceptibility (S) among in vitro passaging of
colistin-R A. baumannii isolates was observed when compared with the
parent colistin-S strains. The aim of this study was to compare the S
proﬁle between PB-R and PB-S A. baumannii patient isolates submitted
to the SENTRY Antimicrobial Surveillance Program.
Methods: A collection of 5,561 A. baumannii clinical isolates was S
tested by the CLSI broth microdilution method and the S rates of 24
epidemiologically unrelated PB-R isolates were compared to those of
PB-S isolates. S rates were analysed by chi2 test using the Epi Info™
Version 3.4.1 software package. P values <0.05 were considered to be
statistically signiﬁcant.
Results: The majority of the antimicrobials tested showed limited
spectrums of activity (S rates, 55.4%) against the PB-S A. baumannii
group, except for imipenem (73.2%), meropenem (76.5%) and some
tetracyclines. Doxycycline, minocycline and tigecycline showed the
highest S rates 74.7, 91.7 and 97.0%, respectively. Overall, the
polymyxin-R group showed a higher S rate for the vast majority
of antimicrobials tested. This shift was not observed among those
antimicrobial agents with higher activity against the PB-S group
(i.e. carbapenems and tetracyclines). Statistically signiﬁcant differences
were observed among most drugs showing lower activity, including
ampicillin/sulbactam (S rate 3× higher), aztreonam (4×), cefoxitin
(20×), ceftriaxone (2×) and cefuroxime (8×). Tigecycline was highly
active regardless the susceptibility to PB.
Conclusions: PB-R A. baumannii clinical isolates showed higher S rates
when compared to PB-S isolates for the majority of antimicrobials tested.
These ﬁndings suggest that possible lipopolysaccharide modiﬁcations
among PB-R bacterial cells may increase permeability to the antimicro-
bial agents. These data may provide additional insights for combination
therapeutic options and also for possible novel antimicrobial agents in
drug development.
P1160 Evaluation of tigecycline resistance in a tertiary hospital
H. Moraitou, M. Makarona, I. Galani, V. Spyropoulos, I. Mamai,
F. Havouti, D. Kalikantzaros, S. Kanavaki (Athens, GR)
Objectives: Tigecycline (TG), has a wide spectrum of antimicrobial
activity, and has been recently used against multi-drug resistant
organisms. The aim of this study was to evaluate resistance levels to
tigecycline, since this antimicrobial agent has been administered in our
Hospital, in multidrug-resistant (MDR) Acinetobacter baumannii and
Klebsiella pneumoniae strains isolated from ICU and non-ICU patients.
Methods: From January to September 2007, 220 unique patient
multidrug-resistant A. baumannii and 42 K. pneumoniae strains were
isolated from different clinical samples, both in ICU and non-
ICU patients. The isolates expressed resistance to aminoglycosides,
ﬂuoroquinolones, broad-spectrum cephalosporins and carbapenems.
The strains were identiﬁed using the VITEK2 automated system
(Biomerieux, France). Susceptibility to minocycline was tested by
the VITEK2 and to TG by both Kirby-Bauer (zone breakpoints for
15mg TG discs: Acinetobacter spp. and Enterobacteriaceae, S 24mm,
R 19mm;) and E-test (MIC(90), 2mg/ml). Clonal relatedness of all
TG-resistant strains was determined by Rep-PCR.
Results: All MDR A. baumannii and K. pneumoniae were resistant
to minocycline. Overall TG-resistance rates were 10.9% (24/220) for
MDR A. baumannii strains and 11.9% (5/42) for K. pneumoniae strains
isolated both from ICU and non-ICU patients. ICU resistance rates were
20.3% (14/69) for A. baumannii and 12.0% (3/25) for K. pneumoniae,
while non-ICU resistance rates were 6.6% (10/151) and 11.7% (2/17)
respectively. In addition all TG-resistant K. pneumoniae isolates
expressed carbapenemase activity, with a positive imipenem/EDTA test.
Rep-PCR revealed high relatedness of all A. baumannii, regardless the
origin of isolation, but K. pneumoniae strains were not clonally related.
Conclusion: The TG-resistance rates in MDR A. baumannii are similar
both in ICU and non-ICU patients, while K. pneumoniae shows
higher resistance rates in ICU than in non-ICU patients. Molecular
typing indicates dissemination of related resistant A. baumannii strains
throughout the hospital. However, tigecycline remains a potent and
effective antimicrobial agent for use in hospital-acquired infections.
P1161 Analysis of tigecycline activity against Enterobacteriaceae
and Acinetobacter spp. based on patient location and
clinical specimen source in Europe
D. Draghi, C. Pillar, C. Thornsberry, M. Dowzicky, D. Sahm
(Herndon, Collegeville, US)
Objective: The propensity for Enterobacteriaceae (EN) and Acineto-
bacter spp. (AC) to develop antimicrobial resistance can vary with the
patient location (PL) and the type of infection (as suggested by the
specimen source [SS]) from where the isolates were obtained. Therefore,
to investigate trends in tigecycline (TIG) activity against EN and AC,
analysis of TIG activity was stratiﬁed according to PL and SS using data
collected during 2006 to 2007.
Methods: Isolates were collected from locations broadly dispersed
across Europe (EU; including 11 countries) and were tested centrally
using broth microdilution (CLSI M7-A7). TIG activity was analysed
according to PL (outpatient [OP], intensive-care unit [ICU], and inpatient
non-ICU [IP]) and SS (blood [BL], respiratory [RP], skin and skin
structure [SST], and urine [UR]). EN EUCAST breakpoints (BPs) were
applied to all TIG results (AC EUCAST BPs do not currently exist).
Results: See the table.
Conclusion: For EN, slight variations in %S for TIG were observed
among the evaluated PL and SS; however, all populations were >95% S
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to TIG. For AC, the MIC90 remained 2mg/L and the %S rates for TIG
varied by 10% based on the population studied. All populations of AC
were >83% S to TIG, including the ICU population which is associated
with reduced susceptibility. The ability of these organisms to develop
resistance requires that surveillance be on-going.
TIG
Org Category Total n MIC range MIC90 % Susceptible (S)
EN OP 87 0.06−2 1 98.9
IP 497 0.06−8 1 97.6
ICU 289 0.06−4 1 95.5
BL 323 0.06−8 1 97.2
RP 275 0.06−4 1 96.4
UR 50 0.06−2 1 98
SST 222 0.06−2 1 97.3
AC IP 49 0.06−4 1 93.9
ICU 49 0.06−4 2 83.7
BL 25 0.12−2 1 92
RP 41 0.06−4 2 87.8
SST 38 0.06−4 2 89.5
MIC in mg/L.
P1162 In vitro activities of several antimicrobials alone or in
combination against MDR Acinetobacter baumannii isolated
from intensive care unit
F. Lo´pez-Fabal, F. Gonza´lez-Romo, E. Culebras, J.J. Picazo (Madrid, ES)
Objective: Acinetobacter baumannii has become an important hospital-
acquired pathogen. Carbapenems have been the agents of choice
for serious Acinetobacter infections, but unfortunately, outbreaks of
A. baumannii resistant to all antimicrobials except the polymyxins, have
been reported. This fact creates demand on the application of some
combinations of older antimicrobials on that species. The objective of
this study was to assess the in vitro activity of 27 antibiotics against
MDR strains of A. baumannii isolated from ICU, and determine whether
combinations of colistin with another antibiotics act synergistically
against these strains.
Methods: 32 non-repetitive isolates of A. baumannii were included in
the study. Isolates were recovered from 21–12−2006 to 18−2–2007.
Antibiotic susceptibility testing was determined by the broth dilution
method according to the CLSI recomendations.
Etest with imipenem and imipenem plus EDTA were used to check
metallo-b-lactamase (MBL) production. We also used cefotaxime (CT)/
cefotaxime + clavulanic acid (CTL) and cefepime (PM)/ cefepime +
clavulanic acid (PML) E-test® for testing ESBL production in MDR
A. baumannii isolates.
Four strains of A. baumannii were selected for the synergy study.
Levels of synergistic activity for colistin combined with doxycicline,
rifampicin, imipenem, meropenem and tigecycline were evaluated using
the checkerboard method.
Results: All the isolates showed a high level of resistance to all b-lactam
antibiotics tested. With the exception of colistin (0% of resistance)
there were no antibiotics with good activity against these isolates. Of
the other antibiotics tested, tigecycline shows the best activity with
1.5mg/L of CMI90 value. MBL and ESBL were present in 32 and
0 isolates respectively. All the isolates showed the same susceptibility
results, suggesting an outbreak presence.
The results of the checkerboard synergy analysis for MDR strains
A. baumannii shown partial synergy or indifferent results.
Conclusions:
1. Susceptibility pattern revealed presence of MDR A. baumannii
outbreak in ICU.
2. Metallo-b-lactamases were responsible of carbapenems resistance.
3. In studies of synergy, the effect of the combination treatment is
unclear, although the possibility of a beneﬁcial effect cannot be
excluded
4. Tigecycline and colistin seem like the best option to treat these
multirresistant bacteria.
P1163 Tigecycline activity against geographically diverse
Acinetobacter spp. displaying multidrug-resistant
phenotypes across Europe
C. Thornsberry, D. Draghi, C. Pillar, M. Dowzicky, D. Sahm
(Herndon, Collegeville, US)
Objective: Acinetobacter (AC) is generally a nosocomial pathogen.
There are several risk factors among patients that can be associated
with increased infection of this organism such as extremely ill patients
on a ventilator, those with a prolonged hospital stay, or those with
open wounds. In 2006, tigecycline (TIG) was approved in Europe (EU)
for treatment of complicated skin and skin structure infections and
complicated intra-abdominal infections.
Methods: In total, 104 AC isolates were obtained from 28 hospitals
in eleven countries across EU during 2006 to 2007. Isolates were
tested centrally by broth microdilution (CLSI M7-A7). TIG activity
was analysed according to susceptible (S), non-susceptible (NS), and
multidrug phenotypes [MDR; resistance to3 agents including cefepime
(FEP), ciproﬂoxacin (CIP), gentamicin (GEN), imipenem (IMI), minocy-
cline (MIN), and piperacillin-tazobactam (PTZ)]. Enterobacteriaceae
EUCAST breakpoints (BPs) were applied to all TIG results (BPs do not
currently exist for AC). CLSI (M100-S17) BPs were used to interpret
all comparators (where applicable).
Results: The most common MDR phenotype was 3-drug R with
concurrent R to CIP, GEN, and PTZ (12.5% of all isolates surveyed)
followed by 5-drug R with concurrent R to FEP, CIP, GEN, IMI, and
PTZ (9.6% of all isolates surveyed).
Org Total N TIG MIC (mg/L) %S
Range MIC90
All 104 0.06−4 2 89.4
CIP S 38 0.06−1 1 100
CIP NS 66 0.12−4 2 83.3
FEP S 58 0.06−2 1 96.6
FEP NS 46 0.25−4 2 80.4
IMI S 77 0.06−2 1 92.2
IMI NS 27 0.12−4 2 81.5
Non-MDR 58 0.06−1 1 100
MDR 46 0.25−4 2 76.1
Conclusions: TIG maintained potent in vitro activity against AC. The
TIG MIC90 ranged from 1 to 2mg/L, regardless of resistance or MDR
phenotype. Due to the resistance associated with AC, it is imperative to
monitor the susceptibility patterns of this organism against new agents
such as TIG.
P1164 Evolution of the antimicrobial resistance of A. baumannii
strains isolated at an intensive care unit
E. Chinou, P. Ntavlouros, A. Georgouli, H. Skouteli, P. Giannakakos,
P. Golemati (Athens, GR)
Multiresistant A. baumannii including resistance to carbapenems is a
common cause of severe nosocomial infections.
Objectives: to evaluate the frequency and the antimicrobial resistance
evolution of A. baumannii isolated from ICU patients during a two years
period.
Methods: From July 1st 2005 to June 30th 2007 strains of A. baumannii
were isolated from different clinical samples coming from patients
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hospitalised in the seven beds multidisciplinary ICU of our hospital. The
strains were identiﬁed with the biochemical galleries (API NE) and their
susceptibility to the antimicrobial agents evaluated by the disk diffusion
method and E-test for imipenem, colistin and tigecycline according to
CLSI recommendations.
Results: 335 strains of A. baumannii were isolated from 93 patients
in ICU. 37 of the above group patients developed A. baumannii
bacteraemia. All A. baumannii strains were sensitive to colistine with
MIC90 0.25mgr/lt and to tigecycline with MIC90 1mgr/lit. The sus-
ceptibility rate(%) to Amikacin(A), Ciproﬂoxacin(C), Ceftazidime(CAZ)
and Imipenem(I) decreased noticeably as follow: A: from 16 to 5, C:
from 17 to 0, CAZ: from 16 to 5 and I: from 67 to 23.
Conclusion: The A. baumannii strains isolated in ICU patients during
the period 2005–2007 presented a high level of antimicrobial resistance
which was often associated to a resistance to at least 3 antimicrobial
agents. In some cases the strains were totally resistant and sensitive only
to colistin and tigecycline. The most notable resistance was to Imipenem
which increased from 33% to 77%. Infection control measures must be
constant and intense to eliminate the diffusion of these strains.
P1165 In vitro testing of carbapenem-resistant Acinetobacter
baumannii to colistin (polymyxin E)
I. Goic-Barisic, B. Bedenic, M. Tonkic, A. Novak, V. Punda-Polic
(Split, Zagreb, HR)
Objectives: Carbapenem-resistant strains of A. baumannii have been
reported in almost all European counties. Thus more toxic agents such
as polymyxins have been used as alternative therapeutic drugs against
multidrug-resistant Acinetobacter baumannii infections. At present there
is no agreement about how to look for colistin resistance. The
Societe Francaise de Microbiologie uses a cut off of 2mg/l by broth
microdilution testing, whereas the British Society for Antimicrobial
Chemotherapy sets a cut off of 4mg/l or less as sensitive, and 8mg/l or
more as resistant. There are no US standards for measuring disk diffusion
sensitivity to polymyxin so far whereas CLSI (formerly NCCLS)
documents do currently provide interpretative criteria for minimal
inhibitory concentration by broth microdilution testing of polymyxins
in Acinetobacter spp.
Methods: Twenty-nine non-repetitive A. baumannii isolates with
carbapenem resistance proﬁle were obtained from patients hospitalised
at different Intensive Care Units inside Clinical Hospital Centre Split
during this year and tested by broth microdilution to colistin (polymyxin
E). Isolates were recovered from blood cultures, urine samples and
bronchial secretions. Although disk diffusion sensitivity to polymyxin
is not standardised, the diameter of inhibition zone to colistin (10 mg)
was measured.
Results: Out of total number of tested strains, twenty-two isolates
(22/29) displayed minimum inhibitory concentration of 2mg/l and six
(6/29) isolates MIC of 4mg/l. One isolate displayed MIC of 128mg/l to
polymyxin.
All isolates of A. baumannii displayed intermediate or resistant proﬁle to
imipenem (MICs 8–16mg/L) and meropenem (MICs 8–64mg/L). The
diameter of inhibition zone to colistin by disk diffusion test was larger
than 11mm for all strains.
Conclusion: According to currently available criteria for interpretative
reading for broth microdilution testing of polymixins in Acinetobacter
spp., we found variability in susceptibility of our isolates to polymyxin.
Against CLSI standard, most of our isolates (22/29) displayed
susceptibility to polymyxin showing MIC values of 2mg/l or less as
sensitive. Regarding the results obtained with a disk diffusion test, we
would recommend the conﬁrmation by a dilution method, especially in
the case of serious systemic infections.
P1166 High rate of non-susceptibility to tigecycline in pan-resistant
Acinetobacter spp. from Portugal
S. Quinteira, F. Grosso, L. Peixe (Porto, PT)
Objectives: Tigecycline has been described as an alternative therapeutic
agent against Acinetobacter spp. infections, within a global increase of
multidrug-resistance context. In our country multidrug-resistant Acine-
tobacter spp. isolates have been increasingly recovered, complicating
the patient’s clinical outcomes. In this study we evaluated the in vitro
activity of tigecycline against pan-resistant Acinetobacter spp. (including
resistance to imipenem) isolated in Portuguese hospitals.
Methods: 250 imipenem-resistant Acinetobacter spp. isolates were
collected between 2001 and 2007, from a variety of clinical specimens of
different patients attending distinct wards in ﬁve hospitals. Isolates were
identiﬁed by API32GN and by sequencing the 16S rRNA gene. MICs
of tigecycline were determined by agar dilution method, according to
CLSI guidelines, and a susceptible breakpoint of 2mg/L. PFGE (ApaI
restriction enzyme) was performed. Oxacilinase genes (OXA-23, 40, 51,
and 58) were sought by a multiplex PCR.
Results: From the 250 isolates studied, 248 were identiﬁed as
A. baumannii and 2 as A. haemolyticus. Resistance to several
b-lactams (including imipenem) and variable susceptibility to aztreonam,
ceftazidime, meropenem, amikacin and tobramycin was a common
feature of these isolates. MICs for tigecycline ranged from 0.25–32mg/L,
and MIC50 and MIC90 values were 4 and 8mg/L, respectively. Only 55
(including the two A. haemolitycus) of 250 Acinetobacter spp. isolates
(22%) were susceptible to tigecycline. Tigecycline resistance (MIC
8mg/L) was observed in 67 isolates (26.8%), belonging to the PFGE
patterns disseminated within different hospitals. Among these isolates, 4
presented a MIC of 16mg/L and 7 a MIC of 32mg/L. Noteworthy, 128
isolates were classiﬁed as intermediate to tigecycline (MIC of 4mg/L).
All OXA-23 producing isolates presented MICs to tigecycline 8mg/L.
Conclusion: High rate of non-susceptibility (78%) to tigecycline, the
newest antimicrobial agent for Acinetobacter spp. was observed, further
compromising the treatment of infections by an aetiological agent
currently considered the most troublesome nosocomial pathogen.
P1167 In vitro bactericidal effect of imipenem, meropenem
and piperacillin/tazobactam against b-lactam-resistant
Pseudomonas aeruginosa strains and ESBL-producing
Enterobacteriaceae
C. Muller-Serieys, A. Merens, J.D. Cavallo, C. Laussucq,
M.L. Joly-Guillou, M. Roussel-Delvallez (Paris, Angers, Lille, FR)
Objectives: In France, the spread of acquired multiresistance in
P. aeruginosa (Pa) and Enterobacteriaceae (Eb) has become a great
concern. Infections caused by these bacteria require early treatment with
bactericidal antibiotics. Carbapenems are often the last resort alternative.
The goal of this study was to compare the in vitro kill-rates of imipenem
(IPM), meropenem (MPM) and piperacillin/tazobactam (PTZ) against 7
Pa strains with different b-lactam resistance mechanisms and 4 ESBL-
producing Eb.
Material and Methods: The standard time-kill method was used
to investigate the bactericidal activity of IPM, MPM and PTZ. The
concentrations tested were the breakpoints deﬁned by EUCAST for
Eb (2 and 8mg/L for IPM and MPM) and for Pa (4 and 8mg/L
for IPM, 2 and 8mg/L for MPM). For PTZ: 16/4mg/L was used
for Pa and 8/4mg/L for Eb. The following strains were studied: (i)
P. aeruginosa ATCC 27853, E. coli ATCC 25922 as reference strains, (ii)
seven Pa: efﬂux (overexpression of MexAB/OprM pump), mutation of
OprD2, carbenicillinase PSE-1, extended-spectrum b-lactamase PER-1,
carbapenemases IMP-1 and VIM-2 and overexpressed constitutive
cephalosporinase, (iii) four ESBL Eb: K. pneumoniae CTX-1 and
SHV-2, E. aerogenes TEM-24, E. coli CTX-M15. Bactericidal effect
was deﬁned by a 3 Log10 CFU/mL decrease in viable counts.
Results: A bactericidal effect was obtained at 6−8 hours for IPM
and MPM at 8mg/L for all Pa strains except for those with
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acquired resistance mechanisms to carbapenems (mutation of OprD2
and carbapenemases). The use of lower concentrations of IPM (4mg/L)
or MPM (2mg/L) resulted in a decrease or abolition of bactericidal
effect and a frequent regrowth after 8 h. PTZ was bactericidal only for
the strain displaying efﬂux resistance mechanism. For ESBL-producing
Eb, both carbapenems were bactericidal against all strains in 4−8 hours
at 2mg/L and 8mg/L. MEM was more rapidly bactericidal than IPM
(killing activity at 2 hours for 3 strains/4 at 8mg/L). No regrowth was
observed. PTZ was not bactericidal and only a 2 Log10 decrease of
inoculum was obtained.
Conclusion: IPM and MPM achieved a rapid killing activity against
the most prevalent ESBL Enterobacteriaceae in France and provided a
bactericidal activity at 8mg/L against all P. aeruginosa strains without
OprD2 mutation or carbapenemase.
P1168 In vitro activity of doripenem relative to meropenem and
imipenem against Enterobacteriaceae and P. aeruginosa
isolates from Europe (2006–2007)
M. Torres, D. Draghi, N. Brown, C. Thornsberry, D. Sahm, C. Pillar
(Herndon, US)
Objective: Carbapenems are widely used to treat infections involving
resistant Gram-negative pathogens due to their potent activity against
extended b-lactamase producing enteric bacilli and P. aeruginosa
(PA). Doripenem (DOR), a 1-beta-methyl carbapenem, is approved to
treat complicated urinary tract infections (cUTI) and intra-abdominal
infections (IAI) in the US, and is currently undergoing regulatory review
for the treatment of cUTI and IAI in Europe (EU), and nosocomial
pneumonia both in the US and EU. This study examined the in vitro
activity of DOR relative to other currently available carbapenems against
Gram-negative pathogens recently isolated from EU.
Methods: During 2006 and 2007, Enterobacteriaceae (EN) and PA
isolates from patient specimens were collected from 28 laboratories in
11 EU countries. All isolates were centrally tested by broth microdilution
against DOR, imipenem (IPM), and meropenem (MER) at Euroﬁns
Medinet, Inc. (CLSI; M7–A7). Data were interpreted according to CLSI
M100-S17 for IPM and MER. For DOR, there are no CLSI approved
breakpoints.
Results: By MIC50/90, DOR and MER were similar in activity against
the tested isolates and were superior to IPM, regardless of CAZ
susceptibility. The MICs of DOR and MER were lower than IPM against
the EN and PA tested.
Org Phenotype Total n DOR IPM MER
MIC (mg/L) MIC (mg/L) MIC (mg/L)
Mode MIC50 MIC90 Mode MIC50 MIC90 % S Mode MIC50 MIC90 % S
EN All 1,912 0.03 0.03 0.25 0.25 0.25 2 99.8 0.03 0.03 0.12 100
CAZ S 1,656 0.03 0.03 0.12 0.25 0.25 2 99.9 0.03 0.03 0.06 100
CAZ NS 256 0.03 0.06 0.25 0.25 0.5 2 99.2 0.03 0.06 0.25 100
PA All 533 0.25 0.5 8 2 2 32 76.0 0.25 0.5 8 85.0
CAZ S 421 0.25 0.25 2 2 2 8 85.3 0.25 0.5 4 92.4
CAZ NS 112 8 4 32 32 16 32 41.1 4 4 32 57.1
CAZ: ceftazidime; S: susceptible; NS: non-susceptible
Conclusion: EN from EU were highly susceptible (>99%) to the
carbapenems tested, while susceptibility of PA ranged from 76% for IPM
to 85% for MER, respectively. MICs of IPM were higher against both
PA and EN than MICs of either DOR or MER, which were of similar
activity by MIC50/90. The increasing prevalence of carbapenemases
among EN and the high-level resistance commonly encountered among
PA highlights the importance of continued surveillance of carbapenem
activity against these organisms.
P1169 Ertapenem, imipenem, meropenem, tigecycline and
fosfomycin activity against extended-spectrum b-lactamase
producing Enterobacteriaceae in Austria
P. Apfalter, S. Zasmeta, A. Graf, A. Makristathis, A. Hirschl (Vienna, AT)
Objectives: Reported here are current Austrian susceptibility data on
imipenem, meropenem, ertapenem, tigecycline and fosfomycin in ESBL-
producing enterobacteriaceae.
Methods: ESBL production was detected by CLSI methods and an
expanded double disk diffusion synergy test in 401 non-duplicate
enterobacteriaceae (collection period June 04 to Dec 06). MICs were
determined by means of Etest®. Strains not fully susceptible to
one of the carbapenems were checked for the presence of metallo-
b-lactamases by Etest® and typed by means of random ampliﬁcation
of polymorphic DNA (RAPD) and enterobacterial repetitive intergenic
consensus (ERIC)-PCR.
Results: Strains were isolated from urine (44%), wounds (25%), the
respiratory tract (14.5%), blood (4.5%), faeces (9%), and intravasal
devices (2%). The table displays susceptibility data for the species
E. coli, Klebsiella spp., and Enterobacter spp. No metallo-b-lactamases
could be detected in strains with reduced carbapenem susceptibility. In
addition, these strains were not clonally related.
Conclusions: Carbapenems were the most active antibiotics and E. coli
was the most susceptible species tested. The lowest MICs were found
for meropenem. According to CLSI and EUCAST, 3.4% and 10%
strains were not fully susceptible to ertapenem, respectively. Thus,
its susceptibility cannot reliably be predicted by testing imipenem or
meropenem. Fosfomycin and tigecycline can be therapeutic options, but
empiric susceptibility cannot be safely assumed and both agents should
be tested.
MIC90
(mg/L)
MIC range
(mg/L)
Interpretative results in %
according to CLSI/FDA
(EUCAST) criteria
S I R
E. coli (n = 228)
Ertapenem 0.38 0.003−6 98.7 (95.2) 1.3 (0) 0 (4.8)
Imipenem 0.38 0.016−1 100 (100) 0 (0) 0 (0)
Meropenem 0.064 0.006−2 100 (100) 0 (0) 0 (0)
Tigecycline 1 0.125−3 99.5 (94.3) 0.4 (4.8) 0 (0.9)
Fosfomycin 2 0.064–1024 93 3 4
Klebsiella spp. (n = 99)
Ertapenem 0.38 0.012–32 94 (92) 1 (0) 5 (8)
Imipenem 0.25 0.064−6 99 (99) 1 (1) 0 (0)
Meropenem 0.064 0.012−3 100 (99) 0 (1) 0 (0)
Tigecycline 4 0.25–24 79 (52.5) 16 (16.2) 5 (31)
Fosfomycin 32 0.5–1024 93 1 6
Enterobacter spp. (n = 49)
Ertapenem 1.5 0.023–32 92 (65.3) 6 (12.2) 2 (22.4)
Imipenem 0.75 0.125−2 100 (100) 0 (0) 0 (0)
Meropenem 0.125 0.016−0.38 100 (100) 0 (0) 0 (0)
Tigecycline 3 0.19−8 73 (33) 24.5 (28.6) 2 (39)
Fosfomycin 96 0.16–1024 88 8 4
P1170 Fosfomycin and tigecycline activity in extended-spectrum
b-lactamase producing Enterobacteriaceae with reduced
carbapenem susceptibility
P. Apfalter, S. Zasmeta, A. Graf, W. Barousch, A. Makristathis,
A. Hirschl (Vienna, AT)
Objective: A recent Austrian susceptibility study on 401 ESBL-
producing enterobacteriaceae revealed 16 (4%) and 43 (10.7%) strains
(CLSI vs. EUCAST breakpoints, respectively) not fully susceptible to at
least one carbapenem, the ﬁrst choice agents in empiric ESBL therapy.
The aim of this study was to test the in vitro activity of the new agent
tigecycline and fosfomycin, which could provide therapeutic alternatives.
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Methods: ESBL production was detected by CLSI methods and an
expanded double disk diffusion synergy test in 401 non-duplicate
enterobacteriaceae collected between June 04 and Dec 06. MICs were
determined by means of Etest®. Strains not fully susceptible to one of
the carbapenems were checked for the presence of metallo-b-lactamases
and typed by means of random ampliﬁcation of polymorphic DNA and
enterobacterial repetitive intergenic consensus PCR.
Results: Meropenem was the only carbapenem not affected by reduced
sensitivity. No metallo-b-lactamase production was detected in strains
with reduced sensitivity to ertapenem or imipenem. According to
CLSI (EUCAST) 62.5% (76.7%), 81.2% (74.4%), and 56.2% (46.5%)
strains were susceptible to fosfomycin, tigecycline (FDA) and tigecycline
(EUCAST), respectively. The ﬁgure displays the 16 CLSI criteria applied
strains and their susceptibility to tigecycline and fosfomycin (height on
y-axis stands for interpretative category: 1 space = susceptible; 2 spaces
= intermediate susceptible; 3 spaces = resistant).
Strains with reduced crabpenem sensitivity according to CLSI
Conclusions: Fosfomycin and tigecycline can be therapeutic options in
infections caused by ESBL-producing enterobacteriaceae with reduced
sensitivity to carbapenems, but empiric use cannot be recommended
and testing is mandatory. Applying EUCAST breakpoints affected
signiﬁcantly resistance data for tigecycline, for which every second strain
out of this panel would have to be categorised as not fully susceptible.
The clinical signiﬁcance of this phenomenon caused by breakpoints
deﬁned by various committees remains to be clariﬁed.
P1171 In vitro activity of temocillin vs. extended-spectrum
b-lactamase-producing Enterobacteriaceae from the UK
P. Khanna, D. Wareham (London, UK)
Objectives: Temocillin is a semisynthetic pencillin derivative of
ticarcillin. The methoxy group in the 6-a-position confers loss of
activity against Gram-positive cocci and anaerobic Gram-negative
bacilli but excellent activity against the Enterobacteriaceae family. This
modiﬁcation increases stability to b-lactamases, including AmpC and
ESBLs. Owing to the increasing incidence of infections caused by multi-
drug resistant Gram-negative bacteria and also because of the limited
number of clinically active drugs available against such organisms, we
aimed to determine the in vitro activity of temocillin versus clinical
isolates prevalent in the UK.
Methods: Strains were identiﬁed using chromogenic media and API
20E. Susceptibility to gentamicin, ampicillin, amoxicillin/clavulanate,
cefuroxime, ciproﬂoxacin, piperacillin/tazobactam, amikacin, trimetho-
prim, aztreonam, ceftazidime, nitrofurantion and imipenem was deter-
mined using the BSAC disc diffusion method. Eighty-one isolates of
Enterobacteriaceae were screened for ESBL production by using double
disk synergy test with cefpodoxime and cefpodoxime clavulanate. ESBLs
were characterised by multiplex PCR for genes encoding CTXM3-
like, CTXM-14 like and SHV-like b;-lactamases. Minimum inhibitory
concentrations of Temocillin were determined by agar dilution using
isosensitest agar.
Results: Eighty-one urinary isolates were tested. All isolates were
resistant to cephalexin and ampicillin. 82.5% were also resistant to
trimethoprim and 33.3% to nitrofurantoin, used commonly as ﬁrst line
agents for uncomplicated urinary tract infections. MICs to Temocillin
ranged from 8–128mg/L with an MIC50 of 8 and an MIC90 of 32mg/L.
The most common b-lactamases were CTX-M3 lilke (85.5%) followed
by SHV-1 like (35.5%) and CTX-14 like (11.3%); 32.3% of isolates
contained more that one ESBL. No difference in activity was seen versus
strains exhibiting multi-drug resistance or the production of speciﬁc
ESBLs.
Conclusions: Using the BSAC breakpoint of 32mg/L for urinary isolates
we found 93.9% of the isolates to be sensitive. Moreover, temocillin
achieves urinary levels of 400–600mg/L suggesting a considerable
margin over the MICs. Thus we conclude that temocillin is a useful
option for the growing number of infections, particularly of the urinary
tract, that are caused by ESBL and cephalosporin resistant organisms.
P1172 Evaluation of MicroScan Neg Combo Panel Type
44 for detecting extended spectrum b-lactamases in
Enterobacteriaceae
M.N. Kim, H. Sung, A.J. Song, S.J. Lee (Seoul, Cheongju, KR)
Objectives: Accurate and rapid detection of extended spectrum
b-lactamases (ESBLs) is important to guide proper patient antimicrobial
therapy. The new MicroScan panel, Neg Combo Type 44 (Dade
Behring, Sacramento, Calif., USA), has been developed for conﬁrmation
of ESBL-producing Enterobacteriaceae using the wells containing
ceftazidime/clavulanic acid and cefotaxime/clavulanic acid. We evaluated
the performance of Type 44 panel for conﬁrmation of ESBLs.
Methods: In September 2007, 106 Escherichia coli, 81 Klebsiella
pneumoniae, 11 K. oxytoca, and 8 Proteus mirabilis isolated from
clinical specimens were tested with Type 44 panel. All isolates were
tested with the disk approximation test (DAT) and CLSI phenotypic
ESBL conﬁrmation test (CLSI). The cefotetan-non-susceptible isolates
were tested with cefotaxime and cefotaxime/clavulanate disk containing
boronic acid for detection of plasmid-mediated AmpC b-lactamases
(AmpC).
Result: Forty-four (21.4%) of 206 isolates were conﬁrmed as ESBL-
producers by DAT and/or CLSI including 27 E. coli, 14 K. pneumoniae, 2
K. oxytoca, and 1 P. mirabilis. Thirty-eight isolates ﬂagged as "Conﬁrmed
ESBL" were all conﬁrmed as ESBL-producers. Fourteen K. pneumoniae
isolates ﬂagged as "Possible ESBL, unable to interpret conﬁrm test"
were all conﬁrmed as AmpC-producers. Of which, 6 (2.9%) were
ESBL-producing as well as AmpC. All ESBL-producers were positively
screened and ESBL-producers without AmpC were all conﬁrmed by
Type 44.
Conclusion: Type 44 warrants to be a reliable panel for detection of
ESBLs in Enterobacteriaceae. The isolates that ﬂagged as "Possible
ESBL, unable to interpret conﬁrm test" requires the conﬁrmation for
presence of AmpC.
P1173 Tigecycline activity against geographically diverse
Enterobacteriaceae displaying multidrug-resistant
phenotypes across Europe
C. Pillar, D. Draghi, C. Thornsberry, D. Sahm, M. Dowzicky
(Herndon, Collegeville, US)
Objective: Infections derived from Enterobacteriaceae (EN) commonly
occur among hospitalised patients and can be problematic to treat.
Tigecycline, a new semi-synthetic derivative of minocycline and the ﬁrst
in the glycylcycline class of antibiotics, has previously shown activity
against this family of organisms (Org). In 2006, tigecycline (TIG) was
approved in Europe (EU) for treatment of complicated skin and skin
structure infections and complicated intra-abdominal infections.
Methods: In total, 875 EN isolates were obtained from 28 hospitals
in ten countries across EU during 2006 to 2007. Isolates were tested
centrally by broth microdilution (CLSI M7-A7). TIG activity was anal-
ysed by MDR status deﬁned as resistance to 3 agents which included
ampicillin, cefepime, ceftriaxone, ciproﬂoxacin, gentamicin, imipenem,
minocycline, and piperacillin-tazobactam. EUCAST breakpoints were
used to interpret TIG MIC results and CLSI (M100-S17) breakpoints
were used to interpret all other agents, where applicable.
Results: See Table.
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Org category Total TIG MIC (mg/L) % Susceptible
N Range MIC90
EN All 875 0.06−8 1 97.0
Non-MDR 707 0.06−4 1 98.7
MDR 168 0.06−8 2 89.9
E. coli All 300 0.06−2 0.5 99.3
Non-MDR 244 0.06−2 0.5 99.6
MDR 56 0.06−2 0.5 98.2
K. pneumoniae All 282 0.12−8 1 97.2
Non-MDR 209 0.12−2 1 99.5
MDR 73 0.12−8 1 90.4
Enterobacter spp. All 124 0.25−2 1 91.1
Non-MDR 96 0.25−2 1 96.9
MDR 28 0.5−2 2 71.4
Citrobacter spp. All 87 0.12−1 0.5 100
Non-MDR 79 0.12−1 0.5 100
MDR 8 0.12−1 NA 100
S. marcescens All 82 0.25−4 1 93.9
Non-MDR 79 0.25−4 1 94.9
MDR 3 0.5−4 NA 66.7
Conclusions: Overall, EN was 97% susceptible to TIG. The TIG
MIC90 against all EN tested did not exceed 2mg/L, regardless of MDR
phenotype. The potential for resistance to any new agent to increase with
use and time dictates the need for continuous monitoring of TIG activity
against this group of target pathogens.
P1174 In vitro activity of fosfomycin vs. extended-spectrum
b-lactamase
A. Amin, P. Khanna, C. O’Sullivan, D. Wareham (London, UK)
Objectives: Due to the increased isolation of ciproﬂoxacin resistant
ESBL-producing Enterobacteriaceae from the urinary tract, alternative
antibiotics are urgently required. Among currently available agents,
fosfomycin trometamol may be a useful agent as it concentrates in the
kidney and bladder. We set out to determine the in-vitro activity of
fosfomycin against both community and hospital acquired urinary tract
infection (UTI) isolates from the east London Region of the UK.
Methods: All isolates collected were screened for ESBL production
using double disk synergy tests with cefpodoxime and cefpo-
doxime/clavulanate. Strains were identiﬁed to species level using
a combination of chromogenic media and API 20E identiﬁcation
systems. Susceptibility to gentamicin, ampicillin, amoxicillin/ clavu-
lanate, cephalexin, cefuroxime, ciproﬂoxacin, piperacillin/tazobactam,
amikacin, trimethoprim, aztreonam, ceftazidime, nitrofurantion, minocy-
cline, ampicillin/sulbactam, cefoxitin, trimethorpim/sulfamethoxazole,
fosfomycin and imipenem were determined using the BSAC disc diffu-
sion method. Minimum inhibitory concentrations (MIC) of fosfomycin
were determined by agar dilution using isosensitest agar. All ESBLs
were characterised by multiplex PCR for genes encoding CTXM3-like,
CTXM14-like and SHV-like b-lactamases.
Results: 75 urinary isolates were tested, all of which were resistant to
amoxicillin and cephalexin. 81.3% were also resistant to trimethoprim,
34.7% to nitrofurantoin, and 85.3% to ciproﬂoxacin, 74 out of 75 isolates
(98.7%) were sensitive to fosfomycin, using the BSAC MIC breakpoint
of 128mg/L. MICs to fosfomycin ranged from 0.5−>128mg/L, with
an MIC50 of 16 and an MIC90 of 32mg/L. CTXM3-like genes were
detected in 82.5% of isolates, CTXM14-like genes in 12.3%, and SHV-
like genes in 36.8%.
Conclusions: 98.7% of ESBL-producing urinary isolates tested in this
study were sensitive to fosfomycin, with frequent resistance to other
agents including ciproﬂoxacin. Fosfomycin is an oral agent which is
known to be concentrated in the urine. It is not nephrotoxic, is considered
safe in pregnancy, and is also active against Enterococcus species. This
study suggests that fosfomycin may be a useful option in the treatment
of urinary tract infections caused by multi-resistant organisms.
P1175 Efﬁcacy of a mixture of colloidal silver-hydrogen peroxide
and 2-bromo-2-nitropropan, 1,3-diol compounds against
different Legionella pneumophila strains
A. Kimiran-Erdem, N.O. Sanli-Yurudu, E.O. Arslan-Aydogdu, Z. Zeybek,
S. Gurun, A. Cotuk (Istanbul, TR)
Objectives: Legionella pneumophila, the causative agent of Legion-
naires’ disease and Pontiac fever, can be isolated from a variety
of potential human contact areas (cooling tower systems, potable
water sources, etc.). Because of the potential for any water system
to harbour, amplify and disseminate legionellae, control measures
need to be considered for all water systems. Therefore, in order to
prevent legionellosis outbreaks, contaminated water systems must be
disinfected and the most effective and practical biocides need to be
evaluated. The aim of this study is to determine the lethal activity of
various concentrations of a mixture of colloidal silver-hydrogen peroxide
(CSHP) and 2-bromo-2-nitropropan, 1,3-diol (BNPD) compounds on
L. pneumophila. The susceptibility of environmental isolates [SG 1 and
SG 2–14] and standard strain to biocides was assessed at different contact
times.
Methods: In the current study, the qualitative suspension test method
by Skaliy et al. was modiﬁed based The American Society for Testing
Materials (ASTM) E 645–91 standard test method, which is used for
determining the efﬁcacy of microbicides used in cooling systems.
Results: CSHP compound was found effective at the recommended
dosages (200–500 ppm) against legionellae, since these concentrations
achieved >5 log reduction at 0 hour contact time. Furthermore, all strains
were killed by lower doses (100 ppm and 50 ppm) in 3 hours contact
time. Recommended BNPD concentration (100 ppm) for cooling towers
killed SG 2–14 and standart strains at 3 hours contact time, however SG
1 strain was killed at 6 hours contact time. The antibacterial activity of
lower doses BNPD (50 and 25 ppm) against SG 1 and standard strains
required longer contact times than recommended dosages.
CSHP compound was found more effective than BNPD in terms of
recommended dosages and contact times.
Conclusion: CSHP compound can be recommended for decontamination
of legionellae. Since, several factors such as bacterial strains, biocides
and conditions in the water sytems can affect efﬁciency of a biocide
against bacteria, activity of the biocide needs to be evaluated in
laboratory conditions before practical usage.
P1176 Resistance of Campylobacter spp. to ﬂuoroquinolones and
macrolides in Portugal
A. Vicente, T. Hanscheid (Caldas da Rainha, PT)
Objectives: When indicated, empirical treatment of diarrhoea in adults
is often based on quinolones. However, the resistance of Campylobacter
spp. to quinolones is increasing globally. Because no good data exist
for Portugal, this study aimed to establish the resistance pattern in
Campylobacter spp., isolated from human faeces.
Methods: The antimicrobial susceptibility of Campylobacter strains
isolated from human diarrhoeal stool samples was studied. Strains
isolated in Portuguese Hospital Laboratories, from 2003 onward
were included. The activity of ﬁve antimicrobial drugs was tested:
ciproﬂoxacin (CI), moxiﬂoxacin (MX) and gatiﬂoxacin (GA), as well as
erithromycin (EM) and azitromycin (AZ). The MICs were determined
with E-test strips. Since no speciﬁc breakpoints have yet been established
for Campylobacter spp., we used the breakpoints from the Clinical
Laboratory Standards Institute (CLSI) for Enterobacteriaceae (for CI and
GA), for Staphylococcus spp. (for EM and AZ) and for S. pneumoniae
(for MX). This allows the comparison with other studies, as these
breakpoints are also used by other investigators.
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Results: In this ongoing study, 123 Campylobacter strains were analysed
so far. Campylobacter jejuni was the predominant species recovered:
110 isolates (89.5%), of which 66.7% were identiﬁed as C. jejuni
jejuni 1. A total of 80.5% (99 of 123) of Campylobacter strains
were found to be resistant to ciproﬂoxacin, followed by those strains
resistant to moxiﬂoxacin and gatiﬂoxacin (51.2 and 47.2%, respectively).
Interestingly, both MX and GA still showed antimicrobial activity in
29.3% and 33.3% of CI resistant cases, respectively. The MIC50s values
for MX and GA were 4.0 and 6.0 mg/ml, respectively, while the value
for ciproﬂoxacin was 32mg/ml. A clearly different pattern was observed
with respect to macrolides, to which only 6.5% of the strains studied
were resistant.
Conclusion: Portugal seems to have one of the highest quinolone
resistance rates in Europe, comparable with Spain (~80%). Consequently,
quinolones can no longer be considered the empirical treatment of
choice. If treatment is indicated, macrolides should be used, as most
strains are still sensitive. However, the study raises further questions
that need to be addressed: possible treatment options for the patients
that show quinolone and macrolide resistance and the excessive use of
quinolones in husbandry.
P1177 Comparative activity of various antimicrobial agents
against Bacteroides fragilis group strains
C. Betriu, I. Rodrı´guez-Avial, F. Lo´pez, E. Culebras, M. Go´mez,
J.J. Picazo (Madrid, ES)
Objectives: Bacteroides fragilis group organisms are the most frequently
isolated anaerobic bacteria in clinical infections. Increasing resistance of
this group of organisms to several agents and geographical differences in
resistance patterns have been reported in recent years. The purpose of this
study was to asses the antibiotic susceptibility patterns of Bacteroides
fragilis group strains isolated in our hospital.
Methods: A total of 277 non-duplicate clinical strains of the Bacteroides
fragilis group collected from January 2005 to December 2006 were
included in the study. Organisms were identiﬁed by the Rapid ID
32 A system. Susceptibilities were determined by the agar dilution
method according to the CLSI criteria. The following agents were
studied: metronidazole, chloramphenicol, clindamycin, tigecycline, mox-
iﬂoxacin, amoxicillin-clavulanate, piperacillin-tazobactam, cefoxitin, and
imipenem.
Results: Cefoxitin inhibited 63.5% of the strains at 16mg/L. Clin-
damycin was the least active of the compounds tested (44.7% resistance).
All isolates were susceptible to metronidazole. One isolate showed
intermediate resistance to chloramphenicol, being the rest of them
susceptible to this antibiotic. Tigecycline inhibited at 4mg/L 87% of the
strains. The resistance rates for amoxicillin-clavulanate and piperacillin-
tazobactam were 10.1 and 2.2%, respectively. We found two B. fragilis
isolates that were highly resistant to imipenem (MIC> 256mg/L) and to
all other b-lactam agents tested. For moxiﬂoxacin, MIC50 and MIC90
were 1 and 8mg/L, respectively. Among the different species of the
group, B. fragilis was the most susceptible to clindamycin and cefoxitin,
while B. thetaiotaomicron was the least susceptible to these agents.
Conclusion: The high resistance rates to clindamycin and cefoxitin and
the emergence of resistance to the new b-lactams observed in this study,
indicate the need of continued surveillance of susceptibility of these
organisms in order to detect changes in susceptibility proﬁles and to
select the adequate antimicrobial therapy.
P1178 Resistance of Bacteroides species in Trondheim, Norway
R. Hannula, G. Iversen (Trondheim, NO)
Objectives: Bacteria belonging to the Bacteroides fragilis group are
predominant in clinical anaerobic infections. Increasing resistance to
several antibiotics has been reported in the last decades. From December
2005 until November 2007 all Bacteroides strains from clinical samples
at our hospital were tested with Etest for ﬁve antibiotics.
Methods: The samples were cultured on fastidious anaerobic agar
(FAA). Susceptibility testing was performed for Gram-negative bacteria,
which were identiﬁed biochemically by rapid ID32A (BioMe´rieux) as
Bacteroides species. A suspension of bacteria in Brain Heart broth of 1
McFarland turbidity was ﬂoated on PDM agar with 5% deﬁbrinated horse
blood. Etest strips (BIODISK) were applied on the dry agar surface.
The MIC was read at full inhibition after 24 hours and for clindamycin
after 48 hours of incubation. All culturing and susceptibility testing was
performed in an anaerobic chamber and all media were prereduced.
Results: 125 isolates, cultured mainly from pus obtained by abdominal
surgery and abscess drainage, were available for testing. One strain was
excluded due to no growth on the Etest. The breakpoints recommended
by the Norwegian Working Group on Antimicrobials (NWGA) were
applied. Penicillin resistance was detected in all strains except one
(B. ureolyticus). No strains were resistant to metronidazole, one strain
(B. capillosus) had reduced metronidazole sensitivity. Only one strain
(B. fragilis) was resistant to imipenem. Resistance to clindamycin
and piperacillin/tazobactam was more common, 37.9% and 20.2%
respectively. B. fragilis isolates were more sensitive to these two
antibiotics than non-fragilis species.
Conclusion: Metronidazole and imipenem are good alternatives for
empiric therapy of infections with Bacteroides. Species identiﬁcation
and susceptibility testing should be done in serious infections.
P1179 Comparison of the Etest and the Neo-Sensitabs method for
antimicrobial susceptibility testing of Helicobacter pylori
L. Rasmussen, L. Jonaitis, L. Kupcinskas, L. Andersen (Copenhagen,
DK; Kaunas, LT)
Objectives: To assess the reliability of the E-test (AB BIODISK)
compared with the Neo-Sensitabs (Rosco) method for antimicrobial
susceptibility testing of Helicobacter pylori.
Methods: H. pylori strains were susceptibility tested by both the
E-test and the Neo-Sensitabs method for ampicilin, metronidazole,
ciproﬂoxacin, tetracycline and clarithromycin.
50 clinically isolated H. pylori strains were grown on chocolate agar
plates and incubated at 37ºC in a microaerobic gas chamber. The bacteria
were harvested after 72 hours, suspended in API suspension medium
(bioMe´rieux) and adjusted to a McFarland turbidity standard of 4 (109
CFU/ml). Inoculation was performed by applying 100ml of the bacteria
suspension to each plate (plates were room tempered before inoculation)
and spread by drigalski loop. Before applying the E-test strips and the
Neo-Sensitabs plates were left to dry for 15 minutes. The strips/tablets
were applied using sterile forceps and only one strip/tablet per plate
was applied. Incubation was conducted at 37ºC in a microaerobic gas
chamber and reading after 72 hours.
In order to allow a direct comparison of E-test and tablet results, MIC
(Minimal inhibitory concentration) values were ﬁrst log2 transformed
and then converted to scores ranging from 1 to 15 [1]. Correlations
between scored MIC and zonesize were tested using Pearson’s regression.
Figure 1. Correlation between metronidazole MIC values and zonesizes
with 50 H. pylori isolates.
Results: Zonesize is plotted as a function of scored MIC of
ampicilin, metronidazole, ciproﬂoxacin, tetracycline and clarithromycin
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and correlations calculated. The corresponding correlation coefﬁcients
are −0.49, −0.97, −0.89. −0.49 and −0.67 respectively. As an example
Figure 1 shows the results of metronidazole.
Conclusion: Excellent correlation was demonstrated by statistical
analysis between MIC score and zonesize values for metronidazole
and ciproﬂoxacin while the correlation was acceptable for ampicilin,
tetracycline and clarithromycin.
Reference(s)
[1] Glupczynski et al, 2002. Comparison of the E Test and Agar Dilution
Method for Antimicrobial Susceptibility Testing of Helicobacter
pylori.
P1180 Clarithromycin resistance in Helicobacter pylori positive
patients after therapies failure
L. Franzin, D. Cabodi, N. Bonfrate (Turin, IT)
Objectives: Patients with peptic ulcers who are also infected by
Helicobacter pylori receive antimicrobial therapy, based on different an-
tibiotic combination including clarithromycin in addition to antisecretory
drugs. Eradication is however difﬁcult because of primary and secondary
resistance. The aim of the study is to evaluate in vitro susceptibility of
H. pylori strains isolated in a group of symptomatic patients with failure
of previous eradication treatments.
Methods: 77 adult patients (27 males and 50 females) with peptic ulcers
and other gastric disorders after failure of previous treatment regimens
were studied. The mean age of the subjects was 54.7 years and the range
31–77 years. During endoscopy, four biopsies were taken from antrum
for histology, rapid urease test and culture and two from fundus for
histology and culture. A total of 144 gastric biopsies were collected.
The specimens were homogenised and streaked on fresh blood agar
plates and on Dent agar. The plates were incubated in a microaerophilic
atmosphere at 37ºC for 4 up to 10–14 days. Fresh culture of 3 days were
tested for susceptibility to clarithromycin, amoxicillin, metronidazole and
tetracycline by agar disk diffusion technique and by E-test method. The
plates were incubated in a microaerophilic atmosphere at 37ºC for 3
days.
Results: H. pylori was isolated from 46 (59.7%) patients; in the other
subjects the culture showed no growth or contamination. Best results of
isolation were obtained in blood agar plates, but Dent agar was superior
when bacterial contamination was present. Clarithromycin resistance was
found in 80% of the patients, metronidazole in 75% and amoxicillin in
2.5%. All strains were susceptible to tetracycline. Results obtained by
agar disk diffusion technique and by E-test were concordant. Resistance
to at least one drug was observed in 95% of subjects. Resistance to
both clarithromycin and metronidazole was found in 57.5% of the cases.
All patients with clarithromycin resistance were previously treated with
clarithromycin and amoxicillin.
Conclusion: The percentage of clarithromycin resistant strains from
patients with previous therapies failure is very high (80%); this
percentage grow up to 100% in subjects previously treated with this drug.
Resistance to tetracycline was never observed here. As this antibiotic
should be used in combined alternative treatment, it should be considered
in susceptibility testing.
P1181 Comparison of two disc diffusion methods with minimum
inhibitory concentration for antimicrobial susceptibility
testing of Neisseria gonorrhoeae isolates
P. Khaki, P. Bhalla, P. Sharma, S. Moradi Bidhendi (Karaj, IR; New
Delhi, IN)
Background: Gonorrhoea remains a public health problem in developing
countries. Antimicrobial susceptibility testing of N. gonorrhoeae helps in
monitoring the trends and efﬁcacy of treatment guidelines for syndromic
management of gonorrhoea. Antimicrobial susceptibility testing of
N. gonorrhoeae isolates is widely performed as per the CLSI guidelines
or by the AGSP method. Results of antimicrobial susceptibility testing
by disc diffusion method should be reliable when compared to MIC
values.
Objective: The present study was carried out to compare two disc
diffusion methods (CLSI and AGSP) with MIC determination for
antimicrobial susceptibility testing of gonococcal isolates.
Methods: A total of 100 N. gonorrhoeae isolates were studied. The
strains were isolated from 89 (86.4%) out of 103 men with urethritis, 5
(12.8%) out of 39 women with endocervicitis and 6 (46.1%) out of 13
sexual contacts who attended the STD clinic of Lok Nayak Hospital, New
Delhi between January 2004 and June 2006. All isolates were examined
for susceptibility to penicillin, ciproﬂoxacin, tetracycline, ceftriaxone
and spectinomycin by the disc diffusion methods (CLSI and AGSP).
MIC was determined by E-test method. b-lactamase production was
assayed by chromogenic cephalosporin method. Quality control strains
were included for both disc diffusion and MIC methods.
Results: All isolates were susceptible to ceftriaxone and spectinomycin
while 99 (99%) were resistant to ciproﬂoxacin by both disc diffusion
methods. Thirty-two (32%) strains were found to be resistant to penicillin
by CLSI method, while 40(40%) were resistant to penicillin by AGSP
method. Seventeen (17%) isolates were PPNG and 20 (20%) were
TRNG. All PPNG strains had no zone of inhibition by AGSP, while they
had an inhibition zone ± 19 by CLSI. There was complete agreement
between results of antimicrobial susceptibility testing by both disc
diffusion methods and MIC values for all antibiotics except penicillin
for which the kappa was 0.7 for AGSP and 1 for CLSI.
Conclusion: The continual spread and ongoing emergence of resistance
among N. gonorrhoeae isolates require that an accurate and simple
test be performed to determine antimicrobial susceptibilities. Both disc
diffusion methods showed a high degree of agreement with MIC values.
Although AGSP method is more economical, its feasibility depends on
the availability antimicrobial discs of low potency and it requires more
accuracy in measuring the inhibition zones.
P1182 Antimicrobial susceptibility of Gram-negative bacteria
causing nosocomial infections from 2003–2005 in a
university hospital in Turkey
F. Kibar, B. Kurtaran, A. Candevir, A.S. Inal, A. Bicer, E. Oksun,
Y. Tasova, A. Yaman (Adana, TR)
Objective: The aim of this study was to determine about antibiotic
susceptibilities of Gram-negative bacteria isolated from nosocomial
infections.
Methods: The activity of eight broad-spectrum antimicrobial agents
were assessed against 397 Gram-negative aerobic bacteria isolates
collected from nosocomial infections during 2003, 2004 and 2005
in an university hospital in Turkey. Gram-negative bacteria were
including E. coli(22.6%), K. pneumoniae (21.9%), P. aeruginosa
(20.9%), Acinetobacter spp. (20.1%), Enterobacter spp. (7.3%), Proteus
spp. (3.2%), Morganella spp. (1.2%), Providencia spp. (1.0%), Serratia
spp. (0.7%) and Citrobacter spp. (0.5%). Antimicrobial susceptibility
was investigated using E-test. Extended-spectrum b-lactamase (ESBL)
production was determined using ceftazidime and ceftazidime/clavulanic
acid E-test strips.
Results: Overall, meropenem and imipenem were the most effective an-
tibiotics against Gram-negative organisms, respectively (77.5% suscepti-
ble, MIC50 = 0.125, MIC90 32mg/L; 75.8% susceptible, MIC50 = 0.5,
MIC90 32mg/L); these were followed by piperacillin/tazobactam
(56.4% susceptible; MIC50 = 16, MIC90 256mg/L), ciproﬂoxacin
(44.8% susceptible; MIC50 = 3, MIC90 32mg/L), cefepime (42.8%
susceptible; MIC50 = 24, MIC90 256mg/L), tobramycin (39.2% sus-
ceptible; MIC50 = 16, MIC90 256mg/L), ceftazidime (38.5% suscep-
tible; MIC50 = 24, MIC90 256mg/L) and cefotaxime (25.4% suscep-
tible; MIC50 32, MIC90 32mg/L). When these were compared with
data between 2000–2002, the antibiotic susceptibilities were determined
approximately lower 10% for imipenem, meropenem, piperacillin/
tazobactam; 15% for cephotaxime; 20% for ceftazidime, cefepime,
ciproﬂoxacin and tobramycin in 2003–2005. The rates of production
of ESBL were 77% in K. pneumoniae and 61% in E. coli. These ESBL
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positive isolates were sensitive 100%, 98% to meropenem; 98.5% and
98% to imipenem, respectively. Multi-drug resistance (MDR) rates were
76% in Acinetobacter spp., 66% in P. aeruginosa. Only piperacillin/
tazobactam were more susceptible than 50% against P. aeruginosa.
Carbapenems were the most active agents against Acinetobacter spp.
(meropenem 57.5%, imipenem 55% susceptible) AmpC b-lactamase
was produced by 31.4% of Enterobacter spp., Citrobacter spp. and
S. marcescens. All of these were sensitive to meropenem; 77%, to
imipenem and ciproﬂoxacin.
Conclusion: Antimicrobial resistance has reached very high levels in
hospital. Solving of this problem depends primarily on to prevention of
the development of antimicrobial resistance.
P1183 In vitro activity of tigecycline against multidrug-resistant
Gram-negative clinical isolates
O. Zarkotou, K. Kopsari, E. Korou, J. Tsimettas, P. Mantzouratou,
D. Gianneli, C. Poulopoulou (Athens, GR)
Objectives: To evaluate the antimicrobial performance of tigecycline
against multi-drug resistant (MDR) Gram-negative (GNs) clinical
isolates.
Methods: A total of 78 MDR GN bacterial stains were studied.
They were isolated from various clinical specimens, during a 10-
month period (2/07–11/07), from both ICU and non-ICU patients.
Only one isolate per patient was included in the study. P. aeruginosa
and Proteae strains were excluded, as tigecycline exhibits reduced
antimicrobial potency to these species. Species identiﬁcation and MIC
values determination for 37 antibiotics were performed by the VITEK2
Compact Automated System (bioMerieux, France). The MICs for
tigecycline and ampicillin/sulbactam were determined by the E-test
method (AB Biodisk, Sweden). The susceptibility breakpoints for
tigecycline were those approved by the FDA.
Results: The majority of the MDR strains derived from ICU-patients
(51/78, 65.4%) as expected, followed by surgical patients (19/78,
24.4%). They were isolated from blood (35/78), pus (19/78), catheters
(11/78), bronchial secretions (7/78) and other sources (6/78). The
bacterial species were: K. pneumoniae (31/78), A. baumannii (27/78),
Enterobacter spp. (10/78), E. coli (5/78) and others (5/78). Out of
the 78 MDR strains ﬁve were pan-drug resistant and ten of them
were susceptible only to colistin. Susceptibility to tigecycline was
detected to 4/5 of pan drug resistant isolates (one was intermediately
susceptible) and to 6/10 of colistin-only susceptible isolates (two of
them were tigecycline resistant). MIC90 and MIC50 for tigecycline was
2 and 0.75mg/l respectively (MIC range: 0.064−8mg/l). Acinetobacter
baumannii exhibited higher MIC90 and MIC50 values (3 and 2mg/l,
range: 0.125−8mg/l) compared with Klebsiella pneumoniae (1, 5 and
0, 38mg/l, range: 0.094−8). Resistance to tigecycline was detected
to 2 MDR isolates (2, 6%) with MICs of 8mg/l, while in 5 strains
(6.4%) MICs were 3−4mg/l. Among ICU-patients 8 were treated with
tigecycline. No signiﬁcant differences were observed to the MIC values
of tigecycline for the strains derived from these patients before and after
treatment.
Conclusion: The emergence of multidrug-resistance poses a serious
threat. Tigecycline may represent an option for the treatment of infections
caused by MDR GNs where our choices are limited. Any potential for
selection of resistance should be monitored.
P1184 Current susceptibility patterns for H. inﬂuenzae and M.
catarrahlis isolates from Europe: ﬁndings of the 2007
GLOBAL surveillance program
N. Brown, C. Thornsberry, D. Draghi, M. Aranza, C. Pillar, D. Sahm
(Herndon, US)
Objective: Haemophilus inﬂuenzae (HI) and Moraxella catarrhalis
(MC) associated with community-acquired respiratory tract infections
can become resistant to commonly prescribed agents and these resistance
(R) rates can vary according to regional distributions. The GLOBAL
Surveillance (SUR) initiative was undertaken to track R patterns among
respiratory pathogens. This study tracks the resistance of HI and MC
collected as part of GLOBAL ’07 to empirically used oral agents.
Methods: During 2007, 858 HI and 163 MC isolates from patient
specimens were collected from 6 European (EU) countries: Belgium,
France, Germany, Italy, Spain (SPN), and the United Kingdom. All
isolates were centrally tested by broth microdilution according to CLSI
M7-A7 and the results were interpreted according to CLSI M100-S17.
Data were analysed according to b-lactamase (BL) status as positive (+)
or negative (−).
Results: For all EU countries combined, 130 HI isolates were BL+
(15.2%) and 728 isolates were BL− (84.8%). Overall, current MIC90s
(mg/L) were >8 for ampicillin (AMP), 0.03 for levoﬂoxacin (LFX),
and >4 for trimethoprim-sulfamethoxazole (SXT), regardless of BL
phenotype, except for BL− isolates against AMP (MIC90, 0.5mg/L).
The current overall percent R among the oral agents were 15.4% AMP,
0.1% LFX, and 18.3% SXT. By country, LFX retained potent activity
against HI, regardless of phenotype, based on MIC90s (0.015−0.03mg/L
for all) and susceptibility (%S) was 100% for all, except SPN (overall
%S=99.4), where 1 isolate was non-susceptible. One HI isolate was
found to be BL− ampicillin-resistant. For all EU countries combined,
160 MC isolates were BL+ (98.2%), with <2% BL−. With the exception
of ampicillin and cefuroxime, all agents were highly active against the
tested MC, with 100% susceptibility rates.
Conclusion: Among HI, R to SXT and AMP (BL mediated) was
prevalent throughout EU. In contrast, current %S to LFX remains high
throughout EU against HI. Against MC, isolates are 100% susceptible to
all agents, with the exception of ampicillin and cefuroxime, regardless
of BL+ rates among MC which have reached 98%. Continued SUR
is warranted to monitor any changes that may occur among these
respiratory pathogens to help guide empiric therapy for community-
acquired respiratory tract infections.
P1185 Comparison between AST-N058 card (VITEK2) and
UNMIC/ID-62 panels (BD Phoenix) ESBL test for
detection of extended-spectrum b-lactamases in E. coli and
K. pneumoniae
M. Trevin˜o, L. Martinez-Lamas, P.A. Romero-Jung, L. Moldes,
C. Garcia-Riestra, B.J. Regueiro (Santiago de Compostela, ES)
Objective: The aim of this study was to evaluate the abilities of the
VITEK2 and BD Phoenix in detecting ESBL production.
Methods: One hundred and ninety eight clinical isolates of ESBL
producers (178 E. coli and 20 K. pneumoniae) were assayed by VITEK2
(BioMe´rieux, France) and BD Phoenix System (Becton-Dickinson
Biosciences, Sparks, Md) using AST-N058 cards and UNMIC/ID-
62 panels, respectively. Double-disk synergy test combined with
Etest ESBL (ABBiodisk, Solna, Sweeden) were used as phenotypical
reference method. Moreover, twelve strains with genotipically identiﬁed
b-lactamases were used as controls.
Results: With Etest as the reference for the clinical isolates and the
genoptype as the reference for the control strains, the ESBL speciﬁc test
of the AST-N058 card and UNMIC/ID-62 panels detected the ESBLs
with accuracies of 99.49% and 89.39%, respectively. No signiﬁcant
difference between the systems with regard to the control strains was
detected. Because of BDXpert system, the Phoenix enhanced its accuracy
up to 96.46%. However, the VITEK2 expert system considered as
incoherent the AST results in 7 isolates with ESBL positive tests.
Conclusions: The ESBL test of the VITEK2 system (AST-N058 card)
performed better than Phoenix (UNMIC-ID 62 panel) in detecting the
ESBLs produced by clinical isolates of E. coli and K. pneumoniae.
Nevertheless, the action of expert systems put on the same level both
automated systems.
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P1186 Comparative mutant prevention concentration values for
tigecycline and ciproﬂoxacin against clinical isolates of
Escherichia coli
J. Blondeau, S. Borsos (Saskatoon, CA)
Objectives: The mutant prevention concentration (MPC) deﬁnes the
antimicrobial drug concentration that blocks the growth of the least
susceptible cell from high density bacterial inocula. Tigecycline, a
member of a new class of antimicrobials (glycylcylines) has been
shown to have in vitro activity against clinical isolates of E. coli. We
tested E. coli isolates by MPC against tigecycline and ciproﬂoxacin to
determine if strains with high ciproﬂoxacin MPCs would impact on
values for tigecycline.
Methods: A total of 24 strains collected from patients with urinary
tract infection were studied. For MPC testing, 1010 CFUs were applied
to Mueller-Hinton agar plates containing doubling drug concentrations
of each drug. Following incubation under optimal conditions for 24–48
hours, the lowest concentration preventing growth was recorded as the
MPC.
Results: For all strains tested, tigecycline MPC values ranged from
0.5−2mg/L; 18 strains (75%) having MPCs at 0.5mg/L and 5 (21%) at
1mg/L. For ciproﬂoxacin, MPC values ranged from 0.031 to 32mg/L;
7 strains (29%) had MPC values of 2mg/L with 3 strains (12.5%)
at 32mg/L. Tigecycline MPC against the 7 strains with elevated
ciproﬂoxacin MPC values were 0.5−1mg/L.
Conclusions: Tigecycline MPC values were low against clinical isolates
of E. coli with 96% of strains having values of 0.05−1mg/L. As
well, high MPC values to ciproﬂoxacin did not negatively impact on
tigecycline. Tigecycline may be a suitable alternative for therapy in
patients infected with quinolone resistant E. coli.
P1187 The activity of mecillinam against Escherichia coli with
deﬁned mechanisms of resistance to 3rd generation
cephalosporins
M. Wootton, T.R. Walsh, R.A. Howe (Cardiff, UK)
Objectives: Resistance to 3rd generation cephalosporins (3GC) in
E. coli is an increasing problem across the world with resistance
rates in some parts of Europe (including the UK) of more than
15% in bacteraemia isolates. The main cause has been the spread
of CTX-M Extended Spectrum Beta-Lactamases (ESBLs) but other
enzymes such as plasmid-borne AmpC-type and OXA b-lactamases are
being increasingly recognised and in some parts of the world E. coli
strains with multiple enzymes are becoming more common. Mecillinam
is an amidinopenicillin that is available in Europe as the oral pro-drug
pivmecillinam, and is stable to many b-lactamases. We aimed to establish
the activity of mecillinam against an international collection of E. coli
with deﬁned, often multiple, mechanisms of resistance to 3GC.
Methods: The isolates studied were 30 E. coli from an international
collection with known b-lactamase content. Presence of speciﬁc
b-lactamases has previously been established by PCR and sequencing.
The collection includes isolates with TEM, SHV, CTX-M, CMY, AmpC,
and OXA enzymes, and isolates with multiple enzymes. Susceptibility
testing was performed by the BSAC agar dilution method on IsoSensitest
agar with an inoculum of 104 cfu/spot.
Results: The susceptibility results are shown in the table. All isolates
remained sensitive to mecillinam (breakpoint 8mg/L) and meropenem
irrespective of the presence of b-lactamases. For three isolates that
contained 5 or more b-lactamases, isolate 4 (TEM, CTX-M1, CMY-2,
OXA-1, OXA-2), isolate 7 (TEM, SHV, CTX-M, CMY, OXA-1, OXA-2),
and isolate 8 (TEM, SHV, CTX-M1, CTXM2, OXA-2) the mecillinam
MICs were 1, 4, and, 8mg/L respectively.
Conclusions: With the spread resistance to 3rd generation cephalo-
sporins, it is important to ﬁnd alternative agents. Unfortunately many
strains exhibit multi-resistance to unrelated compounds as seen in this
study. However mecillinam retains activity against E. coli even in the
presence of multiple b-lactamases. It should be further evaluated to
establish its clinical utility in the treatment of infections caused by such
organisms.
MIC50 MIC90 % Sensitive
Mecillinam 0.5 4 100
Meropenem 0.03 0.06 100
Cefotaxime 32 >128 18.8
Amoxicillin >128 >128 0
Co-amoxiclav >128 >128 0
Piperacillin/tazobactam 16 128 56.3
Ciproﬂoxacin 8 128 43.8
Nitrofurantoin 16 64 18.8
Trimethoprim >128 >128 31.3
Gentamicin 0.5 64 56.3
P1188 The in vitro susceptibility of E. coli and P. aeruginosa from
Minsk, Belarus
K. Bowker, V. Gorbunov, L. Titov, A. MacGowan (Bristol, UK;
Minsk, BY)
Objectives: In this study we assessed the antimicrobial susceptibility
of 69 E. coli (2 ESBL+ve) and 61 P. aeruginosa strains from Minsk,
Belarus.
Materials and Methods: The following antimicrobials were utilised;
meropenem (MER), amoxicillin (AMOX), co-amoxiclav (Co-A), cefo-
taxime (CTX), ceftazidime (CAZ), (tigecycline (TGC), sulphamethox-
azole/trimethoprim (COT), piperacillin/tazobactam (P/T), gentamicin
(GEN), amikacin (AMI) and ciproﬂoxacin (CIP). MICs were performed
using CLSI agar dilution methodology using cation-adjusted Mueller
Hinton agar. The percentage resistant using CLSI breakpoints were
calculated.
Results: The range, MIC50 and MIC90 (mg/L) are shown on the table
below. Using CLSI breakpoints and MIC90 data all E. coli strains were
susceptible with the exception of AMOX and Co-A. CIP was the most
potent agent tested (0.015mg/L). Levels of resistance in P. aeruginosa
were much higher with 15–35% of strains being resistant to MER, CAZ,
P/T, AMI and CIP. 77% resistance to GEN was observed.
Antibiotic E. coli n = 69 P. aeruginosa n = 61
range MIC50 MIC90 %R range MIC50 MIC90 %R
Meropenem 0.008−0.12 0.015 0.03 0 0.06–16 4 16 17
Amoxicillin 2−>128 >128 >128 57 NT NT NT NT
Co-amoxiclav 4−>128 32 >128 57 NT NT NT NT
Cefotaxime 0.03–128 0.03 0.12 3 16−>128 32 >128 67
Ceftazidime 0.06–64 0.12 0.5 3 1−>128 4 >128 27
Tigecycline 0.25−0.5 0.25 0.5 0 NT NT NT NT
Sulph/trim 0.12–128 0.03 0.5 0 NT NT NT NT
Pip/taz 1–32 2 16 0 2−>128 16 >128 32
Gentamicin 0.25−>128 1 2 8 1−>128 32 >128 77
Amikacin 0.05−>128 2 4 2 2−>128 16 >128 25
Ciproﬂoxacin <0.008–128 0.015 1 9 0.12−>128 32 64 28
NT = not tested.
Conclusion: Rates of resistance in E. coli were low with signiﬁcant
resistance occurring only to amoxicillin with and without clavulanate.
Two strains were ESBL positive. In contrast resistance in P. aeruginosa
was high, only 20% were susceptible to gentamicin.
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P1189 Activity of ertapenem and other agents against clinical
isolates of Proteeae producing extended-spectrum or
AmpC-type b-lactamases
E. Mantengoli, G.M. Rossolini (Siena, IT)
Background: Proteus spp. and other enterics of the tribe Proteeae
(Morganella morganii and Providencia spp.) are common causes of
urinary tract infections and sometimes responsible of other infections
(e. g. wound, intra-abdominal and bloodstream infections). Strains
with reduced susceptibility to expanded-spectrum cephalosporins due
to production of extended-spectrum b-lactamases (ESBLs) or AmpC-
type enzymes have emerged in several settings and, in Italy, have a
notable epidemiological impact. In this work we investigated the activity
of carbapenems and other potentially active agents against a collection of
clinical isolates of Proteeae producing a variety of ESBLs or AmpC-type
b-lactamases.
Methods: Antibiotic susceptibility was determined by the CLSI agar
dilution method or by Etest. Inoculum size effect was determined
with 106 vs. 104 CFU/spot). Characterisation of ESBLs or AmpC-
type enzymes was carried out by PCR and sequencing. A total of 102
nonreplicated clinical isolates of Proteeae (75 Proteus mirabilis, one
Proteus vulgaris, ﬁve M. morganii, 15 Providencia stuartii and two
Providencia rettgeri) producing an ESBL (TEM-, CTX-M- or PER-type)
or an AmpC enzyme (CMY-2-like) were investigated.
Results: Using a standard inoculum (104 CFU), susceptibility rates
were: ertapenem, 100%; piperacillin/tazobactam, 100%; imipenem,
96%; amoxicillin/clavulanate, 33%; ciproﬂoxacin, 18%; amikacin, 95%;
tobramycin, 50%; and gentamicin 23%. Inoculum size variably affected
carbapenem susceptibility. Overall, with higher inocula, susceptibility
rates decreased to 98% or 42% for ertapenem and imipenem,
respectively. Inoculum size effect was overall higher with strains
producing TEM-type ESBLs or CMY-2-like AmpC enzymes.
Conclusions: Present results indicate that carbapenems and piperacillin-
tazobactam were the most active agents against ESBL- and AmpC-
producing Proteeae of clinical origin. Among carbapenems, ertapenem
was the most active, and MICs remained usually lower than the
breakpoint for susceptibility even in the presence of higher inoculum;
imipenem susceptibility was remarkably affected by the inoculum size.
Acknowledgements:Work supported by a medical education grant from
Merck.
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P1190 Characterisation of Gram-positive conjugative transposons
in enterococci from different sources by a multiplex-PCR
assay
C. Novais, A.R. Freitas, L. Moreira, M.V. Francia, F. Baquero,
L.V. Peixe, T.M. Coque (Porto, PT; Santander, Madrid, ES)
Objectives: Conjugative transposons (CTn) have contributed to the
spread of tetracycline (TeR) and erythromycin (ErR) resistance and
might inﬂuence the adaptation of enterococci to different environments.
Diversity of CTn among enterococcal isolates was analysed by a new
multiplex PCR assay that includes ampliﬁcation of speciﬁc sequences
of known CTn from Gram-positives and others Tn often associated with
them.
Methods: We studied 146 E. faecium (Efm), 140 E. faecalis (Ef), 84
Enterococcus spp. from 114 patients of 3 hospitals (H, n = 314 isolates),
20 samples of 3 piggeries (PE, n = 33), 76 poultry retail samples from
2 butcher shops (P, n =167); 7 hospital sewage/river samples (SR,
n = 33); and 2 healthy humans (HV, n = 3) from 1996 to 2006. Antibiotic
susceptibility and conjugation experiments were performed by standard
procedures. Species identiﬁcation and characterisation of tet (tetM, tetO,
tetL, tetS, tetK)/ermB genes was performed by PCR. A battery of
multiplex PCR were developed for screening integrases, excisionases
or tranposases of Tn916, Tn917; Tn5397, Tn5398, Tn5252, EfcTn1, or
Tn5386. Speciﬁcity of the method was proved by using speciﬁc control
strains and sequencing PCR products.
Results: Most isolates were non susceptible to tetracycline (Te, 81%).
tet genes were identiﬁed among TeR (n = 391/325, 90%) and TeS
(n = 34/235, 10%) isolates. Among isolates containing tet we found tetM,
tetS and tetL in both E. faecalis (100%, 59%, 4%) and E. faecium (92%,
80%, 2%). Occurrence of int/xisTn916 or tnpA/tnpRTn917 was slightly
higher for E. faecalis than for E. faecium or Enterococcus spp. (49%/
32%/ 37% or 37% /25%/ 11%, respectively) and spread among H, P
and PE isolates. Conversely, tndXTn5397 was more common among
E. faecium than E. faecalis or Enterococcus spp. (47%, 6%, 27%,
respectively) and mainly conﬁned to P isolates. EfcTn1 was recovered
from 2 swine isolates (E. faecium and Enterococcus spp.). Most of the
isolates contained sequences of 2 Tn, mostly Tn916/Tn917. Tn sequences
(Tn916, Tn917, Tn5397, Tn5398) were transferred in 58% of the cases.
Conclusion: This method enables to screen CTn and other Tn often
associated with them in a high number of strains. Association of
particular elements with some species probably reﬂects differences
among bacterial communities exchanges to which they belong. We ﬁrstly
described EfcTn1 among enterococcal from swine.
P1191 Molecular epidemiology of vancomycin-resistant enterococci
in Belgium, 2003–2006
S. Malhotra-kumar, C. Emeleer, C. Lammens, S. Chapelle, H. Goossens
(Antwerp, BE)
Background: To study the molecular epidemiology of vancomycin-
resistant enterococci (VRE) isolated from clinical specimens from
hospitalised patients in Belgium during 2003–06.
Methods: VRE were identiﬁed on a multipex PCR detecting vanA, B,
C1/C2, D, E and G, and on vancomycin MICs. Speciation was done on
a duplex PCR detecting ddl genes, and for non-E. faecalis/faecium, on
a sodA PCR and DNA sequencing. MICs to ampicillin, ciproﬂoxacin,
gentamicin, streptomycin, quinupristin/dalfopristin, and linezolid were
determined by agar dilution. Presence of the linezolid resistance mutation
G2576U was studied by PCR of the 23S rRNA and a subsequent RFLP
using NheI. Presence of virulence genes asa1, gelE, cylA, esp, and hyl
was detected by a multiplex PCR. Genetic relatedness was examined
by PFGE using SmaI, and an MLST analysis on the predominant VRE
clones.
Results: Ninety-three VRE were isolated during 2003–06. Of these, 77
(83%) were E. faecium, 12 (13%) E. faecalis, and 4 (4%) E. gallinarum.
vanA, the predominant vancomycin resistance gene, was identiﬁed in
77 VRE, vanB in 5, vanA+vanB in 1, and vanC1/C2 in 4 isolates,
while 6 VRE did not show presence of any van gene. The predominant
PFGE clone 54, which constituted 52% of the VRE studied, was
an ampicillin- and ciproﬂoxacin-resistant, vanA-harbouring, hyl-esp-
positive E. faecium. MLST analysis showed clone 54 to belong to
ST17/CC17. The esp gene was present in 84% of the total VRE
and in 90% of the E. faecium isolates either alone or with hyl,
gelE, asa1, cylA. Ampicillin resistance was observed in 86% isolates,
high-level gentamicin resistance (MIC> 500mg/ml) in 38%, high-level
streptomycin resistance (MIC> 2000mg/ml) in 91%, and combined
high-level gentamicin and streptomycin resistance in 38% isolates.
Among non-E. faecalis VRE, resistance to quinupristin/dalfopristin
(MIC 4mg/ml) was 14%. One E. faecalis was linezolid-resistant (MIC
16mg/ml) and RFLP generated two bands conﬁrming presence of the
G2576U mutation in 23S rRNA. Three E. faecium, of which two
belonged to clone 54, were intermediately resistant to linezolid (MIC
4mg/ml), however, the G2576U mutation was not detected.
Conclusions: Our study highlights the predominance of an ampicillin-
and ciproﬂoxacin-resistant vanA-harbouring, hyl-esp-positive E. faecium
ST17/CC17 clone among hospital-associated VRE infections in Belgium.
The esp virulence gene, a marker for hospital-adapted VRE with an
epidemic potential, was identiﬁed in majority of the VRE studied here.
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P1192 Molecular epidemiology and antibiotic-resistant genes of
Enterococcus faecalis causing paediatric infection in Cuba
D. Quin˜ones-Pe´rez, D. Marrero, A. Llop, N. Kobayashi, R. del Campo
(La Havana, Holguı´n, CU; Sapporo, JP; Madrid, ES)
Objetives: The aim of this work was investigate the genetic relatedness
and antibiotic resistant determinants in Enterococcus faecalis isolates
from clinical samples in a paediatric hospital from Cuba.
Methods: A total of 55 E. faecalis isolates were recovered from different
clinical samples between January 2001/December 2004 from unrelated
children admitted in a paediatric hospital in Cuba. Antimicrobial
susceptibility was assed by the agar dilution method. Pulsed-ﬁeld gel
electrophoresis (PFGE)-SmaI was performed for assessing the clonal
relatedness among the isolates. Presence of the antibiotic resistance
genes: erm(B), erm(A), erm(C), mef(A), tet(M), aac(6′)-aph(2"), aph(3’),
ant(6), ant(3")(9), aph(2")-id and aph(2")-ic were tested by PCR with
speciﬁc primers.
Results: A total of 17 different patterns of PFGE were identiﬁed among
the 55 E. faecalis isolates, detecting the same enterococcal clone in
different patients. Presence of a single clon for a single patient was
only detected in six cases. Particular multi-resistant E. faecalis clones
were detected in different wards from the paediatric hospital suggesting
an intrahospital circulation of the selected clones. aac(6′)-aph(2′′) and
aph(3′) genes was detected in all HLR-gentamicin and HLR-amikacin
isolates, respectively; whereas the ant(6) gene were detected in the
75% of HLR-streptomycin isolates. Most of the isolates contained
simultaneously genes for multiple aminoglycoside-modifying enzymes.
The erm(B) gene was found in 72% of the erythromycin-resistant strains.
Multi-resistance to three or more antibiotic families was observed in 27
isolates which belonged to 13 E. faecalis clones.
Conclusion: The circulation of particular clones exhibiting antibiotic
resistance within the paediatric hospital and the dissemination of genes
among these strains indicated the need of infection control measures
and the monitoring of antibiotic susceptibility to prevent the selection or
dispersion of resistant strains in the hospital.
P1193 Phenotypic and genotypic characterisation of antimicrobial
resistance in faecal enterococci of healthy humans and
animals
C. Torres, M. Lo´pez, E. Ruiz, Y. Sa´enz, E. Domı´nguez, E. Guerra,
C. Tenorio, C. Lozano, F. Ruiz-Larrea, M. Zarazaga (Logron˜o, ES)
Objective: To characterise the phenotypes and genes implicated in
antimicrobial resistance in faecal enterococci of healthy humans and
animals.
Methods: 171 faecal samples of healthy animals (66 pigs, 22 pets and 15
bulls) and humans (50 children under two years old and 18 adults) were
seeded onto mEnterococcus agar plates. Two colonies per sample were
selected and identiﬁed. Susceptibility testing to 10 antimicrobials were
carried out by agar dilution method and aminoglycoside, glycopeptide,
macrolide and tetracycline resistance genes were studied by PCR and
sequencing.
Results: A total of 133 E. faecalis, 63 E. faecium, 55 E. hirae,
4 E. casseliﬂavus, 4 E. gallinarum, 4 E. avium, 3 E. durans and
7 Enterococcus spp. were recovered. E. faecalis was found in 72%
of the isolates from human origin, and this species in addition to
E. hirae were the most prevalent ones among pig samples (43 and
37%, respectively). E. faecium was found in 57% of isolates from pets
and bulls. The percentages of antibiotic resistance (found in isolates
from pigs/pets and bulls/human samples) were as follows: tetracycline
(93/66/54%), erythromycin (81/23/29%), ciproﬂoxacin (18/23/14%),
penicillin (5/6/0%), vancomycin MIC> 8mg/L (0.9/2/4%) and high-level
resistance (HLR) to streptomycin (44/9/12%), gentamicin (6/6/5%) and
kanamycin (37/9/14%). None of the 273 enterococci showed ampicillin-
or teicoplanin-resistance, whereas the highest resistance were found to
tetracycline (72%) and erythromycin (49%). One E. faecalis isolate of
porcine origin showed a VanB phenotype characterised by acquired
inducible resistance to vancomycin and susceptibility to teicoplanin
(MICs of 8mg/L and 0.5mg/L, respectively). The vanC gene was
found in the six E. gallinarum and E. casseliﬂavus isolates recovered
from human and bulls. The ant(6)-Ia, aac(6′)-aph(2′′) and aph(3′)-
III genes were demonstrated in most of the isolates with HLR to
streptomycin, gentamicin and kanamycin, respectively. The ermB and
tet(M) genes were detected in 95% and 92% of erythromycin- and
tetracycline-resistant isolates, respectively.
Conclusions: Differences in antimicrobial resistance percentages were
observed among faecal enterococci of different origins, being those
recovered from pigs the most resistant to tetracycline, erythromycin and
streptomycin. The normal microbiota of healthy humans and animals
represents a considerable reservoir of antimicrobial resistance genes.
P1194 MRSA of clonal lineage ST398 in clinical isolates in Austria
K. Krziwanek, S. Metz-Gercek, H. Mittermayer (Linz, AT)
Objectives: Traditionally, meticillin-resistant Staphylococcus aureus
(MRSA) is a problem of infection control in hospitals, but since the
detection of MRSA in the community and in animals it has received a
new focus. In the present study we aimed at identifying MRSA strains of
clonal lineage MLST 398 in clinical isolates and at looking for possible
associations with animals as well as the magnitude of clinical relevance.
Methods: We investigated all MRSA-isolates detected between January
2006 and November 2007 in Upper Austria (one of the nine federal
provinces in Austria) by PFGE, spa-typing and MLST typing in clinical
isolates. The resistance of these strains to ciproﬂoxacin, clindamycin
(CLI), doxycycline (DOX), erythromycin (ERY), fosfomycin, fusidic
acid, gentamicin, moxiﬂoxacin, mupirocin, rifampicin and vancomycin
was determined using the Etest® method. Furthermore demographic
information and data from patient histories were collected and interpreted
by infection control teams in hospitals as well as physicians in outpatient
care.
Results: During a period of 2 years we identiﬁed 756 patients
colonised/infected with MRSA. In 12 patients (8 male, 4 female; median
age 58 years, range 1–81) we identiﬁed MRSA of clonal lineage ST398
and of spa types t011, t034 and t2346. None of the strains harboured
the PVL gene. The isolates were obtained from chronic wounds (6),
eye (1) or nose/throat/trachea (3). 8 of these patients were colonised, 2
were infected with MRSA ST398, and of 2 the status was unknown. 6
isolates were resistant to CLI, ERY and DOX, 5 isolates were resistant
to only DOX, and 1 isolate was fully susceptible. Epidemiological links
to pig farming could be conﬁrmed in 7 patients, and links to farming in
4 patients.
Conclusions: Similar to other countries, also in Austria, MRSA of
clonal lineage ST398 is associated with animal contact. There are
obvious signs that transmission of MRSA between humans and animals,
especially pigs, occurred. We only investigated clinical isolates, however,
we presume that MRSA colonisation might be more common in the
general population. Further investigations to determine the circumstances
and ramiﬁcations of transmission from animals to humans need to be
performed.
P1195 Prevalence of pig-associated meticillin-resistant
Staphylococcus aureus spa types in the German EUREGIO
Twente/Mu¨nsterland
R. Ko¨ck, A. Mellmann, B. Middendorf, C. von Eiff, K. Becker, F. Kipp,
M.G.R. Hendrix, A.W. Friedrich (Mu¨nster, DE; Twente, NL)
Objectives: Recent studies indicated that pig-farming is a risk factor for
MRSA-colonisation in patients admitted to Dutch hospitals. Pig-related
MRSA mostly belonged to Staphylococcus aureus protein A (spa) type
t011 and its close relatives (t034, t108). Until now, MRSA t011 were
rarely found among patients in German hospitals. Since in the EUREGIO
Twente/Mu¨nsterland pig-farming has a high socio-economic impact, we
raised the question how many patients carry MRSA t011 in the German
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part of the EUREGIO and asked whether these patients can be identiﬁed
by screening for classical nosocomial MRSA risk factors.
Methods: In November 2006, all patients admitted to 39 hospitals in
the German part of the EUREGIO Twente/Mu¨nsterland were screened
by nasal swabbing. Risk factors for MRSA carriage were assessed
including previous MRSA carriage, contact to MRSA patients, antibiotic
prescription, hospitalisation during the past six months, direct transfer
from a nursing home or from hospitals, presence of catheters, skin lesions
or combustions, chronic need of healthcare and haemodialysis.
All MRSA were spa typed and clustered in spa clonal complexes (spa-
CCs) using the Based Upon repeat pattern (BURP) algorithm. Chi-square
test or Fisher’s exact test were used for analysing differences in the
distribution of risk factors and patient population. A p-value <0.05 was
considered statistically signiﬁcant.
Results: Screening yielded a MRSA prevalence of 1.7 MRSA/100
screenings. Among 354 MRSA, 62 isolates clustered in spa-CC011
(17.8%) comprising t011, t034, t108, t567, t1451, and t2011. 286 MRSA
(82.2%) clustered in other spa-CCs (spa-CCnon011). 55% of all spa-
CC011 and 26.6% of all spa-CCnon011 patients lacked any of the
risk factors assessed (p< 0.001). Chronic need of healthcare (p< 0.001),
transfer from nursing homes (p< 0.001), and catheters (p = 0.005) were
less frequent among spa-CC011 patients. spa-CC011 was associated
to patients admitted to surgical departments (p = 0.009) and neurology
or psychiatry (p = 0.02), but was underrepresented in internal medicine
(p = 0.01) and geriatric care (p = 0.009).
Conclusions: MRSA spa-CC011 are prevalent in most hospitals in the
German part of the EUREGIO. Among these, the predominant spa type
was t011. Patients found to carry MRSA spa-CC011 were less frequently
associated with classical nosocomial risk factors compared to other
MRSA patients. Further investigation is needed to assess pig-farming
as a potential risk factor for MRSA in the EUREGIO.
P1196 Multicentre in vitro evaluation of Gram-positive
micro-organisms in the Netherlands for daptomycin
compared with other antibiotics
J.W. Mouton, J.A.J.W. Kluytmans, A.T. Bernards, A. van Mil, A. Voss
(Nijmegen, Breda, Leiden, NL)
Background: Daptomycin (DA) is a new lipopeptide recently approved
in The Netherlands (NL). In a multi-centre study, we aimed to evaluate
the in vitro antibacterial activity of daptomycin and other antibiotics
against various Gram-positive micro-organisms.
Methods: 25 laboratories equally distributed throughout the Netherlands
were asked to participate in the study. Each lab was asked to collect
up to 90 consecutive isolates from clinical samples (patient >72 h in
hospital) during a 3 month period (june-sept 2007), 25 S. aureus (SA),
25 Coagulase Negative Staphylococci (CNS), 20 enterococci (EN) and
20 Streptococcus spp. other then pneumococci (ST). All isolates were
required to be from blood, pus, sites normally sterile or wounds; for CNS
at least two cultures needed to be positive. A maximum of one isolate per
species per patient was allowed. Isolates were identiﬁed by participating
laboratories using their own standard identiﬁcation technique. MIC’s
were determined using Etest on site for DA, vancomycin VA), teicoplanin
(TE), linezolid, gentamicin, erythromycin or clarithromycin, penicillin
and cefotaxim (ST), ampicillin (EC), moxiﬂoxacin and rifampicin
(staphylococci). BHI agar with 2.0 McFarland and 48 h incubation was
used for VA and TE, 0.5 McF on Mueller-Hinton and 24 h incubation
for the others. The cefoxitin disk method was applied to staphylococci.
Control ATCC strains were included. Afterwards, strains were collected
by the central lab for further analysis. All strains were retested to VA,
TE and DA. EUCAST criteria were used for interpretation. Data were
analysed using WHONET 5.4.
Results: 1709 strains were collected, 525 SA, 427 CNS, 394 EC, and
363 ST. MIC50’s for daptomycin were 0.38, 0.5, 1.5 and 0.125mg/L and
MIC90’s 0.75, 1, 3 0.5mg/L, respectively. 36 CNS had MICs of >1mg/L
for DA. 67 strains were categorised as VISE’s based on an increased MIC
(TE> 8mg/L). There was a signiﬁcant correlation between increased
MIC for DA and VA (r=0.42; p< 0.0001) and TE (r=0.34; p< 0.0001)
respectively. VA and TE resistance in enterococci was not observed. Four
SA showed a slightly increased MIC (3× MIC=1.5mg/L; 1× 3mg/L)
Conclusions: Daptomycin showed excellent activity to these clinical
isolates. However, staphylococci with decreased susceptibility to
glycopeptides showed higher MICs to daptomycin too, possibly limiting
the use of daptomycin in this small subgroup.
P1197 Clonal spread of linezolid and teicoplanin-resistant
Staphylococcus haemolyticus in intensive care unit patients
in a tertiary hospital
A. Rodriguez Aranda, M. Daskalaki, J. Villar, F. Sanz, J.R. Otero,
F. Chaves (Madrid, ES)
Objectives: Following the observation of several cases of infections
caused by isolates of linezolid and teicoplanin-resistant S. haemolyticus
(LTRSH) we decided to investigate the epidemiology and clonality of
these isolates, and to determine the molecular mechanism of resistance
to linezolid.
Methods: Medical records of all patients with LTRSH in the last three
years were reviewed. Antimicrobial susceptibility testing was performed
with Wider panels (Soria-Melguizo, Madrid, Spain) and minimun
inhibition contentrations (MIC) were performed by the Etest method
for linezolid, teicoplanin, vancomycin, tigecycline and daptomycin.
Molecular characterisation of LTRSH isolates was performed by pulsed-
ﬁeld gel electrophoresis (PFGE) after SmaI digestion. A 420bp Domain
V region of the 23S gene was ampliﬁed for each isolate and the products
were digested with NheI restriction enzyme for detecting the G2576T
mutation, which has been associated with linezolid resistance.
Results: Between October 2005 and March 2007 we recovered 22
clinical isolates of TLRSH from 15 patients. The mean age was 56
years (SD 11.75) and 66.7% were male. All patients were diagnosed
of LTRSH infections while they were in ICU. Fourteen cases were
considered clinical infections: 11 catheter-related bacteraemia and
4 surgical infections. Eleven patients underwent abdominal surgery,
including four patients with liver transplantation. All isolates were resis-
tant to meticillin, erythromicin, clindamicin, levoﬂoxacin, rifampicin,
trimethoprim-sulfamethoxazole, teicoplanin (range 24–128mg/L) and
linezolid (range 32 to 128mg/L) and susceptible to vancomycin,
tigecycline and daptomycin. PFGE analysis indicated that all isolates
belonged to a single clonal group. All linezolid-resistant isolates had the
same 23S rRNA mutation in domain V, G2576U, and the incomplete
digestion of NheI indicated that not all copies of rRNA genes carried
the mutation.
Conclusion: This report documents the spread and persistence of a single
clone of multidrug-resistant S. haemolyticus, including resistance to
linezolid and teicoplanin, in ICU patients. This study conﬁrmed previous
reports regarding the importance of the G2576T mutation associated
to linezolid resistance in Enterococcus faecium, Staphylococcus epider-
midis and S. haemolyticus. The emergence of LTRSH in hospitals has
important clinical and epidemiological implications.
P1198 Investigation of the genetic basis of erythromycin resistance
in Staphylococcus aureus, including MRSA, from Pakistan
F. Ullah, S.A. Malik, J. Ahmed, A.M. Snelling (Islamabad, Peshawar,
PK; Bradford, UK)
Objectives: Erythromycin (ERY) is used extensively in clinical practice
in Pakistan for skin and throat infections, but little surveillance work has
been done to assess the extent of resistance amongst common pathogens.
Similarly, there is a paucity of information about the MRSA clones
circulating. The aim of this study was to determine the prevalence and
mechanisms of ERY resistance amongst S. aureus from specimens being
processed at a diagnostic laboratory in the North West of Pakistan. Also,
to see if there were differences in the extent of ERY resistance between
meticillin sensitive (MSSA) and resistant (MRSA) strains.
Methods: Sequential isolates of S. aureus were collected from wounds
and burn/skin infections of in- and out-patients at a tertiary care hospital
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in Peshawar. Isolates were identiﬁed by standard methods, including PCR
for mecA/nuc genes to conﬁrm MRSA, which were also ribotyped. MIC
proﬁles for commonly used antibiotics were determined using CLSI
criteria. Presence of erm(A), erm(B), erm(C) and msr(A) genes was
determined by PCR.
Results: Of 133 isolates of S. aureus collected, 59 (44.4%) were resistant
to ERY, with MIC values ranging from 8 to >1024mg/L. Just 3.3%
(n = 3) of the 70 MSSA were resistant, while in contrast, of the 63 MRSA
strains, 41.3% (n = 35) were ERY-R. The most common resistance gene
detected amongst the ERY-R strains was erm(A) (44.1%), followed by
erm(C) (42.3%), msr(A) (8.4%) and erm(B) (5%). No strain carried
multiple genes. Eight ribotypes (A to H) of MRSA were present: erm(A)
was found in ribotypes A, B and C, erm(C) was found in ribotypes D, E
and F. The erm(B) +ve strains were restricted to ribotype G, and msrA to
ribotype H. Overall, ERY-R strains of MRSA were generally co-resistant
to ciproﬂoxacin (86.8%), gentamicin (86.8%) and tetracycline (83.6%).
However, resistance amongst such strains to chloramphenicol and fusidic
acid was much lower (20% and 16.3% respectively).
Conclusion: ERY-R was surprisingly rare amongst skin isolates of
MSSA from this area, and thus this antibiotic may still be useful for
treating infections if MSSA status is conﬁrmed. Amongst the MRSA,
ERY-R is common, mediated mostly by erm(A) and erm(C), and the
resistance genes map to the clonal lineages. Where the skin infection is
due to an MRSA, topical fusidic acid may still have utility in this area
of Pakistan.
P1199 Distribution of macrolide resistance genotypes
and phenotypes among Staphylococcus aureus and
coagulase-negative staphylococci, Italy
G. Gherardi, L. De FLorio, G. Lorino, L. Fico, G. Dicuonzo (Rome, IT)
One-hundred macrolide-resistant staphylococcal isolates from clinically
relevant infections in Italy during a 19-months period were studied to
determine macrolide resistance genotypes and phenotypes. Macrolide
resistance phenotypes were performed by using the triple-disk induction
test with 15-mg ERY disk, 2-mg CLI disk, and 15-mg TEL disk. Four
distinct resistance phenotypes were observed among 100 erythromycin-
resistant isolates: the cMLSB phenotype (24 isolates); the iMLSB
phenotype (41 isolates); the MS phenotype (3 isolates); and the iMTS
phenotype (erythromycin-induced telithromycin resistance) (32 isolates).
All isolates with MS and iMTS phenotypes were msrA-positive, whilst
all isolates with MLSB phenotype were erm-positive. ermC gene
predominated within erythromycin-resistant S. aureus isolates with
iMLSB phenotype, while ermA gene was present in all but one S. aureus
isolates with cMLSB phenotype. The msrA gene was found in only one
S. aureus isolate. Among erythromycin-resistant CoNS isolates half of
the strains showed the iMTS or MS/msrA association. ermC gene was
present in all but 2 erm-positive CoNS isolates. Among 76 erythromycin-
resistant isolates studied by PFGE an high genetic heterogeneity was
observed, with both independent acquisition of macrolide resistance
genes and spread of speciﬁc resistant clones as mechanisms responsible
for occurrence of macrolide resistance. To our knowledge, it is the ﬁrst
report on the prevalence of the erythromycin resistance phenotypes and
genotypes among staphylococcal clinical isolates in Italy.
P1200 Distribution of mefE and ermB in macrolide-resistant
Streptococcus pneumoniae isolated from nasopharynx of
healthy children
I. Korona-Glowniak, A. Malm (Lublin, PL)
Objectives: The vast use of macrolides has been connected with
increased prevalence of macrolide-resistant strains of pneumococci.
In many European countries, the rate of pneumococcal resistance
to macrolides has exceeded the level of resistance to penicillin G.
More than 20% rates of resistance to erythromycin are reported in
France, Spain, Poland, Greece, and Portugal. Macrolide resistance is
mediated by two main mechanisms in pneumococci. The most common
mechanism is mediated by methylase encoded by the erm(B) gene.
Ribosome methylation causes reduced binding of and coresistance
to macrolide, lincosamide, and streptogramin B (MLS) antibiotics.
In streptococci MLS resistance can be expressed either constitutively
(cMLS phenotype) or inducibly (iMLS phenotype). Macrolide efﬂux
mechanism is mediated by an efﬂux pump encoded by mef(E) gene. It is
associated with M phenotype characterised by resistance to 14- and 15-
membered macrolides only. We selected erythromycin-resistant strains
of S. pneumoniae isolated from nasopharynx of healthy children and
tested them for resistance phenotype and analysed for genes responsible
for macrolide resistance.
Methods: 113 erythromycin-resistant S. pneumoniae strains were
tested for resistance phenotype by erythromycin-clindamycin double-
disk (ECDD) test. The presence of erythromycin resistance genes was
investigated by PCR. Primer pairs speciﬁc for detection of erm(B) and
mef(E) and ampliﬁcation and electrophoresis of PCR products were
carried out by Sutcliffe et al. (AAC 1996).
Results: Erythromycin-resistant S. pneumoniae strains belonged mainly
to 19F (55%) and 6B (37%) serotypes and remaining single strains
belonged to 23F, 14, 15B, and 23A. 74% pneumococcal strains were
also non-susceptible to penicillin. All 113 erythromycin-resistant strains
tested using the ECDD assay were assigned to the cMLS phenotype.
iMLS and M phenotypes were not found by this method. All strains had
the erm(B) gene and 29 (25.7%) strains showed both erm(B) and mef(E)
genes. There were no correlation between coexisting erm(B) and mef(E)
and serotypes or resistance to other antibiotics, including penicillin.
Conclusion: The predominance among erythromycin-resistant pneumo-
cocci of isolates carrying the erm(B) gene over those carrying the
mef(E) is consistent with result of other studies from European countries.
Prevalence of isolates with combined mef(E) and erm(B) genotypes is
increasing particularly in children.
P1201 Population structure of erythromycin-resistant Streptococcus
pneumoniae invasive isolates recovered in a Spanish hospital
in Madrid
E. Gomez G. de la Pedrosa, E. Loza, R. del Campo, A. Fenoll,
F. Baquero, R. Canto´n (Madrid, ES)
Objectives: To analyse the population structure of erythromycin resistant
Streptococcus pneumoniae isolates and further characterisation of mef-
positive isolates recovered from blood cultures in a hospital in Madrid.
Prevalence of associated resistance phenotypes and genetic determinants
were also screened as well as the antimicrobial co-resistances.
Methods: Among all 334 S. pneumoniae invasive isolates recovered
from 2000 to 2006 in our hospital a PCR assay was performed to
identify erythromycin resistance genes [erm(B) or mef]. A multiplex-
PCR was designed to distinguish between mef(A) and mef(E).
Susceptibility testing was performed by the standard microdilution
technique (CLSI) and resistance phenotypes by the double disk diffusion
assay. Population structure was studied by serotyping and SmaI-PFGE
among erythromycin resistant isolates and also by MLST within mef-
positive isolates.
Results: A total of 68 erythromycin resistant isolates (20.3%)
were obtained, with no signiﬁcant (Mantel Haenszel test) trend to
decrease over the studied period. Overall resistance values among
these isolates were: penicillin, 61.7%; cefotaxime, 8.8%; clindamycin,
61.7%; tetracycline, 78%; and 1.5%, levoﬂoxacin. Resistance gene
distribution were: erm(B), 75.0%; erm(B)+mef(E), 16.2%; mef(E),
7.3%, and mef(A), 1.5%. The iMLSB and cMLSB phenotypes were
observed in 75.0% and 16.2% of isolates, respectively, whereas the M
phenotype was observed in 8.8%. Serotype 14 (20.5%), 6B (13.2%),
19A (13.2%), 19F (7.3%), 6A (5.8%), and 4 (5.8%) were predominant.
Most isolates belonging to the same serotype showed different PFGE
pattern. Spain6B−2, Sweden15A−25 and Tenesse14−18 international multi-
resistant clones were found within the erm(B)+mef(E) positive isolates.
England14−9 was represented by two isolates, one carrying the mef(A)
gene and the other one the mef(E) gene. Interestingly, Spain9V−3 clone
Antibiotic resistance in Gram-positive organisms S335
were both represented in two mef(E) positive isolates and additionally
in three erm(B)+mef(E) positive isolates.
Conclusions: Erythromycin resistance in our invasive isolates remains
high mainly due to the presence of erm(B) gene. Nevertheless a high
proportion of these isolates also harboured the mef gene endowing
the iMLSB phenotype. A polyclonal population structure was found in
our mef positive S. pneumoniae isolates which included international
multirresistant clones.
P1202 Conjugative transposon Tn5253 of Streptococcus
pneumoniae
F. Iannelli, F. Santoro, M. Oggioni, G. Pozzi (Siena, IT)
Objectives: The conjugative transposon (CT) Tn5253, also called (cat
tet)6001, is a genetic element which integrates at a speciﬁc site into
the chromosome of Streptococcus pneumoniae. Tn5253 was originally
found in S. pneumoniae strain BM6001, a serogroup 19 clinical isolate
resistant to chloramphenicol and tetracycline. Tn5253 was found to carry
resistance genes tet(M) and cat, and could be trasferred by conjugation
to the chromosomes of other pneumococcal strains and of other bacterial
species including Streptococcus pyogenes, Streptococcus agalactiae,
Streptococcus gordonii, and Enterococcus faecalis. Aim of this study was
to obtain the complete nucleotide sequence of Tn5253, as a contribution
to our understanding of the resistance-carrying mobile genetic elements
that are found in the genomes of S. pneumoniae isolates.
Methods: The complete nucleotide sequence of Tn5253 was obtained
by using as a template different PCR fragments (size varies between 0.3
to 22 kb).
Results: Sequence analysis showed that Tn5253 is 64,513 bp in size,
with 78 ORFs. Tn5253 was also found to contain two distinct genetic
elements integrated: (i) a copy of Tn5251, of the Tn916-Tn1545 family
of tet(M)-carrying CT, and (ii) a copy of pC194, a cat-containing plasmid
of Staphylococcus aureus. Tn5251 was found to be 18,039 bp in size and
99% identical to Tn916 of Enterococcus faecalis. The copy of pC194
found in Tn5253 (called pC1945253) was 2816 bp in size and, compared
to pC194, had a deletion of 93 bp involving the plasmid replication
origin. Conclusion.
These data represent the basis for a detatiled analysis of the repertoire
of mobile genetic elements in Streptococcus pneumoniae, and for a
functional analysis of the conjugation properties of this element.
P1203 Distribution of the macrolide resistance genes mefA, mefE,
and erm in S. pneumoniae and S. pyogenes in Germany
from 2005 to 2006
C. Bley, M. van der Linden, R. Reinert (Aachen, DE)
Objectives: Streptococcus pneumoniae is the major cause for many
childhood diseases like respiratory tract infections, acute otitis media
and community-aquired pneumonia. Resistance of S.pneumonia and
S. pyogenes to macrolide antibiotics has become an increasing problem
worldwide due to the spread of the resistance genes mefA, mefE and
ermB. Both mef genes encode an efﬂux pump, resulting in low level
resistance to macrolides (M-phenotype). The sequences of mefA and
mefE are almost identical, but the genes are carried on different genetic
elements: Tn1207.1 and MEGA respectively, that might give rise to
differences in clonal spread. ErmB encodes an rRNA methylase which
modiﬁes the macrolide binding site in the ribosome, thus giving rise to
high level resistance (MLSB-phenotype). We investigated the macrolide
resistance markers in Germany (2005–2006), with special emphasis on
the distribution of mefA and mefE.
Methods: S. pneumoniae and S. pyogenes isolates were collected
between 2005 and 2006 as part of the national surveillance programs
of the German National Reference Centre for Streptococci (GNRCS).
Clarithromycin MICs were determined with the microdilution method
according to the CLSI criteria. A multiplex PCR was performed to
distinguish between mefA and mefE and a separate PCR was used
to detect the ermB gene. Multilocus sequence typing (MLST) was
performed according to standard methods.
Results: Between 2005 and 2006 the GNCRS received 2065 S. pneu-
moniae and 330 S. pyogenes isolates from children and adults from all
over Germany. A total of 481 S. pneumoniae and 26 S. pyogenes isolates
were macrolide resistant and of 446 and 20 of these isolates the resistance
markers were determined. Among the S. pneumoniae isolates the main
resistance marker was mefA (55%), followed by ermB (26%) and mefE
(11%). 4% were mefA+ErmB, 4% mefE+ermB and 0.4% carried neither
mef nor ErmB. Among the S. pyogenes isolates 45% were mefA and 55%
erm. MLST analysis indicated a clonal dissimination of both mefA and
mefE determinants.
Conclusion: mefA is the most common macrolide resistance marker
in S. pneumoniae and S. pyogenes in Germany. This is in contrast to
countries like Spain, Canada and the USA, where mefE is far more
prominent.
P1204 Analysis of structural alterations in the regulatory region
of the erm(TR) gene of Streptococcus agalactiae with
constitutively expressed MLSB resistance
M.E. Llaneza, C. Seral, S. Algarate, A. Martı´nez, C. Garcı´a,
M.C. Rubio, R. Go´mez-Lus (Zaragoza, ES)
Objectives: The methylases conferring MLSB resistance are encoded by
erm(TR) and erm(B) in Streptococcus agalactiae (GBS). The regulatory
region of the erm(TR) gene consists of two leader peptides (LP1 and
LP2) containing a number of inverted repeats that can act in attenuator
regulation, analogous to that found in erm(C). Little has been published
regarding the regulation in GBS of erm(TR). The purpose was to study
the regulatory region in GBS clinical isolates harbouring constitutively
expressed erm(TR) gene.
Methods: Antimicrobial susceptibility testing to MLSB antibiotics
and identiﬁcation of resistance phenotype were performed by broth
microdilution (CLSI guidelines) and triple disk diffusion methodology,
respectively. Ten isolates, with constitutively expressed MLSB resistance
encoded by erm(TR), were selected among 141 MLSB resistant GBS
collected from vaginal swabs obtained from 2002 to 2004 by our Clinical
Laboratory (Hospital Lozano Blesa, Zaragoza, Spain). The erm(TR)
regulatory region of these isolates were ampliﬁed from chromosomal
DNA. Therefore, we determined the nucleotide sequences and deduced
amino acid sequences of erm(TR) regulatory region. Pulsed-ﬁeld gel
electrophoresis (PFGE) analysis was performed on the 10 GBS isolates
following Sma1 digestion.
Results: GBS isolates selected expressed a resistance cMLSB pattern
characterised by high resistance to clindamycin (range >64mg/L) and
low resistance to erythromycin (range 8–16mg/L). Sequencing of the
attenuator region upstream erm(TR) showed six different point mutations
(C57U) (G98A) (A137C) (C170U) (G205A) (G205T) and only one 863
bp insertion were identiﬁed. Most of the changes were found in the ORFs
of the second leader peptide (LP2), mainly due to the mutation (A137C).
One of the ampliﬁcation product was greater than expected and carried
an insertion of 863 bp in position 121 of LP2. Sequencing of the insertion
fragment showed 98% identity with insertion sequence IS1381. Analysis
by PFGE revealed that three isolates were closely related (homology
>80%).
Conclusions: This study showed that mutations and insertions in the
regulatory regions of erm(TR) can be correlated to constitutive MSLB
expression due to the destabilisation of the stem-loop that would lead
to the translation of the erm(TR) gene and results in increased or
constitutive expression of erm(TR) gene.
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P1205 Molecular epidemiology and macrolide resistance traits
of Streptococcus agalactiae and Streptococcus uberis from
bovine mastitis
M. Rato, R. Bexiga, S.F. Nunes, D. Rolo, L.M. Cavaco, C.L. Vilela,
I. Santos-Sanches (Caparica, Lisbon, PT)
Objectives: To evaluate the clonality and resistance patterns against
macrolide and tetracycline of Streptococcus agalactiae (GBS) and of
Streptococcus uberis (SU), both important contagious and environmental
pathogens in bovine mastitis, in order to formulate effective mastitis
control programs for dairy herds.
Methods: A total of 60 GBS and 30 SU ﬁeld isolates were recovered
among 459 milk samples from mastitis quarters of 377 bovines in
12 Portuguese dairy farms, during a national survey performed in
2002–03, and were characterised by pulsed ﬁeld gel electrophoresis
(PFGE) with computer-assisted DNA-band analysis. GBS and SU
representative isolates of different PFGE sub-types were analysed by
multilocus sequence typing (MLST). Resistance against macrolides
(erythromycin-E), lincosamides (pirlimycin-PRL) and tetracycline-T and
the macrolide-lincosamide resistance phenotypes (M/cMLS/iMLS) were
evaluated by disk diffusion. The macrolide and tetracycline resistance
genes mef(A), erm(A), erm(B), tet(M), tet(O), tet(W), tet(L), tet(Q),
tet(K), tet(S) were searched for by PCR among isolates of both species.
Results: A total of 10 PFGE clusters comprised 77% of the GBS and
four PFGE clusters comprised 53% of the SU and almost all were found
to be herd-speciﬁc. The GBS were clustered in ST-2 and ST-61 lineages
previously described among human isolates of GBS (according to the
S. agalactiae MLST database), while the SU isolates were included
into 11 novel lineages (seven of which consist of new alleles) clustered
into three clonal complexes, ST-143, ST-86 and ST-5, known to include
bovine isolates from several geographic locations. Co-resistance to E and
T was found in both GBS (17%) and SU (27%) belonging to several
clones or lineages and most GBS were cMLS erm(B)+/tet(O)+/tet(K)+
while most SU were cMLS-erm(B)+/tet(O)+. SU isolates susceptible to
E and resistant to PRL and T carried the tet(S).
Conclusions: The results suggested contagious and environmental
sources of SU infections and extensive cow-to-cow transmission
of GBS. The detection of the same macrolide and tetracycline
resistance determinants among isolates of both species suggests vertical
and horizontal transmission of these genes. A same phenotype of
susceptibility to macrolides and resistance to lincosamides, previously
detected in GBS of human origin – LSA phenotype, was found in SU
bovine isolates.
P1206 mef(E) is present in Streptococcus pyogenes and can be
transferred by conjugation
M. Del Grosso, G. Barbabella, R. Camilli, R. Creti, J. Blackman
Northwood, D.J. Farrell, A. Pantosti (Rome, IT; London, UK)
Objectives: Efﬂux transport system, associated with the mef gene,
confers resistance to 14- and 15-membered macrolides (M phenotype)
in streptococci. In S. pyogenes, mef(A) was found to be carried by
conjugative genetic elements, whereas a genetic element carrying mef(E)
in S. pyogenes has not been described. Among a global collection of
S. pyogenes clinical isolates, strains carrying mef(E) were identiﬁed.
The aim of the study was to characterise the element carrying mef(E)
in S. pyogenes.
Methods: Among 17 S. pyogenes isolates which were positive
for the presence of mef(E), one isolate from the United States
(MB56SPYO9) was examined: PCR assay and sequencing of mef,
PCR mapping targeting mega, MLST and emm typing were performed.
Conjugation experiments were carried out by using both S. pyogenes and
S. pneumoniae, as recipient strains. Transconjugants were analysed by
PFGE followed by hybridisation with mef(E) probe.
Results: In S. pyogenes MB56SPYO9 belonging to sequence type
ST36 and emm type 12, the presence of mef(E) was conﬁrmed by
sequencing. By PCR mapping targeting mega, the fragments obtained
were of the same size as those obtained with a control strain. This
indicates the presence of mef(E) in a mega element. By conjugation, the
erythromycin resistance was transferred from the donor MB56SPYO9 to
both S. pyogenes and to S. pneumoniae recipient strains. SmaI-restricted
genomic DNA from the donor, the recipients, and the transconjugants
were examined by PFGE. Analysis of the proﬁles showed the appearance
of a novel band in the transconjugants, suggesting the acquisition of an
approximately 50 kb DNA fragment by conjugation. Hybridisation assay
by using mef(E) probe revealed that this fragment included mef(E).
Conclusions: In S. pyogenes, mef(E) is carried by mega and is included
in a large conjugative genetic element. Further investigations will be
done to characterise this element.
P1207 Phenotypic and genotypic characterisation of group A
Streptococcus clinical isolates: antimicrobial resistance
patterns, macrolide-resistance genes and emm typing
A. Michos, C. Bakoula, M. Braoudaki, F. Koutouzi, A. Pangalis,
H. Kirikou, V.P. Syrioupoulou (Athens, GR)
Objectives: The aim of the present study was to characterise
phenotypically and genotypically clinical isolates of group A streptococci
(GAS) from a paediatric population in our geographic region
Methods: A total of 1160 GAS clinical isolates were collected during
1/2003–12/2006. Susceptibility testing was performed using standard
disk diffusion and Etest methods. Mechanism of macrolide resistance
was phenotypically determined using double-diffusion disk test. The
presence of mefA, ermA and ermB genes were detected by PCR. emm
types were identiﬁed by ampliﬁcation and sequencing.
Results: The average rates of resistance to erythromycin, clindamycin,
azithromycin, tetracycline and chloramphenicol were 14.9%, 0.9%,
14.9%, 11.46%, 0.6%, respectively. A signiﬁcant increase in macrolide
resistance was noted from 12.1% in 2003 to 18.8% in 2006 (p = 0.02).
None of the isolates exhibited resistance to penicillin, ceftriaxone,
rifampicin, or ciproﬂoxacin. Among the erythromycin resistant isolates,
93 (53.7%) expressed the M phenotype, 70 (40.5%) the iMLSB and
10 (5.8%) the cMLSB phenotype. Overall, 93 (53.7%) of the isolates
harboured the mefA gene, 70 (40.4%) the ermA and 10 (5.8%) the ermB.
The most prevalent emm types were 12, 77, 4 among macrolide resistant
and 1, 12, 28 among macrolide susceptible isolates. emm types 77, 4,
12, 28 accounted for 75% of invasive isolates and emm types 12, 1,
4, 28, 77 accounted for 75% of non invasive isolates. emm type 77
was found signiﬁcantly more frequent among invasive isolates (p = 0.02).
GAS vaccine (in clinical trials) encompasses almost 80% of emm-types
detected in our study.
Conclusions: Macrolide resistance rates are increasing among GAS
in our region. The predominant determinants conferring resistance to
macrolides were the mefA and ermA genes. The emm types included
in GAS vaccine cover 80% of streptococcal isolates causing infections
in Greece. Continuing surveillance studies are needed to determine
the stability of the trends reported above and to guide therapy and
development of vaccine strategies.
P1208 Decrease in macrolide resistance and clonal instability
among Streptococcus pyogenes in spite of increased
macrolide consumption
C. Silva-Costa, F.R. Pinto, M. Ramirez, J. Melo-Cristino (Lisbon, PT)
Objectives: Although macrolide resistance has remained stable in
Portugal during 1998–2003 (27%), a rapid inversion of the dominant
phenotypes was noted, with a sharp decrease in the proportion of isolates
presenting the MLSB phenotype and a concomitant increase in the
isolates presenting the M phenotype. To gain further insights into the
changes in overall macrolide resistance, in ﬂuctuations of macrolide
resistance phenotypes and in the clonal structure of the macrolide
resistant population, we undertook the phenotypic and molecular
characterisation of 156 macrolide resistant GAS isolated in 2004–2006.
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Methods: Antimicrobial susceptibility testing and macrolide resistance
phenotype were performed by disk diffusion. All the macrolide-resistant
isolates were further characterised. Macrolide and tetracycline resistance
genotypes were determined by PCR. A combination of T typing, emm
typing, pulsed-ﬁeld gel electrophoresis (PFGE) and multilocus sequence
typing (MLST) was used. The Bionumerics software was used to
create UPGMA dendrograms of SmaI/Cfr9I fragment patterns. The Dice
similarity coefﬁcient was used with optimisation and position tolerance
settings of 1.0 and 1.5, respectively. PFGE clusters included isolates with
80% relatedness on the dendrograms. MLST analysis was performed
on representatives of each lineage.
Results: During the three years of the study, the overall rate of
erythromycin resistance was lower than the one documented previously,
and a decrease in the prevalence of isolates presenting the M phenotype
was also noted. PFGE and MLST were highly concordant and
identiﬁed eight major lineages, containing 139 isolates (89%). Molecular
characterisation revealed a very diverse population. Some of the PFGE
clusters identiﬁed had already been found, but others were described for
the ﬁrst time in Portugal.
Conclusion: A decline in macrolide resistance in S. pyogenes was noted,
in spite of high macrolide use, and these changes were accompanied by
clonal variations. The emergence of clones not detected previously, the
change in the prevalence of the clones already described or even the
disappearance of some clones resulted in marked differences in the clonal
composition of the population of macrolide-resistant GAS in Portugal.
P1209 Emergence of moxiﬂoxacin resistance in Swedish epidemic
Clostridium difﬁcile isolates in the era of the global
NAP1/027 epidemic
T. Nore´n, T. Akerlund, J. Andersson, I. Alriksson, M. Unemo (O¨rebro,
Solna, SE)
Objectives: In recent years global outbreaks of Clostridium difﬁcile
associated diarrhoea (CDAD) in the western world involve the
epidemic strain of C. difﬁcile characterised as PCR ribotype 027
and PFGE type NAP1. Increased infection rates and more severe
cases of diarrhoea have featured these epidemics. Use of modern
ﬂuoroquinolones (moxiﬂoxacin/gatiﬂoxacin) has been thought to be the
epidemic trigger selecting moxiﬂoxacin resistance NAP1/027 isolates.
In Sweden the epidemic strain SE17 (Serogroup C, PCR ribotype 012)
has been dominant in nosocomial clustering. Retrospectively only three
historical isolates of NAP1/027 have yet been found in Sweden without
increased morbidity or epidemic clustering. Prior to 2004 both these
Swedish NAP1/027 strains and the SE17 have been fully susceptible
to moxiﬂoxacin as opposed to the epidemic NAP1/027 being resistant.
Hence we used moxiﬂoxacin resistance as a surveillance marker when
testing clinical isolates 2004 (n = 300) and 2007 (n = 300) for any
emergence of moxiﬂoxacin resistance.
Aim: To determine whether moxiﬂoxacin resistance is a useful general
marker of epidemic isolates or exclusively a screening tool of NAP1/027.
Material and Methods: MIC determination. Anaerobically cultured
isolates were suspended in nutrient broth (Oxoid) to a turbidity of 1.0
and seeded on IsoSensitest agar (Oxoid). Etest strips (Biodisk AB)
were placed on top followed by anaerobic incubation at 37ºC for 48 h.
PCR ribotyping of C. difﬁcile isolates. Preparation of template, PCR
reaction, separation of PCR products and analysis of banding patterns
were according to Stubbs et al (1999, J. Clin. Microbiol. 37:461–
463) with minor modiﬁcations (Nore´n et al, 2004, J. Clin. Microbiol.
42:3635–3643) and, accordingly, use of our own nomenclature (preﬁx
SE, Sweden).
Results: In 2004 4% of the clinical isolates showed moxiﬂoxacin
resistance (MIC> 32mg/l) and in 2007 we noted a signiﬁcant increase
of resistant isolates, i.e. the prevalence of resistance was almost six times
as high (22.5%). The antibiograms indicated epidemic SE17 uniformly
and current nosocomial clusters of disease were located mainly in two
geographically distant Dialysis departments and in the Department of
Infectious diseases.
Conclusion: Moxaﬂoxacin resistance may not only be a selecting factor
and screening marker for NAP1/027 but also useful to detect other
virulent C. difﬁcile like for example SE17 (Ribotype 012) in Sweden.
P1210 Antibiotic susceptibility pattern and tetracycline resistance
of Lactobacillus strains of different origin
J. Stsepetova, S. Ko˜ljalg, E. Sepp, K. Lo˜ivukene, E. Songisepp,
M. Ra¨tsep, M. Mikelsaar (Tartu, EE)
During the last years substantial attention has been paid to the fact
that resistance determinants are widespread among isolates from non-
clinical settings. It has been proposed that some food starter cultures and
probiotic additives might contain antibiotic resistance genes, particularly
to the widely used antibiotic tetracycline.
The aim of the study was to test the possibilities for safety assessment
of Lactobacillus strains from food by comparing their phenotypic and
genotypic antibiotic resistance with reference, intestinal and agricultural
strains.
Methods: A total of 44 strains of L. paracasei and L. plantarum
were tested: 25 human (13/12), 4 reference (2/2), 13 silage (7/6)
and 2 food industrial (1/1) strains. The MIC values of lactobacilli to
ampicillin (AM), gentamicin (GM), streptomycin (SM), erythromycin
(EM), tetracycline (TC), chloramphenicol (CL) were assessed according
to EU Commission recommendations. Microbial DNA was extracted
using QIAamp DNA Kit. Integrase Int1 and tetracycline resistance genes
tet(M), (S), (O), (K), (L) were detected by PCR method.
Results: L. paracasei and L. plantarum strains were susceptible
to all tested antibiotics. Compared with L. paracasei L. plantarum
strains showed higher MIC values to TC(p< 0.001), EM(p = 0.014),
CL(p = 0.011) while to AM(p = 0.01), GM(p< 0.001) and SM(p = 0.001)
the in former the MIC values were higher than in latter. No differences
in MIC values were seen between the food and intestinal & agricultural
strains.
All L. paracasei and 19/21 L. plantarum strains contained IntI gene.
The tet genes (M,K, L) alone in different combination were present in
14/23 L. paracasei and 16/21 L. plantarum strains, respectively. The
food L. paracasei strain did not contain any tet genes and expressed
the low TC resistance (0.19mg/ml). Tet(K) gene was more frequently
detected in L. plantarum (16/21 vs 4/23;p< 0.001) strains and more
widely distributed among human isolates as compared to silage & food
strains (15/25 vs. 3/15;p = 0.012). The food L. plantarum strain did not
possess the tet(K) gene but tet(L) and (M) were found resulting in
moderate TC resistance (6mg/ml).
Conclusion: Lactobacillus strains of different origin without phenotypi-
cal resistance may contain genetic determinants, e.g. integrons and tet-res
genes. The comparison of the Lactobacillus food strains with reference,
intestinal and agricultural strains by phenotypic and genotypic antibiotic
resistance methods enables to assess their safety for commercial use.
ESBLs and other b-lactamases – Part 2
P1211 Plasmid-encoded and class 3 integron-associated
extended-spectrum b-lactamase gene blaGES-1 from
Escherichia coli in Switzerland
L. Poirel, T. Bruderer, R. Frei, S. Bernabeu, P. Nordmann (Le Kremlin
Bicetre, FR; Basel, CH)
Objectives: Escherichia coli isolate TB7 showing an extended-spectrum
b-lactamase (ESBL) phenotype was isolated in 1998 from urine of
a Swiss patient who had no recent travel history. That strain was
resistant to most b-lactams, except piperacillin-tazobactam, cephamycins
and carbapenems, with a synergy image between clavulanic acid
and extended-spectrum cephalosporins. In addition, a peculiar synergy
between cefoxitin and cefuroxime was noticed. The aim of the present
study was to identify the ESBL gene and the genetic structures at the
origin of its acquisition.
Methods: Genomic DNA E. coli TB7 was extracted and used for PCR
screening of known ESBL genes. Plasmids were extracted using the
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Kieser technique. Mating-out assays were performed using E. coli J53
as recipient strain and a selection with ceftazidime (30mg/L)- and azide
(100mg/L)-containing media. Class 1 and class 3 integron features were
mapped by PCR using speciﬁc primers.
Results: PCR and sequencing showed that E. coli TB7 expressed the
ESBL GES-1. Mating-out assays remained unsuccessful but electro-
transformation allowed to obtain transformant E. coli (pTB7) harbouring
the blaGES-1 gene on a 12-kb plasmid. E. coli (pTB7) expressed an
ESBL phenotype consistent with GES-1 expression, and was resistant
in addition to amikacin and kanamycin, but susceptible to all other
compounds, including sulfonamides. PCR mapping did not allow
identiﬁcation of class 1 integron features whereas blaGES-1 is usually
associated to those structures. Further screening evidenced class 3
integron features, with the Int3 integrase encoding gene located upstream
of blaGES-1. Downstream of blaGES-1, a repC gene encoding a putative
replicase related to those of broad-host range IncQ plasmids was found.
Conclusion: This study identiﬁed ESBL GES-1 in Switzerland for the
ﬁrst time. This is one of the very few reports of acquisition of antibiotic
resistance gene mediated by a class 3 integron. Noteworthy, the same
blaGES-1-class 3 integron structure association had been evidenced onto
a plasmid from a Klebsiella pneumoniae isolate recovered in 1999 in
Portugal. This ﬁnding strengthens the dissemination of GES-1 enzyme
worldwide, after its identiﬁcation in France, Portugal, Argentina and
Brazil.
P1212 First isolation of GES extended-spectrum b-lactamases in
Enterobactericeae in Belgium
G. Cuzon, P. Bogaerts, T. Naas, C. Bauraing, T. Huang, Y. Glupczynski,
P. Nordmann (Kremlin-Bicetre, FR; Mont-Godinne, Brussels, BE)
Objectives: Extended-spectrum b-lactamase (ESBL) producing En-
terobactericeae strains are increasing worldwide, mainly due to the
emergence of community- and hospital-acquired CTX-M enzymes.
ESBLs of the GES-type (also named IBC) are reported in several Gram-
negative rods, including P. aeruginosa, E. coli, and K. pneumoniae
isolates from Greece, South Africa and Asia. GES-type ESBLs have
the property to extend their spectrum of activity against carbapenems
by single point mutations. Here, we describe the emergence of GES-
6-producing Citrobacter freundii and Enterobacter cloacae strains in
Belgium.
Methods: Clinical isolates were identiﬁed using standard microbiolog-
ical techniques and resistance proﬁle was determined by disc diffusion
methods. ESBL genes were sought by PCR and genetic structures
surrounding the blaGES-type gene were characterised by cloning, PCR
and sequencing. The strains were analysed by plasmid extraction,
conjugation and electroporation assays.
Results: In May 2007, a single C. freundii and a single E. cloacae
isolate were recovered respectively from urine and stool specimens
of two children hospitalised together in the same paediatric ward
at UCL-Saint-Luc hospital, Brussels. The index patient, a 2-year
old girl with a diagnosis of congenital stenosis of the biliary tract
had been transferred from Israel to Belgium for liver transplantation
surgery. Systematic stool screening upon hospital admission revealed
the presence of an ESBL-producing E. cloacae in this patient. The
two strains had a similar resistance pattern, (ceftazidime, amikacin,
cotrimoxazole). A synergy was observed by phenotypic conﬁrmatory
tests using ceftazidime and ceftazidime/clavulanate double discs. PCR-
sequencing revealed the presence of blaGES-6 in both isolates. blaGES-6
was integron-located together with 4 other gene cassettes (aacA4, smr,
dhfrI and aadA1). The blaGES gene was inserted onto a conjugative
plasmid of 120-kb present in both strains, suggesting in vivo horizontal
transfer. The transconjugants displayed an ESBL phenotype but spares
C4 cephalosporinases and carbapenems.
Conclusion: This work illustrates the importance of international
transfer in the spread of GES-type-producing Enterobacterial strains and
suggests that selection of point mutant derivatives of GES-type enzymes,
extending their spectrum towards carbapenem is to fear in the next future.
P1213 Molecular characterisation of PER-1 extended-spectrum
b-lactamase producing Pseudomonas aeruginosa clinical
isolates from Romania
M. Straut, S. Cretoiu, C. Dragulescu, B. Lixandru, A.M. Petrescu,
M. Surdeanu (Bucharest, RO)
Objectives: The presence of PER-1-producing P. aeruginosa isolates in
Romania has been already described since 2005. The aim of the present
study was to characterise the genetic structures associated with the bla
genes harboured by these strains and to establish any clonal relationships
between the isolates.
Methods: Analytical isoelectric focusing was used for preliminary
characterisation of the b-lactamases expressed by the isolates included
in this study. PCR using blaPER-1, blaOXA-2, and blaOXA-10 speciﬁc
primers, followed by DNA sequencing, was performed in order to
identify b-lactamase genes present in P. aeruginosa isolates. The
occurrence of class1 integrons and Tn1213 transposon was assessed
by PCR. Amplicons were further analysed by RFLP (restriction
fragment length polymorphism) technique using several combinations
of restriction endonucleases. Clonal relationships of PER-1 producing
isolates were established by pulsed-ﬁeld gel electrophoresis (PFGE)
analysis of macrorestriction patterns of genomic DNA.
Results: Seventy-four out of 94 ceftazidime resistant clinical isolates
examined were PCR-positive for blaPER-1. In all of the studied
isolates the blaPER-1 gene was located within a composite transposon
Tn1213, bracketed by two different insertion sequences, ISPa12 and
ISPa13 (Poirel et al, 2005, Antimicrob. Agents Chemother.: 1708–1713).
Additionally, PCR experiments revealed the presence of a pair of class
1 integrons of 3350 bp and 3900 bp among the majority of isolates. The
3350 bp class 1 integron harboured blaOXA-74 gene in the ﬁrst gene
cassette position and the aminoglycoside resistance gene aacA4 in the
second place. The blaOXA-2 gene is located within the variable region
of the 3900bp integron. The PER-1 producing isolates, originating from
nine Bucharest hospitals, clustered into four PFGE types with a high
degree of similarity.
Conclusions: PER-1 appears to have a signiﬁcant presence among
the clinical isolates from Bucharest hospitals. PER-1 expression was
inferred to be the major source of oxyimino-b-lactam resistance in
the examined isolates although they also produced other b-lactamases.
Along with some recent reports from other European countries, this
work illustrates the ongoing dissemination of organisms with PER-type
extended-spectrum b-lactamase.
P1214 Molecular diversity of VEB-1 extended-spectrum
b-lactamase-producing Pseudomonas aeruginosa in
Bulgarian hospitals
E. Dobreva, I. Ivanov, R. Vatcheva-Dobrevska, T. Velinov,
T. Kantardjiev (Soﬁa, BG)
Objectives: Pseudomonas aeruginosa causes 10–15% of the nosocomial
infections in the world and in the recent years it constitutes for more
than 35% of the hospital acquired infections in Bulgaria. The emergence
of a large number of VEB-1 ESBL-producing strains raised the need for
their molecular characterisation.
Methods: During the years 2000–2007, we examined a total of 111
ceftazidime resistant P. aeruginosa from more than 25 hospitals across
the country. Identiﬁcation of the strains and their antibiotic susceptibility
were determined by Mini API (BioMerieux, France) and the disc-
diffusion method. Speciﬁc PCR was carried out for detection of the
blaVEB-1 gene. A high resolution multilocus variable number of tandem
repeat analysis (MLVA6) modiﬁed from a previously reported scheme
(Onteniente et al.) was applied for studying the molecular diversity
among the isolates.
Results: The presence of the chromosomal gene blaVEB-1 was detected
in 73% (81/111) of the isolates. The modiﬁed MLVA6 scheme proved
highly discriminatory generating a total of 18 genotypes. More than 35%
of the isolates were grouped within a single cluster that was prevalent
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in the larger city and university hospitals. The other 17 genotypes were
presented with a smaller number of isolates (up to six) and often with
local distribution.
Conclusions: VEB-1 ESBL-producing P. aeruginosa are widespread in
Asia but in Europe are reported only in France. Several recent studies
highlight their importance among the Bulgarian hospitals and this is
the ﬁrst one to investigate the molecular diversity within a large and
representative strain collection. The modiﬁed MLVA6 typing scheme
accurately discriminated both closely related and unrelated isolates from
the same hospital. The provided data suggest that a single cluster is
largely distributed among the Bulgarian hospitals.
P1215 Characterisation of an outbreak of nosocomial infection
caused by a multiresistant Acinetobacter baumannii
producing OXA-30 type-b-lactamase
M. Biendo, B. Canarelli, C. Adjide, D. Thomas, S. Castelain,
F. Rousseau, F. Hamdad, F. Eb (Amiens, FR)
Objectives: 1. Analysis of the molecular mechanisms involved in
the b-lactam resistance of multidrug-resistant A. baumannii isolates;
2. the phenotypically and genotypically comparison of clinical and
environmental outbreak strains to those obtained before the outbreak.
Methods and Results: Forty multiresistant-drug A. baumannii
(MDRAB) isolates were consisted of: 8 preoutbreak isolates, 27 clinical
and 5 environmental outbreak isolates. Thirty-ﬁve clinical isolates were
recovered from twenty-six patients admitted to different wards belonging
to Amiens University Hospital (AUH), France. MDRAB outbreak strains
were observed in the orthopaedic and plastic surgery wards.
The A. baumannii isolates were resistant to all of b-lactams tested (MICs,
48−>256 ug/mL) except imipenem (MIC< 4 ug/mL), to aminoglyco-
sides (MICs, 24−>256 ug/mL), and to ciproﬂoxacin (MIC> 256 ug/mL).
All isolates remained susceptible to colistin (MIC< 2 ug/mL).
The frequency of intl1 gene carriage was 96.8% and 37.8% in the
outbreak and preoutbreak isolates respectively.
By using isoelectric focusing, three b-lactamases were detected:
one produced a band with a pI> 8.0, probably corresponding to a
chromosomal AmpC cephalosporinase, the second focused at pI 5.4 and
was consistent to TEM-1, the third focused at pI 7.3 and corresponded
to OXA-30 type.
blaOXA-30 analysis revealed 3 gene cassettes: intl1 gene with 459-
bp coding for an integrase; aacA4 gene with 759-bp encoding a 6′-
N-aminoglycoside acetyl transferase and blaOXA-30 gene with 852-bp
coding for OXA-30 b-lactamase, with ATG as initiation codon and TAA
as termination codon. The deduced amino acid sequence showed an
enzyme of 276 amino acids long with Ser-Thr-Phe-Lys at positions
71 to 74, Tyr-Gly-Asn at positions 144 to 146, and Lys-Thr-Gly at
positions 215 to 217. blaOXA-30 differed from blaOXA-1 by one base
at codon (AGA 131-GGA) resulting in amino acid substitution Arg128-
Gly. Pulsed Field Gel Electrophoresis with ApaI showed a single pattern
(A) in outbreak and environmental isolates, and 6 unrelated genotypes
(B-G) in preoutbreak isolates.
Conclusion: The present work is the ﬁrst report of A. baumannii clinical
isolates in France that produce an OXA-30 b-lactamase.
P1216 The ﬁrst detection of OXA-35 b-lactamase in Pseudomonas
aeruginosa clinical isolates in Poland and identiﬁcation of
OXA-118, a new extended-spectrum variant of OXA-10
b-lactamase
A.E. Laudy, P. Podbielski, D. Dzierzanowska, S. Tyski, J. Patzer
(Warsaw, PL)
Objectives: The OXA-type enzymes are frequently observed in clinical
isolates of P. aeruginosa. Most of the OXA-type ESBLs are OXA-10
derivatives. Four of these ESBLs (OXA-13, OXA-13−1, OXA-19 and
OXA-28) and OXA-35 (restricted-spectrum b-lactamase) differ in one
or two amino acids substitutions. Moreover, the structures of class 1
integrons carrying blaOXA-13, blaOXA-13−1, blaOXA-19, blaOXA-
28 and blaOXA-35 genes are very similar. Probably OXA-35 is the
progenitor of OXA-13-like ESBLs.
The aim of the study was to identify strains producing OXA-10-like
ESBLs, among P. aeruginosa isolated in two Warsaw’s hospitals.
Methods: P. aeruginosa strains (n = 30) were isolated from various
clinical specimens obtained from patients in A and B Warsaw’s hospitals.
The presence of ESBLs was detected by a double-discs synergy test.
MICs values of antibiotics were determined by agar dilution methods,
according to CLSI recommendation. The presence of class 1 integron
and genes coding OXA-10-like enzymes was detected by PCR. Gene
cassettes were identiﬁed by sequencing the obtained amplicons.
Results: The production of ESBLs by 40 P. aeruginosa strains was
expected in case of resistance to broad-spectrum cephalosporins or
aztreonam. Seven of these isolates were found to contain OXA-10-
like enzymes located in a class 1 integrons. In 6 P. aeruginosa isolates
from hospital A the identical structure of integron was identiﬁed. This
integron contained aac(6′)-Ib and blaOXA-35 genes. The 6 isolates
carrying this integron were resistant to cefepime but 5 of them were
also resistant to aztreonam and cefotaxime. Among strains from hospital
B only in one P. aeruginosa isolate, gene coding OXA-10-like enzyme
was detected. This gene encoded the new extended-spectrum variant
of OXA-10 b-lactamase (named OXA-118). Sequencing showed that
OXA-118 was identical to OXA-10 except two amino acids. The clinical
isolate producing OXA-118 exhibited the inhibitor-sensitive phenotype
(between imipenem and ceftazidime as well as cefepime).
Conclusion: OXA-35 b-lactamase producing P. aeruginosa strains were
identiﬁed for the ﬁrst time in Poland. The presence of blaOXA-35
gene, within integron in 6 clinical isolates suggests the possibility to
create new OXA-13-like ESBLs in Polish hospitals. Moreover, the new
extended-spectrum b-lactamase OXA-118, variant of OXA-10, encoded
by integron-located gene was identiﬁed in P. aeruginosa clinical isolate.
P1217 Characterisation of a naturally-occurring oxacillinase from
Achromobacter xylosoxidans
Y. Doi, L. Poirel, D. Paterson, P. Nordmann (Le K. Bicetre, FR;
Brisbane, AU)
Objectives: Achromobacter xylosoxidans (previously Alcaligenes xy-
losoxidans) is a Gram-negative, glucose-non-fermenting organism that
is increasingly recognised as a nosocomial pathogen. It is reported
as variably resistant to b-lactam antibiotics. The aim of the present
study was to identify the naturally-occurring b-lactamase gene of
A. xylosoxidans.
Methods: A. xylosoxidans CIP69598 was used for cloning. Genomic
DNA was partially digested with Sau3AI and ligated into pBK-CMV
followed by electro-transformation in E. coli TOP10. Selection of
recombinant E. coli strains was made on ticarcillin and kanamycin-
containing plates. Detection of bla(OXA-114a)-like genes in clinical
strains of A. xylosoxidans was performed by PCR. Puriﬁcation of
OXA-114a was performed by ion-exchange chromatography. Kinetic
parameters of OXA-114a were determined by UV spectrophotometry.
Inducibility of b-lactamase production was tested using imipenem and
cefoxitin as inducers
Results: A recombinant strain E. coli TOP10 (p6S3) was obtained that
was resistant to amoxicillin and piperacillin, a phenotype not antagonised
by clavulanic acid or tazobactam addition. Plasmid p6S3 possessed a
1,176-bp insert comprising a novel oxacillinase gene encoding OXA-
114a. Conserved motifs of serine b-lactamase as well as those speciﬁc of
oxacillinases were identiﬁed. The highest amino acid identity (56%) was
observed with a putative oxacillinase of Burkholderia cepacia. Kinetic
parameters indicated robust hydrolysis of piperacillin and cephalothin,
and to a lesser extent, ticarcillin. No hydrolysis of oxacillin or third-
generation cephalosporins was observed. Hydrolysis of imipenem was
noticed, but did not correlate with the susceptibility of the source strain.
Four other OXA-114-like sequences (OXA-114b to OXA-114e) with
no more than four amino acids difference between each other, were
S340 18th ECCMID, Posters
identiﬁed from the four clinical strains. No induction of OXA-114-like
enzymes was detected in clinical isolates.
Conclusion: This study identiﬁed a naturally-occurring b-lactamase
of A. xylosoxidans. It is likely that the contribution of OXA-114-like
enzymes in the ﬁnal b-lactam resistance proﬁle of most A. xylosoxidans
strains may be secondary given its rather narrow spectrum of activity.
This description further strengthens that numerous Gram-negative
aerobes harbour oxacillinase genes in their chromosome.
P1218 Spread of diverse AmpC-type-b-lactamase-producing
E. coli in Madrid, Spain: epidemiology and molecular
characterisation
J. Oteo, E. Cercenado, V. Bautista, A. Delgado-Iribarren, B. Orden,
J. Campos (Majadahonda, Madrid, ES)
Objectives: Little is known about E. coli non-susceptible to 3rd
generation cephalosporins but non ESBL-non-producers. The resistance
mechanisms and the molecular epidemiology of E. coli isolates with
antibiotic resistance proﬁle compatible with AmpC-mediated resistance
were studied.
Methods: From January-2006 to December-2007 2,349 E. coli isolates
(only one isolate by patient) non-susceptible to 3rd generation
cephalosporins were collected by 2 hospitals and 1 community healthcare
centre in Madrid, Spain. Antimicrobial susceptibility testing and ESBL
detection was performed following CLSI guidelines. All isolates
resistant to cefoxitin, amoxicillin–clavulanic acid, and the 3rd generation
cephalosporins with no clavulanic acid synergistic effect were subjected
to: a) molecular characterisation of resistance mechanisms by PCR and
sequenciation; b) Molecular epidemiology by PFGE after XbaI digestion.
Results: A total of 143 (6.1%) isolates accomplishing the selection
criteria; 48 (33.5%) were plasmid mediated AmpC (pAmpC) (45
CMY-2, 2 DHA-1, 1 CMY-4) and 112 (78.3%) were chromosomal
AmpC hyperproducers (hAmpC). Seventeen isolates (11.9%) had both
mechanisms of resistance pAmpC and hAmpC. In addition, 15 isolates
(2 pAmpC and 13 hAmpC) were also ESBL producers, 10 CTX-M-15, 3
CTX-M-14 and 2 CTX-M-9. Mutations in the promoter of chromosomal
ampC gene included 2 main proﬁles: a) −88, −82, −42, −18, −1, +58;
detected in 77 (68.7%) isolates; and b) at least 3 of the following: −73,
−32, −28, +82; detected in 22 (19.6%). By PFGE, only small clusters
were detected affecting mainly CMY-2 and CTX-M-15 producers.
Conclusions: Emergence of the pAmpC CMY-2 and hAmpC in E. coli
is a relevant problem. In addition, the presence of AmpC production in
an epidemic E. coli CTX-M-15 producer suggests that the association of
both mechanisms of resistance may become an important public health
issue.
P1219 Plasmid-mediated CMY-2 AmpC b-lactamase and
CTX-M-14 extended-spectrum b-lactamase in Proteus
mirabilis clinical isolate
S. Simo˜es, L. Lito, J. Melo-Cristino, M. Salgado, A. Duarte (Lisbon, PT)
Objectives: Proteus mirabilis is considered one of the most b-lactam
susceptible members of the Enterobacteriaceae. Although extended-
spectrum b-lactamases (ESBLs) have recently been identiﬁed, there
are few reports of plasmid-mediated AmpC b-lactamase (PCBL)
in P. mirabilis. In general, ESBLs confer resistance to oxyimino-
cephalosporins but not cephamycins and are inhibited by b-lactamase
inhibitors, while PCBLs provide resistance to cephamycins and
oxyimino-cephalosporins and are refractory to b-lactamase inhibitors.
We report the identiﬁcation of ESBL and PCBL enzymes in P. mirabilis
isolate.
Methods: P. mirabilis 10830 isolated from neurological abscess was
collected in Hospital de Santa Maria at Lisboa. Susceptibility to antimi-
crobial agents was determined by disk diffusion test, following CLSI
guidelines. The conjugation assay was performed using Escherichia
coli 802 K as recipient strain. PCR experiments were performed using
speciﬁc primers for ESBL, PCBL, insertion sequences and class 1
integrons. Plasmid extraction was prepared using Kado & Liu method.
Results: The isolate showed resistance to amoxicillin-clavulanate, cefox-
itin, cefpime, cefotaxime; intermediate to ceftazidime and susceptible to
imipenem and ﬂuoroquinolones. It was observed two plasmids in both
P. mirabilis and transconjugant E. coli P10830, which showed the same
susceptibility to b-lactams including cefoxitin.
The double-disk synergy test was observed between clavulanate and
cephalosporins (cefepime and cefotaxime). However, a higher synergic
effect was observed when the cloxacillin was applied to Mueller-Hinton
agar. PCR and sequencing revealed that P. mirabilis 10830 clinical isolate
and the transconjugant E. coli K P10830 harboured CMY-2 AmpC
b-lactamase and CTX-M-14 extended-spectrum b-lactamase; A complex
class 1 integron containing the blaCMY-2 gene; and the blaCTX-M-14
gene was bracketed upstream and downstream by insertion sequences
ISEcp1 and IS903, respectively.
Conclusions: This is the ﬁrst report of a plasmid that carries both
CTX-M-type ESBL and CMY-type PCBL genes. The ﬁnding of the
coexistence of these genes in such a transmissible plasmid that can
propagate in different hosts provides further insight into the mechanisms
of transmission of these b-lactamases in Portugal.
P1220 Expression of blaCMY-14 promoted by insertion sequence
ISEcp1 in P. mirabilis isolates in Greece
I. Galani, M. Souli, Z. Chryssouli, H. Giamarellou (Athens, GR)
Objectives: Proteus mirabilis clinical strains with b-lactam resistance
phenotype consistent with production of an AmpC-type b-lactamase are
isolated with increased frequency in our hospital. The aim of this study
was to identify the mechanism of the high-level expression of blaCMY-
14 and blaCMY-2 genes which are responsible for this phenotype.
Methods: Sixteen nonreplicate P. mirabilis clinical isolates were
analysed. Identiﬁcation and susceptibility testing were carried out
following standard procedures. Molecular typing was performed with
REP-PCR. b-lactamase production was analysed by isoelectric focusing
(IEF). b-lactamase genes were determined by PCR and sequencing. The
ISEcp1 element was detected in the 5′-end of blaCMY genes by PCR.
Sequencing of the resulting amplicons was performed with the same
primers. Sequence similarity searches were carried out with the BLAST
program found at the website of the NCBI.
Results: All isolates were resistant to ampicillin, amoxicillin-clavulanate,
cefotaxime, ceftazidime, cefoxitin and ﬂuoroquinolones; susceptible to
cefepime, aztreonam, piperacillin/tazobactam and carbapenems. Isolates
were obtained during the period Oct 2005 to Feb 2007 from urine
(3), pus (5), sputum (4) or faeces (colonisers) (4) from inpatients in
ICU (7), Internal Medicine department (4) and Surgery department
(5). IEF analysis revealed the presence of b-lactamases of pI 5.4 and
>8.4. PCR analysis revealed the presence of CMY- and TEM-type
genes. Sequencing showed the presence of CMY-14 gene in 14 isolates
and of CMY-2 in two isolates. Extensive analysis showed that ISEcp1
was responsible for mobilisation of a transposition unit including itself
and blaCMY-14 or blaCMY-2. All isolates carried the ISEcp1 mobile
element at the same distance upstream of the blaCMY gene and in four
representative isolates the sequences between them were identical. REP-
PCR showed that isolates were grouped in two main clones probably
related to each other.
Conclusions: CMY-14 reported in Poland was found in P. mirabilis
isolates resistant to cefotaxime, ceftazidime and cefoxitin in Greece.
The putative promoter element of ISEcp1 is necessary for the high-
level expression of blaCMY-14 to confer resistance to extended-spectrum
cephalosporins. The present study underscores the spread and evolution
of the AmpC-producing P. mirabilis in our country.
P1221 Prevalence of plasmid mediated AmpC b-lactamases in
non-typhi salmonella from Ireland
D. Morris, F. Boyle, J. O’Connor, G. Devane, N. DeLappe,
G. Corbett-Feeney, M. Cormican (Galway, IE)
Objectives: The genes encoding AmpC b-lactamases occur naturally
on the chromosome of several members of the Enterobactericeae with
ESBLs and other b-lactamases – Part 2 S341
the exception of Klebsiella spp., Salmonella spp. and Proteus mirabilis.
Since the 1980s the occurrence of plasmid mediated AmpC b-lactamases
has been reported with increasing frequency. The aim of this study was
to determine the presence of plasmid mediated AmpC b-lactamases in
non-Typhi Salmonella from Ireland.
Methods: The National Salmonella Reference Laboratory (NSRL)
of Ireland screens isolates received for susceptibility to a panel of
antimicrobial agents including ampicillin, ceftazidime, cefotaxime, and
cefpodoxime, in accordance with CLSI disk diffusion methods. Isolates
with reduced susceptibility to the expanded spectrum cephalosporins
are further screened for susceptibility to cefoxitin and meropenem and
ESBL production is conﬁrmed by the CLSI combination disk method
using cefpodoxime and cefpodoxime/clavulanate. Isolates resistant to
cefoxitin and cefpodoxime/clavulanate were considered suspect AmpC
b-lactamase producers. Antimicrobial susceptibility test data for 8216
isolates received between January 1st 2000 and October 31st 2007
was reviewed for suspect AmpC b-lactamase production. Screen
positive isolates were examined for the presence of genes encoding 6
phylogenetic groups of plasmid-mediated AmpC b-lactamases using a
multiplex PCR assay (Pe´rez-Pe´rez & Hanson. J Clin Microbiol 2002, 40:
2153–62). The full coding region of the genes identiﬁed were sequenced
using speciﬁc primers.
Results: Seven isolates were identiﬁed as suspect AmpC producers
by the screen criteria applied. PCR and sequencing of the full genes
conﬁrmed the presence of blaCMY-2 in 3 isolates (2 human isolates of
S. Typhimurium isolated in 2007 and 1 human isolate of S. Virchow
isolated in 2006) and blaACC-1 in a single isolate of S. Bareilly isolated
from seawater in 2000.
Conclusions: This is the ﬁrst report of plasmid mediated AmpC
b-lactamases in non-Typhi Salmonella from Ireland.
P1222 Expression analysis of the native ampC gene in Norwegian
clinical isolates of Escherichia coli with deﬁned ampC
promoter mutations and an AmpC-resistance proﬁle
B. Aasnæs, B. Haldorsen, K. Hegstad Dahl, G. Skov Simonsen,
A. Sundsfjord, E. Lundblad (Tromsø, NO)
Objective: The objective was to examine native ampC mRNA levels
by quantitative RT-PCR (qRT-PCR) in Norwegian clinical isolates of
Escherichia coli with deﬁned ampC promoter-attenuator mutations and
relate those to minimum inhibition concentrations (MICs) of cefoxitin,
third generation cephalosporins, piperacillin-tazobactam, and aztreonam.
Methods: The Norwegian Reference Centre for Detection of Antimi-
crobial Resistance (K-res) received 106 clinical isolates of E. coli from
different Norwegian laboratories with reduced susceptibility to third-
generation cephalosporins without clavulanic acid synergy, from 2003
to 2005. Of these, twelve were non-plasmid mediated blaampC strains,
with deﬁned ampC promoter and attenuator alterations compared to the
E. coli wild-type ampC promoter-attenuator. Expression of the native
ampC gene was examined by qRT-PCR. ampC mRNA levels, normalised
to the expression of the reference gene gapA, were compared to those
in six cefoxitin-susceptible isolates of E. coli, including ATCC 25922.
MICs were determined by Etest.
Results: The 12 isolates showed a 27 to 380-fold increase in ampC
mRNA levels compared to the ampC mRNA level in E. coli ATCC
25922. The ampC mRNA levels varied within the different promoter-
attenuator mutation groups. A single strain had an ISEc10 element
inserted between the −35 and −10 boxes, providing an almost perfect
E. coli −35 box 17 bp upstream of the endogenous −10 box. This
isolate showed a 54-fold increase in ampC mRNA level. The ampC
mRNA levels in the ﬁve cefoxitin-susceptible clinical isolates of E. coli
varied from 0.7 to 2.2 fold, suggesting that the mutations observed in
these isolates have no or minor effect on transcription of the ampC
gene. For the isolates with reduced susceptibility to third-generation
cephalosporins we did not observe any signiﬁcant correlation between
ampC mRNA levels and MICs of FOX, CPD, CTX, CAZ, TZP, and
ATM.
Conclusions: (i) Clinical isolates of E. coli with deﬁned ampC promoter-
attenuator alterations overexpressed ampC 27–380-fold compared to
E. coli ATCC 25922. (ii) We did not ﬁnd any signiﬁcant correlation
between ampC mRNA levels and MICs of cefoxitin, third generation
cephalosporins, aztreonam and piperacillin-tazobactam.
P1223 Wide occurrence of plasmid-mediated AmpC b-lactamase-
producing Escherichia coli, Klebsiella spp., Proteus
mirabilis, and Salmonella spp. isolates in Korea: results of
a multicentre survey in 2007
W. Song, J.S. Kim, H. Lee, S.H. Jeong, Y. Uh, S.G. Hong, K. Lee,
G.J. Woo (Seoul, Goyang, Busan, Wonju, Seongnam, KR)
Objectives: Plasmid-mediated AmpC b-lactamases (PABLs) are
cephalosporinases that confer resistance to a wide variety of b-lactam
drugs and that may thereby create serious therapeutic problems. The
PABL-producing organisms are a major concern in nosocomial infections
and should therefore be monitored in surveillance studies. The present
study was conducted to determine the epidemiology and genotypic
distributions of PABL-producing isolates in Korea.
Methods: During the period of May to August 2007, a total of 1,350
consecutive and nonrepeat isolates of Escherichia coli, Klebsiella spp.,
Proteus mirabilis, and Salmonella spp. were collected at 12 hospitals
in Korea. The 248 (18.4%) cefoxitin non-susceptible isolates tested
for multiplex AmpC PCR and DNA sequencing. The PABL-positive
isolates were further investigated for antimicrobial susceptibility by
broth microdilution methodology and extended-spectrum b-lactamases
(ESBLs) by boronic acid disk tests.
Results: PABL producers were found at all the 12 sites in Korea. PABLs
were found in 15/577 E. coli (2.6%; 9 of DHA-like, 5 of CMY-like,
and 1 of ACT-1-like); 152/544 K. pneumoniae (27.9%; 149 of DHA-
like, 1 of CMY-like, and 2 of ACT-1-like); 6/65 K. oxytoca (9.2%; 6
of DHA-like); 3/104 P. mirabilis (2.9%; 1 of DHA-like and 2 of CMY-
like); and 1/60 Salmonella spp. (1.7%; 1 of CMY-like) isolates. One
hundred and four of the 152 PABL-producing K. pneumoniae isolates
(68.4%) coproduced ESBLs. Susceptibilities of the PABL-producing
K. pneumoniae were as follows: ceftazidime, 3%; cefotaxime, 26%;
aztreonam, 26%; cefepime, 79%; imipenem, 99%; gentamicin, 12%;
amikacin, 14%; and ciproﬂoxacin, 11%.
Conclusion: PABL producers were found to be widespread in Korea.
A DHA type is the most prevalent enzyme and the DHA-producing
K. pneumoniae isolates have rapidly increased in Korea. Each of the
PABLs is associated with multidrug resistance. Clinical laboratories
should be able to detect PABLs to ensure optimal patient care and
infection control.
P1224 The association of several amino acid substitutions in the
extended-spectrum AmpC b-lactamases from Escherichia
coli decreases its overall enzymatic activity
S. Le Turnier, F. Eb, P. Nordmann, H. Mammeri (Amiens, Le
K.-Bicetre, FR)
Objectives: class C b-lactamases (AmpC) weakly hydrolyse extended-
spectrum cephalosporins (ESCs) and carbapenems. Recently, a novel
mechanism of resistance, the extended-spectrum AmpC b-lactamases
(ESACs), have emerged among enterobacterial clinical isolates. These
variants exhibited increased catalytic efﬁciencies toward ESCs, leading
to enhanced MICs of ESCs. The structural modiﬁcations responsible
for the broadened hydrolysis-spectrum, mainly amino acid substitutions,
occurred in secondary structures surrounding the binding site: the helix
H-9, the helix H-10, the helix H-11, the R2 loop, and the Omega loop.
The aim of this study was to evaluate if the combination of several
amino acid replacements in ESACs could further enlarge the hydrolysis
spectrum of these b-lactamases.
Methods: Site directed mutagenesis was applied to the ampC EC2 gene
that encoded a wild-type cephalosporinase of E. coli. The resistance
patterns of variants presenting a single substitution at position 219
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(Omega loop), 246 (helix H-11), 287 (helix H-9), and 298 (R2
loop) were compared to those of four variants with the following
double substitutions: E219K+S287N; S287N+N346I; S287N+E219K;
and V298L+N346I.
Results: The single variants S287N and V298L conferred the highest
level of resistance towards ESCs, such as ceftazidime and cefepime,
whereas the MICs for the single variants E219K and N346I were only
slightly modiﬁed. All the double variants displayed decreased MICs of
ESCs as compared to those of the single variants S287N or V298L. In
addition, the MICs of imipenem remained unchanged for all variants as
compared to the wild-type E. coli reference strain.
Conclusion: Double substitution at critical positions in AmpC
b-lactamase of E. coli do not provide enhanced spectrum of hydrolysis.
P1225 Presence and epidemiology of the IRT b-lactamases in
contemporary Escherichia coli isolates in a hospital in
Madrid, Spain
O. Martin S. de la Maza, M.I. Morosini, A. Valverde, R. del Campo,
R. Canto´n (Madrid, ES)
Objectives: Recent data of inhibitor resistant TEM (IRT) b-lactamases
are scarce. We determined the presence and epidemiology of IRT
b-lactamases in contemporary E. coli isolates with reduced susceptibility
to amoxicillin/clavulanate (AMC) recovered in our hospital.
Methods: E. coli isolates with reduced susceptibility to AMC (MIC
16/8mg/L) (WIDER System, Fco. Soria Melguizo, Spain) were
prospectively collected in our hospital between September-2006 and
March-2007. Two additional susceptibility tests, MIC-agar dilution
(AMC ﬁxed 2:1 ratio and 4mg/L-ﬁxed clavulanate concentration) and
disc-diffusion were performed. b-lactam susceptibility phenotypes were
further analysed and IRTs were characterised by isoelectric focusing,
PCR and sequencing. Their population structure (XbaI-PFGE) was also
determined.
Results: 152 out of 3,556 (4.3%) E. coli isolates (40.2% recovered from
hospitalised and 59.8% from outpatients) had reduced susceptibility to
AMC (36.2% resistant and 63.8% intermediate, CLSI-2007). Sources of
isolation were: urine (73.7%), blood (9.8%), wounds (5.3%), respiratory
secretions (4.6%), and others (6.6%). Analysis of the b-lactam-
resistance proﬁles of 99 randomly selected isolates revealed that reduced
susceptibility to AMC could be ascribed to penicillinase (TEM-1)
hyperproduction (60.6%), extended-spectrum b-lactamase synthesis
(15.2%), IRT synthesis (12.1%) or constitutive AmpC overproduction
(12.1%). Conﬁrmed IRT-producing E. coli isolates (n = 32) were mostly
from urine (66.6%). Five (41.7%) isolates were from hospitalised
and 7 (58.3%) from outpatients. No signiﬁcant discrepancies were
obtained between the different susceptibility testing methods, although
IRT phenotype was better detected with 4mg/L ﬁxed clavulanate
concentration. Molecular characterisation of bla genes revealed that the
IRTs were: 4, TEM-30/IRT-2 (pI 5.2); 2, TEM-32/IRT-3 (pI 5.4); 2,
TEM-37/IRT-8 (pI 5.2); 1 TEM-33/IRT-5 (pI 5.4); 1 TEM-36/IRT-7 (pI
5.2); 1 TEM-34/IRT-6 (pI 5.4), and 1, TEM-54 (pI 5.4). IRT-E. coli had
unrelated PFGE patterns.
Conclusion: The IRT-producing E. coli isolates recovered in our
hospital over a 7-month period, most from outpatients with urinary-tract
infections, represent 12.1% of isolates exhibiting reduced susceptibility
to AMC. Interestingly, 7 different IRTs were present in non-related
isolates suggesting an independent emergence of these TEM variants
mainly attributable to antibiotic selective pressure.
P1226 Molecular epidemiology and mechanisms of b-lactam
resistance in Klebsiella pneumoniae isolates with reduced
susceptibility to amoxicillin-clavulanate from a chronic-care
hospital
M.O. Pe´rez-Moreno, M. Cortell, M.J. Centelles, M.I. Llovet, J. Ruiz,
A.M. Jardı´, M.P. Cid (Tortosa, Barcelona, ES)
Objective: A high rate of decreased susceptibility to amoxicillin-
clavulanate (A/C) was noticed amid K. pneumoniae isolates from a
chronic-care hospital. The aim of this study was to investigate their
molecular epidemiology and the mechanisms involved in b-lactam
resistance.
Methods: 94 nonrepetitive K. pneumoniae isolates recovered between
January 2006 and November 2007 from patients admitted to the
above institution were included in the study. Susceptibility testing was
achieved by microdilution or disk diffusion. The presence of integrons
and of oxa-1, tem-1 like, shv-1 like, pse-1 (b-lactam resistance) and
aac(6′)-1b (aminoglycoside resistance) genes was investigated by PCR.
Epidemiological relatedness among isolates with reduced susceptibility
to A/C was studied by REP-PCR.
Results: (a) 46.7% (29/62) and 18.8% (6/32) of isolates collected during
2006 and 2007 were intermediate-resistant to A/C – MIC 16mg/L.
(b) 94.2% (33/35) of these isolates showed a phenotype consistent with
production of inhibitor-resistant TEM (IRT) or OXA b-lactamases, since
they were fully susceptible to cefazolin; the presence of tem-1 like plus
shv-1-like and of oxa-1 plus shv-1-like was demonstrated in 45.5%
and 54.5% of them. (c) All oxa-1-positive isolates were additionally
resistant to nitrofurantoin, tobramycin (Tob), kanamycin (K), nalidixic
acid, ciproﬂoxacin, chloramphenicol and sulphonamides and harboured
aac(6′)-1b, which confers resistance to Tob and K. No integrons could
be detected – except for a single isolate with an integron of 0.8Kb –
with 5′CS and 3′CS primers, although amplicons of ca. 0.7 and 1.8
Kb were obtained when using 5′CS together with aac(6′)-1b or oxa-1
speciﬁc reverse primers. (d) Four different REP patterns were identiﬁed
in the 26 strains available for genotyping: RA (8 tem-1 positive isolates);
RB (5 tem-1 and 8 oxa-1-positive isolates); RC and RD (four and one
oxa-1-positive isolates).
Conclusions: Our ﬁndings indicate that the high prevalence of A/C-
resistance among K. pneumoniae isolates resulted from the spread of
three different epidemic clones and was mediated by the production of
two kinds of penicillinases poorly inhibited by clavulanate (i.e. OXA-1
and inhibitor resistant enzymes, likely of IRT type), a fact that could be
related to the elevated consumption of A/C in the centre. Interestingly,
the present results suggest that oxa-1 might be associated with aac(6′)-
1b, and perhaps other resistance genes, within a class 1 integron.
P1227 Differentiation between BRO-1 and BRO-2 b-lactamases in
clinical isolates of Moraxella catarrhalis collected 2002–2003
L.R. Cossins, J. Blackman Northwood, M.A. Khan, J.P. Hays,
D.J. Farrell (London, UK; Rotterdam, NL)
Objectives: To determine the presence and incidence of the bro1 and
bro2 b-lactamase genes in clinical isolates of Moraxella catarrhalis
collected in the winter of 2002–2003.
Methods: A novel PCR RFLP method was developed and used to screen
1,449 isolates of M. catarrhalis for the presence of either the bro1
or bro2 genes. This was achieved by initially developing primers that
hybridised to conserved promoter sequence regions upstream of both
genes (BROF – 5′-TRGTGAAGTGATTTTKRRMTTG-3′ BROR – 5′-
GCAATTTATTAACTGGATGTA-3′), yielding PCR products differing in
size by 21bp (bro1 = 165bp and bro2 = 144bp).
After PCR thermocycling, the resultant amplicon was digested using the
restriction enzyme tsp509i, yielding visible fragments of 55bp and 91bp
and 91bp alone for bro1 and bro2, respectively. The PCR RFLP products
were visualised on a 3.5% agarose gel. During the analysis, sequencing
was performed on 2 PCR products from isolates that showed anomalies
in their PCR ampliﬁcation products.
Results: Of the 1,449 isolates tested 1,314 (91%) were positive for
bro1 and 65 (4.2%) positive for bro2. Seventy (70) isolates (4.8%) were
negative for both genes. A single bro1 isolate had a single nucleotide
polymorphism (SNP) at position T30C of the promoter region yielding
a PCR RFLP product of 146bp, whilst a second bro1 isolate yielded 3
visible bands of 31bp, 91bp and approximately 150bp.
Conclusions: Consistent with published data, bro1 was found to be
the most common b-lactamase type present within our global, clinical
M. catarrhalis isolates at an incidence of 91%. Also consistent with
published data, 5% of our isolates possessed the bro2 gene. Only 1
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isolate was identiﬁed that possessed nucleotide polymorphisms for the
restriction enzyme used, mirroring the low frequency of mutation within
the promoter regions of bro1 genes. It was found that a PCR RFLP
methodology yielded more accurate results regarding the identiﬁcation
of bro1 and bro2 over PCR alone.
Quinolone and ﬂuoroquinolone
resistance – Part 1
P1228 Topoisomerase alterations and ciproﬂoxacin resistance in
clinical isolates of Klebsiella pneumoniae
S. Aathithan, G. French (London, UK)
Objectives: To determine the frequency and distribution of amino acid
alterations in the quinolone binding region (QBR) of GyrA and ParC
and the effect of these changes in ciproﬂoxacin susceptibility amongst 78
clinical isolates of Klebsiella pneumoniae showing ciproﬂoxacin reduced
susceptibility or resistance.
Methods: Sequencing of PCR derived amplicons from a 626bp region
of gyrA, and a 388bp region of parC covering the extended quinolone
resistance-determining regions (QRDR).
Results: There were 19 different combinations of topoisomerase variants
amongst the 78 isolates. The most common mutation, in 97% of mutants,
occurred at codon 83 in gyrA, mostly resulting in either S83Y or S83F
substitutions in GyrA. There was a strong correlation (r=0.90, 95%CI
0.84−0.93) between the number of target alterations (particularly in
GyrA) and ciproﬂoxacin MICs. No target alteration was found in the 6
isolates with only small reductions in susceptibility. 70/78 isolates with
greater reduced susceptibility had target alterations: 29 had alterations
in S83, and 1 in D87, of GyrA; 39 of the other 40 had different
combinations of double or triple alterations in GyrA and ParC; one
had S83Y and F147Y alterations in GyrA and ParC, respectively. The
ﬁgure shows the association between topoisomerase gene mutations
and ciproﬂoxacin MICs. In this ﬁgure a circle=isolates with wild-
type sequence in QRDR of both gyrA and parC; triangle=single gyrA
mutation; open square=single gyrA mutation at codon D87; inverted
triangle=gyrA double mutations at S83 and D87; solid square=gyrA
double mutations at S83 and D87 and parC single mutation at S80; solid
circle=S83F and D87N in GyrA and E84K in ParC; solid triangle=one
mutation in each of gyrA and parC. 00:00=wild type for S83 and D87
in GyrA and S80 and E84 in ParC in the QBR; X0:00=change at S83
in GyrA but not in ParC; 0X:00= change at D87 in GyrA but not
in ParC; XX:00=changes at S83 and D87 in GyrA and not in ParC;
XX:X0=changes at S83 and D87 in GyrA and at S80 in ParC; XX:0X=
changes at S83 and D87 in GyrA and at E84 in ParC; X0:X0=changes
at S83 in GyrA and at S80 in ParC.
Conclusion: Mutations in the QRDR of gyrA play a major role in
ciproﬂoxacin resistance in these isolates and the degree of resistance
is related to the number of mutations. Double GyrA alterations alone
can produce highly resistant ciproﬂoxacin phenotypes.
P1229 Prevalence of efﬂux pump activity and its role in
ciproﬂoxacin resistance in clinical isolates of Klebsiella
pneumoniae
S. Aathithan, G. French (London, UK)
Objectives: To determine the prevalence of efﬂux pump activity and its
contribution to ciproﬂoxacin resistance in clinical isolates of Klebsiella
pneumoniae.
Methods: Drug accumulation studies were performed on 26
ciproﬂoxacin susceptible and resistant isolates in early log-phase
using [14C] ciproﬂoxacin with and without the proton motive force
dissipater carbonyl cyanide 3-chlorophenylhydrazone (CCCP). The total
accumulation time studied was 20 minutes; CCCP was added at
10 minutes. The efﬂux index, a measure of efﬂux activity, was the
ratio of the amount of drug accumulated at the 18th minute to the
amount accumulated at the 4th minute. Membrane-associated reduced
inﬂux-mediated resistance (MARIM-R) was calculated by dividing the
difference in drug accumulation at the 10th and the 4th minutes (in the
absence of CCCP) by the amount of drug accumulated at the 4th minute.
Values of >1.5 were signiﬁcant.
Results: (Table). 92% of tested isolates were positive for efﬂux. The
contribution of efﬂux to the removal of cell-bound ciproﬂoxacin ranged
from 50% to 90% of total cell-associated drug. In some highly resistant
isolates efﬂux pump activity extruded 90% of the drug. Efﬂux activity
was present in all isolates with ciproﬂoxacin MICs >1mg/L and
contributed to reduced ciproﬂoxacin susceptibility in isolates that had
no target site alteration. High-level activity usually occurred in isolates
with high ciproﬂoxacin MICs, but these isolates usually had double GyrA
alterations as well. None of the 26 isolates had MARIM-R.
Isolate # CIP MIC
mg/L
Efﬂux
index
Efﬂux mediated reduction in
drug accumulation (%)
1 0.016 1.8 46
2 0.032 2.1 44
3 0.064 5.4 81
4 0.25 1.7 49
5 0.5 1.3 6
6 0.5 5.1 79
7 0.125 1.3 30
8 1 5.4 82
9 1 6.8 86
10 2 4.4 79
11 4 2.3 58
12 4 4.1 76
13 4 4.5 69
14 4 5.2 77
15 8 2.0 55
16 8 7.6 87
17 128 6.8 85
18 128 9.0 89
19 >128 7.7 88
20 16 3.0 67
21 32 10.8 89
22 64 5.8 83
23 64 6.1 82
24 128 3.4 71
25 >128 3.5 72
26 >512 8.4 87
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Conclusion: This study demonstrates that efﬂux activity is very common
in K. pneumoniae and contributes to decreased ciproﬂoxacin suscep-
tibility even in the absence of topoisomerase alterations. MARIM-R
was not detected. Efﬂux activity may play a role in initial selection
of isolates with reduced ciproﬂoxacin susceptibility, which then survive
when ciproﬂoxacin is used. Surviving strains may then accumulate
target site alterations and higher pump activity, leading to increasing
ciproﬂoxacin resistance.
P1230 Mechanisms of ﬂuoroquinolone resistance in Salmonella
enteritidis
E. O’ Regan, T. Quinn, S. Fanning (Dublin, IE)
Objectives: To determine the contribution of target gene mutations and
efﬂux pump activity to nalidixic acid resistance in S. enteritidis ﬁeld
isolates (104 and 5408) and their in-vitro selected ciproﬂoxacin resistant
mutants (104-cip and 5408-cip). The ﬁtness cost associated with high-
level ﬂuoroquinolone resistance was also studied.
Methods: Disk diffusion and MIC testing were performed in the
presence and absence of the efﬂux pump inhibitor Phe-Arg-beta-
Naphthylamide (PABN). Ciproﬂoxacin accumulation was measured
ﬂuorometrically. Expression of the efﬂux transporter acrB, the global
regulators soxS, marA, ramA and rob and the outer membrane porin
ompF were measured by real-time RT-PCR. Invasiveness of ciproﬂoxacin
resistant mutants was assessed in Caco-2 intestinal epithelial cells.
Results: High-level nalidixic acid resistance was associated with an
Asp87Tyr mutation in gyrA. This resistance was partially reversed
by PABN. Acquisition of high-level ciproﬂoxacin resistance resulted
in additional mutations in gyrA, gyrB and parE. Ciproﬂoxacin-
resistant mutants accumulated less ciproﬂoxacin than parent strains and
demonstrated a multi-drug resistant phenotype attributable to enhanced
efﬂux activity. Both mutants showed increased expression of acrB and the
global regulator marA and a differential expression of soxS and ramA.
Increased expression of acrB was not associated with mutations in its
local regulator acrR. A mutation was found in the helix-turn-helix region
of soxR in 104-cip that showed increased soxS expression. No mutations
were found in any of the other global regulators investigated. Mutants
formed smaller colonies and demonstrated slower growth rates than their
parental strains. Mutants were signiﬁcantly less invasive than the parents
in Caco-2 cells. Electron microscopy revealed altered morphology of the
mutants.
Conclusion: Both target mutations and efﬂux pump activity contribute
to quinolone resistance in S. enteritidis. Increased expression of acrB
may result from differential expression of global regulators. High-level
ciproﬂoxacin resistance is associated with a ﬁtness cost.
P1231 Virulence genotypes of Escherichia coli strains of human
and avian origin in relation to ciproﬂoxacin resistance status
M. Cerquetti, C. Graziani, G. Parisi, F. Tomei, A. Fioravanti, M. Corro`,
S. Morabito, I. Luzzi, A. Caprioli (Rome, Legnaro, IT)
Objectives: Previous studies have suggested that human ﬂuoroquinolone
resistant (FQr) Escherichia coli strains probably emerged as a
consequence of ﬂuoroquinolone use in poultry. This study aims to
provide further insight on the possible avian origin of human FQr extra-
intestinal pathogenic E. coli (ExPEC) strains.
Methods: The presence of 12 virulence factor (VF) genes (agg, eae, cldt,
cnf, cvaC, ireA, iroN, iss, iucD, iutA, traT, tsh) commonly associated
with human and/or avian ExPEC isolates was investigated by PCR in
125 E. coli isolates from extra-intestinal infections (61 susceptible and
64 ciproﬂoxacin resistant, respectively) and 113 isolates from chicken
and turkeys (47 susceptible and 66 ciproﬂoxacin resistant, respectively).
Genetic relatedness among 40 human and avian E. coli strains belonging
to the traT-iucD-iutA virulence proﬁle was assessed by PFGE.
Results: Irrespective of ciproﬂoxacin susceptibility, human isolates
showed a signiﬁcantly lower prevalence of cvaC, iroN, iss and tsh genes
and a signiﬁcantly higher prevalence of cnf compared to avian strains.
Stratifying by ciproﬂoxacin susceptibility, susceptible human and avian
isolates differed signiﬁcantly for distribution of cnf, cvaC, iroN, iss,
iucD, iutA and tsh genes, being all, except cnf, more frequent in avian
isolates. Resistant human isolates differed from resistant avian isolates
for distribution of 5 VF genes: iroN, iss, tsh (predominant in avian
strains), iucD and iutA (predominant in human strains). Both human and
avian FQr isolates harboured fewer VF genes than susceptible isolates.
The two major VF proﬁles of the human isolates were traT-iucD-iutA
and iucD-iutA, (65.6% of the resistant and 13.1% of the susceptible
isolates). These two proﬁles were detected in a few resistant avian strains
(traT-iucD-iutA, 9.1% and iucD-iutA, 3%). Conversely the two major
proﬁles of avian strains (traT-cvaC-iucD-iroN-iss-tsh-iutA and traT-iroN-
iss) did not occur among human isolates. By PFGE, an extensive genetic
diversity was observed between the human and avian isolates belonging
to the same traT-iucD-iutA proﬁle.
Conclusion: Our results conﬁrm previous data indicating strong
differences in virulence genotype between ciproﬂoxacin susceptible and
resistant human ExPEC strains. However, the resistant human isolates
were distinct from both susceptible and resistant avian isolates and the
results therefore do not support their avian origin.
P1232 Phylogenetic background of Escherichia coli resistant to
quinolone and ﬂuoroquinolone
A. Bas, E. Moreno-Pujol, M.N. Larrosa, A. Andreu, G. Prats on behalf
of the Spanish Network for the Research in Infectious Diseases REIPI
Objective: To assess how resistance to quinolone (Q) and ﬂuoro-
quinolone (FQ), and production of extended-spectrum b-lactamases
(ESBLs) relates to the phylogenetic background of clinical Escherichia
coli isolates.
Methods: A total of 337 E. coli strains, isolated from clinical samples
were selected. The ﬁrst 222 strains were collected consecutively after
the susceptibility test, which allow selecting 120 strains Q and FQ
susceptible (SS), 36 Q resistant and FQ susceptible (RS) and 66 Q
and FQ resistant (RR). Further strains RS and RR were selected
consecutively, till completed a total of 105 and 112 respectively.
Resistance to nalidixic acid and ciproﬂoxacin was tested by disc
diffusion method according to CLSI and presence of ESBLs by
synergy test between clavulanic acid and third generation cephalosporins.
Phylogenetic group was performed by a triplex PCR.
Results: The prevalence of Q resistance was 45.9% (102/222), FQ 29.7%
(66/222), and 4.6% (11/222) produced ESBLs. Among the total of 337
isolates, the most prevalent phylogenetic group was B2 with 177 strains,
followed by group D with 68, group A with 49 and B1 with 43. E. coli
SS and RS showed a similar distribution among phylogenetic groups
(66.7% and 60.9% in group B2, 15% and 20% in D, 11.7% and 8.6% in
A and 6.7% and 10.5% in B1). However RR strains exhibited a shift to
non-B2 groups: 23.2% derived from group A, 21.4% from B1, 25.9%
from D and 29.5% from B2, (RR vs. RS P< 0.01 in groups A, B1, B2;
RR vs. SS P< 0.01 in groups B1, B2, D). Of the 337 E. coli studied,
20 produced ESBLs: 1 strain SS, 6 RS and 13 RR (P< 0.05 in SS vs.
RS and SS vs. RR). ESBLs producers exhibited a similar distribution
among phylogroups A, B1 and D (8.2, 11.6 and 10.2%); whereas were
quite less prevalent in pathogenic group B2 (2.3%; P< 0.05).
Conclusion: E. coli resistant to Q mainly derived from phylogenetic
group B2, whereas isolates resistant to both Q and FQ exhibited shifts
towards groups A, B1 and/or D. This fact led us to suspect that these
two subgroups represent distinct populations, RS isolates could have
derived predominantly from susceptible E. coli group B2 (possibly within
a human host), whereas RR isolates from susceptible E. coli group
A isolates (possibly within an animal host), both in the context of
drug exposure. The depletion for phylogenetic group B2 among ESBLs
producers suggest a similar phenomenon.
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P1233 Genetic relatedness between ciproﬂoxacin-resistant
Salmonella Kentucky isolated from humans and poultry
meat
B. Bouchrif, M. Timinouni, K. Zerouali, N. Cohen, M. Ennaji,
J.D. Perrier-Gros-Claude, F.X. Weill (Casablanca, Mohammedia,
MA; Paris, FR)
Objectives: To compare Salmonella enterica serotype Kentucky strains
(Salmonella Kentucky) resistant to ciproﬂoxacin isolated in France from
travellers returning from Morocco with those from raw poultry meat
produced in Morocco.
Methods: Salmonella Kentucky strains from poultry meat (n = 3) have
been identiﬁed between December 2006 and June 2007 during a food
safety survey conducted since 2004 in Pasteur Institute from Morocco.
Strains from human origin (n = 3) have been isolated from travelers
returning from Morocco (2006: n = 3; 2007, n = 3), and from a patient
hospitalised in the Ibn Rochd Hospital (Casablanca) in 2006. Nalidix
acid and ciproﬂoxacin MICs were performed by E-Test. To identify
the mechanisms of resistance to ciproﬂoxacin, the quinolone-resistance
determining regions of gyrA and parC were sequenced and the presence
of plasmid-mediated quinolone resistance genes (qnrA-B-S, aac(6′)-
Ib-cr) were tested for all isolates. All isolates were genotyped by
pulsed-ﬁeld gel electrophoresis (PFGE) with XbaI restriction following
PulseNet’s running conditions.
Results: Among the 13 strains, 9 (poultry meat, n = 3; patients, n = 3)
were resistant to nalidixic acid and to ciproﬂoxacin (MIC> 16mg/l,
>1mg/l respectively) and have the same amino-acid substitutions
within gyrA and parC (gyrA: Ser83-Phe, Asp87-Asn; parC: Ser80-Ile).
Within parC, an additional substitution (Thr57-Ser) was observed. This
substitution, however, did not appear to be associated with quinolone
resistance because it was also identiﬁed in nalidixic acid-susceptible
isolates. All strains were negative for plasmid mediated quinolone
resistance genes. Among quinolone-resistant isolates, 2 PFGE patterns
were displayed: the ﬁrst one (P1) was observed in all poultry isolates
and 4 human isolates; the second one (1 traveler isolate) shared 80%
identity with P1. For quinolone-susceptible strains, 3 PFGE patterns were
displayed and shared less than 50% identity with previous PFGE proﬁles.
Conclusions: this study showed clearly the close genetic relatedness
among ciproﬂoxacin-resistant Salmonella Kentucky isolates and iden-
tiﬁed poultry meat as a probable source for human contamination.
Moreover, it can be assumed that an unique ciproﬂoxacin-resistant
Salmonella Kentucky has spread all over different poultry ﬂocks in the
Casablanca’s region.
P1234 Epidemiology of elevated ﬂuoroquinolone MICs of
S. pneumoniae, H. inﬂuenzae, and M. catarrhalis from the
GLOBAL Study (1999–2005)
N. Brown, D. Draghi, D. Sahm, C. Pillar (Herndon, US)
Objective: Isolates (ISO) were collected during 1999, 2002, 2003, and
2005 as part of the GLOBAL study, during which 360 S. pneumoniae
(SP) showed levoﬂoxacin (LFX) MICs 2mg/L by broth microdilution.
Serotyping proﬁles of these SP were determined in this study. Previous
experience has shown that in studies where LFX resistance rates were in
excess of 1% that it was often the result of an outbreak of clonal ISO. To
address the relatedness of SP ISO from 2005 with elevated LFX MICs,
pulsed-ﬁeld gel electrophoresis (PFGE) was performed and related to
QRDR proﬁle and serotype (ST). In addition, 8 ISO of H. inﬂuenza
(HI) and M. catarrhalis (MC) with elevated LFX MICs (0.05mg/L)
were subjected to PFGE analysis to determine relatedness, if any.
Methods: ISO were centrally tested by broth microdilution (CLSI; M7-
A7) and interpreted according to CLSI M100-S16 and M45-P (MC). 84
SP with MICs 2mg/L were STed using standard methodology. ISO of
SP, HI, and MC from 2005 with elevated LFX MICs underwent PFGE.
ISO with 90% similarity in PFGE pattern were considered related.
SP were further characterised by sequencing the quinolone resistance
determining regions (QRDRs) of gyrA, gyrB, parC, and parE.
Results: Among the 360 SP with elevated LFX MICs from 1999–2005,
44 STs were identiﬁed and STs 23F, 14, and 19F were the most common
(>10% each). Among the 2005 SP ISO (N=86), STs 8, 19F, and 23F
were detected at >10%. Of these, there were 5 genetically related groups
detected by PFGE (1 centre in Spain (ES) [n = 3], 2 separate centres in
ES [n = 34], 1 centre in Hong Kong (HK) [n = 3], a separate centre in
HK [n = 3], and 1 centre in Germany (DE) [n = 3]). Similar STs and
QRDR proﬁles were observed within each group. The remaining SP
ISO showed little genetic similarity with a wide distribution of STs.
Little genetic relatedness was observed among ISO of HI and MC with
elevated LFX MICs.
Conclusion: Among the SP from 2005 with elevated MICs to LFX, 5
clusters of genetically related ISO were detected suggesting outbreaks
of certain lineages of this phenotype within centres in ES, DE, and
HK. The remaining SP ISO were of variable ST, PFGE patterns and
QRDR proﬁles. Few HI and MC ISO with elevated LFX MICs were
detected in 2005, and no genetic relatedness was apparent among these
ISO. These results illustrate the importance of utilising both surveillance
and molecular epidemiological studies for monitoring the emergence and
spread of resistance.
P1235 Molecular analysis of ﬂuoroquinolone resistance in
Streptococcus pneumoniae in Turkey
O. Koseoglu Eser, K.P. Klugman, L. McGee and the Turkish
Pneumococcal Study Group
Objectives: Fluoroquinolones(FQs) are recommended drugs for the
treatment of Streptococcus pneumoniae infection which increase the
risk for the development of resistance. FQ resistance occurs primarily
by mutations in quinolone resistance determining regions(QRDRs) of
parC, gyrA, parE and/or gyrB genes. The aim of this study was to
evaluate ﬂuoroquinolone-resistant S. pneumoniae in multicentre isolates
from Turkey to investigate the mechanisms of resistance.
Methods: A total of 288 out of 297 study isolates with MIC1g/L for
Levoﬂoxacin(LEV) were ampliﬁed by PCR for the QRDRs of gyrA, parC
and parE. Restriction fragment length polymorphism (RFLP) by HinfI,
MboII, LweI digestions of PCR products was carried out to identify
mutations known to confer FQ resistance. Isolates with mutations
by PCR-RFLP analyses were conﬁrmed by DNA sequence analysis.
MICs were also determined for penicillin(PEN), ceftriaxone(CRO),
erythromycin(EM) and clindamycin(CD) by broth microdilution using
CLSI methods. Serotyping was performed using sequential multiplex-
PCR and quellung reaction with capsular antisera for S. pneumoniae.
Results: Twenty-four(8.1%)S. pneumoniae strains were levoﬂoxacin
nonsusceptible(MIC 4g/L) and antimicrobial susceptibilities of
these isolates are presented in Table 1. Fifteen different serotypes
were recognised. Eleven strains had mutations in QRDR of parC
(K137N(n = 3) and S79Y, D83N(n = 3)). Eighteen isolates had parE
mutations (I460V(n = 38) and D435N(n = 3)). All isolates with MICs of
4g/L contained no mutations in gyrA, parC or parE that are known to
confer resistance to FQs. Although there were eight isolates with MIC
8 g/L, only three of levoﬂoxacin-resistant isolates analysed possessed
a gyrA mutation (S81F). Two of these strains had additional mutations
in parC(S79Y,D83N) and one strain had the D435N mutation in parE
known to confer resistance. They all had different serotypes belonging
to 34, 23F and 6B.
Table 1. Antimicrobial susceptibilities of 24 FQ-resistant isolates
MIC50 MIC90 Range I (%) R (%)
LEV 4 >8 4−>8 16 (66.7) 8 (33.3)
PEN 0.06 >2 0.06−>2 6 (25.0) 5 (20.8)
CRO 0.25 2 0.25−2 5 (20.8) −
EM 0.25 >8 0.25−>8 − 7 (29.2)
CD 0.25 >8 0.25−>8 − 6 (25.0)
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Conclusion: FQ nonsusceptibility was observed in 8.1% of isolates
in this study. Mutations known to confer resistance to FQs were not
observed in strains with MICs of 4g/L. Three of eight strains showing
higher levels of resistance contained mutations in the QRDRs of gyrA,
parC and parE, however 5 strains were either wild-type or contained
mutations which do not confer resistance. This data suggests that perhaps
other mechanisms of resistance to the FQs are present in these strains
such as efﬂux or mutations outside the QRDR region.
P1236 Interactions between serotype and mutations in quinolone-
resistance determining regions of Streptococcus pneumoniae
R. Melano, A. McGeer, S. Drews, S. Pong-Porter, J. Gubbay, C. Seah,
R. Higgins, G. Tyrrell, K. Green, D.E. Low on behalf of the Canadian
Bacterial Surveillance Network
Background: Mutations in QRDR regions are the primary cause of
ﬂuoroquinolone resistance (FQR) in S. pneumoniae (SPN). It is not
known whether the distribution of mutations and/or the association of
QRDR with increasing MIC is similar in different SPN serotypes (STs).
Methods: The Canadian Bacterial Surveillance Network (CBSN) has
been monitoring trends in antimicrobial resistance in SPN in Canada.
From 1995–2006, 27,951 isolates from across Canada have been
collected. Serotyping and sequencing of the gyrA and parC regions was
performed for all FQR isolates FQ (N=451), and a sample of others
(N=3438).
Results: The most common parC mutations were: K137N (N=870),
S79F (293), S79Y (106), D83N (36), D83Y (17), D83G (9), S52G (6),
N91D (6), R95C (5), Y129S (5), D78N (4), S79A (2), A115P (2). 14
other mutations were identiﬁed once. S79F, S79Y, D83N/Y/G, D78N/A,
and A115P were associated with increased MICs to FQ; other mutations
were not. K137N was present in <5% of isolates of SGs 3, 4, 10, 11,
15, 18, 20, 22, 33, 35, 38, >85% of isolates of SGs 12 and 9, and an
intermediate percentage of other SGs. Among FQR, S79Y is signiﬁcantly
more common in isolates of ST 22F, 6A and 6B, and mutations at
position 83 are more common in ST 9N and 9V (P< 0.01). Of isolates
with parC mutations, those of ST 12F had signiﬁcantly lower MICs to
all FQ than those of other STs. 27% of FQS SPN with a parC mutation
at position 79 were ST 12F, compared to 3% of FQR isolates. The most
common gyrA mutations were S81F (N=179), S81Y (33), E85K (33),
S114G (14), E85G (4). 12 other mutations were identiﬁed once. Only
mutations at position 81 and 85 were associated with increased FQ MICs.
The prevalence of gyrA mutations in the presence of parC mutations
varied signiﬁcantly with ST; eg. 10/12 (83%) 19A and 32/40 (80%)
19F strains with a parC mutation also had a gyrA mutation, compared
to 9/24 (38%) ST 3 and 6/17 (35%) ST 12F (P< 0.001). When isolates
were categorised by whether or not their serotypes were included in 7- or
23-valent pneumococcal vaccines, there were no signiﬁcant differences
in the prevalence of parC mutations. Isolates of STs in the 23-valent
vaccine with a parC mutation were somewhat less likely to have a gyrA
mutation than other isolates (66% vs 55%, P = 0.07).
Conclusion: Mutations in QRDR determining regions occur with dif-
fering frequencies in isolates of different ST. Changing ST distributions
associated with pneumococcal vaccination programs may have an impact
on FQR rates.
P1237 Identiﬁcation of SmrA, a novel efﬂux pump involved in
ﬂuoroquinolone resistance in Streptococcus suis
J.A. Escudero, A. San Milla´n, L. Hidalgo, B. Gutierrez, S. Nieto,
L. Domı´nguez, A.G. De la Campa, B. Gonza´lez-Zorn (Madrid, ES)
Objectives: Streptococcus suis is a world-wide distributed pathogen
with increasing prevalence in humans. It has recently been reported
as the cause of high mortality outbreaks in Southeast Asia among the
population in close contact with infected pigs or contaminated food.
During the last years rising ﬂuoroquinolone resistance among Spanish
isolates collected in our laboratory has been observed. We have recently
described the inﬂuence in this phenotype of mutations in gyrA and parC,
the genes encoding the drug’s targets (Escudero et al. AAC 2007 51:777–
82). Interestingly, the MIC of some strains was reduced in presence of
reserpine pointing to the coexistance of a drug efﬂux phenomenon.
Methods: Strains identiﬁcation was PCR based. MICs were car-
ried out following CLSI guidelines. PFGE was performed using
ApaI endonuclease. Sequencing of PCR products was performed
by Secugen S.L. 4Peaks, CLC workbench, DNA Strider and Phyre
(www.sbg.bio.ic.ac.uk/phyre/) were used for sequence analysis and
protein modeling.
Results: S. suis available genomes were scanned for the presence
of putative efﬂux pumps. A gene encoding a 401 aminoacid protein
sharing 58% homology with PmrA, an efﬂux pump related to
ﬂuoroquinolone resistance in S. pneumoniae, was identiﬁed and named
SmrA (suis multidrug resistance). Protein modeling of SmrA, revealed
12 transmembrane segments and elicited to assign this putative pump to
the Major Facilitator Superfamily (MFS). Complete nucleotide sequence
of smrA including its promoter region was determined from ﬁve
ﬂuoroquinolone susceptible clinical isolates, three high level resistant
and two intermediate level resistant strains. PFGE of all strains revealed
no genetic link between all isolates. Sequencing of these regions
revealed the presence of mutations leading to a critical aminoacid
substitution in position 107 (V/T107A) in all ﬁve resistant clinical
isolates. Furthermore the three high level resistant isolates bore mutations
in the putative −10 box, indicating that, as for other MFS members,
protein structure together with expression levels are involved in SmrA
mediated ﬂuoroquinolone resistance in S. suis.
Conclusion: SmrA is a novel member of the Major Facilitator
Superfamily and plays a role in ﬂuoroquinolone resistance in clinical
S. suis isolates. Acquisition of this efﬂux phenotype seems to be a
stepwise phenomenon involving mutations in the promoter region as
well as in the structural gene of SmrA.
P1238 Epidemiological analysis of ﬂuoroquinolone-resistant group
B streptococci
A. Yoshida, Y. Okamoto, T. Tarukawa, S. Koike, H. Wakimoto, H. Yoshida,
A. Hishinuma, K. Okuzumi (Mibu, Tochigi, Nagakute, Aichi, JP)
Objectives: We reported increasing number of ﬂuoroquinolones (FQ)-
resistant group B streptococci (S. agalactiae; GBS) in Japan since 2000.
FQ-resistant GBS was isolated from neonates and their mothers and
elderly patients with underlying urogenital diseases or hematological
malignancies under long-term administration of FQ. Analysis of the
mechanism of FQ-resistance in addition to epidemiological studies was
performed to reveal whether FQ-resistant GBS was genetically related.
Methods: Clinical and epidemiological data were obtained from patients
with GBS isolated in our 1300-bed tertiary hospital between October
2005 and January 2007. FQ-resistance was judged with MIC in case
of >8mg/ml for levoﬂoxacin. Serotypes of GBS were determined
by antisera (Denka Seiken, Tokyo). The nucleotide sequences of the
quinolone resistance-determining region (QRDR) including of gyrA gene
and parC gene were determined. Pulsed-ﬁeld gel electrophoresis (PEGE)
analysis was performed on GBS strains.
Results: From 84 patients, 91 GBS were isolated from 49 genitourinary,
35 respiratory, 4 tissue, 2 blood, one peritoneal specimens. FQ-resistant
GBS were 21 from 17 (20%) patients. All FQ-resistant GBS except one
(94%) was serotype Ib, whereas FQ-sensitive GBS belonged to various
serotypes (VII, V, Ia, Ib, III, II, VIII, and NT). FQ-resistant GBS had
the same triple point mutations within QRDR; In gyrA gene, Ser-81
was changed to Leu (TCA-TTA) in 11/11 strains, and in parC gene Ser-
79 was changed to Phe (TCC-TTC) and Ile-81 had a silent mutation
(ATC-ATT) in 10/10 strains. PFGE on 16 FQ-resistant GBS revealed 4
major groups with high relatedness, although FQ-sensitive GBS showed
slightly related PFGE patterns.
Conclusion: Most of all FQ-resistant GBS was serotype Ib and shared
identical mutations in the QRDR and high related PFGE patterns. These
ﬁndings suggest that the closely related FQ-resistant GBS had been
possibly emerged and disseminated in the community in recent years,
as receiving the antibiotic pressures by quinolone administration.
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P1239 Molecular characterisation of quinolone-resistance in
erythromycin-resistant Streptococcus agalactiae clinical
isolates
M.E. Llaneza, C. Seral, M. Pardos, E. Dura´n, F.J. Castillo, M.C. Rubio,
R. Go´mez-Lus (Zaragoza, ES)
Objectives: Streptococcus agalactiae (GBS) remains susceptible to
penicillin; nevertheless, an increase in the resistance to other antimi-
crobial families, such as macrolides and more rarely ﬂuoroquinolones,
has been described. The purpose of the study was to surveillance
the ﬂuoroquinolone resistance in GBS isolated from blood cultures,
in erythromycin-resistant GBS isolated from vaginal colonisation and
characterise the molecular mechanisms of resistance implicated and their
genetic similarity.
Methods: Antimicrobial susceptibility (according to CLSI guidelines)
of 153 erythromycin-resistant GBS from vaginal colonisation (2002–
2004) and 28 GBS from blood cultures (1994–2004) were recorded
by our Clinical Laboratory (Hospital Lozano Blesa, Zaragoza, Spain).
Levoﬂoxacin and ciproﬂoxacin resistance in GBS was identiﬁed by
disk diffusion and broth microdilution methodology in all the isolates.
Therefore, we determined the nucleotide sequences and deduced amino
acid sequences of gyrA and parC genes including QRDRs in 5
isolates with low-level susceptibility to levoﬂoxacin. These sequences
were compared with those of susceptible strains. Pulsed-ﬁeld gel
electrophoresis (PFGE) analysis was performed on the 5 GBS isolates
following Sma1 digestion.
Results: Five low-level ﬂuoroquinolone-resistant GBS strains were de-
tected (MICs range were 0.5−2mg/l) but no high-level ﬂuoroquinolone-
resistant GBS (MICs >8mg/l) were found in the GBS isolates. Of these,
in 3 isolates no mutations in the QRDR of parC were found, in a blood
isolate collected from a patient previously treated with norﬂoxacin the
sequence analysis of the parC gene showed a base pair chain TCT/CCT
at position 238 that resulted in an aminoacid substitution Ser80Pro and
in a vaginal isolate three parC silent mutations were found and their
implications in quinolone resistance remains unclear. No mutations in
the QRDRs of gyrA were detected. The PFGE pattern study did not
suggest genetic relation of these ﬁve isolates.
Conclusion: Low-level ﬂuoroquinolone-resistant GBS were recovered
from 5 patients and we found that one contained an aminoacid
substitution in the topoisomerase IV gene (Ser80Pro). This mutation
was described previously only in Streptococcus pyogenes. It seems that
parC is the primary target of the quinolones in S. agalactiae. These
ﬁndings emphasise the importance of monitoring antibiotic susceptibility
to quinolones antibiotics.
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P1240 Pharmacokinetics of azithromycin in plasma and sinus tissue
after administration of extended release and immediate
release formulations in chronic rhinosinusitis patients
A.F. Fang, J.N. Palmer, A.G. Chiu, J.L. Blumer, P.H. Crownover,
M.D. Campbell, B.D. Damle (New York, Philadelphia, Cleveland, US)
Objectives: High drug levels at an infection site are desirable for optimal
activity. The aim of this study was to determine if a single dose of
azithromycin (AZ)-extended release (ER) (2 g) achieves higher AZ levels
in sinus tissue compared to AZ-immediate release (IR) (500mg daily for
maximum of 3 days).
Methods: This was a randomised open-label multi-centre study. Seventy-
one chronic rhinosinusitis patients received either a single dose of 2-g
AZ-ER or AZ-IR 500mg once daily dose for 1−3 days. Sinus tissue and
plasma samples were collected at the time of endoscopic surgery, which
was 2, 4, 6, 8, 12, 24, 48, 72, 96, 120, 144 and 168 hr after the ﬁrst AZ
dose, 4 subjects per time point. AZ levels were analysed by LC/MS/MS
method and averaged at each time point. The resultant composite proﬁle
was used for Pharmacokinetics (PK) analyses by a non-compartmental
method.
Results: Sixty-eight patients completed the study. The patients aged
19−81, with majority being white (90%) and males (59%). 53 subjects
were evaluable for PK analysis.
After the administration of both formulations, AZ was absorbed and
distributed quickly in systemic circulation. Sinus tissue concentrations
were measurable at 168 hr from both formulations. PK parameters are
shown in the table.
Matrix Parameter AZ-ER
(n = 24)
AZ-IR
(n = 29)
ER/IR Ratio
Plasma Cmax (ng/mL) 364 112 3.3
AUC24 (ng·h/mL) 4865 933 5.2
AUC168 (ng·h/mL) 10994 N/A
Sinus tissue Cmax (ng/mg) 12.2 1.44 8.5
AUC24 (ng·h/mg) 137 19.7 7.0
AUC168 (ng·h/mg) 684 N/A
N/A = not applicable.
Comparison between formulations: Within the ﬁrst 24 hr, AZ exposure
from ER was 5.2 and 7.0 fold higher than IR in plasma and sinus tissue
respectively. This is consistent with the dose from ER being 4 times
higher than IR.
Comparison between matrices: For ER formulation, AUC24 and AUC168
in sinus tissue were 28.2 and 62.2-fold higher than in plasma, which
indicates that once AZ enters the sinus tissue, it remains for a prolonged
duration. For IR formulation, AUC24 in sinus tissue was 21.1-fold higher
than AUC24 in plasma, which is similar to the ER penetration ratio.
Conclusions: AZ demonstrated good penetration into sinus tissue
regardless of formulation. However, dosing with AZ-ER (2 g) resulted
in an increased exposure compared to the ﬁrst dose of 500mg IR within
the ﬁrst 24 hr after start of therapy.
P1241 Penetration of voriconazole into human tissue
S. Weiler, R. Bellmann-Weiler, M. Joannidis, R. Bellmann
(Innsbruck, AT)
Objectives: Voriconazole (VRC) is a second-generation triazole with
a broad antimycotic spectrum. VRC exhibits a good penetration into
body ﬂuids, such as cerebrospinal ﬂuid, epithelial lining ﬂuid and pleural
effusion. Data on VRC distribution into human tissue after administration
of VRC have been sparse so far. VRC tissue levels were determined in
tissue samples obtained during routine autopsy from patients who have
died during treatment with VRC.
Methods: VRC levels were measured in various samples derived from
different tissues (kidneys, liver, heart, spleen, lung, brain) of 2 patients,
who had been on treatment with VRC. Patient 1 had received a single
dose of 200mg, patient 2 had obtained 200mg/day for 10 days. The
intervals between the last administration and death were 36 and 12
hours, respectively. Both patients had been on vasopressor therapy
and mechanical ventilation. Antimycotic therapy had been initiated for
suspected or proven invasive fungal infections. VRC tissue levels were
assessed by extraction of homogenised tissue samples, puriﬁcation by
solid phase extraction and measurement of VRC by high performance
liquid chromatography.
Results: In VRC treated patients, highest VRC concentrations (mean
± standard deviation) have been found in the kidneys (patient 1:
1.97±0.41mg/mL, patient 2: 6.89±0.06mg/mL) and liver (patient 1:
2.14±0.40mg/mL, patient 2: 4.21±0.77mg/mL). Tissue levels of VRC
in patient 2 exceeded those achieved in patient 1 in all samples. In
different areas of brain tissue VRC was below the limit of detection
(<0.25mg/mL) in patient 1 and achieved levels of 3.34±0.18mg/mL in
patient 2. The levels were comparable in cortex, hippocampus, nucleus
caudatus, medulla oblongata and cerebellum. VRC concentrations
amounted 1.31±0.03mg/mL and 2.95±0.05mg/mL in samples of the
spleen of patient 1 and 2, respectively. In the heart samples of
S348 18th ECCMID, Posters
patient 1 VRC was undetectable, but reached a mean concentration
of 2.44±0.25mg/mL in patient 2. In all lung samples VRC was
measurable and reached mean levels of 1.30±0.63mg/mL (patient 1:
0.74±0.02mg/mL, patient 2: 1.87±0.27mg/mL).
Conclusion: VRC appears to penetrate rapidly into human tissues. VRC
accumulates in the liver and the kidneys. Its penetration into brain and
heart is probably slower.
P1242 Pharmacodynamics of vancomycin against MRSA:
implications of bacterial inoculum for the clinical breakpoint
A. MacGowan, K. Bowker, C. Tobin, A. Lovering, A. Thomson, A. Noel
(Bristol, UK)
Background: Vancomycin (V) is gold standard therapy for MRSA
infection, yet despite wide clinical usage the clinical breakpoint to
deﬁne susceptible S. aureus remains controversial (CLSI S 2mg/L;
EUCAST S 4mg/L). We used an in vitro pharmacokinetic (PK) model
to deﬁne AUC/MIC targets for various V antibacterial effects (ABE)
against MRSA and used these in Monte Carlo simulations using patient
PK data to deﬁne various clinical target attainment rates (TAR).
Methods: An in vitro PK model was used to perform a dose ranging
study with two representative UKEMRSA 15 or 16 strains at inoculum
of 106 or 108 CFU/ml. The AUC/MIC range was 0–2500. Total V
AUC/MIC for 24 h static, 1, 2, 3 or 4 log drop in bacterial count were
established for each inoculum using a Sigmoid Emax model. Patient V
AUC 24 (mg/L.h) was derived from a population PK model developed
for V. Monte Carlo simulations were used to deﬁne TAR using patient
AUC values and AUC/MIC targets from the PK model.
Results: At an inoculum of 106 CFU/mL the total drug AUC/MIC
required at 24 h for a static effect was 34: 1 log drop 66; 2 log drop 254;
3 log drop 303 and 4 log drop >2500. At an inoculum of 108 CFU/ml
the AUC/MIC for a 1 log drop at 24 h was 426, 2 log drop 588 and 3 log
drop >2500. Patient AUC 24 (mg/L.h) was mean 472±221 (min 155,
max 1306, n = 50 subjects). A total V AUC/MIC target associated with
0−1 log drop (initial inoculum 106 CFU/ml) resulted in a TAR of >90%
at an MIC 4mg/L. The AUC/MIC targets associated with a similar ABE
at 108 CFU/mL resulted in a TAR of >80% at MICs of 0.5mg/L.
Conclusion: MRSA inoculum has a signiﬁcant effect on TAR for V.
At an inoculum of 106 CFU/mL a clinical breakpoint for V of 4mg/L
is justiﬁed; at 108 CFU/ml inoculum a breakpoint of 0.5mg/L is more
appropriate.
P1243 Identiﬁcation of mutations in HERG and KCNE2 genes as-
sociated with arrhythmia in patients treated with macrolides
M. Pannacci, A. Caronno, V. Lucini, S. Grosso, F. Scaglione (Milan, IT)
Several new antibiotics have been whitedrawn from the market because
of rare or exceptional but life-threatening adverse effects. Macrolides
and ﬂuoroquinoles are widely prescribed for treatment of infections and
are traditionally known to cause Q-T interval prolongation and are at
risk to induce Torsade de Pointes (TdP) that represent one of the most
dangerous effects with these drugs. Recently, erithromycin was found
to induce TdP, with relative high frequency, even if administered by
oral route. A recent trial conclude that short term clarithromycin in
patients with stable coronary heart disease may signiﬁcantly cause higher
cardiovascular mortality. Genes who are involved in congenital long-
QT (cLQT) syndromes may also be involved in acquired LQT (aLQT),
induced by drugs. Studies of genetic risk factors have been performed in
the United States and Western Europe, suggesting that genetic mutations
in genes codiﬁng for potassium channels and involved in cLQT may be
common in patients with drug-induced arrhythmias. Some studies have
shown prolongation of the QT interval and blockade of the potassium
channel encoded by HERG gene. HERG forms voltage-gated K channels
that are associated with Mink-related peptide 1 (MIRP1), encoded by
KCNE2 gene. Mutations in HERG and KCNE2 genes may be correlated
with susceptibility to drug-induced arrhythmia.
Methods: Venous blood samples from 25 unrelated patients and of
40 unrelated subjects, as control, were taken after informed consent.
Genomic DNA was isolated using standard procedures and PCR was
carried out using speciﬁc primers that cover the complete coding regions
and intron-exon boundaries. Single-strand conformation polymorphism
(SSCP) analysis was performed to identify mutations in the coding
regions and anomalous PCR products were sequenced.
Results: Screening for mutations in HERG and KCNE2 genes with
SSCP, identiﬁed an abnormal SSCP conformer in the KCNE2 gene from
DNA of one patient during treatment with erythromycin and another in
HERG gene from one patient treated with clarithromycin. Sequenced
analysis revealed a mutation, leading to 1-bp deletion (delA, 360) and
(C1039T) respectively.
Conclusion: Individual case reports have shown that patients with
macrolides-induced arrhythmia may carry sporadic mutations in HERG
and KCNE2 genes. These results should be validated by further studies
in a large population in order to evaluate the statistical association with
polymorphisms and drug-induced arrhythmia.
P1244 Pharmacokinetic characterisation of ertapenem following
subcutaneous administration in acutely ill patients
D. Frasca, S. Marchand, O. Mimoz, W. Couet (Poitiers, FR)
Objective: To compare the pharmacokinetic and pharmacodynamic
parameters of sequential intravenous and subcutaneous ertapenem in the
plasma of surgical intensive care unit patients.
Methods: Six patients, all males, between 19 and 82 years old, with
suspected hospital-acquired infection due to an ertapenem-susceptible
bacteria gave their informed consent to participate. Patients with
abnormal renal function (estimated creatinine clearance <30ml/min/1.73
m2), cardiac failure, receiving vasopressor agents or having a body mass
index >30 kg/m2 were excluded. Ertapenem 1g was administered ﬁrst
as a 30min intravenous infusion once a day. At steady-state, between
the fourth and the seventh day after the antibiotic administration started,
the pharmacokinetic study for the intravenous route was performed (13
blood samples). The day thereafter, the pharmacokinetic study for the
subcutaneous route was performed after administration of ertapenem 1g
as a 30 min subcutaneous infusion (12 blood samples). Blood samples
were centrifuged for 10min at 4ºC to separate the plasma, and ertapenem
concentrations were measured using a validated LC-MS/MS assay. A
2 open-compartmental model with zero order administration was used
for pharmacokinetic calculations and derived parameters were used for
simulations.
Table Ia: Mean±SD pharmacokinetic parameters
AUC
(mg/mL×h)
Cmax
(mg/mL)
Tmax (h) MAT (h)
au choix
t 12 (h)
IV infusion 317±158 115±28 0.5 0.25 3.9±1.2
Sub-cut infusion 313±184 43±29* 2.7±1.1* 3.4±2.7 5.4±1.4
*p< 0.01.
Table Ib: Simulated plasma concentrations time over MIC in percentage according
to various MIC values
MIC=
1mg/mL
MIC=
2mg/mL
MIC=
4mg/mL
MIC=
8mg/mL
IV infusion 87±17% 74±19% 58±19% 40±16%
Sub-cut infusion 96±8% 91±13% 71±14% 47±14%
Results: All treatments were well tolerated. Mean±SD pharmacokinetic
parameters are listed in Table Ia. The major observation was that
ertapenem concentrations versus time proﬁles were shifted to the
right after subcutaneous administration and time to peak (Tmax) was
considerably delayed with peak concentrations (Cmax) reduced to about
1/3. However area under the curves (AUC) were similar for both
administration route with a ratio of AUCsubcut/ AUCIV = 0.99±18)
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and simulations indicate that time over MIC had a tendency to be longer
after subcutaneous administration independently on the selected MIC
value (Table Ib).
Conclusion: Subcutaneous administration seems to be an interesting
alternative to intravenous infusion in acutely ill patients.
P1245 Variability in cefazolin concentrations in amniotic ﬂuid: the
relevance of gestational age
K. Allegaert, T. van Mieghem, R. Verbesselt, J. de Hoon, G. Naulaers,
J. Deprest, R. Devlieger (Leuven, BE)
Objectives: Cefazolin is frequently administered for prophylaxis during
foetal surgical interventions, but data on amniotic drug disposition and
the determinants of its variability during pregnancy are still limited. We
therefore wanted to document cefazolin disposition in the amniotic ﬂuid
and the determinants of its variability.
Methods: A ﬁrst dose of cefazolin (2 g iv) was administered (time
interval 30 min) one or two hours before foetal surgical intervention.
Amniotic ﬂuid sampling was performed when puncture of the amniotic
cavity and subsequent sampling of amniotic ﬂuid was part of the routine
clinical care without addition burden for either mother or foetus. Time
of sampling (min) was registered and gestational age (GA, weeks) at
surgery was recorded. Cefazolin concentrations were determined based
on High Performance Liquid Chromatography methodology (1). Data
were reported by median and range, spearman rank correlation and
multiple regression were used to assess the impact of time of sampling
and GA at surgery on the variaibility in cefazolin concentrations
observed in the amniotic ﬂuid.
Results: 57 amniotic ﬂuid samples were collected during foetal surgical
interventions. The median cefazolin amniotic concentration was 0.82
(range 0.06–3.73) mg/L. Median GA was 26 (range 17–34) weeks,
median time at collection was 100 (range 20–370) minutes. There is
a signiﬁcant increase in cefazolin concentration with time (r = 0.41, 95%
CI 0.17–0.6) and with GA (r = 0.58, 95% CI 0.37–0.73). In a multiple
regression model, both variables remained independent determinants of
the amniotic cefazolin concentration (r adj = 0.35)
Conclusions: There is important variability in cefazolin concentrations
in amniotic ﬂuid during pregnancy. In addition to time of sampling after
intravenous maternal administration, gestational age also contributes
to this variability, suggesting the impact of maturational aspects
(protein binding, placental transfer, foetal renal elimination) on cefazolin
disposition during pregnancy.
Reference(s)
[1] Vella-Brincat JW, et al. Br J Clin Pharmacol 2007; 63: 753−7.
P1246 Cerebrospinal ﬂuid compartmental pharmacokinetics of
amikacin in neonates
K. Allegaert, I. Scheers, E. Adams, G. Brajanoski, V. Cossey,
B.J. Anderson (Leuven, Louvain, BE; Auckland, NZ)
Objectives: To describe and investigate covariate effects (leukocytosis,
glycorrhachia, protein concentration) on cerebrospinal ﬂuid (CSF)
pharmacokinetics of amikacin in neonates.
Methods: CSF samples were prospectively collected from neonates in
whom amikacin had been initiated before a diagnostic lumbar puncture
was performed. CSF analysis (amikacin concentration, white blood
count, glucose content, protein concentration) and amikacin therapeutic
drug monitoring results (peak and trough concentrations) in plasma were
recorded. A two compartment (central and CSF) linear disposition model
was used to estimate population pharmacokinetics. The half-time (Teq)
for equilibration between plasma and CSF compartments was used as a
measure of blood brain barrier permeability.
Results: Based on 44 CSF amikacin concentrations and 83 plasma
samples available from 43 neonates, data analysis revealed two distinct
groups of neonates: those with a very short Teq (0.155 SD 0.024 h) and
those with a long Teq (67.9 SD 22.5 h). A white cell count above 21 cells
per mm3 in the CSF was associated with a low Teq while no relationship
between Teq and CSF glucose or protein could be established.
Conclusions: There is important between individual variability in Teq
following amikacin administration in neonates that is associated with
CSF WBC. The impact of CSF WBC on amikacin Teq is of potential
relevance for both effectiveness and ototoxicity of this drug in neonates.
P1247 Contributors to between-individual variability of amikacin
clearance in neonates
K. Allegaert, K. De smet, I. Scheers, E. Adams, V. Cossey,
B.J. Anderson (Leuven, Louvain, BE; Auckland, NZ)
Objectives: We recently documented that size (49%), renal function
(14%) and postmenstrual age (PMA 18%) are the major contributors
to vancomycin clearance variability in neonates, leaving only 18% of
variability unexplained. A variable slope sigmoidal model ﬁtted best to
describe the relationship between vancomycin clearance and PMA (1). A
similar exercise in a large dataset of amikacin concentrations in neonates
was undertaken to test applicability of the current model to others drugs,
like amikacin, cleared by renal elimination.
Methods: Population pharmacokinetics were estimated (NONMEM) in
a cohort of 715 neonates (PMA 24–43 weeks; weight 0.385−4.780 kg)
and were based on 1 862 amikacin time-concentration points. Covariate
analysis included weight, PMA, postnatal age (PNA), creatinaemia, use
of inotropes or ibuprofen, positive blood culture and respiratory support.
A one-compartment linear disposition model with zero order input and
ﬁrst order elimination was used.
Results: The population estimate for volume of distribution (V) was
32.1 L/70kg and 1.21 L/h/70kg for clearance (CL). CL increased from
0.84 L/h/70kg at 28 weeks PMA to 1.23 and 1.56 L/h/70kg by 34 and 40
weeks PMA. Overall 92% of the variability of CL was predictable. Size
explained 66%, PMA 17% and renal function 9%. The use of a variable
slope sigmoidal model to describe the relationship between clearance
and PMA predicted an adult amikacin clearance of 3.87 L/h/70kg.
Conclusions: The explained variability of clearance and the relative
contribution of the different contributors (size, PMA and renal function)
is a similar magnitude with the earlier reported observations on
vancomycin clearance and a variable slope sigmoidal model ﬁtted best to
predict adult amikacin clearance. These ﬁndings strongly suggest that the
current model likely describes the underlying maturation of renal drug
clearance. The development and subsequent validation of such models
should further improve the predictability of drug clearance for drugs
cleared by a similar route.
Anderson B et al. Br J Clin Pharmacol 2007;63(1):75–84
P1248 Cerebrospinal ﬂuid penetration and pharmacodynamic
exposure of meropenem prophylactically administered to
neurosurgical patients
K. Ikawa, R. Tsumura, N. Morikawa, K. Ikeda, M. Shibukawa, K. Iida,
K. Kurisu (Hiroshima, JP)
Objectives: Meropenem is frequently used for the treatment and
prophylaxis of bacterial meningitis. However, the drug’s distribution
within the site of action is poorly understood. This study examined
the penetration and pharmacodynamic exposure of meropenem into
cerebrospinal ﬂuid (CSF).
Methods: Meropenem (0.5 g every 8 h) was prophylactically adminis-
tered to six patients who underwent neurosurgery and external lumbar
drainage for the management of cerebrovascular diseases. Lumbar CSF
and venous blood samples were obtained at the end of the infusion
(0.5 h) and 1, 1.5, 2.5, 4.5, and 8 h thereafter. Pharmacokinetic data in
CSF and plasma were estimated noncompartmentally, analysed using
a 3-compartment pharmacokinetic model, and used for a Monte Carlo
simulation with MIC data of clinical isolates in Japan.
Results: Noncompartmental pharmacokinetic analysis demonstrated that
the observed maximum concentration was 0.66 ±0.17 (mean ± SD)
mg/L at 3.00±1.22 h in CSF and 29.50±6.54mg/L at 0.5 h in plasma,
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and the CSF/plasma ratio was 0.024±0.011. The area under the
drug concentration-time curve (AUC 0–8 h) was 3.76±0.75mg·h/L
in CSF and 35.76±6.15mg·h/L in plasma, and the CSF/plasma
ratio was 0.109±0.035. The Monte Carlo simulation combined with
compartmental pharmacokinetic modeling showed that the probabilities
of achieving the bacteriostatic exposure target in CSF (30% of the
time above the MIC) for 0.5 g every 8 h (0.5-h infusion) were 99.8%
against a Streptococcus pneumoniae population (MIC50 = 0.06mg/L;
MIC90 = 0.5mg/L) and 99.6% against a Haemophilus inﬂuenzae
population (MIC50 = 0.12mg/L; MIC90 = 0.5mg/L), respectively. The
prophylactic regimen of 0.5 g every 8 h was considered to provide
sufﬁcient bacteriostatic exposure in CSF for the two major meningitis
pathogens.
Conclusion: These results expand our knowledge of the rate and extent
of meropenem penetration into the cerebrospinal ﬂuid and space, and
provide a pharmacokinetic-pharmacodynamic rationale for design of a
meropenem regimen to prevent bacterial meningitis.
P1249 Altered pharmacokinetics of linezolid in patients with
severe burn injuries
C. Vinsonneau, A.M. Lovering, J. Stephanazi, L. Hovsepian, H. Carsin,
G. Birraux, P. Bret, R. Le Floch (Paris, FR; Bristol, UK; Clamart,
Nantes, FR)
Background: Signiﬁcant physiological changes occur in patients
with major thermal burn injuries and result in alterations to the
pharmacokinetics (PK) of many agents. These changes usually result
in increased drug clearance and therefore it is necessary to increase the
dosage of many antiobiotics. Today there is no data available describing
the pharmacokinetics of linezolid (LZD) in burn patients and thereby
whether doses need to be adjusted in these patients.
Methods: LZD PK were studied in 8 patients with severe burn injuries
compared to 8 healthy volunteers matched for gender and weight. Mean
(SD) demographic factors for the patients and volunteers were, age 37.0
(11.1) y vs. 37.6 (9.0) y; weight 64.0 (10.7) kg vs. 68.5 (9.4) kg and
burnt area 41.0 (20.7) % vs. 0 (0) %. 600mg LZD was administered as
a 1 h infusion and both blood and urine samples were taken up to 72 h
post dose and assayed by a validated HPLC method. PK parameters were
determined by non-compartmental analysis.
Results: The mean (SD) PK parameters determined for LZD in the
patients and healthy volunteers were: AUC0−∞ 42.5 (24.0) mg.h/L vs.
98.1 (29.2) mg.h/L, half life 2.1(1.0)h vs. 4.8(2.0)h and Vss 50.8 (16.8)
L vs. 39.6 (5.7) L, respectively. The differences for AUC and T1/2 were
statistically signiﬁcant (P = 0.016; Wilcoxon signed rank sum test), but
not the difference for Vss (P = 0.383). Mean concentrations of LZD
dropped below the susceptibility breakpoint (EUCAST 4mg/L) for
staphylococci after 4 h in the patients and 10 h in the volunteers.
Conclusion: The PK of LZD were signiﬁcantly altered in patients
with major burn injuries as compared to healthy volunteers. The drug
exposure, as assessed by AUC, was reduced by approximately 50%
in burn patients suggesting that a different dosage schema might be
required. Today it is not clear how this possible difference should be
addressed, but for a drug that has time-dependent efﬁcacy, it may be
more appropriate to increase the frequency of administration rather than
the dose administered.
P1250 Bioequivalence of marketed voriconazole oral suspension
and tablet formulations: results of a three-period, crossover,
multiple-dose study
N. Wood, B. Damle (Sandwich, UK; New York, US)
Objectives: Voriconazole (VORI) is an extended-spectrum antifungal
drug widely used in the treatment of opportunistic fungal infections,
including invasive aspergillosis and candidaemia. An oral suspension
of VORI has been developed for use in adult patients who are unable
to swallow marketed tablets, and in paediatric patients. This study
assessed the bioequivalence of two batches of VORI oral suspension
(batches differing only in drug particle size of the in-going drug
substance) relative to VORI tablet. The safety and tolerability of the
two formulations were also compared.
Methods: This was a randomised, three-period, crossover, multiple-dose
study, carried out in fasted healthy male subjects aged 18–45 years. In
each study period, subjects received VORI tablet or suspension (batch
1 or 2) 400mg twice daily on Day 1 followed by 200mg twice daily
for 5.5 days; study periods were separated by a wash-out period of at
least 7 days. Blood samples were taken on Day 7 to assay VORI plasma
concentrations at speciﬁed times up to 12 hours post-dose. The safety
analysis included assessment of adverse events, clinical laboratory tests
and physiological parameters.
Results: Pharmacokinetic data were obtained for 48 subjects randomised
to receive VORI: suspension batch 1, n = 43; suspension batch 2, n =
44; tablet, n = 45. Statistical analysis of these data (Table) demonstrated
that both VORI suspension batches were bioequivalent to the tablet
formulation, as 90% CIs for suspension batch 1/tablet and suspension
batch 2/tablet ratios both fell within the standard AUCtau and Cmax
equivalence ranges of 80–125%. The incidence and types of adverse
events were consistent with the known VORI safety proﬁle, with similar
safety proﬁles across the three drug formulations.
Conclusion: Both batches of VORI oral suspension were bioequivalent
and similar in safety to VORI tablet. The availability of VORI oral
suspension can provide further ﬂexibility in patient care, an important
component in the successful management of invasive fungal infections.
Table: Statistical analysis of pharmacokinetic parameters of voriconazole
suspension and tablets on Day 7.
Parameter Adjusted means* Ratio or 90% CI
Suspension
batch
Tablet Difference†
Suspension batch 1 vs tablet
AUCt (ng·h/ml) 11718 11478 Ratio: 102% (99, 106)
Cmax (ng/ml) 2253 2166 Ratio: 104% (98, 111)
Tmax (h) 0.95 1.39 Difference: 0.44 h (−0.66, −0.23)
Suspension batch 2 vs tablet
AUCt (ng·h/ml) 12067 11478 Ratio: 105% (102, 109)
Cmax (ng/ml) 2488 2166 Ratio: 115% (108, 122)
Tmax (h) 0.82 1.39 Difference: 0.57 h (−0.78, −0.36)
AUCt = area under the plasma concentration time curve over dosing interval t;
Cmax = maximum observed plasma concentration; Tmax = time to ﬁrst occurrence
of Cmax.
*Adjusted means are geometric for AUCt and Cmax, and arithmetic for Tmax.
†Ratio = suspension/tablet. Difference = suspension minus tablet.
P1251 Effect of voriconazole on the pharmacokinetics of reduced
doses of sirolimus
B. Damle, A. Fang, R. LaBadie, F. Jen, R. Swanson, P. Glue, J.H. Antin
(New York, Boston, US)
Objectives: Sirolimus (SIR) is metabolised by CYP3A4/5, while
voriconazole (VORI) inhibits CYP3A4-mediated drug clearance. Sys-
temic exposure of SIR (with standard 2mg dose) is signiﬁcantly
increased by VORI coadministration. Hence, concomitant use of VORI
and SIR is contraindicated. Our aim was to determine SIR dose
adjustments, when coadministered with VORI, which result in exposures
similar to monotherapy.
Methods: This was an open-label, nonrandomised, parallel-group,
multiple-dose, ﬁxed-sequence, 2-period study in 30 healthy males. The
effect of steady state oral VORI on the multiple-dose pharmacokinetics
(PK) of 3 reduced doses of SIR (oral solution; 0.25, 0.15 and 0.10mg/d;
n = 30/group) was investigated relative to the standard dose alone in the
same subjects. Serial blood samples were collected at predose and over
a 24-h interval on the ﬁnal day of each study period; SIR and VORI
concentrations were determined by LC/MS/MS. PK were determined by
noncompartmental methods. A modelling approach was used to estimate
the effect of staggered VORI dosing on steady state SIR levels.
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Results: The changes in PK parameters when reduced doses of SIR were
coadministered with VORI are shown in the table.
Treatment AUC24
(ng·h/mL)
Cmax
(ng/mL)
Cmin
(ng/mL)
t 12 (h)
Group 1 Day 4 93.6 10.1 2.5 17.9
Day 9 125.6 8.3 4.3 30.5
Group 2 Day 4 82.0 9.3 2.0 18.9
Day 9 100.4 5.6 3.4 32.6
Group 3 Day 4 106.6 11.3 2.6 20.6
Day 9 86.6 4.6 3.2 36.4
Mean PK parameters of SIR. SIR was given at standard dose on
Days 1−4 and at reduced dose on Days 6−9: 0.25mg/d (group 1),
0.15mg/d (group 2) and 0.10mg/d (group 3). Standard-dose VORI was
given on Days 6−9.
A decrease in SIR AUC24 of 16% (90% CI: 8%-24%), relative to
standard-dose SIR was observed for 0.10mg SIR with concomitant
VORI, resulting in suboptimal exposure to SIR. Conversely, AUC24 was
increased by 23% (90% CI: 11%-36%) and 36% (90% CI: 21%-54%)
with SIR doses of 0.15 and 0.25mg, respectively, resulting in slightly
higher exposure to SIR than with standard-dose monotherapy. Across
all 3 study groups, SIR Cmax values were lower by 19%-59%, Cmin
values were higher by 9%-64% and t 12 values were higher by 70%-77%
compared with standard-dose monotherapy. SIR had no effects on VORI
PK. Modelling indicated that staggering dosing of VORI and SIR is
likely to decrease the magnitude of interaction.
Conclusion: It is possible to coadminister reduced doses of SIR with
VORI to achieve systemic exposures similar to standard-dose SIR
monotherapy. While not speciﬁcally tested in this study, our results
suggest that a 90% reduction in SIR dose would maintain SIR therapeutic
levels when coadministered with VORI. Our results are applicable only
when both drugs are administered simultaneously orally. Further studies
assessing the PK, safety and efﬁcacy of coadministration of reduced SIR
doses and VORI in transplant patients are necessary.
P1252 Population pharmacokinetic analysis of moxiﬂoxacin in
patients undergoing cardiac surgery
M. Blunck, H. Stass, L. Rupprecht, B. Flo¨rchinger, M. Hilker, F. Kees,
F.X. Schmid (Wuppertal, Regensburg, Krefeld, DE)
Objective: A population pharmacokinetic (PPK) model for moxiﬂoxacin
(MXF) in the serum, heart tissue (right atrium and ventricle) and aortic
root of patients undergoing scheduled aortic valve surgery (AVS, Ross
procedure) was to be developed including an estimate of the inﬂuence
of the cardiopulmonary bypass and patient characteristics on the PPK of
MFX.
Methods: The PPK model was based on data from 20 patients who
had undergone AVS. Patients underwent surgery at 3, 7, 10, 13 or 20 h
after start of a 1 hour 400mg MFX infusion. Data collected included
MFX/serum concentration proﬁles and tissue samples. Demographic,
renal parameters, and the AVS procedure were tested as covariates using
the NONMEM software.
Results: The PPK of MFX was described by a three-compartment
model (population mean [% relative standard error] volume of central
compartment Vc=57 L [18%], elimination rate ke=0.17 1/h [14%],
clearance CL =9.8 L/h) with a moderate inter-individual coefﬁcient
of variance of 20% for Vc and 26% for ke, about half of which was
attributable to an effect of weight and sex on Vc and the effect of renal
function (serum creatinine) on ke. The model implied that the MFX
serum concentrations were transiently reduced by about 20% during
application of the priming ﬂuid of the cardiopulmonary bypass. The
tissues behaved as small compartments directly linked to the central
compartment, resulting in swift attainment of high levels of MFX in
tissue. Equilibrium with serum was reached rapidly in the right atrium
and right ventricle, indeed within 1 hour of the end of infusion. The
aortic root tissue reached equilibrium within 2–5 hours. The latter is
in line with differences in perfusion and comparable with other fast
equilibrating tissues.
Conclusion: Despite the sparse sampling, a consistent model was
achieved that describes the fast penetration of MFX into cardiac
tissue. The PPK results support the possible use of MXF in infectious
endocarditis.
P1253 Faropenem pharmacokinetics in AOM children following
oral administration of faropenem medoxomil
A. Arguedas, R. Dagan, G. Rincon, E. Wang, R. Tosiello, R. Echols,
J. Li, A. Beaudry, S. Gill (San Jose, CR; Beer Sheva, IL; Louisville, US)
Objectives: Faropenem medoxomil (FM) is a novel oral prodrug
antibiotic with in-vitro activity against common repiratory tract
pathogens including activity against penicillin and MDR resistant
S. pneumoniae. The objective of this dose-ranging study was to evaluate
faropenem (FAR) pharmacokinetics in paediatric AOM.
Methods: In this phase II study, children with AOM (0.5−7yrs) received
FM BID for 10 days. Blood was collected from 179 children at 0.5, 1, 2
and 4 hours post dose 1. In addition, a single blood sample was obtained
at study Visit 2 (study Days 4−6) in 314 children over a range of time
following dose administration on that day. Doses evaluated were 7.5, 15,
30 and 40mg/kg. FAR plasma concentrations were determined using
a validated LC-MS/MS assay with a lower limit of quantitation of 2.5
ng/mL. Individual subject FAR pharmacokinetic parameters on Day 1
were calculated using non-compartmental analysis.
Results: FAR plasma pharmacokinetics following oral administration of
FM on Day 1 demonstrated increasing exposure with increasing dose.
Median FAR Cmax values were 16.5, 26.0, 54.3, and 57.9mg/L at
doses of 7.5, 15, 30, and 40mg/kg, respectively. Corresponding median
AUC0−4 values were 20.4, 42.3, 93.0 and 112mg*h/L, respectively. FAR
plasma concentrations at Visit 2 were similar to those observed on Day
1.
Conclusions: FAR pharmacokinetic data in paediatric subjects con-
ﬁrmed dose-linearity of AUC, while Cmax values, although approxi-
mately linear, trended toward less than expected increases with increasing
dose. Comparison of paediatric values with those observed in adults
showed an increase of 1.8-fold in CL/F. As expected with a drug that
is renally eliminated, a correlation was observed between increasing
AUC with decreasing CrCl. No gender or age (0.5 to 7 years) related
effects were observed with FAR pharmacokinetics. Similar FAR plasma
concentrations were observed following repeat dosing indicating no
substantial changes in FAR pharmacokinetics over time.
P1254 The pharmacokinetics of posaconazole administered orally
versus via a nasogastric tube in healthy subjects
J. Varkey, G. Krishna, D. Vickery, L. Ma, X. Yu, D. Malavade,
M. Goodwin, J. Perfect, E. Dodds Ashley, E. Power (Durham,
Kenilworth, US)
Objectives: The pharmacokinetics (PK) of single-dose posaconazole
(POS) given either orally (PO) or via nasogastric (NG) tube were
evaluated in healthy subjects.
Methods: This was an open-label, comparative, cross-over study in
healthy subjects. In random sequence, subjects received POS 400mg
PO or NG (Day 1) followed by a 7-day washout and then a second
dose of POS 400mg via the alternate route on Day 8. POS was
administered 5–10 minutes after completion of 8 ﬂuid oz of Boost Plus®
administered via the same route as POS in each dosing period. Blood
samples for POS plasma concentration determination by LC/MS-MS
method were obtained at prespeciﬁed time points over a 12-h period
following POS administration. The log-transformed PK parameters
from a noncompartmental analysis were statistically analysed using an
ANOVA model.
Results: Fifteen subjects (male and female) completed both treatment
periods. Cmax and AUC values for NG tube administration were 81%
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and 76% of those observed following PO administration. The median
Tmax values were the same for both routes, indicating that rates
of absorption of POS is unaffected by PO and NG tube routes of
administration. The mean apparent clearance (CL/F) was 12% higher for
NG tube than that for the oral route of administration. It is likely that
this difference is to due to differences in the amount of POS absorbed
from the different administration routes. The elimination as indicated
by terminal phase half-life (t1/2) of POS would be expected to be
similar regardless of the route of administration. Consistent with this,
the t1/2 values were similar between PO administration and NG Tube
administration. PO and NG tube administration of POS 400mg was
found to be safe and well tolerated when administered to healthy adult
subjects.
Table 1: Mean and % CV of POS PK parameters in healthy subjects
following administration of a 400mg dose (suspension) orally (PO) or
via a NG Tube 5–10 minutes after receiving a nutritional supplement
(Boost Plus®)
Parameter NG Tube PO
Mean % CV Mean % CV
Cmax, ng/mL 266 45.2 324 49.7
Tmax, h 4.0a 2.0−6.0b 4.0a 3.0–12.0b
AUC(I), ng·h/mL 8402 44.8 10866 53.4
t1/2, h 23.7 30.7 21.6 38.9
CL/F, mL/h 594109 52.3 49345 54.2
aMedian; bRange.
Conclusion: In healthy subjects, NG tube administration of a single dose
of 400mg of POS (suspension) appears to lead to Cmax and AUC values
that are about 80% of those observed following PO administration when
both were administered 5–10 minutes after 8 ﬂuid oz of Boost Plus®.
P1255 Pivmecillinam: estimation of adequate dosage for
susceptible and ESBL-producing E. coli by Monte Carlo
PK/PD simulation
K.S. Jensen, A.S. Henriksen, N. Frimodt-Moeller (Copenhagen,
Ballerup, DK)
Objectives: Pivmecillinam (PM) is widely used in the Scandinavian
countries for treatment of urinary tract infections (UTI). It is highly
active against non b-lactamase producing E. coli with MIC values around
0.125–0.5mg/l, but also retains activity against b-lactamase producing,
even many ESBL-producing, E. coli, where the MIC has increased to
a level of 1−2mg/l. We therefore wanted to estimate the probability of
target attainment in serum for a number of dosage regimens for the two
different MIC levels.
Methods: Pharmacokinetic data for mecillinam concentrations after per
oral dosing of 400mg PM (equivalent to 273mg mecillinam) were on
ﬁle at LEO Pharma. 11 measurements of serum concentration within
8 hours from intake were recorded in 17 individuals (age 26.6±7.3
years, weight 73.0 ±13.9 kg). The NPAG program was used to ﬁt a
linear compartment model (seven state variables, six PK parameters)
to the data whereby mean values as well as the covariance matrix
for the PK parameters were obtained. Monte Carlo simulations were
then made with the compartment model assuming lognormal as well as
nonparametric (empirical) frequency distributions for the PK parameters.
Results were obtained on the probability of target attainment with respect
to a Time>MIC of 40% as usual for most b-lactam antibiotics. Since the
drug concentrations in serum are most important for treatment of renal
infection, these were used as surrogate markers in this PK/PD analysis.
Results: After the parameter estimation process, the compartment
model was able to reproduce the measured serum concentrations with
satisfactory precision. With a MIC of 0.25mg/l, a Time>MIC of 40%
(for an unbound fraction eq. to 90% of total dose) could be reached for
95% of the simulated population on a 400mg PM dose TID. The same
population coverage (95%) required 800mg QID if the MIC was around
1mg/l.
Conclusion: The lower dose ﬁts the dosage regimen presently
recommended for treatment of upper UTI. The high dose is still
manageable since PM has low toxicity; a total dose of 60mg/kg is
tolerated in mature humans. Based on the simulation results, a standard
PM dose of 400mg TID is recommended for upper UTI. For ESBL-
producing E. coli, if clinical data allow, the dose should be increased to
800mg QID.
P1256 Three-times weekly teicoplanin in the outpatient treatment
of chronic infections
C. Tascini, E. Tagliaferri, A. Di Paolo, L. Cioﬁ, M. Del Tacca,
P. Lambelet, F. Menichetti (Pisa, IT)
Background: Several types of infections deserve prolonged treatment
for months. In the setting of infections caused by multidrug resistant
Gram-positive cocci, outpatient treatment is difﬁcult to perform
especially in the case of exclusive parenteral options.
Method: We enrolled in this study with teicoplanin three-time weekly
patients who need to be treated with teicoplanin for prolonged time.
After a loading dose of 7mg/Kg everyday for 15 days, patients
received 12mg/Kg on Monday, Wednesday and Friday in an outpatient
setting. Trough and peak concentrations were determined by ﬂuorescence
polarisation immunoassay (Seradyn, USA). Serum concentrations of
teicoplanin were also determined in a control group of inpatients
receiving teicoplanin (7mg/Kg) everyday.
Results: Thirty-three patients were enrolled: 14 with vertebral os-
teomyelitis, 11 with infected orthopaedic implants, 5 with osteomyelitis,
3 with arterial prosthetic infections. Teicoplanin was administered
empirically in 10 patients, for MRSA infections in 12 patients, for MR-
CNS infections in 9 patients, for MSSA infection in 1 patient and for
Propionibacterium spp. infection in 1 patient. The duration of treatment
ranged from 60 to 360 days (median 150±84 days). Cure was obtained
in 21 (63%) and improvement in 12 (37%) cases. Trough and peak
serum concentrations in three-time weekly patients were 16.2±7.2 and
58.7±14.4, respectively. In the control group trough and peak serum
concentrations were 18.9±13.6 and 52.2±27. Adverse effects occurred
in 6 patients and caused discontinuation of treatment only in 1 patient.
Discussion: Three-time weekly teicoplanin was effective in the treatment
of chronic infections. This way of administration yields the same serum
levels of teicoplanin when the drug is administered everyday at standard
doses, while adverse effects are rare and mild.
P1257 Value of pharmacokinetic/pharmacodynamic in dose
management of ceftazidime and imipeneme in ICUs
M. Coudrot, A. Carricajo, S. Guyomarc’h, J. Morel, C. Auboyer,
F. Zeni, G. Aubert (Saint-Etienne, FR)
Objectives: the purpose of our study was to assess the value of serum
assay of ceftazidime (CAZ) and imipeneme (IMI) in patients in the
intensive care unit (ICU) of the Saint-Etienne University Teaching
Hospital and in other ICUs in the region with regard to optimisation
of treatment management.
Methods: Between 01/11/05 and 31/10/07, in patients hospitalised in
ICUs, not on dialysis and undergoing treatment with CAZ given in a
continuous infusion or with IMI (non-continuous), serum assay of the
respective antibiotics was performed 36 hours after the start treatment
using a single serum sample for CAZ and determination of trough
and peak concentrations for IMI. Assays were performed using the
microbiology technique with results 18 hours after sample collection.
CAZ 2 g was given systematically in a bolus at the start of treatment.
Results: assay was performed in 81 and 95 patients respectively for
CAZ and IMI. Mean patient age was 66 years (19 to 89 years) and
mean weight was 73 kg (33 to 122 kg). The dosage was between 1 g
and 6 g/24 h for CAZ and between 500mg and 6 g/24 h for IMI. The
mean serum CAZ concentration was 47.6mg/L (7.4 to 162.3mg/L).
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Serum CAZ concentrations were as follows: 35 to 65mg/L in 37% of
patients, <35mg/L in 43.2% and >65mg/L in 19.8%. Infection was
established in 61 patients, with 52 strains of P. aeruginosa detected.
The serum concentration/MIC ratio was 5 for 84.4% of patients
and >10 for 65.6% of patients. Trough concentrations of IMI were
<0.5mg/L for 14.7% of patients, between 0.5 and 2mg/L for 43.2%, and
>2mg/L for 42.1%. The mean peak concentration of IMI was 19.9mg/L
(3 to 78mg/L). Infection was recorded in 52 patients, including 22
Enterobacter spp. and 12 P. aeruginosa. Antibiotic dosage was adjusted
respectively for CAZ and IMI in 19.8% and 28.4% of patients based on
the initial assay results.
Conclusion: Our study shows that assays are needed in ICUs to conﬁrm
the efﬁcacy of time-dependent antibiotics, to avoid treatment toxicity, to
achieve efﬁcacy as rapidly as possible and to avoid selection of resistant
mutants, particularly in strains having limited susceptibility to antibiotics.
P1258 Moxiﬂoxacin does not require dosage adjustment in patients
with severe hepatic insufﬁciency
J. Barth, D. Jaeger, R. Mundkowski, B. Drewelow, T. Welte,
O. Burkhardt (Halle/Saale, Rostock, Hannover, DE)
Objectives: Severe bacterial infections such as spontaneous bacterial
peritonitis (SBP), pneumonia, or sepsis are well-described life-limiting
complications in patients with advanced liver cirrhosis. Pharmacological
and microbiological characteristics make moxiﬂoxacin an attractive
option in the treatment of such infections. On the other hand,
since moxiﬂoxacin is predominantly metabolised by the liver, a
drug accumulation theoretically can not be excluded in patients with
advanced liver insufﬁciency. Due to a lack of pharmacokinetic data the
therapeutical use of moxiﬂoxacin is currently not recommended in this
patient population.
Patients and Methods: In a single-centre, prospective, open-label study,
9 adult cirrhosis patients with severe liver insufﬁciency (Child–Pugh
class C) and an infection (pneumonia or SBP) were treated with 400mg
moxiﬂoxacin infusion once a day. On days 1 and 3 drug concentrations
in serum and ascites were determined before and at different time points
up to 24 h after medication with a validated HPLC method.
Results: On day 1, serum concentrations of moxiﬂoxacin decreased from
a geometric mean of 3.60mg/L at 1 h to 0.62mg/L at 24 h. On day 3,
serum peak and trough levels showed only a moderate accumulation.
The AUC values were slightly, but not statistically signiﬁcant, increased
on day 3. Calculations of t1/2, MRT, CLtot, and Vss also revealed no
signiﬁcant differences between days 1 and 3. Mean concentrations of
moxiﬂoxacin in ascitic ﬂuid were 1.47mg/L at 3.0 h and 1.39mg/L at
6.0 h on day 1, and 2.07mg/L at 3.0 h and 1.88mg/L at 6.0 h on day 3.
There were no differences in mean ascites/serum ratios between days 1
and 3.
Conclusions: PK parameters of intravenous moxiﬂoxacin in patients
with advanced liver cirrhosis differed only marginally from those from
healthy control groups given in the literature. After multiple dosing only
a moderate drug accumulation was seen. Therefore, we conclude that
a dose adjustment is not necessary in this patient group. In addition to
this, ascitic ﬂuid reached bactericidal levels of moxiﬂoxacin for common
bacteria found in spontaneous bacterial peritonitis.
P1259 Penetration of moxiﬂoxacin into the tissue of heart and
aortic root of patients
L. Rupprecht, B. Flo¨rchinger, M. Hilker, F. Kees, F.X. Schmid
(Regensburg, DE)
Objective: Moxiﬂoxacin is clinically used in respiratory tract and skin
and soft tissue infections. The aim of the present study was to provide
pharmacokinetic data for the possible use of moxiﬂoxacin in infectious
endocarditis.
Methods: 20 patients (12m/8f) with age (median, range) of 53, 23–64
years, weight 84, 61–106 kg, height 175, 156–195 cm, BMI 27.1, 20.7–
48.8 kg/m2) undergoing scheduled aortic valve surgery (Ross procedure)
were enrolled into the study. During surgery, tissue specimens were
sampled in 4 patients each 3, 7, 10, 13 and 20 hours after start of a
1hour infusion of moxiﬂoxacin 400mg. Blood was sampled in order
to compare tissue and concomitant serum concentrations. Moxiﬂoxacin
was determined by HPLC and ﬂuorimetric detection in serum and tissue
homogenate.
Results: The serum concentrations (median) of moxiﬂoxacin were
1.9mg/L after 3 hours and 0.54mg/L after 20 hours. Moxiﬂoxacin
penetrated fast into different structural compartments of the heart. The
peak concentrations in atrium and ventricle were measured already 3
hours after the start of the 1hour infusion, the penetration into the aortic
root was somewhat slower. The global tissue concentration/serum ratio
was 3.4−6.8 in ventricle, 2.6−4.8 in atrium and 2.2−2.8 in aortic root
(see Table).
Tissue concentrations (median, range), concomitant serum concentrations and median tissue to serum ratio (a/s right
atrium/serum, v/s right ventricle/serum, ar/s aortic root/serum) in patients (n = 4/group) following a 1 hour infusion
of moxiﬂoxacin 400mg
t (h) serum (mg/L) atrium (mg/g) ventricle (mg/g) aortic root (mg/g) a/s v/s ar/s
3 1.90, 1.41−2.39 8.93, 3.25–15.5 12.8, 5.53–36.5 4.66, 2.41−6.93 4.8 6.8 2.5
7 1.05, 1.03−1.44 3.14, 2.91−4.59 5.90, 5.46−6.62 2.50, 2.41−5.13 3.0 5.4 2.4
10 1.48, 0.99−1.60 2.77, 2.08−3.47 5.00, 3.50−6.69 2.37, 2.09−3.52 3.0 5.4 2.8
13 0.88, 0.53−1.44 2.07, 1.33−4.30 3.43, 1.60−5.03 1.96, 0.97−3.02 2.7 3.4 2.2
20 0.54, 0.48−0.71 1.39, 1.12−2.00 2.34, 2.14−2.63 1.42, 0.96−1.85 2.6 4.2 2.3
Conclusion: From the pharmacokinetic point of view, moxiﬂoxacin
seems to be adequate for the treatment of infectious endocarditis, caused
by susceptible pathogens.
P1260 Comparison of the activity of ciproﬂoxacin vs. levoﬂoxacin
against Pseudomonas aeruginosa by the continous antibiotic
gradient method: a pharmacodynamic approach in
respiratory infection
H. Drugeon, E. Bigeard, M.E. Juvin (Nantes, Angers, FR)
Objectives: The continous antibiotic gradient method allows to assess
the risk of resistant mutant selection. In this study, the activity of
levoﬂoxacin (LVX) was compared to that of ciproﬂoxacin (CIP) against
50 clinical isolates of Pseudomonas aeruginosa. A pharmacodynamic
approach was performed in order to evaluate this risk in the respiratory
tract.
Methods: The antibiotic gradients were prepared in Mueller Hinton agar
plates by applying ﬁlter paper strips containing different concentrations
of antibiotic at regular intervals at the surface of the plate. Six
different inocula, from 10−5 to 10–11 CFU/ml, were tested for each
strain. Two parameters, the length of homogenous growth and the
length to the most resistant colonies were measured and converted into
antibiotic concentrations: boundary concentration (BC) and no growth
concentration (NGC) respectively. The pharmacodynamic approach was
perfomed by dividing the antibiotic concentrations observed in the
epithelial lining ﬂuid (ELF) by the NGC50. The following concentrations
in ELF observed at 4 hours were used: 22mg/L with levoﬂoxacin 750mg
once daily or 500mg bid and 1.9mg/L with ciproﬂoxacin 500mg bid
respectively.
Results: The evolution of mutant selection was parallel between CIP and
LVX: NGC50 increased by 3−5 fold from a weak to an heavy inoculum.
This value refered to the observed in situ antibiotic concentrations
showed a clear superiority of levoﬂoxacin vs. ciproﬂoxacin, conﬁrmed
by the individual analysis of each strain.
Inoculum
Dilution factor 10−4 10−3 10−2 10−1 Pure
NGC50 CIP 0.84 1.03 1.76 2.02 2.31
NGC50 LVX 1.5 2.9 5.1 6.8 9
CP/NGC50 CIP 2.3 1.8 1.1 0.9 0.8
CP/NGC50 LVX 14.7 7.7 4.3 3.2 2.4
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Conclusion: the in vitro selection of P. aeruginosa resistant mutants
is similar between levoﬂoxacin and ciproﬂoxacin. The emergence of
resistant mutants was observed with the same frequency and the
MIC increase is close. Taking into account the lung concentrations,
levoﬂoxacin shows a clear superiority over the ciproﬂoxacin.
P1261 Analyses supporting phase 2 clinical trial dose selection for
zaboﬂoxacin in community-acquired pneumonia
P. Ambrose, S. Bhavnani, R. Jones, M. Wikler (Albany, North Liberty,
San Diego, US)
Objective: To conduct analyses in support of dose selection for
zaboﬂoxacin in Phase 2 community acquired pneumonia (CAP)
studies. Phase 2 clinical trials will be initiated for zaboﬂoxacin,
a new antimicrobial agent belonging to the ﬂuoroquinolone class.
Zaboﬂoxacin has high in vitro activity against pathogens associated with
CAP/respiratory tract infections, including penicillin- and levoﬂoxacin-
non susceptible strains of Streptococcus pneumoniae.
Methods: Monte Carlo simulation (5,000 iterations) using Phase
1 pharmacokinetic (PK), protein binding, and non-clinical PK-PD
data were utilised to determine the probability of attaining free-drug
AUC:MIC target thresholds for daily doses of zaboﬂoxacin ranging
from 50 to 800mg. PK data were derived from a randomised, placebo-
controlled, ascending multiple-dose (dose range 200–800mg daily orally
for 7 days) study in 24 healthy volunteers. Zaboﬂoxacin clearance
(CL/F) was linear over the dose range studied, with a mean (SD) of
36.3 (12.8) L/hour. A point estimate of zaboﬂoxacin binding to serum
proteins of 77%, as estimated by ultra-ﬁltration methodology, was used
in the simulations. Free-drug AUC:MIC was calculated as the product
of f, where f is the fraction unbound, and dose/CL/F. A log normal
distribution for CL/F was assumed. Resultant free-drug AUC values
were divided by ﬁxed clinically relevant MIC values for zaboﬂoxacin
against pneumococci ranging from 0.008 to 0.25mg/L (MIC50/90/99 for
zaboﬂoxacin against S. pneumoniae: 0.015/0.03/0.06mg/L). The free-
drug AUC:MIC target threshold evaluated in these analyses was 30,
which was associated with complete eradication of S. pneumoniae from
the lungs of immuno-competent mice (inoculated with 106 CFU) after
treatment with zaboﬂoxacin.
Results: The probabilities of PK-PD target attainment are presented in
the Table.
MIC Range (mg/L)
Daily dose (mg) 0.008 0.015 0.03 0.06 0.125 0.25
50 0.884 0.201 0 0 0 0
100 0.999 0.876 0.195 0 0 0
200 1.0 0.998 0.880 0.190 0 0
300 1.0 1.0 0.991 0.626 0.045 0
600 1.0 1.0 1.0 1.0 0.579 0.034
800 1.0 1.0 1.0 1.0 0.852 0.167
Note that for daily doses of 300mg or greater, the probability of PK-PD
target attainment approaches 1.0 for MIC values as high as 0.03mg/L,
the MIC90 for zaboﬂoxacin against S. pneumoniae.
Conclusion: These analyses support a 300mg (or greater) once-daily
dose-regimen for zaboﬂoxacin for the treatment of CAP associated with
S. pneumoniae.
P1262 Treatment optimisation using vancomycin on the critical
patient
J.P. Baptista, P. Casanova, P. Martins, J. Pimentel (Coimbra, PT)
Introduction: It is more difﬁcult to optimise antibiotic serum levels
in critical patients (P). The aim of this study was to assess the
therapeutic levels (20–30mg/ml) of vancomycin (V′) on septic critical
P on continuous intravenous infusion.
Materials and Methods: The study was carried out on 175 consecutive
treatments in P with severe sepsis or septic shock, in a multipurpose
ICU (20 beds) over 30 months. P were divided in to different
categories according to degree of renal failure (RF) based on the
RIFLE classiﬁcation (glomeular ﬁltration rate <60ml/m); correlation
of demographic characteristics and renal function with serum levels;
evaluation of the population with and without sufﬁcient levels of V′.
Statistics: t-student test, Mann-Whitney and Pearson coefﬁcient trending
to p< 0.05.
Results: Average age 55.4 yrs, 137 men (78%), average APACHE II and
SAPS II of 17 and 41.9 respectively. The average doses of vancomycin
were 15.2mg/kg for initial loading dose and 29.2mg/kg on day 1
infusion. Average V′ levels for day 1, 2 and 3 were 19.2, 22.1 and
23.9mg/ml with higher levels in women, independent of renal clearance,
total body surface area and the dose of vancomycin measured in the ﬁrst
24 hours: p = 0.02 for the 1st and 2nd day (14/18.3; 16.4/22.4). Over
the total treatment period (1274 days) the V′ levels were above 20 mg/ml
for 66% of the period and above 25mg/ml for 40%. RF occurred in
31 P (17%) of which 12 (39%) had normal creatinine serum levels.
In 71 P with V′1> 20 (37%), RF occurred in 25 P (35%). The V′1,
2 and 3 were higher in the group with RF (p< 0.05) compared to the
rest (17/27, 21/29, 23/30). The correlations between V′1, clearance and
age were moderate (r = −0.6, p< 0.01, r = 0.44, p< 0.01), in the group
without RF. Supratherapeutic levels (V> 30) occurred in 14 P (8.3%) of
which 12 (86%) had RF and 36% (6 P) had normal renal function.
Conclusions: Critical Septic P without RF showed sub-optimum levels
of V′1 and V′2 (<20) in a high percentage of cases (67% and
49% respectively). Women showed higher levels of V′, and V′varied
proportionally with age. Toxic levels occurred mainly in P with RF.
For P without RF, doses of 15mg /kg (loading) and 30mg /kg/day
(maintenance) seem to be insufﬁcient on day 1. In critical patients,
RF is underdiagnosed, as serum creatinine shows low sensitivity for
diagnosis, and so daily clearance should be used to adjust the initial
dose of antibiotics with preferential renal excretion
P1263 Administartion of probiotics decrease the risk of sepsis by
bloodstream infections in patients with multiple injuries
K. Kotzampasi, E.J. Giamarellos-Bourboulis, K. Kanellakopoulou
(Thessaloniki, Athens, GR)
Background: A recent randomised clinical trial of our group
(Kotzampassi et al. World J Surg 2006) has disclosed considerable
reduction of the infective sequelae after oral administration of Symbiotic
FORTE, the latter being a preparation of Pediococcus pentoseceus 5–
33:3, Leuconostoc mesenteroides 32–77:1, Leuconostoc paracasei ssp
19, and Leuconostoc plantarum. The effect of treatment on microbiology
of the study population has not been published and it is presented herein
Methods: Patients were remaining intubated and they were administered
either placebo or probiotics for 15 days after admission. Upon
presentation of signs of sepsis, a complete diagnostic work-out was done
comprising cultures of blood, urine and tracheobroncial secretions (TBS).
Results: Thirteen patients of the placebo group developed bloodstream
infection (36.1%) compared to seven patients of patients treated with
SynbioticFORTE (19.4%, LR: 16.96, p: 0.009). From the 13 placebo-
treated patients with bloodstream infection all developed signs of sepsis
as opposed to the remaining 23 patients without bloodstream infection
where only 11 developed sepsis (OR: 2.182, p: 0.002). From the
seven SynbioticFORTE-treated patients with bloodstream infection ﬁve
developed signs of sepsis as opposed to the remaining 29 patients
without bloodstream infection where 12 developed sepsis (OR: 1.268,
p: 0.219). The time to progression to primary bacteraemia was longer
among patients treated with SynbioticFORTE compared to placebo (p:
0.0237 between groups). Twelve (33.3%) and ﬁve (13.9%) placebo-
treated and probiotic-treated patients respectively developed ventilator-
associated pneumonia with Acinetobacter baumannii as a bacterial cause
(p: 0.047 between groups).
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Conclusions: Probiotics contained in the oral formula SynbioticFORTE
decrease signiﬁcantly the risk for sepsis by bloodstream infections
and the occurrence of VAP by A. baumannii. An effect on bacterial
translocation may be proposed as a probable mechanism of action.
P1264 Effect of gastric pH, dosing regimen and prandial state,
food and meal timing relative to dose, and gastro-intestinal
motility on absorption and pharmacokinetics of the
antifungal posaconazole
G. Krishna, A. Moton, L. Ma, D. Malavade, M. Medlock, J. McLeod
(Kenilworth, NJ, Austin, TX, US)
Objectives: Absorption of posaconazole (POS) can be enhanced if POS
suspension is taken with food or a high-fat meal; in some patients, this
may not be feasible. Factors with a potential to affect POS absorption
were analysed in a four-part, open-label, randomised, crossover study in
healthy subjects.
Methods: Part 1 (gastric pH, n = 32): treatments were POS 400mg single
dose (SD) vs POS 400mg SD + 12 oz ginger ale (acidic beverage) vs
esomeprazole (proton pump inhibitor [PPI]) 40mg QD, 3 days + POS
400mg SD (Day 3) vs PPI 40mg QD, 3 days + POS 400mg SD + 12
oz ginger ale (Day 3). Part 2 (dosing + prandial state, n = 32): treatments
(7 days each) were POS 400mg BID + Boost (nutritional supplement)
vs POS 400mg BID while fasting vs POS 200mg QID + Boost vs POS
200mg QID while fasting. Part 3 (food/meal timing, n = 32): treatments
were POS 400mg SD while fasting vs before vs during vs after high-
fat meal. Part 4 (gastric motility, n = 33): treatments were POS 400mg
SD + Boost vs metoclopramide (prokinetic) 10mg TID, 2 days + POS
400mg SD + Boost (Day 2) vs POS 400mg SD + Boost + loperamide
(anti-kinetic) 4mg SD. Blood collection for analysis was up to 168 h
post-POS dose. Log-transformed data were analysed with ANOVA.
Table: Mean (%CV) POS PK Parameters
Treatment Comparison Cmax, ng/mL AUC, h·ng/mLa
Part 1: Effect of Gastric pH (n = 12)
POS 400mg SD 151 (58) 5930 (50)
POS 400mg SD + Ginger Ale 286 (55) 9890 (48)
POS 400mg SD + PPI 76.7 (37) 4000 (39)
POS 400mg SD + PPI + Ginger Ale 93.3 (34) 4510 (30)
Part 2: Effect of Dosing Regimen [BID/QID] and Prandial State (n = 12)
POS 400mg BID Alone (7 days)b 982 (62) 52300 (89)
POS 400mg BID + Boost (7 days)b 1590 (61) 80600 (73)c
POS 200mg QID Alone (7 days) 2300 (44) 132000 (54)
POS 200mg QID + Boost (7 days)b 2160 (44) 112000 (49)
Part 3: Effect of Food and Meal Timing (n = 12)
400mg SD Fasted 181 (106) 4540 (42)
400mg SD Before Meal 274 (70) 10300 (66)
400mg SD During Meal 555 (44) 21300 (48)
400mg SD After Meal 544 (50) 21300 (48)
Part 4: Effect of Gastric Motility
POS 400mg SD Alone (n = 12) 303 (40) 9070 (37)d
POS 400mg SD + Metoclopramide (n = 13) 232 (32) 7960 (45)e
POS 400mg SD + Loperamide (n = 12) 294 (42) 11100 (52)f
aAUC to inﬁnity for parts 1, 3, and 4; AUC to ﬁnal measurable sampling time for
part 2.
bn = 11; no concentration data for 1 subject.
cn = 10; no concentration data for 1 subject; missing pre-dose concentration for
1 subject.
dn = 9; PK parameters for 3 subjects were excluded due to extrapolated area >25%
of total AUC.
en = 12; PK parameters for 1 subject were excluded due to extrapolated area >25%
of total AUC.
f n = 11; PK parameters for 1 subject were excluded due to extrapolated area >25%
of total AUC.
Results: Part 1: vs POS 400mg SD (fasting), ginger ale increased POS
Cmax and AUC by 92% and 70%; higher gastric pH (via PPI) decreased
POS Cmax and AUC by 46% and 32% (Table). Part 2: vs POS 400mg
BID for 7 days (fasting), POS 400mg BID + Boost increased POS
Cmax and AUC by 65% and 66%; POS 200mg QID plus and minus
Boost increased Cmax and AUC by 137% and 157% and by 136% and
161%, respectively. Part 3: vs POS 400mg SD (fasting), POS 400mg
administered before a high-fat meal increased Cmax and AUC by 96%
and 111%; administration during and after a high-fat meal increased
Cmax and AUC by 339% and 382% and by 333% and 387%. Part 4: vs
POS 400mg SD + Boost, increased gastric motility (via metoclopramide)
decreased Cmax and AUC by 21% and 19%, and reduced gastric motility
(via loperamide) decreased Cmax by 3% and increased AUC by 11%.
Conclusion: Posaconazole absorption is substantially affected by gastric
pH, prandial state, and dose administration timing. A hierarchy of
strategies, including administration with/after high-fat meal, in divided
doses up to QID, with a nutritional supplement, with acidic beverages,
or without PPIs can maximise POS exposure if patients are likely to
have decreased absorption.
P1265 The safety, tolerability, and pharmacokinetics of the
antifungal posaconazole in hepatic impairment
A. Moton, L. Ma, G. Krishna, D. Malavade, R. Preston, J. McLeod
(Kenilworth, Miami, US)
Objectives: To compare the pharmacokinetics (PK) of posaconazole
(POS) in subjects with different degrees of hepatic impairment and in
healthy subjects and to determine the safety and tolerability of a single
POS dose in subjects with different degrees of hepatic impairment.
Methods: This was an open-label, parallel-group study. Thirty-six
subjects were to be enrolled: up to 18 subjects with various degrees of
chronic liver disease (up to 6 subjects in these categories: mild, moderate,
and severe hepatic impairment) and up to 18 healthy volunteers with
normal hepatic function matched with hepatically impaired subjects for
race, age, height, weight, and gender. Each subject received a 400-
mg single dose of POS in the morning, after a standardised high-fat
breakfast. Blood samples to determine POS plasma concentrations were
collected pre-dose and up to 144 h post-dose. Additional samples were
to be drawn at the outpatient visits on Day 10 (approximately 216 h),
Day 14 (approximately 312 h), Day 21 (approximately 480 h), and Day
28 (approximately 648 h). Samples were analysed by an LC/MS-MS
method. Log-transformed PK data were analysed with an ANOVA model.
Table: Mean (%CV) POS PK Parameters
Group Tmaxa (h) Cmax
(ng/mL)
AUC(tf)
(h·ng/mL)
AUC(I)
(h·ng/mL)
Vd/F
(L)
CL/F
(L/h)
t1/2
(h)
Normal vs. Mild
Normal
(n = 6)
5.00 (5−6) 689 (30) 22900 (17) 23400b
(20)
671b
(14)
17.7b
(20)
26.9b
(19)
Mild
(n = 6)
6.5 (5–12) 694 (41) 32800 (37) 31700b
(40)
754b
(33)
14.4b
(40)
38.5b
(28)
Normal vs. Moderate
Normal
(n = 6)
5.50 (4−8) 517 (80) 19600 (66) 22300b
(59)
866b
(45)
25.1b
(67)
26.5b
(22)
Moderate
(n = 6)
5.00 (4−6) 724 (15) 24900 (23) 25700b
(24)
621b
(23)
16.1b
(19)
27.3b
(24)
Normal vs. Severe
Normal
(n = 6)
5.00 (5−6) 608 (35) 19600 (38) 18700b
(40)
1040b
(60)
26.0b
(58)
27.6b
(20)
Severe
(n = 6)
9 (6–24) 403 (31) 23700 (38) 24400 (37) 1058
(39)
18.6
(41)
43.1
(43)
Normal (pooled)
(n = 18) 5.00 (4−8) 605 (47) 20700 (41) 21500c
(41)
857c
(49)
22.9c
(56)
27.0c
(19)
Mild, Moderate, and Severe (pooled)
(n = 18) 6.00 (4–24) 607 (38) 27100 (36) 27100d
(35)
827d
(41)
16.5d
(35)
36.7d
(39)
Note: PK Parameters of AUC(I), CL/F, Vd/F and t1/2 for 4 subjects (1 matched to
moderate hepatically impaired subject, 1 matched to a severely impaired subject,
and 2 matched to moderately impaired subjects) were excluded because t1/2 could
not be determined.
aMedian (range). bn = 5. cn = 15, dn = 16.
Results: Mean POS Cmax was greater in subjects with moderate
hepatic impairment than in healthy subjects (724 vs 517 ng/mL;
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Table) but was decreased in subjects with severe hepatic impairment.
Mean POS exposure, or AUC(tf), was higher in subjects with
hepatic impairment (32,800 h.ng/mL [mild], 24,900 h.ng/mL [moderate],
23,700 h.ng/mL [severe]) than in healthy subjects (20,700 h.ng/mL,
pooled). Median Tmax observed in subjects with normal hepatic function
was approximately 5 h and was delayed to 6.5 and 9 h for subjects
with mild and severe hepatic impairment, respectively. Similarly, the
elimination half-life (t1/2) was prolonged to approximately 39 h and
approximately 43 h in subjects with mild and severe hepatic impairment,
respectively. The increase in t1/2 did not signiﬁcantly affect AUC
compared with that in healthy subjects, especially for subjects with
severe hepatic impairment. The single 400-mg POS dose was safe and
well tolerated when administered to hepatically impaired and healthy
subjects. No deaths or serious adverse events occurred.
Conclusion: POS exposure in patients with hepatic impairment,
regardless of degree of impairment, shows considerable overlap with
that in healthy subjects. Thus, these data suggest that dose adjustment
of POS in patients with hepatic impairment is not necessary.
P1266 Monte Carlo simulation of ceftaroline for pharmacoki-
netic/pharmacodynamic target attainment and dose selection
Y. Ge, S. Liao, G. Talbot (Alameda, Somerset, US)
Objectives: Ceftaroline (CPT) is a novel, parenteral, broad-spectrum
cephalosporin. CPT exhibits excellent bactericidal activity against Gram-
positive organisms, including MRSA and MDRSP, as well as common
Gram-negative pathogens. The objective of this study was to determine
the PK/PD probability of target attainment (PTA) by Monte Carlo (MC)
simulation to guide appropriate dose selection for Phase 3 studies.
Methods: MC simulation of CPT concentrations was conducted using
the S-Plus program in an advanced population PK model derived
from Phase 1 (a single-/multiple-dose study in healthy subjects and a
study in subjects with renal impairment) and Phase 2 data (a study in
patients with complicated skin and skin structure infections [cSSSI]).
CPT concentrations were simulated for 4000 subjects with normal renal
function (creatinine clearance >80 mL/min) at a dose of 600mg CPT
q12 h IV administered over 1 h. Simulations were also performed for a
3-h infusion (same dose) to provide sustained plasma concentrations to
achieve a high PTA. Accounting for variations anticipated in an actual
patient population, the analysis assumed a 21% coefﬁcient of variation
(between-subject variability of clearance) derived from a population PK
model that includes patients with cSSSI. The percentage of time (%T) of
the dosing interval during which serum free drug concentration exceeded
the minimum inhibitory concentration (MIC) was estimated for MIC
values of 0.25, 0.5, 1, 2, 4, and 8 mg/mL. The %T>MIC was determined
based on a free drug concentration of 80%.
Results: MC simulations of 600mg CPT q12 h administered over 1 h
demonstrated a mean %T>MIC of 51% (MIC=2mg/mL). The simulated
mean %T>MICs with the 3-h infusion were 59% (MIC=2mg/mL) and
41% (MIC=4mg/mL), respectively, as shown below.
Target MIC (mg/mL) % T>MIC
1-h infusion 3-h infusion
Mean LL 90% CI Mean LL 90% CI
0.25 98 86 99 95
0.5 89 67 94 77
1 71 51 78 60
2 51 38 59 46
4 34 25 41 31
8 18 11 20 7
CI = conﬁdence interval; LL = lower limit.
Conclusions: Based on MC simulations in subjects with normal renal
function, 600mg CPT q12 h administered as either a 1-h or 3-h infusion
will achieve a high PTA to be able to eradicate target pathogens at
an MIC of 2mg/mL. A 3-h infusion provides a modest increase in
the %T>MIC and allows good coverage for the target of 4mg/mL.
Given relevant pathogen susceptibility proﬁles, epidemiological data,
and animal PK/PD model data, both of these proposed dosing regimens
will achieve a high PTA for target pathogens associated with relevant
indications.
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P1267 Determinants of antibiotic use in surgical wards and in
intensive care units in southwestern France
C. Dumartin, A.M. Rogues, B. Amadeo, A. Fourrier-Reglat, J.P. Gachie,
P. Parneix (Bordeaux, FR)
Objective: To study factors associated with antibiotic (AB) consumption
in surgical wards and in intensive care units (ICU) and their relevance
for benchmarking, in the context of recent French guidelines promoting
reporting of AB use to health authorities.
Method: Data were retrospectively recorded for the whole years 2002
and 2005 from a convenience sample (51 and 55 surgical wards with
1,105,232 and 991,506 PD, 35 and 31 ICU with 139,102 and 139,976
PD): consumption of AB for systemic use (deﬁned daily doses per 1,000
patient-days: DDD/1,000 PD and per 100 admissions: DDD/100 AD),
number of central-line per 1,000 PD (2005) and hospital characteristics
(administrative type, length of stay (LOS), number of beds: total and for
ICU and surgical wards). Additional data were obtained from nosocomial
infection surveys for 13 ICU and 23 surgical wards. AB were classiﬁed
according WHO recommendations (ATC-DDD system, 2005). Multiple
linear regression was performed in a backward stepwise approach.
Results: Median AB consumption, expressed in DDD/1,000 PD and
DDD/100 AD was 1186 and 621 in 2002 and 1416 and 932 in 2005
in ICU; 477 and 268 in 2002 and 505 and 237 in 2005 in surgical
units. Administrative type of hospital was associated with total AB
use in both areas with highest consumption in public hospitals. Pattern
of AB use was associated with LOS in ICU: use of penicillins with
betalactamase inhibitors (J01CR) was lower in ICU with higher LOS,
use of glycopeptides (J01XA) was higher. Total AB use in ICU was
linked with number of central-line per 1,000 PD in 2005. Surgical units
in public and private hospitals had different patterns of consumption,
with more ﬁrst and second generation cephalosporins in private and more
J01CR in public hospitals in 2005. No relationship was found between
patient characteristics and AB use for the 23 surgical units providing
data on patient case-mix.
Conclusion: Speciﬁc data on risk factors in ICU or surgery were difﬁcult
to collect and did not seem to be more linked with AB use than readily
available characteristics such as type of hospital, LOS, number of beds
and of admissions for each area, number of central-line. Therefore, these
factors seem relevant as surrogate to reﬂect patients case-mix, and should
be used for stratiﬁcation when comparing AB consumption from various
hospitals.
P1268 Predictors of piperacillin-resistant Pseudomonas aeruginosa
among patients with respiratory tract infections: the
predictive value of varying exposure deﬁnitions and the
risk of multiple prior antibiotic exposures
N. Patel, T.P. Lodise (Albany, US)
Objectives: The primary objective was to determine if different
prior antibiotic exposure (PAX) thresholds affected the likelihood
of piperacillin-resistance (PR) among patients with Pseudomonas
aeruginosa (PA) respiratory tract infections. The secondary objective
was to examine the relationship between number of PAXs and PR-PA
within the different PAX thresholds.
Methods: Retrospective cross-sectional study of patients with res-
piratory P. aeruginosa clinical cultures between 2001 and 2005.
Demographics, co-morbid conditions, microbiology, and PAX data
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were collected. Each of the following represents a unique PAX:
piperacillin-tazobactam, cefepime, carbapenem, ﬂuoroquinolone, and
aminoglycoside. Two analyses were performed. In the ﬁrst, the following
PAX thresholds were examined: >24, >48 and >72 hours. Classiﬁcation
and Regression Tree (CART) analysis was also used to identify the PAX
threshold for each drug class associated with an increased risk of PR-PA.
Within each PAX threshold, log-binomial regression model was used to
identify independent predictors of PR-PA. In the second analysis, patients
were categorised by number of PAX (0, 1, 2 or >3) within each PAX
threshold. Similar to the ﬁrst analysis, log-binomial regression model
was used to identify predictors of PR-PA within each PAX threshold.
Results: In the ﬁrst analysis, prior piperacillin exposure was associated
with PR-PA for each PAX threshold evaluated. The association between
PR-PA and the other unique PAX varied according to the PAX threshold
examined; more unique PAX were associated with PR-PA as the duration
of PAX threshold increased in duration. In CART, carbapenems had
the shortest duration of PAX associated with PR-PA (3 days), followed
by ﬂuoroquinolones (4 days), aminoglycosides (5 days), cefepime (9
days) and piperacillin/tazobactam (11 days). For the CART-derived PAX
threshold log-binomial analysis, all classes were found to be associated
with PR-PA, with the exception of carbapenem. In the second model,
when the unique PAX were replaced by number of PAX, the number of
PAX was independently associated with an increased risk of PR-PA at
each threshold examined (table 1).
Log-binomial regression analysis of multiple prior antibiotic exposures
associated with PR-PA
Covariate Prevalence
Ratio
95%CI P-value
24 hours
Number of prior exposures 1.62 (1.31−2.00) <0.001
48 hours
Number of prior exposures 1.56 (1.27−1.93) <0.001
72 hours
Number of prior exposures 1.77 (1.42−2.20) <0.001
CART breakpoints
Number of prior exposures 2.17 (1.67−2.82) <0.001
Conclusion: The results indicate that the antibiotic classes that predict
PR-PA differ depending on the threshold of PAX utilised. The results
also demonstrated that number of PAX, irrespective of class, was a more
consistent and better predictor of PR-PA than unique PAXs.
P1269 Are we still using too many antibiotics for acute bronchitis?
F. Marra, M. Chong, D. Patrick (Vancouver, CA)
Background: Acute bronchitis is a lower respiratory tract infection that
causes reversible bronchial inﬂammation. In up to 95 percent of cases,
the cause is viral. While antibiotics are often prescribed for patients
with acute bronchitis, little evidence shows that these agents provide
signiﬁcant symptomatic relief or shorten the course of the illness and
may in fact lead to the emergence of resistant organisms. We undertook
a study to evaluate the consumption of antibiotics for acute bronchitis
in British Columbia (BC), Canada.
Methods: We obtained data from the BC PharmaNet database
on all outpatient oral antibiotic prescriptions from 1996 to 2005.
Prescriptions were expressed as their deﬁned daily dose (DDD) per 1,000
inhabitants according to the 2006 World Health Organisation Anatomical
Therapeutic Chemical system. This data was linked to the physician
billing system to determine the reason for the antibiotic prescription.
Overall and class-speciﬁc rates of consumption were described by year
for treatment of acute bronchitis.
Results: In 1996, the BC consumption rate for all antibiotics used for
acute bronchitis was 0.98 DDD per 1000 inhabitant-days. This decreased
to a low of 0.63 DDD per 1000 inhabitant-days in 2002 but since then has
increased such that in 2005, the rate was 0.81 DDD per 1000 inhabitant-
days. Increases in ﬂuoroquinolone use, speciﬁcally moxiﬂoxacin (37-fold
from year 2000 to year 2005), clarithromycin (3-fold) and azithromycin
(7-fold) were seen while use of tetracyclines and B lactams declined by
approximately 50%.
Conclusions: Physicians continue to prescribe antibiotics for acute
bronchitis and we need to implement a multi-pronged approach within
the province to change prescribing.
P1270 Antibiotic usage in Queensland public hospitals
L. Davis, D. Paterson, D. Olesen (Brisbane, AU)
Objectives: In Queensland Australia, all the public hospital pharmacies
use a common database for drug transactions. The aim was to regularly
extract data from this database in order to obtain information about
antibiotic consumption across Queensland Health facilities over time.
This information will then be distributed back to pharmacists, infectious
diseases physicians and microbiologists in order to inform formulary
restrictions and inﬂuence clinical practice change in relation to antibiotic
usage at the local hospital level.
Methods: Data of all antimicrobials transactions in the pharmacy
database were extracted into a custom built application. Antibacterial
agents were categorised using the Anatomical Therapeutic Chemical
(ATC) classiﬁcation index with 2007 deﬁned daily doses (DDD).
Antibiotic use was measured using DDD per 1,000 patient days
(DDD/1000 PD). Data was stratiﬁed into intensive care (ICU) based
on classiﬁcation as a level 2 or 3 unit, and non ICU. Outpatient use
was excluded as was data from the large tertiary paediatric facility and
where it was possible to identify paediatric usage in the other facilities
this data was also excluded.
Results: Total antibiotic consumption for Queensland public hospitals
in 2006 was 946 DDD/1000 PD and in ICUs it was 657 DDD/PD. The
b-lactam antibacterials, penicillin (ATC class J01C) accounted for just
over half the total usage (481 DDD/1000PD) but only a third of the ICU
usage (221 DDD/1000PD). The other b-lactam antibacterials (ATC class
J01D) constituted 24% percent of the usage in ICU (156 DDD/1000PD)
and 18% of the overall consumption (173 DDD/1000PD). Macrolides,
lincosomides and streptogramins (ATC class J01F) accounted for 16%
of the ICU antibiotic usage (107 DDD/1000PD) but only 9% of the total
usage (89 DDD/1000PD).
Conclusion: Antibiotic usage in Queensland public hospitals is
comparable with that reported nationally and in other Australian states.
This consumption however, is higher than that reported in countries such
as Denmark, Netherlands & Sweden. Regular and timely feedback of
these antibiotic usage rates to those who have inﬂuence and control over
prescribing and formulary restrictions within the public hospital system
should assist to improve prescribing practices.
P1271 Trends in antibiotic consumption over an 8-year period in
a general hospital of Athens, Greece
C. Loupa, I. Tzannou, V. Tsolaki, A. Dimizas, G. Psatheris,
M. Panagou, M. Divani, M. Lelekis (Athens, GR)
Objective: The aim of the present study was to record the trends in
antibiotic consumption in our 300-bed general hospital over an 8 year
period.
Methods: Antibiotic consumption for the period 1999 to 2006
was studied retrospectively using data from the pharmacy computer.
Antibiotic use was calculated in DDDs per 1000 patient days (ABC
Calc 3.0). We used linear regression for statistical analysis (SPSS 11.5).
Results: Antibiotic consumption was 572, 647, 678, 675, 710, 785,
892 and 822 DDDs/1000 patient days (years 1999, 2000, 2001, 2002,
2003, 2004, 2005 and 2006 respectively) and the trend was signiﬁcant
(p = 0.001). Concerning consumption of major classes of antibiotics,
only penicillins had a decrease (from 83.4 to 55.6 DDDs per 1000
patient days). The consumption of other classes of antibiotics had
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the following trend over time: cephalosporins/aztreonam from 152.6
to 217 (p=NS), penicillins+inhibitors from 133.9 to 210.9 (p = 0.028),
carbapenems from 3.8 to 18 (p = 0.005), aminoglycosides from 45.4 to
35.2 (p=NS), macrolides from 35.9 to 68.2 (p=NS), quinolones from
28.6 to 109.6 (p< 0.001) and glycopeptides from 1.3 to 22.7 DDDs
per 1000 patient days (p = 0.002). It is worth noting that carbapenems,
quinolones and glycopeptides are included in the restricted antibiotics list
for all Hellenic hospitals since late ’80s, together with 3rd-4th generation
cephalosporins/monobactams.
Conclusions: During the study period, total consumption increased
signiﬁcantly and this was the case for almost all major classes of
antibiotics as well, including ones under restriction. Future studies will
reveal if the decrease of total consumption recorded in 2006 compared
to 2005 is incidental or is the beginning of a downwards move of
the consumption. Meanwhile, due to the incremental trend of total and
restricted antibiotics consumption, it is quite obvious that our restriction
policy is unsuccessful and should be revised.
P1272 Demographic factors associated with increase in antibiotic
consumption in Danish primary healthcare
U.S. Jensen, S.S. Olsen, A.M. Hammerum, N. Frimodt-Møller
(Copenhagen, DK)
Objectives: From 1997 to 2006 an increase of 24% in total antibiotic
consumption in Danish pri-mary healthcare has been observed. The aim
was to compare and possibly associate various demo-graphic factors with
the increase in antibiotic consumption.
Methods: Data were obtained from the DANMAP 2006 report, the
Danish Medicines Agency, the National Board of Health and the
Statistics Denmark.
Results: The antibiotic consumption varied between the 15 Danish
counties; however the increase was parallel in all counties throughout
the study period. From 2000–2006 the increase in number treated/1000
inhab./days was 6% for both women and men. A signiﬁcantly higher
proportion of women received antibiotics (358/1000 inhab.) compared
to the proportion of men (261/1000 in-hab.). People of both gender aged
>70 years received 1.6 times more antibiotics than people <70 years of
age.
The distribution by sex in the population did not change throughout the
study period.
From 1997 to 2006 the population has increased by 145,000 inhabitants
to a total of 5.4 million. The major part of this increase was in the
age group; 60–69 years of age (~125,000). An estimated extra antibiotic
consumption of these additional 125,000 people would only increase the
total use of antibiotics in 2006 by 4%. From 1997 to 2006 the overall
number of contacts with primary healthcare – which can be used as a
general measure of the activity in primary healthcare – increased 38%
for women and 32% for men.
During the period the major relative increase in consumption of
individual antibiotic groups was in b-lactamase resistant penicillins
(209%) and b-lactam-inhibitor combinations (500%), but these groups
only constituted 6.9 and 0.8% of the total use, respectively. The
consumption of the largest group, b-lactamase sensitive penicillins
representing 35% of the total consumption in primary healthcare
throughout the entire study period, increased 18%.
Conclusion: The 24% increase in total antibiotic use from 1997 to 2006
in Denmark was parallel in all counties and parallel for women and men
at all age groups. While the total population increased only slightly,
a 32–38% increase in contacts with primary healthcare was observed
during the pe-riod. The overall increase encompassed most antimicrobial
groups. Apparently, the recent increase in antibiotic consumption in
Denmark is due to general socio-health factors with no easy single tar-
gets for intervention.
P1273 The intravenous route in hospital patients – Is this being
misused?
A. George, M. George, S. McKain, K. Shute, K. Swarnkar, I. Grant,
D. Defriend, P. Turner (Newport, Plymouth, Torquay, UK)
Aims: It is assumed that almost every patient who is admitted to hospital
will have a peripheral cannula inserted. It is observed that patients
receive intravenous therapy long after resuming a normal gut function.
The aim of this study was to assess if intravenous therapy could be
terminated sooner thereby avoiding the associated costs and increased
patient morbidity
Methods: 200 randomly selected medical and surgical hospital in-
patients across three NHS Trusts in Southern England who had
a peripheral venous cannulae inserted for intravenous therapy were
monitored daily for 8 days or until removal of the cannula – whichever
came ﬁrst. A non-interventional study was undertaken by gathering
information on all aspects of intravenous therapy including intravenous
ﬂuids and antibiotics that the patient received. The ability of the patient
to take a normal diet was also checked – this signifying that the
patient had a normally functioning gut, which could absorb oral ﬂuids
and medicines, whereby, use of the intravenous route could have been
avoided.
Results: 74% of cannulae continued to be used in patients to give
intravenous ﬂuids and antibiotics inspite of the patient being on a normal
diet. 40% of the cannulae were left in for more than 48 hours after
their use had stopped with a minority being left in for more than 120
hours. The tendency for healthcare personnel to continue patients on
intravenous ﬂuids and medication in spite of the patient on a normal
diet was largely attributed to the lack of awareness among the healthcare
personnel
Discussion: This study highlights an urgent need to increase the
awareness among the healthcare personnel. The ability of a patient
to fully absorb oral medications while on a normal diet is being
stressed along with the need to increase oral ﬂuid intake of the patient
instead of continuing on intravenous ﬂuids. Though peripheral cannulae
are essential in patients, their use should be regulated and carefully
monitored.
Peripheral intravenous cannulation is an innocuous procedure but has
a potential for signiﬁcant morbidity and increased healthcare costs. The
use beyond necessity remains singularly unrecognised. Attention to detail
and continuing education of the healthcare personnel is all important.
P1274 Factors affecting achievement of antimicrobial prescribing
targets in general practice
M. Heginbothom (Cardiff, UK)
Objectives: During the last decade, the emergence and spread
of antimicrobial resistance has become a major global healthcare
concern. There is a plethora of evidence showing that antimicrobial
consumption is the major factor driving resistance and a number
of intervention programmes have been initiated internationally. Of
central importance to these programmes are measures to reduce
inappropriate antimicrobial use. Following government recommendations
to facilitate reduced prescribing, in 2001, the health authorities in Wales
introduced antimicrobial prescribing indicator targets as part of a general
practitioner (GP) prescribing incentive scheme. The aim of this study is
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to investigate factors affecting achievement of antimicrobial prescribing
targets by GPs in Wales.
Methods: 480 general practices comprising 1785 GPs based in Wales
were included in this cross-sectional study. Antimicrobial prescribing
analysis and cost (PACT) data for 2001 was scored against the
prescribing indicator targets for the year (see table). A score of zero
was interpreted as ’failing to achieve’ the target. Logistic regression
modelling was used to explore the relationship between outcome and
possible explanatory variables including age or gender of GP, contracted
hours, place of qualiﬁcation, number of GPs in practice, list size (patients
per GP), deprivation index (Townsend score), dispensing practice,
morbidity data, and practice training status.
Results: Overall, the percentages of practices failing to meet Target 1
(winter), Target 1 (summer), Target 2, and Target 3 were 14.6, 8.5, 11.9,
and 45.8 respectively. Practices that failed to achieve Target 1 (winter)
were situated in areas of high-deprivation where practitioners were
single-handed, not-qualiﬁed in the UK and near retirement (p< 0.001).
However, for the summer quarters failure was associated with training
practices in areas of low-deprivation (p< 0.05). Failure in both Targets
2 & 3 was most strongly associated with dispensing practices (p< 0.05).
Conclusions: The factors associated with failing to achieve the targets
are complex with different practice proﬁles for those failing summer
and winter targets. This may relate to the nature of the targets which
suggests that great care should be taken in target design. The ﬁnancial
incentives associated with being a dispensing practice appear to skew
the prescribing practices of GPs to increased use of ﬂuoroquinolones
and less use of narrow spectrum agents.
P1275 Trends in antibiotic prescription among children attending
daycare centres in France: 1999–2006
C. Van Dijken, P. Bruno, P. Touboul, H. Carsenti-Dellamonica,
M. Roussel-Delvallez, M. Lelieur-Pie´rard, B. Dunais, C. Pradier,
P. Dellamonica (Nice, Lille, FR)
Objectives: to assess trends in antibiotic prescription among children
attending day-care centres (DCC) following promotion of prudent
antibiotic use (PAU) in uncomplicated paediatric respiratory tract
infections (RTI).
Methods: antibiotic prescriptions were recorded from health booklets
over a 3-month period preceding each of 4 pneumococcal nasopharyn-
geal carriage surveys among a random sample of children from January-
March 1999, 2002, 2004, 2006 in DCCs in the Nord (ND) and Alpes
Maritimes (AM) areas. A local intervention promoting PAU in paediatric
RTI was conducted in AM in 2000 and 2003, via academic detailing
visits to all general practitioners and paediatricians, and a national media
campaign began in 2002. Number of treated episodes and distribution
of diagnoses were studied for each survey in both areas.
Table 1: Trends in proportion of treated children
Year N % treated OR 95%CI p
Alpes Maritimes
1999 221 59.30% 1
2002 209 48.80% 0.65 0.44, 0.98 0.03
2004 258 48.80% 0.66 0.45, 0.96 0.02
2006 283 25.40% 0.23 0.16, 0.35 <10−3
Nord
1999 226 74.80% 1
2002 177 65.50% 0.64 0.41, 1.01 0.04
2004 171 55.00% 0.41 0.26, 0.64 <10−3
2006 227 50.20% 0.34 0.022, 0.52 <10−3
Results: The proportion of treated children fell signiﬁcantly over
the study period (Table 1), as did the average number of treated
infections/child, from 1.00±0.07 to 0.33±0.65 in 2006 in AM and from
1.57±1.26 to 0.84±1.09 in ND between 1999 and 2006, respectively
(p< 10−5 for each area). Among documented diagnoses, the proportion
of prescriptions for rhinopharyngitis decreased from 15.1% to 6.5% in
AM (p = 0.08) and from 24.4% to 13.7% in ND (p = 0.06), while that
for acute otitis media increased from 34.2% (N=193) to 45.7% (N=81)
in AM (p = 0.07) and from 31.6% (N=291) to 53.6% (N=168) in ND
(p< 10−5) between 1999 and 2006, respectively.
Distribution of antibiotic classes between 1999 and 2006 shifted towards
3rd generation cephalosporins from 25.8% of prescriptions (N=217)
to. 37.5%(N=104) in AM (p = 0.03) and from 19.0%(N=358) to.
40.8%(N=191) in ND(p< 10−5), respectively, at the expense of 1st
generation cephalosporins and macrolides.
Conclusion: Interventions advising PAU proved effective in RTI
management among children attending DCCs. Fewer children were
treated and rhinopharyngitis accounted for a lower proportion of
prescriptions after the interventions. However, increasing use of wide
spectrum antibiotics may hamper efforts to curb bacterial resistance.
P1276 Role of different classes of antimicrobials on the risk of
acquisition of resistant micro-organisms in critically ill
medical patients
J.A. Martı´nez, J. Vila, E. Delgado, M.R. Monte, A. Alquezar, P. Castro,
A. Trilla, C. Codina, P. Vaselka, J.M. Nicola´s (Barcelona, ES)
Objective: To assess the role of different classes of antibiotics on the
risk of acquisition of resistant micro-organisms in critically ill medical
patients.
Methods: From March 2006 to May 2007, all patients admitted to an
8-bed medical intensive care unit (MICU) were subjected to swabbing
of nares, pharynx and rectum, and culture of respiratory secretions
on admission and thrice weekly thereafter. Acquisition of a resistant
microorganism was deﬁned as the isolation, after 48 hours of MICU stay,
of a strain of meticillin-resistant Staphylococcus aureus, vancomycin-
resistant enterococci, enteric Gram-negative bacilli resistant to third-
generation cephalosporins, Pseudomonas aeruginosa resistant to at
least one class of antipseudomonals or any other non-fermenter from
patients whose admission cultures were either negative or positive for
a susceptible isolate of the same species. The ﬁrst acquired resistant
microorganism deﬁned the outcome. Recorded clinical variables included
demographics, severity scores, underlying conditions and exposure to
any procedure or drugs during MICU stay. Analysis was restricted to
patients with a length of stay greater than 2 days and performed by
using a logistic regression procedure.
Results: Out of 293 patients evaluated, 72 (25%) acquired a resistant
microorganism, including a Gram-positive in 8 (3%), P. aeruginosa in
19 (6%), other non-fermenters in 12 (4%), Escherichia coli in 16 (5%),
Klebsiella spp. in 6 (2%), and an enteric ampC-bearing organism in
11 (4%). The primary site of colonisation involved the rectum in 57
cases (79%). Of 270 (92%) patients exposed to antimicrobials, 204
(76%) received an antipseudomonal regimen, including ceftazidime in
33 (12%), piperacillin-tazobactam in 62 (23%), meropenem in 93 (34%)
and a quinolone in 106 (39%, ciproﬂoxacin in 33 and levoﬂoxacin in
73). Multivariate analysis selected age (OR 1.02, 95%CI 1−1.04), use of
ceftazidime for >3 d (OR 3.8, 95%CI 1.3–11), mechanical ventilation
for >3 d (OR 7.9, 95%CI 2–31) and exposure to a nasogastric tube (OR
15, 95%CI 2.8–79) as the best predictors for the acquisition of resistant
organisms, whereas location in two particular rooms was protective (OR
0.3, 95%CI 0.1−0.8).
Conclusions: Currently, in critical care settings characterised by an
almost universal exposure to antimicrobials, ceftazidime use may
represent the antimicrobial exposure associated with the highest risk
for the acquisition of resistant bacteria.
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P1277 Pharmaceutical quality and supply route of antibiotics
obtained with or without prescription (over the counter) in
Indonesia
U. Hadi, P.J. van den Broek, M. Keuter, E. Kolopaking, W. Gardjito,
I.C. Gyssens (Surabaya, ID; Leiden, Nijmegen, NL)
Background: Our survey of 2996 individuals visiting public healthcare
facilities in Indonesia showed that 17% of antibiotic users obtained
the antibiotics over the counter (OTC) from different suppliers. Use of
amoxicillin, ampicillin, chloramphenicol, ciproﬂoxacin, cotrimoxazole
and tetracycline was most frequently reported.
Objective: To determine the supply route and the pharmaceutical quality
(PQ) of frequently used oral antibiotics outside hospitals.
Methods: Four simulated clients requested antibiotics in 3 areas
surrounding a government hospital and 2 healthcare centres in Surabaya.
Clients went in 4 directions to visit each supplier on their journey in order
to purchase 20 samples of 5 antibiotics. Sampling was equally divided
over the different areas and suppliers. Samples were photographed,
including package. PQ of tablets and capsules was analysed by a certiﬁed
independent Dutch laboratory using HPLC.
Results: 75 pharmacies, 10 drugstores and 40 roadside stalls (kiosks)
were visited. 104 samples were obtained, 76% without prescription and
81% generic. All but one out of 14 manufacturers were Indonesian.
Never was oral information provided. Written information was limited
to a copy of the dosing regimen from the prescription. Although “by
doctor’s prescription only” was printed on all blisters, none of the OTC
requests were refused nor questioned. Only one drugstore sold antibiotics
(tetracycline); 29 kiosks sold either amoxicillin, chloramphenicol,
ciproﬂoxacin or tetracycline. The PQ of 23 chloramphenicol and 19
ciproﬂoxacin samples were within British Pharmacopeia (BP) limits. The
content of 5/20 amoxicillin and 5/22 tetracycline samples were <5%
below BP limits, but in 10/20 of cotrimoxazole tablets, trimethoprim
was 20% below BP limits, 8/9 of which from the same manufacturer.
There was no difference of PQ between suppliers, between generic and
branded samples, or between blister-packed and unpackaged (plastic
bag) samples. Prices of antibiotics from the same manufacturers were
invariably higher in kiosks than in pharmacies; prices per tablet/capsule
varied up to 6 fold for cotrimoxazole to 20 fold for ciproﬂoxacin.
Conclusion: Substandard quality is probably a manufacturing problem.
Although in Indonesia OTC sales of antibiotics are prohibited by law,
antibiotics were sold OTC in pharmacies and some were retailed at higher
prices in kiosks. Enforcement of legislation is urgently needed.
P1278 The effect of antimicrobial use on resistance in Escherichia
coli in Finland
M. Bergman, S. Nyberg, P. Huovinen, A.J. Hakanen and the Finnish
Study Group for Antimicrobial Resistance (FiRe Network)
Objectives: The connection between regional antimicrobial resistance
rates in Escherichia coli and regional outpatient antimicrobial use in
Finland was investigated.
Methods: During a 9-year study period of 1997–2005, more than
700 000 E. coli isolates, mainly from urine samples, were tested for
antimicrobial resistance in 26 microbiological laboratories, representing
18 of the 20 central hospital districts in Finland. The following
antimicrobials were included in the study: amoxicillin, amoxicillin-
clavulanate, ﬁrst-generation cephalosporins (mainly cephalexin), ﬂuoro-
quinolones (of which levoﬂoxacin, norﬂoxacin, and ciproﬂoxacin were
studied separately), trimethoprim, sulfatrimethoprim, pivmecillinam, and
nitrofurantoin (Table). There were two study approaches: (1) the level of
antimicrobial use of one year was compared with the level of resistance
of the next year, and (2) the change in antimicrobial use was compared
with the change in resistance within the study period.
Results: The following signiﬁcant associations were found between
the level of use and the level of resistance (approach No. 1):
nitrofurantoin use vs. nitrofurantoin resistance, cephalosporin use vs.
nitrofurantoin resistance, amoxicillin use vs. ﬂuoroquinolone resistance,
ﬂuoroquinolone use vs. ampicillin resistance. The following signiﬁcant
associations were found between the change in use and change in
resistance (approach No. 2): amoxicillin or amoxicillin-clavulanate
use vs. ampicillin resistance, combined use of trimethoprim and
sulfatrimethoprim vs. trimethoprim and sulfatrimethoprim resistance,
and trimethoprim use vs. sulfatrimethoprim resistance. No other positive
connections were found (Table).
Level of resistance and consumption Change in resistance and consumption
Resistance Consumption Resistance Consumption
Ampicillin vs. Amoxicillin Ampicillin vs. Amoxicillin
Amoxicillin +
Clavulanate
Amoxicillin +
Clavulanate
Fluoroquinolones Fluoroquinolones
Cephalothin vs. Cephalosporins Cephalothin vs. Cephalosporins
Fluoroquinolones Fluoroquinolones
Trimethoprim Trimethoprim
Sulfatimethoprim Sulfatrimethoprim
Trimethoprim +
Sulfatrimethoprim
Trimethoprim +
Sulfatrimethoprim
Nitrofurantoin Nitrofurantoin
Fluoroquinolones vs. Amoxicillin Fluoroquinolones vs. Amoxicillin
Amoxicillin +
Clavulanate
Amoxicillin +
Clavulanate
Cephalosporins Cephalosporins
All ﬂuoroquinolones All ﬂuoroquinolones
Levoﬂoxacin Levoﬂoxacin
Norﬂoxacin Norﬂoxacin
Ciproﬂoxacin Ciproﬂoxacin
Trimethoprim vs. Trimethoprim Trimethoprim vs. Trimethoprim
Sulfatrimethoprim Sulfatrimethoprim
Trimethoprim +
Sulfatrimethoprim
Trimethoprim +
Sulfatrimethoprim
Sulfatrimethoprim vs. Trimethoprim Sulfatrimethoprim vs. Trimethoprim
Sulfatrimethoprim Sulfatrimethoprim
Trimethoprim +
Sulfatrimethoprim
Trimethoprim +
Sulfatrimethoprim
Mecillinam vs. Pivmecillinam Mecillinam vs. Pivmecillinam
Nitrofurantoin vs. Cephalosporins Nitrofurantoin vs. Cephalosporins
Nitrofurantoin Nitrofurantoin
Conclusion: Because of the link between nitrofurantoin consumption
and resistance, more attention should be paid to the prescription of
nitrofurantoin for outpatient E. coli infections. An interesting cross-
connection seems to exist between amoxicillin use vs. ﬂuoroquinolone
resistance and ﬂuoroquinolone use vs. ampicillin resistance. Interestingly,
a connection was not found between ﬂuoroquinolone use and ﬂuoro-
quinolone resistance.
P1279 Relationship between antimicrobial use and antimicrobial
resistance in E. coli and Klebsiella pneumoniae blood
isolates at 5 tertiary hospitals in Korea
H-H. Chang, S-I. Jung, S-W. Kim, Y.S. Kim, H.K. Ki, J.S. Yeom,
K.S. Ko, D.R. Chung, K.R. Peck, J-H. Song on behalf of the KONSID
(Korean Network of Studies on Infectious Diseases)
Objectives: Increases in the prevalence of antibiotic-resistant Gram-
negative bacilli (GNB) in hospitals are frequently related to the high
selective pressure of antibiotics. This study was performed to evaluate
the association between antimicrobial resistance in E. coli & Klebsiella
pneumoniae that caused bacteraemia in hospitalised patients and anti-
GNB antimicrobial use in 5 tertiary teaching hospitals in Korea.
Methods: Data on annual patient-days and consumption (deﬁned daily
dose (DDD) per 100 patient-days) of antibiotics from January 2005
to December 2005 in 5 tertiary hospitals in various regions of Korea
were analysed. A total 302 nonduplicate E. coli & K. pneumoniae
isolates that caused nosocomial bacteraemia was collected from July
2006 to November 2006. To determine the antimicrobial resistance, broth
microdilution test and double disk synergy were performed according to
the CLSI performance standards. Spearman’s correlation coefﬁent was
used to determine the relationship between antibiotic consumption and
resistance.
Results: The prescription of anti-GNB antibiotics in 5 tertiary hospitals
markedly varied (median value 93.04 DDD/ 100 patients-days, range
34.81−117.78 DDD/ 100 patients-days). Ceftazidime-resistant E. coli
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& K. pneumoniae was signiﬁcantly correlated with the higher use of
aminopenicillins (r=0.900, P< 0.05), total aminoglycosides (r=0.900,
P< 0.05), and carbapenems (r=0.900, P< 0.05). Cefotaxime resistance
showed positive correlation with the higher use of aminopenicilllins
and ceftazidime, but had no statistical signiﬁcance (r=0.718, P> 0.05
and r=0.600, P> 0.05, respectively). Imipenem resistance showed week
positive correlation with the higher use of carbapenems, but had no
statistical signiﬁcance (r=0.671, P> 0.05).
Conclusion: The higher consumption of some antibiotics was signiﬁ-
cantly correlated with the higher rate of antibiotic-resistant E. coli &
K. pneumoniae. Continuous surveillance of antibiotic use is needed to
encourage appropriate prescribing of antibiotics and to reduce antibiotic
resistance.
P1280 Junior doctors’ perceptions of the problem of bacterial
resistance in hospitals
C. Pulcini, F. Williams, P. Davey, D. Nathwani (Nice, FR; Dundee, UK)
Objectives: The aim of this study was to assess how the problem of
bacterial resistance was perceived by the junior doctors.
Methods: We surveyed 63 junior doctors in their ﬁrst year of
postgraduate training at one university teaching hospital in Dundee
(Scotland, UK) to assess their attitudes about the importance of antibiotic
resistance, knowledge of its prevalence, beliefs about its causes and
attitudes about interventions designed to address the problem.
Results: The response rate was 70% (63 of 90 doctors). Thirty-ﬁve
(56%) junior doctors were training in a medical speciality and 24
(38%) in a surgical one. Sixty-two (98%) of them had prescribed an
antibiotic within the past 6 months. Antibiotic resistance was perceived
as a national problem by 92% of the respondents, but only 52% rated
the problem as important in their own daily practice. Only 22% of
the junior doctors had a correct idea of the prevalence of MRSA in
UK hospitals. Nearly all doctors (94%) believed that widespread and
inappropriate antibiotic use, or prescription of broad spectrum antibiotics
were important causes of resistance. Excessive durations of antibiotic
treatments were rated as an important cause of resistance by 80% of the
doctors, but only 51% recognised too low antibiotic doses as a potential
cause of bacterial resistance. Finally, only 45% of the doctors identiﬁed
poor hand hygiene practices as an important driver for resistance. More
than 90% of the junior doctors rated the following measures as helpful
to improve antibiotic prescribing: educational sessions, availability
of guidelines and readily accessible advice from a microbiologist/an
Infectious Diseases specialist/a pharmacist/or a colleague. Regular audit
and feedback of the antibiotic prescribing practices on the ward was
found helpful by 82% of the doctors and availability of resistance
data was rated useful by 77% of them. Restrictive measures were not
as popular, with 66% of the junior doctors rating restriction of some
antibiotics useful, and 13% ﬁnding the restriction of all antibiotics
potentially helpful.
Conclusion: Although most junior doctors view antibiotic resistance
as a serious national problem, perceptions about its local importance,
its causes, and possible solutions vary more widely and are not
always evidence-based. These perceptions must be taken into account
to maximise adherence of the junior doctors to the measures aiming at
curbing bacterial resistance.
P1281 Outpatient utilisation of antibiotics in Zagreb, 2006
D. Sˇtimac, J. Culig, D. Jonjic, Z. Sˇostar, M. Bucalic (Zagreb, HR)
Objectives: Antibiotics accounted for 4% of total prescription drug
utilisation in 2006, expressed as DDD/TID, and for 10% of ﬁnancial
drug utilisation. The aim of the study was to assess antibiotic utilisation
in 2006 in the City of Zagreb.
Methods: Data on the number of packages for each individ-
ual drug were collected from all Zagreb Pharmacy units. Based
on these data, the number of deﬁned daily doses(DDD)and
DDD/1000inhabitants/day(DDD/TID)for 2006 were calculated for all
14 drug groups of the Anatomical-Therapeutic-Chemical (ATC) drug
classiﬁcation system at all levels of ATC system for each individual
drug.
Results: Total outpatient utilisation of antibiotics in Zagreb was
37.38DDD/TID, with penicillins accounting for 50%.The subgroup
of penicillin combinations yielded a 54% share in the utilisation of
antibiotics, and referred completely to amoxicillin + clavulanic acid
combination, for years the most frequently prescribed antibiotic in
Zagreb. The subgroup of penicillins sensitive to b-lactamases, accounted
for 23% of penicillin utilisation. The subgroup of broad-spectrum
penicillins, accounted for 21.50% of penicillin utilisation. The majority
of this subgroup utilisation referred to amoxicillin with 3.96 DDD/TID.
The subgroup of b-lactamase resistant penicillins showed lowest share
in the overall antibiotic utilisation. Cephalosporins accounted for 20.5%
of total antibiotic utilisation. Cefuroximeaxetil accounted for the most
part of utilisation with 5.5DDD/TID, followed by cephalexin with
1.44DDD/TID. In the J01E subgroup, sulfamethoxazole+trimethoprim
accounted for the entire utilisation with1.39DDD/TID.The utilisation of
macrolides was 4.04 DDD/TID.Aminoglycosides showed a utilisation
of 0.15DDD/TID.Tetracyclines accounted for 7%, and quinolones, for
6% of antibiotic utilisation in Zagreb. Norﬂoxacin accounted for 70%
of utilisation in this group. In the group of other antimicrobials,
nitrofurantoin accounted for almost entire outpatient utilisation with 0.90
DDD/TID.
Conclusion: Almost one-third of outpatient antibiotic utilisation in the
City of Zagreb in 2006 referred to amoxicillin+clavulanic acid, whereas
current guidelines suggest that narrow-spectrum antibiotics should be
preferred. Therefore, the utilisation of antibiotics in the City of Zagreb
could not be considered appropriate.
Antibiotic usage and abusage: the solutions
P1282 Results after the introduction of a pharmacist-managed
surgical antibiotic use policy
M. Szabo, S. Abraham, R. Benko, M. Matuz, E. Hajdu, G. Lazar
(Szeged, HU)
Objectives: Our study aims at comparing the use of surgical antibiotics
before and after the introduction of local surgical antibiotic use policy.
Methods: The research was performed at an 82-bed General Surgery
Department. The local surgical antibiotic use policy was launched by the
pharmacy service in December 2005. We analysed the surgery-related
antibiotic use in the February months the preceding (2004–2005: Period
I) and in the subsequent two years (2006–2007: Period II). In order to
determine individual antibiotic usage, data were collected retrospectively
from ﬂow-charts and anaesthetic records. Surgical procedures were
classiﬁed according to wound class categories. The following parameters
were compared: the frequency of antibiotic use in different wound class
categories, the timing of antibiotic administration, the duration and the
average price of antibiotic use.
Results: 822 operations were performed (438 in period I; 384 in period
II). In terms of wound class, antibiotics were administered in the
following proportions: 30.3% vs. 44.8% clean, 54.2% vs. 50.0% clean-
contaminated, 41.3% vs. 60.3% contaminated, and 86.2% vs. 83.3%
infected surgeries. The most frequently used antibiotics was cefuroxime
(or cefuroxime-metronidazole combination) in both periods. Concerning
proper timing, Period I saw antibiotics administered in the morning,
disregarding whether the patient was operated immediately afterwards
or only later during the day. In period II antibiotics were administered in
the operating theatre in all instances, concurrently with the induction of
anaesthesia. The average duration of the surgery-related antibiotic use
was 3.3±2.0 days in period I, vs. 2.4±2.0 days in period II. Calculating
with prices valid in 2007, the average price of surgery-related antibiotic
use has decreased from 18.3±5 to 9.0±2 Euro.
Conclusion: The introduction of the local surgery-related antibiotic use
policy was successful in several aspects, since proper timing, shorter
duration of prophylactic antibiotic use and cost savings were achieved.
However, patient-level analysis highlighted ﬁelds of inappropriateness:
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despite the fact that prophylactic or therapeutic antibiotic use would be
in several cases the surgeons did not indicate antibiotic use. Therefore,
we demonstrated that the initiations of the pharmacy service and the
continuous evaluation of its effectiveness are both essential in order to
improve surgery-related antibiotic use.
P1283 Implementation of an intravenous to oral switch policy for
antimicrobials in a secondary care setting
K. Dunn, A. O’Reilly, V. Treacy, T. Rogers, C. Bergin (Dublin, IE)
Objectives: Sequential therapy is deﬁned as the timely transition from
parenteral to oral antimicrobial therapy. It is promoted as intravenous
therapy is more expensive, has signiﬁcant adverse effects, is time
consuming for staff and is not always more efﬁcacious.
To develop and issue guidelines to clinical pharmacists on enacting an
intravenous to oral switch policy in a large Irish teaching hospital.
To implement an intravenous to oral switch policy, and to examine the
effect of this policy.
To ﬁnd out if an earlier switch to an oral antimicrobial resulted in a
shorter hospital stay.
To record where empiric treatment was prescribed, if the initial
antimicrobial chosen complied with the hospital empiric guidelines.
To calculate cost savings generated from the implementation of the
stategy.
Methodology: This was a prospective, controlled before and after study.
A control and study group were included. The intervention consisted of
the application to the drug chart of stickers promoting an oral switch
along with a guide on the criteria for switch. Duration of intravenous
treatment, the number of days after the criteria were met before
antimicrobials were switched to oral, length of stay and cost savings were
measured. Compliance with the hospital empiric antimicrobial guidelines
was assessed.
Results: The study included 236 patients prescribed 289 intravenous
antimicrobial courses. The duration of intravenous treatment reduced
signiﬁcantly between the pre- and post-intervention periods, when
comparing the study group to the control group (p = 0.02). The number
of days after the criteria for switching was met before the patient was
switched to oral antimicrobials reduced signiﬁcantly post-intervention in
the study group compared to the control group (p = 0.017). The median
length of stay did not reduce. The intervention was cost effective, and
resulted in some cost savings, (€6.41 per patient in the post-intervention
study group). 88.8% of prescriptions were concordant with the empiric
antimicrobial prescribing guidelines.
Conclusions: Implementation of the strategy resulted in a reduced
duration of intravenous antimicrobial treatment, with resulting cost
savings. There was no reduction in the median length of stay, likely
due to social reasons and other co-morbidities lengthening stay. This
strategy is to be rolled out to all general medical and surgical wards in
the hospital.
P1284 The Going Home project: implementing a frontline
pharmacist-led team approach towards appropriate IV to
oral antibiotic switch for patients with antibiotic resistant in-
fections and subsequent discharge to outpatient management
K. Bamford, M. Desai, W. Lawson, A. Jacklin, F. Sanderson, A. Holmes,
M. Brown, B. Dean Franklin (London, UK)
Objectives: A previous study showed that 29% of patient on IV
glycopeptides, predominantly used to treat proven or suspected MRSA,
fulﬁlled clinical criteria for switch to oral antibiotics and discharge to
completer treatment as an outpatient with a median reduction in stay
of 5 days. Prior to this study there was no IV-oral switch program for
glycopeptide use with patients usually remaining in hospital until the
end of treatment. The objectives of this work were to assess whether
the predicted beneﬁt of earlier appropriate discharge to home treatment
could be implemented by targeting this group of patients, and if so,
whether this was an effective management strategy.
Methods used: We implemented a study using the same approach. All
patients on IV glycopeptides were screened against pre-determined IV-
oral switch and discharge on oral antibiotics criteria. The study team
identiﬁed patients suitable for IV-oral switch and discharge. Advice was
provided to prescribers on the most appropriate oral antibiotic for switch
and treatment at home. Follow up was arranged as appropriate to clinical
need.
Switch from IV glycopeptides to oral suitable antibiotics, reduction in
length of stay, IV line use, and estimated cost savings were measured.
In addition pharmacist time and interventions proﬁle was assessed.
Results: 81 (52%) of patients on IV glycopeptides were switched
to an oral antibiotic. 64 (41%) were discharged home early on oral
antibiotics. 22 different combinations of oral antibiotic that were
either consistent with trust policy or speciﬁcally approved by senior
microbiology/infectious diseases specialists were used. Overall this
intervention resulted in a reduction of 1215 bed days and a further 511
in-patient IV line days. The study ran in parallel and was complimentary
to the introduction of an OPAT service.
Conclusion: A targeted approach by a dedicated team results in a
signiﬁcant reduction in hospital length of stay for patients being
treated for resistant Gram-positive infections with IV glycopeptides.
This intervention improves the quality of infection management and
resource utilisation. This has resulted in a successful business case for
an enhanced antibiotic pharmacist team.
P1285 Unexpected impact of infectious diseases division
interventions on antibiotic use in two intensive care units
S. Cheriﬁ, J. Massaut, G. Mascart, S. Jamart, R. Karmali (Brussels, BE)
Objectives: The purpose of the present study was to estimate the impact
of infectious diseases division interventions on the antibiotic use in two
intensive care units (ICU) (12 beds of medical intensive care (MIC) and
12 beds of surgical intensive care (SIC) in a Belgium University hospital
between 2003 and 2007.
Methods: One infectious diseases specialist with one microbiologist
specialist constituted the infectious disease division and their main goals
were twofold: 1) a reduction in the amount of broad spectrum antibiotics
(including 3rd generation cephalosporins, cefepim, meropenem, aztre-
onam and piperacillin/tazobactam), ﬂuoroquinolones, glycopeptides and
aminoglycosides administered; 2) a cutback on the length of empirical
treatment. The interventions started in 2005 with quality rounds (twice
a week).
Antibiotic consumption data were obtained from the pharmacy and
expressed as the number of DDDs (Daily Dose Deﬁned) per 100 bed
days.
Results: The interventions of the infectious diseases division resulted in
an increase of total antibiotic consumption in SIC from 224 DDDs/100
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bed days in 2005 to 281 in 2007 whereas a decrease from 492 to 334
DDDs was observed in MIC during the same period. In both intensive
care units, the use of amoxicillin/clavulanic acid increased, particularly
in SIC from 65 to 139 DDDs, while the proportion of broad spectrum
antibiotics given decreased signiﬁcantly. Aminoglycosides remained
stable in both ICU whereas glycopeptides and ﬂuroquinolones decreased
in MIC.
Conclusions: The overall antibiotic consumption in SIC increased
dramatically due to a progressive evolution towards a polyvalent intensive
care with a mixture of surgical and medical pathologies. The pressure
exerted by the intervention division on the ICU physicians led to a
decrease use in broad spectrum antibiotics but at the expense of a
spectacular increase in the consumption of amoxicillin/clavulanic acid.
These preliminary data encouraged us to continue the collaboration with
intensive care physicians and should prompt us to think on the real need
of antibiotic therapy even in the ICU setting.
P1286 Checklist for an optimal early switch to oral antibiotics in
hospitalised patients
D. Mertz, M. Koller, P. Haller, M.L. Lampert, H. Plagge, G. Koch,
M. Battegay, U. Fluckiger, S. Bassetti (Basel, CH)
Background: Several studies have evaluated early switch criteria
from intravenous (IV) to oral antibiotic therapy in restricted patient
populations, e.g. with community-acquired pneumonia. Only few reliable
data are available about using switch criteria in general medicine wards.
Objectives: To evaluate the effect of a checklist for early switch from IV
to oral antibiotics in general medicine wards on duration of IV antibiotic
therapy, safety and costs.
Methods: The study was performed in general medicine wards with
2500 admissions annually in a university hospital. All patients on IV
antibiotics were enrolled. A checklist with 10 switch criteria such as
deﬁned diagnoses, clinical improvement with deﬁned defervescence and
oral suitability of antibiotics was placed in the charts. We analysed the
checklists of the entire study-year (8/06 to 7/07) providing information
about reasons against oral switch and safety aspects (n = 398). In a pre-
post analysis we compared the outcome parameters in the inventorial
phase (April-July 2006, n = 376) to the implementation phase (April-July
2007, n = 350).
Results: A signiﬁcant reduction of 1d IV therapy was achieved (6 to
5d in median, p = 0.005) without any increase of relapses, readmissions
or death. The crude relative reduction of days of IV antibiotic treatment
was 16% (95%CI 4–26%, p = 0.01) and 19% (9%-29%, p = 0.001) after
adjustment for age, gender, Charlson index, presence of malignancy and
consultation by infectious disease specialist. The main reasons not to
switch on day 3 of IV therapy were persisting fever (41% of non-switched
patients) and absence of clinical improvement (41%). Two of 698 patients
experienced a relapse after early switch; both responded to continued IV
antibiotic treatment. A total of 20,000€ of acquisition costs for antibiotics
were saved in the year of the intervention in contrast to a 12.5% (+30,000
€) increase of acquisition costs the year before (2005 to 2006). The
workload for IV applications was reduced by about 350 hours. There
was no similar decrease in antibiotic cost on control wards during the
study period.
Conclusions: The implementation of a checklist with clearly deﬁned
switch criteria leads to a signiﬁcant reduction of IV therapy and costs in
a university hospital. The proposed bedside checklist can be used safely
regarding relapses, readmissions and fatality rate in a mixed population
on medical wards.
P1287 Antimicrobial stewardship programme may help reduce
antimicrobial resistance in the intensive care unit
L. Pagani, R. Aschbacher, M. Falciani, B. Moser, C. Vedovelli,
C. Larcher, P. Mian (Bolzano, IT)
Objectives: Resistance (R) to antimicrobials (AB) is one of the
most challenging issues in the management of ICU patients (pts);
inappropriate use of AB plays a major role in increasing R.
Methods: from Jan 2002 to Dec 2006, a prospective survey of R patterns
among the most important nosocomial pathogens was performed in pts
admitted in ICU >48–72 hrs. From 2003, an antimicrobial stewardship
program (ASP) has been implemented with the following interventions:
I) elimination of 3rd-generation cephalosporin prophylaxis in critical
pts at the time of admission to ICU; II) administration of empirical
AB therapy of suspected ICU-acquired infections based both on local
epidemiology of R and pharmacokinetic/pharmacodynamic (PK/PD)
parameters; III) regular (three times a week, or on-call basis) re-
evaluation of AB therapy, aiming at stepping-down and shortening
duration.
Results: from 2002 (as historical reference) to 2006, the following
important decreases in antimicrobial consumption, evaluated in deﬁned
daily doses (DDD), have been recorded through the ESGAP ABC Calc
3.1b program: AMK −93.1%; SAM −57.7%; CIP −45%; GEN −88.4%;
IPM −60.5%; TEC −95%; VAN −73.3%; CAZ −78.6%. In the same
period, MEM and LZD consumption strongly increased (+1620%, and
+487%, respectively). Contemporarily, an increase in susceptibility of
S. aureus to OXA and CIP (from 65.5 to 84.2%, and from 65.7 to
84.3%, respectively), and of P. aeruginosa to TZP (from 88.8 to 93.5%),
CAZ (from 82.7 to 90.3%), FEP (from 87.5 to 93.5%), AMK (from 93 to
100%) have been observed. However, susceptibility of P. aeruginosa to
IPM decreased from 75.3 to 45.2%, and production of ESBL increased in
E. coli and K. pneumoniae (from 3.6 to 11.3 and 5.6%, respectively). AB
costs did not increase from 2002 to 2006 (109,627.07 and 115,492.63
Euros, respectively) despite a similar number of pts undergoing AB
therapy and increased consumption of very expensive AB, such as LZD
(49,268 Euros only in 2006).
Conclusion: The ASP yielded to progressive reduction in R patterns
of S. aureus, and of P. aeruginosa to the most important AB. Despite
an increased consumption of newer AB, due to an innovative PD-driven
approach, the ASP also led to overall expenditure containment.
P1288 Inﬂuence of rapid antigen detection test use to antibiotic
prescribing for tonsillopharyngitis
A. Berzanskyte, R. Valinteliene, A. Palekauskaite (Vilnius, LT)
Objectives: The aim of the study was to evaluate inﬂuence of diagnostic
tests to antibiotic prescribing and economical beneﬁt.
Methods: Intervention study was carried out in two randomly selected
outpatient (GP) clinics. Intervention consisted of 1) modern knowledge
of diagnostics and appropriate antibiotic use for treatment of upper
respiratory tract infections, particularly of tonsillopharyngitis, and 2)
free rapid antigen detection test (RADT) for Group A hemolytic
streptococcus (GABHS), recommendations for its use and interpretation
of results. All cases (463) of tonsillopahryngitis from randomly selected
patients, who visited GP in 2004, were included in control group. All
cases (318) of tonsillopharyngitis from the patients, who visited GP in
2006, till the needed sample size was reached were included in reference
group.
Results: After implementation of RADT increase in use of other
diagnostic tests was noted. General blood test was performed 1.3 times
(p = 0.03), erythrocyte sedimentation rate – 5.9 times (p = 0.00) more
often, C-reactive protein test (CRP; not used before intervention at
all) was started. The structure of prescribed antibiotics has changed.
Penicillin was prescribed 5 times, clarythromycin and cephadroxyl
2 times more often, while broad spectrum penicillins as amoxicillin
and amoxicillin with clavulanic acid decreased (respectively 2 and 5
times). Antibiotic prescription rate in general hasn’t changed statistically
signiﬁcantly, as discrepancies of prescription rates in both clinics were
found – it decreased 1.4 times (p = 0.02) in one clinic, but increased
1.2 times (p = 0.27) in another clinic. Positive RADT result necessitated
23 times more frequent antibiotic prescription than its negative result.
However even getting negative RADT result, GPs prescribed antibiotics
to 40.4% cases. Proportions of complications and recurrences decreased
(respectively 2.1 and 3.7 times). However economical beneﬁt in treatment
of tonsillopharyngitis using RADT was gained just in one clinic.
Characteristics of used in study RADT were determined: sensitivity
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72.3%, speciﬁcity 92.3%, positive prognostic value 86.1%, negative
prognostic value 83.5%.
Conclusions: After implementation of RADT, other diagnostic tests were
used more often, importance of CRP was found in differential diagnosis
of tonsillopharyngitis. Prescribed antibiotic structure has changed with
the substantial increase of narrow spectrum penicillin.
P1289 A controlled intervention study to improve antibiotic use
in a Russian paediatric hospital
D. Berild, T.G. Abrahamsen, S. Andresen, E. Bjørløw, O. Haug,
I.M. Kossenko, O.I. Kubar, M. Lelek, S.I. Mintchenko, M.F. Pyasetskaya,
S.H. Ringertz, G.S. Sysenko (Oslo, NO; St. Petersburg, RU)
Objective: In a paediatric hospital in Russia a controlled intervention
study was performed to improve antibiotic use and to see if
improvements persisted. During October, November, and December in
2002 clinical and microbiological data, antibiotic use, costs, and outcome
were recorded at two wards for gastrointestinal infections (GII) and two
wards for respiratory tract infections (RTI).
Methods: Guidelines of diagnosis and treatment of infections were
developed and implemented at one ward for GII and one ward for RTI
in 2003. The other two wards served as controls. The same data were
recorded during the same 3 months periods in 2003 and 2004.
Results: At the intervention wards the percentage of patients with GII
who received antibiotics decreased from 94% in 2002 to 41% in 2003,
but increased to 73% in 2004. In RTI these percentages were 90% in
2002, 53% in 2003 and 83% in 2004. The proportions of patients who
received antibiotics in 2004 were still lower than in 2002, risk difference
(RD) 0.217, p = 0.001 in GII, and RD 0.073, p = 0.013 in RTI. From
2002 to 2004 there was a decrease in cephalosporin use (p = 0.021) and
an increase in penicillin use (p = 0.032) in pneumonia. There was no
difference in mortality, duration of fever or duration of hospital stay
between the intervention and control wards.
Conclusion: Antibiotic use could be halved without compromising
quality of patient care, but one year after the intervention the use of
antibiotics approached pre-intervention levels. Strategies to sustain the
effect of interventions are needed.
P1290 Impact of a positive Binax NOW Streptococcus pneumoniae
urinary antigen test on antibiotics policy
M. Matta, A. Buu Hoı¨, E. Varon, L. Gutmann, J.L. Mainardi (Paris, FR)
Objectives: To evaluate the impact of a positive Binax NOW
Streptococcus pneumoniae urinary antigen test (UAT) on the use of
a targeted anti-pneumococcal therapy for the treatment of community-
acquired pneumonia.
Methods: From April 2004 to December 2005, we retrospectively
analysed 96 consecutive patients admitted to the emergency room for
a presumptive diagnosis of pneumonia with a positive UAT. Patients
with associated meningitis were excluded. We reviewed the antimicrobial
therapy used before and after the positive result of the UAT, and
particularly the proportion of patients under amoxicillin.
Results: Among the 96 patients, 92 were available for the study. Mean
age was 64 years (median age 61 y, range 18–99 y) and 49 patients (51%)
were male. Eighty nine patients (97%) had a blood or a respiratory tract
sample which, in 23 patients (25%), was positive for S. pneumoniae.
Prior to the UAT result, 22 patients (24%) had no antibiotics, 11 (12%)
received amoxicillin, 25 (27%) amoxicillin-clavulanic acid (AMC) or
a third-generation cephalosporin (C3G), and 29 (32%) received an
association of b-lactam with a macrolide or a ﬂuoroquinolone. Once
the physician was informed of a positive UAT, among the 22 patients
not treated initially, 7 received amoxicillin secondarily, 7 had AMC or
C3G, and 4 had an association. Overall, the number of patients treated
with amoxicillin rose to 38 (41%), those receiving AMC or C3G rose to
30 (33%) whereas patients under an association of antibiotics decreased
to 12 (13%). Among the 23 patients who had a positive sample for
S. pneumoniae, 12 had an antimicrobial therapy with a broader spectrum
than amoxicillin even once the susceptibility to b-lactams was known.
Conclusions: In case of community-acquired pneumonia at the emer-
gency room, physicians often prefer to prescribe a ﬁrst line antimicrobial
therapy with a broader spectrum than amoxicillin. Although a positive
UAT resulted in an increased number of patients treated by amoxicillin
alone from 12 to 41 percent, it is noteworthy that in almost 60 percent
of the cases antibiotic spectrum was not narrowed.
P1291 The effect of restriction of cephalosporin usage on the
incidence of ESBL-producing Klebsiella pneumoniae in a
tertiary hospital in Cape Town, South Africa
S.P. Oliver (Cape Town, ZA)
Objectives: Several studies have demonstrated a dramatic reduction in
the incidence of ESBL-producing organisms when cephalosporin usage
has been curtailed. This study seeks to reproduce this effect in a large
teaching hospital experiencing an upsurge in ESBL-producing Klebsiella
pneumoniae. ESBL-producing klebsiellas accounted for around 1% of
laboratory isolates in 1994 and had risen to over 60% by 2005.
Methods: Antibiotic usage is controlled in this hospital by the pharmacy
requiring release from a microbiologist for certain restricted agents.
In May 2006 all cephalosporin usage was restricted except for the
use of ceftriaxone for acute bacterial meningitis and cefazolin for
surgical prophylaxis. Co-amoxiclav or piperacillin/tazobactam was made
available for clinical situations where cephalosporins had previously been
used.
Results: Cephalosporin usage dropped by 65%. At the same time co-
amoxiclav usage increased by 468% and piperacillin/tazobactam usage
increased by 252%.
ESBL-producing klebsiellas appeared to be decreasing during the second
half of 2006 but have increased again during 2007. No clustered outbreak
of Klebsiella isolates was noted at any time.
ESBL-producing Klebsiella
Conclusion: The decrease in the incidence of ESBL-producing
Klebsiella in response to decreased cephalosporin usage appears not to
be a sustainable phenomenon in practice.
P1292 Administration of antibiotics via the respiratory tract as
monotherapy for pneumonia
M. Falagas, M. Agraﬁotis, Z. Athanassa, I. Siempos (Athens, GR)
Objective: Recent studies have shown that antibiotics administered via
the respiratory tract may have a role in the prevention of respiratory tract
infections. However, the role of aerosolised antimicrobials administered
as monotherapy for patients with pneumonia is unclear.
Methods: We endeavoured to accumulate and evaluate the published
relevant evidence through searches of PubMed, Scopus, and relevant
bibliographies.
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Results: Seven relevant studies (1 randomised controlled trial, 4 case
series and 2 case reports), including 63 patients, were identiﬁed;
37% (23/63) and 63% (40/63) of those patients suffered from
community-acquired and nosocomial (including ventilator-associated)
pneumonia, respectively. Acinetobacter baumannii (41%), Gram-positive
cocci (37%), and Pseudomonas aeruginosa (16%) were the pathogens
more frequently isolated. Colistin (49%), penicillin (37%), and
aminoglycosides (17%) were the antimicrobials administered via the
respiratory tract. Concurrent systemic antimicrobials (without activity
against the isolated pathogens) were given to 33% (21/63) of patients.
Clinical cure and bacteriological eradication were observed in 86%
(54/63) and 85% (33/39) of patients, respectively. All-cause mortality
was 36% (11/31).
Conclusions: The very limited published data preclude any strong
conclusions. However, the available data seem to suggest that aerosolised
antimicrobial monotherapy for pneumonia should not be a priori
excluded in patients without intravenous access, those denying systemic
treatment, and in patients with severe toxicity of systemic antimicrobial
therapy. Clinicians are encouraged to publish any relevant experience in
order for a considerable body of literature to be accumulated.
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P1293 Virulence traits of Escherichia coli clinical isolates neonatal
sepsis. Comparison between strains causing early and late
neonatal sepsis
S. Soto, J. Bosch, M.T. Jimenez de Anta, J. Vila (Barcelona, ES)
Objective: Neonatal risk factors for invasive bacterial disease and its
diagnosis and therapy remain an important problem for obstetricians
and paediatricians. Neonatal meningitis and septicaemia caused by
E. coli and Streptococcus agalactiae are still major health problems
in industrialised countries. The objective of the present work was to
study the pathogenicity of E. coli strains causing neonatal sepsis and to
compare those involved in early infection and late infections.
Methods: A total of 54 E. coli strains causing septicaemia were collected
from neonates between 0 to 28 days-old. Twenty-two and 32 strains have
been caused of early or late infection, respectively. Phylogenetic group
and the presence of virulence factors were determined by PCR. The type
1 ﬁmbriae expression was tested by agglutination with a Streptococcus
cerevisiae strain. Proportion and means were compared by using the
Chi-square test and t-test.
Results: Twenty-seven (50%), 18 (33%), 6 (11%) and 3 (6%) strains
belonged to phylogenetic groups B2, D, A and B1, respectively. The
factors more frequently showed by the E. coli strains were: ﬁmA (91%),
ibe10 (61%), iucC (59%), papEF (56%) and and papC (46%); the
virulence factors presented in lesser percentage were: cnf1 and sat1 (6%
and 4%, respectively). The ibe10 (ibeA) gene was more prevalent in the
strains involved in early infection than in those involved in late infection
(86% versus 44%, respectively; p = 0.001).
Conclusion: E. coli strains causing early neonatal septicaemia present
higher number of virulence factors than those causing late infection. The
ibeA gene is more prevalent in the E. coli strains causing early neonatal
sepsis and it could be involved in the pass of the infection to the amniotic
ﬂuid.
P1294 Phylogenetic background and virulence proﬁle of
Escherichia coli causing neonatal disease
A. Andreu, E. Moreno-Pujol, M. Tenedor, A.M. Planes, S. Molinos,
E. Ruiz de Gopegui, J. Bosch and REIPI, the Spanish Network for
the Research in Infectious Diseases
Objective: To determine the phylogenetic background and the virulence
proﬁle among E. coli strains causing neonatal disease, and compared
with E. coli causing urinary bacteraemia.
Methods: Thirty-ﬁve E. coli strains, isolated in 4 hospitals within 1996
and 2007, 34 from blood and 1 from blood and CSF, of newborns
within the ﬁrst week of life. We compared them with 50 E. coli strains
isolated from blood of patients with urinary bacteraemia (Moreno et al.
2005. Diag Microbiol Infect Dis: 53; 93). To these 85 epidemiologically
unrelated strains, phylogenetic group and 15 virulence factors were
determined by PCR
Results: Among the 35 E. coli causing neonatal disease, the highly
pathogenic phylogenetic group B2 was the most frequent, 28 isolates
(80%), followed by group D with 4 (11%) and group A with 3
(9%). These strains showed a high prevalence of proven virulent traits
associated to extraintestinal infections, specially kpsMII (89%), malX
(77%), fyuA (91%), and iutA (66%) and a relatively low prevalence of
factors associated to P ﬁmbriae: papA 43% and papG alelle II 34%.
Factors associated to meningitis were ibeA 21%, and sfa/focDE 46%,
but both were present in the strain isolated from CSF. In consequence,
these strains showed a high aggregate virulence score with a mean of
6.8, and a range between 2 and 10 virulent factors/strain.
E. coli causing neonatal disease showed a similar distribution
among phylogenetic groups than E. coli causing urinary bacteraemia
(phylogenetic group B2 70%, group D 16%, group A 10%, and group B1
4%), a similar prevalence of virulent traits associated to extra-intestinal
infections, kpsMII (76%), malX (70%), iutA (78%), and fyuA (88%),
and a similar virulence score 7.2 (range, 1 to 10). However, papA and
papG alelle II were statically associated to E. coli producing urinary
bacteraemia (78% and 66%) in relation to E. coli producing neonatal
septicaemia (P = 0.001 and P = 0.004; respectively).
Conclusions: E. coli producing neonatal disease derived mainly from the
pathogenic phylogroup B2 and exhibited a great concentration virulent
traits which inferred a virulent potential as high as E. coli causing urinary
bacteraemia. However, P ﬁmbriae, which enable bacteria to reach the
kidney, was signiﬁcant more prevalent in urinary bacteraemia.
The similarities between E. coli causing neonatal septicaemia, urinary
bacteraemia and others, strongly suggest that all these E. coli should be
classiﬁed as “Extraintestinal Pathogenic E. coli (ExPEC)”
P1295 Detection of pathogenic genes pap, hlyA and cnf1 IN E. coli
strains isolated from adult patients with urinary tract
infection
E. Alepopoulou, M. Panopoulou, T. Konstantinidis, E. Konstantinidou,
S. Compelitou, E. Petinaki, S. Kartali (Alexandrupolis, Larissa, GR)
Objective: Urinary tract infection (UTI) is one of the most commonly
acquired bacterial infections in ambulatory and hospitalised populations.
Most UTIs are caused by E. coli strains that exhibit certain
virulent factors. Urovirulence factors as pap (pilus associated with
pyelonephritis), hlyA (alfa haemolysin) and CNF (cytotoxic necrotising
factor) play important role in the pathogenesis of E. coli causing
of UTI. The present study was comparable in University hospital of
Alexandroupolis in northern Greece. The aim was to determine the
occurrence of virulence genes expressing pap, hlyA and cnf1 in adult
patients with UTI.
Methods: A total 131 strains E. coli isolated from urines of 131 adult
patients as follow: 103 subjects were women and 29 men. Fifty six
strains were isolated from ambulatory and 75 from hospitalised patients.
The laboratory criterion for acute E. coli UTI was the presence of
positive culture on MC agar with of least 105 CFU/ml. The biochemical
identiﬁcation of the strains was performed by automated system VITEK2
(BioMerieux). Speciﬁc primers were used to amplify sequences of the
pap, hlyA and cnf1 genes. Ampliﬁcation products 336bp, 1177bp and
498 bp respectively were electophoresed in 2% agarose gel and visualised
by ethidium bromide staining.
Results: Overall, of the 131 isolates strains E. coli 67(51%) carried
pathogenic genes. From 67 strains 28(42%) were isolated from
ambulance patients and 54 (80%) from women. The genes pap, hlyA and
cnf occurred in several combinations. The combinations of pathogenic
genes were as follow: 22 (33%) strains yielded pap gene, 2 (3%)
hlyA, 9(13%) cnf1, 9 (13%) pap+cnf1, 8(12%) pap+hlyA, 3 (4%)
cnf1+hlyA and 14 (20%) pap+cnf1+hlyA. From 22 strains pap+ and
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14 strains (pap+cnf1+hlyA)+ 86% and 90% respectively were isolated
from women.
Conclusion: Sixty seven (51%) E. coli isolates were found to carry at
least one pathogenic gene. The most prevalent pathogenic gene was pap
and combination pap+cnf1+hlyA. The frequency of pathogenic genes
was higher in women, speciﬁcally in regard of strains with genes pap
and pap+cnf1+hlyA.
The presence of pathogenic genes in E. coli contributes to colonisation,
invasion, promote bioﬁlm formation and persistence of strains in
the urinary tract. Therefore knowledge of pathogenic genes of the
microorganisms causing the UTI it would anticipate the evolution of
infection in the host
P1296 Distribution of virulence factors in E. coli strains isolated
from women with urinary tract infection by PCR
E. Alepopoulou, M. Panopoulou, E. Konstantinidou, T. Konstantinidis,
D. Kalpini, S. Kartali (Alexandrupolis, GR)
Objective: E. coli is the most common cause of urinary tract
infections (UTI). A variety of urovirulence factors are overrepresent
in uropathogenic E. coli, including ﬁmpriae and adhesins, cytotoxins
such as a-haemolysin and cytotoxic necrotising factor 1, aerobacin-
mediated iron uptake system and others. The dominance of strains
expressing multiple urovirulence factors may further increase the risk
for development of UTI speciﬁcally in women. In the present study, that
was comparables in University hospital of Alexandroupolis in northern
Greece, we analysed the distribution of genes pap, hlyA, cnf1, aer, sfa
and afa in E. coli strains isolated from women with UTI.
Methods: A total of 103 strains E. coli were isolated from 103 women 18
to 83 years old with UTI. The laboratory criterion for acute E. coli UTI
was the presence of positive culture on MC agar response with at least
105 CFU/ml. Multiplex PCR was performed to detect urovirulence genes
pap, hlyA, cnf1, aer, sfa, afa in E. coli strains. Ampliﬁcation products
336bp, 1177 bp, 498 bp, 602 bp, 410 bp and 750 bp respectively were
electophoresed in 2% agarose gel and visualised by ethidium bromide
staining.
Result: Seventy seven (75%) of the 103 strains E. coli were found to
carry at least one urovirulence gene. Frequencies of genes pap, hlyA,
CNF, aer sfa, afa in total 103 isolates were estimated as 45%, 20%, 25%,
47%, 27% and 6% respectively. The data indicated that 2%, 8%, 14%,
17%, 27% and 6% isolated carried six, ﬁve, four, three, two and one
virulence factor respectively. However no virulence factors were found
in 26 (25%) isolates.
Conclusion: The E. coli strains expressing multiple virulence factors
comprise frequent cause developing UTI. The results showed that 75%
of E. coli isolates carried at least one virulence factor. The occurrence
of pap and aer was higher compared with the rest of others genes. In
contrast, afa gene was carried in only 6 strains. Also in the present study
was demonstrated that the multiplex PCR is an efﬁcient tool for rapid
detection and identiﬁcation of UTI virulence factors in E. coli isolates.
P1297 Identiﬁcation and genotyping of uropathogenic Escherichia
coli strains isolated from patients with urinary tract
infection based on papC and papG genes using PCR
B. Zamanzad (Shahrekord, IR)
Introduction: Escherichia coli (E. coli) is the most common aetiologic
agent of Urinary tract infections (UTIs). The most important virulence
factor in Uropathogenic E. coli (UPEC) strains is P ﬁmbriae. P ﬁmbriae
is coded by pap(pyelonephritis associated pili) operon. PapG is the most
common adhesin in this ﬁmbriae and papC is an important gene in this
operon. Fimbriated uropathogenic strains of E. coli have an important
role in causing UTI especially upper tract infections. In this study
prevalence of pap operon (papC and papG genes) in E. coli strains
isolated from nosocomial UTIs were evaluated.
Methods: A total of 182 E. coli isolates cultured from patients with
different clinical forms of UTI referred to Shahre-kord teaching hospital
were included. DNA of bacterial isolates was extracted by boiling
method. PCR method was performed for presence of papC (pap operon)
and papG genes. Also, genotyping of papG (pap operon) positive isolates
were performed using multiplex PCR method.
Results: The prevalence of pap operon in isolates was 36.2%.
Genotyping of P ﬁmbriated isolates for papG gene by multiplex
PCR method showed the prevalence of class 2 and class3 of papG
gene, 23.1% and 6.6% respectively. None of the isolates had class 1
genotype. Furthermore, papG class 2 was predominant in patients with
pyelonephritis and papG class 3 was predominant in ones with cystitis.
In this study, no relationship between the presence of P ﬁmbriae and sex
of the patients was detected.
Conclusion: PapC (and papG)) genes have important roles in
pathogenesis of ﬁmbriated uropathogenic strains of E. coli. We
recommend detection and genotyping of these genes in complicated
UTIs in hospitalised patients enabling speciﬁc diagnosis and treatment
of nosocomial infections with urinary tract origin.
P1298 Clonality and presence of ﬁmbrial adhesin genes of
Escherichia coli isolated in recurrent cystitis from a
48-year-old female
V. Rodrigues, S. Simo˜es, M. Morgado, D. Morgado, T. Hanscheid,
J. Melo-Cristino, A. Duarte (Setubal, Lisbon, PT)
Objectives: Urinary tract infections (UTI) are a common healthcare
problem. Recurrent UTI in healthy, nonpregnant women is deﬁned as
three or more episodes of UTI during a 12-month period. It affects
an estimated 20% of women at some time during their lifetimes. The
uropathogenic E. coli (UPEC) possess adherence factors called pili or
ﬁmbriae (type 1 and P), which allow them to successfully initiate UTI
infections. This adhesins are involved in the colonisation of mucosal
cells, proliferation and cell damage, thus increasing the time of survival
in the host. The aim of this study was to determine the occurrence of
virulence genes and verify the clonal relation of E. coli isolates from
recurrent cystitis.
Methods: A total of ﬁve E. coli isolates were recovered from a 48
year old female with recurrent urinary tract infection. Three strains
were isolated from urine during six months and two strains were
isolated from perineum and rectal swabs, respectively. Identiﬁcation and
antimicrobial susceptibility testing was determinate by VITEK2 system.
The presence of ﬁmbrial adhesins was performed by PCR, using two
pairs of primers: PAP1/PAP2 and ﬁmH_F/ﬁmH_R that amplify type
P and type 1 ﬁmbrial adhesins, respectively. Clonal relationship was
assessed by M13 ﬁngerprinting.
Results: The strains showed the same resistance proﬁle and were
resistant to trimethoprim/sulfamethoxazole, ciproﬂoxacin, norﬂoxacin,
and showed susceptibility to cephalosporins (2nd and 3th generation),
nitrofurantoin and fosfomycin. All strains exhibited the type 1 ﬁmbrial
adhesin and the same M13 ﬁngerprint proﬁle, including the strains
identiﬁed from perineum and rectal swab. These results suggest that
recurrent infections are due to the patient’s inability to eliminate the
microorganism (relapse), and not by reinfection, since all strains isolated
in the period of 6 months belong to the same clone.
Conclusions: One of the main factors for the occurrence of urinary tract
infections is the presence of adhesins, allowing the adherence of bacteria
to uroepithelium hindering its removal, even after therapy.
P1299 Collagen-like proteins from the enterohaemorrhagic E. coli
strain O157:H7
N. Ghosh, I. Roberts, J. Bella (Manchester, UK)
Many phage and bacterial genomes contain collagen-like sequences. The
Escherichia coli strain O157:H7, a serious enterohaemorrhagic pathogen,
has eight putative collagen-like genes that are missing in harmless E. coli
strains. To help establish if collagen-like proteins contribute to O157:H7
virulence we have cloned one of these genes, EclA, into a laboratory
strain and analysed it biophysically. Analytical ultracentrifugtion and
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dynamic light-scattering showed that EclA is trimeric in solution, with
a molecular weight of 132 kDa. EclA forms characteristic dumbbell-
shaped structures visible in electron microscopy images. The "stalk"
region adopts a collagen triple-helical conformation with a maximum
ellipticity at 220 nm demonstrated by CD spectroscopy, while the CD of
full-length EclA is dominated by alpha-helical structure localised to its
N-terminal region. The thermal denaturation of the stalk showed a single
transition at 42ºC, much higher than that of mammalian collagens, that
was consistent with the loss of triple helical structure. On the other
hand, full-length EclA showed two transitions: the ﬁrst transition at
approximately 42ºC corresponds to loss of triple-helical structure; the
second one at 52ºC corresponds to loss of alpha-helical structure. The
ﬁrst transition is much higher than the equivalent seen for mammalian
collagens. The results show that EclA behaves like an unexpectedly
stable collagen protein. While the function of these proteins needs to be
elucidated, mRNA transcripts of collagen-like genes were detected by
RT-PCR both in stationary and exponentially growing cells, suggesting
protein expression and functional signiﬁcance.
P1300 Intracellular crystallisation caused by Proteus mirabilis
plays a signiﬁcant role in recurrent urolithiasis
A. Torzewska, A. Budzynska, M. Bialczak-Kokot, A. Rozalski (Lodz, PL)
Objectives: Proteus mirabilis are the most common bacilli associated
with the formation of bacteria-induced bladder and kidney stones. In 50%
of cases, this is recurrent illness, which can lead to the loss of kidneys
if not properly treated. Bacterial urease is the essential virulence factor
in stones formation. Ammonia, produced by the enzymatic hydrolysis of
urea, elevates urine pH causing a supersaturation and crystallisation of
struvite and apatite. Crystals may grow intra as well as peribacterially.
The aim of this work was to show that P. mirabilis bacilli can grow and
form crystals inside urothelial cells. In this enviroment bacteria may be
protected against antibiotic killing and thus cause persistent or recurrent
infections.
Methods: P. mirabilis strains were recovered from encrusted bioﬁlm on
Foley catheter of long-term catheterised patients. The in vitro model
was used to analyse intracellular growth and crystallisation. In this
model human renal (HRPTEC), ureter (Hu 608) and bladder (HCV 29)
epithelial cells were infected and incubated (3–72 h) in the presence of
synthetic urine and amikacin to prevent extracellular bacterial growth.
Number of intracellular bacteria was determined after host cells lysis
by plating lysates on TSB plates. Crystallisation was determined using
radioactive isotope of calcium. Crystals and bacteria were also observed
by crystal violet and van Kossa method staining.
Results: It was found that P. mirabilis isolated from urinary catheter
demonstrated a signiﬁcant ability to adhere and penetrate normal
urothelium, especially Hu 608 cell lines. These strains could multiply in-
tracellularly within epithelial cells and were able to induce crystallisation.
From 24 to 72 hours after infection a degree of crystallisation increased
and it depended on the number of bacteria within host cells. This ﬁnding
was conﬁrmed by microscopy. The dark deposites of calcium salts within
infected epithelial cells were observed.
Conclusion: Our results showed P. mirabilis ability to persist and form
crystals inside the host cells, despite antibiotics presence. In this situation
bacteria induce infection, usually chronic, which commonly results in the
formation of bladder and kidney stones.
P1301 Comparison of the invasiveness properties of Iranian
Shigella ﬂexneri wild type vs. mutants by cell culture and
electron microscopy
M. Hakemi vala, J. Nowroozi, P. Nabavi tabatabaii, P. Kavakeb
(Tehran, IR)
Objectives: Among pathogenic microorganisms, invasive bacteria such
as shigella has the ability to penetrate mammalian epithelial cells both in
vivo and in vitro. Morona etal, produced a S. ﬂexneri mutant and showed
invasiveness of mutants decreased compared to wild types. So, the aim
of this study was comparing the invasiveness properties of the S. ﬂexneri
wild types (icsA+ strains) v.s S. ﬂexneri mutants (icsA defected) by cell
culture and electron microscopy.
Methods: Shigella ﬂexneri strains were isolated by standard bacterial
methods from faecal specimens of children attending to the 3 children’s
hospitals of Tehran between January 2003 to December 2003. DNA
isolation, was done by sodium perchlorate 4M method. Existence of icsA
gene was determined by PCR. Mutation forming was done by allelic
exchange and using pCACTUS-icsA:: amp r. HeLa cell culture were
prepared using MEM medium and Fetal calf serum and infected with
both S. ﬂexneri wild types and mutants strains
Continuously, electron microscopy investigation was done after ﬁxation,
using resin spur and staining gold sections with saturated Uranyl acetate
and Lead citrate.
Results: From 100 S. ﬂexneri strains recovered from stool specimens,
46% were icsA + by PCR. All transformed bacteria were selected by
temperature sensitivity and sucrase levan production and resistance to
ampicillin. Further PCR on mutants showed no PCR product detection.
Invasive shigella strains penetrated in to HeLa cells compare to mutants
which may adhered but not entered. Further more, pseudopod structures
used to facilitate bacterial cell-to-cell spread were readily identiﬁed by
electron microscopy in wild types.
Conclusion: In this study, all clinical isolated S. ﬂexneri wildtypes
which were IcsA+, showed similar internalisation, cell existence and
cell disruption. In addition, pseudopod ﬁlaments were conﬁrmed with
electron microscopy. In contrast, most of mutants icsA− could not
enter to HeLa cells. Moreover, a few number of these bacteria could
adhere and enter to the HeLa cells, but cell disruption was not detected.
These bacteria might produce necrosis later, but not detected after 3 h
incubation.
P1302 GATC sites might regulate virulence of Salmonella
typhimurium
A. Chatti, A. Landoulsi (Zarzouna, TN)
Background and Objectives: Pathogenesis of Salmonellosis depends
upon a large number of factors controlled by an array of genes
that synergise into the actual virulence of Salmonella. A study was
undertaken to observe the effect of dam and/or seqA on the virulence
and stress response of Salmonella typhimurium.
Methods: All experiments described in this paper were carried out with
Salmonella enterica serovar Typhimurium strain SL1344, LT2, and their
isogenic mutants dam− and seqA−, respectively. For the virulence test,
we are used LD50, competitive index (CI) and bacterial enumeration
from target organs such as liver and spleen. For the study of the effect
of dam or seqA mutation on the stress response, we have chosen to
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study response of these mutants toward bile, acidity, oxygen peroxide
and antimicrobial peptides were tested.
Results: Our results show that dam or mutation attenuates Salmonella
virulence either after intraperitoneal or oral infection. LD50, CI and
enumeration of these mutants in liver and spleen prove a signiﬁcantly
decrease of virulence. On the other hand, in our work we are
demonstrating that dam and seqA gene might control Salmonella
typhimurium stress response (acid, bile, H2O2 and antimicrobial
peptide).
Conclusion: Findings indicated that the dam and seqA genes may
regulate virulence and stress response. We suggest that GATC
distribution among DNA can regulate virulence and stress response of
Salmonella typhimurium.
P1303 stj ﬁmbrial operon has a role on S. typhimurium
pathogenicity
M.D. Avsaroglu, N. Akkoc, M. Akcelik (Ankara, TR)
Objectives: To exhibit the role of stj ﬁmbrial operon on the patogenicity
of S. Typhimurium by animal experiments using mice model system.
Methods: The left and the right-end fragments of stjA gene
were ampliﬁed with following primers; left-end F primer hav-
ing BglII cutting site: GCAGATCTGCGGAAGTGATTTCACCGG/B
primer having SalI cutting site CGGTCGACCCAAATGACATGTAAT-
GCGCGGGTCGGG; right-end F primer having SalI cutting site:
CGGTCGACCTCCAGCATTCACATGGAATATTCAACACC/B primer
having XbaI cutting site GCTCTAGATCCAGTTTCACACCATTGTCG-
GTC. Ampliﬁed fragments were than cloned to pGB704 vector plasmid.
A kanamisin gene cassette was inserted between the two fragments on
the vector plasmid. The recombinant plasmid was transformed to the
S. Typhimurium IR 715 strain by conjugation. By the aid of left and
the right-end fragments of stjA gene on the vector plasmid homolog
recombination was occurred with the stjA gene on the chromosome of
the host and the gene was knocked-out with kanamisin gene cassette.
Animal experiments were performed with the mutant and wild type strain
of S. Typhimurium.
Results: The experiments based on the competition between the wild
type strain and degenerate mutant strain of stj operon. To construct
the knocked-out mutant strain, one of the ﬁve genes in the operon,
stjA, was degenerated with the kanamisin gene cassette on the plasmid
pGP704. The mutants were named S. Typhimurium MA44 and used
in animal experiment as knocked-out mutant strain of stjA gene. In
the animal experiments, mice model system was used. AJB715 (S.
Typhimurium lack of acid phosphotase activity) was used as the stjA wild
type strain. 6−8 week female mice were inoculated orally with MA44
and AJB715. Viable cells in faeces and organ samples were counted
and analysed statistically. It was observed that there was a signiﬁcant
(p< 0.05) reduction in the number of MA44 mutant strain in comparison
to AJB715 wild type strain.
Conclusions: The results exhibited that stj operon plays an important
role in the pathogenicity of S. Typhimurium by effecting the reproduction
and stability functions of host organism in the target tissue systems.
Acknowledgements: This work was supported by the Scientiﬁc and
Technological Research Council of Turkey (TUBITAK) grant 107T459.
P1304 Prevalence of virulence genes among nosocomial and cystic
ﬁbrosis isolates of Pseudomonas aeruginosa from Bulgaria
T. Strateva, B. Markova, I. Mitov, V. Ouzounova-Raykova, G. Petrova
(Soﬁa, BG)
Objectives: To study the prevalence of different virulence factors
(adhesins, invasins and type III effector proteins) in clinical isolates of
Pseudomonas aeruginosa and to perform a comparative analysis of their
incidence according to the patients’ population, localisation of infection
and antimicrobial resistance of the strains.
Methods: A total of 202 clinical P. aeruginosa isolates obtained from
in-patients and cystic ﬁbrosis (CF) patients was collected during 2001–
2006 from ﬁve university hospitals in Soﬁa, Bulgaria. Polymerase chain
reaction ampliﬁcation and sequencing were carried out to determine
the distribution of the following virulence genes: algD (encoding
alginate), pilB (type IV pili), nan1 (neuraminidase), lasB (elastase B),
plcH (haemolytic phospholipase C), exoS (exoenzyme S) and exoU
(exoenzyme U).
Results: The frequencies of virulence genes in all studied strains were:
algD – 91.1%, pilB – 23.8%, nan1 – 21.3%, plcH – 91.6%, lasB – 100%,
exoS – 62.4%, exoU – 30.2%. The prevalence of nan1 was higher in CF
respiratory isolates (38.1%) than in non-CF isolates (16.9%) – P< 0.01.
The distribution of pilB (9.5%) and plcH (71.4%) among CF isolates was
lower than in non-CF nosocomial strains (respectively, 26.9% (P< 0.01)
and 96.9% (P< 0.001)). The dissemination of virulence genes varied
according to the localisation of nosocomial infections in non-CF patients.
The relative proportion of multidrug-resistant (MDR) nosocomial strains
of P. aeruginosa expressing a great number of virulence factors (5)
(38.1%) was higher than the proportion of non-MDR isolates with a
great number of virulence factors (17.6%) – P< 0.01.
Conclusions: The neuraminidase plays a key role in CF pulmonary
disease evolution. Nonpilus adhesins such as the slime layer composed of
alginate are the major virulence factors for attachment of P. aeruginosa to
the respiratory epithelial cells in CF patients. Combined horizontal gene
transfer and recombination of pathogenicity islands and mobile genetic
elements containing antimicrobial resistance genes are the probable
causes for selection of MDR P. aeruginosa strains with a large number
of virulence factors.
P1305 Quorum sensing-deﬁcient respiratory isolates of
Pseudomonas aeruginosa
O. Karatuna, A. Yagci (Istanbul, TR)
Objective: Pseudomonas aeruginosa (PA) is an opportunistic pathogen
which produces several virulence factors including elastase, alkaline
protease, pyocyanin and rhamnolipid. The genes for these products are
often controlled by quorum sensing (QS) systems. In PA, two QS system
were identiﬁed, LasR/I and RhlR /I. We tried to analyse QS regulated
virulence factors of respiratory PA isolates and determine QS deﬁcient
ones.
Methods: PA strains (n: 100) isolated from lower respiratory tract
infections were used. Production of elastase, alkali protease, pyocyanin
and bioﬁlm were quantiﬁed spectrophotometrically. PA01 strain was
used as a standard reference strain. Forward and reverse primers for
LasI, LasR, RhlI, RhlR were used for polymerase chain reaction(PCR)
ampliﬁcation of QS genes. Evaluation of bioﬁlm-forming ability and
genetic typing was done by ERIC-PCR. Antimicrobial resistance was
determined by agar diffusion.
Results: Production of bioﬁlm was detected in 49 strains, whereas
45 strains elastase, 53 strains alkaline protease and 31 strains were
pyocyanin positive. In 16 of the patients any of these factors were found
to be positive. Virulence factor negative strains were not cumulated in
a antibiotic susceptibility pattern or a genotypic subgroup. Four of the
QS related genes were negative in only 3 of the 16 strains.
Conclusion: Depending on the infected tissue some virulence factors
play more important roles than the others in the pathogenesis of PA
infections. During the infection some virulence factors may compensate
for the loss of any single virulence factor. The impact of spontaneous
loss of several virulence factors on the colonisation and infection process
is not well known. Although in 16 of our PA isolates none of the 4
virulence factors were detected phenotypically, genes responsible for the
production for these factors were negative in only 3 of them suggesting
low reliability of phenotypic tests. We can also conclude that PA strains
that lack functional QS can still produce infection.
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P1306 Stenotrophomonas maltophilia isolated from patients
affected by cystic ﬁbrosis: genotyping analysis and
molecular characterisation of virulence determinants
E. Fiscarelli, A. Iacobino, M. Nicoletti, B. Colonna, G. Prosseda,
M. Casalino (Rome, Chieti, IT)
Objectives: In recent years Stenotrophomonas maltophilia has gained
considerable attention being one of the most prominent emerging
pathogens in the airways of CF patients. The role of S. maltophilia in the
pathophysiology of the CF lung disease has not been clearly elucidated,
but a progressive deterioration in pulmonary function has been observed,
particularly in patients chronically colonised for longer periods. Despite
its increasing role as a human pathogen, little is known about the
bacterium, particularly with regard to putative virulence factors. Due
to the remarkable diversity among isolates it is extremely important to
acquire a better deﬁnition of bacterial clones or lineages able to cause
disease in CF patients.
Methods: S. maltophilia clinical strains, isolated from CF patients
at the “Bambin Gesu`” Hospital in Rome (OBG collection), were
analysed for genomic diversity by Pulse Field Gel electrophoresis
(PFGE) and restriction length polymorphism of the gyrase B gene
(gyrB RFLP). By Subtractive Suppression Hybridisation (SSH) genome
analysis, we started to identify speciﬁc DNA regions selectively present
in S. maltophilia OBGTC9, a persistent CF clinical isolate.
Results: While the gyrB RFLP analysis allows to group our
S. maltophilia strains into few clusters, PFGE reveals a high genomic
diversity despite their origin from a single hospital. As far as the
identiﬁcation of potential virulence factors is concerned, we have
obtained a SSH library and we have identiﬁed some speciﬁc DNA
fragments present in S. maltophilia OBGTC9. These genomic regions are
not widespread among the S. maltophilia strains of the OBG collection,
but rather associated only with two strains (OBGTC9, OBGTC10) able
to establish persistent infections in CF patients.
Conclusions: We have analysed a group of S. maltophilia clinical
strains, stemming from persistent or sporadic infections from respiratory
secretions of CF patients, for genomic diversity and for the presence
of virulence traits which may contribute to the pathogenicity process.
PFGE reveals a high genomic diversity of S. maltophilia isolates despite
their origin from a single hospital. Moreover, by SSH analysis we have
identiﬁed speciﬁc DNA regions present only in two S. maltophilia strains
(both persistent CF clinical isolates), which may be considered putative
virulence factors in chronic infection.
This work is supported by the Italian Cystic Fibrosis Foundation (Grant
7/2007)
P1307 Antibody response of cystic ﬁbrosis patients with
S. maltophilia infection/colonisation to the S. maltophilia
ﬁmbria SMF-1
A.C. Azzuz-Chernishev, L..V. da Silva Filho, D. de Oliveira-Garcia
(Sa˜o Paulo, BR)
Objectives: S. maltophilia is an opportunistic pathogen with controver-
sial role in lung disease of cystic ﬁbrosis (CF) patients. This bacterium
expresses ﬁmbria (SMF-1) that may be involved in bacterial adherence
to epithelial cells (de Oliveira-Garcia et al, Cel. Microbiol., 5: 625–636,
2003). It was evaluated the antibody response of cystic ﬁbrosis (CF)
patients naturally infected/colonised with S. maltophilia against SMF-1.
Methods: Twenty-three S. maltophilia isolates were obtained from
respiratory tract of 13 CF patients attending to Pulmonology Unit
of Medical School of University of Sa˜o Paulo, Sa˜o Paulo, Brazil.
S. maltophilia isolates were identiﬁed by classical phenotypic tests
and by PCR and DNA sequencing in some cases. Whole cells were
submitted to imunnoblottings using rabbit antiserum raised against
SMF-1 to assess SMF-1 production. Also human sera obtained from
CF patients colonised/infected with S. maltophilia were used against
SMF-1 puriﬁed to verify the production of antibodies. It was used goat
anti-human IgG and anti-rabbit IgG conjugated to horseradish peroxidase
as secondary antibodies. Other Gram-negative bacteria and human sera
obtained from patients without S. maltophilia infection/colonisation were
used as negative control. SMF-1 puriﬁed and rabbit antiserum raised
against SMF-1 were used as positive control.
Results: All S. maltophilia isolates produced SMF-1. All human sera
tested reacted with SMF-1. Sera from 04 patients presented high title
(1:500), and 02 of these patients had clinical or pulmonary function
decline and sera from one patient presented title 1:2 500.
Conclusion: The presence of antibodies against ﬁmbria is a marker for
infection and production of these antigens in vivo. SMF-1 was produced
in vivo during natural S. maltophilia infections/colonisations and elicited
an immune response against it. This is the ﬁrst description about the
production of human antibodies against SMF-1.
Financial support: FAPESP (02/13111−0)
P1308 First description of Staphylococcus lugdunensis
internalisation into epithelial cells
F. Szabados, B. Heck, S. Rodepeter, M. Kaase, B. Kleine, T. Sakinc,
I. Schmitz, S. Gatermann (Bochum, DE)
Objectives: Staphylococcus lugdunensis belongs to coagulase-negative
Staphylococci(CoNS) and can occasionally cause serious invasive
infections such as osteomyelitis and infective endocarditis. S. lugdunensis
accounts for 18% of infective endocarditis and 44% of native valve
endocarditis caused by CoNS. S. lugdunensis expresses potential
virulence factors, including synergistic toxins, haemolysins, extracellular
enzymes, several adhesion factors, which mediate binding to collagen
type I and IV, human IgG, ﬁbronectin and ﬁbrinogen. Furthermore, a
ﬁbrinogen-binding protein (Fbl), with a high homology to clumping
factor A of S. aureus has been described.
We therefore sought to investigate internalisation of several S. lugdunen-
sis blood culture isolates into different epithelial cell lines.
Methods: Internalisation into the human bladder carcinoma cell line
5637 and Hep2 cells were measured using a FACS-based method as
described previously. The bacteria were stained with FITC and were
incubated for one hour with the cells, gentamicin and lysostaphin was
added for half an hour. The cells were washed and treated with trypsin to
remove adhering bacteria and to detach the eukaryotic cells. For further
discrimination, a gating strategy was used, because bacteria were smaller
in size and FITC stained.
Results: The internalisation of several S. lugdunensis blood culture iso-
lates was signiﬁcantly increased in contrast to non-invasive S. carnosus
TM 300. Internalisation ratio was slightly less compared to S. aureus
Cowan I strain.
Conclusion: Our experiments demonstrate for the ﬁrst time internali-
sation of S. lugdunensis clinical isolates into epithelial cells in a FACS
invasion assay. These results were in line with the clinical suspected
invasive ability of this pathogen. Internalisation into eukariotic cells
could explain an important step of S. lugdunensis pathogenicity in serious
infections e.g. endocarditis in analogy to mechanisms described for
S. aureus.
P1309 The signal peptide of Panton-Valentine leukocidine LukS
component induces increased adhesion to extracellular
matrix components in Staphylococcus aureus
A. Tristan, Y. Benito, E. Dusserre, M.G. Bowden, J. Etienne, G. Lina,
F. Vandenesch (Lyon, FR; Houston, US)
Staphylococcus aureus necrotising pneumonia is a highly severe disease
due to S. aureus strains carrying the Panton Valentine leucocidin (PVL)
genes (lukS-PV & lukF-PV) encoded on various bacteriophages (such as
phiSLT). PVL is a pore forming toxin inducing polymorphonuclear cell
death by necrosis (at high concentration, 200 nM) or by mitochondrial
pathway induced-apoptosis (low concentration 5 nM). However, clinical
PVL+ strains from necrotising pneumonia display additional properties
such as increased adhesion to matrix molecules (type I and IV collagens
and laminin) that could play a role in bacterial adhesion to damaged
airway epithelium in the course of necrotising pneumonia.
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To investigate the basis of this increased adhesion to matrix proteins we
transduced phiSLT in various S. aureus clinical and laboratory strains,
and tested these strains for adhesion to various matrix molecules and to
matrigel® (a solubulised basement membrane preparation).
Transduction of phiSLT in different backgrounds produced an adhesion
phenotype to collagen I and IV, laminin, elastin and matrigel®, similar
to that observed with clinical PVL+ strains. In addition, independent
expression of each of the PVL component in the laboratory strain
RN6390 induced the same adhesion phenotype with an effect more
marked for lukS-PV than for lukF-PV. Cloning and expression of various
LukS-PV sub-fragment revealed that the 28 aa signal peptide of LukS-PV
induced this adhesion phenotype. A synthetic LukS-PV signal peptide
but not other unrelated signal peptide, produced the same adhesion
phenotype in vitro. This study shows for the ﬁrst time in bacteria
the potential post-secretory function of a bacterial signal peptide. One
hypothesis is currently investigated: the cleaved signal peptide could
be released outside the cytoplasmic membrane and, after non-covalent
linking to the peptidoglycan or teichoic acids, could function as an
adhesin for the matrix proteins.
P1310 Extracellular adherence protein of Staphylococcus aureus
in wound infections: surprising differences in transcription
and expression in vivo and in vitro
I. Joost, D. Blass, M. Burian, C. Goerke, M. Bischoff, M. Herrmann
(Homburg, Tubingen, DE)
Objectives: The extracellular adhesion protein (Eap) of S. aureus
belongs to a group of secreted proteins that are non-covalently bound
to the cell surface and exerts versatile effects that fulﬁl prerequisites
for chronic, persistent infections: Adhesion to extracellular matrix
molecules, endothelial (EC) and other cells, reduced angiogenesis and
EC proliferation, immunmodulation and delayed wound healing in mice.
Although eap is prevalent in 100% of clinical isolates, only little is known
whether and how eap is transcribed and expressed by clinical isolates
under in vivo and in vitro conditions. Objectives of the study were the
examination of the eap transcription in vivo from human wounds and
in vitro under deﬁned conditions as well as the corresponding protein
expression.
Methods: RNA-Isolation: RNA was isolated using a modiﬁed Trizol
protocol. Wound swabs were snap frozen in liquid nitrogen immediately.
Quantiﬁcation of eap transcription: Quantiﬁcation was done by RT-PCR
using speciﬁc RNA standards for eap and gyrB.
Protein detection: Standard protocols for isolation of proteins from
supernatants and cell-wall attached proteins were applied.
Results: Our analyses show that eap is transcribed by all clinical
isolates in a strain- and growth phase-dependent manner. Under in vivo
conditions, transcription of eap was found to differ with the degree of
infection, with severe infections possessing the highest eap expression,
which was up to 500-fold higher than under in vitro conditions. Strains
causing wound infections seem to have the capability to transcribe eap
on a higher level than strain Newman, so far known to be the highest
Eap producer. While most of the synthesised Eap in Newman is found
non-covalently bound to the cell surface, we were not able to detect
signiﬁcant amounts of Eap either in the cell surface fractions or the
supernatants of the wound isolate cultures.
Conclusions: Our results prove that eap is transcribed by all clinical
isolates tested. Interestingly, eap transcription seemed to correlate with
the degree of infection, with eap being transcribed at a higher level
under severe conditions than in superﬁcial infections. Surprisingly, eap
transcription of clinical isolates did not appear to correspond with protein
production, indicating either differences in transcription- and translation
efﬁciencies, or a rapid turn-over of Eap in the culture supernatants of
these strains.
P1311 Staphylococcus aureus encoding both TSST-1 and PVL in
the UK
A.M. Kearns, I. McCormick Smith, M. Ganner, C. East, M. Warner,
R.L. Hill, M.J. Ellington (London, UK)
Objectives: TSST-1 and PVL are superantigenic, synergohymenotropic
toxins that have been associated with toxic shock syndrome and
necrotising pneumonia, respectively. These toxins are rarely reported in
the same strain of S. aureus. We sought to determine the genetic diversity
and clinical impact of such isolates across England and Wales during
2005−7.
Methods: S. aureus referred to the national Staphylococcus Reference
Laboratory from 2005 to September 2007, and that tested positive by
PCR for the presence of toxin genes including the lukSF-PV and tst
were retained for study. Isolates were characterised by spa typing, SmaI
PFGE and MLST, as appropriate. In addition: agr allotype, SCCmec
type and ccr type were determined together with MICs of a wide range
of antibiotics. Patient demographic and clinical data were retained for
analysis.
Results: Five MRSA and 16 MSSA encoding TSST-1 and PVL were
identiﬁed. These were geographically and temporally unrelated. The
ﬁve MRSA were from four paediatric patients (3 male) and one 65
year old female. Two isolates were from abscesses, one each from a
nasal swab and eye infection, and one of unknown source. The MRSA
were SCCmecIV, related to known ST5, 22 and 30 isolates by PFGE
and spa typing, and were resistant to up to three antibiotic classes, in
addition to b-lactams. Six of 16 MSSA were from males and nine from
females. Available data indicated the age range was <1 to 58y (mode
= 0 y, median = 31 y). Three isolates were associated with pneumonia,
1 with bacteraemia, 1 with wound infection, 2 with abscesses, 1 was
from pus and 5 were from screening swabs. The MSSA isolates were
genetically diverse (including ST5, 22 and 30), 1 isolate was resistant
to ciproﬂoxacin, 9 resistant to tetracycline and 2 were resistant to
trimethoprim.
Conclusion: Diverse lineages of S. aureus encoding both TSST-1 and
PVL have been identiﬁed sporadically in geographically distinct areas
of the UK. Resistance to multiple antibiotics was noted in MRSA,
but MSSA isolates remain largely susceptible. Like other PVL positive
S. aureus, these strains have a predilection for the young with attendant
impact on clinical management and empiric therapeutic strategies.
P1312 Acid tolerance of Streptococcus anginosus
M. Sasaki, S. Tajika, Y. Kodama, Y. Shimoyama, S. Kimura (Morioka, JP)
Objectives: Streptococci belonging to Streptococcus anginosus comprise
a large proportion of the resident oral microﬂora. In recent years,
however, it has emerged that S. anginosus infection could be closely
related with oral, esophagus and gastric cancers. Since the surfaces of
these organs are generally acidic conditions, the aciduricity, the ability
to survive and grow under conditions of low pH, of S. anginosus may
be associated with the upper gastrointestinal cancers. To elucidate the
aciduricity and the acid tolerance mechanisms of the microbes, in this
study, we examined the viabilities and growth of S. anginosus in acidic
conditions, and the putative acid tolerance mechanisms, the ATPase and
arginine deiminase (ADI) activities, were compared to those of other
oral streptococci.
Methods: S. anginosus ATCC 10713 and the clinical isolates, and other
oral streptococci, S. mutans ATCC 25175, CS. sanguinis ATCC 10556,
CS. gordonii ATCC 10558, CS. mitis ATCC 9811, CS. oralis ATCC
10557 and S. salivarius ATCC 7073, were used. The aciduricity of
the bacteria was assessed by the viabilities of preacidiﬁed bacteria and
the growth in acidic conditions by means of the culture methods using
Todd Hewitt agar. The ATPase and ADI activities were measured by the
colorimetric methods on the permeabilised bacterial cells.
Results: Among the seven oral streptococcal species tested, S. anginosus
and S. mutans showed markedly higher viabilities after the preacidiﬁca-
tion at pH 4.0 for 60 min, whereas the growth depression in acidic
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conditions (pH 4.5−5.0) for S. anginosus was much lower than that for
S. mutans. Both S. anginosus and S. mutans showed relatively higher
ATPase activities than the other oral streptococci. However, the ADI
activity was detected in S. anginosus, S. sanguinis and S. gordonii, but
not in the other oral streptococci including S. mutans. Furthermore, the
ADI activity in S. anginosus was the highest among the three.
Conclusion: Among oral streptococci, S. anginosus could have a
signiﬁcant aciduric property, which may be ascribable to their ATPase
and ADI activities.
P1313 Investigation of afﬁnity properties of receptor protein G of
group G streptococci in different ﬂow-through models using
the approaches of afﬁnity high-performance monolithic
disk chromatography
O. Lozhkina, T. Gupalova, A. Totolian, T. Tennikova (St. Petersburg, RU)
Objectives: The in vitro study of surface proteins of pathogenic
microorganisms in model systems imitating its natural microsurrounding
allows to estimate the role of receptors in pathogenesis of bacteria. The
aim of the present study was to develop several ﬂow-through models
with cell-imitators, intact and inactivated cells of Group G streptococci
immobilised on CIM® monolithic stationary phases (BIA Separations,
Slovenia) and to investigate them using the approaches of afﬁnity high
performance monolithic disk chromatography (AHPMDC) taking as a
reference the interaction between surface protein G and human IgG,
thoroughly studied before [1].
Methods: We developed and investigated four models of surface
of Streptococcus: 1) cell-imitators on the base of monodisperse
polymethylmethacrylate (PMMA) microspheres (1 mkm in diameter)
with covalently attached recombinant protein G; 2) cell-imitators
on the base of monodisperse PMMA microspheres functionalised
with recombinant protein G and dextran, imitating polysaccharidic
microsurrounding of the receptor protein, 3) inactivated cells of Group
G streptococci (strain 148); 4) intact cells of Group G streptococci
(strain 148). All models were covalently immobilised on the surface of
ﬂow-through pores of CIM® disks in order to examine such an afﬁnity
parameter as dissociation constant (Kdiss) of the interaction between
protein G and human IgG by means of AHPMDC.
Results: Cell-imitators as well as cells themselves were immobilised
on the surface of absolutely ﬂow-through pores of monolithic sorbents
and did not block them. Such a design of models allowed to realise
the processes of elution at high speed (2.5ml/min) in comparison
to traditional afﬁnity chromatography where average speed is about
1−2ml/h. Kdiss evaluated for all the models described above were of
the same magnitude, ranging around 10−6–10−7 M. These results are
in good agreement with previously received data [1] and indicate that
streptococcal protein G has an extremely high afﬁnity to human IgG
that does not depend on its microsurrounding and is not inﬂuenced by
covalent immobilisation.
Conclusion: The developed methodical approach seems to be an
attractive tool to study the interactions between human proteins and
microorganisms in order to gain improved knowledge about the
pathogenesis of the last ones.
References.
Reference(s)
[1] Lozhkina O.V., Gupalova T.V., Palagnuk V.G., Totolian A.A.,
Tennikova T.B. J. Chromatogr. A. – 2002, v. 949, p. 185.
P1314 Bacteriophage genes distribution among GAS belonging to
different M serotypes
E. Polyakova, W. Gao, A. Suvorov, Y. Yang, J. Ferretti, A. Totolian
(St.Petersburg, RU; Bejing, CN; Oklahoma City, US)
Objectives: In spite of the intense use of antibiotics in medical practice,
the group A streptococcus (GAS) continues to be one of the most
common bacterial pathogens of humans. Recent sequencing information
has shown that the GAS possess tremendous genetic variability and
one of the reasons for this is the presence of numerous streptococcal
bacteriophages, which often carry genes encoding toxins, mitogens,
enzymes and antibiotic resistance factors. Little is known about the
real impact of speciﬁc phage or phage transported virulence genes in
GAS pathogenicity. The aim of the present work was to study a possible
correlation between the speciﬁc M serotype of GAS and bacteriophage
content.
Methods: 75 GAS strains belonging to serotypes M1, M12 and M49 (31,
22 and 22) were studied. Streptococcus pyogenes strains type M1 and
M12 were obtained from Chinese patients with scarlet fever in Beijing
during 2007. M49 strains known to be from patients with invasive disease
were obtained from CDC in the USA and collected between 2000–
2005. Strains were analysed by PCR with a panel of 27 pairs of primers
corresponding to the genes of phage related virulence factors and a set of
nine phage related integrases. Results were substantiated by microarray
hybridisation.
Results: 75 GAS strains belonging to 3 different M serotypes were
analysed by PCR. Among the GAS strains from serotype M49, the highly
prevalent genes found were speA, speI, speH, int5 and int7. In M1 strains
speA, speH, speC, speC/J, ssa, sdaM, int4 and int7 were determined. In
M12 strains the prevalent genes were speH, ssa, speC and int4 (ﬁg1).
A distinct correlation was found between the M serotype of GAS under
study and phage gene content suggesting that temperate bacteriophages
might be an important factors in the development of epidemic strains
and may be involved in the triggering of GAS infections.
Phage genes distribution.
Conclusions: PCR analysis of bacteriophage gene content in the
epidemic GAS reveals that strains belonging to the same serotype have
similar bacteriophage gene patterns. The role of the bacteriophages in
GAS pathogenicity is discussed.
P1315 Horizontal transfer of the E. faecalis pathogenicity island
between E. faecalis and E. faecium
J. Laverde-Gomez, C. Fleige, I. Klare, G. Werner (Wernigerode, DE)
Objectives: E. faecalis possesses a pathogenicity island (PAI) bearing
the esp gene. In E. faecium a variant esp gene has been described
and integration into a similar PAI structure is supposed. The data we
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present here are to identify and characterise horizontal gene transfer of
the E. faecalis PAI from E. faecalis to E. faecium.
Methods: Horizontal gene transfer was determined using a standard
ﬁlter-mating procedure. Different donor and recipient stains (E. faecium
64/3; E. faecalis JH2−2, OG1RF) were tested. E. faecium transconju-
gants were checked for clonality with the recipient, i.a. by their PFGE
patterns. Presence of esp was identiﬁed by PCR. PFGE, isolation of
plasmid and genomic DNA were done according to standard procedures.
Composition of the PAI was identiﬁed using single gene PCR, long PCR
followed by restriction digestion and partly by DNA sequencing.
Results: While selecting for a transfer of erythromycin resistance
between UW3114 and recipient 64/3 we were able to trigger parallel
transfer of the esp gene. The donor and the esp-positive transconjugant
possessed identical plasmids and plasmid digestion patterns suggesting
chromosome to chromosome transfer of the esp/PAI from E. faecalis
to E. faecium. We did PFGE with DNA from the donor, recipient, esp-
positive and -negative transconjugants. Southern hybridisation identiﬁed
a new 450 kb fragment possessing esp in the esp-positive transconjugant.
Compared to the pattern of the recipient and the esp-negative
transconjugant a 245 kb fragment disappeared in the PFGE pattern of the
esp-positive transconjugant suggesting transfer of a ca. 205 (450–245)
kb fragment bearing esp/PAI. Results of PCR and long PCR identiﬁed
several deletions in the right end of the E. faecalis PAI in the donor and
the esp-positive transconjugant.
Conclusions: In their original description, Shankar et al. (2002) were
unable to transfer the newly described PAI in E. faecalis. However, by
tagging the esp gene with a chloramphenicol marker Coburn et al. (2007)
identiﬁed horizontal gene transfer of a 28 kb internal fragment of this
PAI. We describe here for the ﬁrst time inter-species transfer of the
E. faecalis PAI into the genome of E. faecium. Our present data show
transfer of a ca. 205 kb genomic fragment from E. faecalis bearing an
incomplete but entire PAI element and integration of this fragment into
the E. faecium genome.
P1316 Virulence factors and antimicrobial resistance in H. pylori
clinical isolates by a multiple correspondence analysis
J.A. Garcia-Campos, T. Alarcon, D. Domingo, M. Lopez-Brea
(Madrid, ES)
The aim of this study was to determine the presence of different virulence
factors and antimicrobial resistance in H. pylori clinical isolates and
to analyse the results obtained by a multiple correspondence analysis
(MCA).
Methods: 70 H. pylori strains were obtained from patients attending
to the Gastroenterology Unit due to different symptomatology. 46 out
of the 75 suffered of gastritis and 29 of peptic ulcer. Upper endoscopy
was performed and biopsy cultured following standard methodology.
DNA was extracted from a 48 h culture and PCR performed to detect
cagA gene, vacA s1- and s2-alleles, babA2 gene, hpaA alleles and
hopQ alleles. Speciﬁc primers for the cag empty site were also used to
conﬁrm the absence of the cagPAI (ES-cagA). All PCR products were
analysed by agarose gel stained with ethidium bromide. Lewis antigen
was determined by an Enzimoimmuno assay using monoclonal anti-
LewisX and anti-LewisY and alcaline phosphatase labelled secondary
antidodies. Metronidazole and clarithromycin resistance was determined
by E-test.
Results: Three groups were detected by MCA: (1) strains positive for
cagA gene (non discrepant with ES-cagA), vacAs1, hopQ type I-II,
negative for babA2 and clarithromycin and metronidazole susceptible
(group A). (2) Strains negative for cagA (discrepant with ES-cagA) and
positive for vacAs2, hopQ type II, babA2, hpaA2, clarithromycin and
metronidazole resistant and expressing Lewis antigen (LeXY or LeY)
(group B). (3) A heterogeneous group (group C). Same results were
detected when a dendogram for cluster analysis was drawn.
When the MCA analysis was performed in strains form ulcer patients
the same 3 groups were detected with small differences. In strains
from gastritis higher differences were found. cagA+, vacAs1, hpaA1 and
hopQ I-II strains were associated with clarithromycin and metronidazole
resistance (in ulcer strains were associated with susceptible ones),
the presence of babA2, the expression of LewisXY antigen and the
discrepancies with ES-cagA.
Conclusions: Strains with more virulence factors grouped together when
MCA was performed. Moreover, in strains from gastritis virulence genes
were associated with clarithromycin and metronidazole resistance whilst
in ulcer strains they were associated with susceptible ones.
Acknowledgement: FIS-PI052442
P1317 Relevance of human beta defensin-1 in Helicobacter
pylori-induced gastritis
K.A. Kocsis, Z. Kiss, F. Somogyva´ri, Z. Tiszlavitz, D. Szoke, Y. Ma´ndi
(Szeged, Budapest, HU)
Objectives: Human beta defensins (HBDs) are antimicrobial peptides
that are expressed by epithelia on mucosal surfaces. Recent reports have
demonstrated that Helicobacter pylori infection induces HBD-2, whereas
HBD-1 is thought to be expressed constitutively, and it’s role in H. pylori
infection is controversal. Therefore, the aim of the present study was to
investigate the relevance of three SNPs of the HBD-1 gene in H. pylori
induced chronic gastritis. We have also assessed mRNA expression of
human beta-defensin 1 in by H. pylori infected AGS cells.
Methods: Three SNPs of the DEFB1 gene DEFB1 G-20A (rs11362),
DEFB1 C-44G (rs1800972) and DEFB1 G-52A (rs1799946) were
genotyped either by Custom TaqMan® SNP Genotyping Assays or by
restriction fragment length polymorphisms (RFLP) in 150 patients with
chronic active gastritis. Patients were examined by gastroduodenoscopy.
HP positivity was detected by 13C-UBT and hystopathology. 100
serologically H. pylori-positive subjects without gastric or duodenal
symptoms served as controls. Human beta-defensin1 mRNA expression
in AGS cells was measured by quantitative RT-PCR reaction
Results: No signiﬁcant difference was observed in the case of
investigation the DEFB-1 SNPs at the region of −22 and −44. A deﬁnitive
differences in the frequency of GA and AA genotypes of G-52 A
SNP was observed between patients with gastritis and healthy controls.
Conversely, the wild type genotype (GG) was signiﬁcantly more frequent
(47%) among healthy subjects than in patients (29%).
A dose dependent increase in HBD1 mRNA was observed in AGS cell
line following infection with increasing number of H. pylori
Conclusion: We suppose, that the SNP in the −52 untranslated region
of HBD-1 might be connected with a deﬁcient function of human
b defensin. This could lead to an increased colonisation of H. pylori in
the stomac, with an ineffective clearence, and a consequent inﬂammation.
Considering the results of the genetic and in vitro experiments our results
draw the attention that not only the inducible, but also the constitutive
form of human beta defensin have importance in pathogenesis of
H. pylori induced gastritis.
P1318 Polymorphisms in the NOD1 and IL-8 gene, but not in the
TLR4 gene are associated with Helicobacter pylori-induced
duodenal ulcer and gastritis
Y. Ma´ndi, P. Hofner, Z. Kiss, A. Tiszai, Z. Tiszlavitz, B. Molna´r,
Z. Tulassay (Szeged, Budapest, HU)
Objectives: Intracellular pathogen receptor NOD1 is involved in
the epithelial cell sensing Helicobacter pylori, which results in a
considerable interleukin (IL-8) production. The aim of this study
was to evaluate the relationship between NOD1 and IL-8 genetic
polymorphisms and the development of H. pylori-induced gastritis and
duodenal ulcer (DU), as compared with TLR4 polymorphisms.
Methods: Eighty-ﬁve patients with DU and 135 patients with
gastritis were enrolled in the study. Patients were examined by
gastroduodenoscopy. HP positivity was detected by 13C-UBT and
hystopathology. Seventy-ﬁve serologically H. pylori-positive subjects
without gastric or duodenal symptoms served as controls. The G796A
(E266K) NOD1 polymorphism was determined by restriction fragment
length polymorphism, and the −251 IL-8 polymorphism by ampliﬁcation
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refractory mutation system method. The TLR4 (ASP/299/Gly and
Thr/399/Ile) gene polymorphisms were examined by melting point
analysis.
Results: AA homozygote mutant variants of NOD1 were detected in
20% of the H. pylori-positive patients with DU versus 7% of H. pylori-
positive patients with gastritis and versus 6% of the H. pylori-positive
healthy controls. The IL-8 heterozygote mutant variant was detected with
a signiﬁcantly higher frequency among the DU patients (57.6%) and
those with gastritis (55.9%) than among the H. pylori-positive controls
(40%). However, no signiﬁcant correlation concerning the frequency of
the TLR4 gene polymorphism could be revealed between any group of
patients and the controls.
Conclusions: E266K CARD4/NOD1, but not the TLR4 gene poly-
morphism increases the risk of peptic ulceration in H. pylori-positive
patients. The −251 IL-8 polymorphism was signiﬁcantly associated
with either gastritis or DU in H. pylori-infected subjects. Host factors
including intracellular pathogen receptors and IL-8 production play an
important role in H. pylori-induced gastric mucosal damage.
P1319 Intestinal Oxalobacter formigenes colonisation in children
with calcium oxalate urolithiasis. A study from southeastern
Poland.
P. Sikora, J. Niedzwiadek, E. Mazur, A. Niedzwiadek, M. Zajaczkowska,
M. Koziol-Montewka (Lublin, PL)
Objective: Oxalobacter formigenes is an obligate anaerobic Gram-
negative bacterium colonising the colon of vertebrates, including
humans. This organism utilises oxalate as the only source of carbon
and therefore participates in oxalic acid homeostasis. In adults, it was
suggested that the lack of colonisation with O. formigenes may lead to
the intestinal oxalate hyperabsorption and to calcium oxalate urolithiasis
(CaOxU) as a consequence. To our knowledge this problem was not
investigated in paediatric population. Hence, the aim of our study was the
assessment of O. formigenes colonisation rate in children with CaOxU.
Methods: DNA was extracted from the frozen faecal samples of 84
children and adolescents (41 boys, 43 girls) aged 4.9–17.6 years with
CaOxU and 63 healthy, age- and gender matched subjects. Identiﬁcation
of O. formigenes was performed by polymerase chain reaction (PCR)
using genus speciﬁc primers, according to Sidhu et al. (JCM 1999, 37,
1503–1509).
Results: O. formigenes was found in 23.8% (20/84) of patients with
CaOxU and in 20.6% (13/63) of healthy controls.
Conclusions: In contrast to adults, we did not ﬁnd any signiﬁcant
difference in O. formigenes colonisation rate between individuals with or
without urolithiasis. However, an absence of O. formigenes in majority
of children from both groups requires further explanation. It could be
caused by an overuse of antibiotics in our region. Also, we can not
exclude that extreme variability in the O. formigenes content of stool
samples among individuals may be responsible for the low rate of O.
formigenes identiﬁcation in both examined groups.
The research was supported by the Polish State Committee for Scientiﬁc
Research (KBN grant 2P05D 117 26).
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P1320 Analysis of Haemophilus inﬂuenzae isolated from invasive
disease, in Portugal, during extensive vaccination against
H. inﬂuenzae serotype b
P. Bajanca, D. Louro, M. Canic¸a on behalf of ARSIP (Antibiotic
Resistance Surveillance Programme in Portugal)
Background: Haemophilus inﬂuenzae (Hi), an exclusively human
pathogen is responsible for potentially life threatening invasive disease
such as meningitis and septicaemia. Hi pathogenicity varies depending
on the presence or absence of a capsule and the speciﬁc capsule type.
Hi serotype b (Hib) vaccine was adopted in Portugal since 1994 and
obligated since the year 2000 to children less than ﬁve years old. In
vaccine era, non capsulated (NC) isolates have become the most common
cause of invasive Hi disease in all age groups.
Objectives: We pretend to analyse Hi serotypes as well as antimicrobial
susceptibility changes in the vaccine era and compare with previous
studies in Portugal.
Methods: We collected 102 invasive isolates (20 CSF, 74 blood cultures
and 8 pleural ﬂuids), from 2000 to 2007, in Antibiotic Resistance Unit
from the National Institute of Health, from several Hospital Laboratories
in different regions of Portugal.
Identiﬁcation of Hi was conﬁrmed by standard procedures. Nitroceﬁn
was used to determine b-lactamase production. Susceptibility testing
was performed by micro dilution, according to the CLSI guidelines.
Serotyping was performed by PCR.
Results: Strains were distributed by age as follow: forty-one strains
(40.2%) were from children (<18 years old), being twenty eight of these
(68.3%) from under 5 years old; ﬁfty-nine strains (57.8%) were isolated
from adults.
From all the invasive strains, 10.8% were b-lactamase producers and
5.5% with MIC values to ampicillin and clavulanic acid of 2mg/L, were
considered ampicillin-resistance-non-b-lactamase-producers (ARNBLP).
Resistance to SXT was high: 19%.
As we expected, most strains (76.5%) were NC, being 15 of serotype b
(15.3%).
Two of the 3 serotype a strains, were isolated from children. All 4
serotype f strains and 1 serotype d were from adults.
In a previous study of invasive strains, performed in our laboratory
with strains isolated between 1989 and 2001, we observed a decline
in serotype b strains, from 81% to 16%, accompanied by an increase of
NC strains, from 19% to 80%.
Conclusions: This study continues to documents changes in invasive
infections following the introduction of the vaccine in Portugal. We are
assisting to an increment of NC strains as well as a great decline of Hi
serotype b.
We also expect an increase of non-b-type strains in Hi invasive disease
and a new rule in the virulence of these strains. So, it’s imperative to
continue this kind of studies.
P1321 Changes in invasive pneumococcal disease among children
after the introduction of the heptavalent pneumococcal
conjugate vaccine
M. Gimenez, M. Eril, S. Molinos, M. Azuara, C. Rodrigo, V. Ausina
(Badalona, ES)
Objectives: Pneumococcal conjugate vaccine (PVC-7) has been reported
to prevent invasive disease (IPD) by covering the most prevalent
serotypes isolated from blood or CSF. Implementation of PCV-7 could
have changed epidemiology, clinical and analytical features of IPD. We
analysed the impact of PCV-7 in our community, focusing on emergence
of nonvaccine serogrups, clinical diagnosis, incidence of empyema and
inﬂammatory response (C-reactive protein [CRP], procalcitonin [PCT]).
Methods: we analysed 75 episodes of bacteraemia within two periods,
from 1995 to 2001 (prelicensure period) and from 2002 to September
2007 (postlicensure) in children below 18 years old admitted in the
Department of Paediatrics of a tertiary-care Hospital of Barcelona.
Results: A total of 76 children with pneumococcal bacteraemia were
identiﬁed, with 28 episodes occurring in the prelicensure period and
48 in the postlicensure period. Forty-two (42.1%) were <2 years old,
39.5% were between 2 and 5 years old and 18.4% were >5 years
old. Respiratory (60.5%), occult bacteraemia (15.8%), sepsis without
focus (11.8%) and meningitis (7.9%) were the most frequent clinical
manifestations, without statistical differences between the two periods.
There was a trend towards increasing frequency of respiratory focus
during the second period but changes in incidence of non-vaccine
serotypes were not statistically signiﬁcant. Serotypes 1 and 14 accounted
for 44% of all isolates vs 29% in the pre-licensure period. Serotype 1
was signiﬁcantly associated with empyema, increased CRP and PCT
values, and length of hospitalisation (14±4 days). Serotypes 1 (4 cases),
15B, 19A and 24 caused IPD in 7 vaccinated children. High resistant
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penicillin strains showed an increase from 17.9% to 25% and eritromycin
from 21.4% to 31.3%, between the pre and postlicensure period.
Conclusions: We found an increased number of empyema cases caused
by serotype 1, with high CRP and PCT during the postlicensure period.
Changes towards the emergence of non-vaccine serotypes causing IPD
are not signiﬁcant in our area. We didn’t ﬁnd vaccinated children with
IPD caused by serotypes included in PCV-7.
P1322 Knowledge of healthcare workers regarding occupational
vaccinations
P. Loulergue, Z. Absi, C. Demontpion, F. Moulin, C. Menager,
M. Gorodetzky, G. Vidal-Trecan, D. Gendrel, L. Guillevin, O. Launay
(Paris, FR)
Immunisation against diphteria, tetanus, poliomyelitis, hepatitis B and
tuberculosis are mandatory for healthcare workers (HCW) in France.
The Committee for Public Health (Haut Conseil de la Sante´ Publique)
also strongly recommends immunisations against inﬂuenza, pertussis,
varicella, measles and for non immunised HCW.
Objectives: To evaluate the knowledge of hospital HCW regarding
mandatory or recommended vaccinations.
Methods: We performed a cross-sectional survey in two medical
departments: one in an internal medicine department caring for
immunosuppressed patients, and one in a paediatric department. A self-
administered questionnaire was used to assess all the medical and non
medical staff (physicians, students, nurses, paramedics and staff not
caring for patients) knowledge regarding mandatory and recommended
vaccinations, their current vaccination status and potential reasons for
refusal of vaccine uptake.
Results: Three hundred and ninety-ﬁve questionnaires were analysed
(280 from the Internal medicine and 115 from paediatric departments).
Although 95% of the staff declared a good knowledge of the compulsory
vaccination, only 20.7% of the internal medicine staff and 30.6% of
the paediatric staff could cite them correctly (p = 0.05). More than 70%
declared knowing the recommended vaccinations: 68% cited inﬂuenza,
15.4%, pertussis, 5.7% measlesand 4.7%, varicella.
The overall inﬂuenza vaccination rate in 2006 was higher in paediatrics
than in internal medicine unit (36% vs. 28%; p = 0.012); 50% of the
physicians, 42.7% of the students and 22.6% of the nursing staff
received inﬂuenza vaccine. The strongest motivations for having received
inﬂuenza vaccination were to protect patients (73%) and to protect
oneself (67%). Contrarily, the main reasons for vaccination refusal were
believing the vaccine to be inefﬁcacious (53%) and fearing adverse
effects (21%). Reasons for not having been vaccined against inﬂuenza
may differ between nursing/paramedical staff and physician staff.
Conclusion: Knowledge about vaccinations is poor among HCW. De-
spite recommendations for annual inﬂuenza vaccination, the proportion
of HCW vaccinated is still insufﬁcient, mainly due to a misperception of
the efﬁcacy of the inﬂuenza vaccination. This study highlights the need
to strengthen continuous education of HCW regarding vaccinations.
P1323 Serotype distribution of Haemophilus inﬂuenzae isolates
from post-vaccinated Mexican children: comparison
between antisera and PCR-based typing methods
R. Gonzaga, J. Diaz Garcia, A. Alfaro, A. Villasen˜or Sierra, R. Gracia,
J. Santos, P. Gomez de Leon (Mexico City, Guadalajara, Puebla, MX)
Objective: The world wide use of Haemophilus inﬂuenzae (Hi) type b
conjugate vaccine has resulted in a signiﬁcant decline in the incidence
of invasive disease in children <5 years of age. The 3 doses scheme
of polyribosyl ribitol phosphate (PRP)-T was licensed in our country
in 1999. However it has been speculated that this may lead to a
greater prevalence of nonencapsulated (NE) and encapsulated non-b
strains. Surveillance studies are increasingly important in Mexico for
monitoring the emergence of such strains. In this study we compare
the serotype distribution of post-vaccine Hi isolates using PCR-based
serotyping method to that obtained by slide agglutination serotyping
(SAS), currently considered as the gold standard.
Methods: One hundred and eleven Hi strains were screened by the SAS
method using polyvalent and monovalent antisera. A PCR assay for the
bexA locus was used to detect encapsulated strains. The encapsulated
isolates were genotyped using serotype-speciﬁc primers for the a, b, e,
and f Hi types.
Results: In this study, the SAS method revealed 88 (79.3%) NE Hi
strains, of which 6 were found to be types a (1), f (4) and e (1) when
the PCR capsule genotyping was performed. Additional discrepancies
were observed when 7 NE isolates detected by the PCR method were
misidentiﬁed as serotypes b (6) and f (1) by SAS. The overall 7.2%
(8/111) of the strains contained the f serotype-speciﬁc sequence. There
was 11.7% discrepancy between the SAS and the PCR-based genotyping
methods.
Conclusions: The data showed that Hi serotype f is circulating
among post-vaccinated Mexican children. The gold standard method for
serotyping the Hi strains still offers equivocal results. The genotyping
PCR assay provides a more accurate alternative for determining Hi
serotypes.
P1324 Immunological responses to BCG vaccination in
Mycobacterium bovis-challenged cattle
J. Witchell, M. Vordermeier, A. Wangoo, M. Goyal (Hatﬁeld,
Addlestone, UK)
Objectives: BCG vaccination studies in cattle have shown extreme
variability in protection against Mycobacterium bovis infection. A
critical ﬁrst step in the development of an improved vaccination is the
understanding of the host immune response to infection and vaccination.
Methods: This study focused on four experimental cattle groups BCG
Pasteur vaccinatedM. bovis challenged, BCG vaccinated non challenged,
non vaccinated M. bovis challenged and non vaccinated non challenged.
mRNA expression levels of IFN gamma, TNF alpha, IL10 and IL4 were
measured within thoracic lymph nodes of each animal using quantitative
real time PCR. Protein levels of IFN gamma and TNF alpha were
measured within each lymph node using immunohistochemistry.
Results: Challenge with M. bovis signiﬁcantly increased IFN gamma
mRNA levels (94%), reduced IL10 mRNA levels (56%) and suppressed
IL4 mRNA expression completely. There was a signiﬁcant increase in
IFN gamma protein levels (on a score scale of 1−4, challenged animals
averaged at 2.75 compared to non-challenged at 1.3) however TNF alpha
mRNA and protein levels were not signiﬁcantly affected by M. bovis
challenge. BCG vaccination prior to challenge reduced the level of IFN
gamma mRNA (81%) and IFN gamma protein (averaged score of 1.5)
as compared to the non vaccinated challenged cattle. BCG vaccination
without challenge appeared to have no effect on the cytokine and protein
levels however IL4 mRNA was detectable. There was a strong positive
correlation between IFN gamma mRNA and IFN gamma protein levels
but no correlation was observed between TNF alpha mRNA and TNF
alpha protein.
Conclusion: M. bovis infection activates a strong cell mediated immune
response signiﬁed by the dramatic increase in IFN gamma mRNA
expression. Subsequently IFN gamma protein levels increased leading
to a strong T helper (TH) class 1 proﬁle with the related reduction of
IL10 and IL4 mRNA expression.
Cattle vaccinated with BCG before challenge showed an increase in
IFN gamma mRNA expression but to a lesser degree as compared to
non vaccinated animals due to the primed immune response. The IL10
mRNA levels were not signiﬁcantly reduced in vaccinated animals and
so dampened the pro-inﬂammatory response producing a lower level
of pathology within the vaccinated animals. Finally, it appears that IL10
mRNA may experience post transcriptional regulation due to the absence
of a correlation between mRNA and protein levels.
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P1325 REPEVAX® can be safely administered as a booster
one month after tetanus, diphtheria and poliomyelitis
vaccination: an option for managing increasing incidence
of Bordetella pertussis (whooping cough) infection
J. Beytout, O. Launay, C. Dubray, F. Galtier, C. Noize-Pin, N. Guiso,
M. Baudin, P. Richard, C. Tran, E. Ledesma, A. Fiquet, C. Baptiste,
B. Soubeyrand (Clermont Ferrand, Paris, Montpellier, Villeurbanne,
Lyon, FR)
Objectives: In France it is recommended to administer a booster
dose of a pertussis-containing vaccine in adults which can result in
them receiving 2 doses of tetanus (T) and/or diphtheria (D/d) and/or
poliomyelitis (inactivated, IPV) containing vaccine within a short period
(eg catch-up programme or pertussis outbreak). In children and teenagers
it has been shown that boosters can be safely given with intervals as short
as about 2 years, but in adults there are no data for intervals less than 5
years. We assessed the safety of a booster dose of a pertussis-containing
vaccine (acellular component, aP) shortly after a Td-IPV booster.
Methods: 500 healthy adults 18–40 years, having received 5 doses of
T, D and poliomyelitis vaccine by the age of 18, with the last dose of T
and/or D and/or poliomyelitis vaccine given alone or combined at least 5
years previously, were randomised to receive either Td-IPV (REVAXIS®;
Group 1) or placebo (Group 2) followed by Td5aP-IPV (REPEVAX®)
in both groups one month later in a double-blind trial. Adverse events,
including pre-listed events for the ﬁrst 7 days (injection-site erythema,
swelling, and pain, oral temperature 37.5ºC, headache and myalgia)
were recorded on a diary card.
Results: The groups were similar in terms of age, sex ratio, weight,
height, number of previous vaccinations with D, T, and poliomyelitis
and intervals between last D, T or poliomyelitis vaccination and study
start. 484 subjects who received the second injection were included in
the REPEVAX® safety analysis. The adverse event rates reported after
REPEVAX® were similar in both groups except for a lower incidence
of solicited injection-site reactions in subjects in Group 1.
In Group 1 the rates of injection-site swelling and pain reported within 7
days after REPEVAX® were lower than in Group 2 (19.4% vs 27.7% and
82.6% vs 92.1%, respectively). The conﬁdence interval of the difference
between groups did not include 0 (swelling: −8.3 [−15.7; −0.7], pain:
−9.5 [−15.5; −3.6]), but this was not judged to be clinically meaningful.
Adverse events Group 1, %
(n = 242)
Group 2, %
(n = 242)
Pre-listed (Day 0−7)
Injection-site reactions 84.3 93.0
Systemic adverse events 36.0 37.6
Spontaneously reported (Day 0–14)
Injection-site reactions 14.9 16.1
Systemic adverse events 20.2 19.0
Conclusion: These data support the use of REPEVAX® in adults, even
one month after a booster with Td-IPV. REPEVAX® can be used as a
booster to reduce the incidence of whooping cough.
P1326 Elaboration of a type three secretion system-based Pseu-
domonas aeruginosa live vector for immunotherapy purposes
O. Epaulard, M. Guillaume, M. Derouazi, J. Franetich, A.C. Bretz,
B. Polack, D. Mazier, P.N. Marche, B. Toussaint (Grenoble, Paris, FR)
Objectives: Numerous immunotherapy methods have been designed
to eliminate cell populations (infected or tumour cells). To trigger
an efﬁcient cytotoxic T lymphocyte (CTL)-based response, the target
antigen (Ag) (i.e., viral protein) must 1) be delivered to dendritic
cell (DC) in order to obtain an MHC-I restricted presentation and
a subsequent CTL activation, and 2) be associated with a danger
signal in order to activate DC. We took advantage of Pseudomonas
aeruginosa type three secretion system (TTSS) to elaborate a bacterial
immunotherapy live vector. TTSS is used by Gram-negative rods to inject
protein effectors inside target cells such as (for P. aeruginosa) dendritic
cells and PMN. A TTSS-based live vector would ensure both danger
signal and delivery of Ag to DC.
Methods and Results: By fusing different eukaryotic proteins with
a non-toxic fragment of a TTSS effector, we obtained the secretion
by P. aeruginosa TTSS of these fusion proteins. Ovalbumin was ﬁrst
used as a model antigen. In vitro, murine dendritic cells having
incubated with the ovalbumin-delivering vector were able to activate
speciﬁc anti-ovalbumin CTL. In vivo, after 2 injections of 5.10e6
ovalbumin-delivering bacteria, mice generated anti-ovalbumin CTL.
The efﬁciency of this response was assessed by injecting ovalbumin-
expressing syngenic melanoma cells to these mice; we obtain a complete
protection (no tumour onset) of 7/8 animals, but no protection in animals
injected with a vector delivering a control Ag. A signiﬁcant but less
vigorous protection was observed when the vector delivered a native Ag
of melanoma.
The bacteria had been already attenuated by deleting the genes of TTSS
effectors ExoS and ExoT. Virulence was further altered by deleting
central genes of quorum sensing (coding for synthases LasI and RhlI)
and/or gene aroA (rendering the bacteria auxotrophic for aromatic
amino-acids). The maximally attenuated vector had a LD50 more than
100 times higher and a conserved efﬁciency as immunotherapy vector.
We explored another model by vectorising Plasmodium yoelii circum-
sporozoite protein as to target infection at the liver stage. We observed a
signiﬁcantly delayed blood smear positivation after sporozoite infection
in vaccinated mouse, indicating that the immune response triggered by
the vector was partly efﬁcient.
Conclusion: We believe that this TTSS-based P. aeruginosa vector is a
promising immunotherapy tool in both infectious and tumour diseases.
P1327 The application of Neisseria meningitidis serogroup B outer
membrane vesicle as an adjuvant to induce speciﬁc antibody
against the LPS of Brucella abortus S-99 in animal model
S.D. Siadat, D. Norouzian, A. Sharifat Salmani, H. Ahmadi, M. Nejati,
M. Kheirandish, M. Zangeneh, M.H. Hedayati, A. Moshiri, S.S. Siadat,
S. Shokohi, M. Karbasian, M. Salimi (Tehran, IR)
Objective: Smoth lipopolysaccharide(S-LPS)of Brucella abortus can be
candidated as a potent human vaccine. The adjuvants with microbial
origins are more considerable among the other current adjuvants
nowadays. The outer membrane vesicle(OMV)of Neisseria meningitidis
serogroup B is one of the newly studied adjuvants with microbial origin.
Methods: The S-LPS of Brucella was extracted by Hot phenol-
water with some modiﬁcation as described previously. The noncovalent
complex of S-LPS-OMV was injected subcutaneously into groups
of ten mice with boosters on days 14 and 28 after the primary
immunisation. The following groups were used as control: 1-LPS, 2-LPS
plus incomplete Freunds adjuvan(IFA)and 3-LPS plus Freund’s complete
adjuvant (CFA). The mice were bled on days 0, 14, 28, 42.The humoral
immune responses evaluated by detection of speciﬁc anti-LPS IgM and
IgG titre via ELISA method.
Results: Anti-LPS IgG titre(demonstrated by ELISA)for LPS plus OMV
has been increased 3.9, 3.18 and 1.58 fold after 14 days in comparison
with the LPS, LPS plus IFA and LPS plus CFA control group. The
application of LPS plus CFA led to higher level anti-LPS IgG titre than
LPS plus IFA and LPS with 1.98 and 2.5 fold, respectively. The anti-LPS
IgG titre in LPS plus IFA control group was not signiﬁcantly increased
in comparison with the LPS group. Booster doses have been effective
to signiﬁcantly increase anti-LPS IgG titre in all groups after 28 days.
An increase in anti-LPS IgG titre following the second and third dose
of LPS plus OMV induced 6 and 12.4 fold titres in comparison with
the ﬁrst dose. The highest anti-LPS IgG titre detected two weeks after
the third dose(after 42 days)of LPS plus OMV.Comparative study of
anti-LPS IgM titres were not revealed any signiﬁcant level in all groups.
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Conclusion: In this study, we showed that N. meningitidis serogroup B
OMV in noncovalent complex with Brucella abortus S99 LPS induces
high level of anti-LPS IgG and our puriﬁed OMV could act as an
effective adjuvant. Since the application of most adjuvants is restricted
because of hypersensitivity reactions and the safety of OMV in humans
has been demonstrated in many studies, OMV would be a safe adjuvant
which does not cause hypersensitivity and DTH reactions. Therefore
noncovalent complex of OMV-B. abortus LPS may be a candidate for
further development as a brucellosis vaccine for human use.
P1328 Immunological evaluation of vi-vapsular polysaccharide of
Salmonella typhi vaccine by serum bactericidal assay
H. Ahmadi, B. Tabaraiee, S.D. Siadat, F. Poor mirza gholi,
D. Norouzian, M. Nejati, M.H. Hedayati, K. Mahmoodi, A. Sharifat
Salmani, M. Abbasi, M. Karbasian, A. Adli Moghadam (Tehran, IR)
Objectives: Salmonella typhi Vi-capsular polysaccharide (Vi-CPS) is an
essential virulence factor and a safe and reliable vaccine against typhoid
fever (Acharya et al, 1975: Szu et al, 1994: Yang et al, 2001). Since there
is no any animal model for Salmonella typhi fever to evaluate protective
efﬁcacy of Vi-CPS vaccine, we recommend, serum bactericidal assay
(SBA) as a golden standard to evaluate its potency.
Methods: Vi-CPS was extracted from Salmonella typhi Ty6S (CSBPI-
B-191) according to the modiﬁed Gotschlich method (Ahmadi et al,
1999). Fifty mg of puriﬁed Vi-CPS was injected intramuscularly into
three groups of ﬁve rabbits, Groups 2 and 3 were received additional
booster dose of 50mg Vi-CPS on day 15 and days 15 and 30 respectively.
Each group of pooled serum was tested by SBA on days 0, 15, 30 and
45.
Results: The titers of SBA of anti Vi-CPS were 4, 16 and 16 for group
1 and 4, 32 and 32 for group 2 and 16, 64 and 64 for group 3 in days
15, 30 and 45 respectively.
Our investigation reveals that; Vi-CPS is a potent immunogen. Because,
at even one does of 50mg, could show an excellent bactericidal effect
against pathogenic Salmonella typhi.
Conclusions: Though Vi-CPS is a reliable vaccine against typhoid fever
but sometimes depolymerisation take place during puriﬁcation and may
cause low potency. This draw back can be resolved through potency
test. Since passive hemaglutination test recommended by WHO., does
not indicate potency of the vaccine, we recommend SBA method to
evaluate the ability of Vi-CPS to kill pathogenic Salmonella typhi, as it
has been shown in our present results.
P1329 Constraction of polyvalent anti-streptococcal vaccines and
analysis of their polyvalent features
L.F. Meringova, M.A. Ditina, A. Wang, G.F. Leontieva,
K.B. Grabovskaya, X.Z. Shen, Y.H. Yang, A.A. Totolian, A.N. Suvorov
(St-Petersburg, RU; Beijing, CN)
Objectives: In many occasions when antibiotic prophylactics fails
vaccination becomes the matter of choice. More studies have been made
for streptococcal vaccine development. The most common approach for
streptococcal vaccine generation is based on the obtaining the conjugates
between the polyvalent protein antigens and polysaccharide capsule. This
strategy provides both an immunogenicity, with signiﬁcant protection
and broad level of type speciﬁcity. The present work presents data
on comparison of two variants of vaccines: one based on mixture
of recombinant proteins and another on the conjugation of type III
GBS (PS) capsular polysaccharide with GBS recombinant cell surface
polypeptides.
Methods: Conjugation of polypeptides with PS was obtained by
reductive amination. Immune response had been studied in mice (double
immunisation with aluminum hydroxide as adjuvant). Antibody titer
was tested by ELISA. Biological activity of antibodies was tested by
opsonophagocytosis employing mice peritoneal macrophages.
Results: After optimisation of PS-peptides conjugation conditions (op-
timal concentration of the components, oxidation time, the temperature
of reaction etc.) the best chemical reaction conditions for two of the
recombinant polypeptides under study (P6 and ScaAB) were found.
Vaccine preparations containing P6-PS or ScaAB-PS reacted with
antibodies against each of the vaccine components which proved that
the antigenic structure had been preserved. Covalent binding of the PS
to P6 or ScaAB lead to the four fold increase of the immune response
relatively mono peptides usage with maximum titers against P6 and
ScaAB 1/13000 or 1/104000 concordantly. PS after the binding also
was immunogenic which was proved by appearance of speciﬁc IgG
which were detected up till 70 days after the immunisation. In case
of the mixture of the peptides P6 and ScaAB the titer of speciﬁc
antibodies against ScaAB-components was also increased as well as
length of the antibody circulation – 150 days. Mice antibodies obtained
after immunisation with both type of vaccines were active against GBS
belonging to different serotypes.
P6- and ScaAB-speciﬁc immune response (mixt vaccine and free form
immunisation).
Conclusion: Usage of polyvalent vaccine preparations based on cell
surface expressed recombinant polypeptides of GBS can dramatically
increase their immunological features relatively to monovaccines.
P1330 TSA gene of Leishmania major cloned in eukaryotic
expression vector could stimulated immune system in mice
F. Ghaffarifar, F. Tabatabaie, Z. Shariﬁ, A. Dalimi Asl, S. Ghasemi,
M. Ghafarifar (Tehran, IR)
Objectives: TSA (thiol-speciﬁc-antioxidant antigen) is the immuno-
dominant antigen of Leishmania major considered as the most
promising molecule for a recombinant or DNA vaccine candidate against
leishmaniasis. In the present work.
Methods: Genomic DNA of TSA protein was extracted and ampliﬁcated
as a template. The PCR product has cloned into pTZ57R/T vector
followed by subcloning into the eukaryotic expression vector pcDNA3
(EcoRI and HindIII sites). The expression of plasmid containing TSA
gene was demonstrated by SDS-PAGE and Western-blot. These results
indicated successful expression of plasmid containing TSA gene in
eukaryotic cells.
Results: In the present study, we evaluated TSA-encoded DNA vaccine
against L. major in BALB/C mice. IgG and IFN-g values were markedly
increased in the immunised group, which were signiﬁcantly higher
than in the control groups (p< 0.05) following immunisation and after
challenge with Leishmania major. IL-4 values were increased in all
groups, but there was no statistical difference between the groups
(p> 0.05) following immunisation and after challenge with Leishmania
major.
Conclusion: The ﬁndings of this study indicated that the TSA-encoded
DNA vaccine increased the cellular response and induced protection
against infection with Leishmania in the mice. The TSA-encoded DNA
vaccine may be an excellent candidate for future vaccine developments
against Leishmania.
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P1331 Diversity of pneumococcal surface protein A among
prevalent clones causing invasive disease in adult patients
in Barcelona (1997–2006)
D. Rolo, C. Ardanuy, R. Martı´n, J. Lin˜ares (Barcelona, ES)
Objectives: Pneumococcal surface protein A (PspA) is a recognised
major virulence factor and it has been classiﬁed into family 1 (Fam1:
clades 1 and 2), family 2 (Fam2: clades 3, 4 and 5), and family 3
(Fam3: clade 6). After PCV7 vaccination, serotype/clone replacement
has been observed worldwide. The aim of this study was to determine
the distribution of Fam and clade of PspA among invasive representative
S. pneumoniae (Spn) strains from adult patients from the Hospital
Universitari de Bellvitge, Barcelona, in order to establish the possible
use of PspA as a vaccine candidate.
Methods: In our Hospital, 90% (n = 395) of the invasive pneumococci
isolated from adult patients from 1997 to 2006 were studied by PFGE
(SmaI) and serotyping. A total of 72% of the studied strains were
grouped into 28 major PFGE patterns. A selection of 49 invasive
pneumococci, representative of those dominant PFGE patterns, was
characterised by MLST (ST) and PspA. Clade-deﬁning region of PspA
was ampliﬁed by PCR, sequenced and compared with published data.
Results: PspA sequence analysis revealed that 30 strains belonged to
Fam2, 18 strains to Fam1 and one strain was non-typeable. No Fam3
strains were detected. Association between serotypes and Fam/clade
was not found, however a relationship between Fam/clade and ST was
observed:
– Fam1/clade1 (n = 37) was associated with Spain6B-2, Spain14−5,
England14−9, Colombia5–19, Sweden1–28, Sweden1–40, Nether-
lands8–33, ST97-serotype 10, ST1026-serotype 20, ST311-serotype
23F and ST433-serotype 22 clones
– Fam1/clade2 (n = 3) was associated with ST2217-serotype 35F clone
– Fam2/clade3 (n = 39) was associated with Spain23F-1, Spain9V-3,
Netherlands3–31, Netherlands7F-39, ST110-serotype 18C, ST62-
serotype 11A, ST202-serotype 19A, ST247-serotype 4, ST30-serotype
16, ST67-serotype 9N and ST88-serotype 19F clones
– Fam2/clade4 (n = 3) was associated with Sweden15A-25, Nether-
lands18C-36, ST42-serotype 23A, ST2312-serotype 8 and ST558-
serotype 35B clones
– Fam2/clade5 (n = 3) was associated with Poland6B-20, ST260-
serotype 3 and ST989-serotype 12 clones.
Conclusions: A clear association between PspA (Fam/clade) and
genotype (ST) was found, whereas PspA (Fam/clade) was independent
of serotype. The most important Fam/clades of PspA among invasive
pneumococci isolated from adult patients in our geographical area were
Fam2/clade3 and Fam1/clade1. Since international clones contain PspA
Fam1 and Fam2, both families should be included in a future PspA based
vaccine.
P1332 Comparative analysis of Bordetella pertussis strains
included in the Serbian whole-cell vaccine
T. Pljesa, A. Elomaa, G. Dakic, M. Vignjevic-Krastavcevic, Q. He
(Belgrade, RS; Turku, FI)
Objectives: In Europe, countries use different vaccination strategies
against pertussis. In Serbia, vaccination against pertussis has been in use
for 50 years. The whole-cell pertussis vaccine has been manufactured in
the Torlak Institute, Belgrade, Serbia since 1957.
The vaccine is made of autochthonous Bordetella pertussis strains, and
“new” strains have been added to the vaccine for decades. Current
composition of the vaccine has been used since 1985, and contains four
strains: 1772/57 (year of isolation, 1957), 2047/57 (1957), 23/81 (1981)
and 8/84 (1984). Because antigenic divergence has been found between
B. pertussis vaccine strains and clinical isolates in many European
countries, we wanted to analyse and compare these vaccine strains.
Methods: The analysis included serotyping of ﬁmbriae (Fim) by
slide agglutination, genotyping of pertussis toxin S1 subunit (ptxA)
and pertactin (prn) by sequencing and LightCycler PCR, and DNA
ﬁngerprinting by pulsed-ﬁeld gel electrophoresis (PFGE). The band
patterns obtained by PFGE were analysed using the computer software
BioNumerics. Different proﬁles were deﬁned by band differences in
the DNA band patterns and compared with those from international
reference strains, Finnish vaccine strains (1772 and 18530) and clinical
isolates.
Results: All three serotypes Fim2 (8/84), Fim3 (23/81) and Fim2,3
(1772/57 and 2047/57) were conﬁrmed among the four vaccine strains.
The strains 1772/57 and 2047/57 represented ptxA2, and strains 23/81
and 8/84 were ptxA1.The prn2 occurred only in strain 8/84, and the
other three demonstrated prn1. Four different PFGE proﬁles were found:
BpSR23 (1772/57), BpFINR1 (2047/57), BpFINR9 (23/81) and BpSR46
(8/84). Strain 1772/57 had the same PFGE proﬁle as the Finnish vaccine
strain 1772. Strain 2047/57 had the proﬁle predominant among the
Finnish strains isolated in the 1950s-1960s. The proﬁle of 23/81 was
prevalent in Finland in the 1970s, and the proﬁle of strain 8/84 was
found among the Finnish isolates from the 1970s and early 1990s. The
Finnish vaccine strains represented ptxA2 or ptxA3/prn1, whereas the
current circulating strains represented ptxA1/prn2.
Conclusions: The Serbian vaccine strains showed differences in ptxA
and prn as well as in the PFGE proﬁles. The PFGE proﬁles of the vaccine
strains were similar to the Finnish isolates from the same decades and
different from the current Finnish circulating strains.
P1333 Evaluation of a new meningitis vaccine in healthy African
population: hope on the horizon
B.J. Okoko on behalf of the MVP Trial Group
Introduction: Recurrent severe epidemics of meningococcal disease
strike the meningitis belt extending from Senegal to Ethiopia. Annual
incidences can reach 1,000/100,000 vs. 1/100,000 in developed
countries. Group A meningococcus has remained unique in its ability
to cause large epidemics. A vaccine that induces long-lasting protection
and herd immunity is urgently needed. The Meningitis Vaccine Project
(MVP) was funded in 2001 as a partnership between WHO and PATH to
accelerate the development and introduction of affordable meningococcal
conjugate vaccines. MVP’s goal is to eliminate meningococcal epidemics
in sub-Saharan Africa. A new MenA conjugate vaccine, manufactured
by Serum Institute of India Ltd Pune – India, PsA-TT was safe and
immunogenic with durable immunity when tested in a Phase I study
in Indian adults. The vaccine is currently being tested in two phase
II/III clinical studies where safety and immunogenicity are being studied
among African population 1–29 years of age.
Method: Two observer-blind, randomised, controlled studies to assess
safety, immunogenicity, induction of immune memory, antibody
persistence of PsA-TT and pharyngeal carriage of Meningococcus in
African toddlers aged 1–29 years are underway in Gambia, Mali and
Senegal. After parental informed consent, each participant received a
single intramuscular injection of study vaccine (PsA-TT), reference
vaccine (ACYW135), and control vaccine (Haemophilus inﬂuenzae b) in
the MVP 002 trial. Blood samples were obtained prior to immunisation
and 4 weeks later for serum bactericidal antibody (SBA) activity and
anti-polysaccharide group A (anti-PsA) IgG levels. Participants were
followed for safety evaluation for 4 weeks.
Results: Preliminary result is available for the 601 toddlers aged 12–
23 months from Gambia and Mali. PsA-TT was safe; rSBA GMT at
baseline were 14, 16 and 13 for PsA-TT, PsACWY and Hib-TT; and
rose to 6234, 365 and 61 with four-fold rises observed in 96%, 64% and
36% of recipients respectively, at week 4. 900 children and young adults
aged 2–29 years have been enrolled in Gambia, Mali and Senegal for
safety evaluation, antibody persistence and pharyngeal carriage. There is
no safety issue to date and the study is on-going. The MVP 002 booster
results soon to be available will be presented.
Conclusion: These unambiguous data are encouraging as MVP and
partners continue their efforts to develop an affordable Men A conjugate
vaccine for Sub-Saharan Africa.
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P1334 The serotype-speciﬁc efﬁcacy and immunogenicity of
a 9-valent pneumococcal conjugate vaccine determined
during an efﬁcacy trial in The Gambia, West Africa
J. Okoko, M. Saaka, R.C. Kohberger, E. Biney, G. Enwere, A. Zaman,
D. Goldblatt, F. Cutts, B.M. Greenwood, R.A. Adegbola (Banjul,
GM; Greenwich, US; London, UK)
Background: A large randomised, double-blind, placebo-controlled
vaccine trial in The Gambia showed that a 9-valent pneumococcal
conjugate vaccine (PCV-9) had high efﬁcacy against radiological
pneumonia and invasive pneumococcal disease of vaccine serotype and
reduced substantially hospital admissions and child mortality. Here, we
report post vaccination pneumococcal antibody concentration in a nested
subsample of infants who participated in this trial.
Methods: A single 2−4ml venous blood specimen was collected from
213 4−6 weeks Gambian children after the third dose of vaccine
or placebo and tested by ELISA for type-speciﬁc IgG antibodies
to pneumococcal serotype 1, 4, 5, 6B 9V 14 18C, 19F and 23F
polysaccharides. And from the main trial, we performed per-protocol
and intention-to-treat analyses to assess the serotype speciﬁc vaccine
efﬁcacy.
Results: Geometric Mean Concentrations (GMCs) were signiﬁcantly
higher for each serotype in children receiving three doses of PCV-9
than those in placebo group. Among PCV-9 recipients, GMCs ranged
between 2.61 and 11.09mg/ml with the highest being against serotype 14
and the lowest against 9V. Point estimates of the proportion of infants
with post vaccination antibody concentrations 0.15mg/ml, 0.35 or
1.0mg/ml ranged from 97.9% – 100%, 92.9% – 100% and 83.9% –
95.8%, respectively, for individual polysaccharides. In contrast, only
9.6% – 39.0%, 7.2% – 20.9% and 1.1% – 10.1% of infants in the
placebo group attained these antibody concentrations. The estimated
overall protective level for all the 9 serotypes, based on the vaccine
efﬁcacy against vaccine type speciﬁc invasive pneumococcal disease of
77% (95%CI: 51, 90) observed in the whole trial, was 2.3mg/ml(95%CI:
1.0, 5.0).
Conclusion: The 9-valent pneumococcal conjugate vaccine studied was
immunogenic in a Gambian population where it was also found to be
efﬁcacious
P1335 Serum bactericidal antibody response to polysaccharide
meningococcal vaccination in common variable
immunodeﬁciency and its clinical implications
N. Rezaei, A. Aghamohammadi, S. Siadat, M. Moin, Z. Pourpak,
M. Nejati, H. Ahmadi, S. Kamali, D. Norouzian, B. Tabaraiee, R. Read
(Shefﬁeld, UK; Tehran, IR)
Objectives: Common variable immunodeﬁciency (CVID) is a hetero-
geneous group of disorders, characterised by hypogammaglobulinaemia
and recurrent bacterial infections. Some patients with CVID make a
successful immune response to polysaccharide vaccine. In this study, we
examined the clinical features of those patients with CVID who respond
poorly to polysaccharide meningococcal vaccine.
Methods: Twenty-ﬁve cases with CVID (18 male and 7 female) and
25 healthy volunteers received meningococcal polysaccharide vaccine
A + C. Serum bactericidal antibody (SBA) titres were measured at
baseline and after 3 weeks. Response was correlated with clinical and
immunological manifestations of CVID.
Results: The serum bactericidal geometric mean titres (GMT) post-
vaccination in the CVID patient group was 7.36, which was much lower
than the control group (12.13). Twenty-four of 25 controls (96%) had
a protective SBA titre of 8 post vaccination, whereas only 16 of 25
CVID patients (64%) had a protective titre (P-value=0.013). Amongst
the cases of CVID who were non-responders, there was a signiﬁcantly
increased rate of bronchiectasis (P =0.008), splenomegaly (P =0.016),
and autoimmunity (P =0.034) in comparison with patients who had
protective SBA titres. A reversed CD4/CD8 ratio was more common
in the non-responder group of patients.
Conclusion: The responder patients may have a good prognosis,
while non-responder patients may have undeﬁned immune abnormalities
leading to several complications, such as bronchiectasis, opportunistic
infections, splenomegaly, and autoimmunity. Therefore, vaccination
response may provide a novel functional sub-classiﬁcation of CVID
patients, enabling accurate prognostic evaluation to identify high-risk
patients at the time of diagnosis.
P1336 Changes in the epidemiology of invasive pneumococcal
disease in adults after introduction of PCV7 in children,
Barcelona, Spain
C. Ardanuy, F. Tubau, L. Calatayud, M. Dominguez, D. Rolo, I. Grau,
R. Pallares, R. Martı´n, J. Lin˜ares (L’Hospitalet de Llobregat, ES)
Objectives: The PCV7 pneumococcal vaccine for children was licensed
in June 2001 in Spain. Currently, the estimated uptake of PCV7 is about
40–50%. The aims of this study were to analyse the distributions of
serotypes and genotypes and the changes in the incidence of invasive
pneumococcal disease (IPD) in adult patients in our geographical area
in the pre- and post-vaccine periods.
Methods: A total of 1200 cases of IPD collected in 3 hospitals in
our area in Barcelona were enrolled in order to estimate the incidence
of IPD. Only pneumococci isolated from adult patients admitted to
Hospital Universitari de Bellvitge (n= 876) were available for serotyping
and molecular typing (PFGE and MLST). Antibiotic susceptibility was
performed by microdilution.
Results: The most frequent serotypes throughout 1997–2006 period were
3 (11.3%), 14 (8.3%), 1 (7.8%), 9V (6.2%), 19F (4.9%), 4 (4.8%), 5
(4.4%), 19A (4.4%), and 23F (4.0%), and the dominant genotypes were
Spain9V-3 (11.4%), ST260-serotype 3 (6.7%), Sweden1–28 (5.6%), and
Spain23F-1 (4.5%). When 1997–2001 and 2002–2006 periods were
compared, the following changes were observed (all p< 0.05): a) An
increase in the incidence of IPD (cases/100.000 persons) from 12.9 to
16.4 for all adults and from 7.9 to 10.6 for adults 15–64 years old; b)
The incidence of IPD caused by non-vaccine serotypes rose from 7.8 to
11.6 for all adults, from 5.0 to 7.5 for persons 15–64 years old and from
22.9 to 32.0 for persons >64 years old; c) The incidence of IPD caused
by vaccine serotypes fell 22% (95%CI, −41 to 3) for persons >64 years
old; d) A decrease of vaccine-related clones (Spain23F-1, Spain6B-2,
Spain14−5, ST247-serotype 4 and ST88-serotype 19F); e) An increase
of non-vaccine serotypes 7F, 24 and 35B and non-vaccine clones
(Sweden1–28, Denmark14–32, Netherlands7F-39, ST989-serotype 12,
ST433-serotype 22 and ST558-serotype 35B); f) A decrease of
penicillin-, tetracycline-, chloramphenicol- and cotrimoxazol-resistance.
Conclusion: An increase of incidence of IPD was observed in adult
patients in our area in 2002–2006 period, and it was associated with an
increase of the incidence of IPD caused by non-vaccine serotypes. The
incidence of IPD caused by vaccine-serotypes remained stable among
persons 15 to 64 years of age, whereas it felt for adults over 64. A
signiﬁcant decrease in antibiotic resistance rates related to decrease of
multiresistant clones was observed in our geographical area.
P1337 The evaluation of three pro-inﬂammatory cytokines
A. Sharifat Salmani, S.D. Siadat, H. Ahmadi, D. Norouzian,
B. Tabaraiee, M. Alimagham, S. Farahmand, M. Kheirandish,
M. Zangeneh, Q. Behzadiannejad (Tehran, IR)
Objective: Smooth Lipopolysaccharide (S-LPS) is the most antigenic
structure expressed on the surface of Brucella smooth strains which
promotes the innate and adaptive immune responses. LPS-induced innate
immune responses are involved in the proinﬂammatory reactions and
the release of proinﬂammatory cytokines, such as TNF-a, IL-1Beta
and IL-6. The controlled increase of proinﬂammatory responses would
be achieved by the application of adjuvants and studied as a method
to induce the innate immune responses against the LPS of Brucella.
Outer membrane vesicle of Neisseria meningitidis is one of the
newly studied adjuvants with microbial origin and Several studies
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carried-out about the probability of Neisseria meningitidis OMV
application as an adjuvant. We have analysed the induction of three
proinﬂammatory cytokines(TNF-a, IL-1b and IL-6)in immunised animal
models with extracted S-LPS of B. abortus S99 complexed with OMV
of N.meningitids, as an adjuvant.
Methods: The S-LPS of Brucella was extracted by hot phenol-water
method. Then extracted S-LPS injected to mice in two different patterns,
1: B. abortus S-LPS 2: B. abortus S-LPS-N. meningitidis OMV (OMV
as a probable potent adjuvant) noncovalent complex. After injections,
animals were bled in 7, 14, 21 and 28’th and Finally sera analysed to
detect the level of TNF-alfa, IL-1b and IL-6 by ELISA method.
Results: IL-6 was the ﬁrst detected cytokine one week after the ﬁrst
injection. Peak amount of IL-6 detected two weeks after the ﬁrst injection
and there was not a signiﬁcant difference between IL-6 amounts in
LPS and LPS-OMV immunised groups. TNF-a and IL-1b were not
detected in serum of S-LPS-immunised animals after the injections but
interestingly both of these two cytokines were detected in the serum of
animal inoculated with the S-LPS-OMV complex. The peak amounts of
IL-1b and TNF-a were detected three weeks after the injection.
Conclusion: OMV can efﬁciently induce the production of IL-1b and
TNF-a in the studied animal models. Since IL-1b and TNF-alfa are
cytokines with innate cellular immunity sources and innate immunity is
an important primary barrier against Brucella infection, we can conclude
that OMV could be applied as an effective adjuvant in the candidate
vaccines to elicit a more potent cell mediated innate immune response,
in parallel with the augment of speciﬁc humoral and cellular responses
against Brucella LPS.
P1338 Evaluation of pro/anti inﬂammatory responses after rectal
administration of Mycobacterium bovis BCG
H. Movassagh, S. Rafati, B. Yazdanpanah, F. Khadem, H. Khanahmad
Shahreza, M. Pooya, T. Sohrabi, M. Rostami Baroei, R. Moukhah,
M. Abolhassani (Tehran, IR)
Objectives: Rectal administration of BCG induces a protective immune
response against tuberculosis in animal models interestingly without any
inﬂammatory complications. To understand the lack of inﬂammation
we evaluated expression pattern of pro/anti inﬂammatory agents in
the colorectal epithelial cell lines and fresh prepared epithelial cells
(ECs) in presence or absence of intraepithelial lymphocytes (IELs).
The regulatory mechanism of these expression proﬁles was studied by
comparison of NFkB and PPARg activity.
Methods: IL-8 secretion was measured in Caco-2, HT-29 and SW-480
cell lines challenged with BCG by ELISA method. NFkB activity of the
cell lines was assayed by DNA-based ELISA. IL-8 and IL-4 secretion
was measured in guinea pig and macaque after rectal immunisation of
BCG and also in their corresponding ECs and ECs+IELs. PPARg activity
of macaque EC and ECs+IELs was measured by DNA-based ELISA.
mRNA expression proﬁle of some cytokines and chemokines in mice
vaccinated with rectal BCG was determined using RNase protection
assay (RPA).
Results: In response to BCG, IL-8 increased in a time dependent manner.
This increase was corresponded by increase in NFkB activity. Guinea pig
and macaque ECs showed the same behaviour by remarkable increases
in IL-8 level. However ECs+IELs challenged with BCG didn’t increase
IL-8. We demonstrated a dramatic increase of 4 and 7 fold in IL-4
levels in ECs+IELs. Also PPARg activity was doubled during 24 hours
in ECs. Two and seven days after BCG administration in mice, RPA
was run on RNA from total colon, ECs and EC+IELs. The expression
of pro-inﬂammatory cytokines IL-6, IL-18, IL-12p40, IL-1b, IFNg and
MIF was increased in ECs lonely, whereas this effect was followed only
by 2 days in ECs+IELs or in total colon. But in 7 days after BCG
stimulation, the levels of these inﬂammatory agents were normalised.
The same pattern was observed for the chemokines MIP-2 and MCP-1
while RANTES and IP-10 increased remarkably upto day seven. Anti-
inﬂammatory cytokine IL-10, undetectable in ECs, was highly increased
in ECs+IELs and also in total colon.
Conclusion: Rectal delivery of BCG induces an early balanced
inﬂammatory process orchestrated by pro-inﬂammatory agents and Th2
mediated modulations that are controlled by a late IL-10 response. This
balance is mainly due to IELs interactions which stable homeostasis at
the colorectal mucosal surfaces.
P1339 Recombinant bacterial ghosts as a new vaccination
approach against Helicobacter pylori infection
Y. Talebkhan, M. Esmaeili, M. Bababeik, M. Mohammadi (Tehran, IR)
Objectives: Genetic inactivation of Gram-negative pathogenic bacteria
through controlled expression of cloned lysis gene E originated from
bacteriophage PhiX174 has offered new insights in developing non-living
vaccines specially those meant for oral administeration. Bacterial ghosts
are empty cell envelopes derived mostly from Gram-negative bacteria
by controlled expression of cloned lysis gene E. The induced trans-
membrane tunnels in the cell wall expels the cytoplasmic contents while
maintaining the antigenic properties of a living intact cell.
The high prevalence of Helicobacter pylori (Hp) infection is a major
health problem worldwide especially in developing countries such as
Iran, thus demanding the development of efﬁcient vaccine strategies to
prevent infection in early childhood. Since bacterial ghosts can mimic
bacteria in structural properties, Hp ghosts expressing immunogenic
proteins maybe a suitable approach.
Methods: omp18 gene was ampliﬁed from a local Hp strain through
gene-speciﬁc PCR with designed primers according to published
sequences in the GenBank and cloned under a chemical inducible
promoter into Hp/E. coli shuttle vector.
The second antibiotic selection marker was also cloned in the above
recombinant vector. Protein expression was induced in E. coli by IPTG
and conﬁrmed via immuno blotting using true Hp positive and negative
sera. E. coli cells were co-transformed with lysis and expression vectors.
Developing bacterial ghosts was performed by elevating the temperature
to 42C after primary IPTG induction of Omp18 expression.
Results: The nucleotide homogeneity of Iranian omp18 gene was up to
95%. Kanamycin resistance gene (Kanar) was cloned in the recombinant
vector as the 2nd antibiotic marker. The speciﬁc 25kDa Omp18 protein
was observed on 15% SDS-PAGE and its immunogenicity was conﬁrmed
via immunoblotting. Co-expression of omp18 and lysis genes was
performed and generation of bacterial ghosts expressing Hp Omp18 was
conﬁrmed by blotting.
Conclusion: The expression of recombinant Omp18 protein and
bacterial ghost production in E. coli system has been conﬁrmed. The
expression of two cloned genes (Omp18 and Lysis E protein) is being
optimised and the constructed ghosts are going to be examined in a
helicobacter animal model employing C57BL/6 mice.
P1340 Sources of infection of pertussis in infants too young to be
vaccinated
S.C. de Greeff, A. Westerhof, M. Peeters, H. Verbakel, C.J. Heuvelman,
F.R. Mooi, H.E. de Melker (Bilthoven, Tilburg, NL)
Objectives: Despite high vaccine coverage (96%), pertussis is endemic
in The Netherlands.
Several changes in the vaccination schedule have been implemented:
introduction of an acellular preschool booster in 2001 and replacement
of a whole-cell vaccine by an acellular vaccine since 2005. Still, infants
too young to be vaccinated are at greatest risk for severe pertussis. To
investigate the optimal vaccine strategy to protect infants, we determined
their source of infection.
Methods: From February 2006 until December 2008, all paediatricians,
microbiologists and public health personnel are asked to notify any
hospitalised child younger than 6 months of age with pertussis. From
household members of the hospitalised infant, a nasopharyngeal swab
and buccal cells will be obtained for PCR or culture to identify B.
pertussis or B. parapertussis. Furthermore, IgG-PT and IgA titres are
assessed and clinical symptoms and vaccination history are determined.
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Results: In the ﬁrst 18 months of study, 109 index patients and
411 household members were enrolled. Of the latter, 200 (49%) had
laboratory conﬁrmed B. pertussis infection and 4 (1%) B. parapertussis
infection. Of the infected household members, 88% were vaccinated.
For 73% of these typical cough symptoms were reported, with a median
duration of 30 days. Three children and one adult were hospitalised.
Preliminary results indicate that 25% of the mothers, 10% of the fathers
and 21% of the siblings in the study had introduced pertussis in the
household and thus most likely transmitted the infection to the infant.
Conclusions: Preliminary results demonstrate that siblings and mothers
are most often the source of infection of pertussis in infancy in the
Netherlands. Vaccination of household members of infants may eliminate
a substantial part of pertussis disease burden in infants. Besides,
symptomatic pertussis infection occurs frequently in adults. Dynamic
modelling will be used to determine what vaccination strategy is the
most (cost-)effective way to reduce disease burden due to pertussis, with
prevention of pertussis among infants as main focus.
Diagnosis, pathogenesis and in vitro studies
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P1341 Diagnosing fungaemia faster
J.D. Knudsen, M.C. Arendrup (Hvidovre, DK)
Objective: Rapid initiation of appropriate antifungal treatment is asso-
ciated with a reduction in mortality. Unfortunately species identiﬁcation
and susceptibility testing is time consuming. Recently, a commercial
susceptibility testing card to the VITEK system was developed, and we
decided to evaluate this in a routine laboratory in comparison with the
EUCAST reference method.
Methods: A strain collection of 20 yeast isolates from blood cultures
(8 C. albicans, 6 C. glabrata, 2 C. tropicalis, 2 C. parapsilosis, 1
C. krusei and 1 Cryptococcus neoformans), were tested by VITEK®
by the AST-YS01 card and the results were correlated to the MICs
obtained by the EUCAST method performed at the reference laboratory.
The VITEK resistance card includes amphotericin B, ﬂuconazole,
voriconazole and ﬂucytosine. The EUCAST testing was performed as
part of a surveillance scheme and included amphotericin B, ﬂuconazole,
voriconazole, itraconazole, posaconazole and caspofungin. Agreement
was deﬁned as identical classiﬁcation in S, I/SDD/ and R.
Results: There were 100% agreement for amphotericin B susceptibili-
ties, and all the strain’s MICs were 1mg/mL.
For 17:20 isolates the interpretations were in agreement for the azoles if
S 2mg/mL for ﬂuconazole, S 1mg/mL for voriconazole. Two strains
showed minor disagreements for ﬂuconazole, with MICs of 0.5 and
2mg/mL by the EUCAST, and both 4mg/mL by the VITEK method.
One C. tropicalis showed high level resistance towards ﬂuconazole and
voriconazole by the EUCAST method, MICs >16 and >4mg/mL, but by
VITEK the MIC’s were <1 and <0.12mg/mL, respectively. This strain
will be further examined. Flucytosine susceptibilities were tested by
VITEK, and only the C. krusei were found resistant, MIC=16mg/mL.
The VITEK results were ready after median 18 h (range 13–21).
Conclusion: The susceptibility proﬁles for the antifungals included in
the card were reliably done overnight from colonies on agar plates.
Including an resistance card when using identiﬁcations cards by VITEK,
may be less time consuming, and is economical attractive compared to
our routine methods. There is two disadvantages so far, no echinocandins
are yet included in the card, and there is not yet any easy procedure for
using samples directly from the blood culture bottles.
P1342 Evaluation of two chromogenic Candida agars: need for
additional training to optimise results
S. Cooreman, I. Mermans, H. Goossens, M. Ieven (Edegem, BE)
Objectives: To evaluate two chromogenic agars for the identiﬁcation
of clinically relevant yeasts: OCCA (Oxoid) and Candiselect4 (Biorad).
Candiselect4 allows species identiﬁcation of Candida albicans, Candida
glabrata, Candida krusei and Candida tropicalis. OCCA agar identiﬁes
the same species, as well as Candida dubliniensis, Candida parapsilosis,
Candida kefyr and Candida lusitaniae, but recommends to classify
isolates into 4 clinical relevant groups (C. glabrata + C. parapsilosis;
C. albicans + C.dubliensis; C. krusei; C. tropicalis). The second objective
was to evaluate if the % correct identiﬁcation (PCI) could be improved
by additional training of laboratory technicians.
Methods: 104 well characterised clinical isolates (from fungaemias)
were included. Species distribution was: C. albicans (52), C. glabrata
(33), C. krusei (6), C. parapsilosis (6), C. tropicalis (4), C. inconspicua
(1), C. famata (1) and Cryptococcus neoformans (1). After incubation
(48 h, 37ºC) 14 lab technicians identiﬁed each culture. Educational
material was used concomitantly. The evaluation was repeated after
additional training of lab technicians.
Results: Before additional training, PCI was poor with OCCA for
identiﬁcations at the species level. Misidentiﬁcation, even between
C. albicans and non C. albicans species, was frequent. After the
classiﬁcation into the 4 clinical relevant groups, PCI increased. Both PCI
per species and per group improved signiﬁcantly after training: a single
C. albicans isolate was misidentiﬁed by 1 person only. For Candiselect4,
differences in PCI before and after training were less clear (Table).
Species PCI
on OCCA on Candiselect4
Species
identiﬁcation
Group
classiﬁcation
Species
identiﬁcation
Before
training
After
training
Before
training
After
training
Before
training
After
training
C. albicans 82 92 95 99.8 99 100
C. glabrata 57 71 92 99 71 72
C. krusei 97 100 97 100 100 100
C. tropicalis 71 72 71 72 56 64
C. parapsilosis 53 28 see C. glabrata Not applicable
Conclusion: To reach a correct identiﬁcation of Candida isolates on
chromogenic agars, additional training is required. After this training,
PCI increased for species identiﬁcation as well as for classiﬁcation
into the 4 clinical relevant groups, with a higher improvement for
OCCA than for Candiselect4. PCI for the C. glabrata + C. parapsilosis
group and C. tropicalis was signiﬁcantly better on OCCA compared to
Candiselect4.
P1343 Assessing the role of a fungal blood culture vial in the
diagnosis of Candida spp. bloodstream infection in an Irish
tertiary referral centre
H. McDermott, L. Power, S. McNicholas, M. Morris-Downes,
H. Humphreys, E. Smyth (Dublin, IE)
Candida blood stream infection is an important cause of morbidity
and mortality in hospitalised patients. Diagnosis is primarily based on
isolating Candida spp. in blood cultures, although these have been
found to be negative in approximately 50% of histologically proven
invasive candidiasis at autopsy. This hospital uses conventional aerobic
(BD Bactec plus Aerobic/F TM) and anaerobic (BD Bactec Plus
AnaerobicTM) vials as well as a selective fungal culture vial (BD Bactec
Mycosis-IC/F) in an attempt to optimise the diagnosis of candidaemia
in high risk patients.
Objective: The aim of this study was to quantify the diagnostic beneﬁt
of including a selective fungal blood culture vial with the conventional
set.
Methods: All blood cultures yielding Candida spp. in 2005 and 2006
were retrospectively reviewed. Where conventional aerobic and anaerobic
vials, as well as a selective fungal vial were collected, we analysed the
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paired sets to determine whether the fungal vial increased the sensitivity
or reduced the time to positivity in recovering Candida spp.
Results: In the period studied, there was a total of 167 blood culture
isolates of Candida spp. from 67 patients. There were 52 sets where
paired conventional and fungal blood culture vials were received. Of
these, both sets were positive in 24 cases (46%), the conventional vials
only were positive in 14 (27%) and the fungal vial only was positive in
14 (27%), which gave an additional yield of 36%. In addition, there was
a trend towards more rapid detection of Candida spp. from the fungal
vials with 69% positive within 48 hours, compared to 48% in the case
of the conventional sets.
Conclusion: The inclusion of a selective fungal vial with conventional
aerobic and anaerobic vials improves the recovery rate of Candida
spp. from blood by 36%. The time to recovery of Candida spp. is
also reduced, with an additional 21% detected within 48 hours. This
is clinically important in a disease where time to treatment improves
survival.
P1344 The culture and antifungal sensitivity testing of pathogenic
fungi on a highly porous ceramic
C. Ingham, S. Boonstra, M. Lange, P. Schneeberger (Den Bosch, NL)
Objective: To develop a fast and widely applicable, culture-based
antifungal sensitivity testing (AST) assay developed around the growth
and in situ imaging of fungi on a porous ceramic support.
Methods: Sterile highly porous ceramic (PAO) strips (Anopore, an
inert nanoporous ceramic derived from aluminium oxide) were placed
upon agar plates (Sabauroud media or RPMI) containing deﬁned
concentrations of antifungals. The strips were then inoculated with
the fungi (yeast, Trichophyton) to be tested, incubated, stained with
ﬂuorogenic dyes and imaged by ﬂuorescence microscopy. Digital mages
were processed in ImageJ software [1] to determine the effect of the
antifungal agent.
Figure: Examples from AST of Candida albicans. Upper row shows
a raw image of the yeast cultured on PAO showing growth inhibition
with increasing concentrations of amphotericin B (AmpB). Lower section
shows processed image used to calculate microcolony areas.
Results: A ssigniﬁcant effect of ampB on Candida was demonstrated
within 90 min. MIC values could be derived reliably with 4 h culture
(amphotericin B and caspofungin) or 7 h (voriconazole, itraconazole).
For a total of 74 assays, in 65 cases the assignment by PAO (sensitive [S],
resistant [R], intermediate [I]) was identical to the E-test. Where
differences occurred these were always single category disagreements.
Testing of Trichophyton rubrum and other ﬁlamentous fungi was possible
with 16 h culture time.
Conclusions: Microcolony imaging is a rapid (c. 5× faster than E-test)
and accurate approach to AST testing. Fungi grow well on PAO,
adhere to the material and the images are easy to process. Performing
these tests on PAO facilitates staining and imaging in situ and has
allowed rapid assessment of whether an antifungal was inhibitory to
growth. The method could be improved by multiplexing (more than one
antibiotic/strip), reinforcing the PAO to facilitate handling and using
cheaper dyes. Given that the method is also applicable to bacteria [1]
including TB [2] PAO may be generally usable for antimicrobial testing
and for applications outside clinical microbiology [3]. The PAO approach
may also be useful for the study of heterogeneity of response to
antimicrobials and other research applications.
Reference(s)
[1] Ingham CJ, van den Ende M, Wever PC, Schneeberger PM. J Med
Microbiol. 2006 11:1511−9.
[2] Ingham CJ, Ben Ayad A, Mulder B. IJTLD submitted.
[3] Ingham CJ, Sprenkels A, Bomer J, Molenaar D, van den Berg A,
van Hylckama Vlieg JE, de Vos WM. Proc Natl Acad Sci U S A.
2007 46:18217–22.
P1345 Clinical and management utility of Candida albicans germ
tube antibody detection in critically ill patients. Inﬂuence
on mortality
R. Zaragoza, J. Pema´n, G. Quindo´s, J. Iruretagoyena, M. Cue´tara,
P. Ramirez, M. Alkorta, J. Camarena, A. Viudes, J. Ponto´n on behalf
of the Spanish CAGTA Study Group
Background: Invasive candidiasis in critically ill patients represents a
diagnostic challenge. Recently, an immunoﬂuorescence test for Candida
germ tube antibody (CAGTA) detection has been marketed. The aims
of the present study were to determine the prevalence of CAGTA in an
ICU setting, the clinical and management utility of its detection, and
the inﬂuence of a strategy based on early determination of CAGTA on
mortality in a selected ICU population.
Methods: A prospective and observational multicentre study was
developed in six Spanish University hospitals during 2005. CAGTA
test was performed twice a week if predetermined risk factors were
present, and a positive result was considered if the testing serum
dilution was equal or higher than 1:160 in at least one sample. Clinical,
microbiological and outcome variables were recorded. A multivariate
analysis was performed to assess the inﬂuence of this technique on
mortality.
Results: Fifty-three critically ill patients non-neutropenic (37.7% post
surgery) were included. Twenty-two patients (41.5%) had CAGTA-
positive results, none of them with positive blood culture for Candida.
The intra ICU mortality rate was signiﬁcantly lower (p = 0.004) in
positive CAGTA patients (61.2% vs. 22.7%). A multivariate analysis
conﬁrmed a CAGTA-positive result as the only protective factor
independently associated with ICU mortality (beta coefﬁcient = −0.3856;
95%IC: −0.648; −0.123).
Conclusions: The rate of CAGTA-positive results in a selected group of
ICU patients is high. A strategy based on early determination of CAGTA
might reduce the ICU mortality of patients with risk factors to develop
invasive candidiasis.
P1346 Serum procalcitonin measurement contribution to the early
diagnosis of invasive candidiasis in critically ill patients:
ﬁndings from the CAVA study
P. Charles, C. Castro, C. Leon, C. Gomez, M. Fernandez (Dijon,
FR; Seville, Las Palmas de Gran Canari, ES)
Background: Invasive candidiasis (IC) are life-threatening infections in
the intensive care units (ICUs). Outcome could be improved by the early
administration of antifungals. Risk factors assessment by scoring systems
such as the “Candida Score” (CS) including the search for multifocal
fungal colonisation (MF) has been recently proposed for the selection
of the patients who will actually develop IC among the colonised ones.
Procalcitonin (PCT) is useful for the early diagnosis of sepsis but its
behaviour is unclear in the setting of IC. We investigated PCT variations
in the patients with MF with or without IC.
Methods: A prospective observational study (The Candida Score
Validation Study) including every nonneutropenic critically ill patients
hospitalised for more than 7 days was conducted in 35 ICUs in Spain,
Portugal and France between April 2006 and June 2007. Risk factors for
IC used for the calculation of the CS (i.e., fungal colonisation, surgery,
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total parenteral nutrition and severe sepsis) were assessed, and serum
were collected at the time of inclusion and weekly thereafter. The patients
with MF but without concurrent bacterial infection were randomly
selected for the measurement of PCT (Kryptor, Brahms Diagnostic).
Risk factors for IC were analysed. ROC curves were constructed for
predictive value assessment of PCT and CS.
Results: 147 PCT dosages were performed in 63 patients (MF: n = 33;
IC: n = 30). Patients from each group were comparable regarding age,
gender and APACHE II. However, the patients with IC were more likely
to be surgical (p< 0.001) and to have a high SOFA score (p = 0.008). PCT
after a 7-day hospitalisation was found to be signiﬁcantly more elevated
in the MF+IC group (1.05±1.93 ng/mL), than in the MF (0.63±2.00
ng/mL) (p = 0.007), while next values were comparable. The highest
Candida Score value (CSmax) calculated throughout the patient stay
was the sole independent predictor of IC. The ROC curves analysis
showed that the predictive values of PCT, and CSmax were comparable
(AUC=0.713, and 0.727, respectively; p = 0.863).
Conclusion: PCT after a 7-day hospitalisation is more elevated in the
patients with MF who will develop IC thereafter than in those who
will not, despite its elevation remains mild. The higher proportion of
surgical patients and the higher degree of organ dysfunction could
account for such variations. PCT could however be considered for the
IC risk assessment in addition to the Candida Score.
P1347 Fungal colonisation of gastro-intestinal tract, anti-
Saccharomyces cerevisiae antibodies and anti-mannan
Candida antibodies in patients with inﬂammatory bowel
disease and irritable bowel syndrome
J. Semiano´w-Wejchert, U. Nawrot, D. Ksiadzyna, K. Wlodarczyk,
A. Bartnik, A. Annabhani (Wroclaw, PL)
Introduction: A search for serologic markers useful in diagnostics,
including differential diagnostics of inﬂammatory bowel disease (IBD)
continues. The idea that microorganisms play a role in the aetiology of
IBD has gained ground considerably in recent years. Antibodies against
mannans of Saccharomyces cerevisiae (ASCA) were observed in Crohn’s
disease in 1988. It is said that anti-mannan Candida spp. antibodies
(AMCA) may be useful in diagnostics of often latent fungal infections.
Therapy with antibiotics as well as immunosuppressive treatment favour
fungal infections especially in the presence of intestinal mucosa lesions.
The aim: to assess the level of ASCA and AMCA and the incidence and
intensity of fungal colonisation of gastrointestinal tract in IBD patients
in comparison with irritable bowel syndrom (IBS) patients.
Materials and Methods: 42 patients suffering from ulcerative colitis
(UC) and 26 patients with Crohn’s disease (CD) as well as 19 IBS
patients were subjected to the study. The level of antibodies was
assessed with ELISA. The quantitive and qualitative fungal cultures
of the stool were performed in all the subjects using Sabouraud agar
plates supplemented with chloramphenicol and Chromagar-Candida ID-
32-Biomerieux test.
Results: The results were obtained as shown in the table.
Study group ASCA AMCA SFC
CD (n = 26) 14/24 (58.3%), 6/26 (23.1%) 1/26 (3.9%)
SEM: 77.4±75.6 SEM: 7.8±5.0
UC (n = 42) 1/15 (6.7%) 6/42 (14.3%) 3/42 (7.1%)
SEM: 12.9±14.5 SEM: 10.7±5.6
IBS (n = 19) 5/15 (33.3%) 7/19 (36.8%) 5/19 (26.3%)
SEM: 16.7±11.6 SEM: 10.1±7.0
n = number of subjects; SEM = mean value, SFC = signiﬁcant fungal
colonisation (>105 CFU per 1 g of stool).
Conclusions:
1. ASCA were found in 58.3% of CD, 33.3% of IBS and 6.7% of UC
patients.
2. The level of ASCA in CD patients was signiﬁcantly higher then in
UC and IBS patients (p = 0.002 and p = 0.003, respectively).
3. The increased level of AMCA and signiﬁcant fungal colonisation
were observed more often in IBS patients then in IBD patients.
P1348 Conﬁrmation of positive galactomannan results in serum by
detection of 1,3-beta-D-glucan could eliminate false positive
results of the test
Z. Racil, I. Kocmanova, J. Winterova, M. Lengerova, B. Weinbergerova,
J. Mayer (Brno, CZ)
Objectives: Detection of galactomannan (GM) by Platelia Aspergillus
assay is widely used for early diagnosis of invasive aspergillosis (IA).
One of the main disadvantages of this test are false positive results
that might be caused by many factors (administration of antibiotics,
gluconate-containing solutions etc.). To be able to recognise false
positive results in short time is of a great medical interest. One of the
possibilities is to conﬁrm the detection of GM by detection of other
“panfungal” antigen – 1,3-beta-D-glucan (BG) – in the sample.
Methods: From 2/2007 to 10/2007 4012 samples from 320 patients
were tested for GM using Platelia Aspergillus kit. Patients with IP> 0.5
in 2 consecutive samples have been marked as GM positive. These
2 GM positive serum samples have been subsequently tested for BG
by Fungitell test. Samples with results >60 pg/ml were marked as
BG positive. All GM positive patients were classiﬁed according to
EORTC/MSG criteria (2002) for probability of IA.
GM in
2 samples
GM in
2 samples +
BG in 1 sample
GM in
2 samples +
BG in 2 samples
Total positive pts. 39 20 9
No. of pts. with IA 6 6 6
PPV for diagnosis of IA 16% 30% 66%
Sensitivity for diagnosis of IA 100% 100% 100%
Results: From 320 patients tested 39 patients had two consecutive
samples GM positive (were marked as GM positive pts.). However,
proven and probable IA was found only in 6 of them (PPV = 15%). Thus
in the majority of pts (33 = 85%) the result of the Platelia Aspergillus
assay was false positive.
Fungitell gave positive result in 27 from 78 GM positive samples (35%).
20 pts. (51%) with consecutive GM positivity had also at least one of
the two samples positive for BG, giving PPV 30%. Only 9 pts. (23%)
had the 2 consecutive samples both GM and BG positive. PPV of the
GM test thus increased to 66% when GM positivity was conﬁrmed by
BG positivity in two consecutive samples. Sensitivity for diagnosis of
IA remained 100%.
Conclusion: Conﬁrmation of GM positive results by testing for BG
positivity increased the PPV of the Platelia Aspergillus test from 15% to
66%. This approach did not decrease the sensitivity of the GM assay and
using already obtained samples did not lead to the delay in IA diagnosis.
Using the combination of the results of these two tests might help to
identify false positive GM results and subsequently reduce the possibility
of over treatment.
Supported by IGA NR8452−5/2003.
P1349 3rd Nordic distribution of external quality assessment
samples in medical mycology: do we still need to improve?
K.L. Mortensen, V. Fernandez, P. Gaustad, E. Chryssanthou, P. Sandven,
M.C. Arendrup (Copenhagen, DK; Stockholm, SE; Oslo, NO)
Objectives: A Nordic External Quality Assessment program in medical
mycology was established in 2005. In order to monitor the level of
routine diagnostics, not “best practice”, the specimens were designed to
resemble clinical samples and the laboratories were asked to handle the
samples like routine samples.
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Methods: Five simulated clinical samples were distributed at no cost to
63 Nordic laboratories of clinical microbiology of whom 54 submitted
results. The specimens contained the following microorganisms:
(1) Fusarium solani (corneal scraping), (2) Candida (C.) albicans
and C. krusei in a ratio of 10:1 (blood culture), (3) C. glabrata and
Stenotrophomonas maltophilia (tracheal aspirate), (4) Aspergillus (A.)
fumigatus and C. dubliniensis (BAL), and (5) C. inconspicua (vaginal
secretion). A brief clinical information was given for each specimen.
Results: Specimen 1: 48% (26/54) of the laboratories detected the
mould, of whom 6 correctly identiﬁed it to the species level (23%).
Specimen 2: 83% (45/54) reported the presence of the C. krusei isolate,
but only 57% (31/54) also reported the C. albicans isolate even though
the ratio was in favour of C. albicans. Specimen 3: 94% (51/54) detected
the yeast, of whom 86% (44/51) correctly identiﬁed it as C. glabrata.
Specimen 4: The presence of A. fumigatus was correctly reported by
59% (32/54) of the laboratories while 6% (three laboratories) did not
report growth of a mould at all. Specimen 5: 17% (9/54) correctly
reported the isolate as C. inconspicua, and 35% of the laboratories
reported either the closely related C. norvegensis or non-albicans yeast.
Thirty-four laboratories reported 528 susceptibility results. 22% (5/22)
incorrectly reported the C. glabrata-isolate as ﬂuconazole-susceptible.
One laboratory incorrectly reported the C. albicans-isolate in specimen
2 as ﬂuconazole-resistant.
Conclusion: The results of this third distribution of simulated clinical
samples emphasise that mycological diagnosis is difﬁcult especially
in the routine and polymicrobial setting and that there is a need
for the continuous training of laboratory technicians and clinical
microbiologists. However, a higher proportion of laboratories succeeded
this year detecting the polymicrobial nature of the blood culture and
the Aspergillus-isolate in the presence of yeast. This suggests that
quality assessment programmes including simulated clinical samples
are valuable for the improvement of mycological skills in clinical
laboratories.
P1350 Development of an external quality assessment scheme for
antifungal susceptibility testing
C. Walton, V. James (London, UK)
Objectives: To assess the results from clinical diagnostic laboratories to
a questionnaire on antifungal susceptibility testing performed routinely
and develop a suitable external quality assessment scheme to support
quality assurance of testing in participating laboratories.
Methods: A questionnaire to assess the frequency and range of
antifungal susceptibility testing was distributed to participants of the
UK NEQAS external quality assessment schemes for Mycology and
General Bacteriology. Strains distributed included Candida parapsilosis,
C. tropicalis, C. krusei, Rhodotorula (rubra) mucilaginosa, Cryptococcus
neoformans and C. albicans.
Results: Analysis of the questionnaire revealed that 143 of 445
respondents routinely performed antifungal susceptibility testing, most
commonly for yeasts. The gradient MIC method (Etest®) and Sensititre®
YeastOne™ were the most common tests used. Information from the
survey was used to design the quality assessment specimens and reply
forms. The level of performance with these specimens was variable
with an average of 82% (range 21%–100%) of the results received for
each strain/agent combination concordant with the reference laboratory
results. Overall, the highest percentage of concordant results was
seen for susceptibility testing with amphotericin B (93%), followed
by ﬂuconazole (89%), voriconazole (83%), ﬂucytosine (75%) and
itraconazole (71%). Participants found the Candida krusei the most
problematic with low concordance of results with itraconazole (44%)
and ﬂucytosine (23%).
Conclusions: These data provide an interesting insight into routine
testing methods in participant laboratories and overall performance with
the strain/antifungal combinations. International antifungal susceptibility
testing guidelines have only been validated for Candida species;
breakpoints have yet to be established for voriconazole, moreover,
some commercial methods are not validated for yeasts other than
Candida spp. Therefore, evaluation of participant performance has to
take these provisos into account. EQA plays an important role in
highlighting areas of diagnostic testing where the quality of testing in
clinical diagnostic laboratories can be informed by the development of
international guidelines.
P1351 Development of a bioassay for posaconazole blood levels
and its use in the clinical laboratory
C.B. Moore, N.E. Duddy, D.W. Denning, W.W. Hope (Manchester, UK)
Objectives: Posaconazole is an extended spectrum triazole agent recently
licensed for use in invasive fungal infections in patients intolerant of or
refractory to standard antifungal therapy. There may be a relationship
between drug exposure and the antifungal effect. We developed a
bioassay method to measure posaconazole concentrations in serum, as
a potential aid to optimising the therapeutic outcome of invasive fungal
infections treated with this agent.
Methods: An agar diffusion method with yeast nitrogen base, glucose
and sodium citrate was used with Candida kefyr (San Antonio strain with
posaconazole MIC of 0.03mg/L [CLSI], inoculum of 5×105 cfu/mL)
as the indicator organism. Forty-microlitre volumes of standards (in
triplicate wells), controls or patient specimens (both in duplicate) were
loaded, allowed to diffuse and the plate was incubated at 37-degrees
C overnight (approx. 18 h). Inhibition zone diameters were measured
and used to construct an 8-point standard curve with concentrations
ranging from 0.125 to 10mg/L. Accuracy and variability (precision)
was assessed against 5 controls: lower limit of quantiﬁcation, very low,
low, medium and high. These were analysed every day for 5 days to
determine inter-assay accuracy and precision. Intra-assay variance and
accuracy were determined by analysing these same controls ﬁve times
within one bioassay plate.
Forty-four random serum levels were obtained from 16 patients (range
1−5 samples; 8 males; age range 18–69, 15 outpatients). The dosage
was 400mg bd in all cases.
Results: The assay was linear in the range 0.125–10.0mg/L (r-squared
values >0.99 for all runs, n = 39). Accuracies were within 10%, and
intra- and inter-assay variability (precision) was <7% at 0.25, 0.4, 4 and
8mg/L. The lower limit of quantiﬁcation was 0.125mg/L (accuracies of
<6%, intra- and inter-assay variability within 3 and 10%, resp.). The
limit of detection was 0.1mg/L.
Patient results ranged from 0.63 to >10mg/L. Concentrations (mg/L)
of: <1.0 were found in 7 samples (5 patients), 1.0−2.0 in 24 samples
(10 patients), 2.0−3.0 in 7 samples (7 patients), 3.0−5.0 in 5 samples (4
patients) and >10.0 in 1 sample.
Conclusions: We have developed and validated a clinically useful
bioassay for posaconazole. This assay may be a valuable tool for
therapeutic drug monitoring, especially in laboratories without access
to HPLC or mass spectrometry methodology.
P1352 Analysis of pharmacodynamic interactions between
antifungal drugs against Aspergillus fumigatus using the
fractional inhibitory concentration index
J. Meletiadis, T. Stergiopoulou, R. Petraitiene, V. Petraitis, T. Sein,
R. Schaufele, J. Bacher, E. Roilides, L. Zerva, T. Walsh (Athens,
Thessaloniki, GR; Bethesda, US)
Background: The fractional inhibitory concentration (FIC) index is
commonly used to analyse in vitro antifungal combinations. Synergy and
antagonism is deﬁned when the FIC index is 0.5 and >4, respectively.
However, most combinations are additive/indifferent because FIC indices
range between 0.5 and 4 raising questions about the sensitivity of FIC
index in detecting non-additive interactions. Because there are no in
vivo studies to support these cutoffs, we studied an in vivo synergistic
and antagonistic combination against an Aspergillus fumigatus clinical
isolate (ATCC MYA-3626) with an in vitro microdilution checkerboard
method and the results were analysed with the FIC index analysis.
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Methods: The combinations of voriconazole + anidulafungin
(VOR+ANID) and ravuconazole+amphotericin B (RAV+AMB) were
tested in vivo in an experimental neutropenic rabbit model of invasive
pulmonary aspergillosis using the ATCC MYA-3626. In vivo efﬁcacy
of the monotherapy and combination therapy regimens was assessed
based on several outcome variables. The same combinations were tested
against the ATCC MYA-3626 in triplicate with broth microdilution
checkerboard technique based on the CLSI M-38A. Fungal growth was
assessed spectrophotometrically at 405 nm after incubation at 37ºC for
24 h and 48 h and % of growth was calculated for each drug concentration
compared to the drug-free growth control. The minimal inhibitory
concentration was determined for each drug alone and in combination
as the lowest drug concentration corresponding to <10%. The FIC index
was calculated as the MICA+B/MICA + MICB+A/MICAB where MICA
and MICB are the MICs of the drugs alone and MICA+B and MICB+A
are the MICs of drugs A and B in presence of the other drug, respectively.
Results: In vivo, the combination therapy of VOR+ANID was more
effective than each monotherapy indicating synergistic interactions;
whereas, the combination therapy of RAV+AMB was less effective than
each monotherapy indicating antagonistic interactions. The FIC index
of VOR+ANID was 0.31 (0.25−0.378) after 24 h indicating synergy
and 0.75 (0.63−0.75) after 48 h indicating additivity. The FIC index of
RAV+AMB was 2.25 (2.12−2.5) after 24 h and 1.5 (0.63−1.5) after 48 h
indicating additivity.
Conclusion: Assessing antifungal drug interactions against A. fumigatus
after 24 h may better than after 48 h to predict in vivo outcomes. The
FIC index cutoff of 2 instead 4 could be used to assess antagonistic
interactions.
P1353 H2S and NO affect intracellular killing of Candida albicans
modulating GSH levels
S. Grosso, V. Lucini, M. Pannacci, A. Caronno, F. Scaglione (Milan, IT)
Candida albicans, has become a signiﬁcant nosocomial pathogen. In
macrophages, responsible for control of candida growth, redox status
regulates the intracellular killing. Antioxidant mechanisms are likely to
quench the reactive oxygen species (ROS) and to protect against any
damage but, during infections, these systems are reduced. Glutathione
(GSH) and nitric oxide (NO) are important mediators in various
physiological and pathological conditions. Recent studies, also, show that
endogenous hydrogen sulphide (H2S) could protect cells from oxidative
stress by modulating ROS. In this study, we have examined the role of
GSH during C. Albicans infection and the relationship between the GSH,
H2S and NO in infected murine macrophages.
Methods: J774.1 cells, infected with C. albicans, were maintained
for 1 h at 37ºC, in culture medium with GSH precursors (NAC,
N-acetylcysteine) or with glutathione biosynthesis inhibitors (BSO,
Buthionine-sulfoximine). In addition, in infected macrophages H2S was
induced with Sodium hydrosulphide (NaHS) or inhibited whit DL-
propargylglycine (PAG). GSH concentration was spectrophotometrically
assayed. To determine whether GSH and H2S were, also, important for
the intracellular killing of C. albicans, infected J774A.1 were lysed and
the surnatant was plated on Sabouraud dextrose agar. The number of
viable candida was quantiﬁed with 10-fold dilutions spread. In infected
macrophages, NO production was assessed by measuring of intracellular
nitrite concentrations or by expression of inducible nitric oxide synthase
(iNOS), detected by Real Time PCR.
Results: Treatment with BSO signiﬁcantly reduced killing of C. albicans
and GSH concentration. NAC addition to infected macrophages,
increased GSH levels and induced a signiﬁcant reduction in the viability
of C. albicans (P< 0.001). NaHS caused an increase of GSH levels
and a decrease of viable yeast, while PAG reduced GSH concentration
and intracellular killing. In the presence of BSO, nitrite and iNOS was
increased by 2-fold respect to unstimolated cells (P< 0.001), while NAC
decreased iNOS synthesis and intracellular NO concentration. Moreover,
NaHS signiﬁcantly inhibited NO production, while PAG caused iNOS
expression (P< 0.001).
Conclusions: GSH may play an important role in killing of C. albicans
and in control of opportunistic fungal infections. We have also provided
to evidence that H2S could modulate intracellular killing by increasing
GSH levels and inhibiting NO synthesis.
P1354 Difference in susceptibility to hydrogen peroxide (H2O2)
between Aspergillus fumigatus and Fusarium solani
J. Dotis, M. Simitsopoulou, A. Chatzimoschou, T.J. Walsh, E. Roilides
(Thessaloniki, GR; Bethesda, US)
Objectives: A. fumigatus and F. solani cause life-threatening infections
in immunocompromised patients. Phagocytes, particularly neutrophils
and monocytes/macrophages, constitute the main innate host defences
against these fungal pathogens. The oxidative antifungal pathway of
NADPH oxidase-catalyzed superoxide anion (O2) production leading
to hydrogen peroxide (H2O2) formation is considered critical for the
phagocyte-induced hyphal damage. We previously found that F. solani
hyphae are more resistant to phagocyte-induced hyphal damage than
are hyphae of A. fumigatus [CMI 2005, 11(S2): 364]. Therefore, we
attempted to assess the susceptibility of A. fumigatus and F. solani hyphae
to the antifungal activity of H2O2.
Methods: Suspensions of the two fungi containing 105 conidia per ml
in YNB were incubated in 96-well plates at 37ºC for 16–18 h to become
hyphae. They were then incubated with 0, 50, 100 and 200 mM H2O2 at
room temperature for 10 min. Each hyphal suspension was then washed
with H2O twice before adding 150 microliters of a solution containing
0.25mg/ml XTT plus 40mg/l coenzyme Q. After incubation at 37ºC with
5% CO2 for 30 min, H2O2-induced hyphal damage was colorimetrically
assessed as reduction in metabolic activity of hyphae. ANOVA with
Dunnett test was used for analysis (n = 36).
Results: H2O2 induced a concentration-dependent hyphal damage on
A. fumigatus (p< 0.001). H2O2 induced a non concentration-dependent
hyphal damage on F. solani. The hyphal damage induced by 100 mM
H2O2 on A. fumigatus was higher than that induced on F. solani (72.7%
vs. 53.2%, p = 0.048). At 200 mM, hyphal damage induced by H2O2 on
A. fumigatus was 85.0% as compared to 67.1% for F. solani (p = 0.005).
Hyphal damage induced by H2O2 at a concentration of 50 mM on
A. fumigatus and F. solani was 47.1% and 42.9%, respectively (p=ns).
Conclusion: F. solani hyphae are more resistant than A. fumigatus
hyphae to H2O2, a key antifungal component of the oxidative phagocytic
pathway. This ﬁnding suggests that the activities of soluble mediators
of the innate immune response against medically important ﬁlamentous
fungi are fungal species-dependent and may contribute to differences in
susceptibility of these two pathogens to host defence.
P1355 Pathogenic fungi produce proteases to degrade cerebral
immune proteins and to evade immune attack
G. Rambach, D. Dum, I. Mohsenipour, C. Lass-Flo¨rl, J. Rainer,
R. Wu¨rzner, M.P. Dierich, C. Speth (Innsbruck, AT)
Objectives: Affection of the central nervous system (CNS) in the course
of a fungal infection is fatal in the majority of cases. In order to
determine the reasons for the incomplete elimination of invading fungi
we examined the fungal capacity to degrade complement proteins and
cytokines as well as functional surface molecules of immune cells in the
CNS.
Methods: Aspergillus spp. and other pathogenic fungi were grown in
medium or cerebrospinal ﬂuid (CSF), with or without supplements.
Degradation of soluble immune proteins was investigated by Western
Blot. Hyphal opsonisation was examined by immunoﬂuorescence.
Cellular expression of surface proteins was quantiﬁed by FACS.
Results: The growth of Aspergillus spp. in CSF resulted in secretion
of proteolytic factors which degraded complement proteins. The extent
of the proteolysis was dependent on the time period of fungal growth
and the Aspergillus species. A. fumigatus, the predominant cause of
cerebral aspergillosis, induced a rather quick and strong degradation,
whereas the proteolysis by A. terreus supernatants was weaker and rather
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slow. The fungal secretion of proteases correlated with a diminished
opsonisation of Aspergillus hyphae by complement proteins, suggesting
a better protection against phagocytosis. Furthermore the proteolytic
factors attack complement receptor CR3 (CD11b/CD18) and MHC on
the surface of immune cells and thus interfere with efﬁcient phagocytosis
and antigen presentation. The secretion of proteases as effective
immune evasion mechanism could also be detected for isolates of
the Pseudallescheria group and for zygomycetes (Rhizomucor pusillus,
Rhizopus microsporus).
In order to develop therapeutic approaches that interfere with fungal
proteases and thus with immune evasion we investigated the inﬂuence of
culture conditions on the secretion of proteases. The addition of various
nitrogen sources to CSF prevented the secretion of these proteases.
Glutamin as endogenous substance was tested in detail and was found
to effectively interfere with protease secretion in a dose-dependent
manner. Furthermore, ﬁrst experiments using protease inhibitors showed
promising results.
Conclusion: Aspergillus and other pathogenic fungi secrete proteases
which may play a signiﬁcant role in immune evasion by degrading
complement and surface-bound molecules of cerebral immune cells.
These proteases represent an interesting therapeutic target to decrease
the lethality of cerebral aspergillosis.
P1356 Cytokine production by human polymorphonuclear
leukocytes in response to different zygomycetes
M. Simitsopoulou, E. Roilides, E. Georgiadou, T.J. Walsh
(Thessaloniki, GR; Bethesda, US)
Objectives: Zygomycetes are opportunistic pathogens causing invasive
infections with increased morbidity and mortality in immunocom-
promised patients. These infections are most frequently caused by
Rhizopus oryzae (RO) and Rhizopus microsporus (RM). Infections
caused by Cunninghamella bertholletiae (CB) are uncommon but
severe. Laboratory animal studies have demonstrated that CB is more
virulent than RO and RM in a pulmonary zygomycosis model. As
polymorphonuclear leukocytes (PMNs) are critical components of
antifungal host defence, we compared release of IL-6, IL-8 and TNF-a
cytokines from human PMNs exposed to CB, RO, and RM.
Methods: 105 sporangiospores/ml of CB, RO and RM were incubated
in RPMI at 37ºC for 7, 9 and 9 h, respectively, in order to yield
similar biomass ranging between 0.08−0.1 optical density as measured
by spectrophotometry at 450 nm. PMNs isolated from healthy adult
volunteers by dextran sedimentation/ﬁcoll centrifugation were then added
at effector:target (E:T) ratio of 10:1 or 20:1. The PMN-induced cytokine
release of IL-6, IL-8 and TNF-a was assessed by ELISA quantitative
assay after incubation of PMNs with hyphae for 1 h. Statistical analysis
(n = 3) was performed using ANOVA with Dunnett post-test for multiple
comparisons.
Results: See the table
Treatment Cytokines
IL-8 TNF-a
PMNs 30.8±3.2 0.05±0.02
PMNs+CB 575.3±55.2* 4.8±0.6*
PMNs+RO 915.2±153.7* 0.6±0.2
PMNs+RM 936.7±133.8* 1.0±0.1
*p< 0.01.
CB induced decreased amounts of IL-8 release from PMNs compared
to RO and RM (for both p< 0.05), but increased amounts of TNF-
alpha release compared to RO and RM (for both p< 0.01). IL-6 was
not expressed in PMNs exposed to the three zygomycetes after 1 h.
Conclusion: CB induces higher release of TNF-a and lower release of
IL-8 in PMNs compared to RO and RM, while release of IL-6 remains
unaffected. These ﬁndings provide insight into the possible mechanisms
of increased resistance and severity of CB infections as compared to
those of other zygomycetes.
P1357 In vitro susceptibility of clinical isolates of Dipodascus
capitatus
E. Cendejas, A. Go´mez-Lo´pez, M. Cuenca-Estrella, J. Rodrı´guez-Tudela
(Madrid, Majadahonda, ES)
Background: D. capitatus (teleomorph of Geotrichum capitatum), has
been added to the lengthening list of opportunistic fungal pathogens that
can cause fatal infections in inmunocompromised patients. In order to
give any insight on the management of this emerging infection we have
analysed the antifungal susceptibility proﬁle of eight currently available
antifungal agents against a collection of D.capitatus clinical isolates.
Methods: A total of 35 clinical strains of D. capitatus were included.
The strains were recovered from different Spanish hospitals through
a period of ten years, from 1996 to 2006, and identiﬁed by routine
physiological tests. The susceptibility testing followed strictly the
recommendations proposed by the Antifungal Susceptibility testing
Subcommittee of the European Committee on Antibiotic Susceptibility
Testing for fermentative yeast, including some modiﬁcations to allow
for automation of the method and to permit the incubation period to
be shortened from 72 to 48 h The antifungal agents used in the study
were as follow: Amphotericin B (AMB), ﬂucytosine (5-FC), ﬂuconazole
(FLC), itraconazole (ITC), voriconazole (VRC), ravuconazole (RVC),
posaconazole (POS) and caspofungin (CAS).
Results: All isolates produced clearly visible growth after 48 hours of
incubation following the method described. A wide range of MICs was
observed for AMB with values ranging between 0.06 and 32mg/L. Tree
strains (3/35, 8.6%) showed a AMB MIC 1mg/L. Only one isolate was
resistant in vitro to ﬂucytosine (MIC> 32mg/L). Fluconazole showed
poor activity, with MIC 4mg/L for most of the strains tested (97%).
Among new azole compounds, ITC exhibited the best activity compared
with VRC, RVC and POS (Geometric Mean of MICs, 0.17, 0.22, 0.23
and 0.19 respectively). On the other hand, CAS showed poor in vitro
activity against most of the strains tested (GM 24.25mg/L)
Conclusion: (1) Isolates of D. capitatus were in vitro susceptible to
Amphotericin B, ﬂucytosine and new azole agents, specially ITC. (2) The
majority of D. capitatus tested were resistant to FLC.
P1358 In vitro susceptibilities of clinical isolates of ﬁlamentous
fungi to new antifungal agents
M.J. Linares, F. Solı´s, M. Casal (Co´rdoba, ES)
Objectives: Anidulafungin(AND) and caspofungin (CAS), two new
antifungal agents belonging to the echinocandin, act by inhibiting
beta-1,3 glucan synthetase, and display a broad spectrum of action, even
against isolates resistant to amphotericin B and ﬂuconazole. A study was
made of their action against ﬁlamentous fungi.
Methods: A total de 124 strains of the following ﬁlamentous fungi
species were isolated fron a range of clinical samples: Aspergillus fumi-
gatus (35), Aspergillus terreus (22), Aspergillus ﬂavus (18), Aspergillus
niger (16), Fusarium verticilliodes (9), Fusarium oxysporum (6),
Scedosporium apiospermum (6), Emericella nidulans (4), Scedosporium
proliﬁcans (3), Paecillomyces variotii (3), Fusarium solani (2). The
CLSI, (formerly NCCLS) M38-A document for antifungal susceptibility
testing of ﬁlamentous fungi, broth microdilution method was used.
Concentrations assayed for each antifungal agent ranged from 0.03 to
16mg/ml. C. krusei ATCC 6258 and C. parapsilosis ATCC 22019 were
used for quality control. MICs and minimum effective concentrations
(MECs) for evaluating anidulafungin and caspofungin against moulds.
Anidulafungin and caspofungin MICs(50% inhibition) and MECs
(morfological hyphal changes) were determined.
Results: MIC90 results (mg/ml) for the two antifungal were as follows
(ADN/CAS): Aspergillus fumigatus (2/8), Aspergillus terreus (2/4),
Aspergillus ﬂavus (2/4) Aspergillus niger (4/2), Fusarium verticilliodes
(16/16), Fusarium oxysporum (16/8), Scedosporium apiospermum (2/2),
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Emericella nidulans (0.5/4), Scedosporium proliﬁcans (0.12/0.12),
Paecilomyces variotii (0.06/2), Fusarium solani (4/2). The paradoxical
effectct was more common with caspofungin than with anidulafungin.
Conclusion: Anidulafungin and caspofungin showed moderate in vitro
activity against most of the species tested. Greater activity was displayed
against Scedosporium proliﬁcans and Scedosporium apiospermum.
Anidulafungin was more active than caspofungin against Aspergillus
fumigatus. Aspergillus terreus, Aspergillus ﬂavus and Aspergillus niger
showed little sensitivity to either antifungal agent, both of which
lacked any in vitro activity agains Fusarium verticilliodes and Fusarium
oxysporum.
P1359 Caspofungin Etest endpoint for Aspergillus shows poor
essential agreement with the reference minimum effective
concentration
J. Fuller, A. Schoﬁeld, C. Sand, L. Brietkreutz, L. Turnbull, R. Rennie
(Edmonton, CA)
Objective: The minimum effective concentration (MEC) is the
currently accepted broth microdilution (BMD) endpoint for measuring
echinocandin activity against ﬁlamentous fungi. However, this method
requires microscopic examination of fungal growth, which prevents
many laboratories from adopting this methodology. We evaluated the
caspofungin Etest as an alternative to the BMD for MEC determination
in Aspergillus.
Methods: BMD was performed according to the Clinical Laboratories
Standards Institute (CLSI) document M38-A using 0.016 to 32mg/L
caspofungin. MEC was determined microscopically for the ﬁrst 30
specimens, correlated to the macroscopic appearance of each well,
and then inferred from macroscopic appearance for remaining isolates.
Etest was performed using a modiﬁcation of the CLSI M44-A disk
diffusion method on Mueller-Hinton agar supplemented with glucose
(2%) and methylene blue (0.5mg/L). Caspofungin Etest endpoints were
measured at the intersection between Aspergillus growth and the Etest
strip. Representative CLSI-approved quality control strains were tested
to satisfy reproducibility. All tests were incubated for 24 hours.
Results: 274 clinical Aspergillus isolates were tested, including
A. fumigatus (73), A. ﬂavus (51), A. niger (90), A. terreus (19), and
A. nidulans (41). The Etest endpoint was lower than BMD for 91%
of clinical isolates with an overall essential agreement (1 doubling
dilution variance) of 18.25%. The majority of discordant Etest results
varied from BMD by 2 (26%), 3 (33%), and 4 (15%) doubling dilutions,
and was proportional across all species. Etest endpoints were clearly
deﬁned except for A. ﬂavus and A. terreus, which tended to yield
narrower inhibition zones with microcolony growth (disregarded). This
discordance between BMD and Etest was reproducible using CLSI-
approved quality control strains daily for a 10-day period.
Conclusions: Although susceptibility testing for ﬁlamentous fungi to the
echinocandins is still in its infancy, the results of this study demonstrate
that the caspofungin BMD MEC and Etest endpoint are not comparable
measures. Unless CLSI test conditions can be optimised to reduce this
disparity the caspofungin Etest cannot be used as a BMD alternative for
Aspergillus susceptibility testing.
P1360 Clinical isolates of aspergillus are still fully susceptible to
voriconazole in the POSTVORI era
J. Guinea, S. Recio, T. Pela´ez, E. Bouza (Madrid, ES)
Objectives: Voriconazole (VRC, Pﬁzer Pharmaceutical Group, New
York, NY) is the drug of choice for the treatment of invasive aspergillosis.
It has proven to be very active in vitro against clinical isolates of
Aspergillus. However, recent reports from single institutions alert to an
increasing incidence in the isolation of strains of Aspergillus spp. with
reduced susceptibility to VRC. The aim of our study was to analyse the
in vitro activity of VRC against Aspergillus isolates collected before and
after its commercialisation in 2002.
Methods: We studied 402 clinical strains of Aspergillus spp. The
isolates were grouped into two periods: 197 strains isolated in the
PREVORI period (1999–2002) and 205 strains in the POSTVORI period
(2003–2007). The MICs of VRC were determined following the CLSI
M-38A microdilution procedure. The MIC endpoint was deﬁned as the
lowest concentration producing complete visual inhibition of growth
(MIC-0). Those strains with an MIC 8mg/L for VRC were classiﬁed
as susceptible according to putative breakpoints.
Results:Mean and MIC90, in mg/L, were as follows: overall (0.48/1.00),
PREVORI (0.39/0.5), and POSTVORI (0.57/1.00). No VRC-resistant
strains were detected in either period. However, we found that clinical
strains isolated in the POSTVORI period tended to be slightly less
susceptible than those from the PREVORI period (P< 0.001) (Figure
1).
Figure 1.
During the PREVORI period, 92.9% of strains were inhibited at
0.5mg/L; in contrast, during the POSTVORI period, only 78.5% were
inhibited at 0.5mg/L.
Conclusions: VRC remains very active against Aspergillus spp. clinical
isolates. Although recent strains present slightly higher MICs for VRC,
all strains remain fully susceptible to this agent. The clinical relevance
and trend of this ﬁnding need to be demonstrated. This study was
ﬁnanced by grants from CIBER RES CD06/06/0058 and from FIS
PI070198. Jesu´s Guinea Pharm D, PhD is contracted by the Fondo de
Investigacio´n Sanitaria (FIS), contract number CM05/00171.
P1361 Efﬁcacy of combination therapy of antifungal agents against
Aspergillus: in vitro evaluation with electron microscope
A. Yoshida, Y. Misawa, H. Yoshida, K. Okuzumi, S. Koike, Y. Okamoto,
Y. Yamamoto, T. Ieiri, K. Kobayashi, M. Kobayashi (Mibu, Tochigi,
Nagoya, JP)
Objectives: Combined antifungal chemotherapy has been supposed
to be effective against severe Aspergillus infections such as invasive
pulmonary aspergillosis in immunocompromised patients. However, no
reliable indicators have been established to show its effectiveness in vitro
and in vivo. This study focused on the evaluation of efﬁcacy of combined
antifungals by using transmission electron microscope (TEM).
Methods: We used A. fumigatus isolated from patient with invasive
pulmonary aspergillosis. The fungal inocula and antifungal agents were
prepared in accordance with M38-A recommendation of CLSI, and MICs
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of amphotericin-B (AMB) and voriconazole (VOR), minimum effective
concentration (MEC) of micafungin (MICA) were determined. First,
based on the morphological changes under TEM, the concentrations with
prominent fungicidal features (Fungicidal Activity: AC) were determined
in each agent. Second, in combination of agents, checkerboard synergy
tests were performed to obtain the fractional inhibitory concentration
index (FIC) by examination of the changes under TEM.
Results: MIC and AC of AMB were 0.5mg/ml, and MIC and AC of
VOR were 0.5mg/ml. MEC of MICA was 0.015mg/ml, whereas AC
(disruption of the cell wall, expansion of endoplasmic reticula) was
1mg/ml. In combination AMB with VOR, FIC was 1.0 showing additive
effects. In combination MICA with VOR, FIC was 0.74(= VOR 0.06/
0.25 + MICA 0.5/1.0) suggesting partially synergistic effects.
Conclusion: These ﬁndings suggest that this method based on the
morphological changes could lead to new approaches in case that the
MIC is impossible to determine such as echinocandins for Aspergillus.
P1362 Drug resistance modulation in yeast
J. Subik, M. Sidorova, V. Dzugasova, S. Borecka, J. Cernicka,
Z. Kozovska, I. Hikkel (Bratislava, SK)
Objectives: Multidrug resistance is a defence mechanism used by cells
to cope with rapidly changing growth and stress conditions, allowing
them to survive in the presence of toxic compounds. In Saccharomyces
cerevisiae and pathogenic Candida sp. the multidrug resistance is caused
by an increased drug efﬂux by overexpressed membrane transporters
due to gain-of-function mutations in transcription factors involved in the
control of their expression. This work was aimed at the development of
new strategies to reverse the drug resistance in yeast using S. cerevisiae
and C. albicans as models.
Methods: Drug susceptibilities were determined by microbroth dilution
method in 96-well plates according to the proposed NCCLS M27-A
standard guidelines, by agar diffusion method or by spot assay. Loss-
of-function pdr3 mutants in the genetic background of the S. cerevisiae
strain ZK11−1 were selected on minimal medium containing galactose.
The DNA sequence was determined with the ABI Prism 3100 DNA
sequencer. Accumulation of rhodamine 6G was measured by ﬂow
cytometry.
Results: In this work we show that the susceptibility to antifungals
of drug resistant and drug sensitive yeast cells can be enhanced by
several ways. They involve: 1. The use of multicopy suppressors of drug
resistance generated by loss-of-function mutations in genes encoding
multidrug resistance transcriptional activators. 2. The inactivation of
histone deacetylases associated with the chromatin remodeling. 3. The
use of chemosensitising agents altering the lipid composition of yeast
membranes.
Conclusion: The genetic and biochemical approaches to modulate
multidrug resistance in yeast cells may prove useful in development
of new strategies to combat fungal infections caused by drug resistant
pathogens.
P1363 Cph1p negatively regulating MDR1 involved in drug
resistance in Candida albicans
H-J. Lo, K-Y. Tseng, Y-Y. Kao, M-Y. Tsao, H-L. Lo, Y-L. Yang
(Zhunan, Hsinchu, TW)
Objective: The cph1/cph1 efg1/efg1 double mutant in Candida albicans
is defective in ﬁlamentous growth and avirulent in a mouse model.
Recently, we have reported that Efg1p is involved in drug resistance
by negatively regulating ERG3 in C. albicans. The purpose of this study
is to investigate the effect of CPH1 expression on the drug resistance
efﬂux pump MDR1 in C. albicans.
Methods: CPH1 from C. albicans was cloned and expressed in
Saccharomyces cerevisiae and C. albicans. The expression level of
MDR1 and the susceptibilities to antifungal drugs of the transformants
were determined.
Results: We have found that overexpression of CPH1 in Saccharomyces
cerevisiae increased susceptibility to the antifungal drug ﬂuconazole.
Furthermore, mutations on CPH1 increased the expression of MDR1 as
well as decreased the susceptibility to antifungal drugs in C. albicans.
Conclusion: Our ﬁndings indicate that though Efg1p and Cph1p may
have the same effects on the virulence, they have opposite effects on
drug resistance in C. albicans.
P1364 Efungumab shows no signiﬁcant cytochrome P450
interaction in vitro
S. Awad, I. Al-Shami, J. Burnie, R. Matthews (Manchester, UK)
Objectives: Efungumab (Mycograb®) is a human recombinant mon-
oclonal antibody that inhibits extracellular heat shock protein 90. It
has demonstrated efﬁcacy for the treatment of invasive candidiasis in
combination with amphotericin B. The objective of this study was
to conﬁrm that efungumab does not induce the CYP1A and CYP3A
isoenzymes of cytochrome P450 using primary cultures of human
hepatocytes.
Methods: Hepatocytes were isolated from tissue samples removed from
living donors undergoing liver resection. Live cells were seeded into
24-well collagen-coated tissue culture plates at a density of 1×106
cells/ml, and once attached were incubated with serum-free media for
36 hours. Cells were subsequently incubated for 48 hours in triplicate
with efungumab, the CYP1A1 inducer omeprazole (30 uM), or the
CYP3A4 inducer rifampicin (50 uM). Solutions were then replaced with
0.5ml of either 7-ethoxyresoruﬁn (CYP1A2 probe) or [14C] testosterone
(CYP3A4 probe). The activities of 7-ethoxyresoruﬁn O-deethylase and
testosterone 6beta-hydroxylase were determined using standard end-
point ﬂuorimetric and radiochromatographic methods, respectively.
Results: Compared with control hepatocytes, omeprazole elicited 79.3-
fold, 18.7-fold and 16.4-fold mean increases in CYP1A2 activity. The
corresponding values for efungumab at concentrations of 1, 10 and
90 ug/ml were 1.6-fold, 1.1-fold and 1.6-fold, respectively. Rifampicin
induced CYP3A activity by a mean of 2.3-fold, 1.7-fold and 5.5-fold
over the control cells. Mean CYP3A activity was 1.1-fold, 0.9-fold and
0.9-fold over control for hepatocytes incubated with 1, 10 and 90 ug/ml
efungumab, respectively.
Conclusions: Incubation with efungumab at concentrations up to 90
ug/ml did not elicit marked changes in the CYP1A2 or CYP3A4 activity
of primary human hepatocytes. These data conﬁrm that efungumab is
not an inducer of these enzymes in vitro.
P1365 Pre-incubation with efungumab increases the sensitivity
of Cryptococcus neoformans to amphotericin B and
5-ﬂucytosine combination therapy in vitro
R. Al-Akeel, T. Eyes, L. Nooney, R. Matthews, J. Burnie
(Manchester, UK)
Objectives: Cryptococcal meningitis is associated with poor outcome:
mortality ranges from 88% to 100% in African countries. Conventional
treatment is with amphotericin B (AMB) + 5-ﬂucytosine (5-FC). 5-FC
has intrinsic toxicity and the emergence of resistance is common during
treatment. Efungumab (EFU; Mycograb®) is a recombinant antibody
derived against the LKVIRKNIV epitope of Candida heat shock protein
90 (Hsp90). This study devised an assay to evaluate sensitivity of EFU
pre-treated Cryptococcus neoformans to AMB and 5-FC in vitro.
Methods: Six isolates of C. neoformans were pre-incubated for 2 hours
with EFU 4, 8, 16 or 32 ug/mL. Cells were washed and used to inoculate
single (AMB or 5-FC) or combination (AMB+5-FC) antifungals. The
MIC was determined by microtitre assay at MIC-0 and MIC-2 endpoints
and Fractional Inhibitory Concentration Index (FICI) calculated. Biacore
analysis was performed on a sensor chip surface covalently coated with
2 ug/ml EFU to assess binding of EFU to cryptococcal Hsp90.
Results: Before EFU pre-treatment, AMB MIC-0 ranged from 0.25 to
1 ug/mL and 5-FC MIC-2 ranged from 0.25 to 4 ug/mL. Pre-treatment
with 4 ug/mL EFU reduced AMB MIC-0 range to 0.25–0.5 ug/mL,
but the range of 5-FC MIC-2 was unchanged. At 8 ug/mL EFU pre-
treatment, AMB MIC-0 was 0.125 ug/mL for 5 out of 6 isolates, and
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5-FC MIC-2- ranged from 0.125–2 ug/mL for 4 out of 6 isolates.
At 16 or 32 ug/mL EFU pre-treatment, MICs were reduced by 2–6
dilutions for each antifungal (0.0625–0.25 ug/mL for AMB (MIC-0) and
0.125–1 ug/mL for 5-FC (MIC-2)). Combination of AMB+5-FC gave
lower FICIs when cells were pre-treated with EFU vs not pre-treated.
FICI values decreased as EFU concentration increased (Table). Biacore
analysis demonstrated the high afﬁnity of EFU for C. neoformans Hsp90:
Ka=1.38×105 M−1/S−1, Kd=5.53×10−4 S−1 and KD=4.19×10−9 M.
C. neoformans strain Antifungal FICI value, Efungumab (mg/mL)
0 4 8 16 32
F/7844 AMB+5-FC 1 0.75 0.56 0.31 0.28
F/9002 AMB+5-FC 2 0.75 0.50 0.38 0.25
F/7854 AMB+5-FC 2 0.75 0.50 0.38 0.25
F/7986 AMB+5-FC 0.75 0.50 0.25 0.14 0.13
F/8102 AMB+5-FC 0.75 0.52 0.38 0.26 0.25
NEQAS 6035 AMB+5-FC 2 1 0.50 0.38 0.25
Conclusion: The tight-binding afﬁnity of EFU to cryptococcal Hsp90
enabled EFU+AMB+5-FC triple therapy to be assayed in C. neoformans.
EFU pre-treatment increased the sensitivity of C. neoformans to AMB,
5-FC and AMB+5-FC in vitro, suggesting potential synergy of these
combinations.
P1366 Candida albicans bioﬁlm drug resistance: role of CDR1 gene
V. Agarwal, P. Pruthi, B. Pereira, V. Pruthi (Roorkee, Srinagar, IN)
Objective: Candida albicans is prominent human fungal pathogen which
is known to cause infections mainly in its bioﬁlm mode of growth.
Since years, azole drugs and its derivatives continue to dominate as
antifungal agents against Candida related infections. Even though very
widely acclaimed for their efﬁcacy, these drugs are known to have side
effects and limited action due chemical reaction into bioﬁlm matrix and
over expression of drug efﬂux pumps. In this work, we report that CDR1
gene of C. albicans is responsible for enhanced drug resistance in bioﬁlm
mode of growth.
Methods: The S. cerevisiae strain used was AD1-8u- as cloning host
and Apcdr1 was its derivative expressing Candida drug resistance
protein (Cdr1p). Fluconazole commonly used against Candida infections
was chosen as a positive control. Bioﬁlm quantiﬁcation was done
by XTT (2,3-bis[2-Methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-
carboxanilide) reduction assay.
Results: Characterisation of the clone Apcdr1 showed expression of
CDR1 gene inside S. cerevisiae host AD1−8u-. Data showed that Apcdr1
was about 48 times resistant than AD1-8u- for ﬂuconazole, while in
bioﬁlm mode of growth this resistance was increased to 73 times for the
same drug.
Conclusions: It is encouraging to note that CDR1 gene is responsible for
C. albicans bioﬁlm associated drug resistance and overexpressed during
bioﬁlm formation.
P1367 Bioﬁlm-forming capacity and bioﬁlm antifungal drug
resistance of Candida bloodstream isolates
A. Chatzimoschou, A. Katragkou, M. Simitsopoulou, E. Iosiﬁdes,
E. Georgiadou, C. Antachopoulos, E. Roilides (Thessaloniki, GR)
Objective: Candidaemia is one of the most important nosocomial
bloodstream infections. Bioﬁlm (BF) formation is considered a virulence
factor responsible for catheter-related candidaemia. Our aim was to
investigate the capacity of bloodstream Candida albicans (CA) and
Candida parapsilosis (CP) isolates to form BF and to correlate the degree
of BF formation with the resistance of BF to voriconazole (VRC) and
posaconazole (PSC).
Methods: 5×105 planktonic (PL) cells/mL were grown in YNB medium
with 2% glucose at 37ºC for 24 h. For bioﬁlm formation, 106 cells/mL
were grown on silicone disks placed at the bottom of 96-well plates in
RPMI-1640 under constant shaking at 37ºC for 48–72 h. BF production
was then evaluated by XTT metabolic assay, safranin staining and light
microscopy (LM). Documented BF producers (CA-M61 and CP/PA71)
were used as positive controls (metabolic activity by XTT assay: 100%).
Isolates that a) showed XTT conversion 80% of positive controls, b)
stained with safranin and c) produced microscopically a dense network
of fungal elements were considered high BF producers. XTT conversion
of <80% deﬁned non BF producers, while conversion 80% with
inconsistent safranin and LM ﬁndings deﬁned low BF producers. PL
MICs of VRC and PSC were assessed by CLSI M27-A2 method. BF
MICs were determined as the minimum antifungal concentration causing
50% reduction in the metabolic activity of BF as compared to drug-free
controls. All isolates were tested in triplicate at 3 different experiments.
Results: A total of 43 bloodstream Candida isolates (29 CA and 14 CP)
were examined. BF production was detected in 89% of CA isolates vs.
43% of CP (p< 0.01). Among CA isolates, 72% and 17% were high
and low BF producers, respectively; among CP isolates, the high and
low BF producers were 36% and 7%. PL MIC90 (mg/L) of VRC was
0.037 and of PSC 0.063 for CA isolates, while they were 0.031 and
0.063 for CP isolates, respectively. BF MIC90 of both VRC and PSC
were 1024mg/L for CA and CP. No correlation was observed between
BF-forming capacity and BF azole MIC pattern.
Conclusion: BF-forming capacity is a frequent characteristic especially
among CA clinical isolates. Both high and low BF producers exhibited
high MIC to azoles, which may account for treatment failures with these
agents in BF-related bloodstream infections.
P1368 Adherence and bioﬁlms of Candida species on catheters.
Quantiﬁcation and comparison of the two measures
M.D. Estivill, A. Torres-Lana, A´. Arias, M.P. Arevalo (Manresa.
Barcelona, La Laguna Tenerife, ES)
Objective: comparing adherence and ability to produce bioﬁlms of
Candida species on the surface of catheters expressed in colony forming
units per ml.
Methods: 79 clinically isolates of yeasts from genus Candida: 23
C. albicans, 23 C. parapsilosis, 17 C. glabrata and 16 C. tropicalis
were employed on catheters of three different synthetic material:
polyurethane, polyvinyl chloride (PVC) and Teﬂon. To measure the
adherence catheters were cut into 1 cm segments and were incubated
together with an adjusted inoculum of yeasts (optical density of 1.0
at 540 nm wavelength). The incubation was 35ºC for 90 minutes to
establish baseline adherence and further 72 hours to assess the bioﬁlm
production. The catheter was removed, placed in 2ml of PBS and
vortexed at maximum speed. This suspension was used to determine
the bioﬁlm production counting the viable colonies expressed in ufc
per ml. The results were then transformed into neperian logarithm and
corrected according to the contact surface of the biomaterial.
Results: in adherence measures the four species presented the
highest values on PVC. Signiﬁcant differences were obtained with
C. albicans, C. tropicalis and C. glabrata when comparing PVC
and Teﬂon. Differences between PVC and polyurethane were also
obtained with C. albicans, C. parapsilosis and C. glabrata and in the
case of C. tropicalis differences there were also differences between
polyurethane and Teﬂon.
Bioﬁlms: C. albicans, C. parapsilosis and C. tropicalis presented the
highest bioﬁlm formation on Teﬂon. Statistically signiﬁcant differences
in the ability to produce bioﬁlms of the three species were obtained
when comparing Teﬂon with PVC and with polyurethane. But
differences between polyurethane and PVC were only obtained with
C. tropicalis. The greatest bioﬁlm formation was obtained on PVC with
C. glabrata but without showing signiﬁcant differences between the three
biomaterials.
Conclusion: in adherence measure they all presented a higher adherence
on PVC. There were signiﬁcant differences among the materials. In the
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bioﬁlm formation measure, however, all except for C. glabrata showed
a greater production on Teﬂon. Adherence and bioﬁlm formation vary
depending on the catheter used and on the measuring time.
P1369 Relationships between Candida albicans and free-living
amoebae
A. Bousseau, E. Cateau, M. Grillet, C. Imbert, J.M. Berjeaud,
M.H. Rodier (Poitiers, FR)
Objectives: Dental units water may become heavily contaminated
by various organisms: free living amoebae, Candida sp, Legionella
pneumophila, Pseudomonas aeruginosa, . . . . Patients and dental staff
can be exposed to water and generated aerosols. The objective of
this study was to explore the relationships between Candida albicans
and Hartmannella vermiformis or Acanthamoeba castellanii potentially
recovered from dental units water.
Methods: A. castellanii (ATCC 30234) or H. vermiformis (ATCC 50256)
trophozoites were incubated with C. albicans blastospores in PBS at 27ºC
to give a ﬁnal multiplicity of infection of 0.1. After 2, 4 or 6 h of contact,
a microscopical examination of the cocultivation was realised in order
to verify the potential ingestion of blastospores by amoebae. After 24,
48 or 72 h of cocultivation, lysates obtained from cocultures were plated
on Sabouraud agar to count CFU.
Trophozoites (5·105/ml) of each strain of amoebae were incubated during
24, 48 or 72 h in PBS at 27ºC. Amoebae were then pelleted and
C. albicans blastospores (5·104/ml) were cultivated at 27ºC during 24, 48
or 72 h in the resultant supernatant. After incubation, each tube content
was plated on Sabouraud agar plates to count CFU.
Results: In cocultivation experiments, the presence of A. castellanii
induced a decrease in C. albicans growth, compared to fungal growth in
PBS. On the contrary, H. vermiformis allowed an increase in C. albicans
growth whatever the duration of incubation. Moreover, the microscopic
examination of cocultures showed a C. albicans internalisation only by
A. castellanii.
The only contact with H. vermiformis supernatants led to a number of
fungal CFU increase, particularly noticeable with the 72 h supernatant.
Conclusion: In this preliminary study, A. castellanii and H. vermiformis
in contact with C. albicans had two opposite comportments. A. castel-
lanii was able to phagocyte and destroy C. albicans. At the opposite,
H. vermiformis seemed able to release in the medium substances capable
to increase C. albicans growth. Further studies have to be conducted to
explain these differences.
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P1370 Evaluation of the automated urine culture system Alfred60
for the screening of signiﬁcant bacteriuria
T.D. Huang, C. Debecker, A. Simon (Brussels, BE)
Objectives: Analysis of urine samples is the most prescribed bacterial
diagnostic test in clinical laboratory. We aimed to evaluate the ability of
the new automated incubation system Alfred60 (Alifax, Italy), compared
to classic solid media culture, to screen for samples with signiﬁcant
bacterial growth which would be submitted for manual culture.
Methods: 1025 mid-stream urine samples collected from hospitalised
and ambulatory patients within a one-month period were plated onto
a chromogenic agar Uriselect4 (Uri4, Biorad) using calibrated loop
and transferred into the Alfred60 system for automated testing. A
turbidity-based growth curve generated by Alfred60 for each sample
was converted to an approximate bacterial quantiﬁcation in CFU/ml. A
sample was reported as positive by Alfred60 if it displayed a bacterial
count of 10000 CFU/ml. By Uri4, urine samples were classiﬁed
taking account the bacterial growth quantiﬁcation, the number of species
and the presence of the contamination ﬂora. A sample was considered
positive by Uri4 after interpretation applying the Kass criteria. Samples
reported as negative by Alfred60 and positive by Uri4 underwent further
discrepancy analysis including reviews of urinary leucocytes count and
patient clinical data.
Results: Of the 1025 urine samples tested, 137 were classiﬁed as
positives (13%) and 733 negatives (72%) by both methods, representing
a total agreement of 85%. 136 samples (13%) were positive by Alfred60
and negative by Uri4 while 19 (2%) were negative by Alfred and positive
by Uri4. Of these 19 major discrepancies, 8 bacteriuria were considered
clinically insigniﬁcant, 7 clinically relevant and the signiﬁcation remain
unknown for 3 patients. Positive and negative predictive values after
discrepancy analysis were 50% and 99% respectively.
Conclusion: Alfred60 is a promising urine screening system which
can correctly and quickly (5 h) render results as negative for the
majority (73%) of urine cultures requested and therefore save as many
unnecessary solid culture media. However, Alfred60 positive samples
still require further conﬁrmation by classic culture method with possible
identiﬁcation and susceptibility testing of pathogens.
P1371 Clinical evaluation of a preservative impregnated sponge
to stabilise urine samples transported for microbiological
culture
R. Rennie, L. Turnbull, C. Brosnikoff (Edmonton, CA)
Objective: Evaluation of the clinical ability of a preservative impreg-
nated sponge to preserve the quantity and quality of bacterial pathogens
in urine during transport.
Methods: 935 urines collected for culture were poured over a routine
culture paddle (Starplex Dip N’ Count). The preservative sponge
(Uriswab, Copan Italia) was then dipped into the remaining urine to
absorb the sample (approx. 5s). The culture paddle was incubated 18 to
24 h and read according to standard quantitation protocols. Urine from
the sponge was cultured by squeezing the tube to express the urine;
and with a 0.001ml calibrated loop, the expressed urine was plated on
blood and MacConkey agar. The plates were incubated 18–24 h and read
according to standard quantitation protocols. Signiﬁcant cultures were
considered as those that contained urinary tract pathogens at amounts
considered to reﬂect probable urinary infection. Urine was also sampled
multiple times from the Uriswab to investigate any quantitative difference
in sampling urine from the sponge over time.
Results: 843 of the cultures (90%) yielded equivalent results for
quantitation (± one log10) and micro-organism isolated. There were 92
(9.8%) discrepant results between the two systems where the quantitative
difference was greater than one log10; 29 (3.1%) had potential pathogens
isolated. Of these, 10 were the same organism with the culture paddle
(4) or Uriswab (6) having the higher count; 13 did not grow from the
sponge and the remainder showed various discrepancies. 7 of 17 cultures
grew at signiﬁcant quantities from the dipslide only while the remaining
10 grew signiﬁcant pathogens from the Uriswab only. The remaining 63
discrepant results (6.7%) were not clinically signiﬁcant: 34 of the 63
were lactobacilli or diphtheroids that did not grow from the preservative
sponge. Multiple sampling over time did not alter the quantitation from
the sponge cultures
Conclusions: The two systems agreed in 90% of cases. Quantitative
variation observed in a few cultures may be due to sampling error.
The preservative sponge appeared to reduce the growth of common
contaminants such as lactobacilli and diphtheroids. The clinical utility
of this observation remains to be determined. The preservative sponge
offers a simple, accurate and stable alternative for transport of urine for
microbial culture.
P1372 A comparison of self-collected nasal ﬂocked swabs
with staff-collected nasopharyngeal or nasal swabs for
respiratory tract sampling in volunteers
S. Catriciano, S. Carruthers, S. Buracond, G. So, M. Smieja
(Hamilton, CA)
Objectives: Nasal swabs (NS) for diagnosis of respiratory viruses are
less invasive than nasopharyngeal swabs (NPS), and may enable self-
collection. Previously, we studied 2 NS prototypes, and found them
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equivalent to NPS in sampling epithelial cells, but self-collection was
inferior to staff collection. In this study we modiﬁed one of the
nasal ﬂocked swab (NFS) to optimise sampling and comfort, and to
validate that 2 sequential NS will optimise respiratory cell sampling.
Our objective was to examine if the new Copan NFS is equivalent to
NPS in sampling the respiratory tract, and if self-sampling is equivalent
to staff sampling.
Methods: 55 volunteers had 2 self-administered NFS, followed by 2
staff-administered NS using NFS or rayon swabs in random order.
Pictorial instructions were provided. Discomfort, ease of administration,
and preferences were assessed. The 2nd self-collected swab was
compared with the staff-collected swab. 20 subjects had 2 NPS with
pernasal FS or rayon swab. Swabs were placed in a one mL tube of
UTM; 500 ul was used for nucleic acid extraction and 500 ul to prepare
cell smears. Epithelial cells were counted under an UV microscope;
Averaging 4 ﬁelds or 10 ﬁelds when less than 10 cells per high-powered
ﬁeld (hpf) were present. DNA was quantitated using a beta-Actin real
time PCR.
Results: In the 55 volunteers, the 2nd self-collected NS was superior
to the initial swab, with a mean (SD) of 117 (65) vs. 67 (43) cells/hpf.
The 2nd self-collected NS was superior to staff-collected rayon NS {38
(25) cells/hpf}, and comparable to staff-collected ﬂocked NS {132 (56)
cells/hpf}. In the 20 subjects with NPS, the mean NPS (SD) cell yields
were 145 (43) and 55 (30) for the ﬂocked and rayon, respectively; and
136 (53) and 32 (22) for ﬂocked or rayon staff-administered NS. A high
correlation was found between the cell count and log DNA copies/ml
(R=0.9, P< 0.001). No difference was found between self and staff
administered ﬂocked NS or NPS. Flocked NS performed better than
rayon with signiﬁcant higher mean log DNA count. Mild discomfort or
ease in self-swabbing was reported. Self-swabbing was preferred to staff
collection.
Conclusions: The new Copan nasal ﬂocked swab design is superior
to rayon NPS or NS, and equivalent to ﬂocked NPS, for sampling
respiratory epithelial cells or DNA. Self nasal sampling is feasible and
easy to perform, and equivalent to staff sampling. 2 sequential swabs are
required for optimal cell yield.
P1373 European external quality assurance for the laboratory
diagnosis of diphtheria
S. Neal, A. Efstratiou on behalf of DIPNET
Objectives: The diphtheria surveillance network (DIPNET) is ofﬁcially
recognised as a Dedicated Surveillance Network (DSN) and now
encompasses 25 European countries. A key DIPNET objective is to
assess microbiological procedures for diphtheria in order to harmonise
methods and laboratory performance across the EU.
Methods: A questionnaire requesting detailed information on the
level of reference services offered, methods for identiﬁcation and
toxigenicity testing, was sent to 25 countries. A panel of six simulated
throat specimens were prepared and distributed to all countries in
September 2007. Participants were asked to isolate, identify and perform
toxigenicity testing on any corynebacteria present.
Results: Completed questionnaires and results for the six simulated
specimens were submitted to the coordinating centre in London.
Seventeen participants stated they are designated National Diphtheria
Reference Centres with the UK being the only WHO Collaborating
Centre. A variety of tests were used for screening and identiﬁcation
of corynebacteria, including the cystinase test (11/25), pyrazinamidase
test (12/25) and commercial kits (19/25). Most used the classic Elek
test for toxigenicity testing (18/25) with variations in serum sources and
antitoxin concentration. Many laboratories reported problems obtaining
reagents and media for these specialised tests.
The reported species were concordant with the intended EQA results
in all centres for 3/6 specimens (EQA07−1, Corynebacterium diphthe-
riae; EQA07−2, C. diphtheriae; EQA07−6, C. pseudodiphtheriticum).
However, concordance was lower for EQA07−3 (C. diphtheriae, 11/25
centres), EQA07−4 (C. ulcerans, 21/25) and EQA07−5 (C. diphtheriae,
18/25). Biotype results also revealed discrepancies; from 7/25 matched
for EQA07−5 (var. intermedius) to 24/25 for EQA07−2 (var. gravis).
Alarmingly, the intended toxigenic results were reported as non-toxigenic
or not performed by four and eight centres (for EQA07−2 and EQA07−4,
respectively). Further detailed results will be presented.
Conclusions: Various methods and practices are performed for
identiﬁcation and toxigenicity testing of corynebacteria across Europe.
The discrepancies in this study alarmingly reﬂect the complacency and
minimal awareness that still exists for diphtheria diagnostics. Signiﬁcant
efforts will be made by DIPNET to harmonise methods through training
workshops, EQA studies and revision of the WHO manual for the
laboratory diagnosis of diphtheria.
P1374 Use of quality indicators by clinical bacteriology laboratories
in Ontario, Canada – External quality assessment survey
by Quality Management Program–Laboratory Services
C. Fleming, B. Toye, F. Jamieson, H. Meaney, S. Poutanen,
C. Rutherford, A. Sarabia, J. Gun-Munro, G. Flynn (Toronto, CA)
Objective: To assess current practice on the use of quality indicators
(QIs) by bacteriology labs in Ontario.
Methods: Quality Management Program–Laboratory Services is a
mandatory external quality assessment (EQA) and accreditation program
for clinical labs in Ontario. As part of the microbiology EQA program,
the 104 Ontario labs licensed for bacteriology in June 2007 were required
to complete a questionnaire on QIs monitored in the past ﬁve years
and categorise each QI as pre-analytic, analytic or post-analytic. Labs
occasionally incorrectly categorised the phase of the testing process
being monitored and these results were appropriately reclassiﬁed. For
those QIs monitored in the previous 12 months, labs were asked to
provide details on data collection, target values and whether these
had changed over time, results of monitoring and corrective actions
undertaken.
Results: The 104 labs reported monitoring a total of 947 QIs over the
ﬁve years (mean: 9; median: 9; range: 0–22). Specimen rejection rate
(n = 31), blood culture contamination rate (n = 38), blood culture volume
(n = 35), transit times (n = 31) and number of blood culture sets (n = 39)
were the most common pre-analytic QIs. Results review prior to report
release (n = 35) and correlation of Gram stain results with culture (n = 3)
were the most frequently reported analytic QIs. Report turnaround time
(TAT) for CSF (n = 39) and blood culture (n = 30) Gram stains and review
of reported results for transcription errors (n = 36) were the most common
post-analytic QIs. 125/947 (13%) of the QIs reported by labs were
deemed to be erroneous QIs (e.g. quality control, temperature monitoring
of equipment). Labs reported compiling data manually for most QIs.
Not all labs had established target values for their QIs and some of the
values reported were not well-deﬁned (e.g. reduce specimen rejection).
Only 6% of the target values had been revised over time. Corrective
actions implemented as a result of monitoring QIs were variable and not
all were appropriate.
Conclusion: The use of QIs by bacteriology labs is widespread in
Ontario. Nevertheless, this survey identiﬁed a lack of understanding of
QIs by some labs as evidenced by misidentifying basic QC as a QI,
lack of targets or thresholds for some QIs and the need to revise targets
over time in order to effect process improvement. QMP–LS released
a summary of these ﬁndings to Ontario labs along with educational
commentary to assist labs in improving their quality systems.
P1375 Evaluation of three immunochromatographic assays for
detection of Legionella pneumophila serogroup 1 antigen in
urine
M.J. Mun˜oz, C.M. Toldos, G. Yagu¨e, C. Guerrero, C. Ramirez,
M. Segovia (Murcia, ES)
Objective: The aim of our study was to evaluate three immunochromato-
graphic (ICT) urine antigen tests (Binax NOW Legionella antigen test,
SAS Legionella antigen test and Trinity Biotech Uni-Gold Legionella
antigen test) for the detection of the antigen of Legionella pneumophila
serogroup 1 in frozen urine samples.
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Methods: Urine samples were collected in 2001 during the massive
outbreak of Legionnaires’ disease (LD) in Murcia (Spain) and were
stored at −80ºC until processing was performed. We included 52 urine
samples from 52 patients with LD (cases). A case of LD was deﬁned
as a patient with pneumonia who had radiological signs of inﬁltration
and who showed laboratory evidence of infection with L. pneumophila
by a positive serology. This group of 52 samples was divided in
two, one of them with Binax NOW positive urinary antigen in 2001
(29 nonconcentrated samples, 9 concentrated samples; positive control)
and the other with Binax NOW negative urinary antigen in 2001 (10
nonconcentrated samples, 4 concentrated samples; negative control). The
three test were performed simultaneously and the results were calculated
according to the manufacturers’ instructions.
Results: We compared, six years later, in 2007, the sensitivities and
speciﬁcities of these three assays. The sensitivities and speciﬁcities are
shown in the table.
Nonconcentrated samples Concentrated samples
Binax
NOW
SAS Uni-
Gold
Binax
NOW
SAS Uni-
Gold
Sensitivity 100%
(29/29)
87.9%
(25/29)
55.2%
(16/29)
66.7%
(6/9)
55.6%
(5/9)
33.4%
(3/9)
Speciﬁcity 100%
(10/10)
100%
(10/10)
100%
(10/10)
100%
(4/4)
100%
(4/4)
100%
(4/4)
Conclusion: The Binax NOW urinary antigen test is superior to the
SAS Legionella test and the Biotech Uni-Gold test for the diagnosis of
infections caused by L. pneumophila serogroup 1. As demonstrated here,
the stability of the urine antigen of L. pneumophila serogroup 1 remains
acceptable overtime.
P1376 Value of Gram stain and quantitative culture of washed
sputum samples in patients with lower respiratory tract
infections
N. Ziyade, A. Yagci (Istanbul, TR)
Objectives: Many microorganisms cause lower respiratory tract infec-
tions (LRTI) but approximately in half of the cases aetiological agent
cannot be determined. We analysed the value of Gram smear examination
and quantitative culture of sputum samples for the diagnosis of LRTI.
Methods: A portion of the sputum was used to make the initial Gram
smear and samples contain more than 10 squamous epithelial cells per
low power ﬁeld(LPF), were not further processed. Quality of the sputum
was compared to results obtained using a rapid strip test (Combur
test; Roche Diagnostics, Switzerland). Acceptable specimens were ﬁrst
inoculated into culture plates and than homogenised with physiological
serum, vortexed, centrifuged, and incubated for 15 minutes after adding
N-acetyl-L-cysteine. A second Gram smear was made and 1:10 dilution
of washed sample was inoculated culture plates for incubation. Positivity
threshold was >106 cfu /ml and bacteria were identiﬁed by using
standard procedures.
Results: During a one year period (July 2006-July 2007), 620 sputum
samples taken from 489 patients with a preliminary diagnosis of LRTI
were studied. More then half of the samples (55.3%) were not acceptable
using the number of epithelial cells as rejection criteria and in only
22.1% of samples there were more than 25 leukocytes per LPF. Using
a standard gravity threshold of >1.01, the sensitivity of the strip was
70% and the speciﬁcity was 74%. We detected an aetiological agent
in 63.5% of acceptable specimens by qualitative method, whereas this
rate was 52% for qualitative method (p< 0.05). Haemophilus inﬂuenzae
was the most common isolated pathogen, followed by Gram-negative
bacilli (Pseudomonas spp., Escherichia coli, and Enterobactericae spp.)
and Streptococcus pneumoniae, respectively. The overall sensitivity and
speciﬁcity of Gram staining was 78.6 and 82%, whereas speciﬁcity
was reached to 100% for H. inﬂuenzae and S. pneumoniae. Although
statistically insigniﬁcant, Gram-negative bacteria were very clearly seen
in washed smears. We believe that interpretation of those samples would
be much easier for inexperienced personnel.
Conclusion: Quantitative culture method for sputum sample is superior
to qualitative method and advisable for routine laboratory. Although there
are contradictory results in the literature about the Gram examination of
sputum smear, appearently skilled interpreters will give valuable data for
the empirical therapy of LRTI.
P1377 Development of a new test panel for identiﬁcation of both
Gram-negative and Gram-positive bacteria
A. Franco-Buff, V. Gomez, E. Olender, P. Gadzinski, B. Bochner
(Hayward, US)
The objective of this project was to simplify biochemical/phenotypic
testing of bacteria by developing a single test panel that could be
used to identify both Gram-negative and Gram-positive bacteria. This
has been impossible in the past because bacterial genera are quite
diverse and no one has found universal culture and chromogenic
testing chemistries that would work with a broad range of genera. We
employed Phenotype MicroArrays to study, in detail, the metabolic
and chemical sensitivity properties of diverse bacteria. From this
effort we succeeded in developing assay conditions and a tetrazolium-
based colorimetric chemistry that can be used to ﬁngerprint and
identify more than 1,000 species, including Gram-negative enteric,
non-fermenter, and fastidious species as well as important Gram-
positive species such as Bacillus, Corynebacterium, Staphylococcus,
Streptococcus, Lactobacillus, and Nocardia. Using computer-assisted
analysis we selected from the Phenotype MicroArray assays a ﬁnal set
of 94 tests that are taxonomically informative. The 71 carbon source
utilisation assays include sugars, carbohydrates, sugar alcohols, hexose-
phosphates, hexuronic acids, D- and L-amino acids, carboxylic acids,
and other types of naturally-occurring biochemicals. The 23 chemical
sensitivity assays test the sensitivity to various potentially-inhibitory
conditions. The conditions include high salt (8% NaCl), high lactic acid
(1%), low pH (5.0), and sensitivity to other taxonomically useful agents
such as antibiotics, cations, anions, oxidisers, and detergents. Because
the panel identiﬁes both Gram-negative and Gram-positive species, a
bacterial isolate can be identiﬁed without a Gram-stain or any other
pre-tests. The one-minute set up procedure consists of preparing a cell
suspension from agar-grown cells, and inoculating 100 ml into each well
of the panel. The system recommends 33ºC for incubation, which permits
identiﬁcation of many more species. In addition to simplicity, a major
advantage over identiﬁcation based on 16s-rDNA gene sequence is that
you simultaneously gain detailed information about the properties and
growth phenotypes of the bacterium that you have identiﬁed.
P1378 Evaluation of a rapid antigen detection test for the
diagnosis of Streptococcal pharyngitis in children and its
impact on antibiotic prescribing
H. Maltezou, V. Tsagris, A. Antoniadou, L. Galani, P. Biskini,
K. Douros, A. Maragos, V. Raftopoulos, A. Fretzayas, P. Nikolaidou,
H. Giamarellou (Athens, GR)
Objective: To study the performance of Becton-Dckinson Link 2 Strept
A Rapid Test (RADT) in the diagnosis of streptococcal pharyngitis in
children presenting with upper respiratory tract symptoms and fever and
its impact on antibiotic prescribing
Methods: The study was a prospective non-randomised study in which
private-practice and nosocomial paediatricians participated. Children
2–14 years old presenting with fever and at least one of: tender
anterior cervical lymh nodes, tonsillar exudate or redness and absence
of cough were enrolled in the study. Padiatricians were assigned in two
groups: Group A which included only private-practice paediatricians
who managed children only on clinical grounds and according to their
usual clinical practice. They only had to ﬁll a form with demographic
data and information about the child’s illness, their diagnosis and
antibiotic prescribing. Group B consistent of private-practice (B1) and of
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nosocomial paediatricians (B2) who performed the RADT and a throat
culture. Antibiotic prescribing in this group was guided by a positive
RADT or culture. A similar data form was also ﬁlled as in group A.
Results: During the 2-year study period, 602 children were evaluated.
Streptococcal pharyngitis was diagnosed by RADT and/or culture in
119 (36.6%) of the 325 children tested. The sensitivity, speciﬁcity,
positive and negative predictive values of the RADT were 83.3%, 90.55,
83.8% and 93.3% respectively. A stepwise increase of Radt sensitivity
was noted among children with 2, 3, or 4 clinical criteria (80.6% to
95.8%). By logistic regression analysis tender anterior cervical nodes
and absence of cough were found to predict a positive throat culture
(OR=4.381, CIs=1.106–17.355). Paediatricians of group A prescribed
more frequently antibiotics compared to those of group B(82.3% versus
32.6%, p< 0.001). During the study no streptococcal pharyngitis related
complications were noted and only one child presented with a rash as
an allergic reaction to a cephalosporin
Conclusion: RADT presents with a reliable accuracy in the diagnosis of
streptococcal pharyngitis in children, used in private practice and in the
hospital. It is also associated with a signiﬁcant reduction in antibiotic
prescribing when used to guide therapy in children presenting with
symptoms of pharyngitis. When only clinical criteria can are used, tender
cervical lymph nodes and the absence of cough may predict streptococcal
pharyngitis and guide therapy.
P1379 VIDAS C. difﬁcile toxin A&B assay performance evaluation
and epidemiological analysis of samples collected in UK
and US
A. Foussadier, D. Rolland, L. Bridon, B. Rice, J. Brazier, V. Hall,
S. Young, R. Smith, N. Dumas, M. Amphlett, K. Nancekievill,
C. Delaney, S. Apcar (Marcy l’Etoile, FR; Durham, US; Cardiff,
UK; Alburquerque, US; Cambridge, UK; Valencia, US)
Objective: Evaluate the performance for the VIDAS C. difﬁcile Toxin
A&B test (CDAB): sensitivity and speciﬁcity compared to the Gold
Standard Cytotoxicity Assay (CTA) and assay precision. Positive samples
collected were further identiﬁed by ribotyping.
Methods: Precision was determined at 3 sites: the 6 samples were
tested in duplicate, in 2 runs per day, with each of 2 VIDAS CDAB
reagent lots in 3 sites over a period of 6 days. Sensitivity and speciﬁcity
were determined during a clinical trial where over 1000 samples were
collected from 2 sites, one in the US and one in UK in order to have a
representative collection of 100 positive samples. Fresh stool sent to the
laboratory for suspicion of diarrhoea due to C. difﬁcile were tested in
parallel with VIDAS CDAB and CTA assays. ROC curve analysis was
performed to validate the cut-off established during the development of
the assay. C. difﬁcile strains were isolated from the positive samples and
submitted for PCR ribotyping and identiﬁcation.
Results: Analysis of the precision study results show the CV’s for total
precision are less than 12% for all panel members excepted for the
negative sample. Sensitivity of VIDAS CDAB compared to CTA was
88.3%. Speciﬁcity of VIDAS CDAB compared to CTA was 99.8%. The
PPV was 98.1% and the NPV was 98.4%. The ROC curve analysis
conﬁrmed the choice of the assay cut-off and equivocal zone. Ribotyping
results of over 87 positive samples are presented according to their
geographical origins: ribotype 017(2%), ribotype 027(30%), ribotype
106(16%).
Conclusion: The total precision for the VIDAS CDAB test was <12%
and indicate a precise pre-analytical stool processing method. The
sensitivity and speciﬁcity of the VIDAS CDAB test in comparison to
CTA was 88.3% and 99.8% respectively. The VIDAS CDAB test has the
ability to detect different strains of C. difﬁcile, including the strains 017
and 027, which are very important for the epidemiology and treatment
of C. difﬁcile associated disease.
P1380 Evaluation of three single-use immunoassays for toxins A
and B in the diagnosis of Clostridium difﬁcile associated
diarrhoea
V. Lalande, C. Desconclois, M. Poupard, B. Benet, F. Barbut, J.C. Petit
(Paris, FR)
Background: C. difﬁcile (CD) causes toxin-mediated gastro-intestinal
diseases and is considered as a major nosocomial enteropathogen. So far,
the gold standard for the diagnosis of CD associated disease (CDAD)
is the cytotoxicity assay (CTA). But, since 2006, the use of a rapid
test detecting both toxins A and B is recommended for the diagnosis
of CDAD. We evaluated three single-use immunoassays availables in
France.
Methods: Only consecutive stool specimens from hospitalised adults
with suspected CDAD were included in the study. The purpose of this
evaluation was to compare tree rapid single-use enzyme immunoassays
(ImmunoCard® Toxins A&B) (Meridian Bioscience Europe) (ICTAB)
ToxA/B Quik Chek® (BMD, France) (QCHEK), Xpect® (Oxoid, France)
(XPECT) to an in-house cytotoxicity assay using MRC5-cell culture for
detection of CD in clinical stool specimens. A toxigenic culture (TC)
using TCCA plates (Taurocholate, Cycloserin, Cefoxitin, Agar) was also
systematically performed. All stools were blindly tested simultaneously
and the results were read independently by two persons. For each test,
the intensity of a positive test was noted.
Results: A total of 200 fresh specimens were tested according to the
manufacturer’s instructions. Of these, 30 specimens (15%) were positive
by CTA and 36 (18%) by TC. As compared to CTA, the ICTAB, QCHEK
and XPECT tests have respectively an overall sensitivity of 80, 80 and
53% and a speciﬁcity of 98, 95 and 98% and correlation of 96, 93 and
91% were observed. There was only one discrepant result resolved by
toxigenic culture of which CTA was negative and ICTAB and QCHEK
tests positive. Among true and false positive results of the tests, a faint
intensity of colouration was observed for 17 and 67%, 33 and 100% and
25 and 100% respectively for ICTAB, QCHEK and XPECT tests.
Conclusion: Cytotoxicity assay remains the most speciﬁc and sensitive
assay for the detection of pathogenic CD but the ICTAB and QCHEK
could be considered as valuable alternative test with sensitivity higher
than XPECT. Otherwise, more false positive results were observed with
QCHEK.
P1381 Evaluation of the Uni-Gold™ Legionella Urinary Antigen
Test, a new immunochromatographic test in comparison
with the Binax NOW test
A.M. Freydiere, N. Lagrange, F. Vandenesch, J. Etienne, S. Jarraud
(Bron, FR)
Objectives: Evaluation of the Uni-Gold™ Legionella Urinary Antigen
Test (Trinity Biotech, Wicklow Ireland) sensitivity and speciﬁcity by
using both fresh and retained frozen samples, in comparison with the
Binax NOW Legionella test (Binax, Portland, ME).
Methods: 120 prospective fresh urine samples submitted to our
laboratory for Legionella urinary antigen detection and 30 repository
urine samples from 30 patients with known legionnaires’ disease
collected between 2004 and 2006 and stored at −20ºC until processing,
were tested. Evidence of infection with L. pneumophila was established
on the detection of urinary antigen with the Binax Now Legionella test
and on clinical and/or radiological argument of pneumonia.
Concentrated and unconcentrated urines samples were tested by the
Uni-Gold test and compared to the results of concentrated urines
tested simultaneously by the Binax Now Legionella Urinary Antigen
test. Concentration of urine samples was performed by centrifugal
ultraﬁltration (Amicon Ultra-4; Millipore Corporation, Bedford, Mass).
All samples yielding discordant results were tested by the Biotest EIA
reagent (Biotest, Dreieich, Germany)
Results: On the 120 fresh urine samples, 119 samples urine showed
identical results with the Uni-Gold test and Binax Now Legionella
test including 111 negative and 8 positive urine samples. The results
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were identical for non-concentrated and concentrated urine samples.
The one urine sample yielding a discrepant result between the two tests
was conﬁrmed as Legionella urinary antigen negative with the Biotest
EIA reagent, but positive with the Uni-Gold test only; it was collected
from a patient without pneumonia. The 8 patients with positive urine
samples were conﬁrmed clinically to have legionnaires’ disease. Thus
the speciﬁcity of the Uni-Gold test was 99.1% compared to 100% for
the Binax Now test
On the 30 repository urine samples, 29 and 25 yielded positive Uni-
Gold test results for concentrated and unconcentrated urine samples
respectively and 30 yielded positive Binax Now test result for
concentrated urine. Established on the 38 true positive urines samples,
the sensitivities of the Uni-Gold test were 97.3 and 86.8% for
concentrated and unconcentrated urine respectively.
Conclusion: The Uni-Gold™ Legionella Urinary Antigen Test was
found to be a valuable test for the rapid detection of Legionella
pneumophila serogroup 1 antigen in concentrated urines.
P1382 Impact of rapid identiﬁcation of C. albicans and C. glabrata
directly from blood cultures using PNA FISH technology
on selection of antifungal therapy
P. Della-Latta, S. Whittier, F. Wu (New York City, US)
Objectives: We studied the performance of the peptide nucleic
acid ﬂuorescent in situ hybridisation (PNA FISH) assay for rapid
identiﬁcation of Candida albicans and Candida glabrata directly from
blood cultures within hours, compared to routine methods with time to
results at 1 to 2 days. The impact of differentiating these 2 species in
real time on the selection of or change to the most effective antifungal
treatment (Tx) was evaluated. Our 2007 antibiogram demonstrated
that ﬂuconazole (FLU) susceptibility for isolates of C. albicans and
C. parapsilosis was nearly 100%; FLU resistance was 21%, 50% and
10%, for C. glabrata, C. krusei and C. tropicalis, respectively. The
emerging resistance to FLU in non-albicans strains and their predictable
susceptibility to caspofungin (CP) often results in empiric Tx with CP.
Methods: 37 blood cultures newly Gram stain positive for yeast were
evaluated for the presence of either C. albicans or C. glabrata or neither
by PNA FISH (AdvanDx, Woburn, MA) technology. The assay uses
ﬂuorophore-labeled dual probes with staining green for C. albicans
and red for C. glabrata. Routine identiﬁcation was performed using
MicroScan panels (Dade Behring, Sacramento CA) and CHROMagar
selective media (BD, Sparks, MD).
Results: The Candida spp. recovered included 15 C. glabrata, 10
C. albicans, 5 C. parapsilosis, 2 C. tropicalis, 1 C. krusei, and 1 Candida
dubliniensis. The sensitivity, speciﬁcity, positive and negative predictive
values of PNA FISH for C. glabrata and C. albicans compared to
routine identiﬁcation methods were 100%. One patient isolate negative
by FISH and presumptively positive for C. albicans by CHROMagar
was identiﬁed as C. dubliniensis, a strain known to develop resistance
to FLU. Tx of 7/15 patients (47%) with C. glabrata sepsis, was changed
from FLU to CP within hours of reporting FISH results; for 2/10 patients
(20%) with C. albicans fungaemia CP was switched to FLU after rapid
reporting.
Conclusions: The PNA FISH accurately identiﬁes C. albicans and
C. glabrata directly from positive blood cultures within hours and can
impact on the appropriate selection of the most effective antifungal Tx,
thereby making it a clinically relevant diagnostic assay.
P1383 Evaluation of the new VITEK-2 Neisseria haemophilus card
for the identiﬁcation of fastidious organisms
L. Carrara, B. Mirelis, M. Espan˜ol, R. Pericas, F. Sa´nchez, F. Navarro
(Barcelona, ES)
Objectives: The new VITEK2 Neisseria haemophilus (NH) card
(bioMe´rieux S.A) was evaluated for the identiﬁcation of fastidious
organisms. This card is based on colorimetric technology and results
are interpreted with a computer-assisted algorithm that allows the
identiﬁcation of a total of 28 taxa.
Methods: A total of 73 well-characterised isolates of clinical samples,
included in the VITEK2 NH data-base, were evaluated: 7 Neisseria spp.;
13 Haemophilus spp.; 31 Campylobacter spp.; 7 Moraxella catarrhalis:
and 15 isolates belonging to the HACEK group. 16S rRNA sequencing
was used for the identiﬁcation of the followings genera: Aggregatibacter
aphrophilus, Aggregatibacter actinomycetemcomitans, Capnocytophaga
spp., Cardiobacterium hominis, Eikenella corrodens, H. parainﬂuenzae,
Kingella kingae and Neisseria spp. (except N. meningitidis and
N. gonorrhoeae which were identiﬁed with API NH and home-
made tests). Other genera such as H. inﬂuenzae, M. catarrhalis and
Campylobacter spp. were identiﬁed with routine clinical laboratory tests.
Results: The VITEK2 NH card correctly identiﬁed 70 (95.89%) isolates.
Fifty-three (72.60%) of these were correctly identiﬁed without requiring
further tests. An additional 17 (23.29%) isolates were identiﬁed with
a low level of discrimination, 13 of which belonged to the genera
Campylobacter. Further tests were required in these 17 cases to reach
correct identiﬁcation. Three (4.11%) isolates were misidentiﬁed (1
C. coli, 1 C. jejuni, 1 N. meningitidis).
Conclusions: This new NH card has an extended data-base and results
are available within 6 hours. Both characteristics are advantageous in
comparison with traditional methods when the isolates to be identiﬁed
are previously correctly oriented. The new VITEK2 NH card can thus
be considered a good method for the identiﬁcation of diverse groups of
fastidious organisms
P1384 Evaluation of MALDI-TOF mass spectrometry for the
identiﬁcation of clinical yeast isolates
G. Marklein, M. Josten, U. Klanke, E. Mu¨ller, T. Maier, T. Wenzel,
M. Kostrzewa, A. Ho¨rauf, H.G. Sahl (Bonn, Leipzig, DE)
Objectives: Candida, Cryptococcus and other yeasts are responsible
for several systemic diseases such as fungaemia, meningoencephalitis,
peritonitis and pneumonia. Conventional identiﬁcation of these organ-
isms is not always simple and reliable. Retesting and morphological
examination can be necessary. On the other hand, due to different
anti-fungal proﬁles, rapid presumptive species identiﬁcation is essential.
Matrix-Assisted Laser-Desorption/Ionisation Time-Of-Flight Mass Spec-
trometry (MALDI-TOF MS) is becoming a popular method for rapid
identiﬁcation of microorganisms. We compared the performance of this
technique with conventional biochemical/physiological identiﬁcation.
Methods: A total of 217 clinical isolates of yeasts and yeast-like
organisms on Sabouraud agar were analysed by MALDI-TOF MS.
They had been identiﬁed with chromogenic agar media (CANDI Select
4, BioRad, Mu¨nchen, and/or API 32C (bioMe´rieux, Nu¨rtingen) and
additional tests if necessary. For sample preparation, a yeast colony
was transferred into 300 ml of water, suspended and mixed with 900
ml of ethanol. After centrifugation the pellet was resuspended in 35%
formic acid/50% acetonitrile and centrifuged. 1ml of the supernatant
was used for measurement with alpha-cyano-4-hydroxy cinnamic acid
matrix (Microﬂex LT, Bruker Daltonics, Germany). Bioinformatics was
performed with the BioTyper 2.0 (Bruker Daltonics, Germany).
Results: Identical results were obtained with strains of C. albicans
(n = 31), C. glabrata (n = 30), C. tropicalis (n= 31), ﬁve other Candida
spp. (n= 39), and Cryptococcus neoformans (n = 3). Obviously due to
gaps in the data base, MALDI-TOF MS provided no identiﬁcation of
C. norvegensis (n= 5), Trichosporon spp. (n= 4), and one strain each
of C. holmii, C. rugosa, Geotrichum and Pichia sp. Introduction of a
C. norvegensis database reference resulted in correct identiﬁcation of the
other strains. One strain of C. dubliniensis was identiﬁed on the genus
level as Candida, best hit C. albicans. Introduction of a C. dubliniensis
reference into the database resulted in correct identiﬁcation. The method
is robust, involving simple handling, low cost of consumables and high
speed (10 min per test, 3 h for 96 samples).
Conclusion: MALDI-TOF MS represents a promising tool for rapid
identiﬁcation of the most important Candida species and related yeasts.
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With completion of the data base, this technique may offer signiﬁcant
advantages over currently available methods.
P1385 Evaluation of the RIDA®QUICK Verotoxin/O157 for the
detection of Shiga toxin and Escherichia coli O157 in stool
enrichment cultures
A. Mellmann, H. Leidinger, P. Sander, R. Fischer, K. Becker,
M. Bielaszewska, H. Karch (Mu¨nster, Darmstadt, DE)
Objectives: Shiga toxins (Stx) are the major virulence factors of
enterohaemorrhagic Escherichia coli (EHEC), which can cause diarrhoea
and the life-threatening haemolytic uraemic syndrome (HUS), the major
cause of acute renal failure in childhood. The serogroup O157 is
associated with 70–90% of all EHEC infections. The prompt detection
of the pathogen is mandatory to start the adequate therapy. We therefore
evaluated the new RIDA®QUICK Verotoxin/O157, which detects Stx
and the E. coli serogroup O157 within 16 hours.
Methods: To evaluate the RIDA®QUICK Verotoxin/O157 (R-Biopharm,
Darmstadt, Germany), in total 161 samples were analysed. These
included 51 EHEC reference strains which represent a broad spectrum
of 38 different serotypes, all known Stx subtypes (except for Stx2g
produced by animal strains only), and 6 Stx-low producers. Furthermore,
98 stools, 8 isolates from these stools and 4 animal isolates from
our routine clinical microbiological laboratory and from the consulting
laboratory were investigated for the presence of Stx and O157. The
results were compared to genotypic detection of Stx encoding genes
(stx) and of the sfpA gene that is speciﬁc for a subset of EHEC O157
by PCR. To verify Stx production the Vero cell cytotoxicity assay was
applied in addition.
Results: Of the 161 samples, 145 samples (90.1%) were correctly
diagnosed using the RIDA®QUICK Verotoxin/O157 regarding Stx
production and/or serogroup O157. The serogroup O157 alone was
correctly detected in 157 samples (97.5%) and Stx production was
correctly determined in 147 samples (91.3%) in comparison to PCR
detection and the cytotoxicity assay. Sensitivity, speciﬁcity, positive and
negative predictive values for Stx/O157 detections were 84.3/91.7%,
98.7/98.5%, 98.6/91.7%, and 85.6/98.5%, respectively. False negative
results of Stx detection were mainly due to low Stx production in isolates
(n = 3), to low amounts of EHEC in the stool enrichment broth (5), and
to the presence of rare Stx subtypes (Stx2d, Stx2e) as sole Stxs (2). The
low EHEC concentration also explained 2 false negative O157 results.
In two further samples, false positive O157 results were detected.
Conclusion: Overall, the new RIDA®QUICK Verotoxin/O157 is a highly
speciﬁc method to determine the presence of Stx and the serogroup O157
in stool enrichment cultures within 16 hours. Ongoing studies investigate
the test performance in comparison to Stx targeting ELISA.
P1386 Identiﬁcation of staphylococci by using commercial kits
STAPHYtest 24 and API Staph
I. Sedlacek, P. Petras, E. Pliskova Pakrova, T. Skapova, J. Jancova,
P. Jezek, I. Machova (Brno, Prague, Ostrava, Pribram, CZ)
Objectives: Staphylococci represent a substantial part of the surface
microﬂora of mammals and birds (skin, skin glands, mucous membranes)
and some Staphylococcus species, mainly S. aureus, are found frequently
as aetiological agents of a variety of human and animal infections.
The species identiﬁcation of staphylococci based on biotyping is
still commonly performed in routine clinical laboratories. The aim
of presented study was the comparison of species identiﬁcation of
staphylococci by using two commercial biochemical systems.
Methods: A total of 195 staphylococcal cultures were evaluated in
this comparative study including 40 reference CCM strains and 155
clinical isolates obtained from 3 different microbiological laboratories.
All cultures were identiﬁed by standard procedure (STAPHYtest 24 and
API Staph) according to manufacturer’s instruction. In case of discrepant
identiﬁcation results obtained by commercial kits the ﬁnal identiﬁcation
was performed in the National Reference Laboratory for Staphylococci
based on a large set of tests.
Results: STAPHYtest 24 kit successfully identiﬁed to the species level
160 cultures (82%) of tested, remaining 27 strains (14%) were identiﬁed
to the genus level only and 8 strains (4%) stayed unidentiﬁed or misiden-
tiﬁed. Applying of additional tests recommended by identiﬁcation soft-
ware (TNW v. 7.0) improved species identiﬁcation to 94% when 6 strains
(3%) were misidentiﬁed and next 6 strains (3%) stayed identiﬁed to genus
level only. API Staph kit surprisingly identiﬁed only 103 cultures (53%)
to the species level. Great number of strains, 71 of 195 studied (36%),
was identiﬁed by API Staph just to genus level and 21 strains (11%) were
not identiﬁed or misidentiﬁed. Applying of additional tests according to
identiﬁcation software (apiweb) improved correct species identiﬁcation
to 84%. Unfortunately this step increased false identiﬁcations to 30 cases
and the high number of misidentiﬁed staphylococci represent a great
problem of API Staph kit or identiﬁcation software apiweb.
Conclusion: Our results proved usefulness of the new identiﬁcation kit
STAPHYtest 24 for reliable identiﬁcation of staphylococci. In our view
the STAPHYtest 24 is superior to API Staph as regards of identiﬁcation
efﬁcacy as well as user friendly.
P1387 Differentiating Pseudomonas aeruginosa from common
enteric bacteria by digital tinctorial properties
V. Nilaratanakul, U. Rirerm, T. Chatsuwan, W. Kulwichit (Bangkok, TH)
Objectives: P. aeruginosa is an important pathogen which demands
a distinct empiric antimicrobial coverage. On Gram’s staining, it has
long been observed that P. aeruginosa stains less intensely by safranin
O than common enteric bacteria. In this pilot study, we sought to
determine staining characteristics which may aid clinicians in making an
initial antimicrobial choice and minimising overusage of broad-spectrum
coverage.
Methods: 4 isolates of Escherichia coli, 4 of Pseudomonas aeruginosa
and 3 of Klebsiella pneumoniae were employed. On the Figure, the ﬁrst
isolate of each genus represent ATCC strains (25922, 27853, and 27736,
respectively) followed by clinical isolates. After concurrent growth in
culture media for over 24 hours, the isolates were transferred to 0.85%
NaCl, adjusted to 0.5 McFarland and then smeared on slides by the
same-size loops. A standard Gram’s staining was performed. Microscopic
pictures of the stained smear were digitally taken. 20 to 30 bacilli were
then randomly selected from the pictures of each smear for analysis.
Maximal digital colour value of each bacterium was recorded under
Adobe Photoshop CS2 in the RGB mode with red (R), green (G) and
blue (B) measured separately. The colour intensity ranges from 0 to 255.
Intensity of the corresponding colour on the surrounding background of
each bacterium was also recorded.
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Results: 320 bacilli from the 11 isolates were selected – 120 for
E. coli, 110 for P. aeruginosa and 90 for K. pneumoniae. Given a
strong correlation between the colour intensity of the bacterium and
that of its surrounding background and the variability of background
intensities in different areas, the value of that of background minus
that of the bacterium (BG-R, -G or -B) was used. The mean value
of all the measured adjusted background/bacterium in each isolate was
plotted (Figure). BG-R was 2.41, −1.79, 2.13; BG-G 17.04, 9.25, 19.97;
BG-B −0.2, −4.53, 0.32 for E. coli, P. aeruginosa and K. pneumoniae,
respectively. Intergroup mean difference between E. coli-P. aeruginosa
and P. aeruginosa-K. pneumoniae were both signiﬁcant (p< 0.001) for
all colours. Mean difference between E. coli-K. pneumoniae was not
signiﬁcant for BG-R (p = 0.916), BG-B (p = 0.422), but signiﬁcant for
BG-G (p< 0.001).
Conclusion: Our study demonstrate a potential utility of digital
tinctorial measurement as a diagnostic aid to guide appropriate empiric
antimicrobials. Further analysis on more bacterial genera and from direct
clinical specimens are needed.
P1388 Evaluation of the StrepB Select agar for the detection
of group B streptococci from vaginal and recto-vaginal
specimens
P. Melin, P. Huynen, C. Meex, P. De Mol (Liege, BE)
Background Objective: Current guidelines for the prevention of group B
streptococcal (GBS) perinatal disease are based on prenatal screening
culture for recto-vaginal GBS colonisation. Use of selective and
differential media as Granada type agar (GRA) or ChromID StreptoB
agar (SBID) improves sensitivity and workload of these cultures. This
study was conducted to evaluate performances of the new StrepB Select
Agar (SBS) Bio-Rad, for the selective growth of blue-turquoise colonies
of GBS.
Methods: 500 genital swabs collected from pregnant and non-pregnant
women. Each swab was homogenised in 2ml of sterile saline and 0.05ml
aliquots were inoculated onto SBS, modiﬁed GRA (Becton Dickinson),
SBID (bioMerieux) and blood agar with colistin-nalidixic acid (CNA),
primary cultures. The remaining suspension was added to a selective
enrichment Lim broth. After overnight incubation, aliquots of Lim broth
were inoculated onto SBS, GRA, SBID and CNA. SBS and SBID were
incubated in air, GRA anaerobically and CNA in air + 7% CO2, at 35ºC,
24–48 h. Positive and negative control strains (GBS; E. faecalis) were
cultured with each run. Speciﬁc identiﬁcation of colonies suggestive of
GBS (light blue to dark blue-turquoise on SBS, light pink to red on SBID,
beta-hemolytic on CNA) was performed; orange colonies on GRA were
identiﬁed as GBS.
Results: GBS were recovered from 147 swabs (29.4%): 111 from
primary cultures and 139 after Lim enrichment, respectively from 103
and 134 on SBS, 90 and 123 on GRA, 93 and 124 on SBID, 76
and 113 on CNA. Overall sensitivities were 94.6% on SBS, 84.4% on
GRA, 87.1% on SBID and 81.6% on CNA. Characteristic colonies of
presumptive GBS were not always conﬁrmed as GBS: 41 from primary
cultures and 38 after Lim enrichment on SBS, 22 and 17 on SBID
and 45 and 59 on CNA. Respectively the positive predictive values of
presumptive GBS colonies were 71.5–77.9% (SBS), 80.9–87.9% (SBID)
and 62.8–65.7% (CNA). At 48 h incubation, presumptive GBS were
easily observed on SBS, GRA and SBID even in low numbers.
Conclusions: 1) The highest sensitivity was observed for SBS, followed
by these on SBID and GRA. 2) Due to lack of speciﬁcity, characteristic
colonies on SBS as on SBID or CNA must be isolated to conﬁrm their
identiﬁcation. 3) Presumptive GBS were easily observed on SBS, GRA
and SBID. 4) SBS as SBID are incubated in air and do not require CO2
or anaerobic conditions. 5) SBS, a new useful agar to recommend for
GBS prenatal screening culture.
P1389 Comparison of BACTEC Plus media and BacT/Alert FA
media to detect bacteria in blood culture bottles containing
peak therapeutic levels of antimicrobials
J.Y. Lee, J.H. Hong, M.A. Lee (Seoul, KR)
Objectives: Antimicrobials given to patients before blood has been
obtained can affect the detection of bacteria in subsequent blood cultures.
Blood culture bottles with antimicrobial removal system have been
developed and widely used. This study compared the ability of BACTEC
Plus (Becton Dickinson, USA) bottles and BacT/Alert FA (bioMerieux
Vitek, France) bottles to effectively remove antimicrobials.
Methods: BACTEC Plus and BacT/Alert FA bottles were spiked with
5mL human blood, peak therapeutic concentrations of antimicrobials
(vancomycin, ampicillin, oxacillin, gentamicin, cefepime, ciproﬂoxacin,
cefotaxime, cefoxitin, and ceftriaxone) and 7 type strains of S. aureus
(meticillin susceptible and resistant), S. pneumoniae, E. faecalis, E. coli,
K. pneumoniae and P. aeruginosa and a clinical isolate of meticillin
resistant S. aureus. Three rounds of duplicate testing were completed
per antimicrobials/strains combination and growth control without
antimicrobials. After 5 days incubation, the time to detection (TTD) and
recovery rates for bacteria compared with both automated blood culture
systems.
Results: Overall, the BACTEC Plus and BacT/Alert FA recovered 76%
(128/168) and 34% (57/168) of strains from test bottles, respectively
and both media recovered 100% (48/48) of strains from growth
control bottles. BACTEC Plus detected all of Gram-positive bacteria
except S. pneumoniae with ampicillin (33%) and ceftriaxone (33%),
but BacT/Alert FA detected 0–50% of Gram-positive bacteria except
E. faecalis with vancomycin (100%) and meticillin-resistant S. aureus
with oxacillin (100%). In presence of cefepime, cefotaxime, cefoxitin
and ceftriaxone, BACTEC Plus detected 33–100% of Gram-negative
bacteria, but BacT/Alert FA did not detect at all. In presence
of ciproﬂoxacin, BacT/Alert FA detected 100% of E. coli and
K. pneumoniae strains compared with 33% of those for BACTEC Plus.
In case of gentamicin, both blood culture media were effective to detect
all of Gram-negative bacteria. The overall TTD of BACTEC Plus was
shorter than that of BacT/Alert FA.
Conclusion: In presence of b-lactam antimicrobials and vancomycin,
BACTEC Plus media is more effective and faster detection of bacteria
than BacT/Alert FA. In case of ciproﬂoxacin, BacT/Alert FA is superior
to BACTEC Plus for detection of Gram-negative bacteria.
P1390 Evaluation of the VITEK® 2 NH card for identiﬁcation of
fastidious Gram-negative bacteria
U.W. Soenksen, L. Nielsen, A.M. Hesselbjerg, J.J. Christensen,
D.S. Hansen, B. Bruun (København S, Hillerød, DK)
Objectives: Fastidious Gram-negative bacteria comprise a very hetero-
geneous group, some of them easily recognised by their morphological
features or growth requirements, while for others the identiﬁcation is
both time consuming and difﬁcult. The newly developed VITEK2 NH
card (BioMerrieux) covers 26 clinically important fastidious Gram-
negative bacteria, including Neisseria and Haemophilus. In our study,
we compared the VITEK2 NH card with phenotypic and genotypic
characterisation.
Methods: 100 clinical and reference strains, including 30 type strains,
were examined. 75 of these represented 21 of the 26 taxa included in
the VITEK2 NH database. The remaining 25 strains mainly comprised
species of Neisseria not included in the database plus Pasteurella spp.
Performance was assessed to be correct when the strain was identiﬁed
as the only choice with any level of conﬁdence. Extensive phenotypic
testing was performed according to classical methods and partial 16S
rRNA gene sequencing (526 base pairs) was done with comparison of
the edited sequences with deposited sequences in the “Bacteria” NCBI
database.
Results: 45 of the 75 strains of taxa included in the database were
identiﬁed correctly by the VITEK2 NH card, including the Neisseria
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species (including ProA-positive N. gonorrhoeae), the Haemophilus
species, Moraxella catarrhalis and Eikenella corrodens.
Of the 22 strains incorrectly identiﬁed (n = 3) or identiﬁed with low
discrimination (n = 37), the most problematic were the proA-negative
N. gonorrhoeae, Kingella spp. and Capnocytophaga spp. Of the17 strains
identiﬁed with low discrimination, meaning that two to three different
taxa were given as equally possible, three strains were correctly identiﬁed
with the use of some of the supplementary tests.
Of the 25 strains of taxa not included in the database, only 4 were
correctly “unidentiﬁed”, which means not recognised in the database.
The 21 remaining strains were misidentiﬁed as belonging to some of the
species included in the database.
Conclusion: The VITEK2 is an easily used tool in the routine laboratory.
The results in our study indicate that the VITEK2 NH card will
identify most of the commonly occurring species in the database
correctly, except the proA-negative N.gonorrhoea. There are, however,
identiﬁcation problems when testing strains not included in the database,
but deriving from the same genera as those in the database or from the
same clinical infections, such as animal bite wounds.
Table 1. Identiﬁcation of the 75 strains of 21 taxa included in the VITEK®2 NH database and the 25 strains not
included in the database
Conventional identiﬁcation Number of
strains
Correct
identiﬁcation
Low
discrimination
No
identiﬁcation
Incorrect
identiﬁcation
Included in the database
Actinobacillus ureae 2* 1 1
Capnocytophaga canimorsus 6 1 2 3
Capnocytophaga gingivalis 1* 1
Capnocytophaga ocharacea 1* 1
Capnocytophaga sputigenea 1* 1
Cardiobacterium hominis 2* 2
Eikenella corrodens 3* 3
Haemophilus (Aggregatibacter)
actinomycetemcomitans
3* 2 1**
Haemophilus (Aggregatibacter)
aphrophilus
2* 2
Haemophilus (Aggregatibacter)
paraphrophilus
2* 2
Haemophilus haemolyticus 1* 1
Haemophilus inﬂuenzae 3* 3
Haemophilus parahaemolyticus 3* 1 1 1
Haemophilus parainﬂuenzae 3* 3
Haemophilus (Aggregatibacter)
segnis
3* 2*** 1
Kingella denitriﬁcans 2* 1** 1
Kingella kingae 3* 1 2
Moraxella (Branhamella) catarrhalis 3* 2 1**
Neisseria cinerea 3* 2 1**
Neisseria elongata 3* 3
Neisseria gonorrhoeae 10* 5 2** 3
Neisseria lactamica 2* 2
Neisseria meningitidis 10* 9 1*
Neisseria sicca 2* 2
Suttonella indologenes 1 1
Total 75 47 10 7 11
Not included in the database
Actinobacillus hominis 3* 2 1
Moraxella non-liquefaciens 1* 1
Moraxella osloensis 1* 1
Neisseria animaloris (CDC EF-4a) 3* 2 1
Neisseria ﬂavescens 1* 1
Neisseria mucosa 2* 2
Neisseria pharyngis 1 1
Neisseria polysaccharea 1 1
Neisseria weaveri 3 1 2
Neisseria zoodegmatis (CDC EF-4b) 3* 3
Pasteurella canis 1 1
Pasteurella dagmatis 1 1
Pasteurella multocida 3* 1 2
Pasteurella stomatis 1 1
Total 25 7 4**** 14
*Type strain of species included among the strains.
**Correct identiﬁcation included among suggested identiﬁcations.
***In 1 of 2 strains correct identiﬁcation included among suggested identiﬁcations.
****Correctly unidentiﬁed strains.
P1391 Comparative evaluation of ﬁve Aeromonas phenotypic
identiﬁcation systems
B. Lamy, F. Laurent, I. Verdier, J.W. Decousser, E. Lecaillon, S. Tigaud,
H. De Montclos, A. Kodjo (Sete, Lyon, Bourg en Bresse, Dourdan,
Perpignan, Marcy l’Etoile, FR)
Accurate identiﬁcation of Aeromonas strains involved in human
infections with methods or systems usually encountered in clinical
laboratories has never been extensively studied.
Objectives: to evaluate performances of 5 commercialised methods or
systems in identifying Aeromonas strains in a clinical laboratory.
Methods: Aeromonas identiﬁcation with 20E (A) and 32GN (B) strips
(API, bioMe´rieux, France), GN card (C) (VITEK2, bioMe´rieux, France)
NC47 (D) (Walk Away, USA) and NMIC/ID69 (E) (Phoenix, Becton
Dikinson, USA) was carried out in a 5-centre evaluation. Testing was
performed after control of each system. A total of 88 Aeromonas
strains, of which 82 of clinical importance, was tested. Results were
compared to partial rpoB gene sequence based identiﬁcation used as gold
standard. Species distributed as follows: Aeromonas hydrophila (n = 33),
A. veronii (n = 30), A. caviae (n = 39), A. jandei (n = 3), A. media (n = 3),
A. allosaccharophila (n = 3) and A. bivalvium (n = 3).
Results: Genus agreement was 94%, 100%, 99%, 94%, 98% with A, B,
C, D, E respectively. Discrepancies dealt either with (i) erroneous genus
identiﬁcation (C, n = 3; D, n = 3), (ii) absence of result (E, n = 3) or (iii)
no discrimination between two genus including Aeromonas (A, n = 3).
Genus misidentiﬁcation concerned Vibrio (n = 32) or Francisella (n = 3).
Rates of identiﬁcation to the species level was 33%, 22%, and 98%,
with species agreement of 17%, 6% and 62%, with B, C, E systems
respectively. The two remaining systems (A, D) never reached species
level identiﬁcation without additional tests being requested. Similarly,
B and C systems requested additional tests for 80% of the strains.
Additional tests, done as requested by the four systems enabled to
increase rate of correct identiﬁcation to the species level, although
these tests may be variously easy-available in daily practice. The overall
species agreement was 79%, 78%, 67%, 82% and 62% with A, B, C, D,
E systems respectively.
Conclusion: Phenotypic methods or systems encountered in clinical
laboratories show high performances in identifying Aeromonas strains
to the genus level but low performances in identifying Aeromonas
strains to the species level and should therefore be improved. Aeromonas
identiﬁcation should rely on more appropriate algorithms with available
tests in daily practice, or on molecular methods.
P1392 Rapid identiﬁcation of pneumococci and enterococci in
blood culture bottles using Latex Agglutination
A. Cebollero, M. Lloret, I. Pons, I. Sanfeliu, M. Espasa, D. Fontanals
(Sabadell, ES)
Objective: To evaluate two commercial latex agglutination tests, for
rapid identiﬁcation of pneumococci and enterococci directly from
positive blood culture bottles that showed the presence of Gram-positive
diplococci by the Gram stain.
Methods: Period of study: From November 2005 to November 2007.
Samples: All positive blood culture bottles where we visualised only
Gram-positive diplococci by direct Gram stain. Agglutination test: 1ml
from the positive blood culture bottle was centrifuged at 2500 rpm for 10
min. To test Slidex pneumo-kit ® (bioMe´rieux), one drop of supernatant
was mixed with one drop of latex reagent and to test the Streptococcal
Grouping kit ® (Oxoid Diagnostic Reagents), 1 drop of supernatant was
mixed with 1 drop of each latex group reagent (A, B, C, D, F, G). Boths
reagents were mixed and rotated for 2 min. The results were evaluated
comparing to the standardised identiﬁcation methods from solid media.
Results: A total of 120 positive blood culture bottles were analysed with
the following isolates: 87 Streptococcus pneumoniae, 16 Enterococcus
faecalis, 14 Enterococcus faecium and 3 Enterococcus spp. – Firstly, the
Slidex pneumo-kit ® to identify pneumococci showed a sensitivity of
91.5% and a 100% speciﬁcity, and the positive and negative predictive
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values were 100% and 80%, respectively. Secondly, the Streptococcal
Grouping kit ® evaluation for group D agglutination reagent to identify
enterococci had a sensitivity of 75.8% and a speciﬁcity of 100%, and
the positive and negative predictive values were 100% and 84.6%,
respectively. In addition, we observed that 35 (79.5%) pneumococci
showed positive agglutination with group C latex reagent. Summarising,
both latex agglutination tests showed speciﬁcity values close to 100%
and sensitivity values higher than 75% to identify pneumococci and
enterococci.
Conclusion: The results of this study suggest that both reagents could
be used to provide an earlier identiﬁcation than standard methods of
Gram-positive diplococci, and the combination of the two of them is
useful to distinguish between pneumococci and enterococci. In adition
both test are inexpensive and easy to perform in any laboratory.
P1393 PCR assay for detection of Streptococcus dysgalactiae ssp.
equisimilis
P. Lyskova, M. Vydrzalova, T. Kroupa, J. Mazurova (Pardubice, CZ)
Objectives: Streptococcus dysgalactiae ssp. equisimilis belongs to
Lanceﬁeld serogroup G, which forms heterogeneous group of beta-
hemolytic streptococci. Presently, three taxonomic types of this
serological group can be distinguished, as follows: minute colony
formers from humans (S. anginosus group), and large colony formers
from humans (S. dysgalactiae ssp. equisimilis) and animals (S. canis).
In humans, they may colonise pharynx, skin, gastrointestinal and female
genital tract. In recent years, they have been reported with increasing
frequency as a cause of variety of human infections, such as endocarditis,
arthritis, pharyngitis and sepsis. The differentiation of streptococci
traditionally relies on the evaluation of growth, serological and
biochemical properties. However, developments in genetic technology
have resulted in new methods that can be used for identiﬁcation of
bacteria. The aim of the present work was the development of new PCR
assay for the rapid and reliable identiﬁcation of S. dysgalactiae ssp.
equisimilis.
Methods: Based on the sequence analysis of the 16S-23S rDNA
intergenic spacer region of eight S. dysgalactiae ssp. equisimilis strains
of human origin species-speciﬁc primers were designed using the MEGA
program, version 3.1. Subsequently, a PCR with these primers was
optimalised and was used to identify S. dysgalactiae ssp. equisimilis
strains isolated from humans.
Results: The oligonucleotide primers designed according to the species-
speciﬁc parts of the 16S-23S rDNA intergenic spacer region yielded an
amplicon with a size of 205 bp for all S. dysgalactiae ssp. equisimilis
strains investigated. S. canis, also belonging to Lanceﬁeld’s serogroup
G, and all the other control strains of various species and serogroups
were negative throughout. The limit of detection of S. dysgalactiae ssp.
equisimilis was determined to be 1.4 ng DNA.
Conclusion: PCR method presented in this study allowed a rapid and
reliable identiﬁcation of S. dysgalactiae ssp. equisimilis and might help
to improve the diagnosis of this bacterial species in human infections.
Although this species doesn’t belong among common streptococcal
species, its importance should not be underestimated, because it might
be the cause of various infections, including serious, live-threatening
states. This work was supported by MSM 0021627502.
P1394 Evaluation of clinical and laboratory parameters for
establishing the diagnosis of bacteraemia caused by
coagulase-negative staphylococci
N. Hayirlioglu, I. Mumcuoglu, I. Baran, V. Yetener, S. Kursun,
N. Balaban (Ankara, TR)
Objectives: Coagulase-negative staphylococci (CNS) are both an
important cause of nosocomial blood-stream infections and the most
common contaminants of blood cultures. In this study we evaluated
clinical signiﬁcance of CNS bacteraemia by analysing clinical parameters
of CNS bacteraemia, slime production, incubation times for blood
cultures to become positive, number of positive blood culture bottles
and antimicrobial susceptibility of isolated CNS.
Methods: Between June 2006-June 2007, 710 blood cultures (BactAlert
3D, bioMereux) positive for CNS from 458 patients were collected. Di-
agnostic criteria of Rabdom Medical Center were used for determination
of true bacteraemia. CNS were identiﬁed by growth in sheep blood
agar, Gram staining, catalase and coagulase tests. Further identiﬁcation
and antimicrobial susceptibility analysis were done by using VITEK2
(bioMerieux) automated system. Slime production was determined by
Congo Red agar test. Statistical analyses were performed using the
statistical software SPSS for Windows 10.0.1.
Results: According to Rabdom Medical Center diagnostic criteria 80
(17.5%) of the CNSs isolated from blood cultures were causes of
true bacteraemia and 378 (82.5%) were contaminants. Staphylococcus
epidermidis (48.5%) was the most frequently isolated species associated
with true bacteraemia. Also it was the most frequently isolated
contaminant (84.2%). Slime production was signiﬁcantly higher in
isolates that caused true bacteraemia than contaminants (p< 0.05).
85% of CNS that were isolated from true bacteraemia were resistant
to meticillin whereas % 60.6 of contaminant strains were resistant
(p< 0.005). CNS isolates from true bacteraemia were signiﬁcantly more
resistant to meticillin, gentamicin, erythromycin, clindamycin (p< 0.05).
There was no signiﬁcant relation between number of positive blood
culture bottles and true bacteraemia (p> 0.05). The cut-off value for
incubation time for blood cultures to become positive was determined
19.4 hours according to ROC analysis. Incubation time was signiﬁcantly
shorter for blood cultures of true bacteraemia cases than contaminants
(p< 0.05).
Conclusion: In this study, we concluded that no single method has
a high accuracy to diagnose a true CNS bacteraemia. Both clinical
and laboratory parameters should be evaluated. Species identiﬁcation
of CNS, incubation time, slime production and determination of
antimicrobial susceptibility can be all useful tools for determination of
clinical signiﬁcance of CNS isolates.
P1395 Evaluation and implementation of a chromogenic agar
medium for the detection of Salmonella in stool in routine
laboratory diagnostics
M.J. Bruins, S. van Dijk, G.J.H.M. Ruijs (Zwolle, NL)
Objectives: Each year our laboratory processes more than 5,000 stool
samples from patients with gastro-enteritis for culture of Salmonella
species. On conventional agar media recognition of Salmonella is
generally based on lactose fermentation and H2S production. Speciﬁcity
is low and lactose-fermenting salmonellae may go undetected. We
evaluated which chromogenic Salmonella agar medium would improve
the sensitivity and speciﬁcity of our Salmonella stool culture protocol
and thereby decrease workload and costs.
Methods: In the ﬁrst phase of the study, we tested BBL CHROMagar
Salmonella (BBL; Becton Dickinson, The Netherlands), SM ID2 (SM;
bioMe´rieux, France) and Oxoid Salmonella Chromogenic Medium (OX;
Oxoid, United Kingdom) with 34 Salmonella strains and 19 non-
Salmonella strains. Secondly, we prospectively analysed the two deemed
most appropriate media with stool samples submitted from general
practice patients with gastro-enteritis. The chromogenic media were
processed alongside the conventional media Salmonella–Shigella agar
(SS), Xylose-Lysine-Desoxycholate agar (XLD) and Hektoen-Enteric
agar (HE) according to the current stool culture protocol. This included
subculturing after broth enrichment and presumptive identiﬁcation of
colonies suspected of being Salmonella using conventional biochemical
tests.
Results: With stock isolates, sensitivities of BBL, SM and OX were
100%, 94% and 85% respectively after both 24 h and 48 h of incubation.
Speciﬁcities were 84%, 90% and 74% after 24 h and 68%, 79% and 53%
after 48 h respectively. Based on this, we continued the study with BBL
and SM. Of 1339 stool samples, 32 (2.4%) were Salmonella positive on
at least one medium. After direct plating and enrichment sensitivities
for SS, XLD, HE, BBL and SM were 72%, 97%, 84%, 88% and 78%,
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speciﬁcities were 79%, 80%, 81%, 96% and 96% respectively. On SM
more overgrowth of faecal ﬂora was found compared to BBL. XLD
and BBL together yielded a sensitivity of 100%. The higher speciﬁcities
of the chromogenic media reduced the required amount of presumptive
identiﬁcation considerably.
Conclusion: Of the chromogenic media tested, we found BBL the most
appropriate substitute for conventional Salmonella media. We expect a
combination with XLD to give the best results for Salmonella and to
provide optimal isolation of Shigella. Adaptation of the culture protocol
to this effect will result in a substantial decrease of costs of Salmonella
diagnosis in our laboratory.
P1396 Benchmarking of microbiology laboratories
K. Van Vaerenbergh, R. Cartuyvels, G. Coppens, J. Frans, A. Van
den Abeele, H. De Beenhouwer (Aalst, Hasselt, Genk, Bonheiden,
Ghent, BE)
Objectives: A multi-centre evaluation was performed in order to
compare activities and procedures in microbiology laboratories of
5 hospitals with similar activities in Belgium. This evaluation
was considered a ﬁrst step towards standardisation of microbiology
procedures.
Methods: Five microbiology laboratories were provided with a
questionnaire including parameters measuring hospital size, stafﬁng,
organisation and activities (2004). Consecutively, labs were visited and
the provided data were discussed. Two well deﬁned procedures (MRSA
screening and blood culture) were observed and compared. Participation
was voluntary and based on a network of collaborating microbiologists.
Results: The number of hospital beds in the 5 centres ranged from 460 to
939 (median 822, day care included). All hospitals had a medical/surgical
intensive care unit (range 20–34 beds). Although three centres were
multi-site hospitals, all of them had their microbiology activities
centralised in one laboratory. Activities resorting under microbiology
were bacteriology (n = 3), molecular biology (n = 3), fertility (n = 3),
serology (n = 3) and virology (n = 3). The total number of aerobic cultures
performed (2004) ranged from 26040 to 59218 (median 44285) or 0.17
to 0.28 culture/hospital day, and 0.6 to 1 culture/hospitalisation period.
Work load per laboratory technician ranged from 3219 to 5401 aerobic
cultures/full time equivalent/year. The proportion of aerobic cultures
with AST (antimicrobial susceptibility testing) performed, ranged from
17 to 32%. The number of blood cultures in each centre was 0.03–
0.04 samplings/hospital day, and 0.10−0.15 samplings/hospitalisation
period. All centres used automated blood culture systems, 1 centre used
automation for AST reading, 2 centres for identiﬁcation & AST. For
MRSA screening all centres used a chromogenic agar, three of them
had a procedure of enrichment. The number of screening samples/year
ranged from 1885 to 9597 (median 6670), with 7 to 20% new positive
patients/total number of patients screened.
Fast results and close consultation with the clinicians concerning AB
therapy were key points in all centres.
Conclusions: Numbers and procedures were compared in ﬁve micro-
biology labs of Belgian hospitals with similar activities. Some data
were remarkably comparable while other parameters differed widely.
Labour-intensity of different tests should be considered when comparing
numbers as a reﬂection of productivity rates.
P1397 Comparative evaluation of three selective media for primary
isolation of Helicobacter pylori from gastric biopsies under
routine conditions
V.Y. Miendje Deyi, C. Van den Borre, S. Cadranel, A. Burette,
G. Mascart, N. Douat (Brussels, BE)
Objective: Culture of Helicobacter pylori from gastric biopsies allows
diagnostic of infection, susceptibility testing to antimicrobials and study
of virulence factors. The purpose of this study was to compare, under
routine conditions, three selective media for the primary isolation of
H. pylori.
Methods: From October 3rd to November 21st 2007, the study included
gastric biopsies (1 per patient) from consecutive endoscopies submitted
for routine culture of H. pylori to our laboratory. Media tested included
two commercial: PYL (bioMe´rieux, France) and Helicobacter agar
(Becton Dickinson, USA) and a home made medium (BHA: Brugmann
Helicobacter Agar). Specimens were immediately treated or frozen at
−70ºC until the day of culture. Biopsies were ground in 1ml sterile
distilled water and 250ml of the ﬁnal suspension was inoculated on each
medium by circular streaking with a bent pipette. Plates were incubated
for 10 days at 37ºC under microaerophilic conditions. The growth of
H. pylori was checked after 3 days then daily thereafter. If necessary,
the identiﬁcation of H. pylori was conﬁrmed by the presence of Gram-
negative curved bacilli and a positive test for urease, oxidase and catalase
production. Additionally, number of colonies, days of positivity and
presence of contamination were recorded. Chi Square test was used
to compare the overall recovery rate on the different media. Days of
appearance of colonies and average counts were compared by Friedman
test with Dunn post test.
Results: Biopsies taken from 295 patients (aged from 1 to 96, mean 36
years) were plated in parallel on the media. By combining the results
of the three media, the isolation rate of H. pylori was 23% (68 of
295 biopsies). Of the 68 samples, respectively 60, 61 and 62 were
positive with BHA, PYL and Helicobacter agar, given an isolation rate of
88.2%, 89.7% and 91.2%. Average bacterial counts and day of positivity
were respectively 20.286, 26.239 and 25.366 colonies/ml and 5.3, 4.6
and 4.3 days. Signiﬁcance difference was observed only between BHA
and PYL according to the number of colonies (p = 0.011). Extending
incubation to more than 5 days showed contamination in PYL agar
(10/295: Aspergillus sp.) and Helicobacter agar (7/295: 5 Bacillus sp.,
1 Micrococcus, 1 Pseudomonas sp.). There wasn’t any contamination in
BHA.
Conclusion: The three media are acceptable for primary H. pylori
isolation. BHA offers the advantage to be the most speciﬁc medium.
P1398 Helicobacter heilmanii (Gastrospirilum hominis) in gastric
biopsies of humans – A ﬁfteen-year analysis
R. Botek, V. Melichacova, F. Mateicka, P. Veres, J. Kabatova (Piestany,
Trnava, SK)
Objectives: The “non-pylori” representatives of the genus Helicobacter
have recently been widely discussed. They have been described
in connection with human enteral infections, sepsis, and infectious
vasculitis. Special attendance was devoted to H. heilmanii. This Gram-
negative stained spiral shaped rod with a characteristic morphology is in
humans associated with chronic gastritis, ulcerous stomach disease and
it is suspected to be connected with the risk of lymphoma formation.
Immune response is similar to that observed in H. pylori, though it is
less intensive.
Diagnostics of Helicobacter heilmanii is only based on microscopic
evidence, although utilisation of molecular-biological methods is
possible, yet not applicable in the routine practice. Until recently
Helicobacter heilmanii has been considered a non-cultivable bacteria;
though in 1999 some publication on a successful cultivation evidence
from human material were published, cultivation in a routine laboratory
remains rather problematic. We present our experience on this topic.
Material and Methods: The authors analysed incidence of Helicobacter
heilmanii in 8179 bioptic samples of stomach mucosa acquired from two
gastroenterological out-patient departments in the period between 1993
to 2007.
Material delivered to the laboratory in a transport medium was divided
for urease production evaluation, cultivation a microscopic examination
(Gram and Giemsa stain and starting 1998 also stained by Acridine
orange).
Results: 2739 (33.49%) samples were positive on Helicobacter pylori,
31 (0.37%) were microscopically positive on Helicobacter heilmanii. In
the ﬁve cases we detected in the same sample both Helicobacter spp.
together.
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Patients with H. heilmanii have less severe course of the disease and
reacted well to the therapy. Irrelevant were data concerning animal
contact.
Conclusion: We conﬁrmed the published incidence of Helicobacter
heilmanii (0.1–3%) in bioptic samples. Growing knowledge on its
pathogenic activity are in agreement with the increased interest in the
diagnostic laboratories.
P1399 A reassessment of in the diagnosis of brucellosis in Iran:
ELISA or PCR?
M. Hasibi, A. Amirzargar, A. Soudbakhsh, S. Jafari, M. Hajiabdolbaghi,
M. Asadollahi, M. Abouzari (Tehran, IR)
Objectives: Brucellosis is a worldwide infectious disease that poses an
important public health problem especially in Iran. The development
of a deﬁnite diagnostic test for brucellosis has been actively pursued.
In the present study, the value of ELISA as an alternative method for
the diagnosis of brucellosis has been investigated and compared with
peripheral blood PCR assay.
Methods: A total of 37 consecutive patients with deﬁnite diagnosis
of brucellosis (conﬁrmed by blood culture and standard agglutination
test) in Infectious Diseases Department of Imam Hospital, Medical
Sciences/University of Tehran were prospectively evaluated. Moreover,
blood samples from 78 controls (34 healthy controls and 44 non-
brucellosis febrile patients) were included in the study. The peripheral
blood PCR assay and ELISA IgG test were performed in patients and
controls. In control group we calculated the mean of IgG levels plus
2 standard deviation (SD) as a cutoff value for ELISA IgG. The PCR
target sequence of 223-bp present on a gene encoding a 31-kDa Brucella
abortus antigen was selected for ampliﬁcation.
Results: The blood culture was positive in 21 patients. The SATs were
1:160 and 1:320 in 35 (94.5%) and 28 (75.6%) patients, respectively. The
positive results of PCR were observed in 15 (40.5%) patients and none
of the controls. In patients and controls the mean levels of ELISA IgG
were 171.33 ± 72.27 IU/ml and 19.78 ± 41.71 IU/ml, respectively. The
cutoff point (mean plus 2 SD) was 103.2 IU/ml. The ELISA IgG had
positive results in 33 (89.1%) patients and 4 (5.1%) controls. In 4 patients
with negative results of ELISA IgG, serum level of IgM was measured
by ELISA test. We found that the serum IgM level was more than 200
IU/ml in these 4 patients. The sensitivity, speciﬁcity, positive predictive
value (PPV), and negative predictive value (NPV) were reported 40.5%,
100%, 100%, 78% for PCR assay and 89.1%, 94.8%, 89.1%, 94.8% for
ELISA test.
Conclusion: The results of the present study suggest that the ELISA
test is the most sensitive method for the diagnosis of brucellosis and
with the calculation of cutoff point it would be a reliable test. PCR
assay is promising but standardisation of method is lacking and more
investigations should be performed for better accuracy.
P1400 Distribution of Nocardia species in clinical specimens in
Greece
D. Klapsa, M. Auzou, S. Bartziali, E. Vlahaki, M. Vergi,
C. Koutsia-Carouzou, E. Malamou-Lada, R. Leclercq, E. Petinaki
(Larissa, GR; Caen, FR; Volos, Athens, GR)
Objectives: The aim of this study was to assess the species distribution
of a large number of Nocardia isolates in Greece and to propose a
rapid identiﬁcation test that may be helpful to identify the species most
commonly encountered in clinical material.
Methods: A total of 100 Nocardia spp. isolates, recovered from clini-
cally signiﬁcant specimens, were identiﬁed using API-ZYM, according
to the procedures of manufacturer and a molecular method based on
hsp65 gene. The API-ZYM system, including 19 enzymes (alkaline
phosphatase, esterase lipase, leucine arylamidase, acid phosphatase,
phosphohydrolase, alpha-glucosidase, beta-glucosidase. valine arylami-
dase, cystine arylamidase, trypsin, chymotrypsin, alpha-galactosidase,
beta-glucoronidase, N-acetyl-beta-glucosaminidase, alpha-mannosidase,
alpha-fucosidase, beta-galactosidase, ONPG) determined the enzyme
proﬁle of Nocardia species. On the other hand, DNA extracted from
Nocardia species was ampliﬁed using as target the hsp65 gene. PCR
products were then, puriﬁed and sequenced, while, identiﬁcation to the
species level was done after comparison with all sequences available at
the BLAST Genome.
Results: Results obtained by API-ZYM system failed to discriminate
the isolates to the species level. On the other hand, molecular
method identiﬁed twenty isolates as N. ﬂavorosea, thirty-four as
N. cyriacigeorgica, twenty-six as N. nova, two as N. veterana, twenty-
four as N. farcinica, two as N. abscessus, and two as N. asteroides.
Conclusions: Genus-speciﬁc hsp65 gene sequencing can be a rapid and
reliable adjunct in the diagnosis of Nocardia to the genus and species
level.
P1401 Differentiation of Prevotella intermedia and Prevotella
nigrescens by MALDI-TOF-MS
C.S. Stingu, K. Eschrich, R. Schaumann, H. Jentsch, A.C. Rodloff
(Iasi, RO; Leipzig, DE)
Objectives: The Prevotella intermedia group bacteria (black-pigmented
Gram-negative anaerobic rods commonly found in dental bioﬁlm)
includes two phenotypically indistinguishable species P. intermedia and
P. nigrescens. In order to facilitate identiﬁcation of these two species
from periodontal disease, bacterial identiﬁcation by matrix-assisted
laser desorption/ionisation mass spectrometry (MALDI-TOF-MS) was
evaluated with the present study.
Methods: A total of 37 strains (Prevotella intermedia DSM 20706,
Prevotella nigrescens DSM 13386 and 35 recent clinical isolates from
33 patients with aggressive periodontitis) were used. The clinical strains
were very well identiﬁed as P. intermedia/nigrescens by rapid ID 32 A
system (bioMerieux, Lyon, France) and species differentiation was done
using sequence analysis of 16S rARN gene. In addition MALDI-TOF-
MS was performed. All mass spectra were acquired using an Autoﬂex
II (Bruker Daltonics, Bremen, Germany) operated under the Flexcontrol
software ver.2.4 (Bruker Daltonics). Automated peak extraction was done
with Flexanalysis ver. 2.4 (Bruker Daltonics).
Results: Although the MS spectra of the two species are visually rather
similar the mathematical similarity analysis performed with MatLab
7.3 (The MathWorks Inc., Natick, U.S.A.) could well differentiate
them. The spectra of the P. intermedia strains identiﬁed with MALDI
clustered together into two subtrees which are signiﬁcantly different
from P. nigrescens. The latter fell also into two different subtrees. The
quality of clustering was characterised by calculating an inconsistency
coefﬁcient (Mathworks: /Matlab Reference Manual v2007a/, Statistical
toolbox). The reproducibility of the method was demonstrated by the
similarity of spectra belonging to same species. These results are of
clinical importance since there are several studies which associate
P. intermedia with periodontal disease and P. nigrescens with a healthy
periodontium. However, conﬂicting data were also published. The
availability of a straightforward method to identify the two species might
be helpful to clarify this problem.
Conclusion: This study proves that MALDI-TOF-MS is a new accurate
method capable of separating these two species that cannot be readily
identiﬁed by biochemical analysis. With databases for various groups
of bacteria expanding, MALDI-TOF-MS combined with non-linear
statistics becomes an attractive system even for routine identiﬁcation
of clinical isolates.
P1402 High performance and acceptability of self-colllected anal
swabs for diagnosis of Chlamydia trachomatis and Neisseria
gonorrhoeae in men and women
J.J. van der Helm, E.E.H.G. Brouwers, M.S. Van Rooijen,
C.J.P.A. Hoebe, J.S.A. Fennema, H.F.J. Thiesbrummel,
N.H.T.M. Dukers-Muijrers (Amsterdam, Geleen, NL)
Objectives: Identiﬁcation of sexually transmitted infections (STI) is
hampered by the limited compliance to undergo anal STI testing.
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Therefore, alternative non-invasive diagnostic procedures are needed.
This study asessess usability of self-collected anal swabs (SAS) in
diagnosing anal Chlamydia trachomatis (CT) and Neisseria gonorrhoeae
(NG) among men who have sex with men (MSM) and women. The study
is performed in two regions of the Netherlands with different level of
urbanisation and risk group composition.
Methods: In 2006–2007, MSM and women who attended the
Amsterdam and South Limburg STI clinics and reported receptive anal
sex were asked to ﬁll in a questionnaire and provide SAS in addition
to standard provider collected anal swab (PAS). Swabs were tested
for CT and NG using nucleic acid ampliﬁcation tests (NAAT; Roche,
Becton Dickinson). In Amsterdam PAS are also tested for NG by
culture. Positive NG samples were conﬁrmed by NAAT. Sensitivity (Se),
speciﬁcity (Sp) and kappa (>0.8 good test agreement) of SAS compared
to PAS were calculated. Positive and negative predictive value (PPV,
NPV) was calculated for SAS.
Chlamydia trachomatis Provider swab self-swab PPV NPV ú
+ − Sens. Spec.
+ 135 14
MSM self-swab − 10 1244 88% 99% 91% 99% 0.88
+ 62 6
Women self-swab − 4 643 94% 99% 91% 99% 0.92
Neisseria gonorrhoeae Provider swab self-swab PPV NPV ú
+ − Sens. Spec.
+ 56 13
MSM self-swab − 8 848 88% 98% 81% 99% 0.83
+ 7 1
Women self-swab − 1 500 88% 99% 86% 99% 0.87
Results: Of the participants (1411 MSM, 715 women) CT prevalence
was 11% (MSM) and 9% (women) and NG prevalence was 7% and 1%.
CT prevalence was slightly higher in Amsterdam (highly urbanised). In
2% of MSM and 1% of women there was discrepancy between SAS and
PAS test results. For NG this was 2% and 4%. SAS performance for CT
and NG diagnosis was good in MSM and women (see tables) and was
comparable for both study regions.
Of all participants, 68% ﬁlled in questions on SAS acceptability. Of
respondents, 78% of MSM and 85% of women would prefer SAS in stead
of PAS or had no preference (percentages highest in South Limburg).
Only 6% of MSM and 5% of women would not use SAS again and 3%
would not visit the STI clinic again when SAS was the standard test.
Ten percent of MSM and 14% of women found SAS uncomfortable
(percentage lowest in South Limburg); 3% of MSM and 4% of women
found test instructions unclear.
Conclusions: Considering that substantial part of the population has anal
sex (i.e. 10–20% of all men and women attending STI clinics) and anal
STI is frequently present, anal screening should be essential part of an
STI consultation. Self-collection of anal specimens is feasible, valid and
acceptable for MSM and women in STI clinics. It may be a valid method
for anal screening (especially for CT) in other settings as well.
P1403 Comparison of standard test for bacterial endotoxin
detection with a rapid slide method
M. Christensen, M. Hoegh, B. Rubenhagen, L. Andersen
(Copenhagen, DK)
Objectives: Testing surveillance and environmental samples for endo-
toxin content with the standard test procedure (The LAL endochrome test
from Charles River Laboratories) performed at Rigshospitalet is often
laborious. Furthermore the extend of pipetting work may in the long run
cause arthritis like conditions in the ﬁngers of the technicians working
with the LAL method.
Charles River Laboratories has developed a revolutionary FDA-licensed
endotoxin detection system, the Endosafe PTS, which is a portable and
handheld rapid point-of-use test system comprising a simple one-button
operation. Both the LAL test and the Endosafe PTS method are based
on a kinetic chromogenic methodology.
This study compares the LAL method with the new PTS method.
Methods: A total of 18 tests are performed with the LAL method and
the PTS method.
The ﬁrst step is to dilute an E. coli control standard Endotoxin manually,
thereby creating a standard dilution row. The 18 tests are separated into
3 standard rows each comprising 6 concentrations (0; 0.05; 0.12; 0.25;
0.50; 1.00 EU/ml). From this point the 18 dilutions are subjected to the
LAL procedure ﬁrst (lasting about 1.5 h) and to the PTS method in the
meantime. The PTS method involves an application of 25ml of sample
to 4 wells on a slide, which is then inserted into the PTS apparatus
and the endotoxin measurement is completed within a maximum of 15
minutes. Thus the PTS system requires a minimum of hands-on time.
The measured concentrations of the dilutions in both the LAL and the
PTS method are based on optical densities.
Results: The results are viewed in table 1, which shows the endotoxin
concentration measurements from the LAL method and the PTS method.
Conclusion: When making a graph, based on the values in table 1, it is
clearly seen that the tendency with the LAL method is that the values are
unevenly increasing until the 0.50 point and then the curve decreases.
However the measurements in the PTS method are following a straight
line increasing approximately two-fold, which agrees with the manually
produced dilution rows. Thus a conclusion must be that the standard
method produces uncertain results, most likely caused by an error in
the reader device, and that the PTS system conducts more reliable, all
though systematically low, measurements.
Table 1: Endotoxin measurements from LAL method and from PTS
method
Dilution, EU/ml Row 1 Row 2 Row 3
LAL PTS LAL PTS LAL PTS
0 <min <0.01 −0.191 <0.01 <min <0.01
0.05 0.076 0.022 −0.005 0.018 −0.172 0.016
0.12 0.276 0.039 0.475 0.048 0.063 0.045
0.25 0.587 0.085 0.377 0.084 0.544 0.084
0.50 >max 0.16 0.794 0.22 0.823 0.176
1.00 >max 0.436 0.688 0.429 >max 0.423
P1404 Soluble triggering receptor expressed on myeloid cells-1
(sTREM-1) for distinguishing bacterial (Empyema) from
non-bacterial pleural effusion
H. Shaked, Y. Yuhas, S. Ashkenazi, E. Goldberg, J. Bishara
(Petah-Tiqva, IL)
Objectives: Exudative effusion is a common clinical condition among
hospitalised patients which might be secondary to infection, malignancy,
lymphatic abnormalities, and non-infectious inﬂammation. Biochemical
parameters used nowadays to distinguish bacterial from non-bacterial
pleural effusion before the results of pleural ﬂuid cultures are available,
have wide zones of overlap between the different causes of exudative
effusion. A rapid microbiologic tool is the Gram stain but its sensitivity
is low, approximately 50%. Triggering receptor expressed on myeloid
cells (TREM)-1 is a recently identiﬁed molecule that is involved in
monocytic activation and in the inﬂammatory response. Studies have
shown that TREM-1 is up regulated by microbial products in the plasma,
bronchoalveolar lavage ﬂuid, and cerebrospinal ﬂuid of patients with
sepsis, pneumonia and bacterial meningitis, respectively.
Two recent studies showed that the soluble TREM-1 (sTREM-1) levels
were signiﬁcantly higher in infectious pleural effusions compare to
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pleural effusion of other aetiology. However, in those studies sTREM-1
levels in deﬁnite empyema versus exudative pleural effusion due to other
inﬂammatory processes, such as Dressler’s syndrome were not evaluated.
We aimed to evaluate whether sTREM-1 in exudative pleural effusion
can predict a bacterial infection (pleural empyema).
Methods: Patients of all ages who present with pleural effusion were
identiﬁed through laboratory records. In addition to routine biochemical
markers, differential white blood cells, cytology, Gram stain and pleural
ﬂuid culture, pleural ﬂuid sTREM-1 was measured by ELISA using
a commercial kit (R&D Systems Minneapolis, USA). Empyema was
deﬁned as aspiration of pus, a positive Gram stain or culture results,
pH< 7.2, a glucose level <40mg/dl, and an LDH> 1000 IU/L.
Results: Thirty-eight patients were included in the study. Seven patients
had empyema, 3 – simple parapnomonic effusion, 8 – transudate, 5 –
Dressler’s syndrome, 8 – malignancy, 1 – connective tissue disease, and
6 patients had undetermined effusion. Mean levels of sTREM-1 were
signiﬁcantly higher in empyema (614 ± 184 pg/ml) compared with the
other effusions (61 ± 42 pg/ml, p =0.03).
Conclusions: Our ﬁndings suggest that sTREM-1 is up-regulated in the
pleural effusion of patients with empyema and can potentially assist
clinicians in early early differentiation of bacterial.
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P1405 Reduced transmission of animal-related ST398
meticillin-resistant Staphylococcus aureus in Dutch hospitals
M.W.M. Wassenberg, A. Troelstra, J.A.J.W. Kluytmans, M.J.M. Bonten
(Utrecht, Breda, NL)
Objectives: To determine the transmission rate of animal-related ST398
MRSA and other MRSA isolates within Dutch hospitals.
Methods: Data were collected in 51 Dutch hospitals from July 2006 to
January 2007. An index patient was deﬁned as a carrier of MRSA (not
necessarily infected) that was treated in a hospital without transmission
precautions. As part of the Dutch MRSA policy all possible contact
patients and healthcare workers (HCW) are screened for MRSA after
identiﬁcation of an index patient.
Results: During 306 months of observation, there were 80 index patients:
24 ST398 and 56 with other MRSA genotypes. Other genotypes included
typical hospital-associated genotypes, but not USA300. In 80 clinical
post-exposure surveys 2134 patients and 5758 HCWs were screened
for MRSA. ST398 MRSA carriage was found in 3 HCWs (0.3% of
all screened HCWs) as compared to 62 secondary cases with other
MRSA genotypes (0.6% of screened HCWs; 1.7% of screened contact
patients). No transmission of ST398 MRSA to screened contact patients
(n = 383) was documented. Index patients carrying ST398 MRSA had
been hospitalised shorter before isolation measures were taken than
carriers of other MRSA genotypes (median respectively 1.5 and 4 days;
p = 0.04); the number of contacts screened per day of exposure, however,
did not differ between both groups (p = 0.75). The risk of transmission
of ST398 MRSA per day of exposure was 25% of the risk of spread of
the other MRSA genotypes (95%CI = 0.08 to 0.78; p = 0.01).
Conclusion: During 306 hospital-months the risk of transmission of pig-
related ST398 MRSA was lower than that of other MRSA genotypes.
Not a single documented case of patient-to-patient spread was found.
P1406 MRSA surveillance in the Netherlands shows a different
geographical dissemination of pandemic clones and the
high diversity of the Dutch MRSA population
M. Heck, G. Pluister, M. van Luit, P. Gruteke, H. de Neeling,
W. Wannet (Bilthoven, Amsterdam, NL)
Objectives: MRSA prevalence is much higher in other European
countries than in the Netherlands. Little is known about cross-border
migration of MRSA. Although not fully unambiguous, PFGE and spa
typing allow comparison of internationally distributed strains. Here we
focus on PFGE types en spa types which are part of major international
clonal clusters, i.e. CC5, CC8, CC45 and CC80
Methods: Over the ﬁrst 11 month period of 2007 2730 unique MRSA
isolates were sent to RIVM for subtyping. All strains were characterised
by PFGE and spa typing. Isolates were labeled according to the postal
code of the laboratories which submitted the strains. Maps were created
to show the geographical distibution of strains belonging to major
international clones. Minimum Spanning Trees (MSTs) were generated
to depict the proportion of the major clones among the diverse Dutch
MRSA isolates. Simpson’s diversity indices were calculated for PFGE
and spa typing.
Results: 495 strains were characterised as PFGE and spa types which
belong to international clones. Strains belonging to CC8, CC22 and
CC80 were randomly distributed in the Netherlands. The strains which
belonged to CC45 were predominantly found in the south of the province
of Zuid-Holland and in Zeeland, Noord-Brabant and Limburg especially
in the border regions. This might indicate introduction of these strains
from cross-border regions with high MRSA prevalence. MST’s of both
PFGE and spa types showed the high diversity of the Dutch MRSA
population which was also reﬂected by the calculated diversity indices.
Conclusions: A strain known as(Dutch) PFGE type 113, spa type t038
or closely related t740 and belonging to CC45 present along southern
border region in the Netherlands has not dispersed to other parts of the
country.
Other major clones are present in all dense populated areas in the
Netherlands.
The Dutch MRSA population displays a high degree of diversity and
further reseach on the spread of speciﬁc clones is needed.
P1407 Molecular epidemiology of PFGE non-typeable meticillin-
resistant Staphylococcus aureus in the Netherlands
X.W. Huijsdens, T. Bosch, A. Haenen, M.G. van Santen-Verheuvel,
E. Spalburg, M.E.O.C. Heck, G.N. Pluister, M. van Luit,
E.W. Tiemersma, A.J. de Neeling (Bilthoven, NL)
Objectives: Recently, pigs were identiﬁed as a possible new reservoir
for community-acquired meticillin-resistant Staphylococcus aureus (CA-
MRSA). These pig-related MRSA strains can easily be identiﬁed by
pulsed-ﬁeld gel electrophoresis (PFGE). In PFGE, no banding pattern
is obtained, due to methylation of the SmaI site, and was from then on
referred to as non-typeable (NT)-MRSA. From 2003 to 2007 the number
of NT-MRSA was increasing rapidly and pig-to-human transmission had
occurred.
The present study gives an overview of the NT-MRSA in the Netherlands
in 2007, the characteristics of the NT-MRSA and the clonal structure of
these strains. The data will show the importance of this relatively new
CA-MRSA strain.
Methods: In the Netherlands, the National Institute of Public Health
and the Environment (RIVM) serves as the national reference centre for
surveillance of MRSA. All ﬁrst MRSA isolates, one per patient, are sent
to the RIVM for PFGE typing. From this MRSA database all NT-MRSA
isolates of 2007 were used for further characterisation.
Molecular typing included staphylococcal protein A (spa) typing,
staphylococcal cassette chromosome mec (SCCmec) typing, and
multilocus sequence typing (MLST).
Results: Up till November 2007, a total of 535 MRSA isolates were non-
typeable by PFGE. Spa typing revealed 24 different spa types. Most of
the spa types were closely related, indicating a clonal complex. The two
most prevalent spa types were t011 and t108. All NT-MRSA belonged
to SCCmec type IV or V and were ST398.
Conclusion: In 2007 approximately 30% of all MRSA isolates were
non-typeable. This new CA-MRSA of zoonotic origin appears to spread
rapidly, not only in the Netherlands but also in Europe. In the Netherlands
MRSA guidelines are changed due to this new strain.
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P1408 Molecular characterisation of meticillin-sensitive
Staphylococcus aureus bloodstream isolates in a Dutch
university hospital between 1999 and 2006
E. Nulens, E.E. Stobberingh, H. van Dessel, S. Sebastian, P.S. Beisser,
F.H. van Tiel, R.H. Deurenberg (Bruges, BE; Maastricht, NL)
Objectives: It is suggested that meticillin-resistant Staphylococcus
aureus (MRSA) originated through the transfer of the mobile resistant
determinant staphylococcal cassette chromosome mec (SCCmec) into
meticillin-susceptible S. aureus (MSSA), and that the genetic background
determines the stability of MRSA. To support this hypothesis, MSSA
bloodstream isolates (BSI) in our hospital were characterised and the
genetic background of the MSSA clones compared to endemic MRSA
clones.
Methods: A random selection of MSSA BSI (n = 380), isolated between
1999 and 2006 in the University Hospital Maastricht (azM), were
characterised with spa typing and the algorithm based upon repeat pattern
(BURP). Furthermore, the prevalence of the virulence factors collagen
adhesion (CNA), Panton-Valentine leukocidin (PVL) and toxic shock
syndrome toxin 1 (TSST-1) was investigated.
Results: Up to 50% of the MSSA isolates had a genetic background
common to the endemic MRSA clones, e.g. clonal complex (CC) 1, CC5.
CC8, CC22, CC30, and CC45. Furthermore, several CCs not related to
the endemic MRSA clones, such as CC7 and CC15 (12% and 7% of
the isolates respectively), were observed. CNA, PVL and TSST-1 was
observed in 42%, 2%, and 15% of the isolates respectively. CNA was
associated with CC1, CC12, CC22, CC30, CC45, and CC121, while
TSST-1 was associated with CC30.
Conclusion:
1. Half of the MSSA isolates had a genetic background common to
endemic MRSA clones.
2. Several MSSA lineages, such as CC7 and CC15, were prevalent in
our hospital.
3. The prevalence of MSSA clones with genetic backgrounds both
common and uncommon to MRSA clones, supports the observation
that SCCmec is more stable in certain S. aureus genetic backgrounds.
4. Although endemic MRSA clones could originated through the transfer
of SCCmec into MSSA, it seems more likely that MRSA clones have
been imported from abroad, rather than originated in The Netherlands.
P1409 Diversity of the virulence and genomic backgrounds in
clinical isolates of Staphylococcus aureus collected in a
Spanish hospital 1992 to 2006
M.A. Argudin, M.C. Mendoza, F. Vazquez, M.C. Martin, M.R. Rodicio
(Oviedo, Villaviciosa, ES)
Staphylococcus aureus is an important human pathogen. The major
virulence factors involved in pathogenesis are controlled by the agr
(accessory gene regulator) quorum-sensing system. In this work, we
studied the relationship between virulence (V) and genetic backgrounds
of 30 non-invasive and 31 invasive isolates recovered in the Monte
Naranco Hospital (Asturias, Spain) over 1992 to 2006. All isolates
were typed by SmaI macrorestriction-PFGE followed by UPGMA-cluster
analysis, and the V-gene proﬁle was determined by PCR with primers
speciﬁc for toxins and agr genes. In meticillin resistant isolates, the type
of SSCmec was also identiﬁed.
The 61 isolates displayed 42 PFGE proﬁles, falling into 8 clusters and
11 branches, at S=0.6. One major cluster (15 SmaI-proﬁles including
25 invasive isolates) and 7 minor clusters (6 with non-invasive, and
one with invasive isolates) were revealed. i) All isolates were positive
for the hemolysin hla and hld genes and the leukotoxin lukED gene.
The prevalent proﬁle was hla-hlb-hld-hlg-hlg-variant (92%) with lukPV
(26%). ii) 92% of the isolates were also positive for exfoliative toxins
genes (et). The prevalent was etb, which appeared either alone (41%) or
in combination with eta (20%), etd (26%) or both (5%). iii) 29.5% was
positive for tst, present only in invasive isolates and frequently associated
to agr group III. iv) 98% was positive for classic enterotoxin genes (se),
all of them carrying the enterotoxin gene cluster (egc), in addition to
other se-genes. Statistically signiﬁcant differences between invasive and
non-invasive isolates were: sea (45% vs. 93%), seb (6.5% vs. 47%), sec
(87% vs. 50%), see (0% vs. 13%), and seu (55% vs. 0%). Regarding
the agr type, invasive isolates carried agr group III (35%), while 20%
of non-invasive isolates were positive for both agr group I and II (and
possibly carried an agr-hybrid). Among the meticillin-resistant isolates,
71.4% within the invasive group contained SSCmec IVc, while the non-
invasive group carried SSCmec I, SSCmec III or recombinant derivatives.
In summary, S. aureus causing invasive and non-invasive diseases in a
Spanish Hospital were distributed in different genomic types. Despite of
important differences in the genetic background, isolates of both groups
are in possession of a very high number of common virulence factors.
However, genes encoding potent virulence factors (lukPV, eta and tst)
were more frequently found in the invasive isolates.
P1410 Emergence of a multi-resistant genotype of meticillin-
resistant Staphylococcus aureus in a university hospital in
Barcelona
M.A. Dominguez, V. Mick, F. Tubau, M. Pujol, J. Linares, R. Martin
(Barcelona, ES)
Objectives: Meticillin-resistant S.aureus (MRSA) has been endemic in
Hospital Universitari de Bellvitge (HUB) since 1990. The majority of
strains isolated during the 1990–95 period belonged to the multiresistant
Iberian clone (ST-247; SCCmec-I). However, isolates of Clonal Complex
125 (ST-125; SCCmec-IV), close related to the Paediatric clone,
were dominant from 1996 to 2003. MRSA isolates resistant to
erythromycin, clindamycin, gentamicin, tobramycin, ciproﬂoxacin and
showing decreased susceptibility to rifampin (DS-Rif) were ﬁrst detected
in 2004. These DS-Rif-MRSA isolates increased steadily from 20%
(57/282) in 2004 to 45% (116/256) in 2006. The aims of this study
were: the molecular characterisation of these multiresistant strains and
the analysis of the mutations involved in Rif resistance.
Methods: A selection of non-duplicate DS-Rif-MRSA clinical isolates
(n = 308) collected from HUB between 2004 and 2006 were studied.
Susceptibility to Rif was performed by the disk-diffusion method and
MICs were studied by E-test. The Rif resistance-associated mutations
in the gene rpoB encoding the RNA polymerase beta-subunit were
analysed. Genotyping was performed by PFGE, spa typing, SCCmec
and MLST (ST).
Results: 104 strains had intermediate resistance to Rif by disk-diffusion
method and 4 were resistant. In the Rif-intermediate group, 13 isolates
were susceptible by E-test (MICs 0.75−1mg/L) according to CLSI
criteria. All 108 isolates presented the mutation His481/Asn conferring
low-level Rif resistance. Four isolates with MIC >32mg/L had an
additional mutation Glc468/Lys, Ala477/Thr, or Ile527/Leu, responsible
of high level Rif resistance. The 108 isolates belonged to a single PFGE
pattern, carried SCCmec type I, ST-228 and a spa type t041.
Conclusion: A multiresistant MRSA clone (ST-228; SCCmec-I), related
to the Southern Germany clone, emerged in our hospital in 2004 and
currently represents half of the MRSA in our institution. This clone has
been reported in other hospitals in Spain since 1996, as well as in other
European countries, however none of these reports had informed of the
decreased susceptibility to Rif. The majority of strains isolated in our
institution showed a single mutation in the rpoB gene, conferring low-
level Rif resistance. One tenth of these isolates were misclassiﬁed as Rif
susceptible by CLSI criteria.
P1411 Molecular epidemiology of meticillin-resistant
Staphylococcus aureus in Santander, Spain
M.E. Cano, L. Martı´nez-Martı´nez (Santander, ES)
Objective: To analyse the molecular epidemiology and susceptibility
of meticillin-resistant Staphylococcus aureus (MRSA) in our area
(Santander, Spain) in the period January 04-December 06.
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Methods: In the study period, 1431 MRSA were isolated from
clinical samples of 525 patients. After identiﬁcation and susceptibility
testing, pulsed-ﬁeld gel electrophoresis (PFGE) and staphylococcal
chromosomal cassette mec (SCCmec) typing were performed on 755
isolates, corresponding to the ﬁrst isolate from each patient (including
isolates from different wards or with different resistance phenotype from
the same patient). Multilocus sequence typing (MLST) was performed
on representative isolates from each PFGE type. Finally, 572 isolates
(one isolate per patient, PFGE pattern and resistance phenotype) were
selected for data evaluation. We compared data taking into account if
patients were or were not hospitalised at the moment of MRSA isolation.
Results: We have identiﬁed the following clones: 74.6% of ST125-
MRSA-IV (45.0% for admitted patients and 55.0% for non-admitted
patients), 15.2% of ST5-MRSA-IV (46.0% and 54.0%), 3.7% of
ST8-MRSA-IV (33.3% and 66.7%), 3.5% of ST228-MRSA-I (70.0%
and 30.0%) and other 3.0% of minority clones including: ST22-
MRSA-IV, ST247-MRSA-I, ST398-MRSA-IV, ST125-MRSA-V, ST36-
MRSA-II and two new ones with non-described mutations. We found
a proportional distribution of the main clones over the three year
period. All isolates were susceptible to vancomycin. The percentages
of susceptibility for the main clones to ciproﬂoxacin, erythromycin,
clindamycin and gentamicin were as follows: ST125-MRSA-IV (0.2%;
17.1%; 73.2% and 60.1%), ST5-MRSA-IV (0%; 71.3%; 90.8% and
73.6%), ST8-MRSA-IV (57.1%; 85.7%; 100% and 100%) and ST228-
MRSA-I (0%; 5%; 10% and 0%).
Conclusions: There are 4 main clones in our area that have been
maintained over the study period. These clones were observed among
both hospitalised and not hospitalised patients.
P1412 Molecular characterisation of Panton-Valentine leukocidin
positive Staphylococcus aureus invasive isolates in Spain
M. Pe´rez-Va´zquez, A. Vindel, C. Marcos, J. Oteo, O. Cuevas, P. Trincado,
V. Bautista, J. Campos on behalf of the EARSS Spain spa-typing Group
Objectives: Panton-Valentine leukocidin (PVL) is a Staphylococcus
aureus exotoxin associated with skin and soft-tissue infections and
severe necrotising pneumonia. The aim of this study was to determine
the prevalence of PVL+ S. aureus isolates from blood cultures in
selected Spanish hospitals and to characterise these isolates by molecular
methods.
Methods: Twenty-one Spanish hospitals participated in a multicentre
study (September 2006 to February 2007) collecting the ﬁrst ﬁve
successive meticillin-susceptible S. aureus (MSSA) and meticillin-
resistant S. aureus (MRSA) isolated from patients with invasive
infections. The antimicrobial susceptibility was determined by the disk-
difussion and microdilution methods according to the CLSI guidelines.
PVL detection was performed by PCR following the method of Lina.
Several multiplex PCR were used for to determine the SCCmec types
and the agr-types. All isolates were genotyped by PFGE after digestion
of chromosomal DNA with SmaI. MLST and spa-typing were also
performed.
Results: A total of 203 unduplicated S. aureus isolates (90 MRSA and
113 MSSA) were collected. Of these, 42 isolates (20.7%) were PVL+
(only one MRSA). The unique PVL+ MRSA isolate was resistant to
oxacillin only, SCCmec type IV, agr group I, spa-type t032 (singleton),
ST8 and showed a PFGE proﬁle closely related to the community-
acquired MRSA (type A). The molecular markers in the PVL+ MSSA
isolates were as follows: agr-type I, 36.6%; II, 56.1%; III, 4.9% and
IV, 2.4%; MLST-types ST5, 29.3%; ST15, 19.5%; ST25, 12.2%; ST8,
9.8%; ST121, 4.9%; 2.4% each type ST1, ST12, ST26, ST125, ST188
and ST789; 4 strains, 9.8% had new types; spa-types t002, 17.1%; t067,
9.8%; 7.3% each type t008 and t084; 4.9% each type t078, t148 and t346;
16 strains, 38.4% with several spa-types; in 2 strains the spa-type could
not be determined. PFGE analysis showed 8 clones including 87.8% of
PVL+ MSSA, and 5 sporadic strains.
Conclusions: The prevalence of PVL+ in MSSA invasive strains was
very high in Spain (37.1%), but not in MRSA (1.1%). A half of these
PVL+ MSSA isolates were MLST types ST5 or ST15 and a quarter were
t002 or t067 spa-types; these MLST- and spa-types were also present in
Spanish PVL− MRSA. Surveillance studies are necessary for the control
of PVL+ S. aureus invasive strains.
P1413 Community-acquired meticillin-resistant Staphylococcus
aureus in a reference childrens’ hospital in Spain
M. Urrea-Ayala, M. Rodrı´guez-Plata, C. Mun˜oz-Almagro
(Barcelona, ES)
Objectives: Community-acquired meticillin-resistant Staphylococcus
aureus (CA-MRSA) infection is an emerging health problem in children
and adults. The objectives were (1) to assess if paediatric CA-MRSA
infections are increasing in Barcelona, Spain, (2) to characterise the
clinical manifestations associated with CA-MRSA infections comparing
with hospital-acquired infections MRSA (HA-MRSA), (3) To identify
the presence of risk factors in children with CA-MRSA infections.
Methods: A retrospective study included all children patients (<18
years) attended at the Sant Joan de De´u Hospital during the period
2001–2006, with positive culture for MRSA. MRSA were identiﬁed by
standard microbiological methods. MIC determinations were performed
for oxacillin and other antimicrobials by using Microscan Walkaway
instrument. HA-MRSA was deﬁned as one isolated from a specimen
obtained beyond 72 hours of admission. Isolated rates were calculated
as incidence infection per 100,000 populations.
Results: During the study period we identiﬁed 85 isolated for MRSA
in 77 patients (52% boys, 48% girls) with mean age 6.5 years (SD
6.1). Of the total patients included, 66.2% (51) was CA-MRSA and
33.8% (26) was HA-MRSA. CA-MRSA infection increased from 13
infected patients during 2001–2003 to 38 infected patients during
2004–2006. Comparing the two-study period, the rates of CA-MRSA
increased from 2.4 to 6.1 episodes/100,000 children <18 years (an
increase of 155%, 95%CI 36%-379%; p = 0.002). Abscess predominated
in CA-MRSA patients (82.3%) and surgery wound infection in children
with hospital-acquired infections (27%), (p< 0.001). Among CA-MRSA
patients, only 19.6% presented risk factors vs. 84.6% in HCA-
MRSA group (p< 0.001). Community acquired-pneumonia (4.0%) was
presented in patients with chronic neurological diseases, whereas hospital
acquired-pneumonia (23%) affected in patients with prematurity and
immunosuppression.
Conclusion: The appearance and spread of CA-MRSA represent a new
challenge in paediatric patients and have important clinical implications
for therapy of infections caused by S. aureus. A high level of clinical
suspicion and development of rapid diagnostic methods are matters to
be solved in the future.
P1414 Molecular characterisation of resistance to mupirocin
in meticillin-resistant Staphylococcus aureus isolates in a
tertiary hospital in Spain
M. Daskalaki, J.R. Otero, F. Chaves (Madrid, ES)
Objectives: Mupirocin(Mup) resistance appears either by a mutation,
leading to low level resistance to mupirocin (LMupR), or as a result
of the gene (ileS2) located in a plasmid and expressing high level
resistance to mupirocin (HMupR). The aim of study was to determine
the prevalence of MupR in meticillin resistant S. aureus (MRSA)
in our institution, and to compare the epidemiologic and molecular
characteristics between the MupR and MupS MRSA isolates.
Methods: We conducted a retrospective study between Jan and Dec
2006. All isolates were screened for resistance to Mup on Mueller-
Hinton agar with a 5 mg disk. MupR isolates underwent MIC analysis
by the Etest strip method. PCR detection of the genes mecA and ileS2
was performed. MupR and MupS isolates were typed by Pulsed Field
Gel Electrophoresis (PFGE) following DNA extraction and digestion
with SmaI, multilocus sequence typing (MLST) and (SCC)mec typing.
The clinical charts of all patients were revised and clinical and
epidemiological data were collected.
Results: Of the 207 MRSA isolates available for testing 23 (11.1%)
were resistant to mupirocin. We found 18 isolates (8.7%) with HMupR
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(MIC> 256mg/L) and 5 (2.4%) with LMupR (MIC= 8–256mg/L). In
all isolates with HMupR the ileS2gene was detected by PCR. No
isolate with LMupR had this gene. Gentamycin was more frequent
(66.7%vs 13.2% p< 0.001) in the group of the MupR isolates. The rest
of antibiotics had similar resistance patterns in both of the detected
groups. Regarding epidemiological and clinical characteristics between
MupR and MupS MRSA isolates we did not observe any signiﬁcant
difference. Molecular analysis of the MupR isolates revealed that 15
(83.3%) belonged to ST125-IV, 2 isolates belonged to ST228-I and only
one belonged to ST45-IV. In the MupS isolates, the ST distribution was
similar to the MupR group, except for the ST8-IV presented only in
the MupS isolates. All the LMupR isolates belonged to only one clone
ST228-I.
Conclusions: Although the rate of HMupR isolates has not signiﬁcally
progressed since our last study in 2001, it is important to monitorise the
high resistance to mupirocin, because the transmission of MupR-MRSA
strains and the horizontal plasmid transfer can contribute to increase the
resistance to mupirocin in our institution.
P1415 Meticillin-resistant Staphylococcus aureus with exoﬁative
toxin A in England and Wales during 2006–2007
A.M. Kearns, M. Ganner, C. East, I. McCormick Smith, M. Warner,
M.J. Ellington (London, UK)
Objectives: Exfoliative toxin A (ETA) is associated with staphylococcal
scalded skin syndrome (SSSS) and bullous impetigo. Symptoms include
skin lesions, widespread erythema and exfoliation. Traditionally ETA has
been associated with ‘skin associated’ phage group II MSSA isolates.
More recently community strains of MRSA positive for ETA have been
reported in Switzerland and Japan. We sought to characterise CA-MRSA
with ETA identiﬁed at the England and Wales Staphylococcal Reference
Laboratory (SRL).
Methods: Putative CA-MRSA isolates referred to SRL in 2006−7 were
tested by PCR for the presence of toxin genes, including ETA. ETA
positive isolates were characterised by spa typing and SmaI PFGE. PCRs
detected: mecA and the SCCmec cassette type, ccr type and agr allotype.
MICs of a range of antibiotics were determined. Patient demographic and
clinical data were retained for analysis.
Results: Eighteen ETA-MRSA were detected during 2006−7. Eight
patients were male, 8 were female. Ages ranged from 0–90 years (mode =
0 y, median = 30 y), three patients were >60 y, 6 were <10 y, two isolates
had no patient information. Two patients were community-based, four
isolates occurred in two centres, the remainder occurred sporadically.
Eight isolates were from skin swabs, four from wound swabs, one
each from; a screening swab, sputum, abscess, eye infection and an
undisclosed source. Seven isolates were CC88-SCCmecIV and related
by spa typing; two of these were multi-resistant and one encoded PVL
in addition to ETA. A further eight isolates were CC5-SCCmecIV, were
related by spa typing and encoded various staphylococcal enterotoxins
in addition to ETA; one was multi-resistant. Two isolates were CC45-
SCCmecIV, one of which was multi-resistant. The remaining isolate was
CC121-SCCmecIV and positive for ETB in addition to ETA.
Conclusion: The data show multiple lineages of ETA-positive CA-
MRSA have been identiﬁed in the UK. Their ability to cause skin disease,
notably in young individuals and evidence of association with PVL
demand increased vigilance. This early alert will assist in the monitoring
of these new strain types as they occur.
P1416 Characterisation of community and hospital-associated
Staphylococcus aureus isolates in Southampton
S. Green, P. Marsh, N. Ahmad, J. Jeffries, S. Clarke (Southampton, UK)
Objectives: Meticillin-sensitive S.aureus (MSSA) can acquire the
meticillin resistance determinant mecA, in a mobile genetic element
known as the staphylococcal cassette chromosome-mec (SCCmec),
giving rise to meticillin resistant S.aureus (MRSA). Community-
associated (CA)-MRSA strains appear to contain the smaller, more
mobile versions of the cassette such as SCCmec IV and V, and
some strains may produce Panton-Valentine leukocidin (PVL). We
used molecular typing to characterise hospital (HA) and community-
associated (CA) S.aureus isolates circulating in Southampton, UK and
to investigate the spread of PVL and SCCmec types IV and V.
Methods: We examined 71 CA and HA-MRSA/MSSA isolates
(Southampton General Hospital in-patients and patients recently admitted
or community healthcentre attendees). Isolates were typed by pulsed-ﬁeld
gel electrophoresis (PFGE), sequence types (STs) identiﬁed by multi-
locus sequence typing and PCR used to determine SCCmec type and
detect lukFS for PVL.
Results: Fifteen PVL positive isolates were identiﬁed, ten of which were
MRSA that contained SCCmec IV. Seven of these were ST 30. Of the
ﬁfteen PVL positive strains, seven were community-associated, four of
which were MRSA. Predominant STs were 22 and 30. Amongst ST 22
(n = 38), 12 were conﬁrmed as MRSA, all were PVL negative, and 15
were hospital-associated. Amongst ST 30 (n = 3), 7 were conﬁrmed as
MRSA, all of which were PVL positive, and 5 of which were hospital-
associated. The predominant PFGE type was EMRSA-15 and related
subtypes. For both ST 22 and 30, there was no correlation between site
of acquisition and meticillin-resistance.
Conclusions: Our studies reveal the presence of the mobile mecA-
determinant SCCmec IV in CA- and HA-MRSA isolates some of
which are also PVL positive. SCCmec V was present in two HA-
MRSA isolates. The additional presence of PVL positive MSSA in
community and hospital-derived isolates suggests a risk of gene transfer
from SCCmec IV MRSA to PVL positive MSSA.
P1417 Dissemination of a new CA-MRSA strain in the UK
M.J. Ellington, M. Ganner, I. McCormick Smith, M. Warner,
A.M. Kearns (London, UK)
Objective: Recently we detected a new CA-MRSA strain (ST97-MRSA-
SCCmecV) which can harbour two copies of the arcA locus. The
additional arcA locus is associated with the Arginine Catabolic Mobile
Element (ACME) suggested as a putative virulence or ﬁtness factor in
USA300–0114. We sought to determine the dissemination of this new
ST97-MRSA-SCCmecV strain in England and Wales.
Methods: All putative CA-MRSA isolates referred to the national
staphylococcus reference laboratory in 2005−7 were tested by PCR
for the presence of toxin genes. Isolates positive for staphylococcal
enterotoxins D and J only were tested for spa type, SCCmec type, ccr
type and ACME-arcA. MICs of a range of antibiotics were determined
and SmaI PFGE performed. Patient demographic and clinical data were
collated.
Results: Fourteen SCCmecV MRSA with ACME-arcA and staphylococ-
cal enterotoxins D and J were detected. The isolates occurred in three
geographically distinct centres in patients with an age range 61–93 years
(median 81 years, mode 89 years). Data were available for seven of the
fourteen isolates and indicated all seven were associated with skin and
soft tissue infection. The fourteen isolates were closely related by PFGE
(2 band changes) and by spa typing (t359 and t267). All were agr 1,
harboured SCCmecV and ccrC. The isolates were resistant to b-lactams,
and had variable resistance to erythromycin, ciproﬂoxacin, clindamycin
and/or trimethoprim.
Conclusions: This new strain type was identiﬁed in elderly patients in
multiple diverse locations in the UK, and was strongly associated with
sporadic skin and soft tissue infections. This strain type can be multi-
resistant and encodes a factor possibly associated with skin survival or
transmissibility and requires increased vigilance.
P1418 EARRS-SEQNET surveillance of S. aureus associated with
bacteraemia in the UK during 2006
M.J. Ellington, M. Lillie, I. McCormick Smith, M. Warner, M. Ganner,
B.D. Cookson, R.L. Hill, A.P. Johnson, A.M. Kearns (London, UK)
Objectives: Systematic data regarding the molecular epidemiology of
S. aureus in the UK are limited. However, studies from the late 1990s
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indicated that EMRSA-15 and 16 dominated the bacteraemia-associated-
MRSA landscape in the UK. Through the EARRS-SEQNET initiative
we aimed to assess the molecular epidemiology of MRSA and MSSA
associated with bacteraemia in the UK in 2006.
Methods: Up to ten successive MSSA and MRSA isolates from different
patients were collected from 12 participating laboratories in England,
Wales and Northern Ireland from September 2006. S. aureus were
characterised by phage typing, PCR for mecA, lukSF-PV and spa, and
sequencing of spa amplicons. MICs of a wide range of antibiotics were
determined. Patient demographic and clinical data were retained for
analysis.
Results: 111 S. aureus blood isolates were included for study. For
patients with MRSA, ages ranged from 25 to 92 years (mode=79y,
median = 30y); 66% were male; 29% were community-based; and 24%
died within 14 days of specimen date. For patients with MSSA, ages
ranged from 0 to 95 years (mode=0y, median = 30y); 53% were male;
58% were community-based; and 8% died within 14 days of specimen
date. EMRSA-15 accounted for 94% of the 53 MRSA isolates, 90% of
MRSA isolates tested resistant to ciproﬂoxacin; none tested resistant to
glycopeptides or linezolid. Amongst these, t032 was the most frequent
spa type (34/53 MRSA), various other spa types along with phage typing
indicated a further 16 isolates to be E-15. One EMRSA-16 (t018) was
identiﬁed; the two remaining MRSA were t127. Amongst the 58 MSSA,
over 40 different spa types were identiﬁed. Two MSSA isolates with
unrelated spa types (t2663 & t2864) encoded PVL.
Conclusion: Differences in key demographic data were identiﬁed
between MSSA and MRSA cases. EMRSA-15 (CC22) remains the
predominant MRSA associated with bacteraemia in the UK, the MSSA
are more diverse genotypically, including representatives of 5 major
clonal complexes (CC1, 5, 8, 22 and 30).
P1419 Absence of MRSA in clinical mastitis samples recovered
from dairy cattle across England and Wales
M. Sharma, N. Coldham, J. Rogers, M. Ganner, A. Kearns, C. Teale
(Surrey, London, UK)
Objective: Meticillin resistant Staphylococcus aureus (MRSA) is a
major cause of healthcare associated infection and is under investigation
as a zoonotic pathogen. The current study was conducted to determine
the prevalence of MRSA in dairy cattle across England and Wales. In
addition, the presence of toxin genes and susceptibility to other clinically
important antimicrobials were investigated.
Method: S. aureus isolates (n = 300) were recovered from mastitic
milk samples, and screened by a duplex PCR for the species-speciﬁc
nucA gene and the meticillin resistance gene, mecA. Plate dilution and
disc diffusion susceptibility testing was performed against 10 clinically
important antimicrobials. 250 strains were selected for PFGE-SmaI
characterisation on the basis of antibiogram and geographical data.
Of these, 100 isolates with distinct PFGE and/or antibiograms were
examined by multiplex PCR for the presence of 14 genes encoding
staphylococcal toxins (namely, enterotoxin A-E and G-J, exfoliative
toxins A, B and D, toxic shock syndrome toxin-1 and Panton Valentine
Leukocidin toxin).
Results: All 900 isolates were nucA positive and mecA negative. Antimi-
crobial sensitivity data showed 412 isolates (46%) were resistant to 1
antibiotics. The most common resistance was against penicillin (96.1%).
Resistance to remaining antimicrobials was as follows; ciproﬂoxacin
(10.7%), oxacillin (6.1%), erythromycin (4.9%), amoxicillin/clavulanate
(2.2%), cefoxitin (2.7%), tetracycline (4.4%) and gentamicin (1%).
PFGE analysis demonstrated 47% identity amongst the 250 strains.
Toxin characterisation revealed 43% of isolates possess at least one
toxin. Staphylococcal enterotoxins and TSST-1 were detected as follows;
13.2% (sec), 1.4% (sed), 27.9% (seg), 27.9% (sei), 1.4% (sej) and 14.7%
(tst). All isolates were negative for PVL and exfoliative genes (eta, etb
and etd).
Conclusion: The ﬁndings from this study suggest dairy cattle are not
reservoirs of MRSA and associated PVL toxin across England and
Wales. Dairy cattle could be a potential reservoir of TSST-1 and
enterotoxins but not exfoliative toxins. Resistance to penicillin was
found to be high, this has been shown in many similar animal studies
and relates to the widespread usage of penicillin. There is a need for
continued surveillance of other farmed livestock to understand origins
and epidemiology of MRSA in the UK.
P1420 Community-associated meticillin-resistant Staphylococcus
aureus (CA-MRSA) in southeastern Austria: distribution
to spa-types and ﬁrst occurrence of USA300
G. Zarfel, A.J. Grisold, M. Hoenigl, G. Feierl, E. Leitner, A. Badura,
L. Masoud, U. Wagner, E. Marth (Graz, AT)
Objective: Infections due to community associated Staphylococcus
aureus (CA-MRSA) are a recent worldwide phenomenon. To estimate
the prevalence of CA-MRSA in Austria, determination of the Panton-
valentine leukocidin (PVL) and spa-typing of the CA-MRSA was
performed, followed by a synopsis of the clinical features in the affected
patients.
Methods: A total of 2484 non-duplicated S. aureus strains, isolated
in 2005 at the Institute of Hygiene, Medical University Graz, Austria,
were investigated. The isolates were characterised by routine laboratory
standard methods and the resistance pattern according to the CLSI
guidelines was determined. Additionally polymerase chain reaction tests
for S. aureus-speciﬁc genes, the mecA gene and the Panton-Valentine
leukocidin (PVL) gene were performed. Spa Typing was used for
characterisation of the CA-MRSA strains and the detected spa types
were compared with spa databases.
Results: 84 (3.4%) out of the 2484 S. aureus isolates were identiﬁed
as MRSA, while 13 (16.0%) out of these 84 MRSA strains were
identiﬁed as CA-MRSA, with a positive reaction in the PCR for the PVL-
gene. Patients with CA-MRSA had no risk factors for colonisation by
healthcare associated MRSA (HA-MRSA), such as recent hospitalisation
and/or contact with healthcare workers. All PVL-positive CA-MRSA
strains were non-multiresistant – in addition to the resistance to oxacillin
these CA-MRSA strains exhibited resistance only to the following
antibiotics: Resistance to fusidic acid, tetracycline and erythromycin was
found in 46% of the strains each, ciproﬂoxacin in 31% and gentamicin
in 8% of the strains.
Spa typing showed 5 different Spa types: t004 (5 strains/ CA-MRSA
widely disseminated in Europe), t008 (4 strains/ Northern German
MRSA, USA300), t622 (2 strains), t001 (1 strain/ Southern German
MRSA) and t355 (1 strain).
Clinical features of the CA-MRSA patients were superﬁcial to deep
soft tissue abscess formation with single up to multiple abscesses. After
surgical intervention and antibiotic therapy all patients recovered without
sequelae. Pneumonia could not be observed in any case.
Conclusions: In 2005 16% of MRSA primary-isolates were identiﬁed
as CA-MRSA, which indicates that CA-MRSA spread more and more
into the community in patients in Southeast Austria. Distribution to spa
types shows a tendency of the CA-MRSA to well described European
CA-MRSA strains, and for the ﬁrst time the occurrence of USA300 in
Southeast Austria is could be observed.
P1421 Close links between nosocomial MRSA and carriage MSSA
isolates from the same location in Switzerland
O. Sakwinska, P. Francioli, G. Kuhn, P. Moreillon, D.S. Blanc
(Lausanne, CH)
Staphylococcus aureus is a notorious nosocomial pathogen but it also
harmlessly colonises a large fraction of healthy human population.
Studies which simultaneously survey both carriage strains from healthy
carriers and hospital-associated MRSA are rare. Such studies are,
however, necessary to better understand evolution of this pathogen, and
in particular MRSA. Resistance to meticillin in MRSA is conferred by
the mecA gene situated on a mobile genetic element called SCCmec. It
has been assumed that acquisitions of SCCmec by MSSA are relatively
rare.
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The nasal swabs were collected from 405 newly employed hospital
personnel during their ﬁrst medical check-up at the tertiary care hospital
in Lausanne between October 2005 and July 2006. During 2005 and
2006, 1386 MRSA isolates from hospitalised patients of the same region
were analysed. All isolates were typed by DLST, a newly developed,
high resolution method based on sequencing of partial repeats sequences
of clfB and spa. In addition, carriage MSSA isolates were typed with
MLST.
130 out of 405 (32%) hospital employees were S. aureus carriers. Typing
with DLST allowed distinguishing 115 unique DLST types and only 37
MLST types showing that DLST has superior resolution in comparison
to MLST. Genetic diversity among carriage strains was extremely high,
with majority of carriers colonised with a unique strain. In contrast,
among hospital MRSA isolates nearly 50% were of a single DLST type.
To our surprise, all locally predominant clones of MRSA were very
closely related (single locus DLST type) to the MSSA counterparts
encountered in carriers. What is more, the carriage isolates closely
related to epidemic MRSA clones were also the most abundant ones.
It appears that the same genotypes make the most efﬁcient colonisers as
well as the most successful epidemic clones. This strongly indicates
that epidemic behaviour of these strains is inherent to their genetic
background independently of acquisition of resistance determinants.
P1422 Regional variation and temporal trends of Meticillin-
resistant Staphylococcus aureus using the Sentinel Surveil-
lance of Antibiotic Resistance in Switzerland (SEARCH)
W.C. Albrich, A. Kronenberg, K. Mu¨hlemann for the Sentinel
Surveillance of Antibiotic Resistance in Switzerland (SEARCH)
Objectives: The epidemiology of Meticillin-resistant Staphylococcus
aureus (MRSA) shows large geographic variations. Recently, a
comprehensive national antibiotic resistance database covering in- and
outpatients became available in Switzerland.
Methods: We used a laboratory-based active surveillance system
(SEARCH, www.search.iﬁk.unibe.ch) of in- and outpatients in Switzer-
land with S. aureus isolated from any source to analyse regional and
temporal trends in the epidemiology of MRSA.
Results: The proportion of meticillin-resistance in S. aureus was highest
for long-term facilities (26.2%), followed by general hospital wards
(7.4%) and Intensive Care Units (5.4%) and lowest in outpatients (3.5%)
(p< 0.05 for each comparison). MRSA was more frequent in males than
females (RR 1.19; p< 0.001) and increased with older age (p for trend
<0.001). Meticillin-resistance tended to increase since 2004 from 6.2%
to 6.6% in 2007 (p for trend 0.06) with signiﬁcant increases over time
in the proportion of MRSA within most age groups and for females
(from 5.3% in 2004 to 6.2% in 2007; p for trend <0.001) but not
for males. The proportion of MRSA among S. aureus from general
practitioners and long-term facilities tended to increase since 2004,
whereas no change was evident for hospital isolates. Marked geographic
variations were observed with highest proportions of MRSA in the
South (17.1%), followed by the West of Switzerland (10.4%) and lowest
proportions in Central (3.9%) and Eastern Switzerland (3.8%). While
there was a signiﬁcant increase in the East (3.2% in 2004, 4.0% in 2007;
p for trend 0.04), elsewhere prevalence remained stable (Central) or
showed a non-signiﬁcant increase (West: 8.9% in 2004, 10.7% in 2007)
or decrease (South: 18.1% in 2004, 15.9% in 2007). Cotrimoxazole
(3.8%) and tetracycline resistance (7.9%) in MRSA remained low in
2007, while 43%, 66% and 74% were resistant against clindamycin,
erythromycin and ciproﬂoxacin, respectively. Resistance rates of MRSA
against clindamycin and ciproﬂoxacin decreased signiﬁcantly since 2004.
Temporal resistance trends for individual antibiotics varied markedly
across regions. There was a trend towards an increase of non-multidrug
resistant MRSA since 2004 (p for trend 0.09). The risk of MRSA was
slightly higher during the cold season than in warmer months (RR 1.05;
p 0.04).
Conclusion: MRSA prevalence remains low in Switzerland but both
prevalence and temporal trends differ widely across regions.
P1423 Molecular characterisation of community- and
hospital-acquired meticillin-resistant Staphylococcus aureus
E. Borghi, M. Cainarca, C. Grimaldi, R. Baccalini, M. Lafrancesca,
G. Scelza, G. Morace (Milan, IT)
Objectives: The aim of this work was to investigate the presence of
the Panton-Valentine leukocidin (PVL) gene in Community-Acquired
Meticillin-Resistant Staphylococcus aureus (CA-MRSA) collected from
outpatients in the San Paolo Hospital of Milan from April 2006 to
July 2007. Those isolates were also investigated for their SCCmec
mobile generic element, coding for meticillin resistance. For comparative
purposes we included in this study a matching number of Hospital-
Acquired Meticillin-Resistant Staphylococcus aureus (HA-MRSA).
Methods: We collected twenty six CA-MRSA isolates derived from
skin and soft tissue specimens as well as respiratory tract secretions or
urine; the same number of HA-MRSA strains, coming from patients
hospitalised in various wards of the San Paolo Hospital, was collected
from blood, respiratory tract secretions or other biological ﬂuids. The
DNA extracted was screened by PCR for PVL gene and by multiplex
PCR to determine the mec type.
Results: Three MRSA harboured PVL gene, all belonging to CA-MRSA
group (11.5%); two of them were SCCmec IV and one SCCmec V; the
latter type was conﬁrmed in a subsequent isolate four months later,
differing only (data not shown) for the antimicrobial pattern (acquisition
of erythromycin resistance). The PVL positive MRSA were isolated from
cutaneous abscesses (two) and sputum. SCCmec IV was the predominant
type among CA-MRSA (84.6%) and HA-MRSA (80.7%), followed
by type I (7.7% CA-MRSA and 15.4% HA-MRSA), type III (3.8%
both) and one type V among the CA-MRSA isolates. Interestingly,
type I SCCmec isolates presented a multidrug-resistance phenotype
characterised by gentamycin resistance.
Conclusion: As expected, PVL positive strains were found only among
CA-MRSA and two out of three were associated to cutaneous abscesses.
SCCmec type IV emerged as the most frequent genotype in this series
of MRSA without any signiﬁcant difference among the community or
hospital acquired MRSA. To the better of our knowledge this is the ﬁrst
report on the molecular characterisation of Italian CA-MRSA isolates.
P1424 Analysis of meticillin-resistant Staphylococcus aureus isolates
from catheter infections isolated in a large Italian hospital
D. Petrelli, M. Prenna, C. Ripa, L.A. Vitali, S. Ripa (Camerino,
Ancona, IT)
Objective: Twelve meticillin-resistant Staphylococcus aureus (MRSA)
isolates from nosocomial catheter infections were studied. We de-
termined their antibiotic susceptibility pattern (penicillin, oxacillin,
erythromycin, tetracycline, clindamycin, telithromycin, gentamycin,
ciproﬂoxacin, quinupristin-dalfopristin, rifampin, vancomycin and line-
zolid), and the presence of the genetic determinants of antibiotic
resistance. To evaluate their genetic variability, isolates were subjected to
multilocus sequence typing (MLST), SmaI macrorestriction/PFGE anal-
ysis and to staphylococcal chromosomal cassette/cassette chromosome
recombinase (SCCmec/ccr) complex type determination.
Methods: The determination of the MICs was performed following the
Clinical Laboratory Standards Institute guidelines. Genetic determinants
of antibiotic resistance were screened by PCR, using speciﬁc primer set
described in the literature, while a standard multiplex PCR protocol
was used to assess the SCCmec and ccrAB complex type. MLST,
SmaI macrorestriction of chromosomal DNA and PFGE analysis were
performed according to standard procedures.
Results: An almost complete correlation was found between phenotypes
and genotypic traits of antibiotic resistance. A major group of ten strains
bore the SCCmec type I structure and showed the common sequence type
st228. Among this group, only seven strains had a SmaI macrorestriction
proﬁle matching that of the archaic pandemic clone.
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One strain, resistant to all antibiotics but vancomycin, was st239 and
SCCmec type IIIA. However, its SmaI macrorestriction proﬁle was not
related to that of the pandemic clones having a type IIIA SCCmec.
It was not possible to assign the SCCmec type of the two remaining
strains. They presented very rare multilocus sequence types, one being
st83 and the other st395, and possessed SmaI macrorestriction proﬁles
which were not related to any of the known pandemic clones.
Conclusions:
i. An extremely resistant strain belonging to st239 was isolated and
characterised;
ii. in the st228 group, SmaI macrorestriction analysis was able to identify
different subclones, showing an higher discriminatory power than
MLST;
iii. the analysis of the SCCmec/ccrAB complex of two strains with rare
sequence types was not possible with the multiplex PCR methodology
used, indicating the possible presence of new variants of the SCCmec.
P1425 Molecular characterisation of meticillin-resistant
Staphylococcus aureus strains isolated in a major general
hospital in Italy over a three-year period
R. Baldan, M. Moro, P. Cichero, D. Cirillo (Milan, IT)
Objectives: Meticillin-Resistant Staphylococcus aureus (MRSA) is the
major cause of nosocomial infections worldwide. In the late 1990s
highly virulent MRSA clones have emerged in the community, causing
fatal infections in otherwise healthy people, without predisposing risk
factors. Their characterisation showed a different genetic background on
the staphylococcal cassette chromosome mec (SCCmec). Hospital- and
Community-acquired MRSA (HA-, CA-MRSA) are different in genetic
background, antibiotic susceptibilities and associated virulence factors.
In order to investigate the presence of MRSA clones with the molecular
characteristic of CA-MRSA in a large nosocomial setting, we typed all
the MRSA isolated at the San Raffaele hospital (Milan) over a 3 year
period.
Methods: 187 clinically signiﬁcant MRSA strains were typed by
multiplex PCR targeting unique and speciﬁc loci of SCCmec types I,
II, III, IV and V, with concomitant mecA gene detection, the last used as
a determinant of meticillin resistance and as internal positive control. All
strains were tested for presence of the co-transcribed genes encoding for
the Panton-Valentine leukocydin (PVL), lukS-PV and lukF-PV. Cluster
investigation was performed by Pulsed-Field Gel Electrophoresis after
SmaI restriction and analysed by InfoQuest FP software-version 4.5 (Bio-
Rad).
Results: One hundred eight isolates (57.5%) carried SCCmec cassette
typical of nosocomial strains: 100 harboured SCCmecI, 5 SCCmecII and
3 SCCmecIII. Fifty-eight isolates (31%) harboured one of the SCCmec
associated to CA-MRSA: 57 were SCCmecIV and 1 was SCCmecV.
Twenty-two strains (11.5%) were not typeable. Analysis of sensitivity
patterns to selected antibiotics showed that CA-MRSA were more
susceptible to non b-lactams than HA-MRSA. Two strains were PVL-
positive: both carried SCCmecIV, were resistant to b-lactams only and
were isolated from young patients without risk factors. Cluster analysis
of MRSA harbouring SCCmecIV showed 2 major clades and 3 clusters
of nosocomial transmission, one of them involving 5 patients. Cluster
analysis of the HA-MRSA harbouring SCCmecI showed 11 major clades
with 2 clusters of nosocomial transmission, one of them in Neurosurgical
Intensive Care Unit, involving 19 patients from January to October 2007.
Conclusion: 57.5% of MRSA circulating in our hospital was identiﬁed
as HA-MRSA; we report that 31% of the strains harbours the SCCmec
cassettes associated to CA-MRSA although only 3.4% were PVL
positive.
P1426 Looking back, current status, and future trends of MRSA
clones in Italy
F. Campanile, D. Bongiorno, S. Borbone, G. Mongelli, S. Jeddari,
S. Stefani (Catania, IT)
Objectives: Our aims were i) to track the epidemiology of meticillin-
resistance in Italy, studying the spread and prevalence of various
MRSA clones over two decades; ii) to document MRSA changes in
the phenotypic and genotypic features, and their shifts in the levels of
susceptibility to glycopeptides; iii) to trace the origin of MRSA lineages
in Italy comparing the genotypic backgrounds of contemporary isolates,
with those of a sample of early MRSA strains from 1980.
Methods: Two hundred ﬁfty-eight non-repetitive MRSA clinical isolates
from various Italian hospitals between 1991 and 2006 were analysed
for their antibiotic resistance, and typed by PFGE and SCCmec typing.
All strains were grouped into clonal types, and representative isolates
of the main clones were further characterised by MLST, generating
the corresponding sequence type (ST)-SCCmec types for each MRSA
genotype. A sample of twenty early MRSA strains from 1980 was also
used for comparison.
Results: The most interesting feature was the increase of the Italian
clone (ST228-I; PFGE E) over the last decade (from 27% during the
ﬁrst decade, to 70% during the second one), and its stability over this
time; associated with the replacement of the multi-drug resistant and
highly epidemic Iberian clone (ST247-I/IA; PFGE A), (46% during the
ﬁrst decade to 5% during the second one). The Rome clone (ST247-
I/IA; PFGE C), one of the major local clones in the ﬁrst decade (11%),
has almost disappeared. ST1, ST15 and ST30 were the predominant
earliest MLST types among the MRSA strains in 1980, carrying the
ﬁrst described SCCmec I, in which resistance to antibiotics, other than
b-lactams, was very rare. A temporal shift in the susceptibility levels
to glycopeptides was observed: vancomycin MIC90 value increased two
fold from 1980 to 2006 (0.5–2mg/L), while teicoplanin increased from
0.12 to 4−8mg/L.
Conclusions: We describe the change of multi-resistance MRSA clones,
which occurred in hospitals from 1991 to 2006, and the increase of the
glycopeptide MIC levels, reﬂecting a worldwide trend, due to the abuse
of such molecules in clinical therapy. We document the detection of
ST1, ST15, and ST30 in the earlier isolates; we hypothesises a possible
correlation of these strains with the current C-MRSA clones.
P1427 Molecular characterisation of meticillin-resistant and
-susceptible Staphylococcus aureus from global clinical trials
R.V. Goering, R.M. Shawar, N.E. Scangarella, F.P. O’Hara, H. Madsen,
J. West, M. Dalessandro, J. Breton, J.A. Becker, L. Miller, W. Halsey,
E. Thomas, M. Twynholm, D. Payne (Omaha, Collegeville, North
Triangle Park, Research Triangle Park, US; Greenford, UK)
Objectives: To better understand the global epidemiology of Staphy-
lococcus aureus we genotyped meticillin-resistant (MRSA) and
-susceptible (MSSA) isolates recovered in 2004−5 from patients with
uncomplicated skin infections in 10 countries during ﬁve Phase III
clinical trials of retapamulin, a new topical antibiotic agent.
Methods: S. aureus isolates were tested for the presence of the Panton-
Valentine leukocidin (PVL) genes. All 105 MRSA were analysed to
determine the SCCmec type. All MRSA isolates, 118 PVL-positive
MSSA, plus a representative subset of 69 PVL-negative MSSA were
analysed by pulsed-ﬁeld gel electrophoresis, and multilocus sequence
typing (MLST).
Results: MRSA isolates were recovered mainly from the U.S. (60,
57%), India (27, 26%), Costa Rica (6, 6%), Germany (5, 5%), with the
remainder (7, 6%) from South Africa, Russian Federation, France, and
Peru. The most common MRSA strain (46, 44%), recovered exclusively
in the U.S., was of the community-associated (CA) PVL-positive,
ST8, USA300 type. Another four PVL-negative USA300 variants were
recovered in Costa Rica and India. No pulsed ﬁeld type USA300–0114
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MRSA were found outside the U.S. Interestingly, a total of 10 PVL-
positive and -negative USA300 isolates were found within the MSSA
population from the U.S., South Africa, Peru, and Poland. USA800 was
the second most common MRSA strain (11, 10%), primarily found in the
U.S. and Costa Rica. PVL-positive MSSA isolates were from recovered
South Africa (55, 47%), India (34, 29%), Russian Federation (12, 10%),
U.S. (9, 8%), and Germany (6, 5%), with one isolate each from Canada
and Peru. The most common PVL-positive MSSA strain was USA1200,
primarily found in South Africa and the Russian Federation. This was
followed by EMRSA15-related strains found only in South Africa and
India. There was no predominant strain within the PVL-negative MSSA
group with 29% of isolates exhibiting unknown types.
Conclusions: While results of this study are necessarily limited by the
isolate numbers from countries in which patients were enrolled, the CA-
MRSA strain USA300 was clearly associated with U.S. testing centres
while no isolates of the major European ST80 CA-MRSA clone were
recovered. In a number of instances genetic backgrounds associated
with MRSA outbreaks were found in MSSA. The results underscore the
importance of MRSA and MSSA surveillance to enhance understanding
of the global spread and persistence of different S. aureus populations.
P1428 Genetic relatedness among European meticillin-susceptible
and -resistant Staphylococcus aureus isolates from
ceftobiprole clinical trials
T. Davies, W. Shang, K. Amsler, R. Flamm, K. Bush (Raritan, US)
Objectives: Ceftobiprole (BPR) is an investigational parenteral
cephalosporin that is unique from currently marketed cephalosporins in
that it has broad-spectrum activity, including both meticillin-resistant
Staphylococcus aureus (MRSA) and meticillin-susceptible S. aureus
(MSSA). It is currently under clinical development for treatment of
complicated skin and soft tissue infections (cSSSI) and pneumonia.
The genetic relatedness among European MSSA and MRSA isolates
collected from ceftobiprole cSSSI clinical trials was compared using spa
typing and pulsed-ﬁeld gel electrophoresis (PFGE).
Methods: Baseline isolates of MSSA [N=169; 73 were Panton-Valentine
leukocidin (PVL) positive] and MRSA (N=74; 5 were PVL positive)
from Eastern Europe (Bulgaria, Hungary, Latvia, Lithuania, Romania,
Russia, Serbia & Montenegro, and Ukraine) were analysed. Spa typing
and SCCmec typing (MRSA isolates) was done by PCR and/or DNA
sequencing. PFGE was done on chromosomal DNA digested with SmaI.
BPR MICs were determined according to CLSI methods.
spa
type
MSSA
(N)
MRSA
(N)
No. of
countries
BPR MIC
(mg/L)
PVL+ PVL− PVL+ PVL− MIC50 MIC90
1 1 1 1 20 5 1 1
287 21 − − − 6 0.25 0.25
3 − 1 − 14 4 2 2
Unique − − − 13 1 2 2
35 − 7 − 2 3 0.5 −
73 − 8 − − 2 0.25 −
466 7 − − − 3 0.25 −
312 5 1 − − 4 0.25 −
33 2 4 − − 3 0.25 −
Results: There were 106 different spa types among all isolates analysed:
MSSA PVL− (N=63), MSSA PVL+ (N=33), MRSA PVL− (N=17),
MRSA PVL+ (N=3). Only nine spa types were found among two or
more of the isolate groups. The nine most common spa types (Table)
accounted for 44% (N=108) of isolates. The most prevalent MRSA clone
had spa type 1 but PFGE patterns were not all the same; 57% had
SCCmec type IV. Two MSSA isolates also had spa type I. Spa types 3
and “unique” were similar, differing by one motif. MRSA isolates with
these spa types had SCCmec type III, similar PFGE patterns, higher
BPR MICs (MIC50/90 of 2mg/L) and were predominantly (78%) from
Latvia. The most prevalent MSSA clone had spa type 287, similar PFGE
patterns, and low BPR MICs (MIC50/90 of 0.25mg/L); all were also
PVL+.
Conclusion: There was little genetic similarity between MSSA PVL+,
MSSA PVL−, MRSA PVL+, and MRSA PVL− isolates. From spa
typing, MSSA PVL− isolates seemed the most heterogeneous and
MRSA PVL− isolates the least heterogeneous. Ceftobiprole had excellent
activity (BPR MIC90 of 2mg/L) against all MSSA and MRSA isolates
including those with the most common spa types.
P1429 The prevalence of carriers of meticillin-resistant
Staphylococcus aureus in Copenhagen
A. Kjerulf, R.L. Skov, C. Forsberg, T. Larsen, N-E. Fiehn
(Copenhagen, DK)
Objectives: The aim of the study was to elucidate the frequency of
MRSA carriage in patients receiving treatment at the School of Dentistry
at University of Copenhagen in order to achieve a greater knowledge of
the carrier state of MRSA in a population of children and adults in
Copenhagen.
Methods: During a period of one year from 01.10.06–01.10.07 1200
specimens from 600 patients were collected. A specimen from both
nostrils and a specimen from both tonsils were taken from each patient,
i.e. two specimens per patient. Each specimen was immediately plated
on a 5% blood agar and inoculated into a nutrient selective broth.
Both were incubated overnight at 37ºC. At day two material from the
broth was plated on a chrome agar plate and incubated overnight at
37ºC. Susceptibility testing was performed at day three using a 10 mg
cefoxitin disk (Oxoid, Basingstoke, UK) and semi-conﬂuent growth
on Iso-sensitest agar and incubated overnight at 37ºC. Resistance was
deﬁned as 21mm (SRGA). Cefoxitin resistant S. aureus were sent
to the Staphylococcus Laboratory at Statens Serum Institut where
further investigations including PCR for the mecA gene, spa typing and
susceptibility testing were done.
Results: 518 adults 18 years with a mean age of 41.2 and a range
of 18 to 91 years and 82 children 2 years with a mean age of 7.2
and a range of 2 to 16 years were included in the study. One child was
positive for MRSA in the nose, the strain was a t022 spa type. The strain
was additionally resistant to norﬂoxacin, but sensitive to erythromycin,
tetracyclin, fusidic acid, rifampicin, streptomycin, kanamycin, linezolid
and mupirocin. It was a healthy 13 year old boy born in Denmark of
Danish parents. He had not been hospitalised in Denmark or abroad and
he had not been travelling abroad for the last year. None of the adults
were MRSA positive.
Conclusion: The prevalence of carriers of MRSA in Copenhagen seems
to be very low and in this study only 0.2%. During the last year the
number of patients with MRSA in Denmark has declined as a result of
the implementation of national guidelines to prevent the disease from
spreading in the hospitals and in the community.
P1430 Comparison of PFGE and spa for routine epidemiological
typing to monitor and track spread of MRSA over time at
a regional level
C. Welinder-Olsson, E. Kjellin, K. Flore´n-Johansson, L. Larsson,
C. Berglund, B. So¨derquist, C. A˚hre´n (Go¨teborg, O¨rebro, SE)
Objectives: The epidemiology of meticillin-resistant Staphylococcus
aureus (MRSA) is presently changing due to the worldwide emergence
of community-associated MRSA (CA-MRSA). These clones are more
diverse than the classical nosocomial MRSA clones. Pulsed-ﬁeld gel
electrophoresis (PFGE) of genomic macrorestriction fragments has been
the gold standard method for epidemiological typing of MRSA. Recently,
sequence-based typing methods such as sequencing of the polymorphic
X region of the protein A gene (spa typing) have been commonly
used due to their ease of interpretation, exportability and speed. For
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infection control purposes we have collected, typed and stored all MRSA
isolates detected in the west part of Sweden together with clinical and
epidemiological data since 1983.We here report a comparison of PFGE
with spa-typing for monitoring and tracking spread of MRSA over time.
Methods: The ﬁrst detected CA-MRSA isolate of each PFGE-type
(n = 38) was spa-typed, as well as the ﬁrst isolate of all subsequent
PFGE-subtypes of the nine most prevalent groups (n= 73). In addition
all consecutive MRSA isolates January 2006 to June 2007 were typed by
both methods. PFGE patterns were determined both visually, according
to the Tenover criteria, and by computer matching with BioNumerics 5.0
software. Spa-typing was determined with Ridom StaphType software
1.4.11.
Results: For the ﬁrst 38 isolates of each PFGE-type 25 different spa-
types were found. The nine most prevalent PFGE-groups were found
within 5 spa-groups according to BURP algorithm. The number of
PFGE-subtypes, closely or possible related according to the Tenover
criteria, within a group always exceeded that of the spa-types, and the
relationship varied from 18:12 to12:2. For PFGE-groups belonging to
sequence type (ST) 45 and ST30 PFGE and spa-typing resulted in
concordant epidemiological results, in contrast to those consisting of
ST80 and ST5. For isolates detected in 2006/07 the previous PFGE- and
spa-types usually corresponded, with the exception of two PFGE-groups.
Conclusion: For the current circulating clones in our region, PFGE
has a higher discriminatory power than spa-typing with the exception
of the PFGE-groups belonging to ST45 and ST30. If only spa-typing
had been used isolates of spa-type t002 (ST5) and t044 (ST80) as
well as those of t008, t015, t037 and t127 would have mimicked
outbreak situations which however not was the case according to the
epidemiological investigation.
P1431 Clonal distribution of meticillin-resistant and susceptible
Staphylococcus aureus invasive isolates in Belgium, EARSS/
SeqNet study, 2006–2007
A. Deplano, O. Denis, M. Hallin, S. Rottiers, R. De Ryck, E. Hendrickx,
H. Grundmann, M.J. Struelens (Brussels, BE; Bilthoven, NL)
Objectives: To identify and determine spread of predominant clones of
S. aureus causing invasive infection in Belgium during the 2006–2007
period.
Materials and Methods: As a part of the European Antimicrobial
Resistance Surveillance System (EARSS)/ SeqNet survey, 23 Belgian
hospitals were invited to collect 10 successive, non duplicate S. aureus
isolates (5 MRSA and 5 MSSA) from normally sterile body sites during
a 6 month period. PCR for detection of 16S/ nuc/ mecA and toxin genes
(PVL/ TSST-1) were performed. Molecular typing was performed by spa
sequencing using Ridom StaphType 1.4 (Ridom GMbH) and SCCmec
type characterisation.
Results: A total of 202 S. aureus isolates including 91 (45%) MRSA and
111 (55%) MSSA were recovered from blood cultures (79%), puncture
ﬂuids (20%) and cerebrospinal ﬂuids (1%). Spa typing showed 90 types
clustered into 15 spa clonal complexes (CC) using the BURP algorithm.
The majority of isolates belonged to spa CC008 (20%), CC740 (18%)
and CC002 (15%) corresponding to major epidemic clones ST8, ST45
and ST5 by multi-locus sequence typing, respectively. Most (89%)
MRSA isolates were classiﬁed in 4 clones, spa CC008-ST8-SCCmec IV
(37%), spa CC740-ST45-SCCmec IV (34%), spa CC002-ST5-SCCmecII
(10%) and spa CC002-ST5-SCCmecIV (8%). In contrast, MSSA isolates
showed a wide diversity and belonged to 15 spa CC, each including 2 to
13 isolates. Among MSSA isolates 20% harboured the 3 major MRSA
spa CC and 28% of MSSA isolates were classiﬁed into 3 spa types,
CC084, CC015 and CC078 not found in MRSA isolates. Toxin gene
analysis revealed 2 MRSA isolates carrying PVL genes and belonging to
ST59 and ST8. TSST-1 gene was detected in 7 MRSA isolates belonging
to CC002-ST5-SCCmec IV.
Conclusions: As found in previous surveys in Belgium, 4 major
genotypes predominated among MRSA isolates. In contrast, MSSA
isolates showed a wide genotype diversity, with sharing of common
genotypes with major MRSA strains. PVL and TSST-1 were recovered
in 2% and 8% of MRSA isolates, respectively.
P1432 Phage types versus spa types among MRSA strains isolated
in a Belgian hospital (2002)
C.M. Wildemauwe, P. Bifani, C. Godard, J. Dewit, M. Dehem,
R. Vanhoof (Brussels, BE; Lille, FR)
Staphylococcus aureus represents a growing public health burden owing
to the spread of nosocomial multi-resistant clones and to the emergence
of community-associated meticillin-resistant S. aureus (MRSA). In
Belgium, the proportion of MRSA was estimated at 31% in 2005
(EARSS). Strain typing of pathogens is essential to pinpoint the
sources and routes of transmission and to forecast future trends. Phage
typing has been one of the ﬁrst standardised typing techniques for
S. aureus (International Union of Microbiological Societies). Recently,
spa genotyping has proven to be an effective typing tool to distinguish
strains within a heterogeneous species such as S. aureus. A link
between phage types and spa types among Belgian MRSA isolates was
investigated.
In 2002, from a 487-bed general hospital located in northern Belgium,
159 isolates were received by the National Phage Typing Centre. After
MRSA conﬁrmation (coagulase test, minimum inhibitory concentration
of oxacillin and mecA gene determination) 150 MRSA were further
examined.
[J]* phage types (= lysis only by group III phages) characterised 45%
of them, 12% belonged to a local phage type 29/42E/54/D11*, 41%
were not assigned to a deﬁned group. Three isolates could not be phage
typed. Twelve different spa types (Ridom StaphType) were found: 39%
belonged to t038, 27% to t121, 14% to t041, 5% to t655, and 4% to
t002 and t024 each. Two spa types were only sporadically represented
(2 and 3 isolates) and four were unique to one isolate. The t041 spa
type was speciﬁc for the 29/42E/54/D11* phage type. The majority of
the t121 typed isolates were related to a [J]* phage type, namely the J2*
type (only lysed by phage 54). This was also the case for all our isolates
belonging to the t024 spa type. Within the t038, t655 and t002 spa types
a diversity of phage types was found.
In conclusion, some concordance was found between spa and phage
typing of MRSA. Nevertheless, the combination of both methods allowed
better discrimination among about half of the isolates.
P1433 Spread of MRSA clones in German hospitals and in vitro
activity of tigecycline
M. Kresken, J. Brauers, B. Strommenger, W. Witte (Rheinbach,
Wernigerode, DE)
Objectives: MRSA are now a leading cause of healthcare associated
infections. More recently, MRSA have also established as a signiﬁcant
community-associated pathogen. In Germany, the prevalence of MRSA
is about 20% of all S. aureus. MRSA are often multi-resistant, which has
limited the number of therapeutic options. Vancomycin (VAN) has been
considered as the drug of choice, but new agents are required due to
the emergence of strains with reduced susceptibility to glycopeptides.
Recently, tigecycline (TGC) has become approved for the treatment
of some MRSA infections. The objective of this study (G-TEST) was
to evaluate the distribution of MRSA clones among S. aureus isolates
collected in 15 laboratories and to determine the vitro activity of TGC
and other antimicrobials against these strains.
Methods: From April to August 2005, each laboratory was requested to
collect 10 MRSA from hospitalised patients. Isolates were characterised
by spa sequence typing according to the SeqNet.org protocol. MICs
of TGC, doxycycline (DOX), moxiﬂoxacin (MFX), gentamicin (GEN),
linezolid (LZD), and VAN were determined in a central laboratory by the
microdilution method according to the German DIN standard. EUCAST
breakpoints were applied to interpret MICs, as available.
Results: Of the 155 MRSA collected, 154 were analysed by spa
typing. 65% of the MRSA belonged to MLST types ST5/ST225 (spa
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types t002/t003; n = 33) und ST22 (spa types t022/t032; n = 37). Either
epidemic type was found in 14 laboratories. ST22 was predominant
in Northern Germany and in the Berlin area, while ST5 and ST225
were widely distributed in Western Germany. ST228 was predominant
in Southern Germany. Eight isolates belonged to the ST8 clone, one of
which carried the Pantone-Valentine-leucocidin gene (lukS-lukF). This
strain was identical to the caMRSA clone USA300, as determined by
additional PCR analyses (arcA, msrA, mphB). One isolate belonged to
the caMRSA clone ST80, which is widely disseminated in Europe.
77% of isolates were susceptible to GEN, but only two (1%) were
susceptible to MXF. Ten isolates showed reduced susceptibility to DOX
(MIC> 1mg/L). Of these, three belonged to spa type t037 (ST239). All
MRSA were susceptible to VAN, LZD and TGC.
Conclusion: TGC demonstrated excellent in vitro activity against MRSA
isolates recently recovered from hospitalised patients in Germany.
Therefore, within its range of clinical indications, TGC could be of
potential use for the treatment of MRSA infections.
P1434 Molecular epidemiology of meticillin-resistant Staphylococ-
cus aureus in fourteen cities in China from 2005 to 2006
H. Wang, Y. Liu, N. Du, E. Shen, J. Niu, H. Sun, Y. Xu, M. Chen
(Beijing, Changchun, CN)
Objective: To investigate the prevalence, antimicrobial resistance
pattern, and the molecular epidemiology of MRSA in multiple centres
of China from 2005 to 2006, and to evaluate the antimicrobial activities
of tigecycline, daptomycin, and ceftobiprole against MRSA.
Methods: From 2005 to 2006, 1529 consecutive and non-repetitive
Staphylococcus aureus were collected from 14 cities. The MICs of
antibacterial agents were determined by agar dilution. The genotypes
of SCCmec were determined by multiplex PCR. Pulsed-ﬁeld gel
electrophoresis (PFGE) and multilocus sequence typing (MLST) were
used to type MRSA. Panton-valentine leukocidin (pvl) gene was detected
by PCR for all S. aureus.
Results: The mean prevalence of MRSA was 50.4% (408/809) in
2005, and 43.9% (315/717) in 2006, respectively. Shanghai has the
highest MRSA prevalence (74.0%), followed by Qingdao (69.8%),
Xi‘an (68.0%), and Dalian (61.5%). The prevalence of MRSA was
the lowest in Changchun (24.2%), Nanjing (25.4%), Shenzhen (22.4%)
and Urumchi (29.2%). Only 4.2%-12.6% of MRSA were susceptible
to erythromycin, quinolones, gentamicin, or tetracycline. About 78.6%
of isolates were susceptible to trimethoprim/sulfamethoxazole. All
isolates were susceptible to teicoplanin and vancomycin. Ceftobiprole,
daptomycin, tigecycline, and linezolid had excellent activities with
MIC50 and MIC90 of 2, 2mg/L; 0.5, 0.5mg/L; 0.125, 0.25mg/L; 1,
2mg/L, respectively. SCCmec type III and II accounted for 66.1%
(478/723) and 14.1% (102/723), respectively. However, in Shenyang and
Dalian, SCCmec II was more common than type III. PFGE typing found
24 different patterns. Clone A accounted for 50.1%, existing in 12 cities
and clone R for 23.5%, and existing in 9 cities. Six sequence types
(ST) were found in 53 representative isolates, with ST239 accounting
for 75.5% and ST5 for 17.0%. The prevalence of pvl gene in all
S. aureus was 9.4%. Two isolates from Guangzhou in 2006 belonged
to community-acquired MRSA (CA-MRSA), one with ST88-SCCmec
IV, the other one with ST59-SCCmec IV.
Conclusions: The prevalence of MRSA differed in areas in China. The
most predominant types of MRSA in China were ST239-SCCmecIII
and ST5-SCCmecII, which indicated that several international epidemic
MRSA clones might exist in China. Clone spread resulted in the
higher prevalence of MRSA in big teaching hospitals. CA-MRSA was
uncommon in China. Ceftobiprole, daptomycin, tigecycline and linezolid
showed excellent activities against all MRSA tested.
P1435 spa sequence typing of meticillin-resistant Staphylococcus
aureus isolated in Bulgaria, 2005–2007
D. Nashev, L. Bizeva, K. Toshkova (Soﬁa, BG)
Objectives: The aim of the present study was to deﬁne the most prevalent
spa types of MRSA isolated in Bulgaria in the period 2005–2007 and to
associate them with the corresponding SCCmec type, PVL production
and phenotype of antibiotic resistance.
Methods: A total of 224 MRSA isolated between 2005 and 2007
in 19 hospitals located in 14 cities in Bulgaria were included in the
study. Community-acquired MRSA isolates were also included. The
isolates were grouped according to their resistance phenotypes and 85
representative isolates were selected for further genotyping, including
spa sequence typing, SCCmec typing and PCR detection of the genes
encoding PVL.
Antibiotic susceptibility testing was performed according to CLSI.
Meticillin-resistance was conﬁrmed by latex agglutination test for PBP
2a and PCR detection of mecA gene. SCCmec typing was performed
using multiplex PCR protocol. The presence of PVL genes were assessed
by PCR. The isolates were further analysed by spa sequence typing,
according to SeqNet.org protocol, spa types were designated using
Ridom Staphtype software.
Results: Among the investigated isolates 18 spa types were deﬁned:
t037, t030, t010, t1143, t045, t2168, t1507, t044, t416, t731, t008, t024,
t005, t015, t078, t1194, t1368 and t1531. The most prevalent spa type
was t037 possessing SCCmec type III, associated with the resistance
phenotype K, Gen, Tet, Er, Cli (MLS-const), Cip, SXT, followed by
t030 with SCCmec type III (K, Gen, Tet, Er, Cli (MLS-induc/MLS-
const), Cip, Rif) and t010, SCCmec type IV, which showed resistance to
oxacillin only. The isolates belonging to these spa types were negative
for PVL genes.
Six cases of infections caused by community-acquired MRSA (cMRSA)
were deﬁned. MRSA isolates from 5 patients belonged to spa type t008
(K, Er, Tet, Cip) and from one patient to spa type t044 (K, Tet, Fus).
Both t008 and t044 strains were found positive for PVL and possessed
SCCmec type IV.
Conclusion: In the present study, the most prevalent spa types in the
Bulgarian hospitals were t037 and t030, SCCmec type III, frequently
associated with ST239 (Brazilian/Hungarian) clone, followed by t010,
SCCmec type IV, which possibly belongs to ST5-IV (Paediatric) clone.
Most of the cases of PVL-positive cMRSA infections were caused by
t008, SCCmec type IV, which corresponds to the USA300 strain.
P1436 Molecular characterisation of Staphylococcus aureus isolates
belonging to two most prevalent spa types recovered from
Romanian hospitals during 2006–2007
M. Oprea, E.C. Dragulescu, I.L. Coldea, I. Codita, C. Szmal, M. Straut
(Bucharest, RO)
Objectives: In this study, a molecular analysis was undertaken in order
to further characterise Staphylococcus aureus clinical isolates belonging
to two most prevalent spa types: t030 and t127 that were identiﬁed during
2006–2007, in Romania.
Methods: A total of 91 S. aureus isolates collected from hospital in-
patients were examined phenotypically and subtyped using a single-
locus sequence typing method, namely spa typing. This method is based
upon the polymorphism of S. aureus protein A gene, whose repeats are
variable in number and individual sequence. Isolates belonging to spa
types t030 and t127 were selected for further molecular characterisation
and cluster analysis of the SmaI patterns, generated by pulsed-ﬁeld
gel electrophoresis. Meticillin-resistant S. aureus (MRSA) isolates were
conﬁrmed by PCR targeting mecA gene. Staphylococcal chromosomal
cassette mec (SCCmec) types were determined by performing a
multiplex PCR with speciﬁc primers for the key genetic elements.
The presence of lukS-lukF genes encoding Panton-Valentine leukocidin
(PVL) and other toxin genes was tested by PCR.
Regional spread of MRSA and MSSA S411
Results: spa type t127 comprised 26 S. aureus isolates (28.5% of all
examined isolates) and spa type t030 comprised 18 isolates (20%),
respectively. All t030 isolates were MRSA with mecA gene carried on
a type III SCCmec genetic element. Twenty-one out of 26 t127 isolates
were MRSA and harboured a type IV SCCmec structure. Different
virulence gene proﬁles were identiﬁed, but all the 44 isolates were PVL
and seb genes negative, irrespective of spa type. Clonal relationships
were established within each spa type group of isolates.
Conclusion: We have found that the prevalent spa-types of S. aureus
isolates recovered from Romanian hospitals in 2006 and 2007 were spa-
type t030 associated with SCCmec type III structure and spa-type t127
associated with SCCmec type IV structure. PFGE proﬁles showed that
the isolates which share each of these types belong to the same clone.
More detailed studies, including superantigen genes detection, will be
performed, in order to further characterise the isolates belonging to these
prevalent spa-types.
P1437 Changing molecular epidemiology of Staphylococcus aureus
in Korea over a ten-year period
E.S. Kim, H.B. Kim, H.J. Lee, K.T. Jung, Y.S. Lee, D.H. Shin, S.I. Jung,
K.U. Park, W.B. Park, N.J. Kim, M.D. Oh, E.C. Kim, K.W. Choe
(Goyang, Seoul, Seongnam, Gwangju, KR)
Objectives: Most studies of molecular epidemiology on Staphylococcus
aureus in Korea have been limited to meticillin-resistant S. aureus
(MRSA) isolated in tertiary hospitals. This study was performed to
evaluate the changes of molecular characteristics of S. aureus isolated
both in the community and in hospitals over a 10-year period.
Methods: Antibiotic susceptibility tests, staphylococcal cassette chro-
mosome mec (SCCmec) typing, multilocus sequence typing (MLST),
and toxin gene analyses by multiplex polymerase chain reactions were
performed on S. aureus isolates collected from clinical specimens from
1996 through 2005.
Results: Four-hundred thirty-three S. aureus isolates were tested, which
included 148 meticillin-susceptible S. aureus (MSSA) and 285 MRSA.
The clonal complex 1 strain, including the sequence type 1 (ST1) strain,
was prevalent (29%, 28/96) in MSSA until 2003, but MLST proﬁles
of MSSA showed a great diversity. While ST72, the most common
strain (ST72-MRSA-SCCmec IV/IVa) of community-associated MRSA
(CA-MRSA) in Korea as previously reported (J Antimicrob Chemother
2007;60:1108–14), was found in only one MSSA isolate till 2003, it
has been increasing not only in MSSA (5/31) but also in MRSA (9/15)
from the anterior nares of healthy people since 2005. Moreover, ST239-
MRSA-SCCmec III/IIIa has surpassed ST5-MRSA-SCCmec II/IIa, the
most prevalent strain till 2003, among MRSA isolates from the hospitals
since 2005. Toxin gene proﬁles also showed a diverse distribution,
but certain proﬁles were associated with meticillin resistance and the
SCCmec types. Pvl genes were detected in only 7.4% of the total MSSA
and 1.1% of MRSA during the study period.
Conclusion: The epidemiology of S. aureus in the community and
hospital settings has changed gradually during the past 10 years in Korea.
ST72-MRSA-SCCmec IV/IVa emerged recently in the community, even
if it is uncertain whether this is a new clone or from the hospitals.
P1438 Meticillin-resistant Staphylococcus aureus – Community-
acquired phenotype spread in hospitals in Bogota´, Colombia
G. Buitrago, J.A. Cortes Luna, J.S. Castillo London˜o, A.L. Leal Castro,
R. Sanchez Pedraza, C.A. Alvarez Moreno on behalf of GREBO
Introduction: Meticillin Resistant Staphylococcus aureus (MRSA)
has been largely known as a nosocomial microorganism with clonal
dissemination. In Colombia, the Chilean clone has replaced the previous
one as the most common cause of nosocomial infections in hospitals.
Recently, isolates of community acquired MRSA (CA-MRSA) has
been identiﬁed in Bogota´. The prevalence of CA-MRSA in colombian
hospitals hasn’t been reported. Here we show the observed change in
the frequency of some phenotypes related to the Chilean and CA-MRSA
clones and present a forecast for their behaviour.
Methods: Time-series analysis of MRSA isolates of 23 tertiary
hospitals of the GREBO network between 2001 and 2006 was done.
Microbiological data from hospitals were monthly transferred and
compiled in the GREBO data base. A descriptive analysis of isolates
susceptibility pattern was done with the Whonet (ver. 5.4) software.
Two time-series anlalysis modelling were done by use of the Box-
Jenkins methodology (72 monthly periods): One with the Chilean
phenotype (Oxacillin, ciproﬂoxacin, erythromycin, clindamycin resistant,
susceptible to cotrimoxazole, rifampin and tetracyclines) and one with
the CA-MRSA phenotype (Oxacillin resistant susceptible to the others).
Results: 33156 S. aureus isolates were identiﬁed in the network. Annual
frequency of MRSA starting 2001 was 38%, 46%, 45%, 45%, 38%
and 34%. CA-MRSA phenotype showed an increase from 1% in 2001
to 5.4% in 2006. The Chilean clone series was best described by a
simple exponential (alpha = 0.6677) and for the CA-MRSA phenotype
the Brown lineal model ﬁt better. The forecast for the Chilean clone
phenotype doesn’t show a clear cut trend (high conﬁdence intervals).
On the opposite, the forecast for the CA-MRSA phenotype series shows
a high increase for the followingf year.
Time series and forecasting for Chilean and community-acquired MRSA
clone.
Conclusions: CA-MRSA phenotype showed a sharp increase in the last
years and the forecast predicts a higher percentage for the following
year. The chilean clone seems to have a decrimental trend, but it is not
as clear. This ﬁnding has a big impact on public health measures and
medical education.
P1439 An outbreak of meticillin-resistant Staphylococcus aureus
(spa type t008) in the paediatric intensive care unit of a
university hospital, Tartu
P. Mitt, V. Adamson, K. Truusalu, U¨. Parm, S. Ko˜ljalg, E. Sepp,
K. Lo˜ivukene, I. Lutsar, M. Maimets (Tartu, EE)
Objectives: In Tartu University Hospital the prevalence of meticillin-
resistant Staphylococcus aureus (MRSA) has been low (1−4%) until
now. In November 2006 the routine surveillance of clinical microbiology
laboratory reports revealed a case of MRSA infection in the paediatric
intensive care unit (PICU). The aim of the study was to describe the
outbreak of MRSA in PICU and to detect the genetical relatedness and
protein A type of the consecutive MRSA isolates.
Methods: During the outbreak period, from November 27, 2006 to July
29, 2007, a total of 20 nonduplicated MRSA isolates from clinical
and surveillance samples were obtained. Antibiotic susceptibility was
measured by disk-diffusion method, meticillin-resistance was conﬁrmed
by the detection of mecA gene using PCR. Clonal relatedness of the
isolates was performed with Pulsed Field Gel Electrophoresis (PFGE)
and sequencing of the polymorphic region of protein A (spa typing).
Interventions to control the outbreak included active surveillance, contact
isolation of infants, decolonisation of healthcare workers (HCWs) and
retraining in hand hygiene.
Results: The ﬁrst MRSA strain of the outbreak was isolated from the
eye secretion of a premature baby (birth weight 960g) with congenital
sepsis on his 2nd day of admission. Patient’s mother had been treated
for osteomyelitis before giving birth. During the outbreak 17 patients
among the total of 228 admissions were affected. There were 4 neonates
with bloodstream infection, 8 had noninvasive disease (skin and soft
tissue infection, pneumonia, conjunctivitis) and 5 were colonised with
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MRSA. The majority of patients were premature neonates. The median
time from admission to acquisition of MRSA was 6 days (range 1–
26). Three of the 106 HCWs were colonised with MRSA. MRSA was
not detected from the environmental samples. 60% of MRSA isolates
were susceptible to clindamycin, gentamicin and ciproﬂoxacin, and all
to trimethoprim-sulfamethoxazole and vancomycin. All MRSA strains
showed closely related PFGE pattern and belonged to the spa type t008.
Colonised HCWs were treated with topical mupirocin and hex-
achlorophene showers which ended the outbreak.
Conclusion: This is the ﬁrst reported outbreak of MRSA spa type t008
(commonly found in USA and Europe) in Estonia. We speculate that
the primary source of this outbreak was the mother of the index patient
and secondary sources were colonised HCWs. Routine surveillance for
MRSA has now been implemented in the PICU.
P1440 Meticillin-resistant Staphylococcus aureus clones recovered
from bloodstream infections in Czech hospitals in 2000–2007
V. Jakubu`, H. Zˇemlickova´, P. Urba´sˇkova´, I. Machova´ (Prague, CZ)
Objectives: Czech isolates of meticillin-resistant Staphylococcus aureus
(MRSA) associated with invasive disease were characterised by spa
typing. The aim of the study was to determine the clonality of MRSA
isolates prevalent in Czech hospitals.
Methods: Thirteen national microbiology laboratories participating in
the European Antimicrobial Resistance Surveillance System (EARSS)
submitted to the National Institute of Public Health the ﬁrst 5 consecutive
MRSA isolates collected from individual patients in each hospital in six-
month sampling periods from September to February in 2000 through
2007. The screening of resistance to oxacillin was performed using
Oxoid Chromogenic MRSA Agar. The minimal inhibitory concentrations
(MICs) of oxacillin, erythromycin, clindamycin, chloramphenicol,
gentamicin, tobramycin and vancomycin were determined by the CLSI
broth microdilution method. All MRSA isolates (n = 140) were tested
for the presence of the mecA gene and spa typed. Detection of Panton-
Valentine leucocidin (PVL) genes was performed in 56 isolates.
Results: The number of MRSA isolates per participating laboratory
ranged from 6 to 19. Spa typing revealed 23 different spa types; however,
only 7 spa types were identiﬁed in at least 2 isolates. The most prevalent
spa types were as follows: t003 (n = 72), t030 (n = 23), and t032 (n = 12).
Since the ﬁrst isolation in 2002, spa type t003 has gradually replaced spa
type t030 that was highly prevalent in the Czech Republic until 2002–
2003. The proportion of spa type t003 increased from 0% in 2000–
2001 to 67.6% in 2006–2007 while that of spa type t030 decreased from
62.5% to 0.0%, respectively. PVL genes were found in a single isolate
of spa type t044.
Conclusion: A signiﬁcant shift in the prevalence of spa types was
observed. Spa type t030 (Brazilian clone) has been replaced by spa type
t003 (Rhine Hesse clone). The presence of EMRSA-15 clone of spa type
t032 was also detected in 4 Czech hospitals.
P1441 Community-associated meticillin-resistant Staphylococcus
aureus in Finland: ten-year perspective
S. Salmenlinna, J. Vuopio-Varkila, M. Karde´n-Lilja, M. Kanerva,
T. Mo¨tto¨nen, M. Virtanen, O. Lyytika¨inen (Helsinki, FI)
Objectives: During 1997–1999, one ﬁfth of all Finnish meticillin-
resistant Staphylococcus aureus (MRSA) isolates (n = 308) were obtained
from persons without connection to hospitals, and three strain
types (FIN-4, -11, -14) were associated with community acquisition.
Thereafter, the number of MRSA isolates has remarkably increased and
new strain types appeared. We estimated the proportion of community-
associated MRSA (CA-MRSA) and compared the MRSA isolates
obtained during 2004–2006 in persons with and without hospital contact
in terms of strain type. The results were compared with those reported
from years 1997–1999.
Methods:MRSA isolate was deﬁned as community-associated if MRSA
specimen was obtained outside hospital settings or within two days
of hospital admission from a person who had not been hospitalised
within two years before date of MRSA isolation. We analysed previous
hospitalisations for all MRSA-positive persons during 2004–2006
(n = 3054) by using data from the National Hospital Discharge Register.
The isolates were typed by pulsed ﬁeld gel electrophoresis and tested
for antimicrobial susceptibility. Selectively, multi locus sequence typing
(MLST), spa typing, SCCmec determination, and Panton-Valentine
leukocidin (PVL) gene detection were performed.
Results: Of the 4054 MRSA-positive persons, 4030 (99%) were included
in the study; 570 (14%) had CA-MRSA. A total of 36 strain types were
shared by 5 persons, and 109 sporadic strains were identiﬁed. Ten
different strain types (FIN-4, -5, -11, -12, -15, -17, -19, -20, -25, -30)
as well as sporadic strains were more likely to be found from persons
without hospital contact. All 10 CA-MRSA strain types had SCCmec
IV or V, representing 8 different MLST types and 9 spa types, and 4
were PLV-positive. Of the sporadic CA-MRSA strains, 16 were tested
for PVL genes, and 3 were positive.
Conclusions: The proportion of CA-MRSA did not increase. However,
the absolute number of CA-MRSA isolates rose ﬁve-fold. Two of
the old CA-MRSA strain types persisted and several new emerged.
Internationally recognised, PLV-positive CA-MRSA clones were also
recognised in Finland.
P1442 Evaluation of the resistance proﬁle and detection of
virulence genes in Staphylococcus aureus isolates from
clinical and surveillance samples collected at a Brazilian
teaching hospital
M.V. Pimenta-Rodrigues, N. Gaebler, L. Teixeira Pazzini, D.R. Ustulin,
C.M. Castelo Branco Fortaleza, M.L. Ribeiro de Souza da Cunha
(Botucatu, BR)
Objectives: This study aimed at evaluating the resistance proﬁle and
presence of the gene mecA and enterotoxin genes sea and sed, as well
as toxic shock syndrome toxin-1 (TSST-1) in Staphylococcus aureus
samples isolated from clinical and surveillance samples from patients of
Bauru State Hospital, Brazil.
Methods: Fifty-two S. aureus samples isolated between October/2006
and March/2007 were included. Oxacillin resistance was assessed by
drug diffusion test as recommended by CLSI, using oxacillin (1mg) and
cefoxitin (30mg) disks. Genes mecA, sea, sed and tst were detected by
PCR.
Results: Of the 52 samples analysed, 29 (55.8%) were resistant to
both disks tested, as conﬁrmed by the presence of the mecA gene, and
8 (15.4%) showed colony growth within inhibition halos, suggesting
heteroresistance. These colonies were identiﬁed and retested with
oxacillin and cefoxitin disks, and PCR was once more performed for
the ampliﬁcation of the gene mecA, which conﬁrmed the presence of
oxacillin-resistant(MRSA) heteroresistant S. aureus. The detection of
toxin genes revealed that one of the genes studied was found in 8 samples
(15.4%) while the sea gene was present in 6 (11.5%), and genes tst and
sea were concurrently seen in two (3.8%) of the samples. Of the two
samples exhibiting genes sea and tst, one was resistant to oxacillin and
the other was heteroresistant. Of the six sea-positive samples, two were
MRSA and one was heteroresistant. These results were conﬁrmed by the
ampliﬁcation of the mecA gene.
Conclusion: These ﬁndings highlight the importance of the genotypic
evaluation of MRSA presence, and demonstrate the relationship between
the presence of virulence genes and oxacillin resistance, which may
result in the dissemination of these multiresistent toxigenic strains among
patients hospitalised in this part of Brazil.
Financial Support: FAPESP
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P1443 Community-associated meticillin-resistant Staphylococcus
aureus: prospective surveillance of prevalence and
clinico-epidemiologic feature among patients with otorrhoea
in primary Korean otolaryngology clinic
J. Lee, C.W. Park, Y.B. Seo, J.Y. Song, I.S. Hwang, H.J. Cheong,
W.J. Kim (Seoul, KR)
Objectives: Community-associated meticillin-resistant Staphylococcus
aureus(CA-MRSA) has emerged as an important infection in the
community setting. Most of CA-MRSA infections in Korea are ear
infection(acute ear infection, chronic otitis media), but little is known
about the epidemiology of CA-MRSA in primary otolaryngologic
clinics. To determine the prevalence, and clinical and microbiological
characteristics of CA-MRSA in ear infection of community setting, we
designed a prospective survey. We also investigated the analysis of clonal
relatedness of CA-MRSA from ﬁve different clinics.
Methods: From January to June, 2007, 178 otorrhoea samples were
collected from ﬁve clinics in west area of Seoul and were classiﬁed
MRSA or not. A comparative analysis of risk factors for CA-
MRSA infection was performed. SCCmec typing by multiplex PCR,
molecular typing by pulsed-ﬁeld gel electrophoresis(PFGE) and multi-
locus sequence typing(MLST) were done with MRSA isolates.
Results: Proportion of MRSA was 36.7%(33/90) and was signiﬁcantly
different between 5 clinics(p< 0.01). Recent antibiotic use was most
signiﬁcant risk factor for MRSA infection(p< 0.01). SCCmec type
II isolates were most prevalent(63.6%, 21/33) and type IV isolates
were 21.2%(7/33). 8 MLST types were discovered. Among them, 4
types(ST83, 639, 509, 627) were newly discovered in Korea. Same PFGE
type was discovered in different clinics. Some MRSA isolates had a
similar or same PFGE types in clinic of high MRSA rate.
Conclusion: This study demonstrates that CA-MRSA infection was
prevalent and variable MRSA clones were epidemic in otolaryngologic
clinics of community. Most of MRSA isolates had molecular charac-
teristics of hospital-associated MRSA(HA-MRSA) and some others had
molecular characteristics of CA-MRSA.
P1444 Prevalence of meticillin-resistant Staphylococcus aureus
among patients undergoing peritoneal dialysis in Taiwan
Y.T. Huang, C.H. Liao, C.C. Hung, S.C. Chang, H.C. Yeh, Y.M. Chen,
P.R. Hsueh (Taipei, TW)
Objectives: The aim of current study was to investigate the prevalence
of meticillin-resistant Staphylococcus aureus (MRSA) infection among
patients receiving peritoneal dialysis (PD) and molecular characteristics
of the MRSA isolates.
Methods: From January to November, 2007, 177 patients undergoing PD
at our hospital were screened for MRSA infection using cultures of the
nares and the PD exit site as well as real-time PCR assay (BD, Geneohm).
Swab culture of both sites was repeated one month later for each patient.
All the MRSA isolates were studied on their genetic correlation by pulse-
ﬁeld gel electrophoresis (PFGE). The SCCmec element typing and the
Panton-Valentine leukocidin (PVL) gene were evaluated in all isolates.
A carrier was deﬁned as a patient with indistinguishable MRSA clones
isolated from two different time periods regardless the isolation sites. A
coloniser was deﬁned as a patient with MRSA isolated from only one
of the two different survey cultures regardless the isolation sites.
Results: During the study period, 7 patients (3.9%) were identiﬁed
as carriers and 7 patients (3.9%) as colonisers. A total of 29 MRSA
isolates were obtained from the two surveys of the nares and exit site.
Compared with nasal swab cultures, the sensitivity and speciﬁcity of
real-time PCR assay in the detection of MRSA infection was 90% and
98.8%, respectively. There were 6 pulsotypes identiﬁed (pulsotypes A to
F) with no predominant clone. Three pulsotypes (pulsotypes B, C, and
D) contained SCCmec type IV. Two pulsotypes (pulsotypes A and E)
possessed SCCmec type V and were the only pulsotypes that had PVL
gene. After follow-up for 9 months, one of the 7 carriers developed
MRSA-related exit site infection and none had peritonitis. Of the 7
colonisers, one developed MRSA-related exit site infection and another
one Escherichia coli-related peritonitis.
Conclusion: We found that the prevalence of MRSA infection
among patients undergoing PD was similar to that of community
population (3.5%) and was much lower than that of patients undergoing
hemodialysis (5.9%) in a previous survey in Taiwan.
P1445 Longitudinal carriage of Staphylococcus aureus in families
of non-healthcare workers in Hong Kong
D. Lo, M.V. Boost, E. Cheng, M.M. O’Donoghue (Kowloon, HK)
Objectives: Overall 25% of humans carry S. aureus, but this colonisation
may be transient or persistent, and a high proportion is never colonised.
Transmission of S. aureus has been documented in families of healthcare
workers (HCW). This study investigated longitudinal carriage and
transmission of S. aureus in families without HCWs.
Methods: Nasal samples from 100 non HCW associated families,
each with at least three persons living together, were obtained at
monthly intervals for 3 months. Swabs were cultured on blood
agar, mannitol salt agar (MSA), MSA with 6gg/ ml oxacillin,
and enriched in brain heart infusion broth with 5% salt. Colonies
showing staphylococcal morphology were conﬁrmed as S. aureus using
Staphaurex. Susceptibility to oxacillin and cefoxitin and other antibiotics
was determined by disc diffusion. Strains appearing meticillin resistant
were examined for the presence of mecA by PCR, and characterised for
PVL gene carriage, SCCmec and agr type.
Results: Of 342 subjects, 27.4%, 24.9% and 19.3% were colonised on
the ﬁrst, second, and third sampling respectively. Overall, 11.4% were
colonised persistently, 26.9% transiently, and 61.7% never colonised.
Persistent carriage was more common in those aged <10 and >60. Only
non-carriers were observed in 29 families and two families consisted only
of persistent carriers. Mothers were the most frequently colonised family
member. Of 57 families with at least one colonised member on the ﬁrst
occasion, 16 had at least one other family member with the same strain
(12 of 57 families on the second, and 10 of 48 on the third). Between ﬁrst
and second, and second and third samplings, in 7 and 6 of the colonised
families respectively, another family member had become colonised with
the same strain on the subsequent sampling. MRSA was isolated from
4 subjects in the ﬁrst collection, including a mother and son with the
same strain resistant to b-lactams only (SCCmec type IV variant). The
second collection yielded only one MRSA with SCCmec type IV, but on
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the third, 3 subjects were MRSA-colonised, including a different mother
and son pair with a type IV variant displaying erythromycin resistance.
All MRSA strains were agr type I and none harboured PVL genes.
Conclusions: Transmission occurred in 10 ± 12% of families over a one
month period. Although MRSA colonisation remained low in families
without HCWs (range 0.3−1.1%), transmission of MRSA between a
mother and son occurred on two occasions.
P1446 Panton-Valentine leukocidin gene and staphylococcal
chromosomal cassette mec types among clinical isolates
from patients at a Khon Kaen hospital, Thailand
S. Puapermpoonsiri, C. Prariyachatigul, J. Chumpol (Khon Kaen,
Roit-et, TH)
Background: Increasing interest in Panton-Valentine leukocidin (PVL)-
producing S. aureus, due to its involvement in skin and soft tissue
infections and severe necrotising pneumonia have been reported
worldwide. Recently, we reported ﬁrst case of PVL producing S. aureus
in an HIV patient with a fatal outcome. However, little is known about
PVL producing S. aureus among isolates in Thailand.
Objective: The purpose of this study was to determine the frequency
of PVL gene and staphylococcal chromosomal cassette mec (SCCmec)
types among clinical isolates of S. aureus obtained from patients at
Srinagarind hospital, Thailand, and also to assess the genetic relatedness
of PVL positive strains.
Method: We used PCR method to test for the PVL gene in 316 clinical
isolates of S. aureus obtained from clinical samples between September
2004-March 2005. For all PVL positive S. aureus strains, we analysed
by RAPD method using OPE 20 and P1 primers to assess the genetic
relatedness. MRSA were detected by oxacillin disc diffusion method and
were conﬁrmed by the precence of mec A gene by PCR method. The
SCC mec types of the MRSA isolates were performed by multiplex PCR
assay.
Result: A total of 316 strains (136 MSSA strains and 180 MRSA
strains were analysed. Twenty eight strains of MSSA were found to
harbour the PVL gene. PVL positive S. aureus were 8.86% of all
S. aureus strains analysed. Compared with MSSA alone, PVL positive
strains comprised 20.59%. The RAPD analysis differentiated the PVL
positive S. aureus isolates into 4 to 7 distinct genotypes, according to
the OPC-20 and P1 primer. All the PVL positive isolates had the same
antibiogram pattern, they were susceptible to cephalothin, cotrimoxazole,
clindamicin, erythromycin and oxacillin. None of MRSA strains were
positive for PVL gene and only SCC mec type III and subtype IIIa and
IIIb were found among Thai isolates
Conclusion: Our study found high percentage of PVL positive S. aureus
strains. All MRSA isolates carried the SCC mec type III complex and
did not harbour the PVL genes. The incidence and clinical signiﬁcance
of PVL positive S. aureus in Thailand needs further investigation.
P1447 Meticillin-resistant Staphylococcus in Bahrain: evidence of
MRS transmission and co-carriage of vancomycin-resistant
enterococci
A. Senok, E. Sharaf, A. Al-Mahmeed, E. Udo, G. Botta (Sharjah,
Dubai, AE; Manama, BH; Kuwait, KW; Udine, IT)
Objectives: To determine the transmission of meticillin resistant
Staphylococci (MRS) between the hospital and community and evaluate
the levels of co-colonisation of MRS positive patients with vancomycin
resistant Enterococci (VRE) in our institution
Materials and Methods: From November 2005-April 2006, meticillin
resistant Staphylococcus aureus (MRSA) and meticillin resistant
coagulase negative Staphylococcus (MRCoNS) positive patients at the
Salmaniya Medical Complex, Kingdom of Bahrain were studied. Patients
stool specimens were investigated for Enterococci on bile-esculin-azide
agar. Enterococci were identiﬁed to species level using API 20 STREP,
BD PHOENIX system and PCR. Vancomycin resistance in enterococci
isolates was conﬁrmed by PCR. Nasal and axillary swabs obtained from
family members of patients were screened for MRS. The relatedness of
the MRS strains from matching pairs of patients and family members
was determined using pulsed-ﬁeld gel electrophoresis (PFGE).
Results: In total, 182 MRS positive patients (93 MRSA, 89 MRCoNS)
and 356 family members were studied. Thirteen MRS patients also
carried VRE (12 MRSA & 1 MRCoNS). These were predominantly
E. gallinarum with vanC1 genotype and one strain was E. faecium (vanB
genotype). Two E. gallinarum isolates haboured an additional vanB gene.
Seven MRSA and 41 MRCoNS strains were isolated from the family
members. PFGE analysis revealed the presence of variants of a single
MRSA clone among patients and their relatives. Twelve MRSA isolates
were identical or closely related with six of these showing one to three
band differences indicating a clonal origin.
Conclusion: There is evidence of co-carriage of VRE strains in MRSA
patients thus setting the stage for possible emergence of vancomycin
resistant Staphylococcus aureus. The presence of a single MRSA clone
in patients and relatives indicates its transmission between the hospital
and the community which poses a signiﬁcant threat to public health.
P1448 High Panton-Valentine leukocidin prevalence among
meticillin-sensitive Staphylococcus aureus from Yogyakarta,
Indonesia
R.H. Deurenberg, P.S. Beisser, M.J. Visschers, C. Driessen, T. Utomo,
E.E. Stobberingh (Maastricht, NL; Yogyakarta, ID)
Objectives: During the last decade, community-associated meticillin-
resistant Staphylococcus aureus (CA-MRSA) has emerged. CA-MRSA
is characterised by staphylococcal cassette chromosome mec (SCCmec)
type IV or V, several continent-speciﬁc genetic backgrounds, and the
presence of Panton-Valentine leukocidin (PVL). CA-MRSA clones could
emerge through the transfer of the highly mobile SCCmec type IV
element into PVL-positive meticillin-sensitive S. aureus (MSSA) with
a genetic background common to CA-MRSA. Therefore, studies are
needed to investigate the prevalence of PVL among MSSA isolates.
Methods: During September and October 2006, 440 nasal swabs were
taken from outpatients (n = 320) and their companions (n = 320) at the
Department of Ear, Nose and Throat at the Dr. Sardjito Academic
Hospital in Yogyakarta, Indonesia. The swabs were send to The
Netherlands for isolating and identiﬁcation of S. aureus. These were
characterised with spa typing and the algorithm based upon repeat
pattern (BURP). The prevalence of the virulence factors collagen
adhesion (CNA), PVL and toxic shock syndrome toxin 1 (TSST-1) was
investigated.
Results: From 62 individuals (14%), including 39 outpatients (18%)
and 23 companions (11%), S. aureus was isolated by standard
microbiological methods. Typing revealed 37 spa types (of which 9
were new spa types), and 20 spa types were clustered into 6 spa-clonal
complexes (spa-CCs) (42 isolates). The remaining isolates could not be
classiﬁed into spa-CCs. Up to 69% of these isolates were associated
with a genetic background common to the endemic MRSA clones, e.g.
clonal complex (CC)1, CC8, and CC45. The remaining isolates were
associated with CC12, CC72, and CC121. The prevalence of CNA, PVL
and TSST-1 was 74%, 26% and 16% respectively; the presence of PVL
was strongly associated with CC1.
Conclusions:
1. There was a low S. aureus prevalence (16%) among the population
investigated, compared to the normal prevalence of between 30% and
50%.
2. No MRSA isolates were observed in the population.
3. A relatively high PVL-prevalence among MSSA isolates with a
genetic background common to a virulent and epidemic CA-MRSA
clone (CC1/USA400) was observed.
4. CA-MRSA clones might emerge through the integration of SCCmec
type IV into PVL-positive MSSA with a genetic background common
to CA-MRSA.
5. Studies are necessary to monitor the possible emergence of CA-
MRSA clones, and limit their subsequent dissemination.
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P1449 Community-acquired methicilin-resistant Staphylococcus
aureus as a cause of pyonephrosis necessitating emergent
nephrectomy. A new clinical entity
M. Koukoulaki, I. Baraboutis, E. Belesiotou, E. Platsouka,
V. Papastamopoulos, D. Kontothanasis, K. Petraki, O. Paniara,
A. Skoutelis (Athens, GR)
Introduction: Community acquired-methicilin-resistant Staphylococcus
aureus (CA-MRSA) carrying the Panton-Valentine leucocidin (PVL)
toxin has been linked to skin and soft tissue infections and necrotising
pneumonia. We report a new clinical syndrome related to this emerging
pathogen.
Case presentation: An 84 year-old man, with history of diabetes
mellitus type II, nephrolithiasis, recurrent urinary tract infections and
prostatectomy, presented with constitutional symptoms and fever. He
denied invasive procedures of the genitourinary tract in the last 2
years. Evaluation revealed tenderness of the right costophrenic angle,
leukocytosis, CRP of 35.6mg/dl and preserved renal function. A
computed tomography revealed a right-sided staghorn calculus, with
dilatation of the pelvicalyceal system and attenuation of renal cortex.
Further focal infection was noted at the upper and middle pole of the
right kidney along with enlargement of right ileopsoas muscle. Blood
and urine cultures collected on admission were positive for MRSA.
The patient’s initial therapy with ticarcillin/clavulanate and amikacin
was changed on the third hospital day to meropenem and vancomycin.
The patient gradually became septic, necessitating right nephrectomy
on the fourth hospital day. At surgery, the kidney was found small,
with multiple scars and also with pus inside the renal pelvis and
ureter. Perirenal tissue and psoas muscle were inﬂamed. The MRSA
strain had the “community” phenotype with preserved sensitivity to
trimethoprim-sulfamethoxazole and clindamycin). The assay for PVL
toxin was positive, while PCR for mecA type III and IV was negative
(PCR for mecA type V has been scheduled). Histopathology analysis
reported chronic obstructive pyelonephritis secondary to nephrolithiasis,
along with interstitial nephritis with tubular atrophy and nephrosclerotic
glomerulae. Further infection was extended to pyelocalyceal system,
ureter and peri-renal fatty tissue. The patient completed three weeks
of intravenous vancomycin and was discharged in good condition, albeit
with residual renal insufﬁciency.
Discussion: Community-acquired-MRSA differs from healthcare asso-
ciated MRSA both in epidemiology and genetic characteristics. Recent
reports indicate that CA-MRSA strains have entered tertiary care
hospitals and are the cause of healthcare infections. This is a novel type
of syndrome caused by CA-MRSA. Interestingly, the patient involved
did have risk factors for invasive MRSA infection.
P1450 Family recurrent episodes of skin and soft-tissue infections
by meticillin-susceptible Staphylococcus aureus carrying
Panton-Valentine leukocidin
M. A´lvarez-Martı´nez, F. Marco, C. Pitart, J. Mensa, M. Almela,
J. Martı´nez, A`. Soriano, M. Jime´nez de Anta (Barcelona, ES)
Objectives: Staphylococcus aureus is a common pathogen able of
causing a variety of infections in humans. Pathogenicity is due to several
virulence factors, one of them is Panton-Valentine leukocidin (PVL). The
aim of this study is to show the association between recurrent episodes of
skin and soft-tissue infections in members of the same family, previously
healthly, and the presence of meticillin-susceptible S.aureus (MSSA)
carrying PVL.
Methods: Because of recurrent skin and soft-tissue infections in the
members of the same family, nasal swabs were collected in all members
from March to September 2007. Antimicrobial susceptibility of S.aureus
isolated strains was performed by disk-diffusion method. Genotype
characterisation of PVL was made by coampliﬁcation of the genes lukS-
PV and lukF-PV by PCR. Genomic DNA was extracted from cultures
grown on agar plates, by a modiﬁed DNAeasy tissue kit (QIAGEN)
procedure. Genes were identiﬁed as a 433 pb band in the agarose gel
after electrophoreses of ampliﬁed product.
Results: Recurrent skin and soft-tissue infections were diagnosed in
7 out of 8 members of the same family (father, mother, son #1,
granddaughter, son #2, partner of son #2 and roommate of son #2;
partner of son #1 was not affected) from April 2005 to September 2007,
with no known exposure to healthcare establishments. Abscesses were
located in armpit, back, thigh, knee, leg and buttocks. S.aureus was
isolated in nasal swabs in 5 of the members; nasal swabs were negative
in 2 members, and there were not data from the eighth. S.aureus was
also recovered from one abscess in the armpit. All S.aureus isolates
presented the same phenotype, resistance to penicillin, and susceptibility
to oxacillin, clindamycin, gentamicin, levoﬂoxacin, rifampin, TMP-SMX
and vancomycin. The genes lukS-PV and lukF-PV were identiﬁed in
all 5 of the S.aureus isolated in nasal swabs. All abscesses, except
two, need surgical debridement. Treatment was made with amoxicillin-
clavulanic. Because recurrence of abscesses despite the treatment and
nasal decolonisation, patients carrying MSSA are being treated 5 days
a month with nasal mupirocin and foamy chlorhexidine. At 6 months of
follow up no recurrence has being reported.
Conclusions: Interfamily transmission of MSSA PVL-carrying strain
could be the cause of the recurrent skin and soft-tissue infections. The
decolonisation of nasal carriers of MSSA and hygienic measures could
clear up the problem of recurrence of infections.
P1451 Stress! An investigation of emotional and information
needs of three types of meticillin-resistant Staphylococcus
aureus-carriers in the home situation
S. Vonderhorst, F. Verhoeven, L. van Gemert-Pijnen, M.G.R. Hendrix,
A.W. Friedrich, I. Daniels-Haardt for the Euregio MRSA-net
Twente/Mu¨nsterland
Objectives: To analyse emotional and information needs of Meticillin
Resistant Staphylococcus aureus (MRSA)-carriers in the home situation,
in order to optimise patient education.
Methods: Semi-structured in-depth interviews were conducted with car-
riers of three different MRSA-types (n = 32): Community-Acquired (CA-
MRSA; n = 3), Veterinary-Acquired (VA-MRSA; n = 3) and Hospital-
Associated (HA-MRSA; n = 3), based on cognitive and emotional
coping strategies. A focusgroup with representants of the three MRSA-
types (n = 3) was performed to validate the interview results. Critical
Incident Theory was used to detect stress incidents caused by MRSA-
colonisation.
Results: MRSA-colonisation was particularly perceived as stressful by
CA- and HA-MRSA carriers. Of the 826 reported stress events, 295
(36%) were mentioned by CA-MRSA carriers and 3 40 (41%) by
HA-MRSA carriers. They experienced stress mainly because of feeling
stigmatised and a lack of knowledge, leading to emotional problems and
information needs (174 and 233 of 505 needs citations, respectively).
Used strategies for emotional coping were seeking social support with
family, friends, and colleagues. Information needs were met by actively
searching for background and practical information.
VA-MRSA carriers reported relatively less stress events compared to
CA- and HA-MRSA carriers (191of 826; 23%). Their coping strategies
could be characterised by denial, suppression, and escapism.
In order to fulﬁl information needs, all carriers actively searched
for information on the internet (51 of 164 citations on information
resources), although the internet was perceived as an unreliable source
providing ambiguous information. To fulﬁl emotional needs, CA-
MRSA-carriers consulted the public health department, and HA-MRSA-
carriers contacted the microbiologist, whose information was valued as
insufﬁcient to handle their complaints.
Conclusions: MRSA-colonisation turned out to be a stressful event
for CA- and HA-MRSA-carriers, and therefore they had much more
emotional and information needs compared to VA-MRSA carriers.
Therefore, the provided patient education should depend on the type
of MRSA. CA- and HA-MRSA-carriers have to be addressed more
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personally, e.g., by a personal conversation with a healthcare provider so
that emotional needs are met. VA-MRSA-carriers’ needs can be met by
providing them facts about MRSA.
P1452 First outbreak of MRSA ST398 in a Dutch hospital
M.W.H. Wulf, A. Markestein, F.T.P.M. van der Linden, A. Voss,
C.H.W. Klaassen, C.M. Verduin (Veldhoven, Geldrop, Nijmegen, NL)
Background: In the Netherlands the rate of Meticillin resistant
Staphylococcus aureus infections in hospitals is still low, but community
acquired MRSA occurs more frequently. This increase is mainly caused
by so called ‘non-typable’ MRSA (NT-MRSA, = not typable by PFGE
using Sma1) belonging to MLST type ST398. This strain is widely
disseminated among pigs, veal calves and people in contact with pigs.
Transmission within families as well as solitary cases of colonised
healthcare workers have been described but until now no nosocomial
transmission to multiple patients or HCWs had occurred.
Outbreak: In June 2007 MRSA was isolated from a diabetic foot ulcer
of a patient on a surgical ward. Subsequent screening of contacts among
patients and healthcare workers revealed four additional patients with
MRSA colonisation and/or infection and ﬁve HCW who carried MRSA.
All strains were resistant to tetracycline and non-typable by PFGE. Spa
typing showed that all strains to be t567, a type previously found in
pigs. None of the patients had contact with pigs and/or veal calves. One
healthcare worker lived on a pig farm but neither she nor her partner
came into contact with pigs.
Conclusions: We describe the ﬁrst outbreak of NT-MRSA among
patients and HCW on a surgical ward. While the source is not fully
established it could be the HCW living on a pig farm. This outbreak
makes clear that transmission on a larger scale can occur, even with
NT-MRSA.
P1453 Meticillin-resistant Staphylococcus aureus in horses and
horse personnel at the Finnish veterinary teaching hospital,
2006–2007
M. Rantala, K. Thomson, A-L. Myllyniemi, A. Pitka¨la¨, J. Seppa¨nen,
M. Kanerva, J. Vuopio-Varkila, A. Vainio, O. Lyytika¨inen (Budapest,
HU; Helsinki, FI)
Objectives:We report the emergence of MRSA in horses at the Helsinki
University Veterinary Teaching Hospital, in Finland during October
2006-June 2007.
Methods: After the ﬁrst MRSA isolate in a horse was detected through
routine wound infection surveillance in October 2006, active MRSA
screening of horses at risk (hospitalised >24 h) was implemented.
Swabs were obtained from nostrils, oral mucosa, perineum, and wounds.
Voluntary screening of personnel (nostrils and skin lesions on hands) was
performed on two occasions in 2006 and 2007. MRSA was conﬁrmed
by PCR of mecA and S. aureus speciﬁc nuc genes. MRSA isolates were
characterised by pulsed-ﬁeld gel electrophoresis (PFGE), spa typing,
SCCmec and multilocus sequence typing (MLST). A case was deﬁned
as a horse or staff member with MRSA positive culture result. MRSA
positive horses were handled with barrier nursing precautions in isolation
or cohorts. The importance of hand hygiene and aseptic techniques in
different procedures were emphasised.
Results: The ﬁrst MRSA cluster with 2 wound infections and 3
colonisations among 98 horses (attack rate, AR 5%) occurred during
October-December in 2006; all 24 screened personnel was negative.
The 5 isolates were resistant to macrolides, ﬂuoroquinolones and
aminoglycosides, and identical in PFGE. MRSA strains were of ST125,
spa type t1399, and SCCmec IVA. The second outbreak appeared in May
2007, and was also detected through wound infection surveillance. This
cluster involved 3 infections and 10 colonisations among 61 horses (AR
21%). The index patient was a horse which was hospitalised during the
ﬁrst outbreak but was MRSA negative at that time. In staff screening,
1/25 person was colonised with MRSA. All 14 isolates were resistant to
aminoglycosides and tetracyclines, but susceptible to ﬂuoroquinolones
and macrolides, were non-typeable by PFGE and possessed ST398, spa
type t011, and SCCmec IV.
Conclusion: These are the ﬁrst MRSA infections detected in horses in
Finland. ST125 has been only seldom reported in humans in Finland,
whilst ST398 is a new strain type in our country. Routine wound
infection surveillance in the hospital was crucial in detecting MRSA.
Early outbreak control measures, active screening of patients and staff
training are necessary to prevent spread of MRSA in veterinary premises.
Emerging MRSA infections in animals can cause a public health risk
since strains causing infections in animals cause infections in humans
and vice versa.
P1454 Prevalence of meticillin-resistant Staphylococcus aureus
amongst residents and staff of nursing homes
N. Baldwin, D.F. Gilpin, M. Tunney, P. Kearney, A. Gardiner,
C. Hughes (Belfast, Antrim, UK)
Objectives: It has been suggested that nursing homes can act as
a reservoir for MRSA within the community and may contribute
signiﬁcantly to the spread of MRSA within hospitals when colonised
residents are admitted for medical care. The aim of this study was,
therefore, to determine the prevalence of MRSA amongst residents and
staff in private nursing homes within the Northern Health and Social
Care Trust (NHSCT) in Northern Ireland, and to compare strains isolated
from nursing homes to those currently in circulation in local hospitals.
Methods: Swabs from the anterior nares were taken from 1,111
nursing home residents and 553 staff in 45 private nursing homes and
processed by inoculation onto cefoxitin-containing chromogenic agar.
After 48 h incubation, positive colonies were conﬁrmed as MRSA by
multiplex PCR using primers to detect staphylococcal 16S, nuc and
mecA genes. MRSA strains were further analysed by restriction enzyme
digestion (SmaI), followed by pulsed ﬁeld gel electrophoresis (PFGE)
and compared with strains isolated in local hospitals.
Results: The overall prevalence rate among residents was 23%, with
individual home prevalences ranging from 0% to 73%. The overall
prevalence among staff was found to be 7%, and again this ranged
from 0% to 28%. Staff who were found to be colonised were employed
in various positions throughout the nursing homes, ranging from care
assistants to kitchen workers and maintenance. PFGE analysis showed
that within a home, several MRSA strains could be present, but often,
identical strains were shown to have colonised several individuals within
one home. Staff were found to be colonised with the same strains as
residents. No signiﬁcant differences were determined by PFGE between
nursing home and hospital MRSA isolates.
Conclusions: The results show that MRSA is prevalent within nursing
homes in the NHSCT in Northern Ireland, although the extent of
this prevalence may vary widely between nursing homes. Transmission
of MRSA between nursing homes and hospitals is indicated by the
identiﬁcation of similar strains in both environments. Colonisation of
staff was not limited to only those staff with a direct role in patient care
and this possibly contributes to the transmission of MRSA within the
nursing home environment. These results highlight the need for tailored
infection control guidance for nursing homes.
P1455 The general public’s beliefs about meticillin-resistant
Staphylococcus aureus: a Mental Models approach
F. Verhoeven, J.E.W.C. van Gemert-Pijnen, M.G.R. Hendrix,
A.W. Friedrich, I. Daniels-Haardt for the Euregio MRSA-net
Twente/Mu¨nsterland
Objectives: Meticillin Resistant Staphylococcus aureus (MRSA) is be-
coming an increasing public health threat. Risk communication strategies
should create public awareness in order to prevent misconceptions
leading to non-compliance with infection control measures. Therefore,
risk communication should be matched to the general public’s beliefs
about MRSA. These beliefs were determined in this study.
Methods: The Mental Models Approach was applied. Based on the
literature, a conceptual model was created which was used as an
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interview scheme to elicit (in)correct public beliefs (n = 37). These
beliefs served as items in a a close-ended questionnaire (n = 339) in order
to estimate the prevalence of these beliefs among the general public.
Results: Although the majority of the general public (62%) had
heard of MRSA via television (90%) and/ or newspaper (31%), great
misconceptions exist. E.g., 26% of the public thought MRSA is a
muscular disease, and 9% viewed MRSA as a synonym for repetitive
strain injury.
After revealing the respondents that MRSA is also known as the
hospital bacterium, they appeared to hold correct beliefs concerning
risk factors and consequences of MRSA: 72% believed that MRSA
may cause infections, 59% was convinced hospitalised MRSA-carriers
are treated in isolation, that a weakened immune system increases
one’s risk of getting MRSA-infections (75%), and 62% was aware
that MRSA can also be found outside the hospital. Respondents were
less aware about prevention, reservoir, treatment, and transmission of
MRSA: 70% incorrectly assumed vaccination would prevent MRSA-
colonisation. While 39% thought MRSA can be found in the blood,
only 16% assumed MRSA lives on the skin, and 64% of the sample
was unaware that most antibiotics are ineffective against MRSA. 7%
supposed MRSA is transmitted by insects, and 56% did not know
whether MRSA could be found at cattle or not.
47% of the respondents believed that MRSA is a serious risk for society,
although MRSA was not experienced as a personal health threat.
Conclusions: Although the Dutch general public recognises the well-
known risk factors and consequences of MRSA and is slightly aware
of its threat to society, many misconceptions exist. Important facts, like
MRSA-prevalence among cattle and the presence of MRSA on the skin,
are unfamiliar to the public. Risk communication should show attention
to these misconceptions in order to raise public awareness and prevent
non-compliance with control measures.
P1456 Public knowledge and perceptions of MRSA: results of the
Tayside Survey
P. Easton, F. Williams, K. Stringer, S. Defres, C.A. Marwick,
P.G. Davey, D. Nathwani (Dundee, UK)
Objective: To establish levels of knowledge and concern about MRSA
in the general public in Tayside, Scotland.
Methods: This opportunistic anonymous questionnaire survey was
carried out in 15 general practice surgery waiting areas and two
other establishments. Data collected included respondent demographics,
whether and where respondents had heard of MRSA, knowledge of
possible modes of transmission, treatment possibilities, level of personal
concern, and the perceived accuracy of media information.
Results: Questionnaires were completed by 1000 adults (>16 years old).
59% of respondents were female. 802 (80%) were white Scottish with
4% from non-UK ethnic groups. The age range and ethnic distribution
of respondents were representative of the Tayside population.
856 (86%) of those surveyed had heard of MRSA, 66% via the media.
591 (59%) knew it is a bacterium rather than a virus. The possibility
of healthy carriage was known about by 467 (47%) of respondents, and
32% knew someone who had had MRSA.
Respondents blamed lack of staff hand washing (73%) and lack of
hospital cleanliness (68%) for MRSA infection in hospitals. 50%
thought a patient with MRSA infection could have been infected by an
asymptomatic visitor, while 36% knew that infection could come from
patients’ own carriage. 47% of respondents knew that antibiotics could
be used to treat MRSA.
32% of those surveyed were “a little worried” that if admitted to hospital
they might get MRSA, 20% were “very worried” and 0.7% were “not
at all worried”. Only 59% of respondents stated their perceived level of
risk of getting MRSA infection if admitted to hospital. Answers ranged
from <1% (n = 37) to 75+% (n = 33) with most people selecting between
10% and 50%.
Respondents doubted the accuracy of information about MRSA in
newspapers with 27% thinking it is inaccurate and 36% “not sure”.
55% wanted more information about MRSA citing GP waiting areas as
suitable locations.
Conclusions: This large survey has given new insight into the knowledge
and perception of MRSA among the general public. This knowledge
is reasonably good in some areas but lacking in others. The general
public are sceptical of media reporting and want more information about
MRSA.
P1457 First case of MRSA spondylodiscitis treated successfully
with linezolid
M. Yilmaz, Y. Kilic, A. Mert (Istanbul, TR)
Introduction: Vertebral osteomyelitis is primarily a disease of adults,
with the majority of patients being more than 50 years old. Hematoge-
nous spread from a distant site or focus of infection has remained
the main route for pathogenesis of vertebral osteomyelitis. We present
an MRSA-induced pyogenic spondylodiscitis in an immunocompetent
host, treated successfully with linezolid alone, which occurred 4 months
following a nosocomial MRSA decubitus ulcer infection.
Case Report: A 50-yr-old woman was admitted for severe back pain and
low grade fever of 1.5 months duration. Her back pain had started after
she had been discharged from a hospital where she had stayed for 4
months for cerebrovascular accident. Her medical history records also
revealed that during her hospitalisation she had multiple episodes of
decubitus ulcer infections with MRSA. Physical examination showed no
remnants from stroke but limited activity due to severe back pain upon
movement, including getting out of bed or even turning over in bed. Her
severe pain had markedly restricted ambulation and other activities of
daily living. She did not show any neurological deﬁcits.
Thoracolumber Magnetic-Resonance Imaging (MRI) was characteristic
of T8–T9 spondylodiscitis with loss of height of both vertebral corpi,
vertebral body and disk space enhancements and paravertebral soft tissue
involvement with abscess formation. Fine needle aspiration of this region
yielded Gram-positive cocci identiﬁed as Meticillin resistant S. aureus.
She was started linezolid that she received for 12 weeks (600mg iv, every
12 hours for 6 weeks and 600mg po, every 12 hours for 6 weeks) and
by the third week of therapy, she showed considerable improvement, her
CRP level was normalised, need for analgesia disappeared and was able
to move in bed and walk. The patient was monitored for adverse drug
events but none occurred. She was discharged following an uneventful
treatment course and is doing well.
Discussion: Our case is the ﬁrst case of an MRSA spondylodiscitis,
reported in English language literature, treated successfully with
linezolid. We neither encountered any complications nor any surgical
intervention was necessary. Controlled trials are necessary to show the
efﬁcacy or superiority, if any, of linezolid to glycopepetides in the
treatment of MRSA spondylodiscitis following such promising case
reports with satisfactory outcomes.
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P1458 Comparison of mortality associated with bacteraemia caused
by meticillin-resistant Staphylococcus aureus on arrival at
hospital versus hospital-acquired MRSA bacteraemia: a
cohort analysis from the BURDEN study group
F. Ansari, J. Evans, P. Davey on behalf of the BURDEN (BUrden
of Resistance and Disease in European Nations) Investigators Group
Objective: MRSA bacteraemia is generally regarded as a hospital
acquired infection so may be less likely to be treated empirically when
present on arrival at hospital. We therefore tested the hypothesis that
mortality associated with MRSA bacteraemia on arrival at hospital is
greater than mortality with hospital acquired MRSA bacteraemia.
Methods: The study population was adults (age 18 or over in 2005)
resident in Tayside, Scotland from 1st January 2005 to 30th September
2006 who had a new admission to Ninewells Hospital between 1st
July 2005 and 30th June 2006. The cohort enrolled patients from this
population who were admitted to wards where at least one case of
bacteraemia with MRSA occurred in the study period. We deﬁned
bacteraemia on arrival at hospital as a positive blood culture within
48 h of admission and hospital acquired bacteraemia as a positive blood
culture 48 h after admission. The comparator group was all patients
admitted to the same wards in the same time periods without S. aureus
bacteraemia. The outcome was 30 day mortality, ascertained from the
national registry of deaths. We used multivariable analysis to estimate
the relative risk of mortality associated with MRSA bacteraemia adjusted
for age, sex and Charlson co-morbidity index (CCI) calculated from the
discharge diagnoses of the index admission and of any hospital admission
in the previous year.
Results: The cohort included 4,397 patients; 21 had MRSA bacteraemia
on arrival, 34 had hospital acquired MRSA bacteraemia and 56 had
MSSA bacteraemia. In comparison with other cohort patients those with
MRSA bacteraemia were older (mean age 67 vs 63) and had more
comorbidities. Mean CCI was 3.76 for patients with MRSA bacteraemia
on arrival, 2.56 for hospital acquired MRSA bacteraemia patients and
1.91 for the comparator patients. In comparison with patients with a CCI
of 0 the relative risk of 30 day mortality was 1.98 with CCI 1−2, 2.65
with CCI 3−5 and 4.89 with CCI 6 or greater. After adjustment for age,
sex and CCI the relative risk of 30 day mortality with MRSA bacteraemia
on arrival at hospital (2.48, 95%CI 0.84−7.27) was higher than with
hospital acquired MRSA bacteraemia (1.11, 95%CI 0.38−3.29) and also
higher than with MSSA bacteraemia on arrival at hospital (1.29, 95%CI
0.38−4.39).
Conclusions: Our cohort study supports the hypothesis that MRSA
bacteraemia on arrival at hospital is associated with a higher 30 day
mortality than hospital acquired MRSA bacteraemia.
P1459 Characterisation of baseline meticillin-resistant
Staphylococcus aureus isolates from a phase IV clinical trial
of complicated skin and soft tissue infections
R. Mendes, H. Sader, L. Deshpande, B. Diep, H. Chambers, R. Jones
(North Liberty, San Francisco, US)
Objective: To characterise meticillin-resistant S. aureus (MRSA)
associated with complicated skin and soft tissue infections (cSSTI)
collected during a Phase IV clinical trial comparing linezolid with
vancomycin for the treatment of cSSTI due to MRSA.
Methods: 532 MRSA baseline isolates were collected from subjects
with cSSTI in Latin America (LA; 5 countries, 68 isolates), Europe
(EU; 6 countries, 112), Asia (Singapore [1] and Malaysia [2]), South
Africa (13) and the United States (USA; 336). Susceptibility testing was
performed by CLSI broth microdilution method. Isolates were screened
for heterogeneous resistance to vancomycin (hVISA) using the macro
Etest method. The presence of inducible clindamycin (CC) resistance
(R) phenotype was assessed by D-test; PVL genes and SCCmec types by
PCR and clonality was evaluated by PFGE. Dominant PFGE type strains
from each country were further evaluated by spa typing and multilocus
sequencing typing (MLST).
Results: Most active antimicrobial agents were: linezolid = glycopep-
tides (teicoplanin and vancomycin, 0% R) < quinupristin/dalfopristin
(0.2% R) < trimethoprim/sulfamethoxazole (4.7% R) < tetracycline
(12.6% R) < CC (45.9% R; 18.6% inducible R plus 27.3% constitutive
R) < gatiﬂoxacin (67.1%). (Table). CC-R rates were highest in Asia
and South Africa (100.0%), followed by LA (86.8%), EUR (78.6%) and
the USA (24.1%). Most isolates were R to erythromycin (ERY; 92.9%)
and 29.2% of ERY-R, CC susceptible (S) isolates had a positive D-test
(inducible CC-R). Five (0.9%) isolates were characterised as hVISA, 4
from EUR and 1 from LA. 278 (52.3%) isolates were PVL-positive and
96.8% of those were from the USA. The remaining PVL-positive isolates
were from Colombia (4) and Venezuela (5). 373 (70.1%) isolates were
SCCmec type IV, 89 (16.7%) type II, 44 (8.3%) type I and 26 (4.9%)
type III. Isolates from the USA showed SCCmec type IV (81.2%) or
II (18.8%). The majority of USA isolates clustered within the USA300
PFGE type (77.1%) or USA100 (15.8%). Most countries had a dominant
and unique clone.
Table
Antimicrobial agent MIC50 MIC90 %S %R
1. Linezolid 2 4 100.0 –a
2. Erythromycin >16 >16 7.1 92.1
3. Clindamycin 0.25 >4 54.1 45.9b
4. Gatiﬂoxacin 2 >8 32.2 67.1
5. Tetracycline 0.25 >16 86.8 12.6
6. Trimethoprim/sulfamethoxazole 0.5 0.5 95.2 4.7
7. Quinupristin/dalfopristin 0.25 0.5 99.8 0.2
8. Teicoplanin 1 1 100.0 0.0
9. Vancomycin 1 1 100.0 0.0
aNo resistance breakpoint has been established by the CLSI.
bIncludes constitutive and inducible resistance phenotypes.
Conclusions: All MRSA isolates were S to linezolid and glycopeptides,
and resistance rates were high for ERY, CC and gatiﬂoxacin. The
prevalence of hVISA was low overall and this phenotype was not
observed in the USA. MRSA in the USA were SCCmec IV and PVL
positive, previously associated with community acquired-MRSA; while
in the rest of the world the distribution of SCCmec types and PVL genes
varied by geographical region.
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P1460 Inﬂuence of the method for detecting reduced vancomycin
susceptibility in meticillin-resistant Staphylococcus aureus
bacteraemia. A 14-year study
J.J. Camarena, R. Gonzalez, J.M. Nogueira, R. Zaragoza, P. Andrade,
V. Quintero (Valencia, ES)
Objectives: Actually, in clinical cases of methicilin-resistant Staphy-
lococcus aureus infections with low vancomycin susceptibility
(MIC> 1mg/L) (MRSA-LVS) the new drugs are indicated like
alternative treatment. The aims of this study were to kwon the prevalence
of MRSA-LVS strains in bloodstream infections in our hospital and the
inﬂuence of the method used in routine diagnosis for detecting reduced
vancomycin susceptibility.
Methods: From 1994 to november-2007, 172 patients with a clinically
signiﬁcant MRSA nosocomial or community-adquired bacteraemia were
detected in the Microbiology Department of a university hospital. MIC
vancomycin determination was performed by automated (VITEK2 –
bioMe´rieux) and macro E-Test (AB Biodisk) methods. A compared study
of the MIC vancomycin obtained by both methods in each year of the
period was analised.
Results: During the last 14 years, twenty-one (12.2%) of the MRSA
bacteremic infections showed a LVS (MIC> 1mg/L) with the VITEK-2
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results, in front of 84.3% MRSA-LSV (145 cases) detected by E-Test
method. MIC of all strains was <4mg/L with VITEK2. Fifteen of them
(8.7%) showed a MIC4mg/L by E-Test. The analysis by VITEK2 from
different periods of the study display a signiﬁcant progressive increase
of the MRSA-LVS percentage (1994–99: 6.1%; 2000–03: 7.3%; 2004–
2005: 12.8%; 2006: 14.8%; and 2007: 25.1%). However, by E-Test the
obtained MIC were usually higher since in the 1994–2000 period all
MRSA-LVS were MIC 2mg/L (54.5%) and in 2000–07 period more than
90% showed a MIC 2mg/L. No vancomycin resistant was detected.
Conclusion: Detection in laboratory routine of MRSA with reduced
vancomycin susceptibility is depending on the microbiology method
used. The automated systems show a progressive increase of the MRSA-
LVS bacteremic cases, but is not correlated whit the E-Test MIC results.
The method used to detect MRSA-LVS and their prevalence must be
interpreted cautiously.
P1461 Relationship between hVISA and outcomes among patients
with MRSA bloodstream infections treated with vancomycin
N. Patel, E. Graffunder, A. Evans, M. Helmecke, K. Stellrecht,
T.P. Lodise (Albany, US)
Objectives: To examine the relationship between MRSA strains express
heterogenous resistance to vancomycin (hVISA) and outcomes among
patients with MRSA bloodstream infections treated with vancomycin.
Methods: Study period: 1/05−4/07. Inclusion criteria: (1) 18 yrs,
(2) MRSA bacteraemia (met CDC criteria), (3) received vancomycin
therapy within 48 hours of index MRSA blood culture, and (4) survived
>24 hours after start of therapy. Demographics, co-morbid conditions,
microbiology, and treatment data were collected. MRSA strains with an
MIC value 6mg/L on high inoculum brain heart infusion agar plates
were considered hVISA (method of Walsh et al). Failure was deﬁned
as in-hospital mortality, bacteraemia 7 days on vancomycin therapy,
or recurrence of MRSA bacteraemia within 60 days of vancomycin
discontinuation. Length of stay (LOS) after start of vancomycin was
also compared between groups. Parameters associated with failure by
bivariate analysis (P< 0.2) were included a multivariate analysis and a
stepwise approach was used to identify independent predictors.
Results: During the study period, 92 patients met the inclusion criteria.
Of the 92 patients, 17 (18.5%) were hVISA positive. Comparison of
outcomes between hVISA and non-hVISA patient groups are provided
in the table. In the multivariate analysis, the parameters independently
associated with failure were hVISA (Adjusted odds ratio (AOR), 4.3;
95%CI: 1.3–14.5, p-value=0.02), APACHE-II score 22 (AOR, 16.9;
95%CI: 1.9–80.2, p-value=0.01), and dialysis (AOR, 3.9; 95%CI: 1.3–
11.8, p-value= 0.02.
Bivariate analysis of outcomes between hVISA patient groups
Outcomes hVISA Non-hVISA p-value
(n = 17) (n = 75)
Overall failure 11 (64.7) 21 (28.0) 0.004
In-hospital mortality 4 (23.5) 13 (17.3) 0.5
Bacteraemia 7 days 6 (35.3) 5 (6.7) 0.004
Recurrence within 60 days 6 (35.3) 6 (8.0) 0.003
Hospital LOS after index culture collection,
median days (IQR)
20 (13–32) 13 (7–36) 0.3
*All data presented as number (percent) unless otherwise noted.
Conclusions: The data strongly suggest that patients with hVISA MRSA
bloodstream infections respond poorly to vancomycin. Alternative anti-
MRSA therapies should be considered for these patients.
P1462 Predictors of hVISA among patients with MRSA
bacteraemia
N. Patel, E. Graffunder, A. Evans, M. Helmecke, K. Stellrecht,
T.P. Lodise (Albany, US)
Objectives: The objectives were (1) to determine the proportion
of MRSA bloodstream infections at our institution that express
heterogenous resistance to vancomycin (hVISA) and (2) to identify
clinical predictors of hVISA among the patient population.
Methods: A cross-sectional study was conducted at Albany Medical
Center (Albany, NY). All patients with a positive MRSA bloodstream
culture between 01/2005 and 5/2007 were eligible. Inclusion criteria: age
18 years, non-neutropenic, and MRSA blood culture met CDC criteria
for infection. Demographics, co-morbid conditions, microbiology, and
antibiotic exposure data were collected. MRSA strains with an MIC
value 6mg/L on high inoculum brain heart infusion agar plates were
considered hVISA (method of Walsh et al). Parameters associated with
hVISA by bivariate analysis (P< 0.2) were included a multivariate
analysis and a stepwise approach was used to identify independent
predictors. The CART technique was used to identify signiﬁcant
breakpoints in continuous clinical features that were associated with an
increased proportion of hVISA.
Results: During the study period, 103 patients the inclusion criteria.
Of the 103 patients, 20 (19.4%) were hVISA positive. Bivariate
comparison of clinical paramaters between patients with hVISA and
non-hVISA are provided in the table. Source of infection did not differ
between groups (P = 0.5). In the logistic regression, recent history of
healthcare institution exposure (AOR= 5.7, 95%CI: 1.2–27.8, p = 0.03)
and creatinine clearance (Crcl) 27.6ml/min (AOR=5.3, 95%CI: 1.8–
15.6, P = 0.002) were the only independent predictors of hVISA.
Bivariate analysis of clinical features between hVISA patient groups
Clinical feature Non-hVISA hVISA p-value
Age >59 years* 43 (51.8) 17 (85.0) 0.007
Weight in kg, mean (SD) 82.2 (24.5) 85.5 (24.3) 0.6
Creatinine clearance <27.6ml/min* 19 (22.9) 12 (60.0) 0.001
Recent healthcare institution exposure 52 (62.7) 18 (90.0) 0.02
Dialysis 19 (22.9) 7 (35.0) 0.3
Diabetes mellitus 34 (41.0) 13 (65.0) 0.05
Heart failure 26 (31.3) 5 (25.0) 0.6
COPD 21 (25.3) 4 (20.0) 0.6
Recent surgery in prior 30 days 18 (21.7) 9 (45.0) 0.03
Recent antibiotics in previous 30 days 51 (61.4) 9 (45.0) 0.2
Prior vancomycin 15 (18.1) 1 (5.0) 0.2
Length of stay prior, median (IQR) 1 (0–13) 0.5 (0–12) 0.8
Intensive care unit at onset 23 (27.7) 7 (35.0) 0.5
All data presented as number (percent) unless otherwise indicated.
*CART-derived breakpoint.
Conclusions: Recent healthcare institution exposure and CrCl 27
mL/min were highly predictive of hVISA. This knowledge can be used to
direct therapy decisions by targeting aggressive therapy in pts at highest
risk for hVISA.
P1463 Heteroresistant vancomycin-intermediate Staphylococcus
aureus is associated to recurrent bacteraemia with the same
strain
M. Daskalaki, A. Rodriguez-Aranda, F. Sanz, J.R. Otero, F. Chaves
(Madrid, ES)
Objectives: Recurrence of bacteraemia caused by Staphylococcus aureus
appears despite administration of antibiotics active in vitro and can lead
to increase in patient morbidity and mortality. The aim of study was to
report the prevalence rate of recurrent bacteraemia due to S. aureus in
our institution and to deﬁne the clinical and epidemiologic characteristics
of relapse [isolates with the same Pulsed Field Gel Electrophoresis
(PFGE) pattern] and reinfection (different PFGE pattern). Furthermore,
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to investigate whether relapse with S. aureus meticillin-resistant (MRSA)
was associated with heteroresistance to vancomycin.
Patients and Methods: A retrospective study was conducted between
Jan 2001 and Dec 2006. It included all patients who presented at least
two episodes of S. aureus bacteraemia and recovered after a full course
of antibiotic therapy of the ﬁrst clinical episode. All isolates underwent
a PFGE. A Etest macromethod (BHI agar with an inoculum of 2McF)
was performed on the isolates of the ﬁrst episode of MRSA bacteraemia
and on the isolates of the control group of patients with no recurrence.
MIC8mg/L deﬁned heteroresistance to vancomycin.
Results: During the study period, 883 patients had at least one episode
of S. aureus bacteraemia. Forty three patients had a recurrence with
90 episodes. The recurrence rate was 5%. The PFGE method indicated
that of the 45 episodes of recurrence, 34 (75.5%) were relapse and
11 (24.5%) reinfection. All reinfections were caused by S. aureus
meticillin-susceptible (MSSA) whereas a 58.8% of relapses were caused
by MRSA. According to the univariate analysis, MRSA bacteraemia
was a risk factor for relapse (p< 0.001). Comparing MRSA relapses
with the control group, we found that diabetes, haemodialysis and Etest
macromethod with MIC8mg/L to vancomycin, were associated with
an increased risk of recurrence. From the multivariate logistic regression,
only the Etest macromethod with a MIC 8mg/L to vancomycin was a
predictor of recurrence (OR=4.4, CI 95% (1.03–19.3) p< 0.044.
Conclusions:MRSA is primarily associated with relapse whereas MSSA
is more associated with reinfection. Diabetes and haemodialysis are
risk factors for recurrent bacteraemia. Although we think that recurrent
bacteraemia occurs as a result of multiple factors, heteroresistance to
vancomycin seems to be a probable predictor of relapse. A result of
MIC8mg/L to vancomycin could keep us alarmed of heteroresistance
and furthermore of a possible relapse.
Clostridium difﬁcile: epidemiology
P1464 First cluster of clindamycin-resistant Clostridium difﬁcile
PCR-ribotype 027 associated disease in Switzerland
L. Fenner, A.F. Widmer, A. Goorhuis, C. Harmanus, E.J. Kuijper,
R. Frei (Basel, CH; Leiden, NL)
Objectives: Since June 2006, all patients with Clostridium difﬁcile-
associated diarrhoea (CDAD) are cultured for the presence of C. difﬁcile
at University Hospital Basel (UHBS) and C. difﬁcile isolates are
characterised regarding toxin proﬁle (toxin A/B, binary toxin A/B), PCR-
ribotype, genotype of the putative negative regulator gene (tcdC) and
antibiotic susceptibility. In the time period between October 2006 and
May 2007 a cluster of C. difﬁcile PCR-ribotype 027 at UHBS and a
geriatric hospital was detected and further investigations were performed.
Methods: Genes for toxins A/B and binary toxins were detected by PCR;
tcdC was ampliﬁed and sequenced. PCR-ribotyping and multiple-locus
variable-number tandem-repeat analysis (MLVA) were performed using
standard protocols. Clinical information was obtained by standardised
questionnaires.
Results: From October 2006 to May 2007, the incidence of CDAD at
the geriatric hospital increased from zero to 0.8 cases per 1000 patient
days in March, whereas the incidence at UHBS has not changed. A
total of 16 patients with CDAD caused by C. difﬁcile strain PCR-
ribotype 027 was detected in the time period. The index case was
identiﬁed in October 2006 as a 82-year old female patient previously
hospitalised abroad. C. difﬁcile ribotype 027 was detected in two other
patients at UHBS, whereas 13 cases were detected at the geriatric
hospital. The outbreak ended by the end of June 2007 and since
then no other case with this strain was observed despite intensive
epidemiological and laboratory-based surveillance. The median age of
the 16 patients was 83.5 years (interquartile range 79–92). All isolates
were highly resistant to moxiﬂoxacin (MIC> 32mg/L) and clindamcyin
(MIC> 256mg/L). Genes for toxins A/B, binary toxins and ermB were
detected by PCR in all strains. tcdC gene showed a 18-bp deletion and
a single nucleotide deletion at position 117. MLVA typing revealed one
cluster of genetically highly related (STRD< 2) clindamcyin-resistant
PCR-ribotype 027 strains which differed considerable from control 027
isolates.
Conclusions: We report the ﬁrst cluster of clindamycin-resistant
Clostridium difﬁcile PCR-ribotype 027 in Switzerland, most likely
imported from abroad. When the index patient was transferred to a
geriatric hospital the strain did propagate, but remained undetected by
routine epidemiological surveillance until molecular characterisation of
strains was performed. MLVA proved to be a valuable new typing tool.
P1465 A two-centre study to determine possible geographic
differences in the prevalence of Clostridium difﬁcile
ribotypes in Scotland
D.J. Brown, L. Renwick, M. Lockhart, C. Wiuff, H. Mather, J.E. Coia
(Glasgow, Dundee, UK)
A mandatory national surveillance programme for Clostridium difﬁcile
was introduced in Scotland in 2006 in response to its increasing
prevalence among nosocomial infections in the UK and other countries.
In a parallel prospective typing study, ribotype 106 accounted for more
than 65% of isolates examined in Scotland while the 027 hypervirulent
strain was detected only twice. These ﬁndings vary signiﬁcantly from
reports from England and Wales where ribotypes 001, 027 and 106
each accounted for approximately 25%, and an earlier study in south
east Scotland where type 001 accounted for more than 75%. This
suggests possible geographical or temporal differences in the prevalence
of circulating types.
Objectives: This study was undertaken to determine the ribotype
prevalence of C. difﬁcile in two large teaching hospitals in two distinct
geographical regions of Scotland, one in the west and one in the east,
over the same period in May 2007–June 2007.
Methods: Faecal samples were obtained from consecutive, toxin-positive
patients (50 from hospital E (east) and 54 from hospital W (west)).
C. difﬁcile was cultured from 97 samples and these isolates were typed by
PCR-ribotyping according the method described by O’Neill et al. (1996).
Ribotype patterns were compared with reference strains obtained from
the Anaerobe Reference Laboratory, Cardiff. Patterns were analysed and
compared using BioNumerics® software.
Results: Ribotype 106 was the predominant type in both hospital E
(62.2%) and hospital W (65.4%). Type 001 accounted for 13.3%(E) and
11.5%(W), type 002 accounted for 4.4%(E) and 5.8%(W), type 005
accounted for 2.2%(E) and 3.8%(W). Single isolates of types 018 and
020 were found in both hospitals E and W. Two isolates of 015 and a
single isolate of 026 were found only in hospital E while single isolates
of 012, 014, 017 and 081 were isolated from hospital W. The patterns
from four isolates produced previously unidentiﬁed ribotype patterns that
have yet to be matched with patterns in the UK database.
Conclusion: The prevalence of the most common PCR-ribotypes of
C. difﬁcile isolated at two hospitals during the same time period were the
same suggesting no geographic difference exists in Scotland. This result
supports data from the prospective study indicating that differences exist
in the distribution of ribotypes observed in Scotland and in England
& Wales. Furthermore, type 106 has now replaced type 001 as the
predominant type in Scotland.
P1466 Community-diagnosed Clostridium difﬁcile infection:
preliminary results from enhanced surveillance
C. Jackson, A. Jones, R. Blackburn, J. Davies, N. Potz, A. Pearson
(London, UK)
Objectives: To assess the contribution of cases presenting in the
community to the burden of Clostridium difﬁcile infection as reported
through the English mandatory surveillance system.
Methods: Since April 2007, enhanced surveillance data on C. difﬁcile
infections have been collected through a web-enabled reporting system.
All NHS (National Health Service) acute Trusts (hospital groups) in
England are required to report all C. difﬁcile positive specimens meeting
the case deﬁnition which are processed by their laboratories. The dataset
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includes a ﬁeld indicating the patient location (e.g. acute trust hospital,
GP) at the time of specimen collection. This analysis refers to records
with specimen dates in July – September 2007.
Results: ~13,000 cases of C. difﬁcile infection were reported through
the web-based system between July and September 2007. Overall, 22%
of records gave the patient location at the time of specimen collection as
being outside an acute Trust hospital. This was highly variable between
Trusts, ranging from 0% to 58% (Figure). 16% of specimens reported
by Acute Teaching Trusts were obtained in non-acute settings; in Large
Acute, Medium Acute and Small Acute Trusts the ﬁgure was ~22–25%.
In specialist Trusts, all C. difﬁcile positive specimens were taken from
patients in acute Trust hospitals.
Proportion of C. difﬁcile positive specimens taken in non-acute settings:
England, July–September 2007.
Conclusion: A substantial proportion of C. difﬁcile positive specimens
processed by acute Trust laboratories, and reported as per the
requirements of the mandatory surveillance scheme, are taken in non-
acute settings. Planned reﬁnements to the surveillance system will
help to better identify what proportion of these infections, as well as
those detected within the acute setting, are community-acquired. These
ﬁndings will inform the deﬁnition of the Department of Health’s planned
C. difﬁcile target.
P1467 Phenotypic and genotypic characterisation of Clostridium
difﬁcile isolates in French hospitals from 2001 to 2007
C. Fantinato, P. Cruaud, A. Collignon, I. Poilane (Bondy, Chatenay
Malabry, FR)
Clostridium difﬁcile is an important cause of nosocomial bacterial
diarrhoea in adults. Recent outbreaks of C. difﬁcile-associated disease
(CDAD) have been described in North America and Europe related to
the emergence of a hypervirulent C. difﬁcile strain NAP1/027 that is
resistant to erythromycin and moxiﬂoxacin.
Objectives: The objective of this study was to follow the epidemiology
of CDAD in Jean Verdier-Rene´ Muret hospitals over a 6-year period
by investigating antibiotic susceptibility and molecular characteristics of
C. difﬁcile isolates.
Methods: Fifty strains isolated between 2001 and 2007 from patients
with CDAD were selected. Toxins A and B were detected with
an immunoenzymatic method (ICTAB, Meridian). Binary toxin was
detected by cdtA and cdtB PCR according to Stubbs et al. Antibiotic
susceptibility to metronidazole, vancomycin, erythromycin, moxiﬂoxacin
and linezolid was determined by the disk diffusion method. MICs of
metronidazole, vancomycin and tigecyclin were determined by the E-test
method. Isolates were typed by PCR-ribotyping according to Bidet et al.
Results: From 2001 to 2007, all the isolates studied were susceptible
to metronidazole, vancomycin and tigecyclin. In contrast, we observed
a signiﬁcant decrease of susceptibility to moxiﬂoxacin (100% in 2001
vs 28.5% in 2007) and to erythromycin (60% in 2001 vs 14% in 2007).
Toxins A/B were detected in all the isolates. The binary toxin was
detected in 15% of the isolates; its presence was not correlated with
a speciﬁc PCR-ribotype. Toxin proﬁle TcdA+TcdB+CDT− was the
most common (81.8% of isolates). PCR-Ribotype “18” was the most
prevalent detected since 2006. The isolates displaying this PCR-ribotype
were resistant to erythromycin and moxiﬂoxacin and were principally
found in the same unit, suggesting cross infection.
Conclusion: This study showed that diverse clones of C. difﬁcile
circulated during these 6 years with stable susceptibility to metronidazole
and vancomycin. Recently, an epidemic strain ribotype “18” resistant
to erythromycin and moxiﬂoxacin has emerged in one unit where
ﬂuoroquinolones are frequently used demonstrating the role of antibiotic
selection pressure. The emergence of this strain could explain the
signiﬁcant decrease of susceptibility to moxiﬂoxacin and erythromycin
observed in 2007. However, today, no isolate with a ribotype matching
PCR-ribotype 027 was detected.
P1468 Epidemiology of Clostridium difﬁcile in Scotland – A possible
shift in ribotype distribution
D.J. Brown, C. Wiuff, H. Mather, J.E. Coia (Glasgow, UK)
Clostridium difﬁcile Associated Disease (CDAD) is considered the lead-
ing cause of healthcare associated diarrhoea in Scotland. Surveillance
of CDAD became mandatory in Scotland in 2006 in persons over 65
years old in the healthcare setting. However, only few isolates have been
typed under the mandatory programme in its ﬁrst year. At the same time
a prospective ribotyping study was carried out by an enteric pathogen
laboratory. The results of this study, which is the most recent molecular
typing study of C. difﬁcile isolates from across Scotland, are presented
here.
Objective: The aim of this study is to determine the current distribution
of ribotypes of C. difﬁcile obtained from hospital patients across
Scotland, and by comparison with previous typing studies determine
whether a shift in the strain distribution of C. difﬁcile has occurred.
Methods: 130 isolates were submitted to the laboratory over a period
of 18 months from 12 hospitals in 4 healthboard areas in Scotland.
All isolates were typed using PCR ribotyping according the method
described by O’Neill et al. (1996). Variable-length intragenic spacer
regions of the rRNA complex were ampliﬁed by PCR, and ribotype
patterns were compared directly with those of reference strains obtained
from the UK national reference laboratory for C. difﬁcile in Cardiff.
Results: Most isolates were ribotype 106 (64.6%), with 001 (23.1%),
077 (3.1%), 015 (1.5%) and two isolates of the hypervirulent ribotype
027 (1.5%) were also identiﬁed as part of this study. Furthermore, single
isolates of ribotypes 002, 005, 078, 081 and 188 were identiﬁed. A total
of 3 isolates produced previously unidentiﬁed ribotype patterns, which
have yet to be matched with patterns in the UK database. The less
common ribotypes and the unidentiﬁed ribotypes amounted to 6% of all
typed isolates. The distribution of ribotypes was stable over the18-month
period.
Conclusion: Recent data from England and Wales have indicated that
ribotypes 106, 027 and 001 each account for about 26% of cases in 2005.
A previous study carried out in south-east Scotland in 2005 identiﬁed
ribotype 001 in 75.8% of cases. This current study demonstrates that
ribotype 106 has become the predominant ribotype in Scotland. Ribotype
027 was also isolated for the ﬁrst time in Scotland in this study.
P1469 The epidemiology of the second phase of a hospital
outbreak of Clostridium difﬁcile-associated diarrhoea, Stoke
Mandeville, UK
C. Okoro, J. O’Driscoll, A. Smith, A. Kirk, E. Haworth (London,
Stoke Mandeville, Oxford, UK)
Objectives: To establish the epidemiology of the second phase of a
hospital outbreak of Clostridium difﬁcile associated diarrhoea (CDAD
outbreak at Stoke Mandeville Hospital (SMH) from 1 December 2004
to 31 May 2005, the cases due to ribotype 027, risk factors and document
control measures.
Methods: 229 incident cases of CDAD and readmissions with positive
isolates for both admissions to Buckinghamshire Hospitals NHS Trust
were included. Those with onset of symptoms more than 3 days
from admission were considered hospital acquired cases and those
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with symptom onset within 72 hours of admission were considered
community acquired. Relapses were deﬁned as 2 conﬁrmed diagnoses
more than 3 months apart. Patient demographic and clinical information
was extracted from the case notes in compliance with data protection and
patient conﬁdentiality requirements as agreed by the Local Research
Ethics Committee. Autopsy ﬁndings were extracted from pathology
systems and infection control measures obtained from the infection
control records and clinical notes. Data analysis used STATA 8.2.
Results: The incidence of CDAD at SMH was 2.11/1000 bed days and
accounted 5312 bed days. The monthly incidence was highest in the
winter months with a peak in January. Most cases were due to the 027
ribotype. Eighty eight percent of patients were over 65 years of age, 60%
were female and 25% were community acquired. The mean length of
stay (LOS) in hospital before onset of symptoms was 12.4 days, with an
additional mean LOS of 35.4 days before discharge. MRSA coinfection
occureed in 16.3%. The outbreak was associated with high levels of
ciproﬂoxacin use. CDAD attributable mortality was 15%.
Conclusion: This study conﬁrmed 027 ribotype as an outbreak strain
in the UK with high mortality and morbidity rates which raised the
national proﬁle of CDAD. Applying the national additional hospital cost
of £4000/CDAD the outbreak cost its NHS Trust about £900,000 over
6 months.
P1470 Costs of nosocomial Clostridium difﬁcile-associated
diarrhoea
R.P. Vonberg, C. Reichardt, M. Behnke, F. Schwab, S. Zindler,
P. Gastmeier (Hannover, Berlin, DE)
Objectives: Nosocomial Clostridium difﬁcile-associated diarrhoea
(CDAD) is a common infection in hospitals. A matched case-control
study was done to determine hospital-wide excess costs due to CDAD.
Methods: Cases of CDAD were assessed by prospective hospital-wide
surveillance in a tertiary care university hospital in 2006. Nosocomial
CDAD cases (>72 hours after admission) were matched to control
patients without CDAD in a ratio 1:3 using: (a) the same DRG in
the same year, (b) a control’s length of stay (LOS)  time frame of
cases before infection, (c) a Charlson co-morbidity index ±1. Data
on overall costs per case were provided from the ﬁnancial controlling
department. We excluded patients in psychiatry (who do not receive
DRG codes) and paediatric patients. Evaluation of the application of
matching criteria was done by Wilcoxon test for independent samples
and Fisher’s Exact test. Differences in LOS and costs between matched
cases and controls were calculated following three parameters for the
matched pairs: (a) difference in the LOS, (b) difference in costs per
patient, (c) difference in costs per patient-day. For all parameters median
with 95% conﬁdence interval (CI95) non-parametric (distribution free)
were calculated. A p-value <0.05 or a CI95 that excludes the zero were
considered signiﬁcant.
Results: There were a total of 116 CDAD cases in 2006. Data on costs
were available for 103 CDAD cases (thereof 75 nosocomial CDAD
cases). Out of 4,702 potential control patients, matching was possible
for 45 nosocomial CDAD cases. Cases and controls did not differ with
respect to age (p = 0.930), gender (p = 0.292), LOS on intensive care units
(p = 0.463), and Charlson co-morbidity index (p = 0.902). The difference
in the total LOS in the hospital showed that CDAD cases (median 27
days) stayed signiﬁcant longer than their matched controls (median 20
days; p = 0.006). Overall costs for the 1,634 patient days of the 45 CDAD
cases were 2,429,785 Euro (median 33,840 Euro per case) compared to
6,363,675 Euro for the 3,663 patient days for the 135 controls (median
18,981 Euro per control). CDAD cases were signiﬁcant more expensive
than their matched controls (median 7,147 Euro; CI95: 4,067−9,276).
Conclusion: Nosocomial CDAD is associated with high costs for
healthcare systems. Clinicians should be aware of the ﬁnancial impact
of this disease, and application of appropriate infection control measures
is recommended in order to avoid further pathogen spread.
P1471 First patient-centred, multidisciplinary clinical audit in
hospital/community, study of risk factors, clinical outcomes
and patient perspectives of Clostridium difﬁcile-associated
diarrhoea
A. Guleri, R. Sharma, R. Palmer, T. Huda, S. Ambalkar, P. Luxton
(Blackpool, Liverpool, UK)
Objectives: Blackpool Victoria Hospital is a large DGH in NW England
with two regional speciality centres. Reduction in HCAI is of top
priority and has personal engagement of its chief executive. To inform
designing of a comprehensive strategy for reducing rate of CDAD, the
ﬁrst patient centred, multidisciplinary clinical audit, enhanced to study
associated risk factors, clinical outcomes (cause analysis of deaths) and
patients perspective of their disease was undertaken this year across the
trust/community. Contributors included patients, hospital doctors, GP
and link nurses.
Method: Symptomatic Clostridium difﬁcile toxin positive patients
between February – April 2007 were included. When possible, Patients
completed part B of the questionnaire.
Results: 63 completed questionnaires were obtained from 147 CDT+ve
patients in hospital and community. 85.7% were over 65-years of age and
68.2% females. Majority of patients were from medical units including
care of elderly and were admitted to hospital from their own home. 98%
specimens were received in lab and 90.1% tested within 24-hrs. Oral
Metronidazole used 1st line and up to 78% responded within 5−7 days.
Variable non-compliance to initiation of infection prevention protocols
noted. Consistent correlation of previous ceftriaxone, ciproﬂoxacin,
co-amoxiclav, levoﬂoxacin, imipenem, clarithromycin and PPI was
observed. No association with previous clindamycin use observed. 6
surgical patients had received simultaneous ciproﬂoxacin /cefuroxime
and metronidazole. Most patients became symptomatic within 1−2 weeks
of antibiotic use. 2 patients with fulminant colitis had colectomy and 6
patients deaths unrelated/related/caused to CDAD. Patient perspectives
included disease associated distress to compliments on excellent
management. Variable non-compliance to infection control practices
observed by patients.
Conclusion: Variable non-compliance to hospital CDAD management
policy and antibiotic formulary; infection control practices; treatment
of CDAD; CDT testing; duration and use of antibiotics; informing
patients/relatives, and others. Action plan included engagement of
directors, consultants, managers, senior nurse leads; change to ‘narrow
spectrum’ antibiotic policy; revised CDAD management policy, and
others.
A systematic feedback with a named responsible person for proposed
actions and discussed at different directorates. A repeat audit is planned
at the same time next year. For detailed presentation.
P1472 Factors associated with the severity of Clostridium
difﬁcile-associated disease: a one-year prospective study in
a Lyon university hospital, France
G. Maujean, A. Brulet, M. Giard, V. Kottmann, P. Girardo, M. Reverdy,
J. Etienne, P. Vanhems (Lyon, FR)
Objectives: The hypervirulent Clostridium difﬁcile strain (NAP1/027)
that emerged in North America, Japan and Europe in 2003, was related
with outbreaks of severe Clostridium difﬁcile-associated disease (CDAD)
in North France. After a national alert in March 2006, an active
surveillance was started in a French university hospital (1,000 beds) from
November 1, 2006 to October 31, 2007 to describe cases of CDAD and
to investigate the factors associated with a severe disease.
Methods: Hospitalised patients with either positive stool cytotoxin test
or positive culture of toxin producing CD strain were included. For each
case, demographic characteristics, medical history, microbiological data
and risk factors for CDAD were collected according to a standardised
national data collection form. Cases were classiﬁed as severe (S-
CDAD) if one of the following criteria was present: #1) hospitalisation
for a community-onset CDAD, #2) admission in intensive care unit
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(ICU), #3) elevated leukocytosis, #4) megacolon, #5) colic perforation,
#6) colectomy, #7) death within 30 days after onset related to
CDAD. Severe cases were compared to mild cases using Chi2 or
nonparametric tests. Multivariate logistic regression was used for risk
factors identiﬁcation.
Results: A total of 70 patients (47.1% male, median age of 68.5, range 1
to 96) were included. The average duration of hospital stay was 25 days
(range 1 to 116). Among the 14 (20%) S-CDAD cases, 2 (14.3%) died
and 2 others were admitted in ICU. The characteristics of the population
are described in the table.
Abdominal pain was independently associated with a S-CDAD after
multiple logistic regression (odds ratio = 12.7; [95% conﬁdence interval:
1.4–114.4]; p = 0.02).
Conclusion: Abdominal pain is a signiﬁcant factor associated with
S-CDAD. The recent detection of a severe case related to a 027 strain in
October 2007 in our hospital and the high proportion of hospital-acquired
CDAD underline the importance of such a surveillance in healthcare
settings.
Table: Characteristics of the population included in the surveillance
(n = 70)
CDAD acquisition N (%)
Hospital-acquired 31 (44.3)
Community-onset 25 (35.7)
Imported from another hospital 8 (11.4)
CDAD symptoms
Diarrhoea 68 (97.1)
Abdominal pain 34 (48.6)
Fever >38ºC 25 (35.7)
Ileus 7(10)
Microbiological data
Positive stool cytotoxin test 59 (84.3)
Negative cytotoxin test and positive culture 10 (14.3)
Moxiﬂoxacin resistant strain 5 (7.1)
NAP1/027 1 (1.4)
CDAD risk factors
Antimicrobial therapy 43 (61.4)
Laxatives 17 (24.3)
Immunosuppressive agents 9 (12.9)
Gastrointestinal surgery 3 (4.3)
Preparation before colonoscopy l (l.4)
P1473 Clostridium difﬁcile-associated diseases: a 2-year study
M.R. Vicente, M. Pariente, E. Riquelme, C. Sa´inz de Baranda,
M. Martı´nez, M.D. Crespo (Albacete, ES)
Objective: Establishing the clinical and epidemiological features of
patients with C. difﬁcile-associated diseases (CDAD) and the risk factors
connected with such disease in our environment.
Methods: A retrospective study of patients with a positive detection of
C. difﬁcile toxin in human faeces between 2006–2007 in the Health Area
of our hospital. Qualitative detection of Clostridium difﬁcile toxins A and
B was made using the VIDAS® C. difﬁcile toxin A&B (Biome´rieux ®)
system, and clinical and epidemiological details of patients were gathered
by checking their certiﬁcates of discharge.
Results: The study of C. difﬁcile toxin was made on 1,289 patients and
was positive in 7% (90) of total cases. Seventy-three (81%) patients
were still in hospital and were 74 years old on average. 52% of them
were women. Distribution according to services was as follows: 24.6%
had been admitted to Internal Medicine, 23.3% to Geriatrics, 9.6%
to Haematology and the rest to other services. Most of them showed
underlying pathologies – 23.2% were oncological patients, 22% suffered
from COPD, 19% from diabetes and 31% from other pathologies. 15%
did not show any underlying disease. As to treatments prior to CDAD,
15 patients were following a cherotherapeutic treatment, 14 a corticoids
treatment, 55 an antibiotic treatment and in 11 cases no treatment
had been reported. The most frequent antibiotics were: b-lactams (35),
quinolones (20), aminoglycosides (11) and other (9). Once CDAD was
diagnosed, 64.4% of patients received a treatment with metronidazole
during 10 days on average, 7% received vancomycin, 4% did not need
any treatment and in 24.6% of cases no treatment was reported. 14% of
patients died, but no exitus was directly related to CDAD.
Conclusion: CDAD is the most frequent cause of nosocomial diarrhoea,
but our study shows that a ﬁfth of patients come from our community –
thus we can consider it an emerging community infection. b-lactams
and macrolides have been traditionally reported to show a higher risk of
causing CDAD but, as in other studies, we can also see that treatment
with quinolones contribute to the appearance of diarrhoea. Elderly people
suffering from an underlying disease are still at a high risk of suffering
from CDAD.
P1474 Trends of incidence of Clostridium difﬁcile-associated disease
in a French university hospital between 2002 and 2006
M. Giard, P. Girardo, J. Etienne, M.E. Reverdy, P. Vanhems (Lyon, FR)
Objectives: The incidence of Clostridium difﬁcile-associated disease
(CDAD) ﬁrst increased in North America, and was associated with the
emergence of the highly virulent and antibiotic resistant strain 027.
In France, the investigation of the ﬁrst nosocomial outbreak due to
C. difﬁcile 027 highlighted the need for epidemiological baseline data. In
response to a national alert, the objective of this study was to determine
if CDAD incidence was increasing in a university teaching hospital.
Methods: An analysis of laboratory data collected prospectively was
conducted to report the incidence of C. difﬁcile toxin A detected in
hospitalised patients between 2002 and 2006. The detection of toxin A
was carried out on every suspected stool, while diagnosis policy did
not include systematic toxin B detection. The number of admissions
and number of patient-days per year were used as denominator data. A
CDAD was deﬁned as diarrhoea and detection of C. difﬁcile toxin A
in a clinical stool specimen. Analyses included incidence rate, number
and percentage of C. difﬁcile toxin A detection amongst stool specimens
analysed, and population description.
Results: A total of 3,931 specimen stools were analysed for C. difﬁcile
toxin A detection, amongst which 284 (7.2%) were found positive. The
incidence rate decreased over time (Table 1).
The percentage of C. difﬁcile toxin A detected amongst all stool
specimens analysed for C. difﬁcile toxin A detection decreased over
time (p< 0.001). The absolute number of C. difﬁcile toxin A detected
was higher in medical and surgical units but the percentage in all clinical
stool specimens analysed was higher in gynaecology-obstetrical and
emergency departments (Table 2).
A total of 3,363 patients had a stool specimen analysed for C. difﬁcile
toxin A detection, among whom 275 (8.2%) had a positive test. The
percentage of women was higher amongst patients tested positive (56%)
than negative (48%) (p = 0.01). Mean age of patients having C. difﬁcile
toxin A detected was 61.7 years. The number of C. difﬁcile toxin A
detection increased with age.
Conclusion: CDAD incidence does not increase over time. C. difﬁcile
strain 027 was detected recently in this hospital for one patient,
underlying the need of epidemiological vigilance, appropriate use of
antibiotics and strict implementation of infection control measures to
prevent C. difﬁcile spread.
Table 1. Incidence of Clostridium difﬁcile-associated disease (CDAD) by year
2002 2003 2004 2005 2006 Total
Incidence, /1000 admissions1 0.87 1.04 0.57 0.48 0.49 0.68
Density of incidence, /10,000 patient-days1 2.49 2.44 1.41 1.13 1.31 1.73
1Chi-square for trend: p< 0.01.
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Table 2. Trend of C. difﬁcile toxin A detection by year
Speciality C. difﬁcile toxin A detected
2002 2003 2004 2005 2006 Total
n1 %2 n % n % n % n % n %
Medicine 41 12.2 41 8.7 26 5.2 28 5.1 28 5.6 164 7.0
Surgery 14 9.0 20 11.8 13 7.1 3 1.6 8 4.8 58 6.7
Intensive care unit 13 15.5 20 13.0 8 5.4 4 3.1 6 4.6 51 7.9
Gynaecology–obstetrics 0 0.0 2 28.6 1 12.5 1 33.3 2 20.0 6 20.7
Emergency 1 50.0 1 33.3 0 0.0 2 25.0 1 9.1 5 17.2
Total 69 11.9 84 10.4 48 5.7 38 4.3 45 5.5 284 7.2
1Number of C. difﬁcile toxin A detected.
2Percentage of C. difﬁcile toxin A detected above all clinical stool specimen
analysed for C. difﬁcile toxin detection.
P1475 Emerging disease due to Clostridium difﬁcile PCR Ribotype
078 in the Netherlands
A. Goorhuis, D. Bakker, J. Corver, D. Notermans, C. Harmanus,
S. Debast, E. Kuijper (Leiden, Bilthoven, Amersfoort, NL)
Objective: Since the National Reference laboratory noticed an gradual
increase of human Clostridium difﬁcile associated disease (CDAD) due
to (PCR)(Ribo)Type 078, patients data and strains were investigated in
more detail.
Methods: Strains submitted to the Ref lab were characterised by PCR
ribotyping and presence of toxin genes. In this study, all strains belonging
to Type 078 were sequenced in tcdC region and investigated by Multiple
Locus Variable Number of Tandem Repeat Analysis (MLVA). Porcine
Type 078 strains (n = 30)available from another study were also included.
A standardised questionnaire was used to obtain patient data.
Results: Between February 2005 and November 2007, 81 healthcare
facilities submitted strains from 1553 patients to the Ref lab. Of these
strains, 285 (18.4%) belonged to Type 027, 123 (7.9%) to Type 078
and 1145 (73.7%)to other types. Type 078 was the third most frequently
found type. A gradual increase of type 078 strains was observed from
August 2006 onwards. All 51 Type 078 strains contained tcdA, tcdB
and binary toxin genes. In TcdC, a point mutation was found at position
184, resulting in a stopcodon. MLVA analysis of 20 human and 10
porcine Type 078 isolates showed 2 genetically highly related clusters.
Clinical information was available from 647 of 1553 patients (41.7%).
In comparison with patients with CDAD due to Type 027, patients with
Type 078 were younger (67.8 years vs. 73.6 years: p< 0.0005)and had
more often community-associated disease (27.3% vs 8.3%, OR 4.13,
95% C.I. 1.63–10.4). Severe diarrhoea was found in 40.7%, 35.6% and
27.2% of patients with Type 027, Type 078 and other types, respectively,
with a signiﬁcant difference between Type 027 and other types (OR
5.52, 95% C.I. 2.45–12.5). Overall mortality was 13.1%, 2.3% and
6.9% in patients with Type 027, type 078 and other types. The use
of ﬂuoroquinolones in Type 027 patients was signiﬁcantly higher than
in patients with other types (33.6% vs 19.5%, OR 2.60, 95% C.I.
1.24−5.46).
Conclusions: Animal and human C. difﬁcile Type 078 strains are
genetically highly related, supporting the hypothesis that transmission
is possible. Animal and human Type 078 contained a point mutation in
tcdC at position 184 resulting in a stopcodon and a defective TcdC. The
clinical spectrum of CDAD caused by type 078 is intermediate between
CDAD caused by Type 027 and CDAD caused by other types, but Type
078 presented more frequently as community associated disease.
P1476 Application of MLVA to study the spread of Clostridium
difﬁcile toxin A-negative strains of PCR ribotype 017 in a
general hospital in Buenos Aires, Argentina
A. Goorhuis, M. Legaria, C. Harmanus, C. Klaassen, J. Brazier,
E. Kuijper (Leiden, NL; Buenos Aires, AR; Nijmegen, NL; Wales, UK)
Objectives: Clostridium difﬁcile isolates of patients with C. difﬁcile-
associated disease (CDAD) usually produce both toxin A and toxin B,
but an increasing number of reports mention infections due to TcdA-
negative, TcdB-positive (A-/B+) strains. The ﬁnding of a cluster of
A-/B+ strains in a 200-bed general Argentinean hospital resulted in a
prospective study to the occurrence and spread of this variant strain using
Multiple-Locus Variable-Number-Tandem-Repeat Analysis (MLVA).
Methods: From May 2000 until December 2005, faecal samples from all
patients with clinically suspected CDAD were tested for CDAD. Toxin
positive samples were cultured for the presence of C. difﬁcile. All isolates
were characterised by PCR ribotyping, toxinotyping, MLVA, presence
of binary toxin genes, and alterations of toxin genes. Demographic and
clinical data were collected from all CDAD patients using standardised
questionnaires. Crude relative risks were estimated as odds ratios and
presented with a 95% conﬁdence interval (95%CI). All analyses were
performed using the SPSS for Windows software package, version 13.0.
Results: Between 2000 and 2005, the incidence of CDAD per 1,000
admissions was 3.7 (2000), 8.4 (2001), 6.7 (2002), 4.3 (2003), 4.8
(2004) and 4.2 (2005). The annual percentage of Type 017 strains was
7.7%, 64.6%, 91.4%, 92.0%, 75.0% and 86.4%, respectively. All type
017 strains belonged to toxinotype VIII and had a 1.8 kb deletion in
tcdA. Binary toxin genes were not found. Comparison of 112 Type 017
CDAD patients with 41 non-Type 017 patients revealed that Type 017
patients were more often male (68.8% vs. 46.3%, OR 2.55, 95% C.I.
1.23−5.50). Among the Type 017 isolates, 4 genetically highly related
subclusters (STRD2) were identiﬁed, indicative of clonal spread. This
spread showed no association in time, but was restricted to wards of
Internal Medicine and Pulmonology. Of 10 patients with 21 episodes of
Type 017 CDAD, 55% of recurrences concerned a different MLVA type,
suggesting that the recurrent disease was not a relapse with an identical
strain.
Conclusion: We conclude that C. difﬁcile Type 017 gradually replaced
other circulating PCR ribotypes and that MLVA was capable to recognise
spread on speciﬁc wards.
P1477 Outbreak with Clostridium difﬁcile PCR-ribotypes 027 and
017 simultaneously in a Dutch hospital
B. Goorhuis, S.B. De Bast, J.C. Dutilh, C. van Kinschot, C. Harmanus,
E.J. Kuijper (Leiden, Amersfoort, NL)
Objective: At a large outbreak of Clostridium difﬁcile (CD) in a 1100
bed hospital in The Netherlands, all strains were characterised and
patient information collected. Predisposing factors were investigated with
emphasis on previous antibiotic usage.
Methods: C. difﬁcile strains were characterised by PCR-ribotyping and
toxinotyping. To investigate antibiotic use in the 3 months prior to
CDAD, Deﬁned Daily Doses (DDD’s), as deﬁned by the WHO for each
antibiotic were calculated per individual patient. Data on mortality were
derived from the hospital database until 6 months after diagnosis of
CDAD. Two groups of control patients were selected: a control group
with diarhoea due to other causes than CDAD (group 1) and a control
group without diarroea (group 2).
Results: Between May 2005 and January 2007, 180 CDAD patients
were diagnosed; 48 (26.7%) with Type 027, 58 (32.2%) with type 017
and 74 (41.1%) with other types. All strains form Type 027 belonged
to toxinotype III, whereas all Type 017 strains lacked the tcdA gene
and belonged to toxinotype VIII. Control group 1 consisted of 78
patients and group 2 of 162 patients. The overall mortality was 22.9%,
21.1% and 14.3% for patients with type 027, type 017 and other types,
respectively. The mortality for control group 1 and 2 was 10.5% and
6.4%, respectively. All CDAD patients used signiﬁcantly more 2nd
generation cephalosporins than patients of both control groups. Type 027
patients used more DDD’s 3rd generation cephalosporins than patients
with other types (trend: p = 0.08) and than patients in group 1 (trend:
p = 0.13) and group 2 (p = 0.03). This same association was found for
patients with Type 017. The use of ﬂuoroquinolones was higher for Type
027 and Type 017 patients compared to patients with other types (p= 0.08
and 0.16, respectively) and to patients in both control groups (p = 0.13
and 0.005, respectively). Clindamycin was used in excess in Type 017
patients compared to patients with Type 027 and other types (p = 0.004
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and 0.005, respectively) and patients in both control groups (p = 0.002
and 0.004, respectively).
Conclusion: In an outbreak setting, Types 027 and 017 have a high
mortality, when compared to patients with other types and to control
patients. The use of 2nd generation cephalosporins and ﬂuoroquinolones
was strongly associated with the occurrence of types 027 and 017,
whereas clindamycin was only a risk factor for the development of
CDAD caused by Type 017.
P1478 Detection of infections due to Clostridium difﬁcile PCR
ribotype 027 and implementation of a surveillance system
for severe cases of Clostridium difﬁcile-associated diarrhoea
in Rhineland-Palatine, Germany, 2007
N. Kleinkauf, A. Jansen, B. Weiss, M. Neumann, T. Eckmanns,
H. Michels (Berlin, Trier, DE)
Objectives: A recent increase in the incidence and severity of
Clostridium difﬁcile-associated diarrhoea (CDAD) documented in
several European countries may be related, at least in part, to the
emergence of a highly virulent, ﬂuoroquinolone-resistant, PCR ribotype
027/PFGE NAP1 strain. In 2007, severe cases of CDAD caused by PCR
ribotype 027 were detected in Germany for the ﬁrst time. To asses the
situation for this new strain two surveillance systems were established.
Methods: 1. Active surveillance for severe CDAD was established
locally in a district in Rhineland-Palatine in South West Germany in
which the ﬁrst cases had occurred. All patients in the regional hospitals
with nosocomial as well as community-acquired diarrhoea suspected for
CDAD were screened for C. difﬁcile PCR ribotype 027. 2. Mandatory
reporting of severe cases of CDAD by clinicians was implemented
nationally in November 2007. All laboratories are recommended to
culture C. difﬁcile from toxin positive faeces samples and to store the
isolates for future characterisation and typing. Case deﬁnitions for both
surveillance systems include cases with laboratory conﬁrmed isolates of
C. difﬁcile ribotype 027 and probable cases (laboratory conﬁrmation of
C. difﬁcile toxin A/B and deﬁned clinical criteria for severe CDAD).
Results: Until 30th November 2007, active surveillance identiﬁed 25
probable and 14 conﬁrmed cases in six local hospitals according to
the case deﬁnition. Cases included at least four community-acquired
infections. Gender distribution was 16 male and 23 female patients.
Mean age was 71.8 years. Nine patients died due to a cause attributable
directly or indirectly to the CDAD. Three reports of cases from two
further federal states in South West Germany indicate either additional
imported cases or an unexpected rapid dissemination of this strain.
Conclusion: A C. difﬁcile strain with a new epidemiological proﬁle is
spreading rapidly in Germany. Further investigations are necessary in
order to determine the role of potential driver’s for this development
such as increased ﬂuoroquinolone use and changing age structure.
Increased capacities for detection and typing of C. difﬁcile as well
as heightened awareness of clinicians, infection control specialists and
clinical microbiologists may be required to ensure timely and adequate
response to this emerging pathogen. The results conﬁrm the importance
of establishing an effective surveillance system in a timely manner on a
national level.
P1479 Surveillance of Clostridium difﬁcile NAP1/O27 since 2006
in Belgium
J.V.C. Van Broeck, V. Avesani, M. Janssens, C. Suetens, B. Jans,
M. Delme´e (Brussels, BE)
A European prospective study (Barbut et al. 2005) revealed the presence
of Clostridium difﬁcile NAP1/O27 strains in the Netherlands, Ireland
and Belgium. Since
January 1st 2006 an ofﬁcial reference centre was created in Belgium. The
aim of the centre is to help hospitals in managing C. difﬁcile outbreaks
and in identiﬁying and typing their strains.
Objective:We organised a surveillance program of C. difﬁcile associated
disease (CDAD) in Belgium, which started in January 2006. The aims
were to detect C. difﬁcile clusters, to establish the prevalence of the
NAP1/O27 clone, and to prospectively assess the incidence of CDAD in
acute care hospitals according to a standardised protocol established by
the Belgian Infection Control Society.
Methods: Each participating laboratory was asked to send strains in
case of clusters, and for the prospective component, to report monthly
denominator data as well as clinical data on every case to the Scientiﬁc
Institute of Public Health and to send the ﬁrst ﬁve C. difﬁcile isolates
every six months to the reference laboratory.
Strains were analysed, after species conﬁrmation, for tcdC deletion (RT-
PCR), binary toxin (RT-PCR), toxinotyping (PCR B1-A3 + RFLP) and
ribotyping (RT-PCR). On 92 strains typed as NAP1/O27 we measured
minimal inhibitory concentrations of Ciproﬂoxacin and Moxiﬂoxacin by
use of E-test.
Results: From January 2006 until end of october 2007 we conﬁrmed
1401 strains from 93 centres, as C. difﬁcile; 338 strains (24.1%) from
47 centres (50.5%) belonged to ribotype NAP1/O27. The second most
prevalent ribotype was ribotype 3 (Brazier’s 078) with 68 isolates (5.1%).
All 92 strains tested for Moxiﬂoxacin and Ciproﬂoxacin susceptibility
and all of them were resistant to both drugs. The incidence of
nosocomial CDAD (onset >2 days of hospital stay) in 32 hospitals having
participated to 2 semesters of the prospective surveillance was 1.6 cases
per 10000 patient days (95%CI 1.0−2.1) in the second semester of 2006
and 0.9/10000 (95%CI 0.6−1.2) in the ﬁrst halfyear of 2007.
Conclusions: The NAP1/027 clone has spread all over the country,
accounting for 24% of the strains. It is present in more than 50% of
the hospitals. In some centres it was clearly implicated in outbreaks but
a lot of sporadic cases were also observed.
P1480 Risk factors for Clostridium difﬁcile ribotype 027 infection
in Germany: preliminary results of a retrospective
case-control study
B. Weiss, N. Kleinkauf, M. Neumann, T. Eckmanns, H. Michels,
A. Jansen (Berlin, Trier, DE)
In 2007, severe cases of Clostridium difﬁcile associated diarrhoea
(CDAD) caused by Clostridium difﬁcile ribotype 027 were detected
in Germany for the ﬁrst time. Initially, patients on several wards
in a hospital in southern Germany were affected. Comprehensive
investigations were launched by the local and national health authorities
in order to determine and control the spread of infections due to this
emerging pathogen. To assess the possible risk factors for severe CDAD,
an analytical study was performed.
A retrospective case-control study was conducted in the index hospital.
Cases with laboratory conﬁrmation of C. difﬁcile ribotype 027 and
probable cases (laboratory conﬁrmation of C. difﬁcile toxin A/B and
deﬁned criteria for severe CDAD) were included. Controls were matched
(aiming for a rate of 1:3) for ward, date of admission, and length of stay.
Univariate and nonparametric data analysis was performed using STATA
9.
Two conﬁrmed cases, 4 probable cases and 16 controls were included.
Severe CDAD was strongly associated with receipt of antibiotics in
the three month before onset of symptoms (MOR n.d.; p< 0.01),
namely third generation cephalosporins (MOR n.d.; p< 0.01) and
ﬂuoroquinolones (MOR n.d.; p< 0.01). Admission to the dialysis ward
in the 3 months before the index admission was also associated with
infection (MOR 8.0; p = 0.03). Undergoing endoscopy, surgery, use of
proton pump inhibitors and hospitalisation in the last three months were
not signiﬁcantly associated with the disease.
Although these data are based on a small sample size (recruitment is
ongoing), the preliminary results suggest that severe CDAD is strongly
related to the use of high-risk antibiotics, i.e. ﬂuoroquinolones and
third generation cephalosporins. Control of CDAD may be attained by
minimising the administration of these antibiotics. In addition, our results
indicate transmission of Clostridium difﬁcile especially among dialysis
patients. The frequency of patient visits and prolonged physical contact
with the environment during dialysis treatments make these facilities
potentially efﬁcient settings for nosocomial pathogen transmission.
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Isolation measures and adapted infection control practices are warranted
to reduce nosocomial transmission of CDAD in dialysis units.
P1481 An outbreak of Clostridium difﬁcile-associated disease in a
university hospital in Germany
K. Graf, A. Cohrs, P. Gastmeier, A. Kola, R.P. Vonberg, F. Mattner,
M. Kist, I.F. Chaberny (Hannover, Lubeck, Freiburg, DE)
Objective: The incidence of Clostridium difﬁcile-associated disease
(CDAD) in Germany is increasing, but outbreaks have been reported very
seldom in the past. We investigated an outbreak in a surgical department
of our university hospital during January through April 2007.
Methods: A case-control study and a multivariate analysis were
performed. A case was deﬁned as the onset of diarrhoea 48 h
after admission and (b) either detection of Clostridium difﬁcile (CD)
toxins A or B in stool specimens by ELISA or culturing of toxin-
producing CD. Severe CDAD was deﬁned as non-selﬂimiting course
of disease. All other patients admitted to the same unit during this
time period developing diarrhoea but failed detection of CD served as
controls. Age, gender, underlying diseases, and nosocomial acquisition of
diarrhoea prior antimicrobial treatment were assessed. Culture-positive
samples were investigated by pulsed-ﬁeld electrophoresis (PFGE) using
Gelcompar II (R) software. PCR-ribotyping was performed to test
for the hypervirulent strain O27. Antimicrobial resistance towards
ﬂuoroquinolones, cephalosporins, penicillins, clindamycin, linezolid,
aminoglycosides and glycopeptides was determined.
Cases of CDAD (n = 31).
Results: 31 patients with CDAD were involved. No severe cases of
CDAD were found. 28 patients were included in the control group.
According to multivariate analysis age (OR 7.05, 95%CI: 1.57–50.37)
and the treatment with ﬂuoroquinolones (FQ) (OR 9.23, 95%CI: 1.42–
182.40) showed to be signiﬁcant risk factors for development of CDAD.
By PFGE 11 of the 12 outbreak isolates were undistinguishable. The
predominant strain was ribotype 001, which is the predominant strain in
Germany. The outbreak strain showed resistance towards ciproﬂoxacine,
levoﬂoxacine and moxiﬂoxacine.
Conclusion: Exposure to FQ was a signiﬁcant risk factor for CDAD
acquisition in our study. Restrictive use of antimicrobial substances
including FQ, prospective surveillance of CDAD and appropriate
infection control measures are recommended to prevent the transmission
and the onset of CDAD.
P1482 Comparison of toxigenic status and PCR ribotype of Clostrid-
ium difﬁcile in three university teaching hospitals in Korea
H. Kim, M. Kim, C-K. Kim, K.H. Roh, D. Yong, K. Lee, Y. Chong
(Seoul, KR)
Objectives: Clostridium difﬁcile is the main aetiological agent of
antibiotic-associated diarrhoea and the most common cause of infectious
hospital-acquired diarrhoea. Toxins A (enterotoxin; TcdA) and B
(cytotoxin; TcdB) are well known primary virulence factors of
Clostridium difﬁcile. Toxigenic strains of C. difﬁcile usually produce both
toxin A and B, although toxin A-negative, toxin B-positive strains have
been responsible for C. difﬁcile associated disease (CDAD). Some strains
of C. difﬁcile also produce a binary toxin. The prevalence of strains of
C. difﬁcile producing toxin A, toxin B, and binary toxin has been reported
to vary geographically but has rarely been studied in Korea. The aims of
this work were to compare the toxigenic status of C. difﬁcile isolates in
three teaching hospitals and to evaluate the characteristics of molecular
type by PCR ribotyping.
Methods: A total of 162 unduplicated isolates of C. difﬁcile recovered
from patients with diarrhoea in three teaching hospitals in 2007 were
studied. The three hospitals are triangularly located in Seoul and the
distance is 10 to 20 km each other. PCR was used to amplify genes for
toxin A (tcdA), toxin B (tcdB), the repeating sequence of toxin A (tcdA
rep) and binary toxin (cdtA, cdtB). PCR ribotyping was performed in
all isolates.
Results: The isolation rates of C. difﬁcile in A, S, and Y hospitals were
4.6% (20 isolates/437 cultures), 8.4% (140/1533), and 3.7% (13/347),
respectively. Of the 162 isolates tested, 131 (80.9%) were toxigenic
strains. The proportions of toxin A-negative, toxin B-positive strains
in A, S, and Y hospitals were 20%, 35.6%, and 15.4%, respectively. The
proportions of binary toxin gene positive strains in A, S, and Y hospitals
were 20%, 5.4%, and 15.4% respectively. All binary toxin-producing
strains were toxin A and B positive. Thirty-ﬁve ribotypes were identiﬁed
by PCR ribotyping. A+B+ isolates comprised 25 ribotypes. All A-B+
strains showed the same banding pattern. There was no predominant
ribotype in A and Y hospitals. In S hospital, the most common type
(except toxin A-B+ isolates) accounted for 28% of isolates.
Conclusion: The prevalence of toxin A-B+ and binary toxin gene-
positive strains differ from the three hospitals in one city. The
predominant strains such as toxin A-B+ may contribute to high
prevalence of C. difﬁcile. Further nationwide multicentre surveys are
needed to ensure the prevalence of those strains in Korea.
P1483 First cluster of Clostridium difﬁcile PCR ribotype 027 in
Denmark
S. Persson, J. Jensen, M. Torpdahl, K. Jensen, K. Mølbak, K. Olsen
(Copenhagen, Esbjerg, DK)
Objectives: Clostridium difﬁcile PCR ribotype 027 (CD027) has been
associated with outbreaks and severe clinical manifestations in North
America and Europe. National surveillance of Clostridium difﬁcile-
associated disease (CDAD) in Denmark was initiated in 2007 after the
ﬁrst detected cluster of CD027 in the western part of Denmark.
Methods: Isolates of C. difﬁcile received from hospitals were analysed
by PCR to detect the toxin genes tcdA, tcdB and cdtAB. Isolates positive
for these toxin genes were investigated by the following analyses: (i)
PCR and sequencing in order to detect internal deletions in the tcdA
gene and the toxin-regulating gene, tcdC, (ii) PCR ribotyping, and (iii)
Susceptibility to relevant antibiotics by Etest.
Results: In the period of November 2006 to Marts 2007 a cluster of ten
C. difﬁcile cases were analysed originating from three hospitals within
a region in the western part of Denmark. Seven of these cases were
identiﬁed as CD027. Subsequent surveillance from June to August 2007
revealed ﬁve additional CD027 cases out of 24 submitted isolates of
C. difﬁcile from that particular region.
All CD027 cases were tcdA, tcdB and cdtAB positive, had no internal
deletions in tcdA and a tcdC gene with an 18bp deletion and a one-base
pair deletion at position 117.
Antimicrobial susceptibility testing showed that all CD027 cases were
sensitive to erythromycin, vancomycin, metronidazol and clindamycin
and resistant to ciproﬂoxacin and moxiﬂoxacin.
One non-CD027 isolate from the cluster was identiﬁed with a tcdC
deletion at position 117. This strain was tcdA, tcdB and cdtAB positive,
had no internal deletions in tcdA, a tcdC gene with an 18bp deletion
and the same antimicrobial resistance proﬁle as CD027 except it was
susceptible to moxiﬂoxacin.
No immediate epidemiological link between the patients with CD027
infection was observed.
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Conclusion: This is the ﬁrst report describing CD027 in Denmark.
These CD027 strains harboured toxin genes, toxin gene deletions
and displayed antimicrobial resistance proﬁles characteristic of the
hypervirulent CD027 previously seen in North America and other parts
of Europe.
It is important to improve the surveillance of CD027 and other emerging
PCR ribotypes in order to understand the epidemiology of C. difﬁcile
infections and enhance the infection control.
P1484 Molecular epidemiological analysis of Clostridium difﬁcile
infections in a Swedish County
C. Magnusson, M. Wullt, S. Lo¨fgren, T. A˚kerlund, A. Matussek
(Jo¨nko¨ping, Malmo¨, Solna, SE)
Objectives: This study was conducted to evaluate the occurrence
of Clostridium difﬁcile associated diarrhoea (CDAD) in a Swedish
county. Furthermore, we investigate where the episodes occurred,
and however possible nosocomial transmissions of certain Clostridium
difﬁcile ribotypes could be detected.
Methods: During one year from September 2000 through August 2001,
all Clostridium difﬁcile toxin positive faecal samples in the county
of Jo¨nko¨ping were cultured and isolates were ribotyped using a PCR
based method. Clinical and epidemiological data was then collected by
evaluating medical records of each patient.
Results: We detected a total of 360 episodes in 284 patients (109
episodes/100.000 inhabitants) of CDAD, and a large proportion (36%)
of primary episodes was community acquired. A total of 32 different
ribotypes were identiﬁed, and in concordance to previous Swedish
studies, the most common ribotypes were SE16, SE17, SE20 and SE21.
We did not detect the virulent ribotype O27. Ribotypes SE17 and SE20
were often associated with hospital acquired CDAD, and these types had
the highest transmission rates. The main part of possible transmissions
occurred when patients were hospitalised on the same ward during
the same time period, indicating that the hospital environment is less
important as a bacterial reservoir for transmission.
Conclusion: Some ribotypes of Clostridium difﬁcile seems to be more
virulent than others. In our study, we found SE17 and SE20 to be
more virulent, and others have shown this for ribotype 027. By using
ribotyping, transmission data can easily be evaluated. In addition,
ribotyping is of value to monitor the occurrence and spread of more
virulent isolates. Thus epidemiological and hospital infection control
measures can be improved to minimise spread.
P1485 Surveillance of Clostridium difﬁcile infection in Latvian
multidisciplinary teaching hospital
K. Aksenoka, S. Goonewarden, E. Pujate, A. Balode, E. Miklasevics,
U. Dumpis (Riga, LV)
Introduction: Clostridium difﬁcile (CD) is the common causative agent
of nosocomial diarrhoea. A new highly virulent strain (ribotype 027)
has emerged in many European countries. The study was conducted to
determine the incidence and main risk factors of CD associated diarrhoea
in the large multidisciplinary teaching hospital in Latvia.
Methods: The retrospective analysis of clinical records of all CD cases
starting in 2004–2006 was performed. A CD associaciated diarrhoea
(CDAD) case was deﬁned as diarrhoea in a hospitalised patient
with a stool specimen that tested positive with Culturette CDT latex
agglutination (2004–2006) or Toxin A test (2007) tests. A questionnaire
was completed for all CDAD patients. In 2007 prospective surveillance
of CDAD was initiated. Starting from Sept 2006 CD was cultured and
subjected to ribotyping, CD DNA was extracted from stool and the
presence of the tcdA and tcdB genes was established by PCR.
Results: A total of 112 patients with CDAD were identiﬁed. Their
age varied from 20 to 94 years (mean 58.8) and 60.7% were female.
The overall 3 years (2004–2006) incidence was 9.6 cases per 10 000
admissions with highest annual incidence in 2004 – 16, 1 cases par 10
000 admitted patients. No death, toxic megacolon or perforation due
to CDAD was reported during the study period. Nine patients (8%)
had pseudo-membranous colitis conﬁrmed by colonoscopy, 62, 5% of
patients had fever. The most frequent risk factors identiﬁed were use of
antibiotics (89%), previous hospitalisation in last 6 months (47%) and
antacid use (57%).
Thirty-two percent of the patients with CDAD were identiﬁed
in nephrology ward, 15.2% in gastroenterology ward and 7% in
transplantation unit.
From Sept 2006 to Sept 2007 20 CD (tcdA+, tcdB+) isolates were
ribotyped. 14 isolates displayed different patterns while 6 isolates were
identical according to their ribotype. Identical isolates originated from
nephrology and thoracic surgery wards. None of the isolates belonged
to ribotype 027.
Conclusions: CD infection in our hospital was associated with relatively
low morbidity and mortality. The highest incidence was reported in the
department of nephrology. Clonal analysis indicated the presence of local
outbreaks involving several departments. The new emerging type 027
was not identiﬁed during the active surveillance. Active surveillance
and infection control guidelines for outbreak containment should be
implemented in order to avoid the rapid spread of the new strain.
P1486 Clinical-epidemiological characterisation of Clostridium
difﬁcile – ribotype 053
M. Hell, R. Greil, F. Berr, M. Maass, D. Schmid, S. Huhulescu,
A. Indra, F. Allerberger (Salzburg, Vienna, AT)
Objectives: Clostridium difﬁcile associated disease (CDAD) has been
changing in its clinical severity and epidemicity. Hypervirulent strains
of Clostridium difﬁcile (C.diff.) are causing hospital outbreaks in Europe.
This phenomenon may not only be due to PCR ribotype 027. Hospital
surveillance programs should therefore not focuse only on this ribotype
but also on other potential hypervirulent strains of C.diff. The aims of our
surveillance program are to monitor incidence and death rate of CDAD
in our hospital, to characterise selected clinical cases by ribotyping and
to asses the efﬁcacy of infection control precautions.
Methods: Since February 2006 an active clinically and laboratory based
surveillance program has been in place. All patients with diarrhoea
are obligatory screened for CDAD. Case deﬁnitions according to the
Clostridium difﬁcile working group recommendations (ECDC Advisory
Forum 2006)were used for case identiﬁcation and classiﬁcation. Data
collection was done until October 2007.
Results: 514 patients fulﬁlled the deﬁnition criteria of a case of CDAD
in a period of 19 months. Of these 514 cases 91 were selected because of
a severe course of their CDAD episode, relapse of CDAD and because of
having been related in time and/ or space with the severe or relapse cases.
All 91 cases were retrospectively subjected to extensive epidemiological
and molecular biological investigation including PCR-ribotyping. There
was no ribotype 027 found among the isolates from the 91 cases.
The most prevalent ribotype found was ribotype 053 (45; 49.5%),
whereas 20 of these cases showed a fatal course (44.4%). Ribotype
053 showed a high case-fatality-ratio (0.4) and was also suspected to
be highly transmissible. It was responsible for at least two clusters in
2 neighbouring wards in April and May 2007. We were also able to
demonstrate twice a survival of Ribotype-053-spores in the hospital
environment close to 053 positive patients despite efﬁcacious routine
desinfections measures. For that reason ribotyp 053 should be considered
as a strain of Clostridium difﬁcile with high transmissibility and high
virulence.
Conclusions: Based on ribotyping one major strain was identiﬁed
in a surveillance period of 19 months. Our ﬁndings indicate a high
transmissibility and hypervirulence of strain Ribotype 053. Further
efforts should be put on molecular-microbiological investigations of this
strain and its toxins detecting responsible virulence factors.
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P1487 A national service to determine ribotypes causing
Clostridium difﬁcile infection: C. difﬁcile Ribotyping
Network for England (CDRNE)
M. Wilcox, W. Fawley for the CDRNE Working Group
Objectives: A Health Protection Agency funded network of 6
laboratories (CDRNE) was established in April 2007 to provide access
for hospitals throughout England to C. difﬁcile culture and ribotyping,
according to standardised criteria for submission of faecal samples. We
report results from the ﬁrst phase of CDRNE activity.
Methods: The CDRNE consists of 6 regional microbiology laboratories
in England: Leeds (Reference Laboratory), Birmingham, London,
Manchester, Newcastle and Southampton. The service is centrally
funded, and so referring laboratories/hospitals are not charged. The
CDRNE service is for use by hospitals/infection control teams in
England to investigate: increased frequency of cases or high baseline
rates of CDI; increased severity/complications of CDI cases; increased
mortality associated with CDI; or increased recurrence rate of CDI. We
aim for a 1−2 week turnaround time to culture and then ribotype CD
strains from submitted faecal samples, according to a standardised UK
method. A minimum data set is submitted with each sample to provide
reason for referral, antibiotic risk and outcome data.
Results: 670 CD toxin positive samples from patients with CDI were
processed in the ﬁrst 7 months of the CDRNE service roll out. CD
culture yield for the mailed faecal samples was ~90%. CDRNE samples
represented approximately 1 in 40 of the expected number of CD toxin
positive cases in England, based on data for the previous 6 months. The
overall proportions of the 3 most common CD ribotypes detected, 027,
106 and 001 were 45%, 15% and 11%, respectively. There was a marked
regional variation in the prevalence of CD ribotypes: for example, 027
(8–63%), 106 (3–30%) and (0–30%) 001. The next most common
ribotypes were 002 and 023 (up to 12% and 17% regional prevalence,
respectively). Comparison of CDRNE data with those collected for
all CDI cases in Leeds shows the potential for sampling bias, likely
reﬂecting the submission criteria.
Conclusion: CDRNE has provided increased access to ribotyping as part
of the investigation of increased incidence, severity or complications
associated with CDI. Marked variation in the prevalence of ribotypes
needs to be explained with particular reference to the transmission
of clones and sub-clones within institutions, possibly using additional
highly discriminatory DNA ﬁngerprinting methods.
P1488 Community-onset Clostridium difﬁcile-associated diarrhoea:
is it truly community-acquired?
M. Bauer, D. Veenendaal, L. Verhoef, P. Bloembergen, J.T. Van Dissel,
E.J. Kuijper (Leiden, Haarlem, Utrecht, Zwolle, NL)
Objectives: The incidence and clinical severity of nosocomial Clostrid-
ium difﬁcile-associated disease (CDAD) is on the rise, partly because
of outbreaks due to the hypervirulent strain ribotype 027. Little is
known of the incidence of community-onset CDAD (CO-CDAD), nor
of its characteristics as compared with nosocomial CDAD. Herein, we
investigate CO-CDAD in 3 areas in the Netherlands.
Methods: Three regional Microbiology Labs tested all samples of
unformed stool sent in through general practitioners (GPs) during 3
months for presence of C. difﬁcile toxins by enzyme immunoassay. In
case of a positive toxin test, patients were enrolled in the study and
completed a questionnaire on clinical characteristics of the diarrhoea,
contact with hospitals or nursing homes, prior antibiotic usage or other
medication, co-morbidity and possible animal contacts. Toxin-positive
stools were cultured for C. difﬁcile and characterised by PCR ribotyping.
Results: Over 2200 loose stool samples were analysed of which
41 (1.9%) were toxin positive and C. difﬁcile conﬁrmed by culture.
Preliminary analysis shows that the mean age of CO-CDAD patients
was 59 (range 1 to 91) yrs; 11% were under 20. Diarrhoea usually
was long-lasting and severe, with a mean duration of 17 days, a watery
consistency in 93%, admixture of blood in 50%, a frequency of more
than 10 times daily in over 50%, fever in 43% and abdominal pain in
86% of cases. Part was in line with the GPs standard to order stool tests
only when diarrhoea is severe or lasts 7 days or longer. About half of the
cases lacked any association with healthcare institutions. Half reported
usage of antibiotics in the past year, whereas 50% regularly consulted
a medical specialist for co-morbidity. About 64% of patients used some
medication chronically.
Strains differed clearly from hospital strains and belonged to various
uncommon PCR ribotypes. Frequently found nosocomial PCR ribotypes
078 and 014 were seen in CO-CDAD in 13% of typable strains each.
Conclusion: C. difﬁcile toxin can be demonstrated in up to 2% of
stool samples from severe and/or lasting community-onset diarrhoeal
disease. In these subjects, age, co-morbidity and prior use of antibiotics
varies greatly. Less than half of the cases can be related to healthcare
institutions or antibiotic usage. In accordance herewith, ribotypes of
community-onset C. difﬁcile strains differ from common nosocomial
ribotypes, both suggesting that there is a reservoir in the community.
P1489 Clostridium difﬁcile at a teaching hospital in Western
Australia: providing insight into community acquisition
E. Swingler, S. Cameron, T. Riley (Perth, Adelaide, AU)
Objectives: To describe cases of C. difﬁcile-associated diarrhoea
(CDAD) diagnosed at Royal Perth Hospital (RPH) by demographics,
place of acquisition and risk factors.
Methods: Setting: A 700-bed adult teaching hospital in Western
Australia.
Design: A retrospective chart review of laboratory-conﬁrmed CDAD
diagnosed at RPH between July 2003 and August 2007. CDAD was
deﬁned on the basis of a positive culture and toxin detection (EIA A or
B). Two positive tests for C. difﬁcile greater than 3 months apart in a
given patient were considered separate episodes.
Main outcome measures: demographics, place of acquisition, antibiotic
use for previous 3 months, comorbidities, gastrointestinal medications
and procedures.
Results: A total of 193 episodes of CDAD were identiﬁed in 189
patients, with 53% female and a mean age at diagnosis of 63 years
(range 13–94 years). Medical records were reviewed for 184 patients.
Most cases were associated with hospitalisation: 108 (59%) during
the admission at RPH, 36 (19.6%) during a previous admission at
RPH and 10 (5%) during admission at another hospital in Western
Australia. However, there were 30 cases (16%) with no record of
prior hospital admission in the 3 months before onset of symptoms.
RPH cases had a higher mean age-adjusted Charlson Comorbidity
Index (4) compared with community cases (2.5). Overall, 22% of
cases were not associated with antibiotic use. Community cases were
less likely to have been exposed to antibiotics than RPH cases
(14% vs.67%, p< 0.001). Piperacillin-tazobactam (24%), ticarcillin-
clavulanate (21%), amoxicillin-clavulanate (19%), ciproﬂoxacin (18%)
and cephazolin (17%) were the most frequently implicated antibiotics.
The main antibiotic classes used were penicillins 71(39%), ﬁrst
generation cephalosporins, 39 (21%) and ﬂuoroquinolones 37 (20.1%).
Conclusions: Community acquisition of C. difﬁcile may be more
prevalent than previously thought. Just under one ﬁfth of all cases of
CDAD diagnosed in this tertiary hospital were community acquired and
this is likely an underestimate of prevalence. Diagnostic laboratories
serving community patients need to be aware that C. difﬁcile may
be a signiﬁcant cause of diarrhoea in this setting. Although not
traditionally considered high risk for C. difﬁcile, piperacillin-tazobactam
and ticarcillin-clavulanate were the most common antibiotics implicated,
suggesting healthcare facilities need to evalute their own data when
looking at risk factors.
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P1490 Is the emergency department the place to be for optimum
Clostridium difﬁcile-associated disease control?
E. Dhondt, V. Cossey, A. Schuermans, R. Duerinckx, D. Knockaert
(Leuven, BE)
Background: Alerted by the rise and severity of nosocomial Clostridium
difﬁcile (CD)-associated disease (CDAD) and the high suspicion of
import diarrhoea, a tertiary care teaching hospital set up a hospital-
wide infection control (IC) programme, aiming at increasing CDAD-
detection, improving standard precautions, organising IC practitioner
rounds, environmental disinfection with hypochlorite, early contact
isolation and peroral vancomycine antibiotic treatment. To date CD
ribotype 027 in Belgium accounts for 23% of all strains tested.
Objective: To identify the importance of the emergency department (ED)
as an entry point of CDAD, since its case mix consists of patients at
high risk of both introducing and acquiring infections.
Methods: A retrospective study of CDAD was conducted reviewing ED
admission and discharge data of 4960 patients presenting with diarrhoea
between January 1, 2002 and November 15, 2007. Variables included are
epidemiological (age, sex, origin, dismissal) as well as bacteriological
(CD-culture and -toxin analysis).
Results: A total of 1926 CD-analyses were performed, showing a mean
total detection effort of 40%, yet increasing over the study period:
34% (2002), 32% (2003), 35% (2004), 40% (2005), 41% (2006) and
53% (2007). Of these, 166 (originating from 146 patients) were found
CD-toxin positive, indicating a CD-recovery rate of 9%, which is even
threefold the overall hospital detection yield.
Of the studied ED patients 27% were aged above 65, representing 68%
(99/146) of the CDAD affected. Hospital admission for diarrhoea (3068
out of 4960) accounted for 62%. Only 4.5% were transferred from long-
term care facilities. There was no sex difference observed.
Conclusion: Increasing ED awareness and a high CD-recovery rate stress
the importance of the ED in expediting case detection.
The high hospitalisation rate of patients presenting with diarrhoea and a
clear import pattern moreover urge for early prevention of transmission
by timely syndromic application of contact precautions. Above 65 years
of age, quarantine may be warranted in all diarrhoeic patients, yet
not workable. Isolation based on risk factors (comorbidity, previous
antibiotic or antacid exposure or CDAD history) seems more feasible.
Therefore, this case mix of ED patients needs more reﬁnement.
In the mean time, clinical condition based IC practices should emphasise
on hand hygiene, high touch surface disinfection and careful selection
and handling of medical items.
P1491 Outbreak of Clostridium difﬁcile-associated disease in
Luxembourg
T. Staub, C. Sakka, V. Arendt, J. Schmit, P. Kirpach, F. Hussenet,
F. Henache, F. Schneider, R. Hemmer (Luxembourg, LU)
Since 2003 outbreaks of Clostridium difﬁcile associated disease (CDAD)
have been recognised in Canada and United States and thereafter in
Europe. These outbreaks are caused by a new ribotype called PCR 027.
During the summer 2006 we noticed an increase of the number of cases
of CDAD in our hospital. At that time stool culture was not performed,
stools were tested for antigen and toxins A and B. After the ﬁrst of
September 2006 stools were cultured to isolate CD and ribotyping was
done by a central laboratory. Between the 1st of September 2006 and
the 31st of August 2007 106 cases of CDAD were identiﬁed. The mean
age was 63, there were 53 men and 53 women. Eighty-one strains were
isolated from diarrheic patients with suspected CDAD, 27 strains were
ribotype 027. Sixteen patients died from CDAD or underlying disease,
seven infected with CD 027.
CD ribotype 027 has reached Luxembourg probably in winter or spring
2006 and has spread rapidly causing a large outbreak in our hospital.
Mesures have been taken to avoid the spread from patient to patient with
reinforcing the isolating procedures.
P1492 Microbiological surveillance of Clostridium difﬁcile
infections in Luxembourg, 2006–2007
J. Mossong, P. Reichert, F. Munisso, M. Sertznig, J. Even, F. Schneider
(Luxembourg, LU)
Objectives: Clostridium difﬁcile infections in the elderly have emerged
as major public health problem in many countries including Luxembourg.
The National Health Laboratory department responsible for the
surveillance of enteric pathogens started a prospective microbiological
surveillance of Clostridium difﬁcile strains in October 2006 in
collaboration with hospital and private laboratories. Here we present
ﬁrst results from this national surveillance scheme including ribotyping,
demographic characteristics, and mortality of patients with laboratory
conﬁrmed Clostridium difﬁcile infection.
Methods: Since October 2006, all received Clostridium difﬁcile strains
were ribotyped by PCR. Since July 2007, PCR detection of clostridial
toxin genes tcdA, tcdB and binary toxin genes cdtA and cdtB was added
for further strain characterisation. Routine demographic data (age, sex)
and vital status of laboratory conﬁrmed cases was obtained from the
National Registry System. Mortality was calculated based on date of
strain referral and date of death. A logistic regression model was used
to assess risk factors independently for mortality.
Results: In the ﬁrst 12 months of the microbiological surveillance, we
received strains from 223 patients with laboratory conﬁrmed Clostridium
difﬁcile infection, originating mainly from hospital laboratories, com-
pared to 151 strains of Salmonella and 435 strains of Campylobacter re-
ceived during the same time period. 68 strains (30.5%) had ribotype 027.
Median age of patients was 63 years but differed signiﬁcantly (p = 0.001)
between patients with ribotype 027 (74y.) and patients with other
ribotypes (59y.). No relation between sex and ribotype was observed
(p> 0.05). The mortality rate within the month and within 3 months of
strain referral was 14.8% and 21%, respectively. In a logistic regression
model, one month mortality was signiﬁcantly associated with advanced
age (p< 0.0001), but not with sex (p = 0.66) or ribotype (p = 0.14).
Conclusion: In Luxembourg, Clostridium difﬁcile has emerged as
a major enteric pathogen responsible for substantial morbidity and
mortality among the elderly. Ribotyping is a useful technique for
subtyping strains, but is handicapped by the lack of availability of a
curated online database of ribotype proﬁles. Microbiological surveillance
is essential to detect clusters of cases or to monitor the spread of different
clones through time.
P1493 Molecular analysis of Clostridium difﬁcile strains isolated
from healthy horses in the area of Parma, Italy
M. Ossiprandi, L. Zerbini, M. Buttrini (Parma, IT)
Objectives: Clostridium difﬁcile has been associated with a wide
spectrum of diseases in humans and several animal species. In particular,
C. difﬁcile is an important cause of colitis in adult horses and foals. In
horses, faecal carriage rates of 2–29% have been reported. The aim of
this study was to investigate the molecular characteristics of C. difﬁcile
strains isolated from healthy horses by using toxin gene proﬁle.
Methods: A total of 42 healthy horses (24 adults and 18 foals <14 days
old) faecal samples was tested for the presence of C. difﬁcile toxin A
and B with a commercial enzyme immunoassay (Remel). C. difﬁcile
was isolated onto cycloserine-cefoxitin-fructose agar (CCFA) before
and/or after thermal shock. Preliminary identiﬁcation of C. difﬁcile
was based on colonial appearance, odour, lack of aerotolerance and
cell morphology after Gram staining. Final identiﬁcation was performed
by using a rapid latex agglutination test (OXOID) and Rapid ID32A
(bioMe´rieux) biochemical proﬁles. C. difﬁcile DNA was extracted by
boiling colonies in distilled water and used as a template for screening
of genes encoding for toxin A, B and binary toxin (CDT). PCR detection
for tcdA and tcdB genes was performed as previously described by
Spigaglia and Mastrantonio (2002), and the presence of CDT was tested
by ampliﬁcation of cdtA and cdtB genes as described by Stubbs (2000).
Toxigenic strains were tested for in vitro production of toxins by EIA.
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Results: C. difﬁcile strains were isolated from 14 of 42 faecal samples
(33%): 6 from 24 adult horses (25%) and 8 from 18 foals (44%). Six
(43%) of 14 isolates possessed genes encoding at least one toxin: one
(a foal) possessed tcdA and tcdB genes and 5 possessed only tcdB
gene (3 adult horses and 2 foals). Eight isolates lacked tcdA and tcdB
genes. None of C. difﬁcile strains tested possessed ctdA and ctdB genes.
Only 1 of the 42 (2.4%) faecal samples tested for toxins A/B by EIA
was positive. The C. difﬁcile strain isolated from this sample resulted
tcdA-/tcdB-. All PCR-positive strains resulted negative for in vitro toxin
production by EIA.
Conclusion: The results of this study suggest that C. difﬁcile could be
present in the normal intestinal ﬂora of adult horses, not only in foals.
By PCR it was demonstrated that healthy horses can serve as a potential
reservoir of toxigenic C. difﬁcile.
P1494 Screening for Clostridium difﬁcile in meat from French
retailers
S. Bouttier, M.C. Barc, B. Felix, S. Lambert, A. Torkar, A. Collignon,
F. Barbut (Chatenay Malabry, Paris, FR)
Clostridium difﬁcile is well known as a human pathogen, but it is also
responsible for colonisation or infection in a wide range of animal
species. It has been shown that C. difﬁcile-associated disease is an
important problem in horses, pigs, piglets and calves. Consequently,
concern has been raised about contamination of food products. Recently,
C. difﬁcile has been isolated from retail meat in North America. The
relevance of this presence is unclear but food animal may be a source
of contamination for humans.
Objectives: The aim of this work was to assess the presence of
C. difﬁcile in retail meats in France.
Methods: Meat samples were collected from different retailers and
included 65 ground beef samples (vacuum-packed or not) and 50
pork sausage samples. Five grams of each sample were suspended in
100ml brain heart infusion containing 0.1% taurocholate, cycloserine
and cefoxitine (CCT BHI). After incubation in anaerobiosis at 37ºC
for 72 h, two aliquots were subcultured on Taurocholate Cycloserine
Cefoxitin Agar (TCCA), one of which after alcohol shock.
Results: A total of 115 meat samples were studied. C. difﬁcile
was isolated from 3 of 65 (4.6%) ground beef samples. None was
detected from pork sausages. The 3 isolates were further characterised
by antibiotyping, toxinotyping, detection of binary toxin and PCR-
ribotyping and compared to human strains isolated in France during
the same period. Among the three isolates, two belonged to toxinotype
0 (binary toxin negative, moxiﬂoxacin susceptible) and one to toxinotype
III (binary toxin positive, tcdC deletion −18bp, moxiﬂoxacin resistant).
Conclusion: Further studies are underway to conﬁrm these preliminary
data and to assess the prevalence of animal food contamination by
C. difﬁcile.
P1495 Clostridium difﬁcile PCR ribotype 078 toxinotype V in
Dutch food-producing swine
S.B. Debast, L.A.M.G. Van Leengoed, A. Goorhuis, C. Harmanus,
E.J. Kuijper, A.A. Bergwerff (Amersfoort, Utrecht, Leiden, NL)
Objectives: From recent Clostridium difﬁcile (CD) outbreaks in human
populations with high morbidity and mortality the question was raised
whether animals may play a role as a vector. PCR ribotypes of CD
identiﬁed in humans have indeed been found recently in pigs and calves
as well. Here, the occurrence of CD in Dutch pigs destined for pork
production, was investigated in diarrhoeal animals.
Methods: Two pig breeding farms with neonatal diarrhoea for more
than a year were selected for sampling. A one-strip assay (ICTAB)
was used to screen animal faeces for toxins A and B. Toxin-positive
faeces were cultured for the presence of C. difﬁcile and isolates were
characterised by PCR ribotyping and multi-locus-variable-tandem-repeat
analysis (MLVA). A control group of 17 type 078 isolates obtained from
patients with nosocomial CD-associated disease (CDAD) in the period
2006–2007, was included.
Results: C. difﬁcile was not detected in seven unaffected farms, but
was detected in 1 to 4 days-old diarrhoeal piglets with colitis (6 out
of 12 litters in total) in two farms with persistent neonatal diarrhoeal
outbreaks. Surprisingly, the mother sows (N = 12) were apparently
healthy and ICTAB-negative. Isolates were identiﬁed as PCR ribotype
078 harbouring toxin A (tcdA) and B (tcdB), tcdC and binary toxin
genes, but free from the ermB gene. The tcdC gene showed a 39 bp-
deletion. Application of MLVA on ten pig strains revealed that all strains
were genetically related (STRD< 10) with only variation in 1 of 7 loci
tested. Of 17 human isolates, 15 also belonged to this same cluster.
Conclusion: This is the ﬁrst ﬁnding of C. difﬁcile PCR ribotype 078,
toxinotype V in an animal matrix in The Netherlands. The strains were
genetically related to human isolates of the same PCR ribotype. It is,
therefore, now crucial to assess the risk of this potential zoonosis in the
community.
P1496 Clostridium species found in Norovirus outbreaks in the
Netherlands
S. Svraka, E. Kuijper, E. Duizer, M. Koopmans (Bilthoven, Leiden, NL)
Objectives: Outbreaks (OBs) of acute gastroenteritis (AGE) of suspected
viral aetiology are reported to RIVM as part of the Norovirus (NoV) OB
surveillance system. Since 2002, the epidemiology of NoV has changed.
Simultaneously, the emergence of a variant of Clostridium difﬁcile (CD)
ribotype 027, which appeared to have increased pathogenicity, was
reported. The coincidental increase in NoV OBs and emergence of CD
ribotype 027 raised the question if these events could be related. In
theory, an episode of NoV illness can result in increased growth of
Clostridium spp. and subsequently lead to more severe or prolonged
illness. Additionally, spread of Clostridium spp. could be increased by
multiple episodes of vomiting and diarrhoea caused by NoV infection.
Therefore, we studied the prevalence of CD in OBs of AGE caused by
NoV, rotaviruses (RV) and of unknown aetiology.
Methods: Stool samples of OBs caused by NoV, RV, and of unexplained
aetiology were tested by Premier C. difﬁcile Toxin A&B EIA, positive
samples were tested for the presence of CD by culture methods using an
ethanol shock pretreatment. Suspected colonies were tested using CD-
speciﬁc GluD and ribotyping PCR. Negative samples were further tested
using 16S rRNA PCR.
Results: See the table.
Table 1. Number of Clostridium spp. positive samples and OBs of unexplained,
NoV and RV AGE OBs.
Study population Group 1 Group 2 Group 3
Description unexplained GE NoV RV
N (specimens/OBs) 120/34 350/56 98/21
Positive EIA
(specimens/OBs)
1/1 16/11 l/1
Positive culture
(specimens/OBs)
l/1 15/10 1/1
Positive
morphological criteria
(specimens/OBs)
1/1 13/9 1/1
Positive GluD PCR
(specimens/OBs)
1/1;
C. difﬁcile 001
0/0 0/0
Positive 16S PCR
(specimens/OBs)
1/1 13/9 1/1
Results 16S PCR C. difﬁcile C. disporicum nd
C. perfringens/C. disporicum
C. disporicum
C. disporicum
C. subterminale
C. boltei
C. butyricum
C. bifermentans
C. disporicum
C. sordellii
C. barati
Lactobacillus
Lactobacillus
Clostridium prevalence
in OB of GE
2.9% 16.1% 4.8%
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Conclusions: CD ribotype 027 was not found in any of the OBs
tested. One CD ribotype 001 was detected in a gastroenteritis OB
of unexplained aetiology, but several Clostridium spp. were found in
NoV OBs. These data suggest that NoV infections enable Clostridia to
colonise the gastro intestinal tracts, perhaps in a similar way as antibiotic
treatment. These double infections may contribute to increased severity
of the gastroenteritis episode and were revealed only by comprehensive
virological and bacteriological screening of faecal samples.
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P1497 Waterborne infection caused by a carbapenem-resistant
Enterobacter asburiae isolate producing the class A
carbapenemase IMI-2 in France
L. Poirel, C. Spicq, S. Bernabeu, P. Durand, P. Nordmann (Le Kremlin
Bicetre, FR)
Objectives: Two Enterobacter spp. isolates were recovered from a
2-years-old child hospitalised after a drowning accident that occurred in
a private pond in September 2007 in France. Enterobacter spp. MON-1
was isolated from a tracheal aspiration and showed a wild-type phenotype
of resistance to b-lactams. Enterobacter spp. MON-2 was from urine
and resistant to carbapenems but susceptible to ceftazidime. A peculiar
synergy was noticed between clavulanic-acid and imipenem. The aim of
the study was to identify the mechanism(s) responsible for carbapenem
resistance in isolate MON-2.
Methods: Genomic DNA Enterobacter spp. isolates MON-1 and
MON-2 were extracted and used as template for PCR screening
of known carbapenemase genes. Plasmids were extracted using the
Kieser technique. Mating-out assays were performed using E. coli J53
as recipient strain and a selection with amoxicillin (50mg/L)- and
azide (100mg/L)-containing media. Random-ampliﬁed polymorphism
detection (RAPD) techique was used to compare genotypically both
isolates. Ampliﬁcation and sequencing of 16S RNA and blaampC genes
were used to identify at the genetic level the Enterobacter species.
Results: Molecular techniques showed that both Enterobacter spp.
isolates belonged to the Enterobacter asburiae species. RAPD analysis
showed that isolates MON-1 and MON-2 were clonally-related.
E. asburiae MON-2 expressed the clavulanic-acid inhibited and
carbapenem-hydrolyzing Ambler class A b-lactamase IMI-2. Mating-out
assays remained unsuccessful but electroporation of a plasmid extract
led to Escherichia coli transformant carrying a 150-kb blaIMI-2-positive
plasmid that did not provide any other antibiotic co-resistance marker.
Induction experiments and PCR mapping identiﬁed a LysR-type blaIMI-
R2 regulatory gene upstream of the blaIMI-2 gene.
Conclusion: This study identiﬁed a class A carbapenemase of the IMI-
type for the ﬁrst time in Europe, after the identiﬁcation of IMI-1 and
IMI-2 in Enterobacter cloacae isolates in USA and China, respectively.
This study further identiﬁes the aquatic reservoir as a source of IMI-like
producers.
P1498 Occurrence of carbapenemase-producing Enterobacteri-
aceae clinical isolates in the Asia-Paciﬁc nations
R. Mendes, J. Bell, J. Turnidge, R. Jones, Q. Yang, Y. Yu, Z. Sun
(North Liberty, US; Beijing, Zhejiang, Wuhan, CN)
Objectives: The aim of this study was to determine the occurrence of
carbapenemase (CASE)-producing Enterobacteriaceae (ENT) isolates in
the Asia Paciﬁc (APAC) region during the 2006 SENTRY Program.
Methods: ENT recovered from hospitalised patients in 37 medical
centres (MC), located in 9 countries in the APAC region were tested by
CLSI broth microdilution. Isolates showing imipenem and meropenem
MIC 2mg/L were screened for MBL- (IMP-like, VIM-like, SIM-1,
GIM-1 and SPM-1) and group 2f serine Case- (KPC, IMI, SME,
etc.) encoding genes by PCR and sequencing. Spectrophotometric
measurement of meropenem hydrolysis was performed to access Case
activity among PCR-negative isolates. Presence of quinolone (FQ)
resistance (R) genes (qnr-like and aac[6′]-Ib-cr) was also accessed by
PCR and sequencing. The genetic environment of Case-encoding genes
was investigated by plasmid analysis, conjugation and transformation
experiments.
Results: Among 844 isolates, 9 (1.1%; 1 E. coli, 5 K. pneumoniae
[KPN] and 3 P. mirabilis) met the screening criteria. The majority of the
isolates (7/9; 77.8%) was PCR-negative and did not show meropenem
hydrolysis activity. One KPN isolate (#231–21D) harbouring blaKPC-2
was detected in Zhejiang, China. This isolate was recovered from a
venous catheter infection in a 42 y/o male trauma victim on the 77th
hospital day (HD). A second KPN (#234–49C) carrying blaIMP-4 was
recovered in Wuhan (China) from the sputum (2nd HD) of a 50 d/o
female infant with acute bronchopneumonia. Both cases had favorable
clinical outcomes. Plasmid content of the isolate #231–21D revealed
three plasmids (60-, 5- and 3.5-kb), while the transconjugant (p231–21D)
strain showed only the 60-kb plasmid. The p231–21D strain showed R to
b-lactams, aminoglycosides and decreased susceptibility to FQ. Further
investigations detected qnrB4 in the isolate #231–21D and recipient
strain p231–21D, suggesting both blaKPC-2 and qnrB4 were located in
the 60-kb conjugative plasmid. Experiments failed to identify a plasmid-
borne location for the blaIMP-4.
Conclusion: Occurrence of Case-encoding genes was low in the APAC
region. This is the ﬁrst report of coproduction of KPC-2 and QnrB4
encoded by R genes located in the same conjugative plasmid. This
plasmid may further spread and escalate the R rates for their respective
antimicrobial classes. IMP-4 has been detected in different countries in
the APAC region, suggesting a continued dissemination of this gene in
this region.
P1499 Emergence of a XDR-OXA-23-producing Acinetobacter
baumannii clinical isolate
F. Grosso, S. Quinteira, F. Freitas, J. Ribeiro, L. Peixe (Porto, Viseu, PT)
Objectives: In the last years an increasing resistance of A. baumannii
to carbapenems, mainly due to the production of OXA-type carbapene-
mases, has been described. Treatment options for infections with these
isolates usually include aminoglycosides, polimixins and tigecycline. The
aim of this work was to characterise the emergence during antibiotic
therapy of an OXA-23-producing A. baumannii clinical isolate resistant
to all available antibiotics.
Methods: A. baumannii HST1 and HST3 were recovered, from pus and
pancreatic abscess samples, during the hospitalisation of a patient who
suffered of acute necrohaemorragic pancreatitis. Meropenem therapy was
administrated during 14 days before the isolation of the ﬁrst strain.
The second strain was isolated after the change of the therapy for
an association of ampicillin and amikacin. The patient recovered after
surgical procedure. Identiﬁcation of the isolates was performed by 16S
rRNA gene sequencing. MICs for the b-lactamic antibiotics and to
amikacin were determined by the Etest method (AB Biodisk, Solna,
Sweden) and VITEK2 system. The susceptibility of the isolates to
colistin, minocyclin and tigecycline was determined by the agar dilution
method according to CLSI guidelines. Susceptibility to gentamicin,
kanamycin, netilmicin and ciproﬂoxacin was tested by disk diffusion
method. Oxacilinase genes (OXA-23, 40, 51, and 58) were sought by a
multiplex PCR. ISAba1 insertion sequence upstream of blaOXA-23 gene
was also searched by PCR. PFGE (ApaI) was performed for comparison
of these isolates with imipenem-resistant clone that persist in Portugal
since 1998.
Results: The strains were resistant to all tested antibiotics, including
colistin, minocyclin and tigecycline (MICs were 32, 64 and 16mg/L,
respectively). HST1 was susceptible to amikacin; however, after a therapy
change to amikacin plus ampicillin, a second isolate was collected
demonstrating resistance to amikacin.
PCR reactions detected the presence of blaOXA-23 (conﬁrmed by
sequencing reactions) and ISAba1upstream of the OXA-23 gene.
PFGE showed that the isolates’ proﬁle was related with the imipenem-
resistant A. baumannii clones disseminated throughout the country,
including the endemic OXA-40 producing A. baumannii clone.
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Conclusions: This is a ﬁrst description of a XDR-A. baumannii that
evolved during antibiotic therapy, from a well disseminated clone. The
spread of this isolate is a worrisome situation, especially for debilitated
patients.
P1500 Molecular characterisation of carbapenem-resistant
Acinetobacter species in an Irish tertiary referral hospital
T.W. Boo, F. Walsh, B. Crowley (Dublin, IE)
Objective: Carbapenem resistance is increasing among Acinetobacter
species worldwide with important therapeutic and infection control
implications with this developing trend. There is little data regarding
carbapenem resistance in Acinetobacter in Ireland. We aim to
characterise the carbapenem resistance mechanisms of Acinetobacter
isolates in our hospital.
Methods: Non-consecutive Acinetobacter isolates were prospectively
collected from May 2005 to October 2007. Speciation was conﬁrmed by
rpoB sequencing. Carbapenem-resistant isolates were tested phenotypi-
cally for metallo-b-lactamase using the MBL E-test while genes encoding
for Ambler class B (VIM, IMP) and class D (OXA-23 group, OXA-24
group, OXA-51 group and OXA-58) enzymes and insertion sequence
ISAba1 were sought using PCR, gel electrophoresis and nucleotide
sequencing. Isolates of the same species were typed using pulsed ﬁeld
gel electrophoresis (PFGE).
Results: 114 Acinetobacter isolates were collected over the 30-
month period. 12 isolates were resistant to meropenem. 10 were
Acinetobacter genospecies 3 (AG3), 2 were Acinetobacter baumannii
and Acinetobacter johnsonii respectively. All isolates had tigecycline
and colistin MICs of 0.5mg/L. Although the isolates tested positive
phenotypically for MBL, subsequent PCR for VIM or IMP did not
reveal any corresponding amplicons. Instead, they were positive for
the OXA-23 group gene and ISAba1 insertion sequence was also
present immediately upstream of the gene in all the isolates. Subsequent
nucleotide sequencing conﬁrmed the OXA gene to be blaOXA-23 in
all 12 isolates. PFGE also revealed the polyclonal origins of the AG3
isolates.
Discussion: Carbapenem-resistant isolates have emerged in a signiﬁcant
proportion (10%) of Acinetobacter spp. in our hospital. The epidemiol-
ogy is unusual with the predominance of Acinetobacter genospecies 3
instead of A. baumannii as with most studies. To the authors’ knowledge,
this is also the ﬁrst documented clinical isolate of carbapenem-resistant
A. johnsonii in the literature. The study also demonstrated that OXA-
23 is the predominant gene for carbapenem resistance in our isolates
and ISAba1 probably plays a pivotal role in regulating its expression.
The emergence of carbapenem-resistant Acinetobacter isolates reiterates
the need for stringent infection control policies, judicious use of
antimicrobial agents, resistance surveillance and research into new anti-
Gram-negative antibiotics.
P1501 Acinetobacter baumannii infections in thermally injured: a
multidrug-resistant blaOXA-23 outbreak in a burn wound
centre, Brussels
D. De Vos, Y. Glupczynski, P. Bogaerts, L. Dijkshoorn, T.J.K. Van
der Reijden, F. Bilocq, M. Vaneechoutte, T. Pieters, P. Bosmans,
P. Soentjens, J. Pirson, S. Jennes, J.-P. Pirnay (Brussels,
Mont-Godinne, BE; Leiden, NL; Ghent, BE)
Objectives: Admission screening of a patient transferred from Algeria
revealed colonisation by a MDR carbapenem-resistant Acinetobacter
baumannii (Ab) strain. We aimed to study the epidemicity of this MDR-
Ab and evaluate the efﬁcacy of infection control measures for controlling
the outbreak.
Methods: Clinical isolates (57) from the 8 patients and the environment
(19) were collected and analysed molecularly by AFLP, PFGE ﬁnger-
printing, PCR/sequencing targeting several b-lactamase genes including
OXA-carbapenemases. Strict infection control measures (closure of unit,
enforcement of contact precautions, terminal room disinfection with
hydrogen peroxide ultra mist, increased hospital educational efforts,
increased screening, including personnel and environment) were taken.
Results: Overall 8 patients where infected on wounds and there
respiratory tract during this 11 month period. Four patients died. These
critically ill had all 3rd degree burns (mean Total Body Surface Area
(TBSA) 38%), a mean age of 62 y with signiﬁcant underlying co-
morbidities and co-infections with other pathogens. The direct cause
of death was often sepsis, but no Ab was isolated from the blood. AFLP
genotypic analysis showed the presence of 3 different clones in the index
case. Subsequent molecular typing revealed the emergence of one single
epidemic clone, which retained the MDR carbapenem-R phenotype
(OXA-23 class D carbapenemase). This epidemic clone evolved into a
closely related variant that persisted for around 8 months in the unit. All
patients were treated by Polymixin E the only active agent against this
isolate. One out of the 4 survivors was cured and no major side effects
were observed. The implementation of strict infection control measures
allowed to terminate the epidemic spread.
Conclusions: Despite systematic screening on admission this imported
outbreak caused by a MDR carbapenem-resistant OXA-23 producing
Ab illustrates the epidemic potential of this difﬁcult-to-treat nosocomial
pathogen and the need of permanent alertness on hospital infection
control as well as the usefulness of molecular typing methods to delineate
the epidemiologic relationship of the isolates.
P1502 Dissemination of carbapenem-resistant Acinetobacter
baumannii producing the OXA-23 carbapenemase in a
university hospital, Tunisia
D. Bettaieb, W. Mansour, S. Dahmen, L. Poirel, P. Nordmann,
O. Bouallegue, N. Boujaafar (Sousse, TN; Paris, FR)
Objective: To characterise the clonal relationship, the b-lactamase
content and genetic support of carbapenem-resistant Acinetobacter
baumannii isolates recovered in the University Hospital Sahloul in
Tunisia during a two-years period.
Methods: Ninety-nine non-repetitive carbapenem-resistant A. baumannii
isolates were recovered from January 2005 to December 2006 from
urine, pus and blood samples. The presence of oxacillinase or metallo-
b-lactamase genes was detected by antibiotic susceptibility testing
analysis, PCR and sequencing. In particular, genes coding for the
carbapenem-hydrolysing oxacillinases (CHDL) OXA-23, OXA-40 and
OXA-58 subgroups were searched. Genotyping was done by pulsed ﬁeld
gel electrophoresis (PFGE) using ApaI endonuclease.
Results: Most A. baumannii isolates were from patients hospitalised
in intensive care units and the urology ward. Antibiotyping allowed to
divide these isolates into two main groups (A and B), both being resistant
to all b-lactams including carbapenems. The thirteen A. baumannii
isolates belonging to group A possessed the blaOXA-23 gene. This gene
was very likely chromosomally-located. Insertion sequence ISAba1 was
identiﬁed upstream of the blaOXA-23 gene, enhancing its expression by
providing strong promoter sequences. A. baumannii isolates belonging
to clone B did not express any carbapenemase activity and were found
negative for CHDL encoding genes.
Conclusion: This study reports on the ﬁrst identiﬁcation of b-lactamase
OXA-23 in A. baumannii in Tunisia. The gene encoding OXA-23 was
located on the chromosome of clonally-related A. baumannii isolates
being the source of an outbreak. Interestingly, this epidemiological
survey revealed the concomitant dissemination of two different
carbapenem-resistant A. baumannii clones in the same hospital during
the same period of time.
P1503 Clonal spread of carbapenem-resistant Acinetobacter
baumannii possessing blaOXA-23 in a Bulgarian hospital
T. Stoeva, P.G. Higgins, K. Bojkova, H. Seifert (Varna, BG; Cologne, DE)
Objectives: To investigate the mechanism of carbapenem resistance
(CR) in clinical isolates of Acinetobacter baumannii, collected during
Carbapenem resistance – Part 2 S433
the period 1999–2006 from the University Hospital in Pleven, Bulgaria
and to evaluate the clonal relationship between the isolates.
Methods: From October 1999 to September 2006, 29 CR and 15 car-
bapenem susceptible (CS) A. baumannii isolates, collected from different
wards, were studied. Identiﬁcation was conﬁrmed by gyrB multiplex
PCR and ARDRA. Antimicrobial susceptibility was tested by VITEK2
and agar dilution method and the results were interpreted according
to the current CLSI guidelines. Electrotransformation experiments were
performed to determine carbapenem resistance as chromosomal- or
plasmid-mediated. Detection of the carbapenemase encoding genes and
the associated insertion sequences was performed by PCR, followed by
sequence analysis. Isolates were genotyped by PFGE.
Results: All studied isolates revealed a multidrug resistance phenotype
and possessed blaOXA-51-like and blaAmpC genes. In addition, a
blaOXA-23-like gene was detected in all CR isolates. ISAba1 was
located upstream of the blaOXA-23-like gene. Sequence analysis
conﬁrmed the presence of blaOXA-23. The unsuccessful electrotrans-
formation experiments suggested chromosomal location of the blaOXA-
23 gene. The CR isolates exhibited 2 PFGE pulsotypes. Pulsotype B
dominated in the ICU between 1999 and 2000 and was also detected in
three CS strains isolated from ICU patients during this period. Pulsotype
A accounted for 24 CR strains and was spread among several wards
during the period 2003–2006, but dominated in the ICU. However, one
pulsotype A strain was already recovered in 1999.
Conclusions: The blaOXA-23 gene and ISAba1 were associated
with carbapenem resistance. The increased rate of isolation of CR
A. baumannii in the hospital during the period 1999–2006 was due to
intrahospital dissemination of epidemic strains belonging to 2 clonal
groups, A and B. These data demonstrate both the epidemic spread of
CR A. baumannii and its longevity in the hospital environment.
P1504 OXA-23 and OXA-58 b-lactamase producing Acinetobacter
baumannii clinical isolates from Bulgarian hospitals
T. Stoeva, P.G. Higgins, E. Savov, H. Seifert (Varna, BG; Cologne,
DE; Soﬁa, BG)
Objectives: To investigate the mechanism of carbapenem resistance
(CR) in clinical isolates of Acinetobacter baumannii collected during
2005–2006 from 2 University Hospitals in Bulgaria and to evaluate the
clonal relationship between them.
Methods: A total of 80 nonduplicate isolates of A. baumannii collected
from different wards in Soﬁa (UHS) and Varna (UHV) were studied.
Species identiﬁcation was conﬁrmed by gyrB multiplex PCR and
ARDRA. Antimicrobial susceptibility was tested by VITEK2 and agar
dilution and the results interpreted according to the current CLSI
guidelines. Electrotransformation experiments were performed to deﬁne
CR as chromosomal or plasmid-mediated. Detection of carbapenemase
encoding genes and associated insertion sequences was performed by
PCR, followed by sequence analysis. Isolates were genotyped by PFGE.
Results: The results are summarised in the table. Twelve CR strains
were isolated, all exhibiting a multidrug resistance phenotype. blaOXA-
23-like gene was found in 8 CR isolates and blaOXA-58-like gene
was detected in 4 CR and 1 carbapenem susceptible (CS) isolates. All
80 isolates were positive for blaOXA-51-like gene. Sequence analysis
conﬁrmed the presence of blaOXA-23 and blaOXA-58. There was no
difference in the nucleotide sequence of the blaOXA-58 genes from
UHV. CR was transferable with the blaOXA-58 gene and identiﬁed to
be plasmid-located. The blaOXA-23 gene was not transferable. Eleven
PFGE pulsotypes were detected among all studied isolates. The CR
strains exhibited 3 PFGE pulsotypes. Pulsotype A was isolated from
Medical ICU and Surgical ICU in UHS and pulsotype B from the
Surgical ICU of the same hospital. Pulsotype D is represented by 2
OXA-58 positive strains, recovered from two wards in UHV. Pulsotypes
A and D were also found in CS strains.
Conclusions: CR from UHS was associated with the spread of 2 distinct
clones. Those with pulsotype A have acquired either an OXA-23 or
OXA-58 carbapenemase. The natural reservoirs of these genes remain
unknown. In the second hospital, UHV, 2 isolates were OXA-58 positive
however, only one was CR. Molecular typing reveals intra-hospital, but
not inter-hospital dissemination of CR A. baumannii and demonstrates
that the emergence of CR A. baumannii is caused by acquisition of
resistance determinants by previously susceptible strains and subsequent
cross transmission.
Hospital No. isolates
(CS/CR)
ISAbal-OXA ISAba3-OXA Pulsotype (No.)
UHS 2/11
OXA-23 0/8 8 negative A(5), B(3)
OXA-58 0/3 negative 3 A(3)
OXA-negative 2/0 – – A(1), C(1)
UW 66/1
OXA-58 1/1 2 2 D(2)
OXA-negative 65/0 – – D(21), E(25), F(1),
G(5), H(1), I(9), J(1),
K(2)
P1505 Assessment of carbapenem resistance and presence of
acquired carbapenemases in Russian nosocomial isolates of
Acinetobacter spp.
A. Martinovich, O. Shevchenko, M. Edelstein, R. Kozlov (Smolensk, RU)
Objectives: To determine resistance rates to imipenem (IPM) and
meropenem (MER) and occurrence of acquired metallo-b-lactamases
(MBLs) and class D (OXA) carbapenemases in nosocomial Acineto-
bacter spp. from Russian ICUs.
Materials and Methods: A total of 464 consecutive nosocomial isolates
collected as part of the national surveillance study RESORT in 30 ICUs
of 20 Russian cities in 2002–2004 were studied. The susceptibilities to
IPM and MER were determined by agar dilution method and interpreted
according to CLSI guidelines. A double-disk synergy test with EDTA
was used for phenotypic detection of MBL production. The presence
of the genes for VIM- and IMP-type MBLs and the genes for acquired
class D carbapenemases of three groups: OXA-23-like, OXA-40-like and
OXA-58, was examined by PCR.
Results: A total of 11(2.4%) and 17(3.7%) were nonsusceptible to
IPM (MIC range: 8–128mg/ml) and MER (MIC range: 8–64 mg/ml),
respectively. MBL production was not detected among carbapenem-
nonsusceptible isolates by either phenotypic or molecular tests. The
genes for acquired OXA-type carbapenemases were found in 11 (2.4%)
isolates of A. baumannii exhibiting variable MICs of IPM (4–32mg/ml)
and MER (8–32mg/ml). Eight of these isolates from two hospitals of
Moscow and Novosibirsk harboured the genes for OXA-58 and the
remaining three isolates from Moscow and Irkutsk carried the genes for
OXA-23-like enzymes. No acquired carbapenemase genes were detected
in the other six isolates exhibiting increased resistance to IPM or MER
(MICs: 8–128mg/ml).
Conclusions: Resistance to carbapenems remains rare among nosoco-
mial Acinetobacters in Russia. However, the identiﬁcation of acquired
OXA-type carbapenemases in isolates from geographically distant
regions of Russia poses the risk of future dissemination of resistance.
P1506 The dissemination of OXA-23 harbouring VIM-2 among
Acinetobacter baumannii isolates in two major Saudi Arabia
hospitals
A.A. Al-Sultan, A. Hamouda, S.G.B. Amyes (Edinburgh, UK)
Objectives: Carbapenems have become the drugs of choice for
serious Acinetobacter baumannii infections, however, they are being
compromised by the emergence of carbapenem-hydrolysing b-lactamases
of molecular class B and D. The IMP and VIM are more prevalent
in the Far East, however, OXA carbapenemases are more reported in
Europe. In addition, the genes encoding OXA-23-like and OXA-51-like
enzymes have been found to be linked to insertion element ISAba-1,
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with the OXA-58-like encoding gene adjacent to ISAba-2, ISAba-3 and
IS18. The aim of this work was to investigate the dissemination of these
b-lactamases and to reveal if they are spread clonally.
Methods: A total of 28 nonrepetitive, A. baumannii strains collected
between January 2006 and April 2007 from different specimens. Isolates
were identiﬁed to the species level by restriction analysis of the 16S-
23S rRNA intergenic spacer sequences. The (MIC) of antibiotics was
determined by the agar dilution method following the BSAC Guidelines.
The potency of tigecycline was tested by Disk diffusion test. The metallo-
b-lactamases and the IS genes were detected by multiplex polymerase
chain reaction (MPCR) and PCR respectively, and their identities were
conﬁrmed by sequencing. Pulsed-ﬁeld gel electrophoresis (PFGE) typing
was performed using ApaI restriction endonuclease.
Results: Out of 28 isolates, 11 were resistant to imipenem
(MIC> 8mg/L), of which 4 were highly resistant (MIC = 64mg/L).
Most of these isolates were also multi-drug resistant, they were
resistant to meropenem, ciproﬂoxacin, gentamicin and many b-lactam
antibiotics, but were all sensitive to tigecycline. Six imipenem-resistant
isolates (MIC 16–64mg/L) had OXA-23, of which 4 contained ISAba-1
and ISAba-2 and two with only ISAba-1. Only one isolate (MIC
16mg/L) had OXA-24 and ISAba-1. One imipenem-sensitive isolate
(MIC 0.25mg/L) harboured ISAba-2, ISAba-3 and IS18. A mixture
of 21 imipenem-sensitive and imipenem-resistant isolates had ISAba-1
upstream of blaOXA-51 gene. All imipenem-resistant isolates were
positive by PCR for blaVIM gene, and sequencing conﬁrmed that the
PCR products were 100% identical to the VIM-2. The PFGE showed
that, in one hospital, 4 imipenem-resistant isolates clustered in one big
group. The rest were either clustered in two or grouped with imipenem
sensitive isolates.
Conclusion: Both Oxacillinases and metallo-lactamase, are now
prevalent in imipenem-resistant A. baumannii in Saudi Arabia hospitals.
P1507 Molecular investigation of sequential isolates of
multidrug-resistant Acinetobacter baumannii clones
producing the OXA-40 carbapenemase
C. Valderrey, E. Sevillano, A. Umaran, J.M. Garcı´a-Lobo, L. Gallego
(Leioa, Santander, ES)
Objective: The aim of the study was to analyse sequential isolates of two
multi-drug-resistant A. baumannii clones producing the blaOXA-40-like
carbapenemase gene, including molecular and sequence based typing
based on the ompA (outer membrane protein A), csuE (part of a pilus
assembly system, essential for bioﬁlm formation) and blaOXA-51-like
(the intrinsic carbapenemase gene in A. baumannii) genes.
Material and Methods: 15 isolates were selected from a collection of
total isolates of A. baumannii obtained from a Hospital in Northern
Spain during the years 1999, 2002 and 2005. The representatives
were three per year and clone including blaOXA-40 positive and
negative isolates. Clonal relatedness was conﬁrmed by PFGE with Apa I
enzyme. Multiplex PCR designed to selectively amplify the ompA, csuE
and blaOXA-51-like alleles of a previously identiﬁed clonal complex
designated Group 1 was carried out on all isolates, and sequencing of
these genes carried out on representative isolates. To locate the blaOXA-
40 carbapenemase gene plasmid DNA was digested with EcoRI, PstI and
HindIII endonucleases and hybridised with an OXA-40 speciﬁc probe to
locate the corresponding gene.
Results: Sequence typing conﬁrmed that clones I and II belong to
two highly distinct lineages and comparison with clones from the
United Kingdom showed its homology with sequence type groups 3
and 1 respectively. All isolates were PCR positive for blaOXA-51-like,
conﬁrming their identity as A. baumannii. No isolates were positive for
bla OXA-23–like. Plasmids of similar sizes (ranging from 2.5 to 125
kb) were observed in all isolates, frequently combined in groups of four
structures. Using a blaOXA-40 speciﬁc probe we obtained signal on
different structures but most frequently on a plasmid of 32 kb.
Conclusion: The OXA-40 carbapenemase gene is present in plasmids
harboured by different genotypes indicating the relatioship with a
mobile structure. Both clones bore plasmids of similar sizes frequently
associated in groups of four structures per isolate.
P1508 Identiﬁcation of an OXA-58 carbapenemase in an unusual
Portuguese Acinetobacter baumannii clinical isolate
C. Caneiras, T. Ferreira, A. Duarte, G. da Silva (Lisbon, Coimbra, PT)
Objectives: Several carbapenem oxacillinases have been reported
recently in A. baumannii. Our group characterised a multidrug resistant
(MDR) clone producing an OXA-40 carbapenemase endemic in Portugal
and Spain. Recently, imipenem-resistant isolates with slight different
antibiogram has been found in a Central Hospital Santo Antonio dos
Capuchos (HSAC) at Lisboa. The aim of this study was to screen for
carbapenemases in A. baumannii imipenem-resistant isolates.
Methods: The isolates were grouped on basis of susceptibility proﬁles
determined by VITEK2 System® and RAPD proﬁles. Ampliﬁcation was
performed using speciﬁc primers for OXA type enzymes and class 1
integrons. Plasmid extraction was prepared by Kado & Liu method.
Results: Fifteen representative isolates were clustered in 4 groups:
A1 (n = 3) susceptible to tobramycin and colistin; A2 (n = 3) sus-
ceptible to aminoglycosides (gentamicine, amikacin, tobramycin and
netilmicin), colistin, tetracycline, intermediate/resistant to ceftazidime
and levoﬂoxacin; A3 (n = 3) susceptible to aminoglicosydes and colistin
but intermediate to tetracycline and resistant to ceftazidime; and group
A4 (n = 3) with variable susceptibility. OXA-40 enzyme was found in
10 isolates, not correlating with any particular group. The Ac 156976
isolate, included in group A4, showed an OXA-58 enzyme and was
resistant to aminoglycosides, ceftazidime, and imipenem; susceptible to
ciproﬂoxacin, intermediate to meropenem. The plasmidic blaOXA-58
gene was part of a class 1 integron gene cassette.
Conclusion: The study report the identiﬁcation of an OXA-58 enzyme in
Portugal for the ﬁrst time, and highlight the possibility of an emergence
of a new multidrug resistant clone and its dissemination.
P1509 Nosocomial dissemination of carbapenem-resistant
Acinetobacter spp. isolates in a general hospital in
Thessaloniki, Greece
S. Figueiredo, L. Poirel, A. Papa, V. Koulourida, P. Nordmann (Le
Kremlin Bicetre, FR; Thessaloniki, GR)
Objectives: To characterise the clonal relationship and the b-lactamase
content of carbapenem-resistant Acinetobacter spp. isolates recovered in
a University Hospital in Thessaloniki, Greece.
Methods: Twenty-one non-repetitive carbapenem-resistant Acinetobac-
ter spp. isolates were recovered from August 2001 to November 2006
period at the Papageorgiou General Hospital, Thessaloniki, Greece.
Species identiﬁcation was determined by the biochemical API32 GN
test (bio-Me´rieux, France) and by 16S rRNA sequencing. Susceptibility
testing was done by disk diffusion method and Minimum Inhibitory
Concentration (MICs) were determined by agar dilution. Genes coding
for the carbapenem-hydrolyzing class D b-lactamases OXA-23, OXA-40,
OXA-58 and OXA-51 subgroups and for VIM- and IMP-type metallo-
b-lactamases (MBLs) were searched. The isolates were also screened for
the presence of ISAba1 in the promoter region of the blaOXA-51-like
gene in order to investigate the role of ISAba1 in blaOXA-51 expression.
Genotyping was done by pulsed ﬁeld gel electrophoresis (PFGE) after
digestion by ApaI.
Results: All isolates were identiﬁed as A. baumannii except one isolate
identiﬁed as Acinetobacter genomospecies 16. Genotyping revealed that
the twenty A. baumannii isolates belonged to ﬁve different pulsed-ﬁeld
gel electrophoresis clones. Clones 1 to 3 including sixteen A. baumannii
isolates harboured the blaOXA-58 gene whereas clones 4 and 5 including
four isolates did not possess any carbapenemase gene. ISAba1 was
identiﬁed upstream of the blaOXA-51 gene in three blaOXA-58 negative
A. baumannii isolates. In one of these isolates, ISAba1 was truncated
immediately upstream of the blaOXA-51 gene by a novel insertion
sequence named ISAba9 that may provide promoter sequences for
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blaOXA-51 expression. Acinetobacter genomospecies 16 harboured
VIM-4 MBL determinant. The blaOXA-58 gene was most often plasmid-
located.
Conclusion: This study highlights the diversity of the mechanisms
involved in carbapenem resistance in an Acinetobacter spp. Furthermore,
this is the ﬁrst description of the MBL VIM-4 determinant in
Acinetobacter spp. and the ﬁrst description of ISAba9, a novel insertion
sequence providing promoters for oxacillinase genes expression.
P1510 Persistence of pan-resistant Acinetobacter baumannii strains
recovered from blood cultures in an intensive care unit
M. Orfanidou, V. Miriagou, C. Papagiannitsis, A. Zioga, A. Karabinis,
H. Malamou-Lada (Athens, GR)
Objectives: The aim of our study was to investigate the resistance
mechanisms to carbapenems and to characterise the genotypes of
panresistant A. baumannii (Ab) strains, isolated from blood cultures of
Intensive Care Unit’s (ICU) patients, in a tertiary hospital in Greece,
during eight months period (9/2006−5/2007)
Methods: During the study period 22 panresistant Ab strains were
recovered from blood cultures of ICU’s patients. The strains were
identiﬁed by VITEK2 automated system (bioMerieux). Antibiotic
susceptibility was tested by disk diffusion method and MICs were
determined by VITEK2. All strains were investigated for the production
of metallo-b-lactamases (MBL) by (a) an in house EDTA synergy test
with imipenem and EDTA discs (EDTA/DDST) and (b) E-test strips of
imipenem and imipenem/EDTA (MBL E-test). The presence of the bla
genes of the VIM, OXA-23, OXA-24, OXA-51 and OXA-58 types were
identiﬁed by PCR assays. All strains were genotyped by pulse ﬁeld gel
electrophoresis (PFGE) after digestion with ApaI.
Results: All of the examined strains were unanimously resistant to all
b-lactams, including carbapenems, quinolones and aminoglycosides and
were sensitive to colistin. None of the strains revealed MBL production
by EDTA/DDST, while 9/22 (41%) showed MBL production by MBL
E-test. The blaVIM gene was not detected in any of the strains by PCR.
All strains presented blaOXA-51 and blaOXA-58 type genes by PCR.
Molecular analysis of 21 Ab strains by PFGE showed one major clone
(clone A) with two subtypes (A1 and A3) and the remaining strain
exhibited a unique pattern (U).
Conclusions:
1. Persistence of panresistant Ab strains, susceptible only to colistin,
from blood cultures of patients in ICU was observed during eight
months period
2. All strains produced oxacillinases of the OXA-51 and OXA-58 types
3. The majority of our strains belonged to a single clone, which in
combination with their panresistance, indicates the need for more
strict reinforced infection control in ICU
P1511 Genetics and expression of the carbapenem-hydrolyzing
oxacillinase genes blaOXA-51 and blaOXA-58 in
Acinetobacter baumannii isolates from blood cultures in a
university hospital in Athens, Greece
I. Galani, L. Galani, V. Sakka, M. Souli, Z. Chryssouli, H. Giamarellou
(Athens, GR)
Objectives: Molecular studies showed that carbapenem-resistant Acine-
tobacter baumannii strains isolated from blood cultures of hospitalised
patients in the University General Hospital “Attikon”, belonging to
several clones, contain both blaOXA-58 and the naturally occurring
blaOXA-51-like genes. The objective of our study was to examine
the genetic structures surrounding the blaOXA-51 and blaOXA-58
oxacillinase genes.
Methods: A total of 27 imipenem-resistant (harbouring blaOXA-58
and blaOXA-51-like genes) isolates collected from blood cultures of
hospitalised patients in the University General Hospital “Attikon”, were
studied. Analysis of the sequences bracketing the blaOXA-51 and
blaOXA-58 genes were evaluated by PCR mapping using combinations
of the ISAba primers and the blaOXA-51-like and blaOXA-58-like
reverse primers (Poirel and Nordmann, 2006). Bacterial clones were
identiﬁed by PFGE with ApaI.
Results: ISAba1 element was identiﬁed upstream of the blaOXA-51
gene in all clones of A. baumannii tested. Some variability of the
promoter sequences identiﬁed upstream of the blaOXA-58 gene among
the analysed isolates was indicated by our results. In all isolates an
ISAba3 element was identiﬁed upstream of the blaOXA-58 gene but in
some cases it was truncated by the insertion of ISAba2. Additionally the
ISAba3 was present (not always at the same distance) upstream of the
start codon of blaOXA-58. Another interesting feature was the presence
of ISAba3 downstream of blaOXA-58.
Conclusions: This work identiﬁed variable genetic structures at the
origin of acquisition and expression of a carbapenem-hydrolyzing
b-lactamase OXA-58 harboured by non-clonally related A. baumannii
isolates.
P1512 Presence of the carbapenem-hydrolyzing oxacillinase
Oxa-58 in an Acinetobacter phenon 6/ct13TU clinical isolate
S. Marti, J. Sanchez-Cespedes, M.D. Blasco, V. Alba, J. Vila
(Barcelona, Valencia, ES)
Objectives: The main nosocomial pathogen within the Acinetobacter
genus is Acinetobacter baumannii. Carbapenems usually retain good
activity against these microorganisms. In spite of this, carbapenem
resistance in A. baumannii has been reported worldwide. The main aim
of our study was to investigate the mechanism of resistance to imipenem
(IP) in an Acinetobacter phenon 6/ct13TU clinical isolate.
Methods: The study was performed in two Acinetobacter spp. (Ac054
and Ac058) isolates collected from two Spanish hospital during the
same period of time. The characterisation of these strains was done by
ARDRA and the MICs of IP were determined by Etest. The detection of
OXA-58 was done by PCR and sequencing with speciﬁc primers from
A. baumannii. Expression of the OXA-58 gene was determined by RT-
PCR using the speciﬁc primers for this gene and the 16S as internal
control. The genetic location of the gene was investigated by using the
genomic mapping with I-CeuI followed by Southern blot and double
hybridisation with probes for the blaOXA-58 gene and for the 23S gene.
Results: One isolate was identiﬁed as A. baumannii (Ac058) and the
other as Acinetobacter phenon 6/ct13TU (Ac054). Both isolates, as
expected, were different by Pulse-Field Gel Electrophoresis. Presence
of the OXA-58 gene was determined by PCR with speciﬁc primers. The
OXA-58 genes were sequenced and presented 100% homology. Analysis
of gene expression by RT-PCR also revealed that OXA-58 was expressed
in both isolates. However, A. baumannii strain Ac058 had a MIC of IP
>32mg/L while Acinetobacter phenon 6/ct13TU strain Ac054 had a
MIC of IP = 6mg/L which implies the presence in A. baumannii of an
additional mechanism of resistance to imipenem.
Conclusion: The OXA-58 gene, with 100% homology to the same
gene found in A. baumannii, has been detected for the ﬁrst time in an
Acinetobacter phenon 6/ct13TU clinical isolate. Its location in a plasmid
suggests that these resistance genes may be transferred from one species
to another.
P1513 Outbreak of carbapenem-resistant Acinetobacter baumannii
producing the carbapenemase OXA-58 in Turkey
N. Ozen, A. Ergani-O¨zcan, T. Naas, D. O¨gu¨nc¸, M. Gu¨ltekin, D. Colak,
P. Nordmann (Antalya, TR; Kremlin-Bicetre, FR)
Objectives: The use of carbapenems to eradicate multi-drug resistant
(MDR) Acinetobacter baumannii (Ab) may become compromised by
the spread of carbapenem-resistant genes. Carbapenem-hydrolyzing class
D b-lactamases (OXA-23, OXA-24, OXA-40, or OXA-58) producing
Ab isolates have been reported worldwide. Here we describe the ﬁrst
outbreak of OXA-58 producing Ab in Turkey.
Methods: All MDR clinical isolates of Ab, recovered between June
and November 2003 in a tertiary-care hospital in Antalya, were
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analysed for their DNA content (genomic or plasmid), by isoelectric
focusing (IEF), conjugation assays and PFGE. PCR were performed for
blaIMP, blaVIM, blaOXA-23-like, blaOXA-40-like, blaOXA-58 genes
and blaOXA-51-like genes, blaTEM gene, blaOXA-20, the chromosomal
class C b-lactamase blaAMPC gene and the presence of ISAbaI
inserted upstream of the b-lactamase genes. b-lactamase expression was
monitored by hydrolysis and iso-electrofocusing.
Results: 116 MDR A. baumannii isolates were isolated from 23 patients,
mostly from respiratory samples and from 10 environmental samples.
These MDR isolates, which belonged to a single clone, remained
susceptible to colistin and rifampin only and produced the carbapenem-
hydrolyzing oxacillinase OXA-58. In addition, they were also positive
for the blaOXA-51, for a point mutant derivative of blaAMPC (ADC-7)
genes and for ISAba1. One isogenic carbapenem-susceptible strain
lost its blaOXA-58 gene, through loss of its plasmid. IEF conﬁrmed
the expression of b-lactamases OXA-58 and AmpC. The blaOXA-
58 gene was located onto a non self-transferable 50-kb plasmid that
could be electroporated to Ab7010 reference strain and conferred a
b-lactam resistance pattern consistent with the expression of OXA-58
carbapenemase. PCR mapping and sequencing identiﬁed similar genetic
structures surrounding the blaOXA-58 gene as those reported adjacent to
the blaOXA-58 prototype gene, e.g. presence of two insertion sequences
ISAba3-like elements bracketing blaOXA-58 gene.
Conclusion: This is the ﬁrst molecular description of an outbreak of
OXA-58-producing Ab isolates in Turkey, further underlining the global
spread of such carbapenemase-producing strains.
P1514 Acquired carbapenemase-encoding genes among
Gram-negative isolates in USA medical centres: report
from the MYSTIC Program (2007)
R. Mendes, P. Rhomberg, M. Castanheira, L. Deshpande, R. Jones
(North Liberty, US)
Objective: To evaluate the occurrence of acquired carbapenemase-
encoding genes among Gram-negative patient isolates recovered from
USA MC in the 2007 MYSTIC Program.
Methods: 1,392 Enterobacteriaceae (ENT), 133 Acinetobacter spp.
(ASP) and 465 Pseudomonas spp. (PSP) clinical isolates from 15 USA
MC were susceptibility tested by CLSI reference broth microdilution
method. ENT and PSP isolates showing MIC values 2mg/L and
16mg/L, respectively, for imipenem and meropenem were screened
for KPC- and metallo-b-lactamase (MBL)-encoding genes. ASP isolates
showing MIC values 16mg/L for imipenem and meropenem were
screened for MBL- and OXA-encoding genes. Presence of ISAba1
upstream of the blaOXA-51 and clonality were also investigated by
PCR and PFGE, respectively. Additionally, ASP isolates from previous
MYSTIC Program years were tested for OXA genes.
Results: 42 (3.0% of the total) ENT isolates were screened and 35
(2.5%) isolates from MC located in New York (24/35; 68.6%), New
Jersey (10/35; 28.6%) and Ohio (1/35; 2.8%) harboured blaKPC. This
gene was found in C. freundii (2), E. coli (1), E. cloacae (3), K. oxytoca
(1) and K. pneumoniae (28). Among 133 ASP, 50 (37.6%) isolates were
screened and blaOXA-23 was detected in 10 isolates from MC in New
York (3), Kentucky (3), Arkansas (2) and Colorado (2), while blaOXA-24
was detected in 5 isolates from New Jersey. ISAba1 was associated with
blaOXA-51 in 76.5% of the cases and clonal dissemination of blaOXA-
carrying ASP within MC was noted. In the retrospective sample of
ASP collected from 1999 to 2006, 42 (6.8%) isolates were screened for
blaOXA. blaOXA-23 was observed in 2 isolates from Tennessee (2004)
and one isolate each from Kentucky and Washington (2005). Among
the 36 (7.7%) PSP isolates screened, no carbapenemases were detected.
MBL-encoding genes were not observed.
Conclusions: Although the results presented here document an alarming
presence of blaKPC, the rate (2.5%) was lower when compared with
the previous MYSTIC year (4.5%; P = 0.0063; OR = 1.80, CI 95%
1.15−2.82). However, the KPC gene has spread among several different
ENT species, while it was detected only in Klebsiella spp. in the
previous year. blaOXA genes have been detected in several MYSTIC
Program MC within the USA; ﬁrst detected in 2004. blaOXA genes were
only observed in consecutive years in Kentucky, suggesting a sporadic
appearance in ASP, overall. MBL-encoding genes are still quite rare in
the MYSTIC Program.
P1515 Characterisation of resistance genes among Acinetobacter
spp. isolates in Singapore hospitals
T.T. Tan, L. Widjaya, L.Y. Hsu, T.H. Koh (Singapore, SG)
Objectives: Carbapenem-resistant Acinetobacter baumannii are increas-
ing causes of nosocomial infection worldwide. Several mechanisms
are responsible for carbapenem resistance in Acinetobacter spp. The
carbapenemases described so far belong to either the OXA class D
family of serine b-lactamases or the IMP/VIM class B family of metallo-
b-lactamases. The aim of our study was to investigate the possible
mechanism of resistance to imipenem in Acinetobacter spp. clinical
isolates with regards to the OXA classes and metallo-b-lactamases.
Methods: We studied 145 isolates of Acinetobacter spp. collected over
2 months in 2006 from all public hospitals in Singapore. Susceptibility
patterns according to individual laboratories were correlated with the
resistance genes present. Isolates was screened for blaOXA-23-like,
blaOXA-24-like, blaOXA-58-like, and blaOXA-51-like genes using a
multiplex PCR. Putative metallo-b-lactamase genes were ampliﬁed from
the collection by using published degenerate primers.
Results: 58 strains were carbapenem (imipenem/meropenem) susceptible
while 87 strains were carbapenem resistant. Among carbapenem resistant
strains, 86% and 85% carried blaOXA-23-like and blaOXA-51-like
respectively. Carbapenem-susceptible strains carried these genes at a
frequency of 6% and 62% respectively. Five of both the carbapenem
resistant and susceptible strains carried the blaOXA-58-like gene.
Interestingly, among carbapenem-susceptible strains, 43% carried gene
products coding an blaIMP-like gene. Among carbapenem resistant
strains, the frequency was 50%.
Conclusion: The presence of blaOXA-51 did not correlate with the level
of carbapenem resistance. The presence of blaOXA-23-like genes did
predict for imipenem resistance. Apparently imipenem susceptible strains
may carry the blaIMP-like gene.
P1516 The mechanism of carbapenem resistance in Acinetobacter
baumannii clinical isolates and expression of OXA-72 in
Pichia pastoris
J. Han, D. Wu, Z. Geng, L. Yang, Q. Li (Jinan, CN)
Objectives: To elucidate the mechanism of carbapenams resistance in
Acinetobacter baumannii (Acinetobacter spp.) and to express OXA-72
in Pichia pastoris.
Methods: In 2004, we collected 96 Acinetobacter spp. isolates from
sputum of hospital-acquired pneumonia patients at 2 hospitals in
Jinan, China. Of these, 5(5.2%) were identiﬁed to be carbapenem-
resistant by E-test. Firstly, we investigated the carbapenems genetype
of these 5 isolates by polymerase chain reaction (PCR) with the speciﬁc
primers of bla(OXA-23), bla(OXA-24), bla(IMP) and bla(VIM). The
PCR products were then sequenced. Secondly, we analysed the proﬁles
of out membrane proteins of the 5 isolates. Out membrane proteins
were prepared by supersound, collected by ultra-centrifugation and
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Thirdly, to express the carbapenemase OXA-72 in Pichia
pastoris, we ampliﬁed oxa-72 gene by PCR using the extracted genomic
DNA of the isolate 40 as a template. After the ampliﬁed gene
was cloned into vector pGAPZalphaA, linearised recombinant plasmid
oxa72-pGAPZalphaA was transformed to Pichia pastoris GS115 by
electroporation. Then the positive transformants were screened by colony
PCR, western blot analysis and Nitroceﬁn test.
Results: PCR with the presence of bla(OXA-23)-speciﬁc primers
ampliﬁed a circa 1083-bp fragment with three isolates(isolate 11, 66 and
67), their DNA sequences were identical with blaOXA-23. One isolate
(isolate 40) obtained a circa 1043bp PCR product with the presence
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of bla(OXA-24)-speciﬁc primers, the DNA sequence was identical
with blaOXA-72(GenBank accession numbers AY739646). A protein
of 29kDa decreased in one carbapenem-resistant isolate (isolate 66) and
a protein of 24kDa overexpressed in two carbapenem-resistance isolates
(isolate 66 and 67). One positive transformant was obtained with PCR,
western blot and Nitroceﬁn test all positive.
Conclusion: These ﬁndings indicates that producing class D b-lactamase
OXA-23 and OXA-72 was one of the mechanism for carbapenems
resistance of Acinetobacter spp. in Jinan. The decrease of a 29 kDa
out membrane protein and the overexpression of the 24kDa penicillin-
binding protein were also related to the carbapenems resistance to in
Acinetobacter spp. We found carbapenemase OXA-72 which is seldom
reported and successfully expressed it in Pichia pastoris. Now we are
purifying the carbapenemase OXA-72 and do further study on the
properties of it.
P1517 Warning! Oxacillinase-mediated carbapenem resistance
spreading in Enterobacteriaceae
M. Yilmaz, Y. Aybar Bilir, K. Midilli, R. Ozaras, A. Mert, F. Tabak,
R. Ozturk (Istanbul, TR)
Introduction: Resistance to expanded-spectrum cephalosporins in
Enterobacteriaceae has been reported to be related to the production
of Ambler class A extended-spectrum b-lactamases (ESBLs) and
chromosomal and plasmid-encoded AmpC cephalosporinases. However,
increasing number of reports regarding b-lactamase mediated resistance
to carbapenems in Enterobacteriaceae are being published.
Objectives: Between 2002–2006, we identiﬁed 21 Enterobacteriaceae
strains that are resistant to any of the carbapenems in the infectious
diseases and clinical microbiology laboratory of a 1500 bed university
hospital. The aim of the study was to identify the resistance
mechanism(s) of carbapenems in these strains and to check for clonal
dissemination.
Methods: Bacterial strains and and MIC determinations. All the strains
(15 Klebsiella pneumoniae, 1 Escherichia coli, 2 Enterobacter cloaceae
and 2 Enterobacter aerogenes) were clinical isolates from the Istanbul
University, Cerrahpasa Medical Faculty Hospital, Infectious Diseases and
Clinical Microbiology Laboratory. The strains were identiﬁed with the
API 32GN system. Antibiotic susceptibilities and MICs were with disc
diffusion assay and E-test.
IEF analysis. Isoelectric focusing (IEF) analysis was performed with an
ampholine polyacrylamide gel (pH 3.5 to 9.5).
PCR experiments and DNA sequencing: Using total DNA of each of
the strains, PCR ampliﬁcations of the blaOXA-48 genes were performed
with the primers OXA-48A (5′-TTGGTGGCATCGATTATCGG-3′) and
OXA-48B (5′-GAGCACTTCTTTTGTGATGGC-3′), giving rise to a
743-bp fragment.
Molecular typing. Molecular characterisation of the strains was done
by macrorestriction analysis of genomic DNA with XbaI (New
England BioLabs). DNA fragments were separated by pulsed-ﬁeld
gel electrophoresis (PFGE) in a CHEF-DR II system (Bio-Rad).
Electrophoresis conditions were pulse times ranging from 5 to 35 s for
24 h at 6 V/cm and 14ºC.
Infection control procedures. Patients from whom carbapenem-resistant
Enterobacteriaceae was recovered at any site were visited by a member
of the infection control team. Colonisation or infection was determined
according to the deﬁnition of the Centers for Diseases Control and
Prevention for nosocomial infections.
Results and Conclusion: All the carbapenem resistant strains isolated
produced OXA-48, a class D oxacillinase signiﬁcant with carbapenem-
hydrolysing activity. No relationship was observed among the seven
patients hospitalised in different wards.
P1518 Diversity of antibiotic resistance determinants among
the recent population of Acinetobacter baumannii strains
belonging to European clone II
L. Krizova, M. Maixnerova, L. Dijkshoorn, A. Nemec (Prague, CZ;
Leiden, NL)
Objective: The recent increase in Acinetobacter baumannii resistance to
carbapenems in the Czech Republic has been associated with the spread
of strains belonging to European clone II. Although multidrug resistance
was a common property of these strains, they differed in resistance to
particular agents. The aim of this study was to assess the genetic basis
of this variation.
Methods: Sixty-six strains obtained from 37 intensive care units in the
Czech Republic in 2005−6 were studied. The strains were previously
classiﬁed as European clone II by AFLP and were shown to have
highly similar or identical PFGE patterns. They were tested for MICs to
sulbactam, ceftazidime, meropenem, gentamicin, tobramycin, amikacin,
netilmicin and doxycycline, and for the presence of 20 genes associated
with resistance to these agents.
Results: All strains were positive for the genes encoding OXA-
51, AmpC and the AdeABC efﬂux system while no strain tested
positive for those encoding metallo-b-lactamases, OXA-23 and OXA-
24 carbapenemases, or aminoglycoside-modifying enzymes AAC(3)-
II, AAC(6′)-I, and ANT(2′′)-I. The strains varied with respect to the
presence of the genes encoding the following proteins (% positive
strains): TEM-1 (80), Tet(B) (92), Tet(A) (5), AAC(3)-I (83), APH(3′)-I
(80), APH(3′)-VI (30), OXA-58 (3) and a class 1 integrase (83). ISAba1
was found in 95% strains and three integron variable regions (2.5, 3.0
and 3.5 kb) were identiﬁed, differing only in the number of copies of the
orfX cassette. The presence of particular genes and the corresponding
resistant phenotype were in good agreement. All strains with ISAba1
located upstream of the AmpC gene (n = 33) were resistant to ceftazidime
(MIC> 64mg/l) while those with ISAba1 upstream of the OXA-51 gene
(n = 33) showed increased meropenem MICs (2–32mg/l). Individual
strains carried from 4 to 12 resistance genes in 17 combinations.
Different combinations were also found in isolates from the same ward
and having identical PFGE patterns.
Conclusion: The variation in antibiotic resistance in the studied strains
results from the differences in the presence of acquired resistance genes
and, possibly from the effect of ISAbaI on the expression of intrinsic
genes. The high genetic versatility of European clone II might contribute
to its ability to develop resistance to nearly all clinically relevant
antibiotics.
Supported by grant NR8554−3 of the Ministry of Health of the Czech
Republic.
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P1519 Plasmid-mediated quinolone resistance determinant QepA
from ESBL-producing Escherichia coli in France
V. Cattoir, L. Poirel, P. Nordmann (Le Kremlin Bicetre, FR)
Objectives: Three different plasmid-mediated quinolone resistance
(PMQR) determinants have been described: Qnr, AAC(6′)-Ib-cr and
QepA. QepA is an efﬂux pump responsible for decreased susceptibility
to hydrophilic ﬂuoroquinolones, was identiﬁed in association with RmtB
(responsible for resistance to all aminoglycosides) in two Escherichia
coli isolates from Belgium and Japan. To date, the single epidemiological
survey performed reported a low prevalence of the qepA gene (0.3%)
among E. coli isolates from Japan. The aim of our study was to determine
the presence of qepA gene among ESBL-producing enterobacterial
isolates from a French University hospital.
Methods: Screening was performed on 121 ESBL-producing enterobac-
terial isolates collected in France from January 2007 to October 2007.
PCR with primers speciﬁc for the qepA gene was used for screening.
Detection and identiﬁcation of ESBL genes was performed using speciﬁc
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primers of sequences encoding TEM-, SHV- and CTX-M-type ESBLs.
The presence of qnr-like and aac(6′)-Ib-cr genes were also searched for
qepA-positive isolate. Plasmid extraction was performed by the Kieser
method and transfer of plasmids to E. coli refernce strain was performed
by electroporation.
Results: Out of 121 ESBL-positive enterobacterial isolates tested, a
single Escherichia coli isolate (0.8%) was found to possess the qepA
gene. Sequence analysis revealed a perfect identity with the previously
published qepA. The qepA-positive E. coli clinical isolate was recovered
from urine and blood samples of a patient suffering from pyelonephritis.
This isolate carried the ESBL gene blaCTX-M-15 and also the narrow-
spectrum penicillinase blaTEM-1 gene. That isolate was fully susceptible
to aminoglycosides but showed a high level of resistance to quinolones
and ﬂuoroquinolones. PCR showed that this isolate did not possess Qnr-
type and AAC(6′)-Ib-cr determinants. Transfer of the qepA-positive
plasmid was obtained in an E. coli recipient isolate, giving rise to
reduced susceptibility to norﬂoxacin and ciproﬂoxacin, and co-resistance
to penicillins, chloramphenicol, tetracycline, and sulfonamides, but did
not express an ESBL phenotype.
Conclusion: This study identiﬁed plasmid-mediated quinolone resis-
tance QepA determinant in France. By contrast to previous ﬁndings,
the QepA determinant was not associated with plasmid-mediated
aminoglycoside resistance RmtB determinant.
P1520 Plasmid-mediated quinolone resistance genes in extended-
spectrum b-lactamase-producing Enterobacteriaceae, Italy
C. Mugnaioli, F. Luzzaro, G.M. Rossolini (Siena, Varese, IT)
Objectives: At least 3 types of plasmid-mediated quinolone resistance
(PMQR) mechanisms have emerged in Enterobacteriaceae, including
Qnr proteins (which protect the topoisomerase target), the AAC(6′)-
Ib-cr enzyme (which inactivates some quinolones by acetylation),
and the QepA pump (which can efﬂux hydrophilic quinolones). The
role of these mechanisms in evolution of ﬂuoroquinolone resistance
has been recognised, but current knowledge on their epidemiology
is still limited. Here we studied the prevalence and distribution of
PMQR determinants among Extended-Spectrum b-lactamase- (ESBL-)
producing Enterobacteriaceae from an Italian nationwide survey.
Methods: 271 consecutive nonreplicate ESBL-producing-isolates of
Enterobacteriaceae (Escherichia coli, Klebsiella spp. and Enterobacter
spp.) were obtained from 11 clinical microbiology laboratories located
in different Italian regions during the second ESBL national survey.
Isolates were analysed by colony-blot hybridisation using DNA probes
containing the gene aac(6′)-Ib or qepA or a mixture of qnrA, qnrB and
qnrS genes. The hybridisation-positive isolates were further analysed by
PCR-RFLP and sequencing.
Results: Overall, 62 (23%), 10 (4%) and none of the ESBL producers
were found to harbour the aac(6′)-Ib-cr, qnr (either qnrA or qnrB) and
qepA genes, respectively. aac(6′)-Ib-cr and qnr genes were widespread
across the Italian territory (detected in 6 and 4 of the 11 centres,
respectively). The former was mostly detected in E. coli (61 isolates, 42%
of ESBL-producing E. coli) and occasionally in Klebsiella pneumoniae
(one isolate, 1% of the ESBL-producing K. pneumoniae). In most cases
aac(6′)-Ib-cr was associated with CTX-M-15 (81%), and in a minority
of cases with a TEM-type ESBL (16%) or with SHV-12 (3%). qnrB
gene was detected in K. pneumoniae (4 isolates, 6% of ESBL-producing
K. pneumoniae), and qnrA in Enterobacter cloacae (6 isolates, 46% of
ESBL-producing E. cloacae). Qnr genes were mostly associated with
SHV-12 (80%), and in a minority of cases with a TEM-type ESBL
(20%). No association between aac(6′)-Ib-cr and qnr was found.
Conclusions: Of PMQR genes, only aac(6′)-Ib-cr, qnrA and qnrB
were detected among ESBL-producing isolates of Enterobacteriaceae
circulating in Italy.
P1521 Prevalence of aac(6′)-Ib-cr gene in Escherichia coli isolated
in northern Italy from patients with urinary tract infections
R. Musumeci, V. Galimberti, A. Careddu, G. Giltri, S. Bramati,
C.E. Cocuzza (Monza, IT)
Objectives: The allelic variant aac(6′)-Ib-cr of aac(6′)-Ib gene has
been associated with resistance not only to aminoglycosides but also to
ﬂuoroquinolones such as norﬂoxacin and ciproﬂoxacin. Furthermore, the
presence of the aac(6′)-Ib-cr gene has been associated with that of other
resistance genes, such as blaCTX-M, encoded by the same plasmid. To
estimate the prevalence of this variant and its spread in our geographical
area, a retrospective study was conducted on a collection of urinary
strains of E. coli isolated in northern Italy in 2004 and 2006.
Methods: 236 and 240 E. coli strains, isolated from urine cultures in
the period November-December 2004 and in the same period of 2006,
respectively, in San Gerardo Hospital of Monza (MI), were screened.
The presence of the aac(6′)-Ib-cr gene was evaluated by PCR followed
by amplicons restriction using BstF5I. Unrestricted PCR products were
sequenced to conﬁrm the presence of the allelic variant. A multiplex
PCR, to determine the presence of the qnr genes, was also performed.
The presence of blaCTX-M has also been evaluated.
Results: Positivity for aac(6′)-Ib-cr gene was shown overall in 3 and 8
E. coli strains isolated in 2004 and 2006, respectively.
All strains shown to possess the aac(6′)-Ib-cr gene were found to have
MIC values to norﬂoxacin and ciproﬂoxacin of >16 and >4mg/L,
respectively. None of the qnr genes were detected in aac(6′)-Ib-cr positive
strains. Moreover, all aac(6′)-Ib-cr positive strains were also shown to
possess blaCTX-M group 1 genes.
Conclusion: The prevalence of the aac(6′)-Ib-cr gene in isolates of
E. coli characterised by norﬂoxacin MIC values 1mg/L, raised from
6.1% (3/49) in 2004 to 12.5% (8/64) in 2006, indicating a possible
spread of strains characterised by the presence of this gene in northern
Italy. The presence of the aac(6′)-Ib-cr gene was shown to be associated
with resistance to ﬂuoroquinolones in the isolates analysed. Moreover,
a correlation between the presence of aac(6′)-Ib-cr and the blaCTX-M
group 1 genes was also observed.
This represents the ﬁrst study that demonstrates the presence and
diffusion of this resistance determinant in our geographic area, although
further epidemiological and molecular surveys are necessary.
P1522 Prevalence of qnr genes in Italy among Salmonella strains
with reduced susceptibility to ciproﬂoxacin
A.M. Dionisi, C. Lucarelli, S. Owczarek, I. Luzzi, L. Villa (Rome, IT)
Objectives: Resistance to quinolones commonly develops by spon-
taneous point mutations on chromosomal genes. Recently, plasmid-
mediated resistance of Qnr type has been identiﬁed in several
enterobacterial species. This work aims to evaluate the presence of qnr
genes among human strains of Salmonella spp. collected in Italy.
Methods: Ciproﬂoxacin MICs, was determined for 160 strains of
S. enterica isolated in Italy during 2004–2006 and chosen randomly
among 1811 human isolates already tested for antibiotic susceptibility,
by disc diffusion method. To identify mutations responsible for
ciproﬂoxacin resistance, the quinolone resistance-determining regions
(QRDR) of gyrA, gyrB, parC, parE, were ampliﬁed by PCR
and sequenced. Strains resistant or with reduced susceptibility to
ciproﬂoxacin (MIC0.125mg/ml), were tested by PCR for the presence
of qnrA, qnrB and qnrS genes. Strains positive for qnr genes were
tested for the ability to transfer resistances by conjugation; plasmid DNA
was subsequently used in cloning experiments to investigate the genetic
environment of qnr gene.
Results: Fifty-eight of the 160 strains showed reduced susceptibility to
ciproﬂoxacin, 3 strains (1 S. Typhimurium and 2 S. Kentucky) were
resistant showing the same mutations in the QRDRs, as previously
described.
One S. Typhimurium strain, resistant to ampicillin, cefotaxime,
ceftazidime, kanamycin, trimethoprim/sulfamethoxazole, with a Cip
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MIC=0.38mg/ml, carried a qnrB gene showing 99% of aminoacidic
identity with the sequence of qnrB10 and 98% of identity with qnrB5
found in S. Berta. No mutation in the QRDRs was found. Conjugation
experiments revealed that all resistances were successfully transferred,
except trimethoprim/sulfamethoxazole. Detailed plasmid characterisation
of 16 kb region conferring multidrug resistance, identiﬁed the qnrB
gene ﬂanked by ISEcp1 and IS26, a blaSHV-12 gene ﬂanked by two
open reading frame of unknown function and by IS26, a blaTEM1 gene
followed by truncated class1 integron, containing aadB gene cassette.
Conclusion: The plasmid-mediated quinolone resistance of the Qnr type
is emerging in Enterobacteriaceae in many different geographic areas,
but it remains rare in Salmonella in Italy. However the presence of
qnrB genes in S. Typhimurium, never been described before, deserves
particular attention because of the high prevalence of human infections
due to this ubiquitous serotype.
P1523 Prevalence of the quinolone-modifying enzyme
aac(6′)-Ib-cr in extended-spectrum b-lactamase-producing
enterobacterial isolates in Barcelona
S. Lavilla, J.J. Gonza´lez-Lo´pez, M.N. Larrosa, R.M. Bartolome´, G. Prat
on behalf of the Spanish Network for the Research in Infectious
Diseases REIPI (Barcelona, ES)
Background: Quinolone resistance usually results from mutations
in chromosomal genes coding for type II topoisomerases, efﬂux
pumps, and/or porins alterations. Recently, plasmid-mediated quinolone
resistance mechanisms has been reported by the qnr and the aac(6′)-Ib-cr
genes.
Objective: To evaluate the presence of aac(6′)-Ib-cr among enterobacte-
rial isolates carrying ESBLs in Barcelona, determine the ESBL present
in each isolate and establish if the aac(6′)-Ib-cr and the ESBL genes
were located in the same plasmid.
Methods: A total of 305 non-duplicate clinically relevant ESBL-
producing enterobacterial isolates, obtained at Hospital Vall d’Hebron
(Barcelona), collected between 2003 and 2004 were analysed for the
presence of aac(6′)-Ib. Antimicrobial susceptibility was tested by Etest
and disc diffusion. The screening for the presence of aac(6′)-Ib was
studied by PCR using speciﬁc primers. Positive amplicons were digested
with BstCI and sequenced to identify the aac(6′)-Ib-cr variant. ESBLs
of all aac(6′)-Ib-cr-positive isolates were determined by IEF and PCR
using speciﬁc primers. The quinolonone-resistance-determining region
(QRDR) of gyrA and parC genes was ampliﬁed and sequenced. Plasmid
number and location of aac(6′)-Ib-cr and bla genes was performed on all
aac(6′)-Ib-cr-positive isolates by S1 nuclease digestion and hybridisation
with speciﬁc probes.
Results: Nineteen isolates (6.2%) carried aac(6′)-Ib (8 Escherichia coli,
7 Klebsiella pneumoniae, 3 Enterobacter cloacae and 1 Klebsiella
oxytoca). Of these, 6 isolates (31.6%) carried the aac(6′)-Ib-cr variant (5
E. coli and 1 K. pneumoniae). Among the 6 aac(6′)-Ib-cr-positive isolates
4 were positive for CTX-M-1 group. The ESBLs of the remaining
two isolates are currently been determined. The 5 aac(6′)-Ib-cr-positive
E. coli isolates were resistant to nalidixic acid and ciproﬂoxacin and the
K. pneumoniae aac(6′)-Ib-cr-positive isolate was susceptible. Sequencing
of the QRDR of the gyrA and parC genes identiﬁed amino acid changes
in gyrA (S83-L and D87-N) and parC (S80-I and E84-V) on the 5
E. coli isolates. In the K. pneumoniae isolate no aminoacid changes
were detected. The 4 aac(6′)-Ib-cr-positive isolates positive for CTX-
M-1 group harboured the ESBL gene and aac(6′)-Ib-cr located in the
same plasmid.
Conclusion: The prevalence of aac(6′)-Ib-cr, responsible for low-level
quinolone resistance, among enterobacterial clinical isolates carrying
ESBLs between 2003 and 2004 in Barcelona was 1.9%.
P1524 Emergence and dissemination of plasmid-borne
ﬂuoroquinolone resistance genes and their association
with blaCTX-M genes in Enterobacteriaceae isolates from
Portugal
D. Fe´lix, E. Ferreira, D. Louro, M. Canic¸a and the Antimicrobial
Resistance Surveillance Programme in Portugal (ARSIP)
Objectives: Considering the increasing resistance to ﬂuoroquinolones
among the Enterobacteriaceae and the alarming mobility of some of
the genes responsible, we aimed to understand the level of association
between different plasmid-mediated ﬂuoroquinolone resistance (PMFR)
genes in Portuguese isolates and the correlation between these genes and
a number of b-lactamase genes.
Methods:We screened two collections of Enterobacteriaceae isolates for
the presence of qnrA, qnrB, qnrS and aac(6′)-Ib-cr. The ﬁrst collection
consisted of 104 isolates gathered in 1999 from 16 different Portuguese
hospitals (namely 57 Klebsiella pneumoniae, 42 Escherichia coli, 4
Kluyvera spp. and 1 Hafnia alvei) and the second collection consisted of
467 isolates gathered from 15 hospitals in the period 2004–2006 (namely
314 E. coli, 88 K. pneumoniae, 41 Enterobacter spp., 6 Klebsiella
oxytoca, 6 Serratia marcescens, 6 Morganella morganii, 3 Citrobacter
freundii, 2 Proteus mirabilis and 1 Kluyvera spp.). All isolates from
2004–2006 were identiﬁed as extended-spectrum b-lactamase (ESBL)
producers. PCR and nucleotide sequencing were used with speciﬁc
primers for the PMFR genes and for the b-lactamase genes (blaTEM,
blaSHV, blaOXA, blaCTX-M and ampC).
Results: We observed an emergence of qnrB (from 0% to 10%), qnrS
(from 0% to 8%) and aac(6′)-Ib-cr (from 14% to 65%) from 1999 to
2004–2006, the latter’s more evident in E. coli (from 19% to 79%); qnrB
was mainly found in K. pneumoniae isolates (36%). We also observed
that, while the other genes seem to be evenly distributed across the
country, the frequency of qnrS is 17% in the North region, 5% in
the Centre region and 1% in the Lisbon and Tagus Valley region. The
frequency of blaCTX-M and blaOXA in isolates positive for aac(6′)-Ib-
cr was 80% and 76%, respectively; in isolates negative for aac(6′)-Ib-cr
this frequency was only 32% and 17%, respectively. The gene blaSHV
was more frequent in positive isolates for qnrB (69%) than in negative
(14%). There was also a higher frequency of qnrB in qnrS positive
isolates (22%) than in qnrS negative ones (10%).
Conclusion: The emergence of PMFR genes over time contradicts
previous reports and the uneven distribution of qnrS further implies a
dissemination process. There seems to be a close association between
aac(6′)-Ib-cr and the ESBL gene blaCTX-M. These ﬁndings reinforce a
more careful use of ﬂuoroquinolones and an increased monitorisation of
their related resistance mechanisms.
P1525 Aquatic environment contamination with an epidemic
Escherichia coli clone harbouring blaCTX-M-15, blaOXA-1,
blaTEM-1, and aac(6′)-Ib-cr in Portugal
E. Machado, J. Rocha, T. Coque, R. Canto´n, J. Sousa, H. Ferreira,
L. Peixe (Porto, PT; Madrid, ES)
Objectives: The presence of CTX-M-15-producing isolates in non-
clinical compartments has been scarcely investigated. In this study we
describe the presence of
CTX-M-15-producing Escherichia coli isolates in aquatic environments
in Portugal. We also compared its clonal relationship with CTX-M-
15-producing isolates recovered from clinical settings in the same
geographic area.
Methods: We studied two CTX-M-15-producing E. coli isolates
recovered from sea and streams reaching the shore, in Porto area,
Portugal, during 2006. Water samples were plated on MacConkey agar
with and without 1mg/L ceftazidime or cefotaxime after ﬁltration.
Species identiﬁcation, susceptibility testing and conjugation assays were
performed by standard methods. ESBL characterisation included synergy
test, IEF, and identiﬁcation of known bla genes by PCR and sequencing.
Clonal relatedness was established by RAPD-PCR. The RAPD patterns
S440 18th ECCMID, Posters
were also compared with those obtained in CTX-M-15-producing E. coli
clinical strains. Multilocus sequence typing (MLST) using the standard
seven housekeeping loci was also performed. E. coli phylogenetic groups
were identiﬁed by multiplex PCR. Presence of speciﬁc resistance genes
was searched by PCR [blaOXA, blaTEM, blaCTX-M, aac(6′)-Ib].
Results: Both CTX-M-15-producing E. coli belonged to phylogenetic
group B2 and were clonally related by RAPD analysis. Moreover, they
shared the same RAPD pattern of the predominant Portuguese E. coli
clinical clone, producing CTX-M-15 and belonging to clonal complex
ST131. Both strains were resistant to b-lactams (except carbapenems),
tetracycline, kanamycin, tobramycin and ciproﬂoxacin. blaTEM-1 and
aac(6′)-Ib-cr-blaOXA-1 were also detected. Transfer of CTX-M-15 was
achieved in both isolates.
Conclusions: Aquatic contamination with an epidemic and multiresistant
B2 CTX-M-15-producing E. coli clone belonging to clonal complex
ST131 is a matter of concern. This fact will undoubtedly increase
the possibilities of dissemination of this epidemic clone and the
corresponding blaCTX-M-15 plasmid. Control of release of these
bacteria to the environment should be a public health priority in our
country.
P1526 Environmental emergence of multiresistant
Enterobacteriaceae harbouring blaCTX-M-15, and
aac(6′)-Ib-cr in Portugal
J. Rocha, E. Machado, J. Sousa, L. Peixe, H. Ferreira (Porto, PT)
Objectives: Since our previous reports of seawater contamination
with ESBL producers, we noticed a change in resistance phenotype
in the last years, with emergence of CTX-M proﬁle, in 2004, and
increased resistance to ﬂuorquinolones, in 2006. Spreading of CTX-
M-15 producers in the clinical setting, has already been reported in
Portugal in association with TEM-1, OXA-1 and AAC-(6′)-Ib-cr. In that
way, it was our purpose the detection of CTX-M-15 and AAC-(6′)-Ib-
cr producing isolates, in pluvial water streams reaching the shore and
coastal seawater.
Methods: Pluvial water streams reaching the sea and seawater were
collected from 2004 to 2006, from 3 beaches of the Porto area, in
Portugal. Isolates were selected by membrane ﬁltration technique and
the ﬁlters were placed on MacConkey agar with and without ceftazidime
(2mg/l) or cefotaxime (2mg/l). Lactose fermenters were randomly
selected and susceptibility was determined according to the CLSI
guidelines. Screening for ESBL producers was performed by the double
disk synergy test. Identiﬁcation was achieved by ID 32 GN. b-lactamases
were characterised by isoelectric focusing and, in representative isolates,
were identiﬁed by PCR and sequencing. Conjugation assays were
performed with Escherichia coli HB101 and K802N.
Results: Forty six multiresistant Enterobacteriaceae isolates (mostly
E. coli and Klebsiella pneumoniae), producing CTX-M-15 in different
combinations with TEM-1, OXA-1 and AAC-(6′)-Ib-cr, were recovered
from pluvial water streams presenting faecal contamination and
seawater. Fifteen isolates were able to transfer the CTX-M-15 gene, by
conjugation.
Conclusion: The presence of CTX-M-15 and AAC-(6′)-Ib-cr producers,
in pluvial water streams and seawater, seems to reﬂect unexpected
contamination by wastewater related to the healthcare setting, like
hospitals, tertiary care institutions, long term care and nursing homes.
This situation seems relevant in terms of public health and environmental
protection. The incoming of this kind of multiresistant ESBL producers
to natural environments and the transferability of the ESBL gene by
conjugation, might provide a track for environmental dissemination of
resistant bacteria and genes that may create a source of transferable traits
for environmental bacteria, inﬂuencing natural reservoirs of resistance
with possible transference for emerging pathogens.
P1527 Molecular epidemiology of plasmid-mediated quinolone
resistance determinants in extended-spectrum b-lactamase
producing Escherichia coli and Klebsiella pneumoniae
isolates from Turkey
L. Poirel, D. Gu¨r, L. Minarini, U. Arslan, P. Nordmann on behalf
of the Turkish Study Group on ESBL/Qnr relationships
Objectives: To evaluate the distribution of plasmid-mediated quinolone
resistance (PMQR) of the Qnr and aminoglycoside acetyltransferase
AAC(6′)-Ib-cr types, among clinically-extended-spectrum b-lactamase
(ESBL) producing enterobacterial isolates recovered from blood cultures
of patients in different Turkish hospitals.
Methods: 248 ESBL-producing Escherichia coli and Klebsiella sp.
isolates were collected from blood cultures from January to December
2006 in nine Turkish hospitals. ESBL-positive isolates were detected
according to Clinical and Laboratory Standards Institute (CLSI) criteria.
The bacterial isolates were tested for qnrA, qnrB, qnrS and aac(6′)-
Ib-cr genes by a PCR technique. b-Lactamase-encoding genes were
detected by PCR using primers for detection of TEM, SHV, OXA and
CTX-M variants. Conjugation experiments were performed to determine
whether the plasmids carrying the qnr or aac(6′)-Ib-cr genes were self-
transferable. Genetic structures surrounding the qnr gene were analysed
by PCR and clonings.
Results: A total of 138 and 110 ESBL-producing isolates were identiﬁed
as being E. coli and K. pneumoniae sp., respectively. Sixty-three
percent of the 248 ESBL-producing isolates were resistant to nalidixic
acid. Multiplex PCR-screening detected a single K. pneumoniae isolate
harbouring a qnrB1 gene (0.4%), whereas no qnrA or qnrS gene was
detected. The qnrB1-positive isolate was also positive for the blaCTX-
M-15, blaSHV-12 and aac(6′)-Ib-cr genes. The qnrB1-positive plasmid
was 124-kb in size, co-harboured the blaSHV-12 gene, and attempts to
transfer by conjugation failed. The blaCTX-M-15-positive plasmid co-
harboured the aac(6′)-Ib-cr gene. Out of 50 ESBL-producing isolates
tested, 39 (78%) were positive for the aac(6′)-Ib-cr variant. All isolates
carrying the aac(6′)-Ib-cr gene were resistant to ciproﬂoxacin and two
of them, two K. pneumoniae isolates, were resistant to imipenem due to
the production of b-lactamase OXA-48.
Conclusion: This study constitutes an epidemiological survey of
PMQR determinants among ESBL enterobacterial isolates from highly
signiﬁcant clinical samples (blood isolates) and shows a high prevalence
of AAC(6′)-Ib-cr determinants in Turkey. However Qnr determinants are
very rarely identiﬁed here.
P1528 Low prevalence of plasmid-mediated quinolone resistance
in Norwegian and Swedish clinical isolates of Escherichia
coli and Klebsiella spp.
N. Karah, L. Poirel, M. Sundquist, G. Kahlmeter, S. Bengtsson,
P. Nordmann, A. Sundsfjord, Ø. Samuelsen (Tromsø, NO; Le Kremlin
Biceˆtre, FR; Va¨xjo¨, SE)
Objectives: The objective of this study was to examine the prevalence
of the plasmid-mediated resistance genes, qnr and aac(6′)-Ib-cr, among
Norwegian and Swedish clinical isolates of Escherichia coli and
Klebsiella spp. with reduced susceptibility to ciproﬂoxacin and/or
resistance to nalidixic acid.
Methods: 487 isolates of E. coli (n = 326) and Klebsiella spp.
(n = 31) from (i) Kronoberg Sweden (n = 352) isolated between 2004−5,
(ii) the Norwegian surveillance programme for antimicrobial resistance
(NORM) (n = 318) isolated in 2005 and (iii) ESBL- (n = 304) or
AmpC-producing (n = 33) isolates from the Norwegian Reference Centre
for Detection of Antimicrobial Resistance (K-res) collected between
2003−5, were screened for the presence of qnr and aac(6′)-Ib-cr genes by
multiplex and single PCRs, respectively. PCR products were conﬁrmed
by sequencing and the aac(6′)-Ib-cr variant was also identiﬁed by
BstCI-digestion. The genetic environment of qnrS positive isolates was
examined by targeted PCR and sequence analysis. Transfer of qnr to
E. coli J53 RifR was examined.
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Results: Qnr-like encoding genes were identiﬁed in 8/487 isolates
(1.6%), ﬁve Klebsiella spp. (8.2%) and three E. coli (0.7%). Six isolates
were qnrS1 positive; Kronoberg (n = 3), NORM (n = 3), and K-res (n = 3)
collections. Two isolates were qnrB positive (qnrB1 and qnrB7-like)
in the K-res collection. Interestingly, four qnr positive isolates also
harbored the aac(6′)-Ib-cr variant. Transfer of the qnrS (n = 3) or qnrB
(n = 3) genes to E. coli J53 was obtained using 100mg/L ampicillin as
selection pressure indicating plasmid association and co-transfer with
a b-lactamase gene. The genetic surroundings of the qnrS1 gene were
similar in the three isolates examined. ISEcl2 (orfB A¨orfA) were detected
upstream and A¨res, orf259, and orf213 were detected downstream of the
qnrS1 gene. However, one of the isolates had a further truncated A¨res
gene. One isolate also carried the pbp3 and blaLAP-1 genes upstream
of the qnrS1 gene. The aac(6′)-Ib gene was detected in 76/487 isolates
(15.6%). 66 (86.8%) of these were of the aac(6′)-Ib-cr variant.
Conclusions: (i) The prevalence of qnr (1.6%) and aac(6′)-Ib-cr (13.6%)
genes are low in Norwegian and Swedish clinical isolates of E. coli
and Klebsiella spp. with reduced susceptibility to ﬂuoroquinolones, as
already observed in other European countries. (ii) The genetic context of
the qnrS1 gene in three isolates showed similar structures as previously
described.
P1529 Prevalence and genetic environment of aac(6′)-Ib-cr in
AmpC-producing Enterobacter cloacae, Citrobacter freundii
and Serratia marcescens: a multicentre study from Korea
S.Y. Kim, Y.J. Park, J.K. Yu, K.J. Han (Suwon, Seoul, KR)
Objectives: To investigate the prevalence of aac(6′)-Ib-cr, their associa-
tion with other plasmid-mediated resistance genes, and their inﬂuence on
quinolone susceptibility in AmpC-producing Enterobacteriaceae without
any selection criteria.
Methods: A total of 479 consecutive, non-duplicate isolates of
Enterobacter cloacae (179), Citrobacter freundii (134) and Serratia
marcescens (166) collected from 12 clinical laboratories without any
selection criteria, which we previously studied for the presence of
qnr determinants, were examined. We performed PCR for aac(6′)-Ib
gene, blaoxa-1, ISEcp1, IS26. The data for qnr genes, ESBL (blaTEM,
blaSHV, blaCTX-M), and orf513 were applied from the previous study.
To determine the cr variant of aac(6′)-Ib, all the positive isolates were
further analysed with BstCI digestion. A Mantel-Haenszel Chi2 test was
used for the comparison of dichotomous variables.
Results: The aac(6′)-Ib was detected in 110 (23%) of 479 Enterobacte-
riaceae; 74 (41.3%) of 179 E. cloacae, 25 (18.7%) of 134 C. freundii,
11 (6.6%) of 166 S. marcescens. Among these 110 aac(6′)-Ib-positive
isolates, cr variant was detected in 15 (13.6%) of isolates; 8/74 (10.8%)
of E. cloacae, 5/25 (20%) of C. freundii, 2/11 (18.2%) of S. marcescens.
Blaoxa-1 and orf513 were signiﬁcantly associated with aac(6′)-Ib-cr
in all three species, whereas the association with blaCTX-M, qnr
determinants, ISEcp1, and the resistance to quinolones was variable
among species. Eleven of 15 aac(6′)-Ib-cr producers harboured qnr genes
(6 qnrA, 4 qnrB, 1 qnrS).
Table 1. Characteristics of aac(6′ )-lb-cr-positive and aac(6′ )-lb-cr-negative isolates
Characteristica E. cloacae C. freundii S. marcescens
cr(+)
[n = 8]
n (%)
cr(−)
[n = 171]
n (%)
P cr(+)
[n = 5]
n (%)
cr(−)
[n = 129]
n (%)
P cr(+)
[n = 2]
n (%)
cr(−)
[n = 164]
n (%)
P
ESBL 3/8 (37.5) 56/171 (32.7) 0.78 2/5 (40) 2/129 (1.6) 0.00 0/2 (0) 21/164 (12.8) 0.59
CTX-M 3/8 (37.5) 35/171 (20.5) 0.25 2/5 (40) 1/129 (0.8) 0.00 0/2 (0) 13/164 (7.9) 0.68
SHV ESBL 2/8 (25) 34/171 (19.9) 0.72 0/5 (0) 1/129 (0.8) 0.84 0/2 (0) 9/164 (5.5) 0.73
Plasmid TEM 0/7 (0) 31/171 (18.1) 0.22 1/5 (20) 12/129 (9.3) 0.43 0/2 (0) 25/164 (15.2) 0.55
OXA-1 7/8 (87.5) 9/171 (5.3) 0.00 2/5 (40) 1/129 (0.8) 0.00 1/2 (50) 2/164 (1.2) 0.00
ISEcp1 4/8 (50) 14/171 (8.2) 0.00 2/5 (40) 4/129 (3.1) 0.00 0/2 (0) 10/164 (6.1) 0.72
orf513 6/8 (75) 66/171 (38.6) 0.04 2/5 (40) 9/129 (7) 0.01 1/2 (50) 11/164 (6.7) 0.02
IS26 5/8 (62.5) 81/171 (47.4) 0.40 3/5 (60) 46/129 (35.7) 0.27 0/2 (0) 1/164 (0.6) 0.91
qnrA 5/8 (62.5) 21/171 (12.3) 0.00 0/5 (0) 1/129 (0.8) 0.84 1/2 (50) 0/164 (0) 0.00
qnrB 0/8 (0) 22/171 (12.9) 0.28 3/5 (60) 49/129 (38) 0.32 1/2 (50) 2/164 (1.2) 0.00
qnrS 1/8 (12.5) 1/171 (0.6) 0.00 0/5 (0) 0/129 (0) 0/2 (0) 0/164 (0)
CIP-R 6/8 (75) 29/171 (17) 0.00 3/5 (60) 23/129 (17.8) 0.02 1/2 (50) 21/164 (12.8) 0.12
NA-R 8/8 (100) 65/171 (38) 0.00 5/5 (100) 42/129 (32.6) 0.00 1/2 (50) 83/164 (50.6) 1.00
aCIP, ciproﬂoxacin; NA, nalidixic acid; R, resistant.
Conclusions: The aac(6′)-Ib-cr was present in AmpC-producing
Enterobacteriaceae in Korea and was associated with other resistance
genes (blaoxa-1, blaCTX-M, and qnr determinants) and various mobile
elements (orf513 and ISEcp1).
P1530 The prevalence and distribution of plasmid-mediated
quinolone resistance genes in clinical isolates of Escherichia
coli
G.L. Jones, R. Warren, S. Skidmore (Telford, UK)
Objectives: Plasmid-mediated quinolone-resistance mechanisms in
Enterobacteriaceae include the three genes of the qnr series (qnrA, B
and S), and a variant aminoglycoside acetyltransferase (aac(6′)-Ib-cr)
which increases resistance to tobramycin and amikacin, and inactivates
ciproﬂoxacin and norﬂoxacin. Aac(6′)-1b-cr, initially described in
Shanghai and the USA, is also found in CTX-M-15-bearing plasmids in
Escherichia coli from the UK and Canada. Such CTX-M-15 producing
strains of lineage ST-131 serotype O25 became prevalent in the UK in
2003. A rise in quinolone resistance in E. coli bacteraemias was reported
in the UK in 2001. The aim of this study was to assess the presence of
plasmid encoded quinolone resistance genes in E. coli outside CTX-M-
15 producing strains both historically and currently.
Methods: Ciproﬂoxacin resistant E. coli non-ESBL-producing isolates
included those collected nationally as part of the BSAC UK bacteraemia
surveillance programme between 2001 and 2005, regional urine isolates
collected in early 2000 and local urinary isolates collected in 2006.
PCR was used to amplify and detect the generic aminoglycoside
acetyltransferase gene (aac(6′)-Ib). The ﬂuoroquinolone-modifying
variant of the gene was identiﬁed using restriction fragment length
polymorphism (RFLP). Multiplex PCR was used for detection of qnrA, B
and S. Isolates with aac-(6′)-1b-cr had MIC tests carried out for amikacin
and tobramycin and were serotyped.
Results: The prevalence of the aac(6′)-Ib-cr gene was 3% and 9% in
respectively current urinary and historic bacteraemia quinolone-resistant
non-ESBL isolates of E. coli. Of 521 urinary E. coli isolates from 2000,
only 14 (2.9%) were norﬂoxacin resistant, none of which carried the
aac(6′)-Ib-cr gene. Positive isolates from bacteraemia in 2001/2 were
serotype O102 and in 2004/5, O1 and O25. Positive urinary isolates from
2006 included serotypes O1 and O25. MICs showed unusual amikacin
susceptibility.
Conclusions: Aac(6′)-1b-cr now occurs in E. coli in the UK in the
absence of CTX-M-15 but with a restricted serotype distribution. Its
presence in bacteraemia isolates from 2001 and 2002, prior to the spread
of CTX-M-15 in Britain might suggest either a common source species in
which the gene occurred or a lineage from which plasmid-recombination
occurred. As yet, there is no evidence that this mechanism of quinolone
resistance was responsible for the rise in quinolone resistance in the UK
from 1996 to 2001.
P1531 Prevalence of plasmid-mediated quinolone resistance
determinants QnrA, QnrB, and QnrS among clinical
isolates of Klebsiella pneumoniae in Scotland
A. Younes, A. Hamouda, J. Dave, A. Gibb, S.G.B. Amyes, T. Schneiders
(Edinburgh, UK)
Introduction: Quinolone resistance results from mutations in the
chromosomally-encoded type II topoisomerases, and via the upregulation
of efﬂux pumps, or porin-related genes. Recent studies demonstrate that
the plasmid-mediated qnr genes (QnrA, B and S) play an emerging role
in the dissemination of ﬂuoroquinolone resistance. The ﬁrst plasmid-
mediated quinolone resistance protein Qnr was identiﬁed in a Klebsiella
pneumoniae isolate in 1994 where the presence of the qnr gene increased
the MICs to nalidixic acid and ﬂuoroquinolones by four- to eight-fold.
The qnr gene has been identiﬁed in complex In4 family class 1 integrons,
known as complex sul1-type integrons that may act as a recombinase
for mobilisation of the antibiotic resistance genes located nearby (e.g.,
qnr, blaCTX-M and ampC). In addition, an association of quinolone
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resistance with the production of ESBLs has been reported. This study
aimed to determine the prevalence of qnr genes and its association with
the presence of ESBLs in clinical K. pneumoniae isolates from Scotland.
Methods: Isolates of K. pneumoniae were collected from the Royal
Inﬁrmary Edinburgh in 2007. The qnrA, qnrB, and qnrS genes were
detected by PCR. MICs of ciproﬂoxacin, nalidixic acid, cefotaxime,
ceftazidime, ceftriaxone, cefoxitin and meropenem were performed
according to the BSAC guidelines. ESBL production was conﬁrmed by
double and combination disk methods.
Results: Of the 95 isolates tested, 27 were found to be positive by
PCR for the qnr genes. These positive isolates were further assessed by
PCR where 11 possessed the qnrB gene, 10 contained the qnrA gene
and 2 harboured the qnrS gene. Interestingly four isolates were found
to harbour both the qnrB and qnrS genes. Out of the 27 qnr positive
isolates, 12 (44.4%) isolates were found to be resistant to nalidixic acid,
while the remaining 15 (55.6%) were sensitive to nalidixic acid. Six of
the qnrB positive isolates were associated with CTX-M, SHV and TEM,
one isolate with TEM and SHV b-lactamases. Two qnrA positive isolates
were associated with TEM and SHV only. However of the isolates that
were tested none were found to harbour an ESBL and the qnrS gene.
Conclusion: These ﬁndings indicate the high prevalence of qnr
genes and the co-expression of ﬂuoroquinolone and extended-spectrum
b-lactam resistance among Klebsiella pneumoniae isolates in Scotland.
P1532 First report of plasmid-mediated quinolone resistance
determinants qnrA, qnrB and qnrS among Gram-negative
clinical isolates from Aveiro, Portugal
A. Pereira, S. Ferreira, A. Paradela, F. Cerveira, E. Ramalheira,
S. Mendo (Aveiro, PT)
Objectives: The aim of the present study was to evaluate the prevalence
of qnr genes in a growing number of Gram negative quinolone resistant
strains, in Hospital Infante D. Pedro, Aveiro. Relevance was given
to Escherichia coli isolates causing urinary tract infections, given its
importance in nosocomial and community acquired infections.
Methods: From January 2007 to October 2007, 80 quinolone resistant
Enterobacteriaceae isolates were recovered from different inpatients
of the Hospital Infante D. Pedro de Aveiro, Portugal. The isolates
were identiﬁed by the automatic VITEK2 system and Advanced
Expert System (VITEK2 AES) (BioMe´rieux, Marcy L’E´toile, France).
Antibiotic susceptibilities were also determined by VITEK2 and the
susceptibility reports were edited after interpretation by AES of the
inferred resistance phenotype. Presence of ESBL was conﬁrmed by
Etest® (AB Biodisk) ESBL with Cefotaxime/Cefotaxime + Clavulanic
acid and Ceftazidime/Ceftazidime + Clavulanic acid strips, according
to manufacturer’s instructions. PCR, sequencing and sequence analysis
was used to assess qnr encoding sequences. Sequences obtained were
compared with others deposited in the GeneBank.
Results: qnrA and qnrB genes were detect in both Escherichia coli
and Klebsiella pneumoniae isolates. However, qnrS was detected only in
one Escherichia coli isolate, HIP15, that carries a class 1 integron, with
genes conferring resistance to aminoglycosides and trimetoprim, positive
for the presence of ISCR1 and for the extended-spectrum b-lactamase,
TEM.
Conclusion: This is the ﬁrst report of qnr genes in Portugal. As these
genes are plasmid mediated their high incidence, particularly among
E. coli strains, is disconcerting. Despite the fact that qnr genes being
responsible for low-level of quinolone resistance, in presence of other
chromosomally encoded resistance genes/mechanisms, they could be an
important tool for bacteria to avoid lethal quinolone concentrations.
These results show the tremendous variety of different genetic
determinants that can be found in one single isolate, thus contributing
for the increasing levels of resistance. The genetic environment of the
different resistance structures found is under study.
P1533 qnr genes in ESBL-producing Enterobacteriaceae isolates
from New South Wales, Australia
Z. Zong, S. Partridge, J. Iredell (Westmead, AU)
Objectives: To investigate the prevalence and diversity of qnr quinolone
resistance genes in ESBL-producing isolates of Enterobacteriaceae in
NSW.
Methods: A total of 78 ESBL-producing isolates were investigated,
including 57 Escherichia coli, 15 Klebsiella pneumoniae and 6 belonging
to other enterobacterial species all known to carry blaCTX-M, blaSHV-
12 or blaVEB. qnrA, qnrB and qnrS were screened for by PCR. Mating
experiments were performed for qnr-positive isolates. Clonal relatedness
was determined by PFGE. A qnrB9 variant was cloned into the low
copy vector, pBBR1-MCS1, to construct plasmid pBBR:qnrB9. MICs
of norﬂoxacin, ciproﬂoxacin, gatiﬂoxacin and moxiﬂoxacin against the
transformant with the qnrB9 gene were determined by E-test.
Results: qnrA1 was identiﬁed in 2 SHV-12-producing K. pneumoniae
isolates with different PFGE patterns. qnrB1 was seen in one
K. pneumoniae isolate carrying blaCTX-M-15. A qnrB1 variant with
a deletion of A at position 19 was found in three K. pneumoniae also
carrying blaCTX-M-15. Three isolates (1 K. pneumoniae, 1 Klebsiella
oxytoca and 1 Enterobacter gergoviae) with blaCTX-M-62 also carried
qnrB2. A single Citrobacter freundii isolate carrying blaCTX-M-15
had a qnrB9 variant with 5 nt silent differences compared with the
qnrB9 gene in GenBank accession no. AM774477. Four K. pneumoniae
isolates belonging to a single strain had qnrS1. Conjugative transfer of
qnr genes was successful in 1/2 qnrA1-, 6/8 qnrB- and all 4 qnrS1-
containing isolates. The MICs of norﬂoxacin, ciproﬂoxacin, gatiﬂoxacin
and moxiﬂoxacin against a DH5 carrying pBBR:qnrB9 were 0.75,
0.25, 0.38 and 0.50mg/ml, respectively. These were elevated 4–16 fold
comparing with DH5 carrying pBBR1-MCS1 alone, indicating that
QnrB9 conferred low-level resistance to quinolones.
Conclusions: qnrA, qnrB and qnrS genes have all been detected in
ESBL-producing enterobacterial isolates in Australia, mainly associated
with species other than E. coli. Several qnrB variants were found. The
majority of these qnr genes were associated with conjugative plasmids
which may explain their spread. As expected QnrB9 confers low-level
resistance to quinolones.
P1534 First description of a plasmid-mediated quinolone resistance
determinant qnrS2 in an Aeromonas veronii biovar sobria
clinical isolate
J. Sanchez-Cespedes, M.D. Blasco, S. Marti, V. Alba, E. Alcaide,
C. Esteve, J. Vila (Barcelona, Valencia, ES)
Objective: The main objective of this study was to investigate the
prevalence of the qnrA, qnrB and qnrS genes in a collection of
environmental and clinical Aeromonas sp.
Methods: Fifty seven Aeromonas sp. isolates (resistant and susceptible
to nalidixic acid) were identiﬁed by biochemical tests. Thirty two were
collected from the environment and the other twenty ﬁve were clinical
isolates. Screening of the qnrA, qnrB and qnrS genes was performed
by multiplex PCR using speciﬁc primers and controls for each gene.
The sequence obtained was compared with those published in the
GenBank. Antimicrobial susceptibilities were performed by E-test and
gyrA analyses was carried out by PCR of the QRDR in the qnr+-PCR
isolates. Plasmid extraction was carried out in the qnr-carrying strain.
Results: Among all the analysed isolates only one of them was PCR+.
The positive strain corresponded to an Aeromonas veronii biovar sobria
clinical isolate. It presented two mutations, one in the gyrA gene (Ser83-
Ile) and the other in the parC gene (Ser80-Ile). The qnr determinant
was sequenced and presented 100% homology when compared with the
qnrS2 gene in the GeneBank. The positive isolate had a clinical origin
and it showed resistance to nalidixic acid (>256mg/ml), ciproﬂoxacin
(8mg/ml) and norﬂoxacin (12mg/ml). A 8 Kb plasmid was isolated from
the strain carrying the qnr-like determinant. The plasmid was cut off
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from the agarose gel and the PCR of the qnrS2 gene repeated, showing
the same ampliﬁcation fragment.
Conclusions: This is the ﬁrst time that a plasmid-mediated quinolone re-
sistance qnr-like determinant has been found outside Enterobacteriaceae
and in an Aeromonas veronii biovar sobria clinical isolate.
P1535 Prevalence of the plasmid-mediated quinolone resistance
determinant qnrS among ciproﬂoxacin-resistant Escherichia
coli genotypes in Greece
O. Vasilaki, E. Ntokou, A. Ikonomidis, E. Neou, P. Nikolaidis, S. Alexiou-
Daniel, A. Maniatis, S. Pournaras (Larissa, Thessaloniki, GR)
Objectives: To determine the prevalence of the plasmid-mediated
quinolone resistance qnr genes in resistant ciproﬂoxacin among
Escherichia coli clinical isolates.
Methods: During the period 2005 to 2007, 114 ciproﬂoxacin-resistant
Escherichia coli clinical isolates were collected from separate patients
(the majority originated from urine cultures) hospitalised in four distant
Greek hospitals. Isolates were screened for the presence of genes qnrA,
qnrB and qnrS by PCR, using universal primers for each gene amplifying
all related alleles. The qnrS-positive isolates were also screened by PCR
for the detection of mutations in genes gyrA and parC. DNA-relatedness
of the isolates of the study was examined by PFGE. Transferability
potency of gene qnrS was investigated by conjugation.
Results: A total 12 out of the 114 tested isolates were positive for
the qnrS1 gene but none for qnrA or qnrB gene. The 12 qnrS positive
isolates were clonally unrelated and comprised at least 11 out of the 20
detected genotypes. Quinolone resistance was transferable with relatively
low frequencies.
Conclusions: This is the ﬁrst report of qnrS-positive E. coli in Greece.
The proportion of approx. 10.5% of quinolone-resistant E. coli that
carried qnr genes was considerably high in comparison with respective
percentages from others regions, which ranged from 0.5 to 7.7%. All
isolates belonged to unrelated clones, indicating that the spread of gene
qnrS was not due to clonal dissemination.
P1536 Mechanisms of resistance in non-typhoidal Salmonella
enterica exhibiting a novel quinolone resistance phenotype
J.M. Caddick, M. Lindgren, M.A. Webber, P. Kotilainen, A. Siitonen,
A.J. Hakanen, L.J.V. Piddock (Birmingham, UK; Helsinki, FI)
Objective: To determine the mechanisms which underpin a novel
quinolone resistance phenotype of Salmonella enterica isolates from
Finnish patients. All isolates were susceptible to nalidixic acid but had
reduced susceptibility to ciproﬂoxacin.
Methods: Six Salmonella enterica isolates, consisting of ﬁve serovars
(Corvallis, Stanley, Mbandaka, Montevideo and Virginia) were acquired
by Finnish patients during travel to Malaysia and Thailand. Isolates
were screened for plasmid mediated quinolone resistance by plasmid
extraction and by PCR of qnrA, qnrB, qnrS, aac6′-lb-Cr, qepA and oqxB.
Positive qnr genotypes were compared with previously identiﬁed qnr
plasmids by Southern blotting. Transfer of resistance was examined by
transformation and subsequent MIC testing of transformants. Mutations
in the quinolone resistance determining regions (QRDRs) of gyrA, gyrB,
parC and parE were identiﬁed by PCR and DHPLC. Efﬂux activity
was assessed by determining accumulation of the ﬂuorescent substrate
Hoescht 33342 by all isolates and compared with matched wild strains
of the same serovar.
Results: Plasmid mediated quinolone resistance genes were detected
in all six isolates. One isolate carried qnrA, two qnrS and three both
qnrB and qnrS. aac6′-lb-Cr, qepA and oqxB were not detected. Southern
blotting identiﬁed qnrS1 in Stanley, Montevideo, Virginia and both
Corvallis serovars. All plasmids, when transferred into a wild-type
host had increased MICs of ciproﬂoxacin. In addition, plasmids from
Stanley, Mbandaka and Montevideo serovars conferred increased MICs
of chloramphenicol and tetracycline. No mutations were detected in the
QRDRs of gyrA, gyrB, parC and parE, however, two isolates possessed
mutations in gyrA at codon 396 (Leu to Met). All isolates accumulated
less Hoescht 33342 than wild-type suggesting increased efﬂux activity.
Conclusion: These data demonstrate the rise of a highly mobile genotype
that confers a novel quinolone resistance phenotype, which has become
widely disseminated.
P1537 Absence of plasmid-mediated quinolone resistance in
Salmonella and E. coli strains from healthy cattle, pigs
and chickens from 8 EU countries within the European
Antimicrobial Susceptibility Surveillance in Animals
(EASSA) programme
S.-M. Friederichs, H.-R. Hehnen, A. de Jong, P. Butty, K. Godinho,
V. Thomas, M. Valle´ (Leverkusen, DE; Brussels, BE)
Objectives: In various countries, a variety of plasmid-encoded qnr
genes conferring resistance to quinolones have been described in
Enterobacteriaceae including Salmonella and E. coli. In previous EASSA
studies, antimicrobial susceptibility to ciproﬂoxacin (CIP) has been
investigated among Salmonella spp. and E. coli from food animals at
slaughter across the EU. To assess the prevalence of qnr genes in the
EASSA collection, all Salmonella and a selection of E. coli isolates with
a decreased susceptibility to CIP were screened for qnr. Additionally,
E. coli isolates showing differing levels of resistance were studied. As
qnr genes are sometimes associated with strains that produce extended-
spectrum b-lactamases (ESBLs), isolates with decreased susceptibility
to cefotaxime (CT) were also included.
Methods: In all, 80 Salmonella and 77 E. coli exhibiting decreased
susceptibility (MICs 0.12−2mg/l) or resistance (MICs 4mg/l) to CIP
were selected from the EASSA collection 1999–2005. None of the
Salmonella of the collection was clinically resistant to CIP. In addition,
13 Salmonella and 48 E. coli isolates with decreased susceptibility to CT
(MICs 1–32mg/l) or resistance (MICs 64mg/l) were tested. Presence
of qnr genes was determined by multiplex and simple PCRs for qnrA,
qnrB and qnrS. A positive control for each qnr gene was included in
each test. Strains were tested for susceptibility to nalidixic acid (NA)
and phenotypically for ESBLs according to CLSI guidelines.
Results: None of the 93 Salmonella or the 125 E. coli isolates
exhibited either of the qnr genes. Positive controls for qnrA, qnrB
and qnrS were identiﬁed in each test. For Salmonella, two categories
of NA susceptibilities were found: MICs 128mg/l for 69 isolates
(corresponding to CIP MICs from 0.12 to 0.5mg/l) and MICs of 8
or 16mg/l (11 isolates). Out of 13 Salmonella isolates with decreased
susceptibility to CT, albeit susceptible to CIP, only one strain (S. Rissen)
appeared to be a ESBL producer. For E. coli, NA MICs were 256mg/l
for 75 isolates (corresponding to CIP MICs from 0.12 to 64mg/l), and
were 64mg/l for 2 isolates. Twenty-two strains were identiﬁed as ESBL
producers.
Conclusions: In Salmonella and E. coli strains from healthy animals of
this representative EU collection any qnr genes could not be detected.
Currently, the prevalence of the qnr gene seems to be very uncommon.
On-going surveillance including screening for qnr genes is however
important.
Antimicrobial clinical trials
P1538 Prospective, randomised clinical trial to compare the efﬁcacy
of two 70% (v/v) isopropyl alcohol solutions containing
either 0.5% (w/v) chlorhexidine gluconate or 2% (w/v) CHG
for skin antisepsis during coronary artery bypass grafting
A.L. Casey, A.J. Itrakjy, A.R. Clethro, C. Harbun, P.A. Lambert,
R.S. Bonser, T.R. Graham, J. Mascaro, D. Pagano, S.J. Rooney,
I.C. Wilson, T.S.J. Elliott (Birmingham, UK)
Objectives: Whilst there has been insufﬁcient research examining the
effects of pre-operative skin antiseptics on surgical site infection (SSI)
rates, current guidelines recommend 2% chlorhexidine gluconate (CHG)
in 70% isopropyl alcohol (IPA) prior to insertion of central venous
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access devices in NHS hospitals. Since most UK healthcare institutions
currently use 0.5% (v/v) CHG in 70% (v/v) IPA for skin antisepsis prior
to surgical procedures we are conducting a randomised clinical trial to
compare the efﬁcacy of these two antiseptics.
Methods: 70% (v/v) (IPA) containing either 0.5% (w/v) or 2% (w/v)
CHG was applied to the proposed skin incision site made to harvest
lengths of saphenous vein in patients undergoing coronary artery
bypass grafting at University Hospital Birmingham NHS Foundation
Trust. Skin swabs were taken from the incision sites pre-preparation,
post-preparation and post-wound closure to assess the immediate
and persistent efﬁcacy of each antiseptic agent. Each specimen was
immediately transferred into a chlorhexidine-neutralising solution and
the microorganisms enumerated following microbiological culture. The
number of patients who developed SSI was also determined.
Results: Microbiological specimens were recovered from 30 patients.
The overall baseline bacterial loads pre-preparation from both patient
groups were similar (p = 0.7). There was a greater reduction in the
total numbers of microorganisms present on the skin 2 minutes post-
skin preparation from baseline with the solution containing 2% CHG
compared to 0.5% CHG (99.9% vs 97.3% p= 0.07). There was no
difference between the two groups with regard to microbial numbers
on the skin sampled at subsequent time periods. Four of 15 patients in
the 0.5% CHG group developed a superﬁcial SSI post-discharge from
hospital compared to 0 of the 10 patients in the 2% CHG group (p = 0.1).
Conclusions: The results of this interim analysis suggest that 2% (w/v)
CHG in 70% (v/v) IPA may outperform 0.5% (w/v) CHG in 70% (v/v)
IPA in terms of reducing the total numbers of microorganisms on the
skin and also the number of SSI which subsequently arise. 2% (w/v)
CHG in 70% (v/v) IPA may therefore offer additional protection from
SSI. Further study participants will be recruited.
P1539 Assessment of tolerability of 300 and 600mg doses of
faropenem medoxomil
R. Echols, R. Tosiello, S. Kowlasky (Milford, US)
Objective: To compare the tolerability and safety of the 300mg and
600mg BID doses of faropenem medoxomil (FM), an oral penem
antibiotic in development for the treatment of community respiratory
infections.
Methods: A phase three program of FM (formerly faropenem daloxate)
was conducted by Bayer AG from 2000–2002. Replidyne considered the
600mg dose to be more appropriate for further development. Before
initiating phase 3 studies with 600mg BID dose, Replidyne compared
the 300mg and 600mg dose to assess the relative adverse event (AE)
proﬁle focusing on gastrointestinal AEs. Study 002 was conducted in
healthy volunteers, randomised to 300mg or 600mg (in a 1:2 ratio)
BID for 7 days. Study 001 was then conducted in patients with acute
bacterial sinusitis who underwent a baseline antral tap. Subjects received
either 300mg BID for 7 days or 600mg BID for 5 days in a 1:1 ratio.
FM 300mg 7d
[N= 122]
FM 600mg 5/7d
[N= 175]
N (%) N (%)
Drug-related AEs 28 (22.9) 52 (29.7)
Gastro-intestinal disorders 20 (16.4) 31 (17.7)
Diarrhoea/loose stools 11 (9.0) 17 (9.7)
Flatulence 0 5 (2.8)
Abdominal pain 2 (1.6) 2 (1.1)
Dry mouth 1 (0.8) 3 (1.7)
Dyspepsia 1 (0.8) 1 (0.6)
Constipation 1 (0.8) 1 (0.6)
Vomiting 2 (1.6) 0
Results: The AEs for each dosage were combined and are shown in table.
Overall, drug-related gastrointestinal AEs were similar 16.4% and 17.7%
as were the rates of diarrhoea and loose stools for the 300mg (9.0%) and
600mg (9.7%) respectively. The AEs other than gastrointestinal were too
infrequent to draw conclusions.
Conclusion: There is no difference in the adverse event proﬁle for the
600mg BID dosed subjects compared to subjects receiving 300mg BID.
P1540 Levoﬂoxacin 500mg once daily oral in the treatment of
chronic bacterial prostatitis
K. Naber, S. Decker-Burgard, H. Botto on behalf of the CBP-study
investigators group
Objectives: Levoﬂoxacin is a ﬂuoroquinolone that is active against a
wide range of Gram-negative and Gram-positive bacteria. Levoﬂoxacin
has demonstrated efﬁcacy in the treatment of complicated urinary tract
infections. The study was aimed at further conﬁrming the efﬁcacy and
safety of levoﬂoxacin in chronic bacterial prostatitis (CBP) in Europe.
Methods: Men with a history of CBP, clinical signs and symptoms
and laboratory evidence of prostatitis were enrolled in a prospective,
multinational (8 countries) open-label study to receive levoﬂoxacin
500mg OD per os for 28 days. They were followed for 6 months.
Results: A total of 117 patients were treated (age 45 years, duration of
CBP 48 months, median values). Gram-negative bacteria were identiﬁed
in 57/106 patients (mainly E. coli, n = 37) and Gram-positive bacteria in
60/106 cases (mainly Enterococcus faecalis, n = 38 and Staphylococcus
epidermidis, n = 34) with veriﬁed baseline pathogen.
Of the men evaluable for clinical outcome (ITT population), the clinical
success rate (cured and improved patients, with 95%-CIs) was 92%
[84.8, 96.5], 77.4% [68.2, 84.9], 66.0% [56.2, 75.0], and 61.9% [51.9,
71.2], at 5–12 days, 1 month, 3 months and 6 months post-treatment.
Microbiological eradication rate (in the microbiologically assessable
population evaluated according to study protocol) was 82/98 (83.7%)
[74.8, 90.4] at 1 month and continued eradication rate 52/57 (91.2%)
[80.7, 97.1] at 6 months post-treatment. Comparison of 4 classiﬁcation
schemes in the evaluation of the eradication rate – including the
method described in the study protocol and 3 schemes used in previous
investigations – showed similar results. Thus, it can be concluded that
the present investigation is well comparable in methods and results to
previous studies.
Levoﬂoxacin was well tolerated. Four patients (3.4%) discontinued
therapy for adverse event and 15 patients (12.8%) experienced at least
one adverse event (mainly gastrointestinal (n = 3) and musculoskeletal
and connective tissue disorders (n = 3)) during the treatment period and
the 7 consecutive days.
Conclusions: Levoﬂoxacin 500mg once daily given orally for 28 days
is clinically and microbiologically effective in the treatment of chronic
bacterial prostatitis and is well tolerated.
P1541 Impact of Enterococcus ssp. on mortality and morbidity
of patients with perforation of the small and large bowel.
Retrospective analysis on 473 patients
M.F. Kaffarnik, M. Urban, S. Utzolino, U.T. Hopt (Freiburg, DE)
Objectives: Among other bacteria Enterococcus ssp. are frequently
detected in abdominal ﬂuid after bowel perforation, as well as after
major abdominal surgergy. The commonly administered antibiotics are
not or just partially effective against Enterococcus ssp. The need for
a speciﬁc treatment of Enterococcus ssp. is discussed controversely.
Agents that are effective ex-vivo penetrate tissue insufﬁciently or are
very expensive. Based on this background and the growing number of
vancomycine resistant Enterococci there is demand to identify patients
after abdominal surgery who could beneﬁt from therapy.
Methods: We included 473 patients with intestinal perforation. The
patients were divided into three different groups, 1: Enterococcus ssp.
not detected, no therapy, 2: Enterococcus ssp. detected, no therapy, and
3: Enterococcus ssp. detected, speciﬁc therapy. We compared the groups
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and analysed how far age, sex, immunosuppression, and detection of
Enterococcus ssp. inﬂuence the course of the disease. Primary endpoint
of the study was lethality. Secondary endpoints were morbidity, LOS-
ICU and LOS-Hospital. The severity of the disease was assessed using
the SOFA-Score (Sepsis-related Organ Failure Assessment).
Results: 90-day-mortality was signiﬁcantly higher in group 3 compared
with group 1 and 2 (p< 0.001, graphic 1). There was no difference
between group 1 and group 2. LOS-ICU, LOS-Hospital and SOFA-score
were signiﬁcantly higher in group 3 than in group 1 or 2. Age was the
only independent factor regarding the course of the disease.
Conclusion: Enterococcus ssp. detected in peritoneal ﬂuid after
major abdominal surgery are often due to colonisation and do not
warrant speciﬁc treatment. Nevertheless, Enterococci occurring in
peritoneal ﬂuid become increasingly relevant in critically ill patients,
as they can worsen the prognosis. Therefore, in critically ill and
immunocompromised patients speciﬁc treatment of Enterococcus ssp.
must be considered.
Graphic 1.
Graphic: Statistically signiﬁcant difference between lethality in group 1
and 2 compared group 3 (30-day: n< 0.05; 60-day: n< 0.01 90-day:
n< 0.001). No difference between group 1 compared with group 2
(n< 0.3).
P1542 Efﬁcacy of clindamycin in bacterial vaginosis and risk
factors
F. Hvizdak, Z. Szalayova, P. Beno, P. Kisac, V. Krcmery (Trnava,
Bratislava, SK)
Introduction: Bacterial vaginosis (BV) is a common mucocutaneous
infection in sexually active women and is caused usually by Gardnerella
vaginalis overgrowth in vagina due to new infection (i) or normal
unbalance (ii) or impairment of colonisation resistance by local or
systemic antibiotic (iii), or cleansing during surgery by local antiseptics
or after labour due to disinfection procedures in birth ways (iv).
Patients and Methods: The aim of this study was to assess efﬁcacy and
safety of clindamycin vaginal cream in therapy of BV in a multicentre
study. 3159 patients with BV were enrolled – inclusion criteria was
vaginal discharge. Culture was performed in all 3159 women, risk factors
such as preganancy, lactation, sexual intercourse within last 3 days,
receipt of systemic or local antibiotics or/and antifungal drugs within
7 days, surgery in vaginal or perineal region, etc. were analysed. Lenght
and efﬁcacy of therapy and adverse reaction were evaluated. Those who
failed after therapy were compared in an univariate analysis with those
who were cured using chi square test with Mentel Hanzsel moﬁﬁcation
and Yates correction (EPI INFO statistical package).
Results: From 3159 evaluable cases, 2958 (94.3%) cases were cured
and 181 (5.9%) were improved, only 20 patients failed (0.7%). Most
common risk factors were pregnancy (391 cases, 14.7%), prior local
antibiotic therapy (501 cases, 16.5%), prior STD (5.5%), lactation
(1.9%), systemic ATB therapy (0.9%) or antifungal agents (47 cases,
1.6%). Most commonest culture isolate was, as expected Gardnerella
vaginalis in 807 cases (26.5%) followed by Str. agalactiae (7.1%),
S. aureus (4.6%), Bacteroides fragilis (2.1%), E. coli (1.3%), Candida
albicans (1%). Analysing predictors of failure, pregnancy was signiﬁcant
more frequently observed among failures (25% vs. 12.7%, P = 0.001)
and Streptococcus agalactiae (35% vs. 7.1%, P = 0.002) and C. albicans
(10% vs. 1%, P = 0.005) as well as culture negativity (P = 0.002) were
predictive for inferior outcome.
Conclusions: In conclusio, clindamycin vaginal creme is mostly
effective, safe in the treatment of bacterial vaginosis in health pregnant
and non-pregnant women.
P1544 Microbiological effects of a triclosan dentifrice and tongue
cleaner in the treatment of oral malodour
J. Zambon, P. Moses, B. Clark, V. Haraszthy, P. Sreenivasan, W. DeVizio
(Buffalo, Piscataway, US)
Objectives: Global surveys indicate that oral malodour (halitosis) is a
widespread condition affecting almost 50% of people at sometime. Oral
malodour is frequently associated with bacteria on the dorsal surface of
the tongue. The large surface area and unique anatomy of the dorsal
tongue including ﬁssures and papillae facilitate the growth of halitosis-
associated microorganisms. This study assessed the effect of treatment
for oral malodour on the microﬂora of the dorsal surface of the tongue.
Methods: Adults were screened for oral malodour and were selected
for participation in the study if they exhibited organoleptic scores 3
(scale 0–5) as determined by a trained examiner and mouth air sulfur
levels 250 ppb as determined by portable sulﬁde detector. 15 adults
were enrolled in the study after informed consent. Each subject was
examined at baseline and after 28 days for; (1) organoleptic assessment;
(2) mouth air sulfur levels; (3) tongue coating (scale 0–3); and, (4) tongue
microorganisms. A 2 cm2 area was sampled from the dorsal surface of
the tongue. Bacterial numbers were assessed by microscopy and the
presence of 22 bacterial species/groups was assayed by dot-blot using
DNA probes. Following the baseline examination, the subjects were
instructed to perform oral hygiene with a triclosan-containing dentifrice
and to use a toothbrush with a tongue cleaner.
Results: From the panel of halitosis-associated target bacteria, we ob-
served large numbers of Peptostreptococcus micros, Porphyromonas gin-
givalis, Prevotella intermedia/Prevotella loescheii, Prevotella melanino-
genica, Solobacterium moorei and Streptococcus sp. at baseline. After
28 days, all subjects showed clinical improvement as determined by
signiﬁcant reductions in organoleptic scores and mouth air sulfur
levels compared to baseline (p< 0.0001). Microscopic analysis showed
a greater than 70% reduction in the numbers of microorganisms
(p< 0.001) while dot-blot assays showed signiﬁcant reductions in
Enterococcus faecalis (p< 0.003), Neisseria sp. (p< 0.008), P. micros
(p< 0.0007), P. melaninogenica (p< 0.02), P. gingivalis (p< 0.0001),
S. moorei (p< 0.04), and Streptococci sp (p< 0.03) from the dorsal
tongue surface.
Conclusions: All subjects with oral malodour demonstrated signiﬁcant
improvements in both clinical and microbiological parameters following
use of the triclosan-containing dentifrice and toothbrush with a tongue
cleaner.
P1545 Single-dose azithromycin vs 7 days doxycycline for
Chlamydia trachomatis urethritis in men: a systematic
review and meta-analysis of randomised clinical trials
S. Korolev, V. Rafalski (Tula, Smolensk, RU)
Objectives: Both azithromycin and doxycycline are recommended
as ﬁrst-line treatment for Chlamydia trachomatis urethritis (CTU)
in international and national STD guidelines. Therefore comparative
efﬁcacy and safety of single dose azithromycin (SD) vs 7 days
doxycycline is very important question. A systematic review (SR)
comparing these antibiotics has not demonstrated signiﬁcant clinical or
microbiological efﬁcacy rate after azithromycin vs doxycycline based
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therapy (Chuen-Yen Lau e.a, 2002). However as male with urethritis
only and female with cervicitis mainly were combined in mentioned SR.
The goal of our study was to perform a SR and metaanalysis (MA) for
evaluating the efﬁcacy and safety of azithromycin versus doxycycline in
less heterogeneous population – only in men with CTU.
Methods: We searched the Cochrane Central Register of Controlled
Trials (CENTRAL, in The Cochrane Library Issue 3, 2007), MEDLINE
(1966 – September 2007), EMBASE (1988 – September 2007), reference
lists of articles and abstracts from conference proceedings without
language restriction. Reference lists of urology, infectious diseases and
STD textbooks, review articles and relevant studies. Randomised and
quasi-randomised controlled trials comparing single dose azithromycin
vs 7 days doxycycline in men (>18 years) with uncomplicated CTU
were selected. Two reviewers independently assessed trials quality and
extracted data. Statistical analyses were performed using the random
effects model and the results expressed as relative risk (RR) for
dichotomous outcomes with 95% conﬁdence intervals (CI).
Results: We identiﬁed 6 studies met the inclusion criteria, 436 patients
were evaluated for microbial cure. Microbiological eradication rates were
93.8% for azithromycin and 98.1% for doxycycline, RR = 0.04, p = 0.03;
95%CI = 0.08–0.00.
Conclusion: Doxycycline for 7 days as compared with SD azithromycin
has small but statistically signiﬁcant superiority in eradication rate
of C. trachomatis in men with CTU. Clinical importance of this
difference may not be very signiﬁcant but in further studies we should
consider possible data heterogeneity when combined studies compared
antimicrobials for C. trachomatis infections in patients with different
nosologies (e.a. urethritis and cervicitis).
P1546 Prophylaxis of respiratory tract invasive fungal infections
with aerosolised amphotericin-B deoxycholate in allogeneic
haematopoietic stem cell transplant recipients
I.M. Cavattoni, E. Morello, B. Amato, M. Casini, C. Vedovelli, P. Mian,
L. Pagani (Bolzano, IT)
Objectives: Prophylaxis of fungal infections (IFIs) is still a major
challenge in patients (pts) undergoing stem cell transplantation (HSCT).
The aim of this retrospective study was to evaluate the impact
of prophylactic aerosolised amphotericin-B deoxycholate (d-AmB) on
respiratory tract IFIs in a homogeneous cohort of allogeneic HSCT pts,
transplanted at our institution.
Methods: Since 1999, 87 consecutive pts were transplanted from
matched related (N=65) or unrelated donor (N=22). Analysis was
performed on 78 evaluable pts, in order to monitor the prevalence
of possible, probable, proven IFIs of the respiratory tract within 40
days after HSCT. Conventional antifungal prophylaxis was based on the
association of IV/PO ﬂuconazole (400mg/d), plus aerosolised d-AmB
(15mg bid) in 58 out of 78 cases (74%). All the pts were screened
before transplant and followed-up thereafter with CT or x-rays (paranasal
sinuses, thorax), galactomannan antigenaemia and surveillance swabs.
Chi square test was performed to evaluate correlations between variables.
Results: Aerosolised d-AmB was administered to 74 pts for a median
time of 16 days (range 2–45). Prolonged administration was not
associated with increased life-threatening bacterial infections, nor severe
adverse events were observed; only a pt developed moderate bronchial
spasm. In 13 pts, aerosolised d-AmB was delivered for less than 7
days, due to worsened clinical conditions, or poor compliance. In this
group, proven IFIs were diagnosed in 2 pts (1 mucormycosis and 1
fusariosis), possible aspergillosis in one and probable aspergillosis in
another one. A shortened administration (<7 days) of aerosolised d-AmB
was associated with an increased risk of IFIs (p = 0.004). Overall, 94%
of pts did not experience IFIs and none died due to IFIs. Nine pts
had a pre-transplant nasal swab positive for Aspergillus spp., and 8 of
them received aerosolised d-AmB; their subsequent surveillance swabs
proved negative. The only patient with positive swab who did not
undergo aerosolised d-AmB due to bronchial spasm developed a possible
aspergillosis.
Conclusions: Prolonged aerosolised d-AmB seems to play a role in
preventing respiratory tract IFIs, but a randomised controlled trial is
warranted, in order to verify the impact of such prophylactic regimen in
this setting.
P1547 Is cotrimoxazole prophylaxis still reliable for the prevention
of nocardiosis?
P. Mun˜oz, M. Marin, M. Valerio, E. Cercenado, J. Guinea, P. Martı´n-
Rabada´n, C. Radice, A. Ferna´ndez-Cruz, E. Bouza (Madrid, ES)
Background: Clinical and microbiological spectrum of nocardiosis has
changed recently due to the widespread use of cotrimoxazole (SXT)
prophylaxis, the emergence of new types of immunosuppressed patients
(pts) and the improved identiﬁcation of the isolates by means of
molecular techniques.
Objective: To establish the incidence and the microbiological and
clinical characteristics of nocardiosis in a general hospital over the last
12 years.
Methods: Review of the clinical records of all pts with Nocardia spp.
cultured from a clinical specimen between 1995 and 2006. Nocardia
isolates were identiﬁed with classic procedures and by hsp65 PCR-
RFLP. MICs of SXT, minocycline, imipenem, meropenem, linezolid and
amikacin were determined following the CLSI microdilution method.
Results: Nocardia was recovered from 43 patients. Six were considered
colonised. All had severe underlying pulmonary pathology and were
treated with antimicrobials (6) or corticosteroids (4). Colonising species
corresponded to N. farcinica, N. nova and N. asteroides.
Invasive nocardiosis was diagnosed in 37 pts; 86.5% were men and
mean age was 55.8±17.3 y.o. The most common underlying condition
was HIV infection (10 pts; 27%), followed by neoplasic disease (4 pts;
21.6%), COPD (8 pts; 21.6%), autoimmune diseases (8 pts; 21.6%)
and solid organ transplantation (7; 18.9%). Most important risk factor
was corticosteroids administration (23 pts; 62.2%). Nocardiosis was
disseminated in 5 cases (13.5%), pulmonary in 70.3%, cutaneous in
8.1%, affected the CNS in 5.4%, and caused otomastoiditis in 1 case
(2.7%).
Species were: N. asteroides VI 45.9%, N. farcinica 24.3%, N. otitidis-
caviarum 10.8% and N. nova 5.4%. Antimicrobial resistance rates were:
SXT 8.3%, meropenem 16.6%, imipenem 11.2%, mynocicline, linezolid
and amikacin 0%. Nocardiosis occurred while the patients were on
SXT prophylaxis in 11 pts (29.7%) and the strains isolated in those pts
were susceptible to SXT in 33 (91.6%) and resistant in 3 (8.3%)(SXT
susceptibility not known in one strain). Overall, 13 pts died (21.6%) and
related-mortality was 21.6% (8 pts).
Conclusions: Our results show important changes occurring in
nocardiosis in recent years. HIV infection is presently the most common
underlying condition and species different from N. asteroides account for
more than half of the infections. Moreover, cotrimoxazole prophylaxis
should not be relied upon as universally protective.
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P1548 Oral moxiﬂoxacin versus ciproﬂoxacin plus
amoxicillin/clavulanic acid for low-risk febrile neutropenia –
A prospective, double-blind, randomised, multicentre
EORTC-Infectious Diseases Group (IDG) Trial (protocol
46001, IDG trial XV)
W.V. Kern, O. Marchetti, L. Drgona, H. Akan, M. Aoun, M. Akova,
R. de Bock, M. Paesmans, J. Maertens, C. Viscoli, T. Calandra
(Freiburg, DE; Lausanne, CH; Bratislava, SK; Ankara, TR; Brussels,
BE; Antwerp, Leuven, BE; Genoa, IT)
Background: Oral antibiotic therapy with ciproﬂoxacin plus amox-
icillin/clavulanic acid (C+A) is as efﬁcacious as parenteral therapy
in cancer patients with low-risk febrile neutropenia (FN). Outpatient
management may be an option provided that patients are carefully
selected. Moxiﬂoxacin (Moxi) is a new ﬂuoroquinolone with activity
against streptococci and staphylococci that is superior to that of
ciproﬂoxacin. Moxi given as single daily oral dose might be a suitable
option for empirical therapy of FN.
Methods: The EORTC-IDG performed a prospective, double-blind,
randomised, multicentre trial comparing the efﬁcacy and safety of oral
Moxi (1 x 400mg) and C+A (2 x 750mg + 2 x 1000mg). Inclusion
criteria were FN, a MASCC score >20 (predicting a low risk of medical
complications), and ability to swallow. A single initial dose of parenteral
empirical antibiotic therapy prior to enrolment was allowed. Patients
could be discharged according to predeﬁned medical and non-medical
criteria. The trial was designed to show equivalence (<10% difference
in response rates) of both regimens in terms of efﬁcacy.
Results: The trial was terminated after randomisation of 341 patients of
whom most (66%) were outpatients at fever onset, half had solid tumor,
only few (28%) had received an initial intravenous antibiotic dose prior
to study drug therapy initiation, and 333 were eligible and evaluated in an
intention-to-treat (ITT) analysis. Most of these patients (59%) had fever
without documented infection, and only 12% had bloodstream infection
(44 pathogens, 22 gram-positive, 22 gram-negative). Therapy success in
the ITT population was observed in 136/169 patients given Moxi (80%)
and in 134/164 patients given C+A (82%), a difference of −1% (95%
conﬁdence interval, −9% to 8%) which supports equivalence in efﬁcacy
of the two arms. Study drug treatment duration was 7 days in each
arm. Comparable success rates in the two arms were observed across
different subgroups, and similar proportions of patients in the two arms
were discharged over time. There were slightly fewer patients in the
Moxi arm who developed superinfection (7% vs 14%, p = 0.05). The
rates of patients with at least one adverse event (44% vs 52%, p = 0.13),
or serious adverse events (4% vs 7%, p = 0.15) were similar. Two patients
in each arm died within 30 days following randomisation.
Conclusions: Therapy with Moxi at single daily doses of 400mg orally
is as effective for low-risk FN as C+A.
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P1549 Evaluation of rapid genotypic assays for the detection of
MDR-TB strains from a Cape Town hospital
J.C. Evans, M. Stead, M. Nicol, H. Segal (Cape Town, ZA)
Objectives: An estimated one third of the world’s population is infected
withMycobacterium tuberculosis, with 350 cases per 100 000 population
in sub-Saharan Africa alone. The problem is further compounded
by the emergence of multidrug resistant-M. tuberculosis (MDR-TB),
resistant to rifampicin (RIF) and isoniazid (INH). RIF resistance arises
predominantly due to amino acid substitutions in rpoB, speciﬁcally
at codons 531, 526 and 516. Up to 80% of INH resistance is due
to mutations in KatG (S315T) and inhA (C-15T). Detection of these
mutations often form the basis of rapid diagnostic assays for the detection
of MDR-TB.
The aim of this study was to determine the frequency of resistance-
determinants in MDR-TB strains from Groote Schuur Hospital to
evaluate the efﬁcacy of the GenoType® MTBDRplus assay. Genotyping
was carried out to determine whether particular lineages are associated
with emergence of MDR-TB.
Methods: The GenoType® MTBDRplus assay was evaluated on isolates
identiﬁed as MDR (95), INH mono-resistant (67) and RIF mono-resistant
(11) by drug susceptibility testing.
The presence of KatG S315T and inhA C-15T, identiﬁed using the
GenoType® MTBDRplus assay, was conﬁrmed by multiplex allele-
speciﬁc (MAS) PCR assays and sequencing.
All isolates were genotyped using spoligotyping and MIRU-VNTR.
Results: Of the 46 MDR and 10 RIF mono-resistant isolates, 44 and
6, respectively, were identiﬁed as RIF resistant using the GenoType®
MTBDRplus assay. This assay detected INH resistance in 41/46 MDR
isolates and 25/44 INH mono-resistant strains.
MAS-PCR assays conﬁrmed the presence of the same INH resistance-
determinants in the 41 MDR isolates, and detected INH resistance in
a further 8 INH mono-resistant strains. MAS-PCR failed to detect an
inhA C-15T mutation in one isolate that was detected by the GenoType®
MTBDRplus assay and conﬁrmed by sequencing.
Spoligotyping indicated an association between the W-Beijing lineage
and MDR strains. RIF mono-resistant strains (8/11) were of the
LAM3/F11 lineage and the same MIRU-VNTR cluster.
Conclusion: The GenoType® MTBDRplus assay was successful at
detecting RIF resistance. However, 11% of MDR and 43% of INH mono-
resistant strains were indicated as being INH susceptible, suggesting that
this assay should be interpreted with caution in this setting.
That all the RIF mono-resistant strains cluster together may suggest
the presence of a dominant clone that could emerge as an MDR strain
following conventional TB treatment.
P1550 Detection of mutations conferring rifampicin resistance
in Mycobacterium tuberculosis using real-time PCR and
high-resolution melt analysis
C. Jenkins, C. Ling, T.D. McHugh (London, UK)
Objectives: High-resolution melt (HRM) and the new LCGreen dyes can
be used to detect single nucleotide polymorphisms in ampliﬁed PCR
products. Sequence changes produce a Tm shift and difference in the
melting curve shape compared with the wild-type. Ninety-ﬁve percent
of rifampicin resistance mutations in Mycobacterium tuberculosis (TB)
are located in an 81bp rifampicin-resistant determining region (RRDR)
of the rpoB gene. The aim of this study was to design an assay for the
rapid detection of rifampicin resistance. Rapid detection of resisatnce
is important clinically as appropriate treatment can be commenced
immediately resulting in a more favourable outcome for the patient.
Methods: A 411bp fragment of the rpoB gene including the RRDR
was ampliﬁed using real-time PCR followed immediately by HRM to
determine whether mutations were present.
Results: Of the isolates tested, 22/24 rifampicin-sensitive isolates and
15/15 rifampicin-resistant isolates were correctly identiﬁed. Of the
resistant isolates, HRM analysis differentiated between three of the most
common RRDR mutations (S531L, H526Y and H526D).
Conclusion: This assay is an inexpensive method for the rapid detection
(<3 hrs) of rifampicin-resistance in TB.
P1551 Use of a multi-locus approach to determine the phylogenetic
position of 5 unidentiﬁed Mycobacterium strains isolated
from clinical samples
S. Mignard, J. Flandrois (Lyon, FR)
Molecular sequencing and genomic studies have accumulated evidence
for the deﬁnition of species concept. 16SrRNA is inadequate for a
complete resolution of species of Bacteria. The Multilocus Approach
appears to be useful for the classiﬁcation of Bacteria. We wanted to
perform a MLSA study on the Mycobacterium genes and applied this
method to strain remained unidentiﬁed by the 16S rRNA sequencing.
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Methods: we worked on the whole type strain collection of the genus
Mycobacterium, sequenced 7 genes (16S rRNA, hsp65, rpoB, sodA,
smpB, tuf, ssrA) and created a phylogeny on the concatenated sequence
by Maximum Likelihood method (better tolerance of missing data). We
submitted the 7-genes concatenated sequence of each unknown strain
and reanalysed the global alignment by PHYML.
Results: the phylogeny constructed by ML was the ﬁrst one on this
genus and resulted in the usual topology with early separation of the
rapidly growing group and of the slowly growing group. Usual pathogens
clusters are well grouped. Applying the analysis on the 5 clinical isolates
that remained unidentiﬁed, the MLSA approach conﬁrmed the up-to-now
undescribed status of strains.
Conclusion: As recommended by the Stackebrandt Committee, the
MLSA approach is a useful tool for better resolving species and
necessary for description of new species. And even if this approach still
remains too expensive for a routine use, it might constitute an interesting
trend for bacterial identiﬁcation when the resolving power of the 16S
rRNA is insufﬁcient.
P1552 DNA ﬁngerprinting of Mycobacterium tuberculosis isolates
in the UK: analysis of strains originating from the Indian
sub-continent
J. Evans, K. Ball, E.G. Smith, P. Mateos, R. Webber, P. Hawkey
(Birmingham, London, UK)
Objectives: From 2003 onwards, all isolates ofM. tuberculosis in the UK
Midlands have been analysed by MIRU-VNTR typing. The predominant
group of patients presenting with TB in the Midlands originate from the
Indian Sub-Continent (ISC) and it has been shown that M. tuberculosis
strain types are closely related to host global origin. To detect strain
origin we used OriginsInfo software which analyses given and family
names and then assigns a global origin. This software has been recently
developed to analyse names originating from India. The aim of this study
was to examine and begin to deﬁne the prevalent strains originating from
the ISC.
Methods: From 2003–2007, 4,226 isolates identiﬁed as M. tuberculosis
by the Hain LifeScience GenoType MTBC assay and phenotypic
methods were analysed by MIRU-VNTR typing using 3 ETR loci and
12 MIRU loci analysed on a Transgenomic WAVE system. Patient
ethnic origin was assigned based on names using OriginsInfo software.
Signiﬁcant associations (OR> 1.00, p< 0.05) between clades and patient
populations were identiﬁed using odds ratios.
Results: OriginsInfo software identiﬁed 2,456/4,226 (58.1%) isolates
originating from the ISC. Of 396 VNTR clades present, there were 17
predominant VNTR clades signiﬁcantly associated with the ISC, ranging
from 6–656 isolates in size. The largest distinct clades were VNTR
42235 (656, 15.5%), 42234 (189, 4.5%), and 61464 (44, 1.0%). The ﬁrst
two clades are members of the CAS family. The largest clade (42235)
was shown to be signiﬁcantly associated with patients originating from
Bangladesh, India, and Pakistan with OriginsInfo associating the 42235
clade with 9 states across India and signiﬁcantly with Gujarat, Daman
and Diu, Maharashtra, Goa, the Punjab, and West Bengal. The most
prevalent MIRU-VNTR proﬁles were 42235 225425173533 (100, 2.4%),
42235 226425153533 (45, 1.1%), and 42234 226425173423 (41, 1.0%).
The most prevalent MIRU-VNTR proﬁle was associated with 7 states
and signiﬁcantly associated with patients originating from the Punjab.
Conclusion: There are several prevalent clades of TB present in the
UK Midlands that are signiﬁcantly associated with the ISC. The most
predominant VNTR clade (42235) and MIRU proﬁle (225425173533)
are present in many regions of India. Combination of molecular data with
global anthropological data provided by OriginsInfo provides a powerful
analysis and insight into the origin of M. tuberculosis strains.
P1553 MIRU-VNTR genotyping of Mycobacterium tuberculosis
strains from central region of Russia
M. Afanas’ev, E. Ilina, T. Smirnova, E. Larionova, A. Kuzmin,
S. Andreevskaya, L. Chernousova, V. Govorun (Moscow, RU)
Objectives: The Russian Federation is one of the world’s areas most
affected by a high incidence of tuberculosis (TB). Although TB
morbidity decreased slightly in recent years, the situation remains
alarming due to a major increase in the incidence and prevalence
of multidrug-resistant TB (MDR-TB). The purposes of this study
were to evaluate epidemiological diversity and MDR spreading among
M. tuberculosis strains, circulated in the Central region of Russian
Federation.
Methods: M. tuberculosis strains (n = 35) from sputum of epidemi-
ologically unrelated TB patients from Moscow were selected for
study. Species identiﬁcation and drug susceptibility testing to main
antituberculosis drugs – rifampicin (RIF) and isoniazid (INH) –
were performed according to the WHO recommended protocols.
Standard procedure of MIRU-VNTR typing was carried out as
described previously. For detection of speciﬁc SNPs causing drug
resistance minisequencing reaction followed by matrix-assisted laser
desorption/ionisation time-of-ﬂight mass spectrometry (MALDI-TOF
MS) of the reaction products was used.
Results: Among 65M. tuberculosis strains 33 (50.8%) were identiﬁed as
MDR (i.e. resistant to both RIF and INH), 19 (29.2%) were susceptible
to RIF and INH, and 13 (20.0%) were resistant to INH only. Mutations
in the RRDR of the rpoB gene were detected in all RIF-resistant
strains. The Ser531Leu substitution was prevalent among them (24/33,
72.7%). Aberrations in the Ser315 codon of katG and/or in the inhA
promoter region were found in 41 (89.1%) of 46 INH-resistant strains.
Most of them (33/46, 71.7%) had the mutation Ser315Thr. Thirty ﬁve
different MIRU-VNTR proﬁles were identiﬁed, including the 27 unique
ones. 8 clusters (from 2 to 11 strains in each one) enclosed the 38
strains. Mutations associated with the MDR-phenotype were found more
frequently in strains grouped in clusters (23/38; 60.5%), than for strains
with unique MIRU-VNTR proﬁles (10/27; 37.1%). (Chi2 for trend 4.4;
P< 0.05).
Conclusion: Those strains grouped into the main VNTR clusters and
had the MIRU proﬁles 223325153533, 223325173533 or 223425173533
are associated with MDR-phenotype. It is possible that the spreading of
such strains is related with secondary-acquired resistance and plays a
signiﬁcant role in increasing of MDR TB in the Central region of Russia.
P1554 Immigration and tuberculosis evolution in Catalonia central
region. 10 years (1996–2005)
J. Pina, A. Ferrer, R.M. Sala (Terrassa, ES)
Introduction: Immigrants from countries with a high tuberculosis (TB)
prevalence may affect tuberculosis control in low incidence countries
because there is a gradient of risk of disease among populations. The
foreign-born, have emerged as the largest single component of the burden
of tuberculosis in most industrialised countries.
Methods: Two periods cohort study: from 1996 to 2000 and from 2001
to 2005.TB notiﬁed cases from Catalonia Central Region-CCR-(6577
km2 and 1528144 inhabitants) has been included.
Proportion of immigrants – foreign-born arrived to CCR – were obtained.
Indicators of TB control performance as proportion of tuberculosis
cases with unsuccesful treatment outcome (UTO) and proportion of
contact tracing (CT) within sputum smear positive patients(AFB+) were
estimated as follows:
UTO: defaults, plus treatment failures, plus transfers/total patients with
pulmonary tuberculosis. Goal <10% (IUATLD/WHO)
CT in AFB+ goal: over 85%.
Overall and spanish population TB incidence per 100.000 inhabitants
and its average annual decline (AAD) were calculated.
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Results: Immigrants proportion increased from 1.2% in 1996 to 1.5%
in 2000 and from 2.9% in 2001 to 8.5% in 2005. 95% foreign-borns
came from countries with 50–99 TB cases /100,000 hab.
1996–2000 period:
1530 new TB cases were notiﬁed (6% of whom were immigrants).
UTO: 8.8% in spanish vs 23.2% in immigrants (p< 0001).
CT: 88.5% in spanish vs 40.5% in immigrants (p< 0001).
Overall TB incidence: 28.3 in 1996 and 18.9 in 2000, AAD 9.6%.
Spanish population incidence rates decreased from 27.5 in 1996 to 16.7
in 2000; 11.2% AAD.
2001–2005 period:
1352 new TB cases were notiﬁed (immigrants, 21.8%).
UTO: 7.6% spanish vs 28.9% immigrants (p< 0001).
CT: 91% spanish vs 62.2% immigrants (p< 0001).
Overall TB incidence decreased from 20.8 in 2001 to 18.4 in 2005, 3%
AAD.
Spanish population incidence rates decreased from 18.8 in 2001 to 14.8
in 2005; 5.8% AAD.
Conclusions: Immigrant population shows poorly tuberculosis control
performance results (UTO> 10% and low proportion of contact tracing).
Notiﬁcation data indicate that the decline has slowed down after ﬁrst
period despite spanish population tuberculosis control measures has been
effective (UTO< 10%). As TB incidence decrise in spanish, increase the
proportion of immigrants among tuberculosis cases.
P1555 Epidemiological and clinical features of 85 patients with
tuberculosis at a teaching hospital in Italy
M. Bonadio, U. Vetrano, C. Garzelli, E. Virgone, L. Carneglia (Pisa, IT)
Background: A previous similar study performed at the same institution
(Hospital of Pisa) during the 1996–2000 period showed a TB incidence
ranging from 8.5 to 6.8 (N/100.000), a rate of extrapulmonary TB of
24.5% and a 3.8% frequency of isolates resistant to 2 drugs.
Aim of the study and methods: In order to describe current epidemiologic
and clinical features of patients with TB identiﬁed in the hospital of
Pisa (Italy), a retrospective study of all cases of TB notiﬁed to the
Local Public Health Service during January 2004 – December 2006
was performed. The diagnosis of TB was made following the criteria of
the WHO.
Results: A total of 85 patients (M 39, F 46) affected by TB were
identiﬁed. Diagnosis was microbiologically proved in 81 patients. Thirty-
ﬁve patients were immigrants (mostly from East-Europe and South-East
Asia). The incidence of TB (N/100.000) was 9.5, 8.0 and 7.0 in 2004,
2005 and 2006, respectively. 66.5% of patiens had pulmonary TB; 33.5%
of patients had extrapulmonary or mixed TB.
Extrapulmonary TB was more frequent in immigrant patients (42.8%)
than in italian ones (22%). Five patients were presenting advanced
HIV infection. Microscopic examination for acid fast bacilli in sputum
or bronchial secretion resulted negative in 67.3% of colture proved
pulmonary TB.
7% of the isolated strains of M.tubercolosis were resistant to 2 drugs.
Conclusions: The incidence of TB observed in the present study seems
to be similar to that observed at our institution during the 1996–
2000 period. The rate of extrapulmonary TB shows a trend to increase
expecially in immigrant patients.
The isolation rate of resistant strains to drugs of M. tuberculosis in our
geographical area shows an increasing trend.
P1557 Estimation of tuberculin status among school children on
a Greek island
G. Raptis, K. Barkas, I. Zika, L. Baglatzi, L. Augusti, E. Jelastopulu
(Patras, Corfu, Agrinio, GR)
Objectives: The aim of the study was to estimate the tuberculin status
among ﬁrst class school children in the Island of Corfu.
Methods: In the time period from 1991–2005 tuberculin skin tests were
performed on primary school children at 6 years of age. To all children
qualiﬁed medical and nursing personnel administered intra-dermal Man-
toux test with 0.1ml PPD. The site of the antigen injection was examined
for occurrence of indurations after 48–72 hours. Children with positive
test results (indurations of 10mm and more) were regarded as infected
with M. tuberculosis and were referred to a paediatric clinic for further
examination and investigation. All children who had a response of less
than 10mm (test negative) received a BCG vaccination. Children born in
Albania and showing a response of more than 10mm were also consid-
ered as positive and referred to further investigation, although this fact
could issue from previous BCG-vaccination at birth in the origin country.
Results: During the fourteen year study period a total of 9072 children
were screened for M. tuberculosis infection. A total of 63 of the screened
children were found to be positive giving an average prevalence rate
of 0.7%. Comparing the two seven-year periods (1991–1998 and 1999–
2005) the average prevalence among the primary school children showed
a signiﬁcant decrease from 1.1% to 0.1%.
Conclusions: The prevalence rates of infection among children at school
enrollment demonstrate a falling tendency, supporting the impression
that satisfactory progress has been achieved in control of tuberculosis.
Actually we were expecting a slightly increase in the prevalence of
positive tuberculin skin tests since 1996, when children of immigrants
coming from TB endemic areas were enrolled in the primary school.
On the contrary, we noticed a further reduction of the prevalence rates.
This fact seems to be justiﬁed by vigilant control programmes for the
immigrants realised by the local public services. It is important to retain
low rates of tuberculosis in remote areas and especially in border areas
with a high immigration. Therefore, good organised local control and
surveillance systems are essential in order to achieve effective disease
control and prevention of tuberculosis.
P1558 Tuberculosis in a Canadian paediatric tertiary care
hospital: identiﬁcation of two high-risk communities
M. Clark, C. Hui (Ottawa, CA)
Objectives: The catchment area of the Children’s Hospital of Eastern
Ontario (CHEO) includes three areas: eastern Ontario; western Quebec;
and Bafﬁn Island. The latter is part of the Canadian arctic, accounting
for 1% of the hospital’s total catchment population. Patients from this
region have been transferred to CHEO for care since 1998. Objectives
of this study were: to describe the origin of tuberculosis (TB) patients
at CHEO; and to describe their clinical characteristics.
Methods: All charts with a discharge diagnosis of TB since 1998 were
reviewed. Patients with a positive culture were considered conﬁrmed
TB cases. “Probable” cases included patients with radiological ﬁndings
consistent with TB, absence of a more likely diagnosis, improvement on
antitubercular therapy, and one or more of the following: a positive skin
test; contact with a respiratory, culture-positive case; or a smear positive
for acid-fast bacilli.
Results: Twenty-seven charts were reviewed, of which 19 met our case
deﬁnition. Cases ranged in age from one to 17 years. Ten (53%) were
female. Seven out of 19 total cases (37%) were Canadian-born, Inuit
children from Bafﬁn Island. Seven cases resided in Ontario, while
four lived in Quebec and one in England. There were seven foreign-
born children residing in Ontario or Quebec, all of them from African
countries, including ﬁve from Somalia.
Main diagnostic sites included: lung (10); pleura (3); central nervous
system (CNS) (3); abdomen (1); spine (1); and superﬁcial lymph nodes
(1). Two girls aged 12 years developed cavitary disease. Complications
included oesophageal erosion, corneal ulceration, empyema, and psoas
abscess. CNS disease occurred in two children from Bafﬁn Island, and
an HIV-infected child from Rwanda. One of the two from Bafﬁn Island
died, while the other was left with a hemiparesis. The child from Rwanda
did well after excision of a brain abscess.
Conclusion: Here we identify two communities which make up a small
proportion of the CHEO catchment population, and contribute the vast
majority of the hospital’s TB patients. We also show that TB in children
can present in many different ways, and cause a number of complications.
TB in children is an indicator of ongoing transmission in a community.
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Together, children from Bafﬁn Island and Africa account for 74% of our
TB admissions. The problem in Bafﬁn Island is the result of a home-
grown epidemic, and cannot be attributed to importation from abroad.
P1559 Multidrug and extensive drug-resistant tuberculosis in
Lisbon, Portugal: molecular epidemiology and resistance
mechanisms
J. Perdiga˜o, R. Macedo, I. Joa˜o, E. Fernandes, A. Ribeiro, L. Brum,
I. Portugal (Lisbon, PT)
Objectives: Portugal has one of the highest tuberculosis notiﬁcation rates
of the European Union. In 2003, Portugal reported a tuberculosis inci-
dence rate of 36.4/100 000 and a primary multidrug-resistant tuberculosis
incidence of 1.5%. However, in Lisbon Health Region only, we have
identiﬁed 116 MDR-TB strains in 1200 Mycobacterium tuberculosis
isolated strains. Therefore, our objectives were to assess the multidrug
and extensively-drug resistant tuberculosis situation in Lisbon, through a
molecular epidemiological approach combined with mutational analysis.
Methods: We have analysed 101 multidrug-resistant strains collected
from several hospital units across Lisbon Health Region in the years of
2003 and 2004. All isolates were typed by Mycobacterial Interspersed
Repetitive Units (MIRU) and, screened for mutations conferring
resistance to isoniazid, rifampicin and pyrazinamide accordingly to their
resistance pattern. Drug susceptibility tests for second-line drugs were
also performed.
Results:We have veriﬁed that the majority of the studied isolates belong
to a family of strains, identiﬁed several years ago, designated as family
Lisboa. Despite the high degree of clustering, no signiﬁcant outbreak was
detected. The use of a mutational analysis has allowed the discrimination
between isolates of the same cluster.
We have also determined the most prevalent mutations associated
with resistance to isoniazid, rifampicin and pyrazinamide. Mutations
associated with resistance to isoniazid, rifampicin and pyrazinamide
occurred mainly in the regulatory region of the mabA-inhA operon,
codon 531 of the rpoB gene, and codons 120 and 125 of the pncA gene,
respectively. The prevalence of extensively drug-resistant tuberculosis
among the studied isolates was found to be approximately 54%.
Conclusion: We conclude that the majority multidrug strains circulating
in Lisbon Health Region belong to family Lisboa, a family involved in
an outbreak almost 10 years ago. If measures are not taken to contain
such strains, they will continue to circulate and cause more multidrug
resistant tuberculosis cases and ultimately, developing into extensively
drug-resistant strains, as it is already happening.
The most prevalent mutations associated with drug resistance were also
determined. Such knowledge may be used to develop a locally adapted
molecular diagnostic test.
P1560 Decrease in incidence of tuberculosis in Madrid is associated
to declining rates of recent transmission: an epidemiological
and molecular study between 1997 and 2004
J. In˜igo, E. Palenque, A. Arce, D. Garcı´a de Viedma, F. Chaves
(Madrid, ES)
Objectives: Longitudinal studies using molecular and conventional
epidemiological methods are necessary to understand whether changes in
incidence rates in a particular geographic area can be caused by changes
in ongoing transmission. The aim of this observational study was to
determine to what extent TB trends in Madrid from 1997 to 2004 were
determined by changes in recent transmission of disease.
Methods: Two prospective population-based molecular and epidemi-
ological studies of patients diagnosed with TB were conducted in
three urban districts of Madrid during two different periods. The
ﬁrst one was performed between 1997–1999 (population: 455,050, 4%
immigrants) and the second between 2002–2004 in the same geographic
area (population: 488,518, 14.9% immigrants). DNA ﬁngerprinting was
performed using IS6110 and spoligotyping.
Results: In the ﬁrst period the incidence of TB was on average 30.2
cases/100,000, while for the second was 25.7/100,000 (p< 0.001). The
comparison of TB cases from two study periods showed an important
increase of foreign-born population from 5.3% to 34% (p< 0.001), and a
decrease of HIV infection from 25.7% to 12.2% (p< 0.001). In the ﬁrst
period, 95 of 212 patients (44.8%) were grouped in clusters, and in the
second, 64 of 201 patients (31.8%). The decrease in the overall case rate
was associated to a decrease in the clustered case rate, 7.0 per 100,000
in 1997–1999 to 4.4 in 2002–2004 (p< 0.001). The non-clustered case
rate was 8.6 in 1997–1999 and 9.3 in 2002–2004 (p = 0.45). The overall
incidence among Spain-born population decreased from 29.9 to 20.0
(p< 0.001), and this decrease occurred either in cases attributed to
recent transmission (p< 0.001) and cases attributed to TB reactivation
(p = 0.04). Among the foreign-born population although there was not
signiﬁcant changes in the overall case rate (40.0 vs 58.7), however the
non-clustered case rate increased signiﬁcantly (p = 0.02). Decrease in
clustered case rates were also observed in women (p = 0.02) and persons
younger than 35 years-old (p = 0.02).
Conclusions: The percentage of recent transmission of TB has decreased
from 1997–99 to 2002–04 in Madrid and this change is associated to
declining rates of recent transmission occurring mainly in the Spain-
born population. The reduction in the proportion of clustered cases was
also related to the increase in the number of TB cases among foreigners
which could mean the introduction of new strains.
P1561 Is there any difference between non-smoker and smoker
tuberculous patients in clinical manifestations and
radiographic ﬁndings?
B. Shariﬁ-Mood, M. Metanat (Zahedan, IR)
Introduction and Aim: Cigarette smoking and tuberculosis are
responsible for a large portion of morbidity and mortality in the
developing countries. It has been well documented that smoking
increases the risk of tuberculosis (TB). However, a few studies have
evaluated the impact of smoking on TB. In order to evaluate the
inﬂuences of smoking on the clinical manifestations and radiographic
ﬁndings in smoker tuberculous patients, we conducted this study.
Materials and Methods: From May 2005 to December 2006, two
hundred smear positive pulmonary TB patients who referred to Zahedan
tuberculosis centre for treatment, identiﬁed. Then, we evaluated the
inﬂuences of smoking on the Clinical and radiograohic manifestations
of TB.
Results: A total of 200 TB patients, including 100 (50%) who had
ever smoked, were studied. There was no signiﬁcant difference in
age between smokers and non-smokers. Smokers more likely to have
pulmonary underlying diseases such as chronic bronchitis and asthma
and a duration of symptoms > three months, and less likely to have
extra-pulmonary involvement. Radiographically, more smokers with
pulmonary tuberculosis (PTB) presented with cavitation, miliary lesions,
multiple nodules or masses, and inﬁltrations in two lungs than non-
smokers. Also, there was a signiﬁcant delay in sputum smear conversion
time in smoker patients with pulmonary tuberculosis at 2, 4 and 6 months
of treatment (P< 0.05).
Conclusion: Our results showed that smoking is signiﬁcantly associated
with clinical and radiographic manifestations of PTB and a delay in
sputum smear conversion time.
P1562 Tuberculin response in indigenous Warao children in
Venezuela; BCG vaccination doesn’t affect the positive rates
M. Maes, B. Del Nogal, C. Ferna´ndez de Larrea, Y. Segovia, J.H. de
Waard (Caracas, Tucupita, VE)
Background: The in vitro interferon-gamma (IFN-gamma) assay has
emerged as a more speciﬁc alternative to the tuberculin skin test (TST)
for the diagnosis of latent tuberculosis (TB) infection in BCG vaccinated
persons. However, to justify the introduction of this new and expensive
test, studies in low-income countries must show that BCG vaccination
signiﬁcantly affects the TST results.
Tuberculosis: epidemiological and clinical studies S451
Objective: To determine the speciﬁcity of the TST is diminished in
BCG vaccinated children from a high TB incidence, indigenous Warao
population in Venezuela.
Methods: 1479 children, 1–15 years of age, from different Warao
communities were tested using 2 TU RT 23 tuberculin. Reactions were
measured at 48 hours. The presence of the BCG scar and age of the child
was recorded. A reaction of 10mm or more was considered as positive.
The Kruskal-Wallis and the Pearson test were conducted for the analysis
of the results.
Results: 1088 children in this study had a BCG scar and 391 children did
not. The age distribution in both groups was not signiﬁcantly different.
A positive TST was found in 10.8% of the BCG vaccinated and 8.5%
of the non-vaccinated children, a difference that was not statistically
signiﬁcant. In both groups a positive TST was strongly related with the
age of the child and there was no signiﬁcant difference of TST positive
in the same age groups of the vaccinated and non-vaccinated children.
Conclusion: In this study BCG vaccination does not signiﬁcantly affect
the results of the TST test and is cheaper and easier to perform than the
interferon gamma test. The TST test is still a valuable tool for detecting
tuberculosis infection, especially in this rural setting. In a future study we
will determine whether there is a signiﬁcant difference in the sensitivity
of the two tests for the Warao population.
P1563 Pooled analysis of extra-pulmonary tuberculosis in Turkey:
a review of 2,168 patients
H. Pullukcu, S. Tasbakan, O. Sipahi, M. Tasbakan, S. Calik,
T. Yamazhan (Izmir, TR)
Objectives: In this study it was aimed to review the published
extrapulmonary tuberculosis literature by pooled analysis method.
Methods: To ﬁnd out the published series in last ﬁfteen years
three national databases (Ulakbim Turkish Medical Literature database,
http://www.turkishmedline.com, http://medline.pleksus.com.tr) and two
international databases [Pubmed and Science Citation Index (SCI)]
were searched. Keywords for national databases were ["akciger disi
tuberkuloz” or “ektra pulmoner tuberkuloz” or “tuberkuloz plorezi” or
“tuberkuloz lenfadenit” or “deri tuberkulozu” or “tuberkuloz perikardit”
or “genitouriner sistem tuberkulozu” or “tu¨berku¨loz menenjit” or “milier
tuberkuloz” or “vertebra tuberkulozu” or “larinks tuberkulozu” or
“tuberkuloz peritonit”]. Keywords for Index Medicus and SCI-expanded
were [{“extrapulmonary tuberculosis” or “tuberculosis pleurisy” or
“tuberculosis lymphadenitis” or “skin tuberculosis” or “tuberculosis
pericarditis” or “genitourinary system tuberculosis” or “tuberculosis
meningitis” or “miliary tuberculosis” or “vertebral tuberculosis” or
“larynx tuberculosis” or “tuberculosis peritonitis”} and Turkey]. Articles
i) in which clinical classiﬁcation (ie. Involved organs) of extrapulonary
tuberculosis was not deﬁned, ii) published before 1993, were excluded.
Table. Distribution of the extrapulmonary tuberculosis cases, diagnostic modalities
Clinical diagnosis Total
no. of
cases
Female
(n)
Male
(n)
Age
(mean)
ARB(+)
(n)
Culture(+)
(n)
Diagnosed
by biopsy
(n)
Meningitis 820 393 427 23.6 112 131 –
Pleura 405 146 259 36.1 23 13 180
Lymphadenitis 357 248 109 34.9 26 23 222
Skin 190 115 75 23.1 8 12 172
Bone-joint 124 65 59 36.5 14 19 51
Miliary 88 40 48 44.5 51 41 –
Genito-urinary
system
68 28 40 39.8 21 10 26
Peritonitis 57 31 26 29.4 7 5 41
Pericarditis 11 7 4 47 1 – 3
Larynx 10 – 10 33.1 5 8 6
Other 38 23 15 40 6 7 21
Total* 2168* 1096 1072 – 274* 269* 722*
*Other cases were diagnosed by clinical ﬁndings suitable with tuberculosis +
response to antituberculosis therapy.
Results: Data for 2168 patients (50.55% were females and 49.45%
were males) with the diagnosis of extrapulmonary tuberculosis were
obtained from 71 articles (11 articles published in international peer-
reiew journals, 60 articles in national peer-review journals). Main results
are shown in table. The most clinical symptoms were fever (41%),
sweating (20%), weight loss (17%), fatigue (15%). 6% had contact with
active tuberculosis patients.
Conclusion: Tuberculosis is among the most common infections
in Turkey. Diagnosis of pulmonary and extrapulmonary diagnosis
is challenging. Extrapulmonary tuberculosis should be taken into
consideration in the differantial diagnosis of patients admitting with
symptoms such as night sweating, cough and fever. Evaluation of the
clinical ﬁndings and good microbiologic sampling will increase the
proper diagnosis of the cases.
P1564 Tuberculosis management and drug resistance in Hlabisa
sub-district, KwaZulu Natal
D.J. Sloan, M.J. Dedicoat (Liverpool, UK; Empangeni, ZA)
Background: Hlabisa sub-district, in rural KwaZulu Natal, has a
population of 220,000 and is served by a 300 bed hospital linked to
15 ﬁxed primary healthcare (PHC) clinics. HIV sero-prevalence is 40%.
3000 tuberculosis (TB) cases are notiﬁed annually. TB accounts for 33%
of in-patient mortality. A review of local TB control was undertaken to
identify areas of public health concern.
Methods: South African National Tuberculosis Control Guidelines
(2004) were followed. Diagnosis was made on sputum microscopy,
clinical features and X-Ray. New patients received standard six month
therapy using rifampicin, isoniazid, pyrazinamide and ethambutol.
Retreatment cases and defaulters received eight months of treatment
with a different protocol including intramuscular streptomycin for the
ﬁrst 5 months. Community treatment outcomes from October 2004-April
2005 were recorded. 337 TB in-patients were interviewed in 2005. HIV
testing was offered and details of prior TB therapy recorded. Sputum was
cultured on all hospital and community retreatment cases, defaulters and
smear positive patients who failed to become smear negative on standard
therapy.
Results: Sputum smear positivity in TB diagnosis was low (40%). Only
37% of smear positive patients were cured. 29% were lost to follow-up
before the end of therapy. Defaulting was attributed to ﬁnancial/transport
difﬁculties, lack of community treatment supporters and inadequate
tracing resources. 70% of TB in-patients were HIV positive. 104 (38%)
had received previous TB treatment and 28 (8%) had been treated
multiple times. One or more courses of prior TB therapy was associated
with an increased risk of multi-drug resistant tuberculosis (Relative
Risk: 1.86 [95% Conﬁdence Interval: 1.25−2.70]). 60% of all hospital
and community patients with rifampicin/isoniazid drug resistance were
also resistant to streptomycin. 2 patients had Extremely Drug Resistant
(XDR) TB.
Conclusions:
1. TB & HIV overwhelms district hospitals in KwaZulu Natal
2. Too many patients are lost to follow-up
3. Previous TB treatment is associated with the development of drug
resistance
4. Streptomycin may no longer be an effective second line drug in this
setting
P1565 Increasing incidence of extrapulmonary tuberculosis but sta-
ble rates of resistance of Mycobacterium tuberculosis isolates
to ﬁrst-line anti-tubercular drugs in Kuwait, 1996–2005
E. Mokaddas, S. Ahmad, I. Samir (Dasma, Shuwaikh, KW)
Objective: Continuous nationwide monitoring of drug-resistance levels
is important for proper control/management of tuberculosis (TB). The
aim of this study was to determine the incidence of pulmonary and
extrapulmonary TB and trends in drug resistance patterns among all
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Mycobacterium tuberculosis strains isolated over a ten-year period in
Kuwait.
Methods: Drug susceptibility data for M. tuberculosis isolates recovered
from all pulmonary and extrapulmonary TB patients in Kuwait from
January 1996 to December 2005 were collected and analysed. Patients
were divided into Kuwaiti nationals and expatriates. Prior treatment
status was not recorded.
Results: From 1996 to 2005, 5399 nonrepetitive culture-positive TB
cases (56% from pulmonary sites and 44% from extrapulmonary sites)
among 917 (17%) Kuwaiti nationals and 4482 (83%) expatriates were
identiﬁed. Although the total number of TB cases remained nearly same,
downward and upward trends in the rate of M. tuberculosis isolates
recovered from pulmonary and extrapulmonary specimens, respectively,
were observed. Overall resistance rates were as follows: any drug, 12.5%;
isoniazid, 9.1%; rifampicin, 1.1%; ethambutol, 2.0%; streptomycin,
4.3% and multidrug resistance (MDR), 0.9%. The resistance rates over
the study period remained nearly same. However, signiﬁcantly higher
resistance rates for rifampicin and MDR among pulmonary versus
extrapulmonary cases and for any drug, isoniazid and ethambutol among
isolates recovered from expatriate versus Kuwaiti patients were observed.
Conclusions: The total number of active TB cases from 1996 to
2005 remained nearly same in Kuwait. Moderate and stable single
drug resistance (<10%) and low MDR rates (<1%) were found among
M. tuberculosis strains. The increasing incidence of extrapulmonary TB
cases suggests that majority of active TB cases in Kuwait are occurring
due to reactivation of previously acquired infection. The ﬁndings also
highlight the importance of ongoing control measures to limit the
development and spreading of drug-resistant M. tuberculosis strains in
Kuwait.
Supported in part by KURA grant MI 02/04.
P1566 Treatment outcomes of tuberculosis in HIV-infected
patients after initiation of anti-retroviral therapy in a
resource-limited setting
W. Manosuthi, S. Tansuphaswadikul, W. Mankatitham,
A. Lueangniyomkul, S. Chimsuntorn, S. Sungkanuparph (Nonthaburi,
Bangkok, TH)
Objectives: To study the clinical outcome of tuberculosis (TB) treatment
after initiation of ART in a resource-limited setting with high TB burden.
Methods: A retrospective cohort study was conducted in co-infected
HIV and TB patients who had received anti-TB regimen and were
subsequently initiated ART between January 2004 and December 2005.
TB was diagnosed by clinical features, positive acid fast stain, and/or
positive culture. Outcome of TB treatment was assessed after 48 weeks
of ART.
Results: There were 188 patients with a mean (±SD) age of 36 (±
8) years; 68% were males. The mean (±SD) body weight was 53.3 ±
8.5 kgs. Median (IQR) CD4 cell count and plasma HIV-1 RNA at the
time of TB diagnosis were 36 (15–77) cells/mm3 and 5.6 (5.2−5.9) log
copies/mL, respectively. Of all, 111 (59.0%) patients received nevirapine-
based ART and the others received efavirenz-based ART. Median (IQR)
duration from TB treatment to ART initiation was 1.7 (1.2−3.3) months.
At 48 weeks, 144 (76.6%), 21 (11.2%), 11 (5.8%), 7 (3.7%) and 5 (2.7%)
patients were cure/completed treatment, lost to follow-up, transferred
care, died and receiving TB treatment (recurrent or drug resistant). Four
of 7 (57.1%) causes of death were related to TB and one of these was
related to TB immune reconstitution inﬂammatory syndrome (IRIS).
After 48 weeks of ART, median (IQR) CD4 cell count was 232 (166–347)
cells/mm3 and mean (±SD) body weight was 61.1 (±11.1) kgs; both
were signiﬁcantly different when compared to baseline values (P< 0.05).
By multivariate analysis, patients who received efavirenz-based ART had
a higher tendency of cure/completed treatment of TB than those who
received nevirapine-based ART after adjusting for age, baseline CD4
cell, baseline body weight, site of TB and timing from TB diagnosis to
ART initiation (P = 0.057, OR=2.179, 95%CI=0.977−4.878).
Conclusions: Treatment outcome of TB among co-infected HIV and TB
patients who subsequently receive ART is favorable. Recurrent or drug
resistance rate is less than 3%. The further collaboration between HIV
and TB program will lead to both successful scaling up of ART and
effective treatment of TB among co-infected HIV and TB patients in the
resource-limited settings.
P1567 Study of Chernobyl catastrophe inﬂuence on bovine TB
epizootic process intensity in radioactive polluted and
“clean” territories of Ukraine in 1983–2007
A. Skrypnyk, A. Zavgorodniy, B. Stegniy, V. Skrypnyk, A. Gerilovych
(Kharkiv, Kiev, UA)
Objectives: As a consequence of Chernobyl catastrophe more than
144 000 ha of the agricultural lands were polluted by radiation. The
considerable amount of cattle, including those reacted to tuberculin, is
kept there. The aim of this work was to study the epizootic intensity of
bovine TB in radioactive polluted territories of Ukraine before and after
Chernobyl catastrophe as well as to compare it with such a situation in
the territories free from radiation.
Methods: The most polluted are Kyiv, Rivne, Zhytomyr, Cherkasy and
Chernihiv regions (“polluted” areas). Other regions are relatively “clean”.
The epizootic situation intensity was assessed with the help of such
indices: incidence (on 100 000 heads) and focal index. Incidence was
calculated as ratio of the amount of newly detected cattle reacted to
tuberculin to the total amount of cattle in the period of 1 year. Focal
index was calculated as ratio of the amount of newly detected cattle
reacted to tuberculin to the amount of outbreaks in the period of 1 year.
Results: The graphic shows that before the catastrophe in 1986 the
incidence in “polluted” areas was 20–25, in “clean” – 47–43. From 1987
till 2007 epizootic situation in “clean” areas was characterised by steady
decreasing of the incidence from 40 to 3 respectively. In “polluted” areas
the incidence had the tendency to increase slightly from 24 in 1986 to
32 in 1988 and thereafter it is decreasing till present time, however in
the same time it exceeds the level typical for “clean” areas. Such a
situation is well retraced with the help of trend lines – the trend line of
“clean” territories is decreasing much more steeply then the trend line
of “polluted” areas which is decreasing very gradual.
The epizootic process intensity is similarly characterised by the focal
index. In 1983–85 this index in “clean” areas exceeded such in “polluted”
upon the average in 1.61 times, in 1990–92 this ratio was in the range
of 1. In 2006–07 the average amount of infected cattle per 1 outbreak in
“polluted” areas exceeded the same index in “clean” areas in 2.72 and
1.96 times respectively.
Conclusion: Obtained data demonstrates more intensive epizootic
process of bovine TB in radioactive polluted areas. This could be
explained by the inﬂuence of high radiation doses onto animal organism
as well as onto the biological properties of mycobacteria.
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P1568 Evaluation of the sporicidal and tuberculocidal activity
of the “high level disinfectant” lauryl dimethyl benzyl
ammonium bromide
T. Bello, P. Rosales-Pantoja, E. Acosta-Gio, J.H. de Waard (Caracas,
VE; Mexico City, MX)
Objective. To evaluate the sporicidal and tuberculocidal activity of
two lauryl dimethyl benzyl ammonium bromide formulations (LDBAB)
commercialised in Venezuela as high level disinfectants.
Methods. Sporicidal activity was evaluated with the use of membrane
ﬁlters against a challenge inoculum of 106 Bacillus atrophaeus
spores. Tuberculocidal activity was evaluated against Mycobacterium
tuberculosis H37Rv using the quantitative suspension test described in
the European Standard EN14348:2005.
Results. When tested at the concentrations indicated on their respective
labels, both LDBAB solutions failed to show either sporicidal or
tuberculocidal efﬁcacy.
Conclusion. The LDBAB products tested are widely used in Venezuela
for the disinfection of surgical and dental instruments. Public health
authorities, as well as medical and dental professionals must correctly
identify LDBAB as a low level disinfectant and discourage its use for
instrument disinfection, as this practice may cause iatrogenic infections.
P1569 Effect of intensive education on compliance of tuberculosis
patients in low socio-economic status in Bangladesh
H-C. Jang, S.W. Lee, D.Y. Kim, J.H. Seo, S.W. Park, M-D. Oh,
K.W. Choe (Dhaka, BD; Seoul, KR)
Objectives: Directly observed therapy short-course (DOTS) is main
strategy facing TB in endemic area. However, Bangladesh is still one
of eight countries in which new cases were not detected by DOTS
program. We treated tuberculosis patients who were functionally out of
reach of DOTS in Bangladesh-Korea Friendship Hospital in Bangladesh.
Because compliance is the key of successful outcome in hospital-
based treatment, we performed this study to evaluate whether education
improves compliance of tuberculosis patients in low socio-economic
status (SES) or not.
Methods: All patients who were diagnosed as tuberculosis from Jan
2005 to Mar 2007 were enrolled prospectively. We introduced intensive
education strategy to the tuberculosis patients from May 2006. 6-month
treatment complete rate in patients who were educated intensively were
compared with the rate in control patients.
Results: During the period, 339 patients with tuberculosis visited the
hospital. 26 patients who were transferred or stopped medication by
physician’s decision were excluded. 115 cases (37%) were educated
intensively, while 198 (63%) weren’t. Age (36.3 vs. 34.7, P = 0.37)
and sex (male 58% vs. 64%, P = 0.40) were not different between the
two groups. Treatment complete rate was 74.8% in intensively educated
patients and 70.7% in control patients (P = 0.51).
Conclusion: Intensive education had no signiﬁcant effect on compliance
of tuberculosis patients in low SES in Bangladesh. Effective functioning
of DOTS system is required in this area.
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P1570 Fungiscope – ﬁrst Romanian multicentre study on
fungaemia: preliminary results
M. Mares, M. Flonta, A. Almas, M. Dan, M. Cirlan, O. Bazgan,
L.I. Malic, O. Dorneanu, G. Coman, D. Buiuc (Iasi, Cluj-Napoca, RO)
Objectives: This paper presents the preliminary results of a multicentre
study on fungaemia made under auspices of the Romanian Society of
Medical Mycology and Mycotoxicology in four tertiary hospitals from
Iasi and Cluj-Napoca (Romania) between 2002 and 2007. The aim of
this study is to evaluate the species distribution of fungal strains isolated
from bloodstream cultures.
Methods: The study has included a total number of 3896 blood
cultures from patients hospitalised in departments of cardiovascular
surgery, general surgery, intensive care and infectious diseases. The
range of age varied between 12 days and 82 years. The major clinical
sign which required the bloodstream cultures has been the persistent
fever. The presence of an intravenous central catheter, invasive surgery
and previous broad spectrum antibiotic therapy have been the most
frequent risk factors. In order to detect the fungal strains we used the
Hemoline Performance Duo bottles, the BacT/ALERT®FA bottles, and
the BacT/ALERT Microbial Detection System. The isolated strains have
been identiﬁed on the basis of morphological and biochemical features,
using speciﬁc tests.
Results: The percentage of fungaemia was 1.54% (60 positive blood
cultures). The frequency of fungal species implied in fungaemia
aetiology was: Candida albicans 35%, C. parapsilosis 15%, C. tropicalis
5%, C. pelliculosa 5%, C. krusei 5%, C. sake 5%, C. glabrata 3.33%,
C. dubliniensis 1.66%, C. norvegensis 1.66%, C. norvegica 1.66%,
C. kefyr 1.66%, C. intermedia 1.66%, C. valida 1.66%, C. famata 1.66%,
C. guilliermondii 1.66%, Rhodotorula glutinis 3.33%, Cryptococcus
neoformans 1.66%, Trichosporon asahii 1.66%, Acremonium spp.
3.33%, Pseudallescheria boydii 1.66% and Fusarium solani 1.67%.
Conclusions: The rate of positive blood cultures emphasising fungaemia
is still low comparatively with those exhibiting bacterial infections. The
study underlines the diversity of fungal strains isolated from bloodstream
cultures. It can be noted a relatively low frequency of Candida albicans
strains and the emergence of fungaemia due to non-albicans species
accordingly to worldwide trends. More studies are necessary in order to
evaluate the antifungal susceptibility proﬁle, especially in species with
high risk for resistance to usual antifungal drugs.
P1571 Fungaemia in Slovakia: a prospective, national study
L. Drgona, J. Trupl, A. Roidova, T. Marcek on behalf of the Slovakian
candidaemia Study Group
Objectives: To analyse the incidence of fungaemia/candidaemia, the
aetiology of bloodstream fungal infections and trends in epidemiology
in Slovakia.
Methods: All bloodstream fungal isolates from participating hospitals
(all regional hospitals including all teaching hospitals) were collected
and sent to central study laboratory for identiﬁcation and sensitivity
testing during the study period (September 2005 – March 2007). Germ-
tube tests, chromogenic media (Chromagar, BBL), API 20C and YBC
VITEK (bio´Me´rieux) were used for identiﬁcation of yeasts. The CLSI
M44 method was used to test all yeasts isolates. Quality control strain
C. albicans ATCC 90028 was required to be acceptable within 7 days of
testing. Interpretive breakpoints for ﬂuconazole and voriconazole were
based on zones that correlated with CLSI-S2. All tests results were read
by electronic image-analysis and interpreted and recorded with Biomic
Plate Reader System.
Results: 204 fungal isolates from blood were obtained and analysed.
Repeated cultures from the same episode were not evaluated. In
6 cases 2 different fungal pathogens were identiﬁed simultaneously.
The recent incidence of fungaemia and candidaemia in Slovakia
is 2.57/100,000/year and 2.16/100,000/year, respectively. Non-candida
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fungal pathogens include Acremonium strictum (n = 36) (associated
with nosocomial outbreak in single hospital), Geotrichum spp.(n = 3),
Pichia spp. (n = 3), Trichosporon spp. (n = 3). 171 candida strains were
isolated (83% of all fungaemic isolates) during the study period.
C. albicans was the causative pathogen in 65 cases (38%) followed
by C. parapsilosis (49/28.6%), C. glabrata (29/17%), C. tropicalis
(15/8.7%), C. guilliermondii (7/4%) and C. krusei (6/3.5%). None of
the C. albicans isolates was ﬂuconazole-resistant; 13.5% of non-albicans
isolates were ﬂuconazole-resistant and 7% were voriconazole-resistant.
Conclusion: The results of this national study show the increase of
the incidence of candidaemia in Slovakia comparing previous national
survey. Our data also conﬁrm the shift to non-albicans candida aetiology
with various sensitivity to azoles.
P1572 Fungaemia in the university hospital of Antwerp: species
distribution and antifungal susceptibility of isolates
S. Cooreman, I. Mermans, H. Jansens, M. Ieven (Edegem, BE)
Objectives: To evaluate the species distribution of Candida bloodstream
infections during a 5 year period (jan 2002-dec 2006) in the
University Hospital, Antwerpen (Belgium) and to assess the antifungal
susceptibility.
Methods: A total of 104 fungal bloodstream infections were reviewed.
Biochemical test were used for species identiﬁcation, and the isolates
refered to the reference laboratory for conﬁrmation of the identiﬁca-
tion. Susceptibility to 8 antifungal agents (amphotericin, ﬂuconazole,
ketoconazole, itraconazole, voriconazole, posaconazole, caspofungin and
5-ﬂucytosin) was determined using Sensititre Yeast One plates (Trek
Diagnostic Systems).
Results: The most common species were Candida albicans (52),
Candida glabrata (33), Candida krusei (6) and Candida parapsilosis
(6). There was no signiﬁcant shift in species distribution over these
5 years. Candida tropicalis (4), Candida inconspicua (1), Candida
famata (1) and Cryptococcus neoformans (1) were less frequently
isolated. Susceptibilities to ﬂuconazole, itraconazole and voriconazole
are presented in the table (R: Resistant; SDD: dose dependently
susceptible; S: Susceptible). The ﬂuconazole resistant C. albicans isolate
was also resistant to itraconazole en voriconazole.
Susceptibility to 5-ﬂucytosin was 100%. All Candida isolates had a MIC
1 for caspofungin, while 99 isolates had a MIC 1 for amphotericin,
the remaining 5 isolates had a MIC=2 for amphotericin.
Species (n) Fluconazole, n (%) Itraconazole, n (%) Voriconazole, n (%)
R SDD S R SDD S R SDD S
C. albicans (52) 1 (2) 51 (98) 3 (58) 1 (2) 48 (92) 1 (2) 51 (98)
C. glabrata (33) 7 (21) 14 (42) 12 (36) 17 (52) 2 (6) 14 (42) 3 (9) 2 (6) 28 (85)
C. krusei (6) 5 (83) 1 (17) 1 (17) 5 (83) 1 (17) 5 (83)
C. parapsilosis (6) 6 (100) 6 (100) 6 (100)
C. tropicalis (4) 4 (100) 3 (75) 1 (25) 4 (100)
C. famata (1) 1 1 1
C. inconspicua (1) 1 1 1
C. neoformans (1) 1 1
Total (%) 12.5 16.3 71.2 20.2 12.5 67.3 4.8 1.92 92.3
Conclusions: C. albicans and C. glabrata were the most prevalent
species in bloodstream infections during 2002–2005. These ﬁndings are
concordant with previously reported results. Fluconazole resistance in
C. albicans was rare, supporting the use of ﬂuconazole as the ﬁrst
choice treatment in patients with C. albicans fungaemia. Prevalence
of ﬂuconazole resistance in C. glabrata and C. krusei was 21%
and 83%, respectively. The other non-albicans Candida spp. were
susceptible or dose dependently susceptible to ﬂuconazole, itraconazole
and voriconazole.
P1573 Characteristics of fungaemias in western Malaga over a
period of six years
M.M. Gallardo, R. Rodrı´guez, A. Gutierrez, F. Ropero, M.V. Garcı´a,
L. Mora, E. Granados, A. Pinedo (Ma´laga, ES)
Objectives: The aim of this study was to investigated the clinical and
epidemiological characteristics, as well as the sensitivity of fungaemia
diagnosed in our hospital the last six years.
Methods: A retrospective study was conducted from patients with
fungaemia from January 2001 to December 2006. The identiﬁcation
was carried out through the test ﬁlamentation and the automated system
MicroScan RYI® (Dade Berhing). The susceptibility test was performed
using microdilution system of Sensititre® (Izasa).
Results: We identiﬁed 105 episodes of fungaemia, 65.7% of them
were male with an average age of 59.5 years. In 87.6% of cases,
the patients had a primary disorder being neoplasias (42.9%), diabetes
(31.4%), hypertension (24.8%) and chronic obstructive pulmonary
disease (24.8%) the most frequent. The septic shock (39%) and fever
(28.6%) were the most frequent clinical manifestations. The catheter
(20%) was the most common origin of fungaemia. The risk factors
were the invasive procedures (75.2%) and treatment antibiotics before
isolation (91.4%). C. albicans was the specie more isolated (46.2%),
followed by C. tropicalis (19.2%), C. parapsilosis (15.4%), C. glabrata
(7.7%), C. krusei (5.8%) and others (5.7%). The susceptibility is shown
in Table 1. All strains of C. parapsilosis, C. lusitaniae and C. albicans
were susceptible to all antifungals agents tested.
The mortality of fungaemia was 52.4% being more frequent in the
ﬁrst 20 days. Only 20% of patients received antifungal agents before
isolation, so the treatment was changed in 75.2% of cases after the
report microbiology.
Table 1. Percentage of antifungal susceptibility in invasive yeast
Antifungal Susceptible S-DD Intermediate Resistant
Amphotericine 100% – – –
Ketoconazole 94% − 5% 1%
5-Fluorocytosine 95% − 5% −
Itraconazole 84.2% 12.9% * 3%
Fluconazole 88.1% 8.9% ** 3%
Voriconazole 100% − − −
*S-DD: Susceptible-dose dependent.
Conclusions: Fungaemia by C. albicans was the most frequent, but more
than 50% of these were due to “non-albicans”. C. glabrata, C. tropicalis
and C. krusei were less susceptible species, with an overall resistance
to ﬂuconazole from 3%. Mortality in our environment was very high,
highlighting the importance of microbiological report to appropriate
treatment.
P1574 Nosocomial fungaemias at a general hospital: the change of
epidemiological and clinical characteristics. A comparative
study of 2 cohorts (1993−8 vs. 2002–05)
C. Espinosa, J. Go´mez-Go´mez, E. Garcı´a-Va´zquez, J. Ruiz, M. Canteras,
J.A. Herrero, A. Herna´ndez, V. Ban˜os, M. Valde´s (Murcia, ES)
Objectives: nosocomial fungaemias (NF) have a high mortality rate; in
the last years its incidence has increased. The aim of this study was to
evaluate epidemiological and clinical aspects of 2 different cohorts of
patients with NF and their changes between 2 different periods.
Patients and Methods: observational and comparative study of 2
cohorts of non-paediatric patients with NF admitted at a university
afﬁliated hospital. Data collection from clinical records has been done
according to a standard protocol. We analysed epidemiological, clinical,
microbiological and laboratory data and changes in the 2 cohorts; the
ﬁrst one correspond to our historical cohort studied in 1993–1998 (P1)
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and the second one to the period from 2002 through 2005 (P2). Patients
with NF were identiﬁed by review of results of blood cultures from
the hospital microbiology laboratory. Fungal isolation, identiﬁcation
and sensitivity test (Biomerieux) were performed by standard criteria.
Mortality was assessed till 30 days after diagnosis of NF.
Results: 81 patients were studied during P1 and 107 during P2; incidence
was 9/10000 in P1 and 15.8/10000 admitted-patients in P2 (p< 0.05).
Mean age was 52 years in P1 and 61 years in P2 (p< 0.05); 90% in
P1 and 67% in P2 were patients admitted in Surgical Wards (p< 0.05).
In P1 65.4% NF were due to Candida albicans but in P2 only 44.8%
(p< 0.05); 41% patients in P1 and 19.7% in P2 had also bacteraemia;
diabetes was present in 12.3% in P1 and in 25.2% in P2 (p< 0.05).
All of the patients had previously received at least one course of broad
spectrum antibiotics. A statistically signiﬁcant difference (p< 0.05) in
predisposing conditions was identiﬁed in: central intravenous line rate
(100% in P1 and 73% in P2), previous surgery (43.2% in P1 and 78.5%
in P2). Acute severity of illness at onset and complications (respiratory
distress, renal failure and intravascular disseminated coagulation) were
more frequent in P2 (p< 0.05). Mortality rate was similar in P1 and P2
(50.4% and 50.1%, respectively).
Conclusions: frequency of NF has increased and Candida non-albicans
is now more frequent than C. albicans. The association of bacteraemia
is now higher. NF is associated with a high mortality rate but although
acute severity of illness at onset and complications are now more often,
mortality remains the same.
P1575 Fungal bloodstream infections in a citywide network in
Bogota´, Colombia, 2001–2006
J.A. Cortes, A.L. Leal, G. Buitrago, J.S. Castillo on behalf of GREBO
Background: Fungal infections are common among patients in the icu,
those with cancer and other forms of immunosupression. Bloodstream
fungal infection are specially important due to the high mortality. Sentry
information about Colombia is limited and do not reﬂect the real
epidemiology.
Methods: A citywide network with 23 public and private tertiary
hospitals was established. Laboratory information was transferred
monthly to a central data base and compiled by the use of Whonet
software (WHO, ver 5.4). Bloodstream infections were selected and those
with a fungal isolate were analysed. Infections were stratiﬁed according
to the place of acquisition (intensive care unit – ICU, non ICU wards).
Results: Between 2001 and 2006, a total of 35016 bloodstream infections
were detected. Of those, 3.9% were fungal isolates (1366). C. albicans
was the most commonly microorganism identiﬁed. Non identiﬁed species
of Candida represented 4.2% of the isolates and decresed over time.
The ﬁgure shows the proportion of fungal isolates among patients in the
icu and in non-icu wards. Of note, Cryptococcus neoformans was the
fourth more common isolate among patients with fungaemia out of the
ICU.
Discusion: C. albicans, followed by C. tropicalis and C. parapsilosis
were the most frequently found aetiology of fungaemia. This pattern is
different to that found in other parts of the world. A high frequency
of HIV + patients in third level hospitals are responsible for the high
frequency of Cryptococcus isolates. C. glabrata, a Candida species easily
found in USA and Europe is scarce in our country.
P1576 Factors associated with mortality in patients with fungaemia
M.C. Arendrup, S. Sulim, A. Holm, J.D. Knudsen, L. Nielsen,
J.J. Christensen, K. Fuursted, H.K. Johansen (Copenhagen, A˚rhus,
Odense, Hvidovre, Herlev, DK)
Objective: A semi-national surveillance program of fungaemia in
Denmark has revealed a notably high incidence. Therefore we have
investigated the mortality, underlying conditions and host factors in
fungaemic patients in 2006.
Methods: Participants are 6 departments of clinical microbiology
serving the greater Copenhagen area and major parts of Zealand, Funen
and Jutland (population 2,667,021). From each episode of fungaemia, a
specimen is sent to the National Reference Laboratory for veriﬁcation
of species identiﬁcation and susceptibility testing (EUCAST discussion
document 7.1). A pro forma was provided to gather information on
the patient, concomitant infections, treatment, procedures, and 30-day
mortality, and on the time course of the mycological diagnosis. Fisher’s
exact test was used for comparison of mortality rates.
Results: A total of 316 episodes of fungaemia were recorded correspond-
ing to a rate of 12/100,000 population. C. albicans encountered for 53%
of the cases, C. glabrata for 21%, C. krusei for 8%, C. parapsilosis for
6% and C. tropicalis for 5%. 51% of the patients were at the ICU at
the time of fungaemia, 56% had undergone surgery, which in most cases
was abdominal (81%), while only 5% were leucopenic (<0.5mia/L).
Overall 30 day-mortality was 38%, but 29% (81/280) among patients
who received antifungal treatment. The mortality was higher in ICU
patients, in the patients on mechanical ventilation (both 47%, P 0.0001)
and in patients with leukocyte count of >10mia/L (43%, P 0.0086).
Mortality was not dependent on use of steroids, parenteral nutrition,
dialysis, prior surgery or presence of underlying haematological disease.
Species dependent mortality was C. krusei 36%, C. tropicalis 33%,
C. glabrata 32%, C. albicans 28% and C. parapsilosis 25%, and a trend
towards a higher mortality in the patients with C. glabrata fungaemia
receiving ﬂuconazole vs. caspofungin as ﬁrst antifungal compound was
observed (48% (12/25) vs. 17% (3/18) P 0.0521).
Conclusion: The incidence rate of fungaemia in Denmark is 3 times
higher than reported in other Nordic countries and associated especially
with ICU patients and patients with prior abdominal surgery. Mortality
is highest in the sickest population, is associated with species and choice
of initial antifungal treatment.
P1577 Invasive aspergillosis in haematological patients by exposure
to laminar air ﬂow: description of 65 cases between 2004
and 2006
M.C. Nicolle, A. Thiebaut, F. De Monbrison, N. Voirin, X. Thomas,
F.E. Nicolini, M. Perraud, S. Picot, P. Vanhems, M. Michallet (Lyon, FR)
Objectives: Invasive aspergillosis (IA) occurred mainly in immuno-
suppressed patients (pts) with intensive chemotherapy and/or auto-or
allogeneic hematopoietic stem cell transplantation. The objective was to
describe IA and related care for pts hospitalised (+) or not (−) in a room
with laminar air ﬂow (LAF).
Methods: Proven and probable cases of IA (EORTC criteria) were
collected prospectively between 01/01/2004 and 31/12/2006 in a
university hospital and validated monthly by a multidisciplinary
team. The demographic characteristics, the risk factors, clinical and
mycological features and CT-scan reports were analysed.
Results: 65 IA were identiﬁed with a median age of 56 years.
Conclusion: Delay of onset between admission and diagnosis is similar
between pts hospitalised in LAF rooms or not. The hypothesis on a fungal
carriage before admission can be discussed considering environmental
controls of Aspergillus contamination performed quarterly for each LAF
room were satisfactory. The care management (CT-scans and mycological
sample) was similar between the 2 groups of pts.
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Pt characteristics LAF− LAF+ P-value
n = 34 (%) n = 31 (%)
Hemopathies
Acute myeloid leukaemia (AML), secondary AML 28 (82) 24 (77) 0.66
Acute lymphoid leukaemia 2 (6) 4 (13)
Other 4 (12) 3 (9)
Status
Induction chemotherapy 12 (35) 19 (61) 0.04
Other 22 (65) 12 (39)
Stem cell transplantation <1 year 4 (12) 2 (7) 0.67
Risk factors
Neutropenia <0.5 g/L 29 (85) 29 (94) 0.43
Corticosteroids 10 (29) 3 (10) 0.06
Clinical features
Fever 33 (97) 31 (100)
Pulmonary symptoms 26 (77) 26 (84)
CT-scan performed 32 (94) 31 (100)
Halo sign 27 (84) 25 (81)
Excavation 1 (3) 0 (0)
Serum Aspergillus antigen positive among performed
samples (>1 ng/mL in more than 2 samples)
22/34 (65) 19/31 (61)
Mycological samples performed 22 34
Broncho-alveolar lavage (BAL) 13 (59) 17 (50) 0.81
Biopsies 3 (14) 7 (21)
Other ﬂuids 6 (27) 10 (29)
Mycological samples positive (direct examination
and/or cultures and/or antigenaemia) among performed
samples
18/22 (82) 20/34 (59) 0.08
BAL 10/13 (77) 9/17 (53) 0.26
Biopsies 2/3 (67) 7/7 (86) 0.3
Other ﬂuids 6/6 (100) 5/10 (50) 0.09
EORTC criteria
Proven 4 (12) 10 (32) 0.07
Probable 30 (88) 21 (68)
AI localisation
Pulmonary 30 (88) 27 (87) 1.0
Sinus 1 (3) 1 (3)
Disseminated 3 (9) 3 (10)
Death 1 month after IA 8 (24) 4 (13) 0.34
Death 3 months after IA 20 (59) 11 (35) 0.08
Median delays for clinical diagnosis (days)
Admission–IA diagnosis 17 17 0.49
Admission–neutropenia 5 3 0.34
Neutropenia–AI diagnosis 10 14 0.08
Median delays for complementary investigations (days)
Clinical suspicion of IA–abnormal CT-scan 1 1 0.78
Positive antigenaemia–abnormal CT-scan (n= 30) 4 3 0.91
Abnormal CT-scan–positive antigenaemia (n= 10) 3 5 0.37
P1578 Eleven-year postmortem analysis of ﬁlamentous fungal infec-
tions in intensive care unit patients in a tertiary care hospital
C. Glaeser, M. Schneemann, D.J. Schaer, G. Schoedon, A. Imhof
(Zurich, CH)
Objectives: Mould infections are an important and increasing cause of
morbidity and mortality in patients hospitalised on intensive care units
(ICU).
Methods: To investigate the incidence, underlying diseases, and
pathological features of mould infection in ICU patients in a tertiary care
hospital, all protocols of autopsies performed during a 11-year period
(1997–2007) were reviewed.
Results: This retrospective analysis yielded 50 cases of mould infection.
There were 32 males and 18 females. Median age was 59 years (range
25–81). The median SAPS II score was 52 (range 8–117) and the
median ICU stay was 10 days (1–53). 47 cases with invasive mould
infections (IMI) and 3 patients with aspergilloma were diagnosed.
The most frequent isolates were Aspergillus species (94%) followed
by Fusarium species (2%), Scedosporium apiospermum (2%) and
Zygomycetes (2%). Fungal aetiology was entertained clinically in only
25 (53%) of the patients who were all treated with mould-active
antifungal agents. However, in 37 (79%) patients IMI was the primary
cause of death. Infected sites were lung 34 (72%), disseminated IMI
12 (26%), sinus 1 (2%). The major underlying conditions were hemato-
oncological tumors in 14 patients (30%), followed by 9 patients after
solid organ transplantation (19%), 7 patients with prolonged ICU stays
after surgery (15%), 7 patient with rheumatologic or immunological
disorders receiving high dose corticosteroids (15%), 5 patients with
sepsis or cardiogenic shock (11%), 2 with chronic lung disease (4%),
2 HIV patients (4%) and one patient with nonseminomatous germ cell
tumour (2%). Sixteen (34%) patients were neutropenic. The number of
neutropenic patients decreased signiﬁcantly (p = 0.047) during the study
period. The median duration of ICU stay was signiﬁcantly longer (19.5
vs. 5 days; p = 0.012) in patient without hemato-oncological diseases.
Conclusion: This survey found IMI to be frequent in ICU patients with a
wide range of underlying conditions. The high incidence of not clinically
entertained IMI conﬁrms the importance of autopsy as a tool for quality
control in medical diagnostic and therapeutic activity.
P1579 Four-year survey of zygomycosis in the Swiss Posaconazole
Named Patient Program
S. Zimmerli, O. Marchetti, J. Garbino, M. Weisser, T. Gu¨ngo¨r, Y. Meier
(Berne, Lausanne, Geneva, Basel, Zurich, Lucerne, CH)
Background: Zygomycosis mainly due to Rhizopus andMucor spp. is an
emerging invasive mould infection with high mortality. Response rates
to antifungal therapy up to 40% have been reported. Epidemiological
data for Switzerland are lacking.
Objectives: To describe the clinical characteristics of patients with
zygomycosis identiﬁed among the cohort of 45 patients with invasive
fungal infections treated with posaconazole in a named patient program
in Switzerland between 2003 and 2007.
Methods: Data on clinical presentation, diagnosis, microbiology, and
outcome of 45 patients were retrospectively collected by questionnaire.
Results: 18 patients were diagnosed with invasive zygomycosis (16
proven and 2 possible cases according to the EORTC-MSG criteria).
Eleven of the proven cases were reported between January, 2006 and
April, 2007, when the program became better known. The median
age of patients was 53 years (3 to 67), 80% were male. Underlying
conditions included haematological malignancies in 50% (90% of whom
were neutropenic at the time of diagnosis), solid organ transplantation
in 17%, non-haematological malignancies, diabetes, and trauma in 11%
each. Infection sites were pulmonary in 37% of cases, skin and bone
in 26%, rhinocerebral in 21%, and disseminated in 11%. Absidia spp.
were isolated in 31% of cases, Mucor spp. and Rhizopus spp. both in
19%, Rhizomucor spp. in 12%, and Cunninghamella spp. in 6%. Eighty-
three percent of patients were pretreated for a median of 33 days (0
to 180) with a median of 2 antifungals (0 to 5) before switching to
posaconazole. Most commonly used ﬁrst-line drugs were amphotericin
B deoxycholate (61%), liposomal amphotericin B (50%), voriconazole
(50%), and caspofungin (22%). Reasons for switching to posaconazole
were failure (56%), intolerance to previous medication (17%), and i.v to
oral switch (22%). In addition to antifungal treatment 61% of patients
underwent surgery. Outcome data were available for 15 patients: a
complete response to treatment was recorded in 60%, a partial response
in 20%, and failure in 20%. Patients with complete response were treated
with posaconazole for a median of 4 months (1.5 to 13), those with
partial response for 1.5 months (1 to 3), and those with treatment failure
for 3 days (3 to 4).
Conclusion: This Swiss survey supports that zygomycosis is emerging.
Absidia spp. were the predominant pathogen. New treatment options may
improve the outcome of this life-threatening disease.
P1580 Fungal infections in liver transplant recipients
V. Avkan-Oguz, O. Eren-Kutsoylu, S. Karademir, H. Astarcioglu,
T. Unek (Izmir, TR)
Objectives: The incidence of fungal infections ranges 7–42% in liver
transplantations. Invasive fungal infections usually occur in three months
following transplant surgery. In liver transplant recipients 62–91% of
fungal infections are caused by Candida. Although most specialists
recommend antifungal prophylaxis for liver transplant recipients, the
frequency of fungal infections differs from centre to centre, geographic
locations patients live and to the type of transplant surgery done. We
aimed to ﬁnd out fungal infection incidence in liver transplant patients in
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DEU Hospital (Izmir/Turkey) in order to make a decision for antifungal
prophylaxis.
Methods: Between January 2003 and December 2006, 150 cases
of liver transplantation were performed at our centre. Case records
were examined retrospectively for fungal infection risk factors. Re-
exploration, rejection, retransplantation, drainage catheters, reintubation,
prolonged broad-spectrum antibiotic use, massive blood transfusion, and
CMV infection were accepted as independent risk factors. The patients
were grouped as deﬁnite, possible and probable diagnosis
Results: In this study 64 of 150 patients were consulted with infectious
disease and clinical microbiology specialists because of post-transplant
infections and ﬁve patients were required antifungal treatment. In three
patients fungal pathogens were isolated either in peritoneal ﬂuid or blood
culture. In one patient Candida albicans was isolated from urine sample.
C. albicans was isolated from all specimens. Case 3 was reexplorated for
seven times and massive blood transfusion was performed. Through the
patients given antifungal therapy, only in one patient any fungal pathogen
was isolated (see table for details). Even there was no microbiological
proof, clinical response was determined with antifungal therapy. There
was no Aspergillus infections detected.
Conclusion: As a result the incidence of fungal infection is 3.2% in liver
transplant recipients at our centre. The use of prolonged and broad-
spectrum antibiotics and re-exploration were common risk factors in
all cases. When possible and probable fungal infections were analysed,
the incidence of fungal infections in liver transplant patients was lower
than expected. According to these ﬁndings antifungal prophylaxis after
transplantation is not recommended for the recipients in Dokuz Eylul
University Hospital.
Case 1 Case 2 Case 3 Case 4 Case 5
Re exploration + + + + +
Retransplantation − − − − −
Rejection − + − − −
Use of prolonged
and broad spectrum
antibiotics
+ + + + +
Drainage catheters + − − + +
Massive blood
transfusion
− − + − −
CMV infection − − − − −
Intubation + + + − −
Fungal agent C. albicans C. albicans C. albicans
C. glabrata
C. tropicalis
C. albicans Not detected
Pathogen isolated Peritoneal ﬂuid
culture
Blood culture Peritoneal ﬂuid
Blood culture
Urine culture –
Date of fungal
pathogen determined
321 171 18 9 48
Bacterial pathogen
isolated
Enterococcus
faecalis
Comannonas
spp.
Acinetobacter spp.
ESBL(+) Klebsiella
pneumoniae
Acinetobacter spp.
MRSA
ESBL(+) E. coli
Acinetobacter
spp.
Enterococcus
spp.
Antibacterial Meropenem Pip-tazobactam Pip-tazobactam Pip-tazobactam Pip-tazobactam
treatment Ciproﬂoxacin Vancomycin Cefoperazone Ciproﬂoxacin Meropenem
Vancomycin Ciproﬂoxacin sulbactam Meropenem Cefoperazone-
Netilmicin Teicoplanin sulbactam
Vancomycin Cefoperazone-
sulbactam
Netilmicin
Vancomycin
Amikacin
Total antibiotic
treatment
26 days 15 days 66 days 54 days 60 days
Antifungal treatment Fluconazole Amphotericin B Caspofungin Fluconazole
Amphotericin B
Fluconazole
Prognosis Alive Exitus Alive Exitus Alive
P1581 Clinical and epidemiological features of recent imported
dermatophytoses in Spain
A. Enriquez, A. Amor, C. Toro, M. Baquero (Madrid, ES)
Objective: A changing pattern in dermatomycoses has been reported in
Europe due to recent waves of immigrants from developing countries and
a lesser extent increasing of native travellers to these areas. Data about
dermatomycoses in these populations are useful to know the predominant
species and clinical features to accomplish these infections. The aim
of this study was to describe mycological, clinical and demographic
characteristics in recent immigrants and travellers in our area.
Methods: A retrospective analyse was carried out in immigrant popula-
tion from developing countries including adopted children, and native
travellers between January 2000 to February 2007. Specimens were
examined according to reference methods. Clinical and epidemiological
data were also recorded.
Results: A total of 1344 specimens from superﬁcial cutaneous lesions
were examined. 271 yield positive results for fungal strains and in 154
of them dermatophytes were isolated corresponding to 146 patients, 103
adults and 43 children (under 14 years old). The majority of patients
came from Subsaharian Africa (52%). Among the remain immigrants the
origin was Asia (7.5%), Central and South America (6.9%) and Maghreb
(1.4%). A substantial proportion of dermatomycoses were isolated from
native travellers (28.1%). In 4.1% cases the nationality was unknown.
These dermatophytoses were distributed in tinea corporis (72.7%),
tinea capitis (15.6%) and tinea unguium (11.7%). The most common
dermatophyte species isolated was Trichophyton rubrum (47.4%),
followed by Trichophyton soudanense (17.5%), Trichophyton violaceum
(13.6%), Microsporum audouini (7.1%), Trichophyton mentagrophytes
(5.8%), Microsporum canis (4.6%), Epidermophyton ﬂoccosum (1.3%),
Trichophyton rubrum var. granular (1.3%), Trichophyton tonsurans
(0.7%), and Trichophyton verrucosum (0.7%). All tinea capitis were
isolated in adopted children, most of them from Subsaharian Africa who
carried antropophilic dermatophytes.
Conclusions: Antropophilic dermatophytes were frequent in immigrant
population, specially in paediatric population from Subsaharian African
countries. Of note, a remarkable proportion of native travelers were
infected by dermatomycoses. Surveillance and proper treatment would
be necessary in immigrant populations and travellers from developing
countries to prevent spreading infections.
P1582 Two speciﬁc strains of Histoplasma capsulatum causing
mucocutaneous manifestations of histoplasmosis: a frequent
manifestation of histoplasmosis in Latin America
L. Goldani, V. Cunha, V. Aquino, L. Lunardi (Porto Alegre, BR)
Objectives: Skin lesions, uncommon in US cases (<10%), occur in 38%
85% of cases reported from Latin America. Although these differences
may reﬂect reporting bias, delayed diagnosis, or differences in host
immune response among different ethnic groups, they also could result
from genetic differences changing the pathobiology of the organism. It
is possible that genetic differences among strains of H. capsulatum may
alter the pathogenesis and clinical manifestations of histoplasmosis.
Methods: We examined the clinical features of patients with mucocuta-
neous manifestations of histoplasmosis and performed genetic analysis
based on nucleotide sequence variations in the internal transcribed spacer
regions of rRNA genes of H. capsulatum isolates of patients. Two
pairs of PCR primers were designed to develop to amplify the ITS
regions of H. capsulatum, 5′- TACCCGGCCACCCTTGTCTA-3′ and
5′-AGCGGGTGGCAAAGCCC-3′. These primers were based on the
ITS sequence of Ajellomyces capsulatus, the ascomycetous teleomorph
form of H. capsulatum, deposited in the GenBank (accession number
U18363). Eight patients attending a tertiary-care hospital in southern
Brazil were enrolled into the study. All case patients had skin cultures
growing H. capsulatum at the mycology laboratory.
Results: Six of eight (75%) patients were HIV-positive and presented
involvement of multiples organs by H. capsulatum. Two HIV-negative
patients did not present evidence of involvement of other organs besides
mucosa and skin. ITS sequencing of the H. capsulatum isolates from
the 8 patients revealed two distinct strains. The 2 distinct fragments
(Hc1, Hc2) differed from each other at 7 positions in the ITS regions.
They were identical to strains of H. capsulatum isolated in patients from
Colombia and Argentina, but different from strains isolated in US. The
H. capsulatum clinical strains Hc1 was isolated in 6 patients and Hc2 in
2 patients with mucocutaneous manifestations of histoplasmosis. Both
Hc1 and Hc2 strains were isolated in HIV-infected and non HIV-infected
patients.
Conclusions: Mucocutaneous manifestations of histoplasmosis, which
are frequently seen in Brazilian patients were caused by 2 speciﬁc strains.
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Those strains have been isolated in patients with these particular clinical
features of histoplasmosis in Latin America. Our study suggests that
unique pathogenic characteristics among the Latin America species of
H. capsulatum might explain its increased dermatotropism.
P1583 Hypersensitivity pneumonitis due to Pseudozyma sp. in a
liver-transplanted child
F. Grenouillet, I. Rochat, P. Hotz, R. Corbelli, T. Boekhout,
R. Eisenegger, B. Theelen, G. Reboux (Besancon, FR; Geneva, Zurich,
CH; Utrecht, NL)
Hypersensitivity pneumonitis (HP) in children is rare and mainly
associated with exposure to antigens in home environments.
L, a 5-year-old child, liver-transplanted at 11 months (with long-
term tacrolimus therapy), lives on an old farm in Switzerland.
Diagnosis was made based on clinical history, bilateral ground-glass
and micro-nodular opacities on CT-scan, probable high antigen exposure,
BAL lymphocytosis and conﬁrmed by endobronchial biopsy, revealing
lymphocytic inﬁltrate and non-necrotising peribronchiolar granuloma.
Environmental sampling (home, stable, barn, n = 38) was performed
to prove antigen exposure. Precipitins against 22 different antigens
were investigated. Signiﬁcant precipitins (5 arcs, electrosyneresis) were
observed for only one antigen, extracted from a yeast identiﬁed as
Pseudozyma sp. by rRNA gene sequencing and isolated from two
samples of oat grain. One year later, following corticotherapy and antigen
exposure reduction, HP symptoms had regressed.
Pseudozyma genera are closely related to Ustilago, phytopatogenic
fungi. Because the plantpathogenic dikaryotic state of the latter cannot
be cultivated in vitro, Ustilago were not used to detect precipitins.
Precipitins against the Pseudozyma antigen were retrospectively assessed
in ﬁve Farmer’s lung disease (FLD) cases, 12 exposed and 18 non-
exposed control subjects. Precipitins were signiﬁcant only in 3 out 5
FLD cases. Pseudozyma antigens could be used to assess exposure to
Ustilago in serological diagnosis of HP.
This HP case is unusual due to patient’s age, immunosuppression
(contrasting with hyper-immune response in HP pathogenesis) and
previously undescribed aetiology of HP.
P1584 Pneumocystis jirovecii colonisation in young people with
HIV infection
R. Morilla, M. Montes-Cano, J. Leon Leal, L. Rivero, V. Friaza,
N. Respaldiza, I. Martin, S. Gutierrez-Rivero, P. Solano, J. Medrano,
J. Varela, E. Calderon, C. de la Horra (Seville, ES)
Objectives: The incidence of Pneumocystis pneumonia (PcP) has
declined in AIDS patients in developed countries with the use of speciﬁc
chemoprophylaxis and highly active antiretroviral therapy (HAART),
but still being the major cause of morbidity and mortality. The use of
molecular techniques for diagnosis has revealed the existence of both:
immunosuppressed and immunocompetent carriers of Pneumocystis. The
colonisation in subjects with HIV infection is a risk for developing PcP.
In our environment there is not information about this situation. The
aim was to investigate the frequency of colonisation by P. jirovecii in
young subjects with HIV infection and risk factors associated to this
colonisation.
Patients and Methods: Twenty patients followed since childhoods were
included and their clinical, immunological stage and viral load was
analysed. To determine the presence of P. jirovecii sputum and/or oral
wash samples was obtained in a follow-up visit. PCR techniques were
assayed at two independent loci: The mitochondrial region (mt LSU
rRNA) and DHPS gene (mutations are associated with sulphonamides
resistance). These mutations were identiﬁed by restriction analysis of
polymorphisms (RLFP).
Results: The mean age of cohort was 13.7 years, being 11 of them male.
In 10% a previous PcP episode was diagnosed. The rate of colonisation
by P Jirovecii at the moment of the study was 40% (8/20). None of
these patients shows mutations at DHPS gene. Statistical analysis does
not shown relationship between the presence and absence of colonisation
and, CD4+, CD8+ levels, or viral load.
Conclusions: There is a high rate of colonisation by Pneumocystis in
young HIV infected patients which is associated with a high potential
risk of suffering a PcP, especially when the strains have mutations at
DHPS gene or patients suffered severe immunosuppression.
Project ﬁnanced by FIS 03/1743 and FIS 04/217
P1585 Pulmonary aspergillosis following Mycobacterium kansasii
lung disease
S. Casas, O. Gasch, M. Lo´pez, J. Lora-Tamayo, L. Gonza´lez,
M.R. Guerra, M. Santı´n (L’Hospitalet del Llobregat, ES)
Objectives: The aim of the study is to evaluate the incidence, clinical
features and outcome of Aspergillus lung disease (ALD) in patients (pts)
with Mycobacterium kansasii pulmonary disease.
Methods: Retrospective review of 5 cases of ALD from a cohort of 111
HIV-negative pts with M. kansasii disease, treated in a teaching hospital,
between 1990 and 2005. Diagnosis of ALD was based on radiological
signs, respiratory sample cultures and serology.
Results: Five men with a mean age of 59 years were diagnosed of
ALD (4.5%, incidence rate 1.08 patient-years, 95%CI 0.35−2.53). All
patients were smokers, 3 had COPD, 2 malnutrition and 1 was taking
corticosteroids. Mean time from diagnosis of M. kansasii disease to the
development of ALD was 23 months. ALD developed during treatment
for M. kansasii in 2 patients. All 5 presented cavitary lesions in relation
to M. kansasii disease. Most important clinical manifestations were
hemoptysis (3), dyspnea (2) and weight loss (2). CT showed mycetoma
in 3 cases and pseudonodular inﬁltrates in the other 2. Diagnosis
was established by culture of respiratory samples (4) and histological
examination (1). Aspergillus fumigatus was identiﬁed in the 4 positive
culture cases. Precipitins were positive in 2 of the 3 patients in whom
they were performed. Antifungal therapy was based on itraconazole
(4 courses), voriconazole (3) and amphotericin B (1) with a mean
duration of 135 days. Embolisation and surgical resection because of
recurrent hemoptysis was required in 2 cases. Two patients died due to
postoperative complications and lung cancer respectively, and 3 were
alive after a 45.8-month mean follow-up.
Conclusions: ALD is not an uncommon complication of M. kansasii
pulmonary disease and implies a poor prognosis. Reappearance of
respiratory symptoms in any patient being treated or formerly treated
for M. kansasii disease should raise suspicion of ALD.
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P1586 Inﬂuenza virus vaccination in kidney transplant patients:
serum antibody response to different immunosuppressive
drugs
M.J.C. Salles, Y.A.S. Sens, C.M. Machado, L.V. Boas (Sa˜o Paulo, BR)
Objectives: Inﬂuenza vaccine response in kidney transplanted patients
has shown conﬂicting results, which can be associated with different
immunosuppressive regimens. We prospectively assessed the humoral
immunity to the trivalent inactivated inﬂuenza vaccine in kidney
transplant adult patients.
Methods: 75 renal transplanted patients with at least six months of
transplantation received one dose of inactivated inﬂuenza vaccine 2004–
2005. Anti-hemagglutinin antibody response against each strain was
measured by hemagglutination inhibition test before and monthly up
to 6 months after. The geometric mean titer (GMT) of each strain
was calculated using the log-transformed values from all subjects; the
GMT was taken as the antilog of the mean of the transformed value.
Logistic regression model was used to assess the impact of different
immunosuppressive drugs on the vaccine response rates.
Results: One month after vaccination, 57.4% of patients acquired
protective titers of antibodies to at least one vaccine strain. The GMT
of H1N1 and H3N2 strains increased from 2.75 and 2.44 to 13.54
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(P = 0.001) and 7.30 (P< 0.001) respectively. Pre and post-vaccination
protection rates for H1N1 and H3N2 increased from 9.3% to 45.3%
(P< 0.001) and 9.3% to 33.3% (P< 0.001). The H1N1 and H3N2
seroconversion rates after vaccination were 36% and 25.3%, respectively.
There was no antibody response to inﬂuenza B virus. Compared to the
use of azathioprine (AZA), Mycophenolate Mofetil (MMF) reduced the
H1N1 [P = 0.011, OR 0.26 (IC95% 0.097−0.734)] and H3N2 [P = 0.033,
OR 0.30 (IC95% 0.10−0.91)] protection rates and the seroconversion
rates for the H3N2 strain [P = 0.036, OR 0.26 (IC95% 0.07−0.91)].
Conclusions: Renal transplanted patients submitted to an anti-inﬂuenza
vaccination responded with antibody production against strains H1N1
and H3N2 of inﬂuenza A virus but not to inﬂuenza B virus. Use of MMF
decreased the humoral immune response to the anti-inﬂuenza vaccine.
P1587 Antibody response to inﬂuenza immunisation in kidney
transplant recipients receiving either azathioprine or
mycophenolate: a controlled trial
Maryam Keshtkar Jahromi, H. Argani, M. Rahnavardi, E. Mirchi,
Marzieh Keshtkar Jahromi, S.A. Tara, S. Atabak, T. Mokhtari Azad
(Tehran, Kazeroon, IR)
Objectives: This study aimed to assess the humoral immune response
to inﬂuenza vaccination in adult kidney transplant recipients (KTRs)
subjected to two immunosuppressive regimens containing either my-
cophenolate mofetil (MMF) or azathioprine (Aza).
Methods: Forty eligible KTRs (24 treated with Aza [KTRs-Aza] and
16 treated with MMF [KTRs-MMF]) and 40 matched healthy controls
(HCs) were administered the trivalent 2006–2007 anti-inﬂuenza vaccine.
Antibody (Ab) titers were measured before (pre-vacc) and 1 month
after (post-vacc) vaccination. The proportion of protective Ab titers (i.e.
1:40), the serological response (i.e. 4-fold rise in titers) rates, and
the magnitudes of change in titers were evaluated.
Results: KTRs and HCs were similar in serologic responses, magnitudes
of change in Ab titers, and proportions of newly developed protective
titers against all antigens. Whereas KTRs-MMF and KTRs-Aza were
identical in magnitude of rise in titers as well as in serologic responses,
KTRs-MMF did poorer in newly developing post-vacc protective titers
against A/H1N1 (P< 0.05). The function of the transplanted kidney has
not deteriorated after vaccination.
Conclusions: Anti-inﬂuenza vaccination was safe in KTRs and evoked
Ab responses comparable to those of HCs. KTRs-MMF and KTRs-
Aza responded almost equally to the vaccine. Annual anti-inﬂuenza
vaccination can be recommended to all stable KTRs.
P1588 Effectiveness of the inﬂuenza vaccine – Problems with
selection bias
R. Baxter, B. Fireman, J. Lee (Oakland, US)
Background: Despite a lack of consistent evidence showing a large
beneﬁt, the inﬂuenza vaccine has been recommended for seniors in
the US for almost 50 years. Only one randomised, controlled study
showed a beneﬁt in the elderly, and this diminished with age over 70.
Placebo-controlled trials are unlikely to occur in the near future. Many
observational studies have shown a beneﬁt much greater than is plausible,
considering immune senescence and the known impact of inﬂuenza on
mortality. These observations have led some to believe that the beneﬁts
of the vaccine are truly unknown, and that perceived effectiveness may
be due to wishful thinking and bias in the observational studies. We
looked at vaccine uptake and underlying morbidity in our population
to see if we could ﬁnd insights into the potential bias of observational
studies..
Kaiser Permanente is a medical care organisation in Northern
California with almost 3.3 million members. All medical information is
computerised, including diagnoses, vaccinations, and medications. The
entire population is categorised into risk groups using DxCG® software
(based on 140 diagnostic groups)
Methods: We studied Kaiser members over 65 years of age, during
the years 1997–2004. We compared all-cause mortality in members
vaccinated with any type of inﬂuenza vaccine with the unvaccinated.
Results: Mortality in the vaccinated is extremely low just after
vaccination, then rises to more closely approximate the non-vaccinated
at the end of a year. Mortality in the unvaccinated is very high right after
vaccination, then diminishes over the year. These effects are independent
of the inﬂuenza season, and reveal signiﬁcant bias in observational
studies of vaccinated vs. unvaccinated individuals.
Using DxCG ratings as a marker of underlying morbidity We also found
that healthier people over 65 are more likely to get a ﬂu vaccine, and
that the likelihood of vaccination increases with underlying morbidity, up
to a point. When underlying morbidity reaches a threshold (the sickest
10%), vaccination decreases with increasing morbidity.
P1589 Administration of DNA and protein vaccines containing gD
genes of HSV1 and 2
H. Soleimanjahi, F. Fotouhi (Tehran, IR)
Objectives: Herpes simplex virus type 1&2 infect mucocutaneously
and causes oralabial and genital infection in humans, followed by the
establishment of a latent infection in the sensory ganglia and can
reactivate for life. The prevalence are increasing worldwide and varies
widely with generally higher rate in developing than developed countries.
A need for effective vaccine remains the preferred strategy for control
of HSV infections.
Methods: The PCR ampliﬁed HSV gDs were cloned into desired
plasmids in order to construct DNA vaccine or recombinant expression
vector. Conﬁrmed baculovirus-based recombinant plasmids were trans-
fected into Sf9 cells, cultured in serum-free Grace’s medium at 27ºC and
monitored daily for observation of cytopathic effects. After 72 hours, the
recombinant baculoviruses were harvested from the cell culture medium.
The viral stock was ampliﬁed by re-infecting insect cells and titrated as
pfu. The Sf9 cells were infected with gDs-baculovirus and incubated at
27ºC for various times to express the recombinant protein of interest.
Results: The constructs were conﬁrmed by colony PCR, Restriction
Enzyme Analysis and sequencing. The protein productions in Cos-7
and insect cells were shown by western blot analysis. The recombinant
plasmids and protein of interest were injected in different groups of
BALB/c mice. The expression vector without any fragment and Sf9
cells were used as negative control and injected to control groups. The
inductions of humoral and cellular responses were evaluated.
Conclusion: Although vaccination of mice with a plasmid expressing the
neutralising antigens induced humoral and cellular immune responses,
but the antibody titer were signiﬁcantly lower than that of antibodies
induced by the subunit protein vaccines. Furthermore, the plasmid DNA
as well as recombinant protein vaccine could protect the mice against
HSV-1 and HSV-2 lethal challenge.
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P1590 Viability of live-attenuated vaccine strains in a
pharmaceutical dump
S. Bianchi, M. Canuti, A. Zappa, R. Koncan, G. Cornaglia, E. Tanzi,
G. Tridente, A. Amendola (Milan, Verona, IT)
Objectives: To assess the viability of discarded and buried vaccine
strains, we examined vaccines that had been buried for >20 years in the
12,000m2 waste dump of the bankrupted Istituto Sieroterapico Milanese
(ISM) in Milan, Italy. This dump area was recently reclaimed after nearly
a decade of abandonment. Some recovered material, including vaccines
against human and animal diseases such as rabies, poliomyelitis, anthrax,
Newcastle Disease (ND) and Canine Distemper (CD), were recovered in
hermetically sealed vials, so their contents might have been totally or
partially preserved.
Methods: We selected and analysed two lyophilised live attenuated CD
Virus (CDV) vaccines, recovered and unearthed in the dump.
An ampliﬁcation of a speciﬁc 550bp fragment of CDV NP gene
was performed by nested RT-PCR. The PCR-positive specimens were
then submitted to the viability tests through the inoculation of the
resuspended vaccine on a conﬂuent monolayer of permissive cell cultures
(Vero, African green monkey kidney) and the detection of the speciﬁc
cytopathic effect. As positive control, we used a vaccine against the
CDV currently in use, Caniffa-CHL, (Merial Italy S.p.a., Milan, titre
103 CCID_50).
Results: CDV lyophilised vaccine samples resulted positive to the PCR-
analysis, attesting the competence and integrity of the viral genome in
the vials.
Three days after the inoculation of the sample on Vero cells we observed
the speciﬁc cytopathic effect (lysis plaque formation).
Conclusions: This result conﬁrmed that CDVs recovered in the dump
were endowed with viability, thus showing they retained their replicative
ability, as previously reported for ND Virus vaccine strains (Amendola
et al, Emerg Infect Dis. 2007). The discovery of the maintenance of
the replication activities of lyophilised vaccine strains after 30 years
of burial is relevant because it emphasises that such preparation may
preserve viable strains. This event seems occur independently of the
virus species, and therefore it is also possible that viruses that can cause
hazard to humans (as poxvirus or poliovirus) may persist for years and
be dangerous at the moment of manipulation while reclaiming activities
take place. Altogether, these evidences strongly underline the need of
guidelines for the disposal of such particular products, such as vaccines
and their by-products, and the lack of studies aimed at evaluating the
environmental infection risk from the uncontrolled burial of industrial
bio-material.
P1591 Effect of vaccination for haemorrhagic fever with renal
syndrome: analysis of 5-year experience
H.Y. Kim, N. Lee, O. Kwon, Y. Uh (Wonju, KR)
Objectives: Haemorrhagic fever with renal syndrome (HFRS) is
endemic pyrogenic disease caused by Hantaan virus, and characterised
by fever, renal failure, and bleeding. In Korea, hundreds of patients are
newly diagnosed as HFRS for recent years. We evaluate the effect of
HRFS vaccination (Hantavax, inactivated Hantaan virus solution [ROK
84–105] 4,096 ELISA unit/mL, Green Cross vaccine, Korea) on clinical
features from our experience for years.
Methods: A total of 214 patient were included from a tertiary
Korean hospital. One hundred and thirteen patients were positive in
Hantaan virus antibodies with passive haemagglutination methods or
immunochromatography between 2002 and 2006, and 19 of these were
diagnosed as HFRS on the basis of clinical manifestations (classiﬁed
as Group 1). The other 101 patients (Group 2) were treated as HFRS
between 1986 and 1990 when HFRS vaccine was not developed.
Vaccination were conﬁrmed by patient’s chart review or telephone
surveys.
Results: The patients’ ages (mean ±SD) were 44.0±23.1 vs. 45.4±14.1,
hospitalisation days (mean ±SD) 13.6±8.2 vs. 10.5±9, renal failure
was developed in 12 (63.2%) vs. 96 (95.0%) (P< 0.05), ﬂank pains
2 (10.5%) vs 59 (58.4%) (P< 0.05), haemodialysis was required in 0
(0.0%) vs. 17 (16.8%), mortality 1 (5.3%) vs 12 (11.9%) in group 1 vs.
group 2, respectively. There was signiﬁcantly low incidence (5%, 3/56)
of HFRS in vaccinated people compared with nonvaccinated (21.5%,
11/51) (P< 0.05).
Conclusion: We concluded that vaccination has contributed to declined
incidence and decreased severity of HFRS.
P1592 Long-term follow-up of new-borns of HBsAg positive
mothers vaccinated against hepatitis B
L. Roznovsky, A. Kloudova, L. Kabieszova, I. Orsagova, I. Lochman,
J. Mrazek, L. Lukacova, A. Zjevikova (Ostrava, CZ)
Objectives: Protection after combine passive-active immunisation
against hepatitis B was investigated in 685 neonates of HBsAg positive
mothers in north-eastern part of the Czech Republic.
Methods: Combine passive-active immunisation was commenced in
1988 year and the number of immunised children gradually increased till
the end of 2006 year. The children received hepatitis B immunoglobulin
at birth and three 10mg doses of plasma-derived or recombinant vaccine
at interval 0, 1 and 6 months (30 children of HBeAg positive mothers
at interval of 0, 1 and 2 months). Blood samples were obtained after
immunisation, at 2 years of age, and biennially thereafter. Samples were
tested by ELISA for HBsAg, anti-HBs and anti-HBc. The immunisation
schedules were completed in 657 children.
Results: Anti-HBs antibodies were tested in 641 children after
immunisation; protective anti-HBs antibodies were proved in 598 of
them (93%). Twenty-six children without anti-HBs after immunisation
received one identical booster vaccine; protective anti-HBs were proved
in 24 of them. Vanishing of protective anti-HBs antibodies was detected
in 30%, 49% and 62% children in 5, 10 and 13 years of their life. Vertical
transmission of hepatitis B virus with chronic HBsAg carrier status was
proved in 2 children, one of them was infected by escape mutant of
HBsAg. Asymptomatic infection with long-term presence of anti-HBc
antibodies was observed in 9 children. The anamnestic response with
double increase of anti-HBs without revaccination was proved in 63
children.
Conclusions: The vaccination of neonates of HBsAg positive mothers
against hepatitis B was successful and practically interrupted the vertical
transmission of hepatitis B virus.
Grant support: IGA Ministry of Health, Czech Republic, NR/9257-
3/2007.
P1593 Prevalence for serological markers of hepatotropic viruses
A, B, and C, and hepatitis A and B vaccination needs in
a prospective cohort of patients with chronic liver diseases
awaiting liver transplantation
L. Belarbi, Z. Coutsinos, P. Loulergue, Y. Calmus, F. Conti,
A. Malhaire, S. Grabar, A. Rosenberg, O. Launay (Paris, FR)
Vaccination against hepatitis A and B is widely recommended in patients
with chronic liver disease, especially those awaiting a liver transplant,
because of the increased risk of developing a life-threatening hepatitis
(HAV and HBV), or HVB reactivation when transplanted.
Objectives: The objectives of this study were to investigate the
prevalence of markers of hepatotropic viruses and to identify candidates
for vaccination against hepatitis A and B in a prospective cohort of
patients waiting for a liver transplant in a teaching hospital in Paris,
France.
Methods: Between March 2006 and November 2007, 80 patients on
the liver transplantation waiting list were studied for socio-demographic,
epidemiological, clinical, routine biological data and serological markers
for hepatitis viruses including HAV, HBV and HCV.
Results: The mean age was 51 years (19 to 66). M/F ratio was
2.5. Of these 80 patients, 96% had cirrhosis, mostly due to alcohol
abuse (37.5%), chronic viral hepatitis (31%) or autoimmune disease
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(14%). 22% had liver carcinoma complicating the cirrhosis. Anti-HCV
antibodies were found in 36%, among whom 72% had detectable
viraemia.
On a declarative basis, vaccination rates for hepatitis A and B were 16%
and 9%, respectively.
Prevalence of anti-HAV antibodies was 87.5%. Seromarkers of past
and present infection with HBV was 32.4%: 12.5% had positive HBs
antigen, 11.2% had HBs and HBc antibodies and 8.7% had isolated HBc
antibodies. Only 19% had a vaccinated proﬁle.
Thus, a total of 43 patients (55%) had an indication of vaccination
against viral hepatitis: 4 (5%) patients presented an indication for HAV
vaccination alone, 33 (42.5%) patients for HBV vaccination alone, and
6 (7.5%) patients for both vaccines. Vaccination proposal encountered
no refusal.
Conclusion: In our cohort, we found high prevalence rates of HAV,
HBV and HCV markers. However, vaccination against hepatitis A and B
should be proposed to 12.5% and 50% of the patients respectively. These
results support the recommendation that serologic testing for HAV and
HBV should be done systematically in patients suffering from chronic
liver diseases to propose a vaccination for hepatotropic viruses that could
avoid an aggravation of their status.
P1594 Incidence of human papillomavirus genotypes and estimated
repercussion of quadrivalent vaccine in Cadiz, Spain
M. Cebada, M. Blanco, I. Popa, A. Lozano, M. Reyes, C. Ferna´ndez
(Cadiz, ES)
Objectives: Infection with human papillomavirus (HPV) as an essential
cause of cervical cancer has now been established. The quadrivalent
HPV vaccine protects against infections by HPV6, 11, 16 and 18.
HPV16 and HPV18 cause approximately 70% of cervical cancer
worldwide so, the implementation of the HPV vaccine is a very important
effort toward preventing high-grade cervical lesions.
The aim of the study was to know the incidence of different HPV
genotypes and to estimate a possible repercussion of quadrivalent HPV
vaccine in our sanitary area.
Methods: A total of 950 endocervical or vulvar swabs from woman
suspicious of HPV infection (colposcopy and/or citology) were processed
during 2006 to HPV detection. In 157 samples from 143 ﬁrst visit
patients (criteria for inclusion in the study) we detected any genotype
of HPV. All samples were collected in duplicate and specimens were
stored at 4ºC for a maximum of 6 days before detection. HPV
extraction, ampliﬁcation and detection were carried out according to
the manufacturer (PVHfast, Genomica S.A., Madrid, Spain): a 450
bp fragment of L1 ORF region was ampliﬁed utilising the MY09/11
consensus primers in the thermocycler CeneAmp 2400. An internal
control and endogenous human CFTR gene were co-ampliﬁed. Detection
and typing of ampliﬁed products: RFLP in high resolution 2% agarose
gel.
Results: There were 157 samples positives from 143 patients: 129 with
one HPV genotype, 24 with two and four with more than two genotypes.
The more frequents genotypes detected were HPV16 (25.2% of patients),
HPV6 (22.4%), HPV61 (9.8%), HPV53 (9.1%) and HPV18 (7.7%). A
total of 68 (47.5%) of the 143 patients had genotypes included in vaccine.
Twenty-two patients (15.4%) had high grade cervical lesions, and 15
from these 22 patients (68.2%) associated with HPV16 and HPV18.
Conclusions:
1. The most frecuent HPV infection genotypes in our sanitary area were
HPV16, HPV6 and HPV61.
2. The quadrivalent HPV vaccine will possibly prevent 47.5% of HPV
infections by any genotype and 32.2% by high risk genotypes.
3. The reduction of HPV related CIN2, 3 or adenocarcinoma in situ is
estimated at 68.2%.
P1595 Outbreak of measles in Catalonia (Spain): importance of
laboratory conﬁrmation
N. Torner, A. Dominguez, J. Costa, M.M. Mosquera, I. Barrabeig,
C. Rius, E. Plasencia, S. Minguell, M.R. Sala, A. Martinez, C. Cabezas,
A. Plasencia and the Working Group for the Study of the Measles
Outbreak in Catalonia
Objectives: In 2001, Spain launched a measles elimination programme
and in 2004 circulation of indigenous measles was interrupted. However,
until world-wide eradication occurs, elimination maybe disrupted by
epidemics in indigenous population as a result of an imported case.
The objective of this study was to analyse microbiological and clinical
characteristics of the measles outbreak that began in Catalonia at the end
of 2006.
Methods: Suspected cases reported to the Department of Health,
Generalitat of Catalonia, from 28 August 2006 to 18 June 2007
were studied. Laboratory conﬁrmation was attained by determination
of Measles-speciﬁc IgG and IgM antibodies by enzyme immunoassay
and/or detection of the measles virus (MV) genome in urine with a
multiple nested polymerase chain reaction (PCR) to detect the MV,
rubella and parvovirus B19 viruses simultaneously. If PCR was positive
for MV, conﬁrmation was obtained by a measles-speciﬁc nested PCR.
Results: Of 534 cases involved, 372(69.7%) were conﬁrmed. Laboratory
conﬁrmation was obtained in 327/372 cases (89.5%):137(137/327;42%)
by MV IgM antibodies, 61 (61/327;19%) by MV genome PCR
and 129 (129/327;39%)by both;38/372 (10%) were conﬁrmed by
epidemiological link and 7/372 (2%) were classiﬁed as clinically
compatible due to lack of samples or evidence of direct contact
with a conﬁrmed case. Of 338 urine samples analysed (63.3%
[338/534]), 190 (56.2%) were PCR positive and 114 genotyped to
D4. 38/372 (10%) were conﬁrmed by epidemiological link and 7/372
(2%) were classiﬁed as clinically compatible due to lack of samples
or epidemiologic link to a conﬁrmed case. Hospitalisation rate (HR)
was 16.2% (60/372). Highest HR was observed in 26–35 years age
group (28.8%). In 91 cases complications were present (24.5%),
35 of them were hospitalised. Most common complications were
diarrhoea and/or vomiting (15.2%), otitis (5.4%) and pneumonia (2.1%).
Complications were signiﬁcantly greater in unvaccinated (85/151:56%)
than in vaccinated cases (4/34:12%;p< 0.001. There were no deaths.
Conclusion: Laboratory conﬁrmed cases accounted for 89.5%. Although
laboratory conﬁrmation is not essential during an outbreak, it reﬂects a
sensitivity to disease involving not only laboratory and epidemiological
surveillance units, but also attending physicians and should thus be
encouraged. Thanks to the large number of clinical samples available
for sequencing all cases could be set to belong to the outbreak.
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P1596 Pilot evaluation of a commercial PCR-DNA microarray
system (PneumoVir) for detection of respiratory viruses in
clinical specimens
P. Muir, I.B. Vipond, D. Carrington (Bristol, UK)
Objectives: Diagnosis of respiratory virus infections is complicated by
the large number of viruses implicated and the overlapping clinical
presentations of these infections. Although nucleic acid ampliﬁcation
techniques offer increased sensitivity and improved standardisation
relative to viral culture and antigen detection methods, their application
to respiratory virus detection has been limited by the need to set
up individual assays to detect each virus infection and the limited
multiplexing capacity of real-time PCR. Application of DNA array
technology provides an alternative solution to simultaneous detection
of multiple viruses based on reverse hydridisation of targets ampliﬁed
by multiplex PCR to an array of virus-speciﬁc probes. We therefore
evaluated the PneumoVir Clinical Array (Genomica SA, Madrid) which
has been designed to detect 17 respiratory virus types and subtypes in
clinical specimens.
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Methods: We performed beta testing retrospectively on 47 nasopharyn-
geal aspirate, sputum or bronchio-alveolar lavage samples which had
been submitted for viral diagnosis during the 2006−7 winter season
using the PneumoVir assay, and compared results with those of viral
culture, direct immunoﬂuorescence (DIF) for inﬂuenzavirus (IF) A and
B, respiratory syncytial virus (RSV), parainﬂuenzavirus types 1−3 and
adenovirus, and in-house real-time PCR for IF A and B, RSV and human
metapneumovirus.
Results: One or more viruses were detected in 22, 23, 39 and 40 samples
by viral culture, DIF, in-house PCR and the Pneumovir assay respectively.
The PneumoVir assay detected dual infections in 13 samples and triple
infections in 4 samples and gave concordant results for 19 of 21 viruses
detected by viral culture, 22 of 23 by DIF, and 32 of 39 by in-house
PCR. Discrepancies between PneumoVir and the other assays may reﬂect
sample deterioration prior to the retrospective PneumoVir analysis, or
differences in assay sensitivity and speciﬁcity.
Conclusions: The PneumoVir assay will be useful as a respiratory virus
screen in view of its greater sensitivity than antigen detection and viral
culture, and its greater multiplexing capacity than real-time PCR. The
ability to detect multiple infections may enhance our understanding of
the pathogenesis of respiratory tract infection.
P1597 Prospective evaluation of rapid antigen tests for diagnosis
of respiratory syncytial virus and human metapneumovirus
infections
J. Aslanzadeh, X. Zheng, H. Li, J. Ratkiewicz, S. Meng, P. Hamilton,
Y.W. Tang (Hartford, Chicago, Nashville, US)
Objectives: Respiratory syncytial virus (RSV) and human metapneu-
movirus (hMPV) are two important viral pathogens causing respiratory
tract infections in paediatric population. The use of rapid antigen
detection tests allows for the prompt isolation and treatment of infected
patients.
Methods: In a prospective study, using PCR as the "gold standard",
we evaluated four rapid antigen tests including an EIA test for RSV
(Directigen EZ RSV, Becton Dickinson, Sparks MD), a DFA test
for RSV (Bartels, Trinity Biotech Carlsbad, CA) and two DFA tests
for hMPV manufactured by DHI (Diagnostic Hybrids Inc. Athens
OH) and Imagen (Oxoid, UK). We performed the 4 tests on 515
consecutive nasopharyngeal aspirates, which had adequate volumes and
cells, submitted to the Clinical Microbiology Laboratory at Hartford
Hospital from November 1, 2006 to April 21, 2007. Total nucleic
acid was extracted by an easyMAG (bioMerieux) from each sample
and was subjected to two user developed real-time TaqMan RT-PCR
ampliﬁcations for RSV and hMPV.
Results: The TaqMan assays detected 238 (46%) RSV and 32 (6.2%)
hMPV among all the submitted specimens. The rapid RSV EIA antigen
assay was positive for 219 specimens, giving a sensitivity of 79.8%
and a speciﬁcity of 89.5%. In contrast, RSV DFA was positive for 233
specimens with a sensitivity of 94.1% and a speciﬁcity of 96.8%. The
DHI DFA detected hMPV in 21 specimens, giving a sensitivity of 62.5%
and a speciﬁcity of 99.8%. All inconsistent results between PCR and
antigen assays were conﬁrmed with another RT-PCR directed to a second
target in the RSV or hMPV gemone. The sensitivity, speciﬁcity, positive
and negative predictive value for Imagen DFA for hMPV was 99%,
63.2%, 100% and 100% respectively.
Conclusion: We conclude while RSV EIA is user friendly it lacks
sensitivity and speciﬁcity especially during off peak months. In contrast,
RSV DFA is more sensitive and speciﬁc but is subjective and it
demands technical time and expertise. Similarly, both hMPV DFA are
highly speciﬁc in comparison to RT-PCR, but sensitivity awaits further
improvement.
P1598 Use of a molecular panel in acute viral respiratory infections
C. Minosse, M. Selleri, M.S. Zaniratti, M. Pisciotta, R. Chiappini,
F. Carletti, G. Gualano, N. Bevilacqua, M. Buscaioni, F. Passariello,
R. Giannetti, A. Boschi, M. Giustiniani, S. Pietrini, F. Sciarra,
M.R. Capobianchi, F.N. Lauria (Rome, IT)
Objectives: The aetiology of acute inﬂuenza-like illness (ILI) and of
other respiratory diseases generally is not established, as the diagnosis
is mostly clinical, while laboratory tests for viruses are not diffused
in routine laboratories. We used a molecular panel to detect common
and emerging respiratory viruses in the upper respiratory tract from
patients with ILI referred to our laboratory by general practitioners
during the inﬂuenza season, or attending the respiratory disease clinic
at the National Institute for Infectious Diseases in Rome. The predictive
power and applicability of rapid inﬂuenza tests in the context of ILI was
studied as well.
Methods: During February-April 2006 and 2007, 33 and 42 nasopha-
ryngeal swabs were collected from patients with inﬂuenza-like illness.
Moreover, 25 samples (4 nasopharyngeal swabs, 21 sputum samples)
were obtained from individuals hospitalised for acute respiratory diseases
during the period 30/11/06–11/4/07.
All the samples were analysed by PCR or RT-PCR for the presence
of twelve different viruses (Inﬂuenza A and B, Metapneumovirus,
Adenoviruses, Parainﬂuenza 1, 2 and 3, RSV, Coronaviruses OC43,
229E, NL63 and Rhinovirus). Moreover, nasopharyngeal swabs from
ILI patients were analysed with rapid test for inﬂuenza A and B.
Results: The frequency of positive samples by PCR for at least one virus
was 72.7% in 2006 and 59.5% in 2007; the rate of coinfections, generally
including Rhinovirus, were 21.2% and 9.5%, respectively. By PCR, 11
inﬂuenza infections (33.3%, 9 A and 2 B) in 2006, and 13 in 2007
(30.9%, 9 A and 4 B) were identiﬁed. In 2007, 5 samples (11.9%) were
positive to coronaviruses (3 OC43, 2 NL63), none in 2006. With rapid
tests, only 6/24 (25%) inﬂuenza infections, all type A, were detected.
Concerning the hospitalised patients, all were positive for at least one
virus, 4 (14.8%) presenting coinfection (3 with rhinovirus); 6 inﬂuenza
infections were identiﬁed in 2007 (5 A and 1 B).
On the whole, the most commonly detected viruses were rhinovirus
(44/100 samples, 44.0%), followed by inﬂuenza A (23.0%), generally
H3N2.
Conclusions: Many viruses are frequently detected in respiratory
samples from patients with acute respiratory illness. It is necessary to
evaluate in a larger amount of samples and in distinct clinical contexts the
clinical utility of the extended molecular panels for aetiologic diagnosis
of acute respiratory illness, in order to conﬁrm and/or exclude their viral
aetiology.
P1599 Near-patient diagnosis of inﬂuenza virus infection in adult
patients
C. Steininger, M. Redlberger, W. Graninger, M. Kundi,
T. Popow-Kraupp (Vienna, AT)
Objectives: Rapid and reliable diagnosis of inﬂuenza is essential for
identiﬁcation of contagious patients and effective patient management.
Near-patient assays allow establishing the diagnosis within minutes, but
were evaluated almost exclusively in young children. We evaluated near-
patient assays in relation to the patient’s age.
Methods: 194 patients with laboratory-conﬁrmed inﬂuenza A virus
infection diagnosed within a prospective cohort study were included.
Cryopreserved nasopharyngeal swabs collected from these patients were
tested by four near-patient assays (Binax Now Inﬂuenza A&B, Quick
S-Inﬂu A/B, Inﬂu-A&B Respi-Strip, and Actim Inﬂuenza A&B). Main
outcome measure was sensitivity of near-patient assays in relation to
patient’s age.
Results: The Binax Now, Quick S-Inﬂu, Inﬂu-A&B Respi-Strip, and
Actim assays had an overall sensitivity of 19%, 18%, 26%, and 40%,
respectively. The estimated sensitivity for inﬂuenza A virus detection in
nasopharyngeal swabs was 17%-56% in children one year of age and
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decreased to 8–22% in patients 80 years of age [logistic regression]. The
sensitivity of Inﬂu-A&B Respi-Strip and Actim decreased signiﬁcantly
with increasing age (P = 0.014 and P = 0.033, respectively [logistic
regression]), a trend was observed for Binax Now (P = 0.074 [logistic
regression]), and the low sensitivity of Quick S-Inﬂu was similar in
children and adults.
Conclusions: Less than one-fourth of inﬂuenza A virus infections may
be identiﬁed in elderly patients using a near-patient assay. Consequently,
near-patient assays are of limited value for conﬁrming the clinically
suspect diagnosis of inﬂuenza in adults. Antiviral therapy and additional
diagnostic procedures cannot be withheld on basis of a negative near-
patient test, particularly in adult patients.
P1600 Rapid detection and identiﬁcation of 12 respiratory viruses
by dual priming oligonucleotide system-based multiplex
PCR assay
S.R. Kim, C.S. Ki, N.Y. Lee (Seoul, KR)
Background: Acute respiratory virus infections are among the most
common causes of human disease. Rapid and accurate diagnosis of a
respiratory virus infection is important for providing focused and timely
therapeutic intervention. Recently, a multiplex-PCR assay (Seeplex RV
Detection, Seegene Inc., Seoul, Korea) was developed based on the dual
priming oligonucleotide (DPO) system.
Methods: This study evaluated the Seeplex RV Detection assay for
the simultaneous detection and identiﬁcation of 12 respiratory viruses
including parainﬂuenza viruses 1, 2, and 3, human metapneumovirus,
human coronavirus 229E/NL6 and OC43, adenovirus, inﬂuenza viruses
A and B, human respiratory syncytial viruses A and B, and human
rhinovirus A using two primer mixes.
Results: The limit of detection (LOD) was estimated to be 10
copies/reaction per virus strain, and there was no cross-reactivity with
common bacterial and viral pathogens. A comparison with conventional
viral culture and immunoﬂuorescence (VC/IF) method was carried out
using 101 respiratory specimens from 92 patients. Using the VC/IF
method, ﬁfty-seven specimens (56.4%) showed positive results without
any cases of co-infection. The Seeplex RV Detection assay identiﬁed the
same viral strains in all 57 specimens. Seven out of the 57 specimens
(12.3%) were found to be co-infected with other respiratory viruses, and
19 out of 44 (43.2%) specimens testing negative by VC/IF gave positive
results by the Seeplex RV Detection assay.
Conclusion: Considering the high sensitivity and speciﬁcity, the
Seeplex RV Detection assay might be a signiﬁcant improvement over
conventional methods for the detection of a broad spectrum of respiratory
viruses.
P1601 Interest of a new technique of DNA chips for detection of
respiratory viruses
M. Causse, A. Garcia, J. Gutierrez, M. Casal (Cordoba, ES)
Objective: The aim of this study is to evaluate a multiplex RT-PCR
combined with a new DNA-Chip hybrisation, comparing it to indirect
immunoﬂuorescence for detecting respiratory viruses.
Methods: We used 114 nasopharyngeal washing samples from our
Hospital, each of them corresponding to different patients between
November 2006 and January 2007. They were all between 2 months
and 5 years old.
All the samples were performed: Indirect immunoﬂuorescence (follow-
ing protocol by Bartells©) and DNA Chips (Amersham Biosciences) for
Respiratory Syncitial Virus, Adenovirus, Inﬂuenzavirus A and B and
Parainﬂuenzavirus I, II and III, and Inmunochromatography for RSV
(Binax©, Marnes la Coquette, France).
Those samples which resulted positive by, at least, two techniques, were
considered true positives. The same was considered for true negatives.
Results: See table 1.
Conclusions: DNA chips avoid subjectivity in the interpretation of
Immunoﬂuorescence and are not affected by the tester’s experience,
as results reading is automated (BCS AiM Reader). However, it is a
laborious technique with a higher duration than Immunoﬂuorescence
(about 6 hours vs the 1 and half which takes Immunoﬂuorescence).
We obtained a very similar sensitivity and NPV values with both
techniques close to 95%, but a better statistically signiﬁcant (p< 0.05)
speciﬁty and PPV with DNA-chip.
Table 1.
DNA chip
IFI RSV Inﬂuenza A Inﬂuenza B Negative Total
RSV 45 0 0 6 51
Inf A 0 2 0 0 2
Inf B 0 0 1 0 1
Negative 4 0 1 55 60
Total 49 2 2 61 114
P1602 Role of respiratory synctial virus compared to rhinovirus
in acute respiratory illnesses in childhood
A.M. Lusthusz, J. Stam (Enschede, NL)
Objectives: Acute respiratory illnesses (ARI) are a major cause of hos-
pitalisation in childhood. Common techniques like immunoﬂuoresence
assay (IFA) and viral cultures do not detect all predominant pathogens.
With a recently introduced sensitive technique, the real time polymerase
chain reaction (RT-PCR), a speciﬁc diagnosis can be obtained within
24 hours. The objective of this study was to investigate the role of
the most common respiratory viruses in ARI in childhood that lead to
hospitalisation. Another objective was comparing the sensitivity of both
RT-PCR an IFA in detecting viral pathogens of ARI in childhood.
Methods: Data were collected retrospectively from patients admitted
between September 2006 and March 2007 who were hospitalised
with acute respiratory symptoms at the Medisch Spectrum Twente in
Enschede. Data collected included nasopharyngeal aspirate samples,
clinical symptoms and for some patients biochemical parameters and
X-rays. Virologic diagnosis was made by both RT-PCR and IFA.
Results: Of 149 patients included with ARI, viruses were detected in
80.5%. Most common were respiratory synctial virus (RSV) (42.3%)
and rhinovirus (RV) (19.5%).
The only two signiﬁcant clinical difference between these two major
viral pathogens were a reduced food intake and fever in the RSV-positive
patients. No signiﬁcant differences were found between the RSV and RV
groups regarding age, needed oxygen-therapy, length of hospital stay,
the presence of inﬁltrates on chest X-rays, biochemical parameters and
administration of antibiotics.
In 8 patients (14.8%) with a RSV, the IFA was false negative.
Frequency Percent
Rhinovirus 29 19.5
Human metapneumovirus 11 7.4
Respiratory syncytial virus 63 42.3
Adenovirus 2 1.3
Inﬂuenza virus A 6 4.0
Parainﬂuenzavirus 3 5 3.4
Parainﬂuenzavirus 2/4 2 1.3
Parainﬂuenzavirus 1 2 1.3
Negative 29 19.5
Total 149 100.0
Conclusion: Rhinovirus was the second most common virus after RSV
in hospitalised infants. Except for food intake and fever, both viruses
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showed the same clinical pattern. So although RSV is considered to be
the most virulent viral pathogen in childhood, RV has the same virulence.
The real time RT-PCR showed to be a more sensitive than the IFA
technique to detect RSV infections.
P1603 Molecular epidemiology and disease severity of respiratory
syncytial virus in relation to other potential pathogens in
children hospitalised with acute respiratory infection in
Jordan
N.M. Kaplan, W. Dove, S.A. Abd-Eldayem, A.F. Abu-Zeid,
H.E. Shamoon, C.A. Hart (Amman, JO; Liverpool, UK)
Objectives: To examine the molecular epidemiology of human
respiratory syncytial virus (HRSV) in Jordan. To compare the disease
severity of HRSV subgroups A and B and their associated genotypes
in hospitalised Jordanian children with other potential respiratory
pathogens.
Methods: Between December 2003 and May 2004, a total of 326
Jordanian children younger than 5 years of age and hospitalised with
acute respiratory tract infections were recruited to the study. Total RNA
and DNA were extracted from the collected nasopharyngeal aspirates.
HRSV was detected by reverse transcription polymerase chain reaction
(RT-PCR) using speciﬁc primers that target the nucleocapsid gene to
produce a 278-bp amplicons. HRSV-positive strains were classiﬁed
into subgroup A and B by restriction fragment length polymorphism
analysis. Other respiratory pathogens were detected by RT-PCR and PCR
according to previously published protocols.
Results: A total of 254 patients had at least one potential pathogen
detected and 106 had mixed infections. 67 out of 140 HRSV-positive
patients were co-infected. Signiﬁcantly (p< 0.0005), more HRSV-
infected children had severe disease compared to those uninfected with
HRSV. Severe HRSV infections were signiﬁcantly more likely to occur
in those under 6 months of age (p< 0.01). There was no signiﬁcant
difference between the individual HRSV genotypes as potential causes
of severe respiratory tract disease.
Conclusion: HRSV was the most frequent cause of severe acute
respiratory infection in young children in Jordan. HRSV subgroup A
was more predominant than subgroup B. Only four of the six previously
described N genotypes were found among HRSV strains. Further studies
over longer periods of time are warranted to better determine the
epidemiology and disease severity of HRSV in Jordan.
P1604 Characterisation of viruses causing human respiratory
infections via genomic identiﬁcation for in vitro diagnosis.
Clinical arrays/Clart PneumoVir
A. Aleman, M.A. Marcos, M.J. Pena, P. Muir, B. Vipond, A. Macias,
M.L. Villahermosa (Madrid, Barcelona, ES; Bristol, UK; Las
Palmas, ES)
Acute respiratory infections are among the most frequent diseases in
our area, and they are one of the main reasons for consultation and
hospitalisation. Due to a great variety of possible pathogenic agents and
the high frequency of co-infections, it is necessary to use diagnostic
methods that allow multiple, sensitive, and rapid identiﬁcation of these
viruses.
Objective: To evaluate the capacity of CLINICAL ARRAYS/
CLART®PneumoVir (CA-PV) for simultaneous detection of the 18 most
frequent types of human viruses causing respiratory infections:inﬂuenza
A H1-N1 virus (Flu-A, H1-N1), Flu A H3-N2, Flu-B, Flu-C, parain-
ﬂuenza virus 1 (PIV-1), PIV-2, PIV-3, PIV-4A, PIV-4B, respiratory
syncytial virus type A (RSV-A), RSV-B, human metapneumovirus A
(hMPV-A), hMPV-B, rhinovirus, enterovirus, coronavirus, adenovirus,
and bocavirus. Several Hospitals from Spain and UK have taken part in
this multicentre study.
Method: Virus detection is performed via multiplex RT-PCR for
ampliﬁcation, and a new technology platform based on low-density
micro-arrays (ArrayTube) for visualisation. This technology allows
simultaneous detection of viruses and any necessary control in order
to guarantee the reliability of the results obtained. In order to determine
the diagnostic parameters of the kit, a comparative evaluation of
CA-PV against clinical diagnostic’s current methods (nested-multiplex
PCR/agarose gel, culture) was made. A total of 374 clinical specimens
were tested, being a true positive result judged according to the
concordance between both methods. All the discrepancies were validated
with sequencing, and homemade nested-PCR.
Results: 100% analytical sensitivity was obtained in the detection of 14
recombinant plasmids between 10 and 1000 copies. It was observed that
there were no cases of unspeciﬁc detection of viruses obtaining 100%
analytical speciﬁcity. About the diagnostic sensitivity and speciﬁcity, the
behaviour of each virus after the validation of 374 clinical specimens
showed that most of virus has sensitivity higher than 90%, and speciﬁcity
higher than 98%.
Conclusion: CA-PV is useful in the clinical setting for rapid screening
and detection of a panel of respiratory viral pathogens based on the
following facts: (i) excellent speciﬁcities and sensitivities; (ii) rapid
and automatic procedure; (iii) simultaneous detection allowing the
recognition of co-infections, (iv) hMPV-A, hMPV-B, Flu-A H1N1,
Flu-A H3N2, PIV-4A, and PIV-4B subtypes can be differentially
detected.
P1605 Epidemiology of respiratory virus infections using xTAG
RVP test
J. Mahony, S. Chong, M. Smieja, A. Petrich, S. Buracond, J. Babwah
(Hamilton, CA)
Background: With the discovery of ﬁve new respiratory viruses since
the year 2000 and advances in molecular technology allowing the
detection of 20 respiratory viruses in a single test, we studied the
epidemiology of respiratory virus infections.
Methods: A total of 1,060 nasopharyngeal specimens were collected
from symptomatic patients and used in the study. Approximately 100
specimens per month, 50 paediatric (<20 yr) and 50 adult (>20 yr), were
selected by randomised stratiﬁed sampling from specimens submitted to
the Regional Virology Laboratory from November 2005 to October 2006.
One half of the specimens were from paediatric patients (N=526) and one
half were from adults (N=534). Total nucleic acid (DNA and RNA) was
extracted using the MiniMag extractor (Biomerieux) and an aliquot was
tested by the xTAG RVP Test from Luminex Molecular Diagnostics. The
RVP assay is a multiplex PCR coupled to a ﬂuid microarray that detects
and identiﬁes 20 respiratory virus types and subtypes representing
95% of all known respiratory viruses. A second aliquot was tested for
Bocavirus using a separate PCR. Clinical information was collected by
chart review. Results were analysed by month and by age group.
Results: Of the 1060 specimens tested, 424 (40%) were positive for one
of 16 respiratory viruses including: 205 (19.3%) Rhino/Enterovirus, 58
(5.5%) Inﬂuenza type A or B, 45 (4.1%) Parainﬂuenza (types 1−4), 41
(3.9%) RSV (type A or B), 41 (3.9%) Metapneumovirus, 39 (39/947,
4.1%) Bocavirus, 20 Adenovirus, 14 Coronavirus (OC43, HKU1, NL63).
Twenty ﬁve of 39 Bocavirus infections were dual infections. Only
Rhino/Entero, RSV and Bocavirus were more prevalent in the <20 age
group (p< 0.05). Inﬂuenza, Metapneumovirus and Coronavirus were
only present in winter/spring months while Parainﬂuenza type 4 was
only present in summer months; all others were distributed across most
months. In January 2006, 10 viruses co-circulated in the community.
Conclusion: This study indicated the following: 1) Rhino/Enterovirus
was the most prevalent virus infection of symptomatic children and
adults, 2) only RSV, Rhino/Enteroviurs, and Bocavirus showed higher
infection rates in children compared to adults, 3) 90% of dual infections
(mostly Boca and Rhino/Enterovirus) occured in children summer, and
4) Inﬂuenza, Metapneumovirus and Coronavirus displayed a winter
seasonality. The average rate of positives diagnosed per month for <20
yr group was 63% compared to 23% for adults.
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P1606 Bocavirus in hospitalised children in Italy
A. Pierangeli, C. Scagnolari, S. Trombetti, R. Grossi, M. Battaglia,
F. Midulla, G. Antonelli (Rome, IT)
Objectives: Human bocavirus (HBoV), a novel respiratory agent
identiﬁed in 2005, is now detected worldwide in paediatric as well
as adult populations. However, in the absence of viral isolation and
serological evidences and due to high percentages of co-infection with
other respiratory viruses, its actual role in respiratory diseases is not yet
clearly deﬁned.
A molecular approach was undertaken to detect HBoV and nearly all
known respiratory viruses, in archival and freshly collected respiratory
samples from hospitalised children. In addition, HBoV was investigated
in sera and convalescent samples from hospitalised children and in nasal
washings from children affected by non-respiratory condition.
Methods: During November 2004 to May 2007, nasal washings from
415 children hospitalised with acute respiratory infection (ARI) and
from 21 children hospitalised for non-respiratory illness were tested
for the presence of an extensive range of respiratory viruses with
molecular methods. Reverse transcription-PCR or PCR assays, followed
by sequencing of the ampliﬁed fragments were undertaken to detect
fourteen respiratory viruses: inﬂuenza A and B, respiratory syncytial
virus (RSV), coronavirus OC43 and 229E, adenovirus, rhinovirus,
parainﬂuenza viruses 1−3, human metapneumovirus, coronavirus NL63
and HKU1, HBoV. HBoV positive samples were subjected to Real Time
PCR determination of HBoV speciﬁc viral load in nasal washings.
Results: Viral pathogens were detected in 214/415 cases (51.6%): RSV
and rhinovirus positive samples were respectively 29.2% and 9.6% of
cases. HBoV was the third most frequent agent (8.2%); 21/34 cases
(61.8%) were in co-infection with another virus, mainly RSV. Children
with HBoV as the sole pathogen presented pneumonia or bronchiolitis.
Coinfection HBoV-RSV does not seem to worsen bronchiolitis (gravity
score calculated as reported in Wainwright et al. N. Engl. J. Med. 2003).
HBoV DNA copies in nasal washings were measured to correlate viral
load with disease severity.
Interestingly, two children hospitalised for non-respiratory illness have
been found positive to HBoV: one had gastro enteric symptoms and the
other a clinical diagnosis of exanthema subitum.
Conclusion: This study is a conﬁrming report of HBoV as a frequently
detected respiratory agent and of its association with clinically important
illnesses. HBoV high prevalence in young children does not seem to be
due to persistence in individuals, but to its great circulation.
P1607 Prevalence of respiratory pathogens in children hospitalised
with lower respiratory tract infection in Greece
A. Papa, M. Goutaki, I. Matsini, E. Papadimitriou, L. Damianidou,
M. Eboriadou, K. Haidopoulou (Thessaloniki, GR)
Objectives: Aim of the present study was to determine the prevalence of
respiratory pathogens, including recently recognised viruses, in children
hospitalised with lower respiratory tract infection (LRTI).
Methods: During September 2006 to August 2007, nasopharyngeal swab
samples were collected from 375 previously healthy children, aged 14
days to 14 years old, admitted to paediatric wards of two hospitals
in Greece, because of acute laryngotracheobronchitis, bronchiolitis,
bronchitis or pneumonia. Genetic material was extracted and PCRs
were performed for detection of Mycoplasma pneumoniae, respiratory
syncytial virus (RSV), human metapneumovirus(hMPV), inﬂuenza
viruses, adenoviruses, coronaviruses (HCoVs), human bocavirus (HBoV)
and mimivirus.
Results: At least one aetiologic agent was detected in 37.06% of cases.
Current infection due to M. pneumoniae was diagnosed in 11 (2.93%)
children, aged 4 to13 years (with an exception of a 6 months old infant),
presented mainly with bronchopneumonia or lobar pneumonia. RSV was
detected in 61 (16.27%) children, aged 18 days to 3.5 years, while
hMPV was detected in 4 (1.07%) children, aged 1.5 months to 1.5
years, most of them with acute bronchiolitis. Adenoviruses were detected
in 26 (6.93%) children, aged 2 months to 7 years admitted for acute
bronchiolitis or pneumonia. HBoV was detected in 13 (3.47%) children
aged 2 months to 5 years with acute bronchiolitis, bronchopneumonia
or laryngotracheobronchitis. Inﬂuenza viruses were detected in 10
(2.67%) children, aged 14 days to 6 years with bronchopneumonia and
bronchiolitis. Coronaviruses were detected in 4 (1.07%) children, aged
2.5 months to 5 years. Mimivirus was not detected in any of the samples
tested. Dual infections were identiﬁed in 10 (2.67%) children while one
triple infection was also present.
Conclusions: Atypical pathogens and respiratory viruses are responsible
for a large number of LRTI cases in children. RSV was the most common
cause of viral lower respiratory tract infection while M. pneumoniae was
a frequent cause of LRTI in children older than 5 years old, mainly
presenting with pneumonia not associated with wheezing. Clinical
characteristics of patients diagnosed with M. pneumoniae, RSV and
adenovirus infection are relatively distinct. HBoV, a potential causative
agent of LRTI, was frequently detected in preschool children with acute
bronchiolitis or bronchopneumonia.
P1608 Antiviral effect of a novel inhibitor of inﬂuenza virus
haemagglutinin on inﬂuenza A (H5N1) virus
S. Rak, E. Goncharova, A. Chinarev, A. Tuzikov, N. Bovin, A. Ryzhikov
(Koltsovo, Moscow, RU)
Background: The initial step of inﬂuenza virus infection is the
attachment of the viral glycoprotein hemagglutinin to sialic acid-
containing receptors of the host cells. Human and avian inﬂuenza
A viruses differ in their recognition of host cell receptors: the
former preferentially recognise receptors with saccharides terminating
in Sia2−6Gal, whereas the latter prefer those ending in Sia2−3Gal.
An attractive approach for the prevention of avian inﬂuenza infection
involves inhibition of virus attachment to susceptible cells by synthetic
analogs of cellular receptors on the basis of Sia2−3Gal. The goal of this
investigation was to study the antiviral effect of a novel low-molecular
polyvalent hemagglutinin inhibitor, containing Sia2−3Gal disaccharide
motifs, on avian inﬂuenza A virus.
Methods: Low-molecular polyvalent sialoside was studied as viral
hemagglutinin inhibitor of avian inﬂuenza A (H5N1, H5N2, H5N3) virus
strains in the inhibition assays of virus binding with fetuin molecules
(FBI) and infectious focus forming in MDCK cells. To investigate
the protective effect of hemagglutinin inhibitor in an animal model,
we have infected mice with highly pathogenic inﬂuenza virus strain
A/Chicken/Suzdalka/2005 (H5N1), isolated from poultry and wild birds
in Western Siberia. To study the development of viral resistance to novel
inhibitor we have conducted serial inﬂuenza virus passages in MDCK
cells in the presence of increasing concentrations of hemagglutinin
inhibitor.
Results: The values of 50% inhibiting concentration (IC50) of
hemagglutinin inhibitor obtained in MDCK cells and in FBI assay ranged
from 1.5 to 10.0 microM for different inﬂuenza A virus strains. Intranasal
administration of inhibitor (1.5mg/kg) led to 90.5 (±5.2)% reduction
of virus burden in the lungs of mice infected with highly pathogenic
avian strain A/Chicken/Suzdalka/2005 (H5N1). The results of passaging
experiments indicated that hemagglutinin inhibitor showed no tendency
to induce viral resistance.
Conclusion: The data obtained in vitro and in vivo suggest that novel
low-molecular polyvalent hemagglutinin inhibitor may be useful for the
treatment of avian inﬂuenza virus infection.
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P1609 A case of oto-mastoiditis caused by MRSA of porcine origin
A. Piette, H. Van Hoecke, E. De Leenheer, G. Claeys, I. Dhooge,
M. Struelens, G. Verschraegen (Ghent, Brussels, BE)
Objectives: We report a case of a chronic oto-mastoiditis caused by a
community-acquired meticillin resistant S. aureus (MRSA) in a Belgian
woman living on a pig farm.
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Methods: Samples from middle ear effusion and mastoid tissue were
cultured following routine methods. Swabs taken from the throat, nose
and perineum of the patient and from the nares of 13 pigs were
cultured on a MRSA ID (Biomerieux) agar to detect MRSA. Four
MRSA strains were send to the reference laboratory (Struelens, ULB,
hospital Erasme) for detection of Panton Valentine leucocidin (PVL)
and for characterisation by pulsed ﬁeld gel electrophoresis (PFGE) and
staphylococcal protein A (spa) typing.
Results: A 64-year old woman presented an oto-mastoiditis of the right
ear with bone destruction at the roof of the middle ear cavity with
concomitant cerebrospinal ﬂuid leakage. Culture of middle ear effusion
revealed MRSA. As the patient was living on a pig farm and several
authors reported a link between the occurrence of MRSA in pigs and
pathology in humans, samples of pigs were taken. Ten of 13 pig nares
cultures and the patient’s throat sample were MRSA positive. Four
MRSA strains (3 pig origin, 1 patient origin) were send to the reference
lab. They were PVL negative, non-typeable by PFGE and belonging to
spa type t011, a type frequently isolated from pigs and pig farmers.
Conclusion: This case report describes a case of a severe complication
of otitis media, caused by a community acquired, animal related MRSA
strain.
P1610 Epidemiology of Fusobacterium necrophorum in university
students
J. Howard, H. Ludlam, B. Kingston, L. Donachie, J. Foulkes,
M. Curran, S. Guha (London, Cambridge, UK)
Objectives: Fusobacterium necrophorum (FN) is the cause of Lemierre’s
disease, a life-threatening septicaemia preceded by an acute sore throat.
The epidemiology of infection with this pathogen is unknown. We sought
to clarify this by, examining throat swabs from, and questioning, 411
healthy university students; we also examined throat swabs from 103
patients who presented to local General Practitioners (GPs) with sore
throat.
Methods: Throat swabs were collected between December 2005 and
January 2006 and tested for FN and Epstein Barr Virus (EBV)
DNA by Polymerase Chain Reaction, and cultured for beta-haemolytic
streptococci (BHS).
Students were asked their age, gender, subject studied, occurrence of
sore throat in the previous two weeks, episodes of sore throat over the
previous six months, recent antibiotic treatment, smoking status, number
of household members, number of people who shared their room at night,
kissing (lip to lip) contacts in the past four weeks, frequency of contact
with animals and animal type. Chi-squared and Fisher’s exact tests
using StatsDirect software were carried out to determine whether there
were signiﬁcant differences in frequencies between the Fusobacterium-
positive and negative groups. Students who were positive for EBV or
BHS were excluded from the epidemiological analysis of risk factors.
Results: Overall, 43/411 (10.5%) of the students were positive for FN,
and these students were signiﬁcantly more likely to have had 1 or more
lip to lip kissing contacts in the previous 4 weeks than those who
were negative (OR 3.22 [1.10−9.46]). None of the other variables were
statistically signiﬁcant in the univariate analysis. The number of FN-
positive individuals was signiﬁcantly higher in GP population who had
a sore throat (20/103, 19.4%) than in the student population who had not
had a sore throat in the preceding two weeks (29/304, 9.5%), OR 2.29
(1.23−4.25) p = 0.01. There was an association with carriage of FN with
EBV and BHS for both students (OR 2.99 [1.39−6.40] and GP patients
(OR 3.15 [1.15−8.65])
Conclusion: Although we have previously failed to ﬁnd the organism
in older subjects, our ﬁndings indicate that throat carriage in healthy
university students is common and related to lifestyle, being transmitted
by intimate human physical contact. Our ﬁndings also support the
hypothesis that Fusobacterium necrophorum is a more important cause
of community-acquired sore throat than has hitherto been appreciated.
P1611 Fusobacterium necrophorum from sore throats and healthy
controls
A. Jensen, B. Sørensen, L. Hagelskjær Kristensen, J. Prag (Viborg, DK)
Background and Objectives: Recently several publications have
shown an association between clinical tonsillitis and Fusobacterium
necrophorum. The objective of the study was to identify F. necrophorum
by culture and Real-time PCR in throat swabs from patients with
pharyngotonsillitis and healthy controls.
Methods: The isolation rate in 50 healthy military recruits aged 18 to
24 were compared with the rate in 70 randomly picked patients aged 16
to 30 years old from general practitioners with sore throats by using a
selective anaerobic agar plate with, 5.0mg/l nalidixic acid and 2.5mg/l
vancomycin and analysed by a species speciﬁc real-time PCR assay.
All 1643 swabs sent to our laboratory in 2006 were examined for the
presence of F. necrophorum using the same selective plate.
Results: F. necrophorum was found in 7 healthy controls and in 16
patients, p> 0.05, by culture and by PCR in 14 controls and 35, p = 0.03.
The mean Ct-value of PCR positive samples were signiﬁcantly lower,
p = 0.02, in patients, 27 cycles compared to 31 cycles in controls.
During 12 month F. necrophorum was isolated from 146 throat swabs,
giving an isolation rate of 9%. The highest isolation rate, 20%, was
found in the patients aged 16 to 20 years, while only a few were found
in children less than 10 years old and in adults older than 40 years old
(<5%). A tendency towards a greater, but non-signiﬁcant isolation rate in
males were 10.4% compared to 7.9% for females, p = 0.08). No variation
in the isolation rate was observed through the year. There was a positive
signiﬁcant correlation between the isolation of F. necrophorum and the
isolation of Group C streptococci (p< 0.0001). Contrary, the rate was
signiﬁcant lower when Group A streptococci was present (p< 0.001).
Conclusion: F. necrophorum is frequently a part of the normal
throat ﬂora. However this study also shows that larger quantities
of F. necrophorum may cause tonsillitis, particularly in adolescents.
However, as F. necrophorum can be present as normal throat ﬂora
the clinical symptoms have to be considered when considering
F. necrophorum as the cause of tonsillitis. In addition, there seems to
be an unexplained synergetic relationship between F. necrophorum and
Group C streptococci.
We suggest that throat swabs from patients with a sore throat old negative
in strep-A test should be examined anaerobically for the presence of
F. necrophorum, particularly in patients 10 to 40 years old. Further
studies are needed.
P1612 Fusobacterium necrophorum in acute severe ear, nose and
throat infections
M. Rusan, T.E. Klug, T. Ovesen (Aarhus, DK)
Objectives: To determine the prevalence of Fusobacterium necrophorum
in acute ear, nose, and throat (ENT) infections requiring hospitalisation,
and to further characterise these infections in terms of age and gender
distributions, associated inﬂammatory marker levels, and the effect of
pre-admission antibiotics on culture results.
Methods: A review was performed of all acute infectious cases admitted
to the ENT department at Aarhus University Hospital, Denmark, between
January 1st, 2001 and December 31st, 2006. Patient age and gender, use
of pre-admission antibiotics and microbiological ﬁndings were recorded.
C-reactive protein levels (CRP), leukocyte counts, and erythrocyte
sedimentation rate (ESR) at admission were also noted.
Results: F. necrophorum (13.6%, 195/1430) and Group A Streptococcus
(13.7%, 196/1430) were the most frequent isolates. F. necrophorum
was primarily isolated from cases of peritonsillar abscess (90.8%,
177/195). It was also found in several cases of tonsillitis, cutaneous neck
abscess, retro- and parapharyngeal abscess. F. necrophorum was less
frequently isolated from patients who received pre-admission antibiotics
compared to those who did not (13.7%, 53/387 versus 17.6%, 129/732).
Of patients that received pre-admission antibiotics, 85.2% (46/54)
received penicillin. All F. necrophorum isolates were susceptible to
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penicillin and metronidazole. The majority of F. necrophorum infections
occurred in patients between the ages of 10 to 29 (82.5%, 160/194).
The ratio of males to females was 1.3:1. Females tended to have
F. necrophorum infections at a younger age than males (female median
age = 18, male median age = 21, p = 0.007). F. necrophorum infections
were associated with a signiﬁcantly higher CRP value than infections
with Staphylococcus aureus (p< 0.001), non-hemolytic streptococcus
(p = 0.037), and Streptococcus pneumoniae (p = 0.006), but not Group
A streptococcus (p= 0.116). This pattern was not noted for leukocyte
counts or ESR, although values were in the upper range.
Conclusions: This study suggests that F. necrophorum is a far
more widespread pathogen in severe acute ENT infections than
previously reported. The age and gender distributions suggest increased
susceptibility to the bacterium in puberty and early adulthood. We
report an elevated CRP value for F. necrophorum infections compared
to infections with other common ENT pathogens, however, the clinical
signiﬁcance of this remains to be elucidated.
P1613 Trends in listeriosis in a university hospital (1983–2007)
C. Davila, N. Prim, M.L. Pedro-Botet, N. Sopena, M. Gime´nez,
J.M. Mo`dol, M. Garcı´a-Nu´n˜ez, S. Roure, M. Sabria (Badalona, ES)
Infection caused by Listeria is acquired by the ingestion of contaminated
food which has increased in recent years due to the frequent use of ready-
made meals. This, together with a longer life expectancy of patients with
chronic diseases and a large number of immunosuppressed patients, are
factors which may explain the apparent increase in the incidence of
listeriosis.
Objectives: To know the risk factors and clinical aspects of infection by
Listeria and evaluate epidemiological changes over time.
Methods: We retrospectively reviewed the cases of listeriosis reported
in the Department of Microbiology from 1983 to 2007. Patients were
arbitrarily classiﬁed into 2 groups: group 1 from 1983 to 1995 and group
2: from 1996 to 2007.
Results: 72 patients (21 group1; 49 group 2) with listeriosis were
included. 56.9% (41/72) were males with a mean age of 53.8 years
(0–87). The mean age rose signiﬁcantly in group 2. 10% (7/70) were
hospital-acquired, being signiﬁcantly greater in group 1.Underlying
diseases were present in 81.9% (59/72), including chronic liver disease
(34.3%), alcoholism (28.6%) and cancer (28.6%) and with a signiﬁcant
increase in heart diseases and cancer and a decrease in HIV patients
in group 2. 30% (21/70) and 28.5% (20/70) were receiving corticoids
and immunosuppressive therapy respectively, with an increase, albeit not
signiﬁcant, in group 2. Previous diarrhoea was reported in 7 cases (10%).
7.4% (5/68) were pregnant women, 83.6% (56/68) presented with sepsis,
44.8% (30/67) had meningoencephalitis and 7.3% (5/) focal infections.
Blood culture was positive in 79.1% (57/72) as was CSF culture in 40.2%
(29/72). Serotype 4 was the most prevalent but a signiﬁcant increase
in serotype 1 was observed in group 2. 20.6% (14/68) required ICU
admission and mortality was 20.9%, with a non signiﬁcant increase in
group 2.
Conclusions: Cases of listeriosis have increased in the last decade due
to a rise in sepsis. At present, chronic liver disease continues to be the
most important risk factor, although an increase in the number of cases
with heart disease and cancer receiving immunosuppressive therapy is
of note. In the last decade, mortality has shown a trend to an increase
and has reached a value of 24%.
P1614 Clinical characteristics of Eikenella corrodens infections: a
10-year experience in a tertiary hospital
N. Herna´ndez, J. Lo´pez-Contreras, B. Mothe, R. Pericas, B. Mirelis,
M. Gurguı´ (Barcelona, ES)
Objectives: Eikenella corrodens is a show-growing, gram-negative
bacillus, difﬁcult to isolate. It is commonly found in oral, gastrointestinal,
respiratory and, more rarely, in genitourinary ﬂora. Head and neck
infections and those related with human bite wounds are the most
frequent sites of Eikenella infections reported in the literature.
Methods: Descriptive retrospective study from January 1996 to February
2006 in a 700 bed tertiary hospital. All in-patients with infections where
Eikenella was isolated from a clinical specimen were analysed.
Age, sex, predisposing factors, main diagnosis, infection site, others
isolated organisms, antibiotic sensitivity, antibiotic therapy and outcome
were recorded.
Results: Thirteen patients were identiﬁed during the study period. Nine
were male (69%), the mean age was 61 years (range: 3 months to 75
years). Predisposing factors were: 3 patients had synthetic materials (1
abdominal-aortic bypass, 1 dura mater implant, 1 intrauterine device). 3
had undergone surgical procedures, 1 patient was an intravenous drug
user and another one was an oncology patient.
Eleven patients (85%) had extra oral infections: 4 surgical site infections,
2 cardiovascular infections, 1 gastrointestinal tract, 2 pneumonia, 1 sepsis
and 1 skin infections.
Four patients had monomicrobial isolates and 9 polymicrobial. In
polymicrobial cases the most frequent isolated pathogens were: 67%
Streptococcus viridans, 11% Pseudomonas, 11% E. coli and others in
33%.
All the Eikenella strains were sensitive to penicillin G, amoxicillin-
clavulanic, cefotaxime and ﬂuoroquinolones. All patients required a
surgical procedure in addition to antibiotic therapy, but in two cases only
drainage was made (canaliculitis and peritonsillar abscess). One patient
received only one antibiotic and twelve 2 or more drugs (6 betalactams,
5 amino glycosides, 3 lyncosamines, 3 nitroimidazoles, 2 glycopeptides,
2 quinolones, 1 tetracyclines). All the patients had a favourable clinical
outcome of the infection. One patient died of an unrelated cause.
Conclusions: In this study extra oral locations were more frequent than
previously reported. In 61% of patients one or more predisposing factors
for this infection were identiﬁed. Most of patients had mixed infections.
Eikenella antibiotic sensitivity was similar to that reported in literature.
69% of cases required surgical procedures in addition to the antibiotic
therapy. Outcomes were favourable in all patients.
P1615 Time changes in microbiology of diabetic foot ulcers in a
diabetes clinic, Athens, Greece
C. Loupa, G. Kouppari, K. Papaefstathiou, H. Papadaki, E. Rotas,
E. Voyatzoglou, D. Voyatzoglou (Athens, GR)
Objectives: Infection of the diabetic foot consists a major cause of
morbidity and amputation in diabetic persons. Aim of this study was
to record the microbiology of diabetic foot ulcers and the susceptibility
of isolates to commonly used antibiotics.
Methods: 4-year (2003–2006) retrospective study of 125 consequent
cultures (75 diabetic persons with foot ulcers, Diabetes Outpatient Clinic
and/or Internal Medicine wards).
Results: 88/125 cultures (70.4%) were polymicrobial (2−6 iso-
lates/culture), 36 monomicrobial and 1 sterile (median: 2 iso-
lates/culture). Most common microorganisms isolated were coagulase (−)
staphylococcus (CNS, 42.4% of cultures), Enterococcus spp. (34.8%),
Pseudomonas spp. (33.6%), S. aureus (32.8%), Proteus spp. (12.8%).
Aerobic Gram(+) bacteria were isolated in 84.8% of cultures, while
aerobic Gram(−) in 63.2% and anaerobes in 8.8%. In an older study
of ours (1992–1996), Gram(+) and Gram(−) aerobes were isolated in
65% and 80%, respectively. Meticillin-resistant were 31.7% of S. aureus
and 75.2% of CNS isolates, while 1/43 Enterococcus isolate was VRE.
16.8% of Pseudomonas isolates were imipenem resistant. In our older
study, 50% of Staphylococcus isolates were meticillin-resistant and 23%
of Pseudomonas isolates were imipenem-resistant.
Conclusions: (1) Cultures were mostly polymicrobial. (2) Gram(+)
cocci were more common than Gram(−) rods, contrary to our previous
ﬁndings 10 years ago. (3) Staphylococci and enterococci were the
most common isolates among Gram(+) and Pseudomonas spp. among
Gram(−) bacteria.
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P1616 Biodiversity of UTI pathogens in diabetics
M. Saleem (Bangalore, IN)
Introduction: Urinary tract infection (UTI) is a signiﬁcant health
problem affecting people worldwide. Women are especially prone to
UTI for reasons which are poorly understood, common factor known
is the shortness of urethra which contributes to the easy passage of
uropathogens into the bladder. Any abnormality in the urinary tract that
obstructs the ﬂow of the urine sets a stage for infection.
Diabetic patients have a higher risk of acquiring UTI because of the
changes in the immune system. Any disorder that suppresses the immune
system like diabetes raises a risk of UTI.Some of them are potentially
lethal like mucormycosis which never affects people without diabetes.
Urinary tract is also a cause of bactraemia among patients with diabetes,
it has been established that uropathogens like E. coli grow better in urine
after the addition of glucose in various levels. Many people with diabetes
have dysfunctional bladders which contract poorly & hence allows the
urine to remain stagnant for longer periods thus providing luxorious
ponds for bacteria to grow in.
The current study is based on:
– The incidence of UTI in diabetic patients.
– To detect most prevalent strains of uropathogens.
– To develop link between diabetes and lower socio economic group.
– Risk factors associated with UTI in diabetic patients.
– Screening of MDR strains.
Methods: The prospective study involved collection of urine samples
from diabetic patients belonging to higher & lower socioeconomic group.
Urinalysis and culturing methods were followed to isolate uropathogens
from the samples collected. Conﬁrmation of possible UTI was achieved
through viable colony counts in CFU/ml of the specimen.
Analysis of C-Reactive protein was performed in patients with diabetes,
without diabetes, and in patients with diabetes but no UTI.
Clinically signiﬁcant uropathogens were checked for resistance hence
isolation of some MDR strains was established.
Isolation of plasmids was performed in these strains to detect speciﬁc
mutations associated with diabetes induced UTI.
Experiments were also carried out for the estimation of iron in diabetic
blood samples so as to corelate the association of these factors with UTI.
Results: 500 patients were evaluated for the study, and the results
indicated 46.4% people had diabetes. Enterococcus faecalis 25%,
Pseudomonas aeruginosa 15.94%, E. coli 7.4%, Klebsiella 3% &
Staphylococcus 10.34% were found to be frequently encountered UTI
pathogens.
Conclusion: Prevalence of UTI is higher in diabetic patients.
P1617 Shigella/enteroinvasive E. coli infections in the county of
Frederiksborg, Denmark
B. Olesen, D.S. Hansen, B.G. Bruun (Hillerød, DK)
Objectives: To describe epidemiological and microbiological character-
istics of Shigella/Enteroinvasive E. coli (EIEC) infections over a ﬁve-year
period in a Danish county from 2003 to 2007.
Methods: Stools from patients with gastroenteritis in Frederiksborg
county with 370,000 inhabitants comprising 7% of the Danish population
were examined for enteropathogenic bacteria, including Shigella spp.
and EIEC. Examinations were done at the National Reference Center at
Statens Serum Institut, Copenhagen, in 2003 and until April 1, 2004.
From that date until the present the cultures were examined by the local
microbiology laboratory at Hillerød Hospital. From September 1, 2006,
culturing was supplemented by a LightCycler real time PCR of virulence
genes of diarrhoeagenic E. coli including ipah, characteristic for both
Shigella spp. and EIEC. Detection of production of extended-spectrum
b-lactamases (ESBL) and production of AmpC b-lactamase was done by
a combined disk method.
Results: The number of EIEC infections varied between 0 and 10
annually, while the number of Shigella/EIEC infections ﬂuctuated
between 15 and >60. The percentage of Shigella/EIEC infections
diagnosed in our county compared to the whole country increased
gradually from 8% in 2003 to approximately 16% in 2007. Shigella
spp. comprised mainly Shigella sonnei. The high number of infections
in 2007 was mainly due to a national outbreak with S. sonnei in August,
2007, where the source was determined by Statens Serum Institute’s
national surveillance team to be imported baby corn from Thailand. The
outbreak included one case of bacteraemia. The epidemic strain was
sensitive to ciproﬂoxacin and mecillinam, but resistant to ampicillin,
trimetoprim, sulphonamides and cefuroxime. The strain produced AmpC,
but not ESBLs.
Conclusions: Gastroenteritis with Shigella spp. usually occurs sporad-
ically in our part of Denmark. An exception was an outbreak with
S. sonnei in 2007 which was unusual because the epidemic strain
produced AmpC and because one patient was found with bacteraemia.
The increasing number of Shigella/EIEC infections compared to the
rest of Denmark could be due to the extensive traveling done by the
inhabitants of our county and/or the use of a sensitive diagnostic method.
P1618 Aeromonas infection: clinical observations and laboratory
characteristics of an 82-case French study
B. Lamy, A. Kodjo, F. Laurent (Sete, Marcy l’Etoile, Lyon, FR)
Objectives: to describe characteristics of current human Aeromonosis
in a European country (France).
Methods: A 6-month period prospective study was conducted among a
70-French nonteaching hospital network (may-october 2006). In case
of Aeromonas isolation from biological samples, clinical data and
laboratory ﬁndings were recorded and strain(s) collected for partial
rpoB gene sequence based identiﬁcation and antimicrobial susceptibility
testing (disk diffusion testing).
Results: 99 patients were included, of whom 82 were infected (median
age: 56 years, sex ratio: 1.6) and diseases were distributed as follows:
wound infections (43%), bacteraemia (24%), gastroenteritis (19%),
respiratory disease (7%), peritonitis (4%), ocular infection (1%) and
urinary tract infection (1%). Underlying conditions were found in
35% (malignancy: 55%, diabete mellitus: 20%, hepatobiliary diseases:
14%), wounds in 36% and an environmental exposition in 44%, mainly
clustered in the wound infection group, with telluric-related illnesses
being as prevalent as water-related illnesses. Variations in data according
to the type of infection were noted.
Among 76 strains analysed, species were distributed as follows:
Aeromonas veronii (29), A. hydrophila (26), A. caviae (17), A jandei
(2), A. allosaccharophila (1), A. bivalvium (1). Distribution varied greatly
with the type of infection.
Proportion of susceptible strains were: amoxicillin 3%, co-amoxiclav
18%, cefalotin 47%, imipenem 67%, cefotaxim 96%, nalidixic acid 86%,
oﬂoxacin 91%, tobramycin 80%, gentamicin 100% and tetracyclin 89%.
Rates differed markedly between species. Two strains were found to bear
extended spectrum betalactamase (ESBL) resistance.
Conclusion: this prospective study gives detailed and updated infor-
mation on Aeromonas infection diseases and their management. As
a matter of fact, the most prevalent infection is currently wound
infections, followed by bacteraemia, enteritis and emerging respiratory
tract infections.
P1619 The changes of neutrophil activation markers (CD11A,
CD11B, CD62L, CD66B), serum neutrophil elastase levels
after the operation period, and its relationship with
pre-operative metabolic control parameters in type 2
diabetic patients
F. Demirel, C. Top, O. Oncul, B. Karago¨z (Istanbul, TR)
Aims and Background: The aim of this study was to evaluate the
changes of neutrophil activation markers (CD11A, CD11B, CD62L,
CD66B), serum neutrophil elastase levels after the operation period, and
its relationship with pre-operative metabolic control parameters in type
2 diabetic patients.
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Materials and Methods: Twenty-ﬁve type 2 diabetic patients (aged
60.2 ±12.4 years, BMI: 29.5±5.1 kg/m2) and 14 non-diabetic healthy
controls (aged 51.4 ±16.8 years, BMI: 25.7±5.4 kg/m2) were enrolled
in the study. Serum neutrophil elastase levels was determined by ELISA
method. The neutrophil integrin expression assay were performed by
ﬂow-cytometry as a unit of relative ﬂuorescence intensity (RFI). Samples
were analysed on a FACSCalibur ﬂow cytometer (Becton Dickinson).
The data was analysed using CellQuest software (BD Biosciences).
Results: The study results showed that there were statistically signiﬁcant
difference between study patients (type 2 diabetic patients) and
control subjects in accordance to preoperative CD11a expression (RFI)
(17.3±2.9l vs 19.8 ± 3.6, p< 0.05), preoperative CD11b expression
(RFI) (24.9±7.9 vs 34.2 ± 5.9, p< 0.01). There were no statistically
signiﬁcant difference between study patients (type 2 diabetic patients)
and control subjects in accordance to preoperative CD62L expression
(RFI) (27.8±5.8 vs 31.3±9.5, p> 0.05), preoperative CD66b expression
(RFI) (4.5±1.5 vs 4.4 ± 1.1, p> 0.05), preoperative serum neutrophil
elastase levels (ng/ml) (0.4±0.3 vs 0.4±0.2, p> 0.05). There were
statistically signiﬁcant difference between pre and post operative period
CD11a, CD11b, CD66b expression, serum neutrophil elastase levels
in type 2 diabetic patients. The correlation analyses (Pearson) have
shown that in diabetic subjects, there was a statistically signiﬁcant
correlation between preopCD11a expression and preopCD11b expression
(r = 0.55, p< 0.01), preopCD11a expression and preopCD62L expression
(r = 0.51, p< 0.01), preCD11b expression and preNE level (r = −0.41,
p< 0.05), postopCD11a expression and postopCD11b expression
(r = 0.42, p< 0.05), postCD11b expression and postCD66b expression
(r = 0.55, p< 0.01), postCD62L expression and postNE level (r = 0.43,
p< 0.05).
Conclusion: These results have shown that there may be a relationship
between neutrophil activation and postoperative diabetic complications.
This relationship may be important for developing infectious and other
related complications at postoperative period in type 2 diabetic patients
P1620 Demographic, clinical and laboratory data in 232 typhoid
fever cases
A. Emami Naeini, H. Salehi, M. Rostami, S. Emami Naeini (Isfahan, IR)
Objective: It is estimated that ~21,650,000 episodes of typhoid fever
and 216,500 deaths due to the disease occurred in areas of endemicity
in 2000. The risk of acquiring typhoid fever is increased among travelers
to regions where the disease is endemic. 90% of cases occur each year in
Asia. In this study we review clinical and laboratory aspects of typhoid
fever admitting in a teaching hospital in a nine years period.
Methods: This is a retrospective descriptive study performed upon
patients with deﬁnite diagnosis of typhoid fever (positive blood or bone
marrow culture for S. typhi) in St. Zahra Hospital, Isfahan (centre of Iran)
during 1997 till 2006. The subjects were comprised 232 patients [170
(73.3%) males and 62(26.7%) females aged 1–40 years. The data were
achieved from medical records and analysed by using SSPS software.
Results: Upon this study, 170 (73.3%) were males and 62 (26.7%)
females and among them 141 (60.75%) were aged between 10–30
years. Clinical signs and symptoms: fever 228 (98.2%), headaches 170
(73.2%), nausea and vomiting 117 (33.6%), abdominal pain 101 (43.5%),
diarrhoea 101 (43.5%), constipation 97 (41.8%), myalgia 64 (27.5%)
sore throat 48 (20.6%), dizziness 36 (15.5%), epistaxis 17 (7.3%),
psychic symptoms 11 (4.7%), hematochezia 7 (3.01%), convulsion 2
(0.8%), splenomegaly 103 (44.3%), rose spots 52 (22.4%), abdominal
tenderness and crepitation 4 (1.8%), hepatomegaly 32 (13.7%), cervical
lymphadenopathy 25 (10.7%) pulmonary rales 19 (8.1%) relative
bradycardia 12 (5.1%), meningeal irritation 3 (1.2%). Para clinical
data: positive widal test 158 (68.1%), anaemia 156 (67.2%), leucopenia
111 (47.8%), Transaminase elevation 76 (32.7%), thrombocytopenia 45
(19.3%), leukocytosis 44 (18.2%). Mortality rate 1 (0.4%) an Afghan
refuges due to septic shock.
Conclusion: The clinical and laboratory data’s in typhoid fever are
nonspeciﬁc, it occurs mainly in young males, serology is helpful but
culture is the deﬁnite method for diagnosis. It needs a high index of
suspicion in a patient with prolonged fever who had travel to endemic
areas.
P1621 Risk factors for acute erysipelas: a case-control study
M. Karppelin, T. Siljander, J. Vuopio-Varkila, J. Kere, H. Huhtala,
R. Vuento, T. Jussila, J. Syrja¨nen (Tampere, Helsinki, FI; Stockholm, SE)
Objectives: To analyse clinical risk factors for acute erysipelas (non-
necrotising bacterial cellulitis).
Methods: From March 2004 to March 2005, 90 patients with 98 disease
episodes presenting with acute erysipelas at two hospitals in Tampere,
Finland were recruited in the study. For each patient, one age and sex
matched control subject was recruited from the population of Tampere.
The patients and the controls were interviewed and clinically examined.
Conditional logistic regression analysis was used to identify risk factors.
Results: Fifty-eight of the 90 patients (64%) were men. The median
age was 58 years (range 21–90). Six patients were recruited 2 or 3
times because of recurrence during the study period. Erysipelas was
localised in the lower extremity in 84, in the upper extremity in 7 and
in the face in 7 episodes. In a multivariate analysis, the body mass
index of 30 [OR 5.4 (95% conﬁdence interval 1.5–20.4)], disruption
of the cutaneous barrier [8.2 (2.5–26.2)] and chronic oedema of the
extremity [12.0 (1.1–125.8)] were found as independent risk factors for
acute erysipelas whereas diabetes, malignant or cardiovascular diseases,
smoking, alcoholism or a previous surgical procedure of the ipsilateral
extremity were not. Forty-four (49%) patients had a positive history
(PH) of at least one erysipelas episode before entering the study. The
median age of these patients did not differ from patients with a negative
history (NH) of a previous erysipelas episode. PH patients had been
signiﬁcantly younger at the time of their ﬁrst erysipelas episode (49
years, range 12–78) than NH patients (58 years, range 28–84, p = 0.004).
We also compared the general and local risk factors of PH and NH
patients. Obesity, toe-web intertrigo and previous surgical procedures of
the ipsilateral extremity were more common in PH patients and a recent
(<1 month) traumatic wound in NH patients, respectively.
Conclusion: Previous studies using hospitalised control patients have
found obesity, chronic oedema and disruption of the cutaneous barrier,
especially toe-web intertrigo as independent risk factors for acute
erysipelas. Our study conﬁrms these ﬁndings by using population
controls. Obesity and toe-web intertrigo seem to predispose also for
recurrent erysipelas but other, possibly inherited, factors may also play
a role.
P1622 Spontaneous vertebral osteomyelitis: comparison of cases
without a microbiological diagnosis to deﬁnite pyogenic and
tuberculous cases
R. Luzzati, D. Giacomazzi, M. Danzi, M. Solbiati, A. Tedesco,
E. Concia (Trieste, Verona, IT)
Objectives: Vertebral osteomyelitis is an uncommon but serious entity,
whose aetiologic diagnosis is not always possible. Few data are available
on outcome of cases without a microbiological diagnosis (possible
vertebral osteomyelitis). The aim of this study was to analyse features,
diagnostic approach, management, and outcome of spontaneous vertebral
osteomyelitis cases in adults.
Methods: We performed a retrospective review of 82 cases of vertebral
osteomyelitis presenting over a 11-year period (from 1995 to 2005) to
2 Italian tertiary hospitals. All patients had a strict case deﬁnition. We
compared data in patients with vertebral osteomyelitis due to various
aetiologies and possible vertebral osteomyelitis.
Results: A total of 82 patients met diagnostic criteria for vertebral
osteomyelitis, giving an incidence of 0.83/100,000 inhabitants/year.
The diagnostic yields of blood culture, CT-guided percutaneous needle
biopsy of spine, and surgical culture were 43.6%, 72.7%, and 91.6%,
respectively. Finally, a causative organism was identiﬁed in 60 (73.2%)
of 82 cases. Mycobacterium tuberculosis was the organism most
frequently responsible for the illness, followed by Staphylococcus aureus,
streptococci, and Gram-negative bacilli. The median diagnostic delay
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was longer in tuberculous cases (4 months) than in pyogenic (1 month)
and possible vertebral osteomyelitis cases (0.5 month) (P< 0.017). All
patients received antibiotic treatment, and 21 (25.5%) of them underwent
additional surgical treatment. This was required more frequently in
tuberculous cases (40.7%) than in pyogenic (25.0%) and possible cases
(9.1%) (P< 0.028). Recovery was more frequent in pyogenic (78.1%)
and possible cases (81.8%) than in tuberculous cases (30.8%) (P = 0.26).
Of 67 patients who completed the 1-year follow-up period, 2 relapsed,
3 died and 24 had persisting painful disability. The latter ﬁnding was
more frequent in tuberculous cases (66.7%) than in pyogenic (21.7%)
and possible cases (15.0%) (P< 0.03).
Conclusion: Nearly a fourth of spontaneous vertebral osteomyelitis cases
does not achieve a microbiological diagnosis even after undergoing
invasive diagnostic methods. However, possible vertebral osteomyelitis
cases treated at our institutions have both diagnostic delay and outcome
similar to that shown by pyogenic cases. The challenge continues to
be the earlier recognition of tuberculous vertebral osteomyelitis that is
associated to the highest risk of long-term morbidity.
P1623 Change from oral antidiabetic therapy to insulin and risk
of urinary tract infections in type 2 diabetic patients: a
population-based prescription study
A.K. Sanden, M.B. Johansen, L. Pedersen, H.H. Lervang,
H.C. Schønheyder, H.T. Sørensen, R.W. Thomsen (Aalborg, A˚rhus, DK)
Objective: Diabetes is a risk factor for urinary tract infections (UTI).
This study assessed whether a change from oral antidiabetic drug (OAD)
to insulin therapy with improved glycemic control decreased the rate of
antibiotic prescriptions for UTI among Type 2 diabetics.
Method: We used population-based healthcare databases to identify
2,843 Type 2 diabetic patients who switched from OAD to insulin
therapy. Each patient was observed for 365 days before and after the
change. Episodes of UTI were deﬁned as ﬁlled prescriptions for a UTI-
speciﬁc antibiotic. We used conditional logistic regression to estimate
the relative risk (odds ratio (OR)) of having at least one UTI in the
insulin vs. OAD period, both overall and stratiﬁed by improvements in
glycemic control.
Results: The overall period prevalence of UTI was 15.6% in the OAD
period and 15.9% in the insulin period. The OR for a UTI episode
in the insulin period compared to the OAD period was 1.05 (95%CI
0.87−1.26). After the change to insulin therapy, 53% of all patients
experienced a decrease in mean HbA1c level (median decrease=1.5%,
interquartile range 0.93%-2.30%). Stratifying by gender, we found a
period prevalence of 23.3% among women and 7.3% among men in
the OAD period, compared to 24.0% among women and 8.2% among
men in the insulin period. The corresponding ORs were 0.98 (95%CI:
0.78−1.22) for women and 1.25 (95%CI: 0.87−1.79) for men. The most
pronounced effect of insulin therapy initiation on UTI risk was observed
for patients of both genders with a high baseline comorbidity level, a
history of UTI treatment, and age less than 65 years at study entry (ORs
between 0.67 and 0.85). However, statistical precision was limited
We did not ﬁnd a consistent effect of level of glycemic improvement on
UTI risk.
Conclusion: Initiation of insulin treatment with or without tightened
glycemic control had no impact on risk of treated UTI in Type 2 diabetic
patients.
P1624 Spatial correlation among antimicrobial usage density and
resistance in Escherichia coli community urinary tract
infections: EUREQA Project report
T. Braga, C.R. Kiffer, E.G. Camargo, C.M. Mendes, A.M. Monteiro
on behalf of the EUREQA Project Group Brazil
Objective: Explore space-time correlations among antimicrobial usage
density and resistance in community urinary tract infections (cUTIs)
caused by E. coli within the city of Sa˜o Paulo, Brazil, as part of the
EUREQA Project.
Methods: EUREQA is a multi-phase spatial and temporal project
aimed at interpreting bacterial infections and resistance dynamics and
their correlations with risk factors, mainly antimicrobial usage density.
Routine outpatient urine culture results for E. coli (single isolate
per culture, with 100,000 CFU/ml) between 2002 and 2006 were
considered. In order to detect resistance clusters, cases were categorised
in susceptible (S) or resistant/intermediate (R) to Ciproﬂoxacin (CIP),
Nitrofurantoin (NIT) and Trimethoprim–sulfamethoxazole (STX). Cases
were then geocoded in a digital map and Kernel function method was
used to detect clusters (TerraView 3.2, INPE). Additionally, antimicrobial
usage density (IMS Health, Brazil) was geocoded according to
consumption location origin. Comparison unit was deﬁned as DDD/1000
inhabitants-day. Exploratory spatial correlation was based on Kernel
patterns of resistance and antimicrobial DDDs, to explore possible
concomitant hot spots formations.
Results: 29,199 urine cultures were geocoded during the period, with
R to CIP 15%, NIT 4.6%, and STX 32.5% in the 5 years altogether.
A non-random pattern (hot-spot) of total sample E. coli was observed
in one south-central district repeatedly every year. Although the same
district also presented a hot-spot for CIP, NIT, and STX R E. coli,
other hot-spots of R E. coli were observed in adjacent districts, probably
meaning different risk factors for resistance acquisition and/or spread.
Additionally, hot-spots for CIP, NIT and STX consumption were located
in a larger district inﬂuence area, including the ones where resistance
occurred.
Conclusions: Kernel smoothing function was the initial spatial data
exploratory technique applied for identifying evidences for spatial
clusters. Evidence for independent resistance spatially aggregated was
detected. Antimicrobial consumption presented a similar geographical
pattern and could not be ruled out as a risk factor for resistance
development. However, other methods must be applied to further
quantify and conﬁrm this hypothesis. Geographical information systems,
with spatial and temporal methods, are useful tools for better
understanding and curbing resistance by detecting target areas for public
health interventions.
P1625 Comparison of phylogroups and virulence genes of
Escherichia coli obtained from healthy humans and patients
with urinary tract infection in Denmark
L. Jakobsen, D.J. Spangholm, L. Skjøt-Rasmussen, L.J. Porsbo,
K.E.P. Olsen, A.M. Hammerum, N. Frimodt-Møller (Copenhagen,
Kgs. Lyngby, DK)
Objectives: Escherichia coli (Ec) causing urinary tract infections (UTI)
in women is believed to stem from the patients own faecal ﬂora. Ec
causing UTI often belong to phylogroup B2, which is more virulent
than the other common phylogroups. The objective was to investigate
the phylogroup distribution and the presence of selected virulence genes
(VGs) often detected in extra-intestinal pathogenic Ec of Ec isolates from
healthy humans and patients with UTI in Denmark.
Methods: In 2004, 109 Ec faecal isolates were obtained from healthy
humans as part of the Danish Integrated Antimicrobial Resistance
Monitoring and Research Programme (DANMAP). Furthermore, 131
Ec urine isolates were collected from Danish patients with UTI in 2005.
All isolates were investigated by three multiplex PCR reactions for
their phylogenetic background (A, B1, B2, D) and presence of eight
VGs (kpsM II, iutA, papA, papC, hlyD, sfaS, focG, afa). Results were
analysed using Chi-square, Fisher’s exact and Mann-Whitney test.
Results: Healthy human isolates grouped into phylogroups A (24%),
B1 (16%), B2 (36%) and D (25%) and patient isolates grouped into
phylogroups A (22%), B1 (7%), B2 (47%) and D (24%). B1 isolates were
more prevalent in healthy humans than patients (p = 0.0371). Similar
prevalences of group A, B2 and D isolates from healthy humans and
patients were observed.
The 109 healthy human and the 131 patient isolates had similar
distributions of the VGs (Table 1).
B2 isolates from both groups carried from 0−6 VGs. The median no.
of VGs carried by B2 isolates were highest in isolates from patients
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(3.56 VGs/isolate) compared to isolates from healthy humans (2.63
VGs/isolate) (p = 0.0014). B2 isolates with iutA, papA, papC and hlyD
were signiﬁcantly more prevalent among patient isolates (Table 1). B2
isolates from both healthy humans and patients carried signiﬁcantly more
VGs compared to phylogroups A, B1 and D.
Conclusions: Phylogroups A, B1, B2, D and VGs (kpsM II, iutA, papA,
papC, hlyD, sfaS, focG, afa) were all detected among Ec isolates from
healthy humans and patients.
The prevalence of phylogroup A, B2, D and VGs were similar between
the healthy human and patient isolates.
Comparing B2 isolates only, iutA, papA, papC and hlyD were
signiﬁcantly more prevalent among patient isolates.
The median no. of VGs/isolate was highest in B2 isolates from patients
compared to healthy human isolates.
B2 isolates had more VGs than phylogroup A, B1 and D in both healthy
human and patient isolates.
Table 1. Distribution of virulence genes in Escherichia coli isolates from healthy
humans and patients with UTI
Origin of isolates Virulence genes
kpsMII iutA papA papC hlyD sfaS focG afa
All isolates:
Healthy humans (n = l09) 55% 37% 19% 17% 10% 7% 6% 4%
Patients with UTI (n = 131) 61% 56% 39% 39% 27% 7% 5% 5%
B2 isolates:
Healthy humans (n = 39) 97%* 38% 33% 33% 28% 21% 13% 0%
Patients with UTI (n = 62) 76% 63%* 65%* 65%* 56%* 15% 11% 6%
*P< 0.05 between healthy humans and patients.
P1626 Clinical evolution of patients with hepatic abscesses in a
period of 6 years (2000–2005)
I. Ferna´ndez, J. Lo´pez-Contreras, R. Pericas, M. Gurgui, F. Sa´nchez
(Barcelona, ES)
Objectives: Pyogenic liver abscesses are normally polimicrobial and
caused by enteric bacteria. They can be associated with intestinal or
biliary pathology but the 55% of them are cryptogenic.
Methods: Study:retrospective observational. Cases:in-patients diagnosed
with hepatic abscess. Information: age, sex, risk factors, associated
abdominal diseases, size, location, diagnosis method, isolated mi-
croorganism, type of treatment (antibiotics alone versus drainage plus
antibiotics), antibiotic treatment duration and complications. Data were
analysed with SPSS program for Windows. Stay days at Hospital and
antibiotic treatment days were compared between the two groups: Group
1 patients managed only with antibiotic therapy and Group 2: patients
managed with percutaneous or surgical drainage and systemic antibiotics.
Because of the number of cases and the presence of outliers comparison
between stay days and treatment days initially was done by Mann-
Whitney test. After that t-test and Levene test were done excluding an
outlier patient that had a 158 days of stay.
Results: 60 cases were detected, but only 50 had clinical diagnostic
criteria.58% were male. Average age was 70 years old (31–96).
Risk factors: 66.7% diabetic, 22% underlying cancer and 32%
biliary pathology.38% were cryptogenic. Thirty-seven cases (74%) were
discreet abscesses. Most frequent localisation:right hepatic lobe (40%).
Microbiologic diagnosis was done by ﬁne needle aspiration (FNA) and
blood culture in 17 cases (34%), only by FNA in 17 cases and only
by blood culture in 3 cases. Microorganism were not isolated from 13
patients and diagnosis was asserted by clinical, analytical, radiological
and evolution criteria. Nineteen cases (38%) were polymicrobial,
most frequent microorganisms were: Escherichia coli, viridans group
Streptococcus, Enterococcus and Bacteroides spp. Eighteen cases (36%)
were monomicrobial, most frequent microorganisms were: viridans
group Streptococcus and Escherichia coli. Complications: 22% had
septic shock and attributable mortality was 6.3%. The most frequent
empirical treatment was ceftriaxone plus metronidazole (46%) and the
second was piperacillin-tazobactam (22%).
Medical treatment Drainage + medical
treatment
p
No. of patients 29 21
Treatment (days) 34.7±19.2 (14–81) 35.9±19.9 (6–81) 0.688
Stay (days) 20.5±11.6 (3–48) 34.1±31.5 (6–158) 0.013
Conclusions: 1. Patients treated with antibiotics alone had shorter
hospital stage, but no differences in antibiotic treatment duration were
detected between the two groups. 2. Incidence of liver abscesses of
unknown aetiology was lower than described previously in the literature.
3. Incidence of neoplasm as a risk factor was higher in our study.
P1627 A Trichuris vulpis parasitosis: an unexpected discovery
S. Cortizo-Vidal, L. Rodriguez-Otero, I. Villamil-Cajoto, L. Moldes,
S. Sacarneiro, A´. Mun˜oz, J. Llovo (Santiago de Compostela, ES)
Introduction: Trichuris vulpis is an intestinal nematode that belongs to
the Trichuroidea superfamily; this worm has a woldwide distribution,
and mainly affects dogs, foxes and wolves. This parastosis has
been occasionally decribed in veterinary studies. This human disease
occasionally is reported affecting in the same way childs and adults.
The host becomes infected when it ingests embryonated eggs from the
environment.
Clinical case: Eight-year-old girl; Ethiopia native that turned up to
her paediatrician for her ﬁrst health evaluation after adoption. The
analytic results were: hemoglobin 10.7 g/dL, hematocrit 34.5%; 9.100
leucocytes/mL; 800 eosinophils/ mL(9%); globular sedimentation speed
35mm/h; glucose 83mg/dL; urea 47mg/dL; albumin 4.9 d/dL, ferritin 8
ng/mL; hide blood in faeces was negative. Feacal samples were obtained
for coproparasitological study that was ﬁxed with SAF (saline serum,
acetic acid and formol). The Kato method was used to microscope
analysis and the concentration by the Ritchie method. This methods
demontrated the presence of: Blastocystis hominis, Entamoeba coli,
Iodamoeba butschlii and Giardia intestinalis as well as yellowish-brown
oval-shaped eggs, thick-shelled with two polar plugs, and size 78×40mm.
The nematode larvae culture in agar plate was negative. Epidemiological
data of living in an africanian country and coexisting with canids,
within the microcope analysis of the eggs founded in faeces, estabished
the diagnosis of T. vulpis infestation. The antihelmintic treatment was
mebendazol.
Conclusions: The low T. Vulpis infestation incidence, described by
scientiﬁc literature, could be underestimated by the scant use of ocular
micrometer to measure of eggs size in coproparasitological analysis. The
presence of adult worms in faeces must be searched in faeces after the
treatment to prove the morfometric data of eggs.
P1628 The gastric involvement of Orientia tsutsugamushi in
patients with scrub typhus
J.Y. Park, S.J. Park, K.N. Shim, M.S. Cho, H.J. Choi (Busan, Seoul, KR)
Objectives: Scrub typhus is a systemic illness causing generalised
vasculitis from Orientia tsutsugamushi infection. There are reports of
involvement of upper gastrointestinal (GI) tract in scrub typhus. But,
the gastric mucosal lesion was inﬂuenced by other factors such as pre-
existing peptic ulcer and stress due to infection itself. We aimed to prove
the presence of O. tsutsugamushi in stomach using nested-PCR.
Methods: We selected the patients with scrub typhus undergoing
endoscopic gastroduodenoscopy (EGD) in the two university hospitals
from January 2003 to November 2007. We evaluated clinical severity
index score(CSIS) as the followings: age >56 years old, fever or chill,
myalgia or headache, rash, cough, hemoglobin <12 g/dL, total bilirubin
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>1.2mg/dL, albumin <3 g/dL, creatinine >1.3mg/dL, prothrombin time
>14 sec or partial thrombin time >37 sec. The doxycycline was started at
the time of diagnosis. EGD was performed in case of patient’s agreement.
Gastric mucosal biopsies were done using endoscopic biopsy. The CLO
test was done to conﬁrm Helicobacter pylori infection. Rickettsial DNA
was ampliﬁed using parafﬁn-embedded biopsy tissue or fresh tissue by
nested PCR.
Results: 35 patients were enrolled during study period. The median age
was 62 years old (range, 22 to 81) and males were 13(37.1%). They had
no history of peptic ulcer. The median CSIS was 4(range, 2 to 8). Twenty-
three patients(65.7%) had GI symptoms including nausea(42.9%),
abdominal discomfort (37.1%), dyspepsia(31.4%), vomiting(20%), and
diarrhoea(8.6%). EGD ﬁndings were gastritis(17.1%), erosion(14.3%),
and ulcer(68.6%), which were not related with the symptom duration,
CSIS and the presence of GI symptom. Six patients(17.1%) showed
positive CLO test in the gastric ulcer. Twnety-two patients (62.9%)
were positive nested-PCR for rickettisal DNA. The gastric sample
received earlier after therapy tends to be PCR-positive compared
with others (2.14±0.71 days vs 4.31±2.10 days, p< 0.001). Eighteen
patients(51.4%) were positive nested-PCR at the normal gastric mucosa,
which was not related with CSIS, GI symptom and EGD ﬁnding.
Conclusion: This study showed GI symptoms and gastric inﬂammation
are common. But EGD ﬁnding was not related with CSIS and GI
symptoms. Gastric inﬂammation may be related to direct invasion of
O. tsutsugamushi, which could occur before the symptom develops. The
further investigation is needed for pathogenesis of gastric inﬂammation
in scrub typhus.
P1629 Clinical data of Bartonella infection in northern Greece
M. Pape, K. Mandraveli, S. Alexiou-Daniel (Thessaloniki, GR)
Objective: Cat scratch disease, caused by Bartonella henselae, typically
presents with a localised lymphadenopathy. However, there are atypical
cases with a wide spectrum of clinical manifestations. The aim of
this study was to investigate the epidemiologic and clinical aspects of
Bartonella infection in northern Greece.
Methods: Betweeen 2000–2006 we examined 1107 patients (522
adults/585 children) suspected of having CSD. The referring doctors
were requested to provide the following information: contact with
an animal, clinical signs and symptoms, physical ﬁndings and the
histopathological results in the cases where a lymph node biopsy was
performed. All sera were examined using the Bartonella IgG/IgM
indirect immunoﬂuorescent antibody (IFA) test (Focus kit). A serological
diagnosis was made on the basis of either evaluated titers of IgM
antibodies >/1:20 or IgG antibodies >/1:256, or the presence of a
fourfold rise in the serum IgG titer between acute and convalescent
phase. All sera were also tested to Coxiella burnetti, Rickettsia
typhi/conorii, Chlamydia species, Cytomegalovirus, Epstein Barr virus,
Respiratory syncitial virus, Mycoplasma pneumoniae and Legionella
pneumophila to exclude cross reactions.
Results: In 101 patients the diagnosis of Bartonella infection was
conﬁrmed. 67 patients (29 adults/38 children) appeared typical clinical
manifestations of CSD. In 15 out of 29 adults and in 18 out of 38 children
contact with cats was reported. In two cases a contact with dogs was
also reported. In ﬁve patients the histological examination of lymph
nodes pointed out histopathological ﬁndings compatible with CSD. The
most common sites of swollen lymph nodes were the neck (36 cases),
followed by the axilla (25 cases), the inguinal region (3 cases) and the
submandibular region (3 cases).
In 12 patients with fever of unknown origin (4 adults/8 children), 4
patients (3 adults/1 child) with fever and rash, 4 adults with pneumonia,
3 patients with neurological symptoms, and 5 patients with ocular
manifestations the diagnosis of bartonella infection was also established.
In six patients with culture negative endocarditis the association of their
illness with Bartonella quintana infection was strongly suspected, based
only on serological criteria
Conclusion: Bartonella infection was a rarely notiﬁable in Northern
Greece. Our data indicate, however, that it should be considered a public
health problem with several clinical manifestations.
Travel medicine and “exotic” infections
P1630 Travel medicine surveillance in northeastern, Brazil
S. Hinrichsen, T. Vilella, L. Reˆgo, Y. Christian, A. Lobo, C. Lira,
E´. Falca˜o, L. Almeida, R. Cavalcanti (Recife, BR)
Background: Brazil, especially the northeastern coastline region atracts
travelers from Brazil and all over the world. Approximately 8% of
travelers to the developing world require medical care during or after
travel. Due the importance of tourism, travel destination can help
physicians select empiric therapy for diseases developing during or after
travel.
Methods: We reviewed N=253 patients who were admitted in our
infections diseases travel clinic between 02/24/2004 to 12/01/2006
before and after traveling, or during their journey in Recife, Brazil.
We conducted a prospective observational monocentric study. Variables
available for analysis included gender, age, country, ﬁnal diagnosis and if
medical care was before, during or after travelers. A descriptive statistics
of the collected data was done using the software EPI INFO 3.3.2.
Results: 140 (55.3%) were male. The mean age was 33.5 (ranging from
one month to 85 years). 141 (55.7%)were Brazilian travelers (n = 303, in
transient; n = 30, pre-travel; and n = 3, pos-travel) and 112 (44.3%) were
from others countries (n = 35, from Europe; n = 33, from North America).
213 (88.0%) were transient travelers (n = 303 brazilian travelers and
n = 310 international travelers). 32 (12.6%) people (n = 30 brazilians)
came to the service before travel to counseiling. 14 (5.5%) had been in
Malaria and Yellow Fever area less than 30 days before coming to the
hospital, and 3 of them (21.4%) came back from their trip with Malaria
due to P. falciparum (2 from Luanda-Angola; 1 from Manaus-Brazil).
Also, 2 (0.8%) people came back from their trip with Viral Meningitis.
22 (8.7%) were assisted at the emergency service due gastroenteritis
(acute diarrhoea).
Conclusions: Acute diarrhoea (8.7%) was the principal syndrome during
travels and Malaria was the major cause of systemic febrile illness for
travelers returning from endemic areas.
P1631 Description of travel characteristics and diagnosis of the
main syndromes in travellers attending a tropical medicine
unit
A. Perez-Ayala, J. Perez-Molina, P. Zamarron, M. Navarro, F. Norman,
C. Jimenez, R. Lopez-Velez (Madrid, ES)
Objectives: To describe and compare the main syndromes and most
frequent aetiologies among returning travellers with respect to the
geographical area visited, length and type of travel.
Methods: The Tropical Medicine Unit at the Ramon y Cajal Hospital, is
a referral unit where immigrants and ill returned travellers are attended
since the year 1989
Length of travel was divided into three groups: <30, 30–180 and >180
days. Type of travel was classiﬁed into four groups: professional or
tourism, high or low risk (PHR; PLR, THR, TLR). Discrete variables
were compared by means of Chi squared or Fisher exact test. For
quantitative data an independent samples t-test was used.
Results: 2993 travellers were seen at our unit during 1989–2006. A
progressive increase in the number of patients was observed over the
years. There were 52.1% of men and the mean age was 35 years
(interquartile range: 28–40). Long term travel was signiﬁcantly more
frequent in the PHR group (71.5%)
The main reasons for seeking medical advice were: fever: 34.6% (most
frequent diagnosis: malaria 25.5%), diarrhoea: 28% (86.2% bacterial
gastrointestinal infection), skin diseases: 23% (31.8% skin infections),
eosinophilia 19.7% (15.1% ﬁlarias) and respiratory tract infections 7.5%
(41.3%upper tract infection).
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Fever was most frequently diagnosed in travellers returning from
Australasia/Oceania (57.1%) followed by South-East Asia (46.2%),
diarrhoea: South-West Asia (32.1%) and North Africa (29.5%),
eosinophilia: South-East Asia (27.3%), skin disease: South America
(31.9%) and South-East Asia (28.7%).
Syndrome Incidence by type of travel (%)
PLR TLR THR PHR p-value
Febrile 38.9 36.2 40.6 27.5 <0.001
Diarrhoea 26.8 32.1 29.7 24.0 <0.001
Skin disease 22.3 26.3 27.1 17.9 <0.001
Eosinophilia 8.6 6.9 7.4 10.4 0.037
Syndrome Incidence by length of travel (%)
<30 days 30–180 days >180 days p-value
Febrile 41.2 29.4 24.6 <0.001
Diarrhoea 30.2 29.5 22.0 0.015
Skin disease 26.3 20.0 18.5 <0.001
Eosinophilia 6.1 9.7 12.5 <0.001
Conclusions: PHR and long term travellers showed less risk of
fever, diarrhoea and skin disease on return and an increased risk of
eosinophilia. This could be due to the short duration of the former
illnesses which typically tend to occur during travel whereas eosinophilia
which takes longer to develop is usually detected on return.
P1632 Mycotic aneurysm in northeastern Thailand: the important
role of Burkholderia pseudomallei
S. Anunnatsiri, P. Chetchotisakd (Khon Kaen, TH)
Objectives: Mycotic aneurysm is a rare condition and related to
devastating outcomes. Based on the limited data of the disease, the study
was conducted to evaluate the natural history and clinical outcomes of
mycotic aneurysm in northeastern Thailand, where melioidosis is an
endemic.
Methods: A 15-year retrospective study was conducted in Srinagarind
University Hospital during January 1993–June 2007. All patients with
mycotic aneurysm based on clinical presentations, radiographic features,
intra-operative surgical ﬁndings, and pathological reports during the
study period were eligible to the study.
Results: There were 37 cases with diagnosis of mycotic aneurysm.
The majority of patients were male (29 cases, 78.7%) and elder as
the mean (SD) age of 62.9 (12.1) years. Of those, 21 cases (56.8%)
had pre-existing diseases, which the 3 most common diseases were
diabetes mellitus, chronic kidney diseases and hypertension. All patients
presented with pain at the aneurysm site and fever was found in
25 cases (67.6%). Median (range) duration of illness was 14 (3–
150) days. Thirty-three cases (89.2%) were involved abdominal aorta.
All but one were culture-proven mycotic aneurysm cases. The most
common aetiological pathogens were Burkholderia pseudomallei (15
cases, 40.5%), followed by Salmonella group D (10 cases, 27.0%).
Escherichia coli and Pseudomonas sp. were found two cases each.
Salmonella group B, Staphylococcus aureus, Aeromonas hydrophila,
Klebsiella pneumoniae, Enterobacter sp., Enterococcus sp., and non-
hemolytic Streptococcus not group D was found one case each. The most
common sites of pathogen isolation were aneurysm (29 cases, 78.4%),
followed by blood (7 cases, 18.9%). Overall in-hospital mortality rate
was 24.3% (9 cases; 4 cases in B. pseudomallei mycotic aneurysm).
There were no statistically signiﬁcant differences according to age,
sex, pre-existing diseases, clinical presentations, site of aneurysm,
and mortality between patients with mycotic aneurysm causing by
B. pseudomallei and other bacteria. Postoperative complications was
signiﬁcantly more common in patients with B. pseudomallei mycotic
aneurysm compared to those with other bacteria [10 cases (66.7%) vs.
4 cases (19.0%); p = 0.01].
Conclusion: In endemic area of melioidosis, the empirical antimicrobial
therapy for suspected mycotic aneurysm should cover B. pseudomallei.
P1633 The benign nature of dengue in the elderly in Singapore,
2004
D.C. Lye, V. Lee, Y. Sun, Y.S. Leo (Singapore, SG)
Objectives: Children are at higher risk of dengue haemorrhagic fever
(DHF). However, increased mortality in older adults was noted in Cuba
and Puerto Rico. In Singapore, patients 55 years comprised 10.1% of
dengue cases in 2005 and 22.8% in 2006. This study aims to determine if
older dengue patients in Singapore have greater morbidity and mortality.
Methods: All dengue patients admitted to our department in 2004
were retrospectively reviewed. Demographic, clinical, laboratory and
outcome data of dengue patients 60 years and <60 years were
collected and compared. Using data from entire clinical course, all cases
were re-classiﬁed into dengue fever and DHF based on World Health
Organisation criteria.
Results: Of 1971 laboratory-conﬁrmed dengue cases, 66 were 60
years. Older patients were signiﬁcantly less likely to be male (44%
vs. 66%), and more likely to be Singaporean by nationality (91%
vs. 61%), have diabetes (17% vs. 2%), hypertension (48% vs. 4%),
ischaemic heart disease (6% vs. 0.1%), hyperlipidaemia (18% vs. 1%)
and secondary dengue infections (64% vs. 34%). Clinical features were
similar except older patients were less likely to report fever (92% vs.
99%). Older patients were signiﬁcantly less likely to have leukopenia
(32% vs. 51%) and haemoconcentration (0 vs. 5%) on admission. Older
patients were not more likely to develop DHF, bleeding, hypotension,
severe thrombocytopenia and transaminitis. However, older patients were
signiﬁcantly more likely to receive platelet transfusion (23% vs. 12%).
Their length of hospital stay, risk of intensive care unit admission and
death were not statistically different.
Conclusions: Despite greater co-morbidity and secondary dengue
infection, older dengue patients in Singapore did not have greater
morbidity and mortality.
P1634 Lack of beneﬁt of prophylactic platelet transfusion in adult
dengue patients
D.C. Lye, V. Lee, Y. Sun, Y.S. Leo (Singapore, SG)
Objectives: Thrombocytopenia is common in dengue and there is
concern about risk of bleeding. One retrospective paediatric intensive
care study showed no beneﬁt in prophylactic platelet transfusion
for thrombocytopenia <30,000/uL. This study aims to determine if
prophylactic platelet transfusion has clinical beneﬁt in adult dengue
patients.
Methods: All dengue patients admitted to our department in 2004 were
retrospectively reviewed. Using data from the entire clinical course,
all cases were re-classiﬁed into dengue fever and DHF based on
World Health Organisation criteria. Patients without bleeding when
their platelet count dropped <20,000/uL were evaluated. Prophylactic
platelet transfusion was deﬁned as platelet transfusion without clinical
bleeding excluding petechiae. Baseline demographic data on admission
and clinical data when patients’ platelet count ﬁrst dropped <20,000/uL
were compared. Outcome measures included: any bleeding after platelet
transfusion, median platelet increase the next day, median time to platelet
count 50,000/uL, median length of hospital stay, and death.
Results: Of 1973 laboratory-conﬁrmed dengue patients, 256 developed
thrombocytopenia <20,000/uL without bleeding, of whom 188 were
given prophylactic platelet transfusion. Baseline demographic, clinical
and laboratory features at that platelet threshold were similar, except
transfused patients were signiﬁcantly more likely to be febrile (33% vs.
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18%). Median platelet count on day of platelet transfusion was 15,000/uL
in transfused vs. 16,000/uL in non-transfused patients. Bleeding occurred
subsequently in 1 of 188 transfused (0.5%) and 2 of 68 non-transfused
(3%) (p = 0.17). Median platelet increase the next day was 6000/uL vs.
13,000/uL, and median time to platelet 50,000/uL was 3 days vs. 2
days, in transfused vs. non-transfused patients respectively. There was
no difference in length of stay and death.
Conclusions: There was no beneﬁt from prophylactic platelet transfusion
in adult dengue patients.
P1635 The efﬁcacy of oral ribavirin in children with
Crimean-Congo haemorrahgic fever in Iran
B. Shariﬁ Mood, M. Mardani, M. Metanat (Zahedan, Tehran, IR)
Background: Crimean-Congo haemorrahgic fever (CCHF) is a viral
haemorrhagic fever of the Nairovirus group. The disease is endemic in
many countries in Africa, Europe and Asia, and during recent years,
outbreaks have been recorded in Iran. The data on the efﬁcacy of
Ribavirin in in children with CCFH is scanty. This study was conducted
to analyse the outcome of this disease, and efﬁcacy of ribavirin therapy
in children with CCHF in Southeast of Iran.
Pati ents and method: During 1999 till 2006, 184 conﬁrmed Crimean-
Congo haemorrahgic Fever(CCHF) case was admitted in BooAli hospital
in Systan province of Iran, of whom 34 cases were below age 18 years
old, were included in this study. The diagnosis was conﬁrmed through
detection of IgM ELISA and/or genomic segment of PCR CCHF virus.
We conducted the outcome analysis of survived treated patients in this
study.
Results: Out of 34 children with Crimean-Congo haemorrhagic fever
(23 Male, 11 Female)with age range 5 to 18 years old.
24 patients had been treated by oral ribavirin within the initial three
days, 8 patients were treated after three days of the onset of disease
and two cases had not been treated with ribavirin. Out of the32 treated
patients, 6 cases were died. Fatality rate was 18.75% in treated patients.
26 patients with oral ribavirin survived(survival rate=81.25%).
The recovery rate was higher in the children who were treated during
the initial 3 days than children who were treated after this time or were
not treated (85.2% versus 24.8%).
Both these two children who had not been treated with ribavirin were
died.
Conclusion: In children who suffered from CCHF in Iran, treatment with
oral Ribavirin can increased survival rate. The recovery rate was higher
in the children who were treated during the initial 3 days of the illness.
We conclude that the oral Ribavirin is an effective drug in children with
CCHF.
P1636 Risk factors for human infection with scrub typhus
D-M. Kim, S.Y. Rye, S.H. Lee (Gwang-Joo, Pusan, KR)
Background: Scrub typhus is a mite-borne infectious disease caused
by Orientia tsutsugamushi. However, no epidemiological studies have
been conducted to examine the risk factors of developing scrub typhus
in Korea.
Methods: We conducted this case-control study during the month of
May 2006. Cases were 156 patients with scrub typhus who were resided
in the southwestern area of Korea (Cholla province and Kwangju city)
and registered to the Korean Center for Disease Control and Prevention
(KCDC) in 2005. Controls were 130 patient’s neighbors who had as
same socioeconomic status.
Results: The risk of developing scrub typhus was relatively 2.44 times
(95%CI; 1.04−5.69) higher in those who were engaged in farming fruits;
2.05 times (95%CI; 1.09−3.87) higher in those who were engaged in
gathering chestnuts; and 3.06 times (95%CI; 1.50−6.22) higher in those
who had lunch or a snack on the spot. In addition, it was relatively 0.45
times (95%CI; 0.24−0.83) lower in those who were given informations
or a health education programme about the prevention of scrub typhus.
Conclusions: In conclusion, our results indicate that a health education
programme will lower the risk of developing scrub typhus in a high-risk
group of patients who are engaged in farming fruits, gathering chestnuts
and having lunch or a snack on the spot.
P1637 A farmer with a skin ulcer: anthrax or not?
A. Azap, E. Yanmaz, N. Bayraktar, D. Aksu, E. Erdemli (Ankara, TR)
A 52 year-old farmer was admitted to the hospital with a painful ulcer
in his left palm. The ulcer was purple in colour with hyperemic and
endurated margins. There was hyperaemia and tenderness lining through
the left forehand, suggesting lymphangitis or thrombophlebitis. A small
painful epitrochlear lymph node was palpable. The patient was afebrile
and in good health. Physical examination was unremarkable besides
the deﬁned lesion. He had a history of sheep slaughtering in the week
before the ulcer had occured. After blood cultures were taken, crystalline
penicillin G 3 million units IV q4 h was initiated with the initial diagnosis
of cutaneous anthrax and complicated skin ulcer. No microorganism
was seen in the Gram staining of the material taken from the edge
of the lesion and cultures grew no bacteria. Inﬂammation and pain
resolved at the end of seven days of therapy. A biopsy was performed.
Transmission electron microscopy of the biopsy specimen revealed oval
virions consisting of a core surrounded by a thin envelope, characteristic
for parapoxvirus (ﬁgure). The parapoxvirus particles seen were presumed
to be orf viruses. Orf virus causes skin diseases in sheep and goats. It is
occasionally transmitted to humans. The clinical importance of orf skin
ulcer is that it can be misdiagnosed as anthrax, especially in countries
where anthrax is still endemic.
P1638 The iliopsoas abscess: aetiology, therapy, and outcome
T. Turunc, Y.Z. Demiroglu, T. Turunc, H. Aliskan, S. Colakoglu,
H. Arslan (Ankara, TR)
Objective: Iliopsoas abscesses are suppurative collections within the
fascia surrounding the psoas and iliacus muscles. Psoas abscess is
regarded as a rare disease in the medical literature. The incidence of
psoas abscess is not known, but it has probably increased in recent
years. In this report we describe 13 cases of psoas abscess presenting to
a university hospital in Turkey in the last ﬁve years.
Methods: We reviewed clinical data about patients diagnosed with a
psoas abscess from June 2001 to June 2004 at Baskent University Faculty
of Medicine, Adana, Turkey.
Results: The median age of the patients was 47.8 years (range: 18–
70 years) with a male to female ratio of 8/5. Out of 13 patients, one
had primary psoas abscess, while 12 had secondary psoas abscess. The
predisposing conditions were diabetes mellitus, pancreatic carcinoma,
autoimmune hepatitis, sickle cell anaemia and chronic renal failure.
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Of twelve cases of psoas abscess secondary to vertebral osteomyelitis,
ﬁve had tuberculosis, one had brucellosis and six had urinary tract
infection. The most common complaints were fever and lower back pain.
The causative agent was isolated in psoas abscess cultures of 10 cases
(Mycobacterium tuberculosis in 5 cases, Brucella melitensis in 1 case,
Acinetobacter baumannii in 1 case, meticillin sensitive Staphylococcus
aureus in 2 cases and meticillin resistant S. aureus in 1 case). Culture
results were negative in two patients and it was not possible to obtain
specimen from one patient. Eleven patients underwent percutaneous
drainage, which was successful in all cases. Two patients were treated
with surgical drainage.
Conclusion: With the advent of modern imaging techniques, the
diagnosis of psoas abscess without typical clinical symptoms has become
easier. However, despite the improvement in diagnostic techniques, this
disease remains a problem as the development of abscesses is often
associated with an underlying chronic illness. It is striking that in our
series none of the patients had psoas abscess secondary to a disease of
the digestive tract, while this is the most common cause of secondary
psoas abscess in the literature. Even if the incidence of tuberculosis is
actually increasing, tuberculosis abscesses are rare in Western countries.
However, it should be kept in mind that Brucellosis and Tuberculosis
can be the cause of psoas abscess in developing countries like Turkey
where tuberculosis and brucellosis are still endemic.
Food and waterborne pathogens and
infections
P1639 Salmonella typhimurium and norovirus food-borne outbreak
in a restaurant
C. Arias Varela, M.R. Sala Farre´, A. Recasens Recasens, R. Bartolome´
(Terrassa, Barcelona, ES)
Objectives: Salmonella Typhimurium (ST) and norovirus (NV) are the
leading cause of food borne outbreaks of gastroenteritis in Catalonia;
however outbreaks caused with mixed viral-bacterial gastroenteritis are
unusual. This report describes the ﬁrst food borne detected in Catalonia
with ST and NV together implicated. Two groups of costumers ate on
the same restaurant in a two consecutive days before became ill.
Methods: A study of historic cohorts was performed. The case was
deﬁned by the presence of diarrhoea and vomiting. Data were gathered
on age, sex, foods consumed and clinical symptoms. Attack rates
and relative risk were calculated. Food and stool samples from cases
and food handlers were analysed for bacterial and viruses (test RT-
PCR). Bacterial isolated strains were studied using pulsed-ﬁeld gel
electrophoresis (PFGE). Food handlers were asked about food procedures
and a inspection of the restaurant was undertaken.
Results: The outbreak occurred from August 7 to 9, 2005 involving
20 cases (65% total attack rate). Clinical symptoms included general
malaise (95%), diarrhoea 85, headache (85%), abdominal pain (80%),
muscular pain (80%), fever (75%), nausea (33%) and vomiting (25%).
Median duration of the disease was 4 days.
There were a signiﬁcant association with the disease and eating mixed
vegetables (RR= 4.95; CI 95%, 1.40–17.50) and ﬁsh salad (RR= 2.25;
CI 95%, 1.25−4.05). Stool samples of 4 cases were ST positives ST, one
case for NV and 5 cases for ST and NV. Stool samples from food handler
were ST positives (1) and both ST and NV (2). Furthermore ST was also
isolated in the food samples. The ST strains from 9 conﬁrmed cases,
from food handlers and food had identical PFGE patterns. Restaurant
inspection detected that cross contamination of food were possible.
Conclusion: This food borne epidemic outbreak was caused by ST
and NV. Epidemiological analysis shows that mixed vegetables and
ﬁsh salad were the main foods implicated. Microbiological information
is consistent with the outbreak could occurred as a result of food
contamination by a food handler. ST infection could be also as a result
of cross contamination and mishandling of food.
P1640 Clinical features and possible sources of sporadic Yersinia
enterocolitica infections in Finland
E. Huovinen, L.M. Sihvonen, K. Haukka, A. Siitonen, M. Kuusi
(Helsinki, FI)
Objectives: Yersinia enterocolitica is an important cause of gastroen-
teritis in Finland causing around 500 infections yearly. Y. enterocolitica
species is divided into several bio- and serotypes. The ability to
cause gastrointestinal symptoms differ between the bioserotypes as
well as the possible sources of infection. We conducted a case-control
study to characterize the clinical features and to identify sources of
Y. enterocolitica bioserotypes.
Methods: All Yersinia strains isolated in 10 clinical microbiology
laboratories in 2006 were collected. Patients with culture conﬁrmed
Y. enterocolitica infection were enrolled to questionnaire study. Controls
matched on age-, gender- and geography were randomly selected from
population registry. Questionnaire included questions related to Yersinia
infection, consumption of different food items, traveling etc.
Results: A total of 294 cases were accepted to case control study. Most
patients had biotype (BT) 1A (N=187) ﬁnding, bio-/serotypes 3−4/O:3
or 2/O:9 were detected in 61patients. Patients with other serotypes were
excluded from further analyses. Patients with 3−4/O:3 or 2/O:9 ﬁndings
were younger than those with BT 1A ﬁndings (P< 0.001 for difference
in means) and small children under three years were overrepresented
among those with serotypes O:3 or O:9 (10/61=16%). Many patients
with biotype 1A were unable to deﬁne any special symptomatic period.
Diarrhoea and abdominal cramps were most common symptoms, fever
was more common among patients with serotypes O:3 or O:9 and
vomiting among subjects with biotype 1A. Signiﬁcant associations in
preliminary analyses were found between both 1A and O:3 or O:9 types
and travelling abroad. Serotypes O:3 or O:9 were associated to eating or
tasting medium or raw pork. Those who always washed vegetables had
decreased risk of Y. enterocolitica infection.
Conclusion: Clinical feature of Y. enterocolitica infections differ
between bio-serotypes signiﬁcantly. Substantial proportion of Y. ente-
rocolitica infections in Finland is associated with traveling. Pork is a
signiﬁcant source of serotype O:3 or O:9 Y. enterocolitica, but it doesn’t
explain all infections.
P1641 Severity of non-typhoid salmonellosis as a predictor of 0–30
and 31–365 day mortality
K.O. Gradel, T. Ejlertsen, H.C. Schønheyder, H. Nielsen (Aalborg, DK)
Objectives: To evaluate whether hospitalisation, ordering of blood
cultures, or detection of bacteraemia were predictors of mortality in
patients with non-typhoid salmonellosis (NTS).
Methods: Population-based registry study comprising all patients with
a ﬁrst-time NTS detected in stool cultures, in North Jutland County
(Denmark) from 1995 through 2003. Patients were categorised into
four groups: group 1) not hospitalised; group 2) hospitalised 30 days
within their NTS without blood cultures (BC) being ordered; group
3) hospitalised with negative BC only; group 4) hospitalised with
bacteraemia. We obtained data in the county’s hospital discharge registry
on comorbidity as recorded from 1977 and hospitalisation. Complete
follow-up was possible through the Danish civil registration system.
Age and comorbidity adjusted Cox’s regression analyses were used to
compute mortality rate ratios (MRR) with 95% conﬁdence intervals (CI)
at 0–30 and 31–365 days.
Results: Among 1,764 NTS patients, 1,082 (61.3%) were not
hospitalised, 344 (19.5%) were hospitalised without BC being ordered,
245 (13.9%) were hospitalised with negative BC, and 93 (5.3%) had
bacteraemia (Salmonella in 81, other pathogens in 12). Within one year,
2 (0.2%) died in group 1, 14 (4.1%) in group 2, 20 (8.2%) in group
3, and 19 (20.4%) in group 4. Using group 2 as reference, 0–30 day
adjusted MRR (95%CI) could not be calculated in group 1 (no deaths),
whereas they were 1.8 (0.6−5.7) and 1.3 (0.4−4.6) in groups 3 and
4, respectively. For 31–365 days, adjusted MRR (95%CI) were 0.16
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(0.03−0.78) in group 1, 1.6 (0.69−3.9) in group 3, and 2.3 (1.0−5.5) in
group 4.
Conclusion: The general practitioner’s decision to hospitalize NTS
patients was a predictor of short-term and long-term mortality
independent of age and comorbidity. When hospitalised, the physician’s
decision to obtain blood cultures or the detection of bacteraemia were
independent predictors of mortality, albeit the statistical precision was
low.
P1642 Prosthetic mitral valve endocarditis due to Salmonella
paratyphi B
C. Hatipoglu, T. Sari, G. Ertem, B. Oral (Ankara, TR)
Objectives: Endocarditis due to Salmonella species is a rare clinical
entity. We report a case of prosthetic mitral valve endocarditis caused
by Salmonella paratyphi B in which vegetation could be demonstrated
by transoesophageal echocardiography.
Case: A 37-year-old male patient was admitted to the hospital
in September 2007 with complaints of fever, cough, expectoration,
palpitation and generalised aches for two weeks. He had a history of
mitral valve replacement ten years ago. Physical examination revealed
tachycardia, jaundice, hepatomegaly, crepitation on both sides of the
chest and metallic sound of prosthetic valve. The leukocyte count
was 4000/mm3, hemoglobin 15.4 g/dl, platelets 39000/mm3, erythrocyte
sedimentation rate 49mm/hour. In urinalysis leukocytes (160/mm3) were
detected. Chest X-ray showed bilateral lung inﬁltrates. Transthoracic
echocardiography did not reveal any vegetation. The treatment started
with ampicillin-sulbactam (4×1.5 g) and ciproﬂoxacin (2×400mg)
intravenously against pneumonia and urinary tract infection, but urine
culture was negative. All of six blood cultures yielded Salmonella
paratyphi B sensitive to ampicillin, ciproﬂoxacin, chloramphenicol,
cefotaxime and trimethoprim-sulfamethoxazole. None of stool cultures
revealed salmonella. On day 8, his clinical status deteriorated; dyspnea,
arrhythmia, edema, leukocytosis (greater than 20000/mm3) were added.
No vegetation was detected by repeated transthoracic echocardiography.
Medications for cardiac failure were added to the treatment. On day 10,
transoesophageal echocardiography showed two vegetations (1.7×0.4 cm
and 0.3×0.3 cm) on prosthetic mitral valve. Cardiovascular surgeons
did not suggest surgical intervention. The patient had transferred to a
cardiology clinic on day 11 because of the worsened clinical status. We
learned that the antimicrobial treatment was continued in the cardiology
clinic and that mental functions of the patient worsened because of
temporal infarction detected by cranial tomography. After eigth weeks
of the treatment he was discharged from hospital with a sequel without
any surgical intervention.
Conclusion: Complication and mortality rate of salmonella endocarditis
is high and early surgical intervention is needed commonly. In this
case we could make the diagnosis of endocarditis on 10th day of
admission. We strongly recommend early practice of transoesophageal
echocardiography in patients with suspected endocarditis.
P1643 Signiﬁcant presence of adenoviruses in raw and treated
sewage derived from biological treatment plants in Greece
G. Komninou, D. Venieri, G. Diamandi, E. Jelastopulu (Patras, GR)
Objectives: Water quality and, therefore human health may be signif-
icantly affected by the presence of pathogenic enteric microorganisms,
derived from sewage discharged to the aquatic environment. Outbreaks
of enteric virus disease have been linked to water at various times
and to different causes. Adenoviruses are pathogenic to humans and
their presence in the environmental samples (polluted waters) may cause
infections. Adenoviruses are the only human enteric viruses that contain
DNA. Many adenoviruses serotypes are difﬁcult to culture in regular cell
lines. The stability of human adenoviruses in environmental waters and
their resistance to physicochemical treatment processes used by sewage
treatment plants may facilitate their transmission.
Our purpose was to perform a complete procedure for virus
concentration from sewage and the detection of the speciﬁc viruses
by ampliﬁcation of DNA and cDNA with the appropriate primers, in
order to overcome the problems of the cultivation methods concerning
adenoviruses.
Methods: In this study raw and treated sewage samples were collected
from three treatment plants in Greece. Two of them are located in the
prefecture of Achaia (Patras and Rio) and the other in the prefecture of
Preveza (city of Preveza).
In total, 60 sewage samples (30 raw and 30 treated sewage samples)
were collected, during the period March 2006–June 2006.
Our approach consisted of a simple concentration of viruses from sewage
samples followed by nested PCR in order to increase the sensitivity of
adenovirus detection.
Results: In total, adenoviruses were detected in 55% of the samples
tested. Reviewing results obtained from each treatment plant separately,
positive samples from Patras, Rio and Preveza were 75%, 67% and 50%,
respectively. Furthermore, adenoviruses were detected in 24 raw sewage
samples (80%) and in 9 treated sewage samples (30%).
Conclusions: The detection of adenoviruses, in raw and treated sewage
with this speciﬁc, fast and sensitive method is a valuable indicator of
quality control of the process applied by the biological treatment plant,
as it can be used for the examination of treated efﬂuents as well as
raw sewage samples. The signiﬁcant isolation of adenoviruses in treated
sewage indicates their stability as virological indicators of the pollution
of the environment and their more persistence in sewage.
P1644 Detection of enteroviruses in raw and treated sewage in
Greece
D. Venieri, G. Komninou, K. Nelly, E. Jelastopulu (Patras, GR)
Objectives: Enteroviruses have been associated with outbreaks of
waterborne non-bacterial gastroenteritis and are of important concern for
public health. Signiﬁcant numbers of viruses can be isolated from faeces
and urine of humans as well as from sewage and polluted waters. The
purpose of this study was to investigate the presence of enteroviruses in
raw and treated sewage samples derived from a biological treatment plant
in Greece, applying molecular biological techniques. Furthermore, there
was an effort to overview enteroviruses’ inactivation, as a consequence
of the disinfection of sewage.
Methods: In this study raw and treated sewage samples were collected
from three treatment plants in Greece. Two of them are located in the
prefecture of Achaia (Patras and Rio) and the other in the prefecture of
Preveza (city of Preveza).
In total, 60 sewage samples (30 raw and 30 treated sewage samples) were
collected, during the period March 2006–June 2006. Our approach was
consisted of a simple concentration of viruses from sewage samples,
followed by RT-nested PCR in order to increase the sensitivity of
enterovirus detection.
Results: In total, enteroviruses were detected in 8% of the samples
tested. All samples from Patras’ treatment plant were negative, while in
Rio and Preveza positive samples for the presence of enteroviruses were
8% and 9%, respectively. What seems to be important is the detection
and isolation of enteroviruses in raw and treated samples, as well.
Speciﬁcally, 13% of raw sewage samples were positive for the presence
of enteroviruses, while this proportion for treated sewage samples was
lower and 3%.
Conclusions: The detection of enteroviruses, in raw and treated sewage
with this speciﬁc, fast and sensitive method is a valuable indicator of
quality control of the process made by the biological treatment plant.
This methodology can be easily used for the examination of treated
efﬂuents and raw sewage samples, for the fulﬁlment of epidemiological
studies as well as for the implementation of monitoring and management
plans.
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P1645 The survey of common bacterial contamination in bottled
mineral water
M. Mardani, L. Gachkar, S. Najar Peerayeh, A. Asgari, B. Hajikhani,
R. Amiri (Tehran, IR)
Background: Bottled mineral water, generally considered more pure
than tap water in developing countries. Immunocompromised patient
and whom with commorbid condition often receive bottled mineral water
under the assumption that it is safer than tap water. To determine the
risk of common bacterial contamination of commercial bottled mineral
water in Iran, we conducted this study in 2006.
Materials and Methods: The design of the research is descriptive study.
68 samples (35 brand named company) of bottled mineral water was
collected from different province of Iran. Initially 200ml of bottled water
was ﬁltered with 0.45 micrometer pore (Sartorius label). The ﬁlter was
divided by sterile pence and scissor to multiple pieces, suspension in
nutrient broth and centrifuged. The culture was made by use of selective
media: nutrient agar and broth, dextrose sodium azide agar, yersinia
agar, and Clostridium selective agar. The bacterial contamination were
detected after incubation in 42ºC, 35ºC and 25ºC for 24 h, 48 h and 7
days.
Results: Out of 68 samples of bottled mineral water (35 brands),
41 samples (60%) showed evidence of contamination with common
bacterial, including 15 samples (36%) Gram-positive sporforming bacilli,
20 Samples (49%) Gram-positive non sporforming bacilli (diphteroids)
and 6 Samples (15%) Gram-positive cocci. The marker organisms, i.e.
the classic faecal contamination indicators were not detected in any of
samples.
Conclusion: This ﬁnding indicated that the use of bottled mineral water
in immunocompotent persons is safe, but the use of this bottled mineral
water in immunocompromised patients should be done with meticulouse
precaution. Some of bacteria were known human commensals suggesting
contamination of waters prior to bottling. It is recommended that
bottling, packaging and distribution of this water should be done more
surveillance.
P1646 Vibrio cholerae O139 requires neither capsule nor
lipopolysaccharide O side chain to grow inside
Acanthamoeba castellanii
H. Abd, A. Saeed, B. Edvinsson, A. Weintraub, G. Sandstro¨m
(Stockholm, SE)
Objectives: Vibrio cholerae O139, the causative agent of cholera, has
grown and survived in the aquatic free-living amoeba Acanthamoeba
castellanii. The aim of the present study was to examine the ability
of the clinical isolate V. cholerae O139 MO10 to grow with each of
A. castellanii, A. culbertsoni and A. polyphaga as well as to determine
effect of bacterial capsule and LPS O side chain on the intracellular
growth of V. cholerae O139 MO10 in A. castellanii.
Methods: Acanthamoeba species and V. cholerae strains were alone
and co-cultivated for two weeks. Gentamicin assay was used to kill
extracellular V. cholerae as well as to examine ability of amoeba to
protect intracellular V. cholerae. Interaction between microorganisms
was studied by viable count, mannose assay, electron microscopy and
statistical analysis.
Results: The results showed that A. castellanii, A. culbertsoni and
A. polyphaga grew in the presence of V. cholerae O139 MO10 and the
amoeba number increased ten-fold, 2 times and 4 times after 14 days,
respectively.
Growth of the wildtype V. cholerae MO10, V. cholerae MO10-T4 lacking
capsule, and V. cholerae Bengal-2R lacking LPS O side chain was
enhanced signiﬁcantly in the presence of A. castellanii (p = 0.00003).
Intracellular growth of V. cholerae strains in A. castellanii was not
signiﬁcant; p value of Chi-2 test was 0.999).
The addition of mannose did not affect intracellular growth of V. cholerae
MO10 in A. castellanii, which indicated that the mannose did not inhibit
adherence of V. cholerae to A. castellanii explaining that V. cholerae cells
adhered nonspeciﬁcally to A. castellanii and nonspeciﬁc adherence plays
a role of bacteria attachment to A. castellanii. The number of viable
V. cholerae O139 MO10 inside A. castellanii with or without mannose
was not signiﬁcantly different (p = 0.94).
Electron microscopy showed that the intracellular localisation of the
bacteria was in vacuoles in the cytoplasm of trophozoites a few hours
after co-cultivation. Multiplication of bacterial cells occurred in the
cytoplasm of trophozoites one day after co-cultivation and the bacteria
were found in the cysts of A. castellanii 6 and 7 days after co-cultivation.
Conclusions: Neither the capsule nor the LPS O side chain of V. cholerae
O139 was found to play an important antiphagocytic role against
A. castellanii disclosing the intracellular behaviour of V. cholerae as well
as the role of Acanthamoebae as environmental hosts for V. cholerae
P1647 Ability of Acanthamoeba polyphaga to host cholera toxin
producing Vibrio cholerae O1 classical strains
G. Sandstro¨m, H. Abd (Stockholm, Solna, SE)
Objectives: Vibrio cholerae O1 is a waterborne bacterium that infects
humans and causes cholera. Since the infections dose is 108-109 cells,
V. cholerae requires a host for multiplication to be able to reach this dose.
Acanthamoeba is a genus of free-living amoeba that can host pathogenic
bacteria and acts as a model cell to study interaction between eukaryotes
and prokaryotes. Our previous studies have shown that V. cholerae O1
and O139 can grow and survive symbiotically inside Acanthamoeba
castellanii, which indicates that free-living amoeba may have a roll in
the epidemiology of V. cholerae. The aim of this study is to examine
ability of A. polyphaga to host V. cholerae O1 classical.
Methods: A. polyphaga and V. cholerae were alone and co-cultivated for
two weeks. Gentamicin assay used to discriminate between extracellular
and intracellular growing V. cholerae. Interaction between amoebae and
bacteria was studied by viable count, electron microscopy and statistical
analysis.
Results: Number of viable A. polyphaga in absence or presence of
V. cholerae increased from 2×105 cell/ml at day 0 to 1.6×106 cell/ml
and to7×105 cell/ml at day 15, respectively. Presence of V. cholerae did
not inhibit growth of the amoebae; p of t-test was 0.30.
Viable count of V. cholerae in presence of A. polyphaga was 2×106
CFU/ml at day 0 and increased to 2×109 CFU/ml at day 1. The bacteria
survived more than two weeks and the viable count was 2×108 CFU/ml
at day 15. Viable count of V. cholerae in absence of A. polyphaga
decreased from 2×106 CFU/ml at day 0 to 0 CFU/ml. The difference in
growth was signiﬁcant (p< 0.0.5).
V. cholerae grew inside A. polyphaga from 0 CFU/l at day 0 to 2×106
CFU/ml at day 1. The intracellular bacteria survived more than two
weeks and their viable count was 5×105 CFU/ml at day 15. Electron
microscopy visualised the intracellular localisation of V. cholerae cells
in vacuoles of the trophozoites as well as in cysts of A. polyphaga.
Conclusions: A. polyphaga and V. cholerae live together in co-culture.
Growth of the amoebae was not inhibited, and growth of the bacteria
was enhanced and the bacterial growth occurred inside amoeba cells
indicating a symbiotic relation between A. polyphaga and V. cholerae
O1 classical strains.
P1648 An investigation into clostridia toxins as a cause of
gastro-intestinal disease in companion animals
S. Newell, M. Rich (Wetherby, UK)
Objectives: Diarrhoeal disease is a common clinical presentation in
companion animals. The most common bacterial agents are Salmonella
species, and Campylobacter species. Studies have clearly demonstrated
that Clostridium species can cause a number of disease states in
production animals; however, evidence of investigation into Clostridium
species as a causative agent of gastro-intestinal disease in companion
animals is scant. It would be expected to isolate Clostridium species from
most clinical faecal samples, however, it is important to demonstrate
toxogenicity in these isolates, as toxin production is the primary
pathogenicity factor. Two species of Clostridium have been primarily
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connected to intestinal disease in both humans and animals; these are
C. perfringens and C. difﬁcile. The primary aim of this study is to
identify the presence of Clostridium species in the faecal samples of
companion animals with no other detectable disease process to explain
their gastro-intestinal symptoms. The investigation will include culturing
the samples for the conﬁrmation of Clostridium species and toxin
detection for the presence of C. perfringens enterotoxin and C. difﬁcile
toxins A and B.
Methods: An investigation was carried out into the prevalence of
C. perfringens and C. difﬁcile in companion animals. We investigated
faecal samples from 132 dogs and 56 cats, all with a history of diarrhoea.
The investigation consisted of testing all samples (in two groups of
94) using the ELISA tests, C. difﬁcile TOX A/B II and C. perfringens
enterotoxin. The ﬁrst batch of samples were cultured anaerobically and
pheynotypically identiﬁed as Clostridium species. The second set of
samples were further sub-cultured to achieve a pure growth and identiﬁed
using Clostridium PET.
Results: 27.3% of dogs and 14.3% of cats were positive using the
C. difﬁcile ELISA. 49.2% of dogs and 51.8% of cats were positive on the
C. perfringens ELISA. Culture results showed the ﬁrst set of specimens
to be 51.6% positive for Clostridial growth in dogs and 50% in cats.
The second set showed that 2.9% of dogs and 3.8% of cats carried
C. difﬁcile, 2.9% of dogs and 7.7% of cats carried C. perfringens and
42.6% of dogs and 46.2% of cats carried other species or unidentiﬁed
Clostridium species.
Conclusion: This investigation demonstrates that dogs and cats carry
both C. difﬁcile and C. perfringens. This study used samples from
animals that had conﬁrmed cases of diarrhoea. Further work needs to
be carried out to investigate the prevalence of Clostridium species in
healthy animals and to identify whether it is a signiﬁcant causative agent
of diarrhoea or a harmless commensal present in the majority of animals.
P1649 Farm to fork tracing of broiler-derived salmonellae and
thermotolerant campylobacters in a Hungarian county
using molecular epidemiology methods
G. Kardos, I. Damjanova, N. No´gra´dy, J. Me´sza´ros, Zs. Gala´ntai,
I. Turcsa´nyi, A. Bistya´k, T. Farkas, A´. Juha´sz, J. Pa´szti, I. Kiss
(Debrecen, Budapest, HU)
Objectives: Our aim was to follow salmonellae and campylobacters
from ﬂock through abattoir to retail shops in seven broiler ﬂocks and
to monitor human disease occurring in the region where the meat was
sold. Five ﬂocks were kept consecutively in the same henhouse.
Methods: Faecal samples were collected at least at three weeks of age
and before slaughter. At abattoir hygienic, neckskin and breast ﬁlet, while
at shops different meat samples were collected. Sampling followed the
ofﬁcial guidelines. All human stool samples sent for examination from
patients older than one year from the region were included. Cultured
salmonellae and campylobacters were subjected to phage- and ﬂa-typing,
respectively, results were conﬁrmed by PFGE.
Results: Only the two independent ﬂocks were Salmonella positive
at premise. Neckskin samples were always positive, but prevalence
in faeces-negative ﬂocks was lower. Abattoir meat of negative ﬂocks
yielded only one of ﬁve or no positive samples, while in case of positive
ﬂocks was always 100% positive similarly to retail meat. Retail meat of
only one abattoir-negative ﬂock remained negative in the shop indicating
that meat may become contaminated in the shop. All 109 isolated
salmonellae were S. Infantis, and together with all 17 human S. Infantis
isolates belonged to the clone known to be widespread in Hungary.
All ﬂocks were Campylobacter positive at three weeks and before
slaughter, but generally negative at earlier ages. Contamination has in
all ﬂocks been passed to abattoir- and retail meat (30/35 and 45/55
positives, respectively). C. jejuni was predominant. Culture-conﬁrmed
campylobacteriosis occurred in 2.5−4.5% of sampled enteritic patients,
showing an incidence of 3.1 to 8.3/100000 per month.
Typing of campylobacters revealed that all ﬂocks harboured a unique
strain detected in the majority of animal-derived, abattoir and retail meat
samples. Passing of campylobacters between ﬂocks was rare even in
ﬂocks kept in the same henhouse. Human isolates were diverse, all ﬂock-
speciﬁc patterns were detected in human samples.
Conclusion: This work models a way to trace food-borne pathogens from
farm to fork. S. Infantis was highly clonal, widespread among ﬂocks and
human cases. Campylobacters, in contrast, show signiﬁcant diversity,
and each broiler ﬂock seems to have a unique dominant Campylobacter
clone, which led to a high diversity in human disease.
The work was supported by GVOP-3.1.1.-2004–05−0472/03 grant.
P1650 Comparison of the microbial load of incoming and distal
outlet water from dental unit water systems
I. Tu¨retgen, D. Go¨ksay, A. Cotuk (Istanbul, TR)
Objectives: The objective is to compare the total microbial load of
the incoming and distal outlet water in dental unit water systems using
two methods, traditional culture method and epiﬂuorescence microscopy.
Additionally, the presence of Legionella pneumophila bacterium which
is responsible for Legionnaires’ Disease was also tested by standard ISO
method in distal outlet waters.
Method: 123 water samples were taken from the high-speed handpieces
lines, air-water syringe lines and source (incoming) water supplies from
41 dental units. 21 dental units were randomly selected from private
practices, whereas the other 20 units were at the same hospital’s dental
clinic. The samples were assayed for live/dead bacteria (DAPI+CTC
dual dye combination), heterotrophic bacterial counts and presence of
L. pneumophila bacteria (L. pneumophila only in high-speed handpiece
outlet water).
Results: In our study, 39 out of 41 dental units were not able to
meet the limit of 200 CFU/ml in dental unit water. Live bacterial
counts were found 1−1.5 orders of magnitude higher than aerobic
mesophilic heterotrophic bacteria. L. pneumophila (serogroup 2–14) was
isolated from 5 units out of 41. Source water of eight unit was heavily
contaminated which were fed up by commercially bottled drinking water.
Sample source N Mean count log10 CFU/ml
AMHB
Inlet water 41 3.17
High-speed handpiece 41 3.51
A/W Syringe 41 3.29
Live Microorganisms
Inlet water 41 4.02
High-speed handpiece 41 4.09
A/W Syringe 41 4.83
Total Microorganisms
Inlet water 41 8.95
High-speed handpiece 41 9.41
A/W Syringe 41 9.03
AMHB: aerobic mesophilic heterotrophic bacteria; A/W: Air/water.
Conclusion: In general, the microbiological quality of dental unit water
from dental practice is poor. In some practices the source water was
found heavily contaminated, but the use of water with an initial low
contamination level did not prevent its increase within dental units.
Dental unit waterlines must be maintained regularly to deliver output
water of an acceptable microbiologic quality.
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P1651 Klebsiella pneumoniae ESBL, a protracted outbreak
B. Lytsy, A˚. Melhus, C. Artinger, O. Aspevall, B. Eriksson, G. Gu¨nther,
A. Hambraeus, U. Ransjo¨ on behalf of the Klebsiella ESBL Working
Group
Objectives: Increasing numbers of multi-resistant K. pneumoniae
isolates were found during May-Aug 2005 in Uppsala University
Hospital, predominantly in urinary samples. The objective of the study
was to identify risk factors for colonisation, develop screening strategies,
and to reduce spread of resistant Enterobacteriaceae.
Methods: Isolates were typed with PhenePlate and PFGE, and belonged
to a single clone, producing CTXM-15. Numbers of new cases were
few after November 2005, but increased greatly during June-August
2006. The hospital then formed a Klebsiella ESBL steering group
and working group with representatives from Microbiology, Infectious
disease, Infection control, and Hospital administration.
Interventions used to terminate the outbreak:
– Placing cases with urinary catheters, diarrhoea, and/or discharging
wounds in single rooms
– Enforced contact precautions for all levels of staff: short-sleeved
working clothes, alcohol hand disinfection before and after any patient
contact, gloves and plastic aprons at risk of soilage.
– Emphasis on hand hygiene for patients and visitors.
– Antimicrobial stewardship
To improve case-ﬁnding, screening strategies were developed, concen-
trating on stool samples from all patients in all wards, using selective
media and PCR for CTXM group 1.
Results: Over 40 000 screening samples were taken Oct 2006-Aug 2007.
From May 2005 to September 2007, 257 patients were found to carry
the outbreak strain in >50 different wards and departments, but not
in intensive care units. A case-control study identiﬁed naso-gastric
feeding, urinary tract catheters, diarrhoea, surgery, and use of third-
generation cephalosporins/ﬂuoroquinolons/ carbapenems as independent
risk factors.
During June-Aug 2007, only 4 new clinical cases occured, as compared
to 41 during June-Aug 2006. Use of hand alcohol increased from 31
to 81ml/ per patient day. Improved compliance with contact precautions
was observed. Cephalosporin use was reduced from approx 12000 to
4000 DDD/ six months. New patient beds were opened and stafﬁng
increased, to reduce overcrowding in risk wards. The cost of the outbreak
is estimated at 3 million EUR.
Conclusion: When cases do not seem to be related in time and space,
and most patients are only colonised, an outbreak can become very
large before it is recognised. Joint efforts are needed to control such an
outbreak, focussing on hand hygiene for patients and staff, reduction of
overcrowding, and antimicrobial stewardship.
P1652 Antimicrobial resistance and extended-spectrum
b-lactamase production of Enterobacteriaceae from
inpatients and outpatients with urinary tract infection
S. Kurutepe, S. Surucuoglu, H. Gazi, T. Ecemis, G. Dinc, O. Tunger
(Izmir, TR)
Objectives: Extended-spectrum b-lactamases (ESBL) are important
resistance traits for nosocomial isolates Enterobacteriaceae and their
spread in the community generates increasing concern. This study
was performed to investigate the prevalence of ESBL producers in
Enterobacteriaceae isolated from both inpatients and outpatients with
urinary tract infection and their resistance to antimicrobial agents.
Methods: A total of 965 strain of Enterobacteriaceae were isolated
from urine samples; 434 isolates from inpatients and, 531 from
outpatients from June 2006 to September 2007. Suspected strains
are presumptively deﬁned as ESBL producers according to result of
disc diffusion method, using ESBL marker antibiotics ceftazidime
(CAZ), cefotaxime (CTX) and aztreonam (ATM). Those isolates
were retested with double-disc sinergy test (DDST)-CAZ, CTX,
ATM and amoxicillin-clavulanic acid (AMC) disc implementation
(CLSI). Enhancement of inhibition zone (or so called ghost zone)
indicated presence of ESBL. Antimicrobial susceptibility to b-lactam
antibiotics, gentamicin, trimethoprim-sulfamethoxazole, ciproﬂoxacin,
nitrofurantoin was performed by disc diffusion method according to the
recommendations of the CLSI.
Results: The species distribution as follows: Escherichia coli 79.3%,
Klebsiella spp. 12.7%, Entrobacter spp. 3.2%, Proteus spp. 3.0%,
Citrobacter spp. 1.0%, Morganella morganii 0.4%, Serratia marcescens
0.3%, Pantoea agglomerans 0.1%. The average prevalence of ESBL
producers was 47.0% among isolates from inpatients and 8.7% among
outpatient isolates. Approximately 95% of the ESBL-producing strains
belonged to just two species E. coli (n = 194/25.4%) and Klebsiella spp.
(n = 45/36.9%).
The resistance rates of non-ESBL producers and ESBL producers
to imipenem 0.0% versus 1.6%, to nitrofurantoin 5.7% versus
30.5% (p = 0.000), to gentamicin 15.3% versus 63.6% (p = 0.000),
to ciproﬂoxacin 25.8% versus 58.0% (p = 0.000), to trimethoprim-
sulfamethoxazole 38.2% versus 68.8% (p = 0.000) respectively.
Conclusion: ESBL production has been obsorved in large percantage
of urinary isolates and their expression is usually associated with multi-
drug resistance. Thus, surveillance of ESBL dissemination appears to be
important also community acquired infections.
P1653 Risk factors and clinical outcome for extended-spectrum
b-lactamase producing Escherichia coli blood stream
infection
K.W. Hong, S.Y. Park, J.W. Park, J.S. Kim, J.S. Eom (Seoul, KR)
Objective: Extended-spectrum b-lactamase (ESBL)-producing E. coli
have been increasingly isolated around the world. The aim of this
study is to determine the risk factors and the inﬂuence on clinical
outcome of ESBL-producing E. coli bloodstream infection (BSI). We
also investigated the inﬂuence of quinolone-resistant E. coli BSI on the
clinical outcome.
Methods: A retrospective study of 30 patients with bacteraemia due to
ESBL-producing E. coli and of 107 patients with non-ESBL-producing
E. coli in a tertiary hospital from 2005 to 2007 was conducted upon
review of patients’ medical records. 107 patients with non-ESBL-
producing E. coli BSI were divided into two groups according to the
resistance to quinolone and compared with each other. All data were
analysed by Statystical Analysis System (version 9.13).
Results: Multiple logistic regression analysis identiﬁed the prior
administration of 3rd generation cephalosporins [odds ratio(OR)=11.177,
p = 0.022], history of hospitalisation at intensive care unit (OR= 20.917,
p = 0.0026) in the previous 30 days were the independent risk factors for
ESBL-producing E. coli BSI. Patients with bacteraemia due to ESBL-
producing E. coli were treated with appropriate antibiotics less often than
controls (OR= 9.83, p = 0.0054). And clinical success was slightly more
frequent in the group with ESBL-producing E. coli BSI than control
group (OR= 20.815, p = 0.0031). The status of ESBL production showed
no association with hospital mortality (OR= 3.23, p = 0.2648). Among
107 patients with non-ESBL-producing E. coli BSI, 43%(47/107) of
isolates were resistant to quinolones. Patients with bacteraemia due to
quinolone resistant E. coli were treated with appropriate antibiotics less
often than control group (OR= 418.43, p< 0.0001). But, there was no
signiﬁcant difference in clinical success (OR= 1.036, p = 0.9676) and
hospital mortality (OR= 2.859, p = 0.3448).
Conclusion: The administration of 3rd generation cephalosporins,
history of hospitalisation at intensive care unit in the previous 30days
were the independent risk factors for ESBL-producing E. coli BSI. And
the status of ESBL production showed no association with hospital
mortality though patients with bacteraemia due to ESBL-producing
E. coli were treated with inappropriate antibiotics more often.
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P1654 Multidrug-resistant Pseudomonas aeruginosa among
hospitalised patients: risk and prognosis factors
R. Rodrı´guez, F. Ropero, M.V. Garcı´a, M.M. Gallardo, E. Granados,
A. Gutierrez, L. Mora, I. Viciana, A. Pinedo (Ma´laga, ES)
Objectives: Due to the increasing strains of multidrug resistance
P. aeruginosa (MRPA) we want to know the risk and prognosis factors
associated with its acquisition.
Methods: A case-control study was designed based in patients with
isolated nosocomial MRPA. The identiﬁcation and susceptibility test of
the strains was performed using the system Walk-Away® (Dade-Behring)
and E-test® (Izasa) methods according to CLSI standards. Statistical
analysis was performed with the SPSS/PC version 11.5.
Results: From October 2002 to December 2004 were isolated 81
nosocomial strains of MRPA that were matched by age and sex with
other 81 nosocomial strains of susceptible P. aeruginosa (SPA). Most
of them were male (77%) and the average age was 61.73 years. The
majority of patients with MRPA stayed in ICUs (54.3%, p< 0007). The
average stay from admission to the isolation (27.7 p< 0043), as well as
length of hospitalisation after that (28.69, p< 0001) were longer in the
cases. 57.7% of MRPA were associated with the development of severe
infection (p< 0016). Both the crude mortality (30.9% vs. 23.5%) and
the attributable (12.3% vs. 2.5%, p< 0.016) was greater in the cases. All
invasive procedures were more common in patients with PAMR, being
statistically signiﬁcant tracheal intubation, mechanical ventilation 48
hours, nasogastric tube, urinary catheters and others. Antibiotic treatment
before the isolation with carbapenem, quinolones, aminoglycosides was
statistically signiﬁcant as well. A logistic regression model identiﬁed
hospitalisation the previous month, incoming due to respiratory disease,
No. of comorbidities: 2, respiratory maneuvers and prior carbapenem
and aminoglycosides use, among others, as independent risk factors for
acquisition of MRPA. Among patients with isolations MRPA were found
as factors of poor prognosis the stay in ICUs and onco-haematology
services, invasive respiratory maneuvers, smoking among others.
Conclusions: The stay in ICUs and extended hospitalisation are
risk factors for acquiring MRPA. It is often associated with clinical
respiratory and with a mortality higher than the susceptible strains. The
previous contact with the hospital, as well as the respiratory manoeuvres
and prior use of certain antibiotics are independent risk factors for the
acquisition of PAMR. On the other hand, admission in onco-haematology
wards, sepsis and invasive maneuvers as MV 7 days were independent
factors of bad pronogsis among patients with MRPA.
P1655 Epidemiological and clinical features associated with
the colonisation/infection by Acinetobacter baumannii
heteroresistant to carbapenems
F. Ferna´ndez-Cuenca, M.C. Go´mez-Sa´nchez, J. Rodrı´guez-Ban˜o, J. Vila,
G. Bou, A. Pascual (Seville, Barcelona, La Corun˜a, ES)
Objective: To determine the epidemiological and clinical features
associated with the colonisation/infection by Acinetobacter baumannii
(Ab) Heteroresistant (HR) to Carbapenems (CP).
Methods: Sixty four Ab (identiﬁed by ARDRA) representing all the
pulsotypes (PFGE-type) and susceptibility patterns to CP (MIC range:
2 to 32mg/L) observed during November 2000 from 25 Spanish
hospitals were included. Isolates were considered HR if there was growth
of colonies within the inhibition zone of disks containing imipenem (IP)
or MPM (agar diffusion method). Clinical and epidemiological data from
patients with Ab HR to CP were compared with those of patients with
Ab non HR to CP (prospective cohort study). Chi-square or Fisher test
were used in the univariate analysis for qualitative variables. Differences
were signiﬁcative for p0.05.
Results: Of the 64 isolates 41 (64%) showed HR to CP and 23 (37%) did
not. All the Ab non HR to CP were susceptible to IP (MIC 4mg/L),
whereas 14 (34%) of Ab HR to CP were susceptible to IP. Fifty nine
Ab (38 HR to CP and 21 non HR to CP; 35 different PFGE-types)
isolated from 59 patients with available clinical and epidemiological
data were analysed. Differences in the predisposing factors between
patients with Ab HR to CP and patients with Ab non HR to CP were
signiﬁcative for ICU admission (61% vs 33%; p = 0.04), COPD (8% vs
29%; p = 0.05) and previous use of penicillins (49% vs 14%; p = 0.01).
For previous use of CP the differences were 26% vs 5% (p = 0.07). The
frequency of clinical and outcome variables in patients with Ab HR to
CP and in patients with Ab non HR to CP were: infection (65% vs 48%;
p = 0.2), sepsis (76% vs 70%; p = 0.6), respiratory tract infection (56%
vs 50%; p=1), urinary tract infection (4% vs 30%; p = 0.06), skin and
soft tissue infection (28% vs 10%; p = 0.3), primary bacteraemia (8% vs
0%; p = 0.2), treatment with CP (62% vs 33%; p = 0.2), crude mortality
(patients with infection: 29% vs 40%, p = 0.6; patients treated with CP:
25% vs 33%, p=1; all patients: 22% vs 24%, p=1).
Conclusions: Variables signiﬁcantly associated with Ab HR to CP
isolates were: ICU stay and previous administration of penicillins.
Central venous catheter and previous receipt of CP almost reached
signiﬁcance. On the contrary, COPD was more frequent among patients
with Ab non HR to CP. Ab non HR to CP more frequently caused UTI.
No other clinical differences were found. The low number of cases with
infection limits the analysis of the clinical signiﬁcance of HR to CP.
P1656 A carbapenem-resistant Acinetobacter baumannii outbreak
in ICU. Diagnostic value of rep-PCR for a rapid charac-
terisation of different genotypes, Montevideo, Uruguay
A. Galiana, N. Estrada, M. Godino, I. Christophersen, S. Machiavello,
N. Ramos, A. Fajardo, W. Pedreira, H. Bagnulo (Montevideo, UY)
Introduction: Acinetobacter baumannii (Ab) is the 2nd Gram-negative
agent associated with nosocomial colonisation-infection. 20–30% has
clinical signiﬁcance. Multiresistance – included Carbapenems – limits
their therapeutic options. Control measures require recognition of
resistance and genotypes proﬁles. Molecular methods (PCR and rep-
PCR) are useful for typing and detect resistant mechanisms.
Objective: To describe the emergence of Carbapenem multiresistant
Ab (CRAb), resistant phenotypes, clinical signiﬁcance and rep-PCR
genotypes
Methods: Prospective observational surveillance study of 390 ICU (22
beds) consecutive patients admitted in January-October 2007.
Ab identiﬁed by conventional methods and API NF ®. Susceptibility test:
disk diffusion agar CLSI 2007 and Minimal Inhibitory Concentration
(MIC) by E-test ®. Carbapenemase activity: Hodge Test, MBL E-test®,
and blank disks with EDTA-mercaptopropionic acid. Genotyping by rep-
PCR and electrophoresis in polyacrylamide gel.
Results: Overall: Ab isolated in 51 patients from 390 admissions: Blood
1, Spinal ﬂuid 3, Lower respiratory tract 35, Wound 5, Urine 6, Catheter
1. Clinical signiﬁcance: 13 (25%).
Period 1) Until June all (12) were Carbapenems susceptible:MIC 1mg/
L, and lower MICs (<1.5) to Tygecicline (TYG), Minocycline (MIN)
and Colistin; Resistant to Ceftazidime MIC> 256mg/L, Ciproﬂoxacin
MIC> 32mg/L and 50% Amikacin resistant. Clinical signiﬁcance: 3
(25%): 1.8 Ab infections 1000 patients-day. Rep-PCR genotypes: 2
proﬁles A-B.
Period 2) June-October: 39 Ab. Clinical signiﬁcance: 10 (25.6%): 5.0
Ab infections 1000 patients-day. From June an outbreak of CRAb
(25) emerges. Low level resistance: Imipenem MIC range 2−8mg/L,
Meropenem MIC range 4–32mg/L, susceptible to TYG, MIN, COL
and to Sulbactam in MIC range 8–64mg/L. Hodge test, MBL E-test®
and inhibition EDTA disks: negative for carbapenemase activity. Rep-
PCR: new proﬁle C. (First case from Argentine frontier). Remarkable
relationship between mortality and clone C: 8 (all) patient dead
associated with this genotype.
Conclusion: Outbreak and rapid spread of a CRAb clone associated
with mortality. Resistant phenotypes proﬁles not related to (MBL)
metaloenzymes, not being able to exclude OXA type enzymes. Rep-PCR
is useful for surveillance; the results were soon available differentiating
an emerging clone from endemic.
The low values observed in Carbapenem MICs may be incorrectly
identiﬁed by agar disk diffusion tests.
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P1657 A new fear for intensive care unit patients: colistin-resistant
MDR Gram-negatives
F.V. Kontopidou, E. Koratzanis, K. Pontikis, A. Armaganidis,
H. Giamarellou (Athens, GR)
Objectives: Selective pressure due to extensive colistin (Col) use seems
to lead to the emergence of Col resistance among Gram(−) strains,
jeopardising treatment choices in the ICU. The aim of this study was
to present the emergence of Col R Gram(−) strains isolated from ICU
patients in association with the exposure to Col.
Methods: The study was performed in a 12-bed University General ICU
from Nov 2003 to Dec 2006. Empirical antimicrobial treatment was
guided by weekly active surveillance of patients’ ﬂoras. All specimens
were cultured in MC agar plates containing antibiotics in order to
focus on resistant pathogen detection. Col R was deﬁned by Etest
according to the BSAC breakpoints (>4mg/ml). Epidemiological typing
was performed by REP-PCR in the ﬁst sensitive and the ﬁrst Col R
isolate from each patient.
Results: 152 patients were included in the study. Patients were colonised
by K. pneumoniae (54%), P. aeruginosa (57%), A.baummanni (75%),
Enterobacter spp. (17%), E. coli (28%) and S. maltophilia (30%) while
ColR strains were 37%, 4.5%, 2.5%, 4%, 7.3% and 44% respectively.
Among patients colonised with at least one ColR strain, 95% had
been exposed to Col while among patients who had been exposed to
Col, 66% developed at least one ColR strain. Epidemiological typing
demonstrated 20 distinct clones of ColR K. pneumoniae isolated from
30 patients. The median duration of exposure to Col, for patients that
were colonised or infected by distinct ColR K. pneumoniae clone during
their hospitalisation was 18 days. For 6 patients whose sensitive and
resistant isolate belonged to the same clone, the median duration of
exposure was 16 days. 6 patients had exposed to Col 4 days (0−4).
In all of these cases epidemiological typing showed that there was
horizontal transmission of the resistant clone among co hospitalised
patients. Patients that were colonised by K. pneumoniae ColR strains
were colonised also by ColR A.baummanni and P. aeruginosa strains.
18.5% of patients were also colonised with an intrinsically ColR
enterobacteriacae; among them 93% had been exposed to Col (p< 0.01,
OR:11.66). Blood stream infections(10) and VAP(2) from intrinsically
ColR enterobacteriacae were reported only in patients exposed to Col.
Conclusion: The treatment choices for infections caused by MDR
pathogens in ICUs are already limited. Unnecessary and/or prolonged
(>2weeks) COL administration should be eliminated due to increasing
resistance to Col among Gram(−) strains.
P1658 Antibiotic resistance in Pseudomonas aeruginosa from
food-producing animals: is it a threat for hospital-acquired
infections?
A. Hamouda, L. Vali, D.J. Walker, A. Mateus, J. Dave, A.P. Gibb,
S. Dancer, S.G.B. Amyes (Edinburgh, Glasgow, UK)
Objectives: It is well known that injudicious use of antibiotics in humans
plays a major role in developing antibiotic resistance in hospital bacteria,
however, there is controversy surrounding the use of antimicrobials in
food-producing animals, and their adverse effect on humans. In addition,
there is clear evidence that in the case of zoonotic bacteria direct transfer
to humans has taken place, but these pathogens are not a problem
in hospitals. The real threat comes rather from multi-resistant clinical
bacteria such as Pseudomonas aeruginosa. In this context, the aim of
this study was to investigate whether there is a link between antibiotic-
resistant P. aeruginosa isolated from food-producing animals and human
isolates.
Methods: Samples were taken from 31 farms and two abattoirs. Samples
(1034) were collected from cattle, sheep and pigs. In addition, 30 meat
products were bought from supermarkets and local shops. P. aeruginosa
clinical isolates (29) were obtained from two major Scottish hospitals.
Ten grams of faeces and food were homogenised in peptone water and
inoculated into acetamide broth then incubated for 24 hrs at 37ºC. This
was spread (500ml) onto cetrimide agar and incubated at 42ºC. Suspected
isolates were characterised by the API 20NE test, and polymerase chain
ampliﬁcation (PCR) of 16s rDNA was used to identify P. aeruginosa. The
minimum inhibitory concentration (MIC) of antibiotics was determined
by the agar dilution method following the BSAC Guidelines. Pulsed-ﬁeld
gel electrophoresis (PFGE) typing was performed using SpeI restriction
endonuclease.
Results: Out of 1034 animal samples processed, 40 (3.96%) were
positive for P. aeriginosa. There were 25 isolates from pigs, of which
7 (28%) had low-level imipenem resistance (LIR) (MIC 8–16mg/L), 8
from sheep and 7 from cattle. All isolates were sensitive to ciproﬂoxacin,
ceftazidime, piperacillin/tazobactam and meropenem. No carbapenemase
genes were detected in LIR. The PFGE showed that out of 40 animal
isolates 29 (72.5%) grouped in 8 clusters, with one cluster containing
LIR isolates; while out of 29 (6.89%) human isolates only 2 grouped in
one cluster with the remaining 27 isolates constituted individual proﬁles.
Not a single human isolate grouped with the animal cluster.
Conclusion: We showed that only few animal isolates had LIR but all
were sensitive to other major antibiotics. In addition, all animal isolates
were genetically distinct from human isolates by PFGE.
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P1659 Whole genome typing strategy for phylogenetic assignment
of species
S. Panaiotov, V. Levterova, N. Brankova, K. Tankova, T. Kantardjiev
(Soﬁa, BG)
Ampliﬁed fragment-length polymorphism (AFLP) is a whole genome
typing technique based on selective ampliﬁcation of digested DNA in
order to create ﬁngerprint for a particular genome. AFLP is utilised for
typing of microbial organisms, genealogical studies and phylogenetic
studies. AFLP technique generates large numbers of speciﬁc marker
fragments that could be used for phylogenetic assignment.
Objectives: To develop methodology that assigns phylogenetic related-
ness between known genetic patterns and species under study.
Methods: More than 150 mycobacterial isolates, 80 fungi and other 120
bacterial species have been tested. BamHI, PstI, MboI, HindIII, HaeIII
and XhoI restriction enzymes, appropriate adaptors for the restriction
sites, primer variations and ampliﬁcation conditions have been tested to
identify characteristic AFLP species-speciﬁc patterns. AFLP fragments
were separated on ALFexpress II sequencer and data elaboration with
GelCompar II software.
Resutls: Best results were obtained with PstI and BamHI restrictases,
adaptors ligated by T4 ligase to the restriction sites and fragments
ampliﬁed with PstI and Cy5 labeled BamHI primers. We demonstrate
species have unique AFLP pattern. Database of AFLP patterns has been
created and in use for identiﬁcation of new AFLP patterns.
Conclusions: Commercially available AFLP kits use EcoRI and MseI
restrictases. The fragments are ampliﬁed by using A-, T-, G- C- or
combinations for selective fragment ampliﬁcation. As a result only
the number of the ampliﬁed fragments is reduced and no additional
polymorphic sites are found. More restriction enzymes should be
investigated to identify maximum valuable polymorphisms. To obtain
good and reproducible AFLP proﬁles it is essential that DNA is isolated
from fresh cultures and free of RNA. Residual RNA molecules could
seriously compromise PCR ampliﬁcation. Residual non ligated adaptors
inhibit AFLP analysis. Comparison of different AFLP patterns could
identify genus, species, and strains’ speciﬁc bands. For phylogenetic
studies and identiﬁcation purposes, genus and strain speciﬁc bands are
of major interest. For epidemiological strains’ typing, of major interest
are the highly polymorphic strain speciﬁc bands. AFLP analysis might
prove to be a reliable tool for identiﬁcation and typing of unidentiﬁed
isolate(s) and assignment of phylogenetic position. Establishing an AFLP
database one can identify isolates and assign phylogenetic relations.
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P1660 Assessment of Bordetella pertussis genotypes distributed
in Bulgaria by direct analysis of clinical samples by
multiple-locus variable-number tandem repeat
S. Panaiotov, N. Brankova, V. Levterova, K. Tankova (Soﬁa, BG)
Bordetella pertussis, the causative agent of whooping cough is endemic
in Bulgaria despite extensive nationwide vaccination since 1950s. It is
suspected that strain variation plays a major role in the upsurges of
the disease. We applied multiple-locus variable-number tandem repeat
analysis (MLVA-VNTR) for typing of B. pertussis directly in clinical
samples.
Objectives: To study the genotypes of B. pertussis distributed in Bulgaria
applying MLVA typing strategy. The pertussis genotypes identiﬁed in
Bulgaria were also compared with those found in a selected Italian
samples.
Methods: More than 400 clinical samples were tested for the species-
speciﬁc IS1111 target of B. pertussis by PCR. Swabs were collected
from children (age 0–15) suspected for pertussis. Positive by PCR
samples were selected for typing according to the quantity of DNA
available from the swabs. 35 positive samples were typed for the
variability of four VNTR markers, following methods already described.
Ten Italian samples were used to compared the results. Each VNTR
locus was ampliﬁed using ﬂuorescently labelled primer. In order to
reduce the number of PCR reactions two VNTR loci were ampliﬁed by
multiplex PCR. Simultaneous ampliﬁcation of all four VNTR loci was
not manageable directly on clinical swabs. The Shannon-Weiner diversity
index was calculated for each locus and ranged from 0.5 to 0.7. In one
sample duplication of VNTR3 locus yielded two fragments differing in
size of 5 bases. The relationship between various genotypes is visualised
by constructing a minimum spanning tree and a dendrogram.
Results: Genotypes in both countries differ, but one prevalent
genotype could be identiﬁed. 9 VNTR polymorphisms and 4 genotypes
were identiﬁed. More VNTR loci should be added to increase the
discriminatory power of the methodology.
Conclusions: These preliminary results seems to be very promising to
understang the biodiversity of pertussis strains circulating in our country.
VNTR could be applied as screening strategy in identifying outbreaks
and epidemiological studies.
P1661 Characterisation of an emm12/T12 GAS clone associated
with paediatric invasive disease in Portugal
A. Fria˜es, M. Ramirez, J. Melo-Cristino (Lisbon, PT)
Objectives: We have previously reported a signiﬁcant association
between a clone presenting the emm12/T12 gene and paediatric invasive
infections among a collection of 160 Group A Streptococci (GAS)
isolates recovered from normally sterile sites in Portugal, during 2000–
2005. The aim of the present work is to further characterize this clone
with respect to antimicrobial susceptibility and to the presence of several
genes encoding streptococcal exotoxins and ﬁbronectin- or collagen-
binding proteins.
Methods: All isolates (n = 10) were characterised by T typing,
emm typing, pulsed-ﬁeld gel electrophoresis (PFGE) macrorestriction
proﬁling, and multilocus sequence typing. Susceptibility to penicillin,
clindamycin, erythromycin, and tetracycline was tested by disk diffusion.
The presence of the streptococcal exotoxin genes speA, speB, speC, speF,
speH, speI, speK, speJ, ssa, and smeZ, and of the ﬁbronectin- or collagen-
binding proteins encoding genes prtF1, prtF2, and cpa was assessed by
PCR with speciﬁc primers.
Results: During 2000–2005, ten emm12/T12 isolates were identiﬁed
among a collection of 160 GAS strains isolated from invasive infections
in Portugal, of which seven were recovered from paediatric patients
(18 years), showing a statistically signiﬁcant association between
emm12/T12 isolates and paediatric invasive disease (p = 0.002, one-tailed
Fisher’s exact test). All isolates were susceptible to the antimicrobial
agents tested and were included in the same PFGE clone (Dice coefﬁcient
80% in an UPGMA dendrogram), which is characterised by T12,
emm12, ST36, and by the presence of the gene speH (three isolates
were also positive for speC).
Conclusion: An association of a clone deﬁned by a characteristic
PFGE proﬁle, emm12, T12, ST36, and carrying the speH gene, with
paediatric invasive disease was observed in Portugal. A high frequency
of carriage of this clone in children may contribute to this association,
as well as a preference of this clone for colonising or causing infections
in children rather than adults. The association between emm12 and
paediatric invasive infections was previously reported in the Netherlands,
although the data available does not allow us to conclude if it was the
same clone as the one reported here.
P1662 Molecular epidemiology of clinical isolates of Streptococcus
pneumoniae at a children’s hospital in Turkey
O. Koseoglu Eser, K.P. Klugman, D. Gur, L. McGee (Ankara, TR;
Atlanta, US)
Objectives: Pneumoccal diseases are the leading vaccine preventable
cause of childhood deaths. Pneumococcal vaccines are not in routine use
as part of the national immunisation programme for children in Turkey.
Effective surveillance of pneumococcal isolates can assist in evaluating
the necessity of pneumococcal vaccines in Turkish children. This study
investigates the molecular epidemiology of Streptococcus pneumoniae
strains isolated from children in Ankara, Turkey.
Methods: Clinical isolates were obtained from children attending
Hacettepe University Ihsan Dogramaci’s Children Hospital in Ankara,
Turkey. Multilocus sequence typing (MLST) was performed for a total of
96 S. pneumoniae strains. All isolates were serotyped by multiplex-PCR
and quellung reaction with speciﬁc capsular antisera of S. pneumoniae.
Results: All isolates were found in 34 different serotypes and 6 isolates
were untypeable. The most frequent serotypes were 19F, 14, 6A, 6B,
respectively. Thirty-seven (38.5%) isolates were 7-valent (excluding
6A) vaccine types. Only three of the isolates were invasive. MLST
analysis of isolates demonstrated a diversity of strains as 69 different
allelic proﬁles were present. Thirty-seven (38.5%) new STs were
determined. MLST revealed that 28 (29.2%) of the isolates were
related to 7 international clones identiﬁed by Pneumococcal Molecular
Epidemiology Network. These seven clones were England14−9 (n = 4),
Spain23F-1 (n = 7), Spain6B-2 (n = 4), Spain9V-3 (n = 4), Portugal19F-
21 (n = 4), Taiwan19F-14 (n = 4), Taiwan23F-15 (n = 1). Evidence of
serotype replacement was observed in the isolates related to the
England14−9 and Spain23F-1 clone, which indicates capsular switching.
Conclusion: The coverage of the 7-valent vaccine was low with only
38.5% of strains included. Among the 69 MLST STs found in these
96 isolates, 37 new STs were identiﬁed and strains belonging to well
described international clones were also present. This suggests that the
distribution of strains in Turkey differs somewhat from those encountered
in other countries and that multiple clonal spread is occurring within
the region. This study may provide an important baseline to assess the
future use of pneumococcal vaccines in routine vaccination programmes
in children in Turkey.
P1663 Clonal complexes causing invasive meningococcal disease
in the Czech Republic in 2005–2007
J. Kalmusova, M. Musilek, P. Kriz (Prague, CZ)
Objectives: Surveillance of invasive meningococcal disease (IMD) has
been performed in the Czech Republic since 1993. Molecular methods
of characterisation of Neisseria meningitidis, which have been used
continuously in the National Reference Laboratory for Meningococcal
Infections (NRL) allow precise assessment of the epidemiological
situation and give a base for precise vaccination strategy in the
country. The NRL participates in the EMERT (European Meningococcal
Epidemiology in Real Time) project organised by the EMGM (European
Monitoring Group on Meningococci) with data submitted from January
2007 (http://emgm.eu/emert/).
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Methods: All isolates from IMD sent to the NRL were characterised,
with a total of 136 N. meningitidis isolates causing IMD in the
Czech Republic in the period 2005–2007 (October). The isolates were
characterised by serogrouping, serotyping, PorA and FetA sequencing
(http://neisseria.org/nm/typing/) and multilocus sequence typing (MLST)
(http://pubmlst.org/neisseria/).
Results: Serogroup B (MenB) was prevalent (66.2%), followed by
serogroup C (MenC) (29.4%). Among MenB isolates, 52 sequence types
(STs) were identiﬁed, 29 of them were new, described for the ﬁrst time on
Czech isolates. These 52 STs belonged to 12 clonal complexes, 17.8% of
MenB isolates were unassigned to clonal complexes. The most frequent
clonal complex among MenB isolates was cc41/44, followed by cc32,
cc18 and cc269. Among MenC isolates, 12 STs were identiﬁed, 6 of
them were new. These 12 STs belonged to 4 clonal complexes. 2.5% of
MenC isolates were unassigned to clonal complexes. The most frequent
clonal complex among MenC isolates was cc11, followed by cc41/44.
PorA and FetA sequencing showed lower heterogeneity of MenC isolates
compared to MenB. Five isolates of serogroup Y were found and two of
them belonged to the hypervirulent cc23. Only one isolate of serogroup
X was detected, not belonging to a clonal complex.
Conclusion: N. meningitidis B isolates were prevalent and showed higher
genetic heterogeneity compared to N. meningitidis C isolates. Among
all isolates two clonal complexes prevailed: cc11 (22.1%) and cc41/44
(21.3%).
Acknowledgement: This work was supported by Ministry of Health, by
research grant 1A8688−3 and made use of the Multi Locus Sequence
Typing website (http://pubmlst.org/neisseria/) sited at the University of
Oxford and funded by the Wellcome Trust and European Union.
P1664 Design and implementation of an external quality assurance
scheme for Neisseria meningitidis characterisation for
cultures and non-culture material
S.J. Gray, A.J. Fox, N. Patel, V. James, L. Newbold, C. Walton
(Manchester, London, UK)
An external quality assurance (EQA) scheme was designed to
optimise and standardise European meningococcal reference laboratory
meningococcal strain characterisation and detection to ensure accurate
surveillance.
Three panels of N. meningitidis isolates and simulated septicaemic blood
samples were distributed for phenotypic and genotypic (meningococcal
nucleic acid detection, serogroup determination and sequence typing)
characterisation as performed by EU-IBIS participating Reference
laboratories. Isolates were selected to represent important circulating
strains in Europe. The simulated septicaemic blood samples comprised
“standardised” heat-killed suspensions of organisms diluted in deﬁbri-
nated horse blood prepared by the HPA Meningococcal Reference Unit.
Freeze-drying, panel distribution and reporting were carried out by the
HPA Quality Assurance Laboratory.
Each participating laboratory received a report comparing their results to
the consensus for each sample characteristic. There was good agreement
for the phenotypic characteristics. Minor clerical errors in reporting and
some differences in nomenclature were identiﬁed. In those laboratories
undertaking genotypic characterisation (including porA sequencing and
Multilocus Sequence Typing) there was excellent agreement but notable
differences with the weaker positive (lower copy number) material were
observed.
European phenotypic and genotypic strain characterisation including
nucleic acid detection and non-culture genotyping was successfully
established for EU-IBIS participants. The EQA distributions demon-
strated the utility and improved standardisation obtained by molecular
strain characterisation. The second EQA distribution identiﬁed areas
for improvement primarily concerning low copy number nucleic acid
detection for non-culture conﬁrmation of infection and subsequent strain
characterisation including serogroup identiﬁcation. Also highlighted
were issues regarding reporting, nomenclature and reagent availability.
The second distribution informed cthe design of the third distribution,
the results of which are awaited.
P1665 Population structure of Enterococcus isolates from Portugal
A.R. Freitas, C. Novais, P. Ruı´z-Garbajosa, T.M. Coque, L. Peixe
(Porto, PT; Madrid, ES)
Objectives: Portugal is one of the EU countries with highest
vancomycin-resistant enterococci (VRE) rate. Our aim is to analyse the
population structure of enterococci and their relationship with the spread
of glycopeptide resistance.
Methods: We studied 24 E. faecalis (Efc) and 24 E. faecium (Efm)
isolates of a large Portuguese collection (1996–2004) from nosocomial
infections (H, n = 32; from 3 cities), environment (E, n = 3), healthy
humans (C, n = 5) and animals (swine-S, n = 1; poultry-P, n = 7). Clonal
relatedness was established by PFGE and MLST. Virulence traits (gel,
asa, cyl, hyl and esp) were searched by PCR. Analysis of GRE included
characterisation of Tn1546 backbone (PCR overlapping; sequencing),
transferability and genomic location (I-CeuI/S1 nuclease; vanA/23S
rDNA probes).
Results: Efc strains from hospitalised persons were classiﬁed as high-
risk enterococcal clonal complexes (HiRCC) CC2 (ST6) or CC21 (ST21,
ST22, ST117), and singletons ST159 (a new ST located in two cities 4
years apart), ST19, ST30, ST41, ST55, most observed in both VRE
and VSE strains. STs from other sources were ST16 (C, P), ST35
(P), ST26 (C) and the new ST160 (C). Most Efc contained gel, asa,
cyl and esp (95%, 89%, 53% and 47%, respectively). Six Tn1546-
types were detected, although variant PP4 containing ISEf1 conﬁned
to H and located on large transferable plasmids (84–145 kb) was the
predominant. Most VREfm strains (17/18) from H, E and C belonged
to the widely disseminated CC17 (ST18, ST80, ST280, ST16, ST132,
ST366, ST367, ST368 and ST369). ST366-ST369 were identiﬁed in H
and E and assigned as new variants of CC17. CC5 (ST6) was observed in
2 VRE strains from H and S, both containing Tn1546-type D. All VREfm
isolates from P were grouped in ST9 (n = 2) and ST12 (n = 3). Efm strains
from H and E carried only esp gene (50%) or hyl (19%). PP-4/PP-5
ISEf1-carrying Tn1546-types from H were also predominant among Efm
strains and located on large conjugative plasmids (80–110kb).
Conclusions: Our results conﬁrm the relevance of the worldwide spread
Efc and Efm HiRCC. Dissemination and persistence of ST159-Efc
among Portuguese hospitals might reﬂect the emergence of a new
epidemic CC. The similarity of Tn1546 and plasmid proﬁles found
among different STs indicates that horizontal transfer also plays a
relevant role in VRE spread in Portugal.
P1666 Clonal analysis of vancomycin-resistant Enterococcus
faecium by MLVA and PFGE typing
E. Jagiello, A. Kuch, E. Sadowy, W. Hryniewicz (Warsaw, PL)
Objective: The aim of the study was to reveal the clonal structure of
a vancomycin-resistant E. faecium (VREM) population by MLVA and
PFGE approaches and to compare these methods in an epidemiologic
investigation.
Methods: This study was performed on 121 VREM isolates collected
from several Polish hospitals in the National Medicines Institute in
Warsaw between January 2006 and November 2007. The VREM were
obtained from rectal swabs (n = 91), wound lesions (n = 7), blood (n =
13), urine (n = 8) and CSF (n = 2). PCR for van genes was performed
for all isolates, followed by MLVA and PFGE (SmaI digest) typing.
Results: There were 35 vanA and 85 vanB genotypes detected among
the isolates. In 2007 90% of isolates were vanA-positive, in contrast with
2006, when only 9.3% of isolates had the vanA genes.MLVA and PFGE
resulted in 35 and 21 types of 119 and 117 typeable isolates, respectively.
Comparable values of the discriminatory power, 0.6391 for MLVA and
0.6309 for PFGE, were observed. Among the determined MLVA types
(MTs) 12 were new. MT159 was predominant in 2007, representing
77.9% isolates from that year. The most of 2007 isolates (74.7%)
belonged to 15 subtypes of the PFGE type PT1, which comprised
92.5% of the MT159 isolates. Both MLVA and PFGE revealed greater
genetic diversity among 2006 isolates (12 MTs and 22 PTs among 30
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isolates) than among those from 2007 (11 MTs and 15 PTs among
91 isolates). No predominant MLVA or PFGE type was detected in
2006. The majority of isolates from 2006 and 2007 (>70% and >90%
respectively) were classiﬁed into the CC17 clonal complex based on
allele proﬁles determined by MLVA.
Conclusion: MLVA appeared to be comparably usefull to PFGE in
the epidemiologic analysis of VREM. Both methods reﬂected highly
concordant data concerning the level of genetic diversity among the
investigated isolates.
P1667 Evaluation of multi-locus VNTR sequence typing for
clustering of vancomycin-resistant Enterococcus faecium
clinical isolates
B. Middendorf, D. Harmsen, A.W. Friedrich, R. Ko¨ck, J. Top,
R.J.L. Willems, A. Mellmann (Mu¨nster, DE; Utrecht, NL)
Objectives: Vancomycin-resistant Enterococcus faecium (VREF) cause
nosocomial infections especially in compromised patients. Their
molecular epidemiology is primarily characterised by pulsed-ﬁeld gel
electrophoresis (PFGE). However, this method is very laborious and difﬁ-
cult to standardize for intra- and inter-laboratory comparisons. Recently,
MLST (multilocus sequence typing)- and MLVA (multilocus variable-
number of tandem repeats)-schemes were developed to overcome these
drawbacks. Due to their low discriminatory power their applicability in
outbreak investigations is limited. Therefore, we evaluated a multilocus
VNTR (variable number of tandem repeats) sequence typing (MLVST)
scheme for VREF.
Methods: To identify suitable repeat regions for MLVST, we analysed
the genome sequence of E. faecium DO with the programme ‘Tandem
Repeats Finder’. From a total number of 1580 repeat regions, three
were ﬁnally selected for further analysis (VNTR0032, VNTR0047, and
VNTR1398). The corresponding regions were sequenced from a well-
characterized reference collection comprising 144 environmental and
clinical VREF strains. To evaluate MLVST, the discriminatory index
(DI), the concordance to MLST and MLVA was determined for different
VNTR combinations, and tested in routine diagnostics using 47 clinical
isolates from related and unrelated strains based on PFGE data isolated
at the University Hospital Mu¨nster, Germany.
Results: Preliminary tests with the strain collection demonstrated that
the three VNTRs displayed individual DIs of 0.718 (VNTR0032),
0.794 (VNTR0047), and 0.835 (VNTR1398), whereas MLST and
MLVA resulted in DIs of 0.971 and 0.935, respectively. Typeability
was 100% (VNTR0032), 91.67% (VNTR0047), 84.03% (VNTR1398),
100% (MLST), and 80.56% (MLVA). Analysis between the combination
of all three VNTRs and MLST/MLVA resulted in concordances of
93.1%/91.6%. The combination VNTR1398/atpA/ddl (both genes from
the MLST scheme) accomplished the highest DI value of 0.974 and was
used for further analysis. Applying MLVST on the 47 clinical isolates,
43 were clustered concordant to PFGE grouping.
Conclusion: VNTR regions are appropriate targets for sequence-
based typing approaches. MLVST is a faster and less cost-intensive
alternative typing method for VREF in comparison to MLST and
results in clustering concordant to PFGE. Ongoing studies investigate
the performance in comparison to PFGE and the applicability in daily
clinical routine on a broader scale.
P1668 Genetic characterisation of vancomycin resistant isolates of
Enterococcus faecium isolated from patients in Tehran
M. Feizabadi, B. Fatollahzadeh, S. Sayadi, M. Parvin (Tehran, IR)
Objectives: We have previously found that up to 12% of clinical isolates
of E. faecium at Tehran hospitals showed resistance to vancomycin.
However, little data was available on the genetic heterogeneity of
vancomycin resistant isolates (VRE) among the Iranian population of
this organism. Therefore the emergence of infections with the new clones
of VRE needs to be investigated.
Materials and Methods: Collectively, 103 non replicative isolates of
enterococci grown from urine samples in the ﬁrst quarter of 2005 were
screened for their susceptibilities to different antibiotics. Ribotyping was
then used to genetically characterize the isolates of VRE.
Results: Using disk diffusion method, all isolates were found susceptible
to linezolid and nitrofurantoin. All isolates of E. faecalis (n = 86)
were susceptible to vancomycin. Conversely, over 70% of E. faecium
isolates (n = 12) showed resistance to this glycopepide. The VRE isolates
recovered from patients in 2005 were heterogenous comparing with those
of 2000.
Conclusion: Conventional bacteriology conﬁrmed the increase in rate of
VRE. It appears that a variety of new VRE clones have arisen recently
at different wards of this hospital as determined by ribotyping.
P1669 Identiﬁcation of enterococcal plasmids by multiplex-PCR-
based relaxase typing
P. Goicoechea, M. Romo, T.M. Coque, F. Baquero, F. de la Cruz,
L. Martı´nez-Martı´nez, M.V. Francia (Santander, Madrid, ES)
Objectives: Identiﬁcation of plasmids is important in order to analyse
their distribution and relationships to host cells, their evolutionary
origins, and the horizontal gene transfer, a process with a great impact
in the spread of antimicrobial resistance. Although methods for the
identiﬁcation of plasmids from enterobacteria were soon developed, no
such methods are currently available for enterococcal plasmids. We have
developed a novel PCR-based typing method to describe the ecology
of the antibiotic resistance plasmids in Enterococcus and evaluate their
role in the spread of antimicrobial resistance. Since plasmid transfer is
an almost universal procedure for gene spread among bacteria, a typing
method based in the relaxase, the crucial protein involved in initiation
of transfer, could be widely applicable.
Methods: 14 pairs of primers were designed on the basis of
published enterococcal relaxases sequences. 27 reference enterococcal
plasmids/strains were ﬁrst tested using simplex-PCR with each pair of
primers for initial testing of the oligonucleotides. 3 Multiplex-PCRs
were then performed on the reference plasmids/strains. Sequencing of
the amplicons was done by standard procedures for conﬁrmation of the
results.
Results: The speciﬁcity of each primer pair was tested on two plasmid-
free Enterococcus strains: E. faecium BM4105RF and E. faecalis
UV202. None of the primer pairs gave any ampliﬁcation using both
templates. Multiplex 1, 2 and 3 correctly detected the relaxases encoded
on the reference plasmids and no false positive results were observed.
Conclusions: The method developed is speciﬁc and sensitive and
does not require a laborious work. Individual or multiple plasmids
present in the same cell can be easily detected. Therefore, this
approach is potentially applicable for the typing of known enterococcal
plasmids present in diverse collections of strains. It will facilitate the
understanding of the tremendous spread of the antibiotic resistance in
Enterococcus.
P1670 Are the days of PFGE numbered? A comparison of
PCR-based typing methods with PFGE for identiﬁcation
of nosocomial transmission of MRSA
M.V.N. O’Sullivan, V. Sintchenko, G.L. Gilbert (Sydney, AU)
Objectives: Several new PCR-based typing techniques for meticillin-
resistant Staphylococcus aureus (MRSA) have been recently described
as alternatives to Pulse ﬁeld gel electrophoresis (PFGE) of SmaI
digested genomic DNA. However, their relative utility for identifying
nosocomial transmission episodes remains controversial. This study
sought to determine the usefulness of some of these techniques for this
purpose.
Methods: Fifty multiresistant MRSA isolates from epidemiologically
conﬁrmed nosocomial transmission events were studied. The isolates
came from two Sydney tertiary referral hospitals, where the prevalence
of MRSA amongst S. aureus isolates is approximately 50%. Additionally,
18 sporadic isolates with the same antibiograms from patients who
attended emergency departments or outpatient clinics but who were not
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admitted before or since were also collected. PFGE, Multilocus variable
number of tandem repeats analysis (MLVA) and spa sequence typing
were performed using published methods. Toxin gene proﬁling (TGP)
and SCCmec subtyping were performed using multiplex PCR and reverse
line blot assays developed in our laboratory.
The relative performance of the ﬁve methods was assessed using
Simpson’s index of diversity, the mean similarity of each pair of
transmission isolates, and the Pearson correlation of the similarity
matrix obtained using cluster analysis of the clinical relatedness with
the similarity matrix obtained using each typing method (clinical
congruence).
Results: The results are shown in the table below. MLVA and PFGE
performed equally well in predicting the clinical relatedness of isolates,
but were clearly superior to spa typing, TGP and SCCmec subtyping
for this purpose. The effect of combining PCR-based methods was also
assessed. Combining spa typing, TGP or SCCmec subtyping with MLVA
did not appear to improve performance.
Table. Performance of ﬁve typing methods in identiﬁcation of
nosocomial MRSA transmission. Values are percentages
PFGE MLVA spa TGP SCCmec
Simpson’s Index of Diversity 99 99 83 73 60
Mean similarity 80 70 66 93 93
Clinical congruence 31 31 16 11 14
Conclusions: Of the PCR-based methods studied, MLVA appears
to be the best candidate to replace PFGE for the identiﬁcation
of nosocomial transmission episodes of MRSA. However, TGP and
SCCmec subtyping may be useful to provide molecular markers of
clinically and epidemiologically relevant phenotypic characteristics.
P1671 Detection and genotyping of multidrug-resistant
Acinetobacter baumannii strains contain multiple
blaOXA-like genes in two burn hospitals, Tehran, Iran
M. Taherikalani, P. Maleknejad, G. Etemadi, S. Setareh, M. Feizabadi
(Tehran, IR)
Objectives: This study was designed to detection of multidrug-resistant
(MDR) Acinetobacter baumannii, distribution of blaOXA-like genes and
genotyping analysis of them among burns unit of two hospital of Tehran,
Iran.
Methods: during this study the susceptibility of 60 isolates of
A. baumannii from burn wounds (n = 48), blood samples (n = 4) and
trachea (n = 8) was determined with disk agar diffusion method.
Also susceptibility to imipenem and meropenem was determined by
minimum inhibitory concentration (MIC) according to CLSI guidelines.
Distribution of blaOXA-like genes was detected by Multiplex-PCR and
then these isolates were typed by PFGE.
Results: Result show that 66.6% (n= 40) of all Acinetobacter baumannii
isolates were MDR. Colistin and tigecycline were effective against 88.3%
(n = 53) and 83.3. % (n = 50) of isolates respectively. 66.6% (n = 40) and
65% (n = 39) of isolates were resistant to imipenem and meropenem
in both DAD and micobroth dilution method, respectively (with MIC
ranged of 64 to 256). All MDR strains possessed at least two blaOXA-
like genes especially blaOXA-51 and blaOXA-23-like carbapenemases.
Analysis of PFGE showed the existence of 2 clones (A and B) with
different sub clone in both hospitals. Clone A was dominant one of the
study hospital was studied.
Conclusion: Our study was shown spread of MDR Acinetobacter
baumannii with blaOXA-like carbapenemase and similar clonality in
burn hospitals of Tehran, Iran. Detection of some strain with high
resistance to all antimicrobial agents including carbapenems, colistin
and tigecyclin and spread of similar clone in our hospitals suggest that
the current protocol for prevention and controlling of infections with
these MDR isolates needs to be investigated.
P1672 Molecular epidemiology of Acinetobacter baumannii in
hospitals in the Mediterranean area using pulsed-ﬁeld gel
electrophoresis and sequence-based typing
R. Zarrilli, M. Giannouli, F. Tomasone, A. Agodi, A. Tsakris,
H. Vahaboglu, Z. Daoud, M. Triassi (Naples, Catania, IT; Athens,
GR; Kocaeli, TR; Beirut, LB)
Objectives: To investigate the geographical distribution and genetic
relatedness of outbreak isolates of Acinetobacter baumannii recovered
from the intensive care units of 18 hospitals in Greece, Italy, Lebanon,
and Turkey from 1999 to 2006.
Methods: Genotyping was performed by pulsed-ﬁeld gel electrophoresis
(PFGE) analysis of ApaI-digested genomic DNA and sequence-based
typing (ST) using outer membrane protein A (ompA), pilus assembly
system protein (csuE) and blaOXA-51-like gene sequences (Turton et
al., Clin Microbiol Infect, 13, 807, 2007).
Results: PFGE analysis of a collection of 30 A. baumannii strains
associated with epidemic episodes occurred in four different European
countries of the Mediterranean area led to the identiﬁcation of 12 distinct
PFGE proﬁles. ST analysis assigned 4 of them to ST group 1, 5 to
ST group 2, and 2 to ST group 4. ST group 1 and 2 corresponded
to the previously identiﬁed European clone II and I, respectively, ST
group 4 has not been identiﬁed before. PFGE proﬁle A of ST group 1
predominated, being isolated in 4 distinct hospitals in Naples, Italy, and
in different hospitals of Thessaloniki, Larissa, and Serres, Greece from
2002 to 2006. Additional PFGE types of ST group 1 were isolated in
Greece and Italy; PFGE types of ST group 2 were isolated in Greece,
Italy, and Lebanon. The two distinct PFGE proﬁles belonging to ST
group 4 were isolated in Thessaloniki, Greece, during 2003, and in
Kocaeli, Turkey, during 2005 and 2006. Ten out of 12 PFGE proﬁles
of A. baumannii epidemic isolates showed resistance to carbapenems.
The blaOXA-58 gene was identiﬁed in 9 distinct PFGE proﬁles of ST
groups 1, 2, and 4, and in 4 additional PFGE proﬁles of either sporadic
or micro-epidemic A. baumannii isolates from Italy and Turkey; the
blaOXA-23 gene was identiﬁed only in one epidemic-associated PFGE
type of ST group 4 from Kayseri, Turkey.
Conclusions: A. baumannii epidemics occurring in Mediterranean
hospitals have been sustained by the spread of distinct genotypes
belonging to ST group 1, 2 and 4, one single PFGE proﬁle of ST
group 1 being particularly successful in Greece and Italy since 2002.
The blaOXA-58 gene was present in the majority of carbapenem resistant
genotypes.
P1673 Molecular characterisation of carbapenem-resistant
Acinetobacter baumannii isolates from intensive care unit
in a hospital, Bogota, Columbia
S. Saavedra, J. Herna´ndez, M. Murcia, S. Gualteros, G. Arias, L. Ortiz,
A. Leal, C. Saavedra (Bogota, CO)
Objectives: Typing molecular from isolates carbapenem-resistant
Acinetobacter baumannii and to detected microbiological and molecular
ocurrence from carbapenemases.
Methods: One hundred thirty two isolates carbapenem-resistant A. bau-
mannii from ICU of twelve hospital in Bogota´ were collected from 2005
to 2006. The isolates were re-identiﬁcated with API 20NE (bioMe´rieux)
and the conﬁrmation of minimum inhibitory concentrations (MICs) of
imipenem and meropenem were determined with Etest (AB Biodisk).
For detection of metallo-carbapenemases we used MBL Etest strip and
gene identiﬁcation from metallo and oxa-type carbapenemases was by
PCR. Ampliﬁcation products were evaluated by sequentiation.
The characterisation molecular by assessment the relatedness of the
isolates was realised by pulsed-ﬁeld gel electrophoresis (PFGE) of
ApaI-digest genomic DNA. The cluster analysis was realised with
Fingerprinting II software (Bio-Rad).
Results: All Isolates were resistant to meropenem with MIC> 32mg/mL
and 131 resistant to imipinem with MIC> 32mg/mL and one isolate
showed had intermediate resistant with MIC 8mg/mL. From isolates
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studied only thirty isolates were positive for detection MBL for E-test
but neither had VIM or IMP genes by PCR. PCR detection from OXA-
carbapenemases gene suggested presence from gene blaOXA-51-like in
all isolates. In another hand we founded blaOXA-23-like in 129 isolates,
blaOXA-24-like only in one isolate and in the case blaOXA-58-like
none ampliﬁcated. Sequencing from ampliﬁcation products conﬁrmed
the presence from OXA-72 carbapenemase in one isolate and OXA-23
carbapenemase in the others isolates.
Typing results showed presence a predominant clone conformed by
88 isolates from all hospitals, the others isolates were distributed the
following form 3 clones had 2, 5 and 6 isolates each one and two clones
conformed by 3 isolates and ﬁnally, 14 isolates unique ﬁngerprints.
Conclusions: our results indicate the ocurrence from a predominant
clone from A. baumannii Carbapenems resistant, this clone were
disseminated in all ICU Hospitals from Bogota´ studied.
Carbapenemase OXA-23 was the most frecuently founded in our isolates,
while OXA 72 was detected in only one intermediate resistant isolate
to Imipenem, this is the ﬁst report from this class from OXA-types
Carbapenemases from Colombia.
P1674 A multi-locus sequence typing scheme for Stenotrophomonas
maltophilia
S. Kaiser, K. Biehler, D. Jonas (Freiburg, DE)
Stenotrophomonas maltophilia is ubiquitous in nature, but also a highly
resistant pathogen and cause of nosocomial infections. In the past, there
have been several changes in the taxonomy of Stenotrophomonas spp.
and delineation of S. africana from S. maltophilia has been debated.
Using Ampliﬁed Fragment Length Polymorphism (AFLP), strains were
assigned to genogroups.
Apparently, isolates of environmental and clinical origin predominate in
different groups.
The MLST scheme was developed on the basis of a selected highly
diverse S. maltophilia strain collection comprising 52 strains of clinical
and 16 strains of environmental origin from seven countries in all
continents. They included the type strains of S. maltophilia, S. africana,
S. acidaminaphila, S. nitrireducens, as well as strains belonging to the 10
different S. maltophilia genogroups, as previously deﬁned on the basis
of AFLP-patterns.
Compared with all S. maltophilia isolates, the DNA similarity of
S. africana was on average of all seven loci 95.8%, which was above
the average of all S. maltophilia strains (95.1%). Following this it
was considered that the S. africana type strain belongs to the species
S. maltophilia. Sequence data on 70 S. maltophilia strains, including
the strains R551−3 and K279a from genome sequencing projects, were
assigned to 54 sequence types (ST) based on the allelic proﬁles in the
seven loci (atpD, gapA, guaA, mutM, nuoD, ppsA and recA). Analysis
of strains from ﬁve outbreaks demonstrated the stability of the allelic
proﬁle over at least a 90-day period. A neighbour-net presentation of the
concatenated sequences conﬁrmed previously deﬁned nine genogroups
and revealed ﬁve additional groups. 18 out of 31 isolates from respiratory
tract specimens, including 12 out of 14 isolates from cystic ﬁbrosis
patients, belonged to genogroup 6. However, 16 invasive strains isolated
from blood cultures belonged to nine different genogroups. Three
genogroups contained isolates of strictly environmental origin only.
This MLST scheme for S. maltophilia presents a discriminatory typing
method with stable markers appropriate for studying the population
structure. According to DNA similarities S. africana belongs to the
species S. maltophilia. MLST data conﬁrmed the existence of previously
deﬁned genogroups and an additional ﬁve genogroups on the basis of
the isolates examined in this study. The predominance of clinical isolates
in genogroup 6 requires further elucidation.
P1675 Pulmonary multiple colonisation of distinct genotypes
of Pseudomonas aeruginosa in a patient admitted to
an intensive care cardiology unit: use of a combined
ﬁngerprinting approach by rep-PCR and f-AFLP
L. Putignani, A. Petrucca, C. Manfredini, L. Coltella, R. Sessa,
D. Menichella, C. Russo, P. Cipriani (Rome, IT)
Objectives: The human opportunistic pathogen, Pseudomonas aerug-
inosa, is a major cause of infectious-related mortality and morbidity
among critically ill patients, and carriers the highest case fatality
rate of all Gram-negative infections. In our study, we monitored a
multiple P. aeruginosa colonisation, occurred in a patient affected by
chronic illness, that led us to isolate 12 strains showing different
susceptibility patterns and morphological traits, probably associated to
distinct genotypes. In order to study their genetic relationships we
characterised the entire P. aeruginosa panel of strains at molecular level.
Methods: Susceptibility patterns were performed by using VITEK2
Automatic System (BioMerieux). P. aeruginosa genotypes were analysed
by, the ﬂuorescent-AFLP (f-AFLP) method (AFLP Microbial Finger-
printing; Applied BioSystem) as reference system and the rep-PCR based
on DiversiLab platform (Biomerieux) as rapid but non-standardised
typing method. Bioinformatics analysis of f-AFLP traces were performed
by BioNumerics Software v. 5.00 (Applied Maths) while the web-based
DiversiLab Software (v. 3.3) was used for the analysis of rep-PCR
ﬁngerprinting.
Results: Drug susceptibility patterns showed three completely different
and four highly correlated antibiotypes. The interpretation of f-AFLP
ﬁngerprintings, highlighted the presence of three distinct clonal proﬁling,
antibiotype correlated. Rep-PCR electropherograms, analysed using the
Pearson correlation and the Kullback-Leibler algorithm, provided a high
similarity rate amongst all the strains; the threshold, ﬁxed between 96–
97%, showed three differentially identiﬁed groups, consistently with the
f-AFLP inferred patterns.
Conclusion: The identiﬁcation of different clones is a crucial crossing
border to establish a correlation between genotype plasticity and
resistance patterns in P. aeruginosa, especially in patients with life-
threatening conditions.
P1676 Molecular epidemiology of Pseudomonas aeruginosa from
Italian cystic ﬁbrosis patients
P. Morelli, G. Melioli, M. Mentasti, N. Cirilli, E. Manso, F. Gioffre`,
D. Scuteri, A. D’Aprile, G. Manno (Genoa, Ancona, Soverato,
Cerignola, IT)
Background: The means of transmission of Pseudomonas aeruginosa
(PA) in Cystic Fibrosis (CF) affected patients have not been clearly
established. Many CF patients appear to acquire the organisms from the
natural environment and not from other CF patients (Speert et al., 2002).
Other indications, on the contrary, suggest that some clonal lineages
are widespread among the CF population, apparently contracted through
cross infection from other CF patients.
Aim: Address the type of transmission and/or environmental acquisition
of PA and deﬁne if epidemic strains are circulating in Italy.
Methods: A collection of 340 strains from 183 pts attending 4 CF
centres located in north (A), centre (B) and south Italy (C and D),
and 55 environmental (11 from hospital sinks, 44 from swimming
pool and mineral water) were genotyped by BOX-PCR (Rademarker
J.L.W et al. 1998). A PA panel control strains included: PA01, ATCC
27853, European clone C (EC), Manchester Epidemic Strain (MES) and
Liverpool Epidemic Strain (LES). The cluster analysis was performed by
“Gel Compar II”. MLST analysis of major clonal group was performed
as described by Curran et al. 2004 (http://pubmlst.org/paeruginosa).
Results: A total of 179 genotypes were found. 132 pts were colonised
with a single PA genotype, and 46 with two o more genotypes. A
total of 82 pts showed genotyped “shared” with other pts while 86 pts
had “unique” genotype. 36 groups of pts carrying the same genotype
(clusters) were observed: 22 of 2 pts size, 7 of 3 pts, 5 of 4 pts and 2 of
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5 pts. For environmental strains 25 genotypes were found: 12 not shared,
while 13 shared.13 clusters were found: 10 of 2 and 3of 3 sources. No
Italian PA CF Strains showed genetically correlation with EC, LES and
MES. No genetically correlation was observed between environmental
and CF strains. No genotypes correlated were found among strains from
Centres A, B and C. 3 genotypes found in 3 pts of centre B are highly
correlated with 3 genotypes found in 2 pts of centre D. The proﬁle (acs
39; aro 35; gua 71; mut 81; nuo 56; pps 36; trp 54), obtained by MLST,
of this clonal group not showed relationship with European clones.
Conclusions: Environmental acquisition was not documented. The
number of cluster found, suggest that person-to-person transmission may
occurred, and the need of continuous survey, in the help of the infection
control measures.
This study was supported by the Italian Cystic Fibrosis Foundation Grant
FFC #8/2005
P1677 A newly identiﬁed clonal Pseudomonas aeruginosa strain
has a high prevalence in the Dutch cystic ﬁbrosis population
R. van Mansfeld, H. Lemjadhi, C.K. van de Ent, T.F.W. Wolfs,
R. Willems, M.J.M. Bonten (Utrecht, NL)
Objectives: In the last decade, different Pseudomonas aeruginosa (PA)
clones have been associated with increased colonisation and infection of
patients with cystic ﬁbrosis (CF), such as the Liverpool, Manchester
and Midlands epidemic strains and Melbourne pulsotype I strain,
amongst others. Transmission of these, often virulent, clones between
CF patients has been documented as well, which has lead to strict
segregation policies for CF patients in many countries, including the
Netherlands. However, little information was available on the prevalence
and population structure of PA among Dutch CF patients. The aim of
this study was to determine the prevalence and genetic linkage of PA
genotypes in the CF population of the UMC Utrecht, which contains
about 30% of the total Dutch CF population.
Methods: A cross-sectional study was conducted of all CF patients that
visited the UMC Utrecht in 2007. The isolates of the ﬁrst respiratory
tract culture yielding PA of each patient were typed with multilocus
sequence typing (MLST), as described by Curran et al., including all
different PA phenotypes found in this ﬁrst positive culture. Sequences
were analysed in BioNumerics 5.0®.
Results: Of the 1300 CF patients in the Netherlands, 372 (29%) visited
the UMC Utrecht in 2007. The prevalence of PA colonisation in this
population was 52% (192/372).
140 samples of 95 patients were MLST-typed (results of 100 isolates are
pending). We found 63 different sequence types (STs); 50 patients (53%)
harboured a unique ST and 45 (47%) carried a strain shared by other
patients. 11 STs were documented in 2−4 patients and there was one
dominant ST (ST406) documented in 21 of 95 (22%) patients. Based
on MLST, this clone is genetically distinct from the known (epidemic)
strains.
41 (43%) patients had phenotypically different strains in the sputum
culture and in only 5 (12%) patients these strains were also genotypically
different.
Conclusion: Approximately 22% of the Dutch CF population harbours
the ST406 strain of PA, which differs genetically from the previously
reported epidemic clones in other countries. Further research is needed
to elucidate why ST406 is highly prevalent in the Dutch CF population.
P1678 Use of MIRU-VNTR typing to differentiate Mycobacterium
tuberculosis isolates from Bulgaria and comparison with
IS6110-RFLP typing and spoligotyping
V. Valcheva, I. Mokrousov, O. Narvskaya, N. Rastogi, N. Markova
(Soﬁa, BG; St. Petersburg, RU; Abymes, FR)
Objectives: To assess the discriminatory power of different molecular
typing methods (IS6110-RFLP, Spoligotyping, MIRU-VNTR) used
alone and in different combinations to evaluate the most appropriate
combination and usefulness of VNTRs for molecular-epidemiological
studies of M. tuberculosis in Bulgaria.
Methods: IS6110-RFLP, Spoligotyping, MIRU-VNTR were used for
strain differentiation.
Results: 73 M. tuberculosis strains were subdivided into 68 types
(21-loci and 15-loci MIRU-VNTR scheme), 59 types (12-loci MIRU-
VNTR scheme), 51 types (IS6110-RFLP) and 31 types (spoligotyping).
Among 21 tested VNTR loci, we selected 5 loci that allowed to
achieve sufﬁciently high discrimination (52 types). The Hunter-Gaston
discriminatory index was as follows: Spoligotyping (0.939), IS6110-
RFLP typing (0.983), 12-loci MIRU-VNTR typing (0.992), 5-loci
MIRU-VNTR typing (0.988), 21-loci and 15-loci MIRU-VNTR typing
(0.997).
Conclusion: We conclude that both MIRU-VNTR typing and spolig-
otyping methods are rapid, highly reliable and discriminatory methods
for epidemiological typing of M. tuberculosis; in the Bulgarian setting,
MIRU-VNTR typing is the epidemiological method of choice for the
near future.
Acknowledgments: This work was supported by NATO grant SFP
982319 “Detect drug-resistant TB”.
P1679 Mycobacterial interspersed repetitive units typing reveals
high genetic diversity of Mycobacterium tuberculosis isolates
in Austria
A. Pietzka, A. Sto¨ger, D. Pietzka, P. Hasenberger, A. Indra,
W. Ruppitsch, F. Allerberger (Vienna, Leoben, AT)
Objectives: The aim of the study was to determine the suitability
of Mycobacterial interspersed repetitive units (MIRU) typing for
recognising biodiversity of Mycobacterium tuberculosis isolates in
Austria. Austria has a total population of 8 million and a yearly incidence
of tuberculosis of 11/100,000.
Methods: Mycobacterial interspersed repetitive units (MIRU) typing
is a PCR-based typing method which assigns the number of tandem
repeats in 12, 15, or 24 independent loci (MIRUs). MIRU-analysis was
performed with the 24 MIRU primer system as described [1] on 1294
isolates collected from 2003 to 2005 in Austria. Ampliﬁed products were
analysed on an automated sequencer. User deﬁned ﬁltering and grouping
was performed with an own software tool.
Results: Two of the 24 MIRU-VNTR primers did not generate analysable
results. The remaining 22 primer allowed the classiﬁcation of the 1294
isolates into 1085 different MIRU types. The eight most frequently
found MIRU proﬁles contained 14, 13, 11, eight, and six isolates. All
other types were comprised of ﬁve or less isolates. The MIRU type
comprising 14 isolates was assigned to the Haarlem lineage, the MIRU
type comprising 11 isolates was assigned to the Beijing lineage, and one
MIRU type comprising six isolates was assigned to the URAL lineage.
All of the other frequently found MIRU proﬁles could not be assigned
to known lineages [1].
Eighty-eight of the 1294 isolates were of the Beijing spoligotype; they
yielded 71 different MIRU types. One MIRU type was found in 11
Beijing isolates, seven types were found in two isolates each, and 63
types were shown by a single isolate only.
Clonal variants within the same host were detected in 27 out of 44 cases.
Conclusion: Our results highlight the diversity of M. tuberculosis
isolates in Austria. MIRU is more discriminative than spoligotyping or
IS6110 RFLP [2]. MIRU even allows the differentiation of the Beijing
family in 71 separate MIRU types. We consider MIRU typing to be
a valuable typing method suitable to allow for differentiation between
reactivation and reinfection in individual cases, and to provide the
discriminatory power necessary to recognize clusters of tuberculosis in
Austria.
Reference(s)
[1] www.miru-vntrplus.org
[2] Oeleman MC, Diel R, Vatin V, et al. (2007) J. Clin Microbiol. 45:
691–697.
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P1680 The use of MIRU-VNTR for the detection of mixed
Mycobacterium tuberculosis infection
R. Stavrum, K. Øvrea˚s, M. Mphahlele, H.M.S. Grewal (Bergen, NO;
Pretoria, ZA)
Objective: Patients infected with latent Mycobacterium tuberculosis
(Mtb) can develop disease via either reactivation of the latent bacilli,
or by exogenous reinfection with a second mycobacterial strain. The
presence of strains with different drug-susceptibility patterns could
lead to improper drug-administration and eventually result in treatment
failure. The use of molecular typing techniques, such as spoligotyping [2]
and IS6110 RFLP [3] generally assume the isolation of only 1 strain from
each patient and the detection of a second infection requires a second
sampling from the same patient at a later time. Isolates are, based on
spoligotyping, grouped into families deﬁned by deletions of particular
spacers. Two M. tuberculosis families, which are highly prevalent are
the T (ST53) and Beijing families [1]. Isolates belonging to the Beijing
family shares a highly characteristic pattern with the absence of spacers
1–34 and the presence of spacers 35–43, whereas the T family is poorly
deﬁned as only lacking spacers 33–36. Thus, the objective of this study
was to investigate for the presence of mixed Mtb subpopulations among
cultures from two common mycobacterial families; 1 well-deﬁned and
1 poorly deﬁned, using the 15 loci MIRU-VNTR method.
Methods: Fifty-ﬁve isolates (29 ST53 and 26 Beijing) were selected for
further characterisation using the 15 loci MIRU-VNTR as described [4]
and analysed using the Peak Scanner Software v1.0 (PE Applied
Biosystems).
Results: MIRU-VNTR of the 26 Beijing isolates showed only one
product for all 15 loci tested, indicating a single Mtb subpopulation.
Of the 29 isolates belonging to the ST53 lineage, two PCR products was
observed in 7 loci for 2 isolates, 5 loci for 3 isolates, 4 loci for 2 isolates,
3 loci for 2 isolates and 2 loci for 1 isolate. Five isolates produced two
PCR products for 1 loci (ETR-A, ETR-C, Qub-11b and 2 for MIRU10).
Conclusion: The 15 loci MIRU-VNTR is highly discriminatory and
can, thus, be used to detect mixed Mtb subpopulations. Further
characterisation of the isolates that has been classiﬁed as belonging to
the ST53 lineage by MIRU-VNTR may be useful to give a more precise
estimate of the prevalence of this family.
Reference(s)
[1] Brudey, K. et al, 2006. BMC Microbiol 6:23.
[2] Dale, J. W., et al, 2001. 5:216−9.
[3] Groenen, P. M. et al, 1993. Mol Microbiol 10:1057–65.
[4] Supply, P. et al, 2006. J Clin Microbiol 44:4498–510.
P1681 Establishment of molecular typing scheme for determination
of recurrence and reinfection of Mycobacterium tuberculosis
J-J. Lu, Y-C. Lee, J-R. Sun, S-Y. Lee (Taipei, TW)
Objectives: The purpose of this study was to establish a typing scheme
to distinguish between recurrence and reinfection of Mycobacterium
tuberculosis (MTB).
Methods: Four hundreds and nine MTB isolates from 323 patients were
typed by two different molecular typing methods including mycobacterial
interspersed repetitive unit (MIRU) and spoligotyping. Nineteen loci
were selected for MIRU typing, and a commercial kit was used for
spoligotyping. Patients with multiple MTB isolates of different types
were considered reinfected, and those with multiple isolates of the
same types were considered as having recurrent infection or incomplete-
treatment.
Results: By spoligotyping, 229 of the 409 (56.0%) isolates were
determined to belong to the Beijing genotypes, and the other 180 (44.0%)
were non-Beijing genotypes. A total of 160 MIRU types were identiﬁed
among the 409 MTB isolates. 66 patients were found to have more than
one MTB infection and therefore had more than one MTB isolate. 51 of
these patients had multiple MTB isolates with the same genotypes and
antibiotic susceptibility patterns. The other 15 patients had multiple MTB
isolates with different MIRU types or antibiotic susceptibility patterns,
including 4 with isolates with different MIRU genotypes, 8 with isolates
of different antibiotic susceptibility patterns, and 3 with isolates that
were different in both genotypes and antibiotic susceptibility patterns.
Therefore, 7 of these patients (7/66; 10.6%) were classiﬁed as reinfected
and the other 59 (89.4%) belonged to the recurrence or incomplete-
treatment group. Isolates with antibiotic susceptibility changed from
susceptible to resistant were mainly from patients treated with isoniazid
and rifampin.
Conclusion: MIRU molecular typing is a reliable and efﬁcient method
not only for epidemiological study and outbreak surveillance but also
for determination of recurrence and reinfection of Mycobacterium
tuberculosis. This method could also provide physicians with useful
information for outcome treatment.
P1682 Diversilab typing for management of Enterobacter cloacae
outbreaks at a neonatal ICU
C.E. Visser, B. de Wever, M. Rijnsburger, L. Spanjaard, L. van Toledo,
P. Savelkoul, B. Duim (Amsterdam, NL)
Objectives: In April 2007 the neonatal ICU observed a possible outbreak
of Enterobacter cloacae. Concern was raised when several children
presented with clinically signiﬁcant infections due to E. cloacae.
Methods: To establish the relation between these infections all clinical
isolates were collected and all patients were screened for the presence
of E. cloacae in throat and rectal swabs. At approximately the same
time a new typing system was introduced in our laboratory: Diversilab
(bioMerieux). This system enables automated genotyping of bacteria,
yeasts and moulds, applying kits for ampliﬁcation of repetitive extragenic
palindromic (REP-PCR) sequences. PCR fragments are analysed on
an Agilent® 2100 Bioanalyzer. Web-based software stores sample
ﬁngerprints, normalizes the data for comparison and analyses similarity
between ﬁngerprints. To validate Diversilab typing, extracted DNA of
all E. cloacae strains was also typed by AFLP as gold standard.
Results: Diversilab and AFLP data were concordant and showed
identical strains in 5 patients and unrelated strains in 3 patients. Hygienic
measures were enhanced in the following weeks and consequently
the number of E. cloacae-positive patients decreased. In July a
sudden increase in E. cloacae-positive cultures was observed, and we
hypothesised that the outbreak strain persisted in a niche on the neonatal
ward. Again strains collected from both surveillance and clinical cultures
were typed with Diversilab and AFLP. Both typing systems showed
that the hypothesis was refuted. An unrelated E. cloacae strain was
responsible for the second outbreak. This strain was present in 5
patients. One patient, epidemiologically related to the ﬁrst outbreak,
tested positive for the outbreak strain of the ﬁrst episode. One patient,
who was present on the ward during both episodes, tested positive for
an unrelated E. cloacae strain in both episodes. We concluded that both
outbreaks on the neonatal ICU were not the result of one single persisting
strain, but rather based on the successive introduction of unrelated
E. cloacae strains. In October 2007 again an increase of E. cloacae
positive cultures was observed and typing showed no new outbreak, as
all but 2 strains were unrelated.
Conclusion: The analysis of the presented outbreaks demonstrated that
the Diversilab is a very fast, robust and reproducible tool to determine
clonal outbreaks of E. cloacae and typing of bacterial strains is crucial
for adequate outbreak management.
P1683 PFGE analysis of MDR isolates of Klebsiella pneumoniae
cultured from patients at Tehran hospitals
M. Feizabadi, S. Mohammadi-Yeganeh, F. Nili, A.A. Mirsalehian,
S.M. Mirafshar (Tehran, IR)
Objectives: Multi-Drug Resistance (MDR) Klebsiella pneumoniae have
caused major therapeutic problems worldwide due to emergence of
Extended-spectrum b-lactamase (ESBL)-producing strains of Klebsiella
pneumoniae. Identifying genetic phylogeny of hospital pathogens is
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essential for ﬁnding source of infections and prescription of proper
antibiotics are important for control of nosocomial infections.
The goals of this study were to determine the susceptibility of Klebsiella
pneumoniae isolated from Tehran Hospitals to different antimicrobial
agents and genetically characterize ESBLs isolates by pulsed ﬁeld gel
electrophoresis (PFGE).
Methods: 147 isolates of Klebsiella pneumoniae were collected from
Tehran hospitals during September 2006 to July 2007, and tested for
susceptibility to 16 antibiotics. Production of ESBL was assessed using
Double Disk Synergy (DDS) and Phenotypic Conﬁrmatory (PCT) Tests.
The genomic DNA was extracted from the strains and separated by PFGE
after digesting with Xba I endonuclease.
Results: Production of ESBL was detected in 72.8% of isolates. The
majority of Neonatal and ICU isolates showed the ESBL phenotype.
Susceptibility to imipenem and meropenem were 100% followed
by levoﬂoxacin (76.9%), piperacillin/tazobactam (53.7%) and cefti-
zoxime (58%) respectively. The most resistance was observed against
ampicillin/sulbactam and aztreonam (71.4%), cefotaxime (66.7%) and
gentamicin (62.3%).
In PFGE, all neonatal strains from one of the hospitals were identical. A
dominant cluster was observed in ICU isolates of K. pneumoniae, too.
But other isolates showed different genetic patterns.
Discussion: The most effective antibiotics against ESBL-producing K.
pneumonia were carbapenems followed by levoﬂoxacin. It appears that
outbreaks with ESBL-producing K. pneumoniae had occurred in neonatal
and ICU setting in one of the Hospitals.
PFGE is a reliable technique for genetic analysis of K. pneumoniae
collected from community and it can be use to reveals the source
outbreaks with MDR-Klebsiella pneumonia in hospitals.
P1684 Molecular characterisation of Klebsiella pneumoniae strains
isolated from blood culture
M. Damian, C-R. Usein, A-M. Palade, M. Cosman (Bucharest, RO)
Klebsiella pneumoniae strains are recognised as a common cause of
hospital acquired infections associated with bacteraemia and lethal
sepsis.
Objectives: The aim of present study was to characterize the strains
isolated from blood culture in hospitalised patients in order to detect
a correlation between the genetic pattern of strains and the source of
isolation.
Methods: A total of 31 strains isolated from blood culture of
inpatients from four different hospital units for new born children were
characterised by biochemical testing, phage typing and antimicrobial
sensitivity testing. PCR targeting fur gene and other subtractive
sequences noted by as SL002, SL003, SL019, SL020, SL021, and SL025
was used to identify the genetic pattern of strains. The genetic relatedness
of the isolates was assessed by PFGE.
Results: All strains were PCR positive for fur gene and negative for
SL021 and SL025 sequences. The most frequently detected sequences
were SL020 (30 strains) and SL 019 (27 strains). SL002 sequence was
identiﬁed in 6 strains and SL003 in 10 strains. When the total proﬁle
of ampliﬁcation was analysed, the strains gathered in six different gene
patterns. Two PCR proﬁles grouped 24 strains, the remaining 7 strains
displaying other 4 gene proﬁles. When PFGE was used to characterize
the strains a total of 11 patterns were identiﬁed. Strains displaying the
same PCR proﬁle showed the same PFGE type and suggested a common
source of infection.
Conclusion: Strains isolated from the same hospital presented a
correlation between phage type, PCR proﬁle and PFGE pattern. When
the phage typing could not discriminate between strains, PCR and PFGE
were useful.
Similarity of PCR proﬁles and PFGE patterns suggests a hospital
acquired infection.
P1685 Molecular epidemiology of plasmid-mediated AmpC
b-lactamase and extended-spectrum-b-lactamase from
clinical isolates of children in Wuhan area, China
Y. Shangyou, Y. Tao (Wuhan City, CN)
Objectives: To investigate molecular epidemiology characteristics
of b-lactamases in plasmid-mediated AmpC and extended-spectrum-
b-lactamases (ESBLs) producing in Escherichia coli and Klebsiella
pneumoniae from children in Wuhan area.
Methods: A total of 228 clinic isolates, including 161 cefoxitin-
resistant or medium, 67 cefoxitin-sensitive ESBLs producing E. coli
and Klebsiella pneumoniae were collected at The Children’s Hospital of
Wuhan during a period from Aug 2005 to July 2006. Three-dimensional
extract test was used for primary analysis of plasmid-mediated AmpC-
lactamases and phenotypic conﬁrmatory test was done for ESBLs.
Transformation experiment was used to position drug resistant gene.
Universal primer PCR for AmpC and CTX-M gene ampliﬁcation
and DNA sequencing were carried out for genotype of b-lactamases.
Detection and subtyping of bla-CTX-M genes was done by Restriction
Fragment Length Polymorphism (RFLP)analysis.
Results: Both DHA-1 and ACT-1 genotypes were determined to be
the primary plasmid-mediated-AmpC-lactamase genes among the 228
isolates, and CTX-M-14 and CTX-M-3 genotype were proved to be
the predominant ESBLs genes. The number of isolates producing both
DHA-1 and ACT-1 at the same time was much higher than isolates
producing only one kind of these AmpC enzymes. The combination
genotypes of AmpC and CTX-M were observed in isolates. Among
which, CTX-M-14+DHA-1+ACT-1 genotype was the much common
isolates in E. coli. However, for K. pneumoniae, the main combination
genotypes of AmpC and CTX-M was CTX-M-3+DHA-1+ACT-1. On the
other hand, a new ACT genotype was founded in Klebsiella pneumoniae,
and DNA sequence was shown that new ACT genotype has 84%
homogeneity with ACT.
Conclusion: E. coli and K. pneumoniae producing both ESBLs genes
and AmpC b-lactamase have higher proportions than that producing
single plasmid-mediated AmpC enzyme. CTX-M-14 or CTX-M-3 plus
DHA-1and ACT-1 was the primary genotype in children at Wuhan area.
P1686 Ribotyping in molecular epidemiological studies of
uropathogenic Escherichia coli. A critical assessment
L. Strand, A. Jenkins, N. Grude, H. Mykland, A.G. Allum,
B.E. Kristiansen, N.I. Potaturkina-Nesterova (Skien, Porsgrunn,
Skien/Tromsø, NO; Ulianovsk, RU)
Objectives: To compare PCR phylogrouping and ribotyping in
epidemiological study of uropathogenic E. coli.
Methods: Fluroquinolone resistant (N=35) and sensitive (N=31) UTI
isolates, commensal isolates (N=20) from Norway and UTI isolates
from Russia (N=31) were investigated. Isolates were typed using
PCR phylogrouping, Ribotyping and PFGE. Minimal inhibitory con-
centrations were determined for ampicillin, mecillinam, nitrofurantoin,
sulphonamide, trimethoprim, tetracycline, nalidixic acid, ciproﬂoxacin,
gentamicin and chloramphenicol. Virulence factors (type 1, P, and S
ﬁmbriae, papG class I, II and III, haemagglutinin, capsule K1, capsule
K5, aerobactin and hemolysin) were detected by multiplex PCR.
Results: 33 ribotypes were found. 7 groups of similar ribotypes could
be identiﬁed (Ribogroups RiboA−G). There was evident correlation
between ribogroup and country of origin, biological source and
ﬂuoroquinolone resistance. Phylogroup correlated with ribotype and
ribogroup but correspondence was not perfect. Ribogroup G was
predominantly phylogroup D, urovirulent, and related to clonal group A
(CgA). Antibiotic resistance (excepting ﬂuoroquinolone) and virulence
proﬁles were unrelated to ribogroup. Isolates with similar PFGE patterns
had similar, but not always identical ribotypes.
Conclusion: Ribotyping is a convenient, but costly typing method that
correlates with clinically relevant biological parameters and geographical
origin. Surprisingly, ribotypes are not homogeneous with respect to
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phylogenetic group, suggesting that the genetic loci tested may be
subject to horizontal exchange, which might limit the value of these
methods. The identiﬁcation of a ribotype group, riboG, consisting of
predominantly urovirulent Phylogroup D may provide insights into the
origin of the urovirulent clonal group A (CgA).
P1687 Molecular typing of enteropathogenic Escherichia coli by
multilocus sequence typing
A. Pitondo-Silva, L.A.R. Minarini, I.L.B.C. Camargo, M. Brocchi,
A.L.C. Darini (Ribeira˜o Preto, BR)
Objectives: This study analyses by MLST (Multilocus Sequence Typing)
a collection of 30 enteropathogenic Escherichia coli (EPEC) isolated
from patients with diarrhoea, admitted to an University Hospital from
Brazil.
Methods: 30 strains of EPEC were studied and previously classiﬁed
by different molecular techniques, including by pulsed-ﬁeld gel
electrophoresis. MLST was performed based on DNA sequences of 7
conserved housekeeping genes: adk (adenylate kinase), fumC (fumarate
hydratase), icd (isocitrate dehydrogenase), purA (adenylosuccinate
dehydrogenase), gyrB (DNA gyrase), recA (ATP/GTP binding motif)
and mdh (malate dehydrogenase). The detailed protocol of the MLST
procedure, including allelic type and sequence type methods, may be
found at the MLST website. Clonal relationship among the 30 strains
and the strains of MLST database was performed using eBURST
V3 algorithm to obtain a population snapshot and to get the most
likely patterns of evolutionary descent in our collection. An UPGMA
dendrogram was constructed from the data matrix of allelic mismatches
of the strains in this study, by START. To analyse the variable alleles,
MEGA version 2.1 was used to construct a circle style phylogenetic
tree, with the neighbour-joining algorithm and the nucleotide p-distance
model of genetic distance.
Results: 6 new alleles were described which determined 14 new
ST among 18 strains indicating the existence of considerable genetic
variability among the strains; 20 strains were associated with 8 ST
previously described. The strains were divided into 12 clonal complexes
and CC10 was the major one, harboured 3 strains of this study and other
9 Brazilian strains, indicating an endemic prevalence of these clones in
the country. The purA & recA housekeeping genes presented minor
variation in relation to the other genes. The number of individual alleles
for each one of the 7 housekeeping genes ranged from 8 for purA, 10
for recA, 11 for gyrB, 12 for adk, fumC, icd and mdh.
Conclusion: MLST has been rarely used in epidemiologic and
phylogenetic studies involving EPEC strains, particularly in Brazil.
There were only 23 strains in MLST E. coli database, and this study
included other 30 strains of EPEC previously analysed and classiﬁed
by different phenotypic and molecular techniques. This study allowed
including E. coli data from Brazil in the E. coli MLST database and
this fact permits the use of data about the Brazilian E. coli strains in
epidemiologic worldwide studies.
P1688 Comparison between rep-PCR-based DNA ﬁngerprint and
sequence analyses of clinically relevant Nocardia species
J. Embry, D. Sussland, K. Reece, W. Dutch, C. Smith, E. Atkins, T. Ross,
S. Abedi, S. Frye, M. Saubolle, M. Healy (Athens, Phoenix, US)
Objectives: Nocardiosis is a localised or disseminated infection caused
by ubiquitous, soil borne, aerobic, and saprophytic actinomycetes.
Nocardia species most often affect immunocompromised patients.
Nocardia asteroides (causes at least 50% of invasive infections). Other
pathogenic species include N. farcinica, N. nova, N. transvalensis,
N. brasiliensis, and N. pseudobrasiliensis. In the United States, an
estimated 500−1,000 new cases of Nocardia infection occur annually and
other reports indicate fewer instances in European countries and Japan.
Generally, for accurate identiﬁcation to the species level sequencing
is performed. rep-PCR based DNA ﬁngerprinting has shown promise
for rapid species and strain-level discrimination for some bacteria and
fungi. In this study, we compared rep-PCR-based DNA ﬁngerprint and
sequence analyses of clinically relevant Nocardia species.
Methods: A total of 12 Nocardia species were purchased from ATCC
including N. abscessus, N. africana, N. asteroides, N. brasiliensis,
N. brevicatena, N. carnea, N. farcinica, N. nova, N. otitidiscaviarum,
N. paucivorans, N. pseudobrasiliensis, and N. transvalensis. In addition,
30 clinical isolates were collected and analysed. The isolates were
cultured, and genomic DNA was extracted from each isolate. DNA was
then ampliﬁed using the DiversiLab Nocardia Fingerprinting Kit (beta
version). The data were processed using the DiversiLab software.
Results: DNA ﬁngerprints were obtained for all Nocardia species
using the DiversiLab System. Rep-PCR-based clustering of all Nocardia
isolates was in agreement with the sequence-based identiﬁcation of
the clinical isolates and the ATCC isolates. Additionally, the rep-PCR
method showed sub-species discrimination.
Conclusions: The DiversiLab System is a rapid molecular genotyping
tool that shows promise for differentiation of Nocardia species. The
sub-species discrimination indicates potential as a strain typing tool for
epidemiological studies.
P1689 Molecular diversity among Bulgarian Bacillus anthracis
strains: the emergence of novel genotypes
I. Ivanov, K. Marinov, E. Tsvetkova, R. Nenova, R. Vatcheva-Dobrevska,
E. Dobreva, T. Kantardjiev (Soﬁa, BG)
Objectives: Human anthrax is a relatively rare disease in Bulgaria with
up to ten cases per year occurring mainly in two endemic regions
located in the Northern part of country. After the bioterrorism attacks
in 2001 a particular interest has emerged for introducing efﬁcient high-
resolution typing systems that are readily applied for the global mapping
of the B. anthracis genotypes. The current study was conducted in order
to investigate the molecular diversity among a Bulgarian collection of
B. anthracis isolates collected for more than 50 years and to shed some
light on the genotypes circulating on the Balkans.
Methods: A total of 43 B. anthracis isolates positive for both virulence
plasmids pXO1 and pXO2 were included in the study. The isolates were
previously cultured either from humans, animals or from environmental
sources for the period 1960–2006. They were identiﬁed by several
different conventional methods as well as by speciﬁc PCR that was
targeted at two chromosomal and two plasmid markers. The multilocus
variable number of tandem repeat analysis (MLVA) system proposed by
Keim et al. was applied for studying the molecular diversity among these
isolates. The fragment analysis was carried out in a fully automated high-
resolution capillary system HDA-12 (eGene Inc., USA) which produces
results within six minutes.
Results: The isolates were grouped in three major clusters with
several subclusters. The chromosomal vrrC1 and vrrC2 markers were
characterised by two previously undescribed alleles with sizes 436 bp and
334 bp respectively found in seven strains each and generating a total of
four novel genotypes. These new alleles found so far only in Bulgarian
isolates were also veriﬁed by sequence analysis. Interestingly one of
the new genotypes was associated with a fatal case of septic anthrax.
More than half of the investigated isolates (n = 23) were grouped within
the A1.a subcluster (Keim et al.) which ranges over a geographically
heterogeneous group with members from Europe and North America.
Conclusions: The study brings information on the molecular diversity
of B. anthracis on the Balkans and reveals several previously
undescribed genotypes among the Bulgarian isolates. The MLVA8 typing
system represents an efﬁcient tool for studying the epidemiology and
phylogenetics of this high-risk pathogen.
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P1690 A common F. tularensis outbreak MLVA genotype in the
Balkans
P.I. Padeshki, I.N. Ivanov, S. Gu¨rcan, S. Panaiotov, B. Popov,
R. Nenova, T. Kantardjiev (Soﬁa, BG; Ancara, TR)
Objectives: Tularaemia is a major problem in the Balkans and in
Bulgaria. After publishing our initial results for Bulgaria, strains from
Turkey were obtained and comparative genetic analysis realised.
Methods: In this study we have performed high resolution multiple-locus
variable-number tandem repeat analysis (MLVA) in order to compare
the Bulgarian and Turkish strains from the two outbreaks and to shed
some light on the genotypic structure of F. tularensis populations on the
Balkans and Anatolia.
Results: A total of four genotypes were found among the nine isolates
investigated (7 Bulgarian and 2 Turkish). The M3 marker appeared to
be the most variable one showing four different alleles among the nine
strains studied followed by M6 (3 alleles) and M20 (2 alleles). All other
markers were presented with a single allele. The two Turkish strains were
found to be identical to each other and identical to one of the Bulgarian
outbreak clusters.
Conclusion: Using the MLVA method we obtained a direct evidence
for identity of strains isolated in Turkey and Bulgaria. As the two
outbreaks occurred in very distantly located regions (over 500 km) a
direct epidemiological relation is highly improbable however a common
Balkan genotype could exist.
P1691 Evolution of endemic clones of Legionella pneumophila
serogroup 1 in France from 1995 to 2007
C. Ginevra, C. Campe`se, F. Forey, D. Che, M. Reyrolle, J. Etienne,
S. Jarraud (Bron, Saint Maurice, FR)
Objective: In France, Legionella pneumophila serogroup 1 (Lp1) is
involved in more than 80% of Legionnaires’ disease cases. This infection
can be due to sporadic (unrelated isolates with unique genotype),
epidemic (same genotype shared by time and space related isolates) or
endemic (same genotype shared by epidemiologically unrelated isolates)
strains of Legionella. The aim of this work was to monitor the evolution
of the populations of Lp1 endemic strains isolated from clinical samples
in France from 1995 to 2007.
Methods: All French Legionella clinical isolates were systematically
genotyped by pulsed-ﬁeld gel electrophoresis (PFGE). The French
database of Legionella PFGE patterns was analysed (~2000 patterns of
clinical strains isolated from 1995 to 2007). The sequence types (ST) of
unrelated isolates sharing identical PFGE patterns were determined.
Results: Five different populations of unrelated isolates with same
genotype (PFGE patterns and ST) were identiﬁed; these populations
belonged to the ﬁve major French endemic clones: Paris, Lorraine,
Louisa, Mondial and Biarritz. Their distribution over the time was
different: (i) the Paris strain was the major endemic clone identiﬁed
(its isolation rate ranged from 6 to 12% since 1996); (ii) the Lorraine
strain has emerged since 2002 (it has accounted for 10% of clinical
isolates since 2005); (iii) the Louisa strain was ﬁrstly detected in 2001
and has emerged since 2004 (from this year, its clinical isolation rate has
increased continually reaching to 7% in 2007); (iv) the Mondial strain
was identiﬁed in 1998 during an outbreak (from this year, its clinical
isolation rate has decreased progressively); (v) the Biarritz strain was
detected almost every year with an isolation rate never higher than 5%.
In total, these 5 endemic clones accounted for up to 29% of clinical
isolates in 2006 and 2007.
Conclusion: Five major endemic clones of Lp1 have been identiﬁed,
in France. The distribution over the time of these clones, isolated from
clinical samples, was variable. Some clones seemed to be continually
detected, at a low level (Biarritz) or at a higher level (Paris). The Mondial
clone seemed to disappear with the year, whereas the Lorraine and the
Louisa clones seemed to emerge among the clinical isolates for the past
few years.
P1692 Cluster of human listeriosis cases traced by molecular
typing to taleggio cheese, Italy
C. Mammina, G. Manfreda, A. Aleo, A. De Cesare, V. Ferretti,
N. Pellissier, C. Romani, A. Nastasi, M. Pontello (Palermo, Bologna,
Milan, Florence, IT)
Objectives: Listeria monocytogenes is a foodborne pathogen responsible
for severe invasive disease in humans and animals. A number of large
outbreaks have been described in many industrialised countries, but most
cases are considered to be sporadic.
Frequent clustering was detected by a retrospective subtyping analysis
of 24 human isolates identiﬁed from apparently sporadic cases of
infection in the Lombardy region, Italy, in the years 2006–2007, by
using serotyping and DNA-based subtyping methods. The objective of
this study was to evaluate a possible causative role of L. monocytogenes
strains isolated from cheese and salami samples on sale in the same
geographic area.
Methods: Serotyping
All strains tested were serotyped following the manufacturer’s instruc-
tions using commercial speciﬁc antisera (Denka Seiken, Tokyo, Japan).
Ribotyping
Isolates were characterised by automated ribotyping using the
RiboPrinter® (Qualicon, Inc. Wilmington, DE, USA) and selecting
EcoRI as the restriction enzyme. Ribotypes were ﬁrstly classiﬁed into
ribotypes by automatic classiﬁcation and, then, some isolates were
submitted to manual classiﬁcation after visual inspection.
PFGE analysis
PFGE was performed according to PulseNet protocol with enzymes
AscI and ApaI. New PFGE proﬁles obtained by AscI were marked
by subsequent numbers. Closely related patterns, differing from each
other by one to three bands, were assigned an additional capital letter.
Indistinguishable or closely related strains were subsequently cleaved
with ApaI.
Results: Seven clusters including two to three isolates were identiﬁed
within human isolates. Isolates from salami were heterogeneous but all
were different by ribotyping and PFGE from the available human isolates.
Taleggio and gorgonzola cheese samples proved to contain two different
strains of L. monocytogenes.
A cluster, including human isolates from the geographic area under study,
consisted of three strains indistinguishable by serotyping – serotype 1/2b,
PFGE after AscI and ApaI digestion and EcoRI ribotyping – ribotype
DUP-1034 – from L. monocytogenes strains detected on the rinds of
Taleggio cheeses produced in an Italian plant.
Conclusion: Listeriosis control strategies should include subtyping of
human isolates and take into account that a large proportion of cases
may represent foodborne outbreaks. PFGE and ribotyping databases
representing isolates from different sources may be invaluable to identify
source-speciﬁc subtypes.
P1693 Relapsing cellulitis and bacteraemia due to Campylobacter
coli in an agammaglobulinemic patient
A.M. Dionisi, I. Quinti, H. Martini, A. Parisi, S. Owczarek, I. Luzzi
(Rome, Bari, IT)
Objective: Campylobacter spp., a frequent aetiologic agent of diarrhoea
in humans worldwide, uncommonly causes bacteraemia or extraintestinal
infections especially in immunocompromised patients.
Aim of this study is to describe a case with X-linked agammaglobuli-
naemia (XLA) with relapsing episodes of leg cellulitis and bacteraemia
due to C. coli. The work aims also to characterize, by molecular methods,
all patient’s C. coli isolates including a strain isolated from the patient’s
stool in 1997.
Methods: Stool, blood and skin lesion specimens were collected
and cultured as conventional protocols. Identiﬁcation of isolates was
performed by biochemical and PCR tests as previously described.
Susceptibility to erythromycin, gentamycin, kanamycin, nalidixic acid,
ciproﬂoxacin, norﬂoxacin, ampicillin, amikacin, cephalotin, cefotaxime,
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ceftazidime, ceftriaxone, cefoxitin, imipenem, cloramphenicol, trimetho-
prim/sulphametoxazole, tetracycline, was tested by disk diffusion
method.
Molecular characterisation of strains was performed by Pulsed Field Gel
Electrophoresis, using SmaI and SalI as restriction enzymes; Multi Locus
Sequence Typing were also applied to all isolates. PCR and sequencing
were performed to detect mutations within 23S rDNA gene, conferring
erythromycin resistance.
Results: Stool, blood and skin lesion culture were positive for C. coli.
From stools 2 colonies with different morphology (A, B) were
both identiﬁed as C. coli. All strains were susceptible to imipenem,
cloramphenicol, tetracycline, gentamycin, kanamycin, amikacin. The
strain from colony A was also susceptible to erythromycin. All
strains were resistant to quinolones, ﬂuoroquinolones and b-lactam
antimicrobials. Oral tetracycline associated with bacitracin/neomycin
was then administered. Stool, blood, skin lesion cultures became rapidly
negative. After 3 weeks tetracycline therapy was discontinued and he was
treated for additional four weeks with bacitracin/neomicyn. All cultures
were persistently negative and there has been no disease recurrence after
3 months.
Pulsed Field Gel Electrophoresis performed with both enzymes and
analysis by Multi Locus Sequence Typing showed genetic identity for
all C. coli strains including the 1997 isolate.
Conclusions: This is the ﬁrst isolation of C. coli from cellulitis lesion. In
spite of Campylobacter genetic instability, all isolates from this patient
were genetically identical supporting a latent infection in the intestine
for years.
P1694 Molecular characterisation of Campylobacter jejuni isolated
from healthy bovine, ovine and free-range poultry faeces
in the Basque Country (northern Spain)
B. Oporto, J. Esteban, G. Aduriz, R. Juste, A. Hurtado (Derio, ES)
Objectives: Domestic farm animals are reservoirs of pathogenic
campylobacters like Campylobacter jejuni, the most frequently isolated
bacterial pathogen in cases of human gastroenteritis in developed
countries. A prevalence study carried out in the Basque Country
identiﬁed 28.3% (34/120) of ovine and 18.0% (37/206) of bovine farms
positive for C. jejuni, and even higher values (38.2%, 13/34) in free-range
poultry farms. The high incidence of human Campylobacter infections in
the Basque Country (121 cases per 100,000 inhabitants in 2005) and the
relatively high prevalence in primary production units of this foodborne
pathogen prompted us to further characterize the animal isolates to
investigate the relationships among strains from different sources.
Methods: A selection of isolates from the different host species
(sheep, cattle and poultry) were analysed using three molecular typing
techniques: pulsed-ﬁeld gel electrophoresis (PFGE) of pure cultures
digested with SmaI, restriction fragment length polymorphism analysis
of the PCR ampliﬁed ﬂaA gene (ﬂaA PCR-RFLP) and multilocus
sequence typing (MLST) of seven housekeeping genes (aspA, glnA,
glyA, gltA, pgm, uncA and tkt).
Results: PFGE and MLST showed higher discriminatory power than
ﬂaA PCR-RFLP since ﬂaA PCR-RFLP proﬁles present in different
production systems were further discriminated by both PFGE and MLST.
Nevertheless, different genetic types were observed between farms and
within the same farm suggesting the co-existence of several strains
probably originating from different sources.
Conclusion: The use of at least two molecular typing methods is needed
for optimal discrimination. Typing of C. jejuni strains was a useful tool
for the identiﬁcation of sources of infection within the farm. In addition,
MLST data provided information on the overall population structure of
the organisms that can be used in future population genetic approaches.
P1695 Genotyping Helicobacter pylori from faecal DNA
M. McMillan, W.G. MacKay, C.L. Williams, L.T. Weaver (Glasgow, UK)
Objectives: Helicobacter pylori is the commonest chronic bacterial
infection of mankind. It is usually acquired during childhood and in the
developed world it is the principal cause of duodenal ulcer disease and
a risk factor for gastric cancer. In the developing world it is associated
with undernutrition and short stature. Non-invasive methods of diagnosis
and detection involve the urea breath test, serology and faecal antigen
analysis. However genotyping bacterial isolates from children could
enhance epidemiological investigations into routes of transmission of
this microorganism. This study exploits the excretion of H. pylori in the
faeces to obtain H. pylori DNA for genotyping and thereby to generate
dendograms to explore patterns of intrafamilial transmission.
Methods: Subjects were children (<16y) attending the Royal Hospital
for Sick Children in Glasgow for urea breath test for suspected H. pylori
infection. Each subject, and close family members (parents and sibs),
was asked to provide a stool sample, which was stored at −80ºC
until analysis. Twenty-eight stool samples that were positive by HpSA
faecal antigen test (Meridian Diagnostics Inc) were analysed. H. pylori
DNA was recovered using phenol: chloroform: isoamylalcohol and
ethanol precipitation followed by isolation using a speciﬁc biotinylated
oligonucleotide probe with magnetic capture. RAPD PCR [1] was used
as a means of genotyping H. pylori DNA isolated from faeces.
Results: Data from sixteen families were analysed. One family had four
members, one had three members, seven had two members and seven
had one member. RAPD analysis revealed a typeability of ninety-three
percent. Loose similarities were observed between family one involving
mother and children but not between father and children. Similarly in
two other families samples from mother and child bore similarities. All
parent samples and those from other families bore little correlation.
Conclusion: Isolation of puriﬁed H. pylori by gene capture offers a
means of extracting DNA from faecal samples which can be use to
genotype the microorganism. The majority of faecal H. pylori isolates
were successfully genotyped using RAPD which proved to be highly
discriminating.
Reference(s)
[1] Akopyanz, N., N.O. Bykanov, T.U. Westblom, S. Kresovich and D.E.
Berg. 1992. DNA diversity among clinical isolates of Helicobacter
pylori detected by PCR-based RAPD ﬁngerprinting. Nucleic Acids
Res. 20. 5137–5142.
P1696 Is Helicobacter pylori the only aetiologic factor involved
in the pathogenesis of gastric cancer among Iranian
population?
N. Mohajerani, Y. Talebkhan, M. Esmaeili, M. Bababeik, A. Oghalaie,
A. Nahvijoo, M. Eshagh Hosseini, M.A. Mohagheghi, A. Abdirad,
M. Mohammadi (Tehran, IR)
Objectives: Helicobacter pylori has been documented as an aetiological
agent in gastric cancer (GC) development. Hp immuno-reactive proteins
and its main virulence factors, CagA and VacA, are implicated in
the pathogenesis of related diseases. On the other hand, host genetic
susceptibility and gastric hormones have been proposed as important
indicators in screening approaches for GC development. This study
has aimed to explore the aetiologic role of Hp, its antigens and their
association with the other mentioned factors in developing GC among
Iranian patients.
Methods: Hp status was determined by three gold standard tests. 309
patients referring for endoscopy and 198 GC cases were included in this
study. Immunoblotting, ELISA and gene-speciﬁc PCRs were performed
on collected samples.
Results: Hp infection was detected in 78.8% of all subjects composed of
80.3% of dyspeptic (non GC) subjects and 76.5% of GC patients. Sero-
reactivity toward Hp was detected in 91–93% of both studied groups.
vacA s1m1 and s2m2 genotypes were most prevalent in GC and non
GC patients, respectively. Serological data revealed that unlike cagA
genotyping which revealed no association with disease, the presence of
anti CagA antibody can be a predictive marker in GC development.
Antibody response towards Hp LMW antigens especially 35kDa and
37kDa proteins are differentially prevalent in two studied groups. Histo-
pathological data revealed that there is no signiﬁcant association between
Molecular typing on a per species basis S493
the type of tumour and Hp positivity. Host interleukin-1 genotyping
indicated that there is a higher prevalence of Hp infection in subjects
with L/L genotype of IL-1RN irrespective of the clinical picture while
Hp negative subjects possess mostly the 2/2 allele. In both Hp positive
and negative groups the mean and standard deviation of pepsinogen I
and II levels were similar.
Conclusion: This study showed that although the absolute majority of
the studied subjects were infected with Hp, genotyping of isolated Hp
strains and serological analysis can be appropriate screening approaches
for high risk populations. Evaluation of host susceptibility factors
revealed that IL-1 beta and its receptor antagonist may be involved in
GC pathogenesis irrespective of Hp infection. The genetic background
of the normal population, however, should be investigated before making
a ﬁrm conclusion about this contribution to GC development.
P1697 Human papillomavirus genotyping before the introduction
of quadrivalent vaccine against HPV on the Romanian
population
L. Manolescu, A. Dragodan, G. Anton, C. Sultana, S. Ruta
(Bucharest, RO)
Objective: To study the prevalence of Human Papillomavirus (HPV)
genotypes in Romanian population before the introduction of anti HPV
vaccine in order to be able to ﬁnd out the changes that will occur in
HPV genotypes in our population once the vaccine will be applied.
Methods: 115 patients, average age 32.8±8.85 years (limits 3–63 years
old), 82% women, were tested for the presence and genotype of HPV
during a period of one year before the introduction of HPV vaccine. The
patients presented with cervical lesions, vulvar, vaginal, or penian warts,
cervical intraepithelial neoplasia grade 2 or 3, adenocarcinoma in situ,
conjunctival papillomas, oral papillomas, and other cutaneous lesions
and as sexual partners of women diagnosed with HPV. Genotyping
was performed after the ampliﬁcation of the extracted DNA target by
hybridisation on strips provided through Inno-Lipa HPV Genotyping CE
Assay.
Results: We found a high prevalence of the HPV infection in the studied
population. 79.3% patients were HPV positive, but women were more
affected than men: 88.8% positive women vs. 63.6% positive men. The
following genotypes were founded: HPV 6 (in 17.4% cases); HPV 16 (in
17.4% cases); HPV 18 (in 8.7% cases); HPV 31 (in 21.7% cases); HPV
51 (in 13% cases); HPV 53 (in 4.3% cases); HPV 66 (in 4.3% cases);
HPV 68 (in 4.3% cases); HPV 70 (in 4.3% cases) and in 26% cases we
could not determine the genotype. Also 17.4% from the positive patients
presented at least 2 HPV genotypes at the same time. The most frequent
associations were: 6 + 68; 16 +18 + 31; 18 + 31 and 16 + 51.
Conclusion: Due to the high prevalence of HPV infection in our
population we recommend molecular diagnostics and genotyping as a
routine examination and a possible indication for the anti HPV vaccine
in patients with characteristic lesions for HPV infection.
P1698 A novel DHPLC assay for identifying genotypes of SHV-type
L. Xu, T. Ling, P. Hawkey (Birmingham, UK; Hong Kong, CN)
Objective: To develop a sensitive, rapid and high-throughput method
using DHPLC (Wave® Nucleic-Acid Fragment Analysis System,
Transgenomic) for genotyping blaSHV producing ESBLs.
Method: PCR primers were designed to amplify 234bp fragments of the
ORF of all blaSHV. Six well-deﬁned blaSHV ESBL-producing strains
(blaSHV-12, -2a, -6, -14, -55 and -5) were used as controls to develop
and optimize the DHPLC genotyping assay. The blaSHV-11 strain was
used as the reference strain. Heteroduplex PCR products were formed
by mixing an equal amount of DNA (5ml) ampliﬁed from the reference
strain blaSHV-11 and one of six blaSHV control strains. The mixtures
were heated to 95ºC for 5 min and then gradually cooled to 25ºC to form
heteroduplex DNA molecules. Aliquots of 6 ml duplexed PCR products
were then analysed by DHPLC on the Wave® Nucleic-Acid Fragment
Analysis System.
Results: The sequences of the PCR amplicons of the reference and
control strains were aligned and analysed. It was found that two
substitutions led to a change in the amino acid sequence and four were
silent mutations. Unique DHPLC chromatogram proﬁles were obtained
for all six blaSHV types.
Conclusion: This is a ﬁrst report of a novel DHPLC assay for genotyping
of blaSHV ESBLs; it offers a speciﬁc, sensitive, economical and high-
throughput approach to screen blaSHV producing ESBLs. The two most
frequently encountered genotypes worldwide, blaSHV-12 and -5, were
easily distinguished from each other and other genotypes tested. It has a
great potential for determining the clinical relevance of different known
and new blaSHV genotypes, as well as for epidemiological studies
and surveillance programmes. Applying the newly developed dHPLC
assay for genotyping blaSHV positive clinical isolates is currently being
undertaken.
P1699 Phylogenetic analysis of a rubella outbreak in Madrid,
Spain in 2004/2005
A.O. Martı´nez-Torres, M.M. Mosquera, J.C. Sanz, B. Ramos,
J.E. Echevarrı´a (Majadahonda, Madrid, ES)
Objective: Phylogenetic analysis of an rubella virus outbreak from
Madrid, Spain in 2004/2005.
Methods: Serum, oropharyngeal swab and urine specimens were
collected from patients from a Rubella outbreak which occurred in
2005 in the Community of Madrid. The outbreak affected mostly
Latin American immigrant population and Spanish men. The isolation
was realised in Cell Culture and conﬁrmed by immunoﬂuorescence
assay and nested reverse transcription-PCR. Phylogenetic analysis of
the 739 nucleotides from the E1 gene recommended by Word Health
Organization (WHO) was realised in all isolated and clinical samples
using MEGA v3.1 software.
Results: Eighteen isolates out of 38 clinical samples from the outbreak
were obtained, including two isolated from congenital rubella syndrome
(CRS) cases. These results showed that only one RUBV genotype
circulated in Madrid during the outbreak, and it was assigned to genotype
1j. The homology range falls into 97.8 to 98.2 compared with the
reference sequence of genotype 1j.
Conclusion: Probably, the origin of this genotype was not Latin
American, because the circulation in that region corresponded to
genotype 1C. Moreover, the published sequences of genotype 1j come
from Japan and Philippines. Finally, this study also represents the ﬁrst
report of detection of this genotype in Europe.
P1700 Multilocus sequence typing for Candida albicans strains
from patients with candidaemia
J.H. Shin, M. Yoon, J.S. Lee, S.I. Jung, S. Kee, S. Kim, M. Shin, S. Suh,
D. Ryang (Gwangju, KR)
Objectives: To investigate the clonal stabilities or evolutionary changes
of C. albicans isolates from candidaemia patients, and to investigate
whether the candidaemia agents diagnosed at our hospital are related to
internationally distributed C. albicans lineages, we performed multilocus
sequence typing (MLST) of 45 C. albicans isolates from various clinical
specimens of 23 patients with candidaemia.
Methods: The internal regions of seven housekeeping genes (AAT1a,
ACC1, ADP1, MPIb, SYA1, VPS13, and ZWF1b) were sequenced.
The MLST results were compared with the results of Southern blot
hybridisation of the C1 fragment of Ca3 as the probe (C1 ﬁngerprinting)
and pulsed-ﬁeld gel electrophoresis (PFGE) analysis. PFGE analysis
included restriction endonuclease analysis of genomic DNAs using
BssHII (REAG-B) and SﬁI (REAG-S).
Results: Overall, the 45 isolates yielded 20 unique diploid sequence
types (DSTs) by MLST, 19 different REAG-B patterns, 18 REAG-S
patterns, and 21 C1 ﬁngerprinting types. By MLST, 33 isolates from 18
patients belonged to new sequence types (16 distinct DSTs), whereas 12
isolates from 5 patients belonged to the previously described types (4
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DSTs). The intra-individual isolates showed minor genetic differences
(microevolution) by MLST (5 patients), REAG-B (4 patients), REAG-S
(2 patients), and C1 ﬁngerprinting (4 patients). All of four genotyping
methods used revealed that two distinct genotypes were shared among 10
isolates from nine patients in a neonatal intensive care unit, suggesting
two nosocomial clusters. However, none of the blood isolates from
these two clusters showed any microevolution by any of the genotyping
methods used.
Conclusion: The present study shows that MLST had similar or greater
discriminatory ability than PFGE or C1 ﬁngerprinting, and some of the
C. albicans strains that cause candidaemia at our hospital share the same
MLST type with strains from other geographic regions of the world. In
addition, a genetically stable strain of the C. albicans strains may be
responsible for nosocomial cross-infection.
P1701 25S intron-restriction endonuclease genotyping of Candida
albicans isolates
Z.C. Karahan, B. Saran, H. Agirbasli, A. Tekeli, A.M. Aksoy (Ankara,
Istanbul, TR)
Objectives: There isn’t any universally accepted gold-standard genotyp-
ing method for differentiating Candida albicans isolates. The presence
of transposable group I intron in the 25S rDNA gene makes C. albicans
isolates divided into three genotypes by 25S intron analysis. Genotype-A
isolates were previously shown to contain different subgroups which
were determined by restriction endonuclease and sequence analysis. In
this study, our aim was to establish a new genotyping method based
on PCR ampliﬁcation of 25S intron region followed by restriction
endonuclease analysis with two different endonucleases.
Methods: 111 C. albicans strains obtained from different infection
sites of 64 leukemic patients were genotyped. PCR ampliﬁcation
was performed by using primers designed to span the transposable
group I intron region of the 25S rDNA gene. To obtain the
genotypes, PCR products were digested by HaeIII and MspI restriction
endonucleases. The resulting band patterns were determined by agarose
gel electrophoresis. Groups were differentiated due to the differences in
the patterns. Discriminatory power (DP) was calculated for each method.
Results: 25S intron analysis divided the isolates into three genotypes.
Eightyone of the isolates were found to be genotype-A, 18 genotype-B,
and 12 genotype-C (DP= 0.43). HaeIII restriction of genotype-A isolates
gave 18 subgroups, while genotype B and genotype-C isolates clustered
in single subgroups (DP= 0.89). MspI restriction of genotype A isolates
gave 14 subgroups, while genotype-B and genotype-C isolates again
clustered in single subgroups (DP= 0.80). When the results obtained by
both enzyme digestions were combined, 33 subgroups were obtained
for genotype-A isolates, while genotype-B and genotype-C isolates both
gave single subgroups (DP= 0.92).
Conclusion: As the DP of 25S intron analysis is below the
acceptable limits (<0.90), its use for investigating C. albicans strains
epidemiologically would not be appropriate. By combining 25S intron
genotyping with HaeIII and MspI restriction endonucelase analyses, the
DP rises to 0.92 and it becomes suitable for epidemiological purposes.
The method is easy to perform, cheap, and labour ﬁrendly.
Acknowledgement: This study was supported by a grant from
the Biotechnology Institute of Ankara University (Project No:
2001K120240).
P1702 ompA genotyping and epidemiological investigation of
Chlamydia trachomatis urethritis in male patients, Athens,
Greece
T.E. Pittaras, J. Papaparaskevas, N.J. Legakis, A. Tsakris,
H. Papadogeorgakis (Athens, GR)
Objectives: The epidemiological investigation of male urethral infec-
tions due to Chlamydia trachomatis in Athens, Greece.
Methods: During the period 2005–2006, a total of 210 male patients
with acute urethritis, referred to the Outpatient Dpt. of the "Andreas
Sygros" Hospital for Skin and Venereal Diseases, were enrolled in
the study. Diagnosis of C. trachomatis and Neisseria gonorrhoeae was
performed on intra-urethral swabs using conventional microbiology and
the CT/NG COBAS AMPLICOR system (Roche Inc, Branchburg, USA).
Chlamydial serotype assignment was performed after ampliﬁcation and
DNA sequencing of the whole C. trachomatis ompA gene. Patient
information collected included age, profession, nationality, place of
residence, family status, antibiotic use during the previous three months,
sexual preference and number of sexual companions during the previous
six months, other sexually transmitted disease in the past, and duration
from symptoms onset to hospital visit. Statistical analysis was performed
using the SPSS 13.0 software.
Results: In total, 46 of the 210 (21.9%) patients tested were diagnosed
with C. trachomatis urethritis.
Serotypes E (34.8%) and G (26.1%) prevailed; additional serotypes
recorded were F (13.0%), D (13.0%), Ja (10.8%), and B (4.3%). Overall
gonococcal co-infection rate was 28%. Among patients with serotype
Ja infection, co-infection rate was 100%, whereas the respective rates
for serotypes D, E, F and G, were 50, 19, 16, and 16% (p = 0.003).
Mean patient age was 31 years (range 16–57). Patients with a serotype
D infection had a mean age of 36 years (range 22–49), whereas patients
with an infection due to other serotypes had a mean age of 29 years
(range 16–57). Mean duration to hospital visit was 17 days (range 1–95
days). Patients with an infection due to serotype Ja presented earlier to
the hospital (mean duration to visit 3 days), whereas for serotypes G, B,
E, D and F, time to visit were 10, 12, 20, 23, and 33 days respectively
(p= 0.077 and 0.058 for comparing mean durations for serotypes D, E
and F with those for G or Ja, respectively). Mean number of sexual
companions was 4 (range 1–24).
Conclusion: In this ﬁrst report of epidemiological investigation of
C. trachomatis in Athens, Greece, serotypes E and G prevailed among
male patients diagnosed with acute urethritis. Serotype distribution
was associated with gonococcal co-infection rates and duration from
symptoms onset to hospital visit.
P1703 New tests for syphilis: rational design of a PCR method for
detection of Treponema pallidum in clinical specimens
A. Kharitonova, O. Abramov (Moscow, RU)
Objectives: A sensitive and speciﬁc PCR method to detect Treponema
pallidum in clinical specimens was developed. PCR primers were
designed based on two unique features of the DNA polymerase I gene
(polA). The ﬁrst distinctive characteristic is that the region codes for
a high cysteine content and has low homology with similar regions
of DNA polymerase I gene from known microorganisms. The second
unique feature is the presence of four insertions in the gene. PCR tests
using primers designed on the basis these regions reacted with various
pathogenic T. pallidum subspecies but did not react with nonpathogenic
treponemal species or other spirochetes. An additional 59 species of
bacteria and viruses, including those that cause genital ulcers, tested
negative. This PCR method is extremely robust and sensitive. The
detection limit is about 10 to 25 organisms when analysed on gel.
However, the analytic sensitivity can be increased by at least 1 log, to a
detection limit of a single organism, when the ABI 310 Prism Genetic
Analyzer is used to detect ﬂuorescence-labeled amplicons. We further
used this test in a clinical setting and compared the results with results
from a previously reported multiplex-PCR test (for T. pallidum).
Results: We tested 42 genital ulcer specimens by the polA PCR,
obtaining a sensitivity of 95.8% and a speciﬁcity of 95.7%.
Conclusion: These results suggest that the polA PCR is applicable as a
routine clinical diagnostic test for syphilis.
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P1704 Sequencing and molecular typing of hypervariable loci in
the Treponema pallidum genomes: characterisations of type
strains and clinical isolates
D. Smajs, P. Matejkova, M. Strouhal, V. Woznicova, G.M. Weinstock
(Brno, CZ; Houston, US)
Objectives: Using Comparative Genomic Sequencing (CGS) approach,
hypervariable regions in Treponema pallidum genome were identiﬁed.
These regions comprised hypothetical genes TP0136 and TP0548.
Nucleotide sequences of these genes were determined and compared
in 4 groups of T. pallidum strains: in ssp. pallidum (6 strains causing
syphilis), in ssp. pertenue (6 strains causing yaws), in ssp. endemicum (2
strains causing endemic syphilis) and in 1 strain of unclassiﬁed simian
isolate. In addition, 9 PCR positive clinical samples were analysed.
Methods: Primary screening of clinical specimens was performed using
nested PCR detection of two T. pallidum speciﬁc loci (tmpC, polA). In
PCR positive samples, direct Sanger sequencing of TP0136 and TP0548
PCR products was used to determine the corresponding sequences.
Sequencing reads were analysed using computer-assisted assembly and
the ﬁnal nucleotide and protein sequences were clustered.
Results: The TP0136 and TP0548 analysed loci showed discrete clusters
in 4 groups of type strains. Analysis of strains belonging to ssp. pallidum
revealed two discrete subclusters containing Nichols-like and SS14-like
sequences, respectively. All clinical isolates clustered with the SS14-like
subgroup. In 4 clinical isolates, unique sequences in either TP0136 or
TP0548 were found. Sequencing of different samples obtained from the
same patient resulted in identical sequences.
Conclusions: Our results showed that TP0136 and TP0548 loci represent
promising targets for molecular typing of pathogenic treponemes
including clinical samples.
This work was supported by the grants from the Internal Grant Agency
of the Ministry of Health of the Czech Republic (NR/8967−4/2006) and
from the Grant Agency of the Czech Republic (310/07/0321).
P1705 Genotyping of Giardia lamblia by multilocus sequence typing
R. Jansen, T.G. Mank, W. Ramparichan, A. van de Craats, P. Mittelberg
(Haarlem, NL)
The intestinal parasite G. lamblia occurs worldwide and infects humans
and animals. The infection route is expected to be the oral–faecal route
between humans, and between humans and animals. To be able to
trace the sources of infection and to elucidate the zoonotic potential
of G. lamblia, a high resolution genotyping method is needed to trace
individual strains of G. lamblia.
Objective: Development of a multilocus sequencing typing method
(MLST) for G. lamblia.
Methods: The MLST uses sequence variation in the genes for ferredoxin
(FD), glutamate dehydrogenase (GDH) and giardin (GD) to make a
genetic ﬁngerprint of G. lamblia strains. The method can be used on
faeces from patients without the need to culture this fastidious parasite.
Results: The MLST was validated on a panel of hundred patients with
well described medical and demographic data. The faeces samples were
collected in the routine diagnostics during a three month period in the
western urban area of the Netherlands. In a previous study the two
genotypes assemblage A and B were determined of the G. lamblia strains
of these patients. We found thusfar 9, 8, and 11 variants of the FD,
GDH, and GD gene respectively. In the patient samples we have analysed
28 samples yet and found eight different MLST types, indicating that
the method has a good discriminatory power. The MLST types were
grouped by cluster analysis. As expected, there was a clear digotomy
between the MLST types of G. lamblia strains with A or B assemblages
of these patients, indicating the large genetic differences between these
two genotypes. Moreover a clear correlation between MLST type and
demographic data of the patients was found, indicating that the method
is able to distinguish epidemiologically related groups.
Conclusions: The described MLST using three genes is able to
distinguish G. lamblia strains from separate outbreaks. Currently, we are
working on the implementation of two additional genes in the MLST
sceme to increase the resolution of this genotyping method.
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P1706 Trends in incidence of and serotypes causing invasive
pneumococcal disease in Finland during 1995–2007:
implications for introduction of conjugate vaccine
H. Nohynek, T. Kaijalainen, J. Ollgren, O. Lyytika¨inen, H. Salo,
P. Klemets, P. Nuorti, M. Leinonen, P. Ruutu, T. Kilpi (Helsinki, FI;
Atlanta, US)
Introduction: Pneumococcal (Pnc) conjugate vaccines (PCV) decrease
vaccine type speciﬁc incidence of invasive Pnc disease (IPD) but
also increase non-vaccine serotype IPD. How much such phenomena
is caused by underlying secular trends and evolutionary processes
irrespective of PCV use is not well known. In anticipation of PCV
introduction into national immunisation programme, we analysed trends
of IPD and causative serotypes in Finland during years 1995–2006.
Methods: Notiﬁable IPD was deﬁned as clinical condition with
Pnc isolated from normally sterile site (blood, CSF, other). Isolates
were obtained from adults and children hospitalised for IPD. Pnc
were serotyped using quellung, Latex and/or CIEP (antisera from
StatensSerumInstitute, Denmark) in KTL Reference Laboratory.
Results: Total 7193 Pnc isolates were identiﬁed. During observation
period, overall IPD incidence grew signiﬁcantly (1.5-fold) from 9/100
000 in 1995 to 14/100 000 in 2006. Increase was signiﬁcant in children
<5 and adults >50 years. Strong seasonal pattern in IPD was observed
with annual peaks December and May. In 2006, most common Pnc
serotypes were 14, 4, 6B, 23F, 3, 7F, 9V and 19F constituting 70% of all
isolates, although among children <5 serotypes 3, 4, 7F, and 9V were
observed less frequently. Since 1995, proportion of serotypes 14 and
9V had signiﬁcantly increased, 4 and 7F decreased, while proportion of
others remained constant, as did composition of most prevalent serotypes
in children <5 (i.e. 6B, 14, 19F, 23F, 18C, 19A). During observation
period among children <2 years, coverage of 7PCV serotypes ﬂuctuated
between 47 and 81% (mean 70%). Among those >2 years, coverage
of 7PCV serotypes increased signiﬁcantly from 47 to 59% (p for trend
0.000).
Age group 7PCV 10PCV 13PCV
<2 years 47–81; 70 55–84; 75 78–96; 91
NS NS NS
2 years 47–59; 53 57–66; 62 73–80; 77
0.000 0.03 NS
In Table, range and mean % of vaccine serotype coverage among those
to be vaccinated (<2 year olds) and those who might beneﬁt from herd
effect of PCV (>2 year olds), and p for linear trend of increase during
12 years of observation period.
While incidence of IPD has increased in past 12 years, seasonal
pattern and constancy in composition of majority serotypes prevails with
ﬂuctuation in rank order of prevalent serotypes among children <2 years.
In others, proportion of 7PCV and 10PCV serotypes has signiﬁcantly
increased.
P1707 Streptococcus pneumoniae septicaemia associated with red
cell transfusion
M. Polizzotto, M. Borosak, H. Neo, D. Spelman, J. Shortt, P. Wong,
E. Wood, M. Cole-Sinclair (Melbourne, AU)
Background: Bacterial contamination of blood components remains an
important residual infective risk of transfusion. We report a case of red
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cell (RC) transfusion-transmitted bacterial infection (TTBI) caused by
Streptococcus pneumoniae. This fragile non-commensal organism has
not to our knowledge previously been implicated as a cause of RC TTBI.
Case and Investigation: The transfusion recipient was a 79 year old
man with a myelodysplastic syndrome pancytopenia, with no history of
splenectomy. Forty minutes after commencement of a RC transfusion
he became febrile to 39.6ºC, hypotensive and hypoxic. Transfusion was
ceased, and empiric therapy with intravenous antibiotics instituted with
good clinical effect.
Cultures performed on recipient samples and the RC each demon-
strated heavy growth of Gram-positive alpha-haemolytic diplococci
characteristic of S. pneumoniae, conﬁrmed by automated identiﬁcation
and susceptibility testing. The organisms from unit and recipient were
serotype four.
The implicated RC unit had been collected ten days before transfusion.
Venesection and processing had been uncomplicated. The donor was a
53 year old man, with no history of splenectomy or respiratory tract
infection, who had not been vaccinated against S. pneumoniae. He had
donated on numerous occasions prior to the index donation without
complication. There had been no infective symptoms near the time of
donation. Cultures of blood and of swabs obtained from nose, throat
and both antecubital fossae were negative, as was urinary testing for
pneumococcal antigen.
The ability of S. pneumoniae to survive in the refrigerated conditions of
RC storage was explored. An expired RC unit was inoculated with 1×103
organisms of S. pneumoniae derived from the original cultures. The RC
unit was maintained at 4ºC for ten days, following which samples were
cultured and again demonstrated abundant growth of S. pneumoniae.
Conclusions: This case demonstrates that even organisms which are
neither commensal nor psychrophilic may cause TTBI. The source
of contamination could not be established deﬁnitively, but may have
originated from transient donor bacteraemia. Even in retrospect no
symptoms which might have led to donor deferral were identiﬁable.
Prompt recognition of the source of sepsis enabled institution of
appropriate therapy and liaison with the blood service to enable
immediate recall of associated components.
P1708 Pneumococcal colonisation in the elderly in a non-outbreak
setting
J. Flamaing, W.E. Peetermans, J. Verhaegen (Leuven, BE)
Objectives: To study the prevalence, dynamics, and risk factors of
pneumococcal nasopharyngeal colonisation in elderly subjects (n = 503,
mean age = 80.3 ±10 SD) in the community (n = 109, mean age =
66.2±4.5 SD), nursing homes (n = 296, mean age = 84.3±7.4 SD), and
the hospital (n = 98, mean age = 83.8±6.4 SD).
Methods: A nasopharyngeal swab (NPS) was taken through each nostril.
The ﬁrst NPS was directly plated on a selective blood agar and the
second NPS after enrichment in broth. Pneumococci were identiﬁed
using classical bacteriological techniques. A subset of nursing home
residents colonised with pneumococci (n = 14) and negative controls (n
= 26) were re-swabbed at 1, 2, 4, 8, and 12 weeks. In a subset of nursing
home residents (n = 203, mean age: 84.4±7.1 SD) a PCR with a lytA
gene probe was performed on DNA extracted from the primary NPS.
Results: The overall pneumococcal colonisation rate was 4.9% (25/503)
(5.5% (6/109) in the community, 5.4% (16/296) in nursing homes and
3.1% (3/98) in hospital, P = NS). There were no signiﬁcant differences
in age and gender distribution, presence of comorbidities, vaccination
status, hospitalisation and antibiotic use history, and functionality
between colonised and non-colonized subjects. The broth enrichment
technique on the second NPS yielded 28% (7/25) of the colonising
pneumococci. Sixty-four % of the subjects initially colonised, carried
a pneumococcus during the 3 month follow-up compared to 23% of the
initially negative controls (P = 0.017). Compared to the PCR the bacterial
culture technique had a sensitivity, speciﬁcity, positive predictive, and
negative predictive value of 11.1%, 97%, 44.4%, and 83.5%, respectively.
Conclusions: Pneumococcal carriage-rate in the elderly, detected by
bacteriological culture techniques, is low. Nursing home residents
frequently carry pneumococci during a follow-up period of 3 months. In
elderly subjects, the risk factors associated with pneumococcal carriage,
the optimal bacteriological technique, and the value of molecular
detection techniques need further study.
P1709 Serotype distribution and analysis of invasive Streptococcus
pneumoniae isolates pre-7-valent pneumococcal conjugate
vaccine introduction in the Republic of Ireland
I. Vickers, S. Murchan, M. Fitzgerald, S. Cotter, M. Cafferkey,
H. Humphreys (Dublin, IE)
Objectives: The aims of this study were (1) to obtain data on serotype
distribution of invasive Streptococcus pneumoniae (Spn) isolates, pre-
7-valent pneumococcal conjugate vaccine (PCV7) introduction in the
Republic of Ireland (RoI), (2) to determine the coverage provided
by PCV7, and the 23-valent pneumococcal polysaccharide vaccine
(PPV23) (3) to assess the proportion of invasive isolates with decreased
susceptibility to penicillin (PNSP), and perform genotypic analysis of
isolates.
Methods: Serotyping was performed using serological methods and
multiplex PCR. Penicillin susceptibility was assessed by the E-test
method (AB Biodisk, Solna, Sweden), following CLSI guidelines. MLST
analysis was performed using standard procedures.
Results: Between April-November 2007, 161 invasive isolates were
received from 25 laboratories nationwide. Thirty-one capsular serotypes
were identiﬁed. The most common serotypes were 14 (n = 18), 7F
(n = 14), 4 (n = 13), 6B (n = 11), 9V (n = 11), 19A (n = 11), and 1 (n = 10).
In this study, 90% and 73% of isolates obtained from very young children
(<2y) and children (<5y), respectively, were covered by PCV7; within
the older population (65y) 51% of isolates. An observed coverage
of 88% occurred within the main target population (adults 65y) for
PPV23.
The incidence of PNSP was 12.4%; the most prevalent PNSP serotypes
were: 9V (n = 8), 19F (n = 4) and 14 (n = 4). Preliminary MLST analysis
of these isolates demonstrated the presence of ST156, ST2511 and
ST1697, amongst others.
Conclusion: Based on epidemiological data to date, the introduction
of PCV7 in the RoI is highly recommended. Continued surveillance of
serotype distribution and the monitoring of PNSP isolates is of utmost
importance, as the incidence of PNSP in the RoI is relatively high.
P1710 Epidemiological survey of invasive pneumococci in Hungary
O. Dobay, A´. Ungva´ri, J. Szabo´, E. Hajdu´, F. Rozgonyi, S.G.B. Amyes,
K. Nagy (Budapest, Debrecen, Szeged, HU; Edinburgh, UK)
Objectives: Streptococcus pneumoniae is a major pathogen able to cause
severe infections such as pneumonia, sepsis, or meningitis with high
mortality rates if not treated correctly. The highest burden of disease is
present in young children, and to protect them, the 7-valent conjugate
vaccine (PCV7) was developed. As this vaccine was introduced in
Hungary at the end of 2005, it was important to get an insight to the
situation of pneumococci causing invasive infections in our country.
Methods: One hundred and six non-repeated invasive Streptococcus
pneumoniae isolates were collected at seven different diagnostic
laboratories throughout Hungary. The species identity of all strains was
conﬁrmed by the presence of the lytA gene. Their antibiotic sensitivity
to 7 drugs was determined by agar dilution, according to the BSAC
guidelines. Serotyping was done both conventionally with antisera and
with a PCR-based method. The genetic relatedness of the strains was
examined using pulsed-ﬁeld gel electrophoresis (PFGE).
Results: We had 8 penicillin-resistant (R) strains among the isolates
(8.4%, MIC = 2 or 4mg/L), while there was virtually no resistance
to cefotaxim or imipenem. The erythromycin resistance was 41.9%. The
resistance to levoﬂoxacin and moxiﬂoxacin were around 3%. The isolates
were fully sensitive to telithromycin and vancomycin. The detected
serotypes in ranking order were: 6 (mostly 6A, 26.3%), 14 (17.1%),
23 (10.5%), 3 (9.2%), followed by 15, 9, 19, 7, 4, 18, 1, 11 and 8.
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The penicillin-R strains were of serotypes 14, 23 or 19A. The serotype
23 strains required higher penicillin MICs, but were all sensitive to
macrolides. The higher ﬂuoroquinolone MICs were observed mainly for
serotypes 3, 4, 18 and 19. Interestingly, serotypes 6, 9 and 23 were
mostly isolated from pneumonia. Based on the PFGE results, the strains
showed a relatively high genetic diversity.
Conclusions: The antibiotic sensitivity pattern of the strains was similar,
but the serotype distribution was different from that previously observed
in the general pneumococcal population in Hungary. Based on our data,
the theoretical vaccine coverage for the PCV7 (serotypes 4, 6B, 9V, 14,
18C, 19F, 23F) is 51.3%, which is very low. This would increase to
59.2% with the soon coming 10-valent vaccine, and to 89.5% with the
future 13-valent vaccine, thus this latter would be very welcomed in
Hungary.
P1711 Phenotypic and genotypic characterisation of Streptococcus
pneumoniae carriage strains from paediatric population in
Arkhangelsk region, Russia
V. Vorobieva, A. Furberg, T. Bazhukova, O. Lebedeva, BC. Haldorsen,
L. Buaro, B. Aasnaes, D. Caugant, A. Sundsfjord, GS. Simonsen
(Tromso, NO; Arkhangelsk, RU)
Objectives: To determine the prevalence of the nasopharyngeal carriage
of Streptococcus pneumoniae in children from Arkhangelsk region,
Russia, and characterize the strains with regard to population structure
and antimicrobial resistance.
Methods: A single nasopharyngeal (NP) swab from 438 non-vaccinated
healthy children aged 1−7 years, at 10 day-care centres in the
Arkhangelsk region in November 2006. S. pneumoniae isolates were
identiﬁed by standard methods and examined for the susceptibility to
oxacillin (OXA), tetracycline (TET), erythromycin (ERY), norﬂoxacin
(NOR), and trimethoprim-sulfamethoxazole (TMP/SMX), with agar
disk diffusion (Oxoid LTD, UK) using breakpoints deﬁned by the
Norwegian Working Group for Antibiotics (NWGA) and the Swedish
Reference Group for Antibiotics (SRGA). OXA-resistant isolates were
further examined for their susceptibility to penicillin G (PENG),
cefuroxime, cefotaxime and meropenem by Etest. ERY-resistant isolates
were examined by the double disk diffusion method with ERY and
clindamycin (CLI) (Oxoid) as well as for erm(B) and mef-gen by PCRs.
NOR-resistant isolates were examined by Etest for their susceptibility
to ciproﬂoxacin (CIP), norﬂoxacin (NOR), moxiﬂoxacin (MXE) and
levoﬂoxacin (LVX), using SRGA and EUCAST-breakpoints. Multi-
drug resistance (MDR) was deﬁned as resistance to 3 groups of
antibiotics. Ongoing analyses of the population structure are performed
by serotyping and MLST.
Results: S. pneumoniae was recovered from 171 (39%) NP-samples.
The rates of non-susceptibility were: TMP/SMX (n = 143;84%), TET
(n = 54;32%), OXA (n = 31;18%), ERY (n = 18;11%), and NOR (n = 1;
<1%). 22/31 (71%) of OXA-resistant strains were conformed non-
susceptible for PENG (range 0.094−1mg/L). Double disk diffusion
analysis of ERY-resistant strains (n = 16) revealed the following
phenotypes: iMLSB(n = 9), cMLSB (n = 4), and M-type (n = 3), which
was conﬁrmed by erm(B) and mef(A)-PCRs. One NOR-resistant strain
revealed the following MIC proﬁle: NOR32mg/L, CIP4mg/L, and
susceptible to LVX (2mg/L), MXE (0.25mg/L). MDR was detected in
19 strains (11%).
Conclusions: (i)The prevalence of pneumococcal colonisation (39%)
in children aged 1−7 years in Arkhangelsk is relatively high. (ii)High
to moderate rates of non-susceptibility to commonly used antibiotics
were observed: TMP/SMX (84%), TET (32%), PENG (13%) and ERY
(11%) were observed. (iii)A low prevalence (<1%) of resistance to
ﬂuoroquinolones was observed.
P1712 Comparison of pneumococci isolated from invasive and
non-invasive disease in pre-school children
S. Aguiar, J. Melo-Cristino, M. Ramirez (Lisbon, PT)
Objective: Characterisation of pneumococcal isolates recovered from
invasive and non-invasive disease in children with less than 6 years, in
Portugal.
Methods: Streptococcus pneumoniae is recognised as an important
cause of morbidity and mortality especially among pre-school children.
The infections caused by S. pneumoniae range in severity from mild
infections such as otitis media to life threatening such as meningitis.
Epidemiological studies have shown an association between certain
serotypes and invasive infections. Nevertheless, serotype distribution
varies considerably in terms of geographic localisation. In this work,
we analysed and compared 72 isolates responsible for invasive and non-
invasive disease in children with less than 6 years, recovered in 2003.
Each isolate, was characterised using a combination of antimicrobial
susceptibility proﬁle, serotyping, macrorestriction proﬁling, using SmaI
and pulsed-ﬁeld gel electrophoresis (PFGE). Multilocus sequence typing
(MLST) was performed for representatives of the main PFGE clones
obtained.
Results: A signiﬁcant modiﬁcation of the distribution of serotypes in
2003 was observed, which included the absence of isolates expressing
the main serotype found between 1999 and 2002, namely serotype 14.
Nevertheless, molecular analysis did not show a radical change in clonal
composition. Serotype distribution among non-invasive isolates differed
signiﬁcantly from the one found in the invasive population. Regarding
molecular typing, no marked differences were found among the clonal
composition. In terms of antimicrobial resistance, 88.5% and 40.0% of
the invasive and non-invasive strains, respectively, were resistant to at
least one of the antimicrobials analysed. Among the invasive collection,
penicillin and erythromycin resistance decreased in 2003, which was
associated with a decline of a small number of serotypes including some
present in the heptavalent conjugate vaccine. Regarding non-invasive
disease, while penicillin resistance also declined, erythromycin resistance
increased considerably in 2003.
Conclusion: The results obtained in the present study indicate that
the invasive pneumococcal population is changing in the age groups
considered. The absence of serotype 14 isolates and associated clones
was the most striking feature of this change, which was not observed
among non-invasive isolates. The results indicate that, although related,
the two populations are evolving along different lines.
P1713 emm-types distribution and susceptibility pattern of group
A streptococci isolated from pharyngitis patients in Serbia
V. Mijac, N. Opavski, M. Markovic, L. Ranin, C. Heeg, R. Reinert
(Belgrade, RS; Aachen, DE)
Objective: Pharyngitis is one of the most frequent diseases caused by
group A streptococci (GAS). Distribution of GAS emm types causing
pharyngitis vary with time and geographical region. Although GAS
remains susceptible to penicillin, an increased resistance to macrolides
and other antibiotics has been noticed recently. The aim of this study
was to investigate emm type distribution and susceptibility pattern of
GAS isolates from patients with pharyngitis in Serbia.
Methods: Seventy pharyngeal isolates of GAS collected from various
regions throughout Serbia were included in the study. The presence
of emm genes was determined by PCR using “all M” primers
following a previously published protocol by Podbielski and co-workers.
Susceptibility to penicillin, erythromycin, clarythromycin, clindamycin,
levoﬂoxacin and tetracycline was determined by broth microdilution test
according to the recommendations of CLSI standard, or on Phoenix
automated system (BD, USA), using SMIC-10 panel.
Results: A total of 14 different emm types were identiﬁed among the
tested isolates. The most common ones were emm 12 (21%), emm 6
(20%), emm 1 (18%), emm 3 (15%) and emm 4 and emm 28 (6% each).
Resistance to erythromycin/clarythromycin was encountered in only 3%
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of isolated strains. These isolates were also resistant to clindamycin
indicating constutive MLS resistance, as well as to tetracycline. Overall,
tetracycline resistance was recorded in 12% of isolates, while all strains
were susceptible to levoﬂoxacin.
Conclusion: The emm type distribution of pharyngeal isolates of GAS
is similar to the reports from other parts of Europe, with the exception
of relatively high prevalence of emm 6. Our results indicate that
erythromycine resistance is not widespread in Serbia, despite its high
prevalence in the neighbouring countries.
P1714 Comparison of macrolide-resistant and macrolide-
susceptible populations of group A streptococci from
asymptomatic oropharyngeal colonisation in Portugal
R. Pires, D. Rolo, J.F. Almeida, A. Brito-Avoˆ, A. Morais,
J. Gonc¸alo-Marques, I. Santos-Sanches (Caparica, Oeiras, Lisbon, PT)
Objectives: To assess the structure and evolution of macrolide resistant
and susceptible populations of group A streptococci (GAS) from
asymptomatic oropharyngeal colonisation during 2000 to 2005.
Methods: A total of 850 GAS collected from healthy carriers at day
care centres (DCC) were tested for macrolide resistance frequency
and phenotypes (M or MLSB) by disk diffusion. Out of these, all
(n = 141) macrolide resistant (MR) isolates and part of the macrolide
susceptible (MS) isolates [368 isolates collected at DCC where high
(15%) colonisation rates were observed] were characterised by SmaI
or Cfr9I DNA-band pulsed-ﬁeld gel electrophoresis (PFGE) proﬁling.
Representatives of different PFGE patterns were characterised by
T-typing, emm-typing and multilocus sequence typing (MLST).
Results: Resistance to macrolides was approximately 10% in 2000–02,
28% in 2003, 20% in 2004 and 3% in 2005. M phenotype isolates
increased from 40% in 2000 to >80% during 2001–04 and were not
detected in 2005. In parallel the MLSB phenotype isolates were prevalent
in 2000 (60%) and in 2005 (100%).
Three major clonal lineages accounted for the majority of the
M phenotype isolates (70% of 117 isolates) and were preva-
lent in different years: ST28 (emm1;emm107/T1/PFGE.CX) in
2001, ST36 (emm12/T12;others/PFGE.AP) in 2002/03 and ST39
(emm4;emmstMrp6/T4;others/PFGE.CZ) in 2004.
Also three major clonal lineages accounted for the majority of the MLSB
phenotype isolates (63% of 24 isolates) and were as well detected in
different years: ST46 (emm22;emm73/T13/PFGE.A) in 2000/01 and
2003, ST52/bacitracin-resistant (emm28/T28/PFGE.F) in 2003/04, and
ST403 (emm11/T11;NT/PFGE.BO) in 2004/05.
Most of the MS isolates (69%) were included in six clones also variable
in frequency and year of detection: ST55 (emm79/T2.12/PFGE.BH),
ST382 (emm1;emm6/T6/PFGE.AD), ST36 (emm12/T3;other/PFGE.AP),
ST403 (emm1/T1/PFGE.BG), ST28 (emm1/T1/PFGE.X), and ST-not
assigned (emm12/T12/PFGE.AB).
Conclusions: The epidemiology of MR and MS GAS from asymp-
tomatic colonisation changed rapidly during 2000–05. However, several
lineages of MR and MS were identiﬁed which were described as
prevalent and capable of causing a broad range of streptococcal
infections in Europe. Two lineages (ST36 and ST403) were found to
comprise MR and MS isolates of different T, emm and PFGE types. This
study stresses the role of carriers as reservoirs of particular strains either
resistant or susceptible to antimicrobials with high ability to colonize and
disseminate.
P1715 Prevalence of group A streptococcal carriers in healthy
school children
D. Toprak, T. Demirdal, N. Demirturk, Z. Asci, S. Orhan
(Afyonkarahisar, TR)
Objectives: The aim of this study was to investigate the prevalence of
nasopharyngeal Streptococcus pyogenes in asymptomatic school children
in Afyonkarahisar, Turkey. A secondary aim was to investigate whether
pharyngitis occurred among the asymptomatic carriers.
Methods: The study groups included 1129 primary school children in
Afyonkarahisar, Turkey. An infectious disease specialist rubbed sterile
swabs over the posterior nasopharyngeal walls of the 1129 children who
had no symptoms of pharyngitis. Throat swabs were cultured for bacteria
which were identiﬁed using standard microbiological methods. During
the one year period of control, asymptomatic carriers were monitored
for developing pharyngitis.
Results: Of the 1129 children 73 (6.5%) were isolated S. pyogenes. We
diagnosed 4 (5.5%) cases of pharyngitis among group A streptococcal
carries.
Conclusion: Our data shows that S. pyogenes nasopharyngeal carriage
was found 6.5% in healthy school children. We observed a low
occurrence of pharyngitis among asymptomatic school children.
P1716 Carriage of group B streptococcus in pregnant women from
Tehran, Iran
M.M. Soltan Dallal, R. Bakhtiari, J. Zaeimi Yazdi, J. Fallah,
M.R. Pourmand, S. Bagherzadeh Yazdchi, S. Hajikhani, B. Chehri
Chamchamani (Tehran, Yazd, IR)
Objectives: Group B streptococcus (GBS) is the most common cause of
life-threatening infection in neonates but is preventable if the mother is
diagnosed before and treated at delivery. The objective of this study was
to determine the colonisation rate of GBS in Iranian pregnant women.
Methods: Vaginal and anal swabs were obtained from 125 pregnant
women at 35–37 weeks’ gestation. Two anal and vaginal swabs were
taken from each patient. One swab was inoculated to Todd-Hewitt broth
supplemented with antibiotic. The other swab was used for a PCR assay,
which uses speciﬁc primers for cfb gene sequence of GBS DNA.
Results: Out of 125 pregnant women, 12(9.6%) were GBS positive by
PCR assay while culture identiﬁed 10(8%) women as carriage of Group
B streptococcus. Using culture as the gold standard, the sensitivity of
PCR assay was 100% and speciﬁcity was 98%. The positive predictive
value (PPV) and negative predictive value (NPV) for PCR assay were
98% and 100%, respectively.
Conclusion: Group B streptococcus colonisation rate among Iranian
pregnant women is relatively high (9.6%). The PCR method seems
rapid, speciﬁc and highly sensitive assay to detect GBS in anal and
vaginal samples taken from pregnant women. The results of this study,
recommend screening of pregnant women at 35–37 weeks’ gestation
for GBS to reduce neonatal morbidity and mortality caused by this
bacterium.
P1717 An outbreak of Streptococcus agalactiae catheter-related
bacteraemia in a haemodialysis unit
I. Baraboutis, E. Platsouka, K. Papanikolaou, K. Doris,
E. Papathanasiou, V. Papastamopoulos, T. Apostolou, O. Paniara,
A. Skoutelis (Athens, GR)
Introduction: Rates of invasive (Group B streptococcus, Streptococcus
agalactiae) GBS disease in adults are on the rise. Factors associated
with increased risk for community-acquired GBS infection, besides age,
include cirrhosis, diabetes mellitus, stroke, breast or nonhaematologic
cancer, decubitus ulcer, and neurogenic bladder. Nosocomial infection
has been associated with age, placement of a central venous catheter
(CVC), diabetes mellitus, congestive heart failure, and seizure disorder.
We report an outbreak of GBS catheter-related bacteraemia in a
hemodialysis (HD) unit.
Materials and Methods: Two patients with end-stage renal disease
on hemodialysis done at the same outpatient hemodialysis unit were
admitted on the same day in our hospital with catheter-related GBS
bacteraemia. A retrospective study was undertaken at the HD unit to
address risk factors for febrile illness on the last HD session day. A
detailed questionnaire addressing risk factors for invasive GBS disease
was completed by all HD patients treated on the same day with the
2 GBS patients (total of 12 HD patients) and by all members of the
nursing and medical staff. Medical and nursing records of the HD unit
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were reviewed as well as infection control and catheter care practices. All
patients and staff members submitted rectal swabs for culture (females
submitted vaginal swabs in addition).
Results: No rectal or vaginal culture of any HD patient or staff member
was positive for GBS. One of the 2 GBS patients had a febrile syndrome
that started 3 days before admission with documented high fever during
the last 2 HD sessions while the other one developed fever a few hours
after the last HD session. The two GBS patients received catheter care
by 3 different nurses during the last 3 HD sessions before admission and
their beds were not in immediate proximity. The probability of febrile
illness on the day of last HD was associated with patient care for more
than 30 minutes during at least 2 out of 3 most recent HD sessions by
a speciﬁc nurse (p 0.045), while association with presence of CVC for
HD did not reach statistical signiﬁcance (p 0.09).
Conclusions: We speculate that the GBS strain (same antibiogram,
PFGE not done) was transmitted from one patient to the other through
the hands of medical personnel. No such outbreak has been ever reported
in HD patients. The importance of strict infection control practices in HD
units and avoidance of CVCs for long term HD should be emphasised.
P1718 Molecular identiﬁcation of clinical isolates of Nocardia
and related Actinomycetes in the French Observatory for
Nocardiosis (OFN) – New epidemiology data of nocardiosis
in France between 2000 and 2007
V. Rodriguez Nava, A. Couble, F. Laurent, D. Mounie´e, D. Blaha,
P. Boiron (Lyon, FR)
Nocardiosis is a severe infection that usually affects immunosuppressed
patients but also immunocompetent hosts. The number of patients
suffering this infection is in regular increase in the world. Nocardia are
aerobic Gram-positive actinobacteria which are in constant taxonomic
evolution because of the development of new molecular tools that
have lead the discovery of numerous new species; actually, this genus
encompasses 69 species with validly published names. The French
Observatory for Nocardiosis (OFN) is the expert centre in charge of
the survey of nocardiosis since 1999. During these last years, the OFN
is interested in developing speciﬁc molecular techniques to improve and
to assure the best identiﬁcation of pathogenic aerobic Actinomycetes.
We show the results of seven years of work in the nocardiosis
surveillance. 607 strains were obtained from clinical isolates during the
period 2000–2007. Species identiﬁcation was performed by using partial
sequencing of the 16S rDNA gene and some of these identiﬁcations
were conﬁrmed by the sequencing of hsp65 gene. 75% of the
isolates belonged to N. farcinica (26%), N. nova (20%), N. abscessus
(18%) and N. cyriacigeorgica (12%). The last 25% was formed by
less incident species like N. brasiliensis (3%), N. otitidiscaviarum
(3%), N. transvalensis (3%), N. beijingensis (2%), N. veterana (2%),
Nocardia sp. strains not identiﬁed (2%) and other species (9%). In
this last 9% OFN has identiﬁed up to 23 different species from
where N. asteroides, N. cerradoensis, N. paucivorans, N. shimofusensis–
N. higofusensis, N. carnea, N. puris and N. pneumoniae are the most
common.
The average age of the patients was 63 years-old and sex-ratio
was 1.6. The most common clinical specimens were collected from
bronchoalveolar lavage (28%), pus (23%), sputum (19%) biopsy (7%),
cerebrospinal ﬂuid (3%) and other specimens (20%). The identiﬁcation
at genus level of other aerobic Actinomycetes was realised by using
speciﬁc-PCR. Among these 273 strains collected, OFN identiﬁed
different genus such as Streptomyces (54%), Mycobacterium (30%),
Gordonia (6%) and other Actinomycetes (10%).
It clearly appears that the change of molecular tools modiﬁed
dramatically the epidemiological data.
P1719 In vitro-activity of tigecycline and daptomycin against
vancomycin-resistant enterococci and meticillin-resistant
staphylococci
A. Tsiringa, B. Skandami-Epitropaki, A. Xanthaki, P. Arida,
E. Marounga, M. Toutouza (Athens, GR)
Objective: Tigecycline, a glycylcycline and daptomycin, a lipopeptide
are novel antibacterial compounds undergoing clinical development. The
aim of this study was to assess the in vitro-activity of Tigecycline and
Daptomycin against VRE and Meticillin-resistant Staphylococci from
patients with positive cultures in our hospital.
Methods: A total of 32 clinical isolates of VRE (28 E. faecium and
4 E. faecalis) and 30 Staphylococci (20 MRSA and 10 MRSE) were
isolated from various clinical specimens in one year. Identiﬁcation
was determined with the use of VITEK-II system (BIOMERIEUX-
France). The antimicrobial susceptibility was determined by Kirby-
Bauer, CLSI guidelines. Phenotypically all isolates of Enterococci were
VanA type (MIC Vancomycin >256mg/ml,MIC Teicoplanin >16mg/ml).
They were also susceptible to linezolid, except one, and expressed
various susceptibility patterns to other antibiotics. All isolates of Staphy-
lococci were susceptible to Vancomycin, Teicoplanin Linezolid and
expressed various susceptibility patterns to other antibiotics. MICs were
determined by E-test method (AB Biodisk). The susceptible breakpoints,
according to CLSI guidelines were:.MIC Tigecycline0.25mg/l, MIC
Daptomycin 4mg/l for enterococci and MIC Tigecycline 0.5mg/l,
MIC Daptomycin <1mg/l for Staphylococci.
Results: The isolates of enterococci and staphylococci were all
susceptible to tigecycline. All the isolates of enterococci were susceptible
to daptomycin, except one. All the MRSA and all the MRSE, except one,
were susceptible to daptomycin.
Tigecycline MIC values:
For VRE faecium (28): 42.9% at 0.064mg/l and 57.1% at 0.094mg/l
For VRE faecalis (4): 75% at 0.064%mg/l and 25% at 0.094% mg/l
For MRSA(20): 20% at 0.19mg/l, 40% at 0.25mg/l, 35% at 0.38mg/l
and 5% at 0.5mg/l
For MRSE (10): 20% at 0.064mg/l, 20% at 0.094mg/l, 10% at 0.19mg/l,
20% at 0.25mg/l, 10% at 0.38mg/l and 20% at 0.5mg/l.
Daptomycin MIC values:
For VRE faecium (28): 39.4% at 2mg/l, 35.7% at 3mg/l, 21.5% at 4mg/l
and 3.4% at 8mg/l.
For VRE faecalis (40): 25% at 1mg/l, 25% at1.5mg/l, 25% at 2mg/l
and 25% at3mg/l.
For MRSA (20): 5% at 0.38mg/l, 10% at 0.5mg/l, 45% at 0.75mg/l and
40% at1mg/l.
For MRSE (10): 11.2% at 0.38mg/l, 22.2% at 0.75mg/l and 66.6% at
1mg/l.
Conclusion: These results suggest that both tigecycline and daptomycin
may play important roles in the treatment of infections caused by VRE
and meticillin-resistant staphylococci including drug-resistant strains.
P1720 In vitro activity of daptomycin against various VanA VRE
species derived from clinical specimens
A. Stylianakis, S. Tsiplakou, V. Papaioannou, D. Paraskevopoulou,
E. Pantazis, S. Sardiniari, A. Koutsoukou (Athens, GR)
Objectives: To evaluate the in vitro activity of daptomycin against a
collection of Vancomycin Resistant Enterococcus (VRE) type VanA
isolates belonging to various species, derived from clinical specimens.
Methods:We examined 48 VRE clinical isolates originated from diverse
specimens (pus [n = 24], blood [n = 19], urine [n = 3] and bronchoalveolar
excretions [n = 2]) of 48 patients treated in different wards of our
hospital during a three year time period (2005–2007). These isolates
were identiﬁed to species level using the automated system VITEK2
(Biomerieux, France).
The enterococci were characterised as VanA phenotypically, by suscep-
tibility to teicoplanin (i.e teicoplanin MIC of 32mg/L, as probable
VanA), and were conﬁrmed genotypically by a sandwich hybridisation
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method using the commercial EVIGENETM VRE detection kit (Statens
Serum Institut, Denmark). The MIC levels of teicoplanin, vancomycin
and daptomycin were determined using the E-test strips (AB Biodisk,
Solna, Sweden) according to the manufacturer’s recommendations. As
sensitive to daptomycin VRE isolates were considered those with
MIC< 4mg/Ln in accordance to CLSI guidelines (issue M100 S17).
Results: The identiﬁcation of the isolates showed Enterococcus faecium
(n = 32), Enterococcus faecalis (n = 13), Enterococcus avium (n = 2) and
Enterococcus durans (n = 1). All the examined VRE isolates belonged
to VanA genotype. Both vancomycin and teicoplanin MIC values ranged
between 96 and 256mg/L. The MIC levels of daptomycin varied
between 1mg/L and 4mg/L. All the 4 VanA VRE species corresponding
to the examined isolates were sensitive to daptomycin.
Conclusion: Daptomycin showed very good in vitro activity against this
collection of various VanA VRE species. There were no resistant isolates
to daptomycin regardless to enterococcal species. This new antibiotic
could be an new option in the treatment of some infections caused by
diverse VanA glycopeptide-resistant enterococcus species.
P1721 Evaluation of the in vitro susceptibility of meticillin-reistant
staphylococcus strains isolated from nosocomial infection to
vancomycin, teicoplanin, linezolid and tigecycline by E-test
method
T. Sami Pelitli, S. Cesur, S. Kinikli, H. Irmak, A. Pekcan Demiroz,
E. Karakoc¸ (Ankara, TR)
Objectives: The aim of this study was to determine the MIC value
of vancomycin, teicoplanin, tigecycline and linezolid susceptibilities of
100 meticillin-resistant staphyloccocus strains (21 meticillin-resistant
Staphylococcus aureus (MRSA) and 79 meticillin-resistant coagulase
negative staphylococcus (MR-CNS) isolated from nosocomial infection
at Ankara Education and Researc Hospital in June 2005–March 2007.
Methods: The MIC values of 100 meticillin-resistant staphyloccus strain
[(21 (MRSA), 79 (MR-CNS)] for vancomycin teicoplanin, linezolid
and tigecycline were tested by E-test method. MIC values were
determined according to the catalog of manufacturer (AB Biodisk,
Sweden), Antibiotic susceptibilities were determined according to the
recommendations of CLSI. For linezolid; strains MIC value of 4mg/ml
were considered susceptible. For tigecycline strains with MIC value of
0.5mg/ml were considered susceptible.
Results: For overall 100 meticillin-resistant staphylococcus strains MIC
values were as follows: for vancomycin MIC value 0.125−2mg/ml range,
mean 0.83mg/ml, for teicoplanin MIC value 0.125−6mg /ml range,
mean 1.95mg/ml, for linezolid MIC value 0.047−0.38mg/ml range, mean
0.21mg/ml, for tigecycline MIC value 0.064−0.38mg/ml range, mean
0.28mg/ml.
Conclusion: No resistance to vancomycin, teicoplanin, tigecycline and
linezolid was established in meticillin-resistant staphylococcus strains
isolated from the inpatients in our hospital and who had nosocomial
infections. The most active antibiotic was established to be linezolid
(mean MIC value 0.21 mg/ml) to be followed by tigecycline (mean
MIC value: 0.28), vancomycin (mean MIC value:0.83) and teicoplanin
(mean MIC value: 1.95), respectively. When glicopeptide antibiotics
were compared with each other, MIC value of vancomycin was found to
be lower than that of teicoplanin.
It is favourable that no resistance was found against glicopeptide group
alternative antibiotics which are new treatment options in meticillin-
resistant staphyloccus infections.
However, it should be borne in mind that infection control measures,
surveillance of the antibiotic susceptibility results and judicious use of
antibiotics are more important than the advent of new antibiotics in
the prevention of the development of resistance to antibiotics and of
nosocomial infections.
P1722 Efﬁcacy of ertapenem against staphylococci isolates
A. Poiata, M. Cuciureanu, C. Tuchilus (Iasi, RO)
Ertapenem is a new carbapenem with excellent activity against different
Gram-negative and Gram-positive bacteria and a long serum half-life. Its
good antibacterial activity is closely related to high hydrolysis resistance
by bacterial b-lactamases. Acquired resistance to ertapenem is usually
mediated by up-regulation of efﬂux mechanisms and by the selection of
porin-deﬁcient mutants.
Objectives: The aim of this study was to evaluate antimicrobial activity
of ertapenem by comparison that of meticillin, gatiﬂoxacin, cefepime and
linezolid against 455 staphylococci collected during 2006–2007 period
from healthy individuals.
Material and Methods: Microorganisms: A total of 455 staphylococci,
214 coagulase-positive staphylococci (CPS) and 241 coagulase-negative
staphylococci (CNS), colonising skin and nasal mucous, were obtained
from medical personal during 2006–2007. Isolates were identiﬁed as
CPS by demonstrating a positive coagulase test.
Antimicrobial agents: Powders of ertapenem, meticillin, gatiﬂoxacin,
cefepime and linezolid obtained from commercial sources were tested
in concentration range from 0.125 to 128mg/l.
Sensitivity study: Minimum inhibitory concentrations (MICs) were
determined by the agar dilution method established by NCCLS
guidelines.
Results: Ertapenem was very active agent against staphylococci
with MICs at which 99% of isolates are inhibited of 2mg/L
(susceptibility breakpoint) for both coagulase-positive and coagulase-
negative staphylococci. Resistance to ertapenem was observed in four of
all tested staphylococci strains.
Conclusion: Ertapenem has an activity comparable to the other tested
agents. Resistance rate was 1% for all investigated staphylococci strains.
Epidemiology of antimicrobial resistance
among Gram-positives
P1723 German surveillance study on the in vitro activity of
daptomycin against Gram-positive cocci
M. Kresken, J. Brauers (Rheinbach, DE)
Objectives: Drug resistance (R) in Gram+ bacteria has become an
increasing problem over the past 20 years. New antimicrobial agents
such as the lipopeptide daptomycin (DAP) have been developed to
address this problem. Shortly after the approval of DAP in the EU, a
surveillance study was started by a network of 73 laboratories to monitor
the susceptibility of Gram+ bacteria to DAP in Germany. The objective
of this study was to evaluate the susceptibility of isolates of six clinically
important Gram+ species to DAP and other antimicrobial agents.
Methods: A total of 2,646 isolates incl. meticillin-susceptible S. aureus
(MSSA, n = 661), meticillin-resistant S. aureus (MRSA, n = 439),
S. epidermidis (Se, n = 425), E. faecalis (Es, n = 341), E. faecium (Em,
n = 324), S. pyogenes (Spy, n = 319) and S. agalactiae (Sag, n = 137)
were tested against DAP, linezolid (LZD), vancomycin (VAN) and other
drugs. Primary isolates obtained from hospitalised patients with skin and
soft tissue infections, respiratory tract infections, foreign body/catheter
infections or sepsis were included. MICs were determined in a central
laboratory using the microdilution method according to the German
DIN standard. For DAP, the Ca2+ concentration of the test solution
was adjusted to 50mg/L. MICs were interpreted by EUCAST criteria,
when possible.
Results: Isolates were primarily recovered from wound swabs (65%),
blood samples (21%) and respiratory specimens (9%). MIC50/90s of
DAP for MSSA, MRSA, and Se each were 0.5/1mg/L. All but one
isolates were inhibited by DAP at the breakpoint of 1mg/L. The
remaining isolate had an MIC of 2mg/L. All staphylococci were
susceptible to LZD and VAN. The highest MIC of VAN for MRSA
was 2mg/L. Based on MIC50/90s, DAP was up to 4-times more active
than LZD or VAN against staphylococci.
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Of the Em and Es isolates, 33 (10%) and one (0.3%) were R to
VAN, respectively. DAP inhibited all strains at 4mg/L. One Es isolate
was resistant to LZD (MIC 32mg/L). High-level R to gentamicin
(MIC> 500mg/L) was observed in 35/42% of Es/Em isolates.
DAP, with an MIC50/90 of 0.125/0.25mg/L, was more active than LZD
(1/1mg/L) or VAN (0.25/0.5mg/L) against Spy. Against Sag, DAP
(0.5/1mg/L) was more active than LZD (1/2mg/L) and comparably
active to VAN (0.5/0.5mg/L). R to erythromycin was detected in 9%
of Spy isolates and 20% of Sag isolates.
Conclusions: DAP demonstrated excellent in vitro activity against a
large collection of German Gram+ cocci including MRSA and VRE.
P1724 Gram-positive anaerobic cocci are resistant to penicillin
and clindamycin
C.E. Nord for the ESCMID Study Group on Antimicrobial Resistance
in Anaerobic Bacteria
Objectives: Gram-positive anaerobic cocci (GPAC) are a heterogeneous
group of microorganisms. GPAC are involved in one-quarter of all
anaerobic isolates from human clinical infections. The prevalence of
GPAC as pathogens is increasing and information regarding their
antimicrobial susceptibilities is relatively limited compared with that of
other anaerobic species. The aim of this study was to examine the current
status of antimicrobial resistance in clinical isolates of GPAC in Europe.
Methods: Collaborators in each participating country (Austria, Croatia,
Czech Republic, Denmark, Finland, France, Great Britain, Greece,
Hungary and Sweden) collected consecutive clinical isolates of GPAC.
The isolates were identiﬁed by Gram staining, biochemical tests and gas–
liquid chromatography. Minimum inhibitory concentrations of penicillin,
clindamycin, metronidazole, vancomycin and linezolid were determined
by the agar dilution method according to the Clinical and Laboratory
Standards Institute. Production of b-lactamase was determined by the
nitroceﬁn test.
Results: 299 strains were identiﬁed as GPAC and 23 isolates as other
species. Most isolates were collected in Sweden (22%), Finland (19%)
and Great Britain (18%). The majority of isolates were identiﬁed as
Finegoldia magna (111), Parvimonas micra (53), Peptoniphilus harei
(44), Anaerococcus vaginalis (21) and P. anaerobius (20). Nineteen
isolates were identiﬁed as Peptostreptococcus sp. The remaining isolates
were identiﬁed as Peptoniphilus asaccharolyticus (8), Peptoniphilus
ivorii (5), Peptoniphilus indolicus (8), Peptoniphilus lacrimalis (5),
Anaerococcus octavius (1), Anaerococcus prevotii (2), Anaerococcus
tetradius (1) and Anaerococcus lactolyticus (1). All isolates were
susceptible to metronidazole, vancomycin and linezolid. A total of 21
isolates were resistant to penicillin and/or clindamycin. The majority
of resistant strains were collected in Great Britain. Eight of the isolates
were identiﬁed as F. magna, of which four were resistant to clindamycin,
three to both penicillin and clindamycin and one isolate to penicillin. No
isolates produced b-lactamases. The origins of resistant isolates were
blood, abscesses and soft tissue infections.
Conclusion: Antimicrobial susceptibility testing of anaerobic cocci in
patients with severe infections as well as continuous surveillance of
antimicrobial susceptibility in GPAC seem highly justiﬁed.
P1725 Daptomycin activity and spectrum when tested against
Gram-positive species responsible for bloodstream infections
in European medical centres
H. Sader, P. Rhomberg, T. Fritsche, R. Jones (North Liberty, US)
Objective: As part of the Daptomycin Surveillance Program, we
evaluated the in vitro activity of daptomycin against clinical Gram-
positive organisms isolated from patients with bloodstream infections
(BSI) in Europe. Daptomycin is a novel cyclic lipopeptide approved by
European Health Authorities for the treatment of complicated skin and
soft tissue infections (cSSTI), right sided infective endocarditis (RIE)
due to S. aureus and for S. aureus bacteraemia (SAB) when associated
with RIE or with cSSTI.
Methods: BSI isolates (11,764) were collected from 32 medical
centres located in Europe (13 countries) and Israel in 2003–2007. The
following pathogens were evaluated: S. aureus (28.3% oxacillin [OXA]-
resistant [R]); coagulase-negative staphylococci (CoNS; 77.4% OXA-R),
E. faecalis (EF; 1% vancomycin [VAN]-R), E. faecium (EFM; 14.9%
VAN-R), beta-haemolytic Streptococcus spp. (BHS; 627), and viridans
group Streptococcus spp. (VGS; 497). The strains were susceptibility (S)
tested by broth microdilution methods in cation-adjusted Mueller-Hinton
broth, additionally supplemented to 50mg/L of calcium for daptomycin
tests. Numerous comparators were also tested.
Results: Daptomycin was highly active against S. aureus and CoNS
(MIC90, 0.5mg/L) and the activity was not adversely affected by co-
resistance to OXA. Only 1 S. aureus strain was non-S to daptomycin
(MIC, 2mg/L). E. faecalis showed high rates of S to daptomycin
(100.0%), linezolid (100.0%), ampicillin (99.7%) and VAN (98.9%),
whereas E. faecium showed low S to VAN (82.9%). Daptomycin (100.0%
S) was the most active compound tested against VAN-R E. faecium,
followed by linezolid (98.4% S) and quinupristin/dalfopristin (73.3%
S; most non-S strains were from France). Rates of VAN-R E. faecium
increased from 10.7% in 2003 to 20.4% in 2007, and were highest in
Ireland, Israel and the United Kingdom (36.1–37.5%). Elevated rates
of high-level gentamicin (33.6%) and streptomycin (42.2%) R were
observed among enterococci and daptomycin was the only compound
active against all enterococcal strains at the S breakpoint. Daptomycin
was also very active against BHS and VGS (MIC90, 0.25 and 0.5mg/L
respectively).
Organism (no. of
isolates)
Cumulative % inhibited at daptomycin MIC
(mg/L) of:
No. of non-S
strains (%)a
0.12 0.25 0.5 1 2 4
S. aureus (5,324)
OXA-S (3,816) 5.3 82.6 99.6 >99.9 100.0 – 1 (<0.1)
OXA-R (1,508) 2.5 64.2 98.7 100.0 – – 0 (0.0)
CoNS (3,232) 8.4 61.2 96.9 99.8 >99.9 100.0 6 (0.2)
E. faecalis (1,345) 0.7 5.9 53.2 96.1 99.9 100.0 0 (0.0)
E. faecium (739)
VAN-S (613) 0.8 1.3 6.2 30.8 78.5 100.0 0 (0.0)
VAN-R (126) 0.0 1.6 7.9 41.3 87.3 100.0 0 (0.0)
BHS (627) 81.8 97.9 100.0 – – – 0 (0.0)
VGS (497) 32.8 63.4 93.0 99.8 100.0 – 1 (0.2)
aUS-FDA/CLSI interpretive criteria.
Conclusions: Daptomycin showed signiﬁcant potency and broad-
spectrum activity against recent clinical Gram-positive isolates collected
from European medical centres, including MDR subsets. R to other
compounds did not adversely inﬂuence daptomycin potency against
staphylococci, enterococci or streptococci.
P1726 Quantifying factors associated with changes in antibiotic sus-
ceptibility patterns of enterococci isolated from dairy cattle
K.S. Lang, R. Singer (Saint Paul, US)
Objective: The objective of this study was to quantify factors associated
with changes in antibiotic susceptibility patterns in enterococci isolated
from bovine faeces over a 2.5-year longitudinal study. We hypothesised
that increasing levels of resistance would be positively associated with
prior antibiotic treatment and younger animals. We also hypothesised that
farms with the highest overall use of antibiotics would have the highest
levels of resistance, but that the speciﬁc resistance patterns would vary
among species of enterococci.
Methods: Four dairy farms were chosen in central Illinois, USA, and
a cohort of approximately 50 animals of different ages was randomly
selected on each farm. Faecal samples were collected from each animal
every three months. Multiplex PCR was used to speciate the isolates into
E. faecium, E. faecalis, E. hirae or Enterococcus spp. For each isolate,
minimum inhibitory concentrations (MICs) for 17 antimicrobial agents
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were determined using microbroth dilution and CLSI-recommended
control strains.
Results: E. faecium (n = 1481) and E. hirae (n = 1355) were the
predominant species isolated. Resistance was found more commonly
in E. faecium isolates compared to E. hirae isolates for bacitracin
(78%, 5%), ciproﬂoxacin (16%, 1%), erythromycin (14%, 1%),
and quinupristin/dalfopristin (24%, 11%). Decreased susceptibility to
ﬂavomycin was observed in 88% of all E. faecium and 84% of E. hirae
isolates. Tetracycline resistance was more common in E. hirae isolates
than E. faecium, occurring in 54% and 31% of isolates respectively.
Various resistances, including tetracycline and ciproﬂoxacin, were
positively associated with the amount of antibiotic used on the farm.
Calves were more likely to have resistance enterococci than older
animals.
Conclusions: At the farm level, the prevalence and diversity of resistance
was greatest in those farms using the most antibiotic. During the study,
resistance levels did not change signiﬁcantly within the farm. As seen
in other studies, young animals had bacterial populations with more
resistance, and this appeared to be independent of antibiotic treatment.
Although E. faecium and E. hirae were exposed to the same selection
pressures, there were noticeable differences in the resistance patterns
between them. With many isolates having multidrug resistance, the
choice of antibiotic on the farm becomes more challenging knowing
that a single antibiotic can co-select for multiple resistances.
P1727 A comparison of antimicrobial susceptibility and
MIC-distributions in Enterococcus isolates originating from
humans, animals and retail meat
M. Sjo¨lund, J. Whichard, K. Joyce, R. Howie, A. Krueger, E. Barzilay,
P. McDermott, E. Hall-Robinson, C. Jackson, P. Fedorka-Cray,
D. White (Atlanta, Baltimore, Athens, US)
Objectives: The National Antimicrobial Resistance Monitoring System
(NARMS) is a collaborative effort between the U.S. Food and Drug
Administration’s Center for Veterinary Medicine (FDA CVM), U.S.
Department of Agriculture (USDA), and the Centers for Disease
Control and Prevention (CDC). The NARMS programme monitors
resistance among zoonotic pathogenic (Salmonella and Campylobacter)
and commensal (Escherichia coli and Enterococcus) bacteria recovered
from food animal, retail meat and human sources. Enterococcal data
from the NARMS programme has however, yet to be compared among
these sources. In this study, we report on antimicrobial susceptibility
and MIC-distributions of Enterococcus isolates recovered from humans,
chickens at slaughter and retail meat.
Methods: The ﬁrst 100 consecutive isolates of Enterococcus faecium and
Enterococcus faecalis from each source submitted in 2005 were included.
Minimum inhibitory concentrations (MIC) for 12 antimicrobial agents
were determined using broth microdilution methods and interpreted
according to CLSI standards, where available. MIC-histograms were
constructed and compared with wild type distributions proposed by the
European Committee on Antimicrobial Susceptibility Testing (EUCAST)
(www.eucast.org). For each distribution, the MIC50 was calculated.
Results: There was good agreement among MIC-distributions of human,
chicken and retail meat isolates. For the majority of antimicrobial agents,
the MIC50 of the three distributions agreed or was within one dilution
step. The most pronounced difference was observed for E. faecium and
tetracycline. The MIC50 of human E. faecium isolates was 4mg/L
whereas the MIC50 for both the chicken and retail meat isolates was
32mg/L. MIC-distributions of susceptible isolates from all three U.S.
sample sources correlated well with the wild type distributions proposed
by EUCAST.
Conclusion: The MIC50 for all tested antimicrobial agents were similar
for all enterococcal isolates, regardless of origin, with the exception
of tetracycline where the MIC50 was higher for chicken and retail
meat isolates. Additionally, MIC-distributions of susceptible enterococci
from all three U.S. sample sources agreed well with the wild type
distributions deﬁned by EUCAST. This implies that the enterococcal
wild type distributions are similar regardless of geographic origin and
sample source.
P1728 Activity of tigecycline tested against vancomycin-resistant
enterococci, including clonal complex-17 E. faecium strains,
isolated in Europe
H. Sader, T. Fritsche, R. Jones (North Liberty, US)
Objectives: To evaluated the activity of tigecycline when tested against
clinical strains of enterococci collected in European medical centres,
including E. faecium strains characterised as being clonal complex 17
(CC-17).CC-17 characterizes a lineage of E. faecium with resistance
(R) to ampicillin (AMP) and ciproﬂoxacin (CIP) with or without R to
vancomycin (VANC), a pathogenicity island and an association with
hospital outbreaks, which have spread globally.
Methods: Enterococcal strains were submitted from 34 medical
centres located in Europe (13 countries) and Israel during 2000–
2007. Strains were susceptibility (S) tested against tigecycline and
>20 antimicrobials using CLSI broth microdilution methods and US-
FDA/EUCAST interpretative criteria (tigecycline S at 0.25mg/L).
VanA E. faecium strains R to AMP and CIP were characterised as a
CC-17. A subset of CC-17 strains were further characterised by PFGE
and PCR for esp gene.
Results: 4,591 enterococcal strains (7.1% VANC-R) were collected,
including 3,070 E. faecalis (1.6% VANC-R) and 1,337 E. faecium
(22.3% VANC-R). VANC-R was observed in 27 (79.4%) centres (all
countries surveyed). Higher rates of VANC-R were found in Germany,
Ireland and the United Kingdom. High level gentamicin R was observed
in 33.3% of E. faecalis and 40.9% of E. faecium, while only 73.5%
of E. faecium were S to quinupristin/dalfopristin. Tigecycline was very
active against enterococci (MIC90, 0.25mg/L; 97.3% S), including
VANC-R E. faecium (MIC90, 0.12mg/L; 99.7% S) and E. faecalis
(MIC90, 0.25mg/L; 94.0% S) strains (see Table). Tigecycline was also
highly active against VANC-R E. faecium CC-17 phenotype strains
(MIC90, 0.12mg/L; 100.0% S).
Organism (no. tested) Cumulative % inhibited at
TIGa MIC (mg/L) of:
TIG non-S
isolates
0.12 0.25 0.5 1 No. (%)
All Enterococci (4,591) 75.5 97.3 >99.9 100.0 124 (2.7)
E. faecalis
VANC-S (3,020) 68.6 96.9 99.9 100.0 95 (3.1)
VANC-non-S (50) 60.0 94.0 100.0 – 3 (6.0)
E. faecium
VANC-S (1,039) 89.9 98.6 99.8 100.0 15 (1.4)
VANC-non-S (298) 94.6 99.7 100.0 – 1 (0.3)
CC-17 VANC-R phenotype (162) 96.3 100.0 – – 0 (0.0)
aTIG = tigecycline.
Conclusions: Tigecycline was very active against strains of enterococci
causing infections in European hospitals and its activity was not
adversely affected by R to VANC or other antimicrobials. This novel
glycylcycline represents an important therapeutic option for infections
caused by vancomycin-resistant enterococci, including the epidemic
E. faecium CC-17 strains.
P1729 In vitro evaluation of tigecycline against drug-resistant
Enterococci and S. aureus in the United States
J. Johnson, D. Hoban, B. Johnson, S. Bouchillon, T. Stevens,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Tigecycline (TIG), a member of a new class of
antimicrobials (glycylcyclines), has been shown to have potent activity
against many Gram-positive and -negative organisms. The T.E.S.T.
Program determined the in vitro activity of TIG against S. aureus
and enterococci resistant to 10 commonly prescribed antimicrobials:
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amoxicillin-clavulanic acid (AUG), piperacillin-tazobactam (PT), lev-
oﬂoxacin (LVX), ceftriaxone (CAX), linezolid (LZD), minocycline
(MIN), vancomycin (VAN), ampicillin (AMP), penicillin (P) and
imipenem (IMP). Study strains were collected from hospitals globally
throughout 2004–2006.
Methods: A total of 7,343 clinical isolates (2,903 enterococci, 4,440
S. aureus) from 193 labs in the United States were identiﬁed to
the species level at each participating site and conﬁrmed by the
central laboratory. Minimum Inhibitory Concentrations (MICs) were
determined by the local laboratory using broth microdilution panels.
Antimicrobial resistance was interpreted according to CLSI and FDA
(TIG) breakpoints.
Results: 840 (29%) enterococci and 1706 (38%) S. aureus (including
MR + MS strains) were resistant to two or more drug classes. Among
the enterococci, resistance rates were LVX 99%, P 85%, AMP 84%,
VAN 76%, MIN 9%, and LZD 0%. Resistant rates for S. aureus were
P 100%, AMP 100%, AUG 74%, LVX 99%, PT 63%, CAX 44%, IMP
15%, LZD 0%, MIN 0.2% and VAN 0%. TIG inhibited 100% of all
the enterococci and S. aureus resistant to other drugs. Modal TIG MICs
ranged between 0.06 and 0.12 mg/ml and were generally the same for
most resistant and susceptible strains.
Conclusions: TIG retained potent activity against drug-resistant
S. aureus and enterococcal isolates, inhibiting 100% of all resistant
strains tested. TIG should prove to be a useful drug for therapy of
infections with these resistant Gram-positive pathogens.
P1730 Cost of bacteraemia caused by meticillin-resistant
Staphylococcus aureus in Spain
J. Garau, S. Grau, L. Martı´nez-Martı´nez, C. Rubio-Terre´s,
N. Garcı´a-Escribano on behalf of the Cost of Resistance Study Group,
Barcelona, ES
Objectives: Meticillin-resistant Staphylococcus aureus (MRSA) is
associated with complicated infections. Hospitalisation costs associated
with MRSA infection are higher than those associated with meticillin-
sensitive Staphylococcus aureus (MSSA). Limited information about
costs from bacteraemia caused by MRSA is available. This study aimed
to calculate the impact of MRSA bacteraemia on healthcare resources
and associated costs in Spain.
Methods: Multicentre retrospective observational case–control study
of the use of healthcare resources and the associated costs in the
treatment of infections caused by MRSA was carried out. The results
obtained on the use of resources enabled us to calculate the costs of
a bacteremic episode caused by resistant or sensitive strains. Data on
the use of resources were collected over a 12-month period (Jan-Dec
2005). Patients with MRSA and MSSA bacteraemia admitted in Spanish
hospitals were included. Patients’ clinical characteristics were recorded
and comorbidity was assessed by Charlson index. The study was carried
out from the perspective of the National Health Service; therefore, only
use of healthcare resources was recorded. The costs of bacteraemia
were expressed as direct healthcare costs. Qualitative and quantitative
descriptive analyses were made for all the variables.
Results: We reviewed the clinical histories of 366 patients (28 hospitals)
with bacteraemia S. aureus (121 MRSA and 245 MSSA). No differences
in comorbidity were observed, although there was a greater presence
of septic shock in the MRSA group. Prior antimicrobial therapy was
administered in 47.1% and 7.8% of patients with and without MRSA,
respectively (p< 0.001). The differences in the total length of antibiotic
therapy were not statistically signiﬁcant. Patients with MRSA had a
longer hospital stay (8.2d more) and a higher ICU admission rate (7.6%
more). The average cost per episode of bacteraemia rose to €14,854.89
(MRSA) and €11,079.54 (MSSA) difference of €3,775.35; 1.34 times
greater.
Conclusions: Treatment of infections caused by MRSA generates an
additional cost of €3,775.35 per episode of bacteraemia. The costs of
an episode of MRSA bacteraemia increased 1.34 times compared with
MSSA. This increase in costs related to MRSA bacteraemia is due
mainly to the greater rate of admissions to the ICU and the longer length
of stay.
P1731 Evolution of glycopeptide MICs in MRSA and MSSA
isolates in a Spanish hospital between 2002 and 2006
A. Garcı´a-Can˜as, P. Garcı´a-Hierro, J. Sa´nchez-Rubio,
F. Rodrı´guez-Salvane´s, J.I. Alo´s (Getafe, Madrid, ES)
In recent years increased MICs of vancomycin has been described in
meticillin-resistant Staphylococcus aureus (MRSA). The objetive of this
study was to evaluate MIC trends of vancomycin and teicoplanin in
clinical MRSA and meticillin-susceptible S. aureus (MSSA) isolates over
a 5 year period (2002–2006).
MICs of vancomycin and teicoplanin were studied by broth microdilution
in 567 MRSA and 2,575 MSSA clinical strains (one per patient) isolated
between 2002 to 2006. BHI broth with 4mg/L of vancomycin was used
to screen vancomycin resistance. MICs of each antibiotic obtained in the
different years was compared by the linear trend chi-square test.
All isolates were susceptible to vancomycin and teicoplanin. No
statistically signiﬁcant diference was observed in vancomycin for MRSA
(X2 = 0.01; p = 0.91), and for MSSA (X2 = 0.08; p = 0.78). No
statistically signiﬁcant diference was observed in teicoplanin for MRSA
(X2 = 3.06; p = 0.08), but a statistically signiﬁcant trend to more
susceptibility was observed in teicoplanin for MSSA (X2 = 5.19;
p = 0.02).
Consumption of parenteral vancomycin in our Hospital in DDD/100
stays were: 2002 (1.91), 2003 (1.63), 2004 (1.74), 2005 (2.06), and
2006 (1.64). Oral vancomycin consumption for selective digestive
decontamination in DDD/100 stays of ICU patients were: 2002 (63.5),
2003 (54.2), 2004 (49.5), 2005 (44.4), and 2006 (58.2).
In a scenary of few variations of vancomycin consumption, we did not
notice important changes in vancomycin MICs in MRSA and MSSA
clinical isolates over the period studied.
P1732 Decling susceptibility of S. aureus and coagulase-negative
staphylococci to vancomycin during an 18-year period in
Denmark
L. Nielsen, M. Arpi (Herlev, DK)
Objectives: Several authors have reported treatment failure with
vancomycin for staphylococci with MICs 4mg/l. and it has been
proposed to lower the breakpoint for sensitivity to vancomycin for
staphylococci from 4mg/l to 2mg/l. The aim of the present study
was to elucidate the trend over time of the susceptibility of S.aureus
and coagulase-negative staphylococci (CNS) to vancomycin at Herlev
University Hospital.
Methods: Herlev University Hospital is receiving specimens from the
primary and secondary sector from the former Copenhagen County.
During the 18 year period 1990–2007 vancomycin susceptibility testing
of S. aureus and CNS was performed either by a disc diffusion method
using Oxoid discs or by MIC determination with E-test (Biodisc). The
disc diffusion method was applied to 2173 isolates of S.aureus and 9857
isolates of CNS and MIC determination was done on 1245 isolates of
S. aureus and 1989 isolates of CNS. Results from the three periods
1990–1995, 1996–2001 and 2003–2007 were compared.
Results: The mean vancomycin zone for S. aureus decreased from 20.6
to 16.0mm (p< 0.001) from the ﬁrst time period till the last. For CNS
a decrease was observed from 21.8mm to 16.8mm (p< 0.001). In the
ﬁrst two periods all S. aureus isolates had MICs 2mg/l as compared
to only 62.6% in the last period. In the last period 21.5% of the isolates
had MICs 4mg/l. The proportion of MICs 2mg/l for CSN decreased
from 77.8% in the ﬁrst time period to 41.0% in the last period. In the
last period 40.0% of CNS had MICs 4mg/l.
Conclusion: Both S. aureus and CNS showed a declining sensitivity
to vancomycin during the 18 year period. A trend which is worrying
considering the reported risk of treatment failure when the MIC to
vancomycin is 4mg/l. This applied to 40% of CNS and 20% of
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S.aureus investigated and may be a problem especially when treating
infections in difﬁcult accessible foci.
P1733 The prevalence of ﬂuroquinolone resistance amongst
staphylococci isolated from houshold pets
V. Young, M. Rich (Wetherby, UK)
Objectives: The prevalence of ﬂuoroquinolone resistance using en-
roﬂoxacin as a marker was investigated amongst 21,261 isolates of
staphylococci from animal origin. This was followed by the identiﬁcation
and characterisation of staphylococcal isolates over a 3-month period at
IDEXX Laboratories. These isolates were then subjected to antimicrobial
susceptibility testing against a range of 9 ﬂuoroquinolones. These isolates
were also examined for evidence of cross-resistance with other classes
of antimicrobials.
Methods: Identiﬁcation was initially carried out using recognised routine
laboratory methods, plus the use of the VITEK automated system.
This was then corroborated using ribotyping. The ﬂuoroquinolone
susceptibility testing was done using disc diffusion against the
antimicrobials marboﬂoxacin, enroﬂoxacin, ciproﬂoxacin, peﬂoxacin,
moxiﬂoxacin, lomeﬂoxacin, levoﬂoxacin, oﬂoxacin and norﬂoxacin.
Analysis of cross-resistance was conducted using sensitivity data from
the VITEK analyser.
Results: Fluoroquinolone resistance was found to in the order of 6%
among all staphylococcal isolates. It was most prevalent in meticillin-
resistant Staphylococcus aureus (MRSA) isolates (93.4%), followed
by coagulase-negative staphylococci (CNS) (10.9%), S. aureus (3.7%)
and ﬁnally S. intermedius (2.7%). The identiﬁcation methods used
were found to correlate well with DNA ribotyping. The order of
efﬁcacy gained for the range of ﬂuoroquinolones was oﬂoxacin (least
active), through peﬂoxacin, norﬂoxacin, lomeﬂoxacin, ciproﬂoxacin,
enroﬂoxacin, marboﬂoxacin, levoﬂoxacin to moxiﬂoxacin (most active).
Cross, or multi-resistance was taken as resistance to 3 or more classes
of antimicrobials. It was seen most often in S. intermedius, followed by
CNS and MRSA. Cross-resistance was not seen in isolates of MSSA or
S. schleiferi ssp. coagulans.
Conclusion: The results gained from this project correlate well with
those of previous studies. This indicates that staphylococci of animal
origin appear to follow similar resistance patterns to human isolates.
Further research into CNS isolates from animals is necessary due to the
low number of isolates obtained.
P1734 Antibiotic susceptibility of Staphylococcus epidermidis
isolated from prosthetic joint infections with special focus
on rifampicin and variability of the rpoB gene
B. Hellmark, M. Unemo, A˚. Nilsdotter, B. So¨derquist (O¨rebro, SE)
Objectives: Staphylococcus epidermidis is a commensal that comprises
a substantial part of the normal skin ﬂora of humans. Nevertheless, this
bacterium has emerged as the most important pathogen in infections
related to implanted foreign body materials, especially prosthetic joint
infections (PJIs).
A major problem with the treatment of PJIs caused by S. epidermidis
is the ability of the bacterium, when accumulating on a surface such as
an implant, to produce bioﬁlm. The bioﬁlm reduces the accessibility
of antibiotics and host immune components such as complement
and antibodies. Cell wall antibiotics such as isoxazolyl-penicillin or
glycopeptides have not been successful agents for treatment of PJIs.
On the contrary, rifampicin has the ability to penetrate the bioﬁlm, is
active also against stationary phase bacteria, and hence has emerged
as an effective antimicrobial agent for PJIs. However, resistance to
rifampicin may rapidly emerge and rifampicin monotherapy should be
avoided. Accordingly, effective antibiotics for combination therapy with
rifampicin are needed.
The aim of this study was to investigate the antimicrobial activity of
various antibiotics against S. epidermidis isolated from PJIs, with special
focus on rifampicin and the molecular mechanisms for development of
rifampicin resistance.
Methods: Thirty-three S. epidermidis isolates obtained during revision
surgery due to PJIs with extraction or exchange were analysed. The
minimum inhibitory concentrations (MICs) of 16 different antibiotics
were determined using the Etest method. A real-time PCR followed by
sequencing of a 1052 bp segment of the rpoB gene was used.
Results: Among the rifampicin resistant isolates (39%), one or two
single nucleotide polymorphisms (SNPs) in rpoB were identiﬁed, with
one exception.
Furthermore, 79% of the isolates were resistant to ciproﬂoxacin, 79%
to gentamicin, 67% to clindamycin and 39% to fucidic acid. All of
the isolates were susceptible to linezolid and tigecycline, and 97% to
daptomycin. The MIC50 and MIC90 of dalbavancin was 0.032 and
0.047mg/ml and of ceftobiprole 0.5 and 1.5mg/ml, respectively. mecA
was detected in 85% of the isolates.
Conclusion: S. epidermidis isolates causing PJIs are often multiresistant
including rifampicin. The rifampicin resistance is mainly caused by one
or two SNPs. However, some of the newer antimicrobial agents may
provide potential alternatives for monotherapy or combination therapy
with rifampicin.
P1735 Trends of meticillin-resistant Staphylococcus aureus
prevalence in ambulatory care in the Berlin area, 2000–2006
I. Noll, E. Zill, D. Emrich, M. Chahin, M. An der Heiden, T. Eckmanns
(Berlin, DE)
Objectives: Surveillance data prove an increase in meticillin-resistant
Staphylococcus aureus (MRSA) prevalence in German hospitals since
the 1990s. Little is known about the situation in ambulatory care settings
in Germany. A dataset from a laboratory serving for physicians in the
city and surroundings of Berlin covering the period from 2000 to 2006
was analysed.
Methods: Staphylococcus aureus identiﬁcation and antimicrobial
susceptibility testing (AST) were performed by VITEK 1 system
(bioMerieux). The phenotypical detection of MRSA was conﬁrmed by
subsequent PCR for MecA gene. Trends stratiﬁed for disciplines (internal
medicine, general medicine, surgery, paediatrics, gynaecology and ear,
nose and throat) and materials were calculated.
Results: In 12,723 (10.1%) out of 125,822 clinical specimens a S. aureus
was detected. For 11,993 (94.3%) isolates AST was carried out resulting
in an average MRSA proportion of 13.2 percent. From 2000 to 2006 the
overall percentage of MRSA in ambulatory care increased from three
percent to 17 percent with a yearly increment of 2.4% (CI: 2.0−2.8).
With regard to specimen type the sample was composed as follows:
37.0% of the isolates came from wound swabs, 26.3% from swabs of
unknown sites, 26.2% from nose and throat swabs, 7.0% from urines,
and 3.5% from sputum. MRSA proportions ranged from 11.1% in urines
to 14.8% in nose and throat swabs. Results can be stratiﬁed by the
specialty of the physician who sent the specimen: MRSA proportions
differ signiﬁcantly with highest proportions in internal medicine (28.1%),
followed by GPs (16.1%) and surgery (9.8%) and low proportions in
ENT (3.8%), paediatrics (1.6%), and gynaecology (0.9%). The amount of
community acquired MRSA cannot be estimated. All disciplines except
paediatrics and gynaecology showed an increase over the years. Internal
medicine peaked with 36% in 2006.
Conclusions: Analysis of AST data from the Berlin area showed a
continuous increase of MRSA proportions in ambulatory care settings
within the period from 2000 to 2006 reaching and passing levels known
from hospital settings. In the light of these results the ambulatory
care sector should be included into a national antimicrobial resistance
surveillance system; this will be started in Germany in 2008.
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P1736 Ciproﬂoxacin resistance in Staphylococcus aureus: a 12-year
experience in a major Canadian health centre
K. Kowalewska-Grochowska, G. Armstrong (Edmonton, CA)
Objective: To observe an evolution of a ciproﬂoxacin resistance pattern
in Staphylococcus aureus isolated from a patient population served by a
large Canadian hospital over 12 years.
Method: Staphylococcus aureus isolated from clinical specimens
collected between 1994 and 2005 was used as the representative
organism in this retrospective study. Microbiology laboratory database
was reviewed for three sentinel years (1994, 1999 and 2005) regarding
patient age, gender and specimen source. Organism identiﬁcation and
resistance to ciproﬂoxacin was determined by either/or: BioMerrieux
VITEK, Becton Dickinson Phoenix, Kirby Bauer disk diffusion,
AB Biodisk E-test, Becton Dickinson Pasco and/or Dade Behring
MicroScan, using resistance criteria from Clinical and Laboratory
Standards Institute(CLSI). Repeat specimens of the same sample type
collected within one month were excluded from analysis. Microsoft
Excel was used for data analysis.
Results: The 5280 pathogenic S. aureus strains from 4089 patients
were distributed uniformly throughout three sentinel periods of the
study. The most common specimen source for all three periods was
surface/wound swab, followed by sputum and ﬂuid/aspirate. Overall
ciproﬂoxacin resistance rates were 3.13% for 1994; this was followed by
an increase to 8.82% for 1999 and to 17.9% for 2005. Resistance rates
were highest in sputum isolates for 1994 (7%), and urine isolates for
1999 and 2005 (13.3 and 31.1% respectively). In every sentinel period,
highest resistance rates were seen elderly (over 60 years of age); males
with resistant S. aureus far outnumbered the females.
Conclusions: Overall ciproﬂoxacin resistance rates increased over a
12 year surveillance period. The unexpected plateau of this increase
between 1999 and 2005 was most likely due to change in prescribing
habits caused by new region-wide antibiotic control initiative. In view
of popularity of quinolones in clinical practice we advise a targeted
approach by restricting these drugs in elderly males to further limit
development of resistance.
P1737 Evaluation of the Etest GRD strip for identiﬁcation of
hGISA
S. Leonard, K. Rossi, M. Rybak (Detroit, US)
Objective: Continued selective pressure from glycopeptide use has led
to non-susceptible strains of Staphylococcus aureus including hGISA.
Infections with hGISA are associated with prolonged bacteraemia
and vancomycin (VA) failure. The gold standard for identiﬁcation of
hGISA is population analysis proﬁle – area under the curve assay
(PAP-AUC) where the isolate is plated on agar plates with increasing
VA concentrations and resulting CFU/mL are plotted versus VA
concentration (Wooton et al. J Clin Microbiol.2007;45:329–32.). This
method is time consuming and labor intensive and not suitable for use
in clinical laboratories. This study compared a new Etest gradient strip
(GRD) for detection of hGISA to PAP-AUC and the Etest macromethod
(MET) (Walsh et al. J Clin Microbiol. 2001;39:2439–44.).
Methods: 93 clinical hGISA and 25 clinical non-hGISA strains deﬁned
by PAP-AUC were tested with GRD strip consisting of a double-sided
gradient with VA and teicoplanin (TP), according to the manufacturer’s
instructions. An inoculum suspension (0.5 McFarland turbidity) was
streaked on a Mueller-Hinton (MH) and MH + 5% sheep blood (MHB)
agar plates. Etest VA strip was applied to the MH plate and GRD strip
to the MHB plate. VA MIC results were read at 24 h and GRD results
were read at 24 and 48 h. For GRD, VA or TP results 8mg/mL and
Etest VA MIC of 4 was interpreted as positive for hGISA. MET was
done as previously described.
Results: Sensitivity and speciﬁty for GRD was 81% and 96% at 24 h
and 93% and 79% at 48 h, respectively and for MET, 76% and 100%
at 48 h. For hGISA strains, VA MIC50/90 were 1.5/2mg/mL and for
non-hGISA, corresponding values were 1/1.5.
Conclusion: Etest GRD correctly identiﬁed 81% of hGISA at 24 h
with high speciﬁcity and sensitivity improved to 93% at 48 h. Further
evaluation of this test is warranted.
P1738 Surveillance of Staphylococcus aureus susceptibility to
fusidic acid in ﬁve Canadian laboratories
R. Rennie, C. Brosnikoff, M. Harris, L. Turnbull, P. Kidson,
D. Yamamura, M. Kelly, K. Forward, M. Laverdiere, R. Skov, A. Larsen
(Edmonton, Thornhill, Toronto, Burnaby, Halifax, Montreal, CA;
Copenhagen, DK)
Objective: Fusidic acid has been available on the Canadian market since
the early 1980s. The objective of this study was to perform regular
surveillance of fusidic acid susceptibility of Staphylococcus aureus
strains in ﬁve Canadian diagnostic laboratories.
Methods: S. aureus strains were collected from cultures submitted to the
routine laboratory during March and September on an annual basis. Sixty
(60) strains were collected from each of the ﬁve diagnostic laboratory
sites; 10 strains from each site were meticillin resistant Staph. aureus
(MRSA) isolates. Only one strain per patient was tested in each test
period. Routine antimicrobial susceptibility testing was performed in the
submitting laboratory by an automated susceptibility method. Testing
for fusidic acid susceptibility was performed by disk diffusion (Oxoid,
Nepean, Ontario) and ETest® (AB Biodisk, Solna, Sweden) on Mueller
Hinton agar plates. The plates were incubated at 35º C for 18–20 hr in
ambient air. A zone diameter of >20mm and an MIC of 2mg/L (Leo
Pharma Inc) were considered to be susceptible.
Results: 603 S. aureus strains were tested for fusidic acid susceptibility
during 2007, including 100 MRSA strains. 187/603 (31%) of strains were
collected from inpatients and 416/603 (69%) from outpatients. 22/300
(7.3%) were resistant to fusidic acid in March and 32/303 (10.6%) in
September. 3/50 (6%) strains of MRSA were resistant to fusidic acid in
March and 2/50 (4%) in September. All 5 strains of MRSA resistant to
FA in 2007 were isolated from one laboratory. Spa typing showed that
the fusidic acid resistant strains appeared to be clonal, and not related
to resistant clones observed in Europe.
Conclusions: Fusidic acid is the most widely prescribed topical
antimicrobial in Canada. Compared to data gathered over the previous 7
years, ongoing surveillance suggests that there has been no trend towards
increasing fusidic acid resistance in S. aureus strains isolated across the
country. The resistance rate remains low even among the MRSA strains
submitted for testing. These data support the importance of continuing
surveillance and suggest that fusidic acid has maintained its efﬁcacy over
the years.
P1739 Occurrence of ﬂuoroquinolone resistance in members of the
Staphylococcus sciuri group
I. Cirkovic, M. Svabic Vlahovic, T. Hauschild, D. Vukovic, P. Jezek,
S. Stepanovic (Belgrade, RS; Bialystok, PL; Pribram, CZ)
Objectives: The Staphylococcus sciuri group includes S. sciuri, S. lentus,
and S. vitulinus. It has been reported that as much as 83% of
tested S. sciuri isolates exhibit intermediate resistance, and 17% near
intermediate resistance to ciproﬂoxacin. It was suggested that this
property may be related to the intrinsic resistance of the organism to
novobiocin and nalidixic acid, other antibiotics that inhibit DNA gyrase
activity. The aim of this study was to establish the frequency of resistance
to ﬂuoroquinolones in large number of the S. sciuri group isolates and
to test the hypothesis that these bacteria display natural resistance to
ﬂuoroquinolones.
Methods: A total of 322 S. sciuri group isolates were investigated
in this study: 295 S. sciuri, 14 S. lentus, and 8 S. vitulinus strains,
and reference strains S. vitulinus CCM 4511, S. lentus CCM 3472,
S. sciuri ssp. sciuri CCM 3473, S. sciuri ssp. rodentium CCM 4657,
S. sciuri ssp. carnaticus CCM 4835. The susceptibility to ciproﬂoxacin,
levoﬂoxacin, oﬂoxacin, norﬂoxacin, and enoxacin was tested by disk
diffusion method in accordance with the recommendations given by
Clinical and Laboratory Standards Institute.
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Results: Among 322 tested members of the S. sciuri group resistance to
ﬂuoroquinolones was observed in only 3 isolates (0.9%). The resistance
was detected in 2 of 298 (0.7%) S. sciuri and 1 of 15 (6.7%)
S. lentus isolates, while all S. vitulinus strains were susceptible to
tested ﬂuoroquinolones. One S. sciuri strain displaying resistance was
isolated from a hospitalised patient, and another from the hospital
environment. The PFGE analysis of these isolates showed that they were
not related. Resistant S. lentus isolate was isolated from an outpatient
with frequent urinary tract infections treated with various antibiotics,
including ﬂuoroquinolones. Therefore, it seems reasonable to assume
that all ﬂuoroquinolone resistant isolates have previously been in contact
with ﬂuoroquinolones.
Conclusion: In contrast with previously reported high rate of
intermediate resistance to ﬂuoroquinolones in the S. sciuri group
members, our survey showed low frequency of resistance to these
antimicrobials in large series of the S. sciuri group isolates. Great
majority of the isolates displayed full susceptibility to ﬂuoroquinolones
which strongly suggests that members of the S. sciuri group are not
naturally resistant to these antimicrobials.
P1740 Vancomycin MIC distributions in MRSA isolates from a
large acute English hospital: no evidence of MIC shift,
1999–2006
K. Bowker, S. Tomaselli, A. MacGowan (Bristol, UK)
Objectives: Over the last two decades there has been a steady
increase in the use of vancomycin for treatment of severe MRSA
infection. Recently concerns have been raised regarding the decreasing
efﬁcacy of vancomycin in the clinical setting. In addition there
have been conﬂicting reports of a ‘shift’ in vancomycin MICs for
Staphylococci and Enterococci. In our hospital glycopeptides account
for 2.2% of all antibiotic use (upper quartile for SW England) average
5000DDD/annum; >90% of which is vancomycin. The aim of this study
was to compare the vancomycin MICs of MRSAs from 1999–2000 and
2006−7.
Methods: A total 396 MRSA isolates from 1999–2000 (197) and 2006–
2007 (197) held in the collection at Microbiology Dept, Southmead
Hospital were tested. MICs were performed using modiﬁed CLSI agar
dilution methodology using MIC concentrations of 0.25, 0.5, 1, 1.5, 2
and 4mg/L.
Results: The range, MIC50 and MIC90 for 1999–2000 and 2000–2007
were equivalent <0.25−1.5, 1 and 1mg/L respectively. The modal MIC
for both sets was 1mg/L. All isolates were inhibited by vancomycin
2mg/L.
MIC No. of isolates
1999–2000 (n = 197) 2006–2007 (n = 197)
0.25 2 1
0.5 49 51
1 144 144
1.5 2 1
2 0 0
4 0 0
Conclusions: Vancomycin shift was not observed over the 6 year period
tested despite high vancomycin usage. Vancomycin remains a viable
option for the treatment of MRSA infection in our hospital.
P1741 In vitro susceptibility of group B Streptococcus strains
isolated from genital tract of pregnant women
J. Bosch, C. Guardia`, T. Juncosa, A. Andreu, J. Lite, I. Sanfeliu
and the Microbiologist Group for the Study of Vertical Transmission
Infections, from the Catalan Society for Clinical Microbiology and
Infectious Diseases
Objectives: Group B Streptococcus (GBS) early neonatal sepsis
prevention, requires GBS detection in pregnant women genital tract,
and intrapartum prophylaxis with penicillin or ampicillin administration.
In women with allergy to penicillin, administration of clindamycin or
erythromycin, and vancomycin in case of resistance to these antibiotics,
is suggested. The aim of the study is the GBS resistance surveillance.
Methods: Between May to November 2007, in six different Microbi-
ology laboratories of Barcelona, Spain, the in vitro susceptibility of
591 GBS strains was studied. The strains were isolated from genital
tract (vaginal and/or rectal swabs) of women between 35–37 weeks
of gestation. Susceptibility to clindamycin, erythromycin, telithromycin
and fosfomycin was performed by disk-diffusion and/or microdilution
tests. The resistance mechanisms to clindamycin, erythromycin and
telithromycin were assessed by disk-diffusion method.
Results: 140 strains (236%) showed resistance to any of four antibiotics:
102 (17.2%) to clindamycin, 106 (17.9%) to erythromycin, 18 (3.0%) to
telithromycin and 29 (4.9%) to fosfomycin.
86 strains presented a constitutive MLS-B phenotype (clindamycin and
erythromycin resistant), 14 inducible MLS-B phenotype (erythromycin
resistant and clindamycin inducible resistance), 6 M phenotype
(erythromycin resistant and clindamycin susceptible) and 2, unknown
mechanism (erythromycin susceptible and clindamycin resistant). Of the
18 strains with resistance to telithromycin, 13 presented a constitutive
phenotype and 5 an inducible phenotype.
Increasing resistance rate to these antibiotics has been observed since the
last multicentre study performed in Spain in year 2002 (with resistance
rates as follows: 12.4% to erythromycin, 11.8% to clindamycin, 1.8% to
telithromycin and 0.3% to fosfomycin).
Conclusion: Susceptibility surveillance is required in genital GBS
strains isolated from penicillin allergic women, due to the high and
increasing resistance rates to clindamycin and erythromycin. Since GBS
remains quite susceptible to fosfomycin, this antibiotic could be an
alternative in some cases.
P1742 Serotyping and antimicrobial resistance of group B
Streptococcus in Korea
J.D. Chae, M. Ki, Y.S. Seo, K.Y. Oh, J-H. Shin, Y.R. Song, J.M. Kim,
M.Y. Kim, J-Y. Yang, S.Y. Bae, H.R. Yoon, B. Foxman (Seoul, Daejeon,
KR; Michigan, US)
Purpose: Because of the prevalence of Group B Streptococcus
(Streptococcus agalactiae, GBS) among pregnant women and disease
burdens in neonates and adults are increasing in Korea; we carried out
this molecular epidemiologic study on GBS to estimate the serotype
distribution and antimicrobial resistance among colonising and invasive
isolates.
Materials and Methods: Colonising isolates (199) were collected
by GBS screening in pregnant women (35–37 weeks) between Nov.
2004 and Mar. 2007 in four hospitals of Seoul and Daejeon. Invasive
isolates (243) came from patients of clinics or hospitals in whole country
between Feb. 2006 and Mar. 2007. To conﬁrm serotype of GBS, co-
agglutination assay (serotyping kit) and microarray methods were used.
To test antimicrobial resistance, disc diffusion method for colonising
isolates and MIC for invasive isolates were used.
Results: Serotype III was predominant and V was the next frequent in
colonising isolates, but serotype V was predominant and III was the
next in invasive isolates. Antimicrobial resistances for colonising and
invasive isolates were high; resistance to erythromycin (27.9%, 35.3%,
respectively) and resistance to clindamycin (46.3%, 48.7%, respectively).
We also conﬁrmed the resistance to cefazolin and cefuroxime at ﬁrst
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in Korea. Antimicrobial resistance was high in serotype V, VII and
VIII, and especially, resistance to clindamycin rather than erythromycin
was very high in serotype III. When the isolates showed resistance to
erythromycin, they also showed resistance to clindamycin except two
isolates. However, when the isolates had resistance to clindamycin,
31.7% of them (almost of all was serotype III) were susceptible to
erythromycin, which were very different characteristics of Korean GBS
isolates.
Conclusion: Serotypes of Korean GBS isolates were moved to virulent
serotype V, VII, and VIII and antimicrobial resistance to erythromycin
and clindamycin were still increasing: further research and control on
GBS were very important in Korea.
P1743 Antimicrobial susceptibility proﬁles of group B
streptococci in 2006–2007, including one unusual penicillin
non-susceptible strain
O. Karatuna, G. Soyletir (Istanbul, TR)
Objectives: We have determined the antimicrobial susceptibilities of
group B streptococci (GBS) strains isolated in our laboratory from
clinical specimens to explore the penicillin MIC values for which the
organism is considered to be susceptible and investigated inducible
clindamycin resistance among these strains.
Methods: A total of 158 GBS have been isolated in our laboratory
between 2006 and 2007. Identiﬁcation has been performed using latex
agglutination test (Pastorex Strep B, Bio-Rad). For all the strains
penicillin MIC values have been established with Etest strips (following
manufacturer’s instructions) and disc diffusion test for erythromycin,
clindamycin and tetracycline according to CLSI. Erythromycin and
clindamycin discs have been placed 25mm apart from each other (centre
to centre) to observe the inducible clindamycin resistance. A blunting
in the inhibition zone of clindamycin facing the erythromycin disc has
been considered positive for inducible clindamycin resistance.
Results: Tetracycline, erythromycin and clindamycin resistance has been
found as 94.3%, 34.2% and 29.7%, respectively. Inducible clindamycin
resistance has been observed in 3 (1.9%) of the strains. Penicillin MIC50
and MIC90 values have been found as 0.047 ug/ml and 0.064 ug/ml,
respectively. Excluding one GBS strain with penicillin MIC of 1 ug/ml,
penicillin MIC values have been found in susceptibility limits with the
highest penicillin MIC value being 0.094 ug/ml.
Conclusion: The penicillin nonsusceptible results for GBS have been
reported in the last years from different geographic areas. In this study
we have detected one penicillin nonsusceptible GBS strain with penicillin
MIC of 1 ug/ml. This strain isolated from a patient’s urine indicates that
penicillin susceptibility of GBS strains should be monitored carefully.
P1744 Antimicrobial susceptibilities of Streptococcus pyogenes
isolated from respiratory and skin infections in the United
States in 2005–2006
I.A. Critchley, S.D. Brown, M.M. Traczewski, G.S. Tillotson, N. Janjic
(Louisville, Wilsonville, Milford, US)
Objective: Streptococcus pyogenes (SP) causes a variety of diseases
ranging from non-invasive mild infections such as pharyngitis and
impetigo to severe invasive infections such as bacteraemia, pneumonia
and necrotising fasciitis. Macrolides are widely used to treat SP
infections in subjects with known allergies to b-lactams. Macrolide-
resistant SP has been reported and continues to emerge in the U.S. The
aim of the study was to assess the prevalence of resistant phenotypes of
SP collected in the U.S. in the 2005–2006 Faropenem surveillance study.
Methods: 1001 SP were collected from 104 centres in the USA during
2005–2006 and tested against azithromycin (AZI), cefdinir (CDN),
cefuroxime (CFX), co-amoxyclav (AMC), co-trimoxazole (TMP-SMX),
faropenem (FAR), levoﬂoxacin (LEV), penicillin (PEN), telithromycin
(TEL) by broth microdilution according to CLSI guidelines. AZI
resistance (AZI-R) was determined using CLSI breakpoints and results
analysed according to geographic and demographic information.
Results: AZI-R was 7% for all U.S. isolates and varied by region ranging
from 3.9% in south central to 9.3% in the northeast. The MIC90s for AZI
ranged from 0.25mg/L for susceptible (S) strains to >16mg/L for AZI-R
strains. AZI-R varied with age of subject ranging from 12.9% (<2 yrs)
to 0% (>65 yrs), and specimen source with R rates of 3.7, 7 and 9.4%
respectively in blood, skin and respiratory isolates. AZI-S and AZI-R SP
were equally susceptible to all b-lactams tested including FAR (MIC90,
0.03mg/L). In contrast, TEL was less active against AZI-R strains
(MIC90, 8mg/L) when compared with AZI-S SP (MIC90, 0.12mg/L).
All isolates were inhibited by LEV at concentrations 2mg/L.
Conclusions: AZI-R SP remained prevalent in the U.S. in 2005–2006
especially in isolates from children 2 yrs old. FAR, other b-lactams
and TMP-SMX retain activity against AZI-S-and AZI-R phenotypes.
P1745 Activity of faropenem against U.S. paediatric isolates of
serotype 19A Streptococcus pneumoniae collected in the
2005–2006 respiratory season
I.A. Critchley, M.R. Jacobs, S.D. Brown, M.M. Traczewski,
G.S. Tillotson, N. Janjic (Louisville, Cleveland, Wilsonville, US)
Objective: Streptococcus pneumoniae (SP) is the leading cause of bac-
terial pneumonia, sinusitis and acute otitis media in children worldwide.
The heptavalent pneumococcal vaccine (PCV7) was considered to be
a promising strategy for reducing invasive pneumococcal infections
in children following its introduction in the U.S. in 2000. However,
increasing antibiotic resistance is now being observed in the U.S.
especially among serotypes of SP not covered by PCV7 such as
multidrug-resistant serotype 19A strains. The aim of the study was to
assess the serotype distribution and antimicrobial susceptibility of SP
collected from U.S. children in 2005–2006.
Methods: 393 SP were collected from children at 104 U.S. centres;
307 (<5 yrs), 86 (6–14 yrs). Specimen sources included 199
invasive, 119 non-invasive and 74 carriage sites. Serotyping was
performed by quellung reaction with type-speciﬁc antisera. MICs of
azithromycin (AZI), cefdinir (CDN), cefuroxime (CFX), co-amoxyclav
(AMC), co-trimoxazole (TMP-SMX), faropenem (FAR), levoﬂoxacin
(LEV), penicillin (PEN) and telithromycin (TEL) were determined and
interpreted according to CLSI guidelines.
Results: Serotype 19A was the most frequent type, accounting for
30.5% of isolates, followed by serotypes 6A, 3, 19F, 35B, 23A and
15A with prevalence ranging from 9.9% to 3.6%. FAR was the most
potent b-lactam against serotype 19A strains (MIC90 1mg/L) compared
with AMC, CDN and CFX (MIC90s of 8, >8 and 16mg/L, respectively,
with >35% of isolates nonsusceptible to these agents). Serotype 19A
strains also had reduced susceptibility to AZI and TMP-SMX with
MIC90s of >16 and >8mg/L, and 64% and 73% of isolates resistant,
respectively. All serotype 19A strains were susceptible to LEV and TEL,
agents unlikely to be widely used to treat paediatric infections in children
because of safety concerns.
Conclusions: Serotype 19A and other non-vaccine serotypes of SP were
more prevalent than the vaccine serotypes covered by PCV7 in 2005–
2006. FAR was the most potent b-lactam against SP serotype 19A
isolates and was 8-fold more active than AMC. Further studies are
warranted to evaluate clinical efﬁcacy of FAR against infections caused
by serotype 19A isolates.
P1746 Prevalence of low-level and high-level resistance to ﬂuoro-
quinolones in Streptococcus pneumoniae in Getafe, Spain
A. Garcı´a-Can˜as, P. Garcı´a-Hierro, T. Soria, F.J. Pe´rez-Milla´n, J.I. Alo´s
(Getafe, ES)
Fluoroquinolone (FQ) resistance among strains of Streptococcus
pneumoniae has emerged worlwide. Strains with high-level resistance
and even with low-level resistance (ﬁrst-step mutants) have been
associated with treatment failures.
Objectives: The aim of this study was to assess the prevalence of
low-level and high-level resistance to ﬂuoroquinolones in Streptococcus
pneumoniae strains of Getafe, Spain.
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Methods: A total of 100 S. pneumoniae strains (28 from children and
72 from adults) were isolated from clinical samples between November
2006 and June 2007 at the Department of Clinical Microbiology of
Getafe University Hospital. The main sources of the isolates were blood
samples (42%), conjunctival exudates (17%), and respiratory samples
(37%).
Susceptibility to 5 FQ (levoﬂoxacin, norﬂoxacin, peﬂoxacin, cipro-
ﬂoxacin, and sparﬂoxacin) was performed using disk diffusion method.
The results were interpreted following the phenotypic test designed for
Varon et al. (Antimicrob Agents Chemother 2006;50:572−9) for the
detection of the low- and high-level FQ-resistant mutants according to
the inhibition zone diameters of the 5 FQ.
We also performed the broth microdilution method to determine the
susceptibility to levoﬂoxacin.
Results: 4 of the isolates showed resistance to levoﬂoxacin (high-level
resistant mutants) and 96 were susceptible by the broth microdilution
method and CLSI guidelines. Using the FQ disks and the interpretations
of Varon et al. 60 strains had the wild phenotype (susceptible), 5 strains
had an increased efﬂux and the rest harboured a phenotype compatible
with topoisomerase IV (28 strains) or gyrase (3 strains) mutations.
Conclusions: The results of the study showed that 34.5% of the strains
susceptible to levoﬂoxacin by the CLSI had a low-level resistance to this
antibiotic and so the potencial to generate high level resistant mutants.
P1747 Epidemiological survey of resistance to b-lactams (AMX,
CFX, CRO), macrolides (CLR, TEL), and ﬂuoroquinolones
(LVX, MXF) in a Belgian collection of community-acquired
pneumonia isolates of Streptococcus pneumoniae
A. Lismond, F. Van Bambeke, S. Carbonnelle, F. Jacobs, M.J. Struelens,
J. Gigi, A. Simon, Y. Van Laethem, A. Dediste, D. Pierard, A. De
Bel, P.M. Tulkens (Brussels, BE)
Objectives: Evaluate current resistance trends in Streptococcus pneu-
moniae (SP) (including efﬂux) from CAP patients towards the main
antibiotics registered for this indication.
Methods: 142 SP isolated in 4 major teaching hospitals over the last
3 years from patients admitted from the community and with CAP
diagnosis conﬁrmed by retrospective analysis of medical records. MIC
determined by microdilution in CAMH broth + 2.5% horse blood.
Susceptibility assessed according to EUCAST and CLSI bkpts.
Results: Based on CLSI bkpt, 99.3% of isolates remained susceptible
to AMX, but MIC90 values are elevated. Non-susceptibility to CFX
and CRO was observed in about 15% and 10% of isolates, respectively,
whatever the bkpt considered. More than 34% of isolates were resistant
to CLR, among which 20% [7% of the collection] remained susceptible
to clindamycin (denoting efﬂux). 7% of isolates could be categorised
as TEL-I or -R using EUCAST bkpts but only 1.4% would appear as
TEL-I according to CLSI. MICs of LVX were higher than those of MXF,
but non-susceptibility to both drugs remained low (due to higher LVX
bkpts). Reserpine had only a modest effect (0.7% remaining LVX-R
according to EUCAST, no change for MXF).
AB MIC50 MIC90 Range EUCASTa CLSIb
min max % I %R % I %R
Amoxycillin [AMX] 0.06 1.5 0.03 16 0 0.7
Cefuroxime [CFX] 0.06 8 0.03 16 2.1 13.4 2.8 12.7
Ceftriaxone [CRO] 0.06 1.5 0.016 3 11.3 0.7 10.6 0
Clarithromycin [CLR] 0.06 >32 0.06 >32 0 35.2 0.7 34.5
Telithromycin [TEL] 0.06 0.25 0.06 2 4.2 2.8 1.4 0
Levoﬂoxacin [LVX] 0.75 1.5 0.375 12 0 2.1 1.4 0.7
Moxiﬂoxacin [MXF] 0.25 0.25 0.05 3 0 0.7 0.7 0
EUCAST bkpts: AMX: none proposed; CFX (published): S 0.5, R> 1; CRO
(published): S 0.5, R> 2; CLR (proposed): S 0.25, R> 0.5; TEL (proposed):
S 0.25, R> 0.5; LVX (published): S 2<R; MXF (published): S 0.5<R.
bCLSI bkpts: AMX: S 2, R 8; CFX: S 0.5, R 2; CRO: S 1, R 4;
CLR: S 0.25, R 1; TEL: S 1, R 4; LVX: S 2, R 8; MXF: S 1, R 4.
Conclusion: The data show a marked decreased susceptibility of SP to
cephalosporins, and a high prevalence of MLSB resistance. Resistance
to TEL and quinolones remains negligible based on CLSI breakpoints,
but become noticeable for TEL if using EUCAST proposed bkpt. LVX
MICs are clearly increased. Efﬂux signiﬁcantly impacts on macrolide
susceptibility but does not markedly affect LVX or MXF. The data (i)
underline the risk of empirical treatment of CAP with cephalosporins
and macrolides, (ii) justify the high dose approach with AMX; and (iii)
illustrate the importance of setting appropriate bkpts.
P1748 Trends in nasopharyngeal carriage of Streptococcus
pneumoniae among children attending daycare centres in
France: 1999–2006
B. Dunais, P. Bruno, P. Touboul, H. Carsenti-Dellamonica,
M. Roussel-Delvallez, C. Laurans, M. Lelieur-Pie´rard, C. Pradier,
P. Dellamonica (Nice, Lille, FR)
Objectives: To assess trends in pneumococcal carriage among children
attending day-care centres (DCC) in France following implementation
of pneumococcal conjugate vaccine (Pn7) and interventions promoting
prudent antibiotic use.
Method: Cross-sectional surveys were performed in the Alpes Maritimes
(AM) and Nord (ND) areas between January and March 1999, 2002,
2004 and 2006 on a random sample of children attending group day-
care. A local intervention promoting prudent antibiotic use in paediatric
respiratory tract infections was conducted in AM in 2000 and 2003, via
academic detailing visits to all general practitioners and paediatricians,
and a national media campaign began in 2002. Pn7 became available
in 2002. For each study period, antibiotic susceptibility and serotype
distribution of isolates from nasopharyngeal aspirates were recorded, as
well as immunisation status.
Results: Nasopharyngeal carriage of SP remained stable in AM: 161/298
(54.0%) samples in 1999 and 168/335 in 2006; and in ND: 117/250
(46.8%) samples in 1999 and 146/288 (50.7%) in 2006, while the
proportion of SP with diminished susceptibility to penicillin (PDSP)
decreased signiﬁcantly in both areas between 1999 and 2006, from
101/161 (62.7%) to 57/168 (33.9%) in AM (p< 10−3), and from 84/117
(71.8%) to 82/146 (56.2%) in ND (p< 10−3). Antibiotic use as reported
by parents dropped signiﬁcantly in both areas, by 50% in AM and by
25% in ND. Overall susceptibility of strains to antibiotics increased.
Over two-thirds of the children had received at least one vaccine dose
in 2006. A shift from Pn7 serotypes (6B, 9V, 19F, 23F) towards Pn7
cross-reactive (6A, 19A, 23 non-F) and non-vaccine types was observed
(Figure 1).
Pooling both areas, among PDSP, serotype 6A, 19A, 19F and 15 together
accounted for 75% of strains in 2006 versus 16% in 1999 (p< 105).
Conclusion: The distribution of nasopharyngeal carriage of SP has
changed since the introduction of Pn7 in favour of vaccine-related and of
non-vaccine strains with a signiﬁcant increase in antibiotic susceptibility;
however the proportion of non-vaccine types has increased among PDSP.
Replacement strains must be protected from selective pressure resulting
from inappropriate antibiotic use in order to uphold the beneﬁt provided
by the vaccine.
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P1749 In vitro susceptibility of respiratory isolates of Streptococcus
pneumoniae and Streptococcus pyogenes in a twelve-month
period
G.A. Popescu, E. Benea, C. Popescu, M. Popoiu, M. Furtuna,
D. Antonica, M. Ivan, S. Botea, A. Streinu-Cercel (Bucharest, RO)
Therapy is often empirical in respiratory tract infections and there is a
need for local data on the rate of resistance to available antimicrobials.
Increased levels of macrolide-resistant Streptococcus pyogenes and
Streptococcus pneumoniae in several regions have been reported.
Objective: To study the antimicrobial susceptibility of two major
pathogens: Streptococcus pneumoniae and Streptococcus pyogenes, to
deﬁne the place of several alternative regimens in the ﬁrst line therapy
for pharyngitis and lower respiratory tract infection.
Methods: Antimicrobial susceptibility tests analysis for a total of
232 unique isolates of Streptococcus pyogenes and 107 isolates of
Streptococcus pneumoniae recovered between December 2006 and
November 2007 at the National Matei Bals Infectious Diseases Institute,
Bucharest, as a part of the MART surveillance study. Antibiotic
susceptibilities were determined with disk diffusion method and
conﬁrmed with E-tests for penicillin.
Results: S. pyogenes isolates were uniformly susceptible to b-lactams,
sulfamethoxazole/trimethoprim and vancomycin; macrolide-resistance
was noted for 6.55% of strains (9 strains with M phenotype
and 6 strains with MLSB resistance). Three isolates were resistant
to levoﬂoxacin (1.4%), all macrolide-susceptible, and six isolates
resistant to tetracycline (5.3%), two of them macrolide-resistant ones.
S. pneumoniae strains were uniformly susceptible for moxiﬂoxacin,
vancomycin and linezolid; diminished susceptibility to penicillin was
noted for 57.1% strains, macrolide-resistance for 47.2% strains (two
thirds with MLSB phenotype) and multiresistance for 43.9% strains.
Susceptibility of penicillin-resistant strains was: 96.3% for rifampin,
85.5% for cloramphenicol, 80% for tetracycline, 44% for clindamycin.
Susceptibility of macrolide resistant strains were: rifampine 98.7%,
ceftriaxone 62.6%, tetracycline 21%.
Conclusion: Macrolide-resistance is yet at low level for S. pyogenes,
but higher for S. pneumoniae, probably due to increased consumption
of macrolides. The risk of selective pressure with continuous rise
of macrolide-resistance whatever it is the indication for usage,
could impose a restricted access, especially in outpatient pharyngitis
or respiratory infections. A similar situation could be deﬁned for
sulfamethoxazole/trimethoprim; concerning doxycycline, is possible that
breakpoints are too high and/or deﬁned daily dose too low for
pneumococcal infections.
P1750 Global trends of penicillin resistance rates in Streptococcus
pneumoniae, 2004–2007
R. Badal, S. Bouchillon, B. Johnson, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: The percentage rates of penicillin-resistant (PenR) S. pneu-
moniae (SPN) vary by country and region. The purpose of this analysis
was to determine changes in regional variations of PenR and PenNS
strains of SPN, and the current activity of tigecycline (TIG), amoxicillin-
clavulanic acid (AC), ceftriaxone (CFX), levoﬂoxacin (LEV), linezolid
(LNZ), and vancomycin (VAN) against pen-resistant isolates.
Methods: 5,010 clinically relevant isolates of SPN were collected from
patients in 387 hospitals worldwide from 2004 to 2007. MIC’s to all
agents tested were determined by broth microdilution and interpreted
following CLSI guidelines.
Results: Number of SPN and the percentage non-susceptible to penicillin
from 2004–2007 are summarised in the table.
% of PenR SPN susceptible to AC ranged from 34–100; CFX from 33–
100. 100% of PenR SPN were susceptible to TIG, LEV, LNZ, and VAN.
Conclusions: Rates of PenNS for SPN range from 29% in Europe to
59% in South Africa. Magnitude of changes from 2004 to 2007 varied
by region, being fairly constant in Europe, Middle East, and North
America, but showing swings ranging from 10–31% (Latin America
and Asia/Paciﬁc Rim, respectively). Generally speaking, PenNS rates
were essentially constant from 2006–2007; however, the advent of new
higher CLSI breakpoints for intravenous penicillin for non-meningitis
SPN in 2008 will lead to signiﬁcant declines in reported PenNS rates in
countries using CLSI standards. Utility of AC and CFX vs. PenR SPN
varies widely by region, and local susceptibility patterns must be taken
into account when selecting therapy.
Region Number of strains (%R+I)
2004 2005 2006 2007
South Africa – 19 (58%) 47 (73%) 22 (59%)
Asia/Paciﬁc Rim 22 (18%) 43 (35%) 120 (49%) 147 (42%)
Europe 220 (28%) 208 (28%) 510 (29%) 325 (29%)
Latin America – 63 (29%) 146 (37%) 84 (39%)
Middle East – 10 (40%) 11 (36%) 14 (43%)
North America 447 (45%) 741 (42%) 1213 (43%) 598 (37%)
P1751 Trends in antimicrobial resistance in S. pneumoniae,
Canada, 1993–2007
K. Green, A. McGeer, A. Plevneshi, S. Pong-Porter, D. Low on behalf
of the Canadian Bacterial Surveillance Network
Background: The Canadian Bacterial Surveillance Network (CBSN) has
been monitoring resistance trends in Canadian isolates of S. pneumoniae
(SP) since 1993.
Methods: CBSN is a collaborative network of microbiology laboratories
from across Canada that submit bacterial isolates to a central laboratory
for standardised antimicrobial susceptibility testing performed according
to CLSI protocols.
Results: Of the 28,915 SP isolates submitted and tested between 1993
and July of 2007, 37% were from blood/CSF, 41% from sputum, 22%
from other sites. The trends in antimicrobial susceptibility are expressed
below as percentage resistant. Macrolide resistance and tetracycline
resistance have both increased slightly since 2006 (19.2 vs 21.7 and 11.3
vs 12.3 respectively). Resistance to ﬂuoroquinolones declined slightly
since 2006 (in 2007: Cip 1.7%; Levo 0.8%; Moxi 0.5%). Rates of
resistance to b-lactams were increased in 2006 compared to previous
years but penicillin resistance decreased in 2007 from to 6.2% in 2006
to 4.1%, P = 0.009). Ceftriaxone resistance (meningeal breakpoint MIC
2) decreased slightly from 3.7% to 2.5, P=NS. Amoxicillin resistance
increased signiﬁcantly from 0.1% in 2000 to 1.4% in 2006, and 1.3% in
2007.
’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07
Pen NS 5.7 8.1 8.8 12.1 13.6 15.1 13.5 12.4 14.5 15.0 14.9 14.8 15.3 15.2 15.9
Pen R 0.9 1.3 2.2 4.2 6.6 5.7 5.9 5.9 6.9 6.5 6.3 5.4 4.8 6.2 4.1
Amox R 0 0 0 0 0.1 0.1 0.2 0.1 0.5 0.6 1.2 1.1 1.1 1.4 1.3
Eryth R 1.9 3.4 3.2 5.1 6.8 10.6 9.9 11.2 12.9 14.2 16.1 18. 19.1 19.2 21.7
Clinda R 0 1.7 1.3 2.5 3.6 5.2 4.4 5.5 5.8 6.6 7.3 8.1 8.2 8.6 8.4
T/S R 3.8 4.7 9.7 12.6 14.6 12.3 12.0 11.3 11.9 13.1 13.4 13.4 12.2 11.8 10.6
Tet R 1.4 2.3 3.4 2.5 6.4 9.1 7.1 5.5 9.1 9.9 9.8 10.9 10.4 11.3 12.3
Ceftrx R(M) 0 0.2 0.1 0.7 1.3 2.5 1.5 2.0 2.4 1.5 1.8 2.5 1.9 3.7 2.5
Ceftrx R(NM) 0 0.4 0 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.2 0.2
Cipro R 0.5 0.8 0.7 0.8 1.8 1.8 1.7 1.4 2.4 2.7 1.6 2.1 2.4 2.7 1.7
Levo R 0 0.4 0.1 0.2 0.5 0.3 0.4 0.9 1.3 1.9 1.1 1.5 1.5 1.7 0.8
Moxi R NT NT 0 0 0.3 0.2 0.3 0.4 0.3 0.3 0.3 0.6 0.7 0.9 0.5
Conclusions: We continue to see an increasing trend in rates of
macrolide resistance in Canada. The signiﬁcant increase in b-lactam
resistance recognised in 2006 has stabilised in 2007. Fluoroquinolone
resistance appears to be declining.
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P1752 European survey of macrolide resistance mechanisms among
S. pneumoniae from 2006–2007 and activity of telithromycin
D.J. Farrell, C. Couturier (London, UK; Paris, FR)
Objectives: To determine the activity of telithromycin against macrolide-
resistant strains of Streptococcus pneumoniae from patients with
community-acquired respiratory tract infections (RTIs).
Methods: Isolates were collected between January 2006 and April 2007
in 17 European countries (156 centres) from patients with community-
acquired RTIs either in the community or from those hospitalised for
less than 48 hours. In vitro antibacterial activity and susceptibilities of
S. pneumoniae isolates were determined at a central laboratory using
Clinical and Laboratory Standards Institute methodology and interpretive
criteria. Macrolide resistance genotypes were determined by PCR.
Results: Of the 3026 S. pneumoniae isolates collected, 26.0% were
resistant to macrolides. Macrolide resistance rates varied widely between
countries, ranging from 3.8% in the Netherlands to 52.2% in Italy.
High rates of resistance (>20%) were observed in Belgium, Finland,
France, Hungary, Italy, Poland, the Slovak Republic and Spain. Overall,
the most common macrolide resistance mechanism was erm(B) which
was found in 19.3% of all isolates (74.4% of erythromycin-resistant
S. pneumoniae [ERSP]), while the efﬂux gene mef(A) was found in
5.6% of all isolates (21.2% of ERSP). erm(B) and mef(A) mechanisms
were found together in 0.5% of all isolates (2.0% of ERSP). The erm(B)
gene was the predominant mechanism in all countries except Austria
and the UK, where efﬂux was more prevalent than erm(B). Overall,
99.2% of S. pneumoniae isolates were susceptible to telithromycin. The
susceptibility rates for telithromycin in macrolide-resistant isolates were
95.9% (erm[B]), 99.4% (mef[A]), 100% (erm[B] + mef[A]) and 100%
(ribosomal mutations).
Conclusions: Macrolide resistance remains high across Europe, with
erm(B) being the most common form of resistance. This surveillance
study conﬁrms that telithromycin is active against macrolide-resistant
isolates of S. pneumoniae, irrespective of the macrolide resistance
mechanism.
P1753 Pneumococcal invasive diseases in Slovenia, 2004–2007
M. Paragi, T. Kastrin, M. Cizˇman, J. Kolman, V. Mioc (Ljubljana, SI)
Objectives: Streptococcus pneumoniae (SP) is one of the most frequent
cause of bacterial invasive diseases in children and elderly. In Slovenia
the epidemiologic situation of invasive pneumococcal diseases has
been constantly monitored since 1993 in order to formulate optimal
vaccination strategy.
Methods: Isolates of S. pneumoniae, isolated from blood or CSF of
patients with invasive diseases, were nationally collected. All isolates
were typed with capsular swelling reaction. Antibiotic susceptibility
was determined by disc diffusion test and E-test following the CLSI
recommendations. The results were also interpreted according to the
criteria from the NCCLS standards.
Results: From the year 2004 to October 2007 a total of 685 invasive
isolates of SP were collected. The incidence of pneumococcal invasive
infections was stable (~9.7/100.000), except in the year 2007, where we
observed the increase in incidence among children (from 10.3 in 2004 to
17.8* in 2007). Total resistance by year is presented in Table 1. The most
common serotypes in children were 14, 1, 6B, 4, 23F, 19F and 18C, in
adults 3, 1, 14, 4, 9V, 7F and 23F. The most prevalent serotypes among
penicillin resistant isolates in children were 14 and 9V (76.9%), in adults
14, 9V, 19A and 19F (75.3%). We detected also 9 multiresistant isolates
(PEN, ERY, TMP/SMX) in children (5.5%) and 10 isolates (1.9%) in
adults.
Conclusions: The patterns of resistance and serotypes indicate the
presence of multiresistant clones of SP in Slovenia. To determine these
clones molecular typing has to be done. Nevertheless the prevalent
multiresistant isolates belong to serotypes which are included in 7-valent
conjugated pneumococcal vaccine.
Table 1: Percentage of resistance (I+R) in invasive S. pneumoniae in
Slovenia, 2004–2007*
Year No. PEN CTX
(mening)
ERY TET TMP/SMX CHL
2004 171 27.5 11.7 11.7 7.0 27.0 0
2005 211 12.8 6.2 12.3 6.2 12.3 1.3
2006 155 20.6 5.8 13.5 7.7 18.8 0
2007* 148* 18.9* 4.1* 18.9* 10.8* 20.9* 2.0*
*Data till October 2007. PEN – penicillin, ERY – erythromycin,
CTX – cephotaxime, TET – tetracycline, TMP/SMX – trimethoprim/
sulfamethoxazole, CHL – chloramphenicol.
P1754 Impact of PCV7 on invasive pneumococcal disease in
Scotland
J. Wilson, R. Hill, A. Eastaway (Glasgow, UK)
Objectives: In September 2006, the 7-valent pneumococcal conjugate
vaccine (PCV7) was introduced into the Scottish Routine Childhood
Immunisation Programme with a catch-up campaign to two years of
age. There is a concern that there will be an emergence of serotypes not
contained in the 7-valent vaccine.
This study evaluated the impact of the 7-valent pneumococcal conjugate
vaccine on invasive pneumococcal disease (IPD) in Scotland.
Methods: Health Protection Scotland has routinely collected data on IPD
as part of the European Antimicrobial Resistance Surveillance System
(EARSS) since 2003.
Data collected between October 2004 and September 2007 inclusive were
analysed for this study. Serotype distribution and antimicrobial resistance
was investigated for the following age groups:
• <2 years
• 2–65 years
• >65 years
Results: The total number of cases of IPD in Scotland has decreased
since the introduction of the PCV7 into the Scottish Routine Childhood
Immunisation Programme.
The number of cases in the under two year old population has statistically
signiﬁcantly reduced.
A reduction in the number of cases can also be seen in the over 65 year
population.
There has been an increase in some serotypes not covered by the vaccine.
There were a signiﬁcant number of emergent cases of serotype 35B in the
under two year old population and a signiﬁcant increase in the numbers
of serotype 7F was observed in the sixty ﬁve and over population.
Table 1 shows that susceptibility of Streptococcus pneumoniae to
penicillin, erthromycin and ciproﬂoxacin has increased since the
introduction of PCV7.
Table 1 Antimicrobial susceptibility of Streptococcus pneumoniae
Sep 2004
to
Aug 2005
Sep 2005
to
Aug 2006
Sep 2006
to
Aug 2007
No. of isolates 486 643 646
% penicillin non-susceptible 2.9% 3.3% 1.9%
% erythromycin non-susceptible 11.3% 12.6% 4.2%
% ciproﬂoxacin non-susceptible 2.1% 7.5% 4.0%
Conclusion: The introduction of PCV7 into the routine childhood
vaccination schedule in Scotland has resulted in a decrease of the
incidence of vaccine-serotype IPD, and consequently a fall in the overall
incidence of IPD. A decline in IPD incidence in all age groups, including
those not targeted in the vaccination programme has also been observed.
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This suggests a strong herd community. There has been an increase in
susceptibility to penicillin, erythromycin and ciproﬂoxacin. There has
however been an increase in the numbers of serotypes not covered by
the vaccine which highlights the fact that continued surveillance of IPD
is essential.
P1755 Prevalence of ﬂuoroquinolone resistance and QRDR
mutations in S. pneumoniae in Toronto, Canada, 1995–2006
A.L. McGeer, K. Green, R. Melano, S. Drews, S. Pong-Porter,
A. Plevneshi, D.E. Low on behalf of the Toronto Invasive Bacterial
Diseases Network
Background: The emergence of ﬂuoroquinolone resistance (FQR) in
S. pneumoniae (SP) is a concern. We examined FQ use, FQR and QRDR
mutations in pneumococci in Toronto, Canada.
Methods: From 1995–2006, the Toronto Invasive Bacterial Diseases
Network (TIBDN) collected all sterile site isolates of pneumococci
isolated from residents of Toronto/Peel, CA (pop 4M); from 2002–2006,
all respiratory tract isolates were also collected. Broth microdilution
susceptibility testing to CLSI standards is performed on all isolates,
sequencing of QRDR regions was performed on all FQR isolates, and
a representative sample of FQ susceptible isolates. Popn FQ use was
obtained from IMS Health Canada. Demographic and medical data were
collected for all patients.
Results: From 1995 to 2006, overall FQ use increased from 67
to 94 scripts/1000pop/yr; levoﬂoxacin use increased from 0 to 12.6
scripts/1000pop/yr, and moxiﬂoxacin use increased from 0 to 15.3
scripsts/1000 population per year. 7038/7909 (89%) of case isolates were
available for testing. Ciproﬂoxacin non-susceptibility rates increased
from 0.9% in 1995 to 4.1% in 2002, then decreased to 2.7% in 2006.
Levo R rates increased from 0 in 1995 to 3.0% in 2002, then decreased to
1.8% in 2006. Moxi R rates have increased slowly, to 1.3% in 2005, then
decreased to 1.1% in 2006. In cipro susceptible isolates (MIC< 4), the
prevalence of parC mutations was 18/1053 (1.7%) and the prevalence of
gyrA mutations was 1/1053 (0.09%). The prevalence of parC and gyrA
mutations in isolates with levo MIC< 2ug/ml was 0.6% (18/3058) and
0.03%.(1/3058). The prevalence of parC and gyrA mutations in isolated
with moxi MIC< 0.25ug/ml was 0.5% (14/2952) and 0 (0/2952). There
was no increase over time in the prevalence of mutations in isolates
susceptible to FQ. Isolates mutations in gyrA but not in parC were ﬁrst
detected in 2002 (a single isolate), and remain rare (2 isolates in 2006).
Conclusions: Despite increasing use of FQ antibiotics FQR is stable
or decreasing in Toronto. Isolates with mutations in gyrA and parC
remain very rare in FQ susceptible isolates, Similarly, mutations in gyrA
alone remain exceedingly uncommon, suggesting the moxiﬂoxacin exerts
minimal selective pressure for resistance.
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P1756 Clinical comparison fo the molecular-based BD GeneOhm
Cdiff assay to the cytotoxicity tissue culture assay for the
direct detection of toxin B gene from toxigenic Clostridium
difﬁcile strains in faecal specimens
D. Fuller, R. Buckner, K. Newcomer, E. Davis, T. Davis, P. Lineback,
G. Kolb, S. Allen, D. Blue (Indianapolis, US)
Objectives: The primary objective of this prospective evaluation was
to demonstrate the use of the BD GeneOhm™ Cdiff (BD Diagnostics,
San Diego, CA) real-time Polymerase Chain Reaction (PCR) assay as a
diagnostic test for the detection of toxigenic Clostridium difﬁcile (Cdiff)
strains from faecal specimens. The performance of PCR was compared
to a cytotoxicity reference standard (TechLab®, Blacksburg, VA). The
BD GeneOhm™ Cdiff assay is a qualitative in vitro diagnostic test
performed on the Cepheid SmartCycler® (Cepheid, Sunnyvale, CA), a
random-access real-time PCR instrument. The assay utilizes PCR for
the ampliﬁcation of the toxin B gene (tcdB) and ﬂuorogenic target-
speciﬁc hybridisation probes for the detection of the ampliﬁed DNA.
The ampliﬁcation, detection and interpretation of the signals are done
automatically by the SmartCycler® software.
Methods: Liquid to soft stools received in the clinical laboratory for
Cdiff testing were included in the evaluation. Brieﬂy, stools were tested
with the TechLab Cdiff chek™-60 enzyme immunoassay (EIA) for
detection of the “common antigen”, glutamate dehydrogenase (GDH),
and positive results were conﬁrmed with the Tox A/B assay. If the
Tox A/B was negative, a cytotoxicity neutralisation assay was also
performed. Concurrently, the BD GeneOhm™ PCR assay was also
performed on each stool specimen. Additional test methods (culture,
cytotoxin/neutralisation testing) were also performed on discordant
specimens to aid in resolving discrepancies. Each stool was collected,
processed, and tested according to the institution’s standard of care and
each assay was performed according to manufacturer’s package insert.
Results: Of the 298 specimens included in this study, 247 (83%) tested
negative with both PCR and cytotoxicity while 29 (10%) tested positive
with both assays yielding 90.6% sensitivity and 92.9% speciﬁcity. After
resolution of discordant results, the sensitivity and speciﬁcity was 93.6%
and 98.4% respectively with a prevalence of nearly 15%.
Conclusions: The diagnosis of toxigenic C. difﬁcile is usually done by a
combination of cytotoxicity assay, culture and EIA, all of which are either
labor intensive and time-consuming or lack sensitivity or speciﬁcity. The
BD GeneOhm™ Cdiff assay (performed directly on stool specimens)
offers sensitivity and speciﬁcity that is comparable to the cytotoxicity
references standard and produces results in about one hour.
P1757 Comparison of an eSwab to a traditional swab for screening
patients for Staphylococcus aureus colonisation by culture
and by GeneOhm™ MRSA assay
C. Fontana, M. Favaro, P. Martora, F. Demin, P. Nardi, G. Pellegrino,
C. Favalli (Rome, IT)
Objectives: S.aureus (SA) meticillin-resistant (MR) and-susceptible
(MS), cause healthcare- and community-associated infections. The
objective was to compare the performance of a Copan eSwab (a ﬂocked
swab in Amies liquid) to their conventional swab (wound swab in Stuart
medium) for S. aureus using culture and BD GeneOhm™ MRSA (GO)
(Becton & Dickinson) assay and to determine the prevalence of MRSA
and MSSA in Cardiac Surgical Ward of our hospital.
Methods: Two nasal swabs were collected from 171 patients when
admitted to the surgical ward. The traditional swab was processed for
culture only; the eSwab was used for culture and the GO assay. All
cultures were read at 24 h and 48 h. Biochemical identiﬁcation and
antimicrobial susceptibility testing of the isolates were performed using
VITEK2 (bioMerie´ux).
Results: Of the 171 patients 35 (20.46%) had MSSA and 3 (1.75%) had
MRSA isolated. All the MRSA were also identiﬁed by culture methods.
In addition, culture identiﬁed 35 MSSA isolates. All the antimicrobial
susceptibility testing performed on the isolates conﬁrmed either the
negative- or the positive-results of the GO assay. The eSwab samples
had 1 to 2 logs of colony counts (CFU/ml) more than the traditional
swabs.
Conclusion: The Copan eSwab can be used for both culture and
molecular testing and provide a greater number of colonies. The GO
is revealed to be a reliable and efﬁcient assays. The combination of
molecular methods with culture can improve turn around time by 24–40
hours.
P1758 Rapid detection of meticillin-resistant Staphylococcus
aureus directly from swab culture using EVIGENE
K.G. Madsen, T.P. Larsen, A.K.I. Rasmussen (Vedbaek, DK)
Background: Meticillin-resistant Staphylococcus aureus (MRSA) is
a challenging nosocomial pathogen due to its associated morbidity,
mortality, and healthcare costs. Therefore, rapid identiﬁcation of MRSA
carriers is essential for implementation of infection control to prevent
spreading. The aim of the study was to evaluate the diagnostic
S512 18th ECCMID, Posters
performance of parallel testing in S. aureus EVIGENE and mecA
EVIGENE on swab cultures.
Method: 243 swabs from nares (77), throat (63), axil (30), perineum
(28), inguen (11), wound (9), and other sites (25) were collected at Herlev
Hospital, Denmark, and inoculated into salt-enriched semi-selective
nutrient broth. After 18–24 hours incubation one aliquot was subcultured
onto MRSA-ID agar and another aliquot (1.5 mL) was tested directly
with both S.aureus EVIGENE and mecA EVIGENE.
Presumptive MRSA isolates on MRSA-ID agar plate were conﬁrmed by
colony morphology, coagulase test, cefoxitine-disc-diffusion and mecA
PCR. Presumptive MRSA result found after directly testing swab cultures
in EVIGENE were subcultured and isolates were re-tested in S.aureus
EVIGENE and mecA EVIGENE as conﬁrmation.
Results: Parallel testing in S.aureus EVIGENE and mecA EVIGENE
showed 100% (218/218) speciﬁcity for all swab samples. Parallel testing
in S.aureus EVIGENE and mecA EVIGENE gave no false positive
result due to mixture of methicilllin-susceptible S.aureus (MSSA)
and meticillin-resistant coagulase-negative staphylococci (MR-CNS).
Sensitivity was 100% (7/7) on nasal swabs, 100% (3/3) on wound swabs,
100% (2/2) on inguen swabs, 73% (8/11) on throat swabs, and 0% (0/1)
on cikatrice and 0% (0/1) mouth swabs.
Conclusion: Presumptive MRSA results from parallel EVIGENE testing
(S. aureus EVIGENE and mecA EVIGENE) on swab cultures were
available one day earlier than presumptive results obtained from MRSA-
ID agar plates (24 h).
MRSA conﬁrmation results by S.aureus EVIGENE and mecA EVI-
GENE were available one day earlier than results obtained by MRSA-
ID agar plates + disc-diffusion + mecA PCR. Another, advantage of
EVIGENE is that swab cultures and isolates can be tested in the same
run.
P1759 Development of a electrical biochip-based detection system
for rapid detection of meticillin-resistant Staphylococcus
aureus
K. Steinhauer, A. Hofmann, B. Elsholz, R. Wo¨rl, L. Blohm, R. Hintsche,
P. Goroncy-Bermes, P. Oltmanns (Norderstedt, Itzehoe, DE)
Objectives: Meticillin-resistant Staphylococcus aureus is one of the
most important pathogens causing nosocomial infections. Screening
and rapid identiﬁcation of patients carrying MRSA on submission to
the hospital can thus signiﬁcantly reduce the risk of future outbreaks
and nosocomial infections caused by MRSA. The aim of our study
was therefore, to develop a rapid and portable detection-system, which
enables the rapid screening of patients for MRSA, and to demonstrate
its use by testing clinical MRSA-isolates of epidemiological relevance,
as well as challenging the detection system with clinical isolates,
including coagulase-negative Staphylococcus-isolates. Performance of
the system was compared to the PCR-based, commercially available
MRSA-detection system GeneXpert.
Methods: The electrical biochip-based detection system comprises of
a PCR-ampliﬁcation step, targeting the SCCmec and orfX elements.
Detection is achieved via a hybridisation reaction on the biochip and
data are subsequently detected by generation of an electrical signal.
For the performance test, 29 MRSA-strains of epidemiological relevance
were tested. Furthermore, 20 clinical isolates including coagulase-
negative Staphylococci were analysed. All isolates were also checked
by conventional PCR targeting mecA and nuc, and by cultivation on
MRSA-Ident agar. Analysis of the strains by the GeneXpert was done
according to the manufacturers instructions.
Results: With the electrical Biochip-based detection system time for
analysis of MRSA could be reduced to a total of 35 min. This is
signiﬁcantly shorter, as compared to culture-based techniques as well
as to currently commercially available rapid detection systems on the
market, which take between 5 hrs to 75 min. for analysis of MRSA.
Analysis of the 29 MRSA-strains resulted in 28 correct ID’s. Analysis
of the 20 clinical isolates, including coagulase-negative Staphylococci
resulted in 14 correct ID’s. Similar results were obtained when using the
GeneXpert MRSA-detection system for analysis, resulting in 29 correct
ID’s for the tested MRSA-strains and 14 correct ID’s when analysing the
clinical isolates including coagulase-negative Staphylococci.
Conclusion: These data demonstrates, that with the newly developed
electrical Biochip-detection system analysis of MRSA can be achieved
within only 35 min. Furthermore, the reliability of the system has been
demonstrated to be comparable to the commercially available, PCR-
based GeneXpert-System.
P1760 Microbiological evaluation of a new growth-based approach
designated for rapid detection of meticillin-resistant
Staphylococcus aureus directly from specimens
C. von Eiff, D. Maas, G. Sander, A. Eggemann, A.W. Friedrich,
K. Becker (Mu¨nster, DE)
Background: Active screening and compliance to appropriate infection
control activities have been shown to play an important role in the control
of meticillin-resistant Staphylococcus aureus (MRSA). Rapid diagnostic
tests make these efforts even more effective. Thus, infection prevention
has taken a step forward with the introduction of various tests for rapid
identiﬁcation of MRSA carriers. To evaluate the reliability of a new rapid
screening tool, the 3M™ BacLite™ Rapid MRSA Test, to successfully
detect MRSA strains, a well-characterized S. aureus strain collection was
tested in this study.
Material and Methods: All staphylococcal strains were freshly isolated
from clinical material at the University of Mu¨nster or during the course
of various German multicentre studies. In total, the 724 S. aureus
strains tested comprised 211 meticillin-susceptible S. aureus (MSSA)
and 513 MRSA strains. To determine the clonal lineages of MRSA
strains, spa typing was performed as previously described. spa clonal
complexes were assigned by using the BURP algorithm. The 3M™
BacLite™ Rapid MRSA Test, that is utilising growth methodology
and provides results within ﬁve hours, was used according to the
instructions of the manufacturer. Ten microliters of each prepared
bacterial suspension (McFarland standard 0.5) was directly transferred
into each vial containing the selective broth.
Results: All 513 MRSA strains tested were recognised as MRSA,
while none of the 211 MSSA strains was detected positive. These
results are particularly impressive as the MRSA strains used in this
study, represent more than 90 different spa types covering >90% of all
registered European MRSA spa types within the SeqNet network. Beside
several singletons, the MRSA enrolled in this study were grouped into
eight spa clonal complexes. Thus, a very large number of MRSA strains
with different genetic background were recognised as MRSA using this
method.
Conclusions: The new growth based rapid MRSA assay was shown to
detect without exception all MRSA strains of large collections of strains
comprising highly diverse genetic backgrounds. Such a phenotypic test
might be potentially more likely to cope with new strains. Further studies
are warranted to evaluate this method using clinical specimens.
P1761 Speciﬁc identiﬁcation of Staphylococcus aureus using the
extracellular adherence protein gene as a novel target
K. Becker, M. Hussain, B. Sinha, I. Joost, M. Herrmann, G. Peters,
C. von Eiff (Mu¨nster, Wurzburg, Homburg/Saar, DE)
Objectives: The widely used diagnostic assays based on biochemical
or immunologic reactions to identify the species Staphylococcus aureus
present various problems including unsatisfying sensitivity, speciﬁcity,
and assay time. Here, the cell surface-associated extracellular adherence
protein (Eap) – mediating adherence of S. aureus to host extracellular
matrix components and inhibiting inﬂammation, wound healing and
angiogenesis – was analysed as target for S. aureus identiﬁcation
purposes. The feasibility of an eap-based approach was systematically
analysed on genomic, transcriptional and protein levels using a large
collection of S. aureus and non-S. aureus staphylococcal isolates.
Methods: A well-characterized collection of S. aureus (n = 597) and
non-S. aureus staphylococcal isolates (n = 216) comprising human and
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veterinary isolates from different European and non-European countries
was tested for the presence of the Eap-encoding gene (eap) by PCR. In
addition, Western and Northern blot analyses were performed. Clinical
isolates were identiﬁed on species level using biochemical test kits. If the
identiﬁcation was ambiguous or categorised as unacceptable, universal
target gene sequencing (16S rRNA, rpoB) was performed. PCR assays
for detection of S. aureus and S. intermedius speciﬁc nuc genes were
applied to conﬁrm the identiﬁcation of both species.
Results: Due to the polymorphism of the eap gene, novel PCR
oligonucleotide primers for diagnostic purposes were designed. While all
S. aureus isolates were eap-positive using the newly designed primers,
this gene was not detected in non-S. aureus staphylococci comprising 47
different species and subspecies of coagulase-negative staphylococci and
non-aureus coagulase positive/variable staphylococci. Furthermore, none
of the non-S. aureus isolates expressed EAP homologs on transcriptional
and protein levels. Based on these data, the sensitivity and speciﬁcity of
the newly developed PCR targeting the eap gene were both 100%.
Conclusion: Eap was shown to be a virulence factor speciﬁcally
restricted to S. aureus, occurring in all isolates of this species tested.
Thus, Eap seems to be a core trait of S. aureus, offering a promising
tool particularly suitable for molecular diagnostics of this pathogen.
P1762 Screening practices for detection of MRSA-carriers in
Belgian acute care hospitals and nursing homes, 2006
B. Jans, C. Suetens, M. Struelens (Brussels, BE)
In Belgium, national guidelines for the prevention and control of MRSA
are available since 1993 (updated: 2003) for hospitals and since 2005
for nursing homes (NH). In 2006, a nation-wide survey measured the
implementation of these guidelines in both types of facilities.
Aims and methodology: All acute care hospitals (n = 201) and high care
NHs (n = 986) in Belgium received a care type speciﬁc questionnaire,
investigating the implemented measures for MRSA prevention and
control. Several topics were examined: antibiotic policy, hand hygiene,
isolation, additional precautions and screening and decontamination of
reservoirs. This abstract reports the results of the implemented screening
practices.
Results: A total of 131 hospitals (65%) and 484 NHs (49%) completed
the questionnaire.
In hospitals, 95% performed “target” screening, 2% screened all patients
and 4% never screened. Target screening was done after transfer
from ICU (88%) and from geriatric (52%), surgical (23%) or medical
wards (16%). Target screening at hospital admission was also performed
for patients coming from NHs (99%), from another hospital (79%)
or from a foreign country (26%). All respondents carried out nasal
screening: 4% only nasal, 87% nasal combined with other sites. The
combined screening of nose, throat and at least one skin site (axilla, groin
or perineum) was performed by 42% of the hospitals. Rectal screening
was done by 7%. Screening of the nursing staff was only carried out
in epidemic situations (41%) or in speciﬁc situations: known carriers,
personnel at risk, etc (13%).
Among NHs, 15% never screened residents. Screening at readmission
after hospitalisation was performed by 47% of the NHs when no transfer
document was available. When the transferring hospital mentioned
that MRSA was isolated during hospitalisation, 66% of the NHs
always screened and an additional 10% only if the resident was not
decontaminated. Intermediate MRSA screening based on a combination
of risk factors (3 of 4: high care dependency, presence of wound/catheter,
use of antibiotics in previous month and known MRSA carriage) was
done by 52%. At least 85% of the NH did nasal screening and 42%
always sampled the classic ‘nose-throat-skin”.
Conclusion: Hospitals have a longer experience with screening practices
and are more ‘target’ minded. In NHs, standardisation of screening
practices is required. The use of transfer documents between hospitals
and NHs should be optimised.
P1763 Prediction of pre-operative nasal carriage of meticillin-
resistant Staphylococcus aureus in an outpatient evaluation
clinic by using a simple questionnaire
A.M.R.F.R. Schuermans, R. Nuyttens, E. Vandermeulen, I. Degeest,
V. Cossey (Leuven, BE)
Objectives: To develop a questionnaire based on known risk factors for
nasal carriage of Meticillin resistant Staphylococcus aureus (MRSA) and
to test this instrument for sensitivity, speciﬁcity positive predictive value
(PPV) and negative predictive value (NPV) in a preoperative outpatient
evaluation clinic at the University Hospitals Leuven. This questionnaire
would allow a more selective screening for MRSA carriage, the recovery
rate of the systematic nasal screening for MRSA being only 1.36% at
that moment.
Methods: As a standard of care, all patients presenting at the
preoperative outpatient clinic are screened for nasal carriage of MRSA. A
questionnaire including 7 questions (prior hospitalisation in the last year,
resident of a long term care facility, antibiotic use in the last 6 months,
presence of a chronic wound, presence of diabetes, healthcare worker
or professional contact with animals and prior carriage of MRSA?) was
developed.
During February 2007, all patients were asked to answer the
questionnaire. Sensitivity, speciﬁcity, PPV, NPV, and likelihood ratio of
a positive and negative test result (LR+ and LR−) were calculated, both
when patients answered positive on 1 of the 7 questions (cut-off value
of 1) and on 2 of the 7 questions (cut-off value of 2). No difference was
made between the questions.
Results: 680 patients answered the questionnaire.
At a cut-off value of 1, a sensitivity of 100% and a speciﬁcity of 40%
was measured (PPV 2.2% and NPV 100%, LR+1.6 and LR−0).
By using a cut-off value of 2 instead of 1, the sensitivity dropped to
67% and the speciﬁcity rose to 74% (PPV 3.3% and NPV 99%, LR+2.5
and LR−0.4).
Conclusion: By using a simple questionnaire with a limited number of
questions and a cut-off value of 1, all MRSA positive patients were
identiﬁed and a reduction of 40% of the microbiological analysises
was possible. This reduction in the number of screening samples has
a considerable ﬁnancial impact and no consequences on the recovery
rate of MRSA positive patients in our preoperative outpatient evaluation
clinic.
P1764 Determination of a simple clinical score for screening of
elderly patients at risk for MRSA carriage upon hospital
admission in acute geriatric wards
S. Bettens, D. Schoevaerdts, C. Swine, B. Delaere, Y. Glupczynski
(Yvoir, BE)
Objectives: MRSA transmission is an important public health problem
in acute hospitals as well as in nursing homes and in the community.
Furthermore, MRSA carriage plays an important role in the morbidity
and mortality in the elderly. Screening at risk patients upon admission
in geriatric units appears as a logical approach to prevent the spread of
MRSA to frail elderly patients. We aimed to ﬁnd a simple clinical score
allowing to target accurately patients at higher risk of MRSA carriage
while limiting at the same time both the nursing’s extra-workload as well
as the number of unnecessary laboratory analysis.
Patients and Methods: All consecutive patients admitted in our 27-
bed acute geriatric unit from October 2006 to April 2007 were included
prospectively in the trial. For each admitted patient, informations on
11 potential risk factors met in the literature were collected. Each
risk factor was evaluated by an uni- and multivariate analysis (logistic
regression). MRSA carriage was screened from nose, throat and skin
swabs by conventional microbiological culture methods using selective
chromogenic culture media.
Results: Overall 221 patients were admitted over the study period.
MRSA carriage was observed in 22 patients. 6 of the 11 putative risk
factors were signiﬁcant by univariate analysis: age >86.9y (P = 0.002),
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prior MRSA carriage (P< 0.001), multiple hospitalisations (P< 0.001),
chronic wounds (P< 0.001), prior antibiotherapy (P = 0.003), long-course
catheters (P = 0.005). Following multivariate analysis, only the ﬁrst 5
criteria were retained and we computed the score for each patient (1 point
per risk factor). The medians were 2/5 points (95% IC: 1.40−3.00) for the
MRSA-positive group and 1/5 points (0.00−1.00) for the MRSA-negative
group (P< 0.0001). The sensitivity, speciﬁcity and negative predictive
value were respectively 72.7%, 82.4% and 96.5% (cutoff >1 point; local
prevalence= 10%).
Conclusion: We propose an “easy-to-use” scoring system in order to
help geriatric nursing to target and screen only the patients at higher
risk of MRSA carriage upon hospital admission. Patients with a score
>1 were 12.5 fold more at risk (95% IC 4.56–34.19) than those with less
than 2 points. In this study, the reliance on such a clinical score would
have allowed to screen only 23% of the patients. Although promising,
this simple clinical MRSA scoring system should be further evaluated
in a larger cohort of patients, preferably in the setting of a multicentric
study.
P1765 The value of active surveillance for meticillin-resistant
Staphylococcus aureus in orthopaedic patients
K.Y. Tan, M.S. Lim, L.C. Lee, M.K. Wong, A. Kurup, M.L. Ling
(Singapore, SG)
Objectives: This project aims ﬁrstly, to identify the burden of MRSA
in Orthopaedic patients and secondly, to successfully segregate MRSA
patients from others who were MRSA-free
Method: This project was conducted from March to June 2007 on all
Orthopaedic patients at a 1600-bedded acute tertiary care hospital in
Singapore. In the ﬁrst 2 weeks, all trauma and elective patients were
screened for MRSA. Subsequently only high risk patients were identiﬁed
for active surveillance for MRSA by the following criteria – previously
known MRSA, transfers either from inter-hospital or overseas transfers,
long-term care facility transfers, every 7 days amongst inpatients and
end-stage renal failure patients on dialysis. Nasal swabs were taken and
cultured on chromogenic MRSA agar plate after overnight incubation
at the Diagnostic Bacteriology Laboratory. Besides isolation, MRSA
inpatients were also given antiseptic wash to reduce bioload. MRSA
outpatients listed for surgeries were given mupirocin nasal ointment,
4% chlorhexidine body wash for application prior admission, and
vancomycin surgical prophylaxis. Limited isolation rooms prompted the
creation of MRSA cohorts to segregate patients from those who were
MRSA free.
Result: A total of 367 patients were screened, of whom 32 (8.7%)
were identiﬁed as MRSA colonizers Amongst the high-risk categories,
MRSA was identiﬁed in 9.3% (4/43) of trauma patients, 3.5% (6/170)
elective patients, 4.5% (1/22) same-day admission patients and 11.8%
(9/76) inpatients.. Of signiﬁcant note is the ﬁnding of MRSA acquisition
in 21.4% (12/56) inpatients who stayed longer than 7 days. Physical
segregation of MRSA patients in cohort areas in open wards was difﬁcult
to achieve and maintain.
Conclusion: The study underscored the the value of active surveillance
in highlighting the signiﬁcant burden of MRSA in the Orthopaedic
population in our setting. Hence, we have embarked on implementing in
phases active surveillance as part of our patient care protocol for high-
risk group patients. Detecting MRSA early may facilitate interventions
that may reduce MRSA bioburden, surgical site infections, and cross
transmission.
P1766 An audit of the effectiveness of measures to prevent the
transmission of meticillin-resistant Staphylococcus aureus
within a teaching hospital in the United Kingdom
H. Ludlam, R. Swayne, J. Howard, A. Kearns, K. Gunning,
R. Burnstein, C. Nicholl, N. Brown, M. Farrington, J. Sule, D. Brown
(Cambridge, London, UK)
Objectives: To audit the adherence of Healthcare Workers (HCWs)
within a teaching hospital to local hand hygiene policies and to evaluate
patients’ hand hygiene against the same audit standards.
Methods: The ﬁrst audit standard was that no transmission of meticillin
resistant Staphylococcus aureus (MRSA) should occur from a positive
to a negative site on the patient’s skin or their environment via HCWs’
hands. The second standard was that no transmission of MRSA should
occur via the patient’s own hands. Three units were audited: the neuro-
critical care unit, the medical intensive care unit and the department
of elderly medicine. During a two-hour Observation Period for each of
24 known MRSA-positive patients (eight in each of the three locations)
swabs were taken of the patient’s skin, their environment, and hands
of the attending HCWs. Observations were made of all hand contacts.
MRSA recovered from possible episodes of transmission were typed
by pulsed ﬁeld gel electrophoresis, performed at the Health Protection
Agency Staphylococcal Reference Laboratory.
Results: The ﬁrst audit standard was met in 15 of the 24 Observation
Periods (62.5%), 23 episodes of transmission occurring via HCW hands
in 9 Observation Periods. The second audit standard was met in 22
(91.7%) of the 24 Observation Periods, two episodes of transmission
occurring via patients’ hands in two Observation Periods. For 18 of
the total of 25 episodes of transmission involving either HCWs’ or
patients’ hands, the origin of the MRSA which contaminated the hands
was evident, and the patients’ skin was the most common source.
Conclusion: The audit standard that transmission of MRSA should
not occur via HCWs’ hands was not met in a signiﬁcant proportion
of Observation Periods. However, the audit standard was judged
unnecessarily stringent, as bacterial transmission between surfaces is
difﬁcult to avoid and prevention of transmission is unnecessary for
healthcare procedures representing a negligible hazard to patients. The
same principle should be applied to patients’ hand hygiene. A modiﬁed
approach to HCWs’ hand hygiene is also proposed in the most recent
international guidelines. Revising the audit standard according to these
demonstrates HCW compliance in 22/24 Observation Periods (91.7%).
This audit provides the ﬁrst proof, based on molecular typing, that
MRSA is transmitted via hands of HCW hands, and the ﬁndings also
demonstrate that this is the most important mechanism of transmission.
P1767 Control of meticillin-resistant Staphylococcus aureus in a
higly endemic setting: a 6-year experience in a teaching
hospital in Slovenia
V. Tomic, P. Svetina Sorli, M. Novak (Golnik, SI)
Introduction: Endemic MRSA increases morbidity, length of hospital
stay and hospital costs. In 2002, we introduced a comprehensive infection
control programme (ICP) to reduce the hospital transmission of MRSA
in our 230-bed tertiary care, teaching hospital in Slovenia where MRSA
has become endemic.
Methods: The ICP includes use of alcohol handrub, active surveillance
cultures on admission to identify MRSA carriers, barrier precautions
for patients with MRSA, and eradication (decolonisation) of MRSA
carriage. Selective screening was routinly performed within 72 hours of
hospital admission in all patients with risk factors for MRSA carriage.
Surveillance cultures performed were always obtained from the nose
and throat. Additionally swabs from open wounds (when present), urine
samples (when urinary catheter present >24 hours) or tracheal aspirate
(intubated patients were obtained. MRSA carriers were placed in a single
room, cohorted or at least 1 m between patients’ beds was ensured.
Gloves and gowns were required for all contacts with carriers or their
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environment. Masks were required only when caring for patients with
MRSA in the respiratory tract or wound.
Results: During the 6 years 42946 patients were admitted to our hospital.
Growth of S. aureus was detected from at least 1 specimen in 2411
(0.6%) patients. Of these, 253 (10.5%) were colonised with MRSA;
70.4% were men. Two hundred fourteen MRSA cases (84.6%) were
imported, and 39 (15.4%) were acquired in our hospital. In the ICU
50 MRSA carriers were detected (19.8% all MRSA carriers). Of these,
39 (78%) patients were already colonised on admission, and 11 (22%)
patients acquired MRSA during the stay in our ICU. The proportion of
MRSA cases acquired in our hospital declined from 35% in 2001 to
6.1% in 2002, whereas proportion of imported MRSA cases increased
from 65% to 93.9%. From 2003 to 2006 the proportions of MRSA cases
acquired in our hospital were 18.3%, 16.7%, 6.0, and 5.7%, respectively.
Patients with imported MRSA carriage (214 cases) were transfered from
other hospitals (30.4%), nursing homes (13.6%), and rehabilitation centre
(0.9%) or were hospitalised at least once in the past 3 years prior to
admission to our hospital (55.1%).
Conclusions: With a comprehensive ICP it is possible to reduce
nosocomial transmissions of MRSA and keep them that way. A two-
year increase in the number of MRSA cases acquired in our hospital
was mainly due to lapses in active surveillance procedures.
P1768 Risk factors for acquisition of meticillin-resistant
Staphylococcus aureus and clonal spread of the isolates in
a medical intensive care unit
E. Alp, M. Yerer, D. Esel, G. Metan, M. Doganay (Kayseri, TR)
Objectives: Meticillin-resistant Staphylococcus aureus (MRSA) is
still commonest pathogen in hospital-acquired infections with high
morbidity and mortality.MRSA colonisation usually precedes infection
and dissemination of microorganism. The aim of this study was to
determine risk factors for the colonisation and infection with MRSA
in medical intensive care unit (MICU) and show the genetic relatedness
of the strains.
Methods: This study was conducted prospectively between 1 December
2004 and 31 January 2006 in MICU. Patients (>16 years) admitted to
the MICU were screened for MRSA on admission (in the ﬁrst 48 hours),
weekly during prolonged ICU stay, and at ICU discharge using anterior
nares, axilla and groin swabs. Patients, stayed shorter than 48 hours and
admitted with MRSA colonisation or infection, were not evaluated for the
risk factors. Also, healthcare-workers (HCWs), close contact with these
patients, were screened for nasal colonisation at the beginning and end of
their ward rotation. Patient data was collected for risk factors evaluation.
Genotyping analysis was performed by pulsed-ﬁeld gel electrophoresis
(PFGE) at the Infectious Disease Laboratory of Hacettepe University.
Results: During the study period, 259 patients were evaluated for the
risk factors of MRSA acquisition. The colonisation rate was 18.5%. The
mean time for MRSA acquisition was 12.7 days (range 4 to 66 days)
after admission. The anterior nares were the most frequent site (87.5%)
of MRSA colonisation. MRSA infection occurred in 15 (31%) of 48
colonised patients. In four patients, MRSA infection developed unless
colonisation was determined. Nasal carriage of MRSA wasn’t detected in
HCWs during study period. In multiple logistic regression analysis, only
length of stay in MICU and mechanical ventilation were the signiﬁcant
risk factors for colonisation. On the other hand, MRSA colonisation and
tracheostomy were the signiﬁcant risk factors for infection. In genotyping
analysis, four clones (clone A, B, C, D) were determined in colonised
patients on admission and also patients colonised in MICU had same
clones (clone A, B, C). Moreover 57% of these clones were clone B.
Conclusion: This study shows the clonal spread of MRSA in an ICU and
supports the results of previously published reports. Despite the efforts to
improve hand hygiene (reminder posters, bedside alcohol-based products,
staff education), the problem emerges because of understafﬁng and high
workload in a developing country.
P1769 Healthcare workers’ knowledge of their patients’
meticillin-resistant Staphylococcus aureus carriage
A.M. Rogues, A.G. Venier, A. Lasheras, H. Boulestreau, A. Diallo,
S. Pereyre-Wassner, C.M. Be´be´ar, J.P. Gachie (Bordeaux, FR)
Objective: To assess the knowledge of healthcare workers (HCWs)
knowledge of their patient’s meticillin-resistant Staphylococcus aureus
carriage in our hospital.
Method: Since 1999, a repeated prospective survey has been conducted
in the teaching hospital of Bordeaux. In this 3,500 beds hospital, the
infection control (IC) team daily receives a copy of the laboratory
examination results when MRSA is identiﬁed. For 13 weeks per year,
IC nurses systematically go to the unit where a patient is notiﬁed as
carrying MRSA, they complete a questionnaire by face to face interview
with the ﬁrst HCW they meet regarding his/her knowledge of the
carriage and record barriers precautions taken (alcohol-based handrub
solution, nonsterile disposable medical gloves and gowns placed close
by MRSA-positive patient). The change over the time of percentage was
studied with the chi-square test for trend (P 0.05 was considered to be
signiﬁcant).
Results: Total percentage of patients’ MRSA carriage knowledge by
HCWs increased signiﬁcantly from 33% in 1999 to 76% in 2006. This
gradual increase concerned all kind of wards. However, knowledge in
the medical wards was always lower than in surgical or intensive care
units (medicine wards: increase 34 to 61%, surgical wards: 29 to 81%,
intensive care units 29 to 78%). Between 1999 and 2006, the frequency
of barriers precautions increased gradually and concurrently with the
knowledge of MRSA carriage from 74% to 94%. Furthermore, the
proportion of MRSA acquired in our hospital decreased from 77% in
1999 to 62% in 2006, represented a decrease of more than 50% in
nosocomial MSRA acquired during the annual study period (1.10 to
0.46 acquired SARM per 1,000 patient-days). In 2006, percentage of
knowledge of MRSA carriage was higher for hospital acquired MRSA
than for hospital imported MRSA (76% vs 65%; p< 0.02).
Conclusion: Knowledge of MRSA carriage by all HCWs is crucial for
the implementation of infection control measures in hospitals, lack of
information delays appropriate isolation measures. We have to improve
interHCWs communication about patient carriage of MRSA. This kind
of repeated active intervention is essential in infection control strategies
against the spread of MRSA. Furthermore, it could help to identify
units that should beneﬁt from focused interventions to improve isolation
practices.
P1770 Factors inﬂuencing the success or failure of meticillin-
resistant Staphylococcus aureus decolonisation protocols
D.F. Gilpin, S. Small, P. Kearney, A. Gardiner, M. Tunney (Belfast,
Antrim, UK)
Objectives: Meticillin resistant Staphylococcus aureus (MRSA) is a
leading cause of nosocomial infection. Colonisation, often the precursor
to infection, can prove difﬁcult to eradicate with many patients remaining
MRSA positive despite repeated attempts at decolonisation. This study
attempts to analyse factors, which may inﬂuence the success or failure of
MRSA decolonisation protocols currently in use in the Northern Health
and Social Care Trust in Northern Ireland.
Methods: Restriction enzyme digestion (SmaI), followed by PFGE was
used to identify strain differences in isolates from successfully and
unsuccessfully decolonised patients. Successfully decolonised patients
are currently being re-screened at 6 and 12 months. If positive, PFGE
will be used to determine whether the patient has been persistently
colonised with the same strain, or has been re-colonised with a new
strain. Determination of the susceptibilities of the isolates to mupirocin
was determined using E-test™.
Results: To date, 296 patients have been recruited to the study, of
which 127 have been removed due to death, a worsening of their
underlying medical condition or non-compliance. Sixty patients have
failed decolonisation. In almost all patients examined, identical MRSA
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isolates were observed before and after decolonisation. However, in
a few cases, a different MRSA strain was isolated before and after
decolonisation, suggesting that the patient may have been re-colonised
with a second MRSA strain. Eighty-one patients were successfully
decolonised, of which 31 have been re-screened at 6 or 12 months.
Of these, ten patients were found to be MRSA positive, in some cases
with a different strain. The susceptibilities of isolates from 42 patients,
who failed decolonisation, to mupirocin were determined by E-test™.
Fifteen patients (35.6%) were found to have MRSA isolates, which
were considered resistant to mupirocin (MIC value >1024mg/L). Patient
medicals histories are currently also being examined
Conclusions: This study has shown that current decolonisation protocols
can in many cases be successful, with a substantial proportion of patients
remaining MRSA negative at 6 and 12 months post decolonisation.
Failure of MRSA decolonisation protocols may be due to several patient
factors (e.g. frequent contact with healthcare providers, movement
between wards or failure to adequately carry out the decolonisation
protocols) or due to the acquisition of mupirocin resistant MRSA.
P1771 Superspreading MRSA in a hospital ward by non-
compliance with hygiene: an agent-based modelling study
L. Temime, P.Y. Boe¨lle, L. Opatowski, Y. Pannet, D. Guillemot (Paris, FR)
Objectives: MRSA colonisation of patients within hospital wards is
largely due to indirect transmission by healthcare workers (HCWs). Here,
we study transmission of MRSA in a hospital ward where HCWs may not
fully comply with hygiene measures such as hand-washing. We examine
whether individual non-compliance can lead to “superspreading” of
MRSA.
Methods: We developed an agent-based model for MRSA transmission
in a hospital ward. The model simulates patients and HCWs in a spatially
explicit description of the ward. MRSA cross-transmission in patients
occurs through HCWs. Two HCW proﬁles are allowed: one with frequent
contacts with a limited number of patients (nurse proﬁle), and the other
with fewer contacts but with more patients (MD proﬁle).
Model parameters include: epidemiological characteristics of MRSA
colonisation in patients (colonisation duration of 15 days before detection
and isolation or treatment) and HCWs (transient colonisation); ward
organisation (mean length of stay of 10 days, HCW daily allocation and
schedule); and compliance with hand hygiene. Values for the parameters
are taken from the literature on MRSA and to reﬂect observations in
hospitals.
Results: In a 20-bed ward with a 1:4 to 1:6 HCW-patient ratio, the
probability of at least one secondary case of MRSA colonisation in
the ward following the introduction of a single colonised patient was
52% [44%-60%] when all HCWs complied with hygiene measures. This
probability increased rapidly with the presence of a few non-compliant
HCWs. In the hypothesis where more than half of the HCWs were non-
compliant, MRSA colonisation persisted in over 85% of cases.
When compliance decreased a little in all HCWs rather than fully in
one HCW, the frequency of secondary colonisations dropped by 10%,
showing the impact of heterogeneity in HCW behaviour for MRSA
transmission.
In simulated epidemics, non compliant HCWs were responsible for a
larger share of between patients transmission events than expected by
chance. For instance, a single non-compliant HCW (representing 6% of
the staff) could be responsible for 13% (for a nurse) to 21% (for a MD)
of MRSA transmissions.
Conclusion: Individual non-compliance with hygiene measures among
HCW can lead to epidemic outbreaks of MRSA colonisation which
would otherwise have been prevented. Importantly, a global reduction
in hand hygiene for all HCWs leads to smaller effects. This suggests
that non-compliant HCWs may actually act as superspreaders in the
hospital.
Clostridium difﬁcile: diagnosis and treatment
P1772 Rapid detection of pathogenic Clostridium difﬁcile strains
and recognition of PCR ribotypes 017 and 027
M. Reijans, B. Mulders, E. Kuijper, G. Simons (Maastricht, Leiden, NL)
Clostridium difﬁcile is the causative agent of antibiotic-associated
diarrhoea and pseudomembranous colitis. Clinical and epidemiological
data suggests that there is an increase in severity, frequency and relapse
of C. difﬁcile-associated disease (CDAD) in Europe and North America
due to hypervirulent PCR ribotype 027 strains. Recently, outbreaks due to
PCR ribotype 017 have also been noticed. Based upon the MultiFinder-
technology we developed a multiplex assay to allow the identiﬁcation of
the new emerging 017 and 027 PCR ribotypes
Method: A set of 34 C. difﬁcile strains with 9 different ribotypes
was screened by Ampliﬁed Fragment Length Polymorphism (AFLP).
Ribotype speciﬁc AFLP fragments were sequenced. BLAST analyses
with these sequences were performed on the genome of C. difﬁcile strain
630 and external primers were designed to amplify speciﬁc fragments
of various PCR ribotypes. These PCR fragments were sequenced and
compared with each other to identify ribotype speciﬁc polymorphisms.
These polymorphisms were used for the design of ribotype speciﬁc
MultiFinder probes.
Results: A set of 34 C. difﬁcile strains with 9 different ribotypes was
screened by AFLP. Twenty four ribotype speciﬁc AFLP fragments were
isolated and sequenced. In total 43 ribotype speciﬁc polymorphisms were
identiﬁed. Speciﬁc MultiFinder probes for PCR ribotype 017, 027 and
a C. difﬁcile universal probe were designed. In addition, probes were
designed to determine the presence of toxins A, B and the binary toxin.
The MLPA probes were subsequently validated on a reference set of 86
C. difﬁcile strains with 22 different PCR ribotypes.
Conclusions: We developed a multiplex assay based upon the
MultiFinder technology which combines the recognition of pathogenic
C. difﬁcile strains by the presence of toxin genes with the speciﬁc
identiﬁcation of PCR ribotypes 017 and 027. The speciﬁc MLPA probes
for ribotype 017, 027 showed no cross reactivity with the other ribotypes.
The assay, which can be performed within 6 hour, allows a fast screening
without special equipment.
P1773 Development and validation of a real-time PCR assay for
detection of toxigenic Clostridium difﬁcile, as part of a
Dutch study on the epidemiology of gastro-enteritis
R.F. de Boer, J. Wijma, T. Schuurman, D.S. Luijt, B. Dijk-Alberts,
A. Ott, A.M.D. Kooistra-Smid, Y.T.H.P. van Duynhoven (Groningen,
Bilthoven, NL)
Objectives: Clostridium difﬁcile is the aetiologic agent responsible for
human diseases ranging from mild diarrhoea to severe pseudomembra-
nous colitis, which are collectively referred to as C. difﬁcile associated
disease (CDAD). The cell cytotoxicity (CT) assay is considered the gold
standard for detection of toxigenic C. difﬁcile. However, this method
is laborious and time-consuming (turn-around time: >48 hours). Rapid
diagnosis of CDAD is important, since it may result in early treatment
and help prevent nosocomial transmission. Therefore, a real-time PCR
based assay was developed and validated. Also, this assay will be used
as a screening tool for a gastro-enteritis study (GEops Study). This study
will commence in May 2008 in 6 hospitals in The Netherlands. Its
primary goal is to assess the incidence, aetiology and course of patients
hospitalised for gastro-enteritis.
Methods: An assay targeting the tcdA and tcdB genes was developed.
Stools were processed with the easyMAG speciﬁc A stool protocol
(bioMe´rieux). The phocine herpes virus-1 was used as internal control.
The selectivity of the assay was validated with a panel of well
characterised C. difﬁcile strains and clinical isolates (n = 50) and non-
C. difﬁcile strains (n = 43). The analytical sensitivity was assessed by
dilution series (n = 3), spiked in a homogenous faecal matrix. Also, the
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assay was compared with the CT assay in a clinical validation performed
on stool samples (n = 163) of patients suspected of CDAD.
Results: The screening assay proved to be speciﬁc for C. difﬁcile as
no cross-reaction was observed. The assay was capable of detecting
approximately 1560 CFU/g of stool with a 100% hit rate. Sixteen PCR
positive and 139 PCR negative samples were in complete concordance
with the CT assay. The PCR was positive in 8 additional samples which
remained negative in the CT assay. One of these 8 samples could be
conﬁrmed as truly positive by CT in a consecutive sample of the same
patient. In comparison with the gold standard (CT) PCR showed 100%
sensitivity, 95% speciﬁcity, 67% positive predictive value, and 100%
negative predictive value. PCR inhibition was observed in less than 1%
of all 163 screened stool samples.
Conclusions:
1. This in-house real-time PCR assay offers a rapid and sensitive method
for the ﬁrst screening for CDAD.
2. The assay will be used as a rapid screening tool for the detection of
C. difﬁcile in the GEops Study that will commence in May 2008.
P1774 Development and validation of a rapid molecular screening
panel for the detection of Clostridium difﬁcile ribotype 027
R.F. de Boer, B. Dijk-Alberts, A. Ott, A.M.D. Kooistra-Smid
(Groningen, NL)
Objectives: Clostridium difﬁcile is the aetiologic agent responsible for
human diseases ranging from mild diarrhoea to severe pseudomembra-
nous colitis, which are collectively referred to as C. difﬁcile associated
disease (CDAD). Since 2002, an epidemic C. difﬁcile clone characterised
as PCR ribotype 027, North American pulsed-ﬁeld type I, and restriction-
endonuclease analysis group type B is associated with higher morbidity
and mortality rates, and increased antimicrobial resistance. Therefore,
rapid identiﬁcation methods for C. difﬁcile ribotype 027 isolates are
needed, since this ribotype requires modiﬁed treatment and hygienic
measures. In this study real-time PCR based typing assays for C. difﬁcile
ribotype 027 were developed and validated.
Methods: We developed typing assays targeting the tcdC gene (delta117
and delta330–347) and the binairy toxin gene (CDTb). Stools were
processed with the easyMAG speciﬁc A stool protocol (bioMe´rieux). The
selectivity of the assays was validated with a panel of well characterised
C. difﬁcile strains and clinical isolates (n = 50, of which 9 were ribotype
027) and non-C. difﬁcile strains (n = 43). The analytical sensitivity was
assessed by a dilution series (n = 1), spiked in a homogenous faecal
matrix. Also, the assays were used in a clinical validation performed on
stool samples (n = 163) of patients suspected of CDAD. Samples were
pre-screened for toxigenic C. difﬁcile with a real-time PCR targeting the
tcdA and tcdB genes. To conﬁrm our typing assays, ribotyping PCR was
performed at Leiden University Medical Centre (LUMC) on all cultured
isolates.
Results: The combined results of the three typing assays proved to be
speciﬁc for C. difﬁcile ribotype 027, as no cross-reaction was observed.
The assays were capable of detecting approximately 3×103, 3×103, and
3×105 CFU/g of stool with a 100% hit rate with the delta117, delta330–
347, and CDTb PCR respectively. Of the 163 clinical stool samples
tested, 24 were positive for C. difﬁcile in the screening PCR (14.7%).
By our typing assays 2 of the 24 C. difﬁcile PCR positive samples were
identiﬁed as C. difﬁcile ribotype 027 (1.2%). Ribotyping PCR performed
on cultured isolates from the same patients conﬁrmed these 2 samples
to contain ribotype 027.
Conclusion: In combination with a C. difﬁcile screening PCR, these in-
house real-time PCR typing assays offer a rapid and sensitive detection
method for C. difﬁcile ribotype 027 directly from stool specimens.
P1775 Rapid detection of hypervirulent Clostridium difﬁcile strains
in a diagnostic microbiological laboratory
J. Antikainen, E. Tarkka, T. Pasanen, M. Vaara, P. Tissari (Helsinki, FI)
Objectives: The spread of hypervirulent Clostridium difﬁcile strains,
especially PCR ribotype 027, is a diagnostic challenge for micro-
biological laboratories. For rapid diagnostic purposes, we developed
a simple one-tube multiplex PCR approach taking advantage of the
virulence-associated markers of the hypervirulent C. difﬁcile ribotype
027. The virulence proﬁle of the C. difﬁcile strains in Finnish patient
samples has not been earlier determined; therefore we characterised the
polymorphism in the tcdC-gene in toxin-positive C. difﬁcile isolates.
Methods: A multiplex-PCR method for simultaneous ampliﬁcation of
C. difﬁcile toxin genes (tcdA, tcdB), binary toxin genes (cdtA, cdtB) and
regulator gene tcdC was developed. With this new method, we analysed
consecutive C. difﬁcile cultivation positive faecal samples during four
weeks in November 2007. Genetic variation in tcdC gene from a
representative set of the samples was analysed by sequencing.
Results: The developed multiplex-PCR method speciﬁcally identiﬁed the
control strains used. From non-027 control strains toxin genes and tcdC
gene were ampliﬁed. From 027 control strains, besides the toxin genes,
also the binary toxin genes were ampliﬁed as well as the tcdC gene,
where 18-bp deletion was clearly detectable. Of the clinical samples
(n = 336), 73 (22%) were binary toxin positive and contained the 18-bp
deletion in tcdC gene. TcdC gene sequencing revealed further mutations
as described by Curry et al., 2007 (J Clin Microbiol 45:215–221). Two
strains contained the 39-bp deletion in tcdC gene representing tcdC
sequence type A as described by Spigaglia and Mastrantonio (J Clin
Microbiol. 2002. 40:3470–3475). One strain with an 18-bp deletion, with
a tcdC sequence corresponding to tcdC type B, and without binary toxin
genes was detected. Two strains contained binary toxin genes and larger
54-bp deletion in tcdC, which has not previously been characterised to
our knowledge.
Conclusion: With this method, we can easily analyse approx. 80
samples in less than six hours. The method proved speciﬁc and sensitive
for identiﬁcation of the C. difﬁcile strains containing virulence genes
associated with e.g. ribotype 027. In addition, we have initiated the
development of a real-time PCR method and examination of the
strains by rep-PCR. The development of rapid and reliable methods
for diagnosis of these new hypervirulent strains may help to control
epidemics caused by them.
P1776 Development of a real-time PCR assay for the detection of
toxigenic Clostridium difﬁcile
E.M. Tyler, E.L. Ziegler, S.R. Visuri (Waukesha, US)
Objectives: Clostridium difﬁcile (C. diff) is a common cause of
nosocomial diarrhoea and incidences of infection have been on the
rise in recent years. Due to increasing incidence, the emergence of a
hypervirulent strain (ribotype 027), and the necessity for a sensitive,
speciﬁc, and rapid test, we designed a Real Time PCR assay along
with an automated extraction method for the detection of toxigenic
C. diff. Typically, EIAs have a rapid turn-around-time but lack in
sensitivity while the tissue culture cytotoxin assay (CTA) is sensitive
and speciﬁc, but takes 24–48 hours to complete. The resultant PCR
assay was retrospectively tested against clinical stool samples previously
determined as positive or negative for C. diff using the Remel ProSpecT
EIA. A second study (in process at the time of abstract submission) was
performed prospectively on clinical stool samples comparing the PCR
assay to the CTA.
Methods: The C. Diff molecular assay utilised the bioMe´rieux Nuclisens
easyMAG for automated nucleic acid extraction. Real Time PCR
using Taqman chemistry was performed on the Cepheid SmartCyclerII.
Speciﬁcity was assessed by testing a variety of organisms that present
the same symptoms as C. diff. The retrospective study analysed 363 stool
samples (176 positive and 187 negative by the EIA). The retrospective
and prospective studies were used to evaluate the clinical performance
of the PCR assay.
Results: The PCR assay detected the Positive Control down to 5 copies
per reaction (Figure 1). The PCR assay did not cross-react with any of
the speciﬁcity organisms tested. Retrospective testing resulted in 164
PCR positive of 176 EIA positive samples and 173 PCR negative of 187
EIA negative samples. Two of the EIA negative samples were inhibited
resulting in an inhibition rate of 0.55%. Twelve of the EIA negative
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samples were positive by PCR and 12 of the EIA positive samples were
negative by PCR. These results led us to perform prospective testing
in comparison to the CTA as false positives and negatives have been
reported when using EIAs for C. diff detection.
Dynamic range of the PCR assay. Positive Control DNA was serially
diluted from 5×109 to 5×10−1 copies/reaction.
Conclusion: We developed a Real Time PCR assay that is sensitive,
speciﬁc, and can be performed in less than 4 hours. With the
increased incidence of C. diff associated disease and the emergence of a
hypervirulent strain, it is imperative that a reliable, accurate, and rapid
test is available to clinical laboratories to aid in diagnosis and treatment
of C. diff.
P1777 Relapsing Clostridium difﬁcile-associated diarrhoea:
predictive value of faecal toxin assay and anti-Clostridium
difﬁcile whey protein to aid prevention of relapses
M. Bauer, S. Numan, E. Kuijper, J.T. Van Dissel (Leiden, NL)
Background: Antibiotic treatment generally is effective to attain
symptomatic recovery in Clostridium difﬁcile-associated diarrhoea
(CDAD), but many patients suffer relapses of diarrhoea. An sIgA-
enriched immune whey (Anti-CD-WPC) made of milk of immunised
cows may reduce CDAD relapse rate; in those who relapse still, the
dose of whey may be insufﬁcient to neutralize completely faecal toxins
in CDAD. Herein, we assess the ability of the standard dose of Anti-
CD-WPC to neutralize faecal toxins, in relation to relapses of CDAD.
Methods, design, patients: Prospective cohort study of Anti-CD-WPC-
40% in 107 epsiodes in 100 consecutive patients with CDAD (cf. Gut
2007;56(6):888). After completion of 10 days of Metronidazole (n = 48),
Vancomycin (n = 56) or both (n = 3), patients received Anti-CD-WPC-
40% 5 g tid for two weeks (Day 1–14), with a follow-up period of 60
days. Outcome measures were the occurrence of relapse CDAD, faeces
C. difﬁcile-toxin (Vidas, BioMerieux) and culture positivity during (on
relapse) and 4 days after completion of Anti-CD-WPC (Day 18).
Results: Eleven of 107 CDAD episodes (~10%) were followed by a
relapse. Seven patients relapsed before day 18: all tested toxin and culture
positive at relapse, despite use of (n = 4) or shortly after (n = 2) the course
of Anti-CD-WPC. An additional 4 patients relapsed between Day 21 and
40. On Day 18, 4 days after completing Anti-CD-WPC, a positive faeces
toxin assay and/or positive C. difﬁcile culture were strongly associated
with risk of subsequent relapse (RR 8.20, 95%-CI 1.04–64; and RR
4.7, 95%-CI 0.5–47, respectively). Moreover, in 18 patients toxin assays
were performed on Day 5−7 while taking Anti-CD-WPC: one of 4 toxin
positive patients relapsed during Anti-CD-WPC, as compared to none
of 14 cases assayed negative.
In an additional 5 CDAD cases, toxin assays were positive during Anti-
CD-WPC-40% but reverted to negative upon doubling the Anti-CD-WPC
dose.
Conclusion: Patients at high risk for CDAD relapse despite taking
immune whey are those still testing positive for faeces toxins while
taking or shortly after stopping Anti-CD-WPC. In these, Anti-CD-WPC-
40% 5 g tid apparently is insufﬁcient to fully neutralize C. difﬁcile toxins.
It should now be investigated whether individually titrating on the basis
of the faeces toxin test the amount (e.g., 5 g Anti-CD-WPC-80% instead
of -40%) or extend the use of Anti-CD-WPC >14 days can increase
further its efﬁcacy to help prevent CDAD relapses.
P1778 Antimicrobial susceptibility patterns of Clostridium difﬁcile
from two tertiary referral trusts within Birmingham, UK
L. Green, T. Worthington, A.C. Hilton, P.A. Lambert (Birmingham, UK)
Objectives: To determine and compare the antibiogram proﬁles of sixty
two clinical isolates of Clostridium difﬁcile recovered from patients
within two tertiary referral Trusts, Birmingham, UK. Antibiogram
proﬁles of C. difﬁcile NCTC 11204 and C. difﬁcile Ribotype 027
(Anaerobic Reference Laboratory, Cardiff) were also determined.
Methods: Minimum Inhibitory Concentrations (MIC) were determined
by agar dilution. Antibiotics tested were: cefotaxime, chloramphenicol,
clindamycin, erythromycin, fusidic acid, imipenem, levoﬂoxacin, line-
zolid, metronidazole, rifampicin, tetracycline and vancomycin. Twenty
four hour cultures of C. difﬁcile grown in Wilkins Chalgren Anaerobe
Broth were adjusted to 107 CFU/ml and 10 microlitres inoculated
onto the surface of the antimicrobial Wilkins Chalgren Anaerobe Agar.
Inoculated plates were incubated anaerobically for 48 hours at 37ºC.
MICs were determined as the lowest concentration where growth was
inhibited. Breakpoints used were pharmalogical non species speciﬁc
breakpoints deﬁned by the Swedish Reference Group for Antibiotics
unless European Committee on Antimicrobial Susceptibility Testing
breakpoints were available.
Results: Varying degrees of resistance was observed against all
antibiotics tested with the exception of vancomycin and metronidazole.
Resistance towards fusidic acid and cefotaxime occurred in 92% and
98% of isolates respectively. Levoﬂoxacin resistance was seen in 89% of
isolates and clindamycin, tetracycline and erythromycin resistance was
78%; 73% and 70% respectively. Resistance among isolates was less
common towards rifampicin (53%), imipenem (41%), chloramphenicol
(20%) and linezolid (2%). Of all the isolates tested only 40% were
sensitive to 6 of the antibiotics. Ninety-three percent of isolates
recovered from one Trust were resistant to 6 of the antibiotics,
compared to those obtained from the second Trust where only 34%
exhibited resistance to 6 of the antibiotics.
Conclusion: Whilst all isolates of C. difﬁcile in this study retained
sensitivity to vancomycin and metronidazole, resistance to other
antibiotics is widespread. Resistance patterns are likely to be governed
by location and antibiotic prescribing policy within individual Trusts.
Furthermore the antibiogram proﬁles obtained highlight phenotypic
differences which may be used potentially to differentiate between strains
and indicate differences at the genetic level.
P1779 An investigation into antibiotic susceptibility and ribotype
proﬁles among community-acquired and hospital-acquired
Clostridium difﬁcile strains isolated in a university teaching
hospital laboratory
F.L. Craig, D.J. Brown, J. Stewart, H. Mather, A.D. Sutherland,
J.E. Coia (Glasgow, UK)
Clostridium difﬁcile associated diarrhoea (CDAD) is associated with
many risk factors, the most signiﬁcant being previous antibiotic
exposure. We currently diagnose C. difﬁcile by toxin detection. Culture,
antibiotic susceptibility testing and ribotyping are reserved for outbreaks
or therapeutic failures.
Objectives: The aim of this study was to determine the susceptibility
of toxin positive C. difﬁcile isolates to Metronidazole, Vancomycin,
Ciproﬂoxacin and Cefotaxime, to correlate this with previous antibiotic
exposure, and to compare antimicrobial sensitivities and ribotypes in
isolates from hospital and community acquired (CA) cases.
Methods: Over a period of 6 months, 200 toxin positive stool samples,
including 24 CA samples, submitted to a large hospital laboratory in
Glasgow were cultured for C. difﬁcile. All isolates were tested for
antimicrobial susceptibility using E-strips (AB Biodisk). PCR-ribotyping
was carried out on a subset of isolates comprising all CA cases and
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time matched hospital cases. Community acquired cases were deﬁned
as showing symptoms within 48 hrs of admission with no history of
hospitalisation in the previous 3 months. Antibiotic history was obtained
from patient records.
Results: C. difﬁcile was isolated from 184 stool samples. All
isolates were sensitive to Metronidazole and Vancomycin. Resistance to
Ciproﬂoxacin was detected in 179 isolates (97.3%) and to Cefotaxime in
173 isolates (94.0%). Four isolates (2.2%) were sensitive to all antibiotics
tested.
Ribotyping results were obtained for 45 isolates. The most common
ribotypes were 106 (29%), 001 (26%), 005 (7%), 014 (7%), and 017
(4%). Most ribotypes were obtained from both hospital and CA cases.
Ribotypes 002 and 027 were only identiﬁed among CA cases, while 078
was identiﬁed among hospital cases.
The ribotype patterns obtained for 6 isolates have yet to be matched with
patterns from the UK database.
Conclusion: There was no correlation between antibiotic susceptibility
and previous antibiotic exposure. The data are still being assessed for
ribotype correlation with antimicrobial susceptibility patterns.
Recent data from Scotland (Mutlu et al, 2007) suggested ribotype 001
was approximately 10 times more common than ribotype 106, however in
the current study this was not the case, and the distribution of ribotypes
001 (26% overall) and 106 (29% overall) are quite similar.
This is the ﬁrst time ribotype 027 has been isolated from the community
in Scotland.
P1780 Antimicrobial susceptibility and molecular epidemiology
of Clostridium difﬁcile (CD) isolated from faecal CD
toxin-positive patients in a UK teaching hospital
M. Clark, K. Levi, S. Soo, K. Towner (Nottingham, UK)
Objectives: Clostridium difﬁcile causes a range of important nosocomial
infections varying from diarrhoea to pseudomembranous colitis, known
collectively as C. difﬁcile-associated disease (CDAD). In Nottingham
University Hospitals NHS Trust there has been an increase in severe
cases of CDAD, which, in turn, has increased morbidity and mortality.
At present CDAD is diagnosed using enzyme immunoassay, but this does
not provide any information on antibiotic susceptibility or epidemiology.
This study aimed to determine the local epidemiology and antimicrobial
susceptibility of C. difﬁcile in Nottingham.
Methods: Between 1 April and 8 June 2006, 100 C. difﬁcile toxin-
positive faecal samples were cultured using the alcohol shock method.
Susceptibilities to metronidazole, vancomycin, cefuroxime, moxiﬂoxacin
and erythromycin were determined using a modiﬁed Stoke’s method, and
the isolates were typed using 16–23S rRNA PCR-ribotyping. Isolates that
were non-UK epidemic ribotypes were examined by PCR for the toxin
A and toxin B genes; isolates that were toxin A-negative were further
examined for deletions in the toxin A gene.
Results: All 100 isolates were metronidazole-sensitive, vancomycin-
sensitive and cefuroxime-resistant. Most (n = 86) isolates were
moxiﬂoxacin-resistant and 82 isolates were erythromycin-resistant. In
total, 61 isolates belonged to ribotype 106, 18 to ribotype 027, seven to
ribotype 001, and 14 to other non-UK epidemic ribotypes. The majority
of the non-UK epidemic ribotypes (11/14) were toxin A-positive and all
were toxin B-positive. PCR ampliﬁcation of the toxin A gene (tcdA)
demonstrated two different deletions in the 3′-end of the tcdA gene.
Conclusion: The predominant local epidemic strain of C. difﬁcile
belonged to ribotype 106. Ciproﬂoxacin, erythromycin and cefuroxime
are commonly prescribed antibiotics in Nottingham, and this antibiotic
policy is likely to be a contributing factor to the selection of antibiotic-
resistant C. difﬁcile ribotypes in Nottingham. There is evidence that the
tcdA-negative isolates detected in this study may have novel deletions
in the tcdA gene, and that these isolates may play a role in the evolving
local epidemiology of CDAD.
P1781 Characterisation of moxiﬂoxacin-resistant Clostridium
difﬁcile mutants selected in vitro
P. Spigaglia, F. Barbanti, P. Mastrantonio (Rome, IT)
Objectives: To perform an analysis of point mutations in the
quinolone resistance-determining region (QRDR) of the DNA gyrase
of Clostridium difﬁcile strains after “in vitro” exposure to increasing
concentrations of moxiﬂoxacin (MX).
Methods: Five MX susceptible C. difﬁcile strains were selected: strain
C253 and 630 (toxinotype 0), strain CD5 (toxinotype V), strain A422
and BI1 (toxinotype III). MIC values for MX were determined using the
Agar Dilution method. The breakpoint used was 8mg/L. Selection of
MX-resistant mutants was performed by growing bacteria on Mueller-
Hinton (MH) plates with twofold increases in concentrations of MX
(from 2 to 32mg/L) for 48 h. Resistant mutants were grown for three
repeated passages on MH plates without MX. The QRDRs of gyrA and
gyrB were ampliﬁed and sequenced.
Results: Before induction, all C. difﬁcile strains had MICs for MX
between 1 and 2mg/L. No strain showed mutations in GyrA or GyrB,
except CD5 that had a mutation in GyrB already described in susceptible
strains. BI1 resistant mutants, isolated from the ﬁrst step of selection
(2mg/L of MX), showed the substitution Arg447 to Lys in GyrB. At the
fourth step (16mg/L of MX) these mutants acquired another mutation
(Asp426 to Asn) in GyrB. MICs of BI1 mutants were comprised between
16 and 32mg/L. C253, 630 and A422 mutants were isolated from
the third step of selection (8mg/L of MX) and showed the substitution
Ala118 to Ser in GyrA, Asp426 to Val in GyrB and Asp81 to Asn
in GyrA, respectively. The third mutation resulted new. MICs of C253
mutants ranged 8–16mg/L, those of 630 mutants were 16mg/L, whereas
MICs of A422 mutants ranged 16–24mg/L. Two different CD5 mutants
were isolated: those from the second step (4mg/L of MX) showed the
new mutation Ala92 to Glu in GyrA, whereas those from the third step
(8mg/L of MX) showed both mutations Ala118 to Ser and Thr82 to Ile
in GyrA. The MICs of the mutants with Ala92 to Glu ranged 4−8mg/L,
whereas those of the mutants with Ala118 to Ser and Thr82 to Ile were
comprised between 16 and 32mg/L.
Conclusion: These results demonstrate that MX is able in vitro to
generate different mutations in both GyrA and B of C. difﬁcile strains.
One or two mutations can be present in the same protein and two new
mutations were identiﬁed in GyrA. The apparent easiness in developing
resistant mutants may explain the circulation of highly resistant strains,
such as C. difﬁcile ribotype 027, in the hospital environment.
P1782 Susceptibility of Clostridium difﬁcile spores to copper
surfaces: the Germination Theory
L.J. Wheeldon, T. Worthington, C.J. Lowden, A.C. Hilton, P.A. Lambert,
T.S.J. Elliott (Birmingham, UK)
Objectives: Over the past decade the number of cases of Clostridium
difﬁcile associated disease has risen signiﬁcantly and C. difﬁcile
is now the leading cause of nosocomial diarrhoea in the UK.
Contributing factors include the persistence of C. difﬁcile spores on
surfaces in the clinical environment, and their resistance to common
antimicrobials. However, it is well recognised that germinating bacterial
spores demonstrate increased susceptibility to many antimicrobials. The
antimicrobial activity of copper surfaces against many microorganisms
is well documented; however there has been no research into the efﬁcacy
of copper against spores of C. difﬁcile. The aim of this investigation was
to determine the antimicrobial activity of copper surfaces on dormant
and germinating spores of C. difﬁcile.
Methods: A controlled carrier test system was designed comprising
inoculation of copper and control stainless steel discs with ten microliters
of a 106 CFU/ml spore suspension of C. difﬁcile NCTC 11204, in aerobic
conditions to simulate the clinical environment. The antimicrobial
efﬁcacy of copper surfaces against dormant spores of C. difﬁcile and
spores exposed to the germinant 1% (w/v) sodium taurocholate was
assessed over a 3 hour period, with sampling every 30 minutes. Each
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sample was neutralised with D/E neutralising broth before culturing onto
Fastidious Anaerobe Agar (containing 0.1% sodium taurocholate).
Results: There was no log reduction in the number of C. difﬁcile spores
recovered from control stainless steel discs, both in the presence and
absence of sodium taurocholate over 3 hours. When spores of C. difﬁcile
NCTC 11204 were exposed to copper, without the incorporation of
sodium taurocholate, there was no log reduction. However, in the
presence of the germinant, there was a 3.54 log reduction (99.9%
reduction) in the number C. difﬁcile spores after 3 hours.
Conclusion: The antimicrobial efﬁcacy of copper surfaces against
germinating spores of C. difﬁcile NCTC 11204 is clearly demonstrated
in this study. Incorporation of copper surfaces and the use of a germinant
solution within the clinical setting may facilitate the reduction of
infection due to C. difﬁcile. Further investigation is warranted.
P1783 Efﬁcacy of faecal therapy for recurrent Clostridium
difﬁcile-associated diarrhoea
E. van Nood, M. Nieuwdorp, H. van Heukelem, C.E. Visser, E.J. Kuijper,
P. Speelman, J.F.W.M. Bartelsman, J.J. Keller (Amsterdam, Leiden, NL)
Objectives: Recurrent Clostridium difﬁcile associated diarrhoea
(CDAD) is an increasing problem partly due to the highly virulent
ribotype 027 strain. Antibiotic therapy for a ﬁrst recurrence of
CDAD fails in approximately 55% of cases. Treatment of subsequent
recurrences is even less successful illustrating an urgent need for more
powerful treatment strategies. We describe our results with faecal therapy
in patients with recurrent CDAD.
Methods: Patients with a proven relapse of CDAD (diarrhoea and
positive ELISA for C. difﬁcile toxin) after at least 2 courses of antibiotic
treatment were included. Patients were pre-treated with vancomycin
500mg qid during 4−7 days followed by bowel lavage with polyethylene
glycol and infusion of donor faeces in the cecum or jejunum. Fresh
donor faeces were donated by healthy relatives of the patients who were
screened for infectious agents (intestinal pathogens and parasites, HIV,
and hepatitis viruses). Donor faeces (150–200 g) were dissolved into
a 400 cc solution with 0.9% saline. After infusion of donor faeces
resolution of diarrhoea and clearance of faecal C. difﬁcile toxin was
assessed.
Results: Eight patients (aged 48–82 years, 5 males and 3 females)
received faecal therapy. Two patients were infected with the ribotype
027 strain. Patients had been treated with antibiotics for CDAD during
a median time of 70 (range 55–139) days prior to faecal therapy,
and isolation precautions were required during a median duration of
80 (range 72–151) days for hospitalised patients (n = 6). In 6 of 8
patients, diarrhoea resolved within 4 days after donor faeces infusion.
In 2 patients, CDAD recurred but a succesful outcome was achieved
with subsequent courses of faecal therapy using another stool donor.
C. difﬁcile toxin test and culture were repeatedly negative after resolution
of diarrhoea in 7 of 8 patients. One treated patient was considered an
asymptomatic carrier with a persistant positive toxin test and culture,
with absence of diarrhoea. One patient died 4 weeks after faecal therapy
due to respiratory failure unrelated to donor stool infusion. One patient
had another episode of CDAD, four months after faecal therapy.
Conclusion: Faecal therapy seems a promising treatment strategy for
recurrent CDAD, also in patients infected with the hypervirulent ribotype
027 strain. A randomised trial to compare the efﬁcacy of faecal therapy
with conventional antibiotics for recurrent CDAD has been initiated.
P1784 In vitro selection of probiotic multispecies against
Clostridium difﬁcile 027
D. Veenendaal, M. Dijkstra, H. Timmerman (Haarlem, Amsterdam, NL)
Clostridium difﬁcile (CD) ribotype 027 is an emerging disease causing
severe outbreaks of diarrhoea in hospitals as wel as the community
in Europe, North America, Canada and Japan. Treatment options for
C. difﬁcile associated diarrhoea (CDAD) consists of preventive and
treatment measures i.e. controlled use of antibiotics, hygiene measures
and treatment with vancomycin or metronidazol. Still mortality (>10%)
and mutiple relapses (>20%) are persisting challenges to overcome.
Sofar probiotics have no place in the treatment or prevention of 027
associated CDAD due tot lack of convincing clinical studies and
severe side effects e.g. the yeast Saccharomyces boulardii. Most of the
clinical studies are carried out with only one or a limited numer of
probiotic strains. Still many lactic acid producing probiotic species like
lactobacilli, biﬁdobacteria and lactococci have found to inhibit CD. We
studied the inhibitory potential of 28 probiotic species against 6 CD
027 and non-027 strains in solid as well as liquid culture. Whereas
all CD strains were equally effected, substantial differences were found
between probiotic strains even within one specie. Probiotic whole cell
cultures (cells + extracellular components) were found to be signiﬁcantly
more effective than extracellular components only. Remarkably no
correlation was found between CD growth inhibition and pH nor the
natural production of lactic acid. Probiotic multispecies were found
more effective against CD 027 in liquid co-cultures as compared tot
singlespecies. Still single probiotic species were found to inhibit toxin
production despite a failure in reducing growth of CD 027. Co-culture
in solid as well as liquid media may be very helpfull in selecting
potential combinations of probiotic multispecies for clinical treatment
or preventive studies against C. difﬁcile.
P1785 Vaccinal strategy against Clostridium difﬁcile associated
disease with surface proteins of C. difﬁcile
S. Pe´chine´, C. Dene`ve-Larrazet, S. Hoys, K. Alkhuder, C. Janoir,
A. Collignon (Chatenay Malabry, FR)
Clostridium difﬁcile is a cause of enteric diseases ranging from
mild diarrhoea to severe pseudomembranous colitis, particularly after
antibiotic treatment. The two toxins A and B are the main virulence
factors. In addition, a number of bacterial virulence factors associated
with adherence to the gut are implicated in the ﬁrst step of pathogenesis,
the colonisation process. Blocking the primary stages of infection,
namely bacterial attachment to host cells and colonisation of the mucosal
surface, may be an effective strategy to prevent C. difﬁcile infection.
Objectives: In this study, using the hamster model of C. difﬁcile
infection, we assessed the immunogenic and protective effect of cell
wall extract of a non toxigenic strain of C. difﬁcile and the protease
Cwp84 used as vaccine antigens for mucosal immunisation.
Methods: Hamsters were divided in three groups immunised respectively
with: PBS for the control group, the recombinant protease Cwp84 for
the second and cell wall extract of a non toxigenic strain of C. difﬁcile
for the last group.
After three immunisations by the rectal route with antigens combined
with Cholera toxin as adjuvant, hamsters received Clindamycine. Then,
ﬁve days later, they were challenged by a toxigenic stain of C. difﬁcile.
Intestinal colonisation and post-challenge survival was followed. For all
groups, animal sera were sampled before and after immunisation for
immunological analysis. Sera of hamsters immunised with the protease
Cwp84 were analysed by ELISA and sera of hamsters immunised with
the cell wall extract were analysed by two-dimensional electrophoresis
coupled with an immunoblot and mass spectrometry in order to reveal
the most immunogenic proteins.
Results: In the two immunised groups, survival was prolonged as
compared to the control group with a statistically signiﬁcant difference.
Enumeration of C. difﬁcile in faecal samples showed that survival
animals were not colonised by C. difﬁcile. As the immune response
analysis is concern, the speciﬁc antibody level observed by ELISA
between the control group and the group immunised by Cwp84 was
not signiﬁcantly different. For the group immunised by cell wall extract,
the most immunogenic proteins observed by immunoblot in the animal
sera were identiﬁed.
Conclusion: These results suggest that mucosal immunisation with
surface proteins could at least partially protect the hamster against
C. difﬁcile infection.
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P1786 The dilemma of reporting culture-positive, toxin-negative
Clostridium difﬁcile results on patients with diarrhoeal stools
J.M. Balada-Llasat, L.V. McFarland, R.A. Miller, J.E. Clarridge III
(Seattle, US)
Objectives: C. difﬁcile (CD) is a major cause of hospital-acquired
diarrhoea. Production of TcdA and/or TcdB toxins is the primary
virulence factor, although the binary toxin CdtB may also be important.
Because strains in our institution are used for epidemiological and
susceptibility studies, both culture and toxin detection are performed.
The purpose of this work was to investigate if tests where toxin was
negative but culture was positive represented C. difﬁcile associated
disease (CDAD) and should be reported as CD positive.
Methods: From strains isolated from specimens submitted for CD testing
from patients with diarrhoeal stools, we selected only those strains
originally culture positive and toxin negative. These CD strains were
ﬁrst screened after subculture to detect TcdA and/or TcdB employing the
ELISA test directly from the colony. If negative, PCR for the detection
of tcdB was performed. Further analysis consisted of detecting cdtB and
typing by pulse ﬁeld gel electrophoresis (PFGE).
Results: During the 2005–2006 period 1891 specimens were processed,
67% were culture−/toxin−, 16% were culture+/toxin+, 6% were
culture−/toxin+ and 11% were culture+/toxin−. Of the 215 strains that
were culture+/toxin−, we assumed that the 135 strains that were positive
for toxin on a prior or subsequent specimen from the same patient would
likely be toxin positive (based on previous work) and were not further
analysed. Of the rest, 68 strains were available for further testing and
40 of these tested toxin positive from the colonies. Of the 28 strains
that were further tested 8 had the tcdB gene (7 were toxinotype O and
one was toxinotype VIII). None of the 20 strains that were tcdB negative
carried the cdtB gene and their PFGE type did not resemble other known
strains. The clinical history of these 20 patients indicated that none had
been treated for CDAD. The clinical history of patients for whom we had
reported CD culture+/toxin− but whose strains were eventually shown
to produce toxin showed more disease and treatment.
Conclusion: Detection of toxin from the colony is helpful but not
as sensitive as molecular methods. Most of the initial culture+/toxin−
reports represented strains that were eventually shown to be toxin
producers. The culture+/toxin− report was important in that it sometimes
predicted a subsequent toxin positive report or was the only positive
result in a patient who had CDAD.
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P1787 Candidaemia in a tertiary hospital: analysis of trends and
mortality
P. Martin-Davila, J. Fortun, A. Belso, J. Luengo, M. Agundez,
M. Alvarez, A. Sanchez-Sousa, E. Loza, S. Moreno (Madrid, ES)
Background: Candidaemia is associated with signiﬁcant mortality and
morbidity.
Methods: Retrospective review of the episodes of candidaemia diag-
nosed from Jan.00 to Dec.05 in our Centre. We include all episodes with,
at least, 1 positive BC yielding Candida sp. Clinical, microbiological
and epidemiological data were obtained and analysed. Candidaemia was
considered nosocomially-acquired (N-A) if the diagnosis was done72 h
after hospital admission (HA) also pts diagnosed after discharge within
60 d of a previous admission.
Results: 146 episodes of candidaemia were identiﬁed. Mean age was
54 yrs-o (2 m-96 yrs-o). Mean time from HA to candidaemia was
27 d (0–150, ±25). 89% were considered N-A. Origin of candidaemia
was catheter-related (CR) in 40%, followed by primary candidaemia(PC)
(30%), urinary tract infection (UTI) (10%) and intrabdominal infection
(IAI) (9%). 51% were C. albicans (CA) and 48% were caused by non-
albicans species (NA-C). 39% were oncohaematologic (OH) patients.
In OH-pts is more frequent N-A spp. (55%). 11% have neutropenia.
Attending to the site of admission:medical wards (42%), ICU (39%),
surgical wards (19%). In CR infection the most frequent isolated was
C. parapsilosis (57.6%). C. albicans was the predominant species in PC
(53.5%), UTI (64%) and IAI (61%). N of episodes of candidaemia per
year has increased (15 cases/yr in 2000 to 32 cases/yr in 2005). The
distribution of CA and NA-C spp. per year remains stable. Mortality
during 1st month was 39%. Mean time from candidaemia to exitus was
11 d (0–30, ±9.1). Mortality rates varies according to the different origin
of candidaemia: CR (32%), PC (44%), UTI (28.6%), IAI (23%).
In univariate analysis of mortality, N-A (p = 0.001), age 50 yrs-
old (p = 0.02), presence of metastatic neoplasia (p = 0.004), shock
(p< 0.001), renal failure (p = 0.005), respiratory failure (p = 0.01) and
receiving antifungal therapy <5 d (p< 0.001) were associated with
mortality.
Conclusions: The number of cases of candidaemia per year is increasing.
The distribution of CA and NA-C spp. remains stable. The most frequent
source of candidaemia was catheter-related. Candidaemia has a high
mortality rate. Age, presence of metastatic neoplasia, shock, renal failure,
respiratory failure and receiving antifungal therapy <5 d was associated
with mortality in univariate analysis.
P1788 Incidence of candidaemia: 5-year results from emerging
infections in patients from the intensive care unit of a
tertiary hospital
S. Cortizo-Vidal, I. Santiago, I. Villamil-Cajoto, L. Rodriguez-Otero,
L. Martinez-Lamas, A. Aguilera-Guirao, C. Garcı´a-Riestra,
A´. Garcı´a-Zaabarte (Santiago de Compostela, ES)
Introduction: The incidence of severe Candida bloodstream infections
(BSI) is rapidly increasing since the 90‘s and it is becoming a major
cause of morbidity and mortality in intensive care unit patients. Candida
species are now the fourth most common cause of hospital-acquired
bloodstream infections. Although the incidence of candidaemia among
previously hospitalised patients increased, recent reports suggest that the
incidence has stabilised.
Objectives: The purpose of this study was to know the incidence and
the tendency of candidaemia during 5 years in an Intensive Care Unit
(ICU) from a tertiary hospital.
Methods: A case of candidaemia was deﬁned as the incident isolation
of Candida spp. from a blood culture. Candidaemia occurring >30 days
after the incident isolation was deﬁned as a new case. To calculate
incidence rates, the numbers of admissions and patient-days were
collected. Incidence rates were calculated as the number of candidaemias
per 1,000 admissions. To compare the tendency of annuals incidences
of candidaemias Chi-square test was performed.
Results:We collected a total of 77 consecutive episodes of Candida BSI
in adults from ICU. Candida albicans was the most prevalent isolated
species (n = 35); the remaining 42 strains were Candida parapsilosis
(n = 29); Candida glabrata (n = 4), Candida tropicalis (n = 2); Candida
krusei (n = 2); Candida guilliermondii (n = 1) and other Candida spp.
(n = 4). The incidence of BSI of Candida albicans rate per 1000
admissions and by year were 2.39, 2.71, 2.87, 2.62 and 3.59; and
other Candida non-albicans 2.39, 4.51, 3.28, 3.37 and 3.59. The overall
incidence of BSI of Candida rate per 1000 admissions was 7.07, (4.78,
7.22, 6.16, 5.99; 7.18). No signiﬁcative diferences were found among
the annual incidence rates of candidaemia in ICU patients: p = 0.8344
(whole candidaemias); p = 0.9453 (Candida albicans) and p = 0.835
(non-albicans Candida).
Conclusions: Although the study period was reduced, the results do not
reveal signiﬁcative changes in the incidence rates of all candidaemia
episodes caused by Candida albicans and non-albicans Candida.
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P1789 Risk factors associated to mortality in intensive care unit
patients with candidaemia
S. Cortizo-Vidal, I. Santiago, I. Villamil-Cajoto, L. Rodriguez-Otero,
C. Varo´n, A. Aguilera-Guirao, C. Garcı´a-Riestra, A´. Garcı´a-Zaabarte
(Santiago de Compostela, ES)
Introduction: After technological and scientiﬁc advances during the last
three decades, invasive fungal infections turned to emerging infections
associated to important morbidity and mortality rates. Medical and
surgical ICUs have become the epicentre of candidaemia.
Objectives: Identify main risk factors associated to mortality in intensive
care unit (ICU) patients with candidaemia in the Complejo Hospitalario
Universitario de Santiago de Compostela in Galicia, Spain.
Methods: We carried out a retrospective study of candidaemia episodes
collected at the Complejo Hospitalario Universitario de Santiago de
Compostela Microbiology Laboratory from January 2000 to December
2005. We selected the candidaemia isolations from the medical and
surgical critical care units. The association study between qualitative
variables has been carried out by means of the chi-square test and
the Fisher exact test. In order to identify predictive variables for
mortality, univariate and multivariate logistic regression models have
been adjusted. The following independent variables were analysed:
sex, abdominal surgery in the last three months, parenteral nutrition,
antifungal treatment, antibiotic treatment, inmunosupresor treatment,
catheterisation, mechanical ventilation, Candida albicans fungaemia and
being more than 65 years old.
Results: During the study, 77 episodes of ICU-acquired candidaemia
were identiﬁed. Mortality rate was 50%, but it was higher in patients with
Candida albicans fungaemia (odds ratio [OR], 3.1; conﬁdence interval
of 95% [CI], 1.2 to 7.9; P< 0.05), in patients older than 65 years ([OR],
4.4; 95% [CI], 1.6 to 11.7; P< 0.05) and in women ([OR], 2.9; 95%
[CI], 1.1 to 7.6; P< 0.05). On the contrary, no signiﬁcant associations
between mortality and the rest of the analysed variables were observed.
Conclusion: Candidaemia was associated with a high mortality rate in
our ICU. The main risk factors associated with mortality were Candida
albicans fungaemia, advanced age and female sex.
P1790 Trends in incidence of candidaemia in ICU: an eight-year
experience
M. Bassetti, L. Nicolini, E. Malfatto, M.P. Molinari, B. Rebesco,
F. Bobbio Pallavicini, G. Orengo, C. Viscoli (Genoa, IT)
Objective: Candida spp. is the most important non-bacterial pathogen
in critically ill patients (pts). The aim of this study is to evaluate trends
in incidence of candidaemia and distribution of C. albicans and non-
albicans over a 8 years period (1999–2007) and to assess its relationship
with ﬂuconazole (ﬂuco) use.
Methods: Cases of candidaemia were retrospectively screened. Fluco
use (in deﬁned daily doses, DDD) and incidence of candidaemia are
expressed per 10000 patients/day for each year of evaluation.
Results: During the 96-month-period a total of 213 episodes of
candidaemia (average incidence 1.42 episodes/10000 pts-day/year, range
0.36−3.02 episodes) were collected in a mixed medical and surgical
ICU in S. Martino Hospital in Italy. C. albicans was the most prevalent
isolated species (n = 98, 46%); the remaining strains (n = 115, 54%) were
non-albicans, more represented by C. parapsilosis (n = 40, 35%) and less
by C. glabrata (n= 28, 25%). The incidence of candidaemia by year and
species and ﬂuco consumption are indicated in the table 1.
Table 1
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
Candidaemia/10,000 pts-day 0.84 1.53 1.79 2.62 3.02 0.36 0.39 0.44 0.37
Candidaemia due to
C. albicans /10,000 pts-day
0.52 1.2 0.6 0.7 0.73 0.15 0.34 0.33 0.37
DDD of ﬂuco /10,000 pts/day 36 44 57 108 86 74 57 63 38
Conclusion: The study showed that the incidence of candidaemia
decreased in the last 4 years of observation. Incidence of candidaemia
due to non-albicans species increased until 2003 and this was apparently
correlated with an increasing use of ﬂuco for prophylaxis. C. albicans
candidaemia remained stable during the eight years. The knowledge
of the local epidemiological trends in Candida spp. isolated in blood
cultures is important to guide therapeutic choices.
P1791 Candidaemia: incidence, risk factors, characteristics, and
outcomes in immunocompetent critically ill patients
K. Vardakas, A. Michalopoulos, K. Kiriakidou, E. Siampli, G. Samonis,
M. Falagas (Athens, Heraklion, GR)
Objective: To determine the risk factors for development of candidaemia
in patients requiring intensive care unit (ICU) treatment for more than
48 h and to study the role of antifungal prophylaxis in the development
and outcome of candidaemia.
Methods: A matched case control study was conducted. Patients
admitted to the medical-surgical ICU who developed candidaemia after
at least 48 h were matched to a control group of ICU patients according to
ﬁve variables: length of ICU stay until development of candidaemia, age,
admission department (medical, surgical and ICU), year of admission
and sex.
Results: Forty-ﬁve patients with candidaemia were enrolled in the
study; 46 yeasts were isolated from blood cultures. The incidence of
candidaemia was 0.6 cases per 1000 patient days. Candida albicans
was the most commonly isolated yeast followed by C. tropicalis. The
risk factors associated with development of candidaemia were Candida
colonisation, duration of mechanical ventilation, GIT surgery, total
parenteral nutrition, absolute lymphocyte count <1000/ml at the day
of the positive blood culture, and diabetes mellitus. In the regression
analysis Candida colonisation and GIT surgery were independently
associated with candidaemia development. Prophylactic administration
of antifungal agents was not associated with better outcomes or non-
albicans candidaemia. ICU and total in-hospital mortality rates were
40% and 66.7%, respectively. Candidaemia related mortality was 20%.
Candidaemia treatment failure was the only variable associated with in-
hospital mortality (p = 0.008).
Conclusions: Candidaemia mainly develops in critically ill patients with
multiple organ failure and end-stage disease and it is associated with
increased morbidity and mortality. Patient populations that may beneﬁt
from preventive measures, including the use of antifungal prophylaxis,
should be further studied.
P1792 Survey of candidaemia in a tertiary care hospital in Greece.
A. Skiada, K. Masgala, L. Chatzihannas, I. Anyfantis, A. Travlos,
I. Stefanou, A. Mitroussia-Ziouva, G.L. Daikos, G. Petrikkos
(Athens, GR)
Objectives: Candida is an important pathogen in the hospital setting.
The aim of this study was to analyse the morbidity and mortality related
to candidaemia in our hospital, as well as to record the isolated species
of the fungus.
Methods: Prospective epidemiological study, in a tertiary care hospital.
The demographic characteristics of all the patients who developed
candidaemia were recorded, as well as the underlying diseases, possible
predisposing factors, such as presence of central venous catheters,
diabetes mellitus, renal failure, etc. The species of Candida isolated
from blood cultures was identiﬁed with Chromagar and API 32C and
sensitivity testing was done with the microdilution method.
Results: The study started in January 2006 and is in progress. We report
the results of the ﬁrst 18 months. During this period 49 episodes of
candidaemia were recorded in 49 patients. Their mean age was 60 years
(range 20 to 90) and 65% of them were male. Twenty-eight were from
the surgical, 2 from the urology and 9 from the medical departments
and 10 from the ICU. One patient (2%) was neutropenic, 35 (71%) had
central venous lines and were receiving parenteral nutrition.
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The isolated species were C. albicans (17), C. parapsilosis (19),
C. glabrata (8), C. sake (1), C. lusitaniae (1), Pichia ohmeri (1)
and C. tropicalis (2). The C. glabrata strains were all, except one,
resistant to ﬂuconazole, two were intermediately and one fully resistant
to voriconazole, while the C. parapsilosis, C. lusitaniae, as well as the
C. albicans strains were susceptible to all antifungals tested, with the
exception of two isolates of C. parapsilosis resistant to caspofungin
and one strain of C. albicans resistant to ﬂuconazole, itraconazole and
voriconazole. In addition, there were three strains of C. parapsilosis
with dose-dependent resistance to ﬂuconazole and two to itraconazole.
The isolate of Pichia ohmeri was resistant to caspofungin and had
dose-dependent resistance to ﬂuconazole and itraconazole. The crude
mortality of the patients who developed candidaemia was 42%.
Conclusions: Non-albicans Candida species are more common than
C. albicans in our hospital and C. parapsilosis is the prevailing species.
The greatest number of cases is recorded in surgical patients and
not in patients with neutropenia or other medical underlying diseases.
Total parenteral nutrition is very common in patients who develop
candidaemia.
P1793 Candidaemia in oncology patients over the past ﬁve years
E. Chinou, P. Ntavlouros, A. Georgouli, H. Skouteli, P. Giannakakos,
P. Golemati (Athens, GR)
Objectives: All cases of candidaemia diagnosed in our department
over the past ﬁve years (2003–2007) were retrospectively analysed to
investigate the isolation and distribution rate of Candida spp. in blood
cultures and to evaluate their antifungal susceptibility.
Methods: Positive blood cultures with BacT/Alert system were
examined microscopically directly for yeasts or pseudoyphae and
subcultured on Sabouraud agar. Candida isolates were screened by germ
tube test and identiﬁed using API 20 CAUX. Antifungal MIC was
performed by using ATB fungus 3 (Biomerieux) and Etest (Biodisk)
on RPMI 1640 for the following antifungal: amphotericin B (AB),
ﬂuorocytosinec (5F), itraconazole (I), ﬂuconazole (F) and voriconazole
(V).
Results: During the study period there were 41 (2.9%) yeast isolates
from a total of 1389 patients exhibiting positive blood culture.
The underlying disease was a solid tumour in 30 patients and an
haematological malignancy in 11 patients. 16 patients were in the ICU
at diagnosis with mechanical ventilation. Previous Candida colonisation
was occurred in 22 patients and central venous catheter in 15 patients.
The causative species were: C. albicans 26 strains (63%). C. tropicalis
6 (14.6%), C. parapsilosis 5 (12%), C.glabatra 2 (4.9%)and C. krusei
2 (4.9%). C. parapsilosis isolated from patients with a central venous
catheter. The 2 patients with C. krusei had haematological malignancy.
Sensitivity rates (%) of C. albicans to all antifungal agents were 100
except to F (80). The MIC of the two strains of C. krusei to AB was
2mg/lit.
Conclusions: Candidaemia in oncology patients is predominantly caused
by C. albicans. The frequency of candidaemia due to Candida non-
albicans is quite high (37%). The highest degree of resistance was
observed to ﬂuconazole while voriconazole was very active against all
species of Candida.
P1794 Epidemiology of nosocomial Candidaemia in a Finnish
tertiary care hospital, 1987–2004
E. Poikonen, O. Lyytika¨inen, V. Anttila, P. Kuusela, P. Koukila-Ka¨hko¨la¨,
P. Ruutu (Vantaa, Helsinki, FI)
Objectives: Nosocomial bloodstream infections (BSI) caused by
Candida sp. (i.e. candidaemia) have been shown to be a growing problem
in the US. In addition to immunocompromised patients, intensive care
and surgical patients are also at risk, mainly because of wide spectrum
antibacterial treatment, invasive monitoring and gastrointestinal surgery.
We studied the changes in epidemiology of candidaemia by assessing the
incidence and outcome of candidaemia as well as causative Candida sp.
in the Helsinki University Central Hospital (HUCH) during 1987–2004.
Methods: HUCH with 1600 beds serves a population of 1.66 million in
Southern Finland. All patients with at least one blood culture positive
for Candida sp. during 1987–1998 were retrospectively identiﬁed from
the laboratory logbooks, and the patient charts were reviewed. During
1999–2004, candidaemia episodes were identiﬁed through prospective
laboratory-based surveillance of nosocomial BSIs, which was carried
out as a part of the Finnish Hospital Infection Program. Centers for
Disease Control and Prevention deﬁnitions for nosocomial BSIs were
used.
Overall incidence of candidaemia per 10,000 patient-days as well as
incidences by Candida sp., Helsinki University Central Hospital, 1987–
2004.
Results: A total of 373 episodes of nosocomial candidaemias were
observed (average annual incidence, 0.40 per 10,000 patient-days; range
by year, 0.27−0.59); no increase in annual incidence was detected (Figure
1). Median age of candidaemia patients was 52 years (range, 0–89 years)
and 59% were male. Most common causative species was C. albicans
(65%), followed by C. parapsilosis (13%), C. glabrata (9%), C. krusei
(5%), C. tropicalis (3%) and others (13%); no increase in proportion
of non-albicans sp. was observed. During 1987–1998, the proportion of
intensive care patients with candidaemia varied between 24–27%, but by
the period of years 1999–2004 it increased to 44%. The increase was
observed in neonatal (15–21%) and surgical (46–55%) patients but not
in patients with haematologic malignancy, whose proportion decreased
(21–11%). Most (68%) patients with candidaemia had central-lines. The
one-month case fatality was 31%; no changes over the six-year periods
were observed (range, 30–32%).
Conclusions: During the 18-year study period, no increasing trend in
the incidence of nosocomial candidaemia was detected and no shift
towards non-albicans sp. occurred. Crude mortality remained high.
The changes in the patients groups at risk may reﬂect differences in
prevention strategies which need to be analysed for further improvement
of prevention.
P1795 Epidemiology, risk factors, and clinical outcome of
candidaemia in a tertiary care hospital in Korea
M.S. Lee, S.Y. Moon, S.M. Moon, J.S. Sohn, H.J. Lee (Seoul, KR)
Objectives: Candida spp. is the fourth most common cause of
bloodstream infections, and C. albicans is the most common species.
However, changes in Candida spp. epidemiology have been reported.
The purpose of this study is to determine the epidemiology, risk factors
and outcome of C. albicans (CAB) and non-albicans BSI (CNAB) in a
tertiary care centre in Korea.
Methods: All inpatient, adult candidaemia cases between 2003 and 2006
were identiﬁed at our centre. Demographic characteristics, risk factors,
time to antifungal agent, and mortality within 30 days of culture were
obtained from retrospective record review.
Results: A total of 300 episodes of candidaemia occurred in 101 patients
over the 4-year period. The distributions of species were as follows:
48 C. albicans, 23 C. tropicalis, 13 C. glabrata, 12 C. parapsilosis,
4 unclassiﬁed spp., and 1 C. krusei. There was signiﬁcant difference
between the incidences of CAB (32.4%) and CNAB (67.6%) in
2006 (p = 0.021). There was no signiﬁcant difference in demographic
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characteristics, risk factors, underlying diseases, time to antifungal
therapy, and clinical outcome between CAB and CNAB. Of 73 (72.3%)
central venous catheters at the culture date, 43 (53.9%) were removed.
Catheter related candidaemia which proven by tip culture was 13 cases.
The 57 (56.4%) of these 101 cases were cultured at ICU. Of 101 patients,
the median age was 66 year (range, 32–86 year); 65.3% were males.
Median length of stay before the ﬁrst positive culture date was 22
days, and APACHE II score at culture date was 18. Antifungal therapy
had been done for 59 patients (58.4%) after median 4 days of culture.
Fluconazole was primarily used in 45 (76.3%) patients, and switched
to amphotericin B (9) as second-line drug. Reasons for absence of
antifungal therapy were: death or hopelessly discharged before culture
result (24), clinical improvement or felt to contamination (13), and
unknown (5). Overall, 52 patients (51.5%) died. Attributable mortality
of candidaemia was signiﬁcantly higher in untreated cases than treated
(59.5% vs. 22.0%, p = 0.002).
Conclusion: Currently CNAB is increasing without speciﬁc risk factors
in our centre. Strategies should be needed to decrease the incidence of
untreated candidaemia, which related with high mortality. Educational
efforts should be also needed to reinforce the clinical signiﬁcance of
candidaemia, early empiric therapy for high-risk patients, and earlier
detection of candidaemia.
P1796 Mortality, hospital stay and costs associated with
candidaemia in major oesophagus, stomach, duodenum and
small and large intestinal procedures
C. Wood, R. Turpin, S. Chandwani, M. Shivaprakash, S. Rajagopalan
(Whitehouse Station, Williamsville, US)
Objectives: To describe the mortality and cost consequences of
candidaemia in major oesophagus, stomach, duodenum and small and
large intestinal procedures.
Methods: The Premier’s Perspective Comparative Database was used
to assess mortality, length of stay (LOS) and costs for all oesophagus,
stomach, duodenum, small and large intestine DRGs between January
2005 and December 2006 in 296 U.S. hospitals. Patients with and without
candidaemia were compared on mortality, APR severity of illness and
risk of mortality subclasses, LOS and costs. Candidaemia was deﬁned
as an ICD-9 discharge diagnosis of 112.5 (disseminated candidaemia).
A General Linear Model (GLM) assessed the effect of candidaemia on
total costs after controlling for confounders. Costs are reported in U.S.
dollars.
Candidaemia
(n = 283)
w/o Candidaemia
(n = 5653)
Mortality 24.0 17.5
APR Risk of mortality subclass
% Mild 0.0 9.0
% Moderate 2.8 14.9
% Severe 18.7 28.3
% Extreme 78.5 47.9
Mean LOS (SD) 37.8 (34.0) 23.5 (19.9)
Mean total cost $ (SD) $78,715 (78,823) $50,667 (45,280)
Mean antifungal cost $ (SD) $3,130 (5,018) $1,221 (2,360)
Results: Caucasian ethnicity and age in the candidaemia and non-
candidaemia groups were signiﬁcantly different (% white = 60.1 & 68.9,
respectively, p = 0.0019; mean age = 67.7 & 65.1 years, p= 0.0037);
there were no signiﬁcant differences in sex (% female = 59.0 & 55.9%).
Candidaemia was associated with a 63.8% increase in the percent of
patients with extreme severity APR risk of mortality, 37.1% greater in-
hospital mortality, 61.2% longer mean LOS, and 55.4% higher total
costs. Anti-fungal drug treatment represents 4.0% and 2.4% of total
costs for patients with and w/o candidaemia, respectively. In unadjusted
analyses, differences in mortality were not statistically signiﬁcant; all
other table differences were signiﬁcant (p< 0.0001). The presence of
candidaemia was associated with a signiﬁcant increase in total costs
($15,727; F = 34.4; p< 0.0001) after controlling for age, ethnicity, APR
severity risk, APR mortality risk and discharge status.
Conclusion: Candidaemia extracts a high toll in LOS and costs; anti-
fungal costs represent a minor portion of the total. This highlights the
importance of improved prevention and treatment of candidaemia in
patients undergoing major oesophagus, stomach, duodenum and small
and large intestinal procedures.
P1797 Relationship between candidaemia and prior colonisation
with Candida species in critically ill adults
J. Troughton, G. Browne, D. McAuley, J. Walker, R. McMullan
(Belfast, UK)
Objectives: Pre-emptive antifungal therapy in the critical care setting
is based upon the species and drug susceptibilities of Candida species
isolated from at least 2 non-contiguous skin and mucosal sites of high
risk patients. However the relationship between colonising Candida spp.
and those causing invasive disease is not deﬁnitively established. The
aim of this study was to determine the proportion of patients with
candidaemia who had prior Candida colonisation of 2 non-contiguous
anatomic sites and to describe the species involved.
Methods: Prospectively collected laboratory records of blood cultures
from ICU patients at a University hospital in Belfast were analysed
retrospectively. Patients with Candida spp. cultured from blood in
alternate years from 1999–2007 were selected and data collected on
cultures from non-sterile sites in this cohort. A per-isolate analysis was
conducted.
Results: A total of 49 patients had conﬁrmed candidaemia; since four
of these were mixed candidaemias there were 53 blood isolates, in
total. Overall, for 19 (36%) of the blood isolates, the same species of
Candida was recovered from at least 2 non-sterile non-contiguous sites;
for 18 (34%) of the blood isolates, the same species was recovered
from only one non-sterile site. Sixteen (30%) blood isolates were
recovered from 15 patients who had no Candida spp. recovered from
non-sterile sites. C. glabrata candidaemia was signiﬁcantly less likely
to be preceded by positive non-sterile site cultures than non-glabrata
species (15/18 vs 9/35, p< 0.0001). Moreover, of three patients in whom
there was discordance between blood and non-sterile site isolates all had
C. glabrata candidaemia.
Conclusions: These data suggest that the current pre-emptive prescribing
practice that is widely adopted in ICUs may be inadequate, since almost
two thirds of candidemic patients in this series would not have received
an antifungal drug on this basis alone. Moreover, C. glabrata, which
often exhibits reduced susceptibility to ﬂuconazole, is especially likely
to present with candidaemia without prior colonisation.
P1798 The relationship between Candida species isolated from
non-sterile sites and blood in critically ill adults
J. Troughton, G. Browne, D. McAuley, J. Walker, R. McMullan
(Belfast, UK)
Objectives: Pre-emptive prescribing of antifungal drugs has become a
widespread therapeutic strategy in critically ill adults; antifungal drug
selection is based upon the Candida species isolated from patients’
non-sterile sites and their drug susceptibility. However, few data are
available that convincingly prove a consistent relationship between
isolates recovered from skin and mucosal anatomic sites and those
responsible for invasive disease. The aim of this study was to investigate:
ﬁrstly, whether the species distribution of blood isolates was signiﬁcantly
different to those recovered from non-sterile sites, and, secondly whether
there was a difference in the proportion of ﬂuconazole (fcz) sensitive
isolates between blood and non-sterile sites.
Methods: Prospectively collected laboratory records of blood cultures
and non-sterile site specimens from ICU patients at a University hospital
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in Belfast were analysed retrospectively. Data from alternate years from
1999–2007 were evaluated and included if a Candida sp. had been
cultured. Only the ﬁrst isolate of any species from a given site (non-
sterile site or blood) from each patient was included.
Results: In total, 51 blood cultures and 1002 non-sterile specimens from
927 patients were evaluated. From blood, 51% isolates were C. albicans,
35.3% C. glabrata and 13.7% non-albicans/non-glabrata species. From
non-sterile sites, 79.3% isolates were C. albicans, 10.4% C. glabrata
and 10.4% non-albicans/non-glabrata species. Overall, a signiﬁcantly
higher proportion of Candida spp. from non-sterile sites were C. albicans
compared with blood; and a signiﬁcantly higher proportion of Candida
spp. from blood were C. glabrata compared with non-sterile sites (see
graph). There was no difference in the proportion of non-albicans/
non-glabrata species between blood and non-sterile sites. A signiﬁcantly
greater proportion of isolates from non-sterile sites were fcz-sensitive
compared with blood (p< 0.001).
Conclusions: Candida spp. isolated from non-sterile sites were not
representative of isolates from blood, either in terms of species
distribution or fcz sensitivity. This brings into question the validity of
the premise on which extant pre-emptive prescribing is based.
P1799 Invasive candidiasis, Candida colonisation and antifungal
treatment in intensive care patients after cardiothoracic
surgery
C. Kratzer, S. Tobudic, W. Graninger, A. Lassnigg, A. Vorderwinkler,
H. Fischer, E. Presterl (Vienna, AT)
Objectives: To improve the diagnosis, the timing of diagnostic
procedures and antifungal treatment of invasive Candida infections in
intensive care patients, a prospective surveillance study was performed
at our cardiothoracic intensive care unit (ICU) of the Medical University
of Vienna.
Methods: Patients admitted to the cardiothoracic ICU between
December 2006 and November 2007 were enrolled into the study. Two
times weekly surveillance cultures (n = 2413) of inguinal swabs (17%),
axillary swabs (17%), pharyngeal swabs (17%), urine (14%), nasal
swabs (13%), bronchial lavage (11%), surgical wounds (4%) and anal
swabs (2%) were taken. At each time point material from at least ﬁve
different body sites was analysed for presence of Candida. The Candida
Colonization Index (CI) was calculated for each patient by the number
of Candida positive samples per all samples. Patients were grouped as
follows: no colonisation (CI 0.2; n = 19), colonisation (CI> 0.2< 0.6;
n = 30) and severe colonisation (CI 0.6; n = 36). As risk factors time of
stay on the ICU, number and type of surgeries, sex and age of patients
and start of antifungal treatment were investigated.
Results: A total of 85 patients were enrolled into the study, the
overall mortality was 39.2%. The different types of surgeries included
valve replacement, aortocoronary bypass, heart or lung transplantation,
implantation of left ventricular assist device or artiﬁcial heart with a
mean of 2.1 surgeries per patient. During the ﬁrst four weeks on ICU
Candida albicans was the predominating pathogen (39 to 49% of all
cultures). The percentage of Non-albicans species, particularly Candida
parapsilosis and Candida glabrata increased over time. Sex, age of
patients, the type of surgery and the start of antifungal treatment were no
signiﬁcant risk factors for severe colonisation. A signiﬁcant difference
between colonised and severly colonised patients was detected for the
time of stay on ICU (median= 23 days versus 48 days; p< 0.001) and
the number of surgeries (median= 1.7 versus 2.7; p = 0.02). All patients
who developed Candidaemia (n = 4) were previously severly colonised
with Candida. The mortality rate in multifocal colonised patients was
50%.
Conclusion: Prolonged stay on ICU and number of surgical interventions
>2 predicted for severe colonisation in patients at a cardiothoracic ICU.
Candidaemia was exclusively detected in patients who were previously
severly colonised with Candida.
P1800 Incidence of newer antifungal consumption and incidence
of Candidaemia in an adult intensive care unit
J. Garbino, N. Vernaz, C. Peant, K. Bouchuiguir-Wafa, P. Rohner,
J. Romand (Geneva, CH)
Objectives: A large proportion of nosocomial infections are acquired in
intensive care units (ICU). Candida spp. are the leading non-bacterial
nosocomial pathogens, and candidaemia carries a high risk of mortality
in critically ill patients. Candida spp. are responsible for the majority of
nosocomial fungal infections.
The study objectives were to describe the local epidemiology of
candidaemia in the ICU of a tertiary care hospital, to analyse the
sensitivity of Candida strains to the antifungal compounds and to
describe the consumption of the newer antifungals compounds.
Methods: Hospital medical records of adult patients with candidaemia
were reviewed from January 2000 to December 2006. We analysed the
candidaemia episodes at the adult ICU of the institution. Demographic
information and overall mortality were retrieved. We tested the
susceptibility of Candida strains isolated during the last ﬁve years in
our institution.
Results: A total of 212 episodes of candidaemia occurred in the
institution. 49 (23%) developed in the ICU: 67% in surgical ICU and
33% in medical ICU. The median age of patients with candidaemia
was 54.7 years; 27 (55%) were males. The mortality rate was 39%.
Candida albicans was responsible for 71% (n = 35) of infections acquired
in ICUs. Non-albicans Candida species (29%) were equally distributed
throughout the study period. C. glabrata was identiﬁed in 8 episodes
(16%), followed by C. parapsilosis in 2 (4%), C. tropicalis in 3 (6%),
and unspeciﬁed Candida species in 1 (2%). During the study period no
switch was noted in the distribution of C. albicans and non-albicans
Candida species. The range of candidaemia incidence varied from 0.6
to 3.4 episodes/1000 patients throughout the study period. Most strains
of C. albicans (94%) remained highly sensitive to ﬂuconazole and all the
newer antifungals tested. A decrease of the use of Amphotericin B was
observed. A trend to increase the consumption of the newer antifungal
compounds was observed from 2,200 DDD/year to 3,000 DDD/year.
Conclusion: Fungal infection remains a severe disease associated with
high crude mortality. We observed a variable incidence of candidaemia
during the study period. C. albicans was the most commonly isolated
species. A trend to increase the use of the newer antifungal compounds
consumption was observed but not a decrease in candidaemia incidence.
P1801 Species distribution and resistance proﬁle to antifungal
agents of Candida bloodstream infections in ICU-patients.
Emergence of voriconazole resistance
A. Stylianakis, V. Papaioannou, S. Tsiplakou, E. Pantazis, I. Merianos,
F. Zoumpouloglou, A. Koutsoukou (Athens, GR)
Objectives: To study the Candida species caused fungaemia in ICU-
patients and their in vitro resistance proﬁle to commonly used antifungal
agents.
Methods: during a two year time period (2005–2007) we examined 84
fungal isolates recovered from positive blood cultures of equal numbered
patients hospitalised in the three ICUs of our hospital.
The yeasts were differentiated by using germ-tube test and by the
automated system VITEK2 (Biomerieux, France). Sensitivity testing was
performed by the system Fungus 3 (Biomerieux, France) and conﬁrmed
by the determination of MIC values of the examined antifungal
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agents by E-test strips (AB Biodisk, Solna, Sweden) in accordance to
the manufacturer’s recommendations. MICs were noted after 24 h of
incubation. MICs (mg/L) at which 90% of the strains were inhibited
were 1 for amphotericin B, 32 for 5-ﬂucytosine, 8 for ﬂuconazole and
0.25 for voriconazole.
Results: The more often encountered species was Candida parapsilosis
n = 55 (65.5%), followed by C. albicans n = 17 (20.2%), C. glabrata n = 5
(5.9%), C. famata n = 4 (4.6%), C. lusitaniae n = 2 (2.3%) and C. utilis
n = 1 (1.2%).
No resistance to amphotericin B was observed to any kind of Candida
spp. The resistance level of the examined fungal isolates to ﬂuconazole
was 14.3%, to itraconazole 19% and to 5-ﬂucytosine 51.3%. The second
year two (2.3%) C. albicans isolates were found resistant to voriconazole,
for the ﬁrst time in our hospital and one isolate of C. albicans with
decreased sensitivity (dose-depended) to the same antifungal agent.
Conclusion: The most prevalent isolated species recovered from blood
stream infections of ICU-patients was Candida parapsilosis. Resistance
to voriconazole emerged for the ﬁrst time in our hospital making the
treatment of fungal infections due to C. albicans species, more difﬁcult.
Amphotericin B remains an agent with very good activity for the
treatment of Candida blood stream infections.
P1802 Distribution of Candida species in a neonatal intensive
care unit before and after the introduction of ﬂuconazole
prophylaxis for very low birth-weight babies
D. Farren, J. Walker, D. Sweet, E. McHenry, G. Ong (Belfast, UK)
Objectives: On 1st October 2003, a protocol for administering
prophylactic ﬂuconazole therapy to very low birth weight babies with
identiﬁed risk factors was implemented at our institution. Accordingly,
the potential for this to result in a species-shift towards in ﬂuconazole
resistant species such as C. glabrata and C. krusei merits epidemiological
surveillance. The aim of this study was to investigate whether any species
shift had occurred in association with the protocol.
Methods: Prospectively collected data from the mycology laboratory
records were analysed retrospectively. All Candida isolates from the
Neonatal Intensive Care Unit (NICU) were included in the analysis. Data
from two time periods were compared; the ﬁrst was from 1st October
1999 to 30th September 2003 and the second from 1st October 2003
to 30th September 2007. Isolates from each period were classiﬁed as
“Candida albicans” or “non-albicans Candida” from either “blood” or
“other” sites. Differences observed between the two time periods were
tested for signiﬁcance using Fisher’s exact test.
Results: Prior to the implementation of the protocol there were 93
isolates of Candida. Of these 68 were Candida albicans (16 blood, 52
other sites) and 25 were non-albicans Candida (5 blood and 20 other
sites). After the application of the protocol there were 65 isolates of
Candida; 62 isolates of Candida albicans (13 blood, 49 other sites) and 3
non-albicans Candida (0 blood and 3 other sites). There was a signiﬁcant
trend towards increasing Candida albicans versus non-albicans isolates
from all sites (p = 0.0002). This may be explained by a trend in isolates
from non-sterile sites (p = 0.002); there was no signiﬁcant change in
species distribution of blood isolates (p = 0.1317).
Conclusions: We did not observe an increase in non-albicans Candida
following the implementation of the ﬂuconazole prophylaxis protocol.
In fact, surprisingly, there was a signiﬁcant reduction in the proportion
of non-albicans Candida. Furthermore, there were no isolates of
ﬂuconazole resistant Candida spp. recovered in either four year period.
P1803 Impact of highly active antiretroviral therapy and Candida
spp. oral colonisation in AIDS patients in a Brazilian
tertiary-care university hospital
A.C. Delgado, F.H. Aoki, A. Colombo, R.J. Pedro, M. Resende,
P. Trabasso, M.S. Oliveira, M.L. Moretti (Campinas, Sao Paulo, BR)
Objectives: To evaluate Candida spp. oral colonisation in AIDS patients
under highly active antiretroviral therapy (HAART).
Methods: prospective cohort study of 331 patients assisted in
a University tertiary care hospital. An oral swab was performed
and inoculated in CHROMagar™ Candida. Candida species were
determined using ID32C and serotypes of C. albicans were identiﬁed by
Candida check test. Antifungal susceptibility testing, by microdilution,
was performed in all isolates for 5-FC, azoles, amphotericin B, nistatin.
Clinical and laboratorial data were collected to identify the association
with Candida colonisation. Karyotyping was done in C. albicans isolates.
Results: 161 Candida spp. isolates were detected in 147 (44.4%)
patients and C. albicans represented 137(85%) of the isolates followed
by C. glabrata (29%); C. tropicalis (16.7%); C. norvegensis (12.5%);
C. dubliniensis and C. krusei (8.3%). Seven patients had oral candidiasis
at the moment of sampling the oral cavity. All C. albicans were
susceptible to all the tested antifungal drugs. Among the non-albicans,
six isolates were SDD to ﬂuconazole; nine to itraconazole and seven to
cetoconazol. Azole resistance was not detected. Karyotyping showed
15 different proﬁles in C. albicans serotype A (117strais) and 90%
of C. albicans serotype B (18/20 strains) had the same DNA proﬁle.
The isolation of Candida was signiﬁcantly higher in patients with
detectable viral load (83/147) (p = 0.0002) and CD4+ T-lymphocyte
<200 cells/mm3 (30/83)(p = 0.0003); the median CD4+T cells/mm3
in the colonised group (374.4) was signiﬁcantly lower than the non-
colonized (471.5) (p = 0.003). The incidence of Candida in oral cavity
was not different in patients under HAART with or without protease
inhibitor (PI) (colonized: 78/133; non colonised: 91/170) (p = 0.60)
Conclusion: Oral Candida colonisation in patients under HAART was
associated with low CD4+ T cells/mm3 and failure response to HAART.
Despite PI had in vitro antifungal activity, the use of this class of
antiretroviral did not inﬂuence the presence of Candida in the oral cavity
of AIDS patients.
P1804 Lower saliva ﬂow rates are associated with oral affection
of Candida sp. after radiation therapy
J. Karbach, M. Herzog, K. Ponto, B. Al-Nawas (Mainz, DE)
Objectives: Xerostomia is one of the late side effects of radiation therapy
in patients with head and neck cancer associated with great impairment
of quality of life. Radiation therapy can also predispose to oral candidal
colonisation of the oral mucosa in the immuncompromised patients. This
study was focused on correlation between the total unstimulated saliva
ﬂow rate and the fungal colonisation of the oral cavity.
Methods: In 30 patients who had radiation therapy the unstimulated
saliva ﬂow rate was analysed during ﬁve minutes. According to the
measured rates the results were divided into pronounced xerostomia
(unstimulated whole saliva ﬂow rate = 0.0ml/min), xerostomia
(unstimulated whole saliva ﬂow rate 0.1ml/min) and hyposalivation
(unstimulated whole saliva ﬂow rate >0.1−<0.25ml/min). After deter-
mination of the saliva ﬂow rate 2ml sodium chloride were used to rinse
out the mouth for 20 seconds. Candida colonisation was deﬁned using
sabouraud agar and identiﬁed using API Candida (biomerieux) in the
mouth rinsing water of patients.
Results: Pronounced Xerostomia was detected in 17 patients (median =
106 cfu; range 0−107 cfu), xerostomia in 11 patients (median = 105
cfu; range 0–106 cfu) and hyposalivation in 5 patients (median = 0 cfu;
range 0–106). Spearman’s correlation coefﬁcient was −0.331 (p = 0.06).
In our collective there was no patient having a normal saliva ﬂow
rate. 11 Candida-species were identiﬁed as Candida albicans, 5 as
Candida famata, 4 as Candida glabrata, 1 as Candida tropicalis, 1 as
Candida dubliniensis and 3 as Saccharomyces cerevisiae. In 8 patients
no Candida-species were detected.
Conclusion: Lower saliva ﬂow rates correlate with a higher risk for
Candida affection in patients after radiation therapy.
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P1805 The economic and service impact of invasive candidiasis in
the UK
P. McEwan, C. Morgan, D. Irwin, Y. Asukai, S. Gasper (Cardiff,
London, UK; Chapel Hill, New York, US)
Background: Invasive candidiasis (IC) is a serious nosocomial infection
likely to impact length of stay (LOS) and medical resource use in
hospital. We examined the consequences of acquiring IC on healthcare
resources to estimate their potential burden on the UK healthcare system.
Methods: We utilised data from the UK Clinical Hospital Knowledge
System (CHKS), comprising national hospital inpatient activity and the
Secondary Linked Inpatient to Mortality Dataset (SLIM) comprising the
resident population of Cardiff and the Vale of Glamorgan (population
of 424,000 – 2001 estimate). Patients with a diagnosis of invasive
candidiasis as deﬁned by selected ICD-10 codes (B37.1, B37.5, B37.6,
B37.7, B37.8, B37.9) during 1995–2005 in SLIM and during 2005–
2006 in CHKS were identiﬁed from inpatient admissions. A matched-
pair analysis was performed by selecting control patients without IC
matched on age, gender, primary diagnosis and procedure. LOS, mean
admission costs and mortality were compared to determine the excess
burden of IC.
Results: The majority of admissions had a primary diagnosis other than
IC. From SLIM 275 IC patients were identiﬁed and 241 (96%) of these
with a secondary diagnosis of IC were matched. Patients with a diagnosis
of IC had increased medical resource use: longer mean LOS (13.3 days
vs. 8 days), increased mean admission cost (£1,879 vs. £1,616) and
increased hospital mortality (11% vs. 5%). From CHKS 6,105 (95.1%)
patients with secondary diagnosis of IC were matched to patients without
IC. Again, patients with a diagnosis of IC had increased mean LOS (16.6
vs. 5.6 days), higher mean admission costs (£1,739 vs. £1,531) and
higher in-hospital mortality (11.3% vs. 5.0%). Patients with a diagnosis
of IC who were in the ICU had longer mean overall hospital LOS (40.3 v
20.8 days) and increased mean LOS in ICU compared to non-IC patients
(16.7 days v. 7.5 days).
Conclusions: Patients with IC have overall longer LOS in hospital and
in the ICU compared to patients without IC, resulting in both service
and economic impacts. These data probably underestimate the true IC
impact as it does not account for individuals with IC coded as general
septicaemia. The difference in mean costs is also likely to be higher
when excess bed day HRG costs and ICU per diem costs are included.
CHKS matched pair analysis results
Cases
(n = 6,105)
Controls
(n = 6,105)
Mean (sd) LOS
Total hospital days 16.6 (33.2) 5.6 (12.5)
– for patients with ICU/HDU stay 40.3 (40.3) 20.8 (28.3)
ICU days 16.7 (18.8) 7.5 (15.9)
Total hospital mortality* (%) 11.3% 5.0%
Mean (sd) admission cost £1,739 (1,711) £1,531 (1,235)
*p< 0.05 cases vs. controls.
P1806 Review of vulvovaginal candidiasis isolated in a Spanish
hospital in a two-year period (2005–2007)
M.C. Nieto, G. Martı´n Saco, N. Peyman-Fard, A. Rezusta, M.J. Revillo
(Zaragoza, ES)
Objectives: Better understanding of the aetiologic agent of all
vulvovaginal candidiasis (VVC) isolated in our hospital during a two-
year period.
Methods: 2052 samples received in H.U. Miguel Servet from June 2005
to June 2007 belonging to 1912 women between ages 1 and 94 with a
diagnose of VVC were reviewed.
Samples were cultured in OCCA (Oxoid® Chromogenic Candida Agar)
and Oxoid® Sheep Blood Agar.
Initial chromogenic identiﬁcation of the different yeast species was
conﬁrmed by biochemical tests using API 20 C AUX® Biomerieux.
Results: With a prevalence of 86.5% C. albicans remains the
dominant species non-albicans species more frequently found was
C. glabrata (10.3%), followed by C. krusei (1.3%), C. parapsilosis
(0.8%), C. tropicalis (0.6%), C. kefyr (0.1%), C. lusitaniae (0.1%) and
Saccharomyces cerevisiae (0.2%).
In our reviewed samples, 140 patients had some recurrence, of which
5% had at least two or three episodes per year, and 0.3% had a chronic
VVC (four or more episodes per year). Also, a higher incidence of VVC
was observed between the second and the fourth decade of life, followed
by a sharp decline in the ﬁfth decade.
Conclusions: In the last years there has been a rise in the share of VVC
attributable to non-albicans Candida species, specially C. glabrata and
C. krusei, which are less susceptible to azole-derived antifungal agents,
and therefore more difﬁcult to eradicate.
In studies from other geographical regions, non-albicans yeasts isolated
in VVC patients show a different distribution pattern. This fact stresses
the importance of knowing the aetiological agents in each hospital and
in each population in order to obtain the most precise diagnosis and
treatment.
P1807 Genital candidiasis in prepubertal and pubertal girls
S. Baka, S. Antonopoulou, V. Genimata, P. Salomidou, F. Petropoulou,
E. Plati, E. Logothetis, K. Gerolymatos, E. Kouskouni (Athens, GR)
Objectives: Vulvovaginal candidiasis is a frequent infection in women,
especially of reproductive age. Although insufﬁciently studied in
children, its prevalence is lower in children of prepubertal or pubertal
age. High estrogen levels were associated with the presence of yeasts in
vaginal samples of symptomatic women while low estrogen levels during
childhood result in a lower incidence in prepubertal girls. This study
was conducted in order to determine the prevalence of culture-positive
candida infection in children with genital symptoms in our hospital.
Methods: We obtained and cultured 439 vaginal samples from an equal
number of Virgo girls aged from 1 to 18 years old presenting to our
hospital from May 2005 to October 2007 with signs and symptoms of
vulvovaginitis. In order to isolate Candida spp., all samples were cultured
on Sabouraud Dextrose Agar (Conda, Madrid, Spain) for 24–48 hours at
37ºC. Candida spp. were identiﬁed on the basis of the macroscopic
appearance of colonies, direct microscopy of wet mount and Gram-
stained specimens. Finally, the identiﬁcation to the species level was
completed using the API System ID 32 C (BioMerieux, France).
Results: Out of the 439 vaginal samples studied, 40 samples yielded
Candida spp., which represent the 9.1% of the samples. In particular, we
isolated 27 C. albicans (67.5%), 7 C. glabrata (17.5%), 5 C. tropicalis
(12.5%) and 1 C. sake (2.5%). When we attempted to sort the 40 cases
with Candida by age groups, in the 1−5 years age group we included 2
samples (5.0%), in the 6–10 years group 1 sample (2.5%), in the 11–15
years group 7 samples (17.5%) and in the 16–18 years group 30 samples
(75.0%).
Conclusion: In girls less than 11 years old we observed a low prevalence
of Candida spp. In contrast, in pubertal girls a higher incidence of
Candida spp. was noted, probably because of the rise in estrogen
levels. Candida albicans was the most frequently isolated yeast from
vulvovaginal candidiasis in our study group.
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P1808 Pulmonary Mycobacterium simiae infection. Comparison
with pulmonary tuberculosis
J. Bishara, D. Shitrit, Z. Samra, N. Peled, M.R. Kramer, C. Maoz
(Petah-Tikva, IL)
Objectives: M. simiae is endemic to Israel. Recently, we observed an
emergence of M. simiae as the most frequently isolated non-tuberculous
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mycobacterium in respiratory specimens in our institution, followed
by M. fortuitum, Mycobacterium-avium-complex, and M. chelonae.
The distinction of M. simiae respiratory infection from pulmonary
tuberculosis on the basis of simple clinical and radiological features has
signiﬁcant therapeutic and infection control importance. The objective of
this study was to identify clinical and radiological features distinguishing
M. simiae respiratory infection from pulmonary tuberculosis.
Methods: The database of the Laboratory of Clinical Microbiology
of a major tertiary medical centre was searched for all patients with
culture-positive M. simiae respiratory infection from 1996 to 2004. Data
on demographics, underlying conditions, and clinical and radiological
ﬁndings were collected and compared with consecutive patients who
attended two tuberculosis centres in the same geographic area from 1999
to 2005.
Results: The M. simiae group included 102 patients and the tuberculosis
group, 121. The patients in the M. simiae group were signiﬁcantly
older (mean 69 ±16 years vs 47±21 years, p = 0.000), with a female
predominance (62% vs 45%, p = 0.008). Only 4% were of Ethiopian
origin compared to 25% of the tuberculosis group (p = 0.000). M. simiae
infection was associated with signiﬁcantly higher rates of smoking
history, underlying chronic obstructive pulmonary disease, diabetes
mellitus, ischemic heart disease, and malignancy, and treatment with
immunosuppressive drugs. HIV infection was found in 10% of the
patients with tuberculosis and in none of the patients with M. simiae
infection (p = 0.001). In the M. simiae group, clinical signs were blunted,
and noncavitary inﬁltrates in the lower/middle lobes were observed more
often on chest x-ray.
Conclusions: HIV-negative patients with M. simiae respiratory infection
are distinguishable from patients with pulmonary tuberculosis by several
demographic, clinical, and radiological features. These ﬁndings have
important diagnostic and therapeutic implications.
P1809 Are mycobacteria present in colon biopsies from patients
with early inﬂammatory bowel disease?
I. Szpinda, S. Lothe, P. Ricanek, M. Vatn, T. Tønjum (Oslo,
Nordbyhagen, NO)
Objectives: Crohn’s disease is a chronic condition with inﬂammation in
the intestines. A strong correlation between the presence of Mycobac-
terium avium ssp. paratuberculosis and Crohn’s disease has previously
been inferred, and a far higher incidence of M. a. paratuberculosis
PCR positivity has been shown in the gut of Crohn’s patients than in
healthy people. It is, however, not clear if M. a. paratuberculosis has an
aetiological impact in the pathogenesis of Crohn’s disease, or if it is just
a coincidence in that Crohn’s patients have an increased predisposition
for colonisation by M. a. paratuberculosis. We extended this question to
ask if there is an increased presence of mycobacteria in general in colon
biopsies from patients with inﬂammatory bowel disease (IBD; Crohn’s
disease and ulcerous colitis) as compared to healthy people. To facilitate
the mycobacterial detection we used cultivation in enriched media in
combination with direct detection by PCR.
Methods: Biopsies were prospectively taken from inﬂammatory lesions
from all sections of the colon from 400 patients with suspected IBD
and 140 controls submitted to colonoscopy (the IBSEN II study). One
hundred and ﬁfty control patients were also included. Patients were
later grouped according to IBD status: Crohn’s disease, ulcerous colitis,
other condition or healthy colon. The biopsies were investigated for
the presence of mycobacteria by 16S rRNA gene PCR analysis and
cultivation in the BACTEC MGIT 960 continuous culture system. The
specimens were cultivated in mycobactin-enriched BBLTM Middlebrook
7H9 medium. Mycobacterial strains isolated were identiﬁed by species-
speciﬁc hybridisation, M. a. paratuberculosis-speciﬁc IS900 PCR and
16S rDNA PCR sequencing and blast analysis. Specimens from selected
patients were subjected to metagenomics analysis to describe the global
gut ﬂora.
Results: Among the samples from the 540 patients investigated, only
1 patient was mycobacterial culture positive and IS900 PCR positive.
This patient had a liver transplant after primary sclerosing cholangitis
and contracted Crohn’s disease. Mycobacteria were so far not detected
in biopsies from the healthy controls.
Conclusion: Taken together the ﬁndings from this study will generate
novel knowledge on the occurrence of mycobacteria in the human gut.
This will extend the basis for deﬁning a putative aetiological role of
mycobacteria in early IBD, with special emphasis on Crohn’s disease.
P1810 Utilising clinical parameters to differentiate
mycobacteraemia from Mycobacterium tuberculosis v.s.
from Mycobacterium avium complex on the day of blood
culture signal detection
O. Putcharoen, N. Udomsantisuk, W. Kulwichit (Bangkok, TH)
Objectives: Disseminated MAC (DMAC) and TB (DMTB) share many
clinical features and treatment of these two entities are different. Not
all mycobacterial laboratories, especially in developing countries, are
equipped to perform rapid, same-day molecular identiﬁcation of the
grown mycobacteria. We sought to identify clinical predictors to aid
clinicians in species prediction on the day of positive signals.
Methods: At our hospital, blood cultures for mycobacteria and fungi
are incubated in Bactec MYCO/F bottles. Content from positive-signals
bottles is stained for acid-fast bacilli (AFB) and subcultured. Specimens
with AFB are subjected to commercial, and, when deemed necessary,
manual, molecular identiﬁcation to the species level. We analysed certain
clinical parameters that may correlate with disseminated TB (DTB) or
MAC (DMAC).
Results: A total of 2,040 blood specimens were sent for mycobacterial
and fungal isolation by Bactec MYCO/F medium during Jan 2005-
Nov 2007. TB and MAC were isolated in 109 patients. Clinical data
were available in 87 of them. The prevalence of mycobacteraemia from
MTB is higher. Sensitivity and speciﬁcity of AFB smear from Bactec
content for mycobacterial identiﬁcation are 92% and 96% respectively.
Smear of content of Bactec MYCO/F medium, which gives positive
signals, can accurately predict growth of mycobacterium. Most patients
had low CD4 cells (mean 89, median 48). The CD4 in patients with
DMAC was signiﬁcantly lower (p< 0.05). Mycobacteraemia from MAC
gave positive signals faster than that from MTB. Patients with DTB
tended to have abnormal chest x-ray and higher levels of serum alkaline
phosphatase. DMAC had normal chest x-ray or had pulmonary inﬁltrates
clearly attributable to another opportunistic agent.
Demographic, baseline CD4, laboratory ﬁndings and time until positive
signal of Bactec M/F LYTIC
Characteristics TB MAC
Number of patients (%) 55 45
Sex (M:F) 29:20 27:11
Age (years)
Median 36 32
Range 22–61 25–63
CD4 (cells/mm3)
Median 62 37 p< 0.05
Mean 103 53
Range 3–389 1–143
Alkaline phosphatase (U/L) 370 156 p< 0.05
Abnormal chest ﬁlm 30/32 3/26 (PCP= l,
old pulmonary TB= 2)
Days for detection of
positive signal from Bactec
(days)
Median 27 12 p< 0.05
Mean 28 13
Range 10–46 2–42
From total 87 patients.
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Conclusion: In our country, with high incidence of TB, prevalence
of mycobacteraemia from DMTB in advanced HIV-infected patients is
higher than that from DMAC. All patients with CD4< 60 who had either
normal chest x-ray or known lung lesions from other causes, whose
blood culture give positive signals faster than 15 days, have DMAC and
not DTB. Our data can be used for selection of an appropriate initial
treatment regimen in HIV-infected patients with suspected disseminated
mycobacterial infection.
P1811 Prevalence of atypical mycobacteriosis in aquarium ﬁsh in
northern Italy
E. Bozzetta, M. Pezzolato, I. Giorgi, V. Audino, K. Varello, M. Prearo
(Turin, IT)
Objectives: MOTT or NTM include members of genus Mycobacterium
not belonging to M. tuberculosis complex. NTM are ubiquitous, oppor-
tunist and some of them like Mycobacterium marinum, M. chelonae and
M. fortuitum are considered zoonotic agents. They are often founded in
aquarium environments and may cause chronic granulomatous diseases
in ﬁsh and cutaneous infections in ﬁsh handlers. Nevertheless the
presence and distribution of mycobacterial species in aquarium ﬁsh and
their environment has not been adequately explored yet.
The present study reports the prevalence of mycobacteria in aquarium
ﬁsh of Northern Italy sent to the Istituto Zooproﬁlattico Sperimentale of
Piemonte, Liguria e Valle d’Aosta from 2005 to 2007.
Methods: 525 aquarium ﬁsh, both from fresh and salt water,
were subjected to anatomopathological examination and mycobacterial
isolation. When positive growth was obtained the colonies were
subjected to biochemical identiﬁcation. Granulomatous lesions identiﬁed
macroscopically were evaluated by Haematoxylin and Eosin (HE),
acid-fast (Ziehl-Neelsen – ZN) and Auramine-Rhodamine staining
and by Immunohistochemistry with a polyclonal antibody against
Mycobacterium bovis.
Results: 226 out of 525 (43%) resulted positive for Mycobacterium
spp. We identiﬁes the following species: 100 M. chelonae complex
(59 M. chelonae and 41 M. abscessus); 81 M. fortuitum complex (42
M. peregrinum and 39 M. fortuitum); 41 M. gordonae; 3 M. marinum
and 1 M. scrofulaceum.
Microscopically granulomas presented a central eosinophilic area
(necrosis) surrounded by inﬂammatory cells and enclosed by a thin
capsule. All granulomas resulted ZN positive and the other staining
conﬁrmed these results.
Conclusion: Our data indicate that MOTT are densely diffuse in
aquarium and that they could represent a possible source of infection
for both aquarium ﬁsh and immunodeﬁcient ﬁsh handlers. Our results
are in agreement with the recent mycobacterial bibliography.
P1812 Delayed diagnosis of mycobacterial skin and soft tissue
infections in non-immunocompromised hosts
A. Witteck, C. O¨hlschlegel, K. Boggian (St. Gallen, CH)
The awareness of atypical pathogens in skin and soft tissue infections is
low and therefore the diagnosis is often delayed. We report three cases
of mycobacterial skin and soft tissue infections in normal hosts. The
diagnosis was delayed for 3–10 months in all 3 cases.
Our goal is to raise the awareness of atypical pathogens in non-
immunocompromised patients with prolonged skin and soft tissue
infections, particularly, if there was an injury with biological materials.
Case 1: A 58 year-old ﬂorist injured herself with a rose thorn.
Despite antibiotic treatment and surgery the wound continued to
suppurate and after 3 months she developed a tendosynovitis. As steroid
inﬁltration did not result in improvement, there was another surgical
approach. Histology revealed a granulomatous inﬂammation. Due to
infectious diseases consultation material for mycobacterial culture was
obtained. Culture grew M. marinum and the patient was treated with
doxycycline for 3 months. Due to incomplete recovery another surgical
revision was performed and treatment with ethambutol, rifampicin and
clarithromycine for 3 months, followed by clarithromycine monotherapy
for another 3 months resulted in complete recovery.
Case 2: A 60 year-old farmer’s wife had a little wound due to a raspberry
bush. After 4 months she developed a synovialitis of metacarpopha-
langeal joint. Despite inﬁltrations with steroids the synovialitis persisted
and worsened. 7 months after the initial injury, sugery was performed
and the histopathological exam revealed granulomatous inﬂammation.
M. marinum could be identiﬁed and a triple therapy with ethambutol,
rifampicin and clarithromycine was given for 2 months, followed by 4
months clarithromycine alone.
Case 3: A 21 year-old woman had an injury due to a little wood span.
4 months later she presented with a ﬁstulating wound. The ﬁstula was
excised. She was treated with different antibiotics, but the ﬁstula relapsed
several times. No osteomyelitis was found. After 10 months, due to
an infectious diseases consultation, mycobacterial culture was done and
M. chelonae could be identiﬁed. A treatment with clarithromycine was
installed.
These 3 cases illustrate the importance of the awareness of atypical
pathogens in relapsing or persisting skin and soft tissue infections.
Infections with atypical mycobacteria in non-immunocompromised hosts
are rare, but not impossible.
P1813 Identiﬁcation of mycobacteria by Raman spectroscopy
H.F.M. Willemse-Erix, P.C.A.M. Buijtels, P.L.C. Petit, H.Ph. Endtz,
G.J. Puppels, H.A. Verbrugh, K. Maquelin, A. van Belkum, D. van
Soolingen (Rotterdam, Schiedam, Bilthoven, NL)
Objectives: To analyse the capabilities of Raman spectroscopy for the
identiﬁcation of clinically relevant Mycobacterium species.
Methods: Strains were cultured in the MGIT system (Becton Dickinson
Microbiology Systems, Cockeysville, Md., US) until indicated as positive
by the system. The reproducibility of Raman spectroscopy was evaluated
for killed/inactivated mycobacteria versus viable mycobacteria. 16S
rRNA sequencing was used as a gold standard for the identiﬁcation
of M. tuberculosis complex strains and the most frequently found strains
of nontuberculous mycobacteria (NTM). Sixty-three strains, belonging
to 8 distinct species were analysed. Biomass from the MGIT system was
suspended in 10 microliter of sterile distilled water, transferred onto a
quartz slide and allowed to dry. Spectroscopic ﬁngerprints were obtained
using a dedicated Raman spectrometer, requiring approx. 1 min. per
sample. Cluster analysis on these ﬁngerprints was performed using the
pair wise correlations as a distance measure in combination with Ward’s
cluster algorithm.
Results: The spectra of the inactivated bacteria showed minimal
differences as compared to the spectra of viable mycobacteria. Therefore,
identiﬁcation of mycobacteria appears possible without biosafety level
III precautions. The reproducibility of the Raman procedure was high.
Correlation coefﬁcients between repeated cultures of the same strain
were signiﬁcantly higher than the correlation coefﬁcients between strains
of different species. The sensitivity of Raman spectroscopy for the
identiﬁcation of Mycobacterium species was 95.2%. All M. tuberculosis
strains were correctly identiﬁed (7/7; 100%) as were 54 of 57 NTM
strains (94%). The differentiation between M. tuberculosis and NTM
was invariably correct for all strains.
Conclusion: The spectra of the inactivated bacteria showed minimal
differences as compared to the spectra of viable mycobacteria. Therefore,
identiﬁcation of mycobacteria appears possible without biosafety level III
precautions. Raman spectroscopy provides a novel answer to the need
for rapid species identiﬁcation of cultured mycobacteria in a clinical
diagnostic setting.
P1814 Characterisation of human mycobacterial isolates using
random ampliﬁed polymorphic DNA (RAPD) ﬁngerprinting
M. Haghighi, M. Moatazedian, F. Aleyasin, A. Mohabati Mobarez,
K. Ghazi Saeed (Bushehr, Shiraz, Tehran, IR)
Objective: Tuberculosis is a global problem responsible for the
deaths 2−3 million people each year. In this study, we developed a
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simple random ampliﬁed polymorphic DNA (RAPD) assay for rapid
identiﬁcation of different species of mycobacteria and compared with
the traditional cultural and biochemical tests.
Methods: We studied 56 clinically isolates and 22 reference my-
cobacteria strains. The isolates categorised based on growth rate
and photoreactive characteristics as nonchromogenic, photochromogen,
scotochromogen and rapid grower groups.
Twenty seven commercial primers screened between seven, four, ﬁve
and six DNA of reference strains of nonchromogenic, photochromogens,
scotochromogens and rapid grower mycobacteria by RAPD respectively.
The mean of similarity index (Jaccards similarity) of different primers
for each clinical isolate compare to reference strain are evaluated. By
using sub value 0.65 as a cut off point, maximum genomic similarity of
each clinically isolate with related reference strain used for identiﬁcation
of each clinically isolates.
Result: By using short oligomer primers (10-mers) with arbitrarily
chosen sequences in the polymerase chain reaction, distinctive and
reproducible sets of RAPD proﬁles were observed for clinically
and reference isolates of mycobacteria. The primers 308,304,301 in
nonchromogenic mycobacteria, 348,313,AB1–15 in scotochromogens,
348,324,AB1–15,AB1–02 in photochromogens and 348.327,313,301 in
rapid grower mycobacteria were identiﬁed to be the most suitable primer
when tested with related clinical and reference strains. The mean of
similarity index of different primers for clinical isolates compare to
reference strain of nonchromogenic Mycobacteria group were equal to
M. tuberculosis in 46 Isolates, Photochromogen mycobacteria group
were equal to M. kansasii in 2 isolates, Scotochromogen mycobacteria
group were equal to M.gordonae in 2 isolates and 1 isolate of each of
M. ﬂavescens and M. xenopi, Rapid grower’s mycobacteria group were
equal to M. fortuitum in 4 isolates and M. smegmatis in 1 isolate.
Conclusion: RAPD analysis should be useful in providing genotypic
characters for taxonomic descriptions, for typing of Mycobacteria
species. The complete procedure required only 48 h from receipt of
a mycobacterial culture to ﬁnal identiﬁcation and it is a universal
system of identifying Mycobacteria to the species level that does not
require specialised knowledge and that even allows no specialised
microbiologists to make proper identiﬁcations.
P1815 Routine use of molecular methods for identiﬁcation of non-
tuberculous mycobacteria species in the clinical laboratory
R. Moure, A. Andreu, E. Castelblanco, V. Mick, M. Santı´n, R. Martı´n,
F. Alcaide (Hospitalet de Ll., ES)
Objective: To date, many nontuberculous mycobacteria (NTM) species
are isolated from clinical samples. The identiﬁcation to the species
level is frequently relevant for patient management, and molecular
methods seem to be the best approach for that purpose. Nowadays,
there is not a clear systematic procedure for molecular identiﬁcation
of these microorganisms. The objective of this study was to determine
the usefulness and limitations of molecular techniques to identify NTM
species and to ﬁnd the best identiﬁcation strategy.
Methods: A prospective study of all NTM isolates from infected patients
in our geographical area (Costa de Ponent, Barcelona) was carried out
(2004–2007; 41-months). Genetic characterisation to species level was
determined as follows: a) two reverse-hybridisation commercial systems:
INNO-LiPA (June 2004-March 2007) and GenoType assays (since April
2007); b) two in-house methods: PCR-RFLP analysis of hsp65 gene
(PRA), and 16S rDNA sequencing (16Seq). In addition, conventional
phenotypic methods (growth rate, pigmentation, and biochemical tests)
were used in combination with in-house molecular methods.
Results: A total of 489 isolates of MNT were identiﬁed during the study
period: Four hundred and ﬁfty-one of them (92.2%) were identiﬁed
by commercial systems: 316 of 347 (91.1%) by INNO-LiPA (12
different species) and 135 of 142 (95.1%) by GenoType (17 different
species). The MNT species identiﬁed by both methods were as follows:
M. gordonae (142), M. avium (60), M. chelonae (44), M. fortuitum (44),
M. intracellulare (40), M. kansasii (39), M. xenopi (34), M. avium-
M. intracellulare (17), M. scrofulaceum (10), M. mucogenicum (4),
M. celatum (3), M. genavense (2), M. malmoense (2), M. marinum (2),
M. peregrinum (2), M. simiae (2), M. abscessus (1), M. interjectum (1),
M. smegmatis (1), and M. szulgai (1). The remaining 38 isolates that
were not characterised by commercial techniques (7.8%) were identiﬁed
by PRA (22; 4.5%) or/and 16Seq (16; 3.3%).
Conclusions: Although a high number of different NTM species were
isolated in our geographical area, the greater part of them was identiﬁed
by the available commercial methods. GenoType assay showed a higher
level of species discrimination than INNO-LiPA system. Despite PRA
and, specially, 16Seq are the ﬁnest molecular methods to identify the
majority of NTM species, conventional phenotypic techniques should be
added in many cases to do a precise and deﬁnitive identiﬁcation.
P1816 Evaluation of multiplex PCR coupled with DNA sequencing
of 16S-23S internal transcribed spacer region for rapid
differentiation and species-speciﬁc identiﬁcation of
non-tuberculous mycobacteria
E. Mokaddas, S. Ahmad (Dasma, KW)
Objective: Speciﬁc identiﬁcation is of clinical relevance since treatment
varies according to the mycobacterial species causing infection. The
aim of this study was to evaluate a multiplex PCR (mPCR) assay for
rapid differentiation of MGIT 960 culture isolates as non-tuberculous
mycobacteria (NTM) or Mycobacterium tuberculosis complex (MTC)
members and to conﬁrm the NTM status of each isolate by DNA
sequencing of 16S-23S internal transcribed spacer (ITS) region.
Methods: A total of 993 mycobacterial isolates grown with MGIT 960
system over a two-year period in Kuwait were used for evaluation. The
DNA from heat-killed liquid cultures was extracted by incorporating
removal of PCR inhibitors and mPCR targeting oxyR-ahpC intergenic
region and rpoB gene was performed to differentiate NTM from MTC
members. The 16S-23S ITS region was ampliﬁed and sequenced by
using pan-mycobacterial primers. Mixed cultures were identiﬁed by a
line probe assay.
Results: The mPCR identiﬁed 67 isolates (from 49 patients) as NTM,
924 isolates as MTC members and two isolates as mixed cultures.
Thirteen different NTM species were identiﬁed. Of the 49 individual
patient NTM isolates, 11, 10, 6, 5, 5, 2, 2 and 2 isolates were identiﬁed
as M. fortuitum, M. kansasii, M. avium, M. intracellulare, M. abscessus,
M. lentiﬂavum, M. gordonae, and M. chelonae, respectively. One
isolate each was identiﬁed as M. chimaera, M. parascrofulaceum
and M. immunogenum while two isolates could only be identiﬁed as
Mycobacterium species. One NTM isolate contained a mixed culture,
M. kansasii and M. scrofulaceum. The repeat NTM isolates recovered
from some patients yielded identical results. The 150 randomly selected
MTC isolates were identiﬁed as M. tuberculosis by 16S-23S ITS
sequencing and/or hybridisation with M. tuberculosis-speciﬁc probes.
The two mixed cultures identiﬁed by mPCR contained M. tuberculosis
and M. fortuitum.
Conclusions: The mPCR accurately and rapidly differentiated all NTM
isolates from MTC members. The DNA sequencing of 16S-23S ITS
region led to species-speciﬁc identiﬁcation of nearly all NTM isolates.
Since majority of mycobacterial infections in developing countries are
caused by MTC members, rapid differentiation of all mycobacterial
isolates as NTM or MTC members by mPCR followed by species-
speciﬁc identiﬁcation of NTM by DNA sequencing is most suitable for
proper management of mycobacterial infections.
Supported by KURA grant MI02/04.
P1817 Mycobacterium avium ssp. paratuberculosis and cytokine
response in inﬂammatory bowel diseases
A. Szkaradkiewicz, R. Marciniak, I. Chudzicka-Strugala, A. Wasilewska,
M. Drews, P. Majewski, B. Zwozdziak, T. Karpinski (Poznan, PL)
Objectives: The studies aimed at analysis of manifestation of
Mycobacterium avium ssp. paratuberculosis (MAP) infections as related
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to secretion of selected cytokines (TNF-alpha, IL-1beta, IL-8 and IL-10)
in patients with ulcerative colitis (UC) and Crohns disease (CD).
Methods: The studies were performed on three groups of adult patients:
group 1 included 20 persons with UC, group 2 consisted of 12 patients
with CD, group 3 (control group) was formed by 15 healthy adult
volunteers, in whom routine colonoscopy was performed.
Material for the studies consisted of sera originating from the patients
of all the three groups and intestinal biopsies from patients of group 1
and group 2. In the sera levels of TNF-alpha, IL-1beta, IL-8 and IL-10
were estimated, employing high sensitivity ELISA kits (Quantikine HS,
R and D Systems) for estimation of TNF-alpha, IL-1beta and IL-10 and
ELISA kit (Quantikine, R and D Systems) for estimation of IL-8. DNA
was isolated from tissue material (QIAamp DNA Mini Kit, Qiagen) and
tested for the presence MAP DNA using IS900-speciﬁc nested PCR test
(Institut Pourquier, France).
Results: In group 1 with UC MAP DNA was detected in 5 (25%)
patients. Mean concentrations of studied cytokines amounted to: TNF-
alpha – 1.64 pg/ml, IL-1beta – 1.44 pg/ml, IL-8 – 49.74 pg/ml, IL-10 –
2.97 pg/ml.
In group 2 with CD MAP DNA was detected in 8 (66.6%) patients. Man
concentrations of studied cytokines were as follows: TNF-alpha – 3.12
pg/ml, IL-1beta – 0.77 pg/ml, IL-8 – 53.70 pg/ml, IL-10 – 2.59 pg/ml.
In statistical analysis MAP DNA was found to manifest signiﬁcantly
more frequently in patients with CD. In parallel, independently of the
presence/absence of MAP infection, serum concentrations of TNF-alpha,
IL-1beta and IL-8 in patients with inﬂammatory bowel diseases were
elevated as compared to those in the control group while serum levels
of IL-10 were the same in all the studied groups.
Conclusion: Inadequate secretion of IL-10 in parallel to the augmented
secretion of pro-inﬂammatory cytokines (TNF-alpha, IL-1beta and IL-8)
may play a principal role in development of inﬂammatory bowel
diseases, while the dominating stimulant of pro-inﬂammatory cytokines
production in CD seems to involve MAP.
P1818 Intrinsic drug resistance of M. avium–M. intracellulare
complex: the role played by efﬂux pumps
L. Rodrigues, D. Wagner, M. Viveiros, D. Sampaio, M. Martins,
I. Couto, M. Vavra, W. Kern, L. Amaral (Lisbon, PT; Freiburg, DE)
Objectives: The Mycobacterium avium–M. intracellulare complex
(MAC) accounts for the nontuberculous mycobacteria most frequently
found in clinical specimens, especially in AIDS patients in industrialised
countries. Treatment of infections caused by MAC is problematic due to
its intrinsic resistance to antibiotics. Although efﬂux pumps (EPs) have
been shown to be of clinical relevance in other bacteria, the importance of
drug efﬂux in mycobacteria is not yet fully understood. In this work, we
have characterised the EPs activity in ten MAC clinical strains through an
automated ﬂuorometric method and correlated it with intrinsic resistance
to antibiotics.
Methods: Two MAC reference strains (M. avium ATCC25291T and
M. intracellulare ATCC13950T) and ten clinical strains isolated from
AIDS patients were evaluated for accumulation and efﬂux of ethidium
bromide (EtBr) in the presence or absence of the EPs inhibitors (EPIs)
thioridazine (TZ), chlorpromazine (CPZ), verapamil (VP) and the proton
uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP). For this
purpose, an automated real-time ﬂuorometric method that separately
assesses accumulation and extrusion of EtBr was used. The effect of
the above agents on the MICs of several antibiotics was determined by
the broth microdilution method (CLSI).
Results: The automated real-time ﬂuorometric method allowed the
detection and quantiﬁcation of EtBr transport across MAC cell wall.
Accumulation of EtBr inside the cell was found to be temperature-
dependent and signiﬁcantly increased by the EPIs TZ, CPZ, CCCP
and VP, at half their MICs. The removal of these agents from the
medium resulted in energy dependent efﬂux of EtBr. EPIs promoted the
reduction of MICs of MAC strains towards clarithromycin, erythromycin,
ethambutol and to a minor extent, rifampicin and amikacin.
Conclusion: The results presented in this work are the ﬁrst clear
evidence of the role played by EPs in the intrinsic resistance of MAC
to drugs. In particular, we were able to demonstrate active efﬂux
contribution to intrinsic drug resistance in ten clinical MAC strains
isolated from AIDS patients. Furthermore, we found that MAC intrinsic
resistance to antibiotics is affected by EPIs such as TZ or CPZ, an effect
that might be important in research and development of new and more
effective antimycobacterial therapies.
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P1819 Effect of delay in the administration of adequate antibiotic
treatment in Streptococcus pneumoniae bacteraemia
E. Garcı´a-Cabrera, A. Diaz-Martin, V. Gonzalez-Galan,
J. Revuelto-Rey, R. Jimenez-Alvarez, J. Lepe, T. Aldabo´-Pallas, J. Aznar
Martin, J. Garnacho Montero (Seville, ES)
Objective: To determine risk factors associated with mortality in
patients admitted to the hospital with Streptococcus pneumoniae
bacteraemia, particularly analysing the impact of delayed adequate
antibiotic administration.
Methods: All adult patients with community-acquired Streptococcus
pneumoniae bacteraemia admitted to the hospital from January 2005
to November 2007 were enrolled in this protocol study. The following
variables were registered: age, gender, source of bacteraemia, severity
of illness at hospital admission evaluated by APACHE II score,
degree of organ dysfunction (SOFA scale), underlying disease, Charlson
comorbidity index, time from the hospital admission to ﬁrst antibiotic
dose, time from the hospital admission to ﬁrst dose of adequate antibiotic
treatment, ICU admission, development of septic shock, and in-hospital
mortality. For statistical analysis, categorical variables were evaluated
using the chi-square test and Fisher’s test when appropriate. Continuous
variables were compared using the unpaired Student’s t-test and the
Mann-Whitney U when appropriate. A multivariate regression model
was performed to determine the independent effect of the variables on
survival.
Results: One hundred and seventy-ﬁve patients were included; 86 of
them (71%) were male. The median of Charlson comorbidity index
was 6. The source of bacteraemia was pneumonia (n = 144), meningitis
(n = 20), others (n = 12). The mortality rate was 19.3% (34 patients).
Overall, the median delay of adequate antibiotic treatment was 5 h
(15min – 96 h). In patients with pneumonia, the median delay of
adequate antibiotic therapy was 4 h (15min – 96 h) in survivors and
6.5 h (15min – 72 h) in non-survivors (p = 0.159). The mortality rate in
pneumonia was 25/144 (17.4%) vs 9/32 (28%) (p = NS). In the entire
group, the independent risk factors associated with mortality were: age
OR 1.05 CI 95% (1.006−1.095), Charlson comorbidity index OR 1.274
(1.029−1.577) and SOFA score 1.319 (1.168−1.490). In patients with
Streptococcus pneumoniae bacteremic pneumonia age OR 1.067 IC 95%
(1.011−1.125); Apache II OR 1.162 (1.014−1.331), time to adequate
antibiotic treatment OR 1.122 (1.002−1.255), and septic shock OR 8.27
(1.317–51.94) were the independent predictors of mortality.
Conclusions: After controlling for confounding variables, a delay in
the administration of adequate antibiotic treatment is an independent
risk factor of mortality in Streptococcus pneumoniae bacteraemia of
pulmonary source.
P1820 Evolution of Campylobacter bacteraemia before and in the
era of highly active anti-retroviral therapy
A. Ferna´ndez-Cruz, P. Mun˜oz, R. Mohedano, M. Valerio,
M. Rodriguez-Creixems, E. Bouza (Madrid, Legane´s, ES)
Objective: Campylobacter is a very uncommon cause of bloodstream
infection (BSI), but was relatively frequent in HIV positive patients.
The impact of HAART and new forms of immunocompromise on CB
incidence has not been sufﬁciently assessed. To analyse the evolution of
the incidence, microbiological and clinical characteristics of all cases of
CB during a 22-year period.
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Methods: Review of the clinical records of all patients with
Campylobacter bacteraemia (CB) from 1985 to 2007. PreHAART (1985
to 1996) and HAART periods (1997–2007) were compared. Available
strains were re-identiﬁed with universal PCR.
Results: There were 69 CB in 61 patients (0.25% of all BSI) and
the incidence remained stable (mean of 0.06/1000 admissions and
0.49/100,000 inhabitants). Median age was 53 y (IQR 30–74) and
82% were male. Underlying conditions included: liver disease (32.2%),
HIV infection (22.7%), neoplasia (12%), solid organ transplantation
(SOT)(3.4%) and others (4.7%). CB was community-acquired in 80%.
Origin of the BSI was gastrointestinal (34%), unknown (28%) or extra-
intestinal (36%:respiratory 15%, intraabdominal 8%, cellulitis 4.5% and
urinary 8%). C. jejuni was recovered in 68% of the cases (41% primary
CB vs secondary 78%; p 0.013), C. fetus in 18% and C. coli in 10%.
Molecular methods reclassiﬁed 6 strains: C. fetus (2) and C. jejuni
(1) formerly identiﬁed as Campylobacter sp and 3 C. fetus formerly
identiﬁed as C. jejuni. Complications appeared in 25% of the patients.
Quinolone-resistance was found in 67% of the isolates and empirical
therapy was appropriate in 64%. Mortality rate was 17% and was
higher in HIV + pts (33% vs 10%; p 0.04) and in the presence of
complications (50% vs 4%; p< 0.0001). Three patients with humoral
immunodeﬁciency recurred (5%).
When preHAART and HAART periods were compared we found that
patients with CB were younger in the ﬁrst period (39 vs 67; p< 0.001)
and that C. coli was only detected in the ﬁrst period. Although forms of
immunocompromise have changed between the two periods, differences
did not reach statistical signiﬁcance: immunocompromise (38% vs
46%; p 0.6), HIV+ (28% vs 15%, p = 0.4), solid (7.5% vs 0%) or
haematological neoplasia (2.5%vs 12%), SOT (0 vs 8%).
Conclusions: Campylobacter bacteraemia is no longer a disease of
HIV+ patients, but often affects immunocompromised patients. CB has
an extraintestinal origin in as much as 36% of cases and humoral
immunodeﬁciency must be sought for in patients with recurrent episodes.
P1821 Differences of urinary tract infection patients with and
without bacteraemia: a pilot study
I. Hager, T. Peppas, A. Papadimitriou, N. Tsiberakis, I. Binikos,
D. Petropoulou, S. Pappas (Piraeus, GR)
Aim: To assess differences in appearance and outcome of medical
patients with documented urinary tract infection (UTI) regarding whether
bacteraemia (B) was noted or not
Patients and Method: All medical patients admitted from Emergency of
a tertiary hospital hving symptoms compatible with UTI were screened
for SIRS criteria [Chest 1992; 1644], prospectively enrolled with all
clinical, laboratory and microbiology data entered in PC database (SPSS)
until discharge. Only cases with documented UTI were included, and
those having B with the same pathogen were matched with an equal
number of UTI pts whose blood cultures were negative Analysis by
chi square, Mann-Whitney and t-test, as appropriate Time: Feb 2006-
November 2007
Results: There were 25 (M: 9) cases of UTI with B (Group A) and
25 (M: 11) without B (Group B) Age and mean N of SIRS criteria
on admission for A and B respectively, were 76.8 v 71.7 yrs (NS) and
2.60±0.86 v 1.88±1.01 (p = 0.01) There were similar trends in CRP
values, pathogen distribution, comorbidity, previous antimicrobial use
or hospitalisation Signiﬁcant difference was noted in hospital length of
stay with a mean of 14.3±11 days for Group A v 7.7±2.8 for Group B
(p = 0.01) Mortality tall was higher in bacteraemic patients (7/25) v 2/25
of Group B (p = 0.06)
Conclusions: Patients with UTI eventually proven bacteraemic had a
higher sepsis score on admission and special attention should be focused
on this simple evaluation tool, as the impact of bacteraemia on prognosis,
above all, and also hospital saty was found, as expected, is considerably
greater. Seeking microbiology documentation is, obviously, mandatory
for patient beneﬁt and prompt management
P1822 Epidemiological and bacteriological proﬁle of
community-acquired infective endocarditis
A. Slavcovici, D. Bedeleanu, M. Barsan, N. Hagau, A. Radulescu,
V. Zanc, D. Tatulescu, A. Rotar, C. Cismaru, A. Dicea, C. Marcu,
R. Iubu, A. Cioara, C. Jianu, D. Carstina (Cluj-Napoca, RO)
Background: The epidemiological and bacteriological proﬁles of
infective endocarditis have changed due to longevity, more invasive
procedures and immunity disorders.
Objectives: To describe community-acquired infective endocarditis
(CA-IE) according to host characteristics and evaluation of the
microbiological spectrum.
Methods: Design: prospective study performed in the Cluj-Napoca
Teaching Hospital of Infectious Diseases between 1998 and 2007.
According to modiﬁed Duke criteria 186 deﬁnite and probable CA-
IE were studied. Bacteriologic assessment was performed using the
automatic system BactT/Alert and resistance patterns were determined
with API 20E, Api 20NE and ATB automatic methods under CLSI 2006
standards. EPIInfo 6 was used for statistical analysis.
Results: CA-IE was diagnosed in 186 patients (73%) of 254 consecutive
cases of infective endocarditis. Most of the cases were native valve
endocarditis (153 cases – 82%). Demographic characteristics: age range
7–89 years (median 52 yrs), sex ratio M:F 1.66:1. Immunity disorders
were found in 43 cases (23%) including: diabetes mellitus, chronic
hepatitis, kidney failure, malignancies, corticosteroid treatment, asplenia.
The elderly of more than 60 years represented 30.6% (57) of all
cases. Presumed portal of entry represented by poor oral hygiene
and periodontal disease, gastrointestinal and urinary tract disorders
was identiﬁed in 102 patients (55%). The bacteriological proﬁle was
dominated by streptococci (20.4% – 38 strains), from which 21%
were group C and D. The other common causes were represented
by: staphylococci – 29 strains (15.6%), enterococci – 15 isolates
(8%) and Gram-negative rods – 8 strains (4.3%). In the elderly the
most frequent isolates were streptococci and enterococci. We found
signiﬁcant correlation between digestive or urinary portal of entry and
enterococcal aetiology (OR 8; 95%CI, 1.95–32.8) and for periodontal
disease and oral streptococci (OR 115; 95%CI, 15.6–2367). Almost all
isolates were susceptible to common antibiotics except 10 strains of
Staphylococcus aureus and coagulase-negative staphylococci that were
meticillin resistant. Glycopeptide resistance was never found in these
strains.
Conclusion: Underlying diseases and presumed portal of entry
are of utmost importance in diagnosing and management of CA-
IE. The microbiological proﬁle sustains the usefulness of guideline
recommendations.
P1823 Clinical epidemiology and microbiological spectrum of
nosocomial endocarditis
A. Slavcovici, A. Radulescu, D. Bedeleanu, N. Hagau, M. Barsan,
D. Tatulescu, V. Zanc, A. Dicea, A. Cioara, A. Rotar, C. Jianu,
D. Carstina (Cluj-Napoca, RO)
Background: The epidemiological features of infective endocarditis
have changed during the last decades because of an increase in placement
of prosthetic valves and exposure to invasive procedures.
Objectives: To assess clinical epidemiology and microbiological
spectrum of nosocomial endocarditis (NE) deﬁned according to Duke
modiﬁed criteria.
Methods: Design: prospective study performed in a teaching hospital of
infectious diseases.
During the study period (1998–2007) 46 cases of NE were admitted.
NE was deﬁned according to accepted deﬁnition: endocarditis associated
with invasive procedures performed in hospital during the 8 week period
before the onset of the disease or endocarditis occurring >48 h after
admission.
Results: Deﬁnite NE was present in 46 patients (18%) of 254
consecutive cases of infective endocarditis, age range: 21–72 years
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(median 49 yrs), sex ratio M:F was 3:1. Comorbities that predispose
to infection were found in 14 patients (30.4%): 4 cases – diabetes
mellitus, 5 cases – chronic kidney failure, 5 cases – immunosuppressive
conditions. Cardiac risk factor represented by prosthetic valves was
found in 21 cases – 45.6%. NE was documented based on bacteraemia
related to surgical or medical procedures: 22 cases (47.8%) after
cardiovascular procedures (less than 1 year after valve placement,
intravascular devices, pacemakers implants); 13 cases (28.3%) after
genitourinary procedures; 5 cases (10.9%) after gastrointestinal surgical
interventions and procedures; 6 cases (13%) after other invasive
procedures (endoscopy and ORL procedures). Thirty ﬁve percent of NE
(16 cases) occurred within the ﬁrst year after valve implantation (early
prosthetic valve endocarditis). The most commonly isolated organism
was staphylococci – 21 cases (45.6%), 18 strains Staphylococcus
aureus and 3 strains coagulase negative staphylococci. Other isolated
microorganisms were: enterococci (8 cases – 17.4%), Gram-negative
rods (5 cases – 10.9%), uncommon bacteria (2 cases – 4.3%). No
vancomycin resistant Gram-positive cocci were isolated. Twenty-three
patients (50%) had unfavourable outcome: 4 deaths and 19 complicated
cases referred for surgical treatment.
Conclusions: Intracardiac, intravascular devices and genitourinary tract
procedures represented the most important risk factors for nosocomial
bacteraemia. The leading cause of NE was staphylococci bacteraemia.
Cardiothoracic surgery is needed in a high proportion of NE.
P1824 Group G streptococcal bacteraemia and emm types
S. Rantala, S. Va¨ha¨kuopus, J. Vuopio-Varkila, R. Vuento, J. Syrja¨nen
(Tampere, Helsinki, FI)
Objectives: We studied clinical features and severity of disease in
bacteraemia caused by group G beta-haemolytic streptococci (GGS) in
relation to emm type of the isolates.
Methods: The medical records of all adult (over 16 years of age) patients
in the Pirkanmaa Health District (460 000 inhabitants), Finland, with
one or more blood cultures positive for GGS during the 10-year period
from January 1995 to December 2004 were retrospectively reviewed.
Mortality was recorded within 30 days from the positive blood culture.
A severe disease was deﬁned as death during the 30 days or admittance
to Intensive Care Unit. Disseminated intravascular coagulation (DIC)
was deﬁned as a platelet count lower than 100 x 109 /l. The streptococci
were classiﬁed for their group antigen G and the isolates were emm
sequenced.
Results: GGS grew in 128 cultures; 126 of isolates were analysed,
two are underway. 14 different emm types were found; stG480 (27
isolates), stG6 (22 isolates), stG485 (17 isolates), stG643 (10 isolates),
stC6979 (9 isolates), stG166b (6 isolates), and stC74a (5 isolates) were
the seven most common emm types covering 76% of all isolates. Fifteen
isolates remained nontypable (NT). We divided bacteraemia episodes
into two groups: those caused by the seven most common emm types
(96 episodes, ie. common types) and those caused by less common or
NT emm types (30 episodes, ie. rare types). Age or underlying diseases
did not differ between the groups. Instead, patients with an ultimately or
rapidly fatal underlying disease were more often linked to bacteraemia
caused by rare types than that caused by common types [18/30 vs. 36/96;
OR 2.5 (95%CI 1.1 to 5.8)]. Mortality was higher in bacteraemia caused
by rare types than that caused by common types [10/30 vs. 9/96; OR 4.8
(1.7 to 13.2)]. A severe disease was caused more often by rare types than
common types [12/30 vs. 10/96; OR 5.7 (2.0 to 14.2)]. The association
between a severe disease and a rare type remained statistically signiﬁcant
also in a multivariate model which was adjusted for the occurrence of an
ultimately or rapidly fatal underlying disease and for age [OR 4.8 (1.7 to
13.2)]. DIC was also a more common ﬁnding in patients suffering from
bacteraemia caused by rare types than common types [5/30 vs. 1/96; OR
19.0 (2.1 to 170.1)].
Conclusion: GGS bacteraemia is caused by variety of emm types, seven
of them covering 76% of all isolates. Rare emm types were associated
with a more severe disease.
P1825 Bacteraemia complicating pressure ulcers
E. Espejo, M. Andre´s, M.A. Morera, R.M. Borrallo, M. Simo´, F. Bella
(Terrassa, ES)
Objectives: To evaluate the characteristics and prognostic factors of
bacteraemia complicating pressure ulcers (BCPU).
Methods: Prospective study of all episodes of signiﬁcant BCPU, from
1984 to 2006, in a general hospital. Diagnosis was based on positive
blood cultures, isolation of the same microorganism in the ulcer culture,
and absence of another source of the bacteraemia.
Results: We studied 47 consecutive episodes of BCPU in 44 patients
(17 males, 27 females) aged 77±13 yr. The main causative agents were:
Staphylococcus aureus (14 cases), Proteus mirabilis (13), Bacteroides
sp. (12), Escherichia coli (4), and Pseudomonas aeruginosa (4).
Bacteraemia was polimicrobial in 11 cases (23%). Dementia, diabetes,
stroke and femur fracture were the most common underlying conditions.
The ulcers were already present at admission in 41 cases (87%), but the
bacteraemia was hospital-acquired in 17 cases (36%). Multiple ulcers
were present in 35 cases. The sacrum was the most common site
(38 cases) followed by heels (18) and trochanteric region (16). In 5
cases, the ulcers did not show distinct local signs of infection; in 4 of
these episodes, S. aureus was isolated from blood and ulcer cultures.
Surgical debridement was performed in 30 cases (64%). Osteomyelitis
was documented in 8 cases. Crude mortality was 42% and mortality
related to bacteraemia was 21%. Variables associated with a higher
mortality were: septic shock (RR 2.1; 95%CI 1.2−3.7) and serum
albumin <23 g/l (RR 2.2; 95%CI 1.1−4.5). Surgical debridement was
associated with a lower mortality (RR 0.5; 95%CI 0.2−0.9).
Conclusions: BCPU is associated with a high mortality, although
many deaths were not directly related to bacteraemia. Polimicrobial
bacteraemia is common. Shock and hypoalbuminaemia were adverse
prognostic factors, whereas surgical debridement was associated with a
lower mortality. Empirical antibiotic therapy should be active against
enteric Gram-negative bacilli, S. aureus, and anaerobes including
B. fragilis.
P1826 Glycopetide-dependent enterococcal bacteraemia following
treatment of antibiotic-associated diarrhoea
S. Soleimanian, D. Bean, D. Wareham (London, UK)
Objectives: There are a small number of reports in which Gylcopeptide
dependent enterococci (GDE) have been recovered from stool, intra
abdominal collections, urine and rarely blood cultures. We describe a
case of GDE bacteraemia and its possible risk factors.
Methods: A 21 year old female was admitted with a ﬁve day history of
pyrexia, abdominal pain and vomiting. A diagnosis of severe necrotising
pancreatitis was made and imipenem administered for seven days.
Fourteen days after admission the patient developed severe diarrhoea
and tested positive for Clostridium difﬁcile toxin. Treatment with oral
metronidazole and oral vancomycin was initiated and, after a further 48
hours, intravenous vancomycin and gentamicin were also, Vancomycin,
intravenous and oral, was continued for sixteen days. On day 30 blood
cultures became positive and a Gram stain revealed Gram-positive cocci
in chains.
Results: The bottles were subcultured onto blood and chocolate agar.
Examination of culture plates revealed no growth on any of the
media except around both the vancomycin and teicoplanin discs on the
sensitivity plates, suggesting a dependence on glycopeptides for growth.
The concentration of glycopeptide required for growth was determined as
0.25mg/L of vancomycin and 0.094mg/L of teicoplanin. The organism
was identiﬁed as Enterococcus faecium by DNA sequencing of the
16S rRNA gene. Susceptibility testing performed using IsoSensitest
media supplemented with 8mg/L vancomycin indicated resistance
to amoxicillin and rifampicin, but susceptibility to linezolid and
quinupristin/dalfopristin. The high level of resistance to vancomycin
(MIC> 256mg/L) and teicoplanin (MIC 32mg/L) suggested carriage of
the vanA gene which was conﬁrmed by PCR.2 The organism reverted
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to non-dependence on standard media at a frequency of 2.6×10−3 with
both dependent and revertant strains having identical genetic ﬁngerprints
when examined by pulsed ﬁeld gel electrophoresis.
Conclusions: We emphasize on association between bacteraemia due
to GDE, Clostridium difﬁcile associated diarrhoea and prolonged IV
and oral vancomycin therapy. As vancomycin at high doses (250mg, 6
hourly) is now recommended by some authorities for the management
of severe C. difﬁcile diarrhoea this may facilitate further the problem of
glycopeptide dependence in enterococci.
P1827 Infective endocarditis in children: a single cohort study of
51 cases in a French university hospital
A. Abouchraa, J.R. Zahar, E. Carbonnelle, F. Bajolle, F. Ribadeau-
Dumas, F. Mechai, C. Offredo, D. Sidi, O. Lortholary (Paris, FR)
Introduction: Infective endocarditis (IE) in children is rare. Considering
the lack of recent data, we performed an epidemiological study to
determine diagnostic, therapeutic and outcome features of infective
endocarditis in the paediatric setting.
Materials and Methods: We conduct a retrospective study of children
IE cases at Necker Enfants-Malades university hospital in Paris (1994–
2006). All had a deﬁnite IE according to Duke criteria. Data collected
included, demographics, underlying heart disease, type of valvular
damage, septic localisations, microbiological data, antibiotic therapy and
outcome.
Results: From 51 children recorded, 37 (72.5%) were boys, with a
median age of 10 years [3 months-17 y ]. Median time from symptom’s
onset to treatment was 7 days. The average follow-up period was 49
months. Thirty nine patients (76%) had congenital heart disease or a
valve damaged. Mitral and tricuspid valves were involved in 27% of
cases. In 14 cases (27.4%) a foreign cardiac material was infected Thirty
two cases (62.7%) had a valvular failure, 3 children had a annular
abscess. Ten (19.6%) cases were nosocomially acquired (2 staphylococci,
1 Gram-negative bacillus, 1 enterococcus, 3 yeasts). Portal of entry was
identiﬁed in 27 cases. Gram-positive cocci accounted for 70.6% (36
cases) (streptococci 17 cases, staphylococci 17 cases and enterococci 2
cases). Twenty patients (39.2%) experienced arterial embolism with lung
(10 cases), and brain (6 cases), being the most frequent organs involved.
Twelve patients (23.4%) had a severe clinical form (ie, septic shock,
acute renal failure, myocardial dysfunction) The treatment was medical
alone in 26 cases and medico-surgical in 25 cases.
To date 46 patients (90%) are alive and 5 (9.8%) died, the death occurred
in 2 cases during treatment at 8 and 23 days after diagnosis because
of ventricular tachychardia. Recurrent endocarditis was detected in 4
children (a new episode of valvular infection occurred in 2 cases and a
relapse in 2 cases). One patient surgically treated and 4 treated medically,
died
Conclusion: In our children endocarditis study, 20% are nosocomially
acquired with foreign cardiac materials in 28%. The most frequent portal
of entry was dental, 87% of children had a 4 years survival free of any
cardiac event.
P1828 Risk factors for hospital admission in patients with
occult Escherichia coli bacteraemia discharged from the
emergency department
G. Peralta, M.J. Rodriguez-Lera, B. Ceballos, S. Alonso, M.P. Roiz,
I. De Benito, R. Teira, M.B. Sanchez, J.C. Garrido, F. Mateos,
E. Padron (Torrelavega, Santander, ES)
Background: Escherichia coli is the most frequent Gram-negative
organism causing bacteraemia. Few studies dealing with occult
bacteraemia in adult patients have been published, and none of them
addresses speciﬁcally E. coli bacteraemia.
Methods: In our hospital patients with occult bacteraemia discharged
from the emergency department (ED) are followed with a speciﬁc
protocol. We reviewed all patients with occult E. coli bacteraemia
discharged from the ED in a ten year period. A total of more than
20 variables including epidemiological and clinical aspects of E. coli
bacteraemia cases were evaluated. Chi square test or the Fisher test were
used for categorical variables and t-test for continuous variables. Logistic
regression model was used to identify factors independently associated
with hospital admission after detecting bacteraemia.
Results: From January 1997 to December 2006 we identiﬁed 261
patients with occult bacteraemia due to E. coli discharged from the ED.
Of them, 174 (66.7%) required hospital admission. The origin of the
bacteraemia was a urinary infection in 207 (79.9%), unknown in 32
(12.4%), biliary in 10 (3.8%) and other origins in 12 (4.6%). A higher
proportion of patients who did not require hospitalisation were younger
than 65 years (51.1 vs 35.6%, p = 0.03), received adequate antibiotic
empirical treatment (84.4% vs 71.3%, p = 0.01) or at least one dose of
parenteral antibiotic in the ED (77.6% vs 58.6%, p = 0.001). Among
160 patients who had received adequate antibiotic empirical treatment
we detected signiﬁcant differences in the rates of hospital admission
depending on the reception of at least one dose of parenteral antibiotic
(62.9% vs 82.9%, p = 0.002). In a regression logistic analysis, age older
than 65 years (ORa, 95%CI: 1.74, 1.01−2.99, p = 0.05), and receiving
at least one dose of parenteral antibiotic in the ED (ORa, 95%CI: 0.41,
0.23−0.71, p = 0.002) were associated with hospital admission.
Conclusion: Our data suggest that in patients with suspected bacteraemia
due to E. coli discharged from an ED, initial treatment with at least one
dose of adequate parenteral antibiotic could avoid hospital admissions.
P1829 Time-to-positivity of blood cultures in patients with
Klebsiella spp. bacteraemia
G. Peralta, M.P. Roiz, I. De Benito, R. Teira, B. Ceballos, S. Alonso,
J.C. Garrido, F. Mateos, M.B. Sanchez, E. Padron (Torrelavega, ES)
Background: time to positivity of blood cultures (TTP) is considered
a surrogate marker of blood bacterial concentration. We evaluate the
relationship between the TTP with clinical parameters, in patients with
Klebsiella spp. bloodstream infections.
Methods: retrospective study of cases of Klebsiella spp. monomicrobial
bloodstream infections from January 1997 to June 2007 in our institution.
The association of more than 20 variables, including epidemiological and
clinical aspects of Klebsiella spp. cases, with TTP was evaluated. When
multiple cultures were positive only the shortest TTP was selected for
the analysis. Chi-square test or the Fisher test were used for categorical
variables and t-test for continuous variables.
Results: during the study period we identiﬁed 78 cases of Klebsiella
spp. monomicrobial bacteraemia, with a mortality of 11.5%. Median
(interquartile range) TTP was: 12.5 h (10.5–15.1). In one case TTP was
unknown. Signiﬁcant correlation among TTP and the number of positive
blood cultures was found (Spearman’s coefﬁcient = −0.44, p< 0.001).
Association of TTP with several clinical parameters is reﬂected the table.
Mortality in patients with TTP <9 h was 33.3% (2/6), in those with TTP
between 9–10 h 14.3% (1/7), and in patients with TTP >10 h mortality
was 8.4% (5/64) (chi for trend, p = 0.06).
Characteristics TTP< 10.5 TTP> 10.5 p RR (95%CI)
N= 19 n = 58
Nosocomial, n (%) 8 (42.1) 14 (24.6) 0.12 1.79 (0.83−3.83)
Age >65 years, n (%) 15 (78.9) 50 (87.7) 0.28 0.64 (0.26−1.56)
Severe sepsis or shock, n (%) 9 (47.4) 10 (17.5) 0.01 2.7 (1.37−5.6)
Altered consciousness, n (%) 7 (36.8) 6 (10.7) 0.02 2.78 (1.36−5.69)
Required ICU, n (%) 3 (15.8) 0 0.01
On antibiotic treatment 6 (31.6) 6 (10.9) 0.045 2.39 (1.13−5.02)
Conclusions: in patients with Klebsiella spp. bacteraemia, TTP is
associated with the severity of the infection and with the outcome.
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P1830 Detection of the causative pathogen in infective endocarditis
by means of the LightCycler SeptiFAST® test
O. Janata, K. Herbich, Y. Haas, P. Elliott, R. Schuster, P. Apfalter
(Vienna, AT)
Objective: Detection of the causative microorganism in infective
endocarditis (IE) in pre-treated patients is still a challenge. At least 35%
of cases of culture-negative IE can be attributed to prior antimicrobial
therapy.
Reported here is a patient with culture negative IE, in whom the causative
agent could be diagnosed by means of the new LightCycler SeptiFAST®
test, a real-time based multiplex PCR assay allowing for DNA-detection
of 25 pathogens within 6 hours from EDTA-treated blood specimens
(Roche, Mannheim, Germany).
Case report: A 58-year-old male patient with malaise and anaemia was
admitted to hospital. He reported a history of coronary heart disease
and diabetes mellitus type II. Four weeks prior to hospitalisation a
transurethral prostatic resection had been performed. Laboratory results
showed signs of mild, chronic inﬂammation. Without deﬁnitive diagnosis
over a period of 17 days he received amoxicillin/clavulanic acid due to
elevated C-reactive-protein levels. Under this therapy he developed fever
of 38.6ºC on day 3 after admission. Transthoracic echocardiography
showed no pathology at that time and antibiotics were not changed.
After 17 days the patient had to be transferred to the ICU because
of cerebral deterioration and respiratory insufﬁciency. The immediate
follow-up revealed an aortic valve endocarditis as well as an embolic
stroke by means of transoesophageal echocardiography and computed
tomography, respectively. Multiple blood cultures remained negative,
supposedly because of prior antibiotic therapy. The new LightCycler
SeptiFAST® test was applied and revealed Enterococcus faecalis (Gram-
positive panel, chanel 705, melting temperature 62.6ºC). The treatment
was changed to amoxicillin and daptomycin and the aortic valve was
replaced. No enterococci could be cultured from valve-tissue, but
ampliﬁcation of part of the 16S rDNA gene (560bp of the V3-region;
Escherichia coli position 8–575; ampliﬁcation primers 27F and 556R)
followed by cycle sequencing (ABI PRISM Genetic Analyzer 3130;
primer 27F) conﬁrmed the presence of E. faecalis-DNA.
Conclusion: To our knowledge this is the ﬁrst report of microbiological
diagnosis in IE by means of the LightCycler SeptiFAST® test. Further
use of this new molecular-biological tool is warranted to conﬁrm its
application in pre-treated IE. The method, however, will not replace
conventional blood cultures because no antimicrobial susceptibility data
are provided.
P1831 Bacteraemia due to enteropathogenic bacteria in a
paediatric hospital in Athens, Greece
E. Lebessi, A. Doudoulakakis, G. Antonaki, P. Zouni, M. Papadimitriou,
N. Paleologou, K. Kallergi (Athens, GR)
Objective: To review the clinical and bacteriological features of patients
with bacteraemia due to enteropathogenic bacteria over a ﬁve-year period
(2003–2007).
Methods: We retrospectively reviewed the medical records of all
included patients for clinical symptoms, laboratory ﬁndings, predis-
posing factors, treatment and outcome. Blood culture, identiﬁcation,
antimicrobial susceptibility and Salmonella spp. serotyping were
performed by standard methods.
Results: We evaluated 42 bacteremic patients (23 boys, 19 girls).
The median age was 18 months (35 days-15 years). Fever (93%) and
diarrhoea (76%) were the most common initial symptoms, followed by
vomiting (31%) and convulsions (7%). Laboratory ﬁndings on admission
included: median WBC=11.3×109/L (2.9 to 30.6×109/L in children with
no underlying disease) and median CRP= 76mg/L (2 to 374mg/L).
Leukocytosis (>10×109/L) was present in 23/42 (55%) children and
CRP> 10mg/L in 35/42 (83%). Underlying disease was present in
ﬁve patients (one with congenital heart disease; three haematogical
malignancy and one immunodeﬁciency/hypoglobulinaemia). The in-
volved pathogens were the following: Salmonella enterica (38/42),
Campylobacter spp. (3/42) and Aeromonas hydrophila (1/42). S.
Enteritidis was the most predominant serovar (24/38, 63%), followed by
S. Typhimurium (3/38, 8%). Nine cases were due to other Salmonellae
and only one was due to S. Typhi. Two patients presented osteomyelitis;
one immunocompetent (S. Kottbus) and one neutropenic with acute
myeloblastic leukaemia (A. hydrophila). One child had urinary tract
infection due to S. Enteritidis. Overall, 27 patients among 38 tested
(71%) had positive stool cultures for the involved bacteria. Twenty
out of 38 (53%) patients with Salmonella spp. bacteraemia were given
third generation cephalosporins; the remaining were given ampicillin or
cotrimoxazole. Recurrent disease was not recorded among the evaluated
patients. All but one strains were found susceptible to ampicillin and
cotrimoxazole, and all strains were found susceptible to cefotaxime and
ciproﬂoxacin. All three strains of Campylobacter spp. were susceptible
to erythromycin and one was resistant to ciproﬂoxacin.
Conclusions: Bacteraemia associated with enteropathogenic bacteria is
a fairly uncommon entity, but it should be considered in children,
especially infants with symptoms of febrile gastroenteritis. Focal
symptoms are rare and the usual outcome after proper antimicrobial
treatment is favourable.
P1832 The spectrum of invasive bacterial disease in Arctic
areas – A population-based study in Greenland
A. Koch, A. Meyer, P. Poulsen, K. Ladefoged (Copenhagen, DK;
Nuuk, GL)
Objectives: The incidence and mortality of invasive pneumococcal
disease in Greenland and in other Arctic areas is high compared with
western countries, but it is unknown if this applies only to S. pneumoniae
or to invasive bacterial diseases (IBD) in general. The objectives of this
study were to describe the full spectrum of IBD in Greenland with
respect to microorganisms, patient demographics, clinical presentation,
severity and outcome.
Methods: For the years 1995–2004 laboratory information of all
bacterial isolates from cases of IBD in Greenland were identiﬁed. De-
mographic patient information was obtained from the Civil Registration
System in Greenland. Medical information was obtained retrospectively
from patient ﬁles.
Results: In total 281 unique bacterial isolates from 254 episodes of
IBD among 242 patients were identiﬁed; 72% of isolates from blood,
18% from cerebrospinal ﬂuid, and 10% from samples from other
compartments. In total 20 different bacterial species were identiﬁed with
S. pneumoniae (32.7% of isolates), staphylococci (20.3% of isolates),
and E. coli (15.7% of isolates) being the most common. The overall
incidence of IBD was 45 episodes/100,000/year with highest incidence
among children <2 years and the elderly. Incidence was higher in
ethnic Greenlanders than in Danes (51 vs. 29 episodes/100,000/year,
respectively, age adjusted incidence rate ratio 1.8). Twenty-two percent
of patients had an underlying medical condition relevant to the risk of
IPD such as chronic lung infection, cancer, systemic immunosuppressive
treatment, or HIV. Seventy-six percent of patients smoked and 23%
abused alcohol. Overall mortality was 19%; 29% in S. pneumoniae cases,
while the mortality associated with N. meningitidis and H. inﬂuenzae
type B was 0%.
Conclusion: The importance of S. pneumoniae as a cause of IBD in
Greenland was conﬁrmed, also relative to other IBD-causing bacteria
with S. pneumoniae comprising 1/3 of isolates, but overall the incidence
of IBD appeared not to be uniformly increased compared with
western countries. Most IBD cases appeared in persons without known
underlying medical risk factors. Prevalence of smoking and alcohol
abuse among IBD cases was not substantially different from those of
the background population. The known high mortality in Arctic areas
associated with S. pneumoniae was conﬁrmed, but clinical presentation,
severity and outcome of other IBD cases was highly heterogenous and
depended on the causal microorganism.
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P1833 Histoplasma capsulatum var. capsulatum endocarditis in
metropolitan France
A. Lefort, F. Dromer, F. Tamion, L. Favennec, C. Bouges-Michel,
T. Lecompte, M.F. Biava, E. Moalic, A. Renault, O. Lortholary for
the MYCENDO Study Group
Objectives: 44 cases of Histoplasma capsulatum endocarditis (HcE)
have been reported in the literature since 1943. We report 4 additional
imported cases of HcE recently observed in metropolitan France through
the surveillance performed by the National Reference Center for
Mycoses and Antifungals.
Methods: Two HcE cases were collected through the French nationwide
prospective study on fungal endocarditis “MYCENDO” (2005–2006).
Two additional cases had been observed earlier.
Results: See the table.
Characteristics Case 1 Case 2 Case 3 Case 4
Year 1993 2003 2005 2006
Age (y) 39 81 58 75
Gender Female Male Female Male
Stay in endemic area
(dates)
Haiti (1954–83) Guinea, Cote d’Ivoire
(1950−4)
Cuba (2002),
Brazil (2003)
Brazil (2005)
Predisposing condition HIV infection None Oral prednisone,
adalimumab
HIV infection
Prior cardiopathy No Mitral valve IE 9mo
before
No No
Time to Dg 7 d 20 d (autopsy) 1 mo 1 mo
Valve(s) involved Tricuspid Mitral Mitral Mitral
Other organs involved Lung, skin, mouth
(ulcers)
Lung, mediastinal
lymph nodes
Lung Lung, bone marrow
Lung and bone
Mycologic Dg BAL and bronchial
biopsy direct exam.
BAL, skin and oral
lesions culture; Ab
BAL direct exam.;
Autopsy lymph node,
mitral valve and lung
valve direct exam.
Leg arterial
embolism and
mitral valve direct
exam.
marrow direct exam.,
PCR (autopsy valve
culture medium), Ab
Medical treatment
(duration)
AmB (2mo);
oral itra (22mo)
AmB (1 d) LAmB (65 d),
IV itra (6 d)
LAmB (2 d)
Cardiac surgery (date
from Dg)
No No Yes (d 1) No
Outcome (follow-up
duration, cause of
death)
Death (2 y,
P. aeruginosa
sepsis)
Death (l d, HcE) Death (2.5mo,
valve thrombosis)
Death (2 d, HcE)
Ab, antibodies; AmB. amphotericin B; BAL, bronchoalveolar lavage; d, day; Dg, diagnosis; exam., examination;
HIV, human immunodeﬁciency virus; IE, infective endocarditis; itra, itraconazole; IV, intravenous; LAmB, liposomal
amphotericin B; mo, months; P. aeruginosa, Pseudomonas aeruginosa; y, years.
Conclusions: Despite the availability of active antifungals, prognosis
of HcE remains very poor and contrasts with that of disseminated
histoplasmosis even in immunocompromised hosts; one explanation may
be a delayed diagnosis thereby emphasising that European clinicians
should suspect HcE in culture-negative endocarditis in patients who
stayed in an endemic area, even several years earlier.
P1834 A prospective survey of intravascular-catheter related
infection in patients being treated for infective endocarditis
F. Ahmed, J. Sandoe, W. Baig (Leeds, UK)
Objectives: To determine the incidence of intravasular-catheter related
infection (CRI) in patients receiving intravenous antibiotics for infective
endocarditis (IE) and to examine whether rates of infection vary with
type of device used.
Methods: A prospective study of inpatients receiving intravenous (IV)
antibiotics for IE over a 26 month period, Jan 1st 2005 – 28th Feb 2007.
Patients classiﬁed as having Duke possible or deﬁnite IE were included
in this study. Clinical data was gathered regarding type, site and
duration of intravascular catheter used. All cases of CRI (including exit
site infections and intravascular catheter-related bloodstream infection,
CRBSI) and their sequelae were then recorded.
Results: 103 episodes treated with IV antibiotics for deﬁnite or possible
endocarditis had complete data sets and were included in the study.
15 (15%) developed CRI. Of these, 12 (12%) developed CRBSI. 5
cases of CRBSI were attributable to a non-tunnelled central venous
catheter (CVC), and 7 cases were associated with cuffed, tunnelled
venous catheters. None were associated with peripheral venous cannulae.
There were 3 cases (3%) of exit site infections in total. 2 cases was
related to a cuffed, tunnelled venous catheter and 1 case associated with
a peripheral catheter.
CRI were signiﬁcantly more frequent in patients managed with
CVC & tunnelled venous catheters compared to those managed with
peripheral cannulae (p =0.0018, Fisher’s exact test). In all cases of
CRBSI and exit site infection the culprit device was removed. The
most frequently implicated pathogens causing CRBSI were, coagulase
negative staphylococci, enterococci and Candida spp. There were no
serious complications associated with peripheral cannulae.
Conclusion: CRI with serious adverse events occurred during treatment
of IE. CRBSI was more common than exit site infections. Rates of
CRBSI were greatest with CVC’s and cuffed, tunnelled venous catheters.
Peripheral venous catheters and were not associated with CRBSI or
serious sequelae. Where possible placement of central venous catheters
solely for delivery of antibiotics should be avoided and peripheral
cannulae used instead. We are moving away from routine use of central
venous access for delivery of antibiotics in these patients due to the
frequency and seriousness of complications.
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P1835 Q fever in New York City: report of a rare and unusual case
C. Pavia, C. McCalla (New York, US)
Objectives: Since the year 1999, human Q fever has become a reportable
disease throughout most of the United States. It is extremely rare in the
New York City (NYC) area, with only 5 cases being reported over the
past 6 years. The aim of this study is to describe an unusual Q fever
case, which is the ﬁrst well documented case of its kind occurring in the
Queens section of NYC.
Methods: Biopsied tissue samples derived from the patient’s liver and
bone marrow were analysed for pathological changes and for pathogenic
organisms after staining with hematoxylin-eosin, Giemsa and the Gram
stain. Serum was analysed for elevated immunoﬂuorescent antibody
(IFA) titers to Coxiella burnetii antigens.
Results: In April 2006, a 46-year-old male resident of Queens, NY,
presented with 2 weeks of fever, chills, sweats, and a 1 year history
of frequent urination. He appeared anicteric, had undulating fevers
with a Tmax of 104oC, but had no rash or cervical adenopathy. He
had not traveled outside the NYC area for the past 20 years since
immigrating from Guyana, South America, to the USA in 1986. He
denied any recent exposure to farm animals or possible insect vectors.
CT scan revealed hepatosplenomegaly, and there was a slight pleural
effusion on chest x-ray. Laboratory tests revealed leucocytosis, abnormal
liver enzyme levels, haematuria and proteinuria. Granulomatous changes
appeared in both bone marrow and liver. A non-culturable Gram-negative
coccobacillus was identiﬁed following bone marrow biopsy. Q fever was
suspected and conﬁrmed based on elevated phase I and phase II serum
IgM/IgG antibodies against C. burnetii. The patient was treated with a 2
week course of doxycycline and his disease status improved dramatically
and he has remained symptom-free.
Conclusion: Our ﬁndings indicate that an extremely rare case of Q fever
occurring in a non-rural or highly urbanised setting emphasizes the need
to consider such an unusual zoonotic infection as the possible cause of
prolonged fevers, chills, and urinary and/or hepatic abnormalities.
P1836 Outbreak investigation of a Q fever outbreak in a rural
setting in the Netherlands
I. Karagiannis, B. Schimmer, A. van Lier, A. Rietveld,
P.M. Schneeberger, B. van Rotterdam, A. Timen, C. Wijkmans, Y. van
Duynhoven (Bilthoven, ’s Hertogenbosch, NL)
Objectives: Annually, 5 to 20 cases of Q fever are reported in The
Netherlands. In May 2007, an alert was issued in a rural area in the south
of The Netherlands about an unusual increase in adult pneumonia cases.
These were were later attributed to Coxiella burnetii in what ended up as
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the ﬁrst described human outbreak of community-acquired Q fever in the
country. Active case ﬁnding and a case control study were performed
in the epicentre of the outbreak in order to identify risk factors for
acquisition of Coxiella infection and the mode of transmission.
Methods: A case-control study was performed in three villages
(population 12500) with the highest attack rate. In total, 35 cases and 697
controls from this cluster area were invited to participate in the study to
achieve at least a 1:2 case-non case ratio, taking expected seropositivity
rates (15%) and anticipated participation rates into account. All study
participants were screened for acute Q fever infection with IFA (Focus
Diagnostics) for phase I and II IgG and IgM antibodies with a single
1:64 serum dilution. A standardised questionnaire was administered for
identiﬁcation of potential risk factors. Univariate and multiple logistic
regression analyses were performed. Geospatial analyses were done
to assess the distance of cases’ residence to goat farms in the area.
Environmental and animal samples were taken from a commercial and
a hobby goat farm.
Results: Of the 408 participants at risk at the beginning of the study, 76
(18.6%) were found to be positive for acute Q fever infection. The most
frequent symptoms were fatigue (44.0%), headache (43.1%), inﬂuenza-
like symptoms (41.3%), cough (37.0%) and fever (30.6%). The overall
attack rate in the most affected village was 12.6% (age range 18–
84 years, corrected for overall age and sex distribution). Both farms
were positive for C. burnetii by use of PCR (41 out of a total of 77
samples). Preliminary risk analyses showed that attack rates for acute Q
fever infection were higher in the proximity of positive goat farms. The
extremely dry weather conditions in April may have played a contributing
role in this outbreak.
Conclusion: Over 260 inhabitants of the most affected village are
estimated to have acquired C. burnetii infection in the spring of 2007.
C. burnetii infected goat farms in the region appear to be a risk factor.
Further analyses should elucidate if other risk factors were involved as
well.
P1837 Pulmonary involvement in leptospirosis, Northern Greece
D. Theocharidou, K. Loga, A. Papa-Konidari (Thessaloniki, GR)
Objectives: Leptospirosis is a zoonotic disease of great importance,
caused by spirochetes of the genus Leptospira. Its clinical presentation
may vary from a ﬂu-like-syndrome to the severe form of Weil’s disease.
Recently, co-existing pulmonary manifestations are becoming more
prevalent, with a reported incidence of 20–70%. Leptospirosis is endemic
in Greece, and cases, sometimes severe or even fatal, occur every year.
Aim of the present study was to ﬁnd out the prevalence and the severity
of respiratory leptospirosis cases in Northern Greece.
Methods: Epidemiological and clinical data from 123 patients with
conﬁrmed leptospirosis who were hospitalised during 1998–2007 were
analysed retrospectively. The median age of patients was 51 years (6–83
years) and most (82.1%) of them were male. Diagnosis of leptospirosis
had been achieved by serological and/or molecular methods.
Results: The source of infection was deﬁned in 63 cases: 73% rural,
occupational exposure (farmers), 14.3% urban occupational exposure,
6.5% house-holding activities, 3.2% recreational activities. The icteric
form of the disease was present in 44.7% of the cases, and 22% had
the classical Weil’s disease. The mortality rate was 8%. Among patients,
25.2% presented pulmonary manifestations, with main symptoms being
cough, haemoptysis and dyspnea; half of those cases turned out to
Adult Respiratory Distress Syndrome or Acute Respiratory Failure.
The mortality rate of patients with respiratory involvement was 28.6%.
It was found that pulmonary manifestations in leptospirosis correlate
signiﬁcantly with the mortality rate (OR= 5.2, 95%CI: 1.38–20.18,
p = 0.015< 0.05).
Conclusion: Leptospirosis in Greece is closely related to rural
occupation and affects mainly males. Jaundice is a very common
symptom, most probably related with the causative Leptospira species.
Respiratory leptospirosis is quite common (25.2% of hospitalised cases)
and appears to be a high risk factor for fatal outcome, deteriorating the
patient’s prognosis and increasing mortality rate. Prompt and accurate
diagnosis and treatment are essential for patients’ life.
P1838 Leptospirosis: prognostic factors associated with mortality
A. Rodrı´guez-Guardado, M. Rodrı´guez Pe´rez, V. Asensi, P. Alonso,
J. Ferna´ndez, A. Sampere, J.A. Carto´n (Oviedo, ES)
Background: Leptospirosis is a zoonosis that occurs worldwide. It is
characterised by great clinical variability ranging from a mild ﬂu-like
illness to acute life-threatening condition. We conducted a retrospective
study to identify the factors associated with the prognosis and mortality
of this infection.
Methods: All the episodes of leptospirosis diagnosed in the Hospital
Central de Asturias, a universitary hospital in the Northern of Spain,
between 1997–2007 were retrospectively reviewed. The diagnosis was
based on a positive serology using an indirect agglutination test or
IgM speciﬁc ELISA and a clinical setting consistent with leptospirosis.
Continuous valous were compared using Student t test or U of Man-
Whitney. Categorical values were compared using Fisher’s exact test
or chi2-test. A p value less than to 0.05 was considered statistically
signiﬁcant
Results: Twenty-three episodes were reviewed. Seventy-three (70%)
patients were male, (mean age 51 years, limits 17–79). All patients
have pertinent epidemiological context, including occupational exposure
(19 cases) or swimming in a river (4 cases). All patients have positive
agglutination from 1/32 to 1/10565 and fourteen patients have IgM
positive. The mean delay between onset the ﬁrst symptoms and hospital
admission was 6±4 days (limits 2–18 days). In the blood test all the
patients showed impaired liver function: AST (mean 465 IU/L; limits
100−4.300), ALT (mean 678 IU/L; limits 111−8.862) and bilirrubine
(mean 11.68; limits 4–40). Nineteen patients showed impaired renal
function: creatinine (mean: 3.6; (limits 1.2−7.6) and urea nitrogen
(mean 128, limits 33–267). All patients received antibiotic treatment
except one patient that dead before the treatment. The treatments were:
intravenous penicillin (8 cases), ampicillin (6 cases), third-generation
cefhalosporines (6 cases) and doxicycline (one case). 30% of the
patients were admitted to the ICU. The most frequents complications
were: distress respiratory (9 cases), haemorrhages (4 cases) and renal
insufﬁciency (5 cases). Seven patients (30.6%) dead due to infection.
The mortality was associated with: impaired renal function (P = 0.20)
and presence of distress respiratory (6 vs 9, p = 0.007, OR= 0.04) in
univariable and multivariable analysis.
Conclusion: The mortality of leptospirosis remains high despite the
treatments and admission in intensive care unit. The mortality is
associated a severe renal disease, and lung complications.
P1839 Leptospirosis: overview of the 2004–2007 cases in a
Portuguese population
R. Matos, C. Benoliel, A. Matos, J. Santos, A. Moniz (Lisbon, PT)
Leptospirosis is a very acute disease caused by Leptospira interrogans
(sensu lato). The range of symptoms can vary from ﬂue like symptoms
to renal failure, haemorrhagy and jaundice. The disease is widely spread
all over the world, with a higher incidence is the tropical areas of the
globe. In Portugal, the average number of declared cases for the past 5
years (2002–2006) was 48 cases/year, with a higher incidence on adult
men. The Instituto Nacional de Sau´de Dr. Ricardo Jorge (INSA) is one of
the few laboratories in the country diagnosing the disease, and receives
serum samples from all over Portugal to perform the MAT (Microscopic
Agglutination Test).
The main objective of this work is to present an overview of the main
results obtained for the leptospirosis diagnosis in INSA.
Mat was performed on 1640 serum samples sent to INSA by hospitals
from all the country, during 2004–2007. The tested serogroups were:
Australis, Autumnalis, Canicola, Celledoni, Cynopteri, Grippotiphosa,
Icterohaemorragiae, Louisiana, Mini, Pomona, Rachmati, Sejroe, Sher-
mani. These samples came from patients who were suspicious for
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leptospirosis. 98 patients were positive (presented MAT titers 100).
75% of the positive cases were male. The average age was F=55 years
(min = 18 max=75); M=57 years (min = 23 max=86). These results are
consistent with the epidemiology of the disease, being a disease of rural
workers. Cases occurred mainly in the spring and autumn, the rainiest
seasons in Portugal, as expected. In fact, the spread of leptospires is
increased during the wet seasons. The majority of the cases (52%)
occurred in the North of Portugal (more rural areas), 23% in the Lisbon
area. The analyses of In the north of Portugal, the most frequent speciﬁc
serogroup agglutination found was with Louisiana (n = 9; 17% of the
cases), Pomona (n = 7, 14%) and Ballum (n = 5, 10%). In the Lisbon
area, the most frequent speciﬁc serogroup agglutination was Ballum
(n = 5, 23%) and Australis (n = 4, 17%). In 24% of the cases no speciﬁc
serogroup agglutination was observed. In these cases, sera presented
mild agglutination in most of the serogroups tested.
Leptospirosis is still an important health problem, with a considerable
number of cases/year in Portugal, and, in the eminence of climate
changes, it may become a very important problem in Mediterranean
countries.
P1840 Inﬂuence of climatic factors on tick-borne encephalitis
incidence in the Czech Republic
M. Daniel, B. Kriz, V. Danielova´, J. Valter, I. Kott (Prague, CZ)
Objectives: The major objective was to ﬁnd out whether there exist any
demonstrable relationships between the incidence of human tick-borne
encephalitis (TBE) infections and meteorological factors, to specify their
character and make an attempt at an interpretation of the action of the
latter.
Methods: Epidemiological data were extracted from the EPIDAT
database (National Institute of Public Health, Prague). The basic datum
characterising each case was the date of primary symptoms, whereby
in comparisons with the course of the weather enabling to respect the
incubation period (since the attachment of an infected tick). Analysed
was a total of 4613 cases of disease in 1994–2001. The results obtained
were compared with those in later years.
Meteorological data were from the database of the Czech Hydromete-
orological Institute in Prague. That contained data (9 parameters) from
22 selected stations located in a region of the Czech Republic known
for its continued incidence of TBE.
Statistical methods testing the relationship between TBE occurrence as
a dependent variable with meteorological factors in the role of predictor,
were carried out with the aid of the STATISTICA6 package.
Results: A linear relationship has been found between TBE incidence
and temperature factors in all the years under study. Quadratic relations
(with a shift in time by 6–15 days with respect to incubation of the
infection) were demonstrably better in precipitation, relative humidity
of the air and soil. In the period under follow-up, vast year-to-year
differences in weather characteristics were observed over the warm
period. In combination with data on TBE incidence it was possible in
each year under follow-up to identify an extraordinary in character period
of time fundamentally inﬂuencing this infection.
Conclusions: Effects of the current course of the meteorological
situation (as well as long-term year-to-year changes) on TBE incidence
are foremost mediated by the inﬂuence of climatic factors on Ixodes
ricinus ticks and their host-seeking activity. These mutual connections
have been demonstrated in parallel a long-term monitoring of this
vector and the manifested human TBE virus infections. Under certain
conditions there also have to be taken into account the effects the
momentary meteorological situation has on human behaviour in as TBE
in the Czech Republic is a recreational infection.
P1841 Shifts in the altitudinal distribution of the tick-borne
encephalitis virus and the incidence of disease inﬂuenced
by the warming climate in the Czech Republic
V. Danielova´, M. Daniel, S. Kliegrova´, B. Kriz (Prague, Hradec
Kra´love´, CZ)
Objectives: The sharp increase in tick-borne encephalitis (TBE)
incidence in the 1990s and its high level were not evenly spread over
the whole territory of the Czech Republic. It was manifest markedly
in the Highland Region where TBE incidence is double that of the
countrywide average. Therefore, an environmental epidemiological study
has been undertaken and the results compared with a long-term follow-
up of changes in the vertical distribution of Ixodes ricinus ticks and
of the infectious agents transmitted by them, as inﬂuenced by climate
warming in the area of the Krkonosˇe Mts., the highest mountain range
in the Czech Republic.
Methods: Data on the incidence of human cases of TBE, including
the places of probable infection have been excerpted from the EPIDAT
data base (National Institute of Public Health, Prague). Meteorological
data are from the data base of the Czech Hydrometeorological Institute
(CHMI), Hradec Kra´love´ and from CHMI, Prague. Data on cleft-hoof
game are from the data base of the Czech Ministry of Agriculture. For
the evaluation of the average annual and monthly temperatures, the least-
squares multiple linear regression was used.
Results: In the decades 1971 through 1992 the incidence of TBE
in the Highland Region didn’t reach the countrywide average, a rise
being noted only since 1997; in the year 2006, TBE incidence was
more than double that of the countrywide average. There have not
been found any socio-economic or land-use changes or any in the
numbers of game animals, that could have had an effect on the situation.
The rise was markedly steeper in localities with occurring infection
above 500 m a.s.l. than below that level. At those altitudes there
was observed an increase in average monthly temperatures above the
countrywide average, namely over the period of maximum I. ricinus
activity (May–August). Comparisons with results of long-term ﬁeld
experiments in the Krkonosˇe Mts., conﬁrm the causal connection
between the meteorological phenomenon and increased TBE incidence.
Conclusions: Analyses made show that in locations at higher altitudes
(at the previously observed vertical limit of I. ricinus) the increase in
average temperatures in the spring-summer season is greater than that of
the overall average in the Czech Republic. At a summer vertical gradient
of 0.6 ºC/100 m, a systematic 1.1−2.8ºC change in the Czech-Moravian
Highland corresponds to environmental conditions formerly prevailing
at altitudes lower by around 200−450m.
P1842 Prevalence of antibodies to Bartonella henselae in patients
with suspected cat scratch disease in Crete, Greece
G. Minadakis, A. Psaroulaki, D. Chochlakis, D. Kofteridis, A. Gikas,
Y. Tselentis (Heraklion – Crete, GR)
Introduction: Cat scratch disease (CSD) is caused by a fastidious
intracellular Gram-negative bacillus as result of cat contact or kitten ﬂeas
contact. In immuno-competent patients it causes a self-limited disease,
which often resolves without therapy, characterised mainly by fever and
regional lymphadenopathy. In immuno-compromised patients it causes
bacillary angiomatosis, liver and splenic peliosis.
A number of atypical cases of CSD implicating encephalitis, endocardi-
tis, osteomyelitis, Parinaud occuloglandular syndrome, granulomatous
hepatitis, neuroretinitis, transverse myelitis, show severe morbidity and
complicated course. Symptoms such as persistent fever, night sweats and
malaise can simulate malignancy leading to expensive, unnecessary and
often invasive evaluations.
Patients and Methods: From January 2006 to November 2007 470
serum samples, of patients hospitalised in the 5 major hospitals in
Crete, were examined using IFA. Titers of IgG 1/512 or IgM 1/80
or IgG 128 and IgM 40 were considered as serologically positive.
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Results: Of the 470 samples tested, 15.7% (74/470) revealed positive
IgG titers, 19.1% (90/470) revealed positive IgM titers and 21.7%
(102/470) revealed positive titers for both IgM and IgG. Thirty seven
percent (65/176) of males and 36.5% of females (95/260) were
serologically positive. Of the 57 patients for which a second sample was,
also, tested, 34 (59.6%) showed seroconversion. During the 4 seasons the
seropositivities were: December-February 26.9% (28/104), March-May
35% (43/123), June-August 39.3% (48/122) and September-November
33.3% (48/144).
Of 40 of the seropositive patients, medical and epidemiological
history was obtained and the predominant clinical manifestations were
fever (60%), lympadenopathy (67.5%), spleen enlargement (10%),
arthralgia (7.5%), headache (5%), malaise (5%), anorhexia (5%), vomits
(2.5%), haematuria (5%), rash (5%), impaired vision (5%), tonsilar
hypertrophy (2.5%) and red swollen tonque (2.5%). Other symptoms
were: rhinitis, Gullain Barrett syndrome, encephalitis, pericarditis and
liver enlargement. Cat scratches or contact with cats were conﬁrmed in
10% of cases.
Conclusions: Accurate and timely diagnosis is, therefore, of clinical
importance.
P1843 Seropevalence study of cat scratch disease in Crete, Greece
G. Minadakis, A. Psaroulaki, D. Chochlakis, S. Kokkini, A. Gikas,
Y. Tselentis (Heraklion – Crete, GR)
CSD is considered as an emerging disease and its causative factor has
been established to be Bartonella henselae. The primary reservoir of this
bacterium is the cat and its ﬂeas.
Purpose: The purpose of this study was to establish the seroprevalence
of B. henselae antibodies in a representative sample of healthy blood
donors in the island of Crete.
Materials and Methods: 481 samples of healthy blood donors
(statistically representative sample) were collected randomly, from July
2005 to October 2006, from the respected units of the major hospitals
in the 4 prefectures of Crete. All samples were tested by IFA (FOCUS,
USA) against IgM and IgG antibodies of B. henselae (cut-off points: IgG
1/64, IgM 1/20). To perform the statistical analysis the donors were
separated into 5 age groups (<20, 21–30, 31–40, 41–50, >51), gender
(males and females), 2 groups based on occupation (low and high contact
possibility with the pathogen), and 2 groups based on residence (urban
and rural). The statistical analysis was performed using SPSS v. 13.
Results: The seroprevalence against IgG antibodies was estimated at
43.2% (208/481), while the titers ranged from 0 to 1/1024. Seventeen
percent of these IgG positive sera, also, revealed positive titers against
IgM antibodies.
In each respecting prefecture, the seroprevalence was as follows:
Prefecture of Heraklion: 48.1% (78/162), prefecture of Rethymnon:
45.2% (42/93), prefecture of Chania: 50.5% (52/103), prefecture of
Lassithi: 34.1% (31/91). A lower seroprevalence was recorded in males
(42.2%) than in females (44.9%). The highest seroprevalences were
observed among the age groups of 41–50 (49.2%) and 21–30 (43.9%).
No statistically signiﬁcant differences were revealed among the age
groups (t = 0.81, f = 0.39), gender (t = 0.39, f = 0.71), and residence
(t = 0.99, f = 0.00). A statistically signiﬁcant difference was observed
between the two occupation groups (t = 0.038, f = 4.35).
Conclusions: We conﬁrmed the increasing frequency of the Cretan
population towards the exposure to the pathogen. Due to the high
seroprevalence revealed, it is guessed there might be inconspicuous
B. henselae infections among the population. Clinicians should include
B. henselae as an agent of potential infection in patients with
lymphadenopathy, fever, and history of cat contact.
P1844 Changes in the activated cytotoxic suppressor T-lymphocytes
in elderly patients with Mediterranean spotted fever
M. Gospodinova, M. Nenova (Varna, BG)
Aging of the population is the process with the steadiest development.
Clinical observations of the aging process lead to the conclusion that old
age is the most widely distributed type of immunodeﬁciency.
Objectives: To ﬁnd if changes happen in the cytotoxic suppres-
sor T-lymphocytes in elderly patients with Mediterranean spotted
fever(MSF).
Methods: We investigated the cell immunity of 20 patients of age over
60 years with MSF, using immunoﬂuocytometry. The control group was
composed of 10 young patients and 10 healthy individuals over the age
of sixty. The data were processed using several statistical methods. In the
investigated group 43.3% of the patients had severe form of the disease,
46.6% had intermediate clinical course, 10.1% had mild forms.
Results: Signiﬁcantly more increased expression of CD8+/CD38+ was
found in the elderly patients (22.35±4.71), compared to the patients
of the control group – (22.35±5.76) for the young patients and
(22.43±7.31) for the healthy persons over 60 years (p< 0.05 for both).
The correlative dependence r for CD8+/CD38+ for the healthy elderly
is 0.59; for the young patients is 0.37; for the elderly in the investigated
group is 0.03. These results are determined not only by the age but also
by the severity of the illness.
Conclusion: Expression of the activated cytotoxic suppressor
T-lymphocytes in elderly patients with MSF is increased and shows
correlation with the severity of the disease.
P1845 Tick-borne rickettsiosis in the Altai region of Russia
S. Shpynov, P.E. Fournier, N. Rudakov, I. Arseneva, M. Granitov,
I. Tarasevich, D. Raoult (Omsk, RU; Marseille, FR; Barnaul,
Moscow, RU)
Objectives: North Asian tick typhus (NATT) is a tick-borne zoonosis
caused by Rickettsia sibirica ssp. sibirica (R. sibirica) in the Asiatic
part of Russia. More than 66,000 cases of NATT have been registered
in Russia from 1936 to summer 2007. In the Altai region of West
Siberia, the average morbidity is 50 100,000 inhabitants per year.
NATT is transmitted to humans by Dermacentor nuttalli, D. silvarum,
D. marginatus, D. reticulatus, Haemaphysalis concinna and Ixodes
persulcatus. In addition, R. sibirica and R. raoultii were detected using
PCR in D. nuttalli ticks collected in the Altai Republic. We carried
out molecular identiﬁcation of a collection of 15 spotted fever group
(SFG) rickettsiae cultivated from patients and from ticks from Altai
from 1965 to 1989. We also screened ticks collected in forest-steppe
zone of Altai region (Aleiskiy, Byiskiy and Shypunovskiy districts) for
alpha-protobacteria from the order Rickettsiales.
Methods: Rickettsial strains were identiﬁed using partial ampliﬁcation
of the 5′-end of the ompA gene (190–70 and 190–701 primers). alpha-
protobacteria were detected in ticks by amplifying the gltA gene (CS1d-
CS535r and CS409d-RP1258n primer pairs). Positive PCR products were
sequenced and compared to GenBank.
Results: Fourteen strains were identiﬁed as R. sibirica. These strains
were isolated from humans (2) and six ticks species (D. nuttalli [2],
D. silvarum [2], D. marginatus [4], D. reticulatus [2], H. concinna [1]
and I. persulcatus [1]). The remaining strain, isolated from H. concinna,
was identiﬁed as R. heilongjiangensis.
In D. reticulatus and D. marginatus ticks, we detected R. raoultii. In
I. persulcatus collected in Aleiskiy district, we detected “Candidatus
R. tarasevichiae”, Ehrlichia muris, Anaplasma phagocytophilum, a
rickettsia closely related to R. tamurae, bacterium “Montezuma” and
R. raoultii. Several of these ticks were co-infected by two or more
of these bacteria. In H. concinna, we detected a co-infection with
R. heilongjiangensis and R. raoultii.
Conclusion: We conﬁrm the aetiological role R. sibirica as agent of
NATT, and the role of six tick species as vectors for this agent. However,
we detected several other members of the order Rickettsiales, some
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of which being recognised pathogens, in ticks from Altai. Our results
highlight the need to pursue molecular identiﬁcation of tick-borne human
infections in this region.
P1846 Diphtheria in Latvia – Still important healthcare problem
B. Rozentale, J. Storozenko, A. Aukstikalne, V. Kuse, I. Vingre (Riga, LV)
Introduction: Diphtheria in Latvia and other former USSR republics
broke out during the last decade of the 20th century. The reason was
shortcomings in diphtheria surveillance and immunisation programmes.
The highest number of cases in Latvia was recorded in year. The aim
deﬁned by World Health Organisation in 1999 was to decrease diphtheria
incidence in Europe by year 2010 to 0.1 cases per 100,000.
Aims, Material and Methods: Using retrospective analysis of case-
records – to summarize results of immunological examinations,
peculiarities of the course and outcomes of diphtheria in 25 patients
treated in Infectology Center of Latvia (ICL) during the year 2006.
The other aim was to detect level of antitoxic antibodies in blood of
ICL employees by Corynebacterium diphtheriae IgG-ELISA (NovaTec
immundiagnostica GmbH).
Results: There are 32 diphtheria patients registered in Latvia during the
year 2006, it means – 1.4 per 100,000 inhabitants. Twenty ﬁve of them
were treated in ICL. Patients age ranged from 18 to 63 years. In all cases
Corynebacterium diphtheriae toxig. gravis was isolated from pharynx.
From those only 2 patients in the age group between 20 and 25 years
were vaccinated. Others either were not vaccinated according to deﬁned
scheme or considered themselves non-vaccinated. In ten patients severe
course of disease with complications – myocarditis, nephritis, bulbar
syndrome and polyneuropathy developed. There were 3 lethal cases.
Mild course of disease was observed in two vaccinated 20 and 23 year
old subjects. The level of determined antitoxic antibodies indicated that
patients have not good individual protection from diphtheria.
Antitoxic antibodies against Corynebacterium diphtheriae were detected
in 340 employees of ICL. Vaccination according to the deﬁned
immunisation scheme has been performed only in 209 persons. In 70
persons concentration of antibodies were below protective level of 0.1
IU/ml. Twenty two of them were vaccinated according to the deﬁned
scheme. The lowest level was observed in employees older than 45 years.
Conclusions:
1. The high incidence of diphtheria in Latvia is due to lack of protective
immunity.
2. Priority in prevention of diphtheria is vaccination of all non-immune
individuals.
P1847 Weissella spp.: lactic acid bacteria emerging as a human
pathogen
W. Kulwichit, S. Nilgate, S. Krajiw, C. Unhasuta, T. Chatsuwan,
A. Chongthaleong (Bangkok, TH)
Objectives: Weissella is lactic-acid bacteria closely related to Leu-
conostoc and Lactobacillus. Human infections are rarely reported. We
reviewed Weissella clinical isolates in our institute during the past
decade.
Methods: Catalase-negative, Gram-positive bacteria from clinical
specimens from 1997-present were studied. The bacteria were tested by
manual phenotypic assays (vancomycin MIC, Gram’s stain, PYR, LAP,
gas from MRS broth, and ADH), API 20 STREP commercial assay, and
some by API 50 CHL. Isolates phenotypically identiﬁed as Leuconostoc,
Lactobacillus or Weissella were subjected to 16S rDNA sequencing (J
Clin Microbiol 2003;41:4134). Final identiﬁcation as Weissella required
both compatible phenotypic characteristics and at least 99.5% sequencing
similarity to a Weissella GenBank isolate plus a signiﬁcantly lower
degree of sequence matching with the other genera. Clinical details of
the patients were then studied for the Weissella isolates.
Results: Of thousands of catalase-negative coccoid or coccobacillary
bacteria, 51 met either the manual or the commercial phenotypic criteria.
11 isolates had ﬁnal identiﬁcation as Weissella (Table). A young female
with arteriovenous malformation involving left mandible, having under-
gone surgical removal and bone grafting, suffered from postoperative
osteomyelitis with chronic discharge. She received ampicillin-sulbactam
and operative debridement of necrotic bone. Culture of the bone tissue
grew Weissella confusa. An elderly female with long-standing bilateral
uveitis and reactive VDRL and TPHA underwent lumbar puncture to
evaluate for neurosyphilis. The cerebrospinal ﬂuid had visible blood
contamination, revealed no evidence of inﬂammation nor reactive for
VDRL, but grew W. cibaria. She received penicillin therapy for syphilis
(which might as well have covered Weissella). All positive blood cultures
were of either single-bottled or one-of-two types. Although weissella is
not generally considered skin ﬂora, transient ‘bacteraemia’ in our cases
makes clinical correlation difﬁcult.
Conclusion: Weissella has been rarely reported clinically. The organism
is of low virulence. Infections occur mostly in patients with impaired
host defence, with foreign materials, and with antimicrobial pressure.
Without knowledge of this group of organisms and availability of full-
scale phenotypic and genotypic assays, these bacteria would be identiﬁed
as either viridans or other streptococci, Leuconostoc, or Lactobacillus.
Organism
% seq. identity
Clinical
specimen
Relevant
clinical
diagnosis
C*
or
H*
Host status Antibiotic
pressure
Foreign
body or
device
Clinical
signiﬁcance
Treatment &
outcome
W. cibaria
100%
blood chronic
arthritis
U normal yes tiny piece
of wood
probable drainage &
antibiotic
recovered
W. confusa
99%
blood fever with
rash
C Infant no no probable spontaneous
recovery
W. viridescens
99.9%
blood +ve blood
culture
U diabetes
stroke
no PEG tube possible antibiotic
expired
W. cibaria
100%
postmortem
lung swab
probable
aspiration
pneumonia
C epilepsy no no probable expired on
arrival
W. confusa
99.6%
bone chronic
osteomyelitis
H postoperative
complication
yes no yes debridement
antibiotic
recovered
W. cibaria
99.5%
urine sepsis C multiple
myeloma
no no unknown N/A
W. confusa
99.9%
blood bacteraemia H alcoholic
liver dis.
stroke
yes aneurysm
clips
unknown N/A
W. confusa
99.6%
blood pneumonia C biliary atresia no no probable antibiotic
recovered
W. cibaria
99.5%
CSF† uveitis C chronic uveitis
latent syphilis
no no unknown N/A
W. confusa
99.6%
blood fever H bile duct
carcinoma
yes yes probable antibiotic
recovered
W. confusa
100%
ND ND ND ND ND ND ND ND
*community or hospital acquired; U = uncertain; N/A = not applicable; ND = no data.
P1848 Outbreak of acute gastroenteritis caused by Staphylococcal
enterotoxins affecting an Austrian school centre
H. Lagler, K. Stich, D. Schmid, R. Gattringer, W. Ruppitsch,
S. Huhulescu, F. Allerberger, W. Graninger, S. Knapp (Vienna, AT)
In September 2006 an outbreak of food poisoning (FP) in a federal
accommodation facility for pupils in Eisenstadt (Burgenland) in Eastern
Austria was reported. Shortly after a lunch that was considered
responsible for this FP, 113 (of 240) persons fulﬁlled the outbreak case
deﬁnition; yielding an overall attack rate of 47.1%. Eighty individuals
(70.8%) suffered from diarrhoea, 77 (68.1%) from abdominal cramps,
103 (91.2%) from nausea and vomiting, 28 (24.8%) developed fever and
60 (53%) had symptoms of hypotension. Most of these pupils required
ﬂuid replacement and a total of 101 persons were hospitalised. All 113
patients recovered within a period of no more than 48 h.
Previous investigations, which excluded Salmonella, EH E. coli,
Yersinia, Campylobacter or norvovirus as causative pathogens, pointed
towards S. aureus related FP. In order to identify the bacterial toxin
pattern, clonality and source of contamination, we conducted bacterial
investigations on S. aureus recovered from stool specimens of patients,
the suspicious meal as well as from nasal and palmar swabs from food
handlers.
Materials and Methods: S. aureus isolates were analysed for clonal
similarities by pulse-ﬁeld gel electropheresis (PFGE). To deﬁne the
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individual toxin-pattern of each bacterial isolate, screening of 19
previously described staphylococcal pyrogenic toxin superantigen genes
was performed by single gene PCR. The toxins investigated included the
toxic shock syndrome 1 gene tst, and staphylococcal enterotoxin- (se)
and enterotoxin-like (sel) genes such as sea to see, seg to selr and selu.
Results: S. aureus was isolated from the rice meal, from nasal and
palmar swabs of the foodhandlers and from 44 stool samples of the
patients. Almost all examined bacterial isolates (41 out of 48) displayed
an identical PFGE-pattern (1 meal, 1 palmar, 39 stool) thus indicating
a clonal outbreak. Moreover, an identical staphylococcal PTSAg gene
pattern (sea, sed, selj, selr) could be identiﬁed in 39 bacterial isolates (1
meal, 1 palmar, 37 stool) by PCR.
Conclusion: We hereby conﬁrmed the clonality and identiﬁed the
enterotoxin pattern associated with a recent outbreak of S. aureus food
poisoning in Austria. Moreover, our results enabled us to track down the
source of S. aureus to a food handler. These results, together with the
clinical course of food poisoning, once again underline the importance
of personal and kitchen hygiene among food handlers.
P1849 A case of pneumonia caused by Bacillus anthracis secondary
to gastro-intestinal anthrax
M. Meric Koc, A. Willke, B. Muezzinoglu, A. Karadenizli, T. Hosten
(Kocaeli, TR)
Objective: Gastrointestinal anthrax (GIA) is a very rare form of anthrax
with high fatality rate. We report here a fatal case of pneumonia due to
Bacillus anthracis secondary to GIA.
Case: A 59 years-old man with carotid stenosis, diabetes mellitus
and hypertension was admitted to our hospital for performing of the
elective endovascular carotid stent procedure. He had only a ﬁve-
month history of vision loss. On physical examination; his general
status was good with normal vital signs including body temperature
(36.7ºC). Systemic ﬁndings were normal except vision loss. During the
endovascular procedure, suddenly he complained severe abdominal pain.
His general status became bad with tachycardia (110/min), tachypnea
(32/min) and hypertansion (240/140mmHg). He was transferred to the
intensive care unit (ICU). Laboratory ﬁndings were as follows; WBC
count of 11400 /mm3, ESR 32mm/h, CRP 2.33mg/dl (Normal: 0−0.8).
On the following day, acute abdomen was developed and laparotomy was
performed suspicion of mesenteric ischaemia. Resected bowel section
was sent to patology. Ceftriaxon (1g every 12 h) and metronidazole
(500mg every 8 h) therapy was started. His general status and vital
signs were normal after the surgery. On the postoperative second day,
he became febrile (39ºC) and respiratory arrest was developed. After
the entubation; cultues of tracheal aspirate and blood were performed.
Following day, non-haemolytic Gram-positive bacilli similar to Bacillus
anthracis yielded on the culture of the tracheal aspiration material.
It was found out that he had consumed meat from endemic region
for anthrax from his detailed history. Previous antibiotic therapy was
stopped. Crystalise penicillin G (4MU every 4 h, intravenously) and
ciproﬂoxacin (200mg every 12 h, intravenously) was started with the
diagnosis of anthrax pneumonia. The capsule formation of the bacilli
was detected after 5 hours incubation of the bacteria in the deﬁbrinated
sheep blood. B. anthracis isolated from the patient was susceptiple to
penicillin by disk diffusion testing. Encapsulated Gram-positive bacilli
were seen in the Giemsa and Gram stain of the parafﬁn tissue section
from the necrotic ileum parts. His fever persisted and unfortunately he
died in spite of the all supportive therapy on the nineth day of the
treatment.
Conclusion: Anthrax should be considered when suspected bacilli
obtained from any culture of the patients especially in endemic countries.
P1850 A rare case of Nocardia puris postoperative endophthalmitis
D. Papaventsis, N. Siafakas, L. Kondyli, M. Akritidou, P. Pantazi,
E. Perdikari, G. Bethimoutis, L. Zerva, G. Chatzakis (Athens, GR)
Objectives: Nocardiosis is a localised or disseminated infection caused
by soilborne aerobic actinomycetes. The genus Nocardia currently
contains more than 50 species that have not been subjected to the
same level of analysis by phenotypic and molecular methods. Apart
from the two species most frequently isolated, N. asteroides and
N. brasiliensis, new species recently characterised have been reported as
human pathogens. We report the ﬁrst case of scleral buckle associated
N. puris endophthalmitis in an 80-year-old male.
Methods: The patient was initially treated in 1986 for retinal detachment
by scleral buckle surgery in Vienna, Austria. Twenty years later,
he was referred to the 2nd Department of Ophthalmology, Hellenic
Red Cross Hospital, Athens, with a severe inﬂammatory reaction
in the anterior chamber and vitreous body. After silicone sponge
explant removal, the microbiological diagnosis of a Nocardia strain was
made by conventional identiﬁcation procedures (Gram stain, modiﬁed
Kinyoun stain, colonial morphology, nitrate reductase and urease
production, esculin hydrolysis) and 16S rRNA gene sequencing and
phylogenetic analysis, according to the protocol described by Hiraishi
et al. (1992). The primers used for ampliﬁcation were the forward
primer F16S (5′-AGAGTTTGATCCTGGCTCAG-3′, position 8–27 on
the 16S rRNA gene of E. coli) and the reverse primer R16S (5′-
GGTTACCTTGTTACGACTT-3′, position 1510–1492).
Results: Pairwise comparison of the obtained 16S rRNA gene sequence
with the respective sequences of all bacterial species and strains available
in GenBank database revealed that the Nocardia isolate of the present
study had a 99% sequence similarity with Nocardia puris. The infection
resolved after systemic administration of moxiﬂoxacin hydrochloride
(400mg po q24 h for >1mo), and topical-eye combination therapy with
antibiotics and corticosteroids.
Conclusion: To our knowledge, this is the ﬁrst report of N. puris
endophthalmitis, worldwide. Postoperative endophthalmitis may occur
weeks to years following surgery, but such a delayed infection in an
immunocompetent patient was likely due to the low-virulence of the
organism introduced at the time of surgery. Surgical therapy remains
the cornerstone of therapy, however, antimicrobials, particularly newer
fourth generation ﬂuoroqunilones, seem to play an important role in
clinical recovery.
P1851 Clinical features of spondylodiscitis: a four-year survey
V. Turkulov, J. Vukadinov, A. Knezˇevic, S. Sevic, R. Doder, G. Canak
(Novi Sad, RS)
Objectives: The spinal column diseases take a prominent place in
the morbidity of adults. Spondylodiscitis represents an inﬂammatory
process, localised in the bodies of spinal vertebrae and intervertebral
disk. This research aimed to determine the most common complaints and
clinical features of patients with spondylodiscitis as well as to analyse the
correlation between the disease outcome and the beginning of therapy.
Methods: retrospective analysis of medical documentation was used,
which encompassed 40 patients treated for spondylodiscitis at the Clinic
for infectious diseases, Clinical Centre of Vojvodina, during the last
four years. The diagnosis was conﬁrmed in all patients using magnetic
resonance (MR) imaging of spinal column.
Results: The average age of the patients was 58.5 years. In most of them,
the inﬂammatory process was located in lumbar region (67.5%), then in
lumbar sacral segment of spinal column (17.5%), while in the minority
of the patients it was located in thoracic (7.5%) and cervical segment.
The time before onset of the disease and establishing the diagnosis and
beginning the therapy varied from one month (45%) to six and more
months (17.5%). In all the patients the laboratory ﬁndings showed signs
of inﬂammatory process. The aetiological agent has not been proved in
80% of them, in 12.5% it was tuberculosis of spinal column and in 7.5%
brucellosis was found out. All patients were subjected to conservative-
parenteral antibiotic therapy (tuberculostatic in case of tuberculosis).
A combination of two or three antibiotics during six weeks to six
months (51.6 days in average) was applied. Most often used antibiotics
were the third generation cephalosporins, vancomycin, metronidazole,
ﬂuorochinolones, and aminoglycosides. In 4 (10%) patients surgical
treatment was necessary in addition to the conservative one. The results
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of the therapy were followed out by clinical examination, as well as by
laboratory ﬁndings and MR imaging.
Conclusion: The outcome of the disease was favourable in most of the
patients – recovery or recuperation with lesser or major sequels. The
sooner the diagnosis was established, the more favourable outcome was.
It is important to consider this disease because timely diagnostics and
therapy shorten the duration of the illness, reduce the costs of treatment
and minimize the possibility of sequels.
P1852 Laboratory acquired brucellosis – A review of published
reports 1950–2007
C.E. Brown, N.J. Beeching, R.P.D. Cooke (Liverpool, UK)
Objectives: To review the follow up and management of people exposed
to brucellosis in laboratory settings.
Methods: Comprehensive review of all individual and aggregated case
reports of laboratory exposures to brucellosis since 1950, identiﬁed
through Medline, Scopus, reviews and textbooks. Mesh search terms
combined “brucellosis”, “laboratory infection”, “occupational exposure”,
“risk factors”, “drug therapy”.
Results: 8 reports described the outcomes after multiple staff exposures
in single laboratory incidents, with attack rates in personnel ranging from
0–31%. Approaches to post exposure risk assessment and prophylaxis
(PEP) vary greatly, but no cases occurred after receiving any type of PEP.
Compliance with prolonged post event surveillance is poor, and dual
therapies for PEP are not well tolerated. 59 cases of laboratory acquired
brucellosis were identiﬁed, of which 39 were due to Brucella melitensis:
all except one had clinical symptoms at the time of diagnosis. Risk
factors included aerosolisation and inadequate safety practices, especially
before the organism had been identiﬁed. Many treatment regimens and
durations were used, reﬂecting changes in international guidelines over
time. 17 (29%) received monotherapy. The most common regimen was
rifampicin and doxycycline for 6 weeks. 11 (19%) cases had relapse, 3
to 38 weeks after therapy ﬁnished. Cotrimoxazole was usually used in
pregnancy. Of 6 pregnant women, only 3 delivered at term.
Conclusions: Brucellosis remains a hazard for laboratory staff. There is
no clear evidence base for the correct PEP regimen but monotherapy is
better tolerated. A standardised approach to risk assessment, surveillance
and PEP is being developed, based on this literature review and an
ongoing survey of recent laboratory experiences in the UK.
P1853 Pandrug-resistant Klebsiella pneumoniae, Pseudomonas
aeruginosa, and Acinetobacter baumannii infections:
characteristics and outcomes in a series of 28 patients
M. Falagas, P. Rafailidis, D. Matthaiou, S. Virtzili, D. Nikita,
A. Michalopoulos (Athens, GR)
Objectives: Clinical data regarding nosocomial infections due to
pandrug-resistant (PDR) Gram-negative bacteria and their outcome are
scarce. We describe our experience on the outcome of PDR Klebsiella
pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii
infections.
Methods: Retrospective, observational study of hospitalised patients at a
tertiary-care hospital during a 17-month period (1/1/2006–31/05/2007).
Results: Twenty-eight patients with isolation of PDR Gram-negative
bacteria were identiﬁed; 24 patients had infection and 4 colonisation.
The most frequent PDR isolate was K. pneumoniae (24 isolates); three
isolates were P. aeruginosa and 2 A. baumannii. The site of infection
was central venous catheter related in 6 out of 24 patients, bacteraemia
5, respiratory system 5, surgical site 4, urinary system 2, ascitic ﬂuid
1, and central nervous system 1. Twenty of 24 patients with infection
received an antibiotic regimen containing colistin (in combination with
meropenem in 8). The overall in-hospital mortality was 41.6% (10/24);
8 patients died because of the PDR infection (infection-related mortality
33.3%). Signiﬁcant comorbidity was present in patients that died but
also in survivors.
Conclusions: PDR Gram-negative bacterial infections are associated
with considerable mortality, though not that high one would think of,
given the fact that the isolates were resistant to all tested antibiotics,
including polymyxins. Antibiotics that are ineffective in vitro may prove
life saving for some of these patients, especially combination regimens
containing colistin. However, comparative studies are necessary to
estimate the attributable mortality of these infections and the appropriate
treatment
P1854 Isolation of carbapenemase-producing Pseudomonas otitidis
from a patient with chronic otitis media
K. Lee, C.K. Kim, D. Yong, J.H. Yum, M.H. Chung, Y. Chong,
M.C. Thaller, G.M. Rossolini (Seoul, KR; Rome, Siena, IT)
Objectives: To report otitis media due to metallo-b-lactamase (MBL)-
producing isolate of Pseudomonas otitidis.
Methods: A 53-year-old man visited a Korean Eye and ENT hospital
in April 2005. The patient had chronic otitis media since childhood.
At the time of the visit, otalgia was absent but purulent discharge
from perforated tympanic membrane was present. Prulent material
was cultured and susceptibility was determined by tests of CLSI disk
diffusion, broth microdilution and E-test. 16S rRNA gene sequencing
was used to identify the species.
Results: A culture of the purulent material yielded two isolates,
identiﬁed as Pseudomonas aeruginosa (PAE) by conventional tests, of
which one was resistant to imipenem (IPM) and meropenem (MICs,
>32 ug/ml) but susceptible to aztreonam, ceftazidime, cefepime, cef-
piramide, cefoperazone-sulbactam, piperacillin, pipracillin-tazobactam,
ciproﬂoxacin and trimethoprim-sulphamethoxazole (SXT). The IPM-
resistant isolate was positive for MBL activity by the IPM-disk
Hodge, and an IPM-EDTA plus SMA double disk synergy test. IPM-
hydrolysing activity was detectable in a crude cell extract, independently
of carbapenem exposure. However, PCR was negative for IMP-1, VIM-2
and SIM-1 genes, which were the only MBL genes reported in Korea
at that time. Tests performed to investigate possible misidentiﬁcation
showed that the isolate was an oxidase-positive glucose nonfermenter,
but pyocyanin and ﬂuorescein production were negative. Many of
the biochemical tests were inconsistent for PAE or Stenotrophomonas
maltophilia. ID32 GN failed to identify the isolate. 16S rRNA gene
sequencing identiﬁed it as P. otitidis, a new species causing otic
infections, ﬁrst isolated in the U.S.A. and reported in 2006. The patient
was successfully treated with SXT and topical oﬂoxacin.
Conclusion: To our best knowledge, this is the ﬁrst report of a P. otitidis
infection outside the U.S.A. This observation underscore the possibility
that some PAE isolates from otic infections could actually be P. otitidis.
The mechanism of carbapenem resistance of this isolate, possibly due
to production of a narrow-spectrum MBL, is under investigation. The
clinical signiﬁcance of the peculiar susceptibility pattern needs further
study.
P1855 Microbiological documentation of Pseudomonas aeruginosa
in bone and joint infections: analysis of 79 cases from a
reference centre on a myoskeletal infections in Greece
S. Athanasia, E. Giannitsioti, A. Papadopoulos, PJ. Papagelopoulos,
D. Plachouras, V. Sakka, E. Koratzanis, K. Kouvelas, H. Giamarellou,
K. Kanellakopoulou (Athens, GR)
Objectives: Pseudomonas aeruginosa is not a frequent pathogen in bone
and joint (BJ) infections. In the current study, clinical characteristics and
outcome of patients treated for P. aeruginosa BJ in our outpatient clinic
from 1999–2007 were analysed.
Patients and Methods: All cases of BJ infections that were
clinically, radiologically, laboratory and microbiologically assessed, were
retrospectively analysed via an electronic data-base registry. From a
total of 574 records, 79 (13.7%) were microbiologically documented
(cultures from pus, intra-operative tissues, bone and foreign material
samples) as BJ infections caused by P. aeruginosa. Treatment success
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was the clinical, radiological and microbiological resolution of the BJ
infection while failure referred to all cases that did not ﬁt this deﬁnition.
Demographics, surgical operations, antimicrobial treatment outcome and
infection relapses were evaluated.
Results: Male (n = 51, 64.5%) mean age 47.5 (SD+17.2) and the history
of a car accident related to the BJ infection (n = 38, 48%) characterised
P. aeruginosa BJ infections. These parameters (including age >65
years) did not correlate with poor outcome (p = 0.4, p = 0.5, p = 0.6
respectively). However, the presence of an infected orthopaedic device
(n = 20/79) either arthroplasty or osteosynthesis, might slightly inﬂuence
outcome (success 14/20 with and 27/59 without an infected device,
p = 0.1). Surgical debridement predicted a successful outcome (21/36
vs 20/42, p = 0.04). The administration of high doses of ciproﬂoxacin
(1500mg or 2000mg/24 h) that suggested a P. aeruginosa isolate
susceptible to quinolones and offer the chance of per os treatment, is
a strong predictor of good outcome (36/66 vs 5/11, p = 0.002). Neither
dosing nor duration of antimicrobial treatment (mean 11, SD+ 30.3
months) seemed to inﬂuence outcome (p = 0.4 and p = 0.7 respectively).
In a long-term follow-up (median 29 months, range 2–60) only 3 relapses
of the infection were recruited. Overall success rates reached 50%
(39/79).
Conclusions: 1. P aerugionosa BJ infections are often post-traumatic
2.Surgical debridement is the cornerstone of treatment in these infections
along with appropriate antimicrobial therapy. 3 P. aeruginosa BJ
infection is characterised by a high incidence (50%) of treatment failure
despite adequate surgical and conservative therapy.
Brucellosis
P1856 Clinical manifestations and outcomes of therapy in 44 cases
of brucellar spondylitis
M.R. Hasanjani Roushan, A. Laly, M.J. Soleimani Amiri,
N. Janmohammadi (Babol, IR)
Objectives: For assessing the clinical features and outcome of treatment
in brucellar spondylitis
Methods: This study was conducted on 44 cases with brucellar
spondylitis from April 1998 through September 2007.The clinical
manifestations and outcome of treatment were recorded
Results: Twenty six (59.1%) cases were male. the mean age of the
patients was 47.9±16 years. Back pain, sweating, fever and artheralgia
were the most clinical ﬁndings. The disease was acute in 23 (52.3%),
sub-acute in 18 (40.9%) and chronic in 3 (6.8%) of the cases. Brucellar
spondylitis was seen in 38 (86.4%) cases in lumbar and lumbo-sacral
in 3 (6.8%) cases in cervical regions. Twenty cases were treated with
doxycycline plus rifampin for 4 months. Relapse was seen in 1 (5%)
case. Relapse was seen in 1 (9.1%) of 11 cases who were treated with
cotrimoxazole plus rifampin for 4 months. Relapse was not seen in
15 cases treated with streptomycin for 14 days plus doxycycline and
rifampin for 4 months
Conclusion: Brucellar spondylitis may develop in any sites of the spine
mostly in the lumbar region. Streptomycin for 14 days plus doxycycline
plus rifampin for four months may be better regimen for therapy of
brucellar spondylitis.
P1857 Brucellosis: an evaluation of 100 cases in Central Anatolia
H. Naz, N. Aykin, F. Cevik, C. Bal (Eskisehir, TR)
Objectives: Brucellosis is a frequently encountered zoonosis in various
regions of the world, including the Mediterranian region. It is endemic in
some regions of our country, especially in the central Anatolian region.
In our study we investigated restrospectively the brucellosis cases, in our
hospital, our aim was to share the clinic, laboratory and therapy ﬁndings
and to investigate their relationship with relapse rates.
Methods: A total of 100 patients diagnosed as brucellosis in our clinic
between 2001 and 2006 were reviewed. The diagnosis was made by
clinical symptoms together with laboratory results; titer >1:160 in the
standard tube agglutination test (STA) and/or isolation of brucella species
from blood and other bodily ﬂuids or tissues. The Chi-squared test,
Student’s, Mann-Whitney U test, Kolmogorov-Smirnov Test were used
for statistically analysis.
Results: In the 6 year study time 100 cases of brucellosis were
established. 66 were male, and 34 were female. Among the 100 cases
diagnosed as brucellosis, a total of 70 complications were found in 54
patients. The most common complications were found in osteoarticular,
gastrointestinal and genitourinary systems as showed in the table 1.
During follow up after treatment, relaps were seen in 28 cases. When the
patients’ demographic, clinical, and laboratory ﬁndings were evaluated,
in relation to relapse, family history of brucellosis, living in rural areas
and the presence of complications were related to higher relapse rates.
Comparison of 100 patients with brucellosis with or without relapse
are given in table 2. The most frequently used antibiotic combinations
were; 77 doxycycline+rifampin, 10 doxycycline+streptomycin, 10
rifampin+ciproﬂoxacin, 1 doxycycline+rifampin+ciproﬂoxacin, 1 doxy-
cycline+gentamycin, 1 doxycycline+streptomycin+ciproﬂoxacin. There
was no signiﬁcant statistical difference in the relapse rates according to
the antibiotic used (p = 0.697). There was no mortalities.
Conclusion: In our study, we found that relapse was related to positive
family history, living in rural areas, and the presence of complications.
Brucellosis, still preserves its importance in our country, as it is endemic,
shows a great variety of symptoms, can affect different systems, and there
is still therapy handicaps and relapses are seen frequently. The efforts
shown for the diagnosis and therapy should also be shown for protection
and control strategies.
Table 1. Comparison of 100 patients with brucellosis with or without
relapse
Relapse
(n = 28)
Without
relapse
(n = 72)
p
Age, years (mean±SD) 50.9±19.1 45.3±16.9 0.155
Male gender 16 (53.8) 50 (36.6) 0.352
Positive family history 11 (30.8) 13 (12.6) 0.049*
Animal contact 15 (56.4) 33 (40.9) 0.637
Rural area 19 (66.7) 30 (46.4) 0.033*
Clinical type
acute 20 (61.5) 55 (79.8) 0.931
subacute 5 (10.3) 10 (12)
chronic 3 (28.2) 7 (8.2)
Hepatomegaly 13 (35.9) 23 (20.8) 0.261
Splenomegaly 5 (15.4) 5 (7.1) 0.137
Lymphadenopathy 1 (5.1) 1 (2.9) 0.484
Complications 21 (69.2) 33 (44.8) 0.016*
Sedimentation rate (>20mm/h) 15 (38.5) 25 (32.2) 0.134
CRP 13 29 0.738
Anaemia 9 (28.2) 15 (14.7) 0.353
Leukocytosis 4 (15.4) 8 (8.7) 0.735
Leukopenia 3 (12.8) 8 (7.1) 1.000
Thrombocytopenia 5 (12.8) 8 (12.6) 0.508
Elevated AST (>40 IU/L) 15 (35.9) 23 (23.5) 0.077
Elevated ALT (>40 IU/L) 14 (33.3) 25 (22.9) 0.239
Standard tube agglutination
(median, range)
320
(160−1280)
240
(160−1280)
0.536
*Signiﬁcant.
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P1858 Focal organ involvement in a series of 99 brucellosis patients
T. Turunc, Y. Demiroglu, H. Aliskan, S. Colakoglu, H. Arslan
(Ankara, TR)
Objectives: Brucellosis is a zoonosis which affects all organs and
systems and causes severe complications. The aim of this study was to
evaluate demographic features, clinical ﬁndings and treatment outcomes
of brucellosis with focal involvement.
Methods: This is a prospective study and included 99 patients with
brucellosis aged over 15 years and presenting to our clinic between
January 2003 and July 2007.
Results: The study included 99 patients, of whom 50 (50.5%) were
female and 49 (49.5%) were male. They were aged between 15 and 77
years with a mean of 50.1 years. Out of 99 patients, 69 (69.6%) had
acute brucellosis, 24 (24.2%) subacute brucellosis and 6 (6.2%) chronic
brucellosis. Eighty-two patients (82.8%) had a history of consumption
of unpasteurised milk and dairy products and 29 patients (29.2%) had a
history of stockbreeding. In addition, 16 patients (16.1%) had a history
of brucellosis at least one year before. The most frequent complication
was musculoskeletal involvement (n = 80), followed by endocarditis
(n = 9) and peritonitis (n = 1). The most frequent musculoskeletal in-
volvement was spondylodiscitis (n = 50;50.5%), followed by sacroileitis
(n = 21;21.2%) and peripheric arthritis (n = 9;9.09%). Brucella melitensis
was isolated in blood cultures of 42 patients, spinal ﬂuid cultures of one
patient, ascites ﬂuid culture of one patient, joint ﬂuid culture of one
patient and psoas abscess culture of one patient.
Conclusion: Brucellosis is a disease presenting with various clinical
pictures and severe complications and difﬁcult to diagnose. Therefore,
caution should be exerted with focal organ involvement and brucellosis
cases should be followed at regular intervals in regions where the disease
is endemic. In addition, it should be kept in mind that Brucella spp.
can be isolated in all sterile bodily ﬂuids and that specimens should be
obtained from appropriate sites.
P1859 Four cases of sickle cell anaemia accompanied by brucellosis
causing pain crisis
T. Turunc, Y. Demiroglu, E. Kizilkilic, H. Aliskan, S. Colakoglu,
H. Ozdogu, H. Arslan (Ankara, TR)
Objectives: Pain crisis which frequently appears in cases of sickle cell
anaemia causes such complaints as severe pain in the extremities and
the back and fever at the beginning. Among the factors which trigger
pain crisis are extreme changes in temperature and stress. However, the
cause is usually unknown. The aim of this study was to determine clinical
features, laboratory results and treatment outcomes of sickle cell anaemia
accompanied by brucellosis causing pain crisis. To our knowledge, there
have not been such cases in the literature.
Methods: Four patients with sickle cell anaemia diagnosed with acute
brucellosis when under supervision for pain crisis in Haematology
Department between June 2004 and September 2006 were consecutively
enrolled in the study.
Results: Out of four patients, two were male and two were female.
The patients were aged 26–46 years. All patients had a history of
consumption of unpasteurised milk and milk products. The most frequent
complaints were fever (4/4), severe joint pain (3/4) and severe muscle
pain (3/4). Brucellosis agglutination test was positive at 1/1280 in all
patients and blood cultures showed Brucella melitensis in two patients.
Only one patient had focal organ involvement in the form of epidural
abscess in the lumbar region. This patient was administered doxycycline
200mg/day (p.o.), rifampicin 600mg/day (p.o.) and cotrimoxazole
800mg/day (p.o.) for 6 months. The others patients were treated
doxycycline 200mg/day (p.o.), rifampicin 600mg/day (p.o.) for 45 days.
All patients recovered following completion of the medical treatment.
The patient with epidural abscess had a relapse about 8 months after
completion of the treatment. The other patients had no relapses.
Conclusion: High fever and severe joint pain are the most frequent signs
of pain crisis in sickle cell anaemia. However, those symptoms may
indicate acute brucellosis as in our series. Therefore, brucellosis should
be kept in mind in patients with sickle cell anaemia presenting with high
fever in regions where brucellosis is endemic and appropriate tests and
blood cultures should be performed for the diagnosis of brucellosis.
P1860 Brucellosis: a cause of peripheral neuropathy
G. Kutlu, G. Ertem, O. Coskun, U. Ergun, L.E. Inan, N. Tulek (Ankara,
Samsun, TR)
Objectives: Brucellosis is a common infectious disease in Mediterranean
countries. Central nervous system (CNS) involvement is rare, occurring
<5% of adult cases. We evaluated the peripheral nerve involvement in
patients with brucellosis.
Methods: Thirty-one patients diagnosed with brucellosis were included
in this study. All patients were investigated for paraproteinaemia,
endocrinopathy, vitamin B12 and folate deﬁciencies, connective tissue
disorder, infections other than brucellosis, alcohol abuse, hepatic and
renal failure. Four patients were excluded from the study because of
B12 deﬁciency and a history of diabetes mellitus. The remaining 27
patients were included. Average age was 45.19±16.21. Seventeen of
these patients were male and the other 10 were female. All patients
underwent nerve conduction and electromyography (EMG) studies and
20 normal healthy subjects were used as a control group.
Results: Among 27 patients of brucellosis, six of them had CNS
involvement. In electrophysiological examinations, sensory-motor neu-
ropathy was determined in nine patients who had abnormal neurological
examination. One patient had also polyradiculoneuritis together with
peripheral neuropathy. The other eight patients had hypoactive deep
tendon reﬂexes and paresthesia in distal extremities. All patients
had received combination treatment (rifampin and doxycycline and/or
ceftriaxone) for 3−9 months. After six months of the treatment,
nerve conduction studies and neurological examination were nearly
normal in all patients. The EMG ﬁndings of 18 patients, who had no
prominent peripheral neuropathy and normal neurological examination,
were compared with normal healthy subjects. The motor conduction
velocities of median (p< 0.05), ulnar (p< 0.05), peroneal (p< 0.001)
nerve was decreased. F wave latencies was prolonged in posterior tibial
and peroneal nerve, distal latency was also prolonged in posterior
tibial nerve in brucellosis patients compared to normal (p< 0.05).
Sensory conduction velocities of median (p< 0.001), ulnar (p< 0.05)
and sural (p< 0.05) nerve was also decreased. There were no statistically
differences in terms of age, sex and duration of the symptoms between
the patients with and without peripheral neuropathy.
Conclusions: Clinical or subclinical sensory-motor peripheral neu-
ropathy may be observed in patients with brucellosis. Consequently
brucellosis may be considered as a cause of peripheral neuropathy
especially in endemic areas.
P1861 Copper and zinc plasma level in brucellosis patients in Iran
M. Hajabdolbaghi, S. Jafari, A. Alipouran, M. Mobayen (Tehran, IR)
Objectives: Brucellosis which is a zoonotic disease is a common
endemic disease and health problem in Iran. Based on multiple studies,
copper and zinc have inﬂuence on immune system. In other studies it
has been shown that plasma levels of these trace elements in patient with
Brucellosis are changing. The aim of this study was to measure the serum
zinc and copper level in patients with brucellosis and in comparison with
healthy individuals.
Methods: In this cross sectional study the plasma level of zinc and
copper of brucellosis patients were measured and compared to the level
of healthy individuals.
Results: Forty three patients (34 men and 9 women) with brucellosis
matched with 43 healthy (34 men and 9 women) individuals were
included in two teaching hospital in two cities of Iran in 2006. The
mean age of patients were 40.14 years old (range 14–60 years old)
and the mean age of healthy individuals were 40.3±15.89 years old
(range 14–60 years old). The plasma level of copper was found to be
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signiﬁcantly higher in patients with brucellosis than healthy individuals
(160.84±54.61 vs 101.74±27.37mg/dl). The plasma level of zinc was
less than healthy individuals (91.47± 46.91 vs 107.19±35.18mg/dl) but
was not statistically signiﬁcant. Zinc plasma concentration was lower
in female brucellosis patients compared with healthy female individuals
(80.33± 44.2 vs 119±28.17mg/dl).
Conclusion: Plasma zinc and copper level showed signiﬁcant alterations
in patients with brucellosis compared with healthy persons and there is
inﬂuenced of gender on it. It is still not clear that these changes are result
of the disease or these changes predispose individuals to infection.
P1862 Brucella melitensis DNA persistence in patients with chronic
brucellosis
M.J. Castan˜o Aroca, E. Navarro, J.C. Segura, E. Alfaro-Martı´nez,
M.D. Mun˜oz, A.I. Martı´nez, S. Lorente, J. Solera (Albacete, ES)
Objective: The aim of this study was to evaluate the evolution of
bacterial load (B. melitensis DNA copies/ml sample) at baseline, during
therapy and post-therapy follow-up in patients with chronic brucellosis.
Methods: For that purpose, we applied the Real-Time Quantitative
Polymerase Chain reaction technique (QPCR) described by our team
in a previous study [1]. We analysed 125 whole-blood and 122 serum
samples from 10 patients using QPCR. Blood culture and serological
tests (rose bengal stain, serum agglutination test (SAT) and Coombs
test) were performed for each sample.
Results: The mean bacterial load (± SD) at baseline was 634±1403
copies/ml and 1738±4813 copies/ml for whole-blood and serum
samples, respectively. Eight patients received therapy, doxycycline alone
or in combination with rifampin or cotrimoxazol. The duration of
therapy ranged from 90 to 430 days (mean 140 days). Therapy improved
symptoms in all patients. During the ﬁrst month of the treatment period
the bacterial load declined to 19±39 copies/ml and 26±102 copies/ml
for whole-blood and serum samples, respectively. Thereafter, there was
an increase in load until the end of the therapy (1507±3787 copies/ml
blood and 2669±7790 copies/ml serum).
In the ﬁrst 3 months of the post-therapy follow-up, the bacterial load
decreased again to 29±126 copies/ml and 222±882 copies/ml for whole-
blood and serum samples, respectively. Only six patients were followed
for more than 12 months. At the end of the follow-up period, the bacterial
load amounted to 2917 ±11354 and 2549±8691 copies/ml in whole-
blood and serum samples respectively for 33% (2/6) patients.
In 4 patients, although presenting clinical features of brucellosis,
the samples collected were negative for all the classical serological
procedures. However B. melitensis DNA was still detectable by QPCR.
Conclusion: In conclusion, we detect ﬂuctuating B. melitensis DNA
levels in patients with chronic brucellosis during the course of the disease
despite positive clinical response to therapy. We found a subgroup of
brucellosis patients showing negative serology but presenting detectable
levels of B. melitensis DNA assed by QPCR.
Reference(s)
[1] Navarro et al, Clin Infect Dis 2006 May 1; 42(9):1266–73.
P1863 Quantiﬁcation of Brucella melitensis DNA in patients with
brucellosis
E. Navarro, M.J. Castan˜o, E. Alfaro-Martı´nez, J.C. Segura, S. Lorente,
L. Garijo, C. Romero, J.L. Beato, J. Solera (Albacete, ES)
In the present study we describe the evolution of bacterial load
(B. melitensis DNA copies/ml of blood) at baseline, during therapy
and post-therapy follow-up in patients with brucellosis. Patients were
assigned to two different groups according to the evolution of the disease
after treatment: non-relapse patients (group I) and relapse patients
(group II).
To this aim, we applied the Real-Time Quantitative Polymerase Chain
reaction technique (PCRQ) described by our team in a previous study [1].
Peripheral blood samples from 14 non-relapse (N = 103) and 8 relapse
(N = 90) patients were analysed using PCRQ. Blood culture and
serological tests were performed for each sample (rose bengal stain,
serum agglutination test (SAT) and Coombs test).
The evolution of the bacterial load was similar in both groups during
the acute episode. Basal load was 1619±2076 copies/ml (mean, s.d.) and
2778±3909 copies/ml for groups I and II, respectively. Bacterial load
decreased during the ﬁrst month of treatment in both groups, but the
difference was statistically signiﬁcant only for the non-relapse group
(p = 0.03). Between day 29 and the end of treatment, bacterial load
increased in mean value (930±2105 copies/ml and 677±1115 copies/ml
for groups I and II, respectively) without reaching statistical signiﬁcance
(p = 0.205).
Follow-up of group I patients showed a decrease in bacterial load
down to 120±274 copies/ml during the ﬁrst three months. Thereafter,
there was a mild increase in load until the ninth month of follow-up
(220±475 copies/ml). At the end of the follow-up period, the bacterial
load amounted to 22±34 copies/ml for 50% of non-relapse patients.
In relapse patients, bacterial load initially decreased to 83±78 copies/ml
during the ﬁrst two months of follow-up before relapse occurred. At the
time of relapse, the bacterial load increased to 4626±7013 copies/ml,
decreasing progressively with the re-instated treatment until the end of
the follow-up period.
In patients with brucellosis, we were able to intermittently detect
Brucella melitensis DNA after the treatment period, despite positive
clinical response to therapy. We have been unable to determine the level
of basal load that may be predictive of relapse. However, we found
that only the non-relapse patients showed a signiﬁcant decrease in the
bacterial load during the ﬁrst month of treatment.
Reference(s)
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P1864 Brucella endocarditis in Iran, a treatable disease
M. Rasoolinejad, S. Borna, N. Esmailpour bazaz, B. Moradmand
Badie, S. Moradmand Badie (Tehran, IR)
Objectives: Brucellosis is a worldwide zoonosis caused by pathogens
of the genus Brucella. Endocarditis is a rare focal complication of this
disase with destructive valvular lesions and the most common cause of
brucellosis-related mortality. In this study we have presented 9 cases of
brucella endocarditis who were admitted in infectious diseases wards of
Imam Khomeini Teaching Hospital in Iran from 2000–2005.
Methods: The charts of all cases with diagnosis of brusella endocarditis
were reviewed to assess their clinical course, treatment and outcome.
Results: There were 9 patients with diagnosis of brucella endocarditis
in period of 2000–2005.The mean age of the patients were 38.11 years
(range14–69 years), among them, 7 were men and 2 were women. Seven
patients (77.7%) had consumed nonpasteurised dairy products and 1
had occupational contact with goat. Underlying cardiopathy was present
in 3 patients (33.3%). The median duration of the symptoms prior to
diagnosis was 5.33 months. All of the patients had fever. Endocarditis
involved the aortic valve in 6 cases (66.6%), the mitral valve in 2 cases
(22.2%), and the aortic plus mitral valve in 1 case (11.1%). Serologic
tests were positive in eight (88.8%) and blood cultures were positive in
2 patients (22.2%). Aortic valve replacement surgery was undertaken
in 5 patients (55.5%). Radial artery aneurismectomy was done in one
patient. One patient died because of arrhythmia. All other 8 patients
improved and were symptom free at the time of discharge from hospital.
All patients received triple therapy with different appropriate antibiotics.
Conclusion: Brusella endocarditis which is the main cause of mortality
in brucellosis could be a treatable disease if diagnosed and managed
in a proper time. Diagnosis is usually based on epidemiologic, clinical
and para clinical parameters. A combination of medical and surgical
intervention is usually the treatment of choice in these patients.
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P1865 Neurobrucellosis: the evalution of a rare presentation of
brucellosis from a tertiary care centre at Central Anatolia
H. Aslan, G. Metan, E. Alp, O. Yildiz, B. Aygen, B. Sumerkan,
M. Doganay (Kayseri, TR)
Objectives: Brucellosis is a zoonotic and multisystem disease which is
highly endemic in Turkey similiar to other Mediterranean countries. Any
organ or system of the body including nervous system can be involved.
The aim of this study is to describe our experience in the diagnosis,
treatment, and ﬁnal outcome of the patients with neurobrucellosis who
were diagnosed and treated in our clinic.
Patients and Methods: This study was conducted at Erciyes
University Gevher Nesibe Hospital, a 1300-bed tertiary referral centre
in central Anatolia. We retrospectively reviewed the records of the
Department of Infectious Diseases to identiﬁy the patients aged 16
years with neurobrucellosis from January 1997 to December 2006.
Neurobrucellosis was diagnosed by the following criteria: symptoms or
clinical ﬁndings concordant with neurobrucellosis, isolation of Brucella
from the cerebrospinal ﬂuid (CSF) or/and demonstration of antibodies to
Brucella in CSF (at any titer), the presence of any abnormality in CSF
(pleocytosis, increased protein levels and decreased glucose levels) with
positive serology for brucellosis.
Results: Nine hundred and seventeen patients with brucellosis were
admitted to our department during 10-years. Thirty-six patients were
diagnosed as neurobrucellosis. (Table 1). Headache and fever were the
most common symptoms. Neck stiffness was present in 25 of the patients
and the 69.4% of the patients were diagnosed as acute meningitis. Nervus
abducens involvement was detected in two patients. Motor deﬁcit was
determined at the lower extremities at ﬁve and upper extremities in two
patients. Hemiparesis was assigned in two patients. Urinary and gaita
incontinence was observed in two patients.
Brucella spp. was isolated from the blood of nine of patients and from
the CSF of 11. The median serum standart tube agglutination (STA)
value of the patients was 1:320 and positive in 30 patients. The median
CSF STA titer was 1:20 and positive in 21 patients.
Table 1. Features of the patients with neurobrucellosis
Number of patients
Female/Male 17/19 (47.2/52.8%)
Age (mean, years) 36.5±16.4 (range, 18–77)
Duration of symptoms (mean, days) 64.7±111.3 (range, 2–545)
Concomitant disease 7 (19.4%)
Diabetes mellitus (DM) 1
DM + chronic renal insufﬁciency 1
Congestive heart failure 2
Acute myeloid leukaemia 1
Chronic bronchitis 2
Clinical spectrums
Acute 26 (72.2%)
Subacute 8 (22.2%)
Chronic 2 (5.5%)
Meningitis 25 (69.4%)
Meningoencephalitis 11 (30.6%)
Doxycycline (po) plus rifampin (po) with ceftriaxone (iv) was the
most common choice for the treatment. The duration of treatment was
three months in 33 patients and four months in three patients. Overall
mortality was 8% in this study and none of the patients died due to
neurobrucellosis. Relaps occurred in one patient.
Conclusion: Neurobrucellosis presents with hetoregenous clinical signs
and attrending physicians should remind the colourfull picture of
neurobrucellosis in endemic areas.
P1866 Determining in vitro synergistic activities of tigecycline
with several antibiotics against Brucella melitensis using
chequerboard and time-kill assays
H. Aliskan, F. Can, M. Demirbilek, S. Colakoglu, H. Arslan (Ankara, TR)
Objectives: Antimicrobial therapy of Brucella spp. infection is difﬁcult
because there are relatively few effective treatment regimens, and single-
agent therapy frequently fails clinically. Assessing the killing activity
and the effect of combination therapy (synergistic or antagonistic) is
important for antibiotics used to treat brucellosis.
Methods: In this study, the in vitro activity of tigecycline in combination
with gentamicin, streptomycin, rifampin, co-trimoxazole, levoﬂoxacin,
and minocycline was investigated with the chequerboard method in 16
Brucella melitensis isolates. The time-kill method was used to determine
bactericidal activities of combinations of tigecycline with rifampin,
gentamicin, and levoﬂoxacin, which were found to have a synergistic
effect in combination with tigecycline.
Results: Using the chequerboard method, combinations of rifampin,
gentamicin, and levoﬂoxacin with tigecycline yielded synergy in 31.2%,
18.9%, 50% of the isolates respectively. No synergism was observed
between combinations of minocycline, streptomycin, and co-trimoxazole
with tigecycline by the chequerboard method.
Time-kill results showed that tigecycline+gentamicin achieved the fastest
complete killing within 6 h and created a synergy as shown by the
chequerboard method. Although rifampin alone caused complete killing
within 48 h at MIC, rifampin+tigecycline combination exhibited faster
killing only within 24 h. In this study, the time-kill method showed
that tigecycline in combination with levoﬂoxacin had an antagonism,
while the chequerboard method showed that they had synergy and no
interaction effects. Tigecycline alone caused complete killing within 24 h
at MIC and was the fastest acting agent.
Conclusion: The chequerboard method revealed that three antibi-
otic combinations (tigecycline+gentamicin, tigecycline+rifampin, and
tigecycline+levoﬂoxacin) had a synergistic activity. Although tigecy-
cline+gentamicin and tigecycline+rifampin synergistic activities were
conﬁrmed by the time-kill method, the opposite effect was determined
with tigecycline+levoﬂoxacin combination. Several investigators have
found discord between the chequerboard and time-kill methods,
agreement ranges between 44% and 88% and the time-kill method to be
a reliable predictor of in vivo synergy. It appears that the combinations
of tigecycline+rifampin and tigecycline+gentamicin may be used to treat
brucellosis.
Leishmanias
P1867 Cloning and expression of truncated form of tissue
plasminogen activator in Leishmania tarentolae as a new
eukaryotic system
R. Nazari, F. Mahboudi, N. Davoudi (Qom, Tehran, IR)
Objective: Tissue plasminogen activator protein(t-PA) was found as
superior therombolytic agent for treatment of cardiovascular diseases
such as acute myocardial infarction and efforts is currently focused to
improve the t-PA molecule and thereby its pharmacokinetic properties.
Reteplase (K2S) is a derivative t-PA that has a longer half-life and greater
resistance to inhibitor than the natural t-PA molecule. The aim of this
research is cloning and expression of K2S form of the t-PA cDNA in
eukaryotic system Leishmania tarentolae which is recently has been
introduced as a suitable host for expression eukaryotic genes.
Methods: cDNA of t-PA was made by RT-PCR from human blood cells.
PCR with speciﬁc primers for producing truncated form of t-PA (K2S)
were used. For introducing the truncated form of t-PA in Leishmania
tarentolae cells, we constructed two plasmid pFXmlsap1.4sat-K2S
and pFXmlsap1.4hyg-K2S, that each of them contains one antibiotic
selection marker (neursothricin and hygromycin). After development of
constructs electroporation was done on L. tarentolae cells for transfecting
developed constructs.
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Results: All constructs (pFXmlsap1.4sat-K2S and pFXmlsap1.4hyg-
K2S) were conﬁrmed by restriction analysis and PCR. After electro-
poration, screening of cells was done by selecting resistance clones
to antibiotic in media. At this stage we conﬁrmed that our cells carry
truncated form of t-PA in the respected site SSurRNA (18s) and next
step is to conﬁrm the expression of gene.
P1868 Identiﬁcation of Leishmania species isolated from human
cutaneous leishmaniasis in Gonbad-e Qabus using a PCR
method
F. Mesgarian, N. Rahbarian, M. Mahmoudi Rad, H. Hajaran,
F. Shahbazi, Z. Mesgarian, N. Taghipour (Tehran, IR)
Objectives: To determine the epidemiological status of the cutaneous
leishmaniasis outbreak, isolation and identiﬁcation of the parasite using
a PCR method in Gonbad-e Qabus County, north Iran, during 2006–
2007.
Methods: Data was collected on the prevalence of scars and ulcers over
a period of 16 months among 6990 inhabitants of ﬁve villages around
Gonbad-e Qabus County. Cultured promastigotes were identiﬁed using
PCR technique. ITS1 and ITS2 of Non Coding Transcribed region at
ribosomal DNA of 46 Leishmania isolates were ampliﬁed and the PCR
products were separated by electrophoresis in 2% agarose gel (200 mA,
140 V), visualised by staining with ethidium bromide, and photographed.
Results: Among 6990 inhabitants of 5 villages, 62.9% had scars and
1.5% had active lesions. Individuals 11 to 20 years of age were the most
highly infected age group. All the parasite isolates were Leishmania
major.
Conclusion: According to this study, cutaneous leishmaniasis due to
Leishmania major is endemic in Gonbad-e Qabus County, north Iran.
P1869 Efﬁcacy of amphotericin B and voriconazole against
Leishmania tropica with microcapillary culture method
B. Bolukbas, M. Hokelek, Y.E. Beyhan (Samsun, TR)
Objectives: Leishmania parasites cause a wide range of human diseases
from localised self-healing cutaneous lesions to fatal visceral disease.
The causative agent of Cutaneous Leishmaniasis (CL) in southeastern
Turkey is mainly Leishmania tropica. A sensitive microcapillary
culture method (MCM) was developed for rapid diagnosis of CL by
Allahverdiyev et al. The aim of this study is researching the effect
of amphotericin B (AMB) and voriconazole (VOR) on Leishmania
tropica (MHOM/ TR/EP39) using MCM in order to determine more
effective alternatives to antileishmanial drugs which current being used
for treatment.
Methods: In this study, the promastigotes these are growth in NNN
medium and passaged RPMI-1640 medium (with L-glutamine) buffered
with 25 mM HEPES and supplemented with 20% fetal calf serum, are
inoculated in mixed solutions prepared with different drug concentrations
and medium. Capillary tubes will load with medium and drug dilution.
The ends of the capillary tubes were seal with heat-melted candle wax.
All inoculated tubes incubated at +26ºC for 72 hours. End of time, the
capillary tubes are cut off ends and promastigotes are counted on Thoma
chamber. The 50% inhibitory concentrations (IC50) are calculated.
Results: The IC50 values for AMB and VOR were determined that
0.1475mg/ml, 4.682mg/ml, respectively.
Conclusion: In conclusion, it was found that AMB and VOR have got
inhibitory effects of L. tropica promastigotes in vitro. IC50 values of
VOR more than AMB, but due to their too few toxic effects than many
antileishmanial drugs, they may be alternative treatments in future. In
addition, the MCM has been used for the ﬁrst time on drug investigations,
which was seen to be valuable for in vitro drug tests of Leishmania as
well as routine diagnosis of leishmaniasis. Further studies are needed to
develop these results with in vivo CL animal models.
P1870 Induction of apoptosis by the triterpene saponin PX-6518
in promastigotes and amastigotes of Leishmania infantum
M. Vermeersch, M. Deschacht, K. Kuypers, D. Schrijvers, W. Martinet,
P. Cos, L. Maes (Antwerp, BE)
Objectives: Current ﬁrst-line medication of visceral leishmaniasis is
increasingly faced with levels of resistance and new drugs are still
needed to maintain adequate therapeutic options for the future (1). The
13,28 epoxy-oleanane saponin PX-6518 was shown to possess strong
antileishmania properties in vivo (2). Because little is yet known about its
mode of action, the induction of apoptosis was studied on promastigotes
and extracellular and intracellular amastigotes of L. infantum. Miltefosin,
for which apoptosis-inducing action was already demonstrated (3), was
used as reference.
Methods: Early apoptosis, characterised by phosphatidylserine (PS)
exposure from the inner to the outer side of the cell membrane,
was evaluated by Annexin V-FITC/PI labeling (Ann/PI) in treated
promastigotes and extracellular amastigotes. Differential sensitivities
of axenically grown and fresh ex vivo amastigotes were compared.
Microscopic and ﬂow cytometric follow-up studies included DNA
fragmentation in oligonucleosomal fragments using a Tunel assay. The
effects on intracellular amastigotes were studied in J774 and primary
peritoneal macrophages.
Results: Ann/PI evaluation of PX-6518 treated host cells demonstrated
signs of apoptosis induction, whereas treatment of promastigotes and
axenic amastigotes did not induce PS exposure. Evaluation of ex vivo
amastigotes was hampered by the fact that a large proportion of untreated
control cells were Ann-positive and PI-negative. This result conﬁrms
earlier reports of apoptotic mimicry (4). No additional effects of PX-
6518 could be observed in the small fraction of Ann+, PI− amastigotes.
These initial observations are now studied in greater detail using the
Tunel assay.
Conclusion: Conﬁrming earlier reports (5), features of early apoptosis
were observed after treatment of macrophages with PX-6518. The effects
on promastigotes and extracellular amastigotes were marginal. The
results of ongoing follow up Tunel studies on the different Leishmania
stages and host cells will be presented.
Reference(s)
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[2] Maes L. et al., Antimicrobiological Agents & Chemotherapy, 48,
2056–2060, 2004.
[3] Sudhandiran G. et al., Journal of Biological Chemistry 278, 25120–
25132, 2003.
[4] Wanderley J. et al., Journal of Immunology 176, 1834–1839, 2006.
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P1871 Detection of Leishmania by PCR-oligochromatography with
the "Leishmania OligoC-Test"
T. Laurent, S. Deborggraeve, D. Espinoza, T. Leclipteux, P. Bu¨scher,
J. Arevalo, P. Mertens (Gembloux, Antwerp, BE; Lima, PE)
Leishmaniasis is a vector born disease caused by protozoan of the
Leishmania genus. At least 15 species can infect humans causing a broad
spectrum of clinical manifestations like Visceral leishmaniasis (VL),
cutaneous leishmanaisis (CL), muco-cutaneous leishmaniasis (MCL) and
PKDL.
As no vaccine is available, the control of leishmaniasis relies on
diagnosis and treatment of detected cases. Current diagnosis of VL is
based on serology and is conﬁrmed by microscopy (not very sensitive) or
culture, which can take more than 4 days. Leishmanin Skin Test (LST),
culture or microscopy of lesion biopsy are used for CL diagnosis. While
quite sensitive, serology and LST cannot discriminate past and present
infection. Moreover, in immunocompromised patients (eg. transplant,
HIV/VL co-infection) the performance of serology is seriously affected.
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PCR was shown to be a valuable tool for Leishmania diagnosis.
Despite its high sensitivity, PCR is not routinely used in endemic
countries mainly due to it’s complexity, and the equipment costs
that makes it unaffordable by laboratories with limited research
facilities and resources. We have recently developed and evaluated
the “Leishmania OligoC-Test”, a rapid, easy-to-use and sensitive PCR-
oligochromatography (PCR-OC) assay. Both PCR mix and detection
device were designed to be used in limited facilities and resources
settings.
The PCR mix contains an internal control (IC) allowing to highlight
the presence of PCR inhibitors in the sample to validate any negative
results, and dUTP to allow elimination of carry-over contaminations.
The detection of PCR products (Leishmania amplicon and IC amplicon)
is made by Oligochromatography, a one-step assay which combines
hybridisation of speciﬁc probes coupled to colloidal gold and migration
on a dipstick at 55ºC. The detection takes only 10 minutes and is made
in closed tube. All the 12 Leishmania species tested with this assay are
detected.
Up to 10fg (+/− 0.05 parasite) of genomic DNA are detected and it
was possible to detected as few as 10 parasites in spiked blood. No
cross-reactivity was observed with the other pathogenic Trypanosoma
and bacteria we have tested. An evaluation on skin biopsies from Peru
showed that most of the microscopy positive samples are detected with
our assay. Leishmania OligoC-Test is a rapid, sensitive and speciﬁc assay.
Its easiness and the fact that only a water bath is needed for post-PCR
detection render it a valuable tool for a broad use.
P1872 Evaluation of anti-leishmanial efﬁcacy by in vivo
administration of herbal extract Artemisia auckery on
Leishmania major in Balb/c mice
M. Sharif, M. Nasrolahei, A. Daryanii, S. Gohardehi (Sari, IR)
Objectives: Cutaneous infection caused by protozoa the genus Leish-
mania are a major worldwide health problem, with high endemicity in
developing countries including Middle East, Africa and Latin America.
In the absence of a vaccine, there is an urgent need for effective drugs
to replace and supplement those in current use.
Methods: We report in this study the in vivo efﬁcacy of Artemisia
auckery herbal extract on the Leishmania major cutaneouse infection in
murine model in susceptible Balb/c mice. To carry out this investigation,
mice were assigned to the 5 groups (each with 3 mice) as healthy negative
control, saline-treated control, glucantim-treated and treated-groups
with herbal extract. Experimental Leishmaniasis was initiated by the
subcutaneous (s.c.) application of the 2×106 promastigotes of L. major
(MRHO/IR/75/ER) into the basal tail of all groups except the healthy
negative control group. The development of lesions was determined
weekly by measuring the diameters. Inoculations of both Glucantime
and herbal extract were carried out by subcutaneous injections once
daily for 20 days. At the end of treatment course, all mice were killed
humanely by terminal anaestheisa and target tissues including lymph
node, spleen and liver from each mouse were removed and weighted
and their impression smears were also prepared.
Results: The results indicated that our herbal extract was able to affect
on lesion size, its performance and to prevent visceralisation of the
parasite. This is the ﬁrst report indicating visceralisation caused by the
cutaneous form of L. major in the Balb/c mice. During this experiment
no side effects were observed due to the application of herbal extract in
the treated-mice. The impression smears showed a reduction of parasite
burdens in spleen, liver and lymph node.
Conclusion: In comparison with glucantim; the present herbal combi-
nation was more effective on this murine Leishmaniasis, therefore it
could be suggested as a substitute for glucantime in the treatment of
Leishmaniasis for human and animal purposes.
P1873 Five cases of kala azar
T. Turunc, Y. Demiroglu, H. Aliskan, S. Colakoglu, H. Arslan
(Ankara, TR)
Objective: The aim of this study was to evaluate clinical features of kala
azar, transmitted by sand ﬂies. It is the second most frequent infectious
disease caused by parasites following malaria.
Methods: Five patients with kala azar presenting to our clinic between
April 2004 and May 2007 were consecutively enrolled in our study. The
diagnosis of the disease was based on clinical ﬁndings and detection
of amastigot forms of the parasite in bone marrow, liver and spleen
specimens. Three patients were living in a rural area and two in an
urban area.
Results: Out of ﬁve cases, three were female and two were male
with a mean age of 47 years (range: 34–54 years). Two patients had
a history of sand ﬂy bites. The patients most frequently presented
with fever, abdominal pain and weight loss. On history, one patient
received treatment with steroids since he was found to have antinuclear
antibodies during follow-up for accompanying hepatitis B and his
exhaustion and weight loss increased. Meanwhile, the patient was
found to have an increased erythrocyte sedimentation rate and globulin
levels and underwent bone marrow biopsy. Obtained specimens showed
Leishmania amastigots. The remaining two cases did not have any
abnormalities in their bone marrow aspiration biopsies. However, they
had widespread lymphadenopathy in the mediastinum and abdomen and
fever of unknown origin. For these reasons, they underwent splenectomy.
Obtained specimens showed Leishmania amastigots. All patients were
administered liposomal amphotericin B 3mg/kg daily for 5 days and
once on days 14 and 21. None of the patients had relapses.
Conclusion: Kala azar may present with various clinical pictures in
urban areas as well as in rural areas. We recommend that liver and
spleen biopsies should also be performed since bone marrow biopsy
may not show the parasite. Compared to conventional agents, liposomal
amphotericin B seems to be a good treatment alternative in that it has
fewer side-effects, requires a shorter treatment period and produces a
satisfactory outcome.
P1874 Molecular epidemiology of cutaneous leishmaniasis in
Jahrom, southern Iran
M. Motazedian (Jahrom, IR)
Objectives: Cutaneous leishmaniasis is caused by a protozoan parasite
called Leishmania spp. This infection is endemic in different parts of
Iran including Jahrom County (Fars province). Since there were no data
about the species of Leishmania in this county, we conducted this study
to ﬁnd the dominant species of the parasite.
Material and Methods: DNA extraction of positive giemsa-stained
slides of 40 patients was used as a template for Nested-PCR.
Results: Findings of this study indicated the existence of both L. major
& L. tropica in the area, although the dominant species was L. major
(%85 of cases). The highest prevalence was in children under 10 years
old. The most infected organs were hands. Most of the patients had one
ulcer although up to 33 ulcers were observed.
Conclusion: This study showed the changes in the proﬁle of the species
of the parasite from L. tropica to L. major in Jahrom County.
Toxoplasmosis
P1875 Pyrimethamine/sulfadiazine and atovaquone impact
maturation of antibodies and avidity against Toxoplasma
gondii in a murine model of acute infection
A. Niewiadomski, C. Alvarado Esquivel, B. Schweickert, O. Liesenfeld
(Berlin, DE)
Objectives: Infection with Toxoplasma gondii during pregnancy may
result in congenital transmission of the parasite from the mother to the
Toxoplasmosis S549
foetus. Infection is diagnosed using serological tests for IgG, IgM, and
IgA antibodies. Avidity of IgG antibodies is regularly used to exclude
acute infection. It has been suggested that antiparasitic treatment results
in delayed maturation of IgG avidity. However, detailed studies on the
effects of antiparasitic treatment on maturation of IgG avidity are lacking.
We therefore investigated the maturation of antibodies and IgG avidity
in a murine model of acute infection with T. gondii.
Methods: NMRI-mice were orally infected with 10 cysts (ME49) and
treated with spiramycin, pyrimethamine plus sulfadiazine (pyr/sulf),
azithromycin, or atovaquone (at dosages equivalent to patient dosages)
from day 4 to day 10 p.i., or left untreated. Blood samples and
brains were obtained at 14, 25, and 60 days (d) p.i. IgG, IgM, and
IgA anti-T. gondii antibodies and IgG avidity were determined in
serum by ELISA; numbers of cysts in brains were determined by
immunohistochemistry.
Results: Concentrations of speciﬁc IgG, IgM, and IgA increased over
time. IgG avidity also increased between d 14, 25, and 60 p.i. Treatment
with pyr/sulf but not with spiramycin, azithromycin, or atovaquone
signiﬁcantly decreased concentrations of IgG but not IgM or IgA
antibodies at 25 and 60 d p.i. (p< 0.01). This was paralleled by a
signiﬁcant decrease in cyst numbers in brains of mice treated with
pyr/sulf but not other drugs. In contrast, atovaquone but not pyr/sulf
or other drugs signiﬁcantly decreased levels of IgG avidity at 60 d p.i.
(p = 0.02).
Conclusion: Pyr/sulf but not other drugs currently used for the treatment
of acute infection with T. gondii impacted the development of IgG
antibodies against T. gondii and parasite numbers in a murine model
of acute infection. Atovaquone but not pyr/sulf or other antiparasitic
drugs impaired maturation of IgG antibodies. Future studies will have to
investigate the impact of antiparasitic treatment on maturation of avidity
in patients recently infected with T. gondii.
P1876 Use of a clinical laboratory database to estimate the
incidence of Toxoplasma gondii infection among women of
childbearing age: a longitudinal retrospective study
M. Martı´nez-Serrano, J. Bartolome´-A´lvarez, L. Moreno-Parrado,
S. Lorente-Ortun˜o, M. Crespo-Sa´nchez (Albacete, ES)
Objective: To know the incidence of Toxoplasma gondii infection in
women of reproductive age in Albacete, Spain.
Methods:We designed a longitudinal retrospective study of seronegative
childbearing-aged women. This study was conducted in an area where
prenatal serological screening for T. gondii infection is routinely
performed. Serological testing within this area is centralised in a unique
laboratory. We used the database of this central laboratory as the only
source of information for this study. We included in the study all the
women 14–44 years old who fulﬁlled all three criteria that follow:
1) they had at least two determinations of T. gondii IgG performed
between Feb-2001 and Mar-2007, 2) the ﬁrst determination of T. gondii
IgG was negative, and 3) the last determination was separated from
the ﬁrst one by an interval of time of at least one year. The patients
were classiﬁed in: 1) not infected, if all the determinations of T. gondii
IgG were negative, 2) conﬁrmed seroconversions, if the patient had
a) at least two determinations of T. gondii IgG with negative result
followed of at least two determinations with positive result or b) a
determination of T. gondii IgG with negative result followed of at least
two determinations with positive results for both T. gondii IgG and
IgM, and 3) possible seroconversions, if the patient had at least one
determination of T. gondii IgG with negative result followed of at least
one determination with positive result but was not fulﬁlling the criteria
of conﬁrmed seroconversion. For every patient it was calculated a time
at risk of acquiring the infection, which was the interval of time between
the ﬁrst one and the last determination of antibodies.
Results: We studied 2,416 women with a mean age of 29 years (SD =
5). The median time at risk was 35 months (interquartile range = 23–46),
and the total sum of times at risk was 7,121 women-year. There were 5
conﬁrmed and 3 possible seroconversions. None of these seroconversions
was detected during a pregnancy. There were 0.7 conﬁrmed and 0.4
possible seroconversions per 1,000 women-year. So, the true incidence
was between 0.7 and 1.1 seroconversions per 1,000 women-year (that is,
0.5−0.8 per 1,000 women-9 months).
Conclusion: The incidence of T. gondii infection among women of
childbearing age was low. Analysis of the laboratory database is a useful
approach to monitor the incidence of infection in areas where prenatal
screening for toxoplasmosis is performed.
P1877 Seasonal trends in acute toxoplasmosis in pregnancy in
Upper Austria
U. Sagel, R. Mikolajczyk (Linz, AT; Bielefeld, DE)
Objectives: Acute toxoplasmosis in pregnant women bears a risk
of infection for the unborn that might result in moderate to severe
ocular and neurological disorders. Secondary prevention using general
screening during pregnancy and antimicrobial treatment is cumbersome,
still disputed and carried out only in few European countries like Austria.
Pregnant women should be advised to avoid risk factors for infection,
especially eating of undercooked meat. The role of other important risk
factors is less well understood. We seek to verify a recent observation
from Slovenia suggesting a signiﬁcant increase in the incidence of acute
toxoplasmosis in pregnant women in winter.
Methods: We investigated retrospectively records for the largest
statutory health insurance company in Upper Austria (OO¨GKK) about
toxoplasmosis screening of pregnant women participating in the mother-
child-pass preventive programme. We used a general additive model with
locally weighted regression to visualise the trend in weekly incidence
of toxoplasmosis over time and for the estimation of the seasonal
trend during a year. Since the overall number of investigations did
not change over the studied period, we used Poisson distribution to
model the incidence of toxoplasmosis cases. Acute toxoplasmosis has
been regarded as certain in case of signiﬁcant titre rise in indirect
immunoﬂuorescence test and positive IgM, and uncertain if diagnosis
has been solely made by positive IgM and low IgG-avidity.
Results: From 01.01.2000 to 31.01.2005 there were 191 uncertain and
51 certain acute infections. There was a clear variability across time in
uncertain infections, with a higher incidence during the winter months
(Figure 1a). This was conﬁrmed in the seasonal trend analysis, with a
more than 2 times higher incidence during the winter months (Figure
1b). The results were similar when the analysis was restricted only to
certain cases. In seroconversions during pregnancy (n = 45), the mean
duration between the last seronegative and ﬁrst seropositive examination
was 102 days (range: 30–181 days).
Conclusion: We conﬁrmed the trend observed in Slovenia using an
independent sample from Upper Austria. Given the long times between
examinations it can be expected that the observed peak in positive
diagnoses in winter may actually reﬂect an increased incidence of
infection in autumn. Further research should focus on risk factors that
may explain the observed seasonal trends.
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P1878 Toxoplasma gondii infection in centre of Portugal:
seroprevalence during 2000–2006
M.C. Sousa, L. Silveira, J. Poiares-da-Silva, A. Donato (Coimbra, PT)
Toxoplasma gondii is an obligate intracellular protozoan that can infect
all kind of birds and all mammals including humans and is common
throughout the world. The prevalence varies according to social and
cultural habits, pet cats in homes and geographic factors. Domestic
cats are considered to be an important source of T. gondii infection.
Toxoplasmosis is the most widespread zoonosis and an important human
disease particularly the congenital infection where it could cause visual
and neurological impairment and mental retardation in children. In the
present study, the prevalence of T. gondii infection in centre of Portugal
were determined from January 2000 to December 2006 by testing the
sera collected from women (n = 1,003) and men (n = 168) for T. gondii
immunoglobulins G and M antibodies. The anti-toxoplasma IgM and IgG
were determined using ELFA technique (Enzyme Linked Fluorescence
Assay) (VIDAS Toxo, BioMe´riuex). Results for IgG antibodies were
reported in International Units (IU); samples with4 IU were considered
positive for T. gondii immunoglobulin G antibodies. The results for
IgM were reported as positive if the index was >0.65 and negative
if was <0.55. In women, the rates of T. gondii IgM antibodies were
0.9% (9/1,003) and 24.9% (250/1,003) for IgG antibodies. Along the
study period 2000–2006 the toxo anti-IgG ranged from a minimum of
13.6% in 2005 to a maximum of 30.3% in 2001. In men, the rates
of IgM antibodies were 0% and 58.9% (99/168) for IgG antibodies.
The total rate of positively of T. gondii antibodies was 30% (351/1,171)
and the negativity was 70% (820/1,171). The age-adjusted T. gondii
seroprevalence among males with 20–29 years old (n= 24) was 20.8%
and among females with 20–29 years old was 27.3% (135/495). The
prevalence of T. gondii IgG antibodies increased with age: the highest
positive rates (83%) have been founded in persons with age more than
seventy years old (25/30). These results indicate that preventive measures
should be implemented in pregnant women’s to prevent the congenital
toxoplasmosis.
This work was supported FCT POCTI (FEDER).
P1879 Prevalence of Toxoplasma gondii infection in pregnant
women in the Albacete area, Spain
L. Moreno-Parrado, J. Bartolome´-A´lvarez, M. Martı´nez-Serrano,
S. Lorente-Ortun˜o, M. Crespo-Sa´nchez (Albacete, ES)
Objective: Determining the seroprevalence of Toxoplasma gondii in
pregnant women living in the Albacete area, Spain.
Methods: A study on women living in the Albacete area who gave birth
during 2006 and had been serologically screened for anti-T. gondii IgG –
this test is made as a matter of routine to all pregnant women at Albacete
general hospital. Their age, place of birth and residence as well as the
result of determining anti-T. gondii IgG were looked up in the registry.
Results: In 2006, 2,704 births occurred in the study area, 2,627 (97.2%)
out of which had been tested in search of anti-T. gondii IgG at least
once during pregnancy. Four women were excluded from the study as
they presented an undetermined result as to anti-T. gondii IgG, so that the
ﬁnal total number of women included in the study was 2,623. Prevalence
of anti-T. gondii IgG amongst studied women was 20.6% (95%CI=
19.1%-22.2%). Seroprevalence amongst Spain-born women was 15.8%
(95%CI= 14.3%-17.4%) and 50.8% (95%CI= 45.5%-56.1%) amongst
women coming from other countries. Seroprevalence increased linearly
with age, both amongst Spain-born (p< 0.01; Ji-Square for linear trend)
and immigrant (p< 0.01; Ji-Squared for linear trend) women. Amongst
Spain-born women, seroprevalence increase ranged from 9% (95%CI=
6%-14%) in women under 25 to 22% (95%CI= 19%-26%) in women
over 34 years old. Amongst Spain-born women, seroprevalence was
lower in those living in the city of Albacete than in those living in
cities of less than 30,000 inhabitants (14.1% versus 17.9%; OR= 0.75,
95%CI= 0.59−0.96; p = 0.016).
Conclusion: Prevalence of toxoplasmosis in our area is higher amongst
immigrant women than in Spain-born women and it increases with age.
Amongst those women born in Spain, seroprevalence is lower in women
living in the city of Albacete than in those living in smaller cities.
Seroprevalence amongst Spain-born women is the lowest one of those
published so far. Continuous education of pregnant women about risks
of infection is essential.
P1880 Materno-foetal toxoplasmosis: staging of infection and
newborn follow-up
C. Giraldi, F. Greco, R. Tenuta, O. Savino, A. Noto (Cosenza, IT)
Objectives: Toxoplasma gondii infection during pregnancy may be
transmitted to the foetus: risk of infection and seriousness of disease
depend on gestational age at the time of maternal infection. Aim of this
study was to establish correct maternal serologic diagnosis in order to
deﬁne proper therapy and newborn follow-up.
Methods: During 2004–2006, 33 mother/child pairs were followed up
using the following approach: (a) counseling to evaluate fetal risk
tied to gestational age at the time of maternal infection, diagnosis of
prenatal infection, therapy administration and frequency of ultrasound
scans; (b) follow-up of all newborns up to their ﬁrst year by serologic,
immunologic, clinic and instrumental methods. The following tests were
used to diagnose maternal infection: Toxoplasma IgM, IgG and avidity
of IgG by CLIA (DiaSorin, Saluggia, Italy) and detection of Toxoplasma
DNA in amniotic ﬂuid by nested PCR (Nanogen Advanced Diagnostics,
Turin, Italy). The following tests were used for newborn screening:
Toxoplasma IgM, IgG by CLIA (DiaSorin, Saluggia, Italy), ISAGA
(BioMe´rieux, Marcy l’Etoile, France) and Western blot (LDBIO, Lyon,
France). Results were compared with maternal serology outcome.
Results: 33 newborns were followed up by serologic, immunologic,
clinic and instrumental methods for one year. Mothers were treated
during pregnancy in accordance with routine protocols. Only 5 children
were infected, classed as follows: (a) 1 infected child and 13 healthy
children in the group of mothers infected during the ﬁrst trimester of
pregnancy; (b) 3 infected children and 15 healthy children in the group
of mothers infected during the second trimester of pregnancy; (c) 1
infected child in the group of mothers infected during the third trimester
of pregnancy. All infected children were apparently healthy at 1 year of
age.
Conclusions: Serologic and immunologic follow-up of children born
from mothers infected by T. gondii during pregnancy must be extremely
accurate, especially during the ﬁrst 6 months of life. Methods used for
antibody detection in mothers and children (ISAGA, CLIA or EIA and
WB) are used to anticipate diagnosis of congenital infection, generally
obtained for antibody rebound, and to administer proper therapy. In our
clinical experience no infected children born from adequately treated
mothers showed signs of disease.
P1881 Clinical manifestations of congenital toxoplasmosis and their
importance in the prophylaxis of congenital malformations
L.M. Junie on behalf of ESGP
Background: Congenital malformations represent an important aspect
of medicine due to its deep social and inside family implications.
The toxoplasmic infection is one of the major causes of congenital
malformations. We decide to solve some aspects, like the clinical
manifestations of congenital Toxoplasmosis.
Material and Method: We studied 253 children with congenital
malformation. The Toxoplasma infection was detected by demonstrating
the presence of speciﬁc antibodies by indirect IF and ELISA. The
maternal antibodies established in order to identify the acute toxoplasmic
infection during pregnancy.
Results: The studied children were newborn(63.8%)or infants(36.2%).
Trying to demonstrate the presence of antibodies in 68 pairs of mother-
malformed baby, positive results were in 59 cases (86.8%). Our data
suggest that 78% of congenital malformations are the consequence of
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an infection acquired in the ﬁrst months of pregnancy, when the fetal
embryogenesis take place and only 22% of mothers had the infection
during the last period of pregnancy (11.8 in the second semester
and 10.3% in the third semester). The evolution of most pregnancies
of malformed children mothers was apparently normal (57.3%) and
42.7% had abortion and pathologic pregnancies: stillbirth, haemorrhage,
premature birth and others. The majority of malformed children had
isolated ophthalmologic (36.6%) and neurological problems (97.6%),
cranial malformations (23.8%), visceral disease (12.5%), malformations
and visceral disease (11.4%). The neurological manifestations were
especially psychomotor retardation (71.3%), epileptic seizures (11%),
tetraparesis (2.7%), half paresis (4.2%), cerebellum syndrome (1.4%),
cranial nerves paralysis and deafness (7%). As visceral manifestations,
we found anaemia (24.7%), thrombocytopenia (1.4%), jaundice (1.4%),
and heard malformations (2.7%). The congenital malformations were
microcephaly (17.8%), cranial-cerebral dimorphism (9.6%), and hy-
drocephalus (6.9%), microphtalmy (1.4%), cerebella atrophy (1.4%),
frontal-parietal atrophy (1.4%) and cerebral ventricle ecstasy (1.4%).
Conclusions: Our studies afford the necessity of active scientiﬁc
surveillance of pregnant women and newborn children. They emphasize
the need of national programmes for the control of toxoplasmic infections
in which modern techniques of diagnosis of antitoxoplasmic antibodies
should be used both in pregnant women and in newborn children.
P1882 Comparison of two real-time PCR targets (B1 and REP
529) for Toxoplasma gondii DNA detection for the diagnosis
of congenital toxoplasmosis
F. Robert-Gangneux, P. Dupretz, L. Huet, E. Bart-Delabesse,
C. Guiguen, J.P. Gangneux (Rennes, Paris, FR)
Objectives: While often asymptomatic, the infection with the protozoan
parasite Toxoplasma gondii can cause serious damage (i) in the
immunocompromised patient and (ii) in the foetus when it is acquired
during pregnancy. In both situations, DNA parasite detection is essential
for diagnosis, when performed in cerebrospinal ﬂuid (CSF) or blood
(in the case of cerebral or disseminated toxoplasmosis), or amniotic
ﬂuid (AF) and placenta (for prenatal or neonatal diagnosis of congenital
toxoplasmosis, respectively).
Various sequence targets and PCR protocols (conventional PCR,
real-time PCR) have been developed for molecular diagnosis of
toxoplasmosis.
In this study, we evaluated two real-time PCR assays that we had
developed in our lab, using Taqman probes on ABI Prism 7000 system:
a PCR assay targeted at the multicopy gene B1 and a PCR assay targeted
at the repeated sequence REP-529.
Methods: Both techniques were prospectively or retrospectively applied
to 40 clinical samples: 20 samples from patients with proven congenital
toxoplasmosis (7 AF, 12 placentas, and 1 cord blood sample), and 20
placentas from women who had seroconverted during pregnancy but
whose newborns were later proven non-infected. Serial dilutions of
T. gondii RH strain were also ampliﬁed using B1 and REP-529 target
PCRs.
Results: No DNA was ampliﬁed with any of the techniques, in the
20 specimens from patients in whom the diagnosis of congenital
toxoplasmosis was later ruled out. REP-529 sequence was detected in
all 20 samples from patients with congenital toxoplasmosis, whereas B1
gene sequence was detected in only 16 of the 20 specimens. The kappa
value (concordance test) was 0.8. False negative results with B1 gene
were observed in 3 placentas and 1 AF from foetus that were otherwise
proven infected by other techniques and a long-term follow-up of the
newborns. Moreover, in the 16 samples that were positive with both
target sequences, a gain in sensitivity was obtained with the REP-529
ampliﬁcation, since it allowed the detection of DNA with a mean Ct value
that was 4 cycles lower than the Ct value obtained for B1 ampliﬁcation.
Similar results were obtained with the serial dilutions of the RH strain,
used as control.
Conclusion: Real-time PCR using the REP-529 Taqman probes was
more efﬁcient than B1 gene ampliﬁcation for the diagnosis of congenital
toxoplasmosis, since it allowed parasite DNA detection in all clinical
specimens.
P1883 Development of two combined real-time quantitative
OCEANII PCR assays to detect Toxoplasma gondii in
amniotic ﬂuids and sera
L. Putignani, C. Russo, L. Mancinelli, E. Shehi, C. Angelici, V. Meroni,
F. Signore, D. Adlerstein, D. Menichella (Rome, Nerviano, Pavia, IT)
Objectives: Toxoplasmosis is a worldwide infectious disease caused by
the protozoan Toxoplasma gondii mainly acquired by feeding raw meat
containing tissue cysts. Congenital infected foetuses are at risk for severe
or life-threatening disease. In children, the infection may cause cervical
lymphadenopathy or ocular diseases with serious clinical course. Early
detection of T. gondii is therefore crucial to assess proper treatment and
to avoid critical sequela. To date laboratories use customised diagnosis
methods, which produce a large wide of protocols. Our research aims
to provide a real-time quantitative PCR assay for rapid and sensitive
detection of T. gondii in specimens.
Methods: Two real-time PCR assays, targeting internal portions of
the multicopy B1 gene and repeated element RE of T. gondii, were
selected to design the OCEAN II assays (DiaSorin), based on the speciﬁc
hybridisation of a ﬂuorogenic primer forming a three-way-junction with
an anchor probe. In silico simulations identiﬁed optimal paired primers
and thermodynamic conditions to run B1 and RE reactions. Ten-fold
dilutions from 100,000 to 0.1 copy of RH strain genomic DNA was
exploited, in triplicate, to titrate the dynamic range of the real-time PCR
and to assess intra- and inter-assay reproducibility in more than ten
independent experiments. 1ml of sera and amniotic ﬂuids, serologically
negative for T. gondii, were spiked with 10-fold dilutions of tachyzoites
from 100,000 to 0.1 in order to quantitatively correlate parasite extracted
DNA and genome copies. A group of 25 amniotic ﬂuids and sera,
previously tested for T. gondii by seroconversion and PCR, were tested,
as triplicates, to assay the B1- and RE-based real-time systems.
Results: The linearity of the B1 and RE assays was achieved over seven
logs of input DNA, showing a consistent dynamic range and accuracy
for genomic DNA in each assay (R[B1] from 0.994 to 0.999, R[RE]
from 0.987 to 0.999, respectively). High inter-assay reproducibility was
achieved, as inferred by R[B1]=0.998 and R[RE]=0.999. Ct values found
with reference and spiked tachyzoite DNA were highly consistent for
B1 and RE assays on both sera and amniotic ﬂuids (R[B1]=0.991,
R[RE]=0.990) and clinical concordance was obtained for 22 over the
25 collected samples.
Conclusions: The B1 and RE combined real-time PCR assays may
represent a new diagnostic tool for rapid and quantitative detection of
T. gondii in clinical specimens.
P1884 Performance of the Abbott ARCHITECT Toxo IgM assay
D. Smith, J. Prostko, E. Frias, M. Palafox, S. Hsu, M. Matias, D. Pucci
(Abbott Park, US)
Objectives: Infection by Toxoplasmosis gondii continues to be a
ubiquitous disease that may seriously impact the developing foetus.
The clinical implications for the child can include neurological defects,
blindness and death. Therefore, routine monitoring of the Toxo
serological status of pregnant females remains a practice in many
countries. The objective of this study was to evaluate the performance
of the Abbott ARCHITECT Toxo IgM assay as a means of assisting in
the prevention of this disease and the associated congenital defects it
causes.
Methods: The Abbott ARCHITECT Toxo IgM immunoassay is based
on a Mu- capture format in which the patient’s IgM is bound to mouse
anti-human monoclonal antibody coated paramagnetic microparticles.
Speciﬁc detection of the anti-Toxo IgM is acccomplished via incubation
with a Toxoplasma gondii tachyzoite lysate which is complexed to
an acridinium-labeled mouse anti-Toxo P30 monoclonal antibody.
Speciﬁcity testing included 300 samples from random blood donors, 300
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samples from random hospital patients and 299 pregnant female samples
from all trimesters. Sensitivity of the assay was determined by testing
42 seroconversion panels and 155 individual Toxo positive samples. The
results of this testing were compared to the Abbott AxSYM Toxo IgM
assay and employed resolution of discordant samples with another Toxo
IgM assay.
Results: Detection of acute infection, as demonstrated with seroconver-
sion panels, was found to be equivalent to that of the Abbott AxSYM
Toxo IgM assay. Both detected the same ﬁrst positive bleed in 40 panels
and each was ahead in a panel. Resolved sensitivity for the Toxo positive
samples was 99.31% to 100% while that of AxSYM was 96.55. In a
comparison to ISAGA IgM assay results, the relative sensitivity of the
ARCHITECT assay was 97.33–99.32%. The ARCHITECT Toxo IgM
assay was found to have a relative speciﬁcity of 100% for the composite
population of random blood donors, hospital patients or pregnant females
while the speciﬁcity for AxSYM Toxo was 99.89%.
Conclusion: The Abbott ARCHITECT Toxo IgM assay demonstrated
performance which was comparable to the reference assays and provides
an automated method to evaluate the serological status of patients in
conjunction with Toxo IgG and Toxo avidity assays.
P1885 Evaluation of qualitative agreement and quantitative
correlation between the new ARCHITECT Toxo IgG assay
and 4 commercially available Toxo IgG assays
H.B. Braun, E. Sickinger, C. Koch, C. Birkenbach, I. Stenzel, D. Smith,
J. Schultess, M. Hausmann, J. Dhein (Wiesbaden, DE; Chicago, US)
Objectives: Determination of Toxo IgG antibodies to Toxoplasma gondii
is mainly important in pregnant women and immunocompromised
patients to evaluate their serological status. Commercially available Toxo
IgG assays are standardised against International standard preparations
and report IU/ml concentrations. However, there were at least three
different standard preparations available for standardisation of currently
used Toxo IgG immunoassays, which might impact the quantitative
correlation and slope between methods.
In this study we describe the qualitative agreement and quantitative
correlation of the new ARCHITECT Toxo IgG assay, which is
standardised against the WHO First International Standard (01/600) and
utilizes recombinant antigens, and 4 other Toxo IgG assays standardised
against earlier WHO standard preparations.
Methods: 100 pre-characterized Toxo IgG positive and 100 pre-
characterized negative specimens were evaluated on the Vidas, Access,
Enzygnost and AxSYM Toxo IgG assays in comparison to ARCHITECT
Toxo IgG. Qualitative agreement and quantitative correlation was
assessed.
Results: Qualitative agreement between the methods ranged from 98.9
to 100% without grey zone specimens and from 95.5 to 98.4% with grey
zone specimens. Slope of linear regression between methods was very
variable. The slopes and the correlation coefﬁcient r versus Architect
ranged from 0.8 to 3.0 and from 0.81 to 0.96, respectively.
Conclusion: Good qualitative agreement could be observed between all
assays evaluated. Nevertheless, the differences in quantitative determina-
tion of concentrations were considerable. Quantitative differences can be
attributed to differing standardisation, assay format and technology. This
underlines the necessity to perform quantitative comparison of Toxo IgG
levels within one method only.
P1886 Membrane biogenesis in the intracellular parasite
Toxoplasma gondii and its signiﬁcance as a novel
chemotherapeutic target
N. Gupta, M. Zahn, D. Voelker (Berlin, DE; Denver, US)
Objectives: T. gondii, an obligate intracellular protozoan parasite, causes
severe congenital infections in humans and animals. Toxoplasma is also
an opportunistic pathogen associated with AIDS. Successful replication
of T. gondii within its host requires substantial membrane biogenesis. We
characterised the phospholipid metabolism of T. gondii and the selective
disruption of its PtdCho synthesis to inhibit its intracellular growth.
Methods: The phospholipid metabolism of axenic T. gondii was investi-
gated using radio-isotopic precursors and thin layer chromatography. The
selective inhibition of PtdCho metabolism was achieved by treatment of
infected human ﬁbroblasts with dimethylethanolamine (Etn(Me)2).
Results: T. gondii can metabolize the lipid precursors, serine,
ethanolamine, choline and inositol in a time- and concentration-
dependent manner to synthesise PtdSer, PtdEtn, PtdCho and PtdIns,
respectively. The parasite lacks the PtdEtn methylation pathway to
synthesise PtdCho indicating it is a choline or PtdCho auxotroph.
Etn(Me)2 selectively interferes with the PtdCho metabolism of T. gondii
and causes 99.5% inhibition of its growth within ﬁbroblasts. It is readily
incorporated into PtdEtn(Me)2 by the parasite, and during replication
within the host cell it becomes the major phospholipid. The synthesis of
PtdEtn(Me)2 is accompanied by a decrease in PtdCho. Relative to host
cells, the parasites accumulate 7 times as much PtdEtn(Me)2 into their
phospholipid, which disrupts the physical and biochemical integrity of
parasite membrane as conﬁrmed by electron microscopy.
Conclusions: T. gondii has the ability to autonomously synthesise
phospholipids, which renders it uniquely susceptible to modiﬁers of lipid
metabolism. Our ﬁndings also reveal, how selective inhibition of parasite
PtdCho synthesis by a choline analog is a powerful chemotherapeutic
approach to arrest parasite growth within its mammalian host.
Virology
P1887 Molecular characterisation of a rare G8P[14] rotavirus
strain detected in an infant with gastroenteritis in Italy
M.C. Medici, L.A. Abelli, M. Martinelli, G. Dettori, C. Chezzi
(Parma, IT)
Objective: The aim of the present study was to perform the molecular
characterisation and the phylogenetic analysis of a rare G8P[14] group
A rotavirus (GARV) strain detected in Parma, Northern Italy, during a
2004–2005 rotavirus (RV) epidemiological surveillance.
Methods: Two hundred and seventy three RV-like particles positive
stools by electron microscopy (EM) out of 856 stools from children
(median age 1 year 8 months, range 1 month – 10 years 4 months)
hospitalised with gastroenteritis in Parma, Northern Italy, were submitted
to PAGE analysis.
Genotyping of 271 GARV strains was carried out on dsRNA extracted
from 10% PBS stool suspensions by a nested and/or heminested RT-PCR
speciﬁc for VP7 and VP4 genes, using pools of G and P type speciﬁc
primers. One strain (PR/1300/04) displayed G8 speciﬁcity and was not
typeable in the VP4 gene.
After puriﬁcation by “Qiaquick Gel Extraction Kit” (QIAGEN, Italy),
the VP4, VP6, and VP7 ﬁrst amplicons of the G8 GARV strain
were subjected to sequence analysis with automated sequencer 3730
DNA Analyzer (Applied Biosystems, USA). Phylogenetic analysis was
conducted using MEGA version 2.1.
Results: The PR/1300/04 strain exhibited P[14] speciﬁcity and long
e-type. By sequence analysis, the PR/1300/04 VP7 gene displayed high
nucleotide (97.9%) and amino acid (99.4%) identities to bovine Japanese
and South African strains, while the VP4 gene was closely related (96%
and 99.1% nucleotide and amino acid identity) to the human Italian
PA169 strain. The VP6 gene was found to contain subgroup I speciﬁcity.
Phylogenetic analysis demonstrated the animal origin of PR/1300/04
VP7 gene and the human origin of the VP4 gene.
Conclusion: The data obtained seem to suggest that the Italian
PR/1300/04 strain could be the result of a reassortment between a PA169-
like strain with P[14] speciﬁcity, long e-type and subgroup I, already
circulating in Italy, and a G8 animal strain. The increasing number
of reports of atypical RV strains in humans suggests that interspecies
transmission of gene segments greatly contributes to the RV genetic
evolution.
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P1888 Genetic characterisation of G3 rotaviruses detected in an
Italian infantile population in 1993–2005
S. De Grazia, G.M. Giammanco, S. Ramirez, C. Colomba, A. Cascio,
P. Aiello, S. Arista (Palermo, Messina, IT)
Objectives: Group A rotavirus are the most common aetiologic agents
of acute gastroenteritis in children worldwide. Sequence analysis of
the genes coding for the two outer capsid proteins VP7 and VP4,
for the inner capsid protein VP6 and for the non structural protein
NSP4 is useful to gather epidemiological information on rotaviruses.
To date, 15 VP7 G-types, 27 VP4 P-types, 4 VP6 subgroup speciﬁcities
(SGs I, II, I+II and nonI/nonII) and 5 NSP4 genotypes (A to E) have
been established. The most common genotypes are G1P[8], G3P[8] and
G4P[8], in association with SGII and NSP4 B, and G2P[4] SGII NSP4
A. Recently, epidemiologic studies showed an increasing detection of G3
strains in Japan, China, Russia, Ireland and Spain. In Italy, in the past G3
rotaviruses have been detected sporadically or at very low prevalence.
However, in 2003 and 2005 they acquired an important epidemiological
role. To investigate the emergence of G3 rotaviruses in Italy a sequence
analysis was performed on G3 strains detected in Palermo during 13
years.
Methods: A total of 1012 rotavirus positive faecal specimens were
collected from children (<5 years) hospitalised with acute gastroenteritis
at the “G. Di Cristina” Children’s Hospital of Palermo, Italy from 1993
to 2005. Rotaviruses were genotyped by nested RT-PCR to deﬁne their G
and P type. Sequencing and phylogenetic analysis of the VP7, VP4, VP6
and NSP4 genes was performed after ampliﬁcation with type-speciﬁc
primers on representative G3 strains.
Results: Fifty-seven (5.6%) rotavirus positive samples were genotyped
as G3. Of the 19 strains submitted to sequence analysis 11 were typed as
G3P[8] SGII NSP4 B, three as G3P[9] SGII NSP4 A and one as G3P[3]
SGI NSP4 C. In the phylogenetic tree of VP7, the Italian G3P[8] and
G3P[9] rotaviruses were distributed into lineage I while the G3P[3] in
lineage III. Sequence analysis of VP4 revealed that all Italian G3P[8]
rotaviruses clustered in the P[8]-3 lineage. Phylogenies of the NSP4 gene
showed the clustering of Italian strains in two separate groups according
to the year of sampling.
Conclusions: The genetic analysis performed ascertained that strains
circulating in Palermo shared common features in the genome segments
analysed but amino acids mutations in the NSP4 sequence appeared
in 2003 and were conserved through 2005. The periodical increase of
G3 strains circulation seems more linked to a loss of immunity in the
population that to changes in their antigenic determinants.
P1889 Electrophoretic RNA genomic proﬁles of rotavirus
strains prevailing among hospitalised children with acute
gastroenteritis in Tehran, Iran
S. Modarres, A. Rahbarimanesh, M. Karimi, S. Modarres, M. Motamedi
Rad, A. Sohrabi, N. Nasiri Oskoii (Tehran, IR)
Background: Human Rotavirus (HRV) has now been established as the
most important cause of childhood gastroenteritis worldwide. The RNA
genomic electrophoretic diversity of group A Rotavirus strains in Tehran,
Iran, Between April 2002 and March 2005, were investigated in children
stool specimens.
Methods: A total of 1250 Stool samples were obtained from hospitalised
children younger than 5 years old with acute gastroenteritis and RNA
electrophoretype of group A Rotavirus strains was determined using
RNA-PAGE in those samples found to be positive for Rotavirus by EIA.
Results: The predominant RNA proﬁle detected was the long
electrophoretype (90%) followed by the short proﬁle (8.8%). Four cases
(1.2%) had patterns of mixed infection. Fourteen different electrophoretic
RNA patterns, eight of long and six of short, were detected in the study
area. A predominant long RNA electrophoretype persisted during the
years study with peak incidence in cool seasons of the year. The long
pattern occurred throughout the study period and in all age ranges of
patients (1–60 months), but the short proﬁle identiﬁed only in infants
(1–24 months) at varying intervals.
Conclusions: Our data demonstrate epidemiologic differences between
long and short electrophoretypes incidence; the long proﬁles appear to
circulate continuously in the area, whereas the short electrophoretypes
appear in an episodic fashion. This study highlights the simultaneous co-
circulation of multiple group A Rotavirus strains in Tehran and stresses
the need constant monitoring of the genomic diversity resulting from
extensive genomic variation among Rotaviruses in the area.
P1890 Rotavirus diversity in Bulgaria during 2007
Z. Mladenova, N. Korsun, M. Tiholova, T. Geonova (Soﬁa, BG)
Background: Rotaviruses remain one of the leading causes of morbidity
and mortality worldwide. Rotaviruses are RNA containing viruses with
segmented genome and their strain diversity and intensive evolution
are based on accumulation of point mutations and reassortment
events. Rotaviruses are highly infectious and easily distributed among
human population which are preconditions for appearance of new
endemic/epidemic strains. Objectives of the stidy were investigation of
prevalence and rotavirus strain diversity in Bulgaria during 2007 and
comparision of data obtained with the data from previous years.
Materials and Methods: A total of 1267 stool specimens collected
from January to mid October 2007 from children under 10 years of
age with acute gastroenteritis were screened for rotaviruses by enzime
immunoassay, conﬁrmed with PAGE and G and P genotyped by RT-PCR
using two sets of primers.
Results: The results revealed: 1) 29.4% (373 of 1267) stools were
rotavirus-positive; 2) the most predominant G and P genotypes
detected were G2 (52.8%, 105/199) and G9 (36.2%, 72/199) and
P[4] (44.7%, 89/199) and P[8] (28.6%, 57/199) respectively; 3) 34.7%
(69/199) of rotavirus strains failed to be fully/partly genotyped by
Das-Cunliffe/Gentsch primers and 59 strains were retested using
Gouvea/Iturriza primers set; 4) 71.2% (42/59) of rotaviruses remained
G and/or P-untypeable using two primers sets and ongoing sequence
analysis will uncover the probable resons for this; 5) "shift" in the
incidence of rotavirus genotypes: G4P[8] in 2005, G9P[8] in 2006 and
G2P[4] and G9P[8] in 2007; 6) signiﬁcant incidence of infections with
G2P[4] among older children aged 2–10 years; 7) year-round rotavirus
circulation with a peak in winter season and appearance of the second
peak in August-September.
Conclusions: Broad and long-term rotavirus detection and characterisa-
tion among children aged 1 month-15 years using new and improved
detection assays and primers sets will describe the epidemiology of
rotavirus infections in Bulgaria and driving forces of possible appearance
of new rotavirus strains.
P1891 Aetiology of paediatric viral gastroenteritis in Bulgaria
T. Geonova, Z. Mladenova, N. Korsun, I. DiBartolo, L. Fiore,
F.M. Ruggeri, M. Tiholova, A. Mangarov, N. Naydenova, P. Petrov,
K. Peteva, R. Komitova, M. Nenova (Soﬁa, Pazardjik, Pleven, Varna,
BG; Rome, IT)
Background: Acute gastroenteritis is one of the most prevalent diseases
worldwide, being among the leading causes of morbidity and mortality
in infants and young children. The majority of enteric infections are
viral in origin. The main enteric pathogens are members of four
families – rotaviruses, noroviruses, astroviruses and enteric adenoviruses.
The objective of the study is to determine the distribution of viral agents
in hospitalised children with acute gastroenteritis.
Methods: From December 2006 to April 2007 a total of 470 stool
samples from paediatric patients exhibiting symptoms of diarrhoea
and/or vomiting were tested for the presence of enteric viral pathogens
using immunoassay kits (Ridascreen™, R-Biopharm). The results from
ELISA method were compared with polyacrylamide gel electrophoresis
(PAGE) for rotaviruses. RT-PCR was used to conﬁrm rotavirus and
norovirus antigen-positive results and to characterize strain speciﬁcity.
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Results: Viral pathogens were identiﬁed in 215 (45.7%) samples. Group
A rotaviruses were detected in 136 (28.9%) followed by noroviruses – 52
(11.1%), enteric adenoviruses – 36 (7.7%) and astroviruses – 1 (0.2%).
Mixed infections were proved in 10 (4.7%) cases. The most common
co-infections were observed between rotaviruses and adenoviruses.
Using RT-PCR techniques two dominant rotavirus strains (G2P[4] and
G9P[8]) and GGII.4 norovirus strains were identiﬁed and conﬁrmed by
sequencing. The majority of cases were in children aged 7–36 months
and predominated between February and April.
Conclusions: The results of the ﬁrst investigation of causative agents
of acute gastroenteritis in hospitalised children highlight the important
aetiologic role of viral diarrhoeal pathogens in Bulgaria and the
signiﬁcance of rapid screening methods for achieving an early diagnosis.
P1892 Ten-years surveillance of norovirus in outbreaks of
gastroenteritis in Hungary: molecular epidemiology, genetic
diversity and evolution
G. Reuter, K. Krisztalovics, P. Pankovics, G. Szucs (Pe´cs, Budapest, HU)
Objectives: Noroviruses are important pathogens in outbreaks of
gastroenteritis in humans wordwide and they belong to a genetically
diverse group of RNA viruses (family Caliciviridae) with multiple
genogroups (G) and genotypes.
Methods: Between November 1998 and June 2007, 735 (44.6%) of 1647
reported outbreaks of gastroenteritis were investigated prospectively
for norovirus in Hungary. Stool samples in outbreaks of nonbacterial
gastroenteritis were examined by ELISA and RT-PCR methods.
Results: Norovirus was detected in 724 (98.5%) of 735 outbreaks and
conﬁrmed by sequencing in 500 (69%) of epidemics. Strains grouped
into 2 genogroups (GI, 4.6%; GII, 95.4%) and 15 genotypes (GI-1, 2, 3,
4, 6 and a new genotype; GII-1, 1b, 2, 5, 7, 8, b, and a new genotype)
with the predominance of GII-4-Lordsdale (76%) genotype. Four main
genetic variants (epidemic point-mutants) of GII-4 were identiﬁed and
they appeared subsequently in every 2 years (GII-4–2000; GII-4–2002;
GII-4–2004 and GII-4–2006b). Each of them associated with strong,
2-years long epidemic periods mainly in healthcare institutions and
elderly homes. In 2006, an unusual summer and even the highest winter
activity were detected associated with GII-4–2006b. This variant was
also identiﬁed in the largest waterborne outbreak ever seen in Hungary
and affected more than 3600 patients in June 2006. In this outbreak,
the public water system of a large town supplied by karstic water was
contaminated as a consequence of extremely heavy rainfalls ﬂooding the
karstic area. Since 2000, continuous circulation of recombinant strain
GIIb with 4 capsid types were also detected as a second most common
(11%) genotype associated with outbreaks in children. Nearly 90% of
the norovirus outbreaks was caused by only 2 genetic types, the point
mutant variants GII-4 and the genetic recombinant GIIb.
Conclusions: According to this 10-years study noroviruses were the
predominant aetiological agent causing gastroenteritis outbreaks in
Hungary. Elevated numbers of norovirus outbreaks in the population
most likely indicate the emergence of a new GII-4 drift variant as part of
an international epidemic/pandemic. Genetic drift successfully promotes
the re-emergence of genotype GII-4 in the population. This phenomenon
is highly similar to inﬂuenza virus antigen drifts when sufﬁcient level of
immunity in the population has been developing against one predominant
strain over nearly a period of every 2−3 years.
P1893 Retrospective comparison of human papillomavirus
detection in 42 HSIL samples, by using RNA-based
NucliSENS EasyQ™ HPV Assay and DNA genotyping
L. Tissie`res Lovey, J.-L. Pauze´, P.-A. Menoud, C. Di Mito, O. Pe´ter,
G. Praz (Sion, Niederwangen, Geneva, CH)
Objectives: The aim of this study was to evaluate the new NucliSENS
EasyQ™ HPV assay (bioMe´rieux, Boxtel, The Netherlands) by using the
NucliSENS easyMAG® and NucliSENS EasyQ® systems in comparison
with cytology, histology and DNA genotyping.
Methods: Retrospective cervical HSIL samples from 42 women 22–
50 years of age, collected between August 2006 and August 2007 and
stored at room temperature in PreservCyt® transport medium (Cytyc
Corp, MA, USA) were analysed in October 2007.
Total RNA was extracted on NucliSENS easyMAG® system from 1ml
cervix sample and eluted in ﬁnal volume of 50 ml. Eluates were used
for both mRNA and DNA ampliﬁcation.
E6/E7 mRNA expression from high-risk HPV 16, 18, 31, 33 and 45
was detected with multiplex NASBA (NucliSENS EasyQ™ HPV) and
compared with DNA typing results. HPV DNA genotyping was carried
out with INNO-LiPA HPV Genotyping (Innogenetics, Ghent, Belgium),
according to the manufacturer’s procedure.
Results: All samples (42) were deﬁned by pathologist as high-grade
squamous intraepithelial lesion (HSIL). Thirty-ﬁve samples of CIN2+
grade and 2 samples of LSIL were fully concordant with cytological
and histological results. The 5 other samples were not histologically-
evaluated.
Internal control mRNA was successfully ampliﬁed in all cases suggesting
no inhibition or degradation. Among 42 analysed samples, 38 were HPV-
positive (90.5%). Their mRNA based genotypes were: HPV-16 (68%),
HPV-18(8%), HPV-31(8%), HPV-33(13%) and one multi-infection HPV-
16/31 (3%). All these genotypes but one (HPV-33 vs HPV-58) were
found identical by DNA genotyping.
From the 4 HPV-negative mRNA samples, 3 were determined by DNA
genotyping as positive for HPV-51 or HPV-58 type and one HPV-16.
The latter could not be tested further for mRNA.
Conclusion: In the present study, NucliSENS EasyQ™ HPV assay,
designed for the detection of the 5 HPV types 16, 18, 31, 33 and 45,
have shown a good correlation with histology.
P1894 HPV-E5 oncoprotein downregulates IFN-beta signalling in
HaCaT/E5 cells
M.C. Liberto, V. Muto, R. Capicotto, G.S. Barreca, A.G. Lamberti,
A. Quirino, G. Matera, A. Foca` (Catanzaro, IT)
Objectives: HPV oncoprotein are known to interfere at several levels
with both innate and adaptive responses of the host. While the role of
the oncoprotein E6 and E7 is very well known, the biological functions
of E5 are poorly understood. E5 is expressed early in papillomavirus
infection, co-operates with epidermal growth factor, prevents transport
of the major histocompatibility class I to the cell surface and retains the
complex in the Golgi apparatus. Since the E5 functions seem to be linked
to virus ability to circumvent host immunosurveillance, we focus our
attention on the role of E5 protein in the interferon signalling pathway
and we investigated the expression of signal transducer and activator of
transcription (STAT) protein and the expression of some IFN-stimulated
genes (ISGs).
Methods: We used Western Blot to investigate the amount and the
phosphorylation of STAT-1 in HaCaT/E5 cells expressing only E5 gene
of HPV and HaCaT/pMSG as control. Moreover, we used RT-PCR to
address the expression of ISGs including PKR, LMP2, IL-12 and Bak,
which are involved in host resistance to infection and immune function.
Results: We found inhibition of STAT-1 amount and phosphorylation in
cells expressing E5 gene. The E5 protein in turn exerted a transcriptional
repression on several interferon-stimulated genes, including those
codifying for IL-12, PKR, LMP2 and Bak.
Discussion: These data described pathogenetic effect of HPV-E5 protein
and suggest that E5-induced STAT-1 modulation may play a pivotal role
in establishing persistent infection.
P1895 Clinical utility of low-density microarray to evaluate human
papilloma virus genotype distribution in Danish women with
atypical cervical cell ﬁndings diagnosed with HPV infection
J. Bonde, N. Mejlhede Jensen, A. Fomsgaard (Copenhagen, DK)
Objectives: Use of microarray technology (MA) in clinical Human
Papilloma Virus (HPV) diagnostics offers simultaneous diagnostic
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capability along with genotyping of speciﬁc subtypes. Here, we report on
the use of HPV DNA MA analysis to perform detailed diagnostics and
genotyping of HPV infections in women with atypical cervical smears.
Methods: HPV-DNA microarray analysis were performed on 374
individual, clinical sam-ples from women with atypical cervical smears
diagnosed with HPV infection. The low-density HPV MA system
(Genomica, Spain) contains speciﬁc probes for 35 mucosal HPV types,
commonly associated with a higher risk of cervical dysplasia or cervical
cancer.
Results: Use of MA technology allows for simultaneous detection and
genotyping of mul-tiple HPV types. 41% of the individual samples were
found positive for one HPV geno-type, while 27% were positive for 2
HPV genotypes, 12% were positive for 3 HPV geno-types, and 11% were
postive for 4 or more simultaneous HPV genotypes. Up to 12 individual
HPV genotypes were detected in a single sample. Women <25 years
had the higest incidence of multiple HPV infections (63.3%), whereas
37% of the women age >45 years were found to have >2 simultaneous
HPV genotypes. Data from HPV postive samples have resulted in a
newly ranked list of HPV genotypes associated with atypical cervical cell
ﬁndings in Danish women: HPV 16 (13.8%), was most commonly found
whereas HPV 72 (0.35%) was rarely found. A complete list ranking all
35 types included in the analysis will be presented. An analysis of HPV
co-infection patterns was subsequently performed. HPV type 16 was
most commonly found as a single infection (24% multiple infections
versus 76% single infections), whereas HPV type 11 was predominantly
found as part of multiple infections (82% multiple infections versus
17% single infections). Co-infection patterns for all 35 analysed HPV
genotypes will be presented. Finally, the MA analysis was used to
perform longitudinal follow up on individual patients where >3 con-
secutive samples over >2 years were available. Data from these samples
showed that the MA approach allowed for better diagnostics of HPV
types causing chronical infections as compared to a standard My9/11
PCR-Sequencing diagnostic analysis.
Conclusion: Use of HPV-DNA MA technology greatly improves the
diagnostic power with regard to determining single as well as multiple
HPV infections associated with atypical cervical cell ﬁndings.
P1896 Point prevalence study of HPV in a high-risk population
in Havana, Cuba
I. Justo Roll, J.F. Meis, S. Yee Seuret, S. Balcildes Acosta,
C.H. Klaassen, R. Zenhorst, C.F. Prinsen (Havana, CU; Nijmegen, NL)
Objectives: To estimate the human papillomavirus (HPV) prevalence,
classify the infection according to existing genotype risk groups and
estimate its association with previous diagnosis of cervical dysplasia in
an urban, high risk population, in Havana City, Cuba.
Methods: A random, point prevalence study in a population with a
high risk for STD’s in urban areas of Havana City, Cuba. 375 healthy
young adults, 294 females and 81 males, with an age range from 14
to 35 years old gave consent to participate and been tested for STD’s.
A cervical smear in women and urethral smear in men was used for
molecular detection and genotype risk group classiﬁcation of HPV by
means of multiplex HPV PCR and subsequent microarray analysis.
Results: Prevalence of HPV was 45.6%(CI; 40.4–50.8), affecting
particularly females (42.1%; 158/294; OR: 6.1:CI; 37.0–47.3) between
age groups 15 to 20 and 21 to 25 years (14.4%;54/97, respectively).
In general, well known high risk genotypes were present in more
than half of the positives (53.2%;91/171), but infection with types
of unknown risk represented an important part of the sample (33%;
57/171). Nevertheless, most common low risk genotypes (70, 42, 61)
and unknown risk genotypes (2, 3, 57, 74, 87, 71, 84) were usually co-
infecting patients with high risk genotypes. Co-existing HPV infections
of genotypes of the same risk group and different risk groups, resulted
in only 44.4%(76/171) of cases with single infection. Major associations
were seen among genotypes 71 and 2, 42 and 57, 2 and 3, 2 and 84, 3
and 71, 3 and 84, 39 and 2, 45 and 70, 70 and 2, 70 and 68, 84 and 71,
84 and 28. HPV was detected in 8 out of 16 females with a previous
history of cervical dysplasia, among them only one carrying a low risk
genotype (6.3%; 1/16).
Conclusion: HPV is highly prevalent among the studied population with
genotypes 45, 16, 18 the most common high risk genotypes found.
Overall, a broad spectrum of HPV types was found and in almost half
of the infected individuals more than one HPV genotype was detected.
Multiple infections are a known risk factor for the development of
cervical cancer. Although the relation between current detection of HPV
and history of cervical dysplasia could not be completely clariﬁed in this
study, genotypes of unknown risk were found in half of these participants.
P1897 HPV genotypes in anal samples from Italian and
foreign-born males attending an STD unit in Milan, Italy
G. Orlando, E. Tanzi, M.M. Fasolo, R. Beretta, A. Amendola,
S. Bianchi, F. Mazza, A. Valerio, G. Rizzardini (Milan, IT)
Objective: Anal intraepithelial neoplasia (AIN) arising from oncogenic
HPV genotypes is increasingly reported, especially in MSM, and is
less characterised than cervical disease. The relative distribution and
pathogenicity of HPV types has been reported to vary by geographical
region arising some questions on the relative efﬁcacy of preventive HPV
vaccines. This study wants to evaluate HPV genotypes spectrum in a
cohort of males attending an STD unit in MIlan, Italy according to their
nationality.
Methods: Anal Pap smear, Hybrid-capture-II HPV test (HC2) and HPV
genotyping by RFLP technique performed in Italian (IT) and foreign
borne (FB) males recruited from Jan 2003 to Dec 2006 in the STD unit
of the II Dept of Infectious Diseases, L Sacco Hospital, Milan (Italy)
have been evaluated.
Results: Among 194 IT and 47 FB males recruited, HIV infected
patients were 165 (85.05%) and 40 (85.1%) respectively. FB people was
younger than Italian (mean age 32.1±6.1 vs 37.4±9.7 p 0.0003) and
were mostly from south America (91.5%).
Mean CD4 cells and HIV RNA in HIV infected persons at time of
evaluation were comparable. FB patients had a higher rate of abnormal
results (ASCUS, LSIL or HSIL) on anal cytology (93.2% vs 80.9% p
0.046). Distribution of High Risk (HR) HPV genotypes on HC2 was
comparable as so as results on histology.
HPV-16 was identiﬁed in 41.2% of IT and 47.5% of FB and constitutes
the 22.8% and 22.6% of all isolates in the 2 groups respectively; HPV
type speciﬁc prevalence was different between IT and FB people for
most of the 29 other different HPV genotypes identiﬁed. HPV-13, -40,
-44, -54, -64, were speciﬁcally isolated among Italian while HPV-45,
-66, and -69 only in FB persons. Multiple HPV genotypes infections
were demonstrated in 51.7% of Italian and in 68.3% of FB people (p =
NS) with a higher prevalence of HR-HPV other than 16/18 in this latter
group (26.1% vs 42.5% – p 0.041).
Discussion: As already reported for cervical disease, HPV-16 is by
far the most common genotype found in anal cytological samples
independently from geographycal region while the overall distribution
of other HPV genotypes is not overlapping in Italian and Foreign Borne
people. These last patients were more likely to be infected with HR-non
HPV16/18 types and to harbour more than 1 genotype. The inﬂuence of
each genotype and the association with the most prevalent HR HPVs on
cancer development need to be tested.
P1898 Ribavirin and peg-interferon with or without adjuvant
therapy with erythropoietin in patients with hepatitis C:
a randomised controlled trial
M. Petrov, N. Piskunova, A. Anosov (Novosibirsk, RU)
Background: It has been established that dose reduction of Ribavirin and
interferon leads to reduction in end of treatment and sustained virological
response. Erythropoietin can be used to minimise the dose reduction.
However, its effect has not been investigated in the randomised controlled
trial yet. Thereby, our objective was to assess the effect of erythropoietin
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therapy on the Ribavarin and Peg interferon dose reduction in patients
with hepatitis C.
Methods: Ninety-four patients with hepatitis C who received Ribavarin
plus Peg interferon therapy were randomised to erythropoietin (n =
46) or no erythropoietin (n = 48) adjuvant therapy for 3 months. All
patients received 800mg daily and Pegasys 180 ucg weekly. Patients in
the experimental group received erythropoietin when dose reduction was
indicated (HGB< 9). The dose of Ribavirin and Pegasys in the control
group was decreased when HGB< 9 and these patients did not receive
adjuvant therapy at all. T-test was used to compare end of treatment
response and sustained virological response between two groups. P-value
less than 0.05 was considered as signiﬁcant.
Results: Both groups were comparable at the baseline. End of treatment
response in the experimental group was 91% (42 of 46 patients) versus
69% (33 of 48 patients) in the control group (p = 0.01). Sustained
virological response was 87% (40 of 46 patients) in the intervention
group as compared with 65% (31 of 48 patients) in the control group
(p< 0.01).
Conclusion: Adjuvant therapy with erythropoietin over no erythropoietin
therapy results in more favourable outcomes in patients with hepatitis C.
P1899 Anti-orthopoxviral potency of small interfering RNA
targeting two genes of the vaccinia virus replication complex
S. Vigne, R. Germi, S. Duraffour, S. Larrat, G. Andrei, R. Snoeck,
D. Garin, J.M. Crance (Grenoble, FR; Leuven, BE)
Objectives: The concerns about the potential use of smallpox in
bioterrorism have stimulated the development of novel antiviral
treatments. Currently, there are no FDA-approved therapies against
smallpox and new treatment strategies are needed. In this study,
speciﬁcally designed small interfering RNAs (siRNAs), targeting two
proteins, i.e., D5R and B1R, essential for orthopoxvirus replication, were
investigated for their ability to inhibit vaccinia virus replication.
Methods: Cultures of A549 cells were infected with vaccinia virus
strain Western Reserve (VACV-WR), cowpox virus or monkeypox virus,
at a multiplicity of infection of 0.1. Transfections with siD5R-2 and
siB1R-2, i.e., siRNAs targeting the D5R and B1R genes respectively,
were performed for one day, before or after VACV-WR infection,
at concentrations ranging from 1 to 100 nM. VACV-WR virus yield
production was determined and total mRNAs were extracted for real-
time RT-PCR.
Results: siD5R-2 and siB1R-2 decreased VACV-WR replication by 90%
when used either prophylactically or therapeutically (P values <0.05).
Both siRNAs induced a striking concentration-dependent inhibition of
VACV-WR replication and a prolonged prophylactic antiviral effect that
lasted for 72 h. They did not induce any interferon-beta production,
indicating their speciﬁc antiviral potencies. Moreover, our results of
real-time RT-PCR demonstrated the speciﬁc reduction of the D5R and
B1R steady state mRNA levels under siD5R-2 and siB1R-2 treatment,
respectively. These data are in agreement with the inhibition of D5
protein expression as determined by western blotting analysis. Confocal
microscopy examinations showed the efﬁcient siD5R-2 transfection in
the cytoplasm of the cells (using a ﬂuorescent siD5R-2) and revealed a
decrease of green ﬂuorescence emitted by VACV-WR labelled with an
anti-VACV FITC antibody. We also demonstrated the antiviral potency
of those two siRNAs against a pathogenic orthopoxvirus important for
human health, monkeypox virus. Synergistic effects between different
siRNAs, as well as in vivo studies using mice models are currently
under investigation.
Conclusion: Our ﬁndings demonstrate the anti-orthopoxvirus potency
of siD5R-2 and siB1R-2 and suggested their use as potential candidates
to treat poxvirus infections.
P1900 Antiviral activity of isoxazolecarbonitriles against
Coxsackievirus A9
B. Bisignano, R. Timpanaro, A. Garozzo, A. Stivala, G. Tempera,
A. Castro (Catania, IT)
Objectives: Coxsackievirus A9 (CAV9) is a human pathogen causing
symptoms ranging from common colds to fatal infections of the central
nervous system.
In previous studies, it was found that 5-aryl-3-methylthio-4-
isoxazolecarbonitrile derivatives (USA Patent: 6,414,004) possessed a
promising antipicornavirus activity. In view of the novelty of this
structural class as an anti-picornavirus agent, the in vitro antiviral activity
of these compounds against the CAV9 replication was studied. Moreover,
we set up some experiments in order to provide information about their
mechanism of action.
Methods: The inhibitory effect of 5-aryl-3-methylthio-4-isoxazolecarbo-
nitrile derivatives was studied by plaque reduction assay in RD cell
culture.
In order to study the mode of action, we carried out a series of
experiments, including virucidal, pre-treatment, inhibition of virus
adsorption and time of addition assays.
Results: The new series of isoxazole derivatives were found to have
an inhibitory effect on CAV9 replication at doses below the cytotoxic
dose. Our results suggest that the antiviral activity was dependent on the
nature of the substituents on the para position of the phenyl ring. In fact,
compounds with smaller groups on the para position of the phenyl ring
(−OCH3 and −OH for compounds ON-0 and ON-3, respectively) were
completely ineffective against CAV9.
Compound ON-2, with a −OBn group on the para position of the phenyl
ring, showed a slightly antiviral activity.
Isoxazole derivatives (ON-6, ON-7, ON-7/1, ON-7/2) with a longer
intermediate alkyl chain between the phenoxy and the phenyl rings
exhibited an interesting anti-CAV9 activity with high selectivity indexes.
No of the tested compounds showed virucidal activity nor any protective
action for the RD cells.
The effect of the most active compound (ON-7/1) on different steps of the
replicative cycle of CAV9 replication revealed that this was signiﬁcantly
inhibited only if the compound was added within 2 h of infection,
indicating an interference with an early step of the viral replicative cycle
of the virus.
The inﬂuence of the compound on the virus adsorption step, studied by
the infective centre assay, indicated that ON-7/1 did not interfere with
cellular attachment of virus.
Conclusion: These data suggest that ON-7/1 interferes with an early
event of Coxsackievirus A9 replication, after viral adsorption. Further
studies are necessary to understand the precise mode of action of this
compound.
P1901 Identiﬁcation of a novel group 1 coronavirus from Chinese
horseshoe bats
C.S.F. Lam, S.K.P. Lau, P.C.Y. Woo, K.S.M. Li, Y. Huang, M. Wang,
H. Xu, R. Guo, K.H. Chan, B.J. Zheng, K.Y. Yuen (Hong Kong, HK;
Guangzhou, CN)
Objectives: We conducted an extensive surveillance for coronaviruses
in Chinese horseshoe bats in Hong Kong and Guangdong province
of Southern China, in order to better understand the epidemiology
and evolution of the novel group 1 coronavirus and explore possible
recombination events between this coronavirus and bat-SARS-CoV that
could have led to the emergence of SARS-CoV.
Methods: The respiratory and alimentary specimens of Chinese
horseshoe bats (Rhinolophus sinicus) were collected and subjected to
RNA extraction and RT-PCR for coronaviruses. Those positive samples
were sequenced and analysed by comparing with the sequences of the pol
genes of known coronaviruses in the GenBank database. Four complete
genomes of bat-CoV detected in the present study were ampliﬁed and
sequenced.
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Results: A total of 770 respiratory and alimentary specimens from 348
and 64 Chinese horseshoe bats were obtained in Hong Kong and in
the Guangdong province in Southern China, respectively. RT-PCR for
a 440-bp fragment in the RdRp genes of coronaviruses was positive
in alimentary specimens from 58 (16.7%) of the 348 bats from Hong
Kong, and from 8 (12.5%) of the 64 bats from Guandong. None of
the respiratory specimens was positive. Sequencing results suggested
the presence of two different coronaviruses among the 64 positive bats.
Complete genome sequencing of four strains of bat-CoV revealed the
smallest coronavirus genome (27164 nucleotides) and a unique spike
protein evolutionarily distinct from the rest of the genome. This spike
protein, sharing similar deletions with other group 2 coronaviruses in
its C-terminus, also contained a 15-amino acid peptide homologous to
a corresponding peptide within the RBM of spike protein of SARS-
CoV, which was absent in other coronaviruses except bat-SARS-CoV.
Further studies are required to determine if inter-group gene exchange
was responsible for the origin of the spike of bat-CoV and its possible
role in the evolution of the spike of SARS-CoV.
Conclusion: This is the ﬁrst report that documents the presence of a
spike evolutionarily distinct from the other parts of the coronavirus
genome. It also suggests that the RBM of SARS-CoV and the
corresponding region in bat-CoV and bat-SARS-CoV share different
degrees of homologies, consistent with the hypothesis that the RBM of
SARS-CoV may have originated from recombination events.
P1902 Toscana virus, a “Mediterranean” agent of aseptic
meningitis: analysis of 42 consecutive cases
G. Corti, F. Baragli, A. Bartoloni, M.G. Colao, F. Paradisi (Florence, IT)
Objectives: Aseptic meningitis (AM) is mostly caused by a number of
viruses; among those, Toscana virus (Tosv) is an important arbovirus that
is endemically present in our region as well as in both South-European
and North-African shores of the Mediterranean basin. Here we describe
the main features of 42 cases of Tosv-related AM observed in our unit
during a seven-year period.
Methods: Between June 2000 and December 2006, a total of 94 patients
with a diagnosis of AM were admitted to our unit. Of those, 42 cases
(44.7%) resulted positive for IgM + IgG anti-Tosv as detected by an
immune-capture test using monoclonal antibodies bound to the solid
phase (IgM) and by an ELISA technique (IgG) (Chorus®, Diesse, Italy).
Demographics, clinical picture, neuroimaging, and cerebrospinal ﬂuid
(CSF) ﬁndings of Tosv-related AM were reported.
Results: In our area, Tosv-related AM was prevalent during summer
(73.7%) and by 30 years of age (52.4%) without differences per gender
(male 54.8%, female 45.2%). Only 31.1% of patients habitually lived
in the urban area of Florence, the remainder residing in ﬂat and hilly
surroundings. Clinical course was always self-limited, with a mean
duration of the hospital stay of 6.2 days. Headache was present in all
cases; it had an abrupt onset, and was mostly diffuse and moderate-to-
severe. Clinical picture typically included nuchal/spinal rigidity (85.7%),
moderate fever (78.6%), vomiting (64.3%), photophobia (35.7%), and
nausea (33.3%). Systemic manifestations such as asthenia, joint and
muscle pain, diarrhoea, abdominal discomfort, and pharyngodinia as well
as impairment of consciousness were infrequent. Electroencephalography
and CT scan showed brain abnormalities that were typical of encephalitis
in four patients and in another one, respectively. Chemical analysis
revealed clear CSF with increased levels of proteins and white blood
cells (mostly mononuclear) and normal levels of glucose and chloride
in all cases. No speciﬁc therapy was required.
Conclusion: As in other surveys, prevalently from Italy, our patients with
Tosv-related AM generally showed clinical, radiological, and laboratory
features of a self-limited disease. It is important that clinicians are
universally familiar with this infection, that could be acquired during stay
in endemic areas of the Mediterranean basin (Portugal, Spain, Southern
France, Italy, Cyprus, North-African countries) and then clinically
revealed in North America and North-Central Europe, where it is little
or nothing known.
P1903 Molecular typing and epidemiology of Enterovirus in
Belgium, 2005–2007
B. Vincart, F. Brancart, P. Gilot, N. De Schrijver, S. Betermiez,
C. Liesnard (Brussels, BE)
Objectives: Non-Polio Enteroviruses (EVs) are the most common cause
of aseptic meningitis. To evaluate the epidemiology of EVs in Belgium
during the last 3 years, molecular typing of EV positive in cell cultures
and in cerebrospinal ﬂuid (CSF) samples was developed, based on RT-
nested PCR and sequencing analysis.
Methods: From January 2005 to August 2007, typing of EV was
carried out by immunoﬂuorescence using monoclonal antibodies on viral
cultures or genotyping. Eighty-seven cultures, grown on MRC5 or Vero
cells, were identiﬁed as EV positive. During the same period, 121 CSF
from patients suspected of aseptic meningitis were found to contain EV
RNA using PCR or nested PCR assays targeting both 5′UTR and VP1
regions with combinations of PCR primers described previously (Oberste
et al, J.Virol. 1999; Ishiko et al, JID 2002; Thoelen et al, JCM 2004). In
addition, sequencing of 5′UTR or VP1 regions allowed the identiﬁcation
of EV type by comparison with the sequences available in Genbank and
by alignments in the Bionumerics software (Applied Maths, Belgium).
Results: As expected, culture yield for EV isolation on CSF was poor
(26%). All positive cultures, typable or not with monoclonal antibodies,
were identiﬁed by sequence analysis. One hundred twenty-one CSF
samples could be genotyped by our sequence analysis protocol. For 2005,
the major genotyped EVs were Echovirus 9, Echovirus 13, Echovirus 6
and Echovirus 18 (24%, 22%, 14% and 14% respectively). For 2006,
the predominant EVs were Echovirus 6, Coxsackie type B3 and B5
and Echovirus 18 (22%, 14%, 14% and 12% respectively). Finally, from
January to august 2007, the principal types were Echovirus 30, echovirus
11 and echovirus 13 (with 40%, 16% and 12%, respectively).
Conclusion: In Belgium, during those 3 years, the data’s showed that
EVs were mostly belonging to group B but with a diversity of genotypes.
However, three genotypes (Echovirus 6, 9 and 30) were involved in
aseptic meningitis each year of this period, with a clear success of
Echovirus 30 during 2007 (40% of cases). The genotyping protocol is
rapid, sensitive and accurate for molecular typing of EVs directly on
CSF samples and is very useful for epidemiological studies.
P1904 Epstein-Barr virus genotypes and LMP-1 gene variants in
paediatric liver transplant recipients
B. Kasztelewicz, J. Pawlowska, P. Kalicinski, M. Pronicki,
K. Dzierzanowska-Fangrat (Warsaw, PL)
Objectives: The two Epstein-Barr virus (EBV) genotypes vary in their
geographic distribution, tissue tropism and biological features. Latent
Membrane Protein 1 (LMP1) is an oncogene and it is expressed
in most EBV-positive post-transplant lymphoproliterative disorders
(PTLD). Previous studies showed that 30- and 69 bp-deleted variants
of LMP-1 have higher transforming capacity. The aim of this study was
to determine the prevalence of A and B type and LMP-1 gene variants in
blood and tissues of children after liver transplantation (LTx) including
PTLD patients.
Methods: 115 children who had undergone LTx at Childrens’ Memorial
Health Institute between 1999 and 2007 were included in this study.
The study involved 13 patients with histologically conﬁrmed PTLD.
Molecular assays were performed in blood samples of all children, and
in 38 parafﬁn-embedded tissues from 24 patients. EBV genotype was
determined by PCR by simultaneous analysis of two gene loci, EBNA-2
and EBNA-3C. LMP-1 variants were detected by PCR using primers
ﬂanking the site of characteristic 30- and 69-bp deletion.
Results: EBV genotype was determined in blood samples from 69 pts
and in tissues from 16 pts (including 11 PTLD pts). Type A was detected
in blood of 66 (95.6%) pts (including 11 PTLD pts) and in tissues of 15
pts (including 7 PTLD pts). Type B was detected in blood of 3 (4.4%)
pts (including 1 PTLD pt) and in 2 tissue samples from one PTLD pt.
Interestingly, coinfection with A and B EBV genotypes with different
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tissue distribution (liver and lymph node respectively) was determined
for that PTLD patient.
LMP-1 was successfully ampliﬁed in blood samples from 65 pts
(including 12 PTLD pts) and in tissues from 16 pts (including 11
PTLD pts). 30-pb deletion variant was found in blood of 11 (16.9%)
pts (including 2 PTLD pts) and in tissues from 3 (10.7%) pts (1 PTLD
pt). Both wild type and 30-bp deletion variant were detected in blood of
9 (13.8%) pts and in tissues from 3 (27.3%) PTLD pts. No patient had
a 69-bp LMP-1 deletion variant detected.
Conclusion: The strain A with wild type LMP-1 gene is the most
prevalent in children after LTx. The 30-bp deletion in LMP-1 gene does
not seem to be associated with higher risk of PTLD development. There
is a possibility of dual infection either with different EBV genotypes or
LMP-1 gene variants, which can show different tissue distribution.
P1905 Molecular epidemiology of hepatitis C virus in Romania
G. Oprisan, C. Szmal, S. Dinu, A. Oprisoreanu, V. Thiers (Bucharest,
RO; Paris, FR)
Objectives: To evaluate a home-made genotyping method for investi-
gation of Hepatitis C virus (HCV) variability and tracing infections in
Romania.
Methods: sera from Romanian patients were analysed by RT-PCR and
sequencing in the core region. PCR amplicons with degenerated primers
were sequenced using an automated sequencer ABI Prism 3100 Avant
(Applied Biosystems). Multiple sequence alignments and translation
into amino acid sequences were performed with BioEdit programme.
NCBI BLAST database was screened for similar sequences. Phylogenetic
and molecular evolutionary analyses were conducted using MEGA
version 4.0 with the neighbour-joining method. The distance matrix was
calculated by the Kimura two-parameter method using DNADIST.
Results: Two hundred sera from Romanian patients were analysed in
the core region using a home-made semi-nested PCR and sequencing.
Genotype distribution was: 1b − 95%, 1a − 3%, 4a − 1.5% and
3a − 0.5%. Within subtype 1b, the Romanian strains were intermixed
with other 1b strains circulating in European countries. Genetic distances
between six 1a strains isolated from injecting drug users revealed a single
source of infection. The 4a strains presented 97% homology with the
strain ED43 from Egypt. All the core sequences obtained presented an
alternative core reading frame. A nosocomial outbreak of HCV infection
in a urology clinic from Cluj was investigated using the core sequence
analysis. The analysis of 300 nucleotides in the core region allowed
identiﬁcation of a transmission event among the medical staff, involving
one source and two infected persons. The core sequences from three
patients were monophyletic in the core phylogenetic tree and presented
genetic distances of 0.004−0.007 (Kimura two-parameter method). The
other unrelated 1b strains presented genetic distances of 0.040 from the
outbreak strains.
Conclusion: The new RT-PCR in the core region has a good resolving
power for HCV subtyping and evaluating transmission routes. The
predominant HCV subtype in Romania is 1b, while subtypes 1a and
3a might have been recently introduced in Romania as a result of drug
abuse in the younger population.
Therapeutics and infection in animal models
P1906 Comparison of tigecycline and vancomycin for
treatment of experimental foreign body infection due to
meticillin-resistant Staphylococcus aureus
P. Vaudaux, A. Gjinovci, B. Fleury, E. Huggler, D. Lew (Geneva, CH)
Objective: The therapeutic activity of tigecycline (TIG), which has
a broad-spectrum activity against multi-resistant organisms including
MRSA, was compared to that of vancomycin (VAN), in a subcutaneous
tissue cage (TC) rat model of chronic, foreign body-associated MRSA
infection. Previous studies with this animal model have demonstrated the
necessity to reach high local levels of bactericidal antibiotics to decrease
CFU counts in MRSA-infected TC.
Methods: Strain MRGR3, a highly virulent MRSA isolated from
catheter-related sepsis, was used. Freshly prepared, cation-adjusted
Mueller-Hinton broth (CAMHB) was used for each MIC macrodilution
assay. Emergence of resistance to tigecycline was screened on freshly
prepared agar supplemented with 2mg/L of TIG. For in vivo evaluation
of antibiotic activities, chronic localised MRSA infections were
established for 2 weeks before therapy, by inoculating in each TC (s.c.
implanted in rats) 106 CFU of strain MRGR3.
Results: MIC and MBC of VAN for strain MRGR3 were 1 and 2mg/L,
respectively. MIC of TIG for strain MRGR3 was 0.5mg/L (upper
susceptibility breakpoint), albeit not inﬂuenced by broth supplementation
with 50% TC ﬂuid. Incubation of strain MRGR3 for 24 h with supra-
MIC levels (1, 2, and 4mg/L) of TIG led to a 2−3 log10 decrease in
CFU/ml. BID s.c. administration of TIG (7mg/kg) produced TC ﬂuid
TIG levels exceeding its MIC for strain MRGR3 for at least 75% of
each dosing interval.
BID s.c. administration of VAN (50mg/kg) yielded peak and trough, TC
ﬂuid levels of 12 and 2mg/L, respectively. Before therapy, CFU counts
of MRSA MRGR3 were equivalent in the different treatment groups,
ranging from 6.70 to 6.92 log CFU/ml of TC ﬂuid (n = 84). After 7
days of therapy with TIG or VAN, average counts of MRGR3 decreased
signiﬁcantly (P< 0.01) by 0.62±0.17 (n = 29) or 0.76±0.18 (n = 27) log
CFU/ml of TC ﬂuid, respectively, compared to untreated rats (increase of
0.18±0.19 log CFU/ml of TC ﬂuid; n = 28). Average reductions in CFU
counts of rats treated with TIG or VAN were not signiﬁcantly different.
No colonies with increased TIG MICs were detected in TC ﬂuids from
TIG-treated rats by the end of the 7-day therapy.
Conclusion: Despite not being a sensu stricto bactericidal antibiotic,
TIG exhibited similar in vivo activity to VAN against MRSA chronic
foreign body infections, and did not lead to emergence of subpopulations
with increased MIC.
P1907 Intra- and extracellular activity of dicloxacillin and linezolid
against small colony variants of Staphylococcus aureus in
vivo
A. Sandberg, D. Hughes, C. von Eiff, R.L. Skov, N. Frimodt-Møller
(Copenhagen, DK; Uppsala, SE; Mu¨nster, DE)
Objectives: The Small Colony Variants (SCV) phenotype of S. aureus
has been observed in connection with chronic and recurrent infections,
and intracellular persistence of SCVs is suspected. The aim was to
compare the virulence of the wild type and the SCV phenotypes and
their response to Dicloxacillin (DCX) and Linezolid (LNZ) extra- and
intracellularly in vivo
Methods: A clinical menadione auxothrophic SCV isolate (OM 1b)
and the corresponding wild type (WT) isolate (OM 1a) from a patient
with chronic infection were tested in the mouse peritonitis model. The
two phenotypes were clonally identical by PFGE. Both phenotypes were
DXC and LNZ susceptible.
In vivo studies: After i.p. inoculation in mice of 2.5×107 CFU S. aureus
(OM 1a or OM1b) in 5% mucin either one dose of DXC (1.5mg/mouse),
LNZ (0.5mg/mouse) or vehicle was given sc 2 h later.. Four and 24 hr
after treatment, mice were euthanised; a peritoneal wash in saline was
performed and sampled.
Ex vivo separation assay: The total bacterial count (Total) was
quantiﬁed before divid-ing the sample into two identical fractions. The
extracellular bacterial count (Extra) was determined in the supernatant
after centrifugation of one of the sample fractions. In the other sample
fraction, extracellular bacteria were killed by adding lysostaphin to a ﬁnal
concentration of 15mg/ml. The cells were lysed in water after lysostaphin
wash out and the intracellular count (Intra) quantiﬁed. Groups were
compared using the Mann-Whitney test.
Results: As shown in the table, CFUs for untreated Total WT vs SCV
were not different after 2 h but signiﬁcantly lower for SCV after 6 h
(P = 0.0023) indicating slower growth in vivo. Similar lower CFUs were
seen for SCV extra- (P = 0.03) and intracellularly (P< 0.0001). Both
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antibiotics displayed activity both extra- and intracellularly, but the
reduction in CFUs were lower for the SCV than for the WT in all
compartments. DXC showed 0.5−1 logCFU better killing activity than
LNZ overall.
D Log(CFU/ml)from 0 hr (SD)
4 hr 24 hr
Wild type SCV Wild type SCV
total extra intra total extra intra total extra intra total extra intra
Vehicle 0.91 1.45 0.58 0.20 0.24 0.24 ND ND ND* −3.39 −3.39 −3.18
(0.24) (0.58) (0.43) (0.43) (0.75) (0.19) (0.16) (0.15) (0.05)
Dicloxacillin −0.57 −0.82 −0.08 −0.72 −1.24 −0.43 −1.80 −2.51 −1.98 −4.76 −3.54 −2.85
(0.16) (0.14) (0.15) (0.15) (0.13) (0.18) (0.20) (0.51) (0.13) (0.00) (0.00) (0.66)
Linezolid 0.07 0.01 0.40 −0.48 −0.78 0.14 −1.48 −1.70 −1.43 −2.74 −3.29 −2.20
(0.14) (0.06) (0.14) (0.11) (0.14) (0.17) (0.21) (0.49) (0.24) (0.42) (0.28) (0.95)
*Not detected; mice showed signs of irreversible sickness and were euthanised before 24 hrs of infection.
Conclusion: Both the WT and the SCV variant of S. aureus resulted
in intracellular in-fection, however, already after 6 h the SCV showed
signiﬁcantly slower growth than the WT in vivo. The lower activity
in vivo of the two antibiotics against the SCV was probably a result
of the slower growth. Both antibiotics were active extra- as well as
intracellularly with DXC displaying somewhat better killing activity in
both compart-ments.
P1908 Efﬁcacy of fosfomycin alone or combined with imipenem,
linezolid and vancomycin, in vitro and in a murine
peritonitis model due to two strains of GISA
M. Pachon-Iban˜ez, S. Ribes, C. Cabellos, M. Dominguez, O. Murillo,
M. Cardiel, F. Tubau, J. Ariza, F. Gudiol (L’Hospitalet de LL.,
Barcelona, ES)
Objectives: To study the efﬁcacy of Fosfomycin (FOM) and its
combinations with Imipenem (IMP), Vancomycin (VAN) and Linezolid
(LZD) in infections due to GISA strains.
Methods: MICs (mg/l) of the Staphylococcus aureus strains were:
strain A (FOM 4, IMP 32, VAN 4, LZD 1, CLO 1024) and B
(FOM 1024, IMP 64, VAN 8, LZD 2, CLO 1024). In vitro time-
killing curves were performed over 24 h to test bactericidal effect of
FOM, IMP, VAN and LZD and synergy. In vivo studies: Peritonitis
in C57BL/6 mice was induced by intraperitoneal inoculation of 108
CFU/ml. Four hours later (0 h), mice were sorted in Control (not treated),
FOM (100mg/kg/5 h), IMP (30mg/kg/5 h), VAN (60mg/kg/5 h), LZD
(35mg/kg/5 h) and FOM+IMP, FOM+VAN, FOM+LZD, receiving sc
therapy over 25 h. At 0 and 25 h, a blood sample was taken to assess
bacteraemia rates and peritoneal wash was performed to determine
bacterial counts in peritoneal ﬂuid. Mortality was analysed at 25 h.
Bacterial decrease (D log cfu/ml) and bacteraemia rates (Br) at 25 h
Therapy (25 h) Strain A Strain B
n D log cfu/ml Br (%) n D log cfu/ml Br (%)
Control 17 +0.05 100 19 +0.72 100
FOM 14 −2.78a 57a 3 −0.44 100
IMP 10 −1.80a 100 11 −0.46 81
VAN 14 −2.30a 93 16 −1.80a 81
LZD 15 −2.31a 73a 18 −2.27a 67a
FOM+IMP 14 −3.11a,b 50a 4 −0.61 100
FOM+VAN 14 −2.82a 57a 12 −2.33a,c 50a
FOM+LZD 15 − 2.90a,b 43a 4 −2.30 78.6
ap< 0.05 vs control; bp< 0.05 vs VAN; cp< 0.05 vs IMP (ANOVA).
Results: In vitro, the combination of FOM (Cmax and 1×MIC) plus
IMP (1×MIC) were bactericidal and synergistic for strain A. In the
animal model at 25 h, for strain A, all therapies were more effective
than controls and FOM+IMP and FOM+LZD were signiﬁcantly better
than VAN (p< 0.05). For strain B, all treatment groups except IMP
were better than controls and FOM+VAN was signiﬁcantly better than
IMP. Bacterial decrease and bacteraemia rates of the different groups are
shown in the table.
Mortality in controls was 90% and 100% with strain A and B,
respectively, all therapy groups were better than controls except IMP
for strain B (p< 0.05).
Conclusions: Combinations of FOM were effective in the treatment of
infections caused by the hGISA strain. In the treatment of infection
caused by the GISA strain only the combination FOM plus VAN was
effective.
P1909 Comparative efﬁcacy of iclaprim against wild-type and
thymidine kinase-deﬁcient Staphylococcus aureus in a
mouse abscess model
T. Murphy, S. Little, L. Gordon, D. McKenney, A. Haldimann,
S. Hawser, S. Lociuro (Cambridge, US; Reinach, CH)
Objectives: Iclaprim (ICL) is a bactericidal diaminopyrimidine antibiotic
with an extended spectrum of activity and it is notably very potent
against important Gram-positive pathogens, including meticillin resistant
S. aureus. ICL exerts its antibacterial activity by speciﬁcally and
selectively inhibiting microbial dihydrofolate reductase (DHFR), a
key enzyme in the folate pathway synthesis. As for any DAP, the
antimicrobial activity of ICL is known to be antagonised by thymidine
(dT). Unlike humans, where dT levels are extremely low, several animal
species, e.g., rodents, contain high dT levels which can confound
evaluation of DAP activity in vivo. Consequently, successful PK/PD
studies have not been reported so far. In previous studies it has been
shown that Thymidine Kinase (TK)-Deﬁcient S. aureus mutants are a
useful tool in the study of ICL both in vitro and in vivo. The aim of
this study was to verify the utility of these mutants in a mouse abscess
model of infection and, consequently, their potential in determining ICL
PK/PD relationship.
Method: The efﬁcacy of ICL against wild-type S. aureus ATCC
25923 and its TK-deﬁcient mutant AH 1246 was evaluated in
immunocompetent CD-1 mice with subcutaneous abscesses. Abscesses
were induced by s.c. injection of bacteria on cytodex beads. Both strains
were equally virulent. ICL (2–80mg/kg) was initially administered s.c.
once (two hours post infection) and the bioburden determined at 24 hrs
post infection. Linezolid (LZD) was used as control. Subsequently, for
a preliminary evaluation of PK/PD relationship, mice were treated with
5 doses of ICL fractionated into 1, 2, 3, or 4 doses over a 24 hrs period.
Result: ICL exhibited no effect against the wild-type strain when tested
once up to 80mg/kg. By contrast, ICL was efﬁcacious against the TK-
mutant with 1 and 2 log10 CFU reductions at 14.4 and 30mg/Kg,
respectively. LZD gave 1 and 2 log10 reduction at 15.5 and >40mg/Kg,
respectively against both strains. In the second study, fractionation of
the ICL dose was assessed only against the TK-mutant. Analysis of the
data, showed AUC/MIC as the primary parameter with R2 of 0.91.
Conclusion: The study conﬁrms the utility of TK mutants in assessing
ICL in vivo efﬁcacy. Preliminary PK/PD correlation appears to indicate
AUC/MIC as the primary parameter. Further studies with these mutants
are warranted for evaluation of PK/PD in animals.
P1910 Efﬁcacy of telavancin against vancomycin-intermediate
Staphylococcus aureus in the neutropenic mouse
bacteraemia model
S.S. Hegde, S. Difuntorum, R. Skinner, J. Trumbull, K.M. Krause
(South San Francisco, US)
Objectives: Infections caused by Gram-positive organisms displaying
intermediate susceptibility to glycopeptides such as vancomycin (VISA)
are of signiﬁcant concern in the medical community. Telavancin (TLV)
is a novel lipoglycopeptide antibiotic that operates through a unique,
multifunctional mechanism of action to produce potent, rapid bactericidal
activity against resistant Gram-positive pathogens, including VISA. The
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goal of the present study was to compare the efﬁcacy of TLV with
vancomycin (VAN) in a murine model of VISA-induced bacteraemia.
Methods: Immunocompromised mice (female non-Swiss albino, 18–25
g) were inoculated intraperitoneally with VISA HIP5836 (107 colony-
forming units per mL). Starting 4 hours post-inoculation, mice received
two subcutaneous doses (once every 12 hours) of vehicle, TLV or VAN.
Mouse pharmacokinetic data were generated and used to select doses of
TLV (40mg/kg) and VAN (110mg/kg) that equated to clinical exposures.
Reductions in bacterial titre (in blood and spleen) at 12, 24 and 48 hours
post-treatment were quantiﬁed.
Results: Telavancin demonstrated potent antibacterial activity against
VISA strain HIP5836 in vitro in terms of MIC and in vivo in terms of
reduction in blood and spleen bacterial titres compared with vancomycin
(Table).
Table. MICs and blood and spleen bacterial titres
MIC Blood Spleen
(mg/L) (logCFU/mL)* (log CFU/g)*
Pre-treatment titre – 5.5±0.41 8.0±0.24
VAN 4.0 3.6±0.69 7.7±0.49
TLV 0.5 1.0±0.0† 3.8±0.16†
CFU, colony-forming units; MIC, minimum inhibitory concentration.
*Titre at the onset of treatment (in pre-treatment titre row) or at 48 h
post-treatment (in TLV and VAN rows).
†p< 0.05 vs pre-treatment titre and VAN.
Conclusions: TLV is more efﬁcacious than VAN in a mouse model of
VISA bacteraemia infection.
P1911 Efﬁcacy of linezolid vs. vancomycin in the treatment of an
experimental meningitis model caused by meticillin-resistant
Staphylococcus aureus
F. Docobo-Pe´rez, R. Lo´pez-Rojas, M.E. Pacho´n-Iba´n˜ez, C. Pichardo,
M.E. Jime´nez-Mejı´as, J. Pacho´n (Seville, ES)
Objective: To compare in vivo the activity of linezolid (LZD) and
vancomycin (VAN) in a meningitis model in rabbits, caused by
meticillin-resistant S. aureus (MRSA).
Methods: In vitro: MIC of VAN and LZD was determined for 23 MRSA
strains. The bactericidal activity (time-kill curves; 1, 2 and 4×MIC) was
studied for 4 strains (MRSA 8, 10, 13 and 17). In vivo: New Zealand
rabbits (2.5−3 kg) were used, with an inoculum of 8.5−9 Log10 cfu/mL.
PK/PD parameters (blood and CSF) were determined (Cmax [mg/L];
AUC [mg.h/L]; t1/2 [h]; t>MIC [h]; AUC/MIC) after a single dose
of 20mg/kg of each antimicrobial on infected rabbits. Animals were
grouped in untreated (CON), LZD (20mg/kg) every 3 hours (4 doses)
and VAN (20mg/kg) every 12 hours (1 dose). CSF variables analysed
at 0, 6 and 12 h of treatment: bacterial concentration (Log10 cfu/mL),
leukocytes (cels/mL), lactate (mmol/L), proteins (g/L); qualitative blood
cultures were made at 0 and 12 h. Statistical Analysis: Wilcoxon, Mann-
Withney, and Chi-square tests.
Results: In vitro: MIC (mg/L) MRSA 8, 10, 13 and 17: LZD=4, VAN=1.
Bactericidal activity: MRSA 8: LZD (2×MIC) and VAN (1×MIC,
2×MIC, 4×MIC); MRSA 10: VAN (2×MIC, 4×MIC); MRSA 13: VAN
(2×MIC, 4×MIC); MRSA 17: VAN (4×MIC). In vivo: PK/PD (Cmax,
AUC; t1/2; t>MIC; AUC/MIC): Blood LZD (20mg/kg) 12.49, 14.7,
0.67, 1.37; 3.68; Blood VAN (20mg/kg) 51.2; 120.81, 3.26; >6; 120.81;
CSF LZD (20mg/kg) 7.65, 13.25, 1.03, 1.31, 3.31; CSF VAN (20mg/kg)
3.2; 14.52; −; >6; 14.52.
Bacterial concentration (0, 6, 12 h): CON (4.85, 4.93, 4.49), LZD (5.05,
4.02, 4.36), VAN (4.85, 4.83, 4.83). Leukocytes: CON (2750, 5610,
3960), LZD (2830, 4230, 2490), VAN (10.24, 22.70, 22.39). Lactate:
CON (8.46, 22.48, 22.35), LZD (9.58, 14.48, 12.13), VAN (10.24, 22.70,
22.39). Proteins: CON (0.96, 5.34, 3.95), LZD (1.90, 8.46, 8.65), VAN
(2.35, 7.40, 5.12). Sterile blood cultures: CON (90.9%, 81.8%), LZD
(90%, 100%), VAN (100%, 100%).
LZD reduced bacterial concentration at 12 h with respect to 0 h
(p< 0.05). Respect to lactate levels LZD reduced the CSF lactate (vs.
control group at 12 h [p< 0.05] and vs. VAN group at 6 and 12 h
[p< 0.05]).
Conclusions: In this model of murine meningitis by MRSA, linezolid
was better than vancomycin in reducing the CSF bacterial concentration
and lactate levels. It may be an alternative to vancomycin in meningitis
caused by MRSA strains.
P1912 Efﬁcacy of levoﬂoxacin alone and in combination with
rifampin in staphylococcal experimental foreign-body
infection
O. Murillo, M.E. Pacho´n, G. Euba, R. Verdaguer, F. Tubau,
C. Cabellos, J. Cabo, F. Gudiol, J. Ariza (Barcelona, ES)
Objectives: Since levoﬂoxacin at high doses (LHD) was more active than
at conventional doses (LCD) and was the best therapy alone in a rat-
model of foreign-body infection (FBI) by Staphylococcus aureus (Sa),
we tested how these differences affect in the activity of their respective
combinations with rifampin (R) in vitro and in vivo.
Methods: In vitro studies. MICs and MBCs (mg/L) of Sa ATCC 29213
were respectively: 0.5, 1 (levoﬂoxacin) and 0.015, 0.12 (R). 24 h kill-
curves (KC) were performed in the log- (LP) and the stationary-phase
(SP). Animal studies. Two Teﬂon tissue-cages with 2 cover-slips (CV)
each were implanted in rats; after 3 weeks, tissue-cage ﬂuid (TCF) was
infected with Sa and, 3 weeks later, therapy was administered for 7
days (7dT) in all cases and prolonged to 14 days (14dT) for LHD alone
and with R. Therapeutic groups (mg.kg/h): LHD (100/24; PD values
equivalent to human ones for 1000mg/d), LCD (50/24; PD equivalent
to 500mg/d), LHD+R (25/12), LCD+R and controls (C). Criteria of
efﬁcacy: (i) differences in TCF bacterial counts between the beginning
and the end of treatment (Dlog UFC/ml); (ii) bacterial counts in CV at
the end of 14 dT. The presence of levoﬂoxacin- or R-resistant strains
was screened.
Results: KC in LP showed antagonism with all combinations of
levoﬂoxacin at concentrations 1mg/L and R. KC in SP showed
indifference with the combination of peak concentrations of LCD
(4mg/L)+R and tend to antagonism with LHD (12mg/L)+R. The Dlog
UFC/ml at the end of 7dT were (n): LHD −2.08 (50), LCD −1.24 (20),
LHD+R −1.55 (44), LCD+R −1.51 (20) and C 0.33 (22); all groups were
better than C (p< 0.05, T-test), LHD was the best therapy (P< 0.03 vs
LHD+R, P< 0.01 vs LCD). At the end of 14dT the Dlog UFC/ml in
TCF were (n) LHD −3.84 (21), LHD+R −3.37 (21) and C 0.40 (15), and
bacterial counts in CV (logCFU/ml) were 2.24 (LHD), 3.36 (LHD+R)
and 5.4 (C); both groups were signiﬁcantly better than C and LHD better
than LHD+R (P< 0.03) in CV. No resistant strains were detected in either
group at the end of 7dT and 14dT.
Conclusions. LHD conﬁrmed the great efﬁcacy against FBI by Sa, it was
the best treatment and no resistant strains appeared. The addition of R to
LHD showed antagonism effect; the clinical relevance of these ﬁndings
should be further evaluated. In contrast, if R is going to be used, the
dose of levoﬂoxacin did not contribute signiﬁcantly to the efﬁcacy of
the combination and both doses protect against resistance.
P1913 Aqueous humor concentration of topically administered
voriconazole in rabbits
W. Behrens-Baumann, F. Streit, L. Binder, S. Tuchen, C. Knop,
C.K. Vorwerk (Magdeburg, Go¨ttingen, DE)
Objectives: To investigate penetration of voriconazole into the aqueous
humor (AH) of rabbits after topical administration.
Methods: Voriconazole 1% solution was applied onto rabbits cornea
at different time intervals: single drug application with AH sampling
after 30 min, one hour, two hours, 3 hours and 6 hours, respectively.
In addition, we evaluated AH samples after continuous topical
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application of voriconazole every 30 min after 1, 2, 4 and 6 hours.
Furthermore, following continuous drug application every hour we
analysed voriconazole concentration after two hours, 3 hours, 4 hours
and 6 hours. All samples were analysed by high performance liquid
chromatography (HPLC)-UV.
Results: A single application showed a maximum peak in AH of
3.58mg/ml (N = 9) after 30 min and within three hours the concentration
decreased to 0.04mg/ml (N = 11). Application of voriconazole every half
an hour resulted after two hours in a peak value of 6.73mg/ml (N = 10),
decreased after four hours to 6.19mg/ml (N = 10) and was constant at
six hours (6.12mg/ml, N = 6). With hourly administration no such high
values were detected. The maximum value was 2.06mg/ml (N = 8) and
was reached after four hours.
Conclusion: In AH, therapeutic drug levels can be reached that cover
the minimum inhibitory concentrations (MIC) of most fungi. To achieve
a sustained high level of voriconazole as an effective antifungal therapy
for corneal keratitis, voriconazole should be topically administered every
30 min.
P1914 Efﬁcacy of isavuconazole, voriconazole and ﬂuconazole
in neutropenic murine models of disseminated Candida
tropicalis and Candida krusei
J.B. Majithiya, A. Sharp, A. Parmar, D.W. Denning, P.A. Warn
(Manchester, UK)
Objectives: Isavuconazole (ISA) is the water-soluble prodrug of triazole
BAL8557. We examined the dose response of ISA, voriconazole (VCZ)
and ﬂuconazole (FLU) on the tissue burden (TB) after 4 and 7 days
infection in temporarily (TN) and persistently neutropenic (PN) mice
with disseminated Candida tropicalis (CT) or Candida krusei (CK)
infection.
Methods: Male CD1 were immunosuppressed using either 1 dose (TN)
or two doses (PN) of 200mg/kg cyclophosphamide. Mice were infected
IV with 6.8 (TN) or 5.2×104 (PN) CT, or 1×107cfu/mouse CK and
treated 5 hours later with solvent, oral ISA (6, 15, 30, 60, 90, 120,
150mg/kg active compound), IV VCZ (5, 20, 40mg/kg plus grapefruit
gavage BD) or oral FLU (15, 50, 150mg/kg) BD. 101 hours (CT and
CK) or 7 days (CT) post infection mice were killed, kidneys & brains
(CK only) removed for culture.
Results: Solvent controls developed a non-lethal infection with high
burdens in all models (CT 1.25×107–2.1×108 in kidneys; CK 4.1×105–
3.8×106 in kidneys and 1.7−4.9×106 log10cfu/g in brain.
For CT, TN model: ISA (>6mg/kg), VCZ (>5mg/kg) and FLU (all
doses) dose dependently reduced TB (P< 0.05) after 4 and 7 days. ISA
Emax was 60mg/kg (2.3log10) was similar to FLU Emax (50mg/kg)
but was superior to VCZ (40mg/kg). ISA >60mg/kg was superior to
all doses VRC. PN model: ISA (all doses) and FLU (all doses) dose
dependently and VCZ (40mg/kg only) reduced TB (P< 0.05) in 4 day
kidney burden. For 7 day TB ISA (>30mg/kg), VCZ (all dose >5mg/kg)
and FLU (all doses) dose dependently reduced TB. ISA Emax achieved
at >60mg/kg. No treatment sterilised kidneys.
For CK, TN model: ISA, VCZ and FLU dose dependently reduced
kidney burden (P< 0.05 all doses). VCZ 40, ISA 120 & 150 were
superior to other treatments in reducing kidney burden. ISA (all doses)
and VCZ (40mg/kg) reduced brain burden (P< 0.05). FLU (all doses)
and VCZ (5 & 20mg/kg) had no signiﬁcant effect on brain burden. VCZ
40, ISA 120 & 150 were superior at reducing brain burden but FLU had
no signiﬁcant effect.
PN model: ISA (all doses), VCZ (all doses) and FLU (150mg/kg)
reduced kidney burden (p< 0.05) with ISA >90mg/kg and VRC
40mg/kg superior. In the brain ISA and VCZ (all doses) reduced tissue
burden (p< 0.05) FLU had no signiﬁcant even at 15mg/kg.
Conclusions: ISA signiﬁcantly lowered kidney (CT&CK) & brain
burden (CK) and was at least as effective as VCZ. ISA was much more
effective than FLU at reducing brain burden (CK). ISA had maximal
effect by 60mg/kg and was partially effective at all doses >6mg/kg.
P1915 Correlation of in vitro MIC and MFC against isavuconazole,
voriconazole and amphotericin B of Aspergillus with in vivo
outcome in mice with disseminated aspergillosis
J.B. Majithiya, A. Sharp, A. Parmar, D.W. Denning, P.A. Warn
(Manchester, UK)
Background: Assessment of susceptibility of Aspergillus isolates is
commonly performed using the CLSI M38A protocol. In this protocol
breakpoints are assigned using the MIC whilst in many cases there are
large differences between the MIC and MFC. In this study we examined
strains with large differences between the MIC and MFC using time-
kill experiments and murine models of disseminated aspergillosis to
determine which parameter better reﬂects the response to antifungal
therapy.
Methods: MICs and MFCs (99.9%) were determined according to the
CLSI M38A guidelines and a range of strains in which MIC were
similar to MFC and also MICMFC were selected. In vitro time-
kill curves using RPMI 1640 + 2% glucose were set up using 9 strains
of Aspergillus (table 1) exposed to isavuconazole (ISA), voriconazole
(VCZ) and amphotericin B (AmB) and followed for 48 h. Four strains of
A. fumigatus (AF) one ﬂavus (AFL) and one terreus (AT) were used to
study the in vivo effect. Male CD1 mice 22–24g were immunosuppressed
with a single dose of 200mg/kg cyclophosphamide IV then 3 days
later infected IV with a sub-lethal inoculum of Aspergillus (AF4,
A1163, AF210, AF293, AT49, AFL8). Both ungerminated and partially
germinated conidia were used for AF293. 4 hours after infection mice
were treated once daily with either vehicle, ISA (oral), VCZ (IV) plus
grapefruit juice (oral) AmB (IP), or caspofungin (CAS) (IV) for 3−4
days. 72–96 h post infection mice were euthanised and the kidneys
removed for quantitative culture.
Results: MICs and MFCs are shown in table 1. Four strains of AF
with low MIC and MFCs (AF4, AF82, A1163 and AF210) were rapidly
killed in vitro. Other strains with low MIC but high MFCs demonstrated
much slower clearance using in vitro time-kills (for ISA p = 0.046 for
MIC4mg/L AmB and VCZ NS). In vivo strains generated moderately
severe non-lethal infections with heavy and reproducible tissue burdens
in the kidneys. The strains with low MIC and MFCs (A1163 and
AF210) had very low residual tissue burdens following treatment with
all antifungals. In contrast strains with high MFCs had terminal tissue
burdens very similar to control animals.
Table 1
Strains Isavuconazole Voriconazole Amphotericin B
MIC MFC Time kill In vivo MIC MFC Time kill In vivo MIC MFC Time kill In vivo
AF19 0.5 8 Intermediate 0.25 2 Intermediate 0.25 8 Slow
AF1108 0.5 16 Slow 0.25 2 Intermediate 0.5 8 Slow
AF4 0.25 0.5 Rapid Cleared 0.125 1 Intermediate 0.5 2 Rapid
AF82 0.25 2 Intermediate 0.25 1 Rapid 0.25 1 Rapid
Al163 0.25 0.5 Rapid Cleared 0.25 2 Rapid Cleared 0.25 2 Rapid Cleared
AF210 0.5 8 Rapid Cleared 0.25 2 Rapid Cleared 0.25 2 Rapid Cleared
AF293 0.5 16 Slow Not
cleared
0.25 4 Slow Not
cleared
0.25 8 Slow Not
cleared
AT49 0.25 8 Slow Not
cleared
0.25 8 Slow Not
cleared
1 2 Slow Not
cleared
AFL8 1 4 Slow Not
cleared
0.25 2 Slow Not
cleared
0.5 1 Slow Not
cleared
Conclusion: In this study all strains had similar MICs but demonstrated
a wide range of MFCs. The MFC better correlated with the rate of kill in
vitro. Additionally the high MFCs of two strains (AF293 and AT49) were
generally reﬂected by higher terminal tissue burden in murine models of
disseminated aspergillosis.
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P1916 Efﬁcacy of liposomal amphotericin B, amphotericin
B deoxycholate or caspofungin in the treatment of
experimental Candida glabrata catheter infection using the
antifungal-lock technique
J. Gavalda`, P.M. Lo´pez, M.T. Martı´n, N. Ferna´ndez-Hidalgo, X. Gomis,
A. Pahissa (Barcelona, ES)
Objective: Candida glabrata (CG) is the third most frequent species
of Candida causing bloodstream infections; many cases are related to
catheter infections (CI). The ability of Candida to form bioﬁlms difﬁcult
the treatment of infected catheters. Catheter removal is sometimes
difﬁcult despite it is recommended to manage CI due to Candida. The
aim of this study was to evaluate the efﬁcacy of liposomal amphotericin
B (LAB), caspofungin (CAS) and amphotericin B deoxycholate (DAB)
in the treatment of C. glabrata CI using the antifungal-lock technique
(ALT).
Methods: New Zealand rabbits were surgically implanted with a
silicone central venous catheter trough the jugular vein. After insertion,
the catheter was ﬁlled with 0.35 mL of broth culture (antibiotic
medium 3 + 8% glucose) containing a 107 cfu/mL suspension of
C. glabrata (strain CG 171) isolated from a human case of catheter-
related bloodstream infection. 48 h later the inoculum was removed and
catheters were ﬁlled with the appropriate antifungal solution for 48 h.
Animals were randomised into the following groups: Untreated Control;
LAB 5mg/mL; CAS 5mg/mL; and DAB 5mg/mL. At the end of the
treatment period the animals were sacriﬁced and CI was assessed using
transcatheter blood culture, roll-plate, ﬂushing and sonication techniques.
Differences in rate of positive catheters and log cfu were analysed using
Chi-square and Mann-Whitney tests as appropriate. Samples showing no
growth were assumed to be log=0.3. P< 0.05 was considered signiﬁcant.
Results: Results are reﬂected in table 1.
Conclusions: All ALT treatments reduced signiﬁcantly the total number
of culture positive catheters as well as the log ufc compared to untreated
controls. No signiﬁcant differences were found between the three
antifungals. Nevertheless, the number of culture positive treated catheters
remains between 30 and 60%underlinig the need for further studies on
conservative strategies for the treatment of experimental C. glabrata
catheter-related infections.
Table 1
Group N N+
(% of total)
ﬂushing,
mean log ufc
(95%CI)
sonication,
mean log ufc
(95%CI)
Control 13 13 (100) 4.38 (3.45−5.31) 4.83 (4.01−5.64)
LAB 5mg/mL 13 6 (46.2)* 0.77 (0.22−1.33)* 0.82 (0.37−1.28)*
CAS 5mg/mL 9 3 (33.3)* 1.04 (0.03−1.62)* 1.41 (0.09−2.74)*
DAB 5mg/mL 14 8 (57.1)* 1.46 (0.38−2.55)* 1.26 (0.42−2.10)*
N: total number of animals; N+: total number of culture positive
catheters; *p< 0.05 vs control.
P1917 Mecillinam is active against ESBL-CTX-M producing
E. coli in vivo in experimental UTI
N. Frimodt-Møller, C.V. Lundberg, A.S. Henriksen (Copenhagen,
Ballerup, DK)
Objectives: The prevalence of ESBL-producing E. coli, especially the
CTX-M types, are increasing in the Northern Europe, mostly occurring
as causes of urinary tract infection (UTI). Mecillinam (Mec) is active
against many ESBL-producing E. coli in vitro (Livermore et al. JAC,
2006), so we wanted to investigate the effect in vivo – in comparison
with meropenem (Mer) and ciproﬂoxacin (Cip) – in an experimental UTI
model in mice.
Materials and Methods: We used two clinical UTI strains of E. coli,
one producing CTX-M9 (Vec23), and one producing CTX-M15 (DSA
443). The MIC against Mec, Mer and Cip was determined by Etest og
microtitre broth dilution. Presence of type-1 ﬁmbriae was assayed by
the yeast-agglutination assay. HsdWin:CFW1 female mice were treated
for 3 days with 5% glucose in their drinking water. At day 0, they
were anaesthesised with Zoletil/Torbugesic and 50 mcl of a 10E9 cfu/ml
solution in saline inoculated into the bladder via urethral catheterisation
with a 0.63mm tube. Treatment with doses resulting in human-like PK
(Mec, 0.5, Mer, 1, and Cip, 0.18mg/mouse vs. saline treated controls)
was initiated day 1 and continued BID for 3 days. At day 4, all mice were
killed for sampling of urine, bladder and kidneys for CFU determination.
Results: MIC’s (mg/l) for Mec, Mer and Cip were for Vec23: 2, 0.5 and
>32, and for DSA 443: 0.5, 0.32 and 0.125, respectively. Mecillinam and
meropenem were equally active against both isolates, and both better than
ciproﬂoxacin, after 3 days of treatment: E. coli Vec23: (median CFU/ml
or CFU/kidney); *, P< 0.05 as compared to control), Urine: Control:
3.4×103, Mec: 0*, Mer 0*, Cip: 106. Kidneys: Control: 1.6×102, Mec:
0*, Mer: 0*, Cip: 1.1×103. E. coli DSA 443: Urine: Control: 1.03×105,
Mec: 2.0×103*, Mer: 0*, Cip: 85. Kidneys: Control: 6.5×102, Mec:0*,
Mer: 5.5*, Cip: 15.5*. In total (both E. coli strains) Mec sterilised urine
in 7/12 mice, Mer 10/12, Cip 0/12; Mec sterilised kidneys in 9/12 mice,
Mer 8/12, and Cip 4/12. There was no or little effect on bladder CFUs,
as shown for all other antibiotics.
Conclusion: The Vec23 strain was R for Cip explaining the missing
effect of this drug. Mecillinam was as effective as meropenem both
regarding reduction of CFUs in urine and in kidneys. Both drugs
sterilised around 60–80% of mice urine and kidneys of the ESBL-
producing E. coli. Mecillinam is a promising drug for treatment of UTI
caused by ESBL-producing E. coli, and clinical trials are warranted.
P1918 Are carbapenems effective against carbapenem-susceptible,
metallo-b-lactamase producing Enterobacteriaceae? Results
from an animal model
E. Konstantinidou, I. Tzepi, T. Tsaganos, M. Souli, A. Pefanis,
Z. Chryssouli, E. Giamarellos-Bourboulis, H. Giamarellou (Athens, GR)
Background: Although metallo-b-lactamases (MBLs) hydrolyse most
b-lactams including carbapenems, MBL-producing Enterobacteriaceae
very often remain susceptible to carbapenems in vitro. The aim of
this study was to assess the in vivo efﬁcacy of imipenem (IMP),
meropenem (MEM), ertapenem (ERT) and aztreonam (AZT) against
a carbapenem-susceptible VIM-1-producing clinical E. coli strain in a
rabbit intraabdominal abscess model.
Methods:MBL-production in E. coli 6641 was conﬁrmed with PCR and
sequencing. MICs were determined with microdilution method. Rabbits
were inoculated intraperitoneally with 108 CFU/ml of E. coli 6641 and
were assigned to receive no treatment (controls) or i.v. IMP-cilastatin
70 or MEM 125 or ERT 60 or AZT 70mg/Kg/12 h. Antibiotic serum
levels were determined using a microbiological assay. A total of 8 doses
were administered before sacriﬁce. The abscesses were harvested and
quantitatively cultured. Mean viable bacterial counts of each treatment
group were compared using Kruskal-Walis test.
Results: E. coli 6641 carried blaVIM-1 and had IMP, MEM, ERT
and AZT MICs of 1, 0.25, 1.5 and 0.25mg/ml, respectively. Serum
levels conﬁrmed that T>MIC was achieved for 50% of dosing interval
for all tested antibiotics. The log10 CFU/g (mean +-SD) of pus were
as follows: controls (16) 8.71+-1.34 (p< 0.001, vs all other groups),
IMP (15) 5.30+-2.73, MEM (15) 4.24+-2.44, ERT (16) 3.17+-1.85
(p = 0.022, vs IMP), AZT (15) 3.62+-3.05. Mortality among AZT-treated
rabbits (16.7%) was signiﬁcantly reduced compared to controls (69.2%)
(p = 0.006). Four animals in the AZT group (26.7%) had culture-negative
pus.
Conclusion: In the rabbit experimental model, carbapenems were proved
equally effective with AZT in the treatment of intraabdominal infection
due to a carbapenem-susceptible VIM-1 producing clinical E. coli strain.
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P1919 Comparison of quinupristin-dalfopristin and vancomycin
in the treatment of experimental endocarditis due to
ampicillin- and gentamicin-resistant E. faecium
E. Perivolioti, E. Vryonis, P. Fanourgiakis, E. Platsouka, M. Samarkos,
M. Katsimpoulas, E. Balafas, N. Kostomitsopoulos, P. Karagianakos,
A. Skoutelis, O. Paniara (Athens, GR)
Objectives: Drug resistance among enterococci necessitates the search
for new treatment options.
In this study we tested the efﬁcacy of vancomycin and quinupristin-
dalfopristin in a rabbit model of experimental endocarditis due to an
ampicillin (AMP) & gentamicin (GEN) resistant and glycopeptides
susceptible clinical isolate of Enterococcus faecium.
Methods: We used the left side experimental endocarditis model. We
inoculated animals with E. faecium one day after the insertion and
ﬁxation of a polyethylene catheter into the left ventricle. Thirty-six hours
later they were randomly assigned to a control group (C), and groups
receiving quinupristin-dalfopristin 30mg/kg/q8 h IM x 5 days (QD) or
vancomycin 50mg/kg/q12 h IM x 5 days (V). All animals were sacriﬁced
at the end of treatment. Therapy response was determined by blood
cultures and quantitative (log10 cfu/gr of tissue) cultures of aortic valve
vegetations, liver, spleen, kidney and brain.
Results: The results obtained of the different therapeutics groups are
expressed in the Table.
Groups Vegetationa,b Livera,b Kidneya,b Spleena,b Braina,b
C 7.86±0.91 (0/10) 5±2.42 (0/10) 5.8±2.54 (0/9) 5.23±2.67 (0/9) 4.63±1.85 (0/9)
QD 7.41±1.11 (0/8) 5.15±1.05 (0/8) 4.96±1.4 (1/8) 5.11±1.42 (1/8) 4.6±1.19 (1/8)
V 6.19±0.66 (0/10) 4.07±0.79 (0/10) 3.85±0.89 (1/10) 3.8±0.94 (1/10) 3.77±0.57 (1/10)
Mann-Whitney
2-tailed test
C vsQD p= 0.015
C vsV p<0.0001
V vsQD p= 0.043
C vsV p = 0.023
C vsQD p= ns
V vs QD p= ns
C vsV p = 0.01
C vsQD p= ns
V vsQD p= ns
C vsV p = 0.01
V vsQD p= 0.043
C vsQD p= ns
V vsQD p= 0.043
C vsV p = ns
C vsQD p= ns
aMean±SD log10 CFU/g of tissue.
bNo. of sterile vegetations/No. of treated animals.
All the blood cultures of the QD and V group at the end of treatment were negative.
Conclusions: Although both regiments reduce signiﬁcantly the bacterial
count per gram of vegetations, treatment with V was found to be more
potent than QD. Also animals treated with V had lower bacterial counts
per gram of liver, brain and spleen tissue.
P1920 Pseudomonas aeruginosa chronic lung infection model;
therapeutic efﬁcacy of ciproﬂoxacin-betaine after two
treatment cycles
R. Endermann, A. Pickbrenner (Wuppertal, DE)
Objectives: Patients with cystic ﬁbrosis (CF) are at particular risk
of Pseudomonas aeruginosa (PA) infections. In patients with CF,
progressive obstructive lung disease due to chronic infection with
PA is the primary cause of morbidity and mortality. Maintenance
therapy with inhaled antibiotics reduces pulmonary exacerbations and
hospitalisations. A dry powder formulation of ciproﬂoxacin (CIP)-
betaine is currently being developed for maintenance therapy to combat
chronic PA infections in patients with CF. This study reports the
development of a rat model of PA chronic lung infection and the efﬁcacy
of CIP-betaine in the model.
Methods: A rat model of airway infection, using agar beads containing
PA (prepared according to standard methodology) was used. On days
1 and 8 of the study, anaesthetised rats were given intratracheal (IT)
instillation of 0.1 mL PA in 2% agar beads. A concentration of 2 x 107
colony forming units (CFU) were instilled per rat at each infection cycle.
Once-daily IT-treatment with CIP-betaine 2.5mg/kg was performed on
days 5, 6 and 7, with a second treatment cycle on days 13, 14 and 15. On
days 5, 8, 13 and 16, lungs were removed aseptically and homogenised
(n = 5 animals per treatment per sampling point). The viable bacterial
counts (measured as CFU) were determined by plating serial 10-fold
dilutions on agar plates.
Results: Rats infected with PA in agar beads on days 0 and 8 showed
constant levels of infection up to day 16 post-instillation (approximately
105 CFU/mL determined in lung homogenate). Two treatment cycles
with CIP-betaine achieved a signiﬁcant reduction in CFU in the lungs
compared with an untreated infection control group. The reduction in
CFUs was more pronounced after the second treatment (mean reduction
in log CFU of 1.9, with eradication achieved in four of ﬁve animals)
compared with the ﬁrst treatment (mean reduction in log CFU of 1.7,
with eradication achieved in two of ﬁve animals).
Conclusions: A PA chronic lung infection model was established by
use of the agar beads methodology, in which lung infection could
be maintained for up to 16 days. CIP-betaine administered over two
treatment cycles signiﬁcantly reduced the number of PA cells in the
lungs.
P1921 Daptomycin is superior to penicillin for treatment of
murine soft tissue infections caused by group A streptococci
(Streptococcus pyogenes)
A. Rye, R. Kudumula, A. Talati, E. Meals, B. English (Memphis, US)
Objectives: Penicillin (PEN) is the time-honoured therapy for infections
caused by Streptococcus pyogenes (group A streptococcus, GAS).
However, PEN alone is not considered adequate therapy for severe GAS
soft tissue infections because of the “Eagle Effect” (failure of PEN but
not clindamycin (CLI) in severe soft tissue infection in animal models).
The mechanisms responsible for the Eagle Effect are poorly understood
but may include the failure of PEN to kill stationary phase bacteria,
inhibit toxin production, or blunt the host response to GAS. It is not
known whether antibiotics other than clindamycin are also superior to
b-lactams for treatment of severe GAS soft tissue infections. Daptomycin
(DAP) is a novel cyclic lipopeptide antibiotic active against Gram-
positive organisms that is bactericidal but does not appear to trigger
rapid bacterial lysis. We hypothesised that DAP would be superior to
PEN for treatment of severe GAS soft tissue infections in mice.
Methods: We injected groups of 12 SKH1-Charles River hairless
(immunocompetent) mice in the right upper thigh muscle with 1×108–
1.5×109 cfu of an M3T1 clinical strain of GAS. We initiated antibiotic
treatment (either DAP or PEN) at either 18 hours or 40 hours after
bacterial inoculation with 1.5×109 and 108 cfu respectively. All animals
were observed daily, and lesion size and character were monitored.
Results: Mice injected with either 108 or 1.5×109 GAS consistently
developed soft tissue infections; lesions were more extensive and more
necrotic in mice given the higher inoculum. Lesion volume in DAP-
treated animals was consistently less than that in the PEN-treated
animals: 36% less in the animals inoculated with 108 organisms and
64% in the mice inoculated with 1.5×109 organisms. Lesions in the
DAP treated animals were also much less necrotic in appearance.
Conclusions: We found that mice infected with an M3T1 strain of GAS
and treated with DAP developed smaller, less severe soft tissue lesions
compared to mice treated with PEN. We conclude that daptomycin
deserves additional study as potential therapy for severe GAS soft tissue
infections.
P1922 Impact of the interaction of R207910 with rifampicin on
the treatment of murine tuberculosis
N. Lounis, T. Gevers, J. Van Den Berg, K. Andries (Beerse, BE)
Objectives: New drugs are needed to shorten the duration of TB
treatment. R207910, a diarylquinoline, is very active against Mycobac-
terium tuberculosis both in vitro and in mice. In healthy volunteers, co-
administration of rifampicin induces increased metabolism of R207910
and as a result, exposure to R207910 is decreased by 50%. A similar
drug-drug interaction is not observed in mice, and the efﬁcacy in mice
may therefore overestimate the efﬁcacy in patients. The aim of this study
is to evaluate the impact of decreasing doses of R207910 when used in
combination with isoniazid (H), rifampicin (R) and pyrazinamide (Z) on
the efﬁcacy in the mouse model.
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Methods:Mice were infected intravenously with 107 M. tuberculosis and
were treated 2 weeks later with the combination of HRZ and R207910
given at 3, 6.25, 12.5 or 25mg/kg for 2, 4, 6 and 8 weeks. The CFU
counts in the spleens were measured and the proportion of mice having
negative cultures were determined.
Results: When RHZ was combined with 25mg/kg of J, all mice had
culture negative spleens after 6 weeks of treatment. When RHZ was
combined with 12.5mg/kg of J, almost all mice had culture negative
spleens after 8 weeks of treatment. When RHZ was combined with
6mg/kg of J, 4 of 6 mice had culture negative spleens after 8 weeks
of treatment R207910 given at 3mg/kg did not improve the treatment of
mice when combined with RHZ.
Conclusion: In mice, the dose of R207910 could be decreased from 25
to 12.5mg/kg without loosing too much bactericidal efﬁcacy. Neither
the use of a strong background regimen (RHZ) nor the presence of
rifampicin is expected to conceal the efﬁcacy of R207910 in patients.
P1923 Effect of vancomycin versus rifampicin in combination
with ceftriaxone on inﬂammation and hearing loss in
experimental pneumococcal meningitis
M. Wittwer, J. Rohrbach, C. Aebi, S.L. Leib (Berne, CH)
Background: Up to 30% of survivors of bacterial meningitis (BM) suffer
from persisting hearing loss (>90dB) due to damage to the inner ear.
Vancomycin has become an important antibacterial treatment option for
BM due to its efﬁcacy against Streptococcus pneumoniae strains that are
resistant to other antibiotics. However recent studies reported increased
ototoxic effects of vancomycin combined with ceftriaxone in BM.
Aims: In the presented study we assessed the effect of combination
therapies of ceftriaxone with either vancomycin or rifampicin on
cytokine levels in the cerebrospinal ﬂuid (CSF) 6 h after initiation of
antibiotic therapy and at 21 days after infection we assessed the incidence
and extent of hearing loss by auditory brain stem response (ABR) and
neuronal density in the spiral ganglion of the inner ear.
Methods: Eleven days old Wistar rats (n = 46) were injected intracis-
ternally with 10ml saline containing 2×106 cfu/ml S. pneumoniae
(serogroup 3) or sterile saline as controls (n = 10). CSF was obtained
by puncture of the cisterna magna to document infection at 18 h after
infection and to assess cytokine levels at 24 h after infection. Antibiotic
treatment was initiated 18 h after infection. Rats were randomised
for 10 days treatment with either vancomycin (60mg/kg i.p.; bid) in
combination with ceftriaxone (100mg/ml s.c.; bid) or for treatment with
rifampicin (20mg/kg i.p.; bid) in combination with ceftriaxone. Twenty
days after infection ABR was measured, animals were sacriﬁced and
both cochleae processed for histomorphometry.
Results: All infected animals showed increased CSF concentrations
of IFN-gamma, TNF-alpha, IL-1alpha, IL-1beta, IL-6 and IL-10. Of
all infected animals 94% demonstrated a signiﬁcant hearing loss
(P< 0.0001, compared to mock infection). Neuronal density between
1882 and 1099 cells /mm2 was associated with normal hearing capacity.
Hearing started to decline at a neuronal density of 1052 cells/mm2
and below 746 cells /mm2 rats were functionally deaf. Combination
of ceftriaxone with vancomycin vs. ceftriaxone with rifampicin did not
result in signiﬁcant differences between the two treatment groups for all
parameters evaluated.
Conclusions: The combination of vancomycin plus ceftriaxone versus
rifampicin plus ceftriaxone for therapy of experimental pneumococcal
meningitis did not produce signiﬁcant differences in CSF inﬂammation
and the incidence and severity of hearing loss.
P1924 Efﬁcacy of tigecycline versus colistin in a mouse model of
pneumonia caused by carbapenem-resistant Acinetobacter
baumannii
K.T. Kwon, H.S. Cheong, E.S. Kim, J.Y. Suh, J.Y. Park, K.S. Ko,
W.S. Oh, K.R. Peck, J.H. Song (Daegu, Seoul, Suwon, KR)
Objectives: To compare efﬁcacy of tigecycline versus colistin as
monotherapy or combination therapy with rifampin in a mouse model
of pneumonia caused by carbepenem-resistant A. baumannii.
Methods: C57BL/6 mice rendered transiently neutropenic were infected
intratracheally with 106 CFU of carbapenem-resistant A. baumannii.
Mice were treated with tigecycline, colistin, rifampin, tigecycline plus
rifampin, or colistin plus rifampin. The survival rates of mice, the
rates of bacteraemia eradication, and lung colony counts (logCFU/g
(mean±standard deviation)) were compared between each group at 24 h
and 48 h after inoculation.
Results: Tigecylcine plus rifampin were synergic and the most active
regimen among time-kill curves of 0.5 and 1 MIC for 24 h incubation.
The untreated control group showed 73% and 36% of cumulative survival
rates and 100% of bacteraemia rates at 24 h and 48 h. The survival rates
of mice treated with antimicrobial agents except colistin monotherapy
were signiﬁcantly higher than that of the control group (p< 0.05).
Tigecycline monotherapy showed signiﬁcantly higher rates (60%) of the
bacteraemia eradication at 48 h than the colistin monotherapy that were
unable to eradicate the bacteraemia at all (p< 0.05). The rates (100%) of
the bacteraemia eradication in tigecycline plus rifampin group were the
highest among effective antimicrobial treatment groups at 24 and 48 h,
but not statistically signiﬁcant. Tigecycline (10.77±0.28, 9.13±0.93)
and colistin (10.42±0.24, 10.60±0.57) monotherapy did not show the
effect to reduce the lung colony counts compared to the control group
(10.31±0.63, 9.68±0.66) at 24 and 48 h. Rifampin monotherapy showed
signiﬁcantly lower lung colony counts (7.58±0.88, 4.83±0.8) at 24 and
48 h than control group (p< 0.05). The lung colony count of two rifampin
based combination regimens were signifcantly lower than that of the
tigecycline and colistin monotherapy (p< 0.05), but not synergic. They
were not different between each other.
Conclusion: Rifampin based combination regimens with tigecycline
or colistin were effective and comparable to treat mouse model of
bacteraemic pneumonia caused by carpabenem-resistant A. baumannii.
P1925 Immuno-biochemical comparison of susceptible BALB/c
and resistant C57BL/6 mice responses to Leishmania major
infection
M. Amini, H. Nahrevanian, S. Khatami, M. Farahmand, S. Javadian,
S. Fayaz, F. Mirkhani (Tehran, IR)
Objectives: This study has been carried out to compare the patho-
physiological signs, production of nitric oxide, serum concentration
of microelements and liver enzymes including Aspartate Transaminase
(AST), Alanin Transaminase (ALT) and Alkaline Phosphatase (ALP) in
two different susceptible BALB/c and resistant C57BL/6 mice infected
with Leishmania major MRHO/IR/75/ER; as a prevalent strain of
cutaneous leishmaniasis in Iran.
Methods: In order to carry out this investigation, mice were assigned
into 4 groups of 5 mice as control BALB/c, infected BALB/c,
control C57BL/6 and infected C57BL/6. Experimental Leishmaniasis
was initiated by subcutaneous injection of promastigotes into the basal
tail of test groups. The development of lesions was determined weekly
by measuring the two diameters. After 10 weeks, all mice were killed
humanly by terminal anaesthesia and target tissues including lymph
nodes, spleen and liver from each mouse were removed, weighted and
their impression smears were also prepared. Griess microassay method
applied for measurement of NO concentration in plasma, liver and
spleen suspensions. Serum microelements including Zn and Cu were
determined by direct aspiration of 1:10 dilution of serum in deionised
water into the Atomic Absorption Spectrophotometer. Serum AST, ALT
and ALP were determined by Auto Analyzer Technical RA1000.
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Results: NO concentration in plasma, NO2 concentration in tissues,
progress of lesion size, proliferation of amastigotes inside macrophages,
pathogical signs and biochemical factors in two susceptible and resistant
hosts are varied and these variations are depended on mice strain.
Conclusion: Analysis of data from this study revealed an association
between RNI levels with the evolution of disease, which had effects on
pathological sign and able to modify clinical signs. Zn deﬁciency in
plasma of susceptible BALB/c mice infected with L. major indicates
possible therapeutic administration of Zn in this form of leishmaniasis.
Increase in Cu level in C57BL/6 mice might augment resistant to
infection with intracellular pathogens. Our data indicate that Cu/Zn
imbalance can be useful marker for dysfunction in leishmaniasis.
Alteration of liver enzymes concentration is a consequence of
leishmaniasis among BALB/c and C57BL/6 mice. Finally we concluded
that differences between susceptible BALB/c and resistant C57BL/6 mice
were correlated with genetically induced immuno-biochemical factors.
P1926 Engineered Biﬁdobacterium breve with improved clinical
efﬁcacy
R. Sleator (Cork, IE)
Objectives: To engineer the probiotic strain Biﬁdobacterium breve with
improved tolerance to stresses encountered during gastrointestinal transit
and improved clinical efﬁcacy.
Methods and Results: Cloning of the listerial derived stress survival
genes betL (encoding BetL a compatible solute uptake system linked
to improved osmotolerance) and bilE (encoding BilE a bile exclusion
system linked to bile tolerance) into the probiotic strain Biﬁdobacterium
breve, using the expression vector pNZ8048, signiﬁcantly improved the
strain’s ability to cope with a variety of stressful conditions, both external
to and within the host.
Heterologous expression of BetL resulted in improved resistance to low
and high temperatures and desiccation – ex vivo stresses encountered
by probiotics during product (food and/or tablet) formulation and
subsequent storage. While expression of BilE gave rise to improved
in vitro bile tolerance and resulted in a signiﬁcant improvement
in gastric transit and gastrointestinal persistence in a mouse model.
Furthermore, real-time tracking of a luminescent labelled pathogen
(Listeria monocytogenes) in live animal models of infection revealed
a signiﬁcant reduction in the level of infection when mice were fed
B. breve expressing bilE compared to the bilE− control strain (Fig. 1)
prior to oral inoculation with the pathogen.
Conclusion: It is possible to selectively improve probiotic stress survival,
both inside and outside of the host, by heterologous expression of stress
survival genes from more physiologically robust strains.
Such genetically engineered ‘pharmabiotics’ exhibit signiﬁcantly im-
proved clinical efﬁcacy and may ultimately provide an alternative
treatment for recalcitrant, antibiotic resistant infections such as
Clostridium difﬁcile.
Figure 1. The Xenogen IVIS Imaging System allows in vivo real-
time tracking of labelled pathogen and probiotic. Three days post oral
inoculation the levels of L. monocytogenes reaching the liver were 99.9%
lower in animals fed with B. breve expressing betL (blue) as opposed to
the betL minus control strain (red). Thus, proving that probiotic clinical
efﬁcacy can be dramatically improved by genetic manipulation.
P1927 Determination of the impact of pneumoperitoneum on
sepsis severity in an animal model of peritonitis through
C-reactive protein and procalcitonin serum levels assessment
G. Chatzimavroudis, K. Kontopoulou, T. Pavlidis, A. Orfanou,
I. Stergiou, Z. Afkou, S. Atmatzidis, K. Atmatzidis (Thessaloniki, GR)
Objectives: C-reactive protein (CRP) and procalcitonin (PCT) consist
two substantial inﬂammator markers. The aim of this study was to
evaluate the effect of CO2 pneumoperitoneum, induced for different
exposure times, on sepsis cascade through determination of CRP and
PCT serum levels.
Methods: In 30 New Zealand rabbits, peritonitis was induced by
the cecumligation and puncture (CLP)model. After 12 hours, animals
were randomised in 7 groups: group 1; control group, groups 2, 3,
4 and 5; pneumoperitoneum of 10–15mmHg for 60–180 minutes,
groups 6 and 7; laparotomy for 60 and 180 minutes, respectively.
Blood samples were collected before CLP, 12 later and 1, 3 and 6
hours after pneumoperitoneum desufﬂation or abdominal trauma closure
to evaluate bacteraemia, C-reactive protein (CRP) and procalcitonin
(PCT) levels. Furthermore, 2-day mortality was recorded in all animals.
For the assessment of CRP and PCT, 2ml of blood were collected
in pyrogen-free tubes (Vacutainer, Becton Dickinson, Cockeysville,
MD) and centrifuged. The serum was kept refrigerated at −70ºC
until assayed. Serum levels of CRP were quantitatively determined
using an automated immunoturbidimetric assay (Hitachi 912, ROCHE,
Basel, Switzerland), with the detection limit of the assay being
0.5mg/dl.PCT was measured using a commercial immunoluminometric
assay (B.R.A.H.M.S. Diagnostics GmbH, Berlin, Germany)which uses
two antibodies that bind to two sites (calcitonin and katakalcin)of the
procalcitonin molecule, thus ruling out cross-reactivity. The detection
limit of the assay is 0.5 ng/ml.
Results: Bacteraemia was induced in all groups. Moreover, in all groups
signiﬁcant increases of CRP and PCT levels were measured at 12
hours following peritonitis induction, with respect to baseline values
(p< 0.05). Subsequent measurements showed even higher levels of CRP
and PCT in all groups. No differences were recorded among groups in
association to CRP levels at all time intervals. However, serum PCT
reached statistically higher levels (p< 0.05) in groups with laparotomy
compared to groups with pneumoperitoneum and control group at 6
hours. Survival was lower in groups with laparotomy than in groups
with pneumoperitoneum and control group (p< 0.05).
Conclusion: In the presence of peritonitis, CO2 pneumoperitoneum
applied in usual in clinical practi-ce pressures, even for extended time
intervals, attenuates the severity of sepsis and increases survival.
P1928 The Dot/Icm system is essential in the outcome of Legionella
pneumophila pneumonia in vivo
F. Ader, C. Ginevra, M. Molmeret, A. Doleans, B. Guery, S. Jarraud,
J. Etienne, C. Chidiac (Lyon, Lille, FR)
Objective: Legionella pneumophila (L. p) is a facultative intracellular
Gram-negative pathogen responsible for life-threatening pneumonia. The
Legionella pneumophila Dot/Icm system is an important macromolecular
transporter associated with virulence. The aim of the study was
to determine the in vivo involvement of Dot/Icm system in L. p
pathogenesis for 3 clinical isolates responsible for endemic (L. p Paris)
and epidemic (L. p Lens and Philadelphia) cases.
Methods: A/J mice were infected by an intra-tracheal instillation of 106
bacteria using clinical isolates, L. p Paris, Lens and Philadelphia strains
(serogroup 1) and their isogenic mutant invalidated in dotB gene. Acute
lung injury was assessed in a control group and at 24 and 48 h post-
infection by measuring: (i) the protein levels in bronchoalveolar lavage
ﬂuids (BALF); (ii) the lung endothelial permeability to radio labelled
I125 albumin (Perm-I125); (iii) the alveolar inﬂammatory response
through levels of tumour necrosis factor (TNF)-alpha, interferon (IFN)-
gamma, interleukin (IL)-6, IL-12p70 cytokines in BALF. Systemic
spread was assessed by blood, liver, kidneys, spleen and brain cultures.
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Results: Protein levels in BALF and Perm-I125 were signiﬁcantly lower
at 48 h in the mutant strain infected groups than in the wild type infected
groups (P< 0.001 and P< 0.05 respectively). Levels of IFN-gamma,
IL-6, IL-12p70 in BALF, except TNF-alpha, were signiﬁcantly lower at
48 h in the mutant strain infected groups than in the wild type infected
groups (P< 0.001). Bacterial localisation in blood, liver, kidneys, spleen
and brain cultures were signiﬁcantly reduced at 24 and 48 h in the mutant
strain infected groups than in the wild type infected groups (P< 0.001).
Conclusion: The Dot/Icm system of endemic and epidemic strains
of L. p serogroup1 is a critical virulence factor in vivo, associated
with the development of alveolar-capillary barrier injury, alveolar
proinﬂammatory response and bacterial dissemination emphasising its
relevance as a major potential therapeutic target.
P1929 Murine model of lung infection by Parachlamydia
acanthamoebae
N. Casson, J.M. Entenza, N. Borel, A. Pospischil, G. Greub (Lausanne,
Zurich, CH)
Background: Serological and molecular-based studies support the
role of Parachlamydia acanthamoebae as a potential new agent of
pneumonia. Moreover this intracellular bacteria was shown to resist
degradation in human macrophages (i.e the ﬁrst line of innate immune
defence against invading pathogens). To test the third Koch postulate, we
investigated whether P. acanthamoebae may cause pneumonia in mice.
Methods: Living or heat-inactivated P. acanthamoebae bacteria were
injected intratracheally to mice. PBS was injected in additional mice
(negative control). Mice were sacriﬁced at days 0, 2, 4, 7, 10, and 21.
Non-infected mice sharing the cage of infected mice were sacriﬁced
at days 10, 21 and 46. Histology, immunohistochemistry, qPCR and
amoebal co-culture (a cell culture system which uses amoebae as
cell background) were performed on lungs. Serological titers were
determined by immunoﬂuorescence on sera collected at time of sacriﬁce.
Results: All mice challenged with living Parachlamydia presented signs
of pneumonia (purulent n = 11; interstitial n = 3) at histology on day 2,
4 and 7. No control mice presented signs of pneumonia. Presence of
Parachlamydia was conﬁrmed by immunohistochemistry using speciﬁc
rabbit anti-Parachlamydia antibodies. Many Parachlamydia were present
on day 2, 4 and 7 in lungs of infected mice, which presented interstitial
or purulent pneumonia. No control mice (those injected with heat-killed
bacteria and those injected with PBS) presented signs of pneumonia.
About 106 parachlamydial genomic DNA copies were detected by qPCR
in the lungs of mice injected with living Parachlamydia. Mice injected
with PBS were negative.
Using amoebal co-culture, we were able to re-isolate living Parachlamy-
dia from infected lungs. Control mice were negative.
Serology was negative at day 0, 2, 4 and 7. Anti-Waddlia antibody titers
increased to 1/128 at day 14 and 1/512 at day 21 post-infection.
Conclusion: In this study, we established an animal model of lung
infection by P. acanthamoebae. This conﬁrms the third Koch postulate
and strongly supports the role of P. acanthamoebae as an agent of
pneumonia.
P1930 Experimental models of upper urinary tract infections
caused by sexually transmitted diseases isolated or in
conjunction with non-speciﬁc agents
O. Loran, L. Sinyakova, I. Kosova (Moscow, RU)
Objectives: Experimental models of low urinary tract infections caused
by non-speciﬁc agents are known. There are no reports which show the
role of sexually transmitted diseases (STD) in ethiology of upper urinary
tract infections. This study was performed to prove the role of STD in
ethiology of urinary tract infections.
Methods: Experimental model of acute pyelonephritis was created on
13 rabbits by ligation of right ureter near urinary bladder with further
injecting in ureter cultures of Ureaplasma urealyticum, Chlamydia
trachomatis, E. coli, isolated and in different combinations. The ﬁnal
testing was performed on 3 and 7 days.
Results: Inﬂammation process in upper urinary tract of experimental
animals caused by Ureaplasma urealyticum has the following pathologic
characteristics: the presenn˜e of ballooning degeneration of pelvic
epithelium developed in early stages, the absence of intensive
granulocytic reaction. Ureaplasma urealyticum realizes its pathogenic
properties through membrane destruction with further formation of cell
vacuoles and then colliquative necrosis.
The action of Ureaplasma urealyticum in combination with non-speciﬁc
agents (E. coli) leads to intensive cell permeability and to early and more
intensive developing pyoinﬂammation reaction. The action of Chlamydia
trachomatis infection leads to formation of multiple calciﬁed focuses
whether its combination with E. coli – to primary chronical process
formation.
Conclusion: Inﬂammatory process of upper urinary tract of experimental
animals caused by speciﬁc agents (Ureaplasma urealyticum and
Chlamydia trachomatis) in case of isolating injection leads to primary
chronical process and in combination with non-speciﬁc agents to early
and more intensive pyoinﬂammation reaction in the animal’s kidney.
P1931 In the bovine trichomoniasis experimental model, systemic
immunisation, unlike preputial infection, induces protection
against trichomonad colonisation in bulls
E. Cobo, L. Corbeil, R. BonDurant (Davis, San Diego, US)
Trichomonads cause human and bovine sexually-transmitted infections,
with adverse outcomes of pregnancy in both host species. Bovine
trichomoniasis is a useful model because it resembles human tri-
chomoniasis in many ways. Like Trichomonas vaginalis, Tritrichomonas
foetus (T. foetus) is an extracellular obligate protozoon that persistently
and asymptomatically colonizes the genital tract in males although
trichomonad antigens are detected in the preputial mucosal epithelium.
We described a preputial “silent” mode of responsiveness in bulls
infected with T. foetus where males did not mount either a detectable
preputial IgA, IgG, IgM or IgE antibody response or increase in immune-
inﬂammatory cells, including mast cells, B, and T cells, and had a
slightly increased tissue expression of TGF-beta. Only some T. foetus
infected bulls showed eosinophilia in the preputial submucosa. However,
this “sleeping beauty” mode of responsiveness could be awakened since
bulls systemically vaccinated and later challenged with T. foetus were
capable of resisting trichomonad mucosal colonisation by developing
systemic and preputial T. foetus speciﬁc IgG1 and IgG2 responses.
This IgG response was accompanied by an increased population of
preputial submucosal HM57+B cells that may produce a portion of the
IgG antibodies. In addition, mast cells in the submucosa may assist in
transport of IgG from serum to genital lumen by releasing vasoactive
inﬂammatory mediators. Also, in vaccinated and challenged bulls, an
increased population of CD3+ T cells and a slightly increased expression
of IL-5 in preputial mucosa were observed, suggesting ampliﬁed antigen
processing and consequently a more productive immune response.
Deﬁning mechanisms to explain why the bovine male genital mucosa
responds to T. foetus “silently” during infection but with an effective local
and systemic IgG response after systemic immunisation may contribute
to understanding the role of Trichomonas vaginalis in men.
P1932 A new animal model for severe complications in
intra-abdominal chronic infections caused by B. fragilis
M. Glenschek-Sieberth, K. Merfort, S. Obertegger (Wuppertal, DE)
Objectives: Female reproductive organs are often affected by severe
complications following intra-abdominal infections (IAI). Such compli-
cations, including uterine tube infections and tubulo-ovarian abscesses,
can lead to infertility. A new model of chronic uterus infection using
a clinical Bacteroides fragilis isolate was developed. The model was
used to evaluate the efﬁcacy of two antimicrobial agents, moxiﬂoxacin
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(MXF) and piperazillin/tazobactam (TZP), which are both approved for
the treatment of cIAI in the USA.
Methods: C57BL/6JOla mice were given beta-estradiol 20mg/kg s.c.,
followed by beta-estradiol (40mg/mL) supplied via drinking water. After
4 days, the left uterine tube was surgically prepared and injected with 50
ml B. fragilis O6688 (MXF=0.25mg/mL; TZP= 0.5mg/mL) suspension (3
x 108 colony forming units [CFU] per mouse). CFU in the uterine tubes
were determined over 25 days by plating after hysterectomy. Abscess
formation was evaluated.
The therapeutic efﬁcacies of MXF and TZP were evaluated using the
same infection procedure. Infected mice were treated from day 21 post-
infection (p.i.) with MXF 100mg/kg b.i.d. IV or TZP, 400mg/kg b.i.d.
for 4 days. These doses represent the pharmacokinetics (PK) of human
dosages of 400mg once daily MXF IV and 3.375 g q.i.d. TZP IV therapy,
respectively. Efﬁcacy was assessed as the reduction in CFU in the uterine
tube homogenates at day 25 p.i.
Results: A chronic B. fragilis uterine tube infection was successfully
established. Bacterial load in the uterine tube homogenates was stable
over 25 days. Abscess formation was ﬁrst detectable on day 21 p.i. (two
out of three mice).
MXF 100mg/kg b.i.d. achieved a CFU reduction of >−4 logs
(99.99%) whilst TZP 400mg/kg b.i.d. achieved a reduction in CFU
of approximately >−2 logs (99%) compared with control (for both
P = 0.008, Mann-Witney test). Overall, MXF achieved a signiﬁcantly
higher reduction in CFU than TZP (P = 0.008, Mann–Witney test).
Conclusions: Pre-treatment of mice with beta-estradiol and infection of
the uterine tube by surgical preparation allows chronic colonisation of
the uterine tube by B. fragilis and subsequent abscesses formation. MXF
shows superior efﬁcacy to TZP in this model of uterine infection, at
doses equivalent to those used in humans.
P1933 Ceftobiprole is superior to cefepime against a Klebsiella
pneumoniae strain in experimental meningitis
M. Cottagnoud, F. Acosta, A. Stucki, P. Gerber, P.H. Cottagnoud
(Berne, CH)
Objectives: In the present study we tested ceftobiprole (CFT) and
cefepime (CPM) as monotherapy against a Klebsiella pneumoniae strain
in the rabbit meningitis model and determined the penetration of CFT
into inﬂamed meninges.
Methods: We used the rabbit meningitis model as described by Dacey
and Sande. The Klebsiella pneumoniae strain has been kindly provided
by Dr. S. Droz, Inst. Inf. Dis., Bern. The MICs (mg/L) were the
following: CPM: 0.25mg/L, CFT: 0.25mg/L. Meningitis was induced
by intracisternal inoculation of 106 CFU. 8 hours later treatment was
started for 8 hours. CFT (40mg/kg) was injected once at h 0 in order to
mimic kinetics in humans. CPM (100mg/kg) was injected at hour 0 and
4, as a standard dose previously used in this model and corresponding
to high doses in humans. CSF samples were repeatedly collected during
therapy in order to determine killing rates. Results of the bactericidal
activity are expressed in delta log10 CFU/ml·h and delta log10 CFU/ml
over 8 h. Penetration of CFT into inﬂamed meninges was measured by
comparison of CSF AUC/serum AUC (Area Under the Curve).
Results: Killing rates of the different regimens are presented in the table.
Group Inoculum
(log10 CFU/ml)
Killing rates/h
(delta log10 CFU/ml·h)
Killing rates/8 h
(delta log10 CFU/ml·8 h)
Controls (10) 5.39±0.91 +0.20±0.06 +1.76±0.39
Cefepime (10) 5.90±1.23 −0.54±0.17 (1) −4.54±1.32 (2)
Ceftobiprole (10) 6.28±0.58 −0.76±0.23 (1) −5.24±1.05 (2)
(1) P< 0.05, ceftobiprole versus cefepime; (2) P< 0.01, ceftobiprole versus
cefepime.
Penetration of ceftobiprole into inﬂamed meninges: mean: 16.37±5.4%.
Min.: 9.9%; Max.: 23%
Conclusions:
1. Ceftobiprole is superior to cefepime in the treatment of meningitis
due to Klebsiella pneumoniae determined by killing per hour or by
killing rate over 8 hours.
2. The penetration of ceftobiprole into inﬂamed meninges ranged
around 16%.
P1934 Oral administration of a genetically-labelled Enterococcus
faecium strain to pregnant mice leads to its presence in
foetal meconium
E. Jime´nez, R. Martı´n, M.L. Marı´n, J.M. Odriozola, M. Olivares,
J. Xaus, L. Ferna´ndez, J.M. Rodrı´guez (Madrid, Granada, ES)
Objectives: In a previous study, we observed that some bacteria could
be isolated from umbilical chord’s blood of healthy neonates and from
murine amniotic ﬂuid obtained by caesarean section. This suggested that
term foetuses are not completely sterile, and that a prenatal mother-to-
child efﬂux of commensal bacteria may exist. Therefore, presence of
bacteria in human and murine meconium was investigated.
Methods: Twenty-one meconium samples were aseptically collected
from newborns immediately after labor or programmed elective
caesarean and plated onto BHI, VRBA and CNA agar plates, which
were aerobically incubated at 37ºC for 24 h. Parallel, the same samples
were also cultured on WCh and MRS agar plates, which were incubated
anaerobically at 37ºC for 48 h. The isolates were examined to determine
cell morphology and Gram-staining reaction. Subsequently, a percentage
of the isolates, representative of all the colony and cell morphologies
observed were identiﬁed.
Parallel, a group of pregnant mice were orally inoculated with a
genetically-labelled E. faecium strain previously isolated from breast
milk of a healthy woman. One day before the predicted labour date,
they were submitted to caesarean section to collect meconium samples,
which were cultured on MRS agar plates. A number of enterococcal
colonies were randomly selected and tested for the genetic label
Results: Most of the identiﬁed isolates belonged to the Genuses
Enterococcus, Staphylococcus, Streptococcus. The labelled strain could
be isolated and PCR-detected from meconium of the inoculated animals
obtained by caesarean section one day before the predicted labor date.
In contrast, it could not be detected in the samples obtained from a
non-inoculated control group.
Conclusion: In this study, bacteria could be isolated from meconium
obtained from healthy neonates, which suggests that, contrary to what
has been hypothesised up to the present, this biological material may
not be completely sterile. Such bacteria could initiate gut colonisation
as an adaptation of the foetal gut for life outside the mother. Most
of the bacterial species isolated in this study are included among
the opportunistic pathogens in neonates suffering from underlying
conditions. This negative role probably reﬂects an easy access of such
bacteria to predisposed infants since, in fact, they may be part of their
endogenous microbiota even at a foetal stage.
P1935 Chicken model of Enterococcus faecalis native-valve
endocarditis
J. Larsen, M.S. Chadﬁeld, H.C. Schønheyder, A.M. Bojesen,
J.P. Christensen, M. Bisgaard (Frederiksberg, Hillerød, Aalborg, DK)
Objectives: Enterococci represent the third most common cause of
infective endocarditis (IE) and are responsible for 5% to 20% of
all cases, of which Enterococcus faecalis accounts for >80%. In
parallel, antimicrobial resistance continues to evolve and presents serious
challenges in the therapy of invasive enterococcal infections. In one
recent series, native-valve IE accounted for 61.3% of 44 patients with
enterococcal endocarditis. However, most small-animal models of IE
more closely mimic the pathophysiology of prosthetic-valve IE. These
models rely on the production of sterile aortic vegetations by the insertion
of a polyethylene catheter via the right carotid artery, prior to bacterial
challenge, which increases the ability of the bacteria to adhere to and
colonise the endocardium and, at the same time, decreases the efﬁcacy
of the antimicrobial therapy. Therefore, new in vivo technologies for
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screening novel candidate agents to prevent and treat native-valve IE are
urgently needed. The objective of the present study was to develop a
small-animal (chicken) model of E. faecalis native-valve endocarditis.
Methods: E. faecalis isolates 20326H2 and HEF5 from native-valve
IE in chickens and humans, respectively, were tested. Single-age
groups of chickens (5 weeks and 50 weeks of age) were injected
intravenously (jugular vein) with 109 CFU stationary-phase bacteria
or sterile phosphate-buffered saline (control groups). Deﬁnite IE was
identiﬁed pathologically according to the modiﬁed Duke criteria by 21
days postinfection (at autopsy).
Results: Both groups were highly susceptible to infection with 20326H2
(90% deﬁnite IE cases in each group). By contrast, only the adult group
exhibited high susceptibility to infection with HEF5 (80% versus 40%
in the juvenile group), although the observed difference only reached
borderline signiﬁcance (one-tailed p value = 0.08, Fisher’s exact test).
Conclusion: Overall, our data suggest that the chicken model closely
mimics the pathophysiology of enterococcal native-valve IE. This
conclusion is supported by the observation that the susceptibility to
infection with HEF5 increased with age (i.e., due to degenerative
valve disease). The present chicken model is readily adaptable to
evaluating antimicrobial efﬁcacy and should prove to be a useful tool
in identifying bacterial virulence-related factors involved in adhesion to
and colonisation of native valves.
P1937 Caenorhabditis elegans food-choice experiment: a rapid way
to screen for agr-related Staphylococcus aureus toxins
M. Ythier, S. Boisset, F. Vandenesch, P. Moreillon (Lausanne, CH;
Lyon, FR)
Objectives: S.aureus is a remarkably versatile pathogen, capable of
causing a diversity of diseases. C. elegans is a bacteria-feeding nematode
increasingly used for the screening of microbial pathogenic factors.
Recent experiments indicate that C. elegans larvae fed on wild type
S.aureus (RN6390) were progressively killed over 5 days, while only
60% of larvae fed on its agr-negative mutant (RN6911) were killed
during the same period of time. As a control, all larvae fed on
Escherichia coli OP50 survived. Hence, some agr-related products might
be involved in the killing.
Most natural environments offer a variety of food sources to animals
that inhabit them and therefore, feeding usually involves making choices
between foods. Here, we tested whether food-choice could be used as a
rapid method to detect agr-related toxic products.
Methods: We used early food-choice (at 4 h and 24 h) to test whether
the worms could sense agr-related toxins before being killed. About 20
larvae of C. elegans were placed at various positions on a series of
plates that contained 0.5cm diameter lawns of E. coli OP50, S.aureus
RN6390 or RN6911. Three plates were prepared, each containing two
spots of different bacterial lawns. Three zones were demarcated to put
the worms: one between the border of the plate and the ﬁrst bacterial
lawn; the second between the two bacterial lawns and the third between
the second lawn and the other border of the plate.
Results: Three kinds of results were obtained. (a) When larvae were
deposited in the vicinity of a lawn of E. coli, >95% of them roamed
toward the lawn within 4 h, and all of them kept dwelling there at 24 h;
in contrast, <20% of larvae crept toward a lawn of S.aureus after 4 h,
and all of them were creeping away from the bacteria at 24 h. (b) When
E. coli and staphylococci were inoculated equidistantly from the larvae,
>80% of worms crawled toward E. coli irrespective of the S.aureus
arg-type. (c) When isogenic agr-positive/negative staphylococci where
used instead, >60% of the larvae showed a preference for the defective
mutant.
Conclusion: C. elegans could rapidly sense the presence of agr-related
substances. While the nature of the repelling substance(s) has yet to be
determined, the food-choice assay represents a simple and faster assay
(4–24 h) than the 5-days long-term survival assay to screen for putative
microbial virulence factors.
P1938 Intra-catheter leukocyte stain and culture as a diagnostic
tool in an experimental animal model of port-related
bloodstream infection
A. Serrera, A. Martinez, M. Alonso, F. Guillen-Grima, A. Aguinaga,
R. Gonzalez, J. Leiva, J.L. del Pozo (Pamplona, ES)
Objectives: Port-related bloodstream infections (PRBI) are difﬁcult
to diagnose without port removal. Quantitative blood cultures (QBC)
have become the gold standard method for conservative diagnosis.
However, this method is laboring, costly and sometimes insensitive. Intra-
catheter leukocytes can be isolated, stained by acridine orange (AO) and
cultured. The aim of this study was to analyse the usefulness of this
method to perform a rapid diagnose of PRBI in an experimental animal
model. Secondary we determined the optimal threshold for intracatheter
leukocyte culture (ILC) for the diagnosis of PRBI.
Methods: 32 sheep were implanted with venous access ports. Three days
after, a standard Staphylococcus aureus inoculum was locked inside the
port and allowed to dwell for 24 hours. Blood was drawn through port
and a peripheral vein three days post-inoculation. Paired QBC, ILC and
AO stain were performed. To obtain the intra-catheter leucocytes, 1mL
of the blood sample was layered over 1ml of the extraction solution in a
sterile shell vial tube, and centrifuged at 3500 g for 30 minutes. A cellular
monolayer was prepared from 50 microliters of the leukocyte band and
slides were stained with AO. A positive result was the detection of one
microorganism after observing 20 ﬁelds by ﬂuorescence microscopy
(470 nm). Fifty microliters from the leucocyte band were inoculated
into 2 blood agar plates for the ILC. Any cfu observed in the ILC was
considered as a positive culture.
Results:We could obtain paired samples in 28 of the 32 animals; devices
were obstructed in 4 animals. QBC met criteria for PRBI in 89% of
the animals. ILC culture was positive in 100% of the animals, and we
could detect some microorganism in 21.4% of the AO stains. The ROC
analysis showed that the best threshold for the ILC was 420 cfu/mL
(77% sensitivity and 40% speciﬁcity). When the cfu in the ILC were
higher than 5000 per mililiter, the AO stain improved its sensitivity to
66%.
Conclusion: The results obtained in our model suggest that ILC could
be a valid conservative method to diagnose PRBI using a small amount
of port blood (1ml). The AO stain, although it is a simple and quick
test, is not very useful for the diagnosis of PRBI. Limitations of this
study are the small sample size and the short period of time studied
after inoculation, so more studies are warranted.
This work was supported by a grant from Proy. Inst. Carlos III ref.
03/1102
P1939 Factors involved in combined treatment with probiotic and
ﬂuorokinolone in Salmonella typhimurium murine infection
K. Truusalu, R. Mikelsaar, T. Kullisaar, M. Aunapuu, A. Arend,
M. Zilmer, M. Mikelsaar (Tartu, EE)
The aim was to detect the putative factors inﬂuencing the eradication of
Salmonella Typhimurium (ST) by combined treatment with probiotic L.
fermentum ME-3 (ME-3) and oﬂoxacin (OFX) in a murine model.
Material and Methods: Altogether 54 NIH line mice were investigated.
Mice from Gr1, 2 and 3 (n = 12 in each group) were infected with a single
dose of ST (105 cfu/ml) intragastrically; mice of Gr2 were treated with
OFX (20mg/kg) intragastrically daily. Mice of Gr3 were administered
combined treatment with OFX and ME-3 (108cfu/ml) in the drinking
water. The uninfected mice of Gr4 were administered ME-3, while Gr5
served as a control with PBS. The mice were sacriﬁced on Day 5 and
Day 10. Blood, liver, spleen and ileum were seeded onto XLD and MRS
media to detect ST. Histological slides were prepared from liver, spleen
and ileum. GSSG peroxidase and reductase, the glutathione redox ratio
(GSH/GSSG), lipid peroxides (LPO) and cytokines (IL-10, INFa˜ and
TNFa´) in mucosa of ileum and liver were estimated.
Results: Salmonella Typhimurium was found in 4 infected mice from
Gr1 and Gr2 (2 from blood, 4 from spleen and 1 from liver). The
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combined treatment eradicated ST from all investigated sites. Liver
granulomas were found in 8 mice in both Gr1 and 2, while the addition
of ME-3 reduced the number of mice with liver granulomas (p = 0.019).
The combined treatment caused signiﬁcant reduction of LPO in mice of
Gr3 as compared to Gr1 in the liver and ileum (p< 0.001; p = 0.005,
resp.). ST infection equally increased the levels of all investigated
cytokines as compared to control group. However, in the combined
treatment group only the values of IL-10 signiﬁcantly (p = 0.002; 0.001
resp.) exceeded these of TNFa´ and INFa˜.
Conclusion: In the experimental ST infection the combined treatment
with probiotic L.fermentum ME-3 and OFX improves the eradication
of ST from gut and reduces the number of granulomas in the liver of
mice. The putative factors comprise the reduction of oxidative stress
indices and the increase of the anti-inﬂammatory cytokine IL-10. This
may down-regulate the pro-inﬂammatory cytokines INFa˜ and TNFa´ and
inhibit the formation of liver granulomas.
P1940 Quorum sensing controlled rhamnolipid production is
crucial for P. aeruginosas ability to evade the immune
response in a mouse foreign-body infection model
L. Dahl Christensen, M. van Gennip, P. Østrup Jensen, S. Pamp,
R. Phipps, C. Moser, T. Tolker Nielsen, N. Høiby, M. Givskov,
T. Bjarnsholt (Kgs. Lyngby, Copenhagen, DK)
Objectives: Pseudomonas aeruginosa is associated with infections on
foreign-body implants. The problem with these infections is that they are
not cleared even when treated with high doses of conventional antibiotics.
The only option to eradicate P. aeruginosa is to remove the infected
implant. One particular reason for this is the capability of P. aeruginosa
to grow as bioﬁlms on foreign-bodies. It is widely accepted that cell-
cell communication systems, in a process denoted quorum sensing (QS),
enables the bacterium to establish and maintain conditions of chronic
infections. P. aeruginosa uses the QS systems to control the production
and secretion of several virulence factors, including rhamnolipids that
induces fast necrosis of host cells. Previous data by us generated under
in vitro conditions strongly suggests that QS deﬁciency in vivo rescues
the PMNs from the otherwise necrotic effects caused by rhamnolipid
producing bioﬁlms.
In the present study we investigated whether a P. aeruginosa mutant
(rhlA mutant) (which is unable to produce rhamnolipid) will be cleared
rapidly from infected mice as compared to the parent wild-type.
Methods: An intraperitoneal foreign-body infection model was used for
this study were implants, pre-colonized with either P. aeruginosa wild-
type or the rhlA mutant, were inserted in the peritoneal cavity of mice.
Each group consisted of 12 mice and the experiment was performed
twice (N= 48). Three days post-surgical the implants were removed
from the mice, and the number of colony-forming units per implant
was determined.
Results: Pooled data from the two identically performed experiments
showed that almost all the rhlA mutant colonised implants were cleared,
resulting in a median CFU of 0; whereas the median CFU for the wild-
type was 280 (p< 0.0001). This result suggests that the difference in
clearance is due to P. aeruginosa wild-type elimination of the PMNs
with rhamnolipid production as the causative agent. To support this, it
was examined if rhamnolipid production is essential for P. aeruginosa
necrosis of PMNs in an in vitro bioﬁlm system. It was found that a
high fraction of PMNs became necrotic, when exposed to ﬁve days old
bioﬁlms of the wild-type P. aeruginosa. In contrast, no necrotic PMNs
were observed when exposed to bioﬁlms formed by the rhlA mutant.
Conclusion: The present data demonstrates that mutation in a single QS
controlled gene (rhlA) impairs P. aeruginosa in the battle against the
host immune defences.
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P1941 Prevalence of embB306 mutations among ethambutol-
resistant and susceptible isolates: correlation with
ethambutol and multidrug resistance
J. Perdiga˜o, R. Macedo, A. Ribeiro, L. Brum, I. Portugal (Lisbon, PT)
Objectives: Mutations occurring at codon 306 of the embB gene
have been extensively reported as the main mechanism by which
resistance to ethambutol is acquired in Mycobacterium tuberculosis
(M. tuberculosis). Nevertheless, in the last years several contradictory
reports have challenged the role of these particular mutations. The
objectives of this study were to analyse the presence of embB306
mutations in both ethambutol-susceptible and -resistant clinical isolates
and, to investigate a possible correlation between the presence of
embB306 mutations and multi or polidrug resistance.
Methods:We have characterised, by sequencing analysis, a 417bp region
of embB gene encompassing codon 306 of 115 M. tuberculosis clinical
isolates: 66 ethambutol-resistant and 49 ethambutol-susceptible. We have
also tested the minimal inhibitory concentration (MIC) for some of these
isolates. We have selected ethambutol-resistant isolates in vitro, derived
from ethambutol-susceptible H37Rv and clinical M. tuberculosis strains,
by plating in ethambutol-containing medium.
Results: We have observed that 39 (59%) of the ethambutol-resistant
isolates had mutations at codon 306. Eight of the 49 ethambutol-
susceptible isolates also had mutations at codon 306 (M306V). The MIC
for one of these isolates was shown to be less than 3.75 ug/ml. However,
in the in vitro selection for ethambutol resistance, we have obtained two
spontaneous mutants with M306V mutation.
Conclusion: We conclude that there is a high prevalence of embB306
mutations among ethambutol-resistant isolates in the Portuguese setting
and, no correlation with multi or polidrug resistance was encountered.
However, mutations in this codon were also found in susceptible isolates,
one of which had a low MIC for ethambutol. This fact is in agreement
with previous reports stating that embB306 mutations do not cause
resistance to ethambutol. Nevertheless, we have isolated two ethambutol-
selected mutants, both bearing a M306V mutation. This is the ﬁrst report
on the isolation of such mutants, which highlights the need of additional
studies on this matter.
P1942 N-acetyltranserase 2 gene mutations and bioavailability of
isoniazid in tuberculosis patients
A. Zabost, E. Augustynowicz-Kopec, S. Brzezinska, M. Kozinska,
M. Blachnio, Z. Zwolska (Warsaw, Otwock, PL)
Isoniazid (INH) is a most important drug used in the treatment of
tuberculosis. INH is metabolised by N-acetyltransferase type 2 in
the liver. The genetically polymorphic NAT2 is responsible for INH
metabolism and bioavailability to the blood. Individuals can be classiﬁed
as rapid or slow acetylators. The acetylation polymorphism is associated
with an increased risk of drug toxicity and with and increased frequency
of certain cancers. The objective of the study was associations between
NAT2 genotyping and INH concentrations in fast and slow acetylators
for personalised therapeutic dose.
Methods: Blood samples were taken from 22 patients before (time 0) and
1, 3, 6 hrs after drug administration. Plasma concentrations of INH were
determined with biological and chromatography (HPLC) method. In both
methods lowest measurable concentration was 0.2 mg /ml. This methods
guarantee high accuracy and secured repeatable results. Genotyping:
Genomic DNA was extracted by Blood DNA kit and ampliﬁed by PCR
with two primers: NAT1 and NAT2. After ampliﬁcation, the PCR product
was cut separately with 3 different restriction enzymes: Kpn1, Tag1,
and BamH1. A loss of a Kpn1 restriction site denotes NAT2*5 allele, a
Tag1 restriction site denotes NAT2*6 allele, and a BamH1 restriction site
denotes NAT2*7 allele. The products was separated on agarose gels. The
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presence of any 2 mutant alleles deﬁnes the slow-acetylator genotype,
whereas the rapid acetylators have 1 or 2 wild-type NAT2*4 alleles.
Results: Four different NAT 2 alleles were detected in the tested
population. There were 7 different NAT2 genotypes in 22 tuberculosis
patients, including *4/*4, *4/*5, *4/*6, *4/*7, *5/*5, *5/*6, *6/*6.
INH mean plasma concentration of 9 fast acetylators tested by both
methods in 1 h were 2.7 (0.5−5) mg/ml whereas of 13 slow acetylator
4.5 (2−8) mg/ml. For all treated patients concentrations of INH and
AUCtotal observed in the rapid acetylators were considerably lower then
those found in the slow acetylators p< 0.05. The type of mutations in
N-acetylotranserase gene were correlated with plasma concentration of
INH.
Conclusion: On the basis of our results we suggest the using of NAT
2 genotyping for discrimination of the fast and slow acetylators in
monitoring of tuberculosis therapy in one sample of the blood.
This work was supported by KBN nr. 2 PO5B 136 27
P1943 Expression of phagocyte Fcg receptors during
anti-tuberculous treatment
A.A. Garcia-Egido, M.A. Escobar, F.J. Gomez-Soto, F.J. Fernandez,
J.L. Puerto, C. Asencio, J.L. Andrey, P. Ruiz, M. Rosety, C. Rivera,
F. Gomez (El Puerto Santa Maria, ES)
Receptors for IgG (FcgRs) on phagocytic cells are important in host
defence against infection.
Objectives:We have studied the expression of FcgRs by peripheral blood
monocytes (M), M cultured for 72 hours (M/Mø), and granulocytes (G)
in patients with active Tuberculosis (TB), during anti-TB therapy (anti-
TB-Rx) and, after completition of anti-TB-Rx.
Methods: The expression of the three type of FcgRs, FcgRI, FcgRII
and FcgRIII, on M, M/Mø and G were analysed by ﬂow cytometry
in 149 HIV-negative patients with TB (107 men and 42 women), at
diagnosis, and monthly thereafter until completition of anti-TB-Rx.
FcgRs expression was assessed on resting M, M/Mø and G, and on
these cells after stimulation by culture with IFNg.
Results: The expression of FcgRI and FcgRIII by M, M/Mø and G
was enhanced in patients with active TB by: 42±4% and 22±2% for
M, respectively (p< 0.001), 56±6% and 41±4% for M/Mø, respectively
(p< 0.001) and, 119±9% and 37±3% for G, respectively (p< 0.001).
The expression of FcgRIIA by M, M/Mø and G was decreased by
−31±1% (p = 0.02), −46±3% (p< 0.001), and −23±1% (p = 0.002),
respectively. These alterations of FcgRs expression normalised from
the 8th week until the end of effective anti-TB-Rx. The expression of
FcgRI, FcgRIIA and FcgRIII by M, M/Mø or G from patients with
active TB was signiﬁcantly increased by culture in the presence of IFNg
(p< 0.001), returning to normal after 8 wks of anti-TB-Rx. Setting a
cut-off value =25% of the mean ﬂuorescence intensity over controls
for FcgRs surface expression and, assuming a prevalence range of
active TB between 25 and 80% among patients undergoing conﬁrmatory
tests, results in a range of sensitivity, speciﬁcity, positive and, negative
predictive values of: 57%-96%, 48%-97%, 34%-74%, and 59%-98%,
respectively for M-FcgRIIA, 48%-73%, 51%-96%, 38%-74% and 68%-
97%, respectively for M-FcgRIII, 31%-58%, 64%-93%, 37%-79% and
69%-95%, respectively for G-FcgRI and, 52%-71%, 88%-98%, 49%-
77% and 81%-93%, respectively for G-FcgRIIB.
Conclusions: Mø and G from patients with active TB exhibit an altered
expression of FcgRs that disappear after effective anti-TB-Rx. Thus, Mø
and G FcgRs expression may help in predicting the response to anti-TB
therapy.
P1944 Detection of ESAT-6-speciﬁc T-cell responses induced by
vaccination mice with the preparation KpONE6
O. Nosareva, A. Nesterov, A. Boldyrev, O. Smirnova, Y. Tumanov,
S. Tatkov (Koltsovo, RU)
Objectives: The high incidence of tuberculosis (TB) around the world
and the inability of BCG to protect certain populations clearly indicate
that an improved vaccine against TB is needed. The strategy of using the
pathogen itself has given way to creating alternate forms of antigens, new
adjuvants and new delivery systems. Our study focuses on delineation
possible role polysaccharide matrix and ESAT-6 antigen in modulation of
the host immune response. ESAT-6 from M. tuberculosis is an important
T-cell antigen for cell-mediated immunity.
Methods: To construct plasmid pONE6 the esxA gene was cloned into
the eukaryotic expression vector, pcDNA3.1mychislacZ(−) (Invitrogen,
USA). To prepare polysaccharide conjugate we modiﬁed polyglucin
with NaIO4 and subsequent mixing with spermidine. To construct the
preparation KpONE6 polysaccharide conjugate and plasmid pONE6
were mixed together. BALB/c mice were immunised on days 1, 14
and 28 with 50mg of the experimental preparation KpONE6. Cellular
responses in the spleen were characterised using ELISPOT, cytokine and
proliferation assays. Results were expressed as mean (±)SD.
Results: The preparation KpONE6 was constructed, using DNA plasmid
pONE6 and polysaccharide conjugate, to form preparation capable of
expressing ESAT-6. It has been demonstrated that the DNA plasmid
was protected by polysaccharide conjugate from action of DNase. The
experimental preparation KpONE6 was not toxic. We have assessed
humoral and cell immune responses in immunised mice. Immunisation
with construction KpONE6 no triggers the production of speciﬁc
antibodies in mice. The IFN-g ELISPOT assay was used to monitor
Tcell responses to recombinant antigen ESAT-6. We have reported
high levels of antigen-speciﬁc IFN-g secretion in mice immunised
by KpONE6. Responses to ESAT-6 were signiﬁcantly higher in the
experimental group during the 1st and 2nd immunisations compare with
control. Furthermore, we have evaluated cytokine (IFN-g and IL10)
production induced by immunisation mice with KpONE6. We have
reported high level of IFN-g and low level of IL10 after immunisation
by the preparation KpONE6.
Conclusion: So, we have demonstrated that immunisation with prepa-
ration KpONE6 induced a Th1-type immune response in immunised
animals. With further study and improvement, use of the construction
KpONE6 might be a potential vaccine strategy against TB.
P1945 Delayed growth of M. tuberculosis and M. avium in liquid
media after addition of saponin, polypropylene glycol and
sodium polyanetholesulphonate
F. Gamboa, J. Bustillo, A. Alvarado (Bogota, CO)
Objective: The ISOLATOR 10 lysis-centrifugation system (Wampole
Laboratories, Cranbury, N.J.) is a technique with excellent results in the
recovery of mycobacteria from blood specimens. This system contains
saponin (SAP), polypropylenglycol (PPG), and sodium polyanethol-
sulphonate (SPS). This study is aimed at determining the effect of
SAP, PPG and SPS onto the Mycobacterium tuberculosis (4 strains) and
Mycobacterium avium (4 strains) growth in MGIT and Septi-Chek AFB
liquid media.
Methods: SAP, PPG, and SPS were prepared at different concentrations
and 0.1ml of each was added (individually, in pairs, and all of three
mixed) to MGIT and Septi-Chek AFB liquid media. Then, liquid culture
media were individually inoculated by using two different concentrations
(1000 and 100000 CFU/ml) of each of the eight mycobacterial strains
used in this study. The media were incubated at 37ºC and its growth was
daily surveilled and monitored.
Results: Mycobacterial growth was not prevented but delayed (longer
to detect the growth with regard to positive control) by SAP, PPG, and
SPS. This is why three substances concentrations delaying mycobacteria
growth range from 14–28mg/ml, 4−8ml/l, and 10–15 g/l, respectively.
Conclusion: Mycobacterium tuberculosis and Mycobacterium avium
growth in concentrations 1000 and 100000 CFU/ml was delayed by
three substances when added alone or in mixture onto MGIT and Septi-
Chek AFB liquid culture media. These results suggest it is necessary to
propose strategies in order to reduce SAP, PPG, and SPS concentrations
which are present in sediment of blood processed by ISOLATOR 10
lysis-centrifugation system, that are ﬁnally going to be inoculated in
MGIT and Septi-Chek AFB liquid media.
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P1946 The diagnostic performance of an interferon-gamma assay
in HIV- and tuberculosis endemic population
M. Aabye, P. Ravn, G. PrayGod, K. Jeremiah, A. Mugomela, M. Jepsen,
D. Faurholt, N. Range, H. Friis, J. Changalucha, A.B. Andersen
(Copenhagen, Hvidovre, DK; Mwanza, TZ; Frederiksberg, DK; Dar
Es Salaam, TZ)
Objectives: Pulmonary tuberculosis (PTB) in HIV positive patients is
often microscopy negative and the Mycobacterium tuberculosis speciﬁc
Interferon Gamma Release Assays (IGRAs) may be useful in this
situation. The performance of IGRAs however, has not been sufﬁciently
documented in tuberculosis- and HIV-endemic settings. We conducted a
cross-sectional study in Mwanza, northern Tanzania in order to evaluate
the sensitivity of the QuantiFERON TB-Gold In-Tube (QFT-G IT) test
for diagnosing pulmonary tuberculosis disease and evaluate the degree
to which the test is affected by HIV-status and CD4 cell count.
Methods: 287 patients diagnosed with pulmonary tuberculosis were
included in the study and were subjected to control sputum microscopy
and culture, HIV- and QFT-G IT testing and measurement of CD4 cell
count.
Results: Among 193 patients with culture or microscopy positive TB,
sensitivity of the QFT-G IT was 71% (95%CI: 65–77%) and the test was
positive in a larger proportion of sputum positive than sputum negative
subjects (72% vs. 48%, p< 0.0001). Sensitivity of QFT-IT was higher
in HIV uninfected than in infected subjects (78% vs. 62%, p< 0.01).
56 out of 287 subjects (19.5%) had an indeterminate response due to
low mitogen response. The proportion of subjects with an indeterminate
QFT-G IT result was larger in those with a CD4 cell count below
compared to above 200×106/l (38.1% vs. 14.3%, p< 0.0001). No
other differences were found between patients with determinate and
indeterminate responses.
In the 157 subjects with a CD4 cell count above 200×106/l, no difference
in sensitivity was found between HIV-uninfected and -infected subjects
(76% vs. 64%, p< 0.11), and the overall sensitivity was not higher
(71% vs. 72%, p< 0.84). Conversely, the sensitivity was higher when
correcting for QFT-G IT indeterminate results (71% vs. 84%, p< 0.005).
Conclusion: The sensitivity of the QFT-G IT in this study was similar to
previous reports of sputum microscopy sensitivity. The test was affected
by low CD4 cell count however this did not explain all the indeterminate
results, nor did it affect the overall sensitivity. Other factors than the
absolute number of circulating CD4 positive lymphocytes is suggested
to inﬂuence the performance of the test.
P1947 Is interferon-gamma TB-testing in accordance with
guidelines
C.N. Meyer, A. Browatzki (Roskilde, DK)
Objectives: The purpose of this study was to outline the practical use and
clinical value of Quantiferon-TB-Gold (QFT-G) testing in the immuno-
diagnosis of M. tuberculosis infection. The main indication for the test
is diagnosing latent M. tuberculosis infection.
Methods: A retrospective study of all patients tested for M. tuberculosis
infection by the QFT-G test (Celletis International, Australia) from the
1st of January 2005 to the 31st of December 2006 in a Danish regional
hospital.
Results: The QFT-G test was performed in 91 patients. With the
intention of diagnosing active TB (n = 69), the sensitivity was 80% (8/10,
CI=0.55−1.00), speciﬁcity was 85% (50/59), PPV was 47% (8/17), and
NPV was 96% (50/52). Thus, the positive likelihood ratio (LR) was 5.3
(95%CI 2.7–10.4), and the negative LR was 0.24 (95%CI 0.07−0.8).
The doctors prescribing the QFT-G test were specialists of internal
or respiratory medicine (58%, 43/74), infectious diseases (11%, 8/74),
haematology (1%, 1/74), dermatology (3%, 2/74), or were junior doctors
(13%, 10/74). In 13% (10/74), the prescribing doctor could not be
identiﬁed.
With a suboptimal diagnostic setup, the diagnosis of lung cancer was
delayed three months in one patient with a positive QFT-G. For LTBI,
the QFT-G test’s approximated sensitivity was 33% (1/3), speciﬁcity was
93% (13/14), PPV was 50% (1/2), and the NPV was 87% (13/15), when
QFT-G test and Tuberculin Skin Tests were used with the intention of
diagnosing LTBI (n = 17) where no gold-standard exists.
Conclusion: The QFT-G test had a relatively low sensitivity and a
low accuracy in diagnosing active TB, but it was widely used for that
purpose. This was contrasting most international guidelines. As most of
the prescribing doctors were specialists, it can be assumed that a great
deal of uncertainty surrounds the indications for using this relatively new
test.
P1948 Tuberculosis in Buenos Aires: ten-month analysis at a
reference hospital
X. Gonzalo, M. Ambroggi, P. Velji, E. Co´rdoba, T. Brown, S. Poggi, S. Paz,
M. Pion, F. Drobniewski, J. Waisman (Buenos Aires, AR; London, UK)
Objectives: (1) Assess the molecular epidemiology of Mycobacterium
tuberculosis at an infectious disease reference hospital in Argentina. (2)
Investigate the prevalence of drug resistance and the underlying genetic
background for this.
Methods: 157 patients were enrolled, 57 multi drug resistant (MDR)
and 100 fully susceptible. Spoligotyping, VNTR 15 (Variable Number
Tandem Repeats), VNTR 7, SNP (Silent Nucleotide Polymorphism)
detection using macroarrays and rpoB gene sequencing were performed.
Clinical data were collected using a structured questionnaire.
Results: The 157 patients were mainly argentines that lived either in
Buenos Aires City or in Greater Buenos Aires; 33% were HIV (human
immunodeﬁciency virus) positive. 62% presented with pulmonary
tuberculosis (TB), 80% had a positive smear and 86% of the chest x-rays
were abnormal. 18 spoligo families were found. 84% of the 157 strains
were clustered in 7 families. When combined with VNTR 15 results,
32% of the strains remained clustered in 3 groups. After adding VNTR
data, 2 clusters survived with 12% and 5% of the strains respectively. The
57 MDR strains belonged to 25 HIV positive patients, 25 HIV negative
ones and 7 with unknown serologic status. They belonged to 13 spoligo
families, 75% were katG mutants whereas 9% were inh mutants. 56 out
of 57 had an rpoB mutation. The number of drugs to which bacteria
were resistant ranged from 2 to 10.
Conclusions: MDR TB at the Mun˜iz hospital was mainly represented
by 4 spoligo families, with the Haarlem 2 family signiﬁcantly related to
resistance. There was a correlation between the number of drugs to which
the strain was resistant and the number of treatments taken showing that
compliance is still a major problem in the TB patient management at
this hospital.
P1949 Role in quinolone resistance of the new DNA gyrase
mutations, T73A+A83E in GyrA and R411H in GyrB,
found in clinical MDR and XDR strains of M. tuberculosis
S. Matrat, W. Sougakoff, V. Jarlier, E. Cambau, A. Aubry (Paris, FR)
Objectives: Rapid detection of ﬂuoroquinolone (FQ) resistance in
multidrug-resistance tuberculosis (MDR-TB) is crucial since ultraresis-
tant TB (XDR-TB, deﬁned as resistant to rifamipicin, isoniazid, FQ,
aminosides) is emerging as warned by WHO. Indeed, XDR-TB, which
represents 10% of the MDR-TB, are nearly untreatable. Molecular
detection of mutations in the DNA gyrase (sole target of FQ in
M. tuberculosis) could allow the rapid detection of resistance to FQ
in M. tuberculosis. However, all new mutations found in clinical strains
should be evaluated for their implication in FQ resistance. In this work,
we investigated the role of two new mutations (T73A+A83E in GyrA
and R411H in GyrB) found in DNA gyrases of MDR and XDR clinical
strains in resistance to FQ in M. tuberculosis.
Methods: Four mutant genes, reproducing the mutations (T73A+A83E
in GyrA and R411H in GyrB) found in clinical strains, as well as
the two single mutations (T73A or A83E), were produced by site-
directed mutagenesis of the wild type gyrA or gyrB genes previously
cloned in pET vectors. WT and mutant GyrA and GyrB subunits were
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overexpressed in E. coli, puriﬁed and used to reconstitute highly active
gyrase complex. Enzyme inhibition (concentration of drug required to
inhibit the supercoiling activity of the enzyme by 50% = IC50) were
determined for moxiﬂoxacin, gatiﬂoxacin, oﬂoxacin and garenoxacin.
Results: IC50s of FQ were identical for the WT enzyme and the
mutant gyrase carrying the GyrB R411H substitution, demonstrating
that this mutation is not implicated per se in FQ resistance. Interestingly,
gyrase complexes bearing GyrA T73A were hypersusceptible to FQ as
previously shown (IC50s at least 2 fold lower than the WT IC50s),
whereas those bearing GyrA A83E were highly resistant to FQ (IC50s
15 to 25 fold higher than the WT IC50s), an effect that was attenuated
for enzymes bearing both mutations (IC50s 3 to 4 fold higher than the
WT IC50s).
Conclusion: We demonstrated unequivocally (a) the implication of the
single mutation A83E and the double mutation T73A+A83E in GyrA
in resistance to FQ in M. tuberculosis., and (b) the non implication of
the mutation R411H in GyrB in FQ resistance in M. tuberculosis. These
results underlies (a) the importance of demonstrating the role of each
new DNA gyrase mutation in FQ resistance, and (b) the occurrence
of mutations leading to hypersusceptibility and attenuating the level of
resistance of associated mutations.
P1950 In vitro selected mutants of M. tuberculosis do not reﬂect
the in vivo mechanism of isoniazid resistance
I. Bergval, A. Schuitema, P. Klatser, R. Anthony (Amsterdam, NL)
Background: Multidrug-resistant tuberculosis (MDR-TB) is by def-
inition resistant to at least isoniazid (INH) and rifampicin (RIF),
the two most commonly used drugs against M. tuberculosis (MTB).
Monoresistance to INH is much more common in clinical isolates than
monoresistance to RIF. In addition, the in vitro rate of INH resistance
is typically hundreds of times higher than the rate for RIF resistance. It
is generally assumed that the high in vitro mutation frequencies explain
the high prevalence of INH resistance in vivo.
We studied the in vitro mechanisms of INH resistance, in part to
determine the preferred genetic routes to MDR under various conditions.
Here we discuss our ﬁndings on INH resistance mechanisms in vitro.
Methods: We determined the frequencies and rates of spontaneous
mutations conferring INH resistance under various conditions, using
well-characterised MTB laboratory strains. Mutation frequencies were
determined by counting the proportion of resistant mutants on solid
medium and mutation rates were determined by Luria and Delbru¨ck
ﬂuctuation assays (po-method). For each experiment and condition INH-
resistant mutants were picked randomly and characterised by PCR,
sequencing or MLPA.
Results: We found that the INH resistance rates and frequencies were
approximately two logs higher (10−6) than those previously measured
for RIF resistance (10−8). However, the katG gene was partially or
completely deleted in the majority (30–90%, depending on the strain and
condition) of the INH-resistant mutants. In contrast, INH-resistance in
vivo is almost always due to point mutations in katG-315 or inhA(−15).
Attempts to select against katG deletion mutants, in favour of clinically
relevant INH-resistant mutants, by selecting under oxidative conditions,
were unsuccessful.
Conclusion: The high prevalence of INH-resistance in vivo has been
attributed to the high rate of mutations conferring resistance to this drug
in vitro. Based on our results and the scarce literature available, we
feel that this is at best a simpliﬁcation as the majority of the in vitro
mutations are rarely seen in clinical isolates. Moreover, KatG is the
only active defence against oxidative assault in MTB, but the prevalence
of katG deletion mutants was not signiﬁcantly reduced under oxidative
conditions.
These results indicate that additional research into the emergence of INH
resistance is needed and that assumptions based on the observed INH
resistance rates in vitro may be unwarranted.
P1951 Diagnosis of Mycobacterium tuberculosis from
extrapulmonary specimens with real-time PCR
E. Fernandes, A. Garcia, P. Cristova˜o, L. Reis, L. Brum (Lisbon, PT)
Objectives: Tuberculosis remains a public health problem in Portugal.
Rapid detection of Mycobacterium tuberculosis plays a key role in
control of infection. Rapid diagnosis of extrapulmonary tuberculosis has
a greater impact on patients management than on limiting spread of the
disease.
Our objective was to evaluate the routine use of Real Time PCR for
recovery of M. tuberculosis from extrapulmonary specimens and to
compare the results with culture.
Methods: A total of 193 (82 LCR and 111 other extrapulmonary
specimens) were tested using artus M. tuberculosis RG PCR Kit. This
method consists of a system for detection of DNA of all members
of the M. tuberculosis complex, that ampliﬁed a speciﬁc 159 bp
region of mycobacterial genome. The ampliﬁed products were detected
by ﬂuorescent dyes. The same specimens were inoculated in the
solid medium Lowenstein Jensen (LJ) and in the liquid media MGIT
(Mycobacteria Grwth Indicator Tube).
Results: Of the 193 specimens 15 (7.8%) were positive on Real Time
PCR, being 12 LCR and 3 other extrapulmonary specimens. All LCR
samples were negative on culture. The PCR positive extrapulmonary
samples (synovial ﬂuid, knee biopsy and purulent ﬂuid) were also
positive on cultures in both systems LJ and MGIT.
All positive PCR results were conﬁrmed by clinical diagnosis.
Conclusion: Real Time PCR is a sensitive and speciﬁc method which
permits a rapid diagnosis of tuberculosis in particular cases of paucity
bacillary specimens. The application of the technique to extrapulmonary
samples, although not recommended by manufactures is an important
ﬁeld. In this work we demonstrate the useful application of a real time
PCR kit to extrapulmonary samples, particullary to LCR with a very
good sensitivity.
P1952 QuantiFERON®-TB Gold test in homeless shelter staff:
preliminary results
S. Di Renzi, A. Martini, N. Vonesch, L. Rubino, W. D’Amico, F. Tomei,
P. Tomao (Rome, IT)
Objectives: Healthcare workers are particularly at risk of contracting
and/or transmitting tuberculosis (TB), since the spread of the mycobac-
terium often occurs before the diagnosis of the infection. In healthcare
settings, policies and procedures for TB control should be developed,
including health surveillance. Recently, the introduction of new in vitro
serological tests, as the Quantiferon ®TB-Gold in tube (QFT-TB), could
overcome problems associated to the tuberculin skin test.
In this preliminary study 27 nuns (homeless shelter staff) were tested
with QFT-TB and were subjected to a questionnaire in order to identify
the potential risks of their work-related activities and to propose speciﬁc
prevention programmes.
Methods: The study was conducted in September 2007. A questionnaire
was administered to collect information about age, place of residence,
place of work, work-related activities, duration of employment, contacts
with M. tuberculosis, symptoms compatible with TB, previous TB
diagnosis and vaccination state with BCG. The QFT-TB test, performed
according to the manufacturer’s instructions (Cellestis, Australia), is
based on the quantiﬁcation, by ELISA, of interferon-gamma released
from sensitised lymphocytes in whole blood incubated overnight with
PPD from M. tuberculosis and control antigens.
Results: The mean age of the nuns was 45.51±11.75. Fifthteen out
of 27 samples were positive (55.5%); one plasma sample (3.70%)
was indeterminate and the remaining 11 (40.74%) were negative. The
indeterminate result was probably due to the low response of stimulated
T-cells to mitogen (<0.5IU/ml). Data from questionnaires were evaluated
for possible risk factors. Among the 14 nuns coming from countries
endemic for TB, 10 were positive to QFT-TB test. Moreover, other 4
positive subjects had only previously worked in countries endemic for
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TB. Work-related activities of nuns were classiﬁed in 4 groups: homeless
shelter staff involved in the ﬁrst assistance of the guests (62.9%), nurses
(14.8%), ofﬁce staff (11.1%) and food service staff (3.7%); the ﬁrst
group showed the highest positivity to the QFT-TB test.
Conclusion: This study showed that the high prevalence of positive tests
was associated with risk factors such as the places of residence and of
work. Moreover, work-related activities, duration of employment and
contacts with M. tuberculosis were also identiﬁed as contributing to the
increased level of exposure to mycobacterium.
P1953 Quantiferon-TB: a new test for diagnosing tuberculous
uveitis
S. Zimmermann, F. Mackensen, U. Wiehler, A. Dalpke, M. Becker
(Heidelberg, DE)
Purpose: Tuberculose skin test (PPD) has limited power for diagnosing
tuberculosis since active disease cannot be differentiated from immunity.
Therefore, we evaluated the usefulness of a whole-blood interferon-g
enzyme-linked immunosorbent assay (QuantiFERON TB-2G [QFT];
Cellestis) in obtaining a diagnosis of tuberculosis in patients with uveitis
(TB).
Methods: QFT-G is a whole blood, antigen-speciﬁc, test that utilizes
synthetic peptides representing two M. tuberculosis proteins, ESAT-6
and CFP-10. After incubation for 16 to 24 hours, the amount of
interferon-g secreted by T lymphocytes in response to these antigens is
measured. We used the test in 34 uveitis patients in which tuberculosis
was included in the differential diagnosis. These were patients with
either active granulomatous uveitis unresponsive to topical or systemic
corticosteroid therapy (n = 12), or inactive posterior uveitis with a
serpiginous/multifocal chorioiditis (MCP)-like presentation (n = 15), or
posterior uveitis with different clinical pictures (n = 6). These rates were
compared to a group of healthy hospital personnel.
Results: 15/34 patients (44%) were tested positive. Of the patients with
active inﬂammatory disease 4 were tested positive (33%). 60% (9/15) of
our patients with inactive, posterior, serpiginous like uveitis were tested
QFT-positive. Only 1 patient (17%) of the patients with posterior uveitis
of different presentation was QFT positive. The rate of QFT-positivity
in the healthy control group (n = 208) was 6%.
Conclusions: TB-uveitis seems to present in two forms: active
granulomatous disease and inactive disease with chorioretinal scarring
like serpiginous choroiditis or MCP. Admitting patients with the latter
form to QFT testing increases the post-test-probability of TB. QFT
testing seems to be a useful test in the differential diagnosis of
tuberculous uveitis.
P1954 Evaluation of QuantiFERON TB gold assay in tuberculosis
diagnosis
S. Karabela, S. Nikolaou, E. Konstantinidou, P. Ioannidis,
N. Tsagarakis, V. Spyropoulos, P. Sotiropoulou, G. Chras, P. Soukara,
K. Konstantinou, S. Kanavaki (Athens, GR)
Objective: To evaluate QuantiFERON TB Gold assay (QF), in respect
to agreement with Tuberculin Skin Test (TST), BCG vaccination,
immunosuppresion, exposure to M. tuberculosis (MTB) and active TB.
Materials and Method: QF was performed in 480 whole blood samples.
Clinical data was partially available in many instances. Sputum cultured
were 65 patients.
Results:
– In 480 cases studied, QF(+) were 159 (33.1%), QF(−) 298 (62.1%)
and indeterminated 23 (4.8%).
– TST data was available in 443 cases: TST(+) were 297 (67.1%)
(zone diameter 10mm) and TST(−) 146 (32.9%). Among TST(+)
individuals, QF(+) were 123 (41.4%), QF(−) 172 (57.9%) and
indeterminated 2 (0.7%). In TST(−), QF(+) were 28 (19.2%) QF(−)
105 (71.9%) and indeteminated 13 (8.9%) individuals.
– BCG vaccination – TST data was avaible in 161 individuals: 114
(70.8%) were TST(+) QF(−), 45 (27.9%) were TST(+) QF(+) and 2
(1.7%) were TST(−) QF(−).
– In 323 cases, there was sufﬁcient data for immunologic status: 52
were immunosuppressed and 271 immunocompetent. In immunosup-
pressed, TST(+) were 15 (28.8%) and TST(−) 37 (71.2%), while
QF(+) were 17 (32.7%), QF(−) 26 (50%) and indeterminated 9
(17.3%). In imunocompetente, indeterminate results were much lower
6/271 (2.2%).
– MTB exposure – BCG vaccination – TST data was available in 118
cases. Among them, in 48 BCG non vaccinated – MTB exposured
individuals, QF(+) was 14 (29.1%), while TST(+) 25 (52%).
– Sputum cultured – QF tested were 65: In 23 positive cultures, 20 MTB
and 3 NonTB were isolated. All MTB (+) cases were QF(+), while
none in NonTB patients.
Conclusions: 19.2% of TST(−) cases were positively diagnosed for TB
by the QF. Indeterminated results were more common in TST(−) as
well as in immunosuppressed cases. In BCG vaccinated, QF contributed
in diagnosis of 27.9% MTB infections. In immunosuppressed, QF(+)
results were 4% higher than TST(+). TST sensitivity was higher than QF
in exposured individuals. In BCG vaccinated, exposured, QF contributed
in diagnosis MTB infection by 20%. All MTB(+) cultured patients were
QF(+).
P1955 The diagnosis of tuberculous meningitis before and after
antituberculous treatment using nested PCR
S. Iacob, D. Banica, G. Ene, M. Delagramatic (Bucharest, RO)
Objectives: Due to the difﬁcult and tardy bacteriologic conﬁrmation
of tuberculous meningitis (TBM), most patients receive antituberculous
treatment in urgency, based only on clinical and cerebrospinal ﬂuid
(CSF) characteristics. The objective was to establish the efﬁciency of
PCR as a rapid method for the diagnosis of TBM, before an also after
antituberculous treatment starting.
Methods: We evaluated the nested PCR technique using primers
directed against the IS6110 gene, for the detection of Mycobacterium
tuberculosis in 91 samples of CSF, collected from 31 patients
hospitalised in the Infectious Diseases Institute Prof. Dr. Matei Bals,
Bucharest, from December 2006 to September 2007: 15 patients
with TBM and 16 patients with nontuberculous meningitis. The CSF
samples were collected at admission and on 7, 14, 21, 30 days after
antituberculous treatment starting. Clinical, epidemiological dates, CSF
modiﬁcations, other tuberculous locations and the good response to
antituberculous treatment supported the TBM diagnosis. Five patients
were bacteriologically conﬁrmed.
Results: Thirteen out of 15 CSF samples were PCR positive on hospital
admission and also after 7, 14 and 21 days of treatment and 9 out
of 15 CSF samples remained PCR positive after 30 days of treatment.
Ziehl Neelsen smear was positive at admission only at one patient and
culture on Lowenstein media was positive at 5 out of 15 patients; CSF
cytology and biochemical modiﬁcations were characteristic at 13 out of
15 patients on admission and also within the following 14 days after
treatment. There were two false positive PCR results at patients with
bacterial meningitis.
Conclusion: Positive results of nested PCR using IS6110 were observed
at most TBM patients on hospital admission and also after a long period
of antituberculous treatment, compared with bacteriologic or cytochemic
analysis of CSF. PCR method could be helpful in diagnosis of TBM due
to its rapidity and sensitivity even after a long period of antituberculous
treatment starting.
P1956 Comparison of an interferon-gamma assay with tuberculin
skin test for the diagnosis of tuberculosis infection prior to
anti-tumour necrosis factor therapy
S. Casas, X. Juanola, X. Bordas, A. Andreu, R. Moure, F. Alcaide,
L. Anibarro, E.M. Cuchı´, X. Surı´s, M.R. Guerrero, M. Esteve,
G. Salvador, V. Ortiz, J. Martı´nez-Lacasa, J. Cuquet, M. Santı´n
(L’Hospitalet del Llobregat, Pontevedra, Terrassa, Granollers, ES)
Objectives: To compare the tuberculin skin test (TST) with a whole-
blood interferon-gamma (IFN-g) assay in the diagnosis of tuberculosis
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infection (TBI) in patients with inﬂammatory diseases due to star anti-
tumour necrosis factor (TNF) treatment.
Methods: A multicentre, cross-sectional study of the patients evaluated
at 4 Spanish hospitals, from October 2006 to October 2007, before
starting anti-TNF therapy. Diagnosis of TBI was based on TB exposure,
chest X-ray, two-step TST and IFN-g assay (QuantiFERON® TB Gold-
in Tube, QFT). According to the manufacturer’s instruction, QFT was
considered as positive when the TB antigen minus negative control IFN-g
production 0.35 UI/mL; an indeterminate result was deﬁned as either
a positive control IFN-g response of 0.5 UI/mL or a negative control
IFN-g level of >8 UI/mL. A positive TST was deﬁned as a 5mm
induration. Agreement between TST and QFT was assessed by the Cohen
kappa (k) index.
Results: 142 patients were screened for TBI, 51% women, with a mean
age of 49 years. 44% had rheumatoid arthritis, 20% spondyloarthropathy,
19% cutaneous psoriasis, 10% psoriatic arthritis, 6% inﬂammatory bowel
disease and 1% Behc¸et disease. 69% were under immunosuppressive
treatment, mainly corticoids (39%) and methotrexate (38%). 23% were
BCG vaccinated, 4% had a previous story of TBI and 6% had an
abnormal X-ray. 33% of patients had a positive TST compared with
23% positive QFT (p< 0.01). Patients with some TB risk factor had
55% positive TST (p = 0.03) but only 32% positive QFT (p = 0.33).
Overall agreement between the two tests was 81% (113/139), (k=0.54,
95%CI 0.38−0.7). Agreement was lower in patients with positive result
by one of two tests (50%, p = 0.04). Agreement between the two tests
was not inﬂuenced by BCG status (72% versus 83%, p = 0.16) neither by
immunosuppressive treatment (81% versus 79%; p = 0.7). There were 3
(2%) indeterminate QFT results due to low IFN-g production in positive
control.
Conclusions: Overall agreement between TST and QFT was fair, but
among those patients with positive result by either of two tests was low.
These results question the use of QFT as the only diagnostic test for
TBI in this population. The rate of indeterminate results was low.
P1957 Comparison of Two Acid-Fast Microscopy Methods for the
Detection of Acid-Fast Bacilli in Sputum Specimen
V. Avkan-Oguz, N. Sezak, A. Oztop, N. Yapar, S. Surucuoglu, A. Yuce
(Izmir, TR)
Background: The early diagnosis of tuberculosis still depends on the
presence of Acid-Fast Bacilli (AFB) in stained smears. For this reason
different AFB staining methods are used. In this study we aimed to
investigate the efﬁciencies of a two different ﬂuorochrome stains, and
the costs of commercial and in-house prepared stains.
Methods: This study was conducted in a three-month period in
2005. Sputum specimens were obtained from Kahramanlar Region
Tuberculosis Laboratory (Izmir/Turkey) where 3420 specimens were
accepted for routine AFB detection in the study period. We have chosen
1013 specimens from 642 patients by random sampling. Laboratory
procedures were performed as double blinded and prospectively. Three
smears were prepared each sputum specimens. Slides were stained
with commercial Auramine kit, Auramine/Acridine orange (ST 022,
Salubris), in-house prepared ﬂuorochrome stain, Auramine-Rhodamine/
KMnO4, and Ehrlich-Ziehl-Neelsen (EZN) methods. All specimens were
cultured on Lo¨wenstein-Jensen medium. All of the slides identiﬁed as
positive by ﬂuorochrome stains were restained with EZN. Speciﬁcities,
sensitivities, negative and positive predictive values of methods were
calculated according to the culture results and cost of ﬂuorochrome
staining methods were compared.
Results: Among 1013 specimens, 101 were culture positive. Among
these, AFB was detected in 60 specimens by EZN, in 53 specimens
by commercial Auramine kit, in 81 specimens by in-house prepared
ﬂuorochrome method. Speciﬁcities, sensitivities, negative and positive
predictive values of methods according to the culture results are shown
in table. In cost analyses the cost was found 15, 3 euro/100 slides
for commercial Auramine kit, and 17, 8 euro/100 slides for in-house
prepared ﬂuorochrome method.
Staining method Culture results Sens. Spec. PPV NPV
Positive Negative Total (%) (%) (%) (%)
In-house prepared Auramine-rhodamine/KMnO4 80.1 83.8 35.5 97.4
Positive 81 147 228
Negative 20 765 785
Total 101 912 1013
Commercial Auramine/acridine orange 52.4 94.6 42.7 94.6
Positive 53 71 124
Negative 48 841 889
Total 101 912 1013
Conclusion: The commercial Auramine kit was easy and inexpensive
but the sensitivity of Auramine/Acridine orange was lower compared
to Auramine-Rhodamine/ KMnO4. The sensitivity of in-house prepared
Auramine-Rhodamine/KMnO4 method was higher, but it required longer
preparation time, more workload and had more risk for carcinogen
exposure. The speciﬁcity and positive predictive value of Commercial
Auramine/Acridine orange was higher than in-house prepared Auramine-
Rhodamine/KMnO4. In order to increase sensitivity when using the
commercial kit, it may be recommended that KMnO4 should be preferred
instead of acridine orange as the counter stain.
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P1958 Multiplex PCR for speciﬁc detection of meticillin-resistant
staphylococci in a group of patients with infective
endocarditis
B. Zaloudikova, E. Nemcova, M. Machacova, J. Pol, Z. Sorm, K. Novotna´,
P. Nemec, T. Freiberger (Brno, Prague, Hradec Kralove, CZ)
Objectives: Rapid detection of causative pathogen is crucial for
successful antibiotic treatment in patients with infective endocarditis
(IE). Staphylococci are among the most common aetiological agents
in heart valve infections and their resistance to meticillin has become
more frequent in last years. However, cultivation (including antibiotic
resistance testing) takes several days or remains negative due to
prolonged antimicrobial treatment.
The aim of this study was to i) characterize the patients with
staphylococcal IE in details, ii) develop an efﬁcient molecular
identiﬁcation procedure speciﬁc for staphylococci, and iii) determine
meticillin resistance in detected staphylococcal strains.
Methods: Since April 2004 to October 2007 one hundred and eighty four
valve samples from patients with suspected IE were collected. Broad-
range PCR (br-PCR) followed by direct sequencing were used to detect
and identify DNA of responsible pathogens. Out of the positive PCR
samples, 51 (42.3%) were identiﬁed as staphylococci.
In this study, speciﬁc PCR was designed for three target genes with
different length of PCR fragments: i) part of the 16SrRNA gene speciﬁc
for all staphylococci, ii) the femB gene encoding enzyme speciﬁc
for Staphylococcus aureus, and iii) the mecA gene for detection of
meticillin-resistance.
Results: Of the 51 patients included into the study 28 were classiﬁed
as deﬁnite IE (55%), 15 as possible IE (29%) and 8 cases did not fulﬁl
the Duke criteria (16%). Six patients were drug addicts with S. aureus
being the only causative agent found. Prosthetic valves were present in
35 cases (69%).
DNA samples of 45 staphylococcal strains characterised earlier by br-
PCR and sequencing were available for multiplex PCR testing. The
setting included 31 S. aureus, 13 S. epidermidis and 1 coagulase negative
(CN) strain not identiﬁed to the species level. Six samples were excluded
for bad DNA quality. The results of multiplex PCR were available within
six hours and correlated fully with br-PCR and sequencing. Eleven CN
staphylococci but no S. aureus showed presence of meticillin-resistance
gene.
Conclusion: We developed a fast, sensitive and speciﬁc multiplex PCR
system for simultaneous identiﬁcation of S. aureus, CN staphylococci
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and the mecA gene. We evaluated this technique on heart valve
samples in patients with IE. Twenty-four percent (n = 11) of detected
staphylococci in valves were meticillin resistant, all of them were
coagulase negative.
P1959 Discrepancy analysis of conventional culture and PCR for
screening of meticillin-resistant Staphylococcus aureus
A.T.A. Box, M.W.M. Wassenberg, A. Troelstra, J.A.J.W. Kluytmans,
M.J.M. Bonten on behalf of the Dutch Rapid MRSA Diagnostics
Study Group
Objectives: To evaluate discrepancies between MRSA-PCR and
conventional cultures which occurred in a prospective multi-centre study
on cost-efﬁcacy of adding PCR to the currently used search and destroy
policy in the Netherlands.
Methods: The study was performed from 12/05 to 06/07 in 12 hospitals.
In all patients screened for MRSA upon admission swabs were taken
for PCR (BD GeneOhm MRSA PCR) and conventional culturing
including selective enrichment broth (SEB). Cultures were regarded
golden standard. In case of discrepancies, swabs were taken for repeated
PCR and for selective culturing of MSSA. PCR-lysates and culture-
broths were stored for analysis at the end of the study.
Results: From 902 patients, 4 patients (0.4%) had false negative (FN)
PCRs. Bacterial load of MRSA presumably was below PCR-detection
limit in samples of 2 patients, as MRSA was identiﬁed after subculturing
of the SEB only. In 2 patients the assay failed to detect pig-related ST398
MRSA, known for its variability in the SCCmec sequence not always
allowing ampliﬁcation with the panel of primers. Thirtyﬁve patients
(3.9%) had FP results: 6 patient samples revealed MSSA (SCCmec-
orfX positive; mecA negative); in 3 other patients this was suspected
based on characteristics of the PCR-curves; 1 patient was MRSA-positive
with an initial bacterial load below the detection limit of culture; in 7
patients FPs were due to PCR contamination, in 3 patients contamination
was suspected. The reason for false-positivity remained unknow for 15
patients (43%).
Conclusion: In daily practice, routine screening for MRSA with PCR
as compared to conventional culturing with SEB, had a FP rate of 3.9%
and a FN rate of 0.4%. FPs mainly resulted from MSSA containing
a residual SCCmec right-extremity fragment (26%) and contamination
(29%).
P1960 External quality control of the GeneXpert® system for
identifying meticillin-resistant Staphylococcus aureus
A.T.A. Box, M.W.M. Wassenberg, A. Troelstra, J.A.J.W. Kluytmans,
M.J.M. Bonten on behalf of the Dutch Rapid MRSA Diagnostics
Study Group
Objectives: To assess the quality of MRSA testing using the Xpert
MRSA assay on the GeneXpert® system (Cepheid) in 9 Dutch hospitals.
Methods: In a prospective multi-centre study, which started 04/07 and
will last till 04/08, hospitalised patients with a high-risk on MRSA-
carriership are screened for MRSA using the Xpert MRSA assay. The
sequences targeted by this real-time PCR assay are within the right
extremity of the SCCmec cassette and orfX (described by Huletsky). All
participating centres performed testing of a blinded quality control panel
of 6 swabs containing 840, 160, 84, 8.4 and 0.84 CFU of MRSA-ATCC-
43300 per swab and an additional swab containing 160 CFU of MRSA
and 48000 CFU of meticillin-susceptible Staphylococcus epidermidis
(MSSE-ATCC-12228). All cycle-time (Ct) and endpoint values were
analysed.
Results: All laboratories found positive results for swabs containing 840
and 160 CFU of MRSA. Only 2 (22%) detected 84 CFU correctly; with
Ct-values of 35.2 and 35.3. Five laboratories did not detect 84 CFU of
MRSA, but found CT-values ranging from 36.2 tot 38.0; two laboratories
found no CT-values. No laboratory detected 8.4 and 0.84 CFU. All labs
were able to detect MRSA on the swab loaded with MRSA-MSSE with
mean CT-values of 33.6 that were only slightly higher than values for
the swab with MRSA only (mean 32.6).
Conclusion: All participating centres performed comparably well in the
quality control for 840 and 160 CFU of MRSA per swab. Only 2 out of of
9 of laboratories detected 84 CFU. The detection limit of the PCR in this
study was 160 CFU, which is higher than the 50 CF which is reported by
the manufacturer. Abundantly present MSSE did not inﬂuence detection
of MRSA.
P1961 Direct detection of MRSA in surveillance samples by Xpert
MRSA
H. De Beenhouwer, G. Duson, J. Frans, A. Van den Abeele,
R. Cartuyvels, G. Coppens on behalf of the Bilulu Study Group
Objectives: Evaluation in a multi-centre setting of the performance of a
rapid commercial molecular technique (Cepheid’s Xpert MRSA assay)
for the detection of MRSA in surveillance samples of high-risk patients
in comparison to standard culture technique.
Methods: High-risk patients (n = 236) were sampled from April till
June 2007 in 5 Belgian hospitals. Separate nasal, throat and perineal
swabs were collected using the Cepheid collection device (Double Copan
Swab). In addition, swabs were taken according to each speciﬁc hospital
procedure.
One part of the double Copan nose, throat and perineum swabs was
pooled and vortexed in the Elution Reagent and then transferred to
the Xpert MRSA cartridge. Molecular testing was performed on the
GeneXpert according to the manufacturer’s instructions. The system
combines extraction, real-time PCR and detection in one hour.
The other part of the double swabs was pooled, frozen and sent to 1
laboratory that performed the reference culture, using TSB with 5%
NaCl and subculture after 24 hours on a chromogenic agar plate.
The own procedure swabs (nose, throat and perineum) were cultured in-
house, also using selective enrichment and chromogenic agar according
to local procedures.
Results: 27 Samples (11.4%) showed inhibition on the GeneXpert and
were not included in the analysis.
The Xpert MRSA assay identiﬁed 97.4% of the specimens positive
for MRSA and 86.5% of the specimens negative for MRSA. For the
samples tested, the Positive Predictive Value was 62.3% and the Negative
Predictive Value was 99.3%.
The PPV of the GeneXpert results versus the Reference culture and
versus the In-house culture method differed signiﬁcantly (62.3% versus
80.3%). Freezing and thawing might have been injurious to the viability
of MRSA. For almost all hospitals, the PPV decreased signiﬁcantly when
performed with the Reference Culture method.
Ref. culture + Ref. culture − Total (N = 236)
GeneXpert + 38 23 61
GeneXpert − 1 147 148
Total 39 170 209
Invalids 1 26 27
Conclusion: The Cepheid’s Xpert MRSA assay proves to be an efﬁcient
test to rule out MRSA (NPV=99.3%). The test provides rapid results
(about one hour) which might be helpful in prevention and control of
MRSA in hospitals. However, because of a high rate of ‘invalids’ and a
low PPV, a culture method is still needed to conﬁrm a positive result.
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P1962 Cost-efﬁcacy of rapid diagnostic testing of meticillin-
resistant Staphylococcus aureus in a low-endemic setting
M.W.M. Wassenberg, A.T.A. Box, A. Troelstra, J.A.J.W. Kluytmans,
M.J.M. Bonten on behalf of the Dutch Rapid MRSA Diagnostics
Study Group
Objectives: Pre-emptive isolation of high-risk patients is a cornerstone
of the Dutch search and destroy strategy to control MRSA. However,
many high-risk patients are not colonised and remain in isolation for
3 to 5 days awaiting conventional culture results. We determined cost-
efﬁcacy of addition of rapid diagnostic testing (BD GeneOhm MRSA
PCR) to the current prevention policy in a prospective multi-centre study.
Methods: All patients with increased risk of MRSA colonisation
and fulﬁlling the criteria for pre-emptive isolation in 12 participating
hospitals between 12/05 and 06/07 were eligible. In addition to the
standard set of conventional microbiological cultures, MRSA-PCR was
performed directly on patient material. Infection prevention measures
were based upon immediate PCR-results, and, thus withdrawn when
negative.
Results: 902 patients were enrolled. Mean age was 47 year and 55%
were male. Reasons for MRSA screening were hospitalisation abroad
(74%), contact screening related to MRSA-positive index patients (15%)
and contact with pigs (7%). 3406 PCRs were performed (3.8 per patient
including nose, throat, perineum). The MRSA prevalence was 3.0%.
Compared to culture sensitivity, speciﬁcity, positive predictive value
and negative predictive value of the MRSA-PCR were 85.2%, 96.0%,
39.7%, and 99.5%, respectively. In 83% (747/902) of patients isolation
was discontinued upon negative PCR-results (4 patients had a false-
negative result without any clinical consequences). Times from pre-
emptive isolation to notiﬁcation of PCR and culture results were 21
hours and 97 hours respectively. 26% (193/747) of the patients with
negative PCR were already discharged before conventional results were
available. Therefore, 1935 isolation days were saved. Costs of the PCR
were estimated € 52,− per test; therefore costs per isolation day saved
were € 88,−.
Conclusion: In a low-endemicity setting, guiding of pre-emptive
isolation upon MRSA-PCR results is safe and associated with a reduction
in isolation time from four to less than one day at the costs of € 88,−
per isolation day saved.
P1963 Ultra fast protocol for direct detection of MRSA from swabs
U. Eigner, A. Fahr, M. Weizenegger (Heidelberg, DE)
Objectives: We modiﬁed and validated the protocol of the
GenoQuick®MRSA direct version 2 beta (Hain Lifescience, Nehren,
Germany) by introduction of a high speed Taq-Polymerase (Speed-
STAR™ HS-DNA-Polymerase (TaKaRa, Otsu, Japan). The GenoQuick®
MRSA assay is a PCR based assay targeting the staphylococcal cassette
(SCCmec). For the detection of the MRSA speciﬁc amplicon and the
“ampliﬁcation control” (AC) a lateral ﬂow dipstick is used.
Methods: For nucleic acid based identiﬁcation of MRSA from swabs
the prelaunched GenoQuick MRSA version 2 beta was used. The assay
includes a lysis mix for isolation of the staphylococcal DNA, a PCR
based ampliﬁcation mix and a dipstick for detection. 329 DNA isolates
from swabs sent for routine diagnostic were investigated. DNA-isolates
(frozen at −70ºC for several weeks) were taken from a previous study.
The results were compared to routine testing including a chromogenic
agar (CHROMagar MRSA, Becton Dickinson, Heidelberg, Germany)
and a trypticase/soy broth. Cultured MRSA strains were conﬁrmed with
the GenoType MRSA (Hain Lifescience) test.
The PCR protocol recommended by the manufacturer was shortened to
15 min, 95ºC, 40 cycles of 5 sec 95ºC, 10 sec 55ºC, 10 sec 72ºC and for
ﬁnal denaturation 1 cycle of 2 min 95ºC and 5 min 20ºC. Samples run on
a PE 2720 thermo cycler (Applied Biosystems, Darmstadt, Germany).
Results: 48 isolates had a congruent positive result and 277 a congruent
negative result (sensitivity 96.1%, speciﬁcity 99.3%, positive predictive
value 96.1% and negative predictive value 99.3%. Two samples of culture
positive MRSA were missed. Two specimens had a false positive result
with the GenoQuick assay. These two false positives were identiﬁed as
meticillin (oxacillin) susceptible Staphylococcus aureus (MSSA) bearing
a SCCmec missing the mecA gene. Six culture negative samples resulted
weak positive with the PCR-test. All converted negative when repeated.
Conclusions: The modiﬁed GenoQuick®MRSA assay adapted to the
SpeedSTARTMHS-DNA-Polymerase shortens the time to result for the
detection of MRSA from swabs from 2.5 to 1.5 hours. Together with
the quick DNA-isolation procedure and an efﬁcient manual hands on
time this assay represents a very time optimised tool for direct detection
of MRSA. Compared to the manufacturer’s protocol no decline of the
sensitivity and speciﬁcity values were observed.
P1964 Rapid identiﬁcation of clinical bacterial isolates using the
Matrix-Assisted Laser Desorption Ionisation-Time of Flight
mass spectrometry in a clinical laboratory
U. Eigner, A. Hendel, U. Wild, F. Wild, M. Holfelder, A. Fahr
(Heidelberg, DE)
Introduction: Matrix-Assisted Laser Desorption Ionisation-Time of
Flight Mass Spectrometry (MALDI-TOF MS) produces speciﬁc mass
spectral ﬁngerprints for different micro-organisms and is used for the
identiﬁcation of clinical bacteria.
We performed an evaluation study for the implementation of a MALDI-
TOF system (MALDI BioTyper 2.0, Bruker Daltonik GmbH, Bremen,
Germany) in the routine bacteriology laboratory. Therefore, the results
of the phenotypic bacterial identiﬁcation systems (VITEK2, api system
(bioMe´rieux, Nu¨rtingen, Germany) in our routine laboratory were
compared to MALDI-TOF.
Methods: For the evaluation study 541 isolates were collected in clinical
microbiology laboratory. Additionally, 112 isolates of several culture
collections (ATCC, DSMZ) were analysed. All organism were grown
overnight on the respective agar media. MALDI-TOF target plates were
inoculated by applying a small amount of colony material directly onto
the target plate in a thin ﬁlm. Furthermore, an Ethanol/ Formic acid
extraction procedure was compared to the direct method. The microbial
ﬁlm was overlaid with matrix solution and air dried. Measurement was
performed in a MALDI-TOF spectrometer of the FLEX series (microﬂex
LT, Bruker). Analysis of the generated peaks was done with the Biotyper
2.0 software (Bruker). Setup of VITEK2 was performed according to
manufacturers instructions.
Discrepant results were resolved by sequencing of a 16S rDNA fragment
Results: The accuracy of the MALDI-TOF-system in identifying clinical
bacterial isolates to species level was as follows: 94.9% for 271
Enterobacteriaceae tested, 78% for 65 nonfermenting Gram-negative
rods (Pseudomonas aeruginosa showed 100% correct results), 92% for
115 staphylococci, 100% for 31 enterococci, 100% for 21 streptococci
and 93% for 38 others. Of the 122 reference strains tested, 103 (92%)
were correctly identiﬁed to species level.
Workﬂow time with the MALDI-TOF-system was calculated, including
manual time, drying, import into the system, and time to result. The
identiﬁcation of one isolate with the direct smear method was available
in 12 min and in 20 min with the extraction method. For one target plate
(96 isolates) identiﬁcations were available in 1 h 45 min with the direct
smear and in 3 h with the extraction method.
Conclusions: The MALDI-TOF system evaluated in this study proved to
be a rapid and reliable method for the identiﬁcation of the most relevant
bacterial isolates in clinical routine laboratory.
P1965 Inﬂuence of PCR parameters on the prevalence of
Panton-Valentine leukocidin positivity in Staphylococcus
aureus isolates
Z.C. Karahan, I. Dolapci, A. Tekeli (Ankara, TR)
Objectives: Panton-Valentine leukocidin (PVL) is an important virulence
determinant of Staphylococcus aureus strains. PCR ampliﬁcation of the
genes encoding PVL is the most widely used method for determining
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PVL-positivity. In this study, we used two different primer sets and
different annealing conditions for each set to demonstrate the effect of
PCR components on PVL-PCR results.
Methods: 321 non-duplicate S. aureus strains and GRE-14 positive
control strain were included in this study. PCR ampliﬁcation of the PVL
genes were performed by (luk-PV-1 and luk-PV-2) and (PVLup and
PVLdn) primers by previously published methods. For the ﬁrst primer
pair PCR was performed at 55 ºC and 58 ºC, and for the second set of
primer at 50ºC and 48 ºC with the same thermal cycler.
Results: The ﬁrst primer pair gave 161 (50.16%) PVL-positive
amplicons at 55 ºC and 12 (7.45%) at 58 ºC. The second primer set
gave 0 (0%) and 5 (1.56%) PVL-positive amplicons at 50 ºC and
48 ºC respectively. The 161 PVL-positive amplicons were subjected
to BspH1 restriction endonuclease analysis in order to conﬁrm the
accuracy of the ampliﬁed region, and 12 (7.45%) of the 161 isolates
which were also found to be positive with the ﬁrst set of primers at
58 ºC gave the expected restriction patterns of 180, 151 and 102 bp.
Two of the 149 uncut amplicons were selected randomly and subjected
to bi-directional automated sequence analysis with the same primers
used for ampliﬁcation, and the sequence obtained was compared with
the sequences deposited to the GenBank. We found that 95% of this
sequence was 99% identical to the genes encoding some conserved
proteins of Staphylococcus aureus.
Conclusion: Our results show that primer selection and cycling
conditions may lead to false-negative or false-positive results (due to
cross-priming of the primers) in PVL-gene ampliﬁcation. Restriction
endonuclease or sequence analysis may be used to differentiate crossly-
ampliﬁed sequences from true PVL-positive amplicons.
Acknowledgements: This study was supported by the Research Fund of
Ankara University (Project No: 20050809006HPD).
P1966 Problems with real-time PCR for MRSA: why culture is
still required
S. Dancer, M. Coyne, D. Morrison, A. Speekenbrink (East Kilbride,
Glasgow, UK)
Objectives: Real-time PCR processing can detect MRSA from nasal
swabs. We describe the introduction of the IDI MRSA test into a clinical
laboratory over a six-month period, run in parallel with traditional culture
methods.
Methods: One biomedical scientist processed over 2000 nasal swabs
using the IDI MRSA test. IDI MRSA positive-culture negative (false
positive) lysates were retested using original and modiﬁed primers and
the results crosschecked against additional MRSA culture ﬁndings from
patients. IDI MRSA negative-culture positive (false negative) strains
were referred for molecular analysis. Total costs of IDI MRSA and
routine culture were calculated and compared.
Results: A valid IDI MRSA result was achieved for 75% of swabs tested.
About 50% were IDI MRSA and culture negative, 10% were IDI MRSA
and culture positive, 0.5% (nine) were IDI MRSA negative-culture
positive and 18% were IDI MRSA positive-culture negative. Some 14%
samples remained ‘unresolved’ by IDI MRSA, six of which were culture
positive. Repeat testing with modiﬁed primers in combination with
additional culture results showed that 316 of 362 (87%) ‘false positives’
were true positives. Seven of nine false negative strains contained mecA,
and thirteen of fourteen meticillin-susceptible isolates gave false positive
IDI MRSA results, depending upon which preparatory method was used.
Sensitivity and speciﬁcity of the IDI MRSA method were 93.5% and
60.3%, respectively. Positive predictive value (PPV) was only 37.3%.
We recalculated the PPV using additional microbiological data and found
that it increased to 90%, with speciﬁcity increasing to 74%. Negative
predictive value was 99.1%.
Conclusions: The IDI MRSA method was cost neutral compared with
routine culture (£14.30 vs £14.80 per test) but results were obtained
for only 75% of samples. Further and continued work is needed on
the molecular components of this assay. We discuss the reasons for
unresolved tests, invalid controls and misleading results. Culture and
isolation of MRSA still remains the ‘gold standard’ where patients are
concerned.
P1967 Molecular screening of respiratory specimens from
paediatric cystic ﬁbrosis patients to enhance detection of
Pseudomonas aeruginosa
E. McCulloch, C. Lucas, C. Williams (Glasgow, UK)
Objectives: Cystic Fibrosis (CF) is an incurable, genetically inherited
disease that affects some 1 in 3,000 individuals born in the UK. Chronic
colonisation of the lungs with Ps. aeruginosa has a severe impact on
respiratory function, which may be delayed by aggressive antibiotic
therapy following detection of initial colonisation. The risk of acquiring
Ps. aeruginosa increases with age, therefore particular emphasis is
placed on the detection of the organism in respiratory secretions in
younger patients. We have investigated whether a real time PCR method
would be more sensitive than conventional microbial culture for the
detection of Ps. aeruginosa in this setting.
Methods: In our real-time PCR assay, DNA is extracted using the
EZ1 BioRobot (Qiagen) and a tissue extraction kit, then ampliﬁed and
detected using an ABI Prism 7000 sequence detector and Taqman probes
(Applied Biosystems). Each sample is performed in duplicate using
a reaction with which ampliﬁes a speciﬁc Ps. aeruginosa gene target
allowing detection DNA of interest. The specimens were also cultured
as per our standard laboratory procedure.
Results: Of the 373 samples tested (from 145 patients) 336 were negative
by both culture and, 11 were positive by both methods but 25 (from
24 patients) were positive by PCR when culture was negative No false
positive PCR results were detected from all culture negative swabs. The
speciﬁcity of the real-time PCR method was conﬁrmed by sequencing
PCR products from positive specimens and matching to Ps. aeruginosa
by BLAST search of the NCBI database.
Conclusion: The use of real-time PCR on cough swabs allowed
a signiﬁcant improvement over routine culture in the detection of
Ps. aeruginosa. Given the beneﬁts of early institution of antimicrobial
therapy to eradicate carriage, this method has the potential to further
enhance the survival of CF sufferers.
While PCR generated clinically useful information, genetic relatedness
between strains ﬁrst detected by PCR and strains which go on to establish
colonisation, remains to be established. Whether Ps. aeruginosa can be
spread from PCR positive/culture negative patients and what the effect
earlier antibiotic treatment might be on generation of multi-resistant
strains, are currently matters of speculation.
P1968 Evaluation of the prevalence of middle ear pathogens in
the outer ear canal and nasopharyngeal cavity of a healthy
population
T. De Baere, M. Vaneechoutte, P. Deschaght, J. Huyghe, I. Dhooge
(Ghent, BE)
Objectives: Currently there are several studies investigating the role of
Alloiococcus otitidis as a potential pathogen in otitis media with effusion.
The objective of this study was to investigate the prevalence of the known
middle ear pathogens in the outer ear canal and the nasopharyngeal cavity
for a healthy population (n = 70).
Methods: For each of a group of 70 healthy students one swab
each of the outer ear canal and of the nasopharyngeal cavity was
collected. The swabs were sent to the laboratory where they were
resuspended in 250 ml physiological water. After this homogenisation
200 ml was transferred to 800 ml EasyMag extraction buffer and
DNA was extracted using the NucliSense EasyMag automated extractor.
Species-speciﬁc PCR was carried out on all samples for Alloiococcus
otitidis, Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus
inﬂuenzae and Pseudomonas aeruginosa. For a subset of 10 outer ear
samples, culture was carried out to investigate the possibility to detect
Alloiococcus otitidis by culture. Culturing was done by incubating the
samples on a blood agar plate (Tryptic Soy Agar + 5% sheep blood)
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during 5 days at 37ºC, followed by subculturing the small, mostly gamma
haemolytic colonies on Heart Infusion Agar plates (containing 5% sheep
blood).
Results: Percentage of positive PCR results for the 70 patients are
presented in Table 1.
Table 1. Species-speciﬁc PCR results
Detection Outer ear canal swabs Nasopharyngeal swabs
A. otitidis 80 3
H. inﬂuenzae 7 13
M. catarrhalis 0 34
S. pneumoniae 0 9
P. aeruginosa 14 19
For subgroup of 10 people the samples were also cultured. In this group
PCR revealed 9 out of 10 positive for A. otitidis by PCR, and we were
able to detect small colonies for 5 samples in this subgroup after long
incubation periods. We were able to identify these colonies afterwards
as A. otitidis by sequencing.
Conclusion: Alloiococcus otitidis was found to be present in 80% of the
outer ear canal of a healthy study population. Detection can be carried
out in a fast way by automated DNA-extraction on homogenised swab,
followed by species-speciﬁc PCR. Culture is possible but requires long
incubation, increasing the chance of overgrowth by other bacteria and
decreasing sensitivity, compared to PCR.
M. catarrhalis and S. pneumoniae were found to be present in the
nasopharynx with percentages of resp. 34 and 9%, but were not
found once in the outer ear. H. inﬂuenzae and P. aeruginosa could be
demonstrated to be present in both the nasopharynx and the outer ear in
percentages ranging from 7 to 19%.
P1969 Automated DNA extraction with the easyMAG prior to
molecular investigation of blood-borne bacteria and fungi
with SeptiFast
M. Alvarez, S. Carlos, A. Pen˜a, N. Chueca, M. Torres, J.A. Pe´rez-Lo´pez,
G. Piedrola, M.C. Maroto, F. Garcı´a (Granada, ES)
Objective: to evaluate the performance of an automated extraction
system for processing whole blood and sterile ﬂuid samples prior to
ampliﬁcation and detection with the SeptiFast.
Methods: Whole blood K-EDTA anticoagulated samples were spiked
with 300 and 30 UFC/ml of Staphylococcus aureus, Klebsiella
pneumoniae, Pseudomonas aeruginosa or Candida albicans. DNA was
extracted in parallel with the Nuclisens® easyMAGTM (BioMe´rieux)
and with SeptiFast Lys Kit MGRADE and SeptiFast Prep Kit MGRADE
(LightCycler® SeptiFast, Roche Diagnostics). The Nuclisens easyMAG
Speciﬁc A (“off board”) extraction protocol add 1 mL blood to the lysis
buffer (guanidine thiocyanate). Ampliﬁcation and detection were run in
parallel after both extraction methods. 40 sterile ﬂuids were tested with
the automated extraction.
Results: EasyMag DNA extraction was able to detect 300 UFC/ml in:
1/1 for Gram-positive, 2/3 for Gram-negative; 30 UFC/ml in: 1/1 for
Gram-positive, 2/4 for Gram-negative and 1/1 for Candida albicans.
SeptiFast extraction could detect 300 UFC/ml in: 1/1 for Gram-positive,
4/4 for Gram-negative, 1/3 for Candida albicans; 30 UFC/ml in: 1/1 for
Gram-positive, 1/3 for Gram-negative and 0/2 for Candida albicans. No
contamination of the negative controls with the automated system were
noted. 30% of sterile ﬂuids were positive using the easyMAG extraction
(Streptococcus spp., Escherichia coli, Stenotrophomonas maltophilia,
CoNS, Staphylococcus aureus, and Pseudomonas aeruginosa).
Conclusions: EasyMAG has proven to be a versatile, reliable and
adequate method for the extraction of bacterial and fungal DNA prior to
ampliﬁcation with the SeptiFast system, resulting in an improvement of
the workﬂow and hands on time (by two hours) of this novel molecular
method for the diagnosis of bacteria.
We would like to aknowledge Nora Mariela Martinez (Biomerieux
Espan˜a) for technical assistance.
P1970 SeptiFast for the investigation of bacterial and fungal DNA
in sterile ﬂuids
M. Alvarez, J. Parra, A. Pen˜a, S. Carlos, N. Chueca, M. Torres,
J.A. Pe´rez-Lo´pez, G. Piedrola, M.C. Maroto, F. Garcı´a (Granada, ES)
Objective: to investigate the diagnostic performance of a novel
molecular tests for the diagnosis of pathogenic bacteria and fungi
(SeptiFast, Roche Diagnostics) in sterile ﬂuids coming from joints, pleura
and peritoneum, and to compare molecular ﬁndings with conventional
culture microbiological methods.
Patients and Methods: 50 samples from 44 patients were included in
the study. Samples corresponded to synovial ﬂuid (n = 17), pleural ﬂuid
(n = 15), ascytic ﬂuid (n = 9), peritoneal ﬂuid (n = 3), and 6 samples were
bone/tissue/prosthesis samples from prosthetic joint infection. All the
samples were studied using the LightCycler® SeptiFast Test MGRADE
(Roche Diagnostics), a multiplex real time PCR that in six hours
investigates Gram-positive, Gram-negative, and species of Aspergillus
and Candida; in parallel, standard microbiological procedures run in our
laboratory were applied to all the samples.
Results: overall, 30% of the samples were positive using Septifast
and 14% using conventional culture. Bacterial DNA from Coag-
ulase Negative Staphilococci (n = 5), Staphylococcus aureus (n = 4),
Streptococcus spp. (n = 2), Streptococcus pneumoniae, Pseudomonas
aeruginosa, Stenotrophomonas maltophilia, and Escherichia coli. Two
of the Staphylococcus aureus detected with Septifast were also isolated
by convencional methods. Culture positive/Septifast negative results
were present in 5 samples (Staphylococcus aureus, Peptostreptococcus
anaerobius, Streptococcus viridans, Streptococcus agalactiae and
Streptococcus pneumoniae).
A subanalysis taking into account the type of sample investigated
revealed that 66.6% of the joint infection related samples were
positive by both methods (2 Septifast/Culture positive and 2 Septifast
negative/Culture positive), 55.5% of the ascytic ﬂuids (4 Septifast
positive/culture negative and 1 Septifast negative/culture positive), 46.6%
of the pleural ﬂuids (5 Septifast positive/culture negative and 2 Septifast
negative/culture positive). All synovial ﬂuids were culture negative, and
two (11.8%) were positive by Septifast.
Conclusion: Using Septifast, DNA from the panel of bacteria
investigated could be detected in a large number of negative culture
samples. However, the ﬁnding of samples with a positive conventional
culture result and a negative Septifast test sets the rationale, if possible,
for the use of both tests for the diagnostic microbiology of these samples.
P1971 A diagnostic algorithm for accurate identiﬁcation of
non-fermentative Gram-negative rods and epidemic strains
of Pseudomonas aeruginosa from cystic ﬁbrosis patients
S. Warwick, B. Duke, S. Soleimanian, D. Wareham (London, UK)
Objectives: Identiﬁcation of non-fermentative Gram-negative bacteria
using phenotypic tests such as biochemical proﬁling and chromogenic
agar is difﬁcult. Accurate identiﬁcation is most important in individuals
with cystic ﬁbrosis (CF) as some species e.g. P. aeruginosa are
associated with chronic respiratory infection whilst the role of others e.g.
A. xylosoxidans is less well deﬁned. Even amongst P. aeruginosa some
strains such as the Liverpool Epidemic Strain (LES) are associated with
heightened transmissibility and virulence. We developed a diagnostic
algorhithm involving speciﬁc PCR and 16S rDNA sequencing for the
accurate identiﬁcation of CF isolates
Methods: Non-fermentative Gram-negative rods were isolated from CF
sputum by standard techniques. Phenotypic identiﬁcation of oxidase
positive organisms was attempted by colonial morphology using
Pseudomonas isolation agar and API 20 NE. PCR for P. aeruginosa
speciﬁc genes (eta 396 Bp) and LES speciﬁc sequences (LES9 431
bp and PS21 400 bp) was applied to 597 consecutive isolates. Isolates
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negative by P. aeruginosa speciﬁc PCR were identiﬁed by sequence
analysis of the 16S rDNA gene.
Results: Phenotypic identiﬁcation yielded P. aeruginosa (n = 446),
Burkholderia spp. (n = 6), S. maltophilia (n = 5), A. xylosoxidans (n = 2)
and R. pickettii (n = 1). 139 isolates could only be identiﬁed as
‘non-fermenters’. 525 isolates were positive for P. aeruginosa speciﬁc
PCR. Sequence analysis of the 16S rDNA gene of the remaining
isolates yielded; A. xylosoxidans (n = 19), Burkholderia cepacia complex
(n = 10), P. aeruginosa (n = 10), P. putida (n = 9), S. maltophilia (n = 9),
Chryseobacterium spp. (n = 7) along with Agrobacterium, Bacillus
licheniformus, Bacillus simplex, Pseudomonas fulva, Proteus mirabilis,
Neisseria elongata, Enterobacteriaciae, Sphingomonas multivorum (all
n = 1). The LES strain of P. aeruginosa was identiﬁed in 76 isolates from
21 patients.
Conclusions: Phenotypic identiﬁcation of non-fermentative Gram-
negative bacteria from CF patients is extremely unreliable. A combi-
nation of P. aeruginosa speciﬁc PCR with 16S sequence analysis of
negative isolates is a useful approach for the identiﬁcation and detection
of classical and ‘emerging’ pathogens in CF.
P1972 Routine-based evaluation through a 3-year survey of the
commercial Chlamylege assay for direct identiﬁcation by
multiplex PCR of Mycoplasma pneumoniae, Chlamydophila
pneumoniae, Legionella pneumophila and Legionella spp.
in human respiratory infection
F. Grattard, H. Crehalet, A. Ros, A. Carricajo, B. Pozzetto
(Saint-Etienne, FR)
Objectives: Chlamylege is a commercial assay developed by Argene
Biosoft (Varilhes, France) for the detection and identiﬁcation of
M. pneumoniae, C. pneumoniae and Legionella spp. in respiratory
samples, by using a multiplex PCR-hybridisation method. The present
study evaluated the ability of this test to detect atypical pathogens in
samples of patients presenting a respiratory infection, received on a
routine basis in the Microbiology laboratory of a University Hospital
through a 3-year period.
Methods: A total of 2169 respiratory specimens including 1218 (56.1%)
samples from paediatric origin were tested once-a-week through a
35-month period; they consisted of nasopharyngeal aspirates, tracheal
secretions and bronchoalveolar lavages. After a preliminary treatment of
the sample by proteinase K, the Chlamylege assay was performed on
DNA samples extracted manually with silica-based columns in 2005,
with a Kingﬁsher apparatus (Thermolabsystems) in 2006, and with an
Easymag instrument (Biome´rieux) in 2007. In combination with the
latter extraction method, the result was available within two days for
runs of 20 to 25 samples.
Results: The routine use of the Chlamylege assay led to the detection
of the genome of at least one atypical respiratory pathogen in 189 of the
2169 samples (8.7%), including 162 M. pneumoniae, 18 C. pneumoniae,
10 Legionella pneumophila and 3 Legionella spp. signals, respectively.
Only 6 samples were shown to contain PCR inhibitors. All but 5
M. pneumoniae infections were diagnosed in infants and young adults.
A retrospective analysis of the medical ﬁles of patients with samples
found positive with the Chlamylege assay revealed a high prevalence
of multiple infections since M. pneumoniae was associated to a high
amount of another bacterial species in 30% of the cases and with a viral
infection in 12% of them. Interestingly, a familial outbreak involving
both M. pneumoniae and C. pneumoniae infection was documented.
Conclusion: The use on a routine basis of a sensitive molecular assay to
detect simultaneously different atypical pathogens in respiratory samples
is a convenient strategy to detect and identify rapidly fastidious-growing
bacteria and to treat efﬁciently infections due to b-lactams resistant
agents. In addition, this study underlines that the place ofM. pneumoniae
in common respiratory infections is largely underestimated when
molecular tests are not available.
P1973 Molecular diagnostic of sepsis: episodes vs. cases
B. Regueiro, E. Varela-Ledo, L. Martinez-Lamas, M. Perez del Molino,
M. Garea, J. Alvarez (Santiago de Compostela, ES)
Objectives: To evaluate the interpretation of the data obtained after
utilising a multiplex PCR assay that identiﬁes relevant microorganisms
in septic patients. Data analysis of episodes (samples taken at same time)
vs. cases (serial samples in same patient) were compared.
Methods: Sensitivity, sensibility, positive and negative predictive values
were determined in a group of 53 patients from our post surgical/ high-
complexity ICU with systemic inﬂammatory response syndrome (SIRS)
and high clinical risk factors for bloodstream infection. Agreement was
measured by kappa test.
Conﬁrmation by microbiological identiﬁcation of a pathogen in culture
of blood or other locations (conventional microbiology), was used as a
standard for determining if patients were infected or non-infected. The
evaluation was retrospective and observational. In all cases the patients
were covered by aggressive empiric therapy and gave their informed
consent.
PCR results were obtained using multiplex Septifast test (ROCHE),
blood cultures were done with BactAlert and conventional identiﬁcation
was performed with VITEK2 (Biomerieux).
Results: 366 Septifast determinations were obtained for the 53
patients included in the study. We paired blood cultures and Septifast
determinations in 294 episodes, conventional microbiology and Septifast
in 302 episodes, and conventional microbiology plus blood culture vs.
Septifast in 294 episodes. All 53 patients were serially analysed on
days 0, 1, 2, 3, 7, 14 and 28 after ICU admittance the results were
analysed using Septifast as a standard for determining disease or non-
disease status. These results were then matched to see if coincidence
existed with the results from blood and peripheral compartments
obtained consecutively over the time span of a week using conventional
phenotypic methods. Results are in Figure 1.
Figure 1.
Conclusion: Septifast test detects the special condition of DNAhemia.
This condition is independent of the viability needed for microbial
growth in cultures. The sensitivity (75%) and speciﬁcity (86.66%),
positive (81.81%) and negative (81.25%) predictive values and kappa
(0.621) all indicate that the molecular test results are substantially
(0.81) related to patient infection by microorganisms (located in blood
or other compartments). As these patients tend to be refractory to
conventional bacteriological diagnostic approaches, molecular methods
may eventually prove to be a valuable criteria for early adequate
antimicrobial treatment.
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P1974 Multiplex PCR for the detection of bacterial infections in
human faeces
A.S. de Jong, G.K. Harbers, J.M. Bakkers, W.G.V. Quint, L.J. van
Doorn, W.J.G. Melchers (Nijmegen, Voorburg, NL)
Objectives: Diarrhoeal diseases are responsible for thousands of
paediatric deaths per day in developing regions, and the associated
co-morbidity impacts on childhood development, nutritional status and
cognitive function. The aim of this project is to develop molecular
diagnostic tools for multiple enteric pathogens in order to (1) improve
disease surveillance and (2) gain more insight in the possible contribution
of Helicobacter pylori in the epidemiology of diarrhoeal diseases in
developing countries.
Methods: We developed multiplex real-time (rt-)PCR assays for detec-
tion of H. pylori, Salmonella spp., Shigella spp., and Campylobacter
jejuni. Speciﬁcity of the primers was investigated by testing these
on a large panel of bacterial samples. Sensitivity was determined by
performing rt-PCR reactions on dilution series of the speciﬁc bacteria,
both in medium and in spiked human faeces. We isolated bacterial
targets from spiked human faecal samples using four isolation methods;
(1) MagNA-Pure LC isolation after pre-treatment with S.T.A.R. buffer
(Roche), (2) EZ1 biorobot isolation using the EZ1 DNA Tissue Kit
(Qiagen), (3) QiaCube isolation using the QiaAmp DNA Stool Mini Kit
(Qiagen) or (4) manual isolation using the QiaAmp DNA Stool Mini
Kit. Clinical validation on stool samples is ongoing.
Results: All primer sets are highly speciﬁc and did not yield
ampliﬁcation products for any of the bacteria other than the speciﬁc
targets, using up to 106 CFU/PCR reaction as input material. Primer sets
allowed ampliﬁcation of 1 CFU/PCR reaction of a bacterial solution in
medium. Ampliﬁcation of targets isolated from spiked faecal samples
showed that a bacterial concentration of 13−14 CFU/ml faeces was the
lowest detectable, depending on the target and the isolation method. This
corresponds to 1–10 CFU input per PCR reaction. Isolation using the
Qiagen EZ1 biorobot system proved to be the method of choice for
isolation of bacterial targets from faeces, yielding higher sensitivities
and showing less PCR inhibition than the other methods tested.
Conclusion: We have developed a multiplex rt-PCR assay for the
detection of H. pylori, Salmonella spp., Shigella spp., and C. jejuni. in
faecal samples that, combined with the Qiagen EZ1 biorobot isolation
system, allows detection of 13−14 CFU bacteria per ml faeces.
P1975 Comprehensive study comparing a PCR based monitoring
method, solid phase cytometry and standard routine meth-
ods from an artiﬁcially controlled water sample of Legionella
pneumophila Paris strain: the importance of detecting VBNC
E. Dusserre, C. Ginevra, S. Hallier-Soulier, F. Vandenesch, G. Festoc,
J. Etienne, S. Jarraud, M. Molmeret (Lyon, Bruz, FR)
Objectives: Legionella pneumophila is the causative agent of Legion-
naires’ disease. It is an ubiquitous bacterium of aqueous environments,
which requires amoebas as an intracellular replicative niche. Real-
time PCR based methods have been developped for rapid detection of
Legionella DNA in water samples. L. pneumophila have been reported to
enter a viable but non cultivable (VBNC) state, which can be detected by
PCR. In addition of VBNC and cultivable L. pneumophila, PCR could
also detect the presence of dead bacteria.
Methods: In order to understand the signiﬁcance of a positive PCR
result, controlled artiﬁcially contaminated water samples with and
without chlorination treatment were enumerated for L. pneumophila
by conventional growth methods, real time PCR, viability labeling and
immuno-detection assay using solid phase cytometry.
Results: Here, we show that while a clear correlation was observed
between theses techniques for the detection of L. pneumophila in
non-treated water, important discrepancies were seen for treated-water
samples. After 24 h with 0.5 and 1 ppm of chlorine treatment,
the culture was negative, whereas concentrations given by PCR and
immunodetection were still about 106 UG/mL, and the metabolically
active bacteria measured by TVC detected 105 and 102bacteria/mL,
respectiveley. Thus, positive PCR signal includes the presence of bacteria
that were viable (with a positive viability signal) and not cultivable
(no growth on plate), that is VBNC. To conﬁrm this result, VBNC of
L. pneumophila Paris strain, which have been obtained using 0.5 ppm of
chlorine for 24 h and were detected by PCR and immunodetection but
not on plates, recovered their culturability after 5 days of co-culture with
A. polyphaga. Therefore, some of the TVC positive bacteria remained
infective.
Conclusions: Taken together, these data show that a PCR positive signal
includes VBNC and dead bacteria in addition of cuturable bacteria. PCR
represent a very quick, cost effective and reliable tool to detect bacteria
in treated waters that can be potentially associated with a health risk.
P1976 16S rDNA sequence analysis can help in revealing the
aetiologic agent of culture-negative infective endocarditis
A. Fraeyman, A. Van Keerberghen, A. Boel, K. Van Vaerenbergh, H. De
Beenhouwer (Aalst, BE)
Objectives: The diagnosis of infective endocarditis (IE) is based upon
initial clinical suspicion, microbiological data and echocardiographic
ﬁndings. Despite the use of appropriate laboratory techniques, classic
microbiological diagnostics (blood cultures or serology) do not always
provide an aetiological diagnosis. In order to increase the aetiological
diagnosis of IE, the use of PCR followed by sequence analysis (PCR-
SEQ) was assessed.
Methods: From June 2006 to November 2007, 36 IE cases were reported
to the clinical laboratory, according to the Duke criteria (35 cases
deﬁnite, 1 case possible). From all patients at least 2 sets of blood
cultures (BC) were available. From 24 patients surgical samples [heart
valves (HV n= 20) and pacemaker leads (PM, n = 4)] were received.
When no aetiologic agent was identiﬁed, samples were analysed by
nested PCR with primers on 16S-rDNA followed by sequencing and
BLAST-analysis.
Results: In 29 of the 35 deﬁnite IE cases, an aetiologic agent was
proved by positive BC. From 17 of this 29 cases, surgical samples were
received and 7 were culture positive. In the 10 other samples, which
remained culture negative, PCR-SEQ (performed on 8 samples) revealed
an aetiological agent in 8 samples. Germ identiﬁcation with PCR-SEQ
was in all cases identical with the culture results.
In 6 cases all cultures (BC and cultures of the 5 HV and 1 PM lead)
remained negative. However, in 3 out of 6 an unambiguous sequence was
found by PCR-SEQ pointing to the causative infective agent. Results are
shown in ﬁg 1.
PCR-SEQ demonstrated the presence of streptococci (n = 6), including
enterococci, Propionibacterium acnes (n = 1), staphylococci (n = 2),
Listeria monocytogenes (n = 1), Neisseria elongata (n = 1) and Car-
diobacterium hominis (n = 1). In the 3 patients from whom all cultures
remained negative but PCR-SEQ was positive, a history of previous
antibiotic treatment was available.
Conclusion: The application of molecular diagnostics is useful in
patients with IE in whom no causative agent can be found. Cultures
are often negative because of the administration of antibiotics prior to
sample collection. In all tested BC positive cases, PCR-SEQ conﬁrmed
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the aetiologic agent. In 3 out of 6 culture negative cases, PCR-SEQ could
reveal the aetiologic agent.
P1977 Evaluation of a modiﬁed octaplex PCR assay for the
detection of major diarrhoeagenic Escherichia coli
J. Engberg, K. Schønning, F. Scheutz, A. Friis-Møller (Hvidovre,
Copenhagen, DK)
Objectives: To evaluate a modiﬁed PCR assay for identiﬁcation
of diarrhoeagenic Escherichia coli (DEC) and Shigella spp. by
simultaneous and speciﬁc detection of seven virulence genes and a 16S
rDNA internal PCR control. The modiﬁed PCR assay is based in part on
previously published primer sequences and has recently been multiplexed
by Brandal et al.
Methods: PCR target genes were: verocytotoxins 1 (vtx1) and 2 (vtx2),
characteristic of verocytotoxin-producing E. coli (VTEC); intimin (eae),
found in enteropathogenic E. coli (EPEC), attaching and effacing E. coli
(A/EEC) and VTEC; heat-stable enterotoxin (estAh) and heat-labile
enterotoxin (eltB), characteristic of enterotoxigenic E. coli (ETEC); aggR
for enteroaggregative E. coli (EAEC); and invasive plasmid antigen
(ipaH), characteristic of enteroinvasive E. coli (EIEC) and Shigella
spp. The assay performance was tested with a strain collection that
included four non-pathogenic E. coli strains, ﬁve non-E. coli species,
eight Shigella spp. and 71 different DEC strains, representing a variety
of different serotypes and virulence proﬁles: VTEC (n = 20), EPEC (n
= 33), A/EEC (n = 8), ETEC (n = 5), EAEC (n = 3), EIEC (n = 2). In
addition, 160 clinical faecal samples were tested.
Results: The method allowed the simultaneous identiﬁcation of all
eight genes in one reaction. When applied to pure cultures from the
strain collection, virulence genes were identiﬁed in 68/71 (96%) of the
different DEC strains, in all Shigella spp. and no virulence genes were
detected with the four non-pathogenic E. coli strains and ﬁve non-E. coli
species. The three negative DEC strains (two EPEC and one A/EEC)
were positive on repeated testing and suggest a procedure error at initial
testing. Among the clinical specimens, 16/160 (10%) were positive for
one or more virulence gene: EPEC (n = 1), A/EEC (n = 8), ETEC (n =
2), EAEC (n = 4) and EIEC (n = 1).
Conclusion: The modiﬁed octaplex PCR assay provides a simple, rapid
and inexpensive diagnostic procedure for simultaneous detection of
major diarrhoeagenic Escherichia coli and Shigella spp. in the routine
diagnostic laboratory.
P1978 Evaluation of PCR for identifying Brucella species isolated
from blood from patients living in a non-endemic area
H. Aftab, R. Dargis, J.J. Christensen, M. Kemp (Copenhagen, DK)
Objectives: Brucellosis is rare in Denmark. Primary laboratories are
not prepared for handling these BSL class 3 organisms, and there is a
considerable risk of laboratory staff being exposed to the bacterium.
Traditionally, isolates of Brucella species has been referred to our
national reference laboratory and ﬁnal identiﬁcation has been made by
a combination of culture and agglutination by antisera. As speed, safety
and reliability are crucial factors in identiﬁcation of Brucella species we
evaluated these factors using PCR as an alternative.
Methods: Seventeen isolates from blood were analysed by PCR using
primer sets for B. melitensis, B. abortus, and B. suis, respectively.
The three PCR analyses were run in parallel and had PCR products
of different size. Eight isolates previously identiﬁed by culture and
agglutination by antiserum, were re-examined by PCR, and nine
consecutively referred isolates were identiﬁed by PCR only. Two of the
previously identiﬁed isolates had been reported as B. melitensis, four as
B. abortus, and two as Brucella species.
The PCR test was completed in less than one working day, whereas
cultivation and agglutination required at least overnight incubation.
Results: All isolates were postive for B. melitensis by PCR. One
isolate was repeatedly positive in PCR for B. abortus in addition to
B. melitensis, however the PCR product in the B. abortus assay did not
show the expected size. The DNA sequence of the PCR product from
the B. abortus PCR did not allow discrimination between the species.
None of the isolates were identiﬁed as B. abortus or B. suis by PCR.
Conclusions:
1. PCR is faster than culture and agglutination. A deﬁnite conclusion of
whether a suspected isolate is a clinical relevant Brucella species can
be obtained within a few hours.
2. PCR is less hazardous than culture and agglutination. Isolates referred
to the reference laboratory are immediately inactivated in DNA
extraction buffer, allowing all subsequent procedures to be carried
out in BSL class 2 facilities. The suspected isolate may even be
inactivated, e.g. by heating, before shipment. In contrast to live
Brucella bacteria, inactivated material may be send by ordinary means
of transportation.
3. PCR results in deﬁnite species identiﬁcation and there are no
difﬁculties in interpretation of agglutination obtained by more or less
cross-reacting antisera.
PCR for Brucella species is a fast, safe, and reliable method for
identiﬁcation of clinical isolates.
P1979 Real-time PCR detection of enterovirulent Escherichia coli
M. Andersson, M. Vondracek (Stockholm, SE)
Enterovirulent Escherichia coli are a common cause of morbidity
throughout the word. The major categories of pathogenic E. coli
include enterohaemorrhagic E. coli (EHEC), enteropathogenic E. coli
(EPEC), enterotoxigenic E. coli (ETEC) and enteroinvasive E. coli
(EIEC). Targeting speciﬁc genetic elements i.e. vt1 and vt2 (EHEC),
eaeA (EHEC/EPEC), bfpA (EPEC), estA and eltB (ETEC) and ial
(EIEC/Shigella) we have developed a TaqMan-based real time PCR
system to detect these pathogens from primary streaks of stool cultures.
Using a common PCR protocol for all the selected virulence genes
we were able to detect between 1 and 10 genomic equivalents for all
selected targets (except the variant vt2d which was detected at 100
genomic equivalents). The speciﬁcity of the reactions was 100% when
tested against 32 different bacterial strains commonly present in clinical
samples. To validate the protocol both control strains, n = 212 (32 EHEC,
36 EPEC, 97 ETEC and 47 EIEC/Shigella) and primary streaks of stool
cultures, n = 139 (62 EHEC, 17 EPEC, 22 ETEC and 38 EIEC/Shigella)
were tested and compared to a well established diagnostic gel based PCR
protocol. In total, eleven discrepancies were observed; vt1/vt2 (n = 5),
estA/eltB (n = 5) and bfpA (n = 1) which all could be explained by the
higher sensitivity of the real time protocol. Furthermore, after using the
system in routine diagnostics for up to one year the variation of the
reactions were around 2 percent (CV= 1.3−2.1%). We were also able to
correlate the frequency of isolated strains to the amount of target DNA
present in the initial samples. On this basis we have developed a cut off
value which likely corresponds to the lowest DNA content representing
presence of viable pathogens. This raise the question of how to deal with
weakly positive samples from a system based on nucleic acid detection.
In conclusion, we have developed a rapid and robust TaqMan based assay
for routine diagnostics of enterovirulent Escherichia coli. Moreover, the
method opens up for studies on clinical relevance in correlation to low
DNA content in clinical samples.
P1980 Detection of Mycoplasma hominis in amniotic ﬂuid of
pregnant women by real-time PCR
M. Vydrzalova, P. Lyskova, T. Kroupa, D. Kralovcova, J. Mazurova
(Pardubice, CZ)
Objectives: Maternal infection has long been known to play a major
role in perinatal morbidity and mortality and suspected to be a cause of
spontaneous abortion. Intrauterine infection may be largely responsible
for preterm delivery. The most common microorganism involved in
intrauterine infections is Mycoplasma hominis. Mycoplasma hominis
is commonly isolated microorganism from the female genital tract. It
has been linked to pelvic inﬂammatory diseases such as salpingitis,
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endometritis, bacterial vaginosis and infertility. The transmition from
the mother to the developing foetus can be in utero or at delivery.
The relationship between detection of Mycoplasma hominis in mid-
trimester amniotic ﬂuid and subsequent pregnancy outcome was
investigated. Data collected included indication for amniocentesis,
gestational age at amniocentesis, gestational age at delivery, pregnancy
outcome and low birth weight of infants.
Method: The amniotic ﬂuids of 202 women who underwent a
transabdominal amniocentesis at weeks 15–22 of pregnancy were tested
for Mycoplasma hominis by real-time PCR.
Results: Mycoplasma hominis were identiﬁed in 51 (25.2%) samples
of the amniotic ﬂuid. A total of two (28.6%) infants, positive for
Mycoplasma hominis, had the birth weight below 2500g. Ten of the
women had preterm delivery and one of them (10%) was positive for
Mycoplasma hominis.
Conclusion: In this study has not been found statistical correlation
betweenMycoplasma hominis and low birth weight and preterm delivery.
Despite the detection of Mycoplasma hominis in samples of pregnant
women should be considered. Real-time PCR is suitable for diagnostic
of this microorganism in samples of amniotic ﬂuid. This work was
supported by MSM 0021627502.
P1981 Intrapartum screening of group B Streptococcus using
GeneXpert real-time PCR versus late antenatal screening
by culture
N. El Helali, A. Ly, J.C. Nguyen, Y. Giovangrandi, E. Sauvanet
(Paris, FR)
Objective: Actual prevention of neonatal early onset group B
streptococcal (GBS) disease involves giving intrapartum antibiotics to
women. It takes in account either their antenatal culture colonisation
status or for those women with unknown status, the presence of risk
factors. The aim of this study was to evaluate the accuracy of GeneXpert
real-time PCR, for the detection of GBS carriers at the onset of labor,
and to compare it to the current 35 to 37 weeks screening by culture.
Methods: Over a six-month period 630 women were prospectively
enrolled. According to ANAES recommendations in France, specimens
were collected at 35 to 35 weeks by swabbing the lower third of the
vagina, and cultured by direct plating on sheep blood agar.
At time of presentation for delivery, the vaginal swab was repeated using
a double Copan swab. Of these, one swab was processed by culture,
and the other one by GenExpert real-time PCR which integrates the all
processing (extraction-ampliﬁcation-detection) in 70 minutes.
Results: Of enrolled women 89% were eligible for analysis. The GBS
colonisation rate when using culture, was 16.1% intrapartum versus
13.16% at 35 to 37 weeks. Compared with intrapartum culture, the
sensitivity of late antenatal culture for identifying colonisation status
at delivery was 54.1% and the positive predictive value 66.25%. PCR
results were not available for 11% of the samples: 5% due to PCR
inhibition, 3% due to signiﬁcant presence of mucus and 3% due to
manipulation errors. Compared with intrapartum culture, the GeneXpert
real-time PCR test had a sensitivity of 97.9%, a speciﬁcity of 99.7%,
a positive predictive value of 98.9% and a negative predictive value of
99.6%. The molecular test was superior to antenatal culture: sensitivity
97.9% versus 54.1%.
Interestingly 9% of negative screened women at 35 to 37 weeks became
positive on intrapartum, and 34% of positive screened women became
negative. Of screened positive women on time of labor, 47% were not
detected by antenatal culture.
Conclusion: The real-time PCR on GenExpert is a rapid test, highly
sensitive and speciﬁc to detect GBS colonised women at time of labor.
This molecular test is extremely easy to use as a laboratory routine test.
The results could be available 24H a day for antibiotics prescription to
be given before delivery.
P1982 International external quality assessment programme
for the molecular detection of Legionella pneumophila in
respiratory samples: results from 2006 and 2007
R. De Mendonc¸a, W.G. MacKay, P.S. Wallace, S. Rottiers, S. Crevecoeur,
M.J. Struelens, A.M. van Loon (Brussels, BE; Glasgow, UK)
Objectives: To assess the diagnostic proﬁciency of laboratories
performing nucleic acid ampliﬁcation technologies for the detection of
Legionella pneumophila in clinical specimens.
Methods: The 2006 EQA panel consisted of 12 bronchoalveolar lavage
(BAL) or physiological saline solution samples, including eight samples
spiked with L. pneumophila sg 1 or sg 6, two samples spiked with
Legionella micdadei and two negative samples. The 2007 EQA panel
consisted of 10 BAL or transport medium (Dulbecco’s modiﬁed Eagle’s
medium and 10% foetal calf serum) samples including seven samples
spiked with L. pneumophila sg1 or sg6, one with L. micdadei and two
negatives. A scoring system was applied to compare performance: two
points for a correct result and zero points for an incorrect result. A
maximum score of 24 points was attainable in 2006 and 20 points in
2007.
Results: In 2006 a total of 58 datasets were returned from 51 respondents
in 16 countries. The overall mean performance score was 17/24. Three
percent (2/58), 14% (8/58) and 84% (49/58) of datasets exceeded 90%,
80% and 60% of the maximum score (24 points). There were 14 (12%)
false positives reported for the two samples containing L. micdadei. The
rate of false positives on the two true negative samples was 3% (3/116).
In 2007, 65 datasets were submitted by 60 respondents in 21 countries.
The overall mean performance score was 16/20. Twenty percent (13/65),
52% (34/65) and 89% (58/65) of datasets exceeded 90%, 80% and
60% of the maximum score (20 points). There were 19 (29%) false
positives reported for the sample containing L. micdadei. The rate of
false positives on the two true negative samples was 4% (5/130). A
performance comparison between BAL and transport medium suggested
that sample matrix may have inﬂuenced the results.
Conclusion: The overall performance improved from 2006 to 2007.
However the percentage of false positives on true negative and speciﬁcity
samples (L. micdadei) indicated that improvements are still needed in
the detection of L. pneumophila by molecular methods.
P1983 Comparison of three methods: culture, real-time PCR and
ﬂuorescent in situ hybridisation in detecting of Helicobacter
pylori
O. Ozcakir, O. Yonem, H. Demir, A. Altinbas, G. Altinok, D. Orhan,
A. Uner, Y. Akyon (Ankara, TR)
Objectives: H. pylori is one of the most common bacterial pathogens in
humans. It causes chronic gastritis, peptic ulcer disease and it is a major
risk factor for gastric cancer. Detection of this pathogen with accurate
methods is very important.
Aim: to compare H. pylori detection in gastric biopsy specimens by
culture, Real-Time PCR and FISH.
Methods: Biopsy specimens of 148 patients, with dyspeptic complaints
were examined. Culture was performed on Brain Heart Infusion agar,
for Real-Time PCR examination, chromosomal DNA was extracted
by Cetryl-trimethl-ammonium bromide method and the assay was
performed on Light Cycler (Roche Diagnostics, Germany). Melting
peaks of 650C (± 2.00C) showed the detection of H. pylori in
the sample. For FISH examination formalin-ﬁxed parafﬁn-embedded
gastric biopsies were sectioned. The sections were hybridised using
the commercially available test system seaFast H. pylori Combi-Kit
(Theranostics International, Netherlands) according to the manufacturer’s
instructions. Four different sections were examined to give a negative
result.
Results: Among 148 samples 70 were positive by culture, 118 were
positive by PCR and 124 were positive by FISH. Among the 124 samples
determined positive by FISH; 98 were determined positive in the ﬁrst
section, 17 were determined positive in the second section and 9 were
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determined positive in the third section. Culture, PCR and FISH results
were all positive for 63 samples and negative for 24 samples. 54 samples
were culture negative, but PCR and FISH positive. 7 samples were PCR
negative, but culture and FISH positive.
Conclusion: At least two tests are essential for H. pylori determination.
Culture, because of contamination and the difﬁculties of culturing
of H. pylori, has false negative results. However culturing must be
performed, hence antimicrobial susceptibility testing is essential. Among
the three methods Real-Time PCR has more capability to determine the
positive results in the ﬁrst sample, therefore it is easier to perform in
routine laboratory practice.
P1984 Detection of bacterial pneumonia by quantitative PCR,
with special reference to Streptococcus pneumoniae and
Haemophilus inﬂuenzae
G. Abdeldaim, K. Stra˚lin, J. Korsgaard, P. Olce´n, J. Blomberg,
B. Herrmann (Uppsala, O¨rebro, SE; Aalborg, DK)
Objectives: To develop sensitive and speciﬁc quantitative multiplex
real-time PCR for detection of Streptococcus pneumoniae, Haemophilus
inﬂuenzae and Neisseria meningitidis.
Methods: A multiplex quantitative real-time PCR assay was developed
for detection of S. pneumoniae (9802 gene fragment), H. inﬂuenzae (P6
gene) and N. meningitidis (ctrA gene). The analytical sensitivity of the
assay was determined by serial dilutions of target DNAs. The method
was evaluated on bronchoalveolar lavage from 156 immunocompetent
adult patients with lower respiratory tract infection (LRTI) and 44 adult
controls who underwent bronchoscopy for suspected malignancy. The
PCR results were compared with the results of culture.
Results: The analytical sensitivity was 10–60 copies/reaction for
S. pneumoniae and 3–10 copies/reaction for H. inﬂuenzae. The detection
capacity was not affected by using a combined mixture of reagents and a
combined DNA standard (S. pneumoniae/H. inﬂuenzae) in single tubes.
By culture, S. pneumoniae and H. inﬂuenzae were aetiological agents in
21 and 33 of the LTRI patients, respectively.
These pathogens were identiﬁed by real time PCR in 45 and 67 of
the cases, respectively, yielding sensitivities of 76% for S. pneumoniae
and 90% for H. inﬂuenzae, and speciﬁcities of 78% for S. pneumoniae
and 68% for H. inﬂuenzae. A cutoff for clinically signiﬁcant positivity
(104 DNA copies/ml for S. pneumoniae and 5×104 DNA copies/ml for
H. inﬂuenzae) yielded sensitivities of 71% and 78%, and speciﬁcities of
85% and 86% for S. pneumoniae and H. inﬂuenzae, respectively. Of the
103 patients who had taken antibiotics prior to sampling, S. pneumoniae
and H. inﬂuenzae were identiﬁed by culture in 7% and 17% of the cases,
respectively, and by the PCR in 28% and 52% of the cases, respectively.
Among the 44 controls, S. pneumoniae and H. inﬂuenzae were identiﬁed
by culture in 3 and 5 cases, respectively, by PCR in 14 and 17 cases,
respectively, and by PCR with the deﬁned cutoff limits in 5 and 9 cases,
respectively.
N. meningitidis was detected in 7 LRTI patients which indicated that the
multiplex assay may be useful in the diagnosis of meningitis.
Conclusions: The multiplex format of the assay facilitates diagnosis
of S. pneumoniae and H. inﬂuenzae and the assay enable detection
after antibiotic treatment has been installed. Quantiﬁcation increases the
speciﬁcity of aetiology for pneumonia.
P1985 A new PCR assay for the diversity analysis of streptococcal
populations in clinical samples
T. Mas-de-Xaxars, L.J. Garcia-Gil (Girona, ES)
Objectives: Streptococci are a heterogeneous group that includes more
than 30 different species, most of them normal inhabitants of the
human ﬂora, although some constitute important human pathogens. No
molecular tools to study the diversity of the genus Streptococcus in
clinical samples have been developed, to date.
Methods: To study the diversity of this genus by the PCR-DGGE
approach, we have developed a new set of primers consisting of a
genus-speciﬁc forward primer targeting 16S rRNA (1043f) combined
with the universal eubacterial primer 1492r. The ca. 450pb PCR product
encloses three (V7, V8 and V9) hypervariable regions of the small
subunit ribosomal gene and is therefore suitable to determine the speciﬁc
diversity by denaturing gradient gel electrophoresis (DGGE).
Results: The speciﬁcity of the PCR assay was veriﬁed using 45
different bacterial species, including 16 different Streptococcus species.
Positive PCR results were obtained in all Streptococcus species plus
Enterococcus faecalis, whereas PCR was negative in the other specimens.
The ampliﬁcation limit was 900 genome equivalents per reaction (95%
probability).
The new oligonucleotide set was tested on clinical (colon biopsies,
bronco-alveolar lavage, and hip/knee prosthetic infections) samples. Up
to 60% of the sequences retrieved from samples that resulted positive for
streptococcal populations were highly similar to cultured streptococci. In
turn, 40% of the sequences corresponded to yet uncultured streptococci,
and some of them corresponded to new Streptococcus phylotypes.
Furthermore, the new molecular tool was compared with isolation
methods using colon biopsies samples. Of all streptococci identiﬁed,
70% were obtained by conventional culturing methods while 60% were
derived from PCR-DGGE technique. Both methods shared 30% of total
streptococci. The streptococci found only with molecular methods (30%)
represent an abundant fraction and therefore are of potential clinical
interest.
Conclusions: This new Streptococcus-oriented analytical tool will to
provide a deeper insight into the speciﬁc composition of streptococcal
populations, particular those from infected tissues and can be useful to
identify new participants in polymicrobial infections.
P1986 Evaluation of PCR in bronchoalveolar lavage specimens for
diagnosis of pneumococcal pneumonia
I. Marekovic, V. Plecko, Z. Boras, L. Pavlovic, A. Budimir, Z. Bosnjak,
B. Kamauf-Balabanic, S. Marinkovic, L. Zˇele-Starcevic, S. Kalenic
(Zagreb, HR)
Objectives: Due to the limitations of conventional methods, PCR
has been extensively evaluated as an attractive diagnostic tool for
pneumococcal pneumonia. To date most investigators focused on
blood and sputum specimens with blood specimens showing wide
range of sensitivities and sputum specimens showing difﬁculties in
determining whether PCR-positive ﬁndings represent colonisation or
infection, at least when conventional and not quantitative PCR methods
are used. Bronchoalveolar lavage (BAL) is invasive specimen from
lower respiratory tract with minimal risk of contamination by the
oropharyngeal ﬂora. Therefore the aim of this study was to evaluate
PCR performed on BAL specimens for diagnosis of pneumococcal
pneumonia.
Methods: The study included 80 adults with clinical and radiographic
evidence of community-acquired pneumonia (CAP). Sputum, BAL
(when indicated by physicians) and blood specimens were submitted
for culture and urine specimens for urinary pneumococcal antigen test.
PCR that targets the pneumolysin gene was performed on serum and
BAL specimens.
Results: Streptococcus pneumoniae was detected in 25 of 80 (31.25%)
patients. Urinary antigen test was positive in 16 of 76 (21.05%), sputum
cultures in 8 of 64 (12.5%) and BAL cultures in 1 of 19 (5.26%)
patients. There were no positive blood cultures. PCR results in 77
serum specimens were negative. BAL specimens were PCR-positive in
3 of 19 (15.79%) patients who underwent ﬁbreoptic bronchoscopy. In
two of those patients S. pneumoniae was detected only by BAL PCR.
All 3 patients with positive BAL PCR were previously treated with
antimicrobial agents.
Conclusion: According to our results in serum specimens, we agree with
those investigators who claim that PCR performed on blood samples
adds little to existing diagnostic tests for pneumococcal pneumonia.
We conclude that BAL is the most promising specimen in diagnosis
of pneumococcal pneumonia by PCR method, especially in patients
previously treated with antimicrobial agents. Because BAL is invasive
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procedure, BAL PCR would be ideal for patients with slowly resolving
pneumonias when decision about further antimicrobial treatment should
be made. However, evaluation on larger number of BAL specimens is
needed.
Molecular diagnosis of miscellaneous
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P1987 Identiﬁcation of species in the Acinetobacter calcoaceticus–
A. baumannii complex isolated from blood cultures by an
oligonucleotide assay
T-C. Chang, S-C. Su, N-Y. Lee, L. Dijkshoorn, W-C. Ko (Tainan,
TW; Leiden, NL)
Objectives: Acinetobacter calcoaceticus (genomic species 1), A. bau-
mannii (genomic species 2), and unnamed genomic species 3 and
13TU are phenotypically similar and were referred to as a group,
the A. calcoaceticus–A. baumannii (ACB) complex. Members of the
complex are the most common acinetobacters among clinical isolates.
The aim of this study was to construct an oligonucleotide array with
probes based on the ITS sequence to differentiate different species in
the ACB complex and to determine the species distribution of 291 blood
isolates of the complex.
Methods: Four oligonucleotide probes (18- to 30-mers), based on the
intergenic spacer (ITS) sequences, were designed to identify the four
genomic species in the ACB complex. An Acinetobacter-speciﬁc and an
ACB complex-speciﬁc probe were also designed. In addition, a positive
control probe was designed from a highly conserved region in the 16S
rRNA gene. The array (4 by 4mm) contained 12 dots (4 by 3 dots),
including one Acinetobacter-speciﬁc probe, one ACB complex-speciﬁc
probe, four probes for identiﬁcation of each of the four genomic species
in the ACB complex, one positive control probe, two negative control
dots (tracking dye only), and three dots of the position marker probe.
One pair of bacteria-speciﬁc universal primers 2F and 10R was used to
amplify the ITS regions, with each of the two primers labeled with a
digoxigenin molecule at its 5’ end. The ampliﬁed PCR products were
hybridised with the arrays at 50ºC for 90 min. After hybridisation,
alkaline phosphatase-conjugated anti-digoxigenin antibodies were used
to reveal the hybridisation signals.
Results: After testing a collection of 52 strains of the ACB complex
and 137 strains not belonging to the complex, both the identiﬁcation
sensitivity and speciﬁcity of the array were 100%. By using the array, the
species distribution of 291 bacteremic isolates of the ACB complex were
determined to be A. baumannii (221 strains, 75.9%), genomic species
3 (67 strains, 23.0%), genomic species 13 TU (2 strains, 0.7%), and
unidentiﬁed Acinetobacter sp. (1 strain, 0.3%).
Conclusion: In conclusion, clinical isolates of the ACB complex can be
quickly and accurately identiﬁed to species level by the current array.
Acinetobacter baumannii (75.9%) was the predominant species among
monomicrobial bacteraemia caused by the complex. The current method
provides a rapid and accurate way to species identiﬁcation of the ACB
complex.
P1988 Comparison of PCR-reverse line blot and real-time PCR
for the detection of dermatophytes in clinical samples
G. Wisselink, E. van Zanten, S. Coops, A.M.D. Kooistra-Smid
(Groningen, NL)
Objectives: In a previous study PCR-Reverse Line Blot (PCR-RLB) was
compared with culture and the potassium hydroxide test (KOH) for the
detection of dermatophytes. PCR-RLB showed to be more sensitive than
culture and KOH. Drawbacks of the PCR-RLB are the laborious nature
of the test, the difﬁcult standardisation and the interpretation of weak
results. Therefore a multiplex real-time PCR was developed. The aim of
this study was to compare PCR-RLB analysis with multiplex real-time
PCR for the detection of dermatophytes.
Methods: Both PCR-RLB and real-time PCR targeted the ITS1 region
located between the genes coding for 18S and 5.8S rRNA. The RLB
membrane harboured 13 different probes to identify and discriminate
between 9 different dermatophyte species. Real-time PCR consisted of
two multiplex assays. One assay targeted T. rubrum, T. violaceum and
T. tonsurans. The second targeted Microsporum spp., T. interdigitale
group and the whole group of dermatophytes. Phocine herpes virus-1 was
used as internal control for the real-time assays. Samples were processed
using QIAamp® DNA mini kit (Qiagen, Germany) with a separate pre-
lysis step.
Totally 100 clinical samples (52, 38, 10 respectively nail-, skin- and hair
samples) were analysed retrospectively by real-time PCR and compared
with PCR-RLB.
Results: Of the 100 samples 60 were positive with the PCR-RLB
(27 T. rubrum, 14 T. interdigitale, 6 T. tonsurans, 3 T. violaceum, 1
M. canis and 9 Trichophyton spp.). All samples identiﬁed as T. rubrum,
T. interdigitale, T. tonsurans and T. violaceum by the PCR-RLB were
conﬁrmed by the real-time PCR. The sample which tested positive for
M. canis by PCR-RLB was identiﬁed as Microsporum spp. by real-time
PCR.
The 9 samples which scored positive for Trichophyton spp. in the PCR-
RLB yielded weak results. Of these 9 samples real-time PCR identiﬁed
3 samples as T. interdigitale, 1 as T. rubrum, 1 as T. tonsurans, 1 as
dermatophyte positive and 3 samples remained negative.
The real-time PCR detected 8 additional samples which scored negative
with the PCR-RLB. Of these 8 samples real-time PCR identiﬁed 4
samples as T. rubrum, 3 as T. interdigitale and 1 as dermatophyte
positive.
Conclusion: These data show that real-time PCR is a sensitive method
for detection of the most prevalent dermatophytes in nail-, skin- and
hair samples. Furthermore real-time PCR is more standardised and less
laborious than PCR-RLB, making it a useful tool in routine diagnostics.
P1989 Development and validation of an automated 16S rDNA
assay for the detection of bacterial DNA in clinical samples
R.F. de Boer, T. Schuurman, A.M.D. Kooistra-Smid (Groningen, NL)
Objectives: Since 2002 the department of Research and Development
of the Laboratory for Infectious Diseases started to analyse clinical
specimens on request for the presence of bacterial DNA. The assay
consists of a manual DNA extraction method, followed by conventional
broad-range PCR. PCR positive products are subsequently sequenced
to identify the organism that was present in the clinical specimen (ref.
Schuurman et al., JCM. 2004, 42;2 p734). However, the assay is very
laborious and time consuming. To decrease hands on time (HOT) the
extraction and detection procedure were automated. This study describes
the validation of an automated 16S rDNA assay (A) for the detection of
bacterial DNA in clinical samples. Method A was compared with our
conventional detection method (C).
Methods: Prior to DNA extraction, samples were treated with
mechanical disruption for both methods. DNA extraction was performed
with the manual Boom method (C) or with the automated easyMAG
speciﬁc A protocol (bioMe´rieux) (A). Conventional (C) and real-
time (A) PCR were performed with universal primers (probe), which
ampliﬁed/detected the whole 16S rRNA gene. All positive PCR products
were subsequently sequenced. The analytical sensitivity of method A was
assessed by dilution series of different model organisms (n = 3), spiked
in phosphate buffered saline. Also, both methods were compared in a
validation performed on clinical samples (n= 89).
Results: Analytical sensitivity of both methods were comparable, with
limits of detection of approximately 400 – 40 CFU/PCR, 1450 – 145
CFU/PCR, and 800 – 80 CFU/PCR for Gram-negative (E. coli) and
Gram-positive organisms (S. aureus and S. pneumoniae) respectively.
Thirty eight positive and 46 negative samples were in complete
concordance for both methods (94.4%). Method A detected 4 additional
clinical signiﬁcant positive samples (S. intermedius, S. maltophilia,
S. pneumoniae and a mixed sequence). Method C yielded 1 additional
positive result (S. aureus), which also was regarded clinical signiﬁcant.
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PCR inhibition was detected in 10% of all samples for method A in
comparison with 49% for method C. Also, HOT for obtaining a PCR
result decreased (~50%) when method A was applied.
Conclusions: With regards to sensitivity both methods were comparable
in detecting bacterial DNA from clinical samples. However, when
method A was applied HOT was reduced considerably, PCR results were
easier to interpret, and inhibition rates decreased dramatically.
P1990 Novel MALDI-TOF MS based differentiation of bacteria
from clinical samples: alternative to biochemical test
systems ?
S. Schubert (Munich, DE)
Objective: This study compares a novel Matrix Assisted Laser
Desorption/Ionisation–Time of Flight (MALDI-TOF)-based method for
bacterial differentiation with common biochemical test systems. The
study criteria include performance time, accuracy and easy to use of
the method. An answer shall be given to whether this novel system is a
future alternative to the biochemical test systems.
Methods: 600 isolates obtained form clinical samples were investigated
in parallel on the MALDI-TOF system (Microﬂex/BioTyper, Bruker Dal-
tonics, Bremen, Germany) and by using API® bioMe´rieux biochemical
test system. In case of incongruent results in these systems, sequencing
of 16S-rDNA genes was performed for ﬁnal molecular differentiation of
the isolates.
Results: 600 Isolates comprised of 200 isolates of different members
of Enterobacteriaceae, 200 non-fermenting Gram-negative rods (e.g.
Pseudomonas sp.), 80 staphylococci, 80 streptococci and 40 Gram-
positive rods (e.g. corynebacteriae). The time for differentiation was
about 5 min for each isolate irrespective of the group. The overall results
are given in Table 1.
Table 1
Identical
results
MALDI
superior
Biochemical
test superior
Total
no.
Enterobacteriaceae 196 (98%) 2 (1%) 2 (1%) 200
Non-fermenting Gram(−) rods 192 (96%) 6 (3%) 2 (1%) 200
Staphylococci 80 (100%) 0 0 80
Streptococci 73 (91%) 5 (6%) 2 (3%) 80
Gram(+) rods 24 (60%) 2 (5%) 14 (35%) 40
Conclusion: The MALDI-TOF based differentiation only and does not
provide data on antibiotic resistance of the isolate. Moreover, the bacteria
culture on plate is required and it is not suitable for detection of
bacteria directly from clinical sample. The MALDI-TOF based method
for bacterial differentiation provides reliable results within minutes, it is
easy to perform and enables genotyping to a certain extend. Even though
the initial acquisition of the MALDI-TOF apparatus is expensive, there
are essentially no cost for consumables, making this system especially
interesting for large scale diagnostic laboratories.
P1991 Comparison of NucliSens easyMAG and Qiagen nucleic
acid extraction using respiratory specimens
K. Bergs, D. Ursi, H. Goossens, M. Ieven (Edegem, BE)
Background: The NucliSens easyMAG (bioMe´rieux) is an open system
for automated isolation of nucleic acids (NA) from clinical samples,
based upon Boom technology.
Objectives: To evaluate the performance and user convenience of
the NucliSens easyMAG platform for NA extraction from respiratory
specimens compared to manual Qiagen (Qia) extraction.
Materials and Methods: A total of 87 respiratory samples were
included. All samples were spiked with Phocine Herpes virus (PhHV)
to monitor extraction efﬁciency. For Qia extraction, 200ml sample
was extracted according to kit instructions and eluted in 100ml. Two
easyMAG (EM) protocols were applied. Throat swabs were extracted on
the EM using the Generic onboard protocol with an input and elution
volume of 200ml and 55ml respectively. For other sample types EM
extraction was ﬁrst evaluated on endotracheal aspirates (ETA) before
and after pretreatment by an additional lysis step with Proteinase K
for 15 min. at 56ºC. Based on this evaluation, all other samples than
throat swabs were pretreated with this lysis step and extracted on the
EM using the Speciﬁc onboard protocol with an elution volume of 70ml.
NA extracts were analysed by real-time PCR targetting the spiked PhHV
virus. Respiratory samples positive or inconclusive for M. pneumoniae
and B. pertussis in routine with Qia extraction, were tested after EM
extraction and Ct values were compared.
Results: Pretreatment of ETA by an additional lysis step increased the
performance of the EM extraction from 64% to 85%. In total 78 out of
87 samples (90%) produced a comparable or lower Ct value after EM
extraction compared to Qia extraction for the spiked PhHV. Ct values
for M. pneumoniae and B. pertussis were lower in 5/6 nasopharyngeal
aspirates (NPA) extracted with EM compared to Qia extraction, with a
mean Ct difference of 1.9. One NPA was positive for B. pertussis after
EM extraction, but negative after Qia extraction.
Sample type (n) Number of samples with
lower or equal EM Ct
values (n)
Mean difference
Ct Qia-EM
Total (87) 78 −0.67
ETA (13) 11 −0.12
Throat swabs (18) 17 −1.42
Sputum (10) 9 −0.67
Pleural ﬂuid (10) 8 −0.17
NPA (16) 15 −0.66
BAL (10) 9 −0.60
Broncheal aspirate (10) 9 −0.65
Conclusion: The Nuclisens easyMAG extracted DNA from respiratory
specimens more efﬁciently than the manual Qia method. However a
proper pretreatment of these specimens is necessary. The easyMAG
features user-friendly software and has a turn-around time of about 40
minutes for a total of 24 samples.
P1992 Evaluation of E. coli/P. aeruginosa PNA FISH™ and
EK/P. aeruginosa PNA FISH™; two dual colour assays for
identiﬁcation of Gram-negative rods directly from positive
blood culture bottles
D.S. Hansen, L. Leerbeck, M.J. Fiandaca, B. Bruun (Hillerød, DK;
Woburn, US)
Objectives: The three most commonly encountered Gram-negative rods
(GNR) from both community acquired and nosocomial blood stream
infections are Escherichia coli (EC), Klebsiella pneumoniae (KP), and
Pseudomonas aeruginosa (PA). Routine identiﬁcations of GNRs must
await subculture and are therefore not available until the following
day. Thus patients must receive broad spectrum empiric antibiotics
therapy for several days, before a speciﬁc therapy can be instituted,
leading to an overuse or a risk of inappropriate antibiotics therapy.
E. coli/P. aeruginosa PNA FISH™ (AdvanDx) and EK/P. aeruginosa
PNA FISH™ (AdvanDx) are new rapid ﬂuorescence in situ hybridisation
(FISH) tests using ﬂuorescently labeled peptide nucleic acid (PNA)
probes targeting rRNA targets in EC, PA, and KP. E. coli/P. aeruginosa
PNA FISH™ generates green and red ﬂuorescent signals for EC and
PA, respectively. EK/P. aeruginosa PNA FISH™ is the same, except a
green ﬂuorescent signal indicates EC and/or KP in the sample. The tests
are performed directly on smears from positive blood culture bottles and
provide results within 2.5 hours.
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Methods: A total of 55 routine blood culture bottles positive for GNRs
were included. Smears from positive blood culture bottles were analysed
by both GNR PNA FISH assays, and the results were compared to results
of our routine identiﬁcations (VITEK2).
Results: All 32 EC correctly showed green signals in both GNR
PNA FISH assays. Eight KP also reacted correctly, giving green
signal in the EK/P. aeruginosa PNA FISH assay and no signal in the
E. coli/P. aeruginosa PNA FISH assay. Two PA correctly gave red signal
in both assays. Thirteen isolates correctly gave no signal in both assays;
7 miscellaneous enterobacteriae, 4 anaerobes and one Enterococcus
species (erroneous Gram smear). The sensitivities of EC, KP and PA
detection were 100%, and the speciﬁcity of both assays was 100% in
this study.
Conclusion: Using two PNA FISH assays we were able to identify
76% (42/55) of our blood stream pathogens. The E. coli/P. aeruginosa
PNA FISH™ and EK/P. aeruginosa PNA FISH™ assays are rapid
and accurate methods for identiﬁcation of E. coli, K. pneumoniae and
P. aeruginosa directly from positive blood culture bottles.
P1993 Microbe detection in clinical samples within a few hours by
application of DNA microarrays and Lab-on-a-Chip systems
H. Wiesinger-Mayr, M. Mansfeld, R. Pichler, K. Vierlinger, G. Hairer,
M.J. Vellekoop, C. Noehammer (Seibersdorf, Vienna, AT)
We present a novel approach for rapid identiﬁcation of infectious
pathogens by combining PCR ampliﬁcation with microarray analysis.
In comparison to conventional diagnostic procedures, all depending on
bacterial growth, this assay substantially accelerates diagnosis. For a
start a classical oligonucleotide microarray (ﬂuorescence readout) was
established for the identiﬁcation of 26 blood stream infection relevant
pathogens. As expected from sequence similarity in the target genes
(16S/18S rRNA), members of the Enterobacteriaceae family turned out
to be too conserved for accurate species identiﬁcation based on single
species speciﬁc DNA probes. However, typical hybridisation patterns of
each species could be successfully employed for accurate discrimination
of each member of Enterobacteriaceae. Data from all identiﬁcation
experiments were collected to a hybridisation matrix which served as
base for statistical analysis. The combination of rank normalisation and
k-nearest-neighbour method enabled a correct determination of 100% of
the bacteria at genus level and 96.7% at species level. After thorough
assay optimisation (DNA isolation, PCR ampliﬁcation, PCR target
labeling) we succeeded to identify 10 E. coli cells per mL whole blood.
A diagnostic chip for the identiﬁcation of kolpitis causing pathogens
including bacteria, yeasts, moulds, parasites and viruses is currently
under development. Up to now a microarray was established which can
identify kolpitis relevant bacteria and yeasts down to species level. Probe
validation showed good agreements with conventional identiﬁcation
methods and further probes are already introduced for the detection
of intracellular pathogens. Relying on our experiences from pathogen
microarrays we currently develop a Lab-on-a-Chip (LOC) device aiming
to miniaturize and accelerate the diagnostic assay further.
P1994 Application of molecular techniques for the diagnosis of
community-acquired bacterial meningitis in nine Spanish
hospitals
E. Sulleiro, G. Codina, E. Garcı´a-Cabrera, P. Coll, M. Gime´nez,
D. Fontanals, C. Salcedo, F. Tubau, C. Radice, M.A. Meseguer,
M.L. Julia`, G. Prats (Barcelona, Seville, Madrid, Alzira, ES)
Objective: To evaluate the sensitivity of three real-time polymerase
chain reaction (RT-PCR) assays for the diagnosis of community-acquired
bacterial meningitis (Ca-ABM), compared to Gram staining and culture.
Methods: Three different RT-PCR assays were performed in cere-
brospinal ﬂuid (CSF) and/or blood of all patients with Ca-ABM
diagnosed in nine hospitals of the Spanish Network for Investigation in
Infectious Pathology (REIPI). Two multiplex RT-PCR with two different
detection instruments TaqMan system were used for the detection of:
ctrA from Neisseria meningitidis, ply from Streptococcus pneumoniae
and bexA from Haemophilus inﬂuenzae type b. The third RT-PCR was
based on ampliﬁcation of 16S rDNA gene and when is necessary, the
ampliﬁcation product was revealed with DNA-chips by hybridisation.
Gram staining, CSF and blood culture were performed by conventional
methods.
Results: 415 patients were diagnosed of Ca-ABM. Were performed
412 Gram staining, 414 culture and 250 RT-PCR on CSF samples.
Obtaining positive results in 231 (56.2%), 295 (71.3%) and 185 (74%)
respectively. In blood were performed 410 cultures and 149 RT-PCR,
where 214 (55.6%) and 59 (39.6%) were positive. In 134 patients all
diagnosis procedures were performed simultaneously. In CSF, Gram
staining showed a sensitivity of 63.4%, culture 73.1% and RT-PCR
74.6% and in blood culture had a sensitivity of 57.5% and the RT-
PCR 38.8%.Pneumococcal meningitis was diagnosed in 160 (38.6%)
patients. All diagnosis procedures were done in 57 with the follow
sensitivity: CSF Gram staining 80.7%, CSF culture 86% and CSF RT-
PCR 93%, blood culture 66.7% and blood RT-PCR 43.9%. Five CSF
samples showed negative culture whereas RT-PCR was positive and 1
sample showed positive Gram staining and culture with negative RT-
PCR. Meningococcal meningitis was diagnosed in 109 (26.3%) patients;
43 patients with all diagnosis procedures. CSF Gram staining had a
sensitivity of 65.1%, culture 72.1% and RT-PCR 90.7%. Blood culture
showed a sensitivity of 44.2% and RT-PCR 51.2%. Thirteen CSF samples
showed negative culture whereas RT-PCR was positive and 3 had positive
culture with negative RT-PCR.
Conclusions: Gram staining is a faster, economic and speciﬁc procedure.
RT-PCR showed a slightly better sensitivity than culture in CSF whereas
worse results were obtained in blood, however is appropriate when
lumbar puncture is contraindicated. CSF culture is necessary to perform
typing and susceptibility studies.
P1995 MALDI-TOF MS as a universal tool for the characterisation
of pathogenic bacteria – A comparative analysis of
MALDI-TOF MS spectral ﬁngerprints over a six-year period
D. Dare, H. Sutton, H. Shah (Runcorn, London, UK)
Objective: There has been a signiﬁcant increase in the number of papers
demonstrating MALDI-TOF MS as a powerful, rapid, high throughput
technique for the characterisation of pathogenic organisms. These isolate
are generally characterised against a limited database built in house with
the experimentation carried out in relatively quick succession, on the
same sample set and same instrumentation by the same operator. In the
majority of these cases identiﬁcation is based upon a small number of
exclusive peaks associated with each species, since variability is often
observed in the spectral pattern. This paper examines this variability and
hence the ability of the technique for use as a universal tool.
Method: Six strains, Bacteroides fragilis, Pseudomonas aeruginosa,
Escherichia coli, Corynebacterium jeikium, Vibrio parahaemolyticus and
Micrococcus lylae were analysed by MALDI-TOF MS repeatedly over
a period of 6 years. The resulting spectral ﬁngerprints were derived
from isolates cultured from different freeze dried ampoules; media;
reagent stocks; instrumentation and technical personnel. The resulting
spectra patterns were compared for reproducibility and the effects upon
identiﬁcation against an extensive MALDI-TOF MS database of over
5000 spectral entries, covering more than 600 different species examined.
Results: The results demonstrate the spectral ﬁngerprints are very robust,
with variations generally observed in the peak intensity of the mass
patterns. Furthermore the differences observed were insufﬁcient to cause
misidentiﬁcation of the spectral ﬁngerprint against a substantial database.
Conclusion: This extended study therefore validates MALDI-TOF MS
as a tool for rapid universal characterisation of bacteria.
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P1996 Abiotrophia defectiva infection of a total hip arthroplasty
diagnosed by 16S r RNA sequencing
W. Rozemeijer, T.U. Jiya, E.R. Heddema, W. Ang (Amsterdam, NL)
Objective: Abiotrophia defectiva is a fastidious Gram-positive bacterium
that is known for its pleiomorphic coccobacillar forms and that may
appear as streptococci. Previously it was referred to as part of the
nutritionally variant streptococci. Nowadays it is the single species
of the Abiotrophia genus. It is a resident of human oral cavity and
urogenital and intestinal tracts and accounts for approximately 5% of
cases of bacterial endocarditis. There have been some sporadic reports
of A. defectiva as infective agent of osteoarticular infections and we
describe the ﬁrst case of a total hip arthroplasty infection caused by
A. defectiva.
Methods: A 71-year-old woman was admitted to our hospital for
replacement of her left hip arthoplasty that she had undergone 2 years
earlier in another hospital. She presented with a history of increasing pain
in her left upper leg and knee. She had no fever. Progressive osteolysis
near the prothesis was shown on consecutive radiographs and conﬁrmed
by scintigraphy. She was diagnosed with an arthroplasty infection.
Cultures of bone fragments and of pus near the prothesis showed only
growth in broth media and on the plate used to detect anaerobes which
among others contains horse blood and cysteine. Gram stain revealed a
pleiomorphic Gram-positive coccobacillus that could not be identiﬁed
by biochemical techniques. 16S rRNA sequencing was performed and
showed 99% homology with A. defectiva sequences. Retrospectively the
Gram stain matched the species.
Conclusion: Since its pleiomorphic appearance and relatively infrequent
incidence, A. defectiva is difﬁcult to identify. It mimics Gram-positive
rods and therefore might have a place in algorithms used to identify this
group of bacteria. Standard biochemical techniques often fail to identify
this micro-organism. 16 S rRNA sequencing offers a good methodology
to recognize this bacterium.
The proposed afﬁnity of A. defectiva for avascular tissue is underlined by
this ﬁrst report of a hip arthoplasty infection. Considering the increasing
use of foreign body material in modern medicine and the growing us of
molecular diagnostics, one might expect a rising incidence of A. defectiva
associated infections.
P1997 Evaluation of an acromopeptidase based extraction method
and use of the Rotor-Gene to improve the BD GeneOhm
IDI MRSA assay
C. Ling, G. Vanstone, S. Hopkins, E. James, R. Smith, K. Williams,
I. McDonald, T. McHugh, S. Rattenbury, C. Kibbler (London, UK)
Objectives: The IDI MRSA assay was ﬁrst implemented at the RFH
in 2006. Its use has enabled the timely implementation of appropriate
infection control measures, which have contributed to the reduction in
MRSA rates within the Trust. Currently the test is only used for speciﬁc
patient groups, however there is the desire to increase the number of
patients screened using this methodology. Due to the hands on time
required for the IDI MRSA assay, increasing the numbers would have
an effect on the time required to perform each run and would impact
on turnaround times. We therefore set out to evaluate the use of an
acromopeptidase extraction method (ACP) which requires less hands on
time, the Corbett Research CAS-1200 to automate the PCR set up and
the Corbett Research Rotor-Gene platform to increase the capacity of
each run.
Methods: Over a ﬁve week period a preliminary study was performed
during which 511 samples were tested using the routine method (IDI
extraction and the SmartCycler, method 1) and three other methods:
ACP and the SmartCycler (method 2); IDI extraction and the Rotor-Gene
(method 3); and ACP and the Rotor-Gene (method 4). In-house cut-off
values were used to analyse the Rotor-Gene data. Samples that were
from known MRSA positive patients, which were culture positive and/or
positive by all four methods, were regarded as true positive samples.
Results: During the preliminary study the inhibition rates were 35
(6.8%), 37 (7.2%), 9 (1.8%) and 6 (1.2%) for methods 1−4 respectively;
the false positive rates were 5 (1%), 1 (0.2%), 1 (0.2%) and 2 (0.4%)
for methods 1−4 respectively and the false negative rates were 4 (0.8%),
10 (2%), 6 (1.2%) and 7 (1.4%) respectively.
Conclusions: This preliminary study has shown that an ACP extraction
method and the Rotor-Gene could be used to improve the workﬂow of
the IDI MRSA assay without compromising the sensitivity or speciﬁcity
of the assay. The lower inhibition rates observed when using the Rotor-
Gene were a reﬂection of the less stringent in-house cut-off values used.
Subsequent to the study additional measures have been put in place
and the inhibition rate of the routine method has now been reduced to
approximately 2%. To fully validate the use of ACP and the Rotor-Gene
a further 2000 samples are in the process of being tested and appropriate
cut-off values are being established.
P1998 Simple methods to screen efﬂux pump activity and efﬂux
pump inhibitors in multidrug-resistant Escherichia coli
M. Martins, A. Cardoso, M. Viveiros, N. Charepe, L. Rodrigues,
I. Couto, L. Amaral (Lisbon, PT)
Objectives. Over-expression of efﬂux pumps (EPs) in Gram-negative
bacteria is associated with Multi-Drug Resistance (MDR). EPs inhibitors
(EPIs) can be used to detect the activity of EPs and to reverse efﬂux-
mediated MDR. In this study, 3 simple methods were developed to
quantify efﬂux in MDR E. coli and screen for effective EPIs.
Methods. Thirty veterinary E. coli strains with MDR phenotype
(resistance to 2 or more classes of antibiotics) were evaluated for
ethidium bromide (EB) efﬂux activity by an agar-based method. Strains
that showed efﬂux activity were selected for the screening of EPIs by
the microplate method. Brieﬂy, antibiotic discs were placed in 24-well
plates containing media with/without the following EPIs (at half their
MIC): Phe-Arg-napthylamide (PAN), thioridazine (TZ), chlorpromazine
(CPZ) and carbonyl cyanide m-chlorophenylhydrazone (CCCP). After
16 h, wells were examined for absence (reversal of resistance), partial
(reduction of resistance) or full growth (no effect). Strains that showed
reduction or reversal of resistance were then evaluated for efﬂux
with/without EPIs by a semi-automated real-time ﬂuorometric method.
Expression of EPs genes was assayed by RT-PCR.
Results. The EB agar method correctly identiﬁed 4 strains with increased
EPs activity, which was further quantiﬁed by the ﬂuorometric assay. This
efﬂux activity was reduced or even reversed to clinical levels by the EPIs
PAN and TZ. The RT-PCR assay of these strains showed an increased
level of expression of their major EPs.
Conclusion. The methodologies developed and to be described in detail
can be used for detection of MDR strains whose phenotype and gene
expression are consistent with increased efﬂux activity as well as for the
screening of agents for EPI activity against collections of MDR clinical
isolates. These methods are expected to be eventually used in the clinical
bacteriology laboratory.
P1999 Relevance of testing for microbial DNA in critically ill
patients
F. Bloos, J. Regueiro, C. Bruin-Buisson, S. Sachse, F. Hinder,
K. Becker, E. Straube, K. Reinhart, M. Bauer (Jena, DE; Santiago
de Compostela, ES; Cre´teil, FR; Mu¨nster, DE)
Objectives: Blood culture is an important method for identifying the
underlying microorganism causative of sepsis. However, blood culture
results may take up to 48 hours possibly delaying appropriate antibiotic
therapy. The goal of this study was to evaluate the performance of
microbial DNA testing in the blood compared to blood culture in
critically ill patients.
Methods: The study was performed in 3 centres. Inclusion criteria were
either severe sepsis (sepsis group) or elective surgery without evidence
of infection (control group). A blood culture (BC) was obtained and
10ml EDTA blood were simultaneously taken by sterile venous puncture.
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Further samples were taken on max. 3 consecutives days. Microbial
DNA was measured by PCR with the LightCycler System 2.0 (Roche
Diagnostics).
Results: 142 sepsis patients (236 samples) and 63 control patients (111
samples) have been included. Control patients had 3.6% positive PCRs
and 4.5% positive BCs (sensitivity 0; speciﬁcity 0.95). 34.7% of PCRs
were positive in the sepsis group compared to 16.5% of BCs (sensitivity
0.79; speciﬁcity 0.74). Procalcitonin values at diagnosis of sepsis were
higher in PCR/BC positive than in PCR/ BC negative patients (ﬁgure).
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Conclusion: Concordance between blood culture and PCR results is
very good in patients without evidence of infection. In patients with
sepsis, PCR showed positive results more often than the blood culture.
PCR-based culture-independent detection correlated well with disease
severity as reﬂected in plasma procalcitonin levels. In the light of shorter
time to result, PCR based detection might trigger appropriate antibiotic
therapy in the early therapeutic window which determines prognosis of
the patient with severe sepsis.
Acknowledgements: This study was sponsored by Roche Diagnostics,
Penzberg, Germany
P2000 Evaluation of the Hyplex®MBL ID multiplex PCR-ELISA
system for direct detection of blaVIM and blaIMP genes
in blood and other clinical material
E. Kraniotaki, A. Avlami, S. Bekris, G. Ganteris, E. Malamou-Lada,
M. Orfanidou, O. Paniara, C. Papagiannitsis, E. Platsouka, I. Stefanou,
E. Tzelepi, E. Vagiakou, V. Miriagou (Athens, GR)
Objectives: Hyplex®MBL ID Multiplex PCR-ELISA (BAG Health
Care, Germany) is a new diagnostic method for the direct detection of
metallo-b-lactamase (MBL) genes of the VIM and IMP types in clinical
specimens. The method was tested in Greek hospitals, characterised by
high prevalence of MBL-producing isolates.
Methods: The hyplex®MBL ID method involves ampliﬁcation of
blaVIM/blaIMP bacterial DNA by multiplex PCR and hybridisation
of the PCR products to speciﬁc oligonucleotide probes in an ELISA-
based format. The method was applied to 326 samples obtained during
September 2007 in three Athens hospitals. These included 90 positive
blood culture bottles containing at least one Gram-negative species and
236 consecutively collected samples including urine (n = 60), pus swabs
(n = 91) and bronchial secretions (n = 85). Results were compared to
those of a blaVIM/IMP PCR screening of the isolated Gram-negative
bacteria.
Results: Nineteen of the 90 blood cultures were positive by the
hyplex®MBL ID. blaVIM-1- or blaVIM-2-carrying isolates (8 Pseu-
domonas aeruginosa, 9 Klebsiella pneumoniae, 1 Providencia stuartii
and 1 Enterobacter aerogenes) were isolated from all hyplex-positive
samples. blaVIM-carrying isolates were not identiﬁed in any of the
hyplex-negative samples (sensitivity and speciﬁcity 100%). Five of
the urine samples containing blaVIM carriers (2 P. aeruginosa and 3
K. pneumoniae) were positive by the hyplex®MBL ID; MBL-positive
organisms were not detected from 2 hyplex-positive samples. Eight of the
9 pus samples with VIM-producers (5 P. aeruginosa, 2 K. pneumoniae
and 1 E. cloacae) were also positive by hyplex®MBL ID; one sample
appeared hyplex-positive but MBL producers were not isolated; blaVIM
was also identiﬁed in 1 hyplex-negative P. aeruginosa isolate. In
respiratory samples the hyplex®MBL ID method classiﬁed as positive 40
samples containing VIM-producers; MBL producers were not isolated
from 2 hyplex-positive respiratory samples. Sensitivity and speciﬁcity of
the hyplex®MBL ID system for specimens other than blood were 98%
and 97%, respectively.
Conclusion: The hyplex®MBL ID test can be reliably applied for the
timely detection of blaVIM carriage by Gram-negative species in positive
blood cultures in this setting. The assay is also efﬁcient in detecting MBL
genes in other clinical specimens however, the diagnostic utility of this
approach remains to be evaluated.
P2001 Development of a real-time PCR assay for the speciﬁc
detection of Arcobacter spp.
A. Gonza´lez, J. Suski, I. Can˜igral, M.A. Ferru´s (Valencia, ES)
Objectives: Arcobacters are fastidious, Gram-negative, non-sporing,
motile, spiral-shaped organisms that are considered emerging food-borne
pathogens producing enteritis and septicaemia. Routine identiﬁcation is
difﬁcult, and it is frequently misidentiﬁed as atypical Campylobacter
when relying on conventional plating methods and phenotypic tests,
what may lead to a substantial underestimation of their true incidence.
Therefore the objective of this study was the development of a rapid
and reliable real time PCR method to target the emerging pathogen
Arcobacter sp.
Methods: A. butzleri DSM 8739, A. cibarius DSM 17680, A.
cryaerophilus DSM 7289 and A. skirrowii CIP103588 were used as
reference strains to set up the assay. A test panel of 15 collection
strains from different species and genus were also included to study
the speciﬁcity of the assay.
The optimal conditions for the real time PCR were established by testing
different temperatures, MgCl2 and BSA concentrations, and product
extension times. The primer’s set detected a 331-bp fragment of 23S
rRNA gene of Arcobacter sp. Each reaction mixture consisted of 2 ml
of DNA, 0.5 mM of each primer, 2mM MgCl2 and 2 ml of LightCycler
Fast-Star DNA Master SYBR Green I Mix in a reaction volume of 20ml.
The reaction was performed in a LightCycler 2.0 (Roche Applied
Science®) with a preliminary denaturation for 10min at 95ºC (slope
20ºC/s), followed by 40 cycles of denaturation at 95ºC for 10s (20ºC/s),
annealing at 58ºC for 4s (20ºC/s) and primer extension at 72 ºC for
14s (20ºC/s), with a single ﬂuorescence acquisition step at the end of
the extension. This was followed by melting point analysis of the DNA
product with continuous ﬂuorescence acquisition. A ﬁnal cooling step
was performed at 40ºC for 30s (20ºC/s). All the assays were performed
by duplicate.
Results: The real time PCR assay resulted in the expected 331-bp
ampliﬁed DNA fragment from all Arcobacter reference strains, with a
melting temperature ranging from 84 to 84.9ºC, and a range of Ct values
from 10.89 to 22.60 for different DNA concentrations. No ampliﬁcation
was observed when any strains different from Arcobacter spp. were
tested.
Conclusion: The real time PCR assay described in this study provides a
rapid and speciﬁc method to detect Arcobacter spp. and it could be very
useful for assessing Arcobacter contamination in environmental samples,
evaluating the risk of transmission via food chain and its potential as
Public Health Hazard.
P2002 Pili distribution among Streptococcus pneumoniae associated
with invasive disease in Portugal
S. Aguiar, I. Serrano, F.R. Pinto, J. Melo-Cristino, M. Ramirez
(Lisbon, PT)
Objective: Evaluate the distribution of the pilus islet among Streptococ-
cus pneumoniae isolated from invasive infections
Methods: Pilus-like structures were recently recognised in pneumococci
and implicated in the virulence of this bacterium. These structures
are encoded by the genes of the rlrA islet, and signature tagged
mutagenesis studies implicated the rlrA gene, encoding a putative
transcriptional regulator, as an essential virulence gene in murine models
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of infection. Nevertheless, the rlrA islet is not universally distributed
among pneumococcal strains.
To evaluate the distribution of the pilus islet, we determined the presence
of the rlrA gene as a marker for the locus, among a collection of
invasive isolates recovered in Portugal between 1999 and 2002, and
analysed its association with antibiotic resistance, capsular serotypes,
clusters deﬁned by pulsed-ﬁeld gel electrophoretic proﬁles (PFGE) and
multilocus sequence types.
Results: A minority of the isolates were positive for the presence of the
rlrA gene (27%). Nevertheless, serotype distribution analysis showed a
high correspondence between the serotype and the presence or absence of
the rlrA gene (Wallace coefﬁcient, W=0.778). Additionally, even within
serotypes, variation of the presence of the pilus islet between PFGE
clones was observed. A higher Wallace coefﬁcient between PFGE clones
and the presence of the locus (W=0.939) indicates that the presence of
the islet is a clonal property of S. pneumoniae. Analysis of rlrA negative
isolates revealed heterogeneity in the genomic region downstream of the
pﬂ gene, the region where the islet is found in other isolates, compatible
with recent loss of the islet in some lineages.
Conclusion: The low prevalence of the rlrA islet in our collection
of invasive isolates indicates that pili are not essential virulence
factors in human infections and that their potential use in a vaccine
would offer limited beneﬁts. However, its association with a widely
disseminated pneumococcal clone (Spain9V-3) may indicate that pili
could facilitate dissemination or colonisation of the host, as suggested
recently. Nevertheless, since serotype prevalence is changing as a
consequence of vaccine introduction, the acquisition of the pilus islet by
emerging clones or the increase in incidence of clones carrying the rlrA
islet may clarify the role of this surface structure in human infections.
Molecular biology of b-lactamases and other
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P2003 Complete nucleotide sequences of plasmids pEK204 and
pEK516, encoding CTX-M enzymes in two major UK
Escherichia coli strains
E. Karisik, M. Ellington, D. Livermore, N. Woodford (London, UK)
Objectives: E. coli strains with the CTX-M-15 ESBL have become
prevalent in the UK since 2003. They include 5 ancestrally-related
strains, A-E: A is the UK’s most prevalent ESBL-producing E. coli strain
and has the plasmid pEK499 (117,536-bp), sequenced previously; D is
local to one site; B, C and E are scattered. Some strain C isolates produce
CTX-M-3, rather than CTX-M-15 enzyme. We sequenced the blaCTX-
M-3 and blaCTX-M-15-harbouring plasmids pEK204 and pEK516 from
strain C and D representatives, respectively, and compared them with
pEK499 of strain A.
Methods. Plasmids pEK204 and pEK516 were transferred by conjugation
into E. coli J-53. Randomly sheared plasmid fragments were cloned into
pGEM-Teasy vector and transformed into E. coli DH10b. Inserts were
sequenced by dye terminator chemistry. Sequences were assembled using
the Staden Package. Combinatorial PCRs, directed PCRs, and walking
reads were used to assemble the sequences and to ﬁll-in gaps.
Results. Plasmid pEK516 (64,471-bp, strain D) harboured 103 predicted
open reading frames, with 7 antibiotic resistance genes – aac6′-Ib-
cr, aac3-IIa, blaCTX-M-15, blaOXA-1, blaTEM-1, catB4 and tet(A) –
clustered in a 22-kb region. Plasmid pEK204 (93,732-bp, strain C)
carried only blaCTX-M-3 and blaTEM-1. Both were conjugative IncFII
plasmids, but variations in their oriV sequences suggested that they
belonged to different sub-types. blaCTX-M genes were linked to an
ISEcp1 element in both cases, with a 128-bp link for blaCTX-M-3
on pEK204 and a 48-bp link for blaCTX-M-15 on pEK516. Plasmid
pEK516 shared 75% of its DNA sequence with pEK499, albeit with
considerable rearrangements. Plasmid pEK204 showed only c. 10%
homology with these plasmids.
Conclusion. Plasmid pEK516 (strain D) was highly related to plasmid
pEK499, which encodes CTX-M-15 enzyme in epidemic strain A,
but was 53-kb (45%) smaller, encoded gentamicin resistance, and was
conjugative. Plasmid pEK204 (strain C) was very different and had a
longer ISEcp1-blaCTX-M link, as in the Polish plasmid, pCTX-M-3. We
conclude that ancestrally-related E. coli strains have acquired different
plasmids encoding CTX-M ESBLs or separate occasions.
P2004 High prevalence of blaCTX-M-14 in Spain is mainly
associated with the dissemination of an epidemic plasmid
belonging to IncI complex
A. Valverde, R. Canto´n, A. Novais, J.C. Gala´n, F. Baquero, T.M. Coque
(Madrid, ES)
Objectives: CTX-M-14-producing isolates have sporadically been
described in some Asian, American and European countries but is one
of the most prevalent ESBLs in China, Canada and Spain. We described
the molecular characterisation of Spanish CTX-M-14 producing isolates
in order to understand their recent dissemination in our country.
Methods: We analysed 63 isolates from patients (16 hospitalised/17
non-hospitalized), 24 healthy volunteers and 2 food samples (2000–
2005). Clonal relatedness was established by XbaI-PFGE, MLST and
identiﬁcation of phylogenetic E. coli groups. Transfer of blaCTX-M-
14 was searched by broth and ﬁlter mating. Location of blaCTX-M-
14 genes was assessed by hybridisation of I-CeuI digested genomic
DNA with speciﬁc probes (rep, blaCTX-M-14, 16S rDNA). Plasmid
characterisation included detection of size and content (S1 nuclease),
identiﬁcation of incompatibility groups by PCR replicon-typing and the
rep-cop region and comparison of RFLP patterns. Genetic environment
of blaCTX-M-14 was characterised by screening the presence of
sequences associated with blaCTX-M-14 as ISEcp1, ISCR1, and further
PCR overlapping assays based of known sequence structures.
Results: CTX-M-14 producing isolates were mostly recovered from the
community (74.6%) and associated with urinary tract infections (60.3%).
Most isolates were identiﬁed as E. coli (98%) which were clonally
unrelated by PFGE and correspond to different phylogenetic groups:
A (37%), D (34%), and B1 (29%). MLST analysis revealed diversity of
ST among E. coli phylogroups D and B1 while isolates of phylogroup A
mostly belonged to ST10. blaCTX-M-14 was located in plasmids from
45 to 330kb and transferred by conjugation in most cases (75%). The
ISEcp1-blaCTX-M-14-delta IS903 platform was identiﬁed on a 80kb
plasmid belonging to the IncI complex (cop-rep region identical to that
of pR387 which was traditionally classiﬁed as IncK). In three isolates
(2002–03), blaCTX-M-14 was associated with a class 1 integron bearing
ISCR1(In60) as happen for blaCTX-M-9, suggesting recent evolution
from blaCTX-M-9 to blaCTX-M-14.
Conclusions: CTX-M-14 is associated with E. coli causing urinary
tract infections in the community. Recent increase of CTX-M-14 is
mainly associated to the spread of an epidemic plasmid belonging to
the IncI complex although other genetic environments also endemic in
our country might contribute to further spread and persistence.
P2005 International dissemination of a multi-resistant IncA/C2
plasmid containing blaTEM-24, Tn21 and Tn1696 among
epidemic and non-epidemic Enterobacteriaceae species
A. Novais, R. Canto´n, E. Machado, T. Curiao, F. Baquero, L. Peixe,
T.M. Coque (Madrid, ES; Oporto, PT)
Objectives: TEM-24 is a widely disseminated ESBL mostly associated
with epidemic Enterobacter aerogenes and Klebsiella spp. strains. The
aim of this study was to analyse clonal and plasmid diversity among
TEM-24 producing strains from 4 European countries.
Methods: Twenty eight TEM-24-Enterobacteriaceae isolates from
Portugal, Spain, France and Belgium identiﬁed as E. aerogenes (n = 13),
Escherichia coli (n = 6), Klebsiella pneumoniae (n = 6), Proteus mirabilis
(n = 2) and Klebsiella oxytoca (n = 1) were studied (1998–2004). Only
one isolate/patient was included. Clonal relatedness was established
by PFGE and E. coli phylogenetic groups were searched by PCR.
Antibiotic susceptibility testing and conjugation assays were performed
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using standard methods. Plasmid analysis included determination of
size (Barton’s method), incompatibility groups (rep-PCR, hybridisation,
and sequencing) and comparison of RFLP patterns. Characterisation
of integrons (class 1, 2 and 3), transposable elements and sul genes
was performed by screening of sequences related to these elements
(orf5, orf6, IS1326, IS1353, IS6100, tnpA, tnpR, tni, and mer),
PCR overlapping based on Tn21 and Tn1696 sequences, and further
sequencing.
Results: E. aerogenes, K. pneumoniae and P. mirabilis isolates
corresponded to single PFGE types while E. coli were clonally unrelated
(phylogroups D and A), all containing a 170–190kb-IncA/C2 conjugative
plasmid carrying blaTEM-24 and conferring resistance to kanamycin,
tobramycin, chloramphenicol, trimethoprim and sulfonamide. Different
multi-resistant sequences were identiﬁed: i) In4 integron (aacA4) within
Tn1696, ii) In0 derivative (dfrA1-aadA1) within Tn21 sequences, and
iii) Tn3.
Conclusions: International dissemination of TEM-24 is associated
with epidemic strains and an IncA/C2 epidemic plasmid containing
multiple and genetic platforms conferring a multi-resistant phenotype.
Interestingly, this trait was also conserved over the studied period.
P2006 Recent dissemination of blaTEM-52-producing
Enterobacteriaceae in Portugal is caused by spread of IncI
plasmids among Escherichia coli and Klebsiella clones
A. Tedim Pedrosa, A. Novais, E. Machado, R. Canto´n, L. Peixe,
T.M. Coque (Porto, PT; Madrid, ES)
Objectives: Since its ﬁrst description in 1996, TEM-52 has been sporad-
ically identiﬁed in Europe, Korea and Canada among Enterobacteriaceae
from both human and animals. An epidemic IncI1 plasmid containing
blaTEM-52 has been recently identiﬁed among Salmonella enterica in
France. We analysed the diversity of TEM-52 producing isolates from
Portugal in order to understand the reasons for recent spread in our
country.
Methods: Twenty one TEM-52-producing isolates recovered from
Portugal (n = 19 Escherichia coli; n = 2 Klebsiella pneumoniae) between
2002 and 2005 were studied. The isolates were obtained from hospitals
(n = 7), poultry (n = 12) and sewage (n = 2). Only one isolate/phenotype
was included. Clonality was established by PFGE and E. coli
phylogenetic groups by PCR as reported. ESBL identiﬁcation was
achieved by IEF, PCR and sequencing. Standard methods were used
for conjugation assays as well as antibiotic susceptibility testing. bla
location was accessed by hybridisation of I-CeuI-digested DNA with an
intragenic blaTEM-52 probe. Plasmid characterisation was accomplished
by the Barton’s method, identiﬁcation of plasmid incompatibility groups
by PCR, hybridisation and sequencing, and analysis of RFLP patterns.
Presence of sul genes and class 1 and 2 integrons was searched in wild-
type strains by PCR.
Results: High clonal diversity was found among studied isolates (n = 21
PFGE-types). Most E. coli clinical isolates were assigned to phylogenetic
group B1. E. coli recovered from poultry and sewage were identiﬁed as
phylogroups A (4 A0 and 3 A1), B1 (n = 2) and D (3 D1 and 1 D2).
Conjugation was achieved in 71% of the isolates. blaTEM-52 gene was
carried by two different plasmids of approximately 90kb and 30kb. They
contain sequences characteristic of incompatibility groups IncI1 (90kb)
and IncK (30kb), both belonging to the IncI plasmid group. All isolates
harboured one or more sul genes: sul1 (47%) mainly associated with
class 1 integrons, sul2 (65%) and sul3 (35%) which was mainly present
in poultry isolates.
Conclusions: Wide and recent dissemination of blaTEM-52 among
E. coli and K. pneumoniae strains from Portugal seems to be associated
with IncI plasmids rather than clonal expansion.
P2007 Characterisation of plasmids harbouring qnrS1, qnrB2
and qnrB5′ genes in Dutch quinolone-resistant Salmonella
isolates
K.T. Veldman, D.J. Mevius, A. Garcia-Fernandez, D. Fortini,
A. Carattoli (Lelystad, NL; Rome, IT)
Objective: The aim of this study was to identify and characterize
plasmids harbouring qnr genes in quinolone resistant Salmonella
isolated in The Netherlands. Recently the ﬁrst qnrB and qnrS genes
were described in isolates from patients and a broiler chicken from
Netherlands. QnrS1 was predominantly associated with serovar Corvallis
(25 strains), but it was also found in serotype Kentucky, Saintpaul,
Anatum, Montevideo and Stanley. QnrB2 was detected in one strain
of S. Bredeney and qnrB5′ in one strain of S. Typhimurium. Whereas
plasmid-mediated quinolone resistance of the qnr type is emerging in
Enterobacteriaceae worldwide, it remains rare in Salmonella. These
genes had previously been described in very few strains of Salmonella
in collections from USA, France and UK. The heterogeneity of the
strains indicates that the qnr genes are disseminated by plasmids but little
information is available on the type of plasmids carrying the different
qnr gene variants. Currently, there is only one small plasmid (10066 bp)
of the ColE family identiﬁed in a S. Typhimurium strain in UK.
Methods: Plasmids were transferred by conjugation or transformation to
a recipient E. coli K12 strain by standard methods. In the transconjugants
and transformants plasmids were categorised in Incompatibility groups
(Inc) or families by the PCR-based replicon typing and analysed by
RFLP. The b-lactamase blaLAP-2 was identiﬁed by PCR and sequencing.
Results: the qnrS1 gene was located on three kinds of plasmids, one
type of approximately 45–60 kb belonging to IncN identiﬁed in three
different Salmonella serotypes and one type consisting of small ColE
plasmid derivatives, identiﬁed in S. Corvallis, Anatum and Montevideo
strains. The third type of plasmid carrying qnrS1 was >205 kb, belonging
to the IncHI2 group, and positive for blaLAP-2 gene. This plasmid was
identiﬁed in a S. Stanley strain. Both qnrB2 as qnrB5′, were located on
conjugative IncN plasmids.
Conclusions: The molecular epidemiology of the qnr genes in
Enterobacteriaceae is explained by efﬁcient vertical and horizontal
transmission of these genes mediated by mobile genetic elements and
plasmids. The possibility to rapidly identify and recognize plasmid
scaffolds associated to the different qnr gene variants, assigning them
to speciﬁc families is very helpful to better trace the epidemiology and
spread of these variants in isolates from humans, environment and animal
sources.
P2008 blaVEB-6, a novel ESBL gene in a complex structure
Z. Zong, S. Partridge, J. Iredell (Westmead, AU)
Objectives: To characterize a blaVEB gene and its genetic context from
a local Proteus mirabilis isolate (JIE273) resistant to 3rd generation
cephalosporins.
Methods: JIE273 was identiﬁed as an ESBL-producer using the keyhole
disc approximation test. A blaVEB gene, but not blaCTX-M, blaTEM,
blaSHV, or blaGES genes, was detected by PCR and sequenced. Mating
experiments and electroporation were performed to try and obtain a
blaVEB-carrying plasmid from JIE273. The blaVEB gene was cloned
into pBBR1-MCS1 with and without the predicted promoter provided
by a adjacent repeated element (Re1). The MICs of various b-lactams
against transformants containing pBBR:VEB6 (blaVEB-6 alone) and
pBBR:VEB6pro (blaVEB-6 with Re1 promoter) were determined by
E-test. The genetic context of blaVEB-6 was determined by conventional
and long-range PCR.
Results: Sequencing of the blaVEB gene in JIE273 revealed a A53G
point mutation compared with blaVEB-4, the closest match, predicting
one amino acid substitution (I18V) in the leader peptide. This variant
was designated blaVEB-6. Despite repeated attempts, mating and
electroporation with JIE273 plasmid preparations were unsuccessful,
suggesting a possible chromosomal location for blaVEB-6. An E. coli
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transformant containing pBBR:VEB-6 was resistant to ceftazidime
(CAZ, MIC=32mg/mL), but not to cefotaxime (CTX, MIC=0.032)
and cefepime (CFP, MIC=0.075), indicating VEB-6 is a ceftazidimase.
However, an E. coli transformant containing pBBR:VEB-6pro was
resistant to CAZ (MIC> 256), CTX (MIC> 32) and CFP (MIC> 32),
indicating the strong activity of the promoter provided by Re1. blaVEB-6
was found in a similar genetic context to some other blaVEB genes,
associated with repeated elements (Re1 and Re2) and ﬂanked two copies
of 3′-CS. One 3′-CS was adjacent to a cassette array containing a novel
combination of gene cassettes (Figure 1).
Figure 1.
Conclusion: A novel blaVEB-type variant, blaVEB-6, has been detected
in Australia. Its product, VEB-6, is a ceftazidimase, but in the presence
of a strong promoter conferred additional resistance to CTX and CFP.
The two Re and/or the two copies of the 3′-CS ﬂanking blaVEB genes
might be involved in the spread these genes.
P2009 Genetic organisation of transposase regions surrounding
blaKPC carbapenemase genes on plasmids from
K. pneumoniae and E. cloacae
T. Gootz, M.K. Lescoe, B. Dougherty, F. Dib-Hajj (Groton, US)
Objectives: We previously described several carbapenem-resistant (CR)
K. pneumoniae from the NY-Presbyterian Hospital in NYC encoding
KPC carbapenemases. Such strains are spreading to other regions of
the US, South America, and the Middle East. We have determined the
sequence of the ﬂanking regions adjacent to the blaKPC and transposon
genes of K. pneumoniae and E. cloacae isolates to better elucidate the
mechanism of kpc transfer in these isolates.
Methods: Plasmids encoding the blaKPC gene were isolated from
several CR isolates using high speed Maxi kits and characterised by
standard restriction enzyme analysis. Plasmids (65 to 78 Kb) from
non-clonal strains (PFGE) were puriﬁed and submitted for total DNA
sequencing.
Results: Comparison of two plasmids from CR isolates revealed a
conserved 10 kb region representing a probable mobile element of high
G+C content (~62%). The region contains genes for three transposases
and two transposase-associated proteins, the blaKPC, and a 67% G+C
XerC-like recombinase gene that is often part of integrative and
conjugative elements (ICE elements). The genetic environment of the
element containing blaKPC-3 in the E. cloacae isolate indicated insertion
adjacent to DNA containing a disrupted copy of a Tn3 transposase with
nearly 100% identity to a penicillin resistance associated Haemophilus
inﬂuenzae ICE element and, further downstream, plasmid conjugal
transfer and transposase genes. A tnpR resolvase gene and the aad4
was located 11,000 bp upstream of blaKPC3. Further sequencing of the
E. cloacae plasmid indicated the presence of a class I integron, but
the blaKPC and ﬂanking transposase genes did not appear to be part
of this structure. Characterisation of the second plasmid from a CR
K. pneumoniae encoding bla KPC-2 revealed an identical 10 kb region,
but in this case the element disrupted a maturase gene from a group II
self-splicing intron.
Conclusion: Endemic outbreaks of CR K. pneumoniae encoding KPC
carbapenemases in NYC hospitals has become more common and this
resistance gene is now found in many other species of Enterobacteriaceae
and in Pseudomonas aeruginosa in several other parts of the world.
Our data agree with previous studies indicating that portions of
transposase genes ﬂank the kpc structural genes located in plasmids
from K. pneumoniae. In addition, we have found that some of these
transposase genes are intact and in some cases may be part of more
complex genetic elements.
P2010 Genetic structures at the origin of acquisition of the
b-lactamase blaKPC gene
T. Naas, G. Cuzon, M.V. Villegas, M.F. Lartigue, J. Quinn, P. Nordmann
(Kremlin-Bicetre, FR; Cali, CO; Chicago, US)
Objectives: Emergence and dissemination of Enterobacteriaceae isolates
harbouring carbapenemases is a signiﬁcant threat to the management
of nosocomial infections. The Ambler class A carbapenem-hydrolysing
KPC b-lactamase, which hydrolyse all b-lactams except cephamycins,
are increasingly reported in enterobacterial species, mostly in Klebsiella
pneumoniae initially from the US (especially from New York City
hospitals) but also from other countries from different continents, other
enterobacterial species or from Pseudomonas aeruginosa. The aim of
this work was to investigate the molecular determinants for this rapid
spread.
Methods: Genetic structures surrounding the carbapenem-hydrolysing
Ambler class A blaKPC gene were characterised by cloning, PCR
analysis and sequencing in several KPC-positive K. pneumoniae and
P. aeruginosa isolated from the US, Colombia and Greece. The strains
were analysed for their DNA content (genomic or plasmid) by plasmid
extraction, conjugation and electroporation assays.
Results: The blaKPC genes were associated with transposon-related
structures. In K. pneumoniae YC isolate from the US, the b-lactamase
blaKPC-2 gene was located on a novel Tn3-based transposon, Tn4401.
Tn4401 was 10 kb in size, delimited by two 39-bp imperfect inverted
repeat sequences, and harboured in addition to the b-lactamase blaKPC-2
gene, a transposase and a resolvase gene, and two novel insertion
sequences, ISKpn6 and ISKpn7. Tn4401 has been identiﬁed in all
isolates. Two isoforms of this transposon were found, Tn4401a found
in K. pneumoniae YC and K. pneumoniae GR, from the US and Greece,
respectively differed by a 100-bp deletion, located just upstream of
the blaKPC-2 gene, as compared to Tn4401b found in the Colombian
isolates. In all tested isolates, Tn4401 was ﬂanked by a 5-bp target site
duplication, signature of a recent transposition event, and was inserted
in different ORFs located on plasmids varying in size and nature.
Conclusion: Tn4401 is likely at the origin of the carbapenem-
hydrolysing b-lactamase KPC mobilisation to plasmids and its further
spread to various sised plasmids identiﬁed in non-clonally related
K. pneumoniae and P. aeruginosa isolates.
P2011 Diversity of blaOXA-48 genetic environments leading
to variable carbapenemase expression levels among
carbapenem-resistant Klebsiella pneumoniae isolates
A. Carre¨r, L. Poirel, P. Nordmann (Le Kremlin Bicetre, FR)
Objectives: The aim of this study was to investigate the mechanisms
responsible for variability of resistance to carbapenems among 39
carbapenem-resistant Klebsiella pneumoniae isolates expressing the
carbapenem-hydrolysing oxacillinase OXA-48 and involved in a hospital
outbreak in Istanbul, Turkey.
Methods: Genetic relationship of the 39 K. pneumoniae isolates
was assessed by pulsed-ﬁeld gel electrophoresis (PFGE). The genetic
environnement of the blaOXA-48 gene was studied by PCR combination
using speciﬁc primers of IS1999 and blaOXA-48 followed by sequenc-
ing. The level of expression of blaOXA-48 was evaluated by hydrolysis
assay using culture extracts of blaOXA-48-positive Escherichia coli
transconjugants.
Results: PFGE analysis revealed two distinct genotypes featuring clones
A and B (25 and 14 isolates, respectively). The IS1999 element was
identiﬁed upstream of the blaOXA-48 gene in both clones, providing
promoter sequences for blaOXA-48 expression in clone A isolates.
Among isolates belonging to clone B, insertion sequence IS1R was
inserted within IS1999 thus forming an hybrid promoter for blaOXA-48
expression. Hydrolysis measurements showed that the level of expression
of blaOXA-48 was twice in clone B than in clone A isolates.
Discussion: This study showed that higher resistance to carbapenems
in some blaOXA-48-positive K. pneumoniae isolates might be related
S592 18th ECCMID, Posters
to higher expression of this carbapenem-hydrolysing oxacillinase gene.
This discrepancy was linked to the insertion of an IS1R element
forming an hybrid promoter. It indicates an evolution of those OXA-48-
positive K. pneumoniae isolates disseminated in Istanbul toward higher
carbapenem resistance.
P2012 In vivo selection of carbapenem resistance in Acinetobacter
baumannii mediated by ISAba1 mobilisation upstream of
the blaOXA-51 natural oxacillinase gene
S. Figueiredo, L. Poirel, J. Croize, C. Recule, P. Nordmann (Le
Kremlin Bicetre, Grenoble, FR)
Objectives: To analyse the mechanism(s) involved in the acquired
resistance to carbapenems in A. baumannii under in vivo imipenem
selection pressure.
Methods: Species identiﬁcation was done by the biochemical API32 GN
test (bio-Me´rieux, France) and by 16S rRNA sequencing. Susceptibility
testing was done by disk diffusion method and Minimum Inhibitory
Concentration (MICs) were determined by agar dilution. Extended-
spectrum b-lactamase (ESBL) was revealed by performing double-
disk synergy test using disks containing ceftazidime or cefepime
and ticarcillin-clavulanic acid on Mueller-Hinton agar plates. AmpC
cephalosporinase hyperproduction was evaluated by performing cef-
tazidime susceptibility testing on cloxacillin-containing plates. Genes
coding for the carbapenem-hydrolysing class D b-lactamases OXA-23,
OXA-40, OXA-58 and OXA-51 subgroups were searched along with
the presence of blaTEM-type and blaSHV-type genes. The isolates were
analysed for the presence of ISAba1 in the promoter region of the
blaOXA-51-like and blaampC genes in order to investigate the role of
ISAba1 in blaOXA-51 and blaampC expression. Genotyping was done
by pulsed ﬁeld gel electrophoresis (PFGE) after digestion by ApaI.
Results: An imipenem-susceptible A. baumannii (A1) (MIC of 2mg/L)
isolate was recovered from rectal and wound swabs from an ICU
patient. After ten days of imipenem treatment, an imipenem-resistant
A. baumannii isolate (A2) (MIC 8mg/L) was recovered from an
endotracheal aspirate performed in the same patient. Genotyping
revealed that both isolates were clonally-related. Both strains harboured
blaTEM-1 gene and ISAba1 upstream of the blaampC gene leading
to ticarcillin and ceftazidime resistance. Both strains had a naturally-
occurring blaOXA-51-like gene with ISAba1 being identiﬁed upstream
of the blaOXA-51 gene of A. baumannii A2, thus leading to
overexpression of this carbapenem-hydrolysing oxacillinase.
Conclusion: This is the ﬁrst report of an in vivo selection of carbapenem-
resistance in A. baumannii. This acquired resistance trait was related
to selection of an ISAba1 mobilisation event leading to blaOXA-51
overexpression.
P2013 ISEcp1-mediated transposition of qnrB5 gene in Escherichia
coli
V. Cattoir, L. Poirel, J. Silva, P. Espinal, C. Soussy, P. Nordmann
(Le Kremlin Bicetre, FR; Cuernavaca, Morelos, MX; Monteria, CO;
Cre´teil, FR)
Objectives: Plasmid-mediated quinolone resistance due to Qnr determi-
nants is increasingly reported worldwide in enterobacterial isolates being
of the QnrA, QnrB and QnrS types. The qnrA-and qnrB-like genes are
often identiﬁed in sul1-type integrons (ISCR1-based mobilisation). The
aim of this study was (i) to investigate the genetic environment of a qnrB
gene identiﬁed in an Escherichia coli isolate recovered from Colombia,
and (ii) to experimentally evaluate the mobility of that structure in E. coli.
Methods: Cloning experiments were performed with EcoRI-restricted
whole-cell DNA of E. coli clinical isolate R4525 and the genetic
environment surrounding the qnrB gene was determined by primer
walking. The transcription start site was determined by 5’RACE analysis.
The ISEcp1-mediated mobilisation of the qnrB5 gene was attempted
from E. coli R4525 to recA (−) E. coli recipient strain using self-
conjugative and IS-free plasmid pOX38-Gen as a target for transposition
events.
Results: The qnrB5 gene was located at the right-hand extremity of
the ISEcp1 element, forming a 2,739-bp long transposon ﬂanked by a
5-bp duplication of the target site (ATCAA) and inserted inside orf1 of
Tn1721. As opposed to what has been reported for b-lactamase genes of
the CTX-M type, the qnrB5 gene was located in an opposite orientation,
relative to the transposase ORF of ISEcp1. Therefore, ISEcp1 did
not provide promoter sequences for its expression. ISEcp1B-mediated
transposition of qnrB5 into E. coli was successful in vitro and was found
to occur at a frequency of ca. 10−6 per donor by a mechanism similar
to one-ended transposition. The promoter sequences able to enhance the
qnrB5 expression were determined, being made of a −35 box (TTGACG)
and a −10 box (TACCAT) separated by a 17-bp sequence, with the
transcription start site located 30 bp upstream of the codon start. This
allowed us to consider the QnrB5 protein to be 214 amino-acid long thus
shorter than previously hypothesised.
Conclusion: These ﬁndings show that ISEcp1 is at the origin of
acquisition of the qnrB5 gene in E. coli. ISEcp1-like elements have
previously shown to mobilize b-lactamase genes (blaCTX-M) and rmtC
genes (resistance to aminoglycosides).
P2014 Salmonella enterica serovar Typhimurium isolates from
animal origin encoding blaCTX-M1 and harbouring a
non-common integron proﬁle related to a Salmonella
Genomic Island 1 variant
I. Rodrı´guez, J. Beutlich, A. Schroeter, R. Helmuth, W. Barownick,
B. Guerra (Oviedo, ES; Berlin, DE)
Objectives: Molecular characterisation of antimicrobial resistance (R)
in seven Salmonella (S.) Typhimurium isolates showing an ESBLs
phenotype and collected from different animals (4 from horse, 2 from
cat and 1 from bird) in the same German region during 2003–2006.
Methods: Among the S. enterica isolates from animal and food
origin (2003–2007) collected in the National Reference Laboratory for
Salmonella (NRL-Salm) collection (Berlin) showing full or intermediate
resistance to ceftiofur (MIC 4mg/L), 7 S. Typhimurium isolates were
selected for this work. All of them came from the same German region,
but were isolated from different years/animals. Their susceptibility to 17
antimicrobial agents (including the b-lactams ampicillin and ceftiofur,
and amoxycillin/clavulanic acid) by broth microdilution, and also for
a broader panel of 11 b-lactams by the disc-diffusion method was
tested. Molecular methods as PCR ampliﬁcations/sequencing, isoelectric
focusing, PFGE with XbaI, plasmid proﬁle analysis and Southern-
hybridisation were used to characterize the resistance determinants and
resistant isolates.
Results: All seven S. Typhimurium isolates were DT104L and
shared a common R-pattern: [AMP-AMCI-CEF-CXM-TIC-PRL-EFT-
CRO-CTX-CPD]-[CHL-FLO]-GEN-KAN-TET-SUL, with only minor
variations in some antimicrobials: [CAZ-ATM]-STR-SPE-TMP-SXT.
The R-genotype contained in all cases [blaCTX-M1-blaPSE-1]-ﬂoR-
tet(G)-sul1-aadB. Other genes as blaTEM-1, strA-strB, aadA1 or sul2
were also present in some isolates. The strains harboured two class 1
integrons with variable regions of 700 bp and aadB genes, and 1200
bp with blaPSE-1. The detection of this characteristic integron proﬁle
together with the presence of the genes ﬂoR and tetG suggests the
presence of a SGI1-variant. The seven S. Typhimurium isolates present
the same characteristic XbaI-proﬁle (frequent in DT104 strains), with
variations related to the presence of plasmids. Three different plasmid
patterns were found, all of them containing the S. Typhimurium virulence
plasmid (90 kb) detected by spvC PCR. The blaCTX-M1 genes were
located on three different plasmids with sizes between 90–110 kb.
Conclusions: The presence of blaCTX-M1 and the integron proﬁle 700
bp/ aadB, 1200 bp/ blaPSE-1 in combination with a similar XbaI-type
in seven Typhimurium isolates from the same region, are indicative for
the presence of a clone in the area which could have changed through
time and different animal hosts.
Molecular biology of b-lactamases and other resistance genes. Plasmids, integrons etc S593
P2015 Prevalence of In99 among Pseudomonas aeruginosa isolates
from a central region of Portugal (Aveiro) since 2003
T. Caetano, S. Ferreira, L. Tortas, F. Cerveira, E. Ramalheira,
S. Mendo (Aveiro, PT)
Objective: P. aeruginosa is an important pathogen responsible for
nosocomial infections, mainly among immunocompromised patients. In
the last years, several studies describing the occurrence of integrons and
their association with the increasing of antibiotic resistance have been
largely discussed. The aim of this work was to investigate the incidence
and prevalence of integrons in P. aeruginosa since 2003, in a central
region of Portugal (Hospital Infante D. Pedro, Aveiro).
Methods: P. aeruginosa isolates were recovered from patients of
different wards admitted to the hospital within a 48 h period. The isolates
were identiﬁed and antibiotic susceptibilities were determined by the
automatic VITEK2 system and Advanced Expert System (VITEK2
AES) (BioMe´rieux, Marcy L’E´toile, France). The detection of integrons
was performed by PCR followed by sequencing. All the nucleotide and
predicted amino acids sequences were analysed by Clustal W and Blast
programmes. The isolates phylogenetic relationship was investigated by
rep-PCR.
Results: Class 1 integrons were identiﬁed in 18% of the isolates
possessing ﬁve distinct gene cassette arrays (In0, In51, In99, In103 and
InEc682). In99 conferring resistance to aminoglycosides and b-lactams
was the only integron detected in isolates from all years of the timeframe
study. InEc682, containing the genes encoding dihydrofolate reductase
and ORFD, was present only in four isolates collected in 2003. In0 and
In51 were identiﬁed once in 2005. In103 was just detected in 2007’s
strains and it possesses the aac(6’)-Il, blaVIM-2 and aac(6’)-Ib genes.
The presence of class 2, class 3 integrons and plasmids was not detected.
Conclusion: This study demonstrates the prevalence of the In99 integron
in the Hospital Infante D. Pedro environment along the years. The
same integron was previously identiﬁed in a pig’s isolate suggesting
that other ecological niches, as for instance food production, can be
strongly involved in the antibiotic resistance genes inﬂux into the clinical
environment. Moreover, so far, In99 and In103 were detected only
in isolates from the north and central region of Portugal where the
exchange of patients between hospitals is recurrent. Furthermore, to our
knowledge, this is the ﬁrst report of InEc682 in P. aeruginosa isolates.
Class 1 integrons are spread in a considerable fraction of unrelated
P. aeruginosa isolates in these hospital-admitted patients and can be
useful to complement epidemiological studies.
P2016 Occurrence and molecular characterisation of class 1
integrons in Acinetobacter baumannii clinical isolates
collected from 1995 to 2006 in Portugal
A.S. Pereira, S. Domingues, S. Mendo, A. Duarte, G.J. Da Silva
(Coimbra, Aveiro, Lisbon, PT)
Acinetobacter baumannii (Ab) is often resistant to multiple antibiotics.
A major role in dissemination and evolution in antimicrobial resistance
has been attributed to integrons, especially class 1 integrons. The aim
of this study was to investigate the prevalence and the role of class
1 integron in mediating antibiotic resistance in Portuguese Ab clinical
isolates. The isolates comprised strains from 1995 until 2006. Previously,
we have shown the dissemination of clonally related multidrug-resistant
isolates (MDR clone) in various hospitals since 1999, that belongs to
a sub-lineage of European clone II [1,2]. Thus, representative isolates
from ﬁve hospitals, collected over time, were included, as well as, all
the isolates recovered before 1999 (showing a more susceptible and
variable antimicrobial proﬁle). Overall, 147 isolates were screened for
the presence of class 1 integrons by PCR with 5′CS and 3′CS primers,
with further sequencing of amplicons. The results showed that more then
an half (57.3%) of the isolates carried a class 1 integron and 11.7% had
more than one integron. Amplicons of ca 550–600, 800, 1000 and 2500
bp were observed. All amplicons from MDR clone carried an integron of
550 bp, coding for an unknown function protein, while only one code for
a protein of ferric transport (according BLAST search). The others code
for an aadB allele, IMP-5 determinant and an array cassettes of aaC1,
orfX, OrfX′ and aadA1, respectively, already described elsewhere. In
conclusion, Portuguese Ab isolates have revealed an unexpectedly high
genetic stability over this prolonged period of time with limited diversity
of gene cassettes, contributing only in part for the resistance observed.
Instead, it could reﬂect an evolution of a clone capable of acquiring other
mechanisms of resistance, whose integron structure appear quite stable
over time.
Reference(s)
[1] Da Silva GJ et al. (2007) Clin. Microb. Infect. 13:.190–195.
[2] Da Silva GJ et al. (2004) J. Antimicrob. Chemother. 54:.255–258.
P2017 Comparison of class 1 integrons from human and avian
E. coli
M. Psichogiou, A. Vasilakopoulou, G. Petrikkos, L. Tzouvelekis,
C. Kosmidis, E. Charvalos, M. Passiotou, A. Avlami, G.L. Daikos
(Athens, GR)
Objectives: A prospective study for the identiﬁcation and comparison of
class 1 integrons in E. coli from three sources: farm poultry, hospitalised
and non-hospitalized patients.
Methods: A total of 235 E. coli were collected; 80 from hospitalised
patients, 90 from non-hospitalized patients with no prior hospitalisation
in the preceding 3 months, and 65 from farm poultry. Identiﬁcation
of the isolates was performed by the Wider 1 automated system and
susceptibilities to commonly used antimicrobial agents were determined
by the Kirby-Bauer and broth microdilution methods. IntI1-speciﬁc
polymerase chain reaction (PCR), conserved-segment PCR, and DNA
sequencing were used to determine the presence, length, and content of
integrons. The relatedness among the isolates was examined by pulsed-
ﬁeld gel electrophoresis of the XbaI digests of genomic bacterial DNA.
Results: The rate of integron carriage was 49.2% for E. coli derived
from farm poultry, 26.2% and 11.1% for isolates recovered from
hospitalised and non-hospitalized patients. The length of the integrons’
variable regions ranged from 500 to 2700 bp. 96.8% of integron-carrying
organisms exhibited resistance to more than two classes of antibiotics
(MDR), whereas only 34.8% of non-integron-carrying organisms were
MDR (P< 0.001). The most prevalent genes were the aad and dfr gene
families detected in 71.4% and 65% of sequenced integrons respectively.
Identical integrons were detected in E. coli of human and animal sources.
Conclusion: A large reservoir of integrons exists in E. coli of food-
producing animals. The horizontal transfer of class 1 integrons among
bacteria of animal and human origins seems to play an important role
in the dissemination of antimicrobial resistance.
P2018 Characterisation of an unusual class 1 integron in
Escherichia coli isolates of animal origin
Y. Sa´enz, D. Costa, L. Vinue´, S. Somalo, E. Ruiz, F. Ruiz-Larrea,
M. Zarazaga, C. Torres (Logron˜o, ES)
Objective: To characterize the gene cassette arrangement inside an
unusual class 1 integrons that lack the 3′-conserved region, detected
in Escherichia coli isolates of animal origin.
Methods: In a prevalence study of class 1 integrons in cotrimoxazole-
resistant E. coli isolates of animal origin, two strains (Co125 and C1188)
harbouring an unusual class 1 integron that lacked the qacED1 and
sul1 genes on the integron 3′-conserved region, were detected. The
Co125 and C1188 strains were obtained from faecal samples of a pig
and a dog, respectively. The antimicrobial resistance phenotypes were
determined by disk diffusion method and the presence of antibiotic
resistance genes was analysed by PCR, and sequencing. Based on the
known integron sequences previously included in GenBank (accession
numbers EF051037 and EF113389), a wide variety of primers were
designed to determine the genetic structure of their class 1 integrons,
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using the PCR and sequencing primer-walking strategy, and the PCR-
RFLP analysis with different restriction enzymes.
Results: The E. coli Co125 showed a multiple-antibiotic-resistant
phenotype (resistant to nalidixic acid, ciproﬂoxacin, ampicillin, rifampin,
tetracycline, chloramphenicol, sulfamethoxazole, trimethoprim, and
streptomycin), and the E. coli C1188 was resistant to tetracycline,
chloramphenicol, sulfamethoxazole, trimethoprim, and streptomycin.
The tetA, cmlA, sul3, dfrA12, aadA1 and aadA2 genes were found
in both strains, and additionally, the blaTEM1b and dfrA1-like genes
were detected in the Co125 strain. The same gene cassette combination
associated to the sul3-domain was observed in the unusual integron
of both strains, which included in the 7.1 kb sequenced fragment
downstream the intI1 gene, the following arrangement: dfrA12-orfF-
aadA2-cmlA1-aadA1-qacH-IS440-sul3.
Conclusions: To our knowledge this is the ﬁrst report of multiresistant
unusual class 1 integron structure in E. coli isolates of animal origin. The
inclusion of a variety of resistance genes inside integrons constitutes an
effective means to spread multiple antibiotic resistance among bacteria
from different ecosystems.
P2019 Diversity of sul genes (sul1, sul2 and sul3) among human
clinical Enterobacteriaceae isolates recovered during the
last two decades in Spain (1988–2006)
T. Curiao, E. Machado, L. Peixe, R. Canto´n, F. Baquero, T. Coque
(Madrid, ES; Porto, PT)
Objectives: Enterobacteriaceae are often resistant to antibiotics not
currently used in the clinical setting as sulfonamides (sul) or
streptomycin (str). The diversity of sul and str genes among extended-
spectrum b-lactamase (ESBL) and non-ESBL Enterobacteriaceae is
analysed.
Methods: We studied 344 isolates (249 E. coli, 56 K. pneumoniae,
23 Enterobacter, 7 K. oxytoca, 6 Salmonella enterica Paratyphi, and
3 Citrobacter) corresponding to (i) ESBL- and metallo-b-lactamase-
producing isolates (TEM-4, -12, -24, -27, -52; SHV-2, -5, -12, -13;
CTX-M-1, -3, -9, -10, -14, -15, and -32; VIM-1, n = 234], (ii) clinical
non-ESBL isolates (n = 70) and (iii) faecal non-ESBL isolates (n = 40)
from 1988 to 2006. Antibiotic susceptibility was tested by disk diffusion
(CLSI). Presence of sul and str genes and sequences related to their
known genetic platforms (Class 1 integrons, ISCR2, RepCpRSF1010,
QacH, IS26) were analysed by PCR and/or hybridisation. Genetic
environment was characterised by PCR overlapping, long-PCR-RFLP
and sequencing.
Results: Resistance to sulphonamides was similar among ESBL and
non-ESBL isolates (55% vs 48%). Sul genes were absent in 6% of
sulphonamides resistant and present in 8% of susceptible isolates. They
were transferable in 48% of the cases, being mostly associated with
streptomycin (79%), tetracycline (77%) and trimethoprim (75%) and
sporadically with b-lactam resistance. sul1 was more commonly found
than sul2 or sul3 (48%, 36% and 5%, respectively), and presence of
more than one sul gene was frequent (27%). sul1 was mainly associated
with class 1 integrons (78%) widely distributed in different species
and plasmids. sul2 was associated with pRSF1010 sequences (RepC-
sul2-strA-strB, 20%), or different ISCR2 platforms (18%): ISCR2-
glmM-sul2, ISCR2-strB-strA-sul2 or ISCR2-IS26-strB-strA-sul2. Two
strains contained both ISCR2 and RepC-sul2-strA-strB elements. A high
number (69%) was not associated with known sequences. sul3 gene was
only detected among E. coli irrespective of ESBL production (n = 16) and
was mostly associated with different unusual class I integrons containing
qacH (n = 13).
Conclusions: sul genes are widely spread among human Enterobacte-
riaceae isolates and sporadically linked to ESBL plasmids. Although
most sul genes were associated with widely spread platforms as class
1 integrons (sul1, sul3) or pRSF1010 (sul2), a high number of isolates
was not associated with known sequences which indicates other unknown
reservoirs for these genes.
P2020 Replicon typing of plasmids carrying the sul3-atypical
integrons among Salmonella isolates
P. Antunes, A. Novais, T.M. Coque, L. Peixe (Porto, PT; Madrid, ES)
Objectives: The spread of atypical sul3-integron platforms containing
three different gene cassette arrays has been recently detected among
Salmonella isolates from Portugal. The aim of this study was to
characterize the plasmids associated with these genetic elements in a
large collection of Portuguese Salmonella isolates.
Methods: Fifty-two representative isolates carrying sul3-atypical inte-
grons (n = 22) and class 1 integrons (n = 30) from different sources
(human, food products and environment), serotypes and PFGE-
clones were studied. Plasmid analysis included determination of size
(Barton’s method), comparison of RFLP patterns and characterisation
of incompatibility groups by rep-PCR typing method and further
hybridisation.
Results: Plasmids belonging to different Inc groups were identiﬁed.
Those carrying sul3 type I-integrons (5′CS-dfrA12-orfF-aada2-cmlA1-
aadA1-qacH-tnpA-sul3-tnp) were diverse and classify as IncI1 (conjuga-
tive, 100 Kb, in 2 clones, 2 serotypes), IncN (non-transferable, 135 Kb,
n= 1 strain) and FIIA (transferable, 100–165 Kb, 2 clones of 2 serotypes),
a common replicon among Salmonella virulence plasmids. Plasmids
carrying the sul3 type II-integrons (5′CS-dfrA12-orfF-aadA2/1-qacH-
tnpA-sul3-tnp), only described in the MDR S. Rissen clone, did not
amplify with rep primers we used (70 Kb). The sul3 type III-integrons
(5′CS-estX-psp-aadA2-cmlA1-aadA1-qacH-tnpA-sul3-tnp) were located
in non-transferable IncA/C plasmids, (150, 170 and 220 Kb) of S.
Typhimurium DT104, or in a conjugative IncHI1 plasmid (240 Kb) of
a non-DT104 S. Typhimurium isolate. IncFII plasmids were detected
in several isolates carrying class 1 integrons, but the majority of these
isolates were negative by rep-PCR method.
Conclusion: The atypical sul3-integron platforms are located within
plasmids of different Inc plasmid groups, some of them restricted to
speciﬁc clones, and mostly not related to those carrying class 1 integrons
in Salmonella.
P2021 Frequency and molecular epidemiology of integron-carrying
Salmonella enterica ser Typhimurium isolates from the
health region of Terres de l’Ebre, northeastern Spain
M.O. Pe´rez-Moreno, M.J. Centelles, M.I. Llovet, M. Cortell, J. Ruiz,
A.M. Jardı´, M.P. Cid (Tortosa, Barcelona, ES)
Objectives: To compare the frequency and features of class 1 integrons
among clinical isolates of S. enterica ser Typhimurium recovered over
two periods (2000–01 and 2004–06) from patients from Terres de l’Ebre
(North East Spain) as well as to investigate the clonal relationship amid
isolates displaying identical integron proﬁle (IP).
Methods: Isolates were identiﬁed by conventional biochemical methods
and serotyped and phagetyped at the National Reference Centre for
Salmonella. In vitro susceptibility to nitrofurantoin (Nf), amoxicillin (A),
tetracycline (T), streptomycin (St), chloramphenicol (C), sulfonamides
(Sul), cotrimoxazole (T/S) and other antibiotics was studied by
microdilution or disk diffusion. The presence of class 1 integrons and
of several resistance genes within their variable region was investigated
by PCR; integron gene content from at least one isolate exhibiting each
different IP was conﬁrmed by sequencing. Relationship among integron-
carrying isolates was assessed by ERIC and REP-PCR.
Results: (a) Class 1 integrons were present in 44.8% (43/96) of isolates
recovered during 2000–01 and in 55.4% (51/92) of those recovered
during 2004–06. (b) Four different IP were identiﬁed [I: 2 Kb/ oxa-1-
aadA1; Ib: 2 Kb/ oxa-1-aadA1+ 1.6 Kb/ dfrA1- aadA1; II: 1Kb/ aadA2
+ 1.2 Kb/ pse-1; III: 1.2 Kb/ pse-1]. IP I was demonstrated in 20.8%
of isolates obtained between 2000 and 2001 and in 35.9% of 2004–06
isolates; IP Ib in 0% and 3.3%; IP II in 24% and 14.1% and IP III in
0% and 2.2%. (c) Resistance phenotypes: IP I [Nf-A-T-St-C-Sul]; IP Ib
[Nf-A-T-St-C-Sul-T/S]; IP II [A-T-St-C-Sul] and IP III [A-T-C-Sul]. (d)
ERIC and REP-PCR combined patterns revealed six different genotypes
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among integron-carrying isolates with most isolates (79%) belonging to
a majority genotype, irrespective of their IP or phagetype, while the ﬁve
minority genotypes were speciﬁc of certain IP. Genetic diversity was
more common in isolates with IP I.
Conclusions: Frequency of integron-harbouring S. Typhimurium isolates
has substantially increased over the research period, at the expense of
those carrying an integron bearing oxa-1 and aadA1 genes – which
have superseded isolates displaying the IP typical of the pandemic
clone of S.Typhimurium DT104. The emergence of integron-related
multidrugresistant isolates of S. Typhimurium seems to be mainly due
to the spread of a predominant clone, although horizontal transfer of
genetic resistance elements may also have occurred.
P2022 Genetic relatedness among isolates of Shigella sonnei
carrying class 2 integrons in Tehran, Iran, 2002–2003
R. Ranjbar, C. Mammina, A. Aleo, G.M. Giammanco, A.M. Dionisi,
M.M. Soltan-Dallal, M.R. Pourshaﬁe, N. Sadeghifard (Tehran, IR;
Palermo, Rome, IT; Ilam, IR)
Objective: The present study was carried out to investigate genetic
relatedness among isolates of Shigella sonnei carrying class 2 integrons
in Tehran, Iran, 2002–2003.
Material and Methods: Biotyping, drug susceptibility testing, pulsed
ﬁeld gel electrophoresis (PFGE) and analysis of class 2 integrons have
been carried out on 60 S. sonnei isolates, including 57 sporadic isolates
from paediatric cases of shigellosis occurring in 2002 and 2003, two
sporadic isolates recovered in 1984 and the ATCC 9290 strain.
Results: Biotype g and resistance to streptomycin, sulfamethoxazole-
trimethoprim and tetracycline were exhibited by 54 of the 57 recent
isolates. Of the 54 biotype g isolates, 28 exhibited a class 2 integron
of 2161 bp, and 24 a class 2 integron of 1371 bp, respectively. Class
2 integrons were not detected in four isolates only, including the two
endemic isolates recovered in 1984 and two strains from recent sporadic
cases. PFGE divided the strains into eight pulsotypes labeled A to H,
three major pulsotypes – A to C – including the large majority of the
recent sporadic S. sonnei isolates. Pulsotypes A and C were the most
prevalent groups, accounting for 41.6% and 35.0%, respectively, of the
isolates under study.
Conclusion: The results suggest that biotype g, class 2 integron carrying
S. sonnei are prevalent in our geographic area. S. sonnei isolated in the
years 2002 and 2003 could be attributed to a few predominant clusters
including, respectively, strains with pulsotypes B and C carrying a 2161
bp class 2 integron, and those having pulsotype A and a 1371 bp class
2 integron. A few epidemic clones are responsible for the apparently
endemic occurrence of shigellosis in Tehran, Iran.
P2023 Differences in the distribution of common trimethoprim
resistance dfr-genes in E. coli and K. pneumoniae
A. Motakeﬁ, M. Sundqvist, G. Kahlmeter, M. Grape (Stockholm,
Va¨xjo¨, SE)
Objectives: The most important dissemination pathway of trimethoprim
resistance is through horizontal gene transfer of dfr-genes. Most dfr-
genes are carried as gene cassettes in integrons often situated on
plasmids. This study describes the distribution of ﬁve commonly
occurring genes and mobile elements associated with trimethoprim
resistance in Escherichia coli vs. Klebsiella pneumoniae.
Methods: Isolates from urinary cultures of E. coli and K. pneumoniae
resistant to trimethoprim were consecutively collected at the Dept of Clin
Microbiology, Va¨xjo¨ during 2004–2007. Within three periods, during
2004, 2005 and 2006, 320 E. coli isolates were collected whereas
55 K. pneumoniae isolates were collected during the entire period.
Susceptibility testing was performed as recommended by the Swedish
Reference Group on Antibiotics. Detection of the ﬁve most common
trimethoprim resistance genes reported in E. coli; dfrA1, dfrA5, dfrA7,
dfrA12 and dfrA17, was performed using a real-time multiplex PCR.
Integrons, class 1 and 2, were screened for with PCR.
Results: The frequency of class I integrons among the E. coli isolates
was 72% and class II integrons 13%. K. pneumoniae isolates carried
class I integrons in 38% and class II integrons in 4%.The prevalence of
the dfr-genes were in E. coli and K. pneumoniae respectively dfrA1: 35
and 13%, dfrA5: 16 and 13%, dfrA7: 5 and 2%, dfrA12: 4 and 13% and
for dfrA17: 26 and 2%.
Conclusions: The ﬁve dfr-genes were found in 86% of the E. coli
isolates while they only explained trimethoprim resistance in 43% of
the K. pneumoniae isolates. The dfrA17 gene is one of the most
frequent dfr-genes in E. coli but was a rare ﬁnding in K. pneumoniae.
On the other hand, dfrA5 was as common in K. pneumoniae as in
E. coli. The integron frequency also differed. This type of descriptive
resistance gene data is usually available for the most common species
as E. coli. As shown here, that information is not always generally
applicable to other related species. To deﬁne the composition of dfr-
genes in K. pneumoniae, further characterisation of the material will be
performed. The differences observed might be explained by differences
in plasmid host range and could be important in understanding the
increasing trimethoprim resistance seen in both investigated species.
P2024 Investigation of role of IS elements in conversion to hyper-
mutability and emergence of drug resistance in Pseudomonas
aeruginosa from CF patients in Cape Town, South Africa
J.C. Evans, N. Motilal, H. Segal (Cape Town, ZA)
Objectives: Cystic ﬁbrosis (CF) patients frequently succumb to
infections with P. aeruginosa, in part due to its ability to adapt to the
CF lung environment. Continual antibiotic therapy drives the emergence
of multi-drug resistant (MDR) P. aeruginosa, further compromising the
treatment of CF patients.
A plethora of insertion sequence (IS) elements have been described in
P. aeruginosa. Some IS elements play a role in emergence of antibiotic
resistance through insertional inactivation of genes. Additionally, IS6100
causes large chromosomal inversions (LCIs) that disrupt genes involved
in CF lung pathogenesis. IS6100 is of particular concern as it is
associated with conversion to hypermutability, resulting in increased
rates of spontaneous mutations, often associated with MDR.
The aim of this study was to determine whether IS elements are
associated with resistance, particularly to imipenem (IPM), and whether
IS6100 plays a role in conversion to hypermutability in P. aeruginosa
strains from CF patients in Cape Town.
Methods: CF and non-CF P. aeruginosa isolates (52) obtained from
patients at two local hospitals during 2000–2006 were included in the
study.
PCR ampliﬁcation of oprD from all IPM-resistant strains (75) was
carried out to detect insertions that could account for imipenem
resistance.
Strains shown to contain IS6100 by PCR were included in Southern
hybridisation experiments to determine IS6100 copy number.
Mutator assays were carried out and strains were considered hyper-
mutable if their mutation rates were more than 20 times that of
P. aeruginosa PAO1.
Results: PCR ampliﬁcation of oprD in 74 isolates yielded a product of
the expected size (1343bp), while the remaining isolate, strain 8, yielded
a product of 2400bp. Sequence analysis revealed that oprD from strain
8 was interrupted by insertion of a novel IS element, designated ISPa26.
IS6100 was detected in 2 CF and 11 non-CF isolates. Interestingly, strain
6 harbours at least three copies of IS6100, which is associated with LCIs.
Of the CF P. aeruginosa isolates, 4 were hypermutable. However, isolates
containing IS6100 had mutation rates comparable to P. aeruginosa PAO1.
Conclusion: Insertional inactivation of oprD by ISPa26 accounts for
IPM resistance in strain 8.
As IS6100 was not associated with conversion to hypermutability, further
investigation into the genetic environment of IS6100 is necessary as
transmission of this element to CF isolates may negatively impact care
and treatment of CF patients.
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P2025 The Acinetobacter baumannii ATPase gene in diverse strains
is frequently occupied by integrated genomic islands
F. Shaikh, R.P. Spence, K. Levi, K.J. Towner, K. Rajakumar (Leicester,
Nottingham, UK)
Objectives: To determine if the ATPase gene of genetically diverse
A. baumannii strains harbour integrated genomic islands.
Methods: RAPD-PCR was used to investigate the genetic diversity of
ﬁfty A. baumannii strains that were originally isolated from various
clinical specimens. PCR-based interrogation was used to identify strains
with a presumed disrupted ATPase gene. PCR mapping and chromosome
walking were then used to provide deﬁnitive evidence of the presence
of ATPase-borne, chromosomally integrated, genomic islands in these
strains. An ATPase-speciﬁc yeast capture vector was constructed to
enable cloning and characterisation of selected elements.
Results: RAPD-PCR analysis demonstrated that the strains examined
possessed substantial genetic diversity. Forty one of ﬁfty strains tested
contained a disrupted ATPase gene. Of 15 island-bearing strains
subjected to further analysis, 8 were found to contain elements with
ends matching one (2 strains) or both (6 strains) extremities of AbaR1,
the ﬁrst A. baumannii resistance island to be described; the remaining 7
strains possessed islands with ends distinct to those of AbaR1. Using a
recombination-based yeast capture system, we have cloned the integrated
element present within the ATPase gene of A. baumannii strain A14. In
an E. coli background, this element confers resistance to ampicillin,
chloramphenicol and gentamicin, making it only the second known
A. baumannii resistance island to be reported.
Conclusions: The ATPase gene of A. baumannii strains is frequently
occupied by genomic islands. Preliminary data suggest that in addition
to AbaR1-related islands, other distinct entities may also be capable of
targeting this integration locus.
P2026 Multiresistance in Pasteurella multocida is due to
cohabitance of small replicons
A. San Millan, J. Escudero, S. Nieto, B. Gutierrez, L. Hidalgo,
L. Dominguez, M.A. Moreno, B. Gonzalez-Zorn (Madrid, ES)
Objectives: Pasteurella multocida is a world-wide-distributed pathogen
responsible for a large variety of diseases. In the last years there has been
an increase in reports due to P. multocida causing human pneumonia and
meningitis as a result of pet biting or close contact to farm animals.
Tetracyclines and b-lactams are the two main antimicrobial families used
as therapeutic tool against this pathogen. The objective in this work was
to study the molecular basis of antimicrobial multiresistance mechanisms
in P. multocida strains.
Methods: Antimicrobial susceptibility tests were performed following
CLSI standard procedures. Pulsed Field Gel Electrophoresis (PFGE) was
performed after total DNA digestion with ApaI. A blaROB-1 speciﬁc
probe was used for Southern Blot. Plasmid Midi Kit (Qiagen) was
used for plasmid puriﬁcation. DNA digestions were performed following
manufacturer’s instructions. Automated sequencing was carried out at
Secugen S. L. (Madrid, Spain). Sequence analysis was performed with
DNA Strider software (France).
Results: Out of 604 P. multocida animal isolates identiﬁed between 2002
and 2005 in our laboratory, thirteen (2.15%) showed high-level resistance
to b-lactams. Resistance was due to blaROB-1 borne in plasmid pB1000,
a 4613 pb replicon recently described in Haemophilus parasuis (San
Millan, A et al. Antimicrob Agents Chemother. 2007, 51: 2260−4.).
PFGE analysis of the isolates revealed different proﬁles among the
strains, showing that clonal dissemination is not responsible for spread
of this phenotype. In addition to b-lactam resistance six of the twelve
strains were concomitantly resistant to tetracycline, ﬁve were high-level
resistant to streptomycin and two were resistant to both molecules.
Every single multiresistance pattern from these strains corresponded to a
unique plasmid proﬁle, indicating that resistance was related to plasmid
content. Complete nucleotide sequence of all plasmids was determined.
We describe seven different replicons, each one bearing one, maximum
two antimicrobial resistance determinants: pB1000 (blaROB-1), p13142
(tet(O)), p9956 (tet(H)), pTYM1 (sul2, strA), pB1001 (tet(B)), pB1002
(blaROB-1) and pB1003 (sul2, strA). All plasmids could be mobilised
into Escherichia coli.
Conclusion: Multiresistance in P. multocida is due to cohabitance
and spread of small plasmids bearing different antimicrobial resistance
determinants.
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P2027 Characterisation of a P. aeruginosa mutM mutY double
mutant
L.F. Mandsberg, M.D. Macia´, O. Ciofu, A. Oliver, L.E. Christiansen,
N. Høiby (Copenhagen, DK; Palma de Mallorca, ES; Lyngby, DK)
Objectives: The chronic lung infection with Pseudomonas aeruginosa
in the lungs of patients with cystic ﬁbrosis (CF) is characterised by
the bioﬁlm mode of growth and a chronic inﬂammation dominated
by polymorphonuclear leukocytes (PMNs). A high percentage of
P. aeruginosa strains show high frequencies of mutations (MF) and
these isolates also showed signiﬁcantly higher resistance to anti-
pseudomonal drugs. It has previously been shown that hypermutable,
resistant P. aeruginosa isolates have mutations in genes involved with
DNA methyl-directed mismatch repair (MMR).
P. aeruginosa are exposed to many oxygen-radicals both generated by
its own metabolism and especially from a huge number of PMNs which
release oxygen-radicals in response to the chronic CF-lung infection. To
combat the mutagenic consequences of 8-oxodG the mutT, mutY and
mutM from the DNA oxidative repair system (GO) plays an important
role. Previously it has been found that knock out of both mutY and
mutM in E. coli have a synergistic effect on the MF.
Methods: We have constructed PA01 mutY mutM double mutant using
the Lox system and characterised the mutant through determination
of mutation frequency, mutation rate (mutations/cell/generation) and
susceptibility using E-test.
Results: Our result demonstrates that in combination this two repair
gene enhances mutation frequency over 130 fold compared to PAO1
and 89 and 18 fold increase compared to either mutM or mutY mutator
respectively. Mutation rate show similar results. The PA01 mutY mutM
double mutant is as strong as the mutS mutator from the MMR system
and show a similar susceptibility phenotype with an increase in the size
of the resistant mutant subpopulations.
Conclusion: We have found it to be common for clinical CF strains
to harbour mutations in several of the repair genes suggesting that
interaction of oxygen-radicals and GO deﬁciency plays a role for the
adaptation of P. aeruginosa to the stressful CF lung environment.
Oxidative stress might be involved in development of resistance to
antibiotics and suggest the possible use of antioxidants for prevention of
resistance development.
P2028 Mutagenesis of putative substrate binding residues in the
Escherichia coli RND type multidrug efﬂux pump AcrB
J.A. Bohnert, S. Schuster, E. Fa¨hnrich, W.V. Kern (Freiburg, DE)
Background: The E. coli AcrB multidrug resistance (MDR) efﬂux
pump confers resistance to a wide variety of chemically unrelated
compounds. Recent crystallographic studies including analysis of
doxorubicin (DOX)- and minocycline (MIN)-complexed crystals have
suggested that the pump is an asymmetric trimer with one protomer
forming a pocket rich in aromatic side chains including phenylalanines
136, 178, 610, 615, 617, and 628. To examine whether these residues are
involved in the binding/transport of these and other substrates of AcrB,
we constructed and tested mutants to identify key residues involved in
AcrB multidrug binding.
Methods: A phage lambda based homologous recombination system
(Red/ET) was used to introduce an rpsL-neo cassette into acrB of
E. coli 3-AG100 and to subsequently replace the cassette by an
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appropriate oligonucleotide resulting in conversion of phenylalanines
into alanine. By the same method we constructed as a control the
F628F pseudomutant (wild type amino acid sequence, replacement of
TTT for GTT). Susceptibility to various compounds including ethidium
bromide (EtBr), Hoechst33342 (HOE), DOX, novobiocin, and the efﬂux
pump inhibitors (EPIs) phenyl-arginine-b-naphthylamide (PAbN) and
1-naphthylmethylpiperazine (NMP) was measured by a microdilution
assay. Cellular accumulation of selected substrates was also assayed.
Results: Based on a comparison of the MICs for the F628F pseudo-
mutant and a pump-deﬁcient (AcrB::rpsL-neo) control strain, the “best”
substrates (MIC ratio >32) were oxacillin, DOX, novobiocin, macrolides,
pyronine Y, and HOE while “intermediate” substrates (MIC ratio 8–
32) were linezolid, MIN, EtBr, levoﬂoxacin, ciproﬂoxacin, propidium
iodide, PAbN, and chloramphenicol. Gentamicin, spectinomycin and
NMP were no substrates. Mutations F610A and F178A had the most
signiﬁcant impact on substrate MICs. The triple F615A/F617A/F628A
mutant affected MIC values of almost all tested substrates. Surprisingly
little impact on the MICs were noted for DOX and MIN. Accumulation
assay results with DOX, NMP, PAbN, and EtBr correlated with the
observed changes in the MICs.
Conclusions: The results are consistent with the view that some of
phenylalanine residues 136, 178, 610, 615, 617, and 628 funtion as
binding residues of the AcrB protein. The putative pocket formed by
these residues provides the ﬂexibility needed for an efﬁcient MDR efﬂux
pump. The EPIs PAbN and NMP may have different primary targets and
mechanisms of action.
P2029 Regulation of efﬂux-mediated multidrug resistance by
the ramR-ramA region in Salmonella enterica serovar
Typhimurium
S. Baucheron, Y.M. Abouzeed, A. Cloeckaert (Nouzilly, FR)
Objectives: To study the regulation of efﬂux system expression in
multidrug resistant (MDR) Salmonella enterica serovar Typhimurium
(S. Typhimurium) DT104 and DT204 strains.
To determine the involvement of two transcriptional regulators in
multidrug resistance and in overexpression of the AcrAB efﬂux pump.
Methods: Identiﬁcation in the sequenced genome of S. Typhimurium
strain LT2 of an open reading frame coding for a putative regulatory
protein of the TetR family upstream of the ramA gene whose gene
product, homologous to MarA, when overxepressed confers a multidrug
resistance (MDR) phenotype in several bacterial species.
Characterisation of the role of this putative regulatory protein gene
was done by its inactivation and by complementing experiments. The
measure of the expression level of ramA was done by RT-PCR and that
of the AcrAB efﬂux pump by Western blotting. Sequencing of this region
was also performed in strains overproducing AcrAB to identify possible
mutations involved in deregulation of ramA expression.
Results: Inactivation of the putative regulatory protein gene upstream
of ramA in a susceptible S. Typhimurium strain resulted in a
MDR phenotype with a 4-fold increase of resistance levels to
unrelated antibiotics such as quinolones, ﬂuoroquinolones, phenicols,
and tetracycline. Inactivation of this gene resulted also in a 4-fold
increased transcription of ramA and a 4-fold increased expression of
the AcrAB efﬂux pump. These results indicated that the gene encodes a
local repressor of ramA and was thus named ramR.
In quinolone- or ﬂuoroquinolone-resistant strains of S. Typhimurium
overexpressing AcrAB several mutations were identiﬁed in ramR which
consisted of point mutations resulting in amino acid changes or an in
frame shift and also of interruption of ramR by an IS1 element in high-
level ﬂuoroquinolone resistant S. Typhimurium DT204 strains. One S.
Typhimurium DT104 isolate had a two nucleotide deletion in the putative
RamR binding site found upstream of ramA. These mutations were
conﬁrmed to play a role in the MDR phenotype by complementing with
an intact ramR or inactivation of their respective ramA gene.
Conclusions: The ramR gene coding a transcriptional repressor was
identiﬁed in S. Typhimurium to control the transcription of ramA.
Mutations in ramR appear to play a major role in upregulation of
RamA and AcrAB and consecutive efﬂux-mediated MDR phenotype
in S. Typhimurium.
P2030 Mechanisms of amoxicillin resistance in Haemophilus
inﬂuenzae in Spain
S. Garcı´a-Cobos, J. Campos, F. Roma´n, E. Cercenado (Majadahonda,
Madrid, ES)
Objectives: To investigate the most important mechanisms of b-lactam
resistance in Haemophilus inﬂuenzae.
Methods: A total of 197 clinical strains of H. inﬂuenzae, isolated
consecutively, were studied. Of them, 55.8% were from children and the
majority (90.4%) were isolated from respiratory tract infections. Most
isolates were non capsulated, except 1 type f and 2 type b. Ampliﬁcation
and sequencing of the ftsI gene was carried out in all isolates, also, the
TEM b-lactamase gene and its promoter were studied in b-lactamase
producing strains.
Results: 41.6% of the isolates were b-lactamase-non-producing
ampicillin-susceptible (BLNAS), 14.7% were b-lactamase-producing
ampicillin-resistant (BLPAR), 34% were b-lactamase-non-producing
ampicillin resistant (BLNAR) and 9.6% were b-lactamase-producing
amoxicillin/clavulanic acid-resistant (BLPACR). All b-lactamase produc-
ing strains were of the TEM-1 type. Of the 48 (24.4%) b-lactamase
positive isolates, one (0.5%) contained the P3 promoter, 16 (8.1%) the
Pa/Pb promoter, 19 (9.6%) the Pdel promoter, 11 (5.6%) presented the
Prpt promoter, and ﬁnally, one (0.5%) had a new variant of the Prpt
promoter consisting in a double 54 bp insertion (designated 2Prpt). For
the Pa/Pb promoter, the geometric mean for amoxicillin was 41.5mg/l,
for the Pdel promoter 44.4mg/l and for Prpt, 56.4mg/l. For cefaclor,
the geometric mean for the Prpt promoter was 9.66mg/l, whereas for
the Pa/Pb and Pdel promoters, the geometric means were 7.66mg/l and
7.17mg/l, respectively.
Conclusions: In the study collection b-lactamase production alone was
present in 14.7% of the isolates; 34% had amino acid substitutions in the
penicillin-binding protein 3 (PBP3) and both mechanisms were observed
in the 9.6% of the isolates. While all b-lactamase positive strains were
of the TEM-1 type, a remarkable variation was observed in its promoter
region. We describe for the ﬁrst time, the promoter 2Prpt, which presents
an insertion that consists of a double repeat of 54 bp
P2031 Evaluation of active efﬂux in multidrug-resistant isolates
of Acinetobacter baumannii
A. Abdi-ali, P. Nikasa, Z. Falahi, A. Rahmani-badi (Tehran, IR)
Objective: The purpose of this study was to evaluate of the contribution
of active efﬂux in intrinsic multidrug resistance in clinical isolates of
A. baumannii with emphasis on ciproﬂoxacin, gentamicin, ceftazidime
and ethidium bromide (EtBr).
Methods: 65 clinical isolates were obtained throughout a one year period
from different clinical samples (urine, blood, bone marrow and burns)
from 3 hospitals. Isolates tested were all A. baumannii. Using Kirby-
bauer drug susceptibility test for 12 antibiotics, 22 multidrug resistant
strains which showed resistance to more than 10 of these antibiotics were
screened for high resistance to ciproﬂoxacin, gentamicin, ceftazidime by
determining MICs. Subsequently, to show that the high resistance in
these strains depend on proton gradient-dependent efﬂux pump, MICs
were also measured in presence and absence of carbonyle cyanide
m-chlorophenyl hydrazone (CCCP), using microdilution method. CCCP
was added to a concentration of 30 micro M.
Results: MIC for ciproﬂoxacin, gentamicin and ceftazidime were more
than 64, 128 and 256mg/ml, respectively. CCCP decreased the level of
MICs at least in 1 dilution. Consequently the MICs in the presence of
CCCP were lower than the MICs in the absence of the reagent.
Conclusion: This study indicates the MICs and accumulation of EtBr
in the presence and absence of CCCP were different. These results
demonstrate the presence of proton gradient-dependent efﬂux pumps in
clinical isolates of A. baumannii.
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P2032 Molecular cloning and functional analysis of a novel
ATP-dependent multidrug efﬂux pump in Stenotrophomonas
maltophilia
A. Al Hamad, J. Burnie, M. Upton (Manchester, UK)
Objectives: To investigate the presence of a multidrug resistance
encoding ABC-type efﬂux pump in Stenotrophomonas maltophilia, a
nosocomial pathogen that shows signiﬁcant degrees of intrinsic and
acquired resistance to a wide variety of antimicrobial agents.
Methods: Open reading frames (ORFs) of a hypothetical ABC
transporter that are composed of 500 to 800 aa with an N-terminal
membrane spanning domain (MSD) and a C-terminal ATP-binding
cassette (ABC) domain have been identiﬁed in the S. maltophilia
genome. These were then aligned with experimentally proven antibiotic
resistance encoding ABC transporters, and those with signiﬁcant
homology were cloned into a hypersusceptible acrAB mutant E. coli
strain. MICs of several antimicrobial agents were determined and the
post antibiotic effect (PAE) of ciproﬂoxacin was measured.
Results: The identiﬁed ABC transporter (ORF1) has been found to
be similar to N-MDR1, C-MDR1, LmrA, and VcaM with amino
acid homologies of 39.5%, 41.2%, 42.2%, and 67.5%, respectively.
Overexpression of the identiﬁed gene led to an 8-fold increase in the
MIC of ciproﬂoxacin, norﬂoxacin, and tetracycline; other antimicrobial
agents have shown a 2-fold increase in the MIC. Heterologous expression
of the ABC transporter gene in a supersusceptible E. coli strain led to
shorter PAE when exposed to ciproﬂoxacin for 2 hours compared with
the control strain expressing only the lacZ gene (0.9 versus 2.5 hours).
Conclusion: ORF1 is a novel ABC transporter in S. maltophilia, with
a characteristic MSD-ABC domain organisation. Overexpression in a
hypersusceptible E. coli strain was associated with a signiﬁcant increase
in MICs of several antimicrobial agents including ciproﬂoxacin, a drug
that is commonly used in clinical practice. Additionally, data from the
PAE experiment has shown a shorter effect in the strain containing the
cloned ABC transporter when compared to its control, suggesting a lower
intracellular concentration of the antibiotic in the test strain which may
be attributed by a more efﬁcient removal of the antibiotic by the identiﬁed
ABC transporter.
P2033 Functional properties of aminoglycoside-resistant
methyltransferase Sgm
S. Cubrilo, G. Maravic Vlahovicek (Zagreb, HR)
Objective: Aminoglycoside resistance methyltransferase Sgm is a
member of the Arm family of enzymes that confer high level resistance
to 4,6-disubstituted deoxystreptamines. Recently we have modelled
the Sgm structure and analysed the sequence–function relationship
by limited proteolysis and mutagenesis. Here we aimed at deﬁning
the conditions of methyl transfer, substrate requirements and kinetic
parameters of the Sgm enzyme, as well as at its inﬂuence on the bacterial
cell growth and survival.
Methods: The sgm gene with N-terminal His-tag was cloned into expres-
sion vector pET-25b(+), expressed in Escherichia coli C41(DE3)pLysS
cells and puriﬁed to homogeneity. The amount of co-puriﬁed cofactor
S-adenosyl-methionine (AdoMet) was determined by measuring the
A280/A260 ratio. Enzymatic properties of the Sgm enzyme were
analysed by methylation test using variable concentrations of Mg(2+)
and NH(4)Cl at different pH values. To deﬁne the substrate requirements
we tried several substrates: entire ribosome, individual subunits and free
23S and 16S rRNA. Kinetic parameters were determined by varying
concentrations of cofactor AdoMet and the substrate, while keeping the
amount of the enzyme constant. We investigated how the presence of
the Sgm enzyme affects the exponential growth of E. coli by growing
cells in rich and minimal media at different temperatures. In competition
growth assays we examined the ability of the cells carrying the Sgm
methyltransferase to compete with the cells lacking the enzyme.
Results: Nearly 10% of the puriﬁed enzyme contains bound AdoMet.
The enzyme is most active in the presence of 10–15 mM Mg(2+)
and 90 mM NH(4)Cl at pH 7−8. Small ribosomal subunits are readily
methylated by the Sgm enzyme, but neither intact ribosome and 50S
subunit or free 23S and 16S rRNA can serve as a substrate. The Sgm
follows Michaelis-Menten kinetics with KM for AdoMet of 38 mM and
kcat of 0.2 min-1. E. coli cells expressing the Sgm grow slightly faster
compared with the non expressing strain. The effect is shown both in
competition experiments and in individual strain growth.
Conclusions: We deﬁned the enzymatic properties and the substrate of
the Sgm enzyme and observed its positive inﬂuence on cell growth.
Our results set the basis for more detailed studies of the reaction
mechanism and recognition elements in 16S rRNA, which will all help
to ﬁnd the speciﬁc inhibitor of Arm methyltransferases and thus ﬁght
the aminoglycoside resistance.
P2034 The biological cost of antibiotic resistance in urinary
isolates of Escherichia coli
M. Sundqvist, M. Sjo¨lund, G. Cederbrandt, O. Cars, D.I. Andersson,
G. Kahlmeter (Va¨xjo¨, SE; Atlanta, US; Uppsala, SE)
Objectives: The development and stability of a resistant bacterial
population is dependent on the biological cost associated with resistance.
A previous study showed that fosfomycin resistance in Escherichia coli
confers a biological cost in vitro. To investigate whether this holds true
for other resistance determinants in E. coli we have experimentally
measured the biological cost of 12 different antibiotic resistance
phenotypes in clinical isolates of E. coli.
Methods: UTI isolates of E. coli resistant to ampicillin, trimethoprim,
nalidixic acid and/or mecillinam, alone or in combination (n= 11–
54 isolates per phenotype) and E. coli susceptible to all ten tested
antimicrobial agents, wildtype, (n = 50) were collected at the Dept
of Clin Microbiology, Va¨xjo¨. Susceptibility testing was performed as
recommended by the Swedish Reference Group for Antibiotics. Isolates
resistant to nitrofurantoin or cephalosporines were excluded. To estimate
the biological cost of each phenotype, the growth rate was determined
by using BioScreenC, a turbidometric reader which monitors bacterial
growth continuously. Each isolate was inoculated to a ﬁnal density of
105 cfu/ml in a well with 0.4 mL LB. Growth was recorded during
8 h at 37ºC as an increase in optical density at 540 nm. Isolates were
run in triplicate. Viable count was performed to verify the results for
the reference strain (E. coli ATCC 25922) and isolates with isolated
mecillinam resistance. Student’s t-test was used for statistics. p< 0.001
was considered signiﬁcant. Results are presented as means with 95%CI
given in parenthesis.
Results: The mean generation times for mecillinam resistant isolates, as
single, 26.9 min (25.4–28.5), and as part of a combination with other
resistance determinants, 18.7 min (17.2–20.2), were signiﬁcantly longer
than in wildtype isolates, 16.1 min (15.5–16.6). Generation times for
other resistance phenotypes did not differ signiﬁcantly from wildtype.
Conclusions: Based on growth rate measurements in vitro, resistance
to ampicillin, trimethoprim and nalidixic acid alone or in combination
imposed no measurable ﬁtness cost on clinical isolates of E. coli. This
implies that once these resistance determinants are established, they
are likely to persist despite decreases in selective pressure. In contrast
mecillinam resistance conferred signiﬁcantly reduced ﬁtness. This
ﬁnding provides a potential explanation to why mecillinam resistance
is uncommon among clinical isolates.
P2035 Analysis of variations in the target gene penA among
Neisseria meningitidis with decreased susceptibility to
penicillin of serogroups other than C: an additional tool to
improve typing of meningococcal isolates
P. Stefanelli, C. Fazio, A. Neri, S. Starnino, T. Soﬁa, P. Mastrantonio
(Rome, IT)
Objectives: There are many reports correlating decreased susceptibility
to penicillin in meningococci (PenI, 0.06<MIC< 1mg/L) to the
mosaicism of the penA gene due to alterations mainly conﬁned in the
3′ region.
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In this study, we examined 143 Neisseria meningitidis PenI strains
isolated from 2002 through the ﬁrst six months of 2007 to monitor the
penA changes among strains with different phenotypes and genotypes
and to improve typing of meningococci isolated over time.
Methods: Serogroup and sero/subtype were determined for all the
examined strains. Susceptibility to penicillin was evaluated using the
E-test method. The breakpoint for penicillin was 0.094mg/L. The
penA gene of the PenI strains was sequenced and each sequence
compared with the others and with those deposited in Genbank. The
MultiLocusSequenceTyping permitted to assign the isolates to different
clonal lineages.
Results: In Italy, the percentage of PenI strains increased from 24%
in 2002 to 41% in 2007. In particular, after the emergence in 2002 of
the C:2b:P1.5 ST-8 complex/Cluster A4 and in 2004 of the C:2b:P1.5,2
ST-8 complex/Cluster A4, as predominant clones of PenI strains, during
the last two years we have observed their gradual decrease in parallel
with the increase of serogroup B, W135 and Y Pen I strains belonging
to different clonal complexes. The penA sequence analysis showed the
presence of 18 variants analysing the entire gene and of 14 variants when
considering only an internal 402 bp region corresponding to the most
variable part of the gene. Besides the penA12, detected in all strains
C2b:P1.5/P1.5,2 ST-8 complex /Cluster A4, the major alleles found
were penA14 (mostly among B, ST269), penA9 (mostly found among
C, ST11/ET37) and penA20 (exclusively found among Y, ST23/A3).
Conclusion: Invasive disease due to PenI meningococci increased
twofold between 2002 and 2007. Molecular analyses deﬁned the different
serogroups and clonal lineages that replaced the C2b:P1.5/P1.5,2 ST-8
complex/Cluster A4 during the last two years. They represent the
majority of PenI strains recently circulating and are characterised
by the presence of speciﬁc penA alleles predominant in the current
meningococcal population. PenA sequencing could be considered useful
not only for identifying isolates with reduced susceptibility to penicillin
G but also as an additional target gene for molecular tracing of
meningococci over time.
P2036 Genetic basis of ﬂorfenicol resistance in Acinetobacter
isolates from hospital in Chile
C. Ferna´ndez, T. Johnson, G. Gonza´lez, R. Singer (Saint Paul, US;
Concepcio´n, CL)
Objective: DNA Sequence analyses suggest that most of the antibiotic
resistance genes found in the Acinetobacter baumannii strains have
been acquired from bacteria of the genera Pseudomonas, Salmonella, or
Escherichia via horizontal gene transfer (HGT). A ﬂorfenicol resistance
gene (ﬂoR) was detected in A. baumannii strains from two hospitals in
Chile. Florfenicol is not approved for human use; however, it is related
to chloramphenicol and can select for cross-resistance among bacterial
pathogens. The aim of this study was to analyse the ﬂoR-ﬂanking regions
in A. baumannii clinical isolates in order to determine the evolutionary
history of the ﬂoR gene acquisition in A. baumannii, the linkage between
ﬂoR and other antibiotic resistance genes, and the potential impact that
the ﬂoR gene acquisition has on human health.
Methods: The genetic regions upstream and downstream of ﬂoR were
analysed in four ﬂoR-positive, phenicol resistant A. baumannii strains.
These strains were isolated from hospitals in Concepcio´n and Santiago,
Chile, between 1991 and 2000. The Universal GenomeWalker Kit (BD
Biosciences Clontech) was used to PCR amplify and sequence unknown
DNA regions adjacent to the ﬂoR gene, according to the manufacturer’s
instructions.
Results: Comparative sequence analysis of the 10 kb fragment
revealed that the ﬂanking regions of the ﬂoR gene in all isolates
had some similarity to regions within previously described Klebsiella
pneumoniae plasmid R55, Escherichia coli plasmid 10660−1 and Vibrio
cholerae STX animal isolates. Two open reading frames were detected
downstream of ﬂoR gene. The deduced amino acid sequence of orf1
is shows homology with putative regulator protein and the amino acid
sequence of orf2 to those of a putative transposase.
Conclusion: Flanking regions of these isolates indicate that A. bauman-
nii has exchanged genetic material with other bacteria, likely through
HGT. The Acinetobacter strains sequenced in this project were almost
identical in the region ﬂanking the ﬂoR gene, even though these isolates
were collected in hospitals 500 km apart and over a span of 10 years.
Given that A. baumannii is a common nosocomial pathogen and the fact
that these strains were isolated from hospitals, it is unclear when or where
the HGT would have occurred, especially considering that ﬂorfenicol is
used in animal agriculture and has no use in human medicine.
P2037 Trends in antibiotic susceptibility proﬁle and assessment
of tet(O)-mediated tetracycline resistance in Campylobacter
jejuni isolates from human and poultry sources
A. Senok, W. Mazi, A. Al-Mahmeed, A. Arzese, K. Bindayna, G. Botta
(Sharjah, AE; Taif, SA; Manama, BH; Udine, IT)
Objective: This study was conducted to determine the trends in
Campylobacter antibiotic resistance occurring in our setting. Isolates
of human and poultry origin were assessed to determine the plasmid
proﬁles and occurrence of the tet(O) gene in Campylobacter jejuni
strains ciruculating in our population..
Methods: One hundred C. jejuni strains of human and poultry origin
isolated in 2002–2003 (phase A) and 2005–2006 (phase B) in the
Kingdom of Bahrain were evaluated. The disc diffusion and agar
dilution methods were used to assess antimicrobial susceptibility and
the minimum inhibitory concentrations of erythromycin, ciproﬂoxacin
and tetracycline. Plasmid extraction was performed using QIAprep®
Miniprep kit. PCR detection of the tet(O) gene in puriﬁed plasma DNA
carried out.
Results: Erythromycin resistance rates were low in both chicken and
human C. jejuni isolates. Ciproﬂoxacin resistance rates were high with
an increasing trend observed in isolates obtained from both sources
during Phase B. Tetracycline resistance was higher in chicken (80.9%)
compared to human (41.3%) isolates [p< 0.01]. However, tetracycline
resistance rates in human isolates increased to 60.5% during Phase
B. The minimum inhibitory concentration for the tetracycline resistant
C. jejuni isolates ranged from 16 to >512ug/ml. There were 13 isolates
with MIC >512ug/ml with 12 of these being of poultry origin. With the
exception of a tetracycline sensitive human isolate, all the remaining
99 isolates harboured plasmids ranging in size from 15–35kb. The
most commonly detected plasmids were the 23kb and 35-kb size
with signiﬁcant correlation between tetracycline-resistance and plasmid
carriage being observed in isolates of poultry origin. All tetracycline-
resistance C. jejuni strains were positive for the tet(O) gene, while none
of the susceptible strains gave a positive PCR product.
Conclusion: The ﬁndings show continued effectiveness of erythromycin
for campylobacteriosis but an increasing trend of high ciproﬂoxacin
and tetracycline resistance. Tetracycline resistance is most likely due
to transfer of plasmid carrying tet(O) gene between isolates. Possible
trafﬁcking of resistance genes between isolates of poultry and human
sources has the potential for generating increased resistance in humans
even without previous antibiotic exposure.
P2038 Spread of tetracycline resistance genes among German
isolates of Escherichia coli, Enterobacter cloacae, and
Klebsiella pneumoniae and susceptibility to tigecycline
M. Kresken, J. Brauers, L. Knips, E. Leitner, A. Menke, S. Walter,
H. Weiher (Rheinbach, Mu¨nster, DE)
Background: Most common mechanisms for resistance (R) to
tetracyclines (T) are drug efﬂux and ribosomal protection. Tigecycline
(TGC), a glycylcycline, has been shown to overcome R to T conferred by
tet determinants, but R to TGC mediated by multidrug transporters does
occur. During a surveillance study (G-TEST) comprising 15 laboratories
we screened all bacterial isolates for susceptibility to doxycycline (DOX)
and TGC. The objectives of the study were to evaluate the presence
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of tet genes among isolates of E. coli (ECO), E. cloacae (ECL) and
K. pneumoniae (KPN) and to determine the susceptibility to TGC.
Methods: 718 isolates (300 ECO, 232 ECL, 186 KPN) collected between
April and August 2005 were tested. MICs were determined by a central
laboratory using the microdilution method according to the German
DIN standard. EUCAST breakpoints were applied to interpret MICs
of TGC (susceptible 1mg/L, R> 2mg/L). 124 isolates with reduced
susceptibility to DOX (65 ECO, 30 ECL, 29 KPN) were randomly chosen
for the presence of tet(A) to tet(E) and tet(M) using PCR assays.
Results: R to DOX (MIC> 4mg/L) was more common in ECO (44%)
than in ECL (11%) or KPN (27%). 53 of the 65 ECO (82%) encoded for
one or two tet determinants and 12 (18%) were negative for all six tet
genes. Only tet(A) and tet(B) were detected. A single gene was found
in 50/65 (77%) isolates, of which 30 (46%) harboured tet(A) and 20
(31%) tet(B). Three (5%) isolates encoded for both genes. For isolates
harbouring tet(A), DOX MICs were 8–16mg/L in most cases, while the
majority of isolates with tet(B) revealed DOX MICs of 32mg/L. In
contrast, nearly all isolates that were negative for the six tet genes had
DOX MICs of 2−4mg/L.
24/30 ECL isolates (80%) and 22/29 KPN isolates (76%) lacked any
of the screened tet determinants. Three ECL isolates each (10%) were
positive for tet(B) and tet(D). Of the 29 KPL isolates, six encoded for
tet(D) (21%) and one for tet(A) (3%).
TGC inhibited all DOX-resistant ECL at 0.5mg/L, whereas appr. 50%
of the DOX-resistant isolates of KPL and ECL displayed TGC MICs
above the EUCAST resistance breakpoint of 2mg/L.
Conclusions: R to DOX in ECO was widespread and related to tet(A)
and tet(B) in >80% of the screened cases. TGC was active against all
DOX-resistant ECO. In contrast, R to DOX in ECL and KPN, which
was often associated with R to TGC, was predominately mediated by
other mechanisms of R, probably multidrug transporters.
P2039 Prevalence of nim-genes in Bacteroides fragilis group in
Belgium
I. Wybo, O. Soetens, K. Van Doorslaer, D. Pie´rard, S. Lauwers
(Brussels, BE)
Objectives: Metronidazole resistance among anaerobic Gram-negative
bacilli remains low and below 1 percent in species of the B. fragilis
group [1] in Belgium. This resistance has been shown to be associated
with nitroimidazole (nim) resistance genes. The presence of a nim gene
does not necessarily confer metronidazole resistance as nim genes have
been detected in B. fragilis group isolates that have a MIC below 16mg/L
and are therefore considered susceptible. High level metronidazole
resistance can however be induced in nim-gene-carrying B. fragilis group
strains. The purpose of this study was to determine the prevalence of nim
genes in isolates belonging to the B. fragilis group isolated in Belgium.
Methods: From October 2003 to February 2005 238 B. fragilis
group strains were collected in 9 Belgian hospitals [1]. Metronidazole
susceptibility was determined by Etest®. The strains were screened for
nim genes by PCR with speciﬁc primers. When positive, sequencing of
the PCR product was performed.
Results: Nim genes were detected in 5/135 (3.7%) of B. fragilis strains
and 1/103 (0.97%) of other B. fragilis group strains. They were not found
in isolates with a MIC less than 2mg/L. Of isolates with MIC higher
than 1mg/L 62.5% (5/8) B. fragilis strains and 20% (1/5) other B. fragilis
group strains were nim gene positive. The only metronidazole resistant
B. fragilis isolate (MIC=32mg/L) carried the nimA gene. All other nim-
gene carrying B. fragilis isolates (2 nimD, 1 nimB and 1 nimE) were
susceptible, but with relatively high MIC values (3 with MIC=4mg/L
and 1 with MIC=2mg/L). In the other B. fragilis group strains one B.
vulgatus isolate carried the nimD gene and had a MIC of 4mg/L. The
only metronidazole resistant strain (MIC=32mg/L) in this group was a
nim gene negative B. thetaiotaomicron isolate. This either suggests the
presence of another resistance mechanism in this strain or the presence
of a nim gene, that was not detected with the PCR assay used.
Conclusion: Nitroimidazole (nim) resistance genes were present in
2.5% B. fragilis group clinical isolates in Belgium and associated with
higher MIC values (range: 2–32mg/L). The prevalence of nim-genes
in B. fragilis group clinical isolates in Belgium is comparable with the
prevalence other European countries.
Reference(s)
[1] Wybo. I. et al. Third Belgian multicentre survey of antibiotic
susceptibility of anaerobic bacteria. Journal of Antimicrobial
Chemotherapy 2007; 59: 132−9.
Mechanisms and epidemiology of
antimicrobial resistance in Gram-positives
P2040 Tn916-like element EfaB5 genes are highly conserved in in-
vasive Enterococcus faecalis and CC17 Enterococcus faecium
H.L. Leavis, M.J.M. Bonten, F.H. Schuren, M. Asbroek, M.P.M. Caspers,
R.J.L. Willems (Utrecht, Zeist, NL)
Objectives: Enterococcus faecalis and Enterococcus faecium have
evolved in high-risk enterococcal clonal complexes (HiRECC). HiRECC
from both species are emerging as nosomial pathogens, most notably the
E. faecium Clonal Complex 17 (CC17). The extent of virulence gene
exchange between both species, however, is unknown.
Methods: We assessed the presence of orthologs in 16 blood culture
E. faecalis and 97 E. faecium of which 40 belonged to the HiRECC
CC17, through hybridisation to an E. faecium mixed whole genome
microarray (Leavis et al. PLoS Pathog 2007). In addition, we performed
an in silico hybridisation of E. faecalis V583 and the unﬁnished
E. faecium DO genome, and interspecies 16s rRNA and MLST genes
comparisons. PCR and direct sequencing were used to analyse the spatial
arrangement of EfaB5 variant genes in E. faecium DO.
Results: E. faecalis and E. faecium shared only 233 spots (4.4%) in
microarray hybridisation of which 58 were >80% speciﬁc for CC17
E. faecium (sensitivity: 26–98%). Sequencing revealed that eight spots
represented genes, present in seven E. faecalis strains (n[HiRECC]=5),
highly similar to genes previously found on EfaB5, an E. faecalis
Tn916-like element containing several genes related to virulence in
other species. An in silico genome comparison, identiﬁed 24 E. faecium
DO genes, with >85% sequence identity with EfaB5, thus conﬁrming
the presence of an element similar to EfaB5 in E. faecium. Analysis
of spatial arrangements of the EfaB5 orthologues in E. faecium DO
revealed a conserved 3′ end of this mobile element, while genes with high
identity (>95%) to the 5′-end of EfaB5 were found to be scattered on the
E. faecium DO chromosome. In contrast to the high similarity of EfaB5
genes, the sequence identity of the core genomes of the two species
is low, which is reﬂected by the relative high average of 16S rRNA
sequence divergence (4.1%) and the low average nucleotide identity of
housekeeping genes (74.2%).
Conclusion: The presence of highly similar genes in CC17 and HiRECC
E. faecalis suggests genetic exchange between the most prevalent clinical
enterococcal subpopulations, in which EfaB5 might have played a role
in niche adaptation. Scattered presence of part of the EfaB5 variant
genes in E. faecium DO, suggests either recombination after integration
or acquisition at different occasions.
P2041 Gene expression of vancomycin-sensitive Staphylococcus
aureus strain EMRSA-15 following exposure to
sub-inhibitory levels of vancomycin
S. Awad, I. Alshami, J. Burnie, J. Lindsay, K. Gould, J. Hinds,
M. Upton (Manchester, London, UK)
Objectives: Vancomycin is the drug of choice for treatment of infection
with MRSA. It is possible that MRSA may be exposed to sub-lethal
concentrations of vancomycin during therapy. This study aimed to
investigate the effect of sub-lethal concentrations of vancomycin on
global gene expression in a vancomycin sensitive strain of EMRSA-15.
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Methods: A vancomycin sensitive strain of EMRSA-15 was grown in
Brain Heart Infusion broth with and without 0.25mg/l (sub-inhibitory
level) of vancomycin. mRNA was extracted from the two samples using
Qiagen RNeasy Kits with RNA stabilisation reagent and ‘on-column’
DNase treatment. Integrity of RNA was checked by electrophoresis in
agarose gels and the quantity of RNA recovered was determined using a
Bioanalyser. Investigations were performed in three biological replicates.
Gene expression was compared for the isolates using microarray slides
spotted with PCR products representing every gene from seven S. aureus
sequenced genomes. RNA probes were labelled using Cy3 and each prep
was hybridised against a common reference of Cy5 labelled genomic
DNA extracted from strain EMRSA-15. The slides were scanned by
using the Microarray Core Facility at the University of Manchester
using a Genepix 4000B scanner (Axon instruments, UK). BlueFuse for
microarray 3.3 (BlueGnome, UK) was used to convert all scanned images
to raw data. Data analysis was performed in GeneSpring 7.3 (Silicon
Genetics).
Results: Gene expression data were analysed using a median normal-
isation strategy and signiﬁcant differences in gene expression were
identiﬁed using ANOVA with Benjamini and Hochberg false discovery
rate correction. Comparison of gene expression in the EMRSA-15 strain
grown with and without sub-inhibitory levels of vancomycin showed
signiﬁcant differences. Many of the genes with altered expression were
involved in cell wall biosynthesis and regulation, but of particular interest
was the up regulation of genes in the locus responsible for capsule
synthesis.
Conclusion: The data presented support the suggestion that exposure to
vancomycin can inﬂuence gene expression in MRSA and that growth
at sub-lethal concentrations may drive the development of resistance
through physiological modiﬁcations.
P2042 IS257 and heterogeneous location of ileS2 gene in high-level
mupirocin resistance staphylococcal plasmids
E. Pe´rez Roth, J. Alcoba Florez, F. Laich, S. Me´ndez A´lvarez (Santa
Cruz de Tenerife, ES)
Objectives: High-level mupirocin resistance (Hi-Mupr) in S. aureus is
associated with an additional isoleucyl-tRNA synthetase that is encoded
by the ileS2 gene. We have previously reported that the ileS2 was carried
on 9 conjugative plasmids belonging to 4 structural groups (i.e. S1 to S4)
and that the location of ileS2 varied between groups. Different sizes of
ileS2-hybridising HindIII plasmid fragments permitted 5 polymorphs of
the ileS2 locus to be distinguished. In pUSA03 and pGO400 Hi-Mupr
plasmids the ileS2 gene has been found to be ﬂanked by 2 directly
repeated copies of IS257. In this work we analysed the basis of the
heterogeneous location of the ileS2 gene.
Methods: The study attempted to detect the existence of IS257 ﬂanking
the ileS2 gene, and to amplify the spacer regions between the upstream
(IS-L) and downstream (IS-R) copies of IS257 and ileS2 from each
of the 9 Hi-Mupr plasmids. Spacer regions conﬁrmation was done by
hybridisation with 2 probes for the ileS2 and an IS257 internal probe.
Results: IS-L and IS-R copies of IS257 were present in all 9 Hi-
Mupr plasmids. The copy of the IS-L was detected in either orientation
and the sizes of the spacer regions (with IS257 in either orientation)
vary. Heterogeneity was also observed downstream to ileS2. Plasmids of
the same group showed an identical organisation of IS257-ileS2 spacer
regions. The IS-L copies in plasmids belonging to S1 and S2 groups (i.e.
ISpS1-L, ISpS2-L) are in the same orientation as ileS2. On the other
hand, in S3 and S4 plasmids the IS-L copies (i.e. ISpS3-L, ISpS4-L)
are in the reverse orientation. ISpS1-R, ISpS2-R and ISpS3-R are in the
same orientation as ileS2, contrary to the case of ISpS4-R. Considering
both sides, different groups have distinct IS257-ileS2 organisations. As
in pUSA03 and pGO400, plasmids belonging to S1 and S2 groups
showed directly repeated copies of IS257 but upstream IS257-ileS2
ampliﬁcations differed in size. S3 group plasmids have inverted copies
of IS257, while in plasmids belonging to S4 group, both copies were in
opposite orientation to ileS2.
Conclusion: The results support the hypothesis that IS257-mediated
events are responsible for the variable location of the ileS2 gene in
Hi-Mupr plasmids. The IS257-ileS2 spacer regions heterogeneity could
potentially be used as an epidemiological tool for monitoring Hi-
Mupr plasmid dissemination. The molecular basis for the heterogeneity
observed requires additional detailed characterisation.
P2043 Increased mutation frequency among Enterococcus faecium
belonging to clonal complex 17
P. Ruiz-Garbajosa, J. Top, T.M. Coque, R. Canto´n, M.J. Bonten,
F. Baquero, R.J. Willems (Madrid, ES; Utrecht, NL)
Objectives: Mutator phenotype might confer a selective advantage
since different studies have demonstrated a link between elevated
mutation frequencies (mutator phenotype), antibiotic resistance and
pathogenicity. The aim of this study is to assess whether the distinct
genetic Enterococcus faecium Clonal Complex 17 (CC17) subpopulation,
responsible for the majority of E. faecium nosocomial infections and
characterised by high antibiotic resistance and recombination levels,
presents a high mutation frequency (MF) compared to non-CC17.
Methods: 46 epidemiological unrelated E. faecium strains (22 CC17
and 24 non-CC17 strains) were included. MF was determined by
calculating the proportion of CFU on Mueller-Hinton agar (MHA)
supplemented with 256mg/L of fosfomycin plus 100mg/L of glucose-
6-phosphate (after 48 h of incubation) versus total number of viable
cells on MHA without supplements. All strains were susceptible (MIC
range, 16–64mg/L) to this concentration of fosfomycin at the start of
the experiment. Experiments were performed in triplicate for each strain
and mean values were calculated. Stability of mutants was assayed in
selective plates with fosfomycin. The Mann-Whitney U test was used to
determine the statistical signiﬁcance of MF differences between CC17
and non-CC17 (p< 0.05 was considered statistically signiﬁcant).
Results: Among 46 E. faecium strains MF ranged from 7×108 to
5.2×106 (median 6.3×107). Stability was demonstrated in all fosfomycin
mutants (5 colonies from each plate). The MF of the 22 CC17 strains
ranged from 1.3×107 to 5.2×106 with a median of 1.5×106 and was
signiﬁcantly higher than that of the 24 non-CC17 strains ranged from
7×108 to 3.1×106 with a median 3.7×107 (p = 0.001). CC17 strains
with an elevated MF (>1×106) were not conﬁned to particular STs but
were randomly distributed among different STs or sublineages within
CC17.
Conclusions: This study shows for the ﬁrst time that strains belonging to
the E. faecium CC17 genetic subpopulation have an increased MF. This
increased MF may have promoted the emergence of antibiotic resistance,
most notably ampicillin resistance, within this subpopulation providing a
selective advantage that facilitated subsequent adaptation to the hospital
environment.
P2044 Efﬂux-mediated response of Staphylococcus aureus exposed
to ethidium bromide
I. Couto, S.S. Costa, M. Viveiros, M. Martins, L. Amaral (Lisbon, PT)
Objectives: Although over 10 efﬂux pumps (EPs) are described for
S. aureus, their speciﬁc role in drug-response is scarcely characterised.
Adapting S. aureus to increasing concentrations of a known substrate of
EPs, ethidium bromide, in order to increase EPs intrinsic activity and
characterising phenotypically and genotypically the resulting progeny,
we were able to characterize the molecular mechanisms of adaptation of
S. aureus to an EP substrate.
Methods: S. aureus ATCC25923 was grown in increasing, 2-fold
concentrations of ethidium bromide (EB), originating ATCC25923-
EB. The MICs of 8 classes of antibiotics, 8 biocides and 2 dyes
against ATCC25923 and ATCC25923-EB were determined by broth
microdilution (CLSI), with/without efﬂux pumps inhibitors (EPIs)
chlorpromazine (CPZ), thioridazine (TZ), reserpine (RES), verapamil
(VER), ouabain (OUA) and carbonyl cyanide m-chlorophenylhydrazone
(CCCP). Efﬂux activity, in EPIs presence/absence, was evaluated by
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a semi-automated real-time ﬂuorometric method. The presence and
expression of 8 EP genes were assayed by PCR and RT-PCR, respectively.
Mutations in both grlA and gyrA quinolone resistance coding regions
(QRDR), as well as in the norA promoter region, were assayed by DNA
sequencing.
Results: Compared to its parental strain, ATCC25923-EB had a 32-times
higher MIC for EB (6.25 to 200mg/L), as well as decreased susceptibility
to biocides and hydrophilic ﬂuoroquinolones; all of which could be
reduced by the EPIs TZ, CPZ and RES. Whereas ATCC25923 showed
no detectable efﬂux activity, ATCC25923-EB had pronounced efﬂux
activity which was inhibited by TZ, CPZ and RES in a concentration-
dependent manner. Both ATCC25923 and ATCC25923-EB carried norA,
norB, norC, mdeA, mepA and sepA, whereas the genes for EPs QacA
and Smr were not detected. RT-PCR showed that norA is 35-fold over-
expressed in the ATCC25923-EB culture, whereas the remaining EP
genes showed no signiﬁcant increase in their expression. Sequencing of
the norA promoter region detected a 70 bp deletion in ATCC25923-EB.
No mutations were detected in grlA and gyrA QRDR regions.
Conclusion: Exposure of S. aureus strains to quaternary compounds
such as EB results in a decreased susceptibility of the organism towards
a wide variety of compounds, including quinolones, biocides and dyes
through an efﬂux-mediated response, which for strain ATCC25923,
is mainly NorA-mediated. This altered expression may result from
alterations in norA promoter region.
P2045 Selection of Staphylococcus aureus resistant to NXL101 and
identiﬁcation of associated mutations in gyrA
A.M. Girard, D. Platel, M. Black, J. Lowther, H. Drugeon
(Romainville, Beaucouze, FR)
Objective: NXL101 is one of a new class of antibacterial gyrase and
topoisomerase IV inhibitors, showing potent activity against Gram-
positive bacteria including meticillin, ﬂuoroquinolone, vancomycin and
macrolide resistant strains. The aim of this study was to evaluate the
potential of selecting for resistance to NXL101 and to characterize the
associated mutations in the QRDR regions of gyrA, gyrB, grlA and grlB
in S. aureus clinical strains.
Method: Using a modiﬁed method of Szybalski, a geometric gradient of
NXL101 concentrations from 0.03 to 32mg/L, was created in a square
Petri dish. 49 S. aureus strains (7 strains for which the complete genome
is known, and 42 clinical strains exhibiting various meticillin-susceptible
(S) or -resistant (R) and ﬂuoroquinolone-S or -R phenotypes) were
tested for acquisition of resistance to NXL101, using 6 different inocula
for each strain, from 105 to 1011 CFU/ml. All strains were originally
NXL101-susceptible (MIC 0.03−0.125mg/L). NXL101-resistant clones
were collected after incubation at 24 h at 35ºC, their associated MIC
values veriﬁed and QRDR regions from 1 clone of each resistant strain
sequenced.
Results: A signiﬁcant decrease of susceptibility to NXL101 (MIC 8)
was only observed at high inoculum (out of the 49 strains, 5 gave rise
to a MIC of 8–32mg/L at 1010 CFU/ml and 21 to a MIC of 8–64mg/L
at 1011 CFU/ml).
Sequencing of the QRDR regions of the 21 resistant strains obtained
at 1011 CFU/ml showed that resistance to NXL101 was associated
with mutation in the QRDR region of gyrA only. The mutations are
different from those known to be associated with ﬂuoroquinolone-R.
The susceptibility proﬁle of these strains to ﬂuoroquinolones remained
unchanged after selection for resistance to NXL101.
Conclusion: Resistance to NXL101 was obtained at high inoculum only,
suggesting a low spontaneous mutation frequency in response to this
compound.
The mutations associated with NXL101-R were different from those
associated with ﬂuoroquinolone-R, which is consistent with the lack of
cross-resistance observed between NXL101 and ﬂuoroquinolones.
P2046 Induction of telithromycin resistance by several macrolide
antibiotics in Enterococcus spp. and Streptococcus spp.
J. Perez, E. Culebras, M. Gomez, J. Picazo (Madrid, ES)
Objectives:Macrolide resistance in Enterococcus spp. and Streptococcus
spp. is an increasing problem worldwide. Telithromycin (TL) was
developed as an alternative for the treatment of respiratory diseases
caused by microorganisms resistant to macrolides. We evaluated the
resistance to this antibiotic in 10 strains belonging to both genera, all of
them resistant to macrolides and with differences in their genotypic and
phenotypic characteristics.
Methods: We selected 10 clinical isolates resistant to erythromycin
(ER) collected at our Hospital. All isolates showed ﬂattening of the
inhibition halo of TL induced by several macrolides by the disk diffusion
method. The isolates selected for this study were: 4 Enterococcus
spp. (1 E. casseliﬂavus, 1 E. avium, 1 E. faecalis and 1 E. faecium)
and 6 Streptococcus spp. (2 S. agalactiae, 2 S. pyogenes, 1 group G
Streptococcus and 1 group F). We determined their phenotypic patterns
by disk diffusion test and their genotypes by PCR ampliﬁcation with
speciﬁc primers. Susceptibility to different macrolides was determined by
the agar dilution method. MICs of TL were also analysed after induction
with several MLS antibiotics.
Results: All strains were resistant to ER and azithromycin with
MIC90> 256mg/L and 128mg/L respectively. Only three isolates were
resistant to TL. Four strains harboured erm(B) gene, one strain erm(A)
gene, and one strain mef(A) gene. We observed reduction of the
inhibition halo of TL after induction with macrolides in 4 of the
microorganisms analysed (1 E. avium, 1 E. faecalis, 1 group F and
1 group G Streptococcus). However, only in the group F Streptococcus,
an increase in MICs of TL values was observed.
Conclusions: 1) Resistance induction to TL by macrolides is common
in all species of these genera, and it is independent of genotypic
and phenotypic characteristics. 2) ER is the higher inductor of TL
resistance of all the macrolides studied. 3) Absence of correlation
between increased MICs values and reduction of the inhibition halo of
TL is probably due to differences in sensitivity of the methods.
P2047 Characterisation of the mef gene in clinical isolates of
Streptococcus pneumoniae collected during 2004–2005
J. Blackman Northwood, L. Cossins, A. Pantosti, M. Del Grosso,
D.J. Farrell (London, UK; Rome, IT)
Objectives: To determine the presence of a chimeric variant of the
macrolide efﬂux gene mef in Streptococcus pneumoniae, consisting of
mef(A) between 1–570bp and mef(E) from 619bp to the end, previously
found in Streptococcus pyogenes, isolated from the Far East.
Methods: Isolates of S. pneumoniae collected from the Far East with
MIC values demonstrating the M phenotype of resistance to macrolides
were tested for the presence of the mef gene. A random selection of
85 of these isolates were sequenced using primers producing a 920bp
region of the 1218bp mef gene.
Results: One (1) isolate had 100% homology to the S. pneumoniae
mef(A) gene published in genbank (accession number AF227520). When
compared with the mef(E) gene (accession number U83667), 1 isolate
had a single nucleotide polymorphism (SNP) resulting in a stop codon at
position Q147. Two (2) isolates had a SNP resulting in a stop codon at
position E248. All other isolates were 100% homologous to the mef(E)
gene.
Conclusions: The chimeric variant of mef was not identiﬁed in
S. pneumoniae collected 2004–2005 from the Far East. The degree of
variation of the mef gene in S. pneumoniae is considerably less than
the variation of the mef gene in S. pyogenes. Interestingly, 3 isolates
had a stop codon within the coding region of mef. Further investigations
are required to identify whether these isolates are expressing a functional
gene or whether the M phenotype of macrolide resistance is being caused
by another resistance mechanism.
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P2048 Emergence of a linezolid-resistant Staphylococcus cohnii
after exposure to this drug
M. Kanellopoulou, E. Petinaki, M. Martsoukou, D. Klapsa, B. Raitsiou,
K. Valakis, E. Papafrangas (Athens, Larissa, GR)
Objectives: This report describes the ﬁrst linezolid resistant Staphylo-
coccus cohnii, recovered from blood culture in a patient after exposure
to the agent.
Methods: A 84 year old female patient was admitted to the ICU
because of necrotising pancreatitis. She was treated with broad spectrum
antimicrobial agents as well as antifungals, because of VAP and
severe sepsis due to multidrug resistant Gram-negative bacteria and/or
to Candida glabrata. The patient was exposed twice to linezolid in
normal doses, primarily for eight days (treating Vancomycin Sensitive
Enterococci-VSE) and secondly for twelve days (treating VRE). After
the second exposure to linezolid, a Staphylococcus spp. was isolated
from blood culture. Identiﬁcation of the isolate to the species level
and susceptibility testing was done using an semi-automated system
(Wider I Fransisco Soria Melguizo, S.A). In order to verify its linezolid-
resistance, MIC was re-determined by E-test, while the presence of
G2576T mutation was detected by ampliﬁcation of 23S rRNA following
Nhel restriction.
Results: The isolate was identiﬁed as Staphylococcus cohnii and
expressed resistance to meticillin (MIC: 16mg/l), gentamicin (MIC:
16mg/l), levoﬂoxacin (MIC: 8mg/l), clindamycin (MIC: 8mg/l) and
linezolid. The MIC to linezolid was 24mg/l by both methods, while
the strain carried three out of four mutated G2576T alleles, responsible
for the expression of linezolid-resistance.
Conclusion: Exposure to linezolid enhances the G2576T mutations of
23S rRNA, resulting in treatment failure.
P2049 The epidemiology of invasive group A streptococcal
infection in the North American Arctic, 2000–2006
M. Bruce, T. Zulz, K. Rudolph, D. Bruden, T. Tam, M. Lovgren
(Anchorage, US; Ottawa, Edmonton, CA)
Background Invasive group A streptococcus (GAS) infection causes
morbidity and mortality in the Arctic; however, the epidemiology of
this disease is not well described in this region.
Methods: We reviewed population-based data on invasive GAS disease
in Alaska (AK) and Northern Canada (N Can) collected from 2000–
2006 through the International Circumpolar Surveillance (ICS) network.
We deﬁned invasive GAS as an isolate from a normally sterile site (or
surgical wound/deep soft tissue infection) from a surveillance region
resident. Isolates were forwarded to reference labs in AK and N Can
for conﬁrmation. In AK and N Can, emm typing and M typing were
performed, respectively. Chart reviews were conducted on lab-conﬁrmed
cases.
Results: During the study period, a total of 277 cases of invasive
GAS disease were reported from AK (214) and N Can (63); 155
(56%) occurred in indigenous persons. Median age was 42 years, 54.5%
were male; 29 (10.5%) cases were fatal. Common clinical presentations
included cellulitis (32%), pneumonia (14%), and bacteraemia of
unknown source (21%). 11 (4%) cases of necrotising fasciitis occurred;
the case fatality ratio for necrotising fasciitis was 27%. In AK, 163
(76%) GAS isolates were available for emm typing; 30 different types
were identiﬁed; the 3 most common were emm type 3.1 (10%), 41.2
(9%), and 12 (8%). In N Can, 48 (76%) GAS isolates were available for
M typing; 17 different types were identiﬁed; the 3 most common were M
type 3 (12%), 1 (12%), and 5 (10%); 10 (20%) N Can isolates were M
non-typable. There was no association between M/emm type and disease
presentation, including necrotising fasciitis. In AK, annualised incidence
rates were 11.5 and 3.0 cases per 100,000 persons among indigenous
and non-indigenous persons, respectively (RR= 3.8, p< 0.01). In N Can,
rates were 10.2 and 1.1, among indigenous and non-indigenous persons,
respectively (RR= 9.3, p< 0.01). In N Can, incidence rates of invasive
GAS rose over the study period from 5.2 cases in 2000 to 13.5 cases in
2006 (p = 0.04). The increase GAS disease incidence was not associated
with proliferation of a single M/emm type. In AK, annualised incidence
rates demonstrated no discernable trends over the study period.
Conclusions: GAS remains an important cause of invasive bacterial
disease in the North American Arctic. Rates of invasive disease with
GAS were higher among indigenous persons. Incidence rates in N Can
appear to be rising, which merits further evaluation.
P2050 Effect of upstream regulatory regions and growth conditions
on erm(B)-mediated constitutive MLS resistance in Group
A Streptococci
S. Rombini, D. Petrelli, M. Prenna, S. D’Ercole, L.A. Vitali, S. Ripa
(Camerino, IT)
Objective: The upstream sequence of the gene is considered a key factor
in the translational control of erm expression, which can lead to either
a constitutive (cMLS) or an inducible (iMLS) macrolide, lincosamide,
and streptogramin B resistance phenotype. We observed that some GAS
expressing a cMLS phenotype and harbouring erm(B) did not show a
constant phenotype. The present work sought to study the relationship
occurring between this phenotypic instability and the sequence context
of the erm(B).
Methods: cMLS phenotype of ﬁve GAS clinical isolates was studied
by growth in liquid medium using cells induced by preincubation with
ERY (0.1mg/L) followed by challenge with either josamycin (JOS) or
clindamycin (CLI) (both at 50mg/L) in supplemented Muller-Hinton
II (MH). All cultures were incubated at 35–37ºC in 5% CO2 for a
maximum of 24 h. The effect of inoculum preparation (broth culture
or direct colony suspension) was also evaluated.
The sequence of the erm(B) regulatory regions were determined
following standard procedures and the general characteristics of the
genetic elements harbouring erm(B) were determined using PCR.
Results:When inoculum was prepared by direct colony suspension, both
CLI and JOS resistance of 3 strains was induced during the logarithmic
phase of growth ((i-cMLS). When the inoculum was prepared by the
growth method, the same set of strains were insensible to the induction
of CLI and JOS resistance but were susceptible to both antibiotics until
the end of the logarithmic phase.
In these strains, the upstream regulatory sequences and the genetic
context surrounding erm(B) were identical. A fourth strain had the same
genetic characteristics of the i-cMLS strains but showed a constitutive
MLS resistance in all the tested growth conditions, as well as a cMLS
strain used as reference, the latter having a consistent deletion of the
upstream regulatory region of the erm(B).
Conclusions: In GAS, the expression of erm(B) mediated MLS
resistance strongly depends on growth conditions. The contribution of
erm(B) speciﬁc sequences seems to play a secondary role.
P2051 Contribution of drinking water for the dissemination of
Gram-positive and Gram-negative bacteria harbouring
antibiotic resistance genes in Portugal
R. Magalha˜es, C. Abreu, R. Silva, L. Peixe, E. Machado, C. Novais,
J. Sousa (Porto, PT)
Objectives: To assess the contribution of nontreated water for human use
in the spread of Gram-positive (GP) and Gram-negative (GN) bacteria
harbouring antibiotic (AB) resistance or virulence genes.
Methods: Drinking water samples [mines, wells, springs from resi-
dential, forest or agricultural areas (n = 5); springs from not speciﬁed
areas (n = 7)] were collected (North/Centre-2006) and, after enrichment,
plated on Slanetz-Bartley and MacConkey agar with/without AB.
AB susceptibility was done by disk diffusion method (CLSI) and
ESBL expression (in GN) was searched by double disk synergy test.
Species were identiﬁed by API ID32GN (in GN) or PCR (in GP).
Characterisation of AB resistance genes/genetic elements, virulence
factors (in GP) or E. coli phylogenetic groups was done by PCR.
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Results: We identiﬁed 42 enterococci (7 E. faecalis, 1 E. fae-
cium, 6 E. hirae, 28 Enterococcus sp) and 33 Gram-negative
(18 Enterobacteriaceae – 1 E. coli belonged to phylogroup A; 1
P. mendocina, 8 S. maltophilia, 2 A. baumannii, 1 A. hydrophila,
1 V. parahaemolyticus, 2 C. violaceum). Decreased susceptibility to
AB was seen in all sample types to ciproﬂoxacin-69%, quinupristin-
dalfopristin-48%, erythromycin-45%, tetracycline-38%, minocycline-
36%, nitrofurantoin-33%, high level of resistance (HLR) to gentamicin-
21%, HLR-streptomycin-5% or chloramphenicol-2% in enterococci, and
to streptomycin-58%, kanamycin-36%, trimethoprim-27%, tetracyclines-
18%, chloramphenicol-18% or sulfonamides-12% in Gram-negative
bacteria. The following resistance genes/virulence factors were seen:
ermB (31% of all isolates), tetM (40%), tetL (17%), tetS (7%), aac(6′)-
Ie-aph(2′′)-Ia (21%), asa1 (24%), gel (11%) in enterococci, and class 1
integrons variable regions (6%), sul3 (3%), tetA (3%), and blaTEM-1
(6%) in Gram-negative isolates. Although 2 Enterobacteriaceae were
DDST(+) no blaTEM/SHV/CTX-M were seen. We could not amplify
vanA/B/C1/C2, tetO/K, cyl/esp/hyl genes in GP and intI1/2/3, sul1/2,
qnrA, tetB/G in GN.
Conclusion: Our data suggest that AB resistance genes or putative
virulence factors known to be spread in several environments are present
in human drinking water both in areas possibly contaminated by humans
and in locations that apparently do not have antibiotic selective pressure.
The presence of different AB resistance genes/genetic structures is of
concern since such bacteria might be consumed by different hosts and/or
be involved in gene capture, enriching local environment metagenome.
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P2052 Susceptibilities to amphotericin B and ﬂuconazole of
Candida species in TSARY 2006
Y-L. Yang, A-H. Wang, C-W. Wang, W-T. Cheng, H-J. Lo (Hsinchu,
Zhunan, TW)
Objective: The purposes of this study are two folds. First is to determine
the susceptibilities to amphotericin B and ﬂuconazole of the 964 Candida
species collected in Taiwan Surveillance of Antimicrobial Resistance of
Yeasts (TSARY) in 2006. Second is to compare the outcome with the
result from TSARY 2002 to determine the trend of susceptibilities.
Methods: The susceptibilities of the isolates were evaluated by the
broth microdilution method and the minimum inhibitory concentrations
(MICs) of each isolates were determined.
Results: Among the 964 isolates, there were 419 (43.5%) Candida
albicans, 246 (25.5%) Candida tropicalis, 211 (21.9%) Candida
glabrata, 62 (6.4%) Candida parapsilosis, 14 (1.5%) Candida krusei,
and 12 (1.2%) others. The resistant rate to amphotericin B has decreased
comparing to the result from TSARY 2002 (1.8% vs. 2.5%). Among the
17 resistant isolates, 16 were non-albicans Candida species, including
12 C. tropicalis, 2 C. krusei, and one for each of C. glabrata and
C. curvata. On the other hand, there were 165 (17.1%) isolates with
MICs to ﬂuconazole 64mg/l. They consisted of 132 C. tropicalis,
14 C. krusei, 10 C. albicans, and 9 C. glabrata. The prevalence of
isolates with such high MICs has signiﬁcantly increased from 1.9% in
2002 to 17.1% in 2006. Among 132 C. tropicalis isolates having MICs
64mg/l, 96 also exhibited trailing phenomenon. Excluding them, there
were still 36 (accounting for 14.6% of the 246 C. tropicalis isolates
tested) considered to be truly resistant.
Conclusions:
1. The resistant rate to amphotericin B has decreased comparing to the
result from TSARY 2002 (1.8% vs. 2.5%).
2. The prevalence of isolates with MICs to ﬂuconazole 64mg/l has
signiﬁcantly increased from the 1.9% in 2002 to the 17.1% in 2006.
3. High prevalence of C. tropicalis with MICs to ﬂuconazole 64mg/l
is an emerging problem in Taiwan.
P2053 Is trimethoprim adequate as ﬁrst-line empirical treatment
for urinary tract infection?
I. Gallos, L. Yee, E. Diakos (Stafford, Burton upon Trent, UK)
Objectives: To establish whether bacterial urine culture iso-
lates at Mid Staffordshire General Hospital are susceptible to
our 1st {Trimethoprim(TMP) or Nitrofurantoin(NIT)} and 2nd
{Ciproﬂoxacin(CIP), Cephalexin(CEP), Augmentin(AGM)} line empir-
ical antibiotic policy.
Methods: During a 5-year period, all uropathogens and the antibiotic
sensitivities, causing UTI were identiﬁed through our electronic database
and analysed, retrospectively. Patients demographics, age, sex, date of
urine culture isolate and antibiotic sensitivities were recorded. Data
were analysed using SPSS® version 13 for Windows® (SPSS, Chicago,
Illinois, USA).
For tables in which both rows and columns contain ordered values,
Spearman’s rank correlation coefﬁcient, rho, was used. Only Mid Stream
Urine cultures with single uropathogen growth of >103 CFU/ml and
leucocytes of >30cu/ml were included.
Results: The mean age of the population considered was 59 years and
the standard deviation was 24 years. UTI was diagnosed more frequently
in women (80%). E. Coli was the most common uropathogen isolated
and considered responsible for 59.4% of the UTIs. There were 40.770
uropathogens isolated, of which 72.5% were susceptible to TMP, 90%
to NIT, 94% to AGM and CIP and 86% to CEP.. A general trend of
increasing resistance to elder patients (63% sensitivity for patients >85
years old, rho spearman = 0.00) and in the more recent years, (70%
sensitivity for 2007, rho spearman = 0.00) for TMP, was noted. NIT had
a resistance rate of 10% for 2007. The 2nd line antibiotics have reduced
their susceptibility over the years, but still maintain a susceptibility of
about 90% for AGM and CIP and 85% for CEP. Speciﬁcally, CEP and
NIT still uphold their efﬁcacy, with a sensitivity of 90% for NIT and 85%
for CEP, which remained stable over the 5-year period, with statistically
insigniﬁcant change of susceptibility over the ﬁve years (rho spearman
= 0.97 for NIT and rho = 0.065 for CEP).
Conclusion: Resistance to TMP is becoming problematic to several
geographic areas of UK. In view of increasing resistance pattern to
TMP a re-modelling of the local antibiotic policies was considered to
be appropriate. Staffordshire hospitals looked into changing the local
guidelines to meet new resistance antibiotic patterns, with the use as 1st
line antibiotic for empirical treatment of UTI of NIT or CEP and for 2nd
line the use of CIP or AGM, excluding TMP from empirical treatment
of UTI.
P2054 Resistance among isolates of Haemophilus inﬂuenzae to
orally administered b-lactams and ﬂuoroquinolones: results
of a nationwide surveillance study in Germany, winter 2007
M. Kresken, J. Brauers, B. Ko¨rber-Irrgang (Rheinbach, DE)
Background: Haemophilus inﬂuenzae (HI) is an important pathogen
responsible for community-acquired infections of the ear, nose and
throat (CA-ENTI) and of the lower respiratory tract (CA-LRTI). The
main mechanism of resistance (R) to b-lactams (BL) in HI has
been considered the production of b-lactamase (BLA), but BLA-
negative amino-penicillin-resistant strains, which often exhibit reduced
susceptibility to cephalosporins, have also become a problem in some
areas. In contrast to BL, R to ﬂuoroquinolones (FQ) is rare in HI,
but dissemination of a FQ-resistant clone has been observed (AAC
2004;48:3570−2). Here we report the current resistance rates of HI
against frequently administered oral BLs and FQs.
Methods: In a multi-centre study conducted between January and
April 2007, 29 laboratories were requested each to collect 12 non-
duplicate isolates from patients with CA-ENTI or CA-LRTI. Isolates
were identiﬁed by standardised methods. MICs of amoxicillin (AMX),
cefaclor (CEC), cefuroxime (CXM), ceﬁxime (CFM), cefpodoxime
(CPD), ciproﬂoxacin (CIP), levoﬂoxacin (LVX), and moxiﬂoxacin
(MXF), erythromycin (ERY) and doxycycline (DOX) were determined
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in a central laboratory by using the microdilution method according
the standard ISO/FDIS 20776−1:2006. EUCAST breakpoints (BP) were
applied to interpret MICs of FQ, while DIN BP were used for BLs, DOX
and ERY. Production of BLA was detected by using nitroceﬁn discs.
Results: 290 isolates were collected. Among these, 63% were from
the nasopharynges and 21% from LRT specimens. Patients ranged in
age from <1 to 100 years (median 16 years). MICs50/90 obtained
with the antimicrobial agents as well as the rates of susceptible (S),
intermediate (I) and R isolates are shown in the Table. All isolates with
reduced S to AMX (n = 24) were BLA+ (rate 8.3%). The activities of
the cephalosporins were CFM = CPD > CXM > CFC. Two strains
had elevated MICs of CFM and CPD (1mg/L), though rated S. MICs
of AMX for these BLA− isolates were 1 and 2mg/L. CIP and LVX
inhibited all isolates at 0.06mg/L, except one. MICs of CIP, LVX and
MXF for the remaining isolate were 1, 0.5 and 1mg/L, respectively.
MXF was less active against a second isolate (MIC 0.5mg/L), which
was R to DOX.
Table. Susceptibilities of H. inﬂuenzae isolates to antimicrobial agents
Antimicrobial agent MIC (mg/L) Susceptibility (%)
MIC50 MIC90 S I R
Amoxicillin 0.5 2 91.7 0.3 7.9
Cefaclor 2 8 22.1 64.5 13.4
Cefuroxime 0.5 2 83.4 16.2 0.3
Ceﬁxime 0.25 0.25 100 0 0
Cefpodoxime 0.25 0.25 100 0 0
Ciproﬂoxacin 0.06 0.06 99.7 – 0.3
Levoﬂoxacin 0.06 0.06 100 – 0
Moxiﬂoxacin 0.06 0.06 99.7 – 0.3
Doxycycline 0.25 0.5 99.3 0.3 0.3
Erythromycin 8 16 0.3 11.0 88.6
Conclusion: In Germany, BLA+ HI are still relatively uncommon and
accounted for less than 10% of HI isolated from patients with CA-ENTI
or CA-LRTI. Oral cephalosporins of the 2nd and 3rd generation as well
as FQ retained good activity against HI.
P2055 Antibiotic resistance of Haemophilus inﬂuenzae isolated in
invasive and non-invasive forms of children’s infections in
Ural region
L. Boronina, E. Lavrinenko (Ekaterinburg, RU)
Objectives: Antibiotic resistance of Haemophilus inﬂuenzae strains is a
big problem in many countries. The purpose of the current study is to
determine the distribution frequency of different phenotypes antibiotic
resistance of H. inﬂuenzae (HI) strains isolated from children with
different localisation infections from 1991 to 2006 in Ural Region.
Methods: 268 non-typing HI strains obtained from clinical materials
of children with the upper and lower respiratory tract inﬂammatory
diseases, otitis media, sinusitis and 8 HI serotype "b" strains isolated
from liquor and blood by osteomyelitis, meningitis and sepsis were
studied for their antibiotic susceptibility. Antibiotic susceptibility was
tested on Haemophilus Test Medium with the disk diffusion method
(the results were checked with criteria NCCLS-CLSI) and test-systems
ATB NH and ATB Haemo (ATB Expression, bioMerieux, France).
Beta-lactamase was detected with chromogenic cephalosporin (ceﬁnase-
bioMerieux, France).
Results: 187 strains from 268 non-typing strains were tested to
ampicillin. Only 148 (79.14%) strains from the tested 187 ones were
susceptible, 15 (8.06%) were intermediate, 24 (12.8%) were resistant.
Beta-lactamase was detected at 5.1% strains. It was the ﬁrst time in 2003,
when b-lactamase-negative ampicillin-resistant (BLNAR) 5 strains and
b-lactamase-negative ampicillin-intermediate (BLNAI) 2 strains were
revealed, that made 2.5% and 1% accordingly among the strains isolated
from 2000 to 2005. 99 strains were tested to amoxycillin-clavulanate
only 5 (5.05%) from them were resistant. 219 strains were tested to
cephalosporin of the second generation only 7 (3.21%) from them were
resistant. All strains were susceptible to cephalosporin of the third and
fourth generation. 165 strains were tested to ﬂuoroquinolone only 2
(1.21%) from them were resistant.
HI serotype "b" strains which had no b-lactamase were susceptible
to ampicillin, amoxycillin-clavulanate, cefuroxime, cefaclor, oﬂoxacin,
rifampicin and chloramphenicol.
Conclusion: HI serotype "b" susceptibility did not change. But resistance
of non-typing HI strains changed for the investigated period: ampicillin
resistance went up to 13%, resistance to amoxycillin-clavulanate and
cephalosporin of the second generation appeared 5% and 3% accordingly,
b-lactamase was revealed at 5.1% strains. 2.5% b-lactamase-negative
ampicillin-resistant strains were revealed.
P2056 The role of antimicrobial susceptibility testing of anaerobic
bacteria from clinically signiﬁcant isolates
O. Perovic, S. Naidoo, A.G. Duse, G.A. Richards (Johannesburg, ZA)
Objectives: Anaerobic bacteria are usually saprophytic in the human
body however in certain conditions they may cause severe infections.
Increasing resistance to some antimicrobial agents has made susceptibil-
ity patterns less predictable.
This study aimed to determine the antimicrobial susceptibility patterns
of anaerobic organisms isolated from clinical specimens.
Methods: This was a prospective study of the susceptibility data of
anaerobic organisms isolated from clinical specimens from patients
with suspected mixed aerobic/anaerobic infections from June 2005
until February 2007. Specimens were submitted to the microbiology
laboratory where microscopy, culture and susceptibility testing to amoxy-
cillin/clavulanate, clindamycin, metronidazole, penicllin, ertapenem,
cefoxitin, ceftriaxone, chloramphenicol, and piperacillin/tazobactam
were performed. The MIC (minimum inhibitory concentration) proﬁle
was determined on all isolates using the Etest® strip method and
interpretation was made with reference to CLSI guidelines.
Results: Anaerobic organisms were isolated from: ﬂuids (43), pus
(41), tissues (34), blood (27), abscesses (18), bone (3), others (6), and
unknown sites (8).
The most active antimicrobial agents were: chloramphenicol, piperacillin/
tazobactam, ertapenem, amoxicillin/clavulanate, while metronidazole,
cefoxitin, clindamycin and ceftriaxone demonstrated lesser and penicillin
the least activity (see table with MIC50 and MIC90 values for all
anaerobic organisms).
A total of 97 organisms were identiﬁed as belonging to the B. fragilis
group. 100% were susceptible to amoxicillin/clavulanate and the
carbapenems whereas only 86.6% were susceptible to metronidazole and
75% to clindamycin and cefoxitin.
In vitro activity of antimicrobial agents against 180 isolated anaerobic
organisms
Antibiotic MIC (mg/ml) Susceptibility
(breakpoint of susceptibility
mg/ml)
50% 90% Range (%)
Penicillin (<0.5) 12 32 0.002–256 33
Cefoxitin (<16) 3 32 0.016–256 85
Ceftriaxone (<16) 3 32 0.002–256 68
Amoxicillin/clavulanate (<4) 0.19 1 0.016–96 97
Piperacillin/tazobactam (<32) 0.19 4 0.016–256 99
Ertapenem (<4) 0.125 1.5 0.002–32 97
Clindamycin (<2) 0.19 256 0.016–256 82
Chloramphenicol (<8) 1 2 0.016−8 100
Metronidazole (<8) 0.5 16 0.016–256 89
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Conclusions: This study illustrates decreasing antimicrobial suscepti-
bility among anaerobic organisms. The elevated rates of antimicrobial
resistance indicate that susceptibility testing should be performed
periodically to identify emerging trends.
Piperacillin/tazobactam, ertapenem and amoxicillin/clavulanate were
very active against all bacterial species, particularly to B. fragilis group
indicating a need to modify empirical treatment for anaerobic infections.
P2057 Antibiotic susceptibility in Helicobacter pylori strains
isolated from symptomatic Venezuelan patients
M. Urrestarazu, G. Lo`pez, M. Cavazza, N. Serrano (Caracas, VE)
Objective: The aim of this study was to determine the level of
antimicrobial drug resistance in clinical isolate of H. pylori collected
in Caracas, Venezuela.
Methods: Strains from 38 H. pylori patients with duodenal ulcers
were collected from Vargas Hospital, Gastroenterology Service, Caracas,
Venezuela. Primary isolation was performed on Columbia agar with
10% horse blood containing selective supplement (Isavitalex). For
the E-test, a strip of each antibiotic (E-test, AB-Biodisk, Sweden)
was placed upon the agar. The results were read according to the
instructions of the manufacturer. All plates were incubated for 72 h at
37 ºC in microaerophilic atmosphere. Minimal inhibitory concentration
(MIC) used were: Amoxicillin (>2mg/L), Clarithromycin (>8mg/L),
Erythromycin (>2mg/L), Tetracycline (>16mg/L) and Metronidazole
(>8mg/L). (Etest Application Sheet).
Results: The results of MIC values of the ﬁve investigated antimicrobial
agents for the 38 H. pylori strains were: Amoxicillin had MIC for 78%
of the strains equal or less than 0.016mg/L, MIC value of clarithromycin
for 50% of the strains was <0.016mg/L, 36% of the strains had
Erythromycin MIC value of 0.016mg/L and 55% strains had Tetracycline
MIC under this value. Only 16% of H. pylori strains had Metronidazole
MIC of <0.016mg/L. Resistance to Metronidazole occurred in 24/38
strains (63%) while resistance of Erythromycin occurred in 2/24 strains
(8%), Clarithromycin in 2/38 (5%), and Tetracycline in 3/38 (8%) of
the isolated strains. None of the strains was found to be resistant to
amoxicillin. In our study we observed drug multiresistance H. pylori
isolates. Two strains were resistance to Clarithromycin + Tetracycline +
Metronidazole; two strains resistant to Metronidazole + Erythromycin,
and two strains with resistance to Tetracycline + Metronidazole.
Conclusions: The high frequency of resistance to metronidazole in
development countries will be observed because the imidazole derivates
are used frequently for the therapy of intestinal parasitic infections and
gynaecological infections. In Venezuela there are not restrictions for
acquisition of antibiotics and the general populations use them in an
indiscriminate form. In the present study we found multiresistance strains
of H. pylori (5.8%), where metronidazol resistance was always combined
with clarithromycin or tetracycline.
P2058 15-year survey of triclosan efﬁcacy on supragingival plaque
V. Haraszthy, J. Zambon, P. Sreenivasan, G. Haraszthy, W. DeVizio
(Buffalo, Piscataway, US)
Triclosan (TCN) is a broad spectrum antimicrobial formulated in
dentifrices and other oral hygiene preparations for daily use. In clinical
studies, TCN dentifrices demonstrate signiﬁcant improvements in oral
health by reducing dental plaque and gingivitis.
Objectives: This report examined the antimicrobial efﬁcacy of TCN on
human supragingival dental plaque over a 15-year period.
Methods: Adults enrolled in these studies included those who had not
undergone dental procedures or antimicrobial, systemic therapies for
one month prior to study participation. The study was conducted in 11
separate periods with up to 10 subjects recruited for each period. Results
from 92 adult subjects were analysed for this report. Supragingival
plaque was collected from the entire dentition of each volunteer and
placed in pre-reduced Ringer’s solution. Each dental plaque sample was
sonicated and then vortexed at maximal setting for one minute to disperse
bacterial clumps prior to plating dilutions on solid media containing 7.5
or 25mg/ml TCN. Controls included dilutions of each plaque sample
plated on solid media without TCN. Colonies were enumerated from all
solid media following incubation.
Results: Large numbers of viable supragingival bacteria were observed
from all subjects on media without TCN. By contrast, dental plaque
bacteria were substantially inhibited by TCN (p< 0.001). Bacterial
inhibition with 7.5 and 25 mg/ml TCN ranged from 96–100% and 99.6–
100%, respectively. For each concentration of TCN, a one-way ANOVA
examined the percent susceptible bacteria as a response between each
study period that served as a variable. No differences in microbial
susceptibilities were observed between each period assessed over the 15-
year duration (p> 0.3). For each TCN concentration, regression analyses
indicate no alterations or trends in efﬁcacy (p = 0.546 for 7.5mg/ml TCN
and p = 0.378 for 25mg/ml TCN) over time.
Conclusions: Results demonstrate the signiﬁcant efﬁcacy of TCN
on supragingival plaque bacteria over the 15-year duration with no
alterations in microbial susceptibility. Since study participants were not
screened based on their oral hygiene habits or use of oral hygiene
formulations, the results demonstrate that TCN was effective on samples
from a variety of subjects. Together, the results demonstrate that TCN
represents a safe and effective agent for dental plaque bacteria.
P2059 Unsuitability of MIC50, MIC90 for comparison of antibiotic
potency
R. Reynolds for BSAC Working Parties on Resistance Surveillance
Objective: The potency of antibiotics is commonly compared by ranking
their MIC50 or MIC90. This method is plainly unsuitable when there are
distinct resistant subpopulations, but may appear attractive for unimodal
MIC distributions. Its performance was investigated by simulation.
Methods: Simulations, repeated 1000 times, compared two antibiotics,
A and B, each tested on all of 20, 50, 100 or 500 isolates. Simulation
and analysis used the log2 scale where conventional doubling-dilution
MICs (0.25, 0.5, 1, 2mg/L, etc.) become integers (−2, −1, 0, 1, etc.).
The MIC peak for A was set at 0, 0.25, 0.5 or 0.75 i.e. exactly at, or at
various levels between, conventional MICs. Intrinsic variation between
isolates and experimental variation were both modelled as continuous
normal distributions, giving continuous ‘underlying’ MICs that were
rounded up to integers when ‘measured’. Experimental variation had
an SD of 0.3, 0.4 or 0.6 (i.e. about 99%, 94% or 79% of replicate MICs
within±1 dilution). The true relative potency of A and B was constant
in all isolates, differing by 0, 0.25, 0.5, 1 or 2 dilutions, but subject to
experimental variation.
Results: When both drugs had equal potency, their MIC50 and MIC90
often showed apparent differences – in over 40% of simulations in
some cases, even when experimental variation was low. Conversely,
simple comparison of MIC50 or MIC90 could consistently fail to detect
differences of 0.25 or 0.5 doubling dilutions, even with the largest
sample sizes and least experimental variation, if both fell within the
same doubling dilution band. The matched-pairs Wilcoxon signed-ranks
test had a false-positive error rate close to an acceptable 5% level in all
cases. Its power fell with increasing experimental variation (e.g. 95%,
85%, and 61% for a 0.5 dilution difference with N = 20), but increased
with sample size and was unaffected by the exact position of the MICs
relative to doubling dilution bands.
Conclusion: Simple comparison of MIC50 or MIC90 is unsuitable for
the ranking of antibiotic potency: it performs erratically, dependent on
the exact location of MICs and regardless of large sample size, and
often indicates spurious differences or fails to detect real differences.
The Wilcoxon signed-ranks test is safer and more powerful, and a
description of paired MIC differences is more informative. More detailed
understanding of the variation inherent in MIC methodology is needed
for proper assessment of methods to compare MICs.
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P2060 Twenty-six years review to M. tuberculosis resistance in
Co´rdoba
J.B. Gutie´rrez-Aroca, P. Ruı´z-Martı´nez, M. Casal (Co´rdoba, ES)
Objectives: Tuberculosis drug resistance is very important in control
programmes. Surveillance drug resistance is therefore essential. It is
reviewed the M. tuberculosis resistance from 1981 to 2006 in Co´rdoba.
Methods: A total of 1882 samples from patients with suspected
tuberculose were processed. Data were collected from 1981 to 2006
in the Clinical Microbiology Service, Reina Soﬁa University Hospital.
Susceptibility testing to Streptomicine, Rifampicine, Ethambutol, Iso-
niazide, Piranizamide were determined by the radiometric method
(BACTEC 460 TB) and BACTEC MGIT 960, according to the
manufacturers instructions.
Results. See the table.
Resistance percentage against M. tuberculosis
1981−85 1986−90 1991−95 1996−00 2001−05
Strains tested 202 420 499 437 324
Streptomycin 16 2 1 2 0.3
Rifampicine 3 9 9 10 7
Ethambutol 3 10 0 2 0
INH 6 20 22 7 6
Pyrazinamide 0 0 0 0 0.3
Conclusions: There is a decrease in the resistance percentage to front
line antituberculose drugs during the 26 years examined.
Acording to the results exposed, resistance in Cordoba are not high,
although it is remarkable that these patients are difﬁcult to heal.
P2061 Multiple antibiotic resistance in Campylobacter spp. isolated
from hospitalised children in Poland during 2002–2007
E. Rozynek, K. Dzierzanowska-Fangrat, B. Szczepanska,
D. Dzierzanowska (Warsaw, Bydgoszcz, PL)
Introduction: C. jejuni and C. coli have been recognised as a
major cause of foodborne gastrointestinal infections in humans. Many
studies have shown a signiﬁcant rise in resistance to ﬂuoroquinolones,
tetracycline and erythromycin in Campylobacter human isolates.
Objectives: The aim of this study was to analyse the prevalence and
genetic mechanisms of antimicrobial resistance in Polish Campylobacter
strains isolated from diarrhoeal children.
Material and Methods: A total of 163 C. jejuni and 31 C. coli
isolated from stool samples of paediatric patients were analysed in
the study. All samples were collected from children hospitalised in 6
large paediatric hospitals in Poland from 2002 through 2007. Isolation
and identiﬁcation were performed according to WHO recommendations
and conﬁrmed by the PCR assay. MICs of ciproﬂoxacin, tetracycline,
ampicillin, gentamicin, and erythromycin were determined by the E-test.
The presence of the tet(O) gene was detected by PCR. Thr-86-Ile
mutations in the gyrA gene were identiﬁed by MAMA PCR, and
conﬁrmed by PCR-RFLP. The PCR-RFLP method was also used for
the detection of A2074C and A2075G mutations in the 23S rRNA gene
responsible for macrolide-resistance.
Results: A total of 65% C. coli and 63% C. jejuni isolates were resistant
to at least one antimicrobial agent tested. The highest resistance rate
was observed for ciproﬂoxacin (57%), followed by tetracycline (20%),
ampicillin (16%), and gentamicin 2%. Only one C. jejuni strain was
resistant to erythromycin. The results of phenotypic and genetic analyses
of resistance to tetracycline were fully concordant. All tetracycline-
resistant isolates possessed the tet(O) gene. All Campylobacter isolates
resistant to quinolones by the Etest had Thr-86-Ile mutations in the
gyrA gene detected molecular assays. However, these mutations were
also found by both molecular methods in two isolates phenotypically
susceptible to ciproﬂoxacin and nalidixic acid. Both isolates were further
conﬁrmed by direct sequencing to contain Thr-86-Ile mutations. The
highest frequency of double resistance was found for ciproﬂoxacin and
tetracycline (22%). Triple resistance was detected in 4% of isolates
tested. Multiple antibiotic resistance rose signiﬁcantly between 2005 and
2007.
Conclusions: Increasing multiple-resistance among human Campylobac-
ter isolates observed in Poland is an important public health concern.
This imply a need for constant monitoring of resistance.
P2062 Antibiotic resistance in Campylobacter jejuni strains isolated
from humans and poultry in the Czech Republic
J. Bardon, M. Kolar, D. Koukalova (Olomouc, CZ)
Objectives: Thermotolerant Campylobacter species, in particular
Campylobacter jejuni, are among the most frequent pathogens causing
alimentary zoonoses in Europe. The Czech Republic is no exception.
Those were responsible for 15,700 infections reported in the country
between 1 January and 31 August 2007, more than salmonella infections
(12,300 cases). The work aimed at determining the resistance to selected
antibiotics in both human and animal strains of C. jejuni.
Methods: The animal strains of C. jejuni were collected by cloacal
swabs as part of the monitoring of thermotolerant Campylobacter species
carried out in Czech poultry slaughterhouses. The human strains of
C. jejuni were from rectal swabs of patients with diarrhoeal disease.
The suspected isolates, both animal and human, were conﬁrmed by
the PCR. Antibiotic resistance to selected antimicrobial agents was
tested by the microdilution method. The antibiotics and their cut-off
values (mg/L) were as follows: erythromycin (resistant >4), ciproﬂoxacin
(R> 1), tetracycline (R> 2), streptomycin (R> 2), gentamicin (R> 1),
chloramphenicol (R> 8), ampicillin (R> 4) and oxolinic acid (R> 8).
Resistance was tested in 50 strains isolated from cloacal smears in
poultry and in 63 strains from human rectal swabs.
Results: The tested C. jejuni strains showed the highest resistance to
quinolone antibiotics. Resistance to oxolinic acid was detected in 78%
and 57% and to ciproﬂoxacin in 70% and 53% of animal and human
strains, respectively. In case of ampicillin, 26% of poultry and 15%
of human strains were resistant. Ten percent of animal strains but no
human strains showed resistance to streptomycin. Interestingly, resistance
to tetracycline was higher in human than in animal strains (11% vs. 8%,
respectively). Resistance to gentamicin and chloramphenicol was 8% and
2%, respectively in poultry, but undetected in humans. In erythromycin,
6% of poultry and 2% of human strains were resistant.
Conclusion: The acquired results suggest signiﬁcantly higher resistance
to most antibiotics in animal (poultry) strains in comparison with human
ones, the only exception being tetracycline, with higher resistance of
human strains.
Supported by the Czech Ministry of Education, Youth and Sports grant
project no. MSM 6198959223 and NAZVA grant no. 1B53018.
P2063 Infections due to antibiotic-resistant bacteria diagnosed at
hospital admission. Incidence and risk factors
E. Tacconelli, N. Iannotti, S. Venturiello, M. Cataldo, A. Muscatello,
T. Spanu, G. Fadda, R. Cauda (Rome, IT)
Objectives: In recent years a rising incidence of antibiotic resistant
bacteria (ARB) isolated at hospital admission (HA) has been reported.
Little is known about the epidemiological characteristics of patients (pts)
suffering from infections due to ARB at HA. Therefore, objective of the
study was to analyse risk factors for these infections.
Methods: A one-year cohort study was planned. ARB included:
meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-
resistant enterococci (VRE), extended-spectrum b-lactamase (ESBL)-
producing bacteria, ciproﬂoxacin-resistant Escherichia coli or multi-
drug-resistant (MDR) Gram-negative bacteria (>3 resistance to common
used antibiotics) isolated within 72 hours of HA. For the risk factors
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analysis, a nested case-control study was done comparing the ﬁrst
consecutive 100 pts with infection due to ARB to 200 randomised pts
with no infections due to ARB diagnosed throughout hospital stay.
Results: In the cohort study, infections caused by ARB were diagnosed
in 398 pts representing 7 cases per 1,000 hospital admissions. Twenty-
two percent of isolates were ESBL-producing bacteria, 17% MRSA,
10% carbapenems-resistant Pseudomonas aeruginosa and 2% VRE.
According to the 2007 Centers for Disease Control criteria, among 100
infections, 94% were healthcare associated and 6% were community
acquired. Independent risk factors (P< 0.05) included: urinary catheter
(odds ratio [OR] 5.7), Charlson score >3 (OR 3), antibiotic therapy
within 30 days (OR 2.7) and age >60 years (OR 2.2). The presence
of all risk factors was associated with the strongest evidence to rule
in diagnosis of infections due to ARB at HA (likelihood ratio=12).
Analysis of previous therapy revealed that glycopeptides and penicillins
were predictive for meticillin resistance in S. aureus (area under receiver
operator characteristic [ROC] curve), 65%); quinolones and penicillins
for ciproﬂoxacin-resistance in E. coli (area under ROC curve, 68%);
penicillins for ESBL production (area under ROC curve, 59%), for
MDR-resistance in Gram-negative bacteria (area under ROC curve, 58%)
and for vancomycin-resistance in enterococci (area under ROC curve,
71%).
Conclusion: Pts aged >60 yrs with clinical signs of bacterial infections
at HA and urinary catheter, previous use of antibiotics, and severe
underlying conditions are at increased risk for having infections caused
by ARB. Recognition of these risk factors may inﬂuence the selection
of empirical treatment.
P2064 Frequency of isolation of anaerobic bacteria from surgical
infections and their antimicrobial resistance pattern
P. Giannopoulou, A. Kyratsa, I. Grafakos, A. Zambou, Z. Salem,
A. Zaﬁropoulou, E. Trikka-Graphakos (Athens, GR)
Objectives: To estimate the frequency of anaerobic bacteria and their
susceptibility pattern during an 18 month period(2006–2007).
Methods: 1760 specimens were studied retrospectively from intraab-
dominal wounds, diabetic foot ulcers, soft tissue, bone and joint
infections, intrapelvic abscesses, peritoneal ﬂuid infections, burns
and other infectious sites. All samples were cultured according to
conventional methods in aerobic and anaerobic conditions. Antibiotic
susceptibility testing was performed by E-test(AB Biodisk, Sweden).
Results: 167(7.3%)anaerobic bacteria were isolated from 129 anaerobic
cultures. 27 anaerobic cultures were polymicrobial. 42(25.1%) strains
of Gram(+) anaerobic bacteria were isolated (22 Clostridium spp.,
13 Peptostreptococcus spp., 4 Eubacterium spp., 3 Propionibacterium
acnes) and 125(74.8%) strains of Gram(−) anaerobic bacteria (57
Bacteroides fragilis, 36 Bacteroides non-fragilis group, 20 Prevotella
spp., 4 Fusobacterium spp., 4 Veillonella spp., 4 Porphyromonas spp.). 50
strains were isolated from soft tissue infections, 31 from intraabdominal
wounds, 25 from peritoneal ﬂuid infections, 24 from intrapelvic
abscesses, 9 from diabetic foot, 9 from bone and joint infections, 8 from
burns and 11 from other sites. Susceptibility testing was performed to
metronidazole, penicillin, piperacillin-tazobactam, imipenem, cefoxitin,
ceftriaxone, clindamycin, tetracycline and erythromycin. All isolates
were susceptible to imipenem and piperacillin-tazobactam. Resistance to
metronidazole was found in 4 isolates (Prevotella spp., Porphyromonas
spp.). Bacteroides spp. isolates showed high sensitivity to b-lactamase
inhibitors, metronidazole, imipenem and high resistance to clindamycin,
tetracycline and erythromycin.
Conclusions: (1) Frequency of isolation of anaerobic bacteria in
surgical infections was 7.3% with most common pathogen: Bacteroides
spp. (mainly B. fragilis), followed by Clostridium and Prevotella spp.
(2) Penicillin remains the drug of choice for clostridial infections,
with metronidazole and imipenem as alternatives. High resistance to
clindamycin, tetracycline and erythromycin was observed. Resistance
of Gram(−) anaerobic bacteria to imipenem and metronidazole is an
emerging problem.
P2065 Antibiotic susceptibility patterns of Clostridium difﬁcile in
a tertiary hospital in Korea from 2004 to 2005
B-M. Shin, E-J. Lee, E-Y. Kuak, S-J. Yoo (Seoul, KR)
Objectives: Antibiotic resistance to quinolone in C. difﬁcile were
reported after the worldwide spread of ribotype 027 strains. Metron-
idazole and vancomycin MICs in C. difﬁcile strains isolated in Europe
(2005) were known very low. However, vancomycin and metronidazole
resistance were also sporadically reported. Therefore, we investigated the
rate of antibiotic resistance for the epidemiology and effective therapy
of C. difﬁcile in Korea.
Methods: Antibiotic susceptibility tests were performed with 91
C. difﬁcile strains isolated from 2004 (50 strains) to 2005 (41 strains) in a
tertiary teaching hospital in Korea. MICs of vancomycin, metronidazole,
clindamycin, clarithromycin, cefotaxime, meropenem, ciproﬂoxacin and
levoﬂoxacin were determined using the E test (AB Biodisk, Solna,
Sweden) method. Resistance was deﬁned according to the following
breakpoints: vancomycin 32mg/L, metronidazole 32mg/L, clin-
damycin 4mg/L, clarithromycin 128mg/L, cefotaxime 32mg/L,
meropenem 32mg/L ciproﬂoxacin 8mg/L levoﬂoxacin 8mg/L.
PCR ribotyping was done according to the method of O’Neill. PCR
assay for tcdA and tcdB genes and were performed. Van A and van B
gene assay was done in strains showing increased MICs in vancomycin.
Results; Of 91 C. difﬁcile strains, 78 (85.7%) were toxigenic, of which
43 (56%) were toxin variant strains (tcdA-tcdB+). Most of tcdA-
tcdB+ strains were same ribotype and tcdA+tcdB+ strains showed
more diverse ribotypes. All the C. difﬁcile strains were susceptible
to vancomycin, metronidazole and meropenem. However, 11 strains
(12.1%) showed increased MICs in vancomycin (over 6mg/L) although
no van A and van B genes were found. Of them 8 were tcdA-
tcdB+ strains. Median MICs of vancomycin and metronidazole were
0.75 and 0.50mg/L, respectively. Rates of resistance to clindamycin,
clarithromycin, cefotaxime, ciproﬂoxacin and levoﬂoxacin were 85.9%,
88.0%, 95.7%, 96.7% and 96.7%, respectively.
Conclusion: The C. difﬁcile strains isolated in 2004–2005 represented
high resistance to clindamycin, clarithromycin, cefotaxime, ciproﬂoxacin
and levoﬂoxacin regardless of the toxigenicity and ribotypes. No
resistance to vancomycin and metronidazole was observed. However,
a few of them showed increased MIC level in vancomycin.
P2066 Distribution of types of toxigenicity and susceptibility to
antimicrobial agents among Clostridium difﬁcile strains
isolated in two academic hospitals in Warsaw, Poland
H. Pituch, D. Wultanska, P. Obuch-Woszcztynski, G. Nurzynska,
M. Luczak (Warsaw, PL)
Objective: This study investigates the frequence of toxins proﬁle
(A+B+CDT−, A+B+CDT+, A−B+CDT−, A−B−CDT−), and proﬁle of
susceptibility to nine antimicrobial agents among 330 C. difﬁcile strains
isolated from patients hospitalised in two academic hospitals (I and II
between 2005–2006) in Warsaw, Poland.
Methods: Proﬁle of toxigenicity was investigated in 330 C. difﬁcile
strains by phenotypic and genotypic methods. For detection of binary
toxin genes PCR with speciﬁc primers pairs was used. MIC for
clindamycin, erythromycin, ciproﬂoxacin, moxiﬂoxacin, gatiﬂoxacin,
metronidazole, vancomycin, tetracyclin and imipenem were determined
by Etest.
Results: Overall, we identiﬁed four major toxin proﬁles for the
C. difﬁcile strains under investigation. In hospital I (n = 153) were
detected: 41% of A+B+CDT−, 5% of A+B+CDT+, 48% of A−B+CDT−
and 6% of A−B−CDT− and among strains isolated from hospital II
(n = 177) were detected: 49% of A+B+CDT−, 6% of A+B+CDT+, 40%
of A−B+CDT− and 6% of A−B−CDT−. Resistance to clindamycin
and erythromycin was found in 53.6% and 53.6% (hospital I) and
47.5% and 48.6% (hospital II). MLSB resistance is usually due to
an ermB gene. Resistance to ciproﬂoxacin was found in 98% (I) and
98.3% (II), respectively. Resistance to imipenem was found in 72.4% (I)
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and 74.4% (II). Resistance to tetracyclin was found in 22.6% (I and II).
All A−B+CDT− belonging to PCR ribotype 017 strains were resistant
to gatiﬂoxacin and moxiﬂoxacin. Resistance to ciproﬂoxacin was found
in 98% (I) and 98.3% (II). All C. difﬁcile strains were fully-susceptible
to metronidazole and vancomycin.
Conclusion: Distribution of proﬁle of toxigenicity and resistance to
antimicrobial agents among C. difﬁcile strains in two academic hospitals
in Warsaw, Poland is similar. The link between toxin proﬁles and
antibiograms is an important one given the emergence and epidemic
spread of C. difﬁcile strains.
This work was supported by Polish Ministry of Education and Science,
Grant No. 2 P05D 074 27
P2067 European survey of antibacterial activity against
H. inﬂuenzae from 2006–2007: focus on ﬂuoroquinolones
D.J. Farrell, C. Couturier (London, UK; Paris, FR)
Objectives: To document the activity of a range of antibacterial agents,
including levoﬂoxacin, against strains of Haemophilus inﬂuenzae from
patients with community-acquired respiratory tract infections (CARTIs).
Methods: Isolates were collected between January 2006 and April 2007
in 17 European countries (156 centres) from patients with CARTIs
either in the community or from patients hospitalised for <48 hours. In
vitro antibacterial activity and susceptibilities of H. inﬂuenzae isolates
were determined at a central laboratory using Clinical and Laboratory
Standards Institute methodology and interpretive criteria.
Results: Of the 2669 H. inﬂuenzae isolates collected, 12.1% were
b-lactamase positive. This varied across countries, with the highest
prevalence of b-lactamase positivity found in France (24.6%) and
Denmark (19.1%). Of the 2347 b-lactamase negative isolates, 4
(0.2%) were ampicillin-resistant and 36 (1.5%) showed intermediate
susceptibility to ampicillin. Levoﬂoxacin (LEV) and moxiﬂoxacin
(MOX) demonstrated the highest activity overall, with all 2669 isolates
being fully susceptible to LEV and all but one isolate susceptible to
MOX (Table).
Drug All isolates (n = 2669) ABS (n = 344) AECB (n = 1198)
%S MIC50 MIC90 %S MIC50 MIC90 %S MIC50 MIC90
AMC 99.9 0.5 1 100 0.5 1 99.8 0.5 1
CXM 98.1 1 2 98.6 1 2 97.85 1 2
CLA 71.1 8 16 74.1 8 16 70.8 8 16
SXT 80.5 0.12 8 80.8 0.12 8 78.3 0.12 8
LEV 100 0.015 0.03 100 0.015 0.03 100 0.015 0.03
MOX 99.9 0.03 0.03 100 0.015 0.03 99.9 0.03 0.03
TET 97.8 0.5 1 97.7 0.5 1 98.5 0.5 1
ABS, acute bacterial sinusitis; AECB, acute exacerbations of chronic bronchitis;
AMC, amoxicillin–clavulanate; CXM, cefuroxime; CLA, clarithromycin; MOX,
moxiﬂoxacin; SXT, cotrimoxazole; LEV, levoﬂoxacin; TET, tetracycline; MIC,
minimum inhibitory concentration; S, susceptibility.
Clarithromycin was the least effective agent tested, with only 71.1%
of isolates demonstrating full susceptibility. Similar results were
observed when analysing isolates collected from patients with infections
commonly caused by H. inﬂuenzae – acute bacterial sinusitis or acute
exacerbations of chronic bronchitis.
Conclusions: Overall, 100% of H. inﬂuenzae isolates collected in
this study were susceptible to LEV. Among the antibacterials tested,
the ﬂuoroquinolones LEV and MOX demonstrated the best activity,
combining very low MICs and high susceptibility rates.
P2068 Previous exposure to prophylactic co-trimoxazole and
resistance in bacteria from HIV-positive children: absence
of resistance selection pressure of co-trimoxazole
E. Kalavsky, A. Liskova, J. Benca, L. Seng Duong (Bratislava, SK;
Phnom Penh, KH)
Introduction: Co-trimoxazole (COT) prophylaxis and ART (Antiretro-
viral Therapy) showed clear clinical beneﬁt on mortality. We screened
4 years 62 HIV positive children receiving COT prophylaxis for
antimicrobial resistance.
Methods: Sixty two (62) HIV/AIDS positive children from 2 orphanages
in Phnom Penh (House of Family and House of Smile) on HAART
(Highly Active Antiretroviral Therapy) treated with combination of
stavudin, lamivudin and efavirenz for 18–42 months were examined
in 3 months periods. Swabs from respiratory tract were obtained and
transported in ice box within 24 hours to Reference Laboratory for
Antibiotic Resistance in Slovak Republic in Nitra.
Results: Relatively high level of antimicrobial resistance – high occur-
rence of MRSA (Meticillin resistant S. aureus), PRP (Penicillin resistant
pneumococci), ESBL-producing Enterobacteriaceae were observed in
children before they started therapy or prophylaxis with COT and before
treated with any antibiotic or antituberculotic agents for opportunistic
infections. Prior exposure of COT as prevention of PCP (Pneumocystis
carinii pneumonia) did not contribute to antimicrobial resistance in
HIV children. Our results suggest that consumption of COT neither in
prophylaxis nor in therapy did not contribute to increasing occurrence of
Gram-positive (MRSA, PRP) or Gram-negative isolates (ESBL, CIP-R,
COT-R E. coli, Proteus spp.). Similarly, concomitantly administered
antibiotics (in short course, in all cases less than 10 days) in combination
with COT were not signiﬁcantly associated with increase of colonisation
or infection with any of assessed resistotypes. Exception was amoxicillin
together with COT which was associated with MRSA (P = 0.04).
Conclusion: In conclusion, neither COT alone, nor in combination
with antibiotic or antituberculotic agents (RIF, INH, PZA) contribute to
increased antibiotic resistance in respiratory isolates from children with
HIV/AIDS. Prior exposure to oral cephalosporins and aminopenicilins
insigniﬁcantly increased occurrence of PRP.
P2069 Rapid surveillance of multidrug resistance in ICU patients,
by use of antibiotic-containing agar plates
G. Poulakou, D. Plachouras, F. Kontopidou, A. Antoniadou,
E. Papadomichelakis, A. Armaganidis, H. Giamarellou (Haidari, GR)
Objective: Adequate and timely administered antimicrobial treatment
is the cornerstone of successful outcome in ICU infections. The aim
of the study was to assess the efﬁcacy of an in vitro method in the
early screening of multidrug-resistant Gram-negative microorganisms
colonising or infecting ICU patients, in view of guiding initial treatment.
Methods: In an 18-bed general ICU, surveillance cultures were
performed bi-weekly for tracheal aspirates and weekly for urine and
anal swabs. All specimens were directly inoculated on Mac-Conkey agar
plates containing antibiotics at a concentration of 8mg/L for Ceftazidime
(CAZ), 1mg/L for Ciproﬂoxacin (CIP), 4mg/L for Imipenem (IMP) and
16/4mg/L for Piperacilline/Tazobactam (PT). The method was evaluated
for a six week period and was compared to standard microbiological
procedures (disk diffusion method, CLSI 2007 breakpoints of resistance).
For COL BSAC breakpoint for disk diffusion method was used.
Tracheal aspirates were processed quantitatively. Discordant results were
categorised as major error when a resistant isolate did not grow on the
antibiotic containing agar, appearing to be sensitive, and as minor when
the converse occurred.
Results: A total of 604 Gram-negative isolates were compared;
208 Acinetobacter baumannii, 138 Pseudomonas aeruginosa, 27
Stenotrophomonas maltophilia and 271 enterobacteriaceae (115 Kleb-
siella pneumoniae). Concordance of the two methods, minor and major
errors of the tested antibiotic-containing agar plates are displayed in table
1. Specimens with high dense inocula did not affect the sensitivity of the
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method for all antibiotics except PT (p 0.006). The presence of multiple
microorganisms in the specimen reduced signiﬁcantly the sensitivity
of CAZ- and PT-enriched plates (p 0.005 and 0.014 respectively).
COL-enriched plates displayed unacceptably reduced concordance with
standard method, probably reﬂecting the poor diffusion of the antibiotic
in the agar.
In 12 enterobacteriaceae the ﬁnal result of CAZ disk was reported
discordant to that measured by diameter due to an ESBL phenotype,
whereas this was also the case for IMP disk among 30 isolates of
Pseudomonas aeruginosa and enterobacteriaceae with MBL phenotype.
Table 1
Antibiotic containing agar plate
CAZ CIP IMP PT COL
Concordance (%) 75.9 72.3 72.4 69.8 33.3
Major errors (%) 10.09 14.74 14.4 16.6 6.29
Minor errors (%) 13.07 12.75 12.6 12.08 57.8
Conclusions: The use of antibiotic-containing agar plates demonstrates
satisfactory concordance with standard microbiological procedures and
could prove useful in the early guidance of initial treatment of ICU
patients with infections.
P2070 A real-time PCR and pyrosequencing strategy for
screening of penA mosaic alleles and diagnosis of reduced
susceptibility to expanded-spectrum cephalosporins in
Neisseria gonorrhoeae
M. Unemo, P. Olcen, H. Fredlund, S. Thulin (O¨rebro, SE)
Objectives: High levels of resistance in N. gonorrhoeae (GC) to
all traditional gonorrhoea antibiotics are today prevalent globally.
Furthermore, emergence of reduced susceptibility and resistance to
azithromycin and, recently, to expanded-spectrum cephalosporins forms
a serious concern worldwide.
Reduced susceptibility to expanded-spectrum cephalosporins such
as ceftriaxone and ceﬁxime (cefI) is associated with penA gene
polymorphisms and, especially, presence of penA mosaic alleles, which
encode an altered penicillin-binding protein 2 with decreased afﬁnity to
cephalosporins.
The aims of the present study were to develop a rapid, objective and
precise screening method for detection of penA mosaic alleles and,
accordingly, diagnosis of reduced susceptibility to expanded-spectrum
cephalosporins such as ceftriaxone and ceﬁxime in GC.
Methods: An “in silico” examination of all available GC penA sequences
identiﬁed two polymorphic nucleotide sites that are altered in all penA
mosaic alleles of CefI isolates, i.e. C1512G and C1529T, but not in any
cephalosporin susceptible wild type penA isolates.
For development of a penA mosaic alleles screening method, 18 GC CefI
isolates (ceftriaxone MIC0.094mg/l and ceﬁxime MIC0.19mg/l) and
two penA wild type isolates were used. These isolates were earlier
comprehensively characterised, genetically and phenotypically (Lindberg
et al. AAC 2007).
For identiﬁcation of GC CefI isolates, our previously published
N. meningitidis PenI screening method based on real-time PCR and
pyrosequencing (Thulin et al. AAC. In press) was used with minor
modiﬁcations.
Results: Pyrosequencing allowed rapid determination of 40–50 nu-
cleotides in up to 96 different sequences and were in concordance
with conventional Sanger sequencing. The two CefI speciﬁc sites were
effectively identiﬁed and evidently comprised reliable markers for penA
mosaic alleles and, accordingly, reduced susceptibility to ceftriaxone and
ceﬁxime.
Conclusions: Real-time PCR and subsequent pyrosequencing for
screening of penA mosaic alleles in GC is an effective method for genetic
detection of reduced susceptibility to expanded-spectrum cephalosporins
such as ceftriaxone and ceﬁxime. This method enables rapid, objective,
sensitive, speciﬁc and high throughput screening, most probably also
directly of clinical samples.
P2071 Study of Neisseria gonorrhoeae during a seven year period
in a Spanish teaching hospital
S. Agudo, D. Domingo, T. Alarcon, J. Navarro, M. Lo´pez-Brea
(Madrid, ES)
Introduction: The aim of this study was to analyse the antimicrobial
susceptibility of Neisseria gonorrhoeae isolated from men with urethritis
and to study the incidence of the microorganism during a seven year
period in a Spanish teaching hospital.
Methods: One hundred and ninety three strains of Neisseria gonor-
rhoeae were isolated from 683 samples of urethral exudates, received
at the Microbiology Department (Hospital Universitario de la Princesa,
Madrid) from January 2001 to November 2007.
Urethral exudates were collected by standard procedures. They were
examined by Gram stain and inoculated on Modiﬁed Thayer-Martin
medium and Chocolate agar, and incubated at 37º in 10% CO2
until 48 hours. Penicillin, ciproﬂoxacin, tetracycline, ceftriaxone and
spectinomycin suceptibility tests were performed using disc diffusion
method.
Results: The percentage of positive cultures according to the number of
samples received were 19.41%, 20.68%, 23.45%, 25.64%, 32.25% and
39.83% in 2001, 2002, 2003, 2004, 2005 and 2006 years respectivily.
The susceptibility rate was 74.28% for penicillin, 99.42% for ceftriaxone,
72.14% for tetracycline, 63.12% for ciproﬂoxacin and 98.48% for
spectinomycin. The susceptibility to ciproﬂoxacin decreased from
93.33% in the period of 2001–2003 to 67.93% in 2005–2007 years.
Only one and two strains were resistant to ceftriaxone and spectinomycin,
respectivily.
Conclusions: According to our work, resistance to penicillin, tetracy-
cline and ciproﬂoxacin is high and can not be recommended for the
treatment of gonorrhoea in our area. Ceftriaxone and spectinomycin
should be considered the antimicrobial of choice. Quinolone resistance
increased considerabily during the period of this study. Regarding to the
rate of positive cultures, the number of gonorrhoea cases have increased
from 19.41% cases in 2001 to 39.83 cases in 2006, probably due to
changes in surveillance practices.
P2072 Susceptibility patterns of Ureaplasma urealyticum isolates,
obtained form urogenital samples
S. Agudo, D. Domingo, A. Somodevilla, T. Alarcon, M. Lo´pez-Brea
(Madrid, ES)
Introduction: Ureaplasma urealyticum can be isolated from the human
urogenital tract as common comensal or pathogen. It can cause various
pathologies such as non-gonococcal urethritis, bacterial vaginosis,
cervicitis, endometritis or pelvic inﬂammatory disease. The aim of
this study was to analyse antimicrobial susceptibility of Ureaplasma
urealyticum isolated from urogenital samples.
Methods: All the urogenital samples received at the Department of
Microbiology (Hospital Universitario de la Princesa, Madrid) from
January 2005 to November 2007 were collected into the selective broth
and transported to the laboratory. The diagnostic method was using
Mycoplasma IST 2 kit (BioMerieux), a biochemical comercial method.
Susceptibility to doxycycline, josamycin, azithromycin, erythromycin,
clarithromycin, tetracycline, oﬂoxacin and ciproﬂoxacin were tested
using Mycoplasma IST 2 kit.
Results: Six hundred and ﬁfty nine urogenital samples were positive
to Ureaplasma urealyticum in this period. 42.0% were obtained from
women samples (165 endocervical exudates and 112 urine samples)
and 58.0% were obtained from men samples (183 protatitis protocols,
92 uretral exudate and 107 urethritis protocols). The susceptibility rate
was 89.0% for doxycycline, 85.7% for tetracycline, 11.9% for oﬂoxacin,
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2.1% for ciproﬂoxacin, 38.7% for erythromycin, 38.4% for azitromycin,
72.9% for clarithromycin and 73.7% for josamycin. In the previous years,
from January 2001 to December 2004, the susceptibility rate to oﬂoxacin
and erythromycin were 70.7% and 62.5% respectivily.
Conclusion: According our review, the resistance to quinolones was
higher than resistance to other antibiotics tested. Oﬂoxacin resistant
strains have increased from 29.3% in the years 2001–2004 to 88.1%
in the years 2005–2007. The resistance rate to erithromycin also was
higher in the years 2005–2007 than in the previous years.
P2073 Reversibility of antimicrobial resistance in respiratory
isolates in HIV-positive Cambodian children after 42
months of HAART
A. Shahum, J. Benca, A. Kalavska, Z. Havlikova, A. Liskova,
E. Kalavsky, P. Beno, I. Gulasova, V. Krcmery (Bratislava, Trencin, SK)
Objectives: Aim of this study was to assess, if restauration of the
immune system after 42 months treatment with HAART in Cambodian
children has an impact on antibiotic resistance and its reversibility.
Methods: Study participants were HIV positive Cambodian children
treated with HAART stavudine, lamivudine and nevirapine or efavirenz.
Respiratory tract isolates (nose, pharyngeal, ear svabs) from cambodian
previously ART naive children 3–11 years old were assessed every 3
months within 42 months of HAART.
Results: Analysing relationship between duration of HAART, and
colonisation with any speciﬁc resistance pattern, MRSA appeared to
emerge after 6–12 months of HAART in comparison to pre-HAART
period (was 90–93% after 9–12 months vs 50% in HAART naive) and
slightly decreased to 63% after 42 months. Proportion was biphasic.
Presence of multiresistant Klebsiella, and Enterobacter spp. was high
already at baseline and in ﬁrst months of HAART and the proportion
of multiresistant Gram-negative bacteria (MR GNB) decreased later to
14.4% after 42 months. Susceptibility of both Gram-negative and Gram-
positive bacteria showed biphasic but increasing tendency. Proportion of
MR GNB decreased from 21/23 (90%) in the ﬁrst 6 months of HAART,
to 0–11% in those receiving HAART for 15–18 months and to 14%
after 42 months of HAART. Reversibility of MR in GNB took 15–
18 months. However, the baseline of resistance in GNB were relatively
high. Proportion of MRSA increased from 50–55% in ﬁrst 6 months to
93–85.7% after 9–18 months but than decreased. Emergence of MRSA
was slower. Reversibility of MR in St. aureus was longer and took
approximately 24–30 months. Ratio of Gram-positive to Gram-negative
decreased from 1:3.9 (HAART naive) to 1:1.2 (42 month of HAART).
Conclusion: Reversibility of resistance among isolates from respiratory
system was probably due to the reconstitution of their immune system
due to the HAART and therefore less exposition with therapeutic ATB. In
MRSA, the reversibility of resistance took 15–21 months and was slower
than in MR Gram-negative bacilli (Klebsiella, Enterobacter) where the
increase of susceptibility (and the decrease of resistance) took 9–12
months. Prophylactic administration of cotrimoxazol 3× weekly did not
affect the reversibility of resistance and seems to be less promotive for
antibiotic resistance.
P2074 Susceptibility patterns of Helicobacter pylori paediatric
strains in Spain
S. Agudo, T. Alarco´n, D. Domingo, M.J. Moreno, M. Lo´pez-Brea
(Madrid, ES)
Objective: Helicobacter pylori is a Gram-negative microaerophilic
bacillus found in the human stomach and is associated with a wide
range of digestive diseases. H. pylori resistance is an important factor in
the efﬁcacy of the treatment. The aim of this study was to determine the
prevalence of antimicrobial resistance in H. pylori strains from paediatric
patients. Isolates were tested against metronidazole, clarithromycin,
ciproﬂoxacin, amoxicillin and tetracycline.
Methods: 193 samples were collected from gastric biopsies obtained
by endoscopy to symptomatic children from January 2006 to November
2007. 83 out of 193 were positive for H. pylori. Biopsies were cultured
according to standard microbiological procedures. The susceptibility was
determined by E-test using 5% sheep blood agar (3−5 days incubation at
37º C in 10% CO2). Minimum inhibitory concentration was determined
as the lowest concentration of drug able to inhibit visible growth, based
on the CLSI and other previously published data.
Results: The resistance rate was 40.2% for metronidazole, 48.4% for
clarithromycin and 11.4% for ciproﬂoxacin. All isolates of H. pylori
were susceptibility to amoxicillin and tetracycline.
Table 1. Resistance rate
Antibiotic Total Resistant strains %
Metronidazole 97 39 40.2
Clarithromycin 97 47 48.4
Ciproﬂoxacin 96 11 11.4
Amoxicillin 97 0 0
Tetracycline 97 0 0
Conclusions: We found a high rate of clarithromycin and metronidazole
resistance in our study. Due to the fact that clarithromycin resistance is
specially critical and induce treatment failure, the use of this agent in
empirical therapy should not be adviced in the treatment of Helicobacter
pylori in our paediatric population. The data limit the therapeutic arsenal
in Helicobacter pylori infection in children.
P2075 In vitro activity of tigecycline and other antimicrobial
drugs against selected pathogens isolated in Mexico
A. Ponce de Leon, C.F. Amabile-Cuevas, A. Benitez (Mexico City, MX)
Objective: A multi-national, multi-centre susceptibility survey (TEST)
was established to assess the in vitro efﬁcacy of tigecycline and other
antimicrobials against relevant aerobic pathogens. Here we report the
results of 1,280 isolates from 6 hospitals at the three main Mexican
cities
Methods: The survey included fresh isolates of selected pathogens,
identiﬁed as causative of infection; only one isolate per patient
was included, and no more than 25% of the sample came from
urinary tract infections. Minimal inhibitory concentrations (MIC) were
assessed by microdilution to ampicillin (AM), amoxycillin-clavulanate
(AC) piperacillin-tazobactam (PT), levoﬂoxacin (LV), ceftriaxone (CX),
minocycline (MC), imipenem (IM) and tigecycline (TG) for all isolates
(except TG for Acinetobacter and Pseudomonas), and linezolid (LZ),
vancomycin (VA) and penicillin (PN) for Gram-positives, or cefepime
(CF), ceftazidime (CZ) and amikacin (AK) for Gram-negatives. Data
were recorded in forms and compiled in a global database; strains were
stored and shipped to a central lab for further testing (ESBL production
by enteric bacteria, using ceftazidime/cefotaxime+clavulanate disks; and
meticillin resistance in S. aureus, using cefoxitin disks).
Results: Most relevant resistance prevalences include: 48% of S. aureus
are MRSA; only one enterococcus strain was LZ-R; 12.5% of
S. pneumoniae were PN-R; 36% of E. coli and 28% of K. pneumoniae
were ESBL-producers; resistance to carbapenems was common in non-
fermentative Gram-negatives, but absent in enteric bacteria. Only one
strain (K. pneumoniae) out of 1,001 tested were resistant to TG; even
MC-R strains, were susceptible to TG. Resistance to LV was linked to
MRSA (94%, vs. 4% among MSSA), and to ESBL-producers: 65% of
K. pneumoniae (vs. 31% total) and 99% of E. coli (vs. 70% total).
Conclusions: Dangerous multi-resistant organisms (MRSA, VRE,
ESBL-producers) were found at high rates among Mexican pathogens,
some linked to unrelated resistance phenotypes, which could foster
resistance by co-selection. Non-fermentative bacilli were often resistant
to drugs of choice (AK, cephalosporins, carbapenems). Linezolid was, in
vitro, the most effective drug against Gram-positives, and tigecycline the
most effective drug overall, justifying its position against intra-abdominal
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and skin infections. These antibiotics should be used carefully to preserve
their efﬁcacy.
Species % Resistant
AM AC PT CX CZ LE LZ VA IM AK TG LV
S. agalactiae 0 0 0 0 0 0
E. faecalis 0 – 30 0 0 0
E. faecium 85 – 85 0 36 0
S. aureus 83 41 48 0 0 0
E. coli 91 28 50 20 70 3 0
E. cloacae 95 97 25 42 15 10 0
K. pneumoniae 91 24 – 30 32 7 1
P. aeruginosa 29 39 32 20 39
A. baumannii 51 72 19 47 51
P2076 US survey on resistance among the Bacteroides species for
2005–2007
D.R. Snydman, N.V. Jacobus, L.A. McDermott, Y. Golan, D.W. Hecht,
E.J.C. Goldstein, L. Harrell, S. Jenkins, D. Newton, C. Pierson, J. Rihs,
J. Rosenblatt, R. Venezia, V.L. Yu, S.L. Gorbach (Boston, Maywood,
Los Angeles, Durham, New York, Ann Arbor, Pittsburgh, Minneapolis,
Baltimore, US)
Objectives: A US based survey to evaluate the in vitro susceptibility
of the Bacteroides species to commonly used and newer antibiotics, to
determine association of resistance with species, and to evaluate trends
over time was continued.
Methods: The MICs of over 1,000 isolates of Bacteroides species were
determined by agar dilution method following CLSI (NCCLS 2004)
recommendations. Incubation was for 48 h in an anaerobic chamber.
Results: Imipenem, meropenem, ertapenem and piperacillin/tazobactam
continue to demonstrate the highest in vitro activity against these
pathogens. Doripenem, ﬁrst tested in the survey in 2006 had 100%
in-vitro activity against all isolates except for 1 isolate of B. fragilis.
The resistance range to the carbapenems and piperacillin/tazobactam in
B. fragilis was from 0.9−2.3%. Resistance to ampicillin:sulbactam had
yearly increases and was 21.1% for B. distasonis in 2006. Resistance for
tigecycline was 2.8% for B. fragilis in 2006 but resistance was 9.1% in
B. uniformis, 9.7% in B. thetaiotaomicron and 5.3% in B. ovatus.
The highest resistance rates among the antibiotics tested were seen with
clindamycin, moxiﬂoxacin and trovaﬂoxacin; overall resistance to most
species was about 30% to these compounds, and exceeded 50% in
isolates of B. vulgatus. Interestingly, Linezolid was more active than
clindamycin. Three isolates of metronidazole resistant B. fragilis from
one patient were seen in 2007.
Conclusions: Our results indicate that resistance to antibiotics is
greater among the non-fragilis species and are increasing markedly
among species with low frequency of isolation, such as B. caccae
and B. uniformis. Doripenem showed activity similar to imipenem
or meropenem. Tigecycline remained quite active. Resistance to the
ﬂuoroquinolones, moxiﬂoxacin and trovaﬂoxacin, continues to increase
among most of the species of the group. The emergence of resistance
among the non-fragilis species demonstrates the need for speciation
of these organisms, and clinician awareness to species/drug resistant
associations.
P2077 Decreasing b-lactamase production and trimethoprim-
sulfamethoxazole resistance in Haemophilus inﬂuenzae in
Spain (1997–2007)
S. Garcı´a-Cobos, J. Campos, F. Roma´n, E. Cercenado, E. La´zaro,
F. de Abajo (Majadahonda, Madrid, ES)
Objectives: 1) to know the current antimicrobial susceptibility of
Haemophilus inﬂuenzae isolates in 2007 in comparison with a control
group of similar strains isolated in 1997, and 2) to analyse trends on
antimicrobial susceptibility in relation to the evolution of antibiotic
consumption in the community.
Methods: A total of 197 clinical isolates of H. inﬂuenzae were studied;
109 were isolated in 2007 and 88 in 1997 (control group). In both
periods, they were consecutively isolated from January to March from
the same Spanish geographic area (Hospital Gregorio Maran˜o´n, Madrid),
which has not suffered relevant changes over time as regards to
population coverage. The antibiotic susceptibility was determined by the
broth microdilution method according to the CLSI guidelines. Antibiotic
consumption was determined according to the ATC/DDD methodology.
Results: No statistical signiﬁcant differences were found between 2007
and 1997 isolates in relation to their clinical source, patient’s age
and microbiological data. Most of them were from children (56%
in 2007 and 55.7% in 1997) and respiratory infections (93.6% in
2007 and 86.4% in 1997). A total of 34 (31.2%) of the isolates
were resistant to amoxicillin in 2007 and 33 (37.5%) in 1997; the
percentage of b-lactamase production were 17.3% in 2007 and 33% in
1997 (P = 0.01, OR 0.43, 95%CI 0.22−0.83). Resistance to amoxicillin
in b-lactamase negative isolates were 13.8% in 2007 and 5.7% in
1997. The proportion of isolates with an azithromycin MIC 2mg/l
was 87.2% in 2007 and 66% in 1997 (P = 0.0005, OR 3.50, 95%CI
1.72−7.20). The prevalence of cotrimoxazole resistance decreased, from
50.1% (1997) to 34.8% (2007) (P = 0.04, OR 0.53, 95%CI 0.30−0.95).
The antibiotic consumption at the community level of amoxicillin +
b-lactamase inhibitor and azithromycin increased up to 50%.
Conclusions: Resistance to amoxicillin due to b-lactamase production
decreased 15.7% in 10 years in Spain. However, the prevalence
of b-lactamase negative amoxicillin-resistant isolates increased by a
percentage of 8.1%. A good correlation was found between antibiotic
consumption trends in the community and variation on antimicrobial
susceptibility.
P2078 Beta-lactamase activity against H. inﬂuenzae exhibiting
amoxicillin (with or without clavulanate) resistance
phenotypes/genotypes
E. Cercenado, F. Caﬁni, A. Gene´, F. Marco, L. Martı´nez-Martı´nez,
L. Alou, J.L. Go´mez-Garce´s, M. Casal, L. Aguilar (Madrid, Barcelona,
Santander, Co´rdoba, ES)
Objective: To explore the in vitro activity of amoxicillin/clavulanate
(AMC), cefuroxime (CXM), cefdinir (CDR), cefotaxime (CTX), and
cefditoren (CDN) against 150 isolates belonging to the b-lactamase
negative ampicillin (AMP)-resistant (BLNAR) and b-lactamase positive
AMC-resistant (BLPACR) H. inﬂuenzae resistance phenotypes.
Methods: In vitro susceptibility of 126 BLNAR (64 with ampicillin
MIC=2mg/l, and 62 with MIC4mg/l) and 24 BLPACR (19 with AMC
MIC=4mg/l, and 5 with AMC8mg/l) isolates from 6 Spanish hospitals
in 2004–2007, was determined by microdilution following CLSI
recommendations. CLSI susceptibility breakpoints (mg/l) considered
were: AMP 1; AMC 4/2, CXM 4, CDR1, and CTX 2. No CLSI
breakpoints are deﬁned for CDN. Mutations in the ftsI gene encoding
PBP3 were determined by PCR ampliﬁcation and direct sequencing.
Results: MIC50 (mg/l), MIC90 (mg/l), and % susceptibility (%S) are
shown in the Table.
A total of 90.5% BLNAR (AMP MIC 2mg/l) and 79.2% BLPACR
(AMC MIC 4mg/l) phenotype isolates tested exhibited single or
multiple mutations in the ftsI gene, being N526K (present in 112
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isolates), V545I (103 isolates), D350N (83 isolates) and A502T/V (69
isolates) the most frequent.
Conclusion: The range of intrinsic activity in terms of MIC90 values
was: CDN > CTX > AMC = CDR > CXM. CDN exhibited potent
activity (2−4 times higher than CTX) against all H. inﬂuenzae isolates
exhibiting a BLNAR/BLPACR phenotype that showed low susceptibility
rates to AMC, CDR and CXM.
BLNAR (n = 126) BLPACR (n = 24)
AMPMIC= 2 (n = 64) AMPMIC 4 (n = 62) AMC 4
MIC50/MIC90 %S MIC50/MIC90 %S MIC50/MIC90 %S
AMC 2/4 65.6 2/4 66.6 4/8 0.0
CXM 4/16 56.2 4/16 51.6 4/8 50.0
CDR 2/4 48.4 2/8 39.3 1/4 50.0
CTX 0.06/0.25 98.4 0.06/0.5 98.4 0.06/0.12 100
CDN 0.06/0.06 – 0.06/0.12 – 0.03/0.06 –
Epidemiology of antimicrobial resistance
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P2079 Resistance to carbapenems and phenotypic detection of
metallo-b-lactamases in P. aeruginosa clinical isolates
F. Polydorou, K. Moldovanidou, F. Rezoudi, G. Kourtidou,
S. Mouamaridis, T. Vahtsevanou, A. Zaires (Thessaloniki, GR)
The most common cause of bacterial resistance to b-lactam antibiotics
is the production of b-lactamase. Among these, metallo-b lactamases
(MBLs) are responsible for carbapenem resistant P. aeruginosa strains.
Emerging resistance to carbapenems limits therapeutic options, thus
rapid detection of MBLs is crucial for patient treatment. The aim of
this study was to determine the prevalence of carbapenem-resistant
P. aeruginosa strains producing MBL, by using screening tests.
Methods: A total of 115 non-duplicated clinical isolates of P. aeruginosa
collected in our hospital from January 2005 to June 2007, were
investigated for susceptibility to carbapenems. The identiﬁcation and
the determination of antibiotic sensitivity was performed by using the
Wider system (Soria). Carbapenem resistance was conﬁrmed by E-test
(AB Biodisk). All the carbapenem resistant isolates were tested by MBL
E-test and the imipenem–EDTA double-disk-synergy test (DDST), for a
possible metallo-b-lactamase production.
Results: Nineteen strains were found to be resistant to carbapenems.
Fifteen strains were resistant to both carbapenems, three strains had
MIC< 4 for imipenem and MIC 4−8 for meropenem and one strain had
MIC 4 to imipenem but was sensitive to meropenem. Resistance to other
antibiotics was: ciproﬂoxacin 60%, ceftazidime 53%, gentamycin 73%,
tobramycin 46%, piperacillin 53% and piperacillin/tazobactam 33%. Ten
out of the nineteen carbapenem resistant strains were producers of MBLs.
Four strains that were resistant only to one carbapenem, were negative for
MBL production, using both tests. From the remaining ﬁfteen resistant to
both carbapenems strains, ﬁve were negative for MBL, and seven strains
were found to be producers of metallo-b-lactamases by using both, E-test
MBL and the imipenem-EDTA-DDST. Three strains were undetermined
for MBL production using E-test but were positive using the EDTA-
DDST. The most active antibiotics against MBL strains were: colistin
100% sensitive strains, piperacillin/tazobactam 80% and aztreonam 60%.
The least active were: gentamicin (80% resistant strains) and ceftazidime
(50%).
Conclusion: The most active b-lactam antibiotic against MBL P. aerug-
inosa strains was piperacillin/tazobactam. The study showed that MBL
screening tests are simple and easy to perform as routine diagnostic tests
for the detection of MBL-production. DDST is more sensitive and less
expensive than E-test MBL.
P2080 Detection of metallo-b-lactamases in Enterobacteriaceae
clinical isolates
F. Polydorou, A. Papa, S. Chrysohoidou, K. Moldovanidou, F. Rezoudi,
S. Mouamaridis, G. Kourtidou (Thessaloniki, GR)
Metallo-b-lactamases (MBL) have been the focus of increasing
research during the last years due to their ability to hydrolyse most
b-lactams, including carbapenems. Acquired MBLs have emerged among
nosocomial Pseudomonas aeruginosa and Acinetobacter baumannii
isolates and more recently among several enterobacteriaceae isolates. In
the present study we have investigated the emergence of MBL-producing
enterobacteriaceae strains from clinical specimens.
Methods: total of 314 non-replicate enerobacteriaceae isolates (111
isolates of Klebsiella pneumoniae, 101 Proteus mirabilis and 99
Enterobacter cloacae) were obtained from specimens of patients with
nosocomial infections, between June 2005 and July 2007. identiﬁcation
and susceptibility testing was performed with the Wider system (Soria).
The carbapenem resistance was conﬁrmed by E-test (AB Biodisk). All
isolates with reduced susceptibility to carbapenems were phenotypically
tested for MBL production by using the imipenem-EDTA synergy
test (DDST) and the E-test MBL assay (AB Biodisk). The detection
of various bla gene types on these isolates was performed by PCR
ampliﬁcation.
Results: In total, seventeen carbapenem-resistant isolates, three isolates
of K. pneumoniae, seven of E. cloacae and seven of P. mirabilis, were
recovered. Eleven strains had MIC38 to both carbapenems, four strains
had MIC 8 for imipenem and MIC< 4 for meropenem and two strains
had MIC 16 for meropenem and were sensitive to imipenem. The
imipenem-EDTA DDST and the MBL E-test showed a positive result
only for three strains, including one strain for each enterobacteriaceae
species. The E. cloacae and P. mirabilis MBL-positive strains were
isolated from urine samples of two patients from medical wards and the
K. pneumoniae positive strain was isolated from blood of an intensive
care unit patient. The strains were resistant to all b-lactams and only one
of them showed an intermediate sensitivity to aztreonam. With these
strains a PCR was carried out using primers for VIM- and IMP-type
genes which conﬁrmed the presence of bla VIM genes.
Conclusion: The prevalence of MBL in enterobacteriaceae strains is
low. In our hospital, these strains are the ﬁrst enterobacteriaceae species
producing bla VIM genes. Continuous surveillance and detection of
MBL production are needed when the enterobacteriaceae strains show a
suspected proﬁle of resistance.
P2081 Study of metallo-b-lactamase-producing S. marcescens
isolates from a children’s intensive care unit
M.I. Quiles, R. Go´mez-Gil, J. Mingorance, E. Escribano, A. Gutie´rrez
(Madrid, ES)
Objectives: The aim of this study was to determine the occurrence of
MBLs in ﬁve isolates of S. marcescens resistant to carbapenems that had
been isolated from the NICU of the children’s hospital in 2007.
Material and Methods: We study 5 strains (samples: 2 BAS, 2
conjuntival and 1 umbilical) of S. marcescens isolates from 4 newborns
receiving meropenem.
The identiﬁcation and sensitivity analyses were done using Wider panels
MIC/ID Gram-negatives (Soria Melguizo, S.A.®).
Sensitivity to aztreonam, imipenem and meropenem was determined by
E-test.
The MLBs phenotype was conﬁrmed with EDTA-imipenem/imipenem
E-test and diffusion in Mueller-Hinton agar with an imipenem and EDTA
containing disks.
Final molecular characterisation was made by ERIC-PCR, RAPD and
PCR using speciﬁc primers for different metallo-b-lactamases families.
Results: All the isolates were resistant to all b-lactams, except
Aztreonam and showed resistance to trimethoprim-sulfametoxazole.
The MIC to imipenem was >8mg/mL.
The E-test of imipenem/imipenem-EDTA showed an inhibition of the
metaloenzime over more than 4 dilutions
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Analyses by PCR showed the presence of a b-lactamase of the VIM
family of metalloenzymes in a class I integron. Fingerprinting by PCR
showed that the MBL producers belonged to different strains.
Conclusions: This is the ﬁrst description in Spain of S. marcescens
producer of metallo-b-lactamase in a clinical isolates
The fact that different strains carried the same MBL gene indicates
that the integron has repeteadly entered in S. marcescens and has
probably been selected by the use of meropenem. Appropriate control
measures, including introduction of MBL screening in S. marcescens
MIC> 1mg/ml to meropenem, are necessary in order to prevent wider
dissemination of these strains.
P2082 VIM-1 and CTX-M-9 in E. cloacae, K. pneumoniae and
K. oxytoca clinical strains
E. Miro´, C. Segura, F. Navarro, J. Horcajada, L. Sorli, F. Alvarez,
M. Salvado´ (Barcelona, El Prat de Llobregat, ES)
Objectives: The carbapenem-hydrolysis b-lactamases (CHBL) begins
to be clinically relevant. This resistance poses two major challenges,
detection in the microbiology laboratory and the choice of a valid
antibiotic therapy.
We describe 12 Enterobacteriaceae isolates with carbapenemase activity
isolated at Hospital del Mar (Barcelona, Spain) from December 2006 to
May 2007. Two of them also produced the CTX-M-9 ESBL.
Methods: Identiﬁcation and susceptibility of isolates were done
by MicroScan system (Urine ComboS1 and NC36 panels). To
conﬁrm carbapenem resistance, imipenem and ertapenem disc diffusion,
imipenem and imipenem+EDTA E-test and the cloverleaf test were
performed. PFGE using XbaI restriction enzyme was done to disregard
clonality between the different isolates. The b-lactamases genes were
characterised by PCR and sequencing. The incompatibility group of
the CHBL carrying plasmid was determined by incompatibility group
determination, and was made by rep-typing PCR, S1 digestion, PFGE,
Southern Blot and hybridisation with speciﬁc probes for 18 different
incompatibility groups.
Results: Seven Enterobacter cloacae, 2 Klebsiella pneumoniae and 3
Klebsiella oxytoca isolates showed a VIM-1 metallo-b-lactamase. Four
clones were found among the E. cloacae isolates: PFGE-I with 3 strains,
PFGE-II with two strains and PFGE-III and IV with one isolate each. The
three K. oxytoca strains were clonal. The 3 E. cloacae with PFGE pattern
I and three K. oxytoca strains also presented the CTX-M-9 enzyme. Two
plasmids of 38 bp and 75 bp hybridised with the carbapenem resistance
probe, but we were unable to deﬁne the incompatibility group. The
blaCTX-M-9 was found in a HI2 plasmid of 290 pb.
All isolates were classiﬁed as susceptible by MicroScan system; only
two E. cloacae had slightly higher MICs values (IMP 4 mg/ml and
ERT 2mg/ml). The disc diffusion method correctly classiﬁed E. cloacae
isolates as intermediate or resistant but were not the case for Klebsiella
isolates. A slight synergy effect was observed with EDTA in the E-test.
The cloverleaf test was positive in all isolates, but not proved useful in
E. cloacae due to the interference with his chromosomal betalactamase.
Conclusions: It is important for laboratories to be aware of carbapenem
resistance detection because is elusive in some cases. Additional tests
like disk diffusion, E-test, cloverleaves are mandatory when treatment
relies on these antibiotics.
P2083 Frequency and antibiotic susceptibility of extended-
spectrum b-lactamase producing Enterobacteriaceae
isolated from urinary tract infections in a two-year period
V. Skandami-Epitropaki, A. Tsiringa, A. Xanthaki, P. Arida,
V. Dimitriou, M. Toutouza (Athens, GR)
Objectives: To study the isolation frequency and antibiotic susceptibility
of ESBL-producing enterobacteriaceae strains isolated from hospitalised
and community patients with urinary tract infections (UTI).
Methods: During a two-year period (2006–2007), 976 strains of
Escherichia coli and 142 strains of Klebsiella pneumoniae were
isolated from midstream urine samples in our microbiology laboratory.
Identiﬁcation to the species level was performed with the VITEK TWO
system (Bio-Merieux) and susceptibility to antimicrobial agents was
tested by the disk diffusion method according to CLSI recommendations.
Detection of ESBL expression was performed by two methods, the
double-disk synergy (DDS) test and the VITEK TWO card MIC/AST for
ESBL. From the strains tested, 696 (584 E. coli and 112 K. pneumoniae)
were isolated from hospitalised patients and 422 (392 E. coli and 30
K. pneumoniae) from community patients with UTI.
Results: ESBL production was determined in 51 out of 1118 strains
of Enterobacteriaceae (4.6%). The ESBL phenotype was detected in
3.4% (33 out of 976) strains of E. coli and 12.7% (18 out of
142 strains) of K. pneumoniae urine isolates. For E. coli, ESBL
production was detected in 30 out of 584 strains isolated from
hospitalised patients (5.1%) and 3 out of 392 patients of the
community (0.8%). For K. pneumoniae, ESBL production was detected
in 15 out of 112 strains from hospitalised patients (13.4%) and 3
out of 30 strains from community patients (10.0%). The antibiotic
susceptibility rates for the ESBL-producing strains were for E. coli
and K. pneumoniae respectively: imipenem 100%-100%, gentamicin
57.6%-66.7%, amikacin 78.8%-38.9%, netilmicin 69.7%-44.4%, to-
bramycin 48.5%-11.1%, chloramphenicol 57.6%-44.4%, ciproﬂoxacin
24.2%-11.1%, norﬂoxacin 24.2%-11.1%, tetracycline 18.2%-50.0%,
trimethoprim/sulfamethoxazole 24.2%-5.6%. ESBL production and
ﬂuoroquinolone resistance was detected in 25 out of 33 (75.8%) strains
of E. coli and 16 out of 18 (88.9%) strains of K. pneumoniae.
Conclusions: ESBL-producing bacteria are becoming an increasing
therapeutic problem not only in hospitalised but also in community
patients. High resistance rates to quinolones were observed among these
strains, but carbapenems had a good activity. Monitoring of ESBL
production and antibiotic susceptibility testing are necessary to avoid
treatment failure in patients with urinary tract infections.
P2084 Bloodstream infections due to extended-spectrum
b-lactamase-producing Escherichia coli and Klebsiella
pneumoniae: risk factors and clinical outcome
S. Colakoglu, T. Turunc, H. Aliskan, Y. Demiroglu, H. Arslan
(Ankara, TR)
Objectives: The bloodstream infections (BSIs) caused by extended-
spectrum b-lactamase (ESBL) producing Escherichia coli and Klebsiella
pneumoniae are a worlwide problem for hospitalised patients, since
they markedly increase the rates of treatment failure and mortality. The
purpose of this study is to evaluate the risk factors and clinical outcomes
of BSIs by ESBL-producing E. coli and K. pneumoniae.
Methods: We analysed the episodes of E. coli and K. pneumoniae
bacteraemia in Baskent University Adana Research and Practice Center
between January 2006 and August 2007. The antibiotic susceptibilities
and ESBL production of each isolate was determined by the disk
diffusion method, employing the criteria of Clinical and Laboratory
Standards Instutute. Descriptive data were extracted from the medical
records of the patients with E. coli and K. pneumoniae bacteraemia.
The data collected included age, sex, underlying disease, comorbit
conditions, primary site of infection, severity of illness as calculated by
the Acute Physiology and Chronic health Evaluation (APACHE) II score,
duration of hospital stay, antimicrobial regimen, and any antimicrobial
therapy in the 30 days prior to onset of bacteraemia. Each BSI episode
was classiﬁed based upon Centers for Disease Control and Prevention
guidelines. The major study outcome was survival status, which was
calculated as the mortality rate within 30 days after the onset of
bacteraemia.
Results: A total of 118 episodes of E. coli bacteraemia and 41 episodes
of K. pneumoniae bacteraemia were identiﬁed. Of these, 40.7% (48/118)
of the E. coli strains and 31.7% (13/41) of the K. pneumoniae strains
were ESBL-producing organisms. Results are summarised in tables
1 and 2.
Conclusion: In our study, the vast majority (76.7%) of the patients
acquired their bloodstream infection in the hospital. The patients
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with BSIs caused by ESBL-producing E. coli and K. pneumoniae
strains were more likely to have had longer hospitalisations and ICU
stay prior to infection, and to have higher APACHE II score than
were the patients with BSIs caused by non-ESBL-producing. The
invasive procedures, neutropenia, and previous antibiotic therapy were
more common among ESBL-producing group than they were among
non-ESBL group. Bacteraemia caused by ESBL-producing strains is
associated with higher mortality rate (19.7%) than the non-ESBL group
(9.2%).
Table l. Distribution of personal and clinical characteristics of patients with bloodstream infection caused by ESBL-
producing and non-ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae.
Characteristic ESBL group Non-ESBL group P-value
(n = 61; %) (n = 98; %)
Nosocomial onset of infection [no (%) of subjects] 52 (85.2) 70 (71.4) 0.045
Age, mean±SD (range) 62.23±15.48 (17–83) 60.48±17.65 (17–90) 0.49
Sex (male/female) 38/23 (62.3/37.7) 50/48 (51/49) 0.164
No. with K. pneumoniae/E. coli 13/48 (21.3/78.7) 28/70 (28.6/71.4) 0.309
Median length of hospital stay (days) 11.48 7.06 0.03
Status or underlying illness [no (%) of subjects]
Neurological diseases 7 (11.5) 11 (11.2) 0.961
Cardiovascular systemic diseases 6 (9.8) 14 (14.3) 0.411
Liver disease 2 (3.3) 9 (9.2) 0.206
Pancreatobiliary tract disease 0 5 (5.1) 0.075
Renal disease 17 (27.8) 20 (20.4) 0.190
Autoimmune disease 0 2 (2) 0.524
Haematological malignancy 9 (14.7) 9 (9.2) 0.281
Solid tumour 0 1 (1) 0.116
Solid organ transplant 17 (27.8) 17 (17.3) 1.0
Diabetes mellitus 9 (14.7) 11 (11.2) 0.326
Corticosteroid use 0 2 (2) 0.524
Immunosuppressive agent treatment 7 (11.5) 5 (5.1) 0.139
Any surgical procedure and trauma 19 (31.1) 19 (19.4) 0.091
Invasive proceduresa 40 (65.6) 24 (24.5) <0.001
Neutropenia (<500/mm3) 1 (1.6) 12 (12.2) 0.018
Previous antibiotic therapy 28 (46) 31 (31.6) 0.07
Primary site of bacteraemia [no (%) of subjects]
Lower Respiratory Tract 5 (8.2) 3 (3.1) 0.150
Urinary tract 28 (46) 40 (41) 0.448
Skin or soft tissue 11 (18) 13 (13.3) 0.414
Liver-Pancreatobiliary tract 5 (8.2) 11 (11.2) 0.537
Unknown 11 (18) 30 (31) 0.078
APACHE II score, mean±SD (range) 15.5±6.4 (3–33) 9.8±4.84 (0–21) <0.001
ICU stay at time of initial bacteraemia 5.23 2.37 0.013
a Invasive procedures: insertion of catheter (e.g. a central venous catheter and urinary catheter), endoscopic retrograde
cholangiopancreatography, insertion of nasogastric tube, parenteral nutrition.
Table 2. Clinical outcomes for patients with BSIs caused by ESBL-producing
Escherichia coli and Klebsiella pneumoniae isolates versus those for patients with
BSIs caused by non-ESBL-producing Escherichia coli and Klebsiella pneumoniae
isolates
Outcome No. of patients with the indicated outcome (%)
ESBL group Non-ESBL group P
(n = 61; %) (n = 98; %)
Clinical
Complete response 43 (70.5) 90 (91.8) <0.001
Failure 18 (29.5) 3 (3.1) <0.001
Uncertain 5 (5.1)
Death within 30 days 12 (19.7) 9 (9.2) 0.05a
aOR (95%CI), 2.4 (0.95–6.15).
P2085 Salmonella enterica producing extended-spectrum
b-lactamases in Zaragoza, Spain, 2001 to 2005
M. Pardos, C. Seral, M.I. Millan, A. Arias, M.E. Llaneza, S. Algarate,
M. Borras, C. Rubio, F.X. Weill, F.J. Castillo (Zaragoza, ES; Paris, FR)
Objective: To study the prevalence of Salmonella enterica producing
extended-spectrum betalactamases (ESBL) in the sanitary area of the
Hospital “Clinico Universitario Lozano Blesa”, Zaragoza, Spain.
Methods: From the cases of gastroenteritis due to Salmonella enterica
detected in our area from 2001 to 2005, we selected the isolates
with reduced susceptibility to extended spectrum cephalosporins (ESC)
using the Wider® semi-automatic system for identiﬁcation and MIC-
determination. Complete serotyping was performed according to the
Kauffmann-White scheme. The ESBL phenotype was detected by the
double disk synergy test and by E-test. For isolates showing an ESBL
phenotype, the genes of CTX-M, SHV and TEM groups were detected by
PCR and sequencing. Detection of the gene cassettes of class 1 integrons
were also performed by PCR. Transfer of ESC-resistance was performed
by conjugation on solid medium using Escherichia coli K12J5 resistant
to sodium azide. Plasmid analysis was performed by the S1-nuclease
method. Plasmids were typed for their incompatibility group by a PCR-
based replicon typing method. The genetic diversity of the S. enterica
isolates was assessed by a pulsed ﬁeld electrophoresis following the
PulseNet standardised protocol.
Results: We collected 2170 Salmonella enterica isolates from 2001
to 2005. Only ﬁve ESBL-producing isolates were detected (0.23%) in
ﬁve outpatients. Four serotype Virchow isolates produced CTX-M-9.
They showed a reduced susceptibility to ceftriaxone (MIC=32mg/L)
but were susceptible in vitro to ceftazidime (MIC=1mg/L). They
were resistant to aminoglycosides (kanamycin, streptomycin and
spectinomycin), tetracycline, trimethoprim and sulfonamides. A single
class 1 integron gene cassette was found (dfrA16-aadA2), identical to
that of complex integron In60. A 330kb-conjugative plasmid belonging
to the incompatibility group Inc HI2 was found in all the tranconjugants,
co-transferring all the resistances seen in parental isolates. The ﬁfth
isolate belonged to serotype Enteritidis containing a blaCTX-M-1 gene
located on a 290kb-conjugative plasmid of Inc I1 group. Two PFGE
proﬁles sharing 90% of identity were seen in the ESC-resistant Virchow
isolates.
Conclusion: These are the ﬁrst cases of ESBL-producing Salmonella in
our area and seem to be related with other community-acquired isolates
described in Spain and France. The increasing presence of CTX-M genes
among Enterobacteriaceae is probably due to the conjugative plasmid
location.
P2086 Enterobacteriaceae producing extended-spectrum
b-lactamase: report on the ﬁrst nine months notiﬁcations
according to the Swedish Communicable Disease Act
T. So¨derblom, B. Olsson-Liljequist, J. Struwe (Solna, SE)
Objectives: In Sweden, Enterobacteriaceae producing Extended Spec-
trum Beta-Lactamases (ESBL) are mandatory notiﬁable to the authorities
since February 1, 2007. Several local outbreaks of ESBL-producing
bacteria, as well as a governmental bill aiming at decreasing healthcare
related infections, have urged these notiﬁcations. Reporting of bacteria
with ESBL is based on laboratory notiﬁcations only.
Methods: Analysis of all laboratory notiﬁcations posted in the national
web-based surveillance system SmiNet2, 2007–02−01 to 2007–10−31.
Information on age, gender and cultured material was available, but not
information on reason for sampling (screening vs. clinical) and place for
acquisition (imported vs. domestic, community vs. hospital).
Results: A total of 1648 patients were notiﬁed during the period.
Reports came from all 21 counties of Sweden, corresponding to an
average national incidence of 18.0 per 100,000 inhabitants. The most
commonly reported species was E. coli, accounting for 72% of all cases,
followed by K. pneumoniae with 12%. Information concerning species
was missing for 13% of the cases. Bacteria were cultured from urine in
73% of the cases. The second most common source for ESBL-producing
Enterobacteriaceae was faecal samples. Eighty cases grew bacteria in
the blood and one case in cerebrospinal ﬂuid. The distribution of gender
and age differed depending on species. Among ESBL-producing E. coli,
69% were derived from women with a mean age of 54.5 years. This
was almost seven years less than the corresponding mean age of men.
The K. pneumoniae ESBL cases were almost equally distributed between
sexes, but with higher mean ages (68 years for women and 65.5 for men).
Conclusion: The ﬁrst nine months of mandatory notiﬁcation show
that ESBL-producing bacteria have become a nation-wide problem in
Sweden. An endemic situation seems to have developed, possibly putting
patients at risk when receiving empiric antibiotic treatment. In order to
meet the increasing ESBL prevalence in Sweden, an action programme
has been suggested by an expert group from authorities and health
professionals.
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P2087 The efﬁcacy of tigecycline against AmpC producing
Enterobacter spp. and Serratia marcescens
M. Hackel, D. Hoban, B. Johnson, S. Bouchillon, J. Johnson,
M. Dowzicky (Schaumburg, Collegeville, US)
Objectives: Beta-lactamase production is the most common cause
of b-lactam antibiotic resistance in Gram-negative bacteria. AmpC
b-lactamases, presumably chromosomally mediated, are associated with
multi-drug resistance in both Enterobacter spp. and Serratia spp.
The emergence of these difﬁcult to treat strains has severely reduced
therapeutic options and resulted in treatment failures. Tigecycline, a new
glycylcycline, offers the potential of enhanced activity against AmpC
producing strains. The tigecycline evaluation surveillance trial (T.E.S.T.)
evaluated the activity of tigecycline and comparators against AmpC
producing Serratia marcescens and Enterobacter spp. from a global
population.
Methods: 862 clinically signiﬁcant isolates with the AmpC phenotype
were collected between 2004 and 2007. MICs were determined at each
site using common broth microdilution panels and results interpreted
as speciﬁed by CLSI at each site. Additional testing was performed
by Laboratories International for Microbiology Studies (LIMS), a
subsidiary of International Health Management Associates, Inc. (IHMA,
Schaumburg, IL, USA).
Results: MIC50/90 (mg/mL) and % susceptible (S) of tigecycline and
comparators are shown in the table.
Drug Enterobacter spp.
(n = 821)
Serratia marcescens
(n = 41)
%S MIC50 MIC90 %S MIC50 MIC90
Tigecycline 87.6 0.5 4 90.2 1 2
Amikacin 95.5 2 8 85.4 4 32
AmoxClav 0 >32 >32 0 >32 >32
Cefepime 100 4 8 100 4 8
Ceftazidime 0 >32 >32 0 >32 >32
Ceftriaxone 0 >64 >64 0 64 >64
Imipenem 99.6 0.5 1 100 1 1
Conclusions: Tigecycline is a promising expanded broad spectrum
antibiotic showing signiﬁcant activity against AmpC producing Enter-
obacter spp. and Serratia marcescens from a world wide population.
With MIC50 values of 0.5mg/mL versus Enterobacter and 1mg/mL
versus Serratia, this study validates tigecycline’s potent inhibitory
activity against these pathogens.
P2088 Emergence of ﬂuoroquinolone-resistant Shigella ﬂexneri
type 2a from diarrhoea patients in Kolkata, India
S.K. Niyogi, S. Sinha, S. Yamasaki (Kolkata, IN; Osaka, JP)
Objectives: Shigellosis is a major cause of diarrhoeal related morbidity
and mortality, especially in the developing world. Diarrhoea caused
by Shigella can usually be treated effectively by antimicrobial therapy.
However, the emergence and dissemination of multidrug-resistant
strains of Shigella is now an increasing global health problem that
is complicating the therapeutic management of cases of shigellosis.
Recently, ﬂuoroquinolone resiatant Shigella ﬂexneri type 2a strains, the
predominant serotype have emerged in Kolkata, India and found to be
multiple drug resistant (MDR). The aim of this study was to characterize
MDR Shigella ﬂexneri type 2a strains using phenotypic and genotypic
methods.
Methods: Thirty one representative strains of Shigella ﬂexneri 2a,
isolatedduring 2004–2006 from children suffering from diarrhoea were
examined in this study. Shigella species recovered were serotyped by a
slide agglutination test with commercially available antiserum (Denka
Seiken Co. LTD, Tokyo, Japan). Antimicrobial susceptibility pattern,
detection of Shigella enterotoxin genes (set1), and virulence genes,
analysis of plasmid DNA, and Pulse Field Gel Electrophoresis were
performed following standard protocol.
Results: All the isolates tested, exhibited uniform resistance pattern
however all were sensitive to ceftriaxone and azithromycin. All the
isolates showed identical plasmid proﬁle (3.03, 3.9 & 54.24 Kb).PFGE
analysis of XbaI-digested chromosomal DNA of the ﬂuroquinolone
resistant S. ﬂexneri serotype 2a strains yielded 15 to 18 reproducible
DNA fragments ranging in size from approximately 20 to 388 kb.
On the contrary the ﬂuroquinolone-sensitive strains yielded 18 to 20
reproducible DNA fragments ranging in size from approximately 20 to
485 kb.
Conclusion: Multidrug resistance was common among the S. ﬂexneri 2a
strains. These results show that the multidrug resistance among serotype
2a strains could be conferred by plasmids. Fluroquinolone-resistant
isolates showed more genetic homology, in contrast to ﬂuroquinolone-
sensitive strains. Interestingly an overall analysis of the PFGE results
conclude that ﬂuroquinolone sensitive serotype 2a originating from the
different ancestral clones was found previously in Kolkata whereas the
occurrence of ﬂuroquinolone resistant isolates with homogeneous PFGE
pattern in recent times confers that strains originating from a single clone
are circulating in the environment, which was not found before.
P2089 High rates of plasmid-mediated quinolone resistance QnrB
variants among ciproﬂoxacin-resistant Escherichia coli and
Klebsiella pneumoniae from urinary tract infections in Korea
J.H. Shin, H.J. Jung, J.Y. Lee, H.R. Kim, E.Y. Lee, C.L. Chang, J.N. Lee
(Busan, KR)
Objectives: The aims of this study were to investigate the prevalence of
qnrA, qnrB, and qnrS determinants and their molecular characteristics
in ciproﬂoxacin-resistant isolates of Escherichia coli and Klebsiella
pneumoniae from urinary tract infections in Korea.
Methods: A total of 202 non-duplicated clinical isolates of
ciproﬂoxacin-resistant E. coli (N=143) and K. pneumoniae (N=59) were
collected from urinary tract infections between July 2005 and Aug. 2006.
The qnr determinant screening was carried out by PCR ampliﬁcation
of qnrA, qnrB, and qnrS; and all positive results were conﬁrmed by
direct sequencing of the PCR products. For qnr-positive strains and
their conjugants, antimicrobial susceptibility tests and pulsed-ﬁeld gel
electrophoresis were performed.
Results: The qnrB gene was detected in 41 of the 202 isolates. Among
33 of 59 (55.9%) K. pneumoniae isolates showing qnrB, 29 isolates
contained the qnrB4 gene, 3 isolates had the qnrB2 gene, and 1 isolate
had the qnrB6 gene. All 8 (5.6%) of the qnrB-positive isolates among the
143 E. coli strains possessed the qnrB4 gene. The MICs of ciproﬂoxacin
for the transconjugants were 0.03 to 2 ug/ml, representing an increase
of 4 to 256 fold relative to the recipient, E. coli J53Azr. Resistances to
various other antimicrobial agents also were transferred with the plasmid.
The PFGE analysis revealed indistinguishable or closely related patterns
in several strains, and highly diverse patterns in general.
Conclusions: qnrB variants, especially the qnrB4 subtype, are highly
prevalent in ciproﬂoxacin-resistant E. coli and K. pneumoniae from
urinary tract infections in Korea. The emergence of plasmid-mediated
quinolone resistance may contribute by several means to the rapid
increase in bacterial resistance to these drugs. Thus, we are paying close
attention to the course of plasmid-mediated qnr resistance in various
clinical specimens of Enterobacteriaceae.
P2090 Epidemiology of a new population of quinolone-resistant
Salmonella enterica
M. Lindgren, P. Kotilainen, V. Mahlama¨ki, P. Huovinen, S. Lukinmaa,
L.J.V. Piddock, A. Siitonen, A.J. Hakanen (Turku, Helsinki, FI;
Birmingham, UK)
Objectives: In 2003, we described a new quinolone resistance
phenomenon in Salmonella enterica isolates from Southeast Asia. These
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isolates show reduced ciproﬂoxacin susceptibility but are susceptible or
only low-level resistant to nalidixic acid. The purpose of the present
work was to survey the epidemiology of this new resistance phenotype.
Methods: In this study, 599 Salmonella enterica isolates collected
between 2002 and 2007 from Finnish travellers returning from abroad
were analysed and the results were compared with 829 Salmonella
isolates collected between 1995 and 2001. Annually the ﬁrst 100
foreign Salmonella isolates were collected. The MICs of the isolates
to ciproﬂoxacin and nalidixic acid were determined by the standard agar
dilution method according to the Clinical and Laboratory Standards
Institute (CLSI) guidelines. The susceptibility data were analysed by
using the WHONET 5.4 computer programme.
Results: From 1995 to 2002, all Salmonella isolates showing reduced
ciproﬂoxacin susceptibility were uniformly resistant to nalidixic acid.
From 2003 to 2007, 9 (9.0%), 8 (8.1%), 2 (2.0%), 5 (5.0%)
and 13 (13.0%) of the tested isolates, respectively, showed reduced
ciproﬂoxacin susceptibility (MIC 0.125mg/L) but were either suscep-
tible (MIC< 32mg/L) or low-level resistant (MIC=32mg/L) to nalidixic
acid. Epidemiological studies showed that all isolates showing the
new resistance phenotype were from Southeast Asia, whereas the
isolates exhibiting reduced ciproﬂoxacin susceptibility and nalidixic acid
MIC> 32mg/L were from different origins, 50% of them being from
Southeast Asia. Among the new resistance phenotype, S. Corvallis and S.
Stanley were the most prevalent serotypes, whereas among the nalidixic
acid resistant isolates, S. Enteritidis and S. Virchow were the most
prevalent.
Conclusion: Our study revealed that the new phenotype of quinolone-
resistant Salmonella enterica is increasing. Moreover, this phenotype
was found in several serotypes being, thus, not restricted to one clone
only. Although these strains are clustered in Southeast Asia, they are of
concern since the amount of travellers is continuously increasing in that
part of the world.
P2091 First detection of the plasmid-mediated quinolone resistance
in extended-spectrum b-lactamases producing Enterobac-
teriaceae isolated from in-and out-patients in Switzerland
N. Liassine, P. Zulueta-Rodriguez, C. Corbel, C. Lascols, C.J. Soussy,
E. Cambau (Geneva, CH; Cre´teil, FR)
Objective: The aim of the present study was to determine the prevalence
of plasmid-mediated quinolone resistance qnr genes in ESBL-producing
enterobacteriaceae strains isolated in a private laboratory.
Methods: Identiﬁcation and antimicrobial susceptibility testing were
performed using the VITEK2 system (bioMe´rieux SA). PCR detection
for plasmid-mediated quinolone resistance was performed using primers
amplifying intragenic fragments of qnrA, qnrB and qnrS. MICs of
nalidixic acid and ﬂuoroquinolones were determined for the qnr-positive
isolates using the Etest method. ESBL characterisation was performed
for qnr-positive isolates by PCR of the TEM, SHV and CTX-M genes.
Results: 156 non-duplicate ESBL-producing enterobacteriaceae isolated
from April 2001 to February 2006 were analysed. They provided from
155 patients from whom 87 (56.1%) were outpatients and 68 (43.9%)
in-patients. The sex ratio of patients was 112/43 (female/male). Bacterial
specie distributed as follows: Escherichia coli (n = 125, 80%), Klebsiella
pneumoniae (n = 23, 14%), Citrobacter freundii (n = 2), Klebsiella
oxytoca (n = 2), Enterobacter cloacae (n = 1), Morganella morganii
(n = 1), Proteus penneri (n = 1) and Salmonella enterica (n = 1). The
global prevalence of qnr-positive isolates was 3.2% with ﬁve isolates
harbouring a qnrB gene: two isolates of C. freundii with the qnrB4
allele, 2 isolates of K. pneumoniae with the qnrB4 allele and one isolate
of E. coli with the qnrB2 allele. None of the isolates harboured qnrA
or qnrS genes. These ﬁve isolates were coming from urines of four
different patients of whom three were followed by private practitioners
in the community setting. Four isolates presented a high level resistance
to ﬂuoroquinolones (MIC> 32mg/L) and one C. freundii isolate showed
a intermediate level of ﬂuoroquinolone resistance (ﬂuoroquinolone MIC
below 8mg/L). The main type of ESBL of qnr-positive isolates was
CTX-M-15 (n = 3), followed by CTX-M-3 (n = 1) and CTX-M-9 (n = 1).
Conclusion: This is the ﬁrst report of plasmid-mediated quinolone
resistance from clinical isolates in Switzerland, in the hospital as well as
in the community setting. Although a low prevalence of qnr determinants
was observed among ESBL-producing enterobacteriaceae, dissemination
of qnrB genes is already present in Switzerland.
P2092 Prevalence of antimicrobial resistance and detection of qnr
in avian Salmonellae in two EU regions, 1998–2006
S.-M. Friederichs, A. de Jong, H. Greife (Leverkusen, DE)
Objectives: In many countries, nontyphoidal Salmonella is a main
cause of food-borne illness. Antimicrobial treatment is recommended for
severe salmonellosis, with ﬂuoroquinolones (FQs) as drugs of choice. As
poultry is a major source of Salmonella to infect humans, a 9-year survey
of FQ susceptibility was conducted. As plasmid-mediated quinolone
resistance has recently been detected in Salmonella, we evaluated the
isolates with reduced susceptibility to ciproﬂoxacin (CP) for qnr gene
prevalence.
Methods: In the ﬁrst programme, caecal samples from chickens
were randomly taken at a Belgian abattoir. In the second, carcass
samples were collected from chickens and turkeys processed in
various abattoirs across Germany. Susceptibilities to CP and nalidixic
acid (NA) and non-FQs such as ampicillin (AM), cefotaxime (CT),
chloramphenicol (CA), gentamicin (GM), streptomycin (S), tetracycline
(TE) and trimethoprim/sulfadiazine (TS) were assessed by agar dilution.
Resistance was calculated using CLSI breakpoints (M100-S16). The
presence of qnrA, qnrB and qnrS was tested by PCR and sequence
techniques.
Results: In all, 4792 Salmonella isolates (Belgium 408; Germany
4384) comprising 53 serotypes were recovered. In both surveys, clinical
resistance to CP was absent in all but one of the isolates tested (MIC
4mg/l). Reduced CP susceptibility (MICs 0.12−2mg/l) was 32% and
11%. S. Hadar and S. Saintpaul were the most frequent serotypes
exhibiting reduced CP susceptibility, which virtually resembles the
resistance to NA. CT resistance was 1.7 and 0%, respectively, whereas
reduced CT susceptibility (MICs 1–32mg/l) amounted to 4.3 and 0.8%.
In contrast, resistance to AM, CA, S, TE and TS amounted to 46, 9,
29, 34 and 20% in Belgium and 21, 5, 11, 14 and 16% in Germany.
GM resistance did not exceed 1% in either programme. Of 688 isolates
tested for qnr genes, 4 isolates (0.6%) carried qnrS (S. Give, S. Infantis,
S. Saintpaul) or qnrB (S. Derby). These 4 isolates were isolated in 2003,
2004 and twice in 2005.
Conclusions: Clinical resistance among Salmonella from chickens
and turkeys to CP or CT, particularly important drugs for treating
salmonellosis in humans, was zero to very low. However, for most older
drugs notably higher rates were assessed. Reduced susceptibility to CP
and CT varied markedly for CP with the different serotypes. The ﬁndings
also indicate that the occurrence of qnr genes seems to be uncommon
in avian Salmonella within the EU regions.
P2093 Decreasing susceptibility to ciproﬂoxacin in foreign travel-
related cases of enteric fever in England, Wales and Northern
Ireland: results from an enhanced surveillance pilot
J. Lawrence, J. Jones, E. de Pinna, E.J. Threlfall (London, UK)
Objectives: The Laboratory of Enteric Pathogens (LEP) of the Health
Protection Agency of England, Wales, and Northern Ireland (EWNI) is
the reference centre for Salmonella enterica serovars Typhi (ST) and
Paratyphi A (SPA) for the United Kingdom (UK) and receives isolates
from all cases of infection in the UK for conﬁrmation and antibiotic
susceptibility testing. Since 2001, LEP has reported on an increase in
the number of isolates of both ST and SPA that have exhibited decreased
susceptibility to ciproﬂoxacin [MIC: 0.25−1.0mg/L] (CpI), the ﬁrst line
drug of choice for treatment of enteric fever for most physicians in
the UK. Travel history information has, however, been lacking for most
cases. To learn more about enteric fever reported in EWNI and improve
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travel history reporting, a pilot study of enhanced surveillance of cases
began 1 May 2006.
Method: An enhanced questionnaire was completed for each laboratory-
conﬁrmed and typed case of enteric fever as part of routine follow up
according to UK guidelines. The information was collected in a MS
Access database and cases known to have been acquired abroad with
onset dates between 1 May 2006 and 30 April 2007 were extracted and
analysed using MS Excel.
Results: During the report period, 373 cases of enteric fever (176 ST, 193
SPA, and four SPB) that were acquired abroad were reported. Seventy-
two percent of SPA isolates and 75% of ST isolates were CpI, compared
to 35% of ST isolates and 23% of SPA isolates reported by the LEP
in 2001. Country of travel was available for 99% (369/373) of cases
acquired abroad. For paratyphoid A: 93% (100/107) of cases acquired in
India, 32% (21/65) of those acquired in Pakistan, and 100% (13/13)
of those acquired in Bangladesh had isolates of SPA with CpI. For
typhoid: 95% (72/76) of cases acquired in India, 62% (33/53) of those
acquired in Pakistan, and 88% (23/26) of those acquired in Bangladesh
had isolates of ST with CpI. Three further cases acquired in China (two)
and Indonesia (one) also had isolates of SPA with CpI.
Conclusion: Strains of ST and SPA with decreased susceptibility to
ciproﬂoxacin are increasingly being seen in cases that have arrived in
the UK from the Indian sub-continent, in particular from India and
Bangladesh. These results indicate that the use of ciproﬂoxacin may
become increasingly limited as a ﬁrst line treatment and that available
alternatives should be considered, particularly in cases returning from
India or Bangladesh.
P2094 Comparative in vitro activities of tigecycline and 11 other
antimicrobial agents against 217 epidemiologically deﬁned
Acinetobacter bloodstream isolates
T. Paulus, M. Lugenheim, D. Stefanik, H. Wisplinghoff, M. Edmond,
H. Seifert (Cologne, DE; Richmond, US)
Objectives: To evaluate the vitro activity of tigecycline and other an-
timicrobial agents against epidemiologically well-deﬁned Acinetobacter
bloodstream isolates.
Methods: The in vitro activity of tigecycline and 11 other antimicrobial
agents was determined for 217 epidemiologically unrelated isolates
belonging to the A. calcoaceticus-A. baumannii complex. Isolates were
recovered from bloodstream infection in the United States between
1995 and 2002 during a prospective surveillance study (SCOPE).
Species identiﬁcation was conﬁrmed by ARDRA; RAPD-PCR and
PFGE patterns were obtained to exclude isolates that were clonally
related, i.e. only one isolate per strain type was included. MICs were
determined using microbroth dilution. CLSI/NCCLS guidelines were
used for interpretation.
Results: MIC50s and MIC90s (mg/L) are depicted in the table.
Resistance rates were lower in Acinetobacter genomic species 3 and
13TU than in A. baumannii strains.
Antimicrobial agent Range (mg/L) MIC50
(mg/L)
MIC90
(mg/L)
Susceptible
(%)
Resistant
(%)
Tigecycline 0.125−4 0.125 0.5 Nd Nd
Doxycycline 0.25−>32 0.25 4 95.4 4.1
Ampicillin/sulbactam 0.5/0.25–>32/16 4 32 79.3 12.9
Piperacillin 2−>64 16 >64 50.7 30.0
Cefepime 0.25−>32 4 32 54.8 16.1
Imipenem 0.25–32 0.5 2 95.4 1.4
Gentamicin 0.25−>32 1 32 69.6 24.4
Tobramycin 0.25–32 0.5 2 94.9 3.2
Amikacin 1–128 2 8 98.2 0.9
Levoﬂoxacin 0.25−>32 0.25 16 69.1 26.3
Colistin 0.125−4 0.25 0.5 99.1 0.9
Rifampicin 1−>32 4 8 Nd Nd
Conclusions: Tigecycline, amicacin, and colistin showed the highest
in vitro activity against A. baumannii bloodstream isolates. Our
data conﬁrm the high resistance of clinical A. baumannii isolates
against betalactams and quinolones but resistance to imipenem and
aminoglycosides was less than suggested from surveillance studies that
don’t control for copy strains associated with endemic or outbreak
situations.
P2095 Molecular characterisation of aminoglycoside resistance in
Enterobacteriaceae
E. Miro´, F. Grunbaum, L. Go´mez, B. Mirelis, P. Coll, F. Navarro
(Barcelona, ES)
Objectives: Bacterial resistance to antimicrobial agents has become an
increasing problem in clinical practice, limiting the therapeutic options.
Aminoglycoside resistance may be due to several mechanisms, among
which aminoglycoside-modifying enzymes are particularly important.
We report here the prevalence of the aminoglycoside-modifying enzymes
present in aminoglycoside-resistant Enterobacteriaceae isolated during
the ﬁrst three months of 2006.
Methods: The susceptibilities to aminoglycosides: amikacin, gentamicin,
kanamycin, netilmycin, neomycin, spectinomycin, streptomycin and
tobramycin were determined by disc diffusion method. The MICs of the
aminoglycosides resistant isolates were determined by Etest. Detection
and characterisation of the modifying-enzymes was done by PCR. Some
of these amplicons were sequenced. ERIC-PCR or PFGE were used to
study the clonal relationship between bacterial strains carrying the same
aminoglycoside-modifying enzyme.
Results: During this period 803 isolates were recovered from 718
patients, 371 of which (46.2%) presented aminoglycoside resistance. Of
the 8 aminoglycosides tested, the most affected was streptomycin (S)
(342; 42.6%), followed by kanamycin (K) (103; 12.8%), gentamicin (G)
(68; 8.4%), tobramycin (T) (64; 8%), neomycin (N) (62; 7.7%), specti-
nomycin (Sp) (36; 4.5%), netilmycin (Nt) (16; 2%) and amikacin (A)
(6; 0.7%). Thirty-one clonally-related strains were excluded for enzyme
characterisation.
The most frequent enzyme found was APH-3′′-Ib (S) (61%), followed
by ANT-3′′-Ia (S,Sp) (40%), AAC-3-IIa (KGTNt) (10%), APH-3′-Ia
(KN) (7.6%), AAC-6′-Ib (KTANt) (3.8%), ANT-2′′-Ia (KGT) (3.2%)
and AAC-6′-Ic (KTANt) (0.3%). Finally, the ampliﬁcation results were
negative for 37 strains.
Twenty-two percent of the strains presented more than one enzyme. ANT-
2′′-Ia and AAC-6′-Ic were always associated with other enzymes. The
most frequent association was APH-3′′-Ib + ANT-3′′-Ia (48 strains) or
this association with AAC-3-IIa (7) or APH-3′-Ia (6), and APH-3′′-Ib +
AAC-3-Iia (11).
Conclution: Extensive resistance was found within Enterobacteriaceae
for streptomycin and also for kanamycin, tobramycin and netilmycin.
The high number of strains with multiple aminoglycoside-modifying-
enzymes is of particular concern.
P2096 In vitro susceptibility patterns to 13 antimicrobials against
Pseudomonas aeruginosa cystic ﬁbrosis patients in the UK
P. Khanna, S. Soleimanian, D. Wareham (London, UK)
Objectives: Respiratory tract colonisation and infection in cystic ﬁbrosis
(CF) patients contributes to the progressive decline in lung function.
Pseudomonas aeruginosa, is the most common bacterial pathogen and
is often exhibits multi-drug resistance. We conducted a surveillance of
resistance to 13 commonly used agents amongst isolates from a large
UK CF centre to provide an indicator of the prevalence of resistance in
2005–2007.
Methods: 478 strains of P. aeruginosa were isolated from CF
sputum over a 24 month. Strains were identiﬁed by growth on
Pseudomonas Isolation agar, API 20NE and conﬁrmed by speciﬁc
PCR. Isolates were classiﬁed as mucoid or non-mucoid and tested
for susceptibility to amikacin, ceftazidime, ciproﬂoxacin, gentamicin,
imipenem, meropenem, piperacillin/tazobactam, azlocillin, aztreonam,
colistin, tobramycin, cefpirome and ticarcillin/clavulanate by the BSAC
disc diffusion method.
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Results: Only 21.2% of the isolates were sensitive to all antibiotics
tested. The most active agent was colistin (1.1%) followed by tobramycin
(13.4%) and piperacillin/tazobactam (17.8%).11 isolates were resistant
to all antibiotics except for colistin. Resistance to cefpirome was
(74%), ciproﬂoxacin (40.5%), gentamicin (39.3%), ticarcillin/clavulanate
(38.5%), imipenem (38.5%), meropenem (33.3%), aztreonam (31.6%),
azlocillin (28.7%), ceftazidime (26.2%) and amikacin (25.3%). In-
vitro susceptibility of mucoid P. aeruginosa isolates was greater than
non-mucoid isolates (p< 0.05 for gentamicin, tobramycin, amikacin,
ticarcillin/clavulante, azlocillin, aztreonam and ciproﬂoxacin). Multi-
drug resistance (5 antibiotics) occurred in 55.3% of isolates.
Conclusion: P. aeruginosa CF isolates exhibit very high rates of
antimicrobial resistance. This not only complicates treatment of chronic
infection and exacerbations difﬁcult but may be an important reservoir
of antimicrobial resistance determinants for dissemination to non-CF
strains. Continued surveillance of antibiograms and monitoring for new
resistance genes in this population is warranted.
P2097 Antibiotic resistance in Enterobacteriacea in Austrian
intensive care units
S. Metz-Gercek, C. Pointner, M. Polonyi, K. Krziwanek, H. Mittermayer
on behalf of the ICU-Study Group
Background: Infections with resistant Gram-negative (GN) bacteria
in intensive care settings have become a threat to modern medicine
in recent years. Increasing resistance against ﬁrst line drugs such
as ﬂuoroquinolones (FQ) or 3rd generation cephalosporines (3C), the
appearance of metallo-betalactamase resistance (MBL) in some countries
e.g. Greece and Great Britain and the lack of new drug developments
with activity against GN pathogens are the main factors for increasing
complexity of patient management. In the present study we analysed the
current situation and time trends of in vitro activity of vital substances
in intensive care units (ICUs) of 33 hospitals in Austria.
Methods: Susceptibility to 9 antibiotics of 1.125 consecutive enter-
obacteriacea strains isolated in clinical specimen in ICUs all over
Austria during the periods January to May 2005 and January to May
2007 was determined at the National Reference Center for Nosocomial
Infections and Antibiotic Resistance in Linz. Besides that data on patient
characteristics, epidemiology and culturing practice were collected to set
resistance prevalence in relation to factors of patient characteristics and
clinical activity. Data from the European surveillance network EARSS
has been used for comparison and to bring the ﬁndings in a larger
context.
Results: For the most frequent GN pathogen E. coli (eco) rising
resistance for FQ, 3C, and 4th generation Cephalosporins (4C) as well as
an increase of ESBL-producing strains were found in Austrian ICUs. In
contrast to that, the activity of Carbapenems (C) as well as the activity
of the recently introduced drug tigecycline (T) was still very high. In
Klebsiella species (ksp) no rising trend in resistance for FQ, 3C, 4C and
rates of ESBL-producing strains were detected. This is in accordance
with ﬁndings in EARSS where resistance rates of FQ and 3C for invasive
eco isolates has also risen substantially (FQ: 7% to 27%; 3C: 0% to
8%) between 2001 and 2007. Resistance rates for FQ (12%/12%), 3C
(6%/5%) and C (0%/0%) for K. pneumoniae (kpn) have on the other
hand remained stable since the beginning of the EARSS data collection
in 2005.
Conclusions: There is still in vitro activity of a number of substances
especially the reserve drugs C and T against eco and kpn/ksp. It is
surprising that typical nosocomial pathogens such as ksp and kpn show
no change in resistance over time unlike eco which shows an enormous
increase in resistance against ﬁrstline therapeutic options.
P2098 Molecular typing, serotyping and antibiotic resistance
patterns of Salmonella enterica strains isolated from foods
and humans in Valencia, Spain
A.I. Jimenez, Y. Moreno, M. Espinosa, D. Tomas, M.A. Ferrus
(Valencia, ES)
Aims: Salmonellosis is the most common foodborne disease worldwide,
being human and animal excreta the most important sources of
Salmonella in environment. S. Enteriditis and S. Typhimurium are two
of the most prevalent serotypes transmitted from animals to humans.
The emergence of Salmonella strains with resistance to ﬂuoroquinolones
and third-generation cephalosporins is a public health problem, which
results in limitation and even failures of the effective treatment. This
drug-resistant Salmonella emergence is mainly attributed to over use of
antimicrobials in food animals.
The aim of this work consisted in evaluating the prevalence of antibiotic
resistances in Salmonella strains isolated from different sources in our
geographical area, and investigating serovars and genotypes distribution
among the isolates.
Methods: A total of 200 Salmonella strains were isolated from water,
foods (mainly chicken meat), poultry faeces and human clinical samples.
Serotypes, antibiotic resistance patterns and genotypes were investigated.
Resistance to 12 antibiotics was determined by Disk diffusion tests
(NCCLS guidelines). Molecular typing was performed by PFGE with
XbaI enzyme and AFLP techniques.
Results: A total of 25 different serotypes were identiﬁed. S. Enteritidis
was the predominant serotype (26.3%) followed by Typhimurium (18%)
and Hadar (13%). All the strains were susceptible to Ceftriaxone. A
high proportion (86%) of the isolates was resistant to at least one
antibiotic, being 31% multidrug-resistant. Serotypes Typhimurium and
Hadar presented a high rate of multiresistant strains. 34% of the isolates,
most of them from poultry faeces, were quinolone-resistant. PFGE
allowed for clustering strains with similar origin or serotype. AFLP
technique was highly discriminatory, being all the patterns serotype-
speciﬁc. However, neither by PFGE, nor by AFLP it was possible to
correlate genotypes with resistance patterns.
Conclusions: A high prevalence of antibiotic resistant strains were found
among Salmonella enterica strains, most of them from animal food and
poultry faeces, conﬁrming the role of veterinary use of antimicrobial
agents in the emergence of this public health problem. Molecular
typing techniques AFLP and PFGE are useful epidemiological tools for
subtyping Salmonella enterica strains.
Acknowledgements: This work was supported by Ministerio de
Educacio´n y Ciencia, Spain (Project AGL2005–07776-C03–01, national
and FEDER funds).
P2099 Antimicrobial resistance mechanisms in clinical isolates of
Pseudomonas aeruginosa
S. Molan, S. Smith, T. Rogers, F. Walsh (Dublin, IE)
Objectives: Pseudomonas aeruginosa is a signiﬁcant nosocomial
pathogen innately resistant to a wide variety of antimicrobials. It is
an opportunistic pathogen capable of causing both local and systemic
infections.
This study was undertaken to examine the antimicrobial resistance
mechanisms utilised by clinical isolates of P. aeruginosa.
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Methods: Pseudomonas aeruginosa isolates resistant to ﬂuoro-
quinolones, b-lactams, carbapenems and aminoglycoside were collected
from St. James’s Hospital Dublin.
Antibiograms were determined by the disk diffusion method according to
CLSI guidelines. The presence of ﬂuoroquinolone resistance-associated
mutations in gyrA, gyrB and parC was determined by PCR and
sequencing. Genes encoding aminoglycoside-modifying enzymes were
detected using PCR and sequencing. ESBL detection was carried out
using the combined disk test. The presence of b-lactamase enzymes was
determined by nitroceﬁn tests. Isolates were investigated for the presence
of metallo-b-lactamases (MBL) using MBL Etest strips according to
manufacturer’s guidelines
The clonality of the isolates was determined by Pulsed Field Gel
Electrophoresis (PFGE) using the Xba1 enzyme.
Results: 75% of the ﬂuoroquinolone resistant isolates sequenced
possessed a substitution of Ile for Thr-83 in GyrA. This result is in
accordance with previous studies. One isolate possessed the less common
mutation of Asn for Asp-87 in GyrA. No isolates had a mutation
at position 106 in GyrA. No mutations were found in GyrB. The
substitution of Leu for Ser-87 in ParC was found in 67% of isolates
sequenced. An infrequent mutation of Gln for Glu-91 in ParC was
found in two isolates. One isolate was positive for the aminoglycoside-
modifying enzyme aac(6′)-Ib.
No ESBLs were detected. Eleven isolates tested positive using
nitroceﬁn test indicating hyper-production of AmpC. Although MBLs are
associated with high level carbapenem resistance, six isolates with MIC’s
ranging from 16–32g/L were positive according to imipenem Etest.
The PFGE patterns did not suggest the predominance of a single clonal
genotype within the population.
Conclusion: Common and rare chromosomal mutations, associated with
ﬂuoroquinolone resistance, were detected. A high percentage of isolates
have a derepressed AmpC enzyme and preliminary results suggest the
presence of MBLs. This is a worrying trend. Continued reporting along
with antibiotic stewardship are required to prevent the emergence and
spread of resistant isolates.
P2100 P. aeruginosa with hypermutable phenotype in cystic
ﬁbrosis patients
G. Manno, G. Melioli, M. Mentasti, N. Cirilli, E. Manso, A. D’Aprile,
F. Gioffre`, D. Scuteri, P. Morelli (Genoa, Ancona, Cerignola,
Soverato, IT)
Background: Hypermutable phenotype (HPM) strains are those that
have an increased (up to 1,000-fold) spontaneous mutation rate due to
defects in genes involved in DNA repair or error avoidance systems.
The presence, in cystic ﬁbrosis (CF) patients, of a high proportion of
HPM (or mutator) P. aeruginosa (PA) strains, was documented (Oliver
et al. 2000). The acquisition of a stable mutator phenotype may confer a
selective advantage for PA in the pulmonary environment in CF, because
both high mutation rates and increased promiscuous recombination allow
faster adaptation. Aim. Determine occurrence and antibiotic resistance
PA HMPs in Italian CF pts.
Methods: 154 non-mucoid, 100 mucoid and 18 SCV non-multiresistant
PA from 170 pts from 4 Italian CF Centres were studied. HMP was
determined as previously described (Macia et al. 2004) by disk-diffusion
and Etest for 10 antibiotic; results were read after 24 h at 35ºC; plates
were re-incubated for further 12 h and HMPs were deﬁned as strains
showing a sub-population grown after 36 h and resistant to 3 o more
antibiotics. A preliminary comparison between the reference mutation
frequencies measurement test (Oliver et al. 2000) was performed on 10
PA strains and PA01, to assess the laboratory agreement with the disk-
diffusion test for hypermutability. The genetic relationship of all PA was
determined by BOX-PCR.
Results: Our results showed that Macia’s test and the reference mutation
frequencies measurement test overlap in assessing HMP strains. 32% of
pts was colonised with HMPs, mean age 28 yrs; pts without HMPs
showed a mean age of 17 yrs. HMPs distribution was 17% in non-
mucoid, 28% in mucoid and 39% in SCV strains. No correlation with
HMP occurrence and shared genotypes was found. The % of antibiotic
resistance in HMPs was AK 33, TO 12, CL9, FEP 51, CAZ 41, MEM
26, P/T42, T/C 47, CIP 35 and LEV 39.
Conclusion: The occurrence of 32% found, conﬁrm previous rates
reported from CF pts in other country (Oliver et al. 2000). The high
occurrence found of in mucoid (28%) and SCV (39%) strains, typical
in long term chronic colonisation, stress the possible role of CF lung
environment in inducing the expression of HMPs. In these strains the
emerging resistance to TO and particularly to CL is worrisome for
antimicrobial treatment implications.
This study was supported by the Italian Cystic Fibrosis Foundation Grant
FFC#8/2005
P2101 Enterobacteriaceae in urinary tract infections: a laboratory
view
C. Dorobat, A. Teodor, D. Teodor, O. Dorneanu, O. Filip, D. Leca,
E. Miftode (Iasi, RO)
Objective: To ﬁnd out the frequency an antimicrobial resistance on
enterobacteriaceae in urinary tract infections.
Methods: All urine isolates from urine culture were collected from
inpatients in university-afﬁliated Hospital of Infectious Diseases – Iasi
in 2007. The analysis was based on the microbiology laboratory data
according to the standard techniques.
Results: A total of 736 isolates from urine culture were analysed.
There were 79.5% enterobacteriaceae. The predominant species was
E. coli (77.8%), followed by Klebsiella spp. (13.7%) with predom-
inant species K. pneumoniae (88.8%). The other pathogens were:
Enterobacter (4.9%), Proteus (2.7%), Citrobacter (1%), Morganella
spp. and Hafnia (<1%). The highest rate of resistance of E. coli
among the different antimicrobials classes was: amoxicillin-clavulanate
(17%), ceftazidime and cefoperazone (27.1%), ceftriaxone (23.4%),
cefotaxime (15.4%), cefoperazone-sulbactam (4.6%), piperacillin-
tazobactam (7.5%), imipenem (1.1%), ertapenem (0.7%), oﬂoxacin
(29%), ciproﬂoxacin (25%), tobramicine (37.8%), amikacine (20%),
colistin (8.8%); susceptibility to meropenem is 100%. The most im-
portant resistance for Klebsiella were: amoxicillin-clavulanate (35.8%),
ceftazidime (30%), cefoperazone-sulbactam (25.3%), ertapenem (16%),
colistin (6.7%).
Conclusions: The most common pathogen among isolates from urine
culture was E. coli. There is an increasing local resistance of
enterobacteriaceae at available antimicrobial agents.
P2102 Antimicrobial susceptibility proﬁles of Shigella spp. and
Salmonella spp. isolated from children <5 years of age with
diarrhoea in southern Mozambique
I. Mandomando, J. Ruiz, X. Valles, M. Espas, S. Sanz, B. Sigauque,
J. Sacarlal, E. Macete, P. Alonso (Maputo, MZ; Barcelona, ES)
Objective: To assess the antimicrobial proﬁles of Salmonella spp. and
Shigella spp. isolated in children <5 years of age with diarrhoea attended
at the Manhic¸a Hospital District, in Southern Mozambique
Methods: Rectal swabs were systematically collected in children
<5 years of age complaint with diarrhoea. 1351 rectal swabs were
cultured for Salmonella and Shigella isolation. Shigella and Salmonella
strains were characterised biochemically and conﬁrmed by API20E
(BioMerieux, Marcy-I’Etoile, France), and serotypes determined by slide
agglutination using speciﬁc antisera. Antimicrobial susceptibility testing
to ampicillin (Amp), chloramphenicol (Chl), cotrimoxazole (SXT),
tetracycline (Tet), nalidixic acid (Nal), Ceftriaxone (Cro) was performed
by disc diffusion method and interpretative category of susceptibility
(susceptible, intermediate or fully resistant) was determined according
to Clinical Laboratory Standard Institute (CLSI). Nalidixic acid
and ampicillin resistant strains were tested to ciproﬂoxacin (Cip),
and amoxicillin plus clavulanic acid (A/C), respectively. Multi-drug
resistance was considered when the isolates presented full resistance
to three or more non-related antimicrobial agents.
Epidemiology of antimicrobial resistance among Gram-negatives S621
Results: One hundred eleven (8.2%) Shigella (being 95 Shigella ﬂexneri,
15 Shigella sonnei and 1 Shigella dysenteriae) and 42 (3.1%) Salmonella
(10 S. Infantis, 9 S. Typhimurium, 5 S. Virchow, 18 other Salmonella
serotypes) were recovered.
High prevalence of antibiotic resistance was observed among Shigella
strains (55% for Chl, and 84% for SXT). S. ﬂexneri were more
resistant to Amp (68% versus 27%, p = 0.003) and Chl (68% versus
0%, p< 0.0001) than S. sonnei, while S. sonnei were more resistant to
tetracycline (93% versus 63%, p = 0.002). S. ﬂexneri presented high level
of MDR compared to others serotypes isolated in this study
Approximately 13% of resistance to Chl and 40% to Amp was
found among Salmonella strains with S. Typhimurium more resistant
than others. Among others serotypes of Salmonella, two out of three
Salmonella Isangi strains were tested and showed high levels of
resistance to Amp, Chl, Tet and A/C.
Conclusions: Shigella strains were mostly resistant to available,
inexpensive antibiotics including MDR strains while Salmonella spp.
presents lower levels of antimicrobial resistance. Although high level
of Shigella resistance, nalidixic acid which is ﬁrst line treatment of
shigellosis in the country is still effective.
P2103 Resistance trends of E. coli from urinary tract infections
in hospitalised patients and consumption of antimicrobials,
1998–2006
Z. Baklan, R. Saletinger, P. Drofenik, D. Novak (Maribor, SI)
Objectives: To ﬁnd out the frequency of E. coli among urinary pathogens
and to investigate the resistance trends of E. coli to antimicrobials and
the consumption of antimicrobials in hospital in period 1998 to 2006.
Methods: We analysed all pathogens from urine samples from patients
hospitalised at University Clinical Centre Maribor. Urine cultures were
done according to standard techniques and susceptibility was determined
according to NCCL standards by disc diffusion method.
Results: In 1998 and 2006, 2563 and 3005 pathogens from urine cultures
were analysed. The frequency of Gram-negative bacteria increased (from
64.7% to 75.9%) and E. coli was the most common pathogen determined,
representing 39.1% (N=1002) and 44.6% (N=1339) of all isolates.
The resistance rates of E. coli to some most often used antimicrobials in
period 1998–2006 were as follows: to amoxicillin-clavulanate 15.4% and
13.3% (p-NS), to cephalotin 7.8% and 16.8% (p< 0.001), to cefuroxime
2.8% and 3.2% (p-NS), to ciproﬂoxacin 4.9% and 13.0% (p< 0.001),
to gentamicin 2.3% and 5.3% (p< 0.001), to cotrimoxazole 15.0% and
26.1% (p< 0.001).
The consumption of some antimicrobial agents in our clinic in period
1998–2006 was as follows (in DDD/100 hospital days): amoxicillin-
clavulanate 100006 and 140809, cefuroxime 43404 and 100356,
gentamicin 15908 and 13300, ciproﬂoxacin 41592 and 106513.
Conclusion: E. coli remains the most frequently isolated pathogen.
A considerable rise in the resistance rates of E. coli to cephalotin,
ciproﬂoxacin, gentamicin and cotrimoxazole was detected. Amoxicillin-
clavulanate was the only one with slightly improved susceptibility,
although it was the most often prescribed antimicrobial agent to
inpatients and outpatients too. In 2006 we found the resistance rates
of E. coli lower than 10% only to cefuroxime and to gentamicin. ESBL-
producing strains among E. coli were detected in 1.5%.
We believe that it is necessary to rationalize persciption of ciproﬂoxacin
in our clinic in order to prevent a further increase of resistance.
Knowledge of most frequent uropathogens and their antimicrobial
resistance patterns is essential to provide clinically successful, cost
effective antimicrobila therapy for urinary tract infections.
P2104 High levels of antimicrobial resistance of diarrhoegenic
Escherichia coli in Peruvian infants
T.J. Ochoa, M. Vargas, M. Molina, L.J. del Valle, J. Ruiz, A.I. Gil,
L. Ecker, F. Barletta, C.F. Lanata (Lima, PE; Barcelona, ES)
Objective: The purpose of this study was to determine the prevalence
and antimicrobial susceptibility of the diarrheogenic Escherichia coli in
Peruvian children less than 1 year of age with and without diarrhoea.
Methods: This was a prospective longitudinal cohort of 1025 Peruvian
infants followed from 2 to 10 months of age in low-socio-economic
communities in Lima, Peru. Five E. coli colonies per patient were
analysed for the presence of Enterotoxigenic (ETEC), Enteropathogenic
(EPEC), Shiga toxin-producing (STEC), Enteroinvasive (EIEC), En-
teroaggregative (EAEC), and Diffusely Adherent E. coli (DAEC), in a
multiplex real time PCR system, and analysed for their antimicrobial
susceptibility by disk diffusion to ampicillin (Amp), amoxicillin-
clavulanic acid (AMC), cefotaxime (Ctx), ceftazidime (Caz), gentamicin
(Gm), nalidixic acid (Nal), ciproﬂoxacin (Cip), tetracycline (Tc),
chloramphenicol (Cm), cotrimoxazole (Sxt) and nitrofurantoin (Ntr).
Results: The prevalence of the diarrheogenic E. coli was 29% (161/557)
in the diarrhoea group and 30% (58/195) in the control group without
diarrhoea; the most common E. coli groups were EAEC (14% vs.18%),
EPEC (7% vs. 7%), DAEC (4% vs. 3%) and ETEC (4% vs. 2%),
respectively. Among diarrhoeal samples, the diarrhoeogenic E. coli as a
group exhibited high levels of antimicrobial resistance to Amp (85%),
Sxt (79%), Tc (65%), Nal (28%) and Cm (26%); low resistance levels
to Gm (4%), Ntr (3%) and Cip (2%); and no resistance to AMC,
Ctx and Caz. Among the individual E. coli groups, DAEC and EAEC
exhibited higher resistance to Amp, Sxt, Tc and Nal, than EPEC and
ETEC (p< 0.05 for each antibiotic). The frequency of resistance of
control samples isolated from children without diarrhoea was lower than
diarrhoeal samples for Amp (70%, p< 0.05) and Sxt (61%, p< 0.05).
Conclusions: There was a high frequency of antimicrobial resistance
of diarrheogenic E. coli in Peruvian infants. Resistance patterns were
different among the individual E. coli groups. Antimicrobial resistance
in diarrhoeal samples was more frequent than control samples without
diarrhoea, suggesting a possible association of resistance genes with
plasmid-associated virulence genes, such as adherence factors.
P2105 Do blood cultures from E. coli overestimate the rate of
antimicrobial resistance?
K. Heckenbach, I. Noll, W. Pﬁster, T. Pietzcker, S. Schubert, S. Ziesing,
N. Wellinghausen, T. Wichelhaus, T. Eckmanns (Berlin, Jena, Ulm,
Kiel, Hannover, Frankfurt a. M., DE)
Objectives: Many surveillance systems in Germany, Europe, and
worldwide measure the resistance rate in bacteria in hospitals. The
systems differ in the inclusion of single departments, antimicrobials,
and sources of material. The network GENARS (German network for
antimicrobial resistance surveillance) is the only German surveillance
system with standardised methods for antimicrobial testing and the
inclusion of all sources of material in contrast to the European
Antimicrobial Resistance and Surveillance System collecting blood
samples only. The GENARS database was investigated under the
hypothesis that in comparison to urine the measurement of blood isolates
overestimates the resistance rate.
Methods: GENARS consists of 7 German university hospitals, having
isolated 20,000 Escherichia coli in the period from 2002 to 2007.
The isolates were derived from different sources of material and
investigated with routine diagnostics. The antibiograms were conducted
with a standardised panel of antimicrobials. The minimal inhibitory
concentration was interpreted by the DIN standard. The association
between type of material and the resistance against the 12 selected
therapies were tested by logistic regression analysis simultaneously
controlling for age and sex of the patients, laboratories, and the year
of investigation.
Results: A statistically signiﬁcant higher risk for resistance was
associated for pathogens detected in blood, in comparison to urine,
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for ciproﬂoxacin Odds Ratio (OR) 1.2 (95%CI 1.1−1.3), levoﬂoxacin
OR 1.2 (95%CI 1.1−1.3), co-trimoxal OR 1.3 (95%CI 1.2−1.4),
piperacillin OR 1.1 (95%CI 1.0−1.2) and piperacillin/ tazobactam OR
1.1 (95%CI 1.0−1.3). A statistically signiﬁcant lower risk was associated
with ceftazidim OR 0.4 (95%CI 0.4−0.5), cefotaxim OR 0.5 (95%CI
0.4−0.6), and tobramycin OR 0.9 (95%CI 0.8−0.9). No differences were
seen for imipenem, meropenem, ampicillin, and ampicillin/sulbactam.
Conclusion: There are differences in the resistance rate, regarding the
material tested. This observation may reﬂect the result of selection by
speciﬁc antibiotic use. In hospitals urine was presumably investigated
from patients who had been treated for urinary tract infection before.
Antimicrobial Resistance Surveillance systems based on blood samples
may over- or underestimate the resistance rate for single substance
groups. Resistance rates are dependent on the sources of the material
used.
P2106 Trends in antimicrobial susceptibility of Escherichia
coli isolates from urology services of 14 hospitals in the
Netherlands (1998–2005)
S. Nys, P. Terporten, M. Hoogkamp-Korstanje, E. Stobberingh and
The Susceptibility Surveillance Study Group
Objectives: Antibiotic resistance among potential pathogenic micro-
organisms is a worldwide problem. To identify the development of
resistance actual resistance data of common pathogens are essential
to develop therapeutic guidelines. Urinary tract infections are a very
common disease both in and outside the hospital, with E. coli the
most prevalent uropathogen. Optimal antibiotic treatment of UTI may
contribute substantially to the control of antibiotic use and antibiotic
resistance. We studied trends in antibiotic resistance of uropathogenic
E. coli during an eight-year surveillance. Ultimately, these data will be
used to optimize UTI guidelines.
Methods: During the years 1998–2005, 3360 unique consecutive E. coli
from urine samples of patients attending the Urology Services were
collected in hospitals spread over The Netherlands: 4 in the North-East
(NE, n = 1084), 5 in the West (W, n = 1064) and 5 in the South (S,
n = 1212).
The antibiotic susceptibility was determined using microbroth dilution
according to CLSI-guidelines. The agents tested were those relevant for
the treatment of UTI. E. coli ATCC35218 and ATCC25922 were used
as references.
Results: Amoxicillin resistance remained stable over time (37%-47%)
but was higher in the S (44%) as compared to the other regions
(40%; p< 0.02). Piperacillin resistance increased from 4% to 32%
(p< 0.001) and differed between the 3 regions (NE 10%, W 12%, S
14%; p< 0.05). Fluoroquinolones resistance increased from 6% to 13%
over time (p< 0.01) and was different between the 3 regions (NE 7%, W
13%, S 8%; p = 0.000). Resistance to trimethoprim±sulfamethoxazole
remained stable over time (27–37%) although trimethoprim resistance
was higher in the S (36%) compared to the NE (32%) and the W (29%;
p< 0.01). Nitrofurantoin resistance remained low throughout the study
(4%-9%) without signiﬁcant regional differences.
In total 330 strains were resistant for 3 groups of antibiotics (MDR).
The percentage MDR was different for the 3 regions (NE 8%, S 10%,
W 13%; p< 0.05).
Conclusion: Except for piperacillin and the ﬂuoroquinolones, antibiotic
resistance over time did not increase, although regional differences were
observed. Thus, longitudinal surveillance of antibiotic resistance on an
national and regional level is important to keep therapeutic guidelines
up-to-date and in line with the resistance of the micro-organisms to be
treated.
P2107 Ecology of antimicrobial resistance and virulence in
Escherichia coli in a rural watershed
L. Neils, C. Campillo, G. Gonza´lez, E. Carter, C. Angle, A. Keen,
S. Ernst, R. Singer (St. Paul, US; Valdivia, Concepcio´n, CL)
Objective: To examine the phenotypic and genotypic diversity among
Escherichia coli in a rural watershed in southern Chile. The overall goal
of this project is to relate E. coli antimicrobial resistance and virulence
proﬁles among dairy farms, wastewater treatment plants, and surface
waters in a rural watershed.
Methods: Samples were collected over three years in the Valdivia
province of Chile. In Year 1, isolates were collected from cattle (n = 847),
wastewater treatment plants (n = 27), and rivers (n = 222). Comparisons
of microbial load, antibiotic resistance, and virulence were made among
all samples. In Years 2 and 3, samples were collected from surface
water samples in 11 of the 12 communities of the province (n = 575
and n = 692, respectively). Distributions of antimicrobial resistance and
virulence proﬁles were compared among sites. In Year 2, all E. coli
isolates were typed with Box-PCR, and genetic diversity was assessed
among sites.
Results: In Year 1, the microbial load in the surface water samples
was highest near the wastewater treatment plants. E. coli isolates from
the river water samples had different antimicrobial resistance proﬁles
than the cattle isolates. Shiga toxin virulence genes were detected
only in the cattle isolates. In Years 2 and 3, isolates immediately
downstream from the wastewater treatment plants had more resistance
than those immediately before the plants. No shiga-toxin virulence genes
were detected. Genetic diversity was most variable among communities
sampled, but there was considerable variation among sites within
communities as well.
Conclusions: E. coli isolates from surface waters in this study area had
a diversity of antimicrobial resistances. In general, the surface water
isolates had resistance proﬁles that were more similar to the wastewater
treatment plant isolates than to the cattle isolates. Virulence genes were
only detected in the cattle isolates. These data raise questions about the
relative importance of different potential contaminating sources to the
surface waters in this area. In addition, the high genetic diversity that
was observed among communities suggests that the sources of the E. coli
might be very local and not spread broadly among the surface waters of
the province. Overall, these data will assist in the development of public
health interventions in rural communities.
P2108 High proportion of antibiotic resistance in bloodstream
infection by nursing-home-acquired E. coli
A. Delgado-Iribarren, M. Velasco, J. Valverde, J. Losa, I. Buhigas,
J. Fernandez (Madrid, ES)
Background: To evaluate the prevalence of bloodstream infection (BSI)
by E. coli and the relationship between resistance and source of
acquisition.
Methods: We evaluated all the episodes of BSI by E. coli in adult
patients attended in our hospital during the period 2003–2006. Place of
acquisition of bloodstream infection (comunity-acquired [CA], nursing-
home-acquired [NH], nosocomial and procedure-related infection),
clinical source, antibiotic resistance and temporal trend were evaluated.
Results: A total of 752 episodes were detected; mean age of patients
was 71, 8 (SD 17.7) years and 52.8% were women. Number of episodes
remained unchanged from 2003 to 2006. Urinary tract was the most
common source of bacteraemia (58.5%) followed by biliary tract (15%).
According to the place of acquisition of BSI, CA was the most frequent
(57.8%) followed by NH (14.2%) and nosocomial (13%). The prevalence
differed along the period of the study, decreased in CA (from 66.3% to
56.8%, p = 0.033) and increased in NH (from 8.4% to 17.5%, p = 0.006).
Antibiotic resistance showed an unequal distribution, although the higher
rates were observed in quinolone and amoxiciline-clavulanate in NH
acquired BSI (Table)
Epidemiology of vancomycin-resistant enterococci S623
By logistic regresion, ceftriaxone resistance was highly associated to
place of BSI acquisition (OR 7.7, IC95 4.4–13.3) and also to age older
than 75 (OR 1.7, IC95 1−2.7), and to be male (OR 1.7, IC95 1−2.7).
Conclusions: There is an important increase in E. coli BSI NH
acquired. Antibiotic resistance is very high, specially in BSI with NH
acquisition. Empiric treatment in patient from NH might include the use
of carbapenem.
Resistance, %
Community-
acquired
Procedure-
related
Nosocomial Nursing-
home
Total; p
Ceftriaxone 3.9 25.4 25.0 24.3 12.8%; <0.001
Ciproﬂoxacin 18.4 46.4 40.0 62.6 31.6%; <0.001
Gentamicin 6.7 19.1 15.0 17.8 11.2%; 0.001
Amoxicillin–
clavulanate
12.2 27.3 30 44 21.3%; <0.001
Amoxicillin 57.8 72.7 79.0 74.0 65.2%; 0.002
All isolates were susceptible to ertapenem and imipenem.
P2109 Molecular characterisation of antimicrobial resistant
bacteraemic Escherichia coli isolates from an Irish hospital
N. Cooke, S. Smith, T. Rogers (Dublin, IE)
Escherichia coli is the leading cause of bacteraemia worldwide.
Currently, the speciﬁc characteristics of E. coli associated with bacter-
aemia are incompletely deﬁned, with limited data linking antimicrobial
resistance and virulence.
Objectives: This study aimed to characterise clinical E. coli bacteraemic
isolates from St. James’s Hospital (2004–2005), with regards to
antimicrobial resistance genes, phylogenetic background and virulence
factors.
Methods: The susceptibility of 221 clinical E. coli bacteraemia
isolates, to a panel of fourteen antibiotics, was determined using agar
microdilutions following CLSI guidelines. Phylogenetic grouping and
virulence factor content of each isolate was established using triplex and
multiplex PCRs, respectively. The presence of genes encoding TEM,
SHV, CTX-M, OXA and plasmidic ampC b-lactamases, as well as
the presence of mutations in gyrA, parC and the regulatory region of
the ampC chromosomal gene were studied by PCR and sequencing in
resistant isolates.
Results: High levels of resistance to aminopenicillins, third-generation
cephalosporins, ﬂuoroquinolones and aminoglycosides were detected
compared to the European Antimicrobial Resistance Surveillance
System data. Beta-lactamases identiﬁed included TEM-1 (130), inhibitor
resistant TEM’s (13), SHV-1 (3) and plasmidic ampC cephalosporinases
(4 ACC’s and 1 CMY-2). One extended spectrum b-lactamase, CTX-
M-15, was also identiﬁed. Mutations were present in gyrA (60), parC
(55) and ampC chromosomal genes (13). Isolates were predominantly
classed as phylogenetic group B2 strains. The majority of resistant
and multidrug-resistant E. coli belonged to phylogenetic group B2.
Resistant isolates, in general, possessed more virulence factors than
their susceptible counterparts. The most prevalent virulence factor
determinant in the collection was ﬁmH (99%), followed by fyuA (90%)
and traT (72%).
Conclusion: This study highlights a positive association between
virulence genes and antimicrobial resistance within E. coli bacteraemia
isolates from St. James’s Hospital, contrasting to previous studies. The
development of resistant pathogens with increased virulence adds further
to already limited treatment options.
P2110 Prevalence of the tetA gene and class I and class II
integrons in environmental isolates of E. coli
S. Galvin, F. Boyle, D. Morris, B. Tolar, M. Cormican (Galway, IE)
Objectives: The role the environment plays in the dissemination,
maintenance and ampliﬁcation of antimicrobial resistance is an area of
increased study. This study examines the prevalence of tetA as well as
class I and class II integrons in E. coli isolated from various water bodies
in Ireland, including rivers, lakes, efﬂuents and drinking waters.
Methods: Between April 2006 and June 2007, 189 samples from various
sources (hospital efﬂuent (HE), city efﬂuent, source and piped drinking
water, sea water, outﬂow from a secondary wastewater treatment plant,
rivers and lakes) were collected. All samples were screened for the
presence of antimicrobial resistant E. coli by quantitative culture in
the presence and absence of cefotaxime (CTX), ciproﬂoxacin (CIP),
cefoxitin (FOX), ampicillin (A), streptomycin (S), tetracycline (T)
and sulphonamides (Su) as appropriate. Antimicrobial resistance was
conﬁrmed by identiﬁcation and antimicrobial susceptibility testing (CLSI
disk diffusion) of representative isolates. Isolates resistant to 4 or more
antimicrobials were screened for the presence of tetA and class I and
class II integrons by PCR using speciﬁc primers and protocols as
previously described.
Results: Fifty-six E. coli isolates were isolated from; HE (23), city
efﬂuent (4), treated efﬂuent from a waste water treatment facility (6),
sea water (3), source water (11), piped drinking water (6), rivers (1)
and lakes (2). Thirty isolates (54%) harboured the tetA gene, twenty-
nine isolates (52%) harboured a class I integron, and 3 isolates (5%)
(3) harboured a class II integron. The prevalence of tetA, class I and
class II integrons and at the various sites tested was as follows; HE 52%
(12), 61% (14), 4% (1), City efﬂuent 75% (3), 75% (3), 0% (0), lakes
50% (1), 100% (2), 0% (0), piped water 83% (5), 50% (3), 17% (1),
rivers 100% (1), 0% (0), 0% (0), sea water 66% (2), 100% (3), 0% (0),
source water 45% (5), 27% (3), 0% (0), treated efﬂuent 17% (1), 17%
(1), 17% (1). Of the isolates harbouring tetA (30), 17 possessed a class I
integron and 1 possessed a class II integron. One isolate collected from
HE harboured both class I and class II integrons.
Conclusion: Class I integrons are widely disseminated in environmental
isolates of E. coli, with a stronger correlation of tetA with class I
integrons than class II integrons.
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P2111 Plasmid characterisation of vancomycin-resistant Enterococ-
cus faecium strains from different continents (1986–2007)
A.R. Freitas, M.V. Francia, L. Peixe, C. Novais, L. Jensen, R. Willems,
F. Baquero, T.M. Coque (Porto, PT; Madrid, ES; Copenhagen, DK;
Utrecht, NL)
Objectives: Vancomycin-resistance (VR) among E. faecium (Efm)
isolates is frequently transferable by conjugation although little is known
about the molecular epidemiology of transferable plasmids in this
species. We have analysed VREfm plasmids recovered in the last two
decades in different continents.
Methods: Ninety-six VR (88 VanA, 8 VanB) E. faecium isolates were
collected from 14 countries (Portugal, Spain, France, Greece, Germany,
the Netherlands, UK, Hungary, Norway, Denmark, Serbia, USA, Brasil
and Australia) over a 21-year period (1986–2007). They mostly belong
to CC17 and are representative of VREfm clinical outbreaks and
community isolates in these areas. Plasmid characterisation included
determination of size and content, comparison of ClaI-RFLP patterns,
identiﬁcation of relaxases by using a Multiplex-PCR-based relaxase (rel)
typing method (Goicoechea et al, ECCMID submitted), rep initiator
proteins (rep) and toxin-antitoxin systems (TA) by PCR. Results were
conﬁrmed by hybridisation and sequencing.
Results: A high diversity of plasmid content was observed (1−6 /cell,
2–350 kb). Conjugation was successful in 80% of strains, sometimes
involving more than one VR plasmid (25–250 kb). VREfm isolates
from different continents harboured plasmids containing relaxases from
pEF1 (92%), pCIZ2 (48%) or pHTbeta (25%); rep proteins from pRUM
(81%), pRE25 (60%), pHTbeta (50%), pCIZ2 (48%)and Inc18 (41%);
and Axe-Txe (31%) or omega-epsilon-zeta systems (14%). Relaxases
from pRUM, pRE25, and pAD1 were rarely detected. Differences among
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VREfm plasmids from different geographical locations were observed
(rel and rep types content and presence of Axe-Txe system).
Conclusions: VREFfm isolates recovered in the last two decades
contained plasmids with similar relaxases and rep initiator proteins
suggesting a common evolutionary trend in CC17. Conjugative plasmids
containing relaxases from pEF1 seem to have inﬂuenced the spread of
vancomycin resistance worldwide in last decades.
P2112 Plasmid characterisation of vancomycin-resistant Entero-
coccus faecalis strains from different continents (1989–2004)
A.R. Freitas, M.V. Francia, L. Peixe, P. Ruı´z-Garbajosa, C. Novais,
M. Zervos, F. Baquero, T.M. Coque (Porto, PT; Santander, Madrid,
ES; Michigan, US)
Objectives: Vancomycin resistant (VR) enterococci are more associated
with E. faecium than E. faecalis (Ef). Plasmid diversity among VREf
was analysed in order to better understand the plasmid ecology and the
scarce dissemination of vancomycin resistance in this species.
Methods: We analysed 44 VREf-vanA isolates (19 PFGE types, 13
ST types containing 7 Tn1546 types) from 8 countries (Portugal,
Spain, Italy, UK, Cyprus, Serbia, USA and Argentina), recovered
from 1989 to 2004. They are representative isolates causing well
characterised outbreaks, most of them belonging to HiRCC (CC2, CC9
and CC87). Plasmid characterisation included: (i) size and content (S1-
hybridisation), (ii) EcoRI/ClaI-RFLP comparison, (iii) identiﬁcation of
relaxases (rel) by a multiplex-PCR typing method (Goicoechea et al,
ECCMID submitted), (iv) identiﬁcation of rep initiator proteins (rep),
(v) detection of 5 toxin-antitoxin systems (TA) by PCR. Results were
conﬁrmed by hybridisation and sequencing.
Results: A variable number of plasmids (1−4/cell) from 25 to 300 kb
was observed, some isolates containing more than one vanA-plasmid.
RFLP plasmid patterns were highly diverse with some common types
identiﬁed in different countries over years.
VREf isolates contained a diversity of rel [rel pAD1 (93%), rel pRE25
(32%), rel pRUM (32%), rel pCF10 (11%), rel pAMalpha1 (9%), rel
pHTbeta (9%), rel pEF1 (5%)], rep [repAD1 (80%), rep Inc18 (61%), rep
pRE25 (61%), rep pAM373 (18%), rep pHTbeta (9%)] and TA systems
[par (68%), and Axe-Txe (2%)]. Most vanA plasmids hybridised with
probes for rel pAD1, rep pAD1, rep pRE25 and par genes, although
plasmids containing rel pHTbeta (variable rep and TA content) were also
detected in some countries. Differences in plasmid size and rep/rel/TA
content between wild type and corresponding transconjugants were
frequently observed.
Conclusions: VREf plasmids are mainly associated with derivatives of
the narrow host pheromone-responsive pAD1 from E. faecalis. Diversity
in the rep, rel and TA content in the same plasmid platform highlights
the modular structure of enterococcal plasmids and the impact of genetic
exchange in the adaptation and evolution of E. faecalis.
P2113 Evaluation of virulence and resistance genes structure in
vancomycin-resistant E. faecium
A. Brilliantova, G. Kliasova, S. Sidorenko, A. Mironova (Moscow, RU)
Objectives: To analyse the presence of virulence genes and Tn1546
structure of E. faecium isolates resistant to vancomycin presented
by different PFGE types, collected from patients with haematological
malignancies.
Methods: Clonal relatedness of E. faecium strains, harbouring VanA
genes, (October 2004 to May 2007) was evaluated by PFGE. First strain
of each PFGE type was analysed. Presence of virulence traits, such as
Enterococcal surface protein (esp), gelatinase (gelE), cytolysin (cylA),
hyaluronidase (hyl), aggregation substance (agg), and the backbone
structure of Tn1546 were studied using PCR technique.
Results: Typing of 138 E. faecium strains revealed 24 PFGE types. Six
types contained more than one strain and formed epidemic clones. Two
of them predominated, 85 (62%) and 12 (9%) isolates belonged to types
A and F. Other 18 strains were sporadic, each of them presenting one
PFGE-type. PCR analysis of Tn1546 showed that only 16% (8/50) of
epidemic isolates had deletions in either ORF1, VanX or VanY genes.
Other epidemic strains harboured the prototype Tn1546. Higher diversity
of Tn1546 structures was found in sporadic isolates, 7/18 (39% vs 16%,
p = 0.048), which had large deletions in ORF1 genes and insertions
between VanS and VanH. There were six different types of Tn1546
found. Various presence of virulence traits was detected in sporadic and
epidemic isolates. No asa or cylA were present. GelE gene was found
only in 2% (2/50) of epidemic and in 6% (1/18) of sporadic strains.
Esp and hyl genes were detected in 28% (14/50) and 38% (19/50) of
epidemic, in 33% (6/18) and 28% (5/18) of sporadic isolates. Among
the epidemic clones the prevalence of esp-positive isolates was detected
for clone A 43% (13/30), compared to 5% (1/20) for other epidemic
clones (p = 0.005).
Conclusion: The spread of vancomycin-resistant E. faecium was
polyclonal with two predominant clones. Transmission of transposons
among epidemic and sporadic strains could also occur. Prevalence of
prototype Tn1546 elements in epidemic strains observed, could explain
the higher ability, compared to sporadic isolates, to transmit resistance
genes among different epidemic strains and survive in the hospital
environment. Distribution of virulence factors was estimated to be
diverse, with a higher frequency of esp gene in dominating epidemic
clone A.
P2114 Prevalence and epidemiology of vancomycin-resistant
enterococci in a Russian haematology centre
A. Mironova, A. Brilliantova (Moscow, RU)
Objectives: To determine the epidemiology of clinical strains of
vancomycin-resistant Enterococcus faecium (VRFE) isolated from
patients with haematological malignancies. To explore the prevalence
of VREF strains in hospitalised patient of Haematology Unit (HU),
Intensive Care Unit (ICU), and to determine the clonal relationship.
Patients and Methods: Clinical isolates of VRFE were collected from
January 2004 and November 2007. Patients, who stayed in HCU and
HU for seven days and more, than 28 days were investigated. New
patients admitted to the HU were screened. Identiﬁcation of isolates and
presence of vancomycin resistance genes was established using PCR.
Macrorestriction analysis of SmaI digests was performed by pulsed-
ﬁeld gel electrophoresis. PFGE patterns were then compared using
BioNumerics 3.0.
Results: A total of 160 VREF clinical strains were isolated, 13 (8%) in
2004, 49 (31%) in 2005, 62 (39%) in 2006, and 36 (22%) in 2007. VREF
isolates carried vanA (96%) or vanB genes (4%) and were multiresistant
to antimicrobial agents, except linesolide (MIC from 1 to 2mg/L).
Strains of VREF were prevalent in two departments – ICU (34%) and
HU (32%). Bloodstream infections caused by VREF were observed in
ﬁve (3.1%) patients, one (2.0%) in 2005 (ICU), one (1.6%) in 2006
(HU) and three (8.3%) in 2007 (ICU, HU, and other unit). In the ICU
the carriage of VREF increased from 22% (10/46) in patients staying for
seven days to 82% (9/11) in patients staying for more than 28 days. In
the HU the detection of VREF increased from 7.2% (7/96) in patients
staying for seven days to 26% (16/61) in patients staying for more than
28-day. PFGE type A strains prevailed in patients in ICU (75%) and
HU (83%). Since July 2006 to June 2007 none of the patients newly
admitted to the HU (n = 70) carried VREF.
Conclusion: VREF strains were higly of distributed among patients
hospitalised in two departments (HU and ICU). One predominant clone
was disseminated in HU and ICU, suggesting intrahospital transmission.
Detected predominant clone in blood culture isolates may be a threat of
possible transition of VREF colonisation to invasive disease.
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P2115 vanB2-Tn5382 typing in enterococcal clones disseminated
around 16 hospitals in Chile
M. Lo´pez, G. Saavedra, M. Rodriguez-Ban˜os, J.C. Hormaza´bal,
A. Maldonado, J. Silva, C. Torres, R. del Campo (Logron˜o, ES;
Panama, PA; Madrid, ES; Santiago, Antofagasta, CL)
Objectives: To analyse the composition of the genetic element Tn5382
associated with the vanB2 genotype in selected enterococcal clones
disseminated around 16 different Hospitals in Chile, as well as the
presence of other resistance, virulence and bacteriocin genes.
Methods: Seven unrelated PFGE-SmaI clones (2 E. faecalis and 5
E. faecium) corresponding to 10 E. faecalis and 60 E. faecium vanB2
isolates were studied. Strains were collected at the National Reference
Institute in Santiago (ISPCH) from 16 different hospitals of four regions
of Chile. Antimicrobial susceptibility was determined by the agar
dilution method. Presence of ISEnfa110 or ISEnfa200, as well as the
vanX-ORFC fragment or the antimicrobial resistance genes erm(B),
tet(M), tet(L), aph(3′)-III and aac(6′)-aph(2′′) were tested by PCR.
Similarly, esp, hyl, gelE, fsrA, fsrB, fsrC, cylLLS, cylA, cylB, cylM,
and agg virulent factors were tested in all vanB2-enterococcal clones by
PCR. Amino acid changes in PBP5 protein was studied in one penicillin-
resistant E. faecium clone by PCR and sequencing. The purK allele was
analysed by PCR and sequencing. Bacteriocin production was analysed
using 8 indicator bacteria and bacteriocin structural genes were checked
by PCR.
Results: All ﬁve vanB2 E. faecium clones harboured the Tn5382 element
with positive ampliﬁcations for ISEnfa110 upstream of the vanRB gene,
whereas ISEnfa200 was not detected between the intergenic region
vanSB-vanYB. Negative results were obtained for both ISEnfa100/200
elements in the two vanB2-E. faecalis clones. The sequence of vanX-
ORFC fragment corresponded to the described sequence 203412. Eight
amino acid changes were detected in PBP5 protein in one ampicillin-
resistant E. faecium clones respect to the reference one. Almost all
enterococcal clones tested harboured the resistant genes erm(B), tet(M),
aph(3′), and aac(6′)-aph(2′′), and the E. faecalis ones also contained all
the virulence tested factors. The purK1 allele was found in all E. faecium
clones. Bacteriocin production was detected in two E. faecium and two
E. faecalis clones, showing activity against L. monocytogenes, among
others, and they harboured the entA gene.
Conclusions: different vanB2 clones of E. faecium and E. faecalis have
been disseminated in hospitals of four different regions of Chile and
most of them harbour a wide variety of antibiotic resistance genes and
virulence genes.
P2116 Alert patogeny among patients in a medical university
hospital, Gdansk
B. Rybak, L. Naumiuk, E. Naumiuk, M. Bronk, A. Samet (Gdansk, PL)
Objectives: The aim of this study was to analyse the occurrence of alert
pathogens recovered from patients who were hospitalised in the Hospital
of Medical University Gdansk
Methods: We analysed 230678 microbiologic records from 2002 to
2006.
We looked for alert pathogens like ESBL + (Extended-Spectrum
Beta-Lactamases), MRSA (Meticillin-resistant Staphylococcus aureus),
VRE (Vancomycin-Resistant Enterococcus). Strains were identiﬁed
by classical method and VITEK and VITEK2 cards (BioMerieux).
Production of ESBL was detected by double disk method. Only ﬁrst
alert pathogens from diagnostic and not epidemiological specimens were
analysed.
Results: ESBL+ isolates were recovered from 1317 patients.(7.02 100
patient/days) VRE isolates were recovered from 356 patients, (1.98 100
patient/days) MRSA isolates were recovered from 129 patients (0.46 100
patient/days).
ESBL+ were recovered in 2002 from 350 patients (0.068 100
patient/days), 2003 – 514 (0.077), 2004 – 306 (0.06), 2005 – 344 (0.071),
2006 – 471 (0.086). VRE were recovered in 2002 from 76 patients
(0.019 100 patient/days), 2003 – 68 (0.017), 2004 – 74 (0.02), 2005 –
61 (0.018), 2006 – 77 (0.024). MRSA were recovered in 2002 from 40
patients (0.01 100 patient/days), 2003 – 24 (0.006), 2004 – 16 (0.004),
2005 – 26 (0.008), 2006 – 23 (0.007).
Among ESBL+ isolates K. pneumoniae was the most often isolated
35%, E. coli 28%, E. aerogenes 11%, K. oxytoca 7%, E. cloacae 6%,
C. freundii 3% and S. marcescens 3%.
Isolates of ESBL strains were recovered from urine (31%), respiratory
tract (15%), wound specimens (10%), and blood (3%).
Among VRE isolates the most often were Enterococcus faecium 95%,
E. faecalis 1% and E. gallinarum 1%.
They were recovered from respiratory tract (34%), urine (26%), blood
(21%) and wound specimens (16%).
MRSA isolates were recovered from respiratory tract (54%), wound
swabs (36%) and blood (4%).
Conclusions: High percentage of ESBL carriage complicates infection
control and treatment of common urinary tract infection. ESBL-
producing strains are the most often isolated and cause the greatest
concern. There are not signiﬁcant differences in the rate of their
incidence throughout the studied period. VRE are quite seldom isolated
from diagnostic specimens however their carriage rate which was not
analysed here is about three times higher. MRSA infected patients tend
to come from other hospitals and we have not discovered any cross
infections recently due to successful infection control programme.
P2117 Molecular typing of the resistance plasmids of a vancomycin-
resistant enterococci nosocomial outbreak in Spain
M. Romo, P. Goicoechea, T.M. Coque, F. Baquero, F. de la Cruz,
L. Martı´nez-Martı´nez, M.V. Francia (Santander, ES)
Objectives: Vancomycin-resistant enterococcal outbreaks are unusual in
Spain. However, 31 clinical isolates of VanA E. faecium showing high-
level resistance to vancomycin, ampicillin, erythromycin, ciproﬂoxacin
and aminoglycosides were reported in our hospital between October 2002
and April 2004. PFGE typing indicated the presence of three different
epidemic clones, A, B and C (25, 5 and 1 isolates, respectively). The
aim of this work was to investigate the diversity of the plasmids carrying
antibiotic resistance in our VRE isolates.
Methods: Plasmids were characterised using a new Multiplex-PCR
relaxase typing method described in an accompanying communication.
The results were compared to the ones obtained by PCR using
oligonucleotides targeting the replication initiator sequences (rep) of
known enterococcal plasmids. Sequencing of the positive amplicons and
S1-PFGE and hybridisation analyses were done for conﬁrmation of the
results.
Results: Three to seven different plasmids were identiﬁed in our VRE
isolates, independently of the epidemic clone considered. Antibiotic
resistance genes vanA and ermB were generally associated to the same
plasmid. All isolates were shown to harbour pEF1- and pCIZ2-related
plasmids, according to the relaxase encoded and pCIZ2- and pRUM-like
plasmids, based on the rep sequence. Clon A isolates were shown to
speciﬁcally harbour pMG1 related plasmids based on both, relaxase and
rep sequences, and pRE25-like plasmids (only rep sequence). Presence
of pEFNP1-related plasmids was exclusive of clon C.
Conclusions: pEF1-related relaxases and pRUM-like rep sequences are
associated to plasmids carried by all vancomycin resistance E. faecium
isolates in our institution, suggestive of a dissemination among the
different clones. PCR-based typing methods will facilitate studies about
prevalence of particular resistance plasmids in different environments.
P2118 Surveillance of glycopeptide-resistant enterococci in faecal
samples from hospitalised patients during two years in a
tertiary hospital
E. Vagiakou, M. Orfanidou, K. Zourla, D. Lampousaki, P. Karabogia,
H. Malamou-Lada (Athens, GR)
Objectives: The surveillance of glycopeptide resistant Enterococci
(GRE) strains isolated from faecal samples from hospitalised patients in
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General Hospital of Athens “G. Gennimatas” during a two year period
(27/11/05–31/10/07).
Methods: In a prospective study 3253 faecal samples were examined
for GRE. The origin of the samples was: Haematology, Neurosurgery,
Nephrology, Plastic-Burn Unit (PBU), Intensive Care Unit (ICU) and
Internal Medicine Department, as well as faecal samples from all wards
which were sent to the laboratory for Clostridium difﬁcile (Cd). GRE
strains were isolated on esculin azide agar and Cd strains on Cycloserine
Cefoxitin blood agar (BD). The strains were identiﬁed by VITEK2
automated system (bioMerieux).
Results: During the study period 561 GRE strains were isolated from
faecal samples (561/3253, 17.24%). The strains were identiﬁed mainly
as E. faecium (553/561, 98.6%) and only 8 strains were E. faecalis
(8/561, 1.4%). The distribution of the strains per clinical department
was as follows: Internal Medicine 209 (37.2%), Haematology ward 172
(30.7%), PBU 63 (11.2%), Nephrology Ward 54 (9.6%), ICU 43 (7.7%)
and Surgical Department 20 (3.6%). Bacteraemia by GRE strains was
observed in thirteen patients who carried the same strains in their stools.
All cases of bacteraemia were due to E. faecium and were recovered from
PBU (6), Internal Medicine Department (4), Haematology Ward (2) and
ICU (1). Co-existence of GRE and Cd was present in 54 cases (54/561,
9.6%) and in one case the co-existence was followed by bacteraemia.
Conclusions:
1. The enteric carriage of GRE was approximately 17% of our patients
2. Most of the GRE strains were identiﬁed as E. faecium
3. In 13 cases, six of which in PBU patients, carriage of GRE led to
bacteraemia
4. Co-existence of GRE and Cd suggests that specimens submitted for
Cd must also be screened for GRE
5. Antibiotic policy and strict enteric precautions should be implemented
to restrict the GRE carriage
P2119 Clonality of Enterococcus faecalis isolates from infective
endocarditis patients at a Danish hospital
J. Larsen, M.S. Chadﬁeld, H.C. Schønheyder, M. Bisgaard
(Frederiksberg, Hillerød, Aalborg, DK)
Objectives: To investigate the clonality of Enterococcus faecalis isolates
from infective endocarditis (IE) patients at Aalborg Hospital in Denmark.
The issues addressed include the apparent contradiction between the
ability to cause IE and the presumed poor selective advantages as such
infections often lead to rapid host death and poor transmission to new
hosts.
Methods: For this study, we used 27 E. faecalis isolates from patients
with deﬁnite IE according to the modiﬁed Duke criteria. These isolates
were collected prospectively over a 7-year period from 1996 to 2002 at
Aalborg Hospital in Denmark. The clonality of the isolates was inferred
by using multilocus sequence typing (MLST).
Results: The MLST data revealed 15 sequence types (STs) among the 27
isolates. Fourteen isolates clustered in 6 groups of single-locus variants
(SLVs), of which 10 were members of clonal complexes (CC40, CC21,
and CC25), whereas 13 isolates clustered in 7 singleton STs. CC25 (8
isolates) appears to be a high-risk enterococcal clonal complex associated
with human bloodstream infections in Europe, whereas CC40 (1 isolate)
and CC21 (1 isolate) exhibit larger ecologic diversity according to their
host and geographic origin, and commensalism/virulence traits.
Conclusion: The results demonstrated surprising diversity among
E. faecalis isolates causing IE, despite their narrow time-span and
geographic range. The virulence trait was randomly distributed within
E. faecalis, supporting the idea that virulence might be coincidental to
a commensal lifestyle. However, it is also possible that horizontal gene
transfer of virulence-related factors has lead to the emergence of clonal
complexes (i.e., CC25) associated with an increased ability to cause IE.
This work will allow further epidemiological, genetic, and phenotypic
studies devoted to test how virulence evolves in E. faecalis.
P2120 How to analyse and interpret infectious disease data:
statistical insights into the epidemic nature
M. Wolkewitz, M. Schumacher (Freiburg, DE)
Objectives: Highly infectious diseases are often analysed in the same
way as non-communicable diseases, ignoring basic epidemiological
assumptions, as e.g. that the acquisition depends on contact transmission.
The objective is to present adequate statistical methods based on
individual patient data which take this epidemic nature into account. The
main focus is the time-varying transmission rate: the rate with which an
infectious individual has close contacts with other patients in the hospital
unit. Discharge has to be taken into account as a competing event.
Methods: The statistical time-to-event analysis is based on an appropri-
ate compartmental model which describes the transmission dynamics
of the epidemic process. The well-known S-I-R model (Susceptible-
Infectious-Removed) with migration (admission and discharge) is
applied to the hospital setting (ﬁgure). The Reed-Frost assumption
speciﬁes that each colonised individual creates infectious contacts
independently. For the statistical modelling, generalised linear and
additive Aalen models are used.
Results: These methods are applied to simulations and individual
patient data of an outbreak of the pathogen Vancomycin-Resistant-
Enterecocci (VRE) in an onco-haematological unit at the University
Medical Centre Freiburg in Germany. All patients were followed up
for 105 days and 41 patients acquired a VRE during their hospital-stay.
Graphics show the contact pattern with possible cross-infections, the
time-varying transmission and discharge rates. The effect of isolation on
the transmission rate is quantiﬁed.
Conclusion: With our methods, an epidemic spread on the unit-level
in a hospital can be described in an appropriate way and it will give
valuable informations for clinicians working in infection control and
public health.
P2121 Epidemiology of vancomycin-resistant Enterococcus faecium
in Greek hospitals by PFGE and MLST
M. Karanika, D. Klapsa, C. Neokleous, I. Spiliopoulou,
C. Koutsia-Carouzou, M. Economou, K. Karaiskos, K. Kouraki,
D. Krikou, M. Anifantaki, E. Vlahaki, E. Petinaki (Larissa, Patras,
Athens, Volos, GR)
Objectives: Enterococcus spp. is an important cause of nosocomial
infections worldwide. Nowadays, the dissemination of vancomycin-
resistant enterococci (VRE), remains a major problem in hospital en-
vironments. The aim of this study was to investigate the epidemiological
relatedness of vancomycin-resistant Enterococcus faecium isolated from
clinically signiﬁcant specimens in different Greek hospitals.
Materials and Methods: A total of 100 vancomycin-resistant
Enterococcus faecium (VRE), isolated from hospitalised patients
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throughout Greece were included. These isolates were recovered from
urine, stool, blood and pus. Identiﬁcation to the species level was done by
PCR based on sodA gene, while vancomycin-resistance was associated
with vanA gene. The clonality of isolates was tested by PFGE, after
digestion of DNA with SmaI. To increase the sensitivity of our approach,
due to the difﬁculty of determining small differences in band patterns by
PFGE, strains of similar cloning patterns were also subjected to Multi
Locus Sequence Typing (MLST) and the results compared. Detection of
pathogenic genes esp, gel, as, ace and efa genes was performed by PCR,
using speciﬁc primers.
Results: From the 100 VRE isolates, twenty-two different PFGE clones
were noticed. Throughout each hospital, similar clones were observed.
Between strains with similar PFGE pattern, differences were observed
after MLST typing. The majority of isolates carried the esp gene, and
they were negative for all the remaining genes.
Conclusions: PFGE remains a technique that is usefully applied for the
primary surveillance of epidemic clones in hospitals, while MLST is an
extremely important tool and should be used in conjunction with PFGE.
P2122 Molecular analysis of vancomycin-resistant enterococci
isolated in Debrecen, Hungary
S. Domradi, J. Konya, V. Dombradi, J. Szabo (Debrecen, HU)
Objectives: Although vancomycin resistant enterococci (VRE) are
common nosocomial pathogens, they have been rarely isolated in
Hungary. The aim of the present study was to explore the prevalence
of VRE colonising hospitalised patients in the hospitals of the Medical
School at the University of Debrecen, and to identify the van resistance
genes.
Methods: 3946 clinical samples collected between January 2004 and
November 2006 were found to contain various enterococcus strains
by the Bacteriological Diagnostic Laboratory. These isolates were
screened on 6mg/l vancomycin containing BHI agar plate according
to CLSI (NCCLS). 44 screen-positive isolates were tested by E-test
for vancomycin and teicoplanin resistance. Suspicious colonies were
also investigated by the VITEK2® system. PCR ampliﬁcation of the
Enterococcus faecalis and Enterococcus faecium ddl genes as well as
Enterococcus casseliﬂavus and E. faecalis sodA genes were used for
species identiﬁcation. Multiplex PCR was preformed for the detection
of the vanA, vanB, vanC1/C2, vanD, vanE and vanG genes. VanC1 and
vanC2 were differentiated by a method based on the restriction digestion
of the PCR products by HindIII and SalI enzymes. The van gene carrying
PCR products were conﬁrmed by DNA sequencing.
Results: We identiﬁed the vanC1 resistance gene in 4 clinical samples:
1 E. faecalis and 1 E. casseliﬂavus from urine, and 1 E. faecalis
from wound secretion. In one urine sample both E. faecalis vanC1 and
E. casseliﬂavus vanC2 resistance gene carrying bacteria were found. A
highly resistant sample (vancomycin MIC> 256) from femoral wound
was found to contain vanA carrying E. faecalis.
Conclusion: This is the ﬁrst report on the occurrence of the vanC1
resistance gene in Hungary. Furthermore, we found a new vanC2 variant,
having a sequence that is slightly different from the one reported in the
database. We conclude, that molecular screening of the resistance genes
is important in the diagnostics of VRE, and the identiﬁcation of the
carrier by PCR is more reliable than standard biochemical methods
P2123 Prevalence of vancomycin-resistant enterococci colonisation
in gastro-intestinal tract of hospitalised patients in a
hospital, Esfahan Province, Iran
A. Javadi, B. Ataei, F. Khoorvash, S. Mobasherzadeh, S. Tghyani,
M. Soghrati (Isfahan, IR)
Introduction: Vancomycin-resistant enterococci (VRE) are the most
common nosocomial pathogen worldwide. Colonisation with VRE can
lead to serious infection, that some like VRE sepsis can be fatal. Because
VRE are dangerous and important pathogens, we are going to determine
the prevalence of VRE among patients admitted in infectious, surgery
wards and ICU in AL-Zahra Hospital in Isfahan, Iran.
Methods: 100 patients from infectious and surgery (post-operative
patients) wards and ICU were selected by simple sampling method.
Stool specimens were taken from selected patients and cultured in VRE
selective media (bile-esculin agar plate with 6 of vancomycin) and Gram-
positive cocci from black colonies were inoculated to the tryptase soya
broth+ 6.5% Nacl and again Gram-positive cocci were inoculated to bile
esculin and ﬁnally MIC (minimal inhibitory concentration) evaluated by
E-Test for detection of VRE.
Data were analysed by ANOVA and Chi-square tests using SPSS
V13/Win.
Results: 58 out of 100 patients, had positive culture for enterococci. 16
out of 58 were female (27.6%) and 42 (72.4%) were male. Among
58 culture, 17 (29.3%) were highly resistant to vancomycin. There
was signiﬁcant relation between previous antibiotic therapy especially
vancomycin and VRE in this study (P = 0.02). Most of the patients
(74.1%) with negative culture for enterococci had GI surgery. Most
of culture positive patients (46%) had been in infectious ward. No
signiﬁcant relation accompanied between VRE and sex, GI surgery and
admission ward in this study.
Conclusion: Results of this study suggest that previous antibiotic
therapy especially vancomycin and b-lactam is a major risk factor for
colonisation with VRE. Prevalence of VRE was high in our study and
this problem is very important in epidemiology of hospital infections.
Considering the fact that there is no substitute agent for vancomycin in
our country, it is essential to obtain necessary guidelines regarding over
treatment with antibiotics specially vancomycin.
P2124 Clonal spread of vancomycin-resistant enterococci in
Swedish broiler chickens
O. Nilsson, J. Top, C. Greko, A. Franklin, B. Bengtsson (Uppsala,
SE; Utrecht, NL)
Objectives: In Sweden, the occurrence of acquired resistance among
E. coli and Enterococcus spp. isolated from intestinal content from
healthy broiler chickens, pigs and cattle is investigated on a regular basis
within the Swedish Veterinary Antimicrobial Resistance Monitoring
programme (SVARM, www.sva.se). Within SVARM a total number
of 1853 broiler samples have, since 2000, been cultivated both on
Slanetz-Bartley agar and on Slanetz-Bartley agar supplemented with
16mg/l vancomycin. Using non selective media only four VRE have
been isolated through the years. With selective media the number of
positive samples has however been higher and the proportion of positive
samples has gradually increased from 0.6% (2000) to 28.4% (2006).
All VRE isolates have been identiﬁed as Enterococcus faecium with
MIC of vancomycin of >64mg/L and carrying the vanA gene cluster
using phenotypic methods, micro-dilution method and PCR. Similarities
in antibiogram, phenotypic characteristics and macro restriction patterns
indicate clonality. The aim of present study was to conﬁrm that the
increase of VRE is due to clonal spread of a particular VRE strain.
Methods: The genetic relatedness of the ﬁrst two VRE isolates, found in
2000, and a representative set of 46 randomly selected isolates between
2001 and 2007 was determined using multi locus sequence typing
(MLST).
Results: All 46 randomly selected isolates revealed sequence type
(ST)310, while the two 2000 isolates revealed ST13 and a new ST370.
ST310 was previously isolated from a Norwegian poultry sample,
whereas ST13 was isolated in 3 Dutch poultry samples.
Conclusions: This study revealed that the increased occurrence of VRE
in Swedish broilers since 2000 is due to spread of a single clone (ST310).
Apparently the clone persists within and spreads between poultry farms
all over Sweden. This is a concern since a reservoir of the vanA gene is
generated and maintained in broilers, which could spread to humans via
the food chain, and can potentially spread further into hospital settings.
Further research is needed to investigate possible means to minimize
occurrence of VRE in broilers.
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P2125 Rapid screening protocol for the detection of glycopeptid
resistant enterococci using enterococcosel broth,
enterococcosel- and chromID™ VRE agar with subsequent
molecular GenoType enterococcus test
A. Fahr, U. Wild, M. Holfelder, U. Eigner (Heidelberg, DE)
Introduction: Rapid and accurate screening protocols are required to
control spread of vancomycin-resistant enterococci (VRE) and for the
successful management of colonised or infected patients.
We compared the performance of Enterococcosel (EC) broth with
EC agar and subsequent PCR for the rapid detection of VRE in
screening specimens (study phase I). In study phase II a new selective
agar for VRE-detection (chromID™ VRE, bioMe´rieux, Nu¨rtingen) was
compared to EC broth.
Material and Methods: 309 screening specimens were tested (rectal
swabs, stool, urine, wound and others) in study phase I and 80 specimens
in study phase II, respectively. The material was inoculated in trypticase
soy broth and then transferred to Columbia Blood agar, EC agar with
6mg/l vancomycin (Becton Dickinson, Heidelberg, Germany), EC broth
with 6mg/l vancomycin and to chromID VRE. Each positive EC broth
and positive agar media were investigated with the DNA-based strip
assay Genotype Enterococcus (Hain Lifescience, Nehren, Germany) for
the simultaneous identiﬁcation of four Enterococcus species and the
associated van-genes (vanA, B, C1, C2/3) in 4 hours.
Results: In study phase I 61 VRE isolates were detected with the
EC broth, 58 with the EC agar and 29 with Columbia blood agar,
respectively. 26 (43%) of the VRE-containing broth were positive on
day 1, 35 (57%) on day 2. On EC agar 21 (36%) of the VRE isolates
were positive on day 1 and 37 (64%) on day 2. With regard to study
phase II EC broth detected 25 VRE isolates, chromID VRE 22 isolates.
11 (44%) of the VRE-containing broth were positive on day 1, 14 (56%)
on day 2. On chromID VRE 9 (41%) of the VRE isolates were positive
on day 1 and 13 (59%) on day 2. VRE-detection with the molecular
GenoType Enterococcus test directly from the different selective media
performed excellent. Inhibition only occurred in three cases with EC
broth containing stool specimens.
Conclusions: Selective broth and agar media with subsequent PCR test
showed excellent results in detecting VRE from screening specimens in
at least two days.
chromID VRE proved to be a sensitive, speciﬁc and rapid tool for the
detection of VRE from screening specimens. In addition to glycopeptide-
resistance enterococcal species differentiation is possible with the
chromID VRE agar due to different colony colour.
Molecular detection of the van genotypes from EC broth and selective
agar media with the Genotype Enterococcus assay showed excellent
results.
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P2126 The efﬁcacy of chromogenic meticillin-resistant
Staphylococcus aureus agar for inocula preparation in
automated susceptibility testing
M. Wootton, R. Howe for the Welsh Antimicrobial Resistance Programme
Objectives: In many diagnostic laboratories chromogenic MRSA agar
is used to aid rapid detection of MRSA, making reporting of MRSA
within 24 hours of specimen submission possible. Further susceptibility
testing is usually performed from a subculture onto blood agar (BA)
and results reported at 48–96 hours. The use of automated susceptibility
testing techniques is increasingly common, with inocula prepared from
a blood agar recommended. In order to reduce costs and improve speed
of susceptibility testing reporting, we compared susceptibility testing
results on PhoenixTM using standard BA, and two branded Chromogenic
MRSA agars for preparation of the inocula.
Methods: 30 previously conﬁrmed MRSA. All strains were subcultured
onto BA, Oxoid Chromogenic MRSA agar (O) and BioMerieux MRSA
ID agar (B). After 24 h the cultures were used to prepare inocula
for susceptibility testing of 22 antimicrobials in PhoenixTM (Becton
Dickinson). 3 strains were repeated on 3 occasions to predict internal
error. The minimum inhibitory concentration (MIC) plus interpretations
were compared for each strain and agar used. Minor, major and very
major errors were used to denote: change in MIC but not interpretation;
change in MIC with interpretation change from sensitive (S) to
intermediate (I) or resistant (R) and change in MIC with interpretation
change from R or I to S.
Results: When using O agar, 8 out of 22 antimicrobials showed minor,
major or very major errors. 10 antimicrobials were affected by the
use of B agar (See table). Chloramphenicol (C), trimethoprim (T)
and vancomycin (V) MICs varied with repeated testing, with only T
exhibiting major errors. When using O agar, major errors were seen in
C, levoﬂoxacin (L), mupirocin (M), T and very major errors seen in
gentamicin (G) and L. When using B agar major errors were seen in C,
L, M and T, whereas very major errors were seen in only G.
Percentage error rate
Minor Major Very major
Oxoid MRSA agar
Amox/Clav 16.6
Chloramphenicol 2.4 3.3
Gentamicin 3.3
Levoﬂoxacin 6.6 3.3 6.6
Mupirocin 3.3 3.3
Mupirocin high 3.3
Teicoplanin 3.3
Trimethoprim 21.9 43.3
Vancomycin 11.5
BioMerieux MRSA ID agar
Amox/Clav 10
Chloramphenicol 3.3
Clindamycin 3.3
Fusidic acid 3.3
Gentamicin 6.6
Levoﬂoxacin 3.3 3.3
Mupirocin 3.3 3.3
Teicoplanin 3.3
Trimethoprim 48.6 1.9
Vancomycin 31.9
Conclusions: The direct use of chromogenic MRSA agar for suscep-
tibility testing would improve reporting times of susceptibility testing
results for MRSA. No major or very major errors were seen when testing
antimicrobials commonly used to treat MRSA infection. Chromogenic
MRSA agar can be used directly for antimicrobial susceptibility testing
providing interpretation of C, L, G, T and M are taken with care.
P2127 Rapid detection of meticillin-resistant and meticillin-
susceptible Staphylococcus aureus by real-time PCR directly
from positive blood culture bottles
C. Nonhoff, O. Denis, M. Hallin, S. Pavlov, S. Cuvelier, A. Deplano,
M.J. Struelens (Brussels, BE)
Background: Recently, a new automated system Xpert MRSA/SA
assay (Cepheid, USA) has been developed for direct detection of
Staphylococcus aureus and determination of meticillin resistance in
clinical specimens. This real time PCR is a fully-automated molecular
testing platform which combines sample preparation, multiplex PCR
assay and nucleic acid analysis. The objective of this study was to
evaluate the performance of the Xpert MRSA/MSSA assay directly from
positive blood culture bottles.
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Material: Real time PCR assays were prospectively performed directly
on signal positive blood cultures (Bactec 9240, Beckon Dickinson,
USA). 50 ml of blood culture broth were transferred into the
elution reagent tube. The PCR assay was performed according to
the manufacturer’s instructions. Phenotypic identiﬁcation and antibiotic
susceptibility testing were performed in parallel. Suspected colonies of
S. aureus were identiﬁed by latex slide agglutination and coagulase
testing. Oxacillin susceptibility was tested by cefoxitin disk diffusion
according to CLSI recommendations.
Results: A total of 197 signal positive blood cultures from 87 patients
were tested by real time PCR. S. aureus isolates including 22 MRSA
and 32 MSSA which were all correctly detected by Xpert assay. The
sensitivity and speciﬁcity of PCR compared with phenotypic methods
were both 100%. The PCR assay provided results in less than 2 hours
versus 48 hours for conventional methods.
Conclusion: The Xpert MRSA/MSSA assay correctly detected 100% of
MSSA and MRSA isolates from positive blood cultures in less than 2
hours. Prospective studies are needed to evaluate the clinical impact of
this assay for rapid implementation of targeted treatment for S. aureus
bacteraemia.
P2128 Rapid detection of meticillin-resistant Staphylococcus
aureus in critical care units
K. Lamb, A. Downes, M. Cullen (Manchester, UK)
Objectives: The Baclite ﬂex is a rapid culture-based MRSA detection
system with a laboratory processing time of 5 hours. We evaluated
the effect of an early MRSA result compared to standard culture
on 1) individual antibiotic therapy; 2) individual infection control
(IC) measures; 3) ﬁnancial cost of earlier interventions and; 4) bed
management/nursing staff levels in our critical care areas. A technical
evaluation of the technique on blood, vascular catheter tips and
respiratory samples was performed.
Methods: During a 3-month period swabs, respiratory samples, vascular
catheter tips and positive blood cultures taken in our critical care
units were processed by standard culture (salt broth enrichment then
chromogenic agar) and the Baclite method (2-hour selective broth
incubation; extraction of organisms by immuno-magnetic separation;
selective lysis with lysostaphin; measurement of adenylate kinase
levels at baseline and 2 hours). Individual patient management, IC
interventions, bed management and stafﬁng levels were reviewed. The
rapid results were not revealed to staff on the units.
Results: 226 patients (811 samples) were tested. Overall, 6.4% of
patients were MRSA positive. Screening swabs conﬁrmed a high
negative predictive value (NPV) for the rapid method (94%). The
NPV for respiratory samples, line tips and blood cultures was high
(87%), but the positive predictive value was low (11%). Rapid results
would have allowed alteration of antibiotic therapy and instigation of IC
procedures 48 hours earlier for 3 patients on the general ICU (1 patient
requiring increased nursing requirements) thus reducing MRSA exposure
rates by 13 patient-days. No further cases of MRSA colonisation were
identiﬁed due to this additional exposure.
Conclusion: The Baclite ﬂex MRSA detection method performed well
on swabs from patients in critical care units. Low PPVs for respiratory,
blood and line tip specimens would impede its usefulness for early
clinical management of infection. IC interventions could be instigated
up to 48 hours earlier using the rapid result, thus reducing the overall
exposure of patients to MRSA. In a low incidence setting the expected
beneﬁt on MRSA transmission rates is difﬁcult to quantify, although
the cost of earlier intervention can be signiﬁcant. The potential saving,
estimated to be over US$14,000 for a single MRSA bacteraemia, needs
to be considered in the context of overall expenditure.
P2129 MRSA screening – Comparison of chromogenic agar and
enrichment broths
J.V. Bjørnholt, A. Fostervold, T. Ranheim, V. Lauvrak, M. Steinbakk
(Lørenskog, NO)
Objective: The detection of meticillin-resistant Staphylococcus aureus
(MRSA) in clinical samples is important. This is particularly so during
screening in a low prevalence setting, where extensive infection control
measures are imposed by a positive ﬁnding. The NaCl concentration
is important for mecA expression, we therefore compared our routine
chromogenic agar with two variants of enrichment broth one with 0.5%
NaCl and another with 2% NaCl, during two outbreaks in nursing homes.
Methods: The chromogenic agar (bioMe´rieux) were compared with a
modiﬁed enrichment broth originally described by Wertheim et al. with
0.5% NaCl concentration (broth1) and an another identical variant with
2% NaCl concentration (broth 2). Screening samples received from the
nursing homes were inoculated on chromogenic and blood agar and in
broth, MRSA isolates were veriﬁed by presence of mecA and Sa442. All
isolates were characterised with MLST, spa-typing, SCCmec type and
presence/absence of PVL. McNemar and Sign test were used for testing
differences in detection rates.
Results: Broth 1 (0.5% NaCl); 4931 samples were included. MRSA
were found in 187 samples 3.9% (95%CI; 3.3−4.3). The main results
are presented in table 1. Broth 1 and chromogenic agar detected 17%
(95%CI; 12–22) more MRSA-isolates than Chromogenic agar alone.
Table 1
Broth 1 Chromogenic agar
MRSA positive MRSA negative
MRSA positive 83 32
MRSA negative 72 4744
P< 0.001
Broth 2 (2% NaCl); 1697 samples were included. MRSA were found in
104 samples 6.1% (95%CI; 1.5–10). The main results are presented in
table 2. Broth 2 and chromogenic agar detected 31% (95%CI; 22–40)
extra MRSA than chromogenic agar alone and had the same sensitivity
as the Chromogenic agar.
Table 2
Broth 2 Chromogenic agar
MRSA positive MRSA negative
MRSA positive 41 32
MRSA negative 31 1583
P> 0.05
All isolates belonging to the outbreaks were MLST 8, spa-type 304,
SCCmec IV and PVL neg. Oxacillin MIC ranged from 1 to 64mg/l.
Three isolates with oxacillin MIC< 2mg/l were CO2 dependent and
were detected on blood agar only.
Conclusion: The addition of an enrichment broth to chromogenic agar
when screening for MRSA increases sensitivity signiﬁcantly and 2%
NaCl concentration seems better than 0.5%. MRSA isolates with low
mecA expression (low Oxacillin MIC) were not detected by the selective
media.
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P2130 Rapid detection of meticillin-resistant Staphylococcus aureus
from nares and blood cultures using a new chromogenic agar
S. Whittier, P. Della-Latta (New York, US)
Objectives: Controlling the spread of meticillin resistant S. aureus
(MRSA) has become a public health priority. While MRSA has long
been recognised as a potential hospital associated pathogen, recent focus
on more virulent strains of MRSA in the community has dramatically
increased public awareness. Hospitals have been charged with the task
of screening patients for MRSA colonisation and/or infection in order to
prevent transmission in healthcare facilities and to institute appropriate
therapy. Therefore we compared the performance of a new chromogenic
screening agar, Spectra MRSA™ (SM), which selects for and identiﬁes
MRSA within 24 hours, to routine culture which can take 48–72 hours.
Methods: 120 nares swabs and 80 blood cultures positive for Gram-
positive cocci in clusters (N = 80) were cultured on MRSA Spectra™
(Remel, Lenexa, KS) media as well as our routine battery which
includes colistin nalidixic acid (CNA) agar for nares and a sheep
blood/chocolate/MacConkey agar tri-plate for blood cultures (BD,
Sparks, MD). MRSA appear as denim blue colonies on SM agar.
Performance was evaluated based on recovery and time to identiﬁcation.
Identiﬁcations were conﬁrmed by MicroScan (Dade, Sacramento, CA).
Meticillin resistance was conﬁrmed by PBP2′ latex agglutination and
cefoxitin disk screen.
Results: Of the 120 nares swabs, 29 were culture positive for MRSA
and all were detected on SM agar. In addition, 21 meticillin susceptible
SA (MSSA) did not grow on SM agar. For the 80 blood cultures, 19
were culture positive for MRSA and all were detected on SM agar;
18 MSSA did not grow. Overall 98% of MRSA were detected within
24 hours of agar inoculation. The sensitivity, speciﬁcity, positive and
negative predictive values for the SM media were 100%.
Conclusions: Rapid detection/reporting of MRSA from surveillance and
clinical specimens is critical. Timely dissemination of this data enables
appropriate infection control measures to be instituted and proper therapy
or decolonisation protocols to be initiated. Utilisation of the Spectra
MRSA agar would have resulted in almost all MRSA isolates to be
reported within 24 hours. For small to mid-size laboratories that may
not have the ﬁnancial or technical resources to introduce molecular
technology, this screening media is an excellent alternative for the rapid
detection of MRSA. Microbiology laboratories should consider the use
of this selective agar as part of MRSA identiﬁcation algorithms.
P2131 A novel chromogenic formulation for detecting
meticillin-resistant Staphylococcus aureus in surveillance
specimens: comparison to Oxoid Canada’s Demin Blue agar
B.M. Willey, N. Kreiswirth, V. Porter, A. Tyler, E. Cudek, M. Moussa,
K. Wong, T. Mazzulli (Toronto, CA)
Objectives: Previous studies have shown Canada’s Demin Blue (CDB)
to be highly sensitive and speciﬁc, surpassing similar media in its cost-
effectiveness and time to MRSA detection. Incubation at 37C enabled
MRSA conﬁrmation <24 h of plating, as CDB produced larger colonies
earlier than other agars. As occasional Canadian MRSA have low
cefoxitin (fox) MIC, this prospective blinded study aimed to further
enhance our detection capabilities by evaluating a newly formulated
medium without fox, the novel chromogenic formulation (NCF).
Methods: Consecutive MRSA swabs were tested in parallel on CDB and
NCF, with plate order rotated to avoid inoculation bias. After incubation
(~24 h x 37C in the dark), MRSA produced typical demin-blue colonies
on both media. As in earlier studies, hazes, pinpoints and pale colonies
were ignored and MRSA were conﬁrmed directly from CDB and NCF
if possible using Pastorex Staph Plus, tube coagulase, PBP2a and CLSI
oxacillin screen. Discrepancy resolution entailed review of patient culture
history, re-plating of the original swab to CDB and NCF, followed by
broth enrichment and re-inoculation to both media. All MRSA were fully
characterised.
Results: In total, 134 MRSA from 101/1,517 (6.7%) patients at 13 hos-
pitals were grown from 2558 swabs: 65/1246 nares/axilla/groin/perineum
(NAGP); 22/595 nasal; 21/542 rectal; 26/175 wound. 123 MRSA grew
on CDB and 119 on NCF. There were 11 false-positives (FP) from 9
NAGP and 2 rectal swabs on CDB (7 coagulase-negative staphylococci
(CNST), 2 Bacillus sp., 1 Enterococcus, 1 coliform) and 17 FP from
12 NAGP, 3 wound and 2 nasal swabs on NCF (12 CNST, 5 meticillin-
susceptible SA). The overall % sensitivity, speciﬁcity, positive (PPV)
and negative predictive values were 91.8, 99.6, 91.8, 99.6 for CDB
and 89, 99.3, 87.5, 99.4 for NCF. MRSA typing identiﬁed 32 sub-
types from 4 lineages: CMRSA2/USA100/spa2/ST5/SCCmecII-related
MRSA were most prevalent followed by CMRSA10/USA300/spa1/ST8/
SCCmecIVa/pvl+ community strains. No one MRSA type was associated
with failure to grow on either agar; discrepancy analysis suggested
detection failure was more likely due to low CFU/swab. The trend
towards 18 h growth of MRSA on NCF was not signiﬁcant in this sample
size (P = 0.17).
Conclusions: The equivalence in sensitivity (P = 0.86) and speciﬁcity
(P = 0.79) for CDB and NCF indicate that they could be interchangeable
if MRSA with low fox MIC became prevalent. While highly speciﬁc,
PPV of <92% reafﬁrms the need to prove MRSA from all new cases
from any chromogenic media.
P2132 Evaluation of the 3M BacLite Rapid MRSA test for the
direct detection of MRSA from nasal, groin, and combined
nasal/axilla/groin surveillance specimens
D. Cohen, S. OHara, B. Bagoole, M. Almeida (London, Salisbury, UK)
Background: The aim of this study was to determine the performance
characteristics of the 3M™ BacLite™ Rapid MRSA culture based
test for the detection of MRSA direct from screening swab taken
from different body sites when compared to 48hour incubation with
chromogenic agar.
Method: The analytical speciﬁcity and sensitivity of the assay was
determined by challenging the assay with 0.5 Macfarland standard of
stock cultures of a number of organisms:
• Historical wild strains of Ciproﬂoxacin resistant (5) and sensitive (11)
MRSA diluted between 1:10 and 1:10000
• 10 different types of routinely isolated NCTC control strains at 1:100
dilution
The clinical performance of the assay was determined by testing 631
routine nasal (151), groin (148), and combined nasal/axilla/groin (332
NAG) swabs originated from Charing Cross and Chelsea & Westminster
Hospitals. All results were compared to current operating procedures
which consisted of inoculation onto Biomerieux MRSA ID chromogenic
agar incubated aerobically at 37C for 40–48 hrs. Reference method plate
cultures were inoculated ﬁrst followed by the BacLite Rapid MRSA
assay.
Results: Of the spiked MRSA samples there was only a marginal
difference in sensitivity at very low colony forming units (2 or 3 at
1:1000 dilution). All strains grew on both systems. The 3 discrepant
Ciproﬂoxacin Resistant strains were noted at the highest dilutions.
Concordant results at 1:100 dilution were seen with both methods for
both Ciproﬂoxacin sensitive and resistant wild strains. One false positive
result seen in BacLite™ was noted with the non-MRSA C. albicans
NCTC strain at 1:100 low dilution.
Of the 631 clinical specimens 151 were nasal swabs. 3M™ BacLite™
Rapid MRSA detected 146 of the 148 negatives giving a diagnostic
speciﬁcity of 98.6% and a negative predictive value (NPV) of 100%.
Of the 148 groin swabs 3M™ BacLite™ Rapid MRSA detected 127
out of 146 negatives, giving a diagnostic speciﬁcity of 87% and a NPV
of 99.2%. For the 332 NAG swabs the diagnostic speciﬁcity was 82%
(264/323) and NPV 99.2%. The low prevalence rate of MRSA at these
2 hospital sites (3.2%) meant that there was insufﬁcient number of
positives to report reliable performance data on diagnostics sensitivity
from the swabs.
Conclusion: The high negative predictive value of the 3M™ BacLite™
Rapid MRSA test for nasal, groin, and NAG combined sites suggests that
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the 3M™ BacLite™ Rapid MRSA test is a rapid and reliable screening
test in low prevalence settings.
P2133 Cost-efﬁcacy of a chromogenic agar for meticillin-resistant
Staphylococcus aureus screening in a low-endemic setting
M.W.M. Wassenberg, A.T.A. Box, A. Troelstra, J.A.J.W. Kluytmans,
M.J.M. Bonten on behalf of the Dutch Rapid MRSA Diagnostics
Study Group
Objectives: Screening and pre-emptive isolation of high-risk patients
are key factors of the Dutch search and destroy strategy to control
MRSA. However, the majority of high-risk patients are not colonised and
remain in isolation for 3−5 days awaiting conventional culture results.
In a multi-centre study we evaluated the chromogenic medium MRSA-
ID (bioMe´rieux, Marcy-l’Etoile, France) for identiﬁcation of MRSA
in a low endemic setting and determined cost savings when isolation
measures would have been based upon these results.
Methods: As part of a multi-centre study, high-risk patients for
MRSA colonisation who fulﬁlled the criteria for pre-emptive isolation
in 10 participating hospitals between 03/06 and 06/07 were eligible.
In addition to the standard microbiological cultures, specimens were
directly inoculated onto chromogenic media; results were read (based
on morphology only) after 24 hours of incubation, however, did not
inﬂuence decisions on isolation status.
Results: 711 patients were included (38% in the out-patient department),
because of previous hospitalisation abroad (72%), contact with pigs
(11%) and contact screening related to MRSA-positive patients (9%). A
total of 2420 specimens were tested by chromogenic agar. The MRSA
prevalence among these patients was 2.7%. Compared to conventional
culture (including broth enrichment) sensitivity, speciﬁcity, positive
predictive value and negative predictive value (NPV) of the chromogenic
agar were 84.2%, 96.4%, 39.0%, and 99.6%, respectively.
Times from start of isolation up to notiﬁcation of chromogenic agar or
culture results were 30 12 hours and 92 hours, respectively. When isolation
measures would have been discontinued upon negative chromogenic agar
results, 94% (415/443) of hospitalised patients would have beneﬁted and
821 isolation days would have been saved. There was 1 hospitalised
patient with a false-negative chromogenic agar result. Costs of the
chromogenic agar when added to conventional cultures were calculated
€ 1.78 per test, yielding a cost per isolation day saved of € 3.50.
Conclusion: Direct plating on chromogenic agar is suitable for MRSA
screening in a low-endemicity setting with a NPV of 99.6%, potentially
decreasing isolation time with 2 12 days per patient at the costs of € 3.50
per isolation day saved.
P2134 A comparative evaluation of chromogenic culture media for
the detection of meticillin-resistant Staphylococcus aureus
from clinical specimens
E. Kilgour, A. Leanord, D. Murray, A. Stark, L. Williams, R. Yates,
A. Brown, J. Cloke, D. Medrala (Airdrie, Basingstoke, UK)
Objectives: Meticillin resistant Staphylococcus aureus (MRSA) is
a major cause of nosocomial and community-acquired infection
worldwide. Infection Control Teams and clinicians rely on accurate
and timely results from patient screening to ensure appropriate control
measures are implemented. Chromogenic culture media have been shown
to have superior sensitivity and speciﬁcity in comparison with traditional
culture methods for detecting MRSA from clinical samples. This
evaluation was designed to examine the performance of a new medium
from Oxoid (Brilliance™ MRSA) in comparison to the current Oxoid
product (Chromogenic MRSA Agar), Becton Dickinson CHROMagar™
MRSA Agar and bioMe´rieux ChromID™ MRSA Agar.
Methods: Three hundred freshly collected swabs from a total of 99
patients were analysed in this study. Samples from sites commonly
associated with carriage or colonisation (e.g. nasal, groin, axillae,
wounds, intravenous lines and urinary catheter sites) were preferentially
included. The swabs were emulsiﬁed in 3ml sterile saline and
vortexed. Each medium was inoculated with 10 microlitres of the
sample suspension using the diminishing sweep technique. Results
were recorded after 18–24 hours aerobic incubation at 35 to 37ºC.
CHROMagar and ChromID plates showing negative results were
re-incubated to 48 hours, in accordance with the manufacturers’
recommendations.
Results: When combined results for all media were analysed, 269 of
the 300 clinical samples were identiﬁed as negative for MRSA. Both
Oxoid media correctly identiﬁed the highest number of samples positive
for MRSA (28/31) within 24 hours, yielding a sensitivity of 90.3%.
CHROMagar and ChromID required 48 hours incubation and both media
yielded sensitivities of 83.9% (26/31). The highest speciﬁcity was also
achieved by Oxoid Brilliance™ MRSA (97.4%), which yielded only 7
false positive results. Oxoid Chromogenic MRSA Agar gave 9 false
positive results, providing a speciﬁcity of 96.7%. CHROMagar and
ChromID yielded 30 and 33 false positives, providing speciﬁcities of
88.8% and 87.7%, respectively.
Conclusion: The new Oxoid Brilliance™ MRSA demonstrated com-
parable performance to Chromogenic MRSA Agar and achieved the
best overall results within 24 hours. CHROMagar™ and ChromID™
required 48 hours incubation before all ﬁnal results were obtained and
demonstrated lower sensitivity and speciﬁcity. Oxoid Brilliance™MRSA
provided the best performance with the shortest incubation time.
P2135 Accuracy of SensiTitre microdilution panels in detecting
oxacillin resistance in Staphylococcus aureus and
coagulase-negative staphylococci
K.M. Doing, M.J. Henry, M.S. Hintz, M.L. Kulikowski (Bangor, US)
Objectives: Staphylococcus aureus and coagulase negative staphylococci
(CoNS) can be signiﬁcant human pathogens. Oxacillin resistance in both
groups of organisms has continued to expand and must be considered
when treating staphylococcal infections. We prospectively evaluated
SensiTitre microdilution panels incubated in the TREK Automated
Reading and Incubation System (ARIS) for accuracy in detecting
oxacillin resistance in clinical isolates of S. aureus and CoNS, with
comparison to mecA PCR, and oxacillin supplemented agar.
Methods: Susceptibility testing was completed on 674 clinical isolates of
S. aureus and 85 strains of CoNS using SensiTitre GPN2F microdilution
panels. SensiTitre panels were auto-inoculated and then placed in the
ARIS for incubation and auto-reading. All panels were read by the
instrument after 24 hours of incubation; MICs were determined and
interpreted using software and CLSI standards. S. aureus strains were
also tested on Mueller-Hinton agar supplemented with 4% NaCl and
6.0 ug of oxacillin. Real-time PCR for detection of the mecA gene was
performed on all isolates.
Results: Oxacillin resistance was conﬁrmed in 324 (48%) and 53 (62%)
isolates of S. aureus and CoNS respectively. Resistance was accurately
detected with SensiTitre panels isolates, except one strain of CoNS; this
isolate was reproducibly PCR positive for mecA, and repeatedly yielded
an MIC of 0.25 ug/ml. For all 759 isolates, the MIC interpretation
and the mecA PCR result were in agreement 98.4% of the time. False-
negative mecA PCRs were noted in 12 instances involving 4 isolates
of CoNS and 8 isolates of S. aureus. As expected, oxacillin agar was
very reliable in detecting resistance in S. aureus; however, two resistant
strains were not identiﬁed. Both had reproducible MICs of 4.0 ug/ml,
and one isolate was also mecA PCR positive.
Conclusions: Susceptibility testing remains an important function in
clinical microbiology, and laboratories increasingly rely on commercial
systems to standardize and expedite this process. The inability of
automated susceptibility testing systems to accurately detect oxacillin
resistance in staphylococci has been reported, necessitating supplemental
testing. This study evaluated the precision of the ARIS and SensiTitre
microdilution panels in detecting oxacillin resistance. SensiTitre panels
proved to be quite reliable in detecting resistance, and compared
favourably with mecA PCR and oxacillin agar.
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P2136 Comparison of two chromogenic media for recovering
vancomycin-resistant strains enterococci from stool samples
G. Haase, J. Weber-Heynemann, R. Lu¨tticken,
H. Peltroche-Llacsahuanga (Aachen, DE)
Objectives: Identifying of patients with gut colonisation by vancomycin-
resistant strains of Enterococcus faecalis (VREfs) or E. faecium
(VREfm) is of growing importance in order to minimize their
transmission. Therefore, a reliable, easy-to-perform and cost-effective
test procedure is needed. Several commercially available media had been
introduced recently claiming to fulﬁl these demands. We here compare
the performance of two of them.
Methods: For enrichment of VRE from stool from endangered patients
approx. 20 mul was cultivated at 37º C overnight in a bhi broth (9ml)
with addition of one antibiotic disc containing 30 mug vancomycin.
Then a subculture was performed on CHROMagar® (CHR; MAST
Diagnostika) and ChromID VRE® (C-ID; bioMe´rieux). After 24 and
48 h of incubation at 37ºC the plates were evaluated for growth of
suspicious colonies using the criteria given by the manufactures (rose–
mauve colonies, bluish green or violet colonies; respectively). In case
of tiny colonies a stereomicroscope was used. After performing a
Gram stain of suspected VRE colonies they were further conﬁrmed
by susceptibility testing of furazolidone 50mug, mupirocin 10 mug
(both Rosco), vancomycin, teicoplanin (both Etest®) and fermentation of
D-xylose in order to rule out presence of intrinsic low-level vancomycin-
resistant enterococci i. e. E. casseliﬂavus or E. gallinarum.
Results: Plating all type strains of the genus Enterococcus (n = 32)
on both media revealed no growth whereas using VREfs (n = 1) and
VREfc (n = 2) reference strains showed the described typical colonial
appearance.
By screening of 116 stool samples so far we recovered 34 (29.3%)
VREfm strains. All of them grow on both media after 24 h of cultivation
and exhibiting a MIC 256mg/l for vancomycin and 24mg/l for
teicoplanin consistent with the presence of a vanA gene. After 48 h
of cultivation no growth could be revealed on 63 CHR plates in
contrast to 48 in the case of C-ID. Microbes other than VRE cultivated
are yeasts, Gram-negative and Gram-positive bacteria not showing the
typical colonial appearance of VRE. Evaluation of C-ID plates was
somehow easier than that of CHR because tiny colonies on the latter
one could be not so easily detected due to minor contrast caused by the
milky media.
Conclusion: Both chromogenic media tested could be used for detecting
of VRE from stool samples with a high speciﬁcity. A prior selective
enrichment culture avoids unnecessary workload caused by growth of
other microorganism.
Borreliosis
P2137 Co-infection with Borrelia burgdorferi, Anaplasma
phagocytophilum, Bartonella sp. and Babesia microti in
patients suspected of Lyme disease
J. Chmielewska-Badora, E. Cisak, J. Zwolinski (Lublin, PL)
The aim of this study was to determine coinfection with 4 different
infectious agents in patients suspected of Lyme disease.
Sera collected from 110 patients and 50 blood donors were examined
with ELISA IgM and ELISA IgG for antibodies to B. burgdorferi. Also
antibodies to A. phagocytophilum, Bartonella sp. and B. microti were
detected with speciﬁc IgG immunoﬂuorescence assay kits.
Antibodies for B. burgdorferi were found in 65 (59.1%) of suspected
patients. In 82 (74.5%) patients antibodies for Bartonella sp. were found,
and antibodies for B. microti and A. phagocytophilum were detected in
31 (28.2%) and 23 (20.9%) patients, respectively.
No serum without any antibodies was found. In 35 sera only one kind
of antibodies was found. In 75 sera coinfection was noted (60 sera with
2 agents, 14 sera with 3 agents, and 1 serum with all for agents).
In 41 patients (37.3%) the most common coinfection of B. burgdorferi
and Bartonella sp. was evidenced (in 32 cases with these two agents,
in 5 cases with additional B. microti, in 3 cases with additional
A. phagocytophilum, and in one case where all 4 agents were detected).
In the control group there was found 12 positive results (24%) for
Bartonella sp., 4 (8%) for B. burgdorferi, 3 (6%) for A. phagocytophilum,
0 positive results for B. microti. In one case coinfection was determined
(Bartonella sp. and A. phagocytophilum).
These results prove that coinfection is common in patients suspected
of Lyme disease and laboratory testing for coinfection is necessary to
establish exact diagnosis and treatment.
P2138 Evaluation of a CLIA test for detection of Borrelia burgdor-
feri speciﬁc IgM-antibody production in cerebrospinal ﬂuid
V. Fingerle, S. Mathes, U. Schulte-Spechtel, G. Jinliang, C. Hizo-Teufel
(Munich, DE)
Objective: Detection of Borrelia burgdorferi speciﬁc antibody synthesis
in cerebrospinal ﬂuid (CSF) by calculation of the Borrelia speciﬁc
antibody index (AI) is of paramount importance for diagnosis of
neuroborreliosis. Combined with unspeciﬁc CSF ﬁndings – lymphocytic
pleocytosis, elevated protein, CSF/blood barrier dysfunction – a reliable
diagnosis can be achieved.
VlsE is an immunodominant antigen for serological diagnosis in early
and late manifestations of Lyme borreliosis including neuroborreliosis. It
was recently demonstrated to be a powerful tool for increasing sensitivity
of IgG-immunoassays for detection of Borrelia antibodies in serum as
well as for determination of the IgG-AI. By contrast, studies on IgM-AI
determination are rare so far. Therefore, we studied performance of a
new chemiluminescent (CLIA) Borrelia IgM assay (LIAISON® Borrelia
IgM Quant, DiaSorin), using recombinant VlsE and OspC for Borrelia
speciﬁc intrathecal antibody production in comparison to an evaluated
in-house ELISA based on a B. afzelii strain PKo ultrasonicate.
Methods: We studied 31 paired serum/CSF samples collected from
patients with well deﬁned stage II neuroborreliosis. A prospective panel
included 218 consecutive paired serum/CSF samples collected from
subjects investigated for neuroborreliosis. Whenever possible the AI was
calculated by the method of Reiber.
Results: 29 out of 31 samples collected from patients with neuroborre-
liosis had measurable Borrelia IgM antibodies in CSF samples by the
CLIA test. Calculation of the AI resulted in 23 positive, 1 equivocal and
5 negative (diagnostic sensitivity was 23/31, corresponding to 74.2%).
Out of the 31 samples 22 had measurable Borrelia IgM antibodies in
CSF samples by the in-house test. The calculated AI was positive in
20, equivocal in 1 and negative in 1 (diagnostic sensitivity was 20/31,
corresponding to 64.5%).
Out of the 218 consecutive CSF samples 211 and 208 were negative by
the in-house and the CLIA method, respectively. 7 AI were concordant
positive with both methods while 3 CSF samples had measurable
antibodies by CLIA only. The AI of those 3 samples were negative,
equivocal, and positive in one each. The positive sample showed also a
positive AI for IgG.
Conclusion: The results indicate that the fully automated CLIA Borrelia
IgM assay is a reliable test for detection of Borrelia-speciﬁc intrathecal
IgM antibody production that may add signiﬁcantly to the diagnosis of
early neuroborreliosis.
P2139 Nested-PCR in the diagnostic of different forms of Lyme
borreliosis
D. Pı´cha, L. Moravcova´, D. Holeckova´, J. Hercogova´, M. Valesˇova´,
D. Vanousova´, V. Maresˇova´ (Prague, CZ)
Objectives: The newly derived targets speciﬁc for Borrelia burgdorferi
sensu lato were tested in the group of patients with different clinical
forms of Lyme borreliosis. Nested-PCR system was used and ﬁve targets
were applied in parallel. Sensitivity and clinical utilisation of PCR were
evaluated.
Methods: 124 patients were enrolled into the prospectively designed
study – 53 patients suffered from neuroborreliosis, 23 patients had
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lyme arthritis and acute erythema migrans had 48 patients. Diagnosis
was established on the typical clinical symptoms and proof of speciﬁc
antibodies in serum, and/or in CSF in neuroborreliosis, and in synovial
ﬂuid in arthritis. Five targets were tested in parallel – speciﬁc for 16S
rDNA, ﬂagellin, p66, OspA and OspC proteins. DNA was examined in
plasma and urine in all patients. Moreover, CSF in neuroborreliosis and
synovial ﬂuid in arthritis were examined before treatment.
Results: 41 patients (77.4%) were positive for neuroborreliosis, 27 DNA
positive patients (56.3%) were found in the group with skin involvement
and 13 patients (56.5%) were DNA positive in group with arthritis. The
speciﬁc DNA was found in 50% of patients with neuroborreliosis (22
patients) after treatment, in 7 patients with erythema migrans and in
10 patients with lyme arthritis. After 3 months the DNA positivity was
found in 29 patients (29.0%) and after 6 months in 7 patients (9.0%).
The highest frequency of positive ampliﬁcations showed the primer
speciﬁc for 16S rDNA (38.7%) and the lowest one for p66 protein
(positive only 11 times – 4.4%). By using one primer (16S rDNA)
only 48 positive patients (38.7%) would have been diagnosed with two
parallel ampliﬁcations 65 positive patients (52.4%) would have been
found. Three parallel ampliﬁcations would dicover 74 (59.7%) patients.
Conclusion: The nested-PCR method achieved before treatment in all
clinical forms of Lyme borreliosis the general sensitivity 65.3% (81
positive patients out of 124) by using ﬁve parallel ampliﬁcation. The
highest sensitivity was found in the sequence speciﬁc for 16S rDNA
(38.7% of all positive ampliﬁcations) the using of two or three parallel
ampliﬁcation is suitable to obtain the sufﬁcient clinical sensitivity.
Sensitivity of primers didn’t differ in all clinical groups of borreliosis.
Study was supported by public government grants CR IGA8293, MSM
0021620812.
P2140 Comparison of automated immunoassay LIAISON®
Borrelia and ELISA Enzygnost® Borreliosi for the diagnosis
of Lyme disease
M. Ruscio, F. Piuzzi, N. Blasone (San Daniele del Friuli, IT)
Objectives: Lyme borreliosis is multisystem diseases caused by the tick-
borne spirochetes belonging to the species Borrelia burgdorferi sensu
lato. The diagnosis of Lyme disease is based on clinical manifestations
and laboratory ﬁndings. The serological detection of Borrelia antibodies
represents a stone corner for diagnosis. Aim of the present study was
to evaluate the diagnostic performances of automated immunoassay
LIAISON® Borrelia IgG and IgM antibodies (DiaSorin – Italy) to
Borrelia burgdorferi in comparison with ELISA Enzygnost® Borreliosi
IgG and IgM (Dade Behring – Germany).
Methods: Study group: 256 serum specimens from patients with
clinically characterised Lyme borreliosis at different stages. All patients
came from an endemic area in the North East of Italy. All serum
specimens were tested in parallel with Enzygnost® Lyme LinkVlsE
IgG and Borreliosi IgM (Dade Behring-Germany) and with LIAISON®
Borrelia IgG and LIAISON® Borrelia IgM Quant (DiaSorin-Italy).
Enzygnost® Borreliosi IgG and IgM are immunoenzymatic assays based
on a mixture of inactivated Borrelia burgdorferi antigens for qualitative
IgG and IgM determination in serum/plasma.
LIAISON® Borrelia IgG and LIAISON® Borrelia IgM Quant are
chemiluminescent (CLIA) fully automated assays for quantitative
determination of speciﬁc antibodies IgG or IgM in serum/plasma and
CSF. Recombinant VlsE antigen is used for coating magnetic particles
in the IgG assay. Two recombinant antigens OspC and VlsE are used
for coating magnetic particles in the IgM assay. When the sample was
positive for IgG and/or IgM the specimens was graded reactive. The
discordant samples were solved with immunoblot assay.
Results: The diagnostic sensitivity was determined by testing 256 serum
specimens from patients with clinically characterised Lyme borreliosis
at different stages (Eythema migrans, Neuroborreliosis, Arthritis). The
percent IgG and/or IgM positive sera was 93% for Enzygnost® Lyme
LinkVlsE IgG and Borreliosi IgM and 97% for LIAISON® Borrelia
IgG and LIAISON® Borrelia IgM Quant.: nº4 Neuroborreliosis sera are
positive for IgG and IgM LIAISON® Borrelia, Enzygnost® IgG positive
and Enzygnost® IgM negative.
Conclusions: These preliminary data show a good diagnostic sensitivity
of LIAISON® Borrelia IgG and LIAISON® Borrelia IgM Quant. Further
study are going to evaluate the diagnostic speciﬁcity by testing 250
routine serum specimen from subjects living in non endemic area with
all assays.
P2141 Recombinant Borrelia burgdorferi protein antigens in the
serology of early Lyme borreliosis
I. Christova, M. Lesseva, G. Miloshev, E. Tasseva, T. Gladnishka
(Soﬁa, BG)
Objectives: Early diagnosis and treatment of Lyme borreliosis are
of particular interest to prevent late untreatable manifestations of the
disease. OspC, FlaB, DbpA, and VlsE proteins of B. burgdorferi are
known to be among the limited number of antigens that induce immune
response in early Lyme borreliosis.
Methods: OspC, ﬂab, dbpA, and vlsE genes were ampliﬁed from
genomic DNA of B. burgdorferi and cloned in E. coli. Speciﬁcity of the
obtained proteins was conﬁrmed by speciﬁc monoclonal antibodies in
immunoblot. Recombinant ELISAs with each protein as a single antigen
were developed and a serum panel from 50 patients with clinically
deﬁned early Lyme borreliosis (erytema migrans) was tested. Serum
samples from 10 healthy individuals served to calculate the cut-off. A
serum panel, consisting of sera from 10 patients with syphilis and 10
patients with rheumatoid arthritis, both groups known to give cross-
reactivity, was used to test the assays speciﬁcity.
Results: OspC and VlsE ELISAs showed the best balance between
sensitivity and speciﬁcity.
Conclusions: Neither antigen was enough sensitive and speciﬁc to be
used in a single antigen based ELISA.
P2142 Quantiﬁcation of the synthesis of antibodies against Borrelia
burgdorferi-speciﬁc antigens within the central nervous
system by chemiluminescent and enzyme immunoassay
P. Lange, A. Spreer, R. Nau (Go¨ttingen, DE)
Objectives: Diagnosis of central nervous system (CNS) involvement of
infections by Borrelia burgdorferi sensu lato may be difﬁcult when the
clinical syndrome is atypical or when the interval between infection
and cerebrospinal ﬂuid (CSF) analysis is long. Diagnostic analysis
of the CSF is complicated by antigenetic heterogeneity of Borrelia
burgdorferi strains and differences in antigen compositions of diagnostic
tests. This study compared the ability of chemiluminescent (CLIA) and
enzyme immunoassay (EIA) to detect antibody synthesis directed against
Borrelia burgdorferi sensu lato within the CNS.
Methods: Antibodies against Borrelia burgdorferi in CSF and serum
pairs from 90 patients were quantiﬁed by CLIA (LIAISON BORRELIA,
Diasorin, Saluggia, Italy) or by EIA (in-house method using ENZYG-
NOST Lyme Link VlsE plates, Dade Behring, Schwalbach, Germany).
The Borrelia-speciﬁc IgG and IgM antibody index (AIIgG, AIIgM) was
calculated: (Borrelia-speciﬁc Ig in CSF/Borrelia-speciﬁc Ig in serum)/
(total Ig in CSF//total Ig in serum).
An AI> 1.5 was considered abnormal.
Results: In 47 cases, an elevated AI either for IgG or IgM or both
suggesting Borrelia-speciﬁc antibody synthesis within the CNS was
detected both by CLIA and EIA. The absolute AI values, however,
showed considerable deviation among both methods. In 39 cases,
AIIgG and AIIgM were normal or the Borrelia-speciﬁc CSF antibody
concentration of IgG, IgM or both was below the quantiﬁcation limit.
In 3 cases, EIA detected IgG or IgM synthesis in CSF, whereas the AIs
determined by CLIA were normal. In one case, AIIgM determined by
CLIA was elevated, but below the detection limit when measured by
EIA.
When Borrelia-speciﬁc IgG and IgM were analysed separately, the rate
of incongruent results between the two methods was higher. In 29
S634 18th ECCMID, Posters
cases, AIIgG was normal as determined by EIA, but not measurable by
IML. In 5 cases with normal AIIgG determined by EIA, CLIA yielded
implausibly low AIIgG (<0.5). In 11 cases, AIIgM was not detectable
by EIA, but elevated when measured by CLIA.
Conclusion: CLIA was more sensitive than EIA in detecting Borrelia-
speciﬁc IgM synthesis. EIA was more sensitive to detect Borrelia-
speciﬁc IgG in CSF of patients with an elevated or normal AIIgG.
P2143 A cell envelope protein array of Borrelia burgdorferi to
proﬁle the humoral response of patients with Lyme disease
Y. Xu, J. Bruno, B. Luft (Stony Brook, US)
Objective: To determine the cell envelope proteins of Borrelia
burgdorferi recognised by immune sera of patients with late Lyme
disease.
Methods: We developed a Borrelia microarray containing proteins
encoded by 90 cell envelope genes and their homologs described in the
annotated genomic sequence of B. burgdorferi, strain B31. The protein
microarray was used to proﬁle the humoral immune response using sera
from 14 individuals with late Lyme disease and 4 negative controls.
Results: Although there were sera-speciﬁc responses, 15 of the cell-
envelope proteins were recognised by 9 or more samples. Sera from
non-infected individuals lacked reactivity against any of the proteins
on the array. Among the most antigenic envelope proteins, protein
sequence analysis using the BLASTx programme of GenBank revealed
little homology to known microbial proteins from other species. Seven
of the 15 highly antigenic proteins were hypervariable with multiple
homologs found in our genomic analyses of various strains in the species.
Approximately one half of the proteins that were highly antigenic in our
array analysis were not found in Borrelia cultured in vitro. The proteins
that were highly seropositive included BBA24 (decorin binding protein A
(dbpA))(12 out of 14 samples), and paralogous family gbb fam_PF05714
(immunogenic protein P35) (9 of 14 samples).
Conclusions: The accurate diagnosis of Lyme disease depends on
correlating objective clinical abnormalities with serological evidence of
exposure to B. burgdorferi. A protein array of the envelope proteins
of Borrelia burgdorferi may be very useful in speciﬁcally identifying
patients with Lyme disease. This approach could contribute to a more
rapid discovery of antigens not expressed in vitro which may be useful
for the development of vaccine and diagnostics.
P2144 Protein expression of Borrelia burgdorferi sensu lato strains
during long-term in vitro cultivation
U. Glinsek, E. Ruzic-Sabljic, F. Strle (Ljubljana, SI)
Objective: To establish whether and how long-term cultivation
inﬂuences the expression of borrelial ﬂagellin, proteins in the range
of heat shock proteins (Hsps) and in outer surface proteins (Osps), i.e.
proteins known to be involved in pathogenesis of and immune response
to borrelia infection.
Material and Methods: We analysed 24 Borrelia strains (8 B. afzelii,
6 B. garinii, and 10 B. burgdorferi sensu stricto) Strains were cultivated
in MKP medium and passages were performed in the exponential phase
of growth. 20 passages of each strain were performed during a period
of approximately 1 year and ﬁve protein proﬁles were determined: the
initial immediately after establishing positive culture result, the second
after 5th, the third after 10th, the fourth after 15th and the last after
20th passage. Protein proﬁle was performed using sodium dodecyl
sulfat polyacrilamid electrophoresis (SDS-PAGE). The presence and the
quantity of the expressed proteins were assessed and compared within
individual strain.
Results: Hsps proteins and ﬂagellin were consistently expressed in
all analysed strains throughout the entire cultivation period, while
pronounced differences in the expression of Osps were found. In
some strains changes from expression to weak expression or even to
non expression and to re-expression were established. During entire
cultivation period only 5/24 (21%) isolates remained unchanged while
in 19/24 (79%) isolates distinctions in Osps were established: after 5th
passage in 8 (33%) isolates, after 10th in additional 7 (29%) isolates,
after 15th in 3 (13%) and after 20th passage in 1 (4%) additional isolate.
Most often (in 16/24 isolates – 67%) alterations in expression of OspC
occurred, followed by variations in OspB (10/24 – 42%) and OspA
(7/24 – 29%). In 4 isolates changes of all three Osps occurred, in 6
isolates variations in two Osps were found (in 3 OspA and OspB, in other
3 OspB and OspC) while in 9 isolates solely changes in the expression of
OspC were established. The most pronounced variations were ascertained
among B. afzelii isolates, while in the other two Borrelia species the
changes in the expression of Osps in the course of cultivation were less
frequent.
Conclusion: During long-term borrelia cultivation Hsps proteins and
ﬂagellin are consistently expressed, while pronounced differences in the
expression of Osps (most notably OspC) occur. The most prominent
variations are present among B. afzelii isolates.
P2145 Seroprevalence of Borrelia infection among tick-bitten
asymptomatic teenagers in risk region of southern Podlasie,
Poland
A. Panczuk, M. Koziol-Montewka, M. Tokarska-Rodak (Biala Podlaska,
Lublin, PL)
Objectives: The annual number of Lyme borreliosis (LB) cases in
Poland shows a growing tendency and was amounted to 6680 in 2006.
The highest incidence of LB is reported from Podlasie (north-eastern
Poland), which is an endemic area and the rate reached the value of
77.2 per 100,000. The aim of the study was to educate and verify the
knowledge about preventive methods reducing risk for infection as well
as to evaluate the level of tick bites and the seroprevalence of antibodies
against Borrelia burgdorferi in healthy teenagers bitten by tick.
Methods: The ﬁrst stage of the study included 1044 healthy pupils
from southern Podlasie region and level of tick bites was assessed.
The levels of IgM and IgG antibodies against B. burgdorferi were
determined in selected 85 (aged 16–18) bitten pupils by means of
ELISA immunoenzymatic method, Borrelia 14 kD + OspC IgM ELISA
and Borrelia IgG + VlsE ELISA (DRG Diagnostics, Germany) and
conﬁrmed with Borrelia Blot IgM and IgG. All participants were
examined at the ﬁnal period of tick activity (September 2007).
Results: Among teenagers 49.9 p.c. (n = 521/1044) were bitten by tick,
14.4 p.c. (n = 150/1044) more than twice. Positive results for IgM
B. burgdorferi were revealed in 16.5 p.c. (n = 14/85) and 4 were doubtful,
and for IgG, 3.5 p.c. (n = 3/85) individuals were positive. Detection with
Borrelia Blot IgG (DRG) conﬁrmed the presence of antibodies anty-
VIsE and others speciﬁc protein. In two cases IgG antibody levels were
extremely high (165.6 and 54.7 U/ml).
Conclusion: High percent of tick bitten teenagers and positive results
of antibody levels conﬁrm necessity of education of how to reduce the
risk for infection, including daily self-examination for ticks, selective
use of acaricides and tick repellents, use of practices that reduce tick
populations in forest and tourist relaxation spots. Positive results for
B. burgdorferi antibodies in asymptomatic period may change serological
picture in case of the future clinical manifestation of borreliosis.
P2146 Study on the occurrence of Borrelia burgdorferi, Anaplasma
phagocytophilum, Babesia microti and Bartonella sp. in ticks
from the Roztocze National Park (eastern Poland)
E. Cisak, J. Chmielewska-Badora, J. Zwolinski, A. Wo´jcik-Fatla
(Lublin, PL)
The objective of the study was to evaluate the risk of acquring infection
of Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia microti
and Bartonella sp. for workers and visitors of Roztocze National Park
(Eastern Poland).
Material and Methods: 606 Ixodes ricinus ticks (females, males and
nymphs) collected from forest areas of Roztocze National Park (RNP)
were examined for the presence of Borrelia burgdorferi sensu lato
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(B.b.s.l.), Anaplasma phagocytophilum, Babesia microti and Bartonella
sp by PCR method.
Results: The total infection rate of Bbsl, A. phagocytophilum, B. microti
and Bartonella sp amounted: 11.6%, 6.1%, 0.5% and 2.2% respectively.
Adult ticks were infected by these pathogens in the greater proportion
than nymphs. In 6.5% of infected ticks coinfections with B.b.s.l. and
A. phagocytophilum were observed.
Conclusion: The results proved that four pathogens transmitted by ticks
are present in the forest environment of RNP and indicate a risk for
the workers of RNP as well as for visitors to acquire infections caused
by these pathogens, especially by Borrelia burgdorferi and Anaplasma
phagocytophilum.
P2147 A high-virulence clone of Borrelia burgdorferi sensu stricto
is distributed widely in Europe and North America
Y. Xu, J. Bruno, B. Luft (Stony Brook, US)
Objective: Among the multiple Borrelia burgdorferi species causing
Lyme disease, only B. burgdorferi sensu stricto is found in both North
America and Europe. We investigated the evolutionary link between
the European and North American populations of B. burgdorferi sensu
stricto by comparing the DNA sequences of isolates from the United
States.
Methods: We sequenced one chromosomal locus (16S-23S ribosomal
RNA intergenic spacer, IGS) and three highly variable plasmid loci
(ospC on cp26, dbpA on lp54, and BBD14 on lp17) from U.S. (n = 36)
and European (n = 32) isolates. Cluster analysis of multilocus sequences
revealed 19 intra-speciﬁc genomic groups, 16 of which were strictly
endemic lineages. One genomic group, the B31 clonal type, is the most
frequent group in both continents. One single-nucleotide substitution and
one gene-conversion over a span of 3,800 nucleotides distinguished the
European and North American B31-type isolates. Sequence variations of
the outer surface protein gene (ospC) were associated with the divergence
of incipient genomic groups in both continents, corroborating the
lineage-deﬁning role of ospC variations. Linkage breakdowns between
ospC and genomic groups were observed in one European isolate and
50% of the midwestern U.S. isolates, suggesting stable population sizes
in those regions, in contrast to the rapid clonal diversiﬁcation in the
northeastern U.S.
Conclusions: We conclude that the bi-continental distribution of
B. burgdorferi sensu stricto is due to post-glacial vicariance, indigenous
diversiﬁcation, and accelerated migration in modern times. The broad
host- and vector-species range of a small number of intra-speciﬁc
lineages (e.g., the B31 type) may underline their high pathogenecity
in humans, and the introduction and preferential growth of these clones
may have played a role in the rapid emergence of Lyme disease in the
United States in recent decades.
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P2148 Oncogenic HPV subtypes in HIV-positive women
C. Ni Cheallaigh, O. Sheils, S. Delamere, M. Grifﬁths, G. McHugh,
P. Webster, C. Martin, J. McInerney, H. Keegan, J. O’Leary, F. Lyons,
C. Bergin, F. Mulcahy, S. Clarke for the Irish Cervical Screening
Research Consortium
Background: Women with HIV, especially those with low CD4 counts
and high HIV viral loads, are more likely to have persistent genital
oncogenic human papillomavirus infection and to develop cervical
cytological abnormalities and neoplasia. HPV 16 and 18 are the most
common oncogenic subtypes in the European population. African women
are more likely to have non 16/18 subtypes.
As part of the Irish Cervical Screening Research Consortium, we are
performing more intensive screening on HIV + patients to determine the
effect of ART on HPV subtypes and cytology.
Method: All female patients attending the HIV clinic are being
prospectively recruited into the study, with cervical cytology samples
taken at baseline and regularly during follow-up.
The presence of HPV DNA was analysed using proprietary Hybrid
Capture® 2 (hc2) signal-ampliﬁcation (Digene) and PreTect HPV-Proofer
was used to identify the 5 high-risk types 16, 18, 31, 33 and 45.
Results: To date, 91 women have been screened at baseline. Of
these 48/91 (52%) were on ART. Only 7/91(8%) had a CD4 count
<200×106/L.
Oncogenic HPV subtypes were detected in a total of 15/91 (16%)
women. 10/15 (64%) had non-16/18 subtypes. 8/15 had HPV 45, and
4/15 had HPV 33. 4/15 had more than one subtype. 7/15 of women eith
oncogenic HPV were receiving ART, all of whom had a viral load <50
cpm. 1/15 (7%) had a CD4 count of <200×106/L.
Cytological abnormalities (6 baseline nuclear abnormalities, 12 CIN1, 2
CIN2, 1 CIN3) were detected in 21 women, of whom 6 had oncogenic
HPV infection detected on this occasion. Women with oncogenic HPV
were more likely to have cytological abnormalities (OR 2.71, p = 0.08).
Of the 21 with cytological abnormalities, 8/21 were on ART and
7/21 had a CD4 count of <200×106/L. The odds ratio of having
cytological abnormalities in those with CD4 counts <200×106/L was
3.67 (p = 0.13).
Conclusion: More than half of the oncogenic HPV subtypes detected
in this population were not 16 or 18, which has implications for
vaccine use in women with HIV. Although oncogenic HPV infection was
associated with a higher risk of cytological abnormalities, the majority
of women with cytological abnormalities did not have HPV detected in
this occasion. Further research will determine the suitability of using
HPV detection in cervical screening.
Oncogenic HPV and/or cytological abnormalities was found in 22/84
(26%) women with high CD4 counts highlighting the importance of
continuing cervical screening in this population.
P2149 Novel methods for the diagnosis of HPV infection
M. Dalessandro, R. Zappacosta, F. Conti, T. Santone, K. Falasca, A. Di
Girolamo, P. Ripani, M. Liberati, S. Rosini, E. Pizzigallo, J. Vecchiet
(Chieti, IT)
Introduction: Human Papilloma Virus (HPV) infection is more common
among HIV positive women. HPV-associated lesions are more frequent,
more aggressive, and less responsive to therapy when compared to
seronegative women. Classic methods (gynaecological examination,
transvaginal US-scan, colposcopy and Pap test) in association with
molecular test such as Hybrid Capture 2 (HC-2, Digene – Italy) are
employed for diagnosis of HPV infection in HIV seronegative, and
seropositive women. The purpose of this work is to evaluate the use
of Pretect HPV Proofer for the detection of E6/E7 mRNA expression
also in seropositive women.
Materials and Methods: We considered 25 HIV positive women
admitted at the Clinic of Infectious Diseases of “G. d’Annunzio”
University in Chieti. All women were evaluated with gynaecological
examination, transvaginal US-scan and colposcopy. We have also used
cytological techniques (Pap test) and molecular test (HC-2, and Pretect
HPV Proofer).
Results: LSIL has been found in 28% of HIV positive women and
HSIL in 8%. Abnormal cytology was more frequent among women
with HIV viral load between 400 and 10.000 copies/ml (25% ASCUS,
42% LSIL e 100% HSIL), and lower CD4+ lymphocyte levels. Using
HC-2 test HR-HPV genotype has been detected in 40% of women; 12%
of women showed a positivity for LR, and HR-HPV infection. HPV
infection is more common among women with high HIV viral load
(p = 0.001; r = 0.62) and CD4 lymphocyte count below 500 cells/ml. A
negative result for mRNA test was found in 68% of HIV+ women. The
diagnosis of ANTZ was more frequent when HIV viral load was >10,000
copies/ml (p = 0.04; r = 0.43).
Discussion: HIV+ women are at higher risk for HR-HPV infection
than uninfected women. This risk seem associated with high HIV viral
load and low CD4 lymphocyte count. The role of HAART on HPV
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infection evolution toward cervical dysplasia and cancer is somewhat
unclear. Molecular techniques for HPV diagnosis and typing are more
speciﬁc and accurate, when compared with other methods. In HIV+
women PreTect HPV Proofer is a promsing new tool for the diagnosis
of HPV infection, for identiﬁcation high risk HPV genotypes, allowing
a more reliable follow up of HIV-HPV coinfection.
P2150 Demographic and epidemiological factors associated to
Treponema pallidum infection in pregnant women
R. Figueroa (Mexico City, MX)
Sexually transmitted infections (STI) constitute a pandemic with an
estimated 15 millions persons acquiring a new STI each year. The
possible resurgence of infectious syphilis, a disease previously believed
to be close to eradication, is a matter of increasing global concern.
Untreated cases of syphilis in pregnant women has been associated with
adverse pregnancy outcome and serious health effects in the foetus and
the newborn.
Objective: To identify demographic and epidemiological factors
associated with syphilis in pregnant women.
Methods: A total of 27 consecutive pregnant women complicated with
syphilis were studied, in eight the diagnosis was made with the physical
ﬁnding of a genital chancre and a positive FTA-ABS test; in the rest, the
diagnosis was suspected with a positive VDRL, and conﬁrmed by means
of the positively of the FTA-ABS test. For each pregnant woman with
syphilis, four apparently healthy women were included as comparison
group. Demographic, epidemiologic and obstetric characteristics of the
two groups of patients were compared. Categorical data were analysed by
Chi-square test or Fisher exact test; the Student’s t-test was performed
to analyse numerical data with a normal distribution. The strength of
association was calculated with Odd Ratios (OR) with 95% conﬁdence
interval (CI). A multivariate analysis was made by means of logistic
regression.
Results: The mean age of the patients was 24.2 ±7.4 years, and the
mean age of begin sexual activity was 17.5 ±3.3 years. Eleven (40.7%)
presented their ﬁrst pregnancy. The variables that were associated with
maternal syphilis during the gestation were: age less than 29 years,
begin the sexual activity before 19 years, not to be married, multiple
sexual partners, six or less years of formal education, and didn’t have
prenatal care. The logistic regression analysis showed that the variables
independently associated with syphilis in pregnant women were six or
less years of formal education and the marital status of not married.
Conclusion: The principals ﬁnding in the patients of this study was a
low schooling, and an instable marital status with a high percentage of
pregnant women not married who were single or live in free union, as
the factors strongly associated to syphilis during pregnancy.
P2151 Incidence of syphilis in a cohort of HIV-infected subjects,
Italy
A. Matteelli, R. Basche´, A. Carvalho, G. Cristini, G. Paraninfo,
S. Caligaris, S. Capone, F. Castelnuovo, I. El Hamad, G. Carosi
(Brescia, IT)
Background and Objective: Syphilis is a reliable marker of behaviours
at increased risk for transmission/acquisition of sexually transmitted
infections (STI) and HIV. Among HIV infected persons the incidence
of syphilis reﬂects the potential for further spreading of the HIV virus
in the community. We measured the incidence of syphilis in a cohort of
HIV infected persons and described association with demographic and
behavioural variables.
Methods: Retrospective, cohort analysis. All consecutive HIV infected
persons registered at the Institute of Infectious and Tropical Diseases,
Spedali Civili, Brescia from 1 January 2001 to 30 June 2007 were
included. The Institute did not adopt speciﬁc strategies to reduce the risk
of acquiring /transmitting STIs during the study period. All demographic,
behavioural, and syphilis treponemal tests (TPHA) results were collected
from clinical charts.
Results: Out of 1905 new HIV infected subjects enrolled during the
study period 1280 (67.2%) had at least one TPHA test. A positive
syphilis serology at the ﬁrst test was documented in 238 subjects
(18.6%). Of the 1042 remainder subjects 509 (48.8%) had at least one
repeated test and were included in the retrospective cohort analysis.
47 (9%) seroconverters were identiﬁed over a mean follow-up period
of 759 days (SD±668 days). Syphilis incidence was 43.8/1000 person/
year (95%CI: 32.0–57.9). At univariate analysis, being male (OR 5.22,
95%CI: 1.84–14.81, p< 0.005) and homo/bisexual (OR 6.24, 95%CI:
3.32–11.72, p< 0.00) were associated with a higher risk of new syphilis
infection. Nor age neither virological/immunological parameters were
associated with the risk of syphilis. The Cox regression analysis showed
that homo/bisexuality was independently associated with an increased
risk of syphilis (HR 4.39, 95%CI: 2.33−8.30, p< 0.005).
Comments: In the absence of speciﬁc risk reduction programmes the
incidence of syphilis remains high among HIV infected homo/bisexual
males in Northern Italy. These data document the potential for continuous
spread of HIV infection and other STI in this population.
P2152 Audit of laboratory diagnostic methods for syphilis in
England and Wales
A. Amin, R. Manuel, C. Ison, R. Woodham, M. Shemko, H. Maguire,
I. Giraudon, J. Forde, S.H. Gillespie (London, UK)
Objectives: The number of cases of infectious syphilis is increasing
rapidly across England and Wales (E&W). Both clinicians and
microbiologists have expressed concerns about delays in providing
patients with timely results and the potential impact on patient care.
A standard operating procedure (SOP) for the serological diagnosis of
syphilis has recently been developed by the Health Protection Agency
(HPA) and ratiﬁed. Our objectives were to describe syphilis testing in
primary diagnostic laboratories including timeline of result reporting, to
describe the referral process to regional and reference laboratories, and
to describe the experience of users.
Methods: A web-based questionnaire was designed, which incorporated
feedback from an initial consultation process. All microbiology
departments, genito-urinary medicine (GUM) clinics, and antenatal
clinics in E&W were asked to complete this questionnaire. A pilot study
was performed in London prior to national roll-out.
Results: Responses were obtained from 116/181 microbiology de-
partments, 119/172 GUM clinics, and 169/199 antenatal clinics. The
proportion of microbiology departments performing EIA, TPPA/TPHA,
RPR/VDRL, and EIA IgM were 93.7%, 34.7%, 41.1%, and 10.5%
respectively. Dark ground microscopy was performed by 34.5% of GUM
clinics. 81% of microbiology departments reported a turnaround time for
negative results of <1 week. There was a large variation in turnaround
times for positive results (range <1 week to 6−8 weeks), with 18.5%
of GUM clinics reporting turnaround times of >3 weeks. Delays in
turnaround time which were reported to have had an adverse effect on
patient management were reported by 25.2% of GUM clinics and 5.3%
of antenatal clinics.
Conclusion: Syphilis testing and delays in providing results vary across
E&W. To limit the spread of infection, turnaround times for the diagnosis
of syphilis need to be signiﬁcantly reduced.
P2153 Re-emergence of infectious syphilis in Constanta county,
Romania
R. Stoicescu, V. Braga, V. Badea, M. Botnarciuc, L. Voineagu, A. Barbu,
D. Tencaliec, C. Rusu, S. Tomasian (Constanta, RO)
Objectives: To evidence the re emergence of infectious syphilis in
Constanta County, by testing the patients hospitalised in the wards
of clinical hospital in Constanta (other than dermato-venerology
department) for Treponema pallidum.
Methods: Serum samples were taken from 10712 patients admitted in
Clinical Hospital (internal medicine ward, obstetrics, cardiology, surgery,
neurology, paediatrics, intensive care unit and psychiatry). Cerebrospinal
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ﬂuid was collected from 4 patients(3 new born babies and one patient
in neurology).
The used tests were RPR (Rapid Plasma Reagin test) and
TPHA(Treponema pallidum haemagglutination test).
Results: Positive results were obtained in 320 cases representing 2.98%
of investigated patients(42 males and 178 women, 210 adults and 10
children)
All 4 cerebrospinal ﬂuid samples were positive for Treponema pallidum.
We detected a number of 216 pregnant women and 8 new born babies
which have been treated according to the therapeutical protocols.
Conclusion: A greater vigilance and screening for syphilis in population
are needed, mainly among pregnant women and newborns. Thus we will
be able to decrease the incidence of syphilis which is rising among
women in Romania.
Control methods should be based on ante natal screening in the ﬁrst
trimester, supported by treatment and partner notiﬁcation. These control
methods are highly cost effective but depends on well structured
healthcare system. Congenital syphilis is a preventable disease and its
re emergence reﬂects a failure in syphilis control programmes.
P2154 Prevalence of Chlamydia trachomatis and Neisseria
gonorrhoeae in low-risk and high-risk female population
in Novosibirsk, Russia
A. Khryanin, V. Reshetnikov (Novosibirsk, RU)
Objectives: Epidemiology of sexually transmitted diseases (STDs) is
largely based on surveillance data. The aim of the present study was
to examine the prevalence of Chlamydia trachomatis and Neisseria
gonorrhoeae infections in low-risk and high-risk groups among young
women in Novosibirsk, Western Siberia.
Methods: We examined female university students, gynaecology clinic
attendees, medical workers, and pregnant women. Overall, 439 women
voluntarily participated in the study. After a conﬁdential interview, a
gynaecologic examination was performed with collection of endocervical
specimens. Gen-Probe Pace 2 and APTIMA COMBO 2 Assay (Gen-
Probe Incorporated, San Diego, CA, USA) were used for N. gonorrhoeae
and C. trachomatis testing.
Results: The prevalence of C. trachomatis and N. gonorrhoeae infections
are shown in the Table.
University
students
(n = 100)
Gynaecology
clinic
attendees
(n = 104)
Medical
workers
(n = 128)
Pregnant
women
(n = 107)
Mean age (range) 20.6
(16–24)
25.8
(16–44)
26.3
(16–45)
25.9
(18–37)
CT 12.0 6.7 4.7 4.7
NG 2.0 5.8 1.6 0.0
Half of N. gonorrhoeae-positive females were also infected with
C. trachomatis. In univariate analysis, STDs were signiﬁcantly associated
with age under 25 years (p = 0.02), age at ﬁrst sexual intercourse less than
18 years (p = 0.02), alcohol or drug intoxication during ﬁrst intercourse
(p = 0.003), migration from rural regions (p = 0.001), lower educational
attainment (p = 0.037), and a higher number of lifetime sexual partners
(p = 0.01). Marital status, family income, previous STDs, and condom
use did not differ between infected and non-infected women. Among
reported symptoms, vaginal discharge (p = 0.02) and intensive menstrual
bleeding (p = 0.05) were more frequent in infected women.
Conclusion: The prevalence of C. trachomatis and N. gonorrhoeae
infections in young females in Novosibirsk is similar to that in the USA.
As in other populations, risky sexual behaviour has a signiﬁcant effect
on the risk of bacterial STDs.
P2155 Chlamydia and gonorrhoea in high-risk areas in Havana,
Cuba: a point prevalence study
I. Justo Roll, S. Yee Seuret, S. Balcildes Acosta, J.W. Mouton,
C.H. Klaassen, J.F. Meis (Havana, CU; Nijmegen, NL)
Objectives: No studies on the prevalence of Chlamydia and gonorrhoea
among the general population have been carried out in Cuba. We studied
the prevalence of Chlamydia and gonorrhoea in a young, high-risk,
population for contracting sexually transmitted diseases in Havana and
describe associated risk factors for their transmission.
Methods: A random, point prevalence study was performed in a high
risk population for contracting sexual transmitted diseases in urban areas
of Havana, Cuba. 375 healthy young adults, 294 females and 81 males,
with an age ranging from 14 to 35 years old gave their consent to
participate. Participants older than 35 years, younger than 14, without
previous sexual intercourse and those who were under current broad
spectrum antibiotics or in the previous 4 weeks were excluded. A cervical
smear in women and an urethral smear in men were used for Chlamydia
and gonorrhoea testing (ProbeTec, BD, France).
Results: 5.6% (21/375) of the participants were positive for Chlamydia,
71.4% (15/21) were female and 28.6% male (6/15). Adolescent females
at school age were identiﬁed as the highest risk group. Having a steady
sexual partner for the last 6 months was not protective for infection
(OR:1.86, p = 0.131), but more than 1 sexual partner in the last ﬁve year
doubled the risk (OR:2.02; p = 0.147). Some well known complications
of Chlamydia infection were already present among the infected group.
Only 0.5% (2/375) participants tested positive for gonorrhoea.
Conclusions: Chlamydia infection prevalence in our study group
appeared to be high enough to justify early diagnosis and treatment
although it has the lowest prevalence in the Caribbean region. Focussing
screening to teens older than 15 years at school would probably provide
the most efﬁcacious prevention approach in this scenario.
P2156 Practice of Chlamydia trachomatis testing; using laboratory
surveillance and STI clinic data from 2002–2006
A.M. Niekamp, C.J.P.A. Hoebe, M.I.S.L. Werner,
N.H.T.M. Dukers-Muijrers (Geleen, NL)
There is limited knowledge about the testing practice of Chlamydia
trachomatis (Ct). Considerable debate exists on the preferred testing
policy.
The current study assesses practice of Ct testing and trends in Ct
positivity rate.
Preliminary laboratory surveillance (LS) data of one laboratory and data
from our STI clinic in The Netherlands (2002–2006) was used.
LS shows that between 2002 and 2006 the number of test requests for
Ct has doubled. The main healthcare providers who request genital Ct
testing are STI clinic (share of 27%), general practitioners (GP: 30%)
and gynaecologists (Gyn: 37%). At most (92%) consultations only one
anatomical site, mainly genital, from a person was tested. Anal Ct-tests
were only requested by STI clinic. GP tested a higher share of women
(75%) and persons were older (median age 28 years) than compared to
STI clinic (62% women, median age 25 years). Median age of women
tested by Gyn was 32 years.
The proportion of positive genital Ct diagnoses (positivity rate) increased
slightly in men (9% in 2002 to 10% in 2006) and women (5% to 6%).
This translated in increases in incidence, calculated using population
data on the coverage area of the laboratory, from 33 to 96 per 100.000
for men and from 84 to 197 for women.
Although all providers requested more tests over time, the positivity rate
increased only for attendees of the STI clinic. Notably, increases in men
were not only caused by homosexual (4.4% in 2003 to 6.1% in 2006)
but also by heterosexual men (5.3% to 8.4%).
Overall, genital Ct was diagnosed in 7.1% of men and 9.8% of women
attending STI clinic, while for GP, this was 13.2% and 6.8%. For women
tested by Gyn, the proportion was 3.1%. For all providers, the highest
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positivity rate was observed among those 25 years of age or younger.
Anal Ct was diagnosed in 5.7% of men and 8.2% of women.
Several healthcare providers increasingly test for Ct. Positivity rates
increase as well, but only at the STI clinic where Ct testing is standard,
and not at GP who opportunistically screen risk groups.
A possible explanation for the high positivity rate in men tested by GP
is that GP seem to adopt a stricter test policy (only on indication) for
men than for women. A negative consequence of this may be that an
unknown number of Ct cases will be missed. Considering the relatively
high proportion of positive anal Ct cases seen at our STI clinic, other
healthcare providers should more often include this test in their test-
package.
P2157 Prevalence and determinants of Chlamydia trachomatis
infection among young women (14–24 years) in Turin, Italy
M.C. Salfa, M.A. Latino, V. Regine, D. De Maria, C. Rosso, G. De
Intinis, L. Camoni, B. Longo, B. Suligoi (Rome, Turin, IT)
Objectives: To estimate the prevalence of Chlamydia trachomatis
infection in young women (14–24 years) from the general population
and to determine risk factors associated with infection.
Methods: The study population consisted of sexually active young (14
years old) women attending a public gynaecology clinic in the city
of Turin (northern Italy) for a ﬁrst visit between January 2002 and
December 2005. Chlamydia was detected with the Ligase Chain Reaction
test performed on an endocervical sample.
Results: A total of 1,849 young women were included in the study. The
mean age was 21.6±2.1 years; 76.7% were Italian; 66.4% had two or
more lifetime partners; 70.0% were single; 57.6% had a high school
diploma. Chlamydia was detected in 6.2% of the study population.
Among 407 asymptomatic women, the prevalence was 2.7%, whereas
among the remaining 1,440 was 7.2%. Among 431 women originating
from outside Italy, the prevalence was 9.3% (12.0% among 225 women
from Eastern Europe, 7.3% among 124 women from Africa), and 5.3%
among Italian women.
Chlamydia prevalence was 8.1% in the group aged 14–21 years and 4.8%
in the group aged 22–24 years (p< 0.005). At the multivariate analysis,
the positivity for Chlamydia was signiﬁcantly associated with originating
from outside of Italy (OR 2.62), high number of lifetime sexual partners
(2−3 vs. 1 partner; OR 2.85), and having had more than one partner in
the previous six months (OR 2.30).
Conclusion: The prevalence found in this study was higher compared
to that reported in a previous Italian study conducted between 1997
and 2000 in a population of women of same age in the same geographic
area (prevalence: 3.5%) (Latino et al., Sex Transm Inf, 2002). Even when
disaggregating by presence of symptoms or by age group, the prevalence
observed in our study was higher. This ﬁnding can be attributed to: a)
higher proportion of foreign women in our study (23.3%) compared
to the study of Latino et al. (9.6%); b) a true increase in incidence
of Chlamydia infection after year 2000. The high prevalence observed
among foreign women is probably associated with the high frequency of
Chlamydia in their countries of origin. The risk factors for Chlamydia
infection found in our study suggest that testing should be primarily
offered to women younger than 22 years, even if asymptomatic, and
also to foreign women and women with multiple partners.
P2158 Molecular evidence of Chlamydia trachomatis in a female
patient with ocular lymphoma and chronic hepatitis B
C. Contini, S. Seraceni, F. Lanza, S. Carradori, A. Sebastiani, P. Perri
(Ferrara, IT)
Objectives: Ocular adnexal non-Hodgkin lymphoma (OANHL), consti-
tute a heterogeneous group of neoplasms that have been associated to
a high prevalence of Chlamydia psittaci infection in tumour tissues and
peripheral blood mononuclear cells (PBMCs) without evidence of other
Chlamydia spp. or other microrganisms.
Methods: We carried out cell cultures and PCR methods to investigate
Chlamydia spp. in tumour tissue and PBMC specimens collected from a
patient with OANHL. The patient was a 53-years-old woman suffering
from chronic B hepatitis, who was referred in September 2007 to the
Section of Ophthalmology of University of Ferrara because of right
ocular lymphoplasmacytic lymphoma (immunocitoma) of conjunctiva
with microscopic evidence of typical salmon masses. In 2001, the
patient had developed an analogous tumour in the left eye treated with
radiotherapy. Common routine microbiological and serological tests were
all negative for recent infections. Quantiﬁcation of hepatitis B viral load
showed highly detectable DNA viraemia. Because of the possible link
between chlamydial infections and malignant lymphomas, the patient
was referred to the Section of Infectious Diseases of our University
to investigate Chlamydiae and other pathogens. DNA extraction from
PBMC and lymphoma tissue samples was carried out following a
standard phenol/chloroform extraction technique after proteinase K
digestion. PCR with primer sets amplifying Chlamydiae gene 16s RNA
and MOMP was assayed on DNA from fresh specimens, supernatant and
cells culture (Hep-2).
Results: A PCR positive product (527 bp) corresponding to C. tra-
chomatis MOMP was found in cultured tissues and PBMC specimens
only. After sequencing, this fragment did show a strict homology
with C. trachomatis (BLAST). No C. psittaci nor C. pneumoniae
DNA sequences were detected. The patient was treated 4 weeks with
doxycycline 100mg, twice a day and PBMC chlamydial DNA did
result negative after the conclusion of antibiotic treatment. A signiﬁcant
reduction of the previously described ocular lesions was observed.
Conclusions: This is the ﬁrst study which demonstrates the presence of
C. trachomatis DNA in PBMCs of a patient with ocular lymphoma. Like
other chlamydiae, this pathogen causes persistent infection which may
favour the development of OAL. The combination of culture with PCR
has shown to improve the sensitivity of PCR thus suggesting its potential
use to detect C. trachomatis and to monitor the efﬁcacy of therapy.
P2159 Seroepidemiology of sexually transmitted infections in East
and South Georgia, 1998–2002
E. Lew, C. Newman (Rochester, Atlanta, US)
Objectives: Retrospective 5 year data analysis of patients seeking HIV,
Syphilis, Chlamydia, and Gonorrhoea testing at public health clinics in
suburban East (EG) and rural South (SG) Georgia from 1998–2002.
Methods: Using an ELISA and a conﬁrmatory Western blot, 40094
individuals were HIV tested; 20199 (50%) lived in EG, 22718 (56%)
were female, 15748 (39%) were Caucasian, 22127 (55%) were African
American, 1132 (7%) identiﬁed themselves as men who have sex with
men (MSM). 8663 (22%) were <20, 15080 (38%) between 20–29, 8696
between 30–39, and 7654 (19%) >40. From 1998–2002, 9142, 16984,
and 766 cases of Gonorrhoea, Chlamydia, and Syphilis were reported
respectively.
Results: Starting in 2002, HIV infection rate decreased in EG (1.1% in
1998, 0.5% in 2002; p = 0.006), but had remained stable in SG (0.8%).
In EG, HIV infection was associated with gender (male, p< 0.001),
race/ethnicity (African American, p< 0.01), age >30 (p< 0.01), sexual
orientation (MSM, p< 0.01), and having a “sex partner at risk”
(p< 0.01). In SG, HIV infection was associated with race/ethnicity
(African American, p< 0.01), age >40 (p< 0.01), sexual orientation
(MSM, p< 0.01), and having a “sex partner at risk” (p< 0.01), but not
with gender. From 1998–2002, HIV seroconversion rates remained stable
in SG (0.4%), but had ranged from 0.4−1.1% in EG. Only 50% of those
testing HIV negative received post-test counseling. Gonorrhoea cases
were higher in women (55% in EG, 58% in SG), African American (83%
in EG, 67% in SG), and those <24 (68% in EG and SG). Chlamydia cases
were higher in women (82% in EG, 87% in SG), African American (74%
in EG, 51% in SG), and those <19 (41% in EG, 45% in SG). Syphilis
cases were higher in men (54% in both EG and SG), African American
(90% in EG, 80% in SG), and those >30 (58% in both EG and SG). In
2000 EG was composed of 57% Caucasian, and 52% female, while SG
was composed of 73% Caucasian, and 50% female.
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Conclusion: From 1998–2002, HIV infection rates was stable in South
Georgia while it had decreased in East Georgia. Syphilis, Chlamydia,
and Gonorrhoea cases remained stable in both areas. With recent reports
of an increase in HIV cases in parts of Europe, and with the age of
onset of sexual activities continuing to drop, education and prevention
programmes need to continue to target teenagers, females, ethnic and
sexual minorities. The importance of post-test counseling needs also be
stressed, particularly to those who had tested HIV negative.
P2160 Quality of life in patients with recurrent urinary
tract infections associated with sexually transmitted
diseases – A healthcare problem
O. Loran, L. Sinyakova, I. Kosova (Moscow, RU)
Objectives: Probably 60% of women with sexual dysfunction and 61%
of women with dyspareunia have recurrent urinary tract infection.
Methods: 120 patients with recurrent urinary tract infections (UTI) in
age of 16–40 years old were examined from 2003–2007. Polymerase
chain reaction (PCR), culture methods and serological tests were
used for detection of sexually transmitted diseases, urinary culture
for bacteriological tests of urine. Questionnaire “Pelvic Pain and
Urgency/Frequency Patient Symptom Score” by L. Parson was used for
quality of life tests.
Results: E. coli was detected in 55.1% (43) cases. Presence of agents of
STD were found in 84.2% (101): Ureaplasma urealyticum in 34.5%(35)
of patients, Chlamydia trachomatis in 20% (20) of patients, Herpes
simplex I, II type in 25.2% (26) patients, in other 20% (20) cases
it was mixed-infection. Pollakiuria up to 11–14 times per day in
latent period had 31.6% (38) of patients, 96% (115) of women had
dyspareunia, and because of pain and urinary tract symptoms during
or after intercourse 92% (110) of patients avoid sexual life. Mild and
extensive pain associated with bladder, pelvis, vagina, perineum, urethra
during intercourse which leads to social and sexual disadaptation of
women had 86% (103) of patients. Urgency and frequency after sexual
intercourse had 88% (105) of patients, but extensive symptoms had only
28% (34)of patients. Symptom score less than 10 was in 8% (10), 10–14
in 28% (34), 15–19 – 36% (43) and more than 20 – 28% (34) of patients.
Conclusion: Recurrent urinary tract infections associated with STD in
patents in young reproductive age lead to social and sexual disadaptation
of women and decrease their quality of life.
P2161 Bacterial vaginosis and associated microﬂora in women of
reproductive age
I. Hadzi-Petruseva Meloska, B. Kurcik Trajkovska, G. Jankoska,
V. Trajkovski, A. Jankijevic, M. Petrovska (Skopje, MK)
Objective: The purpose of this study was to determine the prevalence
of bacterial vaginosis (BV) and BV vaginosis associated microﬂora in
women of reproductive age.
Methods: This study was conducted in a period of 6 months (January 1–
June 30, 2007) and we evaluated a total of 2638 both vaginal and cervical
swabs. They were collected from all women, aged 16–49 years, with
and without symptoms of BV, who visited the Gynaecology Clinic. BV
was diagnosed microscopically by Nugent’s score and was deﬁned as
a modiﬁed Nugent score of 6 and above. Leukocytes detection in the
Gram-stained slides was noted, too. Detection of aerobic and anaerobic
bacteria and fungi was performed by standard microbiological methods.
The swabs were plated on ship blood-, Thayer Martin-, Gardnerella-
and Sabouraud-agar and when necessary, we used VITEK system
(bioMe´rieux, France) to make a conﬁrmation of the isolated anaerobes.
Results: Normal vaginal ﬂora was microscopically detected in 2311
(83.8%). The prevalence of BV, Nugent’s score above 6, was 10.2%
(269 swabs), consistent with isolation of Gardnerella vaginalis in 243
(9.2%) cases. The rest 26 cases of BV represented isolation of other
anaerobes (predominately Bacteroides). BV was most frequent (33%) in
the younger age group (16–26 years). Furthermore, there were a total of
158 (6%) cases with leukocytes and Nugent’s score 4−6. Out of those in
25 (15.8%) and 10 cases, anaerobic Gram-negative rods (Bacteroides
or Prevotella) and anaerobic Gram-positive cocci (Peptococcus and
Peptostreptococcus), were isolated respectively. In the evaluation period,
Mobiluncus has not been detected. Other bacteria isolated from the total
of the samples include approximately 10% streptococci (Streptococcus
agalactiae and Enterococcus), 3% Staphylococcus aureus and 10%
coliformes (predominately E. coli and Klebsiella), but not associated
with any particular microﬂlora. Candida spp. was found in 498 (22.0%)
of all swabs.
Conclusion: BV, a syndrome characterised by a change of vaginal
ﬂora from predominant Lactobacillus to partial or total replacement
with anaerobes has a higher prevalence in the younger age group.
The isolation of Gardnerella vaginalis and other anaerobes is strongly
associated with BV diagnosis by Nugent’s score. Leukocyte detection is
useful tool for microbiology diagnosis in women with vaginal discharge.
P2162 Bacterial vaginosis and vaginal leukorrhoea: an association
with concomitant vaginal and cervical infections
Sp. Fokas, St. Fokas, G. Altouvas, M. Tsironi, M. Kalkani,
M. Dionysopoulou (Sparta, GR)
Objectives: Bacterial vaginosis (BV) is a vaginal condition characterised
by the absence or scarcity of white blood cells (WBCs) in the vaginal
discharge. We aimed to evaluate whether an increased vaginal WBCs
in women with BV is associated with fungal, bacterial, or protozoan
vaginal and cervical infections.
Methods: Our study was carried out over a 3-years period
(9/2004−8/2007) and included 135 new nonpregnant premenopausal
patients who attended the outpatient gynaecology dpt of our general
hospital. All these women were diagnosed as having BV based on
the Nugent scoring system. Vaginal leukorrhoea was deﬁned as more
than 10 WBCs per ﬁeld X 400. Swabs were taken from posterior
vaginal vault and the endocervical canal. Culture media included BAP,
CHOC with IsoVitaleX, MTM, Sabouraud and MAC agar. Trichomonas
vaginalis and Candida spp. detection was achieved by direct wet mount
examination and testing for Chlamydia trachomatis was performed using
chromatographic immunoassay.
Results: Of the 135 women enrolled in the study, 91 (67%) were
symptomatic, while 44 (33%) were asymptomatic. The mean age was 26
years (range 17–48) and most of these women were less than 30 years
old (98, 73%). Elevated vaginal WBC count was found in 19 (14%)
women and the majority of them (15/19, 79%) were symptomatic. The
prevalence of Candida spp.-C. trachomatis-T. vaginalis-N. gonorrhoeae
in women with both BV and leukorrhoea was 21% (4/19), 37% (7/19),
21% (4/19), and 0% (0/19) respectively, whereas, in women without
leukorrhoea the prevalence rates were 3.4% (5/116), 6.9% (8/116),
0% (0/116), and 0% (0/116) respectively. Leukorrhoea was statistically
associated with Candida spp. (c2 = 7.35, P< 0.01; OR 5.9, 95%CI 1.43
to 24.2), C. trachomatis (c2 = 14.8, P< 0.001; OR 7.87, 95%CI 2.4 to
25.2), and T. vaginalis (c2 = 25.1, P< 0.001). Women with both BV and
leukorrhoea were signiﬁcantly more likely to be co-infected (c2 = 45.5,
P< 0.001; RR= 7.04, 95%CI 4 to 12.2).
Conclusions: In the studied population, we found that among
nonpregnant women with BV, vaginal leukorrhoea is strongly associated
with co-infection with Candida spp.–C. trachomatis–T. vaginalis and
these women were 7.04 times more likely to be co-infected than women
without leukorrhoea. The prevalence of C. trachomatis in women with
both BV and leukorrhoea (37%) is high and further tests should be
performed to promote early detection and treatment.
P2163 Frequency of occurrence of Mycoplasma genitalium in
women with unexplained (idiopathic) infertility
J. Grzesko, B. Maczynska, M. Elias, U. Kasprzykowska, A. Janczura,
M. Tlaczala, M. Goluda (Wroclaw, PL)
Objectives: In the last 20 years, infertility has become a growing social
and economic problem, especially in highly-developed countries. There
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exist many deﬁned and diagnosable causes of infertility of partners but
idiopathic infertility, in the case of which it is impossible to identify
the real reason of infertility using standard diagnostic methods, still stirs
much controversy. Mycoplasma genitalium is a microorganism which
may cause NGU, oligosymptomatic genital infections, disorders in the
structure and mobility of sperm, and at the same time is impossible
to detect in routine diagnostic tests. The objective of this study was
to estimate the frequency of occurrence of Mycoplasma genitalium in
the reproductive organs of women with infertility in comparison with a
group of healthy patients who have given birth to at least one child. An
attempt was also made to determine the correlation between the presence
of the above species in the genital tract and fertility impairment.
Material and Methods: The study covered 51 patients with primary
infertility, including 24 women with idiopathic infertility and 23 women
with proven fertility. Cervical swabs and smear from the peritoneal
cavity (pouch of Douglas) performed during laparoscopy. Presence of
the genetic material of Mycoplasma genitalium in the material analysed
using PCR.
Results: As a result of the analysis performed, Mycoplasma genitalium
were found in the cervical channel of 19.6% of all infertile patients and
in 4.4% of fertile patients. Additionally, the pathogen was discovered in
the cervical canal of 29% patients with unexplained infertility, which in
comparison with the group of fertile women was a statistically signiﬁcant
difference. In the abdominal cavity,Mycoplasma genitalium was found in
5.8% patients from the infertile group (in 8.4% patients with idiopathic
infertility), while it was not detected at all in the laparoscopy material
obtained from the studied fertile patients.
Conclusion: A signiﬁcantly more frequent occurrence of Mycoplasma
genitalium in the genital tracts of women with idiopathic infertility
was found (both in the cervical canal and in the abdominal cavity)
compared with the control group. The results obtained may suggest
that Mycoplasma genitalium is a species having an impact on impaired
fertility in women.
Acknowledgments: This study was supported by the Polish Committee
of Scientiﬁc Studies (MNiSW Grant No 2 P05E 08229), Wroclaw
Medical Uniwersity (GR 632/2005)
P2164 A comparison of predictors for high-grade CIN in the
triage of women with abnormal smears
J. Cuzick, A. Szarewski, L. Ambroisine, L. Cadman, J. Austin, L. Ho,
G. Terry, S. Liddle, W.P. Soutter, D. Lyons (London, UK)
Objectives: It is well established that certain types of the human
papillomavirus (HPV) are the primary risk factor for cervical cancer.
Studies have shown that HPV DNA testing is substantially more sensitive
than cytology for the detection of high grade cervical lesions, but lacks
speciﬁcity. If HPV testing is to be used in cervical screening, improving
the speciﬁcity is highly desirable. In this study we compared sensitivity,
speciﬁcity and positive predictive value (PPV) of several adjunctive tests
for the detection of high-grade disease (CIN2+ and CIN3+).
Methods: 954 eligible women aged 18 to 72 referred for colposcopy
following one or more abnormal cervical smears participated in the
study after having given written informed consent. Repeat cytology and
up to six DNA or mRNA tests were carried out on a liquid PreservCyt®
sample using commercially available kits or prototypes: Hybrid Capture
II (Digene), Amplicor (Roche), HPV-Proofer (Norchip), APTIMA HPV
assay (Gen-Probe), Linear Array (Roche), Clinical-Arrays (Genomica).
p16INK4a immunocytochemistry was also performed. Sensitivity,
speciﬁcity and PPV were based on the worst histology at baseline.
Results: 700 women (73.4%) had an abnormal repeat smear result
(borderline or worse) including 541 (56.7%) with a mild dyskaryosis
smear result or worse. Overall, 279 women (29.2%) had high grade
disease (CIN2+) on worst histology, of which 173 (18.1%) had a CIN3+
result. Repeat cytology with borderline or worse considered positive
had a sensitivity of 97.5%, speciﬁcity of 36.6% and PPV of 38.9% for
CIN2+. For CIN3+ lesions, repeat cytology had a sensitivity of 98.3%,
speciﬁcity of 32.1% and PPV of 24.3%. The performance of the different
HPV tests and p16INK4a expression is ongoing and will be presented
at the meeting.
Conclusions: Five of the tests (Amplicor, HCll, Linear Array, repeat
cytology, APTIMA) had sensitivity >95%. Of these ﬁve tests, APTIMA
shows the best speciﬁcity. HPV-Proofer was less sensitive than the other
tests but much more speciﬁc.
In vitro susceptibility of Candida spp.
P2165 In vitro susceptibility of Candida species isolated from
blood to common antifungal agents in a Spanish tertiary
medical centre
M. Alkorta, J. Hernandez-Almaraz, E. Eraso, G. Quindo´s (Barakaldo,
Bilbao, ES)
Objectives: To evaluate the susceptibilities of Candida blood isolates to
common antifungal agents in the Hospital de Cruces, a Spanish tertiary
medical centre.
Methods: A total of 206 blood isolates of different species of Candida
were collected in the clinical routine in the period January 2004–
October 2007. The yeasts were identiﬁed by conventional mycological
methods. In vitro susceptibilities to 5-ﬂuorocytosine (5FC), amphotericin
B (AMB), ﬂuconazole (FLC), itraconazole (ITC), ketoconazole (KTC),
and voriconazole (VRC) were determined using the Etest method. MICs
were recorded after 24 h of incubation at 37 ºC.
Results: The most frequently isolated species was Candida parapsilosis
(87 isolates, 42.2%) followed by Candida albicans (79 isolates, 38.3%).
Other non-C. albicans species, such as Candida tropicalis (17 isolates,
8.3%), Candida glabrata (10 isolates, 4.9%), Candida guilliermondii (7
isolates, 3.4%), or Candida krusei (4 isolates, 1.9%), were recovered
in minor frequency. MICs at which 90% of the clinical isolates were
inhibited were 0.5mg/L for 5FC, 1mg/L for AMB, 4mg/L for FLC,
0.38mg/L for ITC, 0.094mg/L for KTC and 0.125mg/L for VRC. AMB,
VRC and KTC were very active in vitro against all blood isolates, even
those that were resistant to ITC or FLC. A total of 23 isolates (11.2%)
showed decreased susceptibility to ITC (MIC> 0.25mg/L) and 10
isolates (4.9%) showed decreased susceptibility to FCZ (MIC> 8mg/L).
FLC resistance (32mg/L) was limited to 4 C. krusei isolates and to
one isolate each of C. glabrata and C. guilliermondii. ITC resistance
(2mg/L) was limited to 3 C. glabrata isolates, 2 C. guilliermondii, 2
C. tropicalis and 1 C. krusei.
Conclusions: Scarce antifungal resistances were found in Candida blood
isolates from our institution. FLC resistance was limited to 4 C. krusei
isolates and to one isolate each of C. glabrata and C. guilliermondii.
Funding: Projects PI061895 from Fondo de Investigacio´n Sanitaria
(Ministerio de Sanidad y Consumo of Spain) and IT-222–07 from
Departamento de Educacio´n, Universidades e Investigacio´n (Gobierno
Vasco).
P2166 Trends in susceptibility to ﬂuconazole of yeasts isolated
from patients in Saint Petersburg, Russia, during a 3-year
period, 2004–2007
N. Vasilyeva, I. Vybornova, T. Bogomolova, N. Klimko (Saint
Petersburg, RU)
Objectives: To determine prevalence of resistance to ﬂuconazole in
clinical yeast isolates in Saint Petersburg during the period from October
1, 2004 to September 30, 2007.
Methods: Evaluation of susceptibility to ﬂuconazole was performed by
disk-diffusion method according to CLSI M44-A protocol.
Results: The total of 1600 yeast isolates from various clinical materials
(genital, oral, blood, urine, sputum, cerebrospinal ﬂuid, bile, wound and
other) were tested for susceptibility to ﬂuconazole (511 strains were
isolated during the period from October 1, 2004 to September 30, 2005;
586 strains – from October 1, 2005 to September 30, 2006 and 503
strains – from October 1, 2006 to September 30, 2007).
In vitro susceptibility of Candida spp. S641
Candida albicans was most common – 1126 strains (70.3%), Candida-
non-albicans – 414 (25.9%), Cryptococcus neoformans – 26 (1.6%),
other yeasts – 34 (2.1%).
The number of resistant yeast strains during the whole period of
investigation was 103 (6.4%), but prevalence of resistance to ﬂuconazole
ranged from 6.1% (1st year period) to 5.7% (2nd year period) and 7.6%
(3rd year period). The incidence of susceptible-dose-dependent isolates
was 4.3%, ranging from 2.9% to 4.9% and 5.8% during three successive
years of observation. Most of the isolates (89.3%) were susceptible to
ﬂuconazole.
Prevalence of resistance to ﬂuconazole in C. albicans isolates was
0.53% and ranged from1.0% to 0.0% and 0.6% during three years of
observation.
Conclusion: Prevalence of resistance to ﬂuconazole in the yeasts isolated
from patients in Saint Petersburg during the period of 2004–2007 is low,
but the number of resistant and dose-dependent strains has increased.
P2167 In vitro susceptibility of Candida species to micafungin: a
comparison of methods
V.L. Gray, N.E. Duddy, S. Harris, S.J. Howard, D.W. Denning,
C.B. Moore (Manchester, UK)
Objective: Clinical isolates of Candida species (n = 123) were taken
from sterile and non-sterile sites to determine in vitro MIC’s and mini-
mum fungicidal concentrations (MFC) to the echinocandins micafungin
and caspofungin. Differing methodologies for testing micafungin were
employed for comparison.
Table 1. GM MIC’s and MFC’s for mica fungin are shown for various Candida
species determined using various methods
Species n Method GM
MIC
(mg/L)
MIC range
(mg/L)
GM
MFC
(mg/L)
MFC range
(mg/L)
C. albicans 32 EUCAST 0.016 0.015−0.06 9.722 0.125−>8
ODDS 0.016 0.015−0.03 0.355 0.015−>8
CLSI (24 h) 0.016 0.015−0.03 2.406 0.015−>8
CLSI (48 h) 0.019 0.015−0.5 0.392 0.015−>8
C. glabrata 16 EUCAST 0.017 0.015−0.125 0.040 0.015−>8
ODDS 0.017 0.015−0.06 0.028 0.015−1
CLSI (24 h) 0.016 0.015−0.06 0.028 0.015−4
CLSI (48 h) 0.017 0.015−0.25 0.048 0.015−>8
C. parapsilosis 12 EUCAST 1.130 0.5−4 9.665 4−>8
ODDS 0.542 0.125−1 4.219 1−>8
CLSI (24 h) 0.722 0.5−1 6.128 2−>8
CLSI (48 h) 1.130 0.5−2 4.537 1−>8
C. tropicalis 12 EUCAST 0.017 0.015−0.03 6.307 0.06−>8
ODDS 0.016 0.015−0.03 0.068 0.015−0.25
CLSI (24 h) 0.020 0.015−0.5 1.577 0.03−>8
CLSI (48 h) 0.024 0.015−1 0.160 0.03−>8
C. krusei 11 EUCAST 0.108 0.06−0.25 0.354 0.25−1
ODDS 0.108 0.06−0.25 0.149 0.125−0.25
CLSI (24 h) 0.108 0.06−0.125 0.250 0.25
CLSI (48 h) 0.124 0.06−0.25 0.210 0.125−0.25
C. guilliermondii 10 EUCAST 0.235 0.06−1 7.246 1−>8
ODDS 0.248 0.06−0.5 10.767 1−>8
CLSI (24 h) 0.472 0.125−1 16.000 >8
CLSI (48 h) 0.500 0.25−0.5 16.000 >8
C. kefyr 10 EUCAST 0.043 0.015−0.06 0.092 0.06−0.25
ODDS 0.034 0.015−0.06 0.080 0.06−0.25
CLSI (24 h) 0.037 0.03−0.125 0.060 0.06
CLSI (48 h) 0.040 0.03−0.06 0.080 0.03−0.25
C. lusitaniae 10 EUCAST 0.060 0.03−0.125 4.391 0.06−>8
ODDS 0.039 0.015−0.06 0.549 0.03−>8
CLSI (24 h) 0.050 0.03−0.06 0.606 0.03−>8
CLSI (48 h) 0.060 0.03−8 0.606 0.03−>8
C. inconspicua 3 EUCAST 0.030 0.015−0.125 – –
ODDS 0.026 0.015−0.06 – –
CLSI (24 h) 0.030 0.015−0.125 – –
CLSI (48 h) 0.035 0.015−0.125 – –
Methods: Four methods were employed to determine MIC and MFC
values to micafungin: EUCAST, Odds (Odds et. al., 2004, JCM 42:3475),
CLSI M27-A2 (24 h and 48 h incubation). Parameters for EUCAST,
Odds and CLSI methods respectively were as follows: inocula: 1×105,
1×103 and 1×103 CFU/ml; media: 2% glucose, no additional glucose
and 2% glucose; incubation period: 24, 24 and 48 h; endpoint calculation:
50, 50 and 80%. Caspofungin was tested using the Odds method and 24 h
MFC’s. Data analysis was performed substituting 16 for >8mg/L. Drug
dilution stability at −80ºC was assessed monthly using the EUCAST
QC panel. For each species and method GM MIC and MFC values and
ranges (mg/L) were calculated. MFC’s (99% kill on 0.1ml) for the CLSI
method MFC’s were recorded for both time points.
Results: Micafungin drug dilutions were stable for 6 months at −80ºC.
All species exhibited low MIC values to micafungin however inter-
species variation was observed. Where the GM MIC was relatively
higher, e.g. C. guilliermondii and C. parapsilosis, the differing methods
produced notable intra-species variation in MIC values. Reproducibility
data (20%) was excellent. For C. parapsilosis MIC’s to micafungin
varied from 0.125−1.0, and caspofungin from 0.5−2 (Odds). MFC’s for
micafungin produced markedly different results dependent on the method
utilised; the MFC value frequently ranged from <0.015 to >8mg/L for
a single isolate. A signiﬁcant range of results for MFC’s was noted for
all species.
Conclusion: The differing methods did not produce markedly different
MIC values for the echinocandin micafungin, with most isolates
exhibiting low MIC’s to the drug, typically lower than caspofungin. In
contrast Micafungin and caspofungin MFC values varied signiﬁcantly
dependent on the method employed; this correlated with the inoculum
level.
P2168 In vitro activity of micafungin combined with amphotericin
B or ﬂuconazole against Candida parapsilosis
C. Marcos-Arias, E. Eraso, A.J. Carrillo-Mun˜oz, J. Ponto´n, G. Quindo´s
(Leioa, Barcelona, ES)
Objective: The aim of this study was to evaluate the in vitro activities
of the combinations micafungin (MFG, Astellas, Japan) + amphotericin
B (AMB, Sigma, USA) and MFG + ﬂuconazole (FLC, Pﬁzer, Spain),
against 30 blood isolates of Candida parapsilosis.
Methods: The minimum inhibitory concentrations (MIC) were de-
termined according to Clinical and Laboratory Standards Institute
guidelines for yeasts, and deﬁned as the lowest drug concentrations
that produced a 50% inhibition of visible fungal growth after 24 h
of incubation. Drug interactions were assessed by the checkerboard
microdilution method. Antifungal agents were placed in rows or
columns of trays with MFG concentrations ranging from 0.06 mg/mL to
32mg/mL, AMB concentrations ranging from 0.06mg/mL to 4mg/mL,
and FLC concentrations ranging from 0.03mg/mL to 2mg/mL. The
fractional inhibitory concentration index (FICI) was used to classify
drug interaction as follows: FICI 0.5, synergistic; 0.5< FICI 4,
indifferent; and FICI> 4, antagonistic. Candida krusei ATCC 6258 and
C. parapsilosis ATCC 22019 were used as quality control strains.
Results: Overall, MFG MICs ranged from 2mg/mL to 16mg/mL. The
MICs at which 50% and 90% of all the isolates tested were inhibited
(MIC50 and MIC90, respectively) were 8mg/mL and 16mg/mL and
the MIC geometric mean (GM) 7.64mg/mL. AMB MICs ranged from
0.25mg/mL to 1mg/mL. The MIC50 and MIC90 were 0.25 mg/mL and
1mg/mL, respectively, and the GM, 0.40mg/mL. FLC MICs ranged from
0.25mg/mL to 1mg/mL. The MIC50 and MIC90 were 0.5mg/mL and
5mg/mL, respectively, and the GM, 0.41 mg/mL.
The highest percentage of synergy was obtained combining MFG + AMB
(22.2%) and the lowest combining MFG + FLC (6.7%). The remaining
combinatory results were indifferent.
Conclusion: The highest number of synergistic interactions against
C. parapsilosis was found for the combination MFG + AMB but only
against 22.2% of isolates.
Funding: Projects PI061895 from Fondo de Investigacio´n Sanitaria
(Ministerio de Sanidad y Consumo of Spain) and IT-222–07 from
S642 18th ECCMID, Posters
Departamento de Educacio´n, Universidades e Investigacio´n (Gobierno
Vasco).
P2169 Inﬂuence of anidulafungin on different Candida species in
a continuous ﬂow culture system
H. Bernhardt, M. Knoke, G. Schwesinger, A. Gloeckner, J. Buﬂer,
V. Czaika, K. Ludwig, J. Bernhardt (Greifswald, Karlsruhe, Bad
Saarow, Rostock, DE)
Objectives: We investigated the antifungal effect of anidulafungin
(ANID) on bioﬁlms and MIC values of different Candida species in
a miniature ﬂow cell system.
Methods: Strains of C. albicans (Ca), C. glabrata (Cg), C. krusei (Ck),
C. parapsilosis (Cp) and C. lusitaniae (Cl) from blood culture isolates
were grown in ﬂow cells (0.16 mL). Peptone-yeast extract (0.5%/0.2%) +
50 mM glucose +/− ANID (8mg/L) was supplied at very low ﬂow rates
(1.3 mL/h). Biomass production, glucose metabolism, pH and planktonic
CFUs were measured. MIC testing was performed by Etest® on RPMI
or Mueller-Hinton methylene blue agar. Morphology of adherent fungal
cells was assessed microscopically after staining with lactophenol cotton
blue.
Results: For Ca (3 isolates, 5 experiments) we found a strong decrease of
biomass production, elevated concentrations of glucose and an increase
in pH after continuous input of ANID. MICs of baseline strains were
0.003−0.004mg/L. The same MIC values were found on day 2, 4 and
5. After 5 d sometimes, the bioﬁlm did not show any growth. In one
experiment, an increase of MIC to 0.75mg/L was to be seen, but there
was no development of resistance (no growth of bioﬁlm on day 7). In
5 experiments with Cg (4 strains) glucose metabolism stopped within
24 h and no biomass remained after 3−4 d. MIC 0.012−0.016mg/L.
Ck bioﬁlm (1 strain, 1 experiment) was most susceptible to ANID
(MIC 0.004mg/L) equally for baseline strain and bioﬁlm. Cp (4 strains,
8 experiments) showed different degrees of susceptibility. In some
experiments, we saw small inhibition zones (MIC 4−8mg/L). In others,
we found no inhibition and no production of bioﬁlm under the inﬂuence
of ANID. Cl (1 strain, 1 experiment) was found to be good susceptible
to ANID. The produced bioﬁlm stopped after ANID exposure (MIC
0.023mg/L).
Conclusion: Under continuous ﬂow conditions, the strains of Ca, Cg and
Ck were most susceptible to ANID as described for static conditions. Cl
was also very susceptible. Cp showed different degrees of susceptibility.
P2170 In vitro activity of anidulafungin combined with
amphotericin B or ﬂuconazole against Candida parapsilosis
E. Eraso, C. Marcos-Arias, A.J. Carrillo-Mun˜oz, J. Ponto´n, G. Quindo´s
(Bilbao, Barcelona, ES)
Objective: The aim of this study was to evaluate the in vitro activities
of the combinations anidulafungin (AFG, Pﬁzer, Spain) + amphotericin
B (AMB, Sigma, USA) and AFG + ﬂuconazole (FLC, Pﬁzer), against
30 blood isolates of Candida parapsilosis.
Methods: The minimum inhibitory concentrations (MIC) were de-
termined according to Clinical and Laboratory Standards Institute
guidelines for yeasts, and deﬁned as the lowest drug concentrations
that produced a 50% inhibition of visible fungal growth after 24 h
of incubation. Drug interactions were assessed by the checkerboard
microdilution method. Antifungal agents were placed in rows or
columns of trays with AFG concentrations ranging from 0.015 mg/mL
to 8mg/mL, AMB concentrations ranging from 0.06mg/mL to 4mg/mL,
and FLC concentrations ranging from 0.03mg/mL to 2mg/mL. The
fractional inhibitory concentration index (FICI) was used to classify
drug interaction as follows: FICI 0.5, synergistic; 0.5< FICI 4,
indifferent; and FICI> 4, antagonistic. Candida krusei ATCC 6258 and
C. parapsilosis ATCC 22019 were used as quality control strains.
Results: Overall, AFG MICs ranged from 0.5 mg/mL to 4mg/mL. The
MICs at which 50% and 90% of all the isolates tested were inhibited
(MIC50 and MIC90, respectively) were 2 mg/mL and 4mg/mL and
the MIC geometric mean (GM) 1.66mg/mL. AMB MICs ranged from
0.25mg/mL to 1mg/mL. The MIC50 and MIC90 were 0.25 mg/mL and
1mg/mL, respectively, and the GM, 0.40mg/mL. FLC MICs ranged from
0.25mg/mL to 1mg/mL. The MIC50 and MIC90 were 0.5mg/mL and
5mg/mL, respectively, and the GM, 0.41 mg/mL.
The highest percentage of synergy was obtained combining AFG + AMB
(33.3%) and the lowest combining AFG + FLC (6.7%). The remaining
combinatory results were indifferent.
Conclusions: The highest number of synergistic interactions against
C. parapsilosis was found for the combination AFG + AMB but only
against one third of the isolates tested.
Funding: Projects PI061895 from Fondo de Investigacio´n Sanitaria
(Ministerio de Sanidad y Consumo of Spain) and IT-222–07 from
Departamento de Educacio´n, Universidades e Investigacio´n (Gobierno
Vasco).
P2171 In vitro susceptibility testing of fungal isolates from
immunosuppressed, organ-transplanted patients for
anidulafungin and azoles
L. Antoniewicz, C. Poitschek, B. Willinger, A. Geusau (Vienna, AT)
Objectives: Organ transplant recipients (OTR) are predisposed to
mucocutaneous Candida infections. The aim of our study was to compare
the minimum inhibitory concentration (MIC) of the newly introduced
drug anidulafungin, an echinocandin, and already marked azoles (ﬂu-,
itra-, vori-, posaconazole) in strains obtained from this particular risk
group in comparison to healthy controls.
Methods: From 400 OTR and 405 sex- and age-matched controls, two
body sites were sampled for fungal culture (oral and genital mucosa/glans
penis). Susceptibility testing was carried out in parallel for the azoles
using the E-test (AB Biodisk, Sona Sweden). Results were read after
24 hours (MIC 80). For anidulafungin MIC (90) was obtained by
broth microdilution method according to CLSI standard and determined
visually and by spectophotometry after 48 h.
Results: From 529 isolates (273 from OTR, 256 from controls)
susceptibility tests were carried out (418 oral mucosa, 111 genital
area/mucosa). The number of Candida non-albicans species was
signiﬁcantly increased in OTR in the late post-transplantation period
(>18 months) compared to the early period and the controls. For
ﬂuconazole, 2.2% (n = 1) of C. glabrata were resistant (MIC 64ug/ml),
for itraconazole, 82.6% (n = 38) of C. glabrata, 66.7% (n = 2) of
C. krusei (MIC 1ug/ml); all strains were susceptible for voriconazole
(MIC 1ug/ml). For posaconazole and anidulafungin no reference
values for break points exist. For posaconazole, 10.9% (n = 5) of
C. glabrata showed a MIC (80) 4ug/ml (all other strains range
0.002−0.38 ug/ml). C. albicans, C. glabrata, C. tropicalis, C. krusei,
C. lusitaniae, C. norvegensis were most susceptible for anidulafungin
(MIC (90), 0.03 to 0.25 ug/ml); C. parapsilosis and C. dubliniensis were
the least susceptible (MIC (90), 0.25 to 16 ug/ml). C. guilliermondii
was neither isolated from OTR nor from controls. With regard to in
vitro activity there was no difference between strains from OTR and
controls, no shift towards decreased susceptibility of the Candida strains
obtained in the late post-transplantation period or with the type of organ
transplanted.
Conclusion: With the exception of C. glabrata, Candida spp. obtained
from OTR exhibit very good in vitro activity towards azoles. With
regard to anidulafungin all Candida strains from these patients including
C. glabrata showed an excellent in vitro activity with the exception of
C. parapsilosis and C. dubliniensis showing higher MICs than other
Candida spp.
In vitro susceptibility of Candida spp. S643
P2172 Anidulafungin exhibits potent activity against multi-
echinocandin multi-azole cross-resistant Candida
parapsilosis isolates
J. Vazquez, J. Chandra, P. Mukherjee, D. Baxa, M. Ghannoum
(Detroit, Cleveland, US)
Objectives: Echinocandins (ECs) are typically less active against certain
Candida species, especially C. parapsilosis (Cp) and C. guilliermondii
(Cg), but are believed to have similar activities. However, recent case
reports suggest that differences in in vitro activity do exist.
Materials: We evaluated and compared the in vitro activity of the 3
ECs [anidulafungin (afgn), caspofungin (cfgn), and micafungin (mfgn)]
and two azoles (ﬂuconazole and voriconazole) against 76 C. parapsilosis
(Cp) and 13 C. albicans (Ca) isolates (obtained from patients, healthcare
workers, and the hospital environment) using the Clinical Laboratory
Standards Institute M27-A2 methodology. Effects of the ECs on the
cell morphologies of cfgn/mfgn-susceptible and -non susceptible isolates
were assessed using scanning electron microscopy (SEM). Expression
of efﬂux pumps CDR1/CDR2 and MDR1 were analysed by Northern
blotting. Additionally, analysis of the FKS-1 gene to determine point
mutations associated with reduced EC susceptibility was also evaluated.
Results:We found that Cp isolates obtained from burn unit patients were
more susceptible to afgn (MIC 2mg/ml), than to cfgn or mfgn (MICs
8mg/ml). Furthermore, it was not uncommon to observe CP that showed
multi-EC resistance to Mfgn-Cfgn, while remaining susceptible to afgn.
However, Cp isolates obtained from healthcare workers or environmental
sources were remained susceptible to all of the antifungals examined.
SEM revealed that incubation of cfgn-susceptible and -non-susceptible
Cp strains with afgn led to cell damage and eventual death. Low
concentrations of afgn (2mg/mL), but much higher concentration of cfgn
(16mg/mL), were needed to induce morphological changes in a cfgn-
non susceptible strains of Cp. MDR1 expression was upregulated, while
FKS1 mutations were not detected in sequential isolates that exhibited
multi-EC cross-resistance.
Conclusions: This study demonstrates the emergence of EC-cross
resistance in one institution. The in vitro studies demonstrate that the
activity of all ECs is not the same. In fact, in these Cp isolates, the
antifungal activity of afgn was more effective and quite different then
the in vitro activity of cfgn and mfgn against certain Cp isolates. The
results also suggest that the cross-resistance detected in these isolates
appears to be mediated by multiple factors. The clinical impact of these
multi-EC isolates are yet to be determined.
P2173 Effect of protein-binding on the in vitro efﬁcacy of
echinocandins against Candida species
J. Vazquez, D. Vager (Detroit, US)
Objective: The echinocandin (EC) class of antifungals demonstrate a
high degree of protein-binding (>95%) for all 3 ECs. Several studies
have suggested that this high degree of binding may decrease the efﬁcacy
of the ECs against fungi in vivo. The aim of this study was to investigate
the differential effect of serum on the in vitro activity of the ECs against
different Candida spp. and compare them to the activity of azoles and
amphotericin B.
Methodology: 160 Candida isolates were evaluated and included 58
C. albicans (Ca), 48 C. glabrata (Cg), 14 C. parapsilosis (Cp), 10
C. tropicalis (Ct), 10 C. krusei (Ckr), 10 C. lusitaniae (Cl), and 10
C. kefyr (Cke). MICs and time kill assays were used to evaluate the in
vitro efﬁcacy of anidulafungin (Afgn), caspofungin (Cfgn), micafungin
(Mfgn), amphotericin B (AmB), ﬂuconazole (Flz), and voriconazole
(Vcz). MICs were performed using CLSI M27-A2 methodology in
either RPMI or RPMI/50% human serum to determine and compare
the differential in vitro activities. Time kill assays (TKA) in RPMI and
in RPMI/50% serum were performed fo all six antifungals against one
strain each of the different Candida spp. All assays were conducted in
duplicate.
Results: In general, 50% serum signiﬁcantly decreased the activity of
all 3 ECs in vitro, from as low as 2-fold ﬂucuations to as much as a 64-
fold increases in MIC. Cfgn had the narrowest alterations in MICs. The
greatest differences were seen among Cke and Ckr with a 64-fold change
in EC activity with and without serum. In addition, to complement the
MIC data, TKA also demonstrated similar decreases in activity with all
3 ECs, especially Cfgn against Ckr. In contrast, the in vitro activity of
AmB, Vcz, and Flz did not change when the MICs were performed in
50% serum or in RPMI.
Conclusion: In general, the data supports the fact that serum consistently
and dramatically decreases the in vitro activity of all 3 ECs in vitro, and
this effect was demonstrated in all 3 ECs. In contrast, the decrease in
activity in serum was not observed with AmB, Flz, or Vcz. For the ECs,
the signiﬁcance of this decrease in in vitro activity in serum is not fully
understood and the clinical impact of this alteration in efﬁcacy has yet
to be determined.
P2174 Activity of echinocandins against Candida albicans strains
with decreased susceptibility to ﬂuconazole isolated from
APECED patients
E. Siikala, R. Rautemaa, M. Richardson, M. Pfaller, J. Perheentupa,
H. Saxen (Helsinki, FI; Iowa, US)
Objectives: Autoimmune polyendocrinopathy-candidiasis-ectodermal
dystrophy (APECED) is an autosomal recessive disease exceptionally
common in Finland. Chronic mucocutaneous candidosis (CMC) is the
most common component of APECED and most patients suffer from
it since early childhood. Most patients receive repeated treatment and
maintenance courses of azole antifungals, principally ketoconazole and
ﬂuconazole, throughout their lives. This has resulted in mycological and
clinical resistance. The aim of this study was to determine the activity
of the echinocandins caspofungin, anidulafungin and micafungin against
43 Candida albicans isolates from Finnish APECED patients treated and
followed in Helsinki University Central Hospital.
Methods: C. albicans isolates from 10 APECED patients reported to
have decreased ﬂuconazole sensitivity (n = 18, MIC range: 16–32mg/L)
and from 17 APECED patients reported to be sensitive to ﬂuconazole
(n = 25, MIC range: 0.120−8mg/L) were tested for their sensitivity to
caspofungin, anidulafungin and micafungin. The C. albicans strains had
been isolated during the years 1994–2004. A broth dilution technique as
detailed in the CLSI document M23-A2 was used.
Results: All C. albicans isolates were sensitive to the three
echinocandins tested. The mean MIC of all isolates was 0.048mg/L
(range 0.007−0.600) for caspofungin, 0.037mg/L (range 0.007−0.120)
for anidulafungin and 0.020 g/L (range 0.007−0.060) for micafungin.
Decreased ﬂuconazole susceptibility did not affect the susceptibility to
the echinocandins.
Conclusions: All three echinocandins tested were found to be highly
active against C. albicans strains from APECED patients. No cross-
resistance between triazoles and echinocandins could be seen since
strains with decreased ﬂuconazole susceptibility were found to be
susceptible. Micafungin was found to be the most potent echinocandin
against C. albicans strains with decreased ﬂuconazole susceptibility.
P2175 A global evaluation of voriconazole activity against recent
clinical isolates of Candida
D. Diekema, P. Hogan, S. Messer, R. Hollis, L. Boyken, S. Tendolkar,
J. Kroeger, M. Pfaller (Iowa City, New York, US)
Objectives: Approved by the FDA in 2002, voriconazole (VOR) has been
widely used for prevention and treatment of invasive fungal infection.
As a result, prospective surveillance for emergence of in vitro resistance
to VOR is indicated.
Methods: From January 2004-December 2006, we collected 5615
invasive (blood or sterile site) clinical isolates of Candida from 78
centres in 30 countries worldwide (by region: 1011 from Asia-Paciﬁc
[AP], 1829 Europe [EU], 1118 Latin America [LA], 1657 North America
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[NA]). In vitro susceptibility to VOR was performed at a central lab using
the CLSI M27-A2 method and CLSI breakpoints to classify organisms as
susceptible (S), susceptible dose-dependent (SDD), or resistant (R). We
present results overall, by species, by country, and region. In addition,
we compare in vitro activity of this recent collection with that of 5866
isolates collected during global surveillance from 1997–2001, prior to
the availability or use of VOR.
Results: Species distribution was 54% C. albicans, 14% C. glabrata,
14% C. parapsilosis, 11% C. tropicalis, and 3% C. krusei. VOR was
very active overall: MIC50/MIC90, 0.007/0.25mg/mL; 98% S. Of the 96
isolates not S to VOR (n = 66 R, 30 SDD), 87 (91%) were C. glabrata,
primarily from centres in NA and EU. Finland had the highest rate of
VOR resistance (10% R, 8% SDD, 82% S among 73 total isolates). In
all other countries, 97% of Candida were S to VOR. No temporal
trends in species or MIC distribution were noted over the 3 years of
surveillance. In comparison to 5866 Candida isolates collected during
global surveillance from 1997–2001, there were no changes in mean
MIC or MIC distribution (mean MIC = 0.13, MIC90, 0.25mg/mL for
both collections).
Conclusion: VOR is highly active in vitro against a global collection of
recent invasive Candida isolates, and there is no evidence for emerging
resistance or “MIC creep” compared with isolates collected prior to VOR
availability. VOR SDD and VOR R isolates were primarily C. glabrata
isolates from centres in NA and EU.
P2176 Comparison between Isavuconazole and other azoles against
characterised clinical isolates and yeast model systems
D. Sanglard, F. Ischer, A. Coste, S. Ferrari (Lausanne, CH)
Objectives: Isavuconazole (ISA) is a novel azole with a broad activity
range and is evaluated in clinical trials. In order to compare ISA against
other azoles utilised in the therapy of fungal diseases (Fluco-, FLC;
Vori-, VRC, Itra-, ITR; Posaconazole, POS), Saccharomyces cerevisiae
(Sc) was used as a host for the expression of Candida albicans (Ca)
genes involved in azole resistance (ABC transporters CDR1, CDR2
and Major Facilitator (MF) MDR1; ERG11 alleles with mutations) and
16 pairs of Ca matched clinical isolates with known azole resistance
mechanisms were investigated. Testing of azole susceptibility among
these different yeast isolates allows quantitative comparisons between
the above-mentioned azoles.
Methods: Sc isolates expressing CDR1, CDR2, MDR1 and ERG11
alleles were described elsewhere (AAC 39: 1995). Sequential Ca clinical
isolates with increasing MICs to several azoles were obtained from
the University Hospital Centre and their azole resistance mechanisms
described elsewhere (EC 3: 1994; EC 6:2007). The collection of
clinical Ca isolates (38) is representative for most of the existing azole
resistance mechanisms and their combinations. Susceptibility testing was
performed according to CLSI standards using RPMI for clinical isolates
and YNB for Sc.
Results: When transporters were expressed in Sc, results showed that
FLC, VRC, ITR, POS and ISA were substrates of CDR1 and CDR2,
since their expression resulted in relative MIC increase to all azoles
tested as compared to control. On the opposite, the expression of MDR1
did not increase POS, ITR and ISA MIC, suggesting that these azoles
were poor substrates for MDR1. When mutated ERG11 alleles were
expressed, relative increases of azole MIC (from 4- to 32-fold) were
observed for FLC, VOR and ISA when at least 2 mutations were present
in the same ERG11 allele, whereas no MIC increase were measured when
ITR and POS were tested. These results suggest that ERG11 mutations
have limited effect on ITR and POS activity. Upon MIC testing of clinical
Ca isolates with azoles, the MIC90 for FLC, VRC, ITR, POS and ISA
were 128, 2, 1, 0.5 and 2mg/ml, respectively, and showed that ISA had
comparable activities than ITR, POS and VOR.
Conclusions: Resistance mechanisms of clinical isolates have differen-
tiated impact on azole MIC depending on the azole structure. The main
resistance mechanisms in yeasts involving ABC transporters and ERG11
decrease the activity of ISA, while MDR1 has limited effect.
P2177 In vitro post antibiotic effect of isavuconazole, voriconazole
and amphotericin B against a strain of C. albicans with
concentration-dependent pharmacokinetics in a murine
model and susceptibility of strains for murine kidneys post
infection
P.A. Warn, A. Sharp, J.B. Majithiya, A. Parmar, D.W. Denning
(Manchester, UK)
Objective: Isavuconazole (ISA) is a water soluble triazole suitable for IV
and oral dosing in Phase III trials. Understanding the pharmacodynamics
(PD) of antimicrobials is a essential in deﬁning the treatment schedules
for optimum outcomes. Using a strain of C. albicans used to determine
the PD of ISA the post-antifungal-effect (PAE) of ISA, voriconazole
(VCZ) and amphotericin B (AmB) were determined in vitro. Also the
susceptibility of this C. albicans strain was determined from kidneys of
mice following treatment with low or high dose ISA.
Method: PAEs were determined in RPMI broth + 2% glucose buffered
with MOPS. Log phase growth cultures (106 CFU/mL) were exposed to,
solvent, ISA or VCZ at 0.1, 0.5, 1, 2, 5, 10, 40 and 100×MIC; AmB
cultures were exposed at 2×MIC. Following 3 hours of exposure all
drugs were removed by serial washing prior to dilution and transfer to
fresh pre-warmed media. Cultures were incubated on an orbital shaking
and viable CFUs determined hourly for 8 h then at 11 and 21 h. The
log10 count was plotted against time and PAE deﬁned as the difference
is the time required for the count in solvent and drug exposed cultures
and to increase 1×log10 above the count following drug removal. Mice
were immunocompromised with cyclophosphamide then infected with
the same strain of Candida then treated 5 h post infection with vehicle
6 or 24mg/kg of ISA. 24 h post treatment mice were culled and kidneys
cultured onto Sabouraud agar plus ISA (containing 0.25−2.5×MIC).
Recovered fungi had MICs tested by CLSI M27A2.
Results: The in vitro PAE of ISA was absent at MIC for ISA but was
2−2.5 hours for all doses 2×MIC. The PAE was much shorter <1
hour for all doses of VCZ. As expected a much longer PAE of 11 hours
was seen with AmB. The burden following infection of 2.7×105 for
vehicle, 1.7×105 for 6mg/kg and 9.5×103 for 24mg/kg was recovered
from drug free plates. ~75% of this burden was recovered from ISA
containing plates following prolonged incubation. Colonies recovered
from ISA containing plates had identical MICs to the input cultures
indicating no generation of resistance.
Conclusions: ISA demonstrated very signiﬁcant PAE at drug concentra-
tions 2× MIC. Plasma and tissue ISA levels of >100× Candida MICs
are easily attainable in humans and animal models so PAE might have a
signiﬁcant effect on the therapeutic response and PD. Candida recovered
from organs post treatment had MICs unaffected by drug exposure.
P2178 Antifungal susceptibilities of Candida bloodstream isolates
from two different Turkish hospitals
M. Yu¨cesoy, Y. Ayhan, O. Irmak, G. Gu¨lﬁdan, S. O¨zer (Izmir, TR)
Background: Candida spp. are among the leading aetiologic agents of
bloodstream infections in hospitalised patients. Antifungal susceptibili-
ties of these isolates are very important for the management of patients
with invasive candidiasis.
Objectives: This study was performed to investigate the in vitro
antifungal susceptibility patterns of Candida bloodstream isolates from
two different hospitals located in the same city.
Methods: A total number of 139 non duplicate Candida bloodstream
isolates (49 C. albicans, 24 C. parapsilosis, 11 C. tropicalis, eight
C. glabrata, three C. kefyr, three C. utilis, two C. guilliermondii, one
C. famata, one C. krusei and one C. lusitaniae from Dokuz Eylul
(DEU) hospital; 12 C. albicans, 16 C. parapsilosis, three C. famata,
three C. pelliculosa and two C. guilliermondii from Dr Behcet Uz
Children’s Hospital (BU)) cultured within one year period were tested
against amphotericin B, ﬂuconazole and voriconazole using CLSI M27-
A2 microdilution method. The identiﬁcation of the isolates were done
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according to germ tube test, morphology on corn meal tween 80 agar
and CHROMagar Candida and API 20C AUX system.
Results: The MIC50 and MIC90 values detected for C. albicans,
C. parapsilosis, C. tropicalis and C. glabrata strains are shown in
the table. All isolates except one C. lusitaniae were susceptible to
amphotericin B. One C. krusei, one C. parapsilosis, three C. tropicalis
isolates were resistant to ﬂuconazole while the rest of the strains were
susceptible. For voriconazole one C. albicans, two C. tropicalis and one
C. utilis were detected to be resistant and one C. albicans was found as
dose dependent susceptible.
Candida species MIC for DEU isolates (mg/ml) MIC for BU isolates (mg/ml)
AMB FLU VORI AMB FLU VORI
50 90 50 90 50 90 50 90 50 90 50 90
C. albicans 0.125 0.25 0.25 0.50 0.015 0.06 0.125 0.25 0.25 0.50 0.015 0.03
C. parapsilosis 0.125 0.25 0.50 2.0 0.015 0.06 0.125 0.25 0.5 1.0 0.015 0.015
C. tropicalis 0.25 0.50 4 64 0.06 4
C. glabrata 0.25 0.25 4 8 0.06 0.5
Conclusion: According to our results it can be concluded that
amphotericin B, ﬂuconazole and voriconazole are detected to be
active against our Candida bloodstream isolates and they remain to
be appropriate choices for the treatment of patients with Candida
bloodstream infections.
P2179 Identiﬁcation rate and susceptiblity of Candida isolates
from blood cultures
U. Dagwadordsch, E. Dosa, I. Doczi, D. Wilhelms, E. Nagy,
A.S. Kekule´ (Halle/Saale, DE; Szeged, HU)
Objective: The incidence of invasive candidiasis has increased over
the past 2 decades and it is an important cause of complications and
death in hospitalised patients. Due to the life-threatening nature of
these infections and increasing drug resistances, susceptibility testing
of Candida spp. has crucial importance. During a 2-year period (2005–
2007), Candida infections were analysed in two institutions, the 1208-
bed University Hospital in Halle, Germany, and the 1240-bed University
Hospital in Szeged, Hungary.
Methods: Results of 41.423 blood culture samples were reviewed.
The samples had been analysed by BacT/ALERT® 3D (bioMe´rieux)
and BACTEC™ (BD) automated systems in Halle and Szeged,
respectively. The maximum incubation time was 10 days. All positive
samples were microscopically examined by Gram stain. For the
identiﬁcation of Candida species, we used CHROMagar® Candida
(MAST DIAGNOSTICA/BD, rice agar, Auxacolor 2 (Sanoﬁ Diagnostics
Pasteur), ID 32 C and the VITEK® 2 YST card (bioMe´rieux).
In vitro antifungal activities of amphotericin B, ﬂucytosine, ﬂuconazole,
itraconazole, voriconazole, posaconazole, caspofungin and anidulafungin
were investigated by Etest® (AB Biodisk).
Results: Of the examined blood culture samples (1–13 samples/patient,
mean 3 samples/patient), 16.7% were positive for bacteria and/or fungi.
The most prevalent isolates were aerobic bacteria, found in 91% of
the positive cultures. Candida spp. were detected in 172 patients. They
constituted the second most common isolates, with a mean isolation
frequency of 6.3%. Anaerobic bacteria were found in 2.7% of the positive
cultures.
Most specimens positive for Candida spp. were received from intensive
care units, from patients with cancer, organ transplants, burns and
surgical infections. The most prevalent species was C. albicans (55.8%
of isolates). From each of the 172 patients positive for Candida
spp., one representative isolate was referred to further investigation.
All tested isolates were sensitive to amphotericin B, voriconazole
and posaconazole. Only one isolate of C. albicans and 6 isolates of
C. parapsilosis displayed decreased susceptibilities to both caspofungin
and anidulafungin (MIC> 1mg/mL).
Conclusion: The new antifungals posaconazole and anidulafungin have
excellent in vitro activities against invasive isolates of Candida spp.
P2180 Resistance to antifungal drugs of yeasts isolated from
genital specimens
M. Botnarciuc, V. Braga, L. Voineagu, R. Stoicescu, V. Badea, A. Barbu
(Constanta, RO)
Objectives: Identiﬁcation of yeasts in genital specimens and testing their
sensitivity to various antifungal drugs, in order to appreciate the rate of
resistance to the most used of them. The study was realised during one
year, September 2006-September 2007. All the specimens were collected
from women with clinical symptomatology of infection present
Methods: We used CANDIFAST kit (International Microbio-France),
which allows the identiﬁcation of the main human pathogenic yeasts as
well as testing their sensitivity to antifungal agents: polyene Nystatine
and azoles Flucytosine, Econazole, Fluconazole, Miconazole. Due to the
fact that the strains were isolated from vaginal samples, we tested them
also to Ketoconazole, by disk diffusion method
Results: We analysed 160 specimens of vaginal secretions that had
positive cultures on Sabouraud gelose. From 160 isolated strains,
142 were identiﬁed as Candida albicans, 12 strains identiﬁed as
Saccharomyces sp., 4 strains as Candida glabrata and 2 strains as
Candida krusei. Candida glabrata strains were resistant to Flucy-
tosine, Miconazole, Fluconazole and Clotrimazole. Candida krusei
were resistant to Nystatine, Flucytosine, Miconazole Fluconazole and
Clotrimazole. Saccharomyces sp. did not presented resistance to the
tested drugs. For Candida albicans strains the most important resistant
rates were obtained for Ketoconazole (in 122 strains – 85.9%) and
the lowest rate of resistance were for Nystatine and Econazole (in 12
strains − 8.6%).
Conclusions: Candida albicans remains the most frequent fungus
isolated from genital infections. The sensitivity to antifungal drugs
was good, in vitro, for Nystatine, Econazole, Clotrimazole Miconazole,
Fluconazole and Flucytosine. We found important resistance in vitro to
Ketoconazole. The difference between these two groups was signiﬁcant.
P2181 Rapid determination of the antifungal susceptibility of
Candida isolates using direct samples of blood from patients
with fungaemia: the role of the Etest
J. Guinea, S. Recio, T. Pela´ez, A. Zorzano, A. Eworo,
M. Rodrı´guez-Cre´ixems, C. Sa´nchez-Carrillo, E. Bouza (Madrid, ES)
Objectives: Prompt and adequate antifungal treatment is crucial for
good outcome in patients (pts) with fungaemia. Although antifungal
susceptibility testing can help, standard procedures are laborious. Even
with commercial systems such as Sensititre YeastOne® (SYO), results
may take 48–72 h after diagnosis. We prospectively performed antifungal
susceptibility testing by the E-Test (ET) on direct blood samples from
65 pts with fungaemia (88 strains) and compared it with SYO.
Methods: We included 86 different blood culture sets (BACTEC):
C. parapsilosis (37), C. albicans (27), C. tropicalis (9), C. glabrata (8),
C. guilliermondii (2), C. glabrata + C. albicans (2), and T. mucoides
(1). We inoculated 10 drops from 1 bottle of a hemoculture set from
each pt onto RPMI 1640 agar and placed ET strips of amphotericin B
(AMB), ﬂuconazole (FLU), voriconazole (VRC), posaconazole (POS),
and caspofungin (CAS) on the agar. The MIC was read after 24 h of
incubation. Breakpoints for FLU, VRC and POS (similar breakpoints
than for VRC) followed CLSI recommendations. Strains with MICs
>>1mg/mL for CAS and AMB were considered resistant. Errors were
very major (VM) when a strain was susceptible by ET and resistant by
SYO, and major (M) when a strain was resistant by ET but susceptible
by SYO.
Results: The % of strains classiﬁed as correct/VM/M for each
agent was POS (100/0/0), FLU (98.8/0/1.2), VRC (98.8/1.2/0), AMB
(58.1/38.4/3.5), and CAS (91.9/8.1/0). VM errors detected for CAS
were only seen in C. parapsilosis. The 73 strains from purportedly
FLU-susceptible species (C. parapsilosis, C. albicans, and C. tropicalis)
were correctly classiﬁed by ET for the 3 azoles. Of the remaining
13 strains from species with low susceptibility to azoles (C. glabrata,
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C. guilliermondii, and T. mucoides), 100% were correctly classiﬁed for
POS and only 7.7% were M for FLU (T. mucoides) and VM for VRC
(C. glabrata). The % of strains with MIC discrepancies of no more than
±2-fold dilutions between both methods were 76.7, 68.6, 70.9, 54.6, and
81.2 for POS, FLU, VRC, AMB, and CAS, respectively.
Conclusions: Overall, ET correctly classiﬁed >97% of strains for azoles,
and 85% of species with low susceptibility to FLU. ET is rapid, easy, and
can determine the antifungal susceptibility of azoles against isolates from
pts with fungaemia. J. Guinea is contracted by the Fondo de Investigacio´n
Sanitaria (contract number CM05/00171). This study was ﬁnanced by
grants from CIBER RES CD06/06/0058.
P2182 Comparison of Candida susceptibility testing between CLSI
broth micro-dilution and Vitek AST-YS01 card
B.W.F. de Koning, M.W.H. Wulf, B. Janssen, C.M. Verduin
(Veldhoven, NL)
Objective: To compare yeast susceptibility testing between CLSI broth
micro dilution method with the VITEK2 using the AST-YS01card
(bioMerieux, Baumes-Les Grotte, France).
Materials and Methods: 82 clinical isolates were tested, among which
21 Candida albicans, 23 C. glabrata, and Candida sp. other than
albicans or glabrata. CLSI Broth micro dilution method (M27-A) was
performed in the following way. Micro dilution plates containing 100
ml of the twofold serial dilutions of the antifungal drugs in standard
RPMI 1640 medium were inoculated with 100 ml of yeast suspension
containing between 1.0×103 and 5×103 CFU/ml. Plates were incubated
at 35ºC, and MICs were determined after 24 and 48 h. Reference
MICs corresponded to the lowest drug dilution that showed prominent
growth inhibition (50% or more). The VITEK2 ST-YS01 card was used
according to the manufacturers guidelines. The AST-YS01 card contains
the antifungal agents Amphotericin B, Fluconazole, Flucytosine and
Voriconazole in four dilutions Each card also contains an growth control.
The total incubation time is maximal 36 hours.
Results: A total of 82 clinical isolates of 12 different Candida species
were tested. For Candida albicans all isolates had similar values for
all antifungals. For other Candida species, all isolates had identical
MIC’s for amphothericin B. 11 (13.4%) isolates had different MIC
levels for ﬂuconazol and in six (7.3%) instances this lead to a different
interpretation of susceptibility. Five of these 11 isolates were Candida
glabrata but only in one case this resulted in a major interpretation
error (R> S). For ﬂucytosine 2 of 82 (2.4%) isolates had discrepant
values (2.4%) leading to different interpretation For voriconazole for 12
(14.6%) isolates different values were found but only in one instance
this lead to a different interpretation.
Conclusions: The VITEK2 is a reliable method for determining the
susceptibility of C. albicans. For other yeast species the results for
amphothericin B, ﬂucytosine and voriconazole appear to be reliable but
for ﬂuconazol and C. glabrata have to be interpreted with caution.
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P2183 Preliminary evaluation of a commercially available rapid
immunochromatographic method for the detection of IgM
antibody response to chikungunya and dengue viruses
G. Rossini, F. Cavrini, L. Luconi, A. Pierro, N. Spataro, R. Angelini,
F. Benini, V. Sambri (Bologna, Ravenna, IT)
Objectives: Chikungunya virus (CHIKV) belongs to the family of
arthropod-borne viruses and it’s transmitted to humans by Aedes
mosquitoes in tropical and sub-tropical areas. In August 2007, the ﬁrst
epidemic outbreak within the territory of the EU has started in the
province of Ravenna in North-Eastern Italy. Up to today more than
200 laboratory conﬁrmed cases have been reported and more than
1000 patients underwent laboratory investigation. The large diffusion
of Aedes albopictus (the tiger mosquito) in Northern and Central Italy
was the condition that allowed the epidemic diffusion of CHIKV. The
laboratory diagnosis is performed by detecting the viral RNA in blood by
RT-PCR within the ﬁrst 6 days after onset and by serological evaluation
immediately after this period.
Methods: The presence of an IgM speciﬁc response to CHIKV and
Dengue was evaluated by two different methods: immunoﬂuorescence
(IIFT) test (Euroimmun) and a newly available immunochromatographic
(IC) method (CTK OnSite Duo) that is designed to distinguish between
IgM response to CHIKV and Dengue. The samples used were obtained,
during the recent outbreak, from 67 different patients with clinical and
epidemiological evidence of suspected acute CHIKV infection (high
fever and multiple arthralgia) living in the area of Ravenna.
Results: 45 samples were detected negative for IgM against CHIKV and
Dengue by using IIFT and 50 specimens were scored as negative by IC.
No IgM reaction against Dengue were detected. The use of IIFT allowed
to identify as positive for CHIKV 22 samples but only 17 were conﬁrmed
with the IC method. The relative sensitivity of IC (versus IIFT chosen
as the reference method) is 90%. The relative speciﬁcity of IC is 100%.
Conclusion: The use of a quick and simple test, like the IC evaluated in
this study, could be proposed as a “ﬁeld” method to rapidly discriminate
the true CHIKV infections during epidemic outbreaks. The availability
of a rapid response is useful for the appropriate targeting of the
environmental interventions devoted to the control of vector mosquitoes.
A correct environmental intervention has been demonstrated as the most
efﬁcacious methods to stop the spread of CHIKV during the recent
outbreak in Italy. The use of “ﬁeld” tests is not sufﬁcient to achieve
a correct diagnosis of CHIKV infection and the use of more sensitive
laboratory tests such as IIFT is mandatory to conﬁrm the clinical suspect.
P2184 Early diagnosis of dengue infection using blood and
non-blood specimens: a pilot study
G. Suwanpimolkul, C. Pinyochotiwong, C. Kittitrakul, S. Krajiw,
K. Arunyingmongkol, C. Pancharoen, U. Thisyakorn, W. Kulwichit
(Bangkok, TH)
Objectives: Dengue infection is the most wide-spread mosquito-borne
disease worldwide. Serologic diagnosis is often made retrospectively
upon clinical recovery. Our group has demonstrated the value of late
febrile and early postfebrile urine and oral specimens in dengue virologic
and serologic diagnoses. In this study, we sought to determine clinical
utility of reverse transcription-polymerase chain reaction (RT-PCR) using
early febrile blood and non-blood specimens for virologic diagnosis of
dengue infection.
Methods: Adults with acute fever of no more than 3 days and without
obvious organ-speciﬁc symptoms during June 2006 to October 2007
entered the study. Saliva, buccal brush, urine, plasma, and peripheral
blood mononuclear cells (PBMC) were collected and tested by dengue-
speciﬁc RT-nested PCR with primers targeting conserved regions of
the 3′ untranslated region of the virus. Where available, 3 consecutive
specimens from febrile days 3, 4, and 5 were tested. Diagnosis of
dengue infection was based on positive standard ELISA assay on paired
serum/plasma specimens. Those with negative dengue ELISA tests
served as a control group.
Specimens Sensitivity Speciﬁcity PPV NPV
Urine 6/12 cases 12/12 cases 6/6 cases 12/18 cases
(50%) (100%) (100%) (66.7%)
Saliva 4/12 cases 11/12 cases 4/5 cases 11/19 cases
(33.3%) (91.7%) (80%) (57.9%)
Buccal brush 4/12 cases 11/12 cases 4/5 cases 11/19 cases
(33.3%) (91.7%) (80%) (57.9%)
Plasma 12/12 cases 11/12 cases 12/13 cases 11/11 cases
(100%) (91.7%) (92.3%) (100%)
PBMC 12/12 cases 11/12 cases 12/13 cases 11/11 cases
(100%) (91.7%) (92.3%) (100%)
Saliva + Buccal brush 6/12 cases 11/12 cases 6/7 cases 11/17 cases
(50%) (91.7%) (85.7%) (64.7%)
All non-blood specimens 9/12 cases 11/12 cases 9/10 cases 11/14 cases
(75%) (91.7%) (90%) (91.7%)
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Results: Of over 30 enrolled patients, 24 were eligible for analysis.
Secondary dengue infection was diagnosed in 12 patients, leaving the
other 12 as negative controls. The virus was detected in urine in half
of the patients. The results were the same using both saliva and the
buccal brush. With all non-blood specimens combined, three-fourths of
the patients were detected. Plasma and PBMC both provided perfect
yields (Table).
Conclusion: This is the ﬁrst study demonstrating utility of both blood
and non-blood specimens for early dengue virologic diagnosis. Even
though this is only a pilot study, the results are promising. We are further
performing the study in more patients. A similar study in paediatric
patients is also under way.
P2185 Serum TNF-alpha and interleukin-4 (IL-4) levels in patients
with Crimean-Congo haemorrhagic fever
S. Kinikli, N. Yilmaz, S. Cesur, C. Bulut, A. Aydemir, H. Irmak,
A. Pekcan Demiroz, G. Kinikli (Ankara, TR)
Objectives: Crimean-Congo haemorrhagic fever (CCHF) is a zoonotic
infection mainly transmitted by ticks. In Turkey, spordic and endemic
CCHF cases have been reported.
The aim of this study is to compare serum TNF-alpha and interleukin-4
(IL-4) levels in patients diagnosed with CCHF with those in healthy
controls.
Methods: Forty-two adult patients diagnosed with CCHF based upon
clinical and laboratory ﬁndings and 40 healthy adult volunteeers
were included in the study. The diagnosis of CCHF was made with
IgM positivity or 4 fold increase in IgG titration and/or Real-time
polymerase chain reaction (RT-PCR) positivity. In the sera of patient and
control groups, TNF-alpha and IL-4 levels were measured according to
recommendations of the manufacturer.
Serum TNF-alpha and IL-4 levels in patient and control groups were
compared statistically by using Student’s t test.
Results: Serum TNF-alpha and IL-4 levels were found to be signiﬁcantly
higher in patients with CCHF than those found in healthy controls (p:000,
p< 0.05 signiﬁcant). Results are shown in the Table.
Table. Serum TNF-a and IL-4 levels in patients with CCHF and healthy subjects
Number TNF-a (mg/ml) IL-4 (mg/ml)
Median Range (min–max) Median Range (min–max)
CCHF 42 15.01 6.98–70.86 1.07 0−5.6
Control 40 7.69 4.06–11.87 0.00 0.00−7.14
Conclusion: Tha fact that serum TNF-alpha, a proinﬂammatory
cytokine, and IL-4, an anti-inﬂammatory cytokine, levels were found
to be signiﬁcantly higher in patients with CCHF than those in control
group suggests that cellular immune response (Th1 and Th2) may play an
important role in this disease. In order to determine the role of cytokines
in the pathogenesis of CCHF, further studies with larger samples are
required.
P2186 A survey of Crimean-Congo haemorrhagic fever virus in
tick populations and wild-life animals in Turkey
A. Gargili, K. Midilli, Z. Vatansever, S. Ergin, A. Deniz, N. Selek
Aysul, G. Yilmaz, K. Altas (Istanbul, Kars, Ankara, Aydin, TR)
Objectives: CCHF epidemic which was recognised in 2002 is still
expanding regarding both of the clinical cases and geographical
distribution in Turkey. The role of the vector ticks and wild-life animals
was not studied nationwide. In this study, we aimed to clarify these
aspects of the CCHF in Turkey.
Methods: A total of 3236 tick samples from the domestic and wild
animals, and ground were collected from epidemic and non-epidemic
centres from all of geographic regions of Turkey. The study was
conducted between April through October 2006 and 2007. Blood samples
were collected from 89 hunted wild boars and hares from exclusively
epidemic regions throughout the year. Collected ticks were pooled as 5–
20 samples according to their species and collection sites and screened
for the presence of CCHF virus. Viral RNA was extracted from ticks and
animal blood samples using commercial blood or/ tissue RNA extraction
kits. Following reverse transcription, a part of CCHF virus S segment
were ampliﬁed with speciﬁc primer sets by nested PCR ampliﬁcation.
PCR products of the positive samples were sequenced using ABI 310.
Results: Three of wild-boar blood samples, 2 of wild hare blood samples,
13 pools of ticks collected from hunted animals and 6 pools of ticks
collected from domestic animals were found as positive for CCHF
virus. Positive pools were encountered in both endemic and non-endemic
sampling sites. Viral RNA was detected in Hyalomma marginatum,
Rhipicephalus bursa, Boophilus annulatus and Dermacentor marginatus
pools. In this study we obtained some interesting results; One of the wild
boars hunted in early spring harboured CCHF virus, and we found viral
RNA in an unfed D. marginatus sample which has not been previously
shown to be involved in CCHF epidemiology in Turkey. Sequenced
isolates were similar to those encountered previously, namely Europe II
clade.
Conclusions: Based on the results of this study, CCHF virus is widely
distributed in Turkey, including epidemic and non-epidemic centres.
Although the role of migratory birds can not be excluded; wild-life
animals and their ticks may play a major role for the propagation and
spreading of the virus between domestic and wild animals and human
populations. The positiviy of wild boars in early spring, and a tick
species, D. marginatus, which is active throughout the year suggests
that CCHF virus may maintained in wild-life also during the winter
season in which the major vector ticks is non-active.
P2187 2007 outbreak of viral meningitis in Romania: cases
managed in a national institute of infectious diseases
C. Popescu, V. Arama, R. Bacruban, A. Streinu-Cercel, A. Hristea,
A. Abagiu, D. Antonica, N. Irimescu, M. Iosipenco, I. Badicut
(Bucharest, RO)
In 1996 in south-eastern part of Romania a meningitis epidemic due to
West Nile virus affected 863 persons. Therefore, in June 2007 when a
new meningitis epidemic occurred we decided to perform a prospective
analysis of these cases. We made a descriptive study about the cases
admitted in our Institute.
Objective: to analyse the cases of meningitis in order to identify a
possible aetiological agent.
Methods: we excluded the cases of bacterial meningitis (tuberculosis
included). We analysed 132 cases of meningitis and the case
deﬁnition was: fever, meningian syndrome and CSF with more than
7 leukocytes/mm3.
Results: Mean age was 23.8 years (between 14 and 72 years),
the predominance of male, equivalent distribution regarding rural
versus urban provenience and water distribution were described. Most
of cases were admitted in August (40.15%) and in July (28.7%).
Clinical description: moderate cases, without encephalitis syndrome,
with moderate meningian syndrome in 46% of cases. 56 patients
associated sinusitis, 65.9% had moderate increased level of ﬁbrinogen
and 15.9% had more than 12000 leucocytes /mmc. CSF examination
showed in 95.3% of cases – less than 500 cells/mm3. CSF protein was
increased but the value was below 2.5g/l for all patients (below 1g/l for
81.8% of cases). For 23 patients we isolated ECHO 4 virus from CSF.
All the patients received pathogenic and symptomatic medication and
the outcome was favourable in all the cases. This epidemic was different
than that due to West Nile, which associated encephalitis, affected old
people and had unfavourable outcome in 20% of cases.
Conclusions: 2007 viral meningitis epidemic affected young people,
male, and outcome were favourable in all the cases.
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P2188 Haemorrhagic fever with renal syndrome and leptospirosis
in Champagne-Ardenne: comparison of clinical, biological
and epidemiological pictures
C. Strady, A. Servettaz, N. Saude, R. Jaussaud, C. Penalba (Reims,
Charleville-Mezie`res, FR)
Objectives: The haemorrhagic fever with renal syndrome (HFRS)
caused by Puumala virus and the leptospirosis are two zoonoses found
in Champagne-Ardenne. Their clinical, biological and epidemiological
proﬁles are relatively similar. The aim of this study is to compare these
proﬁles for an effective therapeutic direction.
Methods: A retrospective study led from 1995 to 2005 included 44
HFRS cases and 45 non-icteric leptospirosis hospitalised during the study
period. HFRS diagnosis rests on the serology – presence of IgM or
increase of IgG rate (44/44); and leptospirosis diagnosis rests on the
Martin Petit serodiagnosis (38/45).
Results: The number of cases per year, the monthly distribution, the
average age and the sex ratio do not show any signiﬁcant differences
between the two pathologies. Leptospirosis mainly concerns occupational
hazards – farmers – and leisure activities like swimming; and HFRS
concerns foresters, walks in forests and cleaning of attics. Lumbago
(p< 0.001), abdominal pains (p = 0.007), visual trouble (p = 0.003), rise
of blood pressure (p< 0.001) and pharyngites (p = 0.01) are more
frequently found in HFRS. ASAT (p = 0.006), CPK (p< 0.0001) and CRP
(p< 0.0001) are higher in leptospirosis, whereas creatinine (p = 0.009) is
higher in HFRS.
Conclusions: Only visual trouble is really speciﬁc to the HFRS
diagnosis, even though differences are observed between the two
pathologies in the biological and clinical proﬁles.
Thus, the quick screening test of IgM by immuno-chromatography
regarding HFRS is useful to the differential diagnosis allowing then
an effective therapeutic direction.
P2189 Preliminary study on possible risk co-factors in the
transmission route of HHV-8 with promoter blood
sucking arthropods. Survey through questionnaires in two
sub-Saharan African countries: Cameroon and Senegal
R. Romano, F. Fratini, G. Russo, F. Tabacchi, G.M. Paganotti,
M. Coluzzi (Rome, IT)
Objectives: Human herpesvirus-8 (HHV-8) infection in Africa occurs
mostly in childhood and through interfamilial contacts. This oncogenic
virus maybe considered as an emergent pathogen due to its spreading in
connection with the AIDS pandemic. Assuming as working hypothesis
that blood sucking promoter arthropods are involved in the transmission
of HHV-8, we observed the following possible risk-cofactors related to
the virus infection route: i) the saliva of seropositive mothers used on
children’s skin to relieve itching, ii) the use of traditional medication
based on crushed and often premasticated herbs, and so probably
contaminated with saliva, iii) the local inﬂammatory reaction related
to child’s hypersensitivity response to the bite and iv) fever as systemic
symptom.
Methods: We carried out survey with questionnaires in students (age
5–13) interviewed at schools in Cameroon and in Senegal.
Results: In Cameroon 200 questionnaires revealed the following
frequencies: use of traditional methods (113/200) 56.5%; saliva (22/200)
11% and herbs (91/200) 45.5%, fever after bite (83/194) 42.8%, skin
irritation and swelling, respectively (96/200) 48% and (135/200) 67.5%,
lasting of skin boring: <3 days (136/185) 73.5%, 3−7 days (37/185) 20%
and >7 days (12/185) 6.5%.The relation between traditional methods
and fever was not statistically signiﬁcant (p< 0.055) but the variable
fever showed statistically signiﬁcant direct relation with use of herbs
(p< 0.001) and fever more frequent if the lasting of skin boring
time is >3 days (p< 0.001). In Senegal 104 questionnaires revealed
the following frequencies: traditional methods (23/89) 25.8%; saliva
(15/89) 16.9%, herbs (8/86) 9.3%, fever (25/99) 25.3%, irritation (6/98)
6.1% and swelling (85/98) 86.7%, lasting of skin boring: <3 days
(86/90) 95.6%, 3−7 days (1/90) 1.1% and >7 days (3/90) 3.3%. As in
Cameroon the variable fever showed statistically signiﬁcant relation with
herbs (p< 0.007) and with skin boring lasting for >3 days (p< 0.01).
Furthermore there was a statistically signiﬁcant relation with skin
reaction (p< 0.013).
Conclusion: Data show that swelling, fever when the skin boring is
lasting >3 days and herbal-based medication, are possible risk-cofactors
in the transmission route of HHV-8 with promoter arthropods. Further
surveys will be directed to analyse the kind of blood sucking arthropods
involved in the transmission and the effect of salivary gland proteins and
of herbs on the reactivation of the HHV-8.
P2190 A natural focus of hantavirus infection in the Sˇumava
region (Czech Republic)
M. Pejcoch, E. Pauchova, B. Kriz (Prague, Brno, CZ)
Objectives: To ﬁnd whether the human cases in the Prachatice district
(CR) are of hantavirus origin and if so, to identify the causative
genospecies and map its circulation in the natural focus likely to be
the reservoir of infection.
Methods: Sera from patients with suspected HRFS and occupationally
exposed individuals were screened for anti-hantavirus antibodies by
commercial ELISA kits from Progen Biotechnik. Terrestrial rodents
were captured in the suspected areas. The speciﬁc PUU antigen was
detected from homogenised lungs of these animals using the commercial
kits Hantagnost from the Chumakov Institute of Poliomyelitis and Viral
Encephalitides of the Russian Academy of Medical Sciences, Moscow.
Results: Hantavirus infections are emerging diseases as the causative
agent was only recognised in 1978. More than 20 hantavirus genospecies
have been identiﬁed to date. In Central Europe, three hantavirus
genospecies, i.e. Dobrava-Belgrade (DOB), Puumala (PUU) and Tula
(TUL), are known to circulate in natural foci. Their respective hosts
are yellow-necked mouse (Apodemus ﬂavicollis), bank vole (Myodes
glareolus) and common vole (Microtus arvalis). In Eurasia, the major
hantavirus disease is haemorrhagic fever with renal syndrome (HFRS).
In Central Europe, the most serious infection is caused by DOB. TUL
is generally non-pathogenic for humans. In the Czech Republic (CR),
hantavirus infections have been reported sporadically. In the Czech
Republic, the seroprevalence of hantaviroses in adults is about 0.8%.
A local outbreak of hantavirus infection was observed in 2004 in the
Sˇumava region, with some cases still persisting.
Eight patients admitted to the Prachatice district hospital with suspected
HFRS and interstitial nephritis as the major symptom had primarily
IgM antibodies against PUU. Two of the screened individuals showed
seropositivity for IgG antibodies. The PUU antigen was detected from
the lungs of a bank vole captured in the area where the forest workers
had been working.
Conclusion:We detected a PUU natural focus in the Sˇumava region with
hantavirus infection cases in humans. PUU was detected in its speciﬁc
host Myodes glareolus from this biotope. The PUU focus is adjacent
to another one situated on the other side of the border and reported
previously by German authors. These ﬁndings need further study.
Supported by IGA MZCR-NR9420−3/07.
P2191 Passive immunisation protects cynomolgus macaques
against Puumala hantavirus challenge
J. Klingstro¨m, M. Stoltz, J. Hardestam, C. Ahlm, A˚. Lundkvist
(Stockholm, Umea˚, SE)
Objectives: Hantaviruses cause two severe and often fatal human
diseases: haemorrhagic fever with renal syndrome (HFRS) and
hantavirus pulmonary syndrome (HPS). Presently, there is no effective
prevention available for HFRS or HPS. Here, we studied the effect of
passive immunisation on the course of infection in cynomolgus macaques
challenged with wild-type Puumala hantavirus (PUUV-wt).
Methods: A pool of serum, drawn from previously PUUV-wt-infected
monkeys, was used for immunisation, and a pool of serum from the
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same monkeys that was obtained before infection was used as a control.
Immunisations were administered three days before and 15 days after
challenge with PUUV-wt. After challenge, monkeys were sampled once
a week and analysed for markers of PUUV-infection.
Results: All three monkeys treated with non-immune serum became
positive for PUUV-RNA in plasma and showed PUUV nucleocapsid-
speciﬁc IgM-responses after challenge. In contrast, no PUUV-RNA or
anti-PUUV speciﬁc IgM-response was detected in the three passively
immunised monkeys. As seen in PUUV-infected humans, the control
monkeys showed a marked decrease in the amount of platelets and
increased levels of creatinine, IL-6, IL-10, and TNF after inoculation. In
contrast, no marked changes in the amount of platelets were observed
in the immunised monkeys and they did not show elevated levels of
creatinine, IL-6, IL-10, or TNF after virus challenge.
Conclusion: The results show that passive immunisation in monkeys,
using serum from previously hantavirus-infected individuals, can induce
sterile protection and protect against pathogenesis. Convalescent-phase
antibodies may represent a potential therapy that can induce immediate
protection against HFRS and HPS.
P2192 Acute Chagas’ disease in a European stem cell transplant
recipient
P. Martin-Rico, I. Perez de Pedro, M.A. Cuesta-Casas, Y. Faez-Herrera,
M.J. Pascual-Gascon, J. Porras-Ballesteros, P. Blanch-Iribarren,
M.C. Villarta-Camacho, M.I. Mun˜oz Perez, A.I. Heiniger-Mazo,
J.D. Colmenero-Castillo (Ma´laga, ES)
Objective: We report a recent case of acute transfusion-acquired Chagas
disease in a bone-marrow transplant recipient in Spain.
Chagas disease is a major public health problem in endemic areas
of South America. Untreated immigrants from endemic areas are a
potential source of infection and spreading to nonendemic areas mainly
via infected blood products used in transfusions.
Acute transfusional cases in immunosuppressed patients can be fatal
unless early recognised and treated.
Methodology: Case report. A 33-year-old male patient received an
allogeneic stem-cell transplantation (11/05/07) from a related donor
because of bone-marrow aplasia diagnosed 2 months earlier. He received
several blood transfusions (both red cells and platelets) before and
after the procedure. On the 9th day after transplantation spiky fever
developed, followed by blurred vision and palpebral edema, which
quickly progressed to facial edema and erythema with palpebral
purplish discolouration. All microbiological and radiological screening
was negative. Fever persisted despite extensive empirical antibiotic and
antifungal treatment. Erythema and edema became generalised and a skin
biopsy was performed showing Trypanosoma cruzi amastigotes. Direct
microscopy (×1000 magniﬁcation) of thick fresh blood showed motile
trypomastigotes, also visible in Giemsa stained thin blood ﬁlm (Fig. 1).
Figure 1.
PCR was positive for Trypanosoma cruzi in blood, bone-marrow, skin
and urine. Chagas serology was negative. Neither the patient nor the
donor had ever visited endemic Chagas areas.
Benznidazole, 300mg qd, was started. Fever resolved in 7 days and
visible parasitaemia disappeared in 10 days. PCR became negative in
one month. Edema did gradually regressed. Treatment was completed
with no major toxicity.
Tranfusional Chagas disease was then searched. Two months before
stem cell transplantation, the patient had received platelets from an
asymptomatic Bolivian donor, with positive Chagas serology.
Conclusions:
1. In the era of globalisation Chagas Disease has to be considered in the
diagnosis of persistent fever in severely immunosuppressed patients.
2. Fever and facial edema and erythema were the most striking
symptoms. Diagnosis is easy when the disease is focused and searched
3. Nonendemic areas must accelerate full implementation of a manda-
tory screening of blood donors from endemic areas, including organ
donors and recipients. Immigrant pregnant women should also be
screened to further prevent vertical transmission
P2193 Update on Scedosporium/Pseudallescheria infections
R. Horre´, M. Lackner, S. de Hoog, J.P. Bouchara on behalf of the
ECMM-ISHAM Working Group on Pseudallescheria/Scedosporium
Infections
Objective: Pseudallescheria boydii and Scedosporium proliﬁcans are
truly emerging fungal pathogens. They cause local and/or disseminated
infections in human and animals. In 2002, a “Working Group on
Pseudallescheria/Scedosporium Infections” was established by the
European Confederation Of Medical Mycology (ECMM) and accepted
as worldwide working group by the International Society For Human
And Animal Mycology (ISHAM) in 2006. The aim of this working
group is to collect strains and data, to improve our knowledge in the
pathogenic mechanisms of these fungi, and to develop new diagnostic
methods and treatment options. A summary of the latest results of the
members of this working group will be presented.
Methods: Studies have been performed about different human and
fungal perspectives, such as: (1) clinical signiﬁcance studies, (2)
taxonomical research, (3) selective detection using different techniques
(e.g. serology, PCR, culture, histopathology), (4) resistance studies, (5)
treatment investigations, (6) virulence factors, (7) epidemiology, and (8)
ecology.
Results: For better understanding of these fungi as human and animal
pathogens results have been obtained with
• a recently developed selective culture media, which was used for the
isolation from environmental, as well as, from clinical specimen
• taxonomic evaluation and reclassiﬁcation
• resistance studies
• occurrence in artiﬁcal and native environment
• analyses of published case reports
Conclusion: Since the ﬁrst meeting of the ECMM (-ISHAM) Working
Group on Pseudallescheria/Scedosporium Infections (April 2004), lots of
interesting results have been achieved and established by our worldwide
network of members.
We welcome interested physicians to support our work by sending
strains, participating in studies, or sending data. Further information
is available on our website: http://www.scedosporium-ecmm.com.
P2194 Parasitaemia with Plasmodium falciparum in a patient after
cardiac surgery and blood transfusion in a non-endemic
country
E. Garcı´a-Va´zquez, A. Moreno, F. Ferrer-Marı´n, E. Sanz, J.A. Herrero,
J. Go´mez-Go´mez, J. Rivera (Murcia, ES)
Objectives: Physicians should be aware of the possibility of post-
transfusional malaria and blood smear should be included in the clinical
work-up of patients with fever of unclear origin.
Patients and Methods: We describe the case of an Argentinean patient
who developed fever 15 days after coronary artery bypass surgery
(CABS).
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Results: the patient required plasma, platelets and red cells transfusion
(2, 10 and 2 units respectively) during surgery; 15 days later he
complained of fever; physical examination revealed a mildly-ill-
appearing man with a temperature of 39ºC but otherwise not remarkable
ﬁndings. Laboratory data revealed mild pancytopenia. Blood and urine
cultures were negative, hepatitis B, C and HIV viral load were negative
as were serology for these viruses. A blood smear revealed Plasmodium
falciparum gametocytes. The rapid malaria diagnostic test (NOW® ITC
Malaria Test; Binax, INC., Portland, ME) was strongly positive detecting
HRPII antigen (P. falciparum speciﬁc) and mild-positive for the common
Plasmodium sp. antigen. Serology (IFAT) and PCR were also positive
for P. falciparum. Treatment with quinine sulphate and doxycycline
was begun; 2 months later the patient was asymptomatic and control
blood smear were negative. Fourteen donors were associated with the
transfusions but none had epidemiological background of travel to
P. falciparum malaria areas; one donor refused to be tested; Plasmodium
sp. serology was negative in 13 of them; PCR and chromatography were
negative in 12 donors (these test could not be done in one of the donors).
An investigation of all the patients who were operated at the same
surgery-room and the same day was also negative for epidemiological
malaria contact. Another patient received red-cells from the donor who
refused to be tested but no other case of post-transfusion malaria was
reported in the region.
Conclusions: The aetiology of malaria infection in the reported case
remains unknown but might be linked to blood transfusion as there
is no other epidemiological background although malaria due to the
establishment of Plasmodium sp. in an indigenous or aircraft-travelling
mosquito remains a possibility. Increases in international exchanges and
migration from endemic areas enhance the possibility that blood donors
might have been in contact with malaria parasites. Accurate histories of
potential exposure to blood transfusions are necessary in the work-up of
patients with fever.
Paediatric infections
P2195 Isolated renal hydatid cyst in a child: case report and
review on renal hydatidosis
M. Metanat, B. Shariﬁ-Mood, B. Pejman, R. Ahmadi (Tehran, IR)
Introduction: Hydatid disease is endemic in many parts of the world.
Urinary tract involvement develops in only 2−4% of all cases, and
isolated renal cysts are extremely rare. Renal hydatidosis in children is
rare. There are no speciﬁc signs or symptoms that will reliably conﬁrm
the diagnosis of renal echinococcosis. A serological markers are not
sensitive for the diagnosis of a hydatic cyst, it may be confused with a
cyst in the organ involved. We wanted to emphasize the importance of
keeping in mind the possibility of hydatid disease in cystic renal lesions,
particularly in endemic regions.
Case report: A 13-year-old female was admitted to our clinic with
a 3-month history of moderate preumblical pain. During the last 20
days, these symptoms had worsened. There was no history of recurrent
urinary tract infection, calculi, or lower urinary tract symptoms. On
physical examination, we found abdominal tenderness, and systemic
examination was unremarkable. Urinalysis and results of laboratory
studies were within normal range. A detailed history was obtained from
the patient. She had been living in Zahedan city, and her family raised
livestock. She had a history of contact with sheep and cattle. Ultrasound
revealed a cortical cystic mass 9×8cm in size at the left kidney, but
do not including multiple small cysts with internal echo. Computed
tomography conﬁrmed this lesion. It showed a unilocular cystic lesion
without internal septa which originated from the left kidney and bulged
superiorly to the kidney. Liver and other abdominal structures were all
normal. Chest ﬁlms were also normal.
The patient underwent surgical exploration of the left kidney with ﬂank
incision. After ruling out malignancy and the diagnosis of a renal hydatid
cyst, the whole cyst layers were removed. During the postoperative
period, albendazole treatment was started. Pathological examination
conﬁrmed the diagnosis of a renal hydatid cyst.
Conclusions: To conclude, this case emphasizes that hydatidosis should
be considered in the differential diagnosis of any cystic lesion, especially
in regions where it is endemic.
To avoid misdiagnosis, a careful examination of cystic lesions in kidneys
should be carried out in endemic areas for the detection of hydatid cysts.
P2196 Turicella otitidis as a cause of middle ear infection: some
clinical and bacteriological aspects
F. Fendukly, M. Elias (Eskilstuna, Stockholm, SE)
Objectives: Turicella otitidis is a newly described non fermentative
coryneform bacterium isolated almost exclusively from the ear exudates
of cases of middle ear infection. The role played by this bacterium in
the pathogenesis of acute and chronic otitis media is still a controversial
issue.
Method: The clinical manifestations of all the cases of middle ear
infections associated with T. otitidis were obtained by a retrospective
analysis of the patients’ medical charts. Microbiological analysis
including identiﬁcation and antimicrobial susceptibility testing was done
at the Clinical Microbiology Laboratory of the Karolinska University
Hospital, Stockholm, during the period from January 2002 to September
2005.
Results: We recovered T. otitidis in the ear swabs of 13 patients
presenting with otitis media. The patients studied were 7 males and
6 females (mean age 7 years, median age 3 years). Five patients
presented with bilateral otitis media (38%), and a perforated tympanic
membrane was observed in 8 cases (62%). A more protracted course
with frequent relapses and repeated antibiotic courses over a period of
months or years were noticed in 3 patients (23%). Two patients (15%)
suffered complications attributable to their middle ear infections namely
mastoiditis in one patient and facial paralysis in another. In only two
patients (15%) a second pathogen was identiﬁed namely Moraxella
catarrhalis in one patient and Pseudomonas aeruginosa in another.
Identiﬁcation of the organism was primarily carried out by the API
Coryne (bioMe´rieux, Marcy lE´toile, France) and was further conﬁrmed
by the typical Gram-staining reaction and the colonial morphology. All
the isolates were susceptible to penicillin by the Etest. Amoxicillin with
or without clavulanic acid was the most widely used ﬁrst line treatment.
Conclusion: T. otitidis is an easily identiﬁed and well deﬁned
microorganism that is often missed by most microbiology laboratories.
Its clinical role in the pathogenesis of middle ear pathologies is still
unresolved and further studies are required for this purpose.
P2197 Antibiotics for nasopharyngitis are associated with a lower
risk of ofﬁce-based physician visits for acute otitis media
within 14 days for 3- to 6-year-old children
J. Salomon, A. Sommet, C. Bernede Bauduin, C. Toneatti, C. Carbon,
D. Guillemot (Garches, Paris, FR)
Objectives: This study was designed to analyse factors potentially
inﬂuencing children’s return visits to physicians for symptoms of
acute otitis media (AOM) within 14 days after being diagnosed with
nasopharyngitis (NP), and the impact of recent antibiotic use.
Design: A controlled population-based pharmacoepidemiological trial in
3- to 6-year-old children conducted from January to May 2000.
Setting: Three different geographical regions in France.
Participants: Among 2507 eligible children, 2456 could be analysed
and 505 children had 634 ofﬁce-based physician visits (OBPV) for NP
symptoms.
Interventions: The statistical associations between antibiotics prescribed
for NP and an OBPV for AOM within 14 days in a population-based
study were analysed along with risk factors of AOM.
Main outcomes measure Clinical events and antibiotic use.
Results: During the 2 weeks following physician-diagnosed NP,
antibiotic use, especially a b-lactam, signiﬁcantly decreased the risk of
OBPV for AOM in children (OR= 0.2, 95%CI=0.09 to 0.7; P = 0.002).
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Conclusion: Antibiotics prescribed to children for NP seem to protect
during the following 2 weeks against the risk of OBPV for AOM. It
remains to be determined whether a subgroup at high risk of developing
AOM after a viral infection exists and what might be the best strategy
to adopt for NP in a national programme of optimal antibiotic use.
P2198 Evolution of nasopharyngeal bacterial populations during
acute and convalescent phase of otitis media
L. Lindholm, P. Ta¨htinen, M. Keina¨nen, A. Hakanen, P. Huovinen,
A. Ruohola, J. Jalava (Turku, FI)
Objectives. The source of middle ear pathogens is nasopharynx. Normal
microbiota of human nasopharynx is a complex ecosystem which
consists of hundreds of different bacterial species. The role of pathogenic
bacteria in acute otitis media (AOM) is well established, but the role
of normal nasopharyngeal bacteria in the development and recovery
of acute otitis media is still unclear. Further, both qualitative and
quantitative data of the composition of the nasopharyngeal microbiota
in general, is scarce.
The aim of this ongoing study is to follow the evolution of the bacterial
populations of nasopharyngeal microbiota during acute otitis media and
during the recovery process of otitis media.
Methods. The project is linked to a randomised, double-blind placebo-
controlled trial of the antibiotic treatment of acute otitis media. The
participating young children are closely followed for one year on regular
visits. Nasopharyngeal specimens are taken on study days 1, 8, 15,
30, 60, 180, and 365. On day 1, patients with acute upper respiratory
tract infection without AOM will serve as a control group. Both
semi-quantitative culture-based methods in combination with accurate
molecular identiﬁcation as well as DNA-based culture independent
methods are used for analysing nasopharyngeal microbiota.
Results. This far more than 1000 nasopharyngeal specimens have been
collected and analysed of which more than 5500 bacterial strains have
been isolated and identiﬁed. Here we present bacteriological data from
day 1 samples. The number of patients with acute otitis media was 185
and the patients with acute upper respiratory tract infection without AOM
was 103. The composition of bacterial ﬂora in both groups is shown on
ﬁgure 1.
Figure 1. Bacterial ﬂora in nasopharynx of patients with acute otitis
media (AOM) vs. patients with acute upper respiratory tract infection
without AOM.
The most common bacterial pathogens were Streptococcus pneumoniae,
Haemophilus inﬂuenzae and Moraxella catarrhalis. The numbers of
Streptococcus pneumoniae and Moraxella catarrhalis in AOM group
were signiﬁcantly (P< 0.01) higher than in a non-AOM group.
Conclusion. On day 1, the composition as well as the quantity of
bacteriological ﬁndings correlates with the diagnosis. The unique
antibiotic vs. placebo study and quantitative culture provides opportunity
to follow both the qualitative and quantitative changes of microbiota
during convalescent phase of otitis media. After the study drug code is
opened also the long term effects on microbiota can be evaluated.
P2199 Molecular biological study of infectious mechanisms in con-
junctivitis, otitis media, and rhinosinusitis in young children
R. Sugita, G. Sugita, T. Funaki, D. Billal, M. Hotomi, N. Yamanaka
(Urayasu, Tokyo, Wakayama, JP)
Objectives: Acute conjunctivitis together with acute otitis media and
acute rhinosinusitis are common bacterial infectious diseases with a
high incidence during infancy and childhood. The present study was
designed to ﬁnd infectious mechanisms in this disease complex by use
of bacteriological and molecular-biological techniques.
Methods: The subjects of this study were children at ages 60 months or
less who visited our clinic, with nasal discharge and ear symptoms and/or
conjunctivitis. Their nasal discharges (ND), conjunctival lavage ﬂuids
(CLF) and middle ear ﬂuids (MEF) were subjected to bacterial culture.
The antibiotic susceptibilities and PCR-based genotype of isolated
bacteria were examined. When the pairs of bacteria isolated from ND and
MEF or CLF were thought to be identical, the genomic polymorphysm
were further analysed by pulsed-ﬁeld gel electrophoresis (PFGE).
Results: The ages of 170 subjects ranged from 5 to 48 months (mean:
21.3 months). A total 172 S. pneumoniae was isolated from patients
with conjunctivitis and rhinosinusitis and/or otitis media. Seven (7.2%)
isolates from ND and 5 (9.8%) isolates from CLF were gPRSP strains.
A total 294 H. inﬂuenzae was isolated from patients with conjunctivitis
and rhinosinusitis and/or otitis media. Thirty-ﬁve (26.9%) isolates from
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ND, 32 (27.8%) from CLF and 10 (18.2%) from MEF were gBLNAR
strains. All 12 pairs of S. pneumoniae from ND, CLF, and MEF showed
identical clones. Among 31 pairs of S. pneumoniae from ND and CLF,
29 pairs (93.5%) showed identical clones of S. pneumoniae. All 13 pairs
of S. pneumoniae from ND and MEF showed identical clones.
Conclusion: In the present study, it is noteworthy that BLNAR strains,
in which PBP3 mutation is responsible for development of resistance
(MIC of ampicillin 4mg/ml), accounted for 27.8% of all H. inﬂuenzae
strains isolated. Based on the fact that PFGE revealed 98.9% of patients
possessed indistinguishable clone of H. inﬂuenzae. Bacterial isolates
from CLF and MEF in younger children were found to be identical with
those from nasal discharge by the molecular-biological analysis. These
results strongly suggest that bacteria in nasopharynx and nasal discharge
will cause otitis media and conjunctivitis by ascending infections via
Eustachian tube to middle ear cavity resulting otitis media and via naso-
lacrimal duct to conjunctiva resulting conjunctivitis.
P2200 Procalcitonin in the diagnosis of acute bacterial otitis media
A. Arguedas, R. Dagan, E. Leibovitz, A. Pavlova-Wolf, E. Wang, J. Song,
R. Echols (San Jose, CR; Beer Sheva, IL; Baltimore, Milford, US)
Objective: PCT has been used for differentiating clinical syndromes that
may be associated with bacterial infection from those that are not. The
accuracy of PCT as a diagnostic test to differentiate between bacterial
and non-bacterial AOM was studied in an investigator-blinded dose
ranging study of faropenem medoxomil in AOM.
Methods: 328 subjects aged 6 months to <7 years were enrolled in a
double tympanocentesis study of AOM. 277 subjects were analysed after
excluding those who had received antibiotics in the preceding 7 days and
those missing a baseline PCT assay. Subjects were evaluated using the
Dagan severity of symptoms score consisting of scores of 5 signs and
symptoms with a possible maximum score of 15. A PCT value of 0.5
ng/ml was used as a cutpoint indicating bacterial infection.
Results: 164 subjects (59%) had single or mixed bacterial pathogens
cultured from middle ear ﬂuid. PCT levels in the different groups (Table).
Organism N Mean Dagan
Severity
score
Mean (±S.D.)
Procalcitonin
n> 0.05
(%)
N>0.5
(%)
No Growth 113 9.50 0.12 (0.43)* 34 4
S. pneumoniae 66 10.12 0.14 (0.35) 41 7
H. inﬂuenzae 53 9.53 0.08 (0.14) 32 4
M. catarrhalis 16 9.13 0.07 (0.13) 25 6
S. pyogenes 11 10.09 0.03 (0.02) 18 0
Mixed infections 18 9.28 0.13 (0.19) 39 6
*Excluding single outlier procalcitonin of 4.39, mean (SD) for no
organism group was 0.09 (0.15).
There was no difference in mean Dagan scores or PCT levels between
bacterial and non-bacterial AOM. The mean PCT concentration was
higher in S. pneumoniae and mixed infections vs. non-bacterial AOM,
but this did not reach statistical signiﬁcance. At cutpoints of 0.05 or
0.5, the likelihood ratio of a positive test indicating a S. pneumoniae
infection (vs. non-bacterial infection) is 1.2 and 3.5, respectively. The
sensitivity and speciﬁcity are 41% and 66% for 0.05 and 7% and 98%
for 0.5 cutpoints. Mean PCT concentration was more than halved at TOC
regardless of bacteriologic or clinical outcome.
Conclusion: PCT was unable to differentiate bacterial from non-bacterial
AOM, even when the most inﬂammatory infection due to S. pneumoniae
is the cause. This may be due to the lesser degree of inﬂammation with
AOM compared with sepsis or pneumonia. PCT level cannot be used to
decide upon initiation of an antibiotic to treat AOM.
P2201 Rapid diagnosis of Streptococcus pneumoniae serotype 1 by
real-time PCR
C. Mun˜oz-Almagro, D. Tarrago, M.T. Rodriguez-Plata, C. Esteva,
M. Fernandez de Sevilla, A.C. Aguilar, J.J. Garcia-Garcia, R. Pallares
(Esplugues-Barcelona, Madrid, Bellvitge-Barcelona, ES)
Streptococcus pneumoniae serotype 1 is an important cause of invasive
pneumococcal disease (IPD) and can produce epidemic outbreaks.
Recently, emergence of IPD (particularly empyema), caused by serotype
1 has been reported in paediatric patients. Serotyping based on the
quellung reaction requires substantial training and time.
Objective: The purpose of this study was to develop a Real-Time PCR
for rapid diagnosis of S. pneumoniae serotype 1 in direct samples of
patients with IPD and healthy carriers.
Methods: This is a prospective study including all paediatric patients
with IPD who were diagnosed by culture or pneumolisin-Real-Time
PCR at our institution (January–November 2007). In addition, we also
included the results of oropharyngeal swabs of a cohort of 65 healthy
children studied during the same period. Real time PCR of ugd (cpsk)
gene speciﬁc of serotype 1 was performed in direct samples, and the
time of detection was less than 3 hours.
Results: We included a total of 71 episodes of IPD in 69 paediatric
patients (range age 2 months-17 years, mean age 4 years). 30 episodes
were positive by culture and Real-Time PCR and 41 only by Real-Time
PCR. Serotype 1 accounted for 26% of episodes identiﬁed by culture
(8 of 30 episodes) and 24% of episodes identiﬁed only by Real-Time
PCR (10 of 41 episodes, p=NS). All 18 children with IPD caused by
serotype 1 were diagnosed of pneumonia (16 of them with empyema).
Among 65 healthy children in whom oropharyngeal swabs were cultured,
17 (26%) were pneumococcal carriers, and serotype 1 was identiﬁed in
only 1 case; speciﬁc serotype 1 Real Time PCR did not identify any
additional case. All pneumococcal strains of serotype 1 were susceptible
to penicillin and Erythromycin.
Conclusion: Real Time PCR allows a rapid identiﬁcation of Strepto-
coccus pneumoniae serotype 1. Since this serotype is not included in
the current licensed 7 valent-pneumococcal conjugate vaccine (PCV7),
rapid identiﬁcation of epidemic serotypes (like serotype 1) is mandatory
to implement other preventive measures and control outbreaks.
P2202 Nasal carriership of Staphylococcus aureus, Streptococcus
pyogenes and Streptococcus pneumoniae in children visiting
daycare centres
R.C.H. Boesten, S. Nys, N.H.T.M. Dukers-Muijrers, P.H.A. Jacobs,
E.E. Stobberingh, C.J.P.A. Hoebe (Geleen, Maastricht, Venlo, NL)
Staphylococcus aureus (SA) and Streptococcus pyogenes (SPy) can
cause signiﬁcant morbidity in children (e.g. impetigo). Streptococcus
pneumoniae (SPn) is the most common cause of bacterial meningitis in
adults and children. In the Netherlands neonates are vaccinated for SPn
since April 2006. In this study the (risk factors for) carriership of SA,
SPy and SPn in children visiting daycare centres were determined.
Cross-sectional study between March and July 2007 in which nasal
swabs and questionnaires (including socio-demographics, as well as
some behavioral characteristics) were taken from 620 children (aged
0−4 years) in 48 randomly chosen daycare centres in the southern part of
the Netherlands. Identiﬁcation of SA, SPy and SPn was performed using
standard biochemical tests. Susceptibility for fucidic acid was determined
using the disc diffusion method. Logistic regression analyses were done
to identify independent risk factors for carriership (p< 0.1).
A nasal carriership of 17.3% was shown for SA, 0.8% for SP and 37.8%
for SPn. MRSA was not found in any tested sample. 5.7% of the SA
positive samples were resistant and 23.5% were intermediate susceptible
for fucidic acid, the standard treatment. Only 0.9% were resistant of
mupirocine, the second choice treatment.
Preliminary analyses on 371 subjects revealed that independent
predictors for presence of SA were young age (p = 0.09) and skin
diseases (mostly eczema, p = 0.01), but this was only the case for children
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under the age of 2. Carriership of SPy and SPn were inversely related
(p< 0.001). Two respondents who reported keeping pigs were both
carrier of SA (p = 0.04). Respondents keeping farm-animals tend to be
less often sensitive to fusidic acid (p = 0.09).
The absence of SA was the only predictor for carriership of SPn.
Carriership of SPn is not different between children who received (at
least one) SPn vaccination and non-vaccinated children.
Nasal carriership of SA in children is slightly lower than the carriership
in the common population (20–55% in the Netherlands). A high
percentage of carriers are diminished susceptible for the standard
treatment of impetigo caused by SA. Further research on the carriership
and transmission patterns of SA is currently being conducted.
We showed that SPn can be successfully obtained from nasal swabs.
Results further suggest that SPn vaccinated children are still part of the
SPn transmission chain.
P2203 Bioﬁlm formation of Streptococcus pneumoniae isolates
from nasopharynx and middle-ear effusion
T. Tapiainen, J. Sevander, T. Kaijalainen, A. Saukkoriipi, M. Renko,
M. Leinonen, M. Uhari (Oulu, FI)
Objectives: We aimed to evaluate the bioﬁlm formation of pneumococci
in vitro in a large number of clinical isolates obtained from middle ear
effusion and nasopharynx.
Methods: In total 153 clinical isolates from children attending an otitis
media prevention trial were used. All isolates were serotyped at the
National Public Health Institute in Oulu, Finland. Bacteria were grown
in BHI until mid-logarithmic phase and diluted 1:100 in BHI or in BHI
supplemented with 0.5% glucose or 0.5% fructose. Two hundred ul of
diluted bacterial suspension was incubated in triplicate on a polystyrene
plate for 18 h at 37ºC with 5% CO2. After removal of supernatant
and after crystal violet stain (0.4% 50 ul 15 min) wells were washed
three times with PBS to remove unattached cells. Optical density was
measured at 540 nm after dissolving bioﬁlm in 50 ul of DMSO. To
validate the method we used scanning electron microscopy to visualize
the structure of bioﬁlms on bottoms of polyvinyl plates. Quantitative
PCR was used to measure the number of pneumococcal genomes in
bioﬁlm.
Results: Altogether 62 of 153 (41% strains from nasopharynx and
middle ear ﬂuid were good bioﬁlm producers (the mean OD >0.5) in
nutrition-rich environment after supplementing BHI with 0.5% glucose
or 0.5% fructose. The ability to form bioﬁlm in vitro varied among
pneumococcal isolates between different serotypes. Pneumococcal
serotypes that most effectively produced bioﬁlm were 6A, 14, 6B, 19A,
and 19F. The site of isolation did not affect the ability of pneumococcal
strains to form bioﬁlm in vitro. In BHI supplemented with 0.5% glucose
the OD value of pneumococcal isolates from middle ear effusion was
0.47 (SD 0.11) and 0.50 (SD 0.13) in isolates from nasopharynx (95%CI
of the difference −0.08 to 0.021).
Conclusions: The ability of pneumococcal strains isolated from
nasopharynx and from middle ear effusion of children to form bioﬁlm
in vitro was common. The serotype of pneumococcal isolate seemed to
affect its ability to form bioﬁlm. The serotypes that most effectively
produced bioﬁlm in our study (6A, 14, 6B, 19F) are among the
pneumococcal serotypes that most often cause pneumococcal otitis
media in children in our country.
P2204 Invasive pneumococcal disease in children after introduction
of pneumococcal conjugate vaccine
E. Cendejas, M. Romero, F. Baquero, R. Gomez-Gil, A. Gutierrez
(Madrid, ES)
Objectives: Determination of antibiotic susceptibility and serotype
distribution causing invasive pneumococcal disease (IPD) in children
after comercialisation of the 7- pneumococcal valent conjugate vaccine
(7PCV).
Methods: We analysed the clinical and microbiological data from
paediatric patients with invasive strains of S. pneumoniae. We included
all paediatric patients with isolation of S. pneumoniae in blood,
cerebrospinal ﬂuid or pleural ﬂuid. Bacterial identiﬁcation testing was
performed using the VITEK2 automated system (bioMerieux, France).
Serotyping and antibiotic susceptibility were conducted in The National
Reference Laboratory of Pneumococci, at the Nacional Center for
Microbiology of Majadahonda, Madrid. Antimicrobial susceptibilities
were interpreted according to Clinical Laboratory Standards Institute
(CLSI) methodology and interpretive meningitis breakpoints.
Results: From January 2005 to December 2006, a total of forty-four
S. pneumoniae invasive isolates were recovered from clinical specimens:
38 blood, 5 cerebrospinal ﬂuid and 1 pleural ﬂuid. Overall, 79.54%
isolates were serotypes no contained in 7PCV. The most frequently
isolated serotypes were 1 (9/44), 19A (9/44), 7 (6/44), 5 (5/44). The
others 15 isolates were divided among the remaining serotypes 6A, 23F,
9V, 6B, 35F, 15C, 10A, 18C, 16, 14, 19F.
The main clinical manifestations included sepsis/bacteraemia (15.9%),
pneumonia (50%) and meningitis (18.18%).
One case of meningitis, among NVS group, showed intermediate
resistance to cefotaxime.
Isolates in NVS group showed a low level of resistance to penicillin
(resistant 2.85%, intermediate 8.57%, susceptible 88.57%) and cefo-
taxime (resistant 0.0%, intermediate 5.71%, susceptible 94.28%) and
moderate resistance to erythromycin (resistant 17.14%, intermediate
0.0%, susceptible 82.85%).
The VS group showed reduced susceptibility to penicillin (resistant
22.22%, intemediate 44.44%, susceptible 33.33%) and cefotaxime
(resistant 0.0%, intermediate 22.22%, susceptible 77.78%) and high
resistance to erythromycin (resistant 44.44%, intermediate 0.0%,
susceptible 55.55%).
Conclusions: Our ﬁndings suggest a replacement of vaccine serotypes
(VS) by nonvaccine serotypes (NVS) betwen the distribution of
pneumococcal serotypes causing IPD in paediatric patients.
NVS isolates showed a lower level of resistance to antibiotics used as
ﬁrst choice treatment in pneumococcal invasive disease, penicillin and
cefotaxime, than VS.
P2205 Nasopharyngeal carriage of Streptococcus pneumoniae in
healthy Venezuelan children
I. Rivera-Olivero, B. del Nogal, M.C. Sisco, D. Bogaert, P.H.M. Hermans,
J.H. de Waard (Caracas, VE; Boston, US; Nijmegen, NL)
Objective: To determine the prevalence of, risk factors and serotype-
distribution of pneumococcal carriage in healthy Venezuelan children
in Caracas, with emphasis on the theoretical coverage of the 7-valent
pneumococcal conjugate vaccine.
Methods: Nasopharyngeal swabs were taken from 557 healthy children
aged 3–36 months attending the Healthy Children Service at Hospital
de Nin˜os “J.M. de Los Rios” in Caracas between December 2006 and
August 2007. The swabs were cultured for Streptococcus pneumoniae,
the isolates were serotyped and their susceptibility for penicillin,
erythromycin, clindamycin, tetracycline, levoﬂoxacin, vancomycin,
trimethoprim/sulfamethaxazole and linezolid assessed by disk diffusion.
Risk factors such as care centre attendance, young age, recent antibiotic
use, race, current otitis media and social level were analysed by univariate
and multivariate logistic regression analysis.
Results: In total, 111 pneumococcal isolates were collected. The overall
carriage rate for S. pneumoniae was 20%, not signiﬁcantly varying
with age or time of year the sample was taken. The most important
capsular serotypes/serogroups were 6 A and B (42%), 14 (11.3%),
23F (8%), 19A (6.5%) and 19F (5%). The theoretical coverage of the
7-valent pneumococcal conjugate vaccine was 74% (including cross-
reactive serotypes). 45% of the pneumococcal isolates were resistant to
one or more antibiotics. The rate of penicillin and macrolide resistance
were 30% and 28%, respectively. Multi-drug resistance was found in
25% of the strains. No risk factors for pneumococcal carriage were
identiﬁed.
Conclusions: The prevalence of pneumococcal colonisation in these
children was low (20%) and didn’t vary with age. A possible reason
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for the low carriage rate might be the fact that this epidemiological
survey addressed only healthy children. The serotypes most frequently
found in our healthy population (6 A/B, 14, 23F, 19A and 19F)
are those commonly involved in invasive pneumococcal diseases in
Venezuela, highlighting the importance of nasopharyngeal carriage
in the development of severe infections. The theoretical coverage of
the 7-valent pneumococcal conjugate vaccine was high. None of the
risk factors described in previous studies were found to be related
to pneumococcal colonisation in this population. However, this is an
ongoing study and the small number of carriers found up to now is
limiting the statistical power of univariate and multivariate analysis.
P2206 Prevalence of multidrug-resistant Streptococcus pneumoniae
in children with community-acquired pneumonia
A. Makri, G. Tzanakaki, K. Papavasileiou, H. Iliadou, M. Sioumala,
K. Kalimeratzi, J. Kremastinou, A. Voyatzi (Penteli, Athens, GR)
Objective: To evaluate the incidence of pneumococcal infections in
children with community acquired pneumonia (CAP), the serotype and
the antimicrobial susceptibility.
Material and Methods: During a three year period (2005–2007)
450 children with bacterial CAP were hospitalised. A total of 240
Streptococcus pneumoniae (S.pn) strains were isolated from 100 purulent
sputum (41.6%), 80 bronchoalveolar ﬂuid (33.3%), 42 pleural effusions
(17.5%) and 18 blood (7.5%). Identiﬁcation and susceptibility testing
(MICs) were performed by VITEK2 (bioMe`rieux). Serotyping of S.pn
isolates was carried out by multiplex-PCR assay at the National
Meningitis Ref. Laboratory.
Results: Bacteraemic and non bacteraemic pneumococcal pneumonia
occurred in 240 cases, 53.3% (males 54.1%-females 45.9%). The
incidence of CAP, peaks between winter and early spring months.
A total of 39.1% S.pn strains were considered to be susceptible to
penicillin (PSSP), 37.6% showed intermediate resistance (IM) and 23.3%
high level resistance to penicillin (PNSP), (MIC50,90 0.5−>2mg/l).
Increased resistance was also observed to cotrimoxalole (SXT) 37.9%
(MIC50,90 0.5−>8mg/l), tetracycline 36.6%, Quinopristin/Dalfopristin
9.1% (MIC50,90 0.5−2mg/l). Lower resistance was found to third gener-
ation cephalosporins 8.3% (MIC50,90 0.25−2mg/l) and chloramphenicol
4.17% (MIC50,90 0.25−4mg/l). Signiﬁcant resistance was observed
for erythromycin (IM 5%, HLR 40%; MIC50,90 (0.5−>1mg/l) and
clindamycin 16.6. All S.pn strains were susceptible to newer quinilones,
linezolide and vancomycin. The M-phenotype accounted for 55.5%
of the erythromycin-resistant isolates. The overall multidrug resistance
(MDR) was 28% (PNSP 74.6%, PSSP 25.3%). The most prevalent
serotypes were: 19F, 6B, 14, 19A, 3 and a high proportion were of
not typable (not included in the 7-valent conjugate vaccine).
Conclusions. S.pn remains the leading cause of CAP in children less than
3 years old. The appearance of MDR among PNSP isolates probably
complicate treatment of severe CAP with empyema. A signiﬁcant
proportion of serotypes causing CAP are not included in the heptavalent
vaccine.
P2207 The cost-effectiveness of palivizumab for respiratory
syncytial virus prophylaxis in premature infants with a
gestational age of 32–35 weeks in Canada
K. Lanctoˆt, P. Francis, B. Paes, A. Chiu, C. Hui, P. Oh (Toronto,
Hamilton, Winnipeg, Ottawa, CA)
Prophylactic therapy with palivizumab, a humanised monoclonal
antibody, reduces the number of respiratory syncytial virus (RSV)-related
hospitalisations in preterm infants, including those in the 32 to 35 weeks
gestational age (GA) subgroup. The cost-effectiveness of this therapy
from the payer and societal perspectives in Canada is unknown.
Objectives: To evaluate the cost-effectiveness of palivizumab as
respiratory syncytial virus prophylaxis in premature infants born at 32
to 35 weeks GA.
Design: A decision analytic model was designed in this subgroup of
premature infants to compare both direct and indirect medical costs of
the patient with future lost productivity and beneﬁts of prophylaxis. Four
types of sensitivity analyses were performed to ascertain the robustness
of the model based on mortality, health utility scales, variable discounting
rates and administration costs.
Setting: Canadian publicly funded healthcare system (base-case
analysis).
Participants: Canadian infants born at 32 to 35 weeks gestation without
chronic lung disease.
Interventions: Palivizumab prophylaxis versus no prophylaxis.
Main outcome measures: Expected costs and incremental cost-
effectiveness ratio expressed as cost per quality-adjusted life-year
(QALY) gained using $ Canadian (CAD) 2006.
Results: The expected costs were higher for palivizumab prophylaxis as
compared with no prophylaxis. The incremental cost-effectiveness ratio
for the base-case scenario was $16,605 per QALY after discounting,
which is considered highly cost-effective. The model was not sensitive
to variation in the mortality rate associated with RSV. Sub-analyses
that varied the number of risk factors in a Canadian validated risk
scoring tool (Fig 1) were sensitive to the resulting variation in RSV-
related hospitalisation rates. In instances where one risk factor or less
was present, palivizumab was not cost-effective. However, for infants
with two or more risk factors, or at least moderate risk (Figure 1),
palivizumab had incremental costs per QALYs that indicated moderate
to strong evidence for adoption (range: −$3642 [cost savings] to $77,495
per QALY).
Conclusions: Palivizumab was cost-effective and our model supports
prophylaxis for infants born at 32 to 35 weeks GA, particularly those
with two or more risk factors.
Figure 1. Risk assessment tool.
P2208 Clinical, epidemiological and virological features of an
aseptic meningitis outbreak in northeastern France, 2005
N. Leveque, D. Brunel, J. Jacques, F. Renois, J. Motte, L. Andreoletti
(Reims, FR)
Introduction: The frequency of aseptic meningitis outbreaks is
increasing worldwide and enteroviruses (EVs) are now considered as a
major viral aetiological cause of this neurological syndrome in paediatric
patients.
Objectives: To assess the clinical, epidemiological and virological
features of an aseptic meningitis outbreak in North-East of France, 2005
Patients and Methods: FromMay to November 2005, we retrospectively
selected 80 children hospitalised in the North-East of France (Sex
ratio M/F: 2.64; median age: 7.5 years (range 1 month-17 years)) who
demonstrated classical clinical or biological signs of aseptic meningitis.
Classical bacterial and virological culture assays (cell culture and
seroneutralisation assays) were performed on cerebrospinal ﬂuid (CSF),
throat and faeces samples. Herpesviridae multiplex and enterovirus PCR
assays were performed on CSF samples of the study patients. In cases
of EV positive CSF samples, a phylogenetic comparison of partial EV
VP1 capsid protein region was performed.
Results: A typical aseptic meningitis syndrome was diagnosed in 2/3
of study cases. A fatal leukoencephalitis was developed in 18 months
infants during the outbreak. No other atypical neurological syndromes
was observed during the study. EVs were identiﬁed as aetiological cause
of aseptic meningitis in 73 of 80 (91%) cases, whereas HHV6 and VZV
were identiﬁed in 3 (4%) of study children. ECHOvirus 30, 18, 13, 6, 3
and Coxsackievirus A16 were the most frequently identiﬁed EV strains
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(84%, 6%, 2%, 4%, 2% and 2%, respectively). Phylogenetic analysis
revealed that our ECHOvirus 30 strains were genetically closer to those
isolated during 2000 aseptic meningitis outbreak comparatively to those
identiﬁed during 2004 and 2006 non epidemic years. Moreover, our
genetic analysis indicated the co-circulation of two distinct ECHOvirus
30 variants during the 2005 outbreak.
Conclusion: ECHOvirus 30 is actually the most common enterovirus
strain involved in aseptic meningitis outbreaks. The present study
highlights the need for a sentinel laboratory network for a national
surveillance of clinical, epidemiological and virological features of EV
paediatric infections. The potential genetic drift or recombination of EV
genomic RNA could be responsible for the emergence of new potential
epidemic strains associated with new neurological syndromes.
P2209 Impact of real-time polymerase chain reaction in the
diagnosis of acute meningitis in children
N. Tormo, J.C. Latorrre, T. Garcia, M.A. Clari, D. Navarro, C. Gimeno
(Valencia, ES)
Introduction: Meningitis is one of the most important infectious
syndromes in medical emergencies in hospitals, due to its high morbidity
and mortality. Meningitis caused by viruses normally present milder
symptoms and are the most common, however bacterial meningitis
causes greater mortality. Both aetiologies must be quickly distinguished
in order to manage patients properly.
Objectives: To compare real-time polymerase chain reaction (PCR) with
traditional cell and bacterial cultures in the diagnosis of acute meningitis.
Materials and Methods: 173 cerebrospinal ﬂuid samples (CSF) and
blood culture samples from children aged 55 days to 14 years old,
collected from January 2006 to November 2007, were tested in the
Microbiology Unit of Clinic Hospital of Valencia (Spain).
All samples were cultured for bacterial and viral detection follow-
ing the laboratory standard procedure. Chocolate agar, Sabouraud-
chloramphenicol agar and Brain Heart Infusion broth were used for
bacterial culture; and for viral detection the samples were inoculated
in RD, VERO and MRC-5 cell cultures.
Nucleic acid was extracted using a BioRobot EZ1 Workstation with
EZ1 Viral Mini Kit v2.0 (Qiagen) and with EZ1 DNA Blood 200 ml Kit
(Qiagen) for RNA and DNA respectively.
Multiplex real-time PCR was used to test each sample for Neisseria
meningitidis and Streptococcus pneumoniae using Realcycler MENE-
01 (Ingenie Molecular) in the Smart Cycler® II System (Cepheid).
Enteroviruses were tested using real-time reverse transcription-PCR with
the Enterovirus Analyte Speciﬁc Reagent kit and the Smart Cycler® II
System or Xpert EV kit and a GeneXpert® thermocycler (Cepheid).
Results: Fifty-three patients (30.6%) were positive, 44 of them were
positive for enterovirus; 35 cases were positive only by PCR, 4 only
by cell culture, and 5 by both methods. Sensitivity was 90.9% for the
real-time PCR method but only 20.4% for cell culture.
PCR method was able to detect 6 patients infected with N. meningitidis
and 3 with S. pneumoniae, whether by culture only 4 cases for
N. meningitidis (only 1 from a CSF sample) and 1 case for S. pneumoniae
(by blood culture) were detected. PCR showed 100% sensitivity when
compared to CSF culture (11%) and blood culture (44%).
Conclusion: Real-time PCR has shown to be a powerful and rapid
diagnostic tool in acute meningitis; bacterial and viral aetiologies were
characterised in 4 to 5 hours, helping to reduce antibiotic treatment and
hospitalisation time.
P2210 Evaluation of new enzyme immunoassays for the detection
of meta-pneumovirus infection in a paediatric population
L. Fuenzalida, J. Fa`brega, S. Blanco, J. Domı´nguez, C. Prat, M. Pe´rez,
C. Rodrigo (Badalona, ES)
Objectives: To evaluate the effectiveness of a new enzyme immunoassay
assays: hMPV EIA (Biotrin International Ltd., Ireland) in the diagnostic
of metapneumovirus infection in children, comparing the results with a
molecular assays: real-time RT-PCR (Pro hMPVTM Real Time Assay
Kit. Prodesse).
Methods: 105 nasopharyngeal specimens were collected from 103
children less than 5 years of age hospitalised with symptoms consistent
with viral respiratory infection. Samples were obtained at Paediatric
Service at the University Hospital Germans Trias i Pujol, during
october-april 2007. The assays were performed according to the
recommendations of the manufacturer. Sensitivity, speciﬁcity, correlation
and kappa values were calculated. Clinical dates of the patients were
recorded. Disease severity was determined by the required oxygen
supplementation during the hospitalisation.
Results: EIA detected antigen metapneumovirus in 11/105 samples
(10.5%). In one case the results was uninterpretable. Real-time RT-
PCT was positive in 11/105 cases (10.5%). In 14 cases the reaction
was inhibited.
In 8 cases both tests were positive. The concordance between the EIA
test and real-time RT-PCR with a interpretable results was 94.5% (86/91)
(k =0.731).
The percentage of children who required oxygen therapy was higher in
children infected with hMPV that if there was no infection by the virus.
The children with hMPV infection required oxygen supplementation
more frequently than did children not infected with hMPV (p< 0.036).
Conclusion: The results of hMPV EIA compared with the detection of
metapneumovirus by real-time RT-PCR to indicate a good correlation
between the two techniques.
The technique hMPV EIA is a good alternative for the diagnosis and
management of metapneumovirus respiratory infections in paediatric
populations.
P2211 Human Metapneumovirus and human Bocavirus in
hospitalised children with acute respiratory infections
A. Zappa, M. Canuti, A. Amendola, E. Pariani, D. Colzani, M.L. Ruzza,
C. Farina, A. Podesta`, S. Perin, E. Tanzi (Milan, IT)
Objectives: To determine the contribution in hospitalisation of both
Human Metapneumovirus (hMPV) and Human Bocavirus (hBoV)
infections among children younger than 3 years of age a retrospective
study was performed. We collected and analysed respiratory samples
from a paediatric population hospitalised at the San Carlo Borromeo
hospital in Milan (Italy) between 2004 and 2007.
Methods: The study involved 186 (104 M, 82 F, mean age: 8.1
months) hospitalised children with acute lower respiratory symptoms
(bronchiolitis, pneumonia and asthma). Informed consent was obtained
from the parents of all the children who provided respiratory samples.
Pharyngeal swabs (PS) were collected from each patient and a form,
containing information on demographic data, clinical diagnosis and
epidemiological information, was ﬁlled.
HMPV-RNA and hBoV-DNA were extracted from PS and viral genome
targets were detected by the ampliﬁcation of 151bp of hMPV M gene
and 354bp of hBoV NP gene.
Results: Overall, hMPV-RNA was detected in 19/186 (10.2%) PS
samples and hBoV-DNA in 17/186 (9.1%) PS samples.
hMPV and hBoV infections were detected along with other respiratory
viruses (Rhinovirus, Coronavirus 229E, Respiratory Syncytial Virus,
Inﬂuenza A): the rate of co-infection was 26.3% for hMPV and 47.1% for
hBoV. Ruling out the patients with co-infections, symptoms and clinical
data were similar among hMPV and hBoV-infected children, even though
50% of hMPV-positive patients showed bronchiolitis.
Neither hBoV infections nor hMPV infections were identiﬁed in children
over 2 years of age. Moreover, hMPV infection was more frequently
observed in children with age 6 months respect to older children
(p< 0.05). No differences of age proﬁles were observed in patients with
hBoV infection.
The overall rate of hMPV and hBoV detection in respiratory samples
varied slightly from year to year, although without any signiﬁcant
difference.
When the respiratory samples were stratiﬁed by month of collection, a
statistical variation of the hBoV impact was observed. In fact, the highest
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frequency of hBoV (47.1% of total hBoV-positive samples) was detected
in January. No seasonal variation in hMPV frequency was noted.
Conclusions: HMPV and hBoV has been associated with acute
respiratory infection in young children. Our data suggest that both
viruses are involved in episodes of hospitalisation in the paediatric
population younger than 3 years of age with a similar frequency.
P2212 Comparison of prevalence and clinical features of paediatric
respiratory infections due to respiratory syncytial virus and
human metapneumovirus
C. Beneri, R. Manji, S. Sood, C. Ginocchio (Manhasset, Lake
Success, US)
Objectives: The purpose of this study was to compare the prevalence
and clinical features of two paediatric respiratory pathogens, respiratory
syncytial virus (RSV) and human metapneumovirus (hMPV) in children
<5 yr.
Methods: Respiratory specimens (n = 657) collected 10/2004−4/2006
were tested for RSV and hMPV using NucliSENS analyte speciﬁc
reagents and the NucliSENS EasyQ Basic Kit (bioMe´rieux, Durham,
NC). Prevalence and admission rates were based on the total group.
Chart review (n = 64) was conducted for 35 RSV+, 26 hMPV+, 3
RSV+/hMPV+ children evaluated in the ED or hospitalised. Case report
forms were used to evaluate patient demographics, clinical ﬁndings, and
clinical course.
Results: The overall infection rates were: RSV= 22.5% (<2 yr: 27.5%;
2−<5 yr: 12.7%), hMPV= 5.5% (<2 yr: 5.8%; 2−<5 yr: 4.6%).
RSV and hMPV seasons overlapped although RSV peaked Nov-Jan
and hMPV peaked Feb-April. The percentages of children requiring
hospitalisation were 24.5% (RSV+) and 58.8% (hMPV+). Patients with
chart review showed similar age distribution for RSV+ and hMPV+ (<2
yr: 65.7% vs 65.4%, 2−<5 yr: 34.3% vs 34.6%, respectively). There
was no statistically signiﬁcant difference in underlying co-morbidities,
which included reactive airway disease, signiﬁcant prematurity, muscular
dystrophy, chronic lung disease, congenital heart disease, and leukaemia
(p = 0.4004). Clinical ﬁndings were similar in both groups in terms of
retractions, wheezing, and crackles (p = 0.2300, p = 0.9839, p = 0.3425,
respectively). hMPV+ patients were more likely to present with fever
(p 0.001) and rash (p = 0.0111). RSV+ patients were more likely
to present with rhinorrhoea (p = 0.0033) and diarrhoea (p = 0.0340).
Although not statistically signiﬁcant there was a trend towards more chest
radiographs in hMPV+ patients (p = 0.0553). Upper and lower respiratory
tract infections were seen in all groups but 19.2% of hMPV+ patients
required mechanical ventilation versus 11.4% of RSV+ patients. This
however did not affect length of stay in the intensive care unit or total
hospital stay for either group. Patients co-infected with RSV and hMPV
were not more likely to have severe disease.
Conclusion: RSV is the most prevalent cause of respiratory disease in
children <5 yr. Seasonality and clinical symptoms of RSV and hMPV
overlap, yet there are distinctions in prevalence peaks and clinical
symptoms. This data suggests that hMPV infection may result in more
hospital admissions and increased severity of symptoms.
P2213 A 1-year longitudinal study on the colonisation of ﬁve
upper respiratory tract pathogens within a daycare centre
R. Sa´-Lea˜o, S. Nunes, A. Brito-Avoˆ, C. Alves, J. Carric¸o, J. Saldanha,
J. Almeida, I. Santos-Sanches, H. de Lencastre (Oeiras, Lisbon, PT;
Houston, US; Monte da Caparica, PT)
Day-care centres (DCC) are settings where children are at increased risk
for carriage of upper respiratory tract (URT) pathogens. Longitudinal
studies on the dynamics of colonisation by such pathogens within the
DCC are only a few and have often focused on a single pathogen.
To better understand the patterns of colonisation by such pathogens,
we conducted a large one-year longitudinal study – with 11 sampling
periods – starting in February 1998 on nasopharyngeal carriage
of Streptococcus pneumoniae, Haemophilus inﬂuenzae, Moraxella
catarrhalis, Staphylococcus aureus and Streptococcus pyogenes among
a group of 47 children who attended a single DCC.
Methods: All isolates were antibiotyped. S. pneumoniae and H. inﬂuen-
zae were genotyped by PFGE. S. pneumoniae were also serotyped.
Results: A total of 414 samples were collected of which 83.3% had at
least 2 of the 5 bacterial species and only 2.4% of the samples had none
of them. All children were colonised by H. inﬂuenzae (with a minimum
of 4 positive samples and a maximum of 11) and M. catarrhalis
(minimum 2 positive samples, maximum 10). All but one child were
colonised by pneumococci (maximum 10 positive samples), and 47%
were colonised at some point by S. aureus being the corresponding ﬁgure
for S. pyogenes 55%. Sixty-eight percent of all positive cultures yielded
at least one isolate (H. inﬂuenzae, M. catarrhalis, or S. aureus) that
produced b-lactamase; 24% of the pneumococci were not susceptible
to penicillin; all S. aureus were susceptible to oxacillin, and 23% of
S. pyogenes were resistant to erythromycin. Molecular typing showed
the introduction of pneumococcal and H. inﬂuenzae clones during all
year. Over 95% of all pneumococcal and H. inﬂuenzae isolates belonged
to clones shared by more than one child. Children were sequentially
colonised with up to 6 pneumococcal clones (mean 3.6) and 5 serotypes
(mean 3.4); and 9 H. inﬂuenzae clones (mean 7.1). Clones with increased
capacity for transmission and/or prolonged colonisation were identiﬁed.
Conclusions: Abundant co-colonisation by pathogens of the URT was
found. Antimicrobial resistance was present in all species. Molecular
typing showed a high rate of acquisition and turnover of pneumococci
and H. inﬂuenzae strains and detected very high levels of cross-
transmission. DCC are units where permanent introduction of clones
occurs, and attendees are a pool of hosts where the ﬁttest clones ﬁnd
privileged opportunities to persist and expand.
P2214 Myocarditis outbreak with fatal cases associated to
Adenovirus subgenera C among children, Havana City, 2005
C. Savo´n, B. Acosta, O. Valde´s, A. Goyenechea, A. Pin˜o´n, L. Palerm,
P. Mas, L. Sarmiento, G. Gonza´lez, D. Rosario, V. Capo´, V. Kourı´,
P.A. Martı´nez, J.J. Marchena, G. Gonza´lez-B, A. Llop, M.G. Guzma´n
(Havana, CU)
Background: Acute myocarditis is characterised by inﬂammatory
inﬁltrates of myocardium. Disease has been attributed to multiple causes,
but viruses particulary Enteroviruses and Adenovirusrs are considered
to be the leading causes of usually clinical myocarditis.
In the summer 2005 an outbreak of atypical febrile syndrome
accompanied with acute cardiac decompensation among infants and
young children was observed in Havana City. Eleven patients had a
torpid evolution and eight fatal cases due to myocarditis were informed.
Methods: The aim of the present study was to investigate the aetiological
agent. Two groups of children admitted in paediatric hospitals of Havana
City from July 3 to August 2 were studied. Forty clinical samples
(necropsy tissue, cerebrospinal ﬂuid, stools, serum were collected and
tested by molecular methods to detect 14 Respiratory Viruses, 6
Herpesvirus and generic Enteroviruses, and Flavirus and Alfavirueses.
Virus isolation was performed in A-549 cells. Isolated viruses were typed
by sequence analysis.
Results: Adenovirus genome was detected in 6 of 8 fatal cases, was more
common detected in lung and myocardium 5, (62.5%) and 3(37.5%)
respectively. In two patients was detected in both organs. Virus isolation
was obtained in 5 patients. In the non fatal cases, Adenovirus was
detected in all of them. Virus recover was successful in 2 cases. Viruses
detected and isolated were typed as Adenovirus 5 in the fatal cases and
Adenovirus 1 in the non fatal cases. None other viruses were found.
Conclusions: Our data suggest that Adenovirus was the aetiological
agent implicated in this myocarditis outbreak, after others viruses were
discarded.
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P2215 Prevalence of gastroenteritis caused by rotavirus and
adenovirus in a paediatric population in Athens, Greece
N. Paleologou, F. Lykou, P. Tsialta, P. Zouni, V. Dimitraka,
E. Synodinou, E. Lebessi (Athens, GR)
Objective: Acute gastroenteritis (AGE) is a major source of morbidity
in early childhood. Enteropathogenic viruses are regarded as particularly
relevant causative agents. Our study was performed to estimate the
prevalence of gastroenteritis caused by group A rotavirus and enteric
adenovirus among young children during a two-year period (2006–2007)
in the area of Athens.
Methods: We reviewed retrospectively the laboratory cards of children
under ﬁve years old, who were tested for group A rotavirus and
enteric adenovirus, the major enteric viral pathogens. The detection
of the viruses was carried out according to standard methods using a
commercial immunochromatography assay kit.
Results: A total of 1 228 patients, younger than 5 years of age
seeking medical care for acute diarrhoea in our hospital, were enrolled
in the study. Diarrhoea, vomiting and fever were the main clinical
manifestations. All stool samples from inpatients were collected within
three days of hospitalisation. They were all tested for rotavirus and
adenovirus. Group A rotavirus was the most frequently detected (176/1
228, 14.33%), followed by enteric adenovirus (30/1 228, 2.4%). Dual
infections were found in 2.66% of the positive samples. Group A
rotavirus gastroenteritis occurred in 87 boys and 89 girls and adenovirus
gastronteritis occurred in 12 boys and 18 girls (male/female ratio 1:2).
The median ages were similar (10 months for rotavirus and 11 months
for adenovirus, range 30d-5years). The majority of patients were less
than 3 years old; 82% and 76% for rotavirus and adenovirus infection,
respectively. Rotavirus infection was most common in the winter through
early spring, peaked between January and May. Enteric adenovirus
gastroenteritis occurred year-round. Hospital outbreak was not recorded.
All cases were classiﬁed as community-acquired. The results from 2007
will be completed at the end of the year.
Conclusions: Rotavirus is a signiﬁcant viral agent among children,
especially those younger than three years. The overall incidence of viral
gastroenteritis could have been higher than currently observed, if the
included patients had been tested for astrovirus and calicivirus.
P2216 TCRalfabeta and TCRgammadelta T lymphocytes in severe
infected premature neonates
J. Behrendt, M. Stojewska, B. Krolak-Olejnik, U. Godula-Stuglik
(Zabrze, PL)
Background: The lower value of T cells in premature infants are
considered to be a responsible factor for susceptability to severe early-
onset infections (e-oi).
Aim: To evaluate the relationship between the occurence of severe e-oi
on the % and number of TCRab and TCRgd in prematures regarding
their sex, BW, GA and Apgar score.
Material: The study population: 50 (31 boys, 19 girls) preterm neonates,
among them 27 infected (15 septic, 12 pneumonic, with BW ranged from
1000 to 2390g, mean 1717g, and GA from 26 to 37 weeks, mean 32)
and 23 without infections (controls) with mean BW 1650g and mean GA
32 weeks. Birth asphyxia in 81% of infected and in 30% of noninfected
prematures was noted. Cesarean section in 70%, infectious perinatal risk
factors in 52% of all cases were stated. The most common bacteria
isolated from blood in septic prematures were staphylococcal strains (9).
In 2 cases Str. agalactiae, in 3 – Klebsiella pneumoniae and in 1 case
E. coli were noted. 4 prematures with sepsis complicated by shock
and DIC due to Klebsiella (2) and Staph. epidermidis (2) died. The
ﬂow cytometric immunophenotyping (BD) was performed to determine
TCRab and TCRgd T lymphocytes.
Results: The mean % (58.0±12.8, range 24–83%) and mean number
(3.0±0.9, range 1.591−6.095 g/l) of TCRab in infected prematures
did not differ (p> 0.05) from the mean values in controls (mean
59.6±7.3%, range 45–76%, 3.330±1.463, range 1.586−6.733). The
mean % of TCRgd (3.78±2.34, range 1–10%) was signiﬁcantly
(p = 0.03) higher in severe infected prematures than in controls (range
1−9%, mean 2.8±2.2%). In infected prematures with gastrintestinal
disorders, signiﬁcantly higher the mean % of TCRgd (5.1±2.6%) than
in infected preterm without such disorders (2.7±1.5%) was stated.
Birth asphyxia was connected with signiﬁcantly higher mean % of
TCRab (64.5±10.4 and 52.8±12.3%). There were positive correlations
between the % of TCRab and BW (r = 0.42, p = 0.002) and GA (r = 0.48,
p = 0.032) in infected prematures. Negative correlation between number
of TCRgd and BW (r = −0.12, p = 0.04) and GA (r = −0.2, p = 0.038) was
noted.
Conclusions: 1. Severe e-oi increase the % and number of TCRgd
lymphocytes in preterm neonates. 2. Birth asphyxia may inﬂuence on
increase of percentage of TCRab cells in severe infected prematures. 3.
Increase of % of TCRgd lymphocytes in infected preterm neonates with
gastrointestinal disorders may prove the important role of these cells in
development of those abnormalities.
P2217 Persistence of Escherichia coli clones and resistance genes
in recurrent urinary tract infections in children
K. Truusalu, S. Ko˜ljalg, J. Stsepetova, T. Drell, I. Vainuma¨e, E. Sepp,
M. Mikelsaar (Tartu, EE)
Objectives: We compared the molecular clonality of E. coli (Ec)
from recurrent urinary tract infection (rUTI) episodes with stability of
phenotypic antibiotic resistance and presence of gene cassettes. The
association between the presence of sul genes and previous trimethoprim-
sulfamethoxazole TS treatment was assessed.
Methods: Altogether 78 urinary Ec isolates were obtained during one
year follow-up from 27 patients (pt) (aged 2m-180m, mean 44.8m) with
1−5 episodes after initial UTI. Strain clonality was detected by PFGE.
MIC values to TS, sulfamethoxazole SX, ampicillin AM, cefuroxime
XM, cefotaxime CT, gentamicin GM, ciproﬂoxacin CI were measured
by E-test. Int1, sul1−3 genes were detected by PCR and compared with
TS treatment data.
Results: In 21/27 pt (78%) the unrelated clonality of Ec strains was
detected: in 11 persistent clonal strains (Cs) (n = 24), in 10 both Cs and
individual strains (Is) (n = 24; 16, resp) and in 6 only Is (n = 14) were
found. The pt with only Is were younger than others (med 7.5 vs 48m;
p = 0.03). Ec resistance to TS, SX, AM, XM, CT, GM, CI was 33%, 78%,
40%, 17%, 3%, 2%, 0% resp. The phenotypic antibiotic susceptibility in
Cs was more stabile compared to Is (OR, 8.7; 95%CI, 1.8–40.8) during
different infection episodes.
The integrons were found from 55/78 strains. Int pos strains had higher
MIC values to XM, CT and GM than int neg ones (p< 0.01; 0.03;
0.01). The presence of integrons was similar in Cs and Is. In half of
the pt (n = 14) it did not change, in another 13 the loss of integrons was
more frequent than capture (9/13 vs 2/13, p = 0.01).
Sul genes were found in 42/78 Ec strains, it was in accordance with
phenotypic resistance to SX compared to gene neg ones (p = 0.03). The
Is harboured more sul 1 genes than Cs (p = 0.01). Occurrence of sul
genes was more stabile in pt with Cs compared to Is (OR, 4.4; 95%CI,
1.1–17.7). The Ec strains obtained after previous TS treatment had more
frequently any sul genes than TS non treated (p = 0.01).
Conclusion: In children the majority of Ec rUTI episodes are due to
individual persisting clones. The stability of antibiograms and persistence
of SX resistance encoding sul genes may indicate putative relapses.
Previous TS treatment is associated with corresponding resistance.
P2218 Low incidence of congenital cytomegalovirus infection in
a large maternity hospital in Ireland
C.F. De Gascun, M. Boyle, G. Harrison, A. Waters, J. Connell,
E.J. Molloy, S.J. Knowles, W.W. Hall (Dublin, IE)
Objectives: The aim of this study is to determine the incidence of
congenital CMV (cCMV) infection in a large tertiary referral maternity
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hospital in Ireland. There has been no Irish data reported on this subject
previously.
Methods: The study comprised of two parts: (1) A retrospective review
of laboratory conﬁrmed symptomatic cCMV cases diagnosed over three
years (April 2004 to May 2007); and (2) A prospective pilot cCMV
screening programme was introduced following Ethics Committee
approval. One thousand urine samples are being obtained from neonates
born in the hospital, with parental consent, from November 2006 to
March 2008. Samples are tested in pools of ﬁve, each pool being tested
by real-time polymerase chain reaction (rtPCR) for the presence of CMV
DNA. Individual aliquots from any positive pool are re-tested by rtPCR
to identify the positive specimen. Repeat urine for culture and DEAFF
test, plus serum for CMV IgM, and plasma for CMV DNA are tested to
conﬁrm positive rtPCR results.
Results: (1) Eight children were identiﬁed with symptomatic cCMV
infection. During the study period there were 25,444 births, giving
an incidence of symptomatic cCMV of 0.03%. At birth, symptomatic
cCMV is expected to account for 5–10% of all cCMV cases. Based
on our conﬁrmed cases, therefore, we expect an incidence of 0.3−0.6%
cCMV from the screening study, or between 3 and 6 cases per 1000
babies screened. (2) Four hundred infants have been tested to date; only
one positive baby has been detected, yielding an incidence ﬁgure of
0.25% cCMV. The positive PCR result was conﬁrmed with a positive
urine culture and DEAFF test. Of note, the serum IgM was negative.
This screening study is ongoing and we aim for completion in spring
2008.
Conclusions: The incidence of cCMV infection in the population studied
is low when compared with the published literature (0.3−2.2%). This is
on a background of low CMV seroprevalence in Irish pregnant women
(30% CMV seropositive). Enhanced screening of greater numbers is
required to accurately assess the burden of cCMV disease in Ireland.
P2219 Community-acquired Pseudomonas aeruginosa enterocolitis
and sepsis in infants
C-H. Chuang, C-H. Chiu, Y-C. Huang, T-Y. Lin (Taoyuan, TW)
Objectives: Pseudomonas aeruginosa is an important opportunistic
pathogen that often infects patients with chronic disease or immune-
compromised status. It is a well-known aetiology of nosocomial infection
but community-acquired infection has been rarely reported. P. aeruginosa
is generally not considered as a cause of infectious diarrhoea. Here, we
reported 18 cases of community-acquired pseudomonas enterocolitis and
sepsis in infants.
Methods: There were 18 children with community-acquired P. aerug-
inosa sepsis at Chang Gung Children Hospital from July 2003 to
September 2006. Their demographic data, clinical manifestations,
laboratory data, antibiotic susceptibility and clinical outcome were
collected and analysed. Immunologic studies were performed to screen
the possible immunodeﬁciency. Pulse-ﬁeld gel electrophoresis using
Spe1 was performed for 14 isolates collected to determine their clonal
relationship.
Results: All patients were previously healthy before the infection. The
age distribution among them ranged from 4 to 25 months. Sixteen were
under 1 year of age. Thirteen occurred during July to November. All
patients had fever. Diarrhoea was observed in 17 patients and vomiting
in 5. Concomitant fever and diarrhoea were observed in 14 patients.
Thirteen patients developed ecthyma gangrenosum. Seizure occurred in
4 patients, two of whom had meningitis. Leucopenia was seen in 9.
Thrombocytopenia was observed in 11. C-reactive protein level above
50mg/dl was detected in 16. All isolates were susceptible to various anti-
pseudomonas antibiotics. Fifteen patients received empirical antibiotics
appropriately. Surgical intervention in abdomen was performed in 7
patients and ventriculoperitoneal shunt in 2. Sixteen patients survived, 2
were left with severe neurologic sequelae. Immunologically, 6 patients
had transient hypogammaglobulinaemia. No speciﬁc T cell and B cell
deﬁciency was detected. Pulse-ﬁeld gel electrophoresis revealed no
identical or closely related strains among these isolates.
Conclusion: P. aeruginosa can be a community pathogen to cause
enterocolitis and sepsis in infants. In our cohort of patients, majority
were under 1 year of age. No signiﬁcant immunodeﬁciency was found.
Bacterial isolates appeared diverse in PGFE.
P2220 Inﬂuence of antibiotics during delivery work on early onset
sepsis
A. Aguilar, T. Juncosa, A. Gene´, M. Iriondo, A. Alarco´n, M. Thio´
(Barcelona, ES)
Objectives: 1. To assess the incidence of early onset sepsis with positive
culture during the period 1996–2006 compared to a historic period
previous to implementation of prophylaxis during delivery in women
carrying S. agalactiae (1988–1994). 2. To know the aetiology and the
mortality in these patients during the period of study.
Methods: Retrospective study of newborn less than seven days old,
attended in the Neonatology Unit during the period 1996–2006 with a
diagnosis of sepsis/meningitis and a positive culture of blood and/or CSF.
The isolated microorganism, pregnancy week of the mother at delivery
and evolution of illness were recorded.
Results: Twenty-nine newborns with early onset sepsis and positive
culture (22 of them born in our own hospital and seven coming
from other centres) were attended in the Neonatal Unit. Isolated
microorganisms were: 15 S. agalactiae, 8 E. coli, 2 L.monocitogenes,
1 C. albicans, 1 E. faecalis, 1 P. aeruginosa and 1 S. pneumoniae.
Eleven of the 29 newborn were preterm (38%), less than 37 weeks of
pregnancy. In 10 cases, mothers had received antibiotics during delivery
work. Onset of clinical illness was detected during the ﬁrst day of life in
65.5% of cases. Mortality was due to infection in 17.2% of cases (ﬁve
babies, all of them less than 31 weeks of pregnancy) and the remaining
24 children had a good evolution without sequelae. During the historic
period, the incidence of early onset sepsis with positive culture was of
2.2/1000 live births (43 internal cases per 19453 live births) and that
due to S. agalactiae was of 1.3/1000 live births (26 internal cases). In
contrast, during the studied period the global incidence was of 0.5/1000
live births, with 22 internal cases per 40129 live births (P< 0.001) and
that due to S. agalactiae was of 0.27/1000 live births, with 11 internal
cases (P< 0.001).
Discussion: The use of prevention strategies against neonatal sepsis
during the last years has lead to a signiﬁcant reduction (P< 0.001) of
early onset sepsis both as a global fact (from 2.2 to 0.5/1000 live births)
and as that due to S. agalactiae (from 1.3/1000 to 0.27/1000 live births).
The two predominant infectious agents during the studied period were
S. agalactiae (51%) and E. coli (27%). Mortality has been related to
extreme prematurity.
P2221 A 4-year study on paediatric vulvovaginitis
L. Moreno, E. Riquelme, M. Pariente, M.R. Vicente, M.D. Crespo
(Albacete, ES)
Objective: The purpose of this study is determining the aetiology of
paediatric vulvovaginitis with inﬂammatory exudates in our environment.
Methods: A retrospective study on 0–14 years old girls showing genital
exudates with inﬂammatory cells in Gram stain, where any germ from
resident ﬂora or with a known pathogenicity was isolated between 2004
and 2007. A microbiological study of vulvar (26), vaginal (340) and
vulvovaginal (33) exudates was made. Exudates were seeded in blood
agar, chocolate agar, Thayer-Martin agar, Gardnerella agar, Sabouraud-
chloramphenicol agar and bouillon for Trichomonas. Microorganisms
were identiﬁed following conventional methods.
Results: 399 girls were studied, out of which 177 (29.3%) were
diagnosed with vulvovaginitis. 29.7% of vaginal samples, 30.7% of
vulvar exudates, and 24.2% of vulvovaginal exudates were positive.
Patients were 7 years old on average. Distribution by age group was
as follows: 0−1 years old (19), 2−3 years old (15), 4−5 years old (19),
6–11 years old (35), 12–14 years old (29). Distribution by year was as
follows: 2004 (40), 2005 (41), 2006 (17), 2007 (19). There were obtained
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the following isolations: C. albicans, 42 (35.8%); E. coli, 29 (24.7%);
G. vaginalis, 14 (11.9%); C. glabrata, 7 (6%); S. pyogenes, 4 (3.4%);
S. agalactiae, 4 (3.4%); P. mirabilis, 3 (2.5%); S. aureus, 3 (2.5%);
H. inﬂuenzae, 3 (2.5%); Candida sp, 2 (1.7%); Corynebacterium sp, 1
(0.8%); E. cloacae, 1 (0.8%); P. aeruginosa, 1 (0.8%); M. morganii,
1 (0.8%); K. oxytoca, 1 (0.8%); T. vaginalis, 1 (0.8%). There was not
detected any E. vermicularis or N. gonorrhoeae infection. 87.2% of
girls suffered from vulvovaginitis caused by resident ﬂora. Yeasts were
found in the exudates from 26 patients between 12 and 14 years old.
Vulvovaginitis was speciﬁc in 12.8% of total cases – it always had a
respiratory origin, except for one case having a sexual origin.
Conclusions: As in other studies, vulvovaginitis in our area is more
common at prepuberal age, and vulvovaginitis with an unspeciﬁc origin
is the most common cause of leucorrhoea amongst girls. Symptoms in
minor cases of unspeciﬁc vulvovaginitis can be alleviated by improving
personal hygiene habits. The most frequently isolated microorganism
was C. albicans followed by E. coli, in most cases along with mixed
ﬂora. Candida vulvovaginitis is more common at prepuberal age, more
than half of total patients belonging to that age group.
P2222 Prevalence of Rotavirus, Adenovirus, Norovirus and
Astrovirus infections by rapid EIA and ELISA assays in
hospitalised French children
A. Tran, D. Minette, N. Leveque, J. Jacques, B. Lejeune, C. Payan,
L. Andreoletti (Brest, Reims, FR)
Introduction: Rotavirus, Norovirus, Astrovirus and Adenovirus 40/41
have been recognised as the most important aetiological agents of
childhood viral gastroenteritidis in industrialised countries. Little is
known about the number and the distribution of these viruses in
hospitalised children.
Objectives: To determine the prevalence and the distribution of viruses
responsible for gastroenteritidis in hospitalised children.
Patients and Methods: From January to October 2007, a total of 623
faecal specimens were routinely collected from children with or without
gastroenteritidis signs and who were born or admitted in two French
hospital settings (Reims medical university centre; n = 280; mean age,
2.18±SD 3.64 years, range: 2 days – 12 years; Brest medical university
centre n = 343; mean age, 1.62±2.4years, range: 4 days – 14 years).
Rapid EIA analyses for rotavirus and adenovirus were performed at the
time of hospitalisation (r-Biopharm), and new commercially available
ELISA tests were used retrospectively for the detection of Norovirus
and Astrovirus in frozen stool samples (Ridascreen, r-Biopharm).
Results: The overall rates of prevalence for Rotavirus, norovirus,
adenovirus, and astrovirus were respectively 29, 12, 4.5 and 2.5%
and they did not signiﬁcantly differ between hospitals (P = 0.09). Dual
virus infections were detected in 30 (4.8%) of the 623 study children
and were associated with Norovirus in 19 (63%) infants including 4
prematurity cases. During winter, Norovirus infections accounted for
33% of all hospitalised gastroenteritidis cases at a time where rotavirus
was epidemic, resulting in mixed Norovirus and rotavirus gastrointestinal
tract infections. Of the 299 documented viral gastroenteritidis, 9 (3%)
were identiﬁed as nosocomial infections that 4 occurred in prematurity
cases.
Conclusion: These ﬁndings provide evidence that Noroviruses can be a
leading cause of gastroenteritidis, and highlight the need to implement
norovirus and astrovirus ELISA detection assays in association with rapid
EIA rotavirus and adenovirus EIA detection for the clinical diagnosis
and the nosocomial prevention of gastroenteritidis viral infections in
paediatric departments.
P2223 Enterococcal urinary tract infections in children
A. Makri, K. Papavasileiou, H. Iliadou, T. Guahardo, F. Gavalaki,
G. Oikonomopoulos, A. Voyatzi (Penteli, GR)
Aim of this study was to evaluate the prevalence and resistance patterns
of Enterococci in childhood nosocomial urinary tract infections (UTIs).
Material and Methods: A total of 2801 positive urine cultures (10.2%)
were examined during a four year period (2004–2007). The study
population was children aged 4 months to14 years (males 39%-females
61%). Urine cultures, identiﬁcation and susceptibility were performed
by conventional methods.
Results: Enterococci were isolated in 116 cases, accounting for 4.1%
of the total UTIs. A percentage of 75.8% (88/116) strains were
identiﬁed as E. faecalis, 14.6% (17/116) as E. faecium and 9.4%
(11/116) as Enterococcus spp. The enterococcal UTIs in children
less than 2 years old (median age 6 months) were associated with
urinary tract instrumentation or structural abnormalities (.S.A). All
E. faecalis isolates were resistant to quinupristin/dalfopristin (Q/D)
(MIC50 4mg/l-MIC90 8mg/l) and susceptible to vancomycin (Va),
teicoplanin (Teico), ampicillin (Am), amoxil-clavulanate (AMC) and
linezolide (Li). In contrast E. faecium strains were signiﬁcantly resistant
to Am 94.1% (MIC50 16mg/l-MIC90 32mg/l), AMC 82.3% (MIC50
16mg/l – MIC90 32mg/l), Q/D 47% (MIC50 1mg/l-MIC90 8mg/l);
lower resistance was found to Li 11.7% (MIC50 2mg/l-MIC90 4mg/l).
The resistance rates of E. faecalis and E. faecium to quinolones were:
Levoﬂoxacin 7.41%-41.1%, ciproﬂoxacin 9.2%-64.7% and norﬂoxacin
11.4–58.8%. High level resistance (HLR) was detected to gentamicin and
streptomycin in 15.9% and 36.3% of E. faecalis and in 35.2% and 70.5%
of E. faecium respectively.. One E. faecium multidrug resistant strain,
expressed the Van A genotype (VRE, Va >32mg/l, Teico >32mg/l) was
isolated.
Conclusions: Enterococci were the fourth leading cause of UTIs in
children. Infants less than 2 years old with Enterococcal UTI are highly
indicative for S.A and recurences. E. faecium strains were considered
to have multiple resistance phenotypes emerging a feared nosocomial
pathogen while a signiﬁcant persentage presented the unusual phenotype
expressing susceptibility to Q/D. The overall proportion of vancomycin
and linezolide resistant enterococcal isolates was found low in paediatric
patients.
P2224 Group A Streptococcus virulence and host factors in two tod-
dlers with rheumatic fever following toxic shock syndrome
P. Smeesters, P-A. Dre`ze, D. Biarent, L. Van Melderen, A. Vergison
(Gosselies, Brussels, BE)
Objective: Rheumatic Fever (RF) ‘classically’ occurs after Group A
Streptococcus (GAS) pharyngitis in children over 5 years in developping
countries. GAS Toxic Shock Syndrome (TSS) is uncommon and does not
usually lead to RF. Host-pathogen interactions are of utmost importance
for the development of RF and TSS since speciﬁc combinations of GAS
and hosts appear to be necessary for the disease to occur.
The present report describes bacterial and host determinants of non-
related Belgian toddlers who developped RF after TSS. A molecular
analysis of both the bacterial emm-type and superantigens (exotoxins
that are phage-encoded) and HLA host factors was carried out in an
attempt to decipher the combination that may lead to such uncommon,
but very similar presentations.
Methods: The diagnosis of TSS and RF were based on the consensus
deﬁnition and modiﬁed Jones criteria. emm-typing was performed using
the CDC sequencing protocol. The presence of 17 superantigen genes
was detected by PCR and sequencing. Phages lysates were obtained by
mitomycin C induction and observed by electron microscopy. The HLA
molecular typing was performed using PCR and sequence-speciﬁc oligo-
nucleotide genotyping method.
Results: A 13-month-old boy and a 14-month-old girl presented a GAS
TSS with fever, severe hypotension, renal impairment, coagulopathy,
thrombocytopenia and meningitis. They were treated with penicillin,
clindamycin, intravenous immunoglobulin and intensive care supportive
therapy. After 2 and 3 weeks respectively, multiple subcutaneous nodules
as well as migratory polyarthritis or monoarthritis developed in both
children. RF diagnosis was established since 1 and 2 major plus 3
minor Jones criteria were fulﬁlled for the 2 children respectively. The
molecular analysis of bacterial virulence genes revealed that the 2 GAS
isolates belonged to the usual, although distinct, invasive emm-types 1
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and 3. Both isolates carried a wide set of prophage-encoded virulence
factors, with only the speG and speA superantigen-encoding genes in
common. Both patients shared the HLA DQB1*0301 allele which has
been associated with susceptibility to GAS necrotising fasciitis.
Morphological diversity bacteriophages in GAS isolates 1 and 2.
Transmission electron microscopy after negative staining shows 4
bacteriophages belonging to the siphoviridae family. They present
icosahedral heads of variable size and morphology (B and C: 45 nm,
A and D: 55 nm) and non-contractile tails of variable length (A: 230 nm,
B: 240 nm, C and D: 180 nm) (Magniﬁcation ×160,000).
Conclusion: Our study exempliﬁed the complexity and modularity
of the host-pathogen interactions in GAS diseases. More documented
reports and systematic studies are needed to better understand the
underlying molecular and physiologic mechanisms involved in such
severe pathologies.
P2225 Effectiveness and safety of short versus long duration of
antibiotic therapy for group A streptococcal tonsillopharyn-
gitis: a meta-analysis of randomised controlled trials
M. Falagas, E. Vouloumanou, D. Matthaiou, A. Kapaskelis,
D. Karageorgopoulos (Athens, GR)
Objective: Compliance to traditionally recommended 10-day penicillin
treatment for acute group-A streptococcal (GAS) tonsillopharyngitis is
rather limited. To evaluate the effectiveness and safety of short-course
antibiotic treatment for streptococcal tonsillopharyngitis, we performed
a meta-analysis of randomised controlled trials (RCTs).
Methods: We searched in PubMed, the Cochrane Central Register of
Controlled Trials, and bibliographies of relevant articles, to identify
RCTs performed on patients of all ages, with GAS tonsillopharyngitis,
veriﬁed by microbiologic or serologic methods, comparing short-course
(7 days or less) versus long-course treatment (at least 2 days longer than
short-course), with the same antibiotic, in the same total daily dose.
Results: Eleven RCTs (6 open-label), performed on children and adults,
with GAS tonsillopharyngitis (veriﬁed microbiologically in 10 RCTs,
and microbiologically or serologically in one RCT), comparing short-
course [orally administered penicillin V (3−7 days), cephalosporins (5−7
days), clindamycin (5 days), or intramuscularly administered ceftriaxone
(1 day) in 5, 4, 1, and 1 RCTs, respectively] versus long-course treatment
(7–10 days for oral or 3 days for intramuscular agents), were included.
Microbiological eradication rates of GAS were inferior for short-course
compared to long-course treated patients included in all RCTs [11 RCTs,
1887 patients, ﬁxed effect model (FEM), odds ratio (OR)=0.42, 95%
conﬁdence interval (CI)=0.31−0.56]; RCTs involving mainly children
(8 RCTs, 1372 patients, FEM, OR= 0.55, 95%CI=0.38−0.78); RCTs
comparing 5 to 10-day therapy (6 RCTs, 1167 patients, FEM, OR= 0.51,
95%CI=0.34−0.76); RCTs comparing penicillin V regimens (5 RCTs,
720 patients, FEM, OR= 0.35, 95%CI=0.24−0.51). Findings were
marginally non-signiﬁcant for patients treated with cephalosporins (5
RCTs, 1078 patients, FEM, OR= 0.61, 95%CI=0.37−1.01). Addition-
ally, for patients that received short-course compared to long-course
treatment, clinical success was inferior (6 RCTs, 1277 patients, FEM,
OR= 0.46, 95%CI=0.28−0.75), short-term relapses were not different,
long-term recurrences were more frequent, and adverse events were not
different.
Conclusion: The ﬁndings of this meta-analysis reinforce the idea
that acute tonsillopharyngitis due to GAS should be treated for the
traditionally recommended duration of 10 days, in order to maximize
microbiological eradication, and achieve superior clinical outcomes.
P2226 Evolution of the incidence of early-onset and late-onset
group B Streptococcal disease before and after prevention
policies – Barcelona 1994–2007
A. Andreu, T. Juncosa, J. Bosch, M. Sierra, M. Gimenez, I. Sanfeliu,
J. Lite, E. Dopico, C. Guardia, L. Vin˜as, F. Sanchez for the
Microbiologist Group for the study of Vertical Transmission Infections
from the Catalan Society for Clinical Microbiology and Infectious
Diseases
Objective: Between 1994 and 1999 the prophylactic strategy based
in universal prenatal group B Streptococcal (GBS) screening and
intrapartum antibiotic for GBS-colonized women, and for women with
unknown status and delivery <37 weeks, amniotic membrane rupture
or intrapartum fewer, was progressively implemented in 10 Barcelona-
area hospitals. The aim of the study is to continue monitoring trends
of early-onset GBS disease in these 10 hospitals, and to assess if the
observed decreases in its incidence has been accompanied by increases
in the incidence of late-onset GBS disease.
Results: From 1994 to 2006, 282.046 live infants were born in our
hospitals. Early-onset GBS disease, deﬁned as the presence of GBS in a
sterile ﬂuid (blood, CSF, etc) within the ﬁrst week of life, was diagnosed
in 219 neonates. During the 12 years of the study the incidence decreased
as follows: 2.25 per 1000 in 1994, 1.88 in 1995, 1.53 in 1996, 1.23 in
1997, 0.66 in 1998, 0.48 in 1999, 0.56 in 2000, 0.39 in 2001, 0.47 in
2002, 0.41 in 2003, 0.24 in 2004, 0.58 in 2005 and 0.23 in 2006 These
rates indicated that over this period of time the incidence decreased
by 83% (RR 0.830; 95%CI 0.799−0.863, P< 0.001). In the year 2006,
incidences in individual hospitals ranged from 0.54 to 0 per 1000.
From 1996 to 2006, 245.672 live infants were born in our hospitals.
Late-onset GBS disease, deﬁned as the presence of GBS in a sterile
ﬂuid (blood, CSF, etc) in infants aged between 8 and 90 days of life,
was diagnosed in 90 cases. During the 10 years of the study the incidence
ﬂuctuated as follows: 0.11 per 1000 in 1996, 0.51 in 1997, 0.36 in 1998,
0.39 in 1999, 0.14 in 2000, 0.22 in 2001, 0.35 in 2002, 0.25 in 2003, 0.60
in 2004, 0.58 in 2005 and 0.42 in 2006 (RR 1.068; 95%CI 0.998−1.143,
P =0.057). Although not signiﬁcant, these rates of incidence suggested
a slightly tendency to increase annually by 6.5%.
Conclusions: The application of prevention measures supposed a
substantial decrease in the incidence of early-onset GBS disease during
the ﬁrsts years and a maintained low rates till now. In contrast, the
incidence of late-onset GBS disease ﬂuctuated over the years, and
although not signiﬁcant, there it seems to be a slightly tendency to
increase, suggesting that intrapartum antibiotics is not effective against
late-onset GBS disease. Continue surveillance of late-onset GBS disease
is needed to monitor the impact of the recommended prophylactic
strategy.
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P2227 Evaluation of a real-time PCR (GeneXperTSystem) for the
diagnosis of intrapartum group B Streptococcus colonisation
S. Molinos, W. Coroleu, M. Gimenez, D. Esteban, M.D. Quesada,
J. Lecumberri, C. Rodrigo (Badalona, ES)
Streptococcus agalactiae (GBS) is the leading cause of neonatal sepsis
and meningitis. Maternal screening for GBS colonisation is critical
for providing an appropriate prophylaxis and avoiding early-onset
neonatal GBS disease. The antenatal screening of pregnant women
from immigrant population is not appropriate in some communities; so
unknown intrapartum colonisation status is increasingly frequent in this
group.
Objectives: To compare prospectively the performance characteristics
of a rapid molecular technique, GeneXpertSystem (Cepheid) versus
conventional culture for intrapartum SGB detection. To describe the
clinical impact of rapid delivery results.
Methods: A vaginal and rectal sample was obtained during labor for
conventional culture and RealTime PCR, during a six month period,
following these criteria: unknown colonisation status or colonisation
status older than 5 weeks before partum. Each swab sample was
processed by culture in selective media. A PBS buffer was used to
recover the sample from the collector. It was centrifuged and 200 mcL
of the suspension were inoculated on the detection cartridge obtaining
the results in 90 minutes. Clinical record for every pregnant woman was
followed up before and after providing GBS colonisation results
Results: Forty-four samples were collected. Overall intrapartum
colonisation rate was 22.7%. Conventional culture was positive in
7 women (15.9%) and RealTime PCR in 10 (22.7%). Antibiotic
prophylaxis was administrated in 8 of 10 women when RealTime PCR
was positive. Only 2 of 34 (5.8%) women with negative result for
RealTime PCR were treated following different clinical criteria but SGB
colonisation.
Conclusions:
1. GeneXpertSystem is more sensitive than conventional culture for
detecting SGB in pregnant women.
2. A negative result for RealTime PCR was conclusive in order to avoid
antibiotic prophylaxis in 94.1% of the negative cases.
3. Use of GeneXpertSystem during labor may lead to a potencial
reduction of neonatal infection screening tests and avoid days of
neonatal sepsis treatment.
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P2228 Improving the quality of care for community-acquired
pneumonia using Web-based support for dissemination,
communication and measurement
P.G. Davey, S. Leonard, A. Patton, C. Bucknall on behalf of the
Scottish National Audit Project on Community Acquired Pnemonia
Objectives: Our objective is to improve management of CAP by deﬁning
and implementing a bundle of essential elements of care that must be
delivered within the ﬁrst few hours after arrival at the hospital.
Methods: This prospective improvement study is part of a Scotland Na-
tional Audit Project funded by the Health Foundation and co-ordinated by
the Royal Colleges of Physicians in Scotland (www.snaproject.org.uk/).
We established a multi-disciplinary Steering Group to develop a care
bundle that identiﬁes critical care processes in the ﬁrst 4 hours after
presentation. Care Bundles focus on clinical actions that are proven
(with high level evidence) to improve outcomes. We are testing bundle
implementation and measures for improvement in six hospitals before
spreading to hospitals in all 15 Health Boards across Scotland. We
are using rapid cycle tests of change and small, repeated measures
to bring about change and measure impact. We have established a
password protected Extranet using the service provided by the Institute
for Healthcare Improvement (www.ihi.org). The Extranet provides easy
access to all of the documentation for the project, aids communication
between teams and allows teams to view their results in the context of
aggregated data from all participating hospitals. The cost of an Extranet
is $6,000 per year and requires 4−5 working days to establish.
Results: All six hospitals have posted measures on the Extranet although
the number contributing measures each month has ranged from three to
six. Overall the results show progressive improvement in individual care
processes (for example from 17% to 65% for CURB65 risk assessment)
and from 4% to 32% for compliance with all bundle elements (92%
oxygenation and antibiotics within 4 h plus identiﬁcation of patients
requiring a high dependency plan and of low risk patients who can be
managed at home. Individual hospitals have used a variety of techniques
to drive these improvements (e.g. email of monthly results to junior
doctors, wall posters, reminders on case records).
Conclusions: An Extranet is a practical solution for web based support
for quality improvement projects. Although steady progress has been
achieved with improvement in the quality of care for CAP the overall
compliance with the full care bundle is currently well below our target
level of 95%. The main barrier that remains to be overcome is sustaining
improvement despite increasingly frequent changes of junior medical
staff.
P2229 PAUSE: Prudent Antibiotic User. A collaborative web-based
forum for sharing experience and learning resources between
providers of education about prudent antibiotic prescribing
P.G. Davey, D.N. Nathwani, I. Gyssens, I. Harding, M. Akova (Dundee,
UK; Nijmegen, NL; Upwell, UK; Ankara, TR)
Aim and objectives: The aim of PAUSE is to ensure that practitioners
will be prudent prescribers of antibiotics and will promote prudent use
of antibiotics in whatever clinical context they are working in. Objectives
are to:
• Construct a framework of learning outcomes that deﬁnes a prudent
prescriber.
• Provide ﬂexible web-based learning resources and assessments that
will enable undergraduate medical students to achieve clearly deﬁned
learning outcomes in prudent prescribing, for their level of expertise.
• Provide an exemplary learning platform in prudent antibiotic
prescribing for the development of other healthcare professionals.
Background: In 2003 the Scottish Executive funded the University of
Dundee and the British Society for Antimicrobial Chemotherapy (BSAC)
to develop a web based learning resource for undergraduate medical
education. The site was launched in February 2005 and has been included
as a core component of the University of Dundee Medical School
curriculum since August 2005. In 2006 BSAC began a further 3 year
development to transfer the resources to a new website (PAUSE) with
improved functionality and extension of the content to meet the needs of
different professional groups. In 2007 ESCMID and the ESCMID Study
Group for Antibiotic Policies (ESGAP) agreed to partner BSAC in the
development of the site.
Results: The PAUSE website was launched in August 2007:
http://www.pause-online.org.uk/ By June 2008 160 medical students at
the University of Dundee will have used the materials. Examples of
feedback from students include: “I learnt more about antibiotics in that
week than I had in the previous two years”; “I really felt that we were
learning practical things that will be used regularly when I am a qualiﬁed
doctor”; “Studying the web-based vignettes was useful as it provided
cases to work through which makes teaching more memorable”; “The
web-based material was excellent. This was a real help and can be used
to refer to at a later date”; “The short cases and patient report gave
structure to the week”. NHS Education Scotland have used resources
from the PAUSE site to develop e-learning and assessment modules in
the Doctors’ Online Training Scheme, a compulsory course for doctors
in the ﬁrst two years after qualiﬁcation in Scotland.
Conclusions: The PAUSE website is an established resource that can be
expanded through development and partnership between BSAC, ESGAP,
ESCMID and its afﬁliated Societies.
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P2230 Integrated international molecular databases in monitoring
the emergence and spread of infection
T.J. Dallman, J. Green, S. Gnaneshan, R. Myers and the DIPNET,
EUROROTA and HepSEQ steering committees
Objectives: Integrated molecular databases associated with Dedicated
(disease speciﬁc) Surveillance Networks (DSNs) can fulﬁl a pivotal
role in tracking the spread of infectious diseases. The Health Protection
Agency hosts a wide range of molecular typing databases as components
of National or International Surveillance Networks. Here we describe
three infectious disease resources from the international DSNs associated
with; diphtheria (DIPNET), rotavirus (EUROROTA) and hepatitis B
(HepSEQ) and identify key elements in successfully establishing and
implementing them.
Methods: On-line, integrated databases were established providing a
central portal for the submission and integration of disparate data types.
These included clinical data (e.g. serology), demographic data (e.g.
country of infection, sex, age), epidemiological data (e.g. transmission
route, outbreaks) and molecular data (e.g. nucleotide and protein
sequences, mutation information). On-line databases allowed the storage
of this data in a robust, highly structured way that can be updated,
accessed and queried from any location in real time. A number of
technical and non-technical issues impact on the success of these
resources. Through the projects described we have analysed and
identiﬁed the key elements impacting on the successful development
of an online resource.
Results: The foundation of integrated online DSNs, as well as facilitating
the amalgamation of disparate data types also requires the development
of computational tools to query and display the data. DIPNET and
HeqSEQ provide the ability for users to determine the genotype of
their isolate through the automated interrogation of ribotype proﬁles and
nucleotide sequences respectively. EUROROTA enables the construction
of graphical representations of integrated epidemiological and molecular
data further underpinned by demographic data.
Conclusions: Global approaches including the establishment of inter-
national laboratory-based surveillance networks are imperative for the
control of emerging and established infectious diseases. A network
of reference microbiological laboratories with similar technological
capabilities and molecular typing methods are required to allow
the coordination of surveillance activities and the standardisation of
methodologies and protocols. Efﬁcient disease surveillance requires the
collection and integration of disparate data types which can then be
utilised to provide enhanced disease surveillance.
P2231 e-meducation.org: an open access medical education web
portal focused on infectious diseases
V. Alexiou, M. Falagas (Athens, GR)
Objective: Internet can serve in opening the door to a brand new world
of high quality medical information. However, the chaotic size of data
available in the WWW is often misleading. We sought to provide the
world medical community with a web portal that may be used as a
clearinghouse providing the outlet for dissemination of high quality
WWW educational products, currently focused on infectious diseases.
Methods: Directories of open access WWW resources have been
compiled and others are being currently under development in the ﬁeld
of infectious diseases. Future development aims to cover most medical
ﬁelds. A custom-built medical search engine was created. Really Simple
Syndication (RSS) feeds and video sharing services were reviewed for
their quality and were presented along with case-based educational
presentations through a user-friendly web portal interface. A directory
of guidelines database is also currently under development.
Results: The educational portal “e-meducation” available at http://
www.e-meducation.org/ has been launched in December 2006 and at
the moment, provides links to more than 1000 educational web-pages,
more than 2100 clinical practice guidelines, 32 news feeds, and 14
educational videos. The web site also hosts 40 case-based presentations
(almost all from the ﬁeld of clinical microbiology/infectious diseases)
and a custom medical search engine. Within a year e-meducation.org
has received more than 142000 visits.
Conclusion: Based on the incorporation of simple and tested educational
strategies such as case based instruction and interactive learning,
e-meducation.org aims to become a prototype platform that offers a
more convenient interface to existing products, resources and medical
contents.
P2232 MicrobLog: an online information resource for those
studying or training in medical microbiology, virology and
infectious diseases
A. Hussain (Leicester, UK)
The World Wide Web (WWW) is an abundant source of learning for
all health professionals. The range of learning tools are widely varied
from free websites to those that are subscription based. The Royal
College of Pathologists (RCPath) in the United Kingdom (UK) issues the
curriculum and sets the examinations for gaining membership. Although
trainees are made aware of online resources, there are very few resources
aimed speciﬁcally at trainees in medical microbiology and virology.
The RCPath is currently undertaking a review of electronic learning
resources.
There is a paucity of readily accessible information speciﬁc to the needs
of a trainee microbiologist in the UK. Whilst there is a very good
resource in the UK for trainee virologists, no such website exists for
microbiologists and infectious disease physicians.
I found that recording anecdotes and my personal experience became
invaluable as a learning tool. In preparation for professional exami-
nations, the experiences of trainees are varied across the country and
an appropriate forum for discussion was not available. The MicrobLog
website (http://microblog.me.uk) was started in May 2006, as a result of
my concerns. The aim of the website is to bring these disciplines together,
primarily with an emphasis on medical microbiology. The forum section
allows trainees to discuss local, national and international training
opportunities as well as speciﬁc areas of research and development.
Since July 2006, we have had 730 692 hits, 25.6% of which were
unique visitors. 37.7% of all hits originated from the USA, with only
4.6% originating from the UK. The commonest searched phrases were
“taurolock”, “acinetobacter” and “ganciclovir”, with the commonest
referrer being www.google.com. Currently the site receives 400 hits per
day, 24.8% of which are unique visitations. The worldwide distribution
of website trafﬁc is shown in Figure 1.
The website usage data has highlighted an interesting point. There are
many North American microbiology e-learning websites, covering both
the practical and the theoretical. These websites contain factual as well
as online assessment tools, but their content is not always relevant to
practicing in the UK. Although medical microbiology and virology is
a small speciality, there is a signiﬁcant need to expand the number
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of internet sites with validated content and assessment tools, to bring
medical microbiology and virology in line with other disciplines.
P2233 www.ccrbtyping.net – a web-based typing tool for
staphylococci
M.D. Santos, C. Milheiric¸o, D.C. Oliveira, S. Vinga, A. Oliveira, H. de
Lencastre, J.A. Carric¸o (Lisbon, Oeiras, PT)
Objectives: ccrB typing, based on the DNA sequencing of an internal
fragment of ccrB, was developed as a potential ﬁrst-line SCCmec typing
strategy for meticillin resistant Staphylococcus aureus, since the ccrB
sequence is part of the ccrAB locus, whose allotypes are used for the
deﬁnition of SCCmec types. Clustering of ccrB sequences has been
shown to properly discriminate between different SCCmec types (I, II,
III, IV and VI) (Oliveira et al, J. Antimicrob Chemother 58:23–30). To
make this approach available to the general public, a web based typing
tool interface was developed so that users can submit ccrB sequences
and obtain an automatic assignment to a ccrB allele and presumptive
SCCmec type classiﬁcation.
Methods: The website serves as a front-end for a database and user
management system, coupled with two sequence alignment programmes
(MUSCLE and Clustal) and an alignment and tree viewer software
(Jalview). For each SCCmec type, a set of known sequences are deﬁned
as a prototypes. The user submitted ccrB sequences are then, after an
automatic trimming, compared by multiple sequence alignment with the
deﬁned prototypes, and the most similar prototype deﬁnes the ccrB allele,
allowing the inference of ccrAB allotype and SCCmec type.
Results: The website (www.ccrbtyping.net) is being used since late
October 2007. At the website launch date the database had 98 ccrB
sequences, including 17 prototype sequences, with references and with
other important isolate information. All the public information can be
easily extracted to csv format and an online tutorial explains the users
how to work with the web tool. The data can be saved privately or it can
be submitted to the public database after being reviewed by a system
curator.
Conclusion:Web-based applications have proved to be the best approach
for the comparison of sequence based typing methodologies results.
Anyone with internet connection can contribute with their data to the
public database and help to validate and improve the typing methodology.
The implemented website has demonstrated its usefulness for ccrB typing
giving good results for several staphylococci species, allowing for an
expanding database of curated ccrB sequences. Additionally the web
based typing tool interface was implemented to be rapidly conﬁgurable,
and can be used as a framework for other sequence based typing methods
based either on direct sequence similarity or on the comparison of
repeated patterns.
P2234 Development of a web-based learning tool to enhance
healthcare workers′ knowledge, attitude, and risk perception
about safe work practices concerning meticillin-resistant
Staphylococcus aureus
F. Verhoeven, J.E.W.C. van Gemert-Pijnen, M.G.R. Hendrix,
A.W. Friedrich, I. Daniels-Haardt for the Euregio MRSA-net
Twente/Mu¨nsterland
Objectives: To develop a web-based learning tool based on the available
national Meticillin Resistant Staphylococcus aureus (MRSA) policy,
to enhance healthcare workers’ (HCWs) knowledge, attitude, and risk
perception concerning safe work practices.
Methods: A validated questionnaire and scenario-based tests were used
to determine HCWs’ key questions about safe work practices regarding
MRSA. Next, the questions were categorised into groups by the Card
Sort Method and analysed by WebSort software in order to provide a
user-centred search structure for the web-based learning tool. The study
was conducted among physicians, nurses, and domestic staff in four
hospitals in Germany and the Netherlands.
Results: The results of 276 questionnaires showed inadequate levels
of knowledge (97% of respondents) and risk perception (24%) about
safe work practices, and negative attitudes (63%) toward complying with
these practices. The 28 additional interviews demonstrated that lack of
knowledge is mainly related to being uninformed about transmission
routes of MRSA (14%), resulting in an inadequate perception of the
personal risk to obtain and transmit MRSA (10%). A negative attitude
is caused by HCWs questioning the usefulness of adhering to safe work
practices (14%). These factors lead to non-compliance with safe work
practices. HCWs seem to favour a more personal and social approach
of safe work practice documents, stressing personal risks and the
rationale behind applying the practices. In sum, 167 key questions were
found about which the knowledge, the attitudes or the risk perceptions
were unsatisfactory. The web-based learning tool should address these
questions. The Card Sort Method (n = 10) resulted in ten categories in
which the key questions can be grouped. HCWs are best served with
a web-based system in which they can actively search these questions
in their own language both via a search engine and a table of contents
representing HCWs’ terminology and information needs.
Conclusions: Our study indicated that the mixed-methods design
provides a powerful approach to analyse HCWs’ key questions
concerning safe work practices, and provides us with a search structure
for a user-centred web-based learning tool. HCWs’ involvement in the
development of the tool might encourage compliance with safe work
practices, which remains subject for further investigation.
P2235 National software system for microbiology laboratory
management in Bulgaria: "Clinical Microbiology and
Nosocomial Infections"
M.M. Petrov, B. Kojuharov, T. Velinov, T. Kantardjiev (Soﬁa, BG)
Expedient software systems in clinical microbiology laboratories
constitute very useful and effective component in laboratory and hospital
management. Susceptibility test results of dozens of thousands of
laboratories around the world are stored in paper or in computer
ﬁles, which makes them inaccessible for analysis and comparison. The
“Clinical Microbiology and Nosocomial Infections” (CMNI) programme
provides a software through which data from each laboratory are entered
into a common code and ﬁle format for the corresponding laboratory.
These data could be shared with another laboratory working on CMNI
programme for further collaboration, and utilised, through the main
server, based in the National Center of Infectious and Parasitic Diseases,
Soﬁa, Bulgaria, for a national data analysis and implementation of
various control measures.
CMNI programme is web-based database software in Bulgarian language
for the management of microbiology laboratory results and global
surveillance of bacterial resistance to antimicrobial agents and control
of nosocomial infections. Signiﬁcant parts of HELICS protocols are
implemented in the programme and CMNI software is also compatible
to, and capable to interface with other Laboratory Information Systems –
LIS (e.g. WHONET), the Antibiotic Consumption Calculator (ABC
Calc), and other statistical packages and programmes.
The CMNI programme comprises the following three principal
components:
• Laboratory conﬁguration;
• Data entry;
• Data analysis
The analysis of the information facilitates:
1. The studying and understanding of trends of resistance;
2. The detection of epidemics and nosocomial infections;
3. The differentiation of epidemic from endemic infections;
4. The tracking and evaluation of ﬁnancial expenditures in the
laboratory;
5. The assessment of various risk factors;
6. The monitoring of antibiotic consumption;
7. The development of national antibiotic policy.
The ongoing equipment with LIS “CMNI” is a key component
of the local and national surveillance of antimicrobial resistance,
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antibiotic consumption and nosocomial infections’ control in Bulgaria.
Bulgarian Surveillance Tracking of Antimicrobial Resistance (BulSTAR)
along with the National Laboratory Management System for clinical
microbiology in Bulgaria “Clinical Microbiology and Nosocomial
Infections” constitute the basic components of the Bulgarian national
strategy, aimed at antimicrobial resistance control and prevention and
prudent use of antimicrobial agents.
P2236 Modern information technologies in physicians’ education
in the ﬁeld of socially most important diseases in Russia
and beyond
O. Stetsiouk, Y. Belkova, V. Kostin (Smolensk, RU)
Objectives: Traditional forms of post-graduate education do not
completely meet needs of professional development of physicians.
It is especially evident in countries with large territories and high
prevalence of socially most important diseases (SMID). Therefore
distance education (DE) is of a priority setting and perspective form
of improving physicians’ professional level. The aim is to summarize
experience in development of distance education (DE) on antimicrobial
therapy (AT) of SMID in Russia and beyond as a possible way of post-
graduate education for healthcare professionals in such important topic.
Methods: The educational course "AT of socially most important
diseases" was implemented in Internet centre of DE on the basis of the
web-site "Antibiotics and Antimicrobial Therapy" (www.antibiotic.ru)
founded under the auspices of the Institute of Antimicrobial Chemother-
apy (IAC), the Department of Clinical Pharmacology of Smolensk State
Medical Academy with the support of the United States Pharmacopeia
(USP) and the United States Agency for International Development
(USAID).
Results: The course "AT of socially most important diseases" consists
of 14 speciﬁc topics covering diagnostics, treatment and prophylaxis
of HIV-infection, tuberculosis, chronic viral hepatitis and STDs. Every
topic comes complete with educational materials and on-line tests. Upon
completion of each topic "students" are offered control tests to enable
tutors evaluation of their level of knowledge. The ﬁnal exam is held in
the presence of tutors and includes testing and interview. After passing
ﬁnal exam "students" are awarded the ofﬁcial certiﬁcates.
Since 2004, more then 200 physicians from 26 Russian regions, Belarus,
Kazakhstan, Kyrgyzstan, Lithuania and Ukraine have been trained in
SMID.
IAC provides the support to satellite DE centres in training of their
tutor staff and developing a system for independent work. Currently
11 regional DE centres in Ekaterinburg, Novosibirsk, Penza, Samara,
Vladivostok (2 centres), Minsk, Vitebsk (Belarus), Dnepropetrovsk
(Ukraine), Osh (Kyrgyzstan) are working.
Conclusions: 1) DE via Internet is upcoming form of physicians’
education in SMID. 2) Advantages make DE convenient, effective and
demanded. 3) DE extension with regional centres is promising for further
development.
P2237 What is the impact of a Tuberculosis National Knowledge
Week?
F. Hansraj, A. Roy, G. Jawaheer, P. Kostkova, J. Freed, M. Catchpole,
S. Wiseman (London, UK)
Objectives: National Knowledge Weeks (NKWs) highlight the best
current evidence, enabling busy healthcare professionals to quickly and
easily ﬁnd relevant and reliable information. Our aim was to evaluate the
impact of an NKW on the dissemination of tuberculosis (TB) resources.
Methods: The National electronic Library of Infection (NeLI)
www.neli.org.uk collaborated with the Health Protection Agency
www.hpa.org.uk to host a Tuberculosis National Knowledge Week http://
www.neli.org.uk/IntegratedCRD.nsf/TBNKW?OpenForm from 26th to
30th March 2007, which was timed to link in with World TB day on
24th March.
NeLI is of the Specialist Libraries of the National Library for Health
www.library.nhs.uk. It is a single-entry portal to evidence-based medical
knowledge around infection, providing access to the best available
evidence on prevention, treatment, investigation and control, with
resources that are quality appraised by healthcare professionals. This
makes it ideal to disseminate new TB resources.
This NKW comprised of a comprehensive collection of recent, peer-
reviewed publications on TB. In addition, experts in the ﬁelds of TB
epidemiology, management and treatment provided short reﬂections. A
ﬂyer to promote the TB NKW and the corresponding resources hosted
on NeLI was sent to 512 NHS libraries across England and these were
displayed before and during the NKW.
Results and Conclusions: Web server logs were used to analyse the
impact of this NKW, taking into account the number of page views
received, the popularity of the page, the geographical location of the
incoming trafﬁc, the means of accessing the page and the outgoing trafﬁc
from the page. The impact of this NKW on overall NeLI trafﬁc was also
analysed.
Analyses found that prior to, during, and a week after the NKW, the
NKW page was the 3rd most frequently visited on NeLI (3.31%). Figure
1 shows the geographical distribution of users of the page during the TB
NKW.
The impact of the NKW on overall NeLI trafﬁc was also signiﬁcant;
there was an increase in the number of page views to NeLI in the two
weeks prior to the NKW, which reached a peak during the NKW itself.
However, merely hosting the NKW page could not account for this rise
in page views. Therefore, it is likely that the ﬂyers distributed prior to
the event also had an inﬂuence.
P2238 “DelioCode”: a freeware programme for comparing
oligonucleotidic sequences by veriﬁcation codes
S. Preziuso, A. Camporeale, V. Cuteri (Matelica, Milan, IT)
PCR is a very diffused technique to amplify nucleic sequences by means
of speciﬁc primers, that are continuously developed and published on
international journals. Sometimes transcription mistakes can occur and
erroneous primer sequences can be published, resulting in unexpected
results if experiments are replicated. Although primers are relatively
short, a rapid system for checking the correctness of the transcribed
sequences could mitigate this problem. Veriﬁcation codes are already
used in other disciplines to guarantee the correctness of codiﬁed
information. In this work an algorithm has been deﬁned and the related
software tool developed to ﬁll this gap.
A generic algorithm based on the ASCII coding of characters and their
position within the sequence has been deﬁned to generate a speciﬁc
code on the basis of the sequence composition. Conﬁguration parameters
such as amount of characters and coding syntax have been left open
for modiﬁcation and personalisation. Microsoft Visual Studio 2005 has
been used to compile “DelioCode” (Descriptive Literal Oligonucleotides
Code), a Windows application featuring the algorithm and available on
the web for download. The default algorithm has been used to verify the
correctness of several sequences by testing casual primers with induced
mistakes and primers published sequentially by different authors.
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All induced mistakes were detected by comparing the veriﬁcation codes.
On the basis of DelioCode, some typos have been found in primers
sequences published in peer reviewed journals, and PCR repetition with
these wrong primer sequences did not result in DNA ampliﬁcation.
The DelioCode programme is a tool for rapidly generating a unique
code on the basis of a speciﬁc sequence. The shortness of the performed
veriﬁcation codes allows a rapid comparison among the sequences to
ﬁnd the common mistakes. This is useful every time researchers need
to check the correctness of speciﬁc sequences, such as when sequences
are transcribed from published articles or when oligonucleotidic primers
are orderable by compilation of on-line forms.
The diffusion of the veriﬁcation codes generated by the programme
would avoid typing mistakes in the transcription and would allow to
save time in old-fashioned manual double-checking. The generation of
speciﬁc codes for every primer could be evaluated to create a freeware
“veriﬁed primer sequences bank”, where scientists could ﬁnd rapidly
speciﬁc primers already tested and published.
P2239 10 years of the Aspergillus Website (www.aspergillus.org.uk)
G. Atherton, J. Bartholomew, P. Giles, D.W. Denning (Manchester, UK)
Objectives: Information on Aspergillus and aspergillosis has been widely
distributed and often difﬁcult to access. The Aspergillus website launched
in 1998 with the primary objective of providing an easily accessible
encyclopaedic resource on all Aspergilli, their biology, genomics and
diseases that they cause.
Methods: The evolution and expansion of the website over its ﬁrst 10
years of operation were reviewed, including site statistics.
Results: The website was aimed at the professional reader and offered
help and advice on medical and scientiﬁc issues relating to Aspergillus.
Quality of information is paramount.
Content covered a range of topics including diagnosis and treatment for
medical readers. As Aspergillus genomics grew, so the section expanded.
Sections on veterinary and air quality were added. Historical articles and
summaries were important additions. The library of articles has grown
to provide 1232 pdf’s. More recently sections providing educational
materials (slides & video) and complete case histories have been added.
Content speciﬁcally for research scientists includes a research directory,
laboratory protocols and genomics pages, species (n = 847 names) and
secondary metabolite (n = 354) databases and numerous links. There is a
catalogue with links to all mycology societies. Upcoming conferences are
organised by date with links and we hold over 6000 full abstracts from
many past conferences, and many downloadable full colour posters. More
recently sections on secondary metabolites and species names have been
added, expanded and integrated. A distinctive feature are the hundreds
of images made available for non-proﬁt and commercial use.
The Aspergillus website newsfeeds were initiated 18 months ago and
currently provide 20,000 feeds per month.
On the 10th anniversary of the website, we have >35,000 registered
members, a patient support group of >500 highly active members and
Figure 1. Aspergillus Website Statistics 2003 – 2007
we provide 3 million website pages a year. >25,000 distinct users access
the website each month – ~850 different people per day (Figure 1). 1800
websites link to the Aspergillus website.
Conclusions: The Aspergillus website is a premier resource for those
interested in aspergillosis and the Aspergilli.
P2240 Aspergillus for Patients (www.aspergillus.org.uk/patients)
G. Atherton, J. Bartholomew, P. Giles, D. Denning (Manchester, UK)
Objectives: Information and support on Aspergillus illnesses is difﬁcult
to obtain for patients and carers. The Aspergillus for Patients section of
the Aspergillus website was intended to make information on Aspergillus
and Aspergillosis easy to access and understand for the layperson.
Methods: A short history review of the current Aspergillus for Patients
website, including site statistics.
Results: We set up the ﬁrst Aspergillus support group as a simple
mailing list to coordinate questions and answers from patients but
the group rapidly outgrew that arrangement and we moved it to a
fully featured webpage/email discussion group in January 2003. The
Aspergillus Support group (www.yahoo.co.uk/AspergillusSupport/) now
has 527 members and still growing steadily.
A lot of information was requested repeatedly so a small website (The
Patients website) was set up to provide consistent answers to the common
questions. These pages remain one of the most popular sections of the
Aspergillus website though some of its functions have been taken over
by the Aspergillus Trust’s website (www.aspergillustrust.org) with which
it remains closely allied – the combined viewing ﬁgures are 25,000 page
requests per month.
The Aspergillus Trust charity arose directly from the Yahoo Support
group and is governed by some members of that group in close
collaboration with the Aspergillus website.
The Patients website collected information direct from patients to try
to get a better idea of the range of illnesses people were seeking
information on. 1,232 patients ﬁlled out the form over the next year or
two and the information gathered broke down to the following numbers;
Invasive aspergillosis – 249, CPA – 142, Aspergilloma – 134, ABPA –
359, Allergies – 317, Sinusitis – 355, SBS (Sick building syndrome) –
167, Other – 292. Substantial numbers of rare illnesses e.g. ABPA
and aspergilloma are represented well in this group, indicating we are
reaching our target audience effectively.
Conclusions: The Support groups and Aspergillus for Patients website
section is a major resource for information for the layperson on these
illnesses.
P2241 Publication rate of Turkish infectious diseases and clinical
microbiology and microbiology and clinical microbiology
specialisation theses and microbiology doctorate theses, in
international peer-review journals
O. Sipahi, H. Pullukcu, M. Tasbakan, D. Koseli, D. Caglayan,
T. Yamazhan, B. Arda, S. Ulusoy (Izmir, TR)
Objectives: To investigate the publication rate of Turkish infectious
diseases and clinical microbiology (ID&CM), microbiology and clinical
microbiology (M&CM) specialisation theses and microbiology doctorate
theses in international peer-review journals.
Methods: On 17 August 2007 the thesis database of the Council of
Higher Education of the Republic of Turkey where all specialisation and
doctorate theses are recorded obligatorily, was searched for ID&CM and
M&CM specialisation theses and microbiology doctorate theses. The
publication rate of these theses was found out by searching Science
Citation Index-Expanded database for thesis author and mentor between
17 August–12 September 2007. For statistical comparisons Chi-square
test was used and a p value less than 0.05 was considered as signiﬁcant.
Results: Our search yielded a total of 834 theses (268 ID&CM
speialisation theses, 312 M&CM specialisation theses, 254 doctorate
theses). It was found that the overall publication rate was 11.2% (94/834).
The rates for doctorate, ID&CM and M&CM specialisation theses
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was 13.3% (34/254), 10.0% (27/268), 10.5% (33/312), respectively
(p> 0.005). The publication rate of 2002–2007 theses was 9.3%, whereas
1997–2001 theses was 13.1% (p = 0.08). It was determined that nine of
the 94 published theses were theses of 1997–2001 period and 85 of
2002–2007 period.
Conclusion: Despite an increase in 2002–2007 period (Probably due to
updated criteria of the Council of Higher Education of the Republic
of Turkey for academic promotion in 2000), publication rate of
the investigated theses in international peer-review journals is very
inadequate. Thesis is an important part of specialisation and doctorate
education and necessitates intense work. The created knowledge usually
contain important data about the country and the world. Publication of
the theses supply dissemination of new knowledge and completes the
process of scientiﬁc study. Solutions must be generated to promote the
publication of specialisation and doctorate theses.
P2242 Designing online, educational games about microbes, hand
and respiratory hygiene and prudent antibiotics use for
junior pupils across Europe
D. Farrell, P. Kostkova, D.M. Lecky, C.A.M. McNulty, N. Lai,
S. Beveridge on behalf of the e-Bug Working Group
Objectives: e-Bug is a European-wide, EC funded, antibiotic and
hygiene teaching resource. It reinforces an awareness of microbes,
hygiene and prudent antibiotics use. Our objective is to create web-based
games for school pupils in 17 European countries that complement the
e-Bug educational pack. The pack and games fulﬁll and extend school
curricula. As games will be available for use during school and pupils’
own time, they cannot require that the player has been taught the subject.
They also need to be enjoyable enough for pupils to play by choice.
Methods: To teach appropriate placement of food in a fridge, we
designed a sorting game where the player competes against a clock to
store shopping. Other outcomes were taught through the metaphor of
being shrunken inside the human body in the style of a platform game,
such as Super Mario Brothers, where the player interacts with good and
bad microbes and medicine.
Design Evaluation and Results: Prior to learning outcomes being agreed,
game ideas were discussed in a series of focus groups with 10 school
teachers in the UK.Unlike many ‘edutainment’ games which are themed
appropriately but which separate playing from teaching, we designed
the e-Bug games to use ‘stealth learning’ techniques where the games
incorporate learning outcomes into their core design in a fashion that
allows pupils to be taught realistic science through the act of playing.
Evaluation questionnaires were given to children and used to decide
which artistic look was appropriate.A workshop was carried out with
teachers and partners from each of our partner countries where we
discussed potential approaches to the games and deﬁned our learning
outcomes. At this stage, ideas were discarded that would not appeal
to junior pupils or reinforce e-Bug’s messages. Designs based around
the ﬁnal learning outcomes were iteratively circulated to teachers and
updated based on their feedback.
Conclusions: Early versions of the games will be playable in January
2008. These will be focus-tested with pupils in the UK and updated
prior to an initial launch in February. The pack is being evaluated from
January through December 2008 in a total of 45 junior schools in France,
the Czech Republic and the UK.We will draw from these schools to
evaluate the effectiveness and usability of the website and games. Web
log analysis and observational studies will be conducted in the UK,
Czech Republic and France to determine knowledge gained, usability
and level of enjoyment by pupils.
